Citrus Sinensis ID: 038766
Local Sequence Feature Prediction
| Prediction and (Method) | Result |
|---|
|
|
Close Homologs for Annotation Transfer
Close Homologs in SWISS-PROT Database Detected by BLAST 
Original result of BLAST against SWISS-PROT Database
| ID | Alignment graph | Length |
Definition |
RBH(Q2H) |
RBH(H2Q) |
Q cover |
H cover |
Identity |
E-value |
| Query | 299 | 2.2.26 [Sep-21-2011] | |||||||
| Q9FL28 | 1173 | LRR receptor-like serine/ | yes | no | 0.979 | 0.249 | 0.597 | 2e-98 | |
| C0LGQ5 | 1249 | LRR receptor-like serine/ | no | no | 0.929 | 0.222 | 0.397 | 4e-45 | |
| Q3EDL4 | 472 | Probable serine/threonine | no | no | 0.919 | 0.582 | 0.360 | 1e-44 | |
| O49545 | 1003 | Leucine-rich repeat recep | no | no | 0.933 | 0.278 | 0.377 | 1e-44 | |
| Q9SHI2 | 1101 | Leucine-rich repeat recep | no | no | 0.943 | 0.256 | 0.367 | 2e-44 | |
| O49318 | 1124 | Probable leucine-rich rep | no | no | 0.949 | 0.252 | 0.356 | 3e-43 | |
| Q9FIZ3 | 1252 | LRR receptor-like serine/ | no | no | 0.923 | 0.220 | 0.387 | 4e-43 | |
| Q9M2Z1 | 1002 | Leucine-rich repeat recep | no | no | 0.933 | 0.278 | 0.364 | 7e-43 | |
| O49564 | 642 | Cysteine-rich receptor-li | no | no | 0.933 | 0.434 | 0.350 | 8e-43 | |
| Q9CAL8 | 710 | Proline-rich receptor-lik | no | no | 0.923 | 0.388 | 0.363 | 2e-42 |
| >sp|Q9FL28|FLS2_ARATH LRR receptor-like serine/threonine-protein kinase FLS2 OS=Arabidopsis thaliana GN=FLS2 PE=1 SV=1 | Back alignment and function desciption |
|---|
Score = 358 bits (919), Expect = 2e-98, Method: Compositional matrix adjust.
Identities = 178/298 (59%), Positives = 229/298 (76%), Gaps = 5/298 (1%)
Query: 1 RFDRTEIENATGSFSENNIIGNSNLSTVYKGRLEDGEIVAVKKLNFHQFSAESDKSFYRE 60
RF+ E+E AT SF+ NIIG+S+LSTVYKG+LEDG ++AVK LN +FSAESDK FY E
Sbjct: 857 RFEPKELEQATDSFNSANIIGSSSLSTVYKGQLEDGTVIAVKVLNLKEFSAESDKWFYTE 916
Query: 61 AKTLKELKHRNLVKVLGYAWESGKLKALILEYMENGSLESVIHGPGVDHSRWTLPKRIDV 120
AKTL +LKHRNLVK+LG+AWESGK KAL+L +MENG+LE IHG +L ++ID+
Sbjct: 917 AKTLSQLKHRNLVKILGFAWESGKTKALVLPFMENGNLEDTIHGSAAPIG--SLLEKIDL 974
Query: 121 LISVANGLDYLHSGYDIPIVHCDMKPSNILLDRDFEAHVSDFGTSRMLDVHLQDLSSLST 180
+ +A+G+DYLHSGY PIVHCD+KP+NILLD D AHVSDFGT+R+L ++ ST
Sbjct: 975 CVHIASGIDYLHSGYGFPIVHCDLKPANILLDSDRVAHVSDFGTARILGFREDGSTTAST 1034
Query: 181 -AFQGTIGYLAPEFAYMRIVTTKVDVFSFGIVVMEFLTKRRPTGLDEENGLSPISLRQLV 239
AF+GTIGYLAPEFAYMR VTTK DVFSFGI++ME +TK+RPT L++E+ ++LRQLV
Sbjct: 1035 SAFEGTIGYLAPEFAYMRKVTTKADVFSFGIIMMELMTKQRPTSLNDEDS-QDMTLRQLV 1093
Query: 240 EKALANGINGVRQITDPKLVSSIYEEQEQHQVLEELFKLALVCTSSNPEDRPNMNELL 297
EK++ NG G+ ++ D +L SI +Q + +E+ KL L CTSS PEDRP+MNE+L
Sbjct: 1094 EKSIGNGRKGMVRVLDMELGDSIV-SLKQEEAIEDFLKLCLFCTSSRPEDRPDMNEIL 1150
|
Constitutes the pattern-recognition receptor (PPR) that determines the specific perception of flagellin (flg22), a potent elicitor of the defense response to pathogen-associated molecular patterns (PAMPs). Flagellin-binding to the receptor is the first step to initiate the innate immune MAP kinase signaling cascade (MEKK1, MKK4/MKK5 and MPK3/MPK6), resulting in enhanced resistance against pathogens. Binding to the effector AvrPto1 from Pseudomonas syringae blocks the downstream plant immune response. Arabidopsis thaliana (taxid: 3702) EC: 2EC: .EC: 7EC: .EC: 1EC: 1EC: .EC: 1 |
| >sp|C0LGQ5|GSO1_ARATH LRR receptor-like serine/threonine-protein kinase GSO1 OS=Arabidopsis thaliana GN=GSO1 PE=2 SV=1 | Back alignment and function description |
|---|
Score = 181 bits (460), Expect = 4e-45, Method: Compositional matrix adjust.
Identities = 116/292 (39%), Positives = 174/292 (59%), Gaps = 14/292 (4%)
Query: 6 EIENATGSFSENNIIGNSNLSTVYKGRLEDGEIVAVKKLNFHQFSAESDKSFYREAKTLK 65
+I AT + SE +IG+ VYK LE+GE VAVKK+ + S+KSF RE KTL
Sbjct: 943 DIMEATHNLSEEFMIGSGGSGKVYKAELENGETVAVKKI-LWKDDLMSNKSFSREVKTLG 1001
Query: 66 ELKHRNLVKVLGY-AWESGKLKALILEYMENGSLESVIH--GPGVDHSRWTL--PKRIDV 120
++HR+LVK++GY + +S L LI EYM+NGS+ +H P ++ + L R+ +
Sbjct: 1002 RIRHRHLVKLMGYCSSKSEGLNLLIYEYMKNGSIWDWLHEDKPVLEKKKKLLDWEARLRI 1061
Query: 121 LISVANGLDYLHSGYDIPIVHCDMKPSNILLDRDFEAHVSDFGTSRMLDVHLQDLSSLST 180
+ +A G++YLH PIVH D+K SN+LLD + EAH+ DFG +++L + + +T
Sbjct: 1062 AVGLAQGVEYLHHDCVPPIVHRDIKSSNVLLDSNMEAHLGDFGLAKVLTENCDTNTDSNT 1121
Query: 181 AFQGTIGYLAPEFAYMRIVTTKVDVFSFGIVVMEFLTKRRPTGLDEENGLSPISLRQLVE 240
F + GY+APE+AY T K DV+S GIV+ME +T + PT D G + + + + VE
Sbjct: 1122 WFACSYGYIAPEYAYSLKATEKSDVYSMGIVLMEIVTGKMPT--DSVFG-AEMDMVRWVE 1178
Query: 241 KALANGINGVRQITDPKLVSSI-YEEQEQHQVLEELFKLALVCTSSNPEDRP 291
L + ++ DPKL + +EE QVLE +AL CT ++P++RP
Sbjct: 1179 THLEVAGSARDKLIDPKLKPLLPFEEDAACQVLE----IALQCTKTSPQERP 1226
|
Together with GSO2, receptor-like serine/threonine-kinase required during the development of the epidermal surface in embryos and cotyledons. Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|Q3EDL4|Y1154_ARATH Probable serine/threonine-protein kinase At1g01540 OS=Arabidopsis thaliana GN=At1g01540 PE=1 SV=2 | Back alignment and function description |
|---|
Score = 180 bits (457), Expect = 1e-44, Method: Compositional matrix adjust.
Identities = 106/294 (36%), Positives = 164/294 (55%), Gaps = 19/294 (6%)
Query: 6 EIENATGSFSENNIIGNSNLSTVYKGRLEDGEIVAVKKLNFHQFSAESDKSFYREAKTLK 65
E+E AT E N+IG VY+G L DG VAVK L ++ AE K F E + +
Sbjct: 146 ELEAATNGLCEENVIGEGGYGIVYRGILTDGTKVAVKNLLNNRGQAE--KEFKVEVEVIG 203
Query: 66 ELKHRNLVKVLGYAWESGKLKALILEYMENGSLESVIHGPGVDHSRWTLPKRIDVLISVA 125
++H+NLV++LGY E G + L+ ++++NG+LE IHG D S T R+++++ +A
Sbjct: 204 RVRHKNLVRLLGYCVE-GAYRMLVYDFVDNGNLEQWIHGDVGDVSPLTWDIRMNIILGMA 262
Query: 126 NGLDYLHSGYDIPIVHCDMKPSNILLDRDFEAHVSDFGTSRMLDVHLQDLSSLSTAFQGT 185
GL YLH G + +VH D+K SNILLDR + A VSDFG +++L + S ++T GT
Sbjct: 263 KGLAYLHEGLEPKVVHRDIKSSNILLDRQWNAKVSDFGLAKLLG---SESSYVTTRVMGT 319
Query: 186 IGYLAPEFAYMRIVTTKVDVFSFGIVVMEFLTKRRPTGLDEENGLSPIS--LRQLVEKAL 243
GY+APE+A ++ K D++SFGI++ME +T R P G + + L+ +V
Sbjct: 320 FGYVAPEYACTGMLNEKSDIYSFGILIMEIITGRNPVDYSRPQGETNLVDWLKSMV---- 375
Query: 244 ANGINGVRQITDPKLVSSIYEEQEQHQVLEELFKLALVCTSSNPEDRPNMNELL 297
G ++ DPK+ E + L+ + +AL C + RP M ++
Sbjct: 376 --GNRRSEEVVDPKI-----PEPPSSKALKRVLLVALRCVDPDANKRPKMGHII 422
|
Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|O49545|BAME1_ARATH Leucine-rich repeat receptor-like serine/threonine-protein kinase BAM1 OS=Arabidopsis thaliana GN=BAM1 PE=1 SV=1 | Back alignment and function description |
|---|
Score = 180 bits (456), Expect = 1e-44, Method: Compositional matrix adjust.
Identities = 113/299 (37%), Positives = 167/299 (55%), Gaps = 20/299 (6%)
Query: 1 RFDRTEIENATGSFSENNIIGNSNLSTVYKGRLEDGEIVAVKKLNFHQFSAESDKSFYRE 60
R D T ++ S E+NIIG VYKG + +G++VAVK+L + D F E
Sbjct: 682 RLDFT-CDDVLDSLKEDNIIGKGGAGIVYKGVMPNGDLVAVKRLAAMSRGSSHDHGFNAE 740
Query: 61 AKTLKELKHRNLVKVLGYAWESGKLKALILEYMENGSLESVIHGPGVDHSRWTLPKRIDV 120
+TL ++HR++V++LG+ + + L+ EYM NGSL V+HG H W R +
Sbjct: 741 IQTLGRIRHRHIVRLLGFC-SNHETNLLVYEYMPNGSLGEVLHGKKGGHLHWD--TRYKI 797
Query: 121 LISVANGLDYLHSGYDIPIVHCDMKPSNILLDRDFEAHVSDFGTSRMLDVHLQD--LSSL 178
+ A GL YLH IVH D+K +NILLD +FEAHV+DFG ++ LQD S
Sbjct: 798 ALEAAKGLCYLHHDCSPLIVHRDVKSNNILLDSNFEAHVADFGLAKF----LQDSGTSEC 853
Query: 179 STAFQGTIGYLAPEFAYMRIVTTKVDVFSFGIVVMEFLTKRRPTGLDEENGLSPISLRQL 238
+A G+ GY+APE+AY V K DV+SFG+V++E +T R+P G E G + + Q
Sbjct: 854 MSAIAGSYGYIAPEYAYTLKVDEKSDVYSFGVVLLELVTGRKPVG---EFG-DGVDIVQW 909
Query: 239 VEKALANGINGVRQITDPKLVSSIYEEQEQHQVLEELFKLALVCTSSNPEDRPNMNELL 297
V K + + V ++ DP+L SSI + H +F +A++C +RP M E++
Sbjct: 910 VRKMTDSNKDSVLKVLDPRL-SSIPIHEVTH-----VFYVAMLCVEEQAVERPTMREVV 962
|
Necessary for male gametophyte development, as well as ovule specification and function. Involved in cell-cell communication process required during early anther development, and regulating cell division and differentiation to organize cell layers. Required for the development of high-ordered vascular strands within the leaf and a correlated control of leaf shape, size and symmetry. May regulate the CLV1-dependent CLV3-mediated signaling in meristems maintenance. Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|Q9SHI2|Y1723_ARATH Leucine-rich repeat receptor-like serine/threonine-protein kinase At1g17230 OS=Arabidopsis thaliana GN=At1g17230 PE=2 SV=2 | Back alignment and function description |
|---|
Score = 179 bits (455), Expect = 2e-44, Method: Compositional matrix adjust.
Identities = 109/297 (36%), Positives = 169/297 (56%), Gaps = 15/297 (5%)
Query: 2 FDRTEIENATGSFSENNIIGNSNLSTVYKGRLEDGEIVAVKKLNFHQFSAESDKSFYREA 61
F + +AT +FSE+ ++G TVYK + GE++AVKKLN A SD SF E
Sbjct: 787 FTYQGLVDATRNFSEDVVLGRGACGTVYKAEMSGGEVIAVKKLNSRGEGASSDNSFRAEI 846
Query: 62 KTLKELKHRNLVKVLGYAWESGKLKALILEYMENGSL-ESVIHGPGVDHSRWTLPKRIDV 120
TL +++HRN+VK+ G+ + L+ EYM GSL E + G W R +
Sbjct: 847 STLGKIRHRNIVKLYGFCYHQNS-NLLLYEYMSKGSLGEQLQRGEKNCLLDWN--ARYRI 903
Query: 121 LISVANGLDYLHSGYDIPIVHCDMKPSNILLDRDFEAHVSDFGTSRMLDVHLQDLSSLST 180
+ A GL YLH IVH D+K +NILLD F+AHV DFG ++++D+ S +
Sbjct: 904 ALGAAEGLCYLHHDCRPQIVHRDIKSNNILLDERFQAHVGDFGLAKLIDL---SYSKSMS 960
Query: 181 AFQGTIGYLAPEFAYMRIVTTKVDVFSFGIVVMEFLTKRRPTGLDEENGLSPISLRQLVE 240
A G+ GY+APE+AY VT K D++SFG+V++E +T + P E+ G L V
Sbjct: 961 AVAGSYGYIAPEYAYTMKVTEKCDIYSFGVVLLELITGKPPVQPLEQGG----DLVNWVR 1016
Query: 241 KALANGINGVRQITDPKLVSSIYEEQEQHQVLEELFKLALVCTSSNPEDRPNMNELL 297
+++ N I + ++ D +L ++ +++ H+ + + K+AL CTS++P RP M E++
Sbjct: 1017 RSIRNMIPTI-EMFDARLDTN--DKRTVHE-MSLVLKIALFCTSNSPASRPTMREVV 1069
|
Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|O49318|Y2317_ARATH Probable leucine-rich repeat receptor-like protein kinase At2g33170 OS=Arabidopsis thaliana GN=At2g33170 PE=2 SV=1 | Back alignment and function description |
|---|
Score = 175 bits (444), Expect = 3e-43, Method: Compositional matrix adjust.
Identities = 109/306 (35%), Positives = 172/306 (56%), Gaps = 22/306 (7%)
Query: 1 RFDRTEIENATGSFSENNIIGNSNLSTVYKGRLEDGEIVAVKKLNFHQFSAESDKS---- 56
RF +I AT F ++ I+G TVYK + G+ +AVKKL ++ ++ +
Sbjct: 806 RFTVKDILEATKGFHDSYIVGRGACGTVYKAVMPSGKTIAVKKLESNREGNNNNSNNTDN 865
Query: 57 -FYREAKTLKELKHRNLVKVLGYAWESGKLKALIL-EYMENGSLESVIHGPGVDHSR-WT 113
F E TL +++HRN+V++ + + G L+L EYM GSL ++HG G HS W
Sbjct: 866 SFRAEILTLGKIRHRNIVRLYSFCYHQGSNSNLLLYEYMSRGSLGELLHG-GKSHSMDW- 923
Query: 114 LPKRIDVLISVANGLDYLHSGYDIPIVHCDMKPSNILLDRDFEAHVSDFGTSRMLDVHLQ 173
P R + + A GL YLH I+H D+K +NIL+D +FEAHV DFG ++++D+
Sbjct: 924 -PTRFAIALGAAEGLAYLHHDCKPRIIHRDIKSNNILIDENFEAHVGDFGLAKVIDM--- 979
Query: 174 DLSSLSTAFQGTIGYLAPEFAYMRIVTTKVDVFSFGIVVMEFLTKRRPTGLDEENG-LSP 232
LS +A G+ GY+APE+AY VT K D++SFG+V++E LT + P E+ G L+
Sbjct: 980 PLSKSVSAVAGSYGYIAPEYAYTMKVTEKCDIYSFGVVLLELLTGKAPVQPLEQGGDLAT 1039
Query: 233 ISLRQLVEKALANGINGVRQITDPKLVSSIYEEQEQHQVLEELFKLALVCTSSNPEDRPN 292
+ + + +L + +I DP L + H + + K+A++CT S+P DRP
Sbjct: 1040 WTRNHIRDHSLTS------EILDPYLTKVEDDVILNHMI--TVTKIAVLCTKSSPSDRPT 1091
Query: 293 MNELLI 298
M E+++
Sbjct: 1092 MREVVL 1097
|
Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|Q9FIZ3|GSO2_ARATH LRR receptor-like serine/threonine-protein kinase GSO2 OS=Arabidopsis thaliana GN=GSO2 PE=2 SV=2 | Back alignment and function description |
|---|
Score = 175 bits (443), Expect = 4e-43, Method: Compositional matrix adjust.
Identities = 114/294 (38%), Positives = 169/294 (57%), Gaps = 18/294 (6%)
Query: 6 EIENATGSFSENNIIGNSNLSTVYKGRLEDGEIVAVKKLNFHQFSAESDKSFYREAKTLK 65
+I AT +E +IG+ VYK L++GE +AVKK+ + S+KSF RE KTL
Sbjct: 940 DIMEATHYLNEEFMIGSGGSGKVYKAELKNGETIAVKKI-LWKDDLMSNKSFNREVKTLG 998
Query: 66 ELKHRNLVKVLGY-AWESGKLKALILEYMENGSLESVIHGPGVDHSRWTL--PKRIDVLI 122
++HR+LVK++GY + ++ L LI EYM NGS+ +H + L R+ + +
Sbjct: 999 TIRHRHLVKLMGYCSSKADGLNLLIYEYMANGSVWDWLHANENTKKKEVLGWETRLKIAL 1058
Query: 123 SVANGLDYLHSGYDIPIVHCDMKPSNILLDRDFEAHVSDFGTSRMLDVHLQDLSSLSTAF 182
+A G++YLH PIVH D+K SN+LLD + EAH+ DFG +++L + + +T F
Sbjct: 1059 GLAQGVEYLHYDCVPPIVHRDIKSSNVLLDSNIEAHLGDFGLAKILTGNYDTNTESNTMF 1118
Query: 183 QGTIGYLAPEFAYMRIVTTKVDVFSFGIVVMEFLTKRRPTG--LDEENGLSPISLRQLVE 240
G+ GY+APE+AY T K DV+S GIV+ME +T + PT DEE + + VE
Sbjct: 1119 AGSYGYIAPEYAYSLKATEKSDVYSMGIVLMEIVTGKMPTEAMFDEE-----TDMVRWVE 1173
Query: 241 KALAN--GINGVRQITDPKLVSSI-YEEQEQHQVLEELFKLALVCTSSNPEDRP 291
L G ++ D +L S + EE+ +QVLE +AL CT S P++RP
Sbjct: 1174 TVLDTPPGSEAREKLIDSELKSLLPCEEEAAYQVLE----IALQCTKSYPQERP 1223
|
Together with GSO1, receptor-like serine/threonine-kinase required during the development of the epidermal surface in embryos and cotyledons. Involved in the nuclear division phase of megagametogenesis. Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|Q9M2Z1|BAME2_ARATH Leucine-rich repeat receptor-like serine/threonine-protein kinase BAM2 OS=Arabidopsis thaliana GN=BAM2 PE=1 SV=1 | Back alignment and function description |
|---|
Score = 174 bits (441), Expect = 7e-43, Method: Compositional matrix adjust.
Identities = 109/299 (36%), Positives = 162/299 (54%), Gaps = 20/299 (6%)
Query: 1 RFDRTEIENATGSFSENNIIGNSNLSTVYKGRLEDGEIVAVKKLNFHQFSAESDKSFYRE 60
R D T ++ S E+NIIG VYKG + G++VAVK+L + D F E
Sbjct: 678 RLDFT-CDDVLDSLKEDNIIGKGGAGIVYKGTMPKGDLVAVKRLATMSHGSSHDHGFNAE 736
Query: 61 AKTLKELKHRNLVKVLGYAWESGKLKALILEYMENGSLESVIHGPGVDHSRWTLPKRIDV 120
+TL ++HR++V++LG+ + + L+ EYM NGSL V+HG H W R +
Sbjct: 737 IQTLGRIRHRHIVRLLGFC-SNHETNLLVYEYMPNGSLGEVLHGKKGGHLHWN--TRYKI 793
Query: 121 LISVANGLDYLHSGYDIPIVHCDMKPSNILLDRDFEAHVSDFGTSRMLDVHLQD--LSSL 178
+ A GL YLH IVH D+K +NILLD +FEAHV+DFG ++ LQD S
Sbjct: 794 ALEAAKGLCYLHHDCSPLIVHRDVKSNNILLDSNFEAHVADFGLAKF----LQDSGTSEC 849
Query: 179 STAFQGTIGYLAPEFAYMRIVTTKVDVFSFGIVVMEFLTKRRPTGLDEENGLSPISLRQL 238
+A G+ GY+APE+AY V K DV+SFG+V++E +T ++P G E G + + Q
Sbjct: 850 MSAIAGSYGYIAPEYAYTLKVDEKSDVYSFGVVLLELITGKKPVG---EFG-DGVDIVQW 905
Query: 239 VEKALANGINGVRQITDPKLVSSIYEEQEQHQVLEELFKLALVCTSSNPEDRPNMNELL 297
V + + V ++ D +L S E + +F +AL+C +RP M E++
Sbjct: 906 VRSMTDSNKDCVLKVIDLRLSSVPVHE------VTHVFYVALLCVEEQAVERPTMREVV 958
|
Necessary for male gametophyte development, as well as ovule specification and function. Involved in cell-cell communication process required during early anther development, and regulating cell division and differentiation to organize cell layers. Required for the development of high-ordered vascular strands within the leaf and a correlated control of leaf shape, size and symmetry. May regulate the CLV1-dependent CLV3-mediated signaling in meristems maintenance. Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|O49564|CRK27_ARATH Cysteine-rich receptor-like protein kinase 27 OS=Arabidopsis thaliana GN=CRK27 PE=3 SV=2 | Back alignment and function description |
|---|
Score = 174 bits (441), Expect = 8e-43, Method: Compositional matrix adjust.
Identities = 104/297 (35%), Positives = 163/297 (54%), Gaps = 18/297 (6%)
Query: 2 FDRTEIENATGSFSENNIIGNSNLSTVYKGRLEDGEIVAVKKLNFHQFSAESDKSFYREA 61
FD I AT FS N IG VYKG L DG +AVK+L+ H S + + F E
Sbjct: 321 FDFETIRVATDDFSLTNKIGEGGFGVVYKGHLPDGLEIAVKRLSIH--SGQGNAEFKTEV 378
Query: 62 KTLKELKHRNLVKVLGYAWESGKLKALILEYMENGSLESVIHGPGVDHSRWTLPKRIDVL 121
+ +L+H+NLVK+ G++ + + + L+ E++ N SL+ + P + + KR +++
Sbjct: 379 LLMTKLQHKNLVKLFGFSIKESE-RLLVYEFIPNTSLDRFLFDP-IKQKQLDWEKRYNII 436
Query: 122 ISVANGLDYLHSGYDIPIVHCDMKPSNILLDRDFEAHVSDFGTSRMLDVHLQDLSSLSTA 181
+ V+ GL YLH G + PI+H D+K SN+LLD +SDFG +R D + +++
Sbjct: 437 VGVSRGLLYLHEGSEFPIIHRDLKSSNVLLDEQMLPKISDFGMARQFD--FDNTQAVTRR 494
Query: 182 FQGTIGYLAPEFAYMRIVTTKVDVFSFGIVVMEFLTKRRPTGLDEENGLSPISLRQLVEK 241
GT GY+APE+A + K DV+SFG++V+E +T +R +GL G L
Sbjct: 495 VVGTYGYMAPEYAMHGRFSVKTDVYSFGVLVLEIITGKRNSGLGLGEG------TDLPTF 548
Query: 242 ALANGINGVR-QITDPKLVSSIYEEQEQHQVLEELFKLALVCTSSNPEDRPNMNELL 297
A N I G ++ DP L+ + ++++E Q LE +AL C NP RP M+ ++
Sbjct: 549 AWQNWIEGTSMELIDPVLLQT-HDKKESMQCLE----IALSCVQENPTKRPTMDSVV 600
|
Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: - |
| >sp|Q9CAL8|PEK13_ARATH Proline-rich receptor-like protein kinase PERK13 OS=Arabidopsis thaliana GN=PERK13 PE=2 SV=1 | Back alignment and function description |
|---|
Score = 173 bits (438), Expect = 2e-42, Method: Compositional matrix adjust.
Identities = 110/303 (36%), Positives = 168/303 (55%), Gaps = 27/303 (8%)
Query: 2 FDRTEIENATGSFSENNIIGNSNLSTVYKGRLEDGEIVAVKKLNFHQFSAESDKSFYREA 61
F E+ + T FS++NI+G VYKG+L DG++VAVK+L S + D+ F E
Sbjct: 341 FTYEELTDITEGFSKHNILGEGGFGCVYKGKLNDGKLVAVKQLKVG--SGQGDREFKAEV 398
Query: 62 KTLKELKHRNLVKVLGYAWESGKLKALILEYMENGSLESVIHGPGVDHSRWTLPKRIDVL 121
+ + + HR+LV ++GY + + LI EY+ N +LE +HG G W +R+ +
Sbjct: 399 EIISRVHHRHLVSLVGYCIADSE-RLLIYEYVPNQTLEHHLHGKGRPVLEWA--RRVRIA 455
Query: 122 ISVANGLDYLHSGYDIPIVHCDMKPSNILLDRDFEAHVSDFGTSRMLDVHLQDLSSLSTA 181
I A GL YLH I+H D+K +NILLD +FEA V+DFG +++ D + +ST
Sbjct: 456 IGSAKGLAYLHEDCHPKIIHRDIKSANILLDDEFEAQVADFGLAKLND---STQTHVSTR 512
Query: 182 FQGTIGYLAPEFAYMRIVTTKVDVFSFGIVVMEFLTKRRPTGLDEENGLSPISL----RQ 237
GT GYLAPE+A +T + DVFSFG+V++E +T R+P +D+ L SL R
Sbjct: 513 VMGTFGYLAPEYAQSGKLTDRSDVFSFGVVLLELITGRKP--VDQYQPLGEESLVEWARP 570
Query: 238 LVEKALANGINGVRQITDPKLVSSIYEEQEQHQVLEELFKL---ALVCTSSNPEDRPNMN 294
L+ KA+ G ++ D +L E+H V E+F++ A C + RP M
Sbjct: 571 LLHKAIETGD--FSELVDRRL--------EKHYVENEVFRMIETAAACVRHSGPKRPRMV 620
Query: 295 ELL 297
+++
Sbjct: 621 QVV 623
|
Regulates negatively root hairs elongation. Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
Close Homologs in the Non-Redundant Database Detected by BLAST
Original result of BLAST against Nonredundant Database
| GI | Alignment Graph | Length |
Definition |
Q cover |
H cover |
Identity |
E-value |
| Query | 299 | ||||||
| 224078972 | 1158 | predicted protein [Populus trichocarpa] | 0.979 | 0.253 | 0.705 | 1e-121 | |
| 255557385 | 994 | leucine-rich repeat transmembrane protei | 0.979 | 0.294 | 0.702 | 1e-120 | |
| 359483612 | 1146 | PREDICTED: LRR receptor-like serine/thre | 0.983 | 0.256 | 0.688 | 1e-113 | |
| 147857736 | 1146 | hypothetical protein VITISV_031289 [Viti | 0.983 | 0.256 | 0.688 | 1e-113 | |
| 356510778 | 1163 | PREDICTED: LRR receptor-like serine/thre | 0.983 | 0.252 | 0.665 | 1e-113 | |
| 356528114 | 1165 | PREDICTED: LRR receptor-like serine/thre | 0.983 | 0.252 | 0.655 | 1e-112 | |
| 355346202 | 1157 | flagellin-sensing 2-like protein [Lotus | 0.986 | 0.254 | 0.652 | 1e-110 | |
| 355346200 | 1157 | flagellin-sensing 2-like protein [Lotus | 0.986 | 0.254 | 0.652 | 1e-110 | |
| 449434266 | 1156 | PREDICTED: LRR receptor-like serine/thre | 0.979 | 0.253 | 0.612 | 1e-100 | |
| 297794625 | 1175 | flagellin-sensitive 2 [Arabidopsis lyrat | 0.979 | 0.249 | 0.597 | 2e-97 |
| >gi|224078972|ref|XP_002305701.1| predicted protein [Populus trichocarpa] gi|222848665|gb|EEE86212.1| predicted protein [Populus trichocarpa] | Back alignment and taxonomy information |
|---|
Score = 440 bits (1132), Expect = e-121, Method: Compositional matrix adjust.
Identities = 211/299 (70%), Positives = 254/299 (84%), Gaps = 6/299 (2%)
Query: 1 RFDRTEIENATGSFSENNIIGNSNLSTVYKGRLEDGEIVAVKKLNFHQFSAESDKSFYRE 60
R+DR EIENAT FSE NIIG S+LSTVYKG+LEDG+ +AVK+LNF +FSAESDK FYRE
Sbjct: 855 RYDRNEIENATSFFSEENIIGASSLSTVYKGQLEDGKTIAVKQLNFQKFSAESDKCFYRE 914
Query: 61 AKTLKELKHRNLVKVLGYAWESGKLKALILEYMENGSLESVIHGPGVDHSRWTLPKRIDV 120
KTL +L+HRNLVKVLGYAWES KLK L+LEYM+NGSLES+IH P VD S WTL +RI+V
Sbjct: 915 IKTLSQLRHRNLVKVLGYAWESAKLKVLVLEYMQNGSLESIIHNPQVDQSWWTLYERINV 974
Query: 121 LISVANGLDYLHSGYDIPIVHCDMKPSNILLDRDFEAHVSDFGTSRMLDVHLQDLSSLS- 179
+S+A+ L+YLHSGYD PIVHCD+KPSN+LLD D+ AHVSDFGT+R+L VHLQD +SLS
Sbjct: 975 CVSIASALEYLHSGYDFPIVHCDLKPSNVLLDGDWVAHVSDFGTARILGVHLQDGNSLSS 1034
Query: 180 -TAFQGTIGYLAPEFAYMRIVTTKVDVFSFGIVVMEFLTKRRPTGLDEENGLSPISLRQL 238
+AF+GTIGY+APEFAYMR VTTKVDVFSFGIVVME L KRRPTGL +++GL PISLRQL
Sbjct: 1035 ASAFEGTIGYMAPEFAYMRRVTTKVDVFSFGIVVMEVLMKRRPTGLTDKDGL-PISLRQL 1093
Query: 239 VEKALANGINGVRQITDPKLVSSIYEEQEQHQVLEELFKLALVCTSSNPEDRPNMNELL 297
VE+ALANGI+G+ Q+ DP + ++ E+E LE+LF++A CT+ NPEDRPNMNE+L
Sbjct: 1094 VERALANGIDGLLQVLDPVITKNLTNEEE---ALEQLFQIAFSCTNPNPEDRPNMNEVL 1149
|
Source: Populus trichocarpa Species: Populus trichocarpa Genus: Populus Family: Salicaceae Order: Malpighiales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|255557385|ref|XP_002519723.1| leucine-rich repeat transmembrane protein kinase, putative [Ricinus communis] gi|223541140|gb|EEF42696.1| leucine-rich repeat transmembrane protein kinase, putative [Ricinus communis] | Back alignment and taxonomy information |
|---|
Score = 437 bits (1125), Expect = e-120, Method: Compositional matrix adjust.
Identities = 210/299 (70%), Positives = 251/299 (83%), Gaps = 6/299 (2%)
Query: 1 RFDRTEIENATGSFSENNIIGNSNLSTVYKGRLEDGEIVAVKKLNFHQFSAESDKSFYRE 60
RF+ E+E AT FSE+NIIG+S+LSTVYKG+LEDG++V VKKLN QF AESDK FYRE
Sbjct: 685 RFEPMELEKATNLFSEDNIIGSSSLSTVYKGQLEDGQVVVVKKLNLQQFPAESDKCFYRE 744
Query: 61 AKTLKELKHRNLVKVLGYAWESGKLKALILEYMENGSLESVIHGPGVDHSRWTLPKRIDV 120
KTL +L+HRNLVKV+GY+WES KLKAL+LEYM+NGSL+++IH P VD SRWTL +RIDV
Sbjct: 745 VKTLSQLRHRNLVKVIGYSWESAKLKALVLEYMQNGSLDNIIHDPHVDQSRWTLFERIDV 804
Query: 121 LISVANGLDYLHSGYDIPIVHCDMKPSNILLDRDFEAHVSDFGTSRMLDVHLQDLSSLS- 179
IS+A+GLDY+HSGYD PIVHCD+KPSNILLD ++ AHVSDFGT+R+L VHLQD S LS
Sbjct: 805 CISIASGLDYMHSGYDFPIVHCDLKPSNILLDSNWVAHVSDFGTARILGVHLQDASILSS 864
Query: 180 -TAFQGTIGYLAPEFAYMRIVTTKVDVFSFGIVVMEFLTKRRPTGLDEENGLSPISLRQL 238
+AFQGTIGYLAPEFAYMR VTTKVDVFSFGI+VMEFLTK+RPTG+ EE G PISL QL
Sbjct: 865 ISAFQGTIGYLAPEFAYMRNVTTKVDVFSFGILVMEFLTKQRPTGITEEEG-RPISLSQL 923
Query: 239 VEKALANGINGVRQITDPKLVSSIYEEQEQHQVLEELFKLALVCTSSNPEDRPNMNELL 297
+EKAL NG G+ Q+ DP + ++ +E+E L ELFKLAL CT+ NP+DRPNMNE+L
Sbjct: 924 IEKALCNGTGGLLQVLDPVIAKNVSKEEE---TLIELFKLALFCTNPNPDDRPNMNEVL 979
|
Source: Ricinus communis Species: Ricinus communis Genus: Ricinus Family: Euphorbiaceae Order: Malpighiales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|359483612|ref|XP_002272319.2| PREDICTED: LRR receptor-like serine/threonine-protein kinase FLS2-like [Vitis vinifera] | Back alignment and taxonomy information |
|---|
Score = 415 bits (1066), Expect = e-113, Method: Compositional matrix adjust.
Identities = 206/299 (68%), Positives = 245/299 (81%), Gaps = 5/299 (1%)
Query: 1 RFDRTEIENATGSFSENNIIGNSNLSTVYKGRLEDGEIVAVKKLNFHQFSAESDKSFYRE 60
RF++ ++E ATG FS N+IG S LSTVYKGR +DG+IVAVKKLN QFSAE+DK F RE
Sbjct: 833 RFNQKDLEIATGFFSAENVIGASTLSTVYKGRTDDGKIVAVKKLNLQQFSAEADKCFNRE 892
Query: 61 AKTLKELKHRNLVKVLGYAWESGKLKALILEYMENGSLESVIHGPGVDHSRWTLPKRIDV 120
KTL L+HRNLVKVLGYAWESGK+KAL+LEYME G+L+S+IH PGVD SRWTL +RI+V
Sbjct: 893 VKTLSRLRHRNLVKVLGYAWESGKIKALVLEYMEKGNLDSIIHEPGVDPSRWTLLERINV 952
Query: 121 LISVANGLDYLHSGYDIPIVHCDMKPSNILLDRDFEAHVSDFGTSRMLDVHLQD--LSSL 178
IS+A GL YLHSGYD PIVHCD+KPSN+LLD D EAHVSDFGT+R+L VHLQD S
Sbjct: 953 CISIARGLVYLHSGYDFPIVHCDLKPSNVLLDGDLEAHVSDFGTARVLGVHLQDGSSVSS 1012
Query: 179 STAFQGTIGYLAPEFAYMRIVTTKVDVFSFGIVVMEFLTKRRPTGLDEENGLSPISLRQL 238
S+AF+GTIGYLAPEFAYMR +TTKVDVFSFGI+VMEFLTKRRPTGL E+GL P++LRQL
Sbjct: 1013 SSAFEGTIGYLAPEFAYMRELTTKVDVFSFGIIVMEFLTKRRPTGLAAEDGL-PLTLRQL 1071
Query: 239 VEKALANGINGVRQITDPKLVSSIYEEQEQHQVLEELFKLALVCTSSNPEDRPNMNELL 297
V+ ALA+G + QI DP L S + ++ +VLE+L KLAL CT + P DRP+MNE+L
Sbjct: 1072 VDAALASGSERLLQIMDPFLASIV--TAKEGEVLEKLLKLALSCTCTEPGDRPDMNEVL 1128
|
Source: Vitis vinifera Species: Vitis vinifera Genus: Vitis Family: Vitaceae Order: Vitales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|147857736|emb|CAN78669.1| hypothetical protein VITISV_031289 [Vitis vinifera] | Back alignment and taxonomy information |
|---|
Score = 415 bits (1066), Expect = e-113, Method: Compositional matrix adjust.
Identities = 206/299 (68%), Positives = 245/299 (81%), Gaps = 5/299 (1%)
Query: 1 RFDRTEIENATGSFSENNIIGNSNLSTVYKGRLEDGEIVAVKKLNFHQFSAESDKSFYRE 60
RF++ ++E ATG FS N+IG S LSTVYKGR +DG+IVAVKKLN QFSAE+DK F RE
Sbjct: 833 RFNQKDLEIATGFFSAENVIGASTLSTVYKGRTDDGKIVAVKKLNLQQFSAEADKCFNRE 892
Query: 61 AKTLKELKHRNLVKVLGYAWESGKLKALILEYMENGSLESVIHGPGVDHSRWTLPKRIDV 120
KTL L+HRNLVKVLGYAWESGK+KAL+LEYME G+L+S+IH PGVD SRWTL +RI+V
Sbjct: 893 VKTLSRLRHRNLVKVLGYAWESGKIKALVLEYMEKGNLDSIIHEPGVDPSRWTLLERINV 952
Query: 121 LISVANGLDYLHSGYDIPIVHCDMKPSNILLDRDFEAHVSDFGTSRMLDVHLQD--LSSL 178
IS+A GL YLHSGYD PIVHCD+KPSN+LLD D EAHVSDFGT+R+L VHLQD S
Sbjct: 953 CISIARGLVYLHSGYDFPIVHCDLKPSNVLLDGDLEAHVSDFGTARVLGVHLQDGSSVSS 1012
Query: 179 STAFQGTIGYLAPEFAYMRIVTTKVDVFSFGIVVMEFLTKRRPTGLDEENGLSPISLRQL 238
S+AF+GTIGYLAPEFAYMR +TTKVDVFSFGI+VMEFLTKRRPTGL E+GL P++LRQL
Sbjct: 1013 SSAFEGTIGYLAPEFAYMRELTTKVDVFSFGIIVMEFLTKRRPTGLAAEDGL-PLTLRQL 1071
Query: 239 VEKALANGINGVRQITDPKLVSSIYEEQEQHQVLEELFKLALVCTSSNPEDRPNMNELL 297
V+ ALA+G + QI DP L S + ++ +VLE+L KLAL CT + P DRP+MNE+L
Sbjct: 1072 VDAALASGSERLLQIMDPFLASIV--TAKEGEVLEKLLKLALSCTCTEPGDRPDMNEVL 1128
|
Source: Vitis vinifera Species: Vitis vinifera Genus: Vitis Family: Vitaceae Order: Vitales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|356510778|ref|XP_003524111.1| PREDICTED: LRR receptor-like serine/threonine-protein kinase FLS2-like [Glycine max] | Back alignment and taxonomy information |
|---|
Score = 413 bits (1062), Expect = e-113, Method: Compositional matrix adjust.
Identities = 201/302 (66%), Positives = 247/302 (81%), Gaps = 8/302 (2%)
Query: 1 RFDRTEIENATGSFSENNIIGNSNLSTVYKGRLEDGEIVAVKKLNFHQFSAESDKSFYRE 60
RF+ E+E ATG FS ++IIG S+LSTVYKG++EDG +VA+K+LN QFSA++DK F RE
Sbjct: 853 RFNPNELEIATGFFSADSIIGASSLSTVYKGQMEDGRVVAIKRLNLQQFSAKTDKIFKRE 912
Query: 61 AKTLKELKHRNLVKVLGYAWESGKLKALILEYMENGSLESVIHGPGVDH---SRWTLPKR 117
A TL +++HRNLVKVLGYAWESGK+KAL+LEYMENG+LE++IHG GVD SRWTL +R
Sbjct: 913 ANTLSQMRHRNLVKVLGYAWESGKMKALVLEYMENGNLENIIHGKGVDQSVISRWTLSER 972
Query: 118 IDVLISVANGLDYLHSGYDIPIVHCDMKPSNILLDRDFEAHVSDFGTSRMLDVHLQDLSS 177
+ V IS+A+ LDYLHSGYD PIVHCD+KPSNILLDR++EAHVSDFGT+R+L +H Q S+
Sbjct: 973 VRVFISIASALDYLHSGYDFPIVHCDIKPSNILLDREWEAHVSDFGTARILGLHEQAGST 1032
Query: 178 LST--AFQGTIGYLAPEFAYMRIVTTKVDVFSFGIVVMEFLTKRRPTGLDEENGLSPISL 235
LS+ A QGT+GY+APEFAYMR VTTK DVFSFGI+VMEFLTKRRPTGL EE GL PI+L
Sbjct: 1033 LSSSAALQGTVGYMAPEFAYMRKVTTKADVFSFGIIVMEFLTKRRPTGLSEEEGL-PITL 1091
Query: 236 RQLVEKALANGINGVRQITDPKLVSSIYEEQEQHQVLEELFKLALVCTSSNPEDRPNMNE 295
R++V KALANGI I DP L ++ +E + +VL ELFKL+L CT +PE RPN NE
Sbjct: 1092 REVVAKALANGIEQFVNIVDPLLTWNVTKEHD--EVLAELFKLSLCCTLPDPEHRPNTNE 1149
Query: 296 LL 297
+L
Sbjct: 1150 VL 1151
|
Source: Glycine max Species: Glycine max Genus: Glycine Family: Fabaceae Order: Fabales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|356528114|ref|XP_003532650.1| PREDICTED: LRR receptor-like serine/threonine-protein kinase FLS2-like [Glycine max] | Back alignment and taxonomy information |
|---|
Score = 410 bits (1054), Expect = e-112, Method: Compositional matrix adjust.
Identities = 198/302 (65%), Positives = 248/302 (82%), Gaps = 8/302 (2%)
Query: 1 RFDRTEIENATGSFSENNIIGNSNLSTVYKGRLEDGEIVAVKKLNFHQFSAESDKSFYRE 60
RF+ E+E ATG FS ++IIG+S+LSTVYKG++EDG++VA+K+LN QFSA +DK F RE
Sbjct: 855 RFNPKELEIATGFFSADSIIGSSSLSTVYKGQMEDGQVVAIKRLNLQQFSANTDKIFKRE 914
Query: 61 AKTLKELKHRNLVKVLGYAWESGKLKALILEYMENGSLESVIHGPGVDH---SRWTLPKR 117
A TL +++HRNLVKVLGYAWESGK+KAL+LEYMENG+L+S+IHG GVD SRWTL +R
Sbjct: 915 ANTLSQMRHRNLVKVLGYAWESGKMKALVLEYMENGNLDSIIHGKGVDQSVTSRWTLSER 974
Query: 118 IDVLISVANGLDYLHSGYDIPIVHCDMKPSNILLDRDFEAHVSDFGTSRMLDVHLQDLSS 177
+ V IS+A+ LDYLHSGYD PIVHCD+KPSNILLDR++EAHVSDFGT+R+L +H Q S+
Sbjct: 975 VRVFISIASALDYLHSGYDFPIVHCDLKPSNILLDREWEAHVSDFGTARILGLHEQAGST 1034
Query: 178 LST--AFQGTIGYLAPEFAYMRIVTTKVDVFSFGIVVMEFLTKRRPTGLDEENGLSPISL 235
LS+ A QGT+GY+APEFAYMR VTT+ DVFSFGI+VMEFLTKRRPTGL EE+GL PI+L
Sbjct: 1035 LSSSAALQGTVGYMAPEFAYMRKVTTEADVFSFGIIVMEFLTKRRPTGLSEEDGL-PITL 1093
Query: 236 RQLVEKALANGINGVRQITDPKLVSSIYEEQEQHQVLEELFKLALVCTSSNPEDRPNMNE 295
++V KALANGI + I DP L ++ + + +VL ELFKL+L CT +PE RPN NE
Sbjct: 1094 HEVVTKALANGIEQLVDIVDPLLTWNVTKNHD--EVLAELFKLSLCCTLPDPEHRPNTNE 1151
Query: 296 LL 297
+L
Sbjct: 1152 VL 1153
|
Source: Glycine max Species: Glycine max Genus: Glycine Family: Fabaceae Order: Fabales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|355346202|gb|AER60532.1| flagellin-sensing 2-like protein [Lotus japonicus] | Back alignment and taxonomy information |
|---|
Score = 405 bits (1041), Expect = e-110, Method: Compositional matrix adjust.
Identities = 195/299 (65%), Positives = 239/299 (79%), Gaps = 4/299 (1%)
Query: 1 RFDRTEIENATGSFSENNIIGNSNLSTVYKGRLEDGEIVAVKKLNFHQFSAESDKSFYRE 60
RF E ENATG FS NIIG S+LSTVYKG+ EDG VA+K+LN H F+A++DK F RE
Sbjct: 851 RFKPEEFENATGFFSPANIIGASSLSTVYKGQFEDGHTVAIKRLNLHHFAADTDKIFKRE 910
Query: 61 AKTLKELKHRNLVKVLGYAWESGKLKALILEYMENGSLESVIHGPGVDHSRWTLPKRIDV 120
A TL +L+HRNLVKV+GYAWESGK+KAL LEYMENG+L+S+IH VD SRWTL +R+ V
Sbjct: 911 ASTLSQLRHRNLVKVVGYAWESGKMKALALEYMENGNLDSIIHDKEVDQSRWTLSERLRV 970
Query: 121 LISVANGLDYLHSGYDIPIVHCDMKPSNILLDRDFEAHVSDFGTSRMLDVHLQDLSSLST 180
IS+ANGL+YLHSGY PIVHCD+KPSN+LLD D+EAHVSDFGT+R+L +HLQ+ S+LS+
Sbjct: 971 FISIANGLEYLHSGYGTPIVHCDLKPSNVLLDTDWEAHVSDFGTARILGLHLQEGSTLSS 1030
Query: 181 --AFQGTIGYLAPEFAYMRIVTTKVDVFSFGIVVMEFLTKRRPTGLDEENGLSPISLRQL 238
A QGT+GYLAPEFAY+R VTTK DVFSFGI+VMEFLT+RRPTGL EE+ PI+LR++
Sbjct: 1031 TAALQGTVGYLAPEFAYIRKVTTKADVFSFGIIVMEFLTRRRPTGLSEEDDGLPITLREV 1090
Query: 239 VEKALANGINGVRQITDPKLVSSIYEEQEQHQVLEELFKLALVCTSSNPEDRPNMNELL 297
V +ALANG + I DP L ++ E +VL EL KL+L+CT +PE RPNMNE+L
Sbjct: 1091 VARALANGTEQLVNIVDPMLTCNVTEYHV--EVLTELIKLSLLCTLPDPESRPNMNEVL 1147
|
Source: Lotus japonicus Species: Lotus japonicus Genus: Lotus Family: Fabaceae Order: Fabales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|355346200|gb|AER60531.1| flagellin-sensing 2-like protein [Lotus japonicus] | Back alignment and taxonomy information |
|---|
Score = 405 bits (1041), Expect = e-110, Method: Compositional matrix adjust.
Identities = 195/299 (65%), Positives = 239/299 (79%), Gaps = 4/299 (1%)
Query: 1 RFDRTEIENATGSFSENNIIGNSNLSTVYKGRLEDGEIVAVKKLNFHQFSAESDKSFYRE 60
RF E ENATG FS NIIG S+LSTVYKG+ EDG VA+K+LN H F+A++DK F RE
Sbjct: 851 RFKPEEFENATGFFSPANIIGASSLSTVYKGQFEDGHTVAIKRLNLHHFAADTDKIFKRE 910
Query: 61 AKTLKELKHRNLVKVLGYAWESGKLKALILEYMENGSLESVIHGPGVDHSRWTLPKRIDV 120
A TL +L+HRNLVKV+GYAWESGK+KAL LEYMENG+L+S+IH VD SRWTL +R+ V
Sbjct: 911 ASTLSQLRHRNLVKVVGYAWESGKMKALALEYMENGNLDSIIHDKEVDQSRWTLSERLRV 970
Query: 121 LISVANGLDYLHSGYDIPIVHCDMKPSNILLDRDFEAHVSDFGTSRMLDVHLQDLSSLST 180
IS+ANGL+YLHSGY PIVHCD+KPSN+LLD D+EAHVSDFGT+R+L +HLQ+ S+LS+
Sbjct: 971 FISIANGLEYLHSGYGTPIVHCDLKPSNVLLDTDWEAHVSDFGTARILGLHLQEGSTLSS 1030
Query: 181 --AFQGTIGYLAPEFAYMRIVTTKVDVFSFGIVVMEFLTKRRPTGLDEENGLSPISLRQL 238
A QGT+GYLAPEFAY+R VTTK DVFSFGI+VMEFLT+RRPTGL EE+ PI+LR++
Sbjct: 1031 TAALQGTVGYLAPEFAYIRKVTTKADVFSFGIIVMEFLTRRRPTGLSEEDDGLPITLREV 1090
Query: 239 VEKALANGINGVRQITDPKLVSSIYEEQEQHQVLEELFKLALVCTSSNPEDRPNMNELL 297
V +ALANG + I DP L ++ E +VL EL KL+L+CT +PE RPNMNE+L
Sbjct: 1091 VARALANGTEQLVNIVDPMLTCNVTEYHV--EVLTELIKLSLLCTLPDPESRPNMNEVL 1147
|
Source: Lotus japonicus Species: Lotus japonicus Genus: Lotus Family: Fabaceae Order: Fabales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|449434266|ref|XP_004134917.1| PREDICTED: LRR receptor-like serine/threonine-protein kinase FLS2-like [Cucumis sativus] | Back alignment and taxonomy information |
|---|
Score = 372 bits (954), Expect = e-100, Method: Compositional matrix adjust.
Identities = 183/299 (61%), Positives = 233/299 (77%), Gaps = 6/299 (2%)
Query: 1 RFDRTEIENATGSFSENNIIGNSNLSTVYKGRLEDGEIVAVKKLNFHQFSAESDKSFYRE 60
RFD+ +E T F+ NI+G+S LSTVYKG+L++G++VAVK+LN F+AESD F RE
Sbjct: 851 RFDKKGMEITTEYFANKNILGSSTLSTVYKGQLDNGQVVAVKRLNLQYFAAESDDYFNRE 910
Query: 61 AKTLKELKHRNLVKVLGYAWESGKLKALILEYMENGSLESVIHGPGVDHSRWTLPKRIDV 120
K L +L+HRNLVKVLGYAWES KLKA++LEYMENG+L+ +IH G D L KR+D+
Sbjct: 911 IKILCQLRHRNLVKVLGYAWESQKLKAIVLEYMENGNLDRIIHNSGTDQISCPLSKRVDI 970
Query: 121 LISVANGLDYLHSGYDIPIVHCDMKPSNILLDRDFEAHVSDFGTSRMLDVHLQDLSSLST 180
+S+A+G+ YLH GYD PI+HCD+KPSNILLD D+ AHVSDFGT+R+L V Q S++S+
Sbjct: 971 CVSIASGMQYLHHGYDFPIIHCDLKPSNILLDGDWVAHVSDFGTARVLGVQNQYTSNISS 1030
Query: 181 --AFQGTIGYLAPEFAYMRIVTTKVDVFSFGIVVMEFLTKRRPTGLDEENGLSPISLRQL 238
AF+GTIGYLAPEFAYM VTTKVDVFSFG+++MEFLTK+RPT E +GL PISL+QL
Sbjct: 1031 SAAFEGTIGYLAPEFAYMGKVTTKVDVFSFGVILMEFLTKKRPTATIEAHGL-PISLQQL 1089
Query: 239 VEKALANGINGVRQITDPKLVSSIYEEQEQHQVLEELFKLALVCTSSNPEDRPNMNELL 297
VE+ALANG +RQ+ DP LV + +EQ + LE+L KLAL CT NPE+RP+MN +L
Sbjct: 1090 VERALANGKEELRQVLDPVLVLNDSKEQTR---LEKLLKLALSCTDQNPENRPDMNGVL 1145
|
Source: Cucumis sativus Species: Cucumis sativus Genus: Cucumis Family: Cucurbitaceae Order: Cucurbitales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|297794625|ref|XP_002865197.1| flagellin-sensitive 2 [Arabidopsis lyrata subsp. lyrata] gi|297311032|gb|EFH41456.1| flagellin-sensitive 2 [Arabidopsis lyrata subsp. lyrata] | Back alignment and taxonomy information |
|---|
Score = 361 bits (927), Expect = 2e-97, Method: Compositional matrix adjust.
Identities = 178/298 (59%), Positives = 229/298 (76%), Gaps = 5/298 (1%)
Query: 1 RFDRTEIENATGSFSENNIIGNSNLSTVYKGRLEDGEIVAVKKLNFHQFSAESDKSFYRE 60
RFD E+E AT SF+ NIIG+S+LSTVYKG+LEDG ++AVK LN QFSAESDK FY E
Sbjct: 859 RFDPKELEQATDSFNSANIIGSSSLSTVYKGQLEDGTVIAVKVLNLKQFSAESDKWFYTE 918
Query: 61 AKTLKELKHRNLVKVLGYAWESGKLKALILEYMENGSLESVIHGPGVDHSRWTLPKRIDV 120
AKTL +LKHRNLVK+LG+AWESGK+KAL+L +MENGSLE IHG +L +RID+
Sbjct: 919 AKTLSQLKHRNLVKILGFAWESGKMKALVLPFMENGSLEDTIHGSATPIG--SLSERIDL 976
Query: 121 LISVANGLDYLHSGYDIPIVHCDMKPSNILLDRDFEAHVSDFGTSRMLDVHLQDLSSLST 180
+ +A G+DYLHSG+ PIVHCD+KP+NILLD D AHVSDFGT+R+L ++ ST
Sbjct: 977 CVQIACGIDYLHSGFGFPIVHCDLKPANILLDSDRVAHVSDFGTARILGFREDGSTTAST 1036
Query: 181 -AFQGTIGYLAPEFAYMRIVTTKVDVFSFGIVVMEFLTKRRPTGLDEENGLSPISLRQLV 239
AF+GTIGYLAPEFAYM VTTK DVFSFGI++ME +T++RPT L++E ++LRQLV
Sbjct: 1037 AAFEGTIGYLAPEFAYMSKVTTKADVFSFGIIMMELMTRQRPTSLNDEKS-QGMTLRQLV 1095
Query: 240 EKALANGINGVRQITDPKLVSSIYEEQEQHQVLEELFKLALVCTSSNPEDRPNMNELL 297
EK++ +G G+ ++ D +L +I ++Q + +E+L KL L CTSS PEDRP+MNE+L
Sbjct: 1096 EKSIGDGTEGMIRVLDSELGDAIV-TRKQEEAIEDLLKLCLFCTSSRPEDRPDMNEIL 1152
|
Source: Arabidopsis lyrata subsp. lyrata Species: Arabidopsis lyrata Genus: Arabidopsis Family: Brassicaceae Order: Brassicales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
Prediction of Gene Ontology (GO) Terms
Close Homologs with Gene Ontology terms Detected by BLAST
Original result of BLAST against Gene Ontology (AMIGO)
| ID |
Alignment graph |
Length |
Definition |
Q cover |
H cover |
Identity |
E-value |
| Query | 299 | ||||||
| TAIR|locus:2170483 | 1173 | FLS2 "FLAGELLIN-SENSITIVE 2" [ | 0.979 | 0.249 | 0.590 | 2e-88 | |
| TAIR|locus:2046525 | 1124 | AT2G33170 [Arabidopsis thalian | 0.949 | 0.252 | 0.366 | 7.4e-43 | |
| TAIR|locus:2132353 | 492 | AT4G02630 [Arabidopsis thalian | 0.926 | 0.563 | 0.344 | 1.2e-42 | |
| TAIR|locus:2169965 | 1003 | BAM1 "BARELY ANY MERISTEM 1" [ | 0.939 | 0.280 | 0.370 | 2.5e-42 | |
| TAIR|locus:2020417 | 1101 | AT1G17230 [Arabidopsis thalian | 0.919 | 0.249 | 0.375 | 8.3e-42 | |
| TAIR|locus:2025396 | 472 | AT1G01540 [Arabidopsis thalian | 0.926 | 0.586 | 0.352 | 1.4e-41 | |
| UNIPROTKB|Q8RZV7 | 1294 | P0413C03.22 "Putative extra sp | 0.936 | 0.216 | 0.392 | 1.5e-41 | |
| TAIR|locus:2120362 | 1249 | GSO1 "GASSHO1" [Arabidopsis th | 0.946 | 0.226 | 0.372 | 3.7e-41 | |
| TAIR|locus:2012325 | 466 | AT1G09440 [Arabidopsis thalian | 0.939 | 0.603 | 0.344 | 9.6e-41 | |
| TAIR|locus:2097310 | 1002 | BAM2 "BARELY ANY MERISTEM 2" [ | 0.939 | 0.280 | 0.360 | 1.3e-40 |
| TAIR|locus:2170483 FLS2 "FLAGELLIN-SENSITIVE 2" [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 883 (315.9 bits), Expect = 2.0e-88, P = 2.0e-88
Identities = 176/298 (59%), Positives = 223/298 (74%)
Query: 1 RFDRTEIENATGSFSENNIIGNSNLSTVYKGRLEDGEIVAVKKLNFHQFSAESDKSFYRE 60
RF+ E+E AT SF+ NIIG+S+LSTVYKG+LEDG ++AVK LN +FSAESDK FY E
Sbjct: 857 RFEPKELEQATDSFNSANIIGSSSLSTVYKGQLEDGTVIAVKVLNLKEFSAESDKWFYTE 916
Query: 61 AKTLKELKHRNLVKVLGYAWESGKLKALILEYMENGSLESVIHGPGVDHSRWTLPKRIDV 120
AKTL +LKHRNLVK+LG+AWESGK KAL+L +MENG+LE IHG +L ++ID+
Sbjct: 917 AKTLSQLKHRNLVKILGFAWESGKTKALVLPFMENGNLEDTIHGSAAPIG--SLLEKIDL 974
Query: 121 LISVANGLDYLHSGYDIPIVHCDMKPSNILLDRDFEAHVSDFGTSRMLDVHLQDLSSLST 180
+ +A+G+DYLHSGY PIVHCD+KP+NILLD D AHVSDFGT+R+L ++ ST
Sbjct: 975 CVHIASGIDYLHSGYGFPIVHCDLKPANILLDSDRVAHVSDFGTARILGFREDGSTTAST 1034
Query: 181 -AFQGTIGYLAPEFAYMRIVTTKVDVFSFGIVVMEFLTKRRPTGLDEENGLSPISLRQLV 239
AF+GTIGYLAPEFAYMR VTTK DVFSFGI++ME +TK+RPT L++E+ ++LRQLV
Sbjct: 1035 SAFEGTIGYLAPEFAYMRKVTTKADVFSFGIIMMELMTKQRPTSLNDEDS-QDMTLRQLV 1093
Query: 240 EKALANGINGVRQITDPKLVSSIYXXXXXXXXXXXXFKLALVCTSSNPEDRPNMNELL 297
EK++ NG G+ ++ D +L SI KL L CTSS PEDRP+MNE+L
Sbjct: 1094 EKSIGNGRKGMVRVLDMELGDSIVSLKQEEAIEDF-LKLCLFCTSSRPEDRPDMNEIL 1150
|
|
| TAIR|locus:2046525 AT2G33170 [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 464 (168.4 bits), Expect = 7.4e-43, P = 7.4e-43
Identities = 112/306 (36%), Positives = 170/306 (55%)
Query: 1 RFDRTEIENATGSFSENNIIGNSNLSTVYKGRLEDGEIVAVKKLNFHQF-----SAESDK 55
RF +I AT F ++ I+G TVYK + G+ +AVKKL ++ S +D
Sbjct: 806 RFTVKDILEATKGFHDSYIVGRGACGTVYKAVMPSGKTIAVKKLESNREGNNNNSNNTDN 865
Query: 56 SFYREAKTLKELKHRNLVKVLGYAWESGKLKALIL-EYMENGSLESVIHGPGVDHSR-WT 113
SF E TL +++HRN+V++ + + G L+L EYM GSL ++HG G HS W
Sbjct: 866 SFRAEILTLGKIRHRNIVRLYSFCYHQGSNSNLLLYEYMSRGSLGELLHG-GKSHSMDW- 923
Query: 114 LPKRIDVLISVANGLDYLHSGYDIPIVHCDMKPSNILLDRDFEAHVSDFGTSRMLDVHLQ 173
P R + + A GL YLH I+H D+K +NIL+D +FEAHV DFG ++++D+ L
Sbjct: 924 -PTRFAIALGAAEGLAYLHHDCKPRIIHRDIKSNNILIDENFEAHVGDFGLAKVIDMPLS 982
Query: 174 DLSSLSTAFQGTIGYLAPEFAYMRIVTTKVDVFSFGIVVMEFLTKRRPTGLDEENG-LSP 232
S+S A G+ GY+APE+AY VT K D++SFG+V++E LT + P E+ G L+
Sbjct: 983 --KSVS-AVAGSYGYIAPEYAYTMKVTEKCDIYSFGVVLLELLTGKAPVQPLEQGGDLAT 1039
Query: 233 ISLRQLVEKALANGINGVRQITDPKLVSSIYXXXXXXXXXXXXFKLALVCTSSNPEDRPN 292
+ + + +L + +I DP L K+A++CT S+P DRP
Sbjct: 1040 WTRNHIRDHSLTS------EILDPYLTK--VEDDVILNHMITVTKIAVLCTKSSPSDRPT 1091
Query: 293 MNELLI 298
M E+++
Sbjct: 1092 MREVVL 1097
|
|
| TAIR|locus:2132353 AT4G02630 [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 451 (163.8 bits), Expect = 1.2e-42, P = 1.2e-42
Identities = 101/293 (34%), Positives = 167/293 (56%)
Query: 6 EIENATGSFSENNIIGNSNLSTVYKGRLEDGEIVAVKKLNFHQFSAESDKSFYREAKTLK 65
E+E +T F++ N+IG VY+G LED +VA+K L ++ AE K F E + +
Sbjct: 154 ELEVSTNGFADENVIGQGGYGIVYRGVLEDKSMVAIKNLLNNRGQAE--KEFKVEVEAIG 211
Query: 66 ELKHRNLVKVLGYAWESGKLKALILEYMENGSLESVIHGPGVDH-SRWTLPKRIDVLISV 124
++H+NLV++LGY E G + L+ EY++NG+LE IHG G+ S T R+++++
Sbjct: 212 RVRHKNLVRLLGYCVE-GAHRMLVYEYVDNGNLEQWIHGGGLGFKSPLTWEIRMNIVLGT 270
Query: 125 ANGLDYLHSGYDIPIVHCDMKPSNILLDRDFEAHVSDFGTSRMLDVHLQDLSSLSTAFQG 184
A GL YLH G + +VH D+K SNILLD+ + + VSDFG +++L ++S ++T G
Sbjct: 271 AKGLMYLHEGLEPKVVHRDIKSSNILLDKQWNSKVSDFGLAKLLG---SEMSYVTTRVMG 327
Query: 185 TIGYLAPEFAYMRIVTTKVDVFSFGIVVMEFLTKRRPTGLDEENGLSPISLRQLVEKALA 244
T GY+APE+A ++ + DV+SFG++VME ++ R P +D ++L + +++ +
Sbjct: 328 TFGYVAPEYASTGMLNERSDVYSFGVLVMEIISGRSP--VDYSRAPGEVNLVEWLKRLVT 385
Query: 245 NGINGVRQITDPKLVSSIYXXXXXXXXXXXXFKLALVCTSSNPEDRPNMNELL 297
N + DP++V +AL C N + RP M ++
Sbjct: 386 N--RDAEGVLDPRMVDK-----PSLRSLKRTLLVALRCVDPNAQKRPKMGHII 431
|
|
| TAIR|locus:2169965 BAM1 "BARELY ANY MERISTEM 1" [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 458 (166.3 bits), Expect = 2.5e-42, P = 2.5e-42
Identities = 110/297 (37%), Positives = 162/297 (54%)
Query: 1 RFDRTEIENATGSFSENNIIGNSNLSTVYKGRLEDGEIVAVKKLNFHQFSAESDKSFYRE 60
R D T ++ S E+NIIG VYKG + +G++VAVK+L + D F E
Sbjct: 682 RLDFT-CDDVLDSLKEDNIIGKGGAGIVYKGVMPNGDLVAVKRLAAMSRGSSHDHGFNAE 740
Query: 61 AKTLKELKHRNLVKVLGYAWESGKLKALILEYMENGSLESVIHGPGVDHSRWTLPKRIDV 120
+TL ++HR++V++LG+ + + L+ EYM NGSL V+HG H W R +
Sbjct: 741 IQTLGRIRHRHIVRLLGFC-SNHETNLLVYEYMPNGSLGEVLHGKKGGHLHWDT--RYKI 797
Query: 121 LISVANGLDYLHSGYDIPIVHCDMKPSNILLDRDFEAHVSDFGTSRMLDVHLQDLSSLST 180
+ A GL YLH IVH D+K +NILLD +FEAHV+DFG ++ L S +
Sbjct: 798 ALEAAKGLCYLHHDCSPLIVHRDVKSNNILLDSNFEAHVADFGLAKFLQD--SGTSECMS 855
Query: 181 AFQGTIGYLAPEFAYMRIVTTKVDVFSFGIVVMEFLTKRRPTGLDEENGLSPISLRQLVE 240
A G+ GY+APE+AY V K DV+SFG+V++E +T R+P G E G + + Q V
Sbjct: 856 AIAGSYGYIAPEYAYTLKVDEKSDVYSFGVVLLELVTGRKPVG---EFG-DGVDIVQWVR 911
Query: 241 KALANGINGVRQITDPKLVSSIYXXXXXXXXXXXXFKLALVCTSSNPEDRPNMNELL 297
K + + V ++ DP+L SSI F +A++C +RP M E++
Sbjct: 912 KMTDSNKDSVLKVLDPRL-SSI-----PIHEVTHVFYVAMLCVEEQAVERPTMREVV 962
|
|
| TAIR|locus:2020417 AT1G17230 [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 454 (164.9 bits), Expect = 8.3e-42, P = 8.3e-42
Identities = 109/290 (37%), Positives = 161/290 (55%)
Query: 9 NATGSFSENNIIGNSNLSTVYKGRLEDGEIVAVKKLNFHQFSAESDKSFYREAKTLKELK 68
+AT +FSE+ ++G TVYK + GE++AVKKLN A SD SF E TL +++
Sbjct: 794 DATRNFSEDVVLGRGACGTVYKAEMSGGEVIAVKKLNSRGEGASSDNSFRAEISTLGKIR 853
Query: 69 HRNLVKVLGYAWESGKLKALILEYMENGSL-ESVIHGPGVDHSRWTLPKRIDVLISVANG 127
HRN+VK+ G+ + L+ EYM GSL E + G W RI + A G
Sbjct: 854 HRNIVKLYGFCYHQNS-NLLLYEYMSKGSLGEQLQRGEKNCLLDWNARYRI--ALGAAEG 910
Query: 128 LDYLHSGYDIPIVHCDMKPSNILLDRDFEAHVSDFGTSRMLDVHLQDLSSLSTAFQGTIG 187
L YLH IVH D+K +NILLD F+AHV DFG ++++D+ S+S A G+ G
Sbjct: 911 LCYLHHDCRPQIVHRDIKSNNILLDERFQAHVGDFGLAKLIDLSYS--KSMS-AVAGSYG 967
Query: 188 YLAPEFAYMRIVTTKVDVFSFGIVVMEFLTKRRPTGLDEENGLSPISLRQLVEKALANGI 247
Y+APE+AY VT K D++SFG+V++E +T + P E+ G L V +++ N I
Sbjct: 968 YIAPEYAYTMKVTEKCDIYSFGVVLLELITGKPPVQPLEQGG----DLVNWVRRSIRNMI 1023
Query: 248 NGVRQITDPKLVSSIYXXXXXXXXXXXXFKLALVCTSSNPEDRPNMNELL 297
+ ++ D +L ++ K+AL CTS++P RP M E++
Sbjct: 1024 PTI-EMFDARLDTN---DKRTVHEMSLVLKIALFCTSNSPASRPTMREVV 1069
|
|
| TAIR|locus:2025396 AT1G01540 [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 441 (160.3 bits), Expect = 1.4e-41, P = 1.4e-41
Identities = 103/292 (35%), Positives = 160/292 (54%)
Query: 6 EIENATGSFSENNIIGNSNLSTVYKGRLEDGEIVAVKKLNFHQFSAESDKSFYREAKTLK 65
E+E AT E N+IG VY+G L DG VAVK L ++ AE K F E + +
Sbjct: 146 ELEAATNGLCEENVIGEGGYGIVYRGILTDGTKVAVKNLLNNRGQAE--KEFKVEVEVIG 203
Query: 66 ELKHRNLVKVLGYAWESGKLKALILEYMENGSLESVIHGPGVDHSRWTLPKRIDVLISVA 125
++H+NLV++LGY E G + L+ ++++NG+LE IHG D S T R+++++ +A
Sbjct: 204 RVRHKNLVRLLGYCVE-GAYRMLVYDFVDNGNLEQWIHGDVGDVSPLTWDIRMNIILGMA 262
Query: 126 NGLDYLHSGYDIPIVHCDMKPSNILLDRDFEAHVSDFGTSRMLDVHLQDLSSLSTAFQGT 185
GL YLH G + +VH D+K SNILLDR + A VSDFG +++L + S ++T GT
Sbjct: 263 KGLAYLHEGLEPKVVHRDIKSSNILLDRQWNAKVSDFGLAKLLG---SESSYVTTRVMGT 319
Query: 186 IGYLAPEFAYMRIVTTKVDVFSFGIVVMEFLTKRRPTGLDEENGLSPISLRQLVEKALAN 245
GY+APE+A ++ K D++SFGI++ME +T R P G + +L ++ + N
Sbjct: 320 FGYVAPEYACTGMLNEKSDIYSFGILIMEIITGRNPVDYSRPQGET--NLVDWLKSMVGN 377
Query: 246 GINGVRQITDPKLVSSIYXXXXXXXXXXXXFKLALVCTSSNPEDRPNMNELL 297
+ ++ DPK+ +AL C + RP M ++
Sbjct: 378 RRS--EEVVDPKIPEP-----PSSKALKRVLLVALRCVDPDANKRPKMGHII 422
|
|
| UNIPROTKB|Q8RZV7 P0413C03.22 "Putative extra sporogenous cells" [Oryza sativa Japonica Group (taxid:39947)] | Back alignment and assigned GO terms |
|---|
Score = 453 (164.5 bits), Expect = 1.5e-41, P = 1.5e-41
Identities = 118/301 (39%), Positives = 167/301 (55%)
Query: 1 RFDRTEIENATGSFSENNIIGNSNLSTVYKGRLEDGEIVAVKKLNF-HQFSAESDKSFYR 59
R +I AT +FS+ +IIG+ TVYK L +G VA+K+L+ HQF + D+ F
Sbjct: 989 RVTADDILKATENFSKVHIIGDGGFGTVYKAALPEGRRVAIKRLHGGHQF--QGDREFLA 1046
Query: 60 EAKTLKELKHRNLVKVLGYAWESGKLKALILEYMENGSLESVIHG--PGVDHSRWTLPKR 117
E +T+ ++KH NLV +LGY G + LI EYMENGSLE + ++ W P R
Sbjct: 1047 EMETIGKVKHPNLVPLLGYC-VCGDERFLIYEYMENGSLEMWLRNRADALEALGW--PDR 1103
Query: 118 IDVLISVANGLDYLHSGYDIPIVHCDMKPSNILLDRDFEAHVSDFGTSRMLDVHLQDLSS 177
+ + + A GL +LH G+ I+H DMK SNILLD +FE VSDFG +R++ +
Sbjct: 1104 LKICLGSARGLAFLHHGFVPHIIHRDMKSSNILLDENFEPRVSDFGLARIISACE---TH 1160
Query: 178 LSTAFQGTIGYLAPEFAYMRIVTTKVDVFSFGIVVMEFLTKRRPTGLDEENGLSPISLRQ 237
+ST GT GY+ PE+ TTK DV+SFG+V++E LT R PTG +E G +L
Sbjct: 1161 VSTDIAGTFGYIPPEYGLTMKSTTKGDVYSFGVVMLELLTGRPPTGQEEVQGGG--NLVG 1218
Query: 238 LVEKALANGINGVRQITDPKL-VSSIYXXXXXXXXXXXXFKLALVCTSSNPEDRPNMNEL 296
V +A G ++ DP L VSS++ +A CT+ P RP M E+
Sbjct: 1219 WVRWMIARGKQN--ELFDPCLPVSSVWREQMARVLA-----IARDCTADEPFKRPTMLEV 1271
Query: 297 L 297
+
Sbjct: 1272 V 1272
|
|
| TAIR|locus:2120362 GSO1 "GASSHO1" [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 449 (163.1 bits), Expect = 3.7e-41, P = 3.7e-41
Identities = 110/295 (37%), Positives = 170/295 (57%)
Query: 6 EIENATGSFSENNIIGNSNLSTVYKGRLEDGEIVAVKKLNFHQFSAESDKSFYREAKTLK 65
+I AT + SE +IG+ VYK LE+GE VAVKK+ + S+KSF RE KTL
Sbjct: 943 DIMEATHNLSEEFMIGSGGSGKVYKAELENGETVAVKKILWKD-DLMSNKSFSREVKTLG 1001
Query: 66 ELKHRNLVKVLGY-AWESGKLKALILEYMENGSLESVIHG--PGVDHSRWTLP--KRIDV 120
++HR+LVK++GY + +S L LI EYM+NGS+ +H P ++ + L R+ +
Sbjct: 1002 RIRHRHLVKLMGYCSSKSEGLNLLIYEYMKNGSIWDWLHEDKPVLEKKKKLLDWEARLRI 1061
Query: 121 LISVANGLDYLHSGYDIPIVHCDMKPSNILLDRDFEAHVSDFGTSRMLDVHLQDLSSLST 180
+ +A G++YLH PIVH D+K SN+LLD + EAH+ DFG +++L + + +T
Sbjct: 1062 AVGLAQGVEYLHHDCVPPIVHRDIKSSNVLLDSNMEAHLGDFGLAKVLTENCDTNTDSNT 1121
Query: 181 AFQGTIGYLAPEFAYMRIVTTKVDVFSFGIVVMEFLTKRRPTGLDEENGLSPISLRQLVE 240
F + GY+APE+AY T K DV+S GIV+ME +T + PT D G + + + + VE
Sbjct: 1122 WFACSYGYIAPEYAYSLKATEKSDVYSMGIVLMEIVTGKMPT--DSVFG-AEMDMVRWVE 1178
Query: 241 KALANGINGVRQITDPKLVSSIYXXXXXXXXXXXXFKLALVCTSSNPEDRPNMNE 295
L + ++ DPKL + ++AL CT ++P++RP+ +
Sbjct: 1179 THLEVAGSARDKLIDPKLKPLL---PFEEDAACQVLEIALQCTKTSPQERPSSRQ 1230
|
|
| TAIR|locus:2012325 AT1G09440 [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 433 (157.5 bits), Expect = 9.6e-41, P = 9.6e-41
Identities = 102/296 (34%), Positives = 158/296 (53%)
Query: 2 FDRTEIENATGSFSENNIIGNSNLSTVYKGRLEDGEIVAVKKLNFHQFSAESDKSFYREA 61
F ++E AT FS+ N+IG VY+G L +G +VAVKK+ H AE K F E
Sbjct: 145 FTLRDLEIATNRFSKENVIGEGGYGVVYRGELVNGSLVAVKKILNHLGQAE--KEFRVEV 202
Query: 62 KTLKELKHRNLVKVLGYAWESGKLKALILEYMENGSLESVIHGPGVDHSRWTLPKRIDVL 121
+ ++H+NLV++LGY E G + L+ EYM NG+LE +HG H T R+ VL
Sbjct: 203 DAIGHVRHKNLVRLLGYCIE-GTNRILVYEYMNNGNLEEWLHGAMKHHGYLTWEARMKVL 261
Query: 122 ISVANGLDYLHSGYDIPIVHCDMKPSNILLDRDFEAHVSDFGTSRMLDVHLQDLSSLSTA 181
+ L YLH + +VH D+K SNIL+D F A +SDFG +++L S ++T
Sbjct: 262 TGTSKALAYLHEAIEPKVVHRDIKSSNILIDDRFNAKISDFGLAKLLG---DGKSHVTTR 318
Query: 182 FQGTIGYLAPEFAYMRIVTTKVDVFSFGIVVMEFLTKRRPTGLDEENGLSPISLRQLVEK 241
GT GY+APE+A ++ K DV+SFG++V+E +T R P +D + ++L + ++
Sbjct: 319 VMGTFGYVAPEYANTGLLNEKSDVYSFGVLVLEAITGRDP--VDYARPANEVNLVEWLKM 376
Query: 242 ALANGINGVRQITDPKLVSSIYXXXXXXXXXXXXFKLALVCTSSNPEDRPNMNELL 297
+ G + ++ DP + AL C + E RP M++++
Sbjct: 377 MV--GSKRLEEVIDPNIA-----VRPATRALKRVLLTALRCIDPDSEKRPKMSQVV 425
|
|
| TAIR|locus:2097310 BAM2 "BARELY ANY MERISTEM 2" [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 442 (160.7 bits), Expect = 1.3e-40, P = 1.3e-40
Identities = 107/297 (36%), Positives = 159/297 (53%)
Query: 1 RFDRTEIENATGSFSENNIIGNSNLSTVYKGRLEDGEIVAVKKLNFHQFSAESDKSFYRE 60
R D T ++ S E+NIIG VYKG + G++VAVK+L + D F E
Sbjct: 678 RLDFT-CDDVLDSLKEDNIIGKGGAGIVYKGTMPKGDLVAVKRLATMSHGSSHDHGFNAE 736
Query: 61 AKTLKELKHRNLVKVLGYAWESGKLKALILEYMENGSLESVIHGPGVDHSRWTLPKRIDV 120
+TL ++HR++V++LG+ + + L+ EYM NGSL V+HG H W R +
Sbjct: 737 IQTLGRIRHRHIVRLLGFC-SNHETNLLVYEYMPNGSLGEVLHGKKGGHLHWNT--RYKI 793
Query: 121 LISVANGLDYLHSGYDIPIVHCDMKPSNILLDRDFEAHVSDFGTSRMLDVHLQDLSSLST 180
+ A GL YLH IVH D+K +NILLD +FEAHV+DFG ++ L S +
Sbjct: 794 ALEAAKGLCYLHHDCSPLIVHRDVKSNNILLDSNFEAHVADFGLAKFLQD--SGTSECMS 851
Query: 181 AFQGTIGYLAPEFAYMRIVTTKVDVFSFGIVVMEFLTKRRPTGLDEENGLSPISLRQLVE 240
A G+ GY+APE+AY V K DV+SFG+V++E +T ++P G E G + + Q V
Sbjct: 852 AIAGSYGYIAPEYAYTLKVDEKSDVYSFGVVLLELITGKKPVG---EFG-DGVDIVQWVR 907
Query: 241 KALANGINGVRQITDPKLVSSIYXXXXXXXXXXXXFKLALVCTSSNPEDRPNMNELL 297
+ + V ++ D +L SS+ F +AL+C +RP M E++
Sbjct: 908 SMTDSNKDCVLKVIDLRL-SSV-----PVHEVTHVFYVALLCVEEQAVERPTMREVV 958
|
|
Prediction of Enzyme Commission (EC) Number
EC Number Prediction by Annotation Transfer from SWISS-PROT Entries
Original result of BLAST against SWISS-PROT
No confident hit for EC number transfering in SWISSPROT detected by BLAST
EC Number Prediction by Ezypred Server
Original result from Ezypred Server
Fail to connect to Ezypred Server
EC Number Prediction by EFICAz Software
| Prediction Level | EC number | Confidence of Prediction |
| 4th Layer | 2.7.11.1 | LOW CONFIDENCE prediction! |
| 3rd Layer | 2.7.11 | 0.691 |
Prediction of Functionally Associated Proteins
Functionally Associated Proteins Detected by STRING
Original result from the STRING server
| Your Input: |  |
 |
 |
 |
 |
 |
 |
 |
 |
||
 | gw1.IV.2493.1 | hypothetical protein (1122 aa) | |||||||||
(Populus trichocarpa) | |||||||||||
Predicted Functional Partners: | |||||||||||
 | gw1.V.5114.1 | hypothetical protein (544 aa) | • | • | 0.800 | ||||||
 | gw1.II.1831.1 | hypothetical protein (547 aa) | • | • | 0.800 | ||||||
Conserved Domains and Related Protein Families
Conserved Domains Detected by RPS-BLAST
Original result of RPS-BLAST against CDD database part I
| ID | Alignment Graph | Length |
Definition |
E-value |
| Query | 299 | |||
| pfam00069 | 260 | pfam00069, Pkinase, Protein kinase domain | 2e-47 | |
| cd00180 | 215 | cd00180, PKc, Catalytic domain of Protein Kinases | 1e-45 | |
| smart00220 | 254 | smart00220, S_TKc, Serine/Threonine protein kinase | 9e-43 | |
| smart00219 | 257 | smart00219, TyrKc, Tyrosine kinase, catalytic doma | 3e-41 | |
| smart00221 | 258 | smart00221, STYKc, Protein kinase; unclassified sp | 7e-41 | |
| cd06606 | 260 | cd06606, STKc_MAPKKK, Catalytic domain of the Prot | 2e-40 | |
| pfam07714 | 258 | pfam07714, Pkinase_Tyr, Protein tyrosine kinase | 3e-39 | |
| cd00192 | 262 | cd00192, PTKc, Catalytic domain of Protein Tyrosin | 5e-39 | |
| cd06627 | 254 | cd06627, STKc_Cdc7_like, Catalytic domain of Cell | 6e-38 | |
| cd08215 | 258 | cd08215, STKc_Nek, Catalytic domain of the Protein | 2e-34 | |
| cd05122 | 253 | cd05122, PKc_STE, Catalytic domain of STE family P | 1e-31 | |
| COG0515 | 384 | COG0515, SPS1, Serine/threonine protein kinase [Ge | 1e-30 | |
| cd06623 | 264 | cd06623, PKc_MAPKK_plant_like, Catalytic domain of | 2e-30 | |
| cd06629 | 272 | cd06629, STKc_MAPKKK_Bck1_like, Catalytic domain o | 5e-29 | |
| cd05041 | 251 | cd05041, PTKc_Fes_like, Catalytic domain of Fes-li | 8e-26 | |
| cd06605 | 265 | cd06605, PKc_MAPKK, Catalytic domain of the dual-s | 8e-26 | |
| cd06626 | 264 | cd06626, STKc_MEKK4, Catalytic domain of the Prote | 9e-25 | |
| cd05034 | 261 | cd05034, PTKc_Src_like, Catalytic domain of Src ki | 1e-24 | |
| cd05039 | 256 | cd05039, PTKc_Csk_like, Catalytic domain of C-term | 1e-24 | |
| cd07840 | 287 | cd07840, STKc_CDK9_like, Catalytic domain of Cycli | 3e-24 | |
| cd06621 | 287 | cd06621, PKc_MAPKK_Pek1_like, Catalytic domain of | 7e-24 | |
| cd05118 | 283 | cd05118, STKc_CMGC, Catalytic domain of CMGC famil | 9e-24 | |
| cd05038 | 284 | cd05038, PTKc_Jak_rpt2, Catalytic (repeat 2) domai | 5e-23 | |
| cd05049 | 280 | cd05049, PTKc_Trk, Catalytic domain of the Protein | 8e-23 | |
| cd05033 | 266 | cd05033, PTKc_EphR, Catalytic domain of Ephrin Rec | 2e-22 | |
| cd06610 | 267 | cd06610, STKc_OSR1_SPAK, Catalytic domain of the P | 3e-22 | |
| cd06628 | 267 | cd06628, STKc_MAPKKK_Byr2_like, Catalytic domain o | 4e-22 | |
| cd08529 | 256 | cd08529, STKc_FA2-like, Catalytic domain of the Pr | 5e-22 | |
| cd06630 | 268 | cd06630, STKc_MEKK1, Catalytic domain of the Prote | 5e-22 | |
| PLN00034 | 353 | PLN00034, PLN00034, mitogen-activated protein kina | 1e-21 | |
| cd05071 | 262 | cd05071, PTKc_Src, Catalytic domain of the Protein | 2e-21 | |
| cd05035 | 273 | cd05035, PTKc_Axl_like, Catalytic Domain of Axl-li | 1e-20 | |
| cd05051 | 296 | cd05051, PTKc_DDR, Catalytic domain of the Protein | 1e-20 | |
| cd05578 | 258 | cd05578, STKc_Yank1, Catalytic domain of the Prote | 2e-20 | |
| cd07838 | 287 | cd07838, STKc_CDK4_6_like, Catalytic domain of Cyc | 2e-20 | |
| cd05070 | 260 | cd05070, PTKc_Fyn_Yrk, Catalytic domain of the Pro | 3e-20 | |
| cd08217 | 265 | cd08217, STKc_Nek2, Catalytic domain of the Protei | 3e-20 | |
| cd07829 | 282 | cd07829, STKc_CDK_like, Catalytic domain of Cyclin | 3e-20 | |
| cd05092 | 280 | cd05092, PTKc_TrkA, Catalytic domain of the Protei | 3e-20 | |
| cd05112 | 256 | cd05112, PTKc_Itk, Catalytic domain of the Protein | 6e-20 | |
| cd07841 | 298 | cd07841, STKc_CDK7, Catalytic domain of the Serine | 7e-20 | |
| cd05065 | 269 | cd05065, PTKc_EphR_B, Catalytic domain of the Prot | 2e-19 | |
| cd05148 | 261 | cd05148, PTKc_Srm_Brk, Catalytic domain of the Pro | 2e-19 | |
| cd05067 | 260 | cd05067, PTKc_Lck_Blk, Catalytic domain of the Pro | 2e-19 | |
| cd05063 | 268 | cd05063, PTKc_EphR_A2, Catalytic domain of the Pro | 3e-19 | |
| cd05066 | 267 | cd05066, PTKc_EphR_A, Catalytic domain of the Prot | 3e-19 | |
| cd06614 | 286 | cd06614, STKc_PAK, Catalytic domain of the Protein | 4e-19 | |
| cd05581 | 280 | cd05581, STKc_PDK1, Catalytic domain of the Protei | 7e-19 | |
| cd05068 | 261 | cd05068, PTKc_Frk_like, Catalytic domain of Fyn-re | 7e-19 | |
| cd06632 | 258 | cd06632, STKc_MEKK1_plant, Catalytic domain of the | 8e-19 | |
| cd05058 | 262 | cd05058, PTKc_Met_Ron, Catalytic domain of the Pro | 1e-18 | |
| cd05081 | 284 | cd05081, PTKc_Jak2_Jak3_rpt2, Catalytic (repeat 2) | 2e-18 | |
| cd05059 | 256 | cd05059, PTKc_Tec_like, Catalytic domain of Tec-li | 2e-18 | |
| cd06620 | 284 | cd06620, PKc_MAPKK_Byr1_like, Catalytic domain of | 2e-18 | |
| cd05123 | 250 | cd05123, STKc_AGC, Catalytic domain of AGC family | 3e-18 | |
| cd07832 | 286 | cd07832, STKc_CCRK, Catalytic domain of the Serine | 3e-18 | |
| cd05060 | 257 | cd05060, PTKc_Syk_like, Catalytic domain of Spleen | 4e-18 | |
| cd08225 | 257 | cd08225, STKc_Nek5, Catalytic domain of the Protei | 5e-18 | |
| cd05069 | 260 | cd05069, PTKc_Yes, Catalytic domain of the Protein | 2e-17 | |
| cd05093 | 288 | cd05093, PTKc_TrkB, Catalytic domain of the Protei | 3e-17 | |
| cd05074 | 273 | cd05074, PTKc_Tyro3, Catalytic domain of the Prote | 4e-17 | |
| cd07860 | 284 | cd07860, STKc_CDK2_3, Catalytic domain of the Seri | 5e-17 | |
| cd05094 | 291 | cd05094, PTKc_TrkC, Catalytic domain of the Protei | 6e-17 | |
| cd05085 | 250 | cd05085, PTKc_Fer, Catalytic domain of the Protein | 7e-17 | |
| cd05050 | 288 | cd05050, PTKc_Musk, Catalytic domain of the Protei | 7e-17 | |
| cd05046 | 275 | cd05046, PTK_CCK4, Pseudokinase domain of the Prot | 7e-17 | |
| cd05579 | 265 | cd05579, STKc_MAST_like, Catalytic domain of Micro | 9e-17 | |
| cd06624 | 268 | cd06624, STKc_ASK, Catalytic domain of the Protein | 9e-17 | |
| cd05052 | 263 | cd05052, PTKc_Abl, Catalytic domain of the Protein | 1e-16 | |
| cd06625 | 263 | cd06625, STKc_MEKK3_like, Catalytic domain of MAP/ | 1e-16 | |
| cd07843 | 293 | cd07843, STKc_CDC2L1, Catalytic domain of the Seri | 1e-16 | |
| PLN00113 | 968 | PLN00113, PLN00113, leucine-rich repeat receptor-l | 1e-16 | |
| cd05073 | 260 | cd05073, PTKc_Hck, Catalytic domain of the Protein | 2e-16 | |
| cd05097 | 295 | cd05097, PTKc_DDR_like, Catalytic domain of Discoi | 2e-16 | |
| cd06615 | 308 | cd06615, PKc_MEK, Catalytic domain of the dual-spe | 2e-16 | |
| cd05057 | 279 | cd05057, PTKc_EGFR_like, Catalytic domain of Epide | 2e-16 | |
| cd05040 | 257 | cd05040, PTKc_Ack_like, Catalytic domain of the Pr | 2e-16 | |
| cd08229 | 267 | cd08229, STKc_Nek7, Catalytic domain of the Protei | 2e-16 | |
| cd08218 | 256 | cd08218, STKc_Nek1, Catalytic domain of the Protei | 3e-16 | |
| cd08220 | 256 | cd08220, STKc_Nek8, Catalytic domain of the Protei | 3e-16 | |
| cd07845 | 309 | cd07845, STKc_CDK10, Catalytic domain of the Serin | 3e-16 | |
| cd05045 | 290 | cd05045, PTKc_RET, Catalytic domain of the Protein | 3e-16 | |
| cd05577 | 277 | cd05577, STKc_GRK, Catalytic domain of the Protein | 3e-16 | |
| cd05044 | 269 | cd05044, PTKc_c-ros, Catalytic domain of the Prote | 4e-16 | |
| cd06613 | 262 | cd06613, STKc_MAP4K3_like, Catalytic domain of Mit | 5e-16 | |
| cd05075 | 272 | cd05075, PTKc_Axl, Catalytic domain of the Protein | 6e-16 | |
| cd05072 | 261 | cd05072, PTKc_Lyn, Catalytic domain of the Protein | 7e-16 | |
| cd05053 | 293 | cd05053, PTKc_FGFR, Catalytic domain of the Protei | 8e-16 | |
| cd06631 | 265 | cd06631, STKc_YSK4, Catalytic domain of the Protei | 8e-16 | |
| cd05032 | 277 | cd05032, PTKc_InsR_like, Catalytic domain of Insul | 8e-16 | |
| cd08224 | 267 | cd08224, STKc_Nek6_Nek7, Catalytic domain of the P | 9e-16 | |
| cd06612 | 256 | cd06612, STKc_MST1_2, Catalytic domain of the Prot | 1e-15 | |
| cd07834 | 330 | cd07834, STKc_MAPK, Catalytic domain of the Serine | 1e-15 | |
| cd06649 | 331 | cd06649, PKc_MEK2, Catalytic domain of the dual-sp | 1e-15 | |
| cd06619 | 279 | cd06619, PKc_MKK5, Catalytic domain of the dual-sp | 2e-15 | |
| cd07855 | 334 | cd07855, STKc_ERK5, Catalytic domain of the Serine | 2e-15 | |
| cd06650 | 333 | cd06650, PKc_MEK1, Catalytic domain of the dual-sp | 2e-15 | |
| cd08223 | 257 | cd08223, STKc_Nek4, Catalytic domain of the Protei | 2e-15 | |
| cd06917 | 277 | cd06917, STKc_NAK1_like, Catalytic domain of Funga | 2e-15 | |
| cd07851 | 343 | cd07851, STKc_p38, Catalytic domain of the Serine/ | 5e-15 | |
| cd07846 | 286 | cd07846, STKc_CDKL2_3, Catalytic domain of the Ser | 5e-15 | |
| cd05100 | 334 | cd05100, PTKc_FGFR3, Catalytic domain of the Prote | 6e-15 | |
| cd06648 | 285 | cd06648, STKc_PAK_II, Catalytic domain of the Prot | 7e-15 | |
| cd05582 | 318 | cd05582, STKc_RSK_N, N-terminal catalytic domain o | 7e-15 | |
| cd05611 | 260 | cd05611, STKc_Rim15_like, Catalytic domain of fung | 8e-15 | |
| cd07836 | 284 | cd07836, STKc_Pho85, Catalytic domain of the Serin | 8e-15 | |
| cd07847 | 286 | cd07847, STKc_CDKL1_4, Catalytic domain of the Ser | 8e-15 | |
| cd08528 | 269 | cd08528, STKc_Nek10, Catalytic domain of the Prote | 9e-15 | |
| cd07866 | 311 | cd07866, STKc_BUR1, Catalytic domain of the Serine | 1e-14 | |
| cd07833 | 288 | cd07833, STKc_CDKL, Catalytic domain of Cyclin-Dep | 1e-14 | |
| cd05608 | 280 | cd05608, STKc_GRK1, Catalytic domain of the Protei | 1e-14 | |
| cd05084 | 252 | cd05084, PTKc_Fes, Catalytic domain of the Protein | 1e-14 | |
| cd07852 | 337 | cd07852, STKc_MAPK15, Catalytic domain of the Seri | 2e-14 | |
| PTZ00024 | 335 | PTZ00024, PTZ00024, cyclin-dependent protein kinas | 2e-14 | |
| cd07830 | 283 | cd07830, STKc_MAK_like, Catalytic domain of Male g | 2e-14 | |
| cd05083 | 254 | cd05083, PTKc_Chk, Catalytic domain of the Protein | 3e-14 | |
| cd08228 | 267 | cd08228, STKc_Nek6, Catalytic domain of the Protei | 3e-14 | |
| cd08530 | 256 | cd08530, STKc_CNK2-like, Catalytic domain of the P | 4e-14 | |
| cd06608 | 275 | cd06608, STKc_myosinIII_like, Catalytic domain of | 4e-14 | |
| cd05090 | 283 | cd05090, PTKc_Ror1, Catalytic domain of the Protei | 5e-14 | |
| cd05607 | 277 | cd05607, STKc_GRK7, Catalytic domain of the Protei | 5e-14 | |
| cd05098 | 307 | cd05098, PTKc_FGFR1, Catalytic domain of the Prote | 6e-14 | |
| cd05082 | 256 | cd05082, PTKc_Csk, Catalytic domain of the Protein | 6e-14 | |
| cd06657 | 292 | cd06657, STKc_PAK4, Catalytic domain of the Protei | 7e-14 | |
| cd06656 | 297 | cd06656, STKc_PAK3, Catalytic domain of the Protei | 8e-14 | |
| cd05113 | 256 | cd05113, PTKc_Btk_Bmx, Catalytic domain of the Pro | 9e-14 | |
| cd05095 | 296 | cd05095, PTKc_DDR2, Catalytic domain of the Protei | 1e-13 | |
| cd06651 | 266 | cd06651, STKc_MEKK3, Catalytic domain of the Prote | 1e-13 | |
| cd05048 | 283 | cd05048, PTKc_Ror, Catalytic Domain of the Protein | 1e-13 | |
| cd07842 | 316 | cd07842, STKc_CDK8_like, Catalytic domain of Cycli | 1e-13 | |
| cd05096 | 304 | cd05096, PTKc_DDR1, Catalytic domain of the Protei | 2e-13 | |
| cd05114 | 256 | cd05114, PTKc_Tec_Rlk, Catalytic domain of the Pro | 3e-13 | |
| PTZ00283 | 496 | PTZ00283, PTZ00283, serine/threonine protein kinas | 3e-13 | |
| cd07839 | 284 | cd07839, STKc_CDK5, Catalytic domain of the Serine | 3e-13 | |
| cd05062 | 277 | cd05062, PTKc_IGF-1R, Catalytic domain of the Prot | 4e-13 | |
| cd06609 | 274 | cd06609, STKc_MST3_like, Catalytic domain of Mamma | 4e-13 | |
| cd05572 | 262 | cd05572, STKc_cGK_PKG, Catalytic domain of the Pro | 4e-13 | |
| cd06616 | 288 | cd06616, PKc_MKK4, Catalytic domain of the dual-sp | 4e-13 | |
| cd05101 | 304 | cd05101, PTKc_FGFR2, Catalytic domain of the Prote | 5e-13 | |
| cd05099 | 314 | cd05099, PTKc_FGFR4, Catalytic domain of the Prote | 5e-13 | |
| cd06658 | 292 | cd06658, STKc_PAK5, Catalytic domain of the Protei | 6e-13 | |
| cd07877 | 345 | cd07877, STKc_p38alpha_MAPK14, Catalytic domain of | 7e-13 | |
| cd06607 | 307 | cd06607, STKc_TAO, Catalytic domain of the Protein | 9e-13 | |
| cd07835 | 283 | cd07835, STKc_CDK1_like, Catalytic domain of Cycli | 9e-13 | |
| cd06654 | 296 | cd06654, STKc_PAK1, Catalytic domain of the Protei | 1e-12 | |
| cd06642 | 277 | cd06642, STKc_STK25-YSK1, Catalytic domain of the | 1e-12 | |
| cd08221 | 256 | cd08221, STKc_Nek9, Catalytic domain of the Protei | 1e-12 | |
| cd06611 | 280 | cd06611, STKc_SLK_like, Catalytic domain of Ste20- | 1e-12 | |
| cd05630 | 285 | cd05630, STKc_GRK6, Catalytic domain of the Protei | 1e-12 | |
| cd07856 | 328 | cd07856, STKc_Sty1_Hog1, Catalytic domain of the S | 2e-12 | |
| cd05080 | 283 | cd05080, PTKc_Tyk2_rpt2, Catalytic (repeat 2) doma | 2e-12 | |
| cd06645 | 267 | cd06645, STKc_MAP4K3, Catalytic domain of the Prot | 2e-12 | |
| cd06647 | 293 | cd06647, STKc_PAK_I, Catalytic domain of the Prote | 3e-12 | |
| cd06652 | 265 | cd06652, STKc_MEKK2, Catalytic domain of the Prote | 3e-12 | |
| PLN00009 | 294 | PLN00009, PLN00009, cyclin-dependent kinase A; Pro | 3e-12 | |
| cd05079 | 284 | cd05079, PTKc_Jak1_rpt2, Catalytic (repeat 2) doma | 4e-12 | |
| cd06641 | 277 | cd06641, STKc_MST3, Catalytic domain of the Protei | 5e-12 | |
| cd06655 | 296 | cd06655, STKc_PAK2, Catalytic domain of the Protei | 5e-12 | |
| cd06640 | 277 | cd06640, STKc_MST4, Catalytic domain of the Protei | 6e-12 | |
| cd07864 | 302 | cd07864, STKc_CDK12, Catalytic domain of the Serin | 8e-12 | |
| cd07865 | 310 | cd07865, STKc_CDK9, Catalytic domain of the Serine | 8e-12 | |
| cd08216 | 314 | cd08216, PK_STRAD, Pseudokinase domain of STE20-re | 1e-11 | |
| cd07861 | 285 | cd07861, STKc_CDK1_euk, Catalytic domain of the Se | 1e-11 | |
| cd06659 | 297 | cd06659, STKc_PAK6, Catalytic domain of the Protei | 1e-11 | |
| cd06635 | 317 | cd06635, STKc_TAO1, Catalytic domain of the Protei | 1e-11 | |
| cd06646 | 267 | cd06646, STKc_MAP4K5, Catalytic domain of the Prot | 2e-11 | |
| cd06617 | 283 | cd06617, PKc_MKK3_6, Catalytic domain of the dual- | 2e-11 | |
| cd07879 | 342 | cd07879, STKc_p38delta_MAPK13, Catalytic domain of | 3e-11 | |
| cd07863 | 288 | cd07863, STKc_CDK4, Catalytic domain of the Serine | 3e-11 | |
| cd05601 | 330 | cd05601, STKc_CRIK, Catalytic domain of the Protei | 3e-11 | |
| cd06644 | 292 | cd06644, STKc_STK10_LOK, Catalytic domain of the P | 4e-11 | |
| cd06653 | 264 | cd06653, STKc_MEKK3_like_1, Catalytic domain of MA | 4e-11 | |
| cd05619 | 316 | cd05619, STKc_nPKC_theta, Catalytic domain of the | 4e-11 | |
| cd05605 | 285 | cd05605, STKc_GRK4_like, Catalytic domain of G pro | 4e-11 | |
| cd07880 | 343 | cd07880, STKc_p38gamma_MAPK12, Catalytic domain of | 5e-11 | |
| cd05061 | 288 | cd05061, PTKc_InsR, Catalytic domain of the Protei | 5e-11 | |
| cd07862 | 290 | cd07862, STKc_CDK6, Catalytic domain of the Serine | 6e-11 | |
| cd07869 | 303 | cd07869, STKc_PFTAIRE1, Catalytic domain of the Se | 6e-11 | |
| cd05632 | 285 | cd05632, STKc_GRK5, Catalytic domain of the Protei | 7e-11 | |
| TIGR03903 | 1266 | TIGR03903, TOMM_kin_cyc, TOMM system kinase/cyclas | 7e-11 | |
| cd07848 | 287 | cd07848, STKc_CDKL5, Catalytic domain of the Serin | 9e-11 | |
| cd05620 | 316 | cd05620, STKc_nPKC_delta, Catalytic domain of the | 1e-10 | |
| cd07876 | 359 | cd07876, STKc_JNK2, Catalytic domain of the Serine | 1e-10 | |
| cd05612 | 291 | cd05612, STKc_PRKX_like, Catalytic domain of PRKX- | 1e-10 | |
| cd06634 | 308 | cd06634, STKc_TAO2, Catalytic domain of the Protei | 1e-10 | |
| cd07870 | 291 | cd07870, STKc_PFTAIRE2, Catalytic domain of the Se | 2e-10 | |
| cd07858 | 337 | cd07858, STKc_TEY_MAPK_plant, Catalytic domain of | 2e-10 | |
| PRK13184 | 932 | PRK13184, pknD, serine/threonine-protein kinase; R | 2e-10 | |
| cd06639 | 291 | cd06639, STKc_myosinIIIB, Catalytic domain of the | 2e-10 | |
| cd05089 | 297 | cd05089, PTKc_Tie1, Catalytic domain of the Protei | 2e-10 | |
| cd05593 | 328 | cd05593, STKc_PKB_gamma, Catalytic domain of the P | 2e-10 | |
| cd07878 | 343 | cd07878, STKc_p38beta_MAPK11, Catalytic domain of | 2e-10 | |
| cd07831 | 282 | cd07831, STKc_MOK, Catalytic domain of the Serine/ | 2e-10 | |
| cd07849 | 336 | cd07849, STKc_ERK1_2_like, Catalytic domain of Ext | 2e-10 | |
| cd05036 | 277 | cd05036, PTKc_ALK_LTK, Catalytic domain of the Pro | 2e-10 | |
| cd05583 | 288 | cd05583, STKc_MSK_N, N-terminal catalytic domain o | 3e-10 | |
| cd05580 | 290 | cd05580, STKc_PKA, Catalytic domain of the Protein | 3e-10 | |
| cd05110 | 303 | cd05110, PTKc_HER4, Catalytic domain of the Protei | 3e-10 | |
| cd05613 | 290 | cd05613, STKc_MSK1_N, N-terminal catalytic domain | 4e-10 | |
| cd06633 | 313 | cd06633, STKc_TAO3, Catalytic domain of the Protei | 5e-10 | |
| cd05631 | 285 | cd05631, STKc_GRK4, Catalytic domain of the Protei | 5e-10 | |
| cd05088 | 303 | cd05088, PTKc_Tie2, Catalytic domain of the Protei | 5e-10 | |
| cd05622 | 371 | cd05622, STKc_ROCK1, Catalytic domain of the Prote | 6e-10 | |
| cd05600 | 333 | cd05600, STKc_Sid2p_Dbf2p, Catalytic domain of Fun | 6e-10 | |
| cd07854 | 342 | cd07854, STKc_MAPK4_6, Catalytic domain of the Ser | 7e-10 | |
| cd05109 | 279 | cd05109, PTKc_HER2, Catalytic domain of the Protei | 7e-10 | |
| cd05108 | 316 | cd05108, PTKc_EGFR, Catalytic domain of the Protei | 8e-10 | |
| cd06618 | 296 | cd06618, PKc_MKK7, Catalytic domain of the dual-sp | 8e-10 | |
| cd07867 | 317 | cd07867, STKc_CDC2L6, Catalytic domain of Serine/T | 8e-10 | |
| cd07853 | 372 | cd07853, STKc_NLK, Catalytic domain of the Serine/ | 1e-09 | |
| cd05584 | 323 | cd05584, STKc_p70S6K, Catalytic domain of the Prot | 1e-09 | |
| cd07857 | 332 | cd07857, STKc_MPK1, Catalytic domain of the Serine | 1e-09 | |
| cd05614 | 332 | cd05614, STKc_MSK2_N, N-terminal catalytic domain | 1e-09 | |
| cd06643 | 282 | cd06643, STKc_SLK, Catalytic domain of the Protein | 2e-09 | |
| cd05603 | 321 | cd05603, STKc_SGK2, Catalytic domain of the Protei | 2e-09 | |
| cd05592 | 316 | cd05592, STKc_nPKC_theta_delta, Catalytic domain o | 2e-09 | |
| cd05115 | 257 | cd05115, PTKc_Zap-70, Catalytic domain of the Prot | 2e-09 | |
| cd07874 | 355 | cd07874, STKc_JNK3, Catalytic domain of the Serine | 3e-09 | |
| cd05596 | 370 | cd05596, STKc_ROCK, Catalytic domain of the Protei | 3e-09 | |
| cd07850 | 353 | cd07850, STKc_JNK, Catalytic domain of the Serine/ | 3e-09 | |
| cd05091 | 283 | cd05091, PTKc_Ror2, Catalytic domain of the Protei | 3e-09 | |
| cd07859 | 338 | cd07859, STKc_TDY_MAPK_plant, Catalytic domain of | 4e-09 | |
| cd07844 | 291 | cd07844, STKc_PCTAIRE_like, Catalytic domain of PC | 4e-09 | |
| cd08222 | 260 | cd08222, STKc_Nek11, Catalytic domain of the Prote | 5e-09 | |
| cd05575 | 323 | cd05575, STKc_SGK, Catalytic domain of the Protein | 5e-09 | |
| cd07868 | 317 | cd07868, STKc_CDK8, Catalytic domain of the Serine | 5e-09 | |
| cd05116 | 257 | cd05116, PTKc_Syk, Catalytic domain of the Protein | 7e-09 | |
| cd05602 | 325 | cd05602, STKc_SGK1, Catalytic domain of the Protei | 7e-09 | |
| cd05043 | 280 | cd05043, PTK_Ryk, Pseudokinase domain of Ryk (Rece | 7e-09 | |
| cd05047 | 270 | cd05047, PTKc_Tie, Catalytic domain of Tie Protein | 8e-09 | |
| cd05056 | 270 | cd05056, PTKc_FAK, Catalytic domain of the Protein | 1e-08 | |
| cd05621 | 370 | cd05621, STKc_ROCK2, Catalytic domain of the Prote | 1e-08 | |
| PTZ00036 | 440 | PTZ00036, PTZ00036, glycogen synthase kinase; Prov | 1e-08 | |
| cd06622 | 286 | cd06622, PKc_MAPKK_PBS2_like, Catalytic domain of | 1e-08 | |
| cd05604 | 325 | cd05604, STKc_SGK3, Catalytic domain of the Protei | 1e-08 | |
| PHA03207 | 392 | PHA03207, PHA03207, serine/threonine kinase US3; P | 2e-08 | |
| cd06637 | 272 | cd06637, STKc_TNIK, Catalytic domain of the Protei | 2e-08 | |
| cd05054 | 337 | cd05054, PTKc_VEGFR, Catalytic domain of the Prote | 2e-08 | |
| cd07875 | 364 | cd07875, STKc_JNK1, Catalytic domain of the Serine | 3e-08 | |
| cd06636 | 282 | cd06636, STKc_MAP4K4_6, Catalytic domain of the Pr | 4e-08 | |
| cd05102 | 338 | cd05102, PTKc_VEGFR3, Catalytic domain of the Prot | 4e-08 | |
| cd05586 | 330 | cd05586, STKc_Sck1_like, Catalytic domain of Suppr | 4e-08 | |
| cd05616 | 323 | cd05616, STKc_cPKC_beta, Catalytic domain of the P | 5e-08 | |
| PTZ00267 | 478 | PTZ00267, PTZ00267, NIMA-related protein kinase; P | 7e-08 | |
| cd05064 | 266 | cd05064, PTKc_EphR_A10, Catalytic domain of the Pr | 8e-08 | |
| cd05571 | 323 | cd05571, STKc_PKB, Catalytic domain of the Protein | 8e-08 | |
| cd05111 | 279 | cd05111, PTK_HER3, Pseudokinase domain of the Prot | 8e-08 | |
| cd05587 | 324 | cd05587, STKc_cPKC, Catalytic domain of the Protei | 9e-08 | |
| cd05595 | 323 | cd05595, STKc_PKB_beta, Catalytic domain of the Pr | 1e-07 | |
| cd05570 | 318 | cd05570, STKc_PKC, Catalytic domain of the Protein | 1e-07 | |
| cd05594 | 325 | cd05594, STKc_PKB_alpha, Catalytic domain of the P | 1e-07 | |
| cd05055 | 302 | cd05055, PTKc_PDGFR, Catalytic domain of the Prote | 1e-07 | |
| cd05633 | 279 | cd05633, STKc_GRK3, Catalytic domain of the Protei | 2e-07 | |
| cd05574 | 316 | cd05574, STKc_phototropin_like, Catalytic domain o | 2e-07 | |
| cd08219 | 255 | cd08219, STKc_Nek3, Catalytic domain of the Protei | 2e-07 | |
| cd05615 | 323 | cd05615, STKc_cPKC_alpha, Catalytic domain of the | 3e-07 | |
| cd07871 | 288 | cd07871, STKc_PCTAIRE3, Catalytic domain of the Se | 3e-07 | |
| cd07873 | 301 | cd07873, STKc_PCTAIRE1, Catalytic domain of the Se | 4e-07 | |
| cd05606 | 278 | cd05606, STKc_beta_ARK, Catalytic domain of the Pr | 4e-07 | |
| cd05589 | 324 | cd05589, STKc_PKN, Catalytic domain of the Protein | 4e-07 | |
| cd07872 | 309 | cd07872, STKc_PCTAIRE2, Catalytic domain of the Se | 4e-07 | |
| PTZ00263 | 329 | PTZ00263, PTZ00263, protein kinase A catalytic sub | 4e-07 | |
| cd05609 | 305 | cd05609, STKc_MAST, Catalytic domain of the Protei | 4e-07 | |
| cd07837 | 295 | cd07837, STKc_CdkB_plant, Catalytic domain of the | 5e-07 | |
| cd05624 | 331 | cd05624, STKc_MRCK_beta, Catalytic domain of the P | 2e-06 | |
| cd05037 | 259 | cd05037, PTK_Jak_rpt1, Pseudokinase (repeat 1) dom | 2e-06 | |
| cd05585 | 312 | cd05585, STKc_YPK1_like, Catalytic domain of Yeast | 2e-06 | |
| cd05590 | 320 | cd05590, STKc_nPKC_eta, Catalytic domain of the Pr | 3e-06 | |
| cd05103 | 343 | cd05103, PTKc_VEGFR2, Catalytic domain of the Prot | 4e-06 | |
| cd06638 | 286 | cd06638, STKc_myosinIIIA, Catalytic domain of the | 5e-06 | |
| cd05623 | 332 | cd05623, STKc_MRCK_alpha, Catalytic domain of the | 5e-06 | |
| cd05597 | 331 | cd05597, STKc_DMPK_like, Catalytic domain of Myoto | 5e-06 | |
| PHA03209 | 357 | PHA03209, PHA03209, serine/threonine kinase US3; P | 7e-06 | |
| cd05105 | 400 | cd05105, PTKc_PDGFR_alpha, Catalytic domain of the | 8e-06 | |
| cd05573 | 350 | cd05573, STKc_ROCK_NDR_like, Catalytic domain of R | 8e-06 | |
| PTZ00426 | 340 | PTZ00426, PTZ00426, cAMP-dependent protein kinase | 9e-06 | |
| PHA03390 | 267 | PHA03390, pk1, serine/threonine-protein kinase 1; | 1e-05 | |
| cd05588 | 329 | cd05588, STKc_aPKC, Catalytic domain of the Protei | 4e-05 | |
| cd05610 | 669 | cd05610, STKc_MASTL, Catalytic domain of the Prote | 6e-05 | |
| PTZ00266 | 1021 | PTZ00266, PTZ00266, NIMA-related protein kinase; P | 7e-05 | |
| cd05591 | 321 | cd05591, STKc_nPKC_epsilon, Catalytic domain of th | 7e-05 | |
| cd05107 | 401 | cd05107, PTKc_PDGFR_beta, Catalytic domain of the | 8e-05 | |
| cd05042 | 269 | cd05042, PTKc_Aatyk, Catalytic domain of the Prote | 8e-05 | |
| cd05120 | 155 | cd05120, APH_ChoK_like, Aminoglycoside 3'-phosphot | 1e-04 | |
| cd05617 | 327 | cd05617, STKc_aPKC_zeta, Catalytic domain of the P | 1e-04 | |
| cd08226 | 328 | cd08226, PK_STRAD_beta, Pseudokinase domain of STE | 1e-04 | |
| PHA02988 | 283 | PHA02988, PHA02988, hypothetical protein; Provisio | 2e-04 | |
| PHA03212 | 391 | PHA03212, PHA03212, serine/threonine kinase US3; P | 4e-04 | |
| cd05618 | 329 | cd05618, STKc_aPKC_iota, Catalytic domain of the P | 5e-04 | |
| cd05087 | 269 | cd05087, PTKc_Aatyk1_Aatyk3, Catalytic domain of t | 0.001 |
| >gnl|CDD|215690 pfam00069, Pkinase, Protein kinase domain | Back alignment and domain information |
|---|
Score = 159 bits (404), Expect = 2e-47
Identities = 86/283 (30%), Positives = 133/283 (46%), Gaps = 37/283 (13%)
Query: 19 IIGNSNLSTVYKGR-LEDGEIVAVKKLNFHQFSAESDKSFYREAKTLKELKHRNLVKVLG 77
+G+ + TVYK + G+IVAVK L ++ D++ RE + L+ L H N+V+++
Sbjct: 6 KLGSGSFGTVYKAKHKGTGKIVAVKILKKRSEKSKKDQTARREIRILRRLSHPNIVRLID 65
Query: 78 YAWESGKLKALILEYMENGSLESVIHGPGVDHSRWTLPKRIDVLISVANGLDYLHSGYDI 137
A+E L++EY E G L + + + + + + GL+YLHS
Sbjct: 66 -AFEDKDHLYLVMEYCEGGDLFDYL----SRGGPLSEDEAKKIALQILRGLEYLHS---N 117
Query: 138 PIVHCDMKPSNILLDRDFEAHVSDFGTSRMLDVHLQDLSSLSTAFQGTIGYLAPE---FA 194
I+H D+KP NILLD + ++DFG ++ L SS T F GT Y+APE
Sbjct: 118 GIIHRDLKPENILLDENGVVKIADFGLAKKLLKS----SSSLTTFVGTPWYMAPEVLLGG 173
Query: 195 YMRIVTTKVDVFSFGIVVMEFLTKRRPTGLDEENGLSPISLRQLVEKALANGINGVRQIT 254
KVDV+S G+++ E LT + P EN L + L +R+I
Sbjct: 174 NG--YGPKVDVWSLGVILYELLTGKPP--FSGENILDQLQL--------------IRRIL 215
Query: 255 DPKLVSSIYEEQEQHQVLEELFKLALVCTSSNPEDRPNMNELL 297
P L ++E + EE L C + +P RP E+L
Sbjct: 216 GPPL---EFDEPKWSSGSEEAKDLIKKCLNKDPSKRPTAEEIL 255
|
Length = 260 |
| >gnl|CDD|173623 cd00180, PKc, Catalytic domain of Protein Kinases | Back alignment and domain information |
|---|
Score = 153 bits (388), Expect = 1e-45
Identities = 63/199 (31%), Positives = 103/199 (51%), Gaps = 15/199 (7%)
Query: 20 IGNSNLSTVYKGR-LEDGEIVAVKKLNFHQFSAESDKSFYREAKTLKELKHRNLVKVLGY 78
+G TVY R + G+ VA+K + S+ + RE + LK+L H N+VK+ G
Sbjct: 1 LGEGGFGTVYLARDKKTGKKVAIKIIKKEDSSSLLE-ELLREIEILKKLNHPNIVKLYGV 59
Query: 79 AWESGKLKALILEYMENGSLESVIHGPGVDHSRWTLPKRIDVLISVANGLDYLHSGYDIP 138
+E L++EY E GSL+ ++ + + + + + +L+ + GL+YLHS
Sbjct: 60 -FEDENHLYLVMEYCEGGSLKDLLK---ENEGKLSEDEILRILLQILEGLEYLHS---NG 112
Query: 139 IVHCDMKPSNILLD-RDFEAHVSDFGTSRMLDVHLQDLSSLSTAFQGTIGYLAPE-FAYM 196
I+H D+KP NILLD + + ++DFG S+ L SL GT Y+APE
Sbjct: 113 IIHRDLKPENILLDSDNGKVKLADFGLSK----LLTSDKSLLKTIVGTPAYMAPEVLLGK 168
Query: 197 RIVTTKVDVFSFGIVVMEF 215
+ K D++S G+++ E
Sbjct: 169 GYYSEKSDIWSLGVILYEL 187
|
Protein Kinases (PKs), catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The PK family is part of a larger superfamily that includes the catalytic domains of RIO kinases, aminoglycoside phosphotransferase, choline kinase, phosphoinositide 3-kinase (PI3K), and actin-fragmin kinase. PKs make up a large family of serine/threonine kinases, protein tyrosine kinases (PTKs), and dual-specificity PKs that phosphorylate both serine/threonine and tyrosine residues of target proteins. Majority of protein phosphorylation, about 95%, occurs on serine residues while only 1% occurs on tyrosine residues. Protein phosphorylation is a mechanism by which a wide variety of cellular proteins, such as enzymes and membrane channels, are reversibly regulated in response to certain stimuli. PKs often function as components of signal transduction pathways in which one kinase activates a second kinase, which in turn, may act on other kinases; this sequential action transmits a signal from the cell surface to target proteins, which results in cellular responses. The PK family is one of the largest known protein families with more than 100 homologous yeast enzymes and 550 human proteins. A fraction of PK family members are pseudokinases that lack crucial residues for catalytic activity. The mutiplicity of kinases allows for specific regulation according to substrate, tissue distribution, and cellular localization. PKs regulate many cellular processes including proliferation, division, differentiation, motility, survival, metabolism, cell-cycle progression, cytoskeletal rearrangement, immunity, and neuronal functions. Many kinases are implicated in the development of various human diseases including different types of cancer. Length = 215 |
| >gnl|CDD|214567 smart00220, S_TKc, Serine/Threonine protein kinases, catalytic domain | Back alignment and domain information |
|---|
Score = 146 bits (372), Expect = 9e-43
Identities = 66/197 (33%), Positives = 100/197 (50%), Gaps = 15/197 (7%)
Query: 26 STVYKGR-LEDGEIVAVKKLNFHQFSAESDKSFYREAKTLKELKHRNLVKVLGYAWESGK 84
VY R + G++VA+K + + + + RE K LK+LKH N+V++ + K
Sbjct: 13 GKVYLARDKKTGKLVAIKVIK-KKKIKKDRERILREIKILKKLKHPNIVRLYDVFEDEDK 71
Query: 85 LKALILEYMENGSLESVIHGPGVDHSRWTLPKRIDVLISVANGLDYLHSGYDIPIVHCDM 144
L L++EY E G L ++ R + + L + + L+YLHS IVH D+
Sbjct: 72 L-YLVMEYCEGGDLFDLLK----KRGRLSEDEARFYLRQILSALEYLHS---KGIVHRDL 123
Query: 145 KPSNILLDRDFEAHVSDFGTSRMLDVHLQDLSSLSTAFQGTIGYLAPEFAYMRIVTTKVD 204
KP NILLD D ++DFG +R LD T F GT Y+APE + VD
Sbjct: 124 KPENILLDEDGHVKLADFGLARQLDPG-----EKLTTFVGTPEYMAPEVLLGKGYGKAVD 178
Query: 205 VFSFGIVVMEFLTKRRP 221
++S G+++ E LT + P
Sbjct: 179 IWSLGVILYELLTGKPP 195
|
Phosphotransferases. Serine or threonine-specific kinase subfamily. Length = 254 |
| >gnl|CDD|197581 smart00219, TyrKc, Tyrosine kinase, catalytic domain | Back alignment and domain information |
|---|
Score = 143 bits (362), Expect = 3e-41
Identities = 84/292 (28%), Positives = 130/292 (44%), Gaps = 52/292 (17%)
Query: 17 NNIIGNSNLSTVYKGRLED-----GEIVAVKKLNFHQFSAESDKSFYREAKTLKELKHRN 71
+G VYKG+L+ VAVK L S + + F REA+ +++L H N
Sbjct: 4 GKKLGEGAFGEVYKGKLKGKGGKKKVEVAVKTLKEDA-SEQQIEEFLREARIMRKLDHPN 62
Query: 72 LVKVLGYAWESGKLKALILEYMENGSLESVIHGPGVDHSRWTLPKRIDVLISVANGLDYL 131
+VK+LG E L +++EYME G L S + + +L + + +A G++YL
Sbjct: 63 VVKLLGVCTEEEPLY-IVMEYMEGGDLLSYLRKN---RPKLSLSDLLSFALQIARGMEYL 118
Query: 132 HSGYDIPIVHCDMKPSNILLDRDFEAHVSDFGTSRML---DVHLQDLSSLSTAFQGTIGY 188
S +H D+ N L+ + +SDFG SR L D + + L I +
Sbjct: 119 ES---KNFIHRDLAARNCLVGENLVVKISDFGLSRDLYDDDYYRKRGGKL------PIRW 169
Query: 189 LAPEFAYMRIVTTKVDVFSFGIVVMEFLTKRRPTGLDEENGLSP---ISLRQLVEKALAN 245
+APE T+K DV+SFG+++ E T G P +S +++E L N
Sbjct: 170 MAPESLKEGKFTSKSDVWSFGVLLWEIFT----------LGEQPYPGMSNEEVLEY-LKN 218
Query: 246 GINGVRQITDPKLVSSIYEEQEQHQVLEELFKLALVCTSSNPEDRPNMNELL 297
G Y + EL+ L L C + +PEDRP +EL+
Sbjct: 219 G----------------YRLPQPPNCPPELYDLMLQCWAEDPEDRPTFSELV 254
|
Phosphotransferases. Tyrosine-specific kinase subfamily. Length = 257 |
| >gnl|CDD|214568 smart00221, STYKc, Protein kinase; unclassified specificity | Back alignment and domain information |
|---|
Score = 141 bits (359), Expect = 7e-41
Identities = 80/290 (27%), Positives = 122/290 (42%), Gaps = 47/290 (16%)
Query: 17 NNIIGNSNLSTVYKGRLEDG-----EIVAVKKLNFHQFSAESDKSFYREAKTLKELKHRN 71
+G VYKG L+ VAVK L S + + F REA+ +++L H N
Sbjct: 4 GKKLGEGAFGEVYKGTLKGKGDGKEVEVAVKTLK-EDASEQQIEEFLREARIMRKLDHPN 62
Query: 72 LVKVLGYAWESGKLKALILEYMENGSLESVIHGPGVDHSRWTLPKRIDVLISVANGLDYL 131
+VK+LG E L +++EYM G L + +L + + +A G++YL
Sbjct: 63 IVKLLGVCTEEEPLM-IVMEYMPGGDLLDYLRKNR--PKELSLSDLLSFALQIARGMEYL 119
Query: 132 HSGYDIPIVHCDMKPSNILLDRDFEAHVSDFGTSRMLDVHLQDLSSLSTAFQGTIGYLAP 191
S +H D+ N L+ + +SDFG SR L + I ++AP
Sbjct: 120 ES---KNFIHRDLAARNCLVGENLVVKISDFGLSRDLYDDDYYKVKGG---KLPIRWMAP 173
Query: 192 E-FAYMRIVTTKVDVFSFGIVVMEFLTKRRPTGLDEENGLSP---ISLRQLVEKALANGI 247
E T+K DV+SFG+++ E T G P +S +++E L G
Sbjct: 174 ESLKE-GKFTSKSDVWSFGVLLWEIFT----------LGEEPYPGMSNAEVLEY-LKKG- 220
Query: 248 NGVRQITDPKLVSSIYEEQEQHQVLEELFKLALVCTSSNPEDRPNMNELL 297
P EL+KL L C + +PEDRP +EL+
Sbjct: 221 -YRLPK--PPNCP------------PELYKLMLQCWAEDPEDRPTFSELV 255
|
Phosphotransferases. The specificity of this class of kinases can not be predicted. Possible dual-specificity Ser/Thr/Tyr kinase. Length = 258 |
| >gnl|CDD|173724 cd06606, STKc_MAPKKK, Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-Activated Protein Kinase Kinase Kinase | Back alignment and domain information |
|---|
Score = 140 bits (356), Expect = 2e-40
Identities = 64/211 (30%), Positives = 102/211 (48%), Gaps = 21/211 (9%)
Query: 18 NIIGNSNLSTVYKGRLED-GEIVAVKKLNFHQFSAESDKSFYREAKTLKELKHRNLVKVL 76
++G + +VY +D GE++AVK + S E ++ RE + L L+H N+V+
Sbjct: 6 ELLGRGSFGSVYLALDKDTGELMAVKSVELSGDSEEELEALEREIRILSSLQHPNIVRYY 65
Query: 77 GYAWESGKLKALI-LEYMENGSLESVIHGPGVDH----SRWTLPKRIDVLISVANGLDYL 131
G + K I LEY+ GSL S++ G ++T +L GL YL
Sbjct: 66 GSERDEEKNTLNIFLEYVSGGSLSSLLKKFGKLPEPVIRKYT----RQIL----EGLAYL 117
Query: 132 HS-GYDIPIVHCDMKPSNILLDRDFEAHVSDFGTSRMLDVHLQDLSSLSTAFQGTIGYLA 190
HS G IVH D+K +NIL+D D ++DFG ++ L + + + +GT ++A
Sbjct: 118 HSNG----IVHRDIKGANILVDSDGVVKLADFGCAKRL--GDIETGEGTGSVRGTPYWMA 171
Query: 191 PEFAYMRIVTTKVDVFSFGIVVMEFLTKRRP 221
PE D++S G V+E T + P
Sbjct: 172 PEVIRGEEYGRAADIWSLGCTVIEMATGKPP 202
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKKKs (MKKKs or MAP3Ks) are also called MAP/ERK kinase kinases (MEKKs) in some cases. They phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. This subfamily is composed of the Apoptosis Signal-regulating Kinases ASK1 (or MAPKKK5) and ASK2 (or MAPKKK6), MEKK1, MEKK2, MEKK3, MEKK4, as well as plant and fungal MAPKKKs. Also included in this subfamily are the cell division control proteins Schizosaccharomyces pombe Cdc7 and Saccharomyces cerevisiae Cdc15. Length = 260 |
| >gnl|CDD|219530 pfam07714, Pkinase_Tyr, Protein tyrosine kinase | Back alignment and domain information |
|---|
Score = 137 bits (348), Expect = 3e-39
Identities = 79/280 (28%), Positives = 124/280 (44%), Gaps = 47/280 (16%)
Query: 27 TVYKGRL-----EDGEIVAVKKLNFHQFSAESDKSFYREAKTLKELKHRNLVKVLGYAWE 81
VYKG L VAVK L S E + F EA +K+L H N+V++LG +
Sbjct: 14 EVYKGTLKGDGEGTETKVAVKTLK-EGASEEEREEFLEEASIMKKLSHPNIVRLLGVCTQ 72
Query: 82 SGKLKALILEYMENGSLESVIHGPGVDHSRWTLPKRIDVLISVANGLDYLHSGYDIPIVH 141
L ++ EYM G L + G + TL + + + +A G++YL S VH
Sbjct: 73 GEPLY-IVTEYMPGGDLLDFLRKHG---EKLTLKDLLQMALQIAKGMEYLES---KNFVH 125
Query: 142 CDMKPSNILLDRDFEAHVSDFGTSRMLDVHLQDLSSLSTAFQGTIGYLAPE-FAYMRIVT 200
D+ N L+ + +SDFG SR + I ++APE + T
Sbjct: 126 RDLAARNCLVTENLVVKISDFGLSRDIYEDDYYRKRGGGKL--PIKWMAPESLKDGKF-T 182
Query: 201 TKVDVFSFGIVVMEFLTKRRPTGLDEENGLSP---ISLRQLVEKALANGINGVRQITDPK 257
+K DV+SFG+++ E T G P +S +++E L +G ++ P+
Sbjct: 183 SKSDVWSFGVLLWEIFT----------LGEQPYPGMSNEEVLEL-LEDG----YRLPRPE 227
Query: 258 LVSSIYEEQEQHQVLEELFKLALVCTSSNPEDRPNMNELL 297
+EL++L L C + +PEDRP +EL+
Sbjct: 228 NCP------------DELYELMLQCWAYDPEDRPTFSELV 255
|
Length = 258 |
| >gnl|CDD|173624 cd00192, PTKc, Catalytic domain of Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 137 bits (347), Expect = 5e-39
Identities = 87/293 (29%), Positives = 136/293 (46%), Gaps = 48/293 (16%)
Query: 18 NIIGNSNLSTVYKGRLEDGE----IVAVKKLNFHQFSAESDKS-FYREAKTLKELKHRNL 72
+G VYKG+L+ + VAVK L + ++E ++ F +EA+ +K+L H N+
Sbjct: 1 KKLGEGAFGEVYKGKLKGKDGKTTEVAVKTL--KEDASEEERKDFLKEARVMKKLGHPNV 58
Query: 73 VKVLGYAWESGKLKALILEYMENGSL-----ESVIHGPGVDHSRWTLPKRIDVLISVANG 127
V++LG E L L+LEYME G L +S P + S +L + I +A G
Sbjct: 59 VRLLGVCTEEEPLY-LVLEYMEGGDLLDYLRKSRPVFPSPEKSTLSLKDLLSFAIQIAKG 117
Query: 128 LDYLHSGYDIPIVHCDMKPSNILLDRDFEAHVSDFGTSRMLDVHLQDLSSLSTAFQGTIG 187
++YL S VH D+ N L+ D +SDFG SR + I
Sbjct: 118 MEYLAS---KKFVHRDLAARNCLVGEDLVVKISDFGLSRDVYDDDYYRKKTGGKL--PIR 172
Query: 188 YLAPEFAYMRIVTTKVDVFSFGIVVMEFLTKRRPTGLDEENGLSP---ISLRQLVEKALA 244
++APE I T+K DV+SFG+++ E T G +P +S +++E L
Sbjct: 173 WMAPESLKDGIFTSKSDVWSFGVLLWEIFT----------LGATPYPGLSNEEVLEY-LR 221
Query: 245 NGINGVRQITDPKLVSSIYEEQEQHQVLEELFKLALVCTSSNPEDRPNMNELL 297
G ++ P+ +EL++L L C +PEDRP +EL+
Sbjct: 222 KG----YRLPKPEYCP------------DELYELMLSCWQLDPEDRPTFSELV 258
|
Protein Tyrosine Kinase (PTK) family, catalytic domain. This PTKc family is part of a larger superfamily that includes the catalytic domains of protein serine/threonine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. They can be classified into receptor and non-receptor tyr kinases. PTKs play important roles in many cellular processes including, lymphocyte activation, epithelium growth and maintenance, metabolism control, organogenesis regulation, survival, proliferation, differentiation, migration, adhesion, motility, and morphogenesis. Receptor tyr kinases (RTKs) are integral membrane proteins which contain an extracellular ligand-binding region, a transmembrane segment, and an intracellular tyr kinase domain. RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain, leading to intracellular signaling. Some RTKs are orphan receptors with no known ligands. Non-receptor (or cytoplasmic) tyr kinases are distributed in different intracellular compartments and are usually multi-domain proteins containing a catalytic tyr kinase domain as well as various regulatory domains such as SH3 and SH2. PTKs are usually autoinhibited and require a mechanism for activation. In many PTKs, the phosphorylation of tyr residues in the activation loop is essential for optimal activity. Aberrant expression of PTKs is associated with many development abnormalities and cancers. Length = 262 |
| >gnl|CDD|173731 cd06627, STKc_Cdc7_like, Catalytic domain of Cell division control protein 7-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 134 bits (339), Expect = 6e-38
Identities = 74/208 (35%), Positives = 106/208 (50%), Gaps = 19/208 (9%)
Query: 18 NIIGNSNLSTVYKG-RLEDGEIVAVKKLNFHQFSAESDKSFYREAKTLKELKHRNLVKVL 76
++IG VYKG LE G+ VA+K+++ + E+ KS +E LK LKH N+VK +
Sbjct: 6 DLIGRGAFGVVYKGLNLETGDFVAIKQISLEKIKEEALKSIMQEIDLLKNLKHPNIVKYI 65
Query: 77 GYAWESGKLKALILEYMENGSLESVIHGPGVDHSRWTLPKR--IDVLISVANGLDYLH-S 133
G S L +ILEY ENGSL +I G P+ + V GL YLH
Sbjct: 66 GSIETSDSL-YIILEYAENGSLRQIIKKFG------PFPESLVAVYVYQVLQGLAYLHEQ 118
Query: 134 GYDIPIVHCDMKPSNILLDRDFEAHVSDFGTSRMLDVHLQDLSSLSTAFQGTIGYLAPEF 193
G ++H D+K +NIL +D ++DFG + L D+S + GT ++APE
Sbjct: 119 G----VIHRDIKAANILTTKDGVVKLADFGVA----TKLNDVSKDDASVVGTPYWMAPEV 170
Query: 194 AYMRIVTTKVDVFSFGIVVMEFLTKRRP 221
M +T D++S G V+E LT P
Sbjct: 171 IEMSGASTASDIWSLGCTVIELLTGNPP 198
|
Serine/threonine kinases (STKs), (Cdc7)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Cdc7-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include Schizosaccharomyces pombe Cdc7, Saccharomyces cerevisiae Cdc15, Arabidopsis thaliana mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) epsilon, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast Cdc7 is essential for cell division by playing a key role in the initiation of septum formation and cytokinesis. Budding yeast Cdc15 functions to coordinate mitotic exit with cytokinesis. Arabidopsis MAPKKK epsilon is required for pollen development in the plasma membrane. Length = 254 |
| >gnl|CDD|173755 cd08215, STKc_Nek, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase | Back alignment and domain information |
|---|
Score = 125 bits (316), Expect = 2e-34
Identities = 77/284 (27%), Positives = 122/284 (42%), Gaps = 44/284 (15%)
Query: 20 IGNSNLSTVYKGR-LEDGEIVAVKKLNFHQFSAESDKSFYREAKTLKELKHRNLVKVLGY 78
IG + VY R DG++ +K+++ S + + E K LK+L H N++K
Sbjct: 8 IGKGSFGKVYLVRRKSDGKLYVLKEIDLSNMSEKEREDALNEVKILKKLNHPNIIKYYES 67
Query: 79 AWESGKLKALILEYMENGSLESVIHGPGVDHSRWTLPKRIDVLISVANGLDYLHSGYDIP 138
E GKL +++EY + G L I + + + +D + + L YLHS
Sbjct: 68 FEEKGKL-CIVMEYADGGDLSQKIKKQKKEGKPFPEEQILDWFVQLCLALKYLHS---RK 123
Query: 139 IVHCDMKPSNILLDRDFEAHVSDFGTSRMLDVHLQDLSSLSTAFQGTIGYLAPEF----A 194
I+H D+KP NI L + + DFG S++ L L+ GT YL+PE
Sbjct: 124 ILHRDIKPQNIFLTSNGLVKLGDFGISKV----LSSTVDLAKTVVGTPYYLSPELCQNKP 179
Query: 195 YMRIVTTKVDVFSFGIVVMEFLTKRRP-TGLDEENGLSPISLRQLVEKALANGINGVRQI 253
Y K D++S G V+ E T + P G +L +L K I ++
Sbjct: 180 Y----NYKSDIWSLGCVLYELCTLKHPFEG---------ENLLELALK-----I--LKGQ 219
Query: 254 TDPKLVSSIYEEQEQHQVLEELFKLALVCTSSNPEDRPNMNELL 297
P + S Y EL L +PE+RP++ ++L
Sbjct: 220 YPP--IPSQYS--------SELRNLVSSLLQKDPEERPSIAQIL 253
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase (Nek) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek family is composed of 11 different mammalian members (Nek1-11) with similarity to the catalytic domain of Aspergillus nidulans NIMA kinase, the founding member of the Nek family which was identified in a screen for cell cycle mutants that were prevented from entering mitosis. Neks contain a conserved N-terminal catalytic domain and a more divergent C-terminal regulatory region of various sizes and structures. They are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Length = 258 |
| >gnl|CDD|173659 cd05122, PKc_STE, Catalytic domain of STE family Protein Kinases | Back alignment and domain information |
|---|
Score = 118 bits (297), Expect = 1e-31
Identities = 84/286 (29%), Positives = 124/286 (43%), Gaps = 52/286 (18%)
Query: 20 IGNSNLSTVYKGR-LEDGEIVAVKKLNFHQFSAESDKSFYREAKTLKELKHRNLVKVLGY 78
IG VYK R G+ VA+K + S E + E + LK+ KH N+VK G
Sbjct: 8 IGKGGFGEVYKARHKRTGKEVAIKVIKLE--SKEKKEKIINEIQILKKCKHPNIVKYYGS 65
Query: 79 AWESGKLKALILEYMENGSLESVIHGPGVDHSRWTLPKRI--DVLISVANGLDYLHSGYD 136
+ +L +++E+ GSL+ ++ + TL + V + GL+YLHS
Sbjct: 66 YLKKDELW-IVMEFCSGGSLKDLL-----KSTNQTLTESQIAYVCKELLKGLEYLHS--- 116
Query: 137 IPIVHCDMKPSNILLDRDFEAHVSDFGTSRMLDVHLQDLSSLSTAFQGTIGYLAPEF--- 193
I+H D+K +NILL D E + DFG S L D + +T GT ++APE
Sbjct: 117 NGIIHRDIKAANILLTSDGEVKLIDFGLS----AQLSDTKARNT-MVGTPYWMAPEVING 171
Query: 194 -AYMRIVTTKVDVFSFGIVVMEFLTKRRPTGLDEENGLSPISLRQLVEKAL-ANGINGVR 251
Y K D++S GI +E L + +P + L P+ KAL NG
Sbjct: 172 KPY----DYKADIWSLGITAIE-LAEGKPPYSE----LPPM-------KALFKIATNGPP 215
Query: 252 QITDPKLVSSIYEEQEQHQVLEELFKLALVCTSSNPEDRPNMNELL 297
+ +P+ S +E C NPE RP +LL
Sbjct: 216 GLRNPEKWS------------DEFKDFLKKCLQKNPEKRPTAEQLL 249
|
Protein Kinases (PKs), STE family, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The STE family is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases (STKs), protein tyrosine kinases (PTKs), RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This family is composed of STKs, and some dual-specificity PKs that phosphorylate both threonine and tyrosine residues of target proteins. Most members are kinases involved in mitogen-activated protein kinase (MAPK) signaling cascades, acting as MAPK kinases (MAPKKs), MAPK kinase kinases (MAPKKKs), or MAPK kinase kinase kinases (MAP4Ks). The MAPK signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and activated by a MAPKK, which itself is phosphorylated and activated by a MAPKKK. Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAPKKK to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. Other STE family members include p21-activated kinases (PAKs) and class III myosins, among others. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain, which can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, as well as autophosphorylate the C-terminal motor domain. They play an important role in maintaining the structural integrity of photoreceptor cell microvilli. Length = 253 |
| >gnl|CDD|223589 COG0515, SPS1, Serine/threonine protein kinase [General function prediction only / Signal transduction mechanisms / Transcription / DNA replication, recombination, and repair] | Back alignment and domain information |
|---|
Score = 118 bits (295), Expect = 1e-30
Identities = 70/285 (24%), Positives = 129/285 (45%), Gaps = 26/285 (9%)
Query: 20 IGNSNLSTVYKGRLEDGEIVAVKKLNF-HQFSAESDKSFYREAKTLKELKHRNLVKVLGY 78
+G + VY R D ++VA+K L + ++ + F RE + L L H + L
Sbjct: 8 LGEGSFGEVYLAR--DRKLVALKVLAKKLESKSKEVERFLREIQILASLNHPPNIVKLYD 65
Query: 79 AWESGKLKALILEYMENGSLESVIHGPGVDHSRWTLPKRIDVLISVANGLDYLHSGYDIP 138
++ L++EY++ GSLE ++ G + + + +L + + L+YLHS
Sbjct: 66 FFQDEGSLYLVMEYVDGGSLEDLLKKIG-RKGPLSESEALFILAQILSALEYLHS---KG 121
Query: 139 IVHCDMKPSNILLDRD-FEAHVSDFGTSRMLDVHLQDLS--SLSTAFQGTIGYLAPE--- 192
I+H D+KP NILLDRD + DFG +++L S +L + GT GY+APE
Sbjct: 122 IIHRDIKPENILLDRDGRVVKLIDFGLAKLLPDPGSTSSIPALPSTSVGTPGYMAPEVLL 181
Query: 193 FAYMRIVTTKVDVFSFGIVVMEFLTKRRPTGLDEENGLSPISLRQLVEKALANGINGVRQ 252
+ ++ D++S GI + E LT P ++ + + +L+ ++E
Sbjct: 182 GLSLAYASSSSDIWSLGITLYELLTGLPPFEGEKNSSATSQTLKIILEL----------- 230
Query: 253 ITDPKLVSSIYEEQEQHQVLEELFKLALVCTSSNPEDRPNMNELL 297
++S + + L + +P++R + + L
Sbjct: 231 --PTPSLASPLSPSNPELISKAASDLLKKLLAKDPKNRLSSSSDL 273
|
Length = 384 |
| >gnl|CDD|132954 cd06623, PKc_MAPKK_plant_like, Catalytic domain of Plant dual-specificity MAP kinase kinases and similar proteins | Back alignment and domain information |
|---|
Score = 115 bits (290), Expect = 2e-30
Identities = 63/210 (30%), Positives = 110/210 (52%), Gaps = 27/210 (12%)
Query: 20 IGNSNLSTVYKGRL-EDGEIVAVKKLNFHQFSAES-DKSFYREAKTLKELKHRNLVKVLG 77
+G + VYK R G+I A+KK++ E K RE KTL+ + +VK G
Sbjct: 9 LGQGSSGVVYKVRHKPTGKIYALKKIHV--DGDEEFRKQLLRELKTLRSCESPYVVKCYG 66
Query: 78 YAWESGKLKALILEYMENGSLESVIHGPGVDHSRWTLPKRI--DVLISVANGLDYLHSGY 135
++ G++ +++LEYM+ GSL ++ +P+ + + + GLDYLH+
Sbjct: 67 AFYKEGEI-SIVLEYMDGGSLADLLK------KVGKIPEPVLAYIARQILKGLDYLHT-- 117
Query: 136 DIPIVHCDMKPSNILLDRDFEAHVSDFGTSRMLDVHLQDLSSLSTAFQGTIGYLAPEFAY 195
I+H D+KPSN+L++ E ++DFG S++L+ L ++ F GT+ Y++PE
Sbjct: 118 KRHIIHRDIKPSNLLINSKGEVKIADFGISKVLENTLDQCNT----FVGTVTYMSPE--- 170
Query: 196 MRIV----TTKVDVFSFGIVVMEFLTKRRP 221
RI + D++S G+ ++E + P
Sbjct: 171 -RIQGESYSYAADIWSLGLTLLECALGKFP 199
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, Plant MAPKKs and similar proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include MAPKKs from plants, kinetoplastids, alveolates, and mycetozoa. The MAPKK, LmxPK4, from Leishmania mexicana, is important in differentiation and virulence. Dictyostelium discoideum MEK1 is required for proper chemotaxis. MEK1 null mutants display severe defects in cell polarization and directional movement. Plants contain multiple MAPKKs like other eukaryotes. The Arabidopsis genome encodes for 10 MAPKKs while poplar and rice contain 13 MAPKKs each. The functions of these proteins have not been fully elucidated. There is evidence to suggest that MAPK cascades are involved in plant stress responses. In Arabidopsis, MKK3 plays a role in pathogen signaling, MKK2 is involved in cold and salt stress signaling, MKK4/MKK5 participates in innate immunity, and MKK7 regulates basal and systemic acquired resistance. Length = 264 |
| >gnl|CDD|132960 cd06629, STKc_MAPKKK_Bck1_like, Catalytic domain of fungal Bck1-like MAP Kinase Kinase Kinases | Back alignment and domain information |
|---|
Score = 111 bits (279), Expect = 5e-29
Identities = 82/292 (28%), Positives = 132/292 (45%), Gaps = 45/292 (15%)
Query: 19 IIGNSNLSTVYKG-RLEDGEIVAVKKLNFHQFSAESDKSFYR--------EAKTLKELKH 69
+IG VY + GE++AVK++ A S + E +TLK+L H
Sbjct: 8 LIGKGTYGRVYLALNVTTGEMMAVKQVELPATIAGRHDSRQKDMVKALRSEIETLKDLDH 67
Query: 70 RNLVKVLGYAWESGKLKALILEYMENGSLESVIHGPGVDHSRWTLPKRIDVLISVANGLD 129
N+V+ LG+ + + ++ LEY+ GS+ S + G R+ V GL
Sbjct: 68 LNIVQYLGFE-TTEEYLSIFLEYVPGGSIGSCLRTYG----RFEEQLVRFFTEQVLEGLA 122
Query: 130 YLHSGYDIPIVHCDMKPSNILLDRDFEAHVSDFGTSRMLDVHLQDL--SSLSTAFQGTIG 187
YLHS I+H D+K N+L+D D +SDFG S+ D+ + + + QG++
Sbjct: 123 YLHSK---GILHRDLKADNLLVDADGICKISDFGISK----KSDDIYDNDQNMSMQGSVF 175
Query: 188 YLAPEF--AYMRIVTTKVDVFSFGIVVMEFLTKRRPTGLDEENGLSPISLRQLVEKALAN 245
++APE +Y + + KVD++S G VV+E RRP +E ++ +L K A
Sbjct: 176 WMAPEVIHSYSQGYSAKVDIWSLGCVVLEMFAGRRPWSDEEAIA----AMFKLGNKRSAP 231
Query: 246 GINGVRQITDPKLVSSIYEEQEQHQVLEELFKLALVCTSSNPEDRPNMNELL 297
I P + ++ L C + NP++RP ELL
Sbjct: 232 PI-------PPDVSMNL--SPVALDFLNA-------CFTINPDNRPTARELL 267
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Bck1-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Saccharomyces cerevisiae Bck1 and Schizosaccharomyces pombe Mkh1, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Budding yeast Bck1 is part of the cell integrity MAPK pathway, which is activated by stresses and aggressions to the cell wall. The MAPKKK Bck1, MAPKKs Mkk1 and Mkk2, and the MAPK Slt2 make up the cascade that is important in the maintenance of cell wall homeostasis. Fission yeast Mkh1 is involved in MAPK cascades regulating cell morphology, cell wall integrity, salt resistance, and filamentous growth in response to stress. Length = 272 |
| >gnl|CDD|173629 cd05041, PTKc_Fes_like, Catalytic domain of Fes-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 102 bits (255), Expect = 8e-26
Identities = 80/279 (28%), Positives = 131/279 (46%), Gaps = 36/279 (12%)
Query: 20 IGNSNLSTVYKGRLEDGEIVAVKKLNFHQFSAESDKSFYREAKTLKELKHRNLVKVLGYA 79
IG N VYKG L+ VAVK K F +EA+ LK+ H N+VK++G
Sbjct: 3 IGKGNFGDVYKGVLKGNTEVAVKTCRSTLPPDLKRK-FLQEAEILKQYDHPNIVKLIGVC 61
Query: 80 WESGKLKALILEYMENGSLESVIHGPGVDHSRWTLPKRIDVLISVANGLDYLHSGYDIPI 139
+ + +++E + GSL + + +R T+ K + + + A G++YL S I
Sbjct: 62 VQKQPI-YIVMELVPGGSLLTFLRKKK---NRLTVKKLLQMSLDAAAGMEYLESKNCI-- 115
Query: 140 VHCDMKPSNILLDRDFEAHVSDFGTSRMLDVHLQDLSSLSTAFQGTIGYLAPE-FAYMRI 198
H D+ N L+ + +SDFG SR + + +S Q I + APE Y R
Sbjct: 116 -HRDLAARNCLVGENNVLKISDFGMSREEEGGIYTVSDGLK--QIPIKWTAPEALNYGR- 171
Query: 199 VTTKVDVFSFGIVVMEFLTKRRPTGLDEENGLSPISLRQLVEKALANGINGVRQITDPKL 258
T++ DV+S+GI++ E + G G+S R+ +E G R + P+L
Sbjct: 172 YTSESDVWSYGILLWETFSL----GDTPYPGMSNQQTRERIES-------GYR-MPAPQL 219
Query: 259 VSSIYEEQEQHQVLEELFKLALVCTSSNPEDRPNMNELL 297
EE+++L L C + +PE+RP+ +E+
Sbjct: 220 CP------------EEIYRLMLQCWAYDPENRPSFSEIY 246
|
Protein Tyrosine Kinase (PTK) family; Fes subfamily; catalytic (c) domain. Fes subfamily members include Fes (or Fps), Fer, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr kinase activity. Fes and Fer kinases play roles in haematopoiesis, inflammation and immunity, growth factor signaling, cytoskeletal regulation, cell migration and adhesion, and the regulation of cell-cell interactions. Fes and Fer show redundancy in their biological functions. Length = 251 |
| >gnl|CDD|173723 cd06605, PKc_MAPKK, Catalytic domain of the dual-specificity Protein Kinase, Mitogen-Activated Protein Kinase Kinase | Back alignment and domain information |
|---|
Score = 102 bits (257), Expect = 8e-26
Identities = 80/288 (27%), Positives = 128/288 (44%), Gaps = 51/288 (17%)
Query: 20 IGNSNLSTVYKGR-LEDGEIVAVKKLNFHQFSAESDKSFYREAKTLKELKHRNLVKVLGY 78
+G N V K G+I+AVK + A K RE L + +V G
Sbjct: 9 LGAGNSGVVSKVLHRPTGKIMAVKTIRLEINEAIQ-KQILRELDILHKCNSPYIVGFYGA 67
Query: 79 AWESGKLKALILEYMENGSLESVIHGPGVDHSRWTLPKRI--DVLISVANGLDYLHSGYD 136
+ +G + ++ +EYM+ GSL+ ++ + +P+RI + ++V GL YLH +
Sbjct: 68 FYNNGDI-SICMEYMDGGSLDKIL-----KEVQGRIPERILGKIAVAVLKGLTYLHEKHK 121
Query: 137 IPIVHCDMKPSNILLDRDFEAHVSDFGTSRMLDVHLQDLSSLSTAFQGTIGYLAPEFAYM 196
I +H D+KPSNIL++ + + DFG S L ++SL+ F GT Y+APE
Sbjct: 122 I--IHRDVKPSNILVNSRGQIKLCDFGVSGQL------VNSLAKTFVGTSSYMAPE---- 169
Query: 197 RIV----TTKVDVFSFGIVVMEFLTKRRPTGLDEENGLSPISLRQLVEKALANGINGVRQ 252
RI + K D++S G+ ++E T R P + + L Q
Sbjct: 170 RIQGNDYSVKSDIWSLGLSLIELATGRFPYPPENDPPDGIFELLQ--------------Y 215
Query: 253 ITD---PKLVSSIYEEQEQHQVLEELFKLALVCTSSNPEDRPNMNELL 297
I + P+L S + Q V +C +P +RP+ ELL
Sbjct: 216 IVNEPPPRLPSGKFSPDFQDFV--------NLCLIKDPRERPSYKELL 255
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK or MAP2K), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK or MAP3K). MAPKKs are dual-specificity PKs that phosphorylate their downstream targets, MAPKs, at specific threonine and tyrosine residues. There are three MAPK subfamilies: extracellular signal-regulated kinase (ERK), c-Jun N-terminal kinase (JNK), and p38. In mammalian cells, there are seven MAPKKs (named MKK1-7) and 20 MAPKKKs. Each MAPK subfamily can be activated by at least two cognate MAPKKs and by multiple MAPKKKs. Length = 265 |
| >gnl|CDD|132957 cd06626, STKc_MEKK4, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 4 | Back alignment and domain information |
|---|
Score = 99.7 bits (249), Expect = 9e-25
Identities = 72/220 (32%), Positives = 102/220 (46%), Gaps = 23/220 (10%)
Query: 18 NIIGNSNLSTVYKG-RLEDGEIVAVKKLNFHQFSAESDKSFYREAKTLKELKHRNLVKVL 76
N IG VY L+ GE++AVK++ ++ K E K L+ LKH NLVK
Sbjct: 6 NKIGGGTFGKVYTAVNLDTGELMAVKEIRIQDNDPKTIKEIADEMKVLELLKHPNLVKY- 64
Query: 77 GYAWESGKLKALI-LEYMENGSLESVIHGPGVDHSRWTLPKRIDVLISVANGLDYLHSGY 135
Y E + K I +EY G+LE ++ + + +L GL YLHS
Sbjct: 65 -YGVEVHREKVYIFMEYCSGGTLEELLEHGRILDEHVIRVYTLQLLE----GLAYLHSHG 119
Query: 136 DIPIVHCDMKPSNILLDRDFEAHVSDFGTSRMLDVHLQDLSSLSTAFQGTIGYLAPEFAY 195
IVH D+KP+NI LD + + DFG + L + + + GT Y+APE
Sbjct: 120 ---IVHRDIKPANIFLDHNGVIKLGDFGCAVKLKNNTTTMGEEVQSLAGTPAYMAPEV-- 174
Query: 196 MRIVTTK-------VDVFSFGIVVMEFLTKRRP-TGLDEE 227
I K D++S G VV+E T +RP + LD E
Sbjct: 175 --ITGGKGKGHGRAADIWSLGCVVLEMATGKRPWSELDNE 212
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 4 (MEKK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK4 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK4 activates the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4/MKK7 and MKK3/MKK6. JNK and p38 are collectively known as stress-activated MAPKs, as they are activated in response to a variety of environmental stresses and pro-inflammatory cytokines. MEKK4 also plays roles in the re-polarization of the actin cytoskeleton in response to osmotic stress, in the proper closure of the neural tube, in cardiovascular development, and in immune responses. Length = 264 |
| >gnl|CDD|173626 cd05034, PTKc_Src_like, Catalytic domain of Src kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 99.3 bits (248), Expect = 1e-24
Identities = 65/206 (31%), Positives = 101/206 (49%), Gaps = 22/206 (10%)
Query: 20 IGNSNLSTVYKGRLEDGEIVAVKKLNFHQFSAESDKSFYREAKTLKELKHRNLVKVLGYA 79
+G V+ G VAVK L S E+ F +EA+ +K+L+H LV++ YA
Sbjct: 14 LGAGQFGEVWMGTWNGTTKVAVKTLKPGTMSPEA---FLQEAQIMKKLRHDKLVQL--YA 68
Query: 80 WESGKLKALIL-EYMENGSLESVIHGPGVDHSRWTLPKRIDVLISVANGLDYLHS-GYDI 137
S + I+ EYM GSL + + + LP+ +D+ +A G+ YL S Y
Sbjct: 69 VCSEEEPIYIVTEYMSKGSLLDFLKSG--EGKKLRLPQLVDMAAQIAEGMAYLESRNY-- 124
Query: 138 PIVHCDMKPSNILLDRDFEAHVSDFGTSRMLDVHLQDLSSLSTAFQGT---IGYLAPEFA 194
+H D+ NIL+ + ++DFG +R+++ TA +G I + APE A
Sbjct: 125 --IHRDLAARNILVGENLVCKIADFGLARLIED------DEYTAREGAKFPIKWTAPEAA 176
Query: 195 YMRIVTTKVDVFSFGIVVMEFLTKRR 220
T K DV+SFGI++ E +T R
Sbjct: 177 NYGRFTIKSDVWSFGILLTEIVTYGR 202
|
Protein Tyrosine Kinase (PTK) family; Src kinase subfamily; catalytic (c) domain. Src subfamily members include Src, Lck, Hck, Blk, Lyn, Fgr, Fyn, Yrk, and Yes. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) proteins are cytoplasmic (or non-receptor) tyr kinases which are anchored to the plasma membrane. They contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. They were identified as the first proto-oncogene products, and they regulate cell adhesion, invasion, and motility in cancer cells and tumor vasculature, contributing to cancer progression and metastasis. Src kinases are overexpressed in a variety of human cancers, making them attractive targets for therapy. They are also implicated in acute inflammatory responses and osteoclast function. Src, Fyn, Yes, and Yrk are widely expressed, while Blk, Lck, Hck, Fgr, and Lyn show a limited expression pattern. Length = 261 |
| >gnl|CDD|133171 cd05039, PTKc_Csk_like, Catalytic domain of C-terminal Src kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 99.0 bits (247), Expect = 1e-24
Identities = 76/280 (27%), Positives = 116/280 (41%), Gaps = 45/280 (16%)
Query: 20 IGNSNLSTVYKGRLEDGEIVAVKKLNFHQFSAESDKSFYREAKTLKELKHRNLVKVLGYA 79
IG V G G+ VAVK L +A++ F EA + L+H NLV++LG
Sbjct: 14 IGKGEFGDVMLGDYR-GQKVAVKCLKDDSTAAQA---FLAEASVMTTLRHPNLVQLLGVV 69
Query: 80 WESGKLKALILEYMENGSLESVIHGPGVDHSRWTLPKRIDVLISVANGLDYLHSGYDIPI 139
+ L ++ EYM GSL + G TL +++ + V G++YL
Sbjct: 70 LQGNPL-YIVTEYMAKGSLVDYLRSRGRAVI--TLAQQLGFALDVCEGMEYLEEK---NF 123
Query: 140 VHCDMKPSNILLDRDFEAHVSDFGTSRMLDVHL-QDLSSLSTAFQGTIGYLAPEFAYMRI 198
VH D+ N+L+ D A VSDFG ++ + QD L + + APE +
Sbjct: 124 VHRDLAARNVLVSEDLVAKVSDFGLAK--EASQGQDSGKLP------VKWTAPEALREKK 175
Query: 199 VTTKVDVFSFGIVVME-FLTKRRPTGLDEENGLSPISLRQLVEKALANGINGVRQITDPK 257
+TK DV+SFGI++ E + R P I L+ +V
Sbjct: 176 FSTKSDVWSFGILLWEIYSFGRVP--------YPRIPLKDVVPH---------------- 211
Query: 258 LVSSIYEEQEQHQVLEELFKLALVCTSSNPEDRPNMNELL 297
V Y + E++K+ C +P RP +L
Sbjct: 212 -VEKGYRMEAPEGCPPEVYKVMKDCWELDPAKRPTFKQLR 250
|
Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk) subfamily; catalytic (c) domain. The Csk subfamily is composed of Csk, Chk, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk and Chk are translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk catalyzes the tyr phosphorylation of the regulatory C-terminal tail of Src kinases, resulting in their inactivation. Chk inhibit Src kinases using a noncatalytic mechanism by simply binding to them. As negative regulators of Src kinases, Csk and Chk play important roles in cell proliferation, survival, and differentiation, and consequently, in cancer development and progression. Length = 256 |
| >gnl|CDD|143345 cd07840, STKc_CDK9_like, Catalytic domain of Cyclin-Dependent protein Kinase 9-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 98.8 bits (247), Expect = 3e-24
Identities = 59/210 (28%), Positives = 98/210 (46%), Gaps = 23/210 (10%)
Query: 18 NIIGNSNLSTVYKGR-LEDGEIVAVKKLNFHQFSAESDKSFYREAKTLKELKHRNLVKVL 76
IG VYK R + GE+VA+KK+ + RE K L++L+H N+V++
Sbjct: 5 AQIGEGTYGQVYKARNKKTGELVALKKIRMENEKEGFPITAIREIKLLQKLRHPNIVRLK 64
Query: 77 GYAWESGKLKA-LILEYMENGSLESVIHGPGVDHSRWTLPKRIDVLISVANGLDYLHSGY 135
GK ++ EYM++ L ++ P V ++T + + + GL YLHS
Sbjct: 65 EIVTSKGKGSIYMVFEYMDH-DLTGLLDSPEV---KFTESQIKCYMKQLLEGLQYLHS-- 118
Query: 136 DIPIVHCDMKPSNILLDRDFEAHVSDFGTSR-MLDVHLQDLSSLSTAFQGTIGYLAPE-- 192
I+H D+K SNIL++ D ++DFG +R + D ++ T+ Y PE
Sbjct: 119 -NGILHRDIKGSNILINNDGVLKLADFGLARPYTKRNSADYTNRVI----TLWYRPPELL 173
Query: 193 ---FAYMRIVTTKVDVFSFGIVVMEFLTKR 219
Y +VD++S G ++ E +
Sbjct: 174 LGATRY----GPEVDMWSVGCILAELFLGK 199
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK9 and CDK12 from higher eukaryotes, yeast BUR1, C-type plant CDKs (CdkC), and similar proteins. CDK9, BUR1, and CdkC are functionally equivalent. They act as a kinase for the C-terminal domain of RNA polymerase II and participate in regulating mutliple steps of gene expression including transcription elongation and RNA processing. CDK9 and CdkC associate with T-type cyclins while BUR1 associates with the cyclin BUR2. CDK12 is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 interacts with cyclins L1 and L2, and participates in regulating transcription and alternative splicing. Length = 287 |
| >gnl|CDD|132952 cd06621, PKc_MAPKK_Pek1_like, Catalytic domain of fungal Pek1-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Score = 97.9 bits (244), Expect = 7e-24
Identities = 85/295 (28%), Positives = 128/295 (43%), Gaps = 40/295 (13%)
Query: 12 GSFSENNIIGNSNLSTVYKGRLEDGEIVAVKKLNFHQFSAESDKSFYREAKTLKELKHRN 71
E + +G +V K RL++ ++ K + + K RE + K K
Sbjct: 1 EKIVELSRLGEGAGGSVTKCRLKNTGMIFALKTITTDPNPDLQKQILRELEINKSCKSPY 60
Query: 72 LVKVLG-YAWESGKLKALILEYMENGSLESV---IHGPGVDHSRWTLPKRIDVLISVANG 127
+VK G + ES + +EY E GSL+S+ + G L K + SV G
Sbjct: 61 IVKYYGAFLDESSSSIGIAMEYCEGGSLDSIYKKVKKRGGRIGEKVLGK---IAESVLKG 117
Query: 128 LDYLHSGYDIPIVHCDMKPSNILLDRDFEAHVSDFGTSRMLDVHLQDLSSLSTAFQGTIG 187
L YLHS I+H D+KPSNILL R + + DFG S L ++SL+ F GT
Sbjct: 118 LSYLHSR---KIIHRDIKPSNILLTRKGQVKLCDFGVSGEL------VNSLAGTFTGTSF 168
Query: 188 YLAPEFAYMRI----VTTKVDVFSFGIVVMEFLTKRRPTGLDEENGLSPISLRQLVEKAL 243
Y+APE RI + DV+S G+ ++E R P + E L PI L
Sbjct: 169 YMAPE----RIQGKPYSITSDVWSLGLTLLEVAQNRFPFPPEGEPPLGPIEL-------- 216
Query: 244 ANGINGVRQITDPKLVSSIYEEQEQHQVLEELFKLAL-VCTSSNPEDRPNMNELL 297
++ + + +P+L +E E FK + C +P RP ++L
Sbjct: 217 ---LSYIVNMPNPELK----DEPGNGIKWSEEFKDFIKQCLEKDPTRRPTPWDML 264
|
Protein kinases (PKs), MAP kinase kinase(MAPKK) subfamily, fungal Pek1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include the MAPKKs Pek1/Skh1 from Schizosaccharomyces pombe and MKK2 from Saccharomyces cerevisiae, and related proteins. Both fission yeast Pek1 and baker's yeast MKK2 are components of the cell integrity MAPK pathway. In fission yeast, Pek1 phosphorylates and activates the MAPK Pmk1/Spm1 and is regulated by the MAPKKK Mkh1. In baker's yeast, the pathway involves the MAPK Slt2, the MAPKKs MKK1 and MKK2, and the MAPKKK Bck1. The cell integrity MAPK cascade is activated by multiple stress conditions, and is essential in cell wall construction, morphogenesis, cytokinesis, and ion homeostasis. Length = 287 |
| >gnl|CDD|143333 cd05118, STKc_CMGC, Catalytic domain of CMGC family Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 97.4 bits (243), Expect = 9e-24
Identities = 68/206 (33%), Positives = 97/206 (47%), Gaps = 19/206 (9%)
Query: 20 IGNSNLSTVYKGR-LEDGEIVAVKKLNFHQFSAESDKSFYREAKTLKELKHRNLVKVLGY 78
IG VYK R GEIVA+KK+ S K+ RE K LKEL H N++K+L
Sbjct: 7 IGEGTYGVVYKARDKLTGEIVAIKKIKLRFESEGIPKTALREIKLLKELNHPNIIKLLDV 66
Query: 79 AWESGKLKALILEYMENGSLESVIHGPGVDHSRWTLP-KRI-DVLISVANGLDYLHSGYD 136
G L L+ E+M+ L +I + LP I L + GL + HS
Sbjct: 67 FRHKGDL-YLVFEFMDT-DLYKLI-----KDRQRGLPESLIKSYLYQLLQGLAFCHSHG- 118
Query: 137 IPIVHCDMKPSNILLDRDFEAHVSDFGTSRMLDVHLQDLSSLSTAFQGTIGYLAPEFAY- 195
I+H D+KP N+L++ + ++DFG +R T + T Y APE
Sbjct: 119 --ILHRDLKPENLLINTEGVLKLADFGLARSFGSP----VRPYTHYVVTRWYRAPELLLG 172
Query: 196 MRIVTTKVDVFSFGIVVMEFLTKRRP 221
+ +T VD++S G + E L+ RRP
Sbjct: 173 DKGYSTPVDIWSVGCIFAELLS-RRP 197
|
Serine/Threonine Kinases (STKs), CMGC family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CMGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The CMGC family consists of Cyclin-Dependent protein Kinases (CDKs), Mitogen-activated protein kinases (MAPKs) such as Extracellular signal-regulated kinase (ERKs), c-Jun N-terminal kinases (JNKs), and p38, and similar proteins. CDKs belong to a large subfamily of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Length = 283 |
| >gnl|CDD|173628 cd05038, PTKc_Jak_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases | Back alignment and domain information |
|---|
Score = 95.5 bits (238), Expect = 5e-23
Identities = 77/288 (26%), Positives = 127/288 (44%), Gaps = 30/288 (10%)
Query: 18 NIIGNSNLSTVYKGRLE-----DGEIVAVKKLNFHQFSAESDKSFYREAKTLKELKHRNL 72
+G + V R + GE VAVK LN H + F RE + L+ L H N+
Sbjct: 10 KQLGEGHFGKVELCRYDPLGDNTGEQVAVKSLN-HSGEEQHRSDFEREIEILRTLDHENI 68
Query: 73 VKVLGYAWESG-KLKALILEYMENGSLESVI--HGPGVDHSRWTLPKRIDVLISVANGLD 129
VK G + G + LI+EY+ +GSL + H ++ R L + G+D
Sbjct: 69 VKYKGVCEKPGGRSLRLIMEYLPSGSLRDYLQRHRDQINLKRLLL-----FSSQICKGMD 123
Query: 130 YLHS-GYDIPIVHCDMKPSNILLDRDFEAHVSDFGTSRMLDVHLQDLSSLSTAFQGTIGY 188
YL S Y +H D+ NIL++ + +SDFG +++L +D + + I +
Sbjct: 124 YLGSQRY----IHRDLAARNILVESEDLVKISDFGLAKVLPED-KDYYYVKEPGESPIFW 178
Query: 189 LAPEFAYMRIVTTKVDVFSFGIVVMEFLTKRRPTGLDEENGLSPISLRQLVEKALANGIN 248
APE ++ DV+SFG+ + E T P+ SP + L +A G
Sbjct: 179 YAPECLRTSKFSSASDVWSFGVTLYELFTYGDPS-------QSPPAE-FLRMIGIAQGQM 230
Query: 249 GVRQITDPKLVSSIYEEQEQHQVLEELFKLALVCTSSNPEDRPNMNEL 296
V ++ + L + +E++ L +C + P+DRP+ +L
Sbjct: 231 IVTRLLE-LLKEGERLPRPPS-CPDEVYDLMKLCWEAEPQDRPSFADL 276
|
Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; catalytic (c) domain (repeat 2). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Most Jaks are expressed in a wide variety of tissues, except for Jak3, which is expressed only in hematopoietic cells. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jaks are also involved in regulating the surface expression of some cytokine receptors. The Jak-STAT pathway is involved in many biological processes including hematopoiesis, immunoregulation, host defense, fertility, lactation, growth, and embryogenesis. Length = 284 |
| >gnl|CDD|133180 cd05049, PTKc_Trk, Catalytic domain of the Protein Tyrosine Kinases, Tropomyosin Related Kinases | Back alignment and domain information |
|---|
Score = 94.8 bits (236), Expect = 8e-23
Identities = 67/214 (31%), Positives = 98/214 (45%), Gaps = 23/214 (10%)
Query: 20 IGNSNLSTVYKGRL------EDGEIVAVKKLNFHQFSAESDKSFYREAKTLKELKHRNLV 73
+G V+ G D E+VAVK L S ++ K F REA+ L +H N+V
Sbjct: 13 LGEGAFGKVFLGECYHLEPENDKELVAVKTLK-ETASNDARKDFEREAELLTNFQHENIV 71
Query: 74 KVLGYAWESGKLKALILEYMENGSLESVI--HGP--------GVDHSRWTLPKRIDVLIS 123
K G E ++ EYME+G L + HGP TL + + + +
Sbjct: 72 KFYGVCTEGDPP-IMVFEYMEHGDLNKFLRSHGPDAAFLKSPDSPMGELTLSQLLQIAVQ 130
Query: 124 VANGLDYLHSGYDIPIVHCDMKPSNILLDRDFEAHVSDFGTSRMLDVHLQDLSSLSTAFQ 183
+A+G+ YL S + VH D+ N L+ D + DFG SR DV+ D +
Sbjct: 131 IASGMVYLASQH---FVHRDLATRNCLVGYDLVVKIGDFGMSR--DVYTTDYYRVGGHTM 185
Query: 184 GTIGYLAPEFAYMRIVTTKVDVFSFGIVVMEFLT 217
I ++ PE R TT+ DV+SFG+V+ E T
Sbjct: 186 LPIRWMPPESIMYRKFTTESDVWSFGVVLWEIFT 219
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase (Trk) subfamily; catalytic (c) domain. The Trk subfamily consists of TrkA, TrkB, TrkC, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Trk subfamily members are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, the nerve growth factor (NGF) family of neutrotrophins, leads to Trk receptor oligomerization and activation of the catalytic domain. Trk receptors are mainly expressed in the peripheral and central nervous systems. They play important roles in cell fate determination, neuronal survival and differentiation, as well as in the regulation of synaptic plasticity. Altered expression of Trk receptors is associated with many human diseases. Length = 280 |
| >gnl|CDD|133165 cd05033, PTKc_EphR, Catalytic domain of Ephrin Receptor Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 93.6 bits (233), Expect = 2e-22
Identities = 63/208 (30%), Positives = 104/208 (50%), Gaps = 20/208 (9%)
Query: 17 NNIIGNSNLSTVYKGRL----EDGEIVAVKKLNFHQFSAESDKS-FYREAKTLKELKHRN 71
+IG V +GRL + VA+K L S++ + F EA + + H N
Sbjct: 9 EKVIGGGEFGEVCRGRLKLPGKKEIDVAIKTL--KAGSSDKQRLDFLTEASIMGQFDHPN 66
Query: 72 LVKVLGYAWESGKLKALILEYMENGSLESVIHGPGVDHSRWTLPKRIDVLISVANGLDYL 131
++++ G + +I EYMENGSL+ + + ++T+ + + +L +A+G+ YL
Sbjct: 67 IIRLEGVV-TKSRPVMIITEYMENGSLDKFLR---ENDGKFTVGQLVGMLRGIASGMKYL 122
Query: 132 HSGYDIPIVHCDMKPSNILLDRDFEAHVSDFGTSRMLDVHLQDLSSLSTAFQGTIG--YL 189
++ VH D+ NIL++ + VSDFG SR L+D + T G I +
Sbjct: 123 S---EMNYVHRDLAARNILVNSNLVCKVSDFGLSR----RLEDSEATYTTKGGKIPIRWT 175
Query: 190 APEFAYMRIVTTKVDVFSFGIVVMEFLT 217
APE R T+ DV+SFGIV+ E ++
Sbjct: 176 APEAIAYRKFTSASDVWSFGIVMWEVMS 203
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). They can be classified into two classes (EphA and EphB), according to their extracellular sequences, which largely correspond to binding preferences for either GPI-anchored ephrin-A ligands or transmembrane ephrin-B ligands. Vertebrates have ten EphA and six EhpB receptors, which display promiscuous ligand interactions within each class. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. This allows ephrin/EphR dimers to form, leading to the activation of the intracellular tyr kinase domain. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). The main effect of ephrin/EphR interaction is cell-cell repulsion or adhesion. Ephrin/EphR signaling is important in neural development and plasticity, cell morphogenesis and proliferation, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. Length = 266 |
| >gnl|CDD|173726 cd06610, STKc_OSR1_SPAK, Catalytic domain of the Protein Serine/Threonine Kinases, Oxidative stress response kinase and Ste20-related proline alanine-rich kinase | Back alignment and domain information |
|---|
Score = 93.2 bits (232), Expect = 3e-22
Identities = 74/290 (25%), Positives = 116/290 (40%), Gaps = 44/290 (15%)
Query: 18 NIIGNSNLSTVYKGR-LEDGEIVAVKKLNFHQFSAESDKSFYREAKTLKELKHRNLVKVL 76
+IG + VY L + E VA+K+++ + D +E + + + H N+VK
Sbjct: 7 EVIGVGATAVVYAAICLPNNEKVAIKRIDLEKCQTSVD-ELRKEVQAMSQCNHPNVVKYY 65
Query: 77 GYAWESGKLKALILEYMENGSLESVIHGPGVDHSRWTLPKRI-------DVLISVANGLD 129
+L L++ Y+ GSL ++ + + P+ VL V GL+
Sbjct: 66 TSFVVGDEL-WLVMPYLSGGSLLDIM--------KSSYPRGGLDEAIIATVLKEVLKGLE 116
Query: 130 YLHSGYDIPIVHCDMKPSNILLDRDFEAHVSDFGTSRMLDVHLQDLSSLSTAFQGTIGYL 189
YLHS I H D+K NILL D ++DFG S L + F GT ++
Sbjct: 117 YLHSNGQI---HRDIKAGNILLGEDGSVKIADFGVSASLADGGDRTRKVRKTFVGTPCWM 173
Query: 190 APEFAYMRI-VTTKVDVFSFGIVVMEFLTKRRPTGLDEENGLSPISLRQLVEKALANGIN 248
APE K D++SFGI +E T P + P+ K L +
Sbjct: 174 APEVMEQVHGYDFKADIWSFGITAIELATGAAPY-----SKYPPM-------KVLMLTLQ 221
Query: 249 GVRQITDPKLVSSIYEEQEQHQVLEELFK-LALVCTSSNPEDRPNMNELL 297
DP E ++ + F+ + +C +P RP ELL
Sbjct: 222 N-----DP----PSLETGADYKKYSKSFRKMISLCLQKDPSKRPTAEELL 262
|
Serine/threonine kinases (STKs), oxidative stress response kinase (OSR1) and Ste20-related proline alanine-rich kinase (SPAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The OSR1 and SPAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SPAK is also referred to as STK39 or PASK (proline-alanine-rich STE20-related kinase). OSR1 and SPAK regulate the activity of cation-chloride cotransporters through direct interaction and phosphorylation. They are also implicated in cytoskeletal rearrangement, cell differentiation, transformation and proliferation. OSR1 and SPAK contain a conserved C-terminal (CCT) domain, which recognizes a unique motif ([RK]FX[VI]) present in their activating kinases (WNK1/WNK4) and their substrates. Length = 267 |
| >gnl|CDD|173732 cd06628, STKc_MAPKKK_Byr2_like, Catalytic domain of fungal Byr2-like MAP Kinase Kinase Kinases | Back alignment and domain information |
|---|
Score = 93.0 bits (231), Expect = 4e-22
Identities = 69/220 (31%), Positives = 115/220 (52%), Gaps = 32/220 (14%)
Query: 19 IIGNSNLSTVYKG-RLEDGEIVAVKKLNFHQFSAESDK-------SFYREAKTLKELKHR 70
+IG+ + +VY G GE++AVK++ SA S + RE LKEL+H
Sbjct: 7 LIGSGSFGSVYLGMNASSGELMAVKQVELPSVSASSKDRKRSMLDALAREIALLKELQHE 66
Query: 71 NLVKVLGYAWESGKLKALILEYMENGSLESVIHGPGVDHSRWTLPKRI--DVLISVANGL 128
N+V+ LG + ++ L + LEY+ GS+ ++++ G + + + + + GL
Sbjct: 67 NIVQYLGSSLDADHLN-IFLEYVPGGSVAALLNNYG------AFEETLVRNFVRQILKGL 119
Query: 129 DYLHSGYDIPIVHCDMKPSNILLDRDFEAHVSDFGTSRMLDVHLQDLSSLSTA------- 181
+YLH+ I+H D+K +NIL+D +SDFG S+ L+ +SLST
Sbjct: 120 NYLHNR---GIIHRDIKGANILVDNKGGIKISDFGISKKLE-----ANSLSTKTNGARPS 171
Query: 182 FQGTIGYLAPEFAYMRIVTTKVDVFSFGIVVMEFLTKRRP 221
QG++ ++APE T K D++S G +V+E LT + P
Sbjct: 172 LQGSVFWMAPEVVKQTSYTRKADIWSLGCLVVEMLTGKHP 211
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Byr2-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Schizosaccharomyces pombe Byr2, Saccharomyces cerevisiae and Cryptococcus neoformans Ste11, and related proteins. They contain an N-terminal SAM (sterile alpha-motif) domain, which mediates protein-protein interaction, and a C-terminal catalytic domain. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast Byr2 is regulated by Ras1. It responds to pheromone signaling and controls mating through the MAPK pathway. Budding yeast Ste11 functions in MAPK cascades that regulate mating, high osmolarity glycerol, and filamentous growth responses. Length = 267 |
| >gnl|CDD|173771 cd08529, STKc_FA2-like, Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii FA2 and similar domains | Back alignment and domain information |
|---|
Score = 92.2 bits (229), Expect = 5e-22
Identities = 74/289 (25%), Positives = 125/289 (43%), Gaps = 44/289 (15%)
Query: 14 FSENNIIGNSNLSTVYKG-RLEDGEIVAVKKLNFHQFSAESDKSFYREAKTLKELKHRNL 72
F N IG + V+K R D + A+K+++ + + + EA+ L +L +
Sbjct: 2 FEILNKIGKGSFGVVFKVVRKADKRVYAMKQIDLSKMNRREREEAIDEARVLAKLDSSYI 61
Query: 73 VKVLGYAWESGKLKALILEYMENGSLESVIHG----PGVDHSRWTLPKRIDVLISVANGL 128
++ + GKL +++EY ENG L ++ P + W I + GL
Sbjct: 62 IRYYESFLDKGKLN-IVMEYAENGDLHKLLKMQRGRPLPEDQVWRF------FIQILLGL 114
Query: 129 DYLHSGYDIPIVHCDMKPSNILLDRDFEAHVSDFGTSRMLDVHLQDLSSLSTAFQGTIGY 188
+LHS I+H D+K N+ LD + D G +++L D ++ + GT Y
Sbjct: 115 AHLHSK---KILHRDIKSLNLFLDAYDNVKIGDLGVAKLLS----DNTNFANTIVGTPYY 167
Query: 189 LAPEFAYMRIVTTKVDVFSFGIVVMEFLTKRRPTGLDEENGLSPISLRQLVEKALANGIN 248
L+PE + K DV++ G+V+ E T + P D N + AL I
Sbjct: 168 LSPELCEDKPYNEKSDVWALGVVLYECCTGKHP--FDANN-----------QGALILKI- 213
Query: 249 GVRQITDPKLVSSIYEEQEQHQVLEELFKLALVCTSSNPEDRPNMNELL 297
+R + P VS +Y +Q L +L C + + RP+ +LL
Sbjct: 214 -IRGVFPP--VSQMYSQQ-----LAQLIDQ---CLTKDYRQRPDTFQLL 251
|
Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii FA2-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii FA2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes FA2 and CNK4. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii FA2 was discovered in a genetic screen for deflagellation-defective mutants. It is essential for basal-body/centriole-associated microtubule severing, and plays a role in cell cycle progression. No cellular function has yet been ascribed to CNK4. Length = 256 |
| >gnl|CDD|132961 cd06630, STKc_MEKK1, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 1 | Back alignment and domain information |
|---|
Score = 92.6 bits (230), Expect = 5e-22
Identities = 69/288 (23%), Positives = 120/288 (41%), Gaps = 39/288 (13%)
Query: 19 IIGNSNLSTVYKGR-LEDGEIVAVKKLNFHQFSAESDKSFY----REAKTLKELKHRNLV 73
+G S+ Y+ R ++ G ++AVK++ + + ++ + +E + + L H +++
Sbjct: 7 QLGTGAFSSCYQARDVKTGTLMAVKQVTYVRNTSSEQEEVVEALRKEIRLMARLNHPHII 66
Query: 74 KVLGYAWESGKLKALILEYMENGSLESVIHGPGVDHSRWTLPKRIDVLISVANGLDYLHS 133
++LG E L +E+M GS+ ++ G I+ + GL YLH
Sbjct: 67 RMLGATCEDSHFN-LFVEWMAGGSVSHLLSKYGAFKEAVI----INYTEQLLRGLSYLH- 120
Query: 134 GYDIPIVHCDMKPSNILLDRDFE-AHVSDFGTSRMLDVHLQDLSSLSTAFQGTIGYLAPE 192
+ I+H D+K +N+L+D + ++DFG + L GTI ++APE
Sbjct: 121 --ENQIIHRDVKGANLLIDSTGQRLRIADFGAAARLAAKGTGAGEFQGQLLGTIAFMAPE 178
Query: 193 FAYMRIVTTKVDVFSFGIVVMEFLTKRRPTGLDE-ENGLSPISLRQLVEK-ALANGINGV 250
DV+S G V++E T + P ++ N L L+ K A A +
Sbjct: 179 VLRGEQYGRSCDVWSVGCVIIEMATAKPPWNAEKHSNHL------ALIFKIASATTAPSI 232
Query: 251 RQITDPKLVSSIYEEQEQHQVLEELFKLALVCTSSNPEDRPNMNELLI 298
+ P L + L C PEDRP ELL
Sbjct: 233 PEHLSPGLRD-----------------VTLRCLELQPEDRPPSRELLK 263
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 1 (MEKK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK1 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK1 activates the extracellular signal-regulated kinase 1/2 (ERK1/2) and c-Jun N-terminal kinase (JNK) pathways by activating their respective MAPKKs, MEK1/2 and MKK4/MKK7, respectively. MEKK1 is important in regulating cell survival and apoptosis. MEKK1 also plays a role in cell migration, tissue maintenance and homeostasis, and wound healing. Length = 268 |
| >gnl|CDD|215036 PLN00034, PLN00034, mitogen-activated protein kinase kinase; Provisional | Back alignment and domain information |
|---|
Score = 93.3 bits (232), Expect = 1e-21
Identities = 70/229 (30%), Positives = 111/229 (48%), Gaps = 36/229 (15%)
Query: 10 ATGSFSE---NNIIGNSNLSTVYKGRLE-DGEIVAVKKL-NFHQFSAESDKSFYREAKTL 64
A S SE N IG+ TVYK G + A+K + H+ + + RE + L
Sbjct: 69 AAKSLSELERVNRIGSGAGGTVYKVIHRPTGRLYALKVIYGNHEDTVR--RQICREIEIL 126
Query: 65 KELKHRNLVKVLGYAWESGKLKALILEYMENGSLESVIHGPGVDHSRWTLPKRIDVLISV 124
+++ H N+VK +G+++ L LE+M+ GSLE DV +
Sbjct: 127 RDVNHPNVVKCHDMFDHNGEIQVL-LEFMDGGSLEG--------THIADEQFLADVARQI 177
Query: 125 ANGLDYLHSGYDIPIVHCDMKPSNILLDRDFEAHVSDFGTSRMLDVHLQDLSSLSTAFQG 184
+G+ YLH + IVH D+KPSN+L++ ++DFG SR+L Q + +++ G
Sbjct: 178 LSGIAYLHRRH---IVHRDIKPSNLLINSAKNVKIADFGVSRILA---QTMDPCNSSV-G 230
Query: 185 TIGYLAPEFAYMRIVTT---------KVDVFSFGIVVMEFLTKRRPTGL 224
TI Y++PE RI T D++S G+ ++EF R P G+
Sbjct: 231 TIAYMSPE----RINTDLNHGAYDGYAGDIWSLGVSILEFYLGRFPFGV 275
|
Length = 353 |
| >gnl|CDD|133202 cd05071, PTKc_Src, Catalytic domain of the Protein Tyrosine Kinase, Src | Back alignment and domain information |
|---|
Score = 90.5 bits (224), Expect = 2e-21
Identities = 82/297 (27%), Positives = 133/297 (44%), Gaps = 56/297 (18%)
Query: 4 RTEIENATGSFSENNIIGNSNLSTVYKGRLEDGEIVAVKKLNFHQFSAESDKSFYREAKT 63
R E++ G F E V+ G VA+K L S E+ F +EA+
Sbjct: 9 RLEVKLGQGCFGE-----------VWMGTWNGTTRVAIKTLKPGTMSPEA---FLQEAQV 54
Query: 64 LKELKHRNLVKVLGYAWESGKLKALILEYMENGSLESVIHGPGVDHSRWTLPKRIDVLIS 123
+K+L+H LV++ YA S + ++ EYM GSL + G + R LP+ +D+
Sbjct: 55 MKKLRHEKLVQL--YAVVSEEPIYIVTEYMSKGSLLDFLKGEMGKYLR--LPQLVDMAAQ 110
Query: 124 VANGLDYLHSGYDIPIVHCDMKPSNILLDRDFEAHVSDFGTSRMLDVHLQDLSSLSTAFQ 183
+A+G+ Y+ + VH D++ +NIL+ + V+DFG +R+++ + TA Q
Sbjct: 111 IASGMAYVER---MNYVHRDLRAANILVGENLVCKVADFGLARLIE------DNEYTARQ 161
Query: 184 GT---IGYLAPEFAYMRIVTTKVDVFSFGIVVMEFLTKRRPTGLDEENGLSPISLRQLVE 240
G I + APE A T K DV+SFGI++ E TK R + +V
Sbjct: 162 GAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGR------------VPYPGMVN 209
Query: 241 KALANGIN-GVRQITDPKLVSSIYEEQEQHQVLEELFKLALVCTSSNPEDRPNMNEL 296
+ + + + G R P+ S+++ L C PE+RP L
Sbjct: 210 REVLDQVERGYRMPCPPECPESLHD-------------LMCQCWRKEPEERPTFEYL 253
|
Protein Tyrosine Kinase (PTK) family; Src kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) is a cytoplasmic (or non-receptor) tyr kinase, containing an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region with a conserved tyr. It is activated by autophosphorylation at the tyr kinase domain, and is negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). c-Src is the vertebrate homolog of the oncogenic protein (v-Src) from Rous sarcoma virus. Together with other Src subfamily proteins, it is involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Src also play a role in regulating cell adhesion, invasion, and motility in cancer cells and tumor vasculature, contributing to cancer progression and metastasis. Elevated levels of Src kinase activity have been reported in a variety of human cancers. Several inhibitors of Src have been developed as anti-cancer drugs. Src is also implicated in acute inflammatory responses and osteoclast function. Length = 262 |
| >gnl|CDD|133167 cd05035, PTKc_Axl_like, Catalytic Domain of Axl-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 88.7 bits (220), Expect = 1e-20
Identities = 73/291 (25%), Positives = 132/291 (45%), Gaps = 44/291 (15%)
Query: 19 IIGNSNLSTVYKGRL--EDGEI--VAVKKLNFHQFSAESDKSFYREAKTLKELKHRNLVK 74
I+G +V +G+L +DG VAVK + + + F EA +K+ H N++K
Sbjct: 6 ILGEGEFGSVMEGQLSQDDGSQLKVAVKTMKLDIHTYSEIEEFLSEAACMKDFDHPNVMK 65
Query: 75 VLGYAWESGKLKAL-----ILEYMENGSLESVIHGP--GVDHSRWTLPKRIDVLISVANG 127
++G +E+ L+ + IL +M++G L S + G + L + ++ +A G
Sbjct: 66 LIGVCFEASSLQKIPKPMVILPFMKHGDLHSFLLYSRLGGLPEKLPLQTLLKFMVDIALG 125
Query: 128 LDYLHSGYDIPIVHCDMKPSNILLDRDFEAHVSDFGTSRMLDVHLQDLSSLSTAFQGTIG 187
++YL + +H D+ N +L D V+DFG S+ ++ D + +
Sbjct: 126 MEYLSNR---NFIHRDLAARNCMLREDMTVCVADFGLSK--KIYSGDYYRQGRIAKMPVK 180
Query: 188 YLAPEFAYMRIVTTKVDVFSFGIVVMEFLTKRRPTGLDEENGLSPISLRQLVE--KALAN 245
++A E R+ T+K DV++FG+ + E T+ G +P + E L +
Sbjct: 181 WIAIESLADRVYTSKSDVWAFGVTMWEIATR----------GQTPYPGVENHEIYDYLRH 230
Query: 246 GINGVRQITDPKLVSSIYEEQEQHQVLEELFKLALVCTSSNPEDRPNMNEL 296
G N ++Q D L+EL+ L C ++P+DRP +L
Sbjct: 231 G-NRLKQPED---------------CLDELYDLMYSCWRADPKDRPTFTKL 265
|
Protein Tyrosine Kinase (PTK) family; Axl subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The Axl subfamily consists of Axl, Tyro3 (or Sky), Mer (or Mertk), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl subfamily members are implicated in a variety of cellular effects including survival, proliferation, migration, and phagocytosis. They are also associated with several types of cancer as well as inflammatory, autoimmune, vascular, and kidney diseases. Mer is named after its original reported expression pattern (monocytes, epithelial, and reproductive tissues). It is required for the ingestion of apoptotic cells by phagocytes such as macrophages, retinal pigment epithelial cells, and dendritic cells. Mer is also important in maintaining immune homeostasis. Length = 273 |
| >gnl|CDD|173632 cd05051, PTKc_DDR, Catalytic domain of the Protein Tyrosine Kinases, Discoidin Domain Receptors | Back alignment and domain information |
|---|
Score = 89.3 bits (222), Expect = 1e-20
Identities = 70/279 (25%), Positives = 122/279 (43%), Gaps = 58/279 (20%)
Query: 39 VAVKKLNFHQFSAESDKSFYREAKTLKELKHRNLVKVLGYAWESGKLKALILEYMENGSL 98
VAVK L S + + F +E K L L N+ ++LG +I+EYMENG L
Sbjct: 49 VAVKVLRPDA-SDNAREDFLKEVKILSRLSDPNIARLLG-VCTVDPPLCMIMEYMENGDL 106
Query: 99 -----ESVIHGPGVDHSRWTLPKRIDVLISV--ANGLDYLHSGYDIPIVHCDMKPSNILL 151
+ V G+ + +L + ++ A+G+ YL S + VH D+ N L+
Sbjct: 107 NQFLQKHVAETSGLACNSKSLSFSTLLYMATQIASGMRYLES---LNFVHRDLATRNCLV 163
Query: 152 DRDFEAHVSDFGTSRMLDVHLQDLSSLSTAFQGT----IGYLAPEFAYMRIVTTKVDVFS 207
+++ ++DFG SR +++ D + QG I ++A E + TTK DV++
Sbjct: 164 GKNYTIKIADFGMSR--NLYSSDYYRV----QGRAPLPIRWMAWESVLLGKFTTKSDVWA 217
Query: 208 FGIVVMEFLT--KRRPTG-LDEENGLSPISLRQLVEKALANGINGVRQITDPKLVSSIYE 264
FG+ + E LT + +P L ++ Q++E A +
Sbjct: 218 FGVTLWEILTLCREQPYEHLTDQ---------QVIENA-----------------GHFFR 251
Query: 265 EQEQHQVL-------EELFKLALVCTSSNPEDRPNMNEL 296
+ + L +++++L L C + EDRP E+
Sbjct: 252 DDGRQIYLPRPPNCPKDIYELMLECWRRDEEDRPTFREI 290
|
Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR) subfamily; catalytic (c) domain. The DDR subfamily consists of homologs of mammalian DDR1, DDR2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR subfamily members are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linked to a variety of human cancers including breast, colon, ovarian, brain, and lung. There is no evidence showing that DDRs act as transforming oncogenes. They are more likely to play a role in the regulation of tumor growth and metastasis. Length = 296 |
| >gnl|CDD|173669 cd05578, STKc_Yank1, Catalytic domain of the Protein Serine/Threonine Kinase, Yank1 | Back alignment and domain information |
|---|
Score = 88.1 bits (219), Expect = 2e-20
Identities = 58/218 (26%), Positives = 99/218 (45%), Gaps = 31/218 (14%)
Query: 14 FSENNIIGNSNLSTVYKGRLED-GEIVAVKKLNFHQ-FSAESDKSFYREAKTLKELKHRN 71
F +IG V + D ++ A+K +N + S ++ E + L+EL H
Sbjct: 2 FELLRVIGKGAFGKVCIVQKRDTKKMFAMKYMNKQKCVEKGSVRNVLNERRILQELNHPF 61
Query: 72 LVKVLGYAWESGKLKALILEYMENGSLESVIHGPGVDHSRWTLPKRIDV--------LIS 123
LV L Y+++ + L+++ + G L R+ L +++ +
Sbjct: 62 LVN-LWYSFQDEENMYLVVDLLLGGDL------------RYHLSQKVKFSEEQVKFWICE 108
Query: 124 VANGLDYLHSGYDIPIVHCDMKPSNILLDRDFEAHVSDFGTSRMLDVHLQDLSSLSTAFQ 183
+ L+YLHS I+H D+KP NILLD H++DF + + +L+T+
Sbjct: 109 IVLALEYLHSKG---IIHRDIKPDNILLDEQGHVHITDFNIATKVTP-----DTLTTSTS 160
Query: 184 GTIGYLAPEFAYMRIVTTKVDVFSFGIVVMEFLTKRRP 221
GT GY+APE + + VD +S G+ E L +RP
Sbjct: 161 GTPGYMAPEVLCRQGYSVAVDWWSLGVTAYECLRGKRP 198
|
Serine/Threonine Kinases (STKs), Yank1 or STK32A subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Yank1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily contains uncharacterized STKs with similarity to the human protein designated Yank1 or STK32A. Length = 258 |
| >gnl|CDD|173739 cd07838, STKc_CDK4_6_like, Catalytic domain of Cyclin-Dependent protein Kinase 4 and 6-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 88.5 bits (220), Expect = 2e-20
Identities = 74/238 (31%), Positives = 110/238 (46%), Gaps = 38/238 (15%)
Query: 14 FSENNIIGNSNLSTVYKGR-LEDGEIVAVKKLNFHQFSAESDKSFYREAKTLKELK---H 69
+ E IG TVYK R L G VA+KK+ S RE LK+L+ H
Sbjct: 1 YEELAEIGEGAYGTVYKARDLNTGRFVALKKVRVPLSEEGIPLSTLREIALLKQLESFEH 60
Query: 70 RNLVKVL----GYAWESGKLKALILEYME---NGSLESVIHGPGVDHSRWTLPKRI-DVL 121
N+V++L G + L+ E+++ L PG+ P+ I D++
Sbjct: 61 PNIVRLLDVCHGPRTDRELKLTLVFEHVDQDLATYLSKCPK-PGLP------PETIKDLM 113
Query: 122 ISVANGLDYLHSGYDIPIVHCDMKPSNILLDRDFEAHVSDFGTSRMLDVHLQDLSSLSTA 181
+ G+D+LHS IVH D+KP NIL+ D + ++DFG +R+ +L T+
Sbjct: 114 RQLLRGVDFLHSHR---IVHRDLKPQNILVTSDGQVKIADFGLARIYSFE----MAL-TS 165
Query: 182 FQGTIGYLAPEF----AYMRIVTTKVDVFSFGIVVMEFLTKRRP--TGLDEENGLSPI 233
T+ Y APE +Y T VD++S G + E L +RRP G E + L I
Sbjct: 166 VVVTLWYRAPEVLLQSSYA----TPVDMWSVGCIFAE-LFRRRPLFRGTSEADQLDKI 218
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) and CDK6-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4/6-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 and CDK6 partner with D-type cyclins to regulate the early G1 phase of the cell cycle. They are the first kinase activated by mitogenic signals to release cells from the G0 arrested state. CDK4 and CDK6 are both expressed ubiquitously, associate with all three D cyclins (D1, D2 and D3), and phosphorylate the retinoblastoma (pRb) protein. They are also regulated by the INK4 family of inhibitors which associate with either the CDK alone or the CDK/cyclin complex. CDK4 and CDK6 show differences in subcellular localization, sensitivity to some inhibitors, timing in activation, tumor selectivity, and possibly substrate profiles. Although CDK4 and CDK6 seem to show some redundancy, they also have discrete, nonoverlapping functions. CDK6 plays an important role in cell differentiation. Length = 287 |
| >gnl|CDD|133201 cd05070, PTKc_Fyn_Yrk, Catalytic domain of the Protein Tyrosine Kinases, Fyn and Yrk | Back alignment and domain information |
|---|
Score = 87.8 bits (217), Expect = 3e-20
Identities = 66/204 (32%), Positives = 101/204 (49%), Gaps = 19/204 (9%)
Query: 20 IGNSNLSTVYKGRLEDGEIVAVKKLNFHQFSAESDKSFYREAKTLKELKHRNLVKVLGYA 79
+GN V+ G VAVK L S ES F EA+ +K+L+H LV++ YA
Sbjct: 14 LGNGQFGEVWMGTWNGNTKVAVKTLKPGTMSPES---FLEEAQIMKKLRHDKLVQL--YA 68
Query: 80 WESGKLKALILEYMENGSLESVIHGPGVDHSRWTLPKRIDVLISVANGLDYLHSGYDIPI 139
S + ++ EYM GSL + + LP +D+ VA G+ Y+ +
Sbjct: 69 VVSEEPIYIVTEYMSKGSLLDFLKDG--EGRALKLPNLVDMAAQVAAGMAYIER---MNY 123
Query: 140 VHCDMKPSNILLDRDFEAHVSDFGTSRMLDVHLQDLSSLSTAFQGT---IGYLAPEFAYM 196
+H D++ +NIL+ ++DFG +R+++ + TA QG I + APE A
Sbjct: 124 IHRDLRSANILVGDGLVCKIADFGLARLIE------DNEYTARQGAKFPIKWTAPEAALY 177
Query: 197 RIVTTKVDVFSFGIVVMEFLTKRR 220
T K DV+SFGI++ E +TK R
Sbjct: 178 GRFTIKSDVWSFGILLTELVTKGR 201
|
Protein Tyrosine Kinase (PTK) family; Fyn and Yrk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fyn and Yrk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Fyn, together with Lck, plays a critical role in T-cell signal transduction by phosphorylating ITAM (immunoreceptor tyr activation motif) sequences on T-cell receptors, ultimately leading to the proliferation and differentiation of T-cells. In addition, Fyn is involved in the myelination of neurons, and is implicated in Alzheimer's and Parkinson's diseases. Yrk has been detected only in chickens. It is primarily found in neuronal and epithelial cells and in macrophages. It may play a role in inflammation and in response to injury. Length = 260 |
| >gnl|CDD|173757 cd08217, STKc_Nek2, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 2 | Back alignment and domain information |
|---|
Score = 87.7 bits (218), Expect = 3e-20
Identities = 70/286 (24%), Positives = 119/286 (41%), Gaps = 37/286 (12%)
Query: 18 NIIGNSNLSTVYK-GRLEDGEIVAVKKLNFHQFSAESDKSFYREAKTLKELKHRNLVKVL 76
IG + TV K R DG+I+ K++++ + + + E L+ELKH N+V+
Sbjct: 6 ETIGKGSFGTVRKVRRKSDGKILVWKEIDYGNMTEKEKQQLVSEVNILRELKHPNIVRY- 64
Query: 77 GYAWESGKLKA---LILEYMENGSLESVIHGPGVDHSRWTLPKRIDVLISVANGLDYLHS 133
Y + +++EY E G L +I + +L + L H+
Sbjct: 65 -YDRIIDRSNQTLYIVMEYCEGGDLAQLIQKCKKERKYIEEEFIWRILTQLLLALYECHN 123
Query: 134 GYDIP--IVHCDMKPSNILLDRDFEAHVSDFGTSRMLDVHLQDLSSLSTAFQGTIGYLAP 191
D ++H D+KP+NI LD + + DFG +++L SS + + GT Y++P
Sbjct: 124 RSDPGNTVLHRDLKPANIFLDANNNVKLGDFGLAKILGHD----SSFAKTYVGTPYYMSP 179
Query: 192 EFAYMRIVTTKVDVFSFGIVVMEFLTKRRPTGLDEENGLSPISLRQLVEKALANGINGVR 251
E K D++S G ++ E P + + QL K + G R
Sbjct: 180 EQLNHMSYDEKSDIWSLGCLIYELCALSPP--------FTARNQLQLASK-IKEGK--FR 228
Query: 252 QITDPKLVSSIYEEQEQHQVLEELFKLALVCTSSNPEDRPNMNELL 297
+I P S EL ++ + +P+ RP+ ELL
Sbjct: 229 RI--PYRYS------------SELNEVIKSMLNVDPDKRPSTEELL 260
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 2 (Nek2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek2 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek2 subfamily includes Aspergillus nidulans NIMA kinase, the founding member of the Nek family, which was identified in a screen for cell cycle mutants prevented from entering mitosis. NIMA is essential for mitotic entry and progression through mitosis, and its degradation is essential for mitotic exit. NIMA is involved in nuclear membrane fission. Vertebrate Nek2 is a cell cycle-regulated STK, localized in centrosomes and kinetochores, that regulates centrosome splitting at the G2/M phase. It also interacts with other mitotic kinases such as Polo-like kinase 1 and may play a role in spindle checkpoint. An increase in the expression of the human NEK2 gene is strongly associated with the progression of non-Hodgkin lymphoma. Length = 265 |
| >gnl|CDD|173733 cd07829, STKc_CDK_like, Catalytic domain of Cyclin-Dependent protein Kinase-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 87.9 bits (219), Expect = 3e-20
Identities = 66/202 (32%), Positives = 97/202 (48%), Gaps = 28/202 (13%)
Query: 27 TVYKGR-LEDGEIVAVKKLNFHQFSAESD---KSFYREAKTLKELKHRNLVKVLGYAWES 82
VYK R + GEIVA+KK+ E + + RE LKELKH N+VK+L
Sbjct: 14 VVYKARDKKTGEIVALKKIRLDN---EEEGIPSTALREISLLKELKHPNIVKLLDVIHTE 70
Query: 83 GKLKALILEYMENGSLESVIHGPGVDHSRWTLPKRIDVLISVANGLDYLHSGYDIPIVHC 142
KL L+ EY + L+ + S + K I + + GL Y HS I+H
Sbjct: 71 RKL-YLVFEYCDM-DLKKYLDKRPGPLSPNLI-KSI--MYQLLRGLAYCHSHR---ILHR 122
Query: 143 DMKPSNILLDRDFEAHVSDFGTSRMLDVHLQDLSSLSTAFQGTIGYLAPE-----FAYMR 197
D+KP NIL++RD ++DFG +R + L+ + T+ Y APE Y
Sbjct: 123 DLKPQNILINRDGVLKLADFGLARAFGIPLRTYTHEVV----TLWYRAPEILLGSKHY-- 176
Query: 198 IVTTKVDVFSFGIVVMEFLTKR 219
+T VD++S G + E +T +
Sbjct: 177 --STAVDIWSVGCIFAEMITGK 196
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase (CDK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKs are partly regulated by their subcellular localization, which defines substrate phosphorylation and the resulting specific function. CDK1, CDK2, CDK4, and CDK6 have well-defined functions in the cell cycle, such as the regulation of the early G1 phase by CDK4 or CDK6, the G1/S phase transition by CDK2, or the entry of mitosis by CDK1. They also exhibit overlapping cyclin specificity and functions in certain conditions. Knockout mice with a single CDK deleted remain viable with specific phenotypes, showing that some CDKs can compensate for each other. For example, CDK4 can compensate for the loss of CDK6, however, double knockout mice with both CDK4 and CDK6 deleted die in utero. CDK8 and CDK9 are mainly involved in transcription while CDK5 is implicated in neuronal function. CDK7 plays essential roles in both the cell cycle as a CDK-Activating Kinase (CAK) and in transcription as a component of the general transcription factor TFIIH. Length = 282 |
| >gnl|CDD|173648 cd05092, PTKc_TrkA, Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase A | Back alignment and domain information |
|---|
Score = 87.7 bits (217), Expect = 3e-20
Identities = 61/195 (31%), Positives = 96/195 (49%), Gaps = 19/195 (9%)
Query: 34 EDGEIVAVKKLNFHQFSAESDKSFYREAKTLKELKHRNLVKVLGYAWESGKLKALILEYM 93
+D +VAVK L SA D F REA+ L L+H+++V+ G E G+ ++ EYM
Sbjct: 33 QDKMLVAVKALKEASESARQD--FQREAELLTVLQHQHIVRFYGVCTE-GRPLLMVFEYM 89
Query: 94 ENGSLESVI--HGP---------GVDHSRWTLPKRIDVLISVANGLDYLHSGYDIPIVHC 142
+G L + HGP V + TL + + + +A+G+ YL S + VH
Sbjct: 90 RHGDLNRFLRSHGPDAKILAGGEDVAPGQLTLGQMLAIASQIASGMVYLAS---LHFVHR 146
Query: 143 DMKPSNILLDRDFEAHVSDFGTSRMLDVHLQDLSSLSTAFQGTIGYLAPEFAYMRIVTTK 202
D+ N L+ + + DFG SR D++ D + I ++ PE R TT+
Sbjct: 147 DLATRNCLVGQGLVVKIGDFGMSR--DIYSTDYYRVGGRTMLPIRWMPPESILYRKFTTE 204
Query: 203 VDVFSFGIVVMEFLT 217
D++SFG+V+ E T
Sbjct: 205 SDIWSFGVVLWEIFT 219
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase A (TrkA); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkA is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkA to its ligand, nerve growth factor (NGF), results in receptor oligomerization and activation of the catalytic domain. TrkA is expressed mainly in neural-crest-derived sensory and sympathetic neurons of the peripheral nervous system, and in basal forebrain cholinergic neurons of the central nervous system. It is critical for neuronal growth, differentiation and survival. Alternative TrkA splicing has been implicated as a pivotal regulator of neuroblastoma (NB) behavior. Normal TrkA expression is associated with better NB prognosis, while the hypoxia-regulated TrkAIII splice variant promotes NB pathogenesis and progression. Aberrant TrkA expression has also been demonstrated in non-neural tumors including prostate, breast, lung, and pancreatic cancers. Length = 280 |
| >gnl|CDD|133243 cd05112, PTKc_Itk, Catalytic domain of the Protein Tyrosine Kinase, Interleukin-2-inducible T-cell Kinase | Back alignment and domain information |
|---|
Score = 86.5 bits (214), Expect = 6e-20
Identities = 75/279 (26%), Positives = 130/279 (46%), Gaps = 39/279 (13%)
Query: 20 IGNSNLSTVYKGRLEDGEIVAVKKLNFHQFSAESDKSFYREAKTLKELKHRNLVKVLGYA 79
IG+ V+ G + VA+K + + A S++ F EA+ + +L H LV++ G
Sbjct: 12 IGSGQFGLVWLGYWLEKRKVAIKTI---REGAMSEEDFIEEAQVMMKLSHPKLVQLYGVC 68
Query: 80 WESGKLKALILEYMENGSLESVIHGPGVDHSRWTLPKRIDVLISVANGLDYLHSGYDIPI 139
E + L+ E+ME+G L + S+ TL + + + V G+ YL S +
Sbjct: 69 TERSPI-CLVFEFMEHGCLSDYLRAQRGKFSQETL---LGMCLDVCEGMAYLESS---NV 121
Query: 140 VHCDMKPSNILLDRDFEAHVSDFGTSRMLDVHLQDLSSLSTAFQGTIGYLAPE-FAYMRI 198
+H D+ N L+ + VSDFG +R + L D + ST + + + +PE F++ +
Sbjct: 122 IHRDLAARNCLVGENQVVKVSDFGMTRFV---LDDQYTSSTGTKFPVKWSSPEVFSFSK- 177
Query: 199 VTTKVDVFSFGIVVMEFLTKRRPTGLDEENGLSPISLRQLVEKALANGINGVRQITDPKL 258
++K DV+SFG+++ E ++ + + N ++VE IN ++ P+L
Sbjct: 178 YSSKSDVWSFGVLMWEVFSEGKTPYENRSNS-------EVVET-----INAGFRLYKPRL 225
Query: 259 VSSIYEEQEQHQVLEELFKLALVCTSSNPEDRPNMNELL 297
S E QH C PEDRP+ + LL
Sbjct: 226 ASQSVYELMQH------------CWKERPEDRPSFSLLL 252
|
Protein Tyrosine Kinase (PTK) family; Interleukin-2 (IL-2)-inducible T-cell kinase (Itk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Itk (also known as Tsk or Emt) is a member of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. In addition, Itk contains the Tec homology (TH) domain containing one proline-rich region and a zinc-binding region. Tec kinases are expressed mainly by haematopoietic cells. Itk is expressed in T-cells and mast cells, and is important in their development and differentiation. Of the three Tec kinases expressed in T-cells, Itk plays the predominant role in T-cell receptor (TCR) signaling. It is activated by phosphorylation upon TCR crosslinking and is involved in the pathway resulting in phospholipase C-gamma1 activation and actin polymerization. It also plays a role in the downstream signaling of the T-cell costimulatory receptor CD28, the T-cell surface receptor CD2, and the chemokine receptor CXCR4. In addition, Itk is crucial for the development of T-helper(Th)2 effector responses. Length = 256 |
| >gnl|CDD|143346 cd07841, STKc_CDK7, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 7 | Back alignment and domain information |
|---|
Score = 87.2 bits (217), Expect = 7e-20
Identities = 64/203 (31%), Positives = 94/203 (46%), Gaps = 24/203 (11%)
Query: 27 TVYKGR-LEDGEIVAVKKLNFHQFSAESD---KSFYREAKTLKELKHRNLVKVLGYAWES 82
VYK R E G IVA+KK+ + D + RE K L+ELKH N++ +L +
Sbjct: 15 VVYKARDKETGRIVAIKKIKLGERKEAKDGINFTALREIKLLQELKHPNIIGLLD-VFGH 73
Query: 83 GKLKALILEYMENGSLESVIHGPGVDHSRWTLPKRIDVLISVANGLDYLHSGYDIPIVHC 142
L+ E+ME LE VI + T ++ GL+YLHS + I+H
Sbjct: 74 KSNINLVFEFME-TDLEKVIKDKSI---VLTPADIKSYMLMTLRGLEYLHSNW---ILHR 126
Query: 143 DMKPSNILLDRDFEAHVSDFGTSRML---DVHLQDLSSLSTAFQGTIGYLAPEFAY-MRI 198
D+KP+N+L+ D ++DFG +R + + T T Y APE + R
Sbjct: 127 DLKPNNLLIASDGVLKLADFGLARSFGSPNRKM-------THQVVTRWYRAPELLFGARH 179
Query: 199 VTTKVDVFSFGIVVMEFLTKRRP 221
VD++S G + E L R P
Sbjct: 180 YGVGVDMWSVGCIFAELL-LRVP 201
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 7 (CDK7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK7 plays essential roles in the cell cycle and in transcription. It associates with cyclin H and MAT1 and acts as a CDK-Activating Kinase (CAK) by phosphorylating and activating cell cycle CDKs (CDK1/2/4/6). In the brain, it activates CDK5. CDK7 is also a component of the general transcription factor TFIIH, which phosphorylates the C-terminal domain (CTD) of RNA polymerase II when it is bound with unphosphorylated DNA, as present in the pre-initiation complex. Following phosphorylation, the CTD dissociates from the DNA which allows transcription initiation. Length = 298 |
| >gnl|CDD|173638 cd05065, PTKc_EphR_B, Catalytic domain of the Protein Tyrosine Kinases, Class EphB Ephrin Receptors | Back alignment and domain information |
|---|
Score = 85.3 bits (211), Expect = 2e-19
Identities = 64/210 (30%), Positives = 111/210 (52%), Gaps = 16/210 (7%)
Query: 19 IIGNSNLSTVYKGRLE---DGEI-VAVKKLNFHQFSAESDKSFYREAKTLKELKHRNLVK 74
+IG V +GRL+ EI VA+K L ++ + + F EA + + H N++
Sbjct: 11 VIGAGEFGEVCRGRLKLPGKREIFVAIKTLK-SGYTEKQRRDFLSEASIMGQFDHPNIIH 69
Query: 75 VLGYAWESGKLKALILEYMENGSLESVIHGPGVDHSRWTLPKRIDVLISVANGLDYLHSG 134
+ G +S + +I E+MENG+L+S + + ++T+ + + +L +A G+ YL
Sbjct: 70 LEGVVTKSRPV-MIITEFMENGALDSFLR---QNDGQFTVIQLVGMLRGIAAGMKYLS-- 123
Query: 135 YDIPIVHCDMKPSNILLDRDFEAHVSDFGTSRMLDVHLQDLSSLSTAFQGTIG--YLAPE 192
++ VH D+ NIL++ + VSDFG SR L+ D + +++ G I + APE
Sbjct: 124 -EMNYVHRDLAARNILVNSNLVCKVSDFGLSRFLEDDTSD-PTYTSSLGGKIPIRWTAPE 181
Query: 193 FAYMRIVTTKVDVFSFGIVVMEFLT-KRRP 221
R T+ DV+S+GIV+ E ++ RP
Sbjct: 182 AIAYRKFTSASDVWSYGIVMWEVMSYGERP 211
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; class EphB receptors; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). Class EphB receptors bind to transmembrane ephrin-B ligands. There are six vertebrate EhpB receptors (EphB1-6), which display promiscuous interactions with three ephrin-B ligands. One exception is EphB2, which also interacts with ephrin A5. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). Ephrin/EphR interaction mainly results in cell-cell repulsion or adhesion. EphBRs play important roles in synapse formation and plasticity, spine morphogenesis, axon guidance, and angiogenesis. In the intestinal epithelium, EphBRs are Wnt signaling target genes that control cell compartmentalization. They function as suppressors of color cancer progression. Length = 269 |
| >gnl|CDD|133248 cd05148, PTKc_Srm_Brk, Catalytic domain of the Protein Tyrosine Kinases, Srm and Brk | Back alignment and domain information |
|---|
Score = 85.2 bits (211), Expect = 2e-19
Identities = 74/285 (25%), Positives = 119/285 (41%), Gaps = 40/285 (14%)
Query: 14 FSENNIIGNSNLSTVYKGRLEDGEIVAVKKLNFHQFSAESDKSFYREAKTLKELKHRNLV 73
F+ +G+ V++G ++ VA+K L + F +E + LK L+H++L+
Sbjct: 8 FTLERKLGSGYFGEVWEGLWKNRVRVAIKILK--SDDLLKQQDFQKEVQALKRLRHKHLI 65
Query: 74 KVLGYAWESGKLKALILEYMENGSLESVIHGPGVDHSRWTLPKRIDVLISVANGLDYLHS 133
+ G+ +I E ME GSL + + P + + ID+ VA G+ YL
Sbjct: 66 SLFAVC-SVGEPVYIITELMEKGSLLAFLRSP--EGQVLPVASLIDMACQVAEGMAYLEE 122
Query: 134 GYDIPIVHCDMKPSNILLDRDFEAHVSDFGTSRML--DVHLQDLSSLSTAFQGTIGYLAP 191
+H D+ NIL+ D V+DFG +R++ DV+L + + AP
Sbjct: 123 QN---SIHRDLAARNILVGEDLVCKVADFGLARLIKEDVYLSSDKKIP------YKWTAP 173
Query: 192 EFAYMRIVTTKVDVFSFGIVVMEFLTKRRPTGLDEENGLSPISLRQLVEKALANGINGVR 251
E A +TK DV+SFGI++ E T + + Q+ G R
Sbjct: 174 EAASHGTFSTKSDVWSFGILLYEMFTY---GQVPYPGMNNHEVYDQITA--------GYR 222
Query: 252 QITDPKLVSSIYEEQEQHQVLEELFKLALVCTSSNPEDRPNMNEL 296
K IY K+ L C ++ PEDRP+ L
Sbjct: 223 MPCPAKCPQEIY-------------KIMLECWAAEPEDRPSFKAL 254
|
Protein Tyrosine Kinase (PTK) family; Src-related kinase lacking C-terminal regulatory tyrosine and N-terminal myristylation sites (Srm) and breast tumor kinase (Brk, also called protein tyrosine kinase 6); catalytic (c) domains. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Srm and Brk are a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases in general contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr; they are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Srm and Brk however, lack the N-terminal myristylation sites. Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Brk has been found to be overexpressed in a majority of breast tumors. Length = 261 |
| >gnl|CDD|173640 cd05067, PTKc_Lck_Blk, Catalytic domain of the Protein Tyrosine Kinases, Lymphocyte-specific kinase and Blk | Back alignment and domain information |
|---|
Score = 84.9 bits (210), Expect = 2e-19
Identities = 77/286 (26%), Positives = 126/286 (44%), Gaps = 55/286 (19%)
Query: 20 IGNSNLSTVYKGRLEDGEIVAVKKLNFHQFSAESDKSFYREAKTLKELKHRNLVKVLGYA 79
+G V+ G VA+K L S E+ F EA +K+L+H LV++ YA
Sbjct: 14 LGAGQFGEVWMGYYNGHTKVAIKSLKQGSMSPEA---FLAEANLMKQLQHPRLVRL--YA 68
Query: 80 WESGKLKALILEYMENGSLESVIHGPGVDHSRWTLPKRIDVLISVANGLDYLHSGYDIPI 139
+ + +I EYMENGSL + P + + T+ K ID+ +A G+ ++ I
Sbjct: 69 VVTQEPIYIITEYMENGSLVDFLKTP--EGIKLTINKLIDMAAQIAEGMAFIERKNYI-- 124
Query: 140 VHCDMKPSNILLDRDFEAHVSDFGTSRMLDVHLQDLSSLSTAFQGT---IGYLAPEFAYM 196
H D++ +NIL+ ++DFG +R+++ + TA +G I + APE
Sbjct: 125 -HRDLRAANILVSETLCCKIADFGLARLIE------DNEYTAREGAKFPIKWTAPEAINY 177
Query: 197 RIVTTKVDVFSFGIVVMEFLTKRR---PTGLDEENGLSPISLRQLVEKALANGINGVRQI 253
T K DV+SFGI++ E +T R P +
Sbjct: 178 GTFTIKSDVWSFGILLTEIVTYGRIPYPG------------------------------M 207
Query: 254 TDPKLVSSI---YEEQEQHQVLEELFKLALVCTSSNPEDRPNMNEL 296
T+P+++ ++ Y EEL++L +C PE+RP L
Sbjct: 208 TNPEVIQNLERGYRMPRPDNCPEELYELMRLCWKEKPEERPTFEYL 253
|
Protein Tyrosine Kinase (PTK) family; Lck and Blk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lck (lymphocyte-specific kinase) and Blk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Lck is expressed in T-cells and natural killer (NK) cells. It plays a critical role in T-cell maturation, activation, and T-cell receptor (TCR) signaling. Lck phosphorylates ITAM (immunoreceptor tyr activation motif) sequences on several subunits of TCRs, leading to the activation of different second messenger cascades. Phosphorylated ITAMs serve as binding sites for other signaling factor such as Syk and ZAP-70, leading to their activation and propagation of downstream events. In addition, Lck regulates drug-induced apoptosis by interfering with the mitochondrial death pathway. The apototic role of Lck is independent of its primary function in T-cell signaling. Blk is expressed specifically in B-cells. It is involved in pre-BCR (B-cell receptor) signaling. Length = 260 |
| >gnl|CDD|133194 cd05063, PTKc_EphR_A2, Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A2 | Back alignment and domain information |
|---|
Score = 85.0 bits (210), Expect = 3e-19
Identities = 66/217 (30%), Positives = 106/217 (48%), Gaps = 18/217 (8%)
Query: 12 GSFSENNIIGNSNLSTVYKGRLE----DGEIVAVKKLNFHQFSAESDKSFYREAKTLKEL 67
++ +IG V++G L+ VA+K L ++ + + F EA + +
Sbjct: 5 SHITKQKVIGAGEFGEVFRGILKMPGRKEVAVAIKTLK-PGYTEKQRQDFLSEASIMGQF 63
Query: 68 KHRNLVKVLGYAWESGKLKALILEYMENGSLESVIHGPGVDHSRWTLPKRIDVLISVANG 127
H N++++ G K +I EYMENG+L+ + + S + L + +L +A G
Sbjct: 64 SHHNIIRLEGVV-TKFKPAMIITEYMENGALDKYLRDHDGEFSSYQL---VGMLRGIAAG 119
Query: 128 LDYLHSGYDIPIVHCDMKPSNILLDRDFEAHVSDFGTSRMLDVHLQDLSSLSTAFQGTIG 187
+ YL D+ VH D+ NIL++ + E VSDFG SR+L+ D T G I
Sbjct: 120 MKYLS---DMNYVHRDLAARNILVNSNLECKVSDFGLSRVLE---DDPEGTYTTSGGKIP 173
Query: 188 --YLAPEFAYMRIVTTKVDVFSFGIVVMEFLT-KRRP 221
+ APE R T+ DV+SFGIV+ E ++ RP
Sbjct: 174 IRWTAPEAIAYRKFTSASDVWSFGIVMWEVMSFGERP 210
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA2 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). Ephrin/EphR interaction mainly results in cell-cell repulsion or adhesion, making it important in neural development and plasticity, cell morphogenesis, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. The EphA2 receptor is overexpressed in tumor cells and tumor blood vessels in a variety of cancers including breast, prostate, lung, and colon. As a result, it is an attractive target for drug design since its inhibition could affect several aspects of tumor progression. Length = 268 |
| >gnl|CDD|173639 cd05066, PTKc_EphR_A, Catalytic domain of the Protein Tyrosine Kinases, Class EphA Ephrin Receptors | Back alignment and domain information |
|---|
Score = 85.0 bits (210), Expect = 3e-19
Identities = 65/205 (31%), Positives = 107/205 (52%), Gaps = 17/205 (8%)
Query: 19 IIGNSNLSTVYKGRLE---DGEI-VAVKKLNFHQFSAESDKSFYREAKTLKELKHRNLVK 74
+IG V GRL+ EI VA+K L ++ + + F EA + + H N++
Sbjct: 11 VIGAGEFGEVCSGRLKLPGKREIPVAIKTLKA-GYTEKQRRDFLSEASIMGQFDHPNIIH 69
Query: 75 VLGYAWESGKLKALILEYMENGSLESVIHGPGVDHSRWTLPKRIDVLISVANGLDYLHSG 134
+ G +S K ++ EYMENGSL++ + ++T+ + + +L +A+G+ YL
Sbjct: 70 LEGVVTKS-KPVMIVTEYMENGSLDAFLRK---HDGQFTVIQLVGMLRGIASGMKYLS-- 123
Query: 135 YDIPIVHCDMKPSNILLDRDFEAHVSDFGTSRMLDVHLQDLSSLSTAFQGTIG--YLAPE 192
D+ VH D+ NIL++ + VSDFG SR+L+ D + T G I + APE
Sbjct: 124 -DMGYVHRDLAARNILVNSNLVCKVSDFGLSRVLE---DDPEAAYTTRGGKIPIRWTAPE 179
Query: 193 FAYMRIVTTKVDVFSFGIVVMEFLT 217
R T+ DV+S+GIV+ E ++
Sbjct: 180 AIAYRKFTSASDVWSYGIVMWEVMS 204
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; most class EphA receptors including EphA3, EphA4, EphA5, and EphA7, but excluding EphA1, EphA2 and EphA10; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. One exception is EphA4, which also binds ephrins-B2/B3. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). Ephrin/EphR interaction mainly results in cell-cell repulsion or adhesion, making it important in neural development and plasticity, cell morphogenesis, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. EphARs and ephrin-A ligands are expressed in multiple areas of the developing brain, especially in the retina and tectum. They are part of a system controlling retinotectal mapping. Length = 267 |
| >gnl|CDD|173728 cd06614, STKc_PAK, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase | Back alignment and domain information |
|---|
Score = 85.0 bits (211), Expect = 4e-19
Identities = 75/279 (26%), Positives = 119/279 (42%), Gaps = 54/279 (19%)
Query: 28 VYKG-RLEDGEIVAVKKLNFHQFSAESDKSFYREAKTLKELKHRNLVK------VLGYAW 80
VYK G+ VA+KK+ + ++ + E +K+ KH N+V V W
Sbjct: 35 VYKATDRATGKEVAIKKMRLRK---QNKELIINEILIMKDCKHPNIVDYYDSYLVGDELW 91
Query: 81 ESGKLKALILEYMENGSLESVIHGPGVDHSRWTLPKRI--DVLISVANGLDYLHSGYDIP 138
+++EYM+ GSL +I + + + V V GL+YLHS
Sbjct: 92 -------VVMEYMDGGSLTDII-----TQNFVRMNEPQIAYVCREVLQGLEYLHSQ---N 136
Query: 139 IVHCDMKPSNILLDRDFEAHVSDFGTSRMLDVHLQDLSSLSTAFQGTIGYLAPEFAYMRI 198
++H D+K NILL +D ++DFG + L +S+ GT ++APE +
Sbjct: 137 VIHRDIKSDNILLSKDGSVKLADFGFAAQLTKEKSKRNSVV----GTPYWMAPEVIKRKD 192
Query: 199 VTTKVDVFSFGIVVMEFLTKRRPTGLDEENGLSPISLRQLVEKALANGINGVRQITDPKL 258
KVD++S GI+ +E + + P L E P LR L + G+ + +P+
Sbjct: 193 YGPKVDIWSLGIMCIE-MAEGEPPYLRE----PP--LRAL--FLITT--KGIPPLKNPEK 241
Query: 259 VSSIYEEQEQHQVLEELFKLALVCTSSNPEDRPNMNELL 297
S E C +PE RP+ ELL
Sbjct: 242 WSP------------EFKDFLNKCLVKDPEKRPSAEELL 268
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAK deregulation is associated with tumor development. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). Group II PAKs contain a PBD and a catalytic domain, but lack other motifs found in group I PAKs. Since group II PAKs do not contain an obvious AID, they may be regulated differently from group I PAKs. Group I PAKs interact with the SH3 containing proteins Nck, Grb2 and PIX; no such binding has been demonstrated for group II PAKs. Length = 286 |
| >gnl|CDD|173672 cd05581, STKc_PDK1, Catalytic domain of the Protein Serine/Threonine Kinase, Phosphoinositide-dependent kinase 1 | Back alignment and domain information |
|---|
Score = 84.2 bits (209), Expect = 7e-19
Identities = 61/224 (27%), Positives = 99/224 (44%), Gaps = 31/224 (13%)
Query: 19 IIGNSNLSTVYKGRL-EDGEIVAVKKLNFHQFSAESD-KSFYREAKTLKELK-HRNLVKV 75
IIG + STV + E + A+K L+ Q E K E + L L H ++K+
Sbjct: 8 IIGEGSFSTVVLAKEKETNKEYAIKILDKRQLIKEKKVKYVKIEKEVLTRLNGHPGIIKL 67
Query: 76 LGYAWESGKLKALILEYMENGSLESVIHGPGVDHSRWTLPKRIDVLIS--VANGLDYLHS 133
+ L +LEY NG L I G +L ++ + + L+YLHS
Sbjct: 68 YYTFQDEENL-YFVLEYAPNGELLQYIRKYG------SLDEKCTRFYAAEILLALEYLHS 120
Query: 134 GYDIPIVHCDMKPSNILLDRDFEAHVSDFGTSRMLD----------------VHLQDLSS 177
I+H D+KP NILLD+D ++DFGT+++LD ++
Sbjct: 121 ---KGIIHRDLKPENILLDKDMHIKITDFGTAKVLDPNSSPESNKGDATNIDSQIEKNRR 177
Query: 178 LSTAFQGTIGYLAPEFAYMRIVTTKVDVFSFGIVVMEFLTKRRP 221
+F GT Y++PE + D+++ G ++ + LT + P
Sbjct: 178 RFASFVGTAEYVSPELLNEKPAGKSSDLWALGCIIYQMLTGKPP 221
|
Serine/Threonine Kinases (STKs), Phosphoinositide-dependent kinase 1 (PDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PDK1 carries an N-terminal catalytic domain and a C-terminal pleckstrin homology (PH) domain that binds phosphoinositides. It phosphorylates the activation loop of AGC kinases that are regulated by PI3K such as PKB, SGK, and PKC, among others, and is crucial for their activation. Thus, it contributes in regulating many processes including metabolism, growth, proliferation, and survival. PDK1 also has the ability to autophosphorylate and is constitutively active in mammalian cells. PDK1 is essential for normal embryo development and is important in regulating cell volume. Length = 280 |
| >gnl|CDD|133199 cd05068, PTKc_Frk_like, Catalytic domain of Fyn-related kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 83.6 bits (207), Expect = 7e-19
Identities = 60/205 (29%), Positives = 98/205 (47%), Gaps = 20/205 (9%)
Query: 20 IGNSNLSTVYKGRLEDGEIVAVKKLNFHQFSAESDKSFYREAKTLKELKHRNLVKVLGYA 79
+G V++G + VAVK L + F EA+ +K+L+H L+++ YA
Sbjct: 14 LGAGQFGEVWEGLWNNTTPVAVKTLKPGTMDPKD---FLAEAQIMKKLRHPKLIQL--YA 68
Query: 80 WESGKLKALIL-EYMENGSLESVIHGPGVDHSRWTLPKRIDVLISVANGLDYLHSGYDIP 138
+ + I+ E M+ GSL + G LP+ ID+ VA+G+ YL + I
Sbjct: 69 VCTLEEPIYIVTELMKYGSLLEYLQGGAGRA--LKLPQLIDMAAQVASGMAYLEAQNYI- 125
Query: 139 IVHCDMKPSNILLDRDFEAHVSDFGTSRMLDVHLQDLSSLSTAFQGT---IGYLAPEFAY 195
H D+ N+L+ + V+DFG +R++ + A +G I + APE A
Sbjct: 126 --HRDLAARNVLVGENNICKVADFGLARVIK------EDIYEAREGAKFPIKWTAPEAAL 177
Query: 196 MRIVTTKVDVFSFGIVVMEFLTKRR 220
+ K DV+SFGI++ E +T R
Sbjct: 178 YNRFSIKSDVWSFGILLTEIVTYGR 202
|
Protein Tyrosine Kinase (PTK) family; Human Fyn-related kinase (Frk) and similar proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Frk and Srk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Frk, also known as Rak, is specifically expressed in liver, lung, kidney, intestine, mammary glands, and the islets of Langerhans. Rodent homologs were previously referred to as GTK (gastrointestinal tyr kinase), BSK (beta-cell Src-like kinase), or IYK (intestinal tyr kinase). Studies in mice reveal that Frk is not essential for viability. It plays a role in the signaling that leads to cytokine-induced beta-cell death in Type I diabetes. It also regulates beta-cell number during embryogenesis and early in life. Length = 261 |
| >gnl|CDD|132963 cd06632, STKc_MEKK1_plant, Catalytic domain of the Protein Serine/Threonine Kinase, Plant MAP/ERK kinase kinase 1 | Back alignment and domain information |
|---|
Score = 83.6 bits (207), Expect = 8e-19
Identities = 76/288 (26%), Positives = 126/288 (43%), Gaps = 52/288 (18%)
Query: 20 IGNSNLSTVYKG-RLEDGEIVAVKKLNF---HQFSAESDKSFYREAKTLKELKHRNLVKV 75
+G+ + +VY+G L+DG+ AVK+++ Q E+ K +E L +L+H N+V+
Sbjct: 8 LGSGSFGSVYEGLNLDDGDFFAVKEVSLADDGQTGQEAVKQLEQEIALLSKLQHPNIVQY 67
Query: 76 LGYAWESGKLKALILEYMENGSLESVIHGPGVDHSRWTLPKRIDVLIS-----VANGLDY 130
LG E L + LE + GSL ++ G + P + +I + GL+Y
Sbjct: 68 LGTEREEDNL-YIFLELVPGGSLAKLLKKYG------SFP---EPVIRLYTRQILLGLEY 117
Query: 131 LHSGYDIPIVHCDMKPSNILLDRDFEAHVSDFGTSRMLDVHLQDLSSLSTAFQGTIGYLA 190
LH VH D+K +NIL+D + ++DFG ++ + + S + F+G+ ++A
Sbjct: 118 LHDRN---TVHRDIKGANILVDTNGVVKLADFGMAK----QVVEFSFAKS-FKGSPYWMA 169
Query: 191 PE-FAYMRIVTTKVDVFSFGIVVMEFLTKRRPTGLDEENGLSPISLRQLVEKALANGING 249
PE A D++S G V+E T + P E G+
Sbjct: 170 PEVIAQQGGYGLAADIWSLGCTVLEMATGKPPWSQLE-------------------GVAA 210
Query: 250 VRQITDPKLVSSIYEEQEQHQVLEELFKLALVCTSSNPEDRPNMNELL 297
V +I K + I + +E L C +P RP ELL
Sbjct: 211 VFKIGRSKELPPIPDHLS-----DEAKDFILKCLQRDPSLRPTAAELL 253
|
Serine/threonine kinases (STKs), plant MAP/ERK kinase kinase 1 (MEKK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The plant MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of plant mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) including Arabidopsis thaliana MEKK1 and MAPKKK3. MEKK1 is a MAPKKK that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Arabidopsis thaliana MEKK1 activates MPK4, a MAPK that regulates systemic acquired resistance. MEKK1 also participates in the regulation of temperature-sensitive and tissue-specific cell death. Length = 258 |
| >gnl|CDD|133189 cd05058, PTKc_Met_Ron, Catalytic domain of the Protein Tyrosine Kinases, Met and Ron | Back alignment and domain information |
|---|
Score = 82.9 bits (205), Expect = 1e-18
Identities = 64/214 (29%), Positives = 102/214 (47%), Gaps = 23/214 (10%)
Query: 18 NIIGNSNLSTVYKGRLEDGE----IVAVKKLNFHQFSAESDKSFYREAKTLKELKHRNLV 73
+IG + VY G L D + AVK LN E + F +E +K+ H N++
Sbjct: 1 RVIGKGHFGCVYHGTLIDSDGQKIHCAVKSLN-RITDLEEVEQFLKEGIIMKDFSHPNVL 59
Query: 74 KVLGYAWESGKLKALILEYMENGSLESVI----HGPGVDHSRWTLPKRIDVLISVANGLD 129
+LG S ++L YM++G L + I H P T+ I + VA G++
Sbjct: 60 SLLGICLPSEGSPLVVLPYMKHGDLRNFIRSETHNP-------TVKDLIGFGLQVAKGME 112
Query: 130 YLHSGYDIPIVHCDMKPSNILLDRDFEAHVSDFGTSRMLDVHLQDLSSLSTAFQGT--IG 187
YL S VH D+ N +LD F V+DFG +R D++ ++ S+ +
Sbjct: 113 YLASK---KFVHRDLAARNCMLDESFTVKVADFGLAR--DIYDKEYYSVHNHTGAKLPVK 167
Query: 188 YLAPEFAYMRIVTTKVDVFSFGIVVMEFLTKRRP 221
++A E + TTK DV+SFG+++ E +T+ P
Sbjct: 168 WMALESLQTQKFTTKSDVWSFGVLLWELMTRGAP 201
|
Protein Tyrosine Kinase (PTK) family; Met and Ron; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Met and Ron are receptor tyr kinases (RTKs) composed of an alpha-beta heterodimer. The extracellular alpha chain is disulfide linked to the beta chain, which contains an extracellular ligand-binding region with a sema domain, a PSI domain and four IPT repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Met binds to the ligand, hepatocyte growth factor/scatter factor (HGF/SF), and is also called the HGF receptor. HGF/Met signaling plays a role in growth, transformation, cell motility, invasion, metastasis, angiogenesis, wound healing, and tissue regeneration. Aberrant expression of Met through mutations or gene amplification is associated with many human cancers including hereditary papillary renal and gastric carcinomas. The ligand for Ron is macrophage stimulating protein (MSP). Ron signaling is important in regulating cell motility, adhesion, proliferation, and apoptosis. Aberrant Ron expression is implicated in tumorigenesis and metastasis. Length = 262 |
| >gnl|CDD|133212 cd05081, PTKc_Jak2_Jak3_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3 | Back alignment and domain information |
|---|
Score = 83.3 bits (206), Expect = 2e-18
Identities = 64/206 (31%), Positives = 102/206 (49%), Gaps = 19/206 (9%)
Query: 20 IGNSNLSTVYKGR---LED--GEIVAVKKLNFHQFSAESDKSFYREAKTLKELKHRNLVK 74
+G N +V R L+D GE+VAVKKL +AE + F RE + LK L+H N+VK
Sbjct: 12 LGKGNFGSVELCRYDPLQDNTGEVVAVKKL--QHSTAEHLRDFEREIEILKSLQHDNIVK 69
Query: 75 VLGYAWESGKLK-ALILEYMENGSLESVI--HGPGVDHSRWTLPKRIDVLISVANGLDYL 131
G + +G+ L++EY+ GSL + H +DH + L + G++YL
Sbjct: 70 YKGVCYSAGRRNLRLVMEYLPYGSLRDYLQKHRERLDHRKLLLYAS-----QICKGMEYL 124
Query: 132 HSGYDIPIVHCDMKPSNILLDRDFEAHVSDFGTSRMLDVHLQDLSSLSTAFQGTIGYLAP 191
S VH D+ NIL++ + + DFG +++L ++ + + I + AP
Sbjct: 125 GS---KRYVHRDLATRNILVESENRVKIGDFGLTKVLPQD-KEYYKVREPGESPIFWYAP 180
Query: 192 EFAYMRIVTTKVDVFSFGIVVMEFLT 217
E + DV+SFG+V+ E T
Sbjct: 181 ESLTESKFSVASDVWSFGVVLYELFT 206
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak2 is widely expressed in many tissues while Jak3 is expressed only in hematopoietic cells. Jak2 is essential for the signaling of hormone-like cytokines such as growth hormone, erythropoietin, thrombopoietin, and prolactin, as well as some IFNs and cytokines that signal through the IL-3 and gp130 receptors. Jak3 binds the shared receptor subunit common gamma chain and thus, is essential in the signaling of cytokines that use it such as IL-2, IL-4, IL-7, IL-9, IL-15, and IL-21. Disruption of Jak2 in mice results in an embryonic lethal phenotype with multiple defects including erythropoietic and cardiac abnormalities. It is the only Jak gene that results in a lethal phenotype when disrupted in mice. A mutation in the pseudokinase domain of Jak2, V617F, is present in many myeloproliferative diseases, including almost all patients with polycythemia vera, and 50% of patients with essential thrombocytosis and myelofibrosis. Jak3 is important in lymphoid development and myeloid cell differentiation. Inactivating mutations in Jak3 have been reported in humans with severe combined immunodeficiency (SCID). Length = 284 |
| >gnl|CDD|173637 cd05059, PTKc_Tec_like, Catalytic domain of Tec-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 82.5 bits (204), Expect = 2e-18
Identities = 79/282 (28%), Positives = 128/282 (45%), Gaps = 45/282 (15%)
Query: 20 IGNSNLSTVYKGRLEDGEIVAVKKLNFHQFSAESDKSFYREAKTLKELKHRNLVKVLGYA 79
+G+ V+ G+ VA+K + A S+ F EAK + +L H NLV++ G
Sbjct: 12 LGSGQFGVVHLGKWRGKIDVAIKMIRE---GAMSEDDFIEEAKVMMKLSHPNLVQLYGVC 68
Query: 80 WESGKLKALILEYMENGSLESVIHG-PGVDHSRWTLPKRIDVLISVANGLDYLHS-GYDI 137
+ + ++ EYM NG L + + G + W L D+ V ++YL S G+
Sbjct: 69 TKQRPIF-IVTEYMANGCLLNYLRERKGKLGTEWLL----DMCSDVCEAMEYLESNGF-- 121
Query: 138 PIVHCDMKPSNILLDRDFEAHVSDFGTSR-MLDVHLQDLSSLSTAFQGTIGYLAPE-FAY 195
+H D+ N L+ D VSDFG +R +LD Q SS T F + + PE F Y
Sbjct: 122 --IHRDLAARNCLVGEDNVVKVSDFGLARYVLDD--QYTSSQGTKF--PVKWAPPEVFDY 175
Query: 196 MRIVTTKVDVFSFGIVVMEFLTKRRPTGLDEENGLSPISLRQLVEKALANGINGVRQITD 255
R ++K DV+SFG+++ E ++ + N ++VE +++ G ++
Sbjct: 176 SRF-SSKSDVWSFGVLMWEVFSEGKMPYERFSNS-------EVVE-SVSAGY----RLYR 222
Query: 256 PKLVSSIYEEQEQHQVLEELFKLALVCTSSNPEDRPNMNELL 297
PKL E++ + C PEDRP +LL
Sbjct: 223 PKLAP------------TEVYTIMYSCWHEKPEDRPAFKKLL 252
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) subfamily; catalytic (c) domain. The Tec subfamily is composed of Tec, Btk, Bmx (Etk), Itk (Tsk, Emt), Rlk (Txk), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec kinases are cytoplasmic (or nonreceptor) tyr kinases (nRTKs) with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. In addition, some members contain the Tec homology (TH) domain, which contains proline-rich and zinc-binding regions. Tec kinases form the second largest subfamily of nRTKs and are expressed mainly by haematopoietic cells, although Tec and Bmx are also found in endothelial cells. B-cells express Btk and Tec, while T-cells express Itk, Txk, and Tec. Collectively, Tec kinases are expressed in a variety of myeloid cells such as mast cells, platelets, macrophages, and dendritic cells. Each Tec kinase shows a distinct cell-type pattern of expression. The function of Tec kinases in lymphoid cells have been studied extensively. They play important roles in the development, differentiation, maturation, regulation, survival, and function of B-cells and T-cells. Mutations in Btk cause the severe B-cell immunodeficiency, X-linked agammaglobulinaemia (XLA). Length = 256 |
| >gnl|CDD|132951 cd06620, PKc_MAPKK_Byr1_like, Catalytic domain of fungal Byr1-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Score = 82.5 bits (204), Expect = 2e-18
Identities = 73/288 (25%), Positives = 130/288 (45%), Gaps = 48/288 (16%)
Query: 20 IGNSNLSTVYKGRLEDGEIVAVKKLNFHQFSAESDKSFYREAKTLKELKHRNLVKVLGYA 79
+G N +V K + V KK+ + K RE + + E + +V G A
Sbjct: 13 LGAGNGGSVSKVKHIPTGTVMAKKVVHIGAKSSVRKQILRELQIMHECRSPYIVSFYG-A 71
Query: 80 WESGKLKALILEYMENGSLESVIHGPGVDHSRWTLPKRIDVL----ISVANGLDYLHSGY 135
+ + + +E+M+ GSL+ + G P +++L ++V GL YL+
Sbjct: 72 FLNENNICMCMEFMDCGSLDRIYKKGG--------PIPVEILGKIAVAVVEGLTYLY--N 121
Query: 136 DIPIVHCDMKPSNILLDRDFEAHVSDFGTSRMLDVHLQDLSSLSTAFQGTIGYLAPEFAY 195
I+H D+KPSNIL++ + + DFG S L ++S++ F GT Y++PE
Sbjct: 122 VHRIMHRDIKPSNILVNSRGQIKLCDFGVSGEL------INSIADTFVGTSTYMSPE--- 172
Query: 196 MRI----VTTKVDVFSFGIVVMEFLTKRRP---TGLDEENGLSPISLRQLVEKALANGIN 248
RI T K DV+S GI ++E + P + +D++ P+ + L+++
Sbjct: 173 -RIQGGKYTVKSDVWSLGISIIELALGKFPFAFSNIDDDGQDDPMGILDLLQQ------- 224
Query: 249 GVRQITDPKLVSSIYEEQEQHQVLEELFKLALVCTSSNPEDRPNMNEL 296
+ Q P+L SS + + L + L+ +P +RP +L
Sbjct: 225 -IVQEPPPRLPSSDFP-----EDLRDFVDACLL---KDPTERPTPQQL 263
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal Byr1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include the MAPKKs Byr1 from Schizosaccharomyces pombe, FUZ7 from Ustilago maydis, and related proteins. Byr1 phosphorylates its downstream target, the MAPK Spk1, and is regulated by the MAPKKK Byr2. The Spk1 cascade is pheromone-responsive and is essential for sporulation and sexual differentiation in fission yeast. FUZ7 phosphorylates and activates its target, the MAPK Crk1, which is required in mating and virulence in U. maydis. Length = 284 |
| >gnl|CDD|173660 cd05123, STKc_AGC, Catalytic domain of AGC family Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 81.8 bits (203), Expect = 3e-18
Identities = 58/193 (30%), Positives = 90/193 (46%), Gaps = 21/193 (10%)
Query: 34 EDGEIVAVKKLN-FHQFSAESDKSFYREAKTLKELKHRNLVKVLGYAWES-GKLKALILE 91
+ G++ A+K L + + E L + H +VK L YA+++ KL L+LE
Sbjct: 16 DTGKLYAMKVLKKKKIIKRKEVEHTLTERNILSRINHPFIVK-LHYAFQTEEKL-YLVLE 73
Query: 92 YMENGSLESVIHGPGVDHSRWTLP-KRIDVLIS-VANGLDYLHS-GYDIPIVHCDMKPSN 148
Y G L S + +R + + L+YLHS G I++ D+KP N
Sbjct: 74 YAPGGELFSHLS------KEGRFSEERARFYAAEIVLALEYLHSLG----IIYRDLKPEN 123
Query: 149 ILLDRDFEAHVSDFGTSRMLDVHLQDLSSLSTAFQGTIGYLAPEFAYMRIVTTKVDVFSF 208
ILLD D ++DFG ++ L ++ F GT YLAPE + VD +S
Sbjct: 124 ILLDADGHIKLTDFGLAKELSSEGSRTNT----FCGTPEYLAPEVLLGKGYGKAVDWWSL 179
Query: 209 GIVVMEFLTKRRP 221
G+++ E LT + P
Sbjct: 180 GVLLYEMLTGKPP 192
|
Serine/Threonine Kinases (STKs), AGC (Protein Kinases A, G and C) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The AGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and Phosphoinositide 3-Kinase (PI3K). Members of this family include cAMP-dependent Protein Kinase (PKA), cGMP-dependent Protein Kinase (PKG), Protein Kinase C (PKC), Protein Kinase B (PKB), G protein-coupled Receptor Kinase (GRK), Serum- and Glucocorticoid-induced Kinase (SGK), and 70 kDa ribosomal Protein S6 Kinase (p70S6K or S6K), among others. AGC kinases share an activation mechanism based on the phosphorylation of up to three sites: the activation loop (A-loop), the hydrophobic motif (HM) and the turn motif. Phosphorylation at the A-loop is required of most AGC kinases, which results in a disorder-to-order transition of the A-loop. The ordered conformation results in the access of substrates and ATP to the active site. A subset of AGC kinases with C-terminal extensions containing the HM also requires phosphorylation at this site. Phosphorylation at the HM allows the C-terminal extension to form an ordered structure that packs into the hydrophobic pocket of the catalytic domain, which then reconfigures the kinase into an active bi-lobed state. In addition, growth factor-activated AGC kinases such as PKB, p70S6K, RSK, MSK, PKC, and SGK, require phosphorylation at the turn motif (also called tail or zipper site), located N-terminal to the HM at the C-terminal extension. AGC kinases regulate many cellular processes including division, growth, survival, metabolism, motility, and differentiation. Many are implicated in the development of various human diseases. Length = 250 |
| >gnl|CDD|173736 cd07832, STKc_CCRK, Catalytic domain of the Serine/Threonine Kinase, Cell Cycle-Related Kinase | Back alignment and domain information |
|---|
Score = 82.3 bits (204), Expect = 3e-18
Identities = 54/193 (27%), Positives = 89/193 (46%), Gaps = 17/193 (8%)
Query: 28 VYKGR-LEDGEIVAVKKLNFHQFSAESDKSFYREAKTLKELKHRNLVKVLGYAWESGKLK 86
V+K + E GE VA+KK+ + RE K L+ +H +VK+L + G
Sbjct: 16 VFKAKDRETGETVALKKVALRRLEGGIPNQALREIKALQACQHPYVVKLLD-VFPHGSGF 74
Query: 87 ALILEYMENGSLESVIHGPGVDHSRWTLPKRI--DVLISVANGLDYLHSGYDIPIVHCDM 144
L++EYM L V+ LP+ + + G+ Y+H+ I+H D+
Sbjct: 75 VLVMEYMP-SDLSEVLR-----DEERPLPEAQVKSYMRMLLKGVAYMHA---NGIMHRDL 125
Query: 145 KPSNILLDRDFEAHVSDFGTSRMLDVHLQDLSSLSTAFQGTIGYLAPEFAY-MRIVTTKV 203
KP+N+L+ D ++DFG +R+ ++ L + T Y APE Y R V
Sbjct: 126 KPANLLISADGVLKIADFGLARLFS---EEEPRLYSHQVATRWYRAPELLYGARKYDPGV 182
Query: 204 DVFSFGIVVMEFL 216
D+++ G + E L
Sbjct: 183 DLWAVGCIFAELL 195
|
Serine/Threonine Kinases (STKs), Cell Cycle-Related Kinase (CCRK) p42 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CCRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CCRK was previously called p42. It is a Cyclin-Dependent Kinase (CDK)-Activating Kinase (CAK) which is essential for the activation of CDK2. It is indispensable for cell growth and has been implicated in the progression of glioblastoma multiforme. In the heart, a splice variant of CCRK with a different C-terminal half is expressed, this variant promotes cardiac cell growth and survival and is significantly down-regulated during the development of heart failure. Length = 286 |
| >gnl|CDD|133191 cd05060, PTKc_Syk_like, Catalytic domain of Spleen Tyrosine Kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 81.6 bits (202), Expect = 4e-18
Identities = 73/292 (25%), Positives = 122/292 (41%), Gaps = 55/292 (18%)
Query: 20 IGNSNLSTVYKG--RLEDG-EI-VAVKKLNFHQFSAESDKS-FYREAKTLKELKHRNLVK 74
+G+ N +V KG ++ G E+ VAVK L Q + K F REA + +L H +V+
Sbjct: 3 LGHGNFGSVVKGVYLMKSGKEVEVAVKTL--KQEHIAAGKKEFLREASVMAQLDHPCIVR 60
Query: 75 VLGYAWESGKLKALILEYMENGSLESVIHGPGVDHSRWTLPKRIDVLISVANGLDYLHSG 134
++G + L++E G L + + ++ VA G+ YL S
Sbjct: 61 LIGVCKGEPLM--LVMELAPLGPLLKYL----KKRREIPVSDLKELAHQVAMGMAYLESK 114
Query: 135 YDIPIVHCDMKPSNILLDRDFEAHVSDFGTSRMLDVHLQDLSSLSTAFQGTIGYLAPEFA 194
+ VH D+ N+LL +A +SDFG SR L D +TA + + + APE
Sbjct: 115 H---FVHRDLAARNVLLVNRHQAKISDFGMSRALGAG-SDYYRATTAGRWPLKWYAPECI 170
Query: 195 YMRIVTTKVDVFSFGIVVMEFLTKRRPTGLDEENGLSPISLRQLVEKALANGINGVRQIT 254
++K DV+S+G+ + E A + G ++
Sbjct: 171 NYGKFSSKSDVWSYGVTLWE---------------------------AFSYGAKPYGEMK 203
Query: 255 DPKLVSSIYEEQEQHQVLE-------ELFKLALVCTSSNPEDRPNMNELLIT 299
++++ + E + L E++ + L C PEDRP +EL T
Sbjct: 204 GAEVIAML----ESGERLPRPEECPQEIYSIMLSCWKYRPEDRPTFSELEST 251
|
Protein Tyrosine Kinase (PTK) family; Spleen Tyrosine Kinase (Syk) subfamily; catalytic (c) domain. The Syk subfamily is composed of Syk, ZAP-70, Shark, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. They are involved in the signaling downstream of activated receptors (including B-cell, T-cell, and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferation, differentiation, survival, adhesion, migration, and phagocytosis. Syk is important in B-cell receptor (BCR) signaling, while Zap-70 is primarily expressed in T-cells and NK cells, and is a crucial component in T-cell receptor (TCR) signaling. Syk also plays a central role in Fc receptor-mediated phagocytosis in the adaptive immune system. Shark is exclusively expressed in ectodermally derived epithelia, and is localized preferentially to the apical surface of the epithelial cells, it may play a role in a signaling pathway for epithelial cell polarity. Length = 257 |
| >gnl|CDD|173765 cd08225, STKc_Nek5, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 5 | Back alignment and domain information |
|---|
Score = 81.5 bits (201), Expect = 5e-18
Identities = 73/285 (25%), Positives = 127/285 (44%), Gaps = 45/285 (15%)
Query: 19 IIGNSNLSTVY--KGRLEDGEIVAVKKLNFHQFSAESDKSFYREAKTLKELKHRNLVKVL 76
IG + +Y K + + V +K+++ + + ++ +E L ++KH N+V
Sbjct: 7 KIGEGSFGKIYLAKAKSDSEHCV-IKEIDLTKMPVKEKEASKKEVILLAKMKHPNIVTFF 65
Query: 77 GYAWESGKLKALILEYMENGSLESVIHGPGVDHSRWTLPKRIDVL---ISVANGLDYLHS 133
E+G+L +++EY + G L I + R L +L + ++ GL ++H
Sbjct: 66 ASFQENGRL-FIVMEYCDGGDLMKRI-----NRQRGVLFSEDQILSWFVQISLGLKHIH- 118
Query: 134 GYDIPIVHCDMKPSNILLDRD-FEAHVSDFGTSRMLDVHLQDLSSLSTAFQGTIGYLAPE 192
D I+H D+K NI L ++ A + DFG +R L+ D L+ GT YL+PE
Sbjct: 119 --DRKILHRDIKSQNIFLSKNGMVAKLGDFGIARQLN----DSMELAYTCVGTPYYLSPE 172
Query: 193 FAYMRIVTTKVDVFSFGIVVMEFLTKRRPTGLDEENGLSPISLRQLVEKALANGINGVRQ 252
R K D++S G V+ E T + P E N +L QLV K +
Sbjct: 173 ICQNRPYNNKTDIWSLGCVLYELCTLKHPF---EGN-----NLHQLVLKICQGYFAPI-- 222
Query: 253 ITDPKLVSSIYEEQEQHQVLEELFKLALVCTSSNPEDRPNMNELL 297
S ++ ++ +LFK++ P DRP++ +L
Sbjct: 223 --------SPNFSRDLRSLISQLFKVS-------PRDRPSITSIL 252
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 5 (Nek5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek5 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. The specific function of Nek5 is unknown. Length = 257 |
| >gnl|CDD|133200 cd05069, PTKc_Yes, Catalytic domain of the Protein Tyrosine Kinase, Yes | Back alignment and domain information |
|---|
Score = 80.1 bits (197), Expect = 2e-17
Identities = 60/204 (29%), Positives = 103/204 (50%), Gaps = 19/204 (9%)
Query: 20 IGNSNLSTVYKGRLEDGEIVAVKKLNFHQFSAESDKSFYREAKTLKELKHRNLVKVLGYA 79
+G V+ G VA+K L E+ F +EA+ +K+L+H LV + YA
Sbjct: 14 LGQGCFGEVWMGTWNGTTKVAIKTLKPGTMMPEA---FLQEAQIMKKLRHDKLVPL--YA 68
Query: 80 WESGKLKALILEYMENGSLESVIHGPGVDHSRWTLPKRIDVLISVANGLDYLHSGYDIPI 139
S + ++ E+M GSL + + + LP+ +D+ +A+G+ Y+ +
Sbjct: 69 VVSEEPIYIVTEFMGKGSLLDFLKEGDGKYLK--LPQLVDMAAQIADGMAYIER---MNY 123
Query: 140 VHCDMKPSNILLDRDFEAHVSDFGTSRMLDVHLQDLSSLSTAFQGT---IGYLAPEFAYM 196
+H D++ +NIL+ + ++DFG +R+++ + TA QG I + APE A
Sbjct: 124 IHRDLRAANILVGDNLVCKIADFGLARLIE------DNEYTARQGAKFPIKWTAPEAALY 177
Query: 197 RIVTTKVDVFSFGIVVMEFLTKRR 220
T K DV+SFGI++ E +TK R
Sbjct: 178 GRFTIKSDVWSFGILLTELVTKGR 201
|
Protein Tyrosine Kinase (PTK) family; Yes kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Yes (or c-Yes) is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. c-Yes kinase is the cellular homolog of the oncogenic protein (v-Yes) encoded by the Yamaguchi 73 and Esh sarcoma viruses. It displays functional overlap with other Src subfamily members, particularly Src. It also shows some unique functions such as binding to occludins, transmembrane proteins that regulate extracellular interactions in tight junctions. Yes also associates with a number of proteins in different cell types that Src does not interact with, like JAK2 and gp130 in pre-adipocytes, and Pyk2 in treated pulmonary vein endothelial cells. Although the biological function of Yes remains unclear, it appears to have a role in regulating cell-cell interactions and vesicle trafficking in polarized cells. Length = 260 |
| >gnl|CDD|173649 cd05093, PTKc_TrkB, Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase B | Back alignment and domain information |
|---|
Score = 79.7 bits (196), Expect = 3e-17
Identities = 61/193 (31%), Positives = 93/193 (48%), Gaps = 17/193 (8%)
Query: 34 EDGEIVAVKKLNFHQFSAESDKSFYREAKTLKELKHRNLVKVLGYAWESGKLKALILEYM 93
+D +VAVK L S + K F+REA+ L L+H ++VK G E L ++ EYM
Sbjct: 33 QDKILVAVKTLK--DASDNARKDFHREAELLTNLQHEHIVKFYGVCVEGDPL-IMVFEYM 89
Query: 94 ENGSLESVI--HGP-------GVDHSRWTLPKRIDVLISVANGLDYLHSGYDIPIVHCDM 144
++G L + HGP G + T + + + +A G+ YL S + VH D+
Sbjct: 90 KHGDLNKFLRAHGPDAVLMAEGNRPAELTQSQMLHIAQQIAAGMVYLASQH---FVHRDL 146
Query: 145 KPSNILLDRDFEAHVSDFGTSRMLDVHLQDLSSLSTAFQGTIGYLAPEFAYMRIVTTKVD 204
N L+ + + DFG SR DV+ D + I ++ PE R TT+ D
Sbjct: 147 ATRNCLVGENLLVKIGDFGMSR--DVYSTDYYRVGGHTMLPIRWMPPESIMYRKFTTESD 204
Query: 205 VFSFGIVVMEFLT 217
V+S G+V+ E T
Sbjct: 205 VWSLGVVLWEIFT 217
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase B (TrkB); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkB is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkB to its ligands, brain-derived neurotrophic factor (BDNF) or neurotrophin 4 (NT4), results in receptor oligomerization and activation of the catalytic domain. TrkB is broadly expressed in the nervous system and in some non-neural tissues. It plays important roles in cell proliferation, differentiation, and survival. BDNF/Trk signaling plays a key role in regulating activity-dependent synaptic plasticity. TrkB also contributes to protection against gp120-induced neuronal cell death. TrkB overexpression is associated with poor prognosis in neuroblastoma (NB) and other human cancers. It acts as a suppressor of anoikis (detachment-induced apoptosis) and contributes to tumor metastasis. Length = 288 |
| >gnl|CDD|133205 cd05074, PTKc_Tyro3, Catalytic domain of the Protein Tyrosine Kinase, Tyro3 | Back alignment and domain information |
|---|
Score = 78.8 bits (194), Expect = 4e-17
Identities = 80/301 (26%), Positives = 138/301 (45%), Gaps = 54/301 (17%)
Query: 14 FSENNIIGNSNLSTVYKGRL--EDGEI--VAVKKLNFHQFSAESDKSFYREAKTLKELKH 69
F+ ++G +V + +L EDG VAVK L FS+ + F REA +KE H
Sbjct: 1 FTLGRMLGKGEFGSVREAQLKSEDGSFQKVAVKMLKADIFSSSDIEEFLREAACMKEFDH 60
Query: 70 RNLVKVLGYAWES---GKL--KALILEYMENGSLESVIHGPGVDHSRWTLPKRIDV--LI 122
N++K++G + S G+L +IL +M++G L + + + +TLP + V +I
Sbjct: 61 PNVIKLIGVSLRSRAKGRLPIPMVILPFMKHGDLHTFLLMSRIGEEPFTLPLQTLVRFMI 120
Query: 123 SVANGLDYLHSGYDIPIVHCDMKPSNILLDRDFEAHVSDFGTSRMLDVHLQDLSSLSTAF 182
+A+G++YL S +H D+ N +L+ + V+DFG S+ ++ D A
Sbjct: 121 DIASGMEYLSSK---NFIHRDLAARNCMLNENMTVCVADFGLSK--KIYSGDYYRQGCAS 175
Query: 183 QGTIGYLAPEFAYMRIVTTKVDVFSFGIVVMEFLTKRRPTGLDEENGLSPISLRQLVEKA 242
+ + +LA E + TT DV++FG+ + E +T+ G +P +
Sbjct: 176 KLPVKWLALESLADNVYTTHSDVWAFGVTMWEIMTR----------GQTPYA-------- 217
Query: 243 LANGINGVRQITDPKLVSSIYEE-------QEQHQVLEELFKLALVCTSSNPEDRPNMNE 295
GV S IY ++ LE++++L C S P+ RP+
Sbjct: 218 ------GVEN-------SEIYNYLIKGNRLKQPPDCLEDVYELMCQCWSPEPKCRPSFQH 264
Query: 296 L 296
L
Sbjct: 265 L 265
|
Protein Tyrosine Kinase (PTK) family; Tyro3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyro3 (or Sky) is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Tyro3 is predominantly expressed in the central nervous system and the brain, and functions as a neurotrophic factor. It is also expressed in osteoclasts and has a role in bone resorption. Length = 273 |
| >gnl|CDD|173751 cd07860, STKc_CDK2_3, Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase 2 and 3 | Back alignment and domain information |
|---|
Score = 78.7 bits (194), Expect = 5e-17
Identities = 61/209 (29%), Positives = 100/209 (47%), Gaps = 13/209 (6%)
Query: 13 SFSENNIIGNSNLSTVYKGR-LEDGEIVAVKKLNFHQFSAESDKSFYREAKTLKELKHRN 71
+F + IG VYK R GE+VA+KK+ + + RE LKEL H N
Sbjct: 1 NFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPN 60
Query: 72 LVKVLGYAWESGKLKALILEYMENGSLESVIHGPGVDHSRWTLPKRIDVLISVANGLDYL 131
+VK+L KL L+ E++ + L+ + + S LP L + GL +
Sbjct: 61 IVKLLDVIHTENKL-YLVFEFL-HQDLKKFMDASPL--SGIPLPLIKSYLFQLLQGLAFC 116
Query: 132 HSGYDIPIVHCDMKPSNILLDRDFEAHVSDFGTSRMLDVHLQDLSSLSTAFQGTIGYLAP 191
HS ++H D+KP N+L++ + ++DFG +R V ++ + T+ Y AP
Sbjct: 117 HSHR---VLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYTHEVV----TLWYRAP 169
Query: 192 EFAY-MRIVTTKVDVFSFGIVVMEFLTKR 219
E + +T VD++S G + E +T+R
Sbjct: 170 EILLGCKYYSTAVDIWSLGCIFAEMVTRR 198
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 2 (CDK2) and CDK3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK2/3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK2 is regulated by cyclin E or cyclin A. Upon activation by cyclin E, it phosphorylates the retinoblastoma (pRb) protein which activates E2F mediated transcription and allows cells to move into S phase. The CDK2/cyclin A complex plays a role in regulating DNA replication. CDK2, together with CDK4, also regulates embryonic cell proliferation. Despite these important roles, mice deleted for the cdk2 gene are viable and normal except for being sterile. This may be due to compensation provided by CDK1 (also called Cdc2), which can also bind cyclin E and drive the G1 to S phase transition. CDK3 is regulated by cyclin C and it phosphorylates pRB specifically during the G0/G1 transition. This phosphorylation is required for cells to exit G0 efficiently and enter the G1 phase. Length = 284 |
| >gnl|CDD|173650 cd05094, PTKc_TrkC, Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase C | Back alignment and domain information |
|---|
Score = 78.9 bits (194), Expect = 6e-17
Identities = 74/275 (26%), Positives = 120/275 (43%), Gaps = 44/275 (16%)
Query: 34 EDGEIVAVKKLNFHQFSAESDKSFYREAKTLKELKHRNLVKVLGYAWESGKLKALILEYM 93
+D +VAVK L +A D F REA+ L L+H ++VK G + L ++ EYM
Sbjct: 33 KDKMLVAVKALKDPTLAARKD--FQREAELLTNLQHEHIVKFYGVCGDGDPL-IMVFEYM 89
Query: 94 ENGSLESVI--HGPG----VD------HSRWTLPKRIDVLISVANGLDYLHSGYDIPIVH 141
++G L + HGP VD L + + + +A+G+ YL S + VH
Sbjct: 90 KHGDLNKFLRAHGPDAMILVDGQPRQAKGELGLSQMLHIASQIASGMVYLASQH---FVH 146
Query: 142 CDMKPSNILLDRDFEAHVSDFGTSRMLDVHLQDLSSLSTAFQGTIGYLAPEFAYMRIVTT 201
D+ N L+ + + DFG SR DV+ D + I ++ PE R TT
Sbjct: 147 RDLATRNCLVGANLLVKIGDFGMSR--DVYSTDYYRVGGHTMLPIRWMPPESIMYRKFTT 204
Query: 202 KVDVFSFGIVVMEFLTKRRPTGLDEENGLSPISLRQLVEKALANGINGVRQITDPKLVSS 261
+ DV+SFG+++ E T + LS V + + G R + P++
Sbjct: 205 ESDVWSFGVILWEIFTYGKQPWFQ----LSN----TEVIECITQG----RVLERPRVCP- 251
Query: 262 IYEEQEQHQVLEELFKLALVCTSSNPEDRPNMNEL 296
+E++ + L C P+ R N+ E+
Sbjct: 252 -----------KEVYDIMLGCWQREPQQRLNIKEI 275
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase C (TrkC); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkC is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkC to its ligand, neurotrophin 3 (NT3), results in receptor oligomerization and activation of the catalytic domain. TrkC is broadly expressed in the nervous system and in some non-neural tissues including the developing heart. NT3/TrkC signaling plays an important role in the innervation of the cardiac conducting system and the development of smooth muscle cells. Mice deficient with NT3 and TrkC have multiple heart defects. NT3/TrkC signaling is also critical for the development and maintenance of enteric neurons that are important for the control of gut peristalsis. Length = 291 |
| >gnl|CDD|133216 cd05085, PTKc_Fer, Catalytic domain of the Protein Tyrosine Kinase, Fer | Back alignment and domain information |
|---|
Score = 78.1 bits (192), Expect = 7e-17
Identities = 69/278 (24%), Positives = 117/278 (42%), Gaps = 35/278 (12%)
Query: 19 IIGNSNLSTVYKGRLEDGEIVAVKKLNFHQFSAESDKSFYREAKTLKELKHRNLVKVLGY 78
++G N V+KG L+D VAVK E F EA+ LK+ H N+VK++G
Sbjct: 2 LLGKGNFGEVFKGTLKDKTPVAVKTCK-EDLPQELKIKFLSEARILKQYDHPNIVKLIGV 60
Query: 79 AWESGKLKALILEYMENGSLESVIHGPGVDHSRWTLPKRIDVLISVANGLDYLHSGYDIP 138
+ + +++E + G S + + + + + A G+ YL S
Sbjct: 61 CTQRQPI-YIVMELVPGGDFLSFLRKKKDE---LKTKQLVKFALDAAAGMAYLESK---N 113
Query: 139 IVHCDMKPSNILLDRDFEAHVSDFGTSRMLDVHLQDLSSLSTAFQGTIGYLAPEFAYMRI 198
+H D+ N L+ + +SDFG SR D + S L Q I + APE
Sbjct: 114 CIHRDLAARNCLVGENNVLKISDFGMSRQEDDGIYSSSGLK---QIPIKWTAPEALNYGR 170
Query: 199 VTTKVDVFSFGIVVMEFLTKRRPTGLDEENGLSPISLRQLVEKALANGINGVRQITDPKL 258
+++ DV+S+GI++ E + G+ G++ R+ VEK
Sbjct: 171 YSSESDVWSYGILLWETFS----LGVCPYPGMTNQQAREQVEKG---------------- 210
Query: 259 VSSIYEEQEQHQVLEELFKLALVCTSSNPEDRPNMNEL 296
Y + ++++K+ C PE+RP +EL
Sbjct: 211 ----YRMSCPQKCPDDVYKVMQRCWDYKPENRPKFSEL 244
|
Protein Tyrosine Kinase (PTK) family; Fer kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fer kinase is a member of the Fes subfamily of proteins which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. Fer kinase is expressed in a wide variety of tissues, and is found to reside in both the cytoplasm and the nucleus. It plays important roles in neuronal polarization and neurite development, cytoskeletal reorganization, cell migration, growth factor signaling, and the regulation of cell-cell interactions mediated by adherens junctions and focal adhesions. Fer kinase also regulates cell cycle progression in malignant cells. Length = 250 |
| >gnl|CDD|133181 cd05050, PTKc_Musk, Catalytic domain of the Protein Tyrosine Kinase, Muscle-specific kinase | Back alignment and domain information |
|---|
Score = 78.7 bits (194), Expect = 7e-17
Identities = 64/230 (27%), Positives = 101/230 (43%), Gaps = 36/230 (15%)
Query: 17 NNI-----IGNSNLSTVYKGRL------EDGEIVAVKKLNFHQFSAESDKSFYREAKTLK 65
NNI IG V++ R E +VAVK L + SA+ F REA +
Sbjct: 5 NNIEYVRDIGQGAFGRVFQARAPGLLPYEPFTMVAVKMLK-EEASADMQADFQREAALMA 63
Query: 66 ELKHRNLVKVLGYAWESGKLKALILEYMENGSL------------ESVIHG------PGV 107
E H N+VK+LG GK L+ EYM G L S+ H G+
Sbjct: 64 EFDHPNIVKLLGVCAV-GKPMCLLFEYMAYGDLNEFLRHRSPRAQCSLSHSTSSARKCGL 122
Query: 108 DHSRWTLPKRIDVLISVANGLDYLHSGYDIPIVHCDMKPSNILLDRDFEAHVSDFGTSRM 167
+ + +++ + VA G+ YL + VH D+ N L+ + ++DFG SR
Sbjct: 123 NPLPLSCTEQLCIAKQVAAGMAYLS---ERKFVHRDLATRNCLVGENMVVKIADFGLSR- 178
Query: 168 LDVHLQDLSSLSTAFQGTIGYLAPEFAYMRIVTTKVDVFSFGIVVMEFLT 217
+++ D S I ++ PE + TT+ DV+++G+V+ E +
Sbjct: 179 -NIYSADYYKASENDAIPIRWMPPESIFYNRYTTESDVWAYGVVLWEIFS 227
|
Protein Tyrosine Kinase (PTK) family; Muscle-specific kinase (Musk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Musk is a receptor tyr kinase (RTK) containing an extracellular region with four immunoglobulin-like domains and a cysteine-rich cluster, a transmembrane segment, and an intracellular catalytic domain. Musk is expressed and concentrated in the postsynaptic membrane in skeletal muscle. It is essential for the establishment of the neuromuscular junction (NMJ), a peripheral synapse that conveys signals from motor neurons to muscle cells. Agrin, a large proteoglycan released from motor neurons, stimulates Musk autophosphorylation and activation, leading to the clustering of acetylcholine receptors (AChRs). To date, there is no evidence to suggest that agrin binds directly to Musk. Mutations in AChR, Musk and other partners are responsible for diseases of the NMJ, such as the autoimmune syndrome myasthenia gravis. Length = 288 |
| >gnl|CDD|133178 cd05046, PTK_CCK4, Pseudokinase domain of the Protein Tyrosine Kinase, Colon Carcinoma Kinase 4 | Back alignment and domain information |
|---|
Score = 78.3 bits (193), Expect = 7e-17
Identities = 72/296 (24%), Positives = 125/296 (42%), Gaps = 42/296 (14%)
Query: 13 SFSENNIIGNSNLSTVYKGRL-----EDGE-IVAVKKLNFHQFSAESDKSFYREAKTLKE 66
+ E +G V+ + E GE +V VK L F RE ++
Sbjct: 6 NLQEITTLGRGEFGEVFLAKAKGIEEEGGETLVLVKALQ-KTKDENLQSEFRRELDMFRK 64
Query: 67 LKHRNLVKVLGYAWESGKLKALILEYMENGSLES--VIHGPGVDHSR---WTLPKRIDVL 121
L H+N+V++LG E+ +ILEY + G L+ + + + +++ +
Sbjct: 65 LSHKNVVRLLGLCREAEP-HYMILEYTDLGDLKQFLRATKSKDEKLKPPPLSTKQKVALC 123
Query: 122 ISVANGLDYLHSGYDIPIVHCDMKPSNILLDRDFEAHVSDFGTSRMLDVHLQDLSSLSTA 181
+A G+D+L + VH D+ N L+ E VS S+ DV+ + L A
Sbjct: 124 TQIALGMDHL---SNARFVHRDLAARNCLVSSQREVKVSLLSLSK--DVYNSEYYKLRNA 178
Query: 182 FQGTIGYLAPEFAYMRIVTTKVDVFSFGIVVMEFLTKRRPTGLDEENGLSPISLRQLVEK 241
+ +LAPE +TK DV+SFG+++ E T+ E +S +++ +
Sbjct: 179 LI-PLRWLAPEAVQEDDFSTKSDVWSFGVLMWEVFTQ-------GELPFYGLSDEEVLNR 230
Query: 242 ALANGINGVRQITDPKLVSSIYEEQEQHQVLEELFKLALVCTSSNPEDRPNMNELL 297
A G ++ P+ L+KL C + NP+DRP+ +EL+
Sbjct: 231 LQA----GKLELPVPEGCP------------SRLYKLMTRCWAVNPKDRPSFSELV 270
|
Protein Tyrosine Kinase (PTK) family; Colon Carcinoma Kinase 4 (CCK4); pseudokinase domain. The PTKc (catalytic domain) family, to which this subfamily belongs, includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CCK4, also called protein tyrosine kinase 7 (PTK7), is an orphan receptor tyr kinase (RTK) containing an extracellular region with seven immunoglobulin domains, a transmembrane segment, and an intracellular inactive pseudokinase domain. Studies in mice reveal that CCK4 is essential for neural development. Mouse embryos containing a truncated CCK4 die perinatally and display craniorachischisis, a severe form of neural tube defect. The mechanism of action of the CCK4 pseudokinase is still unknown. Other pseudokinases such as HER3 rely on the activity of partner RTKs. Length = 275 |
| >gnl|CDD|173670 cd05579, STKc_MAST_like, Catalytic domain of Microtubule-associated serine/threonine kinase-like proteins | Back alignment and domain information |
|---|
Score = 78.1 bits (193), Expect = 9e-17
Identities = 52/189 (27%), Positives = 88/189 (46%), Gaps = 17/189 (8%)
Query: 36 GEIVAVKKLNFHQFSAE-SDKSFYREAKTLKELKHRNLVKVLGYAWESGKLKALILEYME 94
G+I A+K + + E L + + +VK L Y+++ K L++EY+
Sbjct: 18 GDIYAIKVIKKADMIRKNQVDQVLTERDILSQAQSPYVVK-LYYSFQGKKNLYLVMEYLP 76
Query: 95 NGSLESVIHGPGVDHSRWTLPKRIDVLIS--VANGLDYLHSGYDIPIVHCDMKPSNILLD 152
G L S++ G L + + + + L+YLHS I+H D+KP NIL+D
Sbjct: 77 GGDLASLLENVGS------LDEDVARIYIAEIVLALEYLHS---NGIIHRDLKPDNILID 127
Query: 153 RDFEAHVSDFGTSRM----LDVHLQDLSSLSTAFQGTIGYLAPEFAYMRIVTTKVDVFSF 208
+ ++DFG S++ ++L D GT Y+APE + + VD +S
Sbjct: 128 SNGHLKLTDFGLSKVGLVRRQINLNDDEKEDKRIVGTPDYIAPEVILGQGHSKTVDWWSL 187
Query: 209 GIVVMEFLT 217
G ++ EFL
Sbjct: 188 GCILYEFLV 196
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MAST kinase subfamily includes MAST kinases, MAST-like (MASTL) kinases, and fungal kinases with similarity to Saccharomyces cerevisiae Rim15 and Schizosaccharomyces pombe cek1. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. MASTL kinases carry only a catalytic domain which contains a long insert relative to other kinases. The fungal kinases in this subfamily harbor other domains in addition to a central catalytic domain, which also contains an insert relative to MAST kinases like MASTL. Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. MAST kinases are cytoskeletal associated kinases of unknown function that are also expressed at neuromuscular junctions and postsynaptic densities. The fungal proteins Rim15 and cek1 are involved in the regulation of meiosis and mitosis, respectively. Length = 265 |
| >gnl|CDD|173730 cd06624, STKc_ASK, Catalytic domain of the Protein Serine/Threonine Kinase, Apoptosis signal-regulating kinase | Back alignment and domain information |
|---|
Score = 78.0 bits (192), Expect = 9e-17
Identities = 63/218 (28%), Positives = 102/218 (46%), Gaps = 24/218 (11%)
Query: 14 FSENN---IIGNSNLSTVYKGRLEDGEI-VAVKKLNFHQFSAESDKSFYREAKTLKELKH 69
+ EN ++G VY R ++ +A+K++ + S + + E LKH
Sbjct: 7 YDENGERVVLGKGTYGIVYAARDLSTQVRIAIKEIP-ERDSRYV-QPLHEEIALHSYLKH 64
Query: 70 RNLVKVLGYAWESGKLKALILEYMENGSLESVIH---GPGVDHSRWTLPKRIDVLISVAN 126
RN+V+ LG E+G K + +E + GSL +++ GP D+ I +
Sbjct: 65 RNIVQYLGSDSENGFFK-IFMEQVPGGSLSALLRSKWGPLKDNE----QTIIFYTKQILE 119
Query: 127 GLDYLHSGYDIPIVHCDMKPSNILLDR-DFEAHVSDFGTSRMLDVHLQDLSSLSTAFQGT 185
GL YLH D IVH D+K N+L++ +SDFGTS+ L ++ + F GT
Sbjct: 120 GLKYLH---DNQIVHRDIKGDNVLVNTYSGVVKISDFGTSK----RLAGINPCTETFTGT 172
Query: 186 IGYLAPEF--AYMRIVTTKVDVFSFGIVVMEFLTKRRP 221
+ Y+APE R D++S G ++E T + P
Sbjct: 173 LQYMAPEVIDKGPRGYGAPADIWSLGCTIVEMATGKPP 210
|
Serine/threonine kinases (STKs), Apoptosis signal-regulating kinase (ASK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ASK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Subfamily members are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) and include ASK1, ASK2, and MAPKKK15. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. ASK1 (also called MAPKKK5) functions in the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4/MKK7 and MKK3/MKK6. It plays important roles in cytokine and stress responses, as well as in reactive oxygen species (ROS)-mediated cellular responses. ASK1 is implicated in various diseases mediated by oxidative stress including inschemic heart disease, hypertension, vessel injury, brain ischemia, Fanconi anemia, asthma, and pulmonary edema, among others. ASK2 (also called MAPKKK6) functions only in a heteromeric complex with ASK1, and can activate ASK1 by direct phosphorylation. The function of MAPKKK15 is still unknown. Length = 268 |
| >gnl|CDD|173633 cd05052, PTKc_Abl, Catalytic domain of the Protein Tyrosine Kinase, Abelson kinase | Back alignment and domain information |
|---|
Score = 78.0 bits (192), Expect = 1e-16
Identities = 76/301 (25%), Positives = 129/301 (42%), Gaps = 56/301 (18%)
Query: 3 DRTEIENATGSFSENNIIGNSNLSTVYKGRLED-GEIVAVKKLNFHQFSAESDKSFYREA 61
+RT+I + + +G VY+G + VAVK L E F +EA
Sbjct: 4 ERTDI-------TMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEE---FLKEA 53
Query: 62 KTLKELKHRNLVKVLGYAWESGKLKALILEYMENGSLESVIHGPGVDHSRWTLPKRIDVL 121
+KE+KH NLV++LG +I E+M G+L + + +R + + +
Sbjct: 54 AVMKEIKHPNLVQLLGVCTREPPF-YIITEFMTYGNLLDYLR----ECNRQEVNAVVLLY 108
Query: 122 IS--VANGLDYLHSGYDIPIVHCDMKPSNILLDRDFEAHVSDFGTSRMLDVHLQDLSSLS 179
++ +++ ++YL I H D+ N L+ + V+DFG SR++ D +
Sbjct: 109 MATQISSAMEYLEKKNFI---HRDLAARNCLVGENHLVKVADFGLSRLMT---GDTYTAH 162
Query: 180 TAFQGTIGYLAPE-FAYMRIVTTKVDVFSFGIVVMEFLTKRRPTGLDEENGLSP---ISL 235
+ I + APE AY + + K DV++FG+++ E T G+SP I L
Sbjct: 163 AGAKFPIKWTAPESLAYNKF-SIKSDVWAFGVLLWEIATY----------GMSPYPGIDL 211
Query: 236 RQLVEKALANGINGVRQITDPKLVSSIYEEQEQHQVLEELFKLALVCTSSNPEDRPNMNE 295
Q+ E L G Y + ++++L C NP DRP+ E
Sbjct: 212 SQVYEL-LEKG----------------YRMERPEGCPPKVYELMRACWQWNPSDRPSFAE 254
Query: 296 L 296
+
Sbjct: 255 I 255
|
Protein Tyrosine Kinase (PTK) family; Abelson (Abl) kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Abl (or c-Abl) is a ubiquitously-expressed cytoplasmic (or nonreceptor) tyr kinase that contains SH3, SH2, and tyr kinase domains in its N-terminal region, as well as nuclear localization motifs, a putative DNA-binding domain, and F- and G-actin binding domains in its C-terminal tail. It also contains a short autoinhibitory cap region in its N-terminus. Abl is normally inactive and requires phosphorylation and myristoylation for activation. Abl function depends on its subcellular localization. In the cytoplasm, Abl plays a role in cell proliferation and survival. In response to DNA damage or oxidative stress, Abl is transported to the nucleus where it induces apoptosis. In chronic myelogenous leukemia (CML) patients, an aberrant translocation results in the replacement of the first exon of Abl with the BCR (breakpoint cluster region) gene. The resulting BCR-Abl fusion protein is constitutively active and associates into tetramers, resulting in a hyperactive kinase sending a continuous signal. This leads to uncontrolled proliferation, morphological transformation and anti-apoptotic effects. BCR-Abl is the target of selective inhibitors, such as imatinib (Gleevec), used in the treatment of CML. Abl2, also known as ARG (Abelson-related gene), is thought to play a cooperative role with Abl in the proper development of the nervous system. The Tel-ARG fusion protein, resulting from reciprocal translocation between chromosomes 1 and 12, is associated with acute myeloid leukemia (AML). The TEL gene is a frequent fusion partner of other tyr kinase oncogenes, including Tel/Abl, Tel/PDGFRbeta, and Tel/Jak2, found in patients with leukemia and myeloproliferative disorders. Length = 263 |
| >gnl|CDD|132956 cd06625, STKc_MEKK3_like, Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 77.5 bits (191), Expect = 1e-16
Identities = 74/273 (27%), Positives = 118/273 (43%), Gaps = 46/273 (16%)
Query: 33 LEDGEIVAVKKLNFHQFSAESDK---SFYREAKTLKELKHRNLVKVLGYAWESGKLKALI 89
++ G +AVK++ F S E+ K + E + LK L+H +V+ G + L ++
Sbjct: 24 VDTGRELAVKQVPFDPDSPETKKEVNALECEIQLLKNLQHERIVQYYGCLRDDETL-SIF 82
Query: 90 LEYMENGSLESVI--HGPGVDHSRWTLPKRIDVLISVANGLDYLHSGYDIPIVHCDMKPS 147
+EYM GS++ + +G + ++I G++YLHS IVH D+K +
Sbjct: 83 MEYMPGGSVKDQLKAYGALTETVTRKYTRQI------LEGVEYLHSNM---IVHRDIKGA 133
Query: 148 NILLDRDFEAHVSDFGTSRMLDVHLQDLSSLST---AFQGTIGYLAPEFAYMRIVTTKVD 204
NIL D + DFG S+ LQ + S T + GT +++PE K D
Sbjct: 134 NILRDSAGNVKLGDFGASK----RLQTICSSGTGMKSVTGTPYWMSPEVISGEGYGRKAD 189
Query: 205 VFSFGIVVMEFLTKRRPTGLDEENGLSPISLRQLVEKALANGINGVRQITDPKLVSSIYE 264
V+S G V+E LT++ P E A+A Q T+P+L S +
Sbjct: 190 VWSVGCTVVEMLTEKPPWAEFE---------------AMAAIFKIATQPTNPQLPSHV-- 232
Query: 265 EQEQHQVLEELFKLALVCTSSNPEDRPNMNELL 297
+ V N + RP+ ELL
Sbjct: 233 ----SPDARNFLRRTFV---ENAKKRPSAEELL 258
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK2 and MEKK3 activate MEK5 (also called MKK5), which activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development. MEKK2 and MEKK3 can also activate the MAPKs, c-Jun N-terminal kinase (JNK) and p38, through their respective MAPKKs. Length = 263 |
| >gnl|CDD|173741 cd07843, STKc_CDC2L1, Catalytic domain of the Serine/Threonine Kinase, Cell Division Cycle 2-like 1 | Back alignment and domain information |
|---|
Score = 78.0 bits (193), Expect = 1e-16
Identities = 57/200 (28%), Positives = 99/200 (49%), Gaps = 24/200 (12%)
Query: 28 VYKGR-LEDGEIVAVKKLNFHQFSAESDKSF----YREAKTLKELKHRNLVKVLGYAWES 82
VY+ R + GEIVA+KKL + + F RE L +L+H N+V V S
Sbjct: 21 VYRARDKKTGEIVALKKLKME----KEKEGFPITSLREINILLKLQHPNIVTVKEVVVGS 76
Query: 83 GKLKA-LILEYMENGSLESVI-HGPGVDHSRWTLPKRIDVLISVANGLDYLHSGYDIPIV 140
K +++EY+E+ L+S++ + + +++ + +G+ +LH + I+
Sbjct: 77 NLDKIYMVMEYVEH-DLKSLMETMKQ----PFLQSEVKCLMLQLLSGVAHLHDNW---IL 128
Query: 141 HCDMKPSNILLDRDFEAHVSDFGTSRMLDVHLQDLSSLSTAFQGTIGYLAPEFAY-MRIV 199
H D+K SN+LL+ + DFG +R L+ + L T+ Y APE +
Sbjct: 129 HRDLKTSNLLLNNRGILKICDFGLAREYGSPLKPYTQLVV----TLWYRAPELLLGAKEY 184
Query: 200 TTKVDVFSFGIVVMEFLTKR 219
+T +D++S G + E LTK+
Sbjct: 185 STAIDMWSVGCIFAELLTKK 204
|
Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 1 (CDC2L1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L1, also called PITSLRE, exists in different isoforms which are named using the alias CDK11(p). The CDC2L1 gene produces two protein products, CDK11(p110) and CDK11(p58). CDC2L1 is also represented by the caspase-processed CDK11(p46). CDK11(p110), the major isoform, associates with cyclin L and is expressed throughout the cell cycle. It is involved in RNA processing and the regulation of transcription. CDK11(p58) associates with cyclin D3 and is expressed during the G2/M phase of the cell cycle. It plays roles in spindle morphogenesis, centrosome maturation, sister chromatid cohesion, and the completion of mitosis. CDK11(p46) is formed from the larger isoforms by caspases during TNFalpha- and Fas-induced apoptosis. It functions as a downstream effector kinase in apoptotic signaling pathways and interacts with eukaryotic initiation factor 3f (eIF3f), p21-activated kinase (PAK1), and Ran-binding protein (RanBPM). Length = 293 |
| >gnl|CDD|215061 PLN00113, PLN00113, leucine-rich repeat receptor-like protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 79.9 bits (197), Expect = 1e-16
Identities = 77/295 (26%), Positives = 129/295 (43%), Gaps = 34/295 (11%)
Query: 7 IENATGSFSENNIIGNSNLSTVYKGRLEDGEI-VAVKKLNFHQFSAESDKSFYREAKTLK 65
I + S E N+I YKG+ + VK++N S+ + +
Sbjct: 685 INDILSSLKEENVISRGKKGASYKGKSIKNGMQFVVKEINDVNSIPSSEIADMGK----- 739
Query: 66 ELKHRNLVKVLGYAWESGKLKALILEYMENGSLESVIHGPGVDHSRWTLPKRIDVLISVA 125
L+H N+VK++G S K LI EY+E +L V+ + +R + I +A
Sbjct: 740 -LQHPNIVKLIGLC-RSEKGAYLIHEYIEGKNLSEVLRN-------LSWERRRKIAIGIA 790
Query: 126 NGLDYLHSGYDIPIVHCDMKPSNILLDRDFEAHVSDFGTSRMLDVHLQDLSSLSTAFQGT 185
L +LH +V ++ P I++D E H L + L L T +
Sbjct: 791 KALRFLHCRCSPAVVVGNLSPEKIIIDGKDEPH---------LRLSLPGLLCTDTKCFIS 841
Query: 186 IGYLAPEFAYMRIVTTKVDVFSFGIVVMEFLTKRRPTGLDEENGLSPISLRQLVEKALAN 245
Y+APE + +T K D++ FG++++E LT + P D E G+ +VE A
Sbjct: 842 SAYVAPETRETKDITEKSDIYGFGLILIELLTGKSPA--DAEFGVH----GSIVEWARYC 895
Query: 246 GIN-GVRQITDPKLVSSIYEEQEQHQVLEELFKLALVCTSSNPEDRPNMNELLIT 299
+ + DP + + Q + + E+ LAL CT+++P RP N++L T
Sbjct: 896 YSDCHLDMWIDPSIRGDVSVNQNE---IVEVMNLALHCTATDPTARPCANDVLKT 947
|
Length = 968 |
| >gnl|CDD|133204 cd05073, PTKc_Hck, Catalytic domain of the Protein Tyrosine Kinase, Hematopoietic cell kinase | Back alignment and domain information |
|---|
Score = 77.4 bits (190), Expect = 2e-16
Identities = 70/265 (26%), Positives = 119/265 (44%), Gaps = 51/265 (19%)
Query: 39 VAVKKLNFHQFSAESDKSFYREAKTLKELKHRNLVKVLGYAWESGKLKALILEYMENGSL 98
VAVK + S E+ F EA +K L+H LVK+ +A + + +I E+M GSL
Sbjct: 33 VAVKTMKPGSMSVEA---FLAEANVMKTLQHDKLVKL--HAVVTKEPIYIITEFMAKGSL 87
Query: 99 ESVIHGPGVDHSRWTLPKRIDVLISVANGLDYLHS-GYDIPIVHCDMKPSNILLDRDFEA 157
+ + S+ LPK ID +A G+ ++ Y +H D++ +NIL+
Sbjct: 88 LDFLKSD--EGSKQPLPKLIDFSAQIAEGMAFIEQRNY----IHRDLRAANILVSASLVC 141
Query: 158 HVSDFGTSRMLDVHLQDLSSLSTAFQGT---IGYLAPEFAYMRIVTTKVDVFSFGIVVME 214
++DFG +R+++ + TA +G I + APE T K DV+SFGI++ME
Sbjct: 142 KIADFGLARVIE------DNEYTAREGAKFPIKWTAPEAINFGSFTIKSDVWSFGILLME 195
Query: 215 FLTKRRPTGLDEENGLSPISLRQLVEKALANGINGVRQITDPKLVSSI---YEEQEQHQV 271
+T G P +++P+++ ++ Y
Sbjct: 196 IVTY----------GRIPYP-----------------GMSNPEVIRALERGYRMPRPENC 228
Query: 272 LEELFKLALVCTSSNPEDRPNMNEL 296
EEL+ + + C + PE+RP +
Sbjct: 229 PEELYNIMMRCWKNRPEERPTFEYI 253
|
Protein Tyrosine Kinase (PTK) family; Hematopoietic cell kinase (Hck); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Hck is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Hck is present in myeloid and lymphoid cells that play a role in the development of cancer. It may be important in the oncogenic signaling of the protein Tel-Abl, which induces a chronic myelogenous leukemia (CML)-like disease. Hck also acts as a negative regulator of granulocyte colony-stimulating factor (G-CSF)-induced proliferation of granulocytic precursors, suggesting a possible role in the development of acute myeloid leukemia (AML). In addition, Hck is essential in regulating the degranulation of polymorphonuclear leukocytes (PMNs). Genetic polymorphisms affect the expression level of Hck, which affects PMN mediator release and influences the development of chronic obstructive pulmonary disease (COPD). Length = 260 |
| >gnl|CDD|133228 cd05097, PTKc_DDR_like, Catalytic domain of Discoidin Domain Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 77.7 bits (191), Expect = 2e-16
Identities = 77/274 (28%), Positives = 121/274 (44%), Gaps = 45/274 (16%)
Query: 38 IVAVKKLNFHQFSAESDKSFYREAKTLKELKHRNLVKVLGYAWESGKLKALILEYMENGS 97
+VAVK L + + F +E K + LK+ N++++LG L +I EYMENG
Sbjct: 46 LVAVKMLR-ADVTKTARNDFLKEIKIMSRLKNPNIIRLLGVCVSDDPL-CMITEYMENGD 103
Query: 98 LESVIHGPGVDHSRWTLPKRI------DVL---ISVANGLDYLHSGYDIPIVHCDMKPSN 148
L + + S +T I ++L + +A+G+ YL S + VH D+ N
Sbjct: 104 LNQFLSQREI-ESTFTHANNIPSVSIANLLYMAVQIASGMKYLAS---LNFVHRDLATRN 159
Query: 149 ILLDRDFEAHVSDFGTSRMLDVHLQDLSSLSTAFQG----TIGYLAPEFAYMRIVTTKVD 204
L+ + ++DFG SR L S QG I ++A E + TT D
Sbjct: 160 CLVGNHYTIKIADFGMSRNL------YSGDYYRIQGRAVLPIRWMAWESILLGKFTTASD 213
Query: 205 VFSFGIVVMEFLTKRRPTGLDEENGLSPISLRQLVEKALANGINGVRQI--TDPKLVSSI 262
V++FG+ + E T L +E S +S Q++E N RQI + L S
Sbjct: 214 VWAFGVTLWEMFT------LCKEQPYSLLSDEQVIENTGEFFRNQGRQIYLSQTPLCPS- 266
Query: 263 YEEQEQHQVLEELFKLALVCTSSNPEDRPNMNEL 296
+FKL + C S + +DRP N++
Sbjct: 267 -----------PVFKLMMRCWSRDIKDRPTFNKI 289
|
Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR)-like proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR-like proteins are members of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linked to a variety of human cancers including breast, colon, ovarian, brain, and lung. There is no evidence showing that DDRs act as transforming oncogenes. They are more likely to play a role in the regulation of tumor growth and metastasis. Length = 295 |
| >gnl|CDD|132946 cd06615, PKc_MEK, Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase | Back alignment and domain information |
|---|
Score = 77.9 bits (192), Expect = 2e-16
Identities = 69/261 (26%), Positives = 112/261 (42%), Gaps = 45/261 (17%)
Query: 59 REAKTLKELKHRNLVKVLGYAWESGKLKALILEYMENGSLESVIHGPGVDHSRWTLPKRI 118
RE K L E +V G + G++ ++ +E+M+ GSL+ V+ G +P+ I
Sbjct: 48 RELKVLHECNSPYIVGFYGAFYSDGEI-SICMEHMDGGSLDQVLKKAG------RIPENI 100
Query: 119 --DVLISVANGLDYLHSGYDIPIVHCDMKPSNILLDRDFEAHVSDFGTSRMLDVHLQDLS 176
+ I+V GL YL + I +H D+KPSNIL++ E + DFG S L +
Sbjct: 101 LGKISIAVLRGLTYLREKHKI--MHRDVKPSNILVNSRGEIKLCDFGVSGQL------ID 152
Query: 177 SLSTAFQGTIGYLAPEFAYMRIVTTKVDVFSFGIVVMEFLTKRRPTGLDEENGLSPISLR 236
S++ +F GT Y++PE T + D++S G+ ++E R P + L + R
Sbjct: 153 SMANSFVGTRSYMSPERLQGTHYTVQSDIWSLGLSLVEMAIGRYPIPPPDAKELEAMFGR 212
Query: 237 QLVEKALANGINGVR-QITD-------------------PKLVSSIYEEQEQHQVLEELF 276
+ E V D PKL S + ++ Q V
Sbjct: 213 PVSEGEAKESHRPVSGHPPDSPRPMAIFELLDYIVNEPPPKLPSGAFSDEFQDFV----- 267
Query: 277 KLALVCTSSNPEDRPNMNELL 297
C NP++R ++ EL
Sbjct: 268 ---DKCLKKNPKERADLKELT 285
|
Protein kinases (PKs), MAP/ERK kinase (MEK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 and MEK2 are dual-specificity PKs that phosphorylate and activate the downstream targets, ERK(extracellular signal-regulated kinase) 1 and ERK2, on specific threonine and tyrosine residues. The ERK cascade starts with extracellular signals including growth factors, hormones, and neurotransmitters, which act through receptors and ion channels to initiate intracellular signaling that leads to the activation at the MAPKKK (Raf-1 or MOS) level, which leads to the transmission of signals to MEK1/2, and finally to ERK1/2. The ERK cascade plays an important role in cell proliferation, differentiation, oncogenic transformation, and cell cycle control, as well as in apoptosis and cell survival under certain conditions. This cascade has also been implicated in synaptic plasticity, migration, morphological determination, and stress response immunological reactions. Gain-of-function mutations in genes encoding ERK cascade proteins, including MEK1/2, cause cardiofaciocutaneous (CFC) syndrome, a condition leading to multiple congenital anomalies and mental retardation in patients. Length = 308 |
| >gnl|CDD|173636 cd05057, PTKc_EGFR_like, Catalytic domain of Epidermal Growth Factor Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 77.5 bits (191), Expect = 2e-16
Identities = 60/229 (26%), Positives = 108/229 (47%), Gaps = 22/229 (9%)
Query: 19 IIGNSNLSTVYKGR-LEDGE----IVAVKKLNFHQFSAESDKSFYREAKTLKELKHRNLV 73
++G+ TVYKG + +GE VA+K L + S +++K EA + + H ++V
Sbjct: 14 VLGSGAFGTVYKGVWIPEGEKVKIPVAIKVLR-EETSPKANKEILDEAYVMASVDHPHVV 72
Query: 74 KVLGYAWESGKLKALILEYMENGSLESVIHGPGVDHSRWTLPKRIDVLISVANGLDYLHS 133
++LG LI + M G L + + L ++ + +A G+ YL
Sbjct: 73 RLLGICL--SSQVQLITQLMPLGCLLDYVRNHKDNIGSQYL---LNWCVQIAKGMSYLE- 126
Query: 134 GYDIPIVHCDMKPSNILLDRDFEAHVSDFGTSRMLDVHLQDLSSLSTAFQGTIGYLAPEF 193
+ +VH D+ N+L+ ++DFG +++LDV + + + I ++A E
Sbjct: 127 --EKRLVHRDLAARNVLVKTPQHVKITDFGLAKLLDV--DEKEYHAEGGKVPIKWMALES 182
Query: 194 AYMRIVTTKVDVFSFGIVVMEFLT-KRRPTGLDEENGLSPISLRQLVEK 241
RI T K DV+S+G+ V E +T +P G+ + + L+EK
Sbjct: 183 ILHRIYTHKSDVWSYGVTVWELMTFGAKPY-----EGIPAVEIPDLLEK 226
|
Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR) subfamily; catalytic (c) domain. EGFR (HER, ErbB) subfamily members include EGFR (HER1, ErbB1), HER2 (ErbB2), HER3 (ErbB3), HER4 (ErbB4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The EGFR proteins are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, resulting in the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. Collectively, they can recognize a variety of ligands including EGF, TGFalpha, and neuregulins, among others. All four subfamily members can form homo- or heterodimers. HER3 contains an impaired kinase domain and depends on its heterodimerization partner for activation. EGFR subfamily members are involved in signaling pathways leading to a broad range of cellular responses including cell proliferation, differentiation, migration, growth inhibition, and apoptosis. Gain of function alterations, through their overexpression, deletions, or point mutations in their kinase domains, have been implicated in various cancers. These receptors are targets of many small molecule inhibitors and monoclonal antibodies used in cancer therapy. Length = 279 |
| >gnl|CDD|133172 cd05040, PTKc_Ack_like, Catalytic domain of the Protein Tyrosine Kinase, Activated Cdc42-associated kinase | Back alignment and domain information |
|---|
Score = 76.7 bits (189), Expect = 2e-16
Identities = 65/258 (25%), Positives = 107/258 (41%), Gaps = 32/258 (12%)
Query: 39 VAVKKLNFHQFSAESDKSFYREAKTLKELKHRNLVKVLGYAWESGKLKALILEYMENGSL 98
VAVK L + S D F +EA + L H NL+++ G L ++ E GSL
Sbjct: 26 VAVKCLKSDKLSDIMD-DFLKEAAIMHSLDHENLIRLYGVVLTH-PLM-MVTELAPLGSL 82
Query: 99 ESVIHGPGVDHSRWTLPKRIDVLISVANGLDYLHSGYDIPIVHCDMKPSNILLDRDFEAH 158
+ + H + + D + +ANG+ YL S +H D+ NILL D +
Sbjct: 83 LDRLRKDALGH--FLISTLCDYAVQIANGMRYLESKR---FIHRDLAARNILLASDDKVK 137
Query: 159 VSDFGTSRMLDVHLQDLSSLSTAFQGTIGYLAPEFAYMRIVTTKVDVFSFGIVVMEFLTK 218
+ DFG R L + +D + + + APE R + DV+ FG+ + E T
Sbjct: 138 IGDFGLMRALPQN-EDHYVMEEHLKVPFAWCAPESLRTRTFSHASDVWMFGVTLWEMFT- 195
Query: 219 RRPTGLDEENGLSPISLRQLVEKALANGINGVRQITDPKLVSSIYEEQEQHQVLEELFKL 278
G + GLS + + ++K ++ P+ ++++ +
Sbjct: 196 ---YGEEPWAGLSGSQILKKIDKEG-------ERLERPEACP------------QDIYNV 233
Query: 279 ALVCTSSNPEDRPNMNEL 296
L C + NP DRP L
Sbjct: 234 MLQCWAHNPADRPTFAAL 251
|
Protein Tyrosine Kinase (PTK) family; Activated Cdc42-associated kinase (Ack) subfamily; catalytic (c) domain. Ack subfamily members include Ack1, thirty-eight-negative kinase 1 (Tnk1), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ack subfamily members are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal catalytic domain, an SH3 domain, a Cdc42-binding CRIB domain, and a proline-rich region. They are mainly expressed in brain and skeletal tissues and are involved in the regulation of cell adhesion and growth, receptor degradation, and axonal guidance. Ack1 is also associated with androgen-independent prostate cancer progression. Tnk1 regulates TNFalpha signaling and may play an important role in cell death. Length = 257 |
| >gnl|CDD|173769 cd08229, STKc_Nek7, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 7 | Back alignment and domain information |
|---|
Score = 77.0 bits (189), Expect = 2e-16
Identities = 74/289 (25%), Positives = 125/289 (43%), Gaps = 42/289 (14%)
Query: 12 GSFSENNIIGNSNLSTVYKGR-LEDGEIVAVKKLN-FHQFSAESDKSFYREAKTLKELKH 69
+F IG S VY+ L DG VA+KK+ F A++ +E LK+L H
Sbjct: 2 ANFRIEKKIGRGQFSEVYRATCLLDGVPVALKKVQIFDLMDAKARADCIKEIDLLKQLNH 61
Query: 70 RNLVKVLGYAWESGKLKALILEYMENGSLESVIHGPGVDHSRWTLPKRI--DVLISVANG 127
N++K E +L ++LE + G L +I + +P++ + + +
Sbjct: 62 PNVIKYYASFIEDNELN-IVLELADAGDLSRMIKH--FKKQKRLIPEKTVWKYFVQLCSA 118
Query: 128 LDYLHSGYDIPIVHCDMKPSNILLDRDFEAHVSDFGTSRMLDVHLQDLSSLSTAFQGTIG 187
L+++HS ++H D+KP+N+ + + D G R SS +TA +G
Sbjct: 119 LEHMHSRR---VMHRDIKPANVFITATGVVKLGDLGLGRFF-------SSKTTAAHSLVG 168
Query: 188 ---YLAPEFAYMRIVTTKVDVFSFGIVVMEFLTKRRPTGLDEENGLSPISLRQLVEKALA 244
Y++PE + K D++S G ++ E + P D+ N L L +K
Sbjct: 169 TPYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSPFYGDKMN------LYSLCKK--- 219
Query: 245 NGINGVRQITDPKLVSSIYEEQEQHQVLEELFKLALVCTSSNPEDRPNM 293
+ Q P L S Y E EL +L +C + +PE RP++
Sbjct: 220 -----IEQCDYPPLPSDHYSE--------ELRQLVNMCINPDPEKRPDI 255
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 7 (Nek7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek7 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek7 is required for mitotic spindle formation and cytokinesis. It is enriched in the centrosome and is critical for microtubule nucleation. Nek7 is activated by Nek9 during mitosis, and may regulate the p70 ribosomal S6 kinase. Length = 267 |
| >gnl|CDD|173758 cd08218, STKc_Nek1, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 1 | Back alignment and domain information |
|---|
Score = 76.4 bits (188), Expect = 3e-16
Identities = 70/265 (26%), Positives = 121/265 (45%), Gaps = 37/265 (13%)
Query: 34 EDGEIVAVKKLNFHQFSAESDKSFYREAKTLKELKHRNLVKVLGYAWESGKLKALILEYM 93
EDG+ +K++N + S + + +E L +KH N+V+ E+G L ++++Y
Sbjct: 23 EDGKQYVIKEINISKMSPKEREESRKEVAVLSNMKHPNIVQYQESFEENGNL-YIVMDYC 81
Query: 94 ENGSLESVIHGP-GVDHSRWTLPKRIDVLISVANGLDYLHSGYDIPIVHCDMKPSNILLD 152
E G L I+ GV + +D + + L ++H D I+H D+K NI L
Sbjct: 82 EGGDLYKKINAQRGVLFPE---DQILDWFVQICLALKHVH---DRKILHRDIKSQNIFLT 135
Query: 153 RDFEAHVSDFGTSRMLDVHLQDLSSLSTAFQGTIGYLAPEFAYMRIVTTKVDVFSFGIVV 212
+D + DFG +R+L+ ++ L+ GT YL+PE R K D+++ G V+
Sbjct: 136 KDGTIKLGDFGIARVLNSTVE----LARTCIGTPYYLSPEICENRPYNNKSDIWALGCVL 191
Query: 213 MEFLTKRRPTGLDEENGLSPISLRQLVEKALANGINGVRQITDPKLVSSIYEEQEQHQVL 272
E T + E G +++ LV K + V S + + ++
Sbjct: 192 YEMCTLKHAF----EAG----NMKNLVLKIIRGSYPPV----------SSHYSYDLRNLV 233
Query: 273 EELFKLALVCTSSNPEDRPNMNELL 297
+LFK NP DRP++N +L
Sbjct: 234 SQLFK-------RNPRDRPSVNSIL 251
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 1 (Nek1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek1 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek1 is associated with centrosomes throughout the cell cycle. It is involved in the formation of primary cilium and in the maintenance of centrosomes. It cycles through the nucleus and may be capable of relaying signals between the cilium and the nucleus. Nek1 is implicated in the development of polycystic kidney disease, which is characterized by benign polycystic tumors formed by abnormal overgrowth of renal epithelial cells. It appears also to be involved in DNA damage response, and may be important for both correct DNA damage checkpoint activation and DNA repair. Length = 256 |
| >gnl|CDD|173760 cd08220, STKc_Nek8, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 8 | Back alignment and domain information |
|---|
Score = 76.4 bits (188), Expect = 3e-16
Identities = 63/271 (23%), Positives = 116/271 (42%), Gaps = 45/271 (16%)
Query: 32 RLEDGEIVAVKKLNFHQFSAESDKSFYREAKTLKELKHRNLVKVLGYAWESGKLKALILE 91
R D ++V +K++ Q + + + E + LK L H N+++ E L +++E
Sbjct: 21 RKADQKLVIIKQIPVEQMTKDERLAAQNECQVLKLLSHPNIIEYYENFLEDKAL-MIVME 79
Query: 92 YMENGSLESVIHGPGVDHSRWTLPKR--IDVLISVANGLDYLHSGYDIPIVHCDMKPSNI 149
Y G+L I L + + + + L ++H+ I+H D+K NI
Sbjct: 80 YAPGGTLAEYIQ----KRCNSLLDEDTILHFFVQILLALHHVHTKL---ILHRDLKTQNI 132
Query: 150 LLDR-DFEAHVSDFGTSRMLDVHLQDLSSLSTAFQ--GTIGYLAPEFAYMRIVTTKVDVF 206
LLD+ + DFG S++ LSS S A+ GT Y++PE + K D++
Sbjct: 133 LLDKHKMVVKIGDFGISKI-------LSSKSKAYTVVGTPCYISPELCEGKPYNQKSDIW 185
Query: 207 SFGIVVMEFLTKRRPTGLDEENGLSPISLRQLVEKALANGINGVRQITDPKLVSSIYEEQ 266
+ G V+ E + +R + N L LV K ++ I+D
Sbjct: 186 ALGCVLYELASLKR--AFEAAN------LPALVLKIMSGTFA---PISD----------- 223
Query: 267 EQHQVLEELFKLALVCTSSNPEDRPNMNELL 297
+ +L +L L + +P RP +++++
Sbjct: 224 ---RYSPDLRQLILSMLNLDPSKRPQLSQIM 251
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 8 (Nek8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek8 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek8 contains an N-terminal kinase catalytic domain and a C-terminal RCC1 (regulator of chromosome condensation) domain. A double point mutation in Nek8 causes cystic kidney disease in mice that genetically resembles human autosomal recessive polycystic kidney disease (ARPKD). Nek8 is also associated with a rare form of juvenile renal cystic disease, nephronophthisis type 9. It has been suggested that a defect in the ciliary localization of Nek8 contributes to the development of cysts manifested by these diseases. Length = 256 |
| >gnl|CDD|173742 cd07845, STKc_CDK10, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 10 | Back alignment and domain information |
|---|
Score = 77.0 bits (190), Expect = 3e-16
Identities = 62/215 (28%), Positives = 99/215 (46%), Gaps = 30/215 (13%)
Query: 14 FSENNIIGNSNLSTVYKGR-LEDGEIVAVKKLNFHQFSAESDK---SFYREAKTLKELKH 69
F + N IG VY+ R GEIVA+KK+ E D S RE L L+H
Sbjct: 9 FEKLNRIGEGTYGIVYRARDTTSGEIVALKKVRMDN---ERDGIPISSLREITLLLNLRH 65
Query: 70 RNLVK----VLGYAWESGKLKALILEYMEN--GSLESVIHGPGVDHSRWTLPKRIDVLIS 123
N+V+ V+G +S L++EY E SL + P ++ + +++
Sbjct: 66 PNIVELKEVVVGKHLDS---IFLVMEYCEQDLASLLDNMPTP------FSESQVKCLMLQ 116
Query: 124 VANGLDYLHSGYDIPIVHCDMKPSNILLDRDFEAHVSDFGTSRMLDVHLQDLSSLSTAFQ 183
+ GL YLH + I+H D+K SN+LL ++DFG +R + + ++
Sbjct: 117 LLRGLQYLHENF---IIHRDLKVSNLLLTDKGCLKIADFGLARTYGLPAKPMTPKVV--- 170
Query: 184 GTIGYLAPEFAY-MRIVTTKVDVFSFGIVVMEFLT 217
T+ Y APE TT +D+++ G ++ E L
Sbjct: 171 -TLWYRAPELLLGCTTYTTAIDMWAVGCILAELLA 204
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein Kinase 10 (CDK10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK10, also called PISSLRE, is essential for cell growth and proliferation, and acts through the G2/M phase of the cell cycle. CDK10 has also been identified as an important factor in endocrine therapy resistance in breast cancer. CDK10 silencing increases the transcription of c-RAF and the activation of the p42/p44 MAPK pathway, which leads to antiestrogen resistance. Patients who express low levels of CDK10 relapse early on tamoxifen. Length = 309 |
| >gnl|CDD|173631 cd05045, PTKc_RET, Catalytic domain of the Protein Tyrosine Kinase, REarranged during Transfection protein | Back alignment and domain information |
|---|
Score = 76.5 bits (188), Expect = 3e-16
Identities = 73/278 (26%), Positives = 123/278 (44%), Gaps = 51/278 (18%)
Query: 39 VAVKKLNFHQFSAESDKSFYREAKTLKELKHRNLVKVLGYAWESGKLKALILEYMENGSL 98
VAVK L + S+E + E LK++ H +++K+ G + G L LI+EY + GSL
Sbjct: 33 VAVKMLKENASSSEL-RDLLSEFNLLKQVNHPHVIKLYGACSQDGPL-LLIVEYAKYGSL 90
Query: 99 ESVIH--------GPGVDHSRWTL--------PKRIDVLISVA----NGLDYLHSGYDIP 138
S + G D +R + + LIS A G+ YL ++
Sbjct: 91 RSFLRESRKVGPSYLGSDGNRNSSYLDNPDERALTMGDLISFAWQISRGMQYLA---EMK 147
Query: 139 IVHCDMKPSNILLDRDFEAHVSDFGTSRMLDVHLQDLSSLSTAFQGTIGYLAPEFAYMRI 198
+VH D+ N+L+ + +SDFG SR DV+ +D + + + ++A E + I
Sbjct: 148 LVHRDLAARNVLVAEGRKMKISDFGLSR--DVYEEDSYVKRSKGRIPVKWMAIESLFDHI 205
Query: 199 VTTKVDVFSFGIVVMEFLTKRRPTGLDEENGLSPISLRQLVEKALANGINGVRQITDPKL 258
TT+ DV+SFG+++ E +T G + G++P L L++
Sbjct: 206 YTTQSDVWSFGVLLWEIVT----LGGNPYPGIAPERLFNLLKTG---------------- 245
Query: 259 VSSIYEEQEQHQVLEELFKLALVCTSSNPEDRPNMNEL 296
Y + EE++ L L C P+ RP ++
Sbjct: 246 ----YRMERPENCSEEMYNLMLTCWKQEPDKRPTFADI 279
|
Protein Tyrosine Kinase (PTK) family; RET (REarranged during Transfection) protein; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. RET is a receptor tyr kinase (RTK) containing an extracellular region with four cadherin-like repeats, a calcium-binding site, and a cysteine-rich domain, a transmembrane segment, and an intracellular catalytic domain. It is part of a multisubunit complex that binds glial-derived neurotropic factor (GDNF) family ligands (GFLs) including GDNF, neurturin, artemin, and persephin. GFLs bind RET along with four GPI-anchored coreceptors, bringing two RET molecules together, leading to autophosphorylation, activation, and intracellular signaling. RET is essential for the development of the sympathetic, parasympathetic and enteric nervous systems, and the kidney. RET disruption by germline mutations causes diseases in humans including congenital aganglionosis of the gastrointestinal tract (Hirschsprung's disease) and three related inherited cancers: multiple endocrine neoplasia type 2A (MEN2A), MEN2B, and familial medullary thyroid carcinoma (FMTC). Length = 290 |
| >gnl|CDD|173668 cd05577, STKc_GRK, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase | Back alignment and domain information |
|---|
Score = 76.4 bits (188), Expect = 3e-16
Identities = 53/203 (26%), Positives = 85/203 (41%), Gaps = 11/203 (5%)
Query: 20 IGNSNLSTVYKGRLED-GEIVAVKKLNFHQFSAESDKSFYREAKTLKELKHRNLVKVLGY 78
+G V +++ G++ A KKL+ + + K + E + L Y
Sbjct: 1 LGKGGFGEVCACQVKATGKMYACKKLDKKRLKKRKGEQMALNEKKILEKVSSRFIVSLAY 60
Query: 79 AWESGKLKALILEYMENGSLESVIHGPGVDHSRWTLPKRIDVLISVANGLDYLHSGYDIP 138
A+E+ L++ M G L+ H V + + I + GL++LH
Sbjct: 61 AFETKDDLCLVMTLMNGGDLK--YHIYNVGEPGFPEARAIFYAAQIICGLEHLHQRR--- 115
Query: 139 IVHCDMKPSNILLDRDFEAHVSDFGTSRMLDVHLQDLSSLSTAFQGTIGYLAPEFAYMRI 198
IV+ D+KP N+LLD +SD G L V L+ + GT GY+APE +
Sbjct: 116 IVYRDLKPENVLLDDHGNVRISDLG----LAVELKGGKKI-KGRAGTPGYMAPEVLQGEV 170
Query: 199 VTTKVDVFSFGIVVMEFLTKRRP 221
VD F+ G + E + R P
Sbjct: 171 YDFSVDWFALGCTLYEMIAGRSP 193
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. GRKs contain a central catalytic domain, flanked by N- and C-terminal extensions. The N-terminus contains an RGS (regulator of G protein signaling) homology (RH) domain and several motifs. The C-terminus diverges among different groups of GRKs. There are seven types of GRKs, named GRK1 to GRK7. They are subdivided into three main groups: visual (GRK1/7); beta-adrenergic receptor kinases (GRK2/3); and GRK4-like (GRK4/5/6). Expression of GRK2/3/5/6 is widespread while GRK1/4/7 show a limited tissue distribution. The substrate spectrum of the widely expressed GRKs partially overlaps. GRKs play important roles in the cardiovascular, immune, respiratory, skeletal, and nervous systems. Length = 277 |
| >gnl|CDD|173630 cd05044, PTKc_c-ros, Catalytic domain of the Protein Tyrosine Kinase, C-ros | Back alignment and domain information |
|---|
Score = 76.4 bits (188), Expect = 4e-16
Identities = 65/215 (30%), Positives = 99/215 (46%), Gaps = 22/215 (10%)
Query: 18 NIIGNSNLSTVYKGRLED------GEI-VAVKKLNFHQFSAESDKSFYREAKTLKELKHR 70
N +G+ VY+G D G I VAVK L E K F +EA + H
Sbjct: 1 NFLGSGAFGEVYEGTATDILGPGSGPIRVAVKTLRKGATDQEK-KEFLKEAHLMSNFNHP 59
Query: 71 NLVKVLGYAWESGKLKALILEYMENGSLESVIHGPGVDHSR---WTLPKRIDVLISVANG 127
N+VK+LG + + + +I+E ME G L S + V+ TL + +D+ + VA G
Sbjct: 60 NIVKLLGVCLLN-EPQYIIMELMEGGDLLSYLRDARVERFGPPLLTLKELLDICLDVAKG 118
Query: 128 LDYLHSGYDIPIVHCDMKPSNILL-----DRDFEAHVSDFGTSRMLDVHLQDLSSLSTAF 182
YL + +H D+ N L+ D D + DFG +R D++ D
Sbjct: 119 CVYLE---QMHFIHRDLAARNCLVSEKGYDADRVVKIGDFGLAR--DIYKSDYYRKEGEG 173
Query: 183 QGTIGYLAPEFAYMRIVTTKVDVFSFGIVVMEFLT 217
+ ++APE TT+ DV+SFG+++ E LT
Sbjct: 174 LLPVRWMAPESLLDGKFTTQSDVWSFGVLMWEILT 208
|
Protein Tyrosine Kinases (PTK) family; C-ros and Drosophila Sevenless proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The proto-oncogene c-ros encodes an orphan receptor tyr kinase (RTK) with an unknown ligand. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. C-ros is expressed in embryonic cells of the kidney, intestine and lung, but disappears soon after birth. It persists only in the adult epididymis. Male mice bearing inactive mutations of c-ros lack the initial segment of the epididymis and are infertile. The Drosophila protein, Sevenless, is required for the specification of the R7 photoreceptor cell during eye development. Length = 269 |
| >gnl|CDD|173727 cd06613, STKc_MAP4K3_like, Catalytic domain of Mitogen-activated protein kinase kinase kinase kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 75.8 bits (187), Expect = 5e-16
Identities = 60/205 (29%), Positives = 94/205 (45%), Gaps = 29/205 (14%)
Query: 20 IGNSNLSTVYKGR-LEDGEIVAVKKLNFHQFSAESD--KSFYREAKTLKELKHRNLVKVL 76
IG+ VYK R + GE+VA+K + D + +E LKE +H N+V
Sbjct: 11 IGSGTYGDVYKARDIATGELVAIKVIKL----EPGDDFEIIQQEISMLKECRHPNIVAYF 66
Query: 77 GYAWESGKLKALILEYMENGSLESVIHGPGVDHSRWTLPKRIDVLIS--VANGLDYLHSG 134
G KL +++EY GSL+ + +R L + + GL YLH
Sbjct: 67 GSYLRRDKL-WIVMEYCGGGSLQDIYQ-----VTRGPLSELQIAYVCRETLKGLAYLHET 120
Query: 135 YDIPIVHCDMKPSNILLDRDFEAHVSDFGTSRMLDVHLQDLSSLS--TAFQGTIGYLAPE 192
I H D+K +NILL D + ++DFG S L ++++ +F GT ++APE
Sbjct: 121 GKI---HRDIKGANILLTEDGDVKLADFGVSAQLT------ATIAKRKSFIGTPYWMAPE 171
Query: 193 FAYMRIV---TTKVDVFSFGIVVME 214
A + K D+++ GI +E
Sbjct: 172 VAAVERKGGYDGKCDIWALGITAIE 196
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily includes MAP4K3, MAP4K1, MAP4K2, MAP4K5, and related proteins. Vertebrate members contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K1, also called haematopoietic progenitor kinase 1 (HPK1), is a hematopoietic-specific STK involved in many cellular signaling cascades including MAPK, antigen receptor, apoptosis, growth factor, and cytokine signaling. It participates in the regulation of T cell receptor signaling and T cell-mediated immune responses. MAP4K2 was referred to as germinal center (GC) kinase because of its preferred location in GC B cells. MAP4K3 plays a role in the nutrient-responsive pathway of mTOR (mammalian target of rapamycin) signaling. It is required in the activation of S6 kinase by amino acids and for the phosphorylation of the mTOR-regulated inhibitor of eukaryotic initiation factor 4E. MAP4K5, also called germinal center kinase-related enzyme (GCKR), has been shown to activate the MAPK c-Jun N-terminal kinase (JNK). Length = 262 |
| >gnl|CDD|173642 cd05075, PTKc_Axl, Catalytic domain of the Protein Tyrosine Kinase, Axl | Back alignment and domain information |
|---|
Score = 75.8 bits (186), Expect = 6e-16
Identities = 71/287 (24%), Positives = 127/287 (44%), Gaps = 39/287 (13%)
Query: 20 IGNSNLSTVYKGRLEDGEI---VAVKKLNFHQFSAESDKSFYREAKTLKELKHRNLVKVL 76
+G +V +G+L + VAVK + + + F EA +KE H N+++++
Sbjct: 7 LGEGEFGSVMEGQLNQDDSILKVAVKTMKIAICTRSEMEDFLSEAVCMKEFDHPNVMRLI 66
Query: 77 GYAWESGKLKA-----LILEYMENGSLESVIHGPGVDHSRWTLPKRIDV--LISVANGLD 129
G ++ + + +IL +M++G L S + + LP ++ V + +A+G++
Sbjct: 67 GVCLQTVESEGYPSPVVILPFMKHGDLHSFLLYSRLGDCPQYLPTQMLVKFMTDIASGME 126
Query: 130 YLHSGYDIPIVHCDMKPSNILLDRDFEAHVSDFGTSRMLDVHLQDLSSLSTAFQGTIGYL 189
YL S +H D+ N +L+ + V+DFG S+ ++ D + + ++
Sbjct: 127 YLSSK---SFIHRDLAARNCMLNENMNVCVADFGLSK--KIYNGDYYRQGRIAKMPVKWI 181
Query: 190 APEFAYMRIVTTKVDVFSFGIVVMEFLTKRRPTGLDEENGLSPISLRQLVEKALANGING 249
A E R+ TTK DV+SFG+ + E T+ + EN LRQ N
Sbjct: 182 AIESLADRVYTTKSDVWSFGVTMWEIATRGQTPYPGVENSEIYDYLRQG---------NR 232
Query: 250 VRQITDPKLVSSIYEEQEQHQVLEELFKLALVCTSSNPEDRPNMNEL 296
++Q D L+ L+ L C NP+DRP+ L
Sbjct: 233 LKQPPD---------------CLDGLYSLMSSCWLLNPKDRPSFETL 264
|
Protein Tyrosine Kinase (PTK) family; Axl; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl is widely expressed in a variety of organs and cells including epithelial, mesenchymal, hematopoietic, as well as non-transformed cells. Axl signaling is important in many cellular functions such as survival, anti-apoptosis, proliferation, migration, and adhesion. Axl was originally isolated from patients with chronic myelogenous leukemia and a chronic myeloproliferative disorder. Axl is overexpressed in many human cancers including colon, squamous cell, thyroid, breast, and lung carcinomas. Length = 272 |
| >gnl|CDD|173641 cd05072, PTKc_Lyn, Catalytic domain of the Protein Tyrosine Kinase, Lyn | Back alignment and domain information |
|---|
Score = 75.4 bits (185), Expect = 7e-16
Identities = 74/280 (26%), Positives = 116/280 (41%), Gaps = 42/280 (15%)
Query: 20 IGNSNLSTVYKGRLEDGEIVAVKKLNFHQFSAESDKSFYREAKTLKELKHRNLVKVLGYA 79
+G V+ G + VAVK L S ++ F EA +K L+H LV++
Sbjct: 14 LGAGQFGEVWMGYYNNSTKVAVKTLKPGTMSVQA---FLEEANLMKTLQHDKLVRLYAVV 70
Query: 80 WESGKLKALILEYMENGSLESVIHGPGVDHSRWTLPKRIDVLISVANGLDYLHSGYDIPI 139
+ + +I EYM GSL + + + LPK ID +A G+ Y+ I
Sbjct: 71 TKEEPI-YIITEYMAKGSLLDFLKSD--EGGKVLLPKLIDFSAQIAEGMAYIERKNYI-- 125
Query: 140 VHCDMKPSNILLDRDFEAHVSDFGTSRMLDVHLQDLSSLSTAFQGT---IGYLAPEFAYM 196
H D++ +N+L+ ++DFG +R+++ + TA +G I + APE
Sbjct: 126 -HRDLRAANVLVSESLMCKIADFGLARVIE------DNEYTAREGAKFPIKWTAPEAINF 178
Query: 197 RIVTTKVDVFSFGIVVMEFLTKRRPTGLDEENGLSPISLRQLVEKALANGINGVRQITDP 256
T K DV+SFGI++ E +T G G+S V AL G R P
Sbjct: 179 GSFTIKSDVWSFGILLYEIVT----YGKIPYPGMS----NSDVMSALQRGYRMPRMENCP 230
Query: 257 KLVSSIYEEQEQHQVLEELFKLALVCTSSNPEDRPNMNEL 296
+EL+ + C E+RP + L
Sbjct: 231 ----------------DELYDIMKTCWKEKAEERPTFDYL 254
|
Protein Tyrosine Kinase (PTK) family; Lyn kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lyn is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Lyn is expressed in B lymphocytes and myeloid cells. It exhibits both positive and negative regulatory roles in B cell receptor (BCR) signaling. Lyn, as well as Fyn and Blk, promotes B cell activation by phosphorylating ITAMs (immunoreceptor tyr activation motifs) in CD19 and in Ig components of BCR. It negatively regulates signaling by its unique ability to phosphorylate ITIMs (immunoreceptor tyr inhibition motifs) in cell surface receptors like CD22 and CD5. Lyn also plays an important role in G-CSF receptor signaling by phosphorylating a variety of adaptor molecules. Length = 261 |
| >gnl|CDD|173634 cd05053, PTKc_FGFR, Catalytic domain of the Protein Tyrosine Kinases, Fibroblast Growth Factor Receptors | Back alignment and domain information |
|---|
Score = 75.9 bits (187), Expect = 8e-16
Identities = 70/276 (25%), Positives = 118/276 (42%), Gaps = 52/276 (18%)
Query: 39 VAVKKLNFHQFSAESD-KSFYREAKTLKEL-KHRNLVKVLGYAWESGKLKALILEYMENG 96
VAVK L + E D E + +K + KH+N++ +LG + G L +++EY +G
Sbjct: 45 VAVKMLKDD--ATEKDLSDLVSEMEMMKMIGKHKNIINLLGVCTQEGPL-YVVVEYAAHG 101
Query: 97 SLESVIHG---PGVDHS---------RWTLPKRIDVLISVANGLDYLHSGYDIPIVHCDM 144
+L + PG S T + VA G+++L S +H D+
Sbjct: 102 NLRDFLRARRPPGEYASPDDPRPPEETLTQKDLVSFAYQVARGMEFLASK---KCIHRDL 158
Query: 145 KPSNILLDRDFEAHVSDFGTSRMLDVHLQDLSSLSTAFQGTIGYLAPEFAYMRIVTTKVD 204
N+L+ D ++DFG +R D+H D +T + + ++APE + R+ T + D
Sbjct: 159 AARNVLVTEDHVMKIADFGLAR--DIHHIDYYRKTTNGRLPVKWMAPEALFDRVYTHQSD 216
Query: 205 VFSFGIVVMEFLTKRRPTGLDEENGLSP---ISLRQLVEKALANGINGVRQITDPKLVSS 261
V+SFG+++ E T G SP I + +L KL+
Sbjct: 217 VWSFGVLLWEIFTL----------GGSPYPGIPVEELF-----------------KLLKE 249
Query: 262 IYEEQEQHQVLEELFKLALVCTSSNPEDRPNMNELL 297
Y ++ +EL+ L C P RP +L+
Sbjct: 250 GYRMEKPQNCTQELYHLMRDCWHEVPSQRPTFKQLV 285
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor (FGFR) subfamily; catalytic (c) domain. The FGFR subfamily consists of FGFR1, FGFR2, FGFR3, FGFR4, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K).PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, and to heparin/heparan sulfate (HS) results in the formation of a ternary complex, which leads to receptor dimerization and activation, and intracellular signaling. There are at least 23 FGFs and four types of FGFRs. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. FGF/FGFR signaling is important in the regulation of embryonic development, homeostasis, and regenerative processes. Depending on the cell type and stage, FGFR signaling produces diverse cellular responses including proliferation, growth arrest, differentiation, and apoptosis. Aberrant signaling leads to many human diseases such as skeletal, olfactory, and metabolic disorders, as well as cancer. Length = 293 |
| >gnl|CDD|132962 cd06631, STKc_YSK4, Catalytic domain of the Protein Serine/Threonine Kinase, Yeast Sps1/Ste20-related kinase 4 | Back alignment and domain information |
|---|
Score = 75.3 bits (185), Expect = 8e-16
Identities = 58/217 (26%), Positives = 107/217 (49%), Gaps = 20/217 (9%)
Query: 14 FSENNIIGNSNLSTVYKGRLEDGEIVAVKKLNFH---QFSAESD-KSFYREAKTLKELKH 69
+++ ++G TVY G G+++AVK++ +AE + + E LK LKH
Sbjct: 2 WTKGEVLGKGAYGTVYCGLTNQGQLIAVKQVELDTSNVLAAEKEYEKLQEEVDLLKSLKH 61
Query: 70 RNLVKVLGYAWESGKLKALILEYMENGSLESVIH--GPGVDHSRWTLPKRIDVLISVANG 127
N+V+ LG + + ++ +E++ GS+ S+++ GP + K+I +G
Sbjct: 62 VNIVQYLGTCLDDNTI-SIFMEFVPGGSISSILNRFGPLPEPVFCKYTKQI------LDG 114
Query: 128 LDYLHSGYDIPIVHCDMKPSNILLDRDFEAHVSDFGTSR---MLDVHLQDLSSLSTAFQG 184
+ YLH + +VH D+K +N++L + + DFG +R + +H S++ + G
Sbjct: 115 VAYLH---NNCVVHRDIKGNNVMLMPNGIIKLIDFGCARRLAWVGLHGTH-SNMLKSMHG 170
Query: 185 TIGYLAPEFAYMRIVTTKVDVFSFGIVVMEFLTKRRP 221
T ++APE K D++S G V E T + P
Sbjct: 171 TPYWMAPEVINESGYGRKSDIWSIGCTVFEMATGKPP 207
|
Serine/threonine kinases (STKs), yeast Sps1/Ste20-related kinase 4 (YSK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YSK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. YSK4 is a putative MAPKKK, whose mammalian gene has been isolated. MAPKKKs (MKKKs or MAP3Ks) phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Length = 265 |
| >gnl|CDD|173625 cd05032, PTKc_InsR_like, Catalytic domain of Insulin Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 75.5 bits (186), Expect = 8e-16
Identities = 59/210 (28%), Positives = 100/210 (47%), Gaps = 19/210 (9%)
Query: 20 IGNSNLSTVYKG---RLEDGEI---VAVKKLNFHQFSAESDKSFYREAKTLKELKHRNLV 73
+G + VY+G + GE VA+K +N + E F EA +KE ++V
Sbjct: 14 LGQGSFGMVYEGLAKGVVKGEPETRVAIKTVNENASMRER-IEFLNEASVMKEFNCHHVV 72
Query: 74 KVLGYAWESGKLKALILEYMENGSLESVI--HGPGVDHSRW----TLPKRIDVLISVANG 127
++LG +G+ +++E M G L+S + P +++ TL K I + +A+G
Sbjct: 73 RLLGVV-STGQPTLVVMELMAKGDLKSYLRSRRPEAENNPGLGPPTLQKFIQMAAEIADG 131
Query: 128 LDYLHSGYDIPIVHCDMKPSNILLDRDFEAHVSDFGTSRMLDVHLQDLSSLSTAFQGTIG 187
+ YL + VH D+ N ++ D + DFG +R D++ D +
Sbjct: 132 MAYLAA---KKFVHRDLAARNCMVAEDLTVKIGDFGMTR--DIYETDYYRKGGKGLLPVR 186
Query: 188 YLAPEFAYMRIVTTKVDVFSFGIVVMEFLT 217
++APE + TTK DV+SFG+V+ E T
Sbjct: 187 WMAPESLKDGVFTTKSDVWSFGVVLWEMAT 216
|
Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The InsR subfamily is composed of InsR, Insulin-like Growth Factor-1 Receptor (IGF-1R), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR and IGF-1R are receptor tyr kinases (RTKs) composed of two alphabeta heterodimers. Binding of the ligand (insulin, IGF-1, or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological function. InsR and IGF-1R, which share 84% sequence identity in their kinase domains, display physiologically distinct yet overlapping functions in cell growth, differentiation, and metabolism. InsR activation leads primarily to metabolic effects while IGF-1R activation stimulates mitogenic pathways. In cells expressing both receptors, InsR/IGF-1R hybrids are found together with classical receptors. Both receptors can interact with common adaptor molecules such as IRS-1 and IRS-2. Length = 277 |
| >gnl|CDD|173764 cd08224, STKc_Nek6_Nek7, Catalytic domain of the Protein Serine/Threonine Kinases, Never In Mitosis gene A-related kinase 6 and 7 | Back alignment and domain information |
|---|
Score = 75.2 bits (185), Expect = 9e-16
Identities = 78/294 (26%), Positives = 131/294 (44%), Gaps = 42/294 (14%)
Query: 11 TGSFSENNIIGNSNLSTVYKGR-LEDGEIVAVKKLN-FHQFSAESDKSFYREAKTLKELK 68
G+F IG S VYK L DG +VA+KK+ F A++ + +E LK+L
Sbjct: 1 LGNFKIEKKIGKGQFSVVYKAICLLDGRVVALKKVQIFEMMDAKARQDCLKEIDLLKQLD 60
Query: 69 HRNLVKVLGYAWESGKLKALILEYMENGSLESVIHGPGVDHSRWTLPKRI--DVLISVAN 126
H N++K L E+ +L ++LE + G L +I + +P+R + + +
Sbjct: 61 HPNVIKYLASFIENNELN-IVLELADAGDLSRMIKH--FKKQKRLIPERTIWKYFVQLCS 117
Query: 127 GLDYLHSGYDIPIVHCDMKPSNILLDRDFEAHVSDFGTSRMLDVHLQDLSSLSTAFQGTI 186
L+++HS I+H D+KP+N+ + + D G R SS +TA +
Sbjct: 118 ALEHMHSKR---IMHRDIKPANVFITATGVVKLGDLGLGRF-------FSSKTTAAHSLV 167
Query: 187 G---YLAPEFAYMRIVTTKVDVFSFGIVVMEFLTKRRPTGLDEENGLSPISLRQLVEKAL 243
G Y++PE + K D++S G ++ E + P D+ N L L +K
Sbjct: 168 GTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSPFYGDKMN------LYSLCKK-- 219
Query: 244 ANGINGVRQITDPKLVSSIYEEQEQHQVLEELFKLALVCTSSNPEDRPNMNELL 297
+ + P L + Y EEL L C + +PE RP+++ +L
Sbjct: 220 ------IEKCDYPPLPADHYS--------EELRDLVSRCINPDPEKRPDISYVL 259
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) and Nek7 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6/7 subfamily is part of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 and Nek7 are the shortest Neks, consisting only of the catalytic domain and a very short N-terminal extension. They show distinct expression patterns and both appear to be downstream substrates of Nek9. They are required for mitotic spindle formation and cytokinesis. They may also be regulators of the p70 ribosomal S6 kinase. Length = 267 |
| >gnl|CDD|132943 cd06612, STKc_MST1_2, Catalytic domain of the Protein Serine/Threonine Kinases, Mammalian Ste20-like protein kinase 1 and 2 | Back alignment and domain information |
|---|
Score = 75.0 bits (185), Expect = 1e-15
Identities = 74/294 (25%), Positives = 120/294 (40%), Gaps = 55/294 (18%)
Query: 13 SFSENNIIGNSNLSTVYKGR-LEDGEIVAVKKLNFHQFSAESDKSFYREAKTLKELKHRN 71
F +G + +VYK E G++VA+K + E + +E LK+
Sbjct: 4 VFDILEKLGEGSYGSVYKAIHKETGQVVAIKVVP----VEEDLQEIIKEISILKQCDSPY 59
Query: 72 LVKVLGYAWESGKLKALILEYMENGSLESVIHGPGVDHSRWTLP-KRID-VLISVANGLD 129
+VK G +++ L +++EY GS+ ++ + TL + I +L GL+
Sbjct: 60 IVKYYGSYFKNTDL-WIVMEYCGAGSVSDIM-----KITNKTLTEEEIAAILYQTLKGLE 113
Query: 130 YLHSGYDIPIVHCDMKPSNILLDRDFEAHVSDFGTSRMLDVHLQDLSSLSTAFQGTIGYL 189
YLHS +H D+K NILL+ + +A ++DFG S L D + GT ++
Sbjct: 114 YLHS---NKKIHRDIKAGNILLNEEGQAKLADFGVSG----QLTDTMAKRNTVIGTPFWM 166
Query: 190 APEFAYMRIVTTKVDVFSFGIVVMEFLTKRRPTGLDEENGLSPISLRQLVEKALANGING 249
APE K D++S GI +E + E G P S I+
Sbjct: 167 APEVIQEIGYNNKADIWSLGITAIE---------MAE--GKPPYS-----------DIHP 204
Query: 250 VRQI------TDPKLVSSIYEEQEQHQVLEELFKLALVCTSSNPEDRPNMNELL 297
+R I P L + + E C +PE+RP+ +LL
Sbjct: 205 MRAIFMIPNKPPPTL-------SDPEKWSPEFNDFVKKCLVKDPEERPSAIQLL 251
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 1 (MST1) and MST2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST1/2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST1, MST2, and related proteins including Drosophila Hippo and Dictyostelium discoideum Krs1 (kinase responsive to stress 1). MST1/2 and Hippo are involved in a conserved pathway that governs cell contact inhibition, organ size control, and tumor development. MST1 activates the mitogen-activated protein kinases (MAPKs) p38 and c-Jun N-terminal kinase (JNK) through MKK7 (a MAPK kinase) and MEKK1 (a MAPK kinase kinase) by acting as a MAPK kinase kinase kinase (MAPKKKK). Activation of JNK by MST1 leads to caspase activation and apoptosis. MST1 has also been implicated in cell proliferation and differentiation. Krs1 may regulate cell growth arrest and apoptosis in response to cellular stress. Length = 256 |
| >gnl|CDD|173737 cd07834, STKc_MAPK, Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 75.6 bits (187), Expect = 1e-15
Identities = 63/208 (30%), Positives = 94/208 (45%), Gaps = 49/208 (23%)
Query: 36 GEIVAVKKLNFHQFSAESD-KSFYREAKTLKELKHRNLVKVLG-------------YAWE 81
G VA+KK++ + F D K RE K L+ L+H N++ +L Y
Sbjct: 25 GRKVAIKKIS-NVFDDLIDAKRILREIKLLRHLRHENIIGLLDILRPPSPEDFNDVY--- 80
Query: 82 SGKLKALILEYMENGSLESVIHGPGV---DHSRWTLPKRIDVLISVANGLDYLHSGYDIP 138
++ E ME L VI P DH ++ L + GL YLHS
Sbjct: 81 ------IVTELMET-DLHKVIKSPQPLTDDHIQY-------FLYQILRGLKYLHSAN--- 123
Query: 139 IVHCDMKPSNILLDRDFEAHVSDFGTSRMLDVHLQDLSSLSTAFQGTIGYLAPE-----F 193
++H D+KPSNIL++ + + + DFG +R +D + L T + T Y APE
Sbjct: 124 VIHRDLKPSNILVNSNCDLKICDFGLARGVDPDEDEKGFL-TEYVVTRWYRAPELLLSSS 182
Query: 194 AYMRIVTTKVDVFSFGIVVMEFLTKRRP 221
Y T +D++S G + E LT R+P
Sbjct: 183 RY----TKAIDIWSVGCIFAELLT-RKP 205
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Typical MAPK pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and activated by a MAPK kinase (MAP2K or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAP3K or MKKK). Each cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. There are three main typical MAPK subfamilies: Extracellular signal-Regulated Kinase (ERK), c-Jun N-terminal Kinase (JNK), and p38. Some MAPKs are atypical in that they are not regulated by MAP2Ks. These include MAPK4, MAPK6, NLK, and ERK7. Length = 330 |
| >gnl|CDD|132980 cd06649, PKc_MEK2, Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 2 | Back alignment and domain information |
|---|
Score = 75.5 bits (185), Expect = 1e-15
Identities = 61/229 (26%), Positives = 106/229 (46%), Gaps = 17/229 (7%)
Query: 20 IGNSNLSTVYKGRLEDGEIVAVKKLNFHQFSAESDKSFYREAKTLKELKHRNLVKVLGYA 79
+G N V K + + ++ +KL + RE + L E +V G
Sbjct: 13 LGAGNGGVVTKVQHKPSGLIMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGFYGAF 72
Query: 80 WESGKLKALILEYMENGSLESVIHGPGVDHSRWTLPKRI--DVLISVANGLDYLHSGYDI 137
+ G++ ++ +E+M+ GSL+ V+ + R +P+ I V I+V GL YL + I
Sbjct: 73 YSDGEI-SICMEHMDGGSLDQVLK----EAKR--IPEEILGKVSIAVLRGLAYLREKHQI 125
Query: 138 PIVHCDMKPSNILLDRDFEAHVSDFGTSRMLDVHLQDLSSLSTAFQGTIGYLAPEFAYMR 197
+H D+KPSNIL++ E + DFG S L + S++ +F GT Y++PE
Sbjct: 126 --MHRDVKPSNILVNSRGEIKLCDFGVSGQL------IDSMANSFVGTRSYMSPERLQGT 177
Query: 198 IVTTKVDVFSFGIVVMEFLTKRRPTGLDEENGLSPISLRQLVEKALANG 246
+ + D++S G+ ++E R P + L I R +V+
Sbjct: 178 HYSVQSDIWSMGLSLVELAIGRYPIPPPDAKELEAIFGRPVVDGEEGEP 226
|
Protein kinases (PKs), MAP/ERK Kinase (MEK) 2 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK2 is a dual-specificity PK that phosphorylates and activates the downstream targets, extracellular signal-regulated kinase (ERK) 1 and ERK2, on specific threonine and tyrosine residues. The ERK cascade starts with extracellular signals including growth factors, hormones, and neurotransmitters, which act through receptors and ion channels to initiate intracellular signaling that leads to the activation at the MAPKKK (Raf-1 or MOS) level, which leads to the transmission of signals to MEK2, and finally to ERK1/2. The ERK cascade plays an important role in cell proliferation, differentiation, oncogenic transformation, and cell cycle control, as well as in apoptosis and cell survival under certain conditions. Gain-of-function mutations in genes encoding ERK cascade proteins, including MEK2, cause cardiofaciocutaneous (CFC) syndrome, a condition leading to multiple congenital anomalies and mental retardation in patients. Length = 331 |
| >gnl|CDD|132950 cd06619, PKc_MKK5, Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 5 | Back alignment and domain information |
|---|
Score = 74.5 bits (183), Expect = 2e-15
Identities = 73/286 (25%), Positives = 124/286 (43%), Gaps = 47/286 (16%)
Query: 18 NIIGNSNLSTVYKG-RLEDGEIVAVKKLNFHQFSAESDKSFYREAKTLKELKHRNLVKVL 76
I+G+ N TVYK L I+AVK + + E K E + L + ++
Sbjct: 7 EILGHGNGGTVYKAYHLLTRRILAVKVIPL-DITVELQKQIMSELEILYKCDSPYIIGFY 65
Query: 77 GYAWESGKLKALILEYMENGSLESVIHGPGVDHSRWTLPKRI--DVLISVANGLDYLHSG 134
G + ++ ++ E+M+ GSL+ +P+ + + ++V GL YL S
Sbjct: 66 GAFFVENRI-SICTEFMDGGSLDVY----------RKIPEHVLGRIAVAVVKGLTYLWS- 113
Query: 135 YDIPIVHCDMKPSNILLDRDFEAHVSDFGTSRMLDVHLQDLSSLSTAFQGTIGYLAPEFA 194
+ I+H D+KPSN+L++ + + DFG S L ++S++ + GT Y+APE
Sbjct: 114 --LKILHRDVKPSNMLVNTRGQVKLCDFGVSTQL------VNSIAKTYVGTNAYMAPERI 165
Query: 195 YMRIVTTKVDVFSFGIVVMEFLTKRRPTGLDEEN--GLSPISLRQ-LVEKALANGINGVR 251
DV+S GI ME R P ++N L P+ L Q +V++
Sbjct: 166 SGEQYGIHSDVWSLGISFMELALGRFPYPQIQKNQGSLMPLQLLQCIVDED--------- 216
Query: 252 QITDPKLVSSIYEEQEQHQVLEELFKLALVCTSSNPEDRPNMNELL 297
P L + E+ H + + C P++RP L+
Sbjct: 217 ---PPVLPVGQFSEKFVHFITQ--------CMRKQPKERPAPENLM 251
|
Protein kinases (PKs), MAP kinase kinase 5 (MKK5) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK5, also referred to as MEK5, is a dual-specificity PK that phosphorylates its downstream target, extracellular signal-regulated kinase 5 (ERK5), on specific threonine and tyrosine residues. MKK5 is activated by MEKK2 and MEKK3 in response to mitogenic and stress stimuli. The ERK5 cascade promotes cell proliferation, differentiation, neuronal survival, and neuroprotection. This cascade plays an essential role in heart development. Mice deficient in either ERK5 or MKK5 die around embryonic day 10 due to cardiovascular defects including underdevelopment of the myocardium. In addition, MKK5 is associated with metastasis and unfavorable prognosis in prostate cancer. Length = 279 |
| >gnl|CDD|173749 cd07855, STKc_ERK5, Catalytic domain of the Serine/Threonine Kinase, Extracellular signal-Regulated Kinase 5 | Back alignment and domain information |
|---|
Score = 75.1 bits (185), Expect = 2e-15
Identities = 57/192 (29%), Positives = 90/192 (46%), Gaps = 20/192 (10%)
Query: 36 GEIVAVKKLNFHQFSA-ESDKSFYREAKTLKELKHRNLVKVLGYAWESGKLKA---LILE 91
G+ VA+KK+ H F K RE K L+ KH N++ + G ++++
Sbjct: 30 GKKVAIKKIP-HAFDVPTLAKRTLRELKILRHFKHDNIIAIRDILRPPGADFKDVYVVMD 88
Query: 92 YMENGSLESVIHGPG---VDHSRWTLPKRIDVLISVANGLDYLHSGYDIPIVHCDMKPSN 148
ME+ L +IH +H R+ L + GL Y+HS ++H D+KPSN
Sbjct: 89 LMES-DLHHIIHSDQPLTEEHIRY-------FLYQLLRGLKYIHSA---NVIHRDLKPSN 137
Query: 149 ILLDRDFEAHVSDFGTSRMLDVHLQDLSSLSTAFQGTIGYLAPEFAY-MRIVTTKVDVFS 207
+L++ D E + DFG +R L + T + T Y APE + TT +D++S
Sbjct: 138 LLVNEDCELRIGDFGMARGLSSSPTEHKYFMTEYVATRWYRAPELLLSLPEYTTAIDMWS 197
Query: 208 FGIVVMEFLTKR 219
G + E L +R
Sbjct: 198 VGCIFAEMLGRR 209
|
Serine/Threonine Kinases (STKs), Extracellular signal-Regulated Kinase 5 (ERK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ERK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. ERK5, also called Big MAPK1 (BMK1) or MAPK7, has a unique C-terminal extension, making it approximately twice as big as other MAPKs. This extension contains transcriptional activation capability which is inhibited by the N-terminal half. ERK5 is activated in response to growth factors and stress by a cascade that leads to its phosphorylation by the MAP2K MEK5, which in turn is regulated by the MAP3Ks MEKK2 and MEKK3. Activated ERK5 phosphorylates its targets including myocyte enhancer factor 2 (MEF2), Sap1a, c-Myc, and RSK. It plays a role in EGF-induced cell proliferation during the G1/S phase transition. Studies on knockout mice revealed that ERK5 is essential for cardiovascular development and plays an important role in angiogenesis. It is also critical for neural differentiation and survival. The ERK5 pathway has been implicated in the pathogenesis of many diseases including cancer, cardiac hypertrophy, and atherosclerosis. Length = 334 |
| >gnl|CDD|132981 cd06650, PKc_MEK1, Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 1 | Back alignment and domain information |
|---|
Score = 75.1 bits (184), Expect = 2e-15
Identities = 58/210 (27%), Positives = 102/210 (48%), Gaps = 17/210 (8%)
Query: 14 FSENNIIGNSNLSTVYKGRLEDGEIVAVKKLNFHQFSAESDKSFYREAKTLKELKHRNLV 73
F + + +G N V+K + ++ +KL + RE + L E +V
Sbjct: 7 FEKISELGAGNGGVVFKVSHKPSGLIMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIV 66
Query: 74 KVLGYAWESGKLKALILEYMENGSLESVIHGPGVDHSRWTLPKRI--DVLISVANGLDYL 131
G + G++ ++ +E+M+ GSL+ V+ G +P++I V I+V GL YL
Sbjct: 67 GFYGAFYSDGEI-SICMEHMDGGSLDQVLKKAG------RIPEQILGKVSIAVIKGLTYL 119
Query: 132 HSGYDIPIVHCDMKPSNILLDRDFEAHVSDFGTSRMLDVHLQDLSSLSTAFQGTIGYLAP 191
+ I +H D+KPSNIL++ E + DFG S L + S++ +F GT Y++P
Sbjct: 120 REKHKI--MHRDVKPSNILVNSRGEIKLCDFGVSGQL------IDSMANSFVGTRSYMSP 171
Query: 192 EFAYMRIVTTKVDVFSFGIVVMEFLTKRRP 221
E + + D++S G+ ++E R P
Sbjct: 172 ERLQGTHYSVQSDIWSMGLSLVEMAIGRYP 201
|
Protein kinases (PKs), MAP/ERK kinase (MEK) 1 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 is a dual-specificity PK that phosphorylates and activates the downstream targets, extracellular signal-regulated kinase (ERK) 1 and ERK2, on specific threonine and tyrosine residues. The ERK cascade starts with extracellular signals including growth factors, hormones, and neurotransmitters, which act through receptors and ion channels to initiate intracellular signaling that leads to the activation at the MAPKKK (Raf-1 or MOS) level, which leads to the transmission of signals to MEK1, and finally to ERK1/2. The ERK cascade plays an important role in cell proliferation, differentiation, oncogenic transformation, and cell cycle control, as well as in apoptosis and cell survival under certain conditions. Gain-of-function mutations in genes encoding ERK cascade proteins, including MEK1, cause cardiofaciocutaneous (CFC) syndrome, a condition leading to multiple congenital anomalies and mental retardation in patients. MEK1 also plays a role in cell cycle control. Length = 333 |
| >gnl|CDD|173763 cd08223, STKc_Nek4, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 4 | Back alignment and domain information |
|---|
Score = 74.2 bits (182), Expect = 2e-15
Identities = 72/269 (26%), Positives = 113/269 (42%), Gaps = 44/269 (16%)
Query: 34 EDGEIVAVKKLNFHQFSAESDKSFYREAKTLKELKHRNLVKVLGYAWESGK-LKALILEY 92
DG+ +KKLN S K+ +EA+ L +LKH N+V +WE L +++ +
Sbjct: 23 TDGKQYVIKKLNLRNASRRERKAAEQEAQLLSQLKHPNIV-AYRESWEGEDGLLYIVMGF 81
Query: 93 MENGSLESVIHGPGVDHSRWTLPKR--IDVLISVANGLDYLHSGYDIPIVHCDMKPSNIL 150
E G L + + LP+ ++ + +A L YLH + I+H D+K N+
Sbjct: 82 CEGGDLYHKLK----EQKGKLLPENQVVEWFVQIAMALQYLHEKH---ILHRDLKTQNVF 134
Query: 151 LDRDFEAHVSDFGTSRMLDVHLQDLSSLSTAFQGTIGYLAPEFAYMRIVTTKVDVFSFGI 210
L R V D G +R+L+ S+L GT Y++PE + K DV++ G
Sbjct: 135 LTRTNIIKVGDLGIARVLENQCDMASTLI----GTPYYMSPELFSNKPYNYKSDVWALGC 190
Query: 211 VVMEFLTKRRPTGLDEENGLSPISLRQLVEKALANGINGVRQITDPKL--VSSIYEEQEQ 268
V E T + + N L V +I + KL + Y +
Sbjct: 191 CVYEMATLKHAFNAKDMNSL-------------------VYRIIEGKLPPMPKDYSPE-- 229
Query: 269 HQVLEELFKLALVCTSSNPEDRPNMNELL 297
L EL L S PE RP++ +L
Sbjct: 230 ---LGELIATML---SKRPEKRPSVKSIL 252
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 4 (Nek4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek4 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Nek4 is highly abundant in the testis. Its specific function is unknown. Length = 257 |
| >gnl|CDD|132991 cd06917, STKc_NAK1_like, Catalytic domain of Fungal Nak1-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 74.4 bits (183), Expect = 2e-15
Identities = 61/210 (29%), Positives = 99/210 (47%), Gaps = 23/210 (10%)
Query: 19 IIGNSNLSTVYKGR-LEDGEIVAVKKLNFHQFSAESDKS-FYREAKTLKELKH---RNLV 73
+IG VY+G+ + G +VA+K +N + + D S RE L +L+ N+
Sbjct: 8 LIGRGAYGAVYRGKHVPTGRVVALKIINLD--TPDDDVSDIQREVALLSQLRQSQPPNIT 65
Query: 74 KVLGYAWESGKLKALILEYMENGSLESVIHGPGVDHSRWTLPKRIDVLI-SVANGLDYLH 132
K G ++ G +I+EY E GS+ +++ + K I V+I V L Y+H
Sbjct: 66 KYYG-SYLKGPRLWIIMEYAEGGSVRTLMKAGPIAE------KYISVIIREVLVALKYIH 118
Query: 133 SGYDIPIVHCDMKPSNILLDRDFEAHVSDFGTSRMLDVHLQDLSSLSTAFQGTIGYLAPE 192
+ ++H D+K +NIL+ + DFG + L SS + F GT ++APE
Sbjct: 119 K---VGVIHRDIKAANILVTNTGNVKLCDFGVA----ALLNQNSSKRSTFVGTPYWMAPE 171
Query: 193 FAY-MRIVTTKVDVFSFGIVVMEFLTKRRP 221
+ TK D++S GI + E T P
Sbjct: 172 VITEGKYYDTKADIWSLGITIYEMATGNPP 201
|
Serine/threonine kinases (STKs), Nak1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nak1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of Schizosaccharomyces pombe Nak1, Saccharomyces cerevisiae Kic1p (kinase that interacts with Cdc31p) and related proteins. Nak1 (also known as N-rich kinase 1), is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Kic1p is required by budding yeast for cell integrity and morphogenesis. Kic1p interacts with Cdc31p, the yeast homologue of centrin, and phosphorylates substrates in a Cdc31p-dependent manner. Length = 277 |
| >gnl|CDD|143356 cd07851, STKc_p38, Catalytic domain of the Serine/Threonine Kinase, p38 Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 73.9 bits (182), Expect = 5e-15
Identities = 58/191 (30%), Positives = 89/191 (46%), Gaps = 24/191 (12%)
Query: 36 GEIVAVKKLNFHQFSAESDKSFYREAKTLKELKHRNLVKVLGYAWESGKLKALILEYMEN 95
G VA+KKL+ SA K YRE + LK + H N++ +L + L+ Y+
Sbjct: 40 GRKVAIKKLSRPFQSAIHAKRTYRELRLLKHMDHENVIGLLDVFTPASSLEDFQDVYL-- 97
Query: 96 GSLESVIHGPGVDHSRWTLPKR-----IDVLI-SVANGLDYLHSGYDIPIVHCDMKPSNI 149
V H G D + ++ I L+ + GL Y+HS I+H D+KPSNI
Sbjct: 98 -----VTHLMGADLNNIVKCQKLSDDHIQFLVYQILRGLKYIHSA---GIIHRDLKPSNI 149
Query: 150 LLDRDFEAHVSDFGTSRMLDVHLQDLSSLSTAFQGTIGYLAPEFAYMRIVTTK-VDVFSF 208
++ D E + DFG +R D + T + T Y APE + + VD++S
Sbjct: 150 AVNEDCELKILDFGLARHTDDEM-------TGYVATRWYRAPEIMLNWMHYNQTVDIWSV 202
Query: 209 GIVVMEFLTKR 219
G ++ E LT +
Sbjct: 203 GCIMAELLTGK 213
|
Serine/Threonine Kinases (STKs), p38 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They function in the regulation of the cell cycle, cell development, cell differentiation, senescence, tumorigenesis, apoptosis, pain development and pain progression, and immune responses. p38 kinases are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. p38 substrates include other protein kinases and factors that regulate transcription, nuclear export, mRNA stability and translation. p38 kinases are drug targets for the inflammatory diseases psoriasis, rheumatoid arthritis, and chronic pulmonary disease. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta, which show varying substrate specificity and expression patterns. p38alpha and p38beta are ubiquitously expressed, p38gamma is predominantly found in skeletal muscle, and p38delta is found in the heart, lung, testis, pancreas, and small intestine. Length = 343 |
| >gnl|CDD|173743 cd07846, STKc_CDKL2_3, Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 2 and 3 | Back alignment and domain information |
|---|
Score = 73.2 bits (180), Expect = 5e-15
Identities = 84/296 (28%), Positives = 135/296 (45%), Gaps = 39/296 (13%)
Query: 19 IIGNSNLSTVYKGR-LEDGEIVAVKKLNFHQFSAESDKSFYREAKTLKELKHRNLVKVLG 77
++G + V K + E G+IVA+KK + K RE + LK+L+H NLV ++
Sbjct: 8 LVGEGSYGMVMKCKHKETGQIVAIKKFLESEDDKMVKKIAMREIRMLKQLRHENLVNLI- 66
Query: 78 YAWESGKLKALILEYMENGSLESVIHGP-GVDHSRWTLPKRIDVLISVANGLDYLHSGYD 136
+ K L+ E++++ L+ + P G+D SR ++ L + G+++ HS
Sbjct: 67 EVFRRKKRLYLVFEFVDHTVLDDLEKYPNGLDESR---VRKY--LFQILRGIEFCHSH-- 119
Query: 137 IPIVHCDMKPSNILLDRDFEAHVSDFGTSRMLDVHLQDLSSLSTAFQGTIGYLAPEF--- 193
I+H D+KP NIL+ + + DFG +R L + T + T Y APE
Sbjct: 120 -NIIHRDIKPENILVSQSGVVKLCDFGFARTLAAPGEVY----TDYVATRWYRAPELLVG 174
Query: 194 --AYMRIVTTKVDVFSFGIVVMEFLTKRRPTGLDEENGLSPISLRQLVEKALANGINGVR 251
Y R VD+++ G +V E LT G G S I + K L N I +
Sbjct: 175 DTKYGR----AVDIWAVGCLVTEMLT-----GEPLFPGDSDIDQLYHIIKCLGNLIPRHQ 225
Query: 252 QITD--PKLVSSIYEEQEQHQVLEELF--------KLALVCTSSNPEDRPNMNELL 297
+I P E ++ + LE+ F LA C +P+DRP+ ++LL
Sbjct: 226 EIFQKNPLFAGMRLPEVKEIEPLEKRFPKLSGLVLDLAKQCLRIDPDDRPSSSQLL 281
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 2 (CDKL2) and CDKL3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL2 and CDKL3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL2, also called p56 KKIAMRE, is expressed in testis, kidney, lung, and brain. It functions mainly in mature neurons and plays an important role in learning and memory. Inactivation of CDKL3, also called NKIAMRE (NKIATRE in rat), by translocation is associated with mild mental retardation. It has been reported that CDKL3 is lost in leukemic cells having a chromosome arm 5q deletion, and may contribute to the transformed phenotype. Length = 286 |
| >gnl|CDD|173652 cd05100, PTKc_FGFR3, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 3 | Back alignment and domain information |
|---|
Score = 73.9 bits (181), Expect = 6e-15
Identities = 49/162 (30%), Positives = 82/162 (50%), Gaps = 18/162 (11%)
Query: 68 KHRNLVKVLGYAWESGKLKALILEYMENGSLESVIHG---PGVDHS---------RWTLP 115
KH+N++ +LG + G L L+ EY G+L + PG+D+S + T
Sbjct: 76 KHKNIINLLGACTQDGPLYVLV-EYASKGNLREYLRARRPPGMDYSFDTCKLPEEQLTFK 134
Query: 116 KRIDVLISVANGLDYLHSGYDIPIVHCDMKPSNILLDRDFEAHVSDFGTSRMLDVHLQDL 175
+ VA G++YL S +H D+ N+L+ D ++DFG +R DVH D
Sbjct: 135 DLVSCAYQVARGMEYLASQ---KCIHRDLAARNVLVTEDNVMKIADFGLAR--DVHNIDY 189
Query: 176 SSLSTAFQGTIGYLAPEFAYMRIVTTKVDVFSFGIVVMEFLT 217
+T + + ++APE + R+ T + DV+SFG+++ E T
Sbjct: 190 YKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLLWEIFT 231
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 3 (FGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR3 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. Many FGFR3 splice variants have been reported with the IIIb and IIIc isoforms being the predominant forms. FGFR3 IIIc is the isoform expressed in chondrocytes, the cells affected in dwarfism, while IIIb is expressed in epithelial cells. FGFR3 ligands include FGF1, FGF2, FGF4, FGF8, FGF9, and FGF23. It is a negative regulator of long bone growth. In the cochlear duct and in the lens, FGFR3 is involved in differentiation while it appears to have a role in cell proliferation in epithelial cells. Germline mutations in FGFR3 are associated with skeletal disorders including several forms of dwarfism. Some missense mutations are associated with multiple myeloma and carcinomas of the bladder and cervix. Overexpression of FGFR3 is found in thyroid carcinoma. Length = 334 |
| >gnl|CDD|132979 cd06648, STKc_PAK_II, Catalytic domain of the Protein Serine/Threonine Kinase, Group II p21-activated kinase | Back alignment and domain information |
|---|
Score = 72.9 bits (179), Expect = 7e-15
Identities = 49/179 (27%), Positives = 91/179 (50%), Gaps = 15/179 (8%)
Query: 36 GEIVAVKKLNFHQFSAESDKSFYREAKTLKELKHRNLVKVLGYAWESGKLKALILEYMEN 95
G VAVKK++ + + + + E +++ +H N+V++ ++ G +++E++E
Sbjct: 44 GRQVAVKKMDLRK--QQRRELLFNEVVIMRDYQHPNIVEMYS-SYLVGDELWVVMEFLEG 100
Query: 96 GSLESVIHGPGVDHSRWTLPKRIDVLISVANGLDYLHSGYDIPIVHCDMKPSNILLDRDF 155
G+L + V H+R + V ++V L +LH+ ++H D+K +ILL D
Sbjct: 101 GALTDI-----VTHTRMNEEQIATVCLAVLKALSFLHAQ---GVIHRDIKSDSILLTSDG 152
Query: 156 EAHVSDFGTSRMLDVHLQDLSSLSTAFQGTIGYLAPEFAYMRIVTTKVDVFSFGIVVME 214
+SDFG + + SL GT ++APE T+VD++S GI+V+E
Sbjct: 153 RVKLSDFGFCAQVSKEVPRRKSLV----GTPYWMAPEVISRLPYGTEVDIWSLGIMVIE 207
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group II, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group II PAKs, also called non-conventional PAKs, include PAK4, PAK5, and PAK6. Group II PAKs contain PBD (p21-binding domain) and catalytic domains, but lack other motifs found in group I PAKs, such as an AID (autoinhibitory domain) and SH3 binding sites. Since group II PAKs do not contain an obvious AID, they may be regulated differently from group I PAKs. While group I PAKs interact with the SH3 containing proteins Nck, Grb2 and PIX, no such binding has been demonstrated for group II PAKs. Some known substrates of group II PAKs are also substrates of group I PAKs such as Raf, BAD, LIMK and GEFH1. Unique group II substrates include MARK/Par-1 and PDZ-RhoGEF. Group II PAKs play important roles in filopodia formation, neuron extension, cytoskeletal organization, and cell survival. Length = 285 |
| >gnl|CDD|173673 cd05582, STKc_RSK_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, 90 kDa ribosomal protein S6 kinase | Back alignment and domain information |
|---|
Score = 73.3 bits (180), Expect = 7e-15
Identities = 77/256 (30%), Positives = 120/256 (46%), Gaps = 46/256 (17%)
Query: 60 EAKTLKELKHRNLVKVLGYAWES-GKLKALILEYMENGSLESVIHGPGVDHSRWTLPKRI 118
E L E+ H +VK L YA+++ GKL LIL+++ G L + + S+ +
Sbjct: 48 ERDILAEVNHPFIVK-LHYAFQTEGKL-YLILDFLRGGDLFTRL-------SKEVMFTEE 98
Query: 119 DV---LISVANGLDYLHSGYDIPIVHCDMKPSNILLDRDFEAHVSDFGTSRMLDVHLQDL 175
DV L +A LD+LHS + I++ D+KP NILLD + ++DFG S+ D
Sbjct: 99 DVKFYLAELALALDHLHS---LGIIYRDLKPENILLDEEGHIKLTDFGLSK----ESIDH 151
Query: 176 SSLSTAFQGTIGYLAPEFAYMRIVTTKVDVFSFGIVVMEFLTKRRP-TGLDEENGLSPIS 234
+ +F GT+ Y+APE R T D +SFG+++ E LT P G D + ++ I
Sbjct: 152 EKKAYSFCGTVEYMAPEVVNRRGHTQSADWWSFGVLMFEMLTGSLPFQGKDRKETMTMIL 211
Query: 235 -----------------LRQLVEKALAN----GINGVRQITDPKLVSSIYEEQEQHQVLE 273
LR L ++ AN G +GV +I S+I + + ++
Sbjct: 212 KAKLGMPQFLSPEAQSLLRALFKRNPANRLGAGPDGVEEIKRHPFFSTIDWNKLYRREIK 271
Query: 274 ELFKLALVCTSSNPED 289
FK A P+D
Sbjct: 272 PPFKPA----VGRPDD 283
|
Serine/Threonine Kinases (STKs), 90 kDa ribosomal protein S6 kinase (RSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. RSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family. They are activated by signaling inputs from extracellular regulated kinase (ERK) and phosphoinositide dependent kinase 1 (PDK1). ERK phosphorylates and activates the CTD of RSK, serving as a docking site for PDK1, which phosphorylates and activates the NTD, which in turn phosphorylates all known RSK substrates. RSKs act as downstream effectors of mitogen-activated protein kinase (MAPK) and play key roles in mitogen-activated cell growth, differentiation, and survival. Mammals possess four RSK isoforms (RSK1-4) from distinct genes. RSK proteins are also referred to as MAP kinase-activated protein kinases (MAPKAPKs), p90-RSKs, or p90S6Ks. Length = 318 |
| >gnl|CDD|173702 cd05611, STKc_Rim15_like, Catalytic domain of fungal Rim15-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 72.5 bits (178), Expect = 8e-15
Identities = 44/146 (30%), Positives = 64/146 (43%), Gaps = 15/146 (10%)
Query: 76 LGYAWESGKLKALILEYMENGSLESVIHGPGVDHSRWTLPKRIDVLISVANGLDYLHSGY 135
L Y+++S L++EY+ G S+I G W + V G++ LH
Sbjct: 62 LYYSFQSKDYLYLVMEYLNGGDCASLIKTLGGLPEDWAK----QYIAEVVLGVEDLH--- 114
Query: 136 DIPIVHCDMKPSNILLDRDFEAHVSDFGTSRMLDVHLQDLSSLSTAFQGTIGYLAPEFAY 195
I+H D+KP N+L+D+ ++DFG SR + F GT YLAPE
Sbjct: 115 QRGIIHRDIKPENLLIDQTGHLKLTDFGLSRN--------GLENKKFVGTPDYLAPETIL 166
Query: 196 MRIVTTKVDVFSFGIVVMEFLTKRRP 221
D +S G V+ EFL P
Sbjct: 167 GVGDDKMSDWWSLGCVIFEFLFGYPP 192
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, fungal Rim15-like kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include Saccharomyces cerevisiae Rim15, Schizosaccharomyces pombe cek1, and similar fungal proteins. They contain a central catalytic domain, which contains an insert relative to MAST kinases. In addition, Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. Rim15 (or Rim15p) functions as a regulator of meiosis. It acts as a downstream effector of PKA and regulates entry into stationary phase (G0). Thus, it plays a crucial role in regulating yeast proliferation, differentiation, and aging. Cek1 may facilitate progression of mitotic anaphase. Length = 260 |
| >gnl|CDD|143341 cd07836, STKc_Pho85, Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Pho85 | Back alignment and domain information |
|---|
Score = 72.9 bits (179), Expect = 8e-15
Identities = 73/278 (26%), Positives = 126/278 (45%), Gaps = 44/278 (15%)
Query: 20 IGNSNLSTVYKGR-LEDGEIVAVKKLNFHQFSAESDKSF-YREAKTLKELKHRNLVKVLG 77
+G +TVYKGR GEIVA+K+++ + E S RE +KELKH N+V++
Sbjct: 8 LGEGTYATVYKGRNRTTGEIVALKEIHLD--AEEGTPSTAIREISLMKELKHENIVRLHD 65
Query: 78 YAWESGKLKALILEYMEN------------GSLESVIHGPGVDHSRWTLPKRIDVLISVA 125
KL L+ EYM+ G+L+ V + L K
Sbjct: 66 VIHTENKL-MLVFEYMDKDLKKYMDTHGVRGALDPNT----VKSFTYQLLK--------- 111
Query: 126 NGLDYLHSGYDIPIVHCDMKPSNILLDRDFEAHVSDFGTSRMLDVHLQDLSSLSTAFQGT 185
G+ + H + ++H D+KP N+L+++ E ++DFG +R + + S+ T
Sbjct: 112 -GIAFCH---ENRVLHRDLKPQNLLINKRGELKLADFGLARAFGIPVNTFSNEVV----T 163
Query: 186 IGYLAPEFAY-MRIVTTKVDVFSFGIVVMEFLTKRRP--TGLDEENGLSPISLRQLVEKA 242
+ Y AP+ R +T +D++S G ++ E +T RP G + E+ L I +++
Sbjct: 164 LWYRAPDVLLGSRTYSTSIDIWSVGCIMAEMITG-RPLFPGTNNEDQLLKIF--RIMGTP 220
Query: 243 LANGINGVRQITDPKLVSSIYEEQEQHQVLEELFKLAL 280
+ G+ Q+ + K Y Q+ Q+ L +
Sbjct: 221 TESTWPGISQLPEYKPTFPRYPPQDLQQLFPHADPLGI 258
|
Serine/Threonine Kinases (STKs), Pho85 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Pho85 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Pho85 is a multifunctional Cyclin-Dependent protein Kinase (CDK) in yeast. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Pho85 is regulated by 10 different cyclins (Pcls) and plays a role in G1 progression, cell polarity, phosphate and glycogen metabolism, gene expression, and in signaling changes in the environment. It is not essential for yeast viability and is the functional homolog of mammalian CDK5, which plays a role in central nervous system development. Length = 284 |
| >gnl|CDD|173744 cd07847, STKc_CDKL1_4, Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 1 and 4 | Back alignment and domain information |
|---|
Score = 72.8 bits (179), Expect = 8e-15
Identities = 67/209 (32%), Positives = 95/209 (45%), Gaps = 32/209 (15%)
Query: 20 IGNSNLSTVYKGR-LEDGEIVAVKKLNFHQFSAESD----KSFYREAKTLKELKHRNLVK 74
IG + V+K R E G+IVA+KK +E D K RE + LK+LKH NLV
Sbjct: 9 IGEGSYGVVFKCRNRETGQIVAIKKF----VESEDDPVIKKIALREIRMLKQLKHPNLVN 64
Query: 75 VLGYAWESGKLKALILEYMENGSLESVIHGP-GVDHSRWTLPKRIDVLISVANGLDYLHS 133
++ KL L+ EY ++ L + P GV L K+I + +++ H
Sbjct: 65 LIEVFRRKRKLH-LVFEYCDHTVLNELEKNPRGVPEH---LIKKI--IWQTLQAVNFCHK 118
Query: 134 GYDIPIVHCDMKPSNILLDRDFEAHVSDFGTSRMLDVHLQDLSSLSTAFQGTIGYLAPEF 193
I H D+KP NIL+ + + + DFG +R+L D T + T Y APE
Sbjct: 119 HNCI---HRDVKPENILITKQGQIKLCDFGFARILTGPGDDY----TDYVATRWYRAPEL 171
Query: 194 -----AYMRIVTTKVDVFSFGIVVMEFLT 217
Y VDV++ G V E LT
Sbjct: 172 LVGDTQY----GPPVDVWAIGCVFAELLT 196
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 1 (CDKL1) and CDKL4 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL1 and CDKL4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL1, also called p42 KKIALRE, is a glial protein that is upregulated in gliosis. It is present in neuroblastoma and A431 human carcinoma cells, and may be implicated in neoplastic transformation. The function of CDKL4 is unknown. Length = 286 |
| >gnl|CDD|173770 cd08528, STKc_Nek10, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 10 | Back alignment and domain information |
|---|
Score = 72.5 bits (178), Expect = 9e-15
Identities = 71/288 (24%), Positives = 129/288 (44%), Gaps = 43/288 (14%)
Query: 20 IGNSNLSTVYKGRLEDG--EIVAVKKLNFH-----QFSAESDKSF---YREAKTLKE-LK 68
+G+ VYK R ++ ++A+K++N H + E DKS E +KE L+
Sbjct: 8 LGSGAFGCVYKVRKKNNGQNLLALKEINVHNPAFGKDKRERDKSIGDIVSEVTIIKEQLR 67
Query: 69 HRNLVKVLGYAWESGKLKALILEYMENGSLESVIHGPGVDHSRWTLPKRIDVLISVANGL 128
H N+V+ E+ +L ++++ +E L + R+T + ++ + + L
Sbjct: 68 HPNIVRYYKTFLENDRL-YIVMDLIEGAPLGEHFNSLKEKKQRFTEERIWNIFVQMVLAL 126
Query: 129 DYLHSGYDIPIVHCDMKPSNILLDRDFEAHVSDFGTSRMLDVHLQDLSSLSTAFQGTIGY 188
YLH + IVH D+ P+NI+L D + ++DFG ++ + S T+ GTI Y
Sbjct: 127 RYLHK--EKRIVHRDLTPNNIMLGEDDKVTITDFGLAKQ-----KQPESKLTSVVGTILY 179
Query: 189 LAPEFAYMRIVTTKVDVFSFGIVVMEFLTKRRPTGLDEENGLSPISLRQLVEKALANGIN 248
PE K DV++FG ++ + T + P N LS LA
Sbjct: 180 SCPEIVKNEPYGEKADVWAFGCILYQMCTLQPP--FYSTNMLS-----------LAT--- 223
Query: 249 GVRQITDPKLVSSIYEEQEQHQVLEELFKLALVCTSSNPEDRPNMNEL 296
K+V ++YE + E++ + C + + E RP++ ++
Sbjct: 224 --------KIVEAVYEPLPEGMYSEDVTDVITSCLTPDAEARPDIIQV 263
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 10 (Nek10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek10 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. No function has yet been ascribed to Nek10. The gene encoding Nek10 is a putative causative gene for breast cancer; it is located within a breast cancer susceptibility loci on chromosome 3p24. Length = 269 |
| >gnl|CDD|143371 cd07866, STKc_BUR1, Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Bypass UAS Requirement 1 and similar proteins | Back alignment and domain information |
|---|
Score = 72.7 bits (179), Expect = 1e-14
Identities = 60/208 (28%), Positives = 95/208 (45%), Gaps = 23/208 (11%)
Query: 28 VYKGR-LEDGEIVAVKKLNFHQFSAESDKSFYREAKTLKELKHRNLVKVLGYAWESGKLK 86
VYK R ++ G +VA+KK+ H + RE K LK+LKH N+V ++ A E
Sbjct: 24 VYKARQIKTGRVVALKKILMHNEKDGFPITALREIKILKKLKHPNVVPLIDMAVERPDKS 83
Query: 87 A-------LILEYMENGSLESVIHGPGVDHSRWTLPKRIDVLISVANGLDYLHSGYDIPI 139
++ YM++ L ++ P V + T + ++ + G++YLH + I
Sbjct: 84 KRKRGSVYMVTPYMDH-DLSGLLENPSV---KLTESQIKCYMLQLLEGINYLHENH---I 136
Query: 140 VHCDMKPSNILLDRDFEAHVSDFGTSRMLDVHLQDLSSLS-------TAFQGTIGYLAPE 192
+H D+K +NIL+D ++DFG +R D + T T Y PE
Sbjct: 137 LHRDIKAANILIDNQGILKIADFGLARPYDGPPPNPKGGGGGGTRKYTNLVVTRWYRPPE 196
Query: 193 F-AYMRIVTTKVDVFSFGIVVMEFLTKR 219
R TT VD++ G V E T+R
Sbjct: 197 LLLGERRYTTAVDIWGIGCVFAEMFTRR 224
|
Serine/Threonine Kinases (STKs), Bypass UAS Requirement 1 (BUR1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The BUR1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. BUR1, also called SGV1, is a yeast Cyclin-Dependent protein Kinase (CDK) that is functionally equivalent to mammalian CDK9. It associates with the cyclin BUR2. BUR genes were orginally identified in a genetic screen as factors involved in general transcription. The BUR1/BUR2 complex phosphorylates the C-terminal domain of RNA polymerase II. In addition, this complex regulates histone modification by phosporylating Rad6 and mediating the association of the Paf1 complex with chromatin. Length = 311 |
| >gnl|CDD|143338 cd07833, STKc_CDKL, Catalytic domain of Cyclin-Dependent protein Kinase Like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 72.4 bits (178), Expect = 1e-14
Identities = 61/200 (30%), Positives = 88/200 (44%), Gaps = 25/200 (12%)
Query: 28 VYKGR-LEDGEIVAVKKLNFHQFSAESDKSFYREAKTLKELKHRNLVKVLGYAWESGKLK 86
V K R GEIVA+KK + + K+ RE K L++L+H N+V + G+L
Sbjct: 17 VLKCRNKATGEIVAIKKFKESEDDEDVKKTALREVKVLRQLRHENIVNLKEAFRRKGRLY 76
Query: 87 ALILEYMENGSLESVIHGP-GVDHSRWTLPKRIDVLI-SVANGLDYLHSGYDIPIVHCDM 144
L+ EY+E LE + P G+ P + I + + Y HS I+H D+
Sbjct: 77 -LVFEYVERTLLELLEASPGGLP------PDAVRSYIWQLLQAIAYCHSH---NIIHRDI 126
Query: 145 KPSNILLDRDFEAHVSDFGTSRML----DVHLQDLSSLSTAFQGTIGYLAPEFAYMRIVT 200
KP NIL+ + DFG +R L L T + T Y APE
Sbjct: 127 KPENILVSESGVLKLCDFGFARALRARPASPL-------TDYVATRWYRAPELLVGDTNY 179
Query: 201 TK-VDVFSFGIVVMEFLTKR 219
K VDV++ G ++ E L
Sbjct: 180 GKPVDVWAIGCIMAELLDGE 199
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like (CDKL) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDKL1-5 and similar proteins. Some CDKLs, like CDKL1 and CDKL3, may be implicated in transformation and others, like CDKL3 and CDKL5, are associated with mental retardation when impaired. CDKL2 plays a role in learning and memory. Length = 288 |
| >gnl|CDD|173699 cd05608, STKc_GRK1, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 1 | Back alignment and domain information |
|---|
Score = 72.6 bits (178), Expect = 1e-14
Identities = 53/187 (28%), Positives = 89/187 (47%), Gaps = 9/187 (4%)
Query: 36 GEIVAVKKLNFHQFSAESD-KSFYREAKTLKELKHRNLVKVLGYAWESGKLKALILEYME 94
G++ A KKLN + + E + L ++ R +V L YA+++ L++ M
Sbjct: 18 GKLYACKKLNKKRLKKRKGYEGAMVEKRILAKVHSRFIVS-LAYAFQTKTDLCLVMTIMN 76
Query: 95 NGSLESVIHGPGVDHSRWTLPKRIDVLISVANGLDYLHSGYDIPIVHCDMKPSNILLDRD 154
G L I+ ++ + P+ + +GL++LH I++ D+KP N+LLD D
Sbjct: 77 GGDLRYHIYNVDEENPGFPEPRACFYTAQIISGLEHLHQRR---IIYRDLKPENVLLDND 133
Query: 155 FEAHVSDFGTSRMLDVHLQDLSSLSTAFQGTIGYLAPEFAYMRIVTTKVDVFSFGIVVME 214
+SD G L V L+D S + + GT G++APE VD F+ G+ + E
Sbjct: 134 GNVRISDLG----LAVELKDGQSKTKGYAGTPGFMAPELLQGEEYDFSVDYFALGVTLYE 189
Query: 215 FLTKRRP 221
+ R P
Sbjct: 190 MIAARGP 196
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK1, also called rhodopsin kinase, belongs to the visual group of GRKs and is expressed in retinal cells. It phosphorylates rhodopsin in rod cells, which leads to termination of the phototransduction cascade. Mutations in GRK1 are associated to a recessively inherited form of stationary nightblindness called Oguchi disease. Length = 280 |
| >gnl|CDD|173645 cd05084, PTKc_Fes, Catalytic domain of the Protein Tyrosine Kinase, Fes | Back alignment and domain information |
|---|
Score = 72.0 bits (176), Expect = 1e-14
Identities = 69/274 (25%), Positives = 121/274 (44%), Gaps = 35/274 (12%)
Query: 20 IGNSNLSTVYKGRLE-DGEIVAVKKLNFHQFSAESDKSFYREAKTLKELKHRNLVKVLGY 78
IG N V+ GRL D VAVK + F +EA+ LK+ H N+V+++G
Sbjct: 3 IGRGNFGEVFSGRLRADNTPVAVKSCR-ETLPPDLKAKFLQEARILKQYSHPNIVRLIGV 61
Query: 79 AWESGKLKALILEYMENGSLESVIHGPGVDHSRWTLPKRIDVLISVANGLDYLHSGYDIP 138
+ + +++E ++ G + + G R + + I ++ + A G++YL S + I
Sbjct: 62 CTQKQPI-YIVMELVQGGDFLTFLRTEG---PRLKVKELIQMVENAAAGMEYLESKHCI- 116
Query: 139 IVHCDMKPSNILLDRDFEAHVSDFGTSRMLDVHLQDLSSLSTAFQGTIGYLAPEFAYMRI 198
H D+ N L+ +SDFG SR + + +S Q + + APE
Sbjct: 117 --HRDLAARNCLVTEKNVLKISDFGMSREEEDGV--YASTGGMKQIPVKWTAPEALNYGR 172
Query: 199 VTTKVDVFSFGIVVMEFLTKRRPTGLDEENGLSPISLRQLVEKALANGINGVRQITDPKL 258
+++ DV+SFGI++ E + G LS R+ +E+ GVR + P+L
Sbjct: 173 YSSESDVWSFGILLWEAFS----LGAVPYANLSNQQTREAIEQ-------GVR-LPCPEL 220
Query: 259 VSSIYEEQEQHQVLEELFKLALVCTSSNPEDRPN 292
+ +++L C +P RP+
Sbjct: 221 CP------------DAVYRLMERCWEYDPGQRPS 242
|
Protein Tyrosine Kinase (PTK) family; Fes (or Fps) kinase subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr kinase activity. Fes kinase is expressed in myeloid, vascular endothelial, epithelial, and neuronal cells. It plays important roles in cell growth and differentiation, angiogenesis, inflammation and immunity, and cytoskeletal regulation. A recent study implicates Fes kinase as a tumor suppressor in colorectal cancer. Length = 252 |
| >gnl|CDD|173747 cd07852, STKc_MAPK15, Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase 15 | Back alignment and domain information |
|---|
Score = 72.2 bits (178), Expect = 2e-14
Identities = 64/201 (31%), Positives = 96/201 (47%), Gaps = 39/201 (19%)
Query: 36 GEIVAVKKLNFHQFSAESD-KSFYREAKTLKELK-HRNLVKVLG-YAWESGKLKALILEY 92
E+VA+KK+ F F +D + +RE L+EL H N+VK+L E+ K L+ EY
Sbjct: 32 KEVVALKKI-FDAFRNATDAQRTFREIMFLQELGDHPNIVKLLNVIKAENDKDIYLVFEY 90
Query: 93 MEN--------GSLESVIHGPGVDHSRWTLPKRIDVLISVANGLDYLHSGYDIPIVHCDM 144
ME LE V H R+ ++ + L Y+HSG ++H D+
Sbjct: 91 METDLHAVIRANILEDV-------HKRY-------IMYQLLKALKYIHSG---NVIHRDL 133
Query: 145 KPSNILLDRDFEAHVSDFGTSRMLDVHLQDLSSLS-TAFQGTIGYLAPEF-----AYMRI 198
KPSNILL+ D ++DFG +R L ++ + T + T Y APE Y
Sbjct: 134 KPSNILLNSDCRVKLADFGLARSLSELEENPENPVLTDYVATRWYRAPEILLGSTRY--- 190
Query: 199 VTTKVDVFSFGIVVMEFLTKR 219
T VD++S G ++ E L +
Sbjct: 191 -TKGVDMWSVGCILGEMLLGK 210
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 15 (MAPK15) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK15 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. Human MAPK15 is also called Extracellular signal Regulated Kinase 8 (ERK8) while the rat protein is called ERK7. ERK7 and ERK8 display both similar and different biochemical properties. They autophosphorylate and activate themselves and do not require upstream activating kinases. ERK7 is constitutively active and is not affected by extracellular stimuli whereas ERK8 shows low basal activity and is activated by DNA-damaging agents. ERK7 and ERK8 also have different substrate profiles. Genome analysis shows that they are orthologs with similar gene structures. ERK7 and ERK 8 may be involved in the signaling of some nuclear receptor transcription factors. ERK7 regulates hormone-dependent degradation of estrogen receptor alpha while ERK8 down-regulates the transcriptional co-activation androgen and glucocorticoid receptors. Length = 337 |
| >gnl|CDD|240233 PTZ00024, PTZ00024, cyclin-dependent protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 72.1 bits (177), Expect = 2e-14
Identities = 62/246 (25%), Positives = 101/246 (41%), Gaps = 42/246 (17%)
Query: 17 NNIIGNSNLSTVYKGR-LEDGEIVAVKKLNFHQFSAESDKSFY------------REAKT 63
+G V K G+IVA+KK+ + S + K RE K
Sbjct: 14 GAHLGEGTYGKVEKAYDTLTGKIVAIKKVKIIEISNDVTKDRQLVGMCGIHFTTLRELKI 73
Query: 64 LKELKHRNLVKVLGYAWESGKLKALILEYMENGSLESVIHGPGVDHSRWTLPKRIDVLIS 123
+ E+KH N++ ++ E + L+++ M L+ V+ R T + +L+
Sbjct: 74 MNEIKHENIMGLVDVYVEGDFIN-LVMDIMA-SDLKKVVD----RKIRLTESQVKCILLQ 127
Query: 124 VANGLDYLHSGYDIPIVHCDMKPSNILLDRDFEAHVSDFGTSR--MLDVHLQDLSSLS-- 179
+ NGL+ LH Y +H D+ P+NI ++ ++DFG +R + LS
Sbjct: 128 ILNGLNVLHKWY---FMHRDLSPANIFINSKGICKIADFGLARRYGYPPYSDTLSKDETM 184
Query: 180 ------TAFQGTIGYLAPEF-----AYMRIVTTKVDVFSFGIVVMEFLT-KRRPTGLDEE 227
T+ T+ Y APE Y VD++S G + E LT K G +E
Sbjct: 185 QRREEMTSKVVTLWYRAPELLMGAEKY----HFAVDMWSVGCIFAELLTGKPLFPGENEI 240
Query: 228 NGLSPI 233
+ L I
Sbjct: 241 DQLGRI 246
|
Length = 335 |
| >gnl|CDD|173734 cd07830, STKc_MAK_like, Catalytic domain of Male germ cell-Associated Kinase-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 71.4 bits (176), Expect = 2e-14
Identities = 57/210 (27%), Positives = 102/210 (48%), Gaps = 30/210 (14%)
Query: 20 IGNSNLSTVYKGR-LEDGEIVAVKKLNFHQFSAESDKSFYREAKTLKELK-HRNLVKVLG 77
+G+ +VY R E GE+VA+KK+ +F + + RE K+L++L H N+VK+
Sbjct: 7 LGDGTFGSVYLARNKETGELVAIKKMK-KKFYSWEECMNLREVKSLRKLNEHPNIVKLKE 65
Query: 78 YAWESGKLKALILEYMENGSLESVIHGPGVDHSRWTLPKRI--DVLISVANGLDYLHS-G 134
E+ +L + EYME G+L ++ D + + ++ + GL ++H G
Sbjct: 66 VFRENDELY-FVFEYME-GNLYQLM----KDRKGKPFSESVIRSIIYQILQGLAHIHKHG 119
Query: 135 YDIPIVHCDMKPSNILLDRDFEAHVSDFGTSRMLDVHLQDLSSLSTAFQGTIGYLAPEF- 193
+ H D+KP N+L+ ++DFG +R ++ T + T Y APE
Sbjct: 120 F----FHRDLKPENLLVSGPEVVKIADFGLAR----EIRSRPPY-TDYVSTRWYRAPEIL 170
Query: 194 ----AYMRIVTTKVDVFSFGIVVMEFLTKR 219
+Y ++ VD+++ G ++ E T R
Sbjct: 171 LRSTSY----SSPVDIWALGCIMAELYTLR 196
|
Serine/Threonine Kinases (STKs), Male germ cell-Associated Kinase (MAK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of human MAK and MAK-related kinase (MRK), Saccharomyces cerevisiae Ime2p, Schizosaccharomyces pombe Mei4-dependent protein 3 (Mde3) and Pit1, Caenorhabditis elegans dyf-5, Arabidopsis thaliana MHK, and similar proteins. These proteins play important roles during meiosis. MAK is highly expressed in testicular cells specifically in the meiotic phase, but is not essential for spermatogenesis and fertility. It functions as a coactivator of the androgen receptor in prostate cells. MRK, also called Intestinal Cell Kinase (ICK), is expressed ubiquitously, with highest expression in the ovary and uterus. A missense mutation in MRK causes endocrine-cerebro-osteodysplasia (ECO), suggesting that this protein plays an important role in the development of many organs. MAK and MRK may be involved in regulating cell cycle and cell fate. Ime2p is a meiosis-specific kinase that is important during meiotic initiation and during the later stages of meiosis. Mde3 functions downstream of the transcription factor Mei-4 which is essential for meiotic prophase I. Length = 283 |
| >gnl|CDD|133214 cd05083, PTKc_Chk, Catalytic domain of the Protein Tyrosine Kinase, Csk homologous kinase | Back alignment and domain information |
|---|
Score = 70.8 bits (173), Expect = 3e-14
Identities = 60/204 (29%), Positives = 103/204 (50%), Gaps = 20/204 (9%)
Query: 19 IIGNSNLSTVYKGRLEDGEIVAVKKLNFHQFSAESDKSFYREAKTLKELKHRNLVKVLGY 78
IIG V +G G+ VAVK + + ++F E + +L H+NLV++LG
Sbjct: 13 IIGEGEFGAVLQGEYT-GQKVAVKNIK----CDVTAQAFLEETAVMTKLHHKNLVRLLGV 67
Query: 79 AWESGKLKALILEYMENGSLESVIHGPGVDHSRWTLPKRIDVLISVANGLDYLHSGYDIP 138
+G +++E M G+L + + G + ++ + + + VA G++YL S
Sbjct: 68 ILHNGLY--IVMELMSKGNLVNFLRTRG--RALVSVIQLLQFSLDVAEGMEYLESK---K 120
Query: 139 IVHCDMKPSNILLDRDFEAHVSDFGTSRMLDVHLQDLSSLSTAFQGTIGYLAPEFAYMRI 198
+VH D+ NIL+ D A VSDFG +R+ + + D S L + + APE +
Sbjct: 121 LVHRDLAARNILVSEDGVAKVSDFGLARVGSMGV-DNSKLP------VKWTAPEALKHKK 173
Query: 199 VTTKVDVFSFGIVVME-FLTKRRP 221
++K DV+S+G+++ E F R P
Sbjct: 174 FSSKSDVWSYGVLLWEVFSYGRAP 197
|
Protein Tyrosine Kinase (PTK) family; Csk homologous kinase (Chk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. Chk is also referred to as megakaryocyte-associated tyrosine kinase (Matk). To inhibit Src kinases, Chk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Chk inhibit Src kinases using a noncatalytic mechanism by simply binding to them. As a negative regulator of Src kinases, Chk may play important roles in cell proliferation, survival, and differentiation, and consequently, in cancer development and progression. Chk is expressed in brain and hematopoietic cells. Studies in mice reveal that Chk is not functionally redundant with Csk and that it plays an important role as a regulator of immune responses. Chk also plays a role in neural differentiation in a manner independent of Src by enhancing Mapk activation via Ras-mediated signaling. Length = 254 |
| >gnl|CDD|173768 cd08228, STKc_Nek6, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 6 | Back alignment and domain information |
|---|
Score = 70.8 bits (173), Expect = 3e-14
Identities = 70/281 (24%), Positives = 124/281 (44%), Gaps = 42/281 (14%)
Query: 20 IGNSNLSTVYKGR-LEDGEIVAVKKLN-FHQFSAESDKSFYREAKTLKELKHRNLVKVLG 77
IG S VY+ L D + VA+KK+ F A++ + +E LK+L H N++K L
Sbjct: 10 IGRGQFSEVYRATCLLDRKPVALKKVQIFEMMDAKARQDCVKEIDLLKQLNHPNVIKYLD 69
Query: 78 YAWESGKLKALILEYMENGSLESVIHGPGVDHSRWTLPKRI--DVLISVANGLDYLHSGY 135
E +L ++LE + G L +I + +P+R + + + ++++HS
Sbjct: 70 SFIEDNELN-IVLELADAGDLSQMIKY--FKKQKRLIPERTVWKYFVQLCSAVEHMHSRR 126
Query: 136 DIPIVHCDMKPSNILLDRDFEAHVSDFGTSRMLDVHLQDLSSLSTAFQGTIG---YLAPE 192
++H D+KP+N+ + + D G R SS +TA +G Y++PE
Sbjct: 127 ---VMHRDIKPANVFITATGVVKLGDLGLGRF-------FSSKTTAAHSLVGTPYYMSPE 176
Query: 193 FAYMRIVTTKVDVFSFGIVVMEFLTKRRPTGLDEENGLSPISLRQLVEKALANGINGVRQ 252
+ K D++S G ++ E + P D+ N S L +K + Q
Sbjct: 177 RIHENGYNFKSDIWSLGCLLYEMAALQSPFYGDKMNLFS------LCQK--------IEQ 222
Query: 253 ITDPKLVSSIYEEQEQHQVLEELFKLALVCTSSNPEDRPNM 293
P L + Y E+ L +L +C +P+ RP++
Sbjct: 223 CDYPPLPTEHYSEK--------LRELVSMCIYPDPDQRPDI 255
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 is required for the transition from metaphase to anaphase. It also plays important roles in mitotic spindle formation and cytokinesis. Activated by Nek9 during mitosis, Nek6 phosphorylates Eg5, a kinesin that is important for spindle bipolarity. Nek6 localizes to spindle microtubules during metaphase and anaphase, and to the midbody during cytokinesis. Length = 267 |
| >gnl|CDD|173772 cd08530, STKc_CNK2-like, Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii CNK2, and similar domains | Back alignment and domain information |
|---|
Score = 70.6 bits (173), Expect = 4e-14
Identities = 68/283 (24%), Positives = 118/283 (41%), Gaps = 44/283 (15%)
Query: 20 IGNSNLSTVYK-GRLEDGEIVAVKKLNFHQFSAESDKSFYREAKTLKELKHRNLVKVLGY 78
+G + +VYK RL D + A+K+++ S + + E + L + H N ++ Y
Sbjct: 8 LGKGSYGSVYKVKRLSDNQFYALKEVDLGSMSQKEREDAVNEIRILASVNHPN---IISY 64
Query: 79 --AWESGKLKALILEYMENGSLESVIHGPGVDHSRWTLPKRI--DVLISVANGLDYLHSG 134
A+ G +++EY G L I R +P++ + I + GL LH
Sbjct: 65 KEAFLDGNKLCIVMEYAPFGDLSKAISKR--KKKRKLIPEQEIWRIFIQLLRGLQALH-- 120
Query: 135 YDIPIVHCDMKPSNILLDRDFEAHVSDFGTSRMLDVHLQDLSSLSTAFQGTIGYLAPEFA 194
+ I+H D+K +NILL + + D G S++L +++ GT Y+APE
Sbjct: 121 -EQKILHRDLKSANILLVANDLVKIGDLGISKVLK------KNMAKTQIGTPHYMAPEVW 173
Query: 195 YMRIVTTKVDVFSFGIVVMEFLTKRRPTGLDEENGLSPISLRQLVEKALANGINGVRQIT 254
R + K D++S G ++ E T P S LR V++ I
Sbjct: 174 KGRPYSYKSDIWSLGCLLYEMATFAPPF-----EARSMQDLRYKVQRGKYPPI------- 221
Query: 255 DPKLVSSIYEEQEQHQVLEELFKLALVCTSSNPEDRPNMNELL 297
IY Q+ + + + P+ RPN +++L
Sbjct: 222 -----PPIY-SQDLQNFIRSMLQ-------VKPKLRPNCDKIL 251
|
Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii Never In Mitosis gene A (NIMA)-related kinase 1 (CNK2)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii CNK2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes CNK1, and -2. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii CNK2 has both cilliary and cell cycle functions. It influences flagellar length through promoting flagellar disassembly, and it regulates cell size, through influencing the size threshold at which cells commit to mitosis. Length = 256 |
| >gnl|CDD|173725 cd06608, STKc_myosinIII_like, Catalytic domain of Class III myosin-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 70.4 bits (173), Expect = 4e-14
Identities = 57/220 (25%), Positives = 92/220 (41%), Gaps = 26/220 (11%)
Query: 9 NATGSFSENNIIGNSNLSTVYKGR-LEDGEIVAVKKLNFHQFSAESDKSFYREAKTLKEL 67
+ TG F +IG VYK R + G++VA+K ++ + ++ E L++
Sbjct: 3 DPTGIFELVEVIGEGTYGKVYKARHKKTGQLVAIKIMDI---IEDEEEEIKEEYNILRKY 59
Query: 68 -KHRNLVKVLGYAWESGKLKA-----LILEYMENGSLESVIHGPGVDHSRWTLPKRIDVL 121
H N+ G + L++E GS+ ++ G + L +
Sbjct: 60 SNHPNIATFYGAFIKKNPPGNDDQLWLVMELCGGGSVTDLVKG--LRKKGKRLKEEWIAY 117
Query: 122 I--SVANGLDYLHSGYDIPIVHCDMKPSNILLDRDFEAHVSDFGTSRMLDVHLQDLSSLS 179
I GL YLH ++H D+K NILL ++ E + DFG S LD L ++
Sbjct: 118 ILRETLRGLAYLHENK---VIHRDIKGQNILLTKNAEVKLVDFGVSAQLDSTLGRRNT-- 172
Query: 180 TAFQGTIGYLAPEF-----AYMRIVTTKVDVFSFGIVVME 214
F GT ++APE + DV+S GI +E
Sbjct: 173 --FIGTPYWMAPEVIACDEQPDASYDARSDVWSLGITAIE 210
|
Serine/threonine kinases (STKs), Class III myosin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins with an N-terminal kinase catalytic domain and a C-terminal actin-binding motor domain. Class III myosins are present in the photoreceptors of invertebrates and vertebrates and in the auditory hair cells of mammals. The kinase domain of myosin III can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, and can autophosphorylate the C-terminal motor domain. Myosin III may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. It may also function as a cargo carrier during light-dependent translocation, in photoreceptor cells, of proteins such as transducin and arrestin. The Drosophila class III myosin, called NinaC (Neither inactivation nor afterpotential protein C), is critical in normal adaptation and termination of photoresponse. Vertebrates contain two isoforms of class III myosin, IIIA and IIIB. This subfamily also includes mammalian NIK-like embryo-specific kinase (NESK), Traf2- and Nck-interacting kinase (TNIK), mitogen-activated protein kinase (MAPK) kinase kinase kinase 4 (MAPKKKK4 or MAP4K4) and MAPKKKK6 (or MAP4K6). MAP4Ks are involved in some MAPK signaling pathways by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Length = 275 |
| >gnl|CDD|133221 cd05090, PTKc_Ror1, Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 1 | Back alignment and domain information |
|---|
Score = 70.4 bits (172), Expect = 5e-14
Identities = 60/240 (25%), Positives = 105/240 (43%), Gaps = 29/240 (12%)
Query: 20 IGNSNLSTVYKGRL-----EDGEIVAVKKLNFHQFSAESDKSFYREAKTLKELKHRNLVK 74
+G +YKG L + ++VA+K L + + F +EA + EL H N+V
Sbjct: 13 LGECAFGKIYKGHLYLPGMDHAQLVAIKTLKDIN-NPQQWGEFQQEASLMAELHHPNIVC 71
Query: 75 VLGYAWESGKLKALILEYMENGSLES--VIHGPGVD-----HSRWTLPKRID------VL 121
+LG + + ++ EY+ G L ++ P D T+ +D +
Sbjct: 72 LLGVVTQEQPV-CMLFEYLNQGDLHEFLIMRSPHSDVGCSSDEDGTVKSSLDHGDFLHIA 130
Query: 122 ISVANGLDYLHSGYDIPIVHCDMKPSNILLDRDFEAHVSDFGTSRMLDVHLQDLSSLSTA 181
I +A G++YL S + VH D+ NIL+ +SD G SR +++ D +
Sbjct: 131 IQIAAGMEYLSSHF---FVHKDLAARNILIGEQLHVKISDLGLSR--EIYSADYYRVQPK 185
Query: 182 FQGTIGYLAPEFAYMRIVTTKVDVFSFGIVVMEFLTKRRPTGLDEENGLSPISLRQLVEK 241
I ++ PE ++ D++SFG+V+ E + GL G S + ++V K
Sbjct: 186 SLLPIRWMPPEAIMYGKFSSDSDIWSFGVVLWEIFS----FGLQPYYGFSNQEVIEMVRK 241
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 1 (Ror1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. Ror kinases are expressed in many tissues during development. Avian Ror1 was found to be involved in late limb development. Studies in mice reveal that Ror1 is important in the regulation of neurite growth in central neurons, as well as in respiratory development. Loss of Ror1 also enhances the heart and skeletal abnormalities found in Ror2-deficient mice. Length = 283 |
| >gnl|CDD|173698 cd05607, STKc_GRK7, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 7 | Back alignment and domain information |
|---|
Score = 70.4 bits (172), Expect = 5e-14
Identities = 56/186 (30%), Positives = 87/186 (46%), Gaps = 10/186 (5%)
Query: 36 GEIVAVKKLNFHQFSAESDKSFYREAKTLKELKHRNLVKVLGYAWESGKLKALILEYMEN 95
G++ A KKL+ + +S + K + E + + L YA+ES L++ M
Sbjct: 18 GKMYACKKLDKKRLKKKSGEKMALLEKEILEKVNSPFIVNLAYAFESKTHLCLVMSLMNG 77
Query: 96 GSLESVIHGPGVDHSRWTLPKRIDVLISVANGLDYLHSGYDIPIVHCDMKPSNILLDRDF 155
G L+ I+ G + + I + G+ +LHS + IV+ DMKP N+LLD
Sbjct: 78 GDLKYHIYNVG--ERGLEMERVIHYSAQITCGILHLHS---MDIVYRDMKPENVLLDDQG 132
Query: 156 EAHVSDFGTSRMLDVHLQDLSSLSTAFQGTIGYLAPEFAYMRIVTTKVDVFSFGIVVMEF 215
+SD G L V L+D ++ T GT GY+APE + VD F+ G + E
Sbjct: 133 NCRLSDLG----LAVELKDGKTI-TQRAGTNGYMAPEILKEEPYSYPVDWFAMGCSIYEM 187
Query: 216 LTKRRP 221
+ R P
Sbjct: 188 VAGRTP 193
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK7 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK7, also called iodopsin kinase, belongs to the visual group of GRKs. It is primarily found in the retina and plays a role in the regulation of opsin light receptors. GRK7 is located in retinal cone outer segments and plays an important role in regulating photoresponse of the cones. Length = 277 |
| >gnl|CDD|133229 cd05098, PTKc_FGFR1, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 1 | Back alignment and domain information |
|---|
Score = 70.4 bits (172), Expect = 6e-14
Identities = 56/193 (29%), Positives = 96/193 (49%), Gaps = 22/193 (11%)
Query: 39 VAVKKLNFHQFSAESDKS-FYREAKTLKEL-KHRNLVKVLGYAWESGKLKALILEYMENG 96
VAVK L + E D S E + +K + KH+N++ +LG + G L +I+EY G
Sbjct: 53 VAVKMLKSD--ATEKDLSDLISEMEMMKMIGKHKNIINLLGACTQDGPL-YVIVEYASKG 109
Query: 97 SLESVIHG---PGVDHS---------RWTLPKRIDVLISVANGLDYLHSGYDIPIVHCDM 144
+L + PG+++ + + + VA G++YL S +H D+
Sbjct: 110 NLREYLRARRPPGMEYCYNPTQVPEEQLSFKDLVSCAYQVARGMEYLASK---KCIHRDL 166
Query: 145 KPSNILLDRDFEAHVSDFGTSRMLDVHLQDLSSLSTAFQGTIGYLAPEFAYMRIVTTKVD 204
N+L+ D ++DFG +R D+H D +T + + ++APE + RI T + D
Sbjct: 167 AARNVLVTEDNVMKIADFGLAR--DIHHIDYYKKTTNGRLPVKWMAPEALFDRIYTHQSD 224
Query: 205 VFSFGIVVMEFLT 217
V+SFG+++ E T
Sbjct: 225 VWSFGVLLWEIFT 237
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 1 (FGFR1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR1 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. Alternative splicing of FGFR1 transcripts produces a variety of isoforms, which are differentially expressed in cells. FGFR1 binds the ligands, FGF1 and FGF2, with high affinity and has also been reported to bind FGF4, FGF6, and FGF9. FGFR1 signaling is critical in the control of cell migration during embryo development. It promotes cell proliferation in fibroblasts. Nuclear FGFR1 plays a role in the regulation of transcription. Mutations, insertions or deletions of FGFR1 have been identified in patients with Kallman's syndrome (KS), an inherited disorder characterized by hypogonadotropic hypogonadism and loss of olfaction. Aberrant FGFR1 expression has been found in some human cancers including 8P11 myeloproliferative syndrome (EMS), breast cancer, and pancreatic adenocarcinoma. Length = 307 |
| >gnl|CDD|133213 cd05082, PTKc_Csk, Catalytic domain of the Protein Tyrosine Kinase, C-terminal Src kinase | Back alignment and domain information |
|---|
Score = 69.6 bits (170), Expect = 6e-14
Identities = 60/197 (30%), Positives = 91/197 (46%), Gaps = 23/197 (11%)
Query: 25 LSTVYKGRLED-------GEIVAVKKLNFHQFSAESDKSFYREAKTLKELKHRNLVKVLG 77
L T+ KG D G VAVK + + +A++ F EA + +L+H NLV++LG
Sbjct: 11 LQTIGKGEFGDVMLGDYRGNKVAVKCIK-NDATAQA---FLAEASVMTQLRHSNLVQLLG 66
Query: 78 YAWESGKLKALILEYMENGSLESVIHGPGVDHSRWTLPKRIDVLISVANGLDYLHSGYDI 137
E ++ EYM GSL + G S + + V ++YL +
Sbjct: 67 VIVEEKGGLYIVTEYMAKGSLVDYLRSRG--RSVLGGDCLLKFSLDVCEAMEYLEAN--- 121
Query: 138 PIVHCDMKPSNILLDRDFEAHVSDFGTSRMLDVHLQDLSSLSTAFQGTIGYLAPEFAYMR 197
VH D+ N+L+ D A VSDFG ++ QD L + + APE +
Sbjct: 122 NFVHRDLAARNVLVSEDNVAKVSDFGLTKEAS-STQDTGKLP------VKWTAPEALREK 174
Query: 198 IVTTKVDVFSFGIVVME 214
+TK DV+SFGI++ E
Sbjct: 175 KFSTKSDVWSFGILLWE 191
|
Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk catalyzes the tyr phosphorylation of the regulatory C-terminal tail of Src kinases, resulting in their inactivation. Csk is expressed in a wide variety of tissues. As a negative regulator of Src, Csk plays a role in cell proliferation, survival, and differentiation, and consequently, in cancer development and progression. In addition, Csk also shows Src-independent functions. It is a critical component in G-protein signaling, and plays a role in cytoskeletal reorganization and cell migration. Length = 256 |
| >gnl|CDD|132988 cd06657, STKc_PAK4, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 4 | Back alignment and domain information |
|---|
Score = 70.1 bits (171), Expect = 7e-14
Identities = 49/186 (26%), Positives = 93/186 (50%), Gaps = 15/186 (8%)
Query: 36 GEIVAVKKLNFHQFSAESDKSFYREAKTLKELKHRNLVKVLGYAWESGKLKALILEYMEN 95
G++VAVKK++ + + + + E +++ +H N+V++ ++ G +++E++E
Sbjct: 45 GKLVAVKKMDLRK--QQRRELLFNEVVIMRDYQHENVVEMYN-SYLVGDELWVVMEFLEG 101
Query: 96 GSLESVIHGPGVDHSRWTLPKRIDVLISVANGLDYLHSGYDIPIVHCDMKPSNILLDRDF 155
G+L + V H+R + V ++V L LH+ ++H D+K +ILL D
Sbjct: 102 GALTDI-----VTHTRMNEEQIAAVCLAVLKALSVLHAQ---GVIHRDIKSDSILLTHDG 153
Query: 156 EAHVSDFGTSRMLDVHLQDLSSLSTAFQGTIGYLAPEFAYMRIVTTKVDVFSFGIVVMEF 215
+SDFG + + SL GT ++APE +VD++S GI+V+E
Sbjct: 154 RVKLSDFGFCAQVSKEVPRRKSLV----GTPYWMAPELISRLPYGPEVDIWSLGIMVIEM 209
Query: 216 LTKRRP 221
+ P
Sbjct: 210 VDGEPP 215
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 4, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK4 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK4 regulates cell morphology and cytoskeletal organization. It is essential for embryonic viability and proper neural development. Mice lacking PAK4 die due to defects in the fetal heart. In addition, their spinal cord motor neurons showed failure to differentiate and migrate. PAK4 also plays a role in cell survival and tumorigenesis. It is overexpressed in many primary tumors including colon, esophageal, and mammary tumors. PAK4 has also been implicated in viral and bacterial infection pathways. Length = 292 |
| >gnl|CDD|132987 cd06656, STKc_PAK3, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 3 | Back alignment and domain information |
|---|
Score = 70.1 bits (171), Expect = 8e-14
Identities = 64/247 (25%), Positives = 114/247 (46%), Gaps = 27/247 (10%)
Query: 20 IGNSNLSTVYKG-RLEDGEIVAVKKLNFHQFSAESDKSFYREAKTLKELKHRNLVKVLGY 78
IG TVY + G+ VA+K++N Q + E ++E K+ N+V L
Sbjct: 27 IGQGASGTVYTAIDIATGQEVAIKQMNLQQ--QPKKELIINEILVMRENKNPNIVNYLD- 83
Query: 79 AWESGKLKALILEYMENGSLESVIHGPGVDHSRWTLPKRIDVLISVANGLDYLHSGYDIP 138
++ G +++EY+ GSL V+ +D + R LD+LHS
Sbjct: 84 SYLVGDELWVVMEYLAGGSLTDVVTETCMDEGQIAAVCR-----ECLQALDFLHSN---Q 135
Query: 139 IVHCDMKPSNILLDRDFEAHVSDFGTSRMLDVHLQDLSSLSTAFQGTIGYLAPEFAYMRI 198
++H D+K NILL D ++DFG + S++ GT ++APE +
Sbjct: 136 VIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSKRSTMV----GTPYWMAPEVVTRKA 191
Query: 199 VTTKVDVFSFGIVVMEFLTKRRPTGLDEENGLSPISLRQLVEKALANGINGVRQITDPKL 258
KVD++S GI+ +E + + P L+E +P+ L+ NG ++ +P+
Sbjct: 192 YGPKVDIWSLGIMAIE-MVEGEPPYLNE----NPLRALYLI------ATNGTPELQNPER 240
Query: 259 VSSIYEE 265
+S+++ +
Sbjct: 241 LSAVFRD 247
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 3, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK3 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). PAK3 is highly expressed in the brain. It is implicated in neuronal plasticity, synapse formation, dendritic spine morphogenesis, cell cycle progression, neuronal migration, and apoptosis. Inactivating mutations in the PAK3 gene cause X-linked non-syndromic mental retardation, the severity of which depends on the site of the mutation. Length = 297 |
| >gnl|CDD|173657 cd05113, PTKc_Btk_Bmx, Catalytic domain of the Protein Tyrosine Kinases, Bruton's tyrosine kinase and Bone marrow kinase on the X chromosome | Back alignment and domain information |
|---|
Score = 69.5 bits (170), Expect = 9e-14
Identities = 65/281 (23%), Positives = 118/281 (41%), Gaps = 39/281 (13%)
Query: 20 IGNSNLSTVYKGRLEDGEIVAVKKLNFHQFSAESDKSFYREAKTLKELKHRNLVKVLGYA 79
+G V G+ VA+K + + + S+ F EAK + +L H LV++ G
Sbjct: 12 LGTGQFGVVKYGKWRGQYDVAIKMI---KEGSMSEDEFIEEAKVMMKLSHEKLVQLYGVC 68
Query: 80 WESGKLKALILEYMENGSLESVIHGPGVDHSRWTLPKRIDVLISVANGLDYLHSGYDIPI 139
+ + ++ EYM NG L + + G R+ + +++ V G+ YL S
Sbjct: 69 TKQRPI-YIVTEYMSNGCLLNYLREHG---KRFQPSQLLEMCKDVCEGMAYLESK---QF 121
Query: 140 VHCDMKPSNILLDRDFEAHVSDFGTSR-MLDVHLQDLSSLSTAFQGTIGYLAPEFAYMRI 198
+H D+ N L+D VSDFG SR +LD + SS+ + F + + PE
Sbjct: 122 IHRDLAARNCLVDDQGCVKVSDFGLSRYVLDD--EYTSSVGSKF--PVRWSPPEVLLYSK 177
Query: 199 VTTKVDVFSFGIVVMEFLTKRRPTGLDEENGLSPISLRQLVEKALANGINGVRQITDPKL 258
++K DV++FG+++ E + L + + ++ ++ P L
Sbjct: 178 FSSKSDVWAFGVLMWEVYS------------LGKMPYERFNNSETVEKVSQGLRLYRPHL 225
Query: 259 VSSIYEEQEQHQVLEELFKLALVCTSSNPEDRPNMNELLIT 299
S E+++ + C E+RP +LL +
Sbjct: 226 AS------------EKVYAIMYSCWHEKAEERPTFQQLLSS 254
|
Protein Tyrosine Kinase (PTK) family; Bruton's tyrosine kinase (Btk) and Bone marrow kinase on the X chromosome (Bmx); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Btk and Bmx (also named Etk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. In addition, Btk contains the Tec homology (TH) domain with proline-rich and zinc-binding regions. Tec kinases are expressed mainly by haematopoietic cells. Btk is expressed in B-cells, and a variety of myeloid cells including mast cells, platelets, neutrophils, and dendrictic cells. It interacts with a variety of partners, from cytosolic proteins to nuclear transcription factors, suggesting a diversity of functions. Stimulation of a diverse array of cell surface receptors, including antigen engagement of the B-cell receptor (BCR), leads to PH-mediated membrane translocation of Btk and subsequent phosphorylation by Src kinase and activation. Btk plays an important role in the life cycle of B-cells including their development, differentiation, proliferation, survival, and apoptosis. Mutations in Btk cause the primary immunodeficiency disease, X-linked agammaglobulinaemia (XLA) in humans. Bmx is primarily expressed in bone marrow and the arterial endothelium, and plays an important role in ischemia-induced angiogenesis. It facilitates arterial growth, capillary formation, vessel maturation, and bone marrow-derived endothelial progenitor cell mobilization. Length = 256 |
| >gnl|CDD|173651 cd05095, PTKc_DDR2, Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 2 | Back alignment and domain information |
|---|
Score = 69.5 bits (170), Expect = 1e-13
Identities = 72/270 (26%), Positives = 120/270 (44%), Gaps = 38/270 (14%)
Query: 38 IVAVKKLNFHQFSAESDKS----FYREAKTLKELKHRNLVKVLGYAWESGKLKALILEYM 93
+VAVK L +++K+ F +E K + LK N++++L S L +I EYM
Sbjct: 48 LVAVKMLR-----EDANKNARNDFLKEIKIMSRLKDPNIIRLLAVCITSDPL-CMITEYM 101
Query: 94 ENGSLESVI-----HGPGVDHSRWTLP--KRIDVLISVANGLDYLHSGYDIPIVHCDMKP 146
ENG L + T+ I + +A+G+ YL S + VH D+
Sbjct: 102 ENGDLNQFLSRHEPQEAAEKADVVTISYSTLIFMATQIASGMKYLSS---LNFVHRDLAT 158
Query: 147 SNILLDRDFEAHVSDFGTSRMLDVHLQDLSSLSTAFQGTIGYLAPEFAYMRIVTTKVDVF 206
N L+ +++ ++DFG SR L + D + I +++ E + TT DV+
Sbjct: 159 RNCLVGKNYTIKIADFGMSRNL--YSGDYYRIQGRAVLPIRWMSWESILLGKFTTASDVW 216
Query: 207 SFGIVVMEFLTKRRPTGLDEENGLSPISLRQLVEKALANGINGVRQITDPKLVSSIYEEQ 266
+FG+ + E LT L +E S +S Q++E + RQ+ PK
Sbjct: 217 AFGVTLWEILT------LCKEQPYSQLSDEQVIENTGEFFRDQGRQVYLPK--------- 261
Query: 267 EQHQVLEELFKLALVCTSSNPEDRPNMNEL 296
+ L+KL L C N ++RP+ E+
Sbjct: 262 -PALCPDSLYKLMLSCWRRNAKERPSFQEI 290
|
Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 2 (DDR2) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR2 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR2 binds mostly to fibrillar collagens. More recently, it has been reported to also bind collagen X. DDR2 is widely expressed in many tissues with the highest levels found in skeletal muscle, skin, kidney and lung. It is important in cell proliferation and development. Mice, with a deletion of DDR2, suffer from dwarfism and delayed healing of epidermal wounds. DDR2 also contributes to collagen (type I) regulation by inhibiting fibrillogenesis and altering the morphology of collagen fibers. It is also expressed in immature dendritic cells (DCs), where it plays a role in DC activation and function. Length = 296 |
| >gnl|CDD|132982 cd06651, STKc_MEKK3, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 3 | Back alignment and domain information |
|---|
Score = 68.9 bits (168), Expect = 1e-13
Identities = 73/269 (27%), Positives = 110/269 (40%), Gaps = 37/269 (13%)
Query: 33 LEDGEIVAVKKLNFHQFSAESDK---SFYREAKTLKELKHRNLVKVLGYAWESG-KLKAL 88
++ G +A K++ F S E+ K + E + LK L+H +V+ G + K +
Sbjct: 24 VDTGRELAAKQVQFDPESPETSKEVSALECEIQLLKNLQHERIVQYYGCLRDRAEKTLTI 83
Query: 89 ILEYMENGSLESVIHGPGVDHSRWTLPKRIDVLISVANGLDYLHSGYDIPIVHCDMKPSN 148
+EYM GS++ + G T +L G+ YLHS IVH D+K +N
Sbjct: 84 FMEYMPGGSVKDQLKAYGALTESVTRKYTRQIL----EGMSYLHSNM---IVHRDIKGAN 136
Query: 149 ILLDRDFEAHVSDFGTSRMLDVHLQDLSSLSTAFQGTIGYLAPEFAYMRIVTTKVDVFSF 208
IL D + DFG S+ L + + + GT +++PE K DV+S
Sbjct: 137 ILRDSAGNVKLGDFGASKRLQTICMSGTGIRSV-TGTPYWMSPEVISGEGYGRKADVWSL 195
Query: 209 GIVVMEFLTKRRPTGLDEENGLSPISLRQLVEKALANGINGVRQITDPKLVSSIYEEQEQ 268
G V+E LT++ P E A+A Q T+P+L S I E
Sbjct: 196 GCTVVEMLTEKPPWAEYE---------------AMAAIFKIATQPTNPQLPSHISEHARD 240
Query: 269 HQVLEELFKLALVCTSSNPEDRPNMNELL 297
L C RP+ ELL
Sbjct: 241 F----------LGCIFVEARHRPSAEELL 259
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK3 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development. In addition, MEKK3 is involved in interleukin-1 receptor and Toll-like receptor 4 signaling. It is also a specific regulator of the proinflammatory cytokines IL-6 and GM-CSF in some immune cells. MEKK3 also regulates calcineurin, which plays a critical role in T cell activation, apoptosis, skeletal myocyte differentiation, and cardiac hypertrophy. Length = 266 |
| >gnl|CDD|133179 cd05048, PTKc_Ror, Catalytic Domain of the Protein Tyrosine Kinases, Receptor tyrosine kinase-like Orphan Receptors | Back alignment and domain information |
|---|
Score = 69.0 bits (169), Expect = 1e-13
Identities = 60/228 (26%), Positives = 99/228 (43%), Gaps = 29/228 (12%)
Query: 6 EIENATGSFSENNIIGNSNLSTVYKGRL------EDGEIVAVKKLNFHQFSAESDKSFYR 59
EI + F E +G VYKG L VA+K L + + F +
Sbjct: 1 EIPLSAVRFLEE--LGEGAFGKVYKGELTGPNERLSATSVAIKTLK-ENAEPKVQQEFRQ 57
Query: 60 EAKTLKELKHRNLVKVLGYAWESGKLKALILEYMENGSLES--VIHGP-----------G 106
EA+ + +L+H N+V +LG + ++ EY+ +G L V + P
Sbjct: 58 EAELMSDLQHPNIVCLLGVCTKEQPT-CMLFEYLAHGDLHEFLVRNSPHSDVGAESGDET 116
Query: 107 VDHSRWTLPKRIDVLISVANGLDYLHSGYDIPIVHCDMKPSNILLDRDFEAHVSDFGTSR 166
V S + + I +A G++YL S + VH D+ N L+ +SDFG SR
Sbjct: 117 VKSSLDC-SDFLHIAIQIAAGMEYLSSHH---FVHRDLAARNCLVGEGLTVKISDFGLSR 172
Query: 167 MLDVHLQDLSSLSTAFQGTIGYLAPEFAYMRIVTTKVDVFSFGIVVME 214
D++ D + + + ++ PE TT+ D++SFG+V+ E
Sbjct: 173 --DIYSADYYRVQSKSLLPVRWMPPEAILYGKFTTESDIWSFGVVLWE 218
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor (Ror) subfamily; catalytic (c) domain. The Ror subfamily consists of Ror1, Ror2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. Ror kinases are expressed in many tissues during development. They play important roles in bone and heart formation. Mutations in human Ror2 result in two different bone development genetic disorders, recessive Robinow syndrome and brachydactyly type B. Drosophila Ror is expressed only in the developing nervous system during neurite outgrowth and neuronal differentiation, suggesting a role for Drosophila Ror in neural development. More recently, mouse Ror1 and Ror2 have also been found to play an important role in regulating neurite growth in central neurons. Ror1 and Ror2 are believed to have some overlapping and redundant functions. Length = 283 |
| >gnl|CDD|173740 cd07842, STKc_CDK8_like, Catalytic domain of Cyclin-Dependent protein Kinase 8-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 69.2 bits (170), Expect = 1e-13
Identities = 61/217 (28%), Positives = 98/217 (45%), Gaps = 44/217 (20%)
Query: 28 VYKGRL---EDGEIVAVKKLNFHQFSAESDKSFY--------REAKTLKELKHRNLVKVL 76
VYK + +DG+ A+KK + DK Y RE L+ELKH N+V ++
Sbjct: 16 VYKAKRKNGKDGKEYAIKKF-------KGDKEQYTGISQSACREIALLRELKHENVVSLV 68
Query: 77 GYAWESGKLKA-LILEYMENGSLESVIHGPGVDHSRWTLPKRIDV--------LISVANG 127
E L+ +Y E+ + +I H + KR+ + L + NG
Sbjct: 69 EVFLEHADKSVYLLFDYAEHDLWQ-IIK----FHRQ---AKRVSIPPSMVKSLLWQILNG 120
Query: 128 LDYLHSGYDIPIVHCDMKPSNILLDRDFEAH----VSDFGTSRMLDVHLQDLSSLSTAFQ 183
+ YLHS + ++H D+KP+NIL+ + + D G +R+ + L+ L+ L
Sbjct: 121 VHYLHSNW---VLHRDLKPANILVMGEGPERGVVKIGDLGLARLFNAPLKPLADLDPVVV 177
Query: 184 GTIGYLAPEFAY-MRIVTTKVDVFSFGIVVMEFLTKR 219
TI Y APE R T +D+++ G + E LT
Sbjct: 178 -TIWYRAPELLLGARHYTKAIDIWAIGCIFAELLTLE 213
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK8, CDC2L6, and similar proteins. CDK8 functions as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the multi-subunit core Mediator complex, a cofactor that is involved in regulating RNA polymerase II (RNAP II)-dependent transcription. CDC2L6 also associates with Mediator in complexes lacking CDK8. In VP16-dependent transcriptional activation, CDK8 and CDC2L6 exerts opposing effects by positive and negative regulation, respectively, in similar conditions. Length = 316 |
| >gnl|CDD|133227 cd05096, PTKc_DDR1, Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 1 | Back alignment and domain information |
|---|
Score = 68.8 bits (168), Expect = 2e-13
Identities = 69/281 (24%), Positives = 117/281 (41%), Gaps = 52/281 (18%)
Query: 38 IVAVKKLNFHQFSAESDKSFYREAKTLKELKHRNLVKVLGYAWESGKLKALILEYMENGS 97
+VAVK L + + F +E K L LK N++++LG + L +I EYMENG
Sbjct: 48 LVAVKILR-PDANKNARNDFLKEVKILSRLKDPNIIRLLGVCVDEDPL-CMITEYMENGD 105
Query: 98 LESVIH--------GPGVDHSRW-------TLPKRIDVLISVANGLDYLHSGYDIPIVHC 142
L + G D + + V + +A+G+ YL S + VH
Sbjct: 106 LNQFLSSHHLDDKEENGNDAVPPAHCLPAISYSSLLHVALQIASGMKYLSS---LNFVHR 162
Query: 143 DMKPSNILLDRDFEAHVSDFGTSRMLDVHLQDLSSLSTAFQGTIGYLAPEFAYMRIVTTK 202
D+ N L+ + ++DFG SR L + D + I ++A E M TT
Sbjct: 163 DLATRNCLVGENLTIKIADFGMSRNL--YAGDYYRIQGRAVLPIRWMAWECILMGKFTTA 220
Query: 203 VDVFSFGIVVMEFLTKRRPTGLDEENGLSPISLRQLVEKALANGINGVRQITDPKLVSSI 262
DV++FG+ + E L L +E ++ Q++E A
Sbjct: 221 SDVWAFGVTLWEILM------LCKEQPYGELTDEQVIENA-----------------GEF 257
Query: 263 YEEQEQHQVL-------EELFKLALVCTSSNPEDRPNMNEL 296
+ +Q + L + L++L L C S + +RP+ +++
Sbjct: 258 FRDQGRQVYLFRPPPCPQGLYELMLQCWSRDCRERPSFSDI 298
|
Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 1 (DDR1) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR1 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR1 binds to all collagens tested to date (types I-IV). It is widely expressed in many tissues. It is abundant in the brain and is also found in keratinocytes, colonic mucosa epithelium, lung epithelium, thyroid follicles, and the islets of Langerhans. During embryonic development, it is found in the developing neuroectoderm. DDR1 is a key regulator of cell morphogenesis, differentiation and proliferation. It is important in the development of the mammary gland, the vasculator and the kidney. DDR1 is also found in human leukocytes, where it facilitates cell adhesion, migration, maturation, and cytokine production. Length = 304 |
| >gnl|CDD|173658 cd05114, PTKc_Tec_Rlk, Catalytic domain of the Protein Tyrosine Kinases, Tyrosine kinase expressed in hepatocellular carcinoma and Resting lymphocyte kinase | Back alignment and domain information |
|---|
Score = 68.0 bits (166), Expect = 3e-13
Identities = 74/283 (26%), Positives = 126/283 (44%), Gaps = 47/283 (16%)
Query: 20 IGNSNLSTVYKGRLEDGEIVAVKKLNFHQFSAESDKSFYREAKTLKELKHRNLVKVLGYA 79
+G+ V+ G+ VA+K +N A S++ F EAK + +L H LV++ G
Sbjct: 12 LGSGQFGVVHLGKWRAQIKVAIKAINE---GAMSEEDFIEEAKVMMKLSHPKLVQLYGVC 68
Query: 80 WESGKLKALILEYMENGSLESVIHGPGVDHSRWTLPKRIDVLIS----VANGLDYLH-SG 134
+ L ++ E+MENG L + + + L K D+L+S V G++YL +
Sbjct: 69 TQQKPL-YIVTEFMENGCLLNYLR-----QRQGKLSK--DMLLSMCQDVCEGMEYLERNS 120
Query: 135 YDIPIVHCDMKPSNILLDRDFEAHVSDFGTSRMLDVHLQDLSSLSTAFQGTIGYLAPEFA 194
+ +H D+ N L+ VSDFG +R + L D + S+ + + + PE
Sbjct: 121 F----IHRDLAARNCLVSSTGVVKVSDFGMTRYV---LDDEYTSSSGAKFPVKWSPPEVF 173
Query: 195 YMRIVTTKVDVFSFGIVVMEFLTKRRPTGLDEENGLSPISLRQLVEKALANGINGVRQIT 254
++K DV+SFG+++ E T+ + + N ++VE ++ G R
Sbjct: 174 NFSKYSSKSDVWSFGVLMWEVFTEGKMPFEKKSN-------YEVVE-MISRGFRLYR--- 222
Query: 255 DPKLVSSIYEEQEQHQVLEELFKLALVCTSSNPEDRPNMNELL 297
PKL S ++++ C PE RP ELL
Sbjct: 223 -PKLASMT------------VYEVMYSCWHEKPEGRPTFAELL 252
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) and Resting lymphocyte kinase (Rlk); catalytic (c) domain. The PTKc family is part of a larger superfamily, that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec and Rlk (also named Txk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. Instead of PH, Rlk contains an N-terminal cysteine-rich region. In addition to PH, Tec also contains the Tec homology (TH) domain with proline-rich and zinc-binding regions. Tec kinases are expressed mainly by haematopoietic cells. Tec is more widely-expressed than other Tec subfamily kinases. It is found in endothelial cells, both B- and T-cells, and a variety of myeloid cells including mast cells, erythroid cells, platelets, macrophages and neutrophils. Rlk is expressed in T-cells and mast cell lines. Tec and Rlk are both key components of T-cell receptor (TCR) signaling. They are important in TCR-stimulated proliferation, IL-2 production and phopholipase C-gamma1 activation. Length = 256 |
| >gnl|CDD|240344 PTZ00283, PTZ00283, serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 69.1 bits (169), Expect = 3e-13
Identities = 83/293 (28%), Positives = 130/293 (44%), Gaps = 50/293 (17%)
Query: 19 IIGNSNLSTV-YKGRLEDGEIVAVKKLNFHQFSAESDKSFYREAKTLKE------LK-HR 70
++G+ TV R+ DGE AVK ++ S E L +K H
Sbjct: 39 VLGSGATGTVLCAKRVSDGEPFAVKVVDMEGMSEADKNRAQAEVCCLLNCDFFSIVKCHE 98
Query: 71 NLVKVLGYAWESGKLKALILEYMENGSLESVIHG------PGVDHSRWTLPKRIDVLISV 124
+ K E+ + AL+L+Y G L I +H L I VL++V
Sbjct: 99 DFAKKDPRNPENVLMIALVLDYANAGDLRQEIKSRAKTNRTFREHEAGLL--FIQVLLAV 156
Query: 125 ANGLDYLHSGYDIPIVHCDMKPSNILLDRDFEAHVSDFGTSRMLDVHLQDLSSLSTAFQG 184
++HS + ++H D+K +NILL + + DFG S+M + D + F G
Sbjct: 157 ----HHVHSKH---MIHRDIKSANILLCSNGLVKLGDFGFSKMYAATVSD--DVGRTFCG 207
Query: 185 TIGYLAPEFAYMRIVTTKVDVFSFGIVVMEFLTKRRPTGLDEENGLSPISLRQLVEKALA 244
T Y+APE + + K D+FS G+++ E LT +RP D EN + +++ K LA
Sbjct: 208 TPYYVAPEIWRRKPYSKKADMFSLGVLLYELLTLKRP--FDGEN------MEEVMHKTLA 259
Query: 245 NGINGVRQITDPKLVSSIYEEQEQHQVLEELFKLALVCTSSNPEDRPNMNELL 297
DP L SI E ++E+ L SS+P+ RP+ ++LL
Sbjct: 260 GRY-------DP-LPPSISPE------MQEIVTALL---SSDPKRRPSSSKLL 295
|
Length = 496 |
| >gnl|CDD|143344 cd07839, STKc_CDK5, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 5 | Back alignment and domain information |
|---|
Score = 68.2 bits (167), Expect = 3e-13
Identities = 58/214 (27%), Positives = 99/214 (46%), Gaps = 34/214 (15%)
Query: 20 IGNSNLSTVYKGR-LEDGEIVAVKKLNFHQFSAESDKSFYREAKTLKELKHRNLVKVLGY 78
IG TV+K + E EIVA+K++ S RE LKELKH+N+V++
Sbjct: 8 IGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLYDV 67
Query: 79 AWESGKLKALILEYME----------NGSLESVIHGPGVDHSRWTLPKRIDVLISVANGL 128
KL L+ EY + NG ++ P + S + + GL
Sbjct: 68 LHSDKKL-TLVFEYCDQDLKKYFDSCNGDID-----PEIVKS---------FMFQLLKGL 112
Query: 129 DYLHSGYDIPIVHCDMKPSNILLDRDFEAHVSDFGTSRMLDVHLQDLSSLSTAFQGTIGY 188
+ HS ++H D+KP N+L++++ E ++DFG +R + ++ S A T+ Y
Sbjct: 113 AFCHSHN---VLHRDLKPQNLLINKNGELKLADFGLARAFGIPVRCYS----AEVVTLWY 165
Query: 189 LAPEFAY-MRIVTTKVDVFSFGIVVMEFLTKRRP 221
P+ + ++ +T +D++S G + E RP
Sbjct: 166 RPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRP 199
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 5 (CDK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK5 is unusual in that it is regulated by non-cyclin proteins, p35 and p39. It is highly expressed in the nervous system and is critical in normal neural development and function. It plays a role in neuronal migration and differentiation, and is also important in synaptic plasticity and learning. CDK5 also participates in protecting against cell death and promoting angiogenesis. Impaired CDK5 activity is implicated in Alzheimer's disease, amyotrophic lateral sclerosis, Parkinson's disease, Huntington's disease and acute neuronal injury. Length = 284 |
| >gnl|CDD|133193 cd05062, PTKc_IGF-1R, Catalytic domain of the Protein Tyrosine Kinase, Insulin-like Growth Factor-1 Receptor | Back alignment and domain information |
|---|
Score = 67.8 bits (165), Expect = 4e-13
Identities = 71/292 (24%), Positives = 125/292 (42%), Gaps = 47/292 (16%)
Query: 20 IGNSNLSTVYKG------RLEDGEIVAVKKLNFHQFSAESDKSFYREAKTLKELKHRNLV 73
+G + VY+G + E VA+K +N S F EA +KE ++V
Sbjct: 14 LGQGSFGMVYEGIAKGVVKDEPETRVAIKTVN-EAASMRERIEFLNEASVMKEFNCHHVV 72
Query: 74 KVLGYAWESGKLKALILEYMENGSLESVIHGPGVD------HSRWTLPKRIDVLISVANG 127
++LG G+ +I+E M G L+S + + + +L K I + +A+G
Sbjct: 73 RLLGVV-SQGQPTLVIMELMTRGDLKSYLRSLRPEMENNPVQAPPSLKKMIQMAGEIADG 131
Query: 128 LDYLHSGYDIPIVHCDMKPSNILLDRDFEAHVSDFGTSRMLDVHLQDLSSLSTAFQGTIG 187
+ YL++ VH D+ N ++ DF + DFG +R D++ D +
Sbjct: 132 MAYLNAN---KFVHRDLAARNCMVAEDFTVKIGDFGMTR--DIYETDYYRKGGKGLLPVR 186
Query: 188 YLAPEFAYMRIVTTKVDVFSFGIVVMEF--LTKRRPTGLDEENGLSPISLRQLVEKALAN 245
+++PE + TT DV+SFG+V+ E L ++ G+ E LR ++E L +
Sbjct: 187 WMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGMSNEQ-----VLRFVMEGGLLD 241
Query: 246 GINGVRQITDPKLVSSIYEEQEQHQVLEELFKLALVCTSSNPEDRPNMNELL 297
+ + LF+L +C NP+ RP+ E++
Sbjct: 242 KPDNCPDM---------------------LFELMRMCWQYNPKMRPSFLEII 272
|
Protein Tyrosine Kinase (PTK) family; Insulin-like Growth Factor-1 Receptor (IGF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. IGF-1R is a receptor tyr kinases (RTK) that is composed of two alphabeta heterodimers. Binding of the ligand (IGF-1 or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, which stimulates downstream kinase activities and biological function. IGF-1R signaling is important in the differentiation, growth, and survival of normal cells. In cancer cells, where it is frequently overexpressed, IGF-1R is implicated in proliferation, the suppression of apoptosis, invasion, and metastasis. IGF-1R is being developed as a therapeutic target in cancer treatment. Length = 277 |
| >gnl|CDD|132940 cd06609, STKc_MST3_like, Catalytic domain of Mammalian Ste20-like protein kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 67.6 bits (166), Expect = 4e-13
Identities = 56/201 (27%), Positives = 87/201 (43%), Gaps = 19/201 (9%)
Query: 20 IGNSNLSTVYKGR-LEDGEIVAVKKLNFHQFSAESDKSFY-REAKTLKELKHRNLVKVLG 77
IG + VYK ++VA+K ++ AE + +E + L + + + K G
Sbjct: 9 IGKGSFGEVYKAIDKRTNQVVAIKVIDLE--EAEDEIEDIQQEIQFLSQCRSPYITKYYG 66
Query: 78 YAWESGKLKALILEYMENGSLESVIHGPGVDHSRWTLPKRIDVLI-SVANGLDYLHSGYD 136
+ KL +I+EY GS ++ PG I ++ V GL+YLH
Sbjct: 67 SFLKGSKL-WIIMEYCGGGSCLDLLK-PGKLDE-----TYIAFILREVLLGLEYLHEEGK 119
Query: 137 IPIVHCDMKPSNILLDRDFEAHVSDFGTSRMLDVHLQDLSSLSTAFQGTIGYLAPEFAYM 196
I H D+K +NILL + + ++DFG S L S F GT ++APE
Sbjct: 120 I---HRDIKAANILLSEEGDVKLADFGVS----GQLTSTMSKRNTFVGTPFWMAPEVIKQ 172
Query: 197 RIVTTKVDVFSFGIVVMEFLT 217
K D++S GI +E
Sbjct: 173 SGYDEKADIWSLGITAIELAK 193
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST3, MST4, STK25, Schizosaccharomyces pombe Nak1 and Sid1, Saccharomyces cerevisiae sporulation-specific protein 1 (SPS1), and related proteins. Nak1 is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Sid1 is a component in the septation initiation network (SIN) signaling pathway, and plays a role in cytokinesis. SPS1 plays a role in regulating proteins required for spore wall formation. MST4 plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. STK25 may play a role in the regulation of cell migration and polarization. Length = 274 |
| >gnl|CDD|173663 cd05572, STKc_cGK_PKG, Catalytic domain of the Protein Serine/Threonine Kinase, cGMP-dependent protein kinase | Back alignment and domain information |
|---|
Score = 67.6 bits (166), Expect = 4e-13
Identities = 63/270 (23%), Positives = 108/270 (40%), Gaps = 57/270 (21%)
Query: 20 IGNSNLSTVYKGRLE-DGEIVAVKKLNFHQFSAES-DKSFYREAKTLKELKHRNLVKVLG 77
+G V +++ A+K + + + E + L+E H +VK+
Sbjct: 1 LGVGGFGRVELVKVKSKNRTFALKCVKKRHIVETGQQEHIFSEKEILEECNHPFIVKLYR 60
Query: 78 YAWESGKLKALILEYMENGSLESVIHGPGV---DHSRWTLPKRIDVLISVANGLDYLHSG 134
+ + L +EY G L +++ G+ +R+ + V +YLH+
Sbjct: 61 TFKDKKYIYML-MEYCLGGELWTILRDRGLFDEYTARF-------YIACVVLAFEYLHN- 111
Query: 135 YDIPIVHCDMKPSNILLDRDFEAHVSDFGTSRMLDVHLQDLSSLSTAFQGTIGYLAPEFA 194
I++ D+KP N+LLD + + DFG ++ L+ T F GT Y+APE
Sbjct: 112 --RGIIYRDLKPENLLLDSNGYVKLVDFGFAK----KLKSGQKTWT-FCGTPEYVAPE-- 162
Query: 195 YMRIVTTK-----VDVFSFGIVVMEFLTKRRPTGLDEEN--------------------- 228
I+ K VD +S GI++ E LT R P G D+E+
Sbjct: 163 ---IILNKGYDFSVDYWSLGILLYELLTGRPPFGEDDEDPMEIYNDILKGNGKLEFPNYI 219
Query: 229 GLSPISL-----RQLVEKALANGINGVRQI 253
+ L R+ E+ L N G++ I
Sbjct: 220 DKAAKDLIKQLLRRNPEERLGNLKGGIKDI 249
|
Serine/Threonine Kinases (STKs), cGMP-dependent protein kinase (cGK or PKG) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mammals have two cGK isoforms from different genes, cGKI and cGKII. cGKI exists as two splice variants, cGKI-alpha and cGKI-beta. cGK consists of an N-terminal regulatory domain containing a dimerization and an autoinhibitory pseudosubstrate region, two cGMP-binding domains, and a C-terminal catalytic domain. Binding of cGMP to both binding sites releases the inhibition of the catalytic center by the pseudosubstrate region, allowing autophosphorylation and activation of the kinase. cGKI is a soluble protein expressed in all smooth muscles, platelets, cerebellum, and kidney. It is also expressed at lower concentrations in other tissues. cGKII is a membrane-bound protein that is most abundantly expressed in the intestine. It is also present in the brain nuclei, adrenal cortex, kidney, lung, and prostate. cGKI is involved in the regulation of smooth muscle tone, smooth cell proliferation, and platelet activation. cGKII plays a role in the regulation of secretion, such as renin secretion by the kidney and aldosterone secretion by the adrenal. It also regulates bone growth and the circadian rhythm. Length = 262 |
| >gnl|CDD|132947 cd06616, PKc_MKK4, Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 4 | Back alignment and domain information |
|---|
Score = 67.8 bits (166), Expect = 4e-13
Identities = 80/303 (26%), Positives = 121/303 (39%), Gaps = 74/303 (24%)
Query: 20 IGNSNLSTVYKGRLED-GEIVAVKKLNFHQFSAESDKSFYREAKTL--------KELKHR 70
IG TV K + G I+AVK++ + D+ +E K L +
Sbjct: 12 IGRGAFGTVNKMLHKPSGTIMAVKRI-----RSTVDE---KEQKRLLMDLDVVMRSSDCP 63
Query: 71 NLVKVLGYAWESGKLKALI-LEYMENGSLES---VIHGPGVDHSRWTLPKRIDVLISVA- 125
+VK G + G I +E M+ SL+ ++ + + +P+ I I+VA
Sbjct: 64 YIVKFYGALFREGD--CWICMELMDI-SLDKFYKYVY----EVLKSVIPEEILGKIAVAT 116
Query: 126 -NGLDYLHSGYDIPIVHCDMKPSNILLDRDFEAHVSDFGTSRMLDVHLQDLSSLSTAFQG 184
L+YL ++ I+H D+KPSNILLDR+ + DFG S L D S T G
Sbjct: 117 VKALNYLKE--ELKIIHRDVKPSNILLDRNGNIKLCDFGISG----QLVD-SIAKTRDAG 169
Query: 185 TIGYLAPEFAYMRIVTT-------KVDVFSFGIVVMEFLTKRRPTGLDEENGLSPISLRQ 237
Y+APE RI + + DV+S GI + E T + P + N + Q
Sbjct: 170 CRPYMAPE----RIDPSARDGYDVRSDVWSLGITLYEVATGKFP--YPKWNSV----FDQ 219
Query: 238 LVEKALANGINGVRQITD---PKLVSSIYEEQEQHQVLEELFKLALVCTSSNPEDRPNMN 294
L Q+ P L +S E+ + +C + RP
Sbjct: 220 L------------TQVVKGDPPILSNS-----EEREFSPSFVNFINLCLIKDESKRPKYK 262
Query: 295 ELL 297
ELL
Sbjct: 263 ELL 265
|
Protein kinases (PKs), MAP kinase kinase 4 (MKK4) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK4 is a dual-specificity PK that phosphorylates and activates the downstream targets, c-Jun N-terminal kinase (JNK) and p38 MAPK, on specific threonine and tyrosine residues. JNK and p38 are collectively known as stress-activated MAPKs, as they are activated in response to a variety of environmental stresses and pro-inflammatory cytokines. Their activation is associated with the induction of cell death. Mice deficient in MKK4 die during embryogenesis and display anemia, severe liver hemorrhage, and abnormal hepatogenesis. MKK4 may also play roles in the immune system and in cardiac hypertrophy. It plays a major role in cancer as a tumor and metastasis suppressor. Under certain conditions, MKK4 is pro-oncogenic. Length = 288 |
| >gnl|CDD|133232 cd05101, PTKc_FGFR2, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 2 | Back alignment and domain information |
|---|
Score = 67.7 bits (165), Expect = 5e-13
Identities = 57/202 (28%), Positives = 101/202 (50%), Gaps = 22/202 (10%)
Query: 30 KGRLEDGEIVAVKKLNFHQFSAESDKS-FYREAKTLKEL-KHRNLVKVLGYAWESGKLKA 87
K + ++ VAVK L + E D S E + +K + KH+N++ +LG + G L
Sbjct: 41 KDKPKEAVTVAVKMLK--DDATEKDLSDLVSEMEMMKMIGKHKNIINLLGACTQDGPL-Y 97
Query: 88 LILEYMENGSLESVIHG---PGVDHS---------RWTLPKRIDVLISVANGLDYLHSGY 135
+I+EY G+L + PG+++S + T + VA G++YL S
Sbjct: 98 VIVEYASKGNLREYLRARRPPGMEYSYDIARVPDEQMTFKDLVSCTYQVARGMEYLASQ- 156
Query: 136 DIPIVHCDMKPSNILLDRDFEAHVSDFGTSRMLDVHLQDLSSLSTAFQGTIGYLAPEFAY 195
+H D+ N+L+ + ++DFG +R DV+ D +T + + ++APE +
Sbjct: 157 --KCIHRDLAARNVLVTENNVMKIADFGLAR--DVNNIDYYKKTTNGRLPVKWMAPEALF 212
Query: 196 MRIVTTKVDVFSFGIVVMEFLT 217
R+ T + DV+SFG+++ E T
Sbjct: 213 DRVYTHQSDVWSFGVLMWEIFT 234
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 2 (FGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR2 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. There are many splice variants of FGFR2 which show differential expression and binding to FGF ligands. Disruption of either FGFR2 or FGFR2b is lethal in mice, due to defects in the placenta or severe impairment of tissue development including lung, limb, and thyroid, respectively. Disruption of FGFR2c in mice results in defective bone and skull development. Genetic alterations of FGFR2 are associated with many human skeletal disorders including Apert syndrome, Crouzon syndrome, Jackson-Weiss syndrome, and Pfeiffer syndrome. Length = 304 |
| >gnl|CDD|133230 cd05099, PTKc_FGFR4, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 4 | Back alignment and domain information |
|---|
Score = 68.1 bits (166), Expect = 5e-13
Identities = 47/162 (29%), Positives = 81/162 (50%), Gaps = 18/162 (11%)
Query: 68 KHRNLVKVLGYAWESGKLKALILEYMENGSLESVIHG---PGVDHS---------RWTLP 115
KH+N++ +LG + G L +I+EY G+L + PG D++ + +
Sbjct: 76 KHKNIINLLGVCTQEGPL-YVIVEYAAKGNLREFLRARRPPGPDYTFDITKVPEEQLSFK 134
Query: 116 KRIDVLISVANGLDYLHSGYDIPIVHCDMKPSNILLDRDFEAHVSDFGTSRMLDVHLQDL 175
+ VA G++YL S I H D+ N+L+ D ++DFG +R VH D
Sbjct: 135 DLVSCAYQVARGMEYLESRRCI---HRDLAARNVLVTEDNVMKIADFGLAR--GVHDIDY 189
Query: 176 SSLSTAFQGTIGYLAPEFAYMRIVTTKVDVFSFGIVVMEFLT 217
++ + + ++APE + R+ T + DV+SFGI++ E T
Sbjct: 190 YKKTSNGRLPVKWMAPEALFDRVYTHQSDVWSFGILMWEIFT 231
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 4 (FGFR4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR4 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. Unlike other FGFRs, there is only one splice form of FGFR4. It binds FGF1, FGF2, FGF6, FGF19, and FGF23. FGF19 is a selective ligand for FGFR4. Although disruption of FGFR4 in mice causes no obvious phenotype, in vivo inhibition of FGFR4 in cultured skeletal muscle cells resulted in an arrest of muscle progenitor differentiation. FGF6 and FGFR4 are uniquely expressed in myofibers and satellite cells. FGF6/FGFR4 signaling appears to play a key role in the regulation of muscle regeneration. A polymorphism in FGFR4 is found in head and neck squamous cell carcinoma. Length = 314 |
| >gnl|CDD|132989 cd06658, STKc_PAK5, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 5 | Back alignment and domain information |
|---|
Score = 67.4 bits (164), Expect = 6e-13
Identities = 52/186 (27%), Positives = 92/186 (49%), Gaps = 15/186 (8%)
Query: 36 GEIVAVKKLNFHQFSAESDKSFYREAKTLKELKHRNLVKVLGYAWESGKLKALILEYMEN 95
G+ VAVKK++ + + + + E +++ H N+V + ++ G +++E++E
Sbjct: 47 GKQVAVKKMDLRK--QQRRELLFNEVVIMRDYHHENVVDMYN-SYLVGDELWVVMEFLEG 103
Query: 96 GSLESVIHGPGVDHSRWTLPKRIDVLISVANGLDYLHSGYDIPIVHCDMKPSNILLDRDF 155
G+L + V H+R + V +SV L YLH+ ++H D+K +ILL D
Sbjct: 104 GALTDI-----VTHTRMNEEQIATVCLSVLRALSYLHNQ---GVIHRDIKSDSILLTSDG 155
Query: 156 EAHVSDFGTSRMLDVHLQDLSSLSTAFQGTIGYLAPEFAYMRIVTTKVDVFSFGIVVMEF 215
+SDFG + + SL GT ++APE T+VD++S GI+V+E
Sbjct: 156 RIKLSDFGFCAQVSKEVPKRKSLV----GTPYWMAPEVISRLPYGTEVDIWSLGIMVIEM 211
Query: 216 LTKRRP 221
+ P
Sbjct: 212 IDGEPP 217
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 5, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK5 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK5 is mainly expressed in the brain. It is not required for viability, but together with PAK6, it is required for normal levels of locomotion and activity, and for learning and memory. PAK5 cooperates with Inca (induced in neural crest by AP2) in the regulation of cell adhesion and cytoskeletal organization in the embryo and in neural crest cells during craniofacial development. PAK5 may also play a role in controlling the signaling of Raf-1, an effector of Ras, at the mitochondria. Length = 292 |
| >gnl|CDD|143382 cd07877, STKc_p38alpha_MAPK14, Catalytic domain of the Serine/Threonine Kinase, p38alpha Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 67.8 bits (165), Expect = 7e-13
Identities = 56/189 (29%), Positives = 92/189 (48%), Gaps = 26/189 (13%)
Query: 39 VAVKKLNFHQFSAESDKSFYREAKTLKELKHRNLVKVLGYAWESGKLKAL----ILEYME 94
VAVKKL+ S K YRE + LK +KH N++ +L + L+ ++ ++
Sbjct: 45 VAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLM 104
Query: 95 NGSLESVIHGPGV--DHSRWTLPKRIDVLISVANGLDYLHSGYDIPIVHCDMKPSNILLD 152
L +++ + DH ++ ++ + GL Y+HS I+H D+KPSN+ ++
Sbjct: 105 GADLNNIVKCQKLTDDHVQF-------LIYQILRGLKYIHSA---DIIHRDLKPSNLAVN 154
Query: 153 RDFEAHVSDFGTSRMLDVHLQDLSSLSTAFQGTIGYLAPEFA--YMRIVTTKVDVFSFGI 210
D E + DFG +R D + T + T Y APE +M T VD++S G
Sbjct: 155 EDCELKILDFGLARHTDDEM-------TGYVATRWYRAPEIMLNWMHYNQT-VDIWSVGC 206
Query: 211 VVMEFLTKR 219
++ E LT R
Sbjct: 207 IMAELLTGR 215
|
Serine/Threonine Kinases (STKs), p38alpha subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38alpha subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38alpha, also called MAPK14, is expressed in most tissues and is the major isoform involved in the immune and inflammatory response. It is the central p38 MAPK involved in myogenesis. It plays a role in regulating cell cycle check-point transition and promoting cell differentiation. p38alpha also regulates cell proliferation and death through crosstalk with the JNK pathway. Its substrates include MAPK activated protein kinase 2 (MK2), MK5, and the transcription factors ATF2 and Mitf. Length = 345 |
| >gnl|CDD|132938 cd06607, STKc_TAO, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids proteins | Back alignment and domain information |
|---|
Score = 67.1 bits (164), Expect = 9e-13
Identities = 78/294 (26%), Positives = 125/294 (42%), Gaps = 67/294 (22%)
Query: 20 IGNSNLSTVYKGR-LEDGEIVAVKKLNFH-QFSAESDKSFYREAKTLKELKHRNLVKVLG 77
IG+ + VY R + E+VA+KK+++ + S E + +E + L++L+H N ++ G
Sbjct: 23 IGHGSFGAVYFARDVRTNEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQQLRHPNTIEYKG 82
Query: 78 ------YAWESGKLKALILEYMENGSLESVIHGPGVDHSRWTLPKRIDVLISVA-NGLDY 130
AW L++EY GS ++ H + I + A GL Y
Sbjct: 83 CYLREHTAW-------LVMEYCL-GSASDILEV----HKKPLQEVEIAAICHGALQGLAY 130
Query: 131 LHSGYDIPIVHCDMKPSNILLDRDFEAHVSDFGTSRMLDVHLQDLSSLSTAFQGTIGYLA 190
LHS I H D+K NILL ++DFG++ ++ + +F GT ++A
Sbjct: 131 LHSHERI---HRDIKAGNILLTEPGTVKLADFGSASLVSP--------ANSFVGTPYWMA 179
Query: 191 PEF-------AYMRIVTTKVDVFSFGIVVMEFLTKRRPTGLDEENGLSPISLRQLVEKAL 243
PE Y KVDV+S GI +E L +R+P L N +S +L + +
Sbjct: 180 PEVILAMDEGQY----DGKVDVWSLGITCIE-LAERKPP-LFNMNAMS--ALYHIAQ--- 228
Query: 244 ANGINGVRQITDPKLVSSIYEEQEQHQVLEELFKLALVCTSSNPEDRPNMNELL 297
D +SS ++ C P+DRP+ ELL
Sbjct: 229 ----------NDSPTLSSNDWSDYFRNFVD-------SCLQKIPQDRPSSEELL 265
|
Serine/threonine kinases (STKs), thousand-and-one amino acids (TAO) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. They activate the MAPKs, p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activating the respective MAP/ERK kinases (MEKs, also known as MKKs or MAPKKs), MEK3/MEK6 and MKK4/MKK7. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Vertebrates contain three TAO subfamily members, named TAO1, TAO2, and TAO3. Length = 307 |
| >gnl|CDD|173738 cd07835, STKc_CDK1_like, Catalytic domain of Cyclin-Dependent protein Kinase 1-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 66.6 bits (163), Expect = 9e-13
Identities = 60/202 (29%), Positives = 94/202 (46%), Gaps = 13/202 (6%)
Query: 20 IGNSNLSTVYKGR-LEDGEIVAVKKLNFHQFSAESDKSFYREAKTLKELKHRNLVKVLGY 78
IG VYK R GEIVA+KK+ + RE LKEL H N+V++L
Sbjct: 7 IGEGTYGVVYKARDKLTGEIVALKKIRLETEDEGVPSTAIREISLLKELNHPNIVRLLDV 66
Query: 79 AWESGKLKALILEYMENGSLESVIHGPGVDHSRWTLPKRIDVLISVANGLDYLHSGYDIP 138
KL L+ E+++ + + P + + L+ G+ Y HS
Sbjct: 67 VHSENKL-YLVFEFLDLDLKKYMDSSPLTGLDPPLIKSYLYQLLQ---GIAYCHSHR--- 119
Query: 139 IVHCDMKPSNILLDRDFEAHVSDFGTSRMLDVHLQDLSSLSTAFQGTIGYLAPEFAY-MR 197
++H D+KP N+L+DR+ ++DFG +R V ++ T T+ Y APE R
Sbjct: 120 VLHRDLKPQNLLIDREGALKLADFGLARAFGVPVRTY----THEVVTLWYRAPEILLGSR 175
Query: 198 IVTTKVDVFSFGIVVMEFLTKR 219
+T VD++S G + E + +R
Sbjct: 176 QYSTPVDIWSIGCIFAEMVNRR 197
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes, plants, and yeasts, as well as CDK2 and CDK3. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyclin A complex controls G2 phase entry and progression while the CDK1/cyclin B complex is critical for G2 to M phase transition. CDK2 is regulated by cyclin E or cyclin A. Upon activation by cyclin E, it phosphorylates the retinoblastoma (pRb) protein which activates E2F mediated transcription and allows cells to move into S phase. The CDK2/cyclin A complex plays a role in regulating DNA replication. Studies in knockout mice revealed that CDK1 can compensate for the loss of the cdk2 gene as it can also bind cyclin E and drive G1 to S phase transition. CDK3 is regulated by cyclin C and it phosphorylates pRB specifically during the G0/G1 transition. This phosphorylation is required for cells to exit G0 efficiently and enter the G1 phase. Length = 283 |
| >gnl|CDD|132985 cd06654, STKc_PAK1, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 1 | Back alignment and domain information |
|---|
Score = 67.1 bits (163), Expect = 1e-12
Identities = 63/247 (25%), Positives = 113/247 (45%), Gaps = 27/247 (10%)
Query: 20 IGNSNLSTVYKGR-LEDGEIVAVKKLNFHQFSAESDKSFYREAKTLKELKHRNLVKVLGY 78
IG TVY + G+ VA++++N Q + E ++E K+ N+V L
Sbjct: 28 IGQGASGTVYTAMDVATGQEVAIRQMNLQQ--QPKKELIINEILVMRENKNPNIVNYLD- 84
Query: 79 AWESGKLKALILEYMENGSLESVIHGPGVDHSRWTLPKRIDVLISVANGLDYLHSGYDIP 138
++ G +++EY+ GSL V+ +D + R L++LHS
Sbjct: 85 SYLVGDELWVVMEYLAGGSLTDVVTETCMDEGQIAAVCR-----ECLQALEFLHSN---Q 136
Query: 139 IVHCDMKPSNILLDRDFEAHVSDFGTSRMLDVHLQDLSSLSTAFQGTIGYLAPEFAYMRI 198
++H D+K NILL D ++DFG + S + GT ++APE +
Sbjct: 137 VIHRDIKSDNILLGMDGSVKLTDFGFC----AQITPEQSKRSTMVGTPYWMAPEVVTRKA 192
Query: 199 VTTKVDVFSFGIVVMEFLTKRRPTGLDEENGLSPISLRQLVEKALANGINGVRQITDPKL 258
KVD++S GI+ +E + + P L+E +P+ L+ NG ++ +P+
Sbjct: 193 YGPKVDIWSLGIMAIEMI-EGEPPYLNE----NPLRALYLI------ATNGTPELQNPEK 241
Query: 259 VSSIYEE 265
+S+I+ +
Sbjct: 242 LSAIFRD 248
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 1, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK1 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). PAK1 is important in the regulation of many cellular processes including cytoskeletal dynamics, cell motility, growth, and proliferation. Although PAK1 has been regarded mainly as a cytosolic protein, recent reports indicate that PAK1 also exists in significant amounts in the nucleus, where it is involved in transcription modulation and in cell cycle regulatory events. PAK1 is also involved in transformation and tumorigenesis. Its overexpression, hyperactivation and increased nuclear accumulation is correlated to breast cancer invasiveness and progression. Nuclear accumulation is also linked to tamoxifen resistance in breast cancer cells. Length = 296 |
| >gnl|CDD|132973 cd06642, STKc_STK25-YSK1, Catalytic domain of the Protein Serine/Threonine Kinase, STK25 or Yeast Sps1/Ste20-related kinase 1 | Back alignment and domain information |
|---|
Score = 66.6 bits (162), Expect = 1e-12
Identities = 76/285 (26%), Positives = 119/285 (41%), Gaps = 40/285 (14%)
Query: 14 FSENNIIGNSNLSTVYKG-RLEDGEIVAVKKLNFHQFSAESDKSFYREAKTLKELKHRNL 72
F++ IG + VYKG E+VA+K ++ + E + +E L + +
Sbjct: 6 FTKLERIGKGSFGEVYKGIDNRTKEVVAIKIIDLEEAEDEIE-DIQQEITVLSQCDSPYI 64
Query: 73 VKVLGYAWESGKLKALILEYMENGSLESVIHGPGVDHSRWTLPKRIDVLISVANGLDYLH 132
+ G + KL +I+EY+ GS ++ PG + +L + GLDYLH
Sbjct: 65 TRYYGSYLKGTKL-WIIMEYLGGGSALDLLK-PGPLEETYI----ATILREILKGLDYLH 118
Query: 133 SGYDIPIVHCDMKPSNILLDRDFEAHVSDFGTSRMLDVHLQDLSSLSTAFQGTIGYLAPE 192
S I H D+K +N+LL + ++DFG + L D F GT ++APE
Sbjct: 119 SERKI---HRDIKAANVLLSEQGDVKLADFGVAG----QLTDTQIKRNTFVGTPFWMAPE 171
Query: 193 FAYMRIVTTKVDVFSFGIVVMEFLTKRRPTGLDEENGLSPISLRQLVEKALANGINGVRQ 252
K D++S GI +E L K P D L P+ + L+ K
Sbjct: 172 VIKQSAYDFKADIWSLGITAIE-LAKGEPPNSD----LHPMRVLFLIPKN---------- 216
Query: 253 ITDPKLVSSIYEEQEQHQVLEELFKLALVCTSSNPEDRPNMNELL 297
+ P L + Q+ + F A C + +P RP ELL
Sbjct: 217 -SPPTL-------EGQYSKPFKEFVEA--CLNKDPRFRPTAKELL 251
|
Serine/threonine kinases (STKs), STK25 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK25 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. STK25 is also called Ste20/oxidant stress response kinase 1 (SOK1) or yeast Sps1/Ste20-related kinase 1 (YSK1). STK25 is localized in the Golgi apparatus through its interaction with the Golgi matrix protein GM130. It may play a role in the regulation of cell migration and polarization. STK25 binds and phosphorylates CCM3 (cerebral cavernous malformation 3), also called PCD10 (programmed cell death 10), and may play a role in apoptosis. Human STK25 is a candidate gene responsible for pseudopseudohypoparathyroidism (PPHP), a disease that shares features with the Albright hereditary osteodystrophy (AHO) phenotype. Length = 277 |
| >gnl|CDD|173761 cd08221, STKc_Nek9, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 9 | Back alignment and domain information |
|---|
Score = 66.3 bits (162), Expect = 1e-12
Identities = 70/275 (25%), Positives = 115/275 (41%), Gaps = 42/275 (15%)
Query: 26 STVYKGRLEDGEIVAVKKLNFHQFSAESDKSFYREAKTLKELKHRNLVKVLGYAWESGKL 85
+T+Y+ R ED +V K++N + S + + E L L+H N++ + + L
Sbjct: 16 ATLYR-RTEDDSLVVWKEVNLTRLSEKERRDALNEIVILSLLQHPNIIAYYNHFMDDNTL 74
Query: 86 KALI-LEYMENGSLESVIHGPGVDHSRWTLPKR--IDVLISVANGLDYLHSGYDIPIVHC 142
LI +EY G+L I V + + L + + + Y+H I+H
Sbjct: 75 --LIEMEYANGGTLYDKI----VRQKGQLFEEEMVLWYLFQIVSAVSYIHK---AGILHR 125
Query: 143 DMKPSNILLDRDFEAHVSDFGTSRMLDVHLQDLSSLSTAFQGTIGYLAPEFAYMRIVTTK 202
D+K NI L + + DFG S++L S++ GT Y++PE K
Sbjct: 126 DIKTLNIFLTKAGLIKLGDFGISKILG----SEYSMAETVVGTPYYMSPELCQGVKYNFK 181
Query: 203 VDVFSFGIVVMEFLTKRRPTGLDEENGLSPISLRQLVEKALANGINGVRQITDPKLVSSI 262
D+++ G V+ E LT +R D N L L I V+ P V S+
Sbjct: 182 SDIWALGCVLYELLTLKRT--FDATNPL-----------NLVVKI--VQGNYTP--VVSV 224
Query: 263 YEEQEQHQVLEELFKLALVCTSSNPEDRPNMNELL 297
Y E ++ L + +PE RP +E+L
Sbjct: 225 Y-SSELISLVHSLLQQ-------DPEKRPTADEVL 251
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 9 (Nek9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek9 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek9, also called Nercc1, is primarily a cytoplasmic protein but can also localize in the nucleus. It is involved in modulating chromosome alignment and splitting during mitosis. It interacts with the gamma-tubulin ring complex and the Ran GTPase, and is implicated in microtubule organization. Nek9 associates with FACT (FAcilitates Chromatin Transcription) and modulates interphase progression. It also interacts with Nek6, and Nek7, during mitosis, resulting in their activation. Length = 256 |
| >gnl|CDD|132942 cd06611, STKc_SLK_like, Catalytic domain of Ste20-like kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 66.3 bits (162), Expect = 1e-12
Identities = 61/216 (28%), Positives = 96/216 (44%), Gaps = 36/216 (16%)
Query: 20 IGNSNLSTVYKGR-LEDGEIVAVKKLNFHQFSAESDKSFYREAKTLKELKHRNLVKVLGY 78
+G+ VYK + E G A K + S E + F E L E KH N+V +
Sbjct: 13 LGDGAFGKVYKAQHKETGLFAAAKIIQIE--SEEELEDFMVEIDILSECKHPNIVGLYEA 70
Query: 79 AWESGKLKALILEYMENGSLESVI----HGPGVDHSRWTLPKRIDVLISVANGLDYLHSG 134
+ KL +++E+ + G+L+S++ G T P+ V + L++LHS
Sbjct: 71 YFYENKL-WILIEFCDGGALDSIMLELERG-------LTEPQIRYVCRQMLEALNFLHSH 122
Query: 135 YDIPIVHCDMKPSNILLDRDFEAHVSDFGTSRMLDVHLQDLSSLSTAFQGTIGYLAPEF- 193
++H D+K NILL D + ++DFG S LQ + F GT ++APE
Sbjct: 123 K---VIHRDLKAGNILLTLDGDVKLADFGVSAKNKSTLQKRDT----FIGTPYWMAPEVV 175
Query: 194 --------AYMRIVTTKVDVFSFGIVVMEFLTKRRP 221
Y K D++S GI ++E L + P
Sbjct: 176 ACETFKDNPY----DYKADIWSLGITLIE-LAQMEP 206
|
Serine/threonine kinases (STKs), Ste20-like kinase (SLK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of the subfamily include SLK, STK10 (also called LOK for lymphocyte-oriented kinase), SmSLK (Schistosoma mansoni SLK), and related proteins. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It also plays a role in mediating actin reorganization. STK10 is responsible in regulating the CD28 responsive element in T cells, as well as leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. SmSLK is capable of activating the MAPK Jun N-terminal kinase (JNK) pathway in human embryonic kidney (HEK) cells as well as in Xenopus oocytes. It may participate in regulating MAPK cascades during host-parasite interactions. Length = 280 |
| >gnl|CDD|173719 cd05630, STKc_GRK6, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 6 | Back alignment and domain information |
|---|
Score = 66.6 bits (162), Expect = 1e-12
Identities = 52/186 (27%), Positives = 84/186 (45%), Gaps = 10/186 (5%)
Query: 36 GEIVAVKKLNFHQFSAESDKSFYREAKTLKELKHRNLVKVLGYAWESGKLKALILEYMEN 95
G++ A KKL + +S K + E + V L YA+E+ L+L M
Sbjct: 25 GKMYACKKLEKKRIKKRKGESMALNEKQILEKVNSRFVVSLAYAYETKDALCLVLTLMNG 84
Query: 96 GSLESVIHGPGVDHSRWTLPKRIDVLISVANGLDYLHSGYDIPIVHCDMKPSNILLDRDF 155
G L+ I+ G + + + + + GL+ LH IV+ D+KP NILLD
Sbjct: 85 GDLKFHIYHMG--EAGFEEGRAVFYAAEICCGLEDLHQER---IVYRDLKPENILLDDHG 139
Query: 156 EAHVSDFGTSRMLDVHLQDLSSLSTAFQGTIGYLAPEFAYMRIVTTKVDVFSFGIVVMEF 215
+SD G L VH+ + ++ GT+GY+APE T D ++ G ++ E
Sbjct: 140 HIRISDLG----LAVHVPEGQTIKGRV-GTVGYMAPEVVKNERYTFSPDWWALGCLLYEM 194
Query: 216 LTKRRP 221
+ + P
Sbjct: 195 IAGQSP 200
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK6 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK6 is widely expressed in many tissues. t is expressed as multiple splice variants with different domain architectures. It is post-translationally palmitoylated and localized in the membrane. GRK6 plays important roles in the regulation of dopamine, M3 muscarinic, opioid, and chemokine receptor signaling. It also plays maladaptive roles in addiction and Parkinson's disease. GRK6-deficient mice exhibit altered dopamine receptor regulation, decreased lymphocyte chemotaxis, and increased acute inflammation and neutrophil chemotaxis. Length = 285 |
| >gnl|CDD|143361 cd07856, STKc_Sty1_Hog1, Catalytic domain of the Serine/Threonine Kinases, Fungal Mitogen-Activated Protein Kinases Sty1 and Hog1 | Back alignment and domain information |
|---|
Score = 66.0 bits (161), Expect = 2e-12
Identities = 55/189 (29%), Positives = 86/189 (45%), Gaps = 31/189 (16%)
Query: 36 GEIVAVKKLNFHQFSAES-DKSFYREAKTLKELKHRNLVKVLGYAWESGKLKALILEYME 94
G+ VA+KK+ FS K YRE K LK L+H N++ L + + +E
Sbjct: 35 GQNVAIKKI-MKPFSTPVLAKRTYRELKLLKHLRHENIIS----------LSDIFISPLE 83
Query: 95 NGSLESVIHGPGVDHSRWTLPKRID------VLISVANGLDYLHSGYDIPIVHCDMKPSN 148
+ V G D R + ++ L + GL Y+HS +VH D+KPSN
Sbjct: 84 DIYF--VTELLGTDLHRLLTSRPLEKQFIQYFLYQILRGLKYVHSA---GVVHRDLKPSN 138
Query: 149 ILLDRDFEAHVSDFGTSRMLDVHLQDLSSLSTAFQGTIGYLAPEFAYM-RIVTTKVDVFS 207
IL++ + + + DFG +R+ D + T + T Y APE + +VD++S
Sbjct: 139 ILINENCDLKICDFGLARIQDPQM-------TGYVSTRYYRAPEIMLTWQKYDVEVDIWS 191
Query: 208 FGIVVMEFL 216
G + E L
Sbjct: 192 AGCIFAEML 200
|
Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) Sty1/Hog1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sty1/Hog1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs Sty1 from Schizosaccharomyces pombe, Hog1 from Saccharomyces cerevisiae, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. Sty1 and Hog1 are stress-activated MAPKs that partipate in transcriptional regulation in response to stress. Sty1 is activated in response to oxidative stress, osmotic stress, and UV radiation. Sty1 is regulated by the MAP2K Wis1, which is activated by the MAP3Ks Wis4 and Win1, which receive signals of the stress condition from membrane-spanning histidine kinases Mak1-3. Activated Sty1 stabilizes the Atf1 transcription factor and induces transcription of Atf1-dependent genes of the core environmetal stress response (CESR). Hog1 is the key element in the high osmolarity glycerol (HOG) pathway and is activated upon hyperosmotic stress. Activated Hog1 accumulates in the nucleus and regulates stress-induced transcription. The HOG pathway is mediated by two transmembrane osmosensors, Sln1 and Sho1. Length = 328 |
| >gnl|CDD|133211 cd05080, PTKc_Tyk2_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2 | Back alignment and domain information |
|---|
Score = 65.7 bits (160), Expect = 2e-12
Identities = 53/184 (28%), Positives = 85/184 (46%), Gaps = 11/184 (5%)
Query: 36 GEIVAVKKLNFHQFSAESDKSFYREAKTLKELKHRNLVKVLGYAWESG-KLKALILEYME 94
GE+VAVK L + ++ + +E LK L H N+VK G E G K LI+EY+
Sbjct: 33 GEMVAVKTLK-RECGQQNTSGWKKEINILKTLYHENIVKYKGCCSEQGGKGLQLIMEYVP 91
Query: 95 NGSLESVIHGPGVDHSRWTLPKRIDVLISVANGLDYLHSGYDIPIVHCDMKPSNILLDRD 154
GSL + ++ ++ L + + G+ YLHS + I H D+ N+LLD D
Sbjct: 92 LGSLRDYLPKHKLNLAQLLLFAQ-----QICEGMAYLHSQHYI---HRDLAARNVLLDND 143
Query: 155 FEAHVSDFGTSRMLDVHLQDLSSLSTAFQGTIGYLAPEFAYMRIVTTKVDVFSFGIVVME 214
+ DFG ++ + + + + + A E + DV+SFG+ + E
Sbjct: 144 RLVKIGDFGLAKAVPEG-HEYYRVREDGDSPVFWYAVECLKENKFSYASDVWSFGVTLYE 202
Query: 215 FLTK 218
LT
Sbjct: 203 LLTH 206
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Tyk2 is widely expressed in many tissues. It is involved in signaling via the cytokine receptors IFN-alphabeta, IL-6, IL-10, IL-12, IL-13, and IL-23. It mediates cell surface urokinase receptor (uPAR) signaling and plays a role in modulating vascular smooth muscle cell (VSMC) functional behavior in response to injury. Tyk2 is also important in dendritic cell function and T helper (Th)1 cell differentiation. A homozygous mutation of Tyk2 was found in a patient with hyper-IgE syndrome (HIES), a primary immunodeficiency characterized by recurrent skin abscesses, pneumonia, and elevated serum IgE. This suggests that Tyk2 may play important roles in multiple cytokine signaling involved in innate and adaptive immunity. Length = 283 |
| >gnl|CDD|132976 cd06645, STKc_MAP4K3, Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 3 | Back alignment and domain information |
|---|
Score = 65.5 bits (159), Expect = 2e-12
Identities = 77/283 (27%), Positives = 119/283 (42%), Gaps = 41/283 (14%)
Query: 20 IGNSNLSTVYKGR-LEDGEIVAVKKLNFHQFSAESDKSFYREAKTLKELKHRNLVKVLGY 78
IG+ VYK R + GE+ A+K + E +E +K+ KH N+V G
Sbjct: 17 IGSGTYGDVYKARNVNTGELAAIKVIKLE--PGEDFAVVQQEIIMMKDCKHSNIVAYFGS 74
Query: 79 AWESGKLKALILEYMENGSLESVIHGPG-VDHSRWTLPKRIDVLISVANGLDYLHSGYDI 137
KL + +E+ GSL+ + H G + S+ R GL YLHS +
Sbjct: 75 YLRRDKL-WICMEFCGGGSLQDIYHVTGPLSESQIAYVSR-----ETLQGLYYLHSKGKM 128
Query: 138 PIVHCDMKPSNILLDRDFEAHVSDFGTSRMLDVHLQDLSSLSTAFQGTIGYLAPEFAYMR 197
H D+K +NILL + ++DFG S + + S F GT ++APE A +
Sbjct: 129 ---HRDIKGANILLTDNGHVKLADFGVSAQITATIAKRKS----FIGTPYWMAPEVAAVE 181
Query: 198 I---VTTKVDVFSFGIVVMEFLTKRRPTGLDEENGLSPISLRQLVEKALANGINGVRQIT 254
D+++ GI +E L + +P D L P+ L+ K+
Sbjct: 182 RKGGYNQLCDIWAVGITAIE-LAELQPPMFD----LHPMRALFLMTKS---------NFQ 227
Query: 255 DPKLVSSIYEEQEQHQVLEELFKLALVCTSSNPEDRPNMNELL 297
PKL + H + K+AL + NP+ RP +LL
Sbjct: 228 PPKLKDKMKWSNSFHHFV----KMAL---TKNPKKRPTAEKLL 263
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K3 plays a role in the nutrient-responsive pathway of mTOR (mammalian target of rapamycin) signaling. MAP4K3 is required in the activation of S6 kinase by amino acids and for the phosphorylation of the mTOR-regulated inhibitor of eukaryotic initiation factor 4E. mTOR regulates ribosome biogenesis and protein translation, and is frequently deregulated in cancer. Length = 267 |
| >gnl|CDD|132978 cd06647, STKc_PAK_I, Catalytic domain of the Protein Serine/Threonine Kinase, Group I p21-activated kinase | Back alignment and domain information |
|---|
Score = 65.3 bits (159), Expect = 3e-12
Identities = 65/247 (26%), Positives = 113/247 (45%), Gaps = 27/247 (10%)
Query: 20 IGNSNLSTVYKG-RLEDGEIVAVKKLNFHQFSAESDKSFYREAKTLKELKHRNLVKVLGY 78
IG TVY + G+ VA+K++N Q + E ++E KH N+V L
Sbjct: 27 IGQGASGTVYTAIDVATGQEVAIKQMNLQQ--QPKKELIINEILVMRENKHPNIVNYLD- 83
Query: 79 AWESGKLKALILEYMENGSLESVIHGPGVDHSRWTLPKRIDVLISVANGLDYLHSGYDIP 138
++ G +++EY+ GSL V+ +D + R L++LHS
Sbjct: 84 SYLVGDELWVVMEYLAGGSLTDVVTETCMDEGQIAAVCR-----ECLQALEFLHSNQ--- 135
Query: 139 IVHCDMKPSNILLDRDFEAHVSDFGTSRMLDVHLQDLSSLSTAFQGTIGYLAPEFAYMRI 198
++H D+K NILL D ++DFG + S + GT ++APE +
Sbjct: 136 VIHRDIKSDNILLGMDGSVKLTDFGFC----AQITPEQSKRSTMVGTPYWMAPEVVTRKA 191
Query: 199 VTTKVDVFSFGIVVMEFLTKRRPTGLDEENGLSPISLRQLVEKALANGINGVRQITDPKL 258
KVD++S GI+ +E + + P L+E +P+ L+ NG ++ +P+
Sbjct: 192 YGPKVDIWSLGIMAIE-MVEGEPPYLNE----NPLRALYLI------ATNGTPELQNPEK 240
Query: 259 VSSIYEE 265
+S+I+ +
Sbjct: 241 LSAIFRD 247
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group I, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group I PAKs, also called conventional PAKs, include PAK1, PAK2, and PAK3. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). They interact with the SH3 domain containing proteins Nck, Grb2 and PIX. Binding of group I PAKs to activated GTPases leads to conformational changes that destabilize the AID, allowing autophosphorylation and full activation of the kinase domain. Known group I PAK substrates include MLCK, Bad, Raf, MEK1, LIMK, Merlin, Vimentin, Myc, Stat5a, and Aurora A, among others. Length = 293 |
| >gnl|CDD|132983 cd06652, STKc_MEKK2, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 2 | Back alignment and domain information |
|---|
Score = 65.1 bits (158), Expect = 3e-12
Identities = 54/192 (28%), Positives = 89/192 (46%), Gaps = 12/192 (6%)
Query: 34 EDGEIVAVKKLNFHQFSAESDK---SFYREAKTLKELKHRNLVKVLGYAWES-GKLKALI 89
+ G +AVK++ F S E+ K + E + LK L H +V+ G + + ++
Sbjct: 25 DTGRELAVKQVQFDPESPETSKEVNALECEIQLLKNLLHERIVQYYGCLRDPMERTLSIF 84
Query: 90 LEYMENGSLESVIHGPGVDHSRWTLPKRIDVLISVANGLDYLHSGYDIPIVHCDMKPSNI 149
+E+M GS++ + G T +L G+ YLHS IVH D+K +NI
Sbjct: 85 MEHMPGGSIKDQLKSYGALTENVTRKYTRQIL----EGVSYLHSNM---IVHRDIKGANI 137
Query: 150 LLDRDFEAHVSDFGTSRMLDVHLQDLSSLSTAFQGTIGYLAPEFAYMRIVTTKVDVFSFG 209
L D + DFG S+ L + + + GT +++PE K D++S G
Sbjct: 138 LRDSVGNVKLGDFGASKRLQTICLSGTGMKSV-TGTPYWMSPEVISGEGYGRKADIWSVG 196
Query: 210 IVVMEFLTKRRP 221
V+E LT++ P
Sbjct: 197 CTVVEMLTEKPP 208
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 2 (MEKK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK2 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK2 also activates ERK1/2, c-Jun N-terminal kinase (JNK) and p38 through their respective MAPKKs MEK1/2, JNK-activating kinase 2 (JNKK2), and MKK3/6. MEKK2 plays roles in T cell receptor signaling, immune synapse formation, cytokine gene expression, as well as in EGF and FGF receptor signaling. Length = 265 |
| >gnl|CDD|177649 PLN00009, PLN00009, cyclin-dependent kinase A; Provisional | Back alignment and domain information |
|---|
Score = 65.2 bits (159), Expect = 3e-12
Identities = 58/204 (28%), Positives = 95/204 (46%), Gaps = 16/204 (7%)
Query: 20 IGNSNLSTVYKGRLE-DGEIVAVKKLNFHQFSAESDKSFYREAKTLKELKHRNLVKVLGY 78
IG VYK R E +A+KK+ Q + RE LKE++H N+V+ L
Sbjct: 10 IGEGTYGVVYKARDRVTNETIALKKIRLEQEDEGVPSTAIREISLLKEMQHGNIVR-LQD 68
Query: 79 AWESGKLKALILEYMENGSLESVIHGPGVDHSRWTLPKRIDV-LISVANGLDYLHSGYDI 137
S K L+ EY++ + + P + P+ I L + G+ Y HS
Sbjct: 69 VVHSEKRLYLVFEYLDLDLKKHMDSSPDFAKN----PRLIKTYLYQILRGIAYCHSHR-- 122
Query: 138 PIVHCDMKPSNILLDRDFEA-HVSDFGTSRMLDVHLQDLSSLSTAFQGTIGYLAPEFAY- 195
++H D+KP N+L+DR A ++DFG +R + ++ + T+ Y APE
Sbjct: 123 -VLHRDLKPQNLLIDRRTNALKLADFGLARAFGIPVRTFTHEVV----TLWYRAPEILLG 177
Query: 196 MRIVTTKVDVFSFGIVVMEFLTKR 219
R +T VD++S G + E + ++
Sbjct: 178 SRHYSTPVDIWSVGCIFAEMVNQK 201
|
Length = 294 |
| >gnl|CDD|173644 cd05079, PTKc_Jak1_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Janus kinase 1 | Back alignment and domain information |
|---|
Score = 65.0 bits (158), Expect = 4e-12
Identities = 66/266 (24%), Positives = 119/266 (44%), Gaps = 25/266 (9%)
Query: 36 GEIVAVKKLNFHQFSAESDKSFYREAKTLKELKHRNLVKVLGYAWESGKLK-ALILEYME 94
GE VAVK L + +E + L+ L H N+VK G E G LI+E++
Sbjct: 33 GEQVAVKSLK-PESGGNHIADLKKEIEILRNLYHENIVKYKGICTEDGGNGIKLIMEFLP 91
Query: 95 NGSLESVIHGPGVDHSRWTLPKRIDVLISVANGLDYLHSGYDIPIVHCDMKPSNILLDRD 154
+GSL+ + + ++ L +++ + + G+DYL S VH D+ N+L++ +
Sbjct: 92 SGSLKEYLPR---NKNKINLKQQLKYAVQICKGMDYLGSR---QYVHRDLAARNVLVESE 145
Query: 155 FEAHVSDFGTSRMLDVHLQDLSSLSTAFQGTIGYLAPEFAYMRIVTTKVDVFSFGIVVME 214
+ + DFG ++ ++ ++ ++ + + APE DV+SFG+ + E
Sbjct: 146 HQVKIGDFGLTKAIETD-KEYYTVKDDLDSPVFWYAPECLIQSKFYIASDVWSFGVTLYE 204
Query: 215 FLTKRRPTGLDEENGLSPISLRQLVEKALANGINGVRQITDPKLVSSIYEEQE---QHQV 271
LT D E+ SP++L + +G Q+T +LV + E +
Sbjct: 205 LLTY-----CDSES--SPMTLFL----KMIGPTHG--QMTVTRLVRVLEEGKRLPRPPNC 251
Query: 272 LEELFKLALVCTSSNPEDRPNMNELL 297
EE+++L C P R L+
Sbjct: 252 PEEVYQLMRKCWEFQPSKRTTFQNLI 277
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak1 is widely expressed in many tissues. Many cytokines are dependent on Jak1 for signaling, including those that use the shared receptor subunits common gamma chain (IL-2, IL-4, IL-7, IL-9, IL-15, IL-21) and gp130 (IL-6, IL-11, oncostatin M, G-CSF, and IFNs, among others). The many varied interactions of Jak1 and its ubiquitous expression suggest many biological roles. Jak1 is important in neurological development, as well as in lymphoid development and function. It also plays a role in the pathophysiology of cardiac hypertrophy and heart failure. A mutation in the ATP-binding site of Jak1 was identified in a human uterine leiomyosarcoma cell line, resulting in defective cytokine induction and antigen presentation, thus allowing the tumor to evade the immune system. Length = 284 |
| >gnl|CDD|132972 cd06641, STKc_MST3, Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 3 | Back alignment and domain information |
|---|
Score = 64.7 bits (157), Expect = 5e-12
Identities = 71/285 (24%), Positives = 118/285 (41%), Gaps = 40/285 (14%)
Query: 14 FSENNIIGNSNLSTVYKG-RLEDGEIVAVKKLNFHQFSAESDKSFYREAKTLKELKHRNL 72
F++ IG + V+KG ++VA+K ++ + E + +E L + +
Sbjct: 6 FTKLEKIGKGSFGEVFKGIDNRTQKVVAIKIIDLEEAEDEIE-DIQQEITVLSQCDSPYV 64
Query: 73 VKVLGYAWESGKLKALILEYMENGSLESVIHGPGVDHSRWTLPKRIDVLISVANGLDYLH 132
K G + KL +I+EY+ GS ++ +D ++ +L + GLDYLH
Sbjct: 65 TKYYGSYLKDTKL-WIIMEYLGGGSALDLLEPGPLDETQIA-----TILREILKGLDYLH 118
Query: 133 SGYDIPIVHCDMKPSNILLDRDFEAHVSDFGTSRMLDVHLQDLSSLSTAFQGTIGYLAPE 192
S I H D+K +N+LL E ++DFG + L D F GT ++APE
Sbjct: 119 SEKKI---HRDIKAANVLLSEHGEVKLADFGVAG----QLTDTQIKRNTFVGTPFWMAPE 171
Query: 193 FAYMRIVTTKVDVFSFGIVVMEFLTKRRPTGLDEENGLSPISLRQLVEKALANGINGVRQ 252
+K D++S GI +E P + L P+ + L+ K
Sbjct: 172 VIKQSAYDSKADIWSLGITAIELAKGEPP-----HSELHPMKVLFLIPK----------- 215
Query: 253 ITDPKLVSSIYEEQEQHQVLEELFKLALVCTSSNPEDRPNMNELL 297
+P + Y + L+E + C + P RP ELL
Sbjct: 216 -NNPPTLEGNYSKP-----LKEFVE---ACLNKEPSFRPTAKELL 251
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. It may also regulate paxillin and consequently, cell migration. MST3 is present in human placenta, where it plays an essential role in the oxidative stress-induced apoptosis of trophoblasts in normal spontaneous delivery. Dysregulation of trophoblast apoptosis may result in pregnancy complications such as preeclampsia and intrauterine growth retardation. Length = 277 |
| >gnl|CDD|132986 cd06655, STKc_PAK2, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 2 | Back alignment and domain information |
|---|
Score = 64.7 bits (157), Expect = 5e-12
Identities = 58/230 (25%), Positives = 109/230 (47%), Gaps = 26/230 (11%)
Query: 36 GEIVAVKKLNFHQFSAESDKSFYREAKTLKELKHRNLVKVLGYAWESGKLKALILEYMEN 95
G+ VA+K++N + + E +KELK+ N+V L ++ G +++EY+
Sbjct: 44 GQEVAIKQINLQK--QPKKELIINEILVMKELKNPNIVNFLD-SFLVGDELFVVMEYLAG 100
Query: 96 GSLESVIHGPGVDHSRWTLPKRIDVLISVANGLDYLHSGYDIPIVHCDMKPSNILLDRDF 155
GSL V+ +D ++ R L++LH+ ++H D+K N+LL D
Sbjct: 101 GSLTDVVTETCMDEAQIAAVCR-----ECLQALEFLHAN---QVIHRDIKSDNVLLGMDG 152
Query: 156 EAHVSDFGTSRMLDVHLQDLSSLSTAFQGTIGYLAPEFAYMRIVTTKVDVFSFGIVVMEF 215
++DFG + S++ GT ++APE + KVD++S GI+ +E
Sbjct: 153 SVKLTDFGFCAQITPEQSKRSTMV----GTPYWMAPEVVTRKAYGPKVDIWSLGIMAIE- 207
Query: 216 LTKRRPTGLDEENGLSPISLRQLVEKALANGINGVRQITDPKLVSSIYEE 265
+ + P L+E +P+ L+ NG ++ +P+ +S I+ +
Sbjct: 208 MVEGEPPYLNE----NPLRALYLI------ATNGTPELQNPEKLSPIFRD 247
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 2, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK2 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). PAK2 plays a role in pro-apoptotic signaling. It is cleaved and activated by caspases leading to morphological changes during apoptosis. PAK2 is also activated in response to a variety of stresses including DNA damage, hyperosmolarity, serum starvation, and contact inhibition, and may play a role in coordinating the stress response. PAK2 also contributes to cancer cell invasion through a mechanism distinct from that of PAK1. Length = 296 |
| >gnl|CDD|132971 cd06640, STKc_MST4, Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 4 | Back alignment and domain information |
|---|
Score = 64.3 bits (156), Expect = 6e-12
Identities = 63/216 (29%), Positives = 99/216 (45%), Gaps = 22/216 (10%)
Query: 14 FSENNIIGNSNLSTVYKG---RLEDGEIVAVKKLNFHQFSAESDKSFYREAKTLKELKHR 70
F++ IG + V+KG R + ++VA+K ++ + E + +E L +
Sbjct: 6 FTKLERIGKGSFGEVFKGIDNRTQ--QVVAIKIIDLEEAEDEIE-DIQQEITVLSQCDSP 62
Query: 71 NLVKVLGYAWESGKLKALILEYMENGS-LESVIHGPGVDHSRWTLPKRIDVLISVANGLD 129
+ K G + KL +I+EY+ GS L+ + GP + T+ K I GLD
Sbjct: 63 YVTKYYGSYLKGTKL-WIIMEYLGGGSALDLLRAGPFDEFQIATMLKEI------LKGLD 115
Query: 130 YLHSGYDIPIVHCDMKPSNILLDRDFEAHVSDFGTSRMLDVHLQDLSSLSTAFQGTIGYL 189
YLHS I H D+K +N+LL + ++DFG + L D F GT ++
Sbjct: 116 YLHSEKKI---HRDIKAANVLLSEQGDVKLADFGVAG----QLTDTQIKRNTFVGTPFWM 168
Query: 190 APEFAYMRIVTTKVDVFSFGIVVMEFLTKRRPTGLD 225
APE +K D++S GI +E L K P D
Sbjct: 169 APEVIQQSAYDSKADIWSLGITAIE-LAKGEPPNSD 203
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 4 (MST4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST4 is sometimes referred to as MASK (MST3 and SOK1-related kinase). It plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. It influences cell growth and transformation by modulating the extracellular signal-regulated kinase (ERK) pathway. MST4 may also play a role in tumor formation and progression. It localizes in the Golgi apparatus by interacting with the Golgi matrix protein GM130 and may play a role in cell migration. Length = 277 |
| >gnl|CDD|173753 cd07864, STKc_CDK12, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 12 | Back alignment and domain information |
|---|
Score = 64.4 bits (157), Expect = 8e-12
Identities = 65/221 (29%), Positives = 104/221 (47%), Gaps = 37/221 (16%)
Query: 18 NIIGNSNLSTVYKGRLED-GEIVAVKKLNFHQFSAESDKSFY-----REAKTLKELKHRN 71
IG VYK R +D GE+VA+KK+ +++K + RE K L++L HRN
Sbjct: 13 GQIGEGTYGQVYKARDKDTGELVALKKVRL-----DNEKEGFPITAIREIKILRQLNHRN 67
Query: 72 LVKVLGY------AWESGKLKA---LILEYMEN---GSLESVIHGPGVDHSRWTLPKRID 119
+V + A + K K L+ EYM++ G LES + DH + + + ++
Sbjct: 68 IVNLKEIVTDKQDALDFKKDKGAFYLVFEYMDHDLMGLLESGLVHFSEDHIKSFMKQLLE 127
Query: 120 VLISVANGLDYLHSGYDIPIVHCDMKPSNILLDRDFEAHVSDFGTSRMLDVHLQDLSSLS 179
GL+Y H +H D+K SNILL+ + ++DFG +R+ + + S
Sbjct: 128 -------GLNYCH---KKNFLHRDIKCSNILLNNKGQIKLADFGLARLYN---SEESRPY 174
Query: 180 TAFQGTIGYLAPEFAY-MRIVTTKVDVFSFGIVVMEFLTKR 219
T T+ Y PE +DV+S G ++ E TK+
Sbjct: 175 TNKVITLWYRPPELLLGEERYGPAIDVWSCGCILGELFTKK 215
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 12 (CDK12) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK12 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK12 is also called Cdc2-related protein kinase 7 (CRK7) or Cdc2-related kinase arginine/serine-rich (CrkRS). It is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 is widely expressed in tissues. It interacts with cyclins L1 and L2, and plays roles in regulating transcription and alternative splicing. Length = 302 |
| >gnl|CDD|173754 cd07865, STKc_CDK9, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 9 | Back alignment and domain information |
|---|
Score = 64.3 bits (157), Expect = 8e-12
Identities = 64/228 (28%), Positives = 104/228 (45%), Gaps = 19/228 (8%)
Query: 18 NIIGNSNLSTVYKGR-LEDGEIVAVKKLNFHQFSAESDKSFYREAKTLKELKHRNLVKVL 76
IG V+K R + +IVA+KK+ + RE K L+ LKH N+V ++
Sbjct: 18 AKIGQGTFGEVFKARHKKTKQIVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLI 77
Query: 77 ----GYAWESGKLKA---LILEYMENGSLESVIHGPGVDHSRWTLPKRIDVLISVANGLD 129
A + K L+ E+ E+ L ++ V ++TL + V+ + NGL
Sbjct: 78 EICRTKATPYNRYKGSFYLVFEFCEH-DLAGLLSNKNV---KFTLSEIKKVMKMLLNGLY 133
Query: 130 YLHSGYDIPIVHCDMKPSNILLDRDFEAHVSDFGTSRMLDVHLQDLSSLSTAFQGTIGYL 189
Y+H I+H DMK +NIL+ +D ++DFG +R + + T T+ Y
Sbjct: 134 YIHRN---KILHRDMKAANILITKDGILKLADFGLARAFSLSKNSKPNRYTNRVVTLWYR 190
Query: 190 APEFAY-MRIVTTKVDVFSFGIVVMEFLTKRRP--TGLDEENGLSPIS 234
PE R +D++ G ++ E T R P G E++ L+ IS
Sbjct: 191 PPELLLGERDYGPPIDMWGAGCIMAEMWT-RSPIMQGNTEQHQLTLIS 237
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK9 together with a cyclin partner (cyclin T1, T2a, T2b, or K) is the main component of distinct positive transcription elongation factors (P-TEFb), which function as Ser2 C-terminal domain kinases of RNA polymerase II. P-TEFb participates in multiple steps of gene expression including transcription elongation, mRNA synthesis, processing, export, and translation. It also plays a role in mediating cytokine induced transcription networks such as IL6-induced STAT3 signaling. In addition, the CDK9/cyclin T2a complex promotes muscle differentiation and enhances the function of some myogenic regulatory factors. Length = 310 |
| >gnl|CDD|173756 cd08216, PK_STRAD, Pseudokinase domain of STE20-related kinase adapter protein | Back alignment and domain information |
|---|
Score = 63.9 bits (156), Expect = 1e-11
Identities = 72/316 (22%), Positives = 120/316 (37%), Gaps = 70/316 (22%)
Query: 21 GNSNLSTVYKGRLED-GEIVAVKKLNFHQFSAESDKSFYREAKTLKELKHRNLVKVLGYA 79
+L V+ + + +VAVKK+N S E K +E T ++L+H N++ +
Sbjct: 9 CFEDLMIVHLAKHKPTNTLVAVKKINLDSCSKEDLKLLQQEIITSRQLQHPNILPYVTSF 68
Query: 80 WESGKLKALILEYMENGSLESVIHGPGVDHSRWTLPKRIDVLI--SVANGLDYLHS-GYD 136
+L ++ M GS E ++ H LP+ I V N LDY+HS G+
Sbjct: 69 IVDSEL-YVVSPLMAYGSCEDLLK----THFPEGLPELAIAFILKDVLNALDYIHSKGF- 122
Query: 137 IPIVHCDMKPSNILLDRDFEAHVSDFGTSRMLDVHLQ-----DLSSLSTAFQGTIGYLAP 191
+H +K S+ILL D + +S S + H + S+ + +L+P
Sbjct: 123 ---IHRSVKASHILLSGDGKVVLSGLRYSVSMIKHGKRQRVVHDFPKSSVKN--LPWLSP 177
Query: 192 EFAY--MRIVTTKVDVFSFGIVVMEFLTKRRPTGLDEENGLSPISLRQ----LVEKALAN 245
E ++ K D++S GI E NG P L+EK
Sbjct: 178 EVLQQNLQGYNEKSDIYSVGITACEL-----------ANGHVPFKDMPATQMLLEK---- 222
Query: 246 GINGVRQITDPKLV--SSIYEEQ----------------EQHQVL------EELFKLALV 281
+ G T P L+ S+ + + E + +
Sbjct: 223 -VRG----TVPCLLDKSTYPLYEDSMSQSRSSNEHPNNRDSVDHPYTRTFSEHFHQFVEL 277
Query: 282 CTSSNPEDRPNMNELL 297
C +PE RP+ ++LL
Sbjct: 278 CLQRDPESRPSASQLL 293
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) subfamily, pseudokinase domain. The STRAD subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpigmentation of the buccal mucosa. There are two forms of STRAD, alpha and beta, that complex with LKB1 and MO25. The structure of STRAD-alpha is available and shows that this protein binds ATP, has an ordered activation loop, and adopts a closed conformation typical of fully active protein kinases. It does not possess activity due to nonconservative substitutions of essential catalytic residues. ATP binding enhances the affinity of STRAD for MO25. The conformation of STRAD-alpha stabilized through ATP and MO25 may be needed to activate LKB1. Length = 314 |
| >gnl|CDD|173752 cd07861, STKc_CDK1_euk, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 1 from higher eukaryotes-like | Back alignment and domain information |
|---|
Score = 64.0 bits (156), Expect = 1e-11
Identities = 61/206 (29%), Positives = 97/206 (47%), Gaps = 20/206 (9%)
Query: 20 IGNSNLSTVYKGR-LEDGEIVAVKKLNFHQFSAESDKSFYREAKTLKELKHRNLVKVLGY 78
IG VYKGR + G+IVA+KK+ + RE LKEL+H N+V +
Sbjct: 8 IGEGTYGVVYKGRNKKTGQIVAMKKIRLESEEEGVPSTAIREISLLKELQHPNIVCLQDV 67
Query: 79 AWESGKLKALILEYME---NGSLESVIHGPGVDHSRWTLPKRIDVLISVANGLDYLHSGY 135
+ +L LI E++ L+S+ P + L K L + G+ + HS
Sbjct: 68 LMQESRL-YLIFEFLSMDLKKYLDSL---PKGQYMDAELVK--SYLYQILQGILFCHSRR 121
Query: 136 DIPIVHCDMKPSNILLDRDFEAHVSDFGTSRMLDVHLQDLSSLSTAFQGTIGYLAPE--F 193
++H D+KP N+L+D ++DFG +R + ++ + T T+ Y APE
Sbjct: 122 ---VLHRDLKPQNLLIDNKGVIKLADFGLARAFGIPVR----VYTHEVVTLWYRAPEVLL 174
Query: 194 AYMRIVTTKVDVFSFGIVVMEFLTKR 219
R +T VD++S G + E TK+
Sbjct: 175 GSPR-YSTPVDIWSIGTIFAEMATKK 199
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyclin A complex controls G2 phase entry and progression. CDK1/cyclin A2 has also been implicated as an important regulator of S phase events. The CDK1/cyclin B complex is critical for G2 to M phase transition. It induces mitosis by activating nuclear enzymes that regulate chromatin condensation, nuclear membrane degradation, mitosis-specific microtubule and cytoskeletal reorganization. CDK1 also associates with cyclin E and plays a role in the entry into S phase. CDK1 transcription is stable throughout the cell cycle but is modulated in some pathological conditions. It may play a role in regulating apoptosis under these conditions. In breast cancer cells, HER2 can mediate apoptosis by inactivating CDK1. Activation of CDK1 may contribute to HIV-1 induced apoptosis and neuronal apoptosis in neurodegenerative diseases. Length = 285 |
| >gnl|CDD|132990 cd06659, STKc_PAK6, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 6 | Back alignment and domain information |
|---|
Score = 63.5 bits (154), Expect = 1e-11
Identities = 50/186 (26%), Positives = 92/186 (49%), Gaps = 15/186 (8%)
Query: 36 GEIVAVKKLNFHQFSAESDKSFYREAKTLKELKHRNLVKVLGYAWESGKLKALILEYMEN 95
G VAVK ++ + + + + E +++ +H+N+V++ ++ G+ +++E+++
Sbjct: 46 GRQVAVKMMDLRK--QQRRELLFNEVVIMRDYQHQNVVEMYK-SYLVGEELWVLMEFLQG 102
Query: 96 GSLESVIHGPGVDHSRWTLPKRIDVLISVANGLDYLHSGYDIPIVHCDMKPSNILLDRDF 155
G+L + V +R + V SV L YLHS ++H D+K +ILL D
Sbjct: 103 GALTDI-----VSQTRLNEEQIATVCESVLQALCYLHSQ---GVIHRDIKSDSILLTLDG 154
Query: 156 EAHVSDFGTSRMLDVHLQDLSSLSTAFQGTIGYLAPEFAYMRIVTTKVDVFSFGIVVMEF 215
+SDFG + + SL GT ++APE T+VD++S GI+V+E
Sbjct: 155 RVKLSDFGFCAQISKDVPKRKSLV----GTPYWMAPEVISRTPYGTEVDIWSLGIMVIEM 210
Query: 216 LTKRRP 221
+ P
Sbjct: 211 VDGEPP 216
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 6, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK6 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK6 may play a role in stress responses through its activation by the mitogen-activated protein kinase (MAPK) p38 and MAPK kinase 6 (MKK6) pathway. PAK6 is highly expressed in the brain. It is not required for viability, but together with PAK5, it is required for normal levels of locomotion and activity, and for learning and memory. Increased expression of PAK6 is found in primary and metastatic prostate cancer. PAK6 may play a role in the regulation of motility. Length = 297 |
| >gnl|CDD|132966 cd06635, STKc_TAO1, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 1 | Back alignment and domain information |
|---|
Score = 63.6 bits (154), Expect = 1e-11
Identities = 81/296 (27%), Positives = 132/296 (44%), Gaps = 59/296 (19%)
Query: 14 FSENNIIGNSNLSTVYKGR-LEDGEIVAVKKLNFH-QFSAESDKSFYREAKTLKELKHRN 71
F++ IG+ + VY R + E+VA+KK+++ + S E + +E K L+ +KH N
Sbjct: 27 FTDLREIGHGSFGAVYFARDVRTNEVVAIKKMSYSGKQSNEKWQDIIKEVKFLQRIKHPN 86
Query: 72 LVKVLG------YAWESGKLKALILEYMENGSLESVIHGPGVDHSRWTLPKRIDVLISVA 125
++ G AW L++EY GS ++ H + I + A
Sbjct: 87 SIEYKGCYLREHTAW-------LVMEYCL-GSASDLLEV----HKKPLQEVEIAAITHGA 134
Query: 126 -NGLDYLHSGYDIPIVHCDMKPSNILLDRDFEAHVSDFGTSRMLDVHLQDLSSLSTAFQG 184
GL YLHS ++H D+K NILL + ++DFG++ + +S + +F G
Sbjct: 135 LQGLAYLHSH---NMIHRDIKAGNILLTEPGQVKLADFGSASI--------ASPANSFVG 183
Query: 185 TIGYLAPEFAYMR---IVTTKVDVFSFGIVVMEFLTKRRPTGLDEENGLSPISLRQLVEK 241
T ++APE KVDV+S GI +E L +R+P L N +S
Sbjct: 184 TPYWMAPEVILAMDEGQYDGKVDVWSLGITCIE-LAERKPP-LFNMNAMS---------- 231
Query: 242 ALANGINGVRQITDPKLVSSIYEEQEQHQVLEELFKLALVCTSSNPEDRPNMNELL 297
+ + Q P L S+ + + ++ V L K+ P+DRP ELL
Sbjct: 232 ----ALYHIAQNESPTLQSNEWSDYFRNFVDSCLQKI--------PQDRPTSEELL 275
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 1 (TAO1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO1 is sometimes referred to as prostate-derived sterile 20-like kinase 2 (PSK2). TAO1 activates the p38 MAPK through direct interaction with and activation of MEK3. TAO1 is highly expressed in the brain and may play a role in neuronal apoptosis. TAO1 interacts with the checkpoint proteins BubR1 and Mad2, and plays an important role in regulating mitotic progression, which is required for both chromosome congression and checkpoint-induced anaphase delay. TAO1 may play a role in protecting genomic stability. Length = 317 |
| >gnl|CDD|132977 cd06646, STKc_MAP4K5, Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 5 | Back alignment and domain information |
|---|
Score = 62.7 bits (152), Expect = 2e-11
Identities = 78/289 (26%), Positives = 119/289 (41%), Gaps = 53/289 (18%)
Query: 20 IGNSNLSTVYKGR-LEDGEIVAVKKLNFHQFSAESDKSFYREAKTLKELKHRNLVKVLGY 78
+G+ VYK R L GE+ AVK + + +E +KE KH N+V G
Sbjct: 17 VGSGTYGDVYKARNLHTGELAAVKIIKLEP--GDDFSLIQQEIFMVKECKHCNIVAYFGS 74
Query: 79 AWESGKLKALILEYMENGSLESVIH--GPGVDHS-----RWTLPKRIDVLISVANGLDYL 131
KL + +EY GSL+ + H GP + R TL GL YL
Sbjct: 75 YLSREKL-WICMEYCGGGSLQDIYHVTGPLSELQIAYVCRETL-----------QGLAYL 122
Query: 132 HSGYDIPIVHCDMKPSNILLDRDFEAHVSDFGTSRMLDVHLQDLSSLSTAFQGTIGYLAP 191
HS + H D+K +NILL + + ++DFG + + + S F GT ++AP
Sbjct: 123 HSKGKM---HRDIKGANILLTDNGDVKLADFGVAAKITATIAKRKS----FIGTPYWMAP 175
Query: 192 EFAYMRI---VTTKVDVFSFGIVVMEFLTKRRPTGLDEENGLSPISLRQLVEKALANGIN 248
E A + D+++ GI +E L + +P D L P+ L+ K+
Sbjct: 176 EVAAVEKNGGYNQLCDIWAVGITAIE-LAELQPPMFD----LHPMRALFLMSKS------ 224
Query: 249 GVRQITDPKLVSSIYEEQEQHQVLEELFKLALVCTSSNPEDRPNMNELL 297
PKL ++ + K++L NP+ RP LL
Sbjct: 225 ---NFQPPKL----KDKTKWSSTFHNFVKISLT---KNPKKRPTAERLL 263
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 5 (MAPKKKK5 or MAP4K5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K5, also called germinal center kinase-related enzyme (GCKR), has been shown to activate the MAPK c-Jun N-terminal kinase (JNK). MAP4K5 also facilitates Wnt signaling in B cells, and may therefore be implicated in the control of cell fate, proliferation, and polarity. Length = 267 |
| >gnl|CDD|173729 cd06617, PKc_MKK3_6, Catalytic domain of the dual-specificity Protein Kinases, MAP kinase kinases 3 and 6 | Back alignment and domain information |
|---|
Score = 62.8 bits (153), Expect = 2e-11
Identities = 56/185 (30%), Positives = 86/185 (46%), Gaps = 44/185 (23%)
Query: 122 ISVANGLDYLHSGYDIPIVHCDMKPSNILLDRDFEAHVSDFGTSRMLDVHLQDLSSLSTA 181
+S+ L+YLHS + ++H D+KPSN+L++R+ + + DFG S +L D S T
Sbjct: 110 VSIVKALEYLHS--KLSVIHRDVKPSNVLINRNGQVKLCDFGISG----YLVD-SVAKTI 162
Query: 182 FQGTIGYLAPEFAYMRI--------VTTKVDVFSFGIVVMEFLTKRRPTGLDEENGLSPI 233
G Y+APE RI K DV+S GI ++E T R P ++ +P
Sbjct: 163 DAGCKPYMAPE----RINPELNQKGYDVKSDVWSLGITMIELATGRFPY----DSWKTPF 214
Query: 234 -SLRQLVEKALANGINGVRQITDPKLVSSIYEEQEQHQVLEELFKLALVCTSSNPEDRPN 292
L+Q+VE+ P+L + + + Q V C N ++RPN
Sbjct: 215 QQLKQVVEE------------PSPQLPAEKFSPEFQDFV--------NKCLKKNYKERPN 254
Query: 293 MNELL 297
ELL
Sbjct: 255 YPELL 259
|
Protein kinases (PKs), MAP kinase kinase 3 (MKK3) and MKK6 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK3 and MKK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK3 and MKK6 are dual-specificity PKs that phosphorylate and activate their downstream target, p38 MAPK, on specific threonine and tyrosine residues. MKK3/6 plays roles in the regulation of cell cycle progression, cytokine- and stress-induced apoptosis, oncogenic transformation, and adult tissue regeneration. In addition, MKK6 plays a critical role in osteoclast survival in inflammatory disease while MKK3 is associated with tumor invasion, progression, and poor patient survival in glioma. Length = 283 |
| >gnl|CDD|143384 cd07879, STKc_p38delta_MAPK13, Catalytic domain of the Serine/Threonine Kinase, p38delta Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 63.0 bits (153), Expect = 3e-11
Identities = 57/191 (29%), Positives = 92/191 (48%), Gaps = 29/191 (15%)
Query: 36 GEIVAVKKLNFHQFSAES-DKSFYREAKTLKELKHRNLVKVLGYAWESGKLKA-----LI 89
GE VA+KKL+ F +E K YRE LK ++H N++ +L + L+
Sbjct: 40 GEKVAIKKLS-RPFQSEIFAKRAYRELTLLKHMQHENVIGLLDVFTSAVSGDEFQDFYLV 98
Query: 90 LEYMENGSLESVIHGPGVDHSRWTLPKRIDVLI-SVANGLDYLHSGYDIPIVHCDMKPSN 148
+ YM+ L+ ++ P + ++ L+ + GL Y+HS I+H D+KP N
Sbjct: 99 MPYMQT-DLQKIMGHPLSE-------DKVQYLVYQMLCGLKYIHSA---GIIHRDLKPGN 147
Query: 149 ILLDRDFEAHVSDFGTSRMLDVHLQDLSSLSTAFQGTIGYLAPE--FAYMRIVTTKVDVF 206
+ ++ D E + DFG +R D + T + T Y APE +M T VD++
Sbjct: 148 LAVNEDCELKILDFGLARHADAEM-------TGYVVTRWYRAPEVILNWMHYNQT-VDIW 199
Query: 207 SFGIVVMEFLT 217
S G ++ E LT
Sbjct: 200 SVGCIMAEMLT 210
|
Serine/Threonine Kinases (STKs), p38delta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38delta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38delta, also called MAPK13, is found in skeletal muscle, heart, lung, testis, pancreas, and small intestine. It regulates microtubule function by phosphorylating Tau. It activates the c-jun promoter and plays a role in G2 cell cycle arrest. It also controls the degration of c-Myb, which is associated with myeloid leukemia and poor prognosis in colorectal cancer. p38delta is the main isoform involved in regulating the differentiation and apoptosis of keratinocytes. Length = 342 |
| >gnl|CDD|143368 cd07863, STKc_CDK4, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 4 | Back alignment and domain information |
|---|
Score = 62.7 bits (152), Expect = 3e-11
Identities = 59/212 (27%), Positives = 91/212 (42%), Gaps = 24/212 (11%)
Query: 20 IGNSNLSTVYKGR-LEDGEIVAVKKLNFHQFSAESDKSFYREAKTLKELK---HRNLVK- 74
IG TVYK R G VA+K + S RE LK L+ H N+V+
Sbjct: 8 IGVGAYGTVYKARDPHSGHFVALKSVRVQTNEDGLPLSTVREVALLKRLEAFDHPNIVRL 67
Query: 75 --VLGYAWESGKLK-ALILEYMENG--SLESVIHGPGVDHSRWTLPKRIDVLISVANGLD 129
V + + K L+ E+++ + + PG+ D++ GLD
Sbjct: 68 MDVCATSRTDRETKVTLVFEHVDQDLRTYLDKVPPPGL-----PAETIKDLMRQFLRGLD 122
Query: 130 YLHSGYDIPIVHCDMKPSNILLDRDFEAHVSDFGTSRMLDVHLQDLSSLSTAFQGTIGYL 189
+LH+ IVH D+KP NIL+ + ++DFG +R+ + T T+ Y
Sbjct: 123 FLHANC---IVHRDLKPENILVTSGGQVKLADFGLARIYSCQMA-----LTPVVVTLWYR 174
Query: 190 APEFAYMRIVTTKVDVFSFGIVVMEFLTKRRP 221
APE T VD++S G + E +R+P
Sbjct: 175 APEVLLQSTYATPVDMWSVGCIFAEMF-RRKP 205
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 partners with all three D-type cyclins (D1, D2, and D3) and is also regulated by INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein and plays a role in regulating the early G1 phase of the cell cycle. It is expressed ubiquitously and is localized in the nucleus. CDK4 also shows kinase activity towards Smad3, a signal transducer of transforming growth factor (TGF)-beta signaling which modulates transcription and plays a role in cell proliferation and apoptosis. CDK4 is inhibited by the p21 inhibitor and is specifically mutated in human melanoma. Length = 288 |
| >gnl|CDD|173692 cd05601, STKc_CRIK, Catalytic domain of the Protein Serine/Threonine Kinase, Citron Rho-interacting kinase | Back alignment and domain information |
|---|
Score = 62.9 bits (153), Expect = 3e-11
Identities = 51/198 (25%), Positives = 91/198 (45%), Gaps = 27/198 (13%)
Query: 36 GEIVAVKKLNFHQFSAESDKSFYREAKTLKELKHRNLVKVLGYAWESGKLKALILEYMEN 95
G+I A+K + A+ SF+ E + + + + + L YA++ L++EY
Sbjct: 26 GDIYAMKVMKKSVLLAQETVSFFEEERDILSISNSPWIPQLQYAFQDKDNLYLVMEYQPG 85
Query: 96 GSLESVIHGPGVDHSRWTLPKRIDVL-ISVANGLDYLHSGYDIPIVHCDMKPSNILLDRD 154
G L S++ +R+ D+ +A + +HS + + VH D+KP N+L+DR
Sbjct: 86 GDLLSLL-------NRYEDQFDEDMAQFYLAELVLAIHSVHQMGYVHRDIKPENVLIDRT 138
Query: 155 FEAHVSDFGTSRMLDVHLQDLSSLSTAFQGTIGYLAPEFAYMRIVTT-----------KV 203
++DFG++ L + S L GT Y+APE ++TT +
Sbjct: 139 GHIKLADFGSAARLTANKMVNSKLPV---GTPDYIAPE-----VLTTMNGDGKGTYGVEC 190
Query: 204 DVFSFGIVVMEFLTKRRP 221
D +S G++ E + R P
Sbjct: 191 DWWSLGVIAYEMIYGRSP 208
|
Serine/Threonine Kinases (STKs), Citron Rho-interacting kinase (CRIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CRIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CRIK is also called citron kinase. It contains a catalytic domain, a central coiled-coil domain, and a C-terminal region containing a Rho-binding domain (RBD), a zinc finger, and a pleckstrin homology (PH) domain, in addition to other motifs. CRIK, an effector of the small GTPase Rho, plays an important function during cytokinesis and affects its contractile process. CRIK-deficient mice show severe ataxia and epilepsy as a result of abnormal cytokinesis and massive apoptosis in neuronal precursors. A Down syndrome critical region protein TTC3 interacts with CRIK and inhibits CRIK-dependent neuronal differentiation and neurite extension. Length = 330 |
| >gnl|CDD|132975 cd06644, STKc_STK10_LOK, Catalytic domain of the Protein Serine/Threonine Kinase, STK10 or Lymphocyte-oriented kinase | Back alignment and domain information |
|---|
Score = 62.4 bits (151), Expect = 4e-11
Identities = 71/284 (25%), Positives = 125/284 (44%), Gaps = 42/284 (14%)
Query: 20 IGNSNLSTVYKGRLEDGEIVAVKKLNFHQFSAESDKSFYREAKTLKELKHRNLVKVLGYA 79
+G+ VYK + ++ +A K+ S E + + E + L H +VK+LG
Sbjct: 20 LGDGAFGKVYKAKNKETGALAAAKV-IETKSEEELEDYMVEIEILATCNHPYIVKLLGAF 78
Query: 80 WESGKLKALILEYMENGSLESVIHGPGVDHSRWTLPKRIDVLI-SVANGLDYLHSGYDIP 138
+ GKL +I E+ G++++++ ++ R +I V+ + L YLHS +
Sbjct: 79 YWDGKLWIMI-EFCPGGAVDAIM----LELDRGLTEPQIQVICRQMLEALQYLHS---MK 130
Query: 139 IVHCDMKPSNILLDRDFEAHVSDFGTSRMLDVHLQDLSSLSTAFQGTIGYLAPEFAYMRI 198
I+H D+K N+LL D + ++DFG S LQ S F GT ++APE
Sbjct: 131 IIHRDLKAGNVLLTLDGDIKLADFGVSAKNVKTLQRRDS----FIGTPYWMAPEVVMCET 186
Query: 199 VTT-----KVDVFSFGIVVMEFLTKRRPTGLDEENGLSPISLRQLVEKALANGINGVRQI 253
+ K D++S GI ++E P + L+P+ + + K
Sbjct: 187 MKDTPYDYKADIWSLGITLIEMAQIEPP-----HHELNPMRVLLKIAK------------ 229
Query: 254 TDPKLVSSIYEEQEQHQVLEELFKLALVCTSSNPEDRPNMNELL 297
++P +S + + + K AL +PE RP+ +LL
Sbjct: 230 SEPPTLSQPSKWSME---FRDFLKTAL---DKHPETRPSAAQLL 267
|
Serine/threonine kinases (STKs), STK10 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Other names for STK10 include lymphocyte-oriented kinase (LOK) and Xenopus polo-like kinase kinase 1 (xPlkk1). STK10 is highly expressed in lymphocytes and is responsible in regulating leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. It plays a role in regulating the CD28 responsive element in T cells, and may also function as a regulator of polo-like kinase 1 (Plk1), a protein which is overexpressed in multiple tumor types. Length = 292 |
| >gnl|CDD|132984 cd06653, STKc_MEKK3_like_1, Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 62.0 bits (150), Expect = 4e-11
Identities = 55/192 (28%), Positives = 90/192 (46%), Gaps = 12/192 (6%)
Query: 34 EDGEIVAVKKLNFHQFSAESDK---SFYREAKTLKELKHRNLVKVLGYAWESGKLK-ALI 89
+ G +AVK++ F S E+ K + E + LK L+H +V+ G + + K ++
Sbjct: 25 DTGRELAVKQVPFDPDSQETSKEVNALECEIQLLKNLRHDRIVQYYGCLRDPEEKKLSIF 84
Query: 90 LEYMENGSLESVIHGPGVDHSRWTLPKRIDVLISVANGLDYLHSGYDIPIVHCDMKPSNI 149
+EYM GS++ + G T +L G+ YLHS IVH D+K +NI
Sbjct: 85 VEYMPGGSIKDQLKAYGALTENVTRRYTRQIL----QGVSYLHSNM---IVHRDIKGANI 137
Query: 150 LLDRDFEAHVSDFGTSRMLDVHLQDLSSLSTAFQGTIGYLAPEFAYMRIVTTKVDVFSFG 209
L D + DFG S+ + + + + GT +++PE K DV+S
Sbjct: 138 LRDSAGNVKLGDFGASKRIQTICMSGTGIKSV-TGTPYWMSPEVISGEGYGRKADVWSVA 196
Query: 210 IVVMEFLTKRRP 221
V+E LT++ P
Sbjct: 197 CTVVEMLTEKPP 208
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain, functionally uncharacterized subgroup 1. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MEKK3-like subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK2 and MEKK3 activate MEK5 (also called MKK5), which activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development. MEKK2 and MEKK3 can also activate the MAPKs, c-Jun N-terminal kinase (JNK) and p38, through their respective MAPKKs. Length = 264 |
| >gnl|CDD|173709 cd05619, STKc_nPKC_theta, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C theta | Back alignment and domain information |
|---|
Score = 62.3 bits (151), Expect = 4e-11
Identities = 54/167 (32%), Positives = 78/167 (46%), Gaps = 24/167 (14%)
Query: 74 KVLGYAWESGKLKAL------------ILEYMENGSLESVIHGPGVDHSRWTLPKRIDVL 121
+VL AWE L L ++EY+ G L I ++ LP+
Sbjct: 47 RVLSLAWEHPFLTHLYCTFQTKENLFFVMEYLNGGDLMFHIQSC----HKFDLPRATFYA 102
Query: 122 ISVANGLDYLHSGYDIPIVHCDMKPSNILLDRDFEAHVSDFGTSRMLDVHLQDLSSLSTA 181
+ GL +LHS IV+ D+K NILLD D ++DFG + + L D + +
Sbjct: 103 AEIICGLQFLHSK---GIVYRDLKLDNILLDTDGHIKIADFGMCK--ENMLGD--AKTCT 155
Query: 182 FQGTIGYLAPEFAYMRIVTTKVDVFSFGIVVMEFLTKRRP-TGLDEE 227
F GT Y+APE + T VD +SFG+++ E L + P G DEE
Sbjct: 156 FCGTPDYIAPEILLGQKYNTSVDWWSFGVLLYEMLIGQSPFHGHDEE 202
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an important and non-redundant role in several aspects of T-cell biology. Although T-cells also express other PKC isoforms, PKC-theta is unique in that upon antigen stimulation, it is translocated to the plasma membrane at the immunological synapse, where it mediates signals essential for T-cell activation. It is essential for TCR-induced proliferation, cytokine production, T-cell survival, and the differentiation and effector function of T-helper (Th) cells, particularly Th2 and Th17. PKC-theta is being developed as a therapeutic target for Th2-mediated allergic inflammation and Th17-mediated autoimmune diseases. Length = 316 |
| >gnl|CDD|173696 cd05605, STKc_GRK4_like, Catalytic domain of G protein-coupled Receptor Kinase 4-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 61.8 bits (150), Expect = 4e-11
Identities = 53/189 (28%), Positives = 81/189 (42%), Gaps = 16/189 (8%)
Query: 36 GEIVAVKKLNFHQFSAESDKSFYREAKTLKELKHRNLVKVLGYAWESGKLKALILEYMEN 95
G++ A KKL + ++ K + E + V L YA+E+ L+L M
Sbjct: 25 GKMYACKKLEKKRIKKRKGEAMALNEKQILEKVNSRFVVSLAYAYETKDALCLVLTLMNG 84
Query: 96 GSLESVIHG---PGVDHSRWTLPKRIDVLISVANGLDYLHSGYDIPIVHCDMKPSNILLD 152
G L+ I+ PG D R + GL+ LH IV+ D+KP NILLD
Sbjct: 85 GDLKFHIYNMGNPGFDEERAVF-----YAAEITCGLEDLHRER---IVYRDLKPENILLD 136
Query: 153 RDFEAHVSDFGTSRMLDVHLQDLSSLSTAFQGTIGYLAPEFAYMRIVTTKVDVFSFGIVV 212
+SD G L V + + ++ GT+GY+APE T D + G ++
Sbjct: 137 DYGHIRISDLG----LAVEIPEGETIRGRV-GTVGYMAPEVVKNERYTFSPDWWGLGCLI 191
Query: 213 MEFLTKRRP 221
E + + P
Sbjct: 192 YEMIEGKSP 200
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4-like group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. Members of the GRK4-like group include GRK4, GRK5, GRK6, and similar GRKs. GRKs in this group contain an N-terminal RGS homology (RH) domain and a catalytic domain, but lack a G protein betagamma-subunit binding domain. They are localized to the plasma membrane through post-translational lipid modification or direct binding to PIP2. Length = 285 |
| >gnl|CDD|143385 cd07880, STKc_p38gamma_MAPK12, Catalytic domain of the Serine/Threonine Kinase, p38gamma Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 62.3 bits (151), Expect = 5e-11
Identities = 59/193 (30%), Positives = 91/193 (47%), Gaps = 28/193 (14%)
Query: 36 GEIVAVKKLNFHQFSAE-SDKSFYREAKTLKELKHRNLVKVLGYAWESGKLKA-----LI 89
G VA+KKL + F +E K YRE + LK +KH N++ +L L L+
Sbjct: 40 GAKVAIKKL-YRPFQSELFAKRAYRELRLLKHMKHENVIGLLDVFTPDLSLDRFHDFYLV 98
Query: 90 LEYMENGSLESVIHGPGVDHSRWTLPKRIDVLI-SVANGLDYLHSGYDIPIVHCDMKPSN 148
+ +M G + H + + RI L+ + GL Y+H+ I+H D+KP N
Sbjct: 99 MPFMGTDL------GKLMKHEKLS-EDRIQFLVYQMLKGLKYIHAA---GIIHRDLKPGN 148
Query: 149 ILLDRDFEAHVSDFGTSRMLDVHLQDLSSLSTAFQGTIGYLAPE--FAYMRIVTTKVDVF 206
+ ++ D E + DFG +R D S T + T Y APE +M T VD++
Sbjct: 149 LAVNEDCELKILDFGLARQTD-------SEMTGYVVTRWYRAPEVILNWMHYTQT-VDIW 200
Query: 207 SFGIVVMEFLTKR 219
S G ++ E LT +
Sbjct: 201 SVGCIMAEMLTGK 213
|
Serine/Threonine Kinases (STKs), p38gamma subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38gamma subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38gamma, also called MAPK12, is predominantly expressed in skeletal muscle. Unlike p38alpha and p38beta, p38gamma is insensitive to pyridinylimidazoles. It displays an antagonizing function compared to p38alpha. p38gamma inhibits, while p38alpha stimulates, c-Jun phosphorylation and AP-1 mediated transcription. p38gamma also plays a role in the signaling between Ras and the estrogen receptor and has been implicated to increase cell invasion and breast cancer progression. In Xenopus, p38gamma is critical in the meiotic maturation of oocytes. Length = 343 |
| >gnl|CDD|133192 cd05061, PTKc_InsR, Catalytic domain of the Protein Tyrosine Kinase, Insulin Receptor | Back alignment and domain information |
|---|
Score = 61.9 bits (150), Expect = 5e-11
Identities = 61/225 (27%), Positives = 104/225 (46%), Gaps = 21/225 (9%)
Query: 20 IGNSNLSTVYKGRLED---GEI---VAVKKLNFHQFSAESDKSFYREAKTLKELKHRNLV 73
+G + VY+G D GE VAVK +N S F EA +K ++V
Sbjct: 14 LGQGSFGMVYEGNARDIIKGEAETRVAVKTVN-ESASLRERIEFLNEASVMKGFTCHHVV 72
Query: 74 KVLGYAWESGKLKALILEYMENGSLESVIHG--PGVDHSRWTLPKRIDVLIS----VANG 127
++LG G+ +++E M +G L+S + P +++ P + +I +A+G
Sbjct: 73 RLLGVV-SKGQPTLVVMELMAHGDLKSYLRSLRPEAENNPGRPPPTLQEMIQMAAEIADG 131
Query: 128 LDYLHSGYDIPIVHCDMKPSNILLDRDFEAHVSDFGTSRMLDVHLQDLSSLSTAFQGTIG 187
+ YL++ VH D+ N ++ DF + DFG +R D++ D +
Sbjct: 132 MAYLNAK---KFVHRDLAARNCMVAHDFTVKIGDFGMTR--DIYETDYYRKGGKGLLPVR 186
Query: 188 YLAPEFAYMRIVTTKVDVFSFGIVVMEF--LTKRRPTGLDEENGL 230
++APE + TT D++SFG+V+ E L ++ GL E L
Sbjct: 187 WMAPESLKDGVFTTSSDMWSFGVVLWEITSLAEQPYQGLSNEQVL 231
|
Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR is a receptor tyr kinase (RTK) that is composed of two alphabeta heterodimers. Binding of the insulin ligand to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological function. InsR signaling plays an important role in many cellular processes including glucose homeostasis, glycogen synthesis, lipid and protein metabolism, ion and amino acid transport, cell cycle and proliferation, cell differentiation, gene transcription, and nitric oxide synthesis. Insulin resistance, caused by abnormalities in InsR signaling, has been described in diabetes, hypertension, cardiovascular disease, metabolic syndrome, heart failure, and female infertility. Length = 288 |
| >gnl|CDD|143367 cd07862, STKc_CDK6, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 6 | Back alignment and domain information |
|---|
Score = 61.6 bits (149), Expect = 6e-11
Identities = 60/215 (27%), Positives = 97/215 (45%), Gaps = 29/215 (13%)
Query: 20 IGNSNLSTVYKGR-LEDG-EIVAVKKLNFHQFSAESDKSFYREAKTLKELK---HRNLVK 74
IG V+K R L++G VA+K++ S RE L+ L+ H N+V+
Sbjct: 9 IGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETFEHPNVVR 68
Query: 75 VLGYAWESGKLK----ALILEYMENG---SLESVIHGPGVDHSRWTLPKRI-DVLISVAN 126
+ S + L+ E+++ L+ V PGV + I D++ +
Sbjct: 69 LFDVCTVSRTDRETKLTLVFEHVDQDLTTYLDKVPE-PGVP------TETIKDMMFQLLR 121
Query: 127 GLDYLHSGYDIPIVHCDMKPSNILLDRDFEAHVSDFGTSRMLDVHLQDLSSLSTAFQGTI 186
GLD+LHS +VH D+KP NIL+ + ++DFG +R + T+ T+
Sbjct: 122 GLDFLHSHR---VVHRDLKPQNILVTSSGQIKLADFGLAR-----IYSFQMALTSVVVTL 173
Query: 187 GYLAPEFAYMRIVTTKVDVFSFGIVVMEFLTKRRP 221
Y APE T VD++S G + E +R+P
Sbjct: 174 WYRAPEVLLQSSYATPVDLWSVGCIFAEMF-RRKP 207
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 6 (CDK6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK6 is regulated by D-type cyclins and INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein, implicating it to function in regulating the early G1 phase of the cell cycle. It is expressed ubiquitously and is localized in the cytoplasm. It is also present in the ruffling edge of spreading fibroblasts and may play a role in cell spreading. It binds to the p21 inhibitor without any effect on its own activity and it is overexpressed in squamous cell carcinomas and neuroblastomas. CDK6 has also been shown to inhibit cell differentiation in many cell types. Length = 290 |
| >gnl|CDD|143374 cd07869, STKc_PFTAIRE1, Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-1 kinase | Back alignment and domain information |
|---|
Score = 61.6 bits (149), Expect = 6e-11
Identities = 50/162 (30%), Positives = 83/162 (51%), Gaps = 16/162 (9%)
Query: 13 SFSENNIIGNSNLSTVYKGRLE-DGEIVAVKKLNFHQFSAESDKSF--YREAKTLKELKH 69
S+ + +G + +TVYKG+ + +G++VA+K + + E F REA LK LKH
Sbjct: 6 SYEKLEKLGEGSYATVYKGKSKVNGKLVALKVIRLQE---EEGTPFTAIREASLLKGLKH 62
Query: 70 RNLVKVLGYAWESGKLKALILEYMENGSLESVIHGPGVDHSRWTLPKRIDV-LISVANGL 128
N+V +L + + L+ EY+ + + PG H P+ + + L + GL
Sbjct: 63 ANIV-LLHDIIHTKETLTLVFEYVHTDLCQYMDKHPGGLH-----PENVKLFLFQLLRGL 116
Query: 129 DYLHSGYDIPIVHCDMKPSNILLDRDFEAHVSDFGTSRMLDV 170
Y+H Y I+H D+KP N+L+ E ++DFG +R V
Sbjct: 117 SYIHQRY---ILHRDLKPQNLLISDTGELKLADFGLARAKSV 155
|
Serine/Threonine Kinases (STKs), PFTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-1 is widely expressed except in the spleen and thymus. It is highly expressed in the brain, heart, pancreas, testis, and ovary, and is localized in the cytoplasm. It is regulated by cyclin D3 and is inhibited by the p21 cell cycle inhibitor. It has also been shown to interact with the membrane-associated cyclin Y, which recruits the protein to the plasma membrane. Length = 303 |
| >gnl|CDD|173721 cd05632, STKc_GRK5, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 5 | Back alignment and domain information |
|---|
Score = 61.5 bits (149), Expect = 7e-11
Identities = 57/216 (26%), Positives = 91/216 (42%), Gaps = 23/216 (10%)
Query: 13 SFSENNIIGNSNLSTVYKGRLE-DGEIVAVKKLNFHQFSAESDKSFYREAKTLKELKHRN 71
+F + ++G V ++ G++ A K+L + +S K + E +
Sbjct: 1 TFRQYRVLGKGGFGEVCACQVRATGKMYACKRLEKKRIKKRKGESMALNEKQILEKVNSQ 60
Query: 72 LVKVLGYAWESGKLKALILEYMENGSLESVIHG---PGVDHSRWTLPKRIDVLISVAN-- 126
V L YA+E+ L+L M G L+ I+ PG + R L A
Sbjct: 61 FVVNLAYAYETKDALCLVLTIMNGGDLKFHIYNMGNPGFEEER--------ALFYAAEIL 112
Query: 127 -GLDYLHSGYDIPIVHCDMKPSNILLDRDFEAHVSDFGTSRMLDVHLQDLSSLSTAFQGT 185
GL+ LH V+ D+KP NILLD +SD G L V + + S+ GT
Sbjct: 113 CGLEDLHRE---NTVYRDLKPENILLDDYGHIRISDLG----LAVKIPEGESIRGRV-GT 164
Query: 186 IGYLAPEFAYMRIVTTKVDVFSFGIVVMEFLTKRRP 221
+GY+APE + T D + G ++ E + + P
Sbjct: 165 VGYMAPEVLNNQRYTLSPDYWGLGCLIYEMIEGQSP 200
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK5 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK5 is widely expressed in many tissues. It associates with the membrane though an N-terminal PIP2 binding domain and also binds phospholipids via its C-terminus. GRK5 deficiency is associated with early Alzheimer's disease in humans and mouse models. GRK5 also plays a crucial role in the pathogenesis of sporadic Parkinson's disease. It participates in the regulation and desensitization of PDGFRbeta, a receptor tyrosine kinase involved in a variety of downstream cellular effects including cell growth, chemotaxis, apoptosis, and angiogenesis. GRK5 also regulates Toll-like receptor 4, which is involved in innate and adaptive immunity. Length = 285 |
| >gnl|CDD|234389 TIGR03903, TOMM_kin_cyc, TOMM system kinase/cyclase fusion protein | Back alignment and domain information |
|---|
Score = 62.6 bits (152), Expect = 7e-11
Identities = 60/196 (30%), Positives = 87/196 (44%), Gaps = 18/196 (9%)
Query: 34 EDGEIVAVKKL-NFHQFSAESDKSFYREAKTLKELKHRNLVKVL--GYAWESGKLKALIL 90
G VA+K L F RE L H N+V +L G A G L A +
Sbjct: 1 MTGHEVAIKLLRTDAPEEEHQRARFRRETALCARLYHPNIVALLDSGEA-PPGLLFA-VF 58
Query: 91 EYMENGSLESVIHGPGVDHSRWTLPKRIDVLISVANGLDYLHSGYDIPIVHCDMKPSNIL 150
EY+ +L V+ G LP + + LD L ++ IVH D+KP NI+
Sbjct: 59 EYVPGRTLREVLAADGA------LPA-GETGRLMLQVLDALACAHNQGIVHRDLKPQNIM 111
Query: 151 LD-RDFEAH--VSDFGTSRML-DVHLQDLSSLS--TAFQGTIGYLAPEFAYMRIVTTKVD 204
+ H V DFG +L V D+++L+ T GT Y APE VT D
Sbjct: 112 VSQTGVRPHAKVLDFGIGTLLPGVRDADVATLTRTTEVLGTPTYCAPEQLRGEPVTPNSD 171
Query: 205 VFSFGIVVMEFLTKRR 220
++++G++ +E LT +R
Sbjct: 172 LYAWGLIFLECLTGQR 187
|
This model represents proteins of 1350 in length, in multiple species of Burkholderia, in Acidovorax avenae subsp. citrulli AAC00-1 and Delftia acidovorans SPH-1, and in multiple copies in Sorangium cellulosum, in genomic neighborhoods that include a cyclodehydratase/docking scaffold fusion protein (TIGR03882) and a member of the thiazole/oxazole modified metabolite (TOMM) precursor family TIGR03795. It has a kinase domain in the N-terminal 300 amino acids, followed by a cyclase homology domain, followed by regions without named domain definitions. It is a probable bacteriocin-like metabolite biosynthesis protein [Cellular processes, Toxin production and resistance]. Length = 1266 |
| >gnl|CDD|173745 cd07848, STKc_CDKL5, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase Like 5 | Back alignment and domain information |
|---|
Score = 61.2 bits (148), Expect = 9e-11
Identities = 55/199 (27%), Positives = 91/199 (45%), Gaps = 14/199 (7%)
Query: 19 IIGNSNLSTVYKGR-LEDGEIVAVKKLNFHQFSAESDKSFYREAKTLKELKHRNLVKVLG 77
++G V K R E EIVA+KK + + E ++ RE K L+ LK N+V++
Sbjct: 8 VVGEGAYGVVLKCRHKETKEIVAIKKFKDSEENEEVKETTLRELKMLRTLKQENIVELKE 67
Query: 78 YAWESGKLKALILEYMENGSLESVIHGPGVDHSRWTLPKRIDVLI-SVANGLDYLHSGYD 136
GKL L+ EY+E LE + + P+++ I + + + H
Sbjct: 68 AFRRRGKL-YLVFEYVEKNMLELL-----EEMPNGVPPEKVRSYIYQLIKAIHWCHKN-- 119
Query: 137 IPIVHCDMKPSNILLDRDFEAHVSDFGTSRMLDVHLQDLSSLSTAFQGTIGYLAPEFAYM 196
IVH D+KP N+L+ + + DFG +R L + ++ T + T Y +PE
Sbjct: 120 -DIVHRDIKPENLLISHNDVLKLCDFGFARNLS---EGSNANYTEYVATRWYRSPELLLG 175
Query: 197 RIVTTKVDVFSFGIVVMEF 215
VD++S G ++ E
Sbjct: 176 APYGKAVDMWSVGCILGEL 194
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 5 (CDKL5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Mutations in the gene encoding CDKL5, previously called STK9, are associated with early onset epilepsy and severe mental retardation [X-linked infantile spasm syndrome (ISSX) or West syndrome]. In addition, CDKL5 mutations also sometimes cause a phenotype similar to Rett syndrome (RTT), a progressive neurodevelopmental disorder. These pathogenic mutations are located in the N-terminal portion of the protein within the kinase domain. Length = 287 |
| >gnl|CDD|173710 cd05620, STKc_nPKC_delta, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C delta | Back alignment and domain information |
|---|
Score = 61.1 bits (148), Expect = 1e-10
Identities = 52/169 (30%), Positives = 80/169 (47%), Gaps = 23/169 (13%)
Query: 74 KVLGYAWESGKLKAL------------ILEYMENGSLESVIHGPGVDHSRWTLPKRIDVL 121
+VL AWE+ L L ++E++ G L I D R+ L +
Sbjct: 47 RVLALAWENPFLTHLYCTFQTKEHLFFVMEFLNGGDLMFHIQ----DKGRFDLYRATFYA 102
Query: 122 ISVANGLDYLHSGYDIPIVHCDMKPSNILLDRDFEAHVSDFGTSRMLDVHLQDLSSLSTA 181
+ GL +LHS I++ D+K N++LDRD ++DFG M ++ + ST
Sbjct: 103 AEIVCGLQFLHSKG---IIYRDLKLDNVMLDRDGHIKIADFG---MCKENVFGDNRAST- 155
Query: 182 FQGTIGYLAPEFAYMRIVTTKVDVFSFGIVVMEFLTKRRPTGLDEENGL 230
F GT Y+APE T VD +SFG+++ E L + P D+E+ L
Sbjct: 156 FCGTPDYIAPEILQGLKYTFSVDWWSFGVLLYEMLIGQSPFHGDDEDEL 204
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), delta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-delta plays a role in cell cycle regulation and programmed cell death in many cell types. It slows down cell proliferation, inducing cell cycle arrest and enhancing cell differentiation. PKC-delta is also involved in the regulation of transcription as well as immune and inflammatory responses. It plays a central role in the genotoxic stress response that leads to DNA damaged-induced apoptosis. Length = 316 |
| >gnl|CDD|143381 cd07876, STKc_JNK2, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 2 | Back alignment and domain information |
|---|
Score = 61.2 bits (148), Expect = 1e-10
Identities = 55/183 (30%), Positives = 87/183 (47%), Gaps = 20/183 (10%)
Query: 39 VAVKKLNFHQFSAESDKSFYREAKTLKELKHRNLVKVLGYAWESGKLKA-----LILEYM 93
VAVKKL+ + K YRE LK + H+N++ +L L+ L++E M
Sbjct: 49 VAVKKLSRPFQNQTHAKRAYRELVLLKCVNHKNIISLLNVFTPQKSLEEFQDVYLVMELM 108
Query: 94 ENGSLESVIHGPGVDHSRWTLPKRIDVLISVANGLDYLHSGYDIPIVHCDMKPSNILLDR 153
+ +L VIH +DH R + +L + G+ +LHS I+H D+KPSNI++
Sbjct: 109 D-ANLCQVIHME-LDHERMSY-----LLYQMLCGIKHLHSA---GIIHRDLKPSNIVVKS 158
Query: 154 DFEAHVSDFGTSRMLDVHLQDLSSLSTAFQGTIGYLAPEFAYMRIVTTKVDVFSFGIVVM 213
D + DFG +R + + T + T Y APE VD++S G ++
Sbjct: 159 DCTLKILDFGLARTACTNF-----MMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMG 213
Query: 214 EFL 216
E +
Sbjct: 214 ELV 216
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 2 (JNK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jnk1 or Jnk2) could survive but disruption of both genes resulted in lethality. However, recent studies have shown that JNK1 and JNK2 perform distinct functions through specific binding partners and substrates. JNK2 is specifically translocated to the mitochondria during dopaminergic cell death. Specific substrates include the microtubule-associated proteins DCX and Tau, as well as TIF-IA which is involved in ribosomal RNA synthesis regulation. Mice deficient in Jnk2 show protection against arthritis, type 1 diabetes, atherosclerosis, abdominal aortic aneurysm, cardiac cell death, TNF-induced liver damage, and tumor growth, indicating that JNK2 may play roles in the pathogenesis of these diseases. Length = 359 |
| >gnl|CDD|173703 cd05612, STKc_PRKX_like, Catalytic domain of PRKX-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 60.5 bits (147), Expect = 1e-10
Identities = 52/204 (25%), Positives = 92/204 (45%), Gaps = 17/204 (8%)
Query: 20 IGNSNLSTVYKGRLEDGE-IVAVKKLNFHQ-FSAESDKSFYREAKTLKELKHRNLVKVLG 77
+G V+ R E A+K + + + ++ + E + LKE+ H ++++
Sbjct: 9 VGTGTFGRVHLVRDRISEHYYALKVMAIPEVIRLKQEQHVHNEKRVLKEVSHPFIIRLFW 68
Query: 78 YAWESGKLKALILEYMENGSLESVIHGPGVDHSRWTLPKRIDVLISVANGLDYLHSGYDI 137
+ L +++EY+ G L S + G R++ + + L+YLHS
Sbjct: 69 TEHDQRFL-YMLMEYVPGGELFSYLRNSG----RFSNSTGLFYASEIVCALEYLHS---K 120
Query: 138 PIVHCDMKPSNILLDRDFEAHVSDFGTSRMLDVHLQDLSSLSTAFQGTIGYLAPEFAYMR 197
IV+ D+KP NILLD++ ++DFG ++ L + GT YLAPE +
Sbjct: 121 EIVYRDLKPENILLDKEGHIKLTDFGFAK-------KLRDRTWTLCGTPEYLAPEVIQSK 173
Query: 198 IVTTKVDVFSFGIVVMEFLTKRRP 221
VD ++ GI++ E L P
Sbjct: 174 GHNKAVDWWALGILIYEMLVGYPP 197
|
Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, PRKX-like kinases, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include human PRKX (X chromosome-encoded protein kinase), Drosophila DC2, and similar proteins. PRKX is present in many tissues including fetal and adult brain, kidney, and lung. The PRKX gene is located in the Xp22.3 subregion and has a homolog called PRKY on the Y chromosome. An abnormal interchange between PRKX aand PRKY leads to the sex reversal disorder of XX males and XY females. PRKX is implicated in granulocyte/macrophage lineage differentiation, renal cell epithelial migration, and tubular morphogenesis in the developing kidney. Length = 291 |
| >gnl|CDD|132965 cd06634, STKc_TAO2, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 2 | Back alignment and domain information |
|---|
Score = 60.4 bits (146), Expect = 1e-10
Identities = 80/296 (27%), Positives = 129/296 (43%), Gaps = 59/296 (19%)
Query: 14 FSENNIIGNSNLSTVYKGR-LEDGEIVAVKKLNFH-QFSAESDKSFYREAKTLKELKHRN 71
FS+ IG+ + VY R + + E+VA+KK+++ + S E + +E + L++L+H N
Sbjct: 17 FSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPN 76
Query: 72 LVKVLG------YAWESGKLKALILEYMENGSLESVIHGPGVDHSRWTLPKRIDVLISVA 125
++ G AW L++EY GS ++ H + I + A
Sbjct: 77 TIQYRGCYLREHTAW-------LVMEYCL-GSASDLLEV----HKKPLQEVEIAAVTHGA 124
Query: 126 -NGLDYLHSGYDIPIVHCDMKPSNILLDRDFEAHVSDFGTSRMLDVHLQDLSSLSTAFQG 184
GL YLHS ++H D+K NILL + DFG++ ++ + + F G
Sbjct: 125 LQGLAYLHSH---NMIHRDVKAGNILLSEPGLVKLGDFGSASIM--------APANXFVG 173
Query: 185 TIGYLAPEFAYMR---IVTTKVDVFSFGIVVMEFLTKRRPTGLDEENGLSPISLRQLVEK 241
T ++APE KVDV+S GI +E L +R+P L N +S
Sbjct: 174 TPYWMAPEVILAMDEGQYDGKVDVWSLGITCIE-LAERKPP-LFNMNAMS---------- 221
Query: 242 ALANGINGVRQITDPKLVSSIYEEQEQHQVLEELFKLALVCTSSNPEDRPNMNELL 297
+ + Q P L S + E ++ V L K+ P+DRP LL
Sbjct: 222 ----ALYHIAQNESPALQSGHWSEYFRNFVDSCLQKI--------PQDRPTSEVLL 265
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 2 (TAO2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Human TAO2 is also known as prostate-derived Ste20-like kinase (PSK) and was identified in a screen for overexpressed RNAs in prostate cancer. TAO2 activates both p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activating the respective MAP/ERK kinases (MEKs, also known as MKKs or MAPKKs), MEK3/MEK6 and MKK4/MKK7. TAO2 contains a long C-terminal extension with autoinhibitory segments. It is activated by the release of this inhibition and the phosphorylation of its activation loop serine. TAO2 functions as a regulator of actin cytoskeletal and microtubule organization. In addition, it regulates the transforming growth factor-activated kinase 1 (TAK1), which is a MAPKKK that plays an essential role in the signaling pathways of tumor necrosis factor (TNF), interleukin 1 (IL-1), and Toll-like receptor (TLR). Length = 308 |
| >gnl|CDD|143375 cd07870, STKc_PFTAIRE2, Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-2 kinase | Back alignment and domain information |
|---|
Score = 60.4 bits (146), Expect = 2e-10
Identities = 58/203 (28%), Positives = 98/203 (48%), Gaps = 23/203 (11%)
Query: 20 IGNSNLSTVYKG--RLEDGEIVAVKKLNFHQFSAESDKSF--YREAKTLKELKHRNLVKV 75
+G + +TVYKG R+ +G++VA+K ++ E F REA LK LKH N+V +
Sbjct: 13 LGEGSYATVYKGISRI-NGQLVALKVISM---KTEEGVPFTAIREASLLKGLKHANIV-L 67
Query: 76 LGYAWESGKLKALILEYMENGSLESVIHGPGVDHSRWTLPKRIDV-LISVANGLDYLHSG 134
L + + + EYM + +I PG H P + + + + GL Y+H
Sbjct: 68 LHDIIHTKETLTFVFEYMHTDLAQYMIQHPGGLH-----PYNVRLFMFQLLRGLAYIHGQ 122
Query: 135 YDIPIVHCDMKPSNILLDRDFEAHVSDFGTSRMLDVHLQDLSSLSTAFQGTIGYLAPEFA 194
+ I+H D+KP N+L+ E ++DFG +R + Q SS T+ Y P+
Sbjct: 123 H---ILHRDLKPQNLLISYLGELKLADFGLARAKSIPSQTYSSEVV----TLWYRPPDVL 175
Query: 195 YMRI-VTTKVDVFSFGIVVMEFL 216
++ +D++ G + +E L
Sbjct: 176 LGATDYSSALDIWGAGCIFIEML 198
|
Serine/Threonine Kinases (STKs), PFTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-2 is also referred to as ALS2CR7 (amyotrophic lateral sclerosis 2 (juvenile) chromosome region candidate 7). It may be associated with amyotrophic lateral sclerosis 2 (ALS2), an autosomal recessive form of juvenile ALS. The function of PFTAIRE-2 is not yet known. Length = 291 |
| >gnl|CDD|143363 cd07858, STKc_TEY_MAPK_plant, Catalytic domain of the Serine/Threonine Kinases, TEY Mitogen-Activated Protein Kinases from Plants | Back alignment and domain information |
|---|
Score = 60.8 bits (148), Expect = 2e-10
Identities = 58/201 (28%), Positives = 88/201 (43%), Gaps = 34/201 (16%)
Query: 34 EDGEIVAVKKLNFHQFSAESD-KSFYREAKTLKELKHRNLVK----VLGYAWESGKLKAL 88
E E VA+KK+ + F D K RE K L+ L H N++ + E+ +
Sbjct: 28 ETNEKVAIKKIA-NAFDNRIDAKRTLREIKLLRHLDHENVIAIKDIMPPPHREAFNDVYI 86
Query: 89 ILEYMENGSLESVIHGPGV---DHSRWTLPKRIDVLISVANGLDYLHSGYDIPIVHCDMK 145
+ E M+ L +I DH ++ L + GL Y+HS ++H D+K
Sbjct: 87 VYELMDT-DLHQIIRSSQTLSDDHCQY-------FLYQLLRGLKYIHSA---NVLHRDLK 135
Query: 146 PSNILLDRDFEAHVSDFGTSRMLDVHLQDLSSLSTAFQGTIGYLAPEF-----AYMRIVT 200
PSN+LL+ + + + DFG +R T + T Y APE Y T
Sbjct: 136 PSNLLLNANCDLKICDFGLARTTSEKGD----FMTEYVVTRWYRAPELLLNCSEY----T 187
Query: 201 TKVDVFSFGIVVMEFLTKRRP 221
T +DV+S G + E L R+P
Sbjct: 188 TAIDVWSVGCIFAELLG-RKP 207
|
Serine/Threonine Kinases (STKs), Plant TEY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TEY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. There are two subtypes of plant MAPKs based on the conserved phosphorylation motif present in the activation loop, TEY and TDY. This subfamily represents the TEY subtype and is further subdivided into three groups (A, B, and C). Group A is represented by AtMPK3, AtMPK6, Nicotiana tabacum BTF4 (NtNTF4), among others. They are mostly involved in environmental and hormonal responses. AtMPK3 and AtMPK6 are also key regulators for stomatal development and patterning. Group B is represented by AtMPK4, AtMPK13, and NtNTF6, among others. They may be involved in both cell division and environmental stress response. AtMPK4 also participates in regulating innate immunity. Group C is represented by AtMPK1, AtMPK2, NtNTF3, Oryza sativa MAPK4 (OsMAPK4), among others. They may also be involved in stress responses. AtMPK1 and AtMPK2 are activated following mechanical injury and in the presence of stress chemicals such as jasmonic acid, hydrogen peroxide and abscisic acid. OsMAPK4 is also called OsMSRMK3 for Multiple Stress-Responsive MAPK3. Length = 337 |
| >gnl|CDD|183880 PRK13184, pknD, serine/threonine-protein kinase; Reviewed | Back alignment and domain information |
|---|
Score = 61.3 bits (149), Expect = 2e-10
Identities = 61/258 (23%), Positives = 103/258 (39%), Gaps = 57/258 (22%)
Query: 55 KSFYREAKTLKELKHRNLVKVLGYAWES-GKLKALILEYMENGSLESVIHG-------PG 106
K F REAK +L H +V V Y+ S G + Y+E +L+S++
Sbjct: 47 KRFLREAKIAADLIHPGIVPV--YSICSDGDPVYYTMPYIEGYTLKSLLKSVWQKESLSK 104
Query: 107 VDHSRWTLPKRIDVLISVANGLDYLHSGYDIPIVHCDMKPSNILLDRDFEAHVSDFGTSR 166
+ ++ + + + ++Y+HS ++H D+KP NILL E + D+G +
Sbjct: 105 ELAEKTSVGAFLSIFHKICATIEYVHSK---GVLHRDLKPDNILLGLFGEVVILDWGAAI 161
Query: 167 MLDVHLQDLSSLSTAFQ--------------GTIGYLAPEFAYMRIVTTKVDVFSFGIVV 212
+ +DL + + GT Y+APE + D+++ G+++
Sbjct: 162 FKKLEEEDLLDIDVDERNICYSSMTIPGKIVGTPDYMAPERLLGVPASESTDIYALGVIL 221
Query: 213 MEFLT----KRRPTG---LDEENGLSPI----------SLRQLVEKALANGINGVRQITD 255
+ LT RR G + LSPI L Q+ KALA D
Sbjct: 222 YQMLTLSFPYRRKKGRKISYRDVILSPIEVAPYREIPPFLSQIAMKALAV---------D 272
Query: 256 PKL----VSSIYEEQEQH 269
P V + ++ E H
Sbjct: 273 PAERYSSVQELKQDLEPH 290
|
Length = 932 |
| >gnl|CDD|132970 cd06639, STKc_myosinIIIB, Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIB myosin | Back alignment and domain information |
|---|
Score = 60.0 bits (145), Expect = 2e-10
Identities = 61/214 (28%), Positives = 95/214 (44%), Gaps = 13/214 (6%)
Query: 9 NATGSFSENNIIGNSNLSTVYK-GRLEDGEIVAVKKLNFHQFSAESDKSFYREAKTLKEL 67
+ T ++ IG VYK +DG + AVK L+ ++ D+ E L+ L
Sbjct: 19 DPTDTWEIIETIGKGTYGKVYKVTNKKDGSLAAVKILDP---ISDVDEEIEAEYNILQSL 75
Query: 68 -KHRNLVKVLGYAWESGKLKA----LILEYMENGSLESVIHGPGVDHSRWTLPKRIDVLI 122
H N+VK G +++ KL L+LE GS+ ++ G + R +L
Sbjct: 76 PNHPNVVKFYGMFYKADKLVGGQLWLVLELCNGGSVTELVKGLLICGQRLDEAMISYILY 135
Query: 123 SVANGLDYLHSGYDIPIVHCDMKPSNILLDRDFEAHVSDFGTSRML-DVHLQDLSSLSTA 181
GL +LH+ I+H D+K +NILL + + DFG S L L+ +S+ T
Sbjct: 136 GALLGLQHLHNNR---IIHRDVKGNNILLTTEGGVKLVDFGVSAQLTSTRLRRNTSVGTP 192
Query: 182 FQGTIGYLAPEFAYMRIVTTKVDVFSFGIVVMEF 215
F +A E Y + DV+S GI +E
Sbjct: 193 FWMAPEVIACEQQYDYSYDARCDVWSLGITAIEL 226
|
Serine/threonine kinases (STKs), class IIIB myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. They may also function as cargo carriers during light-dependent translocation, in photoreceptor cells, of proteins such as transducin and arrestin. Class IIIB myosin is expressed highly in retina. It is also present in the brain and testis. The human class IIIB myosin gene maps to a region that overlaps the locus for Bardet-Biedl syndrome, which is characterized by dysmorphic extremities, retinal dystrophy, obesity, male hypogenitalism, and renal abnormalities. Length = 291 |
| >gnl|CDD|133220 cd05089, PTKc_Tie1, Catalytic domain of the Protein Tyrosine Kinase, Tie1 | Back alignment and domain information |
|---|
Score = 60.0 bits (145), Expect = 2e-10
Identities = 54/215 (25%), Positives = 102/215 (47%), Gaps = 24/215 (11%)
Query: 18 NIIGNSNLSTVYKGRLE-DGEIVAVKKLNFHQFSAESD-KSFYREAKTLKEL-KHRNLVK 74
++IG N V + ++ DG + +F++E+D + F E + L +L H N++
Sbjct: 8 DVIGEGNFGQVIRAMIKKDGLKMNAAIKMLKEFASENDHRDFAGELEVLCKLGHHPNIIN 67
Query: 75 VLGYAWESGKLKALILEYMENGSLESVIHGPGV---------DH---SRWTLPKRIDVLI 122
+LG G L + +EY G+L + V +H S T + +
Sbjct: 68 LLGACENRGYL-YIAIEYAPYGNLLDFLRKSRVLETDPAFAKEHGTASTLTSQQLLQFAS 126
Query: 123 SVANGLDYLHSGYDIPIVHCDMKPSNILLDRDFEAHVSDFGTSRMLDVHLQDLSSLSTAF 182
VA G+ YL + +H D+ N+L+ + + ++DFG SR +V+++ T
Sbjct: 127 DVATGMQYLS---EKQFIHRDLAARNVLVGENLASKIADFGLSRGEEVYVK-----KTMG 178
Query: 183 QGTIGYLAPEFAYMRIVTTKVDVFSFGIVVMEFLT 217
+ + ++A E + TTK DV+SFG+++ E ++
Sbjct: 179 RLPVRWMAIESLNYSVYTTKSDVWSFGVLLWEIVS 213
|
Protein Tyrosine Kinase (PTK) family; Tie1; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie1 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. No specific ligand has been identified for Tie1, although the angiopoietin, Ang-1, binds to Tie1 through integrins at high concentrations. In vivo studies of Tie1 show that it is critical in vascular development. Length = 297 |
| >gnl|CDD|173684 cd05593, STKc_PKB_gamma, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B gamma | Back alignment and domain information |
|---|
Score = 60.1 bits (145), Expect = 2e-10
Identities = 49/165 (29%), Positives = 81/165 (49%), Gaps = 18/165 (10%)
Query: 60 EAKTLKELKHRNLVKVLGYAWESGKLKALILEYMENGSLESVIHGPGV---DHSRWTLPK 116
E++ LK +H L L Y++++ ++EY+ G L + V D +R+ +
Sbjct: 45 ESRVLKNTRHPFLTS-LKYSFQTKDRLCFVMEYVNGGELFFHLSRERVFSEDRTRFYGAE 103
Query: 117 RIDVLISVANGLDYLHSGYDIPIVHCDMKPSNILLDRDFEAHVSDFGTSRMLDVHLQDLS 176
+ + LDYLHSG IV+ D+K N++LD+D ++DFG + + D +
Sbjct: 104 -------IVSALDYLHSG---KIVYRDLKLENLMLDKDGHIKITDFGLCKE---GITDAA 150
Query: 177 SLSTAFQGTIGYLAPEFAYMRIVTTKVDVFSFGIVVMEFLTKRRP 221
++ T F GT YLAPE VD + G+V+ E + R P
Sbjct: 151 TMKT-FCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLP 194
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, gamma (or Akt3) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-gamma is predominantly expressed in neuronal tissues. Mice deficient in PKB-gamma show a reduction in brain weight due to the decreases in cell size and cell number. PKB-gamma has also been shown to be upregulated in estrogen-deficient breast cancer cells, androgen-independent prostate cancer cells, and primary ovarian tumors. It acts as a key mediator in the genesis of ovarian cancer. Length = 328 |
| >gnl|CDD|143383 cd07878, STKc_p38beta_MAPK11, Catalytic domain of the Serine/Threonine Kinase, p38beta Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 60.1 bits (145), Expect = 2e-10
Identities = 54/201 (26%), Positives = 96/201 (47%), Gaps = 28/201 (13%)
Query: 24 NLSTVYKGRLEDGEIVAVKKLNFHQFSAESDKSFYREAKTLKELKHRNLVKVLGYAWESG 83
++ + Y RL + VAVKKL+ S + YRE + LK +KH N++ +L +
Sbjct: 30 SVCSAYDTRLR--QKVAVKKLSRPFQSLIHARRTYRELRLLKHMKHENVIGLLDVFTPAT 87
Query: 84 KLKAL----ILEYMENGSLESVIHGPGV--DHSRWTLPKRIDVLISVANGLDYLHSGYDI 137
++ ++ + L +++ + +H ++ ++ + GL Y+HS
Sbjct: 88 SIENFNEVYLVTNLMGADLNNIVKCQKLSDEHVQF-------LIYQLLRGLKYIHSA--- 137
Query: 138 PIVHCDMKPSNILLDRDFEAHVSDFGTSRMLDVHLQDLSSLSTAFQGTIGYLAPEFA--Y 195
I+H D+KPSN+ ++ D E + DFG +R D + T + T Y APE +
Sbjct: 138 GIIHRDLKPSNVAVNEDCELRILDFGLARQADDEM-------TGYVATRWYRAPEIMLNW 190
Query: 196 MRIVTTKVDVFSFGIVVMEFL 216
M T VD++S G ++ E L
Sbjct: 191 MHYNQT-VDIWSVGCIMAELL 210
|
Serine/Threonine Kinases (STKs), p38beta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38beta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38beta, also called MAPK11, is widely expressed in tissues and shows more similarity with p38alpha than with the other isoforms. Both are sensitive to pyridinylimidazoles and share some common substrates such as MAPK activated protein kinase 2 (MK2) and the transcription factors ATF2, c-Fos and, ELK-1. p38beta is involved in regulating the activation of the cyclooxygenase-2 promoter and the expression of TGFbeta-induced alpha-smooth muscle cell actin. Length = 343 |
| >gnl|CDD|173735 cd07831, STKc_MOK, Catalytic domain of the Serine/Threonine Kinase, MAPK/MAK/MRK Overlapping Kinase | Back alignment and domain information |
|---|
Score = 59.6 bits (145), Expect = 2e-10
Identities = 58/212 (27%), Positives = 98/212 (46%), Gaps = 33/212 (15%)
Query: 12 GSFSENNIIGNSNLSTVYKGR-LEDGEIVAVKKLNFHQFSAESDKSFYREAKTLKELK-H 69
G+FSE V K + + G+ A+K + H S E + RE + L+ L H
Sbjct: 10 GTFSE-----------VLKAQSRKTGKYYAIKCMKKHFKSLEQVNN-LREIQALRRLSPH 57
Query: 70 RNLVKVLG--YAWESGKLKALILEYMENGSLESVIHGPGVDHSRWTLPKRI-DVLISVAN 126
N+++++ + ++G+L AL+ E M+ +L +I G R KR+ + +
Sbjct: 58 PNILRLIEVLFDRKTGRL-ALVFELMD-MNLYELIKG----RKRPLPEKRVKSYMYQLLK 111
Query: 127 GLDYLHSGYDIPIVHCDMKPSNILLDRDFEAHVSDFGTSRMLDVHLQDLSSLSTAFQGTI 186
LD++H I H D+KP NIL+ D ++DFG+ R + +ST +
Sbjct: 112 SLDHMHR---NGIFHRDIKPENILIKDD-ILKLADFGSCRGIYSKPPYTEYISTRW---- 163
Query: 187 GYLAPE-FAYMRIVTTKVDVFSFGIVVMEFLT 217
Y APE K+D+++ G V E L+
Sbjct: 164 -YRAPECLLTDGYYGPKMDIWAVGCVFFEILS 194
|
Serine/Threonine Kinases (STKs), MAPK/MAK/MRK Overlapping Kinase (MOK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MOK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MOK, also called Renal tumor antigen 1 (RAGE-1), is widely expressed and is enriched in testis, kidney, lung, and brain. It is expressed in approximately 50% of renal cell carcinomas (RCC) and is a potential target for immunotherapy. MOK is stabilized by its association with the HSP90 molecular chaperone. It is induced by the transcription factor Cdx2 and may be involved in regulating intestinal epithelial development and differentiation. Length = 282 |
| >gnl|CDD|143354 cd07849, STKc_ERK1_2_like, Catalytic domain of Extracellular signal-Regulated Kinase 1 and 2-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 60.0 bits (146), Expect = 2e-10
Identities = 57/198 (28%), Positives = 94/198 (47%), Gaps = 34/198 (17%)
Query: 36 GEIVAVKKLNFHQFSAESDKSFY-----REAKTLKELKHRNLVKVLGY----AWESGKLK 86
G VA+KK+ F + + RE K L+ KH N++ +L ++ES
Sbjct: 30 GVKVAIKKI--SPF----EHQTFCQRTLREIKILRRFKHENIIGILDIIRPPSFESFNDV 83
Query: 87 ALILEYMENGSLESVIHGPGV--DHSRWTLPKRIDVLISVANGLDYLHSGYDIPIVHCDM 144
++ E ME L +I + DH ++ L + GL Y+HS ++H D+
Sbjct: 84 YIVQELMET-DLYKLIKTQHLSNDHIQY-------FLYQILRGLKYIHSA---NVLHRDL 132
Query: 145 KPSNILLDRDFEAHVSDFGTSRMLDVHLQDLSSLSTAFQGTIGYLAPEFAYM---RIVTT 201
KPSN+LL+ + + + DFG +R+ D D + T + T Y APE M + T
Sbjct: 133 KPSNLLLNTNCDLKICDFGLARIAD-PEHDHTGFLTEYVATRWYRAPEI--MLNSKGYTK 189
Query: 202 KVDVFSFGIVVMEFLTKR 219
+D++S G ++ E L+ R
Sbjct: 190 AIDIWSVGCILAEMLSNR 207
|
Serine/Threonine Kinases (STKs), Extracellular signal-regulated kinases 1 and 2 (ERK1/2) and Fus3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. This ERK1/2-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the mitogen-activated protein kinases (MAPKs) ERK1, ERK2, baker's yeast Fus3, and similar proteins. MAPK pathways are important mediators of cellular responses to extracellular signals. ERK1/2 activation is preferentially by mitogenic factors, differentiation stimuli, and cytokines, through a kinase cascade involving the MAPK kinases MEK1/2 and a MAPK kinase kinase from the Raf family. ERK1/2 have numerous substrates, many of which are nuclear and participate in transcriptional regulation of many cellular processes. They regulate cell growth, cell proliferation, and cell cycle progression from G1 to S phase. Although the distinct roles of ERK1 and ERK2 have not been fully determined, it is known that ERK2 can maintain most functions in the absence of ERK1, and that the deletion of ERK2 is embryonically lethal. The MAPK, Fus3, regulates yeast mating processes including mating-specific gene expression, G1 arrest, mating projection, and cell fusion. Length = 336 |
| >gnl|CDD|133168 cd05036, PTKc_ALK_LTK, Catalytic domain of the Protein Tyrosine Kinases, Anaplastic Lymphoma Kinase and Leukocyte Tyrosine Kinase | Back alignment and domain information |
|---|
Score = 59.8 bits (145), Expect = 2e-10
Identities = 60/212 (28%), Positives = 100/212 (47%), Gaps = 25/212 (11%)
Query: 18 NIIGNSNLSTVYKG--RLEDGEI----VAVKKLNFHQFSAESDKSFYREAKTLKELKHRN 71
+G+ VY+G R DG+ VAVK L S + + F EA + + H+N
Sbjct: 12 RALGHGAFGEVYEGLYRGRDGDAVELQVAVKTLPESC-SEQDESDFLMEALIMSKFNHQN 70
Query: 72 LVKVLGYAWESGKLKALILEYMENGSLESVIHG--PGVDH-SRWTLPKRIDVLISVANGL 128
+V+++G ++E + ++LE M G L+S + P + S T+ + VA G
Sbjct: 71 IVRLIGVSFERLP-RFILLELMAGGDLKSFLRENRPRPERPSSLTMKDLLFCARDVAKGC 129
Query: 129 DYLHSGYDIPIVHCDMKPSNILL-----DRDFEAHVSDFGTSRMLDVHLQDLSSLSTAFQ 183
YL + +H D+ N LL R A ++DFG +R D++
Sbjct: 130 KYLEENH---FIHRDIAARNCLLTCKGPGR--VAKIADFGMAR--DIYRASYYRKGGRAM 182
Query: 184 GTIGYLAPEFAYMR-IVTTKVDVFSFGIVVME 214
I ++ PE A++ I T+K DV+SFG+++ E
Sbjct: 183 LPIKWMPPE-AFLDGIFTSKTDVWSFGVLLWE 213
|
Protein Tyrosine Kinase (PTK) family; Anaplastic Lymphoma Kinase (ALK) and Leukocyte Tyrosine (tyr) Kinase (LTK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyr residues in protein substrates. ALK and LTK are orphan receptor tyr kinases (RTKs) whose ligands are not yet well-defined. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. They are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. ALK appears to play an important role in mammalian neural development as well as visceral muscle differentiation in Drosophila. ALK is aberrantly expressed as fusion proteins, due to chromosomal translocations, in about 60% of anaplastic large cell lymphomas (ALCLs). ALK fusion proteins are also found in rare cases of diffuse large B cell lymphomas (DLBCLs). LTK is mainly expressed in B lymphocytes and neuronal tissues. It is important in cell proliferation and survival. Transgenic mice expressing TLK display retarded growth and high mortality rate. In addition, a polymorphism in mouse and human LTK is implicated in the pathogenesis of systemic lupus erythematosus. Length = 277 |
| >gnl|CDD|173674 cd05583, STKc_MSK_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase | Back alignment and domain information |
|---|
Score = 59.8 bits (145), Expect = 3e-10
Identities = 62/225 (27%), Positives = 105/225 (46%), Gaps = 33/225 (14%)
Query: 31 GRLEDGEIVAVKKLN-----FHQFSAESDKSFYREAKTLKELKHRNLVKVLGYAWESGKL 85
G + G++ A+K L +AE ++ E + L+ ++ + L YA+++
Sbjct: 23 GGHDAGKLYAMKVLKKATIVQKAKTAEHTRT---ERQVLEAVRRCPFLVTLHYAFQTDTK 79
Query: 86 KALILEYMENGSLESVIHGPGVDHSRWTLPKRIDVLIS-VANGLDYLHSGYDIPIVHCDM 144
LIL+Y+ G L + ++ + V I+ + LD+LH + I++ D+
Sbjct: 80 LHLILDYVNGGELFTHLY-----QREHFTESEVRVYIAEIVLALDHLHQ---LGIIYRDI 131
Query: 145 KPSNILLDRDFEAHVSDFGTSRMLDVHLQDLSSLSTAFQGTIGYLAPEFAYMRIVTTK-- 202
K NILLD + ++DFG S+ L + + +F GTI Y+APE ++
Sbjct: 132 KLENILLDSEGHVVLTDFGLSKEF---LAEEEERAYSFCGTIEYMAPE-----VIRGGSG 183
Query: 203 -----VDVFSFGIVVMEFLTKRRPTGLD-EENGLSPISLRQLVEK 241
VD +S G++ E LT P +D E+N S IS R L K
Sbjct: 184 GHDKAVDWWSLGVLTFELLTGASPFTVDGEQNSQSEISRRILKSK 228
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, in response to various stimuli such as growth factors, hormones, neurotransmitters, cellular stress, and pro-inflammatory cytokines. This triggers phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydrophobic motif (HM) in the C-terminal extension of NTD, which facilitates the phosphorylation of the A-loop and activates the NTD, which in turn phosphorylates downstream targets. MSKs are predominantly nuclear proteins. They are widely expressed in many tissues including heart, brain, lung, liver, kidney, and pancreas. There are two isoforms of MSK, called MSK1 and MSK2. Length = 288 |
| >gnl|CDD|173671 cd05580, STKc_PKA, Catalytic domain of the Protein Serine/Threonine Kinase, cAMP-dependent protein kinase | Back alignment and domain information |
|---|
Score = 59.5 bits (145), Expect = 3e-10
Identities = 53/193 (27%), Positives = 88/193 (45%), Gaps = 38/193 (19%)
Query: 36 GEIVAVKKLNFHQF----SAESDKSFYREAKTLKELKHRNLVKVLGYAWESGKLKALILE 91
G+ A+K L+ + E + E + L+ ++H LV + G +++ L++E
Sbjct: 26 GKYYALKILSKAKIVKLKQVEHVLN---EKRILQSIRHPFLVNLYG-SFQDDSNLYLVME 81
Query: 92 YMENGSLES---VIHGPGVDHSRWTLPKRIDVLISVANGLDYLHSGYDIPIVHCDMKPSN 148
Y+ G L S +R+ + V L+YLHS + IV+ D+KP N
Sbjct: 82 YVPGGELFSHLRKSGRFPEPVARFYAAQ-------VVLALEYLHS---LDIVYRDLKPEN 131
Query: 149 ILLDRDFEAHVSDFGTSRMLDVHLQDLSSLSTAFQGTIGYLAPEFAYMRIVTTK-----V 203
+LLD D ++DFG ++ + L GT YLAPE I+ +K V
Sbjct: 132 LLLDSDGYIKITDFGFAKRVKGRTYTLC-------GTPEYLAPE-----IILSKGYGKAV 179
Query: 204 DVFSFGIVVMEFL 216
D ++ GI++ E L
Sbjct: 180 DWWALGILIYEML 192
|
Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This subfamily is composed of the cAMP-dependent proteins kinases, PKA and PRKX. The inactive PKA holoenzyme is a heterotetramer composed of two phosphorylated and active catalytic (C) subunits with a dimer of regulatory (R) subunits. Activation is achieved through the binding of the important second messenger cAMP to the R subunits, which leads to the dissociation of PKA into the R dimer and two active C subunits. PKA is present ubiquitously in cells and interacts with many different downstream targets. It plays a role in the regulation of diverse processes such as growth, development, memory, metabolism, gene expression, immunity, and lipolysis. Length = 290 |
| >gnl|CDD|173655 cd05110, PTKc_HER4, Catalytic domain of the Protein Tyrosine Kinase, HER4 | Back alignment and domain information |
|---|
Score = 59.7 bits (144), Expect = 3e-10
Identities = 52/204 (25%), Positives = 100/204 (49%), Gaps = 16/204 (7%)
Query: 19 IIGNSNLSTVYKG-RLEDGEIV----AVKKLNFHQFSAESDKSFYREAKTLKELKHRNLV 73
++G+ TVYKG + +GE V A+K LN +++ F EA + + H +LV
Sbjct: 14 VLGSGAFGTVYKGIWVPEGETVKIPVAIKILN-ETTGPKANVEFMDEALIMASMDHPHLV 72
Query: 74 KVLGYAWESGKLKALILEYMENGSLESVIHGPGVDHSRWTLPKRIDVLISVANGLDYLHS 133
++LG L+ + M +G L +H + L ++ + +A G+ YL
Sbjct: 73 RLLGVCLSP--TIQLVTQLMPHGCLLDYVHEHKDNIGSQLL---LNWCVQIAKGMMYLE- 126
Query: 134 GYDIPIVHCDMKPSNILLDRDFEAHVSDFGTSRMLDVHLQDLSSLSTAFQGTIGYLAPEF 193
+ +VH D+ N+L+ ++DFG +R+L+ ++ + + + I ++A E
Sbjct: 127 --ERRLVHRDLAARNVLVKSPNHVKITDFGLARLLEGDEKEYN--ADGGKMPIKWMALEC 182
Query: 194 AYMRIVTTKVDVFSFGIVVMEFLT 217
+ R T + DV+S+G+ + E +T
Sbjct: 183 IHYRKFTHQSDVWSYGVTIWELMT 206
|
Protein Tyrosine Kinase (PTK) family; HER4 (ErbB4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER4 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. Ligands that bind HER4 fall into two groups, the neuregulins (or heregulins) and some EGFR (HER1) ligands including betacellulin, HBEGF, and epiregulin. All four neuregulins (NRG1-4) interact with HER4. Upon ligand binding, HER4 forms homo- or heterodimers with other HER proteins. HER4 is essential in embryonic development. It is implicated in mammary gland, cardiac, and neural development. As a postsynaptic receptor of NRG1, HER4 plays an important role in synaptic plasticity and maturation. The impairment of NRG1/HER4 signaling may contribute to schizophrenia. Length = 303 |
| >gnl|CDD|173704 cd05613, STKc_MSK1_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 1 | Back alignment and domain information |
|---|
Score = 59.2 bits (143), Expect = 4e-10
Identities = 59/214 (27%), Positives = 98/214 (45%), Gaps = 31/214 (14%)
Query: 60 EAKTLKELKHRNLVKVLGYAWESGKLKALILEYMENGSLESVIHGPGVDHSRWTLPKRID 119
E + L+ ++ + L YA+++ LIL+Y+ G L + + R+ +
Sbjct: 54 ERQVLEHIRQSPFLVTLHYAFQTDTKLHLILDYINGGELFTHL----SQRERFKEQEVQI 109
Query: 120 VLISVANGLDYLHSGYDIPIVHCDMKPSNILLDRDFEAHVSDFGTSRMLDVHLQDLSSLS 179
+ L++LH + I++ D+K NILLD + ++DFG S+ +D +
Sbjct: 110 YSGEIVLALEHLHK---LGIIYRDIKLENILLDSNGHVVLTDFGLSKEF---HEDEVERA 163
Query: 180 TAFQGTIGYLAPEFAYMRIVT-------TKVDVFSFGIVVMEFLTKRRPTGLD-EENGLS 231
+F GTI Y+AP+ IV VD +S G+++ E LT P +D E+N +
Sbjct: 164 YSFCGTIEYMAPD-----IVRGGDGGHDKAVDWWSMGVLMYELLTGASPFTVDGEKNSQA 218
Query: 232 PISLRQLVEK--------ALANGINGVRQITDPK 257
IS R L + ALA I + DPK
Sbjct: 219 EISRRILKSEPPYPQEMSALAKDIIQRLLMKDPK 252
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK1, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydrophobic motif (HM) of NTD, which facilitates the phosphorylation of the A-loop and activates the NTD, which in turn phosphorylates downstream targets. MSK1 plays a role in the regulation of translational control and transcriptional activation. It phosphorylates the transcription factors, CREB and NFkappaB. It also phosphorylates the nucleosomal proteins H3 and HMG-14. Increased phosphorylation of MEK1 is associated with the development of cerebral ischemic/hypoxic preconditioning. Length = 290 |
| >gnl|CDD|132964 cd06633, STKc_TAO3, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 3 | Back alignment and domain information |
|---|
Score = 58.9 bits (142), Expect = 5e-10
Identities = 64/214 (29%), Positives = 100/214 (46%), Gaps = 36/214 (16%)
Query: 20 IGNSNLSTVY-KGRLEDGEIVAVKKLNFH-QFSAESDKSFYREAKTLKELKHRNLVKVLG 77
IG+ + VY E+VAVKK+++ + + E + +E K L++LKH N ++ G
Sbjct: 29 IGHGSFGAVYFATNSHTNEVVAVKKMSYSGKQTNEKWQDIIKEVKFLQQLKHPNTIEYKG 88
Query: 78 ------YAWESGKLKALILEYMENGSLESVIHGPGVDHSRWTLPKRIDVLISVA-NGLDY 130
AW L++EY GS ++ H + I + A GL Y
Sbjct: 89 CYLKEHTAW-------LVMEYCL-GSASDLLEV----HKKPLQEVEIAAITHGALQGLAY 136
Query: 131 LHSGYDIPIVHCDMKPSNILLDRDFEAHVSDFGTSRMLDVHLQDLSSLSTAFQGTIGYLA 190
LHS ++H D+K NILL + ++DFG++ SS + +F GT ++A
Sbjct: 137 LHSH---NMIHRDIKAGNILLTEPGQVKLADFGSA--------SKSSPANSFVGTPYWMA 185
Query: 191 PEFAYMR---IVTTKVDVFSFGIVVMEFLTKRRP 221
PE KVDV+S GI +E L +R+P
Sbjct: 186 PEVILAMDEGQYDGKVDVWSLGITCIE-LAERKP 218
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 3 (TAO3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO3 is also known as JIK (JNK inhibitory kinase) or KFC (kinase from chicken). It specifically activates c-Jun N-terminal kinase (JNK), presumably by phosphorylating and activating MKK4/MKK7. In Saccharomyces cerevisiae, TAO3 is a component of the RAM (regulation of Ace2p activity and cellular morphogenesis) signaling pathway. TAO3 is upregulated in retinal ganglion cells after axotomy, and may play a role in apoptosis. Length = 313 |
| >gnl|CDD|173720 cd05631, STKc_GRK4, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 4 | Back alignment and domain information |
|---|
Score = 58.9 bits (142), Expect = 5e-10
Identities = 53/189 (28%), Positives = 81/189 (42%), Gaps = 16/189 (8%)
Query: 36 GEIVAVKKLNFHQFSAESDKSFYREAKTLKELKHRNLVKVLGYAWESGKLKALILEYMEN 95
G++ A KKL + ++ K + E + V L YA+E+ L+L M
Sbjct: 25 GKMYACKKLEKKRIKKRKGEAMALNEKRILEKVNSRFVVSLAYAYETKDALCLVLTIMNG 84
Query: 96 GSLESVIHG---PGVDHSRWTLPKRIDVLISVANGLDYLHSGYDIPIVHCDMKPSNILLD 152
G L+ I+ PG D R I + GL+ L IV+ D+KP NILLD
Sbjct: 85 GDLKFHIYNMGNPGFDEQR-----AIFYAAELCCGLEDLQRER---IVYRDLKPENILLD 136
Query: 153 RDFEAHVSDFGTSRMLDVHLQDLSSLSTAFQGTIGYLAPEFAYMRIVTTKVDVFSFGIVV 212
+SD G L V + + ++ GT+GY+APE T D + G ++
Sbjct: 137 DRGHIRISDLG----LAVQIPEGETVRGRV-GTVGYMAPEVINNEKYTFSPDWWGLGCLI 191
Query: 213 MEFLTKRRP 221
E + + P
Sbjct: 192 YEMIQGQSP 200
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK4 has a limited tissue distribution. It is mainly found in the testis, but is also present in the cerebellum and kidney. It is expressed as multiple splice variants with different domain architectures. It is post-translationally palmitoylated and localized in the membrane. GRK4 polymorphisms are associated with hypertension and salt sensitivity, as they cause hyperphosphorylation, desensitization, and internalization of the dopamine 1 (D1) receptor while increasing the expression of the angiotensin II type 1 receptor. GRK4 plays a crucial role in the D1 receptor regulation of sodium excretion and blood pressure. Length = 285 |
| >gnl|CDD|133219 cd05088, PTKc_Tie2, Catalytic domain of the Protein Tyrosine Kinase, Tie2 | Back alignment and domain information |
|---|
Score = 58.9 bits (142), Expect = 5e-10
Identities = 69/302 (22%), Positives = 135/302 (44%), Gaps = 58/302 (19%)
Query: 18 NIIGNSNLSTVYKGRLEDGEI---VAVKKLNFHQFSAESD-KSFYREAKTLKEL-KHRNL 72
++IG N V K R++ + A+K++ +++++ D + F E + L +L H N+
Sbjct: 13 DVIGEGNFGQVLKARIKKDGLRMDAAIKRMK--EYASKDDHRDFAGELEVLCKLGHHPNI 70
Query: 73 VKVLGYAWESGKLKALILEYMENGSLESVIHGPGVDHS--RWTLPKRIDVLIS------- 123
+ +LG G L L +EY +G+L + V + + + +S
Sbjct: 71 INLLGACEHRGYL-YLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHF 129
Query: 124 ---VANGLDYLHSGYDIPIVHCDMKPSNILLDRDFEAHVSDFGTSRMLDVHLQDLSSLST 180
VA G+DYL +H D+ NIL+ ++ A ++DFG SR +V+++ T
Sbjct: 130 AADVARGMDYLSQK---QFIHRDLAARNILVGENYVAKIADFGLSRGQEVYVK-----KT 181
Query: 181 AFQGTIGYLAPEFAYMRIVTTKVDVFSFGIVVMEFLTKRRPTGLDEENGLSP---ISLRQ 237
+ + ++A E + TT DV+S+G+++ E ++ G +P ++ +
Sbjct: 182 MGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSL----------GGTPYCGMTCAE 231
Query: 238 LVEKALANGINGVRQITDPKLVSSIYEEQEQHQVLEELFKLALVCTSSNPEDRPNMNELL 297
L EK L G Y ++ +E++ L C P +RP+ ++L
Sbjct: 232 LYEK-LPQG----------------YRLEKPLNCDDEVYDLMRQCWREKPYERPSFAQIL 274
Query: 298 IT 299
++
Sbjct: 275 VS 276
|
Protein Tyrosine Kinase (PTK) family; Tie2; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie2 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie2 is expressed mainly in endothelial cells and hematopoietic stem cells. It is also found in a subset of tumor-associated monocytes and eosinophils. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2. The binding of Ang-1 to Tie2 leads to receptor autophosphorylation and activation, promoting cell migration and survival. In contrast, Ang-2 binding to Tie2 does not result in the same response, suggesting that Ang-2 may function as an antagonist. Tie2 signaling plays key regulatory roles in vascular integrity and quiescence, and in inflammation. Length = 303 |
| >gnl|CDD|173712 cd05622, STKc_ROCK1, Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 1 | Back alignment and domain information |
|---|
Score = 59.3 bits (143), Expect = 6e-10
Identities = 53/214 (24%), Positives = 100/214 (46%), Gaps = 25/214 (11%)
Query: 12 GSFSENNIIGNSNLSTVYKGRLEDGEIVAVKKLNFHQFSAESDKSFYREAKTLKELKHRN 71
G+F E ++ + + VY A+K L+ + SD +F+ E + + +
Sbjct: 54 GAFGEVQLVRHKSTRKVY----------AMKLLSKFEMIKRSDSAFFWEERDIMAFANSP 103
Query: 72 LVKVLGYAWESGKLKALILEYMENGSLESVIHGPGVDHSRWTLPKRIDVLISVANGLDYL 131
V L YA++ + +++EYM G L +++ V +W +V+++ LD +
Sbjct: 104 WVVQLFYAFQDDRYLYMVMEYMPGGDLVNLMSNYDVP-EKWARFYTAEVVLA----LDAI 158
Query: 132 HSGYDIPIVHCDMKPSNILLDRDFEAHVSDFGTSRMLDVHLQDLSSLSTAFQGTIGYLAP 191
HS + +H D+KP N+LLD+ ++DFGT + ++ + + TA GT Y++P
Sbjct: 159 HS---MGFIHRDVKPDNMLLDKSGHLKLADFGTC--MKMNKEGMVRCDTAV-GTPDYISP 212
Query: 192 EFAYMR----IVTTKVDVFSFGIVVMEFLTKRRP 221
E + + D +S G+ + E L P
Sbjct: 213 EVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTP 246
|
Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK1 (or ROK-beta) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK1 is preferentially expressed in the liver, lung, spleen, testes, and kidney. It mediates signaling from Rho to the actin cytoskeleton. It is implicated in the development of cardiac fibrosis, cardiomyocyte apoptosis, and hyperglycemia. Mice deficient with ROCK1 display eyelids open at birth (EOB) and omphalocele phenotypes due to the disorganization of actin filaments in the eyelids and the umbilical ring. Length = 371 |
| >gnl|CDD|173691 cd05600, STKc_Sid2p_Dbf2p, Catalytic domain of Fungal Sid2p- and Dbf2p-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 59.0 bits (143), Expect = 6e-10
Identities = 57/204 (27%), Positives = 97/204 (47%), Gaps = 25/204 (12%)
Query: 20 IGNSNLSTVYKGRLED-GEIVAVKKLNFHQ-FSAESDKSFYREAKTLKELKHRNLVKVLG 77
+G V+ + +D GEIVA+K++ F + E L K LVK+L
Sbjct: 9 VGQGGYGQVFLAKKKDTGEIVALKRMKKSLLFKLNEVRHVLTERDILTTTKSEWLVKLL- 67
Query: 78 YAWESGKLKALILEYMENGSLESVIHGPGV---DHSRWTLPKRIDVLISVANGLDYLHS- 133
YA++ + L +EY+ G ++++ GV DH+R+ + ++ +V D LH
Sbjct: 68 YAFQDDEYLYLAMEYVPGGDFRTLLNNLGVLSEDHARFYM---AEMFEAV----DALHEL 120
Query: 134 GYDIPIVHCDMKPSNILLDRDFEAHVSDFGTSRMLDVHLQDLSSLSTAFQGTIGYLAPEF 193
GY +H D+KP N L+D ++DFG S+ + + + + G+ Y+APE
Sbjct: 121 GY----IHRDLKPENFLIDASGHIKLTDFGLSK-------GIVTYANSVVGSPDYMAPEV 169
Query: 194 AYMRIVTTKVDVFSFGIVVMEFLT 217
+ VD +S G ++ EFL
Sbjct: 170 LRGKGYDFTVDYWSLGCMLYEFLC 193
|
Serine/Threonine Kinases (STKs), ROCK- and NDR-like subfamily, fungal Sid2p- and Dbf2p-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sid2p- and Dbf2p-like group is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group contains fungal kinases including Schizosaccharomyces pombe Sid2p and Saccharomyces cerevisiae Dbf2p. Group members show similarity to NDR kinases in that they contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Sid2p plays a crucial role in the septum initiation network (SIN) and in the initiation of cytokinesis. Dbf2p is important in regulating the mitotic exit network (MEN) and in cytokinesis. Length = 333 |
| >gnl|CDD|143359 cd07854, STKc_MAPK4_6, Catalytic domain of the Serine/Threonine Kinases, Mitogen-Activated Protein Kinases 4 and 6 | Back alignment and domain information |
|---|
Score = 58.6 bits (142), Expect = 7e-10
Identities = 57/200 (28%), Positives = 93/200 (46%), Gaps = 35/200 (17%)
Query: 39 VAVKKLNFHQFSAESDKSFYREAKTLKELKHRNLVKVLGYAWESG-----------KLKA 87
VAVKK+ +S K RE K ++ L H N+VKV SG +L +
Sbjct: 33 VAVKKIVLTD--PQSVKHALREIKIIRRLDHDNIVKVYEVLGPSGSDLTEDVGSLTELNS 90
Query: 88 L--ILEYMENGSLESVI-HGP-GVDHSRWTLPKRIDVLISVANGLDYLHSGYDIPIVHCD 143
+ + EYME L +V+ GP +H+R + + GL Y+HS ++H D
Sbjct: 91 VYIVQEYMET-DLANVLEQGPLSEEHARL-------FMYQLLRGLKYIHSA---NVLHRD 139
Query: 144 MKPSNILLD-RDFEAHVSDFGTSRMLDVHLQDLSSLSTAFQGTIG--YLAPEFAYM-RIV 199
+KP+N+ ++ D + DFG +R++D H LS +G + Y +P
Sbjct: 140 LKPANVFINTEDLVLKIGDFGLARIVDPHYSHKGYLS---EGLVTKWYRSPRLLLSPNNY 196
Query: 200 TTKVDVFSFGIVVMEFLTKR 219
T +D+++ G + E LT +
Sbjct: 197 TKAIDMWAAGCIFAEMLTGK 216
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 4 (MAPK4) and MAPK6 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK4/6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. MAPK4 is also called ERK4 or p63MAPK, while MAPK6 is also called ERK3 or p97MAPK. MAPK4 and MAPK6 are atypical MAPKs that are not regulated by MAP2Ks. MAPK6 is expressed ubiquitously with highest amounts in brain and skeletal muscle. It may be involved in the control of cell differentiation by negatively regulating cell cycle progression in certain conditions. It may also play a role in glucose-induced insulin secretion. MAPK6 and MAPK4 cooperate to regulate the activity of MAPK-activated protein kinase 5 (MK5), leading to its relocation to the cytoplasm and exclusion from the nucleus. The MAPK6/MK5 and MAPK4/MK5 pathways may play critical roles in embryonic and post-natal development. Length = 342 |
| >gnl|CDD|133240 cd05109, PTKc_HER2, Catalytic domain of the Protein Tyrosine Kinase, HER2 | Back alignment and domain information |
|---|
Score = 58.1 bits (140), Expect = 7e-10
Identities = 69/290 (23%), Positives = 126/290 (43%), Gaps = 52/290 (17%)
Query: 19 IIGNSNLSTVYKG-RLEDGE----IVAVKKLNFHQFSAESDKSFYREAKTLKELKHRNLV 73
++G+ TVYKG + DGE VA+K L S +++K EA + + +
Sbjct: 14 VLGSGAFGTVYKGIWIPDGENVKIPVAIKVLR-ENTSPKANKEILDEAYVMAGVGSPYVC 72
Query: 74 KVLGYAWESGKLKALILEYMENGSLESVIHGPGVDHSRWTLPKRI---DVL---ISVANG 127
++LG S L+ + M G L +D+ R RI D+L + +A G
Sbjct: 73 RLLGICLTS--TVQLVTQLMPYGCL--------LDYVREN-KDRIGSQDLLNWCVQIAKG 121
Query: 128 LDYLHSGYDIPIVHCDMKPSNILLDRDFEAHVSDFGTSRMLDVHLQDLSSLSTAFQGTIG 187
+ YL ++ +VH D+ N+L+ ++DFG +R+LD+ + + + I
Sbjct: 122 MSYLE---EVRLVHRDLAARNVLVKSPNHVKITDFGLARLLDIDETEYH--ADGGKVPIK 176
Query: 188 YLAPEFAYMRIVTTKVDVFSFGIVVMEFLTKRRPTGLDEENGLSPISLRQLVEKALANGI 247
++A E R T + DV+S+G+ V E +T G +G+ + L+EK
Sbjct: 177 WMALESILHRRFTHQSDVWSYGVTVWELMT----FGAKPYDGIPAREIPDLLEKG----- 227
Query: 248 NGVRQITDPKLVSSIYEEQEQHQVLEELFKLALVCTSSNPEDRPNMNELL 297
++ P + + +++ + + C + E RP EL+
Sbjct: 228 ---ERLPQPPICT------------IDVYMIMVKCWMIDSECRPRFRELV 262
|
Protein Tyrosine Kinase (PTK) family; HER2 (ErbB2, HER2/neu); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER2 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. HER2 does not bind to any known EGFR subfamily ligands, but contributes to the kinase activity of all possible heterodimers. It acts as the preferred partner with other ligand-bound EGFR proteins and functions as a signal amplifier, with the HER2-HER3 heterodimer being the most potent pair in mitogenic signaling. HER2 plays an important role in cell development, proliferation, survival and motility. Overexpression of HER2 results in its activation and downstream signaling, even in the absence of ligand. HER2 overexpression, mainly due to gene amplification, has been shown in a variety of human cancers. Its role in breast cancer is especially well-documented. HER2 is up-regulated in about 25% of breast tumors and is associated with increases in tumor aggressiveness, recurrence and mortality. HER2 is a target for monoclonal antibodies and small molecule inhibitors, which are being developed as treatments for cancer. The first humanized antibody approved for clinical use is Trastuzumab (Herceptin), which is being used in combination with other therapies to improve the survival rates of patients with HER2-overexpressing breast cancer. Length = 279 |
| >gnl|CDD|173654 cd05108, PTKc_EGFR, Catalytic domain of the Protein Tyrosine Kinase, Epidermal Growth Factor Receptor | Back alignment and domain information |
|---|
Score = 58.5 bits (141), Expect = 8e-10
Identities = 68/291 (23%), Positives = 131/291 (45%), Gaps = 42/291 (14%)
Query: 14 FSENNIIGNSNLSTVYKGR-LEDGE----IVAVKKLNFHQFSAESDKSFYREAKTLKELK 68
F + ++G+ TVYKG + +GE VA+K+L S +++K EA + +
Sbjct: 9 FKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELR-EATSPKANKEILDEAYVMASVD 67
Query: 69 HRNLVKVLGYAWESGKLKALILEYMENGSL-ESVIHGPGVDHSRWTLPKRIDVLISVANG 127
+ ++ ++LG S LI + M G L + V S++ L + + +A G
Sbjct: 68 NPHVCRLLGICLTSTV--QLITQLMPFGCLLDYVREHKDNIGSQYLL----NWCVQIAKG 121
Query: 128 LDYLHSGYDIPIVHCDMKPSNILLDRDFEAHVSDFGTSRMLDVHLQDLSSLSTAFQGTIG 187
++YL + +VH D+ N+L+ ++DFG +++L ++ + + I
Sbjct: 122 MNYLE---ERRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGADEKEYHA--EGGKVPIK 176
Query: 188 YLAPEFAYMRIVTTKVDVFSFGIVVMEFLTKRRPTGLDEENGLSPISLRQLVEKALANGI 247
++A E RI T + DV+S+G+ V E +T G +G+ + ++EK
Sbjct: 177 WMALESILHRIYTHQSDVWSYGVTVWELMT----FGSKPYDGIPASEISSILEK------ 226
Query: 248 NGVRQITDPKLVSSIYEEQEQHQVLEELFKLALVCTSSNPEDRPNMNELLI 298
G R P + +I +++ + + C + + RP EL+I
Sbjct: 227 -GERLPQPP--ICTI-----------DVYMIMVKCWMIDADSRPKFRELII 263
|
Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EGFR (HER1, ErbB1) is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. Ligands for EGFR include EGF, heparin binding EGF-like growth factor (HBEGF), epiregulin, amphiregulin, TGFalpha, and betacellulin. Upon ligand binding, EGFR can form homo- or heterodimers with other EGFR subfamily members. The EGFR signaling pathway is one of the most important pathways regulating cell proliferation, differentiation, survival, and growth. Overexpression and mutation in the kinase domain of EGFR have been implicated in the development and progression of a variety of cancers. A number of monoclonal antibodies and small molecule inhibitors have been developed that target EGFR, including the antibodies Cetuximab and Panitumumab, which are used in combination with other therapies for the treatment of colorectal cancer and non-small cell lung carcinoma (NSCLC). The small molecule inhibitors Gefitinib (Iressa) and Erlotinib (Tarceva), already used for NSCLC, are undergoing clinical trials for other types of cancer including gastrointestinal, breast, head and neck, and bladder. Length = 316 |
| >gnl|CDD|132949 cd06618, PKc_MKK7, Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 7 | Back alignment and domain information |
|---|
Score = 58.2 bits (141), Expect = 8e-10
Identities = 63/224 (28%), Positives = 95/224 (42%), Gaps = 51/224 (22%)
Query: 20 IGNSNLSTVYKGRLE-DGEIVAVKKLNFHQFSAESDKSFYREAKT-LKELKHRNLVKVLG 77
IG+ VYK R + G ++AVK++ + E +K + LK +VK G
Sbjct: 23 IGSGTCGQVYKMRFKKTGHVMAVKQMRRTG-NKEENKRILMDLDVVLKSHDCPYIVKCYG 81
Query: 78 Y------AWESGKLKALILEYMENGSLESVIHGPGVDHSRWTLPKRI--DVLISVANGLD 129
Y + +L + L+ L I GP +P+ I + +++ L
Sbjct: 82 YFITDSDVFICMELMSTCLD-----KLLKRIQGP--------IPEDILGKMTVAIVKALH 128
Query: 130 YL---HSGYDIPIVHCDMKPSNILLDRDFEAHVSDFGTS-RMLDVHLQDLSSLSTAFQGT 185
YL H ++H D+KPSNILLD + DFG S R++D S T G
Sbjct: 129 YLKEKHG-----VIHRDVKPSNILLDASGNVKLCDFGISGRLVD------SKAKTRSAGC 177
Query: 186 IGYLAPEFAYMRI--------VTTKVDVFSFGIVVMEFLTKRRP 221
Y+APE RI + DV+S GI ++E T + P
Sbjct: 178 AAYMAPE----RIDPPDPNPKYDIRADVWSLGISLVELATGQFP 217
|
Protein kinases (PKs), MAP kinase kinase 7 (MKK7) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK7 is a dual-specificity PK that phosphorylates and activates its downstream target, c-Jun N-terminal kinase (JNK), on specific threonine and tyrosine residues. Although MKK7 is capable of dual phosphorylation, it prefers to phosphorylate the threonine residue of JNK. Thus, optimal activation of JNK requires both MKK4 (not included in this subfamily) and MKK7. MKK7 is primarily activated by cytokines. MKK7 is essential for liver formation during embryogenesis. It plays roles in G2/M cell cycle arrest and cell growth. In addition, it is involved in the control of programmed cell death, which is crucial in oncogenesis, cancer chemoresistance, and antagonism to TNFalpha-induced killing, through its inhibition by Gadd45beta and the subsequent suppression of the JNK cascade. Length = 296 |
| >gnl|CDD|143372 cd07867, STKc_CDC2L6, Catalytic domain of Serine/Threonine Kinase, Cell Division Cycle 2-like 6 | Back alignment and domain information |
|---|
Score = 58.5 bits (141), Expect = 8e-10
Identities = 55/210 (26%), Positives = 96/210 (45%), Gaps = 19/210 (9%)
Query: 20 IGNSNLSTVYKGRLEDGEIVAVKKLNFHQFSAES-DKSFYREAKTLKELKHRNLVKVLG- 77
+G VYK + +DG+ K+ Q S RE L+ELKH N++ +
Sbjct: 9 VGRGTYGHVYKAKRKDGK--DEKEYALKQIEGTGISMSACREIALLRELKHPNVIALQKV 66
Query: 78 YAWESGKLKALILEYMENGSLESVI---HGPGVDHSRWTLPKRI--DVLISVANGLDYLH 132
+ S + L+ +Y E+ L +I + LP+ + +L + +G+ YLH
Sbjct: 67 FLSHSDRKVWLLFDYAEH-DLWHIIKFHRASKANKKPMQLPRSMVKSLLYQILDGIHYLH 125
Query: 133 SGYDIPIVHCDMKPSNILL----DRDFEAHVSDFGTSRMLDVHLQDLSSLSTAFQGTIGY 188
+ + ++H D+KP+NIL+ ++D G +R+ + L+ L+ L T Y
Sbjct: 126 ANW---VLHRDLKPANILVMGEGPERGRVKIADMGFARLFNSPLKPLADLDPVVV-TFWY 181
Query: 189 LAPEFAY-MRIVTTKVDVFSFGIVVMEFLT 217
APE R T +D+++ G + E LT
Sbjct: 182 RAPELLLGARHYTKAIDIWAIGCIFAELLT 211
|
Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 6 (CDC2L6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L6 is also called CDK8-like and was previously referred to as CDK11. However, this is a confusing nomenclature as CDC2L6 is distinct from CDC2L1, which is represented by the two protein products from its gene, called CDK11(p110) and CDK11(p58), as well as the caspase-processed CDK11(p46). CDK11(p110), CDK11(p58), and CDK11(p46)do not belong to this subfamily. CDC2L6 is an associated protein of Mediator, a multiprotein complex that provides a platform to connect transcriptional and chromatin regulators and cofactors, in order to activate and mediate RNA polymerase II transcription. CDC2L6 is localized mainly in the nucleus amd exerts an opposing effect to CDK8 in VP16-dependent transcriptional activation by being a negative regulator. Length = 317 |
| >gnl|CDD|173748 cd07853, STKc_NLK, Catalytic domain of the Serine/Threonine Kinase, Nemo-Like Kinase | Back alignment and domain information |
|---|
Score = 58.2 bits (141), Expect = 1e-09
Identities = 58/194 (29%), Positives = 88/194 (45%), Gaps = 24/194 (12%)
Query: 35 DGEIVAVKKLN--FHQFSAESDKSFYREAKTLKELKHRNLVKVLGYAWESGKLKALILEY 92
DG+ VA+KK+ F S K +RE K L KH N++ L L+ ++
Sbjct: 24 DGKRVALKKMPNVFQNLV--SCKRVFRELKMLCFFKHDNVLSALDI------LQPPHIDP 75
Query: 93 ME-----NGSLESVIHGPGVDHSRWTLPKRIDV-LISVANGLDYLHSGYDIPIVHCDMKP 146
E ++S +H V + + V L + GL YLHS I+H D+KP
Sbjct: 76 FEEIYVVTELMQSDLHKIIVSPQPLS-SDHVKVFLYQILRGLKYLHSAG---ILHRDIKP 131
Query: 147 SNILLDRDFEAHVSDFGTSRMLDVHLQDLSSLSTAFQGTIGYLAPEFAY-MRIVTTKVDV 205
N+L++ + + DFG +R+ + D S T T Y APE R T+ VD+
Sbjct: 132 GNLLVNSNCVLKICDFGLARVEE---PDESKHMTQEVVTQYYRAPEILMGSRHYTSAVDI 188
Query: 206 FSFGIVVMEFLTKR 219
+S G + E L +R
Sbjct: 189 WSVGCIFAELLGRR 202
|
Serine/Threonine Kinases (STKs), Nemo-Like Kinase (NLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mitogen-activated protein kinases (MAPKs) are important mediators of cellular responses to extracellular signals. NLK is an atypical MAPK that is not regulated by a MAPK kinase. It functions downstream of the MAPK kinase kinase Tak1, which also plays a role in activating the JNK and p38 MAPKs. The Tak1/NLK pathways are regulated by Wnts, a family of secreted proteins that is critical in the control of asymmetric division and cell polarity. NLK can phosphorylate transcription factors from the TCF/LEF family, inhibiting their ability to activate the transcription of target genes. In prostate cancer cells, NLK is involved in regulating androgen receptor-mediated transcription and its expression is altered during cancer progression. Length = 372 |
| >gnl|CDD|173675 cd05584, STKc_p70S6K, Catalytic domain of the Protein Serine/Threonine Kinase, 70 kDa ribosomal protein S6 kinase | Back alignment and domain information |
|---|
Score = 57.9 bits (140), Expect = 1e-09
Identities = 55/166 (33%), Positives = 86/166 (51%), Gaps = 20/166 (12%)
Query: 60 EAKTLKELKHRNLVKVLGYAWESGKLKALILEYMENGSLESVIHGPGV---DHSRWTLPK 116
E L+ +KH +V L YA+++G LILEY+ G L + G+ D + + L +
Sbjct: 50 ERNILEAVKHPFIVD-LIYAFQTGGKLYLILEYLSGGELFMHLEREGIFMEDTACFYLSE 108
Query: 117 RIDVLISVANGLDYLHSGYDIPIVHCDMKPSNILLDRDFEAHVSDFGTSRMLDVHLQDLS 176
IS+A L++LH I++ D+KP NILLD ++DFG + + +
Sbjct: 109 -----ISLA--LEHLHQ---QGIIYRDLKPENILLDAQGHVKLTDFGLCKE---SIHE-G 154
Query: 177 SLSTAFQGTIGYLAPEFAYMRIVTTK-VDVFSFGIVVMEFLTKRRP 221
+++ F GTI Y+APE MR K VD +S G ++ + LT P
Sbjct: 155 TVTHTFCGTIEYMAPEIL-MRSGHGKAVDWWSLGALMYDMLTGAPP 199
|
Serine/Threonine Kinases (STKs), 70 kDa ribosomal protein S6 kinase (p70S6K) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p70S6K subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p70S6K (or S6K) contains only one catalytic kinase domain, unlike p90 ribosomal S6 kinases (RSKs). It acts as a downstream effector of the STK mTOR (mammalian Target of Rapamycin) and plays a role in the regulation of the translation machinery during protein synthesis. p70S6K also plays a pivotal role in regulating cell size and glucose homeostasis. Its targets include S6, the translation initiation factor eIF3, and the insulin receptor substrate IRS-1, among others. Mammals contain two isoforms of p70S6K, named S6K1 and S6K2 (or S6K-beta). Length = 323 |
| >gnl|CDD|173750 cd07857, STKc_MPK1, Catalytic domain of the Serine/Threonine Kinase, Fungal Mitogen-Activated Protein Kinase MPK1 | Back alignment and domain information |
|---|
Score = 58.2 bits (141), Expect = 1e-09
Identities = 57/199 (28%), Positives = 93/199 (46%), Gaps = 26/199 (13%)
Query: 34 EDGEIVAVKKLNFHQFSAE-SDKSFYREAKTLKELK-HRNLVKV--LGYAWESGKLKALI 89
+ E VA+KK+ + FS + K RE K L+ + H+N+ + + + G L
Sbjct: 25 SEEETVAIKKIT-NVFSKKILAKRALRELKLLRHFRGHKNITCLYDMDIVF-PGNFNELY 82
Query: 90 L--EYMENGSLESVIHG--PGVD-HSRWTLPKRIDVLISVANGLDYLHSGYDIPIVHCDM 144
L E ME L +I P D H + + + GL Y+HS ++H D+
Sbjct: 83 LYEELME-ADLHQIIRSGQPLTDAHFQS-------FIYQILCGLKYIHSA---NVLHRDL 131
Query: 145 KPSNILLDRDFEAHVSDFGTSRMLDVHLQDLSSLSTAFQGTIGYLAPE--FAYMRIVTTK 202
KP N+L++ D E + DFG +R + + + T + T Y APE ++ T
Sbjct: 132 KPGNLLVNADCELKICDFGLARGFSENPGENAGFMTEYVATRWYRAPEIMLSFQS-YTKA 190
Query: 203 VDVFSFGIVVMEFLTKRRP 221
+DV+S G ++ E L R+P
Sbjct: 191 IDVWSVGCILAELLG-RKP 208
|
Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) MPK1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MPK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs MPK1 from Saccharomyces cerevisiae, Pmk1 from Schizosaccharomyces pombe, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. MPK1 (also called Slt2) and Pmk1 (also called Spm1) are stress-activated MAPKs that regulate the cell wall integrity (CWI) pathway, and are therefore important in the maintainance of cell shape, cell wall construction, morphogenesis, and ion homeostasis. MPK1 is activated in response to cell wall stress including heat stimulation, osmotic shock, UV irradiation, and any agents that interfere with cell wall biogenesis such as chitin antagonists, caffeine, or zymolase. MPK1 is regulated by the MAP2Ks Mkk1/2, which are regulated by the MAP3K Bck1. Pmk1 is also activated by multiple stresses including elevated temperatures, hyper- or hypotonic stress, glucose deprivation, exposure to cell-wall damaging compounds, and oxidative stress. It is regulated by the MAP2K Pek1, which is regulated by the MAP3K Mkh1. Length = 332 |
| >gnl|CDD|173705 cd05614, STKc_MSK2_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 2 | Back alignment and domain information |
|---|
Score = 57.7 bits (139), Expect = 1e-09
Identities = 56/184 (30%), Positives = 86/184 (46%), Gaps = 18/184 (9%)
Query: 60 EAKTLKELKHRNLVKVLGYAWESGKLKALILEYMENGSLESVIHGPGVDHSRWTLPKRID 119
E L+ ++ + L YA+++ LIL+Y+ G E H D+ +
Sbjct: 54 ERNVLEHVRQSPFLVTLHYAFQTEAKLHLILDYVSGG--EMFTHLYQRDNF-----SEDE 106
Query: 120 VLISVAN---GLDYLHSGYDIPIVHCDMKPSNILLDRDFEAHVSDFGTSRMLDVHLQDLS 176
V L++LH + IV+ D+K NILLD + ++DFG S+ L +
Sbjct: 107 VRFYSGEIILALEHLHK---LGIVYRDIKLENILLDSEGHVVLTDFGLSKEF---LSEEK 160
Query: 177 SLSTAFQGTIGYLAPEFAYMRIVTTK-VDVFSFGIVVMEFLTKRRPTGLD-EENGLSPIS 234
+ +F GTI Y+APE + K VD +S GI++ E LT P L+ E N S +S
Sbjct: 161 ERTYSFCGTIEYMAPEIIRGKGGHGKAVDWWSLGILIFELLTGASPFTLEGERNTQSEVS 220
Query: 235 LRQL 238
R L
Sbjct: 221 RRIL 224
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK2, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydrophobic motif (HM) of NTD, which facilitates the phosphorylation of the A-loop and activates the NTD, which in turn phosphorylates downstream targets. MSK2 and MSK1 play nonredundant roles in activating histone H3 kinases, which play pivotal roles in compaction of the chromatin fiber. MSK2 is the required H3 kinase in response to stress stimuli and activation of the p38 MAPK pathway. MSK2 also plays a role in the pathogenesis of psoriasis. Length = 332 |
| >gnl|CDD|132974 cd06643, STKc_SLK, Catalytic domain of the Protein Serine/Threonine Kinase, Ste20-like kinase | Back alignment and domain information |
|---|
Score = 57.3 bits (138), Expect = 2e-09
Identities = 56/201 (27%), Positives = 92/201 (45%), Gaps = 19/201 (9%)
Query: 20 IGNSNLSTVYKGRLEDGEIVAVKKLNFHQFSAESDKSFYREAKTLKELKHRNLVKVLGYA 79
+G+ VYK + ++ ++A K+ S E + + E L H N+VK+L
Sbjct: 13 LGDGAFGKVYKAQNKETGVLAAAKV-IDTKSEEELEDYMVEIDILASCDHPNIVKLLDAF 71
Query: 80 WESGKLKALILEYMENGSLESVIHGPGVDHSRWTLPKRIDVLI-SVANGLDYLHSGYDIP 138
+ L LI E+ G++++V+ ++ R +I V+ L+YLH +
Sbjct: 72 YYENNLWILI-EFCAGGAVDAVM----LELERPLTEPQIRVVCKQTLEALNYLH---ENK 123
Query: 139 IVHCDMKPSNILLDRDFEAHVSDFGTSRMLDVHLQDLSSLSTAFQGTIGYLAPEFAYM-- 196
I+H D+K NIL D + ++DFG S +Q S F GT ++APE
Sbjct: 124 IIHRDLKAGNILFTLDGDIKLADFGVSAKNTRTIQRRDS----FIGTPYWMAPEVVMCET 179
Query: 197 ---RIVTTKVDVFSFGIVVME 214
R K DV+S GI ++E
Sbjct: 180 SKDRPYDYKADVWSLGITLIE 200
|
Serine/threonine kinases (STKs), Ste20-like kinase (SLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It acts as a MAPK kinase kinase (MAPKKK) by phosphorylating ASK1, resulting in the phosphorylation of p38. SLK also plays a role in mediating actin reorganization. It is part of a microtubule-associated complex that is targeted at adhesion sites, and is required in focal adhesion turnover and in regulating cell migration. Length = 282 |
| >gnl|CDD|173694 cd05603, STKc_SGK2, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 2 | Back alignment and domain information |
|---|
Score = 57.3 bits (138), Expect = 2e-09
Identities = 61/202 (30%), Positives = 92/202 (45%), Gaps = 17/202 (8%)
Query: 19 IIGNSNLSTVY-KGRLEDGEIVAVKKLNFHQFSAESDKSFYREAKT--LKELKHRNLVKV 75
+IG + V R DG AVK L + +++ + LK LKH LV
Sbjct: 2 VIGKGSFGKVLLAKRKSDGSFYAVKVLQKKTILKKKEQNHIMAERNVLLKNLKHPFLVG- 60
Query: 76 LGYAWESGKLKALILEYMENGSLESVIHGPGVDHSRWTLPKRIDVLIS-VANGLDYLHSG 134
L Y++++ + +L+Y+ G L H + R L R + VA+ + YLHS
Sbjct: 61 LHYSFQTAEKLYFVLDYVNGGEL--FFH---LQRERCFLEPRARFYAAEVASAIGYLHS- 114
Query: 135 YDIPIVHCDMKPSNILLDRDFEAHVSDFGTSRMLDVHLQDLSSLSTAFQGTIGYLAPEFA 194
+ I++ D+KP NILLD ++DFG + V ++ +S F GT YLAPE
Sbjct: 115 --LNIIYRDLKPENILLDSQGHVVLTDFGLCKE-GVEPEETTS---TFCGTPEYLAPEVL 168
Query: 195 YMRIVTTKVDVFSFGIVVMEFL 216
VD + G V+ E L
Sbjct: 169 RKEPYDRTVDWWCLGAVLYEML 190
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK2 shows a more restricted distribution that SGK1 and is most abundantly expressed in epithelial tissues including kidney, liver, pancreas, and the choroid plexus of the brain. In vitro cellular assays show that SGK2 can stimulate the activity of ion channels, the glutamate transporter EEAT4, and the glutamate receptors, GluR6 and GLUR1. Length = 321 |
| >gnl|CDD|173683 cd05592, STKc_nPKC_theta_delta, Catalytic domain of the Protein Serine/Threonine Kinases, Novel Protein Kinase C theta and delta | Back alignment and domain information |
|---|
Score = 57.1 bits (138), Expect = 2e-09
Identities = 48/167 (28%), Positives = 77/167 (46%), Gaps = 24/167 (14%)
Query: 74 KVLGYAWESGKLKAL------------ILEYMENGSLESVIHGPGVDHSRWTLPKRIDVL 121
+VL AWE L L ++EY+ G L I G R+ +
Sbjct: 47 RVLALAWEHPFLTHLFCTFQTKEHLFFVMEYLNGGDLMFHIQSSG----RFDEARARFYA 102
Query: 122 ISVANGLDYLHSGYDIPIVHCDMKPSNILLDRDFEAHVSDFGTSRMLDVHLQDLSSLSTA 181
+ GL +LH I++ D+K N+LLD+D ++DFG + +++ + +S
Sbjct: 103 AEIICGLQFLHKKG---IIYRDLKLDNVLLDKDGHIKIADFGMCK-ENMNGEGKAS---T 155
Query: 182 FQGTIGYLAPEFAYMRIVTTKVDVFSFGIVVMEFLTKRRP-TGLDEE 227
F GT Y+APE + VD +SFG+++ E L + P G DE+
Sbjct: 156 FCGTPDYIAPEILKGQKYNESVDWWSFGVLLYEMLIGQSPFHGEDED 202
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta and delta-like isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an important and non-redundant role in several aspects of T-cell biology. PKC-delta plays a role in cell cycle regulation and programmed cell death in many cell types. Length = 316 |
| >gnl|CDD|133246 cd05115, PTKc_Zap-70, Catalytic domain of the Protein Tyrosine Kinase, Zeta-chain-associated protein of 70kDa | Back alignment and domain information |
|---|
Score = 56.9 bits (137), Expect = 2e-09
Identities = 69/283 (24%), Positives = 121/283 (42%), Gaps = 51/283 (18%)
Query: 20 IGNSNLSTVYKG--RLEDGEI-VAVKKLNFHQFSAESDKSFYREAKTLKELKHRNLVKVL 76
+G+ N V KG ++ +I VA+K L + D+ REA+ + +L + +V+++
Sbjct: 3 LGSGNFGCVKKGVYKMRKKQIDVAIKVLKNENEKSVRDE-MMREAEIMHQLDNPYIVRMI 61
Query: 77 GYAWESGKLKALILEYMENGSLESVIHGPGVDHSRWTLPKRIDVLISVANGLDYLHSGYD 136
G E+ L L++E G L + G T+ ++++ V+ G+ YL
Sbjct: 62 GVC-EAEAL-MLVMEMASGGPLNKFLSG---KKDEITVSNVVELMHQVSMGMKYLEGK-- 114
Query: 137 IPIVHCDMKPSNILLDRDFEAHVSDFGTSRMLDVHLQDLSSLSTAFQGTIGYLAPEFAYM 196
VH D+ N+LL A +SDFG S+ L +A + + + APE
Sbjct: 115 -NFVHRDLAARNVLLVNQHYAKISDFGLSKALGAD-DSYYKARSAGKWPLKWYAPECINF 172
Query: 197 RIVTTKVDVFSFGIVVMEFLTKRRPTGLDEENGLSPISLRQLVEKALANGINGVRQITDP 256
R +++ DV+S+GI + E A + G +++ P
Sbjct: 173 RKFSSRSDVWSYGITMWE---------------------------AFSYGQKPYKKMKGP 205
Query: 257 KLVSSIYEEQEQHQVLE-------ELFKLALVCTSSNPEDRPN 292
+++S I EQ + L+ E++ L C EDRPN
Sbjct: 206 EVMSFI----EQGKRLDCPAECPPEMYALMKDCWIYKWEDRPN 244
|
Protein Tyrosine Kinase (PTK) family; Zeta-chain-associated protein of 70kDa (Zap-70); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Zap-70 is a member of the Syk subfamily of kinases, which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Zap-70 is primarily expressed in T-cells and NK cells, and is a crucial component in T-cell receptor (TCR) signaling. Zap-70 binds the phosphorylated ITAM (immunoreceptor tyr activation motif) sequences of the activated TCR zeta-chain through its SH2 domains, leading to its phosphorylation and activation. It then phosphorylates target proteins, which propagate the signals to downstream pathways. Zap-70 is hardly detected in normal peripheral B-cells, but is present in some B-cell malignancies. It is used as a diagnostic marker for chronic lymphocytic leukemia (CLL) as it is associated with the more aggressive subtype of the disease. Length = 257 |
| >gnl|CDD|143379 cd07874, STKc_JNK3, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 3 | Back alignment and domain information |
|---|
Score = 57.0 bits (137), Expect = 3e-09
Identities = 53/186 (28%), Positives = 87/186 (46%), Gaps = 20/186 (10%)
Query: 39 VAVKKLNFHQFSAESDKSFYREAKTLKELKHRNLVKVLGYAWESGKLKA-----LILEYM 93
VA+KKL+ + K YRE +K + H+N++ +L L+ L++E M
Sbjct: 45 VAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISLLNVFTPQKSLEEFQDVYLVMELM 104
Query: 94 ENGSLESVIHGPGVDHSRWTLPKRIDVLISVANGLDYLHSGYDIPIVHCDMKPSNILLDR 153
+ +L VI +DH R + +L + G+ +LHS I+H D+KPSNI++
Sbjct: 105 D-ANLCQVIQME-LDHERMSY-----LLYQMLCGIKHLHSA---GIIHRDLKPSNIVVKS 154
Query: 154 DFEAHVSDFGTSRMLDVHLQDLSSLSTAFQGTIGYLAPEFAYMRIVTTKVDVFSFGIVVM 213
D + DFG +R S + T + T Y APE VD++S G ++
Sbjct: 155 DCTLKILDFGLARTAGT-----SFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMG 209
Query: 214 EFLTKR 219
E + +
Sbjct: 210 EMVRHK 215
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 3 (JNK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK3 is expressed primarily in the brain, and to a lesser extent in the heart and testis. Mice deficient in Jnk3 are protected against kainic acid-induced seizures, stroke, sciatic axotomy neural death, and neuronal death due to NGF deprivation, oxidative stress, or exposure to beta-amyloid peptide. This suggests that JNK3 may play roles in the pathogenesis of these diseases. Length = 355 |
| >gnl|CDD|173687 cd05596, STKc_ROCK, Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase | Back alignment and domain information |
|---|
Score = 57.1 bits (138), Expect = 3e-09
Identities = 56/219 (25%), Positives = 100/219 (45%), Gaps = 35/219 (15%)
Query: 12 GSFSENNIIGNSNLSTVYKGRLEDGEIVAVKKLNFHQFSAESDKSFYREAKTLKELKHRN 71
G+F E ++ + + VY A+K L+ + SD +F+ E + + +
Sbjct: 54 GAFGEVQLVRHKSSKQVY----------AMKLLSKFEMIKRSDSAFFWEERDIMAHANSE 103
Query: 72 LVKVLGYAWESGKLKALILEYMENGSLESVIHGPGVDHSRWTLPKRIDVLISVANGLDYL 131
+ L YA++ K +++EYM G L +++ + +W +V+++ LD +
Sbjct: 104 WIVQLHYAFQDDKYLYMVMEYMPGGDLVNLMSNYDIPE-KWARFYTAEVVLA----LDAI 158
Query: 132 HS-GYDIPIVHCDMKPSNILLDRDFEAHVSDFGTSRMLDVHLQDLSSLSTAFQGTIGYLA 190
HS G+ +H D+KP N+LLD+ ++DFGT +D + TA GT Y++
Sbjct: 159 HSMGF----IHRDVKPDNMLLDKSGHLKLADFGTCMKMDANGMVRC--DTAV-GTPDYIS 211
Query: 191 PEF--------AYMRIVTTKVDVFSFGIVVMEFLTKRRP 221
PE Y R + D +S G+ + E L P
Sbjct: 212 PEVLKSQGGDGYYGR----ECDWWSVGVFLYEMLVGDTP 246
|
Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK is also referred to as Rho-associated kinase or simply as Rho kinase. It contains an N-terminal extension, a catalytic kinase domain, and a long C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain. It is activated via interaction with Rho GTPases and is involved in many cellular functions including contraction, adhesion, migration, motility, proliferation, and apoptosis. The ROCK subfamily consists of two isoforms, ROCK1 and ROCK2, which may be functionally redundant in some systems, but exhibit different tissue distributions. Both isoforms are ubiquitously expressed in most tissues, but ROCK2 is more prominent in brain and skeletal muscle while ROCK1 is more pronounced in the liver, testes, and kidney. Studies in knockout mice result in different phenotypes, suggesting that the two isoforms do not compensate for each other during embryonic development. Length = 370 |
| >gnl|CDD|173746 cd07850, STKc_JNK, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase | Back alignment and domain information |
|---|
Score = 57.0 bits (138), Expect = 3e-09
Identities = 54/184 (29%), Positives = 87/184 (47%), Gaps = 20/184 (10%)
Query: 36 GEIVAVKKLNFHQFSAESDKSFYREAKTLKELKHRNLVKVLGYAWESGKLKA-----LIL 90
G+ VA+KKL+ + K YRE +K + H+N++ +L L+ L++
Sbjct: 41 GQNVAIKKLSRPFQNVTHAKRAYRELVLMKLVNHKNIIGLLNVFTPQKSLEEFQDVYLVM 100
Query: 91 EYMENGSLESVIHGPGVDHSRWTLPKRIDVLISVANGLDYLHSGYDIPIVHCDMKPSNIL 150
E M+ +L VI +DH R + +L + G+ +LHS I+H D+KPSNI+
Sbjct: 101 ELMD-ANLCQVIQMD-LDHERMSY-----LLYQMLCGIKHLHSA---GIIHRDLKPSNIV 150
Query: 151 LDRDFEAHVSDFGTSRMLDVHLQDLSSLSTAFQGTIGYLAPEFAYMRIVTTKVDVFSFGI 210
+ D + DFG +R S + T + T Y APE VD++S G
Sbjct: 151 VKSDCTLKILDFGLARTAGT-----SFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGC 205
Query: 211 VVME 214
++ E
Sbjct: 206 IMGE 209
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase (JNK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. They are also essential regulators of physiological and pathological processes and are involved in the pathogenesis of several diseases such as diabetes, atherosclerosis, stroke, Parkinson's and Alzheimer's. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3) that are alternatively spliced to produce at least 10 isoforms. JNKs are specifically activated by the MAPK kinases MKK4 and MKK7, which are in turn activated by upstream MAPK kinase kinases as a result of different stimuli including stresses such as ultraviolet (UV) irradiation, hyperosmolarity, heat shock, or cytokines. JNKs activate a large number of different substrates based on specific stimulus, cell type, and cellular condition, and may be implicated in seemingly contradictory functions. Length = 353 |
| >gnl|CDD|173647 cd05091, PTKc_Ror2, Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 2 | Back alignment and domain information |
|---|
Score = 56.2 bits (135), Expect = 3e-09
Identities = 57/230 (24%), Positives = 96/230 (41%), Gaps = 27/230 (11%)
Query: 6 EIENATGSFSENNIIGNSNLSTVYKGRL------EDGEIVAVKKLNFHQFSAESDKSFYR 59
EI +T F E +G VYKG L E + VA+K L + + F
Sbjct: 1 EINLSTVRFMEE--LGEDRFGKVYKGHLFGTAPGEQTQAVAIKTLK-DKAEGPLREEFKH 57
Query: 60 EAKTLKELKHRNLVKVLGYAWESGKLKALILEYMENGSLES--VIHGPGVD--------- 108
EA L+H N+V +LG + L ++I Y + L V+ P D
Sbjct: 58 EAMMRSRLQHPNIVCLLGVVTKEQPL-SMIFSYCSHSDLHEFLVMRSPHSDVGSTDDDKT 116
Query: 109 -HSRWTLPKRIDVLISVANGLDYLHSGYDIPIVHCDMKPSNILLDRDFEAHVSDFGTSRM 167
S + ++ +A G+++L S + +VH D+ N+L+ +SD G R
Sbjct: 117 VKSTLEPADFVHIVTQIAAGMEFLSSHH---VVHKDLATRNVLVFDKLNVKISDLGLFR- 172
Query: 168 LDVHLQDLSSLSTAFQGTIGYLAPEFAYMRIVTTKVDVFSFGIVVMEFLT 217
+V+ D L I +++PE + D++S+G+V+ E +
Sbjct: 173 -EVYAADYYKLMGNSLLPIRWMSPEAIMYGKFSIDSDIWSYGVVLWEVFS 221
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 2 (Ror2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. Ror2 plays important roles in skeletal and heart formation. Ror2-deficient mice show widespread bone abnormalities, ventricular defects in the heart, and respiratory dysfunction. Mutations in human Ror2 result in two different bone development genetic disorders, recessive Robinow syndrome and brachydactyly type B. Ror2 is also implicated in neural development. Length = 283 |
| >gnl|CDD|143364 cd07859, STKc_TDY_MAPK_plant, Catalytic domain of the Serine/Threonine Kinases, TDY Mitogen-Activated Protein Kinases from Plants | Back alignment and domain information |
|---|
Score = 56.7 bits (137), Expect = 4e-09
Identities = 55/196 (28%), Positives = 90/196 (45%), Gaps = 27/196 (13%)
Query: 36 GEIVAVKKLNFHQFSAESDKS-FYREAKTLKELKHRNLVKVLGYAWESGKLK----ALIL 90
GE VA+KK+N F SD + RE K L+ L+H ++V++ + + ++
Sbjct: 25 GEKVAIKKIN-DVFEHVSDATRILREIKLLRLLRHPDIVEIKHIMLPPSRREFKDIYVVF 83
Query: 91 EYMENGSLESVIHGPG---VDHSRWTLPKRIDVLISVANGLDYLHSGYDIPIVHCDMKPS 147
E ME+ L VI +H ++ L + L Y+H+ + H D+KP
Sbjct: 84 ELMES-DLHQVIKANDDLTPEHHQF-------FLYQLLRALKYIHTA---NVFHRDLKPK 132
Query: 148 NILLDRDFEAHVSDFGTSRMLDVHLQDLSS--LSTAFQGTIGYLAPEF--AYMRIVTTKV 203
NIL + D + + DFG +R V D + T + T Y APE ++ T +
Sbjct: 133 NILANADCKLKICDFGLAR---VAFNDTPTAIFWTDYVATRWYRAPELCGSFFSKYTPAI 189
Query: 204 DVFSFGIVVMEFLTKR 219
D++S G + E LT +
Sbjct: 190 DIWSIGCIFAEVLTGK 205
|
Serine/Threonine Kinases (STKs), Plant TDY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TDY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. Oryza sativa contains at least 17 MAPKs. There are two subtypes of plant MAPKs based on the conserved phosphorylation motif present in the activation loop, TEY and TDY. Arabidopsis thaliana contains more TEY-type MAPKs than TDY-type, whereas the reverse is true for Oryza sativa. This subfamily represents the TDY subtype and is composed of Group D plant MAPKs including Arabidopsis thaliana MPK18 (AtMPK18), Oryza sativa Blast- and Wound-induced MAPK1 (OsBWMK1), OsWJUMK1 (Wound- and JA-Uninducible MAPK1), Zea mays MPK6, and the Medicago sativa TDY1 gene product. OsBWMK1 enhances resistance to pathogenic infections. It mediates stress-activated defense responses by activating a transcription factor that affects the expression of stress-related genes. AtMPK18 is involved in microtubule-related functions. Length = 338 |
| >gnl|CDD|143349 cd07844, STKc_PCTAIRE_like, Catalytic domain of PCTAIRE-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 56.2 bits (136), Expect = 4e-09
Identities = 48/155 (30%), Positives = 76/155 (49%), Gaps = 24/155 (15%)
Query: 20 IGNSNLSTVYKGRLE-DGEIVAVKKLNFHQ-----FSAESDKSFYREAKTLKELKHRNLV 73
+G + +TVYKGR + G++VA+K++ F+A REA LK+LKH N+V
Sbjct: 13 LGEGSYATVYKGRSKLTGQLVALKEIRLEHEEGAPFTA------IREASLLKDLKHANIV 66
Query: 74 KVLGYAWESGKLKALILEYMENGSLESVI--HGPGVDHSRWTLPKRIDVLISVANGLDYL 131
L + K L+ EY++ L+ + G G+ L L + GL Y
Sbjct: 67 -TLHDIIHTKKTLTLVFEYLDT-DLKQYMDDCGGGLSMHNVRL-----FLFQLLRGLAYC 119
Query: 132 HSGYDIPIVHCDMKPSNILLDRDFEAHVSDFGTSR 166
H ++H D+KP N+L+ E ++DFG +R
Sbjct: 120 HQRR---VLHRDLKPQNLLISERGELKLADFGLAR 151
|
Serine/Threonine Kinases (STKs), PCTAIRE-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily share sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. The association of PCTAIRE-like proteins with cyclins has not been widely studied, although PFTAIRE-1 has been shown to function as a CDK which is regulated by cyclin D3 as well as the membrane-associated cyclin Y. PCTAIRE-like proteins show unusual expression patterns with high levels in post-mitotic tissues, suggesting that they may be involved in regulating post-mitotic cellular events. Length = 291 |
| >gnl|CDD|173762 cd08222, STKc_Nek11, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 11 | Back alignment and domain information |
|---|
Score = 55.7 bits (134), Expect = 5e-09
Identities = 49/199 (24%), Positives = 86/199 (43%), Gaps = 13/199 (6%)
Query: 20 IGNSNLSTVY----KGRLEDGEIVAVKKLNFHQFSAESDKSFYREAKTLKELKHRNLVKV 75
+G + TVY K + + + +K++ + + +EA+ L +L H +VK
Sbjct: 8 LGKGSFGTVYLVKDKKAVAEERLKVLKEIPVGELNPNETVQANQEAQLLSKLDHPAIVKF 67
Query: 76 LGYAWESGKLKALILEYMENGSLESVIHGPGVDHSRWTLPKRIDVLISVANGLDYLHSGY 135
E +I EY E L+ + + + + I + G+ Y+H
Sbjct: 68 HASFLERDAF-CIITEYCEGRDLDCKLEELKHTGKTLSENQVCEWFIQLLLGVHYMHQRR 126
Query: 136 DIPIVHCDMKPSNILLDRDFEAHVSDFGTSRMLDVHLQDLSSLSTAFQGTIGYLAPEFAY 195
I+H D+K NI L + + DFG SR+L L+T F GT Y++PE
Sbjct: 127 ---ILHRDLKAKNIFLKNNL-LKIGDFGVSRLL----MGSCDLATTFTGTPYYMSPEALK 178
Query: 196 MRIVTTKVDVFSFGIVVME 214
+ +K D++S G ++ E
Sbjct: 179 HQGYDSKSDIWSLGCILYE 197
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 11 (Nek11) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek11 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek11 is involved, through direct phosphorylation, in regulating the degradation of Cdc25A (Cell Division Cycle 25 homolog A), which plays a role in cell cycle progression and in activating cyclin dependent kinases. Nek11 is activated by CHK1 (CHeckpoint Kinase 1) and may be involved in the G2/M checkpoint. Nek11 may also play a role in the S-phase checkpoint as well as in DNA replication and genotoxic stress responses. Length = 260 |
| >gnl|CDD|173666 cd05575, STKc_SGK, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase | Back alignment and domain information |
|---|
Score = 56.0 bits (135), Expect = 5e-09
Identities = 57/201 (28%), Positives = 88/201 (43%), Gaps = 15/201 (7%)
Query: 19 IIGNSNLSTVYKGR-LEDGEIVAVKKLN-FHQFSAESDKSFYREAKTL-KELKHRNLVKV 75
+IG + V + DG+ AVK L + K E L K +KH LV
Sbjct: 2 VIGKGSFGKVLLAKHKADGKFYAVKVLQKKAILKKKEQKHIMAERNVLLKNVKHPFLVG- 60
Query: 76 LGYAWESGKLKALILEYMENGSLESVIHGPGVDHSRWTLPKRIDVLISVANGLDYLHSGY 135
L Y++++ +L+Y+ G L + + P+ +A+ L YLHS
Sbjct: 61 LHYSFQTADKLYFVLDYVNGGELFFHLQ----RERSFPEPRARFYAAEIASALGYLHS-- 114
Query: 136 DIPIVHCDMKPSNILLDRDFEAHVSDFGTSRMLDVHLQDLSSLSTAFQGTIGYLAPEFAY 195
+ I++ D+KP NILLD ++DFG + + S ++ F GT YLAPE
Sbjct: 115 -LNIIYRDLKPENILLDSQGHVVLTDFGLCK----EGIEHSKTTSTFCGTPEYLAPEVLR 169
Query: 196 MRIVTTKVDVFSFGIVVMEFL 216
+ VD + G V+ E L
Sbjct: 170 KQPYDRTVDWWCLGAVLYEML 190
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGKs are activated by insulin and growth factors via phosphoinositide 3-kinase and PDK1. They activate ion channels, ion carriers, and the Na-K-ATPase, as well as regulate the activity of enzymes and transcription factors. SGKs play important roles in transport, hormone release, neuroexcitability, cell proliferation, and apoptosis. Length = 323 |
| >gnl|CDD|143373 cd07868, STKc_CDK8, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 8 | Back alignment and domain information |
|---|
Score = 55.8 bits (134), Expect = 5e-09
Identities = 56/212 (26%), Positives = 97/212 (45%), Gaps = 23/212 (10%)
Query: 20 IGNSNLSTVYKGRLEDGEI---VAVKKLNFHQFSAESDKSFYREAKTLKELKHRNLVKVL 76
+G VYK + +DG+ A+K++ S S RE L+ELKH N++ +
Sbjct: 9 VGRGTYGHVYKAKRKDGKDDRDYALKQIEGTGISM----SACREIALLRELKHPNVISLQ 64
Query: 77 GYAWESGKLKA-LILEYMENGSLESVI---HGPGVDHSRWTLPKRI--DVLISVANGLDY 130
K L+ +Y E+ L +I + LP+ + +L + +G+ Y
Sbjct: 65 KVFLSHADRKVWLLFDYAEH-DLWHIIKFHRASKANKKPVQLPRGMVKSLLYQILDGIHY 123
Query: 131 LHSGYDIPIVHCDMKPSNILL----DRDFEAHVSDFGTSRMLDVHLQDLSSLSTAFQGTI 186
LH+ + ++H D+KP+NIL+ ++D G +R+ + L+ L+ L T
Sbjct: 124 LHANW---VLHRDLKPANILVMGEGPERGRVKIADMGFARLFNSPLKPLADLDPVVV-TF 179
Query: 187 GYLAPEFAY-MRIVTTKVDVFSFGIVVMEFLT 217
Y APE R T +D+++ G + E LT
Sbjct: 180 WYRAPELLLGARHYTKAIDIWAIGCIFAELLT 211
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK8 can act as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the multi-subunit core Mediator complex, a cofactor that is involved in regulating RNA polymerase II (RNAP II)-dependent transcription. CDK8 phosphorylates cyclin H, a subunit of the general transcription factor TFIIH, which results in the inhibition of TFIIH-dependent phosphorylation of the C-terminal domain (CTD) of RNAP II, facilitating the inhibition of transcription. It has also been shown to promote transcription by a mechanism that is likely to involve RNAP II phosphorylation. CDK8 also functions as a stimulus-specific positive coregulator of p53 transcriptional responses. Length = 317 |
| >gnl|CDD|133247 cd05116, PTKc_Syk, Catalytic domain of the Protein Tyrosine Kinase, Spleen tyrosine kinase | Back alignment and domain information |
|---|
Score = 55.4 bits (133), Expect = 7e-09
Identities = 66/276 (23%), Positives = 115/276 (41%), Gaps = 39/276 (14%)
Query: 20 IGNSNLSTVYKGRLE---DGEIVAVKKLNFHQFSAESDKSFYREAKTLKELKHRNLVKVL 76
+G+ N TV KG + + VAVK L REA +++L + +V+++
Sbjct: 3 LGSGNFGTVKKGMYKMKKSEKTVAVKILKNDNNDPALKDELLREANVMQQLDNPYIVRMI 62
Query: 77 GYAWESGKLKALILEYMENGSLESVIHGPGVDHSRWTLPKRIDVLI-SVANGLDYLHSGY 135
G + L++E E G L + ++ K I L+ V+ G+ YL
Sbjct: 63 GIC--EAESWMLVMELAELGPLNKFLQ-----KNKHVTEKNITELVHQVSMGMKYLE--- 112
Query: 136 DIPIVHCDMKPSNILLDRDFEAHVSDFGTSRMLDVHLQDLSSLSTAFQGTIGYLAPEFAY 195
+ VH D+ N+LL A +SDFG S+ L ++ T + + + APE
Sbjct: 113 ETNFVHRDLAARNVLLVTQHYAKISDFGLSKALGAD-ENYYKAKTHGKWPVKWYAPECMN 171
Query: 196 MRIVTTKVDVFSFGIVVMEFLTKRRPTGLDEENGLSPISLRQLVEKALANGINGVRQITD 255
++K DV+SFG+++ E + G G+ + Q++E +G R
Sbjct: 172 YYKFSSKSDVWSFGVLMWEAFS----YGQKPYKGMKGNEVTQMIE-------SGERMECP 220
Query: 256 PKLVSSIYEEQEQHQVLEELFKLALVCTSSNPEDRP 291
+ +Y +L KL C + ++RP
Sbjct: 221 QRCPPEMY----------DLMKL---CWTYGVDERP 243
|
Protein Tyrosine Kinase (PTK) family; Spleen tyrosine kinase (Syk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk, together with Zap-70, form the Syk subfamily of kinases which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Syk was first cloned from the spleen, and its function in hematopoietic cells is well-established. Syk is involved in the signaling downstream of activated receptors (including B-cell and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferation, differentiation, survival, adhesion, migration, and phagocytosis. More recently, Syk expression has been detected in other cell types (including epithelial cells, vascular endothelial cells, neurons, hepatocytes, and melanocytes), suggesting a variety of biological functions in non-immune cells. Syk plays a critical role in maintaining vascular integrity and in wound healing during embryogenesis. It also regulates Vav3, which is important in osteoclast function including bone development. In breast epithelial cells, where Syk acts as a negative regulator for epidermal growth factor receptor (EGFR) signaling, loss of Syk expression is associated with abnormal proliferation during cancer development suggesting a potential role as a tumor suppressor. In mice, Syk has been shown to inhibit malignant transformation of mammary epithelial cells induced with murine mammary tumor virus (MMTV). Length = 257 |
| >gnl|CDD|173693 cd05602, STKc_SGK1, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 1 | Back alignment and domain information |
|---|
Score = 55.8 bits (134), Expect = 7e-09
Identities = 50/154 (32%), Positives = 77/154 (50%), Gaps = 14/154 (9%)
Query: 64 LKELKHRNLVKVLGYAWESGKLKALILEYMENGSLESVIHGPGVDHSRWTLPKRIDVLIS 123
LK +KH LV L +++++ +L+Y+ G L H + R L R +
Sbjct: 50 LKNVKHPFLVG-LHFSFQTADKLYFVLDYINGGEL--FYH---LQRERCFLEPRARFYAA 103
Query: 124 -VANGLDYLHSGYDIPIVHCDMKPSNILLDRDFEAHVSDFGTSRMLDVHLQDLSSLSTAF 182
+A+ L YLHS + IV+ D+KP NILLD ++DFG + +++ + ST F
Sbjct: 104 EIASALGYLHS---LNIVYRDLKPENILLDSQGHIVLTDFGLCKE---NIEHNGTTST-F 156
Query: 183 QGTIGYLAPEFAYMRIVTTKVDVFSFGIVVMEFL 216
GT YLAPE + + VD + G V+ E L
Sbjct: 157 CGTPEYLAPEVLHKQPYDRTVDWWCLGAVLYEML 190
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK1 is ubiquitously expressed and is under transcriptional control of numerous stimuli including cell stress (cell shrinkage), serum, hormones (gluco- and mineralocorticoids), gonadotropins, growth factors, interleukin-6, and other cytokines. It plays roles in sodium retention and potassium elimination in the kidney, nutrient transport, salt sensitivity, memory consolidation, and cardiac repolarization. A common SGK1 variant is associated with increased blood pressure and body weight. SGK1 may also contribute to tumor growth, neurodegeneration, fibrosing disease, and ischemia. Length = 325 |
| >gnl|CDD|133175 cd05043, PTK_Ryk, Pseudokinase domain of Ryk (Receptor related to tyrosine kinase) | Back alignment and domain information |
|---|
Score = 55.1 bits (133), Expect = 7e-09
Identities = 38/165 (23%), Positives = 78/165 (47%), Gaps = 9/165 (5%)
Query: 57 FYREAKTLKELKHRNLVKVLGYAWESGKLKALILEYMENGSLESVI----HGPGVDHSRW 112
+E+ L L H+N++ +L E G+ ++ YM G+L+ + G +
Sbjct: 55 LLQESCLLYGLSHQNILPILHVCIEDGEPPFVLYPYMNWGNLKLFLQQCRLGEANNPQAL 114
Query: 113 TLPKRIDVLISVANGLDYLHSGYDIPIVHCDMKPSNILLDRDFEAHVSDFGTSRMLDVHL 172
+ + + + I +A G+ YLH ++H D+ N ++D + + ++D SR D+
Sbjct: 115 STQQLVHMAIQIACGMSYLHK---RGVIHKDIAARNCVIDEELQVKITDNALSR--DLFP 169
Query: 173 QDLSSLSTAFQGTIGYLAPEFAYMRIVTTKVDVFSFGIVVMEFLT 217
D L + ++A E + ++ DV+SFG+++ E +T
Sbjct: 170 MDYHCLGDNENRPVKWMALESLVNKEYSSASDVWSFGVLLWELMT 214
|
Protein Tyrosine Kinase (PTK) family; Receptor related to tyrosine kinase (Ryk); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ryk is a receptor tyr kinase (RTK) containing an extracellular region with two leucine-rich motifs, a transmembrane segment, and an intracellular inactive pseudokinase domain. The extracellular region of Ryk shows homology to the N-terminal domain of Wnt inhibitory factor-1 (WIF) and serves as the ligand (Wnt) binding domain of Ryk. Ryk is expressed in many different tissues both during development and in adults, suggesting a widespread function. It acts as a chemorepulsive axon guidance receptor of Wnt glycoproteins and is responsible for the establishment of axon tracts during the development of the central nervous system. In addition, studies in mice reveal that Ryk is essential in skeletal, craniofacial, and cardiac development. Thus, it appears Ryk is involved in signal transduction despite its lack of kinase activity. Ryk may function as an accessory protein that modulates the signals coming from catalytically active partner RTKs such as the Eph receptors. Length = 280 |
| >gnl|CDD|88330 cd05047, PTKc_Tie, Catalytic domain of Tie Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 55.1 bits (132), Expect = 8e-09
Identities = 55/217 (25%), Positives = 106/217 (48%), Gaps = 28/217 (12%)
Query: 18 NIIGNSNLSTVYKGRLEDGEI---VAVKKLNFHQFSAESD-KSFYREAKTLKELKHR-NL 72
++IG N V K R++ + A+K++ +++++ D + F E + L +L H N+
Sbjct: 1 DVIGEGNFGQVLKARIKKDGLRMDAAIKRMK--EYASKDDHRDFAGELEVLCKLGHHPNI 58
Query: 73 VKVLGYAWESGKLKALILEYMENGSLESVIHGPGV---------DH-SRWTLPKR--IDV 120
+ +LG G L L +EY +G+L + V + + TL + +
Sbjct: 59 INLLGACEHRGYL-YLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHF 117
Query: 121 LISVANGLDYLHSGYDIPIVHCDMKPSNILLDRDFEAHVSDFGTSRMLDVHLQDLSSLST 180
VA G+DYL +H D+ NIL+ ++ A ++DFG SR +V+++ T
Sbjct: 118 AADVARGMDYLS---QKQFIHRDLAARNILVGENYVAKIADFGLSRGQEVYVK-----KT 169
Query: 181 AFQGTIGYLAPEFAYMRIVTTKVDVFSFGIVVMEFLT 217
+ + ++A E + TT DV+S+G+++ E ++
Sbjct: 170 MGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVS 206
|
Protein Tyrosine Kinase (PTK) family; Tie subfamily; catalytic (c) domain. The Tie subfamily consists of Tie1 and Tie2. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie proteins are receptor tyr kinases (RTKs) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2, while no specific ligand has been identified for Tie1. The binding of Ang-1 to Tie2 leads to receptor autophosphorylation and activation, promoting cell migration and survival. In contrast, Ang-2 binding to Tie2 does not result in the same response, suggesting that Ang-2 may function as an antagonist. In vivo studies of Tie1 show that it is critical in vascular development. Length = 270 |
| >gnl|CDD|133187 cd05056, PTKc_FAK, Catalytic domain of the Protein Tyrosine Kinase, Focal Adhesion Kinase | Back alignment and domain information |
|---|
Score = 54.7 bits (132), Expect = 1e-08
Identities = 57/208 (27%), Positives = 94/208 (45%), Gaps = 24/208 (11%)
Query: 17 NNIIGNSNLSTVYKG---RLEDGEI-VAVKKLNFHQFSAESDKSFYREAKTLKELKHRNL 72
IG VY+G E+ +I VAVK + +K F +EA +++ H ++
Sbjct: 11 GRCIGEGQFGDVYQGVYMSPENEKIAVAVKTCKNCTSPSVREK-FLQEAYIMRQFDHPHI 69
Query: 73 VKVLGYAWESGKLKALILEYMENGSLESVIHGPGVDHSRWTLPKRIDVLIS--VANGLDY 130
VK++G E+ +++E G L S + ++++L +L S ++ L Y
Sbjct: 70 VKLIGVITENPVW--IVMELAPLGELRSYL-----QVNKYSLDLASLILYSYQLSTALAY 122
Query: 131 LHSGYDIPIVHCDMKPSNILLDRDFEAHVSDFGTSRMLDVHLQDLSSLSTAFQGT--IGY 188
L S VH D+ N+L+ + DFG SR L+ S A +G I +
Sbjct: 123 LES---KRFVHRDIAARNVLVSSPDCVKLGDFGLSRYLEDE-----SYYKASKGKLPIKW 174
Query: 189 LAPEFAYMRIVTTKVDVFSFGIVVMEFL 216
+APE R T+ DV+ FG+ + E L
Sbjct: 175 MAPESINFRRFTSASDVWMFGVCMWEIL 202
|
Protein Tyrosine Kinase (PTK) family; Focal Adhesion Kinase (FAK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FAK is a cytoplasmic (or nonreceptor) tyr kinase that contains an autophosphorylation site and a FERM domain at the N-terminus, a central tyr kinase domain, proline-rich regions, and a C-terminal FAT (focal adhesion targeting) domain. FAK activity is dependent on integrin-mediated cell adhesion, which facilitates N-terminal autophosphorylation. Full activation is achieved by the phosphorylation of its two adjacent A-loop tyrosines. FAK is important in mediating signaling initiated at sites of cell adhesions and at growth factor receptors. Through diverse molecular interactions, FAK functions as a biosensor or integrator to control cell motility. It is a key regulator of cell survival, proliferation, migration and invasion, and thus plays an important role in the development and progression of cancer. Src binds to autophosphorylated FAK forming the FAK-Src dual kinase complex, which is activated in a wide variety of tumor cells and generates signals promoting growth and metastasis. FAK is being developed as a target for cancer therapy. Length = 270 |
| >gnl|CDD|173711 cd05621, STKc_ROCK2, Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 2 | Back alignment and domain information |
|---|
Score = 55.4 bits (133), Expect = 1e-08
Identities = 54/214 (25%), Positives = 98/214 (45%), Gaps = 25/214 (11%)
Query: 12 GSFSENNIIGNSNLSTVYKGRLEDGEIVAVKKLNFHQFSAESDKSFYREAKTLKELKHRN 71
G+F E ++ + + VY A+K L+ + SD +F+ E + + +
Sbjct: 54 GAFGEVQLVRHKSSQKVY----------AMKLLSKFEMIKRSDSAFFWEERDIMAFANSP 103
Query: 72 LVKVLGYAWESGKLKALILEYMENGSLESVIHGPGVDHSRWTLPKRIDVLISVANGLDYL 131
V L A++ K +++EYM G L +++ V +W +V+++ LD +
Sbjct: 104 WVVQLFCAFQDDKYLYMVMEYMPGGDLVNLMSNYDVPE-KWAKFYTAEVVLA----LDAI 158
Query: 132 HSGYDIPIVHCDMKPSNILLDRDFEAHVSDFGTSRMLDVHLQDLSSLSTAFQGTIGYLAP 191
HS + ++H D+KP N+LLD+ ++DFGT +D + TA GT Y++P
Sbjct: 159 HS---MGLIHRDVKPDNMLLDKHGHLKLADFGTCMKMDE--TGMVRCDTAV-GTPDYISP 212
Query: 192 EFAYMR----IVTTKVDVFSFGIVVMEFLTKRRP 221
E + + D +S G+ + E L P
Sbjct: 213 EVLKSQGGDGYYGRECDWWSVGVFLFEMLVGDTP 246
|
Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK2 (or ROK-alpha) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK2 was the first identified target of activated RhoA, and was found to play a role in stress fiber and focal adhesion formation. It is prominently expressed in the brain, heart, and skeletal muscles. It is implicated in vascular and neurological disorders, such as hypertension and vasospasm of the coronary and cerebral arteries. ROCK2 is also activated by caspase-2 cleavage, resulting in thrombin-induced microparticle generation in response to cell activation. Mice deficient in ROCK2 show intrauterine growth retardation and embryonic lethality because of placental dysfunction. Length = 370 |
| >gnl|CDD|173333 PTZ00036, PTZ00036, glycogen synthase kinase; Provisional | Back alignment and domain information |
|---|
Score = 55.0 bits (132), Expect = 1e-08
Identities = 56/216 (25%), Positives = 100/216 (46%), Gaps = 29/216 (13%)
Query: 13 SFSENNIIGNSNLSTVYKGR-LEDGEIVAVKKLNFHQFSAESDKSFYREAKTLKELKHRN 71
S+ NIIGN + VY+ ++ E VA+KK+ + + RE +K L H N
Sbjct: 67 SYKLGNIIGNGSFGVVYEAICIDTSEKVAIKKV------LQDPQYKNRELLIMKNLNHIN 120
Query: 72 LVKVLGYAW-------ESGKLKALILEYMENGSLESVIHGPGVDHSRWTLPKRIDVLIS- 123
++ + Y + E +++E++ + + H +H+ LP + L S
Sbjct: 121 IIFLKDYYYTECFKKNEKNIFLNVVMEFIPQTVHKYMKHYARNNHA---LPLFLVKLYSY 177
Query: 124 -VANGLDYLHSGYDIPIVHCDMKPSNILLD-RDFEAHVSDFGTSRMLDVHLQDLSSLSTA 181
+ L Y+HS + I H D+KP N+L+D + DFG+++ L + +S + +
Sbjct: 178 QLCRALAYIHSKF---ICHRDLKPQNLLIDPNTHTLKLCDFGSAKNLLAGQRSVSYICSR 234
Query: 182 FQGTIGYLAPEFAYMRI-VTTKVDVFSFGIVVMEFL 216
F Y APE TT +D++S G ++ E +
Sbjct: 235 F-----YRAPELMLGATNYTTHIDLWSLGCIIAEMI 265
|
Length = 440 |
| >gnl|CDD|132953 cd06622, PKc_MAPKK_PBS2_like, Catalytic domain of fungal PBS2-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Score = 54.5 bits (131), Expect = 1e-08
Identities = 58/219 (26%), Positives = 100/219 (45%), Gaps = 38/219 (17%)
Query: 20 IGNSNLSTVYKGRLE-DGEIVAVKKLNFHQFSAESDKSFYREAKTLKELK--HR----NL 72
+G N +VYK G +A+K++ E D+S + + + EL H+ +
Sbjct: 9 LGKGNYGSVYKVLHRPTGVTMAMKEIRL-----ELDESKFNQ--IIMELDILHKAVSPYI 61
Query: 73 VKVLGYAWESGKLKALILEYMENGSLESVIHGPGVDHSRWTLPKRIDVLISVANGLDYLH 132
V G + G + + +EYM+ GSL+ ++ GV + +V GL +L
Sbjct: 62 VDFYGAFFIEGAV-YMCMEYMDAGSLDK-LYAGGVATEGIPEDVLRRITYAVVKGLKFLK 119
Query: 133 SGYDIPIVHCDMKPSNILLDRDFEAHVSDFGTSRMLDVHLQDLSSLSTAFQGTIGYLAPE 192
+ I+H D+KP+N+L++ + + + DFG S L ++SL+ G Y+APE
Sbjct: 120 E--EHNIIHRDVKPTNVLVNGNGQVKLCDFGVSGNL------VASLAKTNIGCQSYMAPE 171
Query: 193 FAYMRI----------VTTKVDVFSFGIVVMEFLTKRRP 221
RI T + DV+S G+ ++E R P
Sbjct: 172 ----RIKSGGPNQNPTYTVQSDVWSLGLSILEMALGRYP 206
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal PBS2-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include the MAPKKs Polymyxin B resistance protein 2 (PBS2) from Saccharomyces cerevisiae, Wis1 from Schizosaccharomyces pombe, and related proteins. PBS2 and Wis1 are components of stress-activated MAPK cascades in budding and fission yeast, respectively. PBS2 is the specific activator of the MAPK Hog1, which plays a central role in the response of budding yeast to stress including exposure to arsenite and hyperosmotic environments. Wis1 phosphorylates and activates the MAPK Sty1 (also called Spc1 or Phh1), which stimulates a transcriptional response to a wide range of cellular insults through the bZip transcription factors Atf1, Pcr1, and Pap1. Length = 286 |
| >gnl|CDD|173695 cd05604, STKc_SGK3, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 3 | Back alignment and domain information |
|---|
Score = 54.6 bits (131), Expect = 1e-08
Identities = 60/201 (29%), Positives = 89/201 (44%), Gaps = 15/201 (7%)
Query: 19 IIGNSNLSTVY-KGRLEDGEIVAVKKLNFHQ-FSAESDKSFYREAKTL-KELKHRNLVKV 75
+IG + V R DG+ AVK L + + K E L K +KH LV
Sbjct: 2 VIGKGSFGKVLLAKRKLDGKCYAVKVLQKKIVLNRKEQKHIMAERNVLLKNVKHPFLVG- 60
Query: 76 LGYAWESGKLKALILEYMENGSLESVIHGPGVDHSRWTLPKRIDVLISVANGLDYLHSGY 135
L Y++++ + +L+++ G L + + P+ +A+ L YLHS
Sbjct: 61 LHYSFQTTEKLYFVLDFVNGGELFFHLQ----RERSFPEPRARFYAAEIASALGYLHS-- 114
Query: 136 DIPIVHCDMKPSNILLDRDFEAHVSDFGTSRMLDVHLQDLSSLSTAFQGTIGYLAPEFAY 195
I IV+ D+KP NILLD ++DFG + S +T F GT YLAPE
Sbjct: 115 -INIVYRDLKPENILLDSQGHVVLTDFGLCK----EGIAQSDTTTTFCGTPEYLAPEVIR 169
Query: 196 MRIVTTKVDVFSFGIVVMEFL 216
+ VD + G V+ E L
Sbjct: 170 KQPYDNTVDWWCLGAVLYEML 190
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGK3 is expressed in most tissues and is most abundant in the embryo and adult heart and spleen. It was originally discovered in a screen for antiapoptotic genes. It phosphorylates and inhibits the proapoptotic proteins, Bad and FKHRL1. SGK3 also regulates many transporters, ion channels, and receptors. It plays a critical role in hair follicle morphogenesis and hair cycling. Length = 325 |
| >gnl|CDD|165473 PHA03207, PHA03207, serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Score = 54.8 bits (132), Expect = 2e-08
Identities = 44/173 (25%), Positives = 69/173 (39%), Gaps = 31/173 (17%)
Query: 59 REAKTLKELKHRNLVKVL-GYAWESGKLKAL---------ILEYMENGSLESVIHGPGVD 108
RE LK + HR ++ ++ Y W+S + ++ LE I
Sbjct: 135 REIDILKTISHRAIINLIHAYRWKSTVCMVMPKYKCDLFTYVDRSGPLPLEQAI------ 188
Query: 109 HSRWTLPKRIDVLISVANGLDYLHSGYDIPIVHCDMKPSNILLDRDFEAHVSDFGTSRML 168
T+ +R+ L YLH I+H D+K NI LD A + DFG + L
Sbjct: 189 ----TIQRRL------LEALAYLHGR---GIIHRDVKTENIFLDEPENAVLGDFGAACKL 235
Query: 169 DVHLQDLSSLSTAFQGTIGYLAPEFAYMRIVTTKVDVFSFGIVVMEFLTKRRP 221
D H + + GT+ +PE + K D++S G+V+ E K
Sbjct: 236 DAH--PDTPQCYGWSGTLETNSPELLALDPYCAKTDIWSAGLVLFEMSVKNVT 286
|
Length = 392 |
| >gnl|CDD|132968 cd06637, STKc_TNIK, Catalytic domain of the Protein Serine/Threonine Kinase, Traf2- and Nck-interacting kinase | Back alignment and domain information |
|---|
Score = 53.9 bits (129), Expect = 2e-08
Identities = 56/223 (25%), Positives = 96/223 (43%), Gaps = 28/223 (12%)
Query: 7 IENATGSFSENNIIGNSNLSTVYKGR-LEDGEIVAVKKLNFHQFSAESDKSFYREAKTLK 65
+ + G F ++GN VYKGR ++ G++ A+K ++ + + ++ +E LK
Sbjct: 1 LRDPAGIFELVELVGNGTYGQVYKGRHVKTGQLAAIKVMDV---TGDEEEEIKQEINMLK 57
Query: 66 ELKH-RNLVKVLGYAWESGKLKA-----LILEYMENGSLESVIHGPGVDHSRWTLPKRID 119
+ H RN+ G + L++E+ GS+ +I + TL +
Sbjct: 58 KYSHHRNIATYYGAFIKKNPPGMDDQLWLVMEFCGAGSVTDLIKNTKGN----TLKEEWI 113
Query: 120 VLI--SVANGLDYLHSGYDIPIVHCDMKPSNILLDRDFEAHVSDFGTSRMLDVHLQDLSS 177
I + GL +LH ++H D+K N+LL + E + DFG S LD +
Sbjct: 114 AYICREILRGLSHLHQH---KVIHRDIKGQNVLLTENAEVKLVDFGVSAQLDRTV----G 166
Query: 178 LSTAFQGTIGYLAPEFAYM-----RIVTTKVDVFSFGIVVMEF 215
F GT ++APE K D++S GI +E
Sbjct: 167 RRNTFIGTPYWMAPEVIACDENPDATYDFKSDLWSLGITAIEM 209
|
Serine/threonine kinases (STKs), Traf2- and Nck-interacting kinase (TNIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TNIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to mitogen-activated protein kinase (MAPK), kinase kinase kinase 4 (MAP4K4), and MAP4K6. MAP4Ks participate in some MAPK signaling pathways by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). TNIK is an effector of Rap2, a small GTP-binding protein from the Ras family. TNIK specifically activates the c-Jun N-terminal kinase (JNK) pathway and plays a role in regulating the actin cytoskeleton. Length = 272 |
| >gnl|CDD|173635 cd05054, PTKc_VEGFR, Catalytic domain of the Protein Tyrosine Kinases, Vascular Endothelial Growth Factor Receptors | Back alignment and domain information |
|---|
Score = 54.5 bits (131), Expect = 2e-08
Identities = 50/189 (26%), Positives = 83/189 (43%), Gaps = 32/189 (16%)
Query: 112 WTLPKRIDVLIS----VANGLDYLHSGYDIPIVHCDMKPSNILLDRDFEAHVSDFGTSRM 167
+ P ++ LIS VA G+++L S I H D+ NILL + + DFG +R
Sbjct: 166 YKEPLTLEDLISYSFQVARGMEFLASRKCI---HRDLAARNILLSENNVVKICDFGLAR- 221
Query: 168 LDVHLQDLSSLSTAFQGTIGYLAPEFAYMRIVTTKVDVFSFGIVVMEFLTKRRPTGLDEE 227
D++ + + ++APE + ++ TT+ DV+SFG+++ E +
Sbjct: 222 -DIYKDPDYVRKGDARLPLKWMAPESIFDKVYTTQSDVWSFGVLLWEIFSL--------- 271
Query: 228 NGLSPISLRQLVEKALANGINGVRQITDPKLVSSIYEEQEQHQVLEELFKLALVCTSSNP 287
G SP Q+ E+ G R + E++ + L C +NP
Sbjct: 272 -GASPYPGVQIDEEFCRRLKEGTRM-------------RAPEYATPEIYSIMLDCWHNNP 317
Query: 288 EDRPNMNEL 296
EDRP +EL
Sbjct: 318 EDRPTFSEL 326
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor (VEGFR) subfamily; catalytic (c) domain. The VEGFR subfamily consists of VEGFR1 (Flt1), VEGFR2 (Flk1), VEGFR3 (Flt4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. There are five VEGF ligands in mammals, which bind, in an overlapping pattern to the three VEGFRs, which can form homo or heterodimers. VEGFRs regulate the cardiovascular system. They are critical for vascular development during embryogenesis and blood vessel formation in adults. They induce cellular functions common to other growth factor receptors such as cell migration, survival, and proliferation. VEGFR1 binds VEGFA, VEGFB, and placenta growth factor (PLGF). It regulates monocyte and macrophage migration, vascular permeability, haematopoiesis, and the recruitment of haematopietic progenitor cells from the bone marrow. Length = 337 |
| >gnl|CDD|143380 cd07875, STKc_JNK1, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 1 | Back alignment and domain information |
|---|
Score = 53.9 bits (129), Expect = 3e-08
Identities = 52/183 (28%), Positives = 86/183 (46%), Gaps = 20/183 (10%)
Query: 39 VAVKKLNFHQFSAESDKSFYREAKTLKELKHRNLVKVLGYAWESGKLKA-----LILEYM 93
VA+KKL+ + K YRE +K + H+N++ +L L+ +++E M
Sbjct: 52 VAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIIGLLNVFTPQKSLEEFQDVYIVMELM 111
Query: 94 ENGSLESVIHGPGVDHSRWTLPKRIDVLISVANGLDYLHSGYDIPIVHCDMKPSNILLDR 153
+ +L VI +DH R + +L + G+ +LHS I+H D+KPSNI++
Sbjct: 112 D-ANLCQVIQME-LDHERMSY-----LLYQMLCGIKHLHSA---GIIHRDLKPSNIVVKS 161
Query: 154 DFEAHVSDFGTSRMLDVHLQDLSSLSTAFQGTIGYLAPEFAYMRIVTTKVDVFSFGIVVM 213
D + DFG +R S + T + T Y APE VD++S G ++
Sbjct: 162 DCTLKILDFGLARTAGT-----SFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMG 216
Query: 214 EFL 216
E +
Sbjct: 217 EMI 219
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 1 (JNK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jnk1 or Jnk2) could survive but disruption of both genes resulted in lethality. However, recent studies have shown that JNK1 and JNK2 perform distinct functions through specific binding partners and substrates. JNK1 specifically binds with JAMP (JNK1-associated membrane protein), which regulates the duration of JNK1 activity in response to stimuli. Specific JNK1 substrates include Itch and SG10, which are implicated in Th2 responses and airway inflammation, and microtubule dynamics and axodendritic length, respectively. Mice deficient in Jnk1 are protected against arthritis, obesity, type 2 diabetes, cardiac cell death, and non-alcoholic liver disease, suggesting that JNK1 may play roles in the pathogenesis of these diseases. Length = 364 |
| >gnl|CDD|132967 cd06636, STKc_MAP4K4_6, Catalytic domain of the Protein Serine/Threonine Kinases, Mitogen-Activated Protein Kinase Kinase Kinase Kinase 4 and 6 | Back alignment and domain information |
|---|
Score = 53.1 bits (127), Expect = 4e-08
Identities = 54/226 (23%), Positives = 97/226 (42%), Gaps = 28/226 (12%)
Query: 3 DRTEIENATGSFSENNIIGNSNLSTVYKGR-LEDGEIVAVKKLNFHQFSAESDKSFYREA 61
D + + + G F ++GN VYKGR ++ G++ A+K ++ + + ++ E
Sbjct: 7 DLSALRDPAGIFELVEVVGNGTYGQVYKGRHVKTGQLAAIKVMDV---TEDEEEEIKLEI 63
Query: 62 KTLKELKH-RNLVKVLGYAWESGKLKA-----LILEYMENGSLESVIHGPGVDHSRWTLP 115
LK+ H RN+ G + L++E+ GS+ ++ + L
Sbjct: 64 NMLKKYSHHRNIATYYGAFIKKSPPGHDDQLWLVMEFCGAGSVTDLVKNTKGN----ALK 119
Query: 116 KRIDVLIS--VANGLDYLHSGYDIPIVHCDMKPSNILLDRDFEAHVSDFGTSRMLDVHLQ 173
+ I + GL +LH+ ++H D+K N+LL + E + DFG S LD +
Sbjct: 120 EDWIAYICREILRGLAHLHAHK---VIHRDIKGQNVLLTENAEVKLVDFGVSAQLDRTV- 175
Query: 174 DLSSLSTAFQGTIGYLAPEFAYM-----RIVTTKVDVFSFGIVVME 214
F GT ++APE + D++S GI +E
Sbjct: 176 ---GRRNTFIGTPYWMAPEVIACDENPDATYDYRSDIWSLGITAIE 218
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 4 (MAPKKKK4 or MAP4K4) and MAPKKKK6 (or MAP4K6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K4/MAP4K6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain. MAP4Ks (or MAPKKKKs) are involved in MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K4 is also called Nck Interacting kinase (NIK). It facilitates the activation of the MAPKs, extracellular signal-regulated kinase (ERK) 1, ERK2, and c-Jun N-terminal kinase (JNK), by phosphorylating and activating MEKK1. MAP4K4 plays a role in tumor necrosis factor (TNF) alpha-induced insulin resistance. MAP4K4 silencing in skeletal muscle cells from type II diabetic patients restores insulin-mediated glucose uptake. MAP4K4, through JNK, also plays a broad role in cell motility, which impacts inflammation, homeostasis, as well as the invasion and spread of cancer. MAP4K4 is found to be highly expressed in most tumor cell lines relative to normal tissue. MAP4K6 (also called MINK for Misshapen/NIKs-related kinase) is activated after Ras induction and mediates activation of p38 MAPK. MAP4K6 plays a role in cell cycle arrest, cytoskeleton organization, cell adhesion, and cell motility. Length = 282 |
| >gnl|CDD|133233 cd05102, PTKc_VEGFR3, Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 3 | Back alignment and domain information |
|---|
Score = 53.5 bits (128), Expect = 4e-08
Identities = 46/190 (24%), Positives = 87/190 (45%), Gaps = 32/190 (16%)
Query: 112 WTLPKRIDVLI----SVANGLDYLHSGYDIPIVHCDMKPSNILLDRDFEAHVSDFGTSRM 167
W P ++ LI VA G+++L S +H D+ NILL + + DFG +R
Sbjct: 167 WKSPLTMEDLICYSFQVARGMEFLASR---KCIHRDLAARNILLSENNVVKICDFGLAR- 222
Query: 168 LDVHLQDLSSLSTAFQGTIGYLAPEFAYMRIVTTKVDVFSFGIVVMEFLTKRRPTGLDEE 227
D++ + + + ++APE + ++ TT+ DV+SFG+++ E +
Sbjct: 223 -DIYKDPDYVRKGSARLPLKWMAPESIFDKVYTTQSDVWSFGVLLWEIFSL--------- 272
Query: 228 NGLSPISLRQLVEKALANGINGVRQITDPKLVSSIYEEQEQHQVLEELFKLALVCTSSNP 287
G SP Q+ E+ +G R + P+ + E++++ L C +P
Sbjct: 273 -GASPYPGVQINEEFCQRLKDGTR-MRAPENATP------------EIYRIMLACWQGDP 318
Query: 288 EDRPNMNELL 297
++RP + L+
Sbjct: 319 KERPTFSALV 328
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 3 (VEGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR3 (or Flt4) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. VEGFR3 preferentially binds the ligands VEGFC and VEGFD. VEGFR3 is essential for lymphatic endothelial cell (EC) development and function. It has been shown to regulate adaptive immunity during corneal transplantation. VEGFR3 is upregulated on blood vascular ECs in pathological conditions such as vascular tumors and the periphery of solid tumors. It plays a role in cancer progression and lymph node metastasis. Missense mutations in the VEGFR3 gene are associated with primary human lymphedema. Length = 338 |
| >gnl|CDD|173677 cd05586, STKc_Sck1_like, Catalytic domain of Suppressor of loss of cAMP-dependent protein kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 53.4 bits (128), Expect = 4e-08
Identities = 58/210 (27%), Positives = 91/210 (43%), Gaps = 36/210 (17%)
Query: 20 IGNSNLSTVYKGRLED-GEIVAVKKLNFHQFSAESDKSFYREAKTLKELKHRNLVKV--- 75
IG VY+ R +D I A+K L S K + + + RN++
Sbjct: 1 IGKGTFGQVYQVRKKDTRRIYAMKVL--------SKKEIVAKKEVAHTIGERNILVRTLL 52
Query: 76 --------LGYAWESGKLKALILEYMENGSLESVIHGPGVDHSRWTLPKRIDVLISVANG 127
L +++++ L+ +YM G L + G R++ + + +
Sbjct: 53 DESPFIVGLKFSFQTDSDLYLVTDYMSGGELFWHLQKEG----RFSEDRAKFYIAELVLA 108
Query: 128 LDYLHSGYDIPIVHCDMKPSNILLDRDFEAHVSDFGTSRMLDVHLQDLS--SLSTAFQGT 185
L++LH YDI V+ D+KP NILLD + DFG S+ +L+ + F GT
Sbjct: 109 LEHLHK-YDI--VYRDLKPENILLDATGHIALCDFGLSK------ANLTDNKTTNTFCGT 159
Query: 186 IGYLAPEFAYMRIVTTK-VDVFSFGIVVME 214
YLAPE TK VD +S G++V E
Sbjct: 160 TEYLAPEVLLDEKGYTKHVDFWSLGVLVFE 189
|
Serine/Threonine Kinases (STKs), Fission yeast Suppressor of loss of cAMP-dependent protein kinase (Sck1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sck1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the Schizosaccharomyces pombe STK Sck1. Sck1 plays a role in trehalase activation triggered by glucose and a nitrogen source. Trehalase catalyzes the cleavage of the disaccharide trehalose to glucose. Trehalose, as a carbohydrate reserve and stress metabolite, plays an important role in the response of yeast to environmental changes. Length = 330 |
| >gnl|CDD|173707 cd05616, STKc_cPKC_beta, Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C beta | Back alignment and domain information |
|---|
Score = 53.1 bits (127), Expect = 5e-08
Identities = 43/141 (30%), Positives = 70/141 (49%), Gaps = 12/141 (8%)
Query: 88 LILEYMENGSLESVIHGPGVDHSRWTLPKRIDVLISVANGLDYLHSGYDIPIVHCDMKPS 147
++EY+ G L I G R+ P + +A GL +LHS I++ D+K
Sbjct: 78 FVMEYVNGGDLMYQIQQVG----RFKEPHAVFYAAEIAIGLFFLHSK---GIIYRDLKLD 130
Query: 148 NILLDRDFEAHVSDFGTSRMLDVHLQDLSSLSTAFQGTIGYLAPEFAYMRIVTTKVDVFS 207
N++LD + ++DFG M ++ D + T F GT Y+APE + VD ++
Sbjct: 131 NVMLDSEGHIKIADFG---MCKENMWDGVTTKT-FCGTPDYIAPEIIAYQPYGKSVDWWA 186
Query: 208 FGIVVMEFLTKRRP-TGLDEE 227
FG+++ E L + P G DE+
Sbjct: 187 FGVLLYEMLAGQAPFEGEDED 207
|
Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, beta isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, and gamma. The PKC beta isoforms (I and II), generated by alternative splicing of a single gene, are preferentially activated by hyperglycemia-induced DAG in retinal tissues. This is implicated in diabetic microangiopathy such as ischemia, neovascularization, and abnormal vasodilator function. PKC-beta also plays an important role in VEGF signaling. In addition, glucose regulates proliferation in retinal endothelial cells via PKC-betaI. PKC-beta is also being explored as a therapeutic target in cancer. It contributes to tumor formation and is involved in the tumor host mechanisms of inflammation and angiogenesis. Length = 323 |
| >gnl|CDD|140293 PTZ00267, PTZ00267, NIMA-related protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 53.1 bits (127), Expect = 7e-08
Identities = 75/263 (28%), Positives = 106/263 (40%), Gaps = 48/263 (18%)
Query: 46 FHQFSAESDKSFYR-EAKTLKELKHRNLVKVLGYAWESGKLKALILEYMENGSLESVI-- 102
F + E ++ R E L H +VK KL LI+EY G L I
Sbjct: 100 FVMLNDERQAAYARSELHCLAACDHFGIVKHFDDFKSDDKL-LLIMEYGSGGDLNKQIKQ 158
Query: 103 ----HGPGVDHSRWTLPKRIDVLISVANGLDYLHSGYDIPIVHCDMKPSNILLDRDFEAH 158
H P ++ L +I VL LD +HS ++H D+K +NI L
Sbjct: 159 RLKEHLPFQEYEVGLLFYQI-VL-----ALDEVHSR---KMMHRDLKSANIFLMPTGIIK 209
Query: 159 VSDFGTSRMLDVHLQDLSSLSTA--FQGTIGYLAPEFAYMRIVTTKVDVFSFGIVVMEFL 216
+ DFG S+ D SL A F GT YLAPE + + K D++S G+++ E L
Sbjct: 210 LGDFGFSK----QYSDSVSLDVASSFCGTPYYLAPELWERKRYSKKADMWSLGVILYELL 265
Query: 217 TKRRPTGLDEENGLSPISLRQLVEKALANGINGVRQITDPKLVSSIYEEQEQHQVLEELF 276
T RP S R+++++ L + P VSS +L+ L
Sbjct: 266 TLHRP--------FKGPSQREIMQQVLYGKYDPF-----PCPVSS-----GMKALLDPLL 307
Query: 277 KLALVCTSSNPEDRPNMNELLIT 299
S NP RP +LL T
Sbjct: 308 -------SKNPALRPTTQQLLHT 323
|
Length = 478 |
| >gnl|CDD|133195 cd05064, PTKc_EphR_A10, Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A10 | Back alignment and domain information |
|---|
Score = 52.2 bits (125), Expect = 8e-08
Identities = 51/189 (26%), Positives = 86/189 (45%), Gaps = 22/189 (11%)
Query: 39 VAVKKLNFHQFSAESDKSFYREAKTLKELKHRNLVKVLGYAWESGKLKALILEYMENGSL 98
VA+ L S + + F EA TL + H N+V++ G G ++ EYM NG+L
Sbjct: 36 VAIHTLR-AGCSDKQRRGFLAEALTLGQFDHSNIVRLEGVI-TRGNTMMIVTEYMSNGAL 93
Query: 99 ESVIHGPGVDHSRWTLPKRIDVLISVANGLDYLHS-GYDIPIVHCDMKPSNILLDRDFEA 157
+S + + + + +L +A+G+ YL GY VH + +L++ D
Sbjct: 94 DSFLRK---HEGQLVAGQLMGMLPGLASGMKYLSEMGY----VHKGLAAHKVLVNSDLVC 146
Query: 158 HVSDFGTSRMLDVHLQD--LSSLSTAFQG--TIGYLAPEFAYMRIVTTKVDVFSFGIVVM 213
+S F LQ+ ++ T G + + APE ++ DV+SFGIV+
Sbjct: 147 KISGFR-------RLQEDKSEAIYTTMSGKSPVLWAAPEAIQYHHFSSASDVWSFGIVMW 199
Query: 214 EFLT-KRRP 221
E ++ RP
Sbjct: 200 EVMSYGERP 208
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA10 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). EphA10, which contains an inactive tyr kinase domain, may function to attenuate signals of co-clustered active receptors. EphA10 is mainly expressed in the testis. Ephrin/EphR interaction results in cell-cell repulsion or adhesion, making it important in neural development and plasticity, cell morphogenesis, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. Length = 266 |
| >gnl|CDD|173662 cd05571, STKc_PKB, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B | Back alignment and domain information |
|---|
Score = 52.5 bits (126), Expect = 8e-08
Identities = 45/165 (27%), Positives = 78/165 (47%), Gaps = 18/165 (10%)
Query: 60 EAKTLKELKHRNLVKVLGYAWESGKLKALILEYMENGSLESVIHGPGV---DHSRWTLPK 116
E++ L+ +H L L Y++++ ++EY G L + V D +R+ +
Sbjct: 45 ESRVLQNTRHPFLTA-LKYSFQTHDRLCFVMEYANGGELFFHLSRERVFSEDRARFYGAE 103
Query: 117 RIDVLISVANGLDYLHSGYDIPIVHCDMKPSNILLDRDFEAHVSDFGTSRMLDVHLQDLS 176
+ + L YLHS +V+ D+K N++LD+D ++DFG + + D +
Sbjct: 104 -------IVSALGYLHSC---DVVYRDLKLENLMLDKDGHIKITDFGLCKE---GISDGA 150
Query: 177 SLSTAFQGTIGYLAPEFAYMRIVTTKVDVFSFGIVVMEFLTKRRP 221
++ T F GT YLAPE VD + G+V+ E + R P
Sbjct: 151 TMKT-FCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLP 194
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. It is activated downstream of PI3K and plays important roles in diverse cellular functions including cell survival, growth, proliferation, angiogenesis, motility, and migration. PKB also has a central role in a variety of human cancers, having been implicated in tumor initiation, progression, and metastasis. Length = 323 |
| >gnl|CDD|173656 cd05111, PTK_HER3, Pseudokinase domain of the Protein Tyrosine Kinase, HER3 | Back alignment and domain information |
|---|
Score = 52.3 bits (125), Expect = 8e-08
Identities = 58/237 (24%), Positives = 104/237 (43%), Gaps = 38/237 (16%)
Query: 19 IIGNSNLSTVYKG-RLEDGEI----VAVK----KLNFHQFSAESDKSFYREAKTLKELKH 69
++G+ TV+KG + +G+ VA+K + F +D + L H
Sbjct: 14 LLGSGVFGTVHKGIWIPEGDSIKIPVAIKTIQDRSGRQTFQEITDHML-----AMGSLDH 68
Query: 70 RNLVKVLGYAWESGKLKALILEYMENGSLESVIHGPGVDHSRWTL----PKRI-DVLISV 124
+V++LG G L+ + GSL +DH R P+R+ + + +
Sbjct: 69 AYIVRLLGIC--PGASLQLVTQLSPLGSL--------LDHVRQHRDSLDPQRLLNWCVQI 118
Query: 125 ANGLDYLHSGYDIPIVHCDMKPSNILLDRDFEAHVSDFGTSRMLDVHLQDLSSLSTAFQG 184
A G+ YL + +VH ++ NILL D ++DFG + +L + D + +
Sbjct: 119 AKGMYYLE---EHRMVHRNLAARNILLKSDSIVQIADFGVADLL--YPDDKKYFYSEHKT 173
Query: 185 TIGYLAPEFAYMRIVTTKVDVFSFGIVVMEFLTKRRPTGLDEENGLSPISLRQLVEK 241
I ++A E T + DV+S+G+ V E ++ G + G+ P + L+EK
Sbjct: 174 PIKWMALESILFGRYTHQSDVWSYGVTVWEMMS----YGAEPYAGMRPHEVPDLLEK 226
|
Protein Tyrosine Kinase (PTK) family; HER3 (ErbB3); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER3 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. HER3 binds the neuregulin ligands, NRG1 and NRG2. HER3 contains an impaired tyr kinase domain and relies on its heterodimerization partners for activity following ligand binding. The HER2-HER3 heterodimer constitutes a high affinity co-receptor capable of potent mitogenic signaling. HER3 participates in a signaling pathway involved in the proliferation, survival, adhesion, and motility of tumor cells. Length = 279 |
| >gnl|CDD|173678 cd05587, STKc_cPKC, Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C | Back alignment and domain information |
|---|
Score = 52.5 bits (126), Expect = 9e-08
Identities = 41/140 (29%), Positives = 69/140 (49%), Gaps = 12/140 (8%)
Query: 89 ILEYMENGSLESVIHGPGVDHSRWTLPKRIDVLISVANGLDYLHSGYDIPIVHCDMKPSN 148
++EY+ G L I G ++ P + +A GL +LHS I++ D+K N
Sbjct: 79 VMEYVNGGDLMYHIQQVG----KFKEPHAVFYAAEIAIGLFFLHSK---GIIYRDLKLDN 131
Query: 149 ILLDRDFEAHVSDFGTSRMLDVHLQDLSSLSTAFQGTIGYLAPEFAYMRIVTTKVDVFSF 208
++LD + ++DFG M ++ + T F GT Y+APE + VD ++F
Sbjct: 132 VMLDAEGHIKIADFG---MCKENIFGGKTTRT-FCGTPDYIAPEIIAYQPYGKSVDWWAF 187
Query: 209 GIVVMEFLTKRRP-TGLDEE 227
G+++ E L + P G DE+
Sbjct: 188 GVLLYEMLAGQPPFDGEDED 207
|
Serine/Threonine Kinases (STKs), Classical (or Conventional) Protein Kinase C (cPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. cPKCs contain a calcium-binding C2 region in their regulatory domain. There are four cPKC isoforms, named alpha, betaI, betaII, and gamma. cPKCs are potent kinases for histones, myelin basic protein, and protamine. PKC-gamma is mainly expressed in neuronal tissues. It plays a role in protection from ischemia. Length = 324 |
| >gnl|CDD|173686 cd05595, STKc_PKB_beta, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B beta | Back alignment and domain information |
|---|
Score = 51.9 bits (124), Expect = 1e-07
Identities = 45/165 (27%), Positives = 79/165 (47%), Gaps = 18/165 (10%)
Query: 60 EAKTLKELKHRNLVKVLGYAWESGKLKALILEYMENGSLESVIHGPGV---DHSRWTLPK 116
E++ L+ +H L L YA+++ ++EY G L + V + +R+ +
Sbjct: 45 ESRVLQNTRHPFLT-ALKYAFQTHDRLCFVMEYANGGELFFHLSRERVFTEERARFYGAE 103
Query: 117 RIDVLISVANGLDYLHSGYDIPIVHCDMKPSNILLDRDFEAHVSDFGTSRMLDVHLQDLS 176
+ + L+YLHS +V+ D+K N++LD+D ++DFG + + D +
Sbjct: 104 -------IVSALEYLHSR---DVVYRDIKLENLMLDKDGHIKITDFGLCKE---GISDGA 150
Query: 177 SLSTAFQGTIGYLAPEFAYMRIVTTKVDVFSFGIVVMEFLTKRRP 221
++ T F GT YLAPE VD + G+V+ E + R P
Sbjct: 151 TMKT-FCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLP 194
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, beta (or Akt2) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-beta is the predominant PKB isoform expressed in insulin-responsive tissues. It plays a critical role in the regulation of glucose homeostasis. It is also implicated in muscle cell differentiation. Mice deficient in PKB-beta display normal growth weights but exhibit severe insulin resistance and diabetes, accompanied by lipoatrophy and B-cell failure. Length = 323 |
| >gnl|CDD|173661 cd05570, STKc_PKC, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase C | Back alignment and domain information |
|---|
Score = 52.0 bits (125), Expect = 1e-07
Identities = 39/144 (27%), Positives = 67/144 (46%), Gaps = 15/144 (10%)
Query: 89 ILEYMENGSLESVIHGPGVDHSRWTLPKRIDVLISVANGLDYLHSGYDIPIVHCDMKPSN 148
++EY+ G L I G R+ P+ + GL +LH I++ D+K N
Sbjct: 74 VMEYVNGGDLMFHIQRSG----RFDEPRARFYAAEIVLGLQFLHER---GIIYRDLKLDN 126
Query: 149 ILLDRDFEAHVSDFGTSR--MLDVHLQDLSSLSTAFQGTIGYLAPEFAYMRIVTTKVDVF 206
+LLD + ++DFG + +L ++ F GT Y+APE + VD +
Sbjct: 127 VLLDSEGHIKIADFGMCKEGILG------GVTTSTFCGTPDYIAPEILSYQPYGPAVDWW 180
Query: 207 SFGIVVMEFLTKRRPTGLDEENGL 230
+ G+++ E L + P D+E+ L
Sbjct: 181 ALGVLLYEMLAGQSPFEGDDEDEL 204
|
Serine/Threonine Kinases (STKs), Protein Kinase C (PKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, classical PKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. Novel PKCs are calcium-independent, but require DAG and PS for activity, while atypical PKCs only require PS. PKCs phosphorylate and modify the activities of a wide variety of cellular proteins including receptors, enzymes, cytoskeletal proteins, transcription factors, and other kinases. They play a central role in signal transduction pathways that regulate cell migration and polarity, proliferation, differentiation, and apoptosis. Also included in this subfamily are the PKC-like proteins, called PKNs. Length = 318 |
| >gnl|CDD|173685 cd05594, STKc_PKB_alpha, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B alpha | Back alignment and domain information |
|---|
Score = 51.9 bits (124), Expect = 1e-07
Identities = 46/165 (27%), Positives = 80/165 (48%), Gaps = 17/165 (10%)
Query: 60 EAKTLKELKHRNLVKVLGYAWESGKLKALILEYMENGSLESVIHGPGV---DHSRWTLPK 116
E + L+ +H L L Y++++ ++EY G L + V D +R+ +
Sbjct: 45 ENRVLQNSRHPFLTA-LKYSFQTHDRLCFVMEYANGGELFFHLSRERVFSEDRARFYGAE 103
Query: 117 RIDVLISVANGLDYLHSGYDIPIVHCDMKPSNILLDRDFEAHVSDFGTSRMLDVHLQDLS 176
+ + LDYLHS ++ V+ D+K N++LD+D ++DFG + ++D +
Sbjct: 104 -------IVSALDYLHSEKNV--VYRDLKLENLMLDKDGHIKITDFGLCKE---GIKDGA 151
Query: 177 SLSTAFQGTIGYLAPEFAYMRIVTTKVDVFSFGIVVMEFLTKRRP 221
++ T F GT YLAPE VD + G+V+ E + R P
Sbjct: 152 TMKT-FCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLP 195
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, alpha (or Akt1) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-alpha is predominantly expressed in endothelial cells. It is critical for the regulation of angiogenesis and the maintenance of vascular integrity. It also plays a role in adipocyte differentiation. Mice deficient in PKB-alpha exhibit perinatal morbidity, growth retardation, reduction in body weight accompanied by reduced sizes of multiple organs, and enhanced apoptosis in some cell types. PKB-alpha activity has been reported to be frequently elevated in breast and prostate cancers. In some cancer cells, PKB-alpha may act as a suppressor of metastasis. Length = 325 |
| >gnl|CDD|133186 cd05055, PTKc_PDGFR, Catalytic domain of the Protein Tyrosine Kinases, Platelet Derived Growth Factor Receptors | Back alignment and domain information |
|---|
Score = 51.7 bits (124), Expect = 1e-07
Identities = 49/180 (27%), Positives = 82/180 (45%), Gaps = 10/180 (5%)
Query: 39 VAVKKLNFHQFSAESDKSFYREAKTLKEL-KHRNLVKVLGYAWESGKLKALILEYMENGS 97
VAVK L S+E + + E K + L H N+V +LG G + +I EY G
Sbjct: 68 VAVKMLKPTAHSSERE-ALMSELKIMSHLGNHENIVNLLGACTIGGPI-LVITEYCCYGD 125
Query: 98 LESVIHGPGVDHSRWTLPKRIDVLISVANGLDYLHSGYDIPIVHCDMKPSNILLDRDFEA 157
L + + S TL + VA G+ +L S +H D+ N+LL
Sbjct: 126 LLNFLRRK--RESFLTLEDLLSFSYQVAKGMAFLASK---NCIHRDLAARNVLLTHGKIV 180
Query: 158 HVSDFGTSRMLDVHLQDLSSLSTAFQGTIGYLAPEFAYMRIVTTKVDVFSFGIVVMEFLT 217
+ DFG +R + ++ + A + ++APE + + T + DV+S+GI++ E +
Sbjct: 181 KICDFGLARDI-MNDSNYVVKGNARL-PVKWMAPESIFNCVYTFESDVWSYGILLWEIFS 238
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) subfamily; catalytic (c) domain. The PDGFR subfamily consists of PDGFR alpha, PDGFR beta, KIT, CSF-1R, the mammalian FLT3, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. PDGFR kinase domains are autoinhibited by their juxtamembrane regions containing tyr residues. The binding to their ligands leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR subfamily receptors are important in the development of a variety of cells. PDGFRs are expressed in a many cells including fibroblasts, neurons, endometrial cells, mammary epithelial cells, and vascular smooth muscle cells. PDGFR signaling is critical in normal embryonic development, angiogenesis, and wound healing. PDGFRs transduce mitogenic signals for connective tissue cells and are important for cell shape and motility. Kit is important in the development of melanocytes, germ cells, mast cells, hematopoietic stem cells, the interstitial cells of Cajal, and the pacemaker cells of the GI tract. CSF-1R signaling is critical in the regulation of macrophages and osteoclasts. Mammalian FLT3 plays an important role in the survival, proliferation, and differentiation of stem cells. Length = 302 |
| >gnl|CDD|173722 cd05633, STKc_GRK3, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 3 | Back alignment and domain information |
|---|
Score = 51.2 bits (122), Expect = 2e-07
Identities = 54/213 (25%), Positives = 91/213 (42%), Gaps = 28/213 (13%)
Query: 19 IIGNSNLSTVYKGRLED-GEIVAVKKLNFHQFSAESDKSFYREAKTLKELKHRN---LVK 74
IIG VY R D G++ A+K L+ + + ++ + + L +
Sbjct: 1 IIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIV 60
Query: 75 VLGYAWESGKLKALILEYMENGSLESVIHGPGVDHSRWTLPKRIDVLISVANGLDYLHSG 134
+ YA+ + IL+ M G L + GV + ++++ GL+++H+
Sbjct: 61 CMTYAFHTPDKLCFILDLMNGGDLHYHLSQHGVFSEKEMRFYATEIIL----GLEHMHNR 116
Query: 135 YDIPIVHCDMKPSNILLDRDFEAHVSDFGTSRMLDVHLQDLSSLST-AFQGTIGYLAPEF 193
+ +V+ D+KP+NILLD +SD G + D S A GT GY+APE
Sbjct: 117 F---VVYRDLKPANILLDEHGHVRISDLGLA-------CDFSKKKPHASVGTHGYMAPEV 166
Query: 194 -----AYMRIVTTKVDVFSFGIVVMEFLTKRRP 221
AY + D FS G ++ + L P
Sbjct: 167 LQKGTAY----DSSADWFSLGCMLFKLLRGHSP 195
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK3 (also known as beta-adrenergic receptor kinase 2) is widely expressed in many tissues. GRK3-deficient mice show a lack of olfactory receptor desensitization and altered regulation of the M2 muscarinic airway. GRK3 is involved in modulating the cholinergic response of airway smooth muscles. It also plays a role in dopamine receptor regulation. GRK3 promoter polymorphisms may be associated with bipolar disorder. Length = 279 |
| >gnl|CDD|173665 cd05574, STKc_phototropin_like, Catalytic domain of Phototropin-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 51.1 bits (123), Expect = 2e-07
Identities = 60/243 (24%), Positives = 102/243 (41%), Gaps = 61/243 (25%)
Query: 20 IGNSNLSTVYKGRLED-GEIVAVKKLNFHQFSAESDKSFYR---EAKTLKELKHRNLVKV 75
+G ++ V+ RL+ G++ A+K L+ + R E + L L H L +
Sbjct: 9 LGKGDVGRVFLVRLKGTGKLFALKVLD--KKEMIKRNKVKRVLTEQEILATLDHPFLPTL 66
Query: 76 LGYAWESGKLKALILEYMENGSLESVIHG-PG----VDHSRWTLPKRIDVLISVANGLDY 130
++++ L+++Y G L ++ PG + +R+ +VL+ L+Y
Sbjct: 67 YA-SFQTETYLCLVMDYCPGGELFRLLQRQPGKCLSEEVARFYAA---EVLL----ALEY 118
Query: 131 LHSGYDIPIVHCDMKPSNILLDRDFEAHV--SDFGTSRMLDV-------HLQDLSSL--- 178
LH + IV+ D+KP NILL H+ SDF S+ DV L+ S
Sbjct: 119 LHL---LGIVYRDLKPENILLHES--GHIMLSDFDLSKQSDVEPPPVSKALRKGSRRSSV 173
Query: 179 ---------------STAFQGTIGYLAPEFAYMRIV-----TTKVDVFSFGIVVMEFLTK 218
S +F GT Y+APE ++ + VD ++ GI++ E L
Sbjct: 174 NSIPSETFSEEPSFRSNSFVGTEEYIAPE-----VISGDGHGSAVDWWTLGILLYEMLYG 228
Query: 219 RRP 221
P
Sbjct: 229 TTP 231
|
Serine/Threonine Kinases (STKs), Phototropin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The phototropin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Included in this subfamily are plant phototropins and predominantly uncharacterized fungal STKs whose catalytic domains resemble the phototropin kinase domain. One protein from Neurospora crassa is called nrc-2. Phototropins are blue-light receptors that control responses such as phototropism, stromatal opening, and chloroplast movement in order to optimize the photosynthetic efficiency of plants. They are light-activated STKs that contain an N-terminal photosensory domain and a C-terminal catalytic domain. The N-terminal domain contains two LOV (Light, Oxygen or Voltage) domains that binds FMN. Photoexcitation of the LOV domains results in autophosphorylation at multiple sites and activation of the catalytic domain. Neurospora crassa nrc-2 plays a role in growth and development by controlling entry into the conidiation program. Length = 316 |
| >gnl|CDD|173759 cd08219, STKc_Nek3, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 3 | Back alignment and domain information |
|---|
Score = 50.4 bits (120), Expect = 2e-07
Identities = 56/260 (21%), Positives = 110/260 (42%), Gaps = 40/260 (15%)
Query: 40 AVKKLNFHQFSAESDKSFYREAKTLKELKHRNLVKVLGYAWESGKLKALILEYMENGSLE 99
A+K++ + S+ + S +EA L ++KH N+V ++E+ +++EY + G L
Sbjct: 29 AMKEIRLPKSSSAVEDS-RKEAVLLAKMKHPNIV-AFKESFEADGHLYIVMEYCDGGDLM 86
Query: 100 SVIHGPGVDHSRWTLPKR--IDVLISVANGLDYLHSGYDIPIVHCDMKPSNILLDRDFEA 157
I P+ + + + G+ ++H + ++H D+K NI L ++ +
Sbjct: 87 QKIK----LQRGKLFPEDTILQWFVQMCLGVQHIH---EKRVLHRDIKSKNIFLTQNGKV 139
Query: 158 HVSDFGTSRMLDVHLQDLSSLSTAFQGTIGYLAPEFAYMRIVTTKVDVFSFGIVVMEFLT 217
+ DFG++R+ L + + + GT Y+ PE K D++S G ++ E T
Sbjct: 140 KLGDFGSARL----LTSPGAYACTYVGTPYYVPPEIWENMPYNNKSDIWSLGCILYELCT 195
Query: 218 KRRPTGLDEENGLSPISLRQLVEKALANGINGVRQITDPKLVSSIYEEQEQHQVLEELFK 277
+ P S + L+ K + P S E +++++FK
Sbjct: 196 LKHP--------FQANSWKNLILKVCQGSYKPL-----PSHYS-----YELRSLIKQMFK 237
Query: 278 LALVCTSSNPEDRPNMNELL 297
NP RP+ +L
Sbjct: 238 -------RNPRSRPSATTIL 250
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 3 (Nek3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek3 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek3 is primarily localized in the cytoplasm and shows no cell cycle-dependent changes in its activity. It is present in the axons of neurons and affects morphogenesis and polarity through its regulation of microtubule acetylation. Nek3 modulates the signaling of the prolactin receptor through its activation of Vav2 and contributes to prolactin-mediated motility of breast cancer cells. Length = 255 |
| >gnl|CDD|173706 cd05615, STKc_cPKC_alpha, Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C alpha | Back alignment and domain information |
|---|
Score = 50.8 bits (121), Expect = 3e-07
Identities = 39/143 (27%), Positives = 71/143 (49%), Gaps = 11/143 (7%)
Query: 88 LILEYMENGSLESVIHGPGVDHSRWTLPKRIDVLISVANGLDYLHSGYDIPIVHCDMKPS 147
++EY+ G L I G ++ P+ + ++ GL +LH I++ D+K
Sbjct: 78 FVMEYVNGGDLMYHIQQVG----KFKEPQAVFYAAEISVGLFFLHRR---GIIYRDLKLD 130
Query: 148 NILLDRDFEAHVSDFGTSRMLDVHLQDLSSLSTAFQGTIGYLAPEFAYMRIVTTKVDVFS 207
N++LD + ++DFG M H+ D + T F GT Y+APE + VD ++
Sbjct: 131 NVMLDSEGHIKIADFG---MCKEHMVDGVTTRT-FCGTPDYIAPEIIAYQPYGKSVDWWA 186
Query: 208 FGIVVMEFLTKRRPTGLDEENGL 230
+G+++ E L + P ++E+ L
Sbjct: 187 YGVLLYEMLAGQPPFDGEDEDEL 209
|
Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, and gamma. PKC-alpha is expressed in many tissues and is associated with cell proliferation, apoptosis, and cell motility. It plays a role in the signaling of the growth factors PDGF, VEGF, EGF, and FGF. Abnormal levels of PKC-alpha have been detected in many transformed cell lines and several human tumors. In addition, PKC-alpha is required for HER2 dependent breast cancer invasion. Length = 323 |
| >gnl|CDD|143376 cd07871, STKc_PCTAIRE3, Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-3 kinase | Back alignment and domain information |
|---|
Score = 50.4 bits (120), Expect = 3e-07
Identities = 55/203 (27%), Positives = 96/203 (47%), Gaps = 17/203 (8%)
Query: 20 IGNSNLSTVYKGRLE-DGEIVAVKKLNF-HQFSAESDKSFYREAKTLKELKHRNLVKVLG 77
+G +TV+KGR + +VA+K++ H+ A + RE LK LKH N+V L
Sbjct: 13 LGEGTYATVFKGRSKLTENLVALKEIRLEHEEGAPC--TAIREVSLLKNLKHANIV-TLH 69
Query: 78 YAWESGKLKALILEYMENGSLESVIHGPGVDHSRWTLPKRIDVLISVANGLDYLHSGYDI 137
+ + L+ EY+++ L+ + G S + +I + + GL Y H
Sbjct: 70 DIIHTERCLTLVFEYLDS-DLKQYLDNCGNLMSMHNV--KI-FMFQLLRGLSYCHKR--- 122
Query: 138 PIVHCDMKPSNILLDRDFEAHVSDFGTSRMLDVHLQDLSSLSTAFQGTIGYLAPEFAYMR 197
I+H D+KP N+L++ E ++DFG +R V + S+ T+ Y P+
Sbjct: 123 KILHRDLKPQNLLINEKGELKLADFGLARAKSVPTKTYSNEVV----TLWYRPPDVLLGS 178
Query: 198 I-VTTKVDVFSFGIVVMEFLTKR 219
+T +D++ G ++ E T R
Sbjct: 179 TEYSTPIDMWGVGCILYEMATGR 201
|
Serine/Threonine Kinases (STKs), PCTAIRE-3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-3 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-3 shows a restricted pattern of expression and is present in brain, kidney, and intestine. It is elevated in Alzheimer's disease (AD) and has been shown to associate with paired helical filaments (PHFs) and stimulate Tau phosphorylation. As AD progresses, phosphorylated Tau aggregates and forms PHFs, which leads to the formation of neurofibrillary tangles (NFTs). In human glioma cells, PCTAIRE-3 induces cell cycle arrest and cell death. Length = 288 |
| >gnl|CDD|143378 cd07873, STKc_PCTAIRE1, Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-1 kinase | Back alignment and domain information |
|---|
Score = 50.4 bits (120), Expect = 4e-07
Identities = 54/203 (26%), Positives = 96/203 (47%), Gaps = 17/203 (8%)
Query: 20 IGNSNLSTVYKGRLEDGE-IVAVKKLNF-HQFSAESDKSFYREAKTLKELKHRNLVKVLG 77
+G +TVYKGR + + +VA+K++ H+ A + RE LK+LKH N+V L
Sbjct: 14 LGEGTYATVYKGRSKLTDNLVALKEIRLEHEEGAPC--TAIREVSLLKDLKHANIV-TLH 70
Query: 78 YAWESGKLKALILEYMENGSLESVIHGPGVDHSRWTLPKRIDVLISVANGLDYLHSGYDI 137
+ K L+ EY++ L+ + G + + L + GL+Y H
Sbjct: 71 DIIHTEKSLTLVFEYLDK-DLKQYLDDCG---NSINMHNVKLFLFQLLRGLNYCHRR--- 123
Query: 138 PIVHCDMKPSNILLDRDFEAHVSDFGTSRMLDVHLQDLSSLSTAFQGTIGYLAPEFAYMR 197
++H D+KP N+L++ E ++DFG +R + + S+ T+ Y P+
Sbjct: 124 KVLHRDLKPQNLLINERGELKLADFGLARAKSIPTKTYSNEVV----TLWYRPPDILLGS 179
Query: 198 I-VTTKVDVFSFGIVVMEFLTKR 219
+T++D++ G + E T R
Sbjct: 180 TDYSTQIDMWGVGCIFYEMSTGR 202
|
Serine/Threonine Kinases (STKs), PCTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-1 is expressed ubiquitously and is localized in the cytoplasm. Its kinase activity is cell cycle dependent and peaks at the S and G2 phases. PCTAIRE-1 is highly expressed in the brain and may play a role in regulating neurite outgrowth. It can also associate with Trap (Tudor repeat associator with PCTAIRE-2), a physiological partner of PCTAIRE-2; with p11, a small dimeric protein with similarity to S100; and with 14-3-3 proteins, mediators of phosphorylation-dependent interactions in many different proteins. Length = 301 |
| >gnl|CDD|173697 cd05606, STKc_beta_ARK, Catalytic domain of the Protein Serine/Threonine Kinase, beta-adrenergic receptor kinase | Back alignment and domain information |
|---|
Score = 49.9 bits (119), Expect = 4e-07
Identities = 54/213 (25%), Positives = 90/213 (42%), Gaps = 28/213 (13%)
Query: 19 IIGNSNLSTVYKGRLED-GEIVAVKKLNFHQFSAESDKSFYREAKTLKELKHRN---LVK 74
IIG VY R D G++ A+K L+ + + ++ + + L +
Sbjct: 1 IIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIV 60
Query: 75 VLGYAWESGKLKALILEYMENGSLESVIHGPGVDHSRWTLPKRIDVLISVANGLDYLHSG 134
+ YA+ + + IL+ M G L H H ++ + + GL+++H+
Sbjct: 61 CMSYAFHTPDKLSFILDLMNGGDL----HYHLSQHGVFSEAEMRFYAAEIILGLEHMHNR 116
Query: 135 YDIPIVHCDMKPSNILLDRDFEAHVSDFGTSRMLDVHLQDLSSLST-AFQGTIGYLAPEF 193
+ +V+ D+KP+NILLD +SD G + D S A GT GY+APE
Sbjct: 117 F---VVYRDLKPANILLDEHGHVRISDLGLA-------CDFSKKKPHASVGTHGYMAPEV 166
Query: 194 -----AYMRIVTTKVDVFSFGIVVMEFLTKRRP 221
AY + D FS G ++ + L P
Sbjct: 167 LQKGVAY----DSSADWFSLGCMLFKLLRGHSP 195
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, beta-adrenergic receptor kinase (beta-ARK) group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. The beta-ARK group is composed of GRK2, GRK3, and similar proteins. GRK2 and GRK3 are both widely expressed in many tissues, although GRK2 is present at higher levels. They contain an N-terminal RGS homology (RH) domain, a central catalytic domain, and C-terminal pleckstrin homology (PH) domain that mediates PIP2 and G protein betagamma-subunit translocation to the membrane. GRK2 (also called beta-ARK or beta-ARK1) is important in regulating several cardiac receptor responses. It plays a role in cardiac development and in hypertension. Deletion of GRK2 in mice results in embryonic lethality, caused by hypoplasia of the ventricular myocardium. GRK2 also plays important roles in the liver (as a regulator of portal blood pressure), in immune cells, and in the nervous system. Altered GRK2 expression has been reported in several disorders including major depression, schizophrenia, bipolar disorder, and Parkinsonism. Length = 278 |
| >gnl|CDD|173680 cd05589, STKc_PKN, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase N | Back alignment and domain information |
|---|
Score = 50.5 bits (121), Expect = 4e-07
Identities = 44/140 (31%), Positives = 65/140 (46%), Gaps = 13/140 (9%)
Query: 89 ILEYMENGSLESVIHGPGVDHSRWTLPKRIDVLISVANGLDYLHSGYDIPIVHCDMKPSN 148
++EY G L IH ++ P+ + V GL YLH + IV+ D+K N
Sbjct: 80 VMEYAAGGDLMMHIH-----TDVFSEPRAVFYAACVVLGLQYLH---ENKIVYRDLKLDN 131
Query: 149 ILLDRDFEAHVSDFGTSRMLDVHLQDLSSLSTAFQGTIGYLAPEFAYMRIVTTKVDVFSF 208
+LLD + ++DFG + + D +S F GT +LAPE T VD +
Sbjct: 132 LLLDTEGFVKIADFGLCKE-GMGFGDRTS---TFCGTPEFLAPEVLTETSYTRAVDWWGL 187
Query: 209 GIVVMEFLTKRRP-TGLDEE 227
G+++ E L P G DEE
Sbjct: 188 GVLIYEMLVGESPFPGDDEE 207
|
Serine/Threonine Kinases (STKs), Protein Kinase N (PKN) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKN subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKN has a C-terminal catalytic domain that is highly homologous to PKCs. Its unique N-terminal regulatory region contains antiparallel coiled-coil (ACC) domains. In mammals, there are three PKN isoforms from different genes (designated PKN-alpha, beta, and gamma), which show different enzymatic properties, tissue distribution, and varied functions. PKN can be activated by the small GTPase Rho, and by fatty acids such as arachidonic and linoleic acids. It is involved in many biological processes including cytokeletal regulation, cell adhesion, vesicle transport, glucose transport, regulation of meiotic maturation and embryonic cell cycles, signaling to the nucleus, and tumorigenesis. Length = 324 |
| >gnl|CDD|143377 cd07872, STKc_PCTAIRE2, Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-2 kinase | Back alignment and domain information |
|---|
Score = 50.0 bits (119), Expect = 4e-07
Identities = 54/203 (26%), Positives = 96/203 (47%), Gaps = 17/203 (8%)
Query: 20 IGNSNLSTVYKGRLEDGE-IVAVKKLNF-HQFSAESDKSFYREAKTLKELKHRNLVKVLG 77
+G +TV+KGR + E +VA+K++ H+ A + RE LK+LKH N+V L
Sbjct: 14 LGEGTYATVFKGRSKLTENLVALKEIRLEHEEGAPC--TAIREVSLLKDLKHANIV-TLH 70
Query: 78 YAWESGKLKALILEYMENGSLESVIHGPGVDHSRWTLPKRIDVLISVANGLDYLHSGYDI 137
+ K L+ EY++ L+ + G + ++ L + GL Y H
Sbjct: 71 DIVHTDKSLTLVFEYLDK-DLKQYMDDCG---NIMSMHNVKIFLYQILRGLAYCHRR--- 123
Query: 138 PIVHCDMKPSNILLDRDFEAHVSDFGTSRMLDVHLQDLSSLSTAFQGTIGYLAPEFAY-M 196
++H D+KP N+L++ E ++DFG +R V + S+ T+ Y P+
Sbjct: 124 KVLHRDLKPQNLLINERGELKLADFGLARAKSVPTKTYSNEVV----TLWYRPPDVLLGS 179
Query: 197 RIVTTKVDVFSFGIVVMEFLTKR 219
+T++D++ G + E + R
Sbjct: 180 SEYSTQIDMWGVGCIFFEMASGR 202
|
Serine/Threonine Kinases (STKs), PCTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-2 is specifically expressed in neurons in the central nervous system, mainly in terminally differentiated neurons. It associates with Trap (Tudor repeat associator with PCTAIRE-2) and could play a role in regulating mitochondrial function in neurons. Length = 309 |
| >gnl|CDD|140289 PTZ00263, PTZ00263, protein kinase A catalytic subunit; Provisional | Back alignment and domain information |
|---|
Score = 50.2 bits (120), Expect = 4e-07
Identities = 46/189 (24%), Positives = 81/189 (42%), Gaps = 20/189 (10%)
Query: 36 GEIVAVKKLNFHQ-FSAESDKSFYREAKTLKELKHRNLVKVLGYAWESGKLKALILEYME 94
GE A+K L + + + +E L EL H +V ++ + ++ +LE++
Sbjct: 43 GEYYAIKCLKKREILKMKQVQHVAQEKSILMELSHPFIVNMMCSFQDENRV-YFLLEFVV 101
Query: 95 NGSLESVIHGPGVDHSRWTLPKRIDVLIS--VANGLDYLHSGYDIPIVHCDMKPSNILLD 152
G L + + G P + + +YLHS I++ D+KP N+LLD
Sbjct: 102 GGELFTHLRKAG------RFPNDVAKFYHAELVLAFEYLHS---KDIIYRDLKPENLLLD 152
Query: 153 RDFEAHVSDFGTSRMLDVHLQDLSSLSTAFQGTIGYLAPEFAYMRIVTTKVDVFSFGIVV 212
V+DFG ++ + + GT YLAPE + VD ++ G+++
Sbjct: 153 NKGHVKVTDFGFAK-------KVPDRTFTLCGTPEYLAPEVIQSKGHGKAVDWWTMGVLL 205
Query: 213 MEFLTKRRP 221
EF+ P
Sbjct: 206 YEFIAGYPP 214
|
Length = 329 |
| >gnl|CDD|173700 cd05609, STKc_MAST, Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine kinase | Back alignment and domain information |
|---|
Score = 50.2 bits (120), Expect = 4e-07
Identities = 45/158 (28%), Positives = 74/158 (46%), Gaps = 36/158 (22%)
Query: 79 AWESGKLKALILEYMENGSLESVIHGPG---VDHSRWTLPKRIDVLISVANGLDYLHSGY 135
++E+ + +++EY+E G +++ G VD +R + VL L+YLH+
Sbjct: 69 SFETKRHLCMVMEYVEGGDCATLLKNIGALPVDMARMYFAE--TVL-----ALEYLHN-- 119
Query: 136 DIPIVHCDMKPSNILLDRDFEAHVSDFGTSRMLDVHLQDLSSLST------------AFQ 183
IVH D+KP N+L+ ++DFG S++ L SL+T F
Sbjct: 120 -YGIVHRDLKPDNLLITSMGHIKLTDFGLSKI------GLMSLTTNLYEGHIEKDTREFL 172
Query: 184 -----GTIGYLAPEFAYMRIVTTKVDVFSFGIVVMEFL 216
GT Y+APE + VD ++ GI++ EFL
Sbjct: 173 DKQVCGTPEYIAPEVILRQGYGKPVDWWAMGIILYEFL 210
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. There are four mammalian MAST kinases, named MAST1-MAST4. MAST1 is also referred to as syntrophin-associated STK (SAST), while MAST2 is also called MAST205. MAST kinases are cytoskeletal associated kinases of unknown function that are also expressed at neuromuscular junctions and postsynaptic densities. MAST1, MAST2, and MAST3 bind and phosphorylate the tumor suppressor PTEN, and may contribute to the regulation and stabilization of PTEN. MAST2 is involved in the regulation of the Fc-gamma receptor of the innate immune response in macrophages, and may also be involved in the regulation of the Na+/H+ exchanger NHE3. Length = 305 |
| >gnl|CDD|143342 cd07837, STKc_CdkB_plant, Catalytic domain of the Serine/Threonine Kinase, Plant B-type Cyclin-Dependent protein Kinase | Back alignment and domain information |
|---|
Score = 49.8 bits (119), Expect = 5e-07
Identities = 52/209 (24%), Positives = 86/209 (41%), Gaps = 17/209 (8%)
Query: 19 IIGNSNLSTVYKGR-LEDGEIVAVKKLNFHQFSAESDKSFYREAKTLKELKHRN----LV 73
IG VYK R G++VA+KK + RE L+ L L+
Sbjct: 8 KIGEGTYGKVYKARDKNTGKLVALKKTRLEMDEEGIPPTALREISLLQMLSESIYIVRLL 67
Query: 74 KVLGYAWESGK-LKALILEYMENGSLESVIHGPGVDHSRWTLPKRIDVLI-SVANGLDYL 131
V ++GK L+ EY+++ L+ + G R K I + + G+ +
Sbjct: 68 DVEHVEEKNGKPSLYLVFEYLDS-DLKKFMDSNGRGPGRPLPAKTIKSFMYQLLKGVAHC 126
Query: 132 HSGYDIPIVHCDMKPSNILLDRDFEA-HVSDFGTSRMLDVHLQDLSSLSTAFQGTIGYLA 190
H ++H D+KP N+L+D+ ++D G R + ++ T T+ Y A
Sbjct: 127 HK---HGVMHRDLKPQNLLVDKQKGLLKIADLGLGRAFSIPVKSY----THEIVTLWYRA 179
Query: 191 PEFAY-MRIVTTKVDVFSFGIVVMEFLTK 218
PE +T VD++S G + E K
Sbjct: 180 PEVLLGSTHYSTPVDIWSVGCIFAEMSRK 208
|
Serine/Threonine Kinases (STKs), Plant B-type Cyclin-Dependent protein Kinase (CdkB) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CdkB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. The plant-specific B-type CDKs are expressed from the late S to the M phase of the cell cycle. They are characterized by the cyclin binding motif PPT[A/T]LRE. They play a role in controlling mitosis and integrating developmental pathways, such as stomata and leaf development. CdkB has been shown to associate with both cyclin B, which controls G2/M transition, and cyclin D, which acts as a mediator in linking extracellular signals to the cell cycle. Length = 295 |
| >gnl|CDD|173713 cd05624, STKc_MRCK_beta, Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase beta | Back alignment and domain information |
|---|
Score = 48.5 bits (115), Expect = 2e-06
Identities = 51/211 (24%), Positives = 97/211 (45%), Gaps = 19/211 (9%)
Query: 19 IIGNSNLSTVYKGRLEDGE-IVAVKKLNFHQFSAESDKSFYREAKTLKELKHRNLVKVLG 77
+IG V +++ E I A+K LN + ++ + +RE + + + L
Sbjct: 8 VIGRGAFGEVAVVKMKHTERIYAMKILNKWEMLKRAETACFREERNVLVNGDCQWITTLH 67
Query: 78 YAWESGKLKALILEYMENGSLESVIHGPGVDHSRWT--LPKRIDVLISVANGLDYLHSGY 135
YA++ L+++Y G L +++ S++ LP+ + +A + +HS +
Sbjct: 68 YAFQDENYLYLVMDYYVGGDLLTLL-------SKFEDRLPEDMARFY-IAEMVLAIHSIH 119
Query: 136 DIPIVHCDMKPSNILLDRDFEAHVSDFGTSRMLDVHLQDLSSLSTAFQGTIGYLAPEFAY 195
+ VH D+KP N+LLD + ++DFG+ ++ QD + S+ GT Y++PE
Sbjct: 120 QLHYVHRDIKPDNVLLDMNGHIRLADFGSCLKMN---QDGTVQSSVAVGTPDYISPEILQ 176
Query: 196 -----MRIVTTKVDVFSFGIVVMEFLTKRRP 221
M + D +S G+ + E L P
Sbjct: 177 AMEDGMGKYGPECDWWSLGVCMYEMLYGETP 207
|
Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) beta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKbeta is expressed ubiquitously in many tissues. Length = 331 |
| >gnl|CDD|173627 cd05037, PTK_Jak_rpt1, Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases | Back alignment and domain information |
|---|
Score = 47.8 bits (114), Expect = 2e-06
Identities = 57/253 (22%), Positives = 97/253 (38%), Gaps = 59/253 (23%)
Query: 52 ESDKSFYREAKTLKELKHRNLVKVLGYAWESGKLKALILEYMENGSLESVIH--GPGVDH 109
+F+ A + +L H++LVK+ G + ++ EY++ G L+ +H V
Sbjct: 43 RDSLAFFETASLMSQLSHKHLVKLYGVCVRDENI--MVEEYVKFGPLDVFLHREKNNVSL 100
Query: 110 SRWTLPKRIDVLISVANGLDYLHSGYDIPIVHCDMKPSNILLDRDFEAHVSDFGTSRMLD 169
W L DV +A+ L YL D +VH ++ NIL+ R +
Sbjct: 101 H-WKL----DVAKQLASALHYLE---DKKLVHGNVCGKNILVARY------GLNEGYVPF 146
Query: 170 VHLQD----LSSLSTAF-QGTIGYLAPEFAYMRIVTTKVDVF----SFGIVVMEFLTKRR 220
+ L D ++ LS I ++APE +R + + SFG ++E +
Sbjct: 147 IKLSDPGIPITVLSREERVERIPWIAPE--CIRNGQASLTIAADKWSFGTTLLEICS--- 201
Query: 221 PTGLDEENGLSPISLRQLVEKALANGINGVRQITDPKLVSSIYEEQEQHQVLE--ELFKL 278
NG P+S EK Y++Q + + + EL L
Sbjct: 202 -------NGEEPLSTLSSSEKER------------------FYQDQHRLPMPDCAELANL 236
Query: 279 ALVCTSSNPEDRP 291
C + +P RP
Sbjct: 237 INQCWTYDPTKRP 249
|
Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; pseudokinase domain (repeat1). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic domain. Most Jaks are expressed in a wide variety of tissues, except for Jak3, which is expressed only in hematopoietic cells. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jaks are also involved in regulating the surface expression of some cytokine receptors. The Jak-STAT pathway is involved in many biological processes including hematopoiesis, immunoregulation, host defense, fertility, lactation, growth, and embryogenesis. Length = 259 |
| >gnl|CDD|173676 cd05585, STKc_YPK1_like, Catalytic domain of Yeast Protein Kinase 1-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 48.0 bits (114), Expect = 2e-06
Identities = 32/94 (34%), Positives = 49/94 (52%), Gaps = 7/94 (7%)
Query: 128 LDYLHSGYDIPIVHCDMKPSNILLDRDFEAHVSDFGTSRMLDVHLQDLSSLSTAFQGTIG 187
L+ LH +++ D+KP NILLD + DFG ++ +++D +T F GT
Sbjct: 106 LENLHK---FNVIYRDLKPENILLDYQGHIALCDFGLCKL---NMKDDDKTNT-FCGTPE 158
Query: 188 YLAPEFAYMRIVTTKVDVFSFGIVVMEFLTKRRP 221
YLAPE T VD ++ G+++ E LT P
Sbjct: 159 YLAPELLLGHGYTKAVDWWTLGVLLYEMLTGLPP 192
|
Serine/Threonine Kinases (STKs), Yeast protein kinase 1 (YPK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YPK1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the AGC STKs, Saccharomyces cerevisiae YPK1 and Schizosaccharomyces pombe Gad8p. YPK1 is required for cell growth and acts as a downstream kinase in the sphingolipid-mediated signaling pathway of yeast. It also plays a role in efficient endocytosis and in the maintenance of cell wall integrity. Gad8p is a downstream target of Tor1p, the fission yeast homolog of mTOR. It plays a role in cell growth and sexual development. Length = 312 |
| >gnl|CDD|173681 cd05590, STKc_nPKC_eta, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C eta | Back alignment and domain information |
|---|
Score = 47.6 bits (113), Expect = 3e-06
Identities = 51/214 (23%), Positives = 90/214 (42%), Gaps = 13/214 (6%)
Query: 19 IIGNSNLSTVYKGRL-EDGEIVAVKKLNFHQFSAESDKSFYREAKTLKELKHRN-LVKVL 76
++G + V RL E G + AVK L + D K + L + + L
Sbjct: 2 VLGKGSFGKVMLARLKESGRLYAVKVLKKDVILQDDDVECTMTEKRILSLARNHPFLTQL 61
Query: 77 GYAWESGKLKALILEYMENGSLESVIHGPGVDHSRWTLPKRIDVLISVANGLDYLHSGYD 136
+++ ++E++ G L I R+ + + + L +LH D
Sbjct: 62 YCCFQTPDRLFFVMEFVNGGDLMFHIQ----KSRRFDEARARFYAAEITSALMFLH---D 114
Query: 137 IPIVHCDMKPSNILLDRDFEAHVSDFGTSRMLDVHLQDLSSLSTAFQGTIGYLAPEFAYM 196
I++ D+K N+LLD + ++DFG M + + + ST F GT Y+APE
Sbjct: 115 KGIIYRDLKLDNVLLDHEGHCKLADFG---MCKEGIFNGKTTST-FCGTPDYIAPEILQE 170
Query: 197 RIVTTKVDVFSFGIVVMEFLTKRRPTGLDEENGL 230
+ VD ++ G+++ E L P + E+ L
Sbjct: 171 MLYGPSVDWWAMGVLLYEMLCGHAPFEAENEDDL 204
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), eta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-eta is predominantly expressed in squamous epithelia, where it plays a crucial role in the signaling of cell-type specific differentiation. It is also expressed in pro-B cells and early-stage thymocytes, and acts as a key regulator in early B-cell development. PKC-eta increases glioblastoma multiforme (GBM) proliferation and resistance to radiation, and is being developed as a therapeutic target for the management of GBM. Length = 320 |
| >gnl|CDD|133234 cd05103, PTKc_VEGFR2, Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 2 | Back alignment and domain information |
|---|
Score = 47.3 bits (112), Expect = 4e-06
Identities = 45/185 (24%), Positives = 77/185 (41%), Gaps = 28/185 (15%)
Query: 113 TLPKRIDVLISVANGLDYLHSGYDIPIVHCDMKPSNILLDRDFEAHVSDFGTSRMLDVHL 172
TL I VA G+++L S +H D+ NILL + + DFG +R D++
Sbjct: 177 TLEDLICYSFQVAKGMEFLASR---KCIHRDLAARNILLSENNVVKICDFGLAR--DIYK 231
Query: 173 QDLSSLSTAFQGTIGYLAPEFAYMRIVTTKVDVFSFGIVVMEFLTKRRPTGLDEENGLSP 232
+ + ++APE + R+ T + DV+SFG+++ E + G SP
Sbjct: 232 DPDYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSL----------GASP 281
Query: 233 ISLRQLVEKALANGINGVRQITDPKLVSSIYEEQEQHQVLEELFKLALVCTSSNPEDRPN 292
++ E+ G R + P + E+++ L C P RP
Sbjct: 282 YPGVKIDEEFCRRLKEGTR-MRAPDYTTP------------EMYQTMLDCWHGEPSQRPT 328
Query: 293 MNELL 297
+EL+
Sbjct: 329 FSELV 333
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 2 (VEGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR2 (or Flk1) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. The carboxyl terminus of VEGFR2 plays an important role in its autophosphorylation and activation. VEGFR2 binds the ligands VEGFA, VEGFC, VEGFD and VEGFE. VEGFR2 signaling is implicated in all aspects of normal and pathological vascular endothelial cell biology. It induces a variety of cellular effects including migration, survival, and proliferation. It is critical in regulating embryonic vascular development and angiogenesis. VEGFR2 is the major signal transducer in pathological angiogenesis including cancer and diabetic retinopathy, and is a target for inhibition in cancer therapy. Length = 343 |
| >gnl|CDD|132969 cd06638, STKc_myosinIIIA, Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIA myosin | Back alignment and domain information |
|---|
Score = 46.9 bits (111), Expect = 5e-06
Identities = 58/204 (28%), Positives = 83/204 (40%), Gaps = 15/204 (7%)
Query: 20 IGNSNLSTVYK-GRLEDGEIVAVKKLN-FHQFSAESDKSFYREAKTLKELK-HRNLVKVL 76
IG V+K ++G AVK L+ H D+ E LK L H N+VK
Sbjct: 26 IGKGTYGKVFKVLNKKNGSKAAVKILDPIHDI----DEEIEAEYNILKALSDHPNVVKFY 81
Query: 77 GYAWESGKLKA----LILEYMENGSLESVIHGPGVDHSRWTLPKRIDVLISVANGLDYLH 132
G ++ L+LE GS+ ++ G R P +L GL +LH
Sbjct: 82 GMYYKKDVKNGDQLWLVLELCNGGSVTDLVKGFLKRGERMEEPIIAYILHEALMGLQHLH 141
Query: 133 SGYDIPIVHCDMKPSNILLDRDFEAHVSDFGTSRML-DVHLQDLSSLSTAFQGTIGYLAP 191
I H D+K +NILL + + DFG S L L+ +S+ T F +A
Sbjct: 142 VNKTI---HRDVKGNNILLTTEGGVKLVDFGVSAQLTSTRLRRNTSVGTPFWMAPEVIAC 198
Query: 192 EFAYMRIVTTKVDVFSFGIVVMEF 215
E + DV+S GI +E
Sbjct: 199 EQQLDSTYDARCDVWSLGITAIEL 222
|
Serine/threonine kinases (STKs), class IIIA myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. In photoreceptor cells, they may also function as cargo carriers during light-dependent translocation of proteins such as transducin and arrestin. Class IIIA myosin is highly expressed in retina and in inner ear hair cells. It is localized to the distal ends of actin-bundled structures. Mutations in human myosin IIIA are responsible for progressive nonsyndromic hearing loss. Human myosin IIIA possesses ATPase and kinase activities, and the ability to move actin filaments in a motility assay. It may function as a cellular transporter capable of moving along actin bundles in sensory cells. Length = 286 |
| >gnl|CDD|88524 cd05623, STKc_MRCK_alpha, Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase alpha | Back alignment and domain information |
|---|
Score = 47.0 bits (111), Expect = 5e-06
Identities = 43/180 (23%), Positives = 85/180 (47%), Gaps = 20/180 (11%)
Query: 19 IIGNSNLSTVYKGRLEDGE-IVAVKKLNFHQFSAESDKSFYREAKTLKELKHRNLVKVLG 77
+IG V +L++ + + A+K LN + ++ + +RE + + + L
Sbjct: 8 VIGRGAFGEVAVVKLKNADKVFAMKILNKWEMLKRAETACFREERDVLVNGDNQWITTLH 67
Query: 78 YAWESGKLKALILEYMENGSLESVIHG-----PGVDHSRWTLPKRIDVLISVANGLDYLH 132
YA++ L+++Y G L +++ P D +R+ L + + + SV
Sbjct: 68 YAFQDENNLYLVMDYYVGGDLLTLLSKFEDRLPE-DMARFYLAEMVIAIDSV-------- 118
Query: 133 SGYDIPIVHCDMKPSNILLDRDFEAHVSDFGTSRMLDVHLQDLSSLSTAFQGTIGYLAPE 192
+ + VH D+KP NIL+D + ++DFG+ L ++D + S+ GT Y++PE
Sbjct: 119 --HQLHYVHRDIKPDNILMDMNGHIRLADFGSCLKL---MEDGTVQSSVAVGTPDYISPE 173
|
Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKalpha is expressed ubiquitously in many tissues. It plays a role in the regulation of peripheral actin reorganization and neurite outgrowth. It may also play a role in the transferrin iron uptake pathway. Length = 332 |
| >gnl|CDD|173688 cd05597, STKc_DMPK_like, Catalytic domain of Myotonic Dystrophy protein kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 46.7 bits (111), Expect = 5e-06
Identities = 44/176 (25%), Positives = 86/176 (48%), Gaps = 12/176 (6%)
Query: 19 IIGNSNLSTVYKGRLED-GEIVAVKKLNFHQFSAESDKSFYREAKTLKELKHRNLVKVLG 77
+IG V ++++ G++ A+K LN + ++ + +RE + + R + L
Sbjct: 8 VIGRGAFGEVAVVKMKNTGQVYAMKILNKWEMLKRAETACFREERDVLVNGDRRWITNLH 67
Query: 78 YAWESGKLKALILEYMENGSLESVIHGPGVDHSRWTLPKRIDVLISVANGLDYLHSGYDI 137
YA++ L+++Y G L +++ D LP+ + +A + + S + +
Sbjct: 68 YAFQDENNLYLVMDYYVGGDLLTLL-SKFEDR----LPEDM-ARFYLAEMVLAIDSVHQL 121
Query: 138 PIVHCDMKPSNILLDRDFEAHVSDFGTS-RMLDVHLQDLSSLSTAFQGTIGYLAPE 192
VH D+KP N+LLD++ ++DFG+ R+L D + S GT Y++PE
Sbjct: 122 GYVHRDIKPDNVLLDKNGHIRLADFGSCLRLLA----DGTVQSNVAVGTPDYISPE 173
|
Serine/Threonine Kinases (STKs), Myotonic Dystrophy protein kinase (DMPK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The DMPK-like subfamily is composed of DMPK and DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK). Three isoforms of MRCK are known, named alpha, beta and gamma. The DMPK gene is implicated in myotonic dystrophy 1 (DM1), an inherited multisystemic disorder with symptoms that include muscle hyperexcitability, progressive muscle weakness and wasting, cataract development, testicular atrophy, and cardiac conduction defects. The genetic basis for DM1 is the mutational expansion of a CTG repeat in the 3'-UTR of DMPK. DMPK is expressed in skeletal and cardiac muscles, and in central nervous tissues. The functional role of DMPK is not fully understood. It may play a role in the signal transduction and homeostasis of calcium. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKgamma is expressed in heart and skeletal muscles, unlike MRCKalpha and MRCKbeta, which are expressed ubiquitously. Length = 331 |
| >gnl|CDD|177557 PHA03209, PHA03209, serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Score = 46.8 bits (111), Expect = 7e-06
Identities = 31/124 (25%), Positives = 52/124 (41%), Gaps = 14/124 (11%)
Query: 124 VANGLDYLHSGYDIPIVHCDMKPSNILLDRDFEAHVSDFGTSRMLDVHLQDLSSLSTAFQ 183
+ GL YLH+ I+H D+K NI ++ + + D G ++ V L
Sbjct: 166 ILEGLRYLHA---QRIIHRDVKTENIFINDVDQVCIGDLGAAQFPVVAPAFL-----GLA 217
Query: 184 GTIGYLAPEFAYMRIVTTKVDVFSFGIVVMEFLT------KRRPTGLDEENGLSPISLRQ 237
GT+ APE +K D++S GIV+ E L + P+ +E L +
Sbjct: 218 GTVETNAPEVLARDKYNSKADIWSAGIVLFEMLAYPSTIFEDPPSTPEEYVKSCHSHLLK 277
Query: 238 LVEK 241
++
Sbjct: 278 IIST 281
|
Length = 357 |
| >gnl|CDD|173653 cd05105, PTKc_PDGFR_alpha, Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor alpha | Back alignment and domain information |
|---|
Score = 46.6 bits (110), Expect = 8e-06
Identities = 44/173 (25%), Positives = 77/173 (44%), Gaps = 28/173 (16%)
Query: 124 VANGLDYLHSGYDIPIVHCDMKPSNILLDRDFEAHVSDFGTSRMLDVHLQDLSSLSTAFQ 183
VA G+++L S VH D+ N+LL + + DFG +R + +H + S + F
Sbjct: 246 VARGMEFLASK---NCVHRDLAARNVLLAQGKIVKICDFGLARDI-MHDSNYVSKGSTFL 301
Query: 184 GTIGYLAPEFAYMRIVTTKVDVFSFGIVVMEFLTKRRPTGLDEENGLSPISLRQLVEKAL 243
+ ++APE + + TT DV+S+GI++ E + G +P +V+
Sbjct: 302 -PVKWMAPESIFDNLYTTLSDVWSYGILLWEIFSL----------GGTPYP-GMIVDSTF 349
Query: 244 ANGINGVRQITDPKLVSSIYEEQEQHQVLEELFKLALVCTSSNPEDRPNMNEL 296
N I ++ P + +V + + K C +S PE RP+ L
Sbjct: 350 YNKIKSGYRMAKP--------DHATQEVYDIMVK----CWNSEPEKRPSFLHL 390
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) alpha; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR alpha is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR alpha forms homodimers or heterodimers with PDGFR beta, depending on the nature of the PDGF ligand. PDGF-AA, PDGF-AB, and PDGF-CC induce PDGFR alpha homodimerization. PDGFR signaling plays many roles in normal embryonic development and adult physiology. PDGFR alpha signaling is important in the formation of lung alveoli, intestinal villi, mesenchymal dermis, and hair follicles, as well as in the development of oligodendrocytes, retinal astrocytes, neural crest cells, and testicular cells. Aberrant PDGFR alpha expression is associated with some human cancers. Mutations in PDGFR alpha have been found within a subset of gastrointestinal stromal tumors (GISTs). An active fusion protein FIP1L1-PDGFR alpha, derived from interstitial deletion, is associated with idiopathic hypereosinophilic syndrome (HES) and chronic eosinophilic leukemia (CEL). Length = 400 |
| >gnl|CDD|173664 cd05573, STKc_ROCK_NDR_like, Catalytic domain of ROCK- and NDR kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 46.5 bits (111), Expect = 8e-06
Identities = 47/214 (21%), Positives = 89/214 (41%), Gaps = 44/214 (20%)
Query: 34 EDGEIVAVKKLNFHQFSAESDKSFYREAKTLKELKHRNLVKVLGYAWESGKLKALILEYM 93
+ G++ A+K L + + R + + + L Y+++ + L++EYM
Sbjct: 24 DTGQVYAMKVLRKSDMIKRNQIAHVRAERDILADADSPWIVKLYYSFQDEEHLYLVMEYM 83
Query: 94 ENGSLESVIHGPGV---DHSRWTLPKRIDVLISVANGLDYLHS-GYDIPIVHCDMKPSNI 149
G L +++ V + +R+ + + + +A LD +H G+ +H D+KP NI
Sbjct: 84 PGGDLMNLLIRKDVFPEETARFYIAE-----LVLA--LDSVHKLGF----IHRDIKPDNI 132
Query: 150 LLDRDFEAHV--SDFGTS-RMLDVHLQ---DLSSLSTAFQ-------------------- 183
L+D D H+ +DFG +M + S + F+
Sbjct: 133 LIDAD--GHIKLADFGLCKKMNKAKDREYYLNDSHNLLFRDNVLVRRRDHKQRRVRANST 190
Query: 184 -GTIGYLAPEFAYMRIVTTKVDVFSFGIVVMEFL 216
GT Y+APE + D +S G+++ E L
Sbjct: 191 VGTPDYIAPEVLRGTPYGLECDWWSLGVILYEML 224
|
Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) and Nuclear Dbf2-Related (NDR)-like kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK- and NDR-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include ROCK and ROCK-like proteins such as DMPK, MRCK, and CRIK, as well as NDR and NDR-like proteins such as LATS, CBK1 and Sid2p. ROCK and CRIK are effectors of the small GTPase Rho, while MRCK is an effector of the small GTPase Cdc42. NDR and NDR-like kinases contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Proteins in this subfamily are involved in regulating many cellular functions including contraction, motility, division, proliferation, apoptosis, morphogenesis, and cytokinesis. Length = 350 |
| >gnl|CDD|173616 PTZ00426, PTZ00426, cAMP-dependent protein kinase catalytic subunit; Provisional | Back alignment and domain information |
|---|
Score = 46.1 bits (109), Expect = 9e-06
Identities = 55/216 (25%), Positives = 90/216 (41%), Gaps = 31/216 (14%)
Query: 10 ATGSFSENNII--GNSNLSTVYKGRLEDGEIVAVKKLNFHQFSAESDKSFYREAKTLKEL 67
TGSF + N + V R E +I+ K+++ H FS E K L +
Sbjct: 39 GTGSFGRVILATYKNEDFPPVAIKRFEKSKIIKQKQVD-HVFS---------ERKILNYI 88
Query: 68 KHRNLVKVLGYAWESGKLKALILEYMENGSLESVIHGPGVDHSRWTLPKRIDVLISVANG 127
H V + G +++ L+LE++ G + + P + +
Sbjct: 89 NHPFCVNLYG-SFKDESYLYLVLEFVIGGEFFTFLR------RNKRFPNDVGCFYAAQIV 141
Query: 128 L--DYLHSGYDIPIVHCDMKPSNILLDRDFEAHVSDFGTSRMLDVHLQDLSSLSTAFQGT 185
L +YL S + IV+ D+KP N+LLD+D ++DFG ++++D L GT
Sbjct: 142 LIFEYLQS---LNIVYRDLKPENLLLDKDGFIKMTDFGFAKVVDTRTYTLC-------GT 191
Query: 186 IGYLAPEFAYMRIVTTKVDVFSFGIVVMEFLTKRRP 221
Y+APE D ++ GI + E L P
Sbjct: 192 PEYIAPEILLNVGHGKAADWWTLGIFIYEILVGCPP 227
|
Length = 340 |
| >gnl|CDD|223069 PHA03390, pk1, serine/threonine-protein kinase 1; Provisional | Back alignment and domain information |
|---|
Score = 45.6 bits (109), Expect = 1e-05
Identities = 42/178 (23%), Positives = 81/178 (45%), Gaps = 17/178 (9%)
Query: 68 KHRNLVKVLGYAWESGKLKALILEYMENGSLESVIHGPGVDHSRWTLPKRIDVLISVANG 127
+ N +K L Y+ + K LI++Y+++G L ++ G + + + ++ +
Sbjct: 67 DNPNFIK-LYYSVTTLKGHVLIMDYIKDGDLFDLLKKEG----KLSEAEVKKIIRQLVEA 121
Query: 128 LDYLHSGYDIPIVHCDMKPSNILLDR-DFEAHVSDFGTSRMLDVHLQDLSSLSTAFQGTI 186
L+ LH I+H D+K N+L DR ++ D+G +++ + + GT+
Sbjct: 122 LNDLHKHN---IIHNDIKLENVLYDRAKDRIYLCDYGLCKIIGT--------PSCYDGTL 170
Query: 187 GYLAPEFAYMRIVTTKVDVFSFGIVVMEFLTKRRPTGLDEENGLSPISLRQLVEKALA 244
Y +PE D ++ G++ E LT + P DE+ L SL + +K L
Sbjct: 171 DYFSPEKIKGHNYDVSFDWWAVGVLTYELLTGKHPFKEDEDEELDLESLLKRQQKKLP 228
|
Length = 267 |
| >gnl|CDD|173679 cd05588, STKc_aPKC, Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C | Back alignment and domain information |
|---|
Score = 44.0 bits (104), Expect = 4e-05
Identities = 31/100 (31%), Positives = 52/100 (52%), Gaps = 9/100 (9%)
Query: 122 ISVANGLDYLHSGYDIPIVHCDMKPSNILLDRDFEAHVSDFGTSRMLDVHLQDLSSLSTA 181
IS+A L++LH I++ D+K N+LLD + ++D+G M ++ + ST
Sbjct: 105 ISLA--LNFLHER---GIIYRDLKLDNVLLDAEGHIKLTDYG---MCKEGIRPGDTTST- 155
Query: 182 FQGTIGYLAPEFAYMRIVTTKVDVFSFGIVVMEFLTKRRP 221
F GT Y+APE VD ++ G+++ E + R P
Sbjct: 156 FCGTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSP 195
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. They contain a C2-like region, instead of a calcium-binding (C2) region found in classical PKCs, in their regulatory domain. There are two aPKC isoforms, zeta and iota. aPKCs are involved in many cellular functions including proliferation, migration, apoptosis, polarity maintenance and cytoskeletal regulation. They also play a critical role in the regulation of glucose metabolism and in the pathogenesis of type 2 diabetes. Length = 329 |
| >gnl|CDD|173701 cd05610, STKc_MASTL, Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine-like kinase | Back alignment and domain information |
|---|
Score = 44.1 bits (104), Expect = 6e-05
Identities = 28/92 (30%), Positives = 49/92 (53%), Gaps = 7/92 (7%)
Query: 76 LGYAWESGKLKALILEYMENGSLESVIHGPGVDHSRWTLPKRIDVLISVANGLDYLHSGY 135
L Y+ +S L++EY+ G ++S++H G + + + VA LDYLH
Sbjct: 69 LYYSLQSANNVYLVMEYLIGGDVKSLLHIYGY----FDEEMAVKYISEVALALDYLHRH- 123
Query: 136 DIPIVHCDMKPSNILLDRDFEAHVSDFGTSRM 167
I+H D+KP N+L+ + ++DFG S++
Sbjct: 124 --GIIHRDLKPDNMLISNEGHIKLTDFGLSKV 153
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST-like (MASTL) kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. The MASTL kinases in this group carry only a catalytic domain, which contains a long insertion relative to MAST kinases. The human MASTL gene has also been labelled FLJ14813. A missense mutation in FLJ14813 is associated with autosomal dominant thrombocytopenia. To date, the function of MASTL is unknown. Length = 669 |
| >gnl|CDD|173502 PTZ00266, PTZ00266, NIMA-related protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 44.0 bits (103), Expect = 7e-05
Identities = 49/227 (21%), Positives = 88/227 (38%), Gaps = 30/227 (13%)
Query: 20 IGNSNLSTVYKGRLE-DGEIVAVKKLNFHQFSAESDKSFYREAKTLKELKHRNLVKVLGY 78
IGN V+ + + E K +++ E ++ELKH+N+V+ +
Sbjct: 21 IGNGRFGEVFLVKHKRTQEFFCWKAISYRGLKEREKSQLVIEVNVMRELKHKNIVRYIDR 80
Query: 79 AWESGKLKALIL-EYMENGSLESVIHGPGVDHSRWTLPKRIDVLISVANGLDYLHSGYDI 137
K IL E+ + G L I + +D+ + + L Y H+ D
Sbjct: 81 FLNKANQKLYILMEFCDAGDLSRNIQKCYKMFGKIEEHAIVDITRQLLHALAYCHNLKDG 140
Query: 138 P----IVHCDMKPSNILLDRDFE-----------------AHVSDFGTSRMLDVHLQDLS 176
P ++H D+KP NI L A + DFG S+ + +
Sbjct: 141 PNGERVLHRDLKPQNIFLSTGIRHIGKITAQANNLNGRPIAKIGDFGLSKNIGIE----- 195
Query: 177 SLSTAFQGTIGYLAPEFAY--MRIVTTKVDVFSFGIVVMEFLTKRRP 221
S++ + GT Y +PE + K D+++ G ++ E + + P
Sbjct: 196 SMAHSCVGTPYYWSPELLLHETKSYDDKSDMWALGCIIYELCSGKTP 242
|
Length = 1021 |
| >gnl|CDD|173682 cd05591, STKc_nPKC_epsilon, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C epsilon | Back alignment and domain information |
|---|
Score = 43.3 bits (102), Expect = 7e-05
Identities = 31/109 (28%), Positives = 52/109 (47%), Gaps = 11/109 (10%)
Query: 124 VANGLDYLHSGYDIPIVHCDMKPSNILLDRDFEAHVSDFGTSR--MLDVHLQDLSSLSTA 181
V L +LH +++ D+K NILLD + ++DFG + +L+ +T
Sbjct: 105 VTLALMFLHRH---GVIYRDLKLDNILLDAEGHCKLADFGMCKEGILN------GVTTTT 155
Query: 182 FQGTIGYLAPEFAYMRIVTTKVDVFSFGIVVMEFLTKRRPTGLDEENGL 230
F GT Y+APE VD ++ G+++ E + + P D E+ L
Sbjct: 156 FCGTPDYIAPEILQELEYGPSVDWWALGVLMYEMMAGQPPFEADNEDDL 204
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), epsilon isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-epsilon has been shown to behave as an oncoprotein. Its overexpression contributes to neoplastic transformation depending on the cell type. It contributes to oncogenesis by inducing disordered cell growth and inhibiting cell death. It also plays a role in tumor invasion and metastasis. PKC-epsilon has also been found to confer cardioprotection against ischemia and reperfusion-mediated damage. Other cellular functions include the regulation of gene expression, cell adhesion, and cell motility. Length = 321 |
| >gnl|CDD|133238 cd05107, PTKc_PDGFR_beta, Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor beta | Back alignment and domain information |
|---|
Score = 43.5 bits (102), Expect = 8e-05
Identities = 31/94 (32%), Positives = 49/94 (52%), Gaps = 5/94 (5%)
Query: 124 VANGLDYLHSGYDIPIVHCDMKPSNILLDRDFEAHVSDFGTSRMLDVHLQDLSSLSTAFQ 183
VANG+++L S VH D+ N+L+ + DFG +R + +S ST
Sbjct: 248 VANGMEFLASK---NCVHRDLAARNVLICEGKLVKICDFGLARDIMRDSNYISKGSTFL- 303
Query: 184 GTIGYLAPEFAYMRIVTTKVDVFSFGIVVMEFLT 217
+ ++APE + + TT DV+SFGI++ E T
Sbjct: 304 -PLKWMAPESIFNNLYTTLSDVWSFGILLWEIFT 336
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) beta; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR beta is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR beta forms homodimers or heterodimers with PDGFR alpha, depending on the nature of the PDGF ligand. PDGF-BB and PDGF-DD induce PDGFR beta homodimerization. PDGFR signaling plays many roles in normal embryonic development and adult physiology. PDGFR beta signaling leads to a variety of cellular effects including the stimulation of cell growth and chemotaxis, as well as the inhibition of apoptosis and GAP junctional communication. It is critical in normal angiogenesis as it is involved in the recruitment of pericytes and smooth muscle cells essential for vessel stability. Aberrant PDGFR beta expression is associated with some human cancers. The continuously-active fusion proteins of PDGFR beta with COL1A1 and TEL are associated with dermatofibrosarcoma protuberans (DFSP) and a subset of chronic myelomonocytic leukemia (CMML), respectively. Length = 401 |
| >gnl|CDD|133174 cd05042, PTKc_Aatyk, Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases | Back alignment and domain information |
|---|
Score = 43.0 bits (101), Expect = 8e-05
Identities = 55/212 (25%), Positives = 90/212 (42%), Gaps = 24/212 (11%)
Query: 20 IGNSNLSTVYKGRLEDGEIVA---VKKLNFHQFSAESDK--SFYREAKTLKELKHRNLVK 74
IGN V G G A VK+L + SA D+ F +E + +EL H N+++
Sbjct: 3 IGNGWFGKVLLGEAHRGMSKARVVVKEL---RASATPDEQLLFLQEVQPYRELNHPNVLQ 59
Query: 75 VLGYAWESGKLKALILEYMENGSLESVIHGPGVDHSRWTLPKRIDVLIS--VANGLDYLH 132
LG ES L+LE+ G L++ + K + ++ VA+GL +LH
Sbjct: 60 CLGQCIESIPY-LLVLEFCPLGDLKNYLRSNRG-MVAQMAQKDVLQRMACEVASGLLWLH 117
Query: 133 SGYDIPIVHCDMKPSNILLDRDFEAHVSDFGTSRMLDVHLQDLSSLSTAFQGTIGYLAPE 192
+H D+ N L D + D+G + L+ + +D + +LAPE
Sbjct: 118 QAD---FIHSDLALRNCQLTADLSVKIGDYGLA--LEQYPEDYYITKDCHAVPLRWLAPE 172
Query: 193 FAYMR-------IVTTKVDVFSFGIVVMEFLT 217
+R T K +++S G+ + E T
Sbjct: 173 LVEIRGQDLLPKDQTKKSNIWSLGVTMWELFT 204
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase (Aatyk) subfamily; catalytic (c) domain. The Aatyk subfamily is also referred to as the lemur tyrosine kinase (Lmtk) subfamily. It consists of Aatyk1 (Lmtk1), Aatyk2 (Lmtk2, Brek), Aatyk3 (Lmtk3), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk proteins are mostly receptor tyr kinases (RTKs) containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 does not contain a transmembrane segment and is a cytoplasmic (or nonreceptor) kinase. Aatyk proteins are classified as tyr kinases based on overall sequence similarity and the phylogenetic tree. However, analysis of catalytic residues suggests that Aatyk proteins may be multispecific kinases, functioning also as serine/threonine kinases. They are involved in neural differentiation, nerve growth factor (NGF) signaling, apoptosis, and spermatogenesis. Length = 269 |
| >gnl|CDD|240159 cd05120, APH_ChoK_like, Aminoglycoside 3'-phosphotransferase (APH) and Choline Kinase (ChoK) family | Back alignment and domain information |
|---|
Score = 41.2 bits (97), Expect = 1e-04
Identities = 37/159 (23%), Positives = 60/159 (37%), Gaps = 22/159 (13%)
Query: 28 VYKGRLEDGEIVAVKKLNFHQFSAESDKSFYREAKTLKELKHRNLV--KVLGYAWESGKL 85
VY +D + V +K S E RE L+ L + L KVL ES
Sbjct: 14 VYLLGTKDEDYV-LKINP----SREKGADREREVAILQLLARKGLPVPKVLAS-GESDGW 67
Query: 86 KALILEYMENGSLESVIHGPGVDHSRWTLPKRIDVLISVANGLDYLHSGYDIP-IVHCDM 144
L++E++E +L+ V + D+ +A L LH + + H D+
Sbjct: 68 SYLLMEWIEGETLDEVSEEE-----------KEDIAEQLAELLAKLHQ-LPLLVLCHGDL 115
Query: 145 KPSNILLDRDFEAHVSDFGTSRMLDVHLQDLSSLSTAFQ 183
P NIL+D + D+ + DL++
Sbjct: 116 HPGNILVDDGKILGIIDWEYAGYGPPAF-DLAAALLFNL 153
|
The APH/ChoK family is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). The family is composed of APH, ChoK, ethanolamine kinase (ETNK), macrolide 2'-phosphotransferase (MPH2'), an unusual homoserine kinase, and uncharacterized proteins with similarity to the N-terminal domain of acyl-CoA dehydrogenase 10 (ACAD10). The members of this family catalyze the transfer of the gamma-phosphoryl group from ATP (or CTP) to small molecule substrates such as aminoglycosides, macrolides, choline, ethanolamine, and homoserine. Phosphorylation of the antibiotics, aminoglycosides and macrolides, leads to their inactivation and to bacterial antibiotic resistance. Phosphorylation of choline, ethanolamine, and homoserine serves as precursors to the synthesis of important biological compounds, such as the major phospholipids, phosphatidylcholine and phosphatidylethanolamine and the amino acids, threonine, methionine, and isoleucine. Length = 155 |
| >gnl|CDD|173708 cd05617, STKc_aPKC_zeta, Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C zeta | Back alignment and domain information |
|---|
Score = 42.7 bits (100), Expect = 1e-04
Identities = 31/102 (30%), Positives = 51/102 (50%), Gaps = 7/102 (6%)
Query: 127 GLDYLHSGYDIPIVHCDMKPSNILLDRDFEAHVSDFGTSRMLDVHLQDLSSLSTAFQGTI 186
L++LH + I++ D+K N+LLD D ++D+G M L + ST F GT
Sbjct: 108 ALNFLH---ERGIIYRDLKLDNVLLDADGHIKLTDYG---MCKEGLGPGDTTST-FCGTP 160
Query: 187 GYLAPEFAYMRIVTTKVDVFSFGIVVMEFLTKRRPTGLDEEN 228
Y+APE VD ++ G+++ E + R P + +N
Sbjct: 161 NYIAPEILRGEEYGFSVDWWALGVLMFEMMAGRSPFDIITDN 202
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, zeta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-zeta plays a critical role in activating the glucose transport response. It is activated by glucose, insulin, and exercise through diverse pathways. PKC-zeta also plays a central role in maintaining cell polarity in yeast and mammalian cells. In addition, it affects actin remodeling in muscle cells. Length = 327 |
| >gnl|CDD|173766 cd08226, PK_STRAD_beta, Pseudokinase domain of STE20-related kinase adapter protein beta | Back alignment and domain information |
|---|
Score = 42.6 bits (100), Expect = 1e-04
Identities = 74/312 (23%), Positives = 117/312 (37%), Gaps = 49/312 (15%)
Query: 21 GNSNLSTVYKGR-LEDGEIVAVKKLNFHQFSAESDKSFYREAKTLKELKHRNLVKVLGYA 79
G NL++VY R G +V V+ + + E K+ E +H N++
Sbjct: 9 GFCNLTSVYLARHTPTGTLVTVRITDLENCTEEHLKALQNEVVLSHFFRHPNIM-TSWTV 67
Query: 80 WESGKLKALILEYMENGSLESVIHGPGVDHSRWTLPKRIDVLISVANGLDYLH-SGYDIP 138
+ +G +I +M GS S++ + L I L GL+YLH +GY
Sbjct: 68 FTTGSWLWVISPFMAYGSANSLLKTYFPEGMSEALIGNI--LFGALRGLNYLHQNGY--- 122
Query: 139 IVHCDMKPSNILLDRDFEAHVSDFGTSRMLDVHLQ------DLSSLSTAFQGTIGYLAPE 192
+H ++K S+IL+ D +S L + Q D ST+ +L+PE
Sbjct: 123 -IHRNIKASHILISGDGLVSLSGLSHLYSLVRNGQKAKVVYDFPQFSTSVLP---WLSPE 178
Query: 193 FAYMRI--VTTKVDVFSFGIVVMEFLTKRRPTG--------LDEENGL--SP--ISLRQL 238
+ K D++S GI E T R P L + G SP I+
Sbjct: 179 LLRQDLYGYNVKSDIYSVGITACELATGRVPFQDMLRTQMLLQKLKGPPYSPLDITTFPC 238
Query: 239 VEKALANGINGVRQITDPKLVSSIYEEQEQHQVLEE-------------LFKLALVCTSS 285
E + N +GV D + S+ + E L +C
Sbjct: 239 EESRMKNSQSGV----DSGIGESVVAAGMTQTMTSERLRTPSSKTFSPAFQNLVELCLQQ 294
Query: 286 NPEDRPNMNELL 297
+PE RP+ + LL
Sbjct: 295 DPEKRPSASSLL 306
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) beta subfamily, pseudokinase domain. The STRAD-beta subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpigmentation of the buccal mucosa. There are two forms of STRAD, alpha and beta, that complex with LKB1 and MO25. STRAD-beta is also referred to as ALS2CR2 (Amyotrophic lateral sclerosis 2 chromosomal region candidate gene 2 protein), since the human gene encoding it is located within the juvenile ALS2 critical region on chromosome 2q33-q34. It is not linked to the development of ALS2. Length = 328 |
| >gnl|CDD|165291 PHA02988, PHA02988, hypothetical protein; Provisional | Back alignment and domain information |
|---|
Score = 42.0 bits (99), Expect = 2e-04
Identities = 58/292 (19%), Positives = 114/292 (39%), Gaps = 56/292 (19%)
Query: 19 IIGNSNLSTVYKGRLEDGEIVAVKKLN-FHQFSAESDKSFYREAKTLKELKHRNLVKVLG 77
+I ++ +++YKG + + V ++ FH+ E K L+ + N++K+ G
Sbjct: 27 LIKENDQNSIYKGIF-NNKEVIIRTFKKFHKGHKVLIDITENEIKNLRRIDSNNILKIYG 85
Query: 78 YAWE-SGKLK--ALILEYMENGSLESVIHGPGVDHSRWTLPKRIDVLISVANGLDYLHSG 134
+ + L +LILEY G L V+ + ++D+ I GL L+
Sbjct: 86 FIIDIVDDLPRLSLILEYCTRGYLREVLD----KEKDLSFKTKLDMAIDCCKGLYNLYKY 141
Query: 135 YDIPIVHCDMKPSNILLDRDFEAHVSDFGTSRMLDVHLQDLSSLSTAFQGTIGYLAPEFA 194
+ P + ++ + L+ +++ + G ++ LSS + Y +
Sbjct: 142 TNKP--YKNLTSVSFLVTENYKLKIICHGLEKI-------LSSPPFKNVNFMVYFSY--- 189
Query: 195 YMRIV-------TTKVDVFSFGIVVMEFLTKRRPTGLDEENGLSPISLRQLVEKALANGI 247
+++ T K D++S G+V+ E T + P L+ + + N
Sbjct: 190 --KMLNDIFSEYTIKDDIYSLGVVLWEIFTGKIPF-----ENLTTKEIY----DLIINKN 238
Query: 248 NGVRQITD-PKLVSSIYEEQEQHQVLEELFKLALVCTSSNPEDRPNMNELLI 298
N ++ D P + I E CTS + RPN+ E+L
Sbjct: 239 NSLKLPLDCPLEIKCIVEA----------------CTSHDSIKRPNIKEILY 274
|
Length = 283 |
| >gnl|CDD|165478 PHA03212, PHA03212, serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Score = 41.5 bits (97), Expect = 4e-04
Identities = 42/172 (24%), Positives = 76/172 (44%), Gaps = 16/172 (9%)
Query: 60 EAKTLKELKHRNLVKVLGYAWESGKLKALILEYMENGSLESVIHGPGVDHSRWTLPKRID 119
EA L+ + H +++++ G + K LIL ++ ++ + +
Sbjct: 133 EAHILRAINHPSIIQLKG-TFTYNKFTCLILP-----RYKTDLYCYLAAKRNIAICDILA 186
Query: 120 VLISVANGLDYLHSGYDIPIVHCDMKPSNILLDRDFEAHVSDFGTSRM-LDVHLQDLSSL 178
+ SV + YLH I+H D+K NI ++ + + DFG + +D++ ++
Sbjct: 187 IERSVLRAIQYLHEN---RIIHRDIKAENIFINHPGDVCLGDFGAACFPVDIN----ANK 239
Query: 179 STAFQGTIGYLAPEFAYMRIVTTKVDVFSFGIVVMEFLTKRRPTGLDEENGL 230
+ GTI APE VD++S GIV+ E T L E++GL
Sbjct: 240 YYGWAGTIATNAPELLARDPYGPAVDIWSAGIVLFEMATCH--DSLFEKDGL 289
|
Length = 391 |
| >gnl|CDD|88519 cd05618, STKc_aPKC_iota, Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C iota | Back alignment and domain information |
|---|
Score = 40.8 bits (95), Expect = 5e-04
Identities = 28/98 (28%), Positives = 50/98 (51%), Gaps = 7/98 (7%)
Query: 124 VANGLDYLHSGYDIPIVHCDMKPSNILLDRDFEAHVSDFGTSRMLDVHLQDLSSLSTAFQ 183
++ L+YLH + I++ D+K N+LLD + ++D+G M L+ ++ F
Sbjct: 105 ISLALNYLH---ERGIIYRDLKLDNVLLDSEGHIKLTDYG---MCKEGLRP-GDTTSTFC 157
Query: 184 GTIGYLAPEFAYMRIVTTKVDVFSFGIVVMEFLTKRRP 221
GT Y+APE VD ++ G+++ E + R P
Sbjct: 158 GTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSP 195
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, iota isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-iota is directly implicated in carcinogenesis. It is critical to oncogenic signaling mediated by Ras and Bcr-Abl. The PKC-iota gene is the target of tumor-specific gene amplification in many human cancers, and has been identified as a human oncogene. In addition to its role in transformed growth, PKC-iota also promotes invasion, chemoresistance, and tumor cell survival. Expression profiling of PKC-iota is a prognostic marker of poor clinical outcome in several human cancers. PKC-iota also plays a role in establishing cell polarity, and has critical embryonic functions. Length = 329 |
| >gnl|CDD|173646 cd05087, PTKc_Aatyk1_Aatyk3, Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases 1 and 3 | Back alignment and domain information |
|---|
Score = 39.1 bits (91), Expect = 0.001
Identities = 40/150 (26%), Positives = 61/150 (40%), Gaps = 9/150 (6%)
Query: 20 IGNSNLSTVYKGRLEDG---EIVAVKKLNFHQFSAESDKSFYREAKTLKELKHRNLVKVL 76
IGN V G + G V VK+L S + F EA+ + L+H NL++ L
Sbjct: 3 IGNGWFGKVILGEVNSGYTPAQVVVKELRVSA-SVQEQMKFLEEAQPYRSLQHSNLLQCL 61
Query: 77 GYAWESGKLKALILEYMENGSLESVIHGPGVDHSRWTLPKRIDVL-ISVANGLDYLHSGY 135
G E L++E+ G L+ + P + + +A GL +LH
Sbjct: 62 GQCTEVTPY-LLVMEFCPLGDLKGYLRSCRKAELMTPDPTTLQRMACEIALGLLHLHKN- 119
Query: 136 DIPIVHCDMKPSNILLDRDFEAHVSDFGTS 165
+H D+ N LL D + D+G S
Sbjct: 120 --NFIHSDLALRNCLLTADLTVKIGDYGLS 147
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 1 (Aatyk1) and Aatyk3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk1 and Aatyk3 are members of the Aatyk subfamily of proteins. Aatyk3 is a receptor kinase containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 has a similar domain arrangement but without the transmembrane segment and is thus, a cytoplasmic (or nonreceptor) kinase. The expression of Aatyk1 (also referred simply as Aatyk) is upregulated during growth arrest and apoptosis in myeloid cells. Aatyk1 has been implicated in neural differentiation, and is a regulator of the Na-K-2Cl cotransporter, a membrane protein involved in cell proliferation and survival, epithelial transport, and blood pressure control. The function of Aatyk3 is still unknown. Length = 269 |
Conserved Domains Detected by HHsearch
Original result of HHsearch against CDD database
| ID | Alignment Graph | Length |
Definition |
Probability |
| Query | 299 | |||
| KOG0581 | 364 | consensus Mitogen-activated protein kinase kinase | 100.0 | |
| KOG0575 | 592 | consensus Polo-like serine/threonine protein kinas | 100.0 | |
| KOG0591 | 375 | consensus NIMA (never in mitosis)-related G2-speci | 100.0 | |
| KOG0615 | 475 | consensus Serine/threonine protein kinase Chk2 and | 100.0 | |
| KOG0595 | 429 | consensus Serine/threonine-protein kinase involved | 100.0 | |
| KOG0593 | 396 | consensus Predicted protein kinase KKIAMRE [Genera | 100.0 | |
| KOG0661 | 538 | consensus MAPK related serine/threonine protein ki | 100.0 | |
| KOG0598 | 357 | consensus Ribosomal protein S6 kinase and related | 100.0 | |
| KOG0600 | 560 | consensus Cdc2-related protein kinase [Cell cycle | 100.0 | |
| KOG0592 | 604 | consensus 3-phosphoinositide-dependent protein kin | 100.0 | |
| KOG0198 | 313 | consensus MEKK and related serine/threonine protei | 100.0 | |
| KOG0192 | 362 | consensus Tyrosine kinase specific for activated ( | 100.0 | |
| KOG0583 | 370 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| KOG0659 | 318 | consensus Cdk activating kinase (CAK)/RNA polymera | 100.0 | |
| KOG0582 | 516 | consensus Ste20-like serine/threonine protein kina | 100.0 | |
| KOG0578 | 550 | consensus p21-activated serine/threonine protein k | 100.0 | |
| KOG1187 | 361 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| KOG0588 | 786 | consensus Serine/threonine protein kinase [Cell cy | 100.0 | |
| KOG0197 | 468 | consensus Tyrosine kinases [Signal transduction me | 100.0 | |
| KOG0589 | 426 | consensus Serine/threonine protein kinase [General | 100.0 | |
| KOG0660 | 359 | consensus Mitogen-activated protein kinase [Signal | 100.0 | |
| KOG0663 | 419 | consensus Protein kinase PITSLRE and related kinas | 100.0 | |
| cd07848 | 287 | STKc_CDKL5 Catalytic domain of the Serine/Threonin | 100.0 | |
| cd05612 | 291 | STKc_PRKX_like Catalytic domain of PRKX-like Prote | 100.0 | |
| KOG0594 | 323 | consensus Protein kinase PCTAIRE and related kinas | 100.0 | |
| KOG0597 | 808 | consensus Serine-threonine protein kinase FUSED [G | 100.0 | |
| KOG2345 | 302 | consensus Serine/threonine protein kinase/TGF-beta | 100.0 | |
| cd06649 | 331 | PKc_MEK2 Catalytic domain of the dual-specificity | 100.0 | |
| PTZ00263 | 329 | protein kinase A catalytic subunit; Provisional | 100.0 | |
| KOG0616 | 355 | consensus cAMP-dependent protein kinase catalytic | 100.0 | |
| cd07859 | 338 | STKc_TDY_MAPK_plant Catalytic domain of the Serine | 100.0 | |
| cd05102 | 338 | PTKc_VEGFR3 Catalytic domain of the Protein Tyrosi | 100.0 | |
| KOG0605 | 550 | consensus NDR and related serine/threonine kinases | 100.0 | |
| cd05571 | 323 | STKc_PKB Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd05631 | 285 | STKc_GRK4 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07862 | 290 | STKc_CDK6 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd07871 | 288 | STKc_PCTAIRE3 Catalytic domain of the Serine/Threo | 100.0 | |
| cd07869 | 303 | STKc_PFTAIRE1 Catalytic domain of the Serine/Threo | 100.0 | |
| PTZ00283 | 496 | serine/threonine protein kinase; Provisional | 100.0 | |
| KOG0580 | 281 | consensus Serine/threonine protein kinase [Cell cy | 100.0 | |
| PHA03212 | 391 | serine/threonine kinase US3; Provisional | 100.0 | |
| KOG0193 | 678 | consensus Serine/threonine protein kinase RAF [Sig | 100.0 | |
| cd05600 | 333 | STKc_Sid2p_Dbf2p Catalytic domain of Fungal Sid2p- | 100.0 | |
| PTZ00426 | 340 | cAMP-dependent protein kinase catalytic subunit; P | 100.0 | |
| KOG0201 | 467 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| KOG0611 | 668 | consensus Predicted serine/threonine protein kinas | 100.0 | |
| KOG0658 | 364 | consensus Glycogen synthase kinase-3 [Carbohydrate | 100.0 | |
| cd07876 | 359 | STKc_JNK2 Catalytic domain of the Serine/Threonine | 100.0 | |
| KOG0033 | 355 | consensus Ca2+/calmodulin-dependent protein kinase | 100.0 | |
| KOG0585 | 576 | consensus Ca2+/calmodulin-dependent protein kinase | 100.0 | |
| cd06650 | 333 | PKc_MEK1 Catalytic domain of the dual-specificity | 100.0 | |
| cd05593 | 328 | STKc_PKB_gamma Catalytic domain of the Protein Ser | 100.0 | |
| cd05588 | 329 | STKc_aPKC Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05618 | 329 | STKc_aPKC_iota Catalytic domain of the Protein Ser | 100.0 | |
| cd05573 | 350 | STKc_ROCK_NDR_like Catalytic domain of ROCK- and N | 100.0 | |
| cd05595 | 323 | STKc_PKB_beta Catalytic domain of the Protein Seri | 100.0 | |
| cd05585 | 312 | STKc_YPK1_like Catalytic domain of Yeast Protein K | 100.0 | |
| PTZ00036 | 440 | glycogen synthase kinase; Provisional | 100.0 | |
| KOG1989 | 738 | consensus ARK protein kinase family [Signal transd | 100.0 | |
| cd05614 | 332 | STKc_MSK2_N N-terminal catalytic domain of the Pro | 100.0 | |
| cd07878 | 343 | STKc_p38beta_MAPK11 Catalytic domain of the Serine | 100.0 | |
| cd05589 | 324 | STKc_PKN Catalytic domain of the Protein Serine/Th | 100.0 | |
| PLN00034 | 353 | mitogen-activated protein kinase kinase; Provision | 100.0 | |
| cd07863 | 288 | STKc_CDK4 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd07875 | 364 | STKc_JNK1 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05584 | 323 | STKc_p70S6K Catalytic domain of the Protein Serine | 100.0 | |
| cd07853 | 372 | STKc_NLK Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05599 | 364 | STKc_NDR_like Catalytic domain of Nuclear Dbf2-Rel | 100.0 | |
| PF00069 | 260 | Pkinase: Protein kinase domain Protein kinase; unc | 100.0 | |
| cd07874 | 355 | STKc_JNK3 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05582 | 318 | STKc_RSK_N N-terminal catalytic domain of the Prot | 100.0 | |
| cd05594 | 325 | STKc_PKB_alpha Catalytic domain of the Protein Ser | 100.0 | |
| cd05590 | 320 | STKc_nPKC_eta Catalytic domain of the Protein Seri | 100.0 | |
| KOG0694 | 694 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| cd05587 | 324 | STKc_cPKC Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05626 | 381 | STKc_LATS2 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd05605 | 285 | STKc_GRK4_like Catalytic domain of G protein-coupl | 100.0 | |
| cd05608 | 280 | STKc_GRK1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05628 | 363 | STKc_NDR1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05096 | 304 | PTKc_DDR1 Catalytic domain of the Protein Tyrosine | 100.0 | |
| PTZ00284 | 467 | protein kinase; Provisional | 100.0 | |
| PTZ00267 | 478 | NIMA-related protein kinase; Provisional | 100.0 | |
| cd05596 | 370 | STKc_ROCK Catalytic domain of the Protein Serine/T | 100.0 | |
| PTZ00266 | 1021 | NIMA-related protein kinase; Provisional | 100.0 | |
| cd05591 | 321 | STKc_nPKC_epsilon Catalytic domain of the Protein | 100.0 | |
| cd05601 | 330 | STKc_CRIK Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05625 | 382 | STKc_LATS1 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd05629 | 377 | STKc_NDR_like_fungal Catalytic domain of Fungal Nu | 100.0 | |
| cd08223 | 257 | STKc_Nek4 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05592 | 316 | STKc_nPKC_theta_delta Catalytic domain of the Prot | 100.0 | |
| cd05621 | 370 | STKc_ROCK2 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd05570 | 318 | STKc_PKC Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd05598 | 376 | STKc_LATS Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05620 | 316 | STKc_nPKC_delta Catalytic domain of the Protein Se | 100.0 | |
| PHA02988 | 283 | hypothetical protein; Provisional | 100.0 | |
| cd08529 | 256 | STKc_FA2-like Catalytic domain of the Protein Seri | 100.0 | |
| cd05616 | 323 | STKc_cPKC_beta Catalytic domain of the Protein Ser | 100.0 | |
| cd07861 | 285 | STKc_CDK1_euk Catalytic domain of the Serine/Threo | 100.0 | |
| KOG0667 | 586 | consensus Dual-specificity tyrosine-phosphorylatio | 100.0 | |
| cd07839 | 284 | STKc_CDK5 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05619 | 316 | STKc_nPKC_theta Catalytic domain of the Protein Se | 100.0 | |
| cd08217 | 265 | STKc_Nek2 Catalytic domain of the Protein Serine/T | 100.0 | |
| KOG4717 | 864 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| cd05617 | 327 | STKc_aPKC_zeta Catalytic domain of the Protein Ser | 100.0 | |
| cd05607 | 277 | STKc_GRK7 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd08224 | 267 | STKc_Nek6_Nek7 Catalytic domain of the Protein Ser | 100.0 | |
| cd08228 | 267 | STKc_Nek6 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05575 | 323 | STKc_SGK Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd07868 | 317 | STKc_CDK8 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05622 | 371 | STKc_ROCK1 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd05072 | 261 | PTKc_Lyn Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd06646 | 267 | STKc_MAP4K5 Catalytic domain of the Protein Serine | 100.0 | |
| cd07847 | 286 | STKc_CDKL1_4 Catalytic domain of the Serine/Threon | 100.0 | |
| cd05067 | 260 | PTKc_Lck_Blk Catalytic domain of the Protein Tyros | 100.0 | |
| cd06625 | 263 | STKc_MEKK3_like Catalytic domain of MAP/ERK kinase | 100.0 | |
| cd06631 | 265 | STKc_YSK4 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05054 | 337 | PTKc_VEGFR Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd07872 | 309 | STKc_PCTAIRE2 Catalytic domain of the Serine/Threo | 100.0 | |
| PHA03207 | 392 | serine/threonine kinase US3; Provisional | 100.0 | |
| cd05602 | 325 | STKc_SGK1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05070 | 260 | PTKc_Fyn_Yrk Catalytic domain of the Protein Tyros | 100.0 | |
| cd06630 | 268 | STKc_MEKK1 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd05048 | 283 | PTKc_Ror Catalytic Domain of the Protein Tyrosine | 100.0 | |
| cd05106 | 374 | PTKc_CSF-1R Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd06619 | 279 | PKc_MKK5 Catalytic domain of the dual-specificity | 100.0 | |
| cd05627 | 360 | STKc_NDR2 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05052 | 263 | PTKc_Abl Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05064 | 266 | PTKc_EphR_A10 Catalytic domain of the Protein Tyro | 100.0 | |
| cd05630 | 285 | STKc_GRK6 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06613 | 262 | STKc_MAP4K3_like Catalytic domain of Mitogen-activ | 100.0 | |
| cd05104 | 375 | PTKc_Kit Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd06622 | 286 | PKc_MAPKK_PBS2_like Catalytic domain of fungal PBS | 100.0 | |
| cd08218 | 256 | STKc_Nek1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05615 | 323 | STKc_cPKC_alpha Catalytic domain of the Protein Se | 100.0 | |
| cd05603 | 321 | STKc_SGK2 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06610 | 267 | STKc_OSR1_SPAK Catalytic domain of the Protein Ser | 100.0 | |
| KOG0596 | 677 | consensus Dual specificity; serine/threonine and t | 100.0 | |
| cd05071 | 262 | PTKc_Src Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05114 | 256 | PTKc_Tec_Rlk Catalytic domain of the Protein Tyros | 100.0 | |
| cd05069 | 260 | PTKc_Yes Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd08227 | 327 | PK_STRAD_alpha Pseudokinase domain of STE20-relate | 100.0 | |
| cd06615 | 308 | PKc_MEK Catalytic domain of the dual-specificity P | 100.0 | |
| cd05049 | 280 | PTKc_Trk Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd08219 | 255 | STKc_Nek3 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06654 | 296 | STKc_PAK1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06656 | 297 | STKc_PAK3 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05068 | 261 | PTKc_Frk_like Catalytic domain of Fyn-related kina | 100.0 | |
| cd05597 | 331 | STKc_DMPK_like Catalytic domain of Myotonic Dystro | 100.0 | |
| KOG0032 | 382 | consensus Ca2+/calmodulin-dependent protein kinase | 100.0 | |
| cd06638 | 286 | STKc_myosinIIIA Catalytic domain of the Protein Se | 100.0 | |
| cd05113 | 256 | PTKc_Btk_Bmx Catalytic domain of the Protein Tyros | 100.0 | |
| cd05034 | 261 | PTKc_Src_like Catalytic domain of Src kinase-like | 100.0 | |
| cd05604 | 325 | STKc_SGK3 Catalytic domain of the Protein Serine/T | 100.0 | |
| KOG0599 | 411 | consensus Phosphorylase kinase gamma subunit [Carb | 100.0 | |
| cd06639 | 291 | STKc_myosinIIIB Catalytic domain of the Protein Se | 100.0 | |
| cd05116 | 257 | PTKc_Syk Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd07850 | 353 | STKc_JNK Catalytic domain of the Serine/Threonine | 100.0 | |
| cd06628 | 267 | STKc_MAPKKK_Byr2_like Catalytic domain of fungal B | 100.0 | |
| cd08221 | 256 | STKc_Nek9 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06609 | 274 | STKc_MST3_like Catalytic domain of Mammalian Ste20 | 100.0 | |
| KOG0610 | 459 | consensus Putative serine/threonine protein kinase | 100.0 | |
| cd05080 | 283 | PTKc_Tyk2_rpt2 Catalytic (repeat 2) domain of the | 100.0 | |
| cd06645 | 267 | STKc_MAP4K3 Catalytic domain of the Protein Serine | 100.0 | |
| cd07873 | 301 | STKc_PCTAIRE1 Catalytic domain of the Serine/Threo | 100.0 | |
| cd06612 | 256 | STKc_MST1_2 Catalytic domain of the Protein Serine | 100.0 | |
| cd05632 | 285 | STKc_GRK5 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06621 | 287 | PKc_MAPKK_Pek1_like Catalytic domain of fungal Pek | 100.0 | |
| KOG0666 | 438 | consensus Cyclin C-dependent kinase CDK8 [Transcri | 100.0 | |
| KOG4721 | 904 | consensus Serine/threonine protein kinase, contain | 100.0 | |
| cd05062 | 277 | PTKc_IGF-1R Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd05059 | 256 | PTKc_Tec_like Catalytic domain of Tec-like Protein | 100.0 | |
| cd05148 | 261 | PTKc_Srm_Brk Catalytic domain of the Protein Tyros | 100.0 | |
| cd06644 | 292 | STKc_STK10_LOK Catalytic domain of the Protein Ser | 100.0 | |
| PF07714 | 259 | Pkinase_Tyr: Protein tyrosine kinase Protein kinas | 100.0 | |
| cd07867 | 317 | STKc_CDC2L6 Catalytic domain of Serine/Threonine K | 100.0 | |
| cd05574 | 316 | STKc_phototropin_like Catalytic domain of Phototro | 100.0 | |
| cd00192 | 262 | PTKc Catalytic domain of Protein Tyrosine Kinases. | 100.0 | |
| cd06611 | 280 | STKc_SLK_like Catalytic domain of Ste20-like kinas | 100.0 | |
| cd07855 | 334 | STKc_ERK5 Catalytic domain of the Serine/Threonine | 100.0 | |
| PHA03211 | 461 | serine/threonine kinase US3; Provisional | 100.0 | |
| cd05082 | 256 | PTKc_Csk Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd06655 | 296 | STKc_PAK2 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05043 | 280 | PTK_Ryk Pseudokinase domain of Ryk (Receptor relat | 100.0 | |
| cd05075 | 272 | PTKc_Axl Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05073 | 260 | PTKc_Hck Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05035 | 273 | PTKc_Axl_like Catalytic Domain of Axl-like Protein | 100.0 | |
| cd06620 | 284 | PKc_MAPKK_Byr1_like Catalytic domain of fungal Byr | 100.0 | |
| cd08229 | 267 | STKc_Nek7 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07832 | 286 | STKc_CCRK Catalytic domain of the Serine/Threonine | 100.0 | |
| cd06623 | 264 | PKc_MAPKK_plant_like Catalytic domain of Plant dua | 100.0 | |
| cd05033 | 266 | PTKc_EphR Catalytic domain of Ephrin Receptor Prot | 100.0 | |
| cd07833 | 288 | STKc_CDKL Catalytic domain of Cyclin-Dependent pro | 100.0 | |
| KOG0577 | 948 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| cd06608 | 275 | STKc_myosinIII_like Catalytic domain of Class III | 100.0 | |
| cd06637 | 272 | STKc_TNIK Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05093 | 288 | PTKc_TrkB Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd06640 | 277 | STKc_MST4 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06605 | 265 | PKc_MAPKK Catalytic domain of the dual-specificity | 100.0 | |
| cd07841 | 298 | STKc_CDK7 Catalytic domain of the Serine/Threonine | 100.0 | |
| PRK13184 | 932 | pknD serine/threonine-protein kinase; Reviewed | 100.0 | |
| cd05084 | 252 | PTKc_Fes Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd08220 | 256 | STKc_Nek8 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06626 | 264 | STKc_MEKK4 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd05624 | 331 | STKc_MRCK_beta Catalytic domain of the Protein Ser | 100.0 | |
| cd05623 | 332 | STKc_MRCK_alpha Catalytic domain of the Protein Se | 100.0 | |
| PHA03209 | 357 | serine/threonine kinase US3; Provisional | 100.0 | |
| cd07865 | 310 | STKc_CDK9 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05053 | 293 | PTKc_FGFR Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd07843 | 293 | STKc_CDC2L1 Catalytic domain of the Serine/Threoni | 100.0 | |
| cd05578 | 258 | STKc_Yank1 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd06643 | 282 | STKc_SLK Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd06636 | 282 | STKc_MAP4K4_6 Catalytic domain of the Protein Seri | 100.0 | |
| cd07846 | 286 | STKc_CDKL2_3 Catalytic domain of the Serine/Threon | 100.0 | |
| cd06651 | 266 | STKc_MEKK3 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd05580 | 290 | STKc_PKA Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd06652 | 265 | STKc_MEKK2 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd07858 | 337 | STKc_TEY_MAPK_plant Catalytic domain of the Serine | 100.0 | |
| cd06632 | 258 | STKc_MEKK1_plant Catalytic domain of the Protein S | 100.0 | |
| cd07845 | 309 | STKc_CDK10 Catalytic domain of the Serine/Threonin | 100.0 | |
| cd05108 | 316 | PTKc_EGFR Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05036 | 277 | PTKc_ALK_LTK Catalytic domain of the Protein Tyros | 100.0 | |
| cd05032 | 277 | PTKc_InsR_like Catalytic domain of Insulin Recepto | 100.0 | |
| cd05090 | 283 | PTKc_Ror1 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd07842 | 316 | STKc_CDK8_like Catalytic domain of Cyclin-Dependen | 100.0 | |
| cd06617 | 283 | PKc_MKK3_6 Catalytic domain of the dual-specificit | 100.0 | |
| cd06642 | 277 | STKc_STK25-YSK1 Catalytic domain of the Protein Se | 100.0 | |
| cd07860 | 284 | STKc_CDK2_3 Catalytic domain of the Serine/Threoni | 100.0 | |
| cd05586 | 330 | STKc_Sck1_like Catalytic domain of Suppressor of l | 100.0 | |
| cd05094 | 291 | PTKc_TrkC Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd06629 | 272 | STKc_MAPKKK_Bck1_like Catalytic domain of fungal B | 100.0 | |
| cd05051 | 296 | PTKc_DDR Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05060 | 257 | PTKc_Syk_like Catalytic domain of Spleen Tyrosine | 100.0 | |
| cd05079 | 284 | PTKc_Jak1_rpt2 Catalytic (repeat 2) domain of the | 100.0 | |
| cd05085 | 250 | PTKc_Fer Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd08215 | 258 | STKc_Nek Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd06658 | 292 | STKc_PAK5 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05040 | 257 | PTKc_Ack_like Catalytic domain of the Protein Tyro | 100.0 | |
| cd05039 | 256 | PTKc_Csk_like Catalytic domain of C-terminal Src k | 100.0 | |
| cd07856 | 328 | STKc_Sty1_Hog1 Catalytic domain of the Serine/Thre | 100.0 | |
| cd05091 | 283 | PTKc_Ror2 Catalytic domain of the Protein Tyrosine | 100.0 | |
| KOG0586 | 596 | consensus Serine/threonine protein kinase [General | 100.0 | |
| cd05081 | 284 | PTKc_Jak2_Jak3_rpt2 Catalytic (repeat 2) domain of | 100.0 | |
| cd07837 | 295 | STKc_CdkB_plant Catalytic domain of the Serine/Thr | 100.0 | |
| cd05097 | 295 | PTKc_DDR_like Catalytic domain of Discoidin Domain | 100.0 | |
| cd07849 | 336 | STKc_ERK1_2_like Catalytic domain of Extracellular | 100.0 | |
| cd05092 | 280 | PTKc_TrkA Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05088 | 303 | PTKc_Tie2 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05061 | 288 | PTKc_InsR Catalytic domain of the Protein Tyrosine | 100.0 | |
| KOG0194 | 474 | consensus Protein tyrosine kinase [Signal transduc | 100.0 | |
| cd05105 | 400 | PTKc_PDGFR_alpha Catalytic domain of the Protein T | 100.0 | |
| cd05098 | 307 | PTKc_FGFR1 Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd07844 | 291 | STKc_PCTAIRE_like Catalytic domain of PCTAIRE-like | 100.0 | |
| KOG0604 | 400 | consensus MAP kinase-activated protein kinase 2 [S | 100.0 | |
| cd05095 | 296 | PTKc_DDR2 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05055 | 302 | PTKc_PDGFR Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd05045 | 290 | PTKc_RET Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05089 | 297 | PTKc_Tie1 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05103 | 343 | PTKc_VEGFR2 Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd07834 | 330 | STKc_MAPK Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05609 | 305 | STKc_MAST Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06647 | 293 | STKc_PAK_I Catalytic domain of the Protein Serine/ | 100.0 | |
| cd06624 | 268 | STKc_ASK Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd06606 | 260 | STKc_MAPKKK Catalytic domain of the Protein Serine | 100.0 | |
| cd05115 | 257 | PTKc_Zap-70 Catalytic domain of the Protein Tyrosi | 100.0 | |
| PHA03210 | 501 | serine/threonine kinase US3; Provisional | 100.0 | |
| cd05099 | 314 | PTKc_FGFR4 Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd05109 | 279 | PTKc_HER2 Catalytic domain of the Protein Tyrosine | 100.0 | |
| KOG1026 | 774 | consensus Nerve growth factor receptor TRKA and re | 100.0 | |
| cd07880 | 343 | STKc_p38gamma_MAPK12 Catalytic domain of the Serin | 100.0 | |
| cd05111 | 279 | PTK_HER3 Pseudokinase domain of the Protein Tyrosi | 100.0 | |
| cd07870 | 291 | STKc_PFTAIRE2 Catalytic domain of the Serine/Threo | 100.0 | |
| cd05122 | 253 | PKc_STE Catalytic domain of STE family Protein Kin | 100.0 | |
| cd08530 | 256 | STKc_CNK2-like Catalytic domain of the Protein Ser | 100.0 | |
| cd07836 | 284 | STKc_Pho85 Catalytic domain of the Serine/Threonin | 100.0 | |
| cd08225 | 257 | STKc_Nek5 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05083 | 254 | PTKc_Chk Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd07840 | 287 | STKc_CDK9_like Catalytic domain of Cyclin-Dependen | 100.0 | |
| cd05066 | 267 | PTKc_EphR_A Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd05058 | 262 | PTKc_Met_Ron Catalytic domain of the Protein Tyros | 100.0 | |
| cd06648 | 285 | STKc_PAK_II Catalytic domain of the Protein Serine | 100.0 | |
| cd05041 | 251 | PTKc_Fes_like Catalytic domain of Fes-like Protein | 100.0 | |
| cd06653 | 264 | STKc_MEKK3_like_1 Catalytic domain of MAP/ERK kina | 100.0 | |
| cd07864 | 302 | STKc_CDK12 Catalytic domain of the Serine/Threonin | 100.0 | |
| cd05112 | 256 | PTKc_Itk Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd06641 | 277 | STKc_MST3 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06659 | 297 | STKc_PAK6 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07835 | 283 | STKc_CDK1_like Catalytic domain of Cyclin-Dependen | 100.0 | |
| cd05101 | 304 | PTKc_FGFR2 Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd07879 | 342 | STKc_p38delta_MAPK13 Catalytic domain of the Serin | 100.0 | |
| cd07877 | 345 | STKc_p38alpha_MAPK14 Catalytic domain of the Serin | 100.0 | |
| cd05050 | 288 | PTKc_Musk Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05100 | 334 | PTKc_FGFR3 Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd07831 | 282 | STKc_MOK Catalytic domain of the Serine/Threonine | 100.0 | |
| smart00219 | 258 | TyrKc Tyrosine kinase, catalytic domain. Phosphotr | 100.0 | |
| cd07838 | 287 | STKc_CDK4_6_like Catalytic domain of Cyclin-Depend | 100.0 | |
| PLN00009 | 294 | cyclin-dependent kinase A; Provisional | 100.0 | |
| cd06917 | 277 | STKc_NAK1_like Catalytic domain of Fungal Nak1-lik | 100.0 | |
| cd05633 | 279 | STKc_GRK3 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05063 | 268 | PTKc_EphR_A2 Catalytic domain of the Protein Tyros | 100.0 | |
| cd06614 | 286 | STKc_PAK Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd06627 | 254 | STKc_Cdc7_like Catalytic domain of Cell division c | 100.0 | |
| cd05572 | 262 | STKc_cGK_PKG Catalytic domain of the Protein Serin | 100.0 | |
| cd08216 | 314 | PK_STRAD Pseudokinase domain of STE20-related kina | 100.0 | |
| cd05065 | 269 | PTKc_EphR_B Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd07851 | 343 | STKc_p38 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05577 | 277 | STKc_GRK Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd05581 | 280 | STKc_PDK1 Catalytic domain of the Protein Serine/T | 100.0 | |
| KOG1095 | 1025 | consensus Protein tyrosine kinase [Signal transduc | 100.0 | |
| cd05056 | 270 | PTKc_FAK Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05046 | 275 | PTK_CCK4 Pseudokinase domain of the Protein Tyrosi | 100.0 | |
| cd05107 | 401 | PTKc_PDGFR_beta Catalytic domain of the Protein Ty | 100.0 | |
| PHA03390 | 267 | pk1 serine/threonine-protein kinase 1; Provisional | 100.0 | |
| cd07866 | 311 | STKc_BUR1 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd08226 | 328 | PK_STRAD_beta Pseudokinase domain of STE20-related | 100.0 | |
| cd06607 | 307 | STKc_TAO Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd06616 | 288 | PKc_MKK4 Catalytic domain of the dual-specificity | 100.0 | |
| cd07852 | 337 | STKc_MAPK15 Catalytic domain of the Serine/Threoni | 100.0 | |
| cd07857 | 332 | STKc_MPK1 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05077 | 262 | PTK_Jak1_rpt1 Pseudokinase (repeat 1) domain of th | 100.0 | |
| cd05047 | 270 | PTKc_Tie Catalytic domain of Tie Protein Tyrosine | 100.0 | |
| cd05118 | 283 | STKc_CMGC Catalytic domain of CMGC family Serine/T | 100.0 | |
| cd05057 | 279 | PTKc_EGFR_like Catalytic domain of Epidermal Growt | 100.0 | |
| KOG0662 | 292 | consensus Cyclin-dependent kinase CDK5 [Intracellu | 100.0 | |
| cd05038 | 284 | PTKc_Jak_rpt2 Catalytic (repeat 2) domain of the P | 100.0 | |
| cd07854 | 342 | STKc_MAPK4_6 Catalytic domain of the Serine/Threon | 100.0 | |
| PTZ00024 | 335 | cyclin-dependent protein kinase; Provisional | 100.0 | |
| cd08528 | 269 | STKc_Nek10 Catalytic domain of the Protein Serine/ | 100.0 | |
| KOG0574 | 502 | consensus STE20-like serine/threonine kinase MST [ | 100.0 | |
| cd05042 | 269 | PTKc_Aatyk Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd06657 | 292 | STKc_PAK4 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05044 | 269 | PTKc_c-ros Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd05606 | 278 | STKc_beta_ARK Catalytic domain of the Protein Seri | 100.0 | |
| cd05611 | 260 | STKc_Rim15_like Catalytic domain of fungal Rim15-l | 100.0 | |
| KOG0579 | 1187 | consensus Ste20-like serine/threonine protein kina | 100.0 | |
| KOG0671 | 415 | consensus LAMMER dual specificity kinases [Signal | 100.0 | |
| KOG0669 | 376 | consensus Cyclin T-dependent kinase CDK9 [Cell cyc | 100.0 | |
| cd05074 | 273 | PTKc_Tyro3 Catalytic domain of the Protein Tyrosin | 100.0 | |
| KOG4279 | 1226 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| KOG4278 | 1157 | consensus Protein tyrosine kinase [Signal transduc | 100.0 | |
| cd05037 | 259 | PTK_Jak_rpt1 Pseudokinase (repeat 1) domain of the | 100.0 | |
| PHA02882 | 294 | putative serine/threonine kinase; Provisional | 100.0 | |
| cd05579 | 265 | STKc_MAST_like Catalytic domain of Microtubule-ass | 100.0 | |
| cd08222 | 260 | STKc_Nek11 Catalytic domain of the Protein Serine/ | 100.0 | |
| KOG0983 | 391 | consensus Mitogen-activated protein kinase (MAPK) | 100.0 | |
| cd05087 | 269 | PTKc_Aatyk1_Aatyk3 Catalytic domain of the Protein | 100.0 | |
| cd05110 | 303 | PTKc_HER4 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd07829 | 282 | STKc_CDK_like Catalytic domain of Cyclin-Dependent | 100.0 | |
| KOG4645 | 1509 | consensus MAPKKK (MAP kinase kinase kinase) SSK2 a | 100.0 | |
| cd05613 | 290 | STKc_MSK1_N N-terminal catalytic domain of the Pro | 100.0 | |
| cd06635 | 317 | STKc_TAO1 Catalytic domain of the Protein Serine/T | 100.0 | |
| KOG0584 | 632 | consensus Serine/threonine protein kinase [General | 100.0 | |
| KOG1035 | 1351 | consensus eIF-2alpha kinase GCN2 [Translation, rib | 100.0 | |
| cd05086 | 268 | PTKc_Aatyk2 Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd05076 | 274 | PTK_Tyk2_rpt1 Pseudokinase (repeat 1) domain of th | 100.0 | |
| cd06618 | 296 | PKc_MKK7 Catalytic domain of the dual-specificity | 100.0 | |
| cd06634 | 308 | STKc_TAO2 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05583 | 288 | STKc_MSK_N N-terminal catalytic domain of the Prot | 100.0 | |
| cd06633 | 313 | STKc_TAO3 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05123 | 250 | STKc_AGC Catalytic domain of AGC family Protein Se | 100.0 | |
| KOG0607 | 463 | consensus MAP kinase-interacting kinase and relate | 100.0 | |
| cd05078 | 258 | PTK_Jak2_Jak3_rpt1 Pseudokinase (repeat 1) domain | 100.0 | |
| cd07830 | 283 | STKc_MAK_like Catalytic domain of Male germ cell-A | 100.0 | |
| KOG4250 | 732 | consensus TANK binding protein kinase TBK1 [Signal | 100.0 | |
| KOG0986 | 591 | consensus G protein-coupled receptor kinase [Signa | 100.0 | |
| KOG0690 | 516 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| KOG1094 | 807 | consensus Discoidin domain receptor DDR1 [Signal t | 100.0 | |
| KOG4257 | 974 | consensus Focal adhesion tyrosine kinase FAK, cont | 100.0 | |
| KOG0199 | 1039 | consensus ACK and related non-receptor tyrosine ki | 100.0 | |
| cd05576 | 237 | STKc_RPK118_like Catalytic domain of the Protein S | 100.0 | |
| KOG1151 | 775 | consensus Tousled-like protein kinase [Signal tran | 100.0 | |
| KOG0612 | 1317 | consensus Rho-associated, coiled-coil containing p | 100.0 | |
| KOG4236 | 888 | consensus Serine/threonine protein kinase PKC mu/P | 100.0 | |
| cd05610 | 669 | STKc_MASTL Catalytic domain of the Protein Serine/ | 100.0 | |
| PLN00113 | 968 | leucine-rich repeat receptor-like protein kinase; | 100.0 | |
| KOG0668 | 338 | consensus Casein kinase II, alpha subunit [Signal | 100.0 | |
| KOG0614 | 732 | consensus cGMP-dependent protein kinase [Signal tr | 100.0 | |
| KOG0603 | 612 | consensus Ribosomal protein S6 kinase [Signal tran | 100.0 | |
| KOG1006 | 361 | consensus Mitogen-activated protein kinase (MAPK) | 100.0 | |
| KOG2052 | 513 | consensus Activin A type IB receptor, serine/threo | 100.0 | |
| KOG0196 | 996 | consensus Tyrosine kinase, EPH (ephrin) receptor f | 100.0 | |
| KOG0587 | 953 | consensus Traf2- and Nck-interacting kinase and re | 100.0 | |
| PLN03225 | 566 | Serine/threonine-protein kinase SNT7; Provisional | 100.0 | |
| KOG0670 | 752 | consensus U4/U6-associated splicing factor PRP4 [R | 100.0 | |
| smart00220 | 244 | S_TKc Serine/Threonine protein kinases, catalytic | 100.0 | |
| KOG1290 | 590 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| PLN03224 | 507 | probable serine/threonine protein kinase; Provisio | 100.0 | |
| KOG0200 | 609 | consensus Fibroblast/platelet-derived growth facto | 100.0 | |
| KOG1027 | 903 | consensus Serine/threonine protein kinase and endo | 100.0 | |
| KOG0664 | 449 | consensus Nemo-like MAPK-related serine/threonine | 100.0 | |
| KOG3653 | 534 | consensus Transforming growth factor beta/activin | 100.0 | |
| KOG1025 | 1177 | consensus Epidermal growth factor receptor EGFR an | 100.0 | |
| KOG0665 | 369 | consensus Jun-N-terminal kinase (JNK) [Signal tran | 100.0 | |
| KOG0695 | 593 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| KOG0696 | 683 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| cd00180 | 215 | PKc Catalytic domain of Protein Kinases. Protein K | 99.98 | |
| KOG1167 | 418 | consensus Serine/threonine protein kinase of the C | 99.98 | |
| KOG0984 | 282 | consensus Mitogen-activated protein kinase (MAPK) | 99.98 | |
| KOG0608 | 1034 | consensus Warts/lats-like serine threonine kinases | 99.97 | |
| KOG1024 | 563 | consensus Receptor-like protein tyrosine kinase RY | 99.97 | |
| KOG1345 | 378 | consensus Serine/threonine kinase [Signal transduc | 99.97 | |
| KOG1152 | 772 | consensus Signal transduction serine/threonine kin | 99.97 | |
| KOG0576 | 829 | consensus Mitogen-activated protein kinase kinase | 99.97 | |
| smart00221 | 225 | STYKc Protein kinase; unclassified specificity. Ph | 99.96 | |
| smart00750 | 176 | KIND kinase non-catalytic C-lobe domain. It is an | 99.95 | |
| PLN00181 | 793 | protein SPA1-RELATED; Provisional | 99.95 | |
| KOG1240 | 1431 | consensus Protein kinase containing WD40 repeats [ | 99.94 | |
| KOG1164 | 322 | consensus Casein kinase (serine/threonine/tyrosine | 99.94 | |
| KOG0590 | 601 | consensus Checkpoint kinase and related serine/thr | 99.93 | |
| PRK09188 | 365 | serine/threonine protein kinase; Provisional | 99.93 | |
| PF14531 | 288 | Kinase-like: Kinase-like; PDB: 3DZO_A 2W1Z_A 3BYV_ | 99.92 | |
| KOG1163 | 341 | consensus Casein kinase (serine/threonine/tyrosine | 99.92 | |
| COG0515 | 384 | SPS1 Serine/threonine protein kinase [General func | 99.92 | |
| PRK10359 | 232 | lipopolysaccharide core biosynthesis protein; Prov | 99.91 | |
| KOG1165 | 449 | consensus Casein kinase (serine/threonine/tyrosine | 99.9 | |
| cd05147 | 190 | RIO1_euk RIO kinase family; eukaryotic RIO1, catal | 99.9 | |
| KOG0195 | 448 | consensus Integrin-linked kinase [Signal transduct | 99.89 | |
| cd05145 | 190 | RIO1_like RIO kinase family; RIO1, RIO3 and simila | 99.88 | |
| KOG4158 | 598 | consensus BRPK/PTEN-induced protein kinase [Signal | 99.87 | |
| PRK12274 | 218 | serine/threonine protein kinase; Provisional | 99.85 | |
| KOG0603 | 612 | consensus Ribosomal protein S6 kinase [Signal tran | 99.84 | |
| KOG1166 | 974 | consensus Mitotic checkpoint serine/threonine prot | 99.84 | |
| smart00090 | 237 | RIO RIO-like kinase. | 99.82 | |
| KOG1023 | 484 | consensus Natriuretic peptide receptor, guanylate | 99.82 | |
| PRK10345 | 210 | hypothetical protein; Provisional | 99.81 | |
| PRK14879 | 211 | serine/threonine protein kinase; Provisional | 99.78 | |
| cd05144 | 198 | RIO2_C RIO kinase family; RIO2, C-terminal catalyt | 99.78 | |
| TIGR03724 | 199 | arch_bud32 Kae1-associated kinase Bud32. Members o | 99.75 | |
| KOG1033 | 516 | consensus eIF-2alpha kinase PEK/EIF2AK3 [Translati | 99.74 | |
| KOG0606 | 1205 | consensus Microtubule-associated serine/threonine | 99.74 | |
| PRK09605 | 535 | bifunctional UGMP family protein/serine/threonine | 99.73 | |
| KOG0590 | 601 | consensus Checkpoint kinase and related serine/thr | 99.72 | |
| cd05119 | 187 | RIO RIO kinase family, catalytic domain. The RIO k | 99.72 | |
| PRK01723 | 239 | 3-deoxy-D-manno-octulosonic-acid kinase; Reviewed | 99.71 | |
| cd05120 | 155 | APH_ChoK_like Aminoglycoside 3'-phosphotransferase | 99.65 | |
| KOG1243 | 690 | consensus Protein kinase [General function predict | 99.62 | |
| KOG0601 | 524 | consensus Cyclin-dependent kinase WEE1 [Cell cycle | 99.6 | |
| TIGR01982 | 437 | UbiB 2-polyprenylphenol 6-hydroxylase. This model | 99.58 | |
| KOG1266 | 458 | consensus Protein kinase [Signal transduction mech | 99.56 | |
| PRK04750 | 537 | ubiB putative ubiquinone biosynthesis protein UbiB | 99.55 | |
| cd05146 | 197 | RIO3_euk RIO kinase family; eukaryotic RIO3, catal | 99.46 | |
| cd05151 | 170 | ChoK Choline Kinase (ChoK). The ChoK subfamily is | 99.44 | |
| KOG3087 | 229 | consensus Serine/threonine protein kinase [General | 99.32 | |
| cd05154 | 223 | ACAD10_11_like Acyl-CoA dehydrogenase (ACAD) 10 an | 99.3 | |
| KOG0601 | 524 | consensus Cyclin-dependent kinase WEE1 [Cell cycle | 99.28 | |
| COG4248 | 637 | Uncharacterized protein with protein kinase and he | 99.26 | |
| KOG3741 | 655 | consensus Poly(A) ribonuclease subunit [RNA proces | 99.26 | |
| COG3642 | 204 | Mn2+-dependent serine/threonine protein kinase [Si | 99.23 | |
| PF01163 | 188 | RIO1: RIO1 family; InterPro: IPR018934 Protein pho | 99.21 | |
| COG0478 | 304 | RIO-like serine/threonine protein kinase fused to | 99.17 | |
| KOG2137 | 700 | consensus Protein kinase [Signal transduction mech | 99.16 | |
| KOG0606 | 1205 | consensus Microtubule-associated serine/threonine | 99.1 | |
| PRK15123 | 268 | lipopolysaccharide core heptose(I) kinase RfaP; Pr | 99.07 | |
| COG0661 | 517 | AarF Predicted unusual protein kinase [General fun | 99.05 | |
| PRK09902 | 216 | hypothetical protein; Provisional | 98.9 | |
| COG1718 | 268 | RIO1 Serine/threonine protein kinase involved in c | 98.88 | |
| PF06176 | 229 | WaaY: Lipopolysaccharide core biosynthesis protein | 98.86 | |
| PF06293 | 206 | Kdo: Lipopolysaccharide kinase (Kdo/WaaP) family; | 98.83 | |
| KOG1235 | 538 | consensus Predicted unusual protein kinase [Genera | 98.75 | |
| TIGR02172 | 226 | Fb_sc_TIGR02172 Fibrobacter succinogenes paralogou | 98.67 | |
| PF01636 | 239 | APH: Phosphotransferase enzyme family This family | 98.5 | |
| COG2112 | 201 | Predicted Ser/Thr protein kinase [Signal transduct | 98.47 | |
| cd05150 | 244 | APH Aminoglycoside 3'-phosphotransferase (APH). Th | 98.4 | |
| PF12260 | 188 | PIP49_C: Protein-kinase domain of FAM69; InterPro: | 98.34 | |
| KOG1035 | 1351 | consensus eIF-2alpha kinase GCN2 [Translation, rib | 98.27 | |
| KOG2270 | 520 | consensus Serine/threonine protein kinase involved | 98.24 | |
| PF10707 | 199 | YrbL-PhoP_reg: PhoP regulatory network protein Yrb | 98.2 | |
| cd05155 | 235 | APH_ChoK_like_1 Uncharacterized bacterial proteins | 98.19 | |
| PLN02876 | 822 | acyl-CoA dehydrogenase | 98.15 | |
| cd05157 | 235 | ETNK_euk Ethanolamine kinase (ETNK) in eukaryotes. | 98.12 | |
| cd05153 | 296 | HomoserineK_II Homoserine Kinase, type II. Homoser | 98.06 | |
| PRK05231 | 319 | homoserine kinase; Provisional | 98.06 | |
| TIGR02721 | 256 | ycfN_thiK thiamine kinase. Members of this family | 98.06 | |
| KOG2268 | 465 | consensus Serine/threonine protein kinase [Signal | 98.05 | |
| PRK10593 | 297 | hypothetical protein; Provisional | 97.91 | |
| TIGR00938 | 307 | thrB_alt homoserine kinase, Neisseria type. Homose | 97.88 | |
| KOG0576 | 829 | consensus Mitogen-activated protein kinase kinase | 97.87 | |
| PRK09550 | 401 | mtnK methylthioribose kinase; Reviewed | 97.84 | |
| cd05156 | 302 | ChoK_euk Choline Kinase (ChoK) in eukaryotes. The | 97.76 | |
| cd05152 | 276 | MPH2' Macrolide 2'-Phosphotransferase (MPH2'). MPH | 97.67 | |
| PF13095 | 207 | FTA2: Kinetochore Sim4 complex subunit FTA2 | 97.62 | |
| PLN02421 | 330 | phosphotransferase, alcohol group as acceptor/kina | 97.46 | |
| COG3173 | 321 | Predicted aminoglycoside phosphotransferase [Gener | 97.45 | |
| PLN02236 | 344 | choline kinase | 97.45 | |
| PLN02756 | 418 | S-methyl-5-thioribose kinase | 97.37 | |
| KOG1093 | 725 | consensus Predicted protein kinase (contains TBC a | 97.31 | |
| COG5072 | 488 | ALK1 Serine/threonine kinase of the haspin family | 97.25 | |
| TIGR02904 | 309 | spore_ysxE spore coat protein YsxE. Members of thi | 97.18 | |
| PF03881 | 288 | Fructosamin_kin: Fructosamine kinase; InterPro: IP | 97.17 | |
| PF01633 | 211 | Choline_kinase: Choline/ethanolamine kinase; Inter | 97.16 | |
| TIGR01767 | 370 | MTRK 5-methylthioribose kinase. This enzyme is inv | 97.13 | |
| TIGR02906 | 313 | spore_CotS spore coat protein, CotS family. Member | 96.91 | |
| PRK12396 | 409 | 5-methylribose kinase; Reviewed | 96.87 | |
| KOG1826 | 2724 | consensus Ras GTPase activating protein RasGAP/neu | 96.72 | |
| PTZ00384 | 383 | choline kinase; Provisional | 96.67 | |
| PRK06148 | 1013 | hypothetical protein; Provisional | 96.59 | |
| COG3001 | 286 | Uncharacterized protein conserved in bacteria [Fun | 96.51 | |
| KOG1236 | 565 | consensus Predicted unusual protein kinase [Genera | 96.45 | |
| PRK11768 | 325 | serine/threonine protein kinase; Provisional | 96.39 | |
| PF07387 | 308 | Seadorna_VP7: Seadornavirus VP7; InterPro: IPR0099 | 96.38 | |
| PTZ00296 | 442 | choline kinase; Provisional | 96.26 |
| >KOG0581 consensus Mitogen-activated protein kinase kinase (MAP2K) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.1e-53 Score=343.73 Aligned_cols=256 Identities=27% Similarity=0.442 Sum_probs=221.7
Q ss_pred hCCCCCCceeecCCcceEEEEEeC-CCcEEEEEEeccCcCChhhhHHHHHHHHHHHhcCCcceeeeeeEEEcCCCeeEEE
Q 038766 11 TGSFSENNIIGNSNLSTVYKGRLE-DGEIVAVKKLNFHQFSAESDKSFYREAKTLKELKHRNLVKVLGYAWESGKLKALI 89 (299)
Q Consensus 11 ~~~y~~~~~lg~g~~~~v~~~~~~-~~~~~~vK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~lv 89 (299)
.++....+.||+|..|+||++.++ +++.+|+|++. -...+...+++.+|+++++..+||+|+.++|.|+.++....++
T Consensus 78 ~~dle~~~~lG~G~gG~V~kv~Hk~t~~i~AlK~I~-~~~~~~~~~Qi~rEl~il~~~~spyIV~~ygaF~~~~~~isI~ 156 (364)
T KOG0581|consen 78 LSDLERLGVLGSGNGGTVYKVRHKPTGKIYALKVIL-LNIDPALQKQILRELEILRSCQSPYIVGFYGAFYSNGEEISIC 156 (364)
T ss_pred HHHhhhhhhcccCCCcEEEEEEEcCCCeEEEEEeec-ccCCHHHHHHHHHHHHHHhhCCCCCeeeEeEEEEeCCceEEee
Confidence 347788899999999999999875 58999999994 4567888999999999999999999999999999888656999
Q ss_pred EeecCCCChHHHhcCCCCCCCCCChhhHHHHHHHHHHHHHHhhc-CCCCCeeeecccCCceeeCCCCcEEEeeecccccc
Q 038766 90 LEYMENGSLESVIHGPGVDHSRWTLPKRIDVLISVANGLDYLHS-GYDIPIVHCDMKPSNILLDRDFEAHVSDFGTSRML 168 (299)
Q Consensus 90 ~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lh~-~~~~~~~H~dl~~~nil~~~~~~v~l~df~~~~~~ 168 (299)
||||++|+|..++.. -++++|.....++.++++||.|||+ . +|+||||||+|+|++..|.|||+|||.+..+
T Consensus 157 mEYMDgGSLd~~~k~----~g~i~E~~L~~ia~~VL~GL~YLh~~~---~IIHRDIKPsNlLvNskGeVKicDFGVS~~l 229 (364)
T KOG0581|consen 157 MEYMDGGSLDDILKR----VGRIPEPVLGKIARAVLRGLSYLHEER---KIIHRDIKPSNLLVNSKGEVKICDFGVSGIL 229 (364)
T ss_pred hhhcCCCCHHHHHhh----cCCCCHHHHHHHHHHHHHHHHHHhhcc---CeeeccCCHHHeeeccCCCEEeccccccHHh
Confidence 999999999999984 3689999999999999999999996 6 9999999999999999999999999999865
Q ss_pred ccccccccccccccccCcccCChhhhcccCcCccccchhhhHHHHHHHhCCCCCCCCccCCCCchhHHHHHHHHHhcCcc
Q 038766 169 DVHLQDLSSLSTAFQGTIGYLAPEFAYMRIVTTKVDVFSFGIVVMEFLTKRRPTGLDEENGLSPISLRQLVEKALANGIN 248 (299)
Q Consensus 169 ~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~DiwslG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 248 (299)
- +.......||..|||||.+.+..|+.++||||||++++|++.|..|+... ......+.+.+..+..+..+
T Consensus 230 v------nS~a~tfvGT~~YMsPERi~g~~Ys~~sDIWSLGLsllE~a~GrfP~~~~---~~~~~~~~~Ll~~Iv~~ppP 300 (364)
T KOG0581|consen 230 V------NSIANTFVGTSAYMSPERISGESYSVKSDIWSLGLSLLELAIGRFPYPPP---NPPYLDIFELLCAIVDEPPP 300 (364)
T ss_pred h------hhhcccccccccccChhhhcCCcCCcccceecccHHHHHHhhCCCCCCCc---CCCCCCHHHHHHHHhcCCCC
Confidence 4 33678889999999999999999999999999999999999999998655 22233455556555554433
Q ss_pred CcccccCccccchhhHhHHHHHHHHHHHHHHHHhcCCCCCCCCChhhhhcC
Q 038766 249 GVRQITDPKLVSSIYEEQEQHQVLEELFKLALVCTSSNPEDRPNMNELLIT 299 (299)
Q Consensus 249 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rpt~~~il~~ 299 (299)
.... ...+++++++|.+||+.||.+|||+.|+++|
T Consensus 301 ~lP~----------------~~fS~ef~~FV~~CL~Kdp~~R~s~~qLl~H 335 (364)
T KOG0581|consen 301 RLPE----------------GEFSPEFRSFVSCCLRKDPSERPSAKQLLQH 335 (364)
T ss_pred CCCc----------------ccCCHHHHHHHHHHhcCCcccCCCHHHHhcC
Confidence 3321 1367899999999999999999999999988
|
|
| >KOG0575 consensus Polo-like serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.2e-53 Score=360.77 Aligned_cols=250 Identities=25% Similarity=0.406 Sum_probs=215.2
Q ss_pred CCCCCCceeecCCcceEEEEEe-CCCcEEEEEEeccCcC-ChhhhHHHHHHHHHHHhcCCcceeeeeeEEEcCCCeeEEE
Q 038766 12 GSFSENNIIGNSNLSTVYKGRL-EDGEIVAVKKLNFHQF-SAESDKSFYREAKTLKELKHRNLVKVLGYAWESGKLKALI 89 (299)
Q Consensus 12 ~~y~~~~~lg~g~~~~v~~~~~-~~~~~~~vK~~~~~~~-~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~lv 89 (299)
.+|...++||+|+|+.||.+++ .+|+.||+|++..+.. .+...+.+.+|+++.+.++||||++++++|.+ .+..|+|
T Consensus 18 ~~Y~~g~~LGkGgFA~cYe~~~~~tge~~A~KvVpk~~l~k~~~reKv~~EIeIHr~L~HpnIV~f~~~FED-s~nVYiv 96 (592)
T KOG0575|consen 18 KRYKRGRFLGKGGFARCYEARDLDTGEVVAVKVVPKKLLKKPKQREKVLNEIEIHRSLKHPNIVQFYHFFED-SNNVYIV 96 (592)
T ss_pred ceeeeeeeeccCcceEEEEEEEcCCCcEEEEEEeehHHhcCcchHHHHHHHHHHHHhcCCCcEEeeeeEeec-CCceEEE
Confidence 4699999999999999999998 7899999999976443 44557889999999999999999999995555 5566999
Q ss_pred EeecCCCChHHHhcCCCCCCCCCChhhHHHHHHHHHHHHHHhhcCCCCCeeeecccCCceeeCCCCcEEEeeeccccccc
Q 038766 90 LEYMENGSLESVIHGPGVDHSRWTLPKRIDVLISVANGLDYLHSGYDIPIVHCDMKPSNILLDRDFEAHVSDFGTSRMLD 169 (299)
Q Consensus 90 ~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lh~~~~~~~~H~dl~~~nil~~~~~~v~l~df~~~~~~~ 169 (299)
+|.|..++|..+++ ..++++|.+++.++.||+.||.|||+. +|+|||||..|+|++.+.+|||+|||+++.+.
T Consensus 97 LELC~~~sL~el~K----rrk~ltEpEary~l~QIv~GlkYLH~~---~IiHRDLKLGNlfL~~~~~VKIgDFGLAt~le 169 (592)
T KOG0575|consen 97 LELCHRGSLMELLK----RRKPLTEPEARYFLRQIVEGLKYLHSL---GIIHRDLKLGNLFLNENMNVKIGDFGLATQLE 169 (592)
T ss_pred EEecCCccHHHHHH----hcCCCCcHHHHHHHHHHHHHHHHHHhc---CceecccchhheeecCcCcEEecccceeeeec
Confidence 99999999999998 567999999999999999999999999 99999999999999999999999999999765
Q ss_pred cccccccccccccccCcccCChhhhcccCcCccccchhhhHHHHHHHhCCCCCCCCccCCCCchhHHHHHHHHHhcCccC
Q 038766 170 VHLQDLSSLSTAFQGTIGYLAPEFAYMRIVTTKVDVFSFGIVVMEFLTKRRPTGLDEENGLSPISLRQLVEKALANGING 249 (299)
Q Consensus 170 ~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~DiwslG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 249 (299)
...+...+..|||.|.|||++...+.+..+||||+||++|.|+.|.+||... .+.+.+..+-.+.
T Consensus 170 ----~~~Erk~TlCGTPNYIAPEVl~k~gHsfEvDiWSlGcvmYtLL~G~PPFetk--------~vkety~~Ik~~~--- 234 (592)
T KOG0575|consen 170 ----YDGERKKTLCGTPNYIAPEVLNKSGHSFEVDIWSLGCVMYTLLVGRPPFETK--------TVKETYNKIKLNE--- 234 (592)
T ss_pred ----CcccccceecCCCcccChhHhccCCCCCchhhhhhhhHHHhhhhCCCCcccc--------hHHHHHHHHHhcC---
Confidence 3345667788999999999999999999999999999999999999999432 1223332222111
Q ss_pred cccccCccccchhhHhHHHHHHHHHHHHHHHHhcCCCCCCCCChhhhhcC
Q 038766 250 VRQITDPKLVSSIYEEQEQHQVLEELFKLALVCTSSNPEDRPNMNELLIT 299 (299)
Q Consensus 250 ~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rpt~~~il~~ 299 (299)
...+..++.++.+||.+||+.||.+|||+++||.|
T Consensus 235 ---------------Y~~P~~ls~~A~dLI~~lL~~~P~~Rpsl~~vL~h 269 (592)
T KOG0575|consen 235 ---------------YSMPSHLSAEAKDLIRKLLRPNPSERPSLDEVLDH 269 (592)
T ss_pred ---------------cccccccCHHHHHHHHHHhcCCcccCCCHHHHhcC
Confidence 11245677889999999999999999999999987
|
|
| >KOG0591 consensus NIMA (never in mitosis)-related G2-specific serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-53 Score=334.52 Aligned_cols=257 Identities=24% Similarity=0.381 Sum_probs=216.7
Q ss_pred CCCCCCceeecCCcceEEEEEe-CCCcEEEEEEeccCcCChhhhHHHHHHHHHHHhcCCcceeeeeeEE-EcCCCeeEEE
Q 038766 12 GSFSENNIIGNSNLSTVYKGRL-EDGEIVAVKKLNFHQFSAESDKSFYREAKTLKELKHRNLVKVLGYA-WESGKLKALI 89 (299)
Q Consensus 12 ~~y~~~~~lg~g~~~~v~~~~~-~~~~~~~vK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~-~~~~~~~~lv 89 (299)
.+|++.+.||+|+||+||++.. .+|..+|.|.++....+.........|+.+|+.++||||+++++.- ..+...+++|
T Consensus 19 ~~y~Il~~IG~GsFg~vykv~~~~~g~l~a~K~i~f~~md~k~rq~~v~Ei~lLkQL~HpNIVqYy~~~f~~~~evlniv 98 (375)
T KOG0591|consen 19 ADYQILKKIGRGSFGEVYKVQCLLDGKLVALKKIQFGMMDAKARQDCVKEISLLKQLNHPNIVQYYAHSFIEDNEVLNIV 98 (375)
T ss_pred HHHHHHHHHcCCcchheEEeeeccCcchhhhhhcchhhccHHHHHHHHHHHHHHHhcCCchHHHHHHHhhhccchhhHHH
Confidence 4689999999999999999975 6799999999998777778888899999999999999999999944 4444558999
Q ss_pred EeecCCCChHHHhcCCCCCCCCCChhhHHHHHHHHHHHHHHhhcCCCC-CeeeecccCCceeeCCCCcEEEeeecccccc
Q 038766 90 LEYMENGSLESVIHGPGVDHSRWTLPKRIDVLISVANGLDYLHSGYDI-PIVHCDMKPSNILLDRDFEAHVSDFGTSRML 168 (299)
Q Consensus 90 ~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lh~~~~~-~~~H~dl~~~nil~~~~~~v~l~df~~~~~~ 168 (299)
||++.+|+|..+++..+..+..++|..+|.++.|++.||..+|++++. -+.||||||.||+++.+|.|||+|||++..+
T Consensus 99 mE~c~~GDLsqmIk~~K~qkr~ipE~~Vwk~f~QL~~AL~~cH~~~~r~~VmHRDIKPaNIFl~~~gvvKLGDfGL~r~l 178 (375)
T KOG0591|consen 99 MELCDAGDLSQMIKHFKKQKRLIPEKTVWKYFVQLCRALYHCHSKIPRGTVMHRDIKPANIFLTANGVVKLGDFGLGRFL 178 (375)
T ss_pred HHhhcccCHHHHHHHHHhccccCchHHHHHHHHHHHHHHHHHhccccccceeeccCcchheEEcCCCceeeccchhHhHh
Confidence 999999999999998887889999999999999999999999994331 3999999999999999999999999999987
Q ss_pred ccccccccccccccccCcccCChhhhcccCcCccccchhhhHHHHHHHhCCCCCCCCccCCCCchhHHHHHHHHHhcCcc
Q 038766 169 DVHLQDLSSLSTAFQGTIGYLAPEFAYMRIVTTKVDVFSFGIVVMEFLTKRRPTGLDEENGLSPISLRQLVEKALANGIN 248 (299)
Q Consensus 169 ~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~DiwslG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 248 (299)
+ .........+|||.||+||.+.+.+|+.+|||||+||++|+|+.-.+||.++ +..++...+.+. ..+
T Consensus 179 ~----s~~tfA~S~VGTPyYMSPE~i~~~~Y~~kSDiWslGCllyEMcaL~~PF~g~-----n~~~L~~KI~qg---d~~ 246 (375)
T KOG0591|consen 179 S----SKTTFAHSLVGTPYYMSPERIHESGYNFKSDIWSLGCLLYEMCALQSPFYGD-----NLLSLCKKIEQG---DYP 246 (375)
T ss_pred c----chhHHHHhhcCCCcccCHHHHhcCCCCcchhHHHHHHHHHHHHhcCCCcccc-----cHHHHHHHHHcC---CCC
Confidence 6 2344556788999999999999999999999999999999999999999654 222233322221 111
Q ss_pred CcccccCccccchhhHhHHHHHHHHHHHHHHHHhcCCCCCCCCChhhh
Q 038766 249 GVRQITDPKLVSSIYEEQEQHQVLEELFKLALVCTSSNPEDRPNMNEL 296 (299)
Q Consensus 249 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rpt~~~i 296 (299)
+. ....+|.++.+||.-|+.+||+.||+...+
T Consensus 247 ~~----------------p~~~YS~~l~~li~~ci~vd~~~RP~t~~~ 278 (375)
T KOG0591|consen 247 PL----------------PDEHYSTDLRELINMCIAVDPEQRPDTVPY 278 (375)
T ss_pred CC----------------cHHHhhhHHHHHHHHHccCCcccCCCcchH
Confidence 10 035678899999999999999999986443
|
|
| >KOG0615 consensus Serine/threonine protein kinase Chk2 and related proteins [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-51 Score=337.47 Aligned_cols=259 Identities=25% Similarity=0.371 Sum_probs=209.9
Q ss_pred HHHHhCCCCCCceeecCCcceEEEEEe-CCCcEEEEEEeccCcCCh-----hhhHHHHHHHHHHHhcCCcceeeeeeEEE
Q 038766 7 IENATGSFSENNIIGNSNLSTVYKGRL-EDGEIVAVKKLNFHQFSA-----ESDKSFYREAKTLKELKHRNLVKVLGYAW 80 (299)
Q Consensus 7 ~~~~~~~y~~~~~lg~g~~~~v~~~~~-~~~~~~~vK~~~~~~~~~-----~~~~~~~~e~~~l~~l~h~~i~~~~~~~~ 80 (299)
.+.+.+.|.+.+.||+|+||.|-+|.. ++|+.||||+++...... .....+.+|+++|++++||+|+++++++
T Consensus 167 pks~~d~yii~~~LGsGafg~Vkla~e~~tgk~vAiKIi~krk~~~~s~~~~~~~~v~~EieILkkL~HP~IV~~~d~f- 245 (475)
T KOG0615|consen 167 PKSFNDYYIISKTLGSGAFGLVKLAYEKKTGKQVAIKIINKRKSTGCSRAIAKTRDVQNEIEILKKLSHPNIVRIKDFF- 245 (475)
T ss_pred cchhcceeEeeeeecCCceeEEEEEEEcccCcEEEeeeeehhhcccccccccchhhhHHHHHHHHhcCCCCEEEEeeee-
Confidence 345788999999999999999999976 569999999997543222 1234467999999999999999999955
Q ss_pred cCCCeeEEEEeecCCCChHHHhcCCCCCCCCCChhhHHHHHHHHHHHHHHhhcCCCCCeeeecccCCceeeCCC---CcE
Q 038766 81 ESGKLKALILEYMENGSLESVIHGPGVDHSRWTLPKRIDVLISVANGLDYLHSGYDIPIVHCDMKPSNILLDRD---FEA 157 (299)
Q Consensus 81 ~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lh~~~~~~~~H~dl~~~nil~~~~---~~v 157 (299)
+.....|+|+||++||.|.+.+- .++.+.+..-..++.|++.|+.|||++ ||+||||||+|||++.+ ..+
T Consensus 246 ~~~ds~YmVlE~v~GGeLfd~vv----~nk~l~ed~~K~~f~Qll~avkYLH~~---GI~HRDiKPeNILl~~~~e~~ll 318 (475)
T KOG0615|consen 246 EVPDSSYMVLEYVEGGELFDKVV----ANKYLREDLGKLLFKQLLTAVKYLHSQ---GIIHRDIKPENILLSNDAEDCLL 318 (475)
T ss_pred ecCCceEEEEEEecCccHHHHHH----hccccccchhHHHHHHHHHHHHHHHHc---CcccccCCcceEEeccCCcceEE
Confidence 44556699999999999999987 667888999999999999999999999 99999999999999766 789
Q ss_pred EEeeeccccccccccccccccccccccCcccCChhhhcccCcC---ccccchhhhHHHHHHHhCCCCCCCCccCCCCchh
Q 038766 158 HVSDFGTSRMLDVHLQDLSSLSTAFQGTIGYLAPEFAYMRIVT---TKVDVFSFGIVVMEFLTKRRPTGLDEENGLSPIS 234 (299)
Q Consensus 158 ~l~df~~~~~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~---~~~DiwslG~~l~~l~~g~~p~~~~~~~~~~~~~ 234 (299)
|++|||++.... ....+.+..|||.|.|||++.+.+.. .+.|+|||||++|-+++|.+||+..... ..
T Consensus 319 KItDFGlAK~~g-----~~sfm~TlCGTpsYvAPEVl~~kg~~~~~~kVDiWSlGcvLfvcLsG~pPFS~~~~~----~s 389 (475)
T KOG0615|consen 319 KITDFGLAKVSG-----EGSFMKTLCGTPSYVAPEVLASKGVEYYPSKVDIWSLGCVLFVCLSGYPPFSEEYTD----PS 389 (475)
T ss_pred Eecccchhhccc-----cceehhhhcCCccccChhheecCCeecccchheeeeccceEEEEeccCCCcccccCC----cc
Confidence 999999997643 35678889999999999998876533 4679999999999999999999744221 11
Q ss_pred HHHHHHHHHhcCccCcccccCccccchhhHhHHHHHHHHHHHHHHHHhcCCCCCCCCChhhhhcC
Q 038766 235 LRQLVEKALANGINGVRQITDPKLVSSIYEEQEQHQVLEELFKLALVCTSSNPEDRPNMNELLIT 299 (299)
Q Consensus 235 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rpt~~~il~~ 299 (299)
+.+-+.+ -++.. ....-..++++..+||++||.+||++|||+.++|.|
T Consensus 390 l~eQI~~--------------G~y~f---~p~~w~~Iseea~dlI~~mL~VdP~~R~s~~eaL~h 437 (475)
T KOG0615|consen 390 LKEQILK--------------GRYAF---GPLQWDRISEEALDLINWMLVVDPENRPSADEALNH 437 (475)
T ss_pred HHHHHhc--------------Ccccc---cChhhhhhhHHHHHHHHHhhEeCcccCcCHHHHhcC
Confidence 2221111 01111 112255678899999999999999999999999987
|
|
| >KOG0595 consensus Serine/threonine-protein kinase involved in autophagy [Posttranslational modification, protein turnover, chaperones; Intracellular trafficking, secretion, and vesicular transport; Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-49 Score=325.77 Aligned_cols=204 Identities=30% Similarity=0.504 Sum_probs=184.0
Q ss_pred HHhCCCCCCceeecCCcceEEEEEeC-CCcEEEEEEeccCcCChhhhHHHHHHHHHHHhcCCcceeeeeeEEEcCCCeeE
Q 038766 9 NATGSFSENNIIGNSNLSTVYKGRLE-DGEIVAVKKLNFHQFSAESDKSFYREAKTLKELKHRNLVKVLGYAWESGKLKA 87 (299)
Q Consensus 9 ~~~~~y~~~~~lg~g~~~~v~~~~~~-~~~~~~vK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~ 87 (299)
...++|.+.+.||+|+|++||+++++ ++..||||.+..+.......+.+..|+.+|+.++||||+.+++++. .++..+
T Consensus 7 ~~~~~y~~~~~iG~GsfavVykg~h~~~~~~VAIK~i~~~~l~~k~~e~L~~Ei~iLkel~H~nIV~l~d~~~-~~~~i~ 85 (429)
T KOG0595|consen 7 RVVGDYELSREIGSGSFAVVYKGRHKKSGTEVAIKCIAKKKLNKKLVELLLSEIKILKELKHPNIVRLLDCIE-DDDFIY 85 (429)
T ss_pred cccccceehhhccCcceEEEEEeEeccCCceEEeeeehhhccCHHHHHHHHHHHHHHHhcCCcceeeEEEEEe-cCCeEE
Confidence 34678999999999999999999874 5899999999988888889999999999999999999999999554 466779
Q ss_pred EEEeecCCCChHHHhcCCCCCCCCCChhhHHHHHHHHHHHHHHhhcCCCCCeeeecccCCceeeCCC------CcEEEee
Q 038766 88 LILEYMENGSLESVIHGPGVDHSRWTLPKRIDVLISVANGLDYLHSGYDIPIVHCDMKPSNILLDRD------FEAHVSD 161 (299)
Q Consensus 88 lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lh~~~~~~~~H~dl~~~nil~~~~------~~v~l~d 161 (299)
+|||||+||+|.+++. ..+.+++..+..++.||+.||++||++ +|+||||||+|||++.. ..+||+|
T Consensus 86 lVMEyC~gGDLs~yi~----~~~~l~e~t~r~Fm~QLA~alq~L~~~---~IiHRDLKPQNiLLs~~~~~~~~~~LKIAD 158 (429)
T KOG0595|consen 86 LVMEYCNGGDLSDYIR----RRGRLPEATARHFMQQLASALQFLHEN---NIIHRDLKPQNILLSTTARNDTSPVLKIAD 158 (429)
T ss_pred EEEEeCCCCCHHHHHH----HcCCCCHHHHHHHHHHHHHHHHHHHHC---CeeeccCCcceEEeccCCCCCCCceEEecc
Confidence 9999999999999998 445899999999999999999999999 99999999999999764 4589999
Q ss_pred eccccccccccccccccccccccCcccCChhhhcccCcCccccchhhhHHHHHHHhCCCCCCCC
Q 038766 162 FGTSRMLDVHLQDLSSLSTAFQGTIGYLAPEFAYMRIVTTKVDVFSFGIVVMEFLTKRRPTGLD 225 (299)
Q Consensus 162 f~~~~~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~DiwslG~~l~~l~~g~~p~~~~ 225 (299)
||+++.+. ......+..|++.|||||++....|+.|+|+||+|+++|++++|..||...
T Consensus 159 FGfAR~L~-----~~~~a~tlcGSplYMAPEV~~~~~YdAKADLWSiG~Ilyq~l~g~~Pf~a~ 217 (429)
T KOG0595|consen 159 FGFARFLQ-----PGSMAETLCGSPLYMAPEVIMSQQYDAKADLWSIGTILYQCLTGKPPFDAE 217 (429)
T ss_pred cchhhhCC-----chhHHHHhhCCccccCHHHHHhccccchhhHHHHHHHHHHHHhCCCCcccc
Confidence 99999876 234456778999999999999999999999999999999999999999543
|
|
| >KOG0593 consensus Predicted protein kinase KKIAMRE [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-50 Score=318.25 Aligned_cols=274 Identities=23% Similarity=0.309 Sum_probs=217.2
Q ss_pred CCCCCCceeecCCcceEEEEEeC-CCcEEEEEEeccCcCChhhhHHHHHHHHHHHhcCCcceeeeeeEEEcCCCeeEEEE
Q 038766 12 GSFSENNIIGNSNLSTVYKGRLE-DGEIVAVKKLNFHQFSAESDKSFYREAKTLKELKHRNLVKVLGYAWESGKLKALIL 90 (299)
Q Consensus 12 ~~y~~~~~lg~g~~~~v~~~~~~-~~~~~~vK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~lv~ 90 (299)
++|....++|+|++|+|++++++ +|+.||||++.-+..++...+-..+|+++|++++|+|++.++++|....+. ++|+
T Consensus 2 ekYE~LgkvGEGSYGvV~KCrnk~TgqIVAIKkF~Esedd~~VkKIAlREIrmLKqLkH~NLVnLiEVFrrkrkl-hLVF 80 (396)
T KOG0593|consen 2 EKYEKLGKVGEGSYGVVMKCRNKDTGQIVAIKKFVESEDDPVVKKIALREIRMLKQLKHENLVNLIEVFRRKRKL-HLVF 80 (396)
T ss_pred cHHhhhhccccCcceEEEEeccCCcccEEEEEeeccCCccHHHHHHHHHHHHHHHhcccchHHHHHHHHHhccee-EEEe
Confidence 67889999999999999999975 499999999987766677778889999999999999999999988776655 9999
Q ss_pred eecCCCChHHHhcCCCCCCCCCChhhHHHHHHHHHHHHHHhhcCCCCCeeeecccCCceeeCCCCcEEEeeecccccccc
Q 038766 91 EYMENGSLESVIHGPGVDHSRWTLPKRIDVLISVANGLDYLHSGYDIPIVHCDMKPSNILLDRDFEAHVSDFGTSRMLDV 170 (299)
Q Consensus 91 e~~~~~~L~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lh~~~~~~~~H~dl~~~nil~~~~~~v~l~df~~~~~~~~ 170 (299)
||++. ++.+.++. .....+.+.+.+++.|++.|+.|+|++ +++||||||+|||++.+|.+||+|||+++.+..
T Consensus 81 E~~dh-TvL~eLe~---~p~G~~~~~vk~~l~Q~l~ai~~cHk~---n~IHRDIKPENILit~~gvvKLCDFGFAR~L~~ 153 (396)
T KOG0593|consen 81 EYCDH-TVLHELER---YPNGVPSELVKKYLYQLLKAIHFCHKN---NCIHRDIKPENILITQNGVVKLCDFGFARTLSA 153 (396)
T ss_pred eecch-HHHHHHHh---ccCCCCHHHHHHHHHHHHHHhhhhhhc---CeecccCChhheEEecCCcEEeccchhhHhhcC
Confidence 99977 66555554 335788999999999999999999999 999999999999999999999999999987662
Q ss_pred ccccccccccccccCcccCChhhhcc-cCcCccccchhhhHHHHHHHhCCCCCCCCccCCCCch-------hHHHHHHHH
Q 038766 171 HLQDLSSLSTAFQGTIGYLAPEFAYM-RIVTTKVDVFSFGIVVMEFLTKRRPTGLDEENGLSPI-------SLRQLVEKA 242 (299)
Q Consensus 171 ~~~~~~~~~~~~~~~~~y~~PE~~~~-~~~~~~~DiwslG~~l~~l~~g~~p~~~~~~~~~~~~-------~~~~~~~~~ 242 (299)
.+..++..+.|.+|.|||++.+ ..|....||||+||++.||++|.+.|.+...-+...- .+...+...
T Consensus 154 ----pgd~YTDYVATRWYRaPELLvGDtqYG~pVDiWAiGCv~aEl~~G~pL~PG~SDiDQLy~I~ktLG~L~prhq~iF 229 (396)
T KOG0593|consen 154 ----PGDNYTDYVATRWYRAPELLVGDTQYGKPVDIWAIGCVFAELLTGEPLWPGRSDIDQLYLIRKTLGNLIPRHQSIF 229 (396)
T ss_pred ----CcchhhhhhhhhhccChhhhcccCcCCCcccchhhhHHHHHHhcCCcCCCCcchHHHHHHHHHHHcccCHHHHHHh
Confidence 4556677788999999999888 6799999999999999999999999965532211100 000111111
Q ss_pred HhcCccCcccccCccccchhhHhHHHHHHHHHHHHHHHHhcCCCCCCCCChhhhhcC
Q 038766 243 LANGINGVRQITDPKLVSSIYEEQEQHQVLEELFKLALVCTSSNPEDRPNMNELLIT 299 (299)
Q Consensus 243 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rpt~~~il~~ 299 (299)
..+.....-.++.+..++.. +.....++.-+.+++++||..||++|++.+|+|.|
T Consensus 230 ~~N~~F~Gv~lP~~~~~epL--e~k~p~~s~~~ld~~k~cL~~dP~~R~sc~qll~H 284 (396)
T KOG0593|consen 230 SSNPFFHGVRLPEPEHPEPL--ERKYPKISNVLLDLLKKCLKMDPDDRLSCEQLLHH 284 (396)
T ss_pred ccCCceeeeecCCCCCccch--hhhcccchHHHHHHHHHHhcCCccccccHHHHhcC
Confidence 11222222233333333332 22356667789999999999999999999999987
|
|
| >KOG0661 consensus MAPK related serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-50 Score=335.33 Aligned_cols=272 Identities=22% Similarity=0.333 Sum_probs=216.6
Q ss_pred HHHHhCCCCCCceeecCCcceEEEEEe-CCCcEEEEEEeccCcCChhhhHHHHHHHHHHHhcC-CcceeeeeeEEEcCCC
Q 038766 7 IENATGSFSENNIIGNSNLSTVYKGRL-EDGEIVAVKKLNFHQFSAESDKSFYREAKTLKELK-HRNLVKVLGYAWESGK 84 (299)
Q Consensus 7 ~~~~~~~y~~~~~lg~g~~~~v~~~~~-~~~~~~~vK~~~~~~~~~~~~~~~~~e~~~l~~l~-h~~i~~~~~~~~~~~~ 84 (299)
+-.+.++|.+.++||.|+||+||+|+. .+|+.||||.++.+....+ ...-.+|+..|++++ ||||+++.+++.++..
T Consensus 5 ~~~~m~RY~~i~klGDGTfGsV~la~~~~~~~~VAIK~MK~Kf~s~e-e~~nLREvksL~kln~hpniikL~Evi~d~~~ 83 (538)
T KOG0661|consen 5 QVIFMDRYTVIRKLGDGTFGSVYLAKSKETGELVAIKKMKKKFYSWE-ECMNLREVKSLRKLNPHPNIIKLKEVIRDNDR 83 (538)
T ss_pred ehhHHHHHHHHHHhcCCcceeEEEeeecCCCceeeHHHHHhhhccHH-HHHHHHHHHHHHhcCCCCcchhhHHHhhccCc
Confidence 346789999999999999999999985 5699999999986554433 333458999999998 9999999999998887
Q ss_pred eeEEEEeecCCCChHHHhcCCCCCCCCCChhhHHHHHHHHHHHHHHhhcCCCCCeeeecccCCceeeCCCCcEEEeeecc
Q 038766 85 LKALILEYMENGSLESVIHGPGVDHSRWTLPKRIDVLISVANGLDYLHSGYDIPIVHCDMKPSNILLDRDFEAHVSDFGT 164 (299)
Q Consensus 85 ~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lh~~~~~~~~H~dl~~~nil~~~~~~v~l~df~~ 164 (299)
.+++||||| ..+|..+++. .+..+++..+..|+.||+++|+++|.+ |+.|||+||+|||++....+||+|||+
T Consensus 84 ~L~fVfE~M-d~NLYqLmK~---R~r~fse~~irnim~QilqGL~hiHk~---GfFHRDlKPENiLi~~~~~iKiaDFGL 156 (538)
T KOG0661|consen 84 ILYFVFEFM-DCNLYQLMKD---RNRLFSESDIRNIMYQILQGLAHIHKH---GFFHRDLKPENILISGNDVIKIADFGL 156 (538)
T ss_pred eEeeeHHhh-hhhHHHHHhh---cCCcCCHHHHHHHHHHHHHHHHHHHhc---CcccccCChhheEecccceeEeccccc
Confidence 899999999 5599999985 367999999999999999999999999 999999999999999888999999999
Q ss_pred ccccccccccccccccccccCcccCChhhhc-ccCcCccccchhhhHHHHHHHhCCCCCCCCccCCCCchhHHHHHHHHH
Q 038766 165 SRMLDVHLQDLSSLSTAFQGTIGYLAPEFAY-MRIVTTKVDVFSFGIVVMEFLTKRRPTGLDEENGLSPISLRQLVEKAL 243 (299)
Q Consensus 165 ~~~~~~~~~~~~~~~~~~~~~~~y~~PE~~~-~~~~~~~~DiwslG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~ 243 (299)
++.... ....+..+.|.+|+|||++. ...|+.+.|+|++||+++|+++-++.|.+..+-+ ++..+.+.
T Consensus 157 ARev~S-----kpPYTeYVSTRWYRAPEvLLrs~~Ys~pvD~wA~GcI~aEl~sLrPLFPG~sE~D----qi~KIc~V-- 225 (538)
T KOG0661|consen 157 AREVRS-----KPPYTEYVSTRWYRAPEVLLRSGYYSSPVDMWAVGCIMAELYSLRPLFPGASEID----QIYKICEV-- 225 (538)
T ss_pred cccccc-----CCCcchhhhcccccchHHhhhccccCCchHHHHHHHHHHHHHHhcccCCCCcHHH----HHHHHHHH--
Confidence 997652 34566778899999999655 6679999999999999999999999996553211 11112111
Q ss_pred hcCccCcccc------------cCccccchhhHhHHHHHHHHHHHHHHHHhcCCCCCCCCChhhhhcC
Q 038766 244 ANGINGVRQI------------TDPKLVSSIYEEQEQHQVLEELFKLALVCTSSNPEDRPNMNELLIT 299 (299)
Q Consensus 244 ~~~~~~~~~~------------~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rpt~~~il~~ 299 (299)
.+.+....+ ..+...........+. .+.++.++|.+||++||.+||||+++|+|
T Consensus 226 -LGtP~~~~~~eg~~La~~mnf~~P~~~~~~l~~L~p~-~s~~~~~li~~ll~WDP~kRpTA~~al~~ 291 (538)
T KOG0661|consen 226 -LGTPDKDSWPEGYNLASAMNFRFPQVKPSPLKDLLPN-ASSEAASLIERLLAWDPDKRPTASQALQH 291 (538)
T ss_pred -hCCCccccchhHHHHHHHhccCCCcCCCCChHHhCcc-cCHHHHHHHHHHhcCCCccCccHHHHhcC
Confidence 122121111 1122222222222233 78899999999999999999999999987
|
|
| >KOG0598 consensus Ribosomal protein S6 kinase and related proteins [General function prediction only; Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-48 Score=316.31 Aligned_cols=252 Identities=25% Similarity=0.352 Sum_probs=208.2
Q ss_pred HhCCCCCCceeecCCcceEEEEEeC-CCcEEEEEEeccCcCChh-hhHHHHHHHHHHHhcCCcceeeeeeEEEcCCCeeE
Q 038766 10 ATGSFSENNIIGNSNLSTVYKGRLE-DGEIVAVKKLNFHQFSAE-SDKSFYREAKTLKELKHRNLVKVLGYAWESGKLKA 87 (299)
Q Consensus 10 ~~~~y~~~~~lg~g~~~~v~~~~~~-~~~~~~vK~~~~~~~~~~-~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~ 87 (299)
-.++|.+.+.||+|+||.|+.++.+ +++.||+|+++...+... ..+....|..+|.+++||+|++++-.|.. ...+|
T Consensus 23 ~~~dF~~lkviGkG~fGkV~~Vrk~dt~kiYAmKvl~K~~iv~~~e~~~~~~Er~IL~~v~hPFiv~l~ysFQt-~~kLy 101 (357)
T KOG0598|consen 23 GPDDFEILKVIGKGSFGKVFQVRKKDTGKIYAMKVLKKKKIVEKKEVRHTKAERNILSKIKHPFIVKLIYSFQT-EEKLY 101 (357)
T ss_pred ChhheeeeeeeeccCCceEEEEEEcccCceeehhhhhhhHhhhhhhHHHHHHHHHHHHhCCCCcEeeeEEeccc-CCeEE
Confidence 3689999999999999999999864 599999999987655443 67889999999999999999999986655 55569
Q ss_pred EEEeecCCCChHHHhcCCCCCCCCCChhhHHHHHHHHHHHHHHhhcCCCCCeeeecccCCceeeCCCCcEEEeeeccccc
Q 038766 88 LILEYMENGSLESVIHGPGVDHSRWTLPKRIDVLISVANGLDYLHSGYDIPIVHCDMKPSNILLDRDFEAHVSDFGTSRM 167 (299)
Q Consensus 88 lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lh~~~~~~~~H~dl~~~nil~~~~~~v~l~df~~~~~ 167 (299)
+|+||+.||.|...++ ....++|..+..++..|+.||.|||++ +|+||||||+|||++.+|+++|+|||+|..
T Consensus 102 lVld~~~GGeLf~hL~----~eg~F~E~~arfYlaEi~lAL~~LH~~---gIiyRDlKPENILLd~~GHi~LtDFgL~k~ 174 (357)
T KOG0598|consen 102 LVLDYLNGGELFYHLQ----REGRFSEDRARFYLAEIVLALGYLHSK---GIIYRDLKPENILLDEQGHIKLTDFGLCKE 174 (357)
T ss_pred EEEeccCCccHHHHHH----hcCCcchhHHHHHHHHHHHHHHHHHhC---CeeeccCCHHHeeecCCCcEEEeccccchh
Confidence 9999999999999998 566899999999999999999999999 999999999999999999999999999974
Q ss_pred cccccccccccccccccCcccCChhhhcccCcCccccchhhhHHHHHHHhCCCCCCCCccCCCCchhHHHHHHHHHhcCc
Q 038766 168 LDVHLQDLSSLSTAFQGTIGYLAPEFAYMRIVTTKVDVFSFGIVVMEFLTKRRPTGLDEENGLSPISLRQLVEKALANGI 247 (299)
Q Consensus 168 ~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~DiwslG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 247 (299)
.- ..........||+.|||||++...+|+..+|-||||+++|+|++|.+||.... . ..+.+.+.....
T Consensus 175 ~~----~~~~~t~tfcGT~eYmAPEil~~~gy~~~vDWWsLGillYeML~G~pPF~~~~-----~---~~~~~~I~~~k~ 242 (357)
T KOG0598|consen 175 DL----KDGDATRTFCGTPEYMAPEILLGKGYDKAVDWWSLGILLYEMLTGKPPFYAED-----V---KKMYDKILKGKL 242 (357)
T ss_pred cc----cCCCccccccCCccccChHHHhcCCCCcccchHhHHHHHHHHhhCCCCCcCcc-----H---HHHHHHHhcCcC
Confidence 32 22344556789999999999999999999999999999999999999995442 1 222222222110
Q ss_pred cCcccccCccccchhhHhHHHHHHHHHHHHHHHHhcCCCCCCCC----Chhhhhc
Q 038766 248 NGVRQITDPKLVSSIYEEQEQHQVLEELFKLALVCTSSNPEDRP----NMNELLI 298 (299)
Q Consensus 248 ~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rp----t~~~il~ 298 (299)
.. . +...+.+.+++++++|..||++|. ++++|-+
T Consensus 243 ~~-----~------------p~~ls~~ardll~~LL~rdp~~RLg~~~d~~~ik~ 280 (357)
T KOG0598|consen 243 PL-----P------------PGYLSEEARDLLKKLLKRDPRQRLGGPGDAEEIKR 280 (357)
T ss_pred CC-----C------------CccCCHHHHHHHHHHhccCHHHhcCCCCChHHhhc
Confidence 00 0 223567899999999999999996 4554443
|
|
| >KOG0600 consensus Cdc2-related protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-47 Score=321.88 Aligned_cols=271 Identities=25% Similarity=0.319 Sum_probs=218.7
Q ss_pred hCCCCCCceeecCCcceEEEEEe-CCCcEEEEEEeccCcCChhhhHHHHHHHHHHHhcCCcceeeeeeEEEcC-CCeeEE
Q 038766 11 TGSFSENNIIGNSNLSTVYKGRL-EDGEIVAVKKLNFHQFSAESDKSFYREAKTLKELKHRNLVKVLGYAWES-GKLKAL 88 (299)
Q Consensus 11 ~~~y~~~~~lg~g~~~~v~~~~~-~~~~~~~vK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~-~~~~~l 88 (299)
.+.|...++||+|.||.||+|++ .+|+.||+|.+......+.....+.+|+.+|+++.||||+++.+.+.+. ....|+
T Consensus 116 ~~~feki~kIGeGTyg~VYkAr~~~tgkivALKKvr~d~~~~~~~~t~~REI~ILr~l~HpNIikL~eivt~~~~~siYl 195 (560)
T KOG0600|consen 116 ADSFEKIEKIGEGTYGQVYKARDLETGKIVALKKVRFDNEKEGFPITAIREIKILRRLDHPNIIKLEEIVTSKLSGSIYL 195 (560)
T ss_pred hHHHHHHHHhcCcchhheeEeeecccCcEEEEEEeecccCCCcchHHHHHHHHHHHhcCCCcccceeeEEEecCCceEEE
Confidence 45677889999999999999986 5699999999999888888889999999999999999999999988876 567799
Q ss_pred EEeecCCCChHHHhcCCCCCCCCCChhhHHHHHHHHHHHHHHhhcCCCCCeeeecccCCceeeCCCCcEEEeeecccccc
Q 038766 89 ILEYMENGSLESVIHGPGVDHSRWTLPKRIDVLISVANGLDYLHSGYDIPIVHCDMKPSNILLDRDFEAHVSDFGTSRML 168 (299)
Q Consensus 89 v~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lh~~~~~~~~H~dl~~~nil~~~~~~v~l~df~~~~~~ 168 (299)
|+|||+. +|.-++... .-.|++.++..++.|++.||.|+|.+ ++.|||||..|||++.+|++||+|||+++.+
T Consensus 196 VFeYMdh-DL~GLl~~p---~vkft~~qIKc~mkQLl~Gl~~cH~~---gvlHRDIK~SNiLidn~G~LKiaDFGLAr~y 268 (560)
T KOG0600|consen 196 VFEYMDH-DLSGLLSSP---GVKFTEPQIKCYMKQLLEGLEYCHSR---GVLHRDIKGSNILIDNNGVLKIADFGLARFY 268 (560)
T ss_pred EEecccc-hhhhhhcCC---CcccChHHHHHHHHHHHHHHHHHhhc---CeeeccccccceEEcCCCCEEeccccceeec
Confidence 9999976 898888632 34899999999999999999999999 9999999999999999999999999999977
Q ss_pred ccccccccccccccccCcccCChhhhccc-CcCccccchhhhHHHHHHHhCCCCCCCCccCCCCchhHHHHHHHHHhcCc
Q 038766 169 DVHLQDLSSLSTAFQGTIGYLAPEFAYMR-IVTTKVDVFSFGIVVMEFLTKRRPTGLDEENGLSPISLRQLVEKALANGI 247 (299)
Q Consensus 169 ~~~~~~~~~~~~~~~~~~~y~~PE~~~~~-~~~~~~DiwslG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 247 (299)
.. ......+..+.|.+|.|||++.+. .|+...|+||.|||+.||+.|.+.|.+..+ .+-.+.+...+. .
T Consensus 269 ~~---~~~~~~T~rVvTLWYRpPELLLG~t~Yg~aVDlWS~GCIl~El~~gkPI~~G~tE-----veQl~kIfklcG--S 338 (560)
T KOG0600|consen 269 TP---SGSAPYTSRVVTLWYRPPELLLGATSYGTAVDLWSVGCILAELFLGKPILQGRTE-----VEQLHKIFKLCG--S 338 (560)
T ss_pred cC---CCCcccccceEEeeccChHHhcCCcccccceeehhhhHHHHHHHcCCCCcCCccH-----HHHHHHHHHHhC--C
Confidence 63 333446777889999999999986 599999999999999999999999865422 222222222222 1
Q ss_pred cCcccccCc--------cccc---hhhHhHHHHHHHHHHHHHHHHhcCCCCCCCCChhhhhcC
Q 038766 248 NGVRQITDP--------KLVS---SIYEEQEQHQVLEELFKLALVCTSSNPEDRPNMNELLIT 299 (299)
Q Consensus 248 ~~~~~~~~~--------~~~~---~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rpt~~~il~~ 299 (299)
+....+... +... .... .....++....+|+..||..||.+|.||.++|+|
T Consensus 339 P~e~~W~~~kLP~~~~~kp~~~y~r~l~-E~~~~~~~~~l~Ll~~lL~ldP~kR~tA~~aL~s 400 (560)
T KOG0600|consen 339 PTEDYWPVSKLPHATIFKPQQPYKRRLR-ETFKDFPASALDLLEKLLSLDPDKRGTASSALQS 400 (560)
T ss_pred CChhccccccCCcccccCCCCcccchHH-HHhccCCHHHHHHHHHHhccCccccccHHHHhcC
Confidence 111111100 0000 1111 1256677889999999999999999999999976
|
|
| >KOG0592 consensus 3-phosphoinositide-dependent protein kinase (PDK1) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.2e-48 Score=326.70 Aligned_cols=255 Identities=25% Similarity=0.345 Sum_probs=208.7
Q ss_pred hCCCCCCceeecCCcceEEEEEe-CCCcEEEEEEeccCcC-ChhhhHHHHHHHHHHHhc-CCcceeeeeeEEEcCCCeeE
Q 038766 11 TGSFSENNIIGNSNLSTVYKGRL-EDGEIVAVKKLNFHQF-SAESDKSFYREAKTLKEL-KHRNLVKVLGYAWESGKLKA 87 (299)
Q Consensus 11 ~~~y~~~~~lg~g~~~~v~~~~~-~~~~~~~vK~~~~~~~-~~~~~~~~~~e~~~l~~l-~h~~i~~~~~~~~~~~~~~~ 87 (299)
..+|..++.||.|+|++|++|+. .+++.||||++...-+ .....+.+..|-..|.+| .||+|++++-.|.+.. .+|
T Consensus 72 ~~DF~Fg~~lGeGSYStV~~A~~~~t~keYAiKVl~K~~Iike~KvkYV~~Ek~~l~~L~~hPgivkLy~TFQD~~-sLY 150 (604)
T KOG0592|consen 72 PNDFKFGKILGEGSYSTVVLAREKATGKEYAIKVLDKRYIIKEKKVKYVTREKEALTQLSGHPGIVKLYFTFQDEE-SLY 150 (604)
T ss_pred hhhcchhheeccccceeEEEeeecCCCceeeHhhhhHHHHHhhcccchhhHHHHHHHHhhCCCCeEEEEEEeeccc-ceE
Confidence 46899999999999999999986 4699999999864322 233345677899999999 6999999999766655 559
Q ss_pred EEEeecCCCChHHHhcCCCCCCCCCChhhHHHHHHHHHHHHHHhhcCCCCCeeeecccCCceeeCCCCcEEEeeeccccc
Q 038766 88 LILEYMENGSLESVIHGPGVDHSRWTLPKRIDVLISVANGLDYLHSGYDIPIVHCDMKPSNILLDRDFEAHVSDFGTSRM 167 (299)
Q Consensus 88 lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lh~~~~~~~~H~dl~~~nil~~~~~~v~l~df~~~~~ 167 (299)
+|+||.++|.|.++|+.. +.+++..+..++.+|+.||+|||+. ||+||||||+|||+|.++.++|+|||.+..
T Consensus 151 FvLe~A~nGdll~~i~K~----Gsfde~caR~YAAeIldAleylH~~---GIIHRDlKPENILLd~dmhikITDFGsAK~ 223 (604)
T KOG0592|consen 151 FVLEYAPNGDLLDLIKKY----GSFDETCARFYAAEILDALEYLHSN---GIIHRDLKPENILLDKDGHIKITDFGSAKI 223 (604)
T ss_pred EEEEecCCCcHHHHHHHh----CcchHHHHHHHHHHHHHHHHHHHhc---CceeccCChhheeEcCCCcEEEeecccccc
Confidence 999999999999999955 4899999999999999999999999 999999999999999999999999999987
Q ss_pred ccccccc---------ccccccccccCcccCChhhhcccCcCccccchhhhHHHHHHHhCCCCCCCCccCCCCchhHHHH
Q 038766 168 LDVHLQD---------LSSLSTAFQGTIGYLAPEFAYMRIVTTKVDVFSFGIVVMEFLTKRRPTGLDEENGLSPISLRQL 238 (299)
Q Consensus 168 ~~~~~~~---------~~~~~~~~~~~~~y~~PE~~~~~~~~~~~DiwslG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~ 238 (299)
+...... .......++||-.|++||++.+...+..+|||+|||++|+|+.|.+||... ++......
T Consensus 224 l~~~~~~~~~~~~~~~a~s~~~SFVGTAeYVSPElL~~~~~~~~sDiWAlGCilyQmlaG~PPFra~-----NeyliFqk 298 (604)
T KOG0592|consen 224 LSPSQKSQENPVDPNQASSRRSSFVGTAEYVSPELLNDSPAGPSSDLWALGCILYQMLAGQPPFRAA-----NEYLIFQK 298 (604)
T ss_pred CChhhccccCccCcccccCcccceeeeecccCHHHhcCCCCCcccchHHHHHHHHHHhcCCCCCccc-----cHHHHHHH
Confidence 7543222 111225688999999999999999999999999999999999999999533 22222221
Q ss_pred HHHHHhcCccCcccccCccccchhhHhHHHHHHHHHHHHHHHHhcCCCCCCCCChhhhhcC
Q 038766 239 VEKALANGINGVRQITDPKLVSSIYEEQEQHQVLEELFKLALVCTSSNPEDRPNMNELLIT 299 (299)
Q Consensus 239 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rpt~~~il~~ 299 (299)
+.... . ..+.++++.+.+||+++|..||++|+|+++|-+|
T Consensus 299 ---I~~l~---------y---------~fp~~fp~~a~dLv~KLLv~dp~~Rlt~~qIk~H 338 (604)
T KOG0592|consen 299 ---IQALD---------Y---------EFPEGFPEDARDLIKKLLVRDPSDRLTSQQIKAH 338 (604)
T ss_pred ---HHHhc---------c---------cCCCCCCHHHHHHHHHHHccCccccccHHHHhhC
Confidence 11100 0 0134455789999999999999999999999887
|
|
| >KOG0198 consensus MEKK and related serine/threonine protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-47 Score=315.39 Aligned_cols=257 Identities=28% Similarity=0.460 Sum_probs=204.1
Q ss_pred hCCCCCCceeecCCcceEEEEEeC-CCcEEEEEEeccCcCChhhhHHHHHHHHHHHhcCCcceeeeeeEEEcCCC-eeEE
Q 038766 11 TGSFSENNIIGNSNLSTVYKGRLE-DGEIVAVKKLNFHQFSAESDKSFYREAKTLKELKHRNLVKVLGYAWESGK-LKAL 88 (299)
Q Consensus 11 ~~~y~~~~~lg~g~~~~v~~~~~~-~~~~~~vK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~-~~~l 88 (299)
..+|...+.||+|+||+||++... +|...|||.+.... ....+.+.+|+.+|++++||||++++|....... .+++
T Consensus 16 ~~~~~~~~~lG~Gs~G~V~l~~~~~~g~~~AvK~v~~~~--~~~~~~l~~Ei~iL~~l~~p~IV~~~G~~~~~~~~~~~i 93 (313)
T KOG0198|consen 16 ISNWSKGKLLGRGSFGSVYLATNKKTGELMAVKSVELED--SPTSESLEREIRILSRLNHPNIVQYYGSSSSRENDEYNI 93 (313)
T ss_pred cchhhhhccccCccceEEEEEEecCCCcceeeeeeeccc--chhHHHHHHHHHHHHhCCCCCEEeeCCccccccCeeeEe
Confidence 456889999999999999999865 48999999987652 1226778999999999999999999995343343 6799
Q ss_pred EEeecCCCChHHHhcCCCCCCCCCChhhHHHHHHHHHHHHHHhhcCCCCCeeeecccCCceeeCC-CCcEEEeeeccccc
Q 038766 89 ILEYMENGSLESVIHGPGVDHSRWTLPKRIDVLISVANGLDYLHSGYDIPIVHCDMKPSNILLDR-DFEAHVSDFGTSRM 167 (299)
Q Consensus 89 v~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lh~~~~~~~~H~dl~~~nil~~~-~~~v~l~df~~~~~ 167 (299)
.|||+.+|+|.+++...+ + +++++.+..++.||+++|+|||++ +++|+||||+|||++. ++.+||+|||++..
T Consensus 94 ~mEy~~~GsL~~~~~~~g--~-~l~E~~v~~ytr~iL~GL~ylHs~---g~vH~DiK~~NiLl~~~~~~~KlaDFG~a~~ 167 (313)
T KOG0198|consen 94 FMEYAPGGSLSDLIKRYG--G-KLPEPLVRRYTRQILEGLAYLHSK---GIVHCDIKPANILLDPSNGDVKLADFGLAKK 167 (313)
T ss_pred eeeccCCCcHHHHHHHcC--C-CCCHHHHHHHHHHHHHHHHHHHhC---CEeccCcccceEEEeCCCCeEEeccCccccc
Confidence 999999999999998553 1 799999999999999999999999 9999999999999999 79999999999876
Q ss_pred cccccccccccccccccCcccCChhhhccc-CcCccccchhhhHHHHHHHhCCCCCCCCccCCCCchhHHHHHHHHHhcC
Q 038766 168 LDVHLQDLSSLSTAFQGTIGYLAPEFAYMR-IVTTKVDVFSFGIVVMEFLTKRRPTGLDEENGLSPISLRQLVEKALANG 246 (299)
Q Consensus 168 ~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~-~~~~~~DiwslG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~ 246 (299)
... ............||+.|+|||+.... ....++|||||||++.+|+||..||... ......+.......
T Consensus 168 ~~~-~~~~~~~~~~~~Gtp~~maPEvi~~g~~~~~~sDiWSlGCtVvEM~Tg~~PW~~~-------~~~~~~~~~ig~~~ 239 (313)
T KOG0198|consen 168 LES-KGTKSDSELSVQGTPNYMAPEVIRNGEVARRESDIWSLGCTVVEMLTGKPPWSEF-------FEEAEALLLIGRED 239 (313)
T ss_pred ccc-ccccccccccccCCccccCchhhcCCCcCCccchhhhcCCEEEeccCCCCcchhh-------cchHHHHHHHhccC
Confidence 553 11122234457799999999998863 3335999999999999999999998532 11111111111111
Q ss_pred ccCcccccCccccchhhHhHHHHHHHHHHHHHHHHhcCCCCCCCCChhhhhcC
Q 038766 247 INGVRQITDPKLVSSIYEEQEQHQVLEELFKLALVCTSSNPEDRPNMNELLIT 299 (299)
Q Consensus 247 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rpt~~~il~~ 299 (299)
... ..+..++.++.+++++|+..+|++||||+++|+|
T Consensus 240 --~~P--------------~ip~~ls~~a~~Fl~~C~~~~p~~Rpta~eLL~h 276 (313)
T KOG0198|consen 240 --SLP--------------EIPDSLSDEAKDFLRKCFKRDPEKRPTAEELLEH 276 (313)
T ss_pred --CCC--------------CCCcccCHHHHHHHHHHhhcCcccCcCHHHHhhC
Confidence 011 1144567889999999999999999999999987
|
|
| >KOG0192 consensus Tyrosine kinase specific for activated (GTP-bound) p21cdc42Hs [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.2e-47 Score=321.09 Aligned_cols=260 Identities=32% Similarity=0.504 Sum_probs=211.4
Q ss_pred HHHHHhCCCCCCceeecCCcceEEEEEeCCCcEEEEEEeccCcCChhhhHHHHHHHHHHHhcCCcceeeeeeEEEcCCCe
Q 038766 6 EIENATGSFSENNIIGNSNLSTVYKGRLEDGEIVAVKKLNFHQFSAESDKSFYREAKTLKELKHRNLVKVLGYAWESGKL 85 (299)
Q Consensus 6 ~~~~~~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~vK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~ 85 (299)
++++-.+...+.+.||+|+||+||++.+.....||+|++..........+.+.+|+.+|.+++||||++++|++......
T Consensus 35 ~~~i~~~~l~~~~~iG~G~~g~V~~~~~~g~~~vavK~~~~~~~~~~~~~~f~~E~~il~~l~HpNIV~f~G~~~~~~~~ 114 (362)
T KOG0192|consen 35 EEEIDPDELPIEEVLGSGSFGTVYKGKWRGTDVVAVKIISDPDFDDESRKAFRREASLLSRLRHPNIVQFYGACTSPPGS 114 (362)
T ss_pred ceecChHHhhhhhhcccCCceeEEEEEeCCceeEEEEEecchhcChHHHHHHHHHHHHHHhCCCCCeeeEEEEEcCCCCc
Confidence 45555667777888999999999999998555599999987666666688999999999999999999999988776546
Q ss_pred eEEEEeecCCCChHHHhcCCCCCCCCCChhhHHHHHHHHHHHHHHhhcCCCCC-eeeecccCCceeeCCCC-cEEEeeec
Q 038766 86 KALILEYMENGSLESVIHGPGVDHSRWTLPKRIDVLISVANGLDYLHSGYDIP-IVHCDMKPSNILLDRDF-EAHVSDFG 163 (299)
Q Consensus 86 ~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lh~~~~~~-~~H~dl~~~nil~~~~~-~v~l~df~ 163 (299)
+++|+||+++|+|..++... ....++...+..++.+|+.|+.|||+. + ++|+||||+|+|++.++ ++||+|||
T Consensus 115 ~~iVtEy~~~GsL~~~l~~~--~~~~l~~~~~l~~aldiArGm~YLH~~---~~iIHrDLK~~NiLv~~~~~~~KI~DFG 189 (362)
T KOG0192|consen 115 LCIVTEYMPGGSLSVLLHKK--RKRKLPLKVRLRIALDIARGMEYLHSE---GPIIHRDLKSDNILVDLKGKTLKIADFG 189 (362)
T ss_pred eEEEEEeCCCCcHHHHHhhc--ccCCCCHHHHHHHHHHHHHHHHHHhcC---CCeeecccChhhEEEcCCCCEEEECCCc
Confidence 79999999999999999743 367899999999999999999999999 8 99999999999999998 99999999
Q ss_pred cccccccccccccccccccccCcccCChhhhc--ccCcCccccchhhhHHHHHHHhCCCCCCCCccCCCCchhHHHHHHH
Q 038766 164 TSRMLDVHLQDLSSLSTAFQGTIGYLAPEFAY--MRIVTTKVDVFSFGIVVMEFLTKRRPTGLDEENGLSPISLRQLVEK 241 (299)
Q Consensus 164 ~~~~~~~~~~~~~~~~~~~~~~~~y~~PE~~~--~~~~~~~~DiwslG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~ 241 (299)
+++...... ...+...||+.|||||++. ...++.++||||+|+++|+|++|..||... .... .+..
T Consensus 190 lsr~~~~~~----~~~~~~~GT~~wMAPEv~~~~~~~~~~K~DvySFgIvlWEl~t~~~Pf~~~-----~~~~---~~~~ 257 (362)
T KOG0192|consen 190 LSREKVISK----TSMTSVAGTYRWMAPEVLRGEKSPYTEKSDVYSFGIVLWELLTGEIPFEDL-----APVQ---VASA 257 (362)
T ss_pred cceeecccc----ccccCCCCCccccChhhhcCCCCcCCccchhhhHHHHHHHHHHCCCCCCCC-----CHHH---HHHH
Confidence 998644211 2334467899999999999 568999999999999999999999999533 2222 2222
Q ss_pred HHhcCccCcccccCccccchhhHhHHHHHHHHHHHHHHHHhcCCCCCCCCChhhhhc
Q 038766 242 ALANGINGVRQITDPKLVSSIYEEQEQHQVLEELFKLALVCTSSNPEDRPNMNELLI 298 (299)
Q Consensus 242 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rpt~~~il~ 298 (299)
....+.+. .+ +...++.+..|+.+||..||++||++.+++.
T Consensus 258 v~~~~~Rp--~~--------------p~~~~~~l~~l~~~CW~~dp~~RP~f~ei~~ 298 (362)
T KOG0192|consen 258 VVVGGLRP--PI--------------PKECPPHLSSLMERCWLVDPSRRPSFLEIVS 298 (362)
T ss_pred HHhcCCCC--CC--------------CccCCHHHHHHHHHhCCCCCCcCCCHHHHHH
Confidence 22111111 11 1224567899999999999999999999874
|
|
| >KOG0583 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.7e-47 Score=325.26 Aligned_cols=253 Identities=26% Similarity=0.364 Sum_probs=209.6
Q ss_pred HHhCCCCCCceeecCCcceEEEEEe-CCCcEEEEEEeccCcCC---hhhhHHHHHHHHHHHhcC-CcceeeeeeEEEcCC
Q 038766 9 NATGSFSENNIIGNSNLSTVYKGRL-EDGEIVAVKKLNFHQFS---AESDKSFYREAKTLKELK-HRNLVKVLGYAWESG 83 (299)
Q Consensus 9 ~~~~~y~~~~~lg~g~~~~v~~~~~-~~~~~~~vK~~~~~~~~---~~~~~~~~~e~~~l~~l~-h~~i~~~~~~~~~~~ 83 (299)
...++|.+.+.||+|+||.|+++.+ .++..||+|++...... ....+.+.+|+.++++++ ||||+++++++....
T Consensus 14 ~~~g~y~~~~~lG~GsfgkV~~a~~~~t~~~vAiKii~~~~~~~~~~~~~~~i~rEi~~~~~~~~HpnI~~l~ev~~t~~ 93 (370)
T KOG0583|consen 14 LSIGKYELGRTLGSGSFGKVKLAKHRLTGEKVAIKIIDRKKVSSKSQKLDELIKREISILRRLRSHPNIIRLLEVFATPT 93 (370)
T ss_pred cccCceeeeeeecCCCCeeEEEeeeccCCCeEEEEEechhcccccccccchhhHHHHHHHHHhccCCCEeEEEEEEecCC
Confidence 4567999999999999999999976 56899999987654222 234667789999999999 999999999776655
Q ss_pred CeeEEEEeecCCCChHHHhcCCCCCCCCCChhhHHHHHHHHHHHHHHhhcCCCCCeeeecccCCceeeCCC-CcEEEeee
Q 038766 84 KLKALILEYMENGSLESVIHGPGVDHSRWTLPKRIDVLISVANGLDYLHSGYDIPIVHCDMKPSNILLDRD-FEAHVSDF 162 (299)
Q Consensus 84 ~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lh~~~~~~~~H~dl~~~nil~~~~-~~v~l~df 162 (299)
+ .++||||+.||.|.+.+. ...+++|.++..+++|+++|++|+|+. +++||||||+|++++.+ +++||+||
T Consensus 94 ~-~~ivmEy~~gGdL~~~i~----~~g~l~E~~ar~~F~Qlisav~y~H~~---gi~HRDLK~ENilld~~~~~~Kl~DF 165 (370)
T KOG0583|consen 94 K-IYIVMEYCSGGDLFDYIV----NKGRLKEDEARKYFRQLISAVAYCHSR---GIVHRDLKPENILLDGNEGNLKLSDF 165 (370)
T ss_pred e-EEEEEEecCCccHHHHHH----HcCCCChHHHHHHHHHHHHHHHHHHhC---CEeeCCCCHHHEEecCCCCCEEEecc
Confidence 5 699999999999999997 457899999999999999999999999 99999999999999999 99999999
Q ss_pred ccccccccccccccccccccccCcccCChhhhcccC-cC-ccccchhhhHHHHHHHhCCCCCCCCccCCCCchhHHHHHH
Q 038766 163 GTSRMLDVHLQDLSSLSTAFQGTIGYLAPEFAYMRI-VT-TKVDVFSFGIVVMEFLTKRRPTGLDEENGLSPISLRQLVE 240 (299)
Q Consensus 163 ~~~~~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~-~~-~~~DiwslG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~ 240 (299)
|++.... ..........|++.|+|||++.+.. |+ .++||||+|+++|.|++|..||... .......
T Consensus 166 G~s~~~~----~~~~~l~t~cGsp~Y~aPEvl~~~~~Y~g~~aDvWS~GViLy~ml~G~~PF~d~--------~~~~l~~ 233 (370)
T KOG0583|consen 166 GLSAISP----GEDGLLKTFCGSPAYAAPEVLSGKGTYSGKAADVWSLGVILYVLLCGRLPFDDS--------NVPNLYR 233 (370)
T ss_pred ccccccC----CCCCcccCCCCCcccCCHHHhCCCCCcCCchhhhhhhHHHHHHHHhCCCCCCCc--------cHHHHHH
Confidence 9998653 2345667788999999999999987 76 6899999999999999999999542 1222222
Q ss_pred HHHhcCccCcccccCccccchhhHhHHHHHH-HHHHHHHHHHhcCCCCCCCCChhhhhcC
Q 038766 241 KALANGINGVRQITDPKLVSSIYEEQEQHQV-LEELFKLALVCTSSNPEDRPNMNELLIT 299 (299)
Q Consensus 241 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~l~~li~~~l~~dP~~Rpt~~~il~~ 299 (299)
. +..+... .+..+ +.++..|+++||..||.+|+|+.++++|
T Consensus 234 k-i~~~~~~-----------------~p~~~~S~~~~~Li~~mL~~~P~~R~t~~~i~~h 275 (370)
T KOG0583|consen 234 K-IRKGEFK-----------------IPSYLLSPEARSLIEKMLVPDPSTRITLLEILEH 275 (370)
T ss_pred H-HhcCCcc-----------------CCCCcCCHHHHHHHHHHcCCCcccCCCHHHHhhC
Confidence 2 1111111 12233 6789999999999999999999999976
|
|
| >KOG0659 consensus Cdk activating kinase (CAK)/RNA polymerase II transcription initiation/nucleotide excision repair factor TFIIH/TFIIK, kinase subunit CDK7 [Cell cycle control, cell division, chromosome partitioning; Transcription; Replication, recombination and repair] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-46 Score=292.77 Aligned_cols=272 Identities=24% Similarity=0.320 Sum_probs=214.5
Q ss_pred CCCCCCceeecCCcceEEEEEe-CCCcEEEEEEeccCcCChhhhHHHHHHHHHHHhcCCcceeeeeeEEEcCCCeeEEEE
Q 038766 12 GSFSENNIIGNSNLSTVYKGRL-EDGEIVAVKKLNFHQFSAESDKSFYREAKTLKELKHRNLVKVLGYAWESGKLKALIL 90 (299)
Q Consensus 12 ~~y~~~~~lg~g~~~~v~~~~~-~~~~~~~vK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~lv~ 90 (299)
++|...++||+|.||+||+|++ .+|+.||||.+..............+|++.|+.++|+||+.++++|.. ...+.+|+
T Consensus 2 ~rY~~~~~lGEG~~gvVyka~d~~t~~~VAIKKIkl~~~kdGi~~talREIK~Lqel~h~nIi~LiD~F~~-~~~l~lVf 80 (318)
T KOG0659|consen 2 DRYEKLEKLGEGTYGVVYKARDTETGKRVAIKKIKLGNAKDGINRTALREIKLLQELKHPNIIELIDVFPH-KSNLSLVF 80 (318)
T ss_pred chhhhhhhhcCcceEEEEEEEecCCCcEEEEEEeeccccccCccHHHHHHHHHHHHccCcchhhhhhhccC-CCceEEEE
Confidence 5789999999999999999986 579999999999877777777889999999999999999999997665 44559999
Q ss_pred eecCCCChHHHhcCCCCCCCCCChhhHHHHHHHHHHHHHHhhcCCCCCeeeecccCCceeeCCCCcEEEeeecccccccc
Q 038766 91 EYMENGSLESVIHGPGVDHSRWTLPKRIDVLISVANGLDYLHSGYDIPIVHCDMKPSNILLDRDFEAHVSDFGTSRMLDV 170 (299)
Q Consensus 91 e~~~~~~L~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lh~~~~~~~~H~dl~~~nil~~~~~~v~l~df~~~~~~~~ 170 (299)
||++. +|...++. ..-.++...+..++.+++.+++|+|++ .+.||||||.|+|++.+|.+|++|||+++.+..
T Consensus 81 Efm~t-dLe~vIkd---~~i~l~pa~iK~y~~m~LkGl~y~H~~---~IlHRDlKPnNLLis~~g~lKiADFGLAr~f~~ 153 (318)
T KOG0659|consen 81 EFMPT-DLEVVIKD---KNIILSPADIKSYMLMTLKGLAYCHSK---WILHRDLKPNNLLISSDGQLKIADFGLARFFGS 153 (318)
T ss_pred Eeccc-cHHHHhcc---cccccCHHHHHHHHHHHHHHHHHHHhh---hhhcccCCccceEEcCCCcEEeecccchhccCC
Confidence 99965 99999973 456889999999999999999999999 999999999999999999999999999998763
Q ss_pred ccccccccccccccCcccCChhhhccc-CcCccccchhhhHHHHHHHhCCCCCCCCccCCCCchhHHHHHHHHH---hcC
Q 038766 171 HLQDLSSLSTAFQGTIGYLAPEFAYMR-IVTTKVDVFSFGIVVMEFLTKRRPTGLDEENGLSPISLRQLVEKAL---ANG 246 (299)
Q Consensus 171 ~~~~~~~~~~~~~~~~~y~~PE~~~~~-~~~~~~DiwslG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~---~~~ 246 (299)
. .......+.|.+|.|||++.+. .|....|+||.||++.||+-|.+.|.+.++ ..++...+.... ...
T Consensus 154 p----~~~~~~~V~TRWYRAPELLfGsr~Yg~~VDmWavGCI~AELllr~P~fpG~sD----idQL~~If~~LGTP~~~~ 225 (318)
T KOG0659|consen 154 P----NRIQTHQVVTRWYRAPELLFGSRQYGTGVDMWAVGCIFAELLLRVPFFPGDSD----IDQLSKIFRALGTPTPDQ 225 (318)
T ss_pred C----CcccccceeeeeccChHHhccchhcCCcchhhhHHHHHHHHHccCCCCCCCch----HHHHHHHHHHcCCCCccc
Confidence 2 2223333678999999988875 589999999999999999999877754421 111222222211 133
Q ss_pred ccCcccccCccccchhh---HhHHHHHHHHHHHHHHHHhcCCCCCCCCChhhhhcC
Q 038766 247 INGVRQITDPKLVSSIY---EEQEQHQVLEELFKLALVCTSSNPEDRPNMNELLIT 299 (299)
Q Consensus 247 ~~~~~~~~~~~~~~~~~---~~~~~~~~~~~l~~li~~~l~~dP~~Rpt~~~il~~ 299 (299)
|+++..+++........ ........++++.+|+.+|+..||.+|+|+.|+|+|
T Consensus 226 WP~~~~lpdY~~~~~~P~~~~~~lf~aas~d~ldLl~~m~~ynP~~Rita~qaL~~ 281 (318)
T KOG0659|consen 226 WPEMTSLPDYVKIQQFPKPPLNNLFPAASSDALDLLSKMLTYNPKKRITASQALKH 281 (318)
T ss_pred CccccccccHHHHhcCCCCccccccccccHHHHHHHHhhhccCchhcccHHHHhcc
Confidence 33444443322221111 112345567788999999999999999999999987
|
|
| >KOG0582 consensus Ste20-like serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-46 Score=312.00 Aligned_cols=272 Identities=24% Similarity=0.350 Sum_probs=219.6
Q ss_pred HHHHHHhCCCCCCceeecCCcceEEEEEe-CCCcEEEEEEeccCcCChhhhHHHHHHHHHHHhcCCcceeeeeeEEEcCC
Q 038766 5 TEIENATGSFSENNIIGNSNLSTVYKGRL-EDGEIVAVKKLNFHQFSAESDKSFYREAKTLKELKHRNLVKVLGYAWESG 83 (299)
Q Consensus 5 ~~~~~~~~~y~~~~~lg~g~~~~v~~~~~-~~~~~~~vK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~ 83 (299)
.++....+.|.+...||.|..++||+|.. ..++.||||++.....+.+ .+.+++|++.++.+.||||+..+..|.. +
T Consensus 19 ~~~p~n~~~YeL~e~IG~G~sa~V~~A~c~p~~e~VAIK~inLEkc~~~-ld~l~kE~~~msl~~HPNIv~~~~sFvv-~ 96 (516)
T KOG0582|consen 19 KEFPLNAKDYELQEVIGVGASAVVYLARCIPTNEVVAIKIINLEKCNND-LDALRKEVQTMSLIDHPNIVTYHCSFVV-D 96 (516)
T ss_pred ccCCCCccceeEEEEEeccceeEeeeeeecccCCEEEEEEeehhhhhhh-HHHHHHHHHHhhhcCCCCcceEEEEEEe-c
Confidence 44566788999999999999999999985 4579999999987665554 8999999999999999999999996655 6
Q ss_pred CeeEEEEeecCCCChHHHhcCCCCCCCCCChhhHHHHHHHHHHHHHHhhcCCCCCeeeecccCCceeeCCCCcEEEeeec
Q 038766 84 KLKALILEYMENGSLESVIHGPGVDHSRWTLPKRIDVLISVANGLDYLHSGYDIPIVHCDMKPSNILLDRDFEAHVSDFG 163 (299)
Q Consensus 84 ~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lh~~~~~~~~H~dl~~~nil~~~~~~v~l~df~ 163 (299)
..+++||.+|.+|++.++++.. -...++|..+..|+.+++.||.|||++ |.+|||||+.|||++.+|.|+|+|||
T Consensus 97 ~~LWvVmpfMa~GS~ldIik~~--~~~Gl~E~~Ia~iLre~LkaL~YLH~~---G~IHRdvKAgnILi~~dG~VkLadFg 171 (516)
T KOG0582|consen 97 SELWVVMPFMAGGSLLDIIKTY--YPDGLEEASIATILREVLKALDYLHQN---GHIHRDVKAGNILIDSDGTVKLADFG 171 (516)
T ss_pred ceeEEeehhhcCCcHHHHHHHH--ccccccHHHHHHHHHHHHHHHHHHHhc---CceecccccccEEEcCCCcEEEcCce
Confidence 6779999999999999999765 344599999999999999999999999 99999999999999999999999999
Q ss_pred cccccccccccccccccccccCcccCChhhhcc--cCcCccccchhhhHHHHHHHhCCCCCCCCccCCCCchhHHHHHHH
Q 038766 164 TSRMLDVHLQDLSSLSTAFQGTIGYLAPEFAYM--RIVTTKVDVFSFGIVVMEFLTKRRPTGLDEENGLSPISLRQLVEK 241 (299)
Q Consensus 164 ~~~~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~--~~~~~~~DiwslG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~ 241 (299)
.+..+-..............++++|+|||++.. .+|+.|+||||+|++..||.+|..||.. +.+++ ++-.
T Consensus 172 vsa~l~~~G~R~~~rf~tfvgtp~wmAPEvl~q~~~GYdfKaDIwSfGITA~ELA~G~aPf~k-----~pPmk---vLl~ 243 (516)
T KOG0582|consen 172 VSASLFDSGDRQVTRFNTFVGTPCWMAPEVLMQQLHGYDFKADIWSFGITACELAHGHAPFSK-----YPPMK---VLLL 243 (516)
T ss_pred eeeeecccCceeeEeeccccCcccccChHHhhhcccCccchhhhhhhhHHHHHHhcCCCCccc-----CChHH---HHHH
Confidence 988765433322333367789999999998543 5799999999999999999999999942 23222 2222
Q ss_pred HHhcCccCcccccCccccchhhHhHHHHHHHHHHHHHHHHhcCCCCCCCCChhhhhcC
Q 038766 242 ALANGINGVRQITDPKLVSSIYEEQEQHQVLEELFKLALVCTSSNPEDRPNMNELLIT 299 (299)
Q Consensus 242 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rpt~~~il~~ 299 (299)
.+.+..+.... ..........++..++++|..||..||++|||++++|+|
T Consensus 244 tLqn~pp~~~t--------~~~~~d~~k~~~ksf~e~i~~CL~kDP~kRptAskLlkh 293 (516)
T KOG0582|consen 244 TLQNDPPTLLT--------SGLDKDEDKKFSKSFREMIALCLVKDPSKRPTASKLLKH 293 (516)
T ss_pred HhcCCCCCccc--------ccCChHHhhhhcHHHHHHHHHHhhcCcccCCCHHHHhcc
Confidence 22222211110 011122356677799999999999999999999999987
|
|
| >KOG0578 consensus p21-activated serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.1e-47 Score=321.18 Aligned_cols=251 Identities=27% Similarity=0.405 Sum_probs=212.3
Q ss_pred hCCCCCCceeecCCcceEEEEEe-CCCcEEEEEEeccCcCChhhhHHHHHHHHHHHhcCCcceeeeeeEEEcCCCeeEEE
Q 038766 11 TGSFSENNIIGNSNLSTVYKGRL-EDGEIVAVKKLNFHQFSAESDKSFYREAKTLKELKHRNLVKVLGYAWESGKLKALI 89 (299)
Q Consensus 11 ~~~y~~~~~lg~g~~~~v~~~~~-~~~~~~~vK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~lv 89 (299)
...|....+||+|..|.||.|.. .+++.||||++... .....+-+.+|+.+|+..+|+||+.+++.++.. ..+++|
T Consensus 272 ~~~y~~~~kigqgaSG~vy~A~~~~~~~~VaiK~m~l~--~Q~~keLilnEi~Vm~~~~H~NiVnfl~Sylv~-deLWVV 348 (550)
T KOG0578|consen 272 RSKYTDFKKIGQGATGGVYVARKISTKQEVAIKRMDLR--KQPKKELLLNEILVMRDLHHPNIVNFLDSYLVG-DELWVV 348 (550)
T ss_pred hhhhcchhhhccccccceeeeeeccCCceEEEEEEEec--cCCchhhhHHHHHHHHhccchHHHHHHHHhccc-ceeEEE
Confidence 36788999999999999999975 56889999999743 344566788999999999999999999977765 566999
Q ss_pred EeecCCCChHHHhcCCCCCCCCCChhhHHHHHHHHHHHHHHhhcCCCCCeeeecccCCceeeCCCCcEEEeeeccccccc
Q 038766 90 LEYMENGSLESVIHGPGVDHSRWTLPKRIDVLISVANGLDYLHSGYDIPIVHCDMKPSNILLDRDFEAHVSDFGTSRMLD 169 (299)
Q Consensus 90 ~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lh~~~~~~~~H~dl~~~nil~~~~~~v~l~df~~~~~~~ 169 (299)
|||++||+|.+.+. ...++|.++..++..+++||+|||.+ +++|+|||.+|||++.+|.+||+|||+|..+.
T Consensus 349 MEym~ggsLTDvVt-----~~~~~E~qIA~Icre~l~aL~fLH~~---gIiHrDIKSDnILL~~~g~vKltDFGFcaqi~ 420 (550)
T KOG0578|consen 349 MEYMEGGSLTDVVT-----KTRMTEGQIAAICREILQGLKFLHAR---GIIHRDIKSDNILLTMDGSVKLTDFGFCAQIS 420 (550)
T ss_pred EeecCCCchhhhhh-----cccccHHHHHHHHHHHHHHHHHHHhc---ceeeeccccceeEeccCCcEEEeeeeeeeccc
Confidence 99999999999995 45699999999999999999999999 99999999999999999999999999998766
Q ss_pred cccccccccccccccCcccCChhhhcccCcCccccchhhhHHHHHHHhCCCCCCCCccCCCCchhHHHHHHHHHhcCccC
Q 038766 170 VHLQDLSSLSTAFQGTIGYLAPEFAYMRIVTTKVDVFSFGIVVMEFLTKRRPTGLDEENGLSPISLRQLVEKALANGING 249 (299)
Q Consensus 170 ~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~DiwslG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 249 (299)
. ........+|||.|||||+.....|..+.||||||+++.||+.|.+||-. +..+.... .+..++.+.
T Consensus 421 ~----~~~KR~TmVGTPYWMAPEVvtrk~YG~KVDIWSLGIMaIEMveGEPPYln-------E~PlrAly-LIa~ng~P~ 488 (550)
T KOG0578|consen 421 E----EQSKRSTMVGTPYWMAPEVVTRKPYGPKVDIWSLGIMAIEMVEGEPPYLN-------ENPLRALY-LIATNGTPK 488 (550)
T ss_pred c----ccCccccccCCCCccchhhhhhcccCccccchhhhhHHHHHhcCCCCccC-------CChHHHHH-HHhhcCCCC
Confidence 2 22356677899999999999999999999999999999999999999842 22222222 222233222
Q ss_pred cccccCccccchhhHhHHHHHHHHHHHHHHHHhcCCCCCCCCChhhhhcC
Q 038766 250 VRQITDPKLVSSIYEEQEQHQVLEELFKLALVCTSSNPEDRPNMNELLIT 299 (299)
Q Consensus 250 ~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rpt~~~il~~ 299 (299)
+. .+..++..+.+++++||..||.+|+|+.++|+|
T Consensus 489 lk---------------~~~klS~~~kdFL~~cL~~dv~~RasA~eLL~H 523 (550)
T KOG0578|consen 489 LK---------------NPEKLSPELKDFLDRCLVVDVEQRASAKELLEH 523 (550)
T ss_pred cC---------------CccccCHHHHHHHHHHhhcchhcCCCHHHHhcC
Confidence 22 156677899999999999999999999999998
|
|
| >KOG1187 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-45 Score=312.79 Aligned_cols=282 Identities=40% Similarity=0.690 Sum_probs=228.3
Q ss_pred CCChHHHHHHhCCCCCCceeecCCcceEEEEEeCCCcEEEEEEeccCcCChhhhHHHHHHHHHHHhcCCcceeeeeeEEE
Q 038766 1 RFDRTEIENATGSFSENNIIGNSNLSTVYKGRLEDGEIVAVKKLNFHQFSAESDKSFYREAKTLKELKHRNLVKVLGYAW 80 (299)
Q Consensus 1 ~~~~~~~~~~~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~vK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~ 80 (299)
.|++++++..++.|.-.+.||+|+||.||++...+|..||||++....... ...+.+|+..+.+++|||+++++|+|.
T Consensus 64 ~fs~~el~~AT~~Fs~~~~ig~Ggfg~VYkG~l~~~~~vAVK~~~~~~~~~--~~eF~~Ei~~ls~l~H~Nlv~LlGyC~ 141 (361)
T KOG1187|consen 64 SFSYDELRKATNNFSESNLIGEGGFGTVYKGVLSDGTVVAVKRLSSNSGQG--EREFLNEVEILSRLRHPNLVKLLGYCL 141 (361)
T ss_pred eeeHHHHHHHHhCCchhcceecCCCeEEEEEEECCCCEEEEEEecCCCCcc--hhHHHHHHHHHhcCCCcCcccEEEEEe
Confidence 389999999999999999999999999999999888999999876433221 445999999999999999999999999
Q ss_pred cCCCeeEEEEeecCCCChHHHhcCCCCCCCCCChhhHHHHHHHHHHHHHHhhcCCCCCeeeecccCCceeeCCCCcEEEe
Q 038766 81 ESGKLKALILEYMENGSLESVIHGPGVDHSRWTLPKRIDVLISVANGLDYLHSGYDIPIVHCDMKPSNILLDRDFEAHVS 160 (299)
Q Consensus 81 ~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lh~~~~~~~~H~dl~~~nil~~~~~~v~l~ 160 (299)
+.+...++|+||+..|+|.+.+...... +++...+.+|+.++|.||+|||..+...++|||||+.|||+|.+.+.||+
T Consensus 142 e~~~~~~LVYEym~nGsL~d~L~~~~~~--~L~W~~R~kIa~g~A~gL~yLH~~~~~~iiHrDiKssNILLD~~~~aKls 219 (361)
T KOG1187|consen 142 EGGEHRLLVYEYMPNGSLEDHLHGKKGE--PLDWETRLKIALGAARGLAYLHEGCPPPIIHRDIKSSNILLDEDFNAKLS 219 (361)
T ss_pred cCCceEEEEEEccCCCCHHHHhCCCCCC--CCCHHHHHHHHHHHHHHHHHHccCCCCCEecCCCCHHHeeECCCCCEEcc
Confidence 8775569999999999999998754322 88999999999999999999999865579999999999999999999999
Q ss_pred eecccccccccccccccccccc-ccCcccCChhhhcccCcCccccchhhhHHHHHHHhCCCCCCCCccCCCCchhHHHHH
Q 038766 161 DFGTSRMLDVHLQDLSSLSTAF-QGTIGYLAPEFAYMRIVTTKVDVFSFGIVVMEFLTKRRPTGLDEENGLSPISLRQLV 239 (299)
Q Consensus 161 df~~~~~~~~~~~~~~~~~~~~-~~~~~y~~PE~~~~~~~~~~~DiwslG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~ 239 (299)
|||++...... ....... .+|.+|++||+......+.++||||+|+++.+|++|+.+.+.... .....+.++.
T Consensus 220 DFGLa~~~~~~----~~~~~~~~~gt~gY~~PEy~~~g~lt~KsDVySFGVvllElitgr~~~d~~~~--~~~~~l~~w~ 293 (361)
T KOG1187|consen 220 DFGLAKLGPEG----DTSVSTTVMGTFGYLAPEYASTGKLTEKSDVYSFGVVLLELITGRKAVDQSRP--RGELSLVEWA 293 (361)
T ss_pred CccCcccCCcc----ccceeeecCCCCccCChhhhccCCcCcccccccchHHHHHHHhCCcccCCCCC--cccccHHHHH
Confidence 99999543210 1111111 789999999999999999999999999999999999988765431 1122245555
Q ss_pred HHHHhcCccCcccccCcccc-chhhHhHHHHHHHHHHHHHHHHhcCCCCCCCCChhhhhc
Q 038766 240 EKALANGINGVRQITDPKLV-SSIYEEQEQHQVLEELFKLALVCTSSNPEDRPNMNELLI 298 (299)
Q Consensus 240 ~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rpt~~~il~ 298 (299)
......+ ....+.++... ..+.. ......+..+..+|++.+|.+||++.||++
T Consensus 294 ~~~~~~~--~~~eiiD~~l~~~~~~~----~~~~~~~~~~a~~C~~~~~~~RP~m~~Vv~ 347 (361)
T KOG1187|consen 294 KPLLEEG--KLREIVDPRLKEGEYPD----EKEVKKLAELALRCLRPDPKERPTMSQVVK 347 (361)
T ss_pred HHHHHCc--chhheeCCCccCCCCCh----HHHHHHHHHHHHHHcCcCCCcCcCHHHHHH
Confidence 5555544 67777777765 22211 134455889999999999999999999864
|
|
| >KOG0588 consensus Serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.8e-47 Score=326.50 Aligned_cols=251 Identities=24% Similarity=0.353 Sum_probs=214.5
Q ss_pred HhCCCCCCceeecCCcceEEEEEe-CCCcEEEEEEeccC-cCChhhhHHHHHHHHHHHhcCCcceeeeeeEEEcCCCeeE
Q 038766 10 ATGSFSENNIIGNSNLSTVYKGRL-EDGEIVAVKKLNFH-QFSAESDKSFYREAKTLKELKHRNLVKVLGYAWESGKLKA 87 (299)
Q Consensus 10 ~~~~y~~~~~lg~g~~~~v~~~~~-~~~~~~~vK~~~~~-~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~ 87 (299)
..+-|.+++.||.|+.|.|-+|++ .+|+..|||++... .........+.+|+-+|+.+.|||++.+++ +|++...+|
T Consensus 10 tiGpwkLgkTLG~Gstg~vrlakh~~TGqlaaiKii~k~~~~s~s~~~~IerEIviMkLi~HpnVl~Lyd-Vwe~~~~ly 88 (786)
T KOG0588|consen 10 TIGPWKLGKTLGKGSTGCVRLAKHAETGQLAAIKIIPKRSELSSSQPAGIEREIVIMKLIEHPNVLRLYD-VWENKQHLY 88 (786)
T ss_pred cccceeccccccCCCCceehhhhcccccceeEEEeeccccccccccccchhhhhHHHHHhcCCCeeeeee-eeccCceEE
Confidence 346689999999999999999987 56999999999765 344455678889999999999999999999 677788889
Q ss_pred EEEeecCCCChHHHhcCCCCCCCCCChhhHHHHHHHHHHHHHHhhcCCCCCeeeecccCCceeeCCCCcEEEeeeccccc
Q 038766 88 LILEYMENGSLESVIHGPGVDHSRWTLPKRIDVLISVANGLDYLHSGYDIPIVHCDMKPSNILLDRDFEAHVSDFGTSRM 167 (299)
Q Consensus 88 lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lh~~~~~~~~H~dl~~~nil~~~~~~v~l~df~~~~~ 167 (299)
+|.||+++|-|.+++- .++++++.++++++.||+.|+.|+|.. ++||||+||+|+|++..+++||+|||++..
T Consensus 89 lvlEyv~gGELFdylv----~kG~l~e~eaa~ff~QIi~gv~yCH~~---~icHRDLKpENlLLd~~~nIKIADFGMAsL 161 (786)
T KOG0588|consen 89 LVLEYVPGGELFDYLV----RKGPLPEREAAHFFRQILDGVSYCHAF---NICHRDLKPENLLLDVKNNIKIADFGMASL 161 (786)
T ss_pred EEEEecCCchhHHHHH----hhCCCCCHHHHHHHHHHHHHHHHHhhh---cceeccCCchhhhhhcccCEeeeccceeec
Confidence 9999999999999887 567999999999999999999999999 999999999999999999999999999975
Q ss_pred cccccccccccccccccCcccCChhhhcccCcCc-cccchhhhHHHHHHHhCCCCCCCCccCCCCchhHHHHHHHHHhcC
Q 038766 168 LDVHLQDLSSLSTAFQGTIGYLAPEFAYMRIVTT-KVDVFSFGIVVMEFLTKRRPTGLDEENGLSPISLRQLVEKALANG 246 (299)
Q Consensus 168 ~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~-~~DiwslG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~ 246 (299)
...+..-.+..|+|.|++||+..+..|+. ++||||.|++||.|++|..||+.+ +.. ..+.+...
T Consensus 162 -----e~~gklLeTSCGSPHYA~PEIV~G~pYdG~~sDVWSCGVILfALLtG~LPFdDd-----Nir---~LLlKV~~-- 226 (786)
T KOG0588|consen 162 -----EVPGKLLETSCGSPHYAAPEIVSGRPYDGRPSDVWSCGVILFALLTGKLPFDDD-----NIR---VLLLKVQR-- 226 (786)
T ss_pred -----ccCCccccccCCCcccCCchhhcCCCCCCCccccchhHHHHHHHHhCCCCCCCc-----cHH---HHHHHHHc--
Confidence 23456667788999999999999998864 899999999999999999999522 222 22222211
Q ss_pred ccCcccccCccccchhhHhHHHHHHHHHHHHHHHHhcCCCCCCCCChhhhhcC
Q 038766 247 INGVRQITDPKLVSSIYEEQEQHQVLEELFKLALVCTSSNPEDRPNMNELLIT 299 (299)
Q Consensus 247 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rpt~~~il~~ 299 (299)
+...++..++.++++||++||.+||+.|.|++||++|
T Consensus 227 ----------------G~f~MPs~Is~eaQdLLr~ml~VDp~~RiT~~eI~kH 263 (786)
T KOG0588|consen 227 ----------------GVFEMPSNISSEAQDLLRRMLDVDPSTRITTEEILKH 263 (786)
T ss_pred ----------------CcccCCCcCCHHHHHHHHHHhccCccccccHHHHhhC
Confidence 1112256778899999999999999999999999998
|
|
| >KOG0197 consensus Tyrosine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.4e-47 Score=322.57 Aligned_cols=257 Identities=30% Similarity=0.481 Sum_probs=211.2
Q ss_pred hHHHHHHhCCCCCCceeecCCcceEEEEEeCCCcEEEEEEeccCcCChhhhHHHHHHHHHHHhcCCcceeeeeeEEEcCC
Q 038766 4 RTEIENATGSFSENNIIGNSNLSTVYKGRLEDGEIVAVKKLNFHQFSAESDKSFYREAKTLKELKHRNLVKVLGYAWESG 83 (299)
Q Consensus 4 ~~~~~~~~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~vK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~ 83 (299)
++.|+.-.+.++.++.||+|.||.||.+.+.....||+|.+... ....+.+.+|+++|++++|++|+++++++...+
T Consensus 198 ~d~wei~r~~l~l~~~LG~G~FG~V~~g~~~~~~~vavk~ik~~---~m~~~~f~~Ea~iMk~L~H~~lV~l~gV~~~~~ 274 (468)
T KOG0197|consen 198 RDPWEIPREELKLIRELGSGQFGEVWLGKWNGSTKVAVKTIKEG---SMSPEAFLREAQIMKKLRHEKLVKLYGVCTKQE 274 (468)
T ss_pred cCCeeecHHHHHHHHHhcCCccceEEEEEEcCCCcccceEEecc---ccChhHHHHHHHHHHhCcccCeEEEEEEEecCC
Confidence 45566777778889999999999999999988889999999743 344567779999999999999999999887755
Q ss_pred CeeEEEEeecCCCChHHHhcCCCCCCCCCChhhHHHHHHHHHHHHHHhhcCCCCCeeeecccCCceeeCCCCcEEEeeec
Q 038766 84 KLKALILEYMENGSLESVIHGPGVDHSRWTLPKRIDVLISVANGLDYLHSGYDIPIVHCDMKPSNILLDRDFEAHVSDFG 163 (299)
Q Consensus 84 ~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lh~~~~~~~~H~dl~~~nil~~~~~~v~l~df~ 163 (299)
.++||+||++.|+|.+++... .+..+...+.+.++.|||+|++||+++ ++|||||...||||+.++.+|++|||
T Consensus 275 -piyIVtE~m~~GsLl~yLr~~--~~~~l~~~~Ll~~a~qIaeGM~YLes~---~~IHRDLAARNiLV~~~~~vKIsDFG 348 (468)
T KOG0197|consen 275 -PIYIVTEYMPKGSLLDYLRTR--EGGLLNLPQLLDFAAQIAEGMAYLESK---NYIHRDLAARNILVDEDLVVKISDFG 348 (468)
T ss_pred -ceEEEEEecccCcHHHHhhhc--CCCccchHHHHHHHHHHHHHHHHHHhC---CccchhhhhhheeeccCceEEEcccc
Confidence 559999999999999999863 567899999999999999999999999 99999999999999999999999999
Q ss_pred cccccccccccccccccccccCcccCChhhhcccCcCccccchhhhHHHHHHHh-CCCCCCCCccCCCCchhHHHHHHHH
Q 038766 164 TSRMLDVHLQDLSSLSTAFQGTIGYLAPEFAYMRIVTTKVDVFSFGIVVMEFLT-KRRPTGLDEENGLSPISLRQLVEKA 242 (299)
Q Consensus 164 ~~~~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~DiwslG~~l~~l~~-g~~p~~~~~~~~~~~~~~~~~~~~~ 242 (299)
+++... .+.........-+..|.|||.+....++.+|||||+|++|+||+| |..|+. .....++.+.++.
T Consensus 349 LAr~~~---d~~Y~~~~~~kfPIkWtAPEa~~~~~FS~kSDVWSFGVlL~E~fT~G~~py~-----~msn~ev~~~le~- 419 (468)
T KOG0197|consen 349 LARLIG---DDEYTASEGGKFPIKWTAPEALNYGKFSSKSDVWSFGVLLWELFTYGRVPYP-----GMSNEEVLELLER- 419 (468)
T ss_pred cccccC---CCceeecCCCCCCceecCHHHHhhCCcccccceeehhhhHHHHhccCCCCCC-----CCCHHHHHHHHhc-
Confidence 998433 222223333334668999999999999999999999999999998 666653 2223333333222
Q ss_pred HhcCccCcccccCccccchhhHhHHHHHHHHHHHHHHHHhcCCCCCCCCChhhhh
Q 038766 243 LANGINGVRQITDPKLVSSIYEEQEQHQVLEELFKLALVCTSSNPEDRPNMNELL 297 (299)
Q Consensus 243 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rpt~~~il 297 (299)
.+..+.+..+|+.+.+++..||..+|++|||++.+.
T Consensus 420 -------------------GyRlp~P~~CP~~vY~lM~~CW~~~P~~RPtF~~L~ 455 (468)
T KOG0197|consen 420 -------------------GYRLPRPEGCPDEVYELMKSCWHEDPEDRPTFETLR 455 (468)
T ss_pred -------------------cCcCCCCCCCCHHHHHHHHHHhhCCcccCCCHHHHH
Confidence 222333667788999999999999999999998764
|
|
| >KOG0589 consensus Serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-46 Score=318.49 Aligned_cols=255 Identities=24% Similarity=0.374 Sum_probs=221.7
Q ss_pred hCCCCCCceeecCCcceEEEEEeC-CCcEEEEEEeccCcCChhhhHHHHHHHHHHHhcCCcceeeeeeEEEcCCCeeEEE
Q 038766 11 TGSFSENNIIGNSNLSTVYKGRLE-DGEIVAVKKLNFHQFSAESDKSFYREAKTLKELKHRNLVKVLGYAWESGKLKALI 89 (299)
Q Consensus 11 ~~~y~~~~~lg~g~~~~v~~~~~~-~~~~~~vK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~lv 89 (299)
.++|..++++|+|+||.+++++++ +++.+|+|.+............+.+|..++++++||||+.+++.+..++..++||
T Consensus 3 m~~Ye~~~~iG~GafG~a~lvrhk~~~~~~vlK~I~l~~~t~~~r~~A~~E~~lis~~~hP~iv~y~ds~~~~~~~l~Iv 82 (426)
T KOG0589|consen 3 MDNYEVLRQVGRGAFGSALLVRHKSDDKLYVLKKINLEKLTEPERRSAIQEMDLLSKLLHPNIVEYKDSFEEDGQLLCIV 82 (426)
T ss_pred cchhhhhhhcCccccchhhhhhhccCCceEEEEEEeccccCchhhHHHHHHHHHHHhccCCCeeeeccchhcCCceEEEE
Confidence 478999999999999999999864 5889999999988877777889999999999999999999999888888878999
Q ss_pred EeecCCCChHHHhcCCCCCCCCCChhhHHHHHHHHHHHHHHhhcCCCCCeeeecccCCceeeCCCCcEEEeeeccccccc
Q 038766 90 LEYMENGSLESVIHGPGVDHSRWTLPKRIDVLISVANGLDYLHSGYDIPIVHCDMKPSNILLDRDFEAHVSDFGTSRMLD 169 (299)
Q Consensus 90 ~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lh~~~~~~~~H~dl~~~nil~~~~~~v~l~df~~~~~~~ 169 (299)
|+|++||++...+++. .+..++++.++.|+.|++.|+.|||++ ++.|||||+.|||+++++.|+|+|||++..+.
T Consensus 83 m~Y~eGg~l~~~i~~~--k~~~f~E~~i~~~~~Q~~~av~ylH~~---~iLHRDlK~~Nifltk~~~VkLgDfGlaK~l~ 157 (426)
T KOG0589|consen 83 MEYCEGGDLAQLIKEQ--KGVLFPEERILKWFVQILLAVNYLHEN---RVLHRDLKCANIFLTKDKKVKLGDFGLAKILN 157 (426)
T ss_pred EeecCCCCHHHHHHHH--hhccccHHHHHHHHHHHHHHHHHHHhh---hhhcccchhhhhhccccCceeecchhhhhhcC
Confidence 9999999999999865 367899999999999999999999998 99999999999999999999999999998766
Q ss_pred cccccccccccccccCcccCChhhhcccCcCccccchhhhHHHHHHHhCCCCCCCCccCCCCchhHHHHHHHHHhcCccC
Q 038766 170 VHLQDLSSLSTAFQGTIGYLAPEFAYMRIVTTKVDVFSFGIVVMEFLTKRRPTGLDEENGLSPISLRQLVEKALANGING 249 (299)
Q Consensus 170 ~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~DiwslG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 249 (299)
.. ........||+.|++||++.+..|..++|||||||++|+|++-.++|...+ +...+..+....
T Consensus 158 ~~----~~~a~tvvGTp~YmcPEil~d~pYn~KSDiWsLGC~~yEm~~lk~aF~a~~--------m~~Li~ki~~~~--- 222 (426)
T KOG0589|consen 158 PE----DSLASTVVGTPYYMCPEILSDIPYNEKSDIWSLGCCLYEMCTLKPAFKASN--------MSELILKINRGL--- 222 (426)
T ss_pred Cc----hhhhheecCCCcccCHHHhCCCCCCccCcchhhcchHHHHHhcccccCccc--------hHHHHHHHhhcc---
Confidence 21 235567789999999999999999999999999999999999999985442 233333332211
Q ss_pred cccccCccccchhhHhHHHHHHHHHHHHHHHHhcCCCCCCCCChhhhhcC
Q 038766 250 VRQITDPKLVSSIYEEQEQHQVLEELFKLALVCTSSNPEDRPNMNELLIT 299 (299)
Q Consensus 250 ~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rpt~~~il~~ 299 (299)
-.+.+..++.++..+|+.||..+|..||++.++|.+
T Consensus 223 --------------~~Plp~~ys~el~~lv~~~l~~~P~~RPsa~~LL~~ 258 (426)
T KOG0589|consen 223 --------------YSPLPSMYSSELRSLVKSMLRKNPEHRPSALELLRR 258 (426)
T ss_pred --------------CCCCCccccHHHHHHHHHHhhcCCccCCCHHHHhhC
Confidence 112267788899999999999999999999999864
|
|
| >KOG0660 consensus Mitogen-activated protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.8e-47 Score=305.62 Aligned_cols=276 Identities=24% Similarity=0.305 Sum_probs=215.1
Q ss_pred HHhCCCCCCceeecCCcceEEEEEe-CCCcEEEEEEeccCcCChhhhHHHHHHHHHHHhcCCcceeeeeeEEEc----CC
Q 038766 9 NATGSFSENNIIGNSNLSTVYKGRL-EDGEIVAVKKLNFHQFSAESDKSFYREAKTLKELKHRNLVKVLGYAWE----SG 83 (299)
Q Consensus 9 ~~~~~y~~~~~lg~g~~~~v~~~~~-~~~~~~~vK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~----~~ 83 (299)
.+..+|...+.||+|++|.|+.|.+ .+|+.||||.+.......-..++..+|+..|+.++|+||+.+.+++.. .-
T Consensus 19 ~i~~~y~~~~~iG~GAyGvVcsA~~~~t~~~VAIKKi~~~F~~~~~akRtlRElklLr~~~HeNIi~l~di~~p~~~~~f 98 (359)
T KOG0660|consen 19 EIPRYYVLIEPIGRGAYGVVCSAKDKRTGEKVAIKKILNPFENQIDAKRTLRELKLLRHLRHENIIGLLDIFRPPSRDKF 98 (359)
T ss_pred eccceecccccccCcceeeEEEEEEcCCCCEeehhhhhhhhhchHHHHHHHHHHHHHHHhcCCCcceEEeeccccccccc
Confidence 4567788889999999999999986 469999999998666677788999999999999999999999998764 23
Q ss_pred CeeEEEEeecCCCChHHHhcCCCCCCCCCChhhHHHHHHHHHHHHHHhhcCCCCCeeeecccCCceeeCCCCcEEEeeec
Q 038766 84 KLKALILEYMENGSLESVIHGPGVDHSRWTLPKRIDVLISVANGLDYLHSGYDIPIVHCDMKPSNILLDRDFEAHVSDFG 163 (299)
Q Consensus 84 ~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lh~~~~~~~~H~dl~~~nil~~~~~~v~l~df~ 163 (299)
+..|+|+|++ +.+|...++ .+..+++..+..++.|++.||+|+|+. +++|||+||.|++++.++.+|++|||
T Consensus 99 ~DvYiV~elM-etDL~~iik----~~~~L~d~H~q~f~YQiLrgLKyiHSA---nViHRDLKPsNll~n~~c~lKI~DFG 170 (359)
T KOG0660|consen 99 NDVYLVFELM-ETDLHQIIK----SQQDLTDDHAQYFLYQILRGLKYIHSA---NVIHRDLKPSNLLLNADCDLKICDFG 170 (359)
T ss_pred ceeEEehhHH-hhHHHHHHH----cCccccHHHHHHHHHHHHHhcchhhcc---cccccccchhheeeccCCCEEecccc
Confidence 5579999999 569999997 556699999999999999999999999 99999999999999999999999999
Q ss_pred cccccccccccccccccccccCcccCChhhhc-ccCcCccccchhhhHHHHHHHhCCCCCCCCccCCCCchhHHHHHHHH
Q 038766 164 TSRMLDVHLQDLSSLSTAFQGTIGYLAPEFAY-MRIVTTKVDVFSFGIVVMEFLTKRRPTGLDEENGLSPISLRQLVEKA 242 (299)
Q Consensus 164 ~~~~~~~~~~~~~~~~~~~~~~~~y~~PE~~~-~~~~~~~~DiwslG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~ 242 (299)
+++..... ......+..+.|.+|.|||++. ...|+...||||+||++.+|++|.+.|.+.... . ++.-.++..
T Consensus 171 LAR~~~~~--~~~~~mTeYVaTRWYRAPElll~~~~Yt~aiDiWSvGCI~AEmL~gkplFpG~d~v--~--Ql~lI~~~l 244 (359)
T KOG0660|consen 171 LARYLDKF--FEDGFMTEYVATRWYRAPELLLNSSEYTKAIDIWSVGCILAEMLTGKPLFPGKDYV--H--QLQLILELL 244 (359)
T ss_pred ceeecccc--CcccchhcceeeeeecCHHHHhccccccchhhhhhhhHHHHHHHcCCCCCCCCchH--H--HHHHHHHhc
Confidence 99977643 3344557778899999999765 567999999999999999999999999755211 0 011011000
Q ss_pred HhcCccCccccc----------CccccchhhHhHHHHHHHHHHHHHHHHhcCCCCCCCCChhhhhcC
Q 038766 243 LANGINGVRQIT----------DPKLVSSIYEEQEQHQVLEELFKLALVCTSSNPEDRPNMNELLIT 299 (299)
Q Consensus 243 ~~~~~~~~~~~~----------~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rpt~~~il~~ 299 (299)
..........+. .+......+. ...+..++.+.+|+.+||..||.+|+|++|+|+|
T Consensus 245 GtP~~e~l~~i~s~~ar~yi~slp~~p~~~f~-~~fp~a~p~AidLlekmL~fdP~kRita~eAL~h 310 (359)
T KOG0660|consen 245 GTPSEEDLQKIRSEKARPYIKSLPQIPKQPFS-SIFPNANPLAIDLLEKMLVFDPKKRITAEEALAH 310 (359)
T ss_pred CCCCHHHHHHhccHHHHHHHHhCCCCCCCCHH-HHcCCCCHHHHHHHHHHhccCccccCCHHHHhcC
Confidence 000000001111 0111111111 2233667889999999999999999999999987
|
|
| >KOG0663 consensus Protein kinase PITSLRE and related kinases [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.2e-46 Score=298.24 Aligned_cols=273 Identities=23% Similarity=0.263 Sum_probs=212.9
Q ss_pred hCCCCCCceeecCCcceEEEEEe-CCCcEEEEEEeccCcCChhhhHHHHHHHHHHHhcCCcceeeeeeEEEcC-CCeeEE
Q 038766 11 TGSFSENNIIGNSNLSTVYKGRL-EDGEIVAVKKLNFHQFSAESDKSFYREAKTLKELKHRNLVKVLGYAWES-GKLKAL 88 (299)
Q Consensus 11 ~~~y~~~~~lg~g~~~~v~~~~~-~~~~~~~vK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~-~~~~~l 88 (299)
.+.|..++.|++|+||.||+|++ ++++.||+|.++.........-...+|+.+|.+.+||||+.+..++.-. -+..|+
T Consensus 75 v~efe~lnrI~EGtyGiVYRakdk~t~eIVALKr~kmekek~GFPItsLREIniLl~~~H~NIV~vkEVVvG~~~d~iy~ 154 (419)
T KOG0663|consen 75 VEEFEKLNRIEEGTYGVVYRAKDKKTDEIVALKRLKMEKEKEGFPITSLREINILLKARHPNIVEVKEVVVGSNMDKIYI 154 (419)
T ss_pred HHHHHHHhhcccCcceeEEEeccCCcceeEEeeecccccccCCCcchhHHHHHHHHhcCCCCeeeeEEEEeccccceeee
Confidence 35688899999999999999987 4689999999988775555566788999999999999999999987632 244699
Q ss_pred EEeecCCCChHHHhcCCCCCCCCCChhhHHHHHHHHHHHHHHhhcCCCCCeeeecccCCceeeCCCCcEEEeeecccccc
Q 038766 89 ILEYMENGSLESVIHGPGVDHSRWTLPKRIDVLISVANGLDYLHSGYDIPIVHCDMKPSNILLDRDFEAHVSDFGTSRML 168 (299)
Q Consensus 89 v~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lh~~~~~~~~H~dl~~~nil~~~~~~v~l~df~~~~~~ 168 (299)
||||+++ +|.+++... .++|...++..++.|++.|++|||.+ .|+|||||++|+|+++.|.+|++|||+++.+
T Consensus 155 VMe~~Eh-DLksl~d~m---~q~F~~~evK~L~~QlL~glk~lH~~---wilHRDLK~SNLLm~~~G~lKiaDFGLAR~y 227 (419)
T KOG0663|consen 155 VMEYVEH-DLKSLMETM---KQPFLPGEVKTLMLQLLRGLKHLHDN---WILHRDLKTSNLLLSHKGILKIADFGLAREY 227 (419)
T ss_pred eHHHHHh-hHHHHHHhc---cCCCchHHHHHHHHHHHHHHHHHhhc---eeEecccchhheeeccCCcEEecccchhhhh
Confidence 9999976 999999854 37899999999999999999999999 9999999999999999999999999999987
Q ss_pred ccccccccccccccccCcccCChhhhccc-CcCccccchhhhHHHHHHHhCCCCCCCCccCCCCchhHHHHHHHHH----
Q 038766 169 DVHLQDLSSLSTAFQGTIGYLAPEFAYMR-IVTTKVDVFSFGIVVMEFLTKRRPTGLDEENGLSPISLRQLVEKAL---- 243 (299)
Q Consensus 169 ~~~~~~~~~~~~~~~~~~~y~~PE~~~~~-~~~~~~DiwslG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~---- 243 (299)
.. +....+..+.|.+|.|||++.+. .|+.+.|+||+||++.+|+.+.+.|.+..+- .-.+.+-+..
T Consensus 228 gs----p~k~~T~lVVTLWYRaPELLLG~~tyst~iDMWSvGCI~aE~l~~kPlf~G~sE~-----dQl~~If~llGtPt 298 (419)
T KOG0663|consen 228 GS----PLKPYTPLVVTLWYRAPELLLGAKTYSTAVDMWSVGCIFAELLTQKPLFPGKSEI-----DQLDKIFKLLGTPS 298 (419)
T ss_pred cC----CcccCcceEEEeeecCHHHhcCCcccCcchhhhhHHHHHHHHHhcCCCCCCCchH-----HHHHHHHHHhCCCc
Confidence 63 34456777889999999988875 5999999999999999999999998654221 1111111111
Q ss_pred hcCccCccccc------CccccchhhHhHHHHH-HHHHHHHHHHHhcCCCCCCCCChhhhhcC
Q 038766 244 ANGINGVRQIT------DPKLVSSIYEEQEQHQ-VLEELFKLALVCTSSNPEDRPNMNELLIT 299 (299)
Q Consensus 244 ~~~~~~~~~~~------~~~~~~~~~~~~~~~~-~~~~l~~li~~~l~~dP~~Rpt~~~il~~ 299 (299)
..-|+...... .+.............. .++.-++|+..+|..||.+|.||+|.|+|
T Consensus 299 e~iwpg~~~lp~~k~~~f~~~pyn~lr~kF~~~~lse~g~~Lln~llt~dP~kR~tA~~~L~h 361 (419)
T KOG0663|consen 299 EAIWPGYSELPAVKKMTFSEHPYNNLRKKFGALSLSEQGFDLLNKLLTYDPGKRITAEDGLKH 361 (419)
T ss_pred cccCCCccccchhhccccCCCCchhhhhhccccccchhHHHHHHHHhccCccccccHHHhhcc
Confidence 11122222111 1111111111111111 56788999999999999999999999987
|
|
| >cd07848 STKc_CDKL5 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase Like 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-44 Score=303.67 Aligned_cols=272 Identities=23% Similarity=0.256 Sum_probs=203.2
Q ss_pred CCCCCCceeecCCcceEEEEEeC-CCcEEEEEEeccCcCChhhhHHHHHHHHHHHhcCCcceeeeeeEEEcCCCeeEEEE
Q 038766 12 GSFSENNIIGNSNLSTVYKGRLE-DGEIVAVKKLNFHQFSAESDKSFYREAKTLKELKHRNLVKVLGYAWESGKLKALIL 90 (299)
Q Consensus 12 ~~y~~~~~lg~g~~~~v~~~~~~-~~~~~~vK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~lv~ 90 (299)
++|.+.+.||+|++|+||++.+. +++.+|+|++............+.+|+.+++.++||||+++++++.. +...++|+
T Consensus 1 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~-~~~~~lv~ 79 (287)
T cd07848 1 NKFEVLGVVGEGAYGVVLKCRHKETKEIVAIKKFKDSEENEEVKETTLRELKMLRTLKQENIVELKEAFRR-RGKLYLVF 79 (287)
T ss_pred CCceEEEEecccCCEEEEEEEECCCCcEEEEEEEecccccccchhhHHHHHHHHHhCCCccccchhhhEec-CCEEEEEE
Confidence 47999999999999999999875 58899999997654445556778899999999999999999996654 55679999
Q ss_pred eecCCCChHHHhcCCCCCCCCCChhhHHHHHHHHHHHHHHhhcCCCCCeeeecccCCceeeCCCCcEEEeeecccccccc
Q 038766 91 EYMENGSLESVIHGPGVDHSRWTLPKRIDVLISVANGLDYLHSGYDIPIVHCDMKPSNILLDRDFEAHVSDFGTSRMLDV 170 (299)
Q Consensus 91 e~~~~~~L~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lh~~~~~~~~H~dl~~~nil~~~~~~v~l~df~~~~~~~~ 170 (299)
||+.++.+..+.. ....+++..++.++.|++.||.|||+. +++|+||||+||+++.++.++|+|||++.....
T Consensus 80 e~~~~~~l~~~~~----~~~~~~~~~~~~~~~qi~~~L~~lH~~---~i~H~dlkp~Nill~~~~~~kl~Dfg~~~~~~~ 152 (287)
T cd07848 80 EYVEKNMLELLEE----MPNGVPPEKVRSYIYQLIKAIHWCHKN---DIVHRDIKPENLLISHNDVLKLCDFGFARNLSE 152 (287)
T ss_pred ecCCCCHHHHHHh----cCCCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHEEEcCCCcEEEeeccCcccccc
Confidence 9998866655543 335789999999999999999999999 999999999999999999999999999876532
Q ss_pred ccccccccccccccCcccCChhhhcccCcCccccchhhhHHHHHHHhCCCCCCCCccCCCCchhHHHHHHHHHhc-----
Q 038766 171 HLQDLSSLSTAFQGTIGYLAPEFAYMRIVTTKVDVFSFGIVVMEFLTKRRPTGLDEENGLSPISLRQLVEKALAN----- 245 (299)
Q Consensus 171 ~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~DiwslG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~----- 245 (299)
. .........+++.|+|||++.+..++.++|+|||||++|+|++|..||...... .....+......
T Consensus 153 ~---~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslGvil~el~~g~~pf~~~~~~-----~~~~~~~~~~~~~~~~~ 224 (287)
T cd07848 153 G---SNANYTEYVATRWYRSPELLLGAPYGKAVDMWSVGCILGELSDGQPLFPGESEI-----DQLFTIQKVLGPLPAEQ 224 (287)
T ss_pred c---ccccccccccccccCCcHHHcCCCCCCchhHHhHHHHHHHHHhCCCCCCCCCHH-----HHHHHHHHhhCCCCHHH
Confidence 1 111223345788999999999888999999999999999999999999543211 100000000000
Q ss_pred -----CccCcccccCccc-cchhhHhHHHHHHHHHHHHHHHHhcCCCCCCCCChhhhhcC
Q 038766 246 -----GINGVRQITDPKL-VSSIYEEQEQHQVLEELFKLALVCTSSNPEDRPNMNELLIT 299 (299)
Q Consensus 246 -----~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rpt~~~il~~ 299 (299)
..........+.. ............++.++.+|+++||..||++|||++++|+|
T Consensus 225 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dll~~~L~~~P~~R~s~~~~l~h 284 (287)
T cd07848 225 MKLFYSNPRFHGLRFPAVNHPQSLERRYLGILSGVLLDLMKNLLKLNPTDRYLTEQCLNH 284 (287)
T ss_pred HHhhhccchhcccccCcccCcccHHHhhhcccCHHHHHHHHHHccCCcccCCCHHHHhcC
Confidence 0000000000000 00001111233467789999999999999999999999987
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 5 (CDKL5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Mutations in the gene encoding CDKL5, previously called STK9, are associated with early onset epilepsy and severe mental retardation [X-linked infantile spasm syndrome (ISSX) or West syndrome]. In addition, CDKL5 mutations also sometimes |
| >cd05612 STKc_PRKX_like Catalytic domain of PRKX-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-45 Score=308.68 Aligned_cols=247 Identities=23% Similarity=0.324 Sum_probs=200.4
Q ss_pred CCCCCCceeecCCcceEEEEEeC-CCcEEEEEEeccCcC-ChhhhHHHHHHHHHHHhcCCcceeeeeeEEEcCCCeeEEE
Q 038766 12 GSFSENNIIGNSNLSTVYKGRLE-DGEIVAVKKLNFHQF-SAESDKSFYREAKTLKELKHRNLVKVLGYAWESGKLKALI 89 (299)
Q Consensus 12 ~~y~~~~~lg~g~~~~v~~~~~~-~~~~~~vK~~~~~~~-~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~lv 89 (299)
++|.+.+.||+|+||.||++.+. +++.+|+|++..... .......+.+|+.+++.++||||+++++++.. +...++|
T Consensus 1 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~-~~~~~lv 79 (291)
T cd05612 1 DDLERIKTVGTGTFGRVHLVRDRISEHYYALKVMAIPEVIRLKQEQHVHNEKRVLKEVSHPFIIRLFWTEHD-QRFLYML 79 (291)
T ss_pred CCceeeeeeecCCCeEEEEEEEcCCCCEEEEEEEEHHHHhhhHHHHHHHHHHHHHHhCCCCcHhhhHhhhcc-CCeEEEE
Confidence 57999999999999999999875 689999999864332 22345668899999999999999999996554 5667999
Q ss_pred EeecCCCChHHHhcCCCCCCCCCChhhHHHHHHHHHHHHHHhhcCCCCCeeeecccCCceeeCCCCcEEEeeeccccccc
Q 038766 90 LEYMENGSLESVIHGPGVDHSRWTLPKRIDVLISVANGLDYLHSGYDIPIVHCDMKPSNILLDRDFEAHVSDFGTSRMLD 169 (299)
Q Consensus 90 ~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lh~~~~~~~~H~dl~~~nil~~~~~~v~l~df~~~~~~~ 169 (299)
+||+.+++|.+++. ....+++..++.++.|++.||+|||++ +++|+||||+||+++.+|.++|+|||++....
T Consensus 80 ~e~~~~~~L~~~~~----~~~~~~~~~~~~~~~qi~~~l~~lH~~---~i~H~dlkp~NIli~~~~~~kl~Dfg~~~~~~ 152 (291)
T cd05612 80 MEYVPGGELFSYLR----NSGRFSNSTGLFYASEIVCALEYLHSK---EIVYRDLKPENILLDKEGHIKLTDFGFAKKLR 152 (291)
T ss_pred EeCCCCCCHHHHHH----HcCCCCHHHHHHHHHHHHHHHHHHHHC---CeeecCCCHHHeEECCCCCEEEEecCcchhcc
Confidence 99999999999987 445789999999999999999999999 99999999999999999999999999987543
Q ss_pred cccccccccccccccCcccCChhhhcccCcCccccchhhhHHHHHHHhCCCCCCCCccCCCCchhHHHHHHHHHhcCccC
Q 038766 170 VHLQDLSSLSTAFQGTIGYLAPEFAYMRIVTTKVDVFSFGIVVMEFLTKRRPTGLDEENGLSPISLRQLVEKALANGING 249 (299)
Q Consensus 170 ~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~DiwslG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 249 (299)
. ......+++.|+|||.+.+..++.++|||||||++|+|++|..||.... .. .......... ..
T Consensus 153 ~-------~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~~l~~g~~pf~~~~-----~~---~~~~~i~~~~-~~ 216 (291)
T cd05612 153 D-------RTWTLCGTPEYLAPEVIQSKGHNKAVDWWALGILIYEMLVGYPPFFDDN-----PF---GIYEKILAGK-LE 216 (291)
T ss_pred C-------CcccccCChhhcCHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCC-----HH---HHHHHHHhCC-cC
Confidence 1 1223457899999999999889999999999999999999999985431 11 1122211111 00
Q ss_pred cccccCccccchhhHhHHHHHHHHHHHHHHHHhcCCCCCCCCC-----hhhhhcC
Q 038766 250 VRQITDPKLVSSIYEEQEQHQVLEELFKLALVCTSSNPEDRPN-----MNELLIT 299 (299)
Q Consensus 250 ~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rpt-----~~~il~~ 299 (299)
+ +..++..+.++|++||..||.+||+ ++++++|
T Consensus 217 ---~--------------~~~~~~~~~~li~~~l~~dp~~R~~~~~~~~~~~l~h 254 (291)
T cd05612 217 ---F--------------PRHLDLYAKDLIKKLLVVDRTRRLGNMKNGADDVKNH 254 (291)
T ss_pred ---C--------------CccCCHHHHHHHHHHcCCCHHHccCCccCCHHHHhcC
Confidence 0 1223567899999999999999995 9999987
|
Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, PRKX-like kinases, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include human PRKX (X chromosome-encoded protein kinase), Drosophila DC2, and similar proteins. PRKX is present in many tissues including fetal and adult brain, kidney, and lung. The PRKX gene is located in the Xp22.3 subregion and has a homolog called PRKY on the Y chromosome. An abnormal interchange between PRKX aand PRKY leads to the sex reversal disorder of XX males and XY females. PRKX is implicated in granulocyt |
| >KOG0594 consensus Protein kinase PCTAIRE and related kinases [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.6e-45 Score=295.77 Aligned_cols=277 Identities=23% Similarity=0.275 Sum_probs=213.3
Q ss_pred hCCCCCCceeecCCcceEEEEEe-CCCcEEEEEEeccCcCChhhhHHHHHHHHHHHhcCCcc-eeeeeeEEEcCCC----
Q 038766 11 TGSFSENNIIGNSNLSTVYKGRL-EDGEIVAVKKLNFHQFSAESDKSFYREAKTLKELKHRN-LVKVLGYAWESGK---- 84 (299)
Q Consensus 11 ~~~y~~~~~lg~g~~~~v~~~~~-~~~~~~~vK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~-i~~~~~~~~~~~~---- 84 (299)
...|..+++||+|++|+||+|.. .+|+.||+|+++.....+.......+|+.+++.++|+| |+.+.+++....+
T Consensus 10 ~~~~~~~eklGeGtyg~Vykar~~~~g~~VALKkirl~~~~EG~P~taiREisllk~L~~~~~iv~L~dv~~~~~~~~~~ 89 (323)
T KOG0594|consen 10 MFDYEKVEKLGEGTYGVVYKARSKRTGKFVALKKIRLEFEEEGVPSTAIREISLLKRLSHANHIVRLHDVIHTSNNHRGI 89 (323)
T ss_pred HHHHHHHHHhCCCCceEEEEEEEecCCCEEEEEEEeccccccCCCchhhHHHHHHHHhCCCcceEEEEeeeeeccccccc
Confidence 45577788899999999999986 46899999999876554445667789999999999999 9999998887663
Q ss_pred -eeEEEEeecCCCChHHHhcCCCCCCCCCChhhHHHHHHHHHHHHHHhhcCCCCCeeeecccCCceeeCCCCcEEEeeec
Q 038766 85 -LKALILEYMENGSLESVIHGPGVDHSRWTLPKRIDVLISVANGLDYLHSGYDIPIVHCDMKPSNILLDRDFEAHVSDFG 163 (299)
Q Consensus 85 -~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lh~~~~~~~~H~dl~~~nil~~~~~~v~l~df~ 163 (299)
.+++|+|+++. +|..++.........++...+..++.||+.||+|||++ +|+||||||+|++++++|.+||+|||
T Consensus 90 ~~l~lvfe~~d~-DL~~ymd~~~~~~~g~~~~~ik~~m~Qll~gl~~~H~~---~IlHRDLKPQNlLi~~~G~lKlaDFG 165 (323)
T KOG0594|consen 90 GKLYLVFEFLDR-DLKKYMDSLPKKPQGLPPRLIKSFMRQLLRGLAFLHSH---GILHRDLKPQNLLISSSGVLKLADFG 165 (323)
T ss_pred ceEEEEEEeecc-cHHHHHHhccccccCCCHHHHHHHHHHHHHHHHHHHhC---CeecccCCcceEEECCCCcEeeeccc
Confidence 67899999954 99998875432225677789999999999999999999 99999999999999999999999999
Q ss_pred cccccccccccccccccccccCcccCChhhhccc-CcCccccchhhhHHHHHHHhCCCCCCCCccCCCCchhHHHHHHHH
Q 038766 164 TSRMLDVHLQDLSSLSTAFQGTIGYLAPEFAYMR-IVTTKVDVFSFGIVVMEFLTKRRPTGLDEENGLSPISLRQLVEKA 242 (299)
Q Consensus 164 ~~~~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~-~~~~~~DiwslG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~ 242 (299)
++.... .........++|.+|+|||++.+. .|+...||||+||++++|+++...|....+ ..++....+..
T Consensus 166 lAra~~----ip~~~yt~evvTlWYRaPEvLlGs~~Ys~~vDiWs~GcIfaEm~~~~~LFpG~se----~~ql~~If~~l 237 (323)
T KOG0594|consen 166 LARAFS----IPMRTYTPEVVTLWYRAPEVLLGSTSYSTSVDIWSLGCIFAEMFTRRPLFPGDSE----IDQLFRIFRLL 237 (323)
T ss_pred hHHHhc----CCcccccccEEEeeccCHHHhcCCCcCCCCcchHhHHHHHHHHHhCCCCCCCCcH----HHHHHHHHHHc
Confidence 998544 123335667789999999998887 799999999999999999999999966543 11222222222
Q ss_pred Hh---cCccCcccccCccccchhh--H---hHHHHHHHHHHHHHHHHhcCCCCCCCCChhhhhcC
Q 038766 243 LA---NGINGVRQITDPKLVSSIY--E---EQEQHQVLEELFKLALVCTSSNPEDRPNMNELLIT 299 (299)
Q Consensus 243 ~~---~~~~~~~~~~~~~~~~~~~--~---~~~~~~~~~~l~~li~~~l~~dP~~Rpt~~~il~~ 299 (299)
.. ..|+......+.+...... . ....+....+..+++.+||..+|.+|.|++.+|+|
T Consensus 238 GtP~e~~Wp~v~~~~~~k~~f~~~~~~~~l~~~~~~~~~~~~dll~~~L~y~p~~R~Sa~~al~h 302 (323)
T KOG0594|consen 238 GTPNEKDWPGVSSLPDYKAPFPKWPGPKDLSSILPKLDPDGIELLSKLLQYDPAKRISAKGALTH 302 (323)
T ss_pred CCCCccCCCCccccccccccCcCCCCccchHHhccccCccHHHHHHHHhccCcccCcCHHHHhcC
Confidence 11 3333433333333211100 0 11112222489999999999999999999999987
|
|
| >KOG0597 consensus Serine-threonine protein kinase FUSED [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-45 Score=311.46 Aligned_cols=250 Identities=26% Similarity=0.384 Sum_probs=213.8
Q ss_pred hCCCCCCceeecCCcceEEEEEe-CCCcEEEEEEeccCcCChhhhHHHHHHHHHHHhcCCcceeeeeeEEEcCCCeeEEE
Q 038766 11 TGSFSENNIIGNSNLSTVYKGRL-EDGEIVAVKKLNFHQFSAESDKSFYREAKTLKELKHRNLVKVLGYAWESGKLKALI 89 (299)
Q Consensus 11 ~~~y~~~~~lg~g~~~~v~~~~~-~~~~~~~vK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~lv 89 (299)
.++|.+.+.||+|+||.||+++. .+.+.||+|.+..........+.+.+|+++++.++||||+.+++++ +....+++|
T Consensus 1 me~yhv~e~iG~Gsfg~VYKgrrK~t~~~vAik~i~K~gr~~k~l~~l~~ev~i~r~lkHpniv~m~esf-Et~~~~~vV 79 (808)
T KOG0597|consen 1 MEQYHVYEMIGEGSFGRVYKGRRKYTIQVVAIKFIDKSGRNEKELKNLRQEVRILRSLKHPNIVEMLESF-ETSAHLWVV 79 (808)
T ss_pred CcchhHHHHhcCCccceeeecccccceeEEEEEEehhcCCchHHHHHHHHHHHHHHhcCCcchhhHHHhh-cccceEEEE
Confidence 36899999999999999999975 4688999999988777888899999999999999999999999954 556777999
Q ss_pred EeecCCCChHHHhcCCCCCCCCCChhhHHHHHHHHHHHHHHhhcCCCCCeeeecccCCceeeCCCCcEEEeeeccccccc
Q 038766 90 LEYMENGSLESVIHGPGVDHSRWTLPKRIDVLISVANGLDYLHSGYDIPIVHCDMKPSNILLDRDFEAHVSDFGTSRMLD 169 (299)
Q Consensus 90 ~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lh~~~~~~~~H~dl~~~nil~~~~~~v~l~df~~~~~~~ 169 (299)
.||+.| +|..++. ....++|+.+..++.++++||.|||++ ++.|+|+||+||+++.+|.+|++|||+++...
T Consensus 80 te~a~g-~L~~il~----~d~~lpEe~v~~~a~~LVsaL~yLhs~---rilhrd~kPqniLl~~~~~~KlcdFg~Ar~m~ 151 (808)
T KOG0597|consen 80 TEYAVG-DLFTILE----QDGKLPEEQVRAIAYDLVSALYYLHSN---RILHRDMKPQNILLEKGGTLKLCDFGLARAMS 151 (808)
T ss_pred ehhhhh-hHHHHHH----hccCCCHHHHHHHHHHHHHHHHHHHhc---CcccccCCcceeeecCCCceeechhhhhhhcc
Confidence 999966 9999998 677999999999999999999999999 99999999999999999999999999998655
Q ss_pred cccccccccccccccCcccCChhhhcccCcCccccchhhhHHHHHHHhCCCCCCCCccCCCCchhHHHHHHHHHhcCccC
Q 038766 170 VHLQDLSSLSTAFQGTIGYLAPEFAYMRIVTTKVDVFSFGIVVMEFLTKRRPTGLDEENGLSPISLRQLVEKALANGING 249 (299)
Q Consensus 170 ~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~DiwslG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 249 (299)
. .........|||.|||||+..+..|+..+|+|||||++|+++.|.+||... .+......+....
T Consensus 152 ~----~t~vltsikGtPlYmAPElv~e~pyd~~sDlWslGcilYE~~~G~PPF~a~--------si~~Lv~~I~~d~--- 216 (808)
T KOG0597|consen 152 T----NTSVLTSIKGTPLYMAPELVEEQPYDHTSDLWSLGCILYELYVGQPPFYAR--------SITQLVKSILKDP--- 216 (808)
T ss_pred c----CceeeeeccCcccccCHHHHcCCCccchhhHHHHHHHHHHHhcCCCCchHH--------HHHHHHHHHhcCC---
Confidence 2 122334556899999999999999999999999999999999999999432 2233333222111
Q ss_pred cccccCccccchhhHhHHHHHHHHHHHHHHHHhcCCCCCCCCChhhhhcC
Q 038766 250 VRQITDPKLVSSIYEEQEQHQVLEELFKLALVCTSSNPEDRPNMNELLIT 299 (299)
Q Consensus 250 ~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rpt~~~il~~ 299 (299)
.++ +...+..+.+++..+|..||.+|.|-.+++.|
T Consensus 217 ------v~~---------p~~~S~~f~nfl~gLL~kdP~~RltW~~Ll~H 251 (808)
T KOG0597|consen 217 ------VKP---------PSTASSSFVNFLQGLLIKDPAQRLTWTDLLGH 251 (808)
T ss_pred ------CCC---------cccccHHHHHHHHHHhhcChhhcccHHHHhcC
Confidence 111 44677889999999999999999999999887
|
|
| >KOG2345 consensus Serine/threonine protein kinase/TGF-beta stimulated factor [Transcription; Lipid transport and metabolism; Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.8e-46 Score=285.13 Aligned_cols=267 Identities=21% Similarity=0.309 Sum_probs=208.8
Q ss_pred HHHHhCCCCCCceeecCCcceEEEEEe-CCCcEEEEEEeccCcCChhhhHHHHHHHHHHHhcCCcceeeeeeEEEcC---
Q 038766 7 IENATGSFSENNIIGNSNLSTVYKGRL-EDGEIVAVKKLNFHQFSAESDKSFYREAKTLKELKHRNLVKVLGYAWES--- 82 (299)
Q Consensus 7 ~~~~~~~y~~~~~lg~g~~~~v~~~~~-~~~~~~~vK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~--- 82 (299)
+-+-.+||++.+.||.|||+-|++++. .+++.||+|++.++. .+..+...+|++..++++|||++++++.....
T Consensus 16 v~In~~Ryri~~~LgeGGfsfv~LV~~~s~~~~YAlKkI~c~~--~~~~e~~~rEid~~rkf~s~~vl~l~dh~l~~~~D 93 (302)
T KOG2345|consen 16 VIINNKRYRIQRLLGEGGFSFVDLVKGLSTGHLYALKKILCHS--QEDIEEALREIDNHRKFNSPNVLRLVDHQLREEKD 93 (302)
T ss_pred EEEcCceEEEeeeecCCCceeeeeecccCcccchhhheeeccc--hHHHHHHHHHHHHHHhhCCcchHHHHHHHHHhhcc
Confidence 334568999999999999999999984 678999999998655 56788899999999999999999998865432
Q ss_pred -CCeeEEEEeecCCCChHHHhcCCCCCCCCCChhhHHHHHHHHHHHHHHhhcCCCCCeeeecccCCceeeCCCCcEEEee
Q 038766 83 -GKLKALILEYMENGSLESVIHGPGVDHSRWTLPKRIDVLISVANGLDYLHSGYDIPIVHCDMKPSNILLDRDFEAHVSD 161 (299)
Q Consensus 83 -~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lh~~~~~~~~H~dl~~~nil~~~~~~v~l~d 161 (299)
....|++++|+..|+|.+.++.....+..+++.++++|+.+++.||++||+..+ .++|+||||.||+++.++.+++.|
T Consensus 94 ~~~~~yll~Pyy~~Gsl~d~i~~~k~kg~~~sE~~iL~if~gic~gL~~lH~~~~-~yAH~DiKP~NILls~~~~~vl~D 172 (302)
T KOG2345|consen 94 GKHEAYLLLPYYKRGSLLDEIERLKIKGNFVSEAQILWIFLGICRGLEALHEKEP-PYAHRDIKPANILLSDSGLPVLMD 172 (302)
T ss_pred CceeEEEEeehhccccHHHHHHHHhhcCCccCHHHHHHHHHHHHHHHHHHhccCC-cccccCCCcceeEecCCCceEEEe
Confidence 345799999999999999998877677799999999999999999999999811 399999999999999999999999
Q ss_pred ecccccccccccccccc-----ccccccCcccCChhhhcc---cCcCccccchhhhHHHHHHHhCCCCCCCCccCCCCch
Q 038766 162 FGTSRMLDVHLQDLSSL-----STAFQGTIGYLAPEFAYM---RIVTTKVDVFSFGIVVMEFLTKRRPTGLDEENGLSPI 233 (299)
Q Consensus 162 f~~~~~~~~~~~~~~~~-----~~~~~~~~~y~~PE~~~~---~~~~~~~DiwslG~~l~~l~~g~~p~~~~~~~~~~~~ 233 (299)
||.++...-...+.... ...-.-|..|+|||++.- ...+.++|||||||++|.||.|..||...-..+.+
T Consensus 173 ~GS~~~a~i~i~~~~~a~~lQe~a~e~Ct~pyRAPELf~vk~~~ti~ertDIWSLGCtLYa~mf~~sPfe~~~~~GgS-- 250 (302)
T KOG2345|consen 173 LGSATQAPIQIEGSRQALRLQEWAEERCTIPYRAPELFNVKSHCTITERTDIWSLGCTLYAMMFGESPFERIYQQGGS-- 250 (302)
T ss_pred ccCccccceEeechHHHHHHHHHHHHhCCCcccCchheecccCcccccccchhhhhHHHHHHHHcCCcchHHhhcCCe--
Confidence 99998655333222211 111123678999998774 45778999999999999999999999532111111
Q ss_pred hHHHHHHHHHhcCccCcccccCccccchhhHhHHHHHHHHHHHHHHHHhcCCCCCCCCChhhhhc
Q 038766 234 SLRQLVEKALANGINGVRQITDPKLVSSIYEEQEQHQVLEELFKLALVCTSSNPEDRPNMNELLI 298 (299)
Q Consensus 234 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rpt~~~il~ 298 (299)
-.-.+....+ ..+....++..+.++|+.||.+||.+||++.+++.
T Consensus 251 ---------------laLAv~n~q~-----s~P~~~~yse~l~~lik~mlqvdP~qRP~i~~ll~ 295 (302)
T KOG2345|consen 251 ---------------LALAVQNAQI-----SIPNSSRYSEALHQLIKSMLQVDPNQRPTIPELLS 295 (302)
T ss_pred ---------------EEEeeecccc-----ccCCCCCccHHHHHHHHHHhcCCcccCCCHHHHHH
Confidence 0011111000 00112337889999999999999999999999985
|
|
| >cd06649 PKc_MEK2 Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.1e-44 Score=305.40 Aligned_cols=271 Identities=25% Similarity=0.366 Sum_probs=204.4
Q ss_pred HhCCCCCCceeecCCcceEEEEEeC-CCcEEEEEEeccCcCChhhhHHHHHHHHHHHhcCCcceeeeeeEEEcCCCeeEE
Q 038766 10 ATGSFSENNIIGNSNLSTVYKGRLE-DGEIVAVKKLNFHQFSAESDKSFYREAKTLKELKHRNLVKVLGYAWESGKLKAL 88 (299)
Q Consensus 10 ~~~~y~~~~~lg~g~~~~v~~~~~~-~~~~~~vK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~l 88 (299)
..++|.+.+.||+|++|.||++.+. ++..+|+|++... ........+.+|++.++.++||||+++++++.. +...++
T Consensus 3 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~a~k~~~~~-~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~-~~~~~l 80 (331)
T cd06649 3 KDDDFERISELGAGNGGVVTKVQHKPSGLIMARKLIHLE-IKPAIRNQIIRELQVLHECNSPYIVGFYGAFYS-DGEISI 80 (331)
T ss_pred CcccceEEEeecCCCCEEEEEEEECCCCcEEEEEEeecc-cCHHHHHHHHHHHHHHHHCCCCCCCeEEEEEEE-CCEEEE
Confidence 4589999999999999999999875 5888999998643 234456778999999999999999999997665 456699
Q ss_pred EEeecCCCChHHHhcCCCCCCCCCChhhHHHHHHHHHHHHHHhhcCCCCCeeeecccCCceeeCCCCcEEEeeecccccc
Q 038766 89 ILEYMENGSLESVIHGPGVDHSRWTLPKRIDVLISVANGLDYLHSGYDIPIVHCDMKPSNILLDRDFEAHVSDFGTSRML 168 (299)
Q Consensus 89 v~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lh~~~~~~~~H~dl~~~nil~~~~~~v~l~df~~~~~~ 168 (299)
|+||+.+++|.+++. ....+++..++.++.|++.||.|||+. .+++|+||||+||+++.++.++|+|||++...
T Consensus 81 v~e~~~~~~L~~~l~----~~~~~~~~~~~~~~~~i~~~l~~lH~~--~~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~ 154 (331)
T cd06649 81 CMEHMDGGSLDQVLK----EAKRIPEEILGKVSIAVLRGLAYLREK--HQIMHRDVKPSNILVNSRGEIKLCDFGVSGQL 154 (331)
T ss_pred EeecCCCCcHHHHHH----HcCCCCHHHHHHHHHHHHHHHHHHhhc--CCEEcCCCChhhEEEcCCCcEEEccCcccccc
Confidence 999999999999997 445789999999999999999999985 26999999999999999999999999998754
Q ss_pred ccccccccccccccccCcccCChhhhcccCcCccccchhhhHHHHHHHhCCCCCCCCccCCCCchhHHHHHHHHHhcCcc
Q 038766 169 DVHLQDLSSLSTAFQGTIGYLAPEFAYMRIVTTKVDVFSFGIVVMEFLTKRRPTGLDEENGLSPISLRQLVEKALANGIN 248 (299)
Q Consensus 169 ~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~DiwslG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 248 (299)
.. .......+++.|+|||++.+..++.++|||||||++|+|++|..||..... ..+...+.........
T Consensus 155 ~~------~~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~el~tg~~p~~~~~~-----~~~~~~~~~~~~~~~~ 223 (331)
T cd06649 155 ID------SMANSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVELAIGRYPIPPPDA-----KELEAIFGRPVVDGEE 223 (331)
T ss_pred cc------cccccCCCCcCcCCHhHhcCCCCCchHhHHHHHHHHHHHHhCCCCCCCCCH-----HHHHHHhccccccccc
Confidence 31 122334578999999999998999999999999999999999999954321 1111111100000000
Q ss_pred Cccccc----------------Cccccchh-----------hHhHHHHHHHHHHHHHHHHhcCCCCCCCCChhhhhcC
Q 038766 249 GVRQIT----------------DPKLVSSI-----------YEEQEQHQVLEELFKLALVCTSSNPEDRPNMNELLIT 299 (299)
Q Consensus 249 ~~~~~~----------------~~~~~~~~-----------~~~~~~~~~~~~l~~li~~~l~~dP~~Rpt~~~il~~ 299 (299)
...... +....... ........++.++.+||++||..||++|||++++++|
T Consensus 224 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~~P~~Rpt~~ell~h 301 (331)
T cd06649 224 GEPHSISPRPRPPGRPVSGHGMDSRPAMAIFELLDYIVNEPPPKLPNGVFTPDFQEFVNKCLIKNPAERADLKMLMNH 301 (331)
T ss_pred CCccccCcccccccccccccccccccchhHHHHHHHHHhCCCcCCCCccccHHHHHHHHHHccCCcccCCCHHHHhcC
Confidence 000000 00000000 0000012356789999999999999999999999987
|
Protein kinases (PKs), MAP/ERK Kinase (MEK) 2 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK2 is a dual-specificity PK that phosphorylates and activates the downst |
| >PTZ00263 protein kinase A catalytic subunit; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.6e-45 Score=310.45 Aligned_cols=248 Identities=23% Similarity=0.306 Sum_probs=200.7
Q ss_pred hCCCCCCceeecCCcceEEEEEeC-CCcEEEEEEeccCcC-ChhhhHHHHHHHHHHHhcCCcceeeeeeEEEcCCCeeEE
Q 038766 11 TGSFSENNIIGNSNLSTVYKGRLE-DGEIVAVKKLNFHQF-SAESDKSFYREAKTLKELKHRNLVKVLGYAWESGKLKAL 88 (299)
Q Consensus 11 ~~~y~~~~~lg~g~~~~v~~~~~~-~~~~~~vK~~~~~~~-~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~l 88 (299)
.++|.+.+.||+|++|.||++.+. +++.||+|++..... .......+.+|+.+++.++||||+++++++.. ++..++
T Consensus 17 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~-~~~~~l 95 (329)
T PTZ00263 17 LSDFEMGETLGTGSFGRVRIAKHKGTGEYYAIKCLKKREILKMKQVQHVAQEKSILMELSHPFIVNMMCSFQD-ENRVYF 95 (329)
T ss_pred chheEEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHhCCCCCCCcEEEEEEc-CCEEEE
Confidence 478999999999999999999875 589999999864322 22335678899999999999999999996655 556699
Q ss_pred EEeecCCCChHHHhcCCCCCCCCCChhhHHHHHHHHHHHHHHhhcCCCCCeeeecccCCceeeCCCCcEEEeeecccccc
Q 038766 89 ILEYMENGSLESVIHGPGVDHSRWTLPKRIDVLISVANGLDYLHSGYDIPIVHCDMKPSNILLDRDFEAHVSDFGTSRML 168 (299)
Q Consensus 89 v~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lh~~~~~~~~H~dl~~~nil~~~~~~v~l~df~~~~~~ 168 (299)
|+||+.+++|.+.+. ....+++..+..++.|++.||+|||++ +++|+||||+||+++.++.++|+|||++...
T Consensus 96 v~e~~~~~~L~~~l~----~~~~~~~~~~~~~~~qi~~aL~~LH~~---~ivH~dlkp~NIll~~~~~~kl~Dfg~~~~~ 168 (329)
T PTZ00263 96 LLEFVVGGELFTHLR----KAGRFPNDVAKFYHAELVLAFEYLHSK---DIIYRDLKPENLLLDNKGHVKVTDFGFAKKV 168 (329)
T ss_pred EEcCCCCChHHHHHH----HcCCCCHHHHHHHHHHHHHHHHHHHHC---CeeecCCCHHHEEECCCCCEEEeeccCceEc
Confidence 999999999999887 445789999999999999999999999 9999999999999999999999999998754
Q ss_pred ccccccccccccccccCcccCChhhhcccCcCccccchhhhHHHHHHHhCCCCCCCCccCCCCchhHHHHHHHHHhcCcc
Q 038766 169 DVHLQDLSSLSTAFQGTIGYLAPEFAYMRIVTTKVDVFSFGIVVMEFLTKRRPTGLDEENGLSPISLRQLVEKALANGIN 248 (299)
Q Consensus 169 ~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~DiwslG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 248 (299)
.. ......+++.|+|||.+.+..++.++|||||||++|+|++|..||.... .. ........ +..
T Consensus 169 ~~-------~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~-----~~---~~~~~i~~-~~~ 232 (329)
T PTZ00263 169 PD-------RTFTLCGTPEYLAPEVIQSKGHGKAVDWWTMGVLLYEFIAGYPPFFDDT-----PF---RIYEKILA-GRL 232 (329)
T ss_pred CC-------CcceecCChhhcCHHHHcCCCCCCcceeechHHHHHHHHcCCCCCCCCC-----HH---HHHHHHhc-CCc
Confidence 31 1223467899999999999999999999999999999999999995331 11 11222111 100
Q ss_pred CcccccCccccchhhHhHHHHHHHHHHHHHHHHhcCCCCCCCCC-----hhhhhcC
Q 038766 249 GVRQITDPKLVSSIYEEQEQHQVLEELFKLALVCTSSNPEDRPN-----MNELLIT 299 (299)
Q Consensus 249 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rpt-----~~~il~~ 299 (299)
.. +..++..+.+||++||..||.+||+ +++++.|
T Consensus 233 ~~-----------------p~~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~ll~h 271 (329)
T PTZ00263 233 KF-----------------PNWFDGRARDLVKGLLQTDHTKRLGTLKGGVADVKNH 271 (329)
T ss_pred CC-----------------CCCCCHHHHHHHHHHhhcCHHHcCCCCCCCHHHHhcC
Confidence 00 1123457889999999999999997 6999876
|
|
| >KOG0616 consensus cAMP-dependent protein kinase catalytic subunit (PKA) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-44 Score=284.77 Aligned_cols=241 Identities=24% Similarity=0.324 Sum_probs=204.2
Q ss_pred HhCCCCCCceeecCCcceEEEEEeC-CCcEEEEEEeccCcCC-hhhhHHHHHHHHHHHhcCCcceeeeeeEEEcCCCeeE
Q 038766 10 ATGSFSENNIIGNSNLSTVYKGRLE-DGEIVAVKKLNFHQFS-AESDKSFYREAKTLKELKHRNLVKVLGYAWESGKLKA 87 (299)
Q Consensus 10 ~~~~y~~~~~lg~g~~~~v~~~~~~-~~~~~~vK~~~~~~~~-~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~ 87 (299)
--++|.+.+.||.|+||.|.+++.+ +|..+|+|++.....- -...+...+|..+|+.+.||+++++++.+.+ ...++
T Consensus 42 ~l~dfe~~~tlGtGSFGrV~LVr~k~~g~yYAmKvL~k~~vVklKQveH~~nEk~vL~~v~~PFlv~l~~t~~d-~~~ly 120 (355)
T KOG0616|consen 42 SLQDFERLKTLGTGSFGRVHLVREKHSGNYYAMKVLDKQKVVKLKQVEHTHNEKRVLKAVSHPFLVKLYGTFKD-NSNLY 120 (355)
T ss_pred chhhhhheeeeccCccceEEEEEEccCCceeehhhcCHHHHHHHHHHHHHhhHHHHHhhccCceeEEEEEeecc-CCeEE
Confidence 3568999999999999999999874 5899999998754432 2334667889999999999999999996666 55669
Q ss_pred EEEeecCCCChHHHhcCCCCCCCCCChhhHHHHHHHHHHHHHHhhcCCCCCeeeecccCCceeeCCCCcEEEeeeccccc
Q 038766 88 LILEYMENGSLESVIHGPGVDHSRWTLPKRIDVLISVANGLDYLHSGYDIPIVHCDMKPSNILLDRDFEAHVSDFGTSRM 167 (299)
Q Consensus 88 lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lh~~~~~~~~H~dl~~~nil~~~~~~v~l~df~~~~~ 167 (299)
+||||+.||.|.+++. ...+++++.++.+++||+.||+|||+. ++++||+||+|||+|.+|.+|++|||.+..
T Consensus 121 mvmeyv~GGElFS~Lr----k~~rF~e~~arFYAAeivlAleylH~~---~iiYRDLKPENiLlD~~G~iKitDFGFAK~ 193 (355)
T KOG0616|consen 121 MVMEYVPGGELFSYLR----KSGRFSEPHARFYAAEIVLALEYLHSL---DIIYRDLKPENLLLDQNGHIKITDFGFAKR 193 (355)
T ss_pred EEEeccCCccHHHHHH----hcCCCCchhHHHHHHHHHHHHHHHHhc---CeeeccCChHHeeeccCCcEEEEeccceEE
Confidence 9999999999999998 567999999999999999999999999 999999999999999999999999999976
Q ss_pred cccccccccccccccccCcccCChhhhcccCcCccccchhhhHHHHHHHhCCCCCCCCccCCCCchhHHHHHHHHHhcCc
Q 038766 168 LDVHLQDLSSLSTAFQGTIGYLAPEFAYMRIVTTKVDVFSFGIVVMEFLTKRRPTGLDEENGLSPISLRQLVEKALANGI 247 (299)
Q Consensus 168 ~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~DiwslG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 247 (299)
.. ....+..|||.|+|||.+...++..++|=||||+++|+|+.|.+||...+. ..+++ .+....
T Consensus 194 v~-------~rT~TlCGTPeYLAPEii~sk~ynkavDWWalGVLIYEMlaG~pPF~~~~~-----~~iY~---KI~~~~- 257 (355)
T KOG0616|consen 194 VS-------GRTWTLCGTPEYLAPEIIQSKGYNKAVDWWALGVLIYEMLAGYPPFYDDNP-----IQIYE---KILEGK- 257 (355)
T ss_pred ec-------CcEEEecCCccccChHHhhcCCCCcchhHHHHHHHHHHHHcCCCCCcCCCh-----HHHHH---HHHhCc-
Confidence 54 446678899999999999999999999999999999999999999965422 33333 222111
Q ss_pred cCcccccCccccchhhHhHHHHHHHHHHHHHHHHhcCCCCCCCC
Q 038766 248 NGVRQITDPKLVSSIYEEQEQHQVLEELFKLALVCTSSNPEDRP 291 (299)
Q Consensus 248 ~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rp 291 (299)
-..++.++.++.+|++++|.+|-++|.
T Consensus 258 -----------------v~fP~~fs~~~kdLl~~LL~vD~t~R~ 284 (355)
T KOG0616|consen 258 -----------------VKFPSYFSSDAKDLLKKLLQVDLTKRF 284 (355)
T ss_pred -----------------ccCCcccCHHHHHHHHHHHhhhhHhhh
Confidence 112666778999999999999999993
|
|
| >cd07859 STKc_TDY_MAPK_plant Catalytic domain of the Serine/Threonine Kinases, TDY Mitogen-Activated Protein Kinases from Plants | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.2e-44 Score=307.36 Aligned_cols=273 Identities=24% Similarity=0.311 Sum_probs=199.0
Q ss_pred CCCCCceeecCCcceEEEEEeC-CCcEEEEEEeccCcCChhhhHHHHHHHHHHHhcCCcceeeeeeEEEcCC----CeeE
Q 038766 13 SFSENNIIGNSNLSTVYKGRLE-DGEIVAVKKLNFHQFSAESDKSFYREAKTLKELKHRNLVKVLGYAWESG----KLKA 87 (299)
Q Consensus 13 ~y~~~~~lg~g~~~~v~~~~~~-~~~~~~vK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~----~~~~ 87 (299)
+|.+.+.||+|++|.||++.+. ++..||+|++............+.+|+.+++.++||||+++++++.... ...+
T Consensus 1 ry~i~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~~~~ 80 (338)
T cd07859 1 RYKIQEVIGKGSYGVVCSAIDTHTGEKVAIKKINDVFEHVSDATRILREIKLLRLLRHPDIVEIKHIMLPPSRREFKDIY 80 (338)
T ss_pred CeEEEEEEeecCCeEEEEEEECCCCCEEEEEEechhhccchhHHHHHHHHHHHHhCCCCCEeeecceEeccCCCCCceEE
Confidence 6889999999999999999864 6899999998744333444567889999999999999999999775432 3469
Q ss_pred EEEeecCCCChHHHhcCCCCCCCCCChhhHHHHHHHHHHHHHHhhcCCCCCeeeecccCCceeeCCCCcEEEeeeccccc
Q 038766 88 LILEYMENGSLESVIHGPGVDHSRWTLPKRIDVLISVANGLDYLHSGYDIPIVHCDMKPSNILLDRDFEAHVSDFGTSRM 167 (299)
Q Consensus 88 lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lh~~~~~~~~H~dl~~~nil~~~~~~v~l~df~~~~~ 167 (299)
+|+||+. ++|.+++. ....+++..+..++.|++.||.|||+. +++|+||||+||+++.++.++|+|||++..
T Consensus 81 lv~e~~~-~~L~~~l~----~~~~~~~~~~~~i~~qi~~aL~~LH~~---~ivH~dlkp~NIll~~~~~~kL~Dfg~~~~ 152 (338)
T cd07859 81 VVFELME-SDLHQVIK----ANDDLTPEHHQFFLYQLLRALKYIHTA---NVFHRDLKPKNILANADCKLKICDFGLARV 152 (338)
T ss_pred EEEecCC-CCHHHHHH----hcccCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHeEECCCCcEEEccCccccc
Confidence 9999994 68998886 445789999999999999999999999 999999999999999999999999999875
Q ss_pred cccccccccccccccccCcccCChhhhcc--cCcCccccchhhhHHHHHHHhCCCCCCCCccCCCCchhHHHHHHHHHhc
Q 038766 168 LDVHLQDLSSLSTAFQGTIGYLAPEFAYM--RIVTTKVDVFSFGIVVMEFLTKRRPTGLDEENGLSPISLRQLVEKALAN 245 (299)
Q Consensus 168 ~~~~~~~~~~~~~~~~~~~~y~~PE~~~~--~~~~~~~DiwslG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~ 245 (299)
...... .........+++.|+|||++.+ ..++.++|||||||++|+|++|..||..... ......+......
T Consensus 153 ~~~~~~-~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~~DvwSlGvvl~el~tg~~pf~~~~~-----~~~~~~~~~~~~~ 226 (338)
T cd07859 153 AFNDTP-TAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKNV-----VHQLDLITDLLGT 226 (338)
T ss_pred cccccC-ccccccCCCCCCCcCCHHHHhccccccCchhHHHHHHHHHHHHHcCCCCCCCCCh-----HHHHHHHHHHhCC
Confidence 431111 1112234567899999998875 5788999999999999999999999954321 1111111110000
Q ss_pred CccC-cccccCcc---------ccchhhHhHHHHHHHHHHHHHHHHhcCCCCCCCCChhhhhcC
Q 038766 246 GING-VRQITDPK---------LVSSIYEEQEQHQVLEELFKLALVCTSSNPEDRPNMNELLIT 299 (299)
Q Consensus 246 ~~~~-~~~~~~~~---------~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rpt~~~il~~ 299 (299)
.... ...+.... ..............+..+.+++.+||..||++|||++++++|
T Consensus 227 ~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~e~l~h 290 (338)
T cd07859 227 PSPETISRVRNEKARRYLSSMRKKQPVPFSQKFPNADPLALRLLERLLAFDPKDRPTAEEALAD 290 (338)
T ss_pred CCHHHHHHhhhhhHHHHHHhhcccCCCchHHhcCCCChHHHHHHHHHcCcCcccCCCHHHHhcC
Confidence 0000 00000000 000000000012345678999999999999999999999987
|
Serine/Threonine Kinases (STKs), Plant TDY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TDY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. Oryza sativa contains at least 17 MAPKs. There are two subtypes of plant MAPKs based on the conserved phos |
| >cd05102 PTKc_VEGFR3 Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.9e-44 Score=306.99 Aligned_cols=261 Identities=24% Similarity=0.380 Sum_probs=200.5
Q ss_pred HHHhCCCCCCceeecCCcceEEEEEe------CCCcEEEEEEeccCcCChhhhHHHHHHHHHHHhc-CCcceeeeeeEEE
Q 038766 8 ENATGSFSENNIIGNSNLSTVYKGRL------EDGEIVAVKKLNFHQFSAESDKSFYREAKTLKEL-KHRNLVKVLGYAW 80 (299)
Q Consensus 8 ~~~~~~y~~~~~lg~g~~~~v~~~~~------~~~~~~~vK~~~~~~~~~~~~~~~~~e~~~l~~l-~h~~i~~~~~~~~ 80 (299)
+.-.++|++.+.||+|+||.||+|.+ .++..||+|++... ........+.+|+.+++.+ +||||+++++++.
T Consensus 3 ~~~~~~~~~~~~lG~G~fg~Vy~~~~~~~~~~~~~~~vavK~~~~~-~~~~~~~~~~~E~~~l~~l~~h~niv~~~~~~~ 81 (338)
T cd05102 3 EFPRDRLRLGKVLGHGAFGKVVEASAFGIDKKSSCNTVAVKMLKEG-ATASEHKALMSELKILIHIGNHLNVVNLLGACT 81 (338)
T ss_pred ccchhHceeeeEeccCCcceEEEEEEeccCCcccchhhheeccccc-cchHHHHHHHHHHHHHHHhccCcceeeEEeEec
Confidence 44567899999999999999999974 23568999998632 2334456788999999999 7999999999877
Q ss_pred cCCCeeEEEEeecCCCChHHHhcCCCC-----------------------------------------------------
Q 038766 81 ESGKLKALILEYMENGSLESVIHGPGV----------------------------------------------------- 107 (299)
Q Consensus 81 ~~~~~~~lv~e~~~~~~L~~~~~~~~~----------------------------------------------------- 107 (299)
..+...++|+||+++++|.+++.....
T Consensus 82 ~~~~~~~lv~ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 161 (338)
T cd05102 82 KPNGPLMVIVEFCKYGNLSNFLRAKREFFSPYREKSPKQRGRFRAMVEQSRVDRRIEAGQASVLFSRFQPSTSGSTNPPQ 161 (338)
T ss_pred CCCCceEEEEecCCCCcHHHHHHhcchhcccccccchhhhhhhhhhhhhhccccccccccCCccccccccccCcccccch
Confidence 666667999999999999988864211
Q ss_pred -----CCCCCChhhHHHHHHHHHHHHHHhhcCCCCCeeeecccCCceeeCCCCcEEEeeecccccccccccccccccccc
Q 038766 108 -----DHSRWTLPKRIDVLISVANGLDYLHSGYDIPIVHCDMKPSNILLDRDFEAHVSDFGTSRMLDVHLQDLSSLSTAF 182 (299)
Q Consensus 108 -----~~~~~~~~~~~~i~~qi~~~l~~lh~~~~~~~~H~dl~~~nil~~~~~~v~l~df~~~~~~~~~~~~~~~~~~~~ 182 (299)
...++++.++..++.||+.||.|||+. +++|+||||+||+++.++.++|+|||++........ .......
T Consensus 162 ~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~---~ivHrDiKp~Nil~~~~~~~kl~DfG~a~~~~~~~~--~~~~~~~ 236 (338)
T cd05102 162 ETDDLWKSPLTMEDLICYSFQVARGMEFLASR---KCIHRDLAARNILLSENNVVKICDFGLARDIYKDPD--YVRKGSA 236 (338)
T ss_pred hccccccCCCCHHHHHHHHHHHHHHHHHHHHC---CEECCCCccceEEEcCCCcEEEeecccccccccCcc--hhcccCC
Confidence 123578888999999999999999999 999999999999999999999999999875431110 1112233
Q ss_pred ccCcccCChhhhcccCcCccccchhhhHHHHHHHh-CCCCCCCCccCCCCchhHHHHHHHHHhcCccCcccccCccccch
Q 038766 183 QGTIGYLAPEFAYMRIVTTKVDVFSFGIVVMEFLT-KRRPTGLDEENGLSPISLRQLVEKALANGINGVRQITDPKLVSS 261 (299)
Q Consensus 183 ~~~~~y~~PE~~~~~~~~~~~DiwslG~~l~~l~~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 261 (299)
.++..|+|||++.+..++.++|||||||++|+|++ |..||...... ..+ ......+. . ...
T Consensus 237 ~~~~~y~aPE~~~~~~~~~~sDiwslG~il~el~~~g~~pf~~~~~~----~~~----~~~~~~~~-~---~~~------ 298 (338)
T cd05102 237 RLPLKWMAPESIFDKVYTTQSDVWSFGVLLWEIFSLGASPYPGVQIN----EEF----CQRLKDGT-R---MRA------ 298 (338)
T ss_pred CCCccccCcHHhhcCCCCcccCHHHHHHHHHHHHhCCCCCCCCCCcc----HHH----HHHHhcCC-C---CCC------
Confidence 45678999999999899999999999999999997 99998543211 111 11111110 0 000
Q ss_pred hhHhHHHHHHHHHHHHHHHHhcCCCCCCCCChhhhhc
Q 038766 262 IYEEQEQHQVLEELFKLALVCTSSNPEDRPNMNELLI 298 (299)
Q Consensus 262 ~~~~~~~~~~~~~l~~li~~~l~~dP~~Rpt~~~il~ 298 (299)
+...+..+.+++.+||..||++|||+.++++
T Consensus 299 ------~~~~~~~l~~li~~cl~~dp~~RPs~~el~~ 329 (338)
T cd05102 299 ------PENATPEIYRIMLACWQGDPKERPTFSALVE 329 (338)
T ss_pred ------CCCCCHHHHHHHHHHccCChhhCcCHHHHHH
Confidence 2233567899999999999999999999975
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 3 (VEGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR3 (or Flt4) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. V |
| >KOG0605 consensus NDR and related serine/threonine kinases [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.9e-44 Score=303.15 Aligned_cols=259 Identities=22% Similarity=0.293 Sum_probs=204.8
Q ss_pred HhCCCCCCceeecCCcceEEEEEeC-CCcEEEEEEeccCcC-ChhhhHHHHHHHHHHHhcCCcceeeeeeEEEcCCCeeE
Q 038766 10 ATGSFSENNIIGNSNLSTVYKGRLE-DGEIVAVKKLNFHQF-SAESDKSFYREAKTLKELKHRNLVKVLGYAWESGKLKA 87 (299)
Q Consensus 10 ~~~~y~~~~~lg~g~~~~v~~~~~~-~~~~~~vK~~~~~~~-~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~ 87 (299)
-.++|.+.+.||+|+||.||+|+.+ +|+.+|+|+++.+.. .....+.++.|-.+|....+|.|++++-.|.+ ...+|
T Consensus 139 ~~~DFe~Lk~IgkGAfGeVrLarKk~Tg~iyAmK~LkKS~M~~~~Qv~hV~aERdiL~~~ds~~vVKLyYsFQD-~~~LY 217 (550)
T KOG0605|consen 139 SLDDFELLKVIGKGAFGEVRLARKKDTGEIYAMKILKKSEMLKKNQVEHVRAERDILAEVDSPWVVKLYYSFQD-KEYLY 217 (550)
T ss_pred CcccchhheeeccccceeEEEEEEccCCcEEeeecccHHHHHhhhhHHHHHHHHHHhhhcCCCcEEEEEEEecC-CCeeE
Confidence 4578999999999999999999865 599999999976543 23446778899999999899999999986655 55679
Q ss_pred EEEeecCCCChHHHhcCCCCCCCCCChhhHHHHHHHHHHHHHHhhcCCCCCeeeecccCCceeeCCCCcEEEeeeccccc
Q 038766 88 LILEYMENGSLESVIHGPGVDHSRWTLPKRIDVLISVANGLDYLHSGYDIPIVHCDMKPSNILLDRDFEAHVSDFGTSRM 167 (299)
Q Consensus 88 lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lh~~~~~~~~H~dl~~~nil~~~~~~v~l~df~~~~~ 167 (299)
+||||++||++..++. ....+++..+..++.+++.|+..+|+. |++||||||+|+|+|..|++||+|||+|..
T Consensus 218 LiMEylPGGD~mTLL~----~~~~L~e~~arfYiaE~vlAI~~iH~~---gyIHRDIKPdNlLiD~~GHiKLSDFGLs~g 290 (550)
T KOG0605|consen 218 LIMEYLPGGDMMTLLM----RKDTLTEDWARFYIAETVLAIESIHQL---GYIHRDIKPDNLLIDAKGHIKLSDFGLSTG 290 (550)
T ss_pred EEEEecCCccHHHHHH----hcCcCchHHHHHHHHHHHHHHHHHHHc---CcccccCChhheeecCCCCEeeccccccch
Confidence 9999999999999998 667999999999999999999999999 999999999999999999999999999964
Q ss_pred ccccc------------------cc--cc-----------------------ccccccccCcccCChhhhcccCcCcccc
Q 038766 168 LDVHL------------------QD--LS-----------------------SLSTAFQGTIGYLAPEFAYMRIVTTKVD 204 (299)
Q Consensus 168 ~~~~~------------------~~--~~-----------------------~~~~~~~~~~~y~~PE~~~~~~~~~~~D 204 (299)
+.... .. .. ......+|||.|+|||++.+.+|...+|
T Consensus 291 l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~w~~nrr~~a~StVGTPDYiAPEVll~kgY~~~cD 370 (550)
T KOG0605|consen 291 LDKKHRIESYRLDEQMQINLSEAKPSDFPKFNTPRSTMSRREQLQTWKRNRRQLAYSTVGTPDYIAPEVLLGKGYGKECD 370 (550)
T ss_pred hhhhhhhhhhcchhhhhhhhccCCCccccccccccchhhHHHHHHHHHhhhhhhhhcccCCccccchHHHhcCCCCcccc
Confidence 42100 00 00 0112345899999999999999999999
Q ss_pred chhhhHHHHHHHhCCCCCCCCccCCCCchhHHHHHHHHHhcCccCcccccCccccchhhHhHHHHHHHHHHHHHHHHhcC
Q 038766 205 VFSFGIVVMEFLTKRRPTGLDEENGLSPISLRQLVEKALANGINGVRQITDPKLVSSIYEEQEQHQVLEELFKLALVCTS 284 (299)
Q Consensus 205 iwslG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~ 284 (299)
.||||||+|||+.|.+||.....+ +....+.. | ...+..|. ....+.++.+||.+||.
T Consensus 371 wWSLG~ImyEmLvGyPPF~s~tp~--------~T~rkI~n--w--r~~l~fP~----------~~~~s~eA~DLI~rll~ 428 (550)
T KOG0605|consen 371 WWSLGCIMYEMLVGYPPFCSETPQ--------ETYRKIVN--W--RETLKFPE----------EVDLSDEAKDLITRLLC 428 (550)
T ss_pred HHHHHHHHHHHHhCCCCCCCCCHH--------HHHHHHHH--H--hhhccCCC----------cCcccHHHHHHHHHHhc
Confidence 999999999999999999655322 11111110 0 00111111 22334789999999999
Q ss_pred CCCCCCCC---hhhhhcC
Q 038766 285 SNPEDRPN---MNELLIT 299 (299)
Q Consensus 285 ~dP~~Rpt---~~~il~~ 299 (299)
||.+|.- ++||-+|
T Consensus 429 -d~~~RLG~~G~~EIK~H 445 (550)
T KOG0605|consen 429 -DPENRLGSKGAEEIKKH 445 (550)
T ss_pred -CHHHhcCcccHHHHhcC
Confidence 9999986 6666655
|
|
| >cd05571 STKc_PKB Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-44 Score=306.67 Aligned_cols=244 Identities=22% Similarity=0.269 Sum_probs=195.7
Q ss_pred ceeecCCcceEEEEEe-CCCcEEEEEEeccCcC-ChhhhHHHHHHHHHHHhcCCcceeeeeeEEEcCCCeeEEEEeecCC
Q 038766 18 NIIGNSNLSTVYKGRL-EDGEIVAVKKLNFHQF-SAESDKSFYREAKTLKELKHRNLVKVLGYAWESGKLKALILEYMEN 95 (299)
Q Consensus 18 ~~lg~g~~~~v~~~~~-~~~~~~~vK~~~~~~~-~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~lv~e~~~~ 95 (299)
+.||+|+||.||++.+ .+|+.||+|++..... .......+..|+.+++.++||||+++++.+.. +...++|+||+.+
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~hp~i~~~~~~~~~-~~~~~lv~e~~~~ 79 (323)
T cd05571 1 KLLGKGTFGKVILVREKATGKYYAMKILKKEVIIAKDEVAHTLTESRVLQNTRHPFLTALKYSFQT-HDRLCFVMEYANG 79 (323)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhCCCCCCCCEEEEEEc-CCEEEEEEeCCCC
Confidence 4799999999999986 4689999999864322 23344567789999999999999999996655 5567999999999
Q ss_pred CChHHHhcCCCCCCCCCChhhHHHHHHHHHHHHHHhhcCCCCCeeeecccCCceeeCCCCcEEEeeeccccccccccccc
Q 038766 96 GSLESVIHGPGVDHSRWTLPKRIDVLISVANGLDYLHSGYDIPIVHCDMKPSNILLDRDFEAHVSDFGTSRMLDVHLQDL 175 (299)
Q Consensus 96 ~~L~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lh~~~~~~~~H~dl~~~nil~~~~~~v~l~df~~~~~~~~~~~~~ 175 (299)
++|...+. ....+++..+..++.||+.||+|||+. +++||||||+||+++.++.++|+|||++..... .
T Consensus 80 ~~L~~~l~----~~~~~~~~~~~~~~~qi~~~L~~lH~~---~ivHrDlkp~NIll~~~~~~kl~DfG~a~~~~~----~ 148 (323)
T cd05571 80 GELFFHLS----RERVFSEDRARFYGAEIVSALGYLHSC---DVVYRDLKLENLMLDKDGHIKITDFGLCKEGIS----D 148 (323)
T ss_pred CcHHHHHH----HcCCCCHHHHHHHHHHHHHHHHHHHhC---CeEeCCCCHHHEEECCCCCEEEeeCCCCccccc----C
Confidence 99998886 445789999999999999999999999 999999999999999999999999998864321 1
Q ss_pred cccccccccCcccCChhhhcccCcCccccchhhhHHHHHHHhCCCCCCCCccCCCCchhHHHHHHHHHhcCccCcccccC
Q 038766 176 SSLSTAFQGTIGYLAPEFAYMRIVTTKVDVFSFGIVVMEFLTKRRPTGLDEENGLSPISLRQLVEKALANGINGVRQITD 255 (299)
Q Consensus 176 ~~~~~~~~~~~~y~~PE~~~~~~~~~~~DiwslG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 255 (299)
........+++.|+|||.+.+..++.++|||||||++|+|++|..||..... ........... ..
T Consensus 149 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~Pf~~~~~--------~~~~~~~~~~~-~~------ 213 (323)
T cd05571 149 GATMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDH--------EKLFELILMEE-IR------ 213 (323)
T ss_pred CCcccceecCccccChhhhcCCCCCccccCcccchhhhhhhcCCCCCCCCCH--------HHHHHHHHcCC-CC------
Confidence 1223345689999999999999999999999999999999999999953211 11111111110 00
Q ss_pred ccccchhhHhHHHHHHHHHHHHHHHHhcCCCCCCCC-----ChhhhhcC
Q 038766 256 PKLVSSIYEEQEQHQVLEELFKLALVCTSSNPEDRP-----NMNELLIT 299 (299)
Q Consensus 256 ~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rp-----t~~~il~~ 299 (299)
. +..++.++.++|++||..||++|| ++.++++|
T Consensus 214 --~---------p~~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~ll~h 251 (323)
T cd05571 214 --F---------PRTLSPEAKSLLAGLLKKDPKQRLGGGPEDAKEIMEH 251 (323)
T ss_pred --C---------CCCCCHHHHHHHHHHccCCHHHcCCCCCCCHHHHHcC
Confidence 0 223456799999999999999999 89999987
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. It is activated downstream of PI3K and plays important roles in diverse cellular functions including cell survival, growth, proliferation, angiogenesis, motility, and migration. PKB also has a central role in a variety of human cancers, having be |
| >cd05631 STKc_GRK4 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-43 Score=297.85 Aligned_cols=253 Identities=21% Similarity=0.307 Sum_probs=198.9
Q ss_pred CCCCceeecCCcceEEEEEe-CCCcEEEEEEeccCcCC-hhhhHHHHHHHHHHHhcCCcceeeeeeEEEcCCCeeEEEEe
Q 038766 14 FSENNIIGNSNLSTVYKGRL-EDGEIVAVKKLNFHQFS-AESDKSFYREAKTLKELKHRNLVKVLGYAWESGKLKALILE 91 (299)
Q Consensus 14 y~~~~~lg~g~~~~v~~~~~-~~~~~~~vK~~~~~~~~-~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~lv~e 91 (299)
|+..+.||+|+||+||++.+ .+|+.||+|++...... ......+.+|+.+++.++|++++++.+.+.. ++..++|+|
T Consensus 2 f~~~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~iv~~~~~~~~-~~~~~lv~e 80 (285)
T cd05631 2 FRHYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKRILEKVNSRFVVSLAYAYET-KDALCLVLT 80 (285)
T ss_pred ceEEEEEecCCCEEEEEEEEecCCceEEEEEeeHhhhhhhhhHHHHHHHHHHHHhcCCCcEEEEEEEEcc-CCeEEEEEE
Confidence 77889999999999999986 56899999998644322 2234567789999999999999999996654 556799999
Q ss_pred ecCCCChHHHhcCCCCCCCCCChhhHHHHHHHHHHHHHHhhcCCCCCeeeecccCCceeeCCCCcEEEeeeccccccccc
Q 038766 92 YMENGSLESVIHGPGVDHSRWTLPKRIDVLISVANGLDYLHSGYDIPIVHCDMKPSNILLDRDFEAHVSDFGTSRMLDVH 171 (299)
Q Consensus 92 ~~~~~~L~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lh~~~~~~~~H~dl~~~nil~~~~~~v~l~df~~~~~~~~~ 171 (299)
|+.+++|...+... ....+++..++.++.|++.||+|||+. +++|+||||+||+++.++.++|+|||++.....
T Consensus 81 ~~~~g~L~~~~~~~--~~~~~~~~~~~~~~~qi~~~l~~lH~~---~iiH~dikp~Nill~~~~~~kl~Dfg~~~~~~~- 154 (285)
T cd05631 81 IMNGGDLKFHIYNM--GNPGFDEQRAIFYAAELCCGLEDLQRE---RIVYRDLKPENILLDDRGHIRISDLGLAVQIPE- 154 (285)
T ss_pred ecCCCcHHHHHHhh--CCCCCCHHHHHHHHHHHHHHHHHHHhC---CEEeCCCCHHHEEECCCCCEEEeeCCCcEEcCC-
Confidence 99999998877532 234689999999999999999999999 999999999999999999999999999875431
Q ss_pred cccccccccccccCcccCChhhhcccCcCccccchhhhHHHHHHHhCCCCCCCCccCCCCchhHHHHHHHHHhcCccCcc
Q 038766 172 LQDLSSLSTAFQGTIGYLAPEFAYMRIVTTKVDVFSFGIVVMEFLTKRRPTGLDEENGLSPISLRQLVEKALANGINGVR 251 (299)
Q Consensus 172 ~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~DiwslG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 251 (299)
........++..|+|||.+.+..++.++|||||||++|+|++|..||...... ...+.+........ .
T Consensus 155 ----~~~~~~~~g~~~y~aPE~~~~~~~~~~~DvwslGvil~el~~g~~pf~~~~~~-----~~~~~~~~~~~~~~---~ 222 (285)
T cd05631 155 ----GETVRGRVGTVGYMAPEVINNEKYTFSPDWWGLGCLIYEMIQGQSPFRKRKER-----VKREEVDRRVKEDQ---E 222 (285)
T ss_pred ----CCeecCCCCCCCccCHhhhcCCCCCcccCchhHHHHHHHHHhCCCCCCCCCcc-----hhHHHHHHHhhccc---c
Confidence 11223446789999999999999999999999999999999999999654221 11111111111100 0
Q ss_pred cccCccccchhhHhHHHHHHHHHHHHHHHHhcCCCCCCCCC-----hhhhhcC
Q 038766 252 QITDPKLVSSIYEEQEQHQVLEELFKLALVCTSSNPEDRPN-----MNELLIT 299 (299)
Q Consensus 252 ~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rpt-----~~~il~~ 299 (299)
..+..++.++.+|+++||+.||++||| ++++++|
T Consensus 223 --------------~~~~~~s~~~~~li~~~l~~~P~~R~~~~~~~~~~~~~h 261 (285)
T cd05631 223 --------------EYSEKFSEDAKSICRMLLTKNPKERLGCRGNGAAGVKQH 261 (285)
T ss_pred --------------cCCccCCHHHHHHHHHHhhcCHHHhcCCCCCCHHHHhcC
Confidence 002234668899999999999999997 8899876
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK4 has a limited tissue distribution. It is mainly found i |
| >cd07862 STKc_CDK6 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-43 Score=297.11 Aligned_cols=273 Identities=23% Similarity=0.282 Sum_probs=199.7
Q ss_pred CCCCCCceeecCCcceEEEEEeC--CCcEEEEEEeccCcCChhhhHHHHHHHHHHHhc---CCcceeeeeeEEEc----C
Q 038766 12 GSFSENNIIGNSNLSTVYKGRLE--DGEIVAVKKLNFHQFSAESDKSFYREAKTLKEL---KHRNLVKVLGYAWE----S 82 (299)
Q Consensus 12 ~~y~~~~~lg~g~~~~v~~~~~~--~~~~~~vK~~~~~~~~~~~~~~~~~e~~~l~~l---~h~~i~~~~~~~~~----~ 82 (299)
++|++.+.||+|+||+||+|.+. ++..+|+|++..............+|+..++.+ .||||+++++++.. .
T Consensus 1 ~~Y~~~~~lg~G~~g~Vy~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~hpniv~~~~~~~~~~~~~ 80 (290)
T cd07862 1 QQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETFEHPNVVRLFDVCTVSRTDR 80 (290)
T ss_pred CCcceeeEeccCCCeEEEEEEEcCCCCeEEEEEEEecccCCCCchHHHHHHHHHHHhhcccCCCCcceEEEEEecccCCC
Confidence 48999999999999999999863 468899999876544444445566677777665 69999999997752 2
Q ss_pred CCeeEEEEeecCCCChHHHhcCCCCCCCCCChhhHHHHHHHHHHHHHHhhcCCCCCeeeecccCCceeeCCCCcEEEeee
Q 038766 83 GKLKALILEYMENGSLESVIHGPGVDHSRWTLPKRIDVLISVANGLDYLHSGYDIPIVHCDMKPSNILLDRDFEAHVSDF 162 (299)
Q Consensus 83 ~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lh~~~~~~~~H~dl~~~nil~~~~~~v~l~df 162 (299)
+...++|+|++. ++|.+++... ....+++..++.++.|++.||.|||+. +++|+||||+||+++.++.++|+||
T Consensus 81 ~~~~~lv~e~~~-~~l~~~~~~~--~~~~~~~~~~~~i~~qi~~aL~~lH~~---~iiH~dlkp~Nil~~~~~~~kl~Df 154 (290)
T cd07862 81 ETKLTLVFEHVD-QDLTTYLDKV--PEPGVPTETIKDMMFQLLRGLDFLHSH---RVVHRDLKPQNILVTSSGQIKLADF 154 (290)
T ss_pred CCcEEEEEccCC-CCHHHHHHhC--CCCCCCHHHHHHHHHHHHHHHHHHHHC---CeeeCCCCHHHEEEcCCCCEEEccc
Confidence 345789999996 5898888643 234689999999999999999999999 9999999999999999999999999
Q ss_pred ccccccccccccccccccccccCcccCChhhhcccCcCccccchhhhHHHHHHHhCCCCCCCCccCCCCchhHHHHHHHH
Q 038766 163 GTSRMLDVHLQDLSSLSTAFQGTIGYLAPEFAYMRIVTTKVDVFSFGIVVMEFLTKRRPTGLDEENGLSPISLRQLVEKA 242 (299)
Q Consensus 163 ~~~~~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~DiwslG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~ 242 (299)
|++..... ........+++.|+|||.+.+..++.++|||||||++|+|++|..||...... ..+...+...
T Consensus 155 g~~~~~~~-----~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~~f~~~~~~----~~~~~i~~~~ 225 (290)
T cd07862 155 GLARIYSF-----QMALTSVVVTLWYRAPEVLLQSSYATPVDLWSVGCIFAEMFRRKPLFRGSSDV----DQLGKILDVI 225 (290)
T ss_pred cceEeccC-----CcccccccccccccChHHHhCCCCCCccchHHHHHHHHHHHcCCCCcCCCCHH----HHHHHHHHHh
Confidence 99875432 12233455789999999998888999999999999999999999999643211 1111111111
Q ss_pred Hhc---CccCcccccCcccc--chhhHhHHHHHHHHHHHHHHHHhcCCCCCCCCChhhhhcC
Q 038766 243 LAN---GINGVRQITDPKLV--SSIYEEQEQHQVLEELFKLALVCTSSNPEDRPNMNELLIT 299 (299)
Q Consensus 243 ~~~---~~~~~~~~~~~~~~--~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rpt~~~il~~ 299 (299)
... .++....+....+. ...........++..+.+++.+||+.||++|||+.++|+|
T Consensus 226 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~s~~~~l~h 287 (290)
T cd07862 226 GLPGEEDWPRDVALPRQAFHSKSAQPIEKFVTDIDELGKDLLLKCLTFNPAKRISAYSALSH 287 (290)
T ss_pred CCCChhhchhhhcccchhccCCCCCCHHHHccCCCHHHHHHHHHHhccCchhcCCHHHHhcC
Confidence 000 00000000000000 0000011123456788999999999999999999999987
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 6 (CDK6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK6 is regulated by D-type cyclins and INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein, implicating it to function in regulating the early G1 phase of the cell cycle. It is expressed ubiquitously and is localized in the cytopla |
| >cd07871 STKc_PCTAIRE3 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-3 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-43 Score=297.55 Aligned_cols=269 Identities=21% Similarity=0.300 Sum_probs=198.9
Q ss_pred CCCCCCceeecCCcceEEEEEeC-CCcEEEEEEeccCcCChhhhHHHHHHHHHHHhcCCcceeeeeeEEEcCCCeeEEEE
Q 038766 12 GSFSENNIIGNSNLSTVYKGRLE-DGEIVAVKKLNFHQFSAESDKSFYREAKTLKELKHRNLVKVLGYAWESGKLKALIL 90 (299)
Q Consensus 12 ~~y~~~~~lg~g~~~~v~~~~~~-~~~~~~vK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~lv~ 90 (299)
++|.+.+.||+|+||+||++.+. ++..||+|++.... .......+.+|+.+++.++||||+++++++.. +...++|+
T Consensus 5 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~-~~~~~lv~ 82 (288)
T cd07871 5 ETYVKLDKLGEGTYATVFKGRSKLTENLVALKEIRLEH-EEGAPCTAIREVSLLKNLKHANIVTLHDIIHT-ERCLTLVF 82 (288)
T ss_pred ccceEeeEEecCCCEEEEEEEECCCCCEEEEEEecccc-cCCcchhHHHHHHHHHhCCCCCEeeEEEEEcC-CCeEEEEE
Confidence 67999999999999999999864 58999999986433 22334567789999999999999999996654 55679999
Q ss_pred eecCCCChHHHhcCCCCCCCCCChhhHHHHHHHHHHHHHHhhcCCCCCeeeecccCCceeeCCCCcEEEeeecccccccc
Q 038766 91 EYMENGSLESVIHGPGVDHSRWTLPKRIDVLISVANGLDYLHSGYDIPIVHCDMKPSNILLDRDFEAHVSDFGTSRMLDV 170 (299)
Q Consensus 91 e~~~~~~L~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lh~~~~~~~~H~dl~~~nil~~~~~~v~l~df~~~~~~~~ 170 (299)
||+.+ +|.+++... ...+++..+..++.||+.||+|||++ +++|+||||+||+++.++.++|+|||++.....
T Consensus 83 e~~~~-~l~~~l~~~---~~~~~~~~~~~~~~qi~~aL~~LH~~---~ivH~dlkp~Nil~~~~~~~kl~DfG~~~~~~~ 155 (288)
T cd07871 83 EYLDS-DLKQYLDNC---GNLMSMHNVKIFMFQLLRGLSYCHKR---KILHRDLKPQNLLINEKGELKLADFGLARAKSV 155 (288)
T ss_pred eCCCc-CHHHHHHhc---CCCCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCCHHHEEECCCCCEEECcCcceeeccC
Confidence 99965 898887532 34578899999999999999999999 999999999999999999999999999865431
Q ss_pred ccccccccccccccCcccCChhhhcc-cCcCccccchhhhHHHHHHHhCCCCCCCCccCCCCchhHHHHHHHHHhcC---
Q 038766 171 HLQDLSSLSTAFQGTIGYLAPEFAYM-RIVTTKVDVFSFGIVVMEFLTKRRPTGLDEENGLSPISLRQLVEKALANG--- 246 (299)
Q Consensus 171 ~~~~~~~~~~~~~~~~~y~~PE~~~~-~~~~~~~DiwslG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~--- 246 (299)
. ........+++.|+|||.+.+ ..++.++|||||||++|+|++|..||..... ......+.......
T Consensus 156 ~----~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~~l~~g~~pf~~~~~-----~~~~~~~~~~~~~~~~~ 226 (288)
T cd07871 156 P----TKTYSNEVVTLWYRPPDVLLGSTEYSTPIDMWGVGCILYEMATGRPMFPGSTV-----KEELHLIFRLLGTPTEE 226 (288)
T ss_pred C----CccccCceecccccChHHhcCCcccCcHHHHHHHHHHHHHHHhCCCCCCCCCH-----HHHHHHHHHHhCCCChH
Confidence 1 112233456889999998865 5688999999999999999999999954321 11111111111000
Q ss_pred -ccC------cccccCccccchhhHhHHHHHHHHHHHHHHHHhcCCCCCCCCChhhhhcC
Q 038766 247 -ING------VRQITDPKLVSSIYEEQEQHQVLEELFKLALVCTSSNPEDRPNMNELLIT 299 (299)
Q Consensus 247 -~~~------~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rpt~~~il~~ 299 (299)
++. ......+........ ......+.++.+||++||..||.+|||++|+|+|
T Consensus 227 ~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~dll~~mL~~dp~~R~t~~~~l~h 285 (288)
T cd07871 227 TWPGITSNEEFRSYLFPQYRAQPLI-NHAPRLDTDGIDLLSSLLLYETKSRISAEAALRH 285 (288)
T ss_pred HhhccccchhhhccccCccCCCchH-HhCCCCCHHHHHHHHHhcCcCcccCCCHHHHhcC
Confidence 000 000001111000000 1122346788999999999999999999999987
|
Serine/Threonine Kinases (STKs), PCTAIRE-3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-3 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-3 shows a restricted pattern of expression and is present in brain, kidney, and intestine. It is elevated in Alzheimer's disease (AD) and has been shown to associate with paired helical filament |
| >cd07869 STKc_PFTAIRE1 Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-1 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.7e-44 Score=303.04 Aligned_cols=272 Identities=22% Similarity=0.301 Sum_probs=197.2
Q ss_pred hCCCCCCceeecCCcceEEEEEeC-CCcEEEEEEeccCcCChhhhHHHHHHHHHHHhcCCcceeeeeeEEEcCCCeeEEE
Q 038766 11 TGSFSENNIIGNSNLSTVYKGRLE-DGEIVAVKKLNFHQFSAESDKSFYREAKTLKELKHRNLVKVLGYAWESGKLKALI 89 (299)
Q Consensus 11 ~~~y~~~~~lg~g~~~~v~~~~~~-~~~~~~vK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~lv 89 (299)
.++|.+.+.||+|++|+||+|.+. +++.+|+|++.... .........+|+.+++.++||||+++++++.. +...++|
T Consensus 4 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~-~~~~~lv 81 (303)
T cd07869 4 ADSYEKLEKLGEGSYATVYKGKSKVNGKLVALKVIRLQE-EEGTPFTAIREASLLKGLKHANIVLLHDIIHT-KETLTLV 81 (303)
T ss_pred cccceEeeeEEecCCEEEEEEEECCCCCEEEEEEecccc-ccccchhHHHHHHHHhhCCCCCcCeEEEEEec-CCeEEEE
Confidence 478999999999999999999875 68899999986433 22234467789999999999999999996655 5567999
Q ss_pred EeecCCCChHHHhcCCCCCCCCCChhhHHHHHHHHHHHHHHhhcCCCCCeeeecccCCceeeCCCCcEEEeeeccccccc
Q 038766 90 LEYMENGSLESVIHGPGVDHSRWTLPKRIDVLISVANGLDYLHSGYDIPIVHCDMKPSNILLDRDFEAHVSDFGTSRMLD 169 (299)
Q Consensus 90 ~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lh~~~~~~~~H~dl~~~nil~~~~~~v~l~df~~~~~~~ 169 (299)
+||+. ++|.+.+.. ....+++..+..++.|++.||+|||+. +++|+||||+||+++.++.++|+|||++....
T Consensus 82 ~e~~~-~~l~~~~~~---~~~~~~~~~~~~~~~qi~~al~~lH~~---~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~ 154 (303)
T cd07869 82 FEYVH-TDLCQYMDK---HPGGLHPENVKLFLFQLLRGLSYIHQR---YILHRDLKPQNLLISDTGELKLADFGLARAKS 154 (303)
T ss_pred EECCC-cCHHHHHHh---CCCCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHEEECCCCCEEECCCCcceecc
Confidence 99995 588777653 235688999999999999999999999 99999999999999999999999999986433
Q ss_pred cccccccccccccccCcccCChhhhcc-cCcCccccchhhhHHHHHHHhCCCCCCCCccCCCCchhHHHHHHHHHhcC--
Q 038766 170 VHLQDLSSLSTAFQGTIGYLAPEFAYM-RIVTTKVDVFSFGIVVMEFLTKRRPTGLDEENGLSPISLRQLVEKALANG-- 246 (299)
Q Consensus 170 ~~~~~~~~~~~~~~~~~~y~~PE~~~~-~~~~~~~DiwslG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~-- 246 (299)
.. ........+++.|+|||.+.+ ..++.++|||||||++|+|++|..||..... .......+.......
T Consensus 155 ~~----~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~----~~~~~~~~~~~~~~~~~ 226 (303)
T cd07869 155 VP----SHTYSNEVVTLWYRPPDVLLGSTEYSTCLDMWGVGCIFVEMIQGVAAFPGMKD----IQDQLERIFLVLGTPNE 226 (303)
T ss_pred CC----CccCCCCcccCCCCChHHHcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCcc----HHHHHHHHHHHhCCCCh
Confidence 11 112233456889999998865 4578899999999999999999999964311 111111111111000
Q ss_pred --ccCcc---cccCcccc----chhhHhHHHHHHHHHHHHHHHHhcCCCCCCCCChhhhhcC
Q 038766 247 --INGVR---QITDPKLV----SSIYEEQEQHQVLEELFKLALVCTSSNPEDRPNMNELLIT 299 (299)
Q Consensus 247 --~~~~~---~~~~~~~~----~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rpt~~~il~~ 299 (299)
+.... ........ ............+.++.+|+.+||..||++|||++++++|
T Consensus 227 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dli~~mL~~dp~~R~s~~~~l~h 288 (303)
T cd07869 227 DTWPGVHSLPHFKPERFTLYSPKNLRQAWNKLSYVNHAEDLASKLLQCFPKNRLSAQAALSH 288 (303)
T ss_pred hhccchhhccccccccccccCCccHHHHhhccCCChHHHHHHHHHhccCchhccCHHHHhcC
Confidence 00000 00000000 0000000011234678899999999999999999999987
|
Serine/Threonine Kinases (STKs), PFTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-1 is widely expressed except in the spleen and thymus. It is highly expressed in the brain, heart, pancreas, testis, and ovary, and is localized in the cytoplasm. It is regulated by cyclin D3 an |
| >PTZ00283 serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.7e-44 Score=318.51 Aligned_cols=266 Identities=24% Similarity=0.352 Sum_probs=213.9
Q ss_pred hHHHHHHhCCCCCCceeecCCcceEEEEEe-CCCcEEEEEEeccCcCChhhhHHHHHHHHHHHhcCCcceeeeeeEEEcC
Q 038766 4 RTEIENATGSFSENNIIGNSNLSTVYKGRL-EDGEIVAVKKLNFHQFSAESDKSFYREAKTLKELKHRNLVKVLGYAWES 82 (299)
Q Consensus 4 ~~~~~~~~~~y~~~~~lg~g~~~~v~~~~~-~~~~~~~vK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~ 82 (299)
..+.+...++|.+.+.||+|+||+||++.+ .+++.||+|++............+.+|+..+..+.|+|++++.+.+...
T Consensus 24 ~~~~~~~~~rY~i~~~LG~G~fG~Vy~a~~~~~g~~vAvK~i~~~~~~~~~~~~~~~Ei~~l~~~~h~~iv~~~~~~~~~ 103 (496)
T PTZ00283 24 EATAKEQAKKYWISRVLGSGATGTVLCAKRVSDGEPFAVKVVDMEGMSEADKNRAQAEVCCLLNCDFFSIVKCHEDFAKK 103 (496)
T ss_pred cccccccCCCEEEEEEEecCCCEEEEEEEEcCCCCEEEEEEEecccCCHHHHHHHHHHHHHHhcCCCCcEEEeecceecc
Confidence 345567789999999999999999999986 4689999999987666666677888999999999999999998866432
Q ss_pred CC-------eeEEEEeecCCCChHHHhcCCCCCCCCCChhhHHHHHHHHHHHHHHhhcCCCCCeeeecccCCceeeCCCC
Q 038766 83 GK-------LKALILEYMENGSLESVIHGPGVDHSRWTLPKRIDVLISVANGLDYLHSGYDIPIVHCDMKPSNILLDRDF 155 (299)
Q Consensus 83 ~~-------~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lh~~~~~~~~H~dl~~~nil~~~~~ 155 (299)
.. ..++|+||+.+++|.+.+.........+++..++.++.|++.||.|||+. +++|+||||+||+++.++
T Consensus 104 ~~~~~~~~~~i~lV~Ey~~~gsL~~~l~~~~~~~~~l~e~~~~~i~~qll~aL~~lH~~---~IiHrDLKP~NILl~~~~ 180 (496)
T PTZ00283 104 DPRNPENVLMIALVLDYANAGDLRQEIKSRAKTNRTFREHEAGLLFIQVLLAVHHVHSK---HMIHRDIKSANILLCSNG 180 (496)
T ss_pred cccCcccceEEEEEEeCCCCCcHHHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHHhC---CEecCCCCHHHEEEeCCC
Confidence 21 35799999999999998875443556899999999999999999999999 999999999999999999
Q ss_pred cEEEeeeccccccccccccccccccccccCcccCChhhhcccCcCccccchhhhHHHHHHHhCCCCCCCCccCCCCchhH
Q 038766 156 EAHVSDFGTSRMLDVHLQDLSSLSTAFQGTIGYLAPEFAYMRIVTTKVDVFSFGIVVMEFLTKRRPTGLDEENGLSPISL 235 (299)
Q Consensus 156 ~v~l~df~~~~~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~DiwslG~~l~~l~~g~~p~~~~~~~~~~~~~~ 235 (299)
.++|+|||++..+.... .........+++.|+|||++.+..++.++|||||||++|+|++|..||.... .
T Consensus 181 ~vkL~DFGls~~~~~~~--~~~~~~~~~Gt~~Y~aPE~~~~~~~s~k~DVwSlGvilyeLltG~~Pf~~~~--------~ 250 (496)
T PTZ00283 181 LVKLGDFGFSKMYAATV--SDDVGRTFCGTPYYVAPEIWRRKPYSKKADMFSLGVLLYELLTLKRPFDGEN--------M 250 (496)
T ss_pred CEEEEecccCeeccccc--cccccccccCCcceeCHHHhCCCCCCcHHHHHHHHHHHHHHHHCCCCCCCCC--------H
Confidence 99999999987654211 1122334568899999999999999999999999999999999999995331 1
Q ss_pred HHHHHHHHhcCccCcccccCccccchhhHhHHHHHHHHHHHHHHHHhcCCCCCCCCChhhhhcC
Q 038766 236 RQLVEKALANGINGVRQITDPKLVSSIYEEQEQHQVLEELFKLALVCTSSNPEDRPNMNELLIT 299 (299)
Q Consensus 236 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rpt~~~il~~ 299 (299)
.+.+.......... .+..++.++.+++.+||..||++|||+.+++.|
T Consensus 251 ~~~~~~~~~~~~~~-----------------~~~~~~~~l~~li~~~L~~dP~~RPs~~ell~~ 297 (496)
T PTZ00283 251 EEVMHKTLAGRYDP-----------------LPPSISPEMQEIVTALLSSDPKRRPSSSKLLNM 297 (496)
T ss_pred HHHHHHHhcCCCCC-----------------CCCCCCHHHHHHHHHHcccChhhCcCHHHHHhC
Confidence 22222222111100 022345679999999999999999999999875
|
|
| >KOG0580 consensus Serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.3e-45 Score=278.72 Aligned_cols=251 Identities=27% Similarity=0.361 Sum_probs=211.7
Q ss_pred hCCCCCCceeecCCcceEEEEEe-CCCcEEEEEEeccCcCC-hhhhHHHHHHHHHHHhcCCcceeeeeeEEEcCCCeeEE
Q 038766 11 TGSFSENNIIGNSNLSTVYKGRL-EDGEIVAVKKLNFHQFS-AESDKSFYREAKTLKELKHRNLVKVLGYAWESGKLKAL 88 (299)
Q Consensus 11 ~~~y~~~~~lg~g~~~~v~~~~~-~~~~~~~vK~~~~~~~~-~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~l 88 (299)
.++|.+++.||+|-||.||.|+. +++..||+|++..+++. .....++.+|+++-..++||||++++++|.+.... |+
T Consensus 21 l~dfeigr~LgkgkFG~vYlarekks~~IvalKVlfKsqi~~~~v~~qlrREiEIqs~L~hpnilrlY~~fhd~~ri-yL 99 (281)
T KOG0580|consen 21 LDDFEIGRPLGKGKFGNVYLAREKKSLFIVALKVLFKSQILKTQVEHQLRREIEIQSHLRHPNILRLYGYFHDSKRI-YL 99 (281)
T ss_pred hhhccccccccCCccccEeEeeeccCCcEEEEeeeeHHHHHHhcchhhhhheeEeecccCCccHHhhhhheecccee-EE
Confidence 57899999999999999999985 56889999998765543 34467889999999999999999999988876655 99
Q ss_pred EEeecCCCChHHHhcCCCCCCCCCChhhHHHHHHHHHHHHHHhhcCCCCCeeeecccCCceeeCCCCcEEEeeecccccc
Q 038766 89 ILEYMENGSLESVIHGPGVDHSRWTLPKRIDVLISVANGLDYLHSGYDIPIVHCDMKPSNILLDRDFEAHVSDFGTSRML 168 (299)
Q Consensus 89 v~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lh~~~~~~~~H~dl~~~nil~~~~~~v~l~df~~~~~~ 168 (299)
++||..+|.+...+... ...++++...+.++.|++.|+.|+|.. +++||||||+|+|++..|.+|++|||.+-..
T Consensus 100 ilEya~~gel~k~L~~~--~~~~f~e~~~a~Yi~q~A~Al~y~h~k---~VIhRdiKpenlLlg~~~~lkiAdfGwsV~~ 174 (281)
T KOG0580|consen 100 ILEYAPRGELYKDLQEG--RMKRFDEQRAATYIKQLANALLYCHLK---RVIHRDIKPENLLLGSAGELKIADFGWSVHA 174 (281)
T ss_pred EEEecCCchHHHHHHhc--ccccccccchhHHHHHHHHHHHHhccC---CcccCCCCHHHhccCCCCCeeccCCCceeec
Confidence 99999999999988743 456899999999999999999999999 9999999999999999999999999987532
Q ss_pred ccccccccccccccccCcccCChhhhcccCcCccccchhhhHHHHHHHhCCCCCCCCccCCCCchhHHHHHHHHHhcCcc
Q 038766 169 DVHLQDLSSLSTAFQGTIGYLAPEFAYMRIVTTKVDVFSFGIVVMEFLTKRRPTGLDEENGLSPISLRQLVEKALANGIN 248 (299)
Q Consensus 169 ~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~DiwslG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 248 (299)
.........||..|.|||...+...+...|+|++|++.|+++.|.+||... ...+.+..+...-.
T Consensus 175 ------p~~kR~tlcgt~dyl~pEmv~~~~hd~~Vd~w~lgvl~yeflvg~ppFes~-----~~~etYkrI~k~~~---- 239 (281)
T KOG0580|consen 175 ------PSNKRKTLCGTLDYLPPEMVEGRGHDKFVDLWSLGVLCYEFLVGLPPFESQ-----SHSETYKRIRKVDL---- 239 (281)
T ss_pred ------CCCCceeeecccccCCHhhcCCCCccchhhHHHHHHHHHHHHhcCCchhhh-----hhHHHHHHHHHccc----
Confidence 244566778999999999999999999999999999999999999999533 12222222222110
Q ss_pred CcccccCccccchhhHhHHHHHHHHHHHHHHHHhcCCCCCCCCChhhhhcC
Q 038766 249 GVRQITDPKLVSSIYEEQEQHQVLEELFKLALVCTSSNPEDRPNMNELLIT 299 (299)
Q Consensus 249 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rpt~~~il~~ 299 (299)
..+..++.++.++|.+|+..+|.+|.+..|+++|
T Consensus 240 -----------------~~p~~is~~a~dlI~~ll~~~p~~r~~l~~v~~h 273 (281)
T KOG0580|consen 240 -----------------KFPSTISGGAADLISRLLVKNPIERLALTEVMDH 273 (281)
T ss_pred -----------------cCCcccChhHHHHHHHHhccCccccccHHHHhhh
Confidence 1145667789999999999999999999999987
|
|
| >PHA03212 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.7e-43 Score=305.65 Aligned_cols=265 Identities=19% Similarity=0.190 Sum_probs=197.3
Q ss_pred hCCCCCCceeecCCcceEEEEEe-CCCcEEEEEEeccCcCChhhhHHHHHHHHHHHhcCCcceeeeeeEEEcCCCeeEEE
Q 038766 11 TGSFSENNIIGNSNLSTVYKGRL-EDGEIVAVKKLNFHQFSAESDKSFYREAKTLKELKHRNLVKVLGYAWESGKLKALI 89 (299)
Q Consensus 11 ~~~y~~~~~lg~g~~~~v~~~~~-~~~~~~~vK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~lv 89 (299)
.++|.+.+.||+|+||.||++.+ .+++.||+|... ...+.+|++++++++||||+++++++.. +...++|
T Consensus 91 ~~~y~~~~~lg~G~~g~V~~~~d~~~~~~vaiK~~~--------~~~~~~E~~il~~l~HpnIv~~~~~~~~-~~~~~lv 161 (391)
T PHA03212 91 KAGFSILETFTPGAEGFAFACIDNKTCEHVVIKAGQ--------RGGTATEAHILRAINHPSIIQLKGTFTY-NKFTCLI 161 (391)
T ss_pred cCCcEEEEEEcCCCCeEEEEEEECCCCCEEEEechh--------hhhhHHHHHHHHhCCCCCCCCEeEEEEE-CCeeEEE
Confidence 46899999999999999999986 458899999743 2346789999999999999999997655 5566999
Q ss_pred EeecCCCChHHHhcCCCCCCCCCChhhHHHHHHHHHHHHHHhhcCCCCCeeeecccCCceeeCCCCcEEEeeeccccccc
Q 038766 90 LEYMENGSLESVIHGPGVDHSRWTLPKRIDVLISVANGLDYLHSGYDIPIVHCDMKPSNILLDRDFEAHVSDFGTSRMLD 169 (299)
Q Consensus 90 ~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lh~~~~~~~~H~dl~~~nil~~~~~~v~l~df~~~~~~~ 169 (299)
+|++. ++|..++. ....+++.+++.++.|++.||.|||+. +++|+||||+||+++.++.++|+|||++....
T Consensus 162 ~e~~~-~~L~~~l~----~~~~l~~~~~~~i~~qi~~aL~ylH~~---~IvHrDiKP~NIll~~~~~vkL~DFG~a~~~~ 233 (391)
T PHA03212 162 LPRYK-TDLYCYLA----AKRNIAICDILAIERSVLRAIQYLHEN---RIIHRDIKAENIFINHPGDVCLGDFGAACFPV 233 (391)
T ss_pred EecCC-CCHHHHHH----hcCCCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCChHhEEEcCCCCEEEEeCCcccccc
Confidence 99995 68888876 445789999999999999999999999 99999999999999999999999999986432
Q ss_pred cccccccccccccccCcccCChhhhcccCcCccccchhhhHHHHHHHhCCCCCCCCccCCCC---chhHHHHHHHHHhcC
Q 038766 170 VHLQDLSSLSTAFQGTIGYLAPEFAYMRIVTTKVDVFSFGIVVMEFLTKRRPTGLDEENGLS---PISLRQLVEKALANG 246 (299)
Q Consensus 170 ~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~DiwslG~~l~~l~~g~~p~~~~~~~~~~---~~~~~~~~~~~~~~~ 246 (299)
.. .........+|+.|+|||++.+..++.++|||||||++|+|++|..||......... ...+...+.... ..
T Consensus 234 ~~---~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~elltg~~p~~~~~~~~~~~~~~~~l~~i~~~~g-~~ 309 (391)
T PHA03212 234 DI---NANKYYGWAGTIATNAPELLARDPYGPAVDIWSAGIVLFEMATCHDSLFEKDGLDGDCDSDRQIKLIIRRSG-TH 309 (391)
T ss_pred cc---cccccccccCccCCCChhhhcCCCCCcHHHHHHHHHHHHHHHHCCCCcCCcccccccCchhHHHHHHHHHhc-CC
Confidence 11 112223456899999999999989999999999999999999999887543211111 111111111100 00
Q ss_pred ccCcc-----------------cccCccccchhhHhHHHHHHHHHHHHHHHHhcCCCCCCCCChhhhhcC
Q 038766 247 INGVR-----------------QITDPKLVSSIYEEQEQHQVLEELFKLALVCTSSNPEDRPNMNELLIT 299 (299)
Q Consensus 247 ~~~~~-----------------~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rpt~~~il~~ 299 (299)
..... ....+... .........+.++.+||.+||..||.+|||++|+|+|
T Consensus 310 p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~---~~~~~~~~~~~~l~~Li~~mL~~dP~~Rpta~elL~h 376 (391)
T PHA03212 310 PNEFPIDAQANLDEIYIGLAKKSSRKPGSR---PLWTNLYELPIDLEYLICKMLAFDAHHRPSAEALLDF 376 (391)
T ss_pred hhhcCcchhHHHHHHHHHHHhccCCCCCCC---CCHHHHhhhhhhHHHHHHHHhcCChhhCCCHHHHhcC
Confidence 00000 00000000 0011123467789999999999999999999999987
|
|
| >KOG0193 consensus Serine/threonine protein kinase RAF [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-44 Score=308.72 Aligned_cols=264 Identities=28% Similarity=0.426 Sum_probs=215.7
Q ss_pred CChHHHHHHhCCCCCCceeecCCcceEEEEEeCCCcEEEEEEeccCcCChhhhHHHHHHHHHHHhcCCcceeeeeeEEEc
Q 038766 2 FDRTEIENATGSFSENNIIGNSNLSTVYKGRLEDGEIVAVKKLNFHQFSAESDKSFYREAKTLKELKHRNLVKVLGYAWE 81 (299)
Q Consensus 2 ~~~~~~~~~~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~vK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~ 81 (299)
-+-++|++..+++.+...||+|.||+||++.|.+ .||||+++.....++..+.+++|+..+++.+|.||+-+.|++..
T Consensus 382 ~s~~~WeIp~~ev~l~~rIGsGsFGtV~Rg~whG--dVAVK~Lnv~~pt~~qlqaFKnEVa~lkkTRH~NIlLFMG~~~~ 459 (678)
T KOG0193|consen 382 DSLEEWEIPPEEVLLGERIGSGSFGTVYRGRWHG--DVAVKLLNVDDPTPEQLQAFKNEVAVLKKTRHENILLFMGACMN 459 (678)
T ss_pred ccccccccCHHHhhccceeccccccceeeccccc--ceEEEEEecCCCCHHHHHHHHHHHHHHhhcchhhheeeehhhcC
Confidence 3558999999999999999999999999999864 59999999998899999999999999999999999999997765
Q ss_pred CCCeeEEEEeecCCCChHHHhcCCCCCCCCCChhhHHHHHHHHHHHHHHhhcCCCCCeeeecccCCceeeCCCCcEEEee
Q 038766 82 SGKLKALILEYMENGSLESVIHGPGVDHSRWTLPKRIDVLISVANGLDYLHSGYDIPIVHCDMKPSNILLDRDFEAHVSD 161 (299)
Q Consensus 82 ~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lh~~~~~~~~H~dl~~~nil~~~~~~v~l~d 161 (299)
.+ . .||+.+|.|.+|..++.. ....+.....+.|++||++|+.|||.+ +|+|+|||..|||+..++.|||+|
T Consensus 460 p~-~-AIiTqwCeGsSLY~hlHv---~etkfdm~~~idIAqQiaqGM~YLHAK---~IIHrDLKSnNIFl~~~~kVkIgD 531 (678)
T KOG0193|consen 460 PP-L-AIITQWCEGSSLYTHLHV---QETKFDMNTTIDIAQQIAQGMDYLHAK---NIIHRDLKSNNIFLHEDLKVKIGD 531 (678)
T ss_pred Cc-e-eeeehhccCchhhhhccc---hhhhhhHHHHHHHHHHHHHhhhhhhhh---hhhhhhccccceEEccCCcEEEec
Confidence 33 3 899999999999998864 446788899999999999999999999 999999999999999999999999
Q ss_pred eccccccccccccccccccccccCcccCChhhhcc---cCcCccccchhhhHHHHHHHhCCCCCCCCccCCCCchhHHHH
Q 038766 162 FGTSRMLDVHLQDLSSLSTAFQGTIGYLAPEFAYM---RIVTTKVDVFSFGIVVMEFLTKRRPTGLDEENGLSPISLRQL 238 (299)
Q Consensus 162 f~~~~~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~---~~~~~~~DiwslG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~ 238 (299)
||++..-..+ ..........+...|+|||++.. ..|+..+||||+|+++|||++|..||+.. ..+
T Consensus 532 FGLatvk~~w--~g~~q~~qp~gsilwmAPEvIRmqd~nPfS~qSDVYaFGiV~YELltg~lPysi~-~~d--------- 599 (678)
T KOG0193|consen 532 FGLATVKTRW--SGEQQLEQPHGSLLWMAPEVIRMQDDNPFSFQSDVYAFGIVWYELLTGELPYSIQ-NRD--------- 599 (678)
T ss_pred ccceeeeeee--ccccccCCCccchhhhcHHHHhhcccCCCCcccchhhhhHHHHHHHhCcCCcCCC-Chh---------
Confidence 9999864433 22233445567789999998764 56899999999999999999999999622 111
Q ss_pred HHHHHhcCccCcccccCccccchhhHhHHHHHHHHHHHHHHHHhcCCCCCCCCChhhhhc
Q 038766 239 VEKALANGINGVRQITDPKLVSSIYEEQEQHQVLEELFKLALVCTSSNPEDRPNMNELLI 298 (299)
Q Consensus 239 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rpt~~~il~ 298 (299)
+++...... ....+ ........++++.+|+..||+.++++||++.+||.
T Consensus 600 --qIifmVGrG-~l~pd--------~s~~~s~~pk~mk~Ll~~C~~~~~~eRP~F~~il~ 648 (678)
T KOG0193|consen 600 --QIIFMVGRG-YLMPD--------LSKIRSNCPKAMKRLLSDCWKFDREERPLFPQLLS 648 (678)
T ss_pred --heEEEeccc-ccCcc--------chhhhccCHHHHHHHHHHHHhcCcccCccHHHHHH
Confidence 111100000 00000 11225566778999999999999999999999985
|
|
| >cd05600 STKc_Sid2p_Dbf2p Catalytic domain of Fungal Sid2p- and Dbf2p-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-43 Score=303.66 Aligned_cols=255 Identities=20% Similarity=0.277 Sum_probs=202.8
Q ss_pred CCCCCCceeecCCcceEEEEEeC-CCcEEEEEEeccCcCC-hhhhHHHHHHHHHHHhcCCcceeeeeeEEEcCCCeeEEE
Q 038766 12 GSFSENNIIGNSNLSTVYKGRLE-DGEIVAVKKLNFHQFS-AESDKSFYREAKTLKELKHRNLVKVLGYAWESGKLKALI 89 (299)
Q Consensus 12 ~~y~~~~~lg~g~~~~v~~~~~~-~~~~~~vK~~~~~~~~-~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~lv 89 (299)
++|.+.+.||+|++|.||+|.+. +++.||+|++...... ......+..|+.+++.++||||+++++++.. +...++|
T Consensus 1 ~~y~~~~~ig~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~iv~~~~~~~~-~~~~~lv 79 (333)
T cd05600 1 KDFQILTQVGQGGYGQVFLAKKKDTGEIVALKRMKKSLLFKLNEVRHVLTERDILTTTKSEWLVKLLYAFQD-DEYLYLA 79 (333)
T ss_pred CCcEEEEEEeecCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhHHHHHHHHHHHHHhCCCCCCccEEEEEEc-CCEEEEE
Confidence 47999999999999999999875 5899999998643222 2335667889999999999999999996654 5567999
Q ss_pred EeecCCCChHHHhcCCCCCCCCCChhhHHHHHHHHHHHHHHhhcCCCCCeeeecccCCceeeCCCCcEEEeeeccccccc
Q 038766 90 LEYMENGSLESVIHGPGVDHSRWTLPKRIDVLISVANGLDYLHSGYDIPIVHCDMKPSNILLDRDFEAHVSDFGTSRMLD 169 (299)
Q Consensus 90 ~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lh~~~~~~~~H~dl~~~nil~~~~~~v~l~df~~~~~~~ 169 (299)
+||+.+++|.+++. ....+++..++.++.|++.||.|||+. +++|+||||+||+++.++.++|+|||++....
T Consensus 80 ~e~~~g~~L~~~l~----~~~~l~~~~~~~~~~qi~~~l~~lH~~---~ivH~dlkp~Nil~~~~~~~kL~Dfg~a~~~~ 152 (333)
T cd05600 80 MEYVPGGDFRTLLN----NLGVLSEDHARFYMAEMFEAVDALHEL---GYIHRDLKPENFLIDASGHIKLTDFGLSKGIV 152 (333)
T ss_pred EeCCCCCCHHHHHH----HcCCCCHHHHHHHHHHHHHHHHHHHHC---CccccCCCHHHEEECCCCCEEEEeCcCCcccc
Confidence 99999999999997 445789999999999999999999999 99999999999999999999999999987543
Q ss_pred cccccccccccccccCcccCChhhhcccCcCccccchhhhHHHHHHHhCCCCCCCCccCCCCchhHHHHHHHHHhcCccC
Q 038766 170 VHLQDLSSLSTAFQGTIGYLAPEFAYMRIVTTKVDVFSFGIVVMEFLTKRRPTGLDEENGLSPISLRQLVEKALANGING 249 (299)
Q Consensus 170 ~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~DiwslG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 249 (299)
. ......+++.|+|||.+.+..++.++|||||||++|+|++|..||.... ...... ...... .
T Consensus 153 ~-------~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~g~~pf~~~~-----~~~~~~---~i~~~~--~ 215 (333)
T cd05600 153 T-------YANSVVGSPDYMAPEVLRGKGYDFTVDYWSLGCMLYEFLCGFPPFSGST-----PNETWE---NLKYWK--E 215 (333)
T ss_pred c-------ccCCcccCccccChhHhcCCCCCCccceecchHHHhhhhhCCCCCCCCC-----HHHHHH---HHHhcc--c
Confidence 1 2344568899999999999999999999999999999999999995432 111111 111000 0
Q ss_pred cccccCccccchhhHhHHHHHHHHHHHHHHHHhcCCCCCCCCChhhhhcC
Q 038766 250 VRQITDPKLVSSIYEEQEQHQVLEELFKLALVCTSSNPEDRPNMNELLIT 299 (299)
Q Consensus 250 ~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rpt~~~il~~ 299 (299)
....+.... ....++.++.++|.+||..+|++|||++++++|
T Consensus 216 --~~~~~~~~~------~~~~~s~~~~~li~~~l~~~~~rr~s~~~ll~h 257 (333)
T cd05600 216 --TLQRPVYDD------PRFNLSDEAWDLITKLINDPSRRFGSLEDIKNH 257 (333)
T ss_pred --cccCCCCCc------cccccCHHHHHHHHHHhhChhhhcCCHHHHHhC
Confidence 000000000 012356789999999999999999999999986
|
Serine/Threonine Kinases (STKs), ROCK- and NDR-like subfamily, fungal Sid2p- and Dbf2p-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sid2p- and Dbf2p-like group is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group contains fungal kinases including Schizosaccharomyces pombe Sid2p and Saccharomyces cerevisiae Dbf2p. Group members show similarity to NDR kinases in that they contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Sid2p plays a crucial role in the septum initiation network (SIN) and in the initiation of cytokinesis. |
| >PTZ00426 cAMP-dependent protein kinase catalytic subunit; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.1e-44 Score=306.74 Aligned_cols=249 Identities=22% Similarity=0.284 Sum_probs=200.5
Q ss_pred HhCCCCCCceeecCCcceEEEEEeCC--CcEEEEEEeccCcC-ChhhhHHHHHHHHHHHhcCCcceeeeeeEEEcCCCee
Q 038766 10 ATGSFSENNIIGNSNLSTVYKGRLED--GEIVAVKKLNFHQF-SAESDKSFYREAKTLKELKHRNLVKVLGYAWESGKLK 86 (299)
Q Consensus 10 ~~~~y~~~~~lg~g~~~~v~~~~~~~--~~~~~vK~~~~~~~-~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~ 86 (299)
..++|.+.+.||+|+||.||+|.+.+ +..||+|++..... .......+..|+.+++.++||||+++++++.. +...
T Consensus 28 ~~~~y~~~~~ig~G~~g~Vy~a~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~Iv~~~~~~~~-~~~~ 106 (340)
T PTZ00426 28 KYEDFNFIRTLGTGSFGRVILATYKNEDFPPVAIKRFEKSKIIKQKQVDHVFSERKILNYINHPFCVNLYGSFKD-ESYL 106 (340)
T ss_pred ChhhcEEEEEEeecCCeEEEEEEEECCCCeEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhCCCCCCcceEEEEEe-CCEE
Confidence 45689999999999999999997543 46899999864322 23345678889999999999999999997655 5567
Q ss_pred EEEEeecCCCChHHHhcCCCCCCCCCChhhHHHHHHHHHHHHHHhhcCCCCCeeeecccCCceeeCCCCcEEEeeecccc
Q 038766 87 ALILEYMENGSLESVIHGPGVDHSRWTLPKRIDVLISVANGLDYLHSGYDIPIVHCDMKPSNILLDRDFEAHVSDFGTSR 166 (299)
Q Consensus 87 ~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lh~~~~~~~~H~dl~~~nil~~~~~~v~l~df~~~~ 166 (299)
++|+||+.+++|.+++. ....+++..+..++.|++.||.|||+. +++||||||+||+++.++.++|+|||++.
T Consensus 107 ~lv~Ey~~~g~L~~~i~----~~~~~~~~~~~~~~~qi~~aL~~LH~~---~ivHrDLkp~NILl~~~~~ikL~DFG~a~ 179 (340)
T PTZ00426 107 YLVLEFVIGGEFFTFLR----RNKRFPNDVGCFYAAQIVLIFEYLQSL---NIVYRDLKPENLLLDKDGFIKMTDFGFAK 179 (340)
T ss_pred EEEEeCCCCCcHHHHHH----HcCCCCHHHHHHHHHHHHHHHHHHHHC---CeEccCCCHHHEEECCCCCEEEecCCCCe
Confidence 99999999999999997 445799999999999999999999999 99999999999999999999999999987
Q ss_pred ccccccccccccccccccCcccCChhhhcccCcCccccchhhhHHHHHHHhCCCCCCCCccCCCCchhHHHHHHHHHhcC
Q 038766 167 MLDVHLQDLSSLSTAFQGTIGYLAPEFAYMRIVTTKVDVFSFGIVVMEFLTKRRPTGLDEENGLSPISLRQLVEKALANG 246 (299)
Q Consensus 167 ~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~DiwslG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~ 246 (299)
.... ......+++.|+|||++.+..++.++|+|||||++|+|++|..||.... ...... ... ..
T Consensus 180 ~~~~-------~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~ell~G~~Pf~~~~-----~~~~~~---~i~-~~ 243 (340)
T PTZ00426 180 VVDT-------RTYTLCGTPEYIAPEILLNVGHGKAADWWTLGIFIYEILVGCPPFYANE-----PLLIYQ---KIL-EG 243 (340)
T ss_pred ecCC-------CcceecCChhhcCHHHHhCCCCCccccccchhhHHHHHhcCCCCCCCCC-----HHHHHH---HHh-cC
Confidence 5431 1234567899999999999889999999999999999999999995431 111111 111 11
Q ss_pred ccCcccccCccccchhhHhHHHHHHHHHHHHHHHHhcCCCCCCCC-----ChhhhhcC
Q 038766 247 INGVRQITDPKLVSSIYEEQEQHQVLEELFKLALVCTSSNPEDRP-----NMNELLIT 299 (299)
Q Consensus 247 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rp-----t~~~il~~ 299 (299)
... + +...+..+.++|++||..||++|+ |++++++|
T Consensus 244 ~~~---~--------------p~~~~~~~~~li~~~l~~dp~~R~~~~~~~~~~~~~h 284 (340)
T PTZ00426 244 IIY---F--------------PKFLDNNCKHLMKKLLSHDLTKRYGNLKKGAQNVKEH 284 (340)
T ss_pred CCC---C--------------CCCCCHHHHHHHHHHcccCHHHcCCCCCCCHHHHHcC
Confidence 000 0 122345788999999999999995 89999887
|
|
| >KOG0201 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-45 Score=303.50 Aligned_cols=254 Identities=25% Similarity=0.378 Sum_probs=210.9
Q ss_pred HHHhCCCCCCceeecCCcceEEEEEe-CCCcEEEEEEeccCcCChhhhHHHHHHHHHHHhcCCcceeeeeeEEEcCCCee
Q 038766 8 ENATGSFSENNIIGNSNLSTVYKGRL-EDGEIVAVKKLNFHQFSAESDKSFYREAKTLKELKHRNLVKVLGYAWESGKLK 86 (299)
Q Consensus 8 ~~~~~~y~~~~~lg~g~~~~v~~~~~-~~~~~~~vK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~ 86 (299)
..-...|+..+.||+|+||.||++.+ ..++.||+|++.... ..+..+.+++|+..+..++++||.+.++.+.. +..+
T Consensus 9 ~~~~~~~~~~~~IgrGsfG~Vyk~~d~~t~k~vAiKii~Le~-~~deIediqqei~~Ls~~~~~~it~yygsyl~-g~~L 86 (467)
T KOG0201|consen 9 IDPELLYTKLELIGRGSFGEVYKAIDNKTKKVVAIKIIDLEE-AEDEIEDIQQEISVLSQCDSPNITEYYGSYLK-GTKL 86 (467)
T ss_pred CCcccccccchhccccccceeeeeeeccccceEEEEEechhh-cchhhHHHHHHHHHHHhcCcchHHhhhhheee-cccH
Confidence 34456788889999999999999986 568999999997643 44567789999999999999999999996554 6677
Q ss_pred EEEEeecCCCChHHHhcCCCCCCCCCChhhHHHHHHHHHHHHHHhhcCCCCCeeeecccCCceeeCCCCcEEEeeecccc
Q 038766 87 ALILEYMENGSLESVIHGPGVDHSRWTLPKRIDVLISVANGLDYLHSGYDIPIVHCDMKPSNILLDRDFEAHVSDFGTSR 166 (299)
Q Consensus 87 ~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lh~~~~~~~~H~dl~~~nil~~~~~~v~l~df~~~~ 166 (299)
.++|||+.||++.++++ .+..+.+.++..++.+++.|+.|||.. +.+|+|||+.||++..+|.|+|.|||.+.
T Consensus 87 wiiMey~~gGsv~~lL~----~~~~~~E~~i~~ilre~l~~l~ylH~~---~kiHrDIKaanil~s~~g~vkl~DfgVa~ 159 (467)
T KOG0201|consen 87 WIIMEYCGGGSVLDLLK----SGNILDEFEIAVILREVLKGLDYLHSE---KKIHRDIKAANILLSESGDVKLADFGVAG 159 (467)
T ss_pred HHHHHHhcCcchhhhhc----cCCCCccceeeeehHHHHHHhhhhhhc---ceecccccccceeEeccCcEEEEecceee
Confidence 99999999999999997 555669999999999999999999999 99999999999999999999999999987
Q ss_pred ccccccccccccccccccCcccCChhhhcccCcCccccchhhhHHHHHHHhCCCCCCCCccCCCCchhHHHHHHHHHhcC
Q 038766 167 MLDVHLQDLSSLSTAFQGTIGYLAPEFAYMRIVTTKVDVFSFGIVVMEFLTKRRPTGLDEENGLSPISLRQLVEKALANG 246 (299)
Q Consensus 167 ~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~DiwslG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~ 246 (299)
.+. .........+||+.|||||++.+..|+.++||||||+++++|.+|.+|+... .++.+
T Consensus 160 ql~----~~~~rr~tfvGTPfwMAPEVI~~~~Y~~KADIWSLGITaiEla~GePP~s~~-----hPmrv----------- 219 (467)
T KOG0201|consen 160 QLT----NTVKRRKTFVGTPFWMAPEVIKQSGYDTKADIWSLGITAIELAKGEPPHSKL-----HPMRV----------- 219 (467)
T ss_pred eee----chhhccccccccccccchhhhccccccchhhhhhhhHHHHHHhcCCCCCccc-----CcceE-----------
Confidence 654 2234447889999999999999999999999999999999999999998533 11110
Q ss_pred ccCcccccCccccchhhHhHHHHHHHHHHHHHHHHhcCCCCCCCCChhhhhcC
Q 038766 247 INGVRQITDPKLVSSIYEEQEQHQVLEELFKLALVCTSSNPEDRPNMNELLIT 299 (299)
Q Consensus 247 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rpt~~~il~~ 299 (299)
...|..... .......+..+.+++..||+.||+.||||.++|+|
T Consensus 220 ---lflIpk~~P------P~L~~~~S~~~kEFV~~CL~k~P~~RpsA~~LLKh 263 (467)
T KOG0201|consen 220 ---LFLIPKSAP------PRLDGDFSPPFKEFVEACLDKNPEFRPSAKELLKH 263 (467)
T ss_pred ---EEeccCCCC------CccccccCHHHHHHHHHHhhcCcccCcCHHHHhhh
Confidence 111111100 01123567789999999999999999999999987
|
|
| >KOG0611 consensus Predicted serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-44 Score=295.53 Aligned_cols=253 Identities=19% Similarity=0.324 Sum_probs=211.0
Q ss_pred HHHHhCCCCCCceeecCCcceEEEEEe-CCCcEEEEEEeccCcCC-hhhhHHHHHHHHHHHhcCCcceeeeeeEEEcCCC
Q 038766 7 IENATGSFSENNIIGNSNLSTVYKGRL-EDGEIVAVKKLNFHQFS-AESDKSFYREAKTLKELKHRNLVKVLGYAWESGK 84 (299)
Q Consensus 7 ~~~~~~~y~~~~~lg~g~~~~v~~~~~-~~~~~~~vK~~~~~~~~-~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~ 84 (299)
..++.-+|.+.+.||+|.+|.|-+|.. ..|+.||||.++...+. ....-.+.+|+++|..++||||+.++.+|...++
T Consensus 48 khnlkHRyE~~etLGkGTYGKVk~A~e~~sgR~VAiKsIrKdkIkdeqDlvhIRREIeIMSsLNHPhII~IyEVFENkdK 127 (668)
T KOG0611|consen 48 KHNLKHRYEITETLGKGTYGKVKLAYEHKSGREVAIKSIRKDKIKDEQDLVHIRREIEIMSSLNHPHIIQIYEVFENKDK 127 (668)
T ss_pred ccchhhHHHHHHHhcCCcccceeehhhccCCcEeehhhhhhhhcccHHHHHHHHHHHHHHhhcCCCceeehhhhhcCCce
Confidence 356777999999999999999999985 67999999999866553 3446678999999999999999999996655555
Q ss_pred eeEEEEeecCCCChHHHhcCCCCCCCCCChhhHHHHHHHHHHHHHHhhcCCCCCeeeecccCCceeeCCCCcEEEeeecc
Q 038766 85 LKALILEYMENGSLESVIHGPGVDHSRWTLPKRIDVLISVANGLDYLHSGYDIPIVHCDMKPSNILLDRDFEAHVSDFGT 164 (299)
Q Consensus 85 ~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lh~~~~~~~~H~dl~~~nil~~~~~~v~l~df~~ 164 (299)
. .+||||..+|.|.+++. .+..+++.++..++.||.+|+.|+|.+ +++|+|||.+|||+|.++++||.|||+
T Consensus 128 I-vivMEYaS~GeLYDYiS----er~~LsErEaRhfFRQIvSAVhYCHkn---rVvHRDLKLENILLD~N~NiKIADFGL 199 (668)
T KOG0611|consen 128 I-VIVMEYASGGELYDYIS----ERGSLSEREARHFFRQIVSAVHYCHKN---RVVHRDLKLENILLDQNNNIKIADFGL 199 (668)
T ss_pred E-EEEEEecCCccHHHHHH----HhccccHHHHHHHHHHHHHHHHHHhhc---cceecccchhheeecCCCCeeeeccch
Confidence 4 99999999999999998 566899999999999999999999999 999999999999999999999999999
Q ss_pred ccccccccccccccccccccCcccCChhhhcccCcC-ccccchhhhHHHHHHHhCCCCCCCCccCCCCchhHHHHHHHHH
Q 038766 165 SRMLDVHLQDLSSLSTAFQGTIGYLAPEFAYMRIVT-TKVDVFSFGIVVMEFLTKRRPTGLDEENGLSPISLRQLVEKAL 243 (299)
Q Consensus 165 ~~~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~-~~~DiwslG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~ 243 (299)
+..+. ......++.|+|.|.+||+..+..|. +..|.||||++||.|..|..||++... ...+.++.
T Consensus 200 SNly~-----~~kfLqTFCGSPLYASPEIvNG~PY~GPEVDsWsLGvLLYtLVyGtMPFDG~Dh--------k~lvrQIs 266 (668)
T KOG0611|consen 200 SNLYA-----DKKFLQTFCGSPLYASPEIVNGTPYKGPEVDSWSLGVLLYTLVYGTMPFDGRDH--------KRLVRQIS 266 (668)
T ss_pred hhhhc-----cccHHHHhcCCcccCCccccCCCCCCCCccchhhHHHHHHHHhhcccccCCchH--------HHHHHHhh
Confidence 97665 24556778899999999999998875 579999999999999999999965422 23333332
Q ss_pred hcCccCcccccCccccchhhHhHHHHHHHHHHHHHHHHhcCCCCCCCCChhhhhcC
Q 038766 244 ANGINGVRQITDPKLVSSIYEEQEQHQVLEELFKLALVCTSSNPEDRPNMNELLIT 299 (299)
Q Consensus 244 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rpt~~~il~~ 299 (299)
.....+ +.-+.++.-||++||.++|++|.|+++|-.|
T Consensus 267 ~GaYrE-------------------P~~PSdA~gLIRwmLmVNP~RRATieDiAsH 303 (668)
T KOG0611|consen 267 RGAYRE-------------------PETPSDASGLIRWMLMVNPERRATIEDIASH 303 (668)
T ss_pred cccccC-------------------CCCCchHHHHHHHHHhcCcccchhHHHHhhh
Confidence 211111 0112357779999999999999999998665
|
|
| >KOG0658 consensus Glycogen synthase kinase-3 [Carbohydrate transport and metabolism] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-44 Score=292.72 Aligned_cols=268 Identities=26% Similarity=0.341 Sum_probs=203.1
Q ss_pred CCCCCceeecCCcceEEEEEe-CCCcEEEEEEeccCcCChhhhHHHHHHHHHHHhcCCcceeeeeeEEEcCCC----eeE
Q 038766 13 SFSENNIIGNSNLSTVYKGRL-EDGEIVAVKKLNFHQFSAESDKSFYREAKTLKELKHRNLVKVLGYAWESGK----LKA 87 (299)
Q Consensus 13 ~y~~~~~lg~g~~~~v~~~~~-~~~~~~~vK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~----~~~ 87 (299)
.|.-.+++|+|+||+||.+.. .+++.+|||..-+... .--.|+++|+.+.||||+++.-++..... ++.
T Consensus 25 ~~~~~~liG~GsFg~Vyq~~~~e~~~~vAIKKv~~d~r------~knrEl~im~~l~HpNIV~L~~~f~~~~~~d~~~ln 98 (364)
T KOG0658|consen 25 SYEAVRLIGSGSFGVVYQAKLRETEEEVAIKKVLQDKR------YKNRELQIMRKLDHPNIVRLLYFFSSSTESDEVYLN 98 (364)
T ss_pred EEEeeEEEeecccceEEEEEEcCCCceeEEEEecCCCC------cCcHHHHHHHhcCCcCeeeEEEEEEecCCCchhHHH
Confidence 577789999999999999986 4579999999754322 12258999999999999999987764432 456
Q ss_pred EEEeecCCCChHHHhcCCCCCCCCCChhhHHHHHHHHHHHHHHhhcCCCCCeeeecccCCceeeCCC-CcEEEeeecccc
Q 038766 88 LILEYMENGSLESVIHGPGVDHSRWTLPKRIDVLISVANGLDYLHSGYDIPIVHCDMKPSNILLDRD-FEAHVSDFGTSR 166 (299)
Q Consensus 88 lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lh~~~~~~~~H~dl~~~nil~~~~-~~v~l~df~~~~ 166 (299)
+|+||++. +|...++.....+..++.-.+.-+..||+.||+|||+. ++|||||||+|+|+|.+ |.+||+|||.+.
T Consensus 99 lVleymP~-tL~~~~r~~~~~~~~mp~~~iKLYt~Qlfrgl~yLh~~---~IcHRDIKPqNlLvD~~tg~LKicDFGSAK 174 (364)
T KOG0658|consen 99 LVLEYMPE-TLYRVIRHYTRANQRMPLLEIKLYTYQLFRGLAYLHSH---GICHRDIKPQNLLVDPDTGVLKICDFGSAK 174 (364)
T ss_pred HHHHhchH-HHHHHHHHHhhcCCCCceeeeHHHHHHHHHHHHHHHhc---CcccCCCChheEEEcCCCCeEEeccCCcce
Confidence 89999976 99999876555678999999999999999999999998 99999999999999977 899999999998
Q ss_pred ccccccccccccccccccCcccCChhhhccc-CcCccccchhhhHHHHHHHhCCCCCCCCccCCCCchhHHHHHHHHHhc
Q 038766 167 MLDVHLQDLSSLSTAFQGTIGYLAPEFAYMR-IVTTKVDVFSFGIVVMEFLTKRRPTGLDEENGLSPISLRQLVEKALAN 245 (299)
Q Consensus 167 ~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~-~~~~~~DiwslG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~ 245 (299)
.+....+ .....-|..|+|||++.+. .|+.+.||||.||++.||+-|++.|.+.... .++...+......
T Consensus 175 ~L~~~ep-----niSYicSRyYRaPELifga~~Yt~~IDiWSaGCV~aELl~g~plFpG~s~~----dQL~eIik~lG~P 245 (364)
T KOG0658|consen 175 VLVKGEP-----NISYICSRYYRAPELIFGATEYTTSIDIWSAGCVMAELLKGQPLFPGDSSV----DQLVEIIKVLGTP 245 (364)
T ss_pred eeccCCC-----ceeEEEeccccCHHHHcCccccCceeEEhhhhHHHHHHhcCCcccCCCCHH----HHHHHHHHHhCCC
Confidence 7663222 2333447789999988875 6999999999999999999999999654221 1222222111111
Q ss_pred CccCcc-------cccCccccchhhHhHHHHHHHHHHHHHHHHhcCCCCCCCCChhhhhcC
Q 038766 246 GINGVR-------QITDPKLVSSIYEEQEQHQVLEELFKLALVCTSSNPEDRPNMNELLIT 299 (299)
Q Consensus 246 ~~~~~~-------~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rpt~~~il~~ 299 (299)
...++. ....+......+........++++.+|+.++|..+|.+|.|+.|++.|
T Consensus 246 t~e~I~~mn~~y~~~~~p~ik~~~~~~~~~~~~~~d~~dll~~~L~Y~P~~R~~~~~~l~h 306 (364)
T KOG0658|consen 246 TREDIKSMNPNYTEFKFPQIKAHPWHKVFFKRLPPDALDLLSKLLQYSPSKRLSALEALAH 306 (364)
T ss_pred CHHHHhhcCcccccccCcccccccceeecccCCCHHHHHHHHHHhccChhhcCCHHHHhcc
Confidence 111111 111122222222223466677899999999999999999999999987
|
|
| >cd07876 STKc_JNK2 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.2e-43 Score=303.97 Aligned_cols=272 Identities=24% Similarity=0.257 Sum_probs=201.3
Q ss_pred HHhCCCCCCceeecCCcceEEEEEeC-CCcEEEEEEeccCcCChhhhHHHHHHHHHHHhcCCcceeeeeeEEEcCC----
Q 038766 9 NATGSFSENNIIGNSNLSTVYKGRLE-DGEIVAVKKLNFHQFSAESDKSFYREAKTLKELKHRNLVKVLGYAWESG---- 83 (299)
Q Consensus 9 ~~~~~y~~~~~lg~g~~~~v~~~~~~-~~~~~~vK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~---- 83 (299)
.+.++|.+.+.||+|+||.||++.+. +|..+|+|++............+.+|+..++.++||||+++++++....
T Consensus 18 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~ 97 (359)
T cd07876 18 TVLKRYQQLKPIGSGAQGIVCAAFDTVLGINVAVKKLSRPFQNQTHAKRAYRELVLLKCVNHKNIISLLNVFTPQKSLEE 97 (359)
T ss_pred hhhhceEEEEEeecCCCEEEEEEEEcCCCceeEEEEecccccchhHHHHHHHHHHHHHhCCCCCEeeeeeeeccCCCccc
Confidence 56789999999999999999999874 5899999998755444555677889999999999999999999775433
Q ss_pred -CeeEEEEeecCCCChHHHhcCCCCCCCCCChhhHHHHHHHHHHHHHHhhcCCCCCeeeecccCCceeeCCCCcEEEeee
Q 038766 84 -KLKALILEYMENGSLESVIHGPGVDHSRWTLPKRIDVLISVANGLDYLHSGYDIPIVHCDMKPSNILLDRDFEAHVSDF 162 (299)
Q Consensus 84 -~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lh~~~~~~~~H~dl~~~nil~~~~~~v~l~df 162 (299)
...++|+||+.+ +|...+. ..+++..+..++.|++.||.|||++ +++||||||+||+++.++.++|+||
T Consensus 98 ~~~~~lv~e~~~~-~l~~~~~------~~~~~~~~~~~~~qi~~~L~~LH~~---~ivHrDlkp~NIl~~~~~~~kl~Df 167 (359)
T cd07876 98 FQDVYLVMELMDA-NLCQVIH------MELDHERMSYLLYQMLCGIKHLHSA---GIIHRDLKPSNIVVKSDCTLKILDF 167 (359)
T ss_pred cceeEEEEeCCCc-CHHHHHh------ccCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCCHHHEEECCCCCEEEecC
Confidence 246899999965 6766663 2478889999999999999999999 9999999999999999999999999
Q ss_pred ccccccccccccccccccccccCcccCChhhhcccCcCccccchhhhHHHHHHHhCCCCCCCCccCCCCchhHHHHHHH-
Q 038766 163 GTSRMLDVHLQDLSSLSTAFQGTIGYLAPEFAYMRIVTTKVDVFSFGIVVMEFLTKRRPTGLDEENGLSPISLRQLVEK- 241 (299)
Q Consensus 163 ~~~~~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~DiwslG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~- 241 (299)
|++..... ........+++.|+|||.+.+..++.++|||||||++|+|++|..||...... ..+...+..
T Consensus 168 g~a~~~~~-----~~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwSlG~il~el~tg~~pf~~~~~~----~~~~~~~~~~ 238 (359)
T cd07876 168 GLARTACT-----NFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGELVKGSVIFQGTDHI----DQWNKVIEQL 238 (359)
T ss_pred CCcccccc-----CccCCCCcccCCCCCchhccCCCCCcchhhHHHHHHHHHHHhCCCCCCCCCHH----HHHHHHHHhc
Confidence 99864321 11223345788999999999999999999999999999999999999644211 011111100
Q ss_pred -------------HHh---cCccCcccccCccccch---hhHhHHHHHHHHHHHHHHHHhcCCCCCCCCChhhhhcC
Q 038766 242 -------------ALA---NGINGVRQITDPKLVSS---IYEEQEQHQVLEELFKLALVCTSSNPEDRPNMNELLIT 299 (299)
Q Consensus 242 -------------~~~---~~~~~~~~~~~~~~~~~---~~~~~~~~~~~~~l~~li~~~l~~dP~~Rpt~~~il~~ 299 (299)
... ................. ..........+..+.+||.+||..||++|||+.|+|+|
T Consensus 239 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~R~t~~e~l~h 315 (359)
T cd07876 239 GTPSAEFMNRLQPTVRNYVENRPQYPGISFEELFPDWIFPSESERDKLKTSQARDLLSKMLVIDPDKRISVDEALRH 315 (359)
T ss_pred CCCcHHHHHHHHHHHHHHHhhCCCCCCcchhhhccccccccccccccccchhHHHHHHHHhccCcccCCCHHHHhcC
Confidence 000 00000000000000000 00000112235678999999999999999999999987
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 2 (JNK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jn |
| >KOG0033 consensus Ca2+/calmodulin-dependent protein kinase, EF-Hand protein superfamily [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-45 Score=283.78 Aligned_cols=257 Identities=24% Similarity=0.348 Sum_probs=211.7
Q ss_pred HHHhCCCCCCceeecCCcceEEEEEe-CCCcEEEEEEeccCcCChhhhHHHHHHHHHHHhcCCcceeeeeeEEEcCCCee
Q 038766 8 ENATGSFSENNIIGNSNLSTVYKGRL-EDGEIVAVKKLNFHQFSAESDKSFYREAKTLKELKHRNLVKVLGYAWESGKLK 86 (299)
Q Consensus 8 ~~~~~~y~~~~~lg~g~~~~v~~~~~-~~~~~~~vK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~ 86 (299)
-.+.++|.+.+.||+|.|+.|+++.+ .+|+.+++|+++.+..+....+.+.+|+.+.+.++||||+.+.+ .+....+.
T Consensus 7 ~~f~d~y~l~e~igkG~FSvVrRc~~~~tg~~fa~kiin~~k~~~~~~e~l~rEarIC~~LqHP~IvrL~~-ti~~~~~~ 85 (355)
T KOG0033|consen 7 TKFSDNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVRLHD-SIQEESFH 85 (355)
T ss_pred cccchhhhHHHHHccCchHHHHHHHhccchHHHHHHHhhhhhhccccHHHHHHHHHHHHhcCCCcEeehhh-hhccccee
Confidence 34678899999999999999999865 56999999999887777778889999999999999999999999 45556677
Q ss_pred EEEEeecCCCChHHHhcCCCCCCCCCChhhHHHHHHHHHHHHHHhhcCCCCCeeeecccCCceeeC---CCCcEEEeeec
Q 038766 87 ALILEYMENGSLESVIHGPGVDHSRWTLPKRIDVLISVANGLDYLHSGYDIPIVHCDMKPSNILLD---RDFEAHVSDFG 163 (299)
Q Consensus 87 ~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lh~~~~~~~~H~dl~~~nil~~---~~~~v~l~df~ 163 (299)
++|+|.+.|+.|..-+- ....++|..+-.+++||+.||.|+|.+ +|+|||+||.|+++- ...-|||+|||
T Consensus 86 ylvFe~m~G~dl~~eIV----~R~~ySEa~aSH~~rQiLeal~yCH~n---~IvHRDvkP~nllLASK~~~A~vKL~~FG 158 (355)
T KOG0033|consen 86 YLVFDLVTGGELFEDIV----AREFYSEADASHCIQQILEALAYCHSN---GIVHRDLKPENLLLASKAKGAAVKLADFG 158 (355)
T ss_pred EEEEecccchHHHHHHH----HHHHHHHHHHHHHHHHHHHHHHHHHhc---CceeccCChhheeeeeccCCCceeecccc
Confidence 99999999999975443 335789999999999999999999999 999999999999994 34569999999
Q ss_pred cccccccccccccccccccccCcccCChhhhcccCcCccccchhhhHHHHHHHhCCCCCCCCccCCCCchhHHHHHHHHH
Q 038766 164 TSRMLDVHLQDLSSLSTAFQGTIGYLAPEFAYMRIVTTKVDVFSFGIVVMEFLTKRRPTGLDEENGLSPISLRQLVEKAL 243 (299)
Q Consensus 164 ~~~~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~DiwslG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~ 243 (299)
++..+. .........|+|+|+|||++....|+..+|||+-|+++|-|+.|+.||.... ...++ +++.
T Consensus 159 vAi~l~-----~g~~~~G~~GtP~fmaPEvvrkdpy~kpvDiW~cGViLfiLL~G~~PF~~~~-----~~rly---e~I~ 225 (355)
T KOG0033|consen 159 LAIEVN-----DGEAWHGFAGTPGYLSPEVLKKDPYSKPVDIWACGVILYILLVGYPPFWDED-----QHRLY---EQIK 225 (355)
T ss_pred eEEEeC-----CccccccccCCCcccCHHHhhcCCCCCcchhhhhhHHHHHHHhCCCCCCCcc-----HHHHH---HHHh
Confidence 998665 3455667889999999999999999999999999999999999999995421 11222 2222
Q ss_pred hcCccCcccccCccccchhhHhHHHHHHHHHHHHHHHHhcCCCCCCCCChhhhhcC
Q 038766 244 ANGINGVRQITDPKLVSSIYEEQEQHQVLEELFKLALVCTSSNPEDRPNMNELLIT 299 (299)
Q Consensus 244 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rpt~~~il~~ 299 (299)
.. ...+..+. -..+++++.+||++||..||.+|.|+.|.|.|
T Consensus 226 ~g----~yd~~~~~----------w~~is~~Ak~LvrrML~~dP~kRIta~EAL~H 267 (355)
T KOG0033|consen 226 AG----AYDYPSPE----------WDTVTPEAKSLIRRMLTVNPKKRITADEALKH 267 (355)
T ss_pred cc----ccCCCCcc----------cCcCCHHHHHHHHHHhccChhhhccHHHHhCC
Confidence 11 11111111 33456789999999999999999999999987
|
|
| >KOG0585 consensus Ca2+/calmodulin-dependent protein kinase kinase beta and related serine/threonine protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.8e-44 Score=296.41 Aligned_cols=267 Identities=25% Similarity=0.342 Sum_probs=204.4
Q ss_pred CChHHHHHHhCCCCCCceeecCCcceEEEEEeC-CCcEEEEEEeccCcCC------------hhhhHHHHHHHHHHHhcC
Q 038766 2 FDRTEIENATGSFSENNIIGNSNLSTVYKGRLE-DGEIVAVKKLNFHQFS------------AESDKSFYREAKTLKELK 68 (299)
Q Consensus 2 ~~~~~~~~~~~~y~~~~~lg~g~~~~v~~~~~~-~~~~~~vK~~~~~~~~------------~~~~~~~~~e~~~l~~l~ 68 (299)
|+..+-....++|.+.+.||+|.+|.|-+|.+. +++.||+|++...... -...+..++|+.+|+++.
T Consensus 87 ~~~~~~~k~lNqy~l~~eiG~G~yGkVkLar~~~~~~l~AiKil~K~~~~~~~~~~~~~a~~~~~~ekv~~EIailKkl~ 166 (576)
T KOG0585|consen 87 YDDDQDRKQLNQYELIKEIGSGQYGKVKLARDEVDGKLYAIKILPKKELRRQYGFPRQPAMKLMPIEKVRREIAILKKLH 166 (576)
T ss_pred ecCcccceehhheehhhhhcCCccceEEEEeecCCCcEEEEEeechhhhhhhcccccccccccCcHHHHHHHHHHHHhcC
Confidence 445555667889999999999999999999864 6999999998653221 122368899999999999
Q ss_pred CcceeeeeeEEEc-CCCeeEEEEeecCCCChHHHhcCCCCCCCCCChhhHHHHHHHHHHHHHHhhcCCCCCeeeecccCC
Q 038766 69 HRNLVKVLGYAWE-SGKLKALILEYMENGSLESVIHGPGVDHSRWTLPKRIDVLISVANGLDYLHSGYDIPIVHCDMKPS 147 (299)
Q Consensus 69 h~~i~~~~~~~~~-~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lh~~~~~~~~H~dl~~~ 147 (299)
||||++++++.-+ +...+|+|+||+..|.+...-. ++..+++.+++.++..++.+|.|||.+ +++||||||+
T Consensus 167 H~nVV~LiEvLDDP~s~~~YlVley~s~G~v~w~p~----d~~els~~~Ar~ylrDvv~GLEYLH~Q---giiHRDIKPs 239 (576)
T KOG0585|consen 167 HPNVVKLIEVLDDPESDKLYLVLEYCSKGEVKWCPP----DKPELSEQQARKYLRDVVLGLEYLHYQ---GIIHRDIKPS 239 (576)
T ss_pred CcCeeEEEEeecCcccCceEEEEEeccCCccccCCC----CcccccHHHHHHHHHHHHHHHHHHHhc---Ceeccccchh
Confidence 9999999996543 3355799999998777654332 333399999999999999999999999 9999999999
Q ss_pred ceeeCCCCcEEEeeecccccccccc-ccccccccccccCcccCChhhhcccC----cCccccchhhhHHHHHHHhCCCCC
Q 038766 148 NILLDRDFEAHVSDFGTSRMLDVHL-QDLSSLSTAFQGTIGYLAPEFAYMRI----VTTKVDVFSFGIVVMEFLTKRRPT 222 (299)
Q Consensus 148 nil~~~~~~v~l~df~~~~~~~~~~-~~~~~~~~~~~~~~~y~~PE~~~~~~----~~~~~DiwslG~~l~~l~~g~~p~ 222 (299)
|+|++.+|.|||+|||.+....... .+.........|||.|+|||...+.. .+.+.||||+|++||.|+.|..||
T Consensus 240 NLLl~~~g~VKIsDFGVs~~~~~~~~~~~d~~L~~tvGTPAF~APE~c~~~~~~~~~g~a~DiWalGVTLYCllfG~~PF 319 (576)
T KOG0585|consen 240 NLLLSSDGTVKISDFGVSNEFPQGSDEGSDDQLSRTVGTPAFFAPELCSGGNSFSYSGFALDIWALGVTLYCLLFGQLPF 319 (576)
T ss_pred heEEcCCCcEEeeccceeeecccCCccccHHHHhhcCCCccccchHhhcCCCCccccchhhhhhhhhhhHHHhhhccCCc
Confidence 9999999999999999998663221 11122233467999999999887632 356789999999999999999999
Q ss_pred CCCccCCCCchhHHHHHHHHHhcCccCcccccCccccchhhHhHHHHHHHHHHHHHHHHhcCCCCCCCCChhhhhcC
Q 038766 223 GLDEENGLSPISLRQLVEKALANGINGVRQITDPKLVSSIYEEQEQHQVLEELFKLALVCTSSNPEDRPNMNELLIT 299 (299)
Q Consensus 223 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rpt~~~il~~ 299 (299)
..+ .. .+..+.+.... ...+....+...+.+||++||..||++|.++.+|..|
T Consensus 320 ~~~-----~~---~~l~~KIvn~p----------------L~fP~~pe~~e~~kDli~~lL~KdP~~Ri~l~~ik~H 372 (576)
T KOG0585|consen 320 FDD-----FE---LELFDKIVNDP----------------LEFPENPEINEDLKDLIKRLLEKDPEQRITLPDIKLH 372 (576)
T ss_pred ccc-----hH---HHHHHHHhcCc----------------ccCCCcccccHHHHHHHHHHhhcChhheeehhhheec
Confidence 533 11 12222222111 0001122456789999999999999999999998776
|
|
| >cd06650 PKc_MEK1 Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.8e-43 Score=299.07 Aligned_cols=272 Identities=24% Similarity=0.352 Sum_probs=203.2
Q ss_pred HHhCCCCCCceeecCCcceEEEEEeC-CCcEEEEEEeccCcCChhhhHHHHHHHHHHHhcCCcceeeeeeEEEcCCCeeE
Q 038766 9 NATGSFSENNIIGNSNLSTVYKGRLE-DGEIVAVKKLNFHQFSAESDKSFYREAKTLKELKHRNLVKVLGYAWESGKLKA 87 (299)
Q Consensus 9 ~~~~~y~~~~~lg~g~~~~v~~~~~~-~~~~~~vK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~ 87 (299)
...++|.+.+.||+|+||.||++.+. ++..+|+|.+... ........+.+|+++++.++|+||+++++++.. +...+
T Consensus 2 l~~~~y~~~~~lg~g~~g~V~~~~~~~~~~~~a~k~~~~~-~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~-~~~~~ 79 (333)
T cd06650 2 LKDDDFEKISELGAGNGGVVFKVSHKPSGLIMARKLIHLE-IKPAIRNQIIRELQVLHECNSPYIVGFYGAFYS-DGEIS 79 (333)
T ss_pred cchhhhheeccccCCCCEEEEEEEECCCCcEEEEEEeecc-cCHHHHHHHHHHHHHHHHCCCCcccceeEEEEE-CCEEE
Confidence 45689999999999999999999875 5888999987643 234456778899999999999999999997776 45669
Q ss_pred EEEeecCCCChHHHhcCCCCCCCCCChhhHHHHHHHHHHHHHHhhcCCCCCeeeecccCCceeeCCCCcEEEeeeccccc
Q 038766 88 LILEYMENGSLESVIHGPGVDHSRWTLPKRIDVLISVANGLDYLHSGYDIPIVHCDMKPSNILLDRDFEAHVSDFGTSRM 167 (299)
Q Consensus 88 lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lh~~~~~~~~H~dl~~~nil~~~~~~v~l~df~~~~~ 167 (299)
+|+||+.+++|.+++. ....+++..+..++.|++.||.|||+. .+++|+||||+||+++.++.++|+|||++..
T Consensus 80 lv~e~~~~~~L~~~l~----~~~~~~~~~~~~~~~~l~~~l~~lH~~--~~ivH~dlkp~Nili~~~~~~kL~Dfg~~~~ 153 (333)
T cd06650 80 ICMEHMDGGSLDQVLK----KAGRIPEQILGKVSIAVIKGLTYLREK--HKIMHRDVKPSNILVNSRGEIKLCDFGVSGQ 153 (333)
T ss_pred EEEecCCCCcHHHHHH----HcCCCCHHHHHHHHHHHHHHHHHHHhc--CCEEecCCChhhEEEcCCCCEEEeeCCcchh
Confidence 9999999999999987 345689999999999999999999974 1799999999999999999999999999865
Q ss_pred cccccccccccccccccCcccCChhhhcccCcCccccchhhhHHHHHHHhCCCCCCCCccCCCCchhHHHHHHHHHhcCc
Q 038766 168 LDVHLQDLSSLSTAFQGTIGYLAPEFAYMRIVTTKVDVFSFGIVVMEFLTKRRPTGLDEENGLSPISLRQLVEKALANGI 247 (299)
Q Consensus 168 ~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~DiwslG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 247 (299)
+.. .......++..|+|||++.+..++.++|+|||||++|+|++|..||...... .+...+........
T Consensus 154 ~~~------~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~~l~~g~~p~~~~~~~-----~~~~~~~~~~~~~~ 222 (333)
T cd06650 154 LID------SMANSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAIGRYPIPPPDAK-----ELELMFGCPVEGDP 222 (333)
T ss_pred hhh------hccccCCCCccccCHHHhcCCCCCcHHHHHHHHHHHHHHHHCCCCCCCcchh-----HHHHHhcCcccCCc
Confidence 431 1123345788999999999888999999999999999999999998643211 11111100000000
Q ss_pred cCccccc------------Ccccc---------chhhH----hHHHHHHHHHHHHHHHHhcCCCCCCCCChhhhhcC
Q 038766 248 NGVRQIT------------DPKLV---------SSIYE----EQEQHQVLEELFKLALVCTSSNPEDRPNMNELLIT 299 (299)
Q Consensus 248 ~~~~~~~------------~~~~~---------~~~~~----~~~~~~~~~~l~~li~~~l~~dP~~Rpt~~~il~~ 299 (299)
....... .+... ..... ......++.++.+|+.+||..||++|||+++++.|
T Consensus 223 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~~P~~Rpt~~ell~h 299 (333)
T cd06650 223 AESETSPRPRPPGRPLSSYGPDSRPPMAIFELLDYIVNEPPPKLPSGVFGAEFQDFVNKCLIKNPAERADLKQLMVH 299 (333)
T ss_pred cccccCcccCCccchhhhhcccccccccHHHHHHHHhcCCCccCCCCCcCHHHHHHHHHhccCCcccCcCHHHHhhC
Confidence 0000000 00000 00000 00011245678999999999999999999999987
|
Protein kinases (PKs), MAP/ERK kinase (MEK) 1 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 is a dual-specificity PK that phosphorylates and activates the downst |
| >cd05593 STKc_PKB_gamma Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B gamma | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.7e-43 Score=300.46 Aligned_cols=244 Identities=23% Similarity=0.299 Sum_probs=194.5
Q ss_pred ceeecCCcceEEEEEeC-CCcEEEEEEeccCcC-ChhhhHHHHHHHHHHHhcCCcceeeeeeEEEcCCCeeEEEEeecCC
Q 038766 18 NIIGNSNLSTVYKGRLE-DGEIVAVKKLNFHQF-SAESDKSFYREAKTLKELKHRNLVKVLGYAWESGKLKALILEYMEN 95 (299)
Q Consensus 18 ~~lg~g~~~~v~~~~~~-~~~~~~vK~~~~~~~-~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~lv~e~~~~ 95 (299)
+.||+|+||.||++.+. +++.||+|++..... .......+.+|+.+++.+.||||+++.+.+.. +...++|+||+.+
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~-~~~~~lv~Ey~~~ 79 (328)
T cd05593 1 KLLGKGTFGKVILVREKASGKYYAMKILKKEVIIAKDEVAHTLTESRVLKNTRHPFLTSLKYSFQT-KDRLCFVMEYVNG 79 (328)
T ss_pred CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCcceEEEEEc-CCEEEEEEeCCCC
Confidence 47999999999999864 689999999864322 23345677889999999999999999996654 5566999999999
Q ss_pred CChHHHhcCCCCCCCCCChhhHHHHHHHHHHHHHHhhcCCCCCeeeecccCCceeeCCCCcEEEeeeccccccccccccc
Q 038766 96 GSLESVIHGPGVDHSRWTLPKRIDVLISVANGLDYLHSGYDIPIVHCDMKPSNILLDRDFEAHVSDFGTSRMLDVHLQDL 175 (299)
Q Consensus 96 ~~L~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lh~~~~~~~~H~dl~~~nil~~~~~~v~l~df~~~~~~~~~~~~~ 175 (299)
++|...+. ....+++..++.++.||+.||+|||++ +++|+||||+||+++.++.++|+|||++......
T Consensus 80 g~L~~~l~----~~~~l~~~~~~~~~~qi~~aL~~LH~~---~ivHrDikp~NIll~~~~~~kL~DfG~~~~~~~~---- 148 (328)
T cd05593 80 GELFFHLS----RERVFSEDRTRFYGAEIVSALDYLHSG---KIVYRDLKLENLMLDKDGHIKITDFGLCKEGITD---- 148 (328)
T ss_pred CCHHHHHH----hcCCCCHHHHHHHHHHHHHHHHHHHhC---CeEecccCHHHeEECCCCcEEEecCcCCccCCCc----
Confidence 99998886 445789999999999999999999999 9999999999999999999999999998643211
Q ss_pred cccccccccCcccCChhhhcccCcCccccchhhhHHHHHHHhCCCCCCCCccCCCCchhHHHHHHHHHhcCccCcccccC
Q 038766 176 SSLSTAFQGTIGYLAPEFAYMRIVTTKVDVFSFGIVVMEFLTKRRPTGLDEENGLSPISLRQLVEKALANGINGVRQITD 255 (299)
Q Consensus 176 ~~~~~~~~~~~~y~~PE~~~~~~~~~~~DiwslG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 255 (299)
........+++.|+|||.+.+..++.++|||||||++|+|++|..||.... .. .......... ..
T Consensus 149 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~elltG~~Pf~~~~-----~~---~~~~~~~~~~------~~- 213 (328)
T cd05593 149 AATMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQD-----HE---KLFELILMED------IK- 213 (328)
T ss_pred ccccccccCCcCccChhhhcCCCCCccCCccccchHHHHHhhCCCCCCCCC-----HH---HHHHHhccCC------cc-
Confidence 112234568899999999998899999999999999999999999995331 11 1111111100 00
Q ss_pred ccccchhhHhHHHHHHHHHHHHHHHHhcCCCCCCCC-----ChhhhhcC
Q 038766 256 PKLVSSIYEEQEQHQVLEELFKLALVCTSSNPEDRP-----NMNELLIT 299 (299)
Q Consensus 256 ~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rp-----t~~~il~~ 299 (299)
.+..++.++.++|++||..||++|| +++++++|
T Consensus 214 -----------~p~~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~il~h 251 (328)
T cd05593 214 -----------FPRTLSADAKSLLSGLLIKDPNKRLGGGPDDAKEIMRH 251 (328)
T ss_pred -----------CCCCCCHHHHHHHHHHcCCCHHHcCCCCCCCHHHHhcC
Confidence 0223456789999999999999997 89999986
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, gamma (or Akt3) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-gamma is predominantly expressed in neuronal tissues. Mice deficient in PKB-gamma show a reduction in brain weight due to the decreases in cell size and cell number. PKB-gamma has also been shown to be upregulate |
| >cd05588 STKc_aPKC Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.7e-43 Score=298.70 Aligned_cols=253 Identities=17% Similarity=0.225 Sum_probs=195.8
Q ss_pred ceeecCCcceEEEEEeC-CCcEEEEEEeccCcCC-hhhhHHHHHHHHHHHhc-CCcceeeeeeEEEcCCCeeEEEEeecC
Q 038766 18 NIIGNSNLSTVYKGRLE-DGEIVAVKKLNFHQFS-AESDKSFYREAKTLKEL-KHRNLVKVLGYAWESGKLKALILEYME 94 (299)
Q Consensus 18 ~~lg~g~~~~v~~~~~~-~~~~~~vK~~~~~~~~-~~~~~~~~~e~~~l~~l-~h~~i~~~~~~~~~~~~~~~lv~e~~~ 94 (299)
+.||+|+||.||++.+. +++.||+|++...... ......+..|..+++.+ .||||+++++++.. ....++|+||++
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~e~~il~~~~~hp~Iv~~~~~~~~-~~~~~lv~e~~~ 79 (329)
T cd05588 1 RVIGRGSYAKVLLVELKKTRRIYAMKVIKKELVNDDEDIDWVQTEKHVFETASNHPFLVGLHSCFQT-ESRLFFVIEFVS 79 (329)
T ss_pred CeEeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccCCCCCCceEEEEEc-CCEEEEEEeCCC
Confidence 47999999999999864 5889999999753322 23345678899999888 69999999996654 556699999999
Q ss_pred CCChHHHhcCCCCCCCCCChhhHHHHHHHHHHHHHHhhcCCCCCeeeecccCCceeeCCCCcEEEeeecccccccccccc
Q 038766 95 NGSLESVIHGPGVDHSRWTLPKRIDVLISVANGLDYLHSGYDIPIVHCDMKPSNILLDRDFEAHVSDFGTSRMLDVHLQD 174 (299)
Q Consensus 95 ~~~L~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lh~~~~~~~~H~dl~~~nil~~~~~~v~l~df~~~~~~~~~~~~ 174 (299)
+++|...+. ...++++..++.++.|++.||.|||++ +++||||||+||+++.++.++|+|||++.....
T Consensus 80 ~g~L~~~~~----~~~~l~~~~~~~~~~qi~~~l~~lH~~---~ivH~dlkp~Nili~~~~~~kL~Dfg~~~~~~~---- 148 (329)
T cd05588 80 GGDLMFHMQ----RQRKLPEEHARFYSAEISLALNFLHER---GIIYRDLKLDNVLLDAEGHIKLTDYGMCKEGIR---- 148 (329)
T ss_pred CCCHHHHHH----HcCCCCHHHHHHHHHHHHHHHHHHHHC---CeEecCCCHHHeEECCCCCEEECcCcccccccc----
Confidence 999998886 445799999999999999999999999 999999999999999999999999998864221
Q ss_pred ccccccccccCcccCChhhhcccCcCccccchhhhHHHHHHHhCCCCCCCCccCCCCchhHHHHHHHHHhcCccCccccc
Q 038766 175 LSSLSTAFQGTIGYLAPEFAYMRIVTTKVDVFSFGIVVMEFLTKRRPTGLDEENGLSPISLRQLVEKALANGINGVRQIT 254 (299)
Q Consensus 175 ~~~~~~~~~~~~~y~~PE~~~~~~~~~~~DiwslG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 254 (299)
.........+++.|+|||++.+..++.++|+|||||++|+|++|..||..............+.+...........
T Consensus 149 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~~l~el~~g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~---- 224 (329)
T cd05588 149 PGDTTSTFCGTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFDIVGMSDNPDQNTEDYLFQVILEKQIRI---- 224 (329)
T ss_pred CCCccccccCCccccCHHHHcCCCCCCccceechHHHHHHHHHCCCCcccccccccccccchHHHHHHHHcCCCCC----
Confidence 1122234567899999999999999999999999999999999999996432222111111222222221111010
Q ss_pred CccccchhhHhHHHHHHHHHHHHHHHHhcCCCCCCCCC------hhhhhcC
Q 038766 255 DPKLVSSIYEEQEQHQVLEELFKLALVCTSSNPEDRPN------MNELLIT 299 (299)
Q Consensus 255 ~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rpt------~~~il~~ 299 (299)
+..++..+.++|++||+.||.+||| ++++++|
T Consensus 225 -------------p~~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~~i~~h 262 (329)
T cd05588 225 -------------PRSLSVKASSVLKGFLNKDPKERLGCHPQTGFRDIKSH 262 (329)
T ss_pred -------------CCCCCHHHHHHHHHHhccCHHHcCCCCCCCCHHHHhcC
Confidence 2234567899999999999999997 6788876
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. They contain a C2-like region, instead of a calcium-binding (C2) region found in classical PKCs, in their regulatory domain. There are two aPKC isoforms, zeta and iota. aPKCs are involved in many cellular functions incl |
| >cd05618 STKc_aPKC_iota Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C iota | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-42 Score=297.66 Aligned_cols=253 Identities=18% Similarity=0.232 Sum_probs=194.9
Q ss_pred ceeecCCcceEEEEEeC-CCcEEEEEEeccCcC-ChhhhHHHHHHHHHHHhc-CCcceeeeeeEEEcCCCeeEEEEeecC
Q 038766 18 NIIGNSNLSTVYKGRLE-DGEIVAVKKLNFHQF-SAESDKSFYREAKTLKEL-KHRNLVKVLGYAWESGKLKALILEYME 94 (299)
Q Consensus 18 ~~lg~g~~~~v~~~~~~-~~~~~~vK~~~~~~~-~~~~~~~~~~e~~~l~~l-~h~~i~~~~~~~~~~~~~~~lv~e~~~ 94 (299)
+.||+|+||.||++.+. +++.+|+|++..... .......+..|..++..+ +||||+++++++.. ++..++|+||+.
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~~~~hp~iv~~~~~~~~-~~~~~lv~E~~~ 79 (329)
T cd05618 1 RVIGRGSYAKVLLVRLKKTERIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGLHSCFQT-ESRLFFVIEYVN 79 (329)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEhhHhcchhHHHHHHHHHHHHHhcCCCCcCCceeeEEEe-CCEEEEEEeCCC
Confidence 47999999999999864 588999999875432 233455677888888777 79999999996655 556799999999
Q ss_pred CCChHHHhcCCCCCCCCCChhhHHHHHHHHHHHHHHhhcCCCCCeeeecccCCceeeCCCCcEEEeeecccccccccccc
Q 038766 95 NGSLESVIHGPGVDHSRWTLPKRIDVLISVANGLDYLHSGYDIPIVHCDMKPSNILLDRDFEAHVSDFGTSRMLDVHLQD 174 (299)
Q Consensus 95 ~~~L~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lh~~~~~~~~H~dl~~~nil~~~~~~v~l~df~~~~~~~~~~~~ 174 (299)
+++|...+. ....+++..++.++.|++.||.|||+. +++||||||+||+++.++.++|+|||++.....
T Consensus 80 ~~~L~~~~~----~~~~l~~~~~~~i~~qi~~~l~~lH~~---~ivH~Dikp~Nili~~~~~~kL~DfG~~~~~~~---- 148 (329)
T cd05618 80 GGDLMFHMQ----RQRKLPEEHARFYSAEISLALNYLHER---GIIYRDLKLDNVLLDSEGHIKLTDYGMCKEGLR---- 148 (329)
T ss_pred CCCHHHHHH----HcCCCCHHHHHHHHHHHHHHHHHHHHC---CeeeCCCCHHHEEECCCCCEEEeeCCccccccC----
Confidence 999988876 445799999999999999999999999 999999999999999999999999999864321
Q ss_pred ccccccccccCcccCChhhhcccCcCccccchhhhHHHHHHHhCCCCCCCCccCCCCchhHHHHHHHHHhcCccCccccc
Q 038766 175 LSSLSTAFQGTIGYLAPEFAYMRIVTTKVDVFSFGIVVMEFLTKRRPTGLDEENGLSPISLRQLVEKALANGINGVRQIT 254 (299)
Q Consensus 175 ~~~~~~~~~~~~~y~~PE~~~~~~~~~~~DiwslG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 254 (299)
.........+++.|+|||++.+..++.++|+|||||++|+|++|..||................+..........
T Consensus 149 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~Pf~~~~~~~~~~~~~~~~~~~~i~~~~~~----- 223 (329)
T cd05618 149 PGDTTSTFCGTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFDIVGSSDNPDQNTEDYLFQVILEKQIR----- 223 (329)
T ss_pred CCCccccccCCccccCHHHHcCCCCCCccceecccHHHHHHhhCCCCCccCCCcCCcccccHHHHHHHHhcCCCC-----
Confidence 112223456789999999999999999999999999999999999999643222222111222222211111100
Q ss_pred CccccchhhHhHHHHHHHHHHHHHHHHhcCCCCCCCCCh------hhhhcC
Q 038766 255 DPKLVSSIYEEQEQHQVLEELFKLALVCTSSNPEDRPNM------NELLIT 299 (299)
Q Consensus 255 ~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rpt~------~~il~~ 299 (299)
.+...+..+.++|++||..||++|||+ +++++|
T Consensus 224 ------------~p~~~~~~~~~ll~~~L~~dP~~R~~~~~~~~~~~i~~h 262 (329)
T cd05618 224 ------------IPRSLSVKAASVLKSFLNKDPKERLGCHPQTGFADIQGH 262 (329)
T ss_pred ------------CCCCCCHHHHHHHHHHhcCCHHHcCCCCCCCCHHHHhcC
Confidence 022345678899999999999999994 688876
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, iota isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-iota is directly implicated in carcinogenesis. It is critical to oncogenic signaling mediated by Ras and Bcr-Abl. The PKC-iota gene is the target o |
| >cd05573 STKc_ROCK_NDR_like Catalytic domain of ROCK- and NDR kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.5e-43 Score=303.59 Aligned_cols=257 Identities=22% Similarity=0.280 Sum_probs=202.9
Q ss_pred CCCCCCceeecCCcceEEEEEeC-CCcEEEEEEeccCcCCh-hhhHHHHHHHHHHHhcCCcceeeeeeEEEcCCCeeEEE
Q 038766 12 GSFSENNIIGNSNLSTVYKGRLE-DGEIVAVKKLNFHQFSA-ESDKSFYREAKTLKELKHRNLVKVLGYAWESGKLKALI 89 (299)
Q Consensus 12 ~~y~~~~~lg~g~~~~v~~~~~~-~~~~~~vK~~~~~~~~~-~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~lv 89 (299)
++|.+.+.||+|++|+||+|.+. +++.||+|++....... .....+..|+.+++.++|+||+++++++.. ++..++|
T Consensus 1 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~-~~~~~lv 79 (350)
T cd05573 1 DDFEVIKVIGRGAFGEVWLVRDKDTGQVYAMKVLRKSDMIKRNQIAHVRAERDILADADSPWIVKLYYSFQD-EEHLYLV 79 (350)
T ss_pred CCceEEEEEEeCCcEEEEEEEECCCCCEEEEEEEEHHHHhhccHHHHHHHHHHHHHhcCCCCccchhhheec-CCeEEEE
Confidence 57999999999999999999875 68999999987543222 445678889999999999999999996554 5667999
Q ss_pred EeecCCCChHHHhcCCCCCCCCCChhhHHHHHHHHHHHHHHhhcCCCCCeeeecccCCceeeCCCCcEEEeeeccccccc
Q 038766 90 LEYMENGSLESVIHGPGVDHSRWTLPKRIDVLISVANGLDYLHSGYDIPIVHCDMKPSNILLDRDFEAHVSDFGTSRMLD 169 (299)
Q Consensus 90 ~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lh~~~~~~~~H~dl~~~nil~~~~~~v~l~df~~~~~~~ 169 (299)
+||+.+++|.+++. ....+++..++.++.|++.||+|||+. +++|+||||+||+++.++.++|+|||++....
T Consensus 80 ~e~~~~~~L~~~l~----~~~~l~~~~~~~i~~qi~~aL~~LH~~---giiH~Dlkp~NIll~~~~~~kL~Dfg~~~~~~ 152 (350)
T cd05573 80 MEYMPGGDLMNLLI----RKDVFPEETARFYIAELVLALDSVHKL---GFIHRDIKPDNILIDADGHIKLADFGLCKKMN 152 (350)
T ss_pred EcCCCCCCHHHHHH----HcCCCCHHHHHHHHHHHHHHHHHHHHC---CeeccCCCHHHeEECCCCCEEeecCCCCccCc
Confidence 99999999999987 335799999999999999999999998 99999999999999999999999999987654
Q ss_pred cccc-------------------------cccccccccccCcccCChhhhcccCcCccccchhhhHHHHHHHhCCCCCCC
Q 038766 170 VHLQ-------------------------DLSSLSTAFQGTIGYLAPEFAYMRIVTTKVDVFSFGIVVMEFLTKRRPTGL 224 (299)
Q Consensus 170 ~~~~-------------------------~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~DiwslG~~l~~l~~g~~p~~~ 224 (299)
.... ..........+++.|+|||.+.+..++.++|||||||++|+|++|..||..
T Consensus 153 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~ell~g~~Pf~~ 232 (350)
T cd05573 153 KAKDREYYLNDSHNLLFRDNVLVRRRDHKQRRVRANSTVGTPDYIAPEVLRGTPYGLECDWWSLGVILYEMLYGFPPFYS 232 (350)
T ss_pred ccCcccccccccccccccccccccccccccccccccccccCccccCHHHHcCCCCCCceeeEecchhhhhhccCCCCCCC
Confidence 3210 001122345688999999999999999999999999999999999999964
Q ss_pred CccCCCCchhHHHHHHHHHhcCccCcccccCccccchhhHhHHHHHHHHHHHHHHHHhcCCCCCCCCC-hhhhhcC
Q 038766 225 DEENGLSPISLRQLVEKALANGINGVRQITDPKLVSSIYEEQEQHQVLEELFKLALVCTSSNPEDRPN-MNELLIT 299 (299)
Q Consensus 225 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rpt-~~~il~~ 299 (299)
.. .. ........ . ......+. ...++.++.++|.+||. ||.+||+ ++++++|
T Consensus 233 ~~-----~~---~~~~~i~~-~---~~~~~~p~----------~~~~~~~~~~li~~ll~-dp~~R~~s~~~ll~h 285 (350)
T cd05573 233 DT-----LQ---ETYNKIIN-W---KESLRFPP----------DPPVSPEAIDLICRLLC-DPEDRLGSFEEIKSH 285 (350)
T ss_pred CC-----HH---HHHHHHhc-c---CCcccCCC----------CCCCCHHHHHHHHHHcc-ChhhcCCCHHHHhcC
Confidence 42 11 11111111 0 00000000 11146789999999998 9999999 9999987
|
Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) and Nuclear Dbf2-Related (NDR)-like kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK- and NDR-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include ROCK and ROCK-like proteins such as DMPK, MRCK, and CRIK, as well as NDR and NDR-like proteins such as LATS, CBK1 and Sid2p. ROCK and CRIK are effectors of the small GTPase Rho, while MRCK is an effector of the small GTPase Cdc42. NDR and NDR-like kinases contain an N-terminal regulatory (NTR) domain and an insert within the |
| >cd05595 STKc_PKB_beta Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B beta | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.1e-43 Score=300.40 Aligned_cols=244 Identities=23% Similarity=0.272 Sum_probs=194.6
Q ss_pred ceeecCCcceEEEEEe-CCCcEEEEEEeccCcC-ChhhhHHHHHHHHHHHhcCCcceeeeeeEEEcCCCeeEEEEeecCC
Q 038766 18 NIIGNSNLSTVYKGRL-EDGEIVAVKKLNFHQF-SAESDKSFYREAKTLKELKHRNLVKVLGYAWESGKLKALILEYMEN 95 (299)
Q Consensus 18 ~~lg~g~~~~v~~~~~-~~~~~~~vK~~~~~~~-~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~lv~e~~~~ 95 (299)
+.||+|+||.||++.+ .+|..||+|++..... .......+..|+++++.++||||+++++.+.. ....++|+||+.+
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~i~~~~~~~~~-~~~~~lv~E~~~~ 79 (323)
T cd05595 1 KLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTALKYAFQT-HDRLCFVMEYANG 79 (323)
T ss_pred CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhCCCCCCcceeeEEec-CCEEEEEEeCCCC
Confidence 4799999999999986 4689999999864322 23345567789999999999999999996665 4566999999999
Q ss_pred CChHHHhcCCCCCCCCCChhhHHHHHHHHHHHHHHhhcCCCCCeeeecccCCceeeCCCCcEEEeeeccccccccccccc
Q 038766 96 GSLESVIHGPGVDHSRWTLPKRIDVLISVANGLDYLHSGYDIPIVHCDMKPSNILLDRDFEAHVSDFGTSRMLDVHLQDL 175 (299)
Q Consensus 96 ~~L~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lh~~~~~~~~H~dl~~~nil~~~~~~v~l~df~~~~~~~~~~~~~ 175 (299)
++|...+. ....+++..++.++.||+.||+|||+. +++|+||||+||+++.++.++|+|||++..... .
T Consensus 80 ~~L~~~l~----~~~~~~~~~~~~~~~qi~~aL~~LH~~---~ivH~Dlkp~NIll~~~~~~kL~Dfg~~~~~~~----~ 148 (323)
T cd05595 80 GELFFHLS----RERVFTEERARFYGAEIVSALEYLHSR---DVVYRDIKLENLMLDKDGHIKITDFGLCKEGIS----D 148 (323)
T ss_pred CcHHHHHH----HcCCCCHHHHHHHHHHHHHHHHHHHHC---CeEecCCCHHHEEEcCCCCEEecccHHhccccC----C
Confidence 99998886 445789999999999999999999999 999999999999999999999999998864221 1
Q ss_pred cccccccccCcccCChhhhcccCcCccccchhhhHHHHHHHhCCCCCCCCccCCCCchhHHHHHHHHHhcCccCcccccC
Q 038766 176 SSLSTAFQGTIGYLAPEFAYMRIVTTKVDVFSFGIVVMEFLTKRRPTGLDEENGLSPISLRQLVEKALANGINGVRQITD 255 (299)
Q Consensus 176 ~~~~~~~~~~~~y~~PE~~~~~~~~~~~DiwslG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 255 (299)
........+++.|+|||.+.+..++.++|||||||++|+|++|..||..... ............ ..
T Consensus 149 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~ell~g~~Pf~~~~~--------~~~~~~~~~~~~------~~ 214 (323)
T cd05595 149 GATMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDH--------ERLFELILMEEI------RF 214 (323)
T ss_pred CCccccccCCcCcCCcccccCCCCCchhchhhhHHHHHHHHhCCCCCCCCCH--------HHHHHHHhcCCC------CC
Confidence 1122345678999999999988999999999999999999999999853311 111222111110 00
Q ss_pred ccccchhhHhHHHHHHHHHHHHHHHHhcCCCCCCCC-----ChhhhhcC
Q 038766 256 PKLVSSIYEEQEQHQVLEELFKLALVCTSSNPEDRP-----NMNELLIT 299 (299)
Q Consensus 256 ~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rp-----t~~~il~~ 299 (299)
+..++.++.++|.+||..||++|| ++.++++|
T Consensus 215 ------------p~~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~~l~h 251 (323)
T cd05595 215 ------------PRTLSPEAKSLLAGLLKKDPKQRLGGGPSDAKEVMEH 251 (323)
T ss_pred ------------CCCCCHHHHHHHHHHccCCHHHhCCCCCCCHHHHHcC
Confidence 223456789999999999999998 89999876
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, beta (or Akt2) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-beta is the predominant PKB isoform expressed in insulin-responsive tissues. It plays a critical role in the regulation of glucose homeostasis. It is also implicated in muscle cell differentiation. Mice deficient in |
| >cd05585 STKc_YPK1_like Catalytic domain of Yeast Protein Kinase 1-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.1e-43 Score=297.79 Aligned_cols=242 Identities=22% Similarity=0.259 Sum_probs=193.0
Q ss_pred eecCCcceEEEEEeC-CCcEEEEEEeccCcC-ChhhhHHHHHHHHHHHhcCCcceeeeeeEEEcCCCeeEEEEeecCCCC
Q 038766 20 IGNSNLSTVYKGRLE-DGEIVAVKKLNFHQF-SAESDKSFYREAKTLKELKHRNLVKVLGYAWESGKLKALILEYMENGS 97 (299)
Q Consensus 20 lg~g~~~~v~~~~~~-~~~~~~vK~~~~~~~-~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~lv~e~~~~~~ 97 (299)
||+|+||.||++.+. +++.||+|++..... .......+..|+.+++.++||||+++++++.. +...++|+||+.+++
T Consensus 1 lg~G~~g~Vy~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~-~~~~~lv~e~~~~g~ 79 (312)
T cd05585 1 IGKGSFGKVMQVRKRDTQRIYALKTIRKAHIVSRSEVTHTLAERTVLAQVNCPFIVPLKFSFQS-PEKLYLVLAFINGGE 79 (312)
T ss_pred CCcCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCcEeceeeEEec-CCeEEEEEcCCCCCc
Confidence 799999999999875 588999999864322 23345677889999999999999999996654 556799999999999
Q ss_pred hHHHhcCCCCCCCCCChhhHHHHHHHHHHHHHHhhcCCCCCeeeecccCCceeeCCCCcEEEeeeccccccccccccccc
Q 038766 98 LESVIHGPGVDHSRWTLPKRIDVLISVANGLDYLHSGYDIPIVHCDMKPSNILLDRDFEAHVSDFGTSRMLDVHLQDLSS 177 (299)
Q Consensus 98 L~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lh~~~~~~~~H~dl~~~nil~~~~~~v~l~df~~~~~~~~~~~~~~~ 177 (299)
|.+.+. ....+++..+..++.|++.||.|||+. +++||||||+||+++.++.++|+|||++..... ...
T Consensus 80 L~~~l~----~~~~~~~~~~~~~~~qi~~~l~~lH~~---~i~HrDlkp~Nili~~~~~~kl~Dfg~~~~~~~----~~~ 148 (312)
T cd05585 80 LFHHLQ----REGRFDLSRARFYTAELLCALENLHKF---NVIYRDLKPENILLDYQGHIALCDFGLCKLNMK----DDD 148 (312)
T ss_pred HHHHHH----hcCCCCHHHHHHHHHHHHHHHHHHHhC---CeEeCCCCHHHeEECCCCcEEEEECcccccCcc----CCC
Confidence 999887 345789999999999999999999999 999999999999999999999999999864321 112
Q ss_pred cccccccCcccCChhhhcccCcCccccchhhhHHHHHHHhCCCCCCCCccCCCCchhHHHHHHHHHhcCccCcccccCcc
Q 038766 178 LSTAFQGTIGYLAPEFAYMRIVTTKVDVFSFGIVVMEFLTKRRPTGLDEENGLSPISLRQLVEKALANGINGVRQITDPK 257 (299)
Q Consensus 178 ~~~~~~~~~~y~~PE~~~~~~~~~~~DiwslG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 257 (299)
......+++.|+|||.+.+..++.++|||||||++|+|++|..||.... ............ ..
T Consensus 149 ~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvil~el~tg~~pf~~~~--------~~~~~~~~~~~~-~~-------- 211 (312)
T cd05585 149 KTNTFCGTPEYLAPELLLGHGYTKAVDWWTLGVLLYEMLTGLPPFYDEN--------VNEMYRKILQEP-LR-------- 211 (312)
T ss_pred ccccccCCcccCCHHHHcCCCCCCccceechhHHHHHHHhCCCCcCCCC--------HHHHHHHHHcCC-CC--------
Confidence 2334568899999999999999999999999999999999999995331 112222221110 00
Q ss_pred ccchhhHhHHHHHHHHHHHHHHHHhcCCCCCCCC---ChhhhhcC
Q 038766 258 LVSSIYEEQEQHQVLEELFKLALVCTSSNPEDRP---NMNELLIT 299 (299)
Q Consensus 258 ~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rp---t~~~il~~ 299 (299)
.+..++..+.++|.+||..||++|| ++.+++.|
T Consensus 212 ---------~~~~~~~~~~~li~~~L~~dp~~R~~~~~~~e~l~h 247 (312)
T cd05585 212 ---------FPDGFDRDAKDLLIGLLSRDPTRRLGYNGAQEIKNH 247 (312)
T ss_pred ---------CCCcCCHHHHHHHHHHcCCCHHHcCCCCCHHHHHcC
Confidence 0223456789999999999999997 46888876
|
Serine/Threonine Kinases (STKs), Yeast protein kinase 1 (YPK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YPK1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the AGC STKs, Saccharomyces cerevisiae YPK1 and Schizosaccharomyces pombe Gad8p. YPK1 is required for cell growth and acts as a downstream kinase in the sphingolipid-mediated signaling pathway of yeast. It also plays a role in efficient endocytosis and in the maintenance of cell wall integrity. Gad8p is a downstream target of Tor1p, the fission yeast homolog of mTOR. It pl |
| >PTZ00036 glycogen synthase kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.8e-43 Score=309.63 Aligned_cols=271 Identities=21% Similarity=0.264 Sum_probs=196.7
Q ss_pred HhCCCCCCceeecCCcceEEEEEeC-CCcEEEEEEeccCcCChhhhHHHHHHHHHHHhcCCcceeeeeeEEEcC------
Q 038766 10 ATGSFSENNIIGNSNLSTVYKGRLE-DGEIVAVKKLNFHQFSAESDKSFYREAKTLKELKHRNLVKVLGYAWES------ 82 (299)
Q Consensus 10 ~~~~y~~~~~lg~g~~~~v~~~~~~-~~~~~~vK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~------ 82 (299)
..++|.+.+.||+|+||.||+|.+. +++.||+|++.... ....+|+.+++.++||||+++++++...
T Consensus 64 ~~~~y~~~~~LG~G~fg~Vy~~~~~~~~~~vAiK~i~~~~------~~~~~Ei~il~~l~h~niv~l~~~~~~~~~~~~~ 137 (440)
T PTZ00036 64 PNKSYKLGNIIGNGSFGVVYEAICIDTSEKVAIKKVLQDP------QYKNRELLIMKNLNHINIIFLKDYYYTECFKKNE 137 (440)
T ss_pred cCCeEEEeEEEEeCCCEEEEEEEECCCCCEEEEEEEecCc------chHHHHHHHHHhcCCCCCcceeeeEeecccccCC
Confidence 3467999999999999999999874 58899999885321 2334699999999999999998876432
Q ss_pred -CCeeEEEEeecCCCChHHHhcCCCCCCCCCChhhHHHHHHHHHHHHHHhhcCCCCCeeeecccCCceeeCCCC-cEEEe
Q 038766 83 -GKLKALILEYMENGSLESVIHGPGVDHSRWTLPKRIDVLISVANGLDYLHSGYDIPIVHCDMKPSNILLDRDF-EAHVS 160 (299)
Q Consensus 83 -~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lh~~~~~~~~H~dl~~~nil~~~~~-~v~l~ 160 (299)
...+++|+||+.+ +|..++.........+++..++.++.||+.||+|||+. +++||||||+||+++.++ .+||+
T Consensus 138 ~~~~l~lvmE~~~~-~l~~~~~~~~~~~~~l~~~~~~~~~~qi~~gL~yLH~~---~IiHrDLKp~NILl~~~~~~vkL~ 213 (440)
T PTZ00036 138 KNIFLNVVMEFIPQ-TVHKYMKHYARNNHALPLFLVKLYSYQLCRALAYIHSK---FICHRDLKPQNLLIDPNTHTLKLC 213 (440)
T ss_pred CceEEEEEEecCCc-cHHHHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHHC---CEecCCcCHHHEEEcCCCCceeee
Confidence 1346799999965 78777654333556899999999999999999999999 999999999999998664 69999
Q ss_pred eeccccccccccccccccccccccCcccCChhhhccc-CcCccccchhhhHHHHHHHhCCCCCCCCccCCCCchhHHHHH
Q 038766 161 DFGTSRMLDVHLQDLSSLSTAFQGTIGYLAPEFAYMR-IVTTKVDVFSFGIVVMEFLTKRRPTGLDEENGLSPISLRQLV 239 (299)
Q Consensus 161 df~~~~~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~-~~~~~~DiwslG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~ 239 (299)
|||++..+... .......+++.|+|||++.+. .++.++|||||||++|+|++|.+||...... ..+...+
T Consensus 214 DFGla~~~~~~-----~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlGvil~elltG~~pf~~~~~~----~~~~~i~ 284 (440)
T PTZ00036 214 DFGSAKNLLAG-----QRSVSYICSRFYRAPELMLGATNYTTHIDLWSLGCIIAEMILGYPIFSGQSSV----DQLVRII 284 (440)
T ss_pred ccccchhccCC-----CCcccCCCCcCccCHHHhcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChH----HHHHHHH
Confidence 99999755321 122234568899999988764 6899999999999999999999999643211 1111111
Q ss_pred HHHHhcCc-------cCcccccCccccchhhHhHHHHHHHHHHHHHHHHhcCCCCCCCCChhhhhcC
Q 038766 240 EKALANGI-------NGVRQITDPKLVSSIYEEQEQHQVLEELFKLALVCTSSNPEDRPNMNELLIT 299 (299)
Q Consensus 240 ~~~~~~~~-------~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rpt~~~il~~ 299 (299)
........ +....+..+...........+...+.++.+||.+||..||.+|||+.|+|+|
T Consensus 285 ~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~l~~~~p~~~~~~~~~li~~~L~~dP~~R~ta~e~l~h 351 (440)
T PTZ00036 285 QVLGTPTEDQLKEMNPNYADIKFPDVKPKDLKKVFPKGTPDDAINFISQFLKYEPLKRLNPIEALAD 351 (440)
T ss_pred HHhCCCCHHHHHHhchhhhcccCCccCchhHHHHhccCCCHHHHHHHHHHCCCChhHCcCHHHHhCC
Confidence 11000000 0000111111111111122233456789999999999999999999999987
|
|
| >KOG1989 consensus ARK protein kinase family [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-43 Score=316.18 Aligned_cols=255 Identities=20% Similarity=0.272 Sum_probs=203.3
Q ss_pred hCCCCCCceeecCCcceEEEEEeCCC-cEEEEEEeccCcCChhhhHHHHHHHHHHHhcC-CcceeeeeeEEEc-----C-
Q 038766 11 TGSFSENNIIGNSNLSTVYKGRLEDG-EIVAVKKLNFHQFSAESDKSFYREAKTLKELK-HRNLVKVLGYAWE-----S- 82 (299)
Q Consensus 11 ~~~y~~~~~lg~g~~~~v~~~~~~~~-~~~~vK~~~~~~~~~~~~~~~~~e~~~l~~l~-h~~i~~~~~~~~~-----~- 82 (299)
.-+++|.+.|.+|||+.||+|.+..+ ..||+|++... +....+.+.+|+.+|+.|+ |+||+.++|.... .
T Consensus 36 ~~~v~V~~vLAEGGFa~VYla~~~~~~~~~AlKrm~~~--de~~L~~v~~EI~~MK~L~gh~nIV~yidss~~~~~~~~~ 113 (738)
T KOG1989|consen 36 SHRVTVEKVLAEGGFAQVYLAQDVKGGKKYALKRMYVN--DEEALNAVKREIDIMKLLSGHKNIVSYIDSSAINRSSNNG 113 (738)
T ss_pred CEEEEEEEEEccCCcEEEEEEEecCCCceeeeeeeecC--CHHHHHHHHHHHHHHHHhcCCCceeeEeccccccccCCCc
Confidence 44678899999999999999998655 99999998743 6677888999999999998 9999999993221 1
Q ss_pred CCeeEEEEeecCCCChHHHhcCCCCCCCCCChhhHHHHHHHHHHHHHHhhcCCCCCeeeecccCCceeeCCCCcEEEeee
Q 038766 83 GKLKALILEYMENGSLESVIHGPGVDHSRWTLPKRIDVLISVANGLDYLHSGYDIPIVHCDMKPSNILLDRDFEAHVSDF 162 (299)
Q Consensus 83 ~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lh~~~~~~~~H~dl~~~nil~~~~~~v~l~df 162 (299)
....+|.||||.|+.|-++++...+. .|++.++++|+.++++|+++||.. +..++|||||.+|||++.+|..|||||
T Consensus 114 ~~EvllLmEyC~gg~Lvd~mn~Rlq~--~lte~eVLkIf~dv~~AVa~mH~~-~pPiIHRDLKiENvLls~~g~~KLCDF 190 (738)
T KOG1989|consen 114 VWEVLLLMEYCKGGSLVDFMNTRLQT--RLTEDEVLKIFYDVCEAVAAMHYL-KPPIIHRDLKIENVLLSADGNYKLCDF 190 (738)
T ss_pred eeEEEeehhhccCCcHHHHHHHHHhc--cCChHHHHHHHHHHHHHHHHHhcC-CCccchhhhhhhheEEcCCCCEEeCcc
Confidence 13457899999989999999876533 399999999999999999999997 446999999999999999999999999
Q ss_pred cccccccccccccc-----ccccccccCcccCChh---hhcccCcCccccchhhhHHHHHHHhCCCCCCCCccCCCCchh
Q 038766 163 GTSRMLDVHLQDLS-----SLSTAFQGTIGYLAPE---FAYMRIVTTKVDVFSFGIVVMEFLTKRRPTGLDEENGLSPIS 234 (299)
Q Consensus 163 ~~~~~~~~~~~~~~-----~~~~~~~~~~~y~~PE---~~~~~~~~~~~DiwslG~~l~~l~~g~~p~~~~~~~~~~~~~ 234 (299)
|.++..-....... +..-....|+.|++|| ++.+..++.|+|||+|||+||.|+....||....
T Consensus 191 GSatt~~~~~~~~~e~~~ve~eI~k~TTp~YRsPEMIDlysg~pI~eKsDIWALGclLYkLCy~t~PFe~sg-------- 262 (738)
T KOG1989|consen 191 GSATTKILSPTSAQEVNYVEEEIEKYTTPQYRSPEMIDLYSGLPIGEKSDIWALGCLLYKLCYFTTPFEESG-------- 262 (738)
T ss_pred cccccccCCCccHHHHHHHHHHHHhhCCccccChHHHhhhcCCCCcchhHHHHHHHHHHHHHHhCCCcCcCc--------
Confidence 99874321111111 1112334689999999 4567889999999999999999999999996441
Q ss_pred HHHHHHHHHhcCccCcccccCccccchhhHhHHHHHHHHHHHHHHHHhcCCCCCCCCChhhhhc
Q 038766 235 LRQLVEKALANGINGVRQITDPKLVSSIYEEQEQHQVLEELFKLALVCTSSNPEDRPNMNELLI 298 (299)
Q Consensus 235 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rpt~~~il~ 298 (299)
.-.|.+-++.. +....+++.+.+||+.||..||.+||++-|+++
T Consensus 263 ---------------~laIlng~Y~~-----P~~p~ys~~l~~LI~~mL~~nP~~RPnI~Qv~~ 306 (738)
T KOG1989|consen 263 ---------------KLAILNGNYSF-----PPFPNYSDRLKDLIRTMLQPNPDERPNIYQVLE 306 (738)
T ss_pred ---------------ceeEEeccccC-----CCCccHHHHHHHHHHHHhccCcccCCCHHHHHH
Confidence 11222222222 114577889999999999999999999999975
|
|
| >cd05614 STKc_MSK2_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.8e-43 Score=299.25 Aligned_cols=254 Identities=23% Similarity=0.273 Sum_probs=196.5
Q ss_pred CCCCCceeecCCcceEEEEEe----CCCcEEEEEEeccCcC--ChhhhHHHHHHHHHHHhcC-CcceeeeeeEEEcCCCe
Q 038766 13 SFSENNIIGNSNLSTVYKGRL----EDGEIVAVKKLNFHQF--SAESDKSFYREAKTLKELK-HRNLVKVLGYAWESGKL 85 (299)
Q Consensus 13 ~y~~~~~lg~g~~~~v~~~~~----~~~~~~~vK~~~~~~~--~~~~~~~~~~e~~~l~~l~-h~~i~~~~~~~~~~~~~ 85 (299)
+|.+.+.||+|+||+||+++. .+++.||+|++..... .....+....|+.+++.++ |++|+++++++.. +..
T Consensus 1 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~i~~~~~~~~~-~~~ 79 (332)
T cd05614 1 NFELLKVLGTGAYGKVFLVRKVTGHDTGKLYAMKVLQKAALVQKAKTVEHTRTERNVLEHVRQSPFLVTLHYAFQT-EAK 79 (332)
T ss_pred CceEEEEEeecCCEEEEEEEEcccCCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHHhccCCCCcccEEEEEec-CCE
Confidence 588999999999999999975 2588999999864322 2233456788999999995 8999999986554 556
Q ss_pred eEEEEeecCCCChHHHhcCCCCCCCCCChhhHHHHHHHHHHHHHHhhcCCCCCeeeecccCCceeeCCCCcEEEeeeccc
Q 038766 86 KALILEYMENGSLESVIHGPGVDHSRWTLPKRIDVLISVANGLDYLHSGYDIPIVHCDMKPSNILLDRDFEAHVSDFGTS 165 (299)
Q Consensus 86 ~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lh~~~~~~~~H~dl~~~nil~~~~~~v~l~df~~~ 165 (299)
.++|+||+.+++|.+.+. ....+++..++.++.||+.||+|||+. +++||||||+|||++.++.++|+|||++
T Consensus 80 ~~lv~e~~~~g~L~~~l~----~~~~~~~~~~~~~~~qi~~~l~~lH~~---~ivHrDlkp~Nili~~~~~~kl~DfG~~ 152 (332)
T cd05614 80 LHLILDYVSGGEMFTHLY----QRDNFSEDEVRFYSGEIILALEHLHKL---GIVYRDIKLENILLDSEGHVVLTDFGLS 152 (332)
T ss_pred EEEEEeCCCCCcHHHHHH----HcCCCCHHHHHHHHHHHHHHHHHHHHC---CcEecCCCHHHeEECCCCCEEEeeCcCC
Confidence 699999999999999886 445789999999999999999999999 9999999999999999999999999998
Q ss_pred cccccccccccccccccccCcccCChhhhccc-CcCccccchhhhHHHHHHHhCCCCCCCCccCCCCchhHHHHHHHHHh
Q 038766 166 RMLDVHLQDLSSLSTAFQGTIGYLAPEFAYMR-IVTTKVDVFSFGIVVMEFLTKRRPTGLDEENGLSPISLRQLVEKALA 244 (299)
Q Consensus 166 ~~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~-~~~~~~DiwslG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~ 244 (299)
...... .........+++.|+|||.+.+. .++.++|||||||++|+|++|..||....... ...........
T Consensus 153 ~~~~~~---~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~----~~~~~~~~~~~ 225 (332)
T cd05614 153 KEFLSE---EKERTYSFCGTIEYMAPEIIRGKGGHGKAVDWWSLGILIFELLTGASPFTLEGERN----TQSEVSRRILK 225 (332)
T ss_pred cccccc---CCCccccccCCccccCHHHhcCCCCCCCccccccchhhhhhhhcCCCCCCCCCCCC----CHHHHHHHHhc
Confidence 754311 11122345689999999998865 47889999999999999999999996432211 11111111111
Q ss_pred cCccCcccccCccccchhhHhHHHHHHHHHHHHHHHHhcCCCCCCCC-----ChhhhhcC
Q 038766 245 NGINGVRQITDPKLVSSIYEEQEQHQVLEELFKLALVCTSSNPEDRP-----NMNELLIT 299 (299)
Q Consensus 245 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rp-----t~~~il~~ 299 (299)
.. .. .+..++..+.+++.+||..||++|| +++++++|
T Consensus 226 ~~-~~-----------------~~~~~~~~~~~li~~~l~~dp~~R~~~~~~~~~~~l~h 267 (332)
T cd05614 226 CD-PP-----------------FPSFIGPEAQDLLHKLLRKDPKKRLGAGPQGASEIKEH 267 (332)
T ss_pred CC-CC-----------------CCCCCCHHHHHHHHHHcCCCHHHcCCCCCCCHHHHHcC
Confidence 00 00 0123456789999999999999999 78899876
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK2, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydroph |
| >cd07878 STKc_p38beta_MAPK11 Catalytic domain of the Serine/Threonine Kinase, p38beta Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=9e-43 Score=300.19 Aligned_cols=270 Identities=22% Similarity=0.282 Sum_probs=199.5
Q ss_pred HHHhCCCCCCceeecCCcceEEEEEe-CCCcEEEEEEeccCcCChhhhHHHHHHHHHHHhcCCcceeeeeeEEEcCC---
Q 038766 8 ENATGSFSENNIIGNSNLSTVYKGRL-EDGEIVAVKKLNFHQFSAESDKSFYREAKTLKELKHRNLVKVLGYAWESG--- 83 (299)
Q Consensus 8 ~~~~~~y~~~~~lg~g~~~~v~~~~~-~~~~~~~vK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~--- 83 (299)
..+.++|.+.+.||+|+||+||++.+ .+++.||+|++............+.+|+.+++.++|+||+++++++....
T Consensus 11 ~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~ 90 (343)
T cd07878 11 WEVPERYQNLTPVGSGAYGSVCSAYDTRLRQKVAVKKLSRPFQSLIHARRTYRELRLLKHMKHENVIGLLDVFTPATSIE 90 (343)
T ss_pred hhhhhhhhhheecccCCCeEEEEEEECCCCCEEEEEEeCchhhhhHHHHHHHHHHHHHHhcCCCchhhhhhhhccccccc
Confidence 34789999999999999999999986 46889999998654333344566778999999999999999998664322
Q ss_pred --CeeEEEEeecCCCChHHHhcCCCCCCCCCChhhHHHHHHHHHHHHHHhhcCCCCCeeeecccCCceeeCCCCcEEEee
Q 038766 84 --KLKALILEYMENGSLESVIHGPGVDHSRWTLPKRIDVLISVANGLDYLHSGYDIPIVHCDMKPSNILLDRDFEAHVSD 161 (299)
Q Consensus 84 --~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lh~~~~~~~~H~dl~~~nil~~~~~~v~l~d 161 (299)
...+++++++ +++|..++. ...+++..++.++.|++.||.|||+. +++|+||||+||+++.++.++|+|
T Consensus 91 ~~~~~~~~~~~~-~~~l~~~~~-----~~~l~~~~~~~i~~qi~~aL~~LH~~---~ivHrdikp~Nil~~~~~~~kl~D 161 (343)
T cd07878 91 NFNEVYLVTNLM-GADLNNIVK-----CQKLSDEHVQFLIYQLLRGLKYIHSA---GIIHRDLKPSNVAVNEDCELRILD 161 (343)
T ss_pred ccCcEEEEeecC-CCCHHHHHh-----cCCCCHHHHHHHHHHHHHHHHHHHHC---CeecccCChhhEEECCCCCEEEcC
Confidence 3458999988 779988884 34699999999999999999999999 999999999999999999999999
Q ss_pred eccccccccccccccccccccccCcccCChhhhcc-cCcCccccchhhhHHHHHHHhCCCCCCCCccCCCCchhHHHHHH
Q 038766 162 FGTSRMLDVHLQDLSSLSTAFQGTIGYLAPEFAYM-RIVTTKVDVFSFGIVVMEFLTKRRPTGLDEENGLSPISLRQLVE 240 (299)
Q Consensus 162 f~~~~~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~-~~~~~~~DiwslG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~ 240 (299)
||++..... ......+++.|+|||.+.+ ..++.++|||||||++|+|++|..||...... ..+.....
T Consensus 162 fg~~~~~~~-------~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~----~~~~~~~~ 230 (343)
T cd07878 162 FGLARQADD-------EMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLKGKALFPGNDYI----DQLKRIME 230 (343)
T ss_pred CccceecCC-------CcCCccccccccCchHhcCCccCCchhhhHhHHHHHHHHHHCCCCCCCCCHH----HHHHHHHH
Confidence 999875431 1233457889999998876 56889999999999999999999998543211 01111110
Q ss_pred HHHhcCccC-cccccC----------ccccchhhHhHHHHHHHHHHHHHHHHhcCCCCCCCCChhhhhcC
Q 038766 241 KALANGING-VRQITD----------PKLVSSIYEEQEQHQVLEELFKLALVCTSSNPEDRPNMNELLIT 299 (299)
Q Consensus 241 ~~~~~~~~~-~~~~~~----------~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rpt~~~il~~ 299 (299)
.. ...... ...+.. +...... ........++.+.+||.+||..||.+|||++++|+|
T Consensus 231 ~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~li~~mL~~dp~~R~s~~ell~h 298 (343)
T cd07878 231 VV-GTPSPEVLKKISSEHARKYIQSLPHMPQQD-LKKIFRGANPLAIDLLEKMLVLDSDKRISASEALAH 298 (343)
T ss_pred Hh-CCCCHHHHHhcchhhHHHHhhccccccchh-HHHhccCCCHHHHHHHHHHcCCChhhCCCHHHHhcC
Confidence 00 000000 000000 0000000 000112234568899999999999999999999987
|
Serine/Threonine Kinases (STKs), p38beta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38beta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38beta, also called MAPK11, is |
| >cd05589 STKc_PKN Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase N | Back alignment and domain information |
|---|
Probab=100.00 E-value=7e-43 Score=298.47 Aligned_cols=247 Identities=23% Similarity=0.361 Sum_probs=193.1
Q ss_pred CCCCceeecCCcceEEEEEeC-CCcEEEEEEeccCcC-ChhhhHHHHHHHHHH---HhcCCcceeeeeeEEEcCCCeeEE
Q 038766 14 FSENNIIGNSNLSTVYKGRLE-DGEIVAVKKLNFHQF-SAESDKSFYREAKTL---KELKHRNLVKVLGYAWESGKLKAL 88 (299)
Q Consensus 14 y~~~~~lg~g~~~~v~~~~~~-~~~~~~vK~~~~~~~-~~~~~~~~~~e~~~l---~~l~h~~i~~~~~~~~~~~~~~~l 88 (299)
|++.+.||+|++|.||++.+. +++.||+|++..... .....+.+..|..++ +.++||||+++++++.. ++..++
T Consensus 1 y~i~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~l~~e~~~~~~~~~l~hp~i~~~~~~~~~-~~~~~l 79 (324)
T cd05589 1 FRCLAVLGRGHFGKVLLAEYKKTGELYAIKALKKGDIIARDEVESLMCEKRIFETANSERHPFLVNLFACFQT-EDHVCF 79 (324)
T ss_pred CeEEEEEeecCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccccCCCChhceeeEEEc-CCEEEE
Confidence 678999999999999999864 589999999864322 223345566666555 45679999999996554 566799
Q ss_pred EEeecCCCChHHHhcCCCCCCCCCChhhHHHHHHHHHHHHHHhhcCCCCCeeeecccCCceeeCCCCcEEEeeecccccc
Q 038766 89 ILEYMENGSLESVIHGPGVDHSRWTLPKRIDVLISVANGLDYLHSGYDIPIVHCDMKPSNILLDRDFEAHVSDFGTSRML 168 (299)
Q Consensus 89 v~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lh~~~~~~~~H~dl~~~nil~~~~~~v~l~df~~~~~~ 168 (299)
|+||+.+++|...+. ...+++..++.++.|++.||+|||++ +++|+||||+||+++.++.++|+|||++...
T Consensus 80 v~E~~~~~~L~~~~~-----~~~l~~~~~~~~~~qi~~al~~lH~~---~ivHrdlkp~Nill~~~~~~kL~Dfg~~~~~ 151 (324)
T cd05589 80 VMEYAAGGDLMMHIH-----TDVFSEPRAVFYAACVVLGLQYLHEN---KIVYRDLKLDNLLLDTEGFVKIADFGLCKEG 151 (324)
T ss_pred EEcCCCCCcHHHHhh-----cCCCCHHHHHHHHHHHHHHHHHHHhC---CeEecCCCHHHeEECCCCcEEeCcccCCccC
Confidence 999999999988874 34689999999999999999999999 9999999999999999999999999988643
Q ss_pred ccccccccccccccccCcccCChhhhcccCcCccccchhhhHHHHHHHhCCCCCCCCccCCCCchhHHHHHHHHHhcCcc
Q 038766 169 DVHLQDLSSLSTAFQGTIGYLAPEFAYMRIVTTKVDVFSFGIVVMEFLTKRRPTGLDEENGLSPISLRQLVEKALANGIN 248 (299)
Q Consensus 169 ~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~DiwslG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 248 (299)
.. .........+++.|+|||.+.+..++.++|||||||++|+|++|..||..... .+..........
T Consensus 152 ~~----~~~~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~el~~G~~pf~~~~~--------~~~~~~i~~~~~- 218 (324)
T cd05589 152 MG----FGDRTSTFCGTPEFLAPEVLTETSYTRAVDWWGLGVLIYEMLVGESPFPGDDE--------EEVFDSIVNDEV- 218 (324)
T ss_pred CC----CCCcccccccCccccCHhHhcCCCCCcccchhhHHHHHHHHHhCCCCCCCCCH--------HHHHHHHHhCCC-
Confidence 21 11223345688999999999999999999999999999999999999954321 112221111110
Q ss_pred CcccccCccccchhhHhHHHHHHHHHHHHHHHHhcCCCCCCCC-----ChhhhhcC
Q 038766 249 GVRQITDPKLVSSIYEEQEQHQVLEELFKLALVCTSSNPEDRP-----NMNELLIT 299 (299)
Q Consensus 249 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rp-----t~~~il~~ 299 (299)
. . +..++..+.++|.+||..||++|| +++++++|
T Consensus 219 ~-----~------------p~~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~l~~~ 257 (324)
T cd05589 219 R-----Y------------PRFLSREAISIMRRLLRRNPERRLGSGEKDAEDVKKQ 257 (324)
T ss_pred C-----C------------CCCCCHHHHHHHHHHhhcCHhHcCCCCCCCHHHHhhC
Confidence 0 0 223456788999999999999999 67888765
|
Serine/Threonine Kinases (STKs), Protein Kinase N (PKN) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKN subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKN has a C-terminal catalytic domain that is highly homologous to PKCs. Its unique N-terminal regulatory region contains antiparallel coiled-coil (ACC) domains. In mammals, there are three PKN isoforms from different genes (designated PKN-alpha, beta, and gamma), which show different enzymatic properties, tissue distribution, and varied functions. PKN can be activated by the small GTPase Rho, and by fatty acids such as arachidonic and linoleic acids. It is involved |
| >PLN00034 mitogen-activated protein kinase kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-42 Score=300.21 Aligned_cols=250 Identities=26% Similarity=0.365 Sum_probs=193.8
Q ss_pred hCCCCCCceeecCCcceEEEEEeC-CCcEEEEEEeccCcCChhhhHHHHHHHHHHHhcCCcceeeeeeEEEcCCCeeEEE
Q 038766 11 TGSFSENNIIGNSNLSTVYKGRLE-DGEIVAVKKLNFHQFSAESDKSFYREAKTLKELKHRNLVKVLGYAWESGKLKALI 89 (299)
Q Consensus 11 ~~~y~~~~~lg~g~~~~v~~~~~~-~~~~~~vK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~lv 89 (299)
.++|...+.||+|+||.||++.+. +++.||+|++... ........+.+|+++++.++|+||+++++++.. ++..++|
T Consensus 73 ~~~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~-~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~-~~~~~lv 150 (353)
T PLN00034 73 LSELERVNRIGSGAGGTVYKVIHRPTGRLYALKVIYGN-HEDTVRRQICREIEILRDVNHPNVVKCHDMFDH-NGEIQVL 150 (353)
T ss_pred HHHHhhhhhccCCCCeEEEEEEECCCCCEEEEEEEecC-CcHHHHHHHHHHHHHHHhCCCCCcceeeeEecc-CCeEEEE
Confidence 467888999999999999999864 6899999998532 233445678899999999999999999996654 5566999
Q ss_pred EeecCCCChHHHhcCCCCCCCCCChhhHHHHHHHHHHHHHHhhcCCCCCeeeecccCCceeeCCCCcEEEeeeccccccc
Q 038766 90 LEYMENGSLESVIHGPGVDHSRWTLPKRIDVLISVANGLDYLHSGYDIPIVHCDMKPSNILLDRDFEAHVSDFGTSRMLD 169 (299)
Q Consensus 90 ~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lh~~~~~~~~H~dl~~~nil~~~~~~v~l~df~~~~~~~ 169 (299)
+||+.+++|.+.. ..++..++.++.||+.||+|||++ +++|+||||+||+++.++.++|+|||++..+.
T Consensus 151 ~e~~~~~~L~~~~--------~~~~~~~~~i~~qi~~aL~~LH~~---~ivHrDlkp~NIll~~~~~~kL~DfG~~~~~~ 219 (353)
T PLN00034 151 LEFMDGGSLEGTH--------IADEQFLADVARQILSGIAYLHRR---HIVHRDIKPSNLLINSAKNVKIADFGVSRILA 219 (353)
T ss_pred EecCCCCcccccc--------cCCHHHHHHHHHHHHHHHHHHHHC---CEeecCCCHHHEEEcCCCCEEEcccccceecc
Confidence 9999998886432 356778889999999999999999 99999999999999999999999999987654
Q ss_pred cccccccccccccccCcccCChhhhcc-----cCcCccccchhhhHHHHHHHhCCCCCCCCccCCCCchhHHHHHHHHHh
Q 038766 170 VHLQDLSSLSTAFQGTIGYLAPEFAYM-----RIVTTKVDVFSFGIVVMEFLTKRRPTGLDEENGLSPISLRQLVEKALA 244 (299)
Q Consensus 170 ~~~~~~~~~~~~~~~~~~y~~PE~~~~-----~~~~~~~DiwslG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~ 244 (299)
.. ........++..|+|||.+.. ...+.++|||||||++|+|++|..||..... ..+...+.....
T Consensus 220 ~~----~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DvwslGvil~el~~g~~pf~~~~~-----~~~~~~~~~~~~ 290 (353)
T PLN00034 220 QT----MDPCNSSVGTIAYMSPERINTDLNHGAYDGYAGDIWSLGVSILEFYLGRFPFGVGRQ-----GDWASLMCAICM 290 (353)
T ss_pred cc----cccccccccCccccCccccccccccCcCCCcchhHHHHHHHHHHHHhCCCCCCCCCC-----ccHHHHHHHHhc
Confidence 21 112234568899999998743 2345689999999999999999999963211 122222211111
Q ss_pred cCccCcccccCccccchhhHhHHHHHHHHHHHHHHHHhcCCCCCCCCChhhhhcC
Q 038766 245 NGINGVRQITDPKLVSSIYEEQEQHQVLEELFKLALVCTSSNPEDRPNMNELLIT 299 (299)
Q Consensus 245 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rpt~~~il~~ 299 (299)
..... ....++.++.+||.+||..||++|||+.|+|+|
T Consensus 291 ~~~~~-----------------~~~~~~~~l~~li~~~l~~~P~~Rpt~~ell~h 328 (353)
T PLN00034 291 SQPPE-----------------APATASREFRHFISCCLQREPAKRWSAMQLLQH 328 (353)
T ss_pred cCCCC-----------------CCCccCHHHHHHHHHHccCChhhCcCHHHHhcC
Confidence 11000 022345679999999999999999999999987
|
|
| >cd07863 STKc_CDK4 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.7e-42 Score=289.33 Aligned_cols=272 Identities=24% Similarity=0.286 Sum_probs=197.2
Q ss_pred CCCCCceeecCCcceEEEEEeC-CCcEEEEEEeccCcCChhhhHHHHHHHHHHHhc---CCcceeeeeeEEEcC----CC
Q 038766 13 SFSENNIIGNSNLSTVYKGRLE-DGEIVAVKKLNFHQFSAESDKSFYREAKTLKEL---KHRNLVKVLGYAWES----GK 84 (299)
Q Consensus 13 ~y~~~~~lg~g~~~~v~~~~~~-~~~~~~vK~~~~~~~~~~~~~~~~~e~~~l~~l---~h~~i~~~~~~~~~~----~~ 84 (299)
+|++.+.||+|++|+||++.+. +++.+|+|.+..............+|+..++.+ .||||+++++++... ..
T Consensus 1 ~y~~~~~lg~g~~g~v~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~h~ni~~~~~~~~~~~~~~~~ 80 (288)
T cd07863 1 QYEPVAEIGVGAYGTVYKARDPHSGHFVALKSVRVQTNEDGLPLSTVREVALLKRLEAFDHPNIVRLMDVCATSRTDRET 80 (288)
T ss_pred CceEeeEEeecCCeEEEEEEECCCCcEEEEEEeccCcCCCCCchHHHHHHHHHHHhhhcCCCCeeeeeeeeccccCCCCc
Confidence 5899999999999999999875 589999999875443333344556677777665 699999999976532 34
Q ss_pred eeEEEEeecCCCChHHHhcCCCCCCCCCChhhHHHHHHHHHHHHHHhhcCCCCCeeeecccCCceeeCCCCcEEEeeecc
Q 038766 85 LKALILEYMENGSLESVIHGPGVDHSRWTLPKRIDVLISVANGLDYLHSGYDIPIVHCDMKPSNILLDRDFEAHVSDFGT 164 (299)
Q Consensus 85 ~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lh~~~~~~~~H~dl~~~nil~~~~~~v~l~df~~ 164 (299)
..++++|++.+ +|.+++... ....+++..+..++.|++.||.|||+. +++|+||||+||+++.++.++|+|||+
T Consensus 81 ~~~lv~e~~~~-~l~~~~~~~--~~~~~~~~~~~~~~~qi~~al~~lH~~---~ivH~dikp~Nili~~~~~~kl~dfg~ 154 (288)
T cd07863 81 KVTLVFEHVDQ-DLRTYLDKV--PPPGLPAETIKDLMRQFLRGLDFLHAN---CIVHRDLKPENILVTSGGQVKLADFGL 154 (288)
T ss_pred eEEEEEccccc-CHHHHHHhc--CCCCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHEEECCCCCEEECccCc
Confidence 56899999964 888887643 234589999999999999999999999 999999999999999999999999999
Q ss_pred ccccccccccccccccccccCcccCChhhhcccCcCccccchhhhHHHHHHHhCCCCCCCCccCCCCchhHHHHHHHHHh
Q 038766 165 SRMLDVHLQDLSSLSTAFQGTIGYLAPEFAYMRIVTTKVDVFSFGIVVMEFLTKRRPTGLDEENGLSPISLRQLVEKALA 244 (299)
Q Consensus 165 ~~~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~DiwslG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~ 244 (299)
+...... .......++..|+|||.+.+..++.++|||||||++|+|++|.+||...... ............
T Consensus 155 ~~~~~~~-----~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~~l~~l~~g~~~f~~~~~~----~~~~~~~~~~~~ 225 (288)
T cd07863 155 ARIYSCQ-----MALTPVVVTLWYRAPEVLLQSTYATPVDMWSVGCIFAEMFRRKPLFCGNSEA----DQLGKIFDLIGL 225 (288)
T ss_pred cccccCc-----ccCCCccccccccCchHhhCCCCCCcchhhhHHHHHHHHHhCCcCcCCCCHH----HHHHHHHHHhCC
Confidence 8754321 1122345688999999999889999999999999999999999998533111 111111111100
Q ss_pred ---cCccCcccccCccccch--hhHhHHHHHHHHHHHHHHHHhcCCCCCCCCChhhhhcC
Q 038766 245 ---NGINGVRQITDPKLVSS--IYEEQEQHQVLEELFKLALVCTSSNPEDRPNMNELLIT 299 (299)
Q Consensus 245 ---~~~~~~~~~~~~~~~~~--~~~~~~~~~~~~~l~~li~~~l~~dP~~Rpt~~~il~~ 299 (299)
..++............. .........++..+.++|.+||..||++|||+++++.|
T Consensus 226 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~~~l~h 285 (288)
T cd07863 226 PPEDDWPRDVTLPRGAFSPRGPRPVQSVVPEIEESGAQLLLEMLTFNPHKRISAFRALQH 285 (288)
T ss_pred CChhhCcccccccccccCCCCCCchHHhCcCcCHHHHHHHHHHhccCcccCCCHHHHhcC
Confidence 00000000000000000 00011123456788999999999999999999999987
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 partners with all three D-type cyclins (D1, D2, and D3) and is also regulated by INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein and plays a role in regulating the early G1 phase of the cell cycle. It is expressed ubiquitou |
| >cd07875 STKc_JNK1 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-42 Score=301.67 Aligned_cols=272 Identities=21% Similarity=0.231 Sum_probs=201.3
Q ss_pred HHhCCCCCCceeecCCcceEEEEEeC-CCcEEEEEEeccCcCChhhhHHHHHHHHHHHhcCCcceeeeeeEEEcCC----
Q 038766 9 NATGSFSENNIIGNSNLSTVYKGRLE-DGEIVAVKKLNFHQFSAESDKSFYREAKTLKELKHRNLVKVLGYAWESG---- 83 (299)
Q Consensus 9 ~~~~~y~~~~~lg~g~~~~v~~~~~~-~~~~~~vK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~---- 83 (299)
.+.++|.+.+.||+|+||.||++.+. .++.+|+|++............+.+|+.+++.++||||+++++++....
T Consensus 21 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~ii~~~~~~~~~~~~~~ 100 (364)
T cd07875 21 TVLKRYQNLKPIGSGAQGIVCAAYDAILERNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIIGLLNVFTPQKSLEE 100 (364)
T ss_pred chhcceeEEEEeecCCCeEEEEEEECCCCcEEEEEEeCccccCchhHHHHHHHHHHHHhcCCCCccccceeecccccccc
Confidence 46789999999999999999999864 5889999998755444555677889999999999999999999764322
Q ss_pred -CeeEEEEeecCCCChHHHhcCCCCCCCCCChhhHHHHHHHHHHHHHHhhcCCCCCeeeecccCCceeeCCCCcEEEeee
Q 038766 84 -KLKALILEYMENGSLESVIHGPGVDHSRWTLPKRIDVLISVANGLDYLHSGYDIPIVHCDMKPSNILLDRDFEAHVSDF 162 (299)
Q Consensus 84 -~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lh~~~~~~~~H~dl~~~nil~~~~~~v~l~df 162 (299)
...++|+||+.+ +|...+. ..+++..++.++.|++.||+|||++ +++|+||||+||+++.++.++|+||
T Consensus 101 ~~~~~lv~e~~~~-~l~~~~~------~~~~~~~~~~~~~qi~~aL~~LH~~---~ivH~Dlkp~NIll~~~~~~kL~Df 170 (364)
T cd07875 101 FQDVYIVMELMDA-NLCQVIQ------MELDHERMSYLLYQMLCGIKHLHSA---GIIHRDLKPSNIVVKSDCTLKILDF 170 (364)
T ss_pred cCeEEEEEeCCCC-CHHHHHH------hcCCHHHHHHHHHHHHHHHHHHhhC---CeecCCCCHHHEEECCCCcEEEEeC
Confidence 346899999954 7877774 2478889999999999999999999 9999999999999999999999999
Q ss_pred ccccccccccccccccccccccCcccCChhhhcccCcCccccchhhhHHHHHHHhCCCCCCCCccCCCCchhHHHHHHHH
Q 038766 163 GTSRMLDVHLQDLSSLSTAFQGTIGYLAPEFAYMRIVTTKVDVFSFGIVVMEFLTKRRPTGLDEENGLSPISLRQLVEKA 242 (299)
Q Consensus 163 ~~~~~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~DiwslG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~ 242 (299)
|++..... ........++..|+|||++.+..++.++|||||||++|+|++|..||...... ..+...+...
T Consensus 171 G~a~~~~~-----~~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~----~~~~~~~~~~ 241 (364)
T cd07875 171 GLARTAGT-----SFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIKGGVLFPGTDHI----DQWNKVIEQL 241 (364)
T ss_pred CCccccCC-----CCcccCCcccCCcCCHHHHhCCCCCchhhHHhHHHHHHHHHhCCCCCCCCCHH----HHHHHHHHhc
Confidence 99875431 11223446788999999999999999999999999999999999999643211 1111111110
Q ss_pred H-----------------hcCccCcccccCcc-ccchhh--HhHHHHHHHHHHHHHHHHhcCCCCCCCCChhhhhcC
Q 038766 243 L-----------------ANGINGVRQITDPK-LVSSIY--EEQEQHQVLEELFKLALVCTSSNPEDRPNMNELLIT 299 (299)
Q Consensus 243 ~-----------------~~~~~~~~~~~~~~-~~~~~~--~~~~~~~~~~~l~~li~~~l~~dP~~Rpt~~~il~~ 299 (299)
. ....+......... ...... ........+..+.+||.+||..||.+|||++++|+|
T Consensus 242 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~mL~~dP~~R~t~~e~L~h 318 (364)
T cd07875 242 GTPCPEFMKKLQPTVRTYVENRPKYAGYSFEKLFPDVLFPADSEHNKLKASQARDLLSKMLVIDASKRISVDEALQH 318 (364)
T ss_pred CCCCHHHHHhhhHHHHHHHhhCCCcCCCChHhhCccccccccccccccccHHHHHHHHHhcCcCcccCCCHHHHhcC
Confidence 0 00000000000000 000000 000011234678999999999999999999999987
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 1 (JNK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jn |
| >cd05584 STKc_p70S6K Catalytic domain of the Protein Serine/Threonine Kinase, 70 kDa ribosomal protein S6 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.1e-43 Score=298.22 Aligned_cols=245 Identities=24% Similarity=0.332 Sum_probs=193.9
Q ss_pred CceeecCCcceEEEEEe----CCCcEEEEEEeccCcC--ChhhhHHHHHHHHHHHhcCCcceeeeeeEEEcCCCeeEEEE
Q 038766 17 NNIIGNSNLSTVYKGRL----EDGEIVAVKKLNFHQF--SAESDKSFYREAKTLKELKHRNLVKVLGYAWESGKLKALIL 90 (299)
Q Consensus 17 ~~~lg~g~~~~v~~~~~----~~~~~~~vK~~~~~~~--~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~lv~ 90 (299)
.+.||+|+||.||++.. .+++.||+|++..... .......+..|+.+++.++||||+++++.+.. +...++|+
T Consensus 1 ~~~lg~G~~g~V~~~~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~E~~il~~l~hp~iv~~~~~~~~-~~~~~lv~ 79 (323)
T cd05584 1 LKVLGKGGYGKVFQVRKVTGADTGKIFAMKVLKKATIVRNQKDTAHTKAERNILEAVKHPFIVDLIYAFQT-GGKLYLIL 79 (323)
T ss_pred CceeeecCCeEEEEEEEcccCCCCCEEEEEEEEHHHHHhhhhhHHHHHHHHHHHHhCCCCchhceeeEEec-CCeEEEEE
Confidence 36899999999999975 3578999999864322 12234567789999999999999999997665 45669999
Q ss_pred eecCCCChHHHhcCCCCCCCCCChhhHHHHHHHHHHHHHHhhcCCCCCeeeecccCCceeeCCCCcEEEeeecccccccc
Q 038766 91 EYMENGSLESVIHGPGVDHSRWTLPKRIDVLISVANGLDYLHSGYDIPIVHCDMKPSNILLDRDFEAHVSDFGTSRMLDV 170 (299)
Q Consensus 91 e~~~~~~L~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lh~~~~~~~~H~dl~~~nil~~~~~~v~l~df~~~~~~~~ 170 (299)
||+.+++|.+.+. ....+++..+..++.|++.||.|||++ +++|+||||+||+++.++.++|+|||++.....
T Consensus 80 e~~~~~~L~~~~~----~~~~~~~~~~~~~~~qi~~~l~~lH~~---~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~ 152 (323)
T cd05584 80 EYLSGGELFMHLE----REGIFMEDTACFYLSEISLALEHLHQQ---GIIYRDLKPENILLDAQGHVKLTDFGLCKESIH 152 (323)
T ss_pred eCCCCchHHHHHH----HcCCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHeEECCCCCEEEeeCcCCeeccc
Confidence 9999999999887 445788999999999999999999999 999999999999999999999999998864321
Q ss_pred ccccccccccccccCcccCChhhhcccCcCccccchhhhHHHHHHHhCCCCCCCCccCCCCchhHHHHHHHHHhcCccCc
Q 038766 171 HLQDLSSLSTAFQGTIGYLAPEFAYMRIVTTKVDVFSFGIVVMEFLTKRRPTGLDEENGLSPISLRQLVEKALANGINGV 250 (299)
Q Consensus 171 ~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~DiwslG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 250 (299)
.........+++.|+|||++.+..++.++||||||+++|+|++|..||..... ...+.......
T Consensus 153 ----~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~G~~pf~~~~~--------~~~~~~~~~~~---- 216 (323)
T cd05584 153 ----EGTVTHTFCGTIEYMAPEILMRSGHGKAVDWWSLGALMYDMLTGAPPFTAENR--------KKTIDKILKGK---- 216 (323)
T ss_pred ----CCCcccccCCCccccChhhccCCCCCCcceecccHHHHHHHhcCCCCCCCCCH--------HHHHHHHHcCC----
Confidence 11222334678999999999988899999999999999999999999954321 11222221110
Q ss_pred ccccCccccchhhHhHHHHHHHHHHHHHHHHhcCCCCCCCC-----ChhhhhcC
Q 038766 251 RQITDPKLVSSIYEEQEQHQVLEELFKLALVCTSSNPEDRP-----NMNELLIT 299 (299)
Q Consensus 251 ~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rp-----t~~~il~~ 299 (299)
..+ +...+..+.++|++||..||++|| +++++++|
T Consensus 217 ~~~--------------~~~~~~~~~~li~~~l~~~p~~R~~~~~~~~~~l~~h 256 (323)
T cd05584 217 LNL--------------PPYLTPEARDLLKKLLKRNPSSRLGAGPGDAAEVQSH 256 (323)
T ss_pred CCC--------------CCCCCHHHHHHHHHHcccCHhHcCCCCCCCHHHHhcC
Confidence 000 122346789999999999999999 89998876
|
Serine/Threonine Kinases (STKs), 70 kDa ribosomal protein S6 kinase (p70S6K) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p70S6K subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p70S6K (or S6K) contains only one catalytic kinase domain, unlike p90 ribosomal S6 kinases (RSKs). It acts as a downstream effector of the STK mTOR (mammalian Target of Rapamycin) and plays a role in the regulation of the translation machinery during protein synthesis. p70S6K also plays a pivotal role in regulating cell size and glucose homeostasis. Its targets include S6, the translation initiation factor eIF3, and the in |
| >cd07853 STKc_NLK Catalytic domain of the Serine/Threonine Kinase, Nemo-Like Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-42 Score=300.23 Aligned_cols=269 Identities=25% Similarity=0.284 Sum_probs=198.6
Q ss_pred CCCCCceeecCCcceEEEEEe-CCCcEEEEEEeccCcCChhhhHHHHHHHHHHHhcCCcceeeeeeEEEcCC----CeeE
Q 038766 13 SFSENNIIGNSNLSTVYKGRL-EDGEIVAVKKLNFHQFSAESDKSFYREAKTLKELKHRNLVKVLGYAWESG----KLKA 87 (299)
Q Consensus 13 ~y~~~~~lg~g~~~~v~~~~~-~~~~~~~vK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~----~~~~ 87 (299)
+|.+.+.||+|+||+||++.+ .+++.||+|++............+.+|+.+++.++|+||+++++++.... ...+
T Consensus 1 ~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~ 80 (372)
T cd07853 1 DVEPDRPIGYGAFGVVWSVTDPRDGKRVALKKMPNVFQNLVSCKRVFRELKMLCFFKHDNVLSALDILQPPHIDPFEEIY 80 (372)
T ss_pred CCcccceeeeCCCEEEEEEEECCCCCEEEEEeccccccchHHHHHHHHHHHHHHhCCCCCcCCHhheecCCCccccceEE
Confidence 588999999999999999986 46899999998644334445677889999999999999999999766543 2568
Q ss_pred EEEeecCCCChHHHhcCCCCCCCCCChhhHHHHHHHHHHHHHHhhcCCCCCeeeecccCCceeeCCCCcEEEeeeccccc
Q 038766 88 LILEYMENGSLESVIHGPGVDHSRWTLPKRIDVLISVANGLDYLHSGYDIPIVHCDMKPSNILLDRDFEAHVSDFGTSRM 167 (299)
Q Consensus 88 lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lh~~~~~~~~H~dl~~~nil~~~~~~v~l~df~~~~~ 167 (299)
+|+||+. ++|...+. ....+++..+..++.|++.||.|||+. +++|+||||+||+++.++.++|+|||++..
T Consensus 81 lv~e~~~-~~l~~~~~----~~~~l~~~~~~~~~~qi~~aL~~LH~~---~ivH~dlkp~Nili~~~~~~kL~Dfg~a~~ 152 (372)
T cd07853 81 VVTELMQ-SDLHKIIV----SPQPLSSDHVKVFLYQILRGLKYLHSA---GILHRDIKPGNLLVNSNCVLKICDFGLARV 152 (372)
T ss_pred EEeeccc-cCHHHHHh----cCCCCCHHHHHHHHHHHHHHHHHHHhC---CeeCCCCChHHEEECCCCCEEeccccceee
Confidence 9999995 58888775 455799999999999999999999999 999999999999999999999999999875
Q ss_pred cccccccccccccccccCcccCChhhhccc-CcCccccchhhhHHHHHHHhCCCCCCCCccCCCCchhHHHHHHHHHhcC
Q 038766 168 LDVHLQDLSSLSTAFQGTIGYLAPEFAYMR-IVTTKVDVFSFGIVVMEFLTKRRPTGLDEENGLSPISLRQLVEKALANG 246 (299)
Q Consensus 168 ~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~-~~~~~~DiwslG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~ 246 (299)
.... .........+++.|+|||.+.+. .++.++||||+||++|+|++|..||..... ......+.......
T Consensus 153 ~~~~---~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~-----~~~~~~i~~~~g~~ 224 (372)
T cd07853 153 EEPD---ESKHMTQEVVTQYYRAPEILMGSRHYTSAVDIWSVGCIFAELLGRRILFQAQSP-----IQQLDLITDLLGTP 224 (372)
T ss_pred cccC---ccccCCCCCcCCCcCCHHHHcCCCCCCcHHHHHhHHHHHHHHHcCCCCCCCCCH-----HHHHHHHHHHcCCC
Confidence 4311 11122334568899999988774 478999999999999999999999964321 11111111100000
Q ss_pred ccCcccc------------cCcc-ccchhhHhHHHHHHHHHHHHHHHHhcCCCCCCCCChhhhhcC
Q 038766 247 INGVRQI------------TDPK-LVSSIYEEQEQHQVLEELFKLALVCTSSNPEDRPNMNELLIT 299 (299)
Q Consensus 247 ~~~~~~~------------~~~~-~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rpt~~~il~~ 299 (299)
....+ ..+. ..............+.++.+||.+||..||++|||++++|+|
T Consensus 225 --~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~R~t~~e~l~h 288 (372)
T cd07853 225 --SLEAMRSACEGARAHILRGPHKPPSLPVLYTLSSQATHEAVHLLCRMLVFDPDKRISAADALAH 288 (372)
T ss_pred --CHHHHHHhhHHHHHHHHhCCCCCCchHHhcccCCCCCHHHHHHHHHhCCCChhhCcCHHHHhcC
Confidence 00000 0000 000000000112336788999999999999999999999986
|
Serine/Threonine Kinases (STKs), Nemo-Like Kinase (NLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mitogen-activated protein kinases (MAPKs) are important mediators of cellular responses to extracellular signals. NLK is an atypical MAPK that is not regulated by a MAPK kinase. It functions downstream of the MAPK kinase kinase Tak1, which also plays a role in activating the JNK and p38 MAPKs. The Tak1/NLK pathways are regulated by Wnts, a family of secreted proteins that is critical in the control of asymmetric division and cell polarity. NLK can phosphorylate transcription |
| >cd05599 STKc_NDR_like Catalytic domain of Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-42 Score=301.75 Aligned_cols=257 Identities=23% Similarity=0.293 Sum_probs=199.4
Q ss_pred CCCCCCceeecCCcceEEEEEeC-CCcEEEEEEeccCcC-ChhhhHHHHHHHHHHHhcCCcceeeeeeEEEcCCCeeEEE
Q 038766 12 GSFSENNIIGNSNLSTVYKGRLE-DGEIVAVKKLNFHQF-SAESDKSFYREAKTLKELKHRNLVKVLGYAWESGKLKALI 89 (299)
Q Consensus 12 ~~y~~~~~lg~g~~~~v~~~~~~-~~~~~~vK~~~~~~~-~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~lv 89 (299)
++|.+.+.||+|+||+||++.+. +++.||+|++..... .......+.+|+.+++.++||||+++++.+.. +...++|
T Consensus 1 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~il~~l~h~~iv~~~~~~~~-~~~~~lv 79 (364)
T cd05599 1 DDFESIKVIGRGAFGEVRLVQKKDTGHIYAMKKLRKSEMLEKEQVAHVRAERDILAEADNPWVVKLYYSFQD-ENYLYLI 79 (364)
T ss_pred CCceEEEEEEecCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCcceEEEEEc-CCeEEEE
Confidence 47999999999999999999874 589999999864322 22334567889999999999999999996655 5567999
Q ss_pred EeecCCCChHHHhcCCCCCCCCCChhhHHHHHHHHHHHHHHhhcCCCCCeeeecccCCceeeCCCCcEEEeeeccccccc
Q 038766 90 LEYMENGSLESVIHGPGVDHSRWTLPKRIDVLISVANGLDYLHSGYDIPIVHCDMKPSNILLDRDFEAHVSDFGTSRMLD 169 (299)
Q Consensus 90 ~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lh~~~~~~~~H~dl~~~nil~~~~~~v~l~df~~~~~~~ 169 (299)
+||+.+++|.+++. ....+++..+..++.|++.||+|||+. +++|+||||+||+++.++.++|+|||++..+.
T Consensus 80 ~E~~~~g~L~~~l~----~~~~l~~~~~~~~~~qi~~aL~~lH~~---~ivH~Dlkp~NIl~~~~~~~kl~Dfg~~~~~~ 152 (364)
T cd05599 80 MEYLPGGDMMTLLM----KKDTFTEEETRFYIAETILAIDSIHKL---GYIHRDIKPDNLLLDAKGHIKLSDFGLCTGLK 152 (364)
T ss_pred ECCCCCcHHHHHHH----HcCCCCHHHHHHHHHHHHHHHHHHHHC---CeEeccCCHHHeEECCCCCEEEeecccceecc
Confidence 99999999999986 445799999999999999999999999 99999999999999999999999999986543
Q ss_pred ccccccc----------------------------------ccccccccCcccCChhhhcccCcCccccchhhhHHHHHH
Q 038766 170 VHLQDLS----------------------------------SLSTAFQGTIGYLAPEFAYMRIVTTKVDVFSFGIVVMEF 215 (299)
Q Consensus 170 ~~~~~~~----------------------------------~~~~~~~~~~~y~~PE~~~~~~~~~~~DiwslG~~l~~l 215 (299)
....... .......||+.|+|||++....++.++|||||||++|+|
T Consensus 153 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~el 232 (364)
T cd05599 153 KSHRTEFYRILSHALPSNFLDFISKPMSSKRKAETWKRNRRALAYSTVGTPDYIAPEVFLQTGYNKECDWWSLGVIMYEM 232 (364)
T ss_pred ccccccccccccccccccccccccccccccccccchhhcccccccccccCccccCHHHHcCCCCCCeeeeecchhHHHHh
Confidence 1110000 001123588999999999999999999999999999999
Q ss_pred HhCCCCCCCCccCCCCchhHHHHHHHHHhcCccCcccccCccccchhhHhHHHHHHHHHHHHHHHHhcCCCCCCCCC---
Q 038766 216 LTKRRPTGLDEENGLSPISLRQLVEKALANGINGVRQITDPKLVSSIYEEQEQHQVLEELFKLALVCTSSNPEDRPN--- 292 (299)
Q Consensus 216 ~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rpt--- 292 (299)
++|..||.... .. ........ . .. ....+. ...+++++.++|++|+. +|.+|++
T Consensus 233 ~~G~~Pf~~~~-----~~---~~~~~i~~-~-~~--~~~~~~----------~~~~s~~~~~li~~ll~-~p~~R~~~~~ 289 (364)
T cd05599 233 LVGYPPFCSDN-----PQ---ETYRKIIN-W-KE--TLQFPD----------EVPLSPEAKDLIKRLCC-EAERRLGNNG 289 (364)
T ss_pred hcCCCCCCCCC-----HH---HHHHHHHc-C-CC--ccCCCC----------CCCCCHHHHHHHHHHcc-CHhhcCCCCC
Confidence 99999995432 11 11111111 0 00 000000 11235678899999997 9999998
Q ss_pred hhhhhcC
Q 038766 293 MNELLIT 299 (299)
Q Consensus 293 ~~~il~~ 299 (299)
++++++|
T Consensus 290 ~~~ll~h 296 (364)
T cd05599 290 VNEIKSH 296 (364)
T ss_pred HHHHhcC
Confidence 9999986
|
Serine/Threonine Kinases (STKs), Nuclear Dbf2-Related (NDR) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. NDR kinases regulate mitosis, cell growth, embryonic development, and neurological processes. They are also required for proper centrosome duplica |
| >PF00069 Pkinase: Protein kinase domain Protein kinase; unclassified specificity | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-42 Score=287.46 Aligned_cols=255 Identities=31% Similarity=0.479 Sum_probs=200.7
Q ss_pred CCCCceeecCCcceEEEEEeC-CCcEEEEEEeccCcCChhhhHHHHHHHHHHHhcCCcceeeeeeEEEcCCCeeEEEEee
Q 038766 14 FSENNIIGNSNLSTVYKGRLE-DGEIVAVKKLNFHQFSAESDKSFYREAKTLKELKHRNLVKVLGYAWESGKLKALILEY 92 (299)
Q Consensus 14 y~~~~~lg~g~~~~v~~~~~~-~~~~~~vK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~lv~e~ 92 (299)
|++.+.||+|++|+||++... +++.+|+|++...............|+..+++++||||+++++++.. +...++|+|+
T Consensus 1 y~~~~~lg~G~~g~v~~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~-~~~~~~v~~~ 79 (260)
T PF00069_consen 1 YRLVKKLGSGGFGTVYKAKNKKNGQKVAVKIIDKSEIEEEEREENIREIKILRRLRHPNIVQILDVFQD-DNYLYIVMEY 79 (260)
T ss_dssp EEEEEEEEEESSEEEEEEEETTTTEEEEEEEEESTTHHHHHHHHHHHHHHHHHHHTBTTBCHEEEEEEE-SSEEEEEEEE
T ss_pred CEEeEEEEeCCCEEEEEEEECCCCeEEEEEEeccccccccccchhhhhhhccccccccccccccccccc-cccccccccc
Confidence 678899999999999999875 46789999998655444444445669999999999999999997766 5566899999
Q ss_pred cCCCChHHHhcCCCCCCCCCChhhHHHHHHHHHHHHHHhhcCCCCCeeeecccCCceeeCCCCcEEEeeecccccccccc
Q 038766 93 MENGSLESVIHGPGVDHSRWTLPKRIDVLISVANGLDYLHSGYDIPIVHCDMKPSNILLDRDFEAHVSDFGTSRMLDVHL 172 (299)
Q Consensus 93 ~~~~~L~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lh~~~~~~~~H~dl~~~nil~~~~~~v~l~df~~~~~~~~~~ 172 (299)
+.+++|.+++. ....+++..++.++.|++.||.+||+. +++|+||||+||+++.++.++|+|||.+....
T Consensus 80 ~~~~~L~~~l~----~~~~~~~~~~~~~~~qi~~~L~~Lh~~---~i~H~dikp~NIl~~~~~~~~l~Dfg~~~~~~--- 149 (260)
T PF00069_consen 80 CPGGSLQDYLQ----KNKPLSEEEILKIAYQILEALAYLHSK---GIVHRDIKPENILLDENGEVKLIDFGSSVKLS--- 149 (260)
T ss_dssp ETTEBHHHHHH----HHSSBBHHHHHHHHHHHHHHHHHHHHT---TEEESSBSGGGEEESTTSEEEESSGTTTEEST---
T ss_pred ccccccccccc----ccccccccccccccccccccccccccc---cccccccccccccccccccccccccccccccc---
Confidence 98889999997 456889999999999999999999999 99999999999999999999999999987531
Q ss_pred ccccccccccccCcccCChhhhc-ccCcCccccchhhhHHHHHHHhCCCCCCCCccCCCCchhHHHHHHHHHhcCccCcc
Q 038766 173 QDLSSLSTAFQGTIGYLAPEFAY-MRIVTTKVDVFSFGIVVMEFLTKRRPTGLDEENGLSPISLRQLVEKALANGINGVR 251 (299)
Q Consensus 173 ~~~~~~~~~~~~~~~y~~PE~~~-~~~~~~~~DiwslG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 251 (299)
..........++..|+|||... +...+.++|+||||+++++|++|..||... ........+.........
T Consensus 150 -~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~~~~p~~~~-----~~~~~~~~~~~~~~~~~~--- 220 (260)
T PF00069_consen 150 -ENNENFNPFVGTPEYMAPEVLQQGKKYTRKSDIWSLGIILYELLTGKLPFEES-----NSDDQLEIIEKILKRPLP--- 220 (260)
T ss_dssp -STTSEBSSSSSSGGGSCHHHHTTTSSBSTHHHHHHHHHHHHHHHHSSSSSTTS-----SHHHHHHHHHHHHHTHHH---
T ss_pred -ccccccccccccccccccccccccccccccccccccccccccccccccccccc-----cchhhhhhhhhccccccc---
Confidence 1123334456788999999988 888999999999999999999999998533 111222222221110000
Q ss_pred cccCccccchhhHhHHHHHHHHHHHHHHHHhcCCCCCCCCChhhhhcC
Q 038766 252 QITDPKLVSSIYEEQEQHQVLEELFKLALVCTSSNPEDRPNMNELLIT 299 (299)
Q Consensus 252 ~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rpt~~~il~~ 299 (299)
.........+..+.+++.+||..||++|||++++++|
T Consensus 221 -----------~~~~~~~~~~~~l~~li~~~l~~~p~~R~~~~~l~~~ 257 (260)
T PF00069_consen 221 -----------SSSQQSREKSEELRDLIKKMLSKDPEQRPSAEELLKH 257 (260)
T ss_dssp -----------HHTTSHTTSHHHHHHHHHHHSSSSGGGSTTHHHHHTS
T ss_pred -----------ccccccchhHHHHHHHHHHHccCChhHCcCHHHHhcC
Confidence 0000011112689999999999999999999999987
|
Serine/Threonine protein kinases, catalytic domain Tyrosine kinase, catalytic domain; InterPro: IPR017442 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases. Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. Eukaryotic protein kinases [, , , , ] are enzymes that belong to a very extensive family of proteins which share a conserved catalytic core common with both serine/threonine and tyrosine protein kinases. There are a number of conserved regions in the catalytic domain of protein kinases. In the N-terminal extremity of the catalytic domain there is a glycine-rich stretch of residues in the vicinity of a lysine residue, which has been shown to be involved in ATP binding. In the central part of the catalytic domain there is a conserved aspartic acid residue which is important for the catalytic activity of the enzyme []. This entry includes protein kinases from eukaryotes and viruses and may include some bacterial hits too.; GO: 0004672 protein kinase activity, 0005524 ATP binding, 0006468 protein phosphorylation; PDB: 3GC7_A 3ZYA_A 3MPT_A 3NEW_A 3MVM_A 1R3C_A 2FST_X 3E93_A 3HV5_B 3OCG_A .... |
| >cd07874 STKc_JNK3 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-42 Score=300.15 Aligned_cols=271 Identities=24% Similarity=0.272 Sum_probs=202.3
Q ss_pred HHhCCCCCCceeecCCcceEEEEEeC-CCcEEEEEEeccCcCChhhhHHHHHHHHHHHhcCCcceeeeeeEEEcCC----
Q 038766 9 NATGSFSENNIIGNSNLSTVYKGRLE-DGEIVAVKKLNFHQFSAESDKSFYREAKTLKELKHRNLVKVLGYAWESG---- 83 (299)
Q Consensus 9 ~~~~~y~~~~~lg~g~~~~v~~~~~~-~~~~~~vK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~---- 83 (299)
.+.++|.+.+.||+|+||.||++.+. .++.+|+|++............+.+|+..++.++||||+++++++....
T Consensus 14 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~ 93 (355)
T cd07874 14 TVLKRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISLLNVFTPQKSLEE 93 (355)
T ss_pred hhhhceeEEEEeeecCCEEEEEEEecCCCceEEEEEeCCcccChHHHHHHHHHHHHHHHhCCCchhceeeeeeccccccc
Confidence 46789999999999999999999864 5889999998755445555677889999999999999999999775432
Q ss_pred -CeeEEEEeecCCCChHHHhcCCCCCCCCCChhhHHHHHHHHHHHHHHhhcCCCCCeeeecccCCceeeCCCCcEEEeee
Q 038766 84 -KLKALILEYMENGSLESVIHGPGVDHSRWTLPKRIDVLISVANGLDYLHSGYDIPIVHCDMKPSNILLDRDFEAHVSDF 162 (299)
Q Consensus 84 -~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lh~~~~~~~~H~dl~~~nil~~~~~~v~l~df 162 (299)
...++|+||+.+ ++...+. ..+++..++.++.|++.||.|||++ +++||||||+||+++.++.++|+||
T Consensus 94 ~~~~~lv~e~~~~-~l~~~~~------~~l~~~~~~~~~~qi~~aL~~LH~~---givHrDikp~Nill~~~~~~kl~Df 163 (355)
T cd07874 94 FQDVYLVMELMDA-NLCQVIQ------MELDHERMSYLLYQMLCGIKHLHSA---GIIHRDLKPSNIVVKSDCTLKILDF 163 (355)
T ss_pred cceeEEEhhhhcc-cHHHHHh------hcCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCChHHEEECCCCCEEEeeC
Confidence 346899999965 7777664 2478889999999999999999999 9999999999999999999999999
Q ss_pred ccccccccccccccccccccccCcccCChhhhcccCcCccccchhhhHHHHHHHhCCCCCCCCccCCCCchhHHHHHHHH
Q 038766 163 GTSRMLDVHLQDLSSLSTAFQGTIGYLAPEFAYMRIVTTKVDVFSFGIVVMEFLTKRRPTGLDEENGLSPISLRQLVEKA 242 (299)
Q Consensus 163 ~~~~~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~DiwslG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~ 242 (299)
|++..... ........+++.|+|||++.+..++.++|||||||++|+|++|..||...... ..+...+...
T Consensus 164 g~~~~~~~-----~~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~----~~~~~~~~~~ 234 (355)
T cd07874 164 GLARTAGT-----SFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMVRHKILFPGRDYI----DQWNKVIEQL 234 (355)
T ss_pred cccccCCC-----ccccCCccccCCccCHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHH----HHHHHHHHHh
Confidence 99875431 12223446788999999999999999999999999999999999999643211 1111111110
Q ss_pred ------------------HhcCccCcccccCcccc-chh--hHhHHHHHHHHHHHHHHHHhcCCCCCCCCChhhhhcC
Q 038766 243 ------------------LANGINGVRQITDPKLV-SSI--YEEQEQHQVLEELFKLALVCTSSNPEDRPNMNELLIT 299 (299)
Q Consensus 243 ------------------~~~~~~~~~~~~~~~~~-~~~--~~~~~~~~~~~~l~~li~~~l~~dP~~Rpt~~~il~~ 299 (299)
.... .....+..+... ... .........+.++.++|.+||..||++|||+.|+|+|
T Consensus 235 ~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~Rps~~ell~h 311 (355)
T cd07874 235 GTPCPEFMKKLQPTVRNYVENR-PKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRISVDEALQH 311 (355)
T ss_pred CCCCHHHHHhhcHHHHHHHhcC-CccccccchhhccccccccccccccccchHHHHHHHHHhcCCchhcCCHHHHhcC
Confidence 0000 000000000000 000 0001122335678999999999999999999999987
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 3 (JNK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK3 is expressed primarily in the brain, and to a lesser extent in the heart and testis. Mice deficient in Jnk3 are protected against kainic acid-induced seizures, strok |
| >cd05582 STKc_RSK_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, 90 kDa ribosomal protein S6 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.1e-43 Score=299.93 Aligned_cols=245 Identities=27% Similarity=0.326 Sum_probs=194.0
Q ss_pred CceeecCCcceEEEEEe----CCCcEEEEEEeccCcCChhhhHHHHHHHHHHHhcCCcceeeeeeEEEcCCCeeEEEEee
Q 038766 17 NNIIGNSNLSTVYKGRL----EDGEIVAVKKLNFHQFSAESDKSFYREAKTLKELKHRNLVKVLGYAWESGKLKALILEY 92 (299)
Q Consensus 17 ~~~lg~g~~~~v~~~~~----~~~~~~~vK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~lv~e~ 92 (299)
.+.||+|+||.||++.. .+|+.+|+|++...............|++++++++||||+++++++.. +...++|+||
T Consensus 1 l~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~-~~~~~lv~e~ 79 (318)
T cd05582 1 LKVLGQGSFGKVFLVRKITGPDAGQLYAMKVLKKATLKVRDRVRTKMERDILAEVNHPFIVKLHYAFQT-EGKLYLILDF 79 (318)
T ss_pred CceeeeCCCEEEEEEEEeccCCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHhCCCCCcccEEEEEEc-CCEEEEEEcC
Confidence 36799999999999875 358899999997544333445567789999999999999999997665 4566999999
Q ss_pred cCCCChHHHhcCCCCCCCCCChhhHHHHHHHHHHHHHHhhcCCCCCeeeecccCCceeeCCCCcEEEeeecccccccccc
Q 038766 93 MENGSLESVIHGPGVDHSRWTLPKRIDVLISVANGLDYLHSGYDIPIVHCDMKPSNILLDRDFEAHVSDFGTSRMLDVHL 172 (299)
Q Consensus 93 ~~~~~L~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lh~~~~~~~~H~dl~~~nil~~~~~~v~l~df~~~~~~~~~~ 172 (299)
+.+++|.+.+. ....+++..++.++.||+.||+|||+. +++|+||||+||+++.++.++|+|||++......
T Consensus 80 ~~~~~L~~~l~----~~~~l~~~~~~~~~~qi~~~l~~lH~~---~i~H~dlkp~Nil~~~~~~~kL~Dfg~~~~~~~~- 151 (318)
T cd05582 80 LRGGDLFTRLS----KEVMFTEEDVKFYLAELALALDHLHSL---GIIYRDLKPENILLDEEGHIKLTDFGLSKESIDH- 151 (318)
T ss_pred CCCCcHHHHHH----HcCCCCHHHHHHHHHHHHHHHHHHHHC---CEecCCCCHHHeEECCCCcEEEeeccCCcccCCC-
Confidence 99999999886 445789999999999999999999999 9999999999999999999999999998654311
Q ss_pred ccccccccccccCcccCChhhhcccCcCccccchhhhHHHHHHHhCCCCCCCCccCCCCchhHHHHHHHHHhcCccCccc
Q 038766 173 QDLSSLSTAFQGTIGYLAPEFAYMRIVTTKVDVFSFGIVVMEFLTKRRPTGLDEENGLSPISLRQLVEKALANGINGVRQ 252 (299)
Q Consensus 173 ~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~DiwslG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 252 (299)
........+++.|+|||.+.+..++.++|||||||++|+|++|..||.... . ...+....... ..
T Consensus 152 ---~~~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~el~tg~~p~~~~~-----~---~~~~~~i~~~~-~~--- 216 (318)
T cd05582 152 ---EKKAYSFCGTVEYMAPEVVNRRGHTQSADWWSFGVLMFEMLTGSLPFQGKD-----R---KETMTMILKAK-LG--- 216 (318)
T ss_pred ---CCceecccCChhhcCHHHHcCCCCCCccceeccceEeeeeccCCCCCCCCC-----H---HHHHHHHHcCC-CC---
Confidence 112234467889999999998889999999999999999999999985331 1 12222211110 00
Q ss_pred ccCccccchhhHhHHHHHHHHHHHHHHHHhcCCCCCCCCC-----hhhhhcC
Q 038766 253 ITDPKLVSSIYEEQEQHQVLEELFKLALVCTSSNPEDRPN-----MNELLIT 299 (299)
Q Consensus 253 ~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rpt-----~~~il~~ 299 (299)
.+..++.++.++|++||+.||++||| +++++.|
T Consensus 217 --------------~p~~~~~~~~~li~~~l~~~P~~R~~a~~~~~~~~~~~ 254 (318)
T cd05582 217 --------------MPQFLSPEAQSLLRALFKRNPANRLGAGPDGVEEIKRH 254 (318)
T ss_pred --------------CCCCCCHHHHHHHHHHhhcCHhHcCCCCCCCHHHHhCC
Confidence 02234567899999999999999999 5557654
|
Serine/Threonine Kinases (STKs), 90 kDa ribosomal protein S6 kinase (RSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. RSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family. They are activated by signaling inputs from extracellular regulated kinase (ERK) and phosphoinositide dependent kinase 1 (PDK1). ERK phosphorylates and activates the CTD of RSK, serving as a docking site for PDK1, which phosphorylates and activates the NTD, which in turn phosphorylate |
| >cd05594 STKc_PKB_alpha Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B alpha | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.8e-43 Score=299.08 Aligned_cols=244 Identities=22% Similarity=0.266 Sum_probs=193.1
Q ss_pred ceeecCCcceEEEEEe-CCCcEEEEEEeccCcC-ChhhhHHHHHHHHHHHhcCCcceeeeeeEEEcCCCeeEEEEeecCC
Q 038766 18 NIIGNSNLSTVYKGRL-EDGEIVAVKKLNFHQF-SAESDKSFYREAKTLKELKHRNLVKVLGYAWESGKLKALILEYMEN 95 (299)
Q Consensus 18 ~~lg~g~~~~v~~~~~-~~~~~~~vK~~~~~~~-~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~lv~e~~~~ 95 (299)
+.||+|+||.||++.+ .+|+.||+|++..... ..........|.++++.++||||+++.+.+.. ....++||||+.+
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~e~~~l~~~~hp~i~~~~~~~~~-~~~~~lv~E~~~~ 79 (325)
T cd05594 1 KLLGKGTFGKVILVKEKATGRYYAMKILKKEVIVAKDEVAHTLTENRVLQNSRHPFLTALKYSFQT-HDRLCFVMEYANG 79 (325)
T ss_pred CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCCceEEEEEc-CCEEEEEEeCCCC
Confidence 4799999999999986 4689999999864322 22334567789999999999999999996555 5567999999999
Q ss_pred CChHHHhcCCCCCCCCCChhhHHHHHHHHHHHHHHhhc-CCCCCeeeecccCCceeeCCCCcEEEeeecccccccccccc
Q 038766 96 GSLESVIHGPGVDHSRWTLPKRIDVLISVANGLDYLHS-GYDIPIVHCDMKPSNILLDRDFEAHVSDFGTSRMLDVHLQD 174 (299)
Q Consensus 96 ~~L~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lh~-~~~~~~~H~dl~~~nil~~~~~~v~l~df~~~~~~~~~~~~ 174 (299)
++|...+. ....+++..++.++.||+.||+|||+ . +++|+||||+||+++.++.++|+|||++.....
T Consensus 80 ~~L~~~l~----~~~~l~~~~~~~~~~qi~~aL~~lH~~~---~ivHrDikp~NIll~~~~~~kL~Dfg~~~~~~~---- 148 (325)
T cd05594 80 GELFFHLS----RERVFSEDRARFYGAEIVSALDYLHSEK---NVVYRDLKLENLMLDKDGHIKITDFGLCKEGIK---- 148 (325)
T ss_pred CcHHHHHH----hcCCCCHHHHHHHHHHHHHHHHHHHhcC---CEEecCCCCCeEEECCCCCEEEecCCCCeecCC----
Confidence 99998886 44578999999999999999999997 7 999999999999999999999999998864321
Q ss_pred ccccccccccCcccCChhhhcccCcCccccchhhhHHHHHHHhCCCCCCCCccCCCCchhHHHHHHHHHhcCccCccccc
Q 038766 175 LSSLSTAFQGTIGYLAPEFAYMRIVTTKVDVFSFGIVVMEFLTKRRPTGLDEENGLSPISLRQLVEKALANGINGVRQIT 254 (299)
Q Consensus 175 ~~~~~~~~~~~~~y~~PE~~~~~~~~~~~DiwslG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 254 (299)
.........+++.|+|||++.+..++.++|||||||++|+|++|..||..... . .......... ..
T Consensus 149 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~tG~~Pf~~~~~-----~---~~~~~i~~~~------~~ 214 (325)
T cd05594 149 DGATMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDH-----E---KLFELILMEE------IR 214 (325)
T ss_pred CCcccccccCCcccCCHHHHccCCCCCccccccccceeeeeccCCCCCCCCCH-----H---HHHHHHhcCC------CC
Confidence 11122344588999999999998999999999999999999999999953311 1 1111111100 00
Q ss_pred CccccchhhHhHHHHHHHHHHHHHHHHhcCCCCCCCC-----ChhhhhcC
Q 038766 255 DPKLVSSIYEEQEQHQVLEELFKLALVCTSSNPEDRP-----NMNELLIT 299 (299)
Q Consensus 255 ~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rp-----t~~~il~~ 299 (299)
. +..++.++.++|++||..||++|+ ++.++++|
T Consensus 215 ~------------p~~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~il~h 252 (325)
T cd05594 215 F------------PRTLSPEAKSLLSGLLKKDPKQRLGGGPDDAKEIMQH 252 (325)
T ss_pred C------------CCCCCHHHHHHHHHHhhcCHHHhCCCCCCCHHHHhcC
Confidence 0 122456789999999999999997 89999987
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, alpha (or Akt1) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-alpha is predominantly expressed in endothelial cells. It is critical for the regulation of angiogenesis and the maintenance of vascular integrity. It also plays a role in adipocyte differentiation. Mice deficien |
| >cd05590 STKc_nPKC_eta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C eta | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-42 Score=296.50 Aligned_cols=244 Identities=21% Similarity=0.315 Sum_probs=192.0
Q ss_pred ceeecCCcceEEEEEeC-CCcEEEEEEeccCcC-ChhhhHHHHHHHHHHHhc-CCcceeeeeeEEEcCCCeeEEEEeecC
Q 038766 18 NIIGNSNLSTVYKGRLE-DGEIVAVKKLNFHQF-SAESDKSFYREAKTLKEL-KHRNLVKVLGYAWESGKLKALILEYME 94 (299)
Q Consensus 18 ~~lg~g~~~~v~~~~~~-~~~~~~vK~~~~~~~-~~~~~~~~~~e~~~l~~l-~h~~i~~~~~~~~~~~~~~~lv~e~~~ 94 (299)
+.||+|+||+||++.+. +++.||+|++..... ..........|...++.+ .||||+++++++.. ....++||||+.
T Consensus 1 ~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~h~~iv~~~~~~~~-~~~~~iv~Ey~~ 79 (320)
T cd05590 1 RVLGKGSFGKVMLARLKESGRLYAVKVLKKDVILQDDDVECTMTEKRILSLARNHPFLTQLYCCFQT-PDRLFFVMEFVN 79 (320)
T ss_pred CeeeeCCCeEEEEEEEcCCCCEEEEEEEEHHHHhhccHHHHHHHHHHHHHhccCCCchhceeeEEEc-CCEEEEEEcCCC
Confidence 47999999999999875 588999999864322 223445667788888776 59999999996654 556699999999
Q ss_pred CCChHHHhcCCCCCCCCCChhhHHHHHHHHHHHHHHhhcCCCCCeeeecccCCceeeCCCCcEEEeeecccccccccccc
Q 038766 95 NGSLESVIHGPGVDHSRWTLPKRIDVLISVANGLDYLHSGYDIPIVHCDMKPSNILLDRDFEAHVSDFGTSRMLDVHLQD 174 (299)
Q Consensus 95 ~~~L~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lh~~~~~~~~H~dl~~~nil~~~~~~v~l~df~~~~~~~~~~~~ 174 (299)
+++|...+. ....+++..++.++.|++.||.|||+. +++||||||+||+++.++.++|+|||++.....
T Consensus 80 ~g~L~~~i~----~~~~l~~~~~~~~~~ql~~~L~~lH~~---~ivH~dlkp~NIli~~~~~~kL~DfG~~~~~~~---- 148 (320)
T cd05590 80 GGDLMFHIQ----KSRRFDEARARFYAAEITSALMFLHDK---GIIYRDLKLDNVLLDHEGHCKLADFGMCKEGIF---- 148 (320)
T ss_pred CchHHHHHH----HcCCCCHHHHHHHHHHHHHHHHHHHHC---CeEeCCCCHHHeEECCCCcEEEeeCCCCeecCc----
Confidence 999998886 445799999999999999999999999 999999999999999999999999999864321
Q ss_pred ccccccccccCcccCChhhhcccCcCccccchhhhHHHHHHHhCCCCCCCCccCCCCchhHHHHHHHHHhcCccCccccc
Q 038766 175 LSSLSTAFQGTIGYLAPEFAYMRIVTTKVDVFSFGIVVMEFLTKRRPTGLDEENGLSPISLRQLVEKALANGINGVRQIT 254 (299)
Q Consensus 175 ~~~~~~~~~~~~~y~~PE~~~~~~~~~~~DiwslG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 254 (299)
.........+++.|+|||.+.+..++.++|||||||++|+|++|..||.... .. .......... ..
T Consensus 149 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~Pf~~~~-----~~---~~~~~i~~~~------~~ 214 (320)
T cd05590 149 NGKTTSTFCGTPDYIAPEILQEMLYGPSVDWWAMGVLLYEMLCGHAPFEAEN-----ED---DLFEAILNDE------VV 214 (320)
T ss_pred CCCcccccccCccccCHHHHcCCCCCCccchhhhHHHHHHHhhCCCCCCCCC-----HH---HHHHHHhcCC------CC
Confidence 1112234567899999999999889999999999999999999999995432 11 2222221110 00
Q ss_pred CccccchhhHhHHHHHHHHHHHHHHHHhcCCCCCCCCCh------hhhhcC
Q 038766 255 DPKLVSSIYEEQEQHQVLEELFKLALVCTSSNPEDRPNM------NELLIT 299 (299)
Q Consensus 255 ~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rpt~------~~il~~ 299 (299)
. +..++.++.+++++||..||++||++ ++++.|
T Consensus 215 ~------------~~~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~~~~~h 253 (320)
T cd05590 215 Y------------PTWLSQDAVDILKAFMTKNPTMRLGSLTLGGEEAILRH 253 (320)
T ss_pred C------------CCCCCHHHHHHHHHHcccCHHHCCCCCCCCCHHHHHcC
Confidence 0 11245678999999999999999998 777766
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), eta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-eta is predominantly expressed in squamous epithelia, where it plays a crucial role in the signal |
| >KOG0694 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-42 Score=302.31 Aligned_cols=246 Identities=22% Similarity=0.340 Sum_probs=206.1
Q ss_pred HHhCCCCCCceeecCCcceEEEEEeC-CCcEEEEEEeccCcC-ChhhhHHHHHHHHHHHhcC-CcceeeeeeEEEcCCCe
Q 038766 9 NATGSFSENNIIGNSNLSTVYKGRLE-DGEIVAVKKLNFHQF-SAESDKSFYREAKTLKELK-HRNLVKVLGYAWESGKL 85 (299)
Q Consensus 9 ~~~~~y~~~~~lg~g~~~~v~~~~~~-~~~~~~vK~~~~~~~-~~~~~~~~~~e~~~l~~l~-h~~i~~~~~~~~~~~~~ 85 (299)
.-.++|+..++||+|.||.|+++..+ +++.+|||+++...+ ..+..+..+.|.+++.... ||.++.++. ++.....
T Consensus 365 ~~l~~F~~l~vLGkGsFGkV~lae~k~~~e~yAIK~LKK~~Il~~d~Ve~~~~EkrI~~la~~HPFL~~L~~-~fQT~~~ 443 (694)
T KOG0694|consen 365 LTLDDFRLLAVLGRGSFGKVLLAELKGTNEYYAIKVLKKGDILQRDEVESLMCEKRIFELANRHPFLVNLFS-CFQTKEH 443 (694)
T ss_pred ccccceEEEEEeccCcCceEEEEEEcCCCcEEEEEEeeccceeccccHHHHHHHHHHHHHhccCCeEeeccc-ccccCCe
Confidence 34578999999999999999999864 588999999976544 5666788888998888886 999999999 6666778
Q ss_pred eEEEEeecCCCChHHHhcCCCCCCCCCChhhHHHHHHHHHHHHHHhhcCCCCCeeeecccCCceeeCCCCcEEEeeeccc
Q 038766 86 KALILEYMENGSLESVIHGPGVDHSRWTLPKRIDVLISVANGLDYLHSGYDIPIVHCDMKPSNILLDRDFEAHVSDFGTS 165 (299)
Q Consensus 86 ~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lh~~~~~~~~H~dl~~~nil~~~~~~v~l~df~~~ 165 (299)
+|.||||+.||++..++ ....+++..+..+++.|+.||+|||++ +|+|||||.+|||+|.+|.+||+|||+|
T Consensus 444 l~fvmey~~Ggdm~~~~-----~~~~F~e~rarfyaAev~l~L~fLH~~---~IIYRDlKLdNiLLD~eGh~kiADFGlc 515 (694)
T KOG0694|consen 444 LFFVMEYVAGGDLMHHI-----HTDVFSEPRARFYAAEVVLGLQFLHEN---GIIYRDLKLDNLLLDTEGHVKIADFGLC 515 (694)
T ss_pred EEEEEEecCCCcEEEEE-----ecccccHHHHHHHHHHHHHHHHHHHhc---CceeeecchhheEEcccCcEEecccccc
Confidence 89999999999955444 456899999999999999999999999 9999999999999999999999999999
Q ss_pred cccccccccccccccccccCcccCChhhhcccCcCccccchhhhHHHHHHHhCCCCCCCCccCCCCchhHHHHHHHHHhc
Q 038766 166 RMLDVHLQDLSSLSTAFQGTIGYLAPEFAYMRIVTTKVDVFSFGIVVMEFLTKRRPTGLDEENGLSPISLRQLVEKALAN 245 (299)
Q Consensus 166 ~~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~DiwslG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~ 245 (299)
..-- .......+..|||.|+|||++.+..|+.+.|=||||+++|+|+.|..||.++.++ ++.+ .+...
T Consensus 516 Ke~m----~~g~~TsTfCGTpey~aPEil~e~~Yt~aVDWW~lGVLlyeML~Gq~PF~gddEe-----e~Fd---sI~~d 583 (694)
T KOG0694|consen 516 KEGM----GQGDRTSTFCGTPEFLAPEVLTEQSYTRAVDWWGLGVLLYEMLVGESPFPGDDEE-----EVFD---SIVND 583 (694)
T ss_pred cccC----CCCCccccccCChhhcChhhhccCcccchhhHHHHHHHHHHHHcCCCCCCCCCHH-----HHHH---HHhcC
Confidence 7522 2345667888999999999999999999999999999999999999999655332 2222 11111
Q ss_pred CccCcccccCccccchhhHhHHHHHHHHHHHHHHHHhcCCCCCCCCCh
Q 038766 246 GINGVRQITDPKLVSSIYEEQEQHQVLEELFKLALVCTSSNPEDRPNM 293 (299)
Q Consensus 246 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rpt~ 293 (299)
++. .+..++.++.++++++|..+|++|.-+
T Consensus 584 ---------~~~---------yP~~ls~ea~~il~~ll~k~p~kRLG~ 613 (694)
T KOG0694|consen 584 ---------EVR---------YPRFLSKEAIAIMRRLLRKNPEKRLGS 613 (694)
T ss_pred ---------CCC---------CCCcccHHHHHHHHHHhccCcccccCC
Confidence 111 166677899999999999999999976
|
|
| >cd05587 STKc_cPKC Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-42 Score=296.48 Aligned_cols=249 Identities=20% Similarity=0.282 Sum_probs=194.7
Q ss_pred CCCCCceeecCCcceEEEEEeC-CCcEEEEEEeccCcC-ChhhhHHHHHHHHHHHhcCCc-ceeeeeeEEEcCCCeeEEE
Q 038766 13 SFSENNIIGNSNLSTVYKGRLE-DGEIVAVKKLNFHQF-SAESDKSFYREAKTLKELKHR-NLVKVLGYAWESGKLKALI 89 (299)
Q Consensus 13 ~y~~~~~lg~g~~~~v~~~~~~-~~~~~~vK~~~~~~~-~~~~~~~~~~e~~~l~~l~h~-~i~~~~~~~~~~~~~~~lv 89 (299)
+|.+.+.||+|+||.||+|.+. +++.||+|++..... .......+..|.+++..+.|+ +|+++++.+. .....++|
T Consensus 1 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~-~~~~~~lv 79 (324)
T cd05587 1 DFNFLMVLGKGSFGKVMLAERKGTDELYAIKILKKDVIIQDDDVECTMVEKRVLALPGKPPFLTQLHSCFQ-TMDRLYFV 79 (324)
T ss_pred CceEEEEEeeccCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhcCCCCceeeeEEEEE-cCCEEEEE
Confidence 5889999999999999999865 578999999864322 233456677899999999865 5777777554 45567999
Q ss_pred EeecCCCChHHHhcCCCCCCCCCChhhHHHHHHHHHHHHHHhhcCCCCCeeeecccCCceeeCCCCcEEEeeeccccccc
Q 038766 90 LEYMENGSLESVIHGPGVDHSRWTLPKRIDVLISVANGLDYLHSGYDIPIVHCDMKPSNILLDRDFEAHVSDFGTSRMLD 169 (299)
Q Consensus 90 ~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lh~~~~~~~~H~dl~~~nil~~~~~~v~l~df~~~~~~~ 169 (299)
+||+.+++|...+. ....+++..++.++.|++.||.|||+. +++|+||||+||+++.++.++|+|||++....
T Consensus 80 ~E~~~~g~L~~~~~----~~~~~~~~~~~~~~~qi~~al~~lH~~---~ivH~dlkp~Nill~~~~~~kL~Dfg~~~~~~ 152 (324)
T cd05587 80 MEYVNGGDLMYHIQ----QVGKFKEPHAVFYAAEIAIGLFFLHSK---GIIYRDLKLDNVMLDAEGHIKIADFGMCKENI 152 (324)
T ss_pred EcCCCCCcHHHHHH----HcCCCCHHHHHHHHHHHHHHHHHHHHC---CeEecCCCHHHeEEcCCCCEEEeecCcceecC
Confidence 99999999999886 445789999999999999999999999 99999999999999999999999999886432
Q ss_pred cccccccccccccccCcccCChhhhcccCcCccccchhhhHHHHHHHhCCCCCCCCccCCCCchhHHHHHHHHHhcCccC
Q 038766 170 VHLQDLSSLSTAFQGTIGYLAPEFAYMRIVTTKVDVFSFGIVVMEFLTKRRPTGLDEENGLSPISLRQLVEKALANGING 249 (299)
Q Consensus 170 ~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~DiwslG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 249 (299)
. .........+++.|+|||++.+..++.++|+||+||++|+|++|..||.... .. +....... ....
T Consensus 153 ~----~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~elltG~~pf~~~~-----~~---~~~~~i~~-~~~~ 219 (324)
T cd05587 153 F----GGKTTRTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQPPFDGED-----ED---ELFQSIME-HNVS 219 (324)
T ss_pred C----CCCceeeecCCccccChhhhcCCCCCcccchhhhHHHHHHHHhCCCCCCCCC-----HH---HHHHHHHc-CCCC
Confidence 1 1112234467899999999999889999999999999999999999995331 11 11111111 1000
Q ss_pred cccccCccccchhhHhHHHHHHHHHHHHHHHHhcCCCCCCCCCh-----hhhhcC
Q 038766 250 VRQITDPKLVSSIYEEQEQHQVLEELFKLALVCTSSNPEDRPNM-----NELLIT 299 (299)
Q Consensus 250 ~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rpt~-----~~il~~ 299 (299)
+ +..++.++.+++++||..||.+|++. +++++|
T Consensus 220 ---~--------------~~~~~~~~~~li~~~l~~~P~~R~~~~~~~~~~~~~h 257 (324)
T cd05587 220 ---Y--------------PKSLSKEAVSICKGLLTKHPAKRLGCGPTGERDIREH 257 (324)
T ss_pred ---C--------------CCCCCHHHHHHHHHHhhcCHHHcCCCCCCCHHHHhcC
Confidence 0 12345678999999999999999987 677765
|
Serine/Threonine Kinases (STKs), Classical (or Conventional) Protein Kinase C (cPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. cPKCs contain a calcium-binding C2 region in their regulatory |
| >cd05626 STKc_LATS2 Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.6e-42 Score=300.21 Aligned_cols=258 Identities=18% Similarity=0.230 Sum_probs=197.2
Q ss_pred CCCCCCceeecCCcceEEEEEe-CCCcEEEEEEeccCcC-ChhhhHHHHHHHHHHHhcCCcceeeeeeEEEcCCCeeEEE
Q 038766 12 GSFSENNIIGNSNLSTVYKGRL-EDGEIVAVKKLNFHQF-SAESDKSFYREAKTLKELKHRNLVKVLGYAWESGKLKALI 89 (299)
Q Consensus 12 ~~y~~~~~lg~g~~~~v~~~~~-~~~~~~~vK~~~~~~~-~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~lv 89 (299)
+.|.+.+.||+|+||+||+|.+ .+++.||+|++..... .......+..|+.+++.++|+||+++++.+.. +...++|
T Consensus 1 ~~f~~~~~LG~G~~g~Vy~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~E~~il~~l~h~~iv~l~~~~~~-~~~~~lv 79 (381)
T cd05626 1 SMFVKIKTLGIGAFGEVCLACKVDTHALYAMKTLRKKDVLNRNQVAHVKAERDILAEADNEWVVKLYYSFQD-KDNLYFV 79 (381)
T ss_pred CCceEEEEEeecCCEEEEEEEECCCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhcCCCCeeeeEEEEec-CCEEEEE
Confidence 3688999999999999999986 4588999999865432 23345678899999999999999999997665 5567999
Q ss_pred EeecCCCChHHHhcCCCCCCCCCChhhHHHHHHHHHHHHHHhhcCCCCCeeeecccCCceeeCCCCcEEEeeeccccccc
Q 038766 90 LEYMENGSLESVIHGPGVDHSRWTLPKRIDVLISVANGLDYLHSGYDIPIVHCDMKPSNILLDRDFEAHVSDFGTSRMLD 169 (299)
Q Consensus 90 ~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lh~~~~~~~~H~dl~~~nil~~~~~~v~l~df~~~~~~~ 169 (299)
+||+++++|.+++. ....+++..+..++.||+.||+|||+. +++||||||+||+++.++.++|+|||++..+.
T Consensus 80 ~E~~~gg~L~~~l~----~~~~~~e~~~~~~~~qi~~aL~~LH~~---givHrDlKp~Nili~~~~~~kL~DFGl~~~~~ 152 (381)
T cd05626 80 MDYIPGGDMMSLLI----RMEVFPEVLARFYIAELTLAIESVHKM---GFIHRDIKPDNILIDLDGHIKLTDFGLCTGFR 152 (381)
T ss_pred EecCCCCcHHHHHH----hcCCCCHHHHHHHHHHHHHHHHHHHhC---CeeecCCcHHHEEECCCCCEEEeeCcCCcccc
Confidence 99999999999987 445789999999999999999999999 99999999999999999999999999875432
Q ss_pred ccccc-------------------------------------------ccccccccccCcccCChhhhcccCcCccccch
Q 038766 170 VHLQD-------------------------------------------LSSLSTAFQGTIGYLAPEFAYMRIVTTKVDVF 206 (299)
Q Consensus 170 ~~~~~-------------------------------------------~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Diw 206 (299)
..... .........||+.|+|||.+.+..++.++|||
T Consensus 153 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~Diw 232 (381)
T cd05626 153 WTHNSKYYQKGSHIRQDSMEPSDLWDDVSNCRCGDRLKTLEQRATKQHQRCLAHSLVGTPNYIAPEVLLRKGYTQLCDWW 232 (381)
T ss_pred cccccccccccccccccccCcccccccccccccccccchhhccccccccccccccccCCccccCHHHHcCCCCCCcccee
Confidence 10000 00011234688999999999988899999999
Q ss_pred hhhHHHHHHHhCCCCCCCCccCCCCchhHHHHHHHHHhcCccCcccccCccccchhhHhHHHHHHHHHHHHHHHHhcC--
Q 038766 207 SFGIVVMEFLTKRRPTGLDEENGLSPISLRQLVEKALANGINGVRQITDPKLVSSIYEEQEQHQVLEELFKLALVCTS-- 284 (299)
Q Consensus 207 slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~-- 284 (299)
||||++|+|++|..||...... ........ . .....+.. ...++.++.+||.+|+.
T Consensus 233 SlG~il~elltG~~Pf~~~~~~--------~~~~~i~~-~-~~~~~~~~------------~~~~s~~~~dli~~ll~~~ 290 (381)
T cd05626 233 SVGVILFEMLVGQPPFLAPTPT--------ETQLKVIN-W-ENTLHIPP------------QVKLSPEAVDLITKLCCSA 290 (381)
T ss_pred ehhhHHHHHHhCCCCCcCCCHH--------HHHHHHHc-c-ccccCCCC------------CCCCCHHHHHHHHHHccCc
Confidence 9999999999999999643211 11111110 0 00000000 11245678899999654
Q ss_pred CCCCCCCChhhhhcC
Q 038766 285 SNPEDRPNMNELLIT 299 (299)
Q Consensus 285 ~dP~~Rpt~~~il~~ 299 (299)
.+|..|||+++++.|
T Consensus 291 ~~~~~R~~~~~~l~h 305 (381)
T cd05626 291 EERLGRNGADDIKAH 305 (381)
T ss_pred ccccCCCCHHHHhcC
Confidence 455559999999987
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. LATS2 is an essential mitotic regulator responsible for coordinating accurate cytokinesis completion and governing the stabilization of other mitotic regulators. It is also critical in the maintenance of proper chromosome number, genomic stability, mitotic fidelity, and the integrity of centrosome duplication. Downregulation of LATS2 is associated with po |
| >cd05605 STKc_GRK4_like Catalytic domain of G protein-coupled Receptor Kinase 4-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.7e-42 Score=287.76 Aligned_cols=254 Identities=22% Similarity=0.298 Sum_probs=198.9
Q ss_pred CCCCCceeecCCcceEEEEEeC-CCcEEEEEEeccCcCCh-hhhHHHHHHHHHHHhcCCcceeeeeeEEEcCCCeeEEEE
Q 038766 13 SFSENNIIGNSNLSTVYKGRLE-DGEIVAVKKLNFHQFSA-ESDKSFYREAKTLKELKHRNLVKVLGYAWESGKLKALIL 90 (299)
Q Consensus 13 ~y~~~~~lg~g~~~~v~~~~~~-~~~~~~vK~~~~~~~~~-~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~lv~ 90 (299)
.|++.+.||+|++|+||++.+. +++.||+|++....... .....+.+|+.+++.++|+||+++++.+.. +...++|+
T Consensus 1 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~-~~~~~lv~ 79 (285)
T cd05605 1 TFRHYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKQILEKVNSRFVVSLAYAYET-KDALCLVL 79 (285)
T ss_pred CceEEEEEecCCCeEEEEEEEcCCCceEEEEEEehhhhhhhhhHHHHHHHHHHHHhcCCCCEeeeeeeecC-CCeEEEEE
Confidence 3788999999999999999864 68999999986433222 223456789999999999999999996544 55779999
Q ss_pred eecCCCChHHHhcCCCCCCCCCChhhHHHHHHHHHHHHHHhhcCCCCCeeeecccCCceeeCCCCcEEEeeecccccccc
Q 038766 91 EYMENGSLESVIHGPGVDHSRWTLPKRIDVLISVANGLDYLHSGYDIPIVHCDMKPSNILLDRDFEAHVSDFGTSRMLDV 170 (299)
Q Consensus 91 e~~~~~~L~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lh~~~~~~~~H~dl~~~nil~~~~~~v~l~df~~~~~~~~ 170 (299)
||+.+++|.+++... ....+++..+..++.|++.||.|||+. +++|+||+|+||+++.++.++|+|||++.....
T Consensus 80 e~~~~~~L~~~~~~~--~~~~~~~~~~~~~~~qi~~~l~~lH~~---~ivH~dlkp~Nil~~~~~~~~l~Dfg~~~~~~~ 154 (285)
T cd05605 80 TLMNGGDLKFHIYNM--GNPGFDEERAVFYAAEITCGLEDLHRE---RIVYRDLKPENILLDDYGHIRISDLGLAVEIPE 154 (285)
T ss_pred eccCCCcHHHHHHhc--CcCCCCHHHHHHHHHHHHHHHHHHHHC---CcEecCCCHHHEEECCCCCEEEeeCCCceecCC
Confidence 999999999877532 234689999999999999999999999 999999999999999999999999999875431
Q ss_pred ccccccccccccccCcccCChhhhcccCcCccccchhhhHHHHHHHhCCCCCCCCccCCCCchhHHHHHHHHHhcCccCc
Q 038766 171 HLQDLSSLSTAFQGTIGYLAPEFAYMRIVTTKVDVFSFGIVVMEFLTKRRPTGLDEENGLSPISLRQLVEKALANGINGV 250 (299)
Q Consensus 171 ~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~DiwslG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 250 (299)
. .......+++.|+|||++.+..++.++||||+|+++|+|++|..||...... ...+.+.........
T Consensus 155 ~-----~~~~~~~~~~~y~aPE~~~~~~~~~~~Diws~G~~l~el~~g~~pf~~~~~~-----~~~~~~~~~~~~~~~-- 222 (285)
T cd05605 155 G-----ETIRGRVGTVGYMAPEVVKNERYTFSPDWWGLGCLIYEMIEGKSPFRQRKEK-----VKREEVERRVKEDQE-- 222 (285)
T ss_pred C-----CccccccCCCCccCcHHhcCCCCCccccchhHHHHHHHHHHCCCCCCCCchh-----hHHHHHHHHhhhccc--
Confidence 1 1122345788999999999888999999999999999999999999643211 111111111111100
Q ss_pred ccccCccccchhhHhHHHHHHHHHHHHHHHHhcCCCCCCCC-----ChhhhhcC
Q 038766 251 RQITDPKLVSSIYEEQEQHQVLEELFKLALVCTSSNPEDRP-----NMNELLIT 299 (299)
Q Consensus 251 ~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rp-----t~~~il~~ 299 (299)
..+..++..+.+++.+||..||++|| +++++++|
T Consensus 223 ---------------~~~~~~~~~~~~li~~~l~~~P~~R~~~~~~~~~~l~~~ 261 (285)
T cd05605 223 ---------------EYSEKFSEAARSICRQLLTKDPGFRLGCRGEGAEEVKAH 261 (285)
T ss_pred ---------------ccCcccCHHHHHHHHHHccCCHHHhcCCCCCCHHHHhcC
Confidence 00233567789999999999999999 89899876
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4-like group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. Members of the GRK4-like group include GRK4, GRK5, |
| >cd05608 STKc_GRK1 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5e-42 Score=287.39 Aligned_cols=250 Identities=23% Similarity=0.334 Sum_probs=194.0
Q ss_pred eecCCcceEEEEEeC-CCcEEEEEEeccCcCCh-hhhHHHHHHHHHHHhcCCcceeeeeeEEEcCCCeeEEEEeecCCCC
Q 038766 20 IGNSNLSTVYKGRLE-DGEIVAVKKLNFHQFSA-ESDKSFYREAKTLKELKHRNLVKVLGYAWESGKLKALILEYMENGS 97 (299)
Q Consensus 20 lg~g~~~~v~~~~~~-~~~~~~vK~~~~~~~~~-~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~lv~e~~~~~~ 97 (299)
||+|+||+||++.+. +++.+|+|++....... .....+..|+.+++.+.|+||+++.+++.. +...++||||+++++
T Consensus 1 lg~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~i~~~~~~~~~-~~~~~lv~e~~~~g~ 79 (280)
T cd05608 1 LGKGGFGEVSACQMRATGKLYACKKLNKKRLKKRKGYEGAMVEKRILAKVHSRFIVSLAYAFQT-KTDLCLVMTIMNGGD 79 (280)
T ss_pred CCCCCceeEEEEEEccCCcEEEEEeeeHHHHhhhHHHHHHHHHHHHHHhCCCCcEeeeeEEEcC-CCeEEEEEeCCCCCC
Confidence 699999999999864 68899999986433222 233567789999999999999999986554 556799999999999
Q ss_pred hHHHhcCCCCCCCCCChhhHHHHHHHHHHHHHHhhcCCCCCeeeecccCCceeeCCCCcEEEeeeccccccccccccccc
Q 038766 98 LESVIHGPGVDHSRWTLPKRIDVLISVANGLDYLHSGYDIPIVHCDMKPSNILLDRDFEAHVSDFGTSRMLDVHLQDLSS 177 (299)
Q Consensus 98 L~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lh~~~~~~~~H~dl~~~nil~~~~~~v~l~df~~~~~~~~~~~~~~~ 177 (299)
|...+.........+++..++.++.|++.||.|||+. +++|+||||+||+++.++.++|+|||++..+... ..
T Consensus 80 L~~~~~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~---~i~H~dlkp~Nili~~~~~~~l~dfg~~~~~~~~----~~ 152 (280)
T cd05608 80 LRYHIYNVDEENPGFPEPRACFYTAQIISGLEHLHQR---RIIYRDLKPENVLLDNDGNVRISDLGLAVELKDG----QS 152 (280)
T ss_pred HHHHHHhccccCCCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCHHHEEECCCCCEEEeeCccceecCCC----Cc
Confidence 9887754333456799999999999999999999999 9999999999999999999999999998754321 11
Q ss_pred cccccccCcccCChhhhcccCcCccccchhhhHHHHHHHhCCCCCCCCccCCCCchhHHHHHHHHHhcCccCcccccCcc
Q 038766 178 LSTAFQGTIGYLAPEFAYMRIVTTKVDVFSFGIVVMEFLTKRRPTGLDEENGLSPISLRQLVEKALANGINGVRQITDPK 257 (299)
Q Consensus 178 ~~~~~~~~~~y~~PE~~~~~~~~~~~DiwslG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 257 (299)
......+++.|+|||.+.+..++.++|+||+|+++|+|++|..||....... ........... . ..
T Consensus 153 ~~~~~~g~~~y~aPE~~~~~~~~~~~DvwslG~il~el~~g~~pf~~~~~~~----~~~~~~~~~~~-~-----~~---- 218 (280)
T cd05608 153 KTKGYAGTPGFMAPELLQGEEYDFSVDYFALGVTLYEMIAARGPFRARGEKV----ENKELKQRILN-D-----SV---- 218 (280)
T ss_pred cccccCCCcCccCHHHhcCCCCCccccHHHHHHHHHHHHhCCCCCCCCCcch----hHHHHHHhhcc-c-----CC----
Confidence 2234467889999999999999999999999999999999999996432211 01111111100 0 00
Q ss_pred ccchhhHhHHHHHHHHHHHHHHHHhcCCCCCCCC-----ChhhhhcC
Q 038766 258 LVSSIYEEQEQHQVLEELFKLALVCTSSNPEDRP-----NMNELLIT 299 (299)
Q Consensus 258 ~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rp-----t~~~il~~ 299 (299)
..+..++..+.+++.+||+.||++|| |++++++|
T Consensus 219 --------~~~~~~~~~~~~li~~~l~~~P~~R~~~~~~~~~~~l~h 257 (280)
T cd05608 219 --------TYPDKFSPASKSFCEALLAKDPEKRLGFRDGNCDGLRTH 257 (280)
T ss_pred --------CCcccCCHHHHHHHHHHhcCCHHHhcCCCCCCHHHHhcC
Confidence 00233567899999999999999999 77888876
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK1, also called rhodopsin kinase, belongs to the visual g |
| >cd05628 STKc_NDR1 Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.5e-42 Score=298.48 Aligned_cols=257 Identities=22% Similarity=0.270 Sum_probs=196.6
Q ss_pred CCCCCCceeecCCcceEEEEEeC-CCcEEEEEEeccCcC-ChhhhHHHHHHHHHHHhcCCcceeeeeeEEEcCCCeeEEE
Q 038766 12 GSFSENNIIGNSNLSTVYKGRLE-DGEIVAVKKLNFHQF-SAESDKSFYREAKTLKELKHRNLVKVLGYAWESGKLKALI 89 (299)
Q Consensus 12 ~~y~~~~~lg~g~~~~v~~~~~~-~~~~~~vK~~~~~~~-~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~lv 89 (299)
++|.+.+.||+|+||+||++.+. +++.||+|++..... .......+..|..+++.++|++|+++++.+.. +...++|
T Consensus 1 ~~y~~~~~LG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~il~~~~~~~iv~~~~~~~~-~~~~~lv 79 (363)
T cd05628 1 EDFESLKVIGRGAFGEVRLVQKKDTGHVYAMKILRKADMLEKEQVGHIRAERDILVEADSLWVVKMFYSFQD-KLNLYLI 79 (363)
T ss_pred CCceEeEEEEeCCCEEEEEEEECCCCCEEEEEEEEHHHHHHhhHHHHHHHHHHHHHhCCCCCcceEEEEEec-CCeEEEE
Confidence 57999999999999999999864 589999999864322 22334677889999999999999999996655 5567999
Q ss_pred EeecCCCChHHHhcCCCCCCCCCChhhHHHHHHHHHHHHHHhhcCCCCCeeeecccCCceeeCCCCcEEEeeeccccccc
Q 038766 90 LEYMENGSLESVIHGPGVDHSRWTLPKRIDVLISVANGLDYLHSGYDIPIVHCDMKPSNILLDRDFEAHVSDFGTSRMLD 169 (299)
Q Consensus 90 ~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lh~~~~~~~~H~dl~~~nil~~~~~~v~l~df~~~~~~~ 169 (299)
|||+++++|.+++. ....+++..+..++.|++.||+|||+. +++||||||+||+++.++.++|+|||++..+.
T Consensus 80 ~E~~~gg~L~~~l~----~~~~l~~~~~~~~~~qi~~aL~~lH~~---givHrDlKp~NILi~~~~~vkL~DFGla~~~~ 152 (363)
T cd05628 80 MEFLPGGDMMTLLM----KKDTLTEEETQFYIAETVLAIDSIHQL---GFIHRDIKPDNLLLDSKGHVKLSDFGLCTGLK 152 (363)
T ss_pred EcCCCCCcHHHHHH----hcCCCCHHHHHHHHHHHHHHHHHHHhC---CeEecCCCHHHeEECCCCCEEEeeccCccccc
Confidence 99999999999987 446799999999999999999999999 99999999999999999999999999987543
Q ss_pred ccccc-------------------------------ccccccccccCcccCChhhhcccCcCccccchhhhHHHHHHHhC
Q 038766 170 VHLQD-------------------------------LSSLSTAFQGTIGYLAPEFAYMRIVTTKVDVFSFGIVVMEFLTK 218 (299)
Q Consensus 170 ~~~~~-------------------------------~~~~~~~~~~~~~y~~PE~~~~~~~~~~~DiwslG~~l~~l~~g 218 (299)
..... .........||+.|+|||++.+..++.++|||||||++|+|++|
T Consensus 153 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~~~~~DvwSlGvil~ell~G 232 (363)
T cd05628 153 KAHRTEFYRNLNHSLPSDFTFQNMNSKRKAETWKRNRRQLAFSTVGTPDYIAPEVFMQTGYNKLCDWWSLGVIMYEMLIG 232 (363)
T ss_pred ccccccccccccccccccccccccccccccchhhhccccccccccCCccccCHHHHcCCCCCCchhhhhhHHHHHHHHhC
Confidence 11000 00011234689999999999999999999999999999999999
Q ss_pred CCCCCCCccCCCCchhHHHHHHHHHhcCccCcccccCccccchhhHhHHHHHHHHHHHHHHHHhcCCCCC---CCCChhh
Q 038766 219 RRPTGLDEENGLSPISLRQLVEKALANGINGVRQITDPKLVSSIYEEQEQHQVLEELFKLALVCTSSNPE---DRPNMNE 295 (299)
Q Consensus 219 ~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~---~Rpt~~~ 295 (299)
..||.... .. +......... . ....+. ...++.++.++|.+|+. +|. .||++++
T Consensus 233 ~~Pf~~~~-----~~---~~~~~i~~~~--~--~~~~p~----------~~~~s~~~~~li~~l~~-~~~~r~~r~~~~e 289 (363)
T cd05628 233 YPPFCSET-----PQ---ETYKKVMNWK--E--TLIFPP----------EVPISEKAKDLILRFCC-EWEHRIGAPGVEE 289 (363)
T ss_pred CCCCCCCC-----HH---HHHHHHHcCc--C--cccCCC----------cCCCCHHHHHHHHHHcC-ChhhcCCCCCHHH
Confidence 99995331 11 1111111100 0 000000 11245678889998775 444 4689999
Q ss_pred hhcC
Q 038766 296 LLIT 299 (299)
Q Consensus 296 il~~ 299 (299)
+++|
T Consensus 290 i~~h 293 (363)
T cd05628 290 IKTN 293 (363)
T ss_pred HhCC
Confidence 9987
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. NDR1 is highly expressed in thymus, mus |
| >cd05096 PTKc_DDR1 Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-41 Score=287.72 Aligned_cols=263 Identities=24% Similarity=0.356 Sum_probs=195.2
Q ss_pred hCCCCCCceeecCCcceEEEEEeCC-----------------CcEEEEEEeccCcCChhhhHHHHHHHHHHHhcCCccee
Q 038766 11 TGSFSENNIIGNSNLSTVYKGRLED-----------------GEIVAVKKLNFHQFSAESDKSFYREAKTLKELKHRNLV 73 (299)
Q Consensus 11 ~~~y~~~~~lg~g~~~~v~~~~~~~-----------------~~~~~vK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~ 73 (299)
.++|++.+.||+|+||.||++.+.+ +..||+|++... ........+.+|+..+++++||||+
T Consensus 4 ~~~~~~~~~lg~G~fg~V~~~~~~~~~~~~~~~~~~~~~~~~~~~vaiK~~~~~-~~~~~~~~~~~E~~~l~~l~h~niv 82 (304)
T cd05096 4 RGHLLFKEKLGEGQFGEVHLCEVVNPQDLPTLQFPFNVRKGRPLLVAVKILRPD-ANKNARNDFLKEVKILSRLKDPNII 82 (304)
T ss_pred hhhCeeeeEecccCCeEEEEEEeccCcccccccccccccCCcceEEEEEEecCC-CCHHHHHHHHHHHHHHhhcCCCCee
Confidence 5789999999999999999997532 346999998643 2344566788999999999999999
Q ss_pred eeeeEEEcCCCeeEEEEeecCCCChHHHhcCCCC---------------CCCCCChhhHHHHHHHHHHHHHHhhcCCCCC
Q 038766 74 KVLGYAWESGKLKALILEYMENGSLESVIHGPGV---------------DHSRWTLPKRIDVLISVANGLDYLHSGYDIP 138 (299)
Q Consensus 74 ~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~---------------~~~~~~~~~~~~i~~qi~~~l~~lh~~~~~~ 138 (299)
++++++...+ ..++|+||+.+++|.+++..... ....++...++.++.||+.||.|||+. +
T Consensus 83 ~~~~~~~~~~-~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~~---~ 158 (304)
T cd05096 83 RLLGVCVDED-PLCMITEYMENGDLNQFLSSHHLDDKEENGNDAVPPAHCLPAISYSSLLHVALQIASGMKYLSSL---N 158 (304)
T ss_pred EEEEEEecCC-ceEEEEecCCCCcHHHHHHhccccccccccccccccccccccccHHHHHHHHHHHHHHHHHHHHC---C
Confidence 9999776644 56999999999999988754211 123567788999999999999999999 9
Q ss_pred eeeecccCCceeeCCCCcEEEeeeccccccccccccccccccccccCcccCChhhhcccCcCccccchhhhHHHHHHHhC
Q 038766 139 IVHCDMKPSNILLDRDFEAHVSDFGTSRMLDVHLQDLSSLSTAFQGTIGYLAPEFAYMRIVTTKVDVFSFGIVVMEFLTK 218 (299)
Q Consensus 139 ~~H~dl~~~nil~~~~~~v~l~df~~~~~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~DiwslG~~l~~l~~g 218 (299)
++|+||||+||+++.++.++|+|||++....... .........++..|+|||.+....++.++||||||+++|+|+++
T Consensus 159 ivH~dlkp~Nill~~~~~~kl~DfG~~~~~~~~~--~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~~~ 236 (304)
T cd05096 159 FVHRDLATRNCLVGENLTIKIADFGMSRNLYAGD--YYRIQGRAVLPIRWMAWECILMGKFTTASDVWAFGVTLWEILML 236 (304)
T ss_pred ccccCcchhheEEcCCccEEECCCccceecccCc--eeEecCcCCCCccccCHHHHhcCCCCchhhhHHHHHHHHHHHHc
Confidence 9999999999999999999999999987543211 11112233456789999999888899999999999999999874
Q ss_pred --CCCCCCCccCCCCchhHHHHHHHHHhcCccCcccccCccccchhhHhHHHHHHHHHHHHHHHHhcCCCCCCCCChhhh
Q 038766 219 --RRPTGLDEENGLSPISLRQLVEKALANGINGVRQITDPKLVSSIYEEQEQHQVLEELFKLALVCTSSNPEDRPNMNEL 296 (299)
Q Consensus 219 --~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rpt~~~i 296 (299)
..||... ..................... ... +...+..+.+++.+||..||++|||+++|
T Consensus 237 ~~~~p~~~~-----~~~~~~~~~~~~~~~~~~~~~-~~~------------~~~~~~~~~~li~~cl~~~p~~RPs~~~i 298 (304)
T cd05096 237 CKEQPYGEL-----TDEQVIENAGEFFRDQGRQVY-LFR------------PPPCPQGLYELMLQCWSRDCRERPSFSDI 298 (304)
T ss_pred cCCCCCCcC-----CHHHHHHHHHHHhhhcccccc-ccC------------CCCCCHHHHHHHHHHccCCchhCcCHHHH
Confidence 4555322 122222221111111100000 000 12234678999999999999999999998
Q ss_pred hc
Q 038766 297 LI 298 (299)
Q Consensus 297 l~ 298 (299)
.+
T Consensus 299 ~~ 300 (304)
T cd05096 299 HA 300 (304)
T ss_pred HH
Confidence 64
|
Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 1 (DDR1) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR1 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR1 binds to all collagens tested to date (types I-IV). It is widely expressed in many tissues. It is abundant in the brain and is also found in k |
| >PTZ00284 protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.5e-42 Score=306.91 Aligned_cols=270 Identities=20% Similarity=0.256 Sum_probs=194.2
Q ss_pred HHHHhCCCCCCceeecCCcceEEEEEeC-CCcEEEEEEeccCcCChhhhHHHHHHHHHHHhcCC------cceeeeeeEE
Q 038766 7 IENATGSFSENNIIGNSNLSTVYKGRLE-DGEIVAVKKLNFHQFSAESDKSFYREAKTLKELKH------RNLVKVLGYA 79 (299)
Q Consensus 7 ~~~~~~~y~~~~~lg~g~~~~v~~~~~~-~~~~~~vK~~~~~~~~~~~~~~~~~e~~~l~~l~h------~~i~~~~~~~ 79 (299)
.+...++|.+.+.||+|+||+||++.+. .++.||||++... .........|++.++.++| .+++.+++++
T Consensus 124 ~~~~~~~y~i~~~lG~G~fg~V~~a~~~~~~~~vAvK~i~~~---~~~~~~~~~e~~~l~~l~~~~~~~~~~i~~i~~~~ 200 (467)
T PTZ00284 124 IDVSTQRFKILSLLGEGTFGKVVEAWDRKRKEYCAVKIVRNV---PKYTRDAKIEIQFMEKVRQADPADRFPLMKIQRYF 200 (467)
T ss_pred cccCCCcEEEEEEEEeccCEEEEEEEEcCCCeEEEEEEEecc---hhhHHHHHHHHHHHHHHhhcCcccCcceeeeEEEE
Confidence 3345688999999999999999999864 5889999998532 2233345567777777654 4588888877
Q ss_pred EcCCCeeEEEEeecCCCChHHHhcCCCCCCCCCChhhHHHHHHHHHHHHHHhhc-CCCCCeeeecccCCceeeCCCC---
Q 038766 80 WESGKLKALILEYMENGSLESVIHGPGVDHSRWTLPKRIDVLISVANGLDYLHS-GYDIPIVHCDMKPSNILLDRDF--- 155 (299)
Q Consensus 80 ~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lh~-~~~~~~~H~dl~~~nil~~~~~--- 155 (299)
.......++|++++ +++|.+++. ....+++..++.++.||+.||.|||+ . +++||||||+|||++.++
T Consensus 201 ~~~~~~~~iv~~~~-g~~l~~~l~----~~~~l~~~~~~~i~~qi~~aL~yLH~~~---gIiHrDlKP~NILl~~~~~~~ 272 (467)
T PTZ00284 201 QNETGHMCIVMPKY-GPCLLDWIM----KHGPFSHRHLAQIIFQTGVALDYFHTEL---HLMHTDLKPENILMETSDTVV 272 (467)
T ss_pred EcCCceEEEEEecc-CCCHHHHHH----HcCCCCHHHHHHHHHHHHHHHHHHHhcC---CeecCCCCHHHEEEecCCccc
Confidence 76667789999998 678988886 34579999999999999999999997 6 999999999999998765
Q ss_pred -------------cEEEeeeccccccccccccccccccccccCcccCChhhhcccCcCccccchhhhHHHHHHHhCCCCC
Q 038766 156 -------------EAHVSDFGTSRMLDVHLQDLSSLSTAFQGTIGYLAPEFAYMRIVTTKVDVFSFGIVVMEFLTKRRPT 222 (299)
Q Consensus 156 -------------~v~l~df~~~~~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~DiwslG~~l~~l~~g~~p~ 222 (299)
.+||+|||.+.... .......+|+.|+|||++.+..++.++|||||||++|+|++|..||
T Consensus 273 ~~~~~~~~~~~~~~vkl~DfG~~~~~~-------~~~~~~~gt~~Y~APE~~~~~~~~~~~DiwSlGvil~elltG~~pf 345 (467)
T PTZ00284 273 DPVTNRALPPDPCRVRICDLGGCCDER-------HSRTAIVSTRHYRSPEVVLGLGWMYSTDMWSMGCIIYELYTGKLLY 345 (467)
T ss_pred ccccccccCCCCceEEECCCCccccCc-------cccccccCCccccCcHHhhcCCCCcHHHHHHHHHHHHHHHhCCCCC
Confidence 49999999875322 2233456899999999999999999999999999999999999999
Q ss_pred CCCccCCCCchhHHHHHHHHHhcCcc-------------------CcccccCccccchhhHh--HHHHHHHHHHHHHHHH
Q 038766 223 GLDEENGLSPISLRQLVEKALANGIN-------------------GVRQITDPKLVSSIYEE--QEQHQVLEELFKLALV 281 (299)
Q Consensus 223 ~~~~~~~~~~~~~~~~~~~~~~~~~~-------------------~~~~~~~~~~~~~~~~~--~~~~~~~~~l~~li~~ 281 (299)
..... ......+......... .......+......... .........+.+||.+
T Consensus 346 ~~~~~-----~~~~~~i~~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dli~~ 420 (467)
T PTZ00284 346 DTHDN-----LEHLHLMEKTLGRLPSEWAGRCGTEEARLLYNSAGQLRPCTDPKHLARIARARPVREVIRDDLLCDLIYG 420 (467)
T ss_pred CCCCh-----HHHHHHHHHHcCCCCHHHHhhccchhHHHHhhhcccccccCCHHHHHhhhcccchhhhhchHHHHHHHHH
Confidence 64321 1111111111100000 00000000000000000 0001124568899999
Q ss_pred hcCCCCCCCCChhhhhcC
Q 038766 282 CTSSNPEDRPNMNELLIT 299 (299)
Q Consensus 282 ~l~~dP~~Rpt~~~il~~ 299 (299)
||..||++|||++|+|+|
T Consensus 421 mL~~dP~~R~ta~e~L~H 438 (467)
T PTZ00284 421 LLHYDRQKRLNARQMTTH 438 (467)
T ss_pred hCCcChhhCCCHHHHhcC
Confidence 999999999999999987
|
|
| >PTZ00267 NIMA-related protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.5e-42 Score=307.90 Aligned_cols=255 Identities=24% Similarity=0.292 Sum_probs=201.7
Q ss_pred CCCCCCceeecCCcceEEEEEeC-C-CcEEEEEEeccCcCChhhhHHHHHHHHHHHhcCCcceeeeeeEEEcCCCeeEEE
Q 038766 12 GSFSENNIIGNSNLSTVYKGRLE-D-GEIVAVKKLNFHQFSAESDKSFYREAKTLKELKHRNLVKVLGYAWESGKLKALI 89 (299)
Q Consensus 12 ~~y~~~~~lg~g~~~~v~~~~~~-~-~~~~~vK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~lv 89 (299)
..|.+.+.||+|++|.||+|... + +..+|+|.+... .......+..|+..++.++||||+++++.+.. +...++|
T Consensus 67 ~~y~~~~~lg~G~~g~vy~a~~~~~~~~~vv~K~~~~~--~~~~~~~~~~E~~~l~~l~Hpniv~~~~~~~~-~~~~~lv 143 (478)
T PTZ00267 67 HMYVLTTLVGRNPTTAAFVATRGSDPKEKVVAKFVMLN--DERQAAYARSELHCLAACDHFGIVKHFDDFKS-DDKLLLI 143 (478)
T ss_pred eeEEEEEEEEeCCCcEEEEEEEcCCCCeEEEEEEcccC--CHHHHHHHHHHHHHHHhCCCCCEeEEEEEEEE-CCEEEEE
Confidence 34899999999999999999753 3 678888876432 33445567789999999999999999997665 4567999
Q ss_pred EeecCCCChHHHhcCCCCCCCCCChhhHHHHHHHHHHHHHHhhcCCCCCeeeecccCCceeeCCCCcEEEeeeccccccc
Q 038766 90 LEYMENGSLESVIHGPGVDHSRWTLPKRIDVLISVANGLDYLHSGYDIPIVHCDMKPSNILLDRDFEAHVSDFGTSRMLD 169 (299)
Q Consensus 90 ~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lh~~~~~~~~H~dl~~~nil~~~~~~v~l~df~~~~~~~ 169 (299)
|||+++++|.+.+........++++.++..++.|++.||.|||+. +++||||||+||+++.++.++|+|||++..+.
T Consensus 144 ~E~~~gg~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~lH~~---~ivHrDlkp~NIll~~~~~~kL~DFgla~~~~ 220 (478)
T PTZ00267 144 MEYGSGGDLNKQIKQRLKEHLPFQEYEVGLLFYQIVLALDEVHSR---KMMHRDLKSANIFLMPTGIIKLGDFGFSKQYS 220 (478)
T ss_pred EECCCCCCHHHHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHhC---CEEECCcCHHhEEECCCCcEEEEeCcCceecC
Confidence 999999999987754333456789999999999999999999999 99999999999999999999999999987654
Q ss_pred cccccccccccccccCcccCChhhhcccCcCccccchhhhHHHHHHHhCCCCCCCCccCCCCchhHHHHHHHHHhcCccC
Q 038766 170 VHLQDLSSLSTAFQGTIGYLAPEFAYMRIVTTKVDVFSFGIVVMEFLTKRRPTGLDEENGLSPISLRQLVEKALANGING 249 (299)
Q Consensus 170 ~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~DiwslG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 249 (299)
... .........+|+.|+|||++.+..++.++|||||||++|+|++|..||.... . .+.+..........
T Consensus 221 ~~~--~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~tg~~Pf~~~~-----~---~~~~~~~~~~~~~~ 290 (478)
T PTZ00267 221 DSV--SLDVASSFCGTPYYLAPELWERKRYSKKADMWSLGVILYELLTLHRPFKGPS-----Q---REIMQQVLYGKYDP 290 (478)
T ss_pred Ccc--ccccccccCCCccccCHhHhCCCCCCcHHhHHHHHHHHHHHHhCCCCCCCCC-----H---HHHHHHHHhCCCCC
Confidence 211 1112334568999999999999999999999999999999999999985331 1 12222222211110
Q ss_pred cccccCccccchhhHhHHHHHHHHHHHHHHHHhcCCCCCCCCChhhhhcC
Q 038766 250 VRQITDPKLVSSIYEEQEQHQVLEELFKLALVCTSSNPEDRPNMNELLIT 299 (299)
Q Consensus 250 ~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rpt~~~il~~ 299 (299)
. +..++.++.++|.+||..||++|||+++++.|
T Consensus 291 ~-----------------~~~~s~~~~~li~~~L~~dP~~Rps~~~~l~~ 323 (478)
T PTZ00267 291 F-----------------PCPVSSGMKALLDPLLSKNPALRPTTQQLLHT 323 (478)
T ss_pred C-----------------CccCCHHHHHHHHHHhccChhhCcCHHHHHhC
Confidence 0 22345679999999999999999999999865
|
|
| >cd05596 STKc_ROCK Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-42 Score=300.20 Aligned_cols=257 Identities=21% Similarity=0.264 Sum_probs=199.9
Q ss_pred HHhCCCCCCceeecCCcceEEEEEeC-CCcEEEEEEeccCcC-ChhhhHHHHHHHHHHHhcCCcceeeeeeEEEcCCCee
Q 038766 9 NATGSFSENNIIGNSNLSTVYKGRLE-DGEIVAVKKLNFHQF-SAESDKSFYREAKTLKELKHRNLVKVLGYAWESGKLK 86 (299)
Q Consensus 9 ~~~~~y~~~~~lg~g~~~~v~~~~~~-~~~~~~vK~~~~~~~-~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~ 86 (299)
.-.++|.+.+.||+|+||.||++.+. +++.||+|++..... .......+..|+.+++.++||||+++++++. .++..
T Consensus 40 ~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~il~~~~h~~iv~~~~~~~-~~~~~ 118 (370)
T cd05596 40 MKAEDFDVIKVIGRGAFGEVQLVRHKSSKQVYAMKLLSKFEMIKRSDSAFFWEERDIMAHANSEWIVQLHYAFQ-DDKYL 118 (370)
T ss_pred CCHHHcEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhCCCCCcceEEEEEe-cCCEE
Confidence 34568999999999999999999874 588999999864322 2233455778999999999999999998554 46677
Q ss_pred EEEEeecCCCChHHHhcCCCCCCCCCChhhHHHHHHHHHHHHHHhhcCCCCCeeeecccCCceeeCCCCcEEEeeecccc
Q 038766 87 ALILEYMENGSLESVIHGPGVDHSRWTLPKRIDVLISVANGLDYLHSGYDIPIVHCDMKPSNILLDRDFEAHVSDFGTSR 166 (299)
Q Consensus 87 ~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lh~~~~~~~~H~dl~~~nil~~~~~~v~l~df~~~~ 166 (299)
++|+||+.+++|.+++. +..+++..+..++.|++.||+|||+. +++||||||+||+++.++.++|+|||++.
T Consensus 119 ~lv~Ey~~gg~L~~~l~-----~~~l~~~~~~~~~~qi~~aL~~LH~~---~ivHrDLkp~NILl~~~~~~kL~DfG~~~ 190 (370)
T cd05596 119 YMVMEYMPGGDLVNLMS-----NYDIPEKWARFYTAEVVLALDAIHSM---GFIHRDVKPDNMLLDKSGHLKLADFGTCM 190 (370)
T ss_pred EEEEcCCCCCcHHHHHH-----hcCCCHHHHHHHHHHHHHHHHHHHHC---CeeccCCCHHHEEEcCCCCEEEEecccee
Confidence 99999999999999985 23588999999999999999999999 99999999999999999999999999987
Q ss_pred ccccccccccccccccccCcccCChhhhccc----CcCccccchhhhHHHHHHHhCCCCCCCCccCCCCchhHHHHHHHH
Q 038766 167 MLDVHLQDLSSLSTAFQGTIGYLAPEFAYMR----IVTTKVDVFSFGIVVMEFLTKRRPTGLDEENGLSPISLRQLVEKA 242 (299)
Q Consensus 167 ~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~----~~~~~~DiwslG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~ 242 (299)
..... .........+++.|+|||.+... .++.++|+|||||++|+|++|..||..... ...+...
T Consensus 191 ~~~~~---~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~DiwSlGvilyelltG~~Pf~~~~~--------~~~~~~i 259 (370)
T cd05596 191 KMDAN---GMVRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPFYADSL--------VGTYSKI 259 (370)
T ss_pred eccCC---CcccCCCCCCCcCeECHHHhccCCCCCCCCCceeeeehhHHHHHHHhCCCCcCCCCH--------HHHHHHH
Confidence 54311 11122345689999999988653 378899999999999999999999954321 1122222
Q ss_pred HhcCccCcccccCccccchhhHhHHHHHHHHHHHHHHHHhcCCCCCC--CCChhhhhcC
Q 038766 243 LANGINGVRQITDPKLVSSIYEEQEQHQVLEELFKLALVCTSSNPED--RPNMNELLIT 299 (299)
Q Consensus 243 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~--Rpt~~~il~~ 299 (299)
.... .....+. ...++.++.++|.+||..+|.+ |+|+++++.|
T Consensus 260 ~~~~----~~~~~~~----------~~~~s~~~~~li~~~L~~~p~r~~R~s~~ell~h 304 (370)
T cd05596 260 MDHK----NSLTFPD----------DIEISKQAKDLICAFLTDREVRLGRNGVDEIKSH 304 (370)
T ss_pred HcCC----CcCCCCC----------cCCCCHHHHHHHHHHccChhhccCCCCHHHHhcC
Confidence 1110 0000010 1134678999999999999988 9999999987
|
Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK is also referred to as Rho-associated kinase or simply as Rho kinase. It contains an N-terminal extension, a catalytic kinase domain, and a long C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain. It is activated via in |
| >PTZ00266 NIMA-related protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-42 Score=321.73 Aligned_cols=266 Identities=20% Similarity=0.323 Sum_probs=207.2
Q ss_pred hHHHHHHhCCCCCCceeecCCcceEEEEEeC-CCcEEEEEEeccCcCChhhhHHHHHHHHHHHhcCCcceeeeeeEEEcC
Q 038766 4 RTEIENATGSFSENNIIGNSNLSTVYKGRLE-DGEIVAVKKLNFHQFSAESDKSFYREAKTLKELKHRNLVKVLGYAWES 82 (299)
Q Consensus 4 ~~~~~~~~~~y~~~~~lg~g~~~~v~~~~~~-~~~~~~vK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~ 82 (299)
+...+...++|.+.+.||+|+||+||++.+. ++..+|+|++............+..|+.+++.++||||+++++++...
T Consensus 5 ~~~ge~~l~~YeIl~kLG~GgFGtVYLAkdk~tg~~vAlKvIk~~~l~e~~~~~~~~EI~IL~~L~HPNIVrl~d~f~de 84 (1021)
T PTZ00266 5 YDDGESRLNEYEVIKKIGNGRFGEVFLVKHKRTQEFFCWKAISYRGLKEREKSQLVIEVNVMRELKHKNIVRYIDRFLNK 84 (1021)
T ss_pred ccCCccccCCEEEEEEEecCCCeEEEEEEECCCCeEEEEEEEeccccCHHHHHHHHHHHHHHHHcCCCCcCeEEEEEEec
Confidence 3456677889999999999999999999874 578899999876666666678889999999999999999999977644
Q ss_pred -CCeeEEEEeecCCCChHHHhcCCCCCCCCCChhhHHHHHHHHHHHHHHhhcCC----CCCeeeecccCCceeeCCC---
Q 038766 83 -GKLKALILEYMENGSLESVIHGPGVDHSRWTLPKRIDVLISVANGLDYLHSGY----DIPIVHCDMKPSNILLDRD--- 154 (299)
Q Consensus 83 -~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lh~~~----~~~~~H~dl~~~nil~~~~--- 154 (299)
...+++||||+.+++|..++.........+++..++.|+.||+.||.|||+.. ..+|+|+||||+|||++.+
T Consensus 85 ~~~~lyIVMEY~~gGSL~~lL~k~~~~~g~L~E~~Il~Ia~QIL~ALaYLHs~g~~~~~k~IVHRDLKPeNILL~s~~~~ 164 (1021)
T PTZ00266 85 ANQKLYILMEFCDAGDLSRNIQKCYKMFGKIEEHAIVDITRQLLHALAYCHNLKDGPNGERVLHRDLKPQNIFLSTGIRH 164 (1021)
T ss_pred CCCEEEEEEeCCCCCcHHHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHhcccccccCCceeccCcHHHeEeecCccc
Confidence 35679999999999999988653334467999999999999999999999851 0259999999999999642
Q ss_pred --------------CcEEEeeeccccccccccccccccccccccCcccCChhhhcc--cCcCccccchhhhHHHHHHHhC
Q 038766 155 --------------FEAHVSDFGTSRMLDVHLQDLSSLSTAFQGTIGYLAPEFAYM--RIVTTKVDVFSFGIVVMEFLTK 218 (299)
Q Consensus 155 --------------~~v~l~df~~~~~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~--~~~~~~~DiwslG~~l~~l~~g 218 (299)
+.++|+|||++..+.. ........+++.|+|||++.+ ..++.++|||||||++|+|++|
T Consensus 165 lg~i~~~~~n~ng~~iVKLsDFGlAr~l~~-----~s~~~s~vGTp~YmAPEvL~ge~~~~s~KSDVWSLG~ILYELLTG 239 (1021)
T PTZ00266 165 IGKITAQANNLNGRPIAKIGDFGLSKNIGI-----ESMAHSCVGTPYYWSPELLLHETKSYDDKSDMWALGCIIYELCSG 239 (1021)
T ss_pred cccccccccccCCCCceEEccCCccccccc-----cccccccCCCccccCHHHHhccCCCCCchhHHHHHHHHHHHHHHC
Confidence 3489999999875432 112234468999999998864 4578899999999999999999
Q ss_pred CCCCCCCccCCCCchhHHHHHHHHHhcCccCcccccCccccchhhHhHHHHHHHHHHHHHHHHhcCCCCCCCCChhhhhc
Q 038766 219 RRPTGLDEENGLSPISLRQLVEKALANGINGVRQITDPKLVSSIYEEQEQHQVLEELFKLALVCTSSNPEDRPNMNELLI 298 (299)
Q Consensus 219 ~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rpt~~~il~ 298 (299)
..||.... .....+..... . .... ....+.++.+||.+||..+|.+|||+.|+|.
T Consensus 240 k~PF~~~~-------~~~qli~~lk~-~----p~lp-------------i~~~S~eL~dLI~~~L~~dPeeRPSa~QlL~ 294 (1021)
T PTZ00266 240 KTPFHKAN-------NFSQLISELKR-G----PDLP-------------IKGKSKELNILIKNLLNLSAKERPSALQCLG 294 (1021)
T ss_pred CCCCCcCC-------cHHHHHHHHhc-C----CCCC-------------cCCCCHHHHHHHHHHhcCChhHCcCHHHHhc
Confidence 99995321 11122211111 0 0000 1123567999999999999999999999997
Q ss_pred C
Q 038766 299 T 299 (299)
Q Consensus 299 ~ 299 (299)
|
T Consensus 295 h 295 (1021)
T PTZ00266 295 Y 295 (1021)
T ss_pred c
Confidence 5
|
|
| >cd05591 STKc_nPKC_epsilon Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C epsilon | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-42 Score=295.06 Aligned_cols=244 Identities=22% Similarity=0.299 Sum_probs=192.2
Q ss_pred ceeecCCcceEEEEEeC-CCcEEEEEEeccCcC-ChhhhHHHHHHHHHHHhc-CCcceeeeeeEEEcCCCeeEEEEeecC
Q 038766 18 NIIGNSNLSTVYKGRLE-DGEIVAVKKLNFHQF-SAESDKSFYREAKTLKEL-KHRNLVKVLGYAWESGKLKALILEYME 94 (299)
Q Consensus 18 ~~lg~g~~~~v~~~~~~-~~~~~~vK~~~~~~~-~~~~~~~~~~e~~~l~~l-~h~~i~~~~~~~~~~~~~~~lv~e~~~ 94 (299)
+.||+|+||.||++.+. +++.||+|++..... ..........|.++++.+ .||||+++++++.. +...++|+||+.
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~il~~~~~hp~i~~~~~~~~~-~~~~~lv~E~~~ 79 (321)
T cd05591 1 KVLGKGSFGKVMLAELKGTDEVYAIKVLKKDVILQDDDVDCTMTEKRILALAAKHPFLTALHCCFQT-KDRLFFVMEYVN 79 (321)
T ss_pred CccccCCCeEEEEEEECCCCCEEEEEEEeHHHhhhhhHHHHHHHHHHHHHhccCCCCccceeeEEEc-CCeEEEEEeCCC
Confidence 46999999999999875 588999999864322 233445667788888866 69999999996665 455699999999
Q ss_pred CCChHHHhcCCCCCCCCCChhhHHHHHHHHHHHHHHhhcCCCCCeeeecccCCceeeCCCCcEEEeeecccccccccccc
Q 038766 95 NGSLESVIHGPGVDHSRWTLPKRIDVLISVANGLDYLHSGYDIPIVHCDMKPSNILLDRDFEAHVSDFGTSRMLDVHLQD 174 (299)
Q Consensus 95 ~~~L~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lh~~~~~~~~H~dl~~~nil~~~~~~v~l~df~~~~~~~~~~~~ 174 (299)
+++|...+. ....+++..++.++.|++.||.|||+. +++||||||+||+++.++.++|+|||++.....
T Consensus 80 ~~~L~~~l~----~~~~~~~~~~~~~~~qi~~aL~~LH~~---~ivHrDikp~Nill~~~~~~kL~Dfg~~~~~~~---- 148 (321)
T cd05591 80 GGDLMFQIQ----RSRKFDEPRSRFYAAEVTLALMFLHRH---GVIYRDLKLDNILLDAEGHCKLADFGMCKEGIL---- 148 (321)
T ss_pred CCcHHHHHH----HcCCCCHHHHHHHHHHHHHHHHHHHHC---CeeccCCCHHHeEECCCCCEEEeecccceeccc----
Confidence 999998886 445789999999999999999999999 999999999999999999999999998864321
Q ss_pred ccccccccccCcccCChhhhcccCcCccccchhhhHHHHHHHhCCCCCCCCccCCCCchhHHHHHHHHHhcCccCccccc
Q 038766 175 LSSLSTAFQGTIGYLAPEFAYMRIVTTKVDVFSFGIVVMEFLTKRRPTGLDEENGLSPISLRQLVEKALANGINGVRQIT 254 (299)
Q Consensus 175 ~~~~~~~~~~~~~y~~PE~~~~~~~~~~~DiwslG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 254 (299)
.........+++.|+|||.+.+..++.++|||||||++|+|++|..||.... .. .......... ..
T Consensus 149 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~tg~~Pf~~~~-----~~---~~~~~i~~~~------~~ 214 (321)
T cd05591 149 NGVTTTTFCGTPDYIAPEILQELEYGPSVDWWALGVLMYEMMAGQPPFEADN-----ED---DLFESILHDD------VL 214 (321)
T ss_pred CCccccccccCccccCHHHHcCCCCCCccceechhHHHHHHhcCCCCCCCCC-----HH---HHHHHHHcCC------CC
Confidence 1122334567899999999999899999999999999999999999995432 11 1122211110 00
Q ss_pred CccccchhhHhHHHHHHHHHHHHHHHHhcCCCCCCCC-------ChhhhhcC
Q 038766 255 DPKLVSSIYEEQEQHQVLEELFKLALVCTSSNPEDRP-------NMNELLIT 299 (299)
Q Consensus 255 ~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rp-------t~~~il~~ 299 (299)
. +...+.++.+++.+||..||++|| +++++++|
T Consensus 215 ~------------p~~~~~~~~~ll~~~L~~dp~~R~~~~~~~~~~~~~~~h 254 (321)
T cd05591 215 Y------------PVWLSKEAVSILKAFMTKNPNKRLGCVASQGGEDAIKQH 254 (321)
T ss_pred C------------CCCCCHHHHHHHHHHhccCHHHcCCCCCCCCCHHHHhcC
Confidence 0 112346789999999999999999 88888876
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), epsilon isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-epsilon has been shown to behave as an oncoprotein. Its overexpression contributes to |
| >cd05601 STKc_CRIK Catalytic domain of the Protein Serine/Threonine Kinase, Citron Rho-interacting kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.8e-43 Score=299.36 Aligned_cols=255 Identities=20% Similarity=0.256 Sum_probs=199.2
Q ss_pred CCCCCCceeecCCcceEEEEEeC-CCcEEEEEEeccCcC-ChhhhHHHHHHHHHHHhcCCcceeeeeeEEEcCCCeeEEE
Q 038766 12 GSFSENNIIGNSNLSTVYKGRLE-DGEIVAVKKLNFHQF-SAESDKSFYREAKTLKELKHRNLVKVLGYAWESGKLKALI 89 (299)
Q Consensus 12 ~~y~~~~~lg~g~~~~v~~~~~~-~~~~~~vK~~~~~~~-~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~lv 89 (299)
++|.+.+.||+|+||+||++.+. +++.+|+|++..... .......+..|+.+++.+.|+||+++++++.. +...++|
T Consensus 1 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~i~~~~~~~~i~~~~~~~~~-~~~~~lv 79 (330)
T cd05601 1 KDFDVKSLVGRGHFGEVQVVREKATGDIYAMKVMKKSVLLAQETVSFFEEERDILSISNSPWIPQLQYAFQD-KDNLYLV 79 (330)
T ss_pred CCceEEEEEEeccCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCcceeeEEec-CCeEEEE
Confidence 47999999999999999999864 689999999975432 23345667889999999999999999996655 5567999
Q ss_pred EeecCCCChHHHhcCCCCCCCCCChhhHHHHHHHHHHHHHHhhcCCCCCeeeecccCCceeeCCCCcEEEeeeccccccc
Q 038766 90 LEYMENGSLESVIHGPGVDHSRWTLPKRIDVLISVANGLDYLHSGYDIPIVHCDMKPSNILLDRDFEAHVSDFGTSRMLD 169 (299)
Q Consensus 90 ~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lh~~~~~~~~H~dl~~~nil~~~~~~v~l~df~~~~~~~ 169 (299)
+||+++++|.+++... ...+++..++.++.|++.||.|||+. +++||||||+||+++.++.++|+|||++..+.
T Consensus 80 ~e~~~~~~L~~~l~~~---~~~l~~~~~~~~~~qi~~aL~~lH~~---~i~H~Dlkp~NIll~~~~~~kL~Dfg~a~~~~ 153 (330)
T cd05601 80 MEYQPGGDLLSLLNRY---EDQFDEDMAQFYLAELVLAIHSVHQM---GYVHRDIKPENVLIDRTGHIKLADFGSAARLT 153 (330)
T ss_pred ECCCCCCCHHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHHC---CeEcccCchHheEECCCCCEEeccCCCCeECC
Confidence 9999999999998632 25789999999999999999999999 99999999999999999999999999987654
Q ss_pred cccccccccccccccCcccCChhhhc------ccCcCccccchhhhHHHHHHHhCCCCCCCCccCCCCchhHHHHHHHHH
Q 038766 170 VHLQDLSSLSTAFQGTIGYLAPEFAY------MRIVTTKVDVFSFGIVVMEFLTKRRPTGLDEENGLSPISLRQLVEKAL 243 (299)
Q Consensus 170 ~~~~~~~~~~~~~~~~~~y~~PE~~~------~~~~~~~~DiwslG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~ 243 (299)
... ........+++.|+|||++. ...++.++|||||||++|+|++|..||..... . ..+....
T Consensus 154 ~~~---~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~DiwslG~il~el~~g~~Pf~~~~~-----~---~~~~~i~ 222 (330)
T cd05601 154 ANK---MVNSKLPVGTPDYIAPEVLTTMNGDGKGTYGVECDWWSLGVIAYEMIYGRSPFHEGTS-----A---KTYNNIM 222 (330)
T ss_pred CCC---ceeeecccCCccccCHHHhccccccccCCCCCcceeecccceeeeeccCCCCCCCCCH-----H---HHHHHHH
Confidence 211 11223345789999999887 45677899999999999999999999953311 1 1111111
Q ss_pred hcCccCcccccCccccchhhHhHHHHHHHHHHHHHHHHhcCCCCCCCCChhhhhcC
Q 038766 244 ANGINGVRQITDPKLVSSIYEEQEQHQVLEELFKLALVCTSSNPEDRPNMNELLIT 299 (299)
Q Consensus 244 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rpt~~~il~~ 299 (299)
... .....+. ...++.++.+|+.+||. +|++|||+++++.|
T Consensus 223 ~~~--~~~~~~~------------~~~~~~~~~~li~~ll~-~p~~R~t~~~l~~h 263 (330)
T cd05601 223 NFQ--RFLKFPE------------DPKVSSDFLDLIQSLLC-GQKERLGYEGLCCH 263 (330)
T ss_pred cCC--CccCCCC------------CCCCCHHHHHHHHHHcc-ChhhCCCHHHHhCC
Confidence 100 0000110 12345678999999998 99999999999987
|
Serine/Threonine Kinases (STKs), Citron Rho-interacting kinase (CRIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CRIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CRIK is also called citron kinase. It contains a catalytic domain, a central coiled-coil domain, and a C-terminal region containing a Rho-binding domain (RBD), a zinc finger, and a pleckstrin homology (PH) domain, in addition to other motifs. CRIK, an effector of the small GTPase Rho, plays an important function during cytokinesis and affects its contractile process. CRIK-deficient mice show severe ataxia and epilepsy as a result of abnor |
| >cd05625 STKc_LATS1 Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.1e-42 Score=300.16 Aligned_cols=257 Identities=20% Similarity=0.269 Sum_probs=197.0
Q ss_pred CCCCCCceeecCCcceEEEEEe-CCCcEEEEEEeccCcC-ChhhhHHHHHHHHHHHhcCCcceeeeeeEEEcCCCeeEEE
Q 038766 12 GSFSENNIIGNSNLSTVYKGRL-EDGEIVAVKKLNFHQF-SAESDKSFYREAKTLKELKHRNLVKVLGYAWESGKLKALI 89 (299)
Q Consensus 12 ~~y~~~~~lg~g~~~~v~~~~~-~~~~~~~vK~~~~~~~-~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~lv 89 (299)
++|.+.+.||+|+||+||+|.+ .+++.+|+|++..... .......+.+|+.+++.+.|+||+++++.+.. +...++|
T Consensus 1 ~~f~~~~~LG~G~~g~Vy~a~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~E~~il~~~~h~~iv~~~~~~~~-~~~~~lv 79 (382)
T cd05625 1 SMFVKIKTLGIGAFGEVCLARKVDTKALYAMKTLRKKDVLLRNQVAHVKAERDILAEADNEWVVRLYYSFQD-KDNLYFV 79 (382)
T ss_pred CCcEEEEEEEeCCCEEEEEEEECCCCCEEEEEEEeHHHhhhHHHHHHHHHHHHHHHhCCCCcCCeEEEEEEe-CCEEEEE
Confidence 4689999999999999999986 4588999999864322 23335678889999999999999999997665 5567999
Q ss_pred EeecCCCChHHHhcCCCCCCCCCChhhHHHHHHHHHHHHHHhhcCCCCCeeeecccCCceeeCCCCcEEEeeeccccccc
Q 038766 90 LEYMENGSLESVIHGPGVDHSRWTLPKRIDVLISVANGLDYLHSGYDIPIVHCDMKPSNILLDRDFEAHVSDFGTSRMLD 169 (299)
Q Consensus 90 ~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lh~~~~~~~~H~dl~~~nil~~~~~~v~l~df~~~~~~~ 169 (299)
|||+.+++|.+++. ....+++..+..++.||+.||+|||+. +++||||||+|||++.+|.++|+|||++..+.
T Consensus 80 ~E~~~gg~L~~~l~----~~~~~~e~~~~~~~~qi~~al~~lH~~---~ivHrDlKp~NILl~~~g~~kL~DFGla~~~~ 152 (382)
T cd05625 80 MDYIPGGDMMSLLI----RMGIFPEDLARFYIAELTCAVESVHKM---GFIHRDIKPDNILIDRDGHIKLTDFGLCTGFR 152 (382)
T ss_pred EeCCCCCcHHHHHH----hcCCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHEEECCCCCEEEeECCCCcccc
Confidence 99999999999886 345789999999999999999999999 99999999999999999999999999975332
Q ss_pred cccc-------------------------------------------cccccccccccCcccCChhhhcccCcCccccch
Q 038766 170 VHLQ-------------------------------------------DLSSLSTAFQGTIGYLAPEFAYMRIVTTKVDVF 206 (299)
Q Consensus 170 ~~~~-------------------------------------------~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Diw 206 (299)
.... ..........+|+.|+|||++.+..++.++|||
T Consensus 153 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~Diw 232 (382)
T cd05625 153 WTHDSKYYQSGDHVRQDSMDFSNEWGDPANCRCGDRLKPLERRAARQHQRCLAHSLVGTPNYIAPEVLLRTGYTQLCDWW 232 (382)
T ss_pred ccccccccccccccccccccccccccccccccccccccchhhhhccccccccccccccCcccCCHHHhcCCCCCCeeeEE
Confidence 1000 000001234588999999999999999999999
Q ss_pred hhhHHHHHHHhCCCCCCCCccCCCCchhHHHHHHHHHhcCccCcccccCccccchhhHhHHHHHHHHHHHHHHHHhcCCC
Q 038766 207 SFGIVVMEFLTKRRPTGLDEENGLSPISLRQLVEKALANGINGVRQITDPKLVSSIYEEQEQHQVLEELFKLALVCTSSN 286 (299)
Q Consensus 207 slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~d 286 (299)
||||++|+|++|..||..... . +....... . ......+. ...+++++.++|.+|+ .+
T Consensus 233 SlGvil~elltG~~Pf~~~~~-----~---~~~~~i~~-~-~~~~~~p~------------~~~~s~~~~~li~~l~-~~ 289 (382)
T cd05625 233 SVGVILYEMLVGQPPFLAQTP-----L---ETQMKVIN-W-QTSLHIPP------------QAKLSPEASDLIIKLC-RG 289 (382)
T ss_pred echHHHHHHHhCCCCCCCCCH-----H---HHHHHHHc-c-CCCcCCCC------------cccCCHHHHHHHHHHc-cC
Confidence 999999999999999954311 1 11111110 0 00000000 1234567889999987 49
Q ss_pred CCCCCC---hhhhhcC
Q 038766 287 PEDRPN---MNELLIT 299 (299)
Q Consensus 287 P~~Rpt---~~~il~~ 299 (299)
|++|++ +++++.|
T Consensus 290 p~~R~~~~~~~ei~~h 305 (382)
T cd05625 290 PEDRLGKNGADEIKAH 305 (382)
T ss_pred HhHcCCCCCHHHHhcC
Confidence 999998 9999877
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. Promoter methylation, loss of heterozygosity, and missense mutations targeting the LATS1 gene have also been found in human sarcomas and ovarian cancers. In addition, decreased expression of LATS1 is associated with an aggressive phenotype an |
| >cd05629 STKc_NDR_like_fungal Catalytic domain of Fungal Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.6e-42 Score=300.01 Aligned_cols=257 Identities=21% Similarity=0.253 Sum_probs=197.2
Q ss_pred CCCCCCceeecCCcceEEEEEe-CCCcEEEEEEeccCcC-ChhhhHHHHHHHHHHHhcCCcceeeeeeEEEcCCCeeEEE
Q 038766 12 GSFSENNIIGNSNLSTVYKGRL-EDGEIVAVKKLNFHQF-SAESDKSFYREAKTLKELKHRNLVKVLGYAWESGKLKALI 89 (299)
Q Consensus 12 ~~y~~~~~lg~g~~~~v~~~~~-~~~~~~~vK~~~~~~~-~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~lv 89 (299)
++|.+.+.||+|+||.||++.+ .+++.||+|++..... .......+.+|+.+++.+.||||+++++++.. +...++|
T Consensus 1 ~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~il~~l~hp~iv~~~~~~~~-~~~~~lv 79 (377)
T cd05629 1 EDFHTVKVIGKGAFGEVRLVQKKDTGKIYAMKTLLKSEMFKKDQLAHVKAERDVLAESDSPWVVSLYYSFQD-AQYLYLI 79 (377)
T ss_pred CCceEeEEEeecCCEEEEEEEECCCCCEEEEEEEEHHHHHHhHHHHHHHHHHHHHHhCCCCCcceEEEEEEc-CCeeEEE
Confidence 5799999999999999999986 4689999999864321 23345678889999999999999999996655 5567999
Q ss_pred EeecCCCChHHHhcCCCCCCCCCChhhHHHHHHHHHHHHHHhhcCCCCCeeeecccCCceeeCCCCcEEEeeeccccccc
Q 038766 90 LEYMENGSLESVIHGPGVDHSRWTLPKRIDVLISVANGLDYLHSGYDIPIVHCDMKPSNILLDRDFEAHVSDFGTSRMLD 169 (299)
Q Consensus 90 ~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lh~~~~~~~~H~dl~~~nil~~~~~~v~l~df~~~~~~~ 169 (299)
+||+.+++|.+++. ....+++..++.++.|++.||+|||+. +++|+||||+||+++.++.++|+|||++..+.
T Consensus 80 ~E~~~gg~L~~~l~----~~~~~~~~~~~~~~~ql~~aL~~LH~~---givHrDlkp~NIll~~~~~~kl~DfGla~~~~ 152 (377)
T cd05629 80 MEFLPGGDLMTMLI----KYDTFSEDVTRFYMAECVLAIEAVHKL---GFIHRDIKPDNILIDRGGHIKLSDFGLSTGFH 152 (377)
T ss_pred EeCCCCCcHHHHHH----hcCCCCHHHHHHHHHHHHHHHHHHHhC---CeeccCCCHHHEEECCCCCEEEeecccccccc
Confidence 99999999999986 446789999999999999999999999 99999999999999999999999999986332
Q ss_pred ccccc----------cc---------------------------------ccccccccCcccCChhhhcccCcCccccch
Q 038766 170 VHLQD----------LS---------------------------------SLSTAFQGTIGYLAPEFAYMRIVTTKVDVF 206 (299)
Q Consensus 170 ~~~~~----------~~---------------------------------~~~~~~~~~~~y~~PE~~~~~~~~~~~Diw 206 (299)
..... .. .......+|+.|+|||++.+..++.++|||
T Consensus 153 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Diw 232 (377)
T cd05629 153 KQHDSAYYQKLLQGKSNKNRIDNRNSVAVDSINLTMSSKDQIATWKKNRRLMAYSTVGTPDYIAPEIFLQQGYGQECDWW 232 (377)
T ss_pred cccccccccccccccccccccccccccccccccccccchhhhhhhhhcccccccccCCCccccCHHHHccCCCCCceeeE
Confidence 11000 00 000123588999999999998999999999
Q ss_pred hhhHHHHHHHhCCCCCCCCccCCCCchhHHHHHHHHHhcCccCcccccCccccchhhHhHHHHHHHHHHHHHHHHhcCCC
Q 038766 207 SFGIVVMEFLTKRRPTGLDEENGLSPISLRQLVEKALANGINGVRQITDPKLVSSIYEEQEQHQVLEELFKLALVCTSSN 286 (299)
Q Consensus 207 slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~d 286 (299)
||||++|+|++|..||..... . +....... . .....+.. ...++.++.++|.+||. +
T Consensus 233 SlGvil~elltG~~Pf~~~~~-----~---~~~~~i~~-~-~~~~~~p~------------~~~~s~~~~dli~~lL~-~ 289 (377)
T cd05629 233 SLGAIMFECLIGWPPFCSENS-----H---ETYRKIIN-W-RETLYFPD------------DIHLSVEAEDLIRRLIT-N 289 (377)
T ss_pred ecchhhhhhhcCCCCCCCCCH-----H---HHHHHHHc-c-CCccCCCC------------CCCCCHHHHHHHHHHhc-C
Confidence 999999999999999954321 1 11111111 0 00000111 11235678999999998 7
Q ss_pred CCCC---CChhhhhcC
Q 038766 287 PEDR---PNMNELLIT 299 (299)
Q Consensus 287 P~~R---pt~~~il~~ 299 (299)
|.+| +|+.+++.|
T Consensus 290 ~~~r~~r~~~~~~l~h 305 (377)
T cd05629 290 AENRLGRGGAHEIKSH 305 (377)
T ss_pred HhhcCCCCCHHHHhcC
Confidence 7765 599999986
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, fungal NDR-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group is composed of fungal NDR-like proteins including Saccharomyces cerevisiae CBK1 (or CBK1p), Schizosaccharomyces pombe Orb6 (or Orb6p), Ustilago maydis Ukc1 (or Ukc1p), and Neurospora crassa Cot1. Like NDR kinase, group members contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. CBK1 is an essential component in the RAM (regulation of |
| >cd08223 STKc_Nek4 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-41 Score=279.88 Aligned_cols=253 Identities=25% Similarity=0.373 Sum_probs=203.7
Q ss_pred CCCCCceeecCCcceEEEEEeC-CCcEEEEEEeccCcCChhhhHHHHHHHHHHHhcCCcceeeeeeEEEcCCCeeEEEEe
Q 038766 13 SFSENNIIGNSNLSTVYKGRLE-DGEIVAVKKLNFHQFSAESDKSFYREAKTLKELKHRNLVKVLGYAWESGKLKALILE 91 (299)
Q Consensus 13 ~y~~~~~lg~g~~~~v~~~~~~-~~~~~~vK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~lv~e 91 (299)
+|.+.+.||+|++|.||++.+. +++.+++|.+............+.+|++.+++++|+|++++.+.+...+..+++++|
T Consensus 1 ~y~~~~~lg~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~lv~e 80 (257)
T cd08223 1 AYCFVRVVGKGSYGEVSLVRHRTDGKQYVIKKLNLRNASRRERKAAEQEAQLLSQLKHPNIVAYRESWEGEDGLLYIVMG 80 (257)
T ss_pred CceEEEEecCCCCeEEEEEEEcCCCcEEEEEEEehhhcCHHHHHHHHHHHHHHHhCCCCCeeeeeeeecCCCCEEEEEec
Confidence 5889999999999999999864 578999999876555555567788999999999999999999866555566799999
Q ss_pred ecCCCChHHHhcCCCCCCCCCChhhHHHHHHHHHHHHHHhhcCCCCCeeeecccCCceeeCCCCcEEEeeeccccccccc
Q 038766 92 YMENGSLESVIHGPGVDHSRWTLPKRIDVLISVANGLDYLHSGYDIPIVHCDMKPSNILLDRDFEAHVSDFGTSRMLDVH 171 (299)
Q Consensus 92 ~~~~~~L~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lh~~~~~~~~H~dl~~~nil~~~~~~v~l~df~~~~~~~~~ 171 (299)
++++++|.+++... ....+++.+++.++.|++.++.+||+. +++|+||+|+||+++.++.++|+|||++......
T Consensus 81 ~~~~~~l~~~l~~~--~~~~l~~~~~~~~~~~l~~~l~~lH~~---~i~H~di~p~nil~~~~~~~~l~df~~~~~~~~~ 155 (257)
T cd08223 81 FCEGGDLYHKLKEQ--KGKLLPENQVVEWFVQIAMALQYLHEK---HILHRDLKTQNVFLTRTNIIKVGDLGIARVLENQ 155 (257)
T ss_pred ccCCCcHHHHHHHh--cCCCCCHHHHHHHHHHHHHHHHHHHhC---CeeccCCCchhEEEecCCcEEEecccceEEeccc
Confidence 99999999988642 234689999999999999999999999 9999999999999999999999999998765321
Q ss_pred cccccccccccccCcccCChhhhcccCcCccccchhhhHHHHHHHhCCCCCCCCccCCCCchhHHHHHHHHHhcCccCcc
Q 038766 172 LQDLSSLSTAFQGTIGYLAPEFAYMRIVTTKVDVFSFGIVVMEFLTKRRPTGLDEENGLSPISLRQLVEKALANGINGVR 251 (299)
Q Consensus 172 ~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~DiwslG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 251 (299)
........+++.|+|||...+..++.++|+||+|+++++|++|..||.... ..............
T Consensus 156 ----~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~~l~~g~~~~~~~~--------~~~~~~~~~~~~~~--- 220 (257)
T cd08223 156 ----CDMASTLIGTPYYMSPELFSNKPYNYKSDVWALGCCVYEMATLKHAFNAKD--------MNSLVYRIIEGKLP--- 220 (257)
T ss_pred ----CCccccccCCcCccChhHhcCCCCCchhhhHHHHHHHHHHHcCCCCCCCCC--------HHHHHHHHHhcCCC---
Confidence 122334457889999999998889999999999999999999999985321 11111111111000
Q ss_pred cccCccccchhhHhHHHHHHHHHHHHHHHHhcCCCCCCCCChhhhhcC
Q 038766 252 QITDPKLVSSIYEEQEQHQVLEELFKLALVCTSSNPEDRPNMNELLIT 299 (299)
Q Consensus 252 ~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rpt~~~il~~ 299 (299)
..+..++..+.+++.+|++.+|++|||+.++++|
T Consensus 221 --------------~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~~l~~ 254 (257)
T cd08223 221 --------------PMPKDYSPELGELIATMLSKRPEKRPSVKSILRQ 254 (257)
T ss_pred --------------CCccccCHHHHHHHHHHhccCcccCCCHHHHhcC
Confidence 0123455689999999999999999999999986
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 4 (Nek4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek4 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Nek4 is highly abundant in the testis. Its specific function is unknown. |
| >cd05592 STKc_nPKC_theta_delta Catalytic domain of the Protein Serine/Threonine Kinases, Novel Protein Kinase C theta and delta | Back alignment and domain information |
|---|
Probab=100.00 E-value=4e-42 Score=292.64 Aligned_cols=244 Identities=21% Similarity=0.317 Sum_probs=188.8
Q ss_pred ceeecCCcceEEEEEeC-CCcEEEEEEeccCcC-ChhhhHHHHHHHHHHHhc-CCcceeeeeeEEEcCCCeeEEEEeecC
Q 038766 18 NIIGNSNLSTVYKGRLE-DGEIVAVKKLNFHQF-SAESDKSFYREAKTLKEL-KHRNLVKVLGYAWESGKLKALILEYME 94 (299)
Q Consensus 18 ~~lg~g~~~~v~~~~~~-~~~~~~vK~~~~~~~-~~~~~~~~~~e~~~l~~l-~h~~i~~~~~~~~~~~~~~~lv~e~~~ 94 (299)
+.||+|+||.||+|.+. +++.||+|++..... ..........|...+... .||||+++++++.. +...++|+||+.
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~hp~i~~~~~~~~~-~~~~~lv~e~~~ 79 (316)
T cd05592 1 KVLGKGSFGKVMLAELKGTNEFFAIKALKKDVVLEDDDVECTMVERRVLALAWEHPFLTHLFCTFQT-KEHLFFVMEYLN 79 (316)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhccCCCCccceeeEEEc-CCEEEEEEcCCC
Confidence 47999999999999864 588999999874322 222334455566666654 79999999996654 556799999999
Q ss_pred CCChHHHhcCCCCCCCCCChhhHHHHHHHHHHHHHHhhcCCCCCeeeecccCCceeeCCCCcEEEeeecccccccccccc
Q 038766 95 NGSLESVIHGPGVDHSRWTLPKRIDVLISVANGLDYLHSGYDIPIVHCDMKPSNILLDRDFEAHVSDFGTSRMLDVHLQD 174 (299)
Q Consensus 95 ~~~L~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lh~~~~~~~~H~dl~~~nil~~~~~~v~l~df~~~~~~~~~~~~ 174 (299)
+++|...+. ....+++..+..++.|++.||.|||+. +++|+||||+||+++.++.++|+|||++......
T Consensus 80 gg~L~~~~~----~~~~~~~~~~~~~~~qi~~al~~LH~~---~ivH~dlkp~Nill~~~~~~kL~Dfg~a~~~~~~--- 149 (316)
T cd05592 80 GGDLMFHIQ----SSGRFDEARARFYAAEIICGLQFLHKK---GIIYRDLKLDNVLLDKDGHIKIADFGMCKENMNG--- 149 (316)
T ss_pred CCcHHHHHH----HcCCCCHHHHHHHHHHHHHHHHHHHHC---CEEeCCCCHHHeEECCCCCEEEccCcCCeECCCC---
Confidence 999999887 445789999999999999999999999 9999999999999999999999999998643211
Q ss_pred ccccccccccCcccCChhhhcccCcCccccchhhhHHHHHHHhCCCCCCCCccCCCCchhHHHHHHHHHhcCccCccccc
Q 038766 175 LSSLSTAFQGTIGYLAPEFAYMRIVTTKVDVFSFGIVVMEFLTKRRPTGLDEENGLSPISLRQLVEKALANGINGVRQIT 254 (299)
Q Consensus 175 ~~~~~~~~~~~~~y~~PE~~~~~~~~~~~DiwslG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 254 (299)
........+++.|+|||.+.+..++.++|||||||++|+|++|..||.... . ......... ....
T Consensus 150 -~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~G~~Pf~~~~-----~---~~~~~~i~~-~~~~----- 214 (316)
T cd05592 150 -EGKASTFCGTPDYIAPEILKGQKYNESVDWWSFGVLLYEMLIGQSPFHGED-----E---DELFDSILN-DRPH----- 214 (316)
T ss_pred -CCccccccCCccccCHHHHcCCCCCCcccchhHHHHHHHHHhCCCCCCCCC-----H---HHHHHHHHc-CCCC-----
Confidence 122334568999999999999889999999999999999999999995432 1 112211111 1000
Q ss_pred CccccchhhHhHHHHHHHHHHHHHHHHhcCCCCCCCCChh-hhhcC
Q 038766 255 DPKLVSSIYEEQEQHQVLEELFKLALVCTSSNPEDRPNMN-ELLIT 299 (299)
Q Consensus 255 ~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rpt~~-~il~~ 299 (299)
. +..++.++.+++.+||..||++||++. ++++|
T Consensus 215 ---~---------~~~~~~~~~~ll~~~l~~~P~~R~~~~~~l~~h 248 (316)
T cd05592 215 ---F---------PRWISKEAKDCLSKLFERDPTKRLGVDGDIRQH 248 (316)
T ss_pred ---C---------CCCCCHHHHHHHHHHccCCHHHcCCChHHHHcC
Confidence 0 122456788999999999999999975 66654
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta and delta-like isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an imp |
| >cd05621 STKc_ROCK2 Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.2e-42 Score=298.05 Aligned_cols=258 Identities=20% Similarity=0.251 Sum_probs=198.9
Q ss_pred HHHhCCCCCCceeecCCcceEEEEEeC-CCcEEEEEEeccCcC-ChhhhHHHHHHHHHHHhcCCcceeeeeeEEEcCCCe
Q 038766 8 ENATGSFSENNIIGNSNLSTVYKGRLE-DGEIVAVKKLNFHQF-SAESDKSFYREAKTLKELKHRNLVKVLGYAWESGKL 85 (299)
Q Consensus 8 ~~~~~~y~~~~~lg~g~~~~v~~~~~~-~~~~~~vK~~~~~~~-~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~ 85 (299)
+...++|++.+.||+|+||.||++.+. +++.+|+|++..... .......+..|..+++.+.||||+++++.+. .+..
T Consensus 39 ~~~~~~y~~~~~lG~G~fg~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~i~~~~~hp~iv~~~~~~~-~~~~ 117 (370)
T cd05621 39 QMKAEDYDVVKVIGRGAFGEVQLVRHKSSQKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPWVVQLFCAFQ-DDKY 117 (370)
T ss_pred CCCHHHCeEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhCCCCCEeeEEEEEE-cCCE
Confidence 344578999999999999999999875 588999999864222 2233456778999999999999999999655 4666
Q ss_pred eEEEEeecCCCChHHHhcCCCCCCCCCChhhHHHHHHHHHHHHHHhhcCCCCCeeeecccCCceeeCCCCcEEEeeeccc
Q 038766 86 KALILEYMENGSLESVIHGPGVDHSRWTLPKRIDVLISVANGLDYLHSGYDIPIVHCDMKPSNILLDRDFEAHVSDFGTS 165 (299)
Q Consensus 86 ~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lh~~~~~~~~H~dl~~~nil~~~~~~v~l~df~~~ 165 (299)
.++|+||+.+++|.+++.. ..+++..+..++.||+.||+|||+. +++||||||+||+++.++.+||+|||++
T Consensus 118 ~~lv~Ey~~gg~L~~~l~~-----~~~~~~~~~~~~~qil~aL~~LH~~---~IvHrDLKp~NILl~~~~~~kL~DFG~a 189 (370)
T cd05621 118 LYMVMEYMPGGDLVNLMSN-----YDVPEKWAKFYTAEVVLALDAIHSM---GLIHRDVKPDNMLLDKHGHLKLADFGTC 189 (370)
T ss_pred EEEEEcCCCCCcHHHHHHh-----cCCCHHHHHHHHHHHHHHHHHHHHC---CeEecCCCHHHEEECCCCCEEEEecccc
Confidence 7999999999999999852 3588999999999999999999999 9999999999999999999999999998
Q ss_pred cccccccccccccccccccCcccCChhhhcccC----cCccccchhhhHHHHHHHhCCCCCCCCccCCCCchhHHHHHHH
Q 038766 166 RMLDVHLQDLSSLSTAFQGTIGYLAPEFAYMRI----VTTKVDVFSFGIVVMEFLTKRRPTGLDEENGLSPISLRQLVEK 241 (299)
Q Consensus 166 ~~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~----~~~~~DiwslG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~ 241 (299)
...... .........+|+.|+|||++.... ++.++|+|||||++|+|++|..||..... ...+..
T Consensus 190 ~~~~~~---~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~~~~~DiwSlG~ilyell~G~~Pf~~~~~--------~~~~~~ 258 (370)
T cd05621 190 MKMDET---GMVRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLFEMLVGDTPFYADSL--------VGTYSK 258 (370)
T ss_pred eecccC---CceecccCCCCcccCCHHHHhccCCCCCCCcccCEEeehHHHHHHHhCCCCCCCCCH--------HHHHHH
Confidence 765311 111224556899999999887643 77899999999999999999999954321 112222
Q ss_pred HHhcCccCcccccCccccchhhHhHHHHHHHHHHHHHHHHhcCCCCCC--CCChhhhhcC
Q 038766 242 ALANGINGVRQITDPKLVSSIYEEQEQHQVLEELFKLALVCTSSNPED--RPNMNELLIT 299 (299)
Q Consensus 242 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~--Rpt~~~il~~ 299 (299)
..... .....+. ...++..+.+++.+||..+|.+ |+|++++++|
T Consensus 259 i~~~~----~~~~~p~----------~~~~s~~~~~li~~~L~~~~~r~~R~~~~e~l~h 304 (370)
T cd05621 259 IMDHK----NSLNFPE----------DVEISKHAKNLICAFLTDREVRLGRNGVEEIKQH 304 (370)
T ss_pred HHhCC----cccCCCC----------cccCCHHHHHHHHHHccCchhccCCCCHHHHhcC
Confidence 21110 0000000 1234567889999999866544 8999999987
|
Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK2 (or ROK-alpha) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK2 was the first identified target of activated RhoA, and was found |
| >cd05570 STKc_PKC Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase C | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.5e-42 Score=293.33 Aligned_cols=244 Identities=23% Similarity=0.327 Sum_probs=192.8
Q ss_pred ceeecCCcceEEEEEeC-CCcEEEEEEeccCcC-ChhhhHHHHHHHHHHHhc-CCcceeeeeeEEEcCCCeeEEEEeecC
Q 038766 18 NIIGNSNLSTVYKGRLE-DGEIVAVKKLNFHQF-SAESDKSFYREAKTLKEL-KHRNLVKVLGYAWESGKLKALILEYME 94 (299)
Q Consensus 18 ~~lg~g~~~~v~~~~~~-~~~~~~vK~~~~~~~-~~~~~~~~~~e~~~l~~l-~h~~i~~~~~~~~~~~~~~~lv~e~~~ 94 (299)
+.||+|+||+||++.+. +++.||+|++..... ..........|..+++.+ .||||+++++++.. ....++|+||+.
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~il~~~~~h~~i~~~~~~~~~-~~~~~lv~e~~~ 79 (318)
T cd05570 1 KVLGKGSFGKVLLAELKGTDELYAVKVLKKDVILQDDDVECTMTEKRVLALAGKHPFLTQLHSCFQT-KDRLFFVMEYVN 79 (318)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhHHHHHHHHHHHHHhccCCCCccceeeEEEc-CCEEEEEEcCCC
Confidence 47999999999999875 588999999874322 233455667888888887 59999999996655 556799999999
Q ss_pred CCChHHHhcCCCCCCCCCChhhHHHHHHHHHHHHHHhhcCCCCCeeeecccCCceeeCCCCcEEEeeecccccccccccc
Q 038766 95 NGSLESVIHGPGVDHSRWTLPKRIDVLISVANGLDYLHSGYDIPIVHCDMKPSNILLDRDFEAHVSDFGTSRMLDVHLQD 174 (299)
Q Consensus 95 ~~~L~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lh~~~~~~~~H~dl~~~nil~~~~~~v~l~df~~~~~~~~~~~~ 174 (299)
+++|...+. ....+++..+..++.|++.||+|||+. +++|+||||+||+++.++.++|+|||++.....
T Consensus 80 ~~~L~~~~~----~~~~l~~~~~~~~~~qi~~~l~~LH~~---~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~---- 148 (318)
T cd05570 80 GGDLMFHIQ----RSGRFDEPRARFYAAEIVLGLQFLHER---GIIYRDLKLDNVLLDSEGHIKIADFGMCKEGIL---- 148 (318)
T ss_pred CCCHHHHHH----HcCCCCHHHHHHHHHHHHHHHHHHHhC---CeEccCCCHHHeEECCCCcEEecccCCCeecCc----
Confidence 999998886 445799999999999999999999999 999999999999999999999999998864221
Q ss_pred ccccccccccCcccCChhhhcccCcCccccchhhhHHHHHHHhCCCCCCCCccCCCCchhHHHHHHHHHhcCccCccccc
Q 038766 175 LSSLSTAFQGTIGYLAPEFAYMRIVTTKVDVFSFGIVVMEFLTKRRPTGLDEENGLSPISLRQLVEKALANGINGVRQIT 254 (299)
Q Consensus 175 ~~~~~~~~~~~~~y~~PE~~~~~~~~~~~DiwslG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 254 (299)
.........+++.|+|||.+.+..++.++|+|||||++|+|++|..||.... .. .......... ..
T Consensus 149 ~~~~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslGvil~~l~~G~~pf~~~~-----~~---~~~~~i~~~~------~~ 214 (318)
T cd05570 149 GGVTTSTFCGTPDYIAPEILSYQPYGPAVDWWALGVLLYEMLAGQSPFEGDD-----ED---ELFQSILEDE------VR 214 (318)
T ss_pred CCCcccceecCccccCHHHhcCCCCCcchhhhhHHHHHHHHhhCCCCCCCCC-----HH---HHHHHHHcCC------CC
Confidence 1112233457889999999999999999999999999999999999995332 11 1111111100 00
Q ss_pred CccccchhhHhHHHHHHHHHHHHHHHHhcCCCCCCCCCh-----hhhhcC
Q 038766 255 DPKLVSSIYEEQEQHQVLEELFKLALVCTSSNPEDRPNM-----NELLIT 299 (299)
Q Consensus 255 ~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rpt~-----~~il~~ 299 (299)
. +..++..+.++|.+||..||++|||+ .++++|
T Consensus 215 ~------------~~~~~~~~~~li~~~l~~dP~~R~s~~~~~~~~ll~~ 252 (318)
T cd05570 215 Y------------PRWLSKEAKSILKSFLTKNPEKRLGCLPTGEQDIKGH 252 (318)
T ss_pred C------------CCcCCHHHHHHHHHHccCCHHHcCCCCCCCHHHHhcC
Confidence 0 12345678999999999999999999 888876
|
Serine/Threonine Kinases (STKs), Protein Kinase C (PKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, classical PKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. Novel PKCs are calcium-independent, but require DAG and PS for activity, while atypical PKCs only re |
| >cd05598 STKc_LATS Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-42 Score=302.02 Aligned_cols=257 Identities=21% Similarity=0.260 Sum_probs=197.3
Q ss_pred CCCCCCceeecCCcceEEEEEeC-CCcEEEEEEeccCcC-ChhhhHHHHHHHHHHHhcCCcceeeeeeEEEcCCCeeEEE
Q 038766 12 GSFSENNIIGNSNLSTVYKGRLE-DGEIVAVKKLNFHQF-SAESDKSFYREAKTLKELKHRNLVKVLGYAWESGKLKALI 89 (299)
Q Consensus 12 ~~y~~~~~lg~g~~~~v~~~~~~-~~~~~~vK~~~~~~~-~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~lv 89 (299)
++|++.+.||+|+||.||++++. +++.||+|++..... .......+.+|+.+++.+.|+||+++++.+.. +...++|
T Consensus 1 ~~y~~~~~lG~G~~g~V~~a~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~h~~iv~~~~~~~~-~~~~~lv 79 (376)
T cd05598 1 SMFVKIKTIGIGAFGEVCLVRKVDTNALYAMKTLRKADVLMRNQAAHVKAERDILAEADNEWVVKLYYSFQD-KDNLYFV 79 (376)
T ss_pred CCceEEEEEEeCCCeEEEEEEECCCCCEEEEEEEcHHHHHhhhhHHHHHHHHHHHHhCCCCCcceEEEEEEc-CCEEEEE
Confidence 47999999999999999999864 589999999864322 22234667889999999999999999996655 5567999
Q ss_pred EeecCCCChHHHhcCCCCCCCCCChhhHHHHHHHHHHHHHHhhcCCCCCeeeecccCCceeeCCCCcEEEeeeccccccc
Q 038766 90 LEYMENGSLESVIHGPGVDHSRWTLPKRIDVLISVANGLDYLHSGYDIPIVHCDMKPSNILLDRDFEAHVSDFGTSRMLD 169 (299)
Q Consensus 90 ~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lh~~~~~~~~H~dl~~~nil~~~~~~v~l~df~~~~~~~ 169 (299)
|||+++++|.+++. ....+++..+..++.||+.||+|||+. +++||||||+||+++.++.++|+|||++..+.
T Consensus 80 ~E~~~~g~L~~~i~----~~~~~~~~~~~~~~~qi~~al~~lH~~---~ivHrDlkp~Nill~~~~~ikL~DFG~a~~~~ 152 (376)
T cd05598 80 MDYIPGGDMMSLLI----RLGIFEEDLARFYIAELTCAIESVHKM---GFIHRDIKPDNILIDRDGHIKLTDFGLCTGFR 152 (376)
T ss_pred EeCCCCCcHHHHHH----hcCCCCHHHHHHHHHHHHHHHHHHHHC---CeEeCCCCHHHEEECCCCCEEEEeCCCCcccc
Confidence 99999999999987 345789999999999999999999999 99999999999999999999999999975332
Q ss_pred cccc---------------------------------------cccccccccccCcccCChhhhcccCcCccccchhhhH
Q 038766 170 VHLQ---------------------------------------DLSSLSTAFQGTIGYLAPEFAYMRIVTTKVDVFSFGI 210 (299)
Q Consensus 170 ~~~~---------------------------------------~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~DiwslG~ 210 (299)
.... ..........|++.|+|||++.+..++.++|||||||
T Consensus 153 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGv 232 (376)
T cd05598 153 WTHDSKYYQKGDHHRQDSMEPSEEWSEIDRCRLKPLERRRKRQHQRCLAHSLVGTPNYIAPEVLLRTGYTQLCDWWSVGV 232 (376)
T ss_pred ccccccccccccccccccccccccccccccccccchhhhhhhhcccccccccCCCccccCHHHHcCCCCCcceeeeeccc
Confidence 1000 0000112346889999999999999999999999999
Q ss_pred HHHHHHhCCCCCCCCccCCCCchhHHHHHHHHHhcCccCcccccCccccchhhHhHHHHHHHHHHHHHHHHhcCCCCCCC
Q 038766 211 VVMEFLTKRRPTGLDEENGLSPISLRQLVEKALANGINGVRQITDPKLVSSIYEEQEQHQVLEELFKLALVCTSSNPEDR 290 (299)
Q Consensus 211 ~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~R 290 (299)
++|+|++|..||..... . +....... . .....+.. ...++.++.++|.+|+ .+|++|
T Consensus 233 ilyell~G~~Pf~~~~~-----~---~~~~~i~~-~-~~~~~~~~------------~~~~s~~~~~li~~l~-~~p~~R 289 (376)
T cd05598 233 ILYEMLVGQPPFLADTP-----A---ETQLKVIN-W-ETTLHIPS------------QAKLSREASDLILRLC-CGAEDR 289 (376)
T ss_pred eeeehhhCCCCCCCCCH-----H---HHHHHHhc-c-CccccCCC------------CCCCCHHHHHHHHHHh-cCHhhc
Confidence 99999999999954321 1 11111110 0 00000000 1124567888999977 599999
Q ss_pred C---ChhhhhcC
Q 038766 291 P---NMNELLIT 299 (299)
Q Consensus 291 p---t~~~il~~ 299 (299)
+ |+.+++.|
T Consensus 290 ~~~~t~~ell~h 301 (376)
T cd05598 290 LGKNGADEIKAH 301 (376)
T ss_pred CCCCCHHHHhCC
Confidence 9 99999987
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS was originally identified in Drosophila using a screen for genes whose inactivation led to overproliferation of cells. In tetrapods, there are two LATS isoforms, LATS1 and LATS2. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. |
| >cd05620 STKc_nPKC_delta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C delta | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.2e-42 Score=292.56 Aligned_cols=244 Identities=23% Similarity=0.305 Sum_probs=190.0
Q ss_pred ceeecCCcceEEEEEeC-CCcEEEEEEeccCcC-ChhhhHHHHHHHHHHHhc-CCcceeeeeeEEEcCCCeeEEEEeecC
Q 038766 18 NIIGNSNLSTVYKGRLE-DGEIVAVKKLNFHQF-SAESDKSFYREAKTLKEL-KHRNLVKVLGYAWESGKLKALILEYME 94 (299)
Q Consensus 18 ~~lg~g~~~~v~~~~~~-~~~~~~vK~~~~~~~-~~~~~~~~~~e~~~l~~l-~h~~i~~~~~~~~~~~~~~~lv~e~~~ 94 (299)
+.||+|+||.||++.+. +|+.||+|++..... ..........|...+... .||+|+++++.+.. .+..++||||+.
T Consensus 1 ~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~-~~~~~lv~E~~~ 79 (316)
T cd05620 1 KVLGKGSFGKVLLAELKGKGEYFAVKALKKDVVLIDDDVECTMVEKRVLALAWENPFLTHLYCTFQT-KEHLFFVMEFLN 79 (316)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhcchHHHHHHHHHHHHhccCCCCccCeeEEEEe-CCEEEEEECCCC
Confidence 47999999999999875 588999999864322 123345566677777654 79999999996655 557799999999
Q ss_pred CCChHHHhcCCCCCCCCCChhhHHHHHHHHHHHHHHhhcCCCCCeeeecccCCceeeCCCCcEEEeeecccccccccccc
Q 038766 95 NGSLESVIHGPGVDHSRWTLPKRIDVLISVANGLDYLHSGYDIPIVHCDMKPSNILLDRDFEAHVSDFGTSRMLDVHLQD 174 (299)
Q Consensus 95 ~~~L~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lh~~~~~~~~H~dl~~~nil~~~~~~v~l~df~~~~~~~~~~~~ 174 (299)
+++|...+. ....+++..+..++.|++.||+|||++ +++|+||||+||+++.++.++|+|||++.....
T Consensus 80 ~g~L~~~i~----~~~~~~~~~~~~~~~qi~~~l~~lH~~---~ivHrDlkp~Nil~~~~~~~kl~Dfg~~~~~~~---- 148 (316)
T cd05620 80 GGDLMFHIQ----DKGRFDLYRATFYAAEIVCGLQFLHSK---GIIYRDLKLDNVMLDRDGHIKIADFGMCKENVF---- 148 (316)
T ss_pred CCcHHHHHH----HcCCCCHHHHHHHHHHHHHHHHHHHHC---CeEecCCCHHHeEECCCCCEEeCccCCCeeccc----
Confidence 999998886 445789999999999999999999999 999999999999999999999999998864221
Q ss_pred ccccccccccCcccCChhhhcccCcCccccchhhhHHHHHHHhCCCCCCCCccCCCCchhHHHHHHHHHhcCccCccccc
Q 038766 175 LSSLSTAFQGTIGYLAPEFAYMRIVTTKVDVFSFGIVVMEFLTKRRPTGLDEENGLSPISLRQLVEKALANGINGVRQIT 254 (299)
Q Consensus 175 ~~~~~~~~~~~~~y~~PE~~~~~~~~~~~DiwslG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 254 (299)
.........+++.|+|||.+.+..++.++|||||||++|+|++|..||.... .. ........ .....
T Consensus 149 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~el~~g~~Pf~~~~-----~~---~~~~~~~~-~~~~~---- 215 (316)
T cd05620 149 GDNRASTFCGTPDYIAPEILQGLKYTFSVDWWSFGVLLYEMLIGQSPFHGDD-----ED---ELFESIRV-DTPHY---- 215 (316)
T ss_pred CCCceeccCCCcCccCHHHHcCCCCCcccchhhhHHHHHHHHhCCCCCCCCC-----HH---HHHHHHHh-CCCCC----
Confidence 1122334567899999999999999999999999999999999999995332 11 11221111 10000
Q ss_pred CccccchhhHhHHHHHHHHHHHHHHHHhcCCCCCCCCChh-hhhcC
Q 038766 255 DPKLVSSIYEEQEQHQVLEELFKLALVCTSSNPEDRPNMN-ELLIT 299 (299)
Q Consensus 255 ~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rpt~~-~il~~ 299 (299)
+..++.++.++|.+||..||++||++. ++++|
T Consensus 216 -------------~~~~~~~~~~li~~~l~~dP~~R~~~~~~~~~h 248 (316)
T cd05620 216 -------------PRWITKESKDILEKLFERDPTRRLGVVGNIRGH 248 (316)
T ss_pred -------------CCCCCHHHHHHHHHHccCCHHHcCCChHHHHcC
Confidence 112346788999999999999999984 67655
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), delta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-delta plays a role in cell cycle regulation and programmed cell death in many cell types. I |
| >PHA02988 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-41 Score=285.75 Aligned_cols=243 Identities=19% Similarity=0.298 Sum_probs=191.9
Q ss_pred ceeecCCcceEEEEEeCCCcEEEEEEeccCcCChh-hhHHHHHHHHHHHhcCCcceeeeeeEEEc--C-CCeeEEEEeec
Q 038766 18 NIIGNSNLSTVYKGRLEDGEIVAVKKLNFHQFSAE-SDKSFYREAKTLKELKHRNLVKVLGYAWE--S-GKLKALILEYM 93 (299)
Q Consensus 18 ~~lg~g~~~~v~~~~~~~~~~~~vK~~~~~~~~~~-~~~~~~~e~~~l~~l~h~~i~~~~~~~~~--~-~~~~~lv~e~~ 93 (299)
..||+|+++.||++.. +|+.||+|++........ ..+.+.+|+..+++++||||+++++++.+ . ....++|+||+
T Consensus 26 ~~i~~g~~~~v~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~~~g~~~~~~~~~~~~~lv~Ey~ 104 (283)
T PHA02988 26 VLIKENDQNSIYKGIF-NNKEVIIRTFKKFHKGHKVLIDITENEIKNLRRIDSNNILKIYGFIIDIVDDLPRLSLILEYC 104 (283)
T ss_pred eEEeeCCceEEEEEEE-CCEEEEEEeccccccccHHHHHHHHHHHHHHHhcCCCCEEEEeeeEEecccCCCceEEEEEeC
Confidence 6899999999999988 588999999875433222 24677899999999999999999998765 2 34568999999
Q ss_pred CCCChHHHhcCCCCCCCCCChhhHHHHHHHHHHHHHHhhcCCCCCeeeecccCCceeeCCCCcEEEeeeccccccccccc
Q 038766 94 ENGSLESVIHGPGVDHSRWTLPKRIDVLISVANGLDYLHSGYDIPIVHCDMKPSNILLDRDFEAHVSDFGTSRMLDVHLQ 173 (299)
Q Consensus 94 ~~~~L~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lh~~~~~~~~H~dl~~~nil~~~~~~v~l~df~~~~~~~~~~~ 173 (299)
++++|.+++. ....+++...+.++.|++.||.+||+. .+++|+||||+||+++.++.+||+|||++.....
T Consensus 105 ~~g~L~~~l~----~~~~~~~~~~~~i~~~i~~~l~~lH~~--~~~~Hrdlkp~nill~~~~~~kl~dfg~~~~~~~--- 175 (283)
T PHA02988 105 TRGYLREVLD----KEKDLSFKTKLDMAIDCCKGLYNLYKY--TNKPYKNLTSVSFLVTENYKLKIICHGLEKILSS--- 175 (283)
T ss_pred CCCcHHHHHh----hCCCCChhHHHHHHHHHHHHHHHHHhc--CCCCCCcCChhhEEECCCCcEEEcccchHhhhcc---
Confidence 9999999997 445788999999999999999999973 1788999999999999999999999999875431
Q ss_pred cccccccccccCcccCChhhhcc--cCcCccccchhhhHHHHHHHhCCCCCCCCccCCCCchhHHHHHHHHHhcCccCcc
Q 038766 174 DLSSLSTAFQGTIGYLAPEFAYM--RIVTTKVDVFSFGIVVMEFLTKRRPTGLDEENGLSPISLRQLVEKALANGINGVR 251 (299)
Q Consensus 174 ~~~~~~~~~~~~~~y~~PE~~~~--~~~~~~~DiwslG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 251 (299)
......++..|+|||.+.+ ..++.++|||||||++|+|++|..||... ... +...........
T Consensus 176 ----~~~~~~~~~~y~aPE~~~~~~~~~~~k~Di~SlGvil~el~~g~~Pf~~~-----~~~---~~~~~i~~~~~~--- 240 (283)
T PHA02988 176 ----PPFKNVNFMVYFSYKMLNDIFSEYTIKDDIYSLGVVLWEIFTGKIPFENL-----TTK---EIYDLIINKNNS--- 240 (283)
T ss_pred ----ccccccCcccccCHHHhhhccccccchhhhhHHHHHHHHHHHCCCCCCCC-----CHH---HHHHHHHhcCCC---
Confidence 1123346788999999876 67899999999999999999999999532 111 222222111110
Q ss_pred cccCccccchhhHhHHHHHHHHHHHHHHHHhcCCCCCCCCChhhhhc
Q 038766 252 QITDPKLVSSIYEEQEQHQVLEELFKLALVCTSSNPEDRPNMNELLI 298 (299)
Q Consensus 252 ~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rpt~~~il~ 298 (299)
... +...+..+.+++.+||+.||++|||++++++
T Consensus 241 -~~~------------~~~~~~~l~~li~~cl~~dp~~Rps~~ell~ 274 (283)
T PHA02988 241 -LKL------------PLDCPLEIKCIVEACTSHDSIKRPNIKEILY 274 (283)
T ss_pred -CCC------------CCcCcHHHHHHHHHHhcCCcccCcCHHHHHH
Confidence 000 1134567999999999999999999999985
|
|
| >cd08529 STKc_FA2-like Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii FA2 and similar domains | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-41 Score=278.99 Aligned_cols=252 Identities=23% Similarity=0.365 Sum_probs=204.1
Q ss_pred CCCCCceeecCCcceEEEEEeC-CCcEEEEEEeccCcCChhhhHHHHHHHHHHHhcCCcceeeeeeEEEcCCCeeEEEEe
Q 038766 13 SFSENNIIGNSNLSTVYKGRLE-DGEIVAVKKLNFHQFSAESDKSFYREAKTLKELKHRNLVKVLGYAWESGKLKALILE 91 (299)
Q Consensus 13 ~y~~~~~lg~g~~~~v~~~~~~-~~~~~~vK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~lv~e 91 (299)
+|.+.+.||+|++|.||++.+. +++.+++|.+............+.+|++.++.++|||++++++.+.. ++..++|+|
T Consensus 1 ~~~~~~~l~~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~-~~~~~lv~e 79 (256)
T cd08529 1 DFEILNKIGKGSFGVVFKVVRKADKRVYAMKQIDLSKMNRREREEAIDEARVLAKLDSSYIIRYYESFLD-KGKLNIVME 79 (256)
T ss_pred CceEeEEecCCCCeEEEEEEEcCCCcEEEEEEeehhhCCHHHHHHHHHHHHHHHhcCCCCeehheeeecc-CCEEEEEEE
Confidence 4788899999999999999874 58999999987655556667788999999999999999999996655 556799999
Q ss_pred ecCCCChHHHhcCCCCCCCCCChhhHHHHHHHHHHHHHHhhcCCCCCeeeecccCCceeeCCCCcEEEeeeccccccccc
Q 038766 92 YMENGSLESVIHGPGVDHSRWTLPKRIDVLISVANGLDYLHSGYDIPIVHCDMKPSNILLDRDFEAHVSDFGTSRMLDVH 171 (299)
Q Consensus 92 ~~~~~~L~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lh~~~~~~~~H~dl~~~nil~~~~~~v~l~df~~~~~~~~~ 171 (299)
|+.+++|.+++... ....+++..++.++.|++.||.|||+. +++|+||+|+||+++.++.++|+|||++..+...
T Consensus 80 ~~~~~~L~~~l~~~--~~~~~~~~~~~~i~~~l~~al~~lH~~---~i~h~dl~~~nili~~~~~~~l~df~~~~~~~~~ 154 (256)
T cd08529 80 YAENGDLHKLLKMQ--RGRPLPEDQVWRFFIQILLGLAHLHSK---KILHRDIKSLNLFLDAYDNVKIGDLGVAKLLSDN 154 (256)
T ss_pred eCCCCcHHHHHHHh--cCCCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCcceEEEeCCCCEEEcccccceeccCc
Confidence 99999999988643 245789999999999999999999998 9999999999999999999999999988755421
Q ss_pred cccccccccccccCcccCChhhhcccCcCccccchhhhHHHHHHHhCCCCCCCCccCCCCchhHHHHHHHHHhcCccCcc
Q 038766 172 LQDLSSLSTAFQGTIGYLAPEFAYMRIVTTKVDVFSFGIVVMEFLTKRRPTGLDEENGLSPISLRQLVEKALANGINGVR 251 (299)
Q Consensus 172 ~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~DiwslG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 251 (299)
........+++.|+|||...+..++.++|+||||+++++|++|..||.... .. ...........+.
T Consensus 155 ----~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~-----~~---~~~~~~~~~~~~~-- 220 (256)
T cd08529 155 ----TNFANTIVGTPYYLSPELCEDKPYNEKSDVWALGVVLYECCTGKHPFDANN-----QG---ALILKIIRGVFPP-- 220 (256)
T ss_pred ----cchhhccccCccccCHHHhcCCCCCCccchHHHHHHHHHHHhCCCCCCCCC-----HH---HHHHHHHcCCCCC--
Confidence 112233456788999999998889999999999999999999999996442 11 1111111111000
Q ss_pred cccCccccchhhHhHHHHHHHHHHHHHHHHhcCCCCCCCCChhhhhcC
Q 038766 252 QITDPKLVSSIYEEQEQHQVLEELFKLALVCTSSNPEDRPNMNELLIT 299 (299)
Q Consensus 252 ~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rpt~~~il~~ 299 (299)
.+..++..+.+++.+||+.+|++||++.++++|
T Consensus 221 ---------------~~~~~~~~~~~~i~~~l~~~p~~Rp~~~~ll~~ 253 (256)
T cd08529 221 ---------------VSQMYSQQLAQLIDQCLTKDYRQRPDTFQLLRN 253 (256)
T ss_pred ---------------CccccCHHHHHHHHHHccCCcccCcCHHHHhhC
Confidence 022445679999999999999999999999986
|
Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii FA2-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii FA2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes FA2 and CNK4. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii FA2 was discovered in a genetic screen for deflagellation-defective mutants. It is essential for basal-body/centriole-associated microtubule severing, and plays a role in cell cyc |
| >cd05616 STKc_cPKC_beta Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C beta | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.9e-42 Score=292.61 Aligned_cols=249 Identities=20% Similarity=0.288 Sum_probs=194.3
Q ss_pred CCCCCceeecCCcceEEEEEeC-CCcEEEEEEeccCcC-ChhhhHHHHHHHHHHHhcC-CcceeeeeeEEEcCCCeeEEE
Q 038766 13 SFSENNIIGNSNLSTVYKGRLE-DGEIVAVKKLNFHQF-SAESDKSFYREAKTLKELK-HRNLVKVLGYAWESGKLKALI 89 (299)
Q Consensus 13 ~y~~~~~lg~g~~~~v~~~~~~-~~~~~~vK~~~~~~~-~~~~~~~~~~e~~~l~~l~-h~~i~~~~~~~~~~~~~~~lv 89 (299)
+|.+.+.||+|+||.||++.+. +++.+|+|++..... ..........|..++..+. |++|+++.+++.. ....++|
T Consensus 1 df~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~-~~~~~lv 79 (323)
T cd05616 1 DFNFLMVLGKGSFGKVMLAERKGTDELYAIKILKKDVVIQDDDVECTMVEKRVLALSGKPPFLTQLHSCFQT-MDRLYFV 79 (323)
T ss_pred CceEEEEEeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccCCCeEeeEEEEEec-CCEEEEE
Confidence 5889999999999999999865 578999999874322 2223445667778887774 7888888886554 5567999
Q ss_pred EeecCCCChHHHhcCCCCCCCCCChhhHHHHHHHHHHHHHHhhcCCCCCeeeecccCCceeeCCCCcEEEeeeccccccc
Q 038766 90 LEYMENGSLESVIHGPGVDHSRWTLPKRIDVLISVANGLDYLHSGYDIPIVHCDMKPSNILLDRDFEAHVSDFGTSRMLD 169 (299)
Q Consensus 90 ~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lh~~~~~~~~H~dl~~~nil~~~~~~v~l~df~~~~~~~ 169 (299)
+||+.+++|...+. ....+++..+..++.|++.||+|||+. +++|+||||+||+++.++.++|+|||++....
T Consensus 80 ~E~~~~g~L~~~~~----~~~~~~~~~~~~~~~qi~~aL~~LH~~---~ivHrDlkp~Nill~~~~~~kL~DfG~~~~~~ 152 (323)
T cd05616 80 MEYVNGGDLMYQIQ----QVGRFKEPHAVFYAAEIAIGLFFLHSK---GIIYRDLKLDNVMLDSEGHIKIADFGMCKENM 152 (323)
T ss_pred EcCCCCCCHHHHHH----HcCCCCHHHHHHHHHHHHHHHHHHHHC---CEEecCCCHHHeEECCCCcEEEccCCCceecC
Confidence 99999999998886 445789999999999999999999999 99999999999999999999999999886432
Q ss_pred cccccccccccccccCcccCChhhhcccCcCccccchhhhHHHHHHHhCCCCCCCCccCCCCchhHHHHHHHHHhcCccC
Q 038766 170 VHLQDLSSLSTAFQGTIGYLAPEFAYMRIVTTKVDVFSFGIVVMEFLTKRRPTGLDEENGLSPISLRQLVEKALANGING 249 (299)
Q Consensus 170 ~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~DiwslG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 249 (299)
. .........+++.|+|||.+.+..++.++|+|||||++|+|++|..||.... .. ........... .
T Consensus 153 ~----~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~elltg~~Pf~~~~-----~~---~~~~~i~~~~~-~ 219 (323)
T cd05616 153 W----DGVTTKTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQAPFEGED-----ED---ELFQSIMEHNV-A 219 (323)
T ss_pred C----CCCccccCCCChhhcCHHHhcCCCCCCccchhchhHHHHHHHhCCCCCCCCC-----HH---HHHHHHHhCCC-C
Confidence 1 1112234567899999999999999999999999999999999999995432 11 12222111110 0
Q ss_pred cccccCccccchhhHhHHHHHHHHHHHHHHHHhcCCCCCCCCCh-----hhhhcC
Q 038766 250 VRQITDPKLVSSIYEEQEQHQVLEELFKLALVCTSSNPEDRPNM-----NELLIT 299 (299)
Q Consensus 250 ~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rpt~-----~~il~~ 299 (299)
. +..++.++.+++.+||..||++|++. +++++|
T Consensus 220 -----~------------p~~~s~~~~~li~~~l~~~p~~R~~~~~~~~~~i~~h 257 (323)
T cd05616 220 -----Y------------PKSMSKEAVAICKGLMTKHPGKRLGCGPEGERDIKEH 257 (323)
T ss_pred -----C------------CCcCCHHHHHHHHHHcccCHHhcCCCCCCCHHHHhcC
Confidence 0 22345678999999999999999985 677655
|
Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, beta isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, and |
| >cd07861 STKc_CDK1_euk Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 1 from higher eukaryotes-like | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.7e-42 Score=287.34 Aligned_cols=272 Identities=25% Similarity=0.313 Sum_probs=199.9
Q ss_pred CCCCCceeecCCcceEEEEEeC-CCcEEEEEEeccCcCChhhhHHHHHHHHHHHhcCCcceeeeeeEEEcCCCeeEEEEe
Q 038766 13 SFSENNIIGNSNLSTVYKGRLE-DGEIVAVKKLNFHQFSAESDKSFYREAKTLKELKHRNLVKVLGYAWESGKLKALILE 91 (299)
Q Consensus 13 ~y~~~~~lg~g~~~~v~~~~~~-~~~~~~vK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~lv~e 91 (299)
+|.+.+.||+|++|.||++.+. ++..||+|++............+.+|+..++.+.|||++++++++.. +...++|+|
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~-~~~~~~v~e 79 (285)
T cd07861 1 DYTKIEKIGEGTYGVVYKGRNKKTGQIVAMKKIRLESEEEGVPSTAIREISLLKELQHPNIVCLQDVLMQ-ESRLYLIFE 79 (285)
T ss_pred CceEeeEecccCceEEEEEEECCCCcEEEEEEeccccccCCchHHHHHHHHHHHhcCCCCEeeeEEEEee-CCeEEEEEe
Confidence 5889999999999999999874 68999999987654444455778899999999999999999997665 556699999
Q ss_pred ecCCCChHHHhcCCCCCCCCCChhhHHHHHHHHHHHHHHhhcCCCCCeeeecccCCceeeCCCCcEEEeeeccccccccc
Q 038766 92 YMENGSLESVIHGPGVDHSRWTLPKRIDVLISVANGLDYLHSGYDIPIVHCDMKPSNILLDRDFEAHVSDFGTSRMLDVH 171 (299)
Q Consensus 92 ~~~~~~L~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lh~~~~~~~~H~dl~~~nil~~~~~~v~l~df~~~~~~~~~ 171 (299)
|+. ++|.+++.... .+..+++..++.++.|++.||+|||+. +++|+||+|+||+++.++.++|+|||++......
T Consensus 80 ~~~-~~l~~~~~~~~-~~~~~~~~~~~~~~~qi~~~L~~lH~~---~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~ 154 (285)
T cd07861 80 FLS-MDLKKYLDSLP-KGQYMDAELVKSYLYQILQGILFCHSR---RVLHRDLKPQNLLIDNKGVIKLADFGLARAFGIP 154 (285)
T ss_pred cCC-CCHHHHHhcCC-CCCcCCHHHHHHHHHHHHHHHHHHHhC---CeeecCCCHHHEEEcCCCcEEECcccceeecCCC
Confidence 996 58888876432 346789999999999999999999999 9999999999999999999999999998754311
Q ss_pred cccccccccccccCcccCChhhhccc-CcCccccchhhhHHHHHHHhCCCCCCCCccCCCCchhHHHHHHHHHh---cCc
Q 038766 172 LQDLSSLSTAFQGTIGYLAPEFAYMR-IVTTKVDVFSFGIVVMEFLTKRRPTGLDEENGLSPISLRQLVEKALA---NGI 247 (299)
Q Consensus 172 ~~~~~~~~~~~~~~~~y~~PE~~~~~-~~~~~~DiwslG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~---~~~ 247 (299)
........+++.|+|||.+.+. .++.++|+||||+++++|++|..||...... ............ ..+
T Consensus 155 ----~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~~l~tg~~~~~~~~~~----~~~~~~~~~~~~~~~~~~ 226 (285)
T cd07861 155 ----VRVYTHEVVTLWYRAPEVLLGSPRYSTPVDIWSIGTIFAEMATKKPLFHGDSEI----DQLFRIFRILGTPTEDVW 226 (285)
T ss_pred ----cccccCCcccccccChHHhcCCCCcCcHHHHHHHHHHHHHHHHCCCCCCCCCHH----HHHHHHHHHhCCCChhhh
Confidence 1112233457889999987654 4688999999999999999999998643211 001110000000 000
Q ss_pred cCcccccC-----ccccchhhHhHHHHHHHHHHHHHHHHhcCCCCCCCCChhhhhcC
Q 038766 248 NGVRQITD-----PKLVSSIYEEQEQHQVLEELFKLALVCTSSNPEDRPNMNELLIT 299 (299)
Q Consensus 248 ~~~~~~~~-----~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rpt~~~il~~ 299 (299)
.......+ +...... .......++.++.++|++||..||++|||++++++|
T Consensus 227 ~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~li~~~l~~dP~~Rpt~~~ll~~ 282 (285)
T cd07861 227 PGVTSLPDYKNTFPKWKKGS-LRSAVKNLDEDGLDLLEKMLIYDPAKRISAKKALNH 282 (285)
T ss_pred hcchhhHHHHhhccccCcch-hHHhcCCCCHHHHHHHHHHhcCChhhCCCHHHHhcC
Confidence 00000000 0000000 001122356788999999999999999999999987
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyclin A complex controls G2 |
| >KOG0667 consensus Dual-specificity tyrosine-phosphorylation regulated kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.7e-43 Score=301.75 Aligned_cols=200 Identities=25% Similarity=0.362 Sum_probs=172.4
Q ss_pred HHhCCCCCCceeecCCcceEEEEEe-CCCcEEEEEEeccCcCChhhhHHHHHHHHHHHhcC-C-----cceeeeeeEEEc
Q 038766 9 NATGSFSENNIIGNSNLSTVYKGRL-EDGEIVAVKKLNFHQFSAESDKSFYREAKTLKELK-H-----RNLVKVLGYAWE 81 (299)
Q Consensus 9 ~~~~~y~~~~~lg~g~~~~v~~~~~-~~~~~~~vK~~~~~~~~~~~~~~~~~e~~~l~~l~-h-----~~i~~~~~~~~~ 81 (299)
.+..+|.+.+.||+|+||.|.+|.+ ++++.||||+++ .......+...|+.+|..++ | -|+++++++|..
T Consensus 183 ~i~~rY~V~e~LGkGtFGQVvk~~d~~T~e~VAIKIiK---N~k~f~~Q~~~Ei~iL~~ln~~d~~~~~n~Vrm~d~F~f 259 (586)
T KOG0667|consen 183 HIAYRYEVLEVLGKGSFGQVVKAYDHKTGEIVAIKIIK---NKKRFLRQAQIEIRILELLNKHDPDDKYNIVRMLDYFYF 259 (586)
T ss_pred eeEEEEEEEEEecccccceeEEEEecCCCcEEEEEeec---cChHHHHHHHHHHHHHHHHhccCCCCCeeEEEeeecccc
Confidence 4556899999999999999999986 569999999996 34566778888999999997 4 489999997665
Q ss_pred CCCeeEEEEeecCCCChHHHhcCCCCCCCCCChhhHHHHHHHHHHHHHHhhcCCCCCeeeecccCCceeeCC--CCcEEE
Q 038766 82 SGKLKALILEYMENGSLESVIHGPGVDHSRWTLPKRIDVLISVANGLDYLHSGYDIPIVHCDMKPSNILLDR--DFEAHV 159 (299)
Q Consensus 82 ~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lh~~~~~~~~H~dl~~~nil~~~--~~~v~l 159 (299)
.+++|||+|.+ ..+|.++++.. ...+++...++.++.||+.||.+||+. +|+|+||||+|||+.. ...||+
T Consensus 260 -r~HlciVfELL-~~NLYellK~n--~f~Glsl~~ir~~~~Qil~~L~~L~~l---~IIHcDLKPENILL~~~~r~~vKV 332 (586)
T KOG0667|consen 260 -RNHLCIVFELL-STNLYELLKNN--KFRGLSLPLVRKFAQQILTALLFLHEL---GIIHCDLKPENILLKDPKRSRIKV 332 (586)
T ss_pred -ccceeeeehhh-hhhHHHHHHhc--CCCCCCHHHHHHHHHHHHHHHHHHHhC---CeeeccCChhheeeccCCcCceeE
Confidence 55679999999 55999999866 566799999999999999999999999 9999999999999964 347999
Q ss_pred eeeccccccccccccccccccccccCcccCChhhhcccCcCccccchhhhHHHHHHHhCCCCCCCC
Q 038766 160 SDFGTSRMLDVHLQDLSSLSTAFQGTIGYLAPEFAYMRIVTTKVDVFSFGIVVMEFLTKRRPTGLD 225 (299)
Q Consensus 160 ~df~~~~~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~DiwslG~~l~~l~~g~~p~~~~ 225 (299)
+|||.++.... ..+ ...-+..|+|||++.+..|+.+.|||||||+++||++|.+.|.+.
T Consensus 333 IDFGSSc~~~q------~vy-tYiQSRfYRAPEVILGlpY~~~IDmWSLGCIlAEL~tG~PLfpG~ 391 (586)
T KOG0667|consen 333 IDFGSSCFESQ------RVY-TYIQSRFYRAPEVILGLPYDTAIDMWSLGCILAELFTGEPLFPGD 391 (586)
T ss_pred EecccccccCC------cce-eeeeccccccchhhccCCCCCccceeehhhhHHhHhcCccccCCC
Confidence 99999986541 222 555688999999999999999999999999999999998888655
|
|
| >cd07839 STKc_CDK5 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-42 Score=291.35 Aligned_cols=271 Identities=23% Similarity=0.328 Sum_probs=198.9
Q ss_pred CCCCCceeecCCcceEEEEEeC-CCcEEEEEEeccCcCChhhhHHHHHHHHHHHhcCCcceeeeeeEEEcCCCeeEEEEe
Q 038766 13 SFSENNIIGNSNLSTVYKGRLE-DGEIVAVKKLNFHQFSAESDKSFYREAKTLKELKHRNLVKVLGYAWESGKLKALILE 91 (299)
Q Consensus 13 ~y~~~~~lg~g~~~~v~~~~~~-~~~~~~vK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~lv~e 91 (299)
+|.+.+.||+|++|.||++.+. +|+.+++|++............+.+|+..++.++|+|++++++++.. +...++|+|
T Consensus 1 ~y~~~~~l~~g~~~~vy~~~~~~~g~~~~~k~~~~~~~~~~~~~~~~~ei~~l~~l~h~~i~~~~~~~~~-~~~~~lv~e 79 (284)
T cd07839 1 KYEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLYDVLHS-DKKLTLVFE 79 (284)
T ss_pred CceeEEEecccCCeEEEEEEECCCCcEEEEEEeecccccccCccchhHHHHHHHhcCCCCeeeHHHHhcc-CCceEEEEe
Confidence 5888999999999999999874 58999999987654444445677889999999999999999997655 556699999
Q ss_pred ecCCCChHHHhcCCCCCCCCCChhhHHHHHHHHHHHHHHhhcCCCCCeeeecccCCceeeCCCCcEEEeeeccccccccc
Q 038766 92 YMENGSLESVIHGPGVDHSRWTLPKRIDVLISVANGLDYLHSGYDIPIVHCDMKPSNILLDRDFEAHVSDFGTSRMLDVH 171 (299)
Q Consensus 92 ~~~~~~L~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lh~~~~~~~~H~dl~~~nil~~~~~~v~l~df~~~~~~~~~ 171 (299)
|+. ++|.+.+.. ....+++..++.++.||++||.|||+. +++|+||+|+||+++.++.++|+|||++..+...
T Consensus 80 ~~~-~~l~~~~~~---~~~~~~~~~~~~~~~qi~~al~~LH~~---~i~H~dl~~~nil~~~~~~~~l~dfg~~~~~~~~ 152 (284)
T cd07839 80 YCD-QDLKKYFDS---CNGDIDPEIVKSFMFQLLKGLAFCHSH---NVLHRDLKPQNLLINKNGELKLADFGLARAFGIP 152 (284)
T ss_pred cCC-CCHHHHHHh---cCCCCCHHHHHHHHHHHHHHHHHHHHC---CEecCCCCHHHEEEcCCCcEEECccchhhccCCC
Confidence 996 478777653 235689999999999999999999999 9999999999999999999999999998754321
Q ss_pred cccccccccccccCcccCChhhhccc-CcCccccchhhhHHHHHHHhCCCCCCCCccCCCCchhHHHHHHHHHhc----C
Q 038766 172 LQDLSSLSTAFQGTIGYLAPEFAYMR-IVTTKVDVFSFGIVVMEFLTKRRPTGLDEENGLSPISLRQLVEKALAN----G 246 (299)
Q Consensus 172 ~~~~~~~~~~~~~~~~y~~PE~~~~~-~~~~~~DiwslG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~----~ 246 (299)
........++..|+|||.+.+. .++.++|||||||++|+|++|..|+...... ......+...... .
T Consensus 153 ----~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~tg~~p~~~~~~~----~~~~~~~~~~~~~~~~~~ 224 (284)
T cd07839 153 ----VRCYSAEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGNDV----DDQLKRIFRLLGTPTEES 224 (284)
T ss_pred ----CCCcCCCccccCCcChHHHhCCcccCcHHHHHHHHHHHHHHHhcCCCCcCCCCH----HHHHHHHHHHhCCCChHH
Confidence 1112234567889999987764 4688999999999999999999886432111 1111111100000 0
Q ss_pred ccCcccccC----ccccchhhHhHHHHHHHHHHHHHHHHhcCCCCCCCCChhhhhcC
Q 038766 247 INGVRQITD----PKLVSSIYEEQEQHQVLEELFKLALVCTSSNPEDRPNMNELLIT 299 (299)
Q Consensus 247 ~~~~~~~~~----~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rpt~~~il~~ 299 (299)
++....... +..............++.++.++|.+||..||.+|||++++++|
T Consensus 225 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~t~~~il~h 281 (284)
T cd07839 225 WPGVSKLPDYKPYPMYPATTSLVNVVPKLNSTGRDLLQNLLVCNPVQRISAEEALQH 281 (284)
T ss_pred hHHhhhcccccccCCCCCcchhhhhcccCCHHHHHHHHHHhcCChhhcCCHHHHhcC
Confidence 000000000 00111111112233467889999999999999999999999987
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 5 (CDK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK5 is unusual in that it is regulated by non-cyclin proteins, p35 and p39. It is highly expressed in the nervous system and is critical in normal neural development and function. It plays a role in neuronal migration and differentiation, and is also |
| >cd05619 STKc_nPKC_theta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C theta | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.3e-42 Score=290.31 Aligned_cols=244 Identities=23% Similarity=0.349 Sum_probs=189.6
Q ss_pred ceeecCCcceEEEEEeC-CCcEEEEEEeccCcC-ChhhhHHHHHHHHHHHhc-CCcceeeeeeEEEcCCCeeEEEEeecC
Q 038766 18 NIIGNSNLSTVYKGRLE-DGEIVAVKKLNFHQF-SAESDKSFYREAKTLKEL-KHRNLVKVLGYAWESGKLKALILEYME 94 (299)
Q Consensus 18 ~~lg~g~~~~v~~~~~~-~~~~~~vK~~~~~~~-~~~~~~~~~~e~~~l~~l-~h~~i~~~~~~~~~~~~~~~lv~e~~~ 94 (299)
+.||+|+||.||++.+. +++.||+|++..... ..........|...++.. .||||+++++++.. ....++|+||+.
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~hp~iv~~~~~~~~-~~~~~lv~ey~~ 79 (316)
T cd05619 1 KMLGKGSFGKVFLAELKGTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTHLYCTFQT-KENLFFVMEYLN 79 (316)
T ss_pred CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhcchHHHHHHHHHHHHhccCCCcCcceEEEEEe-CCEEEEEEeCCC
Confidence 47999999999999875 578999999864322 122344556677777754 89999999997665 456699999999
Q ss_pred CCChHHHhcCCCCCCCCCChhhHHHHHHHHHHHHHHhhcCCCCCeeeecccCCceeeCCCCcEEEeeecccccccccccc
Q 038766 95 NGSLESVIHGPGVDHSRWTLPKRIDVLISVANGLDYLHSGYDIPIVHCDMKPSNILLDRDFEAHVSDFGTSRMLDVHLQD 174 (299)
Q Consensus 95 ~~~L~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lh~~~~~~~~H~dl~~~nil~~~~~~v~l~df~~~~~~~~~~~~ 174 (299)
+++|..++. ....+++..+..++.|++.||.|||+. +++|+||||+||+++.++.++|+|||++......
T Consensus 80 ~g~L~~~l~----~~~~~~~~~~~~~~~qi~~al~~LH~~---~ivHrdikp~Nil~~~~~~~kl~Dfg~~~~~~~~--- 149 (316)
T cd05619 80 GGDLMFHIQ----SCHKFDLPRATFYAAEIICGLQFLHSK---GIVYRDLKLDNILLDTDGHIKIADFGMCKENMLG--- 149 (316)
T ss_pred CCcHHHHHH----HcCCCCHHHHHHHHHHHHHHHHHHHhC---CeEeCCCCHHHEEECCCCCEEEccCCcceECCCC---
Confidence 999999986 445789999999999999999999999 9999999999999999999999999988643211
Q ss_pred ccccccccccCcccCChhhhcccCcCccccchhhhHHHHHHHhCCCCCCCCccCCCCchhHHHHHHHHHhcCccCccccc
Q 038766 175 LSSLSTAFQGTIGYLAPEFAYMRIVTTKVDVFSFGIVVMEFLTKRRPTGLDEENGLSPISLRQLVEKALANGINGVRQIT 254 (299)
Q Consensus 175 ~~~~~~~~~~~~~y~~PE~~~~~~~~~~~DiwslG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 254 (299)
........+++.|+|||.+.+..++.++||||+||++|+|++|..||.... .. +.........
T Consensus 150 -~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~~G~~pf~~~~-----~~---~~~~~i~~~~-------- 212 (316)
T cd05619 150 -DAKTCTFCGTPDYIAPEILLGQKYNTSVDWWSFGVLLYEMLIGQSPFHGHD-----EE---ELFQSIRMDN-------- 212 (316)
T ss_pred -CCceeeecCCccccCHHHHcCCCCCchhhhhhHHHHHHHHHhCCCCCCCCC-----HH---HHHHHHHhCC--------
Confidence 112234457899999999999899999999999999999999999995431 11 2222111110
Q ss_pred CccccchhhHhHHHHHHHHHHHHHHHHhcCCCCCCCCChh-hhhcC
Q 038766 255 DPKLVSSIYEEQEQHQVLEELFKLALVCTSSNPEDRPNMN-ELLIT 299 (299)
Q Consensus 255 ~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rpt~~-~il~~ 299 (299)
+.. +..++.++.++|.+||..||++||++. +++.|
T Consensus 213 -~~~---------~~~~~~~~~~li~~~l~~~P~~R~~~~~~l~~h 248 (316)
T cd05619 213 -PCY---------PRWLTREAKDILVKLFVREPERRLGVKGDIRQH 248 (316)
T ss_pred -CCC---------CccCCHHHHHHHHHHhccCHhhcCCChHHHHcC
Confidence 000 112346789999999999999999997 77665
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an important and non-redundant role in |
| >cd08217 STKc_Nek2 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-41 Score=281.80 Aligned_cols=255 Identities=25% Similarity=0.405 Sum_probs=206.7
Q ss_pred CCCCCceeecCCcceEEEEEe-CCCcEEEEEEeccCcCChhhhHHHHHHHHHHHhcCCcceeeeeeEEEc-CCCeeEEEE
Q 038766 13 SFSENNIIGNSNLSTVYKGRL-EDGEIVAVKKLNFHQFSAESDKSFYREAKTLKELKHRNLVKVLGYAWE-SGKLKALIL 90 (299)
Q Consensus 13 ~y~~~~~lg~g~~~~v~~~~~-~~~~~~~vK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~-~~~~~~lv~ 90 (299)
+|.+.+.||.|++|.||++.+ .++..+++|++..........+.+..|++.++.++|+|++++++.+.. .+...++++
T Consensus 1 ~y~~~~~lg~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~~~~ 80 (265)
T cd08217 1 DYEVLETIGKGSFGTVRKVRRKSDGKILVWKEIDYGNMTEKEKQQLVSEVNILRELKHPNIVRYYDRIIDRSNQTLYIVM 80 (265)
T ss_pred CceeeeeeccCCCeEEEEeeecCCCCEEEEEEEecccCCHHHHHHHHHHHHHHHhcCCCccceeeeeeecCCCCEEEEEe
Confidence 588999999999999999986 468899999997666666667788999999999999999999997654 345678999
Q ss_pred eecCCCChHHHhcCCCCCCCCCChhhHHHHHHHHHHHHHHhh-----cCCCCCeeeecccCCceeeCCCCcEEEeeeccc
Q 038766 91 EYMENGSLESVIHGPGVDHSRWTLPKRIDVLISVANGLDYLH-----SGYDIPIVHCDMKPSNILLDRDFEAHVSDFGTS 165 (299)
Q Consensus 91 e~~~~~~L~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lh-----~~~~~~~~H~dl~~~nil~~~~~~v~l~df~~~ 165 (299)
||+++++|.+++........++++..++.++.|++.||.+|| +. +++|+||+|+||+++.++.++|+|||++
T Consensus 81 e~~~~~~L~~~l~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~~~~~---~i~h~dl~p~nili~~~~~~kl~d~g~~ 157 (265)
T cd08217 81 EYCEGGDLAQLIQKCKKERKYIEEEFIWRILTQLLLALYECHNRSDPGN---TVLHRDLKPANIFLDANNNVKLGDFGLA 157 (265)
T ss_pred hhccCCCHHHHHHHHhhcccCCCHHHHHHHHHHHHHHHHHHhcCccccC---cceecCCCHHHEEEecCCCEEEeccccc
Confidence 999999999988654334568999999999999999999999 76 9999999999999999999999999998
Q ss_pred cccccccccccccccccccCcccCChhhhcccCcCccccchhhhHHHHHHHhCCCCCCCCccCCCCchhHHHHHHHHHhc
Q 038766 166 RMLDVHLQDLSSLSTAFQGTIGYLAPEFAYMRIVTTKVDVFSFGIVVMEFLTKRRPTGLDEENGLSPISLRQLVEKALAN 245 (299)
Q Consensus 166 ~~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~DiwslG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~ 245 (299)
...... ........+++.|+|||.+.+..++.++|+||||+++++|++|..||.... ...+...+ ..
T Consensus 158 ~~~~~~----~~~~~~~~~~~~~~~pE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~-----~~~~~~~~----~~ 224 (265)
T cd08217 158 KILGHD----SSFAKTYVGTPYYMSPEQLNHMSYDEKSDIWSLGCLIYELCALSPPFTARN-----QLQLASKI----KE 224 (265)
T ss_pred ccccCC----cccccccccCCCccChhhhcCCCCCchhHHHHHHHHHHHHHHCCCcccCcC-----HHHHHHHH----hc
Confidence 865421 111233457889999999998889999999999999999999999985432 11222211 11
Q ss_pred CccCcccccCccccchhhHhHHHHHHHHHHHHHHHHhcCCCCCCCCChhhhhcC
Q 038766 246 GINGVRQITDPKLVSSIYEEQEQHQVLEELFKLALVCTSSNPEDRPNMNELLIT 299 (299)
Q Consensus 246 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rpt~~~il~~ 299 (299)
.. .. ..+...+..+.+++.+||..+|++|||+++|++|
T Consensus 225 ~~--~~--------------~~~~~~~~~~~~l~~~~l~~~p~~Rp~~~~il~~ 262 (265)
T cd08217 225 GK--FR--------------RIPYRYSSELNEVIKSMLNVDPDKRPSTEELLQL 262 (265)
T ss_pred CC--CC--------------CCccccCHHHHHHHHHHccCCcccCCCHHHHhhC
Confidence 10 00 0122345689999999999999999999999987
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 2 (Nek2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek2 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek2 subfamily includes Aspergillus nidulans NIMA kinase, the founding member of the Nek family, which was identified in a screen for cell cycle mutants prevented from entering mitosis. NIMA is essential for mitotic entry and progression through mitosis, and its degradation is essential for mitotic exi |
| >KOG4717 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-42 Score=292.59 Aligned_cols=253 Identities=22% Similarity=0.343 Sum_probs=215.1
Q ss_pred HHhCCCCCCceeecCCcceEEEEEe-CCCcEEEEEEeccCcCChhhhHHHHHHHHHHHhcCCcceeeeeeEEEcCCCeeE
Q 038766 9 NATGSFSENNIIGNSNLSTVYKGRL-EDGEIVAVKKLNFHQFSAESDKSFYREAKTLKELKHRNLVKVLGYAWESGKLKA 87 (299)
Q Consensus 9 ~~~~~y~~~~~lg~g~~~~v~~~~~-~~~~~~~vK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~ 87 (299)
.|++-|.+.+.||+|-|++|-+|++ -+|+.||||++.......-....+.+|++.|+.++||||+++|+ +.+.+.-+|
T Consensus 15 kIAGLYDLekTlG~GHFAVVKLArHVFTGekVAVKviDKTKlD~~st~hlfqEVRCMKLVQHpNiVRLYE-ViDTQTKly 93 (864)
T KOG4717|consen 15 KIAGLYDLEKTLGRGHFAVVKLARHVFTGEKVAVKVIDKTKLDTLSTGHLFQEVRCMKLVQHPNIVRLYE-VIDTQTKLY 93 (864)
T ss_pred ceeeeehhhhhhcCCceehhhhhhhhcccceeEEEEecccccchhhhhHHHHHHHHHHHhcCcCeeeeee-hhcccceEE
Confidence 3667899999999999999999975 67999999999887778888889999999999999999999999 556676779
Q ss_pred EEEeecCCCChHHHhcCCCCCCCCCChhhHHHHHHHHHHHHHHhhcCCCCCeeeecccCCceee-CCCCcEEEeeecccc
Q 038766 88 LILEYMENGSLESVIHGPGVDHSRWTLPKRIDVLISVANGLDYLHSGYDIPIVHCDMKPSNILL-DRDFEAHVSDFGTSR 166 (299)
Q Consensus 88 lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lh~~~~~~~~H~dl~~~nil~-~~~~~v~l~df~~~~ 166 (299)
+|+|.=++|+|.++|-. ....+.|..+.+++.||+.|+.|+|+. .+|||||||+|+.+ .+-|-|||+|||++.
T Consensus 94 LiLELGD~GDl~DyImK---He~Gl~E~La~kYF~QI~~AI~YCHqL---HVVHRDLKPENVVFFEKlGlVKLTDFGFSN 167 (864)
T KOG4717|consen 94 LILELGDGGDLFDYIMK---HEEGLNEDLAKKYFAQIVHAISYCHQL---HVVHRDLKPENVVFFEKLGLVKLTDFGFSN 167 (864)
T ss_pred EEEEecCCchHHHHHHh---hhccccHHHHHHHHHHHHHHHHHHhhh---hhhcccCCcceeEEeeecCceEeeeccccc
Confidence 99999999999998864 346899999999999999999999999 99999999999766 577999999999997
Q ss_pred ccccccccccccccccccCcccCChhhhcccCcCc-cccchhhhHHHHHHHhCCCCCCCCccCCCCchhHHHHHHHHHhc
Q 038766 167 MLDVHLQDLSSLSTAFQGTIGYLAPEFAYMRIVTT-KVDVFSFGIVVMEFLTKRRPTGLDEENGLSPISLRQLVEKALAN 245 (299)
Q Consensus 167 ~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~-~~DiwslG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~ 245 (299)
.+. ++.......|+..|.|||++.+..|+. +.||||||++||-|.+|+.||...+.. +.+..+.
T Consensus 168 kf~-----PG~kL~TsCGSLAYSAPEILLGDsYDAPAVDiWSLGVILyMLVCGq~PFqeANDS--------ETLTmIm-- 232 (864)
T KOG4717|consen 168 KFQ-----PGKKLTTSCGSLAYSAPEILLGDSYDAPAVDIWSLGVILYMLVCGQPPFQEANDS--------ETLTMIM-- 232 (864)
T ss_pred cCC-----CcchhhcccchhhccCchhhhcCccCCcchhhhHHHHHHHHHHhCCCccccccch--------hhhhhhh--
Confidence 765 344556778899999999999998874 789999999999999999999644322 2222211
Q ss_pred CccCcccccCccccchhhHhHHHHHHHHHHHHHHHHhcCCCCCCCCChhhhhcC
Q 038766 246 GINGVRQITDPKLVSSIYEEQEQHQVLEELFKLALVCTSSNPEDRPNMNELLIT 299 (299)
Q Consensus 246 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rpt~~~il~~ 299 (299)
+=++ .++..++.++++||..||..||++|.|.++|..|
T Consensus 233 ---------DCKY-------tvPshvS~eCrdLI~sMLvRdPkkRAslEeI~s~ 270 (864)
T KOG4717|consen 233 ---------DCKY-------TVPSHVSKECRDLIQSMLVRDPKKRASLEEIVST 270 (864)
T ss_pred ---------cccc-------cCchhhhHHHHHHHHHHHhcCchhhccHHHHhcc
Confidence 1111 2377889999999999999999999999999764
|
|
| >cd05617 STKc_aPKC_zeta Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C zeta | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-41 Score=290.22 Aligned_cols=251 Identities=18% Similarity=0.240 Sum_probs=193.7
Q ss_pred ceeecCCcceEEEEEeC-CCcEEEEEEeccCcC-ChhhhHHHHHHHHHHHhc-CCcceeeeeeEEEcCCCeeEEEEeecC
Q 038766 18 NIIGNSNLSTVYKGRLE-DGEIVAVKKLNFHQF-SAESDKSFYREAKTLKEL-KHRNLVKVLGYAWESGKLKALILEYME 94 (299)
Q Consensus 18 ~~lg~g~~~~v~~~~~~-~~~~~~vK~~~~~~~-~~~~~~~~~~e~~~l~~l-~h~~i~~~~~~~~~~~~~~~lv~e~~~ 94 (299)
+.||+|+||.||++... +++.+|+|++..... .....+.+..|..+++++ .||+|+++++.+.. .+..++|+||+.
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~-~~~~~lv~e~~~ 79 (327)
T cd05617 1 RVIGRGSYAKVLLVRLKKNDQIYAMKVVKKELVHDDEDIDWVQTEKHVFEQASSNPFLVGLHSCFQT-TSRLFLVIEYVN 79 (327)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhhcCCCCEeeEEEEEEe-CCEEEEEEeCCC
Confidence 47999999999999864 588999999975332 233456678899999888 59999999995544 556799999999
Q ss_pred CCChHHHhcCCCCCCCCCChhhHHHHHHHHHHHHHHhhcCCCCCeeeecccCCceeeCCCCcEEEeeecccccccccccc
Q 038766 95 NGSLESVIHGPGVDHSRWTLPKRIDVLISVANGLDYLHSGYDIPIVHCDMKPSNILLDRDFEAHVSDFGTSRMLDVHLQD 174 (299)
Q Consensus 95 ~~~L~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lh~~~~~~~~H~dl~~~nil~~~~~~v~l~df~~~~~~~~~~~~ 174 (299)
+++|...+. ....+++..++.++.|++.||+|||++ +++|+||||+||+++.++.++|+|||++.....
T Consensus 80 ~~~L~~~~~----~~~~l~~~~~~~~~~qi~~al~~lH~~---~ivHrDlkp~Nili~~~~~~kl~Dfg~~~~~~~---- 148 (327)
T cd05617 80 GGDLMFHMQ----RQRKLPEEHARFYAAEICIALNFLHER---GIIYRDLKLDNVLLDADGHIKLTDYGMCKEGLG---- 148 (327)
T ss_pred CCcHHHHHH----HcCCCCHHHHHHHHHHHHHHHHHHHHC---CeeccCCCHHHEEEeCCCCEEEeccccceeccC----
Confidence 999998886 345799999999999999999999999 999999999999999999999999998864221
Q ss_pred ccccccccccCcccCChhhhcccCcCccccchhhhHHHHHHHhCCCCCCCCccCCCCchhHHHHHHHHHhcCccCccccc
Q 038766 175 LSSLSTAFQGTIGYLAPEFAYMRIVTTKVDVFSFGIVVMEFLTKRRPTGLDEENGLSPISLRQLVEKALANGINGVRQIT 254 (299)
Q Consensus 175 ~~~~~~~~~~~~~y~~PE~~~~~~~~~~~DiwslG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 254 (299)
.........+++.|+|||.+.+..++.++|||||||++|+|++|..||.......... ..+.+...........
T Consensus 149 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~ell~g~~pf~~~~~~~~~~--~~~~~~~~~~~~~~~~---- 222 (327)
T cd05617 149 PGDTTSTFCGTPNYIAPEILRGEEYGFSVDWWALGVLMFEMMAGRSPFDIITDNPDMN--TEDYLFQVILEKPIRI---- 222 (327)
T ss_pred CCCceecccCCcccCCHHHHCCCCCCchheeehhHHHHHHHHhCCCCCCccCCCcccc--cHHHHHHHHHhCCCCC----
Confidence 1122234568899999999999999999999999999999999999996432221111 1111112111111010
Q ss_pred CccccchhhHhHHHHHHHHHHHHHHHHhcCCCCCCCCCh------hhhhcC
Q 038766 255 DPKLVSSIYEEQEQHQVLEELFKLALVCTSSNPEDRPNM------NELLIT 299 (299)
Q Consensus 255 ~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rpt~------~~il~~ 299 (299)
+..++..+.+++.+||..||++|+++ +++++|
T Consensus 223 -------------p~~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~~i~~h 260 (327)
T cd05617 223 -------------PRFLSVKASHVLKGFLNKDPKERLGCQPQTGFSDIKSH 260 (327)
T ss_pred -------------CCCCCHHHHHHHHHHhccCHHHcCCCCCCCCHHHHHcC
Confidence 22334578899999999999999985 577765
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, zeta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-zeta plays a critical role in activating the glucose transport response. It is activated by glucose, insulin, and exercise through diverse pathways |
| >cd05607 STKc_GRK7 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 7 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-41 Score=284.44 Aligned_cols=246 Identities=25% Similarity=0.319 Sum_probs=188.5
Q ss_pred eecCCcceEEEEEeC-CCcEEEEEEeccCcCChh-hhHHHHHHHHHHHhcCCcceeeeeeEEEcCCCeeEEEEeecCCCC
Q 038766 20 IGNSNLSTVYKGRLE-DGEIVAVKKLNFHQFSAE-SDKSFYREAKTLKELKHRNLVKVLGYAWESGKLKALILEYMENGS 97 (299)
Q Consensus 20 lg~g~~~~v~~~~~~-~~~~~~vK~~~~~~~~~~-~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~lv~e~~~~~~ 97 (299)
||+|+||.||++... +|+.+|+|++........ .......|.++++.++||||+++.+.+.. +...++|+||+.+++
T Consensus 1 lg~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~E~~il~~l~hp~i~~~~~~~~~-~~~~~lv~e~~~g~~ 79 (277)
T cd05607 1 LGKGGFGEVCAVQVKNTGKMYACKKLDKKRLKKKSGEKMALLEKEILEKVNSPFIVNLAYAFES-KTHLCLVMSLMNGGD 79 (277)
T ss_pred CCCCCceEEEEEEEccCCcEEEEEEEcHHHhhcchhhHHHHHHHHHHHhcCCCcEEEEEEEEec-CCeEEEEEecCCCCC
Confidence 799999999999864 589999999864333222 23445679999999999999999996554 566799999999999
Q ss_pred hHHHhcCCCCCCCCCChhhHHHHHHHHHHHHHHhhcCCCCCeeeecccCCceeeCCCCcEEEeeeccccccccccccccc
Q 038766 98 LESVIHGPGVDHSRWTLPKRIDVLISVANGLDYLHSGYDIPIVHCDMKPSNILLDRDFEAHVSDFGTSRMLDVHLQDLSS 177 (299)
Q Consensus 98 L~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lh~~~~~~~~H~dl~~~nil~~~~~~v~l~df~~~~~~~~~~~~~~~ 177 (299)
|.+.+... ....+++..++.++.|++.||+|||+. +++|+||||+||+++.++.++|+|||++...... .
T Consensus 80 L~~~~~~~--~~~~~~~~~~~~~~~qi~~al~~lH~~---~ivH~dikp~Nili~~~~~~~l~Dfg~~~~~~~~-----~ 149 (277)
T cd05607 80 LKYHIYNV--GERGLEMERVIHYSAQITCGILHLHSM---DIVYRDMKPENVLLDDQGNCRLSDLGLAVELKDG-----K 149 (277)
T ss_pred HHHHHHhc--cccCCCHHHHHHHHHHHHHHHHHHHHC---CEEEccCChHhEEEcCCCCEEEeeceeeeecCCC-----c
Confidence 98887533 234588899999999999999999999 9999999999999999999999999998755421 1
Q ss_pred cccccccCcccCChhhhcccCcCccccchhhhHHHHHHHhCCCCCCCCccCCCCchhHHHHHHHHHhcCccCcccccCcc
Q 038766 178 LSTAFQGTIGYLAPEFAYMRIVTTKVDVFSFGIVVMEFLTKRRPTGLDEENGLSPISLRQLVEKALANGINGVRQITDPK 257 (299)
Q Consensus 178 ~~~~~~~~~~y~~PE~~~~~~~~~~~DiwslG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 257 (299)
......++..|+|||.+.+..++.++|+|||||++|+|++|..||....... ............. +..
T Consensus 150 ~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslGv~l~el~~g~~p~~~~~~~~----~~~~~~~~~~~~~------~~~-- 217 (277)
T cd05607 150 TITQRAGTNGYMAPEILKEEPYSYPVDWFAMGCSIYEMVAGRTPFKDHKEKV----AKEELKRRTLEDE------VKF-- 217 (277)
T ss_pred eeeccCCCCCccCHHHHccCCCCCchhHHHHHHHHHHHHhCCCCCCCCcchh----hHHHHHHHhhccc------ccc--
Confidence 1223457889999999998889999999999999999999999985321110 1111111111000 000
Q ss_pred ccchhhHhHHHHHHHHHHHHHHHHhcCCCCCCCCChhhhh
Q 038766 258 LVSSIYEEQEQHQVLEELFKLALVCTSSNPEDRPNMNELL 297 (299)
Q Consensus 258 ~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rpt~~~il 297 (299)
....++.++.+++++||+.||++|||+++++
T Consensus 218 ---------~~~~~~~~~~~li~~~L~~~P~~R~~~~~~~ 248 (277)
T cd05607 218 ---------EHQNFTEESKDICRLFLAKKPEDRLGSREKN 248 (277)
T ss_pred ---------ccccCCHHHHHHHHHHhccCHhhCCCCccch
Confidence 0123466789999999999999999995544
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK7 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK7, also called iodopsin kinase, belongs to the visual gr |
| >cd08224 STKc_Nek6_Nek7 Catalytic domain of the Protein Serine/Threonine Kinases, Never In Mitosis gene A-related kinase 6 and 7 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.1e-41 Score=278.41 Aligned_cols=257 Identities=26% Similarity=0.385 Sum_probs=203.7
Q ss_pred CCCCCCceeecCCcceEEEEEeC-CCcEEEEEEeccCcCC-hhhhHHHHHHHHHHHhcCCcceeeeeeEEEcCCCeeEEE
Q 038766 12 GSFSENNIIGNSNLSTVYKGRLE-DGEIVAVKKLNFHQFS-AESDKSFYREAKTLKELKHRNLVKVLGYAWESGKLKALI 89 (299)
Q Consensus 12 ~~y~~~~~lg~g~~~~v~~~~~~-~~~~~~vK~~~~~~~~-~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~lv 89 (299)
++|.+.+.||+|++|.||++... +|+.+++|.+...... ....+.+.+|++.+++++|++++++++.+.. ++..++|
T Consensus 2 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~ei~~l~~~~~~~i~~~~~~~~~-~~~~~lv 80 (267)
T cd08224 2 GNFKIEKKIGKGQFSVVYKAICLLDGRVVALKKVQIFEMMDAKARQDCLKEIDLLKQLDHPNVIKYLASFIE-NNELNIV 80 (267)
T ss_pred CceeeeeeeccCCceEEEEEEEcCCCCEEEEEEeecccccchhhHHHHHHHHHHHHhCCCCCeeeeeeeeec-CCeEEEE
Confidence 68999999999999999999875 7899999998653332 3346788899999999999999999997765 4566999
Q ss_pred EeecCCCChHHHhcCCCCCCCCCChhhHHHHHHHHHHHHHHhhcCCCCCeeeecccCCceeeCCCCcEEEeeeccccccc
Q 038766 90 LEYMENGSLESVIHGPGVDHSRWTLPKRIDVLISVANGLDYLHSGYDIPIVHCDMKPSNILLDRDFEAHVSDFGTSRMLD 169 (299)
Q Consensus 90 ~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lh~~~~~~~~H~dl~~~nil~~~~~~v~l~df~~~~~~~ 169 (299)
+||+.+++|.+++......+..+++..++.++.+++.||++||+. +++|+||+|+||+++.++.++|+|||++....
T Consensus 81 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~---~i~h~dl~p~nil~~~~~~~~l~d~~~~~~~~ 157 (267)
T cd08224 81 LELADAGDLSRMIKHFKKQKRLIPERTIWKYFVQLCSALEHMHSK---RIMHRDIKPANVFITATGVVKLGDLGLGRFFS 157 (267)
T ss_pred EecCCCCCHHHHHHHhcccCCCcCHHHHHHHHHHHHHHHHHHHhC---CEecCCcChhhEEECCCCcEEEeccceeeecc
Confidence 999999999998864433456789999999999999999999999 99999999999999999999999999987543
Q ss_pred cccccccccccccccCcccCChhhhcccCcCccccchhhhHHHHHHHhCCCCCCCCccCCCCchhHHHHHHHHHhcCccC
Q 038766 170 VHLQDLSSLSTAFQGTIGYLAPEFAYMRIVTTKVDVFSFGIVVMEFLTKRRPTGLDEENGLSPISLRQLVEKALANGING 249 (299)
Q Consensus 170 ~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~DiwslG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 249 (299)
... .......++..|+|||.+.+..++.++|+||||+++|+|++|..||..... ................
T Consensus 158 ~~~----~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~------~~~~~~~~~~~~~~~~ 227 (267)
T cd08224 158 SKT----TAAHSLVGTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSPFYGDKM------NLYSLCKKIEKCDYPP 227 (267)
T ss_pred CCC----cccceecCCccccCHHHhccCCCCchhcHHHHHHHHHHHHHCCCCcccCCc------cHHHHHhhhhcCCCCC
Confidence 211 112234567889999999888899999999999999999999999854321 1112221111100000
Q ss_pred cccccCccccchhhHhHHHHHHHHHHHHHHHHhcCCCCCCCCChhhhhc
Q 038766 250 VRQITDPKLVSSIYEEQEQHQVLEELFKLALVCTSSNPEDRPNMNELLI 298 (299)
Q Consensus 250 ~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rpt~~~il~ 298 (299)
.....++..+.++|.+||..+|++|||+.+|++
T Consensus 228 ----------------~~~~~~~~~~~~~i~~cl~~~p~~Rp~~~~il~ 260 (267)
T cd08224 228 ----------------LPADHYSEELRDLVSRCINPDPEKRPDISYVLQ 260 (267)
T ss_pred ----------------CChhhcCHHHHHHHHHHcCCCcccCCCHHHHHH
Confidence 002245668999999999999999999999875
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) and Nek7 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6/7 subfamily is part of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 and Nek7 are the shortest Neks, consisting only of the catalytic domain and a very short N-terminal extension. They show distinct expression patterns and both appear to be downstream substrates of Nek9. They are required for mitotic spindle formation and cytokinesis. They may a |
| >cd08228 STKc_Nek6 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4e-41 Score=280.00 Aligned_cols=257 Identities=23% Similarity=0.354 Sum_probs=202.0
Q ss_pred CCCCCCceeecCCcceEEEEEeC-CCcEEEEEEeccCc-CChhhhHHHHHHHHHHHhcCCcceeeeeeEEEcCCCeeEEE
Q 038766 12 GSFSENNIIGNSNLSTVYKGRLE-DGEIVAVKKLNFHQ-FSAESDKSFYREAKTLKELKHRNLVKVLGYAWESGKLKALI 89 (299)
Q Consensus 12 ~~y~~~~~lg~g~~~~v~~~~~~-~~~~~~vK~~~~~~-~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~lv 89 (299)
++|.+.+.||+|++|.||++.+. +++.+|+|.+.... ........+.+|+..++.++|||++++++.+.. .+..++|
T Consensus 2 ~~~~i~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~-~~~~~~v 80 (267)
T cd08228 2 ANFQIEKKIGRGQFSEVYRATCLLDRKPVALKKVQIFEMMDAKARQDCVKEIDLLKQLNHPNVIKYLDSFIE-DNELNIV 80 (267)
T ss_pred cceeeeeeeccCCCeeEEEEEEeCCCCEEEEEEeeccccCCHHHHHHHHHHHHHHHhCCCcceeeeeeeEEE-CCeEEEE
Confidence 68999999999999999999864 68999999876432 233445678889999999999999999997665 4566999
Q ss_pred EeecCCCChHHHhcCCCCCCCCCChhhHHHHHHHHHHHHHHhhcCCCCCeeeecccCCceeeCCCCcEEEeeeccccccc
Q 038766 90 LEYMENGSLESVIHGPGVDHSRWTLPKRIDVLISVANGLDYLHSGYDIPIVHCDMKPSNILLDRDFEAHVSDFGTSRMLD 169 (299)
Q Consensus 90 ~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lh~~~~~~~~H~dl~~~nil~~~~~~v~l~df~~~~~~~ 169 (299)
+||+.+++|.+++.........+++..++.++.|++.||.|||++ +++|+||+|+||+++.++.++|+|||++....
T Consensus 81 ~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~---~i~H~dl~~~nil~~~~~~~~l~d~g~~~~~~ 157 (267)
T cd08228 81 LELADAGDLSQMIKYFKKQKRLIPERTVWKYFVQLCSAVEHMHSR---RVMHRDIKPANVFITATGVVKLGDLGLGRFFS 157 (267)
T ss_pred EEecCCCcHHHHHHHhhhccCCCCHHHHHHHHHHHHHHHHHHhhC---CeeCCCCCHHHEEEcCCCCEEECccccceecc
Confidence 999999999988864332345689999999999999999999999 99999999999999999999999999887654
Q ss_pred cccccccccccccccCcccCChhhhcccCcCccccchhhhHHHHHHHhCCCCCCCCccCCCCchhHHHHHHHHHhcCccC
Q 038766 170 VHLQDLSSLSTAFQGTIGYLAPEFAYMRIVTTKVDVFSFGIVVMEFLTKRRPTGLDEENGLSPISLRQLVEKALANGING 249 (299)
Q Consensus 170 ~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~DiwslG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 249 (299)
.. ........+++.|+|||.+.+..++.++|+||+|+++|+|++|..||...... .............+.
T Consensus 158 ~~----~~~~~~~~~~~~~~aPE~~~~~~~~~~~Di~slG~~l~el~~g~~p~~~~~~~------~~~~~~~~~~~~~~~ 227 (267)
T cd08228 158 SK----TTAAHSLVGTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSPFYGDKMN------LFSLCQKIEQCDYPP 227 (267)
T ss_pred ch----hHHHhcCCCCccccChhhhccCCCCchhhHHHHHHHHHHHhcCCCCCcccccc------HHHHHHHHhcCCCCC
Confidence 21 11122345678899999998888999999999999999999999998533111 111111111101000
Q ss_pred cccccCccccchhhHhHHHHHHHHHHHHHHHHhcCCCCCCCCChhhhhc
Q 038766 250 VRQITDPKLVSSIYEEQEQHQVLEELFKLALVCTSSNPEDRPNMNELLI 298 (299)
Q Consensus 250 ~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rpt~~~il~ 298 (299)
.....++..+.+++.+||..+|++|||++++++
T Consensus 228 ----------------~~~~~~~~~~~~li~~cl~~~p~~Rp~~~~vl~ 260 (267)
T cd08228 228 ----------------LPTEHYSEKLRELVSMCIYPDPDQRPDIGYVHQ 260 (267)
T ss_pred ----------------CChhhcCHHHHHHHHHHCCCCcccCcCHHHHHH
Confidence 012345677999999999999999999999985
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 is required for the transition from metaphase to anaphase. It also plays important roles in mitotic spindle formation and cytokinesis. Activated by Nek9 during mitosis, Nek6 phosphorylates Eg5, a kinesin that is important for spindle bipolarity. Nek6 localizes to spindle microtubules during metaphase |
| >cd05575 STKc_SGK Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.5e-42 Score=292.81 Aligned_cols=244 Identities=25% Similarity=0.293 Sum_probs=189.1
Q ss_pred ceeecCCcceEEEEEeC-CCcEEEEEEeccCcCC-hhhhHHHHHHHH-HHHhcCCcceeeeeeEEEcCCCeeEEEEeecC
Q 038766 18 NIIGNSNLSTVYKGRLE-DGEIVAVKKLNFHQFS-AESDKSFYREAK-TLKELKHRNLVKVLGYAWESGKLKALILEYME 94 (299)
Q Consensus 18 ~~lg~g~~~~v~~~~~~-~~~~~~vK~~~~~~~~-~~~~~~~~~e~~-~l~~l~h~~i~~~~~~~~~~~~~~~lv~e~~~ 94 (299)
+.||+|+||+||++.+. +|+.||+|++...... ......+..|.. .++.++||||+++++.+.. ....++|+||+.
T Consensus 1 ~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~~~~~l~hp~iv~~~~~~~~-~~~~~lv~e~~~ 79 (323)
T cd05575 1 KVIGKGSFGKVLLAKHKADGKFYAVKVLQKKAILKKKEQKHIMAERNVLLKNVKHPFLVGLHYSFQT-ADKLYFVLDYVN 79 (323)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhHHHHHHHHHHHHHhhCCCCCCCCeeEEEEe-CCEEEEEEcCCC
Confidence 47999999999999874 6899999998643221 222334445544 5677899999999996655 556699999999
Q ss_pred CCChHHHhcCCCCCCCCCChhhHHHHHHHHHHHHHHhhcCCCCCeeeecccCCceeeCCCCcEEEeeecccccccccccc
Q 038766 95 NGSLESVIHGPGVDHSRWTLPKRIDVLISVANGLDYLHSGYDIPIVHCDMKPSNILLDRDFEAHVSDFGTSRMLDVHLQD 174 (299)
Q Consensus 95 ~~~L~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lh~~~~~~~~H~dl~~~nil~~~~~~v~l~df~~~~~~~~~~~~ 174 (299)
+++|...+. ....+++..+..++.||+.||.|||++ +++|+||||+||+++.++.++|+|||++.....
T Consensus 80 ~g~L~~~l~----~~~~~~~~~~~~~~~qi~~~l~~lH~~---givH~dikp~NIll~~~~~~kl~Dfg~~~~~~~---- 148 (323)
T cd05575 80 GGELFFHLQ----RERSFPEPRARFYAAEIASALGYLHSL---NIIYRDLKPENILLDSQGHVVLTDFGLCKEGIE---- 148 (323)
T ss_pred CCCHHHHHH----hcCCCCHHHHHHHHHHHHHHHHHHHHC---CeEeCCCCHHHeEECCCCcEEEeccCCCccccc----
Confidence 999999886 455789999999999999999999999 999999999999999999999999998864221
Q ss_pred ccccccccccCcccCChhhhcccCcCccccchhhhHHHHHHHhCCCCCCCCccCCCCchhHHHHHHHHHhcCccCccccc
Q 038766 175 LSSLSTAFQGTIGYLAPEFAYMRIVTTKVDVFSFGIVVMEFLTKRRPTGLDEENGLSPISLRQLVEKALANGINGVRQIT 254 (299)
Q Consensus 175 ~~~~~~~~~~~~~y~~PE~~~~~~~~~~~DiwslG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 254 (299)
.........+++.|+|||++.+..++.++|||||||++|+|++|..||.... ..+......... ...
T Consensus 149 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~g~~pf~~~~--------~~~~~~~i~~~~-~~~---- 215 (323)
T cd05575 149 HSKTTSTFCGTPEYLAPEVLRKQPYDRTVDWWCLGAVLYEMLYGLPPFYSRD--------TAEMYDNILNKP-LRL---- 215 (323)
T ss_pred CCCccccccCChhhcChhhhcCCCCCccccccccchhhhhhhcCCCCCCCCC--------HHHHHHHHHcCC-CCC----
Confidence 1122334467899999999999999999999999999999999999995431 112222222111 000
Q ss_pred CccccchhhHhHHHHHHHHHHHHHHHHhcCCCCCCCCCh----hhhhcC
Q 038766 255 DPKLVSSIYEEQEQHQVLEELFKLALVCTSSNPEDRPNM----NELLIT 299 (299)
Q Consensus 255 ~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rpt~----~~il~~ 299 (299)
...++..+.++|++||..||.+||++ +++++|
T Consensus 216 -------------~~~~~~~~~~li~~~l~~~p~~R~~~~~~~~~il~~ 251 (323)
T cd05575 216 -------------KPNISVSARHLLEGLLQKDRTKRLGAKDDFLEIKNH 251 (323)
T ss_pred -------------CCCCCHHHHHHHHHHhhcCHHhCCCCCCCHHHHHcC
Confidence 11235678999999999999999998 477765
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGKs are activated by insulin and growth factors via phosphoinositide 3-kinase and PDK1. They activate ion channels, ion carriers, and the Na-K-ATPase, as well as regulate the activity of enzymes and transcription factors. SGKs play important roles in transport, hormone release, neuroexcitability, cell pr |
| >cd07868 STKc_CDK8 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 8 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.5e-41 Score=286.60 Aligned_cols=274 Identities=20% Similarity=0.298 Sum_probs=190.4
Q ss_pred CceeecCCcceEEEEEeC---CCcEEEEEEeccCcCChhhhHHHHHHHHHHHhcCCcceeeeeeEEEc-CCCeeEEEEee
Q 038766 17 NNIIGNSNLSTVYKGRLE---DGEIVAVKKLNFHQFSAESDKSFYREAKTLKELKHRNLVKVLGYAWE-SGKLKALILEY 92 (299)
Q Consensus 17 ~~~lg~g~~~~v~~~~~~---~~~~~~vK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~-~~~~~~lv~e~ 92 (299)
.++||+|+||+||+|.+. +++.+|+|.+.... ....+.+|+.++++++||||+++++++.. .+...++++||
T Consensus 6 ~~~lG~G~~g~Vy~~~~~~~~~~~~~aiK~~~~~~----~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~lv~e~ 81 (317)
T cd07868 6 GCKVGRGTYGHVYKAKRKDGKDDRDYALKQIEGTG----ISMSACREIALLRELKHPNVISLQKVFLSHADRKVWLLFDY 81 (317)
T ss_pred ccccccCCCeEEEEEEEccCCCCceEEEEEECCCC----CcHHHHHHHHHHHhcCCCCCcceeeeEecCCCcEEEEEEec
Confidence 468999999999999864 46889999986432 23456789999999999999999997754 34567899999
Q ss_pred cCCCChHHHhcCCC-----CCCCCCChhhHHHHHHHHHHHHHHhhcCCCCCeeeecccCCceee----CCCCcEEEeeec
Q 038766 93 MENGSLESVIHGPG-----VDHSRWTLPKRIDVLISVANGLDYLHSGYDIPIVHCDMKPSNILL----DRDFEAHVSDFG 163 (299)
Q Consensus 93 ~~~~~L~~~~~~~~-----~~~~~~~~~~~~~i~~qi~~~l~~lh~~~~~~~~H~dl~~~nil~----~~~~~v~l~df~ 163 (299)
+. ++|.+++.... .....+++..++.++.|++.||+|||++ +++|+||||+||++ +.++.+||+|||
T Consensus 82 ~~-~~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~---~ivHrDlkp~Nil~~~~~~~~~~~kl~DfG 157 (317)
T cd07868 82 AE-HDLWHIIKFHRASKANKKPVQLPRGMVKSLLYQILDGIHYLHAN---WVLHRDLKPANILVMGEGPERGRVKIADMG 157 (317)
T ss_pred cC-CCHHHHHHhcccccccCCcccCCHHHHHHHHHHHHHHHHHHHhC---CEEcCCCCHHHEEEecCCCCcCcEEEeecC
Confidence 95 58888775321 1223689999999999999999999999 99999999999999 456789999999
Q ss_pred cccccccccccccccccccccCcccCChhhhccc-CcCccccchhhhHHHHHHHhCCCCCCCCccCCCCchh-HHHHHHH
Q 038766 164 TSRMLDVHLQDLSSLSTAFQGTIGYLAPEFAYMR-IVTTKVDVFSFGIVVMEFLTKRRPTGLDEENGLSPIS-LRQLVEK 241 (299)
Q Consensus 164 ~~~~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~-~~~~~~DiwslG~~l~~l~~g~~p~~~~~~~~~~~~~-~~~~~~~ 241 (299)
++......... ........+++.|+|||.+.+. .++.++||||+||++|+|++|..||............ ....+..
T Consensus 158 ~a~~~~~~~~~-~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~~f~~~~~~~~~~~~~~~~~~~~ 236 (317)
T cd07868 158 FARLFNSPLKP-LADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCRQEDIKTSNPYHHDQLDR 236 (317)
T ss_pred ceeccCCCCcc-ccccCCccccccccCCHHHcCCCCcCchhhHHHHHHHHHHHHhCCCCccCCcccccccccccHHHHHH
Confidence 99765421111 1112345678899999988764 5889999999999999999999999754332211110 0011111
Q ss_pred HHh-cCc------cCcccccCcccc-ch------------hhHhHHHHHHHHHHHHHHHHhcCCCCCCCCChhhhhcC
Q 038766 242 ALA-NGI------NGVRQITDPKLV-SS------------IYEEQEQHQVLEELFKLALVCTSSNPEDRPNMNELLIT 299 (299)
Q Consensus 242 ~~~-~~~------~~~~~~~~~~~~-~~------------~~~~~~~~~~~~~l~~li~~~l~~dP~~Rpt~~~il~~ 299 (299)
... .+. .....+...... .. ..........+..+.+||.+||..||.+|||++|+|+|
T Consensus 237 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dli~~mL~~dP~~R~t~~e~l~h 314 (317)
T cd07868 237 IFNVMGFPADKDWEDIKKMPEHSTLMKDFRRNTYTNCSLIKYMEKHKVKPDSKAFHLLQKLLTMDPIKRITSEQAMQD 314 (317)
T ss_pred HHHhcCCCChHHhHHHhhccchhhhhhhhhccccCcccccchHHhcCCCCChHHHHHHHHHhccCcccCCCHHHHhcC
Confidence 111 000 000000000000 00 00000011123468899999999999999999999987
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK8 can act as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the multi-subunit core Mediator complex, a cofactor that is involved in regulating RNA p |
| >cd05622 STKc_ROCK1 Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-41 Score=295.25 Aligned_cols=260 Identities=20% Similarity=0.249 Sum_probs=199.6
Q ss_pred HHHHHhCCCCCCceeecCCcceEEEEEeC-CCcEEEEEEeccCcC-ChhhhHHHHHHHHHHHhcCCcceeeeeeEEEcCC
Q 038766 6 EIENATGSFSENNIIGNSNLSTVYKGRLE-DGEIVAVKKLNFHQF-SAESDKSFYREAKTLKELKHRNLVKVLGYAWESG 83 (299)
Q Consensus 6 ~~~~~~~~y~~~~~lg~g~~~~v~~~~~~-~~~~~~vK~~~~~~~-~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~ 83 (299)
+.+...++|.+.+.||+|+||.||++.+. +++.+|+|++..... .......+.+|..+++.++||||+++++.+. .+
T Consensus 37 ~~~~~~~~y~i~~~lG~G~fg~Vy~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~e~~i~~~~~hp~iv~~~~~~~-~~ 115 (371)
T cd05622 37 DLRMKAEDYEVVKVIGRGAFGEVQLVRHKSTRKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPWVVQLFYAFQ-DD 115 (371)
T ss_pred hcCcchhhcEEEEEEeecCCeEEEEEEECCCCcEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhCCCCCCCeEEEEEE-cC
Confidence 34555689999999999999999999875 588999999864222 2233455778999999999999999999655 46
Q ss_pred CeeEEEEeecCCCChHHHhcCCCCCCCCCChhhHHHHHHHHHHHHHHhhcCCCCCeeeecccCCceeeCCCCcEEEeeec
Q 038766 84 KLKALILEYMENGSLESVIHGPGVDHSRWTLPKRIDVLISVANGLDYLHSGYDIPIVHCDMKPSNILLDRDFEAHVSDFG 163 (299)
Q Consensus 84 ~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lh~~~~~~~~H~dl~~~nil~~~~~~v~l~df~ 163 (299)
...++|+||+.+++|.+++.. ..+++..+..++.||+.||.|||+. +++||||||+||+++.++.++|+|||
T Consensus 116 ~~~~lv~Ey~~gg~L~~~~~~-----~~~~~~~~~~~~~qi~~aL~~LH~~---~ivHrDLkp~NIll~~~~~ikL~DfG 187 (371)
T cd05622 116 RYLYMVMEYMPGGDLVNLMSN-----YDVPEKWARFYTAEVVLALDAIHSM---GFIHRDVKPDNMLLDKSGHLKLADFG 187 (371)
T ss_pred CEEEEEEcCCCCCcHHHHHHh-----cCCCHHHHHHHHHHHHHHHHHHHHC---CEEeCCCCHHHEEECCCCCEEEEeCC
Confidence 677999999999999999852 3588999999999999999999999 99999999999999999999999999
Q ss_pred cccccccccccccccccccccCcccCChhhhcccC----cCccccchhhhHHHHHHHhCCCCCCCCccCCCCchhHHHHH
Q 038766 164 TSRMLDVHLQDLSSLSTAFQGTIGYLAPEFAYMRI----VTTKVDVFSFGIVVMEFLTKRRPTGLDEENGLSPISLRQLV 239 (299)
Q Consensus 164 ~~~~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~----~~~~~DiwslG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~ 239 (299)
++...... .........+|+.|+|||++.... ++.++|||||||++|+|++|..||..... ....
T Consensus 188 ~a~~~~~~---~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~~~~DiwSlGvilyell~G~~Pf~~~~~--------~~~~ 256 (371)
T cd05622 188 TCMKMNKE---GMVRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPFYADSL--------VGTY 256 (371)
T ss_pred ceeEcCcC---CcccccCcccCccccCHHHHhccCCCccCCCccceeehhHHHHHHHhCCCCCCCCCH--------HHHH
Confidence 98765311 111233456899999999887543 78899999999999999999999964321 1112
Q ss_pred HHHHhcCccCcccccCccccchhhHhHHHHHHHHHHHHHHHHhcCCCCCC--CCChhhhhcC
Q 038766 240 EKALANGINGVRQITDPKLVSSIYEEQEQHQVLEELFKLALVCTSSNPED--RPNMNELLIT 299 (299)
Q Consensus 240 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~--Rpt~~~il~~ 299 (299)
....... .. ..++. ...++..+.++|.+||..++.+ |++++++++|
T Consensus 257 ~~i~~~~-~~-~~~~~------------~~~~s~~~~~li~~~L~~~~~r~~r~~~~ei~~h 304 (371)
T cd05622 257 SKIMNHK-NS-LTFPD------------DNDISKEAKNLICAFLTDREVRLGRNGVEEIKRH 304 (371)
T ss_pred HHHHcCC-Cc-ccCCC------------cCCCCHHHHHHHHHHcCChhhhcCCCCHHHHhcC
Confidence 2211100 00 00111 2245678899999999844433 7899999986
|
Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK1 (or ROK-beta) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK1 is preferentially expressed in the liver, lung, spleen, testes, an |
| >cd05072 PTKc_Lyn Catalytic domain of the Protein Tyrosine Kinase, Lyn | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.5e-42 Score=282.86 Aligned_cols=254 Identities=26% Similarity=0.408 Sum_probs=199.0
Q ss_pred HHHhCCCCCCceeecCCcceEEEEEeCCCcEEEEEEeccCcCChhhhHHHHHHHHHHHhcCCcceeeeeeEEEcCCCeeE
Q 038766 8 ENATGSFSENNIIGNSNLSTVYKGRLEDGEIVAVKKLNFHQFSAESDKSFYREAKTLKELKHRNLVKVLGYAWESGKLKA 87 (299)
Q Consensus 8 ~~~~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~vK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~ 87 (299)
++-.++|++.++||+|++|+||++...++..+++|.+... ....+.+.+|+.+++.++|+||+++++.+.. +...+
T Consensus 2 ~~~~~~~~~~~~lg~g~~g~v~~~~~~~~~~v~iK~~~~~---~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~-~~~~~ 77 (261)
T cd05072 2 EIPRESIKLVKKLGAGQFGEVWMGYYNNSTKVAVKTLKPG---TMSVQAFLEEANLMKTLQHDKLVRLYAVVTK-EEPIY 77 (261)
T ss_pred cCchHHeEEeeecCCcCCceEEEEEecCCceEEEEEccCC---chhHHHHHHHHHHHHhCCCCCeeeEEEEEcC-CCCcE
Confidence 3456789999999999999999999877888999987532 2345678899999999999999999996654 55569
Q ss_pred EEEeecCCCChHHHhcCCCCCCCCCChhhHHHHHHHHHHHHHHhhcCCCCCeeeecccCCceeeCCCCcEEEeeeccccc
Q 038766 88 LILEYMENGSLESVIHGPGVDHSRWTLPKRIDVLISVANGLDYLHSGYDIPIVHCDMKPSNILLDRDFEAHVSDFGTSRM 167 (299)
Q Consensus 88 lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lh~~~~~~~~H~dl~~~nil~~~~~~v~l~df~~~~~ 167 (299)
+++|++.+++|.+++... ....++...++.++.|++.||+|||+. +++|+||+|+||+++.++.++|+|||++..
T Consensus 78 lv~e~~~~~~L~~~l~~~--~~~~~~~~~~~~~~~~l~~~l~~LH~~---~i~H~dl~p~nili~~~~~~~l~dfg~~~~ 152 (261)
T cd05072 78 IITEYMAKGSLLDFLKSD--EGGKVLLPKLIDFSAQIAEGMAYIERK---NYIHRDLRAANVLVSESLMCKIADFGLARV 152 (261)
T ss_pred EEEecCCCCcHHHHHHHh--cCCCCCHHHHHHHHHHHHHHHHHHHHC---CeeccccchhhEEecCCCcEEECCCcccee
Confidence 999999999999988643 345678889999999999999999998 999999999999999999999999999976
Q ss_pred cccccccccccccccccCcccCChhhhcccCcCccccchhhhHHHHHHHh-CCCCCCCCccCCCCchhHHHHHHHHHhcC
Q 038766 168 LDVHLQDLSSLSTAFQGTIGYLAPEFAYMRIVTTKVDVFSFGIVVMEFLT-KRRPTGLDEENGLSPISLRQLVEKALANG 246 (299)
Q Consensus 168 ~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~DiwslG~~l~~l~~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~ 246 (299)
.... .........++..|+|||......++.++|+||||+++|+|++ |..||... ........+ .. .
T Consensus 153 ~~~~---~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~t~g~~p~~~~-----~~~~~~~~~---~~-~ 220 (261)
T cd05072 153 IEDN---EYTAREGAKFPIKWTAPEAINFGSFTIKSDVWSFGILLYEIVTYGKIPYPGM-----SNSDVMSAL---QR-G 220 (261)
T ss_pred cCCC---ceeccCCCccceecCCHHHhccCCCChhhhhhhhHHHHHHHHccCCCCCCCC-----CHHHHHHHH---Hc-C
Confidence 5421 1111122334567999999988889999999999999999998 88888532 111111111 11 1
Q ss_pred ccCcccccCccccchhhHhHHHHHHHHHHHHHHHHhcCCCCCCCCChhhhhc
Q 038766 247 INGVRQITDPKLVSSIYEEQEQHQVLEELFKLALVCTSSNPEDRPNMNELLI 298 (299)
Q Consensus 247 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rpt~~~il~ 298 (299)
. . ... ...++.++.+++.+||..+|++|||++++++
T Consensus 221 ~-~---~~~------------~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~ 256 (261)
T cd05072 221 Y-R---MPR------------MENCPDELYDIMKTCWKEKAEERPTFDYLQS 256 (261)
T ss_pred C-C---CCC------------CCCCCHHHHHHHHHHccCCcccCcCHHHHHH
Confidence 0 0 000 1123457899999999999999999999874
|
Protein Tyrosine Kinase (PTK) family; Lyn kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lyn is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth fa |
| >cd06646 STKc_MAP4K5 Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-41 Score=281.74 Aligned_cols=254 Identities=24% Similarity=0.332 Sum_probs=197.8
Q ss_pred hCCCCCCceeecCCcceEEEEEe-CCCcEEEEEEeccCcCChhhhHHHHHHHHHHHhcCCcceeeeeeEEEcCCCeeEEE
Q 038766 11 TGSFSENNIIGNSNLSTVYKGRL-EDGEIVAVKKLNFHQFSAESDKSFYREAKTLKELKHRNLVKVLGYAWESGKLKALI 89 (299)
Q Consensus 11 ~~~y~~~~~lg~g~~~~v~~~~~-~~~~~~~vK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~lv 89 (299)
.++|.+.+.||+|++|.||++.. .+++.+|+|++.... ......+.+|+..++.++||||+++++++.. +...++|
T Consensus 8 ~~~y~~~~~lg~g~~g~vy~~~~~~~~~~~aik~~~~~~--~~~~~~~~~e~~~l~~~~h~~ii~~~~~~~~-~~~~~iv 84 (267)
T cd06646 8 QHDYELIQRVGSGTYGDVYKARNLHTGELAAVKIIKLEP--GDDFSLIQQEIFMVKECKHCNIVAYFGSYLS-REKLWIC 84 (267)
T ss_pred hhhcchhheeecCCCeEEEEEEECCCCeEEEEEEEecCc--cchHHHHHHHHHHHHhcCCCCeeeeeEEEEe-CCEEEEE
Confidence 46799999999999999999986 468899999986432 2344567889999999999999999997665 4566999
Q ss_pred EeecCCCChHHHhcCCCCCCCCCChhhHHHHHHHHHHHHHHhhcCCCCCeeeecccCCceeeCCCCcEEEeeeccccccc
Q 038766 90 LEYMENGSLESVIHGPGVDHSRWTLPKRIDVLISVANGLDYLHSGYDIPIVHCDMKPSNILLDRDFEAHVSDFGTSRMLD 169 (299)
Q Consensus 90 ~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lh~~~~~~~~H~dl~~~nil~~~~~~v~l~df~~~~~~~ 169 (299)
+||+.+++|.+++. ...++++..+..++.|++.||+|||+. +++|+|++|+||+++.++.++|+|||++....
T Consensus 85 ~e~~~~~~L~~~~~----~~~~~~~~~~~~~~~qi~~~l~~lH~~---~i~H~dl~p~nill~~~~~~~l~dfg~~~~~~ 157 (267)
T cd06646 85 MEYCGGGSLQDIYH----VTGPLSELQIAYVCRETLQGLAYLHSK---GKMHRDIKGANILLTDNGDVKLADFGVAAKIT 157 (267)
T ss_pred EeCCCCCcHHHHHH----hcCCCCHHHHHHHHHHHHHHHHHHHHC---CccccCCCHHHEEECCCCCEEECcCccceeec
Confidence 99999999999886 445789999999999999999999999 99999999999999999999999999987653
Q ss_pred cccccccccccccccCcccCChhhhc---ccCcCccccchhhhHHHHHHHhCCCCCCCCccCCCCchhHHHHHHHHHhcC
Q 038766 170 VHLQDLSSLSTAFQGTIGYLAPEFAY---MRIVTTKVDVFSFGIVVMEFLTKRRPTGLDEENGLSPISLRQLVEKALANG 246 (299)
Q Consensus 170 ~~~~~~~~~~~~~~~~~~y~~PE~~~---~~~~~~~~DiwslG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~ 246 (299)
.. ........++..|+|||.+. ...++.++|+||+|+++|+|++|..||........ ....
T Consensus 158 ~~----~~~~~~~~~~~~y~~PE~~~~~~~~~~~~~~Dvws~G~il~el~~g~~p~~~~~~~~~--------~~~~---- 221 (267)
T cd06646 158 AT----IAKRKSFIGTPYWMAPEVAAVEKNGGYNQLCDIWAVGITAIELAELQPPMFDLHPMRA--------LFLM---- 221 (267)
T ss_pred cc----ccccCccccCccccCHhHcccccCCCCcchhhHHHHHHHHHHHHhCCCCccccchhhh--------heee----
Confidence 21 11123345778999999874 34477899999999999999999999843211100 0000
Q ss_pred ccCcccccCccccchhhHhHHHHHHHHHHHHHHHHhcCCCCCCCCChhhhhcC
Q 038766 247 INGVRQITDPKLVSSIYEEQEQHQVLEELFKLALVCTSSNPEDRPNMNELLIT 299 (299)
Q Consensus 247 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rpt~~~il~~ 299 (299)
.......+.... ...++..+.++|++||..+|++|||++++++|
T Consensus 222 --~~~~~~~~~~~~-------~~~~~~~~~~li~~~l~~~P~~Rp~~~~il~~ 265 (267)
T cd06646 222 --SKSNFQPPKLKD-------KTKWSSTFHNFVKISLTKNPKKRPTAERLLTH 265 (267)
T ss_pred --ecCCCCCCCCcc-------ccccCHHHHHHHHHHhhCChhhCcCHHHHhcC
Confidence 000000010000 22345689999999999999999999999986
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 5 (MAPKKKK5 or MAP4K5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated |
| >cd07847 STKc_CDKL1_4 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 1 and 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.8e-41 Score=280.96 Aligned_cols=271 Identities=24% Similarity=0.312 Sum_probs=201.4
Q ss_pred CCCCCCceeecCCcceEEEEEeC-CCcEEEEEEeccCcCChhhhHHHHHHHHHHHhcCCcceeeeeeEEEcCCCeeEEEE
Q 038766 12 GSFSENNIIGNSNLSTVYKGRLE-DGEIVAVKKLNFHQFSAESDKSFYREAKTLKELKHRNLVKVLGYAWESGKLKALIL 90 (299)
Q Consensus 12 ~~y~~~~~lg~g~~~~v~~~~~~-~~~~~~vK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~lv~ 90 (299)
++|.+.+.||+|++|.||++.+. +++.+|+|++............+.+|+.+++.++|+|++++++++.. +...++|+
T Consensus 1 ~~y~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~-~~~~~~v~ 79 (286)
T cd07847 1 EKYEKLSKIGEGSYGVVFKCRNRETGQIVAIKKFVESEDDPVIKKIALREIRMLKQLKHPNLVNLIEVFRR-KRKLHLVF 79 (286)
T ss_pred CceeeeeeecccCCeEEEEEEECCCCcEEEEEEEeecccCccccHHHHHHHHHHHhCCCCCEeeeeeEEee-CCEEEEEE
Confidence 57999999999999999999875 58999999986543333445667899999999999999999997655 55669999
Q ss_pred eecCCCChHHHhcCCCCCCCCCChhhHHHHHHHHHHHHHHhhcCCCCCeeeecccCCceeeCCCCcEEEeeecccccccc
Q 038766 91 EYMENGSLESVIHGPGVDHSRWTLPKRIDVLISVANGLDYLHSGYDIPIVHCDMKPSNILLDRDFEAHVSDFGTSRMLDV 170 (299)
Q Consensus 91 e~~~~~~L~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lh~~~~~~~~H~dl~~~nil~~~~~~v~l~df~~~~~~~~ 170 (299)
||+++++|..++. ....+++..++.++.|++.+|.|||+. +++|+||+|+||+++.++.++|+|||++.....
T Consensus 80 e~~~~~~l~~~~~----~~~~~~~~~~~~~~~ql~~~l~~LH~~---~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~ 152 (286)
T cd07847 80 EYCDHTVLNELEK----NPRGVPEHLIKKIIWQTLQAVNFCHKH---NCIHRDVKPENILITKQGQIKLCDFGFARILTG 152 (286)
T ss_pred eccCccHHHHHHh----CCCCCCHHHHHHHHHHHHHHHHHHHHC---CceecCCChhhEEEcCCCcEEECccccceecCC
Confidence 9999887877765 334689999999999999999999999 999999999999999999999999999876542
Q ss_pred ccccccccccccccCcccCChhhhcc-cCcCccccchhhhHHHHHHHhCCCCCCCCccCCCCchhHHHHHHHHHhcCccC
Q 038766 171 HLQDLSSLSTAFQGTIGYLAPEFAYM-RIVTTKVDVFSFGIVVMEFLTKRRPTGLDEENGLSPISLRQLVEKALANGING 249 (299)
Q Consensus 171 ~~~~~~~~~~~~~~~~~y~~PE~~~~-~~~~~~~DiwslG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 249 (299)
.. .......++..|+|||.+.+ ..++.++|+||+|+++++|++|..||..... ......+..........
T Consensus 153 ~~----~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~i~~~l~~g~~p~~~~~~-----~~~~~~~~~~~~~~~~~ 223 (286)
T cd07847 153 PG----DDYTDYVATRWYRAPELLVGDTQYGPPVDVWAIGCVFAELLTGQPLWPGKSD-----VDQLYLIRKTLGDLIPR 223 (286)
T ss_pred Cc----ccccCcccccccCCHHHHhCCCCcCchhhhHHHHHHHHHHHhCCCCCCCCCh-----HHHHHHHHHHhCCCChH
Confidence 11 11223346788999998876 4578899999999999999999999954321 11111111111000000
Q ss_pred ----------cccccCccccchhhHhHHHHHHHHHHHHHHHHhcCCCCCCCCChhhhhcC
Q 038766 250 ----------VRQITDPKLVSSIYEEQEQHQVLEELFKLALVCTSSNPEDRPNMNELLIT 299 (299)
Q Consensus 250 ----------~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rpt~~~il~~ 299 (299)
......+..............++..+.+++.+||..+|++|||+.+++.|
T Consensus 224 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~eil~~ 283 (286)
T cd07847 224 HQQIFSTNQFFKGLSIPEPETREPLESKFPNISSPALSFLKGCLQMDPTERLSCEELLEH 283 (286)
T ss_pred HhhhcccccccccccCCCcccccCHHHHhccCCHHHHHHHHHHhcCCccccCCHHHHhcC
Confidence 00000010000000111233457889999999999999999999999987
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 1 (CDKL1) and CDKL4 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL1 and CDKL4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL1, also called p42 KKIALRE, is a glial protein that is upregulated in gliosis. It is present in neuroblastoma and A431 human carcinoma cells, and may be implicated in neoplastic transformation. The functio |
| >cd05067 PTKc_Lck_Blk Catalytic domain of the Protein Tyrosine Kinases, Lymphocyte-specific kinase and Blk | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-41 Score=280.95 Aligned_cols=254 Identities=28% Similarity=0.436 Sum_probs=200.0
Q ss_pred HHHHhCCCCCCceeecCCcceEEEEEeCCCcEEEEEEeccCcCChhhhHHHHHHHHHHHhcCCcceeeeeeEEEcCCCee
Q 038766 7 IENATGSFSENNIIGNSNLSTVYKGRLEDGEIVAVKKLNFHQFSAESDKSFYREAKTLKELKHRNLVKVLGYAWESGKLK 86 (299)
Q Consensus 7 ~~~~~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~vK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~ 86 (299)
|++..++|++.+.||+|++|+||+|...+++.+|+|.+.... .....+.+|+.++++++|+|++++++++. ....
T Consensus 1 ~~~~~~~~~~~~~ig~G~~g~v~~~~~~~~~~~a~K~~~~~~---~~~~~~~~E~~~l~~l~h~~i~~~~~~~~--~~~~ 75 (260)
T cd05067 1 WEVPRETLKLVKKLGAGQFGEVWMGYYNGHTKVAIKSLKQGS---MSPEAFLAEANLMKQLQHPRLVRLYAVVT--QEPI 75 (260)
T ss_pred CccchHHceeeeeeccCccceEEeeecCCCceEEEEEecCCC---CcHHHHHHHHHHHHhcCCcCeeeEEEEEc--cCCc
Confidence 356788999999999999999999998888999999986433 23457888999999999999999999653 3446
Q ss_pred EEEEeecCCCChHHHhcCCCCCCCCCChhhHHHHHHHHHHHHHHhhcCCCCCeeeecccCCceeeCCCCcEEEeeecccc
Q 038766 87 ALILEYMENGSLESVIHGPGVDHSRWTLPKRIDVLISVANGLDYLHSGYDIPIVHCDMKPSNILLDRDFEAHVSDFGTSR 166 (299)
Q Consensus 87 ~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lh~~~~~~~~H~dl~~~nil~~~~~~v~l~df~~~~ 166 (299)
++++|++.+++|.+++... ....++...++.++.|++.||+|||+. +++|+||+|+||+++.++.++|+|||++.
T Consensus 76 ~~v~e~~~~~~L~~~~~~~--~~~~~~~~~~~~i~~~i~~al~~LH~~---~i~H~dl~p~ni~i~~~~~~~l~dfg~~~ 150 (260)
T cd05067 76 YIITEYMENGSLVDFLKTP--EGIKLTINKLIDMAAQIAEGMAFIERK---NYIHRDLRAANILVSETLCCKIADFGLAR 150 (260)
T ss_pred EEEEEcCCCCCHHHHHHhc--CCCCCCHHHHHHHHHHHHHHHHHHhcC---CeecccccHHhEEEcCCCCEEEccCccee
Confidence 9999999999999988643 345788899999999999999999998 99999999999999999999999999987
Q ss_pred ccccccccccccccccccCcccCChhhhcccCcCccccchhhhHHHHHHHh-CCCCCCCCccCCCCchhHHHHHHHHHhc
Q 038766 167 MLDVHLQDLSSLSTAFQGTIGYLAPEFAYMRIVTTKVDVFSFGIVVMEFLT-KRRPTGLDEENGLSPISLRQLVEKALAN 245 (299)
Q Consensus 167 ~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~DiwslG~~l~~l~~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~ 245 (299)
..... .........++..|+|||.+....++.++||||||+++|+|++ |..||.... .......+..
T Consensus 151 ~~~~~---~~~~~~~~~~~~~y~~pe~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~-----~~~~~~~~~~---- 218 (260)
T cd05067 151 LIEDN---EYTAREGAKFPIKWTAPEAINYGTFTIKSDVWSFGILLTEIVTYGRIPYPGMT-----NPEVIQNLER---- 218 (260)
T ss_pred ecCCC---CcccccCCcccccccCHHHhccCCcCcccchHHHHHHHHHHHhCCCCCCCCCC-----hHHHHHHHHc----
Confidence 54411 1111122234568999999998889999999999999999998 999985331 1112121111
Q ss_pred CccCcccccCccccchhhHhHHHHHHHHHHHHHHHHhcCCCCCCCCChhhhhc
Q 038766 246 GINGVRQITDPKLVSSIYEEQEQHQVLEELFKLALVCTSSNPEDRPNMNELLI 298 (299)
Q Consensus 246 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rpt~~~il~ 298 (299)
.. . .. .+...+.++.+++.+||+.+|++|||++++++
T Consensus 219 ~~-~---~~------------~~~~~~~~~~~li~~~l~~~p~~Rp~~~~l~~ 255 (260)
T cd05067 219 GY-R---MP------------RPDNCPEELYELMRLCWKEKPEERPTFEYLRS 255 (260)
T ss_pred CC-C---CC------------CCCCCCHHHHHHHHHHccCChhhCCCHHHHHH
Confidence 00 0 00 01223467999999999999999999999874
|
Protein Tyrosine Kinase (PTK) family; Lck and Blk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lck (lymphocyte-specific kinase) and Blk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Sr |
| >cd06625 STKc_MEKK3_like Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.6e-41 Score=278.49 Aligned_cols=255 Identities=25% Similarity=0.344 Sum_probs=199.8
Q ss_pred CCCCCCceeecCCcceEEEEEe-CCCcEEEEEEeccCcCCh---hhhHHHHHHHHHHHhcCCcceeeeeeEEEcCCCeeE
Q 038766 12 GSFSENNIIGNSNLSTVYKGRL-EDGEIVAVKKLNFHQFSA---ESDKSFYREAKTLKELKHRNLVKVLGYAWESGKLKA 87 (299)
Q Consensus 12 ~~y~~~~~lg~g~~~~v~~~~~-~~~~~~~vK~~~~~~~~~---~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~ 87 (299)
+.|.+.+.||+|++|.||.+.. .+++.+++|.+....... .....+.+|+..+++++||||+++++++.. +...+
T Consensus 2 ~~~~~~~~lg~g~~~~vy~~~~~~~~~~~~lk~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~-~~~~~ 80 (263)
T cd06625 2 TNWRRGKLLGQGAFGRVYLCYDVDTGRELAVKQVPFDPDSPETKKEVNALECEIQLLKNLQHERIVQYYGCLRD-DETLS 80 (263)
T ss_pred CcccccceecCCCceEEEEEEEcCCCcEEEEEEEeecccchhhHHHHHHHHHHHHHHHhCCCCCeeeeEEEEcc-CCeEE
Confidence 5799999999999999999986 458999999986443222 234567889999999999999999997655 45779
Q ss_pred EEEeecCCCChHHHhcCCCCCCCCCChhhHHHHHHHHHHHHHHhhcCCCCCeeeecccCCceeeCCCCcEEEeeeccccc
Q 038766 88 LILEYMENGSLESVIHGPGVDHSRWTLPKRIDVLISVANGLDYLHSGYDIPIVHCDMKPSNILLDRDFEAHVSDFGTSRM 167 (299)
Q Consensus 88 lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lh~~~~~~~~H~dl~~~nil~~~~~~v~l~df~~~~~ 167 (299)
+|+|++++++|.+.+. ....+++..+..++.|++.||.+||+. +++|+||+|+||+++.++.++|+|||++..
T Consensus 81 ~v~e~~~~~~l~~~~~----~~~~~~~~~~~~~~~~l~~~l~~lH~~---~i~H~dl~p~nilv~~~~~~~l~dfg~~~~ 153 (263)
T cd06625 81 IFMEYMPGGSVKDQLK----AYGALTETVTRKYTRQILEGVEYLHSN---MIVHRDIKGANILRDSAGNVKLGDFGASKR 153 (263)
T ss_pred EEEEECCCCcHHHHHH----HhCCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHEEEcCCCCEEEeeccccee
Confidence 9999999999999887 345688999999999999999999999 999999999999999999999999999875
Q ss_pred cccccccccccccccccCcccCChhhhcccCcCccccchhhhHHHHHHHhCCCCCCCCccCCCCchhHHHHHHHHHhcCc
Q 038766 168 LDVHLQDLSSLSTAFQGTIGYLAPEFAYMRIVTTKVDVFSFGIVVMEFLTKRRPTGLDEENGLSPISLRQLVEKALANGI 247 (299)
Q Consensus 168 ~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~DiwslG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 247 (299)
....... ........++..|+|||...+..++.++||||||+++|+|++|..||.... . . ..........
T Consensus 154 ~~~~~~~-~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~-----~--~-~~~~~~~~~~- 223 (263)
T cd06625 154 LQTICSS-GTGMKSVTGTPYWMSPEVISGEGYGRKADVWSVGCTVVEMLTEKPPWAEFE-----A--M-AAIFKIATQP- 223 (263)
T ss_pred ccccccc-cccccCCCcCccccCcceeccCCCCchhhhHHHHHHHHHHHhCCCCccccc-----h--H-HHHHHHhccC-
Confidence 4321110 011123456788999999999889999999999999999999999984321 1 1 1111111100
Q ss_pred cCcccccCccccchhhHhHHHHHHHHHHHHHHHHhcCCCCCCCCChhhhhcC
Q 038766 248 NGVRQITDPKLVSSIYEEQEQHQVLEELFKLALVCTSSNPEDRPNMNELLIT 299 (299)
Q Consensus 248 ~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rpt~~~il~~ 299 (299)
... ..+..++..+.++|++||..+|.+|||++++++|
T Consensus 224 -~~~--------------~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~ll~~ 260 (263)
T cd06625 224 -TNP--------------QLPSHVSPDARNFLRRTFVENAKKRPSAEELLRH 260 (263)
T ss_pred -CCC--------------CCCccCCHHHHHHHHHHhhcCcccCCCHHHHhhC
Confidence 000 0122345678999999999999999999999986
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades t |
| >cd06631 STKc_YSK4 Catalytic domain of the Protein Serine/Threonine Kinase, Yeast Sps1/Ste20-related kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-41 Score=282.58 Aligned_cols=256 Identities=23% Similarity=0.385 Sum_probs=201.2
Q ss_pred CCCCCceeecCCcceEEEEEeCCCcEEEEEEeccCcCC----hhhhHHHHHHHHHHHhcCCcceeeeeeEEEcCCCeeEE
Q 038766 13 SFSENNIIGNSNLSTVYKGRLEDGEIVAVKKLNFHQFS----AESDKSFYREAKTLKELKHRNLVKVLGYAWESGKLKAL 88 (299)
Q Consensus 13 ~y~~~~~lg~g~~~~v~~~~~~~~~~~~vK~~~~~~~~----~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~l 88 (299)
+|.+.+.||+|+||.||++...+++.+|+|.+...... ......+.+|++.++.++|+||+++.+++.. +...++
T Consensus 1 ~~~~~~~ig~g~~~~v~~~~~~~~~~~avk~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~-~~~~~l 79 (265)
T cd06631 1 EWTKGEVLGKGAYGTVYCGLTNQGQLIAVKQVELDTSNVLAAEKEYEKLQEEVDLLKSLKHVNIVQYLGTCLD-DNTISI 79 (265)
T ss_pred CccccceEeccCCeEEEEEEEcCCCeEEEEEeecCccchhhHHHHHHHHHHHHHHHHhcCCCCEeeEeeEeec-CCeEEE
Confidence 58999999999999999998878999999998654322 2234568889999999999999999997765 466799
Q ss_pred EEeecCCCChHHHhcCCCCCCCCCChhhHHHHHHHHHHHHHHhhcCCCCCeeeecccCCceeeCCCCcEEEeeecccccc
Q 038766 89 ILEYMENGSLESVIHGPGVDHSRWTLPKRIDVLISVANGLDYLHSGYDIPIVHCDMKPSNILLDRDFEAHVSDFGTSRML 168 (299)
Q Consensus 89 v~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lh~~~~~~~~H~dl~~~nil~~~~~~v~l~df~~~~~~ 168 (299)
++||+++++|.+++. ...++++..++.++.|++.+|++||+. +++|+||+|+||+++.++.++|+|||++...
T Consensus 80 v~e~~~~~~L~~~l~----~~~~~~~~~~~~~~~qi~~~l~~lH~~---~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~ 152 (265)
T cd06631 80 FMEFVPGGSISSILN----RFGPLPEPVFCKYTKQILDGVAYLHNN---CVVHRDIKGNNVMLMPNGIIKLIDFGCARRL 152 (265)
T ss_pred EEecCCCCcHHHHHH----hcCCCCHHHHHHHHHHHHHHHHHHHhC---CcccCCcCHHhEEECCCCeEEeccchhhHhh
Confidence 999999999999986 335689999999999999999999998 9999999999999999999999999988754
Q ss_pred ccccc--cccccccccccCcccCChhhhcccCcCccccchhhhHHHHHHHhCCCCCCCCccCCCCchhHHHHHHHHHhcC
Q 038766 169 DVHLQ--DLSSLSTAFQGTIGYLAPEFAYMRIVTTKVDVFSFGIVVMEFLTKRRPTGLDEENGLSPISLRQLVEKALANG 246 (299)
Q Consensus 169 ~~~~~--~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~DiwslG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~ 246 (299)
..... ..........++..|+|||.+.+..++.++|+||||+++|+|++|..||.... . ............
T Consensus 153 ~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~Dv~slG~~~~~l~~g~~p~~~~~-----~--~~~~~~~~~~~~ 225 (265)
T cd06631 153 AWVGLHGTHSNMLKSMHGTPYWMAPEVINESGYGRKSDIWSIGCTVFEMATGKPPLASMD-----R--LAAMFYIGAHRG 225 (265)
T ss_pred hhccccccccccccccCCCccccChhhhcCCCCcchhhHHHHHHHHHHHHhCCCccccCC-----h--HHHHHHhhhccC
Confidence 31100 11112233457889999999998889999999999999999999999985321 1 111111100000
Q ss_pred ccCcccccCccccchhhHhHHHHHHHHHHHHHHHHhcCCCCCCCCChhhhhcC
Q 038766 247 INGVRQITDPKLVSSIYEEQEQHQVLEELFKLALVCTSSNPEDRPNMNELLIT 299 (299)
Q Consensus 247 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rpt~~~il~~ 299 (299)
.... .+..++.++.++|.+||..+|++|||+.+++.|
T Consensus 226 --~~~~--------------~~~~~~~~~~~~i~~~l~~~p~~Rp~~~~~l~~ 262 (265)
T cd06631 226 --LMPR--------------LPDSFSAAAIDFVTSCLTRDQHERPSALQLLRH 262 (265)
T ss_pred --CCCC--------------CCCCCCHHHHHHHHHHhcCCcccCCCHHHHhcC
Confidence 0000 022345678999999999999999999999986
|
Serine/threonine kinases (STKs), yeast Sps1/Ste20-related kinase 4 (YSK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YSK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. YSK4 is a putative MAPKKK, whose mammalian gene has been isolated. MAPKKKs (MKKKs or MAP3Ks) phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. |
| >cd05054 PTKc_VEGFR Catalytic domain of the Protein Tyrosine Kinases, Vascular Endothelial Growth Factor Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-42 Score=295.68 Aligned_cols=263 Identities=25% Similarity=0.367 Sum_probs=201.8
Q ss_pred HHHHhCCCCCCceeecCCcceEEEEEeC------CCcEEEEEEeccCcCChhhhHHHHHHHHHHHhc-CCcceeeeeeEE
Q 038766 7 IENATGSFSENNIIGNSNLSTVYKGRLE------DGEIVAVKKLNFHQFSAESDKSFYREAKTLKEL-KHRNLVKVLGYA 79 (299)
Q Consensus 7 ~~~~~~~y~~~~~lg~g~~~~v~~~~~~------~~~~~~vK~~~~~~~~~~~~~~~~~e~~~l~~l-~h~~i~~~~~~~ 79 (299)
|+.-.++|++.+.||+|+||.||+|... +++.||+|++.... .......+..|+..++++ .|+||+++++.+
T Consensus 2 ~~~~~~~~~i~~~lG~G~fg~Vy~a~~~~~~~~~~~~~va~K~~~~~~-~~~~~~~~~~E~~~~~~l~~h~niv~~~~~~ 80 (337)
T cd05054 2 WEFPRDRLKLGKPLGRGAFGKVIQASAFGIEKSASCRTVAVKMLKEGA-TASEYKALMTELKILIHIGHHLNVVNLLGAC 80 (337)
T ss_pred cccCHHHhhhhcccccCcCceEEeccccccccccccceeeeeeccCCC-CHHHHHHHHHHHHHHHhhccCcchhheeeeE
Confidence 3444578999999999999999999632 25789999986432 334456778899999999 799999999988
Q ss_pred EcCCCeeEEEEeecCCCChHHHhcCCCC----------------------------------------------------
Q 038766 80 WESGKLKALILEYMENGSLESVIHGPGV---------------------------------------------------- 107 (299)
Q Consensus 80 ~~~~~~~~lv~e~~~~~~L~~~~~~~~~---------------------------------------------------- 107 (299)
...+...++++||+++++|.+++.....
T Consensus 81 ~~~~~~~~~v~ey~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 160 (337)
T cd05054 81 TKPGGPLMVIVEYCKFGNLSNYLRSKRECFSPYRNKSTRKREMKQKEGKKQRLDSVSSSQSSASSGFIEDKSLSDVEEDE 160 (337)
T ss_pred ecCCCCEEEEEecCCCCCHHHHHHhccccccccccccccccccccccccccccccCCccccccccccccCcchhhcccch
Confidence 7777777999999999999988753210
Q ss_pred -----CCCCCChhhHHHHHHHHHHHHHHhhcCCCCCeeeecccCCceeeCCCCcEEEeeecccccccccccccccccccc
Q 038766 108 -----DHSRWTLPKRIDVLISVANGLDYLHSGYDIPIVHCDMKPSNILLDRDFEAHVSDFGTSRMLDVHLQDLSSLSTAF 182 (299)
Q Consensus 108 -----~~~~~~~~~~~~i~~qi~~~l~~lh~~~~~~~~H~dl~~~nil~~~~~~v~l~df~~~~~~~~~~~~~~~~~~~~ 182 (299)
...+++...+..++.||+.||+|||++ +++|+||||+||+++.++.++|+|||++..+.... ........
T Consensus 161 ~~~~~~~~~l~~~~~~~~~~qi~~aL~~lH~~---~ivHrDikp~Nill~~~~~vkL~DfG~a~~~~~~~--~~~~~~~~ 235 (337)
T cd05054 161 EGDELYKEPLTLEDLISYSFQVARGMEFLASR---KCIHRDLAARNILLSENNVVKICDFGLARDIYKDP--DYVRKGDA 235 (337)
T ss_pred hhhHHhhcCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCcceEEEeCCCcEEEeccccchhcccCc--chhhccCC
Confidence 023688899999999999999999999 99999999999999999999999999997653211 11112233
Q ss_pred ccCcccCChhhhcccCcCccccchhhhHHHHHHHh-CCCCCCCCccCCCCchhHHHHHHHHHhcCccCcccccCccccch
Q 038766 183 QGTIGYLAPEFAYMRIVTTKVDVFSFGIVVMEFLT-KRRPTGLDEENGLSPISLRQLVEKALANGINGVRQITDPKLVSS 261 (299)
Q Consensus 183 ~~~~~y~~PE~~~~~~~~~~~DiwslG~~l~~l~~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 261 (299)
.++..|+|||.+.+..++.++|||||||++|+|++ |..||...... ..+.. ....+.. ...
T Consensus 236 ~~~~~y~aPE~~~~~~~~~~~Di~SlGv~l~el~t~g~~p~~~~~~~----~~~~~----~~~~~~~----~~~------ 297 (337)
T cd05054 236 RLPLKWMAPESIFDKVYTTQSDVWSFGVLLWEIFSLGASPYPGVQID----EEFCR----RLKEGTR----MRA------ 297 (337)
T ss_pred CCCccccCcHHhcCCCCCccccHHHHHHHHHHHHHcCCCCCCCCCcc----HHHHH----HHhccCC----CCC------
Confidence 45678999999999999999999999999999998 98888543111 11111 1111100 000
Q ss_pred hhHhHHHHHHHHHHHHHHHHhcCCCCCCCCChhhhhcC
Q 038766 262 IYEEQEQHQVLEELFKLALVCTSSNPEDRPNMNELLIT 299 (299)
Q Consensus 262 ~~~~~~~~~~~~~l~~li~~~l~~dP~~Rpt~~~il~~ 299 (299)
+...+.++.+++.+||+.+|++|||++++++|
T Consensus 298 ------~~~~~~~~~~l~~~cl~~~p~~RPs~~ell~~ 329 (337)
T cd05054 298 ------PEYATPEIYSIMLDCWHNNPEDRPTFSELVEI 329 (337)
T ss_pred ------CccCCHHHHHHHHHHccCChhhCcCHHHHHHH
Confidence 12234678999999999999999999999874
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor (VEGFR) subfamily; catalytic (c) domain. The VEGFR subfamily consists of VEGFR1 (Flt1), VEGFR2 (Flk1), VEGFR3 (Flt4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to recepto |
| >cd07872 STKc_PCTAIRE2 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-2 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-41 Score=287.36 Aligned_cols=270 Identities=21% Similarity=0.317 Sum_probs=197.5
Q ss_pred hCCCCCCceeecCCcceEEEEEeC-CCcEEEEEEeccCcCChhhhHHHHHHHHHHHhcCCcceeeeeeEEEcCCCeeEEE
Q 038766 11 TGSFSENNIIGNSNLSTVYKGRLE-DGEIVAVKKLNFHQFSAESDKSFYREAKTLKELKHRNLVKVLGYAWESGKLKALI 89 (299)
Q Consensus 11 ~~~y~~~~~lg~g~~~~v~~~~~~-~~~~~~vK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~lv 89 (299)
.++|.+.+.||+|+||+||++.+. +++.+|+|++.... .......+.+|+..+++++||||+++++++.. +...++|
T Consensus 5 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~-~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~-~~~~~lv 82 (309)
T cd07872 5 METYIKLEKLGEGTYATVFKGRSKLTENLVALKEIRLEH-EEGAPCTAIREVSLLKDLKHANIVTLHDIVHT-DKSLTLV 82 (309)
T ss_pred CCceEEEEEecccCCEEEEEEEecCCCCeEEEEEeeccc-cCCcchhHHHHHHHHHhCCCCCcceEEEEEee-CCeEEEE
Confidence 367999999999999999999864 58889999986433 22334467789999999999999999997665 4556999
Q ss_pred EeecCCCChHHHhcCCCCCCCCCChhhHHHHHHHHHHHHHHhhcCCCCCeeeecccCCceeeCCCCcEEEeeeccccccc
Q 038766 90 LEYMENGSLESVIHGPGVDHSRWTLPKRIDVLISVANGLDYLHSGYDIPIVHCDMKPSNILLDRDFEAHVSDFGTSRMLD 169 (299)
Q Consensus 90 ~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lh~~~~~~~~H~dl~~~nil~~~~~~v~l~df~~~~~~~ 169 (299)
+||+.+ +|.+.+... +..+++..+..++.|++.||+|||+. +++||||||+||+++.++.++|+|||++....
T Consensus 83 ~e~~~~-~l~~~~~~~---~~~~~~~~~~~~~~qi~~aL~~lH~~---~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~ 155 (309)
T cd07872 83 FEYLDK-DLKQYMDDC---GNIMSMHNVKIFLYQILRGLAYCHRR---KVLHRDLKPQNLLINERGELKLADFGLARAKS 155 (309)
T ss_pred EeCCCC-CHHHHHHhc---CCCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHEEECCCCCEEECccccceecC
Confidence 999965 888777532 34578899999999999999999999 99999999999999999999999999986533
Q ss_pred cccccccccccccccCcccCChhhhcc-cCcCccccchhhhHHHHHHHhCCCCCCCCccCCCCchhHHHHHHHHHhcC--
Q 038766 170 VHLQDLSSLSTAFQGTIGYLAPEFAYM-RIVTTKVDVFSFGIVVMEFLTKRRPTGLDEENGLSPISLRQLVEKALANG-- 246 (299)
Q Consensus 170 ~~~~~~~~~~~~~~~~~~y~~PE~~~~-~~~~~~~DiwslG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~-- 246 (299)
.. ........+++.|+|||.+.+ ..++.++||||||+++|+|++|..||...... .....+.......
T Consensus 156 ~~----~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~el~tg~~pf~~~~~~-----~~~~~~~~~~~~~~~ 226 (309)
T cd07872 156 VP----TKTYSNEVVTLWYRPPDVLLGSSEYSTQIDMWGVGCIFFEMASGRPLFPGSTVE-----DELHLIFRLLGTPTE 226 (309)
T ss_pred CC----ccccccccccccccCCHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChH-----HHHHHHHHHhCCCCH
Confidence 11 111223456789999998765 45788999999999999999999999644221 1111110000000
Q ss_pred --ccCc------ccccCccccchhhHhHHHHHHHHHHHHHHHHhcCCCCCCCCChhhhhcC
Q 038766 247 --INGV------RQITDPKLVSSIYEEQEQHQVLEELFKLALVCTSSNPEDRPNMNELLIT 299 (299)
Q Consensus 247 --~~~~------~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rpt~~~il~~ 299 (299)
++.. .....+....... ......++.++.++|.+||..||.+|||++|+++|
T Consensus 227 ~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~li~~~L~~dp~~R~t~~e~l~h 286 (309)
T cd07872 227 ETWPGISSNDEFKNYNFPKYKPQPL-INHAPRLDTEGIELLTKFLQYESKKRISAEEAMKH 286 (309)
T ss_pred HHHhhhcchhhhhhhhcCccCCCch-hhhccCCCHHHHHHHHHhccCChhhCCCHHHHhcC
Confidence 0000 0000010000000 01123456788999999999999999999999987
|
Serine/Threonine Kinases (STKs), PCTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-2 is specifically expressed in neurons in the central nervous system, mainly in terminally differentiated neurons. It associates with Trap (Tudor repeat associator with PCTAIRE-2) and could play |
| >PHA03207 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-41 Score=296.14 Aligned_cols=271 Identities=20% Similarity=0.225 Sum_probs=200.0
Q ss_pred HHhCCCCCCceeecCCcceEEEEEeC---CCcEEEEEEeccCcCChhhhHHHHHHHHHHHhcCCcceeeeeeEEEcCCCe
Q 038766 9 NATGSFSENNIIGNSNLSTVYKGRLE---DGEIVAVKKLNFHQFSAESDKSFYREAKTLKELKHRNLVKVLGYAWESGKL 85 (299)
Q Consensus 9 ~~~~~y~~~~~lg~g~~~~v~~~~~~---~~~~~~vK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~ 85 (299)
.+..+|.+.+.||+|++|.||++... .+..+++|.+... ....+|+++++.++||||+++++.+.. ...
T Consensus 89 ~~~~~y~i~~~Lg~G~~g~Vy~~~~~~~~~~~~v~vK~~~~~-------~~~~~E~~il~~l~h~~iv~~~~~~~~-~~~ 160 (392)
T PHA03207 89 VVRMQYNILSSLTPGSEGEVFVCTKHGDEQRKKVIVKAVTGG-------KTPGREIDILKTISHRAIINLIHAYRW-KST 160 (392)
T ss_pred hccCceEEEEeecCCCCeEEEEEEEcCCccceeEEEEecccc-------ccHHHHHHHHHhcCCCCccceeeeEee-CCE
Confidence 45568999999999999999999753 3678999987522 234579999999999999999996554 556
Q ss_pred eEEEEeecCCCChHHHhcCCCCCCCCCChhhHHHHHHHHHHHHHHhhcCCCCCeeeecccCCceeeCCCCcEEEeeeccc
Q 038766 86 KALILEYMENGSLESVIHGPGVDHSRWTLPKRIDVLISVANGLDYLHSGYDIPIVHCDMKPSNILLDRDFEAHVSDFGTS 165 (299)
Q Consensus 86 ~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lh~~~~~~~~H~dl~~~nil~~~~~~v~l~df~~~ 165 (299)
.++|+|++. ++|..++. ....+++..++.++.|++.||.|||+. +++|+||||+||+++.++.++|+|||++
T Consensus 161 ~~lv~e~~~-~~l~~~l~----~~~~l~~~~~~~i~~ql~~aL~~LH~~---givHrDlkp~Nill~~~~~~~l~DfG~a 232 (392)
T PHA03207 161 VCMVMPKYK-CDLFTYVD----RSGPLPLEQAITIQRRLLEALAYLHGR---GIIHRDVKTENIFLDEPENAVLGDFGAA 232 (392)
T ss_pred EEEEehhcC-CCHHHHHH----hcCCCCHHHHHHHHHHHHHHHHHHHHC---CccccCCCHHHEEEcCCCCEEEccCccc
Confidence 799999995 58888885 456799999999999999999999999 9999999999999999999999999998
Q ss_pred cccccccccccccccccccCcccCChhhhcccCcCccccchhhhHHHHHHHhCCCCCCCCccCCCCchhHHHHHHHHHhc
Q 038766 166 RMLDVHLQDLSSLSTAFQGTIGYLAPEFAYMRIVTTKVDVFSFGIVVMEFLTKRRPTGLDEENGLSPISLRQLVEKALAN 245 (299)
Q Consensus 166 ~~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~DiwslG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~ 245 (299)
..+.... .........+++.|+|||++.+..++.++|||||||++|+|++|..||....... ....+...+.....
T Consensus 233 ~~~~~~~--~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvil~el~~g~~pf~~~~~~~-~~~~l~~i~~~~~~- 308 (392)
T PHA03207 233 CKLDAHP--DTPQCYGWSGTLETNSPELLALDPYCAKTDIWSAGLVLFEMSVKNVTLFGKQVKS-SSSQLRSIIRCMQV- 308 (392)
T ss_pred cccCccc--ccccccccccccCccCHhHhcCCCCCchhhHHHHHHHHHHHHHCCCCCCCCCCCC-cHHHHHHHHHHhcc-
Confidence 7554221 1112234568999999999999999999999999999999999999996543332 12222222221110
Q ss_pred CccCcccccCcc-----------ccc--hhhHhHHHHHHHHHHHHHHHHhcCCCCCCCCChhhhhcC
Q 038766 246 GINGVRQITDPK-----------LVS--SIYEEQEQHQVLEELFKLALVCTSSNPEDRPNMNELLIT 299 (299)
Q Consensus 246 ~~~~~~~~~~~~-----------~~~--~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rpt~~~il~~ 299 (299)
.......-.... ... ..........++.++.++|++||..||++|||+.++|.|
T Consensus 309 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~ml~~dp~~Rpsa~e~l~~ 375 (392)
T PHA03207 309 HPLEFPQNGSTNLCKHFKQYAIVLRPPYTIPPVIRKYGMHMDVEYLIAKMLTFDQEFRPSAQDILSL 375 (392)
T ss_pred CccccCCccchhHHHHHHhhcccccCCccccchhhccCcchhHHHHHHHHhccChhhCCCHHHHhhC
Confidence 000000000000 000 000000112345678999999999999999999999986
|
|
| >cd05602 STKc_SGK1 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-41 Score=290.45 Aligned_cols=239 Identities=24% Similarity=0.293 Sum_probs=184.8
Q ss_pred ceeecCCcceEEEEEeC-CCcEEEEEEeccCcCC-hhhhHHHHHHH-HHHHhcCCcceeeeeeEEEcCCCeeEEEEeecC
Q 038766 18 NIIGNSNLSTVYKGRLE-DGEIVAVKKLNFHQFS-AESDKSFYREA-KTLKELKHRNLVKVLGYAWESGKLKALILEYME 94 (299)
Q Consensus 18 ~~lg~g~~~~v~~~~~~-~~~~~~vK~~~~~~~~-~~~~~~~~~e~-~~l~~l~h~~i~~~~~~~~~~~~~~~lv~e~~~ 94 (299)
+.||+|+||+||++.+. +++.+|+|++...... ......+..|. ..++.+.|+||+++++++.. +...++|+||+.
T Consensus 1 ~~lg~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~l~~~~h~~Iv~~~~~~~~-~~~~~lv~e~~~ 79 (325)
T cd05602 1 KVIGKGSFGKVLLARHKAEEKFYAVKVLQKKAILKKKEEKHIMSERNVLLKNVKHPFLVGLHFSFQT-ADKLYFVLDYIN 79 (325)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHHHhhhHHHHHHHHHHHHHHhCCCCCCCceeEEEEc-CCeEEEEEeCCC
Confidence 47999999999999875 5788999998643221 12223334443 45677899999999996655 556699999999
Q ss_pred CCChHHHhcCCCCCCCCCChhhHHHHHHHHHHHHHHhhcCCCCCeeeecccCCceeeCCCCcEEEeeecccccccccccc
Q 038766 95 NGSLESVIHGPGVDHSRWTLPKRIDVLISVANGLDYLHSGYDIPIVHCDMKPSNILLDRDFEAHVSDFGTSRMLDVHLQD 174 (299)
Q Consensus 95 ~~~L~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lh~~~~~~~~H~dl~~~nil~~~~~~v~l~df~~~~~~~~~~~~ 174 (299)
+++|...+. ....+++..+..++.||+.||.|||++ +++||||||+||+++.++.++|+|||++.....
T Consensus 80 ~~~L~~~~~----~~~~~~~~~~~~~~~qi~~~L~~lH~~---giiHrDlkp~Nili~~~~~~kl~DfG~a~~~~~---- 148 (325)
T cd05602 80 GGELFYHLQ----RERCFLEPRARFYAAEIASALGYLHSL---NIVYRDLKPENILLDSQGHIVLTDFGLCKENIE---- 148 (325)
T ss_pred CCcHHHHHH----hcCCCCHHHHHHHHHHHHHHHHHHHHC---CeEecCCCHHHeEECCCCCEEEccCCCCccccc----
Confidence 999999886 445788999999999999999999999 999999999999999999999999999864321
Q ss_pred ccccccccccCcccCChhhhcccCcCccccchhhhHHHHHHHhCCCCCCCCccCCCCchhHHHHHHHHHhcCccCccccc
Q 038766 175 LSSLSTAFQGTIGYLAPEFAYMRIVTTKVDVFSFGIVVMEFLTKRRPTGLDEENGLSPISLRQLVEKALANGINGVRQIT 254 (299)
Q Consensus 175 ~~~~~~~~~~~~~y~~PE~~~~~~~~~~~DiwslG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 254 (299)
.........+++.|+|||++.+..++.++|||||||++|+|++|..||.... .. +.......... .
T Consensus 149 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~-----~~---~~~~~i~~~~~-~----- 214 (325)
T cd05602 149 HNGTTSTFCGTPEYLAPEVLHKQPYDRTVDWWCLGAVLYEMLYGLPPFYSRN-----TA---EMYDNILNKPL-Q----- 214 (325)
T ss_pred CCCCcccccCCccccCHHHHcCCCCCCccccccccHHHHHHhcCCCCCCCCC-----HH---HHHHHHHhCCc-C-----
Confidence 1122334568899999999999999999999999999999999999995332 11 12222111100 0
Q ss_pred CccccchhhHhHHHHHHHHHHHHHHHHhcCCCCCCCCChh
Q 038766 255 DPKLVSSIYEEQEQHQVLEELFKLALVCTSSNPEDRPNMN 294 (299)
Q Consensus 255 ~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rpt~~ 294 (299)
....++..+.++|++||..||.+||++.
T Consensus 215 ------------~~~~~~~~~~~li~~~l~~~p~~R~~~~ 242 (325)
T cd05602 215 ------------LKPNITNSARHLLEGLLQKDRTKRLGAK 242 (325)
T ss_pred ------------CCCCCCHHHHHHHHHHcccCHHHCCCCC
Confidence 0123456789999999999999999987
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK1 is ubiquitously expressed and is under transcriptional control of numerous stimuli including cell stress (cell shrinkage), serum, hormones (gluco- and mineralocorticoids), gonadotropins, growth factors, interleukin-6, and other cytokines. It plays roles in sodium retention and potassium elimination in the kidney, nutrient transport, salt |
| >cd05070 PTKc_Fyn_Yrk Catalytic domain of the Protein Tyrosine Kinases, Fyn and Yrk | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-41 Score=279.85 Aligned_cols=253 Identities=28% Similarity=0.415 Sum_probs=198.0
Q ss_pred HHHhCCCCCCceeecCCcceEEEEEeCCCcEEEEEEeccCcCChhhhHHHHHHHHHHHhcCCcceeeeeeEEEcCCCeeE
Q 038766 8 ENATGSFSENNIIGNSNLSTVYKGRLEDGEIVAVKKLNFHQFSAESDKSFYREAKTLKELKHRNLVKVLGYAWESGKLKA 87 (299)
Q Consensus 8 ~~~~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~vK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~ 87 (299)
+...++|++.+.||+|++|.||++...++..+++|.+..... ....+.+|+.++++++|++++++++++. ....+
T Consensus 2 ~~~~~~~~~~~~ig~g~~~~v~~~~~~~~~~~~~k~~~~~~~---~~~~~~~E~~~l~~l~~~~i~~~~~~~~--~~~~~ 76 (260)
T cd05070 2 EIPRESLQLIKKLGNGQFGEVWMGTWNGNTKVAVKTLKPGTM---SPESFLEEAQIMKKLRHDKLVQLYAVVS--EEPIY 76 (260)
T ss_pred CCchHHhhhhheeccccCceEEEEEecCCceeEEEEecCCCC---CHHHHHHHHHHHHhcCCCceEEEEeEEC--CCCcE
Confidence 456789999999999999999999987788899999864332 3456889999999999999999999653 33458
Q ss_pred EEEeecCCCChHHHhcCCCCCCCCCChhhHHHHHHHHHHHHHHhhcCCCCCeeeecccCCceeeCCCCcEEEeeeccccc
Q 038766 88 LILEYMENGSLESVIHGPGVDHSRWTLPKRIDVLISVANGLDYLHSGYDIPIVHCDMKPSNILLDRDFEAHVSDFGTSRM 167 (299)
Q Consensus 88 lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lh~~~~~~~~H~dl~~~nil~~~~~~v~l~df~~~~~ 167 (299)
+++||+.+++|.+++... ....+++..++.++.|++.||+|||+. +++|+||+|+||+++.++.++|+|||++..
T Consensus 77 lv~e~~~~~~L~~~~~~~--~~~~~~~~~~~~~~~~l~~al~~lH~~---~i~H~di~p~Nili~~~~~~~l~dfg~~~~ 151 (260)
T cd05070 77 IVTEYMSKGSLLDFLKDG--EGRALKLPNLVDMAAQVAAGMAYIERM---NYIHRDLRSANILVGDGLVCKIADFGLARL 151 (260)
T ss_pred EEEEecCCCcHHHHHHhc--CCCCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCccceEEEeCCceEEeCCceeeee
Confidence 999999999999998643 234688999999999999999999999 999999999999999999999999999976
Q ss_pred cccccccccccccccccCcccCChhhhcccCcCccccchhhhHHHHHHHh-CCCCCCCCccCCCCchhHHHHHHHHHhcC
Q 038766 168 LDVHLQDLSSLSTAFQGTIGYLAPEFAYMRIVTTKVDVFSFGIVVMEFLT-KRRPTGLDEENGLSPISLRQLVEKALANG 246 (299)
Q Consensus 168 ~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~DiwslG~~l~~l~~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~ 246 (299)
+.... ........++..|+|||...+..++.++|+||||+++|+|++ |..||... ... +.........
T Consensus 152 ~~~~~---~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~~g~~p~~~~-----~~~---~~~~~~~~~~ 220 (260)
T cd05070 152 IEDNE---YTARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELVTKGRVPYPGM-----NNR---EVLEQVERGY 220 (260)
T ss_pred ccCcc---cccccCCCCCccccChHHHhcCCCcchhhhHHHHHHHHHHHhcCCCCCCCC-----CHH---HHHHHHHcCC
Confidence 54211 111112234567999999988889999999999999999999 78888432 111 1222211110
Q ss_pred ccCcccccCccccchhhHhHHHHHHHHHHHHHHHHhcCCCCCCCCChhhhhc
Q 038766 247 INGVRQITDPKLVSSIYEEQEQHQVLEELFKLALVCTSSNPEDRPNMNELLI 298 (299)
Q Consensus 247 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rpt~~~il~ 298 (299)
. .. .+...+..+.+++.+||..+|++|||+.++++
T Consensus 221 ~-----~~------------~~~~~~~~~~~li~~~l~~~p~~Rpt~~~l~~ 255 (260)
T cd05070 221 R-----MP------------CPQDCPISLHELMLQCWKKDPEERPTFEYLQS 255 (260)
T ss_pred C-----CC------------CCCcCCHHHHHHHHHHcccCcccCcCHHHHHH
Confidence 0 00 02234567999999999999999999999864
|
Protein Tyrosine Kinase (PTK) family; Fyn and Yrk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fyn and Yrk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that r |
| >cd06630 STKc_MEKK1 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.8e-41 Score=277.77 Aligned_cols=258 Identities=25% Similarity=0.426 Sum_probs=201.9
Q ss_pred CCCCCceeecCCcceEEEEEe-CCCcEEEEEEeccCcCC----hhhhHHHHHHHHHHHhcCCcceeeeeeEEEcCCCeeE
Q 038766 13 SFSENNIIGNSNLSTVYKGRL-EDGEIVAVKKLNFHQFS----AESDKSFYREAKTLKELKHRNLVKVLGYAWESGKLKA 87 (299)
Q Consensus 13 ~y~~~~~lg~g~~~~v~~~~~-~~~~~~~vK~~~~~~~~----~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~ 87 (299)
+|+..+.||+|++|.||++.. .+++.+|+|++...... ......+..|+..+++++|+|++++++++.. ++..+
T Consensus 1 ~~~~~~~lg~g~~~~v~~~~~~~~~~~~alk~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~-~~~~~ 79 (268)
T cd06630 1 EWLKGQQLGTGAFSSCYQARDVKTGTLMAVKQVTYVRNTSSEQEEVVEALRKEIRLMARLNHPHIIRMLGATCE-DSHFN 79 (268)
T ss_pred CccccceecCcCceEEEEEEEcCCCcEEEEEEeecccCCchhHHHHHHHHHHHHHHHHHcCCCceehhhceecc-CCeEE
Confidence 488899999999999999986 56899999998643321 2235678899999999999999999997655 45669
Q ss_pred EEEeecCCCChHHHhcCCCCCCCCCChhhHHHHHHHHHHHHHHhhcCCCCCeeeecccCCceeeCCCC-cEEEeeecccc
Q 038766 88 LILEYMENGSLESVIHGPGVDHSRWTLPKRIDVLISVANGLDYLHSGYDIPIVHCDMKPSNILLDRDF-EAHVSDFGTSR 166 (299)
Q Consensus 88 lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lh~~~~~~~~H~dl~~~nil~~~~~-~v~l~df~~~~ 166 (299)
+|+||+.+++|.+++. ...++++..++.++.|++.||.+||++ +++|+||+|+||+++.++ .++|+|||.+.
T Consensus 80 ~v~e~~~~~~L~~~l~----~~~~~~~~~~~~~~~ql~~al~~LH~~---~i~H~~i~~~nil~~~~~~~~~l~dfg~~~ 152 (268)
T cd06630 80 LFVEWMAGGSVSHLLS----KYGAFKEAVIINYTEQLLRGLSYLHEN---QIIHRDVKGANLLIDSTGQRLRIADFGAAA 152 (268)
T ss_pred EEEeccCCCcHHHHHH----HhCCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHEEEcCCCCEEEEccccccc
Confidence 9999999999999987 345789999999999999999999999 999999999999998775 58999999987
Q ss_pred ccccccccccccccccccCcccCChhhhcccCcCccccchhhhHHHHHHHhCCCCCCCCccCCCCchhHHHHHHHHHhcC
Q 038766 167 MLDVHLQDLSSLSTAFQGTIGYLAPEFAYMRIVTTKVDVFSFGIVVMEFLTKRRPTGLDEENGLSPISLRQLVEKALANG 246 (299)
Q Consensus 167 ~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~DiwslG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~ 246 (299)
.+...............++..|+|||.+.+..++.++|+||||+++++|++|..||...... .............
T Consensus 153 ~~~~~~~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~-----~~~~~~~~~~~~~ 227 (268)
T cd06630 153 RLAAKGTGAGEFQGQLLGTIAFMAPEVLRGEQYGRSCDVWSVGCVIIEMATAKPPWNAEKHS-----NHLALIFKIASAT 227 (268)
T ss_pred ccccccccCCccccccccccceeCHhHhccCCCCcccchHHHHHHHHHHHhCCCCCCCCCCc-----chHHHHHHHhccC
Confidence 66533222222233456788999999998888999999999999999999999998533211 1111111111000
Q ss_pred ccCcccccCccccchhhHhHHHHHHHHHHHHHHHHhcCCCCCCCCChhhhhcC
Q 038766 247 INGVRQITDPKLVSSIYEEQEQHQVLEELFKLALVCTSSNPEDRPNMNELLIT 299 (299)
Q Consensus 247 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rpt~~~il~~ 299 (299)
. ....+..++.++.+++.+||..+|++|||+.+++.|
T Consensus 228 ~----------------~~~~~~~~~~~~~~~i~~~l~~~p~~R~~~~~ll~~ 264 (268)
T cd06630 228 T----------------APSIPEHLSPGLRDVTLRCLELQPEDRPPSRELLKH 264 (268)
T ss_pred C----------------CCCCchhhCHHHHHHHHHHcCCCcccCcCHHHHhcC
Confidence 0 001134456789999999999999999999999987
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 1 (MEKK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK1 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK1 activates the extracellular signal-regulated kinase 1/2 (ERK1/2) and c-Jun N-terminal kinase (JNK) pathways by activating their |
| >cd05048 PTKc_Ror Catalytic Domain of the Protein Tyrosine Kinases, Receptor tyrosine kinase-like Orphan Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-41 Score=283.19 Aligned_cols=257 Identities=23% Similarity=0.374 Sum_probs=199.2
Q ss_pred hCCCCCCceeecCCcceEEEEEeCC------CcEEEEEEeccCcCChhhhHHHHHHHHHHHhcCCcceeeeeeEEEcCCC
Q 038766 11 TGSFSENNIIGNSNLSTVYKGRLED------GEIVAVKKLNFHQFSAESDKSFYREAKTLKELKHRNLVKVLGYAWESGK 84 (299)
Q Consensus 11 ~~~y~~~~~lg~g~~~~v~~~~~~~------~~~~~vK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~ 84 (299)
.++|++.+.||+|++|.||++.... ...+++|++... ........+.+|+..++.++||||+++++++.. ..
T Consensus 4 ~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~v~~K~~~~~-~~~~~~~~~~~ei~~l~~l~h~~i~~~~~~~~~-~~ 81 (283)
T cd05048 4 LSAVRFLEELGEGAFGKVYKGELTGPNERLSATSVAIKTLKEN-AEPKVQQEFRQEAELMSDLQHPNIVCLLGVCTK-EQ 81 (283)
T ss_pred hHHcchhhcccCccCCcEEEEEEecCCCCcceeeEEEEecccC-CCHHHHHHHHHHHHHHHhcCCcccceEEEEEcC-CC
Confidence 4589999999999999999998632 257999988633 234445678899999999999999999997655 44
Q ss_pred eeEEEEeecCCCChHHHhcCCCC------------CCCCCChhhHHHHHHHHHHHHHHhhcCCCCCeeeecccCCceeeC
Q 038766 85 LKALILEYMENGSLESVIHGPGV------------DHSRWTLPKRIDVLISVANGLDYLHSGYDIPIVHCDMKPSNILLD 152 (299)
Q Consensus 85 ~~~lv~e~~~~~~L~~~~~~~~~------------~~~~~~~~~~~~i~~qi~~~l~~lh~~~~~~~~H~dl~~~nil~~ 152 (299)
..++++||+.+++|.+++..... ....+++..++.++.|++.||.|||++ +++|+||||+||+++
T Consensus 82 ~~~~~~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~al~~lH~~---~i~H~dlkp~Nil~~ 158 (283)
T cd05048 82 PTCMLFEYLAHGDLHEFLVRNSPHSDVGAESGDETVKSSLDCSDFLHIAIQIAAGMEYLSSH---HFVHRDLAARNCLVG 158 (283)
T ss_pred ceEEEEecCCCCcHHHHHHhcCCCcccccccccccccCCCCHHHHHHHHHHHHHHHHHHHhC---CeeccccccceEEEc
Confidence 56999999999999998864311 115688899999999999999999999 999999999999999
Q ss_pred CCCcEEEeeeccccccccccccccccccccccCcccCChhhhcccCcCccccchhhhHHHHHHHh-CCCCCCCCccCCCC
Q 038766 153 RDFEAHVSDFGTSRMLDVHLQDLSSLSTAFQGTIGYLAPEFAYMRIVTTKVDVFSFGIVVMEFLT-KRRPTGLDEENGLS 231 (299)
Q Consensus 153 ~~~~v~l~df~~~~~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~DiwslG~~l~~l~~-g~~p~~~~~~~~~~ 231 (299)
.++.++|+|||++...... ..........+++.|+|||.+.+..++.++|||||||++|+|++ |..||....
T Consensus 159 ~~~~~~L~dfg~~~~~~~~--~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDv~slG~il~el~~~g~~p~~~~~----- 231 (283)
T cd05048 159 EGLTVKISDFGLSRDIYSA--DYYRVQSKSLLPVRWMPPEAILYGKFTTESDIWSFGVVLWEIFSYGLQPYYGFS----- 231 (283)
T ss_pred CCCcEEECCCcceeecccc--ccccccCCCcccccccCHHHhccCcCchhhhHHHHHHHHHHHHcCCCCCCCCCC-----
Confidence 9999999999998754311 11112233445778999999988889999999999999999998 988885321
Q ss_pred chhHHHHHHHHHhcCccCcccccCccccchhhHhHHHHHHHHHHHHHHHHhcCCCCCCCCChhhhhcC
Q 038766 232 PISLRQLVEKALANGINGVRQITDPKLVSSIYEEQEQHQVLEELFKLALVCTSSNPEDRPNMNELLIT 299 (299)
Q Consensus 232 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rpt~~~il~~ 299 (299)
...+.. ...... .. ..+..++.++.+|+++||+.||.+|||+.+|+++
T Consensus 232 ~~~~~~---~i~~~~---~~--------------~~~~~~~~~~~~l~~~c~~~~p~~Rp~~~~i~~~ 279 (283)
T cd05048 232 NQEVIE---MIRSRQ---LL--------------PCPEDCPARVYALMIECWNEIPARRPRFKDIHTR 279 (283)
T ss_pred HHHHHH---HHHcCC---cC--------------CCcccCCHHHHHHHHHHccCChhhCcCHHHHHHH
Confidence 112222 111100 00 0133456789999999999999999999999863
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor (Ror) subfamily; catalytic (c) domain. The Ror subfamily consists of Ror1, Ror2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimer |
| >cd05106 PTKc_CSF-1R Catalytic domain of the Protein Tyrosine Kinase, Colony-Stimulating Factor-1 Receptor | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.6e-42 Score=297.85 Aligned_cols=261 Identities=23% Similarity=0.336 Sum_probs=198.1
Q ss_pred HHHHhCCCCCCceeecCCcceEEEEEeC------CCcEEEEEEeccCcCChhhhHHHHHHHHHHHhc-CCcceeeeeeEE
Q 038766 7 IENATGSFSENNIIGNSNLSTVYKGRLE------DGEIVAVKKLNFHQFSAESDKSFYREAKTLKEL-KHRNLVKVLGYA 79 (299)
Q Consensus 7 ~~~~~~~y~~~~~lg~g~~~~v~~~~~~------~~~~~~vK~~~~~~~~~~~~~~~~~e~~~l~~l-~h~~i~~~~~~~ 79 (299)
|....++|.+.+.||+|+||.||++.+. ++..||+|++.... .......+.+|+.+++.+ +|+||+++++.+
T Consensus 33 ~~~~~~~~~~~~~LG~G~fg~V~~~~~~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~~E~~il~~l~~h~nIv~~~~~~ 111 (374)
T cd05106 33 WEFPRDNLQFGKTLGAGAFGKVVEATAFGLGKEDNVLRVAVKMLKASA-HTDEREALMSELKILSHLGQHKNIVNLLGAC 111 (374)
T ss_pred ccccHHHceehheecCCCcccEEEEEEecCCcccccceeEEEeccCCC-CHHHHHHHHHHHHHHHhhccCCceeeEeeEe
Confidence 3445678999999999999999998742 24579999986432 334466788999999999 799999999976
Q ss_pred EcCCCeeEEEEeecCCCChHHHhcCCC-----------------------------------------------------
Q 038766 80 WESGKLKALILEYMENGSLESVIHGPG----------------------------------------------------- 106 (299)
Q Consensus 80 ~~~~~~~~lv~e~~~~~~L~~~~~~~~----------------------------------------------------- 106 (299)
... ...++|+||+.+++|.+++....
T Consensus 112 ~~~-~~~~lv~ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 190 (374)
T cd05106 112 THG-GPVLVITEYCCYGDLLNFLRKKAETFLNFVMALPEISETSSDYKNITLEKKYIRSDSGFSSQGSDTYVEMRPVSSS 190 (374)
T ss_pred cCC-CCeEEeHhhccCCcHHHHHHhhhhhhccccccccccccccccccccchhcccccccccccccccccccccCCcccc
Confidence 654 45699999999999998874311
Q ss_pred -------------CCCCCCChhhHHHHHHHHHHHHHHhhcCCCCCeeeecccCCceeeCCCCcEEEeeeccccccccccc
Q 038766 107 -------------VDHSRWTLPKRIDVLISVANGLDYLHSGYDIPIVHCDMKPSNILLDRDFEAHVSDFGTSRMLDVHLQ 173 (299)
Q Consensus 107 -------------~~~~~~~~~~~~~i~~qi~~~l~~lh~~~~~~~~H~dl~~~nil~~~~~~v~l~df~~~~~~~~~~~ 173 (299)
....++++..++.++.||+.||+|||++ +++||||||+||+++.++.++|+|||++.......
T Consensus 191 ~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~---giiHrDLkp~Nil~~~~~~~kL~DfGla~~~~~~~- 266 (374)
T cd05106 191 SSQSSDSKDEEDTEDSWPLDLDDLLRFSSQVAQGMDFLASK---NCIHRDVAARNVLLTDGRVAKICDFGLARDIMNDS- 266 (374)
T ss_pred ccccccccchhccCCCCCcCHHHHHHHHHHHHHHHHHHHHC---CEEeccCchheEEEeCCCeEEEeeceeeeeccCCc-
Confidence 0123578889999999999999999999 99999999999999999999999999987543211
Q ss_pred cccccccccccCcccCChhhhcccCcCccccchhhhHHHHHHHh-CCCCCCCCccCCCCchhHHHHHHHHHhcCccCccc
Q 038766 174 DLSSLSTAFQGTIGYLAPEFAYMRIVTTKVDVFSFGIVVMEFLT-KRRPTGLDEENGLSPISLRQLVEKALANGINGVRQ 252 (299)
Q Consensus 174 ~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~DiwslG~~l~~l~~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 252 (299)
.........++..|+|||++....++.++|||||||++|+|++ |..||...... ......+ .... .
T Consensus 267 -~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwSlGvil~ellt~G~~Pf~~~~~~----~~~~~~~----~~~~----~ 333 (374)
T cd05106 267 -NYVVKGNARLPVKWMAPESIFDCVYTVQSDVWSYGILLWEIFSLGKSPYPGILVN----SKFYKMV----KRGY----Q 333 (374)
T ss_pred -ceeeccCCCCccceeCHHHhcCCCCCccccHHHHHHHHHHHHhCCCCCCcccccc----HHHHHHH----Hccc----C
Confidence 1111223334567999999988899999999999999999997 99998533111 1111111 1110 0
Q ss_pred ccCccccchhhHhHHHHHHHHHHHHHHHHhcCCCCCCCCChhhhhc
Q 038766 253 ITDPKLVSSIYEEQEQHQVLEELFKLALVCTSSNPEDRPNMNELLI 298 (299)
Q Consensus 253 ~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rpt~~~il~ 298 (299)
... +...+.++.+++.+||..||++|||++++++
T Consensus 334 ~~~------------~~~~~~~l~~li~~cl~~dp~~RPs~~~l~~ 367 (374)
T cd05106 334 MSR------------PDFAPPEIYSIMKMCWNLEPTERPTFSQISQ 367 (374)
T ss_pred ccC------------CCCCCHHHHHHHHHHcCCChhhCcCHHHHHH
Confidence 000 1123467999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Colony-Stimulating Factor-1 Receptor (CSF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CSF-1R, also called c-Fms, is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of CSF-1R to its ligand, CSF-1, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. CSF-1R signaling is criti |
| >cd06619 PKc_MKK5 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-40 Score=279.34 Aligned_cols=252 Identities=27% Similarity=0.361 Sum_probs=196.3
Q ss_pred CCCCCCceeecCCcceEEEEEe-CCCcEEEEEEeccCcCChhhhHHHHHHHHHHHhcCCcceeeeeeEEEcCCCeeEEEE
Q 038766 12 GSFSENNIIGNSNLSTVYKGRL-EDGEIVAVKKLNFHQFSAESDKSFYREAKTLKELKHRNLVKVLGYAWESGKLKALIL 90 (299)
Q Consensus 12 ~~y~~~~~lg~g~~~~v~~~~~-~~~~~~~vK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~lv~ 90 (299)
++|.+.+.||+|++|.||++.+ .+++.+|+|++... ........+.+|+++++++.||||+++++.+.. .+..++|+
T Consensus 1 ~~~~~~~~lg~g~~~~v~~~~~~~~~~~~aiK~~~~~-~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~-~~~~~lv~ 78 (279)
T cd06619 1 QDIQYQEILGHGNGGTVYKAYHLLTRRILAVKVIPLD-ITVELQKQIMSELEILYKCDSPYIIGFYGAFFV-ENRISICT 78 (279)
T ss_pred CcchheeeeccCCCeEEEEEEEcCCCcEEEEEEEecC-CChHHHHHHHHHHHHHHhCCCCCeeeEEEEEEE-CCEEEEEE
Confidence 4788999999999999999986 46889999998643 234445678899999999999999999997766 45568999
Q ss_pred eecCCCChHHHhcCCCCCCCCCChhhHHHHHHHHHHHHHHhhcCCCCCeeeecccCCceeeCCCCcEEEeeecccccccc
Q 038766 91 EYMENGSLESVIHGPGVDHSRWTLPKRIDVLISVANGLDYLHSGYDIPIVHCDMKPSNILLDRDFEAHVSDFGTSRMLDV 170 (299)
Q Consensus 91 e~~~~~~L~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lh~~~~~~~~H~dl~~~nil~~~~~~v~l~df~~~~~~~~ 170 (299)
||+++++|.... .+++..+..++.|++.||.|||+. +++|+||+|+||+++.++.++|+|||++.....
T Consensus 79 e~~~~~~l~~~~--------~~~~~~~~~~~~qi~~~l~~lH~~---~i~H~dlkp~Nill~~~~~~~l~dfg~~~~~~~ 147 (279)
T cd06619 79 EFMDGGSLDVYR--------KIPEHVLGRIAVAVVKGLTYLWSL---KILHRDVKPSNMLVNTRGQVKLCDFGVSTQLVN 147 (279)
T ss_pred ecCCCCChHHhh--------cCCHHHHHHHHHHHHHHHHHHHHC---CEeeCCCCHHHEEECCCCCEEEeeCCcceeccc
Confidence 999998886543 468889999999999999999999 999999999999999999999999999875431
Q ss_pred ccccccccccccccCcccCChhhhcccCcCccccchhhhHHHHHHHhCCCCCCCCccCCCCchhHHHHHHHHHhcCccCc
Q 038766 171 HLQDLSSLSTAFQGTIGYLAPEFAYMRIVTTKVDVFSFGIVVMEFLTKRRPTGLDEENGLSPISLRQLVEKALANGINGV 250 (299)
Q Consensus 171 ~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~DiwslG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 250 (299)
.......++..|+|||.+.+..++.++|+||||+++|+|++|..||............ ..............
T Consensus 148 ------~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~~l~~g~~pf~~~~~~~~~~~~-~~~~~~~~~~~~~~- 219 (279)
T cd06619 148 ------SIAKTYVGTNAYMAPERISGEQYGIHSDVWSLGISFMELALGRFPYPQIQKNQGSLMP-LQLLQCIVDEDPPV- 219 (279)
T ss_pred ------ccccCCCCChhhcCceeecCCCCCCcchHHHHHHHHHHHHhCCCCchhhcccccccch-HHHHHHHhccCCCC-
Confidence 1223346788999999999989999999999999999999999998643211111100 11111111000000
Q ss_pred ccccCccccchhhHhHHHHHHHHHHHHHHHHhcCCCCCCCCChhhhhcC
Q 038766 251 RQITDPKLVSSIYEEQEQHQVLEELFKLALVCTSSNPEDRPNMNELLIT 299 (299)
Q Consensus 251 ~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rpt~~~il~~ 299 (299)
.. ....+.++.+++.+||..+|++||+++++++|
T Consensus 220 --~~-------------~~~~~~~~~~li~~~l~~~P~~Rp~~~eil~~ 253 (279)
T cd06619 220 --LP-------------VGQFSEKFVHFITQCMRKQPKERPAPENLMDH 253 (279)
T ss_pred --CC-------------CCcCCHHHHHHHHHHhhCChhhCCCHHHHhcC
Confidence 00 11234578999999999999999999999986
|
Protein kinases (PKs), MAP kinase kinase 5 (MKK5) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK5, also referred to as MEK5, is a dual-specificity PK that p |
| >cd05627 STKc_NDR2 Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-41 Score=293.47 Aligned_cols=257 Identities=21% Similarity=0.269 Sum_probs=197.9
Q ss_pred CCCCCCceeecCCcceEEEEEeC-CCcEEEEEEeccCcC-ChhhhHHHHHHHHHHHhcCCcceeeeeeEEEcCCCeeEEE
Q 038766 12 GSFSENNIIGNSNLSTVYKGRLE-DGEIVAVKKLNFHQF-SAESDKSFYREAKTLKELKHRNLVKVLGYAWESGKLKALI 89 (299)
Q Consensus 12 ~~y~~~~~lg~g~~~~v~~~~~~-~~~~~~vK~~~~~~~-~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~lv 89 (299)
++|.+.+.||+|+||.||++... +++.||+|++..... .......+..|..++..++|++|+++++.+.. +...++|
T Consensus 1 ~~f~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~iv~~~~~~~~-~~~~~lv 79 (360)
T cd05627 1 DDFESLKVIGRGAFGEVRLVQKKDTGHIYAMKILRKADMLEKEQVAHIRAERDILVEADGAWVVKMFYSFQD-KRNLYLI 79 (360)
T ss_pred CCceEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHhCCCCCEeeEEEEEEc-CCEEEEE
Confidence 47899999999999999999864 589999999864322 23345678889999999999999999996654 5567999
Q ss_pred EeecCCCChHHHhcCCCCCCCCCChhhHHHHHHHHHHHHHHhhcCCCCCeeeecccCCceeeCCCCcEEEeeeccccccc
Q 038766 90 LEYMENGSLESVIHGPGVDHSRWTLPKRIDVLISVANGLDYLHSGYDIPIVHCDMKPSNILLDRDFEAHVSDFGTSRMLD 169 (299)
Q Consensus 90 ~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lh~~~~~~~~H~dl~~~nil~~~~~~v~l~df~~~~~~~ 169 (299)
+||+++++|.+++. ....+++..+..++.|++.||.|||+. +++||||||+||+++.+|.++|+|||++..+.
T Consensus 80 ~E~~~gg~L~~~l~----~~~~l~~~~~~~~~~qi~~~L~~lH~~---givHrDLkp~NIli~~~~~vkL~DfG~~~~~~ 152 (360)
T cd05627 80 MEFLPGGDMMTLLM----KKDTLSEEATQFYIAETVLAIDAIHQL---GFIHRDIKPDNLLLDAKGHVKLSDFGLCTGLK 152 (360)
T ss_pred EeCCCCccHHHHHH----hcCCCCHHHHHHHHHHHHHHHHHHHHC---CeEccCCCHHHEEECCCCCEEEeeccCCcccc
Confidence 99999999999986 445789999999999999999999999 99999999999999999999999999986543
Q ss_pred ccccc-------------------------------ccccccccccCcccCChhhhcccCcCccccchhhhHHHHHHHhC
Q 038766 170 VHLQD-------------------------------LSSLSTAFQGTIGYLAPEFAYMRIVTTKVDVFSFGIVVMEFLTK 218 (299)
Q Consensus 170 ~~~~~-------------------------------~~~~~~~~~~~~~y~~PE~~~~~~~~~~~DiwslG~~l~~l~~g 218 (299)
..... .........||+.|+|||++.+..++.++|+|||||++|+|++|
T Consensus 153 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~APE~~~~~~~~~~~DiwSlGvilyel~tG 232 (360)
T cd05627 153 KAHRTEFYRNLTHNPPSDFSFQNMNSKRKAETWKKNRRQLAYSTVGTPDYIAPEVFMQTGYNKLCDWWSLGVIMYEMLIG 232 (360)
T ss_pred cccccccccccccCCcccccccccccccccccccccccccccccCCCccccCHHHHcCCCCCCcceeccccceeeecccC
Confidence 11000 00011234688999999999999999999999999999999999
Q ss_pred CCCCCCCccCCCCchhHHHHHHHHHhcCccCcccccCccccchhhHhHHHHHHHHHHHHHHHHhcCCCCCCCCC---hhh
Q 038766 219 RRPTGLDEENGLSPISLRQLVEKALANGINGVRQITDPKLVSSIYEEQEQHQVLEELFKLALVCTSSNPEDRPN---MNE 295 (299)
Q Consensus 219 ~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rpt---~~~ 295 (299)
..||.... ... ....... . .....+.. ...++.++.++|.+|+. ||.+|++ +++
T Consensus 233 ~~Pf~~~~-----~~~---~~~~i~~-~-~~~~~~p~------------~~~~s~~~~~li~~l~~-~p~~R~~~~~~~e 289 (360)
T cd05627 233 YPPFCSET-----PQE---TYRKVMN-W-KETLVFPP------------EVPISEKAKDLILRFCT-DSENRIGSNGVEE 289 (360)
T ss_pred CCCCCCCC-----HHH---HHHHHHc-C-CCceecCC------------CCCCCHHHHHHHHHhcc-ChhhcCCCCCHHH
Confidence 99995431 111 1111111 0 00000000 11245678899999874 9999995 788
Q ss_pred hhcC
Q 038766 296 LLIT 299 (299)
Q Consensus 296 il~~ 299 (299)
+++|
T Consensus 290 i~~h 293 (360)
T cd05627 290 IKSH 293 (360)
T ss_pred HhcC
Confidence 8876
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. In addition, NDR2 plays a role in regul |
| >cd05052 PTKc_Abl Catalytic domain of the Protein Tyrosine Kinase, Abelson kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-41 Score=280.84 Aligned_cols=254 Identities=24% Similarity=0.371 Sum_probs=197.6
Q ss_pred HHHhCCCCCCceeecCCcceEEEEEeC-CCcEEEEEEeccCcCChhhhHHHHHHHHHHHhcCCcceeeeeeEEEcCCCee
Q 038766 8 ENATGSFSENNIIGNSNLSTVYKGRLE-DGEIVAVKKLNFHQFSAESDKSFYREAKTLKELKHRNLVKVLGYAWESGKLK 86 (299)
Q Consensus 8 ~~~~~~y~~~~~lg~g~~~~v~~~~~~-~~~~~~vK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~ 86 (299)
+....+|.+.+.||+|++|.||++.+. .++.+++|++... ......+.+|++.++.++|+||+++++++.. +...
T Consensus 2 ~~~~~~~~~~~~ig~g~~~~v~~~~~~~~~~~~~~K~~~~~---~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~-~~~~ 77 (263)
T cd05052 2 EMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKED---TMEVEEFLKEAAVMKEIKHPNLVQLLGVCTR-EPPF 77 (263)
T ss_pred CCchHHeEEeeecCCcccceEEEEEEecCCceEEEEEecCC---chHHHHHHHHHHHHHhCCCCChhheEEEEcC-CCCc
Confidence 344567899999999999999999864 5889999987532 3345678899999999999999999997665 4455
Q ss_pred EEEEeecCCCChHHHhcCCCCCCCCCChhhHHHHHHHHHHHHHHhhcCCCCCeeeecccCCceeeCCCCcEEEeeecccc
Q 038766 87 ALILEYMENGSLESVIHGPGVDHSRWTLPKRIDVLISVANGLDYLHSGYDIPIVHCDMKPSNILLDRDFEAHVSDFGTSR 166 (299)
Q Consensus 87 ~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lh~~~~~~~~H~dl~~~nil~~~~~~v~l~df~~~~ 166 (299)
++++||+.+++|.+++... ....++...++.++.|++++|++||++ +++|+||+|+||+++.++.++|+|||++.
T Consensus 78 ~lv~e~~~~~~L~~~~~~~--~~~~l~~~~~~~~~~ql~~~l~~lH~~---~i~H~dlkp~nil~~~~~~~kl~df~~~~ 152 (263)
T cd05052 78 YIITEFMTYGNLLDYLREC--NRQEVNAVVLLYMATQISSAMEYLEKK---NFIHRDLAARNCLVGENHLVKVADFGLSR 152 (263)
T ss_pred EEEEEeCCCCcHHHHHHhC--CCCCCCHHHHHHHHHHHHHHHHHHHhC---CEeecccCcceEEEcCCCcEEeCCCcccc
Confidence 9999999999999988643 234688899999999999999999998 99999999999999999999999999987
Q ss_pred ccccccccccccccccccCcccCChhhhcccCcCccccchhhhHHHHHHHh-CCCCCCCCccCCCCchhHHHHHHHHHhc
Q 038766 167 MLDVHLQDLSSLSTAFQGTIGYLAPEFAYMRIVTTKVDVFSFGIVVMEFLT-KRRPTGLDEENGLSPISLRQLVEKALAN 245 (299)
Q Consensus 167 ~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~DiwslG~~l~~l~~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~ 245 (299)
..... ..........+..|+|||.+.+..++.++||||||+++|+|++ |..||.... .......+. .
T Consensus 153 ~~~~~---~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~t~g~~p~~~~~-----~~~~~~~~~----~ 220 (263)
T cd05052 153 LMTGD---TYTAHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGID-----LSQVYELLE----K 220 (263)
T ss_pred ccccc---eeeccCCCCCccccCCHHHhccCCCCchhHHHHHHHHHHHHHcCCCCCCCCCC-----HHHHHHHHH----C
Confidence 65421 1111112233567999999998999999999999999999998 888874321 111111111 1
Q ss_pred CccCcccccCccccchhhHhHHHHHHHHHHHHHHHHhcCCCCCCCCChhhhhc
Q 038766 246 GINGVRQITDPKLVSSIYEEQEQHQVLEELFKLALVCTSSNPEDRPNMNELLI 298 (299)
Q Consensus 246 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rpt~~~il~ 298 (299)
.. .... +...+.++.++|.+||..+|++|||+.++++
T Consensus 221 ~~----~~~~------------~~~~~~~~~~li~~cl~~~p~~Rp~~~~l~~ 257 (263)
T cd05052 221 GY----RMER------------PEGCPPKVYELMRACWQWNPSDRPSFAEIHQ 257 (263)
T ss_pred CC----CCCC------------CCCCCHHHHHHHHHHccCCcccCCCHHHHHH
Confidence 10 0000 1234567999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Abelson (Abl) kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Abl (or c-Abl) is a ubiquitously-expressed cytoplasmic (or nonreceptor) tyr kinase that contains SH3, SH2, and tyr kinase domains in its N-terminal region, as well as nuclear localization motifs, a putative DNA-binding domain, and F- and G-actin binding domains in its C-terminal tail. It also contains a short autoinhibitory cap region in its N-terminus. Abl is normally inactive and requires phosphorylation and myristoylation for activation. Abl function depends on its subcellular localization. In the cytoplasm, Abl plays |
| >cd05064 PTKc_EphR_A10 Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A10 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-41 Score=281.02 Aligned_cols=253 Identities=23% Similarity=0.353 Sum_probs=195.6
Q ss_pred HhCCCCCCceeecCCcceEEEEEeC----CCcEEEEEEeccCcCChhhhHHHHHHHHHHHhcCCcceeeeeeEEEcCCCe
Q 038766 10 ATGSFSENNIIGNSNLSTVYKGRLE----DGEIVAVKKLNFHQFSAESDKSFYREAKTLKELKHRNLVKVLGYAWESGKL 85 (299)
Q Consensus 10 ~~~~y~~~~~lg~g~~~~v~~~~~~----~~~~~~vK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~ 85 (299)
..++|++.+.||+|+||.||++.+. .+..+|+|++... ........+.+|+..++.++||||+++++++.. +..
T Consensus 3 ~~~~~~~~~~ig~G~fg~V~~~~~~~~~~~~~~vaik~~~~~-~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~-~~~ 80 (266)
T cd05064 3 DNKSIKIERILGTGRFGELCRGCLKLPSKRELPVAIHTLRAG-CSDKQRRGFLAEALTLGQFDHSNIVRLEGVITR-GNT 80 (266)
T ss_pred chHHeEEeeeecccCCCeEEEEEEecCCCceeeEEEEecCCC-CCHHHHHHHHHHHHHHhcCCCCCcCeEEEEEec-CCC
Confidence 3467999999999999999999753 3668999998643 233445678899999999999999999997665 556
Q ss_pred eEEEEeecCCCChHHHhcCCCCCCCCCChhhHHHHHHHHHHHHHHhhcCCCCCeeeecccCCceeeCCCCcEEEeeeccc
Q 038766 86 KALILEYMENGSLESVIHGPGVDHSRWTLPKRIDVLISVANGLDYLHSGYDIPIVHCDMKPSNILLDRDFEAHVSDFGTS 165 (299)
Q Consensus 86 ~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lh~~~~~~~~H~dl~~~nil~~~~~~v~l~df~~~ 165 (299)
.++|+||+.+++|.+++... ...+++..++.++.|++.||+|||+. +++|+||||+||+++.++.++++|||.+
T Consensus 81 ~~lv~e~~~~~~L~~~l~~~---~~~l~~~~~~~~~~~i~~al~~lH~~---~iiH~dikp~nili~~~~~~~l~dfg~~ 154 (266)
T cd05064 81 MMIVTEYMSNGALDSFLRKH---EGQLVAGQLMGMLPGLASGMKYLSEM---GYVHKGLAAHKVLVNSDLVCKISGFRRL 154 (266)
T ss_pred cEEEEEeCCCCcHHHHHHhC---CCCCCHHHHHHHHHHHHHHHHHHHHC---CEeeccccHhhEEEcCCCcEEECCCccc
Confidence 79999999999999988632 34789999999999999999999999 9999999999999999999999999977
Q ss_pred cccccccccccccccccccCcccCChhhhcccCcCccccchhhhHHHHHHHh-CCCCCCCCccCCCCchhHHHHHHHHHh
Q 038766 166 RMLDVHLQDLSSLSTAFQGTIGYLAPEFAYMRIVTTKVDVFSFGIVVMEFLT-KRRPTGLDEENGLSPISLRQLVEKALA 244 (299)
Q Consensus 166 ~~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~DiwslG~~l~~l~~-g~~p~~~~~~~~~~~~~~~~~~~~~~~ 244 (299)
....... ........++..|+|||.+.+..++.++||||+||++|++++ |..||... ....+...+ ..
T Consensus 155 ~~~~~~~---~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~ell~~g~~p~~~~-----~~~~~~~~~---~~ 223 (266)
T cd05064 155 QEDKSEA---IYTTMSGKSPVLWAAPEAIQYHHFSSASDVWSFGIVMWEVMSYGERPYWDM-----SGQDVIKAV---ED 223 (266)
T ss_pred ccccccc---hhcccCCCCceeecCHHHHhhCCccchhHHHHHHHHHHHHhcCCCCCcCcC-----CHHHHHHHH---HC
Confidence 5432110 011112234567999999999999999999999999999775 99998433 111111111 11
Q ss_pred cCccCcccccCccccchhhHhHHHHHHHHHHHHHHHHhcCCCCCCCCChhhhhc
Q 038766 245 NGINGVRQITDPKLVSSIYEEQEQHQVLEELFKLALVCTSSNPEDRPNMNELLI 298 (299)
Q Consensus 245 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rpt~~~il~ 298 (299)
+ ...+. +..++..+.+++.+||..+|++|||++++++
T Consensus 224 -~----~~~~~------------~~~~~~~~~~li~~c~~~~p~~RP~~~~i~~ 260 (266)
T cd05064 224 -G----FRLPA------------PRNCPNLLHQLMLDCWQKERGERPRFSQIHS 260 (266)
T ss_pred -C----CCCCC------------CCCCCHHHHHHHHHHcCCCchhCCCHHHHHH
Confidence 1 00000 2234567899999999999999999999874
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA10 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchor |
| >cd05630 STKc_GRK6 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.3e-41 Score=281.02 Aligned_cols=254 Identities=22% Similarity=0.301 Sum_probs=197.7
Q ss_pred CCCCCceeecCCcceEEEEEeC-CCcEEEEEEeccCcCCh-hhhHHHHHHHHHHHhcCCcceeeeeeEEEcCCCeeEEEE
Q 038766 13 SFSENNIIGNSNLSTVYKGRLE-DGEIVAVKKLNFHQFSA-ESDKSFYREAKTLKELKHRNLVKVLGYAWESGKLKALIL 90 (299)
Q Consensus 13 ~y~~~~~lg~g~~~~v~~~~~~-~~~~~~vK~~~~~~~~~-~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~lv~ 90 (299)
.|++.+.||+|+||+||++.+. +++.+|+|.+....... .....+.+|+.+++.++|++++++.+.+.. +...++|+
T Consensus 1 ~f~~~~~ig~G~~g~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~i~~~~~~~~~-~~~~~lv~ 79 (285)
T cd05630 1 TFRQYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGESMALNEKQILEKVNSRFVVSLAYAYET-KDALCLVL 79 (285)
T ss_pred CceeeEEeecCCCeEEEEEEEcCCCceEEEEEEehhhccchHHHHHHHHHHHHHHhCCCCCeeeeeEEEec-CCEEEEEE
Confidence 3778899999999999999864 68999999986443322 224567789999999999999999996655 45679999
Q ss_pred eecCCCChHHHhcCCCCCCCCCChhhHHHHHHHHHHHHHHhhcCCCCCeeeecccCCceeeCCCCcEEEeeecccccccc
Q 038766 91 EYMENGSLESVIHGPGVDHSRWTLPKRIDVLISVANGLDYLHSGYDIPIVHCDMKPSNILLDRDFEAHVSDFGTSRMLDV 170 (299)
Q Consensus 91 e~~~~~~L~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lh~~~~~~~~H~dl~~~nil~~~~~~v~l~df~~~~~~~~ 170 (299)
||+.+++|.+.+... ....+++.++..++.|++.||.|||+. +++|+||||+||+++.++.++|+|||++.....
T Consensus 80 e~~~g~~L~~~l~~~--~~~~l~~~~~~~~~~qi~~~l~~lH~~---~iiH~dikp~Nil~~~~~~~~l~Dfg~~~~~~~ 154 (285)
T cd05630 80 TLMNGGDLKFHIYHM--GEAGFEEGRAVFYAAEICCGLEDLHQE---RIVYRDLKPENILLDDHGHIRISDLGLAVHVPE 154 (285)
T ss_pred EecCCCcHHHHHHHh--cccCCCHHHHHHHHHHHHHHHHHHHhC---CEEeCCCCHHHEEECCCCCEEEeeccceeecCC
Confidence 999999999887532 234689999999999999999999998 999999999999999999999999998864331
Q ss_pred ccccccccccccccCcccCChhhhcccCcCccccchhhhHHHHHHHhCCCCCCCCccCCCCchhHHHHHHHHHhcCccCc
Q 038766 171 HLQDLSSLSTAFQGTIGYLAPEFAYMRIVTTKVDVFSFGIVVMEFLTKRRPTGLDEENGLSPISLRQLVEKALANGINGV 250 (299)
Q Consensus 171 ~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~DiwslG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 250 (299)
. .......++..|+|||.+.+..++.++||||+|+++|+|++|..||....... .............
T Consensus 155 ~-----~~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~~l~~l~~g~~Pf~~~~~~~-----~~~~~~~~~~~~~--- 221 (285)
T cd05630 155 G-----QTIKGRVGTVGYMAPEVVKNERYTFSPDWWALGCLLYEMIAGQSPFQQRKKKI-----KREEVERLVKEVQ--- 221 (285)
T ss_pred C-----ccccCCCCCccccChHHHcCCCCCCccccHHHHHHHHHHHhCCCCCCCCCccc-----hHHHHHhhhhhhh---
Confidence 1 11223457889999999998889999999999999999999999996432110 0111111100000
Q ss_pred ccccCccccchhhHhHHHHHHHHHHHHHHHHhcCCCCCCCCC-----hhhhhcC
Q 038766 251 RQITDPKLVSSIYEEQEQHQVLEELFKLALVCTSSNPEDRPN-----MNELLIT 299 (299)
Q Consensus 251 ~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rpt-----~~~il~~ 299 (299)
......++.++.+|+.+||+.||++||| ++++++|
T Consensus 222 --------------~~~~~~~~~~~~~li~~~l~~~p~~R~s~~~~~~~~~~~h 261 (285)
T cd05630 222 --------------EEYSEKFSPDARSLCKMLLCKDPKERLGCQGGGAREVKEH 261 (285)
T ss_pred --------------hhcCccCCHHHHHHHHHHhhcCHHHccCCCCCchHHHHcC
Confidence 0002234567899999999999999999 8899886
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK6 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK6 is widely expressed in many tissues. t is expressed as |
| >cd06613 STKc_MAP4K3_like Catalytic domain of Mitogen-activated protein kinase kinase kinase kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-41 Score=279.94 Aligned_cols=255 Identities=25% Similarity=0.378 Sum_probs=201.5
Q ss_pred hCCCCCCceeecCCcceEEEEEeC-CCcEEEEEEeccCcCChhhhHHHHHHHHHHHhcCCcceeeeeeEEEcCCCeeEEE
Q 038766 11 TGSFSENNIIGNSNLSTVYKGRLE-DGEIVAVKKLNFHQFSAESDKSFYREAKTLKELKHRNLVKVLGYAWESGKLKALI 89 (299)
Q Consensus 11 ~~~y~~~~~lg~g~~~~v~~~~~~-~~~~~~vK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~lv 89 (299)
.++|.+.+.||.|++|.||++.+. +++.+++|++.... ......+.+|+++++.++|||++++++.+.. +..++++
T Consensus 2 ~~~~~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~--~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~-~~~~~l~ 78 (262)
T cd06613 2 QEDYELIQRIGSGTYGDVYKARDIATGELVAIKVIKLEP--GDDFEIIQQEISMLKECRHPNIVAYFGSYLR-RDKLWIV 78 (262)
T ss_pred ccceEEEEEecCCCceEEEEeEecCCCCEEEEEEEEcCc--hhhHHHHHHHHHHHHhCCCCChhceEEEEEe-CCEEEEE
Confidence 368999999999999999999864 57889999987432 2356788899999999999999999996655 5567999
Q ss_pred EeecCCCChHHHhcCCCCCCCCCChhhHHHHHHHHHHHHHHhhcCCCCCeeeecccCCceeeCCCCcEEEeeeccccccc
Q 038766 90 LEYMENGSLESVIHGPGVDHSRWTLPKRIDVLISVANGLDYLHSGYDIPIVHCDMKPSNILLDRDFEAHVSDFGTSRMLD 169 (299)
Q Consensus 90 ~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lh~~~~~~~~H~dl~~~nil~~~~~~v~l~df~~~~~~~ 169 (299)
+||+.+++|.+++... ...+++..++.++.|++.||+|||+. +++|+||+|+||+++.++.++|+|||.+....
T Consensus 79 ~e~~~~~~l~~~~~~~---~~~l~~~~~~~~~~ql~~~l~~lh~~---~i~h~dl~p~ni~i~~~~~~~l~d~g~~~~~~ 152 (262)
T cd06613 79 MEYCGGGSLQDIYQVT---RGPLSELQIAYVCRETLKGLAYLHET---GKIHRDIKGANILLTEDGDVKLADFGVSAQLT 152 (262)
T ss_pred EeCCCCCcHHHHHHhh---ccCCCHHHHHHHHHHHHHHHHHHHhC---CceecCCChhhEEECCCCCEEECccccchhhh
Confidence 9999999999988632 25789999999999999999999999 99999999999999999999999999987544
Q ss_pred cccccccccccccccCcccCChhhhccc---CcCccccchhhhHHHHHHHhCCCCCCCCccCCCCchhHHHHHHHHHhcC
Q 038766 170 VHLQDLSSLSTAFQGTIGYLAPEFAYMR---IVTTKVDVFSFGIVVMEFLTKRRPTGLDEENGLSPISLRQLVEKALANG 246 (299)
Q Consensus 170 ~~~~~~~~~~~~~~~~~~y~~PE~~~~~---~~~~~~DiwslG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~ 246 (299)
.. ........++..|+|||.+... .++.++|+||||+++|+|++|..||..... ... ........
T Consensus 153 ~~----~~~~~~~~~~~~y~~Pe~~~~~~~~~~~~~~Di~slG~~l~~~~tg~~p~~~~~~-----~~~---~~~~~~~~ 220 (262)
T cd06613 153 AT----IAKRKSFIGTPYWMAPEVAAVERKGGYDGKCDIWALGITAIELAELQPPMFDLHP-----MRA---LFLISKSN 220 (262)
T ss_pred hh----hhccccccCCccccCchhhcccccCCcCchhhhHHHHHHHHHHHhCCCCCCCCCH-----HHH---HHHHHhcc
Confidence 21 1122334567789999998776 788999999999999999999999853311 111 11111110
Q ss_pred ccCcccccCccccchhhHhHHHHHHHHHHHHHHHHhcCCCCCCCCChhhhhcC
Q 038766 247 INGVRQITDPKLVSSIYEEQEQHQVLEELFKLALVCTSSNPEDRPNMNELLIT 299 (299)
Q Consensus 247 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rpt~~~il~~ 299 (299)
...+.. .....++.++.+++++||..+|.+|||+++++.|
T Consensus 221 ------~~~~~~-------~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~il~~ 260 (262)
T cd06613 221 ------FPPPKL-------KDKEKWSPVFHDFIKKCLTKDPKKRPTATKLLQH 260 (262)
T ss_pred ------CCCccc-------cchhhhhHHHHHHHHHHcCCChhhCCCHHHHhcC
Confidence 000000 0133456789999999999999999999999986
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily includes MAP4K3, MAP4K1, MAP4K2, MAP4K5, and related proteins. Vertebrate members contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activ |
| >cd05104 PTKc_Kit Catalytic domain of the Protein Tyrosine Kinase, Kit | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.7e-42 Score=296.87 Aligned_cols=259 Identities=22% Similarity=0.324 Sum_probs=196.0
Q ss_pred HHhCCCCCCceeecCCcceEEEEEe------CCCcEEEEEEeccCcCChhhhHHHHHHHHHHHhc-CCcceeeeeeEEEc
Q 038766 9 NATGSFSENNIIGNSNLSTVYKGRL------EDGEIVAVKKLNFHQFSAESDKSFYREAKTLKEL-KHRNLVKVLGYAWE 81 (299)
Q Consensus 9 ~~~~~y~~~~~lg~g~~~~v~~~~~------~~~~~~~vK~~~~~~~~~~~~~~~~~e~~~l~~l-~h~~i~~~~~~~~~ 81 (299)
.-.++|++.+.||+|+||.||++++ .++..||+|++.... .....+.+.+|+.+++.+ +||||+++++++..
T Consensus 32 ~~~~~~~~~~~LG~G~fG~V~~~~~~~~~~~~~~~~vavK~l~~~~-~~~~~~~~~~Ei~il~~l~~HpnIv~l~~~~~~ 110 (375)
T cd05104 32 FPRNRLSFGKTLGAGAFGKVVEATAYGLFKSDAAMTVAVKMLKPSA-HLTEREALMSELKVLSYLGNHINIVNLLGACTV 110 (375)
T ss_pred cchHHeehhheecCCccceEEEEEEeccccCccceeEEEEeccCCc-CcHHHHHHHHHHHHHHHhcCCcceeeeeeeecc
Confidence 3355899999999999999999964 236689999986432 233456788999999999 79999999997765
Q ss_pred CCCeeEEEEeecCCCChHHHhcCCCC------------------------------------------------------
Q 038766 82 SGKLKALILEYMENGSLESVIHGPGV------------------------------------------------------ 107 (299)
Q Consensus 82 ~~~~~~lv~e~~~~~~L~~~~~~~~~------------------------------------------------------ 107 (299)
+...++||||+++|+|.+++.....
T Consensus 111 -~~~~~lv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~ 189 (375)
T cd05104 111 -GGPTLVITEYCCYGDLLNFLRRKRDSFICPKHEDHAEAALYKNLLHQREMSCDSLNEYMDMKPGVSYVVPTKADKRRSV 189 (375)
T ss_pred -CCcceeeehhccCCcHHHHHHhcccccccccccchhhhHHHHhhhhhhcccchhhhhhhhcCCCccccccccccccccc
Confidence 4456999999999999988753210
Q ss_pred -----------------CCCCCChhhHHHHHHHHHHHHHHhhcCCCCCeeeecccCCceeeCCCCcEEEeeecccccccc
Q 038766 108 -----------------DHSRWTLPKRIDVLISVANGLDYLHSGYDIPIVHCDMKPSNILLDRDFEAHVSDFGTSRMLDV 170 (299)
Q Consensus 108 -----------------~~~~~~~~~~~~i~~qi~~~l~~lh~~~~~~~~H~dl~~~nil~~~~~~v~l~df~~~~~~~~ 170 (299)
....+++..++.++.||+.||+|||+. +++|+||||+||+++.++.++|+|||++.....
T Consensus 190 ~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~---~ivH~Dlkp~Nill~~~~~~kl~DfG~a~~~~~ 266 (375)
T cd05104 190 RSGSYIDQDVTSEILEEDELALDTEDLLSFSYQVAKGMSFLASK---NCIHRDLAARNILLTHGRITKICDFGLARDIRN 266 (375)
T ss_pred ccceecccccHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHC---CeeccCCchhhEEEECCCcEEEecCccceeccC
Confidence 112578889999999999999999999 999999999999999999999999999875432
Q ss_pred ccccccccccccccCcccCChhhhcccCcCccccchhhhHHHHHHHh-CCCCCCCCccCCCCchhHHHHHHHHHhcCccC
Q 038766 171 HLQDLSSLSTAFQGTIGYLAPEFAYMRIVTTKVDVFSFGIVVMEFLT-KRRPTGLDEENGLSPISLRQLVEKALANGING 249 (299)
Q Consensus 171 ~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~DiwslG~~l~~l~~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 249 (299)
... ........++..|+|||.+.+..++.++||||||+++|+|++ |..||...... ...... ...+...
T Consensus 267 ~~~--~~~~~~~~~~~~y~aPE~~~~~~~~~~sDi~slG~~l~ellt~g~~p~~~~~~~----~~~~~~----~~~~~~~ 336 (375)
T cd05104 267 DSN--YVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGILLWEIFSLGSSPYPGMPVD----SKFYKM----IKEGYRM 336 (375)
T ss_pred ccc--ccccCCCCCCcceeChhHhcCCCCCCCCCHHHHHHHHHHHHhcCCCCCCCCCch----HHHHHH----HHhCccC
Confidence 111 111122334567999999999999999999999999999998 78887432111 111111 1111000
Q ss_pred cccccCccccchhhHhHHHHHHHHHHHHHHHHhcCCCCCCCCChhhhhc
Q 038766 250 VRQITDPKLVSSIYEEQEQHQVLEELFKLALVCTSSNPEDRPNMNELLI 298 (299)
Q Consensus 250 ~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rpt~~~il~ 298 (299)
.. +...+.++.+++.+||+.||++|||+.++++
T Consensus 337 ----~~------------~~~~~~~l~~li~~cl~~dP~~RPs~~eil~ 369 (375)
T cd05104 337 ----LS------------PECAPSEMYDIMKSCWDADPLKRPTFKQIVQ 369 (375)
T ss_pred ----CC------------CCCCCHHHHHHHHHHccCChhHCcCHHHHHH
Confidence 00 1122457999999999999999999999985
|
Protein Tyrosine Kinase (PTK) family; Kit (or c-Kit); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Kit is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of Kit to its ligand, the stem-cell factor (SCF), leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. Kit is important in the development of melanocytes, germ cells, mast cells, hematopoietic stem ce |
| >cd06622 PKc_MAPKK_PBS2_like Catalytic domain of fungal PBS2-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.7e-41 Score=280.47 Aligned_cols=254 Identities=22% Similarity=0.319 Sum_probs=199.7
Q ss_pred CCCCCCceeecCCcceEEEEEeC-CCcEEEEEEeccCcCChhhhHHHHHHHHHHHhcCCcceeeeeeEEEcCCCeeEEEE
Q 038766 12 GSFSENNIIGNSNLSTVYKGRLE-DGEIVAVKKLNFHQFSAESDKSFYREAKTLKELKHRNLVKVLGYAWESGKLKALIL 90 (299)
Q Consensus 12 ~~y~~~~~lg~g~~~~v~~~~~~-~~~~~~vK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~lv~ 90 (299)
++|.+.+.||+|++|.||++.+. ++..+|+|.+... ........+.+|+..+++++|+||+++++.+.. .+..++|+
T Consensus 1 ~~~~~~~~ig~g~~g~v~~~~~~~~~~~~a~k~~~~~-~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~-~~~~~lv~ 78 (286)
T cd06622 1 DEIEVLDELGKGNYGSVYKVLHRPTGVTMAMKEIRLE-LDESKFNQIIMELDILHKAVSPYIVDFYGAFFI-EGAVYMCM 78 (286)
T ss_pred ChhhhhhhhcccCCeEEEEEEEcCCCcEEEEEEeecc-cCHHHHHHHHHHHHHHHhcCCCcHHhhhhheec-CCeEEEEE
Confidence 57899999999999999999875 6899999988643 234445778899999999999999999996665 55669999
Q ss_pred eecCCCChHHHhcCCCCCCCCCChhhHHHHHHHHHHHHHHhhc-CCCCCeeeecccCCceeeCCCCcEEEeeeccccccc
Q 038766 91 EYMENGSLESVIHGPGVDHSRWTLPKRIDVLISVANGLDYLHS-GYDIPIVHCDMKPSNILLDRDFEAHVSDFGTSRMLD 169 (299)
Q Consensus 91 e~~~~~~L~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lh~-~~~~~~~H~dl~~~nil~~~~~~v~l~df~~~~~~~ 169 (299)
||+++++|..++.... ....+++..+..++.|+++||.|||+ . +++|+||+|+||+++.++.++|+|||++..+.
T Consensus 79 e~~~~~~l~~~~~~~~-~~~~~~~~~~~~~~~~i~~~l~~LH~~~---~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~ 154 (286)
T cd06622 79 EYMDAGSLDKLYAGGV-ATEGIPEDVLRRITYAVVKGLKFLKEEH---NIIHRDVKPTNVLVNGNGQVKLCDFGVSGNLV 154 (286)
T ss_pred eecCCCCHHHHHHhcc-ccCCCCHHHHHHHHHHHHHHHHHHHhcC---CEeeCCCCHHHEEECCCCCEEEeecCCccccc
Confidence 9999999998886421 24578999999999999999999996 5 89999999999999999999999999987543
Q ss_pred cccccccccccccccCcccCChhhhcccC------cCccccchhhhHHHHHHHhCCCCCCCCccCCCCchhHHHHHHHHH
Q 038766 170 VHLQDLSSLSTAFQGTIGYLAPEFAYMRI------VTTKVDVFSFGIVVMEFLTKRRPTGLDEENGLSPISLRQLVEKAL 243 (299)
Q Consensus 170 ~~~~~~~~~~~~~~~~~~y~~PE~~~~~~------~~~~~DiwslG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~ 243 (299)
. .......++..|+|||.+.+.. ++.++|+|||||++|+|++|..||.... .......+....
T Consensus 155 ~------~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~-----~~~~~~~~~~~~ 223 (286)
T cd06622 155 A------SLAKTNIGCQSYMAPERIKSGGPNQNPTYTVQSDVWSLGLSILEMALGRYPYPPET-----YANIFAQLSAIV 223 (286)
T ss_pred C------CccccCCCccCccCcchhcCCCCCccCCCCcccchHhHHHHHHHHHhCCCCCCCcc-----hhhHHHHHHHHh
Confidence 1 1223345677899999876543 4789999999999999999999985321 111112221111
Q ss_pred hcCccCcccccCccccchhhHhHHHHHHHHHHHHHHHHhcCCCCCCCCChhhhhcC
Q 038766 244 ANGINGVRQITDPKLVSSIYEEQEQHQVLEELFKLALVCTSSNPEDRPNMNELLIT 299 (299)
Q Consensus 244 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rpt~~~il~~ 299 (299)
..... ..+..++.++.++|.+||..+|++||++++++.|
T Consensus 224 ~~~~~-----------------~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~l~~~ 262 (286)
T cd06622 224 DGDPP-----------------TLPSGYSDDAQDFVAKCLNKIPNRRPTYAQLLEH 262 (286)
T ss_pred hcCCC-----------------CCCcccCHHHHHHHHHHcccCcccCCCHHHHhcC
Confidence 11100 0123466789999999999999999999999986
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal PBS2-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include |
| >cd08218 STKc_Nek1 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-40 Score=275.55 Aligned_cols=252 Identities=25% Similarity=0.377 Sum_probs=202.6
Q ss_pred CCCCCceeecCCcceEEEEEe-CCCcEEEEEEeccCcCChhhhHHHHHHHHHHHhcCCcceeeeeeEEEcCCCeeEEEEe
Q 038766 13 SFSENNIIGNSNLSTVYKGRL-EDGEIVAVKKLNFHQFSAESDKSFYREAKTLKELKHRNLVKVLGYAWESGKLKALILE 91 (299)
Q Consensus 13 ~y~~~~~lg~g~~~~v~~~~~-~~~~~~~vK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~lv~e 91 (299)
+|++.+.||+|++|.+|++.. .+|+.+++|++............+.+|+..+++++|+||+++.+.+.. +...++|+|
T Consensus 1 ~y~~~~~lg~g~~g~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~-~~~~~lv~e 79 (256)
T cd08218 1 KYVKVKKIGEGSFGKAILVKSKEDGKQYVIKEINISKMSPKEREESRKEVAVLSNMKHPNIVQYQESFEE-NGNLYIVMD 79 (256)
T ss_pred CceEEEEeccCCceEEEEEEEcCCCCEEEEEEEEhHhCChHHHHHHHHHHHHHHhCCCCCeeeeEeeecC-CCeEEEEEe
Confidence 688999999999999999986 468899999987655555566788999999999999999999996544 567799999
Q ss_pred ecCCCChHHHhcCCCCCCCCCChhhHHHHHHHHHHHHHHhhcCCCCCeeeecccCCceeeCCCCcEEEeeeccccccccc
Q 038766 92 YMENGSLESVIHGPGVDHSRWTLPKRIDVLISVANGLDYLHSGYDIPIVHCDMKPSNILLDRDFEAHVSDFGTSRMLDVH 171 (299)
Q Consensus 92 ~~~~~~L~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lh~~~~~~~~H~dl~~~nil~~~~~~v~l~df~~~~~~~~~ 171 (299)
|+.+++|.+.+... ....+++..++.++.|++.|+.+||+. +++|+||+|+||+++.++.++++|||.+......
T Consensus 80 ~~~~~~l~~~~~~~--~~~~~~~~~~~~~~~~l~~~l~~lh~~---~i~h~~l~~~nil~~~~~~~~l~d~~~~~~~~~~ 154 (256)
T cd08218 80 YCEGGDLYKKINAQ--RGVLFPEDQILDWFVQICLALKHVHDR---KILHRDIKSQNIFLTKDGTIKLGDFGIARVLNST 154 (256)
T ss_pred cCCCCcHHHHHHhc--cCCCCCHHHHHHHHHHHHHHHHHHHhC---CEecCCCCHHHEEEcCCCCEEEeeccceeecCcc
Confidence 99999999988632 233678899999999999999999998 9999999999999999999999999998765421
Q ss_pred cccccccccccccCcccCChhhhcccCcCccccchhhhHHHHHHHhCCCCCCCCccCCCCchhHHHHHHHHHhcCccCcc
Q 038766 172 LQDLSSLSTAFQGTIGYLAPEFAYMRIVTTKVDVFSFGIVVMEFLTKRRPTGLDEENGLSPISLRQLVEKALANGINGVR 251 (299)
Q Consensus 172 ~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~DiwslG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 251 (299)
........+++.|+|||...+..++.++|+||+|+++++|++|..||.... ..+............
T Consensus 155 ----~~~~~~~~~~~~~~~pe~~~~~~~~~~~Dv~slG~i~~~l~~g~~~~~~~~--------~~~~~~~~~~~~~~~-- 220 (256)
T cd08218 155 ----VELARTCIGTPYYLSPEICENRPYNNKSDIWALGCVLYEMCTLKHAFEAGN--------MKNLVLKIIRGSYPP-- 220 (256)
T ss_pred ----hhhhhhccCCccccCHHHhCCCCCCCccchhHHHHHHHHHHcCCCCccCCC--------HHHHHHHHhcCCCCC--
Confidence 111223446788999999998889999999999999999999999985321 112222222111100
Q ss_pred cccCccccchhhHhHHHHHHHHHHHHHHHHhcCCCCCCCCChhhhhcC
Q 038766 252 QITDPKLVSSIYEEQEQHQVLEELFKLALVCTSSNPEDRPNMNELLIT 299 (299)
Q Consensus 252 ~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rpt~~~il~~ 299 (299)
.+...+.++.++|.+||+.+|++||++.++++|
T Consensus 221 ---------------~~~~~~~~~~~li~~~l~~~p~~Rp~~~~vl~~ 253 (256)
T cd08218 221 ---------------VSSHYSYDLRNLVSQLFKRNPRDRPSVNSILEK 253 (256)
T ss_pred ---------------CcccCCHHHHHHHHHHhhCChhhCcCHHHHhhC
Confidence 122345679999999999999999999999987
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 1 (Nek1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek1 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek1 is associated with centrosomes throughout the cell cycle. It is involved in the formation of primary cilium and in the maintenance of centrosomes. It cycles through the nucleus and may be capable of relaying signals between the cilium and the nucleus. Nek1 is implicated in the development of polycysti |
| >cd05615 STKc_cPKC_alpha Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C alpha | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.5e-41 Score=287.73 Aligned_cols=249 Identities=19% Similarity=0.296 Sum_probs=192.9
Q ss_pred CCCCCceeecCCcceEEEEEeC-CCcEEEEEEeccCcC-ChhhhHHHHHHHHHHHhcC-CcceeeeeeEEEcCCCeeEEE
Q 038766 13 SFSENNIIGNSNLSTVYKGRLE-DGEIVAVKKLNFHQF-SAESDKSFYREAKTLKELK-HRNLVKVLGYAWESGKLKALI 89 (299)
Q Consensus 13 ~y~~~~~lg~g~~~~v~~~~~~-~~~~~~vK~~~~~~~-~~~~~~~~~~e~~~l~~l~-h~~i~~~~~~~~~~~~~~~lv 89 (299)
+|...+.||+|+||+||+|.+. +++.||+|++..... .....+....|..+++.+. |++|+++.+.+.. ....++|
T Consensus 1 ~f~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~-~~~~~lv 79 (323)
T cd05615 1 DFNFLMVLGKGSFGKVMLAERKGTDELYAIKILKKDVVIQDDDVECTMVEKRVLALQDKPPFLTQLHSCFQT-VDRLYFV 79 (323)
T ss_pred CceEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccCCCchhheeeEEec-CCEEEEE
Confidence 4778899999999999999864 589999999864322 2233456777888888886 4667778775544 5567999
Q ss_pred EeecCCCChHHHhcCCCCCCCCCChhhHHHHHHHHHHHHHHhhcCCCCCeeeecccCCceeeCCCCcEEEeeeccccccc
Q 038766 90 LEYMENGSLESVIHGPGVDHSRWTLPKRIDVLISVANGLDYLHSGYDIPIVHCDMKPSNILLDRDFEAHVSDFGTSRMLD 169 (299)
Q Consensus 90 ~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lh~~~~~~~~H~dl~~~nil~~~~~~v~l~df~~~~~~~ 169 (299)
+||+++++|.+.+. ....+++.+++.++.|++.||+|||+. +++|+||||+||+++.++.++|+|||++....
T Consensus 80 ~Ey~~~g~L~~~i~----~~~~l~~~~~~~i~~qi~~al~~lH~~---~ivHrDikp~Nill~~~~~ikL~Dfg~~~~~~ 152 (323)
T cd05615 80 MEYVNGGDLMYHIQ----QVGKFKEPQAVFYAAEISVGLFFLHRR---GIIYRDLKLDNVMLDSEGHIKIADFGMCKEHM 152 (323)
T ss_pred EcCCCCCcHHHHHH----HcCCCCHHHHHHHHHHHHHHHHHHHHC---CeeccCCCHHHeEECCCCCEEEeccccccccC
Confidence 99999999999886 445799999999999999999999999 99999999999999999999999999886432
Q ss_pred cccccccccccccccCcccCChhhhcccCcCccccchhhhHHHHHHHhCCCCCCCCccCCCCchhHHHHHHHHHhcCccC
Q 038766 170 VHLQDLSSLSTAFQGTIGYLAPEFAYMRIVTTKVDVFSFGIVVMEFLTKRRPTGLDEENGLSPISLRQLVEKALANGING 249 (299)
Q Consensus 170 ~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~DiwslG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 249 (299)
. .........+++.|+|||++.+..++.++|+||+||++|+|++|..||.... .. ...........
T Consensus 153 ~----~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~elltG~~pf~~~~-----~~---~~~~~i~~~~~-- 218 (323)
T cd05615 153 V----DGVTTRTFCGTPDYIAPEIIAYQPYGKSVDWWAYGVLLYEMLAGQPPFDGED-----ED---ELFQSIMEHNV-- 218 (323)
T ss_pred C----CCccccCccCCccccCHHHHcCCCCCCccchhhhHHHHHHHHhCCCCCCCCC-----HH---HHHHHHHhCCC--
Confidence 1 1112234457899999999998889999999999999999999999995432 11 11222211110
Q ss_pred cccccCccccchhhHhHHHHHHHHHHHHHHHHhcCCCCCCCCCh-----hhhhcC
Q 038766 250 VRQITDPKLVSSIYEEQEQHQVLEELFKLALVCTSSNPEDRPNM-----NELLIT 299 (299)
Q Consensus 250 ~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rpt~-----~~il~~ 299 (299)
.. +...+.++.+++.+||..+|.+|++. +++++|
T Consensus 219 ----~~------------p~~~~~~~~~li~~~l~~~p~~R~~~~~~~~~~i~~h 257 (323)
T cd05615 219 ----SY------------PKSLSKEAVSICKGLMTKHPSKRLGCGPEGERDIREH 257 (323)
T ss_pred ----CC------------CccCCHHHHHHHHHHcccCHhhCCCCCCCCHHHHhcC
Confidence 00 12345678999999999999999985 456554
|
Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, a |
| >cd05603 STKc_SGK2 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-41 Score=289.07 Aligned_cols=244 Identities=25% Similarity=0.303 Sum_probs=187.4
Q ss_pred ceeecCCcceEEEEEeC-CCcEEEEEEeccCcC-ChhhhHHHHHHHH-HHHhcCCcceeeeeeEEEcCCCeeEEEEeecC
Q 038766 18 NIIGNSNLSTVYKGRLE-DGEIVAVKKLNFHQF-SAESDKSFYREAK-TLKELKHRNLVKVLGYAWESGKLKALILEYME 94 (299)
Q Consensus 18 ~~lg~g~~~~v~~~~~~-~~~~~~vK~~~~~~~-~~~~~~~~~~e~~-~l~~l~h~~i~~~~~~~~~~~~~~~lv~e~~~ 94 (299)
+.||+|+||.||+|.+. +++.||+|++..... .......+..|.. +++.++||||+++++.+.. .+..++|+||+.
T Consensus 1 ~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~l~~~~h~~iv~~~~~~~~-~~~~~lv~e~~~ 79 (321)
T cd05603 1 KVIGKGSFGKVLLAKRKSDGSFYAVKVLQKKTILKKKEQNHIMAERNVLLKNLKHPFLVGLHYSFQT-AEKLYFVLDYVN 79 (321)
T ss_pred CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHHHHhhHHHHHHHHHHHHHHhCCCCCccceeeEEEc-CCEEEEEEcCCC
Confidence 47999999999999874 588999999864322 1222344555544 5788899999999986654 556699999999
Q ss_pred CCChHHHhcCCCCCCCCCChhhHHHHHHHHHHHHHHhhcCCCCCeeeecccCCceeeCCCCcEEEeeecccccccccccc
Q 038766 95 NGSLESVIHGPGVDHSRWTLPKRIDVLISVANGLDYLHSGYDIPIVHCDMKPSNILLDRDFEAHVSDFGTSRMLDVHLQD 174 (299)
Q Consensus 95 ~~~L~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lh~~~~~~~~H~dl~~~nil~~~~~~v~l~df~~~~~~~~~~~~ 174 (299)
+++|...+. ....+++..+..++.||+.||.|||+. +++||||||+||+++.+|.++|+|||++.....
T Consensus 80 ~~~L~~~l~----~~~~~~~~~~~~~~~qi~~~L~~lH~~---~ivH~Dlkp~NIll~~~~~~kl~Dfg~~~~~~~---- 148 (321)
T cd05603 80 GGELFFHLQ----RERCFLEPRARFYAAEVASAIGYLHSL---NIIYRDLKPENILLDSQGHVVLTDFGLCKEGVE---- 148 (321)
T ss_pred CCCHHHHHH----HcCCCCHHHHHHHHHHHHHHHHHHHHC---CeEeccCCHHHeEECCCCCEEEccCCCCccCCC----
Confidence 999988886 445789999999999999999999999 999999999999999999999999998864221
Q ss_pred ccccccccccCcccCChhhhcccCcCccccchhhhHHHHHHHhCCCCCCCCccCCCCchhHHHHHHHHHhcCccCccccc
Q 038766 175 LSSLSTAFQGTIGYLAPEFAYMRIVTTKVDVFSFGIVVMEFLTKRRPTGLDEENGLSPISLRQLVEKALANGINGVRQIT 254 (299)
Q Consensus 175 ~~~~~~~~~~~~~y~~PE~~~~~~~~~~~DiwslG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 254 (299)
.........+++.|+|||.+.+..++.++|||||||++|+|++|..||.... ............ ..+
T Consensus 149 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~--------~~~~~~~i~~~~----~~~- 215 (321)
T cd05603 149 PEETTSTFCGTPEYLAPEVLRKEPYDRTVDWWCLGAVLYEMLYGLPPFYSRD--------VSQMYDNILHKP----LQL- 215 (321)
T ss_pred CCCccccccCCcccCCHHHhcCCCCCCcCcccccchhhhhhhcCCCCCCCCC--------HHHHHHHHhcCC----CCC-
Confidence 1112234457899999999998889999999999999999999999995431 112222211110 000
Q ss_pred CccccchhhHhHHHHHHHHHHHHHHHHhcCCCCCCCCChh----hhhcC
Q 038766 255 DPKLVSSIYEEQEQHQVLEELFKLALVCTSSNPEDRPNMN----ELLIT 299 (299)
Q Consensus 255 ~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rpt~~----~il~~ 299 (299)
+...+..+.++|.+||..||.+||++. ++++|
T Consensus 216 -------------~~~~~~~~~~li~~~l~~~p~~R~~~~~~~~~~~~~ 251 (321)
T cd05603 216 -------------PGGKTVAACDLLVGLLHKDQRRRLGAKADFLEIKNH 251 (321)
T ss_pred -------------CCCCCHHHHHHHHHHccCCHhhcCCCCCCHHHHhCC
Confidence 122345788999999999999999874 66554
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK2 shows a more restricted distribution that SGK1 and is most abundantly expressed in epithelial tissues including kidney, liver, pancreas, and the choroid plexus of the brain. In vitro cellular assays show that SGK2 can stimulate the activity of ion channels, the glutamate transporter EEAT4, and the glutamate receptors, GluR6 and GLUR1. |
| >cd06610 STKc_OSR1_SPAK Catalytic domain of the Protein Serine/Threonine Kinases, Oxidative stress response kinase and Ste20-related proline alanine-rich kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-40 Score=275.58 Aligned_cols=262 Identities=26% Similarity=0.373 Sum_probs=204.0
Q ss_pred CCCCCCceeecCCcceEEEEEeC-CCcEEEEEEeccCcCChhhhHHHHHHHHHHHhcCCcceeeeeeEEEcCCCeeEEEE
Q 038766 12 GSFSENNIIGNSNLSTVYKGRLE-DGEIVAVKKLNFHQFSAESDKSFYREAKTLKELKHRNLVKVLGYAWESGKLKALIL 90 (299)
Q Consensus 12 ~~y~~~~~lg~g~~~~v~~~~~~-~~~~~~vK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~lv~ 90 (299)
++|.+.+.||.|++|+||++... ++..+++|++....... ....+.+|+..++.++|+|++++++.+.. +...++|+
T Consensus 1 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~-~~~~~~~e~~~l~~l~~~~i~~~~~~~~~-~~~~~iv~ 78 (267)
T cd06610 1 DDYELIEVIGVGATAVVYAAICLPNNEKVAIKRIDLEKCQT-SVDELRKEVQAMSQCNHPNVVKYYTSFVV-GDELWLVM 78 (267)
T ss_pred CcceeeeeecCCCCeEEEEEEEcCCCcEEEEEEeccCCcch-HHHHHHHHHHHHHhcCCCCEEEEEEEEee-CCEEEEEE
Confidence 57999999999999999999864 58899999986433333 56788999999999999999999996655 56679999
Q ss_pred eecCCCChHHHhcCCCCCCCCCChhhHHHHHHHHHHHHHHhhcCCCCCeeeecccCCceeeCCCCcEEEeeecccccccc
Q 038766 91 EYMENGSLESVIHGPGVDHSRWTLPKRIDVLISVANGLDYLHSGYDIPIVHCDMKPSNILLDRDFEAHVSDFGTSRMLDV 170 (299)
Q Consensus 91 e~~~~~~L~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lh~~~~~~~~H~dl~~~nil~~~~~~v~l~df~~~~~~~~ 170 (299)
|++.+++|.+++.... ....+++..++.++.|++.||.+||+. +++|+||+|+||+++.++.++|+|||++..+..
T Consensus 79 e~~~~~~l~~~~~~~~-~~~~~~~~~~~~~~~ql~~al~~lh~~---~i~h~~l~p~ni~~~~~~~~~l~df~~~~~~~~ 154 (267)
T cd06610 79 PYLSGGSLLDIMKSSY-PRGGLDEAIIATVLKEVLKGLEYLHSN---GQIHRDIKAGNILLGEDGSVKIADFGVSASLAD 154 (267)
T ss_pred eccCCCcHHHHHHHhc-ccCCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHhEEEcCCCCEEEcccchHHHhcc
Confidence 9999999999986432 234689999999999999999999999 999999999999999999999999999876653
Q ss_pred ccccccccccccccCcccCChhhhccc-CcCccccchhhhHHHHHHHhCCCCCCCCccCCCCchhHHHHHHHHHhcCccC
Q 038766 171 HLQDLSSLSTAFQGTIGYLAPEFAYMR-IVTTKVDVFSFGIVVMEFLTKRRPTGLDEENGLSPISLRQLVEKALANGING 249 (299)
Q Consensus 171 ~~~~~~~~~~~~~~~~~y~~PE~~~~~-~~~~~~DiwslG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 249 (299)
.............++..|+|||.+... ..+.++|+||||+++++|++|..||...... .............
T Consensus 155 ~~~~~~~~~~~~~~~~~y~~Pe~~~~~~~~~~~~Dv~slG~i~~~l~~g~~p~~~~~~~--------~~~~~~~~~~~~~ 226 (267)
T cd06610 155 GGDRTRKVRKTFVGTPCWMAPEVMEQVHGYDFKADIWSFGITAIELATGAAPYSKYPPM--------KVLMLTLQNDPPS 226 (267)
T ss_pred CccccccccccccCChhhcChHHHccccCcCcccchHhHhHHHHHHHhCCCCccccChh--------hhHHHHhcCCCCC
Confidence 322211222344578899999988776 7889999999999999999999998533211 1111111111100
Q ss_pred cccccCccccchhhHhHHHHHHHHHHHHHHHHhcCCCCCCCCChhhhhcC
Q 038766 250 VRQITDPKLVSSIYEEQEQHQVLEELFKLALVCTSSNPEDRPNMNELLIT 299 (299)
Q Consensus 250 ~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rpt~~~il~~ 299 (299)
.. . ......++..+.+++.+||..||++|||++++++|
T Consensus 227 ~~---~---------~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~ll~~ 264 (267)
T cd06610 227 LE---T---------GADYKKYSKSFRKMISLCLQKDPSKRPTAEELLKH 264 (267)
T ss_pred cC---C---------ccccccccHHHHHHHHHHcCCChhhCcCHHHHhhC
Confidence 00 0 00023456788999999999999999999999987
|
Serine/threonine kinases (STKs), oxidative stress response kinase (OSR1) and Ste20-related proline alanine-rich kinase (SPAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The OSR1 and SPAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SPAK is also referred to as STK39 or PASK (proline-alanine-rich STE20-related kinase). OSR1 and SPAK regulate the activity of cation-chloride cotransporters through direct interaction and phosphorylation. They are also implicated in cytoskeletal rearrangement, cell differentiation, transformation and proliferation. OSR1 |
| >KOG0596 consensus Dual specificity; serine/threonine and tyrosine kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.2e-42 Score=289.92 Aligned_cols=256 Identities=23% Similarity=0.319 Sum_probs=199.3
Q ss_pred hCCCCCCceeecCCcceEEEEEeCCCcEEEEEEeccCcCChhhhHHHHHHHHHHHhcC-CcceeeeeeEEEcCCCeeEEE
Q 038766 11 TGSFSENNIIGNSNLSTVYKGRLEDGEIVAVKKLNFHQFSAESDKSFYREAKTLKELK-HRNLVKVLGYAWESGKLKALI 89 (299)
Q Consensus 11 ~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~vK~~~~~~~~~~~~~~~~~e~~~l~~l~-h~~i~~~~~~~~~~~~~~~lv 89 (299)
...|.+.++||+||.+.||++...+...||+|.+.....++....-+.+|+..|.+++ |.+|++++++-.. +.++|+|
T Consensus 360 g~~Yeilk~iG~GGSSkV~kV~~s~~~iyalkkv~~~~~D~qtl~gy~nEI~lL~KLkg~~~IIqL~DYEv~-d~~lYmv 438 (677)
T KOG0596|consen 360 GREYEILKQIGSGGSSKVFKVLNSDKQIYALKKVVLLEADNQTLDGYRNEIALLNKLKGHDKIIQLYDYEVT-DGYLYMV 438 (677)
T ss_pred cchhhHHHhhcCCCcceeeeeecCCCcchhhhHHHHhhcCHHHHHHHHHHHHHHHHhcCCceEEEEeeeecc-CceEEEE
Confidence 3579999999999999999999888888999998887888888999999999999997 9999999995544 6677999
Q ss_pred EeecCCCChHHHhcCCCCCCCCCChhhHHHHHHHHHHHHHHhhcCCCCCeeeecccCCceeeCCCCcEEEeeeccccccc
Q 038766 90 LEYMENGSLESVIHGPGVDHSRWTLPKRIDVLISVANGLDYLHSGYDIPIVHCDMKPSNILLDRDFEAHVSDFGTSRMLD 169 (299)
Q Consensus 90 ~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lh~~~~~~~~H~dl~~~nil~~~~~~v~l~df~~~~~~~ 169 (299)
||+= ..+|..+++..+ .-++.-.+..+..|+++|+.++|+. +|||.||||.|+++- .|.+||+|||++..+.
T Consensus 439 mE~G-d~DL~kiL~k~~---~~~~~~~lk~ywkqML~aV~~IH~~---gIVHSDLKPANFLlV-kG~LKLIDFGIA~aI~ 510 (677)
T KOG0596|consen 439 MECG-DIDLNKILKKKK---SIDPDWFLKFYWKQMLLAVKTIHQH---GIVHSDLKPANFLLV-KGRLKLIDFGIANAIQ 510 (677)
T ss_pred eecc-cccHHHHHHhcc---CCCchHHHHHHHHHHHHHHHHHHHh---ceeecCCCcccEEEE-eeeEEeeeechhcccC
Confidence 9987 459999997542 2233247888999999999999999 999999999999994 5589999999998765
Q ss_pred cccccccccccccccCcccCChhhhcccC-----------cCccccchhhhHHHHHHHhCCCCCCCCccCCCCchhHHHH
Q 038766 170 VHLQDLSSLSTAFQGTIGYLAPEFAYMRI-----------VTTKVDVFSFGIVVMEFLTKRRPTGLDEENGLSPISLRQL 238 (299)
Q Consensus 170 ~~~~~~~~~~~~~~~~~~y~~PE~~~~~~-----------~~~~~DiwslG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~ 238 (299)
.+-.+ -....-.||+.||+||.+.... .+.++|||||||++|+|+.|..||..-
T Consensus 511 ~DTTs--I~kdsQvGT~NYMsPEAl~~~~s~~~~~~~k~Ki~r~SDvWSLGCILYqMvYgktPf~~~------------- 575 (677)
T KOG0596|consen 511 PDTTS--IVKDSQVGTVNYMSPEALTDMSSSRENGKSKIKISRKSDVWSLGCILYQMVYGKTPFGQI------------- 575 (677)
T ss_pred ccccc--eeeccccCcccccCHHHHhhccccccCCCcceeecCccchhhhhhHHHHHHhcCCchHHH-------------
Confidence 43222 2234557999999999876532 457899999999999999999999522
Q ss_pred HHHHHhcCccCcccccCccccchhhHhHHHHHHHHHHHHHHHHhcCCCCCCCCChhhhhcC
Q 038766 239 VEKALANGINGVRQITDPKLVSSIYEEQEQHQVLEELFKLALVCTSSNPEDRPNMNELLIT 299 (299)
Q Consensus 239 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rpt~~~il~~ 299 (299)
.+.+..+..+.+|..-..+..-... .++.++++.||.+||.+|||+.++|+|
T Consensus 576 -----~n~~aKl~aI~~P~~~Iefp~~~~~----~~li~~mK~CL~rdPkkR~si~eLLqh 627 (677)
T KOG0596|consen 576 -----INQIAKLHAITDPNHEIEFPDIPEN----DELIDVMKCCLARDPKKRWSIPELLQH 627 (677)
T ss_pred -----HHHHHHHHhhcCCCccccccCCCCc----hHHHHHHHHHHhcCcccCCCcHHHhcC
Confidence 1111122233333221111000001 138999999999999999999999987
|
|
| >cd05071 PTKc_Src Catalytic domain of the Protein Tyrosine Kinase, Src | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.8e-41 Score=278.84 Aligned_cols=253 Identities=27% Similarity=0.404 Sum_probs=197.3
Q ss_pred HHHhCCCCCCceeecCCcceEEEEEeCCCcEEEEEEeccCcCChhhhHHHHHHHHHHHhcCCcceeeeeeEEEcCCCeeE
Q 038766 8 ENATGSFSENNIIGNSNLSTVYKGRLEDGEIVAVKKLNFHQFSAESDKSFYREAKTLKELKHRNLVKVLGYAWESGKLKA 87 (299)
Q Consensus 8 ~~~~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~vK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~ 87 (299)
++..++|++.+.||+|++|+||+|.+.++..+++|.+.... ...+.+..|++.++.++|+||+++++.+ . ....+
T Consensus 2 ~~~~~~~~~~~~lg~g~~~~v~~~~~~~~~~valK~~~~~~---~~~~~~~~E~~~l~~l~~~~i~~~~~~~-~-~~~~~ 76 (262)
T cd05071 2 EIPRESLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTLKPGT---MSPEAFLQEAQVMKKLRHEKLVQLYAVV-S-EEPIY 76 (262)
T ss_pred CCChHHeeEeeecCCCCCCcEEEEEecCCceEEEEecccCc---cCHHHHHHHHHHHHhCCCCCcceEEEEE-C-CCCcE
Confidence 44568899999999999999999988766789999986432 2345788899999999999999999865 3 33458
Q ss_pred EEEeecCCCChHHHhcCCCCCCCCCChhhHHHHHHHHHHHHHHhhcCCCCCeeeecccCCceeeCCCCcEEEeeeccccc
Q 038766 88 LILEYMENGSLESVIHGPGVDHSRWTLPKRIDVLISVANGLDYLHSGYDIPIVHCDMKPSNILLDRDFEAHVSDFGTSRM 167 (299)
Q Consensus 88 lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lh~~~~~~~~H~dl~~~nil~~~~~~v~l~df~~~~~ 167 (299)
+|+||+.+++|.+++... ....+++..++.++.|++.||++||+. +++|+||+|+||+++.++.++|+|||.+..
T Consensus 77 lv~e~~~~~~L~~~~~~~--~~~~~~~~~~~~~~~~l~~aL~~lH~~---~i~H~dl~p~Nill~~~~~~~L~dfg~~~~ 151 (262)
T cd05071 77 IVTEYMSKGSLLDFLKGE--MGKYLRLPQLVDMAAQIASGMAYVERM---NYVHRDLRAANILVGENLVCKVADFGLARL 151 (262)
T ss_pred EEEEcCCCCcHHHHHhhc--cccCCCHHHHHHHHHHHHHHHHHHHHC---CccccccCcccEEEcCCCcEEeccCCceee
Confidence 999999999999998642 234678899999999999999999999 999999999999999999999999999875
Q ss_pred cccccccccccccccccCcccCChhhhcccCcCccccchhhhHHHHHHHh-CCCCCCCCccCCCCchhHHHHHHHHHhcC
Q 038766 168 LDVHLQDLSSLSTAFQGTIGYLAPEFAYMRIVTTKVDVFSFGIVVMEFLT-KRRPTGLDEENGLSPISLRQLVEKALANG 246 (299)
Q Consensus 168 ~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~DiwslG~~l~~l~~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~ 246 (299)
..... ........++..|+|||...+..++.++|+||||+++|+|++ |..||.... .... ........
T Consensus 152 ~~~~~---~~~~~~~~~~~~y~~PE~~~~~~~~~~~DvwslG~~l~ellt~g~~p~~~~~-----~~~~---~~~~~~~~ 220 (262)
T cd05071 152 IEDNE---YTARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMV-----NREV---LDQVERGY 220 (262)
T ss_pred ccccc---cccccCCcccceecCHhHhccCCCCchhhHHHHHHHHHHHHcCCCCCCCCCC-----hHHH---HHHHhcCC
Confidence 54211 111123345667999999988889999999999999999999 777774331 1111 11111100
Q ss_pred ccCcccccCccccchhhHhHHHHHHHHHHHHHHHHhcCCCCCCCCChhhhhc
Q 038766 247 INGVRQITDPKLVSSIYEEQEQHQVLEELFKLALVCTSSNPEDRPNMNELLI 298 (299)
Q Consensus 247 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rpt~~~il~ 298 (299)
.. ......+..+.+++.+|++.+|++|||+.++++
T Consensus 221 -----~~------------~~~~~~~~~l~~li~~~l~~~p~~Rp~~~~~~~ 255 (262)
T cd05071 221 -----RM------------PCPPECPESLHDLMCQCWRKEPEERPTFEYLQA 255 (262)
T ss_pred -----CC------------CCccccCHHHHHHHHHHccCCcccCCCHHHHHH
Confidence 00 012344567899999999999999999999874
|
Protein Tyrosine Kinase (PTK) family; Src kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) is a cytoplasmic (or non-receptor) tyr kinase, containing an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region with a conserved tyr. It is activated by autophosphorylation at the tyr kinase domain, and is negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). c-Src is the vertebrate homolog of the oncogenic protein (v-Src) from Rous sarcoma virus. Together with other Src subfamily proteins, it is invo |
| >cd05114 PTKc_Tec_Rlk Catalytic domain of the Protein Tyrosine Kinases, Tyrosine kinase expressed in hepatocellular carcinoma and Resting lymphocyte kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=5e-41 Score=277.76 Aligned_cols=249 Identities=24% Similarity=0.362 Sum_probs=194.8
Q ss_pred CCCCCCceeecCCcceEEEEEeCCCcEEEEEEeccCcCChhhhHHHHHHHHHHHhcCCcceeeeeeEEEcCCCeeEEEEe
Q 038766 12 GSFSENNIIGNSNLSTVYKGRLEDGEIVAVKKLNFHQFSAESDKSFYREAKTLKELKHRNLVKVLGYAWESGKLKALILE 91 (299)
Q Consensus 12 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~vK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~lv~e 91 (299)
++|.+.+.||+|+||.||++.++++..+|+|.+.... ...+.+.+|+..+++++||||+++++++.. ....++|+|
T Consensus 4 ~~~~~~~~lg~G~~~~vy~~~~~~~~~~a~K~~~~~~---~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~-~~~~~iv~e 79 (256)
T cd05114 4 SELTFMKELGSGQFGVVHLGKWRAQIKVAIKAINEGA---MSEEDFIEEAKVMMKLSHPKLVQLYGVCTQ-QKPLYIVTE 79 (256)
T ss_pred HHcEEeeEecCCcCceEEEEEeccCceEEEEecccCC---ccHHHHHHHHHHHHHCCCCCceeEEEEEcc-CCCEEEEEE
Confidence 5688899999999999999998878889999875332 234578889999999999999999996655 455699999
Q ss_pred ecCCCChHHHhcCCCCCCCCCChhhHHHHHHHHHHHHHHhhcCCCCCeeeecccCCceeeCCCCcEEEeeeccccccccc
Q 038766 92 YMENGSLESVIHGPGVDHSRWTLPKRIDVLISVANGLDYLHSGYDIPIVHCDMKPSNILLDRDFEAHVSDFGTSRMLDVH 171 (299)
Q Consensus 92 ~~~~~~L~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lh~~~~~~~~H~dl~~~nil~~~~~~v~l~df~~~~~~~~~ 171 (299)
|+.+++|.+++... ...+++..++.++.|++.||.|||++ +++|+||+|+||+++.++.++|+|||.+......
T Consensus 80 ~~~~~~L~~~~~~~---~~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dl~p~ni~i~~~~~~kl~d~g~~~~~~~~ 153 (256)
T cd05114 80 FMENGCLLNYLRQR---QGKLSKDMLLSMCQDVCEGMEYLERN---SFIHRDLAARNCLVSSTGVVKVSDFGMTRYVLDD 153 (256)
T ss_pred cCCCCcHHHHHHhC---ccCCCHHHHHHHHHHHHHHHHHHHHC---CccccccCcceEEEcCCCeEEECCCCCccccCCC
Confidence 99999999988632 23588899999999999999999999 9999999999999999999999999988754311
Q ss_pred cccccccccccccCcccCChhhhcccCcCccccchhhhHHHHHHHh-CCCCCCCCccCCCCchhHHHHHHHHHhcCccCc
Q 038766 172 LQDLSSLSTAFQGTIGYLAPEFAYMRIVTTKVDVFSFGIVVMEFLT-KRRPTGLDEENGLSPISLRQLVEKALANGINGV 250 (299)
Q Consensus 172 ~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~DiwslG~~l~~l~~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 250 (299)
.........++..|+|||.+.+..++.++|+||+|+++|+|++ |..||.... ... .+........
T Consensus 154 ---~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~s~G~~l~el~~~g~~p~~~~~-----~~~---~~~~i~~~~~--- 219 (256)
T cd05114 154 ---EYTSSSGAKFPVKWSPPEVFNFSKYSSKSDVWSFGVLMWEVFTEGKMPFEKKS-----NYE---VVEMISRGFR--- 219 (256)
T ss_pred ---ceeccCCCCCchhhCChhhcccCccchhhhhHHHHHHHHHHHcCCCCCCCCCC-----HHH---HHHHHHCCCC---
Confidence 1111122234567999999988889999999999999999999 888885331 111 1111111110
Q ss_pred ccccCccccchhhHhHHHHHHHHHHHHHHHHhcCCCCCCCCChhhhhc
Q 038766 251 RQITDPKLVSSIYEEQEQHQVLEELFKLALVCTSSNPEDRPNMNELLI 298 (299)
Q Consensus 251 ~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rpt~~~il~ 298 (299)
... +...+..+.+++.+||..+|++|||++++++
T Consensus 220 --~~~------------~~~~~~~~~~li~~c~~~~p~~Rps~~~l~~ 253 (256)
T cd05114 220 --LYR------------PKLASMTVYEVMYSCWHEKPEGRPTFAELLR 253 (256)
T ss_pred --CCC------------CCCCCHHHHHHHHHHccCCcccCcCHHHHHH
Confidence 000 1112357899999999999999999999985
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) and Resting lymphocyte kinase (Rlk); catalytic (c) domain. The PTKc family is part of a larger superfamily, that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec and Rlk (also named Txk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin h |
| >cd05069 PTKc_Yes Catalytic domain of the Protein Tyrosine Kinase, Yes | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.9e-41 Score=277.56 Aligned_cols=253 Identities=25% Similarity=0.391 Sum_probs=197.3
Q ss_pred HHHhCCCCCCceeecCCcceEEEEEeCCCcEEEEEEeccCcCChhhhHHHHHHHHHHHhcCCcceeeeeeEEEcCCCeeE
Q 038766 8 ENATGSFSENNIIGNSNLSTVYKGRLEDGEIVAVKKLNFHQFSAESDKSFYREAKTLKELKHRNLVKVLGYAWESGKLKA 87 (299)
Q Consensus 8 ~~~~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~vK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~ 87 (299)
|+..++|.+.+.||+|++|.||++.+.++..+++|.+.... ...+.+.+|+.+++.++|+|++++++++. ....+
T Consensus 2 ~~~~~~~~~~~~ig~g~~~~v~~~~~~~~~~~~lK~~~~~~---~~~~~~~~E~~~l~~l~h~~i~~~~~~~~--~~~~~ 76 (260)
T cd05069 2 EIPRESLRLDVKLGQGCFGEVWMGTWNGTTKVAIKTLKPGT---MMPEAFLQEAQIMKKLRHDKLVPLYAVVS--EEPIY 76 (260)
T ss_pred cCChHHeeeeeeecCcCCCeEEEEEEcCCceEEEEEcccCC---ccHHHHHHHHHHHHhCCCCCeeeEEEEEc--CCCcE
Confidence 45567899999999999999999998777789999875322 23456788999999999999999998653 34468
Q ss_pred EEEeecCCCChHHHhcCCCCCCCCCChhhHHHHHHHHHHHHHHhhcCCCCCeeeecccCCceeeCCCCcEEEeeeccccc
Q 038766 88 LILEYMENGSLESVIHGPGVDHSRWTLPKRIDVLISVANGLDYLHSGYDIPIVHCDMKPSNILLDRDFEAHVSDFGTSRM 167 (299)
Q Consensus 88 lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lh~~~~~~~~H~dl~~~nil~~~~~~v~l~df~~~~~ 167 (299)
+++||+.+++|.+++... ....+++..+..++.|++.||.|||+. +++|+||+|+||+++.++.++|+|||.+..
T Consensus 77 ~v~e~~~~~~L~~~~~~~--~~~~~~~~~~~~~~~~l~~al~~lH~~---~i~H~dl~~~Nill~~~~~~~l~dfg~~~~ 151 (260)
T cd05069 77 IVTEFMGKGSLLDFLKEG--DGKYLKLPQLVDMAAQIADGMAYIERM---NYIHRDLRAANILVGDNLVCKIADFGLARL 151 (260)
T ss_pred EEEEcCCCCCHHHHHhhC--CCCCCCHHHHHHHHHHHHHHHHHHHhC---CEeecccCcceEEEcCCCeEEECCCccceE
Confidence 999999999999998643 234578899999999999999999999 999999999999999999999999999875
Q ss_pred cccccccccccccccccCcccCChhhhcccCcCccccchhhhHHHHHHHh-CCCCCCCCccCCCCchhHHHHHHHHHhcC
Q 038766 168 LDVHLQDLSSLSTAFQGTIGYLAPEFAYMRIVTTKVDVFSFGIVVMEFLT-KRRPTGLDEENGLSPISLRQLVEKALANG 246 (299)
Q Consensus 168 ~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~DiwslG~~l~~l~~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~ 246 (299)
.... .........++..|+|||...+..++.++|+||||+++|+|++ |..||.... ... .........
T Consensus 152 ~~~~---~~~~~~~~~~~~~y~~Pe~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~-----~~~---~~~~~~~~~ 220 (260)
T cd05069 152 IEDN---EYTARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELVTKGRVPYPGMV-----NRE---VLEQVERGY 220 (260)
T ss_pred ccCC---cccccCCCccchhhCCHHHhccCCcChHHHHHHHHHHHHHHHhCCCCCCCCCC-----HHH---HHHHHHcCC
Confidence 4311 1111122334667999999988889999999999999999999 888885321 111 111111110
Q ss_pred ccCcccccCccccchhhHhHHHHHHHHHHHHHHHHhcCCCCCCCCChhhhhc
Q 038766 247 INGVRQITDPKLVSSIYEEQEQHQVLEELFKLALVCTSSNPEDRPNMNELLI 298 (299)
Q Consensus 247 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rpt~~~il~ 298 (299)
. .. .+...+..+.+++++||..||++|||++++++
T Consensus 221 ~-----~~------------~~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~ 255 (260)
T cd05069 221 R-----MP------------CPQGCPESLHELMKLCWKKDPDERPTFEYIQS 255 (260)
T ss_pred C-----CC------------CCcccCHHHHHHHHHHccCCcccCcCHHHHHH
Confidence 0 00 02234567999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Yes kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Yes (or c-Yes) is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine an |
| >cd08227 PK_STRAD_alpha Pseudokinase domain of STE20-related kinase adapter protein alpha | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-41 Score=289.19 Aligned_cols=274 Identities=20% Similarity=0.247 Sum_probs=195.5
Q ss_pred CCceeecC--CcceEEEEEe-CCCcEEEEEEeccCcCChhhhHHHHHHHHHHHhcCCcceeeeeeEEEcCCCeeEEEEee
Q 038766 16 ENNIIGNS--NLSTVYKGRL-EDGEIVAVKKLNFHQFSAESDKSFYREAKTLKELKHRNLVKVLGYAWESGKLKALILEY 92 (299)
Q Consensus 16 ~~~~lg~g--~~~~v~~~~~-~~~~~~~vK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~lv~e~ 92 (299)
+.+.||+| ++++||++.. .+|+.||+|++............+..|+.+++.++||||+++++++.. ++..++|+||
T Consensus 2 ~~~~ig~G~~~~~~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~hpniv~~~~~~~~-~~~~~lv~e~ 80 (327)
T cd08227 2 LLTVIGRGFEDLMTVNLARYKPTGEYVTVRRINLEACTNEMVTFLQGELHVSKLFNHPNIVPYRATFIA-DNELWVVTSF 80 (327)
T ss_pred hhhhccccccceEEEEEEeecccCcEEEEEEechhhccHHHHHHHHHHHHHHHhcCCCCeeeEEEEEEE-CCEEEEEEec
Confidence 56789999 6789999976 468999999997655455556778889999999999999999997765 4566999999
Q ss_pred cCCCChHHHhcCCCCCCCCCChhhHHHHHHHHHHHHHHhhcCCCCCeeeecccCCceeeCCCCcEEEeeecccccccccc
Q 038766 93 MENGSLESVIHGPGVDHSRWTLPKRIDVLISVANGLDYLHSGYDIPIVHCDMKPSNILLDRDFEAHVSDFGTSRMLDVHL 172 (299)
Q Consensus 93 ~~~~~L~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lh~~~~~~~~H~dl~~~nil~~~~~~v~l~df~~~~~~~~~~ 172 (299)
+++++|.+++... ....+++..++.++.|++.||+|||+. +++|+||||+||+++.++.++++||+.........
T Consensus 81 ~~~~~l~~~~~~~--~~~~l~~~~~~~i~~qi~~~L~~LH~~---~iiH~dlkp~Nil~~~~~~~~l~~~~~~~~~~~~~ 155 (327)
T cd08227 81 MAYGSAKDLICTH--FMDGMSELAIAYILQGVLKALDYIHHM---GYVHRSVKASHILISVDGKVYLSGLRSNLSMINHG 155 (327)
T ss_pred cCCCcHHHHHHhh--ccCCCCHHHHHHHHHHHHHHHHHHHHC---CEecCCCChhhEEEecCCcEEEcccchhhcccccc
Confidence 9999999998643 234589999999999999999999999 99999999999999999999999998654332111
Q ss_pred cc---ccccccccccCcccCChhhhcc--cCcCccccchhhhHHHHHHHhCCCCCCCCccCCCCchhHHHHHHHHHhcCc
Q 038766 173 QD---LSSLSTAFQGTIGYLAPEFAYM--RIVTTKVDVFSFGIVVMEFLTKRRPTGLDEENGLSPISLRQLVEKALANGI 247 (299)
Q Consensus 173 ~~---~~~~~~~~~~~~~y~~PE~~~~--~~~~~~~DiwslG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 247 (299)
.. .........++..|+|||.+.+ ..++.++|||||||++|+|++|..||........ .............
T Consensus 156 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~----~~~~~~~~~~~~~ 231 (327)
T cd08227 156 QRLRVVHDFPKYSVKVLPWLSPEVLQQNLQGYDAKSDIYSVGITACELANGHVPFKDMPATQM----LLEKLNGTVPCLL 231 (327)
T ss_pred ccccccccccccccceecccChHHhhcccCCCCchhhHHHHHHHHHHHHHCCCCCCCcchhHH----HHHHhcCCccccc
Confidence 00 0111122345677999999876 4588999999999999999999999953211100 0000000000000
Q ss_pred ----------------cCc-ccccCc------cc-cchhhHhHHHHHHHHHHHHHHHHhcCCCCCCCCChhhhhcC
Q 038766 248 ----------------NGV-RQITDP------KL-VSSIYEEQEQHQVLEELFKLALVCTSSNPEDRPNMNELLIT 299 (299)
Q Consensus 248 ----------------~~~-~~~~~~------~~-~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rpt~~~il~~ 299 (299)
... ..+... .. ............++.++.+++.+||..||++|||++++++|
T Consensus 232 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rpt~~ell~~ 307 (327)
T cd08227 232 DTTTIPAEELTMKPSRSGANSGLGESTTVSTPRPSNGESSSHPYNRTFSPHFHHFVEQCLQRNPDARPSASTLLNH 307 (327)
T ss_pred cccchhhhhcccCCcccCCcCCCCcccccCCcCccccCCcccccccccCHHHHHHHHHHHhhCchhcCCHHHHhcC
Confidence 000 000000 00 00000011233456789999999999999999999999986
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) alpha subfamily, pseudokinase domain. The STRAD alpha subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hype |
| >cd06615 PKc_MEK Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-40 Score=281.92 Aligned_cols=268 Identities=25% Similarity=0.375 Sum_probs=199.8
Q ss_pred CCCCCCceeecCCcceEEEEEeC-CCcEEEEEEeccCcCChhhhHHHHHHHHHHHhcCCcceeeeeeEEEcCCCeeEEEE
Q 038766 12 GSFSENNIIGNSNLSTVYKGRLE-DGEIVAVKKLNFHQFSAESDKSFYREAKTLKELKHRNLVKVLGYAWESGKLKALIL 90 (299)
Q Consensus 12 ~~y~~~~~lg~g~~~~v~~~~~~-~~~~~~vK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~lv~ 90 (299)
++|++.+.||+|++|.||++.+. ++..+++|.+... ........+.+|++++++++||||+++++.+.. +...++|+
T Consensus 1 ~~~~~~~~lg~G~~g~v~~~~~~~~~~~~a~k~~~~~-~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~-~~~~~lv~ 78 (308)
T cd06615 1 DDFEKLGELGAGNGGVVTKVLHRPSGLIMARKLIHLE-IKPAIRNQIIRELKVLHECNSPYIVGFYGAFYS-DGEISICM 78 (308)
T ss_pred CCceEEeeccCCCCeEEEEEEEcCCCeEEEEEEeccc-cCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEee-CCEEEEEe
Confidence 47999999999999999999864 5788999987643 234456678899999999999999999997765 55679999
Q ss_pred eecCCCChHHHhcCCCCCCCCCChhhHHHHHHHHHHHHHHhhc-CCCCCeeeecccCCceeeCCCCcEEEeeeccccccc
Q 038766 91 EYMENGSLESVIHGPGVDHSRWTLPKRIDVLISVANGLDYLHS-GYDIPIVHCDMKPSNILLDRDFEAHVSDFGTSRMLD 169 (299)
Q Consensus 91 e~~~~~~L~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lh~-~~~~~~~H~dl~~~nil~~~~~~v~l~df~~~~~~~ 169 (299)
||+++++|.+++. ....+++..+..++.|++.||.|||+ . +++|+||+|+||+++.++.++|+|||++....
T Consensus 79 ey~~~~~L~~~l~----~~~~~~~~~~~~~~~~i~~~l~~lH~~~---~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~ 151 (308)
T cd06615 79 EHMDGGSLDQVLK----KAGRIPENILGKISIAVLRGLTYLREKH---KIMHRDVKPSNILVNSRGEIKLCDFGVSGQLI 151 (308)
T ss_pred eccCCCcHHHHHH----hcCCCCHHHHHHHHHHHHHHHHHHHhhC---CEEECCCChHHEEEecCCcEEEccCCCccccc
Confidence 9999999999987 34578999999999999999999997 5 89999999999999999999999999886443
Q ss_pred cccccccccccccccCcccCChhhhcccCcCccccchhhhHHHHHHHhCCCCCCCCccCCCCchhHHHHHHHHHhcCccC
Q 038766 170 VHLQDLSSLSTAFQGTIGYLAPEFAYMRIVTTKVDVFSFGIVVMEFLTKRRPTGLDEENGLSPISLRQLVEKALANGING 249 (299)
Q Consensus 170 ~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~DiwslG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 249 (299)
. .......++..|+|||.+.+..++.++|+||||+++|+|++|..||...... ................
T Consensus 152 ~------~~~~~~~~~~~~~aPE~~~~~~~~~~~DiwslG~~l~~l~~g~~p~~~~~~~-----~~~~~~~~~~~~~~~~ 220 (308)
T cd06615 152 D------SMANSFVGTRSYMSPERLQGTHYTVQSDIWSLGLSLVEMAIGRYPIPPPDAK-----ELEAMFGRPVSEGEAK 220 (308)
T ss_pred c------cccccCCCCcCccChhHhcCCCCCccchHHHHHHHHHHHHhCCCCCCCcchh-----hHHHhhcCcccccccc
Confidence 1 1123445788999999998888999999999999999999999998533211 1111110000000000
Q ss_pred c-------ccccCccccc--hh--------hHhHHHHHHHHHHHHHHHHhcCCCCCCCCChhhhhcC
Q 038766 250 V-------RQITDPKLVS--SI--------YEEQEQHQVLEELFKLALVCTSSNPEDRPNMNELLIT 299 (299)
Q Consensus 250 ~-------~~~~~~~~~~--~~--------~~~~~~~~~~~~l~~li~~~l~~dP~~Rpt~~~il~~ 299 (299)
. .......... .. ........++.++.+++.+||..+|++|||+++++.|
T Consensus 221 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~ll~~ 287 (308)
T cd06615 221 ESHRPVSGHPPDSPRPMAIFELLDYIVNEPPPKLPSGAFSDEFQDFVDKCLKKNPKERADLKELTKH 287 (308)
T ss_pred CCcccccCCCCCccchhhHHHHHHHHhcCCCccCcCcccCHHHHHHHHHHccCChhhCcCHHHHhcC
Confidence 0 0000000000 00 0000011256679999999999999999999999986
|
Protein kinases (PKs), MAP/ERK kinase (MEK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 and MEK2 are dual-specificity PKs that phosphorylate and activate the down |
| >cd05049 PTKc_Trk Catalytic domain of the Protein Tyrosine Kinases, Tropomyosin Related Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.6e-41 Score=281.54 Aligned_cols=256 Identities=28% Similarity=0.438 Sum_probs=199.1
Q ss_pred hCCCCCCceeecCCcceEEEEEeC------CCcEEEEEEeccCcCChhhhHHHHHHHHHHHhcCCcceeeeeeEEEcCCC
Q 038766 11 TGSFSENNIIGNSNLSTVYKGRLE------DGEIVAVKKLNFHQFSAESDKSFYREAKTLKELKHRNLVKVLGYAWESGK 84 (299)
Q Consensus 11 ~~~y~~~~~lg~g~~~~v~~~~~~------~~~~~~vK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~ 84 (299)
.++|.+.+.||+|++|.||++.+. ++..+|+|++.... ..+....+.+|+++++.++|+||+++++++... .
T Consensus 4 ~~~~~~~~~lg~g~~~~v~~~~~~~~~~~~~~~~vaiK~~~~~~-~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~-~ 81 (280)
T cd05049 4 RDTIVLKRELGEGAFGKVFLGECYHLEPENDKELVAVKTLKETA-SNDARKDFEREAELLTNFQHENIVKFYGVCTEG-D 81 (280)
T ss_pred hHHhhHHhhccccCCceEeeeeeccccCcCCcceEEEEeecccC-CHHHHHHHHHHHHHHHhcCCCCchheeeEEecC-C
Confidence 467899999999999999999763 25789999986432 333467889999999999999999999977664 5
Q ss_pred eeEEEEeecCCCChHHHhcCCC----------CCCCCCChhhHHHHHHHHHHHHHHhhcCCCCCeeeecccCCceeeCCC
Q 038766 85 LKALILEYMENGSLESVIHGPG----------VDHSRWTLPKRIDVLISVANGLDYLHSGYDIPIVHCDMKPSNILLDRD 154 (299)
Q Consensus 85 ~~~lv~e~~~~~~L~~~~~~~~----------~~~~~~~~~~~~~i~~qi~~~l~~lh~~~~~~~~H~dl~~~nil~~~~ 154 (299)
..++|+||+.+++|.+++...+ .....+++..+..++.|++.|+++||++ +++|+||+|+||+++.+
T Consensus 82 ~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~---~i~h~dlkp~nili~~~ 158 (280)
T cd05049 82 PPIMVFEYMEHGDLNKFLRSHGPDAAFLKSPDSPMGELTLSQLLQIAVQIASGMVYLASQ---HFVHRDLATRNCLVGYD 158 (280)
T ss_pred CeEEEEecCCCCCHHHHHHhcCCchhhhcccccccccccHHHHHHHHHHHHHHHHHHhhC---CeeccccccceEEEcCC
Confidence 6699999999999999986532 1335688999999999999999999999 99999999999999999
Q ss_pred CcEEEeeeccccccccccccccccccccccCcccCChhhhcccCcCccccchhhhHHHHHHHh-CCCCCCCCccCCCCch
Q 038766 155 FEAHVSDFGTSRMLDVHLQDLSSLSTAFQGTIGYLAPEFAYMRIVTTKVDVFSFGIVVMEFLT-KRRPTGLDEENGLSPI 233 (299)
Q Consensus 155 ~~v~l~df~~~~~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~DiwslG~~l~~l~~-g~~p~~~~~~~~~~~~ 233 (299)
+.++|+|||++...... ...........++.|+|||.+.+..++.++||||||+++|+|++ |..||.... ..
T Consensus 159 ~~~kl~d~g~~~~~~~~--~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~e~~~~g~~p~~~~~-----~~ 231 (280)
T cd05049 159 LVVKIGDFGMSRDVYTT--DYYRVGGHTMLPIRWMPPESIMYRKFTTESDVWSFGVVLWEIFTYGKQPWYGLS-----NE 231 (280)
T ss_pred CeEEECCcccceecccC--cceecCCCCcccceecChhhhccCCcchhhhHHHHHHHHHHHHhcCCCCCCCCC-----HH
Confidence 99999999998654211 01111223334678999999999999999999999999999998 999985331 11
Q ss_pred hHHHHHHHHHhcCccCcccccCccccchhhHhHHHHHHHHHHHHHHHHhcCCCCCCCCChhhhhc
Q 038766 234 SLRQLVEKALANGINGVRQITDPKLVSSIYEEQEQHQVLEELFKLALVCTSSNPEDRPNMNELLI 298 (299)
Q Consensus 234 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rpt~~~il~ 298 (299)
.....+ . .+... . .+..++..+.+++++||..||++|||++++++
T Consensus 232 ~~~~~~---~-~~~~~--~--------------~~~~~~~~~~~li~~~l~~~p~~Rp~~~eil~ 276 (280)
T cd05049 232 EVIECI---T-QGRLL--Q--------------RPRTCPSEVYDIMLGCWKRDPQQRINIKDIHE 276 (280)
T ss_pred HHHHHH---H-cCCcC--C--------------CCCCCCHHHHHHHHHHcCCCcccCCCHHHHHH
Confidence 111111 1 11000 0 01234567899999999999999999999985
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase (Trk) subfamily; catalytic (c) domain. The Trk subfamily consists of TrkA, TrkB, TrkC, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Trk subfamily members are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, the nerve growth factor (NGF) family of neutrotrophins, leads to Trk receptor oligomerization and activation of the catalyt |
| >cd08219 STKc_Nek3 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.6e-41 Score=276.51 Aligned_cols=250 Identities=20% Similarity=0.315 Sum_probs=198.9
Q ss_pred CCCCCceeecCCcceEEEEEeC-CCcEEEEEEeccCcCChhhhHHHHHHHHHHHhcCCcceeeeeeEEEcCCCeeEEEEe
Q 038766 13 SFSENNIIGNSNLSTVYKGRLE-DGEIVAVKKLNFHQFSAESDKSFYREAKTLKELKHRNLVKVLGYAWESGKLKALILE 91 (299)
Q Consensus 13 ~y~~~~~lg~g~~~~v~~~~~~-~~~~~~vK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~lv~e 91 (299)
+|.+.+.||+|++|.||++.+. ++..+++|.+.... .....+.+.+|+..++.++|+|++++.+.+.. +...++|+|
T Consensus 1 ~y~~~~~lg~g~~g~v~~~~~~~~~~~~~iK~~~~~~-~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~-~~~~~lv~e 78 (255)
T cd08219 1 QYNVLRVVGEGSFGRALLVQHVNSDQKYAMKEIRLPK-SSSAVEDSRKEAVLLAKMKHPNIVAFKESFEA-DGHLYIVME 78 (255)
T ss_pred CceEEEEeeccCCeEEEEEEEcCCCceEEEEEEEcCc-chHHHHHHHHHHHHHHhCCCCCcceEEEEEEE-CCEEEEEEe
Confidence 5889999999999999999874 58999999986433 23455678889999999999999999996554 567799999
Q ss_pred ecCCCChHHHhcCCCCCCCCCChhhHHHHHHHHHHHHHHhhcCCCCCeeeecccCCceeeCCCCcEEEeeeccccccccc
Q 038766 92 YMENGSLESVIHGPGVDHSRWTLPKRIDVLISVANGLDYLHSGYDIPIVHCDMKPSNILLDRDFEAHVSDFGTSRMLDVH 171 (299)
Q Consensus 92 ~~~~~~L~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lh~~~~~~~~H~dl~~~nil~~~~~~v~l~df~~~~~~~~~ 171 (299)
|+++++|.+++... ....+++..++.++.|++.||.+||++ +++|+||+|+||+++.++.++++|||.+.....
T Consensus 79 ~~~~~~l~~~~~~~--~~~~~~~~~~~~~~~~i~~al~~lH~~---~i~H~dl~p~nili~~~~~~~l~dfg~~~~~~~- 152 (255)
T cd08219 79 YCDGGDLMQKIKLQ--RGKLFPEDTILQWFVQMCLGVQHIHEK---RVLHRDIKSKNIFLTQNGKVKLGDFGSARLLTS- 152 (255)
T ss_pred eCCCCcHHHHHHhc--cCCCCCHHHHHHHHHHHHHHHHHHhhC---CcccCCCCcceEEECCCCcEEEcccCcceeecc-
Confidence 99999999887532 234688999999999999999999999 999999999999999999999999999875432
Q ss_pred cccccccccccccCcccCChhhhcccCcCccccchhhhHHHHHHHhCCCCCCCCccCCCCchhHHHHHHHHHhcCccCcc
Q 038766 172 LQDLSSLSTAFQGTIGYLAPEFAYMRIVTTKVDVFSFGIVVMEFLTKRRPTGLDEENGLSPISLRQLVEKALANGINGVR 251 (299)
Q Consensus 172 ~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~DiwslG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 251 (299)
.........+++.|+|||.+.+..++.++|+||+|+++|+|++|..||.... . ...............
T Consensus 153 ---~~~~~~~~~~~~~~~aPE~~~~~~~~~~~Dv~slG~i~~~l~~g~~p~~~~~-----~---~~~~~~~~~~~~~~~- 220 (255)
T cd08219 153 ---PGAYACTYVGTPYYVPPEIWENMPYNNKSDIWSLGCILYELCTLKHPFQANS-----W---KNLILKVCQGSYKPL- 220 (255)
T ss_pred ---cccccccccCCccccCHHHHccCCcCchhhhhhhchhheehhhccCCCCCCC-----H---HHHHHHHhcCCCCCC-
Confidence 1122234457888999999998889999999999999999999999985331 1 111111111110000
Q ss_pred cccCccccchhhHhHHHHHHHHHHHHHHHHhcCCCCCCCCChhhhhc
Q 038766 252 QITDPKLVSSIYEEQEQHQVLEELFKLALVCTSSNPEDRPNMNELLI 298 (299)
Q Consensus 252 ~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rpt~~~il~ 298 (299)
+..++..+.++|.+||..||++|||+++++.
T Consensus 221 ----------------~~~~~~~~~~li~~~l~~~P~~Rp~~~~il~ 251 (255)
T cd08219 221 ----------------PSHYSYELRSLIKQMFKRNPRSRPSATTILS 251 (255)
T ss_pred ----------------CcccCHHHHHHHHHHHhCCcccCCCHHHHhh
Confidence 1234457889999999999999999999985
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 3 (Nek3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek3 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek3 is primarily localized in the cytoplasm and shows no cell cycle-dependent changes in its activity. It is present in the axons of neurons and affects morphogenesis and polarity through its regulation of microtubule acetylation. Nek3 modulates the signaling of the prolactin receptor through its activati |
| >cd06654 STKc_PAK1 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.1e-41 Score=283.45 Aligned_cols=252 Identities=25% Similarity=0.378 Sum_probs=199.7
Q ss_pred HhCCCCCCceeecCCcceEEEEEe-CCCcEEEEEEeccCcCChhhhHHHHHHHHHHHhcCCcceeeeeeEEEcCCCeeEE
Q 038766 10 ATGSFSENNIIGNSNLSTVYKGRL-EDGEIVAVKKLNFHQFSAESDKSFYREAKTLKELKHRNLVKVLGYAWESGKLKAL 88 (299)
Q Consensus 10 ~~~~y~~~~~lg~g~~~~v~~~~~-~~~~~~~vK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~l 88 (299)
...+|.+.+.||+|++|.||++.+ .++..+++|.+.... ......+.+|+.+++.+.|+|++++++.+.. +...++
T Consensus 18 ~~~~y~~~~~lg~g~~~~v~~~~~~~~~~~v~ik~~~~~~--~~~~~~~~~e~~~l~~~~h~~v~~~~~~~~~-~~~~~l 94 (296)
T cd06654 18 PKKKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQ--QPKKELIINEILVMRENKNPNIVNYLDSYLV-GDELWV 94 (296)
T ss_pred cccceeeEEEecCCCCeEEEEEEECCCCcEEEEEEEecCC--cchHHHHHHHHHHHHhCCCCCEeeEEEEEEe-CCEEEE
Confidence 356899999999999999999986 468899999986433 2334678889999999999999999997665 556799
Q ss_pred EEeecCCCChHHHhcCCCCCCCCCChhhHHHHHHHHHHHHHHhhcCCCCCeeeecccCCceeeCCCCcEEEeeecccccc
Q 038766 89 ILEYMENGSLESVIHGPGVDHSRWTLPKRIDVLISVANGLDYLHSGYDIPIVHCDMKPSNILLDRDFEAHVSDFGTSRML 168 (299)
Q Consensus 89 v~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lh~~~~~~~~H~dl~~~nil~~~~~~v~l~df~~~~~~ 168 (299)
|+||+.+++|.+++. ...+++.++..++.|++.||.|||+. +++|+||+|+||+++.++.++|+|||++...
T Consensus 95 v~e~~~~~~L~~~~~-----~~~~~~~~~~~i~~ql~~aL~~LH~~---gi~H~dLkp~Nill~~~~~~kl~dfg~~~~~ 166 (296)
T cd06654 95 VMEYLAGGSLTDVVT-----ETCMDEGQIAAVCRECLQALEFLHSN---QVIHRDIKSDNILLGMDGSVKLTDFGFCAQI 166 (296)
T ss_pred eecccCCCCHHHHHH-----hcCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCHHHEEEcCCCCEEECccccchhc
Confidence 999999999999985 23578899999999999999999999 9999999999999999999999999988754
Q ss_pred ccccccccccccccccCcccCChhhhcccCcCccccchhhhHHHHHHHhCCCCCCCCccCCCCchhHHHHHHHHHhcCcc
Q 038766 169 DVHLQDLSSLSTAFQGTIGYLAPEFAYMRIVTTKVDVFSFGIVVMEFLTKRRPTGLDEENGLSPISLRQLVEKALANGIN 248 (299)
Q Consensus 169 ~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~DiwslG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 248 (299)
... ........+++.|+|||.+.+..++.++|+||+||++|+|++|..||...... .... ......
T Consensus 167 ~~~----~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~s~Gvil~~l~~g~~pf~~~~~~-------~~~~-~~~~~~-- 232 (296)
T cd06654 167 TPE----QSKRSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMIEGEPPYLNENPL-------RALY-LIATNG-- 232 (296)
T ss_pred ccc----ccccCcccCCccccCHHHHcCCCCCccchHHHHHHHHHHHHhCCCCCCCCCHH-------HhHH-HHhcCC--
Confidence 311 11122345778999999999888999999999999999999999999543211 0111 111101
Q ss_pred CcccccCccccchhhHhHHHHHHHHHHHHHHHHhcCCCCCCCCChhhhhcC
Q 038766 249 GVRQITDPKLVSSIYEEQEQHQVLEELFKLALVCTSSNPEDRPNMNELLIT 299 (299)
Q Consensus 249 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rpt~~~il~~ 299 (299)
...... +..++..+.+++.+||..+|++|||+++++.|
T Consensus 233 -~~~~~~------------~~~~~~~l~~li~~~l~~~p~~Rpt~~eil~~ 270 (296)
T cd06654 233 -TPELQN------------PEKLSAIFRDFLNRCLDMDVEKRGSAKELLQH 270 (296)
T ss_pred -CCCCCC------------ccccCHHHHHHHHHHCcCCcccCcCHHHHhhC
Confidence 000001 23455678999999999999999999999976
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 1, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK1 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding |
| >cd06656 STKc_PAK3 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.6e-41 Score=282.56 Aligned_cols=253 Identities=25% Similarity=0.364 Sum_probs=200.7
Q ss_pred HHhCCCCCCceeecCCcceEEEEEe-CCCcEEEEEEeccCcCChhhhHHHHHHHHHHHhcCCcceeeeeeEEEcCCCeeE
Q 038766 9 NATGSFSENNIIGNSNLSTVYKGRL-EDGEIVAVKKLNFHQFSAESDKSFYREAKTLKELKHRNLVKVLGYAWESGKLKA 87 (299)
Q Consensus 9 ~~~~~y~~~~~lg~g~~~~v~~~~~-~~~~~~~vK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~ 87 (299)
...++|.+.+.||+|++|.||++.+ .+++.||+|.+.... ....+.+.+|+.+++.++|+|++++++.+.. +...+
T Consensus 16 ~~~~~y~~~~~lg~g~~g~v~~~~~~~~~~~vaiK~~~~~~--~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~-~~~~~ 92 (297)
T cd06656 16 DPKKKYTRFEKIGQGASGTVYTAIDIATGQEVAIKQMNLQQ--QPKKELIINEILVMRENKNPNIVNYLDSYLV-GDELW 92 (297)
T ss_pred ChhhhceeeeeeccCCCeEEEEEEECCCCCEEEEEEEecCc--cchHHHHHHHHHHHHhCCCCCEeeEEEEEec-CCEEE
Confidence 3458999999999999999999986 468999999986433 2334667889999999999999999997655 55679
Q ss_pred EEEeecCCCChHHHhcCCCCCCCCCChhhHHHHHHHHHHHHHHhhcCCCCCeeeecccCCceeeCCCCcEEEeeeccccc
Q 038766 88 LILEYMENGSLESVIHGPGVDHSRWTLPKRIDVLISVANGLDYLHSGYDIPIVHCDMKPSNILLDRDFEAHVSDFGTSRM 167 (299)
Q Consensus 88 lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lh~~~~~~~~H~dl~~~nil~~~~~~v~l~df~~~~~ 167 (299)
+|+||+++++|.+++. ...+++..+..++.|++.+|.+||+. +++|+||+|+||+++.++.++|+|||++..
T Consensus 93 lv~e~~~~~~L~~~~~-----~~~~~~~~~~~~~~~l~~~L~~LH~~---~i~H~dL~p~Nili~~~~~~~l~Dfg~~~~ 164 (297)
T cd06656 93 VVMEYLAGGSLTDVVT-----ETCMDEGQIAAVCRECLQALDFLHSN---QVIHRDIKSDNILLGMDGSVKLTDFGFCAQ 164 (297)
T ss_pred EeecccCCCCHHHHHH-----hCCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCHHHEEECCCCCEEECcCccceE
Confidence 9999999999999985 24578899999999999999999999 999999999999999999999999998865
Q ss_pred cccccccccccccccccCcccCChhhhcccCcCccccchhhhHHHHHHHhCCCCCCCCccCCCCchhHHHHHHHHHhcCc
Q 038766 168 LDVHLQDLSSLSTAFQGTIGYLAPEFAYMRIVTTKVDVFSFGIVVMEFLTKRRPTGLDEENGLSPISLRQLVEKALANGI 247 (299)
Q Consensus 168 ~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~DiwslG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 247 (299)
.... ........+++.|+|||.+.+..++.++|+||+|+++|+|++|..||......... . ......
T Consensus 165 ~~~~----~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slGvil~~l~tg~~pf~~~~~~~~~-------~-~~~~~~- 231 (297)
T cd06656 165 ITPE----QSKRSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMVEGEPPYLNENPLRAL-------Y-LIATNG- 231 (297)
T ss_pred ccCC----ccCcCcccCCccccCHHHHcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCcchhe-------e-eeccCC-
Confidence 4321 11122345678899999999888999999999999999999999999543211000 0 000000
Q ss_pred cCcccccCccccchhhHhHHHHHHHHHHHHHHHHhcCCCCCCCCChhhhhcC
Q 038766 248 NGVRQITDPKLVSSIYEEQEQHQVLEELFKLALVCTSSNPEDRPNMNELLIT 299 (299)
Q Consensus 248 ~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rpt~~~il~~ 299 (299)
.... ..+..++..+.+++.+||..+|++|||++++++|
T Consensus 232 --~~~~------------~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~ 269 (297)
T cd06656 232 --TPEL------------QNPERLSAVFRDFLNRCLEMDVDRRGSAKELLQH 269 (297)
T ss_pred --CCCC------------CCccccCHHHHHHHHHHccCChhhCcCHHHHhcC
Confidence 0000 0123455678999999999999999999999986
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 3, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK3 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding |
| >cd05068 PTKc_Frk_like Catalytic domain of Fyn-related kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.8e-41 Score=277.75 Aligned_cols=254 Identities=27% Similarity=0.408 Sum_probs=198.7
Q ss_pred HHHhCCCCCCceeecCCcceEEEEEeCCCcEEEEEEeccCcCChhhhHHHHHHHHHHHhcCCcceeeeeeEEEcCCCeeE
Q 038766 8 ENATGSFSENNIIGNSNLSTVYKGRLEDGEIVAVKKLNFHQFSAESDKSFYREAKTLKELKHRNLVKVLGYAWESGKLKA 87 (299)
Q Consensus 8 ~~~~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~vK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~ 87 (299)
|...++|++.+.||+|++|.||++.+.+++.||+|.+.... ...+.+.+|+..+++++|+|++++++++.. ++..+
T Consensus 2 ~~~~~~~~~~~~lg~g~~~~v~~~~~~~~~~v~iK~~~~~~---~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~-~~~~~ 77 (261)
T cd05068 2 EIDRTSIQLLRKLGAGQFGEVWEGLWNNTTPVAVKTLKPGT---MDPKDFLAEAQIMKKLRHPKLIQLYAVCTL-EEPIY 77 (261)
T ss_pred ccchhheeeEEEecccCCccEEEEEecCCeEEEEEeeCCCc---ccHHHHHHHHHHHHHCCCCCccceeEEEec-CCCee
Confidence 45567899999999999999999988777889999986432 235668889999999999999999996655 45569
Q ss_pred EEEeecCCCChHHHhcCCCCCCCCCChhhHHHHHHHHHHHHHHhhcCCCCCeeeecccCCceeeCCCCcEEEeeeccccc
Q 038766 88 LILEYMENGSLESVIHGPGVDHSRWTLPKRIDVLISVANGLDYLHSGYDIPIVHCDMKPSNILLDRDFEAHVSDFGTSRM 167 (299)
Q Consensus 88 lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lh~~~~~~~~H~dl~~~nil~~~~~~v~l~df~~~~~ 167 (299)
+|+|++.+++|.+++... ....++...+..++.|++.||.+||+. +++|+||+|+||+++.++.++|+|||++..
T Consensus 78 lv~e~~~~~~L~~~~~~~--~~~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dl~p~Nil~~~~~~~~l~dfg~~~~ 152 (261)
T cd05068 78 IVTELMKYGSLLEYLQGG--AGRALKLPQLIDMAAQVASGMAYLEAQ---NYIHRDLAARNVLVGENNICKVADFGLARV 152 (261)
T ss_pred eeeecccCCcHHHHHhcc--CCCCCCHHHHHHHHHHHHHHHHHHHhC---CeeeccCCcceEEEcCCCCEEECCcceEEE
Confidence 999999999999998643 234689999999999999999999999 999999999999999999999999999876
Q ss_pred cccccccccccccccccCcccCChhhhcccCcCccccchhhhHHHHHHHh-CCCCCCCCccCCCCchhHHHHHHHHHhcC
Q 038766 168 LDVHLQDLSSLSTAFQGTIGYLAPEFAYMRIVTTKVDVFSFGIVVMEFLT-KRRPTGLDEENGLSPISLRQLVEKALANG 246 (299)
Q Consensus 168 ~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~DiwslG~~l~~l~~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~ 246 (299)
..... .........+..|+|||.+.+..++.++|+||||+++++|++ |..||... ....... .... .
T Consensus 153 ~~~~~---~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~-----~~~~~~~---~~~~-~ 220 (261)
T cd05068 153 IKEDI---YEAREGAKFPIKWTAPEAALYNRFSIKSDVWSFGILLTEIVTYGRMPYPGM-----TNAEVLQ---QVDQ-G 220 (261)
T ss_pred ccCCc---ccccCCCcCceeccCccccccCCCCchhhHHHHHHHHHHHHhcCCCCCCCC-----CHHHHHH---HHHc-C
Confidence 54110 011111122457999999998889999999999999999999 88888432 1111111 1111 1
Q ss_pred ccCcccccCccccchhhHhHHHHHHHHHHHHHHHHhcCCCCCCCCChhhhhc
Q 038766 247 INGVRQITDPKLVSSIYEEQEQHQVLEELFKLALVCTSSNPEDRPNMNELLI 298 (299)
Q Consensus 247 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rpt~~~il~ 298 (299)
. .... +...+..+.+++.+|++.+|++|||+.++++
T Consensus 221 ~----~~~~------------~~~~~~~~~~li~~~l~~~P~~Rp~~~~l~~ 256 (261)
T cd05068 221 Y----RMPC------------PPGCPKELYDIMLDCWKEDPDDRPTFETLQW 256 (261)
T ss_pred C----CCCC------------CCcCCHHHHHHHHHHhhcCcccCCCHHHHHH
Confidence 0 0000 1223467999999999999999999999874
|
Protein Tyrosine Kinase (PTK) family; Human Fyn-related kinase (Frk) and similar proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Frk and Srk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins a |
| >cd05597 STKc_DMPK_like Catalytic domain of Myotonic Dystrophy protein kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-40 Score=285.83 Aligned_cols=257 Identities=21% Similarity=0.246 Sum_probs=195.3
Q ss_pred CCCCCCceeecCCcceEEEEEeC-CCcEEEEEEeccCc-CChhhhHHHHHHHHHHHhcCCcceeeeeeEEEcCCCeeEEE
Q 038766 12 GSFSENNIIGNSNLSTVYKGRLE-DGEIVAVKKLNFHQ-FSAESDKSFYREAKTLKELKHRNLVKVLGYAWESGKLKALI 89 (299)
Q Consensus 12 ~~y~~~~~lg~g~~~~v~~~~~~-~~~~~~vK~~~~~~-~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~lv 89 (299)
++|.+.+.||+|+||+||++.+. +++.||+|++.... ........+..|..+++.++|+||+++++++.. +...++|
T Consensus 1 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~-~~~~~lv 79 (331)
T cd05597 1 DDFEILKVIGRGAFGEVAVVKMKNTGQVYAMKILNKWEMLKRAETACFREERDVLVNGDRRWITNLHYAFQD-ENNLYLV 79 (331)
T ss_pred CCceEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHhCCCCCCCceEEEEec-CCeEEEE
Confidence 57999999999999999999864 58999999986422 223345567889999999999999999996554 5667999
Q ss_pred EeecCCCChHHHhcCCCCCCCCCChhhHHHHHHHHHHHHHHhhcCCCCCeeeecccCCceeeCCCCcEEEeeeccccccc
Q 038766 90 LEYMENGSLESVIHGPGVDHSRWTLPKRIDVLISVANGLDYLHSGYDIPIVHCDMKPSNILLDRDFEAHVSDFGTSRMLD 169 (299)
Q Consensus 90 ~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lh~~~~~~~~H~dl~~~nil~~~~~~v~l~df~~~~~~~ 169 (299)
+||+.+++|.+++... ...+++..+..++.||+.||+|||+. +++|+||||+||+++.++.++|+|||++..+.
T Consensus 80 ~e~~~g~~L~~~l~~~---~~~~~~~~~~~~~~qi~~~l~~lH~~---~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~ 153 (331)
T cd05597 80 MDYYVGGDLLTLLSKF---EDRLPEDMARFYLAEMVLAIDSVHQL---GYVHRDIKPDNVLLDKNGHIRLADFGSCLRLL 153 (331)
T ss_pred EecCCCCcHHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHhC---CeEECCCCHHHEEECCCCCEEEEECCceeecC
Confidence 9999999999998632 34689999999999999999999999 99999999999999999999999999986543
Q ss_pred cccccccccccccccCcccCChhhhcc-----cCcCccccchhhhHHHHHHHhCCCCCCCCccCCCCchhHHHHHHHHHh
Q 038766 170 VHLQDLSSLSTAFQGTIGYLAPEFAYM-----RIVTTKVDVFSFGIVVMEFLTKRRPTGLDEENGLSPISLRQLVEKALA 244 (299)
Q Consensus 170 ~~~~~~~~~~~~~~~~~~y~~PE~~~~-----~~~~~~~DiwslG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~ 244 (299)
.. .........+++.|+|||++.. ..++.++||||+||++|+|++|..||..... .+.......
T Consensus 154 ~~---~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwslG~~l~el~~g~~Pf~~~~~--------~~~~~~i~~ 222 (331)
T cd05597 154 AD---GTVQSNVAVGTPDYISPEILQAMEDGKGRYGPECDWWSLGVCMYEMLYGETPFYAESL--------VETYGKIMN 222 (331)
T ss_pred CC---CCccccceeccccccCHHHHhhccccccCCCCcceeehhhhHHHHHhhCCCCCCCCCH--------HHHHHHHHc
Confidence 21 1111223457899999998863 4567899999999999999999999853211 111111111
Q ss_pred cCccCcccccCccccchhhHhHHHHHHHHHHHHHHHHhcCCCCCC--CCChhhhhcC
Q 038766 245 NGINGVRQITDPKLVSSIYEEQEQHQVLEELFKLALVCTSSNPED--RPNMNELLIT 299 (299)
Q Consensus 245 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~--Rpt~~~il~~ 299 (299)
.. ....+.. ....++..+.++|++||..++.+ |++++++++|
T Consensus 223 ~~--~~~~~~~-----------~~~~~~~~~~~li~~ll~~~~~r~~r~~~~~~l~h 266 (331)
T cd05597 223 HK--EHFQFPP-----------DVTDVSEEAKDLIRRLICSPETRLGRNGLQDFKDH 266 (331)
T ss_pred CC--CcccCCC-----------ccCCCCHHHHHHHHHHccCcccccCCCCHHHHhcC
Confidence 00 0000000 01225678899999988764444 8899999987
|
Serine/Threonine Kinases (STKs), Myotonic Dystrophy protein kinase (DMPK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The DMPK-like subfamily is composed of DMPK and DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK). Three isoforms of MRCK are known, named alpha, beta and gamma. The DMPK gene is implicated in myotonic dystrophy 1 (DM1), an inherited multisystemic disorder with symptoms that include muscle hyperexcitability, progressive muscle weakness and wasting, cataract development, testicular atrophy, |
| >KOG0032 consensus Ca2+/calmodulin-dependent protein kinase, EF-Hand protein superfamily [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-40 Score=284.09 Aligned_cols=256 Identities=23% Similarity=0.323 Sum_probs=209.8
Q ss_pred HHHhCCCCCCceeecCCcceEEEEEeCC-CcEEEEEEeccCcCCh-hhhHHHHHHHHHHHhcC-CcceeeeeeEEEcCCC
Q 038766 8 ENATGSFSENNIIGNSNLSTVYKGRLED-GEIVAVKKLNFHQFSA-ESDKSFYREAKTLKELK-HRNLVKVLGYAWESGK 84 (299)
Q Consensus 8 ~~~~~~y~~~~~lg~g~~~~v~~~~~~~-~~~~~vK~~~~~~~~~-~~~~~~~~e~~~l~~l~-h~~i~~~~~~~~~~~~ 84 (299)
+.+.+.|.+.+.||+|.||.||++.... |+.+|+|++....... .....+.+|+.+|+++. ||||+.+.+++.. ..
T Consensus 31 ~~~~~~Y~l~~~lG~G~Fg~v~~~~~~~tg~~~A~K~i~k~~~~~~~~~~~v~~Ev~il~~l~~hpniv~l~~~~e~-~~ 109 (382)
T KOG0032|consen 31 EDIKEKYELGRELGRGQFGVVYLCREKSTGKEVACKVIPKRKLRGKEDREDVRREVAILQQLSGHPNIVQLKDAFED-PD 109 (382)
T ss_pred ccccccEEehhhhCCCCceEEEEEEecCCCceeEEEEeehhhccccccHHHHHHHHHHHHhccCCCCEEEEEEEEEc-CC
Confidence 4567889999999999999999998754 9999999997544332 34678999999999999 9999999996555 55
Q ss_pred eeEEEEeecCCCChHHHhcCCCCCCCCCChhhHHHHHHHHHHHHHHhhcCCCCCeeeecccCCceeeCCC----CcEEEe
Q 038766 85 LKALILEYMENGSLESVIHGPGVDHSRWTLPKRIDVLISVANGLDYLHSGYDIPIVHCDMKPSNILLDRD----FEAHVS 160 (299)
Q Consensus 85 ~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lh~~~~~~~~H~dl~~~nil~~~~----~~v~l~ 160 (299)
..++|||++.||.|.+.+... .+++..+..++.|++.+++|||+. +++|+|+||+|+|+... +.++++
T Consensus 110 ~~~lvmEL~~GGeLfd~i~~~-----~~sE~da~~~~~~il~av~~lH~~---gvvHrDlKpEN~L~~~~~~~~~~ik~~ 181 (382)
T KOG0032|consen 110 SVYLVMELCEGGELFDRIVKK-----HYSERDAAGIIRQILEAVKYLHSL---GVVHRDLKPENLLLASKDEGSGRIKLI 181 (382)
T ss_pred eEEEEEEecCCchHHHHHHHc-----cCCHHHHHHHHHHHHHHHHHHHhC---CceeccCCHHHeeeccccCCCCcEEEe
Confidence 679999999999999988643 399999999999999999999999 99999999999999643 479999
Q ss_pred eeccccccccccccccccccccccCcccCChhhhcccCcCccccchhhhHHHHHHHhCCCCCCCCccCCCCchhHHHHHH
Q 038766 161 DFGTSRMLDVHLQDLSSLSTAFQGTIGYLAPEFAYMRIVTTKVDVFSFGIVVMEFLTKRRPTGLDEENGLSPISLRQLVE 240 (299)
Q Consensus 161 df~~~~~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~DiwslG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~ 240 (299)
|||++..... ........||+.|+|||.+.+..|+...||||+|+++|.|++|.+||...... . ...
T Consensus 182 DFGla~~~~~-----~~~~~~~~Gtp~y~APEvl~~~~y~~~~DiWS~Gvi~yiLL~G~~PF~~~~~~-----~---~~~ 248 (382)
T KOG0032|consen 182 DFGLAKFIKP-----GERLHTIVGTPEYVAPEVLGGRPYGDEVDVWSIGVILYILLSGVPPFWGETEF-----E---IFL 248 (382)
T ss_pred eCCCceEccC-----CceEeeecCCccccCchhhcCCCCCcccchhHHHHHHHHHhhCCCCCcCCChh-----H---HHH
Confidence 9999987652 44566778999999999999999999999999999999999999999544221 1 111
Q ss_pred HHHhcCccCcccccCccccchhhHhHHHHHHHHHHHHHHHHhcCCCCCCCCChhhhhcC
Q 038766 241 KALANGINGVRQITDPKLVSSIYEEQEQHQVLEELFKLALVCTSSNPEDRPNMNELLIT 299 (299)
Q Consensus 241 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rpt~~~il~~ 299 (299)
.+....+ .+.. ..-..++..+.++|++|+..||.+|+|+.++|+|
T Consensus 249 ~i~~~~~----~f~~----------~~w~~is~~akd~i~~ll~~dp~~R~ta~~~L~H 293 (382)
T KOG0032|consen 249 AILRGDF----DFTS----------EPWDDISESAKDFIRKLLEFDPRKRLTAAQALQH 293 (382)
T ss_pred HHHcCCC----CCCC----------CCccccCHHHHHHHHHhcccCcccCCCHHHHhcC
Confidence 1111111 1111 1133457789999999999999999999999987
|
|
| >cd06638 STKc_myosinIIIA Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIA myosin | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.9e-41 Score=282.29 Aligned_cols=262 Identities=26% Similarity=0.326 Sum_probs=200.8
Q ss_pred HHHHHHhCCCCCCceeecCCcceEEEEEeC-CCcEEEEEEeccCcCChhhhHHHHHHHHHHHhc-CCcceeeeeeEEE--
Q 038766 5 TEIENATGSFSENNIIGNSNLSTVYKGRLE-DGEIVAVKKLNFHQFSAESDKSFYREAKTLKEL-KHRNLVKVLGYAW-- 80 (299)
Q Consensus 5 ~~~~~~~~~y~~~~~lg~g~~~~v~~~~~~-~~~~~~vK~~~~~~~~~~~~~~~~~e~~~l~~l-~h~~i~~~~~~~~-- 80 (299)
+......++|.+.+.||+|++|.||++.+. +++.+++|++... ......+..|+..++.+ +|+|++++++++.
T Consensus 11 ~~~~~~~~~~~~~~~lg~g~~~~vy~~~~~~~~~~~~ik~~~~~---~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~ 87 (286)
T cd06638 11 DSFPDPSDTWEIIETIGKGTYGKVFKVLNKKNGSKAAVKILDPI---HDIDEEIEAEYNILKALSDHPNVVKFYGMYYKK 87 (286)
T ss_pred ecCCCcccceeeeeeeccCCCcEEEEEEECCCCceeEEEeeccc---cchHHHHHHHHHHHHHHhcCCCeeeeeeeeeec
Confidence 445567889999999999999999999864 5889999987532 22335677899999999 6999999999765
Q ss_pred --cCCCeeEEEEeecCCCChHHHhcCCCCCCCCCChhhHHHHHHHHHHHHHHhhcCCCCCeeeecccCCceeeCCCCcEE
Q 038766 81 --ESGKLKALILEYMENGSLESVIHGPGVDHSRWTLPKRIDVLISVANGLDYLHSGYDIPIVHCDMKPSNILLDRDFEAH 158 (299)
Q Consensus 81 --~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lh~~~~~~~~H~dl~~~nil~~~~~~v~ 158 (299)
..+...++|+||+++++|.+++.........+++..++.++.|++.||.|||+. +++|+||+|+||+++.++.++
T Consensus 88 ~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dlkp~nili~~~~~~k 164 (286)
T cd06638 88 DVKNGDQLWLVLELCNGGSVTDLVKGFLKRGERMEEPIIAYILHEALMGLQHLHVN---KTIHRDVKGNNILLTTEGGVK 164 (286)
T ss_pred ccCCCCeEEEEEeecCCCCHHHHHHHhhccCccccHHHHHHHHHHHHHHHHHHHhC---CccccCCCHHhEEECCCCCEE
Confidence 234567999999999999988754333456789999999999999999999999 999999999999999999999
Q ss_pred EeeeccccccccccccccccccccccCcccCChhhhcc-----cCcCccccchhhhHHHHHHHhCCCCCCCCccCCCCch
Q 038766 159 VSDFGTSRMLDVHLQDLSSLSTAFQGTIGYLAPEFAYM-----RIVTTKVDVFSFGIVVMEFLTKRRPTGLDEENGLSPI 233 (299)
Q Consensus 159 l~df~~~~~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~-----~~~~~~~DiwslG~~l~~l~~g~~p~~~~~~~~~~~~ 233 (299)
|+|||++...... ........+++.|+|||.+.. ..++.++|+||+||++|+|++|..||......
T Consensus 165 l~dfg~~~~~~~~----~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slGvi~~el~~g~~p~~~~~~~----- 235 (286)
T cd06638 165 LVDFGVSAQLTST----RLRRNTSVGTPFWMAPEVIACEQQLDSTYDARCDVWSLGITAIELGDGDPPLADLHPM----- 235 (286)
T ss_pred EccCCceeecccC----CCccccccCCCcccChhhhchhhhccccccchhhhhhHHHHHHHHhcCCCCCCCCchh-----
Confidence 9999998754321 112234457889999998753 44788999999999999999999998533110
Q ss_pred hHHHHHHHHHhcCccCcccccCccccchhhHhHHHHHHHHHHHHHHHHhcCCCCCCCCChhhhhcC
Q 038766 234 SLRQLVEKALANGINGVRQITDPKLVSSIYEEQEQHQVLEELFKLALVCTSSNPEDRPNMNELLIT 299 (299)
Q Consensus 234 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rpt~~~il~~ 299 (299)
... ...... ....... +...+..+.+++.+||..||++|||+.++++|
T Consensus 236 --~~~-~~~~~~---~~~~~~~------------~~~~~~~~~~li~~~l~~~p~~Rps~~ell~~ 283 (286)
T cd06638 236 --RAL-FKIPRN---PPPTLHQ------------PELWSNEFNDFIRKCLTKDYEKRPTVSDLLQH 283 (286)
T ss_pred --HHH-hhcccc---CCCcccC------------CCCcCHHHHHHHHHHccCCcccCCCHHHHhhc
Confidence 000 000000 0000001 11234578999999999999999999999987
|
Serine/threonine kinases (STKs), class IIIA myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. In photoreceptor cells, they may also function as cargo carriers during light-dependent translocation of proteins such as transducin and arrestin. Class IIIA myosin is highly expressed in retina and in inner ear |
| >cd05113 PTKc_Btk_Bmx Catalytic domain of the Protein Tyrosine Kinases, Bruton's tyrosine kinase and Bone marrow kinase on the X chromosome | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.5e-41 Score=277.10 Aligned_cols=251 Identities=24% Similarity=0.346 Sum_probs=195.6
Q ss_pred hCCCCCCceeecCCcceEEEEEeCCCcEEEEEEeccCcCChhhhHHHHHHHHHHHhcCCcceeeeeeEEEcCCCeeEEEE
Q 038766 11 TGSFSENNIIGNSNLSTVYKGRLEDGEIVAVKKLNFHQFSAESDKSFYREAKTLKELKHRNLVKVLGYAWESGKLKALIL 90 (299)
Q Consensus 11 ~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~vK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~lv~ 90 (299)
.++|.+.+.||+|++|+||.+...++..+|+|.+.... ...+.+.+|+..++++.||||+++++++.. ....++|+
T Consensus 3 ~~~~~~~~~lg~G~~~~vy~~~~~~~~~~aik~~~~~~---~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~-~~~~~lv~ 78 (256)
T cd05113 3 PKDLTFLKELGTGQFGVVKYGKWRGQYDVAIKMIKEGS---MSEDEFIEEAKVMMKLSHEKLVQLYGVCTK-QRPIYIVT 78 (256)
T ss_pred hHHeEEeeEecCcccceEEEEEecCCCcEEEEEcCCCc---ccHHHHHHHHHHHhcCCCCCeeeEEEEEcc-CCCcEEEE
Confidence 35788999999999999999988777789999886432 234568899999999999999999997654 44569999
Q ss_pred eecCCCChHHHhcCCCCCCCCCChhhHHHHHHHHHHHHHHhhcCCCCCeeeecccCCceeeCCCCcEEEeeecccccccc
Q 038766 91 EYMENGSLESVIHGPGVDHSRWTLPKRIDVLISVANGLDYLHSGYDIPIVHCDMKPSNILLDRDFEAHVSDFGTSRMLDV 170 (299)
Q Consensus 91 e~~~~~~L~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lh~~~~~~~~H~dl~~~nil~~~~~~v~l~df~~~~~~~~ 170 (299)
||+.+++|.+++... ...+++..++.++.|++.||+|||+. +++|+||+|+||+++.++.++|+|||.+.....
T Consensus 79 e~~~~~~l~~~i~~~---~~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dl~p~nili~~~~~~kl~d~g~~~~~~~ 152 (256)
T cd05113 79 EYMSNGCLLNYLREH---GKRFQPSQLLEMCKDVCEGMAYLESK---QFIHRDLAARNCLVDDQGCVKVSDFGLSRYVLD 152 (256)
T ss_pred EcCCCCcHHHHHHhc---CCCCCHHHHHHHHHHHHHHHHHHHhC---CeeccccCcceEEEcCCCCEEECCCccceecCC
Confidence 999999999988642 23689999999999999999999999 999999999999999999999999998865431
Q ss_pred ccccccccccccccCcccCChhhhcccCcCccccchhhhHHHHHHHh-CCCCCCCCccCCCCchhHHHHHHHHHhcCccC
Q 038766 171 HLQDLSSLSTAFQGTIGYLAPEFAYMRIVTTKVDVFSFGIVVMEFLT-KRRPTGLDEENGLSPISLRQLVEKALANGING 249 (299)
Q Consensus 171 ~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~DiwslG~~l~~l~~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 249 (299)
. .........++..|+|||...+..++.++|+||||+++|+|++ |..||.... ...... ........
T Consensus 153 ~---~~~~~~~~~~~~~y~~pe~~~~~~~~~~~Di~slG~~l~~l~~~g~~p~~~~~-----~~~~~~---~~~~~~~~- 220 (256)
T cd05113 153 D---EYTSSVGSKFPVRWSPPEVLLYSKFSSKSDVWAFGVLMWEVYSLGKMPYERFN-----NSETVE---KVSQGLRL- 220 (256)
T ss_pred C---ceeecCCCccChhhCCHHHHhcCcccchhHHHHHHHHHHHHhcCCCCCcCcCC-----HHHHHH---HHhcCCCC-
Confidence 1 1111112234567999999988889999999999999999998 888884321 111111 11111100
Q ss_pred cccccCccccchhhHhHHHHHHHHHHHHHHHHhcCCCCCCCCChhhhhcC
Q 038766 250 VRQITDPKLVSSIYEEQEQHQVLEELFKLALVCTSSNPEDRPNMNELLIT 299 (299)
Q Consensus 250 ~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rpt~~~il~~ 299 (299)
.. +...+..+.+++.+||..+|.+|||+.+++++
T Consensus 221 ----~~------------~~~~~~~~~~li~~cl~~~p~~Rp~~~~ll~~ 254 (256)
T cd05113 221 ----YR------------PHLASEKVYAIMYSCWHEKAEERPTFQQLLSS 254 (256)
T ss_pred ----CC------------CCCCCHHHHHHHHHHcCCCcccCCCHHHHHHh
Confidence 00 11124678999999999999999999999864
|
Protein Tyrosine Kinase (PTK) family; Bruton's tyrosine kinase (Btk) and Bone marrow kinase on the X chromosome (Bmx); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Btk and Bmx (also named Etk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds |
| >cd05034 PTKc_Src_like Catalytic domain of Src kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.6e-41 Score=277.42 Aligned_cols=255 Identities=29% Similarity=0.446 Sum_probs=200.7
Q ss_pred HHHHhCCCCCCceeecCCcceEEEEEeCCCcEEEEEEeccCcCChhhhHHHHHHHHHHHhcCCcceeeeeeEEEcCCCee
Q 038766 7 IENATGSFSENNIIGNSNLSTVYKGRLEDGEIVAVKKLNFHQFSAESDKSFYREAKTLKELKHRNLVKVLGYAWESGKLK 86 (299)
Q Consensus 7 ~~~~~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~vK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~ 86 (299)
||...++|.+.+.||+|++|+||++...++..+++|.+.... ...+.+..|+..++.++|+|++++++++.. +...
T Consensus 1 ~~~~~~~~~i~~~ig~g~~~~v~~~~~~~~~~~~vK~~~~~~---~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~-~~~~ 76 (261)
T cd05034 1 WEIPRESLKLERKLGAGQFGEVWMGTWNGTTKVAVKTLKPGT---MSPEAFLQEAQIMKKLRHDKLVQLYAVCSE-EEPI 76 (261)
T ss_pred CccchhheeeeeeeccCcceEEEEEEEcCCceEEEEEecCCc---cCHHHHHHHHHHHhhCCCCCEeeeeeeeec-CCce
Confidence 356788999999999999999999998778889999986433 345678899999999999999999996554 4566
Q ss_pred EEEEeecCCCChHHHhcCCCCCCCCCChhhHHHHHHHHHHHHHHhhcCCCCCeeeecccCCceeeCCCCcEEEeeecccc
Q 038766 87 ALILEYMENGSLESVIHGPGVDHSRWTLPKRIDVLISVANGLDYLHSGYDIPIVHCDMKPSNILLDRDFEAHVSDFGTSR 166 (299)
Q Consensus 87 ~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lh~~~~~~~~H~dl~~~nil~~~~~~v~l~df~~~~ 166 (299)
++|+|++.+++|.+++... ....++...+..++.|++.|+.|||++ +++|+||+|+||+++.++.++|+|||.+.
T Consensus 77 ~~v~e~~~~~~L~~~i~~~--~~~~~~~~~~~~~~~~i~~al~~lh~~---~i~h~di~p~nili~~~~~~~l~d~g~~~ 151 (261)
T cd05034 77 YIVTEYMSKGSLLDFLKSG--EGKKLRLPQLVDMAAQIAEGMAYLESR---NYIHRDLAARNILVGENLVCKIADFGLAR 151 (261)
T ss_pred EEEEeccCCCCHHHHHhcc--ccCCCCHHHHHHHHHHHHHHHHHHHhC---CcccCCcchheEEEcCCCCEEECccccce
Confidence 9999999999999998643 234689999999999999999999999 99999999999999999999999999987
Q ss_pred ccccccccccccccccccCcccCChhhhcccCcCccccchhhhHHHHHHHh-CCCCCCCCccCCCCchhHHHHHHHHHhc
Q 038766 167 MLDVHLQDLSSLSTAFQGTIGYLAPEFAYMRIVTTKVDVFSFGIVVMEFLT-KRRPTGLDEENGLSPISLRQLVEKALAN 245 (299)
Q Consensus 167 ~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~DiwslG~~l~~l~~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~ 245 (299)
..... ..........+..|+|||.+.+..++.++|+||+|+++++|++ |..||.... . ...+......
T Consensus 152 ~~~~~---~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~il~~l~t~g~~p~~~~~-----~---~~~~~~~~~~ 220 (261)
T cd05034 152 LIEDD---EYTAREGAKFPIKWTAPEAANYGRFTIKSDVWSFGILLTEIVTYGRVPYPGMT-----N---REVLEQVERG 220 (261)
T ss_pred eccch---hhhhhhccCCCccccCHHHhccCCcCchhHHHHHHHHHHHHHhCCCCCCCCCC-----H---HHHHHHHHcC
Confidence 65421 0111112223567999999998889999999999999999998 888884321 1 1222221111
Q ss_pred CccCcccccCccccchhhHhHHHHHHHHHHHHHHHHhcCCCCCCCCChhhhhc
Q 038766 246 GINGVRQITDPKLVSSIYEEQEQHQVLEELFKLALVCTSSNPEDRPNMNELLI 298 (299)
Q Consensus 246 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rpt~~~il~ 298 (299)
. . ... +...+.++.+++.+|+..+|++|||++++++
T Consensus 221 ~-~----~~~------------~~~~~~~~~~~i~~~l~~~p~~Rp~~~~l~~ 256 (261)
T cd05034 221 Y-R----MPR------------PPNCPEELYDLMLQCWDKDPEERPTFEYLQS 256 (261)
T ss_pred C-C----CCC------------CCCCCHHHHHHHHHHcccCcccCCCHHHHHH
Confidence 0 0 000 1122457899999999999999999999874
|
Protein Tyrosine Kinase (PTK) family; Src kinase subfamily; catalytic (c) domain. Src subfamily members include Src, Lck, Hck, Blk, Lyn, Fgr, Fyn, Yrk, and Yes. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) proteins are cytoplasmic (or non-receptor) tyr kinases which are anchored to the plasma membrane. They contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-t |
| >cd05604 STKc_SGK3 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-41 Score=288.56 Aligned_cols=244 Identities=25% Similarity=0.300 Sum_probs=188.3
Q ss_pred ceeecCCcceEEEEEeC-CCcEEEEEEeccCcC-ChhhhHHHHHHHH-HHHhcCCcceeeeeeEEEcCCCeeEEEEeecC
Q 038766 18 NIIGNSNLSTVYKGRLE-DGEIVAVKKLNFHQF-SAESDKSFYREAK-TLKELKHRNLVKVLGYAWESGKLKALILEYME 94 (299)
Q Consensus 18 ~~lg~g~~~~v~~~~~~-~~~~~~vK~~~~~~~-~~~~~~~~~~e~~-~l~~l~h~~i~~~~~~~~~~~~~~~lv~e~~~ 94 (299)
+.||+|+||.||++.+. +|+.+|+|++..... .......+..|.. +++.++||||+++++++.. +...++|+||+.
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~l~~~~hp~iv~~~~~~~~-~~~~~lv~e~~~ 79 (325)
T cd05604 1 KVIGKGSFGKVLLAKRKLDGKCYAVKVLQKKIVLNRKEQKHIMAERNVLLKNVKHPFLVGLHYSFQT-TEKLYFVLDFVN 79 (325)
T ss_pred CceeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHHhCCCCCCccEEEEEec-CCEEEEEEcCCC
Confidence 46999999999999864 689999999864322 2223344555554 4677899999999996655 556699999999
Q ss_pred CCChHHHhcCCCCCCCCCChhhHHHHHHHHHHHHHHhhcCCCCCeeeecccCCceeeCCCCcEEEeeecccccccccccc
Q 038766 95 NGSLESVIHGPGVDHSRWTLPKRIDVLISVANGLDYLHSGYDIPIVHCDMKPSNILLDRDFEAHVSDFGTSRMLDVHLQD 174 (299)
Q Consensus 95 ~~~L~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lh~~~~~~~~H~dl~~~nil~~~~~~v~l~df~~~~~~~~~~~~ 174 (299)
+++|...+. ....+++..+..++.||+.||.|||+. +++|+||||+||+++.++.++|+|||++.....
T Consensus 80 ~~~L~~~l~----~~~~~~~~~~~~~~~qi~~al~~lH~~---givH~Dlkp~NIll~~~~~~kL~DfG~~~~~~~---- 148 (325)
T cd05604 80 GGELFFHLQ----RERSFPEPRARFYAAEIASALGYLHSI---NIVYRDLKPENILLDSQGHVVLTDFGLCKEGIA---- 148 (325)
T ss_pred CCCHHHHHH----HcCCCCHHHHHHHHHHHHHHHHHHHHC---CeeecCCCHHHeEECCCCCEEEeecCCcccCCC----
Confidence 999988886 445799999999999999999999999 999999999999999999999999999864321
Q ss_pred ccccccccccCcccCChhhhcccCcCccccchhhhHHHHHHHhCCCCCCCCccCCCCchhHHHHHHHHHhcCccCccccc
Q 038766 175 LSSLSTAFQGTIGYLAPEFAYMRIVTTKVDVFSFGIVVMEFLTKRRPTGLDEENGLSPISLRQLVEKALANGINGVRQIT 254 (299)
Q Consensus 175 ~~~~~~~~~~~~~y~~PE~~~~~~~~~~~DiwslG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 254 (299)
.........+++.|+|||.+.+..++.++|||||||++|+|++|..||.... . .+.......... . .
T Consensus 149 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~~G~~pf~~~~-----~---~~~~~~~~~~~~-~----~ 215 (325)
T cd05604 149 QSDTTTTFCGTPEYLAPEVIRKQPYDNTVDWWCLGAVLYEMLYGLPPFYCRD-----V---AEMYDNILHKPL-V----L 215 (325)
T ss_pred CCCCcccccCChhhCCHHHHcCCCCCCcCccccccceehhhhcCCCCCCCCC-----H---HHHHHHHHcCCc-c----C
Confidence 1122234567899999999999999999999999999999999999995431 1 122222111100 0 0
Q ss_pred CccccchhhHhHHHHHHHHHHHHHHHHhcCCCCCCCCChh----hhhcC
Q 038766 255 DPKLVSSIYEEQEQHQVLEELFKLALVCTSSNPEDRPNMN----ELLIT 299 (299)
Q Consensus 255 ~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rpt~~----~il~~ 299 (299)
....+..+.+++++||..+|.+||++. ++++|
T Consensus 216 -------------~~~~~~~~~~ll~~ll~~~p~~R~~~~~~~~~i~~h 251 (325)
T cd05604 216 -------------RPGASLTAWSILEELLEKDRQRRLGAKEDFLEIQEH 251 (325)
T ss_pred -------------CCCCCHHHHHHHHHHhccCHHhcCCCCCCHHHHhcC
Confidence 112345788999999999999999885 67665
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGK3 is expressed in most tissues and is most abundant in the embryo and adult heart and spleen. It was originally discovered in a screen for antiapoptotic genes. It phosphorylates and inhibits the proapoptotic proteins, Bad and FKHRL1. SGK3 also regulates many transporters, ion channels, |
| >KOG0599 consensus Phosphorylase kinase gamma subunit [Carbohydrate transport and metabolism] | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.5e-42 Score=266.95 Aligned_cols=260 Identities=24% Similarity=0.362 Sum_probs=208.2
Q ss_pred HHHHHHhCCCCCCceeecCCcceEEEEEe-CCCcEEEEEEeccCcCC------hhhhHHHHHHHHHHHhcC-Ccceeeee
Q 038766 5 TEIENATGSFSENNIIGNSNLSTVYKGRL-EDGEIVAVKKLNFHQFS------AESDKSFYREAKTLKELK-HRNLVKVL 76 (299)
Q Consensus 5 ~~~~~~~~~y~~~~~lg~g~~~~v~~~~~-~~~~~~~vK~~~~~~~~------~~~~~~~~~e~~~l~~l~-h~~i~~~~ 76 (299)
++-....+.|.-.+.||+|..++|-++.+ .+|..+|+|++...... ..-.+.-.+|+.+|+++. ||+|+++.
T Consensus 10 ~aa~~fy~~y~pkeilgrgvss~vrRci~k~t~~e~a~kii~~~at~~~~e~~~~~~EaT~~Ev~ILRqv~GHP~II~l~ 89 (411)
T KOG0599|consen 10 DAAKGFYAKYEPKEILGRGVSSVVRRCIHKETGKEFAVKIIDVTATTESGETPYEMREATRQEISILRQVMGHPYIIDLQ 89 (411)
T ss_pred hhHhhHHhhcChHHHhcccchhhhhhhhhcccccceeEEEEEecccccCCccHHHHHHHHHHHHHHHHHhcCCCcEEEee
Confidence 44455677899999999999999998764 56889999998643221 122344567999999996 99999999
Q ss_pred eEEEcCCCeeEEEEeecCCCChHHHhcCCCCCCCCCChhhHHHHHHHHHHHHHHhhcCCCCCeeeecccCCceeeCCCCc
Q 038766 77 GYAWESGKLKALILEYMENGSLESVIHGPGVDHSRWTLPKRIDVLISVANGLDYLHSGYDIPIVHCDMKPSNILLDRDFE 156 (299)
Q Consensus 77 ~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lh~~~~~~~~H~dl~~~nil~~~~~~ 156 (299)
+ +++...+.++|+|.++.|.|.+.+. +.-.+++.+...|+.|++.++.|||.. +|||+||||+|||++++-+
T Consensus 90 D-~yes~sF~FlVFdl~prGELFDyLt----s~VtlSEK~tR~iMrqlfegVeylHa~---~IVHRDLKpENILlddn~~ 161 (411)
T KOG0599|consen 90 D-VYESDAFVFLVFDLMPRGELFDYLT----SKVTLSEKETRRIMRQLFEGVEYLHAR---NIVHRDLKPENILLDDNMN 161 (411)
T ss_pred e-eccCcchhhhhhhhcccchHHHHhh----hheeecHHHHHHHHHHHHHHHHHHHHh---hhhhcccChhheeeccccc
Confidence 9 6667888899999999999999997 667899999999999999999999999 9999999999999999999
Q ss_pred EEEeeeccccccccccccccccccccccCcccCChhhhcc------cCcCccccchhhhHHHHHHHhCCCCCCCCccCCC
Q 038766 157 AHVSDFGTSRMLDVHLQDLSSLSTAFQGTIGYLAPEFAYM------RIVTTKVDVFSFGIVVMEFLTKRRPTGLDEENGL 230 (299)
Q Consensus 157 v~l~df~~~~~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~------~~~~~~~DiwslG~~l~~l~~g~~p~~~~~~~~~ 230 (299)
++|+|||.++.+. .+..-....|||+|+|||.+.- .+|+...|+|++|+++|.|+.|++||-..
T Consensus 162 i~isDFGFa~~l~-----~GekLrelCGTPgYLAPEtikC~m~e~~pGYs~EVD~Wa~GVImyTLLaGcpPFwHR----- 231 (411)
T KOG0599|consen 162 IKISDFGFACQLE-----PGEKLRELCGTPGYLAPETIKCSMYENHPGYSKEVDEWACGVIMYTLLAGCPPFWHR----- 231 (411)
T ss_pred eEEeccceeeccC-----CchhHHHhcCCCcccChhheeeecccCCCCccchhhHHHHHHHHHHHHcCCCchhHH-----
Confidence 9999999998765 3444566789999999998764 35788899999999999999999998322
Q ss_pred CchhHHHHHHHHHhcCccCcccccCccccchhhHhHHHHHHHHHHHHHHHHhcCCCCCCCCChhhhhcC
Q 038766 231 SPISLRQLVEKALANGINGVRQITDPKLVSSIYEEQEQHQVLEELFKLALVCTSSNPEDRPNMNELLIT 299 (299)
Q Consensus 231 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rpt~~~il~~ 299 (299)
.++ .+-..+..+ ..++..+ .=.+++.+..+||.+||.+||++|.|++++|.|
T Consensus 232 --kQm--lMLR~ImeG---kyqF~sp----------eWadis~~~KdLIsrlLqVdp~~Ritake~LaH 283 (411)
T KOG0599|consen 232 --KQM--LMLRMIMEG---KYQFRSP----------EWADISATVKDLISRLLQVDPTKRITAKEALAH 283 (411)
T ss_pred --HHH--HHHHHHHhc---ccccCCc----------chhhccccHHHHHHHHHeeCchhcccHHHHhcC
Confidence 110 111122222 1111111 134566788999999999999999999999987
|
|
| >cd06639 STKc_myosinIIIB Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIB myosin | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-40 Score=279.62 Aligned_cols=262 Identities=25% Similarity=0.320 Sum_probs=202.5
Q ss_pred HHHHHHhCCCCCCceeecCCcceEEEEEe-CCCcEEEEEEeccCcCChhhhHHHHHHHHHHHhc-CCcceeeeeeEEEcC
Q 038766 5 TEIENATGSFSENNIIGNSNLSTVYKGRL-EDGEIVAVKKLNFHQFSAESDKSFYREAKTLKEL-KHRNLVKVLGYAWES 82 (299)
Q Consensus 5 ~~~~~~~~~y~~~~~lg~g~~~~v~~~~~-~~~~~~~vK~~~~~~~~~~~~~~~~~e~~~l~~l-~h~~i~~~~~~~~~~ 82 (299)
++.....++|.+.+.||+|++|.||++.. .+++.+|+|++... ......+.+|+..++++ +|||++++++++...
T Consensus 15 ~~~~~~~~~y~~~~~l~~g~~~~vy~~~~~~~~~~~aik~~~~~---~~~~~~~~~e~~~l~~l~~h~ni~~~~~~~~~~ 91 (291)
T cd06639 15 ESLGDPTDTWEIIETIGKGTYGKVYKVTNKKDGSLAAVKILDPI---SDVDEEIEAEYNILQSLPNHPNVVKFYGMFYKA 91 (291)
T ss_pred ccCCCCCCCeEEEEEeecCCCeEEEEEEECCCCCEEEEEEeccc---ccHHHHHHHHHHHHHHhcCCCCeEEEEEEEEec
Confidence 55667789999999999999999999986 46889999998532 22345677899999998 799999999987643
Q ss_pred C----CeeEEEEeecCCCChHHHhcCCCCCCCCCChhhHHHHHHHHHHHHHHhhcCCCCCeeeecccCCceeeCCCCcEE
Q 038766 83 G----KLKALILEYMENGSLESVIHGPGVDHSRWTLPKRIDVLISVANGLDYLHSGYDIPIVHCDMKPSNILLDRDFEAH 158 (299)
Q Consensus 83 ~----~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lh~~~~~~~~H~dl~~~nil~~~~~~v~ 158 (299)
+ ...++|+||+.+++|.++++........+++..++.++.|++.||.+||+. +++|+||+|+||+++.++.++
T Consensus 92 ~~~~~~~~~lv~ey~~~~sL~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~---~ivH~dlkp~nili~~~~~~k 168 (291)
T cd06639 92 DKLVGGQLWLVLELCNGGSVTELVKGLLICGQRLDEAMISYILYGALLGLQHLHNN---RIIHRDVKGNNILLTTEGGVK 168 (291)
T ss_pred cccCCCeeEEEEEECCCCcHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHhC---CeeccCCCHHHEEEcCCCCEE
Confidence 3 357999999999999998864433456789999999999999999999999 999999999999999999999
Q ss_pred EeeeccccccccccccccccccccccCcccCChhhhccc-----CcCccccchhhhHHHHHHHhCCCCCCCCccCCCCch
Q 038766 159 VSDFGTSRMLDVHLQDLSSLSTAFQGTIGYLAPEFAYMR-----IVTTKVDVFSFGIVVMEFLTKRRPTGLDEENGLSPI 233 (299)
Q Consensus 159 l~df~~~~~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~-----~~~~~~DiwslG~~l~~l~~g~~p~~~~~~~~~~~~ 233 (299)
|+|||++...... ........++..|+|||.+... .++.++|+|||||++|+|++|..||..... .
T Consensus 169 l~dfg~~~~~~~~----~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slGvi~~el~~g~~p~~~~~~-----~ 239 (291)
T cd06639 169 LVDFGVSAQLTST----RLRRNTSVGTPFWMAPEVIACEQQYDYSYDARCDVWSLGITAIELGDGDPPLFDMHP-----V 239 (291)
T ss_pred Eeecccchhcccc----cccccCccCCccccChhhhcCCCCcccccCCccchHHHHHHHHHHhhCCCCCCCCcH-----H
Confidence 9999988754321 1112234567889999987543 367899999999999999999999853211 0
Q ss_pred hHHHHHHHHHhcCccCcccccCccccchhhHhHHHHHHHHHHHHHHHHhcCCCCCCCCChhhhhcC
Q 038766 234 SLRQLVEKALANGINGVRQITDPKLVSSIYEEQEQHQVLEELFKLALVCTSSNPEDRPNMNELLIT 299 (299)
Q Consensus 234 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rpt~~~il~~ 299 (299)
..+....... ...+.. +...+..+.++|.+||..+|++|||+.++++|
T Consensus 240 ---~~~~~~~~~~---~~~~~~------------~~~~~~~l~~li~~~l~~~p~~Rps~~~il~~ 287 (291)
T cd06639 240 ---KTLFKIPRNP---PPTLLH------------PEKWCRSFNHFISQCLIKDFEARPSVTHLLEH 287 (291)
T ss_pred ---HHHHHHhcCC---CCCCCc------------ccccCHHHHHHHHHHhhcChhhCcCHHHHhcC
Confidence 1111111110 000101 22334579999999999999999999999987
|
Serine/threonine kinases (STKs), class IIIB myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. They may also function as cargo carriers during light-dependent translocation, in photoreceptor cells, of proteins such as transducin and arrestin. Class IIIB myosin is expressed highly in retina. It is also pre |
| >cd05116 PTKc_Syk Catalytic domain of the Protein Tyrosine Kinase, Spleen tyrosine kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.7e-41 Score=276.21 Aligned_cols=246 Identities=24% Similarity=0.385 Sum_probs=191.9
Q ss_pred ceeecCCcceEEEEEe---CCCcEEEEEEeccCcCChhhhHHHHHHHHHHHhcCCcceeeeeeEEEcCCCeeEEEEeecC
Q 038766 18 NIIGNSNLSTVYKGRL---EDGEIVAVKKLNFHQFSAESDKSFYREAKTLKELKHRNLVKVLGYAWESGKLKALILEYME 94 (299)
Q Consensus 18 ~~lg~g~~~~v~~~~~---~~~~~~~vK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~lv~e~~~ 94 (299)
+.||+|++|.||++.+ .++..+|+|++..........+.+..|+.+++.+.|+||+++++++. +...++|+||+.
T Consensus 1 ~~lg~G~~g~v~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~--~~~~~lv~e~~~ 78 (257)
T cd05116 1 GELGSGNFGTVKKGMYKMKKSEKTVAVKILKNDNNDPALKDELLREANVMQQLDNPYIVRMIGICE--AESWMLVMELAE 78 (257)
T ss_pred CcCCCcCCcceEEeEEecCCCceEEEEEEccCCCCcHHHHHHHHHHHHHHHhCCCCCcceEEEEEc--CCCcEEEEecCC
Confidence 3689999999999864 35788999998765555556778899999999999999999999653 345589999999
Q ss_pred CCChHHHhcCCCCCCCCCChhhHHHHHHHHHHHHHHhhcCCCCCeeeecccCCceeeCCCCcEEEeeecccccccccccc
Q 038766 95 NGSLESVIHGPGVDHSRWTLPKRIDVLISVANGLDYLHSGYDIPIVHCDMKPSNILLDRDFEAHVSDFGTSRMLDVHLQD 174 (299)
Q Consensus 95 ~~~L~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lh~~~~~~~~H~dl~~~nil~~~~~~v~l~df~~~~~~~~~~~~ 174 (299)
+++|.+++. ....+++..++.++.|++.||++||++ +++|+||||+||+++.++.++|+|||++.........
T Consensus 79 ~~~L~~~l~----~~~~~~~~~~~~i~~qi~~al~~lH~~---~i~H~dlkp~nill~~~~~~kl~Dfg~~~~~~~~~~~ 151 (257)
T cd05116 79 LGPLNKFLQ----KNKHVTEKNITELVHQVSMGMKYLEET---NFVHRDLAARNVLLVTQHYAKISDFGLSKALGADENY 151 (257)
T ss_pred CCcHHHHHH----hcCCCCHHHHHHHHHHHHHHHHHHHHC---CEeecccchhhEEEcCCCeEEECCCccccccCCCCCe
Confidence 999999986 345789999999999999999999999 9999999999999999999999999998765422111
Q ss_pred ccccccccccCcccCChhhhcccCcCccccchhhhHHHHHHHh-CCCCCCCCccCCCCchhHHHHHHHHHhcCccCcccc
Q 038766 175 LSSLSTAFQGTIGYLAPEFAYMRIVTTKVDVFSFGIVVMEFLT-KRRPTGLDEENGLSPISLRQLVEKALANGINGVRQI 253 (299)
Q Consensus 175 ~~~~~~~~~~~~~y~~PE~~~~~~~~~~~DiwslG~~l~~l~~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 253 (299)
. .......++..|+|||.+....++.++|+||||+++|+|++ |..||... ....+...+.. +. ..
T Consensus 152 ~-~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~-----~~~~~~~~i~~----~~----~~ 217 (257)
T cd05116 152 Y-KAKTHGKWPVKWYAPECMNYYKFSSKSDVWSFGVLMWEAFSYGQKPYKGM-----KGNEVTQMIES----GE----RM 217 (257)
T ss_pred e-eecCCCCCCccccCHhHhccCCcCchhHHHHHHHHHHHHHhCCCCCCCCC-----CHHHHHHHHHC----CC----CC
Confidence 0 11112223568999999988888999999999999999997 88898532 22222222211 10 00
Q ss_pred cCccccchhhHhHHHHHHHHHHHHHHHHhcCCCCCCCCChhhhhc
Q 038766 254 TDPKLVSSIYEEQEQHQVLEELFKLALVCTSSNPEDRPNMNELLI 298 (299)
Q Consensus 254 ~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rpt~~~il~ 298 (299)
.. +...+.++.++|.+||+.||++|||+++|.+
T Consensus 218 ~~------------~~~~~~~l~~li~~~~~~~p~~Rp~~~~i~~ 250 (257)
T cd05116 218 EC------------PQRCPPEMYDLMKLCWTYGVDERPGFAVVEL 250 (257)
T ss_pred CC------------CCCCCHHHHHHHHHHhccCchhCcCHHHHHH
Confidence 00 1234567899999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Spleen tyrosine kinase (Syk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk, together with Zap-70, form the Syk subfamily of kinases which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Syk was first cloned from the spleen, and its function in hematopoietic cells is well-established. Syk is involved in the signaling downstream of activated receptors (including B-cell and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferatio |
| >cd07850 STKc_JNK Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-40 Score=286.65 Aligned_cols=276 Identities=22% Similarity=0.244 Sum_probs=202.0
Q ss_pred HHhCCCCCCceeecCCcceEEEEEeC-CCcEEEEEEeccCcCChhhhHHHHHHHHHHHhcCCcceeeeeeEEEcCC----
Q 038766 9 NATGSFSENNIIGNSNLSTVYKGRLE-DGEIVAVKKLNFHQFSAESDKSFYREAKTLKELKHRNLVKVLGYAWESG---- 83 (299)
Q Consensus 9 ~~~~~y~~~~~lg~g~~~~v~~~~~~-~~~~~~vK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~---- 83 (299)
.+.++|.+.+.||+|++|.||++.+. +++.+|+|++............+.+|+.++++++|+||+++++++....
T Consensus 13 ~~~~~y~~~~~lg~g~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~ 92 (353)
T cd07850 13 TVLKRYQNLKPIGSGAQGIVCAAYDTVTGQNVAIKKLSRPFQNVTHAKRAYRELVLMKLVNHKNIIGLLNVFTPQKSLEE 92 (353)
T ss_pred hhhcceEEEEEeccCCCEEEEEEEECCCCCEEEEEecCccccChhHHHHHHHHHHHHHhcCCCCCcceeeeeccCCCccc
Confidence 57899999999999999999999864 6899999998654444455667888999999999999999999765432
Q ss_pred -CeeEEEEeecCCCChHHHhcCCCCCCCCCChhhHHHHHHHHHHHHHHhhcCCCCCeeeecccCCceeeCCCCcEEEeee
Q 038766 84 -KLKALILEYMENGSLESVIHGPGVDHSRWTLPKRIDVLISVANGLDYLHSGYDIPIVHCDMKPSNILLDRDFEAHVSDF 162 (299)
Q Consensus 84 -~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lh~~~~~~~~H~dl~~~nil~~~~~~v~l~df 162 (299)
...++|+||+. ++|...+.. .+++..+..++.|++.||++||+. +++|+||||+||+++.++.++|+||
T Consensus 93 ~~~~~lv~e~~~-~~l~~~~~~------~l~~~~~~~~~~ql~~aL~~LH~~---gi~H~dlkp~Nil~~~~~~~kL~Df 162 (353)
T cd07850 93 FQDVYLVMELMD-ANLCQVIQM------DLDHERMSYLLYQMLCGIKHLHSA---GIIHRDLKPSNIVVKSDCTLKILDF 162 (353)
T ss_pred cCcEEEEEeccC-CCHHHHHhh------cCCHHHHHHHHHHHHHHHHHHHhC---CeeeCCCCHHHEEECCCCCEEEccC
Confidence 34689999995 588887752 288899999999999999999999 9999999999999999999999999
Q ss_pred ccccccccccccccccccccccCcccCChhhhcccCcCccccchhhhHHHHHHHhCCCCCCCCccCC----------CCc
Q 038766 163 GTSRMLDVHLQDLSSLSTAFQGTIGYLAPEFAYMRIVTTKVDVFSFGIVVMEFLTKRRPTGLDEENG----------LSP 232 (299)
Q Consensus 163 ~~~~~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~DiwslG~~l~~l~~g~~p~~~~~~~~----------~~~ 232 (299)
|++..... ........++..|+|||.+.+..++.++|||||||++|+|++|..||....... ...
T Consensus 163 g~~~~~~~-----~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~ 237 (353)
T cd07850 163 GLARTAGT-----SFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIRGTVLFPGTDHIDQWNKIIEQLGTPS 237 (353)
T ss_pred ccceeCCC-----CCCCCCCcccccccCHHHHhCCCCCCchhhHhHHHHHHHHHHCCCCCCCCCHHHHHHHHHHhcCCCC
Confidence 99875432 111223456788999999999999999999999999999999999986432100 000
Q ss_pred hhHHHHHHHHHhcCccCcccccCccc-------cchhhHhHHHHHHHHHHHHHHHHhcCCCCCCCCChhhhhcC
Q 038766 233 ISLRQLVEKALANGINGVRQITDPKL-------VSSIYEEQEQHQVLEELFKLALVCTSSNPEDRPNMNELLIT 299 (299)
Q Consensus 233 ~~~~~~~~~~~~~~~~~~~~~~~~~~-------~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rpt~~~il~~ 299 (299)
..+...+..................+ .............+..+.++|.+||..||++|||+.++|.|
T Consensus 238 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~eiL~~ 311 (353)
T cd07850 238 DEFMSRLQPTVRNYVENRPKYAGYSFEELFPDVLFPPDSESHNKLKASQARDLLSKMLVIDPEKRISVDDALQH 311 (353)
T ss_pred HHHHHHhhhhhhHHhhcCCCCCCcchhhhCcccccCcccccccccchhHHHHHHHHHcCCChhhCcCHHHHhcC
Confidence 01111111000000000000000000 00000000122346678999999999999999999999987
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase (JNK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. They are also essential regulators of physiological and pathological processes and are involved in the pathogenesis of several diseases such as diabetes, atherosclerosis, stroke, Parkinson's and Alzheimer's. Vetebrates harbor three different JNK |
| >cd06628 STKc_MAPKKK_Byr2_like Catalytic domain of fungal Byr2-like MAP Kinase Kinase Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.5e-41 Score=277.75 Aligned_cols=254 Identities=28% Similarity=0.455 Sum_probs=199.0
Q ss_pred CCCCCceeecCCcceEEEEEeC-CCcEEEEEEeccCcCChh-------hhHHHHHHHHHHHhcCCcceeeeeeEEEcCCC
Q 038766 13 SFSENNIIGNSNLSTVYKGRLE-DGEIVAVKKLNFHQFSAE-------SDKSFYREAKTLKELKHRNLVKVLGYAWESGK 84 (299)
Q Consensus 13 ~y~~~~~lg~g~~~~v~~~~~~-~~~~~~vK~~~~~~~~~~-------~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~ 84 (299)
+|.+...||+|++|.||+|.+. ++..+++|.+........ ..+.+..|+.++++++||||+++++.+.. +.
T Consensus 1 ~~~~~~~ig~g~~~~v~~a~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~-~~ 79 (267)
T cd06628 1 KWIKGALIGSGSFGSVYLGMNASSGELMAVKQVELPSVSASSKDRKRSMLDALAREIALLKELQHENIVQYLGSSLD-AD 79 (267)
T ss_pred CccccceeecCCCeEEEEEEecCCCcEEEEEEecCCCcccchhHHHHHHHHHHHHHHHHHHhcCCCCeeeEEEEEEe-CC
Confidence 5889999999999999999864 588999998865432211 23567889999999999999999997665 45
Q ss_pred eeEEEEeecCCCChHHHhcCCCCCCCCCChhhHHHHHHHHHHHHHHhhcCCCCCeeeecccCCceeeCCCCcEEEeeecc
Q 038766 85 LKALILEYMENGSLESVIHGPGVDHSRWTLPKRIDVLISVANGLDYLHSGYDIPIVHCDMKPSNILLDRDFEAHVSDFGT 164 (299)
Q Consensus 85 ~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lh~~~~~~~~H~dl~~~nil~~~~~~v~l~df~~ 164 (299)
..++++||+++++|.+++. ....+++..+..++.|++.||++||+. +++|+||+|+||+++.++.++|+|||.
T Consensus 80 ~~~lv~e~~~~~~L~~~l~----~~~~l~~~~~~~~~~~l~~~l~~lH~~---~ivH~di~p~nil~~~~~~~~l~dfg~ 152 (267)
T cd06628 80 HLNIFLEYVPGGSVAALLN----NYGAFEETLVRNFVRQILKGLNYLHNR---GIIHRDIKGANILVDNKGGIKISDFGI 152 (267)
T ss_pred ccEEEEEecCCCCHHHHHH----hccCccHHHHHHHHHHHHHHHHHHHhc---CcccccCCHHHEEEcCCCCEEecccCC
Confidence 6689999999999999997 335788999999999999999999998 999999999999999999999999999
Q ss_pred cccccccccc--ccccccccccCcccCChhhhcccCcCccccchhhhHHHHHHHhCCCCCCCCccCCCCchhHHHHHHHH
Q 038766 165 SRMLDVHLQD--LSSLSTAFQGTIGYLAPEFAYMRIVTTKVDVFSFGIVVMEFLTKRRPTGLDEENGLSPISLRQLVEKA 242 (299)
Q Consensus 165 ~~~~~~~~~~--~~~~~~~~~~~~~y~~PE~~~~~~~~~~~DiwslG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~ 242 (299)
+......... .........++..|+|||.+.+..++.++|+||||+++|+|++|..||.... . ... +...
T Consensus 153 ~~~~~~~~~~~~~~~~~~~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~-----~--~~~-~~~~ 224 (267)
T cd06628 153 SKKLEANSLSTKTNGARPSLQGSVFWMAPEVVKQTSYTRKADIWSLGCLVVEMLTGKHPFPDCT-----Q--LQA-IFKI 224 (267)
T ss_pred CcccccccccCCccccccccCCCcCccChhHhccCCCCchhhhHHHHHHHHHHhhCCCCCCCcc-----H--HHH-HHHH
Confidence 8765421111 1111223446788999999998888999999999999999999999985321 1 111 1111
Q ss_pred HhcCccCcccccCccccchhhHhHHHHHHHHHHHHHHHHhcCCCCCCCCChhhhhcC
Q 038766 243 LANGINGVRQITDPKLVSSIYEEQEQHQVLEELFKLALVCTSSNPEDRPNMNELLIT 299 (299)
Q Consensus 243 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rpt~~~il~~ 299 (299)
.... .+ ..+..++..+.++|++||..||.+|||+.++++|
T Consensus 225 ~~~~--------~~---------~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~ 264 (267)
T cd06628 225 GENA--------SP---------EIPSNISSEAIDFLEKTFEIDHNKRPTAAELLKH 264 (267)
T ss_pred hccC--------CC---------cCCcccCHHHHHHHHHHccCCchhCcCHHHHhhC
Confidence 0000 00 0022345678999999999999999999999986
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Byr2-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Schizosaccharomyces pombe Byr2, Saccharomyces cerevisiae and Cryptococcus neoformans Ste11, and related proteins. They contain an N-terminal SAM (sterile alpha-motif) domain, which mediates protein-protein interaction, and a C-terminal catalytic domain. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate |
| >cd08221 STKc_Nek9 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 9 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.9e-40 Score=272.36 Aligned_cols=252 Identities=24% Similarity=0.354 Sum_probs=204.5
Q ss_pred CCCCCceeecCCcceEEEEEe-CCCcEEEEEEeccCcCChhhhHHHHHHHHHHHhcCCcceeeeeeEEEcCCCeeEEEEe
Q 038766 13 SFSENNIIGNSNLSTVYKGRL-EDGEIVAVKKLNFHQFSAESDKSFYREAKTLKELKHRNLVKVLGYAWESGKLKALILE 91 (299)
Q Consensus 13 ~y~~~~~lg~g~~~~v~~~~~-~~~~~~~vK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~lv~e 91 (299)
+|+..+.||.|++|.||.++. .+++.+++|.+............+.+|+.++++++|+||+++++++.. +...++++|
T Consensus 1 ~y~~~~~ig~g~~g~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~-~~~~~~~~e 79 (256)
T cd08221 1 HYIPIRVLGKGAFGEATLYRRTEDDSLVVWKEVNLTRLSEKERRDALNEIVILSLLQHPNIIAYYNHFMD-DNTLLIEME 79 (256)
T ss_pred CceEeeEecccCCceEEEEEEcCCCcEEEEEEEeecccchhHHHHHHHHHHHHHhCCCCCeeEEEeEEec-CCeEEEEEE
Confidence 588999999999999999986 458899999987666666667788899999999999999999997665 556799999
Q ss_pred ecCCCChHHHhcCCCCCCCCCChhhHHHHHHHHHHHHHHhhcCCCCCeeeecccCCceeeCCCCcEEEeeeccccccccc
Q 038766 92 YMENGSLESVIHGPGVDHSRWTLPKRIDVLISVANGLDYLHSGYDIPIVHCDMKPSNILLDRDFEAHVSDFGTSRMLDVH 171 (299)
Q Consensus 92 ~~~~~~L~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lh~~~~~~~~H~dl~~~nil~~~~~~v~l~df~~~~~~~~~ 171 (299)
|+.+++|.+++... ....+++..+..++.|++.+|.+||+. +++|+||+|+||+++.++.++|+|||.+......
T Consensus 80 ~~~~~~L~~~~~~~--~~~~~~~~~~~~~~~~l~~~l~~lh~~---~i~h~dl~p~ni~~~~~~~~kl~d~~~~~~~~~~ 154 (256)
T cd08221 80 YANGGTLYDKIVRQ--KGQLFEEEMVLWYLFQIVSAVSYIHKA---GILHRDIKTLNIFLTKAGLIKLGDFGISKILGSE 154 (256)
T ss_pred ecCCCcHHHHHHhc--cccCCCHHHHHHHHHHHHHHHHHHHhC---CccccCCChHhEEEeCCCCEEECcCcceEEcccc
Confidence 99999999998643 235689999999999999999999998 9999999999999999999999999998755321
Q ss_pred cccccccccccccCcccCChhhhcccCcCccccchhhhHHHHHHHhCCCCCCCCccCCCCchhHHHHHHHHHhcCccCcc
Q 038766 172 LQDLSSLSTAFQGTIGYLAPEFAYMRIVTTKVDVFSFGIVVMEFLTKRRPTGLDEENGLSPISLRQLVEKALANGINGVR 251 (299)
Q Consensus 172 ~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~DiwslG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 251 (299)
. .......+++.|+|||...+..++.++|+||||+++++|++|..||.... . .+............
T Consensus 155 ~----~~~~~~~~~~~y~ape~~~~~~~~~~~Dv~slG~i~~~l~~g~~~~~~~~-----~---~~~~~~~~~~~~~~-- 220 (256)
T cd08221 155 Y----SMAETVVGTPYYMSPELCQGVKYNFKSDIWALGCVLYELLTLKRTFDATN-----P---LNLVVKIVQGNYTP-- 220 (256)
T ss_pred c----ccccccCCCccccCHhhcCCCCCCCcchhHHHHHHHHHHHHCCCCCCCCC-----H---HHHHHHHHcCCCCC--
Confidence 1 12334567889999999988888999999999999999999999985321 1 12221111111000
Q ss_pred cccCccccchhhHhHHHHHHHHHHHHHHHHhcCCCCCCCCChhhhhcC
Q 038766 252 QITDPKLVSSIYEEQEQHQVLEELFKLALVCTSSNPEDRPNMNELLIT 299 (299)
Q Consensus 252 ~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rpt~~~il~~ 299 (299)
....++..+.+++.+||..+|++|||++++++|
T Consensus 221 ---------------~~~~~~~~~~~~i~~~l~~~p~~R~s~~~ll~~ 253 (256)
T cd08221 221 ---------------VVSVYSSELISLVHSLLQQDPEKRPTADEVLDQ 253 (256)
T ss_pred ---------------CccccCHHHHHHHHHHcccCcccCCCHHHHhhC
Confidence 013445678999999999999999999999976
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 9 (Nek9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek9 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek9, also called Nercc1, is primarily a cytoplasmic protein but can also localize in the nucleus. It is involved in modulating chromosome alignment and splitting during mitosis. It interacts with the gamma-tubulin ring complex and the Ran GTPase, and is implicated in microtubule organization. Nek9 associa |
| >cd06609 STKc_MST3_like Catalytic domain of Mammalian Ste20-like protein kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-40 Score=277.81 Aligned_cols=250 Identities=24% Similarity=0.383 Sum_probs=200.7
Q ss_pred CCCCCCceeecCCcceEEEEEeC-CCcEEEEEEeccCcCChhhhHHHHHHHHHHHhcCCcceeeeeeEEEcCCCeeEEEE
Q 038766 12 GSFSENNIIGNSNLSTVYKGRLE-DGEIVAVKKLNFHQFSAESDKSFYREAKTLKELKHRNLVKVLGYAWESGKLKALIL 90 (299)
Q Consensus 12 ~~y~~~~~lg~g~~~~v~~~~~~-~~~~~~vK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~lv~ 90 (299)
++|.+.+.||.|++|.||++.+. +++.+++|++.... .......+.+|++.++.++|+|++++.+.+.. +...++|+
T Consensus 1 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~-~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~-~~~~~~v~ 78 (274)
T cd06609 1 ELFTLLECIGKGSFGEVYKAIDKRTNQVVAIKVIDLEE-AEDEIEDIQQEIQFLSQCRSPYITKYYGSFLK-GSKLWIIM 78 (274)
T ss_pred ChhhhhhhhcCCCCeEEEEEEECCCCeEEEEEEeeccc-cchHHHHHHHHHHHHHHcCCCCeeeeeEEEEE-CCeEEEEE
Confidence 57999999999999999999864 58999999986443 23445667899999999999999999996655 56779999
Q ss_pred eecCCCChHHHhcCCCCCCCCCChhhHHHHHHHHHHHHHHhhcCCCCCeeeecccCCceeeCCCCcEEEeeecccccccc
Q 038766 91 EYMENGSLESVIHGPGVDHSRWTLPKRIDVLISVANGLDYLHSGYDIPIVHCDMKPSNILLDRDFEAHVSDFGTSRMLDV 170 (299)
Q Consensus 91 e~~~~~~L~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lh~~~~~~~~H~dl~~~nil~~~~~~v~l~df~~~~~~~~ 170 (299)
|++.+++|.+++.. .++++..++.++.|++.|+.+||+. +++|+||+|+||+++.++.++|+|||++.....
T Consensus 79 e~~~~~~L~~~~~~-----~~~~~~~~~~~~~ql~~~l~~lh~~---~i~h~dl~p~ni~i~~~~~~~l~d~g~~~~~~~ 150 (274)
T cd06609 79 EYCGGGSCLDLLKP-----GKLDETYIAFILREVLLGLEYLHEE---GKIHRDIKAANILLSEEGDVKLADFGVSGQLTS 150 (274)
T ss_pred EeeCCCcHHHHHhh-----cCCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCCHHHEEECCCCCEEEcccccceeecc
Confidence 99999999999862 2789999999999999999999999 999999999999999999999999999876552
Q ss_pred ccccccccccccccCcccCChhhhcccCcCccccchhhhHHHHHHHhCCCCCCCCccCCCCchhHHHHHHHHHhcCccCc
Q 038766 171 HLQDLSSLSTAFQGTIGYLAPEFAYMRIVTTKVDVFSFGIVVMEFLTKRRPTGLDEENGLSPISLRQLVEKALANGINGV 250 (299)
Q Consensus 171 ~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~DiwslG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 250 (299)
.. .......+++.|+|||.+.+..++.++|+||||+++|+|++|..||.... .... .........+.
T Consensus 151 ~~----~~~~~~~~~~~y~~PE~~~~~~~~~~sDv~slG~il~~l~tg~~p~~~~~-----~~~~---~~~~~~~~~~~- 217 (274)
T cd06609 151 TM----SKRNTFVGTPFWMAPEVIKQSGYDEKADIWSLGITAIELAKGEPPLSDLH-----PMRV---LFLIPKNNPPS- 217 (274)
T ss_pred cc----cccccccCCccccChhhhccCCCCchhhHHHHHHHHHHHHhCCCCcccCc-----hHHH---HHHhhhcCCCC-
Confidence 21 12233456788999999998889999999999999999999999985332 1111 11111100000
Q ss_pred ccccCccccchhhHhHHHHHHHHHHHHHHHHhcCCCCCCCCChhhhhcC
Q 038766 251 RQITDPKLVSSIYEEQEQHQVLEELFKLALVCTSSNPEDRPNMNELLIT 299 (299)
Q Consensus 251 ~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rpt~~~il~~ 299 (299)
.. ...++..+.+++.+||..+|++|||++++++|
T Consensus 218 --~~-------------~~~~~~~~~~~l~~~l~~~p~~Rpt~~~il~~ 251 (274)
T cd06609 218 --LE-------------GNKFSKPFKDFVSLCLNKDPKERPSAKELLKH 251 (274)
T ss_pred --Cc-------------ccccCHHHHHHHHHHhhCChhhCcCHHHHhhC
Confidence 00 11145678999999999999999999999986
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST3, MST4, STK25, Schizosaccharomyces pombe Nak1 and Sid1, Saccharomyces cerevisiae sporulation-specific protein 1 (SPS1), and related proteins. Nak1 is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Sid1 is a component in the septation initiation network (SIN) |
| >KOG0610 consensus Putative serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.1e-41 Score=276.05 Aligned_cols=260 Identities=25% Similarity=0.294 Sum_probs=210.8
Q ss_pred HhCCCCCCceeecCCcceEEEEEeCC-CcEEEEEEeccCcCC-hhhhHHHHHHHHHHHhcCCcceeeeeeEEEcCCCeeE
Q 038766 10 ATGSFSENNIIGNSNLSTVYKGRLED-GEIVAVKKLNFHQFS-AESDKSFYREAKTLKELKHRNLVKVLGYAWESGKLKA 87 (299)
Q Consensus 10 ~~~~y~~~~~lg~g~~~~v~~~~~~~-~~~~~vK~~~~~~~~-~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~ 87 (299)
-.++|++.+.||.|.-|+||++...+ +..+|+|++...... .....+++.|.++|..+.||.+..+|.. ++..++.|
T Consensus 75 ~l~~f~llk~LG~GdiG~VyL~~l~~t~~~fAmKVmdK~~l~~rkKl~Ra~tE~eIL~~lDHPFlPTLYa~-fet~~~~c 153 (459)
T KOG0610|consen 75 GLRHFRLLKRLGCGDIGTVYLVELRGTNCLFAMKVMDKESLASRKKLKRAQTEREILSLLDHPFLPTLYAS-FETDKYSC 153 (459)
T ss_pred CHHHHHHHHHcCCCCceeEEEEEecCCCceEEEEEecHHHHhhhhHHHHHHHHHHHHHhcCCCccchhhhe-eeccceeE
Confidence 34678899999999999999999764 699999999755433 4556788899999999999999999995 55577889
Q ss_pred EEEeecCCCChHHHhcCCCCCCCCCChhhHHHHHHHHHHHHHHhhcCCCCCeeeecccCCceeeCCCCcEEEeeeccccc
Q 038766 88 LILEYMENGSLESVIHGPGVDHSRWTLPKRIDVLISVANGLDYLHSGYDIPIVHCDMKPSNILLDRDFEAHVSDFGTSRM 167 (299)
Q Consensus 88 lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lh~~~~~~~~H~dl~~~nil~~~~~~v~l~df~~~~~ 167 (299)
+|||||.||+|..+.+.. .+..+++..++.++..++.||+|||.. ||++|||||+||||..+|++-|+||.++..
T Consensus 154 l~meyCpGGdL~~LrqkQ--p~~~fse~~aRFYaAEvl~ALEYLHml---GivYRDLKPENILvredGHIMLsDFDLS~~ 228 (459)
T KOG0610|consen 154 LVMEYCPGGDLHSLRQKQ--PGKRFSESAARFYAAEVLLALEYLHML---GIVYRDLKPENILVREDGHIMLSDFDLSLR 228 (459)
T ss_pred EEEecCCCccHHHHHhhC--CCCccchhhHHHHHHHHHHHHHHHHhh---ceeeccCCcceeEEecCCcEEeeecccccc
Confidence 999999999999998765 778999999999999999999999999 999999999999999999999999998854
Q ss_pred cccc-------c---------------------------------------------ccccccccccccCcccCChhhhc
Q 038766 168 LDVH-------L---------------------------------------------QDLSSLSTAFQGTIGYLAPEFAY 195 (299)
Q Consensus 168 ~~~~-------~---------------------------------------------~~~~~~~~~~~~~~~y~~PE~~~ 195 (299)
.... . ......+...+||-.|+|||++.
T Consensus 229 ~~~~Pt~~~s~~~~~~~~~~~~~~~~~s~f~~r~~~~~~~~~k~~~~~~~~~p~~~aep~~~RSnSFVGThEYlAPEvI~ 308 (459)
T KOG0610|consen 229 CPVSPTLVKSSSPRSSGSQPSCRSRQPSCFSPRCLSSSKKRKKKDESASRSLPELVAEPTGARSNSFVGTHEYLAPEVIR 308 (459)
T ss_pred CCCCCeeeccCCCCCCCCCcccccccccccccchhccccccccccccccccchhhhcCCCCccccccccccccccceeee
Confidence 3110 0 00112234566888999999999
Q ss_pred ccCcCccccchhhhHHHHHHHhCCCCCCCCccCCCCchhHHHHHHHHHhcCccCcccccCccccchhhHhHHHHHHHHHH
Q 038766 196 MRIVTTKVDVFSFGIVVMEFLTKRRPTGLDEENGLSPISLRQLVEKALANGINGVRQITDPKLVSSIYEEQEQHQVLEEL 275 (299)
Q Consensus 196 ~~~~~~~~DiwslG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l 275 (299)
+.+-+.+.|=|+||+++|||+.|..||.+...+ +.+..+.... ..+.. ...++..+
T Consensus 309 G~GHgsAVDWWtfGIflYEmLyG~TPFKG~~~~--------~Tl~NIv~~~---------l~Fp~-------~~~vs~~a 364 (459)
T KOG0610|consen 309 GEGHGSAVDWWTFGIFLYEMLYGTTPFKGSNNK--------ETLRNIVGQP---------LKFPE-------EPEVSSAA 364 (459)
T ss_pred cCCCCchhhHHHHHHHHHHHHhCCCCcCCCCch--------hhHHHHhcCC---------CcCCC-------CCcchhHH
Confidence 999999999999999999999999999765332 2222222111 11111 22567789
Q ss_pred HHHHHHhcCCCCCCCCC----hhhhhcC
Q 038766 276 FKLALVCTSSNPEDRPN----MNELLIT 299 (299)
Q Consensus 276 ~~li~~~l~~dP~~Rpt----~~~il~~ 299 (299)
.+||+++|..||++|.- ++||-+|
T Consensus 365 kDLIr~LLvKdP~kRlg~~rGA~eIK~H 392 (459)
T KOG0610|consen 365 KDLIRKLLVKDPSKRLGSKRGAAEIKRH 392 (459)
T ss_pred HHHHHHHhccChhhhhccccchHHhhcC
Confidence 99999999999999999 8888766
|
|
| >cd05080 PTKc_Tyk2_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.6e-41 Score=281.08 Aligned_cols=267 Identities=22% Similarity=0.345 Sum_probs=195.9
Q ss_pred hCCC-CCCceeecCCcceEEEEEe-----CCCcEEEEEEeccCcCChhhhHHHHHHHHHHHhcCCcceeeeeeEEEcC-C
Q 038766 11 TGSF-SENNIIGNSNLSTVYKGRL-----EDGEIVAVKKLNFHQFSAESDKSFYREAKTLKELKHRNLVKVLGYAWES-G 83 (299)
Q Consensus 11 ~~~y-~~~~~lg~g~~~~v~~~~~-----~~~~~~~vK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~-~ 83 (299)
.++| .+.+.||+|+||+||++.. .++..+|+|++.... .......+.+|++.++.++||||+++++++... .
T Consensus 2 ~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~vaiK~~~~~~-~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~ 80 (283)
T cd05080 2 HKRYLKKIRVLGEGHFGKVSLYCYDPANDGTGEMVAVKTLKREC-GQQNTSGWKKEINILKTLYHENIVKYKGCCSEQGG 80 (283)
T ss_pred ChhhceeceecccCCCcEEEEeeEccccCCCCceEEEEEecccc-ChHHHHHHHHHHHHHHhCCCCCEeeEEEEEecCCC
Confidence 3566 8999999999999988642 357889999986432 233456778899999999999999999976554 3
Q ss_pred CeeEEEEeecCCCChHHHhcCCCCCCCCCChhhHHHHHHHHHHHHHHhhcCCCCCeeeecccCCceeeCCCCcEEEeeec
Q 038766 84 KLKALILEYMENGSLESVIHGPGVDHSRWTLPKRIDVLISVANGLDYLHSGYDIPIVHCDMKPSNILLDRDFEAHVSDFG 163 (299)
Q Consensus 84 ~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lh~~~~~~~~H~dl~~~nil~~~~~~v~l~df~ 163 (299)
...++++||+.+++|.+++.. ..+++..++.++.|++.||.|||++ +++|+||||+||+++.++.++|+|||
T Consensus 81 ~~~~lv~e~~~~~~l~~~~~~-----~~l~~~~~~~i~~~l~~~l~~lH~~---~i~H~dlkp~Nili~~~~~~~l~dfg 152 (283)
T cd05080 81 KGLQLIMEYVPLGSLRDYLPK-----HKLNLAQLLLFAQQICEGMAYLHSQ---HYIHRDLAARNVLLDNDRLVKIGDFG 152 (283)
T ss_pred ceEEEEecCCCCCCHHHHHHH-----cCCCHHHHHHHHHHHHHHHHHHHHC---CeeccccChheEEEcCCCcEEEeecc
Confidence 457899999999999999852 3589999999999999999999999 99999999999999999999999999
Q ss_pred cccccccccccccccccccccCcccCChhhhcccCcCccccchhhhHHHHHHHhCCCCCCCCccCCCCchhHHHHHHHHH
Q 038766 164 TSRMLDVHLQDLSSLSTAFQGTIGYLAPEFAYMRIVTTKVDVFSFGIVVMEFLTKRRPTGLDEENGLSPISLRQLVEKAL 243 (299)
Q Consensus 164 ~~~~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~DiwslG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~ 243 (299)
++......... ........++..|+|||...+..++.++||||||+++|+|++|..|+...... +.+......
T Consensus 153 ~~~~~~~~~~~-~~~~~~~~~~~~~~~PE~~~~~~~~~~~Di~slG~~l~el~tg~~p~~~~~~~------~~~~~~~~~ 225 (283)
T cd05080 153 LAKAVPEGHEY-YRVREDGDSPVFWYAVECLKENKFSYASDVWSFGVTLYELLTHCDSKQSPPKK------FEEMIGPKQ 225 (283)
T ss_pred cccccCCcchh-hccCCCCCCCceeeCHhHhcccCCCcccccHHHHHHHHHHHhCCCCCCCCcch------hhhhhcccc
Confidence 98755421110 01112223456799999998888999999999999999999999997543211 000000000
Q ss_pred hc-CccCcccccCccccchhhHhHHHHHHHHHHHHHHHHhcCCCCCCCCChhhhhc
Q 038766 244 AN-GINGVRQITDPKLVSSIYEEQEQHQVLEELFKLALVCTSSNPEDRPNMNELLI 298 (299)
Q Consensus 244 ~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rpt~~~il~ 298 (299)
.. ............. ....+...+..+.+++.+||+.+|++|||++++++
T Consensus 226 ~~~~~~~~~~~~~~~~-----~~~~~~~~~~~~~~li~~cl~~~p~~Rps~~~i~~ 276 (283)
T cd05080 226 GQMTVVRLIELLERGM-----RLPCPKNCPQEVYILMKNCWETEAKFRPTFRSLIP 276 (283)
T ss_pred cccchhhhhhhhhcCC-----CCCCCCCCCHHHHHHHHHHhccChhhCCCHHHHHH
Confidence 00 0000000000000 00012234568999999999999999999999975
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of sign |
| >cd06645 STKc_MAP4K3 Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-41 Score=281.85 Aligned_cols=254 Identities=25% Similarity=0.334 Sum_probs=197.5
Q ss_pred hCCCCCCceeecCCcceEEEEEe-CCCcEEEEEEeccCcCChhhhHHHHHHHHHHHhcCCcceeeeeeEEEcCCCeeEEE
Q 038766 11 TGSFSENNIIGNSNLSTVYKGRL-EDGEIVAVKKLNFHQFSAESDKSFYREAKTLKELKHRNLVKVLGYAWESGKLKALI 89 (299)
Q Consensus 11 ~~~y~~~~~lg~g~~~~v~~~~~-~~~~~~~vK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~lv 89 (299)
.++|.+.+.||+|++|.||+|.+ .+++.+|+|++.... ......+.+|+..++.++||||+++++.+.. +...++|
T Consensus 8 ~~~~~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~--~~~~~~~~~e~~~~~~l~h~~ii~~~~~~~~-~~~~~lv 84 (267)
T cd06645 8 QEDFELIQRIGSGTYGDVYKARNVNTGELAAIKVIKLEP--GEDFAVVQQEIIMMKDCKHSNIVAYFGSYLR-RDKLWIC 84 (267)
T ss_pred HHHHHHHHHhCCCCCeEEEEEEEcCCCcEEEEEEEecCc--hhHHHHHHHHHHHHHhCCCCCeeeEEEEEEe-CCEEEEE
Confidence 46889999999999999999986 458899999986432 2334567889999999999999999997655 5566999
Q ss_pred EeecCCCChHHHhcCCCCCCCCCChhhHHHHHHHHHHHHHHhhcCCCCCeeeecccCCceeeCCCCcEEEeeeccccccc
Q 038766 90 LEYMENGSLESVIHGPGVDHSRWTLPKRIDVLISVANGLDYLHSGYDIPIVHCDMKPSNILLDRDFEAHVSDFGTSRMLD 169 (299)
Q Consensus 90 ~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lh~~~~~~~~H~dl~~~nil~~~~~~v~l~df~~~~~~~ 169 (299)
+||+.+++|.+++. ....+++..++.++.|++.++.|||+. +++|+||+|+||+++.++.++|+|||++....
T Consensus 85 ~e~~~~~~L~~~~~----~~~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dlkp~nili~~~~~~~l~dfg~~~~~~ 157 (267)
T cd06645 85 MEFCGGGSLQDIYH----VTGPLSESQIAYVSRETLQGLYYLHSK---GKMHRDIKGANILLTDNGHVKLADFGVSAQIT 157 (267)
T ss_pred EeccCCCcHHHHHH----hcCCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHEEECCCCCEEECcceeeeEcc
Confidence 99999999999986 445789999999999999999999999 99999999999999999999999999986543
Q ss_pred cccccccccccccccCcccCChhhhc---ccCcCccccchhhhHHHHHHHhCCCCCCCCccCCCCchhHHHHHHHHHhcC
Q 038766 170 VHLQDLSSLSTAFQGTIGYLAPEFAY---MRIVTTKVDVFSFGIVVMEFLTKRRPTGLDEENGLSPISLRQLVEKALANG 246 (299)
Q Consensus 170 ~~~~~~~~~~~~~~~~~~y~~PE~~~---~~~~~~~~DiwslG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~ 246 (299)
.. ........++..|+|||.+. ...++.++|+|||||++|+|++|..||...... .... ......
T Consensus 158 ~~----~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~DvwSlG~il~~l~~~~~p~~~~~~~-----~~~~---~~~~~~ 225 (267)
T cd06645 158 AT----IAKRKSFIGTPYWMAPEVAAVERKGGYNQLCDIWAVGITAIELAELQPPMFDLHPM-----RALF---LMTKSN 225 (267)
T ss_pred Cc----ccccccccCcccccChhhhccccCCCCCchhhhHHHHHHHHHHhcCCCCcccccch-----hhHH---hhhccC
Confidence 21 11123345788999999874 445788999999999999999999998533211 0000 000000
Q ss_pred ccCcccccCccccchhhHhHHHHHHHHHHHHHHHHhcCCCCCCCCChhhhhcC
Q 038766 247 INGVRQITDPKLVSSIYEEQEQHQVLEELFKLALVCTSSNPEDRPNMNELLIT 299 (299)
Q Consensus 247 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rpt~~~il~~ 299 (299)
...+.... ...++..+.++|.+||..+|++|||++++++|
T Consensus 226 ------~~~~~~~~-------~~~~~~~~~~li~~~l~~~P~~R~~~~~ll~~ 265 (267)
T cd06645 226 ------FQPPKLKD-------KMKWSNSFHHFVKMALTKNPKKRPTAEKLLQH 265 (267)
T ss_pred ------CCCCcccc-------cCCCCHHHHHHHHHHccCCchhCcCHHHHhcC
Confidence 00000000 11234568899999999999999999999987
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated |
| >cd07873 STKc_PCTAIRE1 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-1 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-40 Score=281.01 Aligned_cols=270 Identities=21% Similarity=0.304 Sum_probs=197.9
Q ss_pred hCCCCCCceeecCCcceEEEEEeC-CCcEEEEEEeccCcCChhhhHHHHHHHHHHHhcCCcceeeeeeEEEcCCCeeEEE
Q 038766 11 TGSFSENNIIGNSNLSTVYKGRLE-DGEIVAVKKLNFHQFSAESDKSFYREAKTLKELKHRNLVKVLGYAWESGKLKALI 89 (299)
Q Consensus 11 ~~~y~~~~~lg~g~~~~v~~~~~~-~~~~~~vK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~lv 89 (299)
.++|.+.+.||+|++|.||++.+. +++.||+|.+.... .......+.+|+..++.++|+||+++++++.. +...++|
T Consensus 5 ~~~y~~~~~lg~g~~g~vy~~~~~~~~~~vaiK~~~~~~-~~~~~~~~~~E~~~l~~l~h~nI~~~~~~~~~-~~~~~lv 82 (301)
T cd07873 5 LETYIKLDKLGEGTYATVYKGRSKLTDNLVALKEIRLEH-EEGAPCTAIREVSLLKDLKHANIVTLHDIIHT-EKSLTLV 82 (301)
T ss_pred ccceEEeeEeccCcCEEEEEEEEcCCCcEEEEEEEeccc-ccCchhHHHHHHHHHHhcCCCCcceEEEEEec-CCeEEEE
Confidence 467999999999999999999864 58899999986433 22334567789999999999999999997654 5567999
Q ss_pred EeecCCCChHHHhcCCCCCCCCCChhhHHHHHHHHHHHHHHhhcCCCCCeeeecccCCceeeCCCCcEEEeeeccccccc
Q 038766 90 LEYMENGSLESVIHGPGVDHSRWTLPKRIDVLISVANGLDYLHSGYDIPIVHCDMKPSNILLDRDFEAHVSDFGTSRMLD 169 (299)
Q Consensus 90 ~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lh~~~~~~~~H~dl~~~nil~~~~~~v~l~df~~~~~~~ 169 (299)
+||+. ++|.+.+... ...+++..++.++.|+++||.+||+. +++|+||+|+||+++.++.++|+|||++....
T Consensus 83 ~e~~~-~~l~~~l~~~---~~~~~~~~~~~~~~qi~~aL~~lH~~---~i~H~dlkp~Nil~~~~~~~kl~dfg~~~~~~ 155 (301)
T cd07873 83 FEYLD-KDLKQYLDDC---GNSINMHNVKLFLFQLLRGLNYCHRR---KVLHRDLKPQNLLINERGELKLADFGLARAKS 155 (301)
T ss_pred Eeccc-cCHHHHHHhc---CCCCCHHHHHHHHHHHHHHHHHHHhC---CeeCCCCCHHHEEECCCCcEEECcCcchhccC
Confidence 99996 5888877532 34688999999999999999999999 99999999999999999999999999986533
Q ss_pred cccccccccccccccCcccCChhhhccc-CcCccccchhhhHHHHHHHhCCCCCCCCccCCCCchhHHHHHHHHHhc---
Q 038766 170 VHLQDLSSLSTAFQGTIGYLAPEFAYMR-IVTTKVDVFSFGIVVMEFLTKRRPTGLDEENGLSPISLRQLVEKALAN--- 245 (299)
Q Consensus 170 ~~~~~~~~~~~~~~~~~~y~~PE~~~~~-~~~~~~DiwslG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~--- 245 (299)
.. ........+++.|+|||.+.+. .++.++||||||+++|+|++|..||..... ......+......
T Consensus 156 ~~----~~~~~~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~~l~el~tg~~~f~~~~~-----~~~~~~~~~~~~~~~~ 226 (301)
T cd07873 156 IP----TKTYSNEVVTLWYRPPDILLGSTDYSTQIDMWGVGCIFYEMSTGRPLFPGSTV-----EEQLHFIFRILGTPTE 226 (301)
T ss_pred CC----CCcccccceeecccCcHHHhCCCCCccHHHHHHHHHHHHHHHhCCCCCCCCCH-----HHHHHHHHHHcCCCCh
Confidence 11 1112233457899999987654 578899999999999999999999964421 1111111111000
Q ss_pred -CccC------cccccCccccchhhHhHHHHHHHHHHHHHHHHhcCCCCCCCCChhhhhcC
Q 038766 246 -GING------VRQITDPKLVSSIYEEQEQHQVLEELFKLALVCTSSNPEDRPNMNELLIT 299 (299)
Q Consensus 246 -~~~~------~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rpt~~~il~~ 299 (299)
.++. ......+...... .......+++.+.+||.+||..||.+|||++++++|
T Consensus 227 ~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~li~~ml~~dp~~R~t~~eil~h 286 (301)
T cd07873 227 ETWPGILSNEEFKSYNYPKYRADC-LHNHAPRLDSDGAELLSKLLQFEGRKRISAEEAMKH 286 (301)
T ss_pred hhchhhhccccccccccCcccccc-HHhhcCCCCHHHHHHHHHHhcCCcccCcCHHHHhcC
Confidence 0000 0000001100000 001123456788999999999999999999999987
|
Serine/Threonine Kinases (STKs), PCTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-1 is expressed ubiquitously and is localized in the cytoplasm. Its kinase activity is cell cycle dependent and peaks at the S and G2 phases. PCTAIRE-1 is highly expressed in the brain and may pl |
| >cd06612 STKc_MST1_2 Catalytic domain of the Protein Serine/Threonine Kinases, Mammalian Ste20-like protein kinase 1 and 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-40 Score=275.69 Aligned_cols=251 Identities=24% Similarity=0.363 Sum_probs=201.4
Q ss_pred hCCCCCCceeecCCcceEEEEEeCC-CcEEEEEEeccCcCChhhhHHHHHHHHHHHhcCCcceeeeeeEEEcCCCeeEEE
Q 038766 11 TGSFSENNIIGNSNLSTVYKGRLED-GEIVAVKKLNFHQFSAESDKSFYREAKTLKELKHRNLVKVLGYAWESGKLKALI 89 (299)
Q Consensus 11 ~~~y~~~~~lg~g~~~~v~~~~~~~-~~~~~vK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~lv 89 (299)
.++|.+.+.||+|++|.||++.+.+ +..+++|.+.... ....+.+|++.++.++|+|++++++.+.. +...+++
T Consensus 2 ~~~y~~~~~i~~g~~~~v~~~~~~~~~~~~~~k~~~~~~----~~~~~~~e~~~~~~l~~~~i~~~~~~~~~-~~~~~l~ 76 (256)
T cd06612 2 EEVFDILEKLGEGSYGSVYKAIHKETGQVVAIKVVPVEE----DLQEIIKEISILKQCDSPYIVKYYGSYFK-NTDLWIV 76 (256)
T ss_pred cccchhhhhhcCCCCeEEEEEEEcCCCcEEEEEEeecHH----HHHHHHHHHHHHHhCCCCcEeeeeeeeec-CCcEEEE
Confidence 3689999999999999999998764 8899999986332 26788999999999999999999997765 4566999
Q ss_pred EeecCCCChHHHhcCCCCCCCCCChhhHHHHHHHHHHHHHHhhcCCCCCeeeecccCCceeeCCCCcEEEeeeccccccc
Q 038766 90 LEYMENGSLESVIHGPGVDHSRWTLPKRIDVLISVANGLDYLHSGYDIPIVHCDMKPSNILLDRDFEAHVSDFGTSRMLD 169 (299)
Q Consensus 90 ~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lh~~~~~~~~H~dl~~~nil~~~~~~v~l~df~~~~~~~ 169 (299)
+|++.+++|.+++.. ....+++..++.++.|++.|+.+||+. +++|+||+|+||+++.++.++|+|||++....
T Consensus 77 ~e~~~~~~L~~~l~~---~~~~l~~~~~~~~~~~l~~~l~~lh~~---~i~H~dl~~~ni~~~~~~~~~l~dfg~~~~~~ 150 (256)
T cd06612 77 MEYCGAGSVSDIMKI---TNKTLTEEEIAAILYQTLKGLEYLHSN---KKIHRDIKAGNILLNEEGQAKLADFGVSGQLT 150 (256)
T ss_pred EecCCCCcHHHHHHh---CccCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCcceEEECCCCcEEEcccccchhcc
Confidence 999999999998853 235789999999999999999999999 99999999999999999999999999987654
Q ss_pred cccccccccccccccCcccCChhhhcccCcCccccchhhhHHHHHHHhCCCCCCCCccCCCCchhHHHHHHHHHhcCccC
Q 038766 170 VHLQDLSSLSTAFQGTIGYLAPEFAYMRIVTTKVDVFSFGIVVMEFLTKRRPTGLDEENGLSPISLRQLVEKALANGING 249 (299)
Q Consensus 170 ~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~DiwslG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 249 (299)
.. ........++..|+|||.+.+..++.++||||+|+++++|++|..||...... ....... .. .
T Consensus 151 ~~----~~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~s~G~il~~l~~g~~p~~~~~~~--------~~~~~~~-~~--~ 215 (256)
T cd06612 151 DT----MAKRNTVIGTPFWMAPEVIQEIGYNNKADIWSLGITAIEMAEGKPPYSDIHPM--------RAIFMIP-NK--P 215 (256)
T ss_pred cC----ccccccccCCccccCHHHHhcCCCCchhhHHHHHHHHHHHHhCCCCCCCcchh--------hhhhhhc-cC--C
Confidence 21 11223344678899999999889999999999999999999999998532111 0000000 00 0
Q ss_pred cccccCccccchhhHhHHHHHHHHHHHHHHHHhcCCCCCCCCChhhhhcC
Q 038766 250 VRQITDPKLVSSIYEEQEQHQVLEELFKLALVCTSSNPEDRPNMNELLIT 299 (299)
Q Consensus 250 ~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rpt~~~il~~ 299 (299)
.... ..+..++.++.++|.+||..||++|||++++|+|
T Consensus 216 ~~~~------------~~~~~~~~~~~~~i~~~l~~~P~~Rps~~~il~~ 253 (256)
T cd06612 216 PPTL------------SDPEKWSPEFNDFVKKCLVKDPEERPSAIQLLQH 253 (256)
T ss_pred CCCC------------CchhhcCHHHHHHHHHHHhcChhhCcCHHHHhcC
Confidence 0000 0133456789999999999999999999999987
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 1 (MST1) and MST2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST1/2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST1, MST2, and related proteins including Drosophila Hippo and Dictyostelium discoideum Krs1 (kinase responsive to stress 1). MST1/2 and Hippo are involved in a conserved pathway that governs cell contact inhibition, organ size control, and tumor development. MST1 activates the mitogen-activated protein kinases (MAPKs) p38 and c-Jun N-terminal kinase (JNK) through MKK7 (a |
| >cd05632 STKc_GRK5 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-40 Score=277.55 Aligned_cols=254 Identities=20% Similarity=0.282 Sum_probs=196.9
Q ss_pred CCCCCceeecCCcceEEEEEe-CCCcEEEEEEeccCcCC-hhhhHHHHHHHHHHHhcCCcceeeeeeEEEcCCCeeEEEE
Q 038766 13 SFSENNIIGNSNLSTVYKGRL-EDGEIVAVKKLNFHQFS-AESDKSFYREAKTLKELKHRNLVKVLGYAWESGKLKALIL 90 (299)
Q Consensus 13 ~y~~~~~lg~g~~~~v~~~~~-~~~~~~~vK~~~~~~~~-~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~lv~ 90 (299)
.|+..+.||+|+||+||.+.+ .+++.+|+|.+...... ......+.+|+++++.++|++++++.+.+.. ++..++|+
T Consensus 1 ~~~~~~~lg~G~~g~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~i~~~~~~~~~-~~~~~lv~ 79 (285)
T cd05632 1 TFRQYRVLGKGGFGEVCACQVRATGKMYACKRLEKKRIKKRKGESMALNEKQILEKVNSQFVVNLAYAYET-KDALCLVL 79 (285)
T ss_pred CceEEEEEecCCCeEEEEEEECCCCcEEEEEEeehhhhhhhhHHHHHHHHHHHHHHcCCcCceeEEEEEec-CCEEEEEE
Confidence 377889999999999999986 46889999998644332 2234567789999999999999999986554 55679999
Q ss_pred eecCCCChHHHhcCCCCCCCCCChhhHHHHHHHHHHHHHHhhcCCCCCeeeecccCCceeeCCCCcEEEeeecccccccc
Q 038766 91 EYMENGSLESVIHGPGVDHSRWTLPKRIDVLISVANGLDYLHSGYDIPIVHCDMKPSNILLDRDFEAHVSDFGTSRMLDV 170 (299)
Q Consensus 91 e~~~~~~L~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lh~~~~~~~~H~dl~~~nil~~~~~~v~l~df~~~~~~~~ 170 (299)
||+.+++|.+.+... ...++++..+..++.|++.||.|||+. +++|+||+|+||+++.++.++|+|||++.....
T Consensus 80 e~~~~~~L~~~~~~~--~~~~~~~~~~~~~~~ql~~~l~~lH~~---~iiH~dikp~Nili~~~~~~kl~Dfg~~~~~~~ 154 (285)
T cd05632 80 TIMNGGDLKFHIYNM--GNPGFEEERALFYAAEILCGLEDLHRE---NTVYRDLKPENILLDDYGHIRISDLGLAVKIPE 154 (285)
T ss_pred EeccCccHHHHHHHh--cCCCCCHHHHHHHHHHHHHHHHHHHhC---CeeecCCCHHHEEECCCCCEEEecCCcceecCC
Confidence 999999998877532 234699999999999999999999999 999999999999999999999999998865431
Q ss_pred ccccccccccccccCcccCChhhhcccCcCccccchhhhHHHHHHHhCCCCCCCCccCCCCchhHHHHHHHHHhcCccCc
Q 038766 171 HLQDLSSLSTAFQGTIGYLAPEFAYMRIVTTKVDVFSFGIVVMEFLTKRRPTGLDEENGLSPISLRQLVEKALANGINGV 250 (299)
Q Consensus 171 ~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~DiwslG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 250 (299)
........++..|+|||.+.+..++.++|+||+|+++|+|++|..||.... .......+........
T Consensus 155 -----~~~~~~~~g~~~~~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~P~~~~~-----~~~~~~~~~~~~~~~~--- 221 (285)
T cd05632 155 -----GESIRGRVGTVGYMAPEVLNNQRYTLSPDYWGLGCLIYEMIEGQSPFRGRK-----EKVKREEVDRRVLETE--- 221 (285)
T ss_pred -----CCcccCCCCCcCccChHHhcCCCCCcccchHHHHHHHHHHHhCCCCCCCCC-----HHHHHHHHHHhhhccc---
Confidence 111233467899999999988889999999999999999999999995331 1111111111111100
Q ss_pred ccccCccccchhhHhHHHHHHHHHHHHHHHHhcCCCCCCCCC-----hhhhhcC
Q 038766 251 RQITDPKLVSSIYEEQEQHQVLEELFKLALVCTSSNPEDRPN-----MNELLIT 299 (299)
Q Consensus 251 ~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rpt-----~~~il~~ 299 (299)
. . ....++..+.+|+.+||..||++||| +++++.|
T Consensus 222 ~-----~---------~~~~~~~~~~~li~~~l~~~P~~R~~~~~~~~~~l~~~ 261 (285)
T cd05632 222 E-----V---------YSAKFSEEAKSICKMLLTKDPKQRLGCQEEGAGEVKRH 261 (285)
T ss_pred c-----c---------cCccCCHHHHHHHHHHccCCHhHcCCCcccChHHHHcC
Confidence 0 0 02234567889999999999999999 7788775
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK5 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK5 is widely expressed in many tissues. It associates with |
| >cd06621 PKc_MAPKK_Pek1_like Catalytic domain of fungal Pek1-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-40 Score=277.72 Aligned_cols=264 Identities=29% Similarity=0.371 Sum_probs=203.3
Q ss_pred CCCCCCceeecCCcceEEEEEeC-CCcEEEEEEeccCcCChhhhHHHHHHHHHHHhcCCcceeeeeeEEEcC-CCeeEEE
Q 038766 12 GSFSENNIIGNSNLSTVYKGRLE-DGEIVAVKKLNFHQFSAESDKSFYREAKTLKELKHRNLVKVLGYAWES-GKLKALI 89 (299)
Q Consensus 12 ~~y~~~~~lg~g~~~~v~~~~~~-~~~~~~vK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~-~~~~~lv 89 (299)
++|...+.||.|++|.||++.+. +++.+|+|++.... .......+.+|++.++.++||||+++++++... .+..++|
T Consensus 1 ~~~~~~~~lg~g~~~~v~~~~~~~~~~~~~~k~~~~~~-~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~lv 79 (287)
T cd06621 1 EKIVELSRLGEGAGGSVTKCRLKNTGMIFALKTITTDP-NPDLQKQILRELEINKSCKSPYIVKYYGAFLDESSSSIGIA 79 (287)
T ss_pred CceEEEEEeccCCceEEEEEEECCCCeEEEEEEEecCC-chHHHHHHHHHHHHHHhCCCCCeeeeeeEEEccCCCeEEEE
Confidence 46888999999999999999874 58899999986432 334567789999999999999999999977654 3457999
Q ss_pred EeecCCCChHHHhcCCCCCCCCCChhhHHHHHHHHHHHHHHhhcCCCCCeeeecccCCceeeCCCCcEEEeeeccccccc
Q 038766 90 LEYMENGSLESVIHGPGVDHSRWTLPKRIDVLISVANGLDYLHSGYDIPIVHCDMKPSNILLDRDFEAHVSDFGTSRMLD 169 (299)
Q Consensus 90 ~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lh~~~~~~~~H~dl~~~nil~~~~~~v~l~df~~~~~~~ 169 (299)
+||+++++|.+++.........+++..+..++.|++.||.|||+. +++|+||+|+||+++.++.++|+|||++....
T Consensus 80 ~e~~~~~~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~lH~~---~i~H~dl~~~nil~~~~~~~~l~dfg~~~~~~ 156 (287)
T cd06621 80 MEYCEGGSLDSIYKKVKKRGGRIGEKVLGKIAESVLKGLSYLHSR---KIIHRDIKPSNILLTRKGQVKLCDFGVSGELV 156 (287)
T ss_pred EEecCCCCHHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCHHHEEEecCCeEEEeecccccccc
Confidence 999999999887654332456789999999999999999999999 99999999999999999999999999976443
Q ss_pred cccccccccccccccCcccCChhhhcccCcCccccchhhhHHHHHHHhCCCCCCCCccCCCCchhHHHHHHHHHhcCccC
Q 038766 170 VHLQDLSSLSTAFQGTIGYLAPEFAYMRIVTTKVDVFSFGIVVMEFLTKRRPTGLDEENGLSPISLRQLVEKALANGING 249 (299)
Q Consensus 170 ~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~DiwslG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 249 (299)
.. ......++..|+|||...+..++.++|+||||+++|+|++|..||...........+... .........
T Consensus 157 ~~------~~~~~~~~~~y~~pE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~---~~~~~~~~~ 227 (287)
T cd06621 157 NS------LAGTFTGTSFYMAPERIQGKPYSITSDVWSLGLTLLEVAQNRFPFPPEGEPPLGPIELLS---YIVNMPNPE 227 (287)
T ss_pred cc------ccccccCCccccCHHHhcCCCCCchhhHHHHHHHHHHHHhCCCCCCcccCCCCChHHHHH---HHhcCCchh
Confidence 11 112334677899999999888999999999999999999999999755332112222211 111111001
Q ss_pred cccccCccccchhhHhHHHHHHHHHHHHHHHHhcCCCCCCCCChhhhhcC
Q 038766 250 VRQITDPKLVSSIYEEQEQHQVLEELFKLALVCTSSNPEDRPNMNELLIT 299 (299)
Q Consensus 250 ~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rpt~~~il~~ 299 (299)
....... ....++.+.+++.+||..+|++|||+.|+++|
T Consensus 228 ~~~~~~~-----------~~~~~~~~~~li~~~l~~~p~~Rpt~~eil~~ 266 (287)
T cd06621 228 LKDEPGN-----------GIKWSEEFKDFIKQCLEKDPTRRPTPWDMLEH 266 (287)
T ss_pred hccCCCC-----------CCchHHHHHHHHHHHcCCCcccCCCHHHHHhC
Confidence 0000000 11235678999999999999999999999986
|
Protein kinases (PKs), MAP kinase kinase(MAPKK) subfamily, fungal Pek1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include |
| >KOG0666 consensus Cyclin C-dependent kinase CDK8 [Transcription] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.1e-42 Score=273.75 Aligned_cols=286 Identities=23% Similarity=0.267 Sum_probs=215.2
Q ss_pred HHhCCCCCCceeecCCcceEEEEEeC--C---CcEEEEEEeccCcCChhhhHHHHHHHHHHHhcCCcceeeeeeEEEcCC
Q 038766 9 NATGSFSENNIIGNSNLSTVYKGRLE--D---GEIVAVKKLNFHQFSAESDKSFYREAKTLKELKHRNLVKVLGYAWESG 83 (299)
Q Consensus 9 ~~~~~y~~~~~lg~g~~~~v~~~~~~--~---~~~~~vK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~ 83 (299)
.-...|.+.+.||+|.+|.||+|.-+ + .+.+|+|.+..+......--..-+|+..++.++|||++.+..++..++
T Consensus 21 e~l~~ye~ig~Ig~GTYG~VykA~~~~~n~kr~k~yAiKkfk~~kd~tGiS~SAcREiaL~REl~h~nvi~Lv~Vfl~~d 100 (438)
T KOG0666|consen 21 EDLFEYEGIGKIGRGTYGKVYKAVRKNTNDKRTKEYAIKKFKGEKDGTGISMSACREIALLRELKHPNVISLVKVFLSHD 100 (438)
T ss_pred HHHHHhhccceecccccceeeEeeeccCCcccchhhHHHHHhccCCCCCcCHHHHHHHHHHHHhcCCcchhHHHHHhccC
Confidence 34567999999999999999999532 2 337999999866444444556778999999999999999999998888
Q ss_pred CeeEEEEeecCCCChHHHhcCCCC-CCCCCChhhHHHHHHHHHHHHHHhhcCCCCCeeeecccCCceeeCCC----CcEE
Q 038766 84 KLKALILEYMENGSLESVIHGPGV-DHSRWTLPKRIDVLISVANGLDYLHSGYDIPIVHCDMKPSNILLDRD----FEAH 158 (299)
Q Consensus 84 ~~~~lv~e~~~~~~L~~~~~~~~~-~~~~~~~~~~~~i~~qi~~~l~~lh~~~~~~~~H~dl~~~nil~~~~----~~v~ 158 (299)
...++++||.+. +|+..|.-+.. ....++...+.+|+.||+.++.|||++ =+.||||||.||||..+ |.||
T Consensus 101 ~~v~l~fdYAEh-DL~~II~fHr~~~~~~lp~~mvKsilwQil~Gv~YLH~N---WvlHRDLKPaNIlvmgdgperG~VK 176 (438)
T KOG0666|consen 101 KKVWLLFDYAEH-DLWHIIKFHRASKAKQLPRSMVKSILWQILDGVHYLHSN---WVLHRDLKPANILVMGDGPERGRVK 176 (438)
T ss_pred ceEEEEehhhhh-hHHHHHHHhccchhccCCHHHHHHHHHHHHhhhHHHhhh---heeeccCCcceEEEeccCCccCeeE
Confidence 888999999976 99998875422 335789999999999999999999999 89999999999999877 8999
Q ss_pred EeeeccccccccccccccccccccccCcccCChhhhccc-CcCccccchhhhHHHHHHHhCCCCCCCCccCCC--CchhH
Q 038766 159 VSDFGTSRMLDVHLQDLSSLSTAFQGTIGYLAPEFAYMR-IVTTKVDVFSFGIVVMEFLTKRRPTGLDEENGL--SPISL 235 (299)
Q Consensus 159 l~df~~~~~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~-~~~~~~DiwslG~~l~~l~~g~~p~~~~~~~~~--~~~~~ 235 (299)
|+|+|+++.+........ .....+.|.+|.|||++.+. .|+.+.|+|+.||++.||++-.+.|...+.+.. ++...
T Consensus 177 IaDlGlaR~~~~plkpl~-s~d~VVVTiWYRAPELLLGa~hYT~AiDvWAiGCIfaElLtl~PlF~g~E~k~~~~~Pfq~ 255 (438)
T KOG0666|consen 177 IADLGLARLFNNPLKPLA-SLDPVVVTIWYRAPELLLGARHYTKAIDVWAIGCIFAELLTLEPLFKGREEKIKTKNPFQH 255 (438)
T ss_pred eecccHHHHhhccccccc-cCCceEEEEEecChHHhcccccccchhhhHHHHHHHHHHHccCccccchhhhcccCCCchH
Confidence 999999998764333222 23456679999999998886 499999999999999999999998876543322 23333
Q ss_pred HHHHHHHHh------cCccCcccccCccccchhhH-----hH-H------HHHHHHHHHHHHHHhcCCCCCCCCChhhhh
Q 038766 236 RQLVEKALA------NGINGVRQITDPKLVSSIYE-----EQ-E------QHQVLEELFKLALVCTSSNPEDRPNMNELL 297 (299)
Q Consensus 236 ~~~~~~~~~------~~~~~~~~~~~~~~~~~~~~-----~~-~------~~~~~~~l~~li~~~l~~dP~~Rpt~~~il 297 (299)
.......-. ..|+.+..+++.......+. +. . ...-++...+|+.+||..||.+|.|+++.|
T Consensus 256 dQl~rIf~vLG~Pt~~~Wp~lkk~Pe~q~~ls~f~~~~~~n~sL~~~~~~~k~k~~~a~~LL~klL~yDP~kRIta~qAl 335 (438)
T KOG0666|consen 256 DQLDRIFEVLGTPTDKDWPDLKKMPEYQTLLSDFRRHYYDNVSLHKYYHKHKVKDPSALDLLQKLLTYDPIKRITAEQAL 335 (438)
T ss_pred HHHHHHHHHcCCCccccchhhhhCcchHHHHHHhHHhhcCcchHHHHHHHhcCCCchHHHHHHHHhccCchhhccHHHHh
Confidence 333322222 33333333333311111111 10 0 011124589999999999999999999999
Q ss_pred cC
Q 038766 298 IT 299 (299)
Q Consensus 298 ~~ 299 (299)
+|
T Consensus 336 eh 337 (438)
T KOG0666|consen 336 EH 337 (438)
T ss_pred cc
Confidence 87
|
|
| >KOG4721 consensus Serine/threonine protein kinase, contains leucine zipper domain [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-42 Score=295.43 Aligned_cols=249 Identities=30% Similarity=0.438 Sum_probs=207.2
Q ss_pred hHHHHHHhCCCCCCceeecCCcceEEEEEeCCCcEEEEEEeccCcCChhhhHHHHHHHHHHHhcCCcceeeeeeEEEcCC
Q 038766 4 RTEIENATGSFSENNIIGNSNLSTVYKGRLEDGEIVAVKKLNFHQFSAESDKSFYREAKTLKELKHRNLVKVLGYAWESG 83 (299)
Q Consensus 4 ~~~~~~~~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~vK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~ 83 (299)
.+.||+=++...-.+.||+|+.|.||+++.+ ++.||||+++. .. ..+++-|++|+|+||+.+.|+|-. .
T Consensus 116 ~e~WeiPFe~IsELeWlGSGaQGAVF~Grl~-netVAVKKV~e--lk-------ETdIKHLRkLkH~NII~FkGVCtq-s 184 (904)
T KOG4721|consen 116 EELWEIPFEEISELEWLGSGAQGAVFLGRLH-NETVAVKKVRE--LK-------ETDIKHLRKLKHPNIITFKGVCTQ-S 184 (904)
T ss_pred hhhccCCHHHhhhhhhhccCcccceeeeecc-CceehhHHHhh--hh-------hhhHHHHHhccCcceeeEeeeecC-C
Confidence 3567888888888999999999999999986 67899998752 12 236888999999999999998876 5
Q ss_pred CeeEEEEeecCCCChHHHhcCCCCCCCCCChhhHHHHHHHHHHHHHHhhcCCCCCeeeecccCCceeeCCCCcEEEeeec
Q 038766 84 KLKALILEYMENGSLESVIHGPGVDHSRWTLPKRIDVLISVANGLDYLHSGYDIPIVHCDMKPSNILLDRDFEAHVSDFG 163 (299)
Q Consensus 84 ~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lh~~~~~~~~H~dl~~~nil~~~~~~v~l~df~ 163 (299)
..+|||||||..|.|..+++ .+.+++......|..+|+.++.|||.+ .|+|||||.-||||+.+..|||+|||
T Consensus 185 PcyCIiMEfCa~GqL~~VLk----a~~~itp~llv~Wsk~IA~GM~YLH~h---KIIHRDLKSPNiLIs~~d~VKIsDFG 257 (904)
T KOG4721|consen 185 PCYCIIMEFCAQGQLYEVLK----AGRPITPSLLVDWSKGIAGGMNYLHLH---KIIHRDLKSPNILISYDDVVKISDFG 257 (904)
T ss_pred ceeEEeeeccccccHHHHHh----ccCccCHHHHHHHHHHhhhhhHHHHHh---hHhhhccCCCceEeeccceEEecccc
Confidence 56699999999999999998 677999999999999999999999999 99999999999999999999999999
Q ss_pred cccccccccccccccccccccCcccCChhhhcccCcCccccchhhhHHHHHHHhCCCCCCCCccCCCCchhHHHHHHHHH
Q 038766 164 TSRMLDVHLQDLSSLSTAFQGTIGYLAPEFAYMRIVTTKVDVFSFGIVVMEFLTKRRPTGLDEENGLSPISLRQLVEKAL 243 (299)
Q Consensus 164 ~~~~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~DiwslG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~ 243 (299)
-+..+... ...-.+.||..|||||++.....+.|.||||+|++||+|+||..||..- ....+. .
T Consensus 258 TS~e~~~~-----STkMSFaGTVaWMAPEvIrnePcsEKVDIwSfGVVLWEmLT~EiPYkdV-----dssAII------w 321 (904)
T KOG4721|consen 258 TSKELSDK-----STKMSFAGTVAWMAPEVIRNEPCSEKVDIWSFGVVLWEMLTGEIPYKDV-----DSSAII------W 321 (904)
T ss_pred chHhhhhh-----hhhhhhhhhHhhhCHHHhhcCCcccccceehhHHHHHHHHhcCCCcccc-----chheeE------E
Confidence 98876521 2234567899999999999999999999999999999999999998421 111111 1
Q ss_pred hcCccCcccccCccccchhhHhHHHHHHHHHHHHHHHHhcCCCCCCCCChhhhhcC
Q 038766 244 ANGINGVRQITDPKLVSSIYEEQEQHQVLEELFKLALVCTSSNPEDRPNMNELLIT 299 (299)
Q Consensus 244 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rpt~~~il~~ 299 (299)
..+. .....+++...++.+.=|+++||+..|..||++.++|.|
T Consensus 322 GVGs-------------NsL~LpvPstcP~GfklL~Kqcw~sKpRNRPSFrqil~H 364 (904)
T KOG4721|consen 322 GVGS-------------NSLHLPVPSTCPDGFKLLLKQCWNSKPRNRPSFRQILLH 364 (904)
T ss_pred eccC-------------CcccccCcccCchHHHHHHHHHHhcCCCCCccHHHHHHH
Confidence 1111 112224466677788889999999999999999999986
|
|
| >cd05062 PTKc_IGF-1R Catalytic domain of the Protein Tyrosine Kinase, Insulin-like Growth Factor-1 Receptor | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.9e-41 Score=280.53 Aligned_cols=260 Identities=26% Similarity=0.385 Sum_probs=196.7
Q ss_pred HHHHhCCCCCCceeecCCcceEEEEEeC------CCcEEEEEEeccCcCChhhhHHHHHHHHHHHhcCCcceeeeeeEEE
Q 038766 7 IENATGSFSENNIIGNSNLSTVYKGRLE------DGEIVAVKKLNFHQFSAESDKSFYREAKTLKELKHRNLVKVLGYAW 80 (299)
Q Consensus 7 ~~~~~~~y~~~~~lg~g~~~~v~~~~~~------~~~~~~vK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~ 80 (299)
|+...++|++.+.||+|++|+||++.+. ++..+|+|++.... .......+.+|+..++.++|+||+++++++.
T Consensus 1 ~~~~~~~~~~~~~ig~G~~g~v~~~~~~~~~~~~~~~~~aik~~~~~~-~~~~~~~~~~e~~~l~~l~~~~iv~~~~~~~ 79 (277)
T cd05062 1 WEVAREKITMSRELGQGSFGMVYEGIAKGVVKDEPETRVAIKTVNEAA-SMRERIEFLNEASVMKEFNCHHVVRLLGVVS 79 (277)
T ss_pred CcccHHHceeeeeeccccCCeEEEEEeccCCCCCceeEEEEEeccccC-CHHHHHHHHHHHHHHHhCCCCCeeeEEEEEc
Confidence 3567889999999999999999998753 35679999875322 2234556889999999999999999999665
Q ss_pred cCCCeeEEEEeecCCCChHHHhcCCCCC------CCCCChhhHHHHHHHHHHHHHHhhcCCCCCeeeecccCCceeeCCC
Q 038766 81 ESGKLKALILEYMENGSLESVIHGPGVD------HSRWTLPKRIDVLISVANGLDYLHSGYDIPIVHCDMKPSNILLDRD 154 (299)
Q Consensus 81 ~~~~~~~lv~e~~~~~~L~~~~~~~~~~------~~~~~~~~~~~i~~qi~~~l~~lh~~~~~~~~H~dl~~~nil~~~~ 154 (299)
. +...++|+||+.+++|.+++...... ...++...++.++.|++.||.|||+. +++|+||||+||+++.+
T Consensus 80 ~-~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~---~~vH~dlkp~Nil~~~~ 155 (277)
T cd05062 80 Q-GQPTLVIMELMTRGDLKSYLRSLRPEMENNPVQAPPSLKKMIQMAGEIADGMAYLNAN---KFVHRDLAARNCMVAED 155 (277)
T ss_pred C-CCCeEEEEecCCCCCHHHHHHHcCccccccccccCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCcchheEEEcCC
Confidence 4 55669999999999999988642211 23456778899999999999999999 99999999999999999
Q ss_pred CcEEEeeeccccccccccccccccccccccCcccCChhhhcccCcCccccchhhhHHHHHHHh-CCCCCCCCccCCCCch
Q 038766 155 FEAHVSDFGTSRMLDVHLQDLSSLSTAFQGTIGYLAPEFAYMRIVTTKVDVFSFGIVVMEFLT-KRRPTGLDEENGLSPI 233 (299)
Q Consensus 155 ~~v~l~df~~~~~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~DiwslG~~l~~l~~-g~~p~~~~~~~~~~~~ 233 (299)
+.++|+|||++....... .........+++.|+|||.+.+..++.++|+||||+++|+|++ |..||... ...
T Consensus 156 ~~~~l~dfg~~~~~~~~~--~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~~~~p~~~~-----~~~ 228 (277)
T cd05062 156 FTVKIGDFGMTRDIYETD--YYRKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGM-----SNE 228 (277)
T ss_pred CCEEECCCCCccccCCcc--eeecCCCCccCHhhcChhHhhcCCcCchhHHHHHHHHHHHHHcCCCCCCCCC-----CHH
Confidence 999999999886543111 1111122334678999999998889999999999999999998 67777432 121
Q ss_pred hHHHHHHHHHhcCccCcccccCccccchhhHhHHHHHHHHHHHHHHHHhcCCCCCCCCChhhhhc
Q 038766 234 SLRQLVEKALANGINGVRQITDPKLVSSIYEEQEQHQVLEELFKLALVCTSSNPEDRPNMNELLI 298 (299)
Q Consensus 234 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rpt~~~il~ 298 (299)
.... ......... . +...+..+.+++.+||+.||++|||+.++++
T Consensus 229 ~~~~---~~~~~~~~~---~--------------~~~~~~~~~~li~~~l~~~p~~Rps~~e~l~ 273 (277)
T cd05062 229 QVLR---FVMEGGLLD---K--------------PDNCPDMLFELMRMCWQYNPKMRPSFLEIIS 273 (277)
T ss_pred HHHH---HHHcCCcCC---C--------------CCCCCHHHHHHHHHHcCCChhhCcCHHHHHH
Confidence 2111 111111100 0 1123457899999999999999999999986
|
Protein Tyrosine Kinase (PTK) family; Insulin-like Growth Factor-1 Receptor (IGF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. IGF-1R is a receptor tyr kinases (RTK) that is composed of two alphabeta heterodimers. Binding of the ligand (IGF-1 or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, which stimulates downstream kinase activities and biological function. IGF-1R signaling is important in the differentiation, growth, and survival of normal cells. In cancer cells, wh |
| >cd05059 PTKc_Tec_like Catalytic domain of Tec-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.3e-41 Score=276.17 Aligned_cols=249 Identities=24% Similarity=0.372 Sum_probs=194.4
Q ss_pred CCCCCCceeecCCcceEEEEEeCCCcEEEEEEeccCcCChhhhHHHHHHHHHHHhcCCcceeeeeeEEEcCCCeeEEEEe
Q 038766 12 GSFSENNIIGNSNLSTVYKGRLEDGEIVAVKKLNFHQFSAESDKSFYREAKTLKELKHRNLVKVLGYAWESGKLKALILE 91 (299)
Q Consensus 12 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~vK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~lv~e 91 (299)
.+|++.+.||+|++|.||++.+.++..+++|.+.... .....+.+|+..++.++|+||+++++++.. ....++|+|
T Consensus 4 ~~~~~~~~lg~G~~~~v~~~~~~~~~~~~iK~~~~~~---~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~-~~~~~lv~e 79 (256)
T cd05059 4 SELTFLKELGSGQFGVVHLGKWRGKIDVAIKMIREGA---MSEDDFIEEAKVMMKLSHPNLVQLYGVCTK-QRPIFIVTE 79 (256)
T ss_pred HHcchhhhhccCCCceEEEeEecCCccEEEEEeccCC---CCHHHHHHHHHHHHhCCCCCEEEEEEEEcC-CCceEEEEe
Confidence 4689999999999999999998777889999985332 234467789999999999999999996654 456699999
Q ss_pred ecCCCChHHHhcCCCCCCCCCChhhHHHHHHHHHHHHHHhhcCCCCCeeeecccCCceeeCCCCcEEEeeeccccccccc
Q 038766 92 YMENGSLESVIHGPGVDHSRWTLPKRIDVLISVANGLDYLHSGYDIPIVHCDMKPSNILLDRDFEAHVSDFGTSRMLDVH 171 (299)
Q Consensus 92 ~~~~~~L~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lh~~~~~~~~H~dl~~~nil~~~~~~v~l~df~~~~~~~~~ 171 (299)
++++++|.+++... ...+++..++.++.|++.|+++||+. +++|+||+|+||+++.++.++|+|||++......
T Consensus 80 ~~~~~~L~~~l~~~---~~~~~~~~~~~i~~qi~~~l~~lH~~---~i~H~dl~p~ni~i~~~~~~kl~dfg~~~~~~~~ 153 (256)
T cd05059 80 YMANGCLLNYLRER---KGKLGTEWLLDMCSDVCEAMEYLESN---GFIHRDLAARNCLVGEDNVVKVSDFGLARYVLDD 153 (256)
T ss_pred cCCCCCHHHHHHhc---ccCCCHHHHHHHHHHHHHHHHHHHHC---CcccccccHhhEEECCCCcEEECCcccceecccc
Confidence 99999999988632 23689999999999999999999999 9999999999999999999999999988754311
Q ss_pred cccccccccccccCcccCChhhhcccCcCccccchhhhHHHHHHHh-CCCCCCCCccCCCCchhHHHHHHHHHhcCccCc
Q 038766 172 LQDLSSLSTAFQGTIGYLAPEFAYMRIVTTKVDVFSFGIVVMEFLT-KRRPTGLDEENGLSPISLRQLVEKALANGINGV 250 (299)
Q Consensus 172 ~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~DiwslG~~l~~l~~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 250 (299)
..........+..|+|||.+.+..++.++|+||||+++|+|++ |..||.... .......+. ...
T Consensus 154 ---~~~~~~~~~~~~~y~~Pe~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~-----~~~~~~~~~----~~~--- 218 (256)
T cd05059 154 ---QYTSSQGTKFPVKWAPPEVFDYSRFSSKSDVWSFGVLMWEVFSEGKMPYERFS-----NSEVVESVS----AGY--- 218 (256)
T ss_pred ---cccccCCCCCCccccCHHHhccCCCCchhhHHHHHHHHHHHhccCCCCCCCCC-----HHHHHHHHH----cCC---
Confidence 1111112223457999999998889999999999999999998 788885321 111111111 110
Q ss_pred ccccCccccchhhHhHHHHHHHHHHHHHHHHhcCCCCCCCCChhhhhc
Q 038766 251 RQITDPKLVSSIYEEQEQHQVLEELFKLALVCTSSNPEDRPNMNELLI 298 (299)
Q Consensus 251 ~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rpt~~~il~ 298 (299)
.... +...+..+.+++.+||+.+|++|||++++++
T Consensus 219 -~~~~------------~~~~~~~~~~li~~cl~~~p~~Rpt~~~~l~ 253 (256)
T cd05059 219 -RLYR------------PKLAPTEVYTIMYSCWHEKPEDRPAFKKLLS 253 (256)
T ss_pred -cCCC------------CCCCCHHHHHHHHHHhcCChhhCcCHHHHHH
Confidence 0000 1124567999999999999999999999986
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) subfamily; catalytic (c) domain. The Tec subfamily is composed of Tec, Btk, Bmx (Etk), Itk (Tsk, Emt), Rlk (Txk), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec kinases are cytoplasmic (or nonreceptor) tyr kinases (nRTKs) with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows |
| >cd05148 PTKc_Srm_Brk Catalytic domain of the Protein Tyrosine Kinases, Srm and Brk | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.5e-41 Score=278.27 Aligned_cols=253 Identities=28% Similarity=0.458 Sum_probs=200.0
Q ss_pred HHhCCCCCCceeecCCcceEEEEEeCCCcEEEEEEeccCcCChhhhHHHHHHHHHHHhcCCcceeeeeeEEEcCCCeeEE
Q 038766 9 NATGSFSENNIIGNSNLSTVYKGRLEDGEIVAVKKLNFHQFSAESDKSFYREAKTLKELKHRNLVKVLGYAWESGKLKAL 88 (299)
Q Consensus 9 ~~~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~vK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~l 88 (299)
--.++|.+.+.||.|++|+||++.+.++..+++|++... .......+..|+..++.++|+||+++++++.. +...++
T Consensus 3 ~~~~~y~~~~~ig~g~~~~vy~~~~~~~~~~~~k~~~~~--~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~-~~~~~l 79 (261)
T cd05148 3 RPREEFTLERKLGSGYFGEVWEGLWKNRVRVAIKILKSD--DLLKQQDFQKEVQALKRLRHKHLISLFAVCSV-GEPVYI 79 (261)
T ss_pred CcHHHHHHhhhhccCCCccEEEeEecCCCcEEEEecccc--chhhHHHHHHHHHHHhcCCCcchhheeeeEec-CCCeEE
Confidence 345679999999999999999999877999999998643 23345678899999999999999999996655 455699
Q ss_pred EEeecCCCChHHHhcCCCCCCCCCChhhHHHHHHHHHHHHHHhhcCCCCCeeeecccCCceeeCCCCcEEEeeecccccc
Q 038766 89 ILEYMENGSLESVIHGPGVDHSRWTLPKRIDVLISVANGLDYLHSGYDIPIVHCDMKPSNILLDRDFEAHVSDFGTSRML 168 (299)
Q Consensus 89 v~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lh~~~~~~~~H~dl~~~nil~~~~~~v~l~df~~~~~~ 168 (299)
|+||+++++|.+++... ....++...++.++.|++.||+|||++ +++|+||+|+||+++.++.++|+|||.+...
T Consensus 80 v~e~~~~~~L~~~~~~~--~~~~~~~~~~~~~~~~i~~al~~lH~~---~i~h~dl~~~nilv~~~~~~kl~d~g~~~~~ 154 (261)
T cd05148 80 ITELMEKGSLLAFLRSP--EGQVLPVASLIDMACQVAEGMAYLEEQ---NSIHRDLAARNILVGEDLVCKVADFGLARLI 154 (261)
T ss_pred EEeecccCCHHHHHhcC--CCCCCCHHHHHHHHHHHHHHHHHHHHC---CeeccccCcceEEEcCCceEEEccccchhhc
Confidence 99999999999999743 345688999999999999999999999 9999999999999999999999999998754
Q ss_pred ccccccccccccccccCcccCChhhhcccCcCccccchhhhHHHHHHHh-CCCCCCCCccCCCCchhHHHHHHHHHhcCc
Q 038766 169 DVHLQDLSSLSTAFQGTIGYLAPEFAYMRIVTTKVDVFSFGIVVMEFLT-KRRPTGLDEENGLSPISLRQLVEKALANGI 247 (299)
Q Consensus 169 ~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~DiwslG~~l~~l~~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 247 (299)
... ........++..|+|||......++.++|+||||+++|+|++ |..||.... .. +.+..... ..
T Consensus 155 ~~~----~~~~~~~~~~~~~~~PE~~~~~~~~~~~DiwslG~~l~~l~~~g~~p~~~~~-----~~---~~~~~~~~-~~ 221 (261)
T cd05148 155 KED----VYLSSDKKIPYKWTAPEAASHGTFSTKSDVWSFGILLYEMFTYGQVPYPGMN-----NH---EVYDQITA-GY 221 (261)
T ss_pred CCc----cccccCCCCceEecCHHHHccCCCCchhhHHHHHHHHHHHHcCCCCCCCcCC-----HH---HHHHHHHh-CC
Confidence 321 111123334668999999988889999999999999999998 788884332 11 12221111 10
Q ss_pred cCcccccCccccchhhHhHHHHHHHHHHHHHHHHhcCCCCCCCCChhhhhc
Q 038766 248 NGVRQITDPKLVSSIYEEQEQHQVLEELFKLALVCTSSNPEDRPNMNELLI 298 (299)
Q Consensus 248 ~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rpt~~~il~ 298 (299)
. .. .+...+..+.+++.+||+.||++|||+.++++
T Consensus 222 ~----~~------------~~~~~~~~~~~~i~~~l~~~p~~Rpt~~~l~~ 256 (261)
T cd05148 222 R----MP------------CPAKCPQEIYKIMLECWAAEPEDRPSFKALRE 256 (261)
T ss_pred c----CC------------CCCCCCHHHHHHHHHHcCCCchhCcCHHHHHH
Confidence 0 00 02233467899999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Src-related kinase lacking C-terminal regulatory tyrosine and N-terminal myristylation sites (Srm) and breast tumor kinase (Brk, also called protein tyrosine kinase 6); catalytic (c) domains. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Srm and Brk are a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases in general contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr; they are activated by autophosphorylation at the tyr kinase dom |
| >cd06644 STKc_STK10_LOK Catalytic domain of the Protein Serine/Threonine Kinase, STK10 or Lymphocyte-oriented kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-40 Score=278.85 Aligned_cols=254 Identities=23% Similarity=0.335 Sum_probs=197.7
Q ss_pred HhCCCCCCceeecCCcceEEEEEeC-CCcEEEEEEeccCcCChhhhHHHHHHHHHHHhcCCcceeeeeeEEEcCCCeeEE
Q 038766 10 ATGSFSENNIIGNSNLSTVYKGRLE-DGEIVAVKKLNFHQFSAESDKSFYREAKTLKELKHRNLVKVLGYAWESGKLKAL 88 (299)
Q Consensus 10 ~~~~y~~~~~lg~g~~~~v~~~~~~-~~~~~~vK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~l 88 (299)
..+.|++.+.||+|++|.||++.+. ++..+++|++.. ........+..|+..++.++|+|++++++.+.. +...++
T Consensus 10 ~~~~y~i~~~lg~g~~g~vy~~~~~~~~~~~~~k~~~~--~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~-~~~~~l 86 (292)
T cd06644 10 PNEVWEIIGELGDGAFGKVYKAKNKETGALAAAKVIET--KSEEELEDYMVEIEILATCNHPYIVKLLGAFYW-DGKLWI 86 (292)
T ss_pred cchhhhhhheecCCCCeEEEEEEECCCCceEEEEEecc--CCHHHHHHHHHHHHHHHhCCCCcEeeeEEEEEe-CCeEEE
Confidence 3567999999999999999999875 488999999863 244556778889999999999999999997665 446699
Q ss_pred EEeecCCCChHHHhcCCCCCCCCCChhhHHHHHHHHHHHHHHhhcCCCCCeeeecccCCceeeCCCCcEEEeeecccccc
Q 038766 89 ILEYMENGSLESVIHGPGVDHSRWTLPKRIDVLISVANGLDYLHSGYDIPIVHCDMKPSNILLDRDFEAHVSDFGTSRML 168 (299)
Q Consensus 89 v~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lh~~~~~~~~H~dl~~~nil~~~~~~v~l~df~~~~~~ 168 (299)
|+||+.+++|..++.. ....+++..++.++.|++.++++||+. +++|+||+|+||+++.++.++|+|||++...
T Consensus 87 v~e~~~~~~l~~~~~~---~~~~l~~~~~~~~~~ql~~~l~~lH~~---~i~H~dlkp~Nili~~~~~~kl~dfg~~~~~ 160 (292)
T cd06644 87 MIEFCPGGAVDAIMLE---LDRGLTEPQIQVICRQMLEALQYLHSM---KIIHRDLKAGNVLLTLDGDIKLADFGVSAKN 160 (292)
T ss_pred EEecCCCCcHHHHHHh---hcCCCCHHHHHHHHHHHHHHHHHHhcC---CeeecCCCcceEEEcCCCCEEEccCccceec
Confidence 9999999999887643 234689999999999999999999999 9999999999999999999999999987643
Q ss_pred ccccccccccccccccCcccCChhhhc-----ccCcCccccchhhhHHHHHHHhCCCCCCCCccCCCCchhHHHHHHHHH
Q 038766 169 DVHLQDLSSLSTAFQGTIGYLAPEFAY-----MRIVTTKVDVFSFGIVVMEFLTKRRPTGLDEENGLSPISLRQLVEKAL 243 (299)
Q Consensus 169 ~~~~~~~~~~~~~~~~~~~y~~PE~~~-----~~~~~~~~DiwslG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~ 243 (299)
.. .........+++.|+|||.+. ...++.++|+|||||++|+|++|..||.... .. .......
T Consensus 161 ~~----~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slG~il~el~~g~~p~~~~~-----~~---~~~~~~~ 228 (292)
T cd06644 161 VK----TLQRRDSFIGTPYWMAPEVVMCETMKDTPYDYKADIWSLGITLIEMAQIEPPHHELN-----PM---RVLLKIA 228 (292)
T ss_pred cc----cccccceecCCccccCceeeccccccCCCCCchhhhHhHHHHHHHHhcCCCCCcccc-----HH---HHHHHHh
Confidence 21 111223445678899999875 3446788999999999999999999984321 11 1111111
Q ss_pred hcCccCcccccCccccchhhHhHHHHHHHHHHHHHHHHhcCCCCCCCCChhhhhcC
Q 038766 244 ANGINGVRQITDPKLVSSIYEEQEQHQVLEELFKLALVCTSSNPEDRPNMNELLIT 299 (299)
Q Consensus 244 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rpt~~~il~~ 299 (299)
....+ .... +..++.++.++|.+||..+|++||+++++++|
T Consensus 229 ~~~~~---~~~~------------~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~ 269 (292)
T cd06644 229 KSEPP---TLSQ------------PSKWSMEFRDFLKTALDKHPETRPSAAQLLEH 269 (292)
T ss_pred cCCCc---cCCC------------CcccCHHHHHHHHHHhcCCcccCcCHHHHhcC
Confidence 11000 0000 22345578999999999999999999999986
|
Serine/threonine kinases (STKs), STK10 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Other names for STK10 include lymphocyte-oriented kinase (LOK) and Xenopus polo-like kinase kinase 1 (xPlkk1). STK10 is highly expressed in lymphocytes and is responsible in regulating leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. It plays a role in regulating the CD28 responsive element in T cells, and may also function as a regulator of polo-like kinase 1 (Plk1), a protein which is overexpressed in multiple tumor types. |
| >PF07714 Pkinase_Tyr: Protein tyrosine kinase Protein kinase; unclassified specificity | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-41 Score=280.42 Aligned_cols=249 Identities=31% Similarity=0.510 Sum_probs=188.3
Q ss_pred CCceeecCCcceEEEEEeC-----CCcEEEEEEeccCcCChhhhHHHHHHHHHHHhcCCcceeeeeeEEEcCCCeeEEEE
Q 038766 16 ENNIIGNSNLSTVYKGRLE-----DGEIVAVKKLNFHQFSAESDKSFYREAKTLKELKHRNLVKVLGYAWESGKLKALIL 90 (299)
Q Consensus 16 ~~~~lg~g~~~~v~~~~~~-----~~~~~~vK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~lv~ 90 (299)
+.+.||.|.||.||+|.+. .+..|+||++.. .......+.+.+|++.+++++||||+++++++...+. .++|+
T Consensus 3 ~~~~ig~G~fg~v~~~~~~~~~~~~~~~V~vk~~~~-~~~~~~~~~~~~e~~~l~~l~h~ni~~~~g~~~~~~~-~~lv~ 80 (259)
T PF07714_consen 3 LIKQIGEGSFGKVYRAEWKQKDNDKNQPVAVKILKP-SSSEEEEEEFLNEIQILRKLRHPNIVKLYGFCIENEP-LFLVM 80 (259)
T ss_dssp EEEEEEEESSEEEEEEEEESTTTSSEEEEEEEEEST-TSSHHHHHHHHHHHHHHHTHSBTTBE-EEEEEESSSS-EEEEE
T ss_pred EeeEEccCCCcEEEEEEEEcccCCCCEEEEEEEecc-ccccccceeeeeccccccccccccccccccccccccc-ccccc
Confidence 4578999999999999865 367899999953 3344557889999999999999999999998885444 69999
Q ss_pred eecCCCChHHHhcCCCCCCCCCChhhHHHHHHHHHHHHHHhhcCCCCCeeeecccCCceeeCCCCcEEEeeecccccccc
Q 038766 91 EYMENGSLESVIHGPGVDHSRWTLPKRIDVLISVANGLDYLHSGYDIPIVHCDMKPSNILLDRDFEAHVSDFGTSRMLDV 170 (299)
Q Consensus 91 e~~~~~~L~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lh~~~~~~~~H~dl~~~nil~~~~~~v~l~df~~~~~~~~ 170 (299)
||+.+++|.+++... ....++...++.|+.|++.||.|||++ +++|++|+++||+++.++.+||+|||++.....
T Consensus 81 e~~~~g~L~~~L~~~--~~~~~~~~~~~~i~~~i~~~l~~Lh~~---~iiH~~l~~~nill~~~~~~Kl~~f~~~~~~~~ 155 (259)
T PF07714_consen 81 EYCPGGSLDDYLKSK--NKEPLSEQQRLSIAIQIAEALSYLHSN---NIIHGNLSPSNILLDSNGQVKLSDFGLSRPISE 155 (259)
T ss_dssp E--TTEBHHHHHHHT--CTTTSBHHHHHHHHHHHHHHHHHHHHT---TEEEST-SGGGEEEETTTEEEEESTTTGEETTT
T ss_pred ccccccccccccccc--ccccccccccccccccccccccccccc---ccccccccccccccccccccccccccccccccc
Confidence 999999999988743 246789999999999999999999999 999999999999999999999999999876521
Q ss_pred ccccccccccccccCcccCChhhhcccCcCccccchhhhHHHHHHHh-CCCCCCCCccCCCCchhHHHHHHHHHhcCccC
Q 038766 171 HLQDLSSLSTAFQGTIGYLAPEFAYMRIVTTKVDVFSFGIVVMEFLT-KRRPTGLDEENGLSPISLRQLVEKALANGING 249 (299)
Q Consensus 171 ~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~DiwslG~~l~~l~~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 249 (299)
. ..............|+|||.+.+..++.++||||||+++|+|++ |..||. ...... ..........
T Consensus 156 ~--~~~~~~~~~~~~~~~~aPE~~~~~~~~~ksDVysfG~~l~ei~~~~~~p~~-----~~~~~~---~~~~~~~~~~-- 223 (259)
T PF07714_consen 156 K--SKYKNDSSQQLPLRYLAPEVLKDGEYTKKSDVYSFGMLLYEILTLGKFPFS-----DYDNEE---IIEKLKQGQR-- 223 (259)
T ss_dssp S--SSEEESTTSESGGGGS-HHHHHHSEESHHHHHHHHHHHHHHHHTTSSGTTT-----TSCHHH---HHHHHHTTEE--
T ss_pred c--ccccccccccccccccccccccccccccccccccccccccccccccccccc-----cccccc---cccccccccc--
Confidence 1 11122233345678999999999999999999999999999999 667763 222222 2222211110
Q ss_pred cccccCccccchhhHhHHHHHHHHHHHHHHHHhcCCCCCCCCChhhhhc
Q 038766 250 VRQITDPKLVSSIYEEQEQHQVLEELFKLALVCTSSNPEDRPNMNELLI 298 (299)
Q Consensus 250 ~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rpt~~~il~ 298 (299)
... +...+..+.+++.+||..+|++|||++++++
T Consensus 224 ---~~~------------~~~~~~~~~~li~~C~~~~p~~RPs~~~i~~ 257 (259)
T PF07714_consen 224 ---LPI------------PDNCPKDIYSLIQQCWSHDPEKRPSFQEILQ 257 (259)
T ss_dssp ---TTS------------BTTSBHHHHHHHHHHT-SSGGGS--HHHHHH
T ss_pred ---cee------------ccchhHHHHHHHHHHcCCChhhCcCHHHHHh
Confidence 000 1123457899999999999999999999975
|
Tyrosine kinase, catalytic domain; InterPro: IPR001245 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases. Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. Tyrosine-protein kinases can transfer a phosphate group from ATP to a tyrosine residue in a protein. These enzymes can be divided into two main groups []: Receptor tyrosine kinases (RTK), which are transmembrane proteins involved in signal transduction; they play key roles in growth, differentiation, metabolism, adhesion, motility, death and oncogenesis []. RTKs are composed of 3 domains: an extracellular domain (binds ligand), a transmembrane (TM) domain, and an intracellular catalytic domain (phosphorylates substrate). The TM domain plays an important role in the dimerisation process necessary for signal transduction []. Cytoplasmic / non-receptor tyrosine kinases, which act as regulatory proteins, playing key roles in cell differentiation, motility, proliferation, and survival. For example, the Src-family of protein-tyrosine kinases []. ; GO: 0004672 protein kinase activity, 0006468 protein phosphorylation; PDB: 2HYY_C 1OPL_A 2V7A_A 2G2H_B 2G1T_A 3PYY_A 3CS9_D 2HZI_A 2E2B_A 2HIW_A .... |
| >cd07867 STKc_CDC2L6 Catalytic domain of Serine/Threonine Kinase, Cell Division Cycle 2-like 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.9e-40 Score=279.71 Aligned_cols=274 Identities=23% Similarity=0.314 Sum_probs=189.8
Q ss_pred CceeecCCcceEEEEEeC---CCcEEEEEEeccCcCChhhhHHHHHHHHHHHhcCCcceeeeeeEEEc-CCCeeEEEEee
Q 038766 17 NNIIGNSNLSTVYKGRLE---DGEIVAVKKLNFHQFSAESDKSFYREAKTLKELKHRNLVKVLGYAWE-SGKLKALILEY 92 (299)
Q Consensus 17 ~~~lg~g~~~~v~~~~~~---~~~~~~vK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~-~~~~~~lv~e~ 92 (299)
...||+|+||+||+|... ++..+|+|.+.... ....+.+|+.+++.++||||+++++++.. .+...++|+||
T Consensus 6 g~~lG~G~~g~Vy~~~~~~~~~~~~~a~k~~~~~~----~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~lv~e~ 81 (317)
T cd07867 6 GCKVGRGTYGHVYKAKRKDGKDEKEYALKQIEGTG----ISMSACREIALLRELKHPNVIALQKVFLSHSDRKVWLLFDY 81 (317)
T ss_pred ceEeccCCCeeEEEEEecCCCccceEEEEEecCCC----CcHHHHHHHHHHHhCCCCCeeeEEEEEeccCCCeEEEEEee
Confidence 358999999999999864 35789999886332 23457789999999999999999997754 34566899999
Q ss_pred cCCCChHHHhcCCC-----CCCCCCChhhHHHHHHHHHHHHHHhhcCCCCCeeeecccCCceee----CCCCcEEEeeec
Q 038766 93 MENGSLESVIHGPG-----VDHSRWTLPKRIDVLISVANGLDYLHSGYDIPIVHCDMKPSNILL----DRDFEAHVSDFG 163 (299)
Q Consensus 93 ~~~~~L~~~~~~~~-----~~~~~~~~~~~~~i~~qi~~~l~~lh~~~~~~~~H~dl~~~nil~----~~~~~v~l~df~ 163 (299)
+. ++|.+++.... .....+++..++.++.|++.||.|||+. +++|+||||+||++ +.++.++|+|||
T Consensus 82 ~~-~~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~lH~~---~ivH~Dlkp~Nil~~~~~~~~~~~kl~DfG 157 (317)
T cd07867 82 AE-HDLWHIIKFHRASKANKKPMQLPRSMVKSLLYQILDGIHYLHAN---WVLHRDLKPANILVMGEGPERGRVKIADMG 157 (317)
T ss_pred eC-CcHHHHHHhhhccccCCCCccCCHHHHHHHHHHHHHHHHHHHhC---CEEcCCCCHHHEEEccCCCCCCcEEEeecc
Confidence 95 48877764321 1223688999999999999999999999 99999999999999 456789999999
Q ss_pred cccccccccccccccccccccCcccCChhhhcc-cCcCccccchhhhHHHHHHHhCCCCCCCCccCCCCchh-HHHHHHH
Q 038766 164 TSRMLDVHLQDLSSLSTAFQGTIGYLAPEFAYM-RIVTTKVDVFSFGIVVMEFLTKRRPTGLDEENGLSPIS-LRQLVEK 241 (299)
Q Consensus 164 ~~~~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~-~~~~~~~DiwslG~~l~~l~~g~~p~~~~~~~~~~~~~-~~~~~~~ 241 (299)
++......... ........+++.|+|||.+.+ ..++.++|||||||++|+|++|..||.....+...... ....+..
T Consensus 158 ~a~~~~~~~~~-~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~el~tg~~~f~~~~~~~~~~~~~~~~~~~~ 236 (317)
T cd07867 158 FARLFNSPLKP-LADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCRQEDIKTSNPFHHDQLDR 236 (317)
T ss_pred ceeccCCCccc-ccccCcceecccccCcHHhcCCCccCcHHHHHhHHHHHHHHHhCCCCcccccccccccccccHHHHHH
Confidence 99765422111 111234457889999998876 45789999999999999999999999754332221111 0011111
Q ss_pred HHh-cCccCcccccC----------------cccc-chh--hHhHHHHHHHHHHHHHHHHhcCCCCCCCCChhhhhcC
Q 038766 242 ALA-NGINGVRQITD----------------PKLV-SSI--YEEQEQHQVLEELFKLALVCTSSNPEDRPNMNELLIT 299 (299)
Q Consensus 242 ~~~-~~~~~~~~~~~----------------~~~~-~~~--~~~~~~~~~~~~l~~li~~~l~~dP~~Rpt~~~il~~ 299 (299)
... .+......+.. .... ... .........+..+.+|+.+||..||.+|||++|+|+|
T Consensus 237 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~~l~~dP~~R~t~~e~l~h 314 (317)
T cd07867 237 IFSVMGFPADKDWEDIRKMPEYPTLQKDFRRTTYANSSLIKYMEKHKVKPDSKVFLLLQKLLTMDPTKRITSEQALQD 314 (317)
T ss_pred HHHhcCCCChhhhhhhhhcccchhhhhhhcccccCCchhhhhhhcccCCCChHHHHHHHHHhccCcccccCHHHHhcC
Confidence 110 00000000000 0000 000 0000011234568899999999999999999999987
|
Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 6 (CDC2L6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L6 is also called CDK8-like and was previously referred to as CDK11. However, this is a confusing nomenclature as CDC2L6 is distinct from CDC2L1, which is represented by the two protein products from its gene, called CDK11(p110) and CDK11(p58), as well as |
| >cd05574 STKc_phototropin_like Catalytic domain of Phototropin-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-40 Score=281.55 Aligned_cols=258 Identities=24% Similarity=0.286 Sum_probs=202.7
Q ss_pred CCCCCCceeecCCcceEEEEEeC-CCcEEEEEEeccCcCCh-hhhHHHHHHHHHHHhcCCcceeeeeeEEEcCCCeeEEE
Q 038766 12 GSFSENNIIGNSNLSTVYKGRLE-DGEIVAVKKLNFHQFSA-ESDKSFYREAKTLKELKHRNLVKVLGYAWESGKLKALI 89 (299)
Q Consensus 12 ~~y~~~~~lg~g~~~~v~~~~~~-~~~~~~vK~~~~~~~~~-~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~lv 89 (299)
++|.+.+.||+|++|+||++... +++.+|+|.+....... .....+..|++.++.++|+||+++++.+.. +...++|
T Consensus 1 ~~y~~~~~ig~g~~g~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~-~~~~~lv 79 (316)
T cd05574 1 KHFKKIKLLGKGDVGRVFLVRLKGTGKLFALKVLDKKEMIKRNKVKRVLTEQEILATLDHPFLPTLYASFQT-ETYLCLV 79 (316)
T ss_pred CceEEeeeecCCccEEEEEEEEcCCCcEEEEEEEeccccchHHHHHHHHHHHHHHHhCCCCCchhheeeeec-CCEEEEE
Confidence 47899999999999999999875 48999999987544332 345678899999999999999999996544 5667999
Q ss_pred EeecCCCChHHHhcCCCCCCCCCChhhHHHHHHHHHHHHHHhhcCCCCCeeeecccCCceeeCCCCcEEEeeeccccccc
Q 038766 90 LEYMENGSLESVIHGPGVDHSRWTLPKRIDVLISVANGLDYLHSGYDIPIVHCDMKPSNILLDRDFEAHVSDFGTSRMLD 169 (299)
Q Consensus 90 ~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lh~~~~~~~~H~dl~~~nil~~~~~~v~l~df~~~~~~~ 169 (299)
+||+.+++|.+++... ....+++..++.++.|+++||+|||+. +++|+||||+||+++.++.++|+|||++....
T Consensus 80 ~e~~~~~~L~~~~~~~--~~~~l~~~~~~~~~~qi~~~l~~lH~~---~i~H~dlkp~Nili~~~~~~~l~dfg~~~~~~ 154 (316)
T cd05574 80 MDYCPGGELFRLLQRQ--PGKCLSEEVARFYAAEVLLALEYLHLL---GIVYRDLKPENILLHESGHIMLSDFDLSKQSD 154 (316)
T ss_pred EEecCCCCHHHHHHhC--CCCccCHHHHHHHHHHHHHHHHHHHHC---CeeccCCChHHeEEcCCCCEEEeecchhhccc
Confidence 9999999999998633 345789999999999999999999999 99999999999999999999999999987543
Q ss_pred cccccc-------------------------cccccccccCcccCChhhhcccCcCccccchhhhHHHHHHHhCCCCCCC
Q 038766 170 VHLQDL-------------------------SSLSTAFQGTIGYLAPEFAYMRIVTTKVDVFSFGIVVMEFLTKRRPTGL 224 (299)
Q Consensus 170 ~~~~~~-------------------------~~~~~~~~~~~~y~~PE~~~~~~~~~~~DiwslG~~l~~l~~g~~p~~~ 224 (299)
...... ........++..|+|||.+.+..++.++||||||+++|+|++|..||..
T Consensus 155 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Di~slG~ll~~l~~g~~pf~~ 234 (316)
T cd05574 155 VEPPPVSKALRKGSRRSSVNSIPSETFSEEPSFRSNSFVGTEEYIAPEVISGDGHGSAVDWWTLGILLYEMLYGTTPFKG 234 (316)
T ss_pred ccccccccccccccccccccccchhhhcccccCCCCCCcCccCCcCHHHHcCCCCCchHHHHHHHHHHHHHhhCCCCCCC
Confidence 211100 0111234567889999999988899999999999999999999999864
Q ss_pred CccCCCCchhHHHHHHHHHhcCccCcccccCccccchhhHhHHHHHHHHHHHHHHHHhcCCCCCCCCC----hhhhhcC
Q 038766 225 DEENGLSPISLRQLVEKALANGINGVRQITDPKLVSSIYEEQEQHQVLEELFKLALVCTSSNPEDRPN----MNELLIT 299 (299)
Q Consensus 225 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rpt----~~~il~~ 299 (299)
.... ..+....... ..... ...++..+.++|.+||..||++||| +++++.|
T Consensus 235 ~~~~--------~~~~~~~~~~----~~~~~------------~~~~~~~~~~li~~~l~~~p~~R~s~~~~~~~ll~~ 289 (316)
T cd05574 235 SNRD--------ETFSNILKKE----VTFPG------------SPPVSSSARDLIRKLLVKDPSKRLGSKRGAAEIKQH 289 (316)
T ss_pred CchH--------HHHHHHhcCC----ccCCC------------ccccCHHHHHHHHHHccCCHhHCCCchhhHHHHHcC
Confidence 3211 1111111100 00000 1125678999999999999999999 9999986
|
Serine/Threonine Kinases (STKs), Phototropin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The phototropin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Included in this subfamily are plant phototropins and predominantly uncharacterized fungal STKs whose catalytic domains resemble the phototropin kinase domain. One protein from Neurospora crassa is called nrc-2. Phototropins are blue-light receptors that control responses such as phototropism, stromatal opening, and chloroplast movement in order to optimize the photosynthetic efficiency of plants. They are light-activated STKs that contain an N-termin |
| >cd00192 PTKc Catalytic domain of Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-40 Score=274.42 Aligned_cols=250 Identities=33% Similarity=0.478 Sum_probs=197.5
Q ss_pred ceeecCCcceEEEEEeCC----CcEEEEEEeccCcCChhhhHHHHHHHHHHHhcCCcceeeeeeEEEcCCCeeEEEEeec
Q 038766 18 NIIGNSNLSTVYKGRLED----GEIVAVKKLNFHQFSAESDKSFYREAKTLKELKHRNLVKVLGYAWESGKLKALILEYM 93 (299)
Q Consensus 18 ~~lg~g~~~~v~~~~~~~----~~~~~vK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~lv~e~~ 93 (299)
+.||+|++|.||++.... +..+++|.+....... ....+..|+..++.++|+|++++++++.. +...++|+||+
T Consensus 1 ~~ig~g~~g~v~~~~~~~~~~~~~~~~ik~~~~~~~~~-~~~~~~~e~~~l~~~~~~~i~~~~~~~~~-~~~~~lv~e~~ 78 (262)
T cd00192 1 KKLGEGAFGEVYKGKLKGKDGKTTEVAVKTLKEDASEE-ERKDFLKEARVMKKLGHPNVVRLLGVCTE-EEPLYLVLEYM 78 (262)
T ss_pred CccccCCceEEEEEEEecCCCCCceEEeEeeccccchh-HHHHHHHHHHHHhhcCCCChheeeeeecC-CCceEEEEEec
Confidence 479999999999998643 8889999987543222 46788899999999999999999997665 66679999999
Q ss_pred CCCChHHHhcCCCCC-----CCCCChhhHHHHHHHHHHHHHHhhcCCCCCeeeecccCCceeeCCCCcEEEeeecccccc
Q 038766 94 ENGSLESVIHGPGVD-----HSRWTLPKRIDVLISVANGLDYLHSGYDIPIVHCDMKPSNILLDRDFEAHVSDFGTSRML 168 (299)
Q Consensus 94 ~~~~L~~~~~~~~~~-----~~~~~~~~~~~i~~qi~~~l~~lh~~~~~~~~H~dl~~~nil~~~~~~v~l~df~~~~~~ 168 (299)
.+++|.+++...... ...+++..++.++.|++.||.+||++ +++|+||+|+||+++.++.++|+|||.+...
T Consensus 79 ~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~l~~al~~lH~~---~i~H~di~p~nili~~~~~~~l~dfg~~~~~ 155 (262)
T cd00192 79 EGGDLLDYLRKSRPVFPSPEKSTLSLKDLLSFAIQIAKGMEYLASK---KFVHRDLAARNCLVGEDLVVKISDFGLSRDV 155 (262)
T ss_pred cCCcHHHHHhhccccccccccccCCHHHHHHHHHHHHHHHHHHHcC---CcccCccCcceEEECCCCcEEEccccccccc
Confidence 999999998753111 47899999999999999999999999 9999999999999999999999999999865
Q ss_pred ccccccccccccccccCcccCChhhhcccCcCccccchhhhHHHHHHHh-CCCCCCCCccCCCCchhHHHHHHHHHhcCc
Q 038766 169 DVHLQDLSSLSTAFQGTIGYLAPEFAYMRIVTTKVDVFSFGIVVMEFLT-KRRPTGLDEENGLSPISLRQLVEKALANGI 247 (299)
Q Consensus 169 ~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~DiwslG~~l~~l~~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 247 (299)
..... ........++..|+|||.+....++.++||||||+++|+|++ |..||... ....+...+.. ..
T Consensus 156 ~~~~~--~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~-----~~~~~~~~~~~----~~ 224 (262)
T cd00192 156 YDDDY--YRKKTGGKLPIRWMAPESLKDGIFTSKSDVWSFGVLLWEIFTLGATPYPGL-----SNEEVLEYLRK----GY 224 (262)
T ss_pred ccccc--cccccCCCcCccccCHHHhccCCcchhhccHHHHHHHHHHHhcCCCCCCCC-----CHHHHHHHHHc----CC
Confidence 53211 112233446778999999998889999999999999999999 58888543 12222221111 00
Q ss_pred cCcccccCccccchhhHhHHHHHHHHHHHHHHHHhcCCCCCCCCChhhhhcC
Q 038766 248 NGVRQITDPKLVSSIYEEQEQHQVLEELFKLALVCTSSNPEDRPNMNELLIT 299 (299)
Q Consensus 248 ~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rpt~~~il~~ 299 (299)
.... +..++.++.+++.+||..+|++|||+++++++
T Consensus 225 ----~~~~------------~~~~~~~~~~li~~~l~~~p~~Rps~~~l~~~ 260 (262)
T cd00192 225 ----RLPK------------PEYCPDELYELMLSCWQLDPEDRPTFSELVER 260 (262)
T ss_pred ----CCCC------------CccCChHHHHHHHHHccCCcccCcCHHHHHHh
Confidence 0000 22336789999999999999999999999864
|
Protein Tyrosine Kinase (PTK) family, catalytic domain. This PTKc family is part of a larger superfamily that includes the catalytic domains of protein serine/threonine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. They can be classified into receptor and non-receptor tyr kinases. PTKs play important roles in many cellular processes including, lymphocyte activation, epithelium growth and maintenance, metabolism control, organogenesis regulation, survival, proliferation, differentiation, migration, adhesion, motility, and morphogenesis. Receptor tyr kinases (RTKs) are integral membrane proteins which contain an extracellular ligand-binding region, a transmembrane segment, and an intracellular tyr kinase domain. RTKs are usually activated through ligan |
| >cd06611 STKc_SLK_like Catalytic domain of Ste20-like kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-40 Score=279.41 Aligned_cols=253 Identities=25% Similarity=0.379 Sum_probs=199.4
Q ss_pred hCCCCCCceeecCCcceEEEEEeC-CCcEEEEEEeccCcCChhhhHHHHHHHHHHHhcCCcceeeeeeEEEcCCCeeEEE
Q 038766 11 TGSFSENNIIGNSNLSTVYKGRLE-DGEIVAVKKLNFHQFSAESDKSFYREAKTLKELKHRNLVKVLGYAWESGKLKALI 89 (299)
Q Consensus 11 ~~~y~~~~~lg~g~~~~v~~~~~~-~~~~~~vK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~lv 89 (299)
.++|.+.+.||.|++|.||++.+. ++..+++|++... .......+..|+.++++++|+|++++++.+.. +...++|
T Consensus 4 ~~~~~i~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~--~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~-~~~~~lv 80 (280)
T cd06611 4 NDIWEIIGELGDGAFGKVYKAQHKETGLFAAAKIIQIE--SEEELEDFMVEIDILSECKHPNIVGLYEAYFY-ENKLWIL 80 (280)
T ss_pred hhHHHHHHHhcCCCCceEEEEEEcCCCcEEEEEEEeeC--CHHHHHHHHHHHHHHHhCCCCceeEEEEEEec-CCeEEEE
Confidence 467999999999999999999864 5899999998632 34455678889999999999999999997765 5566999
Q ss_pred EeecCCCChHHHhcCCCCCCCCCChhhHHHHHHHHHHHHHHhhcCCCCCeeeecccCCceeeCCCCcEEEeeeccccccc
Q 038766 90 LEYMENGSLESVIHGPGVDHSRWTLPKRIDVLISVANGLDYLHSGYDIPIVHCDMKPSNILLDRDFEAHVSDFGTSRMLD 169 (299)
Q Consensus 90 ~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lh~~~~~~~~H~dl~~~nil~~~~~~v~l~df~~~~~~~ 169 (299)
+||+++++|.+++... ...+++..++.++.|++.+|.|||+. +++|+||+|+||+++.++.++|+|||.+....
T Consensus 81 ~e~~~~~~L~~~~~~~---~~~l~~~~~~~~~~ql~~~l~~lh~~---~i~h~dl~p~nili~~~~~~~l~d~g~~~~~~ 154 (280)
T cd06611 81 IEFCDGGALDSIMLEL---ERGLTEPQIRYVCRQMLEALNFLHSH---KVIHRDLKAGNILLTLDGDVKLADFGVSAKNK 154 (280)
T ss_pred eeccCCCcHHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCChhhEEECCCCCEEEccCccchhhc
Confidence 9999999999988632 34689999999999999999999999 99999999999999999999999999876543
Q ss_pred cccccccccccccccCcccCChhhhc-----ccCcCccccchhhhHHHHHHHhCCCCCCCCccCCCCchhHHHHHHHHHh
Q 038766 170 VHLQDLSSLSTAFQGTIGYLAPEFAY-----MRIVTTKVDVFSFGIVVMEFLTKRRPTGLDEENGLSPISLRQLVEKALA 244 (299)
Q Consensus 170 ~~~~~~~~~~~~~~~~~~y~~PE~~~-----~~~~~~~~DiwslG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~ 244 (299)
. .........+++.|+|||.+. ...++.++|+||||+++|+|++|..||.... .. ..+.....
T Consensus 155 ~----~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~~~~sDi~slG~il~~l~~g~~p~~~~~-----~~---~~~~~~~~ 222 (280)
T cd06611 155 S----TLQKRDTFIGTPYWMAPEVVACETFKDNPYDYKADIWSLGITLIELAQMEPPHHELN-----PM---RVLLKILK 222 (280)
T ss_pred c----cccccceeecchhhcCHHHHhhcccCCCCCCccccHHHHHHHHHHHHhCCCCcccCC-----HH---HHHHHHhc
Confidence 1 112223445788899999875 3456789999999999999999999985321 11 11111111
Q ss_pred cCccCcccccCccccchhhHhHHHHHHHHHHHHHHHHhcCCCCCCCCChhhhhcC
Q 038766 245 NGINGVRQITDPKLVSSIYEEQEQHQVLEELFKLALVCTSSNPEDRPNMNELLIT 299 (299)
Q Consensus 245 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rpt~~~il~~ 299 (299)
... ..... +..++.++.++|.+||..+|++|||++++++|
T Consensus 223 ~~~---~~~~~------------~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~ 262 (280)
T cd06611 223 SEP---PTLDQ------------PSKWSSSFNDFLKSCLVKDPDDRPTAAELLKH 262 (280)
T ss_pred CCC---CCcCC------------cccCCHHHHHHHHHHhccChhhCcCHHHHhcC
Confidence 100 00000 22345678999999999999999999999987
|
Serine/threonine kinases (STKs), Ste20-like kinase (SLK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of the subfamily include SLK, STK10 (also called LOK for lymphocyte-oriented kinase), SmSLK (Schistosoma mansoni SLK), and related proteins. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It also plays a role in mediating actin reorganization. STK10 is responsible in regulating the CD28 responsive element in T cells, as well as leukocyte function associated anti |
| >cd07855 STKc_ERK5 Catalytic domain of the Serine/Threonine Kinase, Extracellular signal-Regulated Kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-40 Score=286.04 Aligned_cols=277 Identities=25% Similarity=0.313 Sum_probs=203.8
Q ss_pred HhCCCCCCceeecCCcceEEEEEeC-CCcEEEEEEeccCcCChhhhHHHHHHHHHHHhcCCcceeeeeeEEEc---CCCe
Q 038766 10 ATGSFSENNIIGNSNLSTVYKGRLE-DGEIVAVKKLNFHQFSAESDKSFYREAKTLKELKHRNLVKVLGYAWE---SGKL 85 (299)
Q Consensus 10 ~~~~y~~~~~lg~g~~~~v~~~~~~-~~~~~~vK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~---~~~~ 85 (299)
+.++|.+.+.||+|++|.||++... +|+.|++|++............+.+|+.+++.++||||+++.+++.. .+..
T Consensus 3 ~~~~y~~~~~lg~g~~g~v~~~~~~~~~~~valK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~ 82 (334)
T cd07855 3 VGSRYKPIENIGSGAYGVVCSAIDTRSGKKVAIKKIPHAFDVPTLAKRTLRELKILRHFKHDNIIAIRDILRPPGADFKD 82 (334)
T ss_pred hhhceeeeeeeecCCCeEEEEEEEcCCCCEEEEEEeccccccccchHHHHHHHHHHHhcCCCCccCHHHhccccCCCCce
Confidence 4589999999999999999999864 59999999987544444556778889999999999999999986643 2346
Q ss_pred eEEEEeecCCCChHHHhcCCCCCCCCCChhhHHHHHHHHHHHHHHhhcCCCCCeeeecccCCceeeCCCCcEEEeeeccc
Q 038766 86 KALILEYMENGSLESVIHGPGVDHSRWTLPKRIDVLISVANGLDYLHSGYDIPIVHCDMKPSNILLDRDFEAHVSDFGTS 165 (299)
Q Consensus 86 ~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lh~~~~~~~~H~dl~~~nil~~~~~~v~l~df~~~ 165 (299)
.++|+||+. ++|.+++. ....+++..++.++.|++.||+|||++ +++|+||||+||+++.++.++|+|||++
T Consensus 83 ~~lv~e~~~-~~l~~~~~----~~~~~~~~~~~~i~~qi~~aL~~LH~~---~ivH~dlkp~Nil~~~~~~~kl~dfg~~ 154 (334)
T cd07855 83 VYVVMDLME-SDLHHIIH----SDQPLTEEHIRYFLYQLLRGLKYIHSA---NVIHRDLKPSNLLVNEDCELRIGDFGMA 154 (334)
T ss_pred EEEEEehhh-hhHHHHhc----cCCCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHEEEcCCCcEEecccccc
Confidence 799999995 58988886 445699999999999999999999999 9999999999999999999999999998
Q ss_pred cccccccccccccccccccCcccCChhhhcc-cCcCccccchhhhHHHHHHHhCCCCCCCCccCCCCchhHHHHHHHHHh
Q 038766 166 RMLDVHLQDLSSLSTAFQGTIGYLAPEFAYM-RIVTTKVDVFSFGIVVMEFLTKRRPTGLDEENGLSPISLRQLVEKALA 244 (299)
Q Consensus 166 ~~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~-~~~~~~~DiwslG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~ 244 (299)
..................++..|+|||.+.+ ..++.++|+||+|+++|+|++|..||...... .....+.....
T Consensus 155 ~~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~Di~slG~~l~el~~g~~pf~~~~~~-----~~~~~~~~~~g 229 (334)
T cd07855 155 RGLSSSPTEHKYFMTEYVATRWYRAPELLLSLPEYTTAIDMWSVGCIFAEMLGRRQLFPGKNYV-----HQLKLILSVLG 229 (334)
T ss_pred eeecccCcCCCcccccccccccccChHHhcCCcccccccchHHHHHHHHHHHcCCCccCCCChH-----HHHHHHHHHhC
Confidence 7654322222222234467889999998765 45789999999999999999999999543211 00000000000
Q ss_pred cCccCc---------cc-ccCccccchhhHhHHHHHHHHHHHHHHHHhcCCCCCCCCChhhhhcC
Q 038766 245 NGINGV---------RQ-ITDPKLVSSIYEEQEQHQVLEELFKLALVCTSSNPEDRPNMNELLIT 299 (299)
Q Consensus 245 ~~~~~~---------~~-~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rpt~~~il~~ 299 (299)
...... .. +..................+.++.++|.+||+.+|++|||+++++.|
T Consensus 230 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~~l~~ 294 (334)
T cd07855 230 SPSEEVLNRIGSDRVRKYIQNLPRKQPVPWSKIFPKASPEALDLLSQMLQFDPEERITVEQALQH 294 (334)
T ss_pred CChhHhhhhhchhhHHHHHhhcccCCCCCHHHHcccCCHHHHHHHHHHccCChhhCcCHHHHHhC
Confidence 000000 00 00000000000011123457889999999999999999999999986
|
Serine/Threonine Kinases (STKs), Extracellular signal-Regulated Kinase 5 (ERK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ERK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. ERK5, also called Big MAPK1 (BMK1) or MAPK7, has a unique C-terminal extension, making it approximately twice as big as other MAPKs. This extension contains transcriptional activation capability which is inhibited by the N-terminal half. ERK5 is activated in response to growth factors and stress by a cascade that leads to its phosphorylation by the |
| >PHA03211 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-40 Score=292.40 Aligned_cols=270 Identities=20% Similarity=0.232 Sum_probs=195.8
Q ss_pred hCCCCCCceeecCCcceEEEEEeC-CCcEEEEEEeccCcCChhhhHHHHHHHHHHHhcCCcceeeeeeEEEcCCCeeEEE
Q 038766 11 TGSFSENNIIGNSNLSTVYKGRLE-DGEIVAVKKLNFHQFSAESDKSFYREAKTLKELKHRNLVKVLGYAWESGKLKALI 89 (299)
Q Consensus 11 ~~~y~~~~~lg~g~~~~v~~~~~~-~~~~~~vK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~lv 89 (299)
...|.+.+.||+|++|.||++.+. .++.||+|... .....+|++++++++|+||+++++++.. +...++|
T Consensus 168 ~~gy~i~~~Lg~G~~G~Vy~a~~~~~~~~vavK~~~--------~~~~~~E~~iL~~L~HpnIv~l~~~~~~-~~~~~lv 238 (461)
T PHA03211 168 GLGFAIHRALTPGSEGCVFESSHPDYPQRVVVKAGW--------YASSVHEARLLRRLSHPAVLALLDVRVV-GGLTCLV 238 (461)
T ss_pred cCCeEEEEEEccCCCeEEEEEEECCCCCEEEEeccc--------ccCHHHHHHHHHHCCCCCCCcEEEEEEE-CCEEEEE
Confidence 447999999999999999999875 47889999642 2235679999999999999999997665 4556999
Q ss_pred EeecCCCChHHHhcCCCCCCCCCChhhHHHHHHHHHHHHHHhhcCCCCCeeeecccCCceeeCCCCcEEEeeeccccccc
Q 038766 90 LEYMENGSLESVIHGPGVDHSRWTLPKRIDVLISVANGLDYLHSGYDIPIVHCDMKPSNILLDRDFEAHVSDFGTSRMLD 169 (299)
Q Consensus 90 ~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lh~~~~~~~~H~dl~~~nil~~~~~~v~l~df~~~~~~~ 169 (299)
+|++. ++|..++.. ....+++..++.++.|++.||.|||++ +++|+||||+|||++.++.++|+|||++....
T Consensus 239 ~e~~~-~~L~~~l~~---~~~~l~~~~~~~i~~qi~~aL~yLH~~---gIvHrDLKP~NILl~~~~~vkL~DFGla~~~~ 311 (461)
T PHA03211 239 LPKYR-SDLYTYLGA---RLRPLGLAQVTAVARQLLSAIDYIHGE---GIIHRDIKTENVLVNGPEDICLGDFGAACFAR 311 (461)
T ss_pred EEccC-CCHHHHHHh---cCCCCCHHHHHHHHHHHHHHHHHHHHC---CEEECcCCHHHEEECCCCCEEEcccCCceecc
Confidence 99995 688887753 234789999999999999999999999 99999999999999999999999999987553
Q ss_pred cccccccccccccccCcccCChhhhcccCcCccccchhhhHHHHHHHhCCCCCCCCccCC---CCchhHHHHHHHHHhcC
Q 038766 170 VHLQDLSSLSTAFQGTIGYLAPEFAYMRIVTTKVDVFSFGIVVMEFLTKRRPTGLDEENG---LSPISLRQLVEKALANG 246 (299)
Q Consensus 170 ~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~DiwslG~~l~~l~~g~~p~~~~~~~~---~~~~~~~~~~~~~~~~~ 246 (299)
.... ........+|..|+|||++.+..++.++|||||||++|+|++|..++....... .....+...+......
T Consensus 312 ~~~~--~~~~~~~~GT~~Y~APE~~~~~~~~~~sDvwSlGviL~El~~g~~~lf~~~~~~~~~~~~~~l~~~i~~~~~~- 388 (461)
T PHA03211 312 GSWS--TPFHYGIAGTVDTNAPEVLAGDPYTPSVDIWSAGLVIFEAAVHTASLFSASRGDERRPYDAQILRIIRQAQVH- 388 (461)
T ss_pred cccc--cccccccCCCcCCcCHHHHcCCCCCchHHHHHHHHHHHHHHHcCCCcccCCcccccCCcHHHHHHHHHhhccc-
Confidence 2111 111224468999999999999999999999999999999999887653321111 1111222222221110
Q ss_pred ccCcccccCccccchh--------------hHhHHHHHHHHHHHHHHHHhcCCCCCCCCChhhhhcC
Q 038766 247 INGVRQITDPKLVSSI--------------YEEQEQHQVLEELFKLALVCTSSNPEDRPNMNELLIT 299 (299)
Q Consensus 247 ~~~~~~~~~~~~~~~~--------------~~~~~~~~~~~~l~~li~~~l~~dP~~Rpt~~~il~~ 299 (299)
................ ........++.++.+||.+||..||.+|||++|+|+|
T Consensus 389 ~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dli~~mL~~DP~~RPsa~elL~h 455 (461)
T PHA03211 389 VDEFPQHAGSRLVSQYRHRAARNRRPAYTRPAWTRYYKLDLDVEYLVCRALTFDGARRPSAAELLRL 455 (461)
T ss_pred cccCCCCcchHHHHHHHhhhhcccCCccCCcchhhhccccchHHHHHHHHcccChhhCcCHHHHhhC
Confidence 0000000000000000 0001112345678999999999999999999999987
|
|
| >cd05082 PTKc_Csk Catalytic domain of the Protein Tyrosine Kinase, C-terminal Src kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-40 Score=274.32 Aligned_cols=246 Identities=26% Similarity=0.375 Sum_probs=195.4
Q ss_pred hCCCCCCceeecCCcceEEEEEeCCCcEEEEEEeccCcCChhhhHHHHHHHHHHHhcCCcceeeeeeEEEcCCCeeEEEE
Q 038766 11 TGSFSENNIIGNSNLSTVYKGRLEDGEIVAVKKLNFHQFSAESDKSFYREAKTLKELKHRNLVKVLGYAWESGKLKALIL 90 (299)
Q Consensus 11 ~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~vK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~lv~ 90 (299)
.++|.+.+.||+|++|.||++... |..+++|.+... .....+.+|+..+++++|+|++++++.+...+...++++
T Consensus 5 ~~~~~~~~~lg~g~~~~v~~~~~~-~~~~~~k~~~~~----~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~lv~ 79 (256)
T cd05082 5 MKELKLLQTIGKGEFGDVMLGDYR-GNKVAVKCIKND----ATAQAFLAEASVMTQLRHSNLVQLLGVIVEEKGGLYIVT 79 (256)
T ss_pred HHhCeeeeeecccCCCeEEEEEEc-CCcEEEEEeCCC----chHHHHHHHHHHHHhCCCCCeeeEEEEEEcCCCceEEEE
Confidence 468999999999999999999765 778999987532 235578899999999999999999998777677779999
Q ss_pred eecCCCChHHHhcCCCCCCCCCChhhHHHHHHHHHHHHHHhhcCCCCCeeeecccCCceeeCCCCcEEEeeecccccccc
Q 038766 91 EYMENGSLESVIHGPGVDHSRWTLPKRIDVLISVANGLDYLHSGYDIPIVHCDMKPSNILLDRDFEAHVSDFGTSRMLDV 170 (299)
Q Consensus 91 e~~~~~~L~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lh~~~~~~~~H~dl~~~nil~~~~~~v~l~df~~~~~~~~ 170 (299)
||+++++|.+++... ....+++..++.++.|++.||++||++ +++|+||+|+||+++.++.++|+|||++.....
T Consensus 80 e~~~~~~L~~~~~~~--~~~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dlkp~nil~~~~~~~kl~dfg~~~~~~~ 154 (256)
T cd05082 80 EYMAKGSLVDYLRSR--GRSVLGGDCLLKFSLDVCEAMEYLEAN---NFVHRDLAARNVLVSEDNVAKVSDFGLTKEASS 154 (256)
T ss_pred ECCCCCcHHHHHHhc--CCCCCCHHHHHHHHHHHHHHHHHHHhC---CEeccccchheEEEcCCCcEEecCCccceeccc
Confidence 999999999988643 233588899999999999999999999 999999999999999999999999998864331
Q ss_pred ccccccccccccccCcccCChhhhcccCcCccccchhhhHHHHHHHh-CCCCCCCCccCCCCchhHHHHHHHHHhcCccC
Q 038766 171 HLQDLSSLSTAFQGTIGYLAPEFAYMRIVTTKVDVFSFGIVVMEFLT-KRRPTGLDEENGLSPISLRQLVEKALANGING 249 (299)
Q Consensus 171 ~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~DiwslG~~l~~l~~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 249 (299)
.......+..|+|||.+.+..++.++|||||||++|+|++ |..||.... ........ ......
T Consensus 155 -------~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~i~~~l~~~g~~p~~~~~--------~~~~~~~~-~~~~~~ 218 (256)
T cd05082 155 -------TQDTGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIP--------LKDVVPRV-EKGYKM 218 (256)
T ss_pred -------cCCCCccceeecCHHHHccCCCCchhhhHHHHHHHHHHHhCCCCCCCCCC--------HHHHHHHH-hcCCCC
Confidence 1122234567999999998889999999999999999997 888874321 11111111 111000
Q ss_pred cccccCccccchhhHhHHHHHHHHHHHHHHHHhcCCCCCCCCChhhhhc
Q 038766 250 VRQITDPKLVSSIYEEQEQHQVLEELFKLALVCTSSNPEDRPNMNELLI 298 (299)
Q Consensus 250 ~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rpt~~~il~ 298 (299)
......+..+.+++.+||..+|++|||+.++++
T Consensus 219 ----------------~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~l~~ 251 (256)
T cd05082 219 ----------------DAPDGCPPVVYDVMKQCWHLDAATRPSFLQLRE 251 (256)
T ss_pred ----------------CCCCCCCHHHHHHHHHHhcCChhhCcCHHHHHH
Confidence 001234567899999999999999999999975
|
Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk catalyzes the tyr phosphorylation of the regulatory C-terminal tail of Src kinases, re |
| >cd06655 STKc_PAK2 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-40 Score=280.11 Aligned_cols=251 Identities=24% Similarity=0.381 Sum_probs=200.0
Q ss_pred hCCCCCCceeecCCcceEEEEEe-CCCcEEEEEEeccCcCChhhhHHHHHHHHHHHhcCCcceeeeeeEEEcCCCeeEEE
Q 038766 11 TGSFSENNIIGNSNLSTVYKGRL-EDGEIVAVKKLNFHQFSAESDKSFYREAKTLKELKHRNLVKVLGYAWESGKLKALI 89 (299)
Q Consensus 11 ~~~y~~~~~lg~g~~~~v~~~~~-~~~~~~~vK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~lv 89 (299)
..+|.+.+.||.|++|.||++.+ .+++.+++|.+.... ....+.+.+|+..++.++|+|++++++.+.. +...++|
T Consensus 18 ~~~y~~~~~lg~g~~g~vy~~~~~~~~~~v~iK~~~~~~--~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~-~~~~~lv 94 (296)
T cd06655 18 KKKYTRYEKIGQGASGTVFTAIDVATGQEVAIKQINLQK--QPKKELIINEILVMKELKNPNIVNFLDSFLV-GDELFVV 94 (296)
T ss_pred cceEEEEEEEecCCCeEEEEEEEcCCCcEEEEEEEeccc--CchHHHHHHHHHHHHhcCCCceeeeeeeEec-CceEEEE
Confidence 35699999999999999999986 568999999986432 2345678899999999999999999997655 5567999
Q ss_pred EeecCCCChHHHhcCCCCCCCCCChhhHHHHHHHHHHHHHHhhcCCCCCeeeecccCCceeeCCCCcEEEeeeccccccc
Q 038766 90 LEYMENGSLESVIHGPGVDHSRWTLPKRIDVLISVANGLDYLHSGYDIPIVHCDMKPSNILLDRDFEAHVSDFGTSRMLD 169 (299)
Q Consensus 90 ~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lh~~~~~~~~H~dl~~~nil~~~~~~v~l~df~~~~~~~ 169 (299)
+||+.+++|..++. ...+++.++..++.|++.|+.+||+. +++|+||+|+||+++.++.++|+|||++....
T Consensus 95 ~e~~~~~~L~~~~~-----~~~l~~~~~~~i~~~l~~al~~LH~~---~i~H~dL~p~Nili~~~~~~kl~dfg~~~~~~ 166 (296)
T cd06655 95 MEYLAGGSLTDVVT-----ETCMDEAQIAAVCRECLQALEFLHAN---QVIHRDIKSDNVLLGMDGSVKLTDFGFCAQIT 166 (296)
T ss_pred EEecCCCcHHHHHH-----hcCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCHHHEEECCCCCEEEccCccchhcc
Confidence 99999999999885 33689999999999999999999999 99999999999999999999999999887543
Q ss_pred cccccccccccccccCcccCChhhhcccCcCccccchhhhHHHHHHHhCCCCCCCCccCCCCchhHHHHHHHHHhcCccC
Q 038766 170 VHLQDLSSLSTAFQGTIGYLAPEFAYMRIVTTKVDVFSFGIVVMEFLTKRRPTGLDEENGLSPISLRQLVEKALANGING 249 (299)
Q Consensus 170 ~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~DiwslG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 249 (299)
.. ........++..|+|||.+.+..++.++|+||||+++|+|++|..||..... . ..+..........
T Consensus 167 ~~----~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slGvil~~lltg~~pf~~~~~-------~-~~~~~~~~~~~~~ 234 (296)
T cd06655 167 PE----QSKRSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMVEGEPPYLNENP-------L-RALYLIATNGTPE 234 (296)
T ss_pred cc----cccCCCcCCCccccCcchhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCH-------H-HHHHHHHhcCCcc
Confidence 21 1112234577899999999988899999999999999999999999854321 1 1111111111000
Q ss_pred cccccCccccchhhHhHHHHHHHHHHHHHHHHhcCCCCCCCCChhhhhcC
Q 038766 250 VRQITDPKLVSSIYEEQEQHQVLEELFKLALVCTSSNPEDRPNMNELLIT 299 (299)
Q Consensus 250 ~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rpt~~~il~~ 299 (299)
... +..++..+.++|++||..||++|||+.+++.|
T Consensus 235 ---~~~------------~~~~~~~~~~li~~~l~~dp~~Rpt~~~il~~ 269 (296)
T cd06655 235 ---LQN------------PEKLSPIFRDFLNRCLEMDVEKRGSAKELLQH 269 (296)
T ss_pred ---cCC------------cccCCHHHHHHHHHHhhcChhhCCCHHHHhhC
Confidence 000 22345678999999999999999999999986
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 2, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK2 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding |
| >cd05043 PTK_Ryk Pseudokinase domain of Ryk (Receptor related to tyrosine kinase) | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-40 Score=278.78 Aligned_cols=259 Identities=22% Similarity=0.368 Sum_probs=202.1
Q ss_pred HHhCCCCCCceeecCCcceEEEEEeCC-----CcEEEEEEeccCcCChhhhHHHHHHHHHHHhcCCcceeeeeeEEEcCC
Q 038766 9 NATGSFSENNIIGNSNLSTVYKGRLED-----GEIVAVKKLNFHQFSAESDKSFYREAKTLKELKHRNLVKVLGYAWESG 83 (299)
Q Consensus 9 ~~~~~y~~~~~lg~g~~~~v~~~~~~~-----~~~~~vK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~ 83 (299)
+..++|.+.+.||+|+||.||++.+.+ +..+++|++.. .........+.+|+..++.++|+|++++++++...+
T Consensus 3 ~~~~~~~~~~~i~~g~~g~V~~~~~~~~~~~~~~~v~~k~~~~-~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~ 81 (280)
T cd05043 3 ISRDRVTLSDLLQEGTFGRIFYGILIDEKPGKEEEVFVKTVKD-HASEIQVTLLLQESCLLYGLSHQNILPILHVCIEDG 81 (280)
T ss_pred cchhheEEeeeecccCCceEEEEEEecCCCCceeEEEEEEccC-CCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEecCC
Confidence 346789999999999999999998754 68899998752 334455677889999999999999999999877766
Q ss_pred CeeEEEEeecCCCChHHHhcCCCCC----CCCCChhhHHHHHHHHHHHHHHhhcCCCCCeeeecccCCceeeCCCCcEEE
Q 038766 84 KLKALILEYMENGSLESVIHGPGVD----HSRWTLPKRIDVLISVANGLDYLHSGYDIPIVHCDMKPSNILLDRDFEAHV 159 (299)
Q Consensus 84 ~~~~lv~e~~~~~~L~~~~~~~~~~----~~~~~~~~~~~i~~qi~~~l~~lh~~~~~~~~H~dl~~~nil~~~~~~v~l 159 (299)
...+++++++.+++|.+++...... ...+++..++.++.|++.||+|||+. +++|+||+|+||+++.++.++|
T Consensus 82 ~~~~~~~~~~~~~~L~~~l~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~---~i~H~di~p~nil~~~~~~~kl 158 (280)
T cd05043 82 EPPFVLYPYMNWGNLKLFLQQCRLGEANNPQALSTQQLVHMAIQIACGMSYLHKR---GVIHKDIAARNCVIDEELQVKI 158 (280)
T ss_pred CCCEEEEEcCCCCcHHHHHHhccccccccccCCCHHHHHHHHHHHHHHHHHHHHC---CEeecccCHhhEEEcCCCcEEE
Confidence 6779999999989999988643211 25689999999999999999999998 9999999999999999999999
Q ss_pred eeeccccccccccccccccccccccCcccCChhhhcccCcCccccchhhhHHHHHHHh-CCCCCCCCccCCCCchhHHHH
Q 038766 160 SDFGTSRMLDVHLQDLSSLSTAFQGTIGYLAPEFAYMRIVTTKVDVFSFGIVVMEFLT-KRRPTGLDEENGLSPISLRQL 238 (299)
Q Consensus 160 ~df~~~~~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~DiwslG~~l~~l~~-g~~p~~~~~~~~~~~~~~~~~ 238 (299)
+|||++..+.... .........++..|+|||.+.+..++.++||||||+++|++++ |..||... ....+...
T Consensus 159 ~d~g~~~~~~~~~--~~~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~-----~~~~~~~~ 231 (280)
T cd05043 159 TDNALSRDLFPMD--YHCLGDNENRPVKWMALESLVNKEYSSASDVWSFGVLLWELMTLGQTPYVEI-----DPFEMAAY 231 (280)
T ss_pred CCCCCcccccCCc--eEEeCCCCCcchhccCHHHHhcCCCCchhhHHHhHHHHHHHhcCCCCCcCcC-----CHHHHHHH
Confidence 9999987543211 0111122334567999999998889999999999999999998 88888432 22222222
Q ss_pred HHHHHhcCccCcccccCccccchhhHhHHHHHHHHHHHHHHHHhcCCCCCCCCChhhhhc
Q 038766 239 VEKALANGINGVRQITDPKLVSSIYEEQEQHQVLEELFKLALVCTSSNPEDRPNMNELLI 298 (299)
Q Consensus 239 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rpt~~~il~ 298 (299)
+.. .. .... ...++.++.+++.+||..||++|||+.++++
T Consensus 232 ~~~----~~----~~~~------------~~~~~~~~~~li~~~l~~~p~~Rps~~~~~~ 271 (280)
T cd05043 232 LKD----GY----RLAQ------------PINCPDELFAVMACCWALDPEERPSFSQLVQ 271 (280)
T ss_pred HHc----CC----CCCC------------CCcCCHHHHHHHHHHcCCChhhCCCHHHHHH
Confidence 211 10 0000 1123457899999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Receptor related to tyrosine kinase (Ryk); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ryk is a receptor tyr kinase (RTK) containing an extracellular region with two leucine-rich motifs, a transmembrane segment, and an intracellular inactive pseudokinase domain. The extracellular region of Ryk shows homology to the N-terminal domain of Wnt inhibitory factor-1 (WIF) and serves as the ligand (Wnt) binding domain of Ryk. Ryk is expressed in many different tissues both during development and in adults, suggesting a widespread function. It |
| >cd05075 PTKc_Axl Catalytic domain of the Protein Tyrosine Kinase, Axl | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-40 Score=276.47 Aligned_cols=255 Identities=24% Similarity=0.384 Sum_probs=194.7
Q ss_pred CCCCceeecCCcceEEEEEeCC-C--cEEEEEEeccCcCChhhhHHHHHHHHHHHhcCCcceeeeeeEEEcCC-----Ce
Q 038766 14 FSENNIIGNSNLSTVYKGRLED-G--EIVAVKKLNFHQFSAESDKSFYREAKTLKELKHRNLVKVLGYAWESG-----KL 85 (299)
Q Consensus 14 y~~~~~lg~g~~~~v~~~~~~~-~--~~~~vK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~-----~~ 85 (299)
|.+.+.||+|++|.||++++.+ + ..+|+|.+..........+.+..|+..++.++|+||+++++.+.... ..
T Consensus 1 ~~i~~~ig~G~~g~V~~~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~ 80 (272)
T cd05075 1 LALGKTLGEGEFGSVMEGQLNQDDSILKVAVKTMKIAICTRSEMEDFLSEAVCMKEFDHPNVMRLIGVCLQTVESEGYPS 80 (272)
T ss_pred CccccccCcccCceEEEeEEccCCCeeeEEEEecccCcCCHHHHHHHHHHHHHHHhCCCCCcceEEEEEccCCcccCCCC
Confidence 4678999999999999998654 3 26899998765545566778889999999999999999999765322 24
Q ss_pred eEEEEeecCCCChHHHhcCC--CCCCCCCChhhHHHHHHHHHHHHHHhhcCCCCCeeeecccCCceeeCCCCcEEEeeec
Q 038766 86 KALILEYMENGSLESVIHGP--GVDHSRWTLPKRIDVLISVANGLDYLHSGYDIPIVHCDMKPSNILLDRDFEAHVSDFG 163 (299)
Q Consensus 86 ~~lv~e~~~~~~L~~~~~~~--~~~~~~~~~~~~~~i~~qi~~~l~~lh~~~~~~~~H~dl~~~nil~~~~~~v~l~df~ 163 (299)
.++++||+.+++|.+++... ......+++..++.++.|++.||+|||++ +++|+||||+||+++.++.++|+|||
T Consensus 81 ~~~v~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dlkp~Nil~~~~~~~kl~Dfg 157 (272)
T cd05075 81 PVVILPFMKHGDLHSFLLYSRLGDCPQYLPTQMLVKFMTDIASGMEYLSSK---SFIHRDLAARNCMLNENMNVCVADFG 157 (272)
T ss_pred cEEEEEeCCCCcHHHHHHHhcccCCcccCCHHHHHHHHHHHHHHHHHHHHC---CeeccccchhheEEcCCCCEEECCCC
Confidence 58999999999998876422 11334689999999999999999999998 99999999999999999999999999
Q ss_pred cccccccccccccccccccccCcccCChhhhcccCcCccccchhhhHHHHHHHh-CCCCCCCCccCCCCchhHHHHHHHH
Q 038766 164 TSRMLDVHLQDLSSLSTAFQGTIGYLAPEFAYMRIVTTKVDVFSFGIVVMEFLT-KRRPTGLDEENGLSPISLRQLVEKA 242 (299)
Q Consensus 164 ~~~~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~DiwslG~~l~~l~~-g~~p~~~~~~~~~~~~~~~~~~~~~ 242 (299)
++........ .........++.|++||...+..++.++||||||+++|+|++ |..||... ....... ..
T Consensus 158 ~~~~~~~~~~--~~~~~~~~~~~~~~~pe~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~-----~~~~~~~---~~ 227 (272)
T cd05075 158 LSKKIYNGDY--YRQGRIAKMPVKWIAIESLADRVYTTKSDVWSFGVTMWEIATRGQTPYPGV-----ENSEIYD---YL 227 (272)
T ss_pred cccccCcccc--eecCCcccCCcccCCHHHccCCCcChHHHHHHHHHHHHHHHcCCCCCCCCC-----CHHHHHH---HH
Confidence 9876542111 111122335678999999999899999999999999999999 77887432 1112222 11
Q ss_pred HhcCccCcccccCccccchhhHhHHHHHHHHHHHHHHHHhcCCCCCCCCChhhhhc
Q 038766 243 LANGINGVRQITDPKLVSSIYEEQEQHQVLEELFKLALVCTSSNPEDRPNMNELLI 298 (299)
Q Consensus 243 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rpt~~~il~ 298 (299)
. .+. . ... +...+..+.++|.+||..||++|||++++++
T Consensus 228 ~-~~~-~---~~~------------~~~~~~~~~~li~~~l~~~p~~Rps~~~l~~ 266 (272)
T cd05075 228 R-QGN-R---LKQ------------PPDCLDGLYSLMSSCWLLNPKDRPSFETLRC 266 (272)
T ss_pred H-cCC-C---CCC------------CCCCCHHHHHHHHHHcCCCcccCcCHHHHHH
Confidence 1 110 0 000 1123456899999999999999999999985
|
Protein Tyrosine Kinase (PTK) family; Axl; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl is widely expressed in a variety of organs and cells including epithelial, mesenchymal, hematopoietic, as well as non-transfor |
| >cd05073 PTKc_Hck Catalytic domain of the Protein Tyrosine Kinase, Hematopoietic cell kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-40 Score=275.11 Aligned_cols=254 Identities=27% Similarity=0.429 Sum_probs=199.4
Q ss_pred HHHHhCCCCCCceeecCCcceEEEEEeCCCcEEEEEEeccCcCChhhhHHHHHHHHHHHhcCCcceeeeeeEEEcCCCee
Q 038766 7 IENATGSFSENNIIGNSNLSTVYKGRLEDGEIVAVKKLNFHQFSAESDKSFYREAKTLKELKHRNLVKVLGYAWESGKLK 86 (299)
Q Consensus 7 ~~~~~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~vK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~ 86 (299)
|++..++|++.+.||+|++|.||++...++..+++|.+... ....+.+.+|+++++.++|+|++++.+.+.. ...
T Consensus 1 ~~~~~~~~~~~~~lg~g~~~~vy~~~~~~~~~~~iK~~~~~---~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~--~~~ 75 (260)
T cd05073 1 WEIPRESLKLEKKLGAGQFGEVWMATYNKHTKVAVKTMKPG---SMSVEAFLAEANVMKTLQHDKLVKLHAVVTK--EPI 75 (260)
T ss_pred CcccccceeEEeEecCccceEEEEEEecCCccEEEEecCCC---hhHHHHHHHHHHHHHhcCCCCcceEEEEEcC--CCe
Confidence 46778999999999999999999998777788999987632 2345678889999999999999999997655 456
Q ss_pred EEEEeecCCCChHHHhcCCCCCCCCCChhhHHHHHHHHHHHHHHhhcCCCCCeeeecccCCceeeCCCCcEEEeeecccc
Q 038766 87 ALILEYMENGSLESVIHGPGVDHSRWTLPKRIDVLISVANGLDYLHSGYDIPIVHCDMKPSNILLDRDFEAHVSDFGTSR 166 (299)
Q Consensus 87 ~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lh~~~~~~~~H~dl~~~nil~~~~~~v~l~df~~~~ 166 (299)
++++||+++++|.+++... ....++...+..++.|++.||.+||+. +++|+||+|+||+++.++.++|+|||.+.
T Consensus 76 ~~v~e~~~~~~L~~~~~~~--~~~~~~~~~~~~~~~~l~~aL~~lH~~---~i~H~dl~p~ni~i~~~~~~~l~d~~~~~ 150 (260)
T cd05073 76 YIITEFMAKGSLLDFLKSD--EGSKQPLPKLIDFSAQIAEGMAFIEQR---NYIHRDLRAANILVSASLVCKIADFGLAR 150 (260)
T ss_pred EEEEEeCCCCcHHHHHHhC--CccccCHHHHHHHHHHHHHHHHHHHhC---CccccccCcceEEEcCCCcEEECCCccee
Confidence 8999999999999998643 234678888999999999999999998 99999999999999999999999999887
Q ss_pred ccccccccccccccccccCcccCChhhhcccCcCccccchhhhHHHHHHHh-CCCCCCCCccCCCCchhHHHHHHHHHhc
Q 038766 167 MLDVHLQDLSSLSTAFQGTIGYLAPEFAYMRIVTTKVDVFSFGIVVMEFLT-KRRPTGLDEENGLSPISLRQLVEKALAN 245 (299)
Q Consensus 167 ~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~DiwslG~~l~~l~~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~ 245 (299)
..... .........++..|+|||.+....++.++|+||||+++|++++ |..||... ........+. .
T Consensus 151 ~~~~~---~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~~l~t~g~~p~~~~-----~~~~~~~~~~----~ 218 (260)
T cd05073 151 VIEDN---EYTAREGAKFPIKWTAPEAINFGSFTIKSDVWSFGILLMEIVTYGRIPYPGM-----SNPEVIRALE----R 218 (260)
T ss_pred eccCC---CcccccCCcccccccCHhHhccCCcCccccchHHHHHHHHHHhcCCCCCCCC-----CHHHHHHHHh----C
Confidence 54321 1111122234567999999988889999999999999999998 88888532 1111111111 1
Q ss_pred CccCcccccCccccchhhHhHHHHHHHHHHHHHHHHhcCCCCCCCCChhhhhc
Q 038766 246 GINGVRQITDPKLVSSIYEEQEQHQVLEELFKLALVCTSSNPEDRPNMNELLI 298 (299)
Q Consensus 246 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rpt~~~il~ 298 (299)
.. ... .....+.++.+++.+|+..+|++|||+.++++
T Consensus 219 ~~----~~~------------~~~~~~~~~~~~i~~~l~~~p~~Rp~~~~l~~ 255 (260)
T cd05073 219 GY----RMP------------RPENCPEELYNIMMRCWKNRPEERPTFEYIQS 255 (260)
T ss_pred CC----CCC------------CcccCCHHHHHHHHHHcccCcccCcCHHHHHH
Confidence 10 000 01234567999999999999999999998864
|
Protein Tyrosine Kinase (PTK) family; Hematopoietic cell kinase (Hck); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Hck is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pa |
| >cd05035 PTKc_Axl_like Catalytic Domain of Axl-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-40 Score=275.62 Aligned_cols=255 Identities=25% Similarity=0.415 Sum_probs=196.7
Q ss_pred CCCCceeecCCcceEEEEEeC----CCcEEEEEEeccCcCChhhhHHHHHHHHHHHhcCCcceeeeeeEEEcCCC-----
Q 038766 14 FSENNIIGNSNLSTVYKGRLE----DGEIVAVKKLNFHQFSAESDKSFYREAKTLKELKHRNLVKVLGYAWESGK----- 84 (299)
Q Consensus 14 y~~~~~lg~g~~~~v~~~~~~----~~~~~~vK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~----- 84 (299)
|.+.+.||+|+||.||.+... .+..+|+|++............+..|+..++.+.|+|++++++++.....
T Consensus 1 ~~~~~~lg~G~~g~v~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~ 80 (273)
T cd05035 1 LKLGKILGEGEFGSVMEGQLSQDDGSQLKVAVKTMKLDIHTYSEIEEFLSEAACMKDFDHPNVMKLIGVCFEASSLQKIP 80 (273)
T ss_pred CccccccCcCCCceEEEEEEecCCCCcceEEEEEeccCcCCHHHHHHHHHHHHHHHhCCCCCeeeEEeeeccCCccccCc
Confidence 678899999999999999853 24789999987655555556788999999999999999999997765332
Q ss_pred eeEEEEeecCCCChHHHhcCC--CCCCCCCChhhHHHHHHHHHHHHHHhhcCCCCCeeeecccCCceeeCCCCcEEEeee
Q 038766 85 LKALILEYMENGSLESVIHGP--GVDHSRWTLPKRIDVLISVANGLDYLHSGYDIPIVHCDMKPSNILLDRDFEAHVSDF 162 (299)
Q Consensus 85 ~~~lv~e~~~~~~L~~~~~~~--~~~~~~~~~~~~~~i~~qi~~~l~~lh~~~~~~~~H~dl~~~nil~~~~~~v~l~df 162 (299)
..++++||+.+++|...+... ......+++..++.++.|++.||.|||+. +++|+||||+||+++.++.++|+||
T Consensus 81 ~~~~v~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~aL~~lH~~---~i~H~dlkp~Nil~~~~~~~kl~df 157 (273)
T cd05035 81 KPMVILPFMKHGDLHSFLLYSRLGGLPEKLPLQTLLKFMVDIALGMEYLSNR---NFIHRDLAARNCMLREDMTVCVADF 157 (273)
T ss_pred ccEEEEeccCCCCHHHHHHHhhccCCcccCCHHHHHHHHHHHHHHHHHHHhC---CeeccccchheEEECCCCeEEECCc
Confidence 368999999999998887432 11334789999999999999999999999 9999999999999999999999999
Q ss_pred ccccccccccccccccccccccCcccCChhhhcccCcCccccchhhhHHHHHHHh-CCCCCCCCccCCCCchhHHHHHHH
Q 038766 163 GTSRMLDVHLQDLSSLSTAFQGTIGYLAPEFAYMRIVTTKVDVFSFGIVVMEFLT-KRRPTGLDEENGLSPISLRQLVEK 241 (299)
Q Consensus 163 ~~~~~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~DiwslG~~l~~l~~-g~~p~~~~~~~~~~~~~~~~~~~~ 241 (299)
|++........ .........+..|+|||.+.+..++.++|||||||++|+|++ |..||.... .....+.+
T Consensus 158 g~~~~~~~~~~--~~~~~~~~~~~~~~~pe~~~~~~~~~~~Dv~SlG~il~el~~~g~~p~~~~~-----~~~~~~~~-- 228 (273)
T cd05035 158 GLSKKIYSGDY--YRQGRIAKMPVKWIAIESLADRVYTSKSDVWAFGVTMWEIATRGQTPYPGVE-----NHEIYDYL-- 228 (273)
T ss_pred cceeecccccc--ccccccccCCccccCHhhcccCCCCcccchHHHHHHHHHHHhCCCCCCCCCC-----HHHHHHHH--
Confidence 99875542111 111112234567999999988889999999999999999999 778874321 11221111
Q ss_pred HHhcCccCcccccCccccchhhHhHHHHHHHHHHHHHHHHhcCCCCCCCCChhhhhc
Q 038766 242 ALANGINGVRQITDPKLVSSIYEEQEQHQVLEELFKLALVCTSSNPEDRPNMNELLI 298 (299)
Q Consensus 242 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rpt~~~il~ 298 (299)
....... .+..++..+.+++.+||+.||++|||+.++++
T Consensus 229 -~~~~~~~-----------------~~~~~~~~~~~li~~~l~~~p~~Rp~~~e~~~ 267 (273)
T cd05035 229 -RHGNRLK-----------------QPEDCLDELYDLMYSCWRADPKDRPTFTKLRE 267 (273)
T ss_pred -HcCCCCC-----------------CCcCCCHHHHHHHHHHcCCChhhCcCHHHHHH
Confidence 1111000 02234567999999999999999999999986
|
Protein Tyrosine Kinase (PTK) family; Axl subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The Axl subfamily consists of Axl, Tyro3 (or Sky), Mer (or Mertk), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl subfamily members are implicated in a variety of cellu |
| >cd06620 PKc_MAPKK_Byr1_like Catalytic domain of fungal Byr1-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-40 Score=277.27 Aligned_cols=259 Identities=24% Similarity=0.366 Sum_probs=203.2
Q ss_pred hCCCCCCceeecCCcceEEEEEeC-CCcEEEEEEeccCcCChhhhHHHHHHHHHHHhcCCcceeeeeeEEEcCCCeeEEE
Q 038766 11 TGSFSENNIIGNSNLSTVYKGRLE-DGEIVAVKKLNFHQFSAESDKSFYREAKTLKELKHRNLVKVLGYAWESGKLKALI 89 (299)
Q Consensus 11 ~~~y~~~~~lg~g~~~~v~~~~~~-~~~~~~vK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~lv 89 (299)
.++|++.+.||+|++|+||++.+. ++..+|+|++.... .....+.+.+|+++++.++||||+++++.+... ..+++|
T Consensus 4 ~~~~~~~~~ig~g~~g~v~~~~~~~~~~~~a~k~~~~~~-~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~-~~~~lv 81 (284)
T cd06620 4 NEDLETISDLGAGNGGSVSKVKHIPTGTVMAKKVVHIGA-KSSVRKQILRELQIMHECRSPYIVSFYGAFLNE-NNICMC 81 (284)
T ss_pred HHHHHHHHHcCCCCCeEEEEEEEcCCCcEEEEEEEEecC-cchHHHHHHHHHHHHHHcCCCCcceEeeeEecC-CEEEEE
Confidence 367899999999999999999864 58899999886432 344567889999999999999999999976654 567999
Q ss_pred EeecCCCChHHHhcCCCCCCCCCChhhHHHHHHHHHHHHHHhhcCCCCCeeeecccCCceeeCCCCcEEEeeeccccccc
Q 038766 90 LEYMENGSLESVIHGPGVDHSRWTLPKRIDVLISVANGLDYLHSGYDIPIVHCDMKPSNILLDRDFEAHVSDFGTSRMLD 169 (299)
Q Consensus 90 ~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lh~~~~~~~~H~dl~~~nil~~~~~~v~l~df~~~~~~~ 169 (299)
+||+++++|.+++. ...++++..+..++.+++.+|.|||+. .+++|+||+|+||+++.++.++|+|||++....
T Consensus 82 ~e~~~~~~L~~~~~----~~~~~~~~~~~~~~~~i~~~l~~LH~~--~~i~H~dl~p~nil~~~~~~~~l~d~gl~~~~~ 155 (284)
T cd06620 82 MEFMDCGSLDRIYK----KGGPIPVEILGKIAVAVVEGLTYLYNV--HRIMHRDIKPSNILVNSRGQIKLCDFGVSGELI 155 (284)
T ss_pred EecCCCCCHHHHHH----hccCCCHHHHHHHHHHHHHHHHHHHHh--cCeeccCCCHHHEEECCCCcEEEccCCcccchh
Confidence 99999999999886 335789999999999999999999963 289999999999999999999999999876432
Q ss_pred cccccccccccccccCcccCChhhhcccCcCccccchhhhHHHHHHHhCCCCCCCCccCCC---CchhHHHHHHHHHhcC
Q 038766 170 VHLQDLSSLSTAFQGTIGYLAPEFAYMRIVTTKVDVFSFGIVVMEFLTKRRPTGLDEENGL---SPISLRQLVEKALANG 246 (299)
Q Consensus 170 ~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~DiwslG~~l~~l~~g~~p~~~~~~~~~---~~~~~~~~~~~~~~~~ 246 (299)
. .......++..|+|||.+.+..++.++|+||+||++|+|++|..||........ ....+.+.........
T Consensus 156 ~------~~~~~~~~~~~~~aPE~~~~~~~~~~~Di~slG~~l~~l~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 229 (284)
T cd06620 156 N------SIADTFVGTSTYMSPERIQGGKYTVKSDVWSLGISIIELALGKFPFAFSNIDDDGQDDPMGILDLLQQIVQEP 229 (284)
T ss_pred h------hccCccccCcccCCHHHHccCCCCccchHHHHHHHHHHHHhCCCCCcccchhhhhhhhhhHHHHHHHHHhhcc
Confidence 1 112234678899999999888899999999999999999999999975432211 1112222222222111
Q ss_pred ccCcccccCccccchhhHhHHHHHHHHHHHHHHHHhcCCCCCCCCChhhhhcC
Q 038766 247 INGVRQITDPKLVSSIYEEQEQHQVLEELFKLALVCTSSNPEDRPNMNELLIT 299 (299)
Q Consensus 247 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rpt~~~il~~ 299 (299)
..... ...++..+.+++.+|+..||++|||+++++.|
T Consensus 230 ~~~~~----------------~~~~~~~~~~li~~~l~~dp~~Rpt~~e~~~~ 266 (284)
T cd06620 230 PPRLP----------------SSDFPEDLRDFVDACLLKDPTERPTPQQLCAM 266 (284)
T ss_pred CCCCC----------------chhcCHHHHHHHHHHhcCCcccCcCHHHHhcC
Confidence 10000 11245678999999999999999999999875
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal Byr1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include |
| >cd08229 STKc_Nek7 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 7 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-40 Score=275.35 Aligned_cols=257 Identities=25% Similarity=0.379 Sum_probs=201.5
Q ss_pred CCCCCCceeecCCcceEEEEEe-CCCcEEEEEEeccCcC-ChhhhHHHHHHHHHHHhcCCcceeeeeeEEEcCCCeeEEE
Q 038766 12 GSFSENNIIGNSNLSTVYKGRL-EDGEIVAVKKLNFHQF-SAESDKSFYREAKTLKELKHRNLVKVLGYAWESGKLKALI 89 (299)
Q Consensus 12 ~~y~~~~~lg~g~~~~v~~~~~-~~~~~~~vK~~~~~~~-~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~lv 89 (299)
++|.+.+.||+|++|.||++.. .+++.+++|.+..... .......+.+|+.+++.+.|+||+++++.+.. ++..+++
T Consensus 2 ~~y~~~~~ig~g~~g~v~~~~~~~~~~~~~vK~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~-~~~~~~v 80 (267)
T cd08229 2 ANFRIEKKIGRGQFSEVYRATCLLDGVPVALKKVQIFDLMDAKARADCIKEIDLLKQLNHPNVIKYYASFIE-DNELNIV 80 (267)
T ss_pred chhhhhhhhcccCCeEEEEEeecCCCceEEEEeeeehhhhhHHHHHHHHHHHHHHHHccCCchhhhhheeEe-CCeEEEE
Confidence 5789999999999999999986 5689999998864332 23345678899999999999999999997665 4566999
Q ss_pred EeecCCCChHHHhcCCCCCCCCCChhhHHHHHHHHHHHHHHhhcCCCCCeeeecccCCceeeCCCCcEEEeeeccccccc
Q 038766 90 LEYMENGSLESVIHGPGVDHSRWTLPKRIDVLISVANGLDYLHSGYDIPIVHCDMKPSNILLDRDFEAHVSDFGTSRMLD 169 (299)
Q Consensus 90 ~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lh~~~~~~~~H~dl~~~nil~~~~~~v~l~df~~~~~~~ 169 (299)
+|++.+++|.+++.........+++..++.++.|++.||.|||+. +++|+||+|+||+++.++.++|+|||++....
T Consensus 81 ~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~---~i~H~dl~p~nili~~~~~~~l~dfg~~~~~~ 157 (267)
T cd08229 81 LELADAGDLSRMIKHFKKQKRLIPEKTVWKYFVQLCSALEHMHSR---RVMHRDIKPANVFITATGVVKLGDLGLGRFFS 157 (267)
T ss_pred EEecCCCCHHHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHEEEcCCCCEEECcchhhhccc
Confidence 999999999998864333456789999999999999999999999 99999999999999999999999999887554
Q ss_pred cccccccccccccccCcccCChhhhcccCcCccccchhhhHHHHHHHhCCCCCCCCccCCCCchhHHHHHHHHHhcCccC
Q 038766 170 VHLQDLSSLSTAFQGTIGYLAPEFAYMRIVTTKVDVFSFGIVVMEFLTKRRPTGLDEENGLSPISLRQLVEKALANGING 249 (299)
Q Consensus 170 ~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~DiwslG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 249 (299)
... .......++..|+|||...+..++.++|+||+|+++|+|++|..||...... ............
T Consensus 158 ~~~----~~~~~~~~~~~~~ape~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~------~~~~~~~~~~~~--- 224 (267)
T cd08229 158 SKT----TAAHSLVGTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSPFYGDKMN------LYSLCKKIEQCD--- 224 (267)
T ss_pred cCC----cccccccCCcCccCHHHhcCCCccchhhHHHHHHHHHHHHhCCCCcccccch------HHHHhhhhhcCC---
Confidence 211 1122345678899999998888999999999999999999999998533211 111111111000
Q ss_pred cccccCccccchhhHhHHHHHHHHHHHHHHHHhcCCCCCCCCChhhhhc
Q 038766 250 VRQITDPKLVSSIYEEQEQHQVLEELFKLALVCTSSNPEDRPNMNELLI 298 (299)
Q Consensus 250 ~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rpt~~~il~ 298 (299)
.+.. ....++..+.+++.+||..+|++|||+++|++
T Consensus 225 -----~~~~--------~~~~~~~~~~~li~~~l~~~p~~Rpt~~~i~~ 260 (267)
T cd08229 225 -----YPPL--------PSDHYSEELRQLVNMCINPDPEKRPDITYVYD 260 (267)
T ss_pred -----CCCC--------CcccccHHHHHHHHHhcCCCcccCCCHHHHHH
Confidence 0000 02235668999999999999999999998764
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 7 (Nek7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek7 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek7 is required for mitotic spindle formation and cytokinesis. It is enriched in the centrosome and is critical for microtubule nucleation. Nek7 is activated by Nek9 during mitosis, and may regulate the p70 ribosomal S6 kinase. |
| >cd07832 STKc_CCRK Catalytic domain of the Serine/Threonine Kinase, Cell Cycle-Related Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.7e-40 Score=276.82 Aligned_cols=271 Identities=24% Similarity=0.303 Sum_probs=202.3
Q ss_pred CCCCCceeecCCcceEEEEEeC-CCcEEEEEEeccCcCChhhhHHHHHHHHHHHhcCCcceeeeeeEEEcCCCeeEEEEe
Q 038766 13 SFSENNIIGNSNLSTVYKGRLE-DGEIVAVKKLNFHQFSAESDKSFYREAKTLKELKHRNLVKVLGYAWESGKLKALILE 91 (299)
Q Consensus 13 ~y~~~~~lg~g~~~~v~~~~~~-~~~~~~vK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~lv~e 91 (299)
+|.+.+.||+|++|.||+|.+. +|..+++|++............+.+|+..++.++|+|++++++++.. +...++|+|
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~vK~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~-~~~~~~v~e 79 (286)
T cd07832 1 RYKILGRIGEGAHGIVFKAKDRETGETVALKKVALRRLEGGIPNQALREIKALQACQHPYVVKLLDVFPH-GSGFVLVME 79 (286)
T ss_pred CceEEeecccCCCcEEEEEEECCCCceEEEEEEEcccccchhhHHHHHHHHHHHhCCCCCCcceeeEEec-CCeeEEEec
Confidence 5889999999999999999874 68999999997655545556788999999999999999999997655 667799999
Q ss_pred ecCCCChHHHhcCCCCCCCCCChhhHHHHHHHHHHHHHHhhcCCCCCeeeecccCCceeeCCCCcEEEeeeccccccccc
Q 038766 92 YMENGSLESVIHGPGVDHSRWTLPKRIDVLISVANGLDYLHSGYDIPIVHCDMKPSNILLDRDFEAHVSDFGTSRMLDVH 171 (299)
Q Consensus 92 ~~~~~~L~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lh~~~~~~~~H~dl~~~nil~~~~~~v~l~df~~~~~~~~~ 171 (299)
|+ +++|.+++... ..++++..++.++.|++.||+|||+. +++|+||+|+||+++.++.++|+|||.+......
T Consensus 80 ~~-~~~L~~~~~~~---~~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dl~p~ni~~~~~~~~~l~dfg~~~~~~~~ 152 (286)
T cd07832 80 YM-PSDLSEVLRDE---ERPLPEAQVKSYMRMLLKGVAYMHAN---GIMHRDLKPANLLISADGVLKIADFGLARLFSEE 152 (286)
T ss_pred cc-CCCHHHHHHhc---CCCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCcCHHHEEEcCCCcEEEeeeeecccccCC
Confidence 99 99999988632 35789999999999999999999999 9999999999999999999999999998765421
Q ss_pred cccccccccccccCcccCChhhhccc-CcCccccchhhhHHHHHHHhCCCCCCCCccCCCCchhHHHHHHHHHhc---Cc
Q 038766 172 LQDLSSLSTAFQGTIGYLAPEFAYMR-IVTTKVDVFSFGIVVMEFLTKRRPTGLDEENGLSPISLRQLVEKALAN---GI 247 (299)
Q Consensus 172 ~~~~~~~~~~~~~~~~y~~PE~~~~~-~~~~~~DiwslG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~---~~ 247 (299)
. ........++..|+|||.+.+. .++.++||||+|+++++|++|.++|..... ...+...+...... .+
T Consensus 153 ~---~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~~l~tg~~~~~~~~~----~~~~~~~~~~~~~~~~~~~ 225 (286)
T cd07832 153 E---PRLYSHQVATRWYRAPELLYGARKYDPGVDLWAVGCIFAELLNGSPLFPGEND----IEQLAIVFRTLGTPNEETW 225 (286)
T ss_pred C---CCccccccCcccccCceeeeccccCCchhHHHHHHHHHHHHHcCCcCcCCCCH----HHHHHHHHHHcCCCChHHH
Confidence 1 1112334578899999987654 468899999999999999999777743321 11111111110000 00
Q ss_pred cCccc------ccCccccchhhHhHHHHHHHHHHHHHHHHhcCCCCCCCCChhhhhcC
Q 038766 248 NGVRQ------ITDPKLVSSIYEEQEQHQVLEELFKLALVCTSSNPEDRPNMNELLIT 299 (299)
Q Consensus 248 ~~~~~------~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rpt~~~il~~ 299 (299)
+.... +..+....... .......+..+.++|.+||..+|.+|||++++|+|
T Consensus 226 ~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~li~~~l~~~p~~R~~~~~~l~h 282 (286)
T cd07832 226 PGLTSLPDYNKITFPESKPIPL-EEIFPDASPEALDLLKGLLVYDPSKRLSAAEALRH 282 (286)
T ss_pred hhccCcchhhcccCCCCCcchH-HHhCCCccHHHHHHHHHHhccChhhCCCHHHHhhC
Confidence 00000 00000000000 01122445789999999999999999999999987
|
Serine/Threonine Kinases (STKs), Cell Cycle-Related Kinase (CCRK) p42 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CCRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CCRK was previously called p42. It is a Cyclin-Dependent Kinase (CDK)-Activating Kinase (CAK) which is essential for the activation of CDK2. It is indispensable for cell growth and has been implicated in the progression of glioblastoma multiforme. In the heart, a splice variant of CCRK with a different C-terminal half is expressed, this variant promotes cardiac cell growth and survival and is significantly down-regulated during the development of hea |
| >cd06623 PKc_MAPKK_plant_like Catalytic domain of Plant dual-specificity MAP kinase kinases and similar proteins | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.3e-40 Score=272.17 Aligned_cols=253 Identities=27% Similarity=0.448 Sum_probs=204.6
Q ss_pred CCCCCCceeecCCcceEEEEEeC-CCcEEEEEEeccCcCChhhhHHHHHHHHHHHhcCCcceeeeeeEEEcCCCeeEEEE
Q 038766 12 GSFSENNIIGNSNLSTVYKGRLE-DGEIVAVKKLNFHQFSAESDKSFYREAKTLKELKHRNLVKVLGYAWESGKLKALIL 90 (299)
Q Consensus 12 ~~y~~~~~lg~g~~~~v~~~~~~-~~~~~~vK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~lv~ 90 (299)
++|.+.+.||+|++|.||++++. +++.+++|++...... .....+.+|+..+++++|+|++++++.+.. +..+++|+
T Consensus 1 ~~~~~~~~i~~g~~~~v~~~~~~~~~~~~~vk~~~~~~~~-~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~-~~~~~lv~ 78 (264)
T cd06623 1 SDLERVKVLGQGSSGVVYKVRHKPTGKIYALKKIHVDGDE-EFRKQLLRELKTLRSCESPYVVKCYGAFYK-EGEISIVL 78 (264)
T ss_pred CcceeeeeeeecCCeEEEEEEEcCCCcEEEEEEeccCcch-HHHHHHHHHHHHHHhcCCCCeeeEEEEEcc-CCeEEEEE
Confidence 46889999999999999999875 5999999998754322 456788999999999999999999996655 56779999
Q ss_pred eecCCCChHHHhcCCCCCCCCCChhhHHHHHHHHHHHHHHhhc-CCCCCeeeecccCCceeeCCCCcEEEeeeccccccc
Q 038766 91 EYMENGSLESVIHGPGVDHSRWTLPKRIDVLISVANGLDYLHS-GYDIPIVHCDMKPSNILLDRDFEAHVSDFGTSRMLD 169 (299)
Q Consensus 91 e~~~~~~L~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lh~-~~~~~~~H~dl~~~nil~~~~~~v~l~df~~~~~~~ 169 (299)
||+.+++|.+++. ...++++..++.++.|++.++++||+ . +++|+||+|+||+++.++.++|+|||.+....
T Consensus 79 e~~~~~~L~~~l~----~~~~l~~~~~~~~~~~l~~~l~~lh~~~---~~~H~~l~~~ni~~~~~~~~~l~df~~~~~~~ 151 (264)
T cd06623 79 EYMDGGSLADLLK----KVGKIPEPVLAYIARQILKGLDYLHTKR---HIIHRDIKPSNLLINSKGEVKIADFGISKVLE 151 (264)
T ss_pred EecCCCcHHHHHH----HcCCCCHHHHHHHHHHHHHHHHHHhccC---CCccCCCCHHHEEECCCCCEEEccCccceecc
Confidence 9999999999997 33678999999999999999999999 8 99999999999999999999999999887654
Q ss_pred cccccccccccccccCcccCChhhhcccCcCccccchhhhHHHHHHHhCCCCCCCCccCCCCchhHHHHHHHHHhcCccC
Q 038766 170 VHLQDLSSLSTAFQGTIGYLAPEFAYMRIVTTKVDVFSFGIVVMEFLTKRRPTGLDEENGLSPISLRQLVEKALANGING 249 (299)
Q Consensus 170 ~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~DiwslG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 249 (299)
.. ........++..|+|||.+....++.++|+||||+++|+|++|..||..... ....+............
T Consensus 152 ~~----~~~~~~~~~~~~y~~pE~~~~~~~~~~~Dv~slG~il~~l~tg~~p~~~~~~-----~~~~~~~~~~~~~~~~~ 222 (264)
T cd06623 152 NT----LDQCNTFVGTVTYMSPERIQGESYSYAADIWSLGLTLLECALGKFPFLPPGQ-----PSFFELMQAICDGPPPS 222 (264)
T ss_pred cC----CCcccceeecccccCHhhhCCCCCCchhhHHHHHHHHHHHHhCCCCCccccc-----cCHHHHHHHHhcCCCCC
Confidence 21 1111234567889999999988899999999999999999999999854422 12223332222111100
Q ss_pred cccccCccccchhhHhHHHHH-HHHHHHHHHHHhcCCCCCCCCChhhhhcC
Q 038766 250 VRQITDPKLVSSIYEEQEQHQ-VLEELFKLALVCTSSNPEDRPNMNELLIT 299 (299)
Q Consensus 250 ~~~~~~~~~~~~~~~~~~~~~-~~~~l~~li~~~l~~dP~~Rpt~~~il~~ 299 (299)
. ... ++..+.++|.+||..+|++|||++++++|
T Consensus 223 ~-----------------~~~~~~~~l~~li~~~l~~~p~~R~~~~~ll~~ 256 (264)
T cd06623 223 L-----------------PAEEFSPEFRDFISACLQKDPKKRPSAAELLQH 256 (264)
T ss_pred C-----------------CcccCCHHHHHHHHHHccCChhhCCCHHHHHhC
Confidence 0 112 56689999999999999999999999986
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, Plant MAPKKs and similar proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of |
| >cd05033 PTKc_EphR Catalytic domain of Ephrin Receptor Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-40 Score=275.29 Aligned_cols=254 Identities=29% Similarity=0.441 Sum_probs=197.0
Q ss_pred hCCCCCCceeecCCcceEEEEEeC----CCcEEEEEEeccCcCChhhhHHHHHHHHHHHhcCCcceeeeeeEEEcCCCee
Q 038766 11 TGSFSENNIIGNSNLSTVYKGRLE----DGEIVAVKKLNFHQFSAESDKSFYREAKTLKELKHRNLVKVLGYAWESGKLK 86 (299)
Q Consensus 11 ~~~y~~~~~lg~g~~~~v~~~~~~----~~~~~~vK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~ 86 (299)
.++|.+.+.||+|+||+||+|.+. +...+++|++... ........+..|+..++.++||||+++++.+.. +...
T Consensus 3 ~~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~vaik~~~~~-~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~-~~~~ 80 (266)
T cd05033 3 PSYVTIEKVIGGGEFGEVCRGRLKLPGKKEIDVAIKTLKAG-SSDKQRLDFLTEASIMGQFDHPNIIRLEGVVTK-SRPV 80 (266)
T ss_pred hHHceeeeEecCCccceEEEEEEccCCCCcceEEEEEcCCC-CChHHHHHHHHHHHHHHhCCCCCcceEeEEEec-CCce
Confidence 468999999999999999999864 2457999988643 234445678889999999999999999996655 5556
Q ss_pred EEEEeecCCCChHHHhcCCCCCCCCCChhhHHHHHHHHHHHHHHhhcCCCCCeeeecccCCceeeCCCCcEEEeeecccc
Q 038766 87 ALILEYMENGSLESVIHGPGVDHSRWTLPKRIDVLISVANGLDYLHSGYDIPIVHCDMKPSNILLDRDFEAHVSDFGTSR 166 (299)
Q Consensus 87 ~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lh~~~~~~~~H~dl~~~nil~~~~~~v~l~df~~~~ 166 (299)
++|+|++.+++|.+++... ...+++..++.++.|++.||.|||+. +++|+||+|+||+++.++.++|+|||++.
T Consensus 81 ~iv~e~~~~~~L~~~~~~~---~~~~~~~~~~~~~~~l~~~l~~Lh~~---~i~H~di~p~nili~~~~~~~l~dfg~~~ 154 (266)
T cd05033 81 MIITEYMENGSLDKFLREN---DGKFTVGQLVGMLRGIASGMKYLSEM---NYVHRDLAARNILVNSNLVCKVSDFGLSR 154 (266)
T ss_pred EEEEEcCCCCCHHHHHHhc---cCCCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCCcceEEEcCCCCEEECccchhh
Confidence 9999999999999998642 24789999999999999999999998 99999999999999999999999999998
Q ss_pred ccccccccccccccccccCcccCChhhhcccCcCccccchhhhHHHHHHHh-CCCCCCCCccCCCCchhHHHHHHHHHhc
Q 038766 167 MLDVHLQDLSSLSTAFQGTIGYLAPEFAYMRIVTTKVDVFSFGIVVMEFLT-KRRPTGLDEENGLSPISLRQLVEKALAN 245 (299)
Q Consensus 167 ~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~DiwslG~~l~~l~~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~ 245 (299)
........ ........+..|+|||.+.+..++.++|+||||+++|+|++ |..||... ........+..
T Consensus 155 ~~~~~~~~--~~~~~~~~~~~y~~Pe~~~~~~~~~~~Dv~slG~~l~~l~~~g~~p~~~~-----~~~~~~~~~~~---- 223 (266)
T cd05033 155 RLEDSEAT--YTTKGGKIPIRWTAPEAIAYRKFTSASDVWSFGIVMWEVMSYGERPYWDM-----SNQDVIKAVED---- 223 (266)
T ss_pred cccccccc--eeccCCCCCccccChhhhccCCCccccchHHHHHHHHHHHccCCCCCCCC-----CHHHHHHHHHc----
Confidence 65411111 11112234568999999998889999999999999999997 88887422 22222221111
Q ss_pred CccCcccccCccccchhhHhHHHHHHHHHHHHHHHHhcCCCCCCCCChhhhhcC
Q 038766 246 GINGVRQITDPKLVSSIYEEQEQHQVLEELFKLALVCTSSNPEDRPNMNELLIT 299 (299)
Q Consensus 246 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rpt~~~il~~ 299 (299)
.... .. +...+..+.+++.+|++.+|++|||+++++++
T Consensus 224 ~~~~----~~------------~~~~~~~l~~li~~cl~~~p~~Rp~~~ei~~~ 261 (266)
T cd05033 224 GYRL----PP------------PMDCPSALYQLMLDCWQKDRNERPTFSQIVST 261 (266)
T ss_pred CCCC----CC------------CCCCCHHHHHHHHHHcCCCcccCcCHHHHHHH
Confidence 1000 00 11234678999999999999999999999863
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). They can be classified into two classes (EphA and EphB), according to their extracellular sequences, which largely correspond to binding preferences for either GPI-anchored ephrin-A ligands or transmembrane ephrin-B ligands. Vertebrates have ten EphA and six EhpB receptors, which display promiscuous ligand interactions within each class. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment |
| >cd07833 STKc_CDKL Catalytic domain of Cyclin-Dependent protein Kinase Like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-40 Score=278.40 Aligned_cols=271 Identities=25% Similarity=0.337 Sum_probs=203.0
Q ss_pred CCCCCCceeecCCcceEEEEEeC-CCcEEEEEEeccCcCChhhhHHHHHHHHHHHhcCCcceeeeeeEEEcCCCeeEEEE
Q 038766 12 GSFSENNIIGNSNLSTVYKGRLE-DGEIVAVKKLNFHQFSAESDKSFYREAKTLKELKHRNLVKVLGYAWESGKLKALIL 90 (299)
Q Consensus 12 ~~y~~~~~lg~g~~~~v~~~~~~-~~~~~~vK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~lv~ 90 (299)
++|.+.+.||+|++|.||++.+. +++.|++|++............+.+|++.++.++|+||+++++.+.. ++..++|+
T Consensus 1 ~~y~~~~~i~~g~~~~v~~~~~~~~~~~v~vK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~-~~~~~iv~ 79 (288)
T cd07833 1 NKYEVLGVVGEGAYGVVLKCRNKATGEIVAIKKFKESEDDEDVKKTALREVKVLRQLRHENIVNLKEAFRR-KGRLYLVF 79 (288)
T ss_pred CceeEEEEecccCCeeEEEEEeCCCCcEEEEehhhhhcccccchhHHHHHHHHHHhcCCCCeeehhheEEE-CCEEEEEE
Confidence 47999999999999999999875 58899999987554455556788999999999999999999997765 55679999
Q ss_pred eecCCCChHHHhcCCCCCCCCCChhhHHHHHHHHHHHHHHhhcCCCCCeeeecccCCceeeCCCCcEEEeeecccccccc
Q 038766 91 EYMENGSLESVIHGPGVDHSRWTLPKRIDVLISVANGLDYLHSGYDIPIVHCDMKPSNILLDRDFEAHVSDFGTSRMLDV 170 (299)
Q Consensus 91 e~~~~~~L~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lh~~~~~~~~H~dl~~~nil~~~~~~v~l~df~~~~~~~~ 170 (299)
||+.++.+..+.. ....+++..++.++.|++.||.|||++ +++|+||+|+||+++.++.++|+|||++.....
T Consensus 80 e~~~~~~l~~~~~----~~~~~~~~~~~~~~~~i~~~l~~LH~~---~i~H~dl~~~ni~~~~~~~~kl~d~g~~~~~~~ 152 (288)
T cd07833 80 EYVERTLLELLEA----SPGGLPPDAVRSYIWQLLQAIAYCHSH---NIIHRDIKPENILVSESGVLKLCDFGFARALRA 152 (288)
T ss_pred ecCCCCHHHHHHh----cCCCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHeEECCCCCEEEEeeecccccCC
Confidence 9998766665554 335689999999999999999999999 999999999999999999999999999876542
Q ss_pred ccccccccccccccCcccCChhhhccc-CcCccccchhhhHHHHHHHhCCCCCCCCccCCCCchhHHHHHHHHHhcCcc-
Q 038766 171 HLQDLSSLSTAFQGTIGYLAPEFAYMR-IVTTKVDVFSFGIVVMEFLTKRRPTGLDEENGLSPISLRQLVEKALANGIN- 248 (299)
Q Consensus 171 ~~~~~~~~~~~~~~~~~y~~PE~~~~~-~~~~~~DiwslG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~- 248 (299)
... .......++..|+|||.+.+. .++.++|+||||+++|+|++|..||..... ...............+
T Consensus 153 ~~~---~~~~~~~~~~~~~~PE~~~~~~~~~~~~Dv~slG~~l~~l~~g~~~~~~~~~-----~~~~~~~~~~~~~~~~~ 224 (288)
T cd07833 153 RPA---SPLTDYVATRWYRAPELLVGDTNYGKPVDVWAIGCIMAELLDGEPLFPGDSD-----IDQLYLIQKCLGPLPPS 224 (288)
T ss_pred Ccc---ccccCcccccCCcCCchhcCCCCcCchhhHHHHHHHHHHHHhCCCCCCCCCH-----HHHHHHHHHHhCCCCHH
Confidence 211 122334567889999998887 889999999999999999999999854321 1100000000000000
Q ss_pred ---------Ccc--cccCccccchhhHhHHHHHHHHHHHHHHHHhcCCCCCCCCChhhhhcC
Q 038766 249 ---------GVR--QITDPKLVSSIYEEQEQHQVLEELFKLALVCTSSNPEDRPNMNELLIT 299 (299)
Q Consensus 249 ---------~~~--~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rpt~~~il~~ 299 (299)
... ...+... ........+..++.++.++|++||..+|++|||++++++|
T Consensus 225 ~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~ 285 (288)
T cd07833 225 HQELFSSNPRFAGVAFPEPSQ-PESLERRYPGKVSSPALDFLKACLRMDPKERLTCDELLQH 285 (288)
T ss_pred HhhhcccCccccccccCCCCC-cHHHHHhcCCccchHHHHHHHHHhccCchhcccHHHHhcC
Confidence 000 0001100 0111111123347889999999999999999999999986
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like (CDKL) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDKL1-5 and similar proteins. Some CDKLs, like CDKL1 and CDKL3, may be implicated in transformation and others, like CDKL3 and CDKL5, are associated with mental retardation when impaired. CDKL2 plays a role in learning |
| >KOG0577 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.6e-42 Score=291.98 Aligned_cols=255 Identities=25% Similarity=0.377 Sum_probs=207.6
Q ss_pred CChHHHHHHhCCCCCCceeecCCcceEEEEEe-CCCcEEEEEEeccCcCC-hhhhHHHHHHHHHHHhcCCcceeeeeeEE
Q 038766 2 FDRTEIENATGSFSENNIIGNSNLSTVYKGRL-EDGEIVAVKKLNFHQFS-AESDKSFYREAKTLKELKHRNLVKVLGYA 79 (299)
Q Consensus 2 ~~~~~~~~~~~~y~~~~~lg~g~~~~v~~~~~-~~~~~~~vK~~~~~~~~-~~~~~~~~~e~~~l~~l~h~~i~~~~~~~ 79 (299)
|..++.|.++.+ .+-||+|+||.||.|.+ .+.+.||||.+.++... .+....+.+|+..|++++|||++.+.| |
T Consensus 19 F~k~DPEklf~d---LrEIGHGSFGAVYfArd~~n~evVAIKKMsySGKQs~EKWqDIlKEVrFL~~l~HPntieYkg-C 94 (948)
T KOG0577|consen 19 FFKDDPEKLFSD---LREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDILKEVRFLRQLRHPNTIEYKG-C 94 (948)
T ss_pred HccCCHHHHHHH---HHHhcCCccceeEEeeccCccceeeeeeccccccccHHHHHHHHHHHHHHHhccCCCcccccc-e
Confidence 455566666555 56899999999999986 57889999999887653 445788999999999999999999999 5
Q ss_pred EcCCCeeEEEEeecCCCChHHHhcCCCCCCCCCChhhHHHHHHHHHHHHHHhhcCCCCCeeeecccCCceeeCCCCcEEE
Q 038766 80 WESGKLKALILEYMENGSLESVIHGPGVDHSRWTLPKRIDVLISVANGLDYLHSGYDIPIVHCDMKPSNILLDRDFEAHV 159 (299)
Q Consensus 80 ~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lh~~~~~~~~H~dl~~~nil~~~~~~v~l 159 (299)
+-.+...++|||||- |+-.+++.. .++++-+.++..|+++.++||+|||+. +.+|||||..|||++..|.|||
T Consensus 95 yLre~TaWLVMEYCl-GSAsDlleV---hkKplqEvEIAAi~~gaL~gLaYLHS~---~~IHRDiKAGNILLse~g~VKL 167 (948)
T KOG0577|consen 95 YLREHTAWLVMEYCL-GSASDLLEV---HKKPLQEVEIAAITHGALQGLAYLHSH---NRIHRDIKAGNILLSEPGLVKL 167 (948)
T ss_pred eeccchHHHHHHHHh-ccHHHHHHH---HhccchHHHHHHHHHHHHHHHHHHHHh---hHHhhhccccceEecCCCeeee
Confidence 655677799999995 588888764 357899999999999999999999999 9999999999999999999999
Q ss_pred eeeccccccccccccccccccccccCcccCChhhhc---ccCcCccccchhhhHHHHHHHhCCCCCCCCccCCCCchhHH
Q 038766 160 SDFGTSRMLDVHLQDLSSLSTAFQGTIGYLAPEFAY---MRIVTTKVDVFSFGIVVMEFLTKRRPTGLDEENGLSPISLR 236 (299)
Q Consensus 160 ~df~~~~~~~~~~~~~~~~~~~~~~~~~y~~PE~~~---~~~~~~~~DiwslG~~l~~l~~g~~p~~~~~~~~~~~~~~~ 236 (299)
+|||.+... .....++|||.|||||++. .+.|+.+.||||||++..+|....+|+... .-.
T Consensus 168 aDFGSAsi~--------~PAnsFvGTPywMAPEVILAMDEGqYdgkvDvWSLGITCIELAERkPPlFnM--------NAM 231 (948)
T KOG0577|consen 168 ADFGSASIM--------APANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNM--------NAM 231 (948)
T ss_pred ccccchhhc--------CchhcccCCccccchhHheeccccccCCccceeeccchhhhhhhcCCCccCc--------hHH
Confidence 999988643 3456788999999999765 467999999999999999999999886422 112
Q ss_pred HHHHHHHhcCccCcccccCccccchhhHhHHHHHHHHHHHHHHHHhcCCCCCCCCChhhhhcC
Q 038766 237 QLVEKALANGINGVRQITDPKLVSSIYEEQEQHQVLEELFKLALVCTSSNPEDRPNMNELLIT 299 (299)
Q Consensus 237 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rpt~~~il~~ 299 (299)
..+..+..+..+... .+.-+..++++++.||..-|.+|||.+++|.|
T Consensus 232 SALYHIAQNesPtLq----------------s~eWS~~F~~Fvd~CLqKipqeRptse~ll~H 278 (948)
T KOG0577|consen 232 SALYHIAQNESPTLQ----------------SNEWSDYFRNFVDSCLQKIPQERPTSEELLKH 278 (948)
T ss_pred HHHHHHHhcCCCCCC----------------CchhHHHHHHHHHHHHhhCcccCCcHHHHhhc
Confidence 222222223222211 34456789999999999999999999999987
|
|
| >cd06608 STKc_myosinIII_like Catalytic domain of Class III myosin-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-40 Score=278.50 Aligned_cols=258 Identities=27% Similarity=0.409 Sum_probs=201.4
Q ss_pred HHhCCCCCCceeecCCcceEEEEEeC-CCcEEEEEEeccCcCChhhhHHHHHHHHHHHhc-CCcceeeeeeEEEcC----
Q 038766 9 NATGSFSENNIIGNSNLSTVYKGRLE-DGEIVAVKKLNFHQFSAESDKSFYREAKTLKEL-KHRNLVKVLGYAWES---- 82 (299)
Q Consensus 9 ~~~~~y~~~~~lg~g~~~~v~~~~~~-~~~~~~vK~~~~~~~~~~~~~~~~~e~~~l~~l-~h~~i~~~~~~~~~~---- 82 (299)
...++|.+.+.||+|++|.||++.+. +++.+++|++.... .....+.+|+.+++++ .|+||+++++.+...
T Consensus 3 ~~~~~y~~~~~l~~g~~~~v~~~~~~~~~~~~~~k~~~~~~---~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~~~~ 79 (275)
T cd06608 3 DPTGIFELVEVIGEGTYGKVYKARHKKTGQLVAIKIMDIIE---DEEEEIKEEYNILRKYSNHPNIATFYGAFIKKNPPG 79 (275)
T ss_pred CchhheeheeeecCCCCeEEEEEEECCCCcEEEEEEEecCc---hhHHHHHHHHHHHHHhcCCCChheEEEEEEecCCCC
Confidence 34689999999999999999999874 57899999986432 3456788999999999 699999999977643
Q ss_pred -CCeeEEEEeecCCCChHHHhcCCCCCCCCCChhhHHHHHHHHHHHHHHhhcCCCCCeeeecccCCceeeCCCCcEEEee
Q 038766 83 -GKLKALILEYMENGSLESVIHGPGVDHSRWTLPKRIDVLISVANGLDYLHSGYDIPIVHCDMKPSNILLDRDFEAHVSD 161 (299)
Q Consensus 83 -~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lh~~~~~~~~H~dl~~~nil~~~~~~v~l~d 161 (299)
+...++|+||+.+++|.+++......+..+++..++.++.|++.||.|||+. +++|+||+|+||+++.++.++|+|
T Consensus 80 ~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~ql~~al~~lH~~---~i~H~~l~p~ni~~~~~~~~~l~d 156 (275)
T cd06608 80 NDDQLWLVMELCGGGSVTDLVKGLRKKGKRLKEEWIAYILRETLRGLAYLHEN---KVIHRDIKGQNILLTKNAEVKLVD 156 (275)
T ss_pred cceEEEEEEEcCCCCcHHHHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHhcC---CcccCCCCHHHEEEccCCeEEECC
Confidence 3457999999999999998865433356899999999999999999999999 999999999999999999999999
Q ss_pred eccccccccccccccccccccccCcccCChhhhcc-----cCcCccccchhhhHHHHHHHhCCCCCCCCccCCCCchhHH
Q 038766 162 FGTSRMLDVHLQDLSSLSTAFQGTIGYLAPEFAYM-----RIVTTKVDVFSFGIVVMEFLTKRRPTGLDEENGLSPISLR 236 (299)
Q Consensus 162 f~~~~~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~-----~~~~~~~DiwslG~~l~~l~~g~~p~~~~~~~~~~~~~~~ 236 (299)
||.+...... ........++..|+|||.+.. ..++.++||||||+++|+|++|..||.... ..
T Consensus 157 ~~~~~~~~~~----~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~-----~~--- 224 (275)
T cd06608 157 FGVSAQLDST----LGRRNTFIGTPYWMAPEVIACDEQPDASYDARSDVWSLGITAIELADGKPPLCDMH-----PM--- 224 (275)
T ss_pred Cccceecccc----hhhhcCccccccccCHhHhcccccccCCccccccHHHhHHHHHHHHhCCCCccccc-----hH---
Confidence 9988754321 122234457889999998754 346788999999999999999999985321 11
Q ss_pred HHHHHHHhcCccCcccccCccccchhhHhHHHHHHHHHHHHHHHHhcCCCCCCCCChhhhhcC
Q 038766 237 QLVEKALANGINGVRQITDPKLVSSIYEEQEQHQVLEELFKLALVCTSSNPEDRPNMNELLIT 299 (299)
Q Consensus 237 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rpt~~~il~~ 299 (299)
..+....... .... ......+..+.++|.+||..||++|||++++++|
T Consensus 225 ~~~~~~~~~~---~~~~------------~~~~~~~~~~~~li~~~l~~dp~~Rpt~~~ll~~ 272 (275)
T cd06608 225 RALFKIPRNP---PPTL------------KSPENWSKKFNDFISECLIKNYEQRPFMEELLEH 272 (275)
T ss_pred HHHHHhhccC---CCCC------------CchhhcCHHHHHHHHHHhhcChhhCcCHHHHhcC
Confidence 1111111100 0000 0123356789999999999999999999999986
|
Serine/threonine kinases (STKs), Class III myosin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins with an N-terminal kinase catalytic domain and a C-terminal actin-binding motor domain. Class III myosins are present in the photoreceptors of invertebrates and vertebrates and in the auditory hair cells of mammals. The kinase domain of myosin III can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, and can autophosphorylate the C-terminal motor domain. Myosin I |
| >cd06637 STKc_TNIK Catalytic domain of the Protein Serine/Threonine Kinase, Traf2- and Nck-interacting kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.6e-40 Score=274.98 Aligned_cols=255 Identities=24% Similarity=0.389 Sum_probs=198.5
Q ss_pred HHhCCCCCCceeecCCcceEEEEEeC-CCcEEEEEEeccCcCChhhhHHHHHHHHHHHhc-CCcceeeeeeEEEcCC---
Q 038766 9 NATGSFSENNIIGNSNLSTVYKGRLE-DGEIVAVKKLNFHQFSAESDKSFYREAKTLKEL-KHRNLVKVLGYAWESG--- 83 (299)
Q Consensus 9 ~~~~~y~~~~~lg~g~~~~v~~~~~~-~~~~~~vK~~~~~~~~~~~~~~~~~e~~~l~~l-~h~~i~~~~~~~~~~~--- 83 (299)
...+.|.+.+.||+|++|.||++.+. +++.+|+|++... ......+..|+..++++ .|+|++++.+.+...+
T Consensus 3 ~~~~~y~~~~~lg~g~~g~vy~~~~~~~~~~~aik~~~~~---~~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~~~~ 79 (272)
T cd06637 3 DPAGIFELVELVGNGTYGQVYKGRHVKTGQLAAIKVMDVT---GDEEEEIKQEINMLKKYSHHRNIATYYGAFIKKNPPG 79 (272)
T ss_pred ChhhhhhHHHheeecCCeEEEEEEEcCCCcEEEEEEEEcC---CccHHHHHHHHHHHHHhcCCCCeeeEeeEEeecCCCC
Confidence 45678999999999999999999864 5889999998643 23456788899999998 5999999999876432
Q ss_pred --CeeEEEEeecCCCChHHHhcCCCCCCCCCChhhHHHHHHHHHHHHHHhhcCCCCCeeeecccCCceeeCCCCcEEEee
Q 038766 84 --KLKALILEYMENGSLESVIHGPGVDHSRWTLPKRIDVLISVANGLDYLHSGYDIPIVHCDMKPSNILLDRDFEAHVSD 161 (299)
Q Consensus 84 --~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lh~~~~~~~~H~dl~~~nil~~~~~~v~l~d 161 (299)
...++|+||+.+++|.+++... ....+++..+..++.|++.|++|||+. +++|+||+|+||+++.++.++|+|
T Consensus 80 ~~~~~~iv~e~~~~~~L~~~l~~~--~~~~l~~~~~~~~~~qi~~~l~~LH~~---~ivh~dl~~~nili~~~~~~~l~D 154 (272)
T cd06637 80 MDDQLWLVMEFCGAGSVTDLIKNT--KGNTLKEEWIAYICREILRGLSHLHQH---KVIHRDIKGQNVLLTENAEVKLVD 154 (272)
T ss_pred CCcEEEEEEEcCCCCcHHHHHHhc--cCCCCCHHHHHHHHHHHHHHHHHHHHC---CCccCCCCHHHEEECCCCCEEEcc
Confidence 3568999999999999988743 234688999999999999999999999 999999999999999999999999
Q ss_pred eccccccccccccccccccccccCcccCChhhhc-----ccCcCccccchhhhHHHHHHHhCCCCCCCCccCCCCchhHH
Q 038766 162 FGTSRMLDVHLQDLSSLSTAFQGTIGYLAPEFAY-----MRIVTTKVDVFSFGIVVMEFLTKRRPTGLDEENGLSPISLR 236 (299)
Q Consensus 162 f~~~~~~~~~~~~~~~~~~~~~~~~~y~~PE~~~-----~~~~~~~~DiwslG~~l~~l~~g~~p~~~~~~~~~~~~~~~ 236 (299)
||++...... ........++..|+|||.+. ...++.++|+||+||++|+|++|..||.... ...
T Consensus 155 fg~~~~~~~~----~~~~~~~~g~~~y~aPE~~~~~~~~~~~~~~~~Dv~slGv~l~el~~g~~p~~~~~-----~~~-- 223 (272)
T cd06637 155 FGVSAQLDRT----VGRRNTFIGTPYWMAPEVIACDENPDATYDFKSDLWSLGITAIEMAEGAPPLCDMH-----PMR-- 223 (272)
T ss_pred CCCceecccc----cccCCcccccccccCHhHhccccCcCCCCCchhhHHHHHHHHHHHHhCCCCccccC-----HHH--
Confidence 9998754321 12233455788999999876 3457889999999999999999999984321 111
Q ss_pred HHHHHHHhcCccCcccccCccccchhhHhHHHHHHHHHHHHHHHHhcCCCCCCCCChhhhhcC
Q 038766 237 QLVEKALANGINGVRQITDPKLVSSIYEEQEQHQVLEELFKLALVCTSSNPEDRPNMNELLIT 299 (299)
Q Consensus 237 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rpt~~~il~~ 299 (299)
... ..... ...... ....+.++.+++.+||..+|.+|||+.++++|
T Consensus 224 ~~~-~~~~~---~~~~~~-------------~~~~~~~~~~li~~~l~~~p~~Rpt~~~il~~ 269 (272)
T cd06637 224 ALF-LIPRN---PAPRLK-------------SKKWSKKFQSFIESCLVKNHSQRPTTEQLMKH 269 (272)
T ss_pred HHH-HHhcC---CCCCCC-------------CCCcCHHHHHHHHHHcCCChhhCCCHHHHhhC
Confidence 100 00000 000000 11234578999999999999999999999987
|
Serine/threonine kinases (STKs), Traf2- and Nck-interacting kinase (TNIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TNIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to mitogen-activated protein kinase (MAPK), kinase kinase kinase 4 (MAP4K4), and MAP4K6. MAP4Ks participate in some MAPK signaling pathways by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). TNIK is an effector of Rap2, a small GTP-binding protein from the Ras family. TNIK specifically activ |
| >cd05093 PTKc_TrkB Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase B | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-40 Score=278.96 Aligned_cols=255 Identities=26% Similarity=0.392 Sum_probs=196.4
Q ss_pred hCCCCCCceeecCCcceEEEEEe------CCCcEEEEEEeccCcCChhhhHHHHHHHHHHHhcCCcceeeeeeEEEcCCC
Q 038766 11 TGSFSENNIIGNSNLSTVYKGRL------EDGEIVAVKKLNFHQFSAESDKSFYREAKTLKELKHRNLVKVLGYAWESGK 84 (299)
Q Consensus 11 ~~~y~~~~~lg~g~~~~v~~~~~------~~~~~~~vK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~ 84 (299)
..+|.+.+.||+|++|.||++.. .++..+++|.+.. ........+.+|+..+++++|+||+++++++.. +.
T Consensus 4 ~~~~~~~~~lg~G~~~~v~~~~~~~~~~~~~~~~~~ik~~~~--~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~-~~ 80 (288)
T cd05093 4 RHNIVLKRELGEGAFGKVFLAECYNLCPEQDKILVAVKTLKD--ASDNARKDFHREAELLTNLQHEHIVKFYGVCVE-GD 80 (288)
T ss_pred hHHeeeccccCCcCCeeEEeeEeccCCCCCcceEEEEEecCC--cCHHHHHHHHHHHHHHHhCCCCCcceEEEEEec-CC
Confidence 46799999999999999999974 2356689998753 233445678899999999999999999997665 55
Q ss_pred eeEEEEeecCCCChHHHhcCCC---------CCCCCCChhhHHHHHHHHHHHHHHhhcCCCCCeeeecccCCceeeCCCC
Q 038766 85 LKALILEYMENGSLESVIHGPG---------VDHSRWTLPKRIDVLISVANGLDYLHSGYDIPIVHCDMKPSNILLDRDF 155 (299)
Q Consensus 85 ~~~lv~e~~~~~~L~~~~~~~~---------~~~~~~~~~~~~~i~~qi~~~l~~lh~~~~~~~~H~dl~~~nil~~~~~ 155 (299)
..++|+||+.+++|.+++...+ .....+++..++.++.|++.||+|||+. +++|+||||+||+++.++
T Consensus 81 ~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~l~~~~~~~~~~ql~~aL~~lH~~---~i~H~dlkp~Nili~~~~ 157 (288)
T cd05093 81 PLIMVFEYMKHGDLNKFLRAHGPDAVLMAEGNRPAELTQSQMLHIAQQIAAGMVYLASQ---HFVHRDLATRNCLVGENL 157 (288)
T ss_pred ccEEEEEcCCCCCHHHHHHHcCCccccccccCCCCCCCHHHHHHHHHHHHHHHHHHHhC---CeeecccCcceEEEccCC
Confidence 6699999999999999886432 1223589999999999999999999999 999999999999999999
Q ss_pred cEEEeeeccccccccccccccccccccccCcccCChhhhcccCcCccccchhhhHHHHHHHh-CCCCCCCCccCCCCchh
Q 038766 156 EAHVSDFGTSRMLDVHLQDLSSLSTAFQGTIGYLAPEFAYMRIVTTKVDVFSFGIVVMEFLT-KRRPTGLDEENGLSPIS 234 (299)
Q Consensus 156 ~v~l~df~~~~~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~DiwslG~~l~~l~~-g~~p~~~~~~~~~~~~~ 234 (299)
.++|+|||++....... .........++..|+|||.+.+..++.++|+||||+++|+|++ |..||.... ..
T Consensus 158 ~~kl~dfg~~~~~~~~~--~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDiwslG~il~~l~t~g~~p~~~~~-----~~- 229 (288)
T cd05093 158 LVKIGDFGMSRDVYSTD--YYRVGGHTMLPIRWMPPESIMYRKFTTESDVWSLGVVLWEIFTYGKQPWYQLS-----NN- 229 (288)
T ss_pred cEEeccCCccccccCCc--eeecCCCCCccccccCHHHhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCC-----HH-
Confidence 99999999987543111 1112223334678999999998889999999999999999998 888874331 11
Q ss_pred HHHHHHHHHhcCccCcccccCccccchhhHhHHHHHHHHHHHHHHHHhcCCCCCCCCChhhhhc
Q 038766 235 LRQLVEKALANGINGVRQITDPKLVSSIYEEQEQHQVLEELFKLALVCTSSNPEDRPNMNELLI 298 (299)
Q Consensus 235 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rpt~~~il~ 298 (299)
+............ . +...+.++.+++.+||+.||.+|||++++++
T Consensus 230 --~~~~~i~~~~~~~-----~------------~~~~~~~l~~li~~~l~~~p~~Rpt~~~v~~ 274 (288)
T cd05093 230 --EVIECITQGRVLQ-----R------------PRTCPKEVYDLMLGCWQREPHMRLNIKEIHS 274 (288)
T ss_pred --HHHHHHHcCCcCC-----C------------CCCCCHHHHHHHHHHccCChhhCCCHHHHHH
Confidence 1222111111000 0 1123457899999999999999999999864
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase B (TrkB); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkB is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkB to its ligands, brain-derived neurotrophic factor (BDNF) or neurotrophin 4 (NT4), results in receptor oligomerization and activation of the catalytic domain. TrkB is broadly |
| >cd06640 STKc_MST4 Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-40 Score=276.25 Aligned_cols=250 Identities=23% Similarity=0.366 Sum_probs=200.4
Q ss_pred hCCCCCCceeecCCcceEEEEEeC-CCcEEEEEEeccCcCChhhhHHHHHHHHHHHhcCCcceeeeeeEEEcCCCeeEEE
Q 038766 11 TGSFSENNIIGNSNLSTVYKGRLE-DGEIVAVKKLNFHQFSAESDKSFYREAKTLKELKHRNLVKVLGYAWESGKLKALI 89 (299)
Q Consensus 11 ~~~y~~~~~lg~g~~~~v~~~~~~-~~~~~~vK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~lv 89 (299)
.+.|...+.||.|++|.||.+.+. ++..+|+|++.... .......+.+|+..++.+.|+||+++++.+.. +...++|
T Consensus 3 ~~~y~~~~~lg~g~~~~vy~~~~~~~~~~vaiK~~~~~~-~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~-~~~~~lv 80 (277)
T cd06640 3 EELFTKLERIGKGSFGEVFKGIDNRTQQVVAIKIIDLEE-AEDEIEDIQQEITVLSQCDSPYVTKYYGSYLK-GTKLWII 80 (277)
T ss_pred HHhhhhhhhcccCCCeEEEEEEEccCCEEEEEEEEeccc-cHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEE-CCEEEEE
Confidence 457888999999999999999874 58899999986432 23446778899999999999999999996655 5677999
Q ss_pred EeecCCCChHHHhcCCCCCCCCCChhhHHHHHHHHHHHHHHhhcCCCCCeeeecccCCceeeCCCCcEEEeeeccccccc
Q 038766 90 LEYMENGSLESVIHGPGVDHSRWTLPKRIDVLISVANGLDYLHSGYDIPIVHCDMKPSNILLDRDFEAHVSDFGTSRMLD 169 (299)
Q Consensus 90 ~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lh~~~~~~~~H~dl~~~nil~~~~~~v~l~df~~~~~~~ 169 (299)
+||+.+++|.+++. ..++++..+..++.|++.||++||+. +++|+||+|+||+++.++.++++|||++....
T Consensus 81 ~e~~~~~~L~~~i~-----~~~l~~~~~~~~~~~l~~~l~~lh~~---~ivH~dl~p~Nil~~~~~~~~l~dfg~~~~~~ 152 (277)
T cd06640 81 MEYLGGGSALDLLR-----AGPFDEFQIATMLKEILKGLDYLHSE---KKIHRDIKAANVLLSEQGDVKLADFGVAGQLT 152 (277)
T ss_pred EecCCCCcHHHHHh-----cCCCCHHHHHHHHHHHHHHHHHHHhC---CccCcCCChhhEEEcCCCCEEEcccccceecc
Confidence 99999999999885 24688999999999999999999999 99999999999999999999999999987543
Q ss_pred cccccccccccccccCcccCChhhhcccCcCccccchhhhHHHHHHHhCCCCCCCCccCCCCchhHHHHHHHHHhcCccC
Q 038766 170 VHLQDLSSLSTAFQGTIGYLAPEFAYMRIVTTKVDVFSFGIVVMEFLTKRRPTGLDEENGLSPISLRQLVEKALANGING 249 (299)
Q Consensus 170 ~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~DiwslG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 249 (299)
.. ........++..|+|||.+.+...+.++|+||||+++|+|++|..||..... ..... ......
T Consensus 153 ~~----~~~~~~~~~~~~y~apE~~~~~~~~~~~Dv~slG~il~el~tg~~p~~~~~~-----~~~~~---~~~~~~--- 217 (277)
T cd06640 153 DT----QIKRNTFVGTPFWMAPEVIQQSAYDSKADIWSLGITAIELAKGEPPNSDMHP-----MRVLF---LIPKNN--- 217 (277)
T ss_pred CC----ccccccccCcccccCHhHhccCCCccHHHHHHHHHHHHHHHHCCCCCCCcCh-----HhHhh---hhhcCC---
Confidence 21 1122334567789999999888899999999999999999999999853211 11111 000000
Q ss_pred cccccCccccchhhHhHHHHHHHHHHHHHHHHhcCCCCCCCCChhhhhcC
Q 038766 250 VRQITDPKLVSSIYEEQEQHQVLEELFKLALVCTSSNPEDRPNMNELLIT 299 (299)
Q Consensus 250 ~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rpt~~~il~~ 299 (299)
. ......++..+.+++.+||..+|++|||+++++.|
T Consensus 218 -----~---------~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~ 253 (277)
T cd06640 218 -----P---------PTLTGEFSKPFKEFIDACLNKDPSFRPTAKELLKH 253 (277)
T ss_pred -----C---------CCCchhhhHHHHHHHHHHcccCcccCcCHHHHHhC
Confidence 0 01133456788999999999999999999999986
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 4 (MST4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST4 is sometimes referred to as MASK (MST3 and SOK1-related kinase). It plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. It influences cell growth and transformation by modulating the extracellular signal-regulated kinase (ERK) pathway. MST4 may also play a role in tumor formation and progression. It localizes in the Golgi apparatus by inter |
| >cd06605 PKc_MAPKK Catalytic domain of the dual-specificity Protein Kinase, Mitogen-Activated Protein Kinase Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-40 Score=274.43 Aligned_cols=255 Identities=27% Similarity=0.426 Sum_probs=202.7
Q ss_pred CCCCCCceeecCCcceEEEEEeC-CCcEEEEEEeccCcCChhhhHHHHHHHHHHHhcCCcceeeeeeEEEcCCCeeEEEE
Q 038766 12 GSFSENNIIGNSNLSTVYKGRLE-DGEIVAVKKLNFHQFSAESDKSFYREAKTLKELKHRNLVKVLGYAWESGKLKALIL 90 (299)
Q Consensus 12 ~~y~~~~~lg~g~~~~v~~~~~~-~~~~~~vK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~lv~ 90 (299)
++|.+.+.||+|++|.||++.+. +++.+++|++.... .......+.+|++.++.+.||||+++++.+... ...++++
T Consensus 1 ~~~~~~~~ig~g~~~~v~~~~~~~~~~~~~ik~~~~~~-~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~-~~~~lv~ 78 (265)
T cd06605 1 DDLEYLGELGAGNSGVVSKVLHRPTGKIMAVKTIRLEI-NEAIQKQILRELDILHKCNSPYIVGFYGAFYNN-GDISICM 78 (265)
T ss_pred CcchHHHHhcCCCCeEEEEEEEcCCCcEEEEEEEeccc-ChHHHHHHHHHHHHHHHCCCCchhhhheeeecC-CEEEEEE
Confidence 46888999999999999999875 58999999986533 335567788999999999999999999976664 6679999
Q ss_pred eecCCCChHHHhcCCCCCCCCCChhhHHHHHHHHHHHHHHhhc-CCCCCeeeecccCCceeeCCCCcEEEeeeccccccc
Q 038766 91 EYMENGSLESVIHGPGVDHSRWTLPKRIDVLISVANGLDYLHS-GYDIPIVHCDMKPSNILLDRDFEAHVSDFGTSRMLD 169 (299)
Q Consensus 91 e~~~~~~L~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lh~-~~~~~~~H~dl~~~nil~~~~~~v~l~df~~~~~~~ 169 (299)
|++.+++|.+++... ...+++..++.++.|++.|+++||+ . +++|+||+|+||+++.++.++|+|||.+....
T Consensus 79 e~~~~~~L~~~~~~~---~~~~~~~~~~~~~~~l~~~l~~lH~~~---~i~H~dl~~~ni~~~~~~~~~l~d~g~~~~~~ 152 (265)
T cd06605 79 EYMDGGSLDKILKEV---QGRIPERILGKIAVAVLKGLTYLHEKH---KIIHRDVKPSNILVNSRGQIKLCDFGVSGQLV 152 (265)
T ss_pred EecCCCcHHHHHHHc---cCCCCHHHHHHHHHHHHHHHHHHcCCC---CeecCCCCHHHEEECCCCCEEEeecccchhhH
Confidence 999989999998743 2678999999999999999999999 8 99999999999999999999999999886543
Q ss_pred cccccccccccccccCcccCChhhhcccCcCccccchhhhHHHHHHHhCCCCCCCCccCCCCchhHHHHHHHHHhcCccC
Q 038766 170 VHLQDLSSLSTAFQGTIGYLAPEFAYMRIVTTKVDVFSFGIVVMEFLTKRRPTGLDEENGLSPISLRQLVEKALANGING 249 (299)
Q Consensus 170 ~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~DiwslG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 249 (299)
.. ......++..|+|||.+.+..++.++|+||||+++++|++|..||...... .....+.+........
T Consensus 153 ~~------~~~~~~~~~~y~~PE~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~---~~~~~~~~~~~~~~~~-- 221 (265)
T cd06605 153 NS------LAKTFVGTSSYMAPERIQGNDYSVKSDIWSLGLSLIELATGRFPYPPENDP---PDGIFELLQYIVNEPP-- 221 (265)
T ss_pred HH------HhhcccCChhccCHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCccccc---cccHHHHHHHHhcCCC--
Confidence 11 111155678899999999999999999999999999999999998543221 1111222222111110
Q ss_pred cccccCccccchhhHhHHHHHHHHHHHHHHHHhcCCCCCCCCChhhhhcC
Q 038766 250 VRQITDPKLVSSIYEEQEQHQVLEELFKLALVCTSSNPEDRPNMNELLIT 299 (299)
Q Consensus 250 ~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rpt~~~il~~ 299 (299)
+... ...++.++.++|.+||..+|++|||+.+++.|
T Consensus 222 ------~~~~--------~~~~~~~~~~li~~~l~~~p~~Rpt~~~ll~~ 257 (265)
T cd06605 222 ------PRLP--------SGKFSPDFQDFVNLCLIKDPRERPSYKELLEH 257 (265)
T ss_pred ------CCCC--------hhhcCHHHHHHHHHHcCCCchhCcCHHHHhhC
Confidence 0000 11256789999999999999999999999976
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK or MAP2K), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK or MAP3K). MAPKKs are dual-specificity |
| >cd07841 STKc_CDK7 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 7 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5e-40 Score=277.74 Aligned_cols=270 Identities=27% Similarity=0.346 Sum_probs=198.4
Q ss_pred CCCCCceeecCCcceEEEEEeC-CCcEEEEEEeccCcCC---hhhhHHHHHHHHHHHhcCCcceeeeeeEEEcCCCeeEE
Q 038766 13 SFSENNIIGNSNLSTVYKGRLE-DGEIVAVKKLNFHQFS---AESDKSFYREAKTLKELKHRNLVKVLGYAWESGKLKAL 88 (299)
Q Consensus 13 ~y~~~~~lg~g~~~~v~~~~~~-~~~~~~vK~~~~~~~~---~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~l 88 (299)
+|.+.+.||+|++|.||++.+. +++.|++|++...... ......+..|+..++.++|+||+++++++.. +...++
T Consensus 1 ~y~~~~~lg~g~~~~vy~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~-~~~~~l 79 (298)
T cd07841 1 RYEKGKKLGEGTYAVVYKARDKETGRIVAIKKIKLGERKEAKDGINFTALREIKLLQELKHPNIIGLLDVFGH-KSNINL 79 (298)
T ss_pred CceeeeeeeeccccEEEEEEECCCCcEEEEEEEeccccccccchhhHHHHHHHHHHhhcCCCCChhhhheeec-CCEEEE
Confidence 5888999999999999999864 5899999999755433 2334567789999999999999999997766 566799
Q ss_pred EEeecCCCChHHHhcCCCCCCCCCChhhHHHHHHHHHHHHHHhhcCCCCCeeeecccCCceeeCCCCcEEEeeecccccc
Q 038766 89 ILEYMENGSLESVIHGPGVDHSRWTLPKRIDVLISVANGLDYLHSGYDIPIVHCDMKPSNILLDRDFEAHVSDFGTSRML 168 (299)
Q Consensus 89 v~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lh~~~~~~~~H~dl~~~nil~~~~~~v~l~df~~~~~~ 168 (299)
|+||+ +++|.+++.... ..+++..++.++.||++||+|||++ +++|+||+|+||+++.++.++|+|||++...
T Consensus 80 v~e~~-~~~L~~~i~~~~---~~~~~~~~~~~~~qi~~al~~lH~~---~i~H~dl~p~nill~~~~~~~l~dfg~~~~~ 152 (298)
T cd07841 80 VFEFM-ETDLEKVIKDKS---IVLTPADIKSYMLMTLRGLEYLHSN---WILHRDLKPNNLLIASDGVLKLADFGLARSF 152 (298)
T ss_pred EEccc-CCCHHHHHhccC---CCCCHHHHHHHHHHHHHHHHHHHhC---CeeecCCChhhEEEcCCCCEEEccceeeeec
Confidence 99999 889999986321 3789999999999999999999999 9999999999999999999999999998765
Q ss_pred ccccccccccccccccCcccCChhhhcc-cCcCccccchhhhHHHHHHHhCCCCCCCCccCCCCchhHHHHHHHHHh---
Q 038766 169 DVHLQDLSSLSTAFQGTIGYLAPEFAYM-RIVTTKVDVFSFGIVVMEFLTKRRPTGLDEENGLSPISLRQLVEKALA--- 244 (299)
Q Consensus 169 ~~~~~~~~~~~~~~~~~~~y~~PE~~~~-~~~~~~~DiwslG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~--- 244 (299)
... ........+++.|+|||.+.+ ..++.++|+|||||++++|++|..+|..... ............
T Consensus 153 ~~~----~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~e~~~g~~~~~~~~~-----~~~~~~~~~~~~~~~ 223 (298)
T cd07841 153 GSP----NRKMTHQVVTRWYRAPELLFGARHYGVGVDMWSVGCIFAELLLRVPFLPGDSD-----IDQLGKIFEALGTPT 223 (298)
T ss_pred cCC----CccccccccceeeeCHHHHhCCCCCCcHHHHHHHHHHHHHHHcCCccccCCcc-----HHHHHHHHHHcCCCc
Confidence 421 112223345678999998764 4578899999999999999999777653321 111111111000
Q ss_pred -cCccCcccccCc---cccchhhHhHHHHHHHHHHHHHHHHhcCCCCCCCCChhhhhcC
Q 038766 245 -NGINGVRQITDP---KLVSSIYEEQEQHQVLEELFKLALVCTSSNPEDRPNMNELLIT 299 (299)
Q Consensus 245 -~~~~~~~~~~~~---~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rpt~~~il~~ 299 (299)
..+......... ...............+..+.++|.+||..+|++|||++++++|
T Consensus 224 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~s~~e~l~~ 282 (298)
T cd07841 224 EENWPGVTSLPDYVEFKPFPPTPLKQIFPAASDDALDLLQRLLTLNPNKRITARQALEH 282 (298)
T ss_pred hhhhhhcccccccccccccCCcchhhhcccccHHHHHHHHHHhcCCcccCcCHHHHhhC
Confidence 000000000000 0000000111223446789999999999999999999999986
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 7 (CDK7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK7 plays essential roles in the cell cycle and in transcription. It associates with cyclin H and MAT1 and acts as a CDK-Activating Kinase (CAK) by phosphorylating and activating cell cycle CDKs (CDK1/2/4/6). In the brain, it activates CDK5. CDK7 is |
| >PRK13184 pknD serine/threonine-protein kinase; Reviewed | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-40 Score=306.87 Aligned_cols=259 Identities=22% Similarity=0.317 Sum_probs=196.7
Q ss_pred CCCCCCceeecCCcceEEEEEeC-CCcEEEEEEeccCcCC-hhhhHHHHHHHHHHHhcCCcceeeeeeEEEcCCCeeEEE
Q 038766 12 GSFSENNIIGNSNLSTVYKGRLE-DGEIVAVKKLNFHQFS-AESDKSFYREAKTLKELKHRNLVKVLGYAWESGKLKALI 89 (299)
Q Consensus 12 ~~y~~~~~lg~g~~~~v~~~~~~-~~~~~~vK~~~~~~~~-~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~lv 89 (299)
++|.+.+.||+|++|.||+|.+. +++.||+|++...... ....+++.+|+++++.++||||+++++++.. ++..++|
T Consensus 2 grYeIi~~LGkGgfG~VYlA~d~~tg~~VAIK~I~~~l~~~e~~~~rflrEi~ILs~L~HPNIVkl~~v~~d-~~~lyLV 80 (932)
T PRK13184 2 QRYDIIRLIGKGGMGEVYLAYDPVCSRRVALKKIREDLSENPLLKKRFLREAKIAADLIHPGIVPVYSICSD-GDPVYYT 80 (932)
T ss_pred CCeEEEEEEecCCCEEEEEEEECCCCcEEEEEEECcccccCHHHHHHHHHHHHHHHhCCCcCcCeEEEEEee-CCEEEEE
Confidence 68999999999999999999875 5899999998743322 2335678899999999999999999997665 4566999
Q ss_pred EeecCCCChHHHhcCCCC-------CCCCCChhhHHHHHHHHHHHHHHhhcCCCCCeeeecccCCceeeCCCCcEEEeee
Q 038766 90 LEYMENGSLESVIHGPGV-------DHSRWTLPKRIDVLISVANGLDYLHSGYDIPIVHCDMKPSNILLDRDFEAHVSDF 162 (299)
Q Consensus 90 ~e~~~~~~L~~~~~~~~~-------~~~~~~~~~~~~i~~qi~~~l~~lh~~~~~~~~H~dl~~~nil~~~~~~v~l~df 162 (299)
|||++|++|.+++..... ....++...++.++.||+.||+|||++ +++||||||+||+++.++.++|+||
T Consensus 81 MEY~eGGSL~~lL~s~~~~~~l~e~~~~~lsv~~iL~I~~QIa~AL~yLHs~---GIIHRDLKPeNILLd~dg~vKLiDF 157 (932)
T PRK13184 81 MPYIEGYTLKSLLKSVWQKESLSKELAEKTSVGAFLSIFHKICATIEYVHSK---GVLHRDLKPDNILLGLFGEVVILDW 157 (932)
T ss_pred EEcCCCCCHHHHHHHhhhccccchhhhcccCHHHHHHHHHHHHHHHHHHHHC---CccccCCchheEEEcCCCCEEEEec
Confidence 999999999998753210 123456677889999999999999999 9999999999999999999999999
Q ss_pred cccccccccccc--------------ccccccccccCcccCChhhhcccCcCccccchhhhHHHHHHHhCCCCCCCCccC
Q 038766 163 GTSRMLDVHLQD--------------LSSLSTAFQGTIGYLAPEFAYMRIVTTKVDVFSFGIVVMEFLTKRRPTGLDEEN 228 (299)
Q Consensus 163 ~~~~~~~~~~~~--------------~~~~~~~~~~~~~y~~PE~~~~~~~~~~~DiwslG~~l~~l~~g~~p~~~~~~~ 228 (299)
|++......... .........||+.|+|||.+.+..++.++|||||||++|+|++|..||......
T Consensus 158 GLAk~i~~~~~~~~~l~~~~~~s~~s~~t~~g~~vGT~~YmAPE~l~g~~~S~kSDIWSLGVILyELLTG~~PF~~~~~~ 237 (932)
T PRK13184 158 GAAIFKKLEEEDLLDIDVDERNICYSSMTIPGKIVGTPDYMAPERLLGVPASESTDIYALGVILYQMLTLSFPYRRKKGR 237 (932)
T ss_pred CcceecccccccccccccccccccccccccCCCCCCCCCCCCHHHhcCCCCCcHhHHHHHHHHHHHHHHCCCCCCCcchh
Confidence 999765211000 011122346899999999999999999999999999999999999999542111
Q ss_pred CCCchhHHHHHHHHHhcCccCcccccCccccchhhHhHHHHHHHHHHHHHHHHhcCCCCCCCCChhhhh
Q 038766 229 GLSPISLRQLVEKALANGINGVRQITDPKLVSSIYEEQEQHQVLEELFKLALVCTSSNPEDRPNMNELL 297 (299)
Q Consensus 229 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rpt~~~il 297 (299)
.... .. ....+... .....++..+.+++.+||..||++||+..+.+
T Consensus 238 -----ki~~---~~---------~i~~P~~~------~p~~~iP~~L~~LI~rcL~~DP~kR~ss~eeL 283 (932)
T PRK13184 238 -----KISY---RD---------VILSPIEV------APYREIPPFLSQIAMKALAVDPAERYSSVQEL 283 (932)
T ss_pred -----hhhh---hh---------hccChhhc------cccccCCHHHHHHHHHHccCChhhCcCHHHHH
Confidence 0000 00 00000000 00234566789999999999999998765543
|
|
| >cd05084 PTKc_Fes Catalytic domain of the Protein Tyrosine Kinase, Fes | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-40 Score=272.83 Aligned_cols=246 Identities=25% Similarity=0.398 Sum_probs=189.9
Q ss_pred ceeecCCcceEEEEEeC-CCcEEEEEEeccCcCChhhhHHHHHHHHHHHhcCCcceeeeeeEEEcCCCeeEEEEeecCCC
Q 038766 18 NIIGNSNLSTVYKGRLE-DGEIVAVKKLNFHQFSAESDKSFYREAKTLKELKHRNLVKVLGYAWESGKLKALILEYMENG 96 (299)
Q Consensus 18 ~~lg~g~~~~v~~~~~~-~~~~~~vK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~lv~e~~~~~ 96 (299)
+.||+|++|.||++.+. +++.+|+|.+.. ....+....+.+|+++++.++||||+++++++.. +...++|+||+.++
T Consensus 1 ~~lg~g~~g~vy~~~~~~~~~~~a~k~~~~-~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~-~~~~~lv~e~~~~~ 78 (252)
T cd05084 1 ERIGRGNFGEVFSGRLRADNTPVAVKSCRE-TLPPDLKAKFLQEARILKQYSHPNIVRLIGVCTQ-KQPIYIVMELVQGG 78 (252)
T ss_pred CccCcccCccEEEEEEecCCceEEEEecCc-cCCHHHHHHHHHHHHHHHhCCCCCcceEEEEEcC-CCCeEEEEeeccCC
Confidence 46999999999999874 688999998753 3345556788999999999999999999997665 45669999999999
Q ss_pred ChHHHhcCCCCCCCCCChhhHHHHHHHHHHHHHHhhcCCCCCeeeecccCCceeeCCCCcEEEeeecccccccccccccc
Q 038766 97 SLESVIHGPGVDHSRWTLPKRIDVLISVANGLDYLHSGYDIPIVHCDMKPSNILLDRDFEAHVSDFGTSRMLDVHLQDLS 176 (299)
Q Consensus 97 ~L~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lh~~~~~~~~H~dl~~~nil~~~~~~v~l~df~~~~~~~~~~~~~~ 176 (299)
+|.+++.. ....+++..++.++.|++.||.|||++ +++|+||+|+||+++.++.++|+|||++....... ..
T Consensus 79 ~L~~~~~~---~~~~~~~~~~~~~~~qi~~~L~~lH~~---~i~H~dl~p~nil~~~~~~~kl~dfg~~~~~~~~~--~~ 150 (252)
T cd05084 79 DFLTFLRT---EGPRLKVKELIQMVENAAAGMEYLESK---HCIHRDLAARNCLVTEKNVLKISDFGMSREEEDGV--YA 150 (252)
T ss_pred cHHHHHHh---CCCCCCHHHHHHHHHHHHHHHHHHHhC---CccccccchheEEEcCCCcEEECccccCccccccc--cc
Confidence 99999863 234688999999999999999999999 99999999999999999999999999987543110 01
Q ss_pred ccccccccCcccCChhhhcccCcCccccchhhhHHHHHHHh-CCCCCCCCccCCCCchhHHHHHHHHHhcCccCcccccC
Q 038766 177 SLSTAFQGTIGYLAPEFAYMRIVTTKVDVFSFGIVVMEFLT-KRRPTGLDEENGLSPISLRQLVEKALANGINGVRQITD 255 (299)
Q Consensus 177 ~~~~~~~~~~~y~~PE~~~~~~~~~~~DiwslG~~l~~l~~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 255 (299)
........+..|+|||.+.+..++.++|+||||+++|+|++ |..||... ........+.. .. . ...
T Consensus 151 ~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~e~~~~~~~p~~~~-----~~~~~~~~~~~---~~--~---~~~ 217 (252)
T cd05084 151 STGGMKQIPVKWTAPEALNYGRYSSESDVWSFGILLWEAFSLGAVPYANL-----SNQQTREAIEQ---GV--R---LPC 217 (252)
T ss_pred ccCCCCCCceeecCchhhcCCCCChHHHHHHHHHHHHHHHhCCCCCcccc-----CHHHHHHHHHc---CC--C---CCC
Confidence 11111223457999999998889999999999999999997 77777422 11111111111 00 0 000
Q ss_pred ccccchhhHhHHHHHHHHHHHHHHHHhcCCCCCCCCChhhhhc
Q 038766 256 PKLVSSIYEEQEQHQVLEELFKLALVCTSSNPEDRPNMNELLI 298 (299)
Q Consensus 256 ~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rpt~~~il~ 298 (299)
+...+..+.+++.+||..+|++|||+.++++
T Consensus 218 ------------~~~~~~~~~~li~~~l~~~p~~Rps~~~~~~ 248 (252)
T cd05084 218 ------------PELCPDAVYRLMERCWEYDPGQRPSFSTVHQ 248 (252)
T ss_pred ------------cccCCHHHHHHHHHHcCCChhhCcCHHHHHH
Confidence 1223567899999999999999999999874
|
Protein Tyrosine Kinase (PTK) family; Fes (or Fps) kinase subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr kinase activity. Fes kinase is expressed in myeloid, vascular |
| >cd08220 STKc_Nek8 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 8 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-40 Score=273.00 Aligned_cols=251 Identities=23% Similarity=0.388 Sum_probs=201.2
Q ss_pred CCCCCceeecCCcceEEEEEe-CCCcEEEEEEeccCcCChhhhHHHHHHHHHHHhcCCcceeeeeeEEEcCCCeeEEEEe
Q 038766 13 SFSENNIIGNSNLSTVYKGRL-EDGEIVAVKKLNFHQFSAESDKSFYREAKTLKELKHRNLVKVLGYAWESGKLKALILE 91 (299)
Q Consensus 13 ~y~~~~~lg~g~~~~v~~~~~-~~~~~~~vK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~lv~e 91 (299)
+|++.+.||+|++|.||++.. .+++.+++|++............+.+|++.++.++|||++++++.+. .+...++|+|
T Consensus 1 ~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~-~~~~~~lv~e 79 (256)
T cd08220 1 KYEKIRVVGRGAFGIVHLCRRKADQKLVIIKQIPVEQMTKDERLAAQNECQVLKLLSHPNIIEYYENFL-EDKALMIVME 79 (256)
T ss_pred CceEEEEecccCceEEEEEEEcCCCcEEEEEEEeccccccHHHHHHHHHHHHHhhCCCCchhheeeeEe-cCCEEEEEEe
Confidence 588999999999999999986 46899999999766656666788999999999999999999999655 4566799999
Q ss_pred ecCCCChHHHhcCCCCCCCCCChhhHHHHHHHHHHHHHHhhcCCCCCeeeecccCCceeeCCC-CcEEEeeecccccccc
Q 038766 92 YMENGSLESVIHGPGVDHSRWTLPKRIDVLISVANGLDYLHSGYDIPIVHCDMKPSNILLDRD-FEAHVSDFGTSRMLDV 170 (299)
Q Consensus 92 ~~~~~~L~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lh~~~~~~~~H~dl~~~nil~~~~-~~v~l~df~~~~~~~~ 170 (299)
|+++++|.+++... ....+++..++.++.|++.++++||++ +++|+||+|+||+++.+ +.++|+|||.+.....
T Consensus 80 ~~~~~~L~~~~~~~--~~~~~~~~~~~~~~~~i~~~l~~lh~~---~i~h~dl~~~nil~~~~~~~~~l~d~~~~~~~~~ 154 (256)
T cd08220 80 YAPGGTLAEYIQKR--CNSLLDEDTILHFFVQILLALHHVHTK---LILHRDLKTQNILLDKHKMVVKIGDFGISKILSS 154 (256)
T ss_pred cCCCCCHHHHHHHh--cccCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHEEEcCCCCEEEEccCCCceecCC
Confidence 99999999998643 234689999999999999999999999 99999999999999855 4579999999876542
Q ss_pred ccccccccccccccCcccCChhhhcccCcCccccchhhhHHHHHHHhCCCCCCCCccCCCCchhHHHHHHHHHhcCccCc
Q 038766 171 HLQDLSSLSTAFQGTIGYLAPEFAYMRIVTTKVDVFSFGIVVMEFLTKRRPTGLDEENGLSPISLRQLVEKALANGINGV 250 (299)
Q Consensus 171 ~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~DiwslG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 250 (299)
. .......++..|+|||.+.+..++.++|+||+|+++++|++|..||..... ............
T Consensus 155 ~-----~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~~l~~~~~~~~~~~~--------~~~~~~~~~~~~--- 218 (256)
T cd08220 155 K-----SKAYTVVGTPCYISPELCEGKPYNQKSDIWALGCVLYELASLKRAFEAANL--------PALVLKIMSGTF--- 218 (256)
T ss_pred C-----ccccccccCCcccCchhccCCCCCcccchHHHHHHHHHHHhCCCCcccCch--------HHHHHHHHhcCC---
Confidence 1 122334567899999999888889999999999999999999999843311 111111111110
Q ss_pred ccccCccccchhhHhHHHHHHHHHHHHHHHHhcCCCCCCCCChhhhhcC
Q 038766 251 RQITDPKLVSSIYEEQEQHQVLEELFKLALVCTSSNPEDRPNMNELLIT 299 (299)
Q Consensus 251 ~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rpt~~~il~~ 299 (299)
..+ +..++.++.+++.+||..+|++|||+++++.|
T Consensus 219 ~~~--------------~~~~~~~l~~li~~~l~~~p~~Rpt~~~ll~~ 253 (256)
T cd08220 219 API--------------SDRYSPDLRQLILSMLNLDPSKRPQLSQIMAQ 253 (256)
T ss_pred CCC--------------CCCcCHHHHHHHHHHccCChhhCCCHHHHhhC
Confidence 000 12245678999999999999999999999986
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 8 (Nek8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek8 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek8 contains an N-terminal kinase catalytic domain and a C-terminal RCC1 (regulator of chromosome condensation) domain. A double point mutation in Nek8 causes cystic kidney disease in mice that genetically resembles human autosomal recessive polycystic kidney disease (ARPKD). Nek8 is also associated with |
| >cd06626 STKc_MEKK4 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.8e-40 Score=271.70 Aligned_cols=257 Identities=30% Similarity=0.408 Sum_probs=202.5
Q ss_pred CCCCCceeecCCcceEEEEEeC-CCcEEEEEEeccCcCChhhhHHHHHHHHHHHhcCCcceeeeeeEEEcCCCeeEEEEe
Q 038766 13 SFSENNIIGNSNLSTVYKGRLE-DGEIVAVKKLNFHQFSAESDKSFYREAKTLKELKHRNLVKVLGYAWESGKLKALILE 91 (299)
Q Consensus 13 ~y~~~~~lg~g~~~~v~~~~~~-~~~~~~vK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~lv~e 91 (299)
+|.+.+.||+|++|.||++... +++.+++|.+............+..|+..++.++|+||+++++.+.. ....++|+|
T Consensus 1 ~y~~~~~lg~G~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~-~~~~~lv~e 79 (264)
T cd06626 1 RWQRGNKIGGGTFGKVYTAVNLDTGELMAVKEIRIQDNDPKTIKEIADEMKVLELLKHPNLVKYYGVEVH-REKVYIFME 79 (264)
T ss_pred CceeeeEeecCCCcEEEEEEECCCCcEEEEEEEECcccchHHHHHHHHHHHHHHhCCCCChhheeeeEec-CCEEEEEEe
Confidence 6899999999999999999864 68999999997665544567889999999999999999999996554 566799999
Q ss_pred ecCCCChHHHhcCCCCCCCCCChhhHHHHHHHHHHHHHHhhcCCCCCeeeecccCCceeeCCCCcEEEeeeccccccccc
Q 038766 92 YMENGSLESVIHGPGVDHSRWTLPKRIDVLISVANGLDYLHSGYDIPIVHCDMKPSNILLDRDFEAHVSDFGTSRMLDVH 171 (299)
Q Consensus 92 ~~~~~~L~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lh~~~~~~~~H~dl~~~nil~~~~~~v~l~df~~~~~~~~~ 171 (299)
|+.+++|.+++. ....+++..+..++.|++.||.+||+. +++|+||+|+||+++.++.++|+|||++......
T Consensus 80 ~~~~~~L~~~~~----~~~~~~~~~~~~i~~~i~~~l~~lh~~---~i~H~dl~~~nil~~~~~~~kl~d~g~~~~~~~~ 152 (264)
T cd06626 80 YCSGGTLEELLE----HGRILDEHVIRVYTLQLLEGLAYLHSH---GIVHRDIKPANIFLDHNGVIKLGDFGCAVKLKNN 152 (264)
T ss_pred cCCCCcHHHHHh----hcCCCChHHHHHHHHHHHHHHHHHHHC---CcccCCCCHHHEEECCCCCEEEcccccccccCCC
Confidence 999999999987 345688999999999999999999999 9999999999999999999999999998765432
Q ss_pred cccccccccccccCcccCChhhhcccC---cCccccchhhhHHHHHHHhCCCCCCCCccCCCCchhHHHHHHHHHhcCcc
Q 038766 172 LQDLSSLSTAFQGTIGYLAPEFAYMRI---VTTKVDVFSFGIVVMEFLTKRRPTGLDEENGLSPISLRQLVEKALANGIN 248 (299)
Q Consensus 172 ~~~~~~~~~~~~~~~~y~~PE~~~~~~---~~~~~DiwslG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 248 (299)
............++..|+|||.+.+.. ++.++||||+|++++++++|..||.... .... ..... .. .
T Consensus 153 ~~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~~~~Dv~s~G~il~~l~~g~~pf~~~~----~~~~--~~~~~-~~-~-- 222 (264)
T cd06626 153 TTTMGEEVQSLAGTPAYMAPEVITGGKGKGHGRAADIWSLGCVVLEMATGKRPWSELD----NEFQ--IMFHV-GA-G-- 222 (264)
T ss_pred CCcccccccCCcCCcCccChhhccCCCCCCCCcccchHHHHHHHHHHHhCCCCccCCc----chHH--HHHHH-hc-C--
Confidence 221111122345678999999988766 8889999999999999999999995321 1111 11111 00 0
Q ss_pred CcccccCccccchhhHhHHHHHHHHHHHHHHHHhcCCCCCCCCChhhhhcC
Q 038766 249 GVRQITDPKLVSSIYEEQEQHQVLEELFKLALVCTSSNPEDRPNMNELLIT 299 (299)
Q Consensus 249 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rpt~~~il~~ 299 (299)
....++. ...++..+.++|.+||..+|++|||+++++.|
T Consensus 223 ~~~~~~~------------~~~~~~~~~~li~~~l~~~p~~R~~~~~i~~~ 261 (264)
T cd06626 223 HKPPIPD------------SLQLSPEGKDFLDRCLESDPKKRPTASELLQH 261 (264)
T ss_pred CCCCCCc------------ccccCHHHHHHHHHHccCCcccCCCHHHHhcC
Confidence 0001111 11235678899999999999999999999976
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 4 (MEKK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK4 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK4 activates the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4 |
| >cd05624 STKc_MRCK_beta Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase beta | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-40 Score=283.09 Aligned_cols=257 Identities=19% Similarity=0.235 Sum_probs=195.7
Q ss_pred CCCCCCceeecCCcceEEEEEeC-CCcEEEEEEeccCc-CChhhhHHHHHHHHHHHhcCCcceeeeeeEEEcCCCeeEEE
Q 038766 12 GSFSENNIIGNSNLSTVYKGRLE-DGEIVAVKKLNFHQ-FSAESDKSFYREAKTLKELKHRNLVKVLGYAWESGKLKALI 89 (299)
Q Consensus 12 ~~y~~~~~lg~g~~~~v~~~~~~-~~~~~~vK~~~~~~-~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~lv 89 (299)
++|.+.+.||+|+||+||++++. +++.||+|++.... ........+.+|..+++.+.|++|+++++.+.. ++..++|
T Consensus 1 d~y~i~~~lG~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~l~~~~~~-~~~~~lv 79 (331)
T cd05624 1 DDFEIIKVIGRGAFGEVAVVKMKHTERIYAMKILNKWEMLKRAETACFREERNVLVNGDCQWITTLHYAFQD-ENYLYLV 79 (331)
T ss_pred CCceEEEEEeeCCCeEEEEEEECCCCCEEEEEEEeHHHHHhhHHHHHHHHHHHHHHhCCCCCEeeEEEEEEc-CCEEEEE
Confidence 57999999999999999999875 58889999986422 122334557789999999999999999996554 5667999
Q ss_pred EeecCCCChHHHhcCCCCCCCCCChhhHHHHHHHHHHHHHHhhcCCCCCeeeecccCCceeeCCCCcEEEeeeccccccc
Q 038766 90 LEYMENGSLESVIHGPGVDHSRWTLPKRIDVLISVANGLDYLHSGYDIPIVHCDMKPSNILLDRDFEAHVSDFGTSRMLD 169 (299)
Q Consensus 90 ~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lh~~~~~~~~H~dl~~~nil~~~~~~v~l~df~~~~~~~ 169 (299)
+||+.+++|.+++... ...+++..+..++.|++.||+|||+. +++|+||||+||+++.++.++|+|||++....
T Consensus 80 ~Ey~~gg~L~~~l~~~---~~~l~~~~~~~~~~qi~~~L~~lH~~---~iiHrDlkp~Nill~~~~~~kl~DfG~a~~~~ 153 (331)
T cd05624 80 MDYYVGGDLLTLLSKF---EDRLPEDMARFYIAEMVLAIHSIHQL---HYVHRDIKPDNVLLDMNGHIRLADFGSCLKMN 153 (331)
T ss_pred EeCCCCCcHHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHHC---CeeeccCchHHEEEcCCCCEEEEeccceeecc
Confidence 9999999999998632 35789999999999999999999999 99999999999999999999999999987543
Q ss_pred cccccccccccccccCcccCChhhhcc-----cCcCccccchhhhHHHHHHHhCCCCCCCCccCCCCchhHHHHHHHHHh
Q 038766 170 VHLQDLSSLSTAFQGTIGYLAPEFAYM-----RIVTTKVDVFSFGIVVMEFLTKRRPTGLDEENGLSPISLRQLVEKALA 244 (299)
Q Consensus 170 ~~~~~~~~~~~~~~~~~~y~~PE~~~~-----~~~~~~~DiwslG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~ 244 (299)
... ........+++.|+|||.+.+ ..++.++|+||+|+++|+|++|..||.... . .+.......
T Consensus 154 ~~~---~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwSlGvil~ell~g~~Pf~~~~-----~---~~~~~~i~~ 222 (331)
T cd05624 154 QDG---TVQSSVAVGTPDYISPEILQAMEDGMGKYGPECDWWSLGVCMYEMLYGETPFYAES-----L---VETYGKIMN 222 (331)
T ss_pred CCC---ceeeccccCCcccCCHHHHhccccCCCCCCCcccEEeeehhhhhhhhCCCCccCCC-----H---HHHHHHHHc
Confidence 211 111223458899999998875 457889999999999999999999995331 1 112222111
Q ss_pred cCccCcccccCccccchhhHhHHHHHHHHHHHHHHHHhcCCCCCC--CCChhhhhcC
Q 038766 245 NGINGVRQITDPKLVSSIYEEQEQHQVLEELFKLALVCTSSNPED--RPNMNELLIT 299 (299)
Q Consensus 245 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~--Rpt~~~il~~ 299 (299)
.. .....+.. ...++.++.++|.+||..++++ |++++++++|
T Consensus 223 ~~----~~~~~p~~---------~~~~~~~~~~li~~ll~~~~~~~~~~~~~~~~~h 266 (331)
T cd05624 223 HE----ERFQFPSH---------ITDVSEEAKDLIQRLICSRERRLGQNGIEDFKKH 266 (331)
T ss_pred CC----CcccCCCc---------cccCCHHHHHHHHHHccCchhhcCCCCHHHHhcC
Confidence 10 00000000 1234568999999999876654 5689999876
|
Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) beta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKbeta is expressed ubiquitously in many tissues. |
| >cd05623 STKc_MRCK_alpha Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase alpha | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.8e-40 Score=282.45 Aligned_cols=257 Identities=20% Similarity=0.246 Sum_probs=194.7
Q ss_pred CCCCCCceeecCCcceEEEEEeC-CCcEEEEEEeccCcC-ChhhhHHHHHHHHHHHhcCCcceeeeeeEEEcCCCeeEEE
Q 038766 12 GSFSENNIIGNSNLSTVYKGRLE-DGEIVAVKKLNFHQF-SAESDKSFYREAKTLKELKHRNLVKVLGYAWESGKLKALI 89 (299)
Q Consensus 12 ~~y~~~~~lg~g~~~~v~~~~~~-~~~~~~vK~~~~~~~-~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~lv 89 (299)
++|.+.+.||+|+||+||++... +++.+|+|++..... .......+..|..++..+.|++|+++.+.+.. ....++|
T Consensus 1 ~~y~~~~~lG~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~-~~~~~lv 79 (332)
T cd05623 1 EDFEILKVIGRGAFGEVAVVKLKNADKVFAMKILNKWEMLKRAETACFREERDVLVNGDNQWITTLHYAFQD-ENNLYLV 79 (332)
T ss_pred CCceEEEEEEeCCCeEEEEEEECCCCCEEEEEEEeHHHHHHhhHHHHHHHHHHHHhhCCCCCEeeEEEEEec-CCEEEEE
Confidence 57999999999999999999865 478899999853221 22234457789999999999999999996554 5567999
Q ss_pred EeecCCCChHHHhcCCCCCCCCCChhhHHHHHHHHHHHHHHhhcCCCCCeeeecccCCceeeCCCCcEEEeeeccccccc
Q 038766 90 LEYMENGSLESVIHGPGVDHSRWTLPKRIDVLISVANGLDYLHSGYDIPIVHCDMKPSNILLDRDFEAHVSDFGTSRMLD 169 (299)
Q Consensus 90 ~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lh~~~~~~~~H~dl~~~nil~~~~~~v~l~df~~~~~~~ 169 (299)
+||+.+++|.+++... ...+++..+..++.|++.||.|||+. +++||||||+||+++.++.++|+|||++..+.
T Consensus 80 ~ey~~~g~L~~~l~~~---~~~l~~~~~~~~~~qi~~al~~lH~~---~iiHrDlkp~Nili~~~~~~kL~DfG~a~~~~ 153 (332)
T cd05623 80 MDYYVGGDLLTLLSKF---EDRLPEDMARFYLAEMVIAIDSVHQL---HYVHRDIKPDNILMDMNGHIRLADFGSCLKLM 153 (332)
T ss_pred EeccCCCcHHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHHC---CeEecCCCHHHEEECCCCCEEEeecchheecc
Confidence 9999999999998632 34689999999999999999999999 99999999999999999999999999986543
Q ss_pred cccccccccccccccCcccCChhhhc-----ccCcCccccchhhhHHHHHHHhCCCCCCCCccCCCCchhHHHHHHHHHh
Q 038766 170 VHLQDLSSLSTAFQGTIGYLAPEFAY-----MRIVTTKVDVFSFGIVVMEFLTKRRPTGLDEENGLSPISLRQLVEKALA 244 (299)
Q Consensus 170 ~~~~~~~~~~~~~~~~~~y~~PE~~~-----~~~~~~~~DiwslG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~ 244 (299)
.. .........+++.|+|||++. ...++.++|||||||++|+|++|..||.... ..+.......
T Consensus 154 ~~---~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DvwSlGvil~ell~g~~Pf~~~~--------~~~~~~~i~~ 222 (332)
T cd05623 154 ED---GTVQSSVAVGTPDYISPEILQAMEDGKGKYGPECDWWSLGVCMYEMLYGETPFYAES--------LVETYGKIMN 222 (332)
T ss_pred cC---CcceecccccCccccCHHHHhccccCCCCCCCcCCEEeeHHHHHHHhcCCCCCCCCC--------HHHHHHHHhC
Confidence 11 111122346899999999886 3457889999999999999999999995331 1122222211
Q ss_pred cCccCcccccCccccchhhHhHHHHHHHHHHHHHHHHhcCCCCCC--CCChhhhhcC
Q 038766 245 NGINGVRQITDPKLVSSIYEEQEQHQVLEELFKLALVCTSSNPED--RPNMNELLIT 299 (299)
Q Consensus 245 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~--Rpt~~~il~~ 299 (299)
.. .....+. ....++.++.+++++||..+|.+ |++++++++|
T Consensus 223 ~~----~~~~~p~---------~~~~~s~~~~~li~~ll~~~~~r~~r~~~~~~~~h 266 (332)
T cd05623 223 HK----ERFQFPA---------QVTDVSEDAKDLIRRLICSREHRLGQNGIEDFKQH 266 (332)
T ss_pred CC----ccccCCC---------ccccCCHHHHHHHHHHccChhhhcCCCCHHHHhCC
Confidence 10 0000000 02234678999999999765554 6899999987
|
Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKalpha is expressed ubiquitously in many tissues. It plays a role in the regulation of peripheral actin reorganization and neurite outgrowth. It may also play a role in the transferrin iron uptake pathw |
| >PHA03209 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-40 Score=285.66 Aligned_cols=267 Identities=18% Similarity=0.213 Sum_probs=191.4
Q ss_pred hCCCCCCceeecCCcceEEEEEeC-CCcEEEEEEeccCcCChhhhHHHHHHHHHHHhcCCcceeeeeeEEEcCCCeeEEE
Q 038766 11 TGSFSENNIIGNSNLSTVYKGRLE-DGEIVAVKKLNFHQFSAESDKSFYREAKTLKELKHRNLVKVLGYAWESGKLKALI 89 (299)
Q Consensus 11 ~~~y~~~~~lg~g~~~~v~~~~~~-~~~~~~vK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~lv 89 (299)
..+|.+.+.||+|++|.||++.+. ++..||+|+.... ....|+.++++++|+||+++++++.. +...++|
T Consensus 65 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~valK~~~~~--------~~~~E~~~l~~l~h~~iv~~~~~~~~-~~~~~lv 135 (357)
T PHA03209 65 SLGYTVIKTLTPGSEGRVFVATKPGQPDPVVLKIGQKG--------TTLIEAMLLQNVNHPSVIRMKDTLVS-GAITCMV 135 (357)
T ss_pred hcCcEEEEEecCCCCeEEEEEEECCCCceEEEEeCCcc--------ccHHHHHHHHhCCCCCCcChhheEEe-CCeeEEE
Confidence 347999999999999999999875 4788999975321 23468999999999999999997665 4566999
Q ss_pred EeecCCCChHHHhcCCCCCCCCCChhhHHHHHHHHHHHHHHhhcCCCCCeeeecccCCceeeCCCCcEEEeeeccccccc
Q 038766 90 LEYMENGSLESVIHGPGVDHSRWTLPKRIDVLISVANGLDYLHSGYDIPIVHCDMKPSNILLDRDFEAHVSDFGTSRMLD 169 (299)
Q Consensus 90 ~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lh~~~~~~~~H~dl~~~nil~~~~~~v~l~df~~~~~~~ 169 (299)
+|++. ++|.+++.. ....+++..++.++.||+.||.|||+. +++||||||+||+++.++.++|+|||++....
T Consensus 136 ~e~~~-~~l~~~l~~---~~~~~~~~~~~~i~~qi~~aL~~LH~~---~ivHrDlkp~Nill~~~~~~kl~DfG~a~~~~ 208 (357)
T PHA03209 136 LPHYS-SDLYTYLTK---RSRPLPIDQALIIEKQILEGLRYLHAQ---RIIHRDVKTENIFINDVDQVCIGDLGAAQFPV 208 (357)
T ss_pred EEccC-CcHHHHHHh---ccCCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHEEECCCCCEEEecCccccccc
Confidence 99995 588877653 345789999999999999999999999 99999999999999999999999999986432
Q ss_pred cccccccccccccccCcccCChhhhcccCcCccccchhhhHHHHHHHhCCCCCCCCccCCCC------chhHHHHHHHHH
Q 038766 170 VHLQDLSSLSTAFQGTIGYLAPEFAYMRIVTTKVDVFSFGIVVMEFLTKRRPTGLDEENGLS------PISLRQLVEKAL 243 (299)
Q Consensus 170 ~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~DiwslG~~l~~l~~g~~p~~~~~~~~~~------~~~~~~~~~~~~ 243 (299)
. ........+++.|+|||++.+..++.++|||||||++|+|+++..++......... ...+...+....
T Consensus 209 ~-----~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvvl~ell~~~~~~f~~~~~~~~~~~~~~~~~l~~~~~~~~ 283 (357)
T PHA03209 209 V-----APAFLGLAGTVETNAPEVLARDKYNSKADIWSAGIVLFEMLAYPSTIFEDPPSTPEEYVKSCHSHLLKIISTLK 283 (357)
T ss_pred c-----CcccccccccccccCCeecCCCCCCchhhHHHHHHHHHHHHHcCCccccCCCCcHHHHHHHHHHHHHHHHHHhc
Confidence 1 11223445789999999999989999999999999999999866655332111100 001111111100
Q ss_pred hcCccCcccccCccccc-------------hhhHhHHHHHHHHHHHHHHHHhcCCCCCCCCChhhhhcC
Q 038766 244 ANGINGVRQITDPKLVS-------------SIYEEQEQHQVLEELFKLALVCTSSNPEDRPNMNELLIT 299 (299)
Q Consensus 244 ~~~~~~~~~~~~~~~~~-------------~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rpt~~~il~~ 299 (299)
................ ..........++.++.++|.+||+.||++|||++|+|+|
T Consensus 284 -~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~Rpta~e~l~h 351 (357)
T PHA03209 284 -VHPEEFPRDPGSRLVRGFIEYASLERQPYTRYPCFQRVNLPIDGEFLVHKMLTFDAAMRPSAEEILNY 351 (357)
T ss_pred -cChhhcCCCCccHHHHHHHhhcccCCCcccccHHHhccCCCchHHHHHHHHHcCCcccCcCHHHHhcC
Confidence 0000000000000000 000001112345677889999999999999999999987
|
|
| >cd07865 STKc_CDK9 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 9 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.7e-40 Score=278.42 Aligned_cols=278 Identities=22% Similarity=0.281 Sum_probs=199.5
Q ss_pred HhCCCCCCceeecCCcceEEEEEeC-CCcEEEEEEeccCcCChhhhHHHHHHHHHHHhcCCcceeeeeeEEEcCC-----
Q 038766 10 ATGSFSENNIIGNSNLSTVYKGRLE-DGEIVAVKKLNFHQFSAESDKSFYREAKTLKELKHRNLVKVLGYAWESG----- 83 (299)
Q Consensus 10 ~~~~y~~~~~lg~g~~~~v~~~~~~-~~~~~~vK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~----- 83 (299)
..++|.+.+.||+|++|.||++.+. +++.||+|++..............+|++.+++++||||+++++++...+
T Consensus 10 ~~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~aik~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~ 89 (310)
T cd07865 10 EVSKYEKLAKIGQGTFGEVFKARHKKTKQIVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEICRTKATPYNR 89 (310)
T ss_pred hhhheEEEEEeecCCCEEEEEEEECCCCcEEEEEEEeccCCcCCchhHHHHHHHHHHhCCCCCccceEEEEecccccccC
Confidence 4568999999999999999999874 5899999998654434444456678999999999999999999775432
Q ss_pred --CeeEEEEeecCCCChHHHhcCCCCCCCCCChhhHHHHHHHHHHHHHHhhcCCCCCeeeecccCCceeeCCCCcEEEee
Q 038766 84 --KLKALILEYMENGSLESVIHGPGVDHSRWTLPKRIDVLISVANGLDYLHSGYDIPIVHCDMKPSNILLDRDFEAHVSD 161 (299)
Q Consensus 84 --~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lh~~~~~~~~H~dl~~~nil~~~~~~v~l~d 161 (299)
...++|+||+. ++|.+.+.. ....+++.+++.++.|+++||.|||++ +++|+||+|+||+++.++.++|+|
T Consensus 90 ~~~~~~lv~e~~~-~~l~~~l~~---~~~~~~~~~~~~i~~qi~~al~~lH~~---~i~H~dl~p~nil~~~~~~~kl~d 162 (310)
T cd07865 90 YKGSFYLVFEFCE-HDLAGLLSN---KNVKFTLSEIKKVMKMLLNGLYYIHRN---KILHRDMKAANILITKDGILKLAD 162 (310)
T ss_pred CCceEEEEEcCCC-cCHHHHHHh---cccCCCHHHHHHHHHHHHHHHHHHHHC---CeeccCCCHHHEEECCCCcEEECc
Confidence 34589999995 488877753 234689999999999999999999999 999999999999999999999999
Q ss_pred eccccccccccccccccccccccCcccCChhhhccc-CcCccccchhhhHHHHHHHhCCCCCCCCccCCCCchhHHHHHH
Q 038766 162 FGTSRMLDVHLQDLSSLSTAFQGTIGYLAPEFAYMR-IVTTKVDVFSFGIVVMEFLTKRRPTGLDEENGLSPISLRQLVE 240 (299)
Q Consensus 162 f~~~~~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~-~~~~~~DiwslG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~ 240 (299)
||++..................++..|+|||.+.+. .++.++|+||+|+++|+|++|..||..... ......+.
T Consensus 163 fg~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~el~t~~~~~~~~~~-----~~~~~~~~ 237 (310)
T cd07865 163 FGLARAFSLSKNSKPNRYTNRVVTLWYRPPELLLGERDYGPPIDMWGAGCIMAEMWTRSPIMQGNTE-----QHQLTLIS 237 (310)
T ss_pred CCCcccccCCcccCCCCccCcccCccccCcHHhcCCcccCchhhhHHHHHHHHHHHhCCCCCCCCCH-----HHHHHHHH
Confidence 999976543222211222344567889999987664 368899999999999999999999854321 11112222
Q ss_pred HHHhcCccCc-------ccc---cCccccc-hhhHhHHHHHHHHHHHHHHHHhcCCCCCCCCChhhhhcC
Q 038766 241 KALANGINGV-------RQI---TDPKLVS-SIYEEQEQHQVLEELFKLALVCTSSNPEDRPNMNELLIT 299 (299)
Q Consensus 241 ~~~~~~~~~~-------~~~---~~~~~~~-~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rpt~~~il~~ 299 (299)
.......... ... ..+.... ...........+..+.++|.+||..||++|||++++|+|
T Consensus 238 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~dli~~~l~~~P~~R~t~~e~l~h 307 (310)
T cd07865 238 QLCGSITPEVWPGVDKLELFKKMELPQGQKRKVKERLKPYVKDPHALDLIDKLLVLDPAKRIDADTALNH 307 (310)
T ss_pred HHhCCCChhhcccccchhhhhhccCCCccchhhHHhcccccCCHHHHHHHHHHhcCChhhccCHHHHhcC
Confidence 2111100000 000 0000000 000000001123567899999999999999999999987
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK9 together with a cyclin partner (cyclin T1, T2a, T2b, or K) is the main component of distinct positive transcription elongation factors (P-TEFb), which function as Ser2 C-terminal domain kinases of RNA polymerase II. P-TEFb participates in multipl |
| >cd05053 PTKc_FGFR Catalytic domain of the Protein Tyrosine Kinases, Fibroblast Growth Factor Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-40 Score=279.60 Aligned_cols=261 Identities=23% Similarity=0.371 Sum_probs=200.1
Q ss_pred HHHHHhCCCCCCceeecCCcceEEEEEeC------CCcEEEEEEeccCcCChhhhHHHHHHHHHHHhc-CCcceeeeeeE
Q 038766 6 EIENATGSFSENNIIGNSNLSTVYKGRLE------DGEIVAVKKLNFHQFSAESDKSFYREAKTLKEL-KHRNLVKVLGY 78 (299)
Q Consensus 6 ~~~~~~~~y~~~~~lg~g~~~~v~~~~~~------~~~~~~vK~~~~~~~~~~~~~~~~~e~~~l~~l-~h~~i~~~~~~ 78 (299)
+++.-.++|.+.+.||+|++|.||++.+. +...+++|.+... ........+.+|+..++.+ +|+||++++++
T Consensus 6 ~~~~~~~~~~~~~~ig~g~~g~v~~~~~~~~~~~~~~~~~a~k~~~~~-~~~~~~~~~~~E~~~l~~l~~h~~i~~~~~~ 84 (293)
T cd05053 6 EWELPRDRLTLGKPLGEGAFGQVVKAEAVGLDNPNETSTVAVKMLKDD-ATEKDLSDLVSEMEMMKMIGKHKNIINLLGV 84 (293)
T ss_pred ccccCHhHeEEeeEecccccccEEEEEEecCCCCCCceeEEEEEccCC-CCHHHHHHHHHHHHHHHhhcCCCCeeeEEEE
Confidence 45666788999999999999999999753 2467999988643 2333456688999999999 79999999997
Q ss_pred EEcCCCeeEEEEeecCCCChHHHhcCCC------------CCCCCCChhhHHHHHHHHHHHHHHhhcCCCCCeeeecccC
Q 038766 79 AWESGKLKALILEYMENGSLESVIHGPG------------VDHSRWTLPKRIDVLISVANGLDYLHSGYDIPIVHCDMKP 146 (299)
Q Consensus 79 ~~~~~~~~~lv~e~~~~~~L~~~~~~~~------------~~~~~~~~~~~~~i~~qi~~~l~~lh~~~~~~~~H~dl~~ 146 (299)
+.. +...++++||+.+++|..++.... .....+++..++.++.|++.||+|||++ +++|+||||
T Consensus 85 ~~~-~~~~~li~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~---~ivH~dlkp 160 (293)
T cd05053 85 CTQ-EGPLYVVVEYAAHGNLRDFLRARRPPGEYASPDDPRPPEETLTQKDLVSFAYQVARGMEFLASK---KCIHRDLAA 160 (293)
T ss_pred EcC-CCCeEEEEEeCCCCcHHHHHHhcCCCccccccccccccccccCHHHHHHHHHHHHHHHHHHHHC---Cccccccce
Confidence 665 445699999999999999886421 2345789999999999999999999999 999999999
Q ss_pred CceeeCCCCcEEEeeeccccccccccccccccccccccCcccCChhhhcccCcCccccchhhhHHHHHHHh-CCCCCCCC
Q 038766 147 SNILLDRDFEAHVSDFGTSRMLDVHLQDLSSLSTAFQGTIGYLAPEFAYMRIVTTKVDVFSFGIVVMEFLT-KRRPTGLD 225 (299)
Q Consensus 147 ~nil~~~~~~v~l~df~~~~~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~DiwslG~~l~~l~~-g~~p~~~~ 225 (299)
+||+++.++.++|+|||.+..+.... .........++..|+|||.+.+..++.++|||||||++|+|++ |..||...
T Consensus 161 ~Nil~~~~~~~kL~Dfg~~~~~~~~~--~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~ 238 (293)
T cd05053 161 RNVLVTEDHVMKIADFGLARDIHHID--YYRKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLLWEIFTLGGSPYPGI 238 (293)
T ss_pred eeEEEcCCCeEEeCcccccccccccc--ceeccCCCCCCccccCHHHhccCCcCcccceeehhhHHHHHhcCCCCCCCCC
Confidence 99999999999999999987654211 1111122234567999999988889999999999999999997 88887432
Q ss_pred ccCCCCchhHHHHHHHHHhcCccCcccccCccccchhhHhHHHHHHHHHHHHHHHHhcCCCCCCCCChhhhhc
Q 038766 226 EENGLSPISLRQLVEKALANGINGVRQITDPKLVSSIYEEQEQHQVLEELFKLALVCTSSNPEDRPNMNELLI 298 (299)
Q Consensus 226 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rpt~~~il~ 298 (299)
........+ .... .... +...+..+.+++.+||..||++|||++++++
T Consensus 239 -----~~~~~~~~~----~~~~----~~~~------------~~~~~~~~~~li~~~l~~~p~~Rps~~eil~ 286 (293)
T cd05053 239 -----PVEELFKLL----KEGY----RMEK------------PQNCTQELYHLMRDCWHEVPSQRPTFKQLVE 286 (293)
T ss_pred -----CHHHHHHHH----HcCC----cCCC------------CCCCCHHHHHHHHHHcccCcccCcCHHHHHH
Confidence 111111111 1110 0000 1123457899999999999999999999986
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor (FGFR) subfamily; catalytic (c) domain. The FGFR subfamily consists of FGFR1, FGFR2, FGFR3, FGFR4, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K).PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, and to heparin/heparan sulfate (HS) results in the formation of a ternary complex, which leads to receptor dimerization and activation, |
| >cd07843 STKc_CDC2L1 Catalytic domain of the Serine/Threonine Kinase, Cell Division Cycle 2-like 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.9e-40 Score=276.66 Aligned_cols=272 Identities=25% Similarity=0.294 Sum_probs=200.1
Q ss_pred CCCCCCceeecCCcceEEEEEeC-CCcEEEEEEeccCcCChhhhHHHHHHHHHHHhcCCcceeeeeeEEEcCC-CeeEEE
Q 038766 12 GSFSENNIIGNSNLSTVYKGRLE-DGEIVAVKKLNFHQFSAESDKSFYREAKTLKELKHRNLVKVLGYAWESG-KLKALI 89 (299)
Q Consensus 12 ~~y~~~~~lg~g~~~~v~~~~~~-~~~~~~vK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~-~~~~lv 89 (299)
++|.+.+.||.|++|.||+|.+. +++.+++|.+............+.+|+..+++++||||+++++++.... ...++|
T Consensus 5 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~~~lv 84 (293)
T cd07843 5 DEYEKLNRIEEGTYGVVYRARDKKTGEIVALKKLKMEKEKEGFPITSLREINILLKLQHPNIVTVKEVVVGSNLDKIYMV 84 (293)
T ss_pred hhhhhhhhhcCCCCeEEEEEEECCCCcEEEEEEEeeccccccchhhHHHHHHHHHhcCCCCEEEEEEEEEecCCCcEEEE
Confidence 57999999999999999999875 5889999999765544444456778999999999999999999776542 677999
Q ss_pred EeecCCCChHHHhcCCCCCCCCCChhhHHHHHHHHHHHHHHhhcCCCCCeeeecccCCceeeCCCCcEEEeeeccccccc
Q 038766 90 LEYMENGSLESVIHGPGVDHSRWTLPKRIDVLISVANGLDYLHSGYDIPIVHCDMKPSNILLDRDFEAHVSDFGTSRMLD 169 (299)
Q Consensus 90 ~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lh~~~~~~~~H~dl~~~nil~~~~~~v~l~df~~~~~~~ 169 (299)
+||+.+ +|.+++... ...+++..++.++.|++.||+|||+. +++|+||+|+||+++.++.++|+|||++....
T Consensus 85 ~e~~~~-~L~~~~~~~---~~~l~~~~~~~i~~qi~~aL~~LH~~---~i~H~dl~p~nili~~~~~~~l~d~g~~~~~~ 157 (293)
T cd07843 85 MEYVEH-DLKSLMETM---KQPFLQSEVKCLMLQLLSGVAHLHDN---WILHRDLKTSNLLLNNRGILKICDFGLAREYG 157 (293)
T ss_pred ehhcCc-CHHHHHHhc---cCCCCHHHHHHHHHHHHHHHHHHHHC---CeeeccCCHHHEEECCCCcEEEeecCceeecc
Confidence 999964 898888642 23689999999999999999999999 99999999999999999999999999887654
Q ss_pred cccccccccccccccCcccCChhhhccc-CcCccccchhhhHHHHHHHhCCCCCCCCccCCCCchhHHHHHHHHHhcC--
Q 038766 170 VHLQDLSSLSTAFQGTIGYLAPEFAYMR-IVTTKVDVFSFGIVVMEFLTKRRPTGLDEENGLSPISLRQLVEKALANG-- 246 (299)
Q Consensus 170 ~~~~~~~~~~~~~~~~~~y~~PE~~~~~-~~~~~~DiwslG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~-- 246 (299)
... .......+++.|+|||.+.+. .++.++|+||||+++++|++|..||..... ......+.......
T Consensus 158 ~~~----~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~~f~~~~~-----~~~~~~~~~~~~~~~~ 228 (293)
T cd07843 158 SPL----KPYTQLVVTLWYRAPELLLGAKEYSTAIDMWSVGCIFAELLTKKPLFPGKSE-----IDQLNKIFKLLGTPTE 228 (293)
T ss_pred CCc----cccccccccccccCchhhcCCccccchhhHHHHHHHHHHHHhCCCCCCCCCh-----HHHHHHHHHHhCCCch
Confidence 221 112233467889999988764 468899999999999999999999854321 11111111100000
Q ss_pred --cc---Cccccc---CccccchhhHhHHHHH-HHHHHHHHHHHhcCCCCCCCCChhhhhcC
Q 038766 247 --IN---GVRQIT---DPKLVSSIYEEQEQHQ-VLEELFKLALVCTSSNPEDRPNMNELLIT 299 (299)
Q Consensus 247 --~~---~~~~~~---~~~~~~~~~~~~~~~~-~~~~l~~li~~~l~~dP~~Rpt~~~il~~ 299 (299)
++ ...... .............+.. +++.+.++|.+||+.+|++|||++|+|+|
T Consensus 229 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~R~t~~ell~~ 290 (293)
T cd07843 229 KIWPGFSELPGAKKKTFTKYPYNQLRKKFPALSLSDNGFDLLNRLLTYDPAKRISAEDALKH 290 (293)
T ss_pred HHHHHhhccchhcccccccccchhhhccccccCCChHHHHHHHHHhccCccccCCHHHHhcC
Confidence 00 000000 0000000001111222 46789999999999999999999999987
|
Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 1 (CDC2L1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L1, also called PITSLRE, exists in different isoforms which are named using the alias CDK11(p). The CDC2L1 gene produces two protein products, CDK11(p110) and CDK11(p58). CDC2L1 is also represented by the caspase-processed CDK11(p46). CDK11(p110), the |
| >cd05578 STKc_Yank1 Catalytic domain of the Protein Serine/Threonine Kinase, Yank1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-40 Score=275.55 Aligned_cols=251 Identities=23% Similarity=0.307 Sum_probs=201.7
Q ss_pred CCCCCceeecCCcceEEEEEeC-CCcEEEEEEeccCcCCh-hhhHHHHHHHHHHHhcCCcceeeeeeEEEcCCCeeEEEE
Q 038766 13 SFSENNIIGNSNLSTVYKGRLE-DGEIVAVKKLNFHQFSA-ESDKSFYREAKTLKELKHRNLVKVLGYAWESGKLKALIL 90 (299)
Q Consensus 13 ~y~~~~~lg~g~~~~v~~~~~~-~~~~~~vK~~~~~~~~~-~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~lv~ 90 (299)
+|.+.+.||.|++|.||++.+. +++.+++|++....... ...+.+.+|++.+++++||||+++++.+ ..+...++|+
T Consensus 1 ~y~~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~-~~~~~~~lv~ 79 (258)
T cd05578 1 HFELLRVIGKGAFGKVCIVQKRDTKKMFAMKYMNKQKCVEKGSVRNVLNERRILQELNHPFLVNLWYSF-QDEENMYLVV 79 (258)
T ss_pred CceEEEEeccCCCceEEEEEEccCCcEEEEEEEehhhhcchhHHHHHHHHHHHHHhCCCCChHHHHHhh-cCCCeEEEEE
Confidence 5889999999999999999875 58999999987543322 4567889999999999999999999955 4466779999
Q ss_pred eecCCCChHHHhcCCCCCCCCCChhhHHHHHHHHHHHHHHhhcCCCCCeeeecccCCceeeCCCCcEEEeeecccccccc
Q 038766 91 EYMENGSLESVIHGPGVDHSRWTLPKRIDVLISVANGLDYLHSGYDIPIVHCDMKPSNILLDRDFEAHVSDFGTSRMLDV 170 (299)
Q Consensus 91 e~~~~~~L~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lh~~~~~~~~H~dl~~~nil~~~~~~v~l~df~~~~~~~~ 170 (299)
||+.+++|...+. ...++++..+..++.|+++||.|||++ +++|+||+|+||+++.++.++|+|||.+.....
T Consensus 80 e~~~~~~L~~~l~----~~~~l~~~~~~~~~~~i~~~l~~lh~~---~i~h~dl~~~nil~~~~~~~~l~d~~~~~~~~~ 152 (258)
T cd05578 80 DLLLGGDLRYHLS----QKVKFSEEQVKFWICEIVLALEYLHSK---GIIHRDIKPDNILLDEQGHVHITDFNIATKVTP 152 (258)
T ss_pred eCCCCCCHHHHHH----hcCCcCHHHHHHHHHHHHHHHHHHHhC---CeeccCCCHHHeEEcCCCCEEEeecccccccCC
Confidence 9999999999986 335889999999999999999999999 999999999999999999999999999876542
Q ss_pred ccccccccccccccCcccCChhhhcccCcCccccchhhhHHHHHHHhCCCCCCCCccCCCCchhHHHHHHHHHhcCccCc
Q 038766 171 HLQDLSSLSTAFQGTIGYLAPEFAYMRIVTTKVDVFSFGIVVMEFLTKRRPTGLDEENGLSPISLRQLVEKALANGINGV 250 (299)
Q Consensus 171 ~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~DiwslG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 250 (299)
. .......++..|+|||.+....++.++|+||||+++|+|++|..||...... ...... ...... .
T Consensus 153 ~-----~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~-----~~~~~~-~~~~~~---~ 218 (258)
T cd05578 153 D-----TLTTSTSGTPGYMAPEVLCRQGYSVAVDWWSLGVTAYECLRGKRPYRGHSRT-----IRDQIR-AKQETA---D 218 (258)
T ss_pred C-----ccccccCCChhhcCHHHHcccCCCCcccchhhHHHHHHHHhCCCCCCCCCcc-----HHHHHH-HHhccc---c
Confidence 1 1223345678899999999888999999999999999999999998644221 111111 111100 0
Q ss_pred ccccCccccchhhHhHHHHHHHHHHHHHHHHhcCCCCCCCCCh--hhhhcC
Q 038766 251 RQITDPKLVSSIYEEQEQHQVLEELFKLALVCTSSNPEDRPNM--NELLIT 299 (299)
Q Consensus 251 ~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rpt~--~~il~~ 299 (299)
...+...+..+.++|.+||..||.+||++ +++++|
T Consensus 219 --------------~~~~~~~~~~~~~~i~~~l~~~p~~R~~~~~~~l~~~ 255 (258)
T cd05578 219 --------------VLYPATWSTEAIDAINKLLERDPQKRLGDNLKDLKNH 255 (258)
T ss_pred --------------ccCcccCcHHHHHHHHHHccCChhHcCCccHHHHhcC
Confidence 00122345789999999999999999999 999876
|
Serine/Threonine Kinases (STKs), Yank1 or STK32A subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Yank1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily contains uncharacterized STKs with similarity to the human protein designated Yank1 or STK32A. |
| >cd06643 STKc_SLK Catalytic domain of the Protein Serine/Threonine Kinase, Ste20-like kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.6e-40 Score=274.87 Aligned_cols=250 Identities=24% Similarity=0.347 Sum_probs=194.7
Q ss_pred CCCCceeecCCcceEEEEEeC-CCcEEEEEEeccCcCChhhhHHHHHHHHHHHhcCCcceeeeeeEEEcCCCeeEEEEee
Q 038766 14 FSENNIIGNSNLSTVYKGRLE-DGEIVAVKKLNFHQFSAESDKSFYREAKTLKELKHRNLVKVLGYAWESGKLKALILEY 92 (299)
Q Consensus 14 y~~~~~lg~g~~~~v~~~~~~-~~~~~~vK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~lv~e~ 92 (299)
|++.+.||+|++|.||++.+. ++..+++|.+... .......+.+|++.++.+.|+|++++++.+.. +...++|+||
T Consensus 7 ~~i~~~lg~g~~g~v~~~~~~~~~~~~~~k~~~~~--~~~~~~~~~~e~~~l~~l~h~~ii~~~~~~~~-~~~~~~v~e~ 83 (282)
T cd06643 7 WEIIGELGDGAFGKVYKAQNKETGVLAAAKVIDTK--SEEELEDYMVEIDILASCDHPNIVKLLDAFYY-ENNLWILIEF 83 (282)
T ss_pred HHHHhhcccCCCeEEEEEEECCCCeEEEEEEeCCC--CHHHHHHHHHHHHHHHHCCCCCeeeEEEEEee-CCEEEEEEEe
Confidence 678899999999999999875 4778899987532 34456678889999999999999999997665 5566999999
Q ss_pred cCCCChHHHhcCCCCCCCCCChhhHHHHHHHHHHHHHHhhcCCCCCeeeecccCCceeeCCCCcEEEeeecccccccccc
Q 038766 93 MENGSLESVIHGPGVDHSRWTLPKRIDVLISVANGLDYLHSGYDIPIVHCDMKPSNILLDRDFEAHVSDFGTSRMLDVHL 172 (299)
Q Consensus 93 ~~~~~L~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lh~~~~~~~~H~dl~~~nil~~~~~~v~l~df~~~~~~~~~~ 172 (299)
+.+++|..++.. ...++++..+..++.|+++||.|||+. +++|+||+|+||+++.++.++|+|||++......
T Consensus 84 ~~~~~l~~~~~~---~~~~l~~~~~~~~~~qi~~~L~~LH~~---~i~H~dlkp~nili~~~~~~kl~dfg~~~~~~~~- 156 (282)
T cd06643 84 CAGGAVDAVMLE---LERPLTEPQIRVVCKQTLEALNYLHEN---KIIHRDLKAGNILFTLDGDIKLADFGVSAKNTRT- 156 (282)
T ss_pred cCCCcHHHHHHh---cCCCCCHHHHHHHHHHHHHHHHHHHHC---CeeecCCCcccEEEccCCCEEEcccccccccccc-
Confidence 999999887752 235789999999999999999999999 9999999999999999999999999998654311
Q ss_pred ccccccccccccCcccCChhhhc-----ccCcCccccchhhhHHHHHHHhCCCCCCCCccCCCCchhHHHHHHHHHhcCc
Q 038766 173 QDLSSLSTAFQGTIGYLAPEFAY-----MRIVTTKVDVFSFGIVVMEFLTKRRPTGLDEENGLSPISLRQLVEKALANGI 247 (299)
Q Consensus 173 ~~~~~~~~~~~~~~~y~~PE~~~-----~~~~~~~~DiwslG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 247 (299)
........+++.|+|||.+. ...++.++|+||+||++|+|++|..||.... .. ...........
T Consensus 157 ---~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slGvil~el~~g~~p~~~~~-----~~---~~~~~~~~~~~ 225 (282)
T cd06643 157 ---IQRRDSFIGTPYWMAPEVVMCETSKDRPYDYKADVWSLGITLIEMAQIEPPHHELN-----PM---RVLLKIAKSEP 225 (282)
T ss_pred ---ccccccccccccccCHhhccccCCCCCCCCccchhhhHHHHHHHHccCCCCccccC-----HH---HHHHHHhhcCC
Confidence 11223345788999999874 3457789999999999999999999984321 11 11111111110
Q ss_pred cCcccccCccccchhhHhHHHHHHHHHHHHHHHHhcCCCCCCCCChhhhhcC
Q 038766 248 NGVRQITDPKLVSSIYEEQEQHQVLEELFKLALVCTSSNPEDRPNMNELLIT 299 (299)
Q Consensus 248 ~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rpt~~~il~~ 299 (299)
. .... +..++.++.++|.+||..+|.+|||++++++|
T Consensus 226 ~---~~~~------------~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~ 262 (282)
T cd06643 226 P---TLAQ------------PSRWSSEFKDFLKKCLEKNVDARWTTTQLLQH 262 (282)
T ss_pred C---CCCC------------ccccCHHHHHHHHHHccCChhhCcCHHHHhcC
Confidence 0 0001 22345689999999999999999999999986
|
Serine/threonine kinases (STKs), Ste20-like kinase (SLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It acts as a MAPK kinase kinase (MAPKKK) by phosphorylating ASK1, resulting in the phosphorylation of p38. SLK also plays a role in mediating actin reorganization. It is part of a microtubule-associated complex that is targeted at adhesion sites, and is required in focal adhesion turnover and in regulating cell migration. |
| >cd06636 STKc_MAP4K4_6 Catalytic domain of the Protein Serine/Threonine Kinases, Mitogen-Activated Protein Kinase Kinase Kinase Kinase 4 and 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.3e-40 Score=276.70 Aligned_cols=258 Identities=24% Similarity=0.374 Sum_probs=199.7
Q ss_pred HHHHHhCCCCCCceeecCCcceEEEEEe-CCCcEEEEEEeccCcCChhhhHHHHHHHHHHHhc-CCcceeeeeeEEEc--
Q 038766 6 EIENATGSFSENNIIGNSNLSTVYKGRL-EDGEIVAVKKLNFHQFSAESDKSFYREAKTLKEL-KHRNLVKVLGYAWE-- 81 (299)
Q Consensus 6 ~~~~~~~~y~~~~~lg~g~~~~v~~~~~-~~~~~~~vK~~~~~~~~~~~~~~~~~e~~~l~~l-~h~~i~~~~~~~~~-- 81 (299)
+.....+.|.+.+.||.|++|.||++.+ .+++.+++|++... ......+..|+..++++ .|+|++++++.+..
T Consensus 10 ~~~~~~~~~~~~~~lg~g~~~~v~~~~~~~~~~~~a~K~~~~~---~~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~ 86 (282)
T cd06636 10 ALRDPAGIFELVEVVGNGTYGQVYKGRHVKTGQLAAIKVMDVT---EDEEEEIKLEINMLKKYSHHRNIATYYGAFIKKS 86 (282)
T ss_pred hhcChhhhhhhheeeccCCCeEEEEEEEcCCCcEEEEEEEecC---hHHHHHHHHHHHHHHHhcCCCcEEEEeeehhccc
Confidence 3344568999999999999999999987 45889999988532 23446678899999998 59999999997753
Q ss_pred ---CCCeeEEEEeecCCCChHHHhcCCCCCCCCCChhhHHHHHHHHHHHHHHhhcCCCCCeeeecccCCceeeCCCCcEE
Q 038766 82 ---SGKLKALILEYMENGSLESVIHGPGVDHSRWTLPKRIDVLISVANGLDYLHSGYDIPIVHCDMKPSNILLDRDFEAH 158 (299)
Q Consensus 82 ---~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lh~~~~~~~~H~dl~~~nil~~~~~~v~ 158 (299)
.+...++++||+.+++|.+++... ....+++..++.++.|++.||+|||+. +++|+||+|+||+++.++.++
T Consensus 87 ~~~~~~~~~iv~e~~~~~~L~~~~~~~--~~~~~~~~~~~~~~~qi~~al~~LH~~---~ivH~dl~~~nili~~~~~~~ 161 (282)
T cd06636 87 PPGHDDQLWLVMEFCGAGSVTDLVKNT--KGNALKEDWIAYICREILRGLAHLHAH---KVIHRDIKGQNVLLTENAEVK 161 (282)
T ss_pred ccCCCCEEEEEEEeCCCCcHHHHHHHc--cCCCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCHHHEEECCCCCEE
Confidence 245679999999999999988643 234578888999999999999999999 999999999999999999999
Q ss_pred EeeeccccccccccccccccccccccCcccCChhhhc-----ccCcCccccchhhhHHHHHHHhCCCCCCCCccCCCCch
Q 038766 159 VSDFGTSRMLDVHLQDLSSLSTAFQGTIGYLAPEFAY-----MRIVTTKVDVFSFGIVVMEFLTKRRPTGLDEENGLSPI 233 (299)
Q Consensus 159 l~df~~~~~~~~~~~~~~~~~~~~~~~~~y~~PE~~~-----~~~~~~~~DiwslG~~l~~l~~g~~p~~~~~~~~~~~~ 233 (299)
|+|||++...... ........+++.|+|||.+. ...++.++|+||||+++|+|++|..||..... .
T Consensus 162 l~dfg~~~~~~~~----~~~~~~~~~~~~y~aPE~l~~~~~~~~~~~~~~DvwslG~~l~el~~g~~p~~~~~~-----~ 232 (282)
T cd06636 162 LVDFGVSAQLDRT----VGRRNTFIGTPYWMAPEVIACDENPDATYDYRSDIWSLGITAIEMAEGAPPLCDMHP-----M 232 (282)
T ss_pred EeeCcchhhhhcc----ccCCCcccccccccCHhhcCcccCcCcCCCcccchhHHHHHHHHHHhCCCCccccCH-----H
Confidence 9999988754311 11223445788999999876 34578899999999999999999999853211 0
Q ss_pred hHHHHHHHHHhcCccCcccccCccccchhhHhHHHHHHHHHHHHHHHHhcCCCCCCCCChhhhhcC
Q 038766 234 SLRQLVEKALANGINGVRQITDPKLVSSIYEEQEQHQVLEELFKLALVCTSSNPEDRPNMNELLIT 299 (299)
Q Consensus 234 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rpt~~~il~~ 299 (299)
.......... .+. .....++.++.++|++||..||.+|||+.++|+|
T Consensus 233 ---~~~~~~~~~~--------~~~--------~~~~~~~~~~~~li~~cl~~~p~~Rp~~~ell~~ 279 (282)
T cd06636 233 ---RALFLIPRNP--------PPK--------LKSKKWSKKFIDFIEGCLVKNYLSRPSTEQLLKH 279 (282)
T ss_pred ---hhhhhHhhCC--------CCC--------CcccccCHHHHHHHHHHhCCChhhCcCHHHHhcC
Confidence 0000000000 000 0022355689999999999999999999999987
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 4 (MAPKKKK4 or MAP4K4) and MAPKKKK6 (or MAP4K6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K4/MAP4K6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain. MAP4Ks (or MAPKKKKs) are involved in MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Ea |
| >cd07846 STKc_CDKL2_3 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 2 and 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-40 Score=277.96 Aligned_cols=271 Identities=26% Similarity=0.365 Sum_probs=200.3
Q ss_pred CCCCCCceeecCCcceEEEEEeC-CCcEEEEEEeccCcCChhhhHHHHHHHHHHHhcCCcceeeeeeEEEcCCCeeEEEE
Q 038766 12 GSFSENNIIGNSNLSTVYKGRLE-DGEIVAVKKLNFHQFSAESDKSFYREAKTLKELKHRNLVKVLGYAWESGKLKALIL 90 (299)
Q Consensus 12 ~~y~~~~~lg~g~~~~v~~~~~~-~~~~~~vK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~lv~ 90 (299)
++|.+.+.||+|++|.||++.+. +++.+|+|++..........+.+.+|++.++.++||||+++++++.. +...++|+
T Consensus 1 ~~y~~~~~lg~g~~~~vy~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~-~~~~~lv~ 79 (286)
T cd07846 1 EKYENLGLVGEGSYGMVMKCKHKETGQIVAIKKFLESEDDKMVKKIAMREIRMLKQLRHENLVNLIEVFRR-KKRLYLVF 79 (286)
T ss_pred CceeEeeeeccCCCeEEEEEEECCCCCEEEEEeHhhccCcchhhHHHHHHHHHHHhcCCcchhhHHHhccc-CCeEEEEE
Confidence 57899999999999999999875 58999999986544444445678899999999999999999997654 55679999
Q ss_pred eecCCCChHHHhcCCCCCCCCCChhhHHHHHHHHHHHHHHhhcCCCCCeeeecccCCceeeCCCCcEEEeeecccccccc
Q 038766 91 EYMENGSLESVIHGPGVDHSRWTLPKRIDVLISVANGLDYLHSGYDIPIVHCDMKPSNILLDRDFEAHVSDFGTSRMLDV 170 (299)
Q Consensus 91 e~~~~~~L~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lh~~~~~~~~H~dl~~~nil~~~~~~v~l~df~~~~~~~~ 170 (299)
||+.+++|..+.. ....+++..++.++.|++.||+|||+. +++|+||+|+||+++.++.++|+|||++.....
T Consensus 80 e~~~~~~l~~~~~----~~~~~~~~~~~~~~~~i~~~l~~LH~~---~i~h~~l~p~ni~~~~~~~~~l~dfg~~~~~~~ 152 (286)
T cd07846 80 EFVDHTVLDDLEK----YPNGLDESRVRKYLFQILRGIEFCHSH---NIIHRDIKPENILVSQSGVVKLCDFGFARTLAA 152 (286)
T ss_pred ecCCccHHHHHHh----ccCCCCHHHHHHHHHHHHHHHHHHHHC---CccccCCCHHHEEECCCCcEEEEeeeeeeeccC
Confidence 9999888887775 334589999999999999999999999 999999999999999999999999999875432
Q ss_pred ccccccccccccccCcccCChhhhcc-cCcCccccchhhhHHHHHHHhCCCCCCCCccCCCCchhHHHHHHHHHhcCccC
Q 038766 171 HLQDLSSLSTAFQGTIGYLAPEFAYM-RIVTTKVDVFSFGIVVMEFLTKRRPTGLDEENGLSPISLRQLVEKALANGING 249 (299)
Q Consensus 171 ~~~~~~~~~~~~~~~~~y~~PE~~~~-~~~~~~~DiwslG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 249 (299)
. ........++..|+|||.+.+ ..++.++||||||+++++|++|..||..... ........ .........
T Consensus 153 ~----~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~el~~g~~~~~~~~~----~~~~~~~~-~~~~~~~~~ 223 (286)
T cd07846 153 P----GEVYTDYVATRWYRAPELLVGDTKYGRAVDIWAVGCLVTEMLTGEPLFPGDSD----IDQLYHII-KCLGNLIPR 223 (286)
T ss_pred C----ccccCcccceeeccCcHHhccccccCchHhHHHHHHHHHHHHcCCCCCCCCch----HHHHHHHH-HHhCCCchh
Confidence 1 122233456788999998775 3467899999999999999999988853321 00111111 000000000
Q ss_pred c----------ccccCccccchhhHhHHHHHHHHHHHHHHHHhcCCCCCCCCChhhhhcC
Q 038766 250 V----------RQITDPKLVSSIYEEQEQHQVLEELFKLALVCTSSNPEDRPNMNELLIT 299 (299)
Q Consensus 250 ~----------~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rpt~~~il~~ 299 (299)
. .....+..............++..+.+++.+||..+|++|||+.++++|
T Consensus 224 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rp~~~~il~~ 283 (286)
T cd07846 224 HQEIFQKNPLFAGMRLPEVKEIEPLEKRFPKLSGLVLDLAKQCLRIDPDDRPSSSQLLHH 283 (286)
T ss_pred hHHHhccchHhhccccccccCcchHHHhCCCcCHHHHHHHHHHhcCCcccchhHHHHhcC
Confidence 0 0000000000001111123457789999999999999999999999987
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 2 (CDKL2) and CDKL3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL2 and CDKL3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL2, also called p56 KKIAMRE, is expressed in testis, kidney, lung, and brain. It functions mainly in mature neurons and plays an important role in learning and memory. Inactivation of CDKL3, also called NKI |
| >cd06651 STKc_MEKK3 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-39 Score=269.67 Aligned_cols=255 Identities=25% Similarity=0.361 Sum_probs=197.2
Q ss_pred CCCCCCceeecCCcceEEEEEe-CCCcEEEEEEeccCcCC---hhhhHHHHHHHHHHHhcCCcceeeeeeEEEcC-CCee
Q 038766 12 GSFSENNIIGNSNLSTVYKGRL-EDGEIVAVKKLNFHQFS---AESDKSFYREAKTLKELKHRNLVKVLGYAWES-GKLK 86 (299)
Q Consensus 12 ~~y~~~~~lg~g~~~~v~~~~~-~~~~~~~vK~~~~~~~~---~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~-~~~~ 86 (299)
..|.+.+.||+|++|.||++.+ .++..+++|++...... ......+.+|+.+++.++||||+++++.+... +...
T Consensus 2 ~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~ 81 (266)
T cd06651 2 INWRRGKLLGQGAFGRVYLCYDVDTGRELAAKQVQFDPESPETSKEVSALECEIQLLKNLQHERIVQYYGCLRDRAEKTL 81 (266)
T ss_pred CCccccceecCCCCEEEEEEEEcCCCcEEEEEEeecCcCCchhHHHHHHHHHHHHHHHHcCCCCeeeEEEEEEcCCCCEE
Confidence 4689999999999999999986 45899999988644322 23345688899999999999999999976643 4667
Q ss_pred EEEEeecCCCChHHHhcCCCCCCCCCChhhHHHHHHHHHHHHHHhhcCCCCCeeeecccCCceeeCCCCcEEEeeecccc
Q 038766 87 ALILEYMENGSLESVIHGPGVDHSRWTLPKRIDVLISVANGLDYLHSGYDIPIVHCDMKPSNILLDRDFEAHVSDFGTSR 166 (299)
Q Consensus 87 ~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lh~~~~~~~~H~dl~~~nil~~~~~~v~l~df~~~~ 166 (299)
++++||+.+++|.+.+. ....+++..++.++.|++.||.+||+. +++|+||+|+||+++.++.++|+|||++.
T Consensus 82 ~l~~e~~~~~~L~~~l~----~~~~l~~~~~~~~~~qi~~~l~~LH~~---~i~H~~l~p~nil~~~~~~~~l~dfg~~~ 154 (266)
T cd06651 82 TIFMEYMPGGSVKDQLK----AYGALTESVTRKYTRQILEGMSYLHSN---MIVHRDIKGANILRDSAGNVKLGDFGASK 154 (266)
T ss_pred EEEEeCCCCCcHHHHHH----HcCCCCHHHHHHHHHHHHHHHHHHHhC---CeeeCCCCHHHEEECCCCCEEEccCCCcc
Confidence 89999999999999886 344688999999999999999999998 99999999999999999999999999987
Q ss_pred ccccccccccccccccccCcccCChhhhcccCcCccccchhhhHHHHHHHhCCCCCCCCccCCCCchhHHHHHHHHHhcC
Q 038766 167 MLDVHLQDLSSLSTAFQGTIGYLAPEFAYMRIVTTKVDVFSFGIVVMEFLTKRRPTGLDEENGLSPISLRQLVEKALANG 246 (299)
Q Consensus 167 ~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~DiwslG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~ 246 (299)
........ ........++..|+|||.+.+..++.++|+||+||++|+|++|..||..... ...+.......
T Consensus 155 ~~~~~~~~-~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~i~~el~~g~~pf~~~~~--------~~~~~~~~~~~ 225 (266)
T cd06651 155 RLQTICMS-GTGIRSVTGTPYWMSPEVISGEGYGRKADVWSLGCTVVEMLTEKPPWAEYEA--------MAAIFKIATQP 225 (266)
T ss_pred cccccccc-CCccccCCccccccCHHHhCCCCCCchhhhHHHHHHHHHHHHCCCCccccch--------HHHHHHHhcCC
Confidence 54321111 1111233467889999999988899999999999999999999999853210 11111111111
Q ss_pred ccCcccccCccccchhhHhHHHHHHHHHHHHHHHHhcCCCCCCCCChhhhhcC
Q 038766 247 INGVRQITDPKLVSSIYEEQEQHQVLEELFKLALVCTSSNPEDRPNMNELLIT 299 (299)
Q Consensus 247 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rpt~~~il~~ 299 (299)
. .+. .+..++..+.+++ +||..+|++|||++++++|
T Consensus 226 ~-------~~~---------~~~~~~~~~~~li-~~~~~~p~~Rp~~~eil~h 261 (266)
T cd06651 226 T-------NPQ---------LPSHISEHARDFL-GCIFVEARHRPSAEELLRH 261 (266)
T ss_pred C-------CCC---------CchhcCHHHHHHH-HHhcCChhhCcCHHHHhcC
Confidence 0 000 0233456678888 6777899999999999987
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK3 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development |
| >cd05580 STKc_PKA Catalytic domain of the Protein Serine/Threonine Kinase, cAMP-dependent protein kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.5e-40 Score=277.68 Aligned_cols=247 Identities=26% Similarity=0.334 Sum_probs=199.9
Q ss_pred CCCCCCceeecCCcceEEEEEeC-CCcEEEEEEeccCcC-ChhhhHHHHHHHHHHHhcCCcceeeeeeEEEcCCCeeEEE
Q 038766 12 GSFSENNIIGNSNLSTVYKGRLE-DGEIVAVKKLNFHQF-SAESDKSFYREAKTLKELKHRNLVKVLGYAWESGKLKALI 89 (299)
Q Consensus 12 ~~y~~~~~lg~g~~~~v~~~~~~-~~~~~~vK~~~~~~~-~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~lv 89 (299)
++|.+.+.||+|++|.||++.+. +++.+|+|++..... .......+.+|++.++++.||||+++++++.. +...++|
T Consensus 1 ~~y~~~~~ig~g~~~~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~-~~~~~~v 79 (290)
T cd05580 1 DDFEFIKTLGTGSFGRVMLVRHKGSGKYYALKILSKAKIVKLKQVEHVLNEKRILQSIRHPFLVNLYGSFQD-DSNLYLV 79 (290)
T ss_pred CceEEEEEeecCCCeEEEEEEEcCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCccceeeEEEc-CCeEEEE
Confidence 47899999999999999999864 589999999864332 22345678899999999999999999996655 5567999
Q ss_pred EeecCCCChHHHhcCCCCCCCCCChhhHHHHHHHHHHHHHHhhcCCCCCeeeecccCCceeeCCCCcEEEeeeccccccc
Q 038766 90 LEYMENGSLESVIHGPGVDHSRWTLPKRIDVLISVANGLDYLHSGYDIPIVHCDMKPSNILLDRDFEAHVSDFGTSRMLD 169 (299)
Q Consensus 90 ~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lh~~~~~~~~H~dl~~~nil~~~~~~v~l~df~~~~~~~ 169 (299)
+||+.+++|.+.+. ....+++..+..++.|++.||.+||+. +++|+||+|+||+++.++.++|+|||++....
T Consensus 80 ~e~~~~~~L~~~~~----~~~~l~~~~~~~~~~qil~~l~~lH~~---~i~H~dl~p~nili~~~~~~kl~dfg~~~~~~ 152 (290)
T cd05580 80 MEYVPGGELFSHLR----KSGRFPEPVARFYAAQVVLALEYLHSL---DIVYRDLKPENLLLDSDGYIKITDFGFAKRVK 152 (290)
T ss_pred EecCCCCCHHHHHH----HcCCCCHHHHHHHHHHHHHHHHHHHHC---CEecCCCCHHHEEECCCCCEEEeeCCCccccC
Confidence 99999999999987 345789999999999999999999999 99999999999999999999999999987543
Q ss_pred cccccccccccccccCcccCChhhhcccCcCccccchhhhHHHHHHHhCCCCCCCCccCCCCchhHHHHHHHHHhcCccC
Q 038766 170 VHLQDLSSLSTAFQGTIGYLAPEFAYMRIVTTKVDVFSFGIVVMEFLTKRRPTGLDEENGLSPISLRQLVEKALANGING 249 (299)
Q Consensus 170 ~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~DiwslG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 249 (299)
.. .....+++.|+|||.+.+...+.++|+||||+++|+|++|..||.... . ......... +...
T Consensus 153 ~~-------~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~-----~---~~~~~~~~~-~~~~ 216 (290)
T cd05580 153 GR-------TYTLCGTPEYLAPEIILSKGYGKAVDWWALGILIYEMLAGYPPFFDDN-----P---IQIYEKILE-GKVR 216 (290)
T ss_pred CC-------CCCCCCCccccChhhhcCCCCCccccHHHHHHHHHHHHhCCCCCCCCC-----H---HHHHHHHhc-CCcc
Confidence 21 233457889999999988888999999999999999999999985432 1 111111111 1000
Q ss_pred cccccCccccchhhHhHHHHHHHHHHHHHHHHhcCCCCCCCC-----ChhhhhcC
Q 038766 250 VRQITDPKLVSSIYEEQEQHQVLEELFKLALVCTSSNPEDRP-----NMNELLIT 299 (299)
Q Consensus 250 ~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rp-----t~~~il~~ 299 (299)
.+...+..+.++|.+||..||.+|+ ++++++.|
T Consensus 217 -----------------~~~~~~~~l~~li~~~l~~~p~~R~~~~~~~~~~l~~~ 254 (290)
T cd05580 217 -----------------FPSFFSPDAKDLIRNLLQVDLTKRLGNLKNGVNDIKNH 254 (290)
T ss_pred -----------------CCccCCHHHHHHHHHHccCCHHHccCcccCCHHHHHcC
Confidence 0122356789999999999999999 88999876
|
Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This subfamily is composed of the cAMP-dependent proteins kinases, PKA and PRKX. The inactive PKA holoenzyme is a heterotetramer composed of two phosphorylated and active catalytic (C) subunits with a dimer of regulatory (R) subunits. Activation is achieved through the binding of the important second messenger cAMP to the R subunits, which leads to the dissociation of PKA into the R dimer and two active C subunits. PKA is present ubi |
| >cd06652 STKc_MEKK2 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-39 Score=269.82 Aligned_cols=255 Identities=24% Similarity=0.315 Sum_probs=198.5
Q ss_pred CCCCCCceeecCCcceEEEEEeC-CCcEEEEEEeccCcCC---hhhhHHHHHHHHHHHhcCCcceeeeeeEEEcC-CCee
Q 038766 12 GSFSENNIIGNSNLSTVYKGRLE-DGEIVAVKKLNFHQFS---AESDKSFYREAKTLKELKHRNLVKVLGYAWES-GKLK 86 (299)
Q Consensus 12 ~~y~~~~~lg~g~~~~v~~~~~~-~~~~~~vK~~~~~~~~---~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~-~~~~ 86 (299)
.+|.+.+.||+|++|.||.+.+. ++..|++|.+...... ......+.+|+..++++.||||+++++.+... +...
T Consensus 2 ~~~~~~~~l~~g~~g~v~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~ 81 (265)
T cd06652 2 TNWRLGKLLGQGAFGRVYLCYDADTGRELAVKQVQFDPESPETSKEVNALECEIQLLKNLLHERIVQYYGCLRDPMERTL 81 (265)
T ss_pred CcceEeeEEecCCceEEEEEEEcCCCcEEEEEEeecCcCCcccHHHHHHHHHHHHHHHhcCCCCeeeEEeEeccCCCceE
Confidence 57999999999999999999864 5899999998643322 22346788899999999999999999966543 3566
Q ss_pred EEEEeecCCCChHHHhcCCCCCCCCCChhhHHHHHHHHHHHHHHhhcCCCCCeeeecccCCceeeCCCCcEEEeeecccc
Q 038766 87 ALILEYMENGSLESVIHGPGVDHSRWTLPKRIDVLISVANGLDYLHSGYDIPIVHCDMKPSNILLDRDFEAHVSDFGTSR 166 (299)
Q Consensus 87 ~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lh~~~~~~~~H~dl~~~nil~~~~~~v~l~df~~~~ 166 (299)
++++||+++++|.+++. ....+++..+..++.|++.||.+||+. +++|+||+|+||+++.++.++|+|||++.
T Consensus 82 ~~v~e~~~~~~L~~~l~----~~~~~~~~~~~~~~~~l~~~l~~lH~~---~i~H~dl~p~nil~~~~~~~~l~Dfg~~~ 154 (265)
T cd06652 82 SIFMEHMPGGSIKDQLK----SYGALTENVTRKYTRQILEGVSYLHSN---MIVHRDIKGANILRDSVGNVKLGDFGASK 154 (265)
T ss_pred EEEEEecCCCcHHHHHH----HcCCCCHHHHHHHHHHHHHHHHHHHhC---CEecCCCCHHHEEecCCCCEEECcCcccc
Confidence 89999999999999886 334688899999999999999999999 99999999999999999999999999887
Q ss_pred ccccccccccccccccccCcccCChhhhcccCcCccccchhhhHHHHHHHhCCCCCCCCccCCCCchhHHHHHHHHHhcC
Q 038766 167 MLDVHLQDLSSLSTAFQGTIGYLAPEFAYMRIVTTKVDVFSFGIVVMEFLTKRRPTGLDEENGLSPISLRQLVEKALANG 246 (299)
Q Consensus 167 ~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~DiwslG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~ 246 (299)
........ ........++..|+|||.+.+..++.++|+||||+++|+|++|..||... .. ... +.......
T Consensus 155 ~~~~~~~~-~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~g~~p~~~~-----~~--~~~-~~~~~~~~ 225 (265)
T cd06652 155 RLQTICLS-GTGMKSVTGTPYWMSPEVISGEGYGRKADIWSVGCTVVEMLTEKPPWAEF-----EA--MAA-IFKIATQP 225 (265)
T ss_pred cccccccc-ccccccCCCCccccChhhhcCCCCCcchhHHHHHHHHHHHhhCCCCCCcc-----ch--HHH-HHHHhcCC
Confidence 55421111 11122345778899999998888999999999999999999999998422 10 111 11111100
Q ss_pred ccCcccccCccccchhhHhHHHHHHHHHHHHHHHHhcCCCCCCCCChhhhhcC
Q 038766 247 INGVRQITDPKLVSSIYEEQEQHQVLEELFKLALVCTSSNPEDRPNMNELLIT 299 (299)
Q Consensus 247 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rpt~~~il~~ 299 (299)
. .+ ..+..++..+.+++++|+. +|++|||++++++|
T Consensus 226 ~-------~~---------~~~~~~~~~~~~~i~~~l~-~p~~Rp~~~~il~~ 261 (265)
T cd06652 226 T-------NP---------VLPPHVSDHCRDFLKRIFV-EAKLRPSADELLRH 261 (265)
T ss_pred C-------CC---------CCchhhCHHHHHHHHHHhc-ChhhCCCHHHHhcC
Confidence 0 00 0134556788999999995 99999999999987
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 2 (MEKK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK2 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK2 also activates ERK1/2, c-Jun N-terminal kinase (JNK) and p38 through their re |
| >cd07858 STKc_TEY_MAPK_plant Catalytic domain of the Serine/Threonine Kinases, TEY Mitogen-Activated Protein Kinases from Plants | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.3e-40 Score=282.79 Aligned_cols=273 Identities=23% Similarity=0.277 Sum_probs=201.6
Q ss_pred HhCCCCCCceeecCCcceEEEEEe-CCCcEEEEEEeccCcCChhhhHHHHHHHHHHHhcCCcceeeeeeEEEcCC----C
Q 038766 10 ATGSFSENNIIGNSNLSTVYKGRL-EDGEIVAVKKLNFHQFSAESDKSFYREAKTLKELKHRNLVKVLGYAWESG----K 84 (299)
Q Consensus 10 ~~~~y~~~~~lg~g~~~~v~~~~~-~~~~~~~vK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~----~ 84 (299)
+..+|.+.+.||+|++|+||++.+ .+++.||+|.+............+..|+..++.++|+||+++++++.... .
T Consensus 3 ~~~~y~~~~~lg~G~~~~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~ni~~~~~~~~~~~~~~~~ 82 (337)
T cd07858 3 VDTKYVPIKPIGRGAYGIVCSAKNSETNEKVAIKKIANAFDNRIDAKRTLREIKLLRHLDHENVIAIKDIMPPPHREAFN 82 (337)
T ss_pred cccceeEEEEeccCCCeEEEEEEecCCCCeEEEEEecccccccchhHHHHHHHHHHHhcCCCCccchHHheecccccccC
Confidence 467899999999999999999986 46899999998754334444567778999999999999999999765432 3
Q ss_pred eeEEEEeecCCCChHHHhcCCCCCCCCCChhhHHHHHHHHHHHHHHhhcCCCCCeeeecccCCceeeCCCCcEEEeeecc
Q 038766 85 LKALILEYMENGSLESVIHGPGVDHSRWTLPKRIDVLISVANGLDYLHSGYDIPIVHCDMKPSNILLDRDFEAHVSDFGT 164 (299)
Q Consensus 85 ~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lh~~~~~~~~H~dl~~~nil~~~~~~v~l~df~~ 164 (299)
..++|+||+. ++|.+++. ....+++..++.++.|++.||.|||++ +++|+||+|+||+++.++.++|+|||+
T Consensus 83 ~~~lv~e~~~-~~L~~~~~----~~~~l~~~~~~~i~~qi~~aL~~LH~~---~i~H~dlkp~Nil~~~~~~~kL~Dfg~ 154 (337)
T cd07858 83 DVYIVYELMD-TDLHQIIR----SSQTLSDDHCQYFLYQLLRGLKYIHSA---NVLHRDLKPSNLLLNANCDLKICDFGL 154 (337)
T ss_pred cEEEEEeCCC-CCHHHHHh----cCCCCCHHHHHHHHHHHHHHHHHHHhC---CEecCCCCHHHEEEcCCCCEEECcCcc
Confidence 4699999995 68988887 445799999999999999999999999 999999999999999999999999999
Q ss_pred ccccccccccccccccccccCcccCChhhhcc-cCcCccccchhhhHHHHHHHhCCCCCCCCccCCCCchhHHHHHHHHH
Q 038766 165 SRMLDVHLQDLSSLSTAFQGTIGYLAPEFAYM-RIVTTKVDVFSFGIVVMEFLTKRRPTGLDEENGLSPISLRQLVEKAL 243 (299)
Q Consensus 165 ~~~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~-~~~~~~~DiwslG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~ 243 (299)
+...... ........++..|+|||.+.. ..++.++|+||||+++|+|++|..||..... ......+....
T Consensus 155 ~~~~~~~----~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~-----~~~~~~~~~~~ 225 (337)
T cd07858 155 ARTTSEK----GDFMTEYVVTRWYRAPELLLNCSEYTTAIDVWSVGCIFAELLGRKPLFPGKDY-----VHQLKLITELL 225 (337)
T ss_pred ccccCCC----cccccccccccCccChHHHhcCCCCCCcccHHHHHHHHHHHHcCCCCCCCCCh-----HHHHHHHHHHh
Confidence 8754321 122233456788999998764 4688999999999999999999999854321 11111111100
Q ss_pred hcCccC-cccccCcccc---------chhhHhHHHHHHHHHHHHHHHHhcCCCCCCCCChhhhhcC
Q 038766 244 ANGING-VRQITDPKLV---------SSIYEEQEQHQVLEELFKLALVCTSSNPEDRPNMNELLIT 299 (299)
Q Consensus 244 ~~~~~~-~~~~~~~~~~---------~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rpt~~~il~~ 299 (299)
...... ...+...... ...........++..+.++|++||+.+|++|||++++++|
T Consensus 226 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rps~~ell~h 291 (337)
T cd07858 226 GSPSEEDLGFIRNEKARRYIRSLPYTPRQSFARLFPHANPLAIDLLEKMLVFDPSKRITVEEALAH 291 (337)
T ss_pred CCCChHHhhhcCchhhhHHHHhcCcccccCHHHHcccCCHHHHHHHHHHhcCChhhccCHHHHHcC
Confidence 000000 0000000000 0000011123567889999999999999999999999987
|
Serine/Threonine Kinases (STKs), Plant TEY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TEY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. There are two subtypes of plant MAPKs based on the conserved phosphorylation motif present in the activati |
| >cd06632 STKc_MEKK1_plant Catalytic domain of the Protein Serine/Threonine Kinase, Plant MAP/ERK kinase kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-39 Score=269.70 Aligned_cols=250 Identities=26% Similarity=0.404 Sum_probs=199.1
Q ss_pred CCCCCceeecCCcceEEEEEeC-CCcEEEEEEeccCcC---ChhhhHHHHHHHHHHHhcCCcceeeeeeEEEcCCCeeEE
Q 038766 13 SFSENNIIGNSNLSTVYKGRLE-DGEIVAVKKLNFHQF---SAESDKSFYREAKTLKELKHRNLVKVLGYAWESGKLKAL 88 (299)
Q Consensus 13 ~y~~~~~lg~g~~~~v~~~~~~-~~~~~~vK~~~~~~~---~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~l 88 (299)
+|+..+.||+|++|.||++... +++.+++|.+..... ..+....+..|+..++.++|+|++++++.+.. +...++
T Consensus 1 ~~~~~~~ig~g~~~~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~-~~~~~l 79 (258)
T cd06632 1 RWRKGELLGSGSFGSVYEGLNLDDGDFFAVKEVSLADDGQTGQEAVKQLEQEIALLSKLQHPNIVQYLGTERE-EDNLYI 79 (258)
T ss_pred CccccceeeecCCceEEEEEEcCCCcEEEEEEEEEccccccchHHHHHHHHHHHHHHhcCCCCchheeeeEec-CCeEEE
Confidence 5888999999999999999875 789999999864332 23355678899999999999999999996654 456699
Q ss_pred EEeecCCCChHHHhcCCCCCCCCCChhhHHHHHHHHHHHHHHhhcCCCCCeeeecccCCceeeCCCCcEEEeeecccccc
Q 038766 89 ILEYMENGSLESVIHGPGVDHSRWTLPKRIDVLISVANGLDYLHSGYDIPIVHCDMKPSNILLDRDFEAHVSDFGTSRML 168 (299)
Q Consensus 89 v~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lh~~~~~~~~H~dl~~~nil~~~~~~v~l~df~~~~~~ 168 (299)
++||+++++|.+++. ....+++..++.++.|++.|+++||+. +++|+||+|+||+++.++.++|+|||.+...
T Consensus 80 v~e~~~~~~L~~~~~----~~~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dl~~~ni~~~~~~~~kl~d~~~~~~~ 152 (258)
T cd06632 80 FLELVPGGSLAKLLK----KYGSFPEPVIRLYTRQILLGLEYLHDR---NTVHRDIKGANILVDTNGVVKLADFGMAKQV 152 (258)
T ss_pred EEEecCCCcHHHHHH----hcCCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCHHHEEECCCCCEEEccCccceec
Confidence 999999999999986 345688999999999999999999999 9999999999999999999999999988764
Q ss_pred ccccccccccccccccCcccCChhhhcccC-cCccccchhhhHHHHHHHhCCCCCCCCccCCCCchhHHHHHHHHHhcCc
Q 038766 169 DVHLQDLSSLSTAFQGTIGYLAPEFAYMRI-VTTKVDVFSFGIVVMEFLTKRRPTGLDEENGLSPISLRQLVEKALANGI 247 (299)
Q Consensus 169 ~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~-~~~~~DiwslG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 247 (299)
... .......++..|++||.+.... ++.++|+||||+++|+|++|..||.... . ..... ......
T Consensus 153 ~~~-----~~~~~~~~~~~y~~pe~~~~~~~~~~~~D~~slG~~l~~l~~g~~pf~~~~-----~--~~~~~-~~~~~~- 218 (258)
T cd06632 153 VEF-----SFAKSFKGSPYWMAPEVIAQQGGYGLAADIWSLGCTVLEMATGKPPWSQLE-----G--VAAVF-KIGRSK- 218 (258)
T ss_pred ccc-----ccccccCCCcceeCHHHhcCCCCCCchhhhHHHHHHHHHHHhCCCCcccCc-----H--HHHHH-HHHhcc-
Confidence 421 1223445778899999887766 8899999999999999999999985331 1 11111 111000
Q ss_pred cCcccccCccccchhhHhHHHHHHHHHHHHHHHHhcCCCCCCCCChhhhhcC
Q 038766 248 NGVRQITDPKLVSSIYEEQEQHQVLEELFKLALVCTSSNPEDRPNMNELLIT 299 (299)
Q Consensus 248 ~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rpt~~~il~~ 299 (299)
.... .+..++..+.+++++||..+|++|||+++++.|
T Consensus 219 -~~~~--------------~~~~~~~~~~~li~~~l~~~p~~Rp~~~~~l~~ 255 (258)
T cd06632 219 -ELPP--------------IPDHLSDEAKDFILKCLQRDPSLRPTAAELLEH 255 (258)
T ss_pred -cCCC--------------cCCCcCHHHHHHHHHHhhcCcccCcCHHHHhcC
Confidence 0000 022345678999999999999999999999986
|
Serine/threonine kinases (STKs), plant MAP/ERK kinase kinase 1 (MEKK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The plant MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of plant mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) including Arabidopsis thaliana MEKK1 and MAPKKK3. MEKK1 is a MAPKKK that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Arabidops |
| >cd07845 STKc_CDK10 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 10 | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.6e-40 Score=277.45 Aligned_cols=273 Identities=25% Similarity=0.323 Sum_probs=199.7
Q ss_pred hCCCCCCceeecCCcceEEEEEeC-CCcEEEEEEeccCcCChhhhHHHHHHHHHHHhcCCcceeeeeeEEEcCC-CeeEE
Q 038766 11 TGSFSENNIIGNSNLSTVYKGRLE-DGEIVAVKKLNFHQFSAESDKSFYREAKTLKELKHRNLVKVLGYAWESG-KLKAL 88 (299)
Q Consensus 11 ~~~y~~~~~lg~g~~~~v~~~~~~-~~~~~~vK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~-~~~~l 88 (299)
.++|.+.+.||+|++|.||++.+. +|+.||+|++..............+|+.++++++|+|++++++++.... ...++
T Consensus 6 ~~~y~~~~~ig~g~~~~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~l 85 (309)
T cd07845 6 VTEFEKLNRIGEGTYGIVYRARDTTSGEIVALKKVRMDNERDGIPISSLREITLLLNLRHPNIVELKEVVVGKHLDSIFL 85 (309)
T ss_pred ccceeEeeeeeecCCEEEEEEEECCCCcEEEEEEEEeccCCCCCcchhhHHHHHHHhCCCCCCcceEEEEecCCCCeEEE
Confidence 468999999999999999999874 5899999998755444444445678999999999999999999776543 45799
Q ss_pred EEeecCCCChHHHhcCCCCCCCCCChhhHHHHHHHHHHHHHHhhcCCCCCeeeecccCCceeeCCCCcEEEeeecccccc
Q 038766 89 ILEYMENGSLESVIHGPGVDHSRWTLPKRIDVLISVANGLDYLHSGYDIPIVHCDMKPSNILLDRDFEAHVSDFGTSRML 168 (299)
Q Consensus 89 v~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lh~~~~~~~~H~dl~~~nil~~~~~~v~l~df~~~~~~ 168 (299)
|+||+. ++|.+++... ...+++..++.++.|++.||+|||+. +++|+||+|+||+++.++.++|+|||.+...
T Consensus 86 v~e~~~-~~l~~~l~~~---~~~l~~~~~~~~~~qi~~~l~~lH~~---~i~H~dl~p~nil~~~~~~~kL~dfg~~~~~ 158 (309)
T cd07845 86 VMEYCE-QDLASLLDNM---PTPFSESQVKCLMLQLLRGLQYLHEN---FIIHRDLKVSNLLLTDKGCLKIADFGLARTY 158 (309)
T ss_pred EEecCC-CCHHHHHHhc---ccCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHEEECCCCCEEECccceeeec
Confidence 999995 4888887632 35789999999999999999999999 9999999999999999999999999998765
Q ss_pred ccccccccccccccccCcccCChhhhcc-cCcCccccchhhhHHHHHHHhCCCCCCCCccCCCCchhHHHHHHHHHhcCc
Q 038766 169 DVHLQDLSSLSTAFQGTIGYLAPEFAYM-RIVTTKVDVFSFGIVVMEFLTKRRPTGLDEENGLSPISLRQLVEKALANGI 247 (299)
Q Consensus 169 ~~~~~~~~~~~~~~~~~~~y~~PE~~~~-~~~~~~~DiwslG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 247 (299)
.... ........+..|+|||.+.+ ..++.++|+||||+++|+|++|..||..... ......+........
T Consensus 159 ~~~~----~~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslG~il~el~~g~~~f~~~~~-----~~~~~~~~~~~~~~~ 229 (309)
T cd07845 159 GLPA----KPMTPKVVTLWYRAPELLLGCTTYTTAIDMWAVGCILAELLAHKPLLPGKSE-----IEQLDLIIQLLGTPN 229 (309)
T ss_pred CCcc----CCCCcccccccccChhhhcCCCCcCchHHHHHHHHHHHHHHhCCCCCCCCCH-----HHHHHHHHHhcCCCC
Confidence 4211 11222234678999998765 4578999999999999999999999853321 111111111111000
Q ss_pred c----Cccccc---Cccccchh--hHhHHHHHHHHHHHHHHHHhcCCCCCCCCChhhhhcC
Q 038766 248 N----GVRQIT---DPKLVSSI--YEEQEQHQVLEELFKLALVCTSSNPEDRPNMNELLIT 299 (299)
Q Consensus 248 ~----~~~~~~---~~~~~~~~--~~~~~~~~~~~~l~~li~~~l~~dP~~Rpt~~~il~~ 299 (299)
. ...... ........ .........+..+.++|.+||..||++|||+++++.|
T Consensus 230 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~ml~~dp~~R~t~~~il~h 290 (309)
T cd07845 230 ESIWPGFSDLPLVGKFTLPKQPYNNLKHKFPWLSEAGLRLLNFLLMYDPKKRATAEEALES 290 (309)
T ss_pred hhhchhhhcccccccccccCCCCCchHHhccccCHHHHHHHHHHhcCChhhCcCHHHHhcC
Confidence 0 000000 00000000 0001122346788999999999999999999999987
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein Kinase 10 (CDK10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK10, also called PISSLRE, is essential for cell growth and proliferation, and acts through the G2/M phase of the cell cycle. CDK10 has also been identified as an important factor in endocrine therapy resistance in breast cancer. CDK10 silencing |
| >cd05108 PTKc_EGFR Catalytic domain of the Protein Tyrosine Kinase, Epidermal Growth Factor Receptor | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-40 Score=281.82 Aligned_cols=252 Identities=24% Similarity=0.423 Sum_probs=193.9
Q ss_pred hCCCCCCceeecCCcceEEEEEeC-CCc----EEEEEEeccCcCChhhhHHHHHHHHHHHhcCCcceeeeeeEEEcCCCe
Q 038766 11 TGSFSENNIIGNSNLSTVYKGRLE-DGE----IVAVKKLNFHQFSAESDKSFYREAKTLKELKHRNLVKVLGYAWESGKL 85 (299)
Q Consensus 11 ~~~y~~~~~lg~g~~~~v~~~~~~-~~~----~~~vK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~ 85 (299)
..+|++.+.||+|+||.||++.+. ++. .||+|++.. .........+..|+..++.++||||+++++++... .
T Consensus 6 ~~~f~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~vaiK~~~~-~~~~~~~~~~~~e~~~l~~l~h~niv~~~g~~~~~--~ 82 (316)
T cd05108 6 ETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELRE-ATSPKANKEILDEAYVMASVDNPHVCRLLGICLTS--T 82 (316)
T ss_pred hhhceeeeeeecCCCceEEEEEEecCCCccceeEEEEeccc-cCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEcCC--C
Confidence 467999999999999999999853 233 489999863 23344566788999999999999999999977653 3
Q ss_pred eEEEEeecCCCChHHHhcCCCCCCCCCChhhHHHHHHHHHHHHHHhhcCCCCCeeeecccCCceeeCCCCcEEEeeeccc
Q 038766 86 KALILEYMENGSLESVIHGPGVDHSRWTLPKRIDVLISVANGLDYLHSGYDIPIVHCDMKPSNILLDRDFEAHVSDFGTS 165 (299)
Q Consensus 86 ~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lh~~~~~~~~H~dl~~~nil~~~~~~v~l~df~~~ 165 (299)
.+++++++.+++|.+.+... ...++...++.++.|++.||+|||+. +++|+||||+||+++.++.++|+|||++
T Consensus 83 ~~~v~e~~~~g~l~~~l~~~---~~~~~~~~~~~~~~qi~~~L~~LH~~---~iiH~dlkp~Nill~~~~~~kl~DfG~a 156 (316)
T cd05108 83 VQLITQLMPFGCLLDYVREH---KDNIGSQYLLNWCVQIAKGMNYLEER---RLVHRDLAARNVLVKTPQHVKITDFGLA 156 (316)
T ss_pred ceeeeecCCCCCHHHHHHhc---cccCCHHHHHHHHHHHHHHHHHHHhc---CeeccccchhheEecCCCcEEEcccccc
Confidence 47999999999999988632 34688889999999999999999999 9999999999999999999999999999
Q ss_pred cccccccccccccccccccCcccCChhhhcccCcCccccchhhhHHHHHHHh-CCCCCCCCccCCCCchhHHHHHHHHHh
Q 038766 166 RMLDVHLQDLSSLSTAFQGTIGYLAPEFAYMRIVTTKVDVFSFGIVVMEFLT-KRRPTGLDEENGLSPISLRQLVEKALA 244 (299)
Q Consensus 166 ~~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~DiwslG~~l~~l~~-g~~p~~~~~~~~~~~~~~~~~~~~~~~ 244 (299)
......... ........+..|++||.+....++.++||||||+++|+|++ |..||... ....+...+.
T Consensus 157 ~~~~~~~~~--~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slGv~l~el~t~g~~p~~~~-----~~~~~~~~~~---- 225 (316)
T cd05108 157 KLLGADEKE--YHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGI-----PASEISSILE---- 225 (316)
T ss_pred ccccCCCcc--eeccCCccceeecChHHhccCCCCchhhhHHHHHHHHHHHcCCCCCCCCC-----CHHHHHHHHh----
Confidence 765421111 01112223567999999999999999999999999999997 88888432 2222222211
Q ss_pred cCccCcccccCccccchhhHhHHHHHHHHHHHHHHHHhcCCCCCCCCChhhhhc
Q 038766 245 NGINGVRQITDPKLVSSIYEEQEQHQVLEELFKLALVCTSSNPEDRPNMNELLI 298 (299)
Q Consensus 245 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rpt~~~il~ 298 (299)
.. ..... +...+.++.+++.+||..+|.+|||+.+++.
T Consensus 226 ~~----~~~~~------------~~~~~~~~~~li~~cl~~~p~~Rps~~~l~~ 263 (316)
T cd05108 226 KG----ERLPQ------------PPICTIDVYMIMVKCWMIDADSRPKFRELII 263 (316)
T ss_pred CC----CCCCC------------CCCCCHHHHHHHHHHccCChhhCcCHHHHHH
Confidence 11 00000 1112346889999999999999999999985
|
Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EGFR (HER1, ErbB1) is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphor |
| >cd05036 PTKc_ALK_LTK Catalytic domain of the Protein Tyrosine Kinases, Anaplastic Lymphoma Kinase and Leukocyte Tyrosine Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.2e-40 Score=276.13 Aligned_cols=258 Identities=25% Similarity=0.368 Sum_probs=195.7
Q ss_pred HhCCCCCCceeecCCcceEEEEEeC------CCcEEEEEEeccCcCChhhhHHHHHHHHHHHhcCCcceeeeeeEEEcCC
Q 038766 10 ATGSFSENNIIGNSNLSTVYKGRLE------DGEIVAVKKLNFHQFSAESDKSFYREAKTLKELKHRNLVKVLGYAWESG 83 (299)
Q Consensus 10 ~~~~y~~~~~lg~g~~~~v~~~~~~------~~~~~~vK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~ 83 (299)
..++|.+.+.||+|++|.||++.+. .+..+++|.+... ........+..|+..++.++|+||+++++++...+
T Consensus 4 ~~~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~v~ik~~~~~-~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~ 82 (277)
T cd05036 4 PRDSITLLRALGHGAFGEVYEGLYRGRDGDAVELQVAVKTLPES-CSEQDESDFLMEALIMSKFNHQNIVRLIGVSFERL 82 (277)
T ss_pred CHHHcEeeeECCCCCCCcEEEEEEecCCCCCCceeEEEEEcCCC-CCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEccCC
Confidence 3567999999999999999999864 3567888887532 23334566888999999999999999999776654
Q ss_pred CeeEEEEeecCCCChHHHhcCCCC---CCCCCChhhHHHHHHHHHHHHHHhhcCCCCCeeeecccCCceeeCCCC---cE
Q 038766 84 KLKALILEYMENGSLESVIHGPGV---DHSRWTLPKRIDVLISVANGLDYLHSGYDIPIVHCDMKPSNILLDRDF---EA 157 (299)
Q Consensus 84 ~~~~lv~e~~~~~~L~~~~~~~~~---~~~~~~~~~~~~i~~qi~~~l~~lh~~~~~~~~H~dl~~~nil~~~~~---~v 157 (299)
..++|+||+.+++|.+++...+. ....+++..++.++.||+.||+|||++ +++|+||+|+||+++.++ .+
T Consensus 83 -~~~lv~e~~~g~~L~~~i~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~---~ivH~dlkp~nil~~~~~~~~~~ 158 (277)
T cd05036 83 -PRFILLELMAGGDLKSFLRENRPRPERPSSLTMKDLLFCARDVAKGCKYLEEN---HFIHRDIAARNCLLTCKGPGRVA 158 (277)
T ss_pred -CcEEEEecCCCCCHHHHHHHhCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHHC---CEeecccchheEEEeccCCCcce
Confidence 45899999999999999865321 123688999999999999999999999 999999999999998654 58
Q ss_pred EEeeeccccccccccccccccccccccCcccCChhhhcccCcCccccchhhhHHHHHHHh-CCCCCCCCccCCCCchhHH
Q 038766 158 HVSDFGTSRMLDVHLQDLSSLSTAFQGTIGYLAPEFAYMRIVTTKVDVFSFGIVVMEFLT-KRRPTGLDEENGLSPISLR 236 (299)
Q Consensus 158 ~l~df~~~~~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~DiwslG~~l~~l~~-g~~p~~~~~~~~~~~~~~~ 236 (299)
+|+|||++....... ..........+..|+|||.+.+..++.++|||||||++|+|++ |..||..... ....
T Consensus 159 kl~dfg~~~~~~~~~--~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~el~~~g~~pf~~~~~-----~~~~ 231 (277)
T cd05036 159 KIADFGMARDIYRAS--YYRKGGRAMLPIKWMPPEAFLDGIFTSKTDVWSFGVLLWEIFSLGYMPYPGRTN-----QEVM 231 (277)
T ss_pred EeccCccccccCCcc--ceecCCCCCccHhhCCHHHHhcCCcCchhHHHHHHHHHHHHHcCCCCCCCCCCH-----HHHH
Confidence 999999987553110 0011112223467999999998889999999999999999996 8888853311 1121
Q ss_pred HHHHHHHhcCccCcccccCccccchhhHhHHHHHHHHHHHHHHHHhcCCCCCCCCChhhhhcC
Q 038766 237 QLVEKALANGINGVRQITDPKLVSSIYEEQEQHQVLEELFKLALVCTSSNPEDRPNMNELLIT 299 (299)
Q Consensus 237 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rpt~~~il~~ 299 (299)
.. ...... ... +..++..+.+++.+||+.+|++|||+.++++|
T Consensus 232 ~~---~~~~~~-----~~~------------~~~~~~~~~~~i~~cl~~~p~~Rps~~~vl~~ 274 (277)
T cd05036 232 EF---VTGGGR-----LDP------------PKGCPGPVYRIMTDCWQHTPEDRPNFATILER 274 (277)
T ss_pred HH---HHcCCc-----CCC------------CCCCCHHHHHHHHHHcCCCcccCcCHHHHHHH
Confidence 11 111110 000 12235678999999999999999999999975
|
Protein Tyrosine Kinase (PTK) family; Anaplastic Lymphoma Kinase (ALK) and Leukocyte Tyrosine (tyr) Kinase (LTK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyr residues in protein substrates. ALK and LTK are orphan receptor tyr kinases (RTKs) whose ligands are not yet well-defined. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. They are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. ALK appears to play an important role in mammalian neural development as well |
| >cd05032 PTKc_InsR_like Catalytic domain of Insulin Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.1e-40 Score=276.11 Aligned_cols=259 Identities=25% Similarity=0.373 Sum_probs=198.3
Q ss_pred HHHhCCCCCCceeecCCcceEEEEEeC------CCcEEEEEEeccCcCChhhhHHHHHHHHHHHhcCCcceeeeeeEEEc
Q 038766 8 ENATGSFSENNIIGNSNLSTVYKGRLE------DGEIVAVKKLNFHQFSAESDKSFYREAKTLKELKHRNLVKVLGYAWE 81 (299)
Q Consensus 8 ~~~~~~y~~~~~lg~g~~~~v~~~~~~------~~~~~~vK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~ 81 (299)
+...++|.+.+.||+|++|.||++.+. .+..+++|.+.... .......+.+|+..++.+.|+||+++++++..
T Consensus 2 ~~~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~aik~~~~~~-~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~ 80 (277)
T cd05032 2 ELPREKITLIRELGQGSFGMVYEGLAKGVVKGEPETRVAIKTVNENA-SMRERIEFLNEASVMKEFNCHHVVRLLGVVST 80 (277)
T ss_pred ccchHHeeEEeEecCCCCceEEEEEEeccCCCCcceeEEEEecCCcc-CHHHHHHHHHHHHHHHhCCCCceeEEEEEEcC
Confidence 456789999999999999999999753 24789999975332 23334567889999999999999999997655
Q ss_pred CCCeeEEEEeecCCCChHHHhcCCCC------CCCCCChhhHHHHHHHHHHHHHHhhcCCCCCeeeecccCCceeeCCCC
Q 038766 82 SGKLKALILEYMENGSLESVIHGPGV------DHSRWTLPKRIDVLISVANGLDYLHSGYDIPIVHCDMKPSNILLDRDF 155 (299)
Q Consensus 82 ~~~~~~lv~e~~~~~~L~~~~~~~~~------~~~~~~~~~~~~i~~qi~~~l~~lh~~~~~~~~H~dl~~~nil~~~~~ 155 (299)
+...++|+||+.+++|.+++..... ....+++..++.++.|++.||.|||+. +++|+||+|+||+++.++
T Consensus 81 -~~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~di~p~nill~~~~ 156 (277)
T cd05032 81 -GQPTLVVMELMAKGDLKSYLRSRRPEAENNPGLGPPTLQKFIQMAAEIADGMAYLAAK---KFVHRDLAARNCMVAEDL 156 (277)
T ss_pred -CCCcEEEEecCCCCCHHHHHHhcccchhhccCCCCCCHHHHHHHHHHHHHHHHHHHhC---CccccccChheEEEcCCC
Confidence 4566999999999999998864321 123478889999999999999999998 999999999999999999
Q ss_pred cEEEeeeccccccccccccccccccccccCcccCChhhhcccCcCccccchhhhHHHHHHHh-CCCCCCCCccCCCCchh
Q 038766 156 EAHVSDFGTSRMLDVHLQDLSSLSTAFQGTIGYLAPEFAYMRIVTTKVDVFSFGIVVMEFLT-KRRPTGLDEENGLSPIS 234 (299)
Q Consensus 156 ~v~l~df~~~~~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~DiwslG~~l~~l~~-g~~p~~~~~~~~~~~~~ 234 (299)
.++|+|||++....... .........++..|+|||.+....++.++||||||+++|++++ |..||... ....
T Consensus 157 ~~kl~dfg~~~~~~~~~--~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~~~~-----~~~~ 229 (277)
T cd05032 157 TVKIGDFGMTRDIYETD--YYRKGGKGLLPVRWMAPESLKDGVFTTKSDVWSFGVVLWEMATLAEQPYQGL-----SNEE 229 (277)
T ss_pred CEEECCcccchhhccCc--ccccCCCCCccccccCHHHHhcCCCCcccchHHHHHHHHHhhccCCCCCccC-----CHHH
Confidence 99999999987543211 1111223345678999999988889999999999999999998 88887432 1122
Q ss_pred HHHHHHHHHhcCccCcccccCccccchhhHhHHHHHHHHHHHHHHHHhcCCCCCCCCChhhhhc
Q 038766 235 LRQLVEKALANGINGVRQITDPKLVSSIYEEQEQHQVLEELFKLALVCTSSNPEDRPNMNELLI 298 (299)
Q Consensus 235 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rpt~~~il~ 298 (299)
... ...... .... +...+..+.+++.+||+.+|++|||+.++++
T Consensus 230 ~~~---~~~~~~---~~~~--------------~~~~~~~~~~li~~~l~~~p~~Rpt~~~l~~ 273 (277)
T cd05032 230 VLK---FVIDGG---HLDL--------------PENCPDKLLELMRMCWQYNPKMRPTFLEIVS 273 (277)
T ss_pred HHH---HHhcCC---CCCC--------------CCCCCHHHHHHHHHHcCCChhhCCCHHHHHH
Confidence 111 111111 0000 1122567899999999999999999999985
|
Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The InsR subfamily is composed of InsR, Insulin-like Growth Factor-1 Receptor (IGF-1R), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR and IGF-1R are receptor tyr kinases (RTKs) composed of two alphabeta heterodimers. Binding of the ligand (insulin, IGF-1, or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological |
| >cd05090 PTKc_Ror1 Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.5e-40 Score=275.07 Aligned_cols=255 Identities=23% Similarity=0.369 Sum_probs=195.3
Q ss_pred CCCCCCceeecCCcceEEEEEe-----CCCcEEEEEEeccCcCChhhhHHHHHHHHHHHhcCCcceeeeeeEEEcCCCee
Q 038766 12 GSFSENNIIGNSNLSTVYKGRL-----EDGEIVAVKKLNFHQFSAESDKSFYREAKTLKELKHRNLVKVLGYAWESGKLK 86 (299)
Q Consensus 12 ~~y~~~~~lg~g~~~~v~~~~~-----~~~~~~~vK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~ 86 (299)
++|++.+.||+|+||+||++.+ .++..+++|.+.... .......+.+|+..++.++||||+++++++.. +...
T Consensus 5 ~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~~ik~~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~-~~~~ 82 (283)
T cd05090 5 SAVRFMEELGECAFGKIYKGHLYLPGMDHAQLVAIKTLKDIN-NPQQWGEFQQEASLMAELHHPNIVCLLGVVTQ-EQPV 82 (283)
T ss_pred hhceeeeeccccCCcceEEEEEecCCCCCcceEEEEeccCCC-CHHHHHHHHHHHHHHhhCCCCCeeeEEEEEec-CCce
Confidence 5788999999999999999974 246789999986422 33445678899999999999999999997655 4556
Q ss_pred EEEEeecCCCChHHHhcCCC-------------CCCCCCChhhHHHHHHHHHHHHHHhhcCCCCCeeeecccCCceeeCC
Q 038766 87 ALILEYMENGSLESVIHGPG-------------VDHSRWTLPKRIDVLISVANGLDYLHSGYDIPIVHCDMKPSNILLDR 153 (299)
Q Consensus 87 ~lv~e~~~~~~L~~~~~~~~-------------~~~~~~~~~~~~~i~~qi~~~l~~lh~~~~~~~~H~dl~~~nil~~~ 153 (299)
++|+||+.+++|.+++.... .....+++..+..++.|++.||+|||++ +++|+||||+||+++.
T Consensus 83 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~~---~i~H~dlkp~nili~~ 159 (283)
T cd05090 83 CMLFEYLNQGDLHEFLIMRSPHSDVGCSSDEDGTVKSSLDHGDFLHIAIQIAAGMEYLSSH---FFVHKDLAARNILIGE 159 (283)
T ss_pred EEEEEcCCCCcHHHHHHhcCCCCccccccccccccccccCHHHHHHHHHHHHHHHHHHHhc---CeehhccccceEEEcC
Confidence 99999999999999874211 1134578889999999999999999999 9999999999999999
Q ss_pred CCcEEEeeeccccccccccccccccccccccCcccCChhhhcccCcCccccchhhhHHHHHHHh-CCCCCCCCccCCCCc
Q 038766 154 DFEAHVSDFGTSRMLDVHLQDLSSLSTAFQGTIGYLAPEFAYMRIVTTKVDVFSFGIVVMEFLT-KRRPTGLDEENGLSP 232 (299)
Q Consensus 154 ~~~v~l~df~~~~~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~DiwslG~~l~~l~~-g~~p~~~~~~~~~~~ 232 (299)
++.++|+|||++....... .........++..|+|||.+.+..++.++|+||||+++|+|++ |..||... ..
T Consensus 160 ~~~~kl~dfg~~~~~~~~~--~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~~g~~p~~~~-----~~ 232 (283)
T cd05090 160 QLHVKISDLGLSREIYSAD--YYRVQPKSLLPIRWMPPEAIMYGKFSSDSDIWSFGVVLWEIFSFGLQPYYGF-----SN 232 (283)
T ss_pred CCcEEeccccccccccCCc--ceecccCCCccceecChHHhccCCCCchhhhHHHHHHHHHHHcCCCCCCCCC-----CH
Confidence 9999999999987643211 1111222334567999999988889999999999999999998 88887432 11
Q ss_pred hhHHHHHHHHHhcCccCcccccCccccchhhHhHHHHHHHHHHHHHHHHhcCCCCCCCCChhhhhc
Q 038766 233 ISLRQLVEKALANGINGVRQITDPKLVSSIYEEQEQHQVLEELFKLALVCTSSNPEDRPNMNELLI 298 (299)
Q Consensus 233 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rpt~~~il~ 298 (299)
..+.+.+ ....... .+..++..+.+++.+||+.||++||++.++++
T Consensus 233 ~~~~~~~---~~~~~~~-----------------~~~~~~~~~~~li~~cl~~~p~~Rp~~~~i~~ 278 (283)
T cd05090 233 QEVIEMV---RKRQLLP-----------------CSEDCPPRMYSLMTECWQEGPSRRPRFKDIHT 278 (283)
T ss_pred HHHHHHH---HcCCcCC-----------------CCCCCCHHHHHHHHHHcccCcccCcCHHHHHH
Confidence 1222211 1111000 01223467899999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 1 (Ror1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase cataly |
| >cd07842 STKc_CDK8_like Catalytic domain of Cyclin-Dependent protein Kinase 8-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-39 Score=277.04 Aligned_cols=282 Identities=24% Similarity=0.284 Sum_probs=200.3
Q ss_pred CCCCCceeecCCcceEEEEEeC---CCcEEEEEEeccCc-CChhhhHHHHHHHHHHHhcCCcceeeeeeEEEcC-CCeeE
Q 038766 13 SFSENNIIGNSNLSTVYKGRLE---DGEIVAVKKLNFHQ-FSAESDKSFYREAKTLKELKHRNLVKVLGYAWES-GKLKA 87 (299)
Q Consensus 13 ~y~~~~~lg~g~~~~v~~~~~~---~~~~~~vK~~~~~~-~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~-~~~~~ 87 (299)
+|.+.+.||+|++|.||++.+. ++..||+|.+.... ........+.+|+.+++.++||||+++++++... +...+
T Consensus 1 ~y~~~~~ig~g~~g~v~~~~~~~~~~~~~~alK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~ 80 (316)
T cd07842 1 KYEIEGCIGRGTYGRVYKAKRKNGKDGKEYAIKKFKGDKEQYTGISQSACREIALLRELKHENVVSLVEVFLEHADKSVY 80 (316)
T ss_pred CceEEEEeccCCcEEEEEEEecCCCCCCeEEEEEeccccccccCccHHHHHHHHHHHhcCCCCccceEEEEeCCCCceEE
Confidence 5889999999999999999874 47999999987533 1223346678899999999999999999977654 25679
Q ss_pred EEEeecCCCChHHHhcCCCCCC-CCCChhhHHHHHHHHHHHHHHhhcCCCCCeeeecccCCceeeCC----CCcEEEeee
Q 038766 88 LILEYMENGSLESVIHGPGVDH-SRWTLPKRIDVLISVANGLDYLHSGYDIPIVHCDMKPSNILLDR----DFEAHVSDF 162 (299)
Q Consensus 88 lv~e~~~~~~L~~~~~~~~~~~-~~~~~~~~~~i~~qi~~~l~~lh~~~~~~~~H~dl~~~nil~~~----~~~v~l~df 162 (299)
+|+|++.+ +|.+++....... ..+++..++.++.|++.||.|||+. +++|+||+|+||+++. ++.++|+||
T Consensus 81 lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~---~i~h~dlkp~Nil~~~~~~~~~~~kl~Df 156 (316)
T cd07842 81 LLFDYAEH-DLWQIIKFHRQAKRVSIPPSMVKSLLWQILNGVHYLHSN---WVLHRDLKPANILVMGEGPERGVVKIGDL 156 (316)
T ss_pred EEEeCCCc-CHHHHHHhhccCCCcCcCHHHHHHHHHHHHHHHHHHHhC---CEeeCCCCHHHEEEcCCCCccceEEECCC
Confidence 99999964 7777765432222 3789999999999999999999999 9999999999999999 899999999
Q ss_pred ccccccccccccccccccccccCcccCChhhhcc-cCcCccccchhhhHHHHHHHhCCCCCCCCccCCCCc-----hhHH
Q 038766 163 GTSRMLDVHLQDLSSLSTAFQGTIGYLAPEFAYM-RIVTTKVDVFSFGIVVMEFLTKRRPTGLDEENGLSP-----ISLR 236 (299)
Q Consensus 163 ~~~~~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~-~~~~~~~DiwslG~~l~~l~~g~~p~~~~~~~~~~~-----~~~~ 236 (299)
|++......... ........++..|+|||.+.+ ..++.++|+||||+++++|++|..||.......... ..+.
T Consensus 157 g~~~~~~~~~~~-~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~~l~~~~~~~~~~~~~~~~~~~~~~~~~~ 235 (316)
T cd07842 157 GLARLFNAPLKP-LADLDPVVVTIWYRAPELLLGARHYTKAIDIWAIGCIFAELLTLEPIFKGREAKIKKSNPFQRDQLE 235 (316)
T ss_pred ccccccCCCccc-ccccCCccccccccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhcCCCCcCCcccccccchhHHHHHH
Confidence 998765422111 111233456788999998766 457889999999999999999999997554332110 0111
Q ss_pred HHHHHHHhcC---------ccCcc----cccCccccchhhHhHHHH--HHHHHHHHHHHHhcCCCCCCCCChhhhhcC
Q 038766 237 QLVEKALANG---------INGVR----QITDPKLVSSIYEEQEQH--QVLEELFKLALVCTSSNPEDRPNMNELLIT 299 (299)
Q Consensus 237 ~~~~~~~~~~---------~~~~~----~~~~~~~~~~~~~~~~~~--~~~~~l~~li~~~l~~dP~~Rpt~~~il~~ 299 (299)
..+....... ..... .................. ..+..+.+++.+||..||++|||++++++|
T Consensus 236 ~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rps~~eil~~ 313 (316)
T cd07842 236 RIFEVLGTPTEKDWPDIKKMPEYDTLMKDFKTKTYPSNSLAKWMEKHKKPDSQGFDLLRKLLEYDPTKRITAEEALEH 313 (316)
T ss_pred HHHHHhCCCchhHHHHHhhcccchhhhhhccCCCCCCccHHHHHHhccCCCHHHHHHHHHHhcCCcccCcCHHHHhcC
Confidence 1111000000 00000 000000000000111111 455689999999999999999999999987
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK8, CDC2L6, and similar proteins. CDK8 functions as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the |
| >cd06617 PKc_MKK3_6 Catalytic domain of the dual-specificity Protein Kinases, MAP kinase kinases 3 and 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-39 Score=272.74 Aligned_cols=255 Identities=25% Similarity=0.320 Sum_probs=192.0
Q ss_pred CCCCCCceeecCCcceEEEEEeC-CCcEEEEEEeccCcCChhhhHHHHHHHHH-HHhcCCcceeeeeeEEEcCCCeeEEE
Q 038766 12 GSFSENNIIGNSNLSTVYKGRLE-DGEIVAVKKLNFHQFSAESDKSFYREAKT-LKELKHRNLVKVLGYAWESGKLKALI 89 (299)
Q Consensus 12 ~~y~~~~~lg~g~~~~v~~~~~~-~~~~~~vK~~~~~~~~~~~~~~~~~e~~~-l~~l~h~~i~~~~~~~~~~~~~~~lv 89 (299)
++|.+.+.||+|+||.||++.+. +|+.||+|++...... .....+..|+.. ++...|||++++++.+.. +...+++
T Consensus 1 ~~~~~~~~ig~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~-~~~~~~~~e~~~~~~~~~~~~iv~~~~~~~~-~~~~~lv 78 (283)
T cd06617 1 DDLEVIEELGRGAYGVVDKMRHVPTGTIMAVKRIRATVNS-QEQKRLLMDLDISMRSVDCPYTVTFYGALFR-EGDVWIC 78 (283)
T ss_pred CCceEEEEecccCCeEEEEEEEcCCCcEEEEEEEecCCCc-HHHHHHHHHHHHHHHHcCCCCeeeeeEEEec-CCcEEEE
Confidence 47899999999999999999874 5999999998754322 234455556554 566689999999997765 4456999
Q ss_pred EeecCCCChHHHhcCCCCCCCCCChhhHHHHHHHHHHHHHHhhcCCCCCeeeecccCCceeeCCCCcEEEeeeccccccc
Q 038766 90 LEYMENGSLESVIHGPGVDHSRWTLPKRIDVLISVANGLDYLHSGYDIPIVHCDMKPSNILLDRDFEAHVSDFGTSRMLD 169 (299)
Q Consensus 90 ~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lh~~~~~~~~H~dl~~~nil~~~~~~v~l~df~~~~~~~ 169 (299)
+||++ ++|.+++......+..+++..++.++.|++.||+|||++ .+++|+||+|+||+++.++.++|+|||++....
T Consensus 79 ~e~~~-~~l~~~l~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~--~~i~h~dlkp~nil~~~~~~~kl~dfg~~~~~~ 155 (283)
T cd06617 79 MEVMD-TSLDKFYKKVYDKGLTIPEDILGKIAVSIVKALEYLHSK--LSVIHRDVKPSNVLINRNGQVKLCDFGISGYLV 155 (283)
T ss_pred hhhhc-ccHHHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHhhc--CCeecCCCCHHHEEECCCCCEEEeecccccccc
Confidence 99996 588887764333456799999999999999999999974 289999999999999999999999999987543
Q ss_pred cccccccccccccccCcccCChhhhcc----cCcCccccchhhhHHHHHHHhCCCCCCCCccCCCCchhHHHHHHHHHhc
Q 038766 170 VHLQDLSSLSTAFQGTIGYLAPEFAYM----RIVTTKVDVFSFGIVVMEFLTKRRPTGLDEENGLSPISLRQLVEKALAN 245 (299)
Q Consensus 170 ~~~~~~~~~~~~~~~~~~y~~PE~~~~----~~~~~~~DiwslG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~ 245 (299)
.. .......++..|+|||.+.+ ..++.++|+|||||++|+|++|..||..... . .+.+......
T Consensus 156 ~~-----~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~----~---~~~~~~~~~~ 223 (283)
T cd06617 156 DS-----VAKTIDAGCKPYMAPERINPELNQKGYDVKSDVWSLGITMIELATGRFPYDSWKT----P---FQQLKQVVEE 223 (283)
T ss_pred cc-----cccccccCCccccChhhcCCcccccccCccccchhhHHHHHHHHhCCCCCCcccc----C---HHHHHHHHhc
Confidence 11 11222456788999998765 4468899999999999999999999842111 0 1111111111
Q ss_pred CccCcccccCccccchhhHhHHHHHHHHHHHHHHHHhcCCCCCCCCChhhhhcC
Q 038766 246 GINGVRQITDPKLVSSIYEEQEQHQVLEELFKLALVCTSSNPEDRPNMNELLIT 299 (299)
Q Consensus 246 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rpt~~~il~~ 299 (299)
.... +. ...++.++.++|.+||..+|++|||++++++|
T Consensus 224 ~~~~---~~-------------~~~~~~~l~~li~~~l~~~p~~Rp~~~~il~~ 261 (283)
T cd06617 224 PSPQ---LP-------------AEKFSPEFQDFVNKCLKKNYKERPNYPELLQH 261 (283)
T ss_pred CCCC---CC-------------ccccCHHHHHHHHHHccCChhhCcCHHHHhcC
Confidence 1000 00 11246689999999999999999999999986
|
Protein kinases (PKs), MAP kinase kinase 3 (MKK3) and MKK6 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK3 and MKK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK3 and MKK6 are dual-specificity PKs |
| >cd06642 STKc_STK25-YSK1 Catalytic domain of the Protein Serine/Threonine Kinase, STK25 or Yeast Sps1/Ste20-related kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-40 Score=278.96 Aligned_cols=250 Identities=25% Similarity=0.398 Sum_probs=198.0
Q ss_pred hCCCCCCceeecCCcceEEEEEeC-CCcEEEEEEeccCcCChhhhHHHHHHHHHHHhcCCcceeeeeeEEEcCCCeeEEE
Q 038766 11 TGSFSENNIIGNSNLSTVYKGRLE-DGEIVAVKKLNFHQFSAESDKSFYREAKTLKELKHRNLVKVLGYAWESGKLKALI 89 (299)
Q Consensus 11 ~~~y~~~~~lg~g~~~~v~~~~~~-~~~~~~vK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~lv 89 (299)
.+.|...+.||+|++|.||++.+. ++..+|+|.+.... .....+.+.+|+..++++.||||+++++.+.. ++..++|
T Consensus 3 ~~~y~~~~~l~~g~~~~vy~~~~~~~~~~vaiK~~~~~~-~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~-~~~~~lv 80 (277)
T cd06642 3 EELFTKLERIGKGSFGEVYKGIDNRTKEVVAIKIIDLEE-AEDEIEDIQQEITVLSQCDSPYITRYYGSYLK-GTKLWII 80 (277)
T ss_pred HHHHHHHHHhcCCCCeeEEEEEEcCCCeEEEEEEecccc-chHHHHHHHHHHHHHHcCCCCccHhhhccccc-CCceEEE
Confidence 355777889999999999999864 57889999886433 23455678899999999999999999996655 5566999
Q ss_pred EeecCCCChHHHhcCCCCCCCCCChhhHHHHHHHHHHHHHHhhcCCCCCeeeecccCCceeeCCCCcEEEeeeccccccc
Q 038766 90 LEYMENGSLESVIHGPGVDHSRWTLPKRIDVLISVANGLDYLHSGYDIPIVHCDMKPSNILLDRDFEAHVSDFGTSRMLD 169 (299)
Q Consensus 90 ~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lh~~~~~~~~H~dl~~~nil~~~~~~v~l~df~~~~~~~ 169 (299)
+||+.+++|.+++. ...+++..++.++.|++.|+.|||++ +++|+||+|+||+++.++.++|+|||++..+.
T Consensus 81 ~e~~~~~~L~~~~~-----~~~~~~~~~~~~~~~i~~~l~~lH~~---~ivH~dl~p~ni~i~~~~~~~l~dfg~~~~~~ 152 (277)
T cd06642 81 MEYLGGGSALDLLK-----PGPLEETYIATILREILKGLDYLHSE---RKIHRDIKAANVLLSEQGDVKLADFGVAGQLT 152 (277)
T ss_pred EEccCCCcHHHHhh-----cCCCCHHHHHHHHHHHHHHHHHHhcC---CeeccCCChheEEEeCCCCEEEcccccccccc
Confidence 99999999999885 34688999999999999999999999 99999999999999999999999999987544
Q ss_pred cccccccccccccccCcccCChhhhcccCcCccccchhhhHHHHHHHhCCCCCCCCccCCCCchhHHHHHHHHHhcCccC
Q 038766 170 VHLQDLSSLSTAFQGTIGYLAPEFAYMRIVTTKVDVFSFGIVVMEFLTKRRPTGLDEENGLSPISLRQLVEKALANGING 249 (299)
Q Consensus 170 ~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~DiwslG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 249 (299)
.. ........++..|+|||.+.+..++.++|+||||+++++|++|..|+.... ....... .....
T Consensus 153 ~~----~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~tg~~p~~~~~-----~~~~~~~----~~~~~-- 217 (277)
T cd06642 153 DT----QIKRNTFVGTPFWMAPEVIKQSAYDFKADIWSLGITAIELAKGEPPNSDLH-----PMRVLFL----IPKNS-- 217 (277)
T ss_pred Cc----chhhhcccCcccccCHHHhCcCCCchhhhHHHHHHHHHHHHhCCCCCcccc-----hhhHHhh----hhcCC--
Confidence 21 111223456788999999998889999999999999999999999985321 1111110 00000
Q ss_pred cccccCccccchhhHhHHHHHHHHHHHHHHHHhcCCCCCCCCChhhhhcC
Q 038766 250 VRQITDPKLVSSIYEEQEQHQVLEELFKLALVCTSSNPEDRPNMNELLIT 299 (299)
Q Consensus 250 ~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rpt~~~il~~ 299 (299)
.+ .....++.++.++|.+||..+|++|||+.+++.|
T Consensus 218 -----~~---------~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~ 253 (277)
T cd06642 218 -----PP---------TLEGQYSKPFKEFVEACLNKDPRFRPTAKELLKH 253 (277)
T ss_pred -----CC---------CCCcccCHHHHHHHHHHccCCcccCcCHHHHHHh
Confidence 00 0022345678999999999999999999999976
|
Serine/threonine kinases (STKs), STK25 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK25 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. STK25 is also called Ste20/oxidant stress response kinase 1 (SOK1) or yeast Sps1/Ste20-related kinase 1 (YSK1). STK25 is localized in the Golgi apparatus through its interaction with the Golgi matrix protein GM130. It may play a role in the regulation of cell migration and polarization. STK25 binds and phosphorylates CCM3 (cerebral cavernous malformation 3), also called PCD10 (programmed cell death 10), and may play a role in apoptosis. Human STK25 |
| >cd07860 STKc_CDK2_3 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase 2 and 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.4e-40 Score=275.20 Aligned_cols=271 Identities=27% Similarity=0.359 Sum_probs=198.1
Q ss_pred CCCCCceeecCCcceEEEEEeC-CCcEEEEEEeccCcCChhhhHHHHHHHHHHHhcCCcceeeeeeEEEcCCCeeEEEEe
Q 038766 13 SFSENNIIGNSNLSTVYKGRLE-DGEIVAVKKLNFHQFSAESDKSFYREAKTLKELKHRNLVKVLGYAWESGKLKALILE 91 (299)
Q Consensus 13 ~y~~~~~lg~g~~~~v~~~~~~-~~~~~~vK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~lv~e 91 (299)
.|++.+.||.|++|.||++++. ++..+++|.+............+.+|++.+++++||||+++++++.. +...++|+|
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~-~~~~~~v~e 79 (284)
T cd07860 1 NFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLDVIHT-ENKLYLVFE 79 (284)
T ss_pred CceeeeeecCCCceEEEEEEECCCCCEEEEEEccccccccccchHHHHHHHHHHhcCCCCCcchhhhccc-CCcEEEEee
Confidence 4888999999999999999874 68999999987555444455678899999999999999999997654 556699999
Q ss_pred ecCCCChHHHhcCCCCCCCCCChhhHHHHHHHHHHHHHHhhcCCCCCeeeecccCCceeeCCCCcEEEeeeccccccccc
Q 038766 92 YMENGSLESVIHGPGVDHSRWTLPKRIDVLISVANGLDYLHSGYDIPIVHCDMKPSNILLDRDFEAHVSDFGTSRMLDVH 171 (299)
Q Consensus 92 ~~~~~~L~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lh~~~~~~~~H~dl~~~nil~~~~~~v~l~df~~~~~~~~~ 171 (299)
|+. ++|.+++... ....+++..++.++.|++.||+|||+. +++|+||+|+||+++.++.++|+|||++......
T Consensus 80 ~~~-~~l~~~~~~~--~~~~l~~~~~~~~~~~i~~~l~~lh~~---~i~H~~l~p~nill~~~~~~~l~dfg~~~~~~~~ 153 (284)
T cd07860 80 FLH-QDLKKFMDAS--PLSGIPLPLIKSYLFQLLQGLAFCHSH---RVLHRDLKPQNLLINTEGAIKLADFGLARAFGVP 153 (284)
T ss_pred ccc-cCHHHHHHhC--CCCCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHEEECCCCCEEEeeccchhhcccC
Confidence 995 5888887543 345689999999999999999999999 9999999999999999999999999998754321
Q ss_pred cccccccccccccCcccCChhhhcccC-cCccccchhhhHHHHHHHhCCCCCCCCccCCCCchhHHHHHHHHHhcC---c
Q 038766 172 LQDLSSLSTAFQGTIGYLAPEFAYMRI-VTTKVDVFSFGIVVMEFLTKRRPTGLDEENGLSPISLRQLVEKALANG---I 247 (299)
Q Consensus 172 ~~~~~~~~~~~~~~~~y~~PE~~~~~~-~~~~~DiwslG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~---~ 247 (299)
. .......++..|+|||.+.+.. ++.++|+||||+++|+|++|..||...... .............. +
T Consensus 154 ~----~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~~l~tg~~p~~~~~~~----~~~~~~~~~~~~~~~~~~ 225 (284)
T cd07860 154 V----RTYTHEVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEI----DQLFRIFRTLGTPDEVVW 225 (284)
T ss_pred c----cccccccccccccCCeEEecCCCCCcHHHHHHHHHHHHHHHHCCCCCCCCCHH----HHHHHHHHHhCCCChhhh
Confidence 1 1122234577899999877644 578899999999999999999998643211 01111110000000 0
Q ss_pred cCcccc-----cCccccchhhHhHHHHHHHHHHHHHHHHhcCCCCCCCCChhhhhcC
Q 038766 248 NGVRQI-----TDPKLVSSIYEEQEQHQVLEELFKLALVCTSSNPEDRPNMNELLIT 299 (299)
Q Consensus 248 ~~~~~~-----~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rpt~~~il~~ 299 (299)
+..... ..+....... ......++.++.++|.+||..||++|||+++++.|
T Consensus 226 ~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~~l~~ 281 (284)
T cd07860 226 PGVTSLPDYKPSFPKWARQDF-SKVVPPLDEDGRDLLSQMLHYDPNKRISAKAALAH 281 (284)
T ss_pred hhhhHHHHHHhhcccccccCH-HHHcccCCHHHHHHHHHhcCCCcccCCCHHHHhcC
Confidence 000000 0000000000 01122356678999999999999999999999987
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 2 (CDK2) and CDK3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK2/3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK2 is regulated by cyclin E or cyclin A. Upon activation by cyclin E, it phosphorylates the retinoblastoma (pRb) protein which activates E2F mediated transcription and allows cells to move into S phase. The CDK2/cyclin A complex |
| >cd05586 STKc_Sck1_like Catalytic domain of Suppressor of loss of cAMP-dependent protein kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.7e-41 Score=286.00 Aligned_cols=243 Identities=24% Similarity=0.269 Sum_probs=185.3
Q ss_pred eecCCcceEEEEEeC-CCcEEEEEEeccCcCC-hhhhHHHHHHHHHHHhc---CCcceeeeeeEEEcCCCeeEEEEeecC
Q 038766 20 IGNSNLSTVYKGRLE-DGEIVAVKKLNFHQFS-AESDKSFYREAKTLKEL---KHRNLVKVLGYAWESGKLKALILEYME 94 (299)
Q Consensus 20 lg~g~~~~v~~~~~~-~~~~~~vK~~~~~~~~-~~~~~~~~~e~~~l~~l---~h~~i~~~~~~~~~~~~~~~lv~e~~~ 94 (299)
||+|+||+||++.+. +++.||+|++...... .........|..++... .||+|+++++++.. ....++|+||+.
T Consensus 1 lG~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~p~i~~~~~~~~~-~~~~~lv~e~~~ 79 (330)
T cd05586 1 IGKGTFGQVYQVRKKDTRRIYAMKVLSKKEIVAKKEVAHTIGERNILVRTLLDESPFIVGLKFSFQT-DSDLYLVTDYMS 79 (330)
T ss_pred CCCCCceEEEEEEECCCCCEEEEEEEeHHHHhhhhHHHHHHHHHHHHHHhccCCCCcCcceEEEEec-CCeEEEEEcCCC
Confidence 799999999999864 5899999998643221 12233445566666655 59999999996554 556699999999
Q ss_pred CCChHHHhcCCCCCCCCCChhhHHHHHHHHHHHHHHhhcCCCCCeeeecccCCceeeCCCCcEEEeeecccccccccccc
Q 038766 95 NGSLESVIHGPGVDHSRWTLPKRIDVLISVANGLDYLHSGYDIPIVHCDMKPSNILLDRDFEAHVSDFGTSRMLDVHLQD 174 (299)
Q Consensus 95 ~~~L~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lh~~~~~~~~H~dl~~~nil~~~~~~v~l~df~~~~~~~~~~~~ 174 (299)
+++|...+. ....+++..++.++.||+.||+|||+. +++|+||||+||+++.++.++|+|||++.....
T Consensus 80 ~g~L~~~l~----~~~~~~~~~~~~~~~qil~al~~LH~~---~ivHrDlkp~Nili~~~~~~kl~Dfg~a~~~~~---- 148 (330)
T cd05586 80 GGELFWHLQ----KEGRFSEDRAKFYIAELVLALEHLHKY---DIVYRDLKPENILLDATGHIALCDFGLSKANLT---- 148 (330)
T ss_pred CChHHHHHH----hcCCCCHHHHHHHHHHHHHHHHHHHHC---CeEeccCCHHHeEECCCCCEEEecCCcCcCCCC----
Confidence 999998886 456799999999999999999999999 999999999999999999999999999864321
Q ss_pred ccccccccccCcccCChhhhccc-CcCccccchhhhHHHHHHHhCCCCCCCCccCCCCchhHHHHHHHHHhcCccCcccc
Q 038766 175 LSSLSTAFQGTIGYLAPEFAYMR-IVTTKVDVFSFGIVVMEFLTKRRPTGLDEENGLSPISLRQLVEKALANGINGVRQI 253 (299)
Q Consensus 175 ~~~~~~~~~~~~~y~~PE~~~~~-~~~~~~DiwslG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 253 (299)
.........+++.|+|||.+.+. .++.++|||||||++|+|++|..||..... .+......... ..+
T Consensus 149 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslGvil~elltG~~Pf~~~~~--------~~~~~~i~~~~----~~~ 216 (330)
T cd05586 149 DNKTTNTFCGTTEYLAPEVLLDEKGYTKHVDFWSLGVLVFEMCCGWSPFYAEDT--------QQMYRNIAFGK----VRF 216 (330)
T ss_pred CCCCccCccCCccccCHHHHcCCCCCCCccceeccccEEEEeccCCCCCCCCCH--------HHHHHHHHcCC----CCC
Confidence 11223345688999999988754 478999999999999999999999854311 12222211110 000
Q ss_pred cCccccchhhHhHHHHHHHHHHHHHHHHhcCCCCCCCC----ChhhhhcC
Q 038766 254 TDPKLVSSIYEEQEQHQVLEELFKLALVCTSSNPEDRP----NMNELLIT 299 (299)
Q Consensus 254 ~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rp----t~~~il~~ 299 (299)
. ...++.++.++|++||..||.+|| +++++++|
T Consensus 217 ~-------------~~~~~~~~~~li~~~L~~~P~~R~~~~~~~~~ll~h 253 (330)
T cd05586 217 P-------------KNVLSDEGRQFVKGLLNRNPQHRLGAHRDAVELKEH 253 (330)
T ss_pred C-------------CccCCHHHHHHHHHHcCCCHHHCCCCCCCHHHHhcC
Confidence 0 112356788999999999999998 68888876
|
Serine/Threonine Kinases (STKs), Fission yeast Suppressor of loss of cAMP-dependent protein kinase (Sck1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sck1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the Schizosaccharomyces pombe STK Sck1. Sck1 plays a role in trehalase activation triggered by glucose and a nitrogen source. Trehalase catalyzes the cleavage of the disaccharide trehalose to glucose. Trehalose, as a carbohydrate reserve and stress metabolite, plays an important role in the response of |
| >cd05094 PTKc_TrkC Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase C | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.7e-40 Score=276.08 Aligned_cols=254 Identities=25% Similarity=0.394 Sum_probs=195.6
Q ss_pred CCCCCCceeecCCcceEEEEEeC------CCcEEEEEEeccCcCChhhhHHHHHHHHHHHhcCCcceeeeeeEEEcCCCe
Q 038766 12 GSFSENNIIGNSNLSTVYKGRLE------DGEIVAVKKLNFHQFSAESDKSFYREAKTLKELKHRNLVKVLGYAWESGKL 85 (299)
Q Consensus 12 ~~y~~~~~lg~g~~~~v~~~~~~------~~~~~~vK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~ 85 (299)
.+|.+.+.||+|++|.||++... ++..+++|.+.. ........+.+|++.+++++|+||+++++.+.. +..
T Consensus 5 ~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~~~~k~~~~--~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~-~~~ 81 (291)
T cd05094 5 RDIVLKRELGEGAFGKVFLAECYNLSPTKDKMLVAVKALKD--PTLAARKDFQREAELLTNLQHEHIVKFYGVCGD-GDP 81 (291)
T ss_pred HHeEEeeeecccCCCeEEEeEeeccCCCCcceeeEEEecCC--ccHHHHHHHHHHHHHHhcCCCCCcceEEEEEcc-CCc
Confidence 56888999999999999999742 355688888752 233345678899999999999999999996654 556
Q ss_pred eEEEEeecCCCChHHHhcCCCC------------CCCCCChhhHHHHHHHHHHHHHHhhcCCCCCeeeecccCCceeeCC
Q 038766 86 KALILEYMENGSLESVIHGPGV------------DHSRWTLPKRIDVLISVANGLDYLHSGYDIPIVHCDMKPSNILLDR 153 (299)
Q Consensus 86 ~~lv~e~~~~~~L~~~~~~~~~------------~~~~~~~~~~~~i~~qi~~~l~~lh~~~~~~~~H~dl~~~nil~~~ 153 (299)
.++|+||+.+++|.+++...+. ....+++..++.++.||+.||++||++ +++|+||||+||+++.
T Consensus 82 ~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~~---~i~H~dlkp~Nil~~~ 158 (291)
T cd05094 82 LIMVFEYMKHGDLNKFLRAHGPDAMILVDGQPRQAKGELGLSQMLHIASQIASGMVYLASQ---HFVHRDLATRNCLVGA 158 (291)
T ss_pred eEEEEecCCCCcHHHHHHhcCcccccccccccccCcCCCCHHHHHHHHHHHHHHHHHHHhC---CeeecccCcceEEEcc
Confidence 6999999999999999864321 234588999999999999999999999 9999999999999999
Q ss_pred CCcEEEeeeccccccccccccccccccccccCcccCChhhhcccCcCccccchhhhHHHHHHHh-CCCCCCCCccCCCCc
Q 038766 154 DFEAHVSDFGTSRMLDVHLQDLSSLSTAFQGTIGYLAPEFAYMRIVTTKVDVFSFGIVVMEFLT-KRRPTGLDEENGLSP 232 (299)
Q Consensus 154 ~~~v~l~df~~~~~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~DiwslG~~l~~l~~-g~~p~~~~~~~~~~~ 232 (299)
++.++|+|||++....... .........++..|+|||.+.+..++.++||||||+++|+|++ |..||.... .
T Consensus 159 ~~~~~l~dfg~a~~~~~~~--~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~~~~~-----~ 231 (291)
T cd05094 159 NLLVKIGDFGMSRDVYSTD--YYRVGGHTMLPIRWMPPESIMYRKFTTESDVWSFGVILWEIFTYGKQPWFQLS-----N 231 (291)
T ss_pred CCcEEECCCCcccccCCCc--eeecCCCCCcceeecChHHhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCC-----H
Confidence 9999999999987543211 1111223345678999999999999999999999999999998 888885431 1
Q ss_pred hhHHHHHHHHHhcCccCcccccCccccchhhHhHHHHHHHHHHHHHHHHhcCCCCCCCCChhhhhc
Q 038766 233 ISLRQLVEKALANGINGVRQITDPKLVSSIYEEQEQHQVLEELFKLALVCTSSNPEDRPNMNELLI 298 (299)
Q Consensus 233 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rpt~~~il~ 298 (299)
.. .+........... ....+..+.+++.+||..+|++|||++++++
T Consensus 232 ~~---~~~~~~~~~~~~~-----------------~~~~~~~~~~li~~~l~~~P~~Rpt~~~v~~ 277 (291)
T cd05094 232 TE---VIECITQGRVLER-----------------PRVCPKEVYDIMLGCWQREPQQRLNIKEIYK 277 (291)
T ss_pred HH---HHHHHhCCCCCCC-----------------CccCCHHHHHHHHHHcccChhhCcCHHHHHH
Confidence 11 1111111110000 1123467899999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase C (TrkC); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkC is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkC to its ligand, neurotrophin 3 (NT3), results in receptor oligomerization and activation of the catalytic domain. TrkC is broadly expressed in the nervous system and in some n |
| >cd06629 STKc_MAPKKK_Bck1_like Catalytic domain of fungal Bck1-like MAP Kinase Kinase Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-39 Score=270.31 Aligned_cols=257 Identities=30% Similarity=0.431 Sum_probs=196.4
Q ss_pred CCCCCceeecCCcceEEEEEeC-CCcEEEEEEeccCcCCh--------hhhHHHHHHHHHHHhcCCcceeeeeeEEEcCC
Q 038766 13 SFSENNIIGNSNLSTVYKGRLE-DGEIVAVKKLNFHQFSA--------ESDKSFYREAKTLKELKHRNLVKVLGYAWESG 83 (299)
Q Consensus 13 ~y~~~~~lg~g~~~~v~~~~~~-~~~~~~vK~~~~~~~~~--------~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~ 83 (299)
+|.+.+.||+|++|.||++... +|+.+|+|.+....... ...+.+..|+..++.++|+|++++++++.. +
T Consensus 2 ~~~~~~~lg~g~~~~vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~-~ 80 (272)
T cd06629 2 KWVKGELIGKGTYGRVYLALNVTTGEMMAVKQVELPATIAGRHDSRQKDMVKALRSEIETLKDLDHLNIVQYLGFETT-E 80 (272)
T ss_pred ceeecceecccCceEEEEEeecCCCceeeeeeeechhhhhcccchHHHHHHHHHHHHHHHHHhcCCCCcceEEEEecc-C
Confidence 5888999999999999999764 58899999886432211 123467789999999999999999996654 5
Q ss_pred CeeEEEEeecCCCChHHHhcCCCCCCCCCChhhHHHHHHHHHHHHHHhhcCCCCCeeeecccCCceeeCCCCcEEEeeec
Q 038766 84 KLKALILEYMENGSLESVIHGPGVDHSRWTLPKRIDVLISVANGLDYLHSGYDIPIVHCDMKPSNILLDRDFEAHVSDFG 163 (299)
Q Consensus 84 ~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lh~~~~~~~~H~dl~~~nil~~~~~~v~l~df~ 163 (299)
...++|+||+.+++|.+++.. ...+++..+..++.|++.||.+||++ +++|+||+|+||+++.++.++|+|||
T Consensus 81 ~~~~lv~e~~~~~~L~~~l~~----~~~l~~~~~~~~~~qi~~~l~~lH~~---~i~H~dl~~~nil~~~~~~~~l~d~~ 153 (272)
T cd06629 81 EYLSIFLEYVPGGSIGSCLRT----YGRFEEQLVRFFTEQVLEGLAYLHSK---GILHRDLKADNLLVDADGICKISDFG 153 (272)
T ss_pred CceEEEEecCCCCcHHHHHhh----ccCCCHHHHHHHHHHHHHHHHHHhhC---CeeecCCChhhEEEcCCCeEEEeecc
Confidence 566999999999999999873 35789999999999999999999999 99999999999999999999999999
Q ss_pred cccccccccccccccccccccCcccCChhhhcccC--cCccccchhhhHHHHHHHhCCCCCCCCccCCCCchhHHHHHHH
Q 038766 164 TSRMLDVHLQDLSSLSTAFQGTIGYLAPEFAYMRI--VTTKVDVFSFGIVVMEFLTKRRPTGLDEENGLSPISLRQLVEK 241 (299)
Q Consensus 164 ~~~~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~--~~~~~DiwslG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~ 241 (299)
++....... .........++..|+|||.+.... ++.++|+||||++++++++|..||..... ...+..
T Consensus 154 ~~~~~~~~~--~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~--------~~~~~~ 223 (272)
T cd06629 154 ISKKSDDIY--DNDQNMSMQGSVFWMAPEVIHSYSQGYSAKVDIWSLGCVVLEMFAGRRPWSDEEA--------IAAMFK 223 (272)
T ss_pred ccccccccc--cccccccccCCccccCHHHhccccCCCCccchhHHHHHHHHHHHhCCCCCcCcch--------HHHHHH
Confidence 987543111 111123345678899999887654 78999999999999999999999842211 011111
Q ss_pred HHhcCccCcccccCccccchhhHhHHHHHHHHHHHHHHHHhcCCCCCCCCChhhhhcC
Q 038766 242 ALANGINGVRQITDPKLVSSIYEEQEQHQVLEELFKLALVCTSSNPEDRPNMNELLIT 299 (299)
Q Consensus 242 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rpt~~~il~~ 299 (299)
..... ....+.. .....++..+.+++.+||..+|++|||++++|+|
T Consensus 224 ~~~~~--~~~~~~~----------~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~ 269 (272)
T cd06629 224 LGNKR--SAPPIPP----------DVSMNLSPVALDFLNACFTINPDNRPTARELLQH 269 (272)
T ss_pred hhccc--cCCcCCc----------cccccCCHHHHHHHHHHhcCChhhCCCHHHHhhC
Confidence 00000 0000000 0122356789999999999999999999999987
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Bck1-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Saccharomyces cerevisiae Bck1 and Schizosaccharomyces pombe Mkh1, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Budding yeast Bck1 is part of the cell inte |
| >cd05051 PTKc_DDR Catalytic domain of the Protein Tyrosine Kinases, Discoidin Domain Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-39 Score=272.86 Aligned_cols=263 Identities=24% Similarity=0.370 Sum_probs=197.0
Q ss_pred hCCCCCCceeecCCcceEEEEEeCC-----------------CcEEEEEEeccCcCChhhhHHHHHHHHHHHhcCCccee
Q 038766 11 TGSFSENNIIGNSNLSTVYKGRLED-----------------GEIVAVKKLNFHQFSAESDKSFYREAKTLKELKHRNLV 73 (299)
Q Consensus 11 ~~~y~~~~~lg~g~~~~v~~~~~~~-----------------~~~~~vK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~ 73 (299)
.++|++.+.||+|+||.||++.+.. +..+|+|.+... ......+.+.+|+++++.++|||++
T Consensus 4 ~~~~~~~~~lg~G~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~~~va~K~~~~~-~~~~~~~~~~~e~~~l~~l~~~~i~ 82 (296)
T cd05051 4 RQPLNFVEKLGEGQFGEVHLCEADGLQDFSEKAFAENDNADAPVLVAVKVLRPD-ASDNAREDFLKEVKILSRLSDPNIA 82 (296)
T ss_pred hhhCcccccccCCCCccEEEEEeccCCcccccccccccccCCceeEEEEEecCc-cCHHHHHHHHHHHHHHHhcCCCCEe
Confidence 4789999999999999999987532 245899988643 2334567788999999999999999
Q ss_pred eeeeEEEcCCCeeEEEEeecCCCChHHHhcCCC-------CCCCCCChhhHHHHHHHHHHHHHHhhcCCCCCeeeecccC
Q 038766 74 KVLGYAWESGKLKALILEYMENGSLESVIHGPG-------VDHSRWTLPKRIDVLISVANGLDYLHSGYDIPIVHCDMKP 146 (299)
Q Consensus 74 ~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~-------~~~~~~~~~~~~~i~~qi~~~l~~lh~~~~~~~~H~dl~~ 146 (299)
++++++... ...++++|++.+++|.+++.... .....+++..++.++.|++.||+|||+. +++|+||||
T Consensus 83 ~~~~~~~~~-~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~al~~LH~~---~i~H~dlkp 158 (296)
T cd05051 83 RLLGVCTVD-PPLCMIMEYMENGDLNQFLQKHVAETSGLACNSKSLSFSTLLYMATQIASGMRYLESL---NFVHRDLAT 158 (296)
T ss_pred EEEEEEecC-CCcEEEEecCCCCCHHHHHHhcccccccccccCCCCCHHHHHHHHHHHHHHHHHHHHc---Cccccccch
Confidence 999976654 56699999999999999886432 1223689999999999999999999998 999999999
Q ss_pred CceeeCCCCcEEEeeeccccccccccccccccccccccCcccCChhhhcccCcCccccchhhhHHHHHHHh--CCCCCCC
Q 038766 147 SNILLDRDFEAHVSDFGTSRMLDVHLQDLSSLSTAFQGTIGYLAPEFAYMRIVTTKVDVFSFGIVVMEFLT--KRRPTGL 224 (299)
Q Consensus 147 ~nil~~~~~~v~l~df~~~~~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~DiwslG~~l~~l~~--g~~p~~~ 224 (299)
+||+++.++.++|+|||++...... ..........++..|+|||.+.+..++.++||||||+++|+|++ +..||..
T Consensus 159 ~Nili~~~~~~~l~dfg~~~~~~~~--~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~~~~~~~p~~~ 236 (296)
T cd05051 159 RNCLVGKNYTIKIADFGMSRNLYSS--DYYRVQGRAPLPIRWMAWESVLLGKFTTKSDVWAFGVTLWEILTLCREQPYEH 236 (296)
T ss_pred hceeecCCCceEEccccceeecccC--cceeecCcCCCCceecCHHHhhcCCCCccchhhhhHHHHHHHHhcCCCCCCCC
Confidence 9999999999999999998754311 11112233445678999999988889999999999999999998 5566632
Q ss_pred CccCCCCchhHHHHHHHHHhcCccCcccccCccccchhhHhHHHHHHHHHHHHHHHHhcCCCCCCCCChhhhhc
Q 038766 225 DEENGLSPISLRQLVEKALANGINGVRQITDPKLVSSIYEEQEQHQVLEELFKLALVCTSSNPEDRPNMNELLI 298 (299)
Q Consensus 225 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rpt~~~il~ 298 (299)
. ................. ...... .+..++.++.+++.+||..||++|||+.++++
T Consensus 237 ~-----~~~~~~~~~~~~~~~~~-~~~~~~------------~~~~~~~~l~~li~~cl~~~p~~Rpt~~el~~ 292 (296)
T cd05051 237 L-----TDQQVIENAGHFFRDDG-RQIYLP------------RPPNCPKDIYELMLECWRRDEEDRPTFREIHL 292 (296)
T ss_pred c-----ChHHHHHHHHhcccccc-ccccCC------------CccCCCHHHHHHHHHHhccChhcCCCHHHHHH
Confidence 2 11111111111100000 000000 02234468999999999999999999999975
|
Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR) subfamily; catalytic (c) domain. The DDR subfamily consists of homologs of mammalian DDR1, DDR2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR subfamily members are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linke |
| >cd05060 PTKc_Syk_like Catalytic domain of Spleen Tyrosine Kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-39 Score=269.74 Aligned_cols=245 Identities=28% Similarity=0.436 Sum_probs=189.9
Q ss_pred ceeecCCcceEEEEEeC----CCcEEEEEEeccCcCChhhhHHHHHHHHHHHhcCCcceeeeeeEEEcCCCeeEEEEeec
Q 038766 18 NIIGNSNLSTVYKGRLE----DGEIVAVKKLNFHQFSAESDKSFYREAKTLKELKHRNLVKVLGYAWESGKLKALILEYM 93 (299)
Q Consensus 18 ~~lg~g~~~~v~~~~~~----~~~~~~vK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~lv~e~~ 93 (299)
+.||+|++|.||++... .+..+|+|.+...... ...+.+..|+..++.+.|+|++++++++. +...++|+||+
T Consensus 1 ~~ig~G~~g~v~~~~~~~~~~~~~~~~iK~~~~~~~~-~~~~~~~~e~~~l~~l~h~~iv~~~~~~~--~~~~~~v~e~~ 77 (257)
T cd05060 1 KELGHGNFGSVVKGVYLMKSGKEVEVAVKTLKQEHIA-AGKKEFLREASVMAQLDHPCIVRLIGVCK--GEPLMLVMELA 77 (257)
T ss_pred CccCccCceeEEEeEeeccCCCcceEEEEecccccch-HHHHHHHHHHHHHHhcCCCCeeeEEEEEc--CCceEEEEEeC
Confidence 47999999999999752 2378999998754433 45677889999999999999999999653 44568999999
Q ss_pred CCCChHHHhcCCCCCCCCCChhhHHHHHHHHHHHHHHhhcCCCCCeeeecccCCceeeCCCCcEEEeeeccccccccccc
Q 038766 94 ENGSLESVIHGPGVDHSRWTLPKRIDVLISVANGLDYLHSGYDIPIVHCDMKPSNILLDRDFEAHVSDFGTSRMLDVHLQ 173 (299)
Q Consensus 94 ~~~~L~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lh~~~~~~~~H~dl~~~nil~~~~~~v~l~df~~~~~~~~~~~ 173 (299)
.+++|.+++. ....+++..++.++.|++.+|++||+. +++|+||+|+||+++.++.++|+|||++........
T Consensus 78 ~~~~L~~~l~----~~~~~~~~~~~~~~~qi~~~l~~lh~~---~i~H~di~p~nili~~~~~~kl~df~~~~~~~~~~~ 150 (257)
T cd05060 78 PLGPLLKYLK----KRREIPVSDLKELAHQVAMGMAYLESK---HFVHRDLAARNVLLVNRHQAKISDFGMSRALGAGSD 150 (257)
T ss_pred CCCcHHHHHH----hCCCCCHHHHHHHHHHHHHHHHHHhhc---CeeccCcccceEEEcCCCcEEeccccccceeecCCc
Confidence 9999999997 334789999999999999999999999 999999999999999999999999999876542211
Q ss_pred cccccccccccCcccCChhhhcccCcCccccchhhhHHHHHHHh-CCCCCCCCccCCCCchhHHHHHHHHHhcCccCccc
Q 038766 174 DLSSLSTAFQGTIGYLAPEFAYMRIVTTKVDVFSFGIVVMEFLT-KRRPTGLDEENGLSPISLRQLVEKALANGINGVRQ 252 (299)
Q Consensus 174 ~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~DiwslG~~l~~l~~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 252 (299)
.. .......++..|+|||.+.+..++.++||||||+++|+|++ |..||... ....+...+.. .. .
T Consensus 151 ~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~~~~~g~~p~~~~-----~~~~~~~~~~~---~~-----~ 216 (257)
T cd05060 151 YY-RATTAGRWPLKWYAPECINYGKFSSKSDVWSYGVTLWEAFSYGAKPYGEM-----KGAEVIAMLES---GE-----R 216 (257)
T ss_pred cc-ccccCccccccccCHHHhcCCCCCccchHHHHHHHHHHHHcCCCCCcccC-----CHHHHHHHHHc---CC-----c
Confidence 10 11111223457999999998889999999999999999997 89998432 22222222211 10 0
Q ss_pred ccCccccchhhHhHHHHHHHHHHHHHHHHhcCCCCCCCCChhhhhc
Q 038766 253 ITDPKLVSSIYEEQEQHQVLEELFKLALVCTSSNPEDRPNMNELLI 298 (299)
Q Consensus 253 ~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rpt~~~il~ 298 (299)
... +..++..+.++|.+||..+|++|||+.++++
T Consensus 217 ~~~------------~~~~~~~l~~li~~cl~~~p~~Rp~~~~l~~ 250 (257)
T cd05060 217 LPR------------PEECPQEIYSIMLSCWKYRPEDRPTFSELES 250 (257)
T ss_pred CCC------------CCCCCHHHHHHHHHHhcCChhhCcCHHHHHH
Confidence 011 2233467899999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Spleen Tyrosine Kinase (Syk) subfamily; catalytic (c) domain. The Syk subfamily is composed of Syk, ZAP-70, Shark, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. They are involved in the signaling downstream of activated receptors (including B-cell, T-cell, and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferation, differentiation, survival, adhesion, mi |
| >cd05079 PTKc_Jak1_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Janus kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.7e-40 Score=276.68 Aligned_cols=261 Identities=24% Similarity=0.400 Sum_probs=196.4
Q ss_pred CCCCCceeecCCcceEEEEEe-----CCCcEEEEEEeccCcCChhhhHHHHHHHHHHHhcCCcceeeeeeEEEcC-CCee
Q 038766 13 SFSENNIIGNSNLSTVYKGRL-----EDGEIVAVKKLNFHQFSAESDKSFYREAKTLKELKHRNLVKVLGYAWES-GKLK 86 (299)
Q Consensus 13 ~y~~~~~lg~g~~~~v~~~~~-----~~~~~~~vK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~-~~~~ 86 (299)
-|.+.+.||+|++|.||++.. .++..+++|.+... ........+.+|+..++.++|||++++.+++... +...
T Consensus 5 ~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~va~K~~~~~-~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~ 83 (284)
T cd05079 5 FLKRIRDLGEGHFGKVELCRYDPEGDNTGEQVAVKSLKPE-SGGNHIADLKKEIEILRNLYHENIVKYKGICTEDGGNGI 83 (284)
T ss_pred hhhhceecCCCCceeEEEEEEccCCCCccceEEEEEcCcc-ccHHHHHHHHHHHHHHHhCCCCCeeeeeeEEecCCCCce
Confidence 468999999999999999973 35788999998633 2344456788999999999999999999977665 3566
Q ss_pred EEEEeecCCCChHHHhcCCCCCCCCCChhhHHHHHHHHHHHHHHhhcCCCCCeeeecccCCceeeCCCCcEEEeeecccc
Q 038766 87 ALILEYMENGSLESVIHGPGVDHSRWTLPKRIDVLISVANGLDYLHSGYDIPIVHCDMKPSNILLDRDFEAHVSDFGTSR 166 (299)
Q Consensus 87 ~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lh~~~~~~~~H~dl~~~nil~~~~~~v~l~df~~~~ 166 (299)
++|+||+++++|.+++... ...+++..++.++.|++.||+|||++ +++|+||||+||+++.++.++|+|||++.
T Consensus 84 ~lv~e~~~g~~L~~~l~~~---~~~~~~~~~~~i~~~i~~aL~~lH~~---gi~H~dlkp~Nil~~~~~~~~l~dfg~~~ 157 (284)
T cd05079 84 KLIMEFLPSGSLKEYLPRN---KNKINLKQQLKYAVQICKGMDYLGSR---QYVHRDLAARNVLVESEHQVKIGDFGLTK 157 (284)
T ss_pred EEEEEccCCCCHHHHHHhc---cCCCCHHHHHHHHHHHHHHHHHHHHC---CeeecccchheEEEcCCCCEEECCCcccc
Confidence 8999999999999998632 23689999999999999999999999 99999999999999999999999999987
Q ss_pred ccccccccccccccccccCcccCChhhhcccCcCccccchhhhHHHHHHHhCCCCCCCCccCCC-------CchhHHHHH
Q 038766 167 MLDVHLQDLSSLSTAFQGTIGYLAPEFAYMRIVTTKVDVFSFGIVVMEFLTKRRPTGLDEENGL-------SPISLRQLV 239 (299)
Q Consensus 167 ~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~DiwslG~~l~~l~~g~~p~~~~~~~~~-------~~~~~~~~~ 239 (299)
.+...... ........++..|+|||.+.+..++.++||||||+++|+|++++.|......... .........
T Consensus 158 ~~~~~~~~-~~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~il~ellt~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 236 (284)
T cd05079 158 AIETDKEY-YTVKDDLDSPVFWYAPECLIQSKFYIASDVWSFGVTLYELLTYCDSESSPMTLFLKMIGPTHGQMTVTRLV 236 (284)
T ss_pred ccccCccc-eeecCCCCCCccccCHHHhccCCCCccccchhhhhhhhhhhcCCCCCccccchhhhhcccccccccHHHHH
Confidence 65421111 1112234456789999999888899999999999999999998766432211000 000011111
Q ss_pred HHHHhcCccCcccccCccccchhhHhHHHHHHHHHHHHHHHHhcCCCCCCCCChhhhhc
Q 038766 240 EKALANGINGVRQITDPKLVSSIYEEQEQHQVLEELFKLALVCTSSNPEDRPNMNELLI 298 (299)
Q Consensus 240 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rpt~~~il~ 298 (299)
.. ...+. . . .....++..+.+|+.+||+.+|++|||++++++
T Consensus 237 ~~-~~~~~-~---~------------~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~il~ 278 (284)
T cd05079 237 RV-LEEGK-R---L------------PRPPNCPEEVYQLMRKCWEFQPSKRTTFQNLIE 278 (284)
T ss_pred HH-HHcCc-c---C------------CCCCCCCHHHHHHHHHHccCCcccCcCHHHHHH
Confidence 11 00000 0 0 001234568999999999999999999999985
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers a |
| >cd05085 PTKc_Fer Catalytic domain of the Protein Tyrosine Kinase, Fer | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-39 Score=267.85 Aligned_cols=245 Identities=27% Similarity=0.415 Sum_probs=190.2
Q ss_pred ceeecCCcceEEEEEeCCCcEEEEEEeccCcCChhhhHHHHHHHHHHHhcCCcceeeeeeEEEcCCCeeEEEEeecCCCC
Q 038766 18 NIIGNSNLSTVYKGRLEDGEIVAVKKLNFHQFSAESDKSFYREAKTLKELKHRNLVKVLGYAWESGKLKALILEYMENGS 97 (299)
Q Consensus 18 ~~lg~g~~~~v~~~~~~~~~~~~vK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~lv~e~~~~~~ 97 (299)
+.||+|++|.||++...++..+|+|++... ........+.+|+..++.+.||||+++++.+... ...++|+||+.+++
T Consensus 1 ~~ig~g~~g~vy~~~~~~~~~~a~K~~~~~-~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~-~~~~lv~e~~~~~~ 78 (250)
T cd05085 1 ELLGKGNFGEVFKGTLKDKTPVAVKTCKED-LPQELKIKFLSEARILKQYDHPNIVKLIGVCTQR-QPIYIVMELVPGGD 78 (250)
T ss_pred CccCCCCCceEEEEEecCCcEEEEEecCCc-CCHHHHHHHHHHHHHHHhCCCCCcCeEEEEEecC-CccEEEEECCCCCc
Confidence 478999999999998878899999998643 2344455788999999999999999999977654 45699999999999
Q ss_pred hHHHhcCCCCCCCCCChhhHHHHHHHHHHHHHHhhcCCCCCeeeecccCCceeeCCCCcEEEeeeccccccccccccccc
Q 038766 98 LESVIHGPGVDHSRWTLPKRIDVLISVANGLDYLHSGYDIPIVHCDMKPSNILLDRDFEAHVSDFGTSRMLDVHLQDLSS 177 (299)
Q Consensus 98 L~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lh~~~~~~~~H~dl~~~nil~~~~~~v~l~df~~~~~~~~~~~~~~~ 177 (299)
|.+++... ...+++..++.++.|++.+|.++|++ +++|+||+|+||+++.++.++|+|||++....... ..
T Consensus 79 L~~~~~~~---~~~~~~~~~~~~~~~i~~~l~~lH~~---~~~H~dl~p~nili~~~~~~~l~d~g~~~~~~~~~---~~ 149 (250)
T cd05085 79 FLSFLRKK---KDELKTKQLVKFALDAAAGMAYLESK---NCIHRDLAARNCLVGENNVLKISDFGMSRQEDDGI---YS 149 (250)
T ss_pred HHHHHHhc---CCCCCHHHHHHHHHHHHHHHHHHHhC---CeeecccChheEEEcCCCeEEECCCccceeccccc---cc
Confidence 99988632 24578999999999999999999998 99999999999999999999999999886433111 11
Q ss_pred cccccccCcccCChhhhcccCcCccccchhhhHHHHHHHh-CCCCCCCCccCCCCchhHHHHHHHHHhcCccCcccccCc
Q 038766 178 LSTAFQGTIGYLAPEFAYMRIVTTKVDVFSFGIVVMEFLT-KRRPTGLDEENGLSPISLRQLVEKALANGINGVRQITDP 256 (299)
Q Consensus 178 ~~~~~~~~~~y~~PE~~~~~~~~~~~DiwslG~~l~~l~~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 256 (299)
.......+..|+|||.+....++.++|+||||+++|++++ |..||... ........+. ... .. ..
T Consensus 150 ~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~ll~~~~~~g~~p~~~~-----~~~~~~~~~~----~~~-~~---~~- 215 (250)
T cd05085 150 SSGLKQIPIKWTAPEALNYGRYSSESDVWSYGILLWETFSLGVCPYPGM-----TNQQAREQVE----KGY-RM---SC- 215 (250)
T ss_pred cCCCCCCcccccCHHHhccCCCCchhHHHHHHHHHHHHhcCCCCCCCCC-----CHHHHHHHHH----cCC-CC---CC-
Confidence 1112233567999999988889999999999999999998 88888432 1111111111 110 00 00
Q ss_pred cccchhhHhHHHHHHHHHHHHHHHHhcCCCCCCCCChhhhhc
Q 038766 257 KLVSSIYEEQEQHQVLEELFKLALVCTSSNPEDRPNMNELLI 298 (299)
Q Consensus 257 ~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rpt~~~il~ 298 (299)
+..++..+.+++.+|++.+|++|||+.++++
T Consensus 216 -----------~~~~~~~~~~li~~~l~~~p~~Rp~~~~l~~ 246 (250)
T cd05085 216 -----------PQKCPDDVYKVMQRCWDYKPENRPKFSELQK 246 (250)
T ss_pred -----------CCCCCHHHHHHHHHHcccCcccCCCHHHHHH
Confidence 1123467999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Fer kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fer kinase is a member of the Fes subfamily of proteins which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. Fer kinase is expressed in a wide variety of tissues, and is found to reside in both the cytoplasm and the nucleus. It plays important roles in neuronal polarization and neurite development, cytoskeletal reorganization, cell migration, growth factor signaling, and the regulation of cell-c |
| >cd08215 STKc_Nek Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-39 Score=267.87 Aligned_cols=254 Identities=27% Similarity=0.433 Sum_probs=206.5
Q ss_pred CCCCCceeecCCcceEEEEEeC-CCcEEEEEEeccCcCChhhhHHHHHHHHHHHhcCCcceeeeeeEEEcCCCeeEEEEe
Q 038766 13 SFSENNIIGNSNLSTVYKGRLE-DGEIVAVKKLNFHQFSAESDKSFYREAKTLKELKHRNLVKVLGYAWESGKLKALILE 91 (299)
Q Consensus 13 ~y~~~~~lg~g~~~~v~~~~~~-~~~~~~vK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~lv~e 91 (299)
+|.+.+.||+|++|.||++.+. ++..+++|++............+..|++.++.++|+|++++.+.+... ...++|+|
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~~~~~~~~~~~-~~~~lv~e 79 (258)
T cd08215 1 KYEIIKQIGKGSFGKVYLVRRKSDGKLYVLKEIDLSNMSEKEREDALNEVKILKKLNHPNIIKYYESFEEK-GKLCIVME 79 (258)
T ss_pred CceEEeeeccCCCeEEEEEEEcCCCcEEEEEEeecccCChHHHHHHHHHHHHHHhcCCCChhheEEEEecC-CEEEEEEE
Confidence 5889999999999999999874 589999999976555556677889999999999999999999976654 66799999
Q ss_pred ecCCCChHHHhcCCCCCCCCCChhhHHHHHHHHHHHHHHhhcCCCCCeeeecccCCceeeCCCCcEEEeeeccccccccc
Q 038766 92 YMENGSLESVIHGPGVDHSRWTLPKRIDVLISVANGLDYLHSGYDIPIVHCDMKPSNILLDRDFEAHVSDFGTSRMLDVH 171 (299)
Q Consensus 92 ~~~~~~L~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lh~~~~~~~~H~dl~~~nil~~~~~~v~l~df~~~~~~~~~ 171 (299)
++++++|.+.+......+..+++..++.++.++++||.+||+. +++|+||+|+||+++.++.++|+|||.+......
T Consensus 80 ~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~---~~~H~dl~~~nil~~~~~~~~l~d~~~~~~~~~~ 156 (258)
T cd08215 80 YADGGDLSQKIKKQKKEGKPFPEEQILDWFVQLCLALKYLHSR---KILHRDIKPQNIFLTSNGLVKLGDFGISKVLSST 156 (258)
T ss_pred ecCCCcHHHHHHHhhccCCCcCHHHHHHHHHHHHHHHHHHHhC---CEecccCChHHeEEcCCCcEEECCccceeecccC
Confidence 9999999998875432357899999999999999999999999 9999999999999999999999999998765422
Q ss_pred cccccccccccccCcccCChhhhcccCcCccccchhhhHHHHHHHhCCCCCCCCccCCCCchhHHHHHHHHHhcCccCcc
Q 038766 172 LQDLSSLSTAFQGTIGYLAPEFAYMRIVTTKVDVFSFGIVVMEFLTKRRPTGLDEENGLSPISLRQLVEKALANGINGVR 251 (299)
Q Consensus 172 ~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~DiwslG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 251 (299)
. .......+++.|+|||...+..++.++|+||+|+++++|++|..||.... . ...............
T Consensus 157 ~----~~~~~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~~~~~l~~g~~p~~~~~-----~---~~~~~~~~~~~~~~~- 223 (258)
T cd08215 157 V----DLAKTVVGTPYYLSPELCQNKPYNYKSDIWSLGCVLYELCTLKHPFEGEN-----L---LELALKILKGQYPPI- 223 (258)
T ss_pred c----ceecceeeeecccChhHhccCCCCccccHHHHHHHHHHHHcCCCCCCCCc-----H---HHHHHHHhcCCCCCC-
Confidence 1 22334467888999999988889999999999999999999999985332 1 122222111111110
Q ss_pred cccCccccchhhHhHHHHHHHHHHHHHHHHhcCCCCCCCCChhhhhcC
Q 038766 252 QITDPKLVSSIYEEQEQHQVLEELFKLALVCTSSNPEDRPNMNELLIT 299 (299)
Q Consensus 252 ~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rpt~~~il~~ 299 (299)
+...+..+.+++.+||..+|++|||++++|+|
T Consensus 224 ----------------~~~~~~~~~~~i~~~l~~~p~~Rp~~~~ll~~ 255 (258)
T cd08215 224 ----------------PSQYSSELRNLVSSLLQKDPEERPSIAQILQS 255 (258)
T ss_pred ----------------CCCCCHHHHHHHHHHcCCChhhCcCHHHHhcC
Confidence 11345678999999999999999999999986
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase (Nek) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek family is composed of 11 different mammalian members (Nek1-11) with similarity to the catalytic domain of Aspergillus nidulans NIMA kinase, the founding member of the Nek family which was identified in a screen for cell cycle mutants that were prevented from entering mitosis. Neks contain a conserved N-terminal catalytic domain and a more divergent C-terminal regulatory region of various sizes and structures. They |
| >cd06658 STKc_PAK5 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.4e-40 Score=276.67 Aligned_cols=250 Identities=25% Similarity=0.408 Sum_probs=195.9
Q ss_pred CCCCCCceeecCCcceEEEEEeC-CCcEEEEEEeccCcCChhhhHHHHHHHHHHHhcCCcceeeeeeEEEcCCCeeEEEE
Q 038766 12 GSFSENNIIGNSNLSTVYKGRLE-DGEIVAVKKLNFHQFSAESDKSFYREAKTLKELKHRNLVKVLGYAWESGKLKALIL 90 (299)
Q Consensus 12 ~~y~~~~~lg~g~~~~v~~~~~~-~~~~~~vK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~lv~ 90 (299)
+.|.....||+|++|.||++... ++..+|+|.+... .....+.+.+|+..++.++|+|++++++.+.. +...++|+
T Consensus 22 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~vaiK~~~~~--~~~~~~~~~~e~~~l~~l~h~~ii~~~~~~~~-~~~~~lv~ 98 (292)
T cd06658 22 EYLDSFIKIGEGSTGIVCIATEKHTGKQVAVKKMDLR--KQQRRELLFNEVVIMRDYHHENVVDMYNSYLV-GDELWVVM 98 (292)
T ss_pred HHHhhhhcccCCCCeEEEEEEECCCCCEEEEEEEecc--hHHHHHHHHHHHHHHHhCCCCcHHHHHHheec-CCeEEEEE
Confidence 44555678999999999999864 5889999988532 23445678899999999999999999996655 55679999
Q ss_pred eecCCCChHHHhcCCCCCCCCCChhhHHHHHHHHHHHHHHhhcCCCCCeeeecccCCceeeCCCCcEEEeeecccccccc
Q 038766 91 EYMENGSLESVIHGPGVDHSRWTLPKRIDVLISVANGLDYLHSGYDIPIVHCDMKPSNILLDRDFEAHVSDFGTSRMLDV 170 (299)
Q Consensus 91 e~~~~~~L~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lh~~~~~~~~H~dl~~~nil~~~~~~v~l~df~~~~~~~~ 170 (299)
||+++++|.+++. ...+++.+++.++.||+.+|+|||+. +++|+||+|+||+++.++.++|+|||++.....
T Consensus 99 e~~~~~~L~~~~~-----~~~l~~~~~~~~~~qi~~~l~~LH~~---~ivH~dlkp~Nill~~~~~~kL~dfg~~~~~~~ 170 (292)
T cd06658 99 EFLEGGALTDIVT-----HTRMNEEQIATVCLSVLRALSYLHNQ---GVIHRDIKSDSILLTSDGRIKLSDFGFCAQVSK 170 (292)
T ss_pred eCCCCCcHHHHHh-----cCCCCHHHHHHHHHHHHHHHHHHHHC---CEeecCCCHHHEEEcCCCCEEEccCcchhhccc
Confidence 9999999999884 34688999999999999999999999 999999999999999999999999999875432
Q ss_pred ccccccccccccccCcccCChhhhcccCcCccccchhhhHHHHHHHhCCCCCCCCccCCCCchhHHHHHHHHHhcCccCc
Q 038766 171 HLQDLSSLSTAFQGTIGYLAPEFAYMRIVTTKVDVFSFGIVVMEFLTKRRPTGLDEENGLSPISLRQLVEKALANGINGV 250 (299)
Q Consensus 171 ~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~DiwslG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 250 (299)
.. .......++..|+|||.+.+..++.++|+||+|+++|+|++|..||.... .......+....
T Consensus 171 ~~----~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slGvil~el~~g~~p~~~~~-----~~~~~~~~~~~~------- 234 (292)
T cd06658 171 EV----PKRKSLVGTPYWMAPEVISRLPYGTEVDIWSLGIMVIEMIDGEPPYFNEP-----PLQAMRRIRDNL------- 234 (292)
T ss_pred cc----ccCceeecCccccCHHHHccCCCCchhhHHHHHHHHHHHHhCCCCCCCCC-----HHHHHHHHHhcC-------
Confidence 11 11233457889999999988889999999999999999999999985321 111111111100
Q ss_pred ccccCccccchhhHhHHHHHHHHHHHHHHHHhcCCCCCCCCChhhhhcC
Q 038766 251 RQITDPKLVSSIYEEQEQHQVLEELFKLALVCTSSNPEDRPNMNELLIT 299 (299)
Q Consensus 251 ~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rpt~~~il~~ 299 (299)
.+... ....++..+.+++.+||..||++|||++++++|
T Consensus 235 ----~~~~~-------~~~~~~~~~~~li~~~l~~~P~~Rpt~~~il~~ 272 (292)
T cd06658 235 ----PPRVK-------DSHKVSSVLRGFLDLMLVREPSQRATAQELLQH 272 (292)
T ss_pred ----CCccc-------cccccCHHHHHHHHHHccCChhHCcCHHHHhhC
Confidence 00000 012345678899999999999999999999986
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 5, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK5 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK5 is mainly express |
| >cd05040 PTKc_Ack_like Catalytic domain of the Protein Tyrosine Kinase, Activated Cdc42-associated kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-39 Score=268.24 Aligned_cols=248 Identities=25% Similarity=0.416 Sum_probs=193.3
Q ss_pred ceeecCCcceEEEEEeCC--C--cEEEEEEeccCcCChhhhHHHHHHHHHHHhcCCcceeeeeeEEEcCCCeeEEEEeec
Q 038766 18 NIIGNSNLSTVYKGRLED--G--EIVAVKKLNFHQFSAESDKSFYREAKTLKELKHRNLVKVLGYAWESGKLKALILEYM 93 (299)
Q Consensus 18 ~~lg~g~~~~v~~~~~~~--~--~~~~vK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~lv~e~~ 93 (299)
+.||+|++|+||++.+.+ + ..+|+|.+...... ...+.+.+|+..+++++|+||+++++.+.. ...++|+|++
T Consensus 1 ~~ig~g~~~~v~~~~~~~~~~~~~~vaiK~~~~~~~~-~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~--~~~~~v~e~~ 77 (257)
T cd05040 1 KKLGDGSFGVVRRGEWSTSGGKVIPVAVKCLKSDKLS-DIMDDFLKEAAIMHSLDHENLIRLYGVVLT--HPLMMVTELA 77 (257)
T ss_pred CcCCccCcccEEeeeEecCCCCceEEEEeecCCcccH-HHHHHHHHHHHHHhhcCCCCccceeEEEcC--CeEEEEEEec
Confidence 468999999999998643 3 36899998754433 567788999999999999999999997766 6679999999
Q ss_pred CCCChHHHhcCCCCCCCCCChhhHHHHHHHHHHHHHHhhcCCCCCeeeecccCCceeeCCCCcEEEeeeccccccccccc
Q 038766 94 ENGSLESVIHGPGVDHSRWTLPKRIDVLISVANGLDYLHSGYDIPIVHCDMKPSNILLDRDFEAHVSDFGTSRMLDVHLQ 173 (299)
Q Consensus 94 ~~~~L~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lh~~~~~~~~H~dl~~~nil~~~~~~v~l~df~~~~~~~~~~~ 173 (299)
.+++|.+.+.... ...+++..++.++.|++.||++||++ +++|+||+|+||+++.++.++|+|||++..+.....
T Consensus 78 ~~~~L~~~l~~~~--~~~~~~~~~~~~~~qi~~~L~~lH~~---~i~H~di~p~nil~~~~~~~kl~dfg~~~~~~~~~~ 152 (257)
T cd05040 78 PLGSLLDRLRKDA--LGHFLISTLCDYAVQIANGMRYLESK---RFIHRDLAARNILLASDDKVKIGDFGLMRALPQNED 152 (257)
T ss_pred CCCcHHHHHHhcc--cccCcHHHHHHHHHHHHHHHHHHHhC---CccccccCcccEEEecCCEEEecccccccccccccc
Confidence 9999999986432 14689999999999999999999999 999999999999999999999999999876542211
Q ss_pred cccccccccccCcccCChhhhcccCcCccccchhhhHHHHHHHh-CCCCCCCCccCCCCchhHHHHHHHHHhcCccCccc
Q 038766 174 DLSSLSTAFQGTIGYLAPEFAYMRIVTTKVDVFSFGIVVMEFLT-KRRPTGLDEENGLSPISLRQLVEKALANGINGVRQ 252 (299)
Q Consensus 174 ~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~DiwslG~~l~~l~~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 252 (299)
. ........++..|+|||.+.+..++.++|||||||++++|++ |..||... ....... ...... ..
T Consensus 153 ~-~~~~~~~~~~~~y~~pE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~-----~~~~~~~---~~~~~~----~~ 219 (257)
T cd05040 153 H-YVMEEHLKVPFAWCAPESLRTRTFSHASDVWMFGVTLWEMFTYGEEPWAGL-----SGSQILK---KIDKEG----ER 219 (257)
T ss_pred c-eecccCCCCCceecCHHHhcccCcCchhhhHHHHHHHHHHHhCCCCCCCCC-----CHHHHHH---HHHhcC----Cc
Confidence 1 111123445678999999998899999999999999999998 99998422 2222222 111111 00
Q ss_pred ccCccccchhhHhHHHHHHHHHHHHHHHHhcCCCCCCCCChhhhhc
Q 038766 253 ITDPKLVSSIYEEQEQHQVLEELFKLALVCTSSNPEDRPNMNELLI 298 (299)
Q Consensus 253 ~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rpt~~~il~ 298 (299)
... +...+..+.+++.+||+.+|++|||+.++++
T Consensus 220 ~~~------------~~~~~~~~~~li~~~l~~~p~~Rps~~~~~~ 253 (257)
T cd05040 220 LER------------PEACPQDIYNVMLQCWAHNPADRPTFAALRE 253 (257)
T ss_pred CCC------------CccCCHHHHHHHHHHCCCCcccCCCHHHHHH
Confidence 000 1233567999999999999999999999975
|
Protein Tyrosine Kinase (PTK) family; Activated Cdc42-associated kinase (Ack) subfamily; catalytic (c) domain. Ack subfamily members include Ack1, thirty-eight-negative kinase 1 (Tnk1), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ack subfamily members are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal catalytic domain, an SH3 domain, a Cdc42-binding CRIB domain, and a proline-rich region. They are mainly expressed in brain and skeletal tissues and are involved in the regulation of cell adhesion and growth, receptor degradation, and axonal guidance. Ack1 is also associated with and |
| >cd05039 PTKc_Csk_like Catalytic domain of C-terminal Src kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-39 Score=269.15 Aligned_cols=247 Identities=28% Similarity=0.434 Sum_probs=196.8
Q ss_pred HhCCCCCCceeecCCcceEEEEEeCCCcEEEEEEeccCcCChhhhHHHHHHHHHHHhcCCcceeeeeeEEEcCCCeeEEE
Q 038766 10 ATGSFSENNIIGNSNLSTVYKGRLEDGEIVAVKKLNFHQFSAESDKSFYREAKTLKELKHRNLVKVLGYAWESGKLKALI 89 (299)
Q Consensus 10 ~~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~vK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~lv 89 (299)
-.++|.+.+.||+|++|.||++... |+.+++|.+.... .....+.+|+.+++.++|+|++++++++.. +...++|
T Consensus 4 ~~~~~~~~~~ig~g~~g~v~~~~~~-~~~v~iK~~~~~~---~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~-~~~~~~v 78 (256)
T cd05039 4 NSKELKLGATIGKGEFGDVMLGDYR-GQKVAVKCLKDDS---TAAQAFLAEASVMTTLRHPNLVQLLGVVLQ-GNPLYIV 78 (256)
T ss_pred ChhhccceeeeecCCCceEEEEEec-CcEEEEEEeccch---hHHHHHHHHHHHHHhcCCcceeeeEEEEcC-CCCeEEE
Confidence 3568999999999999999999875 7889999986432 246778899999999999999999997665 5566999
Q ss_pred EeecCCCChHHHhcCCCCCCCCCChhhHHHHHHHHHHHHHHhhcCCCCCeeeecccCCceeeCCCCcEEEeeeccccccc
Q 038766 90 LEYMENGSLESVIHGPGVDHSRWTLPKRIDVLISVANGLDYLHSGYDIPIVHCDMKPSNILLDRDFEAHVSDFGTSRMLD 169 (299)
Q Consensus 90 ~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lh~~~~~~~~H~dl~~~nil~~~~~~v~l~df~~~~~~~ 169 (299)
+|++.+++|.+++... ....+++..++.++.|++.||.|||+. +++|+||+|+||+++.++.++|+|||.+....
T Consensus 79 ~e~~~~~~L~~~~~~~--~~~~~~~~~~~~~~~qi~~~l~~lh~~---~i~H~di~p~Nili~~~~~~~l~d~g~~~~~~ 153 (256)
T cd05039 79 TEYMAKGSLVDYLRSR--GRAVITLAQQLGFALDVCEGMEYLEEK---NFVHRDLAARNVLVSEDLVAKVSDFGLAKEAS 153 (256)
T ss_pred EEecCCCcHHHHHHhc--CCCCCCHHHHHHHHHHHHHHHHHHHhC---CccchhcccceEEEeCCCCEEEcccccccccc
Confidence 9999999999998643 223689999999999999999999999 99999999999999999999999999987543
Q ss_pred cccccccccccccccCcccCChhhhcccCcCccccchhhhHHHHHHHh-CCCCCCCCccCCCCchhHHHHHHHHHhcCcc
Q 038766 170 VHLQDLSSLSTAFQGTIGYLAPEFAYMRIVTTKVDVFSFGIVVMEFLT-KRRPTGLDEENGLSPISLRQLVEKALANGIN 248 (299)
Q Consensus 170 ~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~DiwslG~~l~~l~~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 248 (299)
.. ......+..|+|||.+....++.++|+||||+++++|++ |..||... ....+.... . ....
T Consensus 154 ~~-------~~~~~~~~~~~ape~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~-----~~~~~~~~~---~-~~~~ 217 (256)
T cd05039 154 QG-------QDSGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRI-----PLKDVVPHV---E-KGYR 217 (256)
T ss_pred cc-------cccCCCcccccCchhhcCCcCCcHHHHHHHHHHHHHHHhcCCCCCCCC-----CHHHHHHHH---h-cCCC
Confidence 11 112233567999999988888999999999999999997 88888432 111111111 1 1100
Q ss_pred CcccccCccccchhhHhHHHHHHHHHHHHHHHHhcCCCCCCCCChhhhhc
Q 038766 249 GVRQITDPKLVSSIYEEQEQHQVLEELFKLALVCTSSNPEDRPNMNELLI 298 (299)
Q Consensus 249 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rpt~~~il~ 298 (299)
... +...++.+.++|++||..+|++|||++++++
T Consensus 218 ----~~~------------~~~~~~~~~~li~~~l~~~p~~Rp~~~~l~~ 251 (256)
T cd05039 218 ----MEA------------PEGCPPEVYKVMKDCWELDPAKRPTFKQLRE 251 (256)
T ss_pred ----CCC------------ccCCCHHHHHHHHHHhccChhhCcCHHHHHH
Confidence 000 1233567899999999999999999999975
|
Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk) subfamily; catalytic (c) domain. The Csk subfamily is composed of Csk, Chk, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk and Chk are translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk |
| >cd07856 STKc_Sty1_Hog1 Catalytic domain of the Serine/Threonine Kinases, Fungal Mitogen-Activated Protein Kinases Sty1 and Hog1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-39 Score=278.72 Aligned_cols=271 Identities=22% Similarity=0.289 Sum_probs=201.5
Q ss_pred HHHhCCCCCCceeecCCcceEEEEEeC-CCcEEEEEEeccCcCChhhhHHHHHHHHHHHhcCCcceeeeeeEEEcCCCee
Q 038766 8 ENATGSFSENNIIGNSNLSTVYKGRLE-DGEIVAVKKLNFHQFSAESDKSFYREAKTLKELKHRNLVKVLGYAWESGKLK 86 (299)
Q Consensus 8 ~~~~~~y~~~~~lg~g~~~~v~~~~~~-~~~~~~vK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~ 86 (299)
..+.++|.+.+.||.|++|.||++.+. +++.+|+|++............+..|+.+++.++|||++++.+++...+...
T Consensus 6 ~~~~~~y~~~~~ig~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~ 85 (328)
T cd07856 6 FEITNRYVDLQPVGMGAFGLVCSARDQLTGQNVAIKKIMKPFSTPVLAKRTYRELKLLKHLRHENIISLSDIFISPLEDI 85 (328)
T ss_pred eccccceEEEEeecccCCeEEEEEEECCCCCEEEEEEecccccccchhHHHHHHHHHHHhcCCCCeeeEeeeEecCCCcE
Confidence 346789999999999999999999864 6899999988654434445677889999999999999999999877666677
Q ss_pred EEEEeecCCCChHHHhcCCCCCCCCCChhhHHHHHHHHHHHHHHhhcCCCCCeeeecccCCceeeCCCCcEEEeeecccc
Q 038766 87 ALILEYMENGSLESVIHGPGVDHSRWTLPKRIDVLISVANGLDYLHSGYDIPIVHCDMKPSNILLDRDFEAHVSDFGTSR 166 (299)
Q Consensus 87 ~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lh~~~~~~~~H~dl~~~nil~~~~~~v~l~df~~~~ 166 (299)
++++|++ +++|..+++ ..++++..+..++.|+++||++||+. +++|+||+|+||+++.++.++|+|||.+.
T Consensus 86 ~lv~e~~-~~~L~~~~~-----~~~~~~~~~~~~~~ql~~aL~~LH~~---~iiH~dl~p~Nili~~~~~~~l~dfg~~~ 156 (328)
T cd07856 86 YFVTELL-GTDLHRLLT-----SRPLEKQFIQYFLYQILRGLKYVHSA---GVVHRDLKPSNILINENCDLKICDFGLAR 156 (328)
T ss_pred EEEeehh-ccCHHHHHh-----cCCCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCCHHHEeECCCCCEEeCcccccc
Confidence 9999999 568988885 34678888999999999999999999 99999999999999999999999999987
Q ss_pred ccccccccccccccccccCcccCChhhhcc-cCcCccccchhhhHHHHHHHhCCCCCCCCccCCCCchhHHHHHHHHHhc
Q 038766 167 MLDVHLQDLSSLSTAFQGTIGYLAPEFAYM-RIVTTKVDVFSFGIVVMEFLTKRRPTGLDEENGLSPISLRQLVEKALAN 245 (299)
Q Consensus 167 ~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~-~~~~~~~DiwslG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~ 245 (299)
.... ......++..|+|||.+.+ ..++.++|+||||+++|+|++|..||..... ......+......
T Consensus 157 ~~~~-------~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~el~tg~~~f~~~~~-----~~~~~~~~~~~~~ 224 (328)
T cd07856 157 IQDP-------QMTGYVSTRYYRAPEIMLTWQKYDVEVDIWSAGCIFAEMLEGKPLFPGKDH-----VNQFSIITDLLGT 224 (328)
T ss_pred ccCC-------CcCCCcccccccCceeeeccCCcCcHHHHHHHHHHHHHHHhCCCCCCCCCH-----HHHHHHHHHHhCC
Confidence 4331 1123345778999998765 5688999999999999999999999854321 1111111111000
Q ss_pred CccC----------cccccCccccchhhHhHHHHHHHHHHHHHHHHhcCCCCCCCCChhhhhcC
Q 038766 246 GING----------VRQITDPKLVSSIYEEQEQHQVLEELFKLALVCTSSNPEDRPNMNELLIT 299 (299)
Q Consensus 246 ~~~~----------~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rpt~~~il~~ 299 (299)
...+ ...+.................++..+.++|.+||..+|++|||+++++.|
T Consensus 225 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~t~~ell~~ 288 (328)
T cd07856 225 PPDDVINTICSENTLRFVQSLPKREPVPFSEKFKNADPSAIDLLEKMLVFDPQKRISAAEALAH 288 (328)
T ss_pred CCHHHHHhccchhhHHHHhhccccCCCcHHHHcCCCCHHHHHHHHHHcCCChhhCCCHHHHhcC
Confidence 0000 00000000000000001112356789999999999999999999999976
|
Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) Sty1/Hog1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sty1/Hog1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs Sty1 from Schizosaccharomyces pombe, Hog1 from Saccharomyces cerevisiae, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. Sty1 and Hog1 are stress-activated MAPKs that partipate in transcriptional regulation in response to stress. Sty1 is activated in response to oxidative stress, osmotic stress, and U |
| >cd05091 PTKc_Ror2 Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.1e-40 Score=276.27 Aligned_cols=256 Identities=21% Similarity=0.310 Sum_probs=195.7
Q ss_pred hCCCCCCceeecCCcceEEEEEeC------CCcEEEEEEeccCcCChhhhHHHHHHHHHHHhcCCcceeeeeeEEEcCCC
Q 038766 11 TGSFSENNIIGNSNLSTVYKGRLE------DGEIVAVKKLNFHQFSAESDKSFYREAKTLKELKHRNLVKVLGYAWESGK 84 (299)
Q Consensus 11 ~~~y~~~~~lg~g~~~~v~~~~~~------~~~~~~vK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~ 84 (299)
..+|++.+.||+|++|.||++.+. .+..+|+|++.... .......+..|..+++.++||||+++++++...+
T Consensus 4 ~~~~~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~vaiK~~~~~~-~~~~~~~~~~e~~~~~~l~h~~iv~~~~~~~~~~- 81 (283)
T cd05091 4 LSTVRFMEELGEDRFGKVYKGHLFGTAPGEQTQAVAIKTLKDKA-EGPLREEFKHEAMMRSRLQHPNIVCLLGVVTKEQ- 81 (283)
T ss_pred HHHHHHHHHhCCCCCCeEEEEEEecCCCCCceeEEEEEEccCCC-CHHHHHHHHHHHHHHhcCCCCCcCeEEEEEcCCC-
Confidence 456888999999999999999753 25789999987432 2334567889999999999999999999776544
Q ss_pred eeEEEEeecCCCChHHHhcCC------------CCCCCCCChhhHHHHHHHHHHHHHHhhcCCCCCeeeecccCCceeeC
Q 038766 85 LKALILEYMENGSLESVIHGP------------GVDHSRWTLPKRIDVLISVANGLDYLHSGYDIPIVHCDMKPSNILLD 152 (299)
Q Consensus 85 ~~~lv~e~~~~~~L~~~~~~~------------~~~~~~~~~~~~~~i~~qi~~~l~~lh~~~~~~~~H~dl~~~nil~~ 152 (299)
..++++||+.+++|.+++... ......++...++.++.|++.||+|||+. +++|+||||+||+++
T Consensus 82 ~~~~~~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ql~~aL~~lH~~---gi~H~dlkp~Nil~~ 158 (283)
T cd05091 82 PLSMIFSYCSHSDLHEFLVMRSPHSDVGSTDDDKTVKSTLEPADFVHIVTQIAAGMEFLSSH---HVVHKDLATRNVLVF 158 (283)
T ss_pred ceEEEEEcCCCCcHHHHHHhcCCCccccccccccccccccCHHHHHHHHHHHHHHHHHHHHc---CccccccchhheEec
Confidence 468999999999999887421 11234588889999999999999999999 999999999999999
Q ss_pred CCCcEEEeeeccccccccccccccccccccccCcccCChhhhcccCcCccccchhhhHHHHHHHh-CCCCCCCCccCCCC
Q 038766 153 RDFEAHVSDFGTSRMLDVHLQDLSSLSTAFQGTIGYLAPEFAYMRIVTTKVDVFSFGIVVMEFLT-KRRPTGLDEENGLS 231 (299)
Q Consensus 153 ~~~~v~l~df~~~~~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~DiwslG~~l~~l~~-g~~p~~~~~~~~~~ 231 (299)
.++.++|+|||++....... .........+++.|+|||.+....++.++|||||||++|+|++ |..||... .
T Consensus 159 ~~~~~kl~Dfg~~~~~~~~~--~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~~~g~~p~~~~-----~ 231 (283)
T cd05091 159 DKLNVKISDLGLFREVYAAD--YYKLMGNSLLPIRWMSPEAIMYGKFSIDSDIWSYGVVLWEVFSYGLQPYCGY-----S 231 (283)
T ss_pred CCCceEecccccccccccch--heeeccCccCCccccCHHHHhcCCCCcchhHHHHHHHHHHHHcCCCCCCCCC-----C
Confidence 99999999999987543211 1111223345678999999988889999999999999999998 77777432 1
Q ss_pred chhHHHHHHHHHhcCccCcccccCccccchhhHhHHHHHHHHHHHHHHHHhcCCCCCCCCChhhhhc
Q 038766 232 PISLRQLVEKALANGINGVRQITDPKLVSSIYEEQEQHQVLEELFKLALVCTSSNPEDRPNMNELLI 298 (299)
Q Consensus 232 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rpt~~~il~ 298 (299)
.. +........... ..+...+..+.+++.+||+.+|.+|||+++|+.
T Consensus 232 ~~---~~~~~i~~~~~~-----------------~~~~~~~~~~~~li~~cl~~~p~~RP~~~~i~~ 278 (283)
T cd05091 232 NQ---DVIEMIRNRQVL-----------------PCPDDCPAWVYTLMLECWNEFPSRRPRFKDIHS 278 (283)
T ss_pred HH---HHHHHHHcCCcC-----------------CCCCCCCHHHHHHHHHHhCCCcccCCCHHHHHH
Confidence 11 222221111100 002234567899999999999999999999975
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 2 (Ror2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase cataly |
| >KOG0586 consensus Serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-40 Score=286.35 Aligned_cols=252 Identities=26% Similarity=0.388 Sum_probs=215.9
Q ss_pred HHhCCCCCCceeecCCcceEEEEEeC-CCcEEEEEEeccCcCChhhhHHHHHHHHHHHhcCCcceeeeeeEEEcCCCeeE
Q 038766 9 NATGSFSENNIIGNSNLSTVYKGRLE-DGEIVAVKKLNFHQFSAESDKSFYREAKTLKELKHRNLVKVLGYAWESGKLKA 87 (299)
Q Consensus 9 ~~~~~y~~~~~lg~g~~~~v~~~~~~-~~~~~~vK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~ 87 (299)
.....|.+.+.||+|.|+.|.++++. ++..||+|.+.....+........+|+++++.++||||++++. +.+....++
T Consensus 53 ~~vg~y~i~~tig~g~f~~V~La~~~~t~~~VaiK~idkt~ln~~~~~k~~rev~imk~l~HPnIvkl~~-v~~t~~~ly 131 (596)
T KOG0586|consen 53 NSVGLYVIIKTIGKGNFAKVKLARHILTGTEVAIKIIDKTQLNPSKRQKLGREVDIMKSLNHPNIVKLFS-VIETEATLY 131 (596)
T ss_pred ccccceeeeeeeccceeEEEEeeEecCCCceEEEEEehhcccChHHHHHHHHHHHHHHhcCCcceeeeee-eeeecceeE
Confidence 45678999999999999999999864 5899999999988888888788999999999999999999999 555577779
Q ss_pred EEEeecCCCChHHHhcCCCCCCCCCChhhHHHHHHHHHHHHHHhhcCCCCCeeeecccCCceeeCCCCcEEEeeeccccc
Q 038766 88 LILEYMENGSLESVIHGPGVDHSRWTLPKRIDVLISVANGLDYLHSGYDIPIVHCDMKPSNILLDRDFEAHVSDFGTSRM 167 (299)
Q Consensus 88 lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lh~~~~~~~~H~dl~~~nil~~~~~~v~l~df~~~~~ 167 (299)
+|+||..++.+.+.+. ...++.+.++..++.|+.+|++|+|++ ++||+|||++|++++.+-++||+|||++..
T Consensus 132 lV~eya~~ge~~~yl~----~~gr~~e~~ar~~F~q~vsaveYcH~k---~ivHrdLk~eNilL~~~mnikIaDfgfS~~ 204 (596)
T KOG0586|consen 132 LVMEYASGGELFDYLV----KHGRMKEKEARAKFRQIVSAVEYCHSK---NIVHRDLKAENILLDENMNIKIADFGFSTF 204 (596)
T ss_pred EEEEeccCchhHHHHH----hcccchhhhhhhhhHHHHHHHHHHhhc---ceeccccchhhcccccccceeeecccccee
Confidence 9999999999999998 445788889999999999999999999 999999999999999999999999999998
Q ss_pred cccccccccccccccccCcccCChhhhcccCcC-ccccchhhhHHHHHHHhCCCCCCCCccCCCCchhHHHHHHHHHhcC
Q 038766 168 LDVHLQDLSSLSTAFQGTIGYLAPEFAYMRIVT-TKVDVFSFGIVVMEFLTKRRPTGLDEENGLSPISLRQLVEKALANG 246 (299)
Q Consensus 168 ~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~-~~~DiwslG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~ 246 (299)
+.. ........|++.|+|||++.+..|. +..|+|+||+++|.|+.|..||.......+....+...+
T Consensus 205 ~~~-----~~~lqt~cgsppyAaPEl~~g~~y~gpe~D~Wslgvvly~LV~GsLPFDG~~lk~Lr~rvl~gk~------- 272 (596)
T KOG0586|consen 205 FDY-----GLMLQTFCGSPPYAAPELFNGKKYDGPEVDIWSLGVVLYALVEGSLPFDGQNLKELRPRVLRGKY------- 272 (596)
T ss_pred ecc-----cccccccCCCCCccChHhhcCcccCCcceehhhhhhhheeeeecccccCCcccccccchheeeee-------
Confidence 763 3445667789999999999988764 689999999999999999999976544333332222211
Q ss_pred ccCcccccCccccchhhHhHHHHHHHHHHHHHHHHhcCCCCCCCCChhhhhcC
Q 038766 247 INGVRQITDPKLVSSIYEEQEQHQVLEELFKLALVCTSSNPEDRPNMNELLIT 299 (299)
Q Consensus 247 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rpt~~~il~~ 299 (299)
..+..++.++.++|+++|-.+|.+|++++++.+|
T Consensus 273 -------------------rIp~~ms~dce~lLrk~lvl~Pskr~~~dqim~~ 306 (596)
T KOG0586|consen 273 -------------------RIPFYMSCDCEDLLRKFLVLNPSKRGPCDQIMKD 306 (596)
T ss_pred -------------------cccceeechhHHHHHHhhccCccccCCHHHhhhh
Confidence 1255667789999999999999999999999875
|
|
| >cd05081 PTKc_Jak2_Jak3_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-39 Score=271.52 Aligned_cols=263 Identities=26% Similarity=0.392 Sum_probs=195.6
Q ss_pred hCCCCCCceeecCCcceEEEEEe-----CCCcEEEEEEeccCcCChhhhHHHHHHHHHHHhcCCcceeeeeeEEEcC-CC
Q 038766 11 TGSFSENNIIGNSNLSTVYKGRL-----EDGEIVAVKKLNFHQFSAESDKSFYREAKTLKELKHRNLVKVLGYAWES-GK 84 (299)
Q Consensus 11 ~~~y~~~~~lg~g~~~~v~~~~~-----~~~~~~~vK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~-~~ 84 (299)
..+|++.+.||+|+||+||++.. .++..|++|.+... .......+.+|++.++.++||||+++.+++... ..
T Consensus 3 ~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~v~iK~~~~~--~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~ 80 (284)
T cd05081 3 ERHLKFIQQLGKGNFGSVELCRYDPLQDNTGEVVAVKKLQHS--TAEHLRDFEREIEILKSLQHDNIVKYKGVCYSAGRR 80 (284)
T ss_pred cccceeeeeccCCCCceEEEEEecCCcCCCCcEEEEEEeccC--CHHHHHHHHHHHHHHHhCCCCCeeEEEEEEccCCCC
Confidence 45899999999999999999863 35789999998632 344466788999999999999999999977543 34
Q ss_pred eeEEEEeecCCCChHHHhcCCCCCCCCCChhhHHHHHHHHHHHHHHhhcCCCCCeeeecccCCceeeCCCCcEEEeeecc
Q 038766 85 LKALILEYMENGSLESVIHGPGVDHSRWTLPKRIDVLISVANGLDYLHSGYDIPIVHCDMKPSNILLDRDFEAHVSDFGT 164 (299)
Q Consensus 85 ~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lh~~~~~~~~H~dl~~~nil~~~~~~v~l~df~~ 164 (299)
..++|+||+++++|.+++... ...+++..++.++.|++.||.|||+. +++|+||||+||+++.++.++|+|||+
T Consensus 81 ~~~lv~e~~~~~~L~~~l~~~---~~~l~~~~~~~~~~~l~~aL~~LH~~---~i~H~dlkp~nili~~~~~~~l~dfg~ 154 (284)
T cd05081 81 NLRLVMEYLPYGSLRDYLQKH---RERLDHRKLLLYASQICKGMEYLGSK---RYVHRDLATRNILVESENRVKIGDFGL 154 (284)
T ss_pred ceEEEEEecCCCCHHHHHHhc---CcCCCHHHHHHHHHHHHHHHHHHHHC---CceeccCCHhhEEECCCCeEEECCCcc
Confidence 578999999999999998632 24688999999999999999999999 999999999999999999999999999
Q ss_pred ccccccccccccccccccccCcccCChhhhcccCcCccccchhhhHHHHHHHhCCCCCCCCccCCC-------CchhHHH
Q 038766 165 SRMLDVHLQDLSSLSTAFQGTIGYLAPEFAYMRIVTTKVDVFSFGIVVMEFLTKRRPTGLDEENGL-------SPISLRQ 237 (299)
Q Consensus 165 ~~~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~DiwslG~~l~~l~~g~~p~~~~~~~~~-------~~~~~~~ 237 (299)
+......... .........+..|+|||...+..++.++|+||||+++++|++|..++........ .......
T Consensus 155 ~~~~~~~~~~-~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 233 (284)
T cd05081 155 TKVLPQDKEY-YKVREPGESPIFWYAPESLTESKFSVASDVWSFGVVLYELFTYSDKSCSPPAEFMRMMGNDKQGQMIVY 233 (284)
T ss_pred cccccCCCcc-eeecCCCCCceEeeCHHHhccCCcChHHHHHHHHHHHHHHhhcCCcCCCcchhhhhhcccccccccchH
Confidence 8765421110 0011111234469999999888899999999999999999998776543211100 0000000
Q ss_pred HHHHHHhcCccCcccccCccccchhhHhHHHHHHHHHHHHHHHHhcCCCCCCCCChhhhhc
Q 038766 238 LVEKALANGINGVRQITDPKLVSSIYEEQEQHQVLEELFKLALVCTSSNPEDRPNMNELLI 298 (299)
Q Consensus 238 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rpt~~~il~ 298 (299)
.+........ .. .....++.++.+++.+||..+|++|||+.++++
T Consensus 234 ~~~~~~~~~~----~~------------~~~~~~~~~~~~li~~cl~~~p~~Rpt~~ei~~ 278 (284)
T cd05081 234 HLIELLKNNG----RL------------PAPPGCPAEIYAIMKECWNNDPSQRPSFSELAL 278 (284)
T ss_pred HHHHHHhcCC----cC------------CCCCCCCHHHHHHHHHHccCChhhCCCHHHHHH
Confidence 0101110000 00 002234567999999999999999999999975
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as th |
| >cd07837 STKc_CdkB_plant Catalytic domain of the Serine/Threonine Kinase, Plant B-type Cyclin-Dependent protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.8e-39 Score=272.00 Aligned_cols=272 Identities=21% Similarity=0.261 Sum_probs=198.2
Q ss_pred CCCCCCceeecCCcceEEEEEeC-CCcEEEEEEeccCcCChhhhHHHHHHHHHHHhcC-CcceeeeeeEEEcCCC----e
Q 038766 12 GSFSENNIIGNSNLSTVYKGRLE-DGEIVAVKKLNFHQFSAESDKSFYREAKTLKELK-HRNLVKVLGYAWESGK----L 85 (299)
Q Consensus 12 ~~y~~~~~lg~g~~~~v~~~~~~-~~~~~~vK~~~~~~~~~~~~~~~~~e~~~l~~l~-h~~i~~~~~~~~~~~~----~ 85 (299)
++|.+.+.||+|++|.||++.+. +++.||+|.+............+.+|+.+++.+. |+||+++++++..... .
T Consensus 1 ~~y~~~~~lg~g~~g~vy~~~~~~~~~~v~lK~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~i~~~~~~~~~~~~~~~~~ 80 (295)
T cd07837 1 DAYEKLEKIGEGTYGKVYKARDKNTGKLVALKKTRLEMDEEGIPPTALREISLLQMLSESIYIVRLLDVEHVEEKNGKPS 80 (295)
T ss_pred CCceEeeEecccCCeEEEEEEECCCCcEEEEEeehhhccccCCchHHHHHHHHHHHccCCCCccceeeeEeecCCCCCce
Confidence 47999999999999999999874 5899999998754433444567888999999996 6999999997765443 3
Q ss_pred eEEEEeecCCCChHHHhcCCCC-CCCCCChhhHHHHHHHHHHHHHHhhcCCCCCeeeecccCCceeeCC-CCcEEEeeec
Q 038766 86 KALILEYMENGSLESVIHGPGV-DHSRWTLPKRIDVLISVANGLDYLHSGYDIPIVHCDMKPSNILLDR-DFEAHVSDFG 163 (299)
Q Consensus 86 ~~lv~e~~~~~~L~~~~~~~~~-~~~~~~~~~~~~i~~qi~~~l~~lh~~~~~~~~H~dl~~~nil~~~-~~~v~l~df~ 163 (299)
.++|+||+.+ +|.+++..... ....+++..++.++.||++||.|||+. +++|+||+|+||+++. ++.++|+|||
T Consensus 81 ~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~L~~LH~~---~i~H~dl~~~nil~~~~~~~~kl~dfg 156 (295)
T cd07837 81 LYLVFEYLDS-DLKKFMDSNGRGPGRPLPAKTIKSFMYQLLKGVAHCHKH---GVMHRDLKPQNLLVDKQKGLLKIADLG 156 (295)
T ss_pred EEEEeeccCc-CHHHHHHHhcccCCCCCCHHHHHHHHHHHHHHHHHHHHC---CeeecCCChHHEEEecCCCeEEEeecc
Confidence 6899999975 88887754321 245789999999999999999999999 9999999999999998 8899999999
Q ss_pred cccccccccccccccccccccCcccCChhhhcc-cCcCccccchhhhHHHHHHHhCCCCCCCCccCCCCchhHHHHHHHH
Q 038766 164 TSRMLDVHLQDLSSLSTAFQGTIGYLAPEFAYM-RIVTTKVDVFSFGIVVMEFLTKRRPTGLDEENGLSPISLRQLVEKA 242 (299)
Q Consensus 164 ~~~~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~-~~~~~~~DiwslG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~ 242 (299)
++..+... ........+++.|+|||.+.+ ..++.++|+||||+++|+|++|..||..... .........
T Consensus 157 ~~~~~~~~----~~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~~~~~~~~----~~~~~~~~~-- 226 (295)
T cd07837 157 LGRAFSIP----VKSYTHEIVTLWYRAPEVLLGSTHYSTPVDIWSVGCIFAEMSRKQPLFPGDSE----LQQLLHIFK-- 226 (295)
T ss_pred cceecCCC----ccccCCcccccCCCChHHhhCCCCCCchHHHHHHHHHHHHHHcCCCCCCCCCH----HHHHHHHHH--
Confidence 88754321 111222345778999998765 4578899999999999999999999854311 111111111
Q ss_pred HhcCccCccccc----------CccccchhhHhHHHHHHHHHHHHHHHHhcCCCCCCCCChhhhhcC
Q 038766 243 LANGINGVRQIT----------DPKLVSSIYEEQEQHQVLEELFKLALVCTSSNPEDRPNMNELLIT 299 (299)
Q Consensus 243 ~~~~~~~~~~~~----------~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rpt~~~il~~ 299 (299)
.........+. .+...... .......++..+.++|.+||..||++|||+++++.|
T Consensus 227 -~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~i~~~l~~~P~~R~~~~eil~~ 291 (295)
T cd07837 227 -LLGTPTEQVWPGVSKLRDWHEFPQWKPQD-LSRAVPDLSPEGLDLLQKMLRYDPAKRISAKAALTH 291 (295)
T ss_pred -HhCCCChhhCcchhhccchhhcCcccchh-HHHhccccCHHHHHHHHHHccCChhhcCCHHHHhcC
Confidence 00000000000 00000000 001123467789999999999999999999999987
|
Serine/Threonine Kinases (STKs), Plant B-type Cyclin-Dependent protein Kinase (CdkB) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CdkB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. The plant-specific B-type CDKs are expressed from the late S to the M phase of the cell cycle. They are characterized by the cyclin binding motif PPT[A/T]LRE. They play a role in controlling mitosis and integrating developm |
| >cd05097 PTKc_DDR_like Catalytic domain of Discoidin Domain Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-39 Score=272.86 Aligned_cols=263 Identities=25% Similarity=0.384 Sum_probs=194.1
Q ss_pred hCCCCCCceeecCCcceEEEEEeCC---------------CcEEEEEEeccCcCChhhhHHHHHHHHHHHhcCCcceeee
Q 038766 11 TGSFSENNIIGNSNLSTVYKGRLED---------------GEIVAVKKLNFHQFSAESDKSFYREAKTLKELKHRNLVKV 75 (299)
Q Consensus 11 ~~~y~~~~~lg~g~~~~v~~~~~~~---------------~~~~~vK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~ 75 (299)
..+|++.+.||+|+||.||++.+.. ...||+|.+... ........+.+|++.+++++|+|++++
T Consensus 4 ~~~~~~~~~lg~G~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~vavK~~~~~-~~~~~~~~~~~ei~~l~~l~h~~i~~~ 82 (295)
T cd05097 4 RQQLRLKEKLGEGQFGEVHLCEAEGLAEFLGEGAPEFDGQPVLVAVKMLRAD-VTKTARNDFLKEIKIMSRLKNPNIIRL 82 (295)
T ss_pred hHhCeehhccCCCCCceEEecccccchhhccccCcccCCCceEEEEEecCCC-CCHHHHHHHHHHHHHHHhCCCCCcCeE
Confidence 4689999999999999999987532 235899998642 334455678899999999999999999
Q ss_pred eeEEEcCCCeeEEEEeecCCCChHHHhcCCCC--------CCCCCChhhHHHHHHHHHHHHHHhhcCCCCCeeeecccCC
Q 038766 76 LGYAWESGKLKALILEYMENGSLESVIHGPGV--------DHSRWTLPKRIDVLISVANGLDYLHSGYDIPIVHCDMKPS 147 (299)
Q Consensus 76 ~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~--------~~~~~~~~~~~~i~~qi~~~l~~lh~~~~~~~~H~dl~~~ 147 (299)
++++.. +...++|+||+.+++|.+++..... ....+++..++.++.|++.||+|||+. +++|+||||+
T Consensus 83 ~~~~~~-~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~~---~i~H~dlkp~ 158 (295)
T cd05097 83 LGVCVS-DDPLCMITEYMENGDLNQFLSQREIESTFTHANNIPSVSIANLLYMAVQIASGMKYLASL---NFVHRDLATR 158 (295)
T ss_pred EEEEcC-CCccEEEEecCCCCcHHHHHHhccccccccccccCCcccHHHHHHHHHHHHHHHHHHHhc---CeeccccChh
Confidence 997655 5566999999999999998853211 112467888999999999999999999 9999999999
Q ss_pred ceeeCCCCcEEEeeeccccccccccccccccccccccCcccCChhhhcccCcCccccchhhhHHHHHHHh--CCCCCCCC
Q 038766 148 NILLDRDFEAHVSDFGTSRMLDVHLQDLSSLSTAFQGTIGYLAPEFAYMRIVTTKVDVFSFGIVVMEFLT--KRRPTGLD 225 (299)
Q Consensus 148 nil~~~~~~v~l~df~~~~~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~DiwslG~~l~~l~~--g~~p~~~~ 225 (299)
||+++.++.++|+|||++...... ..........++..|+|||......++.++|+||||+++++|++ +..||...
T Consensus 159 Nill~~~~~~kl~dfg~~~~~~~~--~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwSlG~~l~el~~~~~~~p~~~~ 236 (295)
T cd05097 159 NCLVGNHYTIKIADFGMSRNLYSG--DYYRIQGRAVLPIRWMAWESILLGKFTTASDVWAFGVTLWEMFTLCKEQPYSLL 236 (295)
T ss_pred hEEEcCCCcEEecccccccccccC--cceeccCcCcCceeecChhhhccCCcCchhhHHHHHHHHHHHHHcCCCCCCccc
Confidence 999999999999999998754311 11111223344678999999988889999999999999999998 44565322
Q ss_pred ccCCCCchhHHHHHHHHHhcCccCcccccCccccchhhHhHHHHHHHHHHHHHHHHhcCCCCCCCCChhhhhc
Q 038766 226 EENGLSPISLRQLVEKALANGINGVRQITDPKLVSSIYEEQEQHQVLEELFKLALVCTSSNPEDRPNMNELLI 298 (299)
Q Consensus 226 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rpt~~~il~ 298 (299)
..................... ... +...+..+.+++++|+..||++|||+++|++
T Consensus 237 -----~~~~~~~~~~~~~~~~~~~~~-~~~------------~~~~~~~l~~li~~~l~~~p~~RPs~~~i~~ 291 (295)
T cd05097 237 -----SDEQVIENTGEFFRNQGRQIY-LSQ------------TPLCPSPVFKLMMRCWSRDIKDRPTFNKIHH 291 (295)
T ss_pred -----ChHHHHHHHHHhhhhcccccc-CCC------------CCCCCHHHHHHHHHHcCCCchhCcCHHHHHH
Confidence 111111111111111000000 000 1123457999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR)-like proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR-like proteins are members of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linked to a variety of human cancers including |
| >cd07849 STKc_ERK1_2_like Catalytic domain of Extracellular signal-Regulated Kinase 1 and 2-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-39 Score=280.37 Aligned_cols=274 Identities=23% Similarity=0.312 Sum_probs=198.3
Q ss_pred HhCCCCCCceeecCCcceEEEEEe-CCCcEEEEEEeccCcCChhhhHHHHHHHHHHHhcCCcceeeeeeEEEcCC----C
Q 038766 10 ATGSFSENNIIGNSNLSTVYKGRL-EDGEIVAVKKLNFHQFSAESDKSFYREAKTLKELKHRNLVKVLGYAWESG----K 84 (299)
Q Consensus 10 ~~~~y~~~~~lg~g~~~~v~~~~~-~~~~~~~vK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~----~ 84 (299)
+.++|.+.+.||+|++|.||++.+ .+|+.||+|++.... .......+.+|+.+++.++|+||+++++++.... .
T Consensus 3 ~~~~y~i~~~lg~G~~g~vy~~~~~~~~~~vaiK~~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~ 81 (336)
T cd07849 3 VGPRYQNLSYIGEGAYGMVCSATHKPTGVKVAIKKISPFE-HQTFCQRTLREIKILRRFKHENIIGILDIIRPPSFESFN 81 (336)
T ss_pred cccceEEEEEEEecCCeEEEEEEEcCCCCeEEEEEecccc-cchhHHHHHHHHHHHHhCCCCCcCchhheeecccccccc
Confidence 568999999999999999999986 468999999985321 2334566788999999999999999998664332 3
Q ss_pred eeEEEEeecCCCChHHHhcCCCCCCCCCChhhHHHHHHHHHHHHHHhhcCCCCCeeeecccCCceeeCCCCcEEEeeecc
Q 038766 85 LKALILEYMENGSLESVIHGPGVDHSRWTLPKRIDVLISVANGLDYLHSGYDIPIVHCDMKPSNILLDRDFEAHVSDFGT 164 (299)
Q Consensus 85 ~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lh~~~~~~~~H~dl~~~nil~~~~~~v~l~df~~ 164 (299)
..++|+|++. ++|...+. ...+++..++.++.|++.||++||+. +++|+||||+||+++.++.++|+|||+
T Consensus 82 ~~~lv~e~~~-~~l~~~~~-----~~~l~~~~~~~i~~ql~~aL~~LH~~---~ivH~dlkp~Nill~~~~~~kl~dfg~ 152 (336)
T cd07849 82 DVYIVQELME-TDLYKLIK-----TQHLSNDHIQYFLYQILRGLKYIHSA---NVLHRDLKPSNLLLNTNCDLKICDFGL 152 (336)
T ss_pred eEEEEehhcc-cCHHHHHh-----cCCCCHHHHHHHHHHHHHHHHHHHhC---CeeccCCCHHHEEECCCCCEEECcccc
Confidence 4689999995 48888774 34789999999999999999999999 999999999999999999999999999
Q ss_pred ccccccccccccccccccccCcccCChhhhcc-cCcCccccchhhhHHHHHHHhCCCCCCCCccCCCCchhHHHHHHHHH
Q 038766 165 SRMLDVHLQDLSSLSTAFQGTIGYLAPEFAYM-RIVTTKVDVFSFGIVVMEFLTKRRPTGLDEENGLSPISLRQLVEKAL 243 (299)
Q Consensus 165 ~~~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~-~~~~~~~DiwslG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~ 243 (299)
+.......... .......++..|+|||.+.+ ..++.++||||+|+++|+|++|..||..... ......+....
T Consensus 153 ~~~~~~~~~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslGvil~el~~G~~~f~~~~~-----~~~~~~~~~~~ 226 (336)
T cd07849 153 ARIADPEHDHT-GFLTEYVATRWYRAPEIMLNSKGYTKAIDIWSVGCILAEMLSNRPLFPGKDY-----LHQLNLILGVL 226 (336)
T ss_pred eeecccccccc-CCcCCcCcCCCccChHHhhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCH-----HHHHHHHHHHc
Confidence 87543221111 11233457889999998654 5688999999999999999999999954311 00000000000
Q ss_pred hcCc-cCcccccCcc---------ccchhhHhHHHHHHHHHHHHHHHHhcCCCCCCCCChhhhhcC
Q 038766 244 ANGI-NGVRQITDPK---------LVSSIYEEQEQHQVLEELFKLALVCTSSNPEDRPNMNELLIT 299 (299)
Q Consensus 244 ~~~~-~~~~~~~~~~---------~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rpt~~~il~~ 299 (299)
.... .....+.... .............++.++.+++.+||..+|++|||+.++++|
T Consensus 227 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rpt~~e~l~h 292 (336)
T cd07849 227 GTPSQEDLNCIISLRARNYIKSLPFKPKVPWNKLFPNADPKALDLLDKMLTFNPHKRITVEEALAH 292 (336)
T ss_pred CCCCHHHHHHhhchhhhhHHhhcCcCCcccHHHHhcccCcHHHHHHHHHcCCChhhCcCHHHHhcC
Confidence 0000 0000000000 000000011123456789999999999999999999999987
|
Serine/Threonine Kinases (STKs), Extracellular signal-regulated kinases 1 and 2 (ERK1/2) and Fus3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. This ERK1/2-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the mitogen-activated protein kinases (MAPKs) ERK1, ERK2, baker's yeast Fus3, and similar proteins. MAPK pathways are important mediators of cellular responses to extracellular signals. ERK1/2 activation is preferentially by mitogenic factors, differentiation stimuli, and cytokines, through a kinase cascade involving the MAPK kinases MEK1/2 and a MAPK kinase |
| >cd05092 PTKc_TrkA Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase A | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.8e-40 Score=273.56 Aligned_cols=255 Identities=25% Similarity=0.403 Sum_probs=195.2
Q ss_pred hCCCCCCceeecCCcceEEEEEe------CCCcEEEEEEeccCcCChhhhHHHHHHHHHHHhcCCcceeeeeeEEEcCCC
Q 038766 11 TGSFSENNIIGNSNLSTVYKGRL------EDGEIVAVKKLNFHQFSAESDKSFYREAKTLKELKHRNLVKVLGYAWESGK 84 (299)
Q Consensus 11 ~~~y~~~~~lg~g~~~~v~~~~~------~~~~~~~vK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~ 84 (299)
..+|.+.+.||+|+||.||++.. .++..+++|.+. .........+.+|++.++.++|+||+++++++.. +.
T Consensus 4 ~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~~~k~~~--~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~-~~ 80 (280)
T cd05092 4 RRDIVLKWELGEGAFGKVFLAECHNLLPEQDKMLVAVKALK--EASESARQDFQREAELLTVLQHQHIVRFYGVCTE-GR 80 (280)
T ss_pred hHhceeccccCCccCCeEEEeEEecCCCCCCceEEEEEecC--cCCHHHHHHHHHHHHHHhcCCCCCCceEEEEEec-CC
Confidence 46788999999999999999963 235678888875 3334456678999999999999999999997665 44
Q ss_pred eeEEEEeecCCCChHHHhcCCCC-----------CCCCCChhhHHHHHHHHHHHHHHhhcCCCCCeeeecccCCceeeCC
Q 038766 85 LKALILEYMENGSLESVIHGPGV-----------DHSRWTLPKRIDVLISVANGLDYLHSGYDIPIVHCDMKPSNILLDR 153 (299)
Q Consensus 85 ~~~lv~e~~~~~~L~~~~~~~~~-----------~~~~~~~~~~~~i~~qi~~~l~~lh~~~~~~~~H~dl~~~nil~~~ 153 (299)
..++++||+.+++|.+++...+. ....+++..++.++.|++.|++|||+. +++|+||||+||+++.
T Consensus 81 ~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~---~i~H~dlkp~nil~~~ 157 (280)
T cd05092 81 PLLMVFEYMRHGDLNRFLRSHGPDAKILAGGEDVAPGQLTLGQMLAIASQIASGMVYLASL---HFVHRDLATRNCLVGQ 157 (280)
T ss_pred ceEEEEecCCCCCHHHHHHhcCcchhhhcccccCCccccCHHHHHHHHHHHHHHHHHHHHC---CeecccccHhhEEEcC
Confidence 56999999999999998864321 123588899999999999999999999 9999999999999999
Q ss_pred CCcEEEeeeccccccccccccccccccccccCcccCChhhhcccCcCccccchhhhHHHHHHHh-CCCCCCCCccCCCCc
Q 038766 154 DFEAHVSDFGTSRMLDVHLQDLSSLSTAFQGTIGYLAPEFAYMRIVTTKVDVFSFGIVVMEFLT-KRRPTGLDEENGLSP 232 (299)
Q Consensus 154 ~~~v~l~df~~~~~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~DiwslG~~l~~l~~-g~~p~~~~~~~~~~~ 232 (299)
++.++|+|||++...... ..........+++.|+|||.+.+..++.++|||||||++|+|++ |..||... ..
T Consensus 158 ~~~~kL~dfg~~~~~~~~--~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~-----~~ 230 (280)
T cd05092 158 GLVVKIGDFGMSRDIYST--DYYRVGGRTMLPIRWMPPESILYRKFTTESDIWSFGVVLWEIFTYGKQPWYQL-----SN 230 (280)
T ss_pred CCCEEECCCCceeEcCCC--ceeecCCCccccccccCHHHhccCCcCchhhHHHHHHHHHHHHcCCCCCCccC-----CH
Confidence 999999999998654311 01111222334678999999999999999999999999999998 88887422 11
Q ss_pred hhHHHHHHHHHhcCccCcccccCccccchhhHhHHHHHHHHHHHHHHHHhcCCCCCCCCChhhhhc
Q 038766 233 ISLRQLVEKALANGINGVRQITDPKLVSSIYEEQEQHQVLEELFKLALVCTSSNPEDRPNMNELLI 298 (299)
Q Consensus 233 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rpt~~~il~ 298 (299)
... +....... .... +..++..+.+++.+||..||.+||+++++++
T Consensus 231 ~~~---~~~~~~~~-----~~~~------------~~~~~~~~~~li~~cl~~~P~~Rp~~~~l~~ 276 (280)
T cd05092 231 TEA---IECITQGR-----ELER------------PRTCPPEVYAIMQGCWQREPQQRMVIKDIHS 276 (280)
T ss_pred HHH---HHHHHcCc-----cCCC------------CCCCCHHHHHHHHHHccCChhhCCCHHHHHH
Confidence 111 11111100 0000 1233467899999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase A (TrkA); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkA is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkA to its ligand, nerve growth factor (NGF), results in receptor oligomerization and activation of the catalytic domain. TrkA is expressed mainly in neural-crest-derived sensory |
| >cd05088 PTKc_Tie2 Catalytic domain of the Protein Tyrosine Kinase, Tie2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.8e-40 Score=277.14 Aligned_cols=253 Identities=26% Similarity=0.413 Sum_probs=192.0
Q ss_pred hCCCCCCceeecCCcceEEEEEeC-CCc--EEEEEEeccCcCChhhhHHHHHHHHHHHhc-CCcceeeeeeEEEcCCCee
Q 038766 11 TGSFSENNIIGNSNLSTVYKGRLE-DGE--IVAVKKLNFHQFSAESDKSFYREAKTLKEL-KHRNLVKVLGYAWESGKLK 86 (299)
Q Consensus 11 ~~~y~~~~~lg~g~~~~v~~~~~~-~~~--~~~vK~~~~~~~~~~~~~~~~~e~~~l~~l-~h~~i~~~~~~~~~~~~~~ 86 (299)
.++|.+.+.||+|+||.||+|.+. ++. .+++|.+.. .........+.+|+..+.++ .|+||+++++++.. +...
T Consensus 6 ~~~~~~~~~lg~G~~g~V~~a~~~~~~~~~~~~ik~~~~-~~~~~~~~~~~~Ei~~l~~l~~h~~iv~~~~~~~~-~~~~ 83 (303)
T cd05088 6 WNDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKE-YASKDDHRDFAGELEVLCKLGHHPNIINLLGACEH-RGYL 83 (303)
T ss_pred hhhceeeeeecCCCCceEEEEEEccCCceeeEEEEEecc-cCCHHHHHHHHHHHHHHHHhcCCCCcceEEEEECC-CCCc
Confidence 468999999999999999999864 354 356666542 22334556788899999999 79999999997655 4556
Q ss_pred EEEEeecCCCChHHHhcCCCC------------CCCCCChhhHHHHHHHHHHHHHHhhcCCCCCeeeecccCCceeeCCC
Q 038766 87 ALILEYMENGSLESVIHGPGV------------DHSRWTLPKRIDVLISVANGLDYLHSGYDIPIVHCDMKPSNILLDRD 154 (299)
Q Consensus 87 ~lv~e~~~~~~L~~~~~~~~~------------~~~~~~~~~~~~i~~qi~~~l~~lh~~~~~~~~H~dl~~~nil~~~~ 154 (299)
++|+||+++++|.+++...+. ....+++..++.++.|++.|++|||+. +++|+||||+||+++.+
T Consensus 84 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~---gi~H~dlkp~Nili~~~ 160 (303)
T cd05088 84 YLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQK---QFIHRDLAARNILVGEN 160 (303)
T ss_pred eEEEEeCCCCcHHHHHHhcccccccccccccccccCcCCHHHHHHHHHHHHHHHHHHHhC---CccccccchheEEecCC
Confidence 999999999999998864321 234689999999999999999999999 99999999999999999
Q ss_pred CcEEEeeeccccccccccccccccccccccCcccCChhhhcccCcCccccchhhhHHHHHHHh-CCCCCCCCccCCCCch
Q 038766 155 FEAHVSDFGTSRMLDVHLQDLSSLSTAFQGTIGYLAPEFAYMRIVTTKVDVFSFGIVVMEFLT-KRRPTGLDEENGLSPI 233 (299)
Q Consensus 155 ~~v~l~df~~~~~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~DiwslG~~l~~l~~-g~~p~~~~~~~~~~~~ 233 (299)
+.++|+|||++..... .........+..|+|||.+.+..++.++||||||+++|+|++ |..||.... ..
T Consensus 161 ~~~kl~dfg~~~~~~~-----~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~-----~~ 230 (303)
T cd05088 161 YVAKIADFGLSRGQEV-----YVKKTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMT-----CA 230 (303)
T ss_pred CcEEeCccccCcccch-----hhhcccCCCcccccCHHHHhccCCcccccchhhhhHHHHHHhcCCCCcccCC-----hH
Confidence 9999999998853221 001111223567999999988889999999999999999998 999884321 11
Q ss_pred hHHHHHHHHHhcCccCcccccCccccchhhHhHHHHHHHHHHHHHHHHhcCCCCCCCCChhhhhc
Q 038766 234 SLRQLVEKALANGINGVRQITDPKLVSSIYEEQEQHQVLEELFKLALVCTSSNPEDRPNMNELLI 298 (299)
Q Consensus 234 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rpt~~~il~ 298 (299)
.... ... ... .... +...+.++.+++.+||+.+|++|||++++++
T Consensus 231 ~~~~---~~~-~~~----~~~~------------~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~ 275 (303)
T cd05088 231 ELYE---KLP-QGY----RLEK------------PLNCDDEVYDLMRQCWREKPYERPSFAQILV 275 (303)
T ss_pred HHHH---HHh-cCC----cCCC------------CCCCCHHHHHHHHHHcCCChhhCcCHHHHHH
Confidence 1111 111 000 0000 1123457899999999999999999999985
|
Protein Tyrosine Kinase (PTK) family; Tie2; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie2 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie2 is expressed mainly in endothelial cells and hematopoietic stem cells. It is also found in a subset of tumor-associated monocytes and eosinophils. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2. The binding of A |
| >cd05061 PTKc_InsR Catalytic domain of the Protein Tyrosine Kinase, Insulin Receptor | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.2e-40 Score=275.14 Aligned_cols=260 Identities=24% Similarity=0.348 Sum_probs=196.4
Q ss_pred HHHHhCCCCCCceeecCCcceEEEEEeC------CCcEEEEEEeccCcCChhhhHHHHHHHHHHHhcCCcceeeeeeEEE
Q 038766 7 IENATGSFSENNIIGNSNLSTVYKGRLE------DGEIVAVKKLNFHQFSAESDKSFYREAKTLKELKHRNLVKVLGYAW 80 (299)
Q Consensus 7 ~~~~~~~y~~~~~lg~g~~~~v~~~~~~------~~~~~~vK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~ 80 (299)
|++..++|.+.+.||+|++|.||++..+ .+..||+|.+.... .......+.+|+..++.+.|+||+++++++.
T Consensus 1 ~~~~~~~~~i~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~ 79 (288)
T cd05061 1 WEVSREKITLLRELGQGSFGMVYEGNARDIIKGEAETRVAVKTVNESA-SLRERIEFLNEASVMKGFTCHHVVRLLGVVS 79 (288)
T ss_pred CcccHHHceeeeeecCCCCcEEEEEEEeccCCCCcceEEEEEECCCcC-CHHHHHHHHHHHHHHHhCCCCCeeeEEEEEc
Confidence 4667899999999999999999998643 25589999876432 2333456778999999999999999999766
Q ss_pred cCCCeeEEEEeecCCCChHHHhcCCCC------CCCCCChhhHHHHHHHHHHHHHHhhcCCCCCeeeecccCCceeeCCC
Q 038766 81 ESGKLKALILEYMENGSLESVIHGPGV------DHSRWTLPKRIDVLISVANGLDYLHSGYDIPIVHCDMKPSNILLDRD 154 (299)
Q Consensus 81 ~~~~~~~lv~e~~~~~~L~~~~~~~~~------~~~~~~~~~~~~i~~qi~~~l~~lh~~~~~~~~H~dl~~~nil~~~~ 154 (299)
.. ...++|+||+.+++|.+++...+. ....++...+..++.|++.||+|||++ +++|+||||+||+++.+
T Consensus 80 ~~-~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~---~i~H~dikp~nili~~~ 155 (288)
T cd05061 80 KG-QPTLVVMELMAHGDLKSYLRSLRPEAENNPGRPPPTLQEMIQMAAEIADGMAYLNAK---KFVHRDLAARNCMVAHD 155 (288)
T ss_pred CC-CCcEEEEeCCCCCCHHHHHHHhccccccCCCCCCCCHHHHHHHHHHHHHHHHHHHhC---CCcCCCCChheEEEcCC
Confidence 54 456999999999999999864221 123456677889999999999999999 99999999999999999
Q ss_pred CcEEEeeeccccccccccccccccccccccCcccCChhhhcccCcCccccchhhhHHHHHHHh-CCCCCCCCccCCCCch
Q 038766 155 FEAHVSDFGTSRMLDVHLQDLSSLSTAFQGTIGYLAPEFAYMRIVTTKVDVFSFGIVVMEFLT-KRRPTGLDEENGLSPI 233 (299)
Q Consensus 155 ~~v~l~df~~~~~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~DiwslG~~l~~l~~-g~~p~~~~~~~~~~~~ 233 (299)
+.++|+|||++....... .........++..|+|||.+.+..++.++|+|||||++|+|++ |..||... ...
T Consensus 156 ~~~~L~Dfg~~~~~~~~~--~~~~~~~~~~~~~y~~pE~~~~~~~~~~~DvwslG~~l~el~~~~~~p~~~~-----~~~ 228 (288)
T cd05061 156 FTVKIGDFGMTRDIYETD--YYRKGGKGLLPVRWMAPESLKDGVFTTSSDMWSFGVVLWEITSLAEQPYQGL-----SNE 228 (288)
T ss_pred CcEEECcCCccccccccc--cccccCCCcccccccCHHHhccCCCChHhHHHHHHHHHHHHHhCCCCCCCCC-----CHH
Confidence 999999999887543111 1111222334667999999988889999999999999999998 67777432 111
Q ss_pred hHHHHHHHHHhcCccCcccccCccccchhhHhHHHHHHHHHHHHHHHHhcCCCCCCCCChhhhhc
Q 038766 234 SLRQLVEKALANGINGVRQITDPKLVSSIYEEQEQHQVLEELFKLALVCTSSNPEDRPNMNELLI 298 (299)
Q Consensus 234 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rpt~~~il~ 298 (299)
. ............. +...+..+.+++.+||+.||++|||+.++++
T Consensus 229 ~---~~~~~~~~~~~~~-----------------~~~~~~~~~~li~~~l~~~p~~Rps~~~ll~ 273 (288)
T cd05061 229 Q---VLKFVMDGGYLDQ-----------------PDNCPERVTDLMRMCWQFNPKMRPTFLEIVN 273 (288)
T ss_pred H---HHHHHHcCCCCCC-----------------CCCCCHHHHHHHHHHcCCChhHCcCHHHHHH
Confidence 1 2111111110000 1122457999999999999999999999985
|
Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR is a receptor tyr kinase (RTK) that is composed of two alphabeta heterodimers. Binding of the insulin ligand to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological function. InsR signaling plays an important role in many cellular processes including glucose homeostasis, glycogen synthesis, lipid and protein meta |
| >KOG0194 consensus Protein tyrosine kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-40 Score=285.48 Aligned_cols=261 Identities=28% Similarity=0.410 Sum_probs=207.9
Q ss_pred ChHHHHHHhCCCCCCceeecCCcceEEEEEeC--CC--cE-EEEEEeccC-cCChhhhHHHHHHHHHHHhcCCcceeeee
Q 038766 3 DRTEIENATGSFSENNIIGNSNLSTVYKGRLE--DG--EI-VAVKKLNFH-QFSAESDKSFYREAKTLKELKHRNLVKVL 76 (299)
Q Consensus 3 ~~~~~~~~~~~y~~~~~lg~g~~~~v~~~~~~--~~--~~-~~vK~~~~~-~~~~~~~~~~~~e~~~l~~l~h~~i~~~~ 76 (299)
....||.-.++..+.++||+|.||.||++... ++ .. ||+|+...+ ....+....+.+|+++++.++||||++++
T Consensus 148 ~r~~Wel~H~~v~l~kkLGeGaFGeV~~G~l~~~~~~~~~~VAvK~~k~~~~~~~~~~~e~m~EArvMr~l~H~NVVr~y 227 (474)
T KOG0194|consen 148 PRQKWELSHSDIELGKKLGEGAFGEVFKGKLKLKNGFKVVPVAVKTTKGSSELTKEQIKEFMKEARVMRQLNHPNVVRFY 227 (474)
T ss_pred cccccEEeccCccccceeecccccEEEEEEEEecCCceeeeeEEEeecccccccHHHHHHHHHHHHHHHhCCCCCEEEEE
Confidence 35668888899999999999999999999753 22 23 899998753 35667788999999999999999999999
Q ss_pred eEEEcCCCeeEEEEeecCCCChHHHhcCCCCCCCCCChhhHHHHHHHHHHHHHHhhcCCCCCeeeecccCCceeeCCCCc
Q 038766 77 GYAWESGKLKALILEYMENGSLESVIHGPGVDHSRWTLPKRIDVLISVANGLDYLHSGYDIPIVHCDMKPSNILLDRDFE 156 (299)
Q Consensus 77 ~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lh~~~~~~~~H~dl~~~nil~~~~~~ 156 (299)
|++...... ++|||++.||+|.++++..+ ..++..+...++.+.+.||+|||++ +++||||-.+|+|++.++.
T Consensus 228 GVa~~~~Pl-~ivmEl~~gGsL~~~L~k~~---~~v~~~ek~~~~~~AA~Gl~YLh~k---~~IHRDIAARNcL~~~~~~ 300 (474)
T KOG0194|consen 228 GVAVLEEPL-MLVMELCNGGSLDDYLKKNK---KSLPTLEKLRFCYDAARGLEYLHSK---NCIHRDIAARNCLYSKKGV 300 (474)
T ss_pred EEEcCCCcc-EEEEEecCCCcHHHHHHhCC---CCCCHHHHHHHHHHHHhHHHHHHHC---CCcchhHhHHHheecCCCe
Confidence 988776655 99999999999999998432 2699999999999999999999999 9999999999999999999
Q ss_pred EEEeeeccccccccccccccccccccccCcccCChhhhcccCcCccccchhhhHHHHHHHh-CCCCCCCCccCCCCchhH
Q 038766 157 AHVSDFGTSRMLDVHLQDLSSLSTAFQGTIGYLAPEFAYMRIVTTKVDVFSFGIVVMEFLT-KRRPTGLDEENGLSPISL 235 (299)
Q Consensus 157 v~l~df~~~~~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~DiwslG~~l~~l~~-g~~p~~~~~~~~~~~~~~ 235 (299)
+|++|||++..-.. .........-+..|+|||.+....++.++||||+|+++||+++ |..||... ..
T Consensus 301 vKISDFGLs~~~~~----~~~~~~~~klPirWLAPEtl~~~~~s~kTDV~sfGV~~~Eif~~g~~Py~g~--------~~ 368 (474)
T KOG0194|consen 301 VKISDFGLSRAGSQ----YVMKKFLKKLPIRWLAPETLNTGIFSFKTDVWSFGVLLWEIFENGAEPYPGM--------KN 368 (474)
T ss_pred EEeCccccccCCcc----eeeccccccCcceecChhhhccCccccccchhheeeeEEeeeccCCCCCCCC--------CH
Confidence 99999999874321 1111112234678999999999999999999999999999998 78887433 22
Q ss_pred HHHHHHHHhcCccCcccccCccccchhhHhHHHHHHHHHHHHHHHHhcCCCCCCCCChhhhhc
Q 038766 236 RQLVEKALANGINGVRQITDPKLVSSIYEEQEQHQVLEELFKLALVCTSSNPEDRPNMNELLI 298 (299)
Q Consensus 236 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rpt~~~il~ 298 (299)
.+.......++.+-.. +...+..+..++.+|+..+|++|||+.++.+
T Consensus 369 ~~v~~kI~~~~~r~~~----------------~~~~p~~~~~~~~~c~~~~p~~R~tm~~i~~ 415 (474)
T KOG0194|consen 369 YEVKAKIVKNGYRMPI----------------PSKTPKELAKVMKQCWKKDPEDRPTMSTIKK 415 (474)
T ss_pred HHHHHHHHhcCccCCC----------------CCCCHHHHHHHHHHhccCChhhccCHHHHHH
Confidence 2333333222221111 2244567889999999999999999998753
|
|
| >cd05105 PTKc_PDGFR_alpha Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor alpha | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.4e-40 Score=288.00 Aligned_cols=259 Identities=23% Similarity=0.324 Sum_probs=195.7
Q ss_pred HHhCCCCCCceeecCCcceEEEEEeC------CCcEEEEEEeccCcCChhhhHHHHHHHHHHHhcC-CcceeeeeeEEEc
Q 038766 9 NATGSFSENNIIGNSNLSTVYKGRLE------DGEIVAVKKLNFHQFSAESDKSFYREAKTLKELK-HRNLVKVLGYAWE 81 (299)
Q Consensus 9 ~~~~~y~~~~~lg~g~~~~v~~~~~~------~~~~~~vK~~~~~~~~~~~~~~~~~e~~~l~~l~-h~~i~~~~~~~~~ 81 (299)
.-.++|++.++||+|+||.||++.+. .+..||+|++... ......+.+.+|+++++++. ||||+++++++..
T Consensus 34 ~~~~~~~~~~~LG~G~fG~Vy~~~~~~~~~~~~~~~vavK~l~~~-~~~~~~~~~~~Ei~~l~~l~~HpnIv~l~~~~~~ 112 (400)
T cd05105 34 FPRDGLVLGRILGSGAFGKVVEGTAYGLSRSQPVMKVAVKMLKPT-ARSSEKQALMSELKIMTHLGPHLNIVNLLGACTK 112 (400)
T ss_pred ccccceehhheecCCCCceEEEEEEcccCCCCCceEEEEEecCCC-CChHHHHHHHHHHHHHHhcCCCCCeeeEEEEEcc
Confidence 34578899999999999999999752 2357999998643 23344567889999999996 9999999997655
Q ss_pred CCCeeEEEEeecCCCChHHHhcCCCC------------------------------------------------------
Q 038766 82 SGKLKALILEYMENGSLESVIHGPGV------------------------------------------------------ 107 (299)
Q Consensus 82 ~~~~~~lv~e~~~~~~L~~~~~~~~~------------------------------------------------------ 107 (299)
+...++|+||+.+++|.+++.....
T Consensus 113 -~~~~~lv~Ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 191 (400)
T cd05105 113 -SGPIYIITEYCFYGDLVNYLHKNRDNFLSRHPEKPKKDLDIFGINPADESTRSYVILSFENKGDYMDMKQADTTQYVPM 191 (400)
T ss_pred -CCceEEEEEecCCCcHHHHHHHhhhhhhccccccccccccccCCCcccccccchhhhhhcccccccccccccccccchh
Confidence 4566999999999999887643110
Q ss_pred --------------------------------------CCCCCChhhHHHHHHHHHHHHHHhhcCCCCCeeeecccCCce
Q 038766 108 --------------------------------------DHSRWTLPKRIDVLISVANGLDYLHSGYDIPIVHCDMKPSNI 149 (299)
Q Consensus 108 --------------------------------------~~~~~~~~~~~~i~~qi~~~l~~lh~~~~~~~~H~dl~~~ni 149 (299)
....+++..++.++.|++.||+|||+. +++|+||||+||
T Consensus 192 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~---~ivH~dikp~Ni 268 (400)
T cd05105 192 LEIKEASKYSDIQRSNYDRPASYKGSNDSEVKNLLSDDGSEGLTTLDLLSFTYQVARGMEFLASK---NCVHRDLAARNV 268 (400)
T ss_pred hhhhhhhhhhhcccCcccccccccCcchhhHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHhC---CeeCCCCChHhE
Confidence 113578888999999999999999999 999999999999
Q ss_pred eeCCCCcEEEeeeccccccccccccccccccccccCcccCChhhhcccCcCccccchhhhHHHHHHHh-CCCCCCCCccC
Q 038766 150 LLDRDFEAHVSDFGTSRMLDVHLQDLSSLSTAFQGTIGYLAPEFAYMRIVTTKVDVFSFGIVVMEFLT-KRRPTGLDEEN 228 (299)
Q Consensus 150 l~~~~~~v~l~df~~~~~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~DiwslG~~l~~l~~-g~~p~~~~~~~ 228 (299)
+++.++.++|+|||++........ ........++..|+|||.+.+..++.++||||||+++|+|++ |..||......
T Consensus 269 ll~~~~~~kL~DfGla~~~~~~~~--~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwSlGvil~ellt~g~~P~~~~~~~ 346 (400)
T cd05105 269 LLAQGKIVKICDFGLARDIMHDSN--YVSKGSTFLPVKWMAPESIFDNLYTTLSDVWSYGILLWEIFSLGGTPYPGMIVD 346 (400)
T ss_pred EEeCCCEEEEEeCCcceecccccc--ccccCCcCCCcceEChhhhcCCCCCchhhHHHHHHHHHHHHHCCCCCCcccchh
Confidence 999999999999999875432111 111223345678999999998889999999999999999997 88888532110
Q ss_pred CCCchhHHHHHHHHHhcCccCcccccCccccchhhHhHHHHHHHHHHHHHHHHhcCCCCCCCCChhhhhc
Q 038766 229 GLSPISLRQLVEKALANGINGVRQITDPKLVSSIYEEQEQHQVLEELFKLALVCTSSNPEDRPNMNELLI 298 (299)
Q Consensus 229 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rpt~~~il~ 298 (299)
..+.. ...... .... +...+..+.+++.+||..+|++|||+.++.+
T Consensus 347 ----~~~~~----~~~~~~----~~~~------------~~~~~~~l~~li~~cl~~dP~~RPt~~~l~~ 392 (400)
T cd05105 347 ----STFYN----KIKSGY----RMAK------------PDHATQEVYDIMVKCWNSEPEKRPSFLHLSD 392 (400)
T ss_pred ----HHHHH----HHhcCC----CCCC------------CccCCHHHHHHHHHHCccCHhHCcCHHHHHH
Confidence 11111 111110 0000 2234567899999999999999999999864
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) alpha; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR alpha is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR alpha forms homodimers or heterodimers with PDGFR beta, depending on the nature of the PDGF ligand. PDGF-AA, PDGF- |
| >cd05098 PTKc_FGFR1 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.1e-40 Score=278.38 Aligned_cols=261 Identities=23% Similarity=0.355 Sum_probs=197.8
Q ss_pred HHHHHhCCCCCCceeecCCcceEEEEEeC--------CCcEEEEEEeccCcCChhhhHHHHHHHHHHHhc-CCcceeeee
Q 038766 6 EIENATGSFSENNIIGNSNLSTVYKGRLE--------DGEIVAVKKLNFHQFSAESDKSFYREAKTLKEL-KHRNLVKVL 76 (299)
Q Consensus 6 ~~~~~~~~y~~~~~lg~g~~~~v~~~~~~--------~~~~~~vK~~~~~~~~~~~~~~~~~e~~~l~~l-~h~~i~~~~ 76 (299)
.++...++|.+.+.||+|+||.||++.+. +...+|+|.+... ........+..|+..++.+ +|+||++++
T Consensus 12 ~~~~~~~~~~i~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~~aiK~~~~~-~~~~~~~~~~~e~~~l~~l~~h~~i~~~~ 90 (307)
T cd05098 12 RWEVPRDRLVLGKPLGEGCFGQVVMAEAIGLDKEKPNRVTKVAVKMLKSD-ATEKDLSDLISEMEMMKMIGKHKNIINLL 90 (307)
T ss_pred cceeehHHeEEeeeeccCCCeeEEEeEEeccCCcccCccceEEEEeccCC-CChHHHHHHHHHHHHHHHhcCCCCEeeEE
Confidence 34556689999999999999999999752 1346999988643 2334456788899999999 699999999
Q ss_pred eEEEcCCCeeEEEEeecCCCChHHHhcCCCC------------CCCCCChhhHHHHHHHHHHHHHHhhcCCCCCeeeecc
Q 038766 77 GYAWESGKLKALILEYMENGSLESVIHGPGV------------DHSRWTLPKRIDVLISVANGLDYLHSGYDIPIVHCDM 144 (299)
Q Consensus 77 ~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~------------~~~~~~~~~~~~i~~qi~~~l~~lh~~~~~~~~H~dl 144 (299)
+++...+ ..++|+||+.+++|.+++..... ....++..+++.++.|++.||+|||+. +++|+||
T Consensus 91 ~~~~~~~-~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~lH~~---gi~H~dl 166 (307)
T cd05098 91 GACTQDG-PLYVIVEYASKGNLREYLRARRPPGMEYCYNPTQVPEEQLSFKDLVSCAYQVARGMEYLASK---KCIHRDL 166 (307)
T ss_pred EEEecCC-ceEEEEecCCCCcHHHHHHhcCCcccccccccccCccccCCHHHHHHHHHHHHHHHHHHHHC---Ccccccc
Confidence 9776544 56999999999999999864321 223588889999999999999999998 9999999
Q ss_pred cCCceeeCCCCcEEEeeeccccccccccccccccccccccCcccCChhhhcccCcCccccchhhhHHHHHHHh-CCCCCC
Q 038766 145 KPSNILLDRDFEAHVSDFGTSRMLDVHLQDLSSLSTAFQGTIGYLAPEFAYMRIVTTKVDVFSFGIVVMEFLT-KRRPTG 223 (299)
Q Consensus 145 ~~~nil~~~~~~v~l~df~~~~~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~DiwslG~~l~~l~~-g~~p~~ 223 (299)
||+||+++.++.++|+|||.+........ .........+..|+|||.+.+..++.++|+|||||++|+|++ |..||.
T Consensus 167 kp~Nill~~~~~~kL~dfg~a~~~~~~~~--~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~el~~~g~~p~~ 244 (307)
T cd05098 167 AARNVLVTEDNVMKIADFGLARDIHHIDY--YKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPYP 244 (307)
T ss_pred cHHheEEcCCCcEEECCCcccccccccch--hhccccCCCccceeChHHhccCCCCcHHHHHHHHHHHHHHHcCCCCCCC
Confidence 99999999999999999999865432110 011111223467999999998889999999999999999998 777774
Q ss_pred CCccCCCCchhHHHHHHHHHhcCccCcccccCccccchhhHhHHHHHHHHHHHHHHHHhcCCCCCCCCChhhhhc
Q 038766 224 LDEENGLSPISLRQLVEKALANGINGVRQITDPKLVSSIYEEQEQHQVLEELFKLALVCTSSNPEDRPNMNELLI 298 (299)
Q Consensus 224 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rpt~~~il~ 298 (299)
... ...+...+. ... . ... +...+.++.+++.+||..+|++|||+.++++
T Consensus 245 ~~~-----~~~~~~~~~----~~~-~---~~~------------~~~~~~~~~~li~~~l~~~p~~Rps~~evl~ 294 (307)
T cd05098 245 GVP-----VEELFKLLK----EGH-R---MDK------------PSNCTNELYMMMRDCWHAVPSQRPTFKQLVE 294 (307)
T ss_pred cCC-----HHHHHHHHH----cCC-C---CCC------------CCcCCHHHHHHHHHHcccChhhCcCHHHHHH
Confidence 321 111222111 110 0 000 1233568889999999999999999999986
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 1 (FGFR1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR1 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to |
| >cd07844 STKc_PCTAIRE_like Catalytic domain of PCTAIRE-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.8e-40 Score=276.04 Aligned_cols=271 Identities=23% Similarity=0.318 Sum_probs=194.7
Q ss_pred hCCCCCCceeecCCcceEEEEEeC-CCcEEEEEEeccCcCChhhhHHHHHHHHHHHhcCCcceeeeeeEEEcCCCeeEEE
Q 038766 11 TGSFSENNIIGNSNLSTVYKGRLE-DGEIVAVKKLNFHQFSAESDKSFYREAKTLKELKHRNLVKVLGYAWESGKLKALI 89 (299)
Q Consensus 11 ~~~y~~~~~lg~g~~~~v~~~~~~-~~~~~~vK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~lv 89 (299)
.++|.+.+.||+|++|+||++... +++.|++|.+..... ......+.+|+.+++.++|+||+++++++.. +...++|
T Consensus 4 ~~~y~~~~~lg~g~~~~vy~~~~~~~~~~~~iK~~~~~~~-~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~-~~~~~lv 81 (291)
T cd07844 4 LETYKKLDKLGEGSYATVYKGRSKLTGQLVALKEIRLEHE-EGAPFTAIREASLLKDLKHANIVTLHDIIHT-KKTLTLV 81 (291)
T ss_pred ccceeEEEEEeecCCeEEEEEEEcCCCcEEEEEEEecccc-cCCchhHHHHHHHHhhCCCcceeeEEEEEec-CCeEEEE
Confidence 478999999999999999999875 589999999865332 2223456789999999999999999997654 5667999
Q ss_pred EeecCCCChHHHhcCCCCCCCCCChhhHHHHHHHHHHHHHHhhcCCCCCeeeecccCCceeeCCCCcEEEeeeccccccc
Q 038766 90 LEYMENGSLESVIHGPGVDHSRWTLPKRIDVLISVANGLDYLHSGYDIPIVHCDMKPSNILLDRDFEAHVSDFGTSRMLD 169 (299)
Q Consensus 90 ~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lh~~~~~~~~H~dl~~~nil~~~~~~v~l~df~~~~~~~ 169 (299)
+||+.+ +|.+++... ...+++..++.++.|+++||.|||+. +++|+||+|+||+++.++.++|+|||++....
T Consensus 82 ~e~~~~-~L~~~~~~~---~~~~~~~~~~~~~~ql~~al~~lH~~---~i~H~dl~p~nil~~~~~~~kl~dfg~~~~~~ 154 (291)
T cd07844 82 FEYLDT-DLKQYMDDC---GGGLSMHNVRLFLFQLLRGLAYCHQR---RVLHRDLKPQNLLISERGELKLADFGLARAKS 154 (291)
T ss_pred EecCCC-CHHHHHHhC---CCCCCHHHHHHHHHHHHHHHHHHHhC---CeecccCCHHHEEEcCCCCEEECccccccccC
Confidence 999965 898887632 23688999999999999999999999 99999999999999999999999999986432
Q ss_pred cccccccccccccccCcccCChhhhcc-cCcCccccchhhhHHHHHHHhCCCCCCCCccCCCCchhHHHHHHHHHhcCcc
Q 038766 170 VHLQDLSSLSTAFQGTIGYLAPEFAYM-RIVTTKVDVFSFGIVVMEFLTKRRPTGLDEENGLSPISLRQLVEKALANGIN 248 (299)
Q Consensus 170 ~~~~~~~~~~~~~~~~~~y~~PE~~~~-~~~~~~~DiwslG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 248 (299)
.. ........++..|+|||.+.+ ..++.++||||+|+++|+|++|..||...... ...+.. +.........
T Consensus 155 ~~----~~~~~~~~~~~~~~aPE~~~~~~~~~~~~Dv~slG~il~~l~~g~~~~~~~~~~---~~~~~~-~~~~~~~~~~ 226 (291)
T cd07844 155 VP----SKTYSNEVVTLWYRPPDVLLGSTEYSTSLDMWGVGCIFYEMATGRPLFPGSTDV---EDQLHK-IFRVLGTPTE 226 (291)
T ss_pred CC----CccccccccccccCCcHHhhcCcccCcHHHHHHHHHHHHHHHhCCCCCCCCccH---HHHHHH-HHHhcCCCCh
Confidence 11 111122235778999998875 45788999999999999999999998543211 001110 0000000000
Q ss_pred C-cccc------cC---ccccchhhHhHHHHHHH--HHHHHHHHHhcCCCCCCCCChhhhhcC
Q 038766 249 G-VRQI------TD---PKLVSSIYEEQEQHQVL--EELFKLALVCTSSNPEDRPNMNELLIT 299 (299)
Q Consensus 249 ~-~~~~------~~---~~~~~~~~~~~~~~~~~--~~l~~li~~~l~~dP~~Rpt~~~il~~ 299 (299)
. .... .. ......... ....... ..+.+++.+||..+|++|||+.+++.|
T Consensus 227 ~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~li~~~L~~~p~~Rps~~e~l~~ 288 (291)
T cd07844 227 ETWPGVSSNPEFKPYSFPFYPPRPLI-NHAPRLDRIPHGEELALKFLQYEPKKRISAAEAMKH 288 (291)
T ss_pred hhhhhhhhccccccccccccCChhHH-HhCcCCCCchhHHHHHHHHhccCcccccCHHHHhcC
Confidence 0 0000 00 000000000 0001122 678899999999999999999999986
|
Serine/Threonine Kinases (STKs), PCTAIRE-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily share sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. The association of PCTAIRE-like proteins with cyclins has not been widely studied, although PFTAIRE-1 has been shown to function as a CDK which is regulated by cyclin D3 as well as the |
| >KOG0604 consensus MAP kinase-activated protein kinase 2 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-40 Score=262.35 Aligned_cols=257 Identities=21% Similarity=0.257 Sum_probs=201.1
Q ss_pred HHHhCCCCCC-ceeecCCcceEEEEEe-CCCcEEEEEEeccCcCChhhhHHHHHHHHHHHhc-CCcceeeeeeEEE---c
Q 038766 8 ENATGSFSEN-NIIGNSNLSTVYKGRL-EDGEIVAVKKLNFHQFSAESDKSFYREAKTLKEL-KHRNLVKVLGYAW---E 81 (299)
Q Consensus 8 ~~~~~~y~~~-~~lg~g~~~~v~~~~~-~~~~~~~vK~~~~~~~~~~~~~~~~~e~~~l~~l-~h~~i~~~~~~~~---~ 81 (299)
..+.++|.+. ++||-|-.|.|-.+.+ .+++++|+|++.. ....++|++..-.. .||||+.+++++. .
T Consensus 57 ~~itedY~is~qvLG~GinGkV~~C~~k~T~ekfALKvL~D-------s~KARrEVeLHw~~s~h~~iV~IidVyeNs~~ 129 (400)
T KOG0604|consen 57 YSITEDYSISWQVLGAGINGKVVQCVHKRTQEKFALKVLLD-------SPKARREVELHWMASGHPHIVSIIDVYENSYQ 129 (400)
T ss_pred ccchhhheehhhhhccccCCceEEEEeccchhhhHHHHHhc-------CHHHHhHhhhhhhhcCCCceEEeehhhhhhcc
Confidence 3467777764 6799999999999875 5699999999862 23456677665555 4999999999663 3
Q ss_pred CCCeeEEEEeecCCCChHHHhcCCCCCCCCCChhhHHHHHHHHHHHHHHhhcCCCCCeeeecccCCceeeC---CCCcEE
Q 038766 82 SGKLKALILEYMENGSLESVIHGPGVDHSRWTLPKRIDVLISVANGLDYLHSGYDIPIVHCDMKPSNILLD---RDFEAH 158 (299)
Q Consensus 82 ~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lh~~~~~~~~H~dl~~~nil~~---~~~~v~ 158 (299)
..+.+.+|||.+.||.|.+.++.. ....++|.++..|+.||+.|+.|||+. +|.||||||+|+|.+ .+..+|
T Consensus 130 ~rkcLLiVmE~meGGeLfsriq~~--g~~afTErea~eI~~qI~~Av~~lH~~---nIAHRDlKpENLLyt~t~~na~lK 204 (400)
T KOG0604|consen 130 GRKCLLIVMECMEGGELFSRIQDR--GDQAFTEREASEIMKQIGLAVRYLHSM---NIAHRDLKPENLLYTTTSPNAPLK 204 (400)
T ss_pred CceeeEeeeecccchHHHHHHHHc--ccccchHHHHHHHHHHHHHHHHHHHhc---chhhccCChhheeeecCCCCcceE
Confidence 346678999999999999999866 356799999999999999999999999 999999999999996 456799
Q ss_pred EeeeccccccccccccccccccccccCcccCChhhhcccCcCccccchhhhHHHHHHHhCCCCCCCCccCCCCchhHHHH
Q 038766 159 VSDFGTSRMLDVHLQDLSSLSTAFQGTIGYLAPEFAYMRIVTTKVDVFSFGIVVMEFLTKRRPTGLDEENGLSPISLRQL 238 (299)
Q Consensus 159 l~df~~~~~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~DiwslG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~ 238 (299)
|+|||++..... ........-||.|+|||++--..|+...|+||+|+++|-|++|.+||........++ .+...
T Consensus 205 LtDfGFAK~t~~-----~~~L~TPc~TPyYvaPevlg~eKydkscdmwSlgVimYIlLCGyPPFYS~hg~aisp-gMk~r 278 (400)
T KOG0604|consen 205 LTDFGFAKETQE-----PGDLMTPCFTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAISP-GMKRR 278 (400)
T ss_pred ecccccccccCC-----CccccCCcccccccCHHHhCchhcCCCCCccchhHHHHHhhcCCCcccccCCccCCh-hHHhH
Confidence 999999975431 222344556899999999999999999999999999999999999997553322221 11111
Q ss_pred HHHHHhcCccCcccccCccccchhhHhHHHHHHHHHHHHHHHHhcCCCCCCCCChhhhhcC
Q 038766 239 VEKALANGINGVRQITDPKLVSSIYEEQEQHQVLEELFKLALVCTSSNPEDRPNMNELLIT 299 (299)
Q Consensus 239 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rpt~~~il~~ 299 (299)
+ .. ....+++ ..=..+|++.-++|+++|+.+|++|.|++++++|
T Consensus 279 I----~~---gqy~FP~----------pEWs~VSe~aKdlIR~LLkt~PteRlTI~~~m~h 322 (400)
T KOG0604|consen 279 I----RT---GQYEFPE----------PEWSCVSEAAKDLIRKLLKTEPTERLTIEEVMDH 322 (400)
T ss_pred h----hc---cCccCCC----------hhHhHHHHHHHHHHHHHhcCCchhheeHHHhhcC
Confidence 1 11 1122222 2245678889999999999999999999999987
|
|
| >cd05095 PTKc_DDR2 Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8e-39 Score=270.17 Aligned_cols=263 Identities=24% Similarity=0.341 Sum_probs=194.1
Q ss_pred hCCCCCCceeecCCcceEEEEEeC-----------------CCcEEEEEEeccCcCChhhhHHHHHHHHHHHhcCCccee
Q 038766 11 TGSFSENNIIGNSNLSTVYKGRLE-----------------DGEIVAVKKLNFHQFSAESDKSFYREAKTLKELKHRNLV 73 (299)
Q Consensus 11 ~~~y~~~~~lg~g~~~~v~~~~~~-----------------~~~~~~vK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~ 73 (299)
.++|.+.+.||+|+||.||++.+. ++..+|+|++... ........+.+|+..++.++|+||+
T Consensus 4 ~~~~~~~~~lg~G~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~~~~a~K~~~~~-~~~~~~~~~~~E~~~l~~l~~~~i~ 82 (296)
T cd05095 4 RKRLTFKEKLGEGQFGEVHLCEAEGMEKFMDKDFSLDVSGNQPVLVAVKMLRED-ANKNARNDFLKEIKIMSRLKDPNII 82 (296)
T ss_pred hhhceeeeeccCCCCCeEEecccccccccccccccccCCCCceeEEEEEecccc-CCHHHHHHHHHHHHHHHhCCCCCcc
Confidence 367999999999999999998532 2346899988643 2334456788999999999999999
Q ss_pred eeeeEEEcCCCeeEEEEeecCCCChHHHhcCCCC-------CCCCCChhhHHHHHHHHHHHHHHhhcCCCCCeeeecccC
Q 038766 74 KVLGYAWESGKLKALILEYMENGSLESVIHGPGV-------DHSRWTLPKRIDVLISVANGLDYLHSGYDIPIVHCDMKP 146 (299)
Q Consensus 74 ~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~-------~~~~~~~~~~~~i~~qi~~~l~~lh~~~~~~~~H~dl~~ 146 (299)
++++++.. +...++|+||+.+++|.+++..... ....+++..++.++.|++.||+|||+. +++|+||||
T Consensus 83 ~~~~~~~~-~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~al~~lH~~---~i~H~dlkp 158 (296)
T cd05095 83 RLLAVCIT-SDPLCMITEYMENGDLNQFLSRHEPQEAAEKADVVTISYSTLIFMATQIASGMKYLSSL---NFVHRDLAT 158 (296)
T ss_pred eEEEEEec-CCccEEEEEeCCCCcHHHHHHhcCcccccccccccccCHHHHHHHHHHHHHHHHHHHHC---CeecccCCh
Confidence 99997655 4456999999999999998864321 223577888999999999999999999 999999999
Q ss_pred CceeeCCCCcEEEeeeccccccccccccccccccccccCcccCChhhhcccCcCccccchhhhHHHHHHHh--CCCCCCC
Q 038766 147 SNILLDRDFEAHVSDFGTSRMLDVHLQDLSSLSTAFQGTIGYLAPEFAYMRIVTTKVDVFSFGIVVMEFLT--KRRPTGL 224 (299)
Q Consensus 147 ~nil~~~~~~v~l~df~~~~~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~DiwslG~~l~~l~~--g~~p~~~ 224 (299)
+||+++.++.++|+|||++..+.... ..........+..|++||......++.++|+|||||++|+|++ |..||..
T Consensus 159 ~Nili~~~~~~~l~dfg~~~~~~~~~--~~~~~~~~~~~~~~~~pe~~~~~~~~~~~DiwSlG~~l~el~~~~~~~p~~~ 236 (296)
T cd05095 159 RNCLVGKNYTIKIADFGMSRNLYSGD--YYRIQGRAVLPIRWMSWESILLGKFTTASDVWAFGVTLWEILTLCKEQPYSQ 236 (296)
T ss_pred heEEEcCCCCEEeccCcccccccCCc--ceeccCcCcCccccCCHHHHhcCCccchhhhhHHHHHHHHHHHhCCCCCccc
Confidence 99999999999999999987543211 1111222334568999998888889999999999999999998 6677743
Q ss_pred CccCCCCchhHHHHHHHHHhcCccCcccccCccccchhhHhHHHHHHHHHHHHHHHHhcCCCCCCCCChhhhhc
Q 038766 225 DEENGLSPISLRQLVEKALANGINGVRQITDPKLVSSIYEEQEQHQVLEELFKLALVCTSSNPEDRPNMNELLI 298 (299)
Q Consensus 225 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rpt~~~il~ 298 (299)
.. ................ ....... +...+..+.+++.+||..||++|||+.++++
T Consensus 237 ~~-----~~~~~~~~~~~~~~~~-~~~~~~~------------~~~~~~~~~~li~~cl~~~p~~Rp~~~~i~~ 292 (296)
T cd05095 237 LS-----DEQVIENTGEFFRDQG-RQVYLPK------------PALCPDSLYKLMLSCWRRNAKERPSFQEIHA 292 (296)
T ss_pred cC-----hHHHHHHHHHHHhhcc-ccccCCC------------CCCCCHHHHHHHHHHcCCCcccCCCHHHHHH
Confidence 21 1111111111111000 0000000 1223467899999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 2 (DDR2) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR2 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR2 binds mostly to fibrillar collagens. More recently, it has been reported to also bind collagen X. DDR2 is widely expressed in many tissues wit |
| >cd05055 PTKc_PDGFR Catalytic domain of the Protein Tyrosine Kinases, Platelet Derived Growth Factor Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-39 Score=274.57 Aligned_cols=260 Identities=22% Similarity=0.327 Sum_probs=199.1
Q ss_pred HHHHHhCCCCCCceeecCCcceEEEEEeC------CCcEEEEEEeccCcCChhhhHHHHHHHHHHHhc-CCcceeeeeeE
Q 038766 6 EIENATGSFSENNIIGNSNLSTVYKGRLE------DGEIVAVKKLNFHQFSAESDKSFYREAKTLKEL-KHRNLVKVLGY 78 (299)
Q Consensus 6 ~~~~~~~~y~~~~~lg~g~~~~v~~~~~~------~~~~~~vK~~~~~~~~~~~~~~~~~e~~~l~~l-~h~~i~~~~~~ 78 (299)
+++...++|.+.+.||+|++|.||++.+. .+..+|+|++.... .....+.+.+|+.+++++ +|+||+++++.
T Consensus 29 ~~~~~~~~~~~~~~ig~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~ 107 (302)
T cd05055 29 KWEFPRNNLSFGKTLGAGAFGKVVEATAYGLSKSDAVMKVAVKMLKPTA-HSSEREALMSELKIMSHLGNHENIVNLLGA 107 (302)
T ss_pred cccccHHHeEEcceeeccCCeeEEEEEEecCCCCCceeEEEEEecCccC-ChHHHHHHHHHHHHHHhccCCCCcceEEEE
Confidence 34556678999999999999999999741 35579999886432 334456788999999999 79999999997
Q ss_pred EEcCCCeeEEEEeecCCCChHHHhcCCCCCCCCCChhhHHHHHHHHHHHHHHhhcCCCCCeeeecccCCceeeCCCCcEE
Q 038766 79 AWESGKLKALILEYMENGSLESVIHGPGVDHSRWTLPKRIDVLISVANGLDYLHSGYDIPIVHCDMKPSNILLDRDFEAH 158 (299)
Q Consensus 79 ~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lh~~~~~~~~H~dl~~~nil~~~~~~v~ 158 (299)
+... ...++|+||+.+++|.+++... ....+++.++..++.|++.||+|||++ +++|+||+|+||+++.++.++
T Consensus 108 ~~~~-~~~~lv~e~~~~~~L~~~i~~~--~~~~l~~~~~~~i~~~i~~~l~~lH~~---~ivH~dlkp~Nil~~~~~~~~ 181 (302)
T cd05055 108 CTIG-GPILVITEYCCYGDLLNFLRRK--RESFLTLEDLLSFSYQVAKGMAFLASK---NCIHRDLAARNVLLTHGKIVK 181 (302)
T ss_pred EecC-CceEEEEEcCCCCcHHHHHHhC--CCCCCCHHHHHHHHHHHHHHHHHHHHC---CeehhhhccceEEEcCCCeEE
Confidence 6654 4569999999999999998642 223489999999999999999999999 999999999999999999999
Q ss_pred EeeeccccccccccccccccccccccCcccCChhhhcccCcCccccchhhhHHHHHHHh-CCCCCCCCccCCCCchhHHH
Q 038766 159 VSDFGTSRMLDVHLQDLSSLSTAFQGTIGYLAPEFAYMRIVTTKVDVFSFGIVVMEFLT-KRRPTGLDEENGLSPISLRQ 237 (299)
Q Consensus 159 l~df~~~~~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~DiwslG~~l~~l~~-g~~p~~~~~~~~~~~~~~~~ 237 (299)
|+|||++..+..... ........++..|+|||.+.+..++.++||||+|+++|+|++ |..||...... .....
T Consensus 182 l~dfg~~~~~~~~~~--~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslGvil~el~t~g~~p~~~~~~~----~~~~~ 255 (302)
T cd05055 182 ICDFGLARDIMNDSN--YVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGILLWEIFSLGSNPYPGMPVD----SKFYK 255 (302)
T ss_pred ECCCcccccccCCCc--eeecCCCCcccccCCHhhhccCCCCcHhHHHHHHHHHHHHHhCCCCCcCCCCch----HHHHH
Confidence 999999875542211 111222345678999999998889999999999999999998 88887533111 11111
Q ss_pred HHHHHHhcCccCcccccCccccchhhHhHHHHHHHHHHHHHHHHhcCCCCCCCCChhhhhc
Q 038766 238 LVEKALANGINGVRQITDPKLVSSIYEEQEQHQVLEELFKLALVCTSSNPEDRPNMNELLI 298 (299)
Q Consensus 238 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rpt~~~il~ 298 (299)
....+.. ... +...+..+.+++.+||..+|++|||+.++++
T Consensus 256 ----~~~~~~~----~~~------------~~~~~~~~~~li~~cl~~~p~~Rpt~~ell~ 296 (302)
T cd05055 256 ----LIKEGYR----MAQ------------PEHAPAEIYDIMKTCWDADPLKRPTFKQIVQ 296 (302)
T ss_pred ----HHHcCCc----CCC------------CCCCCHHHHHHHHHHcCCCchhCcCHHHHHH
Confidence 1111100 000 1123457999999999999999999999985
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) subfamily; catalytic (c) domain. The PDGFR subfamily consists of PDGFR alpha, PDGFR beta, KIT, CSF-1R, the mammalian FLT3, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. PDGFR kinase domains are autoinhibited by their juxtamembrane regions containing tyr residues. The binding to their ligands leads to recept |
| >cd05045 PTKc_RET Catalytic domain of the Protein Tyrosine Kinase, REarranged during Transfection protein | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-39 Score=272.71 Aligned_cols=254 Identities=26% Similarity=0.380 Sum_probs=193.5
Q ss_pred CCCCCceeecCCcceEEEEEeC------CCcEEEEEEeccCcCChhhhHHHHHHHHHHHhcCCcceeeeeeEEEcCCCee
Q 038766 13 SFSENNIIGNSNLSTVYKGRLE------DGEIVAVKKLNFHQFSAESDKSFYREAKTLKELKHRNLVKVLGYAWESGKLK 86 (299)
Q Consensus 13 ~y~~~~~lg~g~~~~v~~~~~~------~~~~~~vK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~ 86 (299)
+|++.+.||+|+||.||++... ....+++|.+... ........+.+|+..++.++||||+++++.+... ...
T Consensus 1 ~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~~~~k~~~~~-~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~-~~~ 78 (290)
T cd05045 1 NLVLGKTLGEGEFGKVVKATAFRLKGRAGYTTVAVKMLKEN-ASSSELRDLLSEFNLLKQVNHPHVIKLYGACSQD-GPL 78 (290)
T ss_pred CccccccccCcCCcceEEEEEecCCCCCcceeEEEEecCCC-CCHHHHHHHHHHHHHHhhCCCCCEeeEEEEEecC-CCc
Confidence 5889999999999999999753 2356888887532 2333456788999999999999999999976654 456
Q ss_pred EEEEeecCCCChHHHhcCCC--------------------CCCCCCChhhHHHHHHHHHHHHHHhhcCCCCCeeeecccC
Q 038766 87 ALILEYMENGSLESVIHGPG--------------------VDHSRWTLPKRIDVLISVANGLDYLHSGYDIPIVHCDMKP 146 (299)
Q Consensus 87 ~lv~e~~~~~~L~~~~~~~~--------------------~~~~~~~~~~~~~i~~qi~~~l~~lh~~~~~~~~H~dl~~ 146 (299)
++++||+.+++|.+++.... .....+++..++.++.|++.||.|||+. +++|+||+|
T Consensus 79 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~---~ivH~dikp 155 (290)
T cd05045 79 LLIVEYAKYGSLRSFLRESRKVGPSYLGSDGNRNSSYLDNPDERALTMGDLISFAWQISRGMQYLAEM---KLVHRDLAA 155 (290)
T ss_pred EEEEEecCCCCHHHHHHhcCCccccccccccccccccccCccccccCHHHHHHHHHHHHHHHHHHHHC---Ceehhhhhh
Confidence 99999999999998875321 1123578899999999999999999998 999999999
Q ss_pred CceeeCCCCcEEEeeeccccccccccccccccccccccCcccCChhhhcccCcCccccchhhhHHHHHHHh-CCCCCCCC
Q 038766 147 SNILLDRDFEAHVSDFGTSRMLDVHLQDLSSLSTAFQGTIGYLAPEFAYMRIVTTKVDVFSFGIVVMEFLT-KRRPTGLD 225 (299)
Q Consensus 147 ~nil~~~~~~v~l~df~~~~~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~DiwslG~~l~~l~~-g~~p~~~~ 225 (299)
+||+++.++.++|+|||++......... .......++..|+|||...+..++.++||||||+++++|++ |..||...
T Consensus 156 ~nill~~~~~~kl~dfg~~~~~~~~~~~--~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~ 233 (290)
T cd05045 156 RNVLVAEGRKMKISDFGLSRDVYEEDSY--VKRSKGRIPVKWMAIESLFDHIYTTQSDVWSFGVLLWEIVTLGGNPYPGI 233 (290)
T ss_pred heEEEcCCCcEEeccccccccccCccch--hcccCCCCCccccCHHHHccCCcchHhHHHHHHHHHHHHHhcCCCCCCCC
Confidence 9999999999999999998754321110 11122234568999999988889999999999999999998 88888432
Q ss_pred ccCCCCchhHHHHHHHHHhcCccCcccccCccccchhhHhHHHHHHHHHHHHHHHHhcCCCCCCCCChhhhhc
Q 038766 226 EENGLSPISLRQLVEKALANGINGVRQITDPKLVSSIYEEQEQHQVLEELFKLALVCTSSNPEDRPNMNELLI 298 (299)
Q Consensus 226 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rpt~~~il~ 298 (299)
....+..... ... .... +..++.++.+++.+||+.+|++|||+.++++
T Consensus 234 -----~~~~~~~~~~----~~~----~~~~------------~~~~~~~~~~~i~~cl~~~P~~Rp~~~~i~~ 281 (290)
T cd05045 234 -----APERLFNLLK----TGY----RMER------------PENCSEEMYNLMLTCWKQEPDKRPTFADISK 281 (290)
T ss_pred -----CHHHHHHHHh----CCC----CCCC------------CCCCCHHHHHHHHHHccCCcccCCCHHHHHH
Confidence 2222222211 110 0000 1233467999999999999999999999975
|
Protein Tyrosine Kinase (PTK) family; RET (REarranged during Transfection) protein; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. RET is a receptor tyr kinase (RTK) containing an extracellular region with four cadherin-like repeats, a calcium-binding site, and a cysteine-rich domain, a transmembrane segment, and an intracellular catalytic domain. It is part of a multisubunit complex that binds glial-derived neurotropic factor (GDNF) family ligands (GFLs) including GDNF, neurturin, artemin, and persephin. GFLs bind RET along with four GPI-anchored coreceptors, bringing two RET molecules together, leadi |
| >cd05089 PTKc_Tie1 Catalytic domain of the Protein Tyrosine Kinase, Tie1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-39 Score=274.47 Aligned_cols=252 Identities=25% Similarity=0.387 Sum_probs=191.2
Q ss_pred CCCCCCceeecCCcceEEEEEeCC-C--cEEEEEEeccCcCChhhhHHHHHHHHHHHhc-CCcceeeeeeEEEcCCCeeE
Q 038766 12 GSFSENNIIGNSNLSTVYKGRLED-G--EIVAVKKLNFHQFSAESDKSFYREAKTLKEL-KHRNLVKVLGYAWESGKLKA 87 (299)
Q Consensus 12 ~~y~~~~~lg~g~~~~v~~~~~~~-~--~~~~vK~~~~~~~~~~~~~~~~~e~~~l~~l-~h~~i~~~~~~~~~~~~~~~ 87 (299)
++|++.+.||+|++|.||++..++ + ..+++|.+.. .........+.+|+..++++ .||||+++++++... ...+
T Consensus 2 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~ik~~~~-~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~~-~~~~ 79 (297)
T cd05089 2 EDIKFEDVIGEGNFGQVIRAMIKKDGLKMNAAIKMLKE-FASENDHRDFAGELEVLCKLGHHPNIINLLGACENR-GYLY 79 (297)
T ss_pred ccceeeeeecCCCcceEEEEEecCCCCcceeEEEEccc-cCCHHHHHHHHHHHHHHHhhcCCCchhheEEEEccC-Ccce
Confidence 689999999999999999998643 3 3468887752 22334456788899999999 699999999976554 4569
Q ss_pred EEEeecCCCChHHHhcCCCC------------CCCCCChhhHHHHHHHHHHHHHHhhcCCCCCeeeecccCCceeeCCCC
Q 038766 88 LILEYMENGSLESVIHGPGV------------DHSRWTLPKRIDVLISVANGLDYLHSGYDIPIVHCDMKPSNILLDRDF 155 (299)
Q Consensus 88 lv~e~~~~~~L~~~~~~~~~------------~~~~~~~~~~~~i~~qi~~~l~~lh~~~~~~~~H~dl~~~nil~~~~~ 155 (299)
+|+||+++++|.+++..... ....+++..++.++.|++.||++||+. +++|+||||+||+++.++
T Consensus 80 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~lH~~---~ivH~dlkp~Nill~~~~ 156 (297)
T cd05089 80 IAIEYAPYGNLLDFLRKSRVLETDPAFAKEHGTASTLTSQQLLQFASDVATGMQYLSEK---QFIHRDLAARNVLVGENL 156 (297)
T ss_pred EEEEecCCCcHHHHHHhccccccccccccccCccCCCCHHHHHHHHHHHHHHHHHHHHC---CcccCcCCcceEEECCCC
Confidence 99999999999998864211 123588999999999999999999998 999999999999999999
Q ss_pred cEEEeeeccccccccccccccccccccccCcccCChhhhcccCcCccccchhhhHHHHHHHh-CCCCCCCCccCCCCchh
Q 038766 156 EAHVSDFGTSRMLDVHLQDLSSLSTAFQGTIGYLAPEFAYMRIVTTKVDVFSFGIVVMEFLT-KRRPTGLDEENGLSPIS 234 (299)
Q Consensus 156 ~v~l~df~~~~~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~DiwslG~~l~~l~~-g~~p~~~~~~~~~~~~~ 234 (299)
.++|+|||++...... ........+..|+|||...+..++.++|||||||++|+|++ |..||.... ..
T Consensus 157 ~~kl~dfg~~~~~~~~-----~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwSlG~il~el~t~g~~pf~~~~-----~~- 225 (297)
T cd05089 157 ASKIADFGLSRGEEVY-----VKKTMGRLPVRWMAIESLNYSVYTTKSDVWSFGVLLWEIVSLGGTPYCGMT-----CA- 225 (297)
T ss_pred eEEECCcCCCccccce-----eccCCCCcCccccCchhhccCCCCchhhHHHHHHHHHHHHcCCCCCCCCCC-----HH-
Confidence 9999999988642211 01111122457999999988889999999999999999997 989984321 11
Q ss_pred HHHHHHHHHhcCccCcccccCccccchhhHhHHHHHHHHHHHHHHHHhcCCCCCCCCChhhhhc
Q 038766 235 LRQLVEKALANGINGVRQITDPKLVSSIYEEQEQHQVLEELFKLALVCTSSNPEDRPNMNELLI 298 (299)
Q Consensus 235 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rpt~~~il~ 298 (299)
........ .. .... +..++..+.+++.+||..+|.+|||++++++
T Consensus 226 --~~~~~~~~-~~----~~~~------------~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~ 270 (297)
T cd05089 226 --ELYEKLPQ-GY----RMEK------------PRNCDDEVYELMRQCWRDRPYERPPFAQISV 270 (297)
T ss_pred --HHHHHHhc-CC----CCCC------------CCCCCHHHHHHHHHHcCCChhhCcCHHHHHH
Confidence 11111111 00 0000 1234567899999999999999999999964
|
Protein Tyrosine Kinase (PTK) family; Tie1; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie1 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. No specific ligand has been identified for Tie1, although the angiopoietin, Ang-1, binds to Tie1 through integrins at high concentrations. |
| >cd05103 PTKc_VEGFR2 Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-40 Score=284.75 Aligned_cols=262 Identities=23% Similarity=0.345 Sum_probs=198.3
Q ss_pred HHHhCCCCCCceeecCCcceEEEEEe------CCCcEEEEEEeccCcCChhhhHHHHHHHHHHHhc-CCcceeeeeeEEE
Q 038766 8 ENATGSFSENNIIGNSNLSTVYKGRL------EDGEIVAVKKLNFHQFSAESDKSFYREAKTLKEL-KHRNLVKVLGYAW 80 (299)
Q Consensus 8 ~~~~~~y~~~~~lg~g~~~~v~~~~~------~~~~~~~vK~~~~~~~~~~~~~~~~~e~~~l~~l-~h~~i~~~~~~~~ 80 (299)
+--.++|++.+.||+|+||.||+|.+ .+++.||+|++.... .......+.+|+..+.++ .|+||+++++.+.
T Consensus 3 ~~~~~~~~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~~E~~~l~~l~~h~niv~~~~~~~ 81 (343)
T cd05103 3 EFPRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGA-THSEHRALMSELKILIHIGHHLNVVNLLGACT 81 (343)
T ss_pred ccchhHhcccccccCCccceEEEEeeccCCccccceeEEEEEeccCC-ChHHHHHHHHHHHHHHhccCCccHhhhcceee
Confidence 34467999999999999999999974 347889999986432 333456788899999999 5899999999887
Q ss_pred cCCCeeEEEEeecCCCChHHHhcCCCC-----------------------------------------------------
Q 038766 81 ESGKLKALILEYMENGSLESVIHGPGV----------------------------------------------------- 107 (299)
Q Consensus 81 ~~~~~~~lv~e~~~~~~L~~~~~~~~~----------------------------------------------------- 107 (299)
..+...++|+||+++++|.+++.....
T Consensus 82 ~~~~~~~lv~ey~~~g~L~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 161 (343)
T cd05103 82 KPGGPLMVIVEFCKFGNLSNYLRSKRGEFVPYKTKDARFRQGKSGYGDISEDLKRRLDSITSSQSSASSGFVEEKSLSDV 161 (343)
T ss_pred cCCCceEEEEeccCCCcHHHHHHhcCCccccccccccccccccccccchhhhhhhhccccccccccccccccCCCccccc
Confidence 777777999999999999988753210
Q ss_pred ----------CCCCCChhhHHHHHHHHHHHHHHhhcCCCCCeeeecccCCceeeCCCCcEEEeeeccccccccccccccc
Q 038766 108 ----------DHSRWTLPKRIDVLISVANGLDYLHSGYDIPIVHCDMKPSNILLDRDFEAHVSDFGTSRMLDVHLQDLSS 177 (299)
Q Consensus 108 ----------~~~~~~~~~~~~i~~qi~~~l~~lh~~~~~~~~H~dl~~~nil~~~~~~v~l~df~~~~~~~~~~~~~~~ 177 (299)
....++...+..++.|++.||+|||+. +++|+||||+||+++.++.++|+|||++....... ...
T Consensus 162 ~~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~---~i~H~dikp~Nil~~~~~~~kl~dfg~~~~~~~~~--~~~ 236 (343)
T cd05103 162 EEEEAEQEDLYKKVLTLEDLICYSFQVAKGMEFLASR---KCIHRDLAARNILLSENNVVKICDFGLARDIYKDP--DYV 236 (343)
T ss_pred hhhhhhhhhhhhccCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCccCeEEEcCCCcEEEEecccccccccCc--chh
Confidence 012467788899999999999999999 99999999999999999999999999987543111 111
Q ss_pred cccccccCcccCChhhhcccCcCccccchhhhHHHHHHHh-CCCCCCCCccCCCCchhHHHHHHHHHhcCccCcccccCc
Q 038766 178 LSTAFQGTIGYLAPEFAYMRIVTTKVDVFSFGIVVMEFLT-KRRPTGLDEENGLSPISLRQLVEKALANGINGVRQITDP 256 (299)
Q Consensus 178 ~~~~~~~~~~y~~PE~~~~~~~~~~~DiwslG~~l~~l~~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 256 (299)
......++..|+|||.+.+..++.++||||||+++|+|++ |..||...... ..... ....+.. ...
T Consensus 237 ~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~----~~~~~----~~~~~~~----~~~- 303 (343)
T cd05103 237 RKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKID----EEFCR----RLKEGTR----MRA- 303 (343)
T ss_pred hcCCCCCCcceECcHHhcCCCCCchhhHHHHHHHHHHHHHCCCCCCCCcccc----HHHHH----HHhccCC----CCC-
Confidence 1222334567999999988889999999999999999997 88887532111 11111 1111100 000
Q ss_pred cccchhhHhHHHHHHHHHHHHHHHHhcCCCCCCCCChhhhhcC
Q 038766 257 KLVSSIYEEQEQHQVLEELFKLALVCTSSNPEDRPNMNELLIT 299 (299)
Q Consensus 257 ~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rpt~~~il~~ 299 (299)
+...+..+.+++.+||..+|++|||+.++++|
T Consensus 304 -----------~~~~~~~~~~~~~~cl~~~p~~Rps~~eil~~ 335 (343)
T cd05103 304 -----------PDYTTPEMYQTMLDCWHGEPSQRPTFSELVEH 335 (343)
T ss_pred -----------CCCCCHHHHHHHHHHccCChhhCcCHHHHHHH
Confidence 11123568899999999999999999999874
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 2 (VEGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR2 (or Flk1) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. The carboxyl terminus of VEGFR2 plays an important role in its autophosp |
| >cd07834 STKc_MAPK Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-39 Score=279.35 Aligned_cols=273 Identities=25% Similarity=0.310 Sum_probs=203.8
Q ss_pred CCCCCceeecCCcceEEEEEeC-CCcEEEEEEeccCcCChhhhHHHHHHHHHHHhcCCcceeeeeeEEEcCC----CeeE
Q 038766 13 SFSENNIIGNSNLSTVYKGRLE-DGEIVAVKKLNFHQFSAESDKSFYREAKTLKELKHRNLVKVLGYAWESG----KLKA 87 (299)
Q Consensus 13 ~y~~~~~lg~g~~~~v~~~~~~-~~~~~~vK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~----~~~~ 87 (299)
+|.+.+.||+|++|.||++... +++.+++|++..........+.+..|+..++.++|+||+++.+++.... ...+
T Consensus 1 ~y~i~~~ig~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~~~~ 80 (330)
T cd07834 1 RYELLKPIGSGAYGVVCSAVDKRTGRKVAIKKISNVFDDLIDAKRILREIKLLRHLRHENIIGLLDILRPPSPEDFNDVY 80 (330)
T ss_pred CceeeeeecCCCCeEEEEEEeCCCCcEEEEEeeccccccchhhhhHHHHHHHHHhcCCcchhhhhhhhcccCcccccceE
Confidence 6899999999999999999875 4899999998754433555678899999999999999999999776554 4569
Q ss_pred EEEeecCCCChHHHhcCCCCCCCCCChhhHHHHHHHHHHHHHHhhcCCCCCeeeecccCCceeeCCCCcEEEeeeccccc
Q 038766 88 LILEYMENGSLESVIHGPGVDHSRWTLPKRIDVLISVANGLDYLHSGYDIPIVHCDMKPSNILLDRDFEAHVSDFGTSRM 167 (299)
Q Consensus 88 lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lh~~~~~~~~H~dl~~~nil~~~~~~v~l~df~~~~~ 167 (299)
+++||+. ++|.+++. ...++++..++.++.|++.||++||+. +++|+||||+||+++.++.++|+|||++..
T Consensus 81 lv~e~~~-~~l~~~l~----~~~~l~~~~~~~i~~~l~~~l~~LH~~---gi~H~dlkp~nili~~~~~~~L~dfg~~~~ 152 (330)
T cd07834 81 IVTELME-TDLHKVIK----SPQPLTDDHIQYFLYQILRGLKYLHSA---NVIHRDLKPSNILVNSNCDLKICDFGLARG 152 (330)
T ss_pred EEecchh-hhHHHHHh----CCCCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHEEEcCCCCEEEcccCceEe
Confidence 9999996 48888886 444899999999999999999999999 999999999999999999999999999986
Q ss_pred cccccccccccccccccCcccCChhhhccc-CcCccccchhhhHHHHHHHhCCCCCCCCccCCCCchhHHHHHHHHHhcC
Q 038766 168 LDVHLQDLSSLSTAFQGTIGYLAPEFAYMR-IVTTKVDVFSFGIVVMEFLTKRRPTGLDEENGLSPISLRQLVEKALANG 246 (299)
Q Consensus 168 ~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~-~~~~~~DiwslG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~ 246 (299)
....... ........++..|+|||.+.+. .++.++|+||||+++|+|++|..||..... .+....+.......
T Consensus 153 ~~~~~~~-~~~~~~~~~~~~y~aPE~~~~~~~~~~~sDi~slG~il~~l~~g~~pf~~~~~-----~~~~~~i~~~~~~~ 226 (330)
T cd07834 153 VDPDEDE-KGFLTEYVVTRWYRAPELLLSSSRYTKAIDIWSVGCIFAELLTRKPLFPGRDY-----IDQLNLIVEVLGTP 226 (330)
T ss_pred ecccccc-cccccccccccCcCCceeeecccCCCcchhHHHHHHHHHHHHcCCCCcCCCCH-----HHHHHHHHHhcCCC
Confidence 5432110 0112334567889999998887 789999999999999999999999964421 11111111100000
Q ss_pred ccC-cccccCccc---------cchhhHhHHHHHHHHHHHHHHHHhcCCCCCCCCChhhhhcC
Q 038766 247 ING-VRQITDPKL---------VSSIYEEQEQHQVLEELFKLALVCTSSNPEDRPNMNELLIT 299 (299)
Q Consensus 247 ~~~-~~~~~~~~~---------~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rpt~~~il~~ 299 (299)
... ......... ............++.++.++|.+||..+|++|||+++++.|
T Consensus 227 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~ll~~ 289 (330)
T cd07834 227 SEEDLKFITSEKARNYLKSLPKKPKKPLSKLFPGASPEAIDLLEKMLVFDPKKRITADEALAH 289 (330)
T ss_pred ChhHhhhccccchhhHHhhcccCCcchhHHhcccCCHHHHHHHHHHccCChhhCCCHHHHHhC
Confidence 000 000000000 00000111123357789999999999999999999999986
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Typical MAPK pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and |
| >cd05609 STKc_MAST Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.2e-40 Score=277.02 Aligned_cols=257 Identities=23% Similarity=0.305 Sum_probs=197.1
Q ss_pred CCCCCCceeecCCcceEEEEEeC-CCcEEEEEEeccCcCC-hhhhHHHHHHHHHHHhcCCcceeeeeeEEEcCCCeeEEE
Q 038766 12 GSFSENNIIGNSNLSTVYKGRLE-DGEIVAVKKLNFHQFS-AESDKSFYREAKTLKELKHRNLVKVLGYAWESGKLKALI 89 (299)
Q Consensus 12 ~~y~~~~~lg~g~~~~v~~~~~~-~~~~~~vK~~~~~~~~-~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~lv 89 (299)
++|.+.+.||+|++|.||++.+. +++.|++|.+...... ......+.+|+++++.++||||+++++.+.. +...++|
T Consensus 1 ~~y~~~~~l~~g~~~~v~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~-~~~~~lv 79 (305)
T cd05609 1 EDFETIKLISNGAYGAVYLVRHKETRQRFAMKKINKQNLILRNQIQQVFVERDILTFAENPFVVSMFCSFET-KRHLCMV 79 (305)
T ss_pred CCceEeeEeecCCCeeEEEEEECCCCcEEEEEEeehhhhhhHHHHHHHHHHHHHHHhCCCCCeeeeEEEEec-CCEEEEE
Confidence 47899999999999999999875 4789999998644321 2334577789999999999999999996654 5567999
Q ss_pred EeecCCCChHHHhcCCCCCCCCCChhhHHHHHHHHHHHHHHhhcCCCCCeeeecccCCceeeCCCCcEEEeeeccccccc
Q 038766 90 LEYMENGSLESVIHGPGVDHSRWTLPKRIDVLISVANGLDYLHSGYDIPIVHCDMKPSNILLDRDFEAHVSDFGTSRMLD 169 (299)
Q Consensus 90 ~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lh~~~~~~~~H~dl~~~nil~~~~~~v~l~df~~~~~~~ 169 (299)
+||+.+++|.+++. ....+++..+..++.|++.||+|||+. +++|+||+|+||+++.++.++|+|||++....
T Consensus 80 ~e~~~g~~L~~~l~----~~~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dl~p~NIll~~~~~~~l~dfg~~~~~~ 152 (305)
T cd05609 80 MEYVEGGDCATLLK----NIGALPVDMARMYFAETVLALEYLHNY---GIVHRDLKPDNLLITSMGHIKLTDFGLSKIGL 152 (305)
T ss_pred EecCCCCcHHHHHH----HcCCCCHHHHHHHHHHHHHHHHHHHHC---CccccCCchHHEEECCCCCEEEeeCCCccccC
Confidence 99999999999996 445789999999999999999999999 99999999999999999999999999875321
Q ss_pred ccccc-----------ccccccccccCcccCChhhhcccCcCccccchhhhHHHHHHHhCCCCCCCCccCCCCchhHHHH
Q 038766 170 VHLQD-----------LSSLSTAFQGTIGYLAPEFAYMRIVTTKVDVFSFGIVVMEFLTKRRPTGLDEENGLSPISLRQL 238 (299)
Q Consensus 170 ~~~~~-----------~~~~~~~~~~~~~y~~PE~~~~~~~~~~~DiwslG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~ 238 (299)
..... .........++..|+|||.+....++.++|+||||+++|+|++|..||.... . .+.
T Consensus 153 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~vl~el~~g~~pf~~~~-----~---~~~ 224 (305)
T cd05609 153 MSLTTNLYEGHIEKDTREFLDKQVCGTPEYIAPEVILRQGYGKPVDWWAMGIILYEFLVGCVPFFGDT-----P---EEL 224 (305)
T ss_pred cCccccccccccccchhhccccCCccCccccCchhccCCCCCchhhHHHHHHHHHHHHhCCCCCCCCC-----H---HHH
Confidence 00000 0001112346778999999988889999999999999999999999985331 1 122
Q ss_pred HHHHHhcCccCcccccCccccchhhHhHHHHHHHHHHHHHHHHhcCCCCCCCCC---hhhhhcC
Q 038766 239 VEKALANGINGVRQITDPKLVSSIYEEQEQHQVLEELFKLALVCTSSNPEDRPN---MNELLIT 299 (299)
Q Consensus 239 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rpt---~~~il~~ 299 (299)
........... ... ...++.++.+++.+||+.+|++||| +.++|+|
T Consensus 225 ~~~~~~~~~~~----~~~-----------~~~~~~~~~~li~~~l~~~P~~R~~~~~~~~ll~~ 273 (305)
T cd05609 225 FGQVISDDIEW----PEG-----------DEALPADAQDLISRLLRQNPLERLGTGGAFEVKQH 273 (305)
T ss_pred HHHHHhcccCC----CCc-----------cccCCHHHHHHHHHHhccChhhccCccCHHHHHhC
Confidence 22211111000 000 1134567899999999999999998 6777765
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. There are four mammalian MAST kinases, named MAST1-MAST4. MAST1 is also referred to as syntrophin-associated STK (SAST), while MAST2 is also called MAST205. MAST kinases are cytoskeletal associated kinases of unknown function that a |
| >cd06647 STKc_PAK_I Catalytic domain of the Protein Serine/Threonine Kinase, Group I p21-activated kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-39 Score=273.47 Aligned_cols=251 Identities=25% Similarity=0.367 Sum_probs=198.7
Q ss_pred hCCCCCCceeecCCcceEEEEEe-CCCcEEEEEEeccCcCChhhhHHHHHHHHHHHhcCCcceeeeeeEEEcCCCeeEEE
Q 038766 11 TGSFSENNIIGNSNLSTVYKGRL-EDGEIVAVKKLNFHQFSAESDKSFYREAKTLKELKHRNLVKVLGYAWESGKLKALI 89 (299)
Q Consensus 11 ~~~y~~~~~lg~g~~~~v~~~~~-~~~~~~~vK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~lv 89 (299)
.++|.+.+.||+|++|.||++.. .++..+++|.+... .....+.+.+|+..++.++|||++++++.+.. +...++|
T Consensus 18 ~~~~~~~~~lg~g~~g~v~~~~~~~~~~~v~iK~~~~~--~~~~~~~~~~e~~~l~~l~hp~i~~~~~~~~~-~~~~~lv 94 (293)
T cd06647 18 KKKYTRFEKIGQGASGTVYTAIDVATGQEVAIKQMNLQ--QQPKKELIINEILVMRENKHPNIVNYLDSYLV-GDELWVV 94 (293)
T ss_pred hhhceeeeEecCCCCeEEEEEEEcCCCCEEEEEEeccc--cchHHHHHHHHHHHHhhcCCCCeeehhheeee-CCcEEEE
Confidence 57899999999999999999986 45889999998533 22335678889999999999999999997665 4556999
Q ss_pred EeecCCCChHHHhcCCCCCCCCCChhhHHHHHHHHHHHHHHhhcCCCCCeeeecccCCceeeCCCCcEEEeeeccccccc
Q 038766 90 LEYMENGSLESVIHGPGVDHSRWTLPKRIDVLISVANGLDYLHSGYDIPIVHCDMKPSNILLDRDFEAHVSDFGTSRMLD 169 (299)
Q Consensus 90 ~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lh~~~~~~~~H~dl~~~nil~~~~~~v~l~df~~~~~~~ 169 (299)
+||+.+++|.+++.. ..+++.++..++.|++.|+.+||++ +++|+||+|+||+++.++.++|+|||++....
T Consensus 95 ~e~~~~~~L~~~~~~-----~~l~~~~~~~i~~~l~~al~~LH~~---gi~H~dL~p~Nili~~~~~~kL~dfg~~~~~~ 166 (293)
T cd06647 95 MEYLAGGSLTDVVTE-----TCMDEGQIAAVCRECLQALEFLHSN---QVIHRDIKSDNILLGMDGSVKLTDFGFCAQIT 166 (293)
T ss_pred EecCCCCcHHHHHhh-----cCCCHHHHHHHHHHHHHHHHHHHhC---CEeeccCCHHHEEEcCCCCEEEccCcceeccc
Confidence 999999999999853 3578899999999999999999999 99999999999999999999999999886543
Q ss_pred cccccccccccccccCcccCChhhhcccCcCccccchhhhHHHHHHHhCCCCCCCCccCCCCchhHHHHHHHHHhcCccC
Q 038766 170 VHLQDLSSLSTAFQGTIGYLAPEFAYMRIVTTKVDVFSFGIVVMEFLTKRRPTGLDEENGLSPISLRQLVEKALANGING 249 (299)
Q Consensus 170 ~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~DiwslG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 249 (299)
.. ........+++.|++||.+....++.++|+||+|+++|++++|..||........ +.......
T Consensus 167 ~~----~~~~~~~~~~~~y~~PE~~~~~~~~~~~Dv~slG~ll~~ll~g~~pf~~~~~~~~--------~~~~~~~~--- 231 (293)
T cd06647 167 PE----QSKRSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMVEGEPPYLNENPLRA--------LYLIATNG--- 231 (293)
T ss_pred cc----ccccccccCChhhcCchhhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCChhhh--------eeehhcCC---
Confidence 21 1122334577889999999888889999999999999999999999954322100 00000000
Q ss_pred cccccCccccchhhHhHHHHHHHHHHHHHHHHhcCCCCCCCCChhhhhcC
Q 038766 250 VRQITDPKLVSSIYEEQEQHQVLEELFKLALVCTSSNPEDRPNMNELLIT 299 (299)
Q Consensus 250 ~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rpt~~~il~~ 299 (299)
.... .....++..+.++|++||..+|++|||+++++.|
T Consensus 232 ~~~~------------~~~~~~~~~l~~li~~~l~~~p~~Rp~~~~il~h 269 (293)
T cd06647 232 TPEL------------QNPEKLSAIFRDFLNRCLEMDVEKRGSAKELLQH 269 (293)
T ss_pred CCCC------------CCccccCHHHHHHHHHHccCChhhCcCHHHHhcC
Confidence 0000 0123355678899999999999999999999987
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group I, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAKs from higher eukaryotes are classified into two groups (I and II), according to their bi |
| >cd06624 STKc_ASK Catalytic domain of the Protein Serine/Threonine Kinase, Apoptosis signal-regulating kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-39 Score=269.62 Aligned_cols=257 Identities=25% Similarity=0.354 Sum_probs=195.8
Q ss_pred HHHHhCCCCCCceeecCCcceEEEEEeC-CCcEEEEEEeccCcCChhhhHHHHHHHHHHHhcCCcceeeeeeEEEcCCCe
Q 038766 7 IENATGSFSENNIIGNSNLSTVYKGRLE-DGEIVAVKKLNFHQFSAESDKSFYREAKTLKELKHRNLVKVLGYAWESGKL 85 (299)
Q Consensus 7 ~~~~~~~y~~~~~lg~g~~~~v~~~~~~-~~~~~~vK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~ 85 (299)
.|...+.+.....||+|++|+||++.+. ++..+++|.+... .......+.+|+..++.++|+||+++++++.. +..
T Consensus 3 ~~~~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~v~~k~~~~~--~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~-~~~ 79 (268)
T cd06624 3 YEYEYDENGERVVLGKGTYGIVYAARDLSTQVRIAIKEIPER--DSRYVQPLHEEIALHSYLKHRNIVQYLGSDSE-NGF 79 (268)
T ss_pred cccccccCCceEEEecCCceEEEEeEecCCCcEEEEEEecCC--CHHHHHHHHHHHHHHHhcCCCCeeeeeeeecc-CCE
Confidence 4455666777789999999999999864 5788999987633 23445678899999999999999999997655 556
Q ss_pred eEEEEeecCCCChHHHhcCCCCCCCCC--ChhhHHHHHHHHHHHHHHhhcCCCCCeeeecccCCceeeCC-CCcEEEeee
Q 038766 86 KALILEYMENGSLESVIHGPGVDHSRW--TLPKRIDVLISVANGLDYLHSGYDIPIVHCDMKPSNILLDR-DFEAHVSDF 162 (299)
Q Consensus 86 ~~lv~e~~~~~~L~~~~~~~~~~~~~~--~~~~~~~i~~qi~~~l~~lh~~~~~~~~H~dl~~~nil~~~-~~~v~l~df 162 (299)
.++|+||+.+++|.+++... ...+ ++..+..++.|++.||+|||+. +++|+||+|+||+++. ++.++|+||
T Consensus 80 ~~lv~e~~~~~~L~~~l~~~---~~~~~~~~~~~~~~~~qi~~al~~lH~~---~i~h~dl~p~nil~~~~~~~~~l~df 153 (268)
T cd06624 80 FKIFMEQVPGGSLSALLRSK---WGPLKDNEQTIIFYTKQILEGLKYLHDN---QIVHRDIKGDNVLVNTYSGVVKISDF 153 (268)
T ss_pred EEEEEecCCCCCHHHHHHHh---cccCCCcHHHHHHHHHHHHHHHHHHHHC---CEeecCCCHHHEEEcCCCCeEEEecc
Confidence 69999999999999988632 1234 7888899999999999999999 9999999999999976 678999999
Q ss_pred ccccccccccccccccccccccCcccCChhhhcccC--cCccccchhhhHHHHHHHhCCCCCCCCccCCCCchhHHHHHH
Q 038766 163 GTSRMLDVHLQDLSSLSTAFQGTIGYLAPEFAYMRI--VTTKVDVFSFGIVVMEFLTKRRPTGLDEENGLSPISLRQLVE 240 (299)
Q Consensus 163 ~~~~~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~--~~~~~DiwslG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~ 240 (299)
|.+...... ........+++.|+|||.+.... ++.++|+||+|+++|+|++|..||....... .....
T Consensus 154 g~~~~~~~~----~~~~~~~~~~~~~~aPE~~~~~~~~~~~~~Dv~slGvvl~~l~~g~~p~~~~~~~~---~~~~~--- 223 (268)
T cd06624 154 GTSKRLAGI----NPCTETFTGTLQYMAPEVIDKGPRGYGAPADIWSLGCTIVEMATGKPPFIELGEPQ---AAMFK--- 223 (268)
T ss_pred hhheecccC----CCccccCCCCccccChhhhccccccCCchhhhHHHHHHHHHHHhCCCCCccccChh---hhHhh---
Confidence 998754321 11122334678999999886543 7889999999999999999999985321110 00000
Q ss_pred HHHhcCccCcccccCccccchhhHhHHHHHHHHHHHHHHHHhcCCCCCCCCChhhhhcC
Q 038766 241 KALANGINGVRQITDPKLVSSIYEEQEQHQVLEELFKLALVCTSSNPEDRPNMNELLIT 299 (299)
Q Consensus 241 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rpt~~~il~~ 299 (299)
...... .+ ..+..++.++.+++.+||..+|++|||++++++|
T Consensus 224 ~~~~~~--------~~---------~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~ll~~ 265 (268)
T cd06624 224 VGMFKI--------HP---------EIPESLSAEAKNFILRCFEPDPDKRASAHDLLQD 265 (268)
T ss_pred hhhhcc--------CC---------CCCcccCHHHHHHHHHHcCCCchhCCCHHHHHhC
Confidence 000000 00 0123345678999999999999999999999987
|
Serine/threonine kinases (STKs), Apoptosis signal-regulating kinase (ASK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ASK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Subfamily members are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) and include ASK1, ASK2, and MAPKKK15. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. ASK1 (also called MAPKKK5) functions in the c-Jun N-terminal kina |
| >cd06606 STKc_MAPKKK Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-Activated Protein Kinase Kinase Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.3e-39 Score=265.13 Aligned_cols=255 Identities=27% Similarity=0.392 Sum_probs=204.8
Q ss_pred CCCCCceeecCCcceEEEEEeC-CCcEEEEEEeccCcCChhhhHHHHHHHHHHHhcCCcceeeeeeEEEcCC-CeeEEEE
Q 038766 13 SFSENNIIGNSNLSTVYKGRLE-DGEIVAVKKLNFHQFSAESDKSFYREAKTLKELKHRNLVKVLGYAWESG-KLKALIL 90 (299)
Q Consensus 13 ~y~~~~~lg~g~~~~v~~~~~~-~~~~~~vK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~-~~~~lv~ 90 (299)
+|...+.||+|++|.||++... ++..+++|++..........+.+.+|+..+++++|+||+++++.+.... ...++++
T Consensus 1 ~~~~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~lv~ 80 (260)
T cd06606 1 EWTRGELLGRGSFGSVYLALDKDTGELMAVKSVELSGDSEEELEALEREIRILSSLQHPNIVRYYGSERDEEKNTLNIFL 80 (260)
T ss_pred CceeeeEeeecCceEEEEEEECCCCcEEEEEEeeccccchHHHHHHHHHHHHHHHcCCCCEeeEEEEEecCCCCeEEEEE
Confidence 5788999999999999999875 6899999998765555566788999999999999999999999776542 5679999
Q ss_pred eecCCCChHHHhcCCCCCCCCCChhhHHHHHHHHHHHHHHhhcCCCCCeeeecccCCceeeCCCCcEEEeeecccccccc
Q 038766 91 EYMENGSLESVIHGPGVDHSRWTLPKRIDVLISVANGLDYLHSGYDIPIVHCDMKPSNILLDRDFEAHVSDFGTSRMLDV 170 (299)
Q Consensus 91 e~~~~~~L~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lh~~~~~~~~H~dl~~~nil~~~~~~v~l~df~~~~~~~~ 170 (299)
|++.+++|.+++.. ...+++..++.++.|++.+|++||+. +++|+||+|+||+++.++.++|+|||.+.....
T Consensus 81 e~~~~~~L~~~~~~----~~~~~~~~~~~~~~~l~~~l~~lh~~---~~~h~dl~p~ni~i~~~~~~~l~d~~~~~~~~~ 153 (260)
T cd06606 81 EYVSGGSLSSLLKK----FGKLPEPVIRKYTRQILEGLAYLHSN---GIVHRDIKGANILVDSDGVVKLADFGCAKRLGD 153 (260)
T ss_pred EecCCCcHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHHC---CccccCCCHHHEEEcCCCCEEEcccccEEeccc
Confidence 99999999999873 34899999999999999999999998 999999999999999999999999999876552
Q ss_pred ccccccccccccccCcccCChhhhcccCcCccccchhhhHHHHHHHhCCCCCCCCccCCCCchhHHHHHHHHHhcCccCc
Q 038766 171 HLQDLSSLSTAFQGTIGYLAPEFAYMRIVTTKVDVFSFGIVVMEFLTKRRPTGLDEENGLSPISLRQLVEKALANGINGV 250 (299)
Q Consensus 171 ~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~DiwslG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 250 (299)
... ........++..|+|||...+...+.++|+||||+++++|++|..||.... .....+...... ...
T Consensus 154 ~~~--~~~~~~~~~~~~y~~pE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~-------~~~~~~~~~~~~--~~~ 222 (260)
T cd06606 154 IET--GEGTGSVRGTPYWMAPEVIRGEEYGRAADIWSLGCTVIEMATGKPPWSELG-------NPMAALYKIGSS--GEP 222 (260)
T ss_pred ccc--cccccCCCCCccccCHhhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCC-------chHHHHHhcccc--CCC
Confidence 211 011334457789999999988889999999999999999999999986443 011111110000 000
Q ss_pred ccccCccccchhhHhHHHHHHHHHHHHHHHHhcCCCCCCCCChhhhhcC
Q 038766 251 RQITDPKLVSSIYEEQEQHQVLEELFKLALVCTSSNPEDRPNMNELLIT 299 (299)
Q Consensus 251 ~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rpt~~~il~~ 299 (299)
. ..+...+..+.++|.+|+..+|++|||+.+++.|
T Consensus 223 ~--------------~~~~~~~~~l~~~i~~~l~~~p~~Rp~~~~ll~~ 257 (260)
T cd06606 223 P--------------EIPEHLSEEAKDFLRKCLRRDPKKRPTADELLQH 257 (260)
T ss_pred c--------------CCCcccCHHHHHHHHHhCcCChhhCCCHHHHhhC
Confidence 0 0122336789999999999999999999999987
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKKKs (MKKKs or MAP3Ks) are also called MAP/ERK kinase kinases (MEKKs) in some cases. They phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. This subfamily is composed of the Apoptosis Signal-regulating Kinases ASK1 (or MAPKK |
| >cd05115 PTKc_Zap-70 Catalytic domain of the Protein Tyrosine Kinase, Zeta-chain-associated protein of 70kDa | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-39 Score=267.27 Aligned_cols=245 Identities=24% Similarity=0.384 Sum_probs=187.7
Q ss_pred eeecCCcceEEEEEeC---CCcEEEEEEeccCcCChhhhHHHHHHHHHHHhcCCcceeeeeeEEEcCCCeeEEEEeecCC
Q 038766 19 IIGNSNLSTVYKGRLE---DGEIVAVKKLNFHQFSAESDKSFYREAKTLKELKHRNLVKVLGYAWESGKLKALILEYMEN 95 (299)
Q Consensus 19 ~lg~g~~~~v~~~~~~---~~~~~~vK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~lv~e~~~~ 95 (299)
.||+|+||.||++.+. .+..+|+|++... ......+.+.+|+.++++++|+||+++++++. ....++|+||+++
T Consensus 2 ~ig~G~~g~v~~~~~~~~~~~~~vavk~~~~~-~~~~~~~~~~~E~~~l~~l~h~~ii~~~~~~~--~~~~~lv~e~~~~ 78 (257)
T cd05115 2 ELGSGNFGCVKKGVYKMRKKQIDVAIKVLKNE-NEKSVRDEMMREAEIMHQLDNPYIVRMIGVCE--AEALMLVMEMASG 78 (257)
T ss_pred ccCCCCcccEEEEEEecCCCceeEEEEEcccc-cChHHHHHHHHHHHHHHhcCCCCeEEEEEEEc--CCCeEEEEEeCCC
Confidence 4899999999998753 3557999998643 23444567889999999999999999999653 3456899999999
Q ss_pred CChHHHhcCCCCCCCCCChhhHHHHHHHHHHHHHHhhcCCCCCeeeecccCCceeeCCCCcEEEeeeccccccccccccc
Q 038766 96 GSLESVIHGPGVDHSRWTLPKRIDVLISVANGLDYLHSGYDIPIVHCDMKPSNILLDRDFEAHVSDFGTSRMLDVHLQDL 175 (299)
Q Consensus 96 ~~L~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lh~~~~~~~~H~dl~~~nil~~~~~~v~l~df~~~~~~~~~~~~~ 175 (299)
++|.+++.. ....+++..++.++.|++.||+|||+. +++|+||||+||+++.++.++|+|||++..+......
T Consensus 79 ~~L~~~l~~---~~~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dlkp~nil~~~~~~~kl~dfg~~~~~~~~~~~- 151 (257)
T cd05115 79 GPLNKFLSG---KKDEITVSNVVELMHQVSMGMKYLEGK---NFVHRDLAARNVLLVNQHYAKISDFGLSKALGADDSY- 151 (257)
T ss_pred CCHHHHHHh---CCCCCCHHHHHHHHHHHHHHHHHHHhc---CeeecccchheEEEcCCCcEEeccCCccccccCCccc-
Confidence 999998863 234789999999999999999999998 9999999999999999999999999998754321111
Q ss_pred cccccccccCcccCChhhhcccCcCccccchhhhHHHHHHHh-CCCCCCCCccCCCCchhHHHHHHHHHhcCccCccccc
Q 038766 176 SSLSTAFQGTIGYLAPEFAYMRIVTTKVDVFSFGIVVMEFLT-KRRPTGLDEENGLSPISLRQLVEKALANGINGVRQIT 254 (299)
Q Consensus 176 ~~~~~~~~~~~~y~~PE~~~~~~~~~~~DiwslG~~l~~l~~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 254 (299)
........++..|+|||.+....++.++||||||+++|++++ |..||... ........+.. +. ...
T Consensus 152 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~-----~~~~~~~~~~~----~~----~~~ 218 (257)
T cd05115 152 YKARSAGKWPLKWYAPECINFRKFSSRSDVWSYGITMWEAFSYGQKPYKKM-----KGPEVMSFIEQ----GK----RLD 218 (257)
T ss_pred eeccCCCCCCcccCCHHHHccCCCCchhhHHHHHHHHHHHhcCCCCCcCcC-----CHHHHHHHHHC----CC----CCC
Confidence 011111223467999999988889999999999999999996 89898432 22222222111 10 000
Q ss_pred CccccchhhHhHHHHHHHHHHHHHHHHhcCCCCCCCCChhhhhc
Q 038766 255 DPKLVSSIYEEQEQHQVLEELFKLALVCTSSNPEDRPNMNELLI 298 (299)
Q Consensus 255 ~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rpt~~~il~ 298 (299)
. +...+.++.+++.+||..+|++||++.+|.+
T Consensus 219 ~------------~~~~~~~l~~li~~c~~~~~~~Rp~~~~i~~ 250 (257)
T cd05115 219 C------------PAECPPEMYALMKDCWIYKWEDRPNFAKVEE 250 (257)
T ss_pred C------------CCCCCHHHHHHHHHHcCCChhhCcCHHHHHH
Confidence 0 1223567899999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Zeta-chain-associated protein of 70kDa (Zap-70); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Zap-70 is a member of the Syk subfamily of kinases, which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Zap-70 is primarily expressed in T-cells and NK cells, and is a crucial component in T-cell receptor (TCR) signaling. Zap-70 binds the phosphorylated ITAM (immunoreceptor tyr activation motif) sequences of the activated TCR zeta-chain through its SH2 domains, leading to its pho |
| >PHA03210 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-39 Score=292.38 Aligned_cols=278 Identities=17% Similarity=0.190 Sum_probs=188.4
Q ss_pred HHhCCCCCCceeecCCcceEEEEEeCC--CcEEEEEEe--------------cc-CcCChhhhHHHHHHHHHHHhcCCcc
Q 038766 9 NATGSFSENNIIGNSNLSTVYKGRLED--GEIVAVKKL--------------NF-HQFSAESDKSFYREAKTLKELKHRN 71 (299)
Q Consensus 9 ~~~~~y~~~~~lg~g~~~~v~~~~~~~--~~~~~vK~~--------------~~-~~~~~~~~~~~~~e~~~l~~l~h~~ 71 (299)
.+.++|++.+.||+|+||+||++..+. +...+.|.+ .. ..........+.+|+.++++++|+|
T Consensus 145 ~~~~~Y~ii~~LG~G~fG~Vyl~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~Ei~il~~l~Hpn 224 (501)
T PHA03210 145 EFLAHFRVIDDLPAGAFGKIFICALRASTEEAEARRGVNSTNQGKPKCERLIAKRVKAGSRAAIQLENEILALGRLNHEN 224 (501)
T ss_pred hhhhccEEEeEecCCCCcceEEEEEeccchhhhhhhccccccccchhhhhhHhHHhhcchHHHHHHHHHHHHHHhCCCCC
Confidence 356899999999999999999986532 222222211 00 0112223456789999999999999
Q ss_pred eeeeeeEEEcCCCeeEEEEeecCCCChHHHhcCCC-CCCCCCChhhHHHHHHHHHHHHHHhhcCCCCCeeeecccCCcee
Q 038766 72 LVKVLGYAWESGKLKALILEYMENGSLESVIHGPG-VDHSRWTLPKRIDVLISVANGLDYLHSGYDIPIVHCDMKPSNIL 150 (299)
Q Consensus 72 i~~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~-~~~~~~~~~~~~~i~~qi~~~l~~lh~~~~~~~~H~dl~~~nil 150 (299)
|+++++++... ...++|++++. ++|.+++.... ..........+..++.|++.||+|||++ +++|+||||+|||
T Consensus 225 Iv~l~~~~~~~-~~~~lv~e~~~-~~l~~~l~~~~~~~~~~~~~~~~~~i~~ql~~aL~yLH~~---gIiHrDLKP~NIL 299 (501)
T PHA03210 225 ILKIEEILRSE-ANTYMITQKYD-FDLYSFMYDEAFDWKDRPLLKQTRAIMKQLLCAVEYIHDK---KLIHRDIKLENIF 299 (501)
T ss_pred cCcEeEEEEEC-CeeEEEEeccc-cCHHHHHhhccccccccccHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHEE
Confidence 99999976654 45689999994 57777654321 1123345667889999999999999999 9999999999999
Q ss_pred eCCCCcEEEeeeccccccccccccccccccccccCcccCChhhhcccCcCccccchhhhHHHHHHHhCCCCCCCCccCCC
Q 038766 151 LDRDFEAHVSDFGTSRMLDVHLQDLSSLSTAFQGTIGYLAPEFAYMRIVTTKVDVFSFGIVVMEFLTKRRPTGLDEENGL 230 (299)
Q Consensus 151 ~~~~~~v~l~df~~~~~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~DiwslG~~l~~l~~g~~p~~~~~~~~~ 230 (299)
++.++.++|+|||++..+... .........++..|+|||++.+..++.++|||||||++|+|++|..++..... ..
T Consensus 300 l~~~~~vkL~DFGla~~~~~~---~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~ell~~~~~p~~~~~-~~ 375 (501)
T PHA03210 300 LNCDGKIVLGDFGTAMPFEKE---REAFDYGWVGTVATNSPEILAGDGYCEITDIWSCGLILLDMLSHDFCPIGDGG-GK 375 (501)
T ss_pred ECCCCCEEEEeCCCceecCcc---cccccccccCCcCCCCchhhcCCCCCcHHHHHHHHHHHHHHHHCCCCCccCCC-CC
Confidence 999999999999999765421 11222345689999999999999999999999999999999998754322111 11
Q ss_pred CchhHHHHHHHHHhcCccCcccccCc-----------c---ccchhhHhHHHHHHHHHHHHHHHHhcCCCCCCCCChhhh
Q 038766 231 SPISLRQLVEKALANGINGVRQITDP-----------K---LVSSIYEEQEQHQVLEELFKLALVCTSSNPEDRPNMNEL 296 (299)
Q Consensus 231 ~~~~~~~~~~~~~~~~~~~~~~~~~~-----------~---~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rpt~~~i 296 (299)
....+...+..... ....+.+. . ..............+.++.++|.+||..||.+|||+.|+
T Consensus 376 ~~~~~~~~~~~~~~----~~~~~p~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~li~kmL~~DP~~Rpsa~el 451 (501)
T PHA03210 376 PGKQLLKIIDSLSV----CDEEFPDPPCKLFDYIDSAEIDHAGHSVPPLIRNLGLPADFEYPLVKMLTFDWHLRPGAAEL 451 (501)
T ss_pred HHHHHHHHHHhccc----ChhhcCCcHHHHHHHhhhhhcccCccchhhHHHhcCCChHHHHHHHHHhccCcccCcCHHHH
Confidence 11122222211100 00001000 0 000000011112244578889999999999999999999
Q ss_pred hcC
Q 038766 297 LIT 299 (299)
Q Consensus 297 l~~ 299 (299)
|+|
T Consensus 452 L~h 454 (501)
T PHA03210 452 LAL 454 (501)
T ss_pred hhC
Confidence 986
|
|
| >cd05099 PTKc_FGFR4 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-39 Score=275.92 Aligned_cols=262 Identities=23% Similarity=0.342 Sum_probs=198.7
Q ss_pred HHHHHHhCCCCCCceeecCCcceEEEEEeC--------CCcEEEEEEeccCcCChhhhHHHHHHHHHHHhc-CCcceeee
Q 038766 5 TEIENATGSFSENNIIGNSNLSTVYKGRLE--------DGEIVAVKKLNFHQFSAESDKSFYREAKTLKEL-KHRNLVKV 75 (299)
Q Consensus 5 ~~~~~~~~~y~~~~~lg~g~~~~v~~~~~~--------~~~~~~vK~~~~~~~~~~~~~~~~~e~~~l~~l-~h~~i~~~ 75 (299)
.+++.-.++|.+.+.||+|++|.||++.+. .+..+|+|.+... ........+..|+..++.+ .||||+++
T Consensus 5 ~~~~~~~~~~~~~~~lg~G~~g~vy~~~~~~~~~~~~~~~~~~aiK~~~~~-~~~~~~~~~~~E~~~l~~l~~h~~iv~~ 83 (314)
T cd05099 5 PKWEFPRDRLVLGKPLGEGCFGQVVRAEAYGIDKSRPDQTVTVAVKMLKDN-ATDKDLADLISEMELMKLIGKHKNIINL 83 (314)
T ss_pred ccccccHHHeeeeeeecCCCcccEEEeeecccCCccCCcceEEEEEecCCC-CChHHHHHHHHHHHHHHhccCCCCeeeE
Confidence 345666789999999999999999999742 2457899987632 2344466788899999999 59999999
Q ss_pred eeEEEcCCCeeEEEEeecCCCChHHHhcCCC------------CCCCCCChhhHHHHHHHHHHHHHHhhcCCCCCeeeec
Q 038766 76 LGYAWESGKLKALILEYMENGSLESVIHGPG------------VDHSRWTLPKRIDVLISVANGLDYLHSGYDIPIVHCD 143 (299)
Q Consensus 76 ~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~------------~~~~~~~~~~~~~i~~qi~~~l~~lh~~~~~~~~H~d 143 (299)
++++.. +...++++||+.+++|.+++.... .....++...+..++.|++.||.|||+. +++|+|
T Consensus 84 ~~~~~~-~~~~~lv~e~~~~g~L~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~lH~~---gi~H~d 159 (314)
T cd05099 84 LGVCTQ-EGPLYVIVEYAAKGNLREFLRARRPPGPDYTFDITKVPEEQLSFKDLVSCAYQVARGMEYLESR---RCIHRD 159 (314)
T ss_pred EEEEcc-CCceEEEEecCCCCcHHHHHHhcCCCcccccccccCCcccccCHHHHHHHHHHHHHHHHHHHHC---Ceeecc
Confidence 997765 445699999999999999886431 1234688889999999999999999998 999999
Q ss_pred ccCCceeeCCCCcEEEeeeccccccccccccccccccccccCcccCChhhhcccCcCccccchhhhHHHHHHHh-CCCCC
Q 038766 144 MKPSNILLDRDFEAHVSDFGTSRMLDVHLQDLSSLSTAFQGTIGYLAPEFAYMRIVTTKVDVFSFGIVVMEFLT-KRRPT 222 (299)
Q Consensus 144 l~~~nil~~~~~~v~l~df~~~~~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~DiwslG~~l~~l~~-g~~p~ 222 (299)
|||+||+++.++.++|+|||.+........ ........++..|+|||.+.+..++.++||||||+++|+|++ |..||
T Consensus 160 lkp~Nill~~~~~~kL~Dfg~~~~~~~~~~--~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~~l~el~~~g~~p~ 237 (314)
T cd05099 160 LAARNVLVTEDNVMKIADFGLARGVHDIDY--YKKTSNGRLPVKWMAPEALFDRVYTHQSDVWSFGILMWEIFTLGGSPY 237 (314)
T ss_pred ccceeEEEcCCCcEEEcccccccccccccc--ccccccCCCCccccCHHHHccCCcCccchhhHHHHHHHHHHhCCCCCC
Confidence 999999999999999999999875542111 011111223457999999988889999999999999999998 77887
Q ss_pred CCCccCCCCchhHHHHHHHHHhcCccCcccccCccccchhhHhHHHHHHHHHHHHHHHHhcCCCCCCCCChhhhhc
Q 038766 223 GLDEENGLSPISLRQLVEKALANGINGVRQITDPKLVSSIYEEQEQHQVLEELFKLALVCTSSNPEDRPNMNELLI 298 (299)
Q Consensus 223 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rpt~~~il~ 298 (299)
... ........+ .... . ... +..++.++.+++.+||..+|++|||+.++++
T Consensus 238 ~~~-----~~~~~~~~~---~~~~--~---~~~------------~~~~~~~l~~li~~cl~~~p~~Rps~~~ll~ 288 (314)
T cd05099 238 PGI-----PVEELFKLL---REGH--R---MDK------------PSNCTHELYMLMRECWHAVPTQRPTFKQLVE 288 (314)
T ss_pred CCC-----CHHHHHHHH---HcCC--C---CCC------------CCCCCHHHHHHHHHHcCCCcccCcCHHHHHH
Confidence 432 111222211 1100 0 000 1223457889999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 4 (FGFR4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR4 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to |
| >cd05109 PTKc_HER2 Catalytic domain of the Protein Tyrosine Kinase, HER2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-39 Score=271.50 Aligned_cols=252 Identities=24% Similarity=0.403 Sum_probs=194.4
Q ss_pred hCCCCCCceeecCCcceEEEEEeC-CCc----EEEEEEeccCcCChhhhHHHHHHHHHHHhcCCcceeeeeeEEEcCCCe
Q 038766 11 TGSFSENNIIGNSNLSTVYKGRLE-DGE----IVAVKKLNFHQFSAESDKSFYREAKTLKELKHRNLVKVLGYAWESGKL 85 (299)
Q Consensus 11 ~~~y~~~~~lg~g~~~~v~~~~~~-~~~----~~~vK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~ 85 (299)
.++|.+.+.||+|++|+||++.+. ++. .||+|++... ........+.+|+..++.+.|+||+++++++.. ..
T Consensus 6 ~~~~~~~~~lg~G~~g~vy~~~~~~~~~~~~~~va~K~~~~~-~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~--~~ 82 (279)
T cd05109 6 ETELKKVKVLGSGAFGTVYKGIWIPDGENVKIPVAIKVLREN-TSPKANKEILDEAYVMAGVGSPYVCRLLGICLT--ST 82 (279)
T ss_pred hhheeeeeecCCCCCceEEEEEEecCCCccceEEEEEEecCC-CCHHHHHHHHHHHHHHHhcCCCCCceEEEEEcC--CC
Confidence 468999999999999999999853 343 4899998643 234446678899999999999999999997764 33
Q ss_pred eEEEEeecCCCChHHHhcCCCCCCCCCChhhHHHHHHHHHHHHHHhhcCCCCCeeeecccCCceeeCCCCcEEEeeeccc
Q 038766 86 KALILEYMENGSLESVIHGPGVDHSRWTLPKRIDVLISVANGLDYLHSGYDIPIVHCDMKPSNILLDRDFEAHVSDFGTS 165 (299)
Q Consensus 86 ~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lh~~~~~~~~H~dl~~~nil~~~~~~v~l~df~~~ 165 (299)
.+++++++++++|.+++.. ....+++..++.++.|++.||+|||++ +++|+||||+||+++.++.++|+|||++
T Consensus 83 ~~l~~~~~~~g~l~~~l~~---~~~~~~~~~~~~~~~qi~~~L~~lH~~---~iiH~dlkp~Nil~~~~~~~kL~dfG~~ 156 (279)
T cd05109 83 VQLVTQLMPYGCLLDYVRE---NKDRIGSQDLLNWCVQIAKGMSYLEEV---RLVHRDLAARNVLVKSPNHVKITDFGLA 156 (279)
T ss_pred cEEEEEcCCCCCHHHHHhh---ccCCCCHHHHHHHHHHHHHHHHHHHHC---CeeccccccceEEEcCCCcEEECCCCce
Confidence 5799999999999998863 234689999999999999999999999 9999999999999999999999999998
Q ss_pred cccccccccccccccccccCcccCChhhhcccCcCccccchhhhHHHHHHHh-CCCCCCCCccCCCCchhHHHHHHHHHh
Q 038766 166 RMLDVHLQDLSSLSTAFQGTIGYLAPEFAYMRIVTTKVDVFSFGIVVMEFLT-KRRPTGLDEENGLSPISLRQLVEKALA 244 (299)
Q Consensus 166 ~~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~DiwslG~~l~~l~~-g~~p~~~~~~~~~~~~~~~~~~~~~~~ 244 (299)
......... .......+++.|+|||...+..++.++|||||||++|+|++ |..||... ........+.
T Consensus 157 ~~~~~~~~~--~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~-----~~~~~~~~~~---- 225 (279)
T cd05109 157 RLLDIDETE--YHADGGKVPIKWMALESILHRRFTHQSDVWSYGVTVWELMTFGAKPYDGI-----PAREIPDLLE---- 225 (279)
T ss_pred eecccccce--eecCCCccchhhCCHHHhccCCCCchhHHHHHHHHHHHHHcCCCCCCCCC-----CHHHHHHHHH----
Confidence 765421111 11112234568999999998889999999999999999998 88887432 1222222211
Q ss_pred cCccCcccccCccccchhhHhHHHHHHHHHHHHHHHHhcCCCCCCCCChhhhhc
Q 038766 245 NGINGVRQITDPKLVSSIYEEQEQHQVLEELFKLALVCTSSNPEDRPNMNELLI 298 (299)
Q Consensus 245 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rpt~~~il~ 298 (299)
.. ..... +...+.++.+++.+||..||++|||+.++++
T Consensus 226 ~~----~~~~~------------~~~~~~~~~~li~~~l~~dp~~Rp~~~~l~~ 263 (279)
T cd05109 226 KG----ERLPQ------------PPICTIDVYMIMVKCWMIDSECRPRFRELVD 263 (279)
T ss_pred CC----CcCCC------------CccCCHHHHHHHHHHcCCChhhCcCHHHHHH
Confidence 11 00000 1123457889999999999999999999874
|
Protein Tyrosine Kinase (PTK) family; HER2 (ErbB2, HER2/neu); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER2 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve |
| >KOG1026 consensus Nerve growth factor receptor TRKA and related tyrosine kinases [Signal transduction mechanisms; Intracellular trafficking, secretion, and vesicular transport] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-40 Score=295.99 Aligned_cols=254 Identities=28% Similarity=0.464 Sum_probs=203.5
Q ss_pred hCCCCCCceeecCCcceEEEEEeC------CCcEEEEEEeccCcCChhhhHHHHHHHHHHHhcCCcceeeeeeEEEcCCC
Q 038766 11 TGSFSENNIIGNSNLSTVYKGRLE------DGEIVAVKKLNFHQFSAESDKSFYREAKTLKELKHRNLVKVLGYAWESGK 84 (299)
Q Consensus 11 ~~~y~~~~~lg~g~~~~v~~~~~~------~~~~~~vK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~ 84 (299)
..+....+.||+|.||.||++... ....||||.++. ......+..+++|++++..++||||++++|+|...+
T Consensus 485 r~~i~~~~eLGegaFGkVf~a~~~~l~p~~~~~lVAVK~LKd-~a~~~~~~dF~REaeLla~l~H~nIVrLlGVC~~~~- 562 (774)
T KOG1026|consen 485 RSDIVFKEELGEGAFGKVFLAEAYGLLPGQDEQLVAVKALKD-KAENQARQDFRREAELLAELQHPNIVRLLGVCREGD- 562 (774)
T ss_pred hhheeehhhhcCchhhhhhhhhccCCCCCccceehhHhhhcc-cccHHHHHHHHHHHHHHHhccCCCeEEEEEEEccCC-
Confidence 455667899999999999999742 356799999863 334446788999999999999999999999998744
Q ss_pred eeEEEEeecCCCChHHHhcCC---------CCC-CCCCChhhHHHHHHHHHHHHHHhhcCCCCCeeeecccCCceeeCCC
Q 038766 85 LKALILEYMENGSLESVIHGP---------GVD-HSRWTLPKRIDVLISVANGLDYLHSGYDIPIVHCDMKPSNILLDRD 154 (299)
Q Consensus 85 ~~~lv~e~~~~~~L~~~~~~~---------~~~-~~~~~~~~~~~i~~qi~~~l~~lh~~~~~~~~H~dl~~~nil~~~~ 154 (299)
.+++|+||+..|+|.+++... +++ ..+++..+.+.|+.|||.++.||-++ .+|||||..+|+||..+
T Consensus 563 P~~MvFEYm~~GDL~eFLra~sP~a~~~~~g~~~~~~L~~~q~L~iA~QIAaGM~YLs~~---~FVHRDLATRNCLVge~ 639 (774)
T KOG1026|consen 563 PLCMVFEYMDHGDLHEFLRARSPKADKLASGQDTPPPLSTSQFLHIATQIAAGMEYLSSH---HFVHRDLATRNCLVGEN 639 (774)
T ss_pred eeEEEEEecccccHHHHHHhhCCccccccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhC---cccccchhhhhceeccc
Confidence 559999999999999988542 111 33489999999999999999999999 99999999999999999
Q ss_pred CcEEEeeeccccccccccccccccccccccCcccCChhhhcccCcCccccchhhhHHHHHHHh-CCCCCCCCccCCCCch
Q 038766 155 FEAHVSDFGTSRMLDVHLQDLSSLSTAFQGTIGYLAPEFAYMRIVTTKVDVFSFGIVVMEFLT-KRRPTGLDEENGLSPI 233 (299)
Q Consensus 155 ~~v~l~df~~~~~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~DiwslG~~l~~l~~-g~~p~~~~~~~~~~~~ 233 (299)
-.|||+|||+++..-. .+.........-+..|||||.+....++.+|||||+|+++||+++ |.-|+. ++...
T Consensus 640 l~VKIsDfGLsRdiYs--sDYYk~~~~t~lPIRWMppEsIly~kFTteSDVWs~GVvLWEIFsyG~QPy~-----glSn~ 712 (774)
T KOG1026|consen 640 LVVKISDFGLSRDIYS--SDYYKVRGNTLLPIRWMPPESILYGKFTTESDVWSFGVVLWEIFSYGKQPYY-----GLSNQ 712 (774)
T ss_pred eEEEecccccchhhhh--hhhhcccCCceeeeecCCHHHhhcCcccchhhhhhhhhhhhhhhccccCccc-----ccchH
Confidence 9999999999985331 122222223344679999999999999999999999999999997 666763 33444
Q ss_pred hHHHHHHHHHhcCccCcccccCccccchhhHhHHHHHHHHHHHHHHHHhcCCCCCCCCChhhh
Q 038766 234 SLRQLVEKALANGINGVRQITDPKLVSSIYEEQEQHQVLEELFKLALVCTSSNPEDRPNMNEL 296 (299)
Q Consensus 234 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rpt~~~i 296 (299)
++.+.+..... ..++...+.++.+|+..||+.+|++||++.||
T Consensus 713 EVIe~i~~g~l--------------------L~~Pe~CP~~vY~LM~~CW~~~P~~RPsF~eI 755 (774)
T KOG1026|consen 713 EVIECIRAGQL--------------------LSCPENCPTEVYSLMLECWNENPKRRPSFKEI 755 (774)
T ss_pred HHHHHHHcCCc--------------------ccCCCCCCHHHHHHHHHHhhcCcccCCCHHHH
Confidence 44443332110 12266778899999999999999999999987
|
|
| >cd07880 STKc_p38gamma_MAPK12 Catalytic domain of the Serine/Threonine Kinase, p38gamma Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-39 Score=278.38 Aligned_cols=273 Identities=23% Similarity=0.280 Sum_probs=202.0
Q ss_pred HHHHHHhCCCCCCceeecCCcceEEEEEe-CCCcEEEEEEeccCcCChhhhHHHHHHHHHHHhcCCcceeeeeeEEEcCC
Q 038766 5 TEIENATGSFSENNIIGNSNLSTVYKGRL-EDGEIVAVKKLNFHQFSAESDKSFYREAKTLKELKHRNLVKVLGYAWESG 83 (299)
Q Consensus 5 ~~~~~~~~~y~~~~~lg~g~~~~v~~~~~-~~~~~~~vK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~ 83 (299)
.++..+.++|.+.+.||+|++|.||++.+ .++..||+|++............+.+|+.+++.++|+||+++++++....
T Consensus 8 ~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~ 87 (343)
T cd07880 8 KTIWEVPDRYRDLKQVGSGAYGTVCSALDRRTGAKVAIKKLYRPFQSELFAKRAYRELRLLKHMKHENVIGLLDVFTPDL 87 (343)
T ss_pred hhhhccccceEEEEEeeecCCeEEEEEEECCCCcEEEEEEecccccchHHHHHHHHHHHHHHhcCCCCccceeeeecCCc
Confidence 35667889999999999999999999975 46899999998644334444567889999999999999999999775433
Q ss_pred C-----eeEEEEeecCCCChHHHhcCCCCCCCCCChhhHHHHHHHHHHHHHHhhcCCCCCeeeecccCCceeeCCCCcEE
Q 038766 84 K-----LKALILEYMENGSLESVIHGPGVDHSRWTLPKRIDVLISVANGLDYLHSGYDIPIVHCDMKPSNILLDRDFEAH 158 (299)
Q Consensus 84 ~-----~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lh~~~~~~~~H~dl~~~nil~~~~~~v~ 158 (299)
. ..++|+|++ +++|..++. ...+++..++.++.|++.||+|||+. +++|+||+|+||+++.++.++
T Consensus 88 ~~~~~~~~~lv~e~~-~~~l~~~~~-----~~~l~~~~~~~i~~qi~~al~~LH~~---gi~H~dlkp~Nill~~~~~~k 158 (343)
T cd07880 88 SLDRFHDFYLVMPFM-GTDLGKLMK-----HEKLSEDRIQFLVYQMLKGLKYIHAA---GIIHRDLKPGNLAVNEDCELK 158 (343)
T ss_pred cccccceEEEEEecC-CCCHHHHHh-----cCCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHEEEcCCCCEE
Confidence 2 348999999 779988884 34689999999999999999999999 999999999999999999999
Q ss_pred EeeeccccccccccccccccccccccCcccCChhhhcc-cCcCccccchhhhHHHHHHHhCCCCCCCCccCCCCchhHHH
Q 038766 159 VSDFGTSRMLDVHLQDLSSLSTAFQGTIGYLAPEFAYM-RIVTTKVDVFSFGIVVMEFLTKRRPTGLDEENGLSPISLRQ 237 (299)
Q Consensus 159 l~df~~~~~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~-~~~~~~~DiwslG~~l~~l~~g~~p~~~~~~~~~~~~~~~~ 237 (299)
|+|||++..... ......+++.|+|||.+.+ ..++.++|+||||+++|+|++|..||...... .....
T Consensus 159 l~dfg~~~~~~~-------~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~ll~~l~~g~~pf~~~~~~----~~~~~ 227 (343)
T cd07880 159 ILDFGLARQTDS-------EMTGYVVTRWYRAPEVILNWMHYTQTVDIWSVGCIMAEMLTGKPLFKGHDHL----DQLME 227 (343)
T ss_pred Eeeccccccccc-------CccccccCCcccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHH----HHHHH
Confidence 999999875431 1223345788999998876 45788999999999999999999998643210 01111
Q ss_pred HHHHHHhcCccCc-ccccC----------ccccchhhHhHHHHHHHHHHHHHHHHhcCCCCCCCCChhhhhcC
Q 038766 238 LVEKALANGINGV-RQITD----------PKLVSSIYEEQEQHQVLEELFKLALVCTSSNPEDRPNMNELLIT 299 (299)
Q Consensus 238 ~~~~~~~~~~~~~-~~~~~----------~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rpt~~~il~~ 299 (299)
.+.. ........ ..+.. +..... ........++..+.++|.+||..||++|||+.+++.|
T Consensus 228 ~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~li~~~l~~dP~~R~t~~~~l~~ 298 (343)
T cd07880 228 IMKV-TGTPSKEFVQKLQSEDAKNYVKKLPRFRKK-DFRSLLPNANPLAVNVLEKMLVLDAESRITAAEALAH 298 (343)
T ss_pred HHHh-cCCCCHHHHHhhcchhHHHHHHhccccCcc-hHHHhccCCChHHHHHHHHHcCCChhhCCCHHHHhcC
Confidence 1100 00000000 00000 000000 0001123456678999999999999999999999986
|
Serine/Threonine Kinases (STKs), p38gamma subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38gamma subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38gamma, also called MAPK12 |
| >cd05111 PTK_HER3 Pseudokinase domain of the Protein Tyrosine Kinase, HER3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-39 Score=270.67 Aligned_cols=252 Identities=22% Similarity=0.358 Sum_probs=191.9
Q ss_pred hCCCCCCceeecCCcceEEEEEeC-CCc----EEEEEEeccCcCChhhhHHHHHHHHHHHhcCCcceeeeeeEEEcCCCe
Q 038766 11 TGSFSENNIIGNSNLSTVYKGRLE-DGE----IVAVKKLNFHQFSAESDKSFYREAKTLKELKHRNLVKVLGYAWESGKL 85 (299)
Q Consensus 11 ~~~y~~~~~lg~g~~~~v~~~~~~-~~~----~~~vK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~ 85 (299)
.++|++.+.||+|++|+||++.+. ++. .+++|++... ........+..|+..++.+.||||+++++++. +..
T Consensus 6 ~~~~~~~~~lg~G~~~~vy~~~~~~~~~~~~~~~~~k~~~~~-~~~~~~~~~~~~~~~l~~l~h~~iv~~~~~~~--~~~ 82 (279)
T cd05111 6 ETELRKLKLLGSGVFGTVHKGIWIPEGDSIKIPVAIKTIQDR-SGRQTFQEITDHMLAMGSLDHAYIVRLLGICP--GAS 82 (279)
T ss_pred HhhceeccccCccCCcceEEEEEcCCCCceeeEEEEeecccc-cchHHHHHHHHHHHHHhcCCCCCcceEEEEEC--CCc
Confidence 468899999999999999999863 343 4788877532 22334466778888999999999999999653 334
Q ss_pred eEEEEeecCCCChHHHhcCCCCCCCCCChhhHHHHHHHHHHHHHHhhcCCCCCeeeecccCCceeeCCCCcEEEeeeccc
Q 038766 86 KALILEYMENGSLESVIHGPGVDHSRWTLPKRIDVLISVANGLDYLHSGYDIPIVHCDMKPSNILLDRDFEAHVSDFGTS 165 (299)
Q Consensus 86 ~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lh~~~~~~~~H~dl~~~nil~~~~~~v~l~df~~~ 165 (299)
.++++|++.+++|.+++.. ....+++..++.++.|++.||.|||+. +++|+||||+||+++.++.++|+|||++
T Consensus 83 ~~~i~e~~~~gsL~~~l~~---~~~~~~~~~~~~i~~qi~~~l~~lH~~---~iiH~dlkp~nili~~~~~~kl~Dfg~~ 156 (279)
T cd05111 83 LQLVTQLSPLGSLLDHVRQ---HRDSLDPQRLLNWCVQIAKGMYYLEEH---RMVHRNLAARNILLKSDSIVQIADFGVA 156 (279)
T ss_pred cEEEEEeCCCCcHHHHHHh---cccCCCHHHHHHHHHHHHHHHHHHHHC---CEeccccCcceEEEcCCCcEEEcCCccc
Confidence 5789999999999999863 234689999999999999999999999 9999999999999999999999999998
Q ss_pred cccccccccccccccccccCcccCChhhhcccCcCccccchhhhHHHHHHHh-CCCCCCCCccCCCCchhHHHHHHHHHh
Q 038766 166 RMLDVHLQDLSSLSTAFQGTIGYLAPEFAYMRIVTTKVDVFSFGIVVMEFLT-KRRPTGLDEENGLSPISLRQLVEKALA 244 (299)
Q Consensus 166 ~~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~DiwslG~~l~~l~~-g~~p~~~~~~~~~~~~~~~~~~~~~~~ 244 (299)
....... .........++..|+|||.+.+..++.++||||||+++|+|++ |..||... ......+.+.
T Consensus 157 ~~~~~~~--~~~~~~~~~~~~~y~~pE~~~~~~~~~~~Dv~slG~il~el~t~g~~p~~~~-----~~~~~~~~~~---- 225 (279)
T cd05111 157 DLLYPDD--KKYFYSEHKTPIKWMALESILFGRYTHQSDVWSYGVTVWEMMSYGAEPYAGM-----RPHEVPDLLE---- 225 (279)
T ss_pred eeccCCC--cccccCCCCCcccccCHHHhccCCcCchhhHHHHHHHHHHHHcCCCCCCCCC-----CHHHHHHHHH----
Confidence 7543211 1111233445678999999998889999999999999999998 98888433 1222222221
Q ss_pred cCccCcccccCccccchhhHhHHHHHHHHHHHHHHHHhcCCCCCCCCChhhhhc
Q 038766 245 NGINGVRQITDPKLVSSIYEEQEQHQVLEELFKLALVCTSSNPEDRPNMNELLI 298 (299)
Q Consensus 245 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rpt~~~il~ 298 (299)
.+ .....+ ...+.++.+++.+|+..+|++|||+.++++
T Consensus 226 ~~----~~~~~~------------~~~~~~~~~li~~c~~~~p~~Rps~~el~~ 263 (279)
T cd05111 226 KG----ERLAQP------------QICTIDVYMVMVKCWMIDENVRPTFKELAN 263 (279)
T ss_pred CC----CcCCCC------------CCCCHHHHHHHHHHcCCCcccCcCHHHHHH
Confidence 11 000111 112346788999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; HER3 (ErbB3); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER3 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr r |
| >cd07870 STKc_PFTAIRE2 Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-2 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-39 Score=272.15 Aligned_cols=269 Identities=22% Similarity=0.269 Sum_probs=193.4
Q ss_pred hCCCCCCceeecCCcceEEEEEe-CCCcEEEEEEeccCcCChhhhHHHHHHHHHHHhcCCcceeeeeeEEEcCCCeeEEE
Q 038766 11 TGSFSENNIIGNSNLSTVYKGRL-EDGEIVAVKKLNFHQFSAESDKSFYREAKTLKELKHRNLVKVLGYAWESGKLKALI 89 (299)
Q Consensus 11 ~~~y~~~~~lg~g~~~~v~~~~~-~~~~~~~vK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~lv 89 (299)
.++|++.+.||+|++|.||++.+ .+++.+++|++.... .........+|+..++.++|+||+++.+++.. +...++|
T Consensus 4 ~~~y~~~~~ig~g~~~~v~~~~~~~~~~~~~iK~~~~~~-~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~-~~~~~lv 81 (291)
T cd07870 4 ATSYLNLEKLGEGSYATVYKGISRINGQLVALKVISMKT-EEGVPFTAIREASLLKGLKHANIVLLHDIIHT-KETLTFV 81 (291)
T ss_pred cceeEEEEEEEecCCEEEEEEEEcCCCcEEEEEEecccC-cCCCcHHHHHHHHHHHhcCCCCEeEEEEEEec-CCeEEEE
Confidence 46899999999999999999986 458899999986433 22334466789999999999999999997654 5567999
Q ss_pred EeecCCCChHHHhcCCCCCCCCCChhhHHHHHHHHHHHHHHhhcCCCCCeeeecccCCceeeCCCCcEEEeeeccccccc
Q 038766 90 LEYMENGSLESVIHGPGVDHSRWTLPKRIDVLISVANGLDYLHSGYDIPIVHCDMKPSNILLDRDFEAHVSDFGTSRMLD 169 (299)
Q Consensus 90 ~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lh~~~~~~~~H~dl~~~nil~~~~~~v~l~df~~~~~~~ 169 (299)
+||+. +++.+.+.. ....+++..+..++.|++.||.|||+. +++|+||||+||+++.++.++|+|||++....
T Consensus 82 ~e~~~-~~l~~~~~~---~~~~~~~~~~~~~~~qi~~~L~~lH~~---~i~H~dlkp~Nil~~~~~~~~l~Dfg~~~~~~ 154 (291)
T cd07870 82 FEYMH-TDLAQYMIQ---HPGGLHPYNVRLFMFQLLRGLAYIHGQ---HILHRDLKPQNLLISYLGELKLADFGLARAKS 154 (291)
T ss_pred Eeccc-CCHHHHHHh---CCCCCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCChHHEEEcCCCcEEEeccccccccC
Confidence 99995 577776642 234578888999999999999999999 99999999999999999999999999886533
Q ss_pred cccccccccccccccCcccCChhhhccc-CcCccccchhhhHHHHHHHhCCCCCCCCccCCCCchhHHHHHHHHHh-cCc
Q 038766 170 VHLQDLSSLSTAFQGTIGYLAPEFAYMR-IVTTKVDVFSFGIVVMEFLTKRRPTGLDEENGLSPISLRQLVEKALA-NGI 247 (299)
Q Consensus 170 ~~~~~~~~~~~~~~~~~~y~~PE~~~~~-~~~~~~DiwslG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~-~~~ 247 (299)
.. ........+++.|+|||.+.+. .++.++|+||||+++|+|++|..||...... .+.+..... .+.
T Consensus 155 ~~----~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~~l~~g~~~f~~~~~~-------~~~~~~~~~~~~~ 223 (291)
T cd07870 155 IP----SQTYSSEVVTLWYRPPDVLLGATDYSSALDIWGAGCIFIEMLQGQPAFPGVSDV-------FEQLEKIWTVLGV 223 (291)
T ss_pred CC----CCCCCCccccccccCCceeecCCCCCcHHHHHHHHHHHHHHHhCCCCCCCchhH-------HHHHHHHHHHcCC
Confidence 21 1112233457889999988754 5788999999999999999999998543211 111111100 000
Q ss_pred ------------cC-cccccCccccchhhHhHHHHHHHHHHHHHHHHhcCCCCCCCCChhhhhcC
Q 038766 248 ------------NG-VRQITDPKLVSSIYEEQEQHQVLEELFKLALVCTSSNPEDRPNMNELLIT 299 (299)
Q Consensus 248 ------------~~-~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rpt~~~il~~ 299 (299)
+. ......................+..+.+++.+|+..||++|||+.+++.|
T Consensus 224 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~~l~~dp~~R~t~~~~l~h 288 (291)
T cd07870 224 PTEDTWPGVSKLPNYKPEWFLPCKPQQLRVVWKRLSRPPKAEDLASQMLMMFPKDRISAQDALLH 288 (291)
T ss_pred CChhhhhhhhhcccccchhccccCCcchhhhccccCCChHHHHHHHHHhCcCcccCcCHHHHhcC
Confidence 00 00000000000000000001124678899999999999999999999987
|
Serine/Threonine Kinases (STKs), PFTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-2 is also referred to as ALS2CR7 (amyotrophic lateral sclerosis 2 (juvenile) chromosome region candidate 7). It may be associated with amyotrophic lateral sclerosis 2 (ALS2), an autosomal recess |
| >cd05122 PKc_STE Catalytic domain of STE family Protein Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.7e-39 Score=263.24 Aligned_cols=250 Identities=29% Similarity=0.434 Sum_probs=200.1
Q ss_pred CCCCCceeecCCcceEEEEEeC-CCcEEEEEEeccCcCChhhhHHHHHHHHHHHhcCCcceeeeeeEEEcCCCeeEEEEe
Q 038766 13 SFSENNIIGNSNLSTVYKGRLE-DGEIVAVKKLNFHQFSAESDKSFYREAKTLKELKHRNLVKVLGYAWESGKLKALILE 91 (299)
Q Consensus 13 ~y~~~~~lg~g~~~~v~~~~~~-~~~~~~vK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~lv~e 91 (299)
+|.+.+.||+|++|.||++.+. +++.+++|++..... .....+.+|+..++.++|++++++++.+.. +...++++|
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~~k~~~~~~~--~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~-~~~~~l~~e 77 (253)
T cd05122 1 LFEILEKIGKGGFGEVYKARHKRTGKEVAIKVIKLESK--EKKEKIINEIQILKKCKHPNIVKYYGSYLK-KDELWIVME 77 (253)
T ss_pred CceeeeeeccCCceEEEEEEECCCCcEEEEEEecccch--hHHHHHHHHHHHHHhCCCCCEeEEEEEEec-CCeEEEEEe
Confidence 5888999999999999999875 688999999864332 456788899999999999999999996655 456699999
Q ss_pred ecCCCChHHHhcCCCCCCCCCChhhHHHHHHHHHHHHHHhhcCCCCCeeeecccCCceeeCCCCcEEEeeeccccccccc
Q 038766 92 YMENGSLESVIHGPGVDHSRWTLPKRIDVLISVANGLDYLHSGYDIPIVHCDMKPSNILLDRDFEAHVSDFGTSRMLDVH 171 (299)
Q Consensus 92 ~~~~~~L~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lh~~~~~~~~H~dl~~~nil~~~~~~v~l~df~~~~~~~~~ 171 (299)
|+.+++|.+++... ...+++..++.++.|++.||++||+. +++|+||+|+||+++.++.++|+|||.+......
T Consensus 78 ~~~~~~L~~~~~~~---~~~~~~~~~~~i~~~i~~~l~~lh~~---~i~h~dl~p~ni~i~~~~~~~l~d~~~~~~~~~~ 151 (253)
T cd05122 78 FCSGGSLKDLLKST---NQTLTESQIAYVCKELLKGLEYLHSN---GIIHRDIKAANILLTSDGEVKLIDFGLSAQLSDT 151 (253)
T ss_pred cCCCCcHHHHHhhc---CCCCCHHHHHHHHHHHHHHHHHhhcC---CEecCCCCHHHEEEccCCeEEEeecccccccccc
Confidence 99989999998642 15789999999999999999999998 9999999999999999999999999998765421
Q ss_pred cccccccccccccCcccCChhhhcccCcCccccchhhhHHHHHHHhCCCCCCCCccCCCCchhHHHHHHHHHhcCccCcc
Q 038766 172 LQDLSSLSTAFQGTIGYLAPEFAYMRIVTTKVDVFSFGIVVMEFLTKRRPTGLDEENGLSPISLRQLVEKALANGINGVR 251 (299)
Q Consensus 172 ~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~DiwslG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 251 (299)
. ......++..|+|||.+.+..++.++|+||||+++++|++|..||.... .. .......... ..
T Consensus 152 ~-----~~~~~~~~~~~~~PE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~-----~~---~~~~~~~~~~---~~ 215 (253)
T cd05122 152 K-----ARNTMVGTPYWMAPEVINGKPYDYKADIWSLGITAIELAEGKPPYSELP-----PM---KALFKIATNG---PP 215 (253)
T ss_pred c-----cccceecCCcccCHHHHcCCCCCccccHHHHHHHHHHHHhCCCCCCCCc-----hH---HHHHHHHhcC---CC
Confidence 1 0234557789999999988888999999999999999999999985321 11 1111111111 00
Q ss_pred cccCccccchhhHhHHHHHHHHHHHHHHHHhcCCCCCCCCChhhhhcC
Q 038766 252 QITDPKLVSSIYEEQEQHQVLEELFKLALVCTSSNPEDRPNMNELLIT 299 (299)
Q Consensus 252 ~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rpt~~~il~~ 299 (299)
.... ...++..+.++|.+||..||++|||+.++++|
T Consensus 216 ~~~~------------~~~~~~~~~~~i~~~l~~~p~~R~t~~~~l~~ 251 (253)
T cd05122 216 GLRN------------PEKWSDEFKDFLKKCLQKNPEKRPTAEQLLKH 251 (253)
T ss_pred CcCc------------ccccCHHHHHHHHHHccCChhhCCCHHHHhcC
Confidence 0000 11135679999999999999999999999987
|
Protein Kinases (PKs), STE family, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The STE family is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases (STKs), protein tyrosine kinases (PTKs), RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This family is composed of STKs, and some dual-specificity PKs that phosphorylate both threonine and tyrosine residues of target proteins. Most members are kinases involved in mitogen-activated protein kinase (MAPK) signaling cascades, acting as MAPK kinases (MAPKKs), MAPK kinase kinases (MAPKKKs), or MAPK kinase kinase kinases (MAP4Ks). The MAPK signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core |
| >cd08530 STKc_CNK2-like Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii CNK2, and similar domains | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-39 Score=267.78 Aligned_cols=252 Identities=23% Similarity=0.337 Sum_probs=203.8
Q ss_pred CCCCCceeecCCcceEEEEEe-CCCcEEEEEEeccCcCChhhhHHHHHHHHHHHhcCCcceeeeeeEEEcCCCeeEEEEe
Q 038766 13 SFSENNIIGNSNLSTVYKGRL-EDGEIVAVKKLNFHQFSAESDKSFYREAKTLKELKHRNLVKVLGYAWESGKLKALILE 91 (299)
Q Consensus 13 ~y~~~~~lg~g~~~~v~~~~~-~~~~~~~vK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~lv~e 91 (299)
+|.+.+.||+|++|.||++.+ .+++.+++|++............+.+|+..++.++|+||+++.+++.. +...++|+|
T Consensus 1 ~y~~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~-~~~~~~v~e 79 (256)
T cd08530 1 DFKVLKKLGKGSYGSVYKVKRLSDNQFYALKEVDLGSMSQKEREDAVNEIRILASVNHPNIISYKEAFLD-GNKLCIVME 79 (256)
T ss_pred CceEeeeecCCCceeEEEEEECCCCCEEEEEEEehhhccHHHHHHHHHHHHHHHhCCCCCchhhhhhhcc-CCEEEEEeh
Confidence 588999999999999999976 468899999987655555556777889999999999999999996665 466799999
Q ss_pred ecCCCChHHHhcCCCCCCCCCChhhHHHHHHHHHHHHHHhhcCCCCCeeeecccCCceeeCCCCcEEEeeeccccccccc
Q 038766 92 YMENGSLESVIHGPGVDHSRWTLPKRIDVLISVANGLDYLHSGYDIPIVHCDMKPSNILLDRDFEAHVSDFGTSRMLDVH 171 (299)
Q Consensus 92 ~~~~~~L~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lh~~~~~~~~H~dl~~~nil~~~~~~v~l~df~~~~~~~~~ 171 (299)
|+++++|.+++.........+++..++.++.|++.||++||+. +++|+||+|+||+++.++.++|+|||++......
T Consensus 80 ~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~l~~al~~lh~~---~i~h~~l~~~ni~~~~~~~~kl~d~g~~~~~~~~ 156 (256)
T cd08530 80 YAPFGDLSKAISKRKKKRKLIPEQEIWRIFIQLLRGLQALHEQ---KILHRDLKSANILLVANDLVKIGDLGISKVLKKN 156 (256)
T ss_pred hcCCCCHHHHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHhhC---CcccCCCCcceEEEecCCcEEEeeccchhhhccC
Confidence 9999999998864332346789999999999999999999999 9999999999999999999999999998765421
Q ss_pred cccccccccccccCcccCChhhhcccCcCccccchhhhHHHHHHHhCCCCCCCCccCCCCchhHHHHHHHHHhcCccCcc
Q 038766 172 LQDLSSLSTAFQGTIGYLAPEFAYMRIVTTKVDVFSFGIVVMEFLTKRRPTGLDEENGLSPISLRQLVEKALANGINGVR 251 (299)
Q Consensus 172 ~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~DiwslG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 251 (299)
......++..|+|||...+..++.++|+||||+++++|++|..||.... ...... ........
T Consensus 157 ------~~~~~~~~~~~~~Pe~~~~~~~~~~~D~~slG~~~~~l~~g~~p~~~~~-----~~~~~~---~~~~~~~~--- 219 (256)
T cd08530 157 ------MAKTQIGTPHYMAPEVWKGRPYSYKSDIWSLGCLLYEMATFAPPFEARS-----MQDLRY---KVQRGKYP--- 219 (256)
T ss_pred ------CcccccCCccccCHHHHCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCC-----HHHHHH---HHhcCCCC---
Confidence 2223446789999999998889999999999999999999999985332 111111 11111100
Q ss_pred cccCccccchhhHhHHHHHHHHHHHHHHHHhcCCCCCCCCChhhhhcC
Q 038766 252 QITDPKLVSSIYEEQEQHQVLEELFKLALVCTSSNPEDRPNMNELLIT 299 (299)
Q Consensus 252 ~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rpt~~~il~~ 299 (299)
..+...+.++.+++.+||..+|++|||+.+++.|
T Consensus 220 --------------~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~~l~~ 253 (256)
T cd08530 220 --------------PIPPIYSQDLQNFIRSMLQVKPKLRPNCDKILAS 253 (256)
T ss_pred --------------CCchhhCHHHHHHHHHHcCCCcccCCCHHHHhcC
Confidence 0123456789999999999999999999999987
|
Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii Never In Mitosis gene A (NIMA)-related kinase 1 (CNK2)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii CNK2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes CNK1, and -2. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii CNK2 has both cilliary and cell cycle functions. It influences flagellar length through promoting flagellar disassembly, an |
| >cd07836 STKc_Pho85 Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Pho85 | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.5e-39 Score=268.06 Aligned_cols=271 Identities=23% Similarity=0.329 Sum_probs=199.3
Q ss_pred CCCCCceeecCCcceEEEEEeC-CCcEEEEEEeccCcCChhhhHHHHHHHHHHHhcCCcceeeeeeEEEcCCCeeEEEEe
Q 038766 13 SFSENNIIGNSNLSTVYKGRLE-DGEIVAVKKLNFHQFSAESDKSFYREAKTLKELKHRNLVKVLGYAWESGKLKALILE 91 (299)
Q Consensus 13 ~y~~~~~lg~g~~~~v~~~~~~-~~~~~~vK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~lv~e 91 (299)
+|.+.+.||.|++|.||++.+. +|..+|+|++..... ......+.+|+..++.++|+|++++++.+... ...++|+|
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~-~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~-~~~~lv~e 78 (284)
T cd07836 1 NFKQLEKLGEGTYATVYKGRNRTTGEIVALKEIHLDAE-EGTPSTAIREISLMKELKHENIVRLHDVIHTE-NKLMLVFE 78 (284)
T ss_pred CceEeeeeccCCceEEEEEEECCCCeEEEEEEeccccc-ccchHHHHHHHHHHHhhcCCCEeeeeeeEeeC-CcEEEEEe
Confidence 5889999999999999999875 589999999875432 33345677899999999999999999977664 45599999
Q ss_pred ecCCCChHHHhcCCCCCCCCCChhhHHHHHHHHHHHHHHhhcCCCCCeeeecccCCceeeCCCCcEEEeeeccccccccc
Q 038766 92 YMENGSLESVIHGPGVDHSRWTLPKRIDVLISVANGLDYLHSGYDIPIVHCDMKPSNILLDRDFEAHVSDFGTSRMLDVH 171 (299)
Q Consensus 92 ~~~~~~L~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lh~~~~~~~~H~dl~~~nil~~~~~~v~l~df~~~~~~~~~ 171 (299)
|+.+ +|.+++...+ ....+++..+..++.|++.||+|||+. +++|+||+|+||+++.++.++|+|||++......
T Consensus 79 ~~~~-~l~~~~~~~~-~~~~~~~~~~~~~~~qi~~~l~~lH~~---~i~h~dl~p~ni~~~~~~~~~l~d~g~~~~~~~~ 153 (284)
T cd07836 79 YMDK-DLKKYMDTHG-VRGALDPNTVKSFTYQLLKGIAFCHEN---RVLHRDLKPQNLLINKRGELKLADFGLARAFGIP 153 (284)
T ss_pred cCCc-cHHHHHHhcC-CCCCcCHHHHHHHHHHHHHHHHHHHHC---CeeeCCCCHHHEEECCCCcEEEeecchhhhhcCC
Confidence 9975 8888876443 345789999999999999999999998 9999999999999999999999999998754321
Q ss_pred cccccccccccccCcccCChhhhcc-cCcCccccchhhhHHHHHHHhCCCCCCCCccCCCCchhHHHHHHHHHhcCcc--
Q 038766 172 LQDLSSLSTAFQGTIGYLAPEFAYM-RIVTTKVDVFSFGIVVMEFLTKRRPTGLDEENGLSPISLRQLVEKALANGIN-- 248 (299)
Q Consensus 172 ~~~~~~~~~~~~~~~~y~~PE~~~~-~~~~~~~DiwslG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~-- 248 (299)
........++..|+|||.+.+ ..++.++|+||||+++|+|++|..||...... ......+.........
T Consensus 154 ----~~~~~~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~~l~~l~~g~~~~~~~~~~----~~~~~~~~~~~~~~~~~~ 225 (284)
T cd07836 154 ----VNTFSNEVVTLWYRAPDVLLGSRTYSTSIDIWSVGCIMAEMITGRPLFPGTNNE----DQLLKIFRIMGTPTESTW 225 (284)
T ss_pred ----ccccccccccccccChHHhcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCcH----HHHHHHHHHhCCCChhhH
Confidence 111122345778999998765 45688999999999999999999998644221 1111111110000000
Q ss_pred ----CcccccC--ccccchhhHhHHHHHHHHHHHHHHHHhcCCCCCCCCChhhhhcC
Q 038766 249 ----GVRQITD--PKLVSSIYEEQEQHQVLEELFKLALVCTSSNPEDRPNMNELLIT 299 (299)
Q Consensus 249 ----~~~~~~~--~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rpt~~~il~~ 299 (299)
....... +..... .........+..+.+++.+||+.||.+|||++++++|
T Consensus 226 ~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~i~~~l~~~p~~R~~~~~~l~~ 281 (284)
T cd07836 226 PGISQLPEYKPTFPRYPPQ-DLQQLFPHADPLGIDLLHRLLQLNPELRISAHDALQH 281 (284)
T ss_pred HHHhcCchhcccccCCChH-HHHHHhhhcCcHHHHHHHHHhcCCcccCCCHHHHhcC
Confidence 0000000 000000 0111233457789999999999999999999999986
|
Serine/Threonine Kinases (STKs), Pho85 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Pho85 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Pho85 is a multifunctional Cyclin-Dependent protein Kinase (CDK) in yeast. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Pho85 is regulated by 10 different cyclins (Pcls) and plays a role in G1 progression, cell polarity, phosphate and glycogen metabolism, gene expression, and in signaling changes in the environment. |
| >cd08225 STKc_Nek5 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-39 Score=267.30 Aligned_cols=252 Identities=25% Similarity=0.394 Sum_probs=199.7
Q ss_pred CCCCCceeecCCcceEEEEEeC-CCcEEEEEEeccCcCChhhhHHHHHHHHHHHhcCCcceeeeeeEEEcCCCeeEEEEe
Q 038766 13 SFSENNIIGNSNLSTVYKGRLE-DGEIVAVKKLNFHQFSAESDKSFYREAKTLKELKHRNLVKVLGYAWESGKLKALILE 91 (299)
Q Consensus 13 ~y~~~~~lg~g~~~~v~~~~~~-~~~~~~vK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~lv~e 91 (299)
+|.+.+.||+|++|.||++... +|..+|+|.+..........+.+.+|++.++.++|+|++++++.+.. +...++|+|
T Consensus 1 ~~~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~E~~~l~~~~h~~i~~~~~~~~~-~~~~~lv~e 79 (257)
T cd08225 1 RYEIIKKIGEGSFGKIYLAKAKSDSEHCVIKEIDLTKMPVKEKEASKKEVILLAKMKHPNIVTFFASFQE-NGRLFIVME 79 (257)
T ss_pred CceEEEEecCCCcceEEEEEEcCCCceEEEEEeeHhhccchhhHHHHHHHHHHHhCCCCChhhhhheecc-CCeEEEEEe
Confidence 5888999999999999999864 58899999987654444556678899999999999999999996655 556799999
Q ss_pred ecCCCChHHHhcCCCCCCCCCChhhHHHHHHHHHHHHHHhhcCCCCCeeeecccCCceeeCCCCc-EEEeeecccccccc
Q 038766 92 YMENGSLESVIHGPGVDHSRWTLPKRIDVLISVANGLDYLHSGYDIPIVHCDMKPSNILLDRDFE-AHVSDFGTSRMLDV 170 (299)
Q Consensus 92 ~~~~~~L~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lh~~~~~~~~H~dl~~~nil~~~~~~-v~l~df~~~~~~~~ 170 (299)
|+.+++|.+++... ....+++..+..++.|+++||.|||+. +++|+||+|+||+++.++. ++|+|||.+.....
T Consensus 80 ~~~~~~L~~~~~~~--~~~~~~~~~~~~~~~~l~~~l~~lh~~---~i~H~dl~~~nil~~~~~~~~~l~d~~~~~~~~~ 154 (257)
T cd08225 80 YCDGGDLMKRINRQ--RGVLFSEDQILSWFVQISLGLKHIHDR---KILHRDIKSQNIFLSKNGMVAKLGDFGIARQLND 154 (257)
T ss_pred cCCCCcHHHHHHhc--cCCCCCHHHHHHHHHHHHHHHHHHHHC---CcccccCCHHHEEEcCCCCeEEecccccchhccC
Confidence 99999999988643 233578999999999999999999999 9999999999999998864 69999998876542
Q ss_pred ccccccccccccccCcccCChhhhcccCcCccccchhhhHHHHHHHhCCCCCCCCccCCCCchhHHHHHHHHHhcCccCc
Q 038766 171 HLQDLSSLSTAFQGTIGYLAPEFAYMRIVTTKVDVFSFGIVVMEFLTKRRPTGLDEENGLSPISLRQLVEKALANGINGV 250 (299)
Q Consensus 171 ~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~DiwslG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 250 (299)
. ........+++.|+|||.+....++.++|+||+|+++++|++|..||.... ...............
T Consensus 155 ~----~~~~~~~~~~~~~~ape~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~--------~~~~~~~~~~~~~~~- 221 (257)
T cd08225 155 S----MELAYTCVGTPYYLSPEICQNRPYNNKTDIWSLGCVLYELCTLKHPFEGNN--------LHQLVLKICQGYFAP- 221 (257)
T ss_pred C----cccccccCCCccccCHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCCcc--------HHHHHHHHhcccCCC-
Confidence 1 112223457888999999988889999999999999999999999985331 111121111111000
Q ss_pred ccccCccccchhhHhHHHHHHHHHHHHHHHHhcCCCCCCCCChhhhhcC
Q 038766 251 RQITDPKLVSSIYEEQEQHQVLEELFKLALVCTSSNPEDRPNMNELLIT 299 (299)
Q Consensus 251 ~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rpt~~~il~~ 299 (299)
. ....+.++.+++.+||..+|++|||+.+++.|
T Consensus 222 --~--------------~~~~~~~~~~~i~~~l~~~p~~Rpt~~~ll~~ 254 (257)
T cd08225 222 --I--------------SPNFSRDLRSLISQLFKVSPRDRPSITSILKR 254 (257)
T ss_pred --C--------------CCCCCHHHHHHHHHHhccChhhCcCHHHHhhC
Confidence 0 12334579999999999999999999999986
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 5 (Nek5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek5 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. The specific function of Nek5 is unknown. |
| >cd05083 PTKc_Chk Catalytic domain of the Protein Tyrosine Kinase, Csk homologous kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-39 Score=268.09 Aligned_cols=244 Identities=26% Similarity=0.449 Sum_probs=192.7
Q ss_pred hCCCCCCceeecCCcceEEEEEeCCCcEEEEEEeccCcCChhhhHHHHHHHHHHHhcCCcceeeeeeEEEcCCCeeEEEE
Q 038766 11 TGSFSENNIIGNSNLSTVYKGRLEDGEIVAVKKLNFHQFSAESDKSFYREAKTLKELKHRNLVKVLGYAWESGKLKALIL 90 (299)
Q Consensus 11 ~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~vK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~lv~ 90 (299)
.++|.+.+.||+|++|.||.+.. +++.+++|.+... .....+.+|+..++.++|||++++.+++... ..++++
T Consensus 5 ~~~~~~~~~lg~g~~g~v~~~~~-~~~~~~iK~~~~~----~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~--~~~~v~ 77 (254)
T cd05083 5 LQKLTLGEIIGEGEFGAVLQGEY-TGQKVAVKNIKCD----VTAQAFLEETAVMTKLHHKNLVRLLGVILHN--GLYIVM 77 (254)
T ss_pred HHHceeeeeeccCCCCceEeccc-CCCceEEEeecCc----chHHHHHHHHHHHHhCCCCCcCeEEEEEcCC--CcEEEE
Confidence 46799999999999999999875 5778999998642 2345788999999999999999999976543 358999
Q ss_pred eecCCCChHHHhcCCCCCCCCCChhhHHHHHHHHHHHHHHhhcCCCCCeeeecccCCceeeCCCCcEEEeeecccccccc
Q 038766 91 EYMENGSLESVIHGPGVDHSRWTLPKRIDVLISVANGLDYLHSGYDIPIVHCDMKPSNILLDRDFEAHVSDFGTSRMLDV 170 (299)
Q Consensus 91 e~~~~~~L~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lh~~~~~~~~H~dl~~~nil~~~~~~v~l~df~~~~~~~~ 170 (299)
||+.+++|.+++... ....+++..++.++.|++.||.+||+. +++|+||+|+||+++.++.++|+|||++.....
T Consensus 78 e~~~~~~L~~~l~~~--~~~~~~~~~~~~~~~qi~~al~~lH~~---~~~H~dl~p~nili~~~~~~kl~Dfg~~~~~~~ 152 (254)
T cd05083 78 ELMSKGNLVNFLRTR--GRALVSVIQLLQFSLDVAEGMEYLESK---KLVHRDLAARNILVSEDGVAKVSDFGLARVGSM 152 (254)
T ss_pred ECCCCCCHHHHHHhc--CcCCCCHHHHHHHHHHHHHHHHHHHhC---CeeccccCcceEEEcCCCcEEECCCccceeccc
Confidence 999999999998643 234688999999999999999999998 999999999999999999999999998864321
Q ss_pred ccccccccccccccCcccCChhhhcccCcCccccchhhhHHHHHHHh-CCCCCCCCccCCCCchhHHHHHHHHHhcCccC
Q 038766 171 HLQDLSSLSTAFQGTIGYLAPEFAYMRIVTTKVDVFSFGIVVMEFLT-KRRPTGLDEENGLSPISLRQLVEKALANGING 249 (299)
Q Consensus 171 ~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~DiwslG~~l~~l~~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 249 (299)
.......+..|+|||.+.+..++.++|+||||+++|+|++ |..||.... .......+. .+. .
T Consensus 153 -------~~~~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~~l~el~~~g~~p~~~~~-----~~~~~~~~~----~~~-~ 215 (254)
T cd05083 153 -------GVDNSKLPVKWTAPEALKHKKFSSKSDVWSYGVLLWEVFSYGRAPYPKMS-----LKEVKECVE----KGY-R 215 (254)
T ss_pred -------cCCCCCCCceecCHHHhccCCcCchhhHHHHHHHHHHHHhCCCCCCccCC-----HHHHHHHHh----CCC-C
Confidence 1112233567999999988889999999999999999997 888885331 112222111 110 0
Q ss_pred cccccCccccchhhHhHHHHHHHHHHHHHHHHhcCCCCCCCCChhhhhc
Q 038766 250 VRQITDPKLVSSIYEEQEQHQVLEELFKLALVCTSSNPEDRPNMNELLI 298 (299)
Q Consensus 250 ~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rpt~~~il~ 298 (299)
... ...++..+.+++.+||+.+|++|||+.++++
T Consensus 216 ---~~~------------~~~~~~~~~~li~~~l~~~p~~Rp~~~~l~~ 249 (254)
T cd05083 216 ---MEP------------PEGCPADVYVLMTSCWETEPKKRPSFHKLRE 249 (254)
T ss_pred ---CCC------------CCcCCHHHHHHHHHHcCCChhhCcCHHHHHH
Confidence 000 1234567899999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Csk homologous kinase (Chk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. Chk is also referred to as megakaryocyte-associated tyrosine kinase (Matk). To inhibit Src kinases, Chk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Chk inhibit Src ki |
| >cd07840 STKc_CDK9_like Catalytic domain of Cyclin-Dependent protein Kinase 9-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.3e-39 Score=269.37 Aligned_cols=272 Identities=24% Similarity=0.305 Sum_probs=199.6
Q ss_pred CCCCceeecCCcceEEEEEeC-CCcEEEEEEeccCcCChhhhHHHHHHHHHHHhcCCcceeeeeeEEEcC-CCeeEEEEe
Q 038766 14 FSENNIIGNSNLSTVYKGRLE-DGEIVAVKKLNFHQFSAESDKSFYREAKTLKELKHRNLVKVLGYAWES-GKLKALILE 91 (299)
Q Consensus 14 y~~~~~lg~g~~~~v~~~~~~-~~~~~~vK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~-~~~~~lv~e 91 (299)
|.+.+.||+|++|.||++.+. +++.+++|++............+.+|+..++.+.|+|++++++++... ....++|+|
T Consensus 1 y~~~~~l~~g~~~~vy~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~lv~e 80 (287)
T cd07840 1 YEKIAQIGEGTYGQVYKARNKKTGELVALKKIRMENEKEGFPITAIREIKLLQKLRHPNIVRLKEIVTSKGKGSIYMVFE 80 (287)
T ss_pred CeeeEEeccCCCeEEEEEEECCCCeEEEEEEEecccccccchHHHHHHHHHHHhccCCCeeeheeeEecCCCCcEEEEec
Confidence 678899999999999999875 488999999986543444456788899999999999999999977765 256799999
Q ss_pred ecCCCChHHHhcCCCCCCCCCChhhHHHHHHHHHHHHHHhhcCCCCCeeeecccCCceeeCCCCcEEEeeeccccccccc
Q 038766 92 YMENGSLESVIHGPGVDHSRWTLPKRIDVLISVANGLDYLHSGYDIPIVHCDMKPSNILLDRDFEAHVSDFGTSRMLDVH 171 (299)
Q Consensus 92 ~~~~~~L~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lh~~~~~~~~H~dl~~~nil~~~~~~v~l~df~~~~~~~~~ 171 (299)
|+.+ +|.+++... ...+++..++.++.|++.||++||+. +++|+||+|+||+++.++.++|+|||.+......
T Consensus 81 ~~~~-~l~~~~~~~---~~~~~~~~~~~i~~~i~~al~~LH~~---~~~h~dl~p~nil~~~~~~~~l~d~g~~~~~~~~ 153 (287)
T cd07840 81 YMDH-DLTGLLDSP---EVKFTESQIKCYMKQLLEGLQYLHSN---GILHRDIKGSNILINNDGVLKLADFGLARPYTKR 153 (287)
T ss_pred cccc-cHHHHHhcc---CCCCCHHHHHHHHHHHHHHHHHHHHC---CceeccCcHHHeEEcCCCCEEEccccceeeccCC
Confidence 9965 888888632 25789999999999999999999999 9999999999999999999999999998765422
Q ss_pred cccccccccccccCcccCChhhhcc-cCcCccccchhhhHHHHHHHhCCCCCCCCccCCCCchhHHHHHHHHHhcCccCc
Q 038766 172 LQDLSSLSTAFQGTIGYLAPEFAYM-RIVTTKVDVFSFGIVVMEFLTKRRPTGLDEENGLSPISLRQLVEKALANGINGV 250 (299)
Q Consensus 172 ~~~~~~~~~~~~~~~~y~~PE~~~~-~~~~~~~DiwslG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 250 (299)
.. .......++..|+|||.+.+ ..++.++||||||+++++|++|..||...... ..+...............
T Consensus 154 ~~---~~~~~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~~l~el~t~~~p~~~~~~~----~~~~~~~~~~~~~~~~~~ 226 (287)
T cd07840 154 NS---ADYTNRVITLWYRPPELLLGATRYGPEVDMWSVGCILAELFLGKPIFQGSTEL----EQLEKIFELCGSPTDENW 226 (287)
T ss_pred Cc---ccccccccccccCCceeeEccccCChHHHHHHHHHHHHHHHhCCCCCCCCChH----HHHHHHHHHhCCCchhhc
Confidence 11 11223345778999997765 45788999999999999999999998543211 111111111000000000
Q ss_pred ccccC---------ccccchhhHhHHHHHHHHHHHHHHHHhcCCCCCCCCChhhhhcC
Q 038766 251 RQITD---------PKLVSSIYEEQEQHQVLEELFKLALVCTSSNPEDRPNMNELLIT 299 (299)
Q Consensus 251 ~~~~~---------~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rpt~~~il~~ 299 (299)
..... ...............++..+.+++++||..+|++|||++++++|
T Consensus 227 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rp~~~~~l~~ 284 (287)
T cd07840 227 PGVSKLPWFENLKPKKPYKRRLREFFKHLIDPSALDLLDKLLTLDPKKRISADQALQH 284 (287)
T ss_pred cccccchhhhhccccccchhHHHHHhcccCCHHHHHHHHHHcCCChhhCcCHHHHhhC
Confidence 00000 00000111111112237789999999999999999999999986
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK9 and CDK12 from higher eukaryotes, yeast BUR1, C-type plant CDKs (CdkC), and similar proteins. CDK9, BUR1, and CdkC are functionally equivalent. They act as a kinase for the C-terminal domain of RNA po |
| >cd05066 PTKc_EphR_A Catalytic domain of the Protein Tyrosine Kinases, Class EphA Ephrin Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.1e-39 Score=268.68 Aligned_cols=254 Identities=27% Similarity=0.454 Sum_probs=195.0
Q ss_pred hCCCCCCceeecCCcceEEEEEeC-C---CcEEEEEEeccCcCChhhhHHHHHHHHHHHhcCCcceeeeeeEEEcCCCee
Q 038766 11 TGSFSENNIIGNSNLSTVYKGRLE-D---GEIVAVKKLNFHQFSAESDKSFYREAKTLKELKHRNLVKVLGYAWESGKLK 86 (299)
Q Consensus 11 ~~~y~~~~~lg~g~~~~v~~~~~~-~---~~~~~vK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~ 86 (299)
.++|++.+.||+|+||.||++.+. + +..+++|.+... ........+.+|+..++.++||||+++++++.. +...
T Consensus 3 ~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~ik~~~~~-~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~-~~~~ 80 (267)
T cd05066 3 ASCIKIEKVIGAGEFGEVCSGRLKLPGKREIPVAIKTLKAG-YTEKQRRDFLSEASIMGQFDHPNIIHLEGVVTK-SKPV 80 (267)
T ss_pred HHHeEeeeeecccCCCceEEEEEecCCCCceEEEEEECCCC-CCHHHHHHHHHHHHHHHhCCCCCcceEEEEEec-CCcc
Confidence 467899999999999999999763 2 347999988643 234456788999999999999999999997654 5566
Q ss_pred EEEEeecCCCChHHHhcCCCCCCCCCChhhHHHHHHHHHHHHHHhhcCCCCCeeeecccCCceeeCCCCcEEEeeecccc
Q 038766 87 ALILEYMENGSLESVIHGPGVDHSRWTLPKRIDVLISVANGLDYLHSGYDIPIVHCDMKPSNILLDRDFEAHVSDFGTSR 166 (299)
Q Consensus 87 ~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lh~~~~~~~~H~dl~~~nil~~~~~~v~l~df~~~~ 166 (299)
++|+||+++++|.+++... ...++..+++.++.|++.|+++||+. +++|+||+|+||+++.++.++|+|||++.
T Consensus 81 ~lv~e~~~~~~L~~~~~~~---~~~~~~~~~~~i~~~i~~~l~~lH~~---~i~h~dlkp~nili~~~~~~~l~dfg~~~ 154 (267)
T cd05066 81 MIVTEYMENGSLDAFLRKH---DGQFTVIQLVGMLRGIASGMKYLSDM---GYVHRDLAARNILVNSNLVCKVSDFGLSR 154 (267)
T ss_pred EEEEEcCCCCCHHHHHHhc---CCCCCHHHHHHHHHHHHHHHHHHHHC---CEeehhhchhcEEECCCCeEEeCCCCccc
Confidence 9999999999999998642 24688899999999999999999999 99999999999999999999999999987
Q ss_pred ccccccccccccccccccCcccCChhhhcccCcCccccchhhhHHHHHHHh-CCCCCCCCccCCCCchhHHHHHHHHHhc
Q 038766 167 MLDVHLQDLSSLSTAFQGTIGYLAPEFAYMRIVTTKVDVFSFGIVVMEFLT-KRRPTGLDEENGLSPISLRQLVEKALAN 245 (299)
Q Consensus 167 ~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~DiwslG~~l~~l~~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~ 245 (299)
......... ........+..|+|||.+.+..++.++|+||||+++|++++ |..||.... .......+. .
T Consensus 155 ~~~~~~~~~-~~~~~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~~l~ell~~g~~p~~~~~-----~~~~~~~~~----~ 224 (267)
T cd05066 155 VLEDDPEAA-YTTRGGKIPIRWTAPEAIAYRKFTSASDVWSYGIVMWEVMSYGERPYWEMS-----NQDVIKAIE----E 224 (267)
T ss_pred cccccccee-eecCCCccceeecCHhHhccCccCchhhhHHHHHHHHHHhcCCCCCcccCC-----HHHHHHHHh----C
Confidence 654211100 00111122457999999998889999999999999999886 999984321 111111111 1
Q ss_pred CccCcccccCccccchhhHhHHHHHHHHHHHHHHHHhcCCCCCCCCChhhhhc
Q 038766 246 GINGVRQITDPKLVSSIYEEQEQHQVLEELFKLALVCTSSNPEDRPNMNELLI 298 (299)
Q Consensus 246 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rpt~~~il~ 298 (299)
.. .... ....+..+.+++.+|++.+|.+|||+.++++
T Consensus 225 ~~----~~~~------------~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~ 261 (267)
T cd05066 225 GY----RLPA------------PMDCPAALHQLMLDCWQKDRNERPKFEQIVS 261 (267)
T ss_pred CC----cCCC------------CCCCCHHHHHHHHHHcccCchhCCCHHHHHH
Confidence 10 0000 1223567899999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; most class EphA receptors including EphA3, EphA4, EphA5, and EphA7, but excluding EphA1, EphA2 and EphA10; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. One exception is EphA4, which also binds ephrins-B2/B3. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellul |
| >cd05058 PTKc_Met_Ron Catalytic domain of the Protein Tyrosine Kinases, Met and Ron | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-39 Score=269.87 Aligned_cols=249 Identities=29% Similarity=0.439 Sum_probs=185.4
Q ss_pred ceeecCCcceEEEEEeC----CCcEEEEEEeccCcCChhhhHHHHHHHHHHHhcCCcceeeeeeEEEcCCCeeEEEEeec
Q 038766 18 NIIGNSNLSTVYKGRLE----DGEIVAVKKLNFHQFSAESDKSFYREAKTLKELKHRNLVKVLGYAWESGKLKALILEYM 93 (299)
Q Consensus 18 ~~lg~g~~~~v~~~~~~----~~~~~~vK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~lv~e~~ 93 (299)
+.||+|+||.||++.+. .+..+|+|.+.. .......+.+.+|...++.++|||++++++++...+...++++||+
T Consensus 1 ~~lg~g~~g~v~~~~~~~~~~~~~~~aiK~~~~-~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~lv~e~~ 79 (262)
T cd05058 1 RVIGKGHFGCVYHGTLIDSDGQKIHCAVKSLNR-ITDLEEVEQFLKEGIIMKDFSHPNVLSLLGICLPSEGSPLVVLPYM 79 (262)
T ss_pred CcccccCCceEEEEEEecCCCceEEEEEEecCc-cCCHHHHHHHHHHHHHHccCCCCCcceEEEEeecCCCCcEEEEecC
Confidence 46899999999999752 246799998752 2233445678889999999999999999997776566678999999
Q ss_pred CCCChHHHhcCCCCCCCCCChhhHHHHHHHHHHHHHHhhcCCCCCeeeecccCCceeeCCCCcEEEeeeccccccccccc
Q 038766 94 ENGSLESVIHGPGVDHSRWTLPKRIDVLISVANGLDYLHSGYDIPIVHCDMKPSNILLDRDFEAHVSDFGTSRMLDVHLQ 173 (299)
Q Consensus 94 ~~~~L~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lh~~~~~~~~H~dl~~~nil~~~~~~v~l~df~~~~~~~~~~~ 173 (299)
.+++|.+++... ....+...+..++.|+++||.|||+. +++|+||+|+||+++.++.++|+|||++........
T Consensus 80 ~~~~L~~~~~~~---~~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dlk~~nili~~~~~~kl~dfg~~~~~~~~~~ 153 (262)
T cd05058 80 KHGDLRNFIRSE---THNPTVKDLIGFGLQVAKGMEYLASK---KFVHRDLAARNCMLDESFTVKVADFGLARDIYDKEY 153 (262)
T ss_pred CCCCHHHHHHhc---CCCCCHHHHHHHHHHHHHHHHHHHhC---CccccccCcceEEEcCCCcEEECCccccccccCCcc
Confidence 999999998632 23456677889999999999999998 999999999999999999999999999875431110
Q ss_pred cccccccccccCcccCChhhhcccCcCccccchhhhHHHHHHHhCC-CCCCCCccCCCCchhHHHHHHHHHhcCccCccc
Q 038766 174 DLSSLSTAFQGTIGYLAPEFAYMRIVTTKVDVFSFGIVVMEFLTKR-RPTGLDEENGLSPISLRQLVEKALANGINGVRQ 252 (299)
Q Consensus 174 ~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~DiwslG~~l~~l~~g~-~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 252 (299)
..........++..|+|||.+....++.++||||||+++|+|++|. +||... ....... .... + ..
T Consensus 154 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~~~~~~~~~-----~~~~~~~---~~~~-~----~~ 220 (262)
T cd05058 154 YSVHNHTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDV-----DSFDITV---YLLQ-G----RR 220 (262)
T ss_pred eeecccccCcCCccccChhHhccCccchHHHHHHHHHHHHHHHcCCCCCCCCC-----CHHHHHH---HHhc-C----CC
Confidence 0011112233466899999998888999999999999999999965 444321 1111111 1111 0 00
Q ss_pred ccCccccchhhHhHHHHHHHHHHHHHHHHhcCCCCCCCCChhhhhc
Q 038766 253 ITDPKLVSSIYEEQEQHQVLEELFKLALVCTSSNPEDRPNMNELLI 298 (299)
Q Consensus 253 ~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rpt~~~il~ 298 (299)
... +...+..+.+++.+||..+|++|||+.++++
T Consensus 221 ~~~------------~~~~~~~~~~li~~cl~~~p~~Rp~~~~il~ 254 (262)
T cd05058 221 LLQ------------PEYCPDPLYEVMLSCWHPKPEMRPTFSELVS 254 (262)
T ss_pred CCC------------CCcCCHHHHHHHHHHcCCChhhCCCHHHHHH
Confidence 000 1123457899999999999999999999985
|
Protein Tyrosine Kinase (PTK) family; Met and Ron; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Met and Ron are receptor tyr kinases (RTKs) composed of an alpha-beta heterodimer. The extracellular alpha chain is disulfide linked to the beta chain, which contains an extracellular ligand-binding region with a sema domain, a PSI domain and four IPT repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Met binds to the ligand, hepatocyte growth factor/scatter factor (HGF/SF), and is also ca |
| >cd06648 STKc_PAK_II Catalytic domain of the Protein Serine/Threonine Kinase, Group II p21-activated kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.8e-39 Score=269.54 Aligned_cols=249 Identities=24% Similarity=0.363 Sum_probs=196.8
Q ss_pred CCCCCceeecCCcceEEEEEe-CCCcEEEEEEeccCcCChhhhHHHHHHHHHHHhcCCcceeeeeeEEEcCCCeeEEEEe
Q 038766 13 SFSENNIIGNSNLSTVYKGRL-EDGEIVAVKKLNFHQFSAESDKSFYREAKTLKELKHRNLVKVLGYAWESGKLKALILE 91 (299)
Q Consensus 13 ~y~~~~~lg~g~~~~v~~~~~-~~~~~~~vK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~lv~e 91 (299)
.|...+.||+|++|.||++.+ .+++.+++|++... .....+.+.+|+.+++.+.|+|++++++.+.. +...++++|
T Consensus 20 ~~~~~~~lg~g~~g~v~~~~~~~~~~~~~iK~~~~~--~~~~~~~~~~e~~~l~~~~h~~vv~~~~~~~~-~~~~~~v~e 96 (285)
T cd06648 20 YLDNFVKIGEGSTGIVCIATDKSTGRQVAVKKMDLR--KQQRRELLFNEVVIMRDYQHPNIVEMYSSYLV-GDELWVVME 96 (285)
T ss_pred hhhcceEeccCCCeEEEEEEECCCCCEEEEEEEecc--chhHHHHHHHHHHHHHHcCCCChheEEEEEEc-CCeEEEEEe
Confidence 566778999999999999986 46889999988532 33345668899999999999999999996655 556699999
Q ss_pred ecCCCChHHHhcCCCCCCCCCChhhHHHHHHHHHHHHHHhhcCCCCCeeeecccCCceeeCCCCcEEEeeeccccccccc
Q 038766 92 YMENGSLESVIHGPGVDHSRWTLPKRIDVLISVANGLDYLHSGYDIPIVHCDMKPSNILLDRDFEAHVSDFGTSRMLDVH 171 (299)
Q Consensus 92 ~~~~~~L~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lh~~~~~~~~H~dl~~~nil~~~~~~v~l~df~~~~~~~~~ 171 (299)
|+.+++|.+++.. .++++..++.++.|++.||++||++ +++|+||+|+||+++.++.++|+|||.+......
T Consensus 97 ~~~~~~L~~~~~~-----~~~~~~~~~~~~~ql~~~l~~lH~~---~i~H~dl~p~Nil~~~~~~~~l~d~g~~~~~~~~ 168 (285)
T cd06648 97 FLEGGALTDIVTH-----TRMNEEQIATVCLAVLKALSFLHAQ---GVIHRDIKSDSILLTSDGRVKLSDFGFCAQVSKE 168 (285)
T ss_pred ccCCCCHHHHHHh-----CCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCChhhEEEcCCCcEEEcccccchhhccC
Confidence 9999999998863 4689999999999999999999999 9999999999999999999999999987654321
Q ss_pred cccccccccccccCcccCChhhhcccCcCccccchhhhHHHHHHHhCCCCCCCCccCCCCchhHHHHHHHHHhcCccCcc
Q 038766 172 LQDLSSLSTAFQGTIGYLAPEFAYMRIVTTKVDVFSFGIVVMEFLTKRRPTGLDEENGLSPISLRQLVEKALANGINGVR 251 (299)
Q Consensus 172 ~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~DiwslG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 251 (299)
........+++.|+|||...+..++.++|+||+|+++|+|++|..||.... . ...+..........
T Consensus 169 ----~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slGv~l~ell~g~~p~~~~~-----~---~~~~~~~~~~~~~~-- 234 (285)
T cd06648 169 ----VPRRKSLVGTPYWMAPEVISRLPYGTEVDIWSLGIMVIEMVDGEPPYFNEP-----P---LQAMKRIRDNLPPK-- 234 (285)
T ss_pred ----CcccccccCCccccCHHHhcCCCCCCcccHHHHHHHHHHHHhCCCCCcCCC-----H---HHHHHHHHhcCCCC--
Confidence 111223457889999999988889999999999999999999999985321 1 11111111110000
Q ss_pred cccCccccchhhHhHHHHHHHHHHHHHHHHhcCCCCCCCCChhhhhcC
Q 038766 252 QITDPKLVSSIYEEQEQHQVLEELFKLALVCTSSNPEDRPNMNELLIT 299 (299)
Q Consensus 252 ~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rpt~~~il~~ 299 (299)
... ...++..+.+++.+||..+|++|||++++++|
T Consensus 235 -~~~------------~~~~~~~l~~li~~~l~~~p~~Rpt~~~il~~ 269 (285)
T cd06648 235 -LKN------------LHKVSPRLRSFLDRMLVRDPAQRATAAELLNH 269 (285)
T ss_pred -Ccc------------cccCCHHHHHHHHHHcccChhhCcCHHHHccC
Confidence 000 12245679999999999999999999999986
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group II, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group II PAKs, also called non-conventional PAKs, include PAK4, PAK5, and PAK6. Group II PAKs contain PBD (p21-binding domain) and catalytic domains, but lack other motifs foun |
| >cd05041 PTKc_Fes_like Catalytic domain of Fes-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.4e-39 Score=264.33 Aligned_cols=246 Identities=29% Similarity=0.443 Sum_probs=190.7
Q ss_pred ceeecCCcceEEEEEeCCCcEEEEEEeccCcCChhhhHHHHHHHHHHHhcCCcceeeeeeEEEcCCCeeEEEEeecCCCC
Q 038766 18 NIIGNSNLSTVYKGRLEDGEIVAVKKLNFHQFSAESDKSFYREAKTLKELKHRNLVKVLGYAWESGKLKALILEYMENGS 97 (299)
Q Consensus 18 ~~lg~g~~~~v~~~~~~~~~~~~vK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~lv~e~~~~~~ 97 (299)
++||.|++|.||++.+.+++.+++|++..... ......+.+|+++++.+.|+||+++++++... ...++|+|++.+++
T Consensus 1 ~~lg~g~~g~v~~~~~~~~~~v~~K~~~~~~~-~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~-~~~~~v~e~~~~~~ 78 (251)
T cd05041 1 EKIGKGNFGDVYKGVLKGNTEVAVKTCRSTLP-PDLKRKFLQEAEILKQYDHPNIVKLIGVCVQK-QPIYIVMELVPGGS 78 (251)
T ss_pred CccccCCCceEEEEEEeCCCcEEEEeccccCC-HHHHHHHHHHHHHHHhCCCCCeEEEEEEEecC-CCeEEEEEcCCCCc
Confidence 47999999999999876699999998864432 24567788999999999999999999976654 45699999999999
Q ss_pred hHHHhcCCCCCCCCCChhhHHHHHHHHHHHHHHhhcCCCCCeeeecccCCceeeCCCCcEEEeeeccccccccccccccc
Q 038766 98 LESVIHGPGVDHSRWTLPKRIDVLISVANGLDYLHSGYDIPIVHCDMKPSNILLDRDFEAHVSDFGTSRMLDVHLQDLSS 177 (299)
Q Consensus 98 L~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lh~~~~~~~~H~dl~~~nil~~~~~~v~l~df~~~~~~~~~~~~~~~ 177 (299)
|.+++... ...+++..+..++.+++.+|++||++ +++|+||+|+||+++.++.++|+|||.+........ ..
T Consensus 79 l~~~l~~~---~~~~~~~~~~~~~~~~~~~l~~lH~~---~i~h~di~p~nili~~~~~~~l~d~g~~~~~~~~~~--~~ 150 (251)
T cd05041 79 LLTFLRKK---KNRLTVKKLLQMSLDAAAGMEYLESK---NCIHRDLAARNCLVGENNVLKISDFGMSREEEGGIY--TV 150 (251)
T ss_pred HHHHHHhc---CCCCCHHHHHHHHHHHHHHHHHHHhC---CEehhhcCcceEEEcCCCcEEEeeccccccccCCcc--ee
Confidence 99988532 24678889999999999999999999 999999999999999999999999999875431110 01
Q ss_pred cccccccCcccCChhhhcccCcCccccchhhhHHHHHHHh-CCCCCCCCccCCCCchhHHHHHHHHHhcCccCcccccCc
Q 038766 178 LSTAFQGTIGYLAPEFAYMRIVTTKVDVFSFGIVVMEFLT-KRRPTGLDEENGLSPISLRQLVEKALANGINGVRQITDP 256 (299)
Q Consensus 178 ~~~~~~~~~~y~~PE~~~~~~~~~~~DiwslG~~l~~l~~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 256 (299)
.......+..|+|||.+.+..++.++|+||||+++|+|++ |..||... ........+.. .. ....
T Consensus 151 ~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~i~~~l~t~~~~p~~~~-----~~~~~~~~~~~----~~----~~~~- 216 (251)
T cd05041 151 SDGLKQIPIKWTAPEALNYGRYTSESDVWSYGILLWETFSLGDTPYPGM-----SNQQTRERIES----GY----RMPA- 216 (251)
T ss_pred ccccCcceeccCChHhhccCCCCcchhHHHHHHHHHHHHhccCCCCccC-----CHHHHHHHHhc----CC----CCCC-
Confidence 1112223567999999988889999999999999999998 77777432 11111221111 00 0000
Q ss_pred cccchhhHhHHHHHHHHHHHHHHHHhcCCCCCCCCChhhhhc
Q 038766 257 KLVSSIYEEQEQHQVLEELFKLALVCTSSNPEDRPNMNELLI 298 (299)
Q Consensus 257 ~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rpt~~~il~ 298 (299)
+...+..+.+++.+||..+|++|||++++++
T Consensus 217 -----------~~~~~~~~~~li~~~l~~~p~~Rp~~~ell~ 247 (251)
T cd05041 217 -----------PQLCPEEIYRLMLQCWAYDPENRPSFSEIYN 247 (251)
T ss_pred -----------CccCCHHHHHHHHHHhccChhhCcCHHHHHH
Confidence 2234567999999999999999999999985
|
Protein Tyrosine Kinase (PTK) family; Fes subfamily; catalytic (c) domain. Fes subfamily members include Fes (or Fps), Fer, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr k |
| >cd06653 STKc_MEKK3_like_1 Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-38 Score=264.24 Aligned_cols=255 Identities=24% Similarity=0.314 Sum_probs=200.2
Q ss_pred CCCCCCceeecCCcceEEEEEeC-CCcEEEEEEeccCc---CChhhhHHHHHHHHHHHhcCCcceeeeeeEEEcC-CCee
Q 038766 12 GSFSENNIIGNSNLSTVYKGRLE-DGEIVAVKKLNFHQ---FSAESDKSFYREAKTLKELKHRNLVKVLGYAWES-GKLK 86 (299)
Q Consensus 12 ~~y~~~~~lg~g~~~~v~~~~~~-~~~~~~vK~~~~~~---~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~-~~~~ 86 (299)
++|++.+.||+|++|.||++.+. +++.+++|++.... ........+.+|+..++.++|+||+++++.+... +...
T Consensus 2 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~~~ei~~l~~l~h~~i~~~~~~~~~~~~~~~ 81 (264)
T cd06653 2 VNWRLGKLLGRGAFGEVYLCYDADTGRELAVKQVPFDPDSQETSKEVNALECEIQLLKNLRHDRIVQYYGCLRDPEEKKL 81 (264)
T ss_pred CceeeeeeEccCCCeEEEEEEEcCCCCEEEEEEEecCcccchhhHHHHHHHHHHHHHHHcCCCCcceEEEEEEcCCCCEE
Confidence 57999999999999999999864 58999999875432 1234456788999999999999999999976553 3556
Q ss_pred EEEEeecCCCChHHHhcCCCCCCCCCChhhHHHHHHHHHHHHHHhhcCCCCCeeeecccCCceeeCCCCcEEEeeecccc
Q 038766 87 ALILEYMENGSLESVIHGPGVDHSRWTLPKRIDVLISVANGLDYLHSGYDIPIVHCDMKPSNILLDRDFEAHVSDFGTSR 166 (299)
Q Consensus 87 ~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lh~~~~~~~~H~dl~~~nil~~~~~~v~l~df~~~~ 166 (299)
++++|++++++|.+.+. ....+++..+..++.|++.||.+||+. +++|+||+|+||+++.++.++|+|||++.
T Consensus 82 ~~v~e~~~~~~L~~~~~----~~~~l~~~~~~~~~~~i~~al~~LH~~---~i~H~dl~p~ni~i~~~~~~~l~dfg~~~ 154 (264)
T cd06653 82 SIFVEYMPGGSIKDQLK----AYGALTENVTRRYTRQILQGVSYLHSN---MIVHRDIKGANILRDSAGNVKLGDFGASK 154 (264)
T ss_pred EEEEEeCCCCcHHHHHH----HcCCCCHHHHHHHHHHHHHHHHHHHhC---CEecCCCCHHHEEEcCCCCEEECcccccc
Confidence 89999999999999886 344688999999999999999999999 99999999999999999999999999987
Q ss_pred ccccccccccccccccccCcccCChhhhcccCcCccccchhhhHHHHHHHhCCCCCCCCccCCCCchhHHHHHHHHHhcC
Q 038766 167 MLDVHLQDLSSLSTAFQGTIGYLAPEFAYMRIVTTKVDVFSFGIVVMEFLTKRRPTGLDEENGLSPISLRQLVEKALANG 246 (299)
Q Consensus 167 ~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~DiwslG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~ 246 (299)
........ ........++..|+|||.+.+..++.++|+||||+++++|++|..||.... ..... .+.....
T Consensus 155 ~~~~~~~~-~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~-------~~~~~-~~~~~~~ 225 (264)
T cd06653 155 RIQTICMS-GTGIKSVTGTPYWMSPEVISGEGYGRKADVWSVACTVVEMLTEKPPWAEYE-------AMAAI-FKIATQP 225 (264)
T ss_pred cccccccc-CccccccCCcccccCHhhhcCCCCCccccHHHHHHHHHHHHhCCCCCCccC-------HHHHH-HHHHcCC
Confidence 65421111 111123457888999999998889999999999999999999999985321 11111 1111111
Q ss_pred ccCcccccCccccchhhHhHHHHHHHHHHHHHHHHhcCCCCCCCCChhhhhcC
Q 038766 247 INGVRQITDPKLVSSIYEEQEQHQVLEELFKLALVCTSSNPEDRPNMNELLIT 299 (299)
Q Consensus 247 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rpt~~~il~~ 299 (299)
.. + ..+..+++.+.+++.+||. +|..|||+.+++.|
T Consensus 226 ~~-------~---------~~p~~~~~~~~~~i~~~l~-~~~~r~~~~~~~~~ 261 (264)
T cd06653 226 TK-------P---------MLPDGVSDACRDFLKQIFV-EEKRRPTAEFLLRH 261 (264)
T ss_pred CC-------C---------CCCcccCHHHHHHHHHHhc-CcccCccHHHHhcC
Confidence 00 0 0134456789999999999 57999999999987
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain, functionally uncharacterized subgroup 1. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MEKK3-like subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phospho |
| >cd07864 STKc_CDK12 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 12 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.2e-39 Score=271.17 Aligned_cols=277 Identities=22% Similarity=0.296 Sum_probs=201.9
Q ss_pred HHHhCCCCCCceeecCCcceEEEEEeC-CCcEEEEEEeccCcCChhhhHHHHHHHHHHHhcCCcceeeeeeEEEcCC---
Q 038766 8 ENATGSFSENNIIGNSNLSTVYKGRLE-DGEIVAVKKLNFHQFSAESDKSFYREAKTLKELKHRNLVKVLGYAWESG--- 83 (299)
Q Consensus 8 ~~~~~~y~~~~~lg~g~~~~v~~~~~~-~~~~~~vK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~--- 83 (299)
+...++|.+.+.||+|++|.||++.+. +|+.|++|++............+.+|+++++.++|||++++++++....
T Consensus 3 ~~~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~e~~~~~~l~h~~i~~~~~~~~~~~~~~ 82 (302)
T cd07864 3 KRCVDKFDIIGQIGEGTYGQVYKARDKDTGELVALKKVRLDNEKEGFPITAIREIKILRQLNHRNIVNLKEIVTDKQDAL 82 (302)
T ss_pred hhhhhhhheeeeecccCCEEEEEEEECCCCcEEEEEEEeecccccCchHHHHHHHHHHHhCCCCCeeeeeheecCcchhh
Confidence 567789999999999999999999875 5889999999765444445567788999999999999999999775433
Q ss_pred ------CeeEEEEeecCCCChHHHhcCCCCCCCCCChhhHHHHHHHHHHHHHHhhcCCCCCeeeecccCCceeeCCCCcE
Q 038766 84 ------KLKALILEYMENGSLESVIHGPGVDHSRWTLPKRIDVLISVANGLDYLHSGYDIPIVHCDMKPSNILLDRDFEA 157 (299)
Q Consensus 84 ------~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lh~~~~~~~~H~dl~~~nil~~~~~~v 157 (299)
...++|+||+++ ++...+.. ....+++..++.++.|++.||+|||+. +++|+||+|+||+++.++.+
T Consensus 83 ~~~~~~~~~~lv~e~~~~-~l~~~l~~---~~~~~~~~~~~~i~~qi~~aL~~LH~~---~i~H~dl~p~nili~~~~~~ 155 (302)
T cd07864 83 DFKKDKGAFYLVFEYMDH-DLMGLLES---GLVHFSEDHIKSFMKQLLEGLNYCHKK---NFLHRDIKCSNILLNNKGQI 155 (302)
T ss_pred hccccCCcEEEEEcccCc-cHHHHHhc---CCCCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHEEECCCCcE
Confidence 356999999965 77776652 234689999999999999999999999 99999999999999999999
Q ss_pred EEeeeccccccccccccccccccccccCcccCChhhhcc-cCcCccccchhhhHHHHHHHhCCCCCCCCccCCCCchhHH
Q 038766 158 HVSDFGTSRMLDVHLQDLSSLSTAFQGTIGYLAPEFAYM-RIVTTKVDVFSFGIVVMEFLTKRRPTGLDEENGLSPISLR 236 (299)
Q Consensus 158 ~l~df~~~~~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~-~~~~~~~DiwslG~~l~~l~~g~~p~~~~~~~~~~~~~~~ 236 (299)
+|+|||++........ ........+..|+|||.+.+ ...+.++|||||||++++|++|..||.... .....
T Consensus 156 kl~dfg~~~~~~~~~~---~~~~~~~~~~~y~~PE~~~~~~~~~~~~Di~slG~~~~el~~g~~~~~~~~-----~~~~~ 227 (302)
T cd07864 156 KLADFGLARLYNSEES---RPYTNKVITLWYRPPELLLGEERYGPAIDVWSCGCILGELFTKKPIFQANQ-----ELAQL 227 (302)
T ss_pred EeCcccccccccCCcc---cccccceeccCccChHHhcCCCCCCchhHHHHHHHHHHHHHhCCCCCCCCC-----hHHHH
Confidence 9999999876542111 11222334678999998765 346889999999999999999999985321 11111
Q ss_pred HHHHHHHhcCcc-CcccccCccc------cch--hhHhHHHHHHHHHHHHHHHHhcCCCCCCCCChhhhhcC
Q 038766 237 QLVEKALANGIN-GVRQITDPKL------VSS--IYEEQEQHQVLEELFKLALVCTSSNPEDRPNMNELLIT 299 (299)
Q Consensus 237 ~~~~~~~~~~~~-~~~~~~~~~~------~~~--~~~~~~~~~~~~~l~~li~~~l~~dP~~Rpt~~~il~~ 299 (299)
..+........+ ....+..... ... .........++..+.+++.+||..||++|||++++++|
T Consensus 228 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rp~~~~il~~ 299 (302)
T cd07864 228 ELISRLCGSPCPAVWPDVIKLPYFNTMKPKKQYRRRLREEFSFIPTPALDLLDHMLTLDPSKRCTAEEALNS 299 (302)
T ss_pred HHHHHHhCCCChhhcccccccccccccccccccccchhhhcCCCCHHHHHHHHHHccCChhhCCCHHHHhcC
Confidence 111111111100 0000000000 000 00001122346789999999999999999999999986
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 12 (CDK12) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK12 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK12 is also called Cdc2-related protein kinase 7 (CRK7) or Cdc2-related kinase arginine/serine-rich (CrkRS). It is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 is widely |
| >cd05112 PTKc_Itk Catalytic domain of the Protein Tyrosine Kinase, Interleukin-2-inducible T-cell Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.4e-39 Score=266.77 Aligned_cols=250 Identities=25% Similarity=0.432 Sum_probs=194.8
Q ss_pred hCCCCCCceeecCCcceEEEEEeCCCcEEEEEEeccCcCChhhhHHHHHHHHHHHhcCCcceeeeeeEEEcCCCeeEEEE
Q 038766 11 TGSFSENNIIGNSNLSTVYKGRLEDGEIVAVKKLNFHQFSAESDKSFYREAKTLKELKHRNLVKVLGYAWESGKLKALIL 90 (299)
Q Consensus 11 ~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~vK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~lv~ 90 (299)
.++|++.+.||+|++|.||++.+.++..+++|.+..... ....+.+|++.++.+.||+++++++.+.. +...++|+
T Consensus 3 ~~~~~~~~~ig~g~~g~v~~~~~~~~~~~~~k~~~~~~~---~~~~~~~e~~~l~~l~~~~i~~~~~~~~~-~~~~~~v~ 78 (256)
T cd05112 3 PSELTLVQEIGSGQFGLVWLGYWLEKRKVAIKTIREGAM---SEEDFIEEAQVMMKLSHPKLVQLYGVCTE-RSPICLVF 78 (256)
T ss_pred hhHeEEEeeecCcccceEEEEEEeCCCeEEEEECCCCCC---CHHHHHHHHHHHHhCCCCCeeeEEEEEcc-CCceEEEE
Confidence 457889999999999999999887788999998864332 34567889999999999999999996655 44569999
Q ss_pred eecCCCChHHHhcCCCCCCCCCChhhHHHHHHHHHHHHHHhhcCCCCCeeeecccCCceeeCCCCcEEEeeecccccccc
Q 038766 91 EYMENGSLESVIHGPGVDHSRWTLPKRIDVLISVANGLDYLHSGYDIPIVHCDMKPSNILLDRDFEAHVSDFGTSRMLDV 170 (299)
Q Consensus 91 e~~~~~~L~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lh~~~~~~~~H~dl~~~nil~~~~~~v~l~df~~~~~~~~ 170 (299)
||+.+++|.+.+... ...+++..++.++.|++.++++||+. +++|+||+|+||+++.++.++|+|||.+.....
T Consensus 79 e~~~~~~L~~~~~~~---~~~~~~~~~~~~~~~l~~~l~~lH~~---~i~h~dl~p~ni~i~~~~~~~l~d~g~~~~~~~ 152 (256)
T cd05112 79 EFMEHGCLSDYLRAQ---RGKFSQETLLGMCLDVCEGMAYLESS---NVIHRDLAARNCLVGENQVVKVSDFGMTRFVLD 152 (256)
T ss_pred EcCCCCcHHHHHHhC---ccCCCHHHHHHHHHHHHHHHHHHHHC---CccccccccceEEEcCCCeEEECCCcceeeccc
Confidence 999999999888632 24678899999999999999999999 999999999999999999999999998875431
Q ss_pred ccccccccccccccCcccCChhhhcccCcCccccchhhhHHHHHHHh-CCCCCCCCccCCCCchhHHHHHHHHHhcCccC
Q 038766 171 HLQDLSSLSTAFQGTIGYLAPEFAYMRIVTTKVDVFSFGIVVMEFLT-KRRPTGLDEENGLSPISLRQLVEKALANGING 249 (299)
Q Consensus 171 ~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~DiwslG~~l~~l~~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 249 (299)
. ..........+..|+|||.+.+..++.++|+||||+++|+|++ |..||.... .. ....... .+.
T Consensus 153 ~---~~~~~~~~~~~~~~~aPe~~~~~~~~~~~Dv~slG~~l~el~~~g~~p~~~~~-----~~---~~~~~~~-~~~-- 218 (256)
T cd05112 153 D---QYTSSTGTKFPVKWSSPEVFSFSKYSSKSDVWSFGVLMWEVFSEGKTPYENRS-----NS---EVVETIN-AGF-- 218 (256)
T ss_pred C---cccccCCCccchhhcCHhHhccCCcChHHHHHHHHHHHHHHHcCCCCCCCcCC-----HH---HHHHHHh-CCC--
Confidence 1 1111122234568999999998889999999999999999998 888884321 11 1111111 110
Q ss_pred cccccCccccchhhHhHHHHHHHHHHHHHHHHhcCCCCCCCCChhhhhc
Q 038766 250 VRQITDPKLVSSIYEEQEQHQVLEELFKLALVCTSSNPEDRPNMNELLI 298 (299)
Q Consensus 250 ~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rpt~~~il~ 298 (299)
.... +...+..+.+++.+||+.+|++|||+.++++
T Consensus 219 --~~~~------------~~~~~~~~~~l~~~~l~~~p~~Rp~~~~~l~ 253 (256)
T cd05112 219 --RLYK------------PRLASQSVYELMQHCWKERPEDRPSFSLLLH 253 (256)
T ss_pred --CCCC------------CCCCCHHHHHHHHHHcccChhhCCCHHHHHH
Confidence 0001 1112457999999999999999999999986
|
Protein Tyrosine Kinase (PTK) family; Interleukin-2 (IL-2)-inducible T-cell kinase (Itk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Itk (also known as Tsk or Emt) is a member of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activ |
| >cd06641 STKc_MST3 Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.8e-39 Score=267.40 Aligned_cols=249 Identities=24% Similarity=0.374 Sum_probs=197.5
Q ss_pred CCCCCCceeecCCcceEEEEEe-CCCcEEEEEEeccCcCChhhhHHHHHHHHHHHhcCCcceeeeeeEEEcCCCeeEEEE
Q 038766 12 GSFSENNIIGNSNLSTVYKGRL-EDGEIVAVKKLNFHQFSAESDKSFYREAKTLKELKHRNLVKVLGYAWESGKLKALIL 90 (299)
Q Consensus 12 ~~y~~~~~lg~g~~~~v~~~~~-~~~~~~~vK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~lv~ 90 (299)
+-|...+.||+|++|.||++.+ .++..+|+|++.... .......+.+|+..+++++||||+++++.+.. +...++|+
T Consensus 4 ~~~~~~~~ig~G~~~~vy~~~~~~~~~~~aiK~~~~~~-~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~-~~~~~lv~ 81 (277)
T cd06641 4 ELFTKLEKIGKGSFGEVFKGIDNRTQKVVAIKIIDLEE-AEDEIEDIQQEITVLSQCDSPYVTKYYGSYLK-DTKLWIIM 81 (277)
T ss_pred HhhhhheeEeecCCeEEEEEEECCCCcEEEEEEecccc-chHHHHHHHHHHHHHHhcCCCCEeEEEEEEEe-CCeEEEEE
Confidence 4477889999999999999976 468899999876433 23445678899999999999999999996655 55679999
Q ss_pred eecCCCChHHHhcCCCCCCCCCChhhHHHHHHHHHHHHHHhhcCCCCCeeeecccCCceeeCCCCcEEEeeecccccccc
Q 038766 91 EYMENGSLESVIHGPGVDHSRWTLPKRIDVLISVANGLDYLHSGYDIPIVHCDMKPSNILLDRDFEAHVSDFGTSRMLDV 170 (299)
Q Consensus 91 e~~~~~~L~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lh~~~~~~~~H~dl~~~nil~~~~~~v~l~df~~~~~~~~ 170 (299)
||+.+++|..++. ...+++..+..++.|++.++.+||+. +++|+||+|+||+++.++.++|+|||++.....
T Consensus 82 e~~~~~~l~~~i~-----~~~~~~~~~~~~~~~l~~~l~~lh~~---~i~h~dl~p~Ni~i~~~~~~~l~dfg~~~~~~~ 153 (277)
T cd06641 82 EYLGGGSALDLLE-----PGPLDETQIATILREILKGLDYLHSE---KKIHRDIKAANVLLSEHGEVKLADFGVAGQLTD 153 (277)
T ss_pred EeCCCCcHHHHHh-----cCCCCHHHHHHHHHHHHHHHHHHccC---CeecCCCCHHhEEECCCCCEEEeecccceeccc
Confidence 9999999999885 34688999999999999999999999 999999999999999999999999998865432
Q ss_pred ccccccccccccccCcccCChhhhcccCcCccccchhhhHHHHHHHhCCCCCCCCccCCCCchhHHHHHHHHHhcCccCc
Q 038766 171 HLQDLSSLSTAFQGTIGYLAPEFAYMRIVTTKVDVFSFGIVVMEFLTKRRPTGLDEENGLSPISLRQLVEKALANGINGV 250 (299)
Q Consensus 171 ~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~DiwslG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 250 (299)
. ........++..|+|||.+.....+.++|+||||+++++|++|..||... ........ ......+.
T Consensus 154 ~----~~~~~~~~~~~~y~~PE~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~-----~~~~~~~~---~~~~~~~~- 220 (277)
T cd06641 154 T----QIKRNTFVGTPFWMAPEVIKQSAYDSKADIWSLGITAIELAKGEPPHSEL-----HPMKVLFL---IPKNNPPT- 220 (277)
T ss_pred c----hhhhccccCCccccChhhhccCCCCchhhHHHHHHHHHHHHcCCCCCCcc-----chHHHHHH---HhcCCCCC-
Confidence 1 11122345678899999998888899999999999999999999998432 11111111 11111000
Q ss_pred ccccCccccchhhHhHHHHHHHHHHHHHHHHhcCCCCCCCCChhhhhcC
Q 038766 251 RQITDPKLVSSIYEEQEQHQVLEELFKLALVCTSSNPEDRPNMNELLIT 299 (299)
Q Consensus 251 ~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rpt~~~il~~ 299 (299)
....++.++.+++.+||..+|++||++.+++.|
T Consensus 221 ----------------~~~~~~~~~~~~i~~~l~~~p~~Rp~~~~~l~~ 253 (277)
T cd06641 221 ----------------LEGNYSKPLKEFVEACLNKEPSFRPTAKELLKH 253 (277)
T ss_pred ----------------CCcccCHHHHHHHHHHccCChhhCcCHHHHHhC
Confidence 022345678999999999999999999999986
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. It may also regulate paxillin and consequently, cell migration. MST3 is present in human placenta, where it plays an essential role in the oxidative stress-induced apoptosis of trophoblasts in normal spontaneous delivery. Dysregulation of trophoblast apoptosis may result in pregnancy complications such as preeclampsia and int |
| >cd06659 STKc_PAK6 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.1e-39 Score=271.95 Aligned_cols=249 Identities=24% Similarity=0.372 Sum_probs=195.1
Q ss_pred CCCCCceeecCCcceEEEEEeC-CCcEEEEEEeccCcCChhhhHHHHHHHHHHHhcCCcceeeeeeEEEcCCCeeEEEEe
Q 038766 13 SFSENNIIGNSNLSTVYKGRLE-DGEIVAVKKLNFHQFSAESDKSFYREAKTLKELKHRNLVKVLGYAWESGKLKALILE 91 (299)
Q Consensus 13 ~y~~~~~lg~g~~~~v~~~~~~-~~~~~~vK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~lv~e 91 (299)
-|.....||+|+||.||++.+. +++.+|+|++.... ....+.+.+|+..++.+.|||++++++.+.. +...++|+|
T Consensus 22 ~~~~~~~ig~g~~g~v~~~~~~~~~~~v~iK~~~~~~--~~~~~~~~~e~~~l~~l~hp~i~~~~~~~~~-~~~~~iv~e 98 (297)
T cd06659 22 LLENYIKIGEGSTGIVCIAREKHSGRQVAVKMMDLRK--QQRRELLFNEVVIMRDYQHQNVVEMYKSYLV-GEELWVLME 98 (297)
T ss_pred hHHhhhhcCCCCceeEEEEEEcCCCCEEEEEEEEecc--cchHHHHHHHHHHHHhCCCCchhhhhhheee-CCeEEEEEe
Confidence 3455668999999999999864 68999999986432 2345678899999999999999999996655 556699999
Q ss_pred ecCCCChHHHhcCCCCCCCCCChhhHHHHHHHHHHHHHHhhcCCCCCeeeecccCCceeeCCCCcEEEeeeccccccccc
Q 038766 92 YMENGSLESVIHGPGVDHSRWTLPKRIDVLISVANGLDYLHSGYDIPIVHCDMKPSNILLDRDFEAHVSDFGTSRMLDVH 171 (299)
Q Consensus 92 ~~~~~~L~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lh~~~~~~~~H~dl~~~nil~~~~~~v~l~df~~~~~~~~~ 171 (299)
|+++++|..++. ...+++..++.++.|++.||++||++ +++|+||+|+||+++.++.++|+|||++......
T Consensus 99 ~~~~~~L~~~~~-----~~~~~~~~~~~~~~qi~~~L~~LH~~---~ivH~dl~p~Nill~~~~~~kL~dfg~~~~~~~~ 170 (297)
T cd06659 99 FLQGGALTDIVS-----QTRLNEEQIATVCESVLQALCYLHSQ---GVIHRDIKSDSILLTLDGRVKLSDFGFCAQISKD 170 (297)
T ss_pred cCCCCCHHHHHh-----hcCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHeEEccCCcEEEeechhHhhcccc
Confidence 999999998874 34689999999999999999999999 9999999999999999999999999998654321
Q ss_pred cccccccccccccCcccCChhhhcccCcCccccchhhhHHHHHHHhCCCCCCCCccCCCCchhHHHHHHHHHhcCccCcc
Q 038766 172 LQDLSSLSTAFQGTIGYLAPEFAYMRIVTTKVDVFSFGIVVMEFLTKRRPTGLDEENGLSPISLRQLVEKALANGINGVR 251 (299)
Q Consensus 172 ~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~DiwslG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 251 (299)
........++..|+|||.+.+..++.++|+||+|+++++|++|..||..... . ..+...........
T Consensus 171 ----~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~g~~p~~~~~~-----~---~~~~~~~~~~~~~~- 237 (297)
T cd06659 171 ----VPKRKSLVGTPYWMAPEVISRTPYGTEVDIWSLGIMVIEMVDGEPPYFSDSP-----V---QAMKRLRDSPPPKL- 237 (297)
T ss_pred ----cccccceecCccccCHHHHccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCH-----H---HHHHHHhccCCCCc-
Confidence 1112334578899999999988899999999999999999999999853211 1 11111111000000
Q ss_pred cccCccccchhhHhHHHHHHHHHHHHHHHHhcCCCCCCCCChhhhhcC
Q 038766 252 QITDPKLVSSIYEEQEQHQVLEELFKLALVCTSSNPEDRPNMNELLIT 299 (299)
Q Consensus 252 ~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rpt~~~il~~ 299 (299)
. ....++..+.++|++||..+|++|||++++++|
T Consensus 238 --~------------~~~~~~~~l~~~i~~~l~~~P~~Rps~~~ll~~ 271 (297)
T cd06659 238 --K------------NAHKISPVLRDFLERMLTREPQERATAQELLDH 271 (297)
T ss_pred --c------------ccCCCCHHHHHHHHHHhcCCcccCcCHHHHhhC
Confidence 0 012234578899999999999999999999986
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 6, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK6 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK6 may play a role i |
| >cd07835 STKc_CDK1_like Catalytic domain of Cyclin-Dependent protein Kinase 1-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.1e-39 Score=270.21 Aligned_cols=270 Identities=26% Similarity=0.350 Sum_probs=197.6
Q ss_pred CCCCceeecCCcceEEEEEe-CCCcEEEEEEeccCcCChhhhHHHHHHHHHHHhcCCcceeeeeeEEEcCCCeeEEEEee
Q 038766 14 FSENNIIGNSNLSTVYKGRL-EDGEIVAVKKLNFHQFSAESDKSFYREAKTLKELKHRNLVKVLGYAWESGKLKALILEY 92 (299)
Q Consensus 14 y~~~~~lg~g~~~~v~~~~~-~~~~~~~vK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~lv~e~ 92 (299)
|.+.+.||.|++|.||++.+ .+|..||+|++............+.+|+..++.++|+|++++++++.. +...++++||
T Consensus 1 y~~~~~l~~g~~~~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~E~~~l~~l~~~~iv~~~~~~~~-~~~~~iv~e~ 79 (283)
T cd07835 1 YQKVEKIGEGTYGVVYKARDKLTGEIVALKKIRLETEDEGVPSTAIREISLLKELNHPNIVRLLDVVHS-ENKLYLVFEF 79 (283)
T ss_pred CchheEecCCCCeEEEEEEEcCCCCEEEEEEeecccccccchhHHHHHHHHHHhcCCCCccCHhheecc-CCeEEEEEec
Confidence 67889999999999999986 469999999987654444445677889999999999999999997655 5667999999
Q ss_pred cCCCChHHHhcCCCCCCCCCChhhHHHHHHHHHHHHHHhhcCCCCCeeeecccCCceeeCCCCcEEEeeecccccccccc
Q 038766 93 MENGSLESVIHGPGVDHSRWTLPKRIDVLISVANGLDYLHSGYDIPIVHCDMKPSNILLDRDFEAHVSDFGTSRMLDVHL 172 (299)
Q Consensus 93 ~~~~~L~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lh~~~~~~~~H~dl~~~nil~~~~~~v~l~df~~~~~~~~~~ 172 (299)
+. ++|.+++... ....+++..++.++.|++.||+|||+. +++|+||+|+||+++.++.++|+|||++......
T Consensus 80 ~~-~~l~~~~~~~--~~~~~~~~~~~~~~~~i~~~L~~lH~~---~~~H~dl~p~nil~~~~~~~~l~df~~~~~~~~~- 152 (283)
T cd07835 80 LD-LDLKKYMDSS--PLTGLDPPLIKSYLYQLLQGIAYCHSH---RVLHRDLKPQNLLIDREGALKLADFGLARAFGVP- 152 (283)
T ss_pred cC-cCHHHHHhhC--CCCCCCHHHHHHHHHHHHHHHHHHHHC---CeeCCCCCHHHEEEcCCCcEEEeecccccccCCC-
Confidence 95 5899888643 124689999999999999999999998 9999999999999999999999999998654311
Q ss_pred ccccccccccccCcccCChhhhccc-CcCccccchhhhHHHHHHHhCCCCCCCCccCCCCchhHHHHHHHHHhcC---cc
Q 038766 173 QDLSSLSTAFQGTIGYLAPEFAYMR-IVTTKVDVFSFGIVVMEFLTKRRPTGLDEENGLSPISLRQLVEKALANG---IN 248 (299)
Q Consensus 173 ~~~~~~~~~~~~~~~y~~PE~~~~~-~~~~~~DiwslG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~---~~ 248 (299)
........++..|+|||.+.+. .++.++|+||||+++|+|++|..||...... .............. +.
T Consensus 153 ---~~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~----~~~~~~~~~~~~~~~~~~~ 225 (283)
T cd07835 153 ---VRTYTHEVVTLWYRAPEILLGSRQYSTPVDIWSIGCIFAEMVNRRPLFPGDSEI----DQLFRIFRTLGTPDEDVWP 225 (283)
T ss_pred ---ccccCccccccCCCCCceeecCcccCcHHHHHHHHHHHHHHHhCCCCCCCCCHH----HHHHHHHHHhCCCChHHhh
Confidence 1111223457789999987664 4688999999999999999999998543211 01111111000000 00
Q ss_pred CcccccC-----ccccchhhHhHHHHHHHHHHHHHHHHhcCCCCCCCCChhhhhcC
Q 038766 249 GVRQITD-----PKLVSSIYEEQEQHQVLEELFKLALVCTSSNPEDRPNMNELLIT 299 (299)
Q Consensus 249 ~~~~~~~-----~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rpt~~~il~~ 299 (299)
......+ +..... ........++..+.++|.+||+.||++|||++++++|
T Consensus 226 ~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~il~~ 280 (283)
T cd07835 226 GVTSLPDYKPTFPKWARQ-DLSKVVPNLDEDGLDLLSKMLVYDPAKRISAKAALQH 280 (283)
T ss_pred hhhhchhhhhhccccccc-chhhhcCCCCHHHHHHHHHHhcCChhhCcCHHHHhcC
Confidence 0000000 000000 0011133455789999999999999999999999986
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes, plants, and yeasts, as well as CDK2 and CDK3. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyc |
| >cd05101 PTKc_FGFR2 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-39 Score=273.80 Aligned_cols=261 Identities=22% Similarity=0.340 Sum_probs=198.8
Q ss_pred HHHHHhCCCCCCceeecCCcceEEEEEeC--------CCcEEEEEEeccCcCChhhhHHHHHHHHHHHhc-CCcceeeee
Q 038766 6 EIENATGSFSENNIIGNSNLSTVYKGRLE--------DGEIVAVKKLNFHQFSAESDKSFYREAKTLKEL-KHRNLVKVL 76 (299)
Q Consensus 6 ~~~~~~~~y~~~~~lg~g~~~~v~~~~~~--------~~~~~~vK~~~~~~~~~~~~~~~~~e~~~l~~l-~h~~i~~~~ 76 (299)
.++...++|.+.+.||+|+||.||++.+. ++..+++|.+... ........+.+|+..++.+ +||||++++
T Consensus 9 ~~~~~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~v~iK~~~~~-~~~~~~~~~~~E~~~l~~l~~h~~i~~~~ 87 (304)
T cd05101 9 RWEFSRDKLTLGKPLGEGCFGQVVMAEALGIDKDKPKEAVTVAVKMLKDD-ATEKDLSDLVSEMEMMKMIGKHKNIINLL 87 (304)
T ss_pred cccccHHHeeecceeeccCCceEEEEEEeccCCCCCCcceeEEeeecccc-cchHHHHHHHHHHHHHHhhccCCCchhee
Confidence 45677889999999999999999999741 2457899987632 2344556788999999999 799999999
Q ss_pred eEEEcCCCeeEEEEeecCCCChHHHhcCCCC------------CCCCCChhhHHHHHHHHHHHHHHhhcCCCCCeeeecc
Q 038766 77 GYAWESGKLKALILEYMENGSLESVIHGPGV------------DHSRWTLPKRIDVLISVANGLDYLHSGYDIPIVHCDM 144 (299)
Q Consensus 77 ~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~------------~~~~~~~~~~~~i~~qi~~~l~~lh~~~~~~~~H~dl 144 (299)
+.+.. ....++++||+.+++|.+++..... ....++...+..++.|++.||+|||++ +++|+||
T Consensus 88 ~~~~~-~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~~---givH~dl 163 (304)
T cd05101 88 GACTQ-DGPLYVIVEYASKGNLREYLRARRPPGMEYSYDIARVPDEQMTFKDLVSCTYQVARGMEYLASQ---KCIHRDL 163 (304)
T ss_pred EEEec-CCceEEEEecCCCCcHHHHHHhcCCcccccccccccCCcccccHHHHHHHHHHHHHHHHHHHHC---Ceeeccc
Confidence 96655 4566999999999999998864211 124578888999999999999999999 9999999
Q ss_pred cCCceeeCCCCcEEEeeeccccccccccccccccccccccCcccCChhhhcccCcCccccchhhhHHHHHHHh-CCCCCC
Q 038766 145 KPSNILLDRDFEAHVSDFGTSRMLDVHLQDLSSLSTAFQGTIGYLAPEFAYMRIVTTKVDVFSFGIVVMEFLT-KRRPTG 223 (299)
Q Consensus 145 ~~~nil~~~~~~v~l~df~~~~~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~DiwslG~~l~~l~~-g~~p~~ 223 (299)
||+||+++.++.++|+|||++........ ........++..|+|||.+.+..++.++||||||+++|+|++ |..||.
T Consensus 164 kp~Nili~~~~~~kl~D~g~~~~~~~~~~--~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~ 241 (304)
T cd05101 164 AARNVLVTENNVMKIADFGLARDVNNIDY--YKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSPYP 241 (304)
T ss_pred ccceEEEcCCCcEEECCCccceecccccc--cccccCCCCCceeeCchhhccCCCCchhhHHHHHHHHHHHHcCCCCCcc
Confidence 99999999999999999999876542111 111122234567999999998889999999999999999998 677763
Q ss_pred CCccCCCCchhHHHHHHHHHhcCccCcccccCccccchhhHhHHHHHHHHHHHHHHHHhcCCCCCCCCChhhhhc
Q 038766 224 LDEENGLSPISLRQLVEKALANGINGVRQITDPKLVSSIYEEQEQHQVLEELFKLALVCTSSNPEDRPNMNELLI 298 (299)
Q Consensus 224 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rpt~~~il~ 298 (299)
.. . ..+......... . ... +...+..+.+++.+||..+|++|||+.++++
T Consensus 242 ~~-----~---~~~~~~~~~~~~-~----~~~------------~~~~~~~~~~li~~cl~~~p~~Rps~~e~l~ 291 (304)
T cd05101 242 GI-----P---VEELFKLLKEGH-R----MDK------------PANCTNELYMMMRDCWHAIPSHRPTFKQLVE 291 (304)
T ss_pred cC-----C---HHHHHHHHHcCC-c----CCC------------CCCCCHHHHHHHHHHcccChhhCCCHHHHHH
Confidence 22 1 122222211110 0 000 1133567899999999999999999999985
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 2 (FGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR2 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to |
| >cd07879 STKc_p38delta_MAPK13 Catalytic domain of the Serine/Threonine Kinase, p38delta Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.3e-39 Score=276.51 Aligned_cols=276 Identities=24% Similarity=0.276 Sum_probs=199.3
Q ss_pred CChHHHHHH----hCCCCCCceeecCCcceEEEEEeC-CCcEEEEEEeccCcCChhhhHHHHHHHHHHHhcCCcceeeee
Q 038766 2 FDRTEIENA----TGSFSENNIIGNSNLSTVYKGRLE-DGEIVAVKKLNFHQFSAESDKSFYREAKTLKELKHRNLVKVL 76 (299)
Q Consensus 2 ~~~~~~~~~----~~~y~~~~~lg~g~~~~v~~~~~~-~~~~~~vK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~ 76 (299)
|+.++.-.. .++|.+.+.||+|++|.||+|.+. +|+.+|+|++............+.+|+.+++.++|+||+++.
T Consensus 1 ~~~~~~~~~~~~~~~~y~~~~~ig~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~ 80 (342)
T cd07879 1 FYREEVNKTVWELPERYTSLKQVGSGAYGSVCSAIDKRTGEKVAIKKLSRPFQSEIFAKRAYRELTLLKHMQHENVIGLL 80 (342)
T ss_pred CchhhhhhhhhccccceEEEEEeeecCCeEEEEEEeCCCCcEEEEEEecCccccccchhHHHHHHHHHHhcCCCCccchh
Confidence 455555533 589999999999999999999864 689999999875433344456678999999999999999999
Q ss_pred eEEEcCC-----CeeEEEEeecCCCChHHHhcCCCCCCCCCChhhHHHHHHHHHHHHHHhhcCCCCCeeeecccCCceee
Q 038766 77 GYAWESG-----KLKALILEYMENGSLESVIHGPGVDHSRWTLPKRIDVLISVANGLDYLHSGYDIPIVHCDMKPSNILL 151 (299)
Q Consensus 77 ~~~~~~~-----~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lh~~~~~~~~H~dl~~~nil~ 151 (299)
+++.... ...++|+|++. .+|..... ..+++..++.++.|++.||+|||+. +++|+||+|+||++
T Consensus 81 ~~~~~~~~~~~~~~~~lv~e~~~-~~l~~~~~------~~~~~~~~~~~~~qi~~aL~~LH~~---~i~H~dlkp~NIll 150 (342)
T cd07879 81 DVFTSAVSGDEFQDFYLVMPYMQ-TDLQKIMG------HPLSEDKVQYLVYQMLCGLKYIHSA---GIIHRDLKPGNLAV 150 (342)
T ss_pred heecccccCCCCceEEEEecccc-cCHHHHHc------CCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCHHHEEE
Confidence 9765432 23589999995 47766652 3588999999999999999999999 99999999999999
Q ss_pred CCCCcEEEeeeccccccccccccccccccccccCcccCChhhhcc-cCcCccccchhhhHHHHHHHhCCCCCCCCccCCC
Q 038766 152 DRDFEAHVSDFGTSRMLDVHLQDLSSLSTAFQGTIGYLAPEFAYM-RIVTTKVDVFSFGIVVMEFLTKRRPTGLDEENGL 230 (299)
Q Consensus 152 ~~~~~v~l~df~~~~~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~-~~~~~~~DiwslG~~l~~l~~g~~p~~~~~~~~~ 230 (299)
+.++.++|+|||++..... ......++..|+|||.+.+ ..++.++|+||||+++|+|++|..||......
T Consensus 151 ~~~~~~kL~dfg~~~~~~~-------~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slGvil~el~~g~~pf~~~~~~-- 221 (342)
T cd07879 151 NEDCELKILDFGLARHADA-------EMTGYVVTRWYRAPEVILNWMHYNQTVDIWSVGCIMAEMLTGKTLFKGKDYL-- 221 (342)
T ss_pred CCCCCEEEeeCCCCcCCCC-------CCCCceeeecccChhhhcCccccCchHHHHHHHHHHHHHHhCCCCCCCCCHH--
Confidence 9999999999999864321 1223356778999998776 45788999999999999999999999643210
Q ss_pred CchhHHHHHHHHHhcCccCc-ccccC---------ccccchhhHhHHHHHHHHHHHHHHHHhcCCCCCCCCChhhhhcC
Q 038766 231 SPISLRQLVEKALANGINGV-RQITD---------PKLVSSIYEEQEQHQVLEELFKLALVCTSSNPEDRPNMNELLIT 299 (299)
Q Consensus 231 ~~~~~~~~~~~~~~~~~~~~-~~~~~---------~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rpt~~~il~~ 299 (299)
..+...+.. .....+.. ..... ................+..+.++|++||..||++|||+++++.|
T Consensus 222 --~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~R~~~~e~l~h 297 (342)
T cd07879 222 --DQLTQILKV-TGVPGPEFVQKLEDKAAKSYIKSLPKYPRKDFSTLFPKASPQAVDLLEKMLELDVDKRLTATEALEH 297 (342)
T ss_pred --HHHHHHHHh-cCCCCHHHHHHhcccchHHHHhhcCCcccchHHHHhcCCCHHHHHHHHHHcCCChhhCcCHHHHhcC
Confidence 011111110 00000000 00000 00000000001122355678999999999999999999999987
|
Serine/Threonine Kinases (STKs), p38delta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38delta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38delta, also called MAPK13 |
| >cd07877 STKc_p38alpha_MAPK14 Catalytic domain of the Serine/Threonine Kinase, p38alpha Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.5e-39 Score=275.79 Aligned_cols=273 Identities=23% Similarity=0.283 Sum_probs=199.5
Q ss_pred HHHHHHhCCCCCCceeecCCcceEEEEEe-CCCcEEEEEEeccCcCChhhhHHHHHHHHHHHhcCCcceeeeeeEEEcCC
Q 038766 5 TEIENATGSFSENNIIGNSNLSTVYKGRL-EDGEIVAVKKLNFHQFSAESDKSFYREAKTLKELKHRNLVKVLGYAWESG 83 (299)
Q Consensus 5 ~~~~~~~~~y~~~~~lg~g~~~~v~~~~~-~~~~~~~vK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~ 83 (299)
.++..+.++|.+.+.||+|++|.||++.+ .+++.||+|++..........+.+.+|+..+++++|+||+++.+++....
T Consensus 10 ~~~~~~~~~y~~~~~lg~G~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~Ei~~l~~l~h~~iv~~~~~~~~~~ 89 (345)
T cd07877 10 KTIWEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPAR 89 (345)
T ss_pred HHHhhccCceEEEEEeeecCCeEEEEEEEcCCCeEEEEEEecCcchhhHHHHHHHHHHHHHHHcCCCcccceeeeeeecc
Confidence 45566889999999999999999999986 46899999998754333444567888999999999999999999764322
Q ss_pred -----CeeEEEEeecCCCChHHHhcCCCCCCCCCChhhHHHHHHHHHHHHHHhhcCCCCCeeeecccCCceeeCCCCcEE
Q 038766 84 -----KLKALILEYMENGSLESVIHGPGVDHSRWTLPKRIDVLISVANGLDYLHSGYDIPIVHCDMKPSNILLDRDFEAH 158 (299)
Q Consensus 84 -----~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lh~~~~~~~~H~dl~~~nil~~~~~~v~ 158 (299)
...+++++++ +++|.++++ ...+++..++.++.|++.||+|||+. +++|+||+|+||+++.++.++
T Consensus 90 ~~~~~~~~~lv~~~~-~~~L~~~~~-----~~~l~~~~~~~i~~qi~~aL~~LH~~---~ivH~dlkp~NIll~~~~~~k 160 (345)
T cd07877 90 SLEEFNDVYLVTHLM-GADLNNIVK-----CQKLTDDHVQFLIYQILRGLKYIHSA---DIIHRDLKPSNLAVNEDCELK 160 (345)
T ss_pred cccccccEEEEehhc-ccCHHHHHh-----cCCCCHHHHHHHHHHHHHHHHHHHHC---CeeecCCChHHEEEcCCCCEE
Confidence 3357888887 779988885 34689999999999999999999999 999999999999999999999
Q ss_pred EeeeccccccccccccccccccccccCcccCChhhhcc-cCcCccccchhhhHHHHHHHhCCCCCCCCccCCCCchhHHH
Q 038766 159 VSDFGTSRMLDVHLQDLSSLSTAFQGTIGYLAPEFAYM-RIVTTKVDVFSFGIVVMEFLTKRRPTGLDEENGLSPISLRQ 237 (299)
Q Consensus 159 l~df~~~~~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~-~~~~~~~DiwslG~~l~~l~~g~~p~~~~~~~~~~~~~~~~ 237 (299)
|+|||++.... .......++..|+|||.+.+ ..++.++|||||||++|+|++|..||...... .....
T Consensus 161 l~dfg~~~~~~-------~~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslG~il~el~~g~~pf~~~~~~----~~~~~ 229 (345)
T cd07877 161 ILDFGLARHTD-------DEMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHI----DQLKL 229 (345)
T ss_pred Eeccccccccc-------ccccccccCCCccCHHHHhCccCCCchhhHHHHHHHHHHHHhCCCCCCCCCHH----HHHHH
Confidence 99999986533 11223456788999998766 46788999999999999999999998532111 11111
Q ss_pred HHHHHHhcCccC-cccccCc----------cccchhhHhHHHHHHHHHHHHHHHHhcCCCCCCCCChhhhhcC
Q 038766 238 LVEKALANGING-VRQITDP----------KLVSSIYEEQEQHQVLEELFKLALVCTSSNPEDRPNMNELLIT 299 (299)
Q Consensus 238 ~~~~~~~~~~~~-~~~~~~~----------~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rpt~~~il~~ 299 (299)
..... ...... ...+... ....... .......+.++.++|.+||..||.+|||+.+++.|
T Consensus 230 ~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~li~~~L~~dp~~R~t~~e~l~h 300 (345)
T cd07877 230 ILRLV-GTPGAELLKKISSESARNYIQSLTQMPKMNF-ANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAH 300 (345)
T ss_pred HHHHh-CCCCHHHHhhcccHhHHHHHHHhcccCCcch-hhhcCCCCHHHHHHHHHHcCCChhhcCCHHHHhcC
Confidence 11000 000000 0000000 0000000 00011235678999999999999999999999987
|
Serine/Threonine Kinases (STKs), p38alpha subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38alpha subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38alpha, also called MAPK14 |
| >cd05050 PTKc_Musk Catalytic domain of the Protein Tyrosine Kinase, Muscle-specific kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.1e-39 Score=270.92 Aligned_cols=257 Identities=26% Similarity=0.381 Sum_probs=195.2
Q ss_pred HhCCCCCCceeecCCcceEEEEEeC------CCcEEEEEEeccCcCChhhhHHHHHHHHHHHhcCCcceeeeeeEEEcCC
Q 038766 10 ATGSFSENNIIGNSNLSTVYKGRLE------DGEIVAVKKLNFHQFSAESDKSFYREAKTLKELKHRNLVKVLGYAWESG 83 (299)
Q Consensus 10 ~~~~y~~~~~lg~g~~~~v~~~~~~------~~~~~~vK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~ 83 (299)
..++|.+.+.||+|++|.||++.+. ++..+++|++... ........+.+|+..++.+.|||++++++++.. +
T Consensus 3 ~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~aiK~~~~~-~~~~~~~~~~~ei~~l~~l~h~~iv~~~~~~~~-~ 80 (288)
T cd05050 3 PRNNIEYVRDIGQGAFGRVFQARAPGLLPYEPFTMVAVKMLKEE-ASADMQADFQREAALMAEFDHPNIVKLLGVCAV-G 80 (288)
T ss_pred ChHhceecccccccccccEEEEEEcccCCCCcceeEEEEecCCC-cCHHHHHHHHHHHHHHHhcCCCchheEEEEEcC-C
Confidence 3578999999999999999999853 4678999988632 233445678899999999999999999996655 4
Q ss_pred CeeEEEEeecCCCChHHHhcCCC------------------CCCCCCChhhHHHHHHHHHHHHHHhhcCCCCCeeeeccc
Q 038766 84 KLKALILEYMENGSLESVIHGPG------------------VDHSRWTLPKRIDVLISVANGLDYLHSGYDIPIVHCDMK 145 (299)
Q Consensus 84 ~~~~lv~e~~~~~~L~~~~~~~~------------------~~~~~~~~~~~~~i~~qi~~~l~~lh~~~~~~~~H~dl~ 145 (299)
...++++||+.+++|.+++.... .....+++.+++.++.|++.||.+||++ +++|+||+
T Consensus 81 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~aL~~lH~~---~i~H~dl~ 157 (288)
T cd05050 81 KPMCLLFEYMAYGDLNEFLRHRSPRAQCSLSHSTSSARKCGLNPLPLSCTEQLCIAKQVAAGMAYLSER---KFVHRDLA 157 (288)
T ss_pred CccEEEEecCCCCCHHHHHHHcCccccccccccccccccccccccccCHHHHHHHHHHHHHHHHHHHhC---Ceeccccc
Confidence 55699999999999998885321 1223578889999999999999999999 99999999
Q ss_pred CCceeeCCCCcEEEeeeccccccccccccccccccccccCcccCChhhhcccCcCccccchhhhHHHHHHHh-CCCCCCC
Q 038766 146 PSNILLDRDFEAHVSDFGTSRMLDVHLQDLSSLSTAFQGTIGYLAPEFAYMRIVTTKVDVFSFGIVVMEFLT-KRRPTGL 224 (299)
Q Consensus 146 ~~nil~~~~~~v~l~df~~~~~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~DiwslG~~l~~l~~-g~~p~~~ 224 (299)
|+||+++.++.++|+|||.+....... ..........+..|+|||...+..++.++|+|||||++|+|++ |..||..
T Consensus 158 p~nil~~~~~~~~l~dfg~~~~~~~~~--~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~~~~~p~~~ 235 (288)
T cd05050 158 TRNCLVGENMVVKIADFGLSRNIYSAD--YYKASENDAIPIRWMPPESIFYNRYTTESDVWAYGVVLWEIFSYGMQPYYG 235 (288)
T ss_pred HhheEecCCCceEECccccceecccCc--cccccCCCccChhhcCHHHHhcCCCCchhHHHHHHHHHHHHHhCCCCCCCC
Confidence 999999999999999999886543110 0011112233567999999988889999999999999999997 7777742
Q ss_pred CccCCCCchhHHHHHHHHHhcCccCcccccCccccchhhHhHHHHHHHHHHHHHHHHhcCCCCCCCCChhhhhc
Q 038766 225 DEENGLSPISLRQLVEKALANGINGVRQITDPKLVSSIYEEQEQHQVLEELFKLALVCTSSNPEDRPNMNELLI 298 (299)
Q Consensus 225 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rpt~~~il~ 298 (299)
. ... +......... . .. .+...+..+.+++.+||+.+|++|||++|++.
T Consensus 236 ~-----~~~---~~~~~~~~~~---~--~~------------~~~~~~~~l~~li~~~l~~~p~~Rpt~~el~~ 284 (288)
T cd05050 236 M-----AHE---EVIYYVRDGN---V--LS------------CPDNCPLELYNLMRLCWSKLPSDRPSFASINR 284 (288)
T ss_pred C-----CHH---HHHHHHhcCC---C--CC------------CCCCCCHHHHHHHHHHcccCcccCCCHHHHHH
Confidence 2 111 1111111100 0 00 01223567999999999999999999999874
|
Protein Tyrosine Kinase (PTK) family; Muscle-specific kinase (Musk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Musk is a receptor tyr kinase (RTK) containing an extracellular region with four immunoglobulin-like domains and a cysteine-rich cluster, a transmembrane segment, and an intracellular catalytic domain. Musk is expressed and concentrated in the postsynaptic membrane in skeletal muscle. It is essential for the establishment of the neuromuscular junction (NMJ), a peripheral synapse that conveys signals from motor neurons to muscle cells. Agrin, a large proteoglycan released from motor neurons, stimulates M |
| >cd05100 PTKc_FGFR3 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.5e-39 Score=276.80 Aligned_cols=262 Identities=22% Similarity=0.331 Sum_probs=199.4
Q ss_pred HHHHHHhCCCCCCceeecCCcceEEEEEeC--------CCcEEEEEEeccCcCChhhhHHHHHHHHHHHhc-CCcceeee
Q 038766 5 TEIENATGSFSENNIIGNSNLSTVYKGRLE--------DGEIVAVKKLNFHQFSAESDKSFYREAKTLKEL-KHRNLVKV 75 (299)
Q Consensus 5 ~~~~~~~~~y~~~~~lg~g~~~~v~~~~~~--------~~~~~~vK~~~~~~~~~~~~~~~~~e~~~l~~l-~h~~i~~~ 75 (299)
.+++....+|.+.+.||+|+||.||+|.+. .+..+|+|++... ........+.+|++.++++ +|+||+++
T Consensus 5 ~~~~~~~~~~~i~~~ig~G~~g~v~~~~~~~~~~~~~~~~~~vaiK~~~~~-~~~~~~~~~~~E~~~l~~l~~h~~iv~~ 83 (334)
T cd05100 5 PKWELSRTRLTLGKPLGEGCFGQVVMAEAIGIDKDKPNKPVTVAVKMLKDD-ATDKDLSDLVSEMEMMKMIGKHKNIINL 83 (334)
T ss_pred cccccCHhHeeecceeccccCCcEEEEEEeccCCccCCcceeEEEEEcccc-cCHHHHHHHHHHHHHHHhhcCCCCeeee
Confidence 467788889999999999999999999742 1236899987632 2344567888999999999 79999999
Q ss_pred eeEEEcCCCeeEEEEeecCCCChHHHhcCCC------------CCCCCCChhhHHHHHHHHHHHHHHhhcCCCCCeeeec
Q 038766 76 LGYAWESGKLKALILEYMENGSLESVIHGPG------------VDHSRWTLPKRIDVLISVANGLDYLHSGYDIPIVHCD 143 (299)
Q Consensus 76 ~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~------------~~~~~~~~~~~~~i~~qi~~~l~~lh~~~~~~~~H~d 143 (299)
++.+... ...++++||+.+++|.+++.... .....++...+..++.|++.||+|||++ +++|+|
T Consensus 84 ~~~~~~~-~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~---givH~d 159 (334)
T cd05100 84 LGACTQD-GPLYVLVEYASKGNLREYLRARRPPGMDYSFDTCKLPEEQLTFKDLVSCAYQVARGMEYLASQ---KCIHRD 159 (334)
T ss_pred eEEEccC-CceEEEEecCCCCcHHHHHHhcCCcccccccccccCccccCCHHHHHHHHHHHHHHHHHHHHC---Ceeccc
Confidence 9977654 45699999999999999886421 1234577888899999999999999999 999999
Q ss_pred ccCCceeeCCCCcEEEeeeccccccccccccccccccccccCcccCChhhhcccCcCccccchhhhHHHHHHHh-CCCCC
Q 038766 144 MKPSNILLDRDFEAHVSDFGTSRMLDVHLQDLSSLSTAFQGTIGYLAPEFAYMRIVTTKVDVFSFGIVVMEFLT-KRRPT 222 (299)
Q Consensus 144 l~~~nil~~~~~~v~l~df~~~~~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~DiwslG~~l~~l~~-g~~p~ 222 (299)
|||+||+++.++.++|+|||++........ ........++..|+|||.+.+..++.++||||||+++|+|++ |..||
T Consensus 160 lkp~Nill~~~~~~kL~Dfg~~~~~~~~~~--~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~ 237 (334)
T cd05100 160 LAARNVLVTEDNVMKIADFGLARDVHNIDY--YKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLLWEIFTLGGSPY 237 (334)
T ss_pred cccceEEEcCCCcEEECCcccceecccccc--cccccCCCcCceEcCHHHhccCCcCchhhhHHHHHHHHHHHhcCCCCC
Confidence 999999999999999999999875432110 011112223467999999999999999999999999999998 77877
Q ss_pred CCCccCCCCchhHHHHHHHHHhcCccCcccccCccccchhhHhHHHHHHHHHHHHHHHHhcCCCCCCCCChhhhhc
Q 038766 223 GLDEENGLSPISLRQLVEKALANGINGVRQITDPKLVSSIYEEQEQHQVLEELFKLALVCTSSNPEDRPNMNELLI 298 (299)
Q Consensus 223 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rpt~~~il~ 298 (299)
.... . .+.......... ... +...+..+.+++.+||..+|++|||+.++++
T Consensus 238 ~~~~-----~---~~~~~~~~~~~~-----~~~------------~~~~~~~l~~li~~cl~~~p~~Rps~~ell~ 288 (334)
T cd05100 238 PGIP-----V---EELFKLLKEGHR-----MDK------------PANCTHELYMIMRECWHAVPSQRPTFKQLVE 288 (334)
T ss_pred CCCC-----H---HHHHHHHHcCCC-----CCC------------CCCCCHHHHHHHHHHcccChhhCcCHHHHHH
Confidence 4321 1 122211111000 000 1123457899999999999999999999986
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 3 (FGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR3 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to |
| >cd07831 STKc_MOK Catalytic domain of the Serine/Threonine Kinase, MAPK/MAK/MRK Overlapping Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-38 Score=266.13 Aligned_cols=266 Identities=22% Similarity=0.268 Sum_probs=192.7
Q ss_pred CCCCceeecCCcceEEEEEeC-CCcEEEEEEeccCcCChhhhHHHHHHHHHHHhcC-CcceeeeeeEEEcC-CCeeEEEE
Q 038766 14 FSENNIIGNSNLSTVYKGRLE-DGEIVAVKKLNFHQFSAESDKSFYREAKTLKELK-HRNLVKVLGYAWES-GKLKALIL 90 (299)
Q Consensus 14 y~~~~~lg~g~~~~v~~~~~~-~~~~~~vK~~~~~~~~~~~~~~~~~e~~~l~~l~-h~~i~~~~~~~~~~-~~~~~lv~ 90 (299)
|++.+.||+|++|.||++... +++.+|+|++....... .......|+..++++. |+|++++++++... .+..++|+
T Consensus 1 y~~~~~lg~g~~~~v~~~~~~~~~~~~aik~~~~~~~~~-~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~~~~~~~lv~ 79 (282)
T cd07831 1 YKILGKIGEGTFSEVLKAQSRKTGKYYAIKCMKKHFKSL-EQVNNLREIQALRRLSPHPNILRLIEVLFDRKTGRLALVF 79 (282)
T ss_pred CceEeeccccccceEEEEEEcCCCcEEEEEEehhccCCc-hhhhHHHHHHHHhhcCCCCCccceEEEEecCCCCcEEEEE
Confidence 678899999999999999864 58899999986433222 2334457888888886 99999999987764 15669999
Q ss_pred eecCCCChHHHhcCCCCCCCCCChhhHHHHHHHHHHHHHHhhcCCCCCeeeecccCCceeeCCCCcEEEeeecccccccc
Q 038766 91 EYMENGSLESVIHGPGVDHSRWTLPKRIDVLISVANGLDYLHSGYDIPIVHCDMKPSNILLDRDFEAHVSDFGTSRMLDV 170 (299)
Q Consensus 91 e~~~~~~L~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lh~~~~~~~~H~dl~~~nil~~~~~~v~l~df~~~~~~~~ 170 (299)
||+.+ +|.+.+.. ....+++..++.++.|++.||++||+. +++|+||+|+||+++. +.++|+|||++.....
T Consensus 80 e~~~~-~l~~~l~~---~~~~~~~~~~~~~~~qi~~~L~~LH~~---~i~H~dl~p~ni~l~~-~~~kl~dfg~~~~~~~ 151 (282)
T cd07831 80 ELMDM-NLYELIKG---RKRPLPEKRVKSYMYQLLKSLDHMHRN---GIFHRDIKPENILIKD-DILKLADFGSCRGIYS 151 (282)
T ss_pred ecCCc-cHHHHHHh---ccCCCCHHHHHHHHHHHHHHHHHHHHC---CceecccCHHHEEEcC-CCeEEEeccccccccc
Confidence 99964 88777753 235789999999999999999999999 9999999999999999 9999999999876532
Q ss_pred ccccccccccccccCcccCChhhhcc-cCcCccccchhhhHHHHHHHhCCCCCCCCccCCCCchhHHHHHHHHHhcCcc-
Q 038766 171 HLQDLSSLSTAFQGTIGYLAPEFAYM-RIVTTKVDVFSFGIVVMEFLTKRRPTGLDEENGLSPISLRQLVEKALANGIN- 248 (299)
Q Consensus 171 ~~~~~~~~~~~~~~~~~y~~PE~~~~-~~~~~~~DiwslG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~- 248 (299)
. .......++..|+|||.+.. ..++.++|+|||||++|+|++|..||..... ................
T Consensus 152 ~-----~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slGv~l~el~~~~~p~~~~~~-----~~~~~~~~~~~~~~~~~ 221 (282)
T cd07831 152 K-----PPYTEYISTRWYRAPECLLTDGYYGPKMDIWAVGCVFFEILSLFPLFPGTNE-----LDQIAKIHDVLGTPDAE 221 (282)
T ss_pred C-----CCcCCCCCCcccCChhHhhcCCCCCcchhHHHHHHHHHHHHcCCcCCCCCCH-----HHHHHHHHHHcCCCCHH
Confidence 1 11122346788999997654 5578899999999999999999999854321 1111111100000000
Q ss_pred --------CcccccCccccchhhHhHHHHHHHHHHHHHHHHhcCCCCCCCCChhhhhcC
Q 038766 249 --------GVRQITDPKLVSSIYEEQEQHQVLEELFKLALVCTSSNPEDRPNMNELLIT 299 (299)
Q Consensus 249 --------~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rpt~~~il~~ 299 (299)
.......+...... .......++.++.++|.+||..+|++|||++++++|
T Consensus 222 ~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~li~~~l~~~P~~R~~~~~~l~~ 279 (282)
T cd07831 222 VLKKFRKSRHMNYNFPSKKGTG-LRKLLPNASAEGLDLLKKLLAYDPDERITAKQALRH 279 (282)
T ss_pred HHHhhcccccccccCccccccc-HHHHcccccHHHHHHHHHHhccCcccccCHHHHhhC
Confidence 00011111111111 011133567899999999999999999999999987
|
Serine/Threonine Kinases (STKs), MAPK/MAK/MRK Overlapping Kinase (MOK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MOK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MOK, also called Renal tumor antigen 1 (RAGE-1), is widely expressed and is enriched in testis, kidney, lung, and brain. It is expressed in approximately 50% of renal cell carcinomas (RCC) and is a potential target for immunotherapy. MOK is stabilized by its association with the HSP90 molecular chaperone. It is induced by the transcription factor Cdx2 and may be involved in regulating intestinal epithelial development and differentiation. |
| >smart00219 TyrKc Tyrosine kinase, catalytic domain | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.9e-39 Score=264.05 Aligned_cols=250 Identities=29% Similarity=0.443 Sum_probs=193.9
Q ss_pred CCCCceeecCCcceEEEEEeCC-----CcEEEEEEeccCcCChhhhHHHHHHHHHHHhcCCcceeeeeeEEEcCCCeeEE
Q 038766 14 FSENNIIGNSNLSTVYKGRLED-----GEIVAVKKLNFHQFSAESDKSFYREAKTLKELKHRNLVKVLGYAWESGKLKAL 88 (299)
Q Consensus 14 y~~~~~lg~g~~~~v~~~~~~~-----~~~~~vK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~l 88 (299)
+.+.+.||.|++|.||++++.. +..+|+|++... ........+..|+..++.+.|+|++++++.+... +..++
T Consensus 1 ~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~vaiK~~~~~-~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~-~~~~~ 78 (258)
T smart00219 1 LTLGKKLGEGAFGEVYKGTLKGLSGEKEVEVAVKTLKED-ADEQQIEEFLREARIMRKLDHPNIVKLLGVCTEE-EPLMI 78 (258)
T ss_pred CcccceeccCCCcceEEEEecCCCCCCCceEEEEEccCC-CChHHHHHHHHHHHHHHhcCCCchheEEEEEcCC-CeeEE
Confidence 4678999999999999998743 388999998533 2233567889999999999999999999977665 55699
Q ss_pred EEeecCCCChHHHhcCCCCCCCCCChhhHHHHHHHHHHHHHHhhcCCCCCeeeecccCCceeeCCCCcEEEeeecccccc
Q 038766 89 ILEYMENGSLESVIHGPGVDHSRWTLPKRIDVLISVANGLDYLHSGYDIPIVHCDMKPSNILLDRDFEAHVSDFGTSRML 168 (299)
Q Consensus 89 v~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lh~~~~~~~~H~dl~~~nil~~~~~~v~l~df~~~~~~ 168 (299)
++|++++++|.+++.... ...+++..++.++.|++.||++||+. +++|+||+|+||+++.++.++|+|||++...
T Consensus 79 i~e~~~~~~l~~~~~~~~--~~~~~~~~~~~~~~ql~~~l~~lh~~---~~~h~dl~~~nil~~~~~~~~l~dfg~~~~~ 153 (258)
T smart00219 79 VMEYMEGGDLLDYLRKNR--PKELSLSDLLSFALQIARGMEYLESK---NFIHRDLAARNCLVGENLVVKISDFGLSRDL 153 (258)
T ss_pred EEeccCCCCHHHHHHhhh--hccCCHHHHHHHHHHHHHHHHHHhcC---CeeecccccceEEEccCCeEEEcccCCceec
Confidence 999999999999986321 11289999999999999999999999 9999999999999999999999999998765
Q ss_pred ccccccccccccccccCcccCChhhhcccCcCccccchhhhHHHHHHHh-CCCCCCCCccCCCCchhHHHHHHHHHhcCc
Q 038766 169 DVHLQDLSSLSTAFQGTIGYLAPEFAYMRIVTTKVDVFSFGIVVMEFLT-KRRPTGLDEENGLSPISLRQLVEKALANGI 247 (299)
Q Consensus 169 ~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~DiwslG~~l~~l~~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 247 (299)
..... .......+++.|+|||...+..++.++|+||||+++++|++ |..||... ....... ......
T Consensus 154 ~~~~~---~~~~~~~~~~~y~~Pe~~~~~~~~~~~Di~slG~i~~~l~~~g~~p~~~~-----~~~~~~~---~~~~~~- 221 (258)
T smart00219 154 YDDDY---YKKKGGKLPIRWMAPESLKDGKFTSKSDVWSFGVLLWEIFTLGESPYPGM-----SNEEVLE---YLKKGY- 221 (258)
T ss_pred ccccc---cccccCCCcccccChHHhccCCCCcchhHHHHHHHHHHHHhCCCCCCCCC-----CHHHHHH---HHhcCC-
Confidence 42211 11111225678999999988889999999999999999998 77777431 1111111 111100
Q ss_pred cCcccccCccccchhhHhHHHHHHHHHHHHHHHHhcCCCCCCCCChhhhhc
Q 038766 248 NGVRQITDPKLVSSIYEEQEQHQVLEELFKLALVCTSSNPEDRPNMNELLI 298 (299)
Q Consensus 248 ~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rpt~~~il~ 298 (299)
.... +...+.++.+++.+||+.+|++|||+.++++
T Consensus 222 ----~~~~------------~~~~~~~~~~~i~~~l~~~p~~Rpt~~~ll~ 256 (258)
T smart00219 222 ----RLPK------------PENCPPEIYKLMLQCWAEDPEDRPTFSELVE 256 (258)
T ss_pred ----CCCC------------CCcCCHHHHHHHHHHCcCChhhCcCHHHHHh
Confidence 0000 1124668999999999999999999999985
|
Phosphotransferases. Tyrosine-specific kinase subfamily. |
| >cd07838 STKc_CDK4_6_like Catalytic domain of Cyclin-Dependent protein Kinase 4 and 6-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.3e-38 Score=263.84 Aligned_cols=271 Identities=26% Similarity=0.308 Sum_probs=197.0
Q ss_pred CCCCceeecCCcceEEEEEeC-CCcEEEEEEeccCcCChhhhHHHHHHHHHHHhc---CCcceeeeeeEEEcCCC----e
Q 038766 14 FSENNIIGNSNLSTVYKGRLE-DGEIVAVKKLNFHQFSAESDKSFYREAKTLKEL---KHRNLVKVLGYAWESGK----L 85 (299)
Q Consensus 14 y~~~~~lg~g~~~~v~~~~~~-~~~~~~vK~~~~~~~~~~~~~~~~~e~~~l~~l---~h~~i~~~~~~~~~~~~----~ 85 (299)
|.+.+.||+|++|.||++.+. +++.+|+|++............+.+|+..++++ .|+|++++++.+..... .
T Consensus 1 y~~~~~l~~g~~~~v~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~h~~i~~~~~~~~~~~~~~~~~ 80 (287)
T cd07838 1 YEELAEIGEGAYGTVYKARDLNTGRFVALKKVRVPLSEEGIPLSTLREIALLKQLESFEHPNIVRLLDVCHGPRTDRELK 80 (287)
T ss_pred CeEEEEecccCceEEEEEEECCCCCEEEEEEeccccccchhhhhHHHHHHHHHHhhccCCCCcceEEEEEeeccCCCCce
Confidence 678899999999999999976 489999999975543333344566777777666 59999999998776543 3
Q ss_pred eEEEEeecCCCChHHHhcCCCCCCCCCChhhHHHHHHHHHHHHHHhhcCCCCCeeeecccCCceeeCCCCcEEEeeeccc
Q 038766 86 KALILEYMENGSLESVIHGPGVDHSRWTLPKRIDVLISVANGLDYLHSGYDIPIVHCDMKPSNILLDRDFEAHVSDFGTS 165 (299)
Q Consensus 86 ~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lh~~~~~~~~H~dl~~~nil~~~~~~v~l~df~~~ 165 (299)
.++++|++.+ +|.+++... ....+++..++.++.|++.||++||+. +++|+||+|+||+++.++.++|+|||++
T Consensus 81 ~~l~~e~~~~-~l~~~l~~~--~~~~l~~~~~~~~~~~i~~al~~LH~~---~i~h~~l~~~nili~~~~~~~l~dfg~~ 154 (287)
T cd07838 81 LTLVFEHVDQ-DLATYLSKC--PKPGLPPETIKDLMRQLLRGVDFLHSH---RIVHRDLKPQNILVTSDGQVKIADFGLA 154 (287)
T ss_pred eEEEehhccc-CHHHHHHHc--cCCCCCHHHHHHHHHHHHHHHHHHHHC---CeeeccCChhhEEEccCCCEEEeccCcc
Confidence 6899999964 888887643 123689999999999999999999999 9999999999999999999999999998
Q ss_pred cccccccccccccccccccCcccCChhhhcccCcCccccchhhhHHHHHHHhCCCCCCCCccCCCCchhHHHHHHHHHhc
Q 038766 166 RMLDVHLQDLSSLSTAFQGTIGYLAPEFAYMRIVTTKVDVFSFGIVVMEFLTKRRPTGLDEENGLSPISLRQLVEKALAN 245 (299)
Q Consensus 166 ~~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~DiwslG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~ 245 (299)
..+... .......++..|+|||.+.+..++.++|+||+|+++|+|++|..||...... ......+......
T Consensus 155 ~~~~~~-----~~~~~~~~~~~~~~PE~~~~~~~~~~~Di~s~G~~l~~l~~~~~~~~~~~~~----~~~~~~~~~~~~~ 225 (287)
T cd07838 155 RIYSFE-----MALTSVVVTLWYRAPEVLLQSSYATPVDMWSVGCIFAELFRRRPLFRGTSEA----DQLDKIFDVIGLP 225 (287)
T ss_pred eeccCC-----cccccccccccccChHHhccCCCCCcchhhhHHHHHHHHHhCCCcccCCChH----HHHHHHHHHcCCC
Confidence 765421 1112234677899999999888999999999999999999999888543211 1111111111000
Q ss_pred C---ccCcccccCccccc--hhhHhHHHHHHHHHHHHHHHHhcCCCCCCCCChhhhhcC
Q 038766 246 G---INGVRQITDPKLVS--SIYEEQEQHQVLEELFKLALVCTSSNPEDRPNMNELLIT 299 (299)
Q Consensus 246 ~---~~~~~~~~~~~~~~--~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rpt~~~il~~ 299 (299)
. +............. ..........++..+.++|.+||+.||++||++++++.|
T Consensus 226 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rp~~~~il~~ 284 (287)
T cd07838 226 SEEEWPRNVSLPRSSFPSYTPRSFKSFVPEICEEGLDLLKKMLTFNPHKRISAFEALQH 284 (287)
T ss_pred ChHhcCCCcccchhhcccccccchhhhhhhhhHHHHHHHHHHhccCCccCCCHHHHhcC
Confidence 0 00000000000000 000012234567888999999999999999999999987
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) and CDK6-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4/6-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 and CDK6 partner with D-type cyclins to regulate the early G1 phase of the cell cycle. They are the first kinase activated by mitogenic signals to release cells from the G0 arrested state. CDK4 and CDK6 are both |
| >PLN00009 cyclin-dependent kinase A; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-38 Score=268.10 Aligned_cols=272 Identities=24% Similarity=0.293 Sum_probs=196.4
Q ss_pred CCCCCCceeecCCcceEEEEEeC-CCcEEEEEEeccCcCChhhhHHHHHHHHHHHhcCCcceeeeeeEEEcCCCeeEEEE
Q 038766 12 GSFSENNIIGNSNLSTVYKGRLE-DGEIVAVKKLNFHQFSAESDKSFYREAKTLKELKHRNLVKVLGYAWESGKLKALIL 90 (299)
Q Consensus 12 ~~y~~~~~lg~g~~~~v~~~~~~-~~~~~~vK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~lv~ 90 (299)
++|.+.+.||+|++|+||++.+. +++.+|+|.+............+.+|++.+++++|+|++++++++.. +...++|+
T Consensus 2 ~~y~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~-~~~~~lv~ 80 (294)
T PLN00009 2 DQYEKVEKIGEGTYGVVYKARDRVTNETIALKKIRLEQEDEGVPSTAIREISLLKEMQHGNIVRLQDVVHS-EKRLYLVF 80 (294)
T ss_pred CceEEEEEecCCCCEEEEEEEecCCCcEEEEEehhhccccccchHHHHHHHHHHHhccCCCEeeEEEEEec-CCeEEEEE
Confidence 67999999999999999999875 68899999987554444445678889999999999999999997665 55679999
Q ss_pred eecCCCChHHHhcCCCCCCCCCChhhHHHHHHHHHHHHHHhhcCCCCCeeeecccCCceeeCC-CCcEEEeeeccccccc
Q 038766 91 EYMENGSLESVIHGPGVDHSRWTLPKRIDVLISVANGLDYLHSGYDIPIVHCDMKPSNILLDR-DFEAHVSDFGTSRMLD 169 (299)
Q Consensus 91 e~~~~~~L~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lh~~~~~~~~H~dl~~~nil~~~-~~~v~l~df~~~~~~~ 169 (299)
||+. ++|.+.+... ....+++..++.++.||+.||+|||++ +++|+||+|+||+++. ++.++|+|||++....
T Consensus 81 e~~~-~~l~~~~~~~--~~~~~~~~~~~~~~~qi~~aL~~LH~~---~i~H~dl~p~nill~~~~~~~kl~dfg~~~~~~ 154 (294)
T PLN00009 81 EYLD-LDLKKHMDSS--PDFAKNPRLIKTYLYQILRGIAYCHSH---RVLHRDLKPQNLLIDRRTNALKLADFGLARAFG 154 (294)
T ss_pred eccc-ccHHHHHHhC--CCCCcCHHHHHHHHHHHHHHHHHHHhC---CeeCCCCCcceEEEECCCCEEEEcccccccccC
Confidence 9995 4787776532 223467888899999999999999999 9999999999999985 5578999999986543
Q ss_pred cccccccccccccccCcccCChhhhcc-cCcCccccchhhhHHHHHHHhCCCCCCCCccCCCCchhHHHHHHHHHh---c
Q 038766 170 VHLQDLSSLSTAFQGTIGYLAPEFAYM-RIVTTKVDVFSFGIVVMEFLTKRRPTGLDEENGLSPISLRQLVEKALA---N 245 (299)
Q Consensus 170 ~~~~~~~~~~~~~~~~~~y~~PE~~~~-~~~~~~~DiwslG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~---~ 245 (299)
.. ........+++.|+|||.+.+ ..++.++|+||+|+++|+|++|..||...... ............ .
T Consensus 155 ~~----~~~~~~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~i~~~l~tg~~pf~~~~~~----~~~~~~~~~~~~~~~~ 226 (294)
T PLN00009 155 IP----VRTFTHEVVTLWYRAPEILLGSRHYSTPVDIWSVGCIFAEMVNQKPLFPGDSEI----DELFKIFRILGTPNEE 226 (294)
T ss_pred CC----ccccccCceeecccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHH----HHHHHHHHHhCCCChh
Confidence 21 111223345788999998765 45788999999999999999999998543211 111111110000 0
Q ss_pred CccCcccccCc-----cccchhhHhHHHHHHHHHHHHHHHHhcCCCCCCCCChhhhhcC
Q 038766 246 GINGVRQITDP-----KLVSSIYEEQEQHQVLEELFKLALVCTSSNPEDRPNMNELLIT 299 (299)
Q Consensus 246 ~~~~~~~~~~~-----~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rpt~~~il~~ 299 (299)
.+.......+. ..... ........++..+.+++.+||+.+|++||+++++++|
T Consensus 227 ~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~i~~~l~~~P~~Rps~~~~l~~ 284 (294)
T PLN00009 227 TWPGVTSLPDYKSAFPKWPPK-DLATVVPTLEPAGVDLLSKMLRLDPSKRITARAALEH 284 (294)
T ss_pred hccccccchhhhhhcccCCCC-CHHHhCcCCChHHHHHHHHHccCChhhCcCHHHHhcC
Confidence 00000000000 00000 0001123456779999999999999999999999986
|
|
| >cd06917 STKc_NAK1_like Catalytic domain of Fungal Nak1-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.7e-39 Score=268.05 Aligned_cols=249 Identities=25% Similarity=0.409 Sum_probs=195.6
Q ss_pred CCCCCceeecCCcceEEEEEe-CCCcEEEEEEeccCcCChhhhHHHHHHHHHHHhcC---CcceeeeeeEEEcCCCeeEE
Q 038766 13 SFSENNIIGNSNLSTVYKGRL-EDGEIVAVKKLNFHQFSAESDKSFYREAKTLKELK---HRNLVKVLGYAWESGKLKAL 88 (299)
Q Consensus 13 ~y~~~~~lg~g~~~~v~~~~~-~~~~~~~vK~~~~~~~~~~~~~~~~~e~~~l~~l~---h~~i~~~~~~~~~~~~~~~l 88 (299)
.|.+.+.||+|++|.||++.+ .+++.+++|++... ........+.+|+.+++.+. |||++++++++.. +...++
T Consensus 2 ~y~~~~~l~~g~~g~v~~~~~~~~~~~~~iK~~~~~-~~~~~~~~~~~e~~~l~~l~~~~~~~vi~~~~~~~~-~~~~~l 79 (277)
T cd06917 2 LYQRLELIGRGAYGAVYRGKHVPTGRVVALKIINLD-TPDDDVSDIQREVALLSQLRQSQPPNITKYYGSYLK-GPRLWI 79 (277)
T ss_pred hhhhhhheeccCCceEEEEEEcCCCcEEEEEEecCC-CCchhHHHHHHHHHHHHHhccCCCCCeeeEeeeeee-CCEEEE
Confidence 578899999999999999986 56899999998643 23344567888999999997 9999999997655 556699
Q ss_pred EEeecCCCChHHHhcCCCCCCCCCChhhHHHHHHHHHHHHHHhhcCCCCCeeeecccCCceeeCCCCcEEEeeecccccc
Q 038766 89 ILEYMENGSLESVIHGPGVDHSRWTLPKRIDVLISVANGLDYLHSGYDIPIVHCDMKPSNILLDRDFEAHVSDFGTSRML 168 (299)
Q Consensus 89 v~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lh~~~~~~~~H~dl~~~nil~~~~~~v~l~df~~~~~~ 168 (299)
|+||+.+++|.+++.. ..+++..++.++.|++.+|.+||+. +++|+||+|+||+++.++.++|+|||++..+
T Consensus 80 v~e~~~~~~L~~~~~~-----~~l~~~~~~~i~~~i~~~l~~lh~~---~i~H~dl~p~ni~i~~~~~~~l~dfg~~~~~ 151 (277)
T cd06917 80 IMEYAEGGSVRTLMKA-----GPIAEKYISVIIREVLVALKYIHKV---GVIHRDIKAANILVTNTGNVKLCDFGVAALL 151 (277)
T ss_pred EEecCCCCcHHHHHHc-----cCCCHHHHHHHHHHHHHHHHHHHhC---CcccCCcCHHHEEEcCCCCEEEccCCceeec
Confidence 9999999999998852 3789999999999999999999999 9999999999999999999999999998765
Q ss_pred ccccccccccccccccCcccCChhhhcc-cCcCccccchhhhHHHHHHHhCCCCCCCCccCCCCchhHHHHHHHHHhcCc
Q 038766 169 DVHLQDLSSLSTAFQGTIGYLAPEFAYM-RIVTTKVDVFSFGIVVMEFLTKRRPTGLDEENGLSPISLRQLVEKALANGI 247 (299)
Q Consensus 169 ~~~~~~~~~~~~~~~~~~~y~~PE~~~~-~~~~~~~DiwslG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 247 (299)
.... .......++..|+|||.+.. ..++.++|+||||+++|+|++|..||...... . ......
T Consensus 152 ~~~~----~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~~ll~g~~p~~~~~~~-----~---~~~~~~---- 215 (277)
T cd06917 152 NQNS----SKRSTFVGTPYWMAPEVITEGKYYDTKADIWSLGITIYEMATGNPPYSDVDAF-----R---AMMLIP---- 215 (277)
T ss_pred CCCc----cccccccCCcceeCHHHhccCCccccchhHHHHHHHHHHHHhCCCCCCCCChh-----h---hhhccc----
Confidence 4221 12233457788999998765 45688999999999999999999998543111 0 000000
Q ss_pred cCcccccCccccchhhHhHHHHHHHHHHHHHHHHhcCCCCCCCCChhhhhcC
Q 038766 248 NGVRQITDPKLVSSIYEEQEQHQVLEELFKLALVCTSSNPEDRPNMNELLIT 299 (299)
Q Consensus 248 ~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rpt~~~il~~ 299 (299)
....+... ...++.++.+++.+||..||++|||+.+++.|
T Consensus 216 ----~~~~~~~~--------~~~~~~~~~~~i~~~l~~~p~~R~~~~~il~~ 255 (277)
T cd06917 216 ----KSKPPRLE--------DNGYSKLLREFVAACLDEEPKERLSAEELLKS 255 (277)
T ss_pred ----cCCCCCCC--------cccCCHHHHHHHHHHcCCCcccCcCHHHHhhC
Confidence 00000000 11145678999999999999999999999876
|
Serine/threonine kinases (STKs), Nak1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nak1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of Schizosaccharomyces pombe Nak1, Saccharomyces cerevisiae Kic1p (kinase that interacts with Cdc31p) and related proteins. Nak1 (also known as N-rich kinase 1), is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Kic1p is required by budding yeast for cell integrity and morphogenesis. Kic1p interacts with Cdc31p, the yeast homologue of cent |
| >cd05633 STKc_GRK3 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.2e-39 Score=269.52 Aligned_cols=244 Identities=22% Similarity=0.253 Sum_probs=184.1
Q ss_pred eeecCCcceEEEEEeC-CCcEEEEEEeccCcCChhh-hHHHHHHHHHHHh---cCCcceeeeeeEEEcCCCeeEEEEeec
Q 038766 19 IIGNSNLSTVYKGRLE-DGEIVAVKKLNFHQFSAES-DKSFYREAKTLKE---LKHRNLVKVLGYAWESGKLKALILEYM 93 (299)
Q Consensus 19 ~lg~g~~~~v~~~~~~-~~~~~~vK~~~~~~~~~~~-~~~~~~e~~~l~~---l~h~~i~~~~~~~~~~~~~~~lv~e~~ 93 (299)
.||+|+||.||++.+. +++.+|+|.+......... ......+...++. ..|++++.+.+.+.. ++..++|+||+
T Consensus 1 ~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~-~~~~~lv~e~~ 79 (279)
T cd05633 1 IIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMTYAFHT-PDKLCFILDLM 79 (279)
T ss_pred CcccCCCeEEEEEEECCCCcEEEEEEEEccccccchHHHHHHHHHHHHHHHhhCCCCcEeEEEEEEec-CCeEEEEEecC
Confidence 4899999999999874 5889999998654332222 2233344433333 468999999986665 44569999999
Q ss_pred CCCChHHHhcCCCCCCCCCChhhHHHHHHHHHHHHHHhhcCCCCCeeeecccCCceeeCCCCcEEEeeeccccccccccc
Q 038766 94 ENGSLESVIHGPGVDHSRWTLPKRIDVLISVANGLDYLHSGYDIPIVHCDMKPSNILLDRDFEAHVSDFGTSRMLDVHLQ 173 (299)
Q Consensus 94 ~~~~L~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lh~~~~~~~~H~dl~~~nil~~~~~~v~l~df~~~~~~~~~~~ 173 (299)
.+++|.+.+. ....+++..+..++.|++.||.|||+. +++|+||||+||+++.++.++|+|||++.....
T Consensus 80 ~~~~L~~~i~----~~~~l~~~~~~~i~~qi~~al~~lH~~---~ivH~dikp~Nil~~~~~~~~l~dfg~~~~~~~--- 149 (279)
T cd05633 80 NGGDLHYHLS----QHGVFSEKEMRFYATEIILGLEHMHNR---FVVYRDLKPANILLDEHGHVRISDLGLACDFSK--- 149 (279)
T ss_pred CCCCHHHHHH----hcCCCCHHHHHHHHHHHHHHHHHHHHC---CcCCCCCCHHHEEECCCCCEEEccCCcceeccc---
Confidence 9999998886 345799999999999999999999999 999999999999999999999999999865431
Q ss_pred cccccccccccCcccCChhhhc-ccCcCccccchhhhHHHHHHHhCCCCCCCCccCCCCchhHHHHHHHHHhcCccCccc
Q 038766 174 DLSSLSTAFQGTIGYLAPEFAY-MRIVTTKVDVFSFGIVVMEFLTKRRPTGLDEENGLSPISLRQLVEKALANGINGVRQ 252 (299)
Q Consensus 174 ~~~~~~~~~~~~~~y~~PE~~~-~~~~~~~~DiwslG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 252 (299)
.......++..|+|||.+. +..++.++|+||+||++|+|++|..||....... . ..........
T Consensus 150 ---~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~-----~-~~~~~~~~~~------ 214 (279)
T cd05633 150 ---KKPHASVGTHGYMAPEVLQKGTAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKD-----K-HEIDRMTLTV------ 214 (279)
T ss_pred ---cCccCcCCCcCccCHHHhcCCCCCCchhhhHHHHHHHHHHHhCCCCcCCCCCcC-----H-HHHHHHhhcC------
Confidence 1112345788999999876 4567899999999999999999999996432211 0 1111110000
Q ss_pred ccCccccchhhHhHHHHHHHHHHHHHHHHhcCCCCCCCC-----ChhhhhcC
Q 038766 253 ITDPKLVSSIYEEQEQHQVLEELFKLALVCTSSNPEDRP-----NMNELLIT 299 (299)
Q Consensus 253 ~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rp-----t~~~il~~ 299 (299)
.. ..+..++.++.++|++||..||++|| |++++++|
T Consensus 215 --~~---------~~~~~~~~~~~~li~~~l~~~p~~R~~~~~~~~~~~~~h 255 (279)
T cd05633 215 --NV---------ELPDSFSPELKSLLEGLLQRDVSKRLGCLGRGAQEVKEH 255 (279)
T ss_pred --Cc---------CCccccCHHHHHHHHHHhcCCHHHhcCCCCCCHHHHHhC
Confidence 00 01234567899999999999999999 69999987
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK3 (also known as beta-adrenergic receptor kinase 2) is wi |
| >cd05063 PTKc_EphR_A2 Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.4e-39 Score=266.53 Aligned_cols=256 Identities=26% Similarity=0.436 Sum_probs=195.4
Q ss_pred HHhCCCCCCceeecCCcceEEEEEeC-CC---cEEEEEEeccCcCChhhhHHHHHHHHHHHhcCCcceeeeeeEEEcCCC
Q 038766 9 NATGSFSENNIIGNSNLSTVYKGRLE-DG---EIVAVKKLNFHQFSAESDKSFYREAKTLKELKHRNLVKVLGYAWESGK 84 (299)
Q Consensus 9 ~~~~~y~~~~~lg~g~~~~v~~~~~~-~~---~~~~vK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~ 84 (299)
+..++|...+.||+|++|.||++... ++ ..+++|.+... ........+.+|+..++.++|+|++++.+++... .
T Consensus 2 i~~~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~ik~~~~~-~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~-~ 79 (268)
T cd05063 2 IHPSHITKQKVIGAGEFGEVFRGILKMPGRKEVAVAIKTLKPG-YTEKQRQDFLSEASIMGQFSHHNIIRLEGVVTKF-K 79 (268)
T ss_pred CChHHceEeeEecCCCCccEEEEEEecCCCCceEEEEEecccc-CCHHHHHHHHHHHHHHhcCCCCCeeEEEEEEccC-C
Confidence 34568899999999999999999864 23 37899988643 2334456788999999999999999999976554 4
Q ss_pred eeEEEEeecCCCChHHHhcCCCCCCCCCChhhHHHHHHHHHHHHHHhhcCCCCCeeeecccCCceeeCCCCcEEEeeecc
Q 038766 85 LKALILEYMENGSLESVIHGPGVDHSRWTLPKRIDVLISVANGLDYLHSGYDIPIVHCDMKPSNILLDRDFEAHVSDFGT 164 (299)
Q Consensus 85 ~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lh~~~~~~~~H~dl~~~nil~~~~~~v~l~df~~ 164 (299)
..++|+|++.+++|.+++... ...+++..+..++.|++.|++|||+. +++|+||+|+||+++.++.++|+|||+
T Consensus 80 ~~~lv~e~~~~~~L~~~~~~~---~~~~~~~~~~~~~~~l~~al~~lH~~---~i~H~dlkp~Nili~~~~~~kl~dfg~ 153 (268)
T cd05063 80 PAMIITEYMENGALDKYLRDH---DGEFSSYQLVGMLRGIAAGMKYLSDM---NYVHRDLAARNILVNSNLECKVSDFGL 153 (268)
T ss_pred CcEEEEEcCCCCCHHHHHHhc---CCCCCHHHHHHHHHHHHHHHHHHHHC---CeeccccchhhEEEcCCCcEEECCCcc
Confidence 569999999999999988632 34688999999999999999999999 999999999999999999999999999
Q ss_pred ccccccccccccccccccccCcccCChhhhcccCcCccccchhhhHHHHHHHh-CCCCCCCCccCCCCchhHHHHHHHHH
Q 038766 165 SRMLDVHLQDLSSLSTAFQGTIGYLAPEFAYMRIVTTKVDVFSFGIVVMEFLT-KRRPTGLDEENGLSPISLRQLVEKAL 243 (299)
Q Consensus 165 ~~~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~DiwslG~~l~~l~~-g~~p~~~~~~~~~~~~~~~~~~~~~~ 243 (299)
+.......... ........+..|+|||.+....++.++|+||||+++|+|++ |..||.... .......+ .
T Consensus 154 ~~~~~~~~~~~-~~~~~~~~~~~y~~PE~~~~~~~~~~~Dv~slG~il~ell~~g~~p~~~~~-----~~~~~~~i---~ 224 (268)
T cd05063 154 SRVLEDDPEGT-YTTSGGKIPIRWTAPEAIAYRKFTSASDVWSFGIVMWEVMSFGERPYWDMS-----NHEVMKAI---N 224 (268)
T ss_pred ceecccccccc-eeccCCCcCceecCHHHhhcCCcChHhHHHHHHHHHHHHHhCCCCCCCcCC-----HHHHHHHH---h
Confidence 87553211100 00111122457999999988889999999999999999997 999984321 11112111 1
Q ss_pred hcCccCcccccCccccchhhHhHHHHHHHHHHHHHHHHhcCCCCCCCCChhhhhc
Q 038766 244 ANGINGVRQITDPKLVSSIYEEQEQHQVLEELFKLALVCTSSNPEDRPNMNELLI 298 (299)
Q Consensus 244 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rpt~~~il~ 298 (299)
... .... ....+..+.+++.+|+..+|++||++.++++
T Consensus 225 ~~~-----~~~~------------~~~~~~~~~~li~~c~~~~p~~Rp~~~~i~~ 262 (268)
T cd05063 225 DGF-----RLPA------------PMDCPSAVYQLMLQCWQQDRARRPRFVDIVN 262 (268)
T ss_pred cCC-----CCCC------------CCCCCHHHHHHHHHHcCCCcccCcCHHHHHH
Confidence 100 0000 1123467899999999999999999999975
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA2 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored |
| >cd06614 STKc_PAK Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-38 Score=266.93 Aligned_cols=253 Identities=28% Similarity=0.411 Sum_probs=200.7
Q ss_pred HhCCCCCCceeecCCcceEEEEEeC-CCcEEEEEEeccCcCChhhhHHHHHHHHHHHhcCCcceeeeeeEEEcCCCeeEE
Q 038766 10 ATGSFSENNIIGNSNLSTVYKGRLE-DGEIVAVKKLNFHQFSAESDKSFYREAKTLKELKHRNLVKVLGYAWESGKLKAL 88 (299)
Q Consensus 10 ~~~~y~~~~~lg~g~~~~v~~~~~~-~~~~~~vK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~l 88 (299)
..+.|.+.+.||+|++|.||++.+. ++..+++|++..... ....+.+|++.++.++|+|++++++.+... ...++
T Consensus 17 ~~~~~~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~---~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~-~~~~l 92 (286)
T cd06614 17 PRELYKNLEKIGEGASGEVYKATDRATGKEVAIKKMRLRKQ---NKELIINEILIMKDCKHPNIVDYYDSYLVG-DELWV 92 (286)
T ss_pred ccccchHhHhccCCCCeEEEEEEEccCCcEEEEEEEecCch---hHHHHHHHHHHHHHCCCCCeeEEEEEEEEC-CEEEE
Confidence 5677999999999999999999875 688999999864332 566788899999999999999999976664 56799
Q ss_pred EEeecCCCChHHHhcCCCCCCCCCChhhHHHHHHHHHHHHHHhhcCCCCCeeeecccCCceeeCCCCcEEEeeecccccc
Q 038766 89 ILEYMENGSLESVIHGPGVDHSRWTLPKRIDVLISVANGLDYLHSGYDIPIVHCDMKPSNILLDRDFEAHVSDFGTSRML 168 (299)
Q Consensus 89 v~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lh~~~~~~~~H~dl~~~nil~~~~~~v~l~df~~~~~~ 168 (299)
++||+.+++|.+++.... ..++...++.++.|++.+|.+||+. +++|+||+|+||+++.++.++|+|||.+...
T Consensus 93 v~e~~~~~~L~~~l~~~~---~~l~~~~~~~i~~~i~~~L~~lH~~---gi~H~dl~p~ni~i~~~~~~~l~d~~~~~~~ 166 (286)
T cd06614 93 VMEYMDGGSLTDIITQNF---VRMNEPQIAYVCREVLQGLEYLHSQ---NVIHRDIKSDNILLSKDGSVKLADFGFAAQL 166 (286)
T ss_pred EEeccCCCcHHHHHHHhc---cCCCHHHHHHHHHHHHHHHHHHHhC---CeeeCCCChhhEEEcCCCCEEECccchhhhh
Confidence 999999899999997431 3789999999999999999999998 9999999999999999999999999987654
Q ss_pred ccccccccccccccccCcccCChhhhcccCcCccccchhhhHHHHHHHhCCCCCCCCccCCCCchhHHHHHHHHHhcCcc
Q 038766 169 DVHLQDLSSLSTAFQGTIGYLAPEFAYMRIVTTKVDVFSFGIVVMEFLTKRRPTGLDEENGLSPISLRQLVEKALANGIN 248 (299)
Q Consensus 169 ~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~DiwslG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 248 (299)
.... .......++..|+|||.+.+..++.++|+||||+++|+|++|..||... ... ............
T Consensus 167 ~~~~----~~~~~~~~~~~y~~PE~~~~~~~~~~~Dv~slGvil~~l~~g~~p~~~~-----~~~---~~~~~~~~~~~~ 234 (286)
T cd06614 167 TKEK----SKRNSVVGTPYWMAPEVIKRKDYGPKVDIWSLGIMCIEMAEGEPPYLRE-----PPL---RALFLITTKGIP 234 (286)
T ss_pred ccch----hhhccccCCcccCCHhHhcCCCCCCccccHHHHHHHHHHHhCCCCCCCC-----CHH---HHHHHHHhcCCC
Confidence 3211 1122334677899999998888999999999999999999999998422 111 111111111100
Q ss_pred CcccccCccccchhhHhHHHHHHHHHHHHHHHHhcCCCCCCCCChhhhhcC
Q 038766 249 GVRQITDPKLVSSIYEEQEQHQVLEELFKLALVCTSSNPEDRPNMNELLIT 299 (299)
Q Consensus 249 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rpt~~~il~~ 299 (299)
. ... ...++..+.++|.+||+.+|.+|||+.++++|
T Consensus 235 ~---~~~------------~~~~~~~l~~li~~~l~~~p~~Rpt~~~il~~ 270 (286)
T cd06614 235 P---LKN------------PEKWSPEFKDFLNKCLVKDPEKRPSAEELLQH 270 (286)
T ss_pred C---Ccc------------hhhCCHHHHHHHHHHhccChhhCcCHHHHhhC
Confidence 0 000 22345679999999999999999999999976
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAK deregulation is associated with tumor development. PAKs from higher eukaryotes are classified into two grou |
| >cd06627 STKc_Cdc7_like Catalytic domain of Cell division control protein 7-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=5e-39 Score=265.20 Aligned_cols=250 Identities=30% Similarity=0.456 Sum_probs=202.2
Q ss_pred CCCCCceeecCCcceEEEEEeC-CCcEEEEEEeccCcCChhhhHHHHHHHHHHHhcCCcceeeeeeEEEcCCCeeEEEEe
Q 038766 13 SFSENNIIGNSNLSTVYKGRLE-DGEIVAVKKLNFHQFSAESDKSFYREAKTLKELKHRNLVKVLGYAWESGKLKALILE 91 (299)
Q Consensus 13 ~y~~~~~lg~g~~~~v~~~~~~-~~~~~~vK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~lv~e 91 (299)
+|.+.+.||+|++|.||++.+. +++.+++|.+............+.+|++.+++++|+|++++.+++.. +...++++|
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~-~~~~~~v~e 79 (254)
T cd06627 1 NYQLGDLIGRGAFGVVYKGLNLETGDFVAIKQISLEKIKEEALKSIMQEIDLLKNLKHPNIVKYIGSIET-SDSLYIILE 79 (254)
T ss_pred CceeeeEEcccCCeEEEEEEEcCCCcEEEEEEecccccCHHHHHHHHHHHHHHHhCCCCCccEEEEEEEe-CCEEEEEEe
Confidence 5889999999999999999865 58899999997665555567789999999999999999999997655 566799999
Q ss_pred ecCCCChHHHhcCCCCCCCCCChhhHHHHHHHHHHHHHHhhcCCCCCeeeecccCCceeeCCCCcEEEeeeccccccccc
Q 038766 92 YMENGSLESVIHGPGVDHSRWTLPKRIDVLISVANGLDYLHSGYDIPIVHCDMKPSNILLDRDFEAHVSDFGTSRMLDVH 171 (299)
Q Consensus 92 ~~~~~~L~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lh~~~~~~~~H~dl~~~nil~~~~~~v~l~df~~~~~~~~~ 171 (299)
++.+++|.+++. ....+++..++.++.|++.++.+||+. +++|+||+|+||+++.++.++|+|||.+......
T Consensus 80 ~~~~~~L~~~~~----~~~~l~~~~~~~~~~~i~~~l~~lH~~---~i~H~dl~p~ni~i~~~~~~~l~d~~~~~~~~~~ 152 (254)
T cd06627 80 YAENGSLRQIIK----KFGPFPESLVAVYVYQVLQGLAYLHEQ---GVIHRDIKAANILTTKDGVVKLADFGVATKLNDV 152 (254)
T ss_pred cCCCCcHHHHHH----hccCCCHHHHHHHHHHHHHHHHHHhhC---CcccCCCCHHHEEECCCCCEEEeccccceecCCC
Confidence 999999999987 335789999999999999999999998 9999999999999999999999999999865422
Q ss_pred cccccccccccccCcccCChhhhcccCcCccccchhhhHHHHHHHhCCCCCCCCccCCCCchhHHHHHHHHHhcCccCcc
Q 038766 172 LQDLSSLSTAFQGTIGYLAPEFAYMRIVTTKVDVFSFGIVVMEFLTKRRPTGLDEENGLSPISLRQLVEKALANGINGVR 251 (299)
Q Consensus 172 ~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~DiwslG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 251 (299)
. .......++..|+|||...+..++.++|+|++|+++++|++|..||.... ... . ........ ..
T Consensus 153 ~----~~~~~~~~~~~y~~pe~~~~~~~~~~~Dv~~lG~~l~~l~~g~~p~~~~~-----~~~--~-~~~~~~~~---~~ 217 (254)
T cd06627 153 S----KDDASVVGTPYWMAPEVIEMSGASTASDIWSLGCTVIELLTGNPPYYDLN-----PMA--A-LFRIVQDD---HP 217 (254)
T ss_pred c----ccccccccchhhcCHhhhcCCCCCcchhHHHHHHHHHHHHhCCCCCCCcc-----HHH--H-HHHHhccC---CC
Confidence 1 11233456788999999888888999999999999999999999985321 111 1 11111110 00
Q ss_pred cccCccccchhhHhHHHHHHHHHHHHHHHHhcCCCCCCCCChhhhhcC
Q 038766 252 QITDPKLVSSIYEEQEQHQVLEELFKLALVCTSSNPEDRPNMNELLIT 299 (299)
Q Consensus 252 ~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rpt~~~il~~ 299 (299)
.. +..++..+.+++.+||..+|++|||+++++.|
T Consensus 218 ~~--------------~~~~~~~~~~~i~~~l~~~p~~R~~~~~~l~~ 251 (254)
T cd06627 218 PL--------------PEGISPELKDFLMQCFQKDPNLRPTAKQLLKH 251 (254)
T ss_pred CC--------------CCCCCHHHHHHHHHHHhCChhhCcCHHHHhcC
Confidence 00 22335678999999999999999999999976
|
Serine/threonine kinases (STKs), (Cdc7)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Cdc7-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include Schizosaccharomyces pombe Cdc7, Saccharomyces cerevisiae Cdc15, Arabidopsis thaliana mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) epsilon, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast |
| >cd05572 STKc_cGK_PKG Catalytic domain of the Protein Serine/Threonine Kinase, cGMP-dependent protein kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-38 Score=263.01 Aligned_cols=245 Identities=24% Similarity=0.368 Sum_probs=194.9
Q ss_pred eecCCcceEEEEEeC-CCcEEEEEEeccCcCC-hhhhHHHHHHHHHHHhcCCcceeeeeeEEEcCCCeeEEEEeecCCCC
Q 038766 20 IGNSNLSTVYKGRLE-DGEIVAVKKLNFHQFS-AESDKSFYREAKTLKELKHRNLVKVLGYAWESGKLKALILEYMENGS 97 (299)
Q Consensus 20 lg~g~~~~v~~~~~~-~~~~~~vK~~~~~~~~-~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~lv~e~~~~~~ 97 (299)
||.|++|.||++.+. +++.+++|++...... ....+.+.+|+..++.++||||+++++.+.. +...++++||+++++
T Consensus 1 lg~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~-~~~~~lv~e~~~~~~ 79 (262)
T cd05572 1 LGVGGFGRVELVKVKSKNRTFALKCVKKRHIVETGQQEHIFSEKEILEECNHPFIVKLYRTFKD-KKYIYMLMEYCLGGE 79 (262)
T ss_pred CCCCCceEEEEEEECCCCcEEEEEEEehhcchhhhHHHHHHHHHHHHHhCCCCCEeeeeeeEEc-CCccEEEEecCCCCc
Confidence 689999999999875 4899999998754332 3456788999999999999999999996654 556799999999999
Q ss_pred hHHHhcCCCCCCCCCChhhHHHHHHHHHHHHHHhhcCCCCCeeeecccCCceeeCCCCcEEEeeeccccccccccccccc
Q 038766 98 LESVIHGPGVDHSRWTLPKRIDVLISVANGLDYLHSGYDIPIVHCDMKPSNILLDRDFEAHVSDFGTSRMLDVHLQDLSS 177 (299)
Q Consensus 98 L~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lh~~~~~~~~H~dl~~~nil~~~~~~v~l~df~~~~~~~~~~~~~~~ 177 (299)
|.+++. ....+++..+..++.|+++||++||+. +++|+||+|+||+++.++.++|+|||++...... .
T Consensus 80 L~~~l~----~~~~l~~~~~~~~~~~i~~~l~~lH~~---~~~h~dl~~~nilv~~~~~~~l~df~~~~~~~~~-----~ 147 (262)
T cd05572 80 LWTILR----DRGLFDEYTARFYIACVVLAFEYLHNR---GIIYRDLKPENLLLDSNGYVKLVDFGFAKKLKSG-----Q 147 (262)
T ss_pred HHHHHh----hcCCCCHHHHHHHHHHHHHHHHHHhhC---CcccCCCCHHHEEEcCCCCEEEeeCCcccccCcc-----c
Confidence 999997 345689999999999999999999998 9999999999999999999999999998765421 1
Q ss_pred cccccccCcccCChhhhcccCcCccccchhhhHHHHHHHhCCCCCCCCccCCCCchhHHHHHHHHHhcCccCcccccCcc
Q 038766 178 LSTAFQGTIGYLAPEFAYMRIVTTKVDVFSFGIVVMEFLTKRRPTGLDEENGLSPISLRQLVEKALANGINGVRQITDPK 257 (299)
Q Consensus 178 ~~~~~~~~~~y~~PE~~~~~~~~~~~DiwslG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 257 (299)
......+++.|+|||.+.+..++.++|+||+|+++|+|++|..||.....+ . ......... + ......
T Consensus 148 ~~~~~~~~~~~~~PE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~---~---~~~~~~~~~-~---~~~~~~-- 215 (262)
T cd05572 148 KTWTFCGTPEYVAPEIILNKGYDFSVDYWSLGILLYELLTGRPPFGEDDED---P---MEIYNDILK-G---NGKLEF-- 215 (262)
T ss_pred ccccccCCcCccChhHhcCCCCCChhhhhhhHHHHHHHHhCCCCcCCCCCC---H---HHHHHHHhc-c---CCCCCC--
Confidence 223345678899999998888999999999999999999999999654321 1 111111110 0 000000
Q ss_pred ccchhhHhHHHHHHHHHHHHHHHHhcCCCCCCCCC-----hhhhhcC
Q 038766 258 LVSSIYEEQEQHQVLEELFKLALVCTSSNPEDRPN-----MNELLIT 299 (299)
Q Consensus 258 ~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rpt-----~~~il~~ 299 (299)
+...+.++.++|.+||..+|++||| ++|+++|
T Consensus 216 ----------~~~~~~~~~~~i~~~l~~~p~~R~~~~~~~~~~l~~~ 252 (262)
T cd05572 216 ----------PNYIDKAAKDLIKQLLRRNPEERLGNLKGGIKDIKKH 252 (262)
T ss_pred ----------CcccCHHHHHHHHHHccCChhhCcCCcccCHHHHhcC
Confidence 1222568999999999999999999 9999886
|
Serine/Threonine Kinases (STKs), cGMP-dependent protein kinase (cGK or PKG) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mammals have two cGK isoforms from different genes, cGKI and cGKII. cGKI exists as two splice variants, cGKI-alpha and cGKI-beta. cGK consists of an N-terminal regulatory domain containing a dimerization and an autoinhibitory pseudosubstrate region, two cGMP-binding domains, and a C-terminal catalytic domain. Binding of cGMP to both binding sites releases the inhibition of the catalytic center by the pseudosubstrate region, allowi |
| >cd08216 PK_STRAD Pseudokinase domain of STE20-related kinase adapter protein | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.1e-39 Score=273.62 Aligned_cols=262 Identities=23% Similarity=0.272 Sum_probs=191.1
Q ss_pred CcceEEEEEeC-CCcEEEEEEeccCcCChhhhHHHHHHHHHHHhcCCcceeeeeeEEEcCCCeeEEEEeecCCCChHHHh
Q 038766 24 NLSTVYKGRLE-DGEIVAVKKLNFHQFSAESDKSFYREAKTLKELKHRNLVKVLGYAWESGKLKALILEYMENGSLESVI 102 (299)
Q Consensus 24 ~~~~v~~~~~~-~~~~~~vK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~lv~e~~~~~~L~~~~ 102 (299)
+.+.||.++.. +++.+|+|++............+.+|+..++.++|+||+++++++.. +...++++||+.+++|.+++
T Consensus 12 ~~~~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~Ei~~l~~l~h~~i~~~~~~~~~-~~~~~~~~e~~~~~~l~~~l 90 (314)
T cd08216 12 DLMIVHLAKHKPTNTLVAVKKINLDSCSKEDLKLLQQEIITSRQLQHPNILPYVTSFIV-DSELYVVSPLMAYGSCEDLL 90 (314)
T ss_pred CCceEEEEEecCCCCEEEEEEEeccccchhHHHHHHHHHHHHHhcCCcchhhhhheeec-CCeEEEEEeccCCCCHHHHH
Confidence 44555666543 58999999997654556677889999999999999999999996655 55569999999999999998
Q ss_pred cCCCCCCCCCChhhHHHHHHHHHHHHHHhhcCCCCCeeeecccCCceeeCCCCcEEEeeecccccccccccc---ccccc
Q 038766 103 HGPGVDHSRWTLPKRIDVLISVANGLDYLHSGYDIPIVHCDMKPSNILLDRDFEAHVSDFGTSRMLDVHLQD---LSSLS 179 (299)
Q Consensus 103 ~~~~~~~~~~~~~~~~~i~~qi~~~l~~lh~~~~~~~~H~dl~~~nil~~~~~~v~l~df~~~~~~~~~~~~---~~~~~ 179 (299)
... ....+++..+..++.|+++||+|||++ +++|+||+|+||+++.++.++++||+.+..+...... .....
T Consensus 91 ~~~--~~~~~~~~~~~~~~~~l~~~L~~LH~~---~ivH~dlk~~Nili~~~~~~kl~d~~~~~~~~~~~~~~~~~~~~~ 165 (314)
T cd08216 91 KTH--FPEGLPELAIAFILKDVLNALDYIHSK---GFIHRSVKASHILLSGDGKVVLSGLRYSVSMIKHGKRQRVVHDFP 165 (314)
T ss_pred HHh--cccCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCcceEEEecCCceEEecCccceeecccccccccccccc
Confidence 743 234688999999999999999999999 9999999999999999999999999988654321111 11112
Q ss_pred cccccCcccCChhhhcc--cCcCccccchhhhHHHHHHHhCCCCCCCCccCCCCchhHHHHHHHHHhcC-----------
Q 038766 180 TAFQGTIGYLAPEFAYM--RIVTTKVDVFSFGIVVMEFLTKRRPTGLDEENGLSPISLRQLVEKALANG----------- 246 (299)
Q Consensus 180 ~~~~~~~~y~~PE~~~~--~~~~~~~DiwslG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~----------- 246 (299)
....++..|+|||.+.. ..++.++|+||+||++++|++|..||....... ...+......
T Consensus 166 ~~~~~~~~y~aPE~~~~~~~~~~~~~Diws~G~il~el~~g~~pf~~~~~~~-------~~~~~~~~~~~~~~~~~~~~~ 238 (314)
T cd08216 166 KSSVKNLPWLSPEVLQQNLQGYNEKSDIYSVGITACELANGHVPFKDMPATQ-------MLLEKVRGTVPCLLDKSTYPL 238 (314)
T ss_pred ccccccccccCHHHhcCCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCHHH-------HHHHHHhccCccccccCchhh
Confidence 33445678999998876 357889999999999999999999996431110 0111100000
Q ss_pred -ccCccc----ccCccccchhhHhHHHHHHHHHHHHHHHHhcCCCCCCCCChhhhhcC
Q 038766 247 -INGVRQ----ITDPKLVSSIYEEQEQHQVLEELFKLALVCTSSNPEDRPNMNELLIT 299 (299)
Q Consensus 247 -~~~~~~----~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rpt~~~il~~ 299 (299)
...... ...+ .............++.++.+++.+||..||++|||++++|+|
T Consensus 239 ~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~ll~~ 295 (314)
T cd08216 239 YEDSMSQSRSSNEHP-NNRDSVDHPYTRTFSEHFHQFVELCLQRDPESRPSASQLLNH 295 (314)
T ss_pred hcCCcCccccccccc-chhhhhhcchhhHHHHHHHHHHHHHhhcCCCcCcCHHHHhcC
Confidence 000000 0000 011112223355677889999999999999999999999987
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) subfamily, pseudokinase domain. The STRAD subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpigmentation of the buc |
| >cd05065 PTKc_EphR_B Catalytic domain of the Protein Tyrosine Kinases, Class EphB Ephrin Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.4e-39 Score=266.09 Aligned_cols=254 Identities=27% Similarity=0.459 Sum_probs=193.9
Q ss_pred hCCCCCCceeecCCcceEEEEEeCC-C---cEEEEEEeccCcCChhhhHHHHHHHHHHHhcCCcceeeeeeEEEcCCCee
Q 038766 11 TGSFSENNIIGNSNLSTVYKGRLED-G---EIVAVKKLNFHQFSAESDKSFYREAKTLKELKHRNLVKVLGYAWESGKLK 86 (299)
Q Consensus 11 ~~~y~~~~~lg~g~~~~v~~~~~~~-~---~~~~vK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~ 86 (299)
.+.|++.+.||+|++|.||+|.+.. + ..|++|++... ........+..|+..++.++||||+++.+.+.. +...
T Consensus 3 ~~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~vaiK~~~~~-~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~-~~~~ 80 (269)
T cd05065 3 VSCVKIEEVIGAGEFGEVCRGRLKLPGKREIFVAIKTLKSG-YTEKQRRDFLSEASIMGQFDHPNIIHLEGVVTK-SRPV 80 (269)
T ss_pred hHHeEEEeEecCCCCCeEEEEEEecCCCCceeEEEEEcCCC-CCHHHHHHHHHHHHHHHhCCCcCcceEEEEECC-CCce
Confidence 3568899999999999999998642 3 36999998642 244456788999999999999999999996544 5566
Q ss_pred EEEEeecCCCChHHHhcCCCCCCCCCChhhHHHHHHHHHHHHHHhhcCCCCCeeeecccCCceeeCCCCcEEEeeecccc
Q 038766 87 ALILEYMENGSLESVIHGPGVDHSRWTLPKRIDVLISVANGLDYLHSGYDIPIVHCDMKPSNILLDRDFEAHVSDFGTSR 166 (299)
Q Consensus 87 ~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lh~~~~~~~~H~dl~~~nil~~~~~~v~l~df~~~~ 166 (299)
++|+||+.+++|.+++... ...++...++.++.|++.||.+||++ +++|+||+|+||+++.++.++|+|||++.
T Consensus 81 ~lv~e~~~~~~L~~~l~~~---~~~~~~~~~~~i~~~l~~al~~lH~~---g~~H~dl~p~nili~~~~~~kl~dfg~~~ 154 (269)
T cd05065 81 MIITEFMENGALDSFLRQN---DGQFTVIQLVGMLRGIAAGMKYLSEM---NYVHRDLAARNILVNSNLVCKVSDFGLSR 154 (269)
T ss_pred EEEEecCCCCcHHHHHhhC---CCCCCHHHHHHHHHHHHHHHHHHHHC---CEeecccChheEEEcCCCcEEECCCcccc
Confidence 9999999999999988642 34688999999999999999999999 99999999999999999999999999887
Q ss_pred ccccccccccccccccc--cCcccCChhhhcccCcCccccchhhhHHHHHHHh-CCCCCCCCccCCCCchhHHHHHHHHH
Q 038766 167 MLDVHLQDLSSLSTAFQ--GTIGYLAPEFAYMRIVTTKVDVFSFGIVVMEFLT-KRRPTGLDEENGLSPISLRQLVEKAL 243 (299)
Q Consensus 167 ~~~~~~~~~~~~~~~~~--~~~~y~~PE~~~~~~~~~~~DiwslG~~l~~l~~-g~~p~~~~~~~~~~~~~~~~~~~~~~ 243 (299)
........ ........ .+..|+|||.+.+..++.++||||+|+++|++++ |..||... ........+ .
T Consensus 155 ~~~~~~~~-~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~DvwslG~~l~e~l~~g~~p~~~~-----~~~~~~~~i---~ 225 (269)
T cd05065 155 FLEDDTSD-PTYTSSLGGKIPIRWTAPEAIAYRKFTSASDVWSYGIVMWEVMSYGERPYWDM-----SNQDVINAI---E 225 (269)
T ss_pred ccccCccc-cccccccCCCcceeecCHhHhccCcccchhhhhhhHHHHHHHhcCCCCCCCCC-----CHHHHHHHH---H
Confidence 54321111 01111111 1347999999998889999999999999999886 88888432 112222211 1
Q ss_pred hcCccCcccccCccccchhhHhHHHHHHHHHHHHHHHHhcCCCCCCCCChhhhhc
Q 038766 244 ANGINGVRQITDPKLVSSIYEEQEQHQVLEELFKLALVCTSSNPEDRPNMNELLI 298 (299)
Q Consensus 244 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rpt~~~il~ 298 (299)
... .... +...+..+.+++.+||..+|++|||+++++.
T Consensus 226 ~~~-----~~~~------------~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~ 263 (269)
T cd05065 226 QDY-----RLPP------------PMDCPTALHQLMLDCWQKDRNARPKFGQIVS 263 (269)
T ss_pred cCC-----cCCC------------cccCCHHHHHHHHHHcCCChhhCcCHHHHHH
Confidence 100 0000 1233457889999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; class EphB receptors; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). Class EphB receptors bind to transmembrane ephrin-B ligands. There are six vertebrate EhpB receptors (EphB1-6), which display promiscuous interactions with three ephrin-B ligands. One exception is EphB2, which also interacts with ephrin A5. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephr |
| >cd07851 STKc_p38 Catalytic domain of the Serine/Threonine Kinase, p38 Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.5e-39 Score=277.74 Aligned_cols=269 Identities=23% Similarity=0.318 Sum_probs=199.2
Q ss_pred HHhCCCCCCceeecCCcceEEEEEeC-CCcEEEEEEeccCcCChhhhHHHHHHHHHHHhcCCcceeeeeeEEEcCCC---
Q 038766 9 NATGSFSENNIIGNSNLSTVYKGRLE-DGEIVAVKKLNFHQFSAESDKSFYREAKTLKELKHRNLVKVLGYAWESGK--- 84 (299)
Q Consensus 9 ~~~~~y~~~~~lg~g~~~~v~~~~~~-~~~~~~vK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~--- 84 (299)
.+.++|.+.+.||+|++|.||++.+. +++.||+|++............+.+|+.+++.+.|+|++++.+++...+.
T Consensus 12 ~~~~~y~~~~~ig~g~~g~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~ 91 (343)
T cd07851 12 EVPDRYQNLSPVGSGAYGQVCSAFDTKTGRKVAIKKLSRPFQSAIHAKRTYRELRLLKHMDHENVIGLLDVFTPASSLED 91 (343)
T ss_pred cccCceEEEEEeccCCceEEEEEEECCCCcEEEEEecccccchhhHHHHHHHHHHHHHhccCCCHHHHHHHhhccccccc
Confidence 46789999999999999999999874 58899999986543344455677889999999999999999886654332
Q ss_pred --eeEEEEeecCCCChHHHhcCCCCCCCCCChhhHHHHHHHHHHHHHHhhcCCCCCeeeecccCCceeeCCCCcEEEeee
Q 038766 85 --LKALILEYMENGSLESVIHGPGVDHSRWTLPKRIDVLISVANGLDYLHSGYDIPIVHCDMKPSNILLDRDFEAHVSDF 162 (299)
Q Consensus 85 --~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lh~~~~~~~~H~dl~~~nil~~~~~~v~l~df 162 (299)
..++|+|++ +++|.+++. ..++++..++.++.|++.||++||+. +++|+||+|+||+++.++.++|+||
T Consensus 92 ~~~~~lv~e~~-~~~L~~~~~-----~~~l~~~~~~~~~~ql~~aL~~LH~~---gi~H~dlkp~Nill~~~~~~kL~df 162 (343)
T cd07851 92 FQDVYLVTHLM-GADLNNIVK-----CQKLSDDHIQFLVYQILRGLKYIHSA---GIIHRDLKPSNIAVNEDCELKILDF 162 (343)
T ss_pred cccEEEEEecC-CCCHHHHHh-----cCCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHeEECCCCCEEEccc
Confidence 369999999 669999885 34799999999999999999999999 9999999999999999999999999
Q ss_pred ccccccccccccccccccccccCcccCChhhhcc-cCcCccccchhhhHHHHHHHhCCCCCCCCccCCCCchhHHHHHHH
Q 038766 163 GTSRMLDVHLQDLSSLSTAFQGTIGYLAPEFAYM-RIVTTKVDVFSFGIVVMEFLTKRRPTGLDEENGLSPISLRQLVEK 241 (299)
Q Consensus 163 ~~~~~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~-~~~~~~~DiwslG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~ 241 (299)
|++..... ......++..|+|||...+ ..++.++||||||+++|+|++|..||..... .......+..
T Consensus 163 g~~~~~~~-------~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslGv~l~elltg~~pf~~~~~----~~~~~~i~~~ 231 (343)
T cd07851 163 GLARHTDD-------EMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGKTLFPGSDH----IDQLKRIMNL 231 (343)
T ss_pred cccccccc-------cccCCcccccccCHHHHhCCCCCCchHhHHHHHHHHHHHHhCCCCCCCCCh----HHHHHHHHHh
Confidence 99875431 1223346778999998765 3678899999999999999999999853321 1111111110
Q ss_pred HHhcCccCc-ccccC----------ccccchhhHhHHHHHHHHHHHHHHHHhcCCCCCCCCChhhhhcC
Q 038766 242 ALANGINGV-RQITD----------PKLVSSIYEEQEQHQVLEELFKLALVCTSSNPEDRPNMNELLIT 299 (299)
Q Consensus 242 ~~~~~~~~~-~~~~~----------~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rpt~~~il~~ 299 (299)
.....+.. ..+.. +....... ......++..+.++|++||+.||++|||+++++.|
T Consensus 232 -~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~s~~l~dli~~~l~~~P~~Rpt~~ell~h 298 (343)
T cd07851 232 -VGTPDEELLQKISSESARNYIQSLPQMPKKDF-KEVFSGANPLAIDLLEKMLVLDPDKRITAAEALAH 298 (343)
T ss_pred -cCCCCHHHHhhccchhHHHHHHhccccCCCCH-HHHhccCCHHHHHHHHHhCCCChhhCCCHHHHhcC
Confidence 00000000 00000 00000000 01122347789999999999999999999999987
|
Serine/Threonine Kinases (STKs), p38 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They function in the regulation of the cell cycle, cell development, cell differentiation, senescence, tumorigenesis, apoptosis, pain development and pain progression, and immune responses. p38 kinases are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK |
| >cd05577 STKc_GRK Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-38 Score=266.89 Aligned_cols=247 Identities=23% Similarity=0.309 Sum_probs=191.2
Q ss_pred eecCCcceEEEEEe-CCCcEEEEEEeccCcCC-hhhhHHHHHHHHHHHhcCCcceeeeeeEEEcCCCeeEEEEeecCCCC
Q 038766 20 IGNSNLSTVYKGRL-EDGEIVAVKKLNFHQFS-AESDKSFYREAKTLKELKHRNLVKVLGYAWESGKLKALILEYMENGS 97 (299)
Q Consensus 20 lg~g~~~~v~~~~~-~~~~~~~vK~~~~~~~~-~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~lv~e~~~~~~ 97 (299)
||+|++|+||++.+ .+|+.+++|++..+... ......+..|+++++.++|||++++++++.. ....++|+||+++++
T Consensus 1 lg~g~~g~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~-~~~~~lv~e~~~~~~ 79 (277)
T cd05577 1 LGKGGFGEVCACQVKATGKMYACKKLDKKRLKKRKGEQMALNEKKILEKVSSRFIVSLAYAFET-KDDLCLVMTLMNGGD 79 (277)
T ss_pred CCCCCceeEEEEEEcCCCcEEEEEEEehhhhhhhhhhHHHHHHHHHHHhCCCCCEeeeeeEEec-CCeEEEEEecCCCCc
Confidence 68999999999976 45899999998654322 2234456789999999999999999996655 456699999999999
Q ss_pred hHHHhcCCCCCCCCCChhhHHHHHHHHHHHHHHhhcCCCCCeeeecccCCceeeCCCCcEEEeeeccccccccccccccc
Q 038766 98 LESVIHGPGVDHSRWTLPKRIDVLISVANGLDYLHSGYDIPIVHCDMKPSNILLDRDFEAHVSDFGTSRMLDVHLQDLSS 177 (299)
Q Consensus 98 L~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lh~~~~~~~~H~dl~~~nil~~~~~~v~l~df~~~~~~~~~~~~~~~ 177 (299)
|.+.+...+ ...+++..++.++.|++.||.|||+. +++|+||+|+||+++.++.++|+|||.+..... ..
T Consensus 80 L~~~l~~~~--~~~~~~~~~~~~~~ql~~~l~~lH~~---~i~H~di~p~Nil~~~~~~~~l~dfg~~~~~~~-----~~ 149 (277)
T cd05577 80 LKYHIYNVG--EPGFPEARAIFYAAQIICGLEHLHQR---RIVYRDLKPENVLLDDHGNVRISDLGLAVELKG-----GK 149 (277)
T ss_pred HHHHHHHcC--cCCCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCCHHHEEECCCCCEEEccCcchhhhcc-----CC
Confidence 999886432 24689999999999999999999999 999999999999999999999999998875432 12
Q ss_pred cccccccCcccCChhhhcccCcCccccchhhhHHHHHHHhCCCCCCCCccCCCCchhHHHHHHHHHhcCccCcccccCcc
Q 038766 178 LSTAFQGTIGYLAPEFAYMRIVTTKVDVFSFGIVVMEFLTKRRPTGLDEENGLSPISLRQLVEKALANGINGVRQITDPK 257 (299)
Q Consensus 178 ~~~~~~~~~~y~~PE~~~~~~~~~~~DiwslG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 257 (299)
......++..|+|||.+.+..++.++|+||+|+++++|++|..||........ ...+....... .
T Consensus 150 ~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~-----~~~~~~~~~~~-----~----- 214 (277)
T cd05577 150 KIKGRAGTPGYMAPEVLQGEVYDFSVDWFALGCTLYEMIAGRSPFRQRKEKVE-----KEELKRRTLEM-----A----- 214 (277)
T ss_pred ccccccCCCCcCCHHHhcCCCCCchhhhHHHHHHHHHHhhCCCCCCCCccccc-----HHHHHhccccc-----c-----
Confidence 22334567789999999888899999999999999999999999854422110 11111100000 0
Q ss_pred ccchhhHhHHHHHHHHHHHHHHHHhcCCCCCCCC-----ChhhhhcC
Q 038766 258 LVSSIYEEQEQHQVLEELFKLALVCTSSNPEDRP-----NMNELLIT 299 (299)
Q Consensus 258 ~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rp-----t~~~il~~ 299 (299)
...+...++++.++|++||..+|++|| ++.+++.|
T Consensus 215 -------~~~~~~~~~~~~~li~~~l~~~p~~R~~~~~~~~~~ll~h 254 (277)
T cd05577 215 -------VEYPDKFSPEAKDLCEALLQKDPEKRLGCRGGSADEVREH 254 (277)
T ss_pred -------ccCCccCCHHHHHHHHHHccCChhHccCCCcccHHHHHhC
Confidence 000223466899999999999999999 77778876
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. GRKs contain a central catalytic domain, flanked by N- and C-terminal extensions. The N-terminus contains an RGS (regulator of |
| >cd05581 STKc_PDK1 Catalytic domain of the Protein Serine/Threonine Kinase, Phosphoinositide-dependent kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.2e-39 Score=269.50 Aligned_cols=254 Identities=26% Similarity=0.341 Sum_probs=202.0
Q ss_pred CCCCCCceeecCCcceEEEEEeC-CCcEEEEEEeccCcC-ChhhhHHHHHHHHHHHhcC-CcceeeeeeEEEcCCCeeEE
Q 038766 12 GSFSENNIIGNSNLSTVYKGRLE-DGEIVAVKKLNFHQF-SAESDKSFYREAKTLKELK-HRNLVKVLGYAWESGKLKAL 88 (299)
Q Consensus 12 ~~y~~~~~lg~g~~~~v~~~~~~-~~~~~~vK~~~~~~~-~~~~~~~~~~e~~~l~~l~-h~~i~~~~~~~~~~~~~~~l 88 (299)
++|.+.+.||+|++|.||++... ++..+++|++..+.. .......+..|..+++++. |+||+++++++.. ++..++
T Consensus 1 ~~y~~~~~lg~g~~~~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~~~~l~~~~~i~~~~~~~~~-~~~~~l 79 (280)
T cd05581 1 DDFKFGKIIGEGSFSTVVLAKEKETNKEYAIKILDKRQLIKEKKVKYVKIEKEVLTRLNGHPGIIKLYYTFQD-EENLYF 79 (280)
T ss_pred CCceEeeeecCCCceEEEEEEEcCCCCEEEEEEechHhccchHHHHHHHHHHHHHHhcccCCCchhHHHHhcC-CceEEE
Confidence 57999999999999999999874 689999999865333 2334567888999999998 9999999996554 556699
Q ss_pred EEeecCCCChHHHhcCCCCCCCCCChhhHHHHHHHHHHHHHHhhcCCCCCeeeecccCCceeeCCCCcEEEeeecccccc
Q 038766 89 ILEYMENGSLESVIHGPGVDHSRWTLPKRIDVLISVANGLDYLHSGYDIPIVHCDMKPSNILLDRDFEAHVSDFGTSRML 168 (299)
Q Consensus 89 v~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lh~~~~~~~~H~dl~~~nil~~~~~~v~l~df~~~~~~ 168 (299)
|+|++.+++|.+++. ....+++..++.++.|++.||.+||+. +++|+||+|+||+++.++.++|+|||++...
T Consensus 80 v~e~~~~~~L~~~l~----~~~~l~~~~~~~i~~ql~~~l~~Lh~~---~~~H~dl~~~ni~i~~~~~~~l~df~~~~~~ 152 (280)
T cd05581 80 VLEYAPNGELLQYIR----KYGSLDEKCTRFYAAEILLALEYLHSK---GIIHRDLKPENILLDKDMHIKITDFGTAKVL 152 (280)
T ss_pred EEcCCCCCcHHHHHH----HcCCCCHHHHHHHHHHHHHHHHHHHHC---CeeecCCCHHHeEECCCCCEEecCCcccccc
Confidence 999999999999997 334799999999999999999999998 9999999999999999999999999998765
Q ss_pred ccccccc----------------cccccccccCcccCChhhhcccCcCccccchhhhHHHHHHHhCCCCCCCCccCCCCc
Q 038766 169 DVHLQDL----------------SSLSTAFQGTIGYLAPEFAYMRIVTTKVDVFSFGIVVMEFLTKRRPTGLDEENGLSP 232 (299)
Q Consensus 169 ~~~~~~~----------------~~~~~~~~~~~~y~~PE~~~~~~~~~~~DiwslG~~l~~l~~g~~p~~~~~~~~~~~ 232 (299)
....... ........++..|+|||......++.++|+||||++++++++|..||.... .
T Consensus 153 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Pe~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~-----~ 227 (280)
T cd05581 153 DPNSSPESNKGDATNIDSQIEKNRRRFASFVGTAEYVSPELLNEKPAGKSSDLWALGCIIYQMLTGKPPFRGSN-----E 227 (280)
T ss_pred CCccccccCCCCCccccccccccccccccccCCccccCHHHhCCCCCChhhhHHHHHHHHHHHHhCCCCCCCcc-----H
Confidence 4322110 012233456788999999988889999999999999999999999986442 1
Q ss_pred hhHHHHHHHHHhcCccCcccccCccccchhhHhHHHHHHHHHHHHHHHHhcCCCCCCCCCh----hhhhcC
Q 038766 233 ISLRQLVEKALANGINGVRQITDPKLVSSIYEEQEQHQVLEELFKLALVCTSSNPEDRPNM----NELLIT 299 (299)
Q Consensus 233 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rpt~----~~il~~ 299 (299)
. .......... . ..+..++..+.++|.+||..+|++|||+ ++++.|
T Consensus 228 ~---~~~~~~~~~~----~--------------~~~~~~~~~~~~li~~~l~~~p~~R~~~~~~~~~ll~~ 277 (280)
T cd05581 228 Y---LTFQKILKLE----Y--------------SFPPNFPPDAKDLIEKLLVLDPQDRLGVNEGYDELKAH 277 (280)
T ss_pred H---HHHHHHHhcC----C--------------CCCCccCHHHHHHHHHHhcCCHhhCCCcccCHHHHhcC
Confidence 1 1111111100 0 0022235678999999999999999999 999987
|
Serine/Threonine Kinases (STKs), Phosphoinositide-dependent kinase 1 (PDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PDK1 carries an N-terminal catalytic domain and a C-terminal pleckstrin homology (PH) domain that binds phosphoinositides. It phosphorylates the activation loop of AGC kinases that are regulated by PI3K such as PKB, SGK, and PKC, among others, and is crucial for their activation. Thus, it contributes in regulating many processes including metabolism, growth, proliferation, and survival. PDK1 also has the ability to auto |
| >KOG1095 consensus Protein tyrosine kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-39 Score=298.45 Aligned_cols=256 Identities=28% Similarity=0.457 Sum_probs=202.6
Q ss_pred hCCCCCCceeecCCcceEEEEEeC--CCc----EEEEEEeccCcCChhhhHHHHHHHHHHHhcCCcceeeeeeEEEcCCC
Q 038766 11 TGSFSENNIIGNSNLSTVYKGRLE--DGE----IVAVKKLNFHQFSAESDKSFYREAKTLKELKHRNLVKVLGYAWESGK 84 (299)
Q Consensus 11 ~~~y~~~~~lg~g~~~~v~~~~~~--~~~----~~~vK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~ 84 (299)
.+.....+.||+|.||.||.+... .|. .||+|.+.. ..+......+.+|..+|+.++||||++++|++...+.
T Consensus 691 ~~~v~l~~~lG~G~FG~VY~g~~~~~~~~~~~~~vaiK~l~~-~~~~~~~~~Fl~Ea~~m~~f~HpNiv~liGv~l~~~~ 769 (1025)
T KOG1095|consen 691 RKNVTLLRVLGKGAFGEVYEGTYSDVPGSVSPIQVAVKSLKR-LSSEQEVSDFLKEALLMSKFDHPNIVSLIGVCLDSGP 769 (1025)
T ss_pred hhheEeeeeeccccccceEEEEEecCCCCccceEEEEEeccc-cCCHHHHHHHHHHHHHHhcCCCcceeeEEEeecCCCC
Confidence 456677899999999999999753 233 488888753 3456678889999999999999999999999999554
Q ss_pred eeEEEEeecCCCChHHHhcCCC---CCCCCCChhhHHHHHHHHHHHHHHhhcCCCCCeeeecccCCceeeCCCCcEEEee
Q 038766 85 LKALILEYMENGSLESVIHGPG---VDHSRWTLPKRIDVLISVANGLDYLHSGYDIPIVHCDMKPSNILLDRDFEAHVSD 161 (299)
Q Consensus 85 ~~~lv~e~~~~~~L~~~~~~~~---~~~~~~~~~~~~~i~~qi~~~l~~lh~~~~~~~~H~dl~~~nil~~~~~~v~l~d 161 (299)
.++++|||.+|+|.+++.+.. .....++....+.++.+||+++.||+++ +++||||..+|+|++....||++|
T Consensus 770 -~~i~leyM~gGDL~sflr~~r~~~~~~~~L~~~dLl~~a~dvA~G~~YLe~~---~fvHRDLAaRNCLL~~~r~VKIaD 845 (1025)
T KOG1095|consen 770 -PLILLEYMEGGDLLSFLRESRPAPFQPSNLSMRDLLAFALDVAKGMNYLESK---HFVHRDLAARNCLLDERRVVKIAD 845 (1025)
T ss_pred -cEEEehhcccCcHHHHHHhcccccCCCCCCCHHHHHHHHHHHhhhhHHHHhC---CCcCcchhhhheeecccCcEEEcc
Confidence 499999999999999997641 1245788999999999999999999999 999999999999999999999999
Q ss_pred eccccccccccccccccccccccCcccCChhhhcccCcCccccchhhhHHHHHHHh-CCCCCCCCccCCCCchhHHHHHH
Q 038766 162 FGTSRMLDVHLQDLSSLSTAFQGTIGYLAPEFAYMRIVTTKVDVFSFGIVVMEFLT-KRRPTGLDEENGLSPISLRQLVE 240 (299)
Q Consensus 162 f~~~~~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~DiwslG~~l~~l~~-g~~p~~~~~~~~~~~~~~~~~~~ 240 (299)
||+++.+.. ...........-+..|||||.+.+..++.++||||||+++||+++ |..||... .+.++..
T Consensus 846 FGlArDiy~--~~yyr~~~~a~lPvkWm~PEsl~d~iFtskSDvWsFGVllWEifslG~~PY~~~-----~n~~v~~--- 915 (1025)
T KOG1095|consen 846 FGLARDIYD--KDYYRKHGEAMLPVKWMPPESLKDGIFTSKSDVWSFGVLLWEIFSLGATPYPSR-----SNFEVLL--- 915 (1025)
T ss_pred cchhHhhhh--chheeccCccccceecCCHHHHhhcccccccchhhhHHHHHHHHhCCCCCCCCc-----chHHHHH---
Confidence 999983321 122222222234578999999999999999999999999999998 67777433 2222222
Q ss_pred HHHhcCccCcccccCccccchhhHhHHHHHHHHHHHHHHHHhcCCCCCCCCChhhhhc
Q 038766 241 KALANGINGVRQITDPKLVSSIYEEQEQHQVLEELFKLALVCTSSNPEDRPNMNELLI 298 (299)
Q Consensus 241 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rpt~~~il~ 298 (299)
.....+ + ...+...++.+.+++.+||+.+|++||++..|++
T Consensus 916 ~~~~gg--R---------------L~~P~~CP~~ly~lM~~CW~~~pe~RP~F~~i~~ 956 (1025)
T KOG1095|consen 916 DVLEGG--R---------------LDPPSYCPEKLYQLMLQCWKHDPEDRPSFRTIVE 956 (1025)
T ss_pred HHHhCC--c---------------cCCCCCCChHHHHHHHHHccCChhhCccHHHHHh
Confidence 222111 1 1115566778999999999999999999999875
|
|
| >cd05056 PTKc_FAK Catalytic domain of the Protein Tyrosine Kinase, Focal Adhesion Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.4e-39 Score=267.24 Aligned_cols=252 Identities=24% Similarity=0.332 Sum_probs=194.2
Q ss_pred HhCCCCCCceeecCCcceEEEEEeCC----CcEEEEEEeccCcCChhhhHHHHHHHHHHHhcCCcceeeeeeEEEcCCCe
Q 038766 10 ATGSFSENNIIGNSNLSTVYKGRLED----GEIVAVKKLNFHQFSAESDKSFYREAKTLKELKHRNLVKVLGYAWESGKL 85 (299)
Q Consensus 10 ~~~~y~~~~~lg~g~~~~v~~~~~~~----~~~~~vK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~ 85 (299)
-.++|.+.+.||+|++|.||++.+.+ ...+++|..... ......+.+.+|+..++.+.|+||+++++++.. ..
T Consensus 4 ~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~v~ik~~~~~-~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~--~~ 80 (270)
T cd05056 4 QREDITLGRCIGEGQFGDVYQGVYMSPENEKIAVAVKTCKNC-TSPSVREKFLQEAYIMRQFDHPHIVKLIGVITE--NP 80 (270)
T ss_pred chhhceeeeeeCCccceeEEEEEEecCCCCCcceEEEecCCc-CCHHHHHHHHHHHHHHHhCCCCchhceeEEEcC--CC
Confidence 35679999999999999999997532 346899987532 224456678899999999999999999996653 33
Q ss_pred eEEEEeecCCCChHHHhcCCCCCCCCCChhhHHHHHHHHHHHHHHhhcCCCCCeeeecccCCceeeCCCCcEEEeeeccc
Q 038766 86 KALILEYMENGSLESVIHGPGVDHSRWTLPKRIDVLISVANGLDYLHSGYDIPIVHCDMKPSNILLDRDFEAHVSDFGTS 165 (299)
Q Consensus 86 ~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lh~~~~~~~~H~dl~~~nil~~~~~~v~l~df~~~ 165 (299)
.++|+||+++++|.+++... ...+++..++.++.|++.||+|||+. +++|+||+|+||+++.++.++|+|||++
T Consensus 81 ~~lv~e~~~~~~L~~~l~~~---~~~~~~~~~~~~~~~l~~~l~~lH~~---~~~H~dl~p~nili~~~~~~~l~d~g~~ 154 (270)
T cd05056 81 VWIVMELAPLGELRSYLQVN---KYSLDLASLILYSYQLSTALAYLESK---RFVHRDIAARNVLVSSPDCVKLGDFGLS 154 (270)
T ss_pred cEEEEEcCCCCcHHHHHHhC---CCCCCHHHHHHHHHHHHHHHHHHHhC---CeeccccChheEEEecCCCeEEccCcee
Confidence 58999999999999998642 23589999999999999999999998 9999999999999999999999999998
Q ss_pred cccccccccccccccccccCcccCChhhhcccCcCccccchhhhHHHHHHHh-CCCCCCCCccCCCCchhHHHHHHHHHh
Q 038766 166 RMLDVHLQDLSSLSTAFQGTIGYLAPEFAYMRIVTTKVDVFSFGIVVMEFLT-KRRPTGLDEENGLSPISLRQLVEKALA 244 (299)
Q Consensus 166 ~~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~DiwslG~~l~~l~~-g~~p~~~~~~~~~~~~~~~~~~~~~~~ 244 (299)
....... ........++..|+|||.+....++.++||||||++++++++ |..||..... ......+. .
T Consensus 155 ~~~~~~~---~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~pf~~~~~-----~~~~~~~~---~ 223 (270)
T cd05056 155 RYLEDES---YYKASKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMLGVKPFQGVKN-----NDVIGRIE---N 223 (270)
T ss_pred eeccccc---ceecCCCCccccccChhhhccCCCCchhhhHHHHHHHHHHHHcCCCCCCCCCH-----HHHHHHHH---c
Confidence 7544211 011112234567999999888889999999999999999886 9999853321 11111111 0
Q ss_pred cCccCcccccCccccchhhHhHHHHHHHHHHHHHHHHhcCCCCCCCCChhhhhc
Q 038766 245 NGINGVRQITDPKLVSSIYEEQEQHQVLEELFKLALVCTSSNPEDRPNMNELLI 298 (299)
Q Consensus 245 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rpt~~~il~ 298 (299)
.. .... +...+.++.+++.+|+..+|++|||+.++++
T Consensus 224 ~~-----~~~~------------~~~~~~~~~~li~~~l~~~P~~Rpt~~~~~~ 260 (270)
T cd05056 224 GE-----RLPM------------PPNCPPTLYSLMTKCWAYDPSKRPRFTELKA 260 (270)
T ss_pred CC-----cCCC------------CCCCCHHHHHHHHHHcCCChhhCcCHHHHHH
Confidence 00 0000 2234568999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Focal Adhesion Kinase (FAK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FAK is a cytoplasmic (or nonreceptor) tyr kinase that contains an autophosphorylation site and a FERM domain at the N-terminus, a central tyr kinase domain, proline-rich regions, and a C-terminal FAT (focal adhesion targeting) domain. FAK activity is dependent on integrin-mediated cell adhesion, which facilitates N-terminal autophosphorylation. Full activation is achieved by the phosphorylation of its two adjacent A-loop tyrosines. FAK is important in mediating signaling initiated at sites of cell adhesions |
| >cd05046 PTK_CCK4 Pseudokinase domain of the Protein Tyrosine Kinase, Colon Carcinoma Kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.5e-39 Score=267.51 Aligned_cols=256 Identities=25% Similarity=0.360 Sum_probs=194.8
Q ss_pred hCCCCCCceeecCCcceEEEEEeC------CCcEEEEEEeccCcCChhhhHHHHHHHHHHHhcCCcceeeeeeEEEcCCC
Q 038766 11 TGSFSENNIIGNSNLSTVYKGRLE------DGEIVAVKKLNFHQFSAESDKSFYREAKTLKELKHRNLVKVLGYAWESGK 84 (299)
Q Consensus 11 ~~~y~~~~~lg~g~~~~v~~~~~~------~~~~~~vK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~ 84 (299)
.++|.+.+.||+|+||.||+++.+ +...+++|.+... ........+.+|++++++++|+||+++++++.. ..
T Consensus 4 ~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~~~k~~~~~-~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~-~~ 81 (275)
T cd05046 4 RSNLQEITTLGRGEFGEVFLAKAKGIEEEGGETLVLVKALQKT-KDENLQSEFRRELDMFRKLSHKNVVRLLGLCRE-AE 81 (275)
T ss_pred hHhceeeeeecccceeEEEEEEeccCCcCCCcceEEEEccCCc-cchHHHHHHHHHHHHHHhcCCcceeeeEEEECC-CC
Confidence 368999999999999999999853 2567899987532 223356778999999999999999999996654 45
Q ss_pred eeEEEEeecCCCChHHHhcCCCCC-----CCCCChhhHHHHHHHHHHHHHHhhcCCCCCeeeecccCCceeeCCCCcEEE
Q 038766 85 LKALILEYMENGSLESVIHGPGVD-----HSRWTLPKRIDVLISVANGLDYLHSGYDIPIVHCDMKPSNILLDRDFEAHV 159 (299)
Q Consensus 85 ~~~lv~e~~~~~~L~~~~~~~~~~-----~~~~~~~~~~~i~~qi~~~l~~lh~~~~~~~~H~dl~~~nil~~~~~~v~l 159 (299)
..++|+||+.+++|.+++...... ...+++..+..++.|++.||+|||+. +++|+||||+||+++.++.+++
T Consensus 82 ~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~l~~~~~~~~~~~l~~~l~~LH~~---~i~H~dlkp~Nili~~~~~~~l 158 (275)
T cd05046 82 PHYMILEYTDLGDLKQFLRATKSKDEKLKPPPLSTKQKVALCTQIALGMDHLSNA---RFVHRDLAARNCLVSSQREVKV 158 (275)
T ss_pred cceEEEEecCCCcHHHHHHhcccccccccccCCCHHHHHHHHHHHHHHHHHhhhc---CcccCcCccceEEEeCCCcEEE
Confidence 569999999999999998643211 12689999999999999999999999 9999999999999999999999
Q ss_pred eeeccccccccccccccccccccccCcccCChhhhcccCcCccccchhhhHHHHHHHh-CCCCCCCCccCCCCchhHHHH
Q 038766 160 SDFGTSRMLDVHLQDLSSLSTAFQGTIGYLAPEFAYMRIVTTKVDVFSFGIVVMEFLT-KRRPTGLDEENGLSPISLRQL 238 (299)
Q Consensus 160 ~df~~~~~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~DiwslG~~l~~l~~-g~~p~~~~~~~~~~~~~~~~~ 238 (299)
+|||++..... ..........++..|+|||...+...+.++||||||+++|+|++ |..||... .... .
T Consensus 159 ~~~~~~~~~~~---~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~~l~~~~~~p~~~~-----~~~~---~ 227 (275)
T cd05046 159 SLLSLSKDVYN---SEYYKLRNALIPLRWLAPEAVQEDDFSTKSDVWSFGVLMWEVFTQGELPFYGL-----SDEE---V 227 (275)
T ss_pred cccccccccCc---ccccccCCceeEEeecChhhhccCCCCchhhHHHHHHHHHHHHhCCCCCcccc-----chHH---H
Confidence 99998764321 11111223345677999999888888999999999999999998 67777422 1111 1
Q ss_pred HHHHHhcCccCcccccCccccchhhHhHHHHHHHHHHHHHHHHhcCCCCCCCCChhhhhc
Q 038766 239 VEKALANGINGVRQITDPKLVSSIYEEQEQHQVLEELFKLALVCTSSNPEDRPNMNELLI 298 (299)
Q Consensus 239 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rpt~~~il~ 298 (299)
......... . +.. ...++..+.+++.+||+.+|++|||+.+++.
T Consensus 228 ~~~~~~~~~-~---~~~------------~~~~~~~l~~~i~~~l~~~p~~Rp~~~~~l~ 271 (275)
T cd05046 228 LNRLQAGKL-E---LPV------------PEGCPSRLYKLMTRCWAVNPKDRPSFSELVS 271 (275)
T ss_pred HHHHHcCCc-C---CCC------------CCCCCHHHHHHHHHHcCCCcccCCCHHHHHH
Confidence 111110000 0 000 1223457999999999999999999999985
|
Protein Tyrosine Kinase (PTK) family; Colon Carcinoma Kinase 4 (CCK4); pseudokinase domain. The PTKc (catalytic domain) family, to which this subfamily belongs, includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CCK4, also called protein tyrosine kinase 7 (PTK7), is an orphan receptor tyr kinase (RTK) containing an extracellular region with seven immunoglobulin domains, a transmembrane segment, and an intracellular inactive pseudokinase domain. Studies in mice reveal that CCK4 is essential for neural development. Mouse embryos containing a truncated CCK4 die perinatally and display craniorachischisis, a severe form of neural tube defect. The mechanism of action of the CCK4 pseudokinase is s |
| >cd05107 PTKc_PDGFR_beta Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor beta | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-38 Score=278.27 Aligned_cols=262 Identities=22% Similarity=0.315 Sum_probs=199.1
Q ss_pred HHHHHhCCCCCCceeecCCcceEEEEEeC------CCcEEEEEEeccCcCChhhhHHHHHHHHHHHhcC-CcceeeeeeE
Q 038766 6 EIENATGSFSENNIIGNSNLSTVYKGRLE------DGEIVAVKKLNFHQFSAESDKSFYREAKTLKELK-HRNLVKVLGY 78 (299)
Q Consensus 6 ~~~~~~~~y~~~~~lg~g~~~~v~~~~~~------~~~~~~vK~~~~~~~~~~~~~~~~~e~~~l~~l~-h~~i~~~~~~ 78 (299)
+++.-.++|.+.+.||+|+||.||++.+. .+..||+|++.... .......+..|+.++.++. ||||+++++.
T Consensus 31 ~~~~~~~~~~~~~~lG~G~fG~Vy~~~~~~~~~~~~~~~vavK~l~~~~-~~~~~~~~~~E~~~l~~l~~H~niv~~~~~ 109 (401)
T cd05107 31 AWEMPRDNLVLGRTLGSGAFGRVVEATAHGLSHSQSTMKVAVKMLKSTA-RSSEKQALMSELKIMSHLGPHLNIVNLLGA 109 (401)
T ss_pred cceecHHHeehhhhccCCCceeEEEEEEcCCCCCCCceEEEEEecCCCC-ChhHHHHHHHHHHHHHhcCCCCCeEEEEEE
Confidence 46777788999999999999999999853 35689999997543 2333456889999999997 9999999997
Q ss_pred EEcCCCeeEEEEeecCCCChHHHhcCCCC---------------------------------------------------
Q 038766 79 AWESGKLKALILEYMENGSLESVIHGPGV--------------------------------------------------- 107 (299)
Q Consensus 79 ~~~~~~~~~lv~e~~~~~~L~~~~~~~~~--------------------------------------------------- 107 (299)
+... ...++|+||+.+++|.+++.....
T Consensus 110 ~~~~-~~~~iv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 188 (401)
T cd05107 110 CTKG-GPIYIITEYCRYGDLVDYLHRNKHTFLQYYLDKNRDDGSLISGGSTPLSQRKSHVSLGSESDGGYMDMSKDESAD 188 (401)
T ss_pred EccC-CCcEEEEeccCCCcHHHHHHhccccchhhhcccccccccccccccccccccccchhhhhccCccccccCCccccC
Confidence 7654 456999999999999988854210
Q ss_pred -------------------------------------------CCCCCChhhHHHHHHHHHHHHHHhhcCCCCCeeeecc
Q 038766 108 -------------------------------------------DHSRWTLPKRIDVLISVANGLDYLHSGYDIPIVHCDM 144 (299)
Q Consensus 108 -------------------------------------------~~~~~~~~~~~~i~~qi~~~l~~lh~~~~~~~~H~dl 144 (299)
....++...++.++.|++.||+|||+. +++|+||
T Consensus 189 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~---~ivHrdl 265 (401)
T cd05107 189 YVPMQDMKGTVKYADIESSNYESPYDQYLPSAPERTRRDTLINESPALSYMDLVGFSYQVANGMEFLASK---NCVHRDL 265 (401)
T ss_pred ccchhcchhhhhhhhhhccCcCCchhhhhcccCCCcchhhhhcCCCCCCHHHHHHHHHHHHHHHHHHhcC---CcCcccC
Confidence 112466777889999999999999998 9999999
Q ss_pred cCCceeeCCCCcEEEeeeccccccccccccccccccccccCcccCChhhhcccCcCccccchhhhHHHHHHHh-CCCCCC
Q 038766 145 KPSNILLDRDFEAHVSDFGTSRMLDVHLQDLSSLSTAFQGTIGYLAPEFAYMRIVTTKVDVFSFGIVVMEFLT-KRRPTG 223 (299)
Q Consensus 145 ~~~nil~~~~~~v~l~df~~~~~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~DiwslG~~l~~l~~-g~~p~~ 223 (299)
||+||+++.++.++|+|||++..+..... ........++..|+|||.+.+..++.++|+||||+++|+|++ |..||.
T Consensus 266 kp~NiLl~~~~~~kL~DfGla~~~~~~~~--~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslGvil~e~l~~g~~P~~ 343 (401)
T cd05107 266 AARNVLICEGKLVKICDFGLARDIMRDSN--YISKGSTFLPLKWMAPESIFNNLYTTLSDVWSFGILLWEIFTLGGTPYP 343 (401)
T ss_pred CcceEEEeCCCEEEEEecCcceecccccc--cccCCCcCCCCceeChHHhcCCCCCcHhHHHHHHHHHHHHHHcCCCCCC
Confidence 99999999999999999999875432111 011122345678999999998889999999999999999998 888875
Q ss_pred CCccCCCCchhHHHHHHHHHhcCccCcccccCccccchhhHhHHHHHHHHHHHHHHHHhcCCCCCCCCChhhhhc
Q 038766 224 LDEENGLSPISLRQLVEKALANGINGVRQITDPKLVSSIYEEQEQHQVLEELFKLALVCTSSNPEDRPNMNELLI 298 (299)
Q Consensus 224 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rpt~~~il~ 298 (299)
.... ....... ...+.. ... +..++.++.+++.+||..+|.+||++++|++
T Consensus 344 ~~~~----~~~~~~~----~~~~~~----~~~------------p~~~~~~l~~li~~cl~~~P~~RPs~~ell~ 394 (401)
T cd05107 344 ELPM----NEQFYNA----IKRGYR----MAK------------PAHASDEIYEIMQKCWEEKFEIRPDFSQLVH 394 (401)
T ss_pred CCCc----hHHHHHH----HHcCCC----CCC------------CCCCCHHHHHHHHHHcCCChhHCcCHHHHHH
Confidence 3311 1111111 111100 000 1223568999999999999999999999985
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) beta; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR beta is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR beta forms homodimers or heterodimers with PDGFR alpha, depending on the nature of the PDGF ligand. PDGF-BB and PDGF-D |
| >PHA03390 pk1 serine/threonine-protein kinase 1; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-38 Score=263.70 Aligned_cols=247 Identities=18% Similarity=0.290 Sum_probs=189.4
Q ss_pred HHHhCCCCCCcee--ecCCcceEEEEEe-CCCcEEEEEEeccCcCChhhhHHHHHHHHHHHhc-CCcceeeeeeEEEcCC
Q 038766 8 ENATGSFSENNII--GNSNLSTVYKGRL-EDGEIVAVKKLNFHQFSAESDKSFYREAKTLKEL-KHRNLVKVLGYAWESG 83 (299)
Q Consensus 8 ~~~~~~y~~~~~l--g~g~~~~v~~~~~-~~~~~~~vK~~~~~~~~~~~~~~~~~e~~~l~~l-~h~~i~~~~~~~~~~~ 83 (299)
-...++|.+.+.+ |+|+||.||++.. .++..+++|++........ |......+ .|+|++++++.+...+
T Consensus 10 ~~~~~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~k~~~~~~~~~~-------e~~~~~~~~~h~~iv~~~~~~~~~~ 82 (267)
T PHA03390 10 VQFLKNCEIVKKLKLIDGKFGKVSVLKHKPTQKLFVQKIIKAKNFNAI-------EPMVHQLMKDNPNFIKLYYSVTTLK 82 (267)
T ss_pred HHHHHhhccccceeecCCCceEEEEEEEcCCCcEEEEEEEehhhcchh-------hHHHHHHhhcCCCEEEEEEEEecCC
Confidence 3345677887777 9999999999986 4588899999864322211 22222222 6999999999776644
Q ss_pred CeeEEEEeecCCCChHHHhcCCCCCCCCCChhhHHHHHHHHHHHHHHhhcCCCCCeeeecccCCceeeCCCC-cEEEeee
Q 038766 84 KLKALILEYMENGSLESVIHGPGVDHSRWTLPKRIDVLISVANGLDYLHSGYDIPIVHCDMKPSNILLDRDF-EAHVSDF 162 (299)
Q Consensus 84 ~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lh~~~~~~~~H~dl~~~nil~~~~~-~v~l~df 162 (299)
..++|+||+++++|.+++. .+..+++.+++.++.|+++||.+||+. +++|+||+|+||+++.++ .++|+||
T Consensus 83 -~~~iv~e~~~~~~L~~~l~----~~~~l~~~~~~~~~~qi~~~l~~lH~~---~i~H~dl~p~nil~~~~~~~~~l~df 154 (267)
T PHA03390 83 -GHVLIMDYIKDGDLFDLLK----KEGKLSEAEVKKIIRQLVEALNDLHKH---NIIHNDIKLENVLYDRAKDRIYLCDY 154 (267)
T ss_pred -eeEEEEEcCCCCcHHHHHH----hcCCCCHHHHHHHHHHHHHHHHHHHhC---CeeeCCCCHHHEEEeCCCCeEEEecC
Confidence 6699999999999999997 344899999999999999999999999 999999999999999988 9999999
Q ss_pred ccccccccccccccccccccccCcccCChhhhcccCcCccccchhhhHHHHHHHhCCCCCCCCccCCCCchhHHHHHHHH
Q 038766 163 GTSRMLDVHLQDLSSLSTAFQGTIGYLAPEFAYMRIVTTKVDVFSFGIVVMEFLTKRRPTGLDEENGLSPISLRQLVEKA 242 (299)
Q Consensus 163 ~~~~~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~DiwslG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~ 242 (299)
|++..... .....++..|+|||.+.+..++.++|+||+|+++|+|++|..||.......... .......
T Consensus 155 g~~~~~~~--------~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~~l~~g~~p~~~~~~~~~~~---~~~~~~~ 223 (267)
T PHA03390 155 GLCKIIGT--------PSCYDGTLDYFSPEKIKGHNYDVSFDWWAVGVLTYELLTGKHPFKEDEDEELDL---ESLLKRQ 223 (267)
T ss_pred ccceecCC--------CccCCCCCcccChhhhcCCCCCchhhHHHHHHHHHHHHHCCCCCCCCCcchhhH---HHHHHhh
Confidence 98875431 122346789999999998889999999999999999999999996432222111 1111110
Q ss_pred HhcCccCcccccCccccchhhHhHHHHHHHHHHHHHHHHhcCCCCCCCCC-hhhhhcC
Q 038766 243 LANGINGVRQITDPKLVSSIYEEQEQHQVLEELFKLALVCTSSNPEDRPN-MNELLIT 299 (299)
Q Consensus 243 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rpt-~~~il~~ 299 (299)
.. .. ......+..+.++|.+||+.+|.+||+ ++++|+|
T Consensus 224 -~~------~~------------~~~~~~~~~~~~li~~~l~~~p~~R~~~~~~~l~h 262 (267)
T PHA03390 224 -QK------KL------------PFIKNVSKNANDFVQSMLKYNINYRLTNYNEIIKH 262 (267)
T ss_pred -cc------cC------------CcccccCHHHHHHHHHHhccChhhCCchHHHHhcC
Confidence 00 00 002245678999999999999999996 5999987
|
|
| >cd07866 STKc_BUR1 Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Bypass UAS Requirement 1 and similar proteins | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-38 Score=270.66 Aligned_cols=275 Identities=25% Similarity=0.303 Sum_probs=198.1
Q ss_pred hCCCCCCceeecCCcceEEEEEeC-CCcEEEEEEeccCcCChhhhHHHHHHHHHHHhcCCcceeeeeeEEEcCC------
Q 038766 11 TGSFSENNIIGNSNLSTVYKGRLE-DGEIVAVKKLNFHQFSAESDKSFYREAKTLKELKHRNLVKVLGYAWESG------ 83 (299)
Q Consensus 11 ~~~y~~~~~lg~g~~~~v~~~~~~-~~~~~~vK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~------ 83 (299)
.++|.+.+.||+|++|.||++.+. +++.+++|++..............+|++.++.++|+||+++++.+....
T Consensus 7 ~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~~ 86 (311)
T cd07866 7 LRDYEILGKLGEGTFGEVYKARQIKTGRVVALKKILMHNEKDGFPITALREIKILKKLKHPNVVPLIDMAVERPDKSKRK 86 (311)
T ss_pred cccEEEEEEeccCCCEEEEEEEECCCCcEEEEEEEEeccCCCCcchhHHHHHHHHHhcCCCCccchhhheeccccccccc
Confidence 589999999999999999999864 5899999998755444434456778999999999999999999765433
Q ss_pred -CeeEEEEeecCCCChHHHhcCCCCCCCCCChhhHHHHHHHHHHHHHHhhcCCCCCeeeecccCCceeeCCCCcEEEeee
Q 038766 84 -KLKALILEYMENGSLESVIHGPGVDHSRWTLPKRIDVLISVANGLDYLHSGYDIPIVHCDMKPSNILLDRDFEAHVSDF 162 (299)
Q Consensus 84 -~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lh~~~~~~~~H~dl~~~nil~~~~~~v~l~df 162 (299)
...++|+||+.+ ++...+.. ....+++..++.++.|+++||+|||+. +++|+||+|+||+++.++.++|+||
T Consensus 87 ~~~~~lv~~~~~~-~l~~~~~~---~~~~~~~~~~~~i~~~l~~al~~lH~~---~i~H~dl~p~nil~~~~~~~~l~df 159 (311)
T cd07866 87 RGSVYMVTPYMDH-DLSGLLEN---PSVKLTESQIKCYMLQLLEGINYLHEN---HILHRDIKAANILIDNQGILKIADF 159 (311)
T ss_pred CceEEEEEecCCc-CHHHHHhc---cccCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHEEECCCCCEEECcC
Confidence 346899999954 77776653 235799999999999999999999999 9999999999999999999999999
Q ss_pred cccccccccccccc-------ccccccccCcccCChhhhccc-CcCccccchhhhHHHHHHHhCCCCCCCCccCCCCchh
Q 038766 163 GTSRMLDVHLQDLS-------SLSTAFQGTIGYLAPEFAYMR-IVTTKVDVFSFGIVVMEFLTKRRPTGLDEENGLSPIS 234 (299)
Q Consensus 163 ~~~~~~~~~~~~~~-------~~~~~~~~~~~y~~PE~~~~~-~~~~~~DiwslG~~l~~l~~g~~p~~~~~~~~~~~~~ 234 (299)
|++........... .......+++.|+|||.+.+. .++.++||||+|+++|+|++|..||..... ..
T Consensus 160 g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~el~~g~~~~~~~~~-----~~ 234 (311)
T cd07866 160 GLARPYDGPPPNPKGGGGGGTRKYTNLVVTRWYRPPELLLGERRYTTAVDIWGIGCVFAEMFTRRPILQGKSD-----ID 234 (311)
T ss_pred ccchhccCCCcccccCCcccccccccceeccCcCChHHhhCCCccCchhHhHHHHHHHHHHHhCCCCCCCCCH-----HH
Confidence 99875542211111 111233457789999987654 578899999999999999999999853321 11
Q ss_pred HHHHHHHHHhc-C------ccCccccc----CccccchhhHhHHHHHHHHHHHHHHHHhcCCCCCCCCChhhhhcC
Q 038766 235 LRQLVEKALAN-G------INGVRQIT----DPKLVSSIYEEQEQHQVLEELFKLALVCTSSNPEDRPNMNELLIT 299 (299)
Q Consensus 235 ~~~~~~~~~~~-~------~~~~~~~~----~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rpt~~~il~~ 299 (299)
....+...... . +....... ....... ........+..+.++|.+||..||++|||+.+++.|
T Consensus 235 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~~~~~i~~~l~~~p~~R~t~~ell~~ 308 (311)
T cd07866 235 QLHLIFKLCGTPTEETWPGWRSLPGCEGVHSFTNYPRT--LEERFGKLGPEGLDLLSKLLSLDPYKRLTASDALEH 308 (311)
T ss_pred HHHHHHHHhCCCChhhchhhhhcccccccccCCCCCcc--HHHHcccCChhHHHHHHHHcccCcccCcCHHHHhcC
Confidence 11111110000 0 00000000 0000000 001122344678999999999999999999999987
|
Serine/Threonine Kinases (STKs), Bypass UAS Requirement 1 (BUR1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The BUR1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. BUR1, also called SGV1, is a yeast Cyclin-Dependent protein Kinase (CDK) that is functionally equivalent to mammalian CDK9. It associates with the cyclin BUR2. BUR genes were orginally identified in a genetic |
| >cd08226 PK_STRAD_beta Pseudokinase domain of STE20-related kinase adapter protein beta | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.8e-38 Score=269.72 Aligned_cols=269 Identities=22% Similarity=0.281 Sum_probs=193.3
Q ss_pred ceeecC--CcceEEEEEeC-CCcEEEEEEeccCcCChhhhHHHHHHHHHHHhcCCcceeeeeeEEEcCCCeeEEEEeecC
Q 038766 18 NIIGNS--NLSTVYKGRLE-DGEIVAVKKLNFHQFSAESDKSFYREAKTLKELKHRNLVKVLGYAWESGKLKALILEYME 94 (299)
Q Consensus 18 ~~lg~g--~~~~v~~~~~~-~~~~~~vK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~lv~e~~~ 94 (299)
..||+| ++++||++.+. +|+.||+|++..........+.+.+|+.+++.++||||+++++++.. +...++|+||+.
T Consensus 4 ~~ig~g~~~~~~v~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~~~~l~h~niv~~~~~~~~-~~~~~~v~e~~~ 82 (328)
T cd08226 4 VEIGRGFCNLTSVYLARHTPTGTLVTVRITDLENCTEEHLKALQNEVVLSHFFRHPNIMTSWTVFTT-GSWLWVISPFMA 82 (328)
T ss_pred HHhCCcccCceeEEEEEEcCCCcEEEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCcceEeeeEec-CCceEEEEeccc
Confidence 455665 99999999874 69999999987655555667888999999999999999999997766 455699999999
Q ss_pred CCChHHHhcCCCCCCCCCChhhHHHHHHHHHHHHHHhhcCCCCCeeeecccCCceeeCCCCcEEEeeecccccccccccc
Q 038766 95 NGSLESVIHGPGVDHSRWTLPKRIDVLISVANGLDYLHSGYDIPIVHCDMKPSNILLDRDFEAHVSDFGTSRMLDVHLQD 174 (299)
Q Consensus 95 ~~~L~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lh~~~~~~~~H~dl~~~nil~~~~~~v~l~df~~~~~~~~~~~~ 174 (299)
+++|.+++.... ...+++..+..++.|++.||+|||+. +++|+||||+||+++.++.++++||+.+.........
T Consensus 83 ~~~l~~~l~~~~--~~~~~~~~~~~~~~qi~~aL~~lH~~---~ivHrDlkp~Nill~~~~~~~~~~~~~~~~~~~~~~~ 157 (328)
T cd08226 83 YGSANSLLKTYF--PEGMSEALIGNILFGALRGLNYLHQN---GYIHRNIKASHILISGDGLVSLSGLSHLYSLVRNGQK 157 (328)
T ss_pred CCCHHHHHHhhc--ccCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHEEEeCCCcEEEechHHHhhhhccCcc
Confidence 999999887542 24589999999999999999999998 9999999999999999999999999865433211000
Q ss_pred ccc---cccccccCcccCChhhhccc--CcCccccchhhhHHHHHHHhCCCCCCCCccCCCCchhHHHHHHHHHhcCccC
Q 038766 175 LSS---LSTAFQGTIGYLAPEFAYMR--IVTTKVDVFSFGIVVMEFLTKRRPTGLDEENGLSPISLRQLVEKALANGING 249 (299)
Q Consensus 175 ~~~---~~~~~~~~~~y~~PE~~~~~--~~~~~~DiwslG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 249 (299)
... ......++..|+|||++.+. .++.++||||+||++|+|++|..||...... ... ...........
T Consensus 158 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~DiwslG~~l~el~~g~~p~~~~~~~----~~~---~~~~~~~~~~~ 230 (328)
T cd08226 158 AKVVYDFPQFSTSVLPWLSPELLRQDLYGYNVKSDIYSVGITACELATGRVPFQDMLRT----QML---LQKLKGPPYSP 230 (328)
T ss_pred ccccccccccccCccCccChhhhcCCCCCCCchhhHHHHHHHHHHHHhCCCCCCCcChH----HHH---HHHhcCCCCCC
Confidence 000 01112234569999998763 4788999999999999999999998533111 000 00000000000
Q ss_pred cc--------------------cccCc--------cccchhhHhHHHHHHHHHHHHHHHHhcCCCCCCCCChhhhhcC
Q 038766 250 VR--------------------QITDP--------KLVSSIYEEQEQHQVLEELFKLALVCTSSNPEDRPNMNELLIT 299 (299)
Q Consensus 250 ~~--------------------~~~~~--------~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rpt~~~il~~ 299 (299)
.. .+... ..............++..+.+|+++||..||++|||++++|+|
T Consensus 231 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rpta~e~l~~ 308 (328)
T cd08226 231 LDITTFPCEESRMKNSQSGVDSGIGESVVAAGMTQTMTSERLRTPSSKTFSPAFQNLVELCLQQDPEKRPSASSLLSH 308 (328)
T ss_pred ccccccchhhhhhccchhhhhcccccchhccccccccccccccchhhhhhhHHHHHHHHHHccCCcccCCCHHHHhhC
Confidence 00 00000 0000001112245677889999999999999999999999987
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) beta subfamily, pseudokinase domain. The STRAD-beta subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpig |
| >cd06607 STKc_TAO Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids proteins | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.4e-38 Score=266.44 Aligned_cols=250 Identities=26% Similarity=0.381 Sum_probs=194.4
Q ss_pred HhCCCCCCceeecCCcceEEEEEeC-CCcEEEEEEeccCcC-ChhhhHHHHHHHHHHHhcCCcceeeeeeEEEcCCCeeE
Q 038766 10 ATGSFSENNIIGNSNLSTVYKGRLE-DGEIVAVKKLNFHQF-SAESDKSFYREAKTLKELKHRNLVKVLGYAWESGKLKA 87 (299)
Q Consensus 10 ~~~~y~~~~~lg~g~~~~v~~~~~~-~~~~~~vK~~~~~~~-~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~ 87 (299)
..++|.+.+.||+|++|+||++.+. +++.|++|++..... .......+.+|+..++.++|||++++.+++.. +...+
T Consensus 13 ~~~~y~~~~~lg~g~~g~vy~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~~Ei~~l~~l~h~niv~~~~~~~~-~~~~~ 91 (307)
T cd06607 13 PEKLFTDLREIGHGSFGAVYFARDVRTNEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQQLRHPNTIEYKGCYLR-EHTAW 91 (307)
T ss_pred cchhhhhheeecCCCCeEEEEEEEcCCCcEEEEEEEeccccCcHHHHHHHHHHHHHHHhCCCCCEEEEEEEEEe-CCeEE
Confidence 3467999999999999999999864 589999999864332 23345678899999999999999999997766 44569
Q ss_pred EEEeecCCCChHHHhcCCCCCCCCCChhhHHHHHHHHHHHHHHhhcCCCCCeeeecccCCceeeCCCCcEEEeeeccccc
Q 038766 88 LILEYMENGSLESVIHGPGVDHSRWTLPKRIDVLISVANGLDYLHSGYDIPIVHCDMKPSNILLDRDFEAHVSDFGTSRM 167 (299)
Q Consensus 88 lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lh~~~~~~~~H~dl~~~nil~~~~~~v~l~df~~~~~ 167 (299)
+|+||+. +++.+.+.. ...++++..+..++.|++.||.|||+. +++|+||+|+||+++.++.++|+|||++..
T Consensus 92 lv~e~~~-g~l~~~~~~---~~~~l~~~~~~~~~~ql~~~L~~LH~~---~i~H~dl~p~nIl~~~~~~~kL~dfg~~~~ 164 (307)
T cd06607 92 LVMEYCL-GSASDILEV---HKKPLQEVEIAAICHGALQGLAYLHSH---ERIHRDIKAGNILLTEPGTVKLADFGSASL 164 (307)
T ss_pred EEHHhhC-CCHHHHHHH---cccCCCHHHHHHHHHHHHHHHHHHHHC---CceecCCCcccEEECCCCCEEEeecCccee
Confidence 9999996 577776643 234689999999999999999999999 999999999999999999999999998864
Q ss_pred cccccccccccccccccCcccCChhhhc---ccCcCccccchhhhHHHHHHHhCCCCCCCCccCCCCchhHHHHHHHHHh
Q 038766 168 LDVHLQDLSSLSTAFQGTIGYLAPEFAY---MRIVTTKVDVFSFGIVVMEFLTKRRPTGLDEENGLSPISLRQLVEKALA 244 (299)
Q Consensus 168 ~~~~~~~~~~~~~~~~~~~~y~~PE~~~---~~~~~~~~DiwslG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~ 244 (299)
.. ......++..|+|||.+. ...++.++||||+|+++|+|++|..||..... .........
T Consensus 165 ~~--------~~~~~~~~~~y~aPE~~~~~~~~~~~~~sDv~s~G~il~el~tg~~p~~~~~~--------~~~~~~~~~ 228 (307)
T cd06607 165 VS--------PANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNA--------MSALYHIAQ 228 (307)
T ss_pred cC--------CCCCccCCccccCceeeeccCCCCCCcccchHHHHHHHHHHHcCCCCCCCccH--------HHHHHHHhc
Confidence 32 112345677899999864 35578899999999999999999999843210 111111111
Q ss_pred cCccCcccccCccccchhhHhHHHHHHHHHHHHHHHHhcCCCCCCCCChhhhhcC
Q 038766 245 NGINGVRQITDPKLVSSIYEEQEQHQVLEELFKLALVCTSSNPEDRPNMNELLIT 299 (299)
Q Consensus 245 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rpt~~~il~~ 299 (299)
..... . .....+..+.++|.+||..+|++|||+.+++.|
T Consensus 229 ~~~~~---~-------------~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~ 267 (307)
T cd06607 229 NDSPT---L-------------SSNDWSDYFRNFVDSCLQKIPQDRPSSEELLKH 267 (307)
T ss_pred CCCCC---C-------------CchhhCHHHHHHHHHHhcCChhhCcCHHHHhcC
Confidence 10000 0 022345679999999999999999999999976
|
Serine/threonine kinases (STKs), thousand-and-one amino acids (TAO) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. They activate the MAPKs, p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activating the respective MAP/ERK kinases (MEKs, also known as MKKs or MAPKKs), MEK3/MEK6 and MKK4/MKK7. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Vertebrates contain three TAO subfamily |
| >cd06616 PKc_MKK4 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-38 Score=266.73 Aligned_cols=258 Identities=25% Similarity=0.295 Sum_probs=192.4
Q ss_pred CCCCCCceeecCCcceEEEEEeC-CCcEEEEEEeccCcCChhhhHHHHHHHHHHHhcC-CcceeeeeeEEEcCCCeeEEE
Q 038766 12 GSFSENNIIGNSNLSTVYKGRLE-DGEIVAVKKLNFHQFSAESDKSFYREAKTLKELK-HRNLVKVLGYAWESGKLKALI 89 (299)
Q Consensus 12 ~~y~~~~~lg~g~~~~v~~~~~~-~~~~~~vK~~~~~~~~~~~~~~~~~e~~~l~~l~-h~~i~~~~~~~~~~~~~~~lv 89 (299)
++|...+.||+|++|.||++.+. +++.+|+|++...... .....+.+|+..+.++. |+||+++++++.. +...+++
T Consensus 4 ~~~~~~~~lg~G~~g~vy~~~~~~~~~~~aiK~~~~~~~~-~~~~~~~~e~~~l~~~~~~~~iv~~~~~~~~-~~~~~~~ 81 (288)
T cd06616 4 EDLKDLGEIGRGAFGTVNKMLHKPSGTIMAVKRIRSTVDE-KEQKRLLMDLDVVMRSSDCPYIVKFYGALFR-EGDCWIC 81 (288)
T ss_pred HHhHHHHHhCCCCceEEEEEEECCCCCEEEEEEehhccCh-HHHHHHHHHHHHHHHhcCCCCEeeeeeEEec-CCcEEEE
Confidence 35667789999999999999864 5899999998744322 45667889999999996 9999999997765 4455899
Q ss_pred EeecCCCChHHHhcC-CCCCCCCCChhhHHHHHHHHHHHHHHhhcCCCCCeeeecccCCceeeCCCCcEEEeeecccccc
Q 038766 90 LEYMENGSLESVIHG-PGVDHSRWTLPKRIDVLISVANGLDYLHSGYDIPIVHCDMKPSNILLDRDFEAHVSDFGTSRML 168 (299)
Q Consensus 90 ~e~~~~~~L~~~~~~-~~~~~~~~~~~~~~~i~~qi~~~l~~lh~~~~~~~~H~dl~~~nil~~~~~~v~l~df~~~~~~ 168 (299)
+|++. .++.++... .......+++..+..++.|++.||+|||+. .+++|+||+|+||+++.++.++|+|||++..+
T Consensus 82 ~e~~~-~~l~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lh~~--~~i~H~dlkp~Nil~~~~~~~kl~dfg~~~~~ 158 (288)
T cd06616 82 MELMD-ISLDKFYKYVYEVLKSVIPEEILGKIAVATVKALNYLKEE--LKIIHRDVKPSNILLDRNGNIKLCDFGISGQL 158 (288)
T ss_pred Eeccc-CCHHHHHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHhhc--CCeeccCCCHHHEEEccCCcEEEeecchhHHh
Confidence 99985 466554321 111345789999999999999999999963 28999999999999999999999999998654
Q ss_pred ccccccccccccccccCcccCChhhhccc---CcCccccchhhhHHHHHHHhCCCCCCCCccCCCCchhHHHHHHHHHhc
Q 038766 169 DVHLQDLSSLSTAFQGTIGYLAPEFAYMR---IVTTKVDVFSFGIVVMEFLTKRRPTGLDEENGLSPISLRQLVEKALAN 245 (299)
Q Consensus 169 ~~~~~~~~~~~~~~~~~~~y~~PE~~~~~---~~~~~~DiwslG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~ 245 (299)
... .......++..|+|||.+... .++.++||||+|+++|+|++|..||.... ...+.+......
T Consensus 159 ~~~-----~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~-------~~~~~~~~~~~~ 226 (288)
T cd06616 159 VDS-----IAKTRDAGCRPYMAPERIDPSARDGYDVRSDVWSLGITLYEVATGKFPYPKWN-------SVFDQLTQVVKG 226 (288)
T ss_pred ccC-----CccccccCccCccCHHHhccccccCCcchhhhhHHHHHHHHHHhCCCCchhcc-------hHHHHHhhhcCC
Confidence 311 111223467889999998876 68899999999999999999999985331 111111111110
Q ss_pred CccCcccccCccccchhhHhHHHHHHHHHHHHHHHHhcCCCCCCCCChhhhhcC
Q 038766 246 GINGVRQITDPKLVSSIYEEQEQHQVLEELFKLALVCTSSNPEDRPNMNELLIT 299 (299)
Q Consensus 246 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rpt~~~il~~ 299 (299)
.. +.... .....++.++.+|+.+||..+|++|||++++++|
T Consensus 227 ~~--------~~~~~-----~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~i~~~ 267 (288)
T cd06616 227 DP--------PILSN-----SEEREFSPSFVNFINLCLIKDESKRPKYKELLEH 267 (288)
T ss_pred CC--------CcCCC-----cCCCccCHHHHHHHHHHccCChhhCcCHHHHhcC
Confidence 00 00000 0012356789999999999999999999999986
|
Protein kinases (PKs), MAP kinase kinase 4 (MKK4) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK4 is a dual-specificity PK that phosphorylates and activates |
| >cd07852 STKc_MAPK15 Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase 15 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-38 Score=272.68 Aligned_cols=275 Identities=25% Similarity=0.309 Sum_probs=200.3
Q ss_pred HHhCCCCCCceeecCCcceEEEEEeC-CCcEEEEEEeccCcCChhhhHHHHHHHHHHHhc-CCcceeeeeeEEEcC-CCe
Q 038766 9 NATGSFSENNIIGNSNLSTVYKGRLE-DGEIVAVKKLNFHQFSAESDKSFYREAKTLKEL-KHRNLVKVLGYAWES-GKL 85 (299)
Q Consensus 9 ~~~~~y~~~~~lg~g~~~~v~~~~~~-~~~~~~vK~~~~~~~~~~~~~~~~~e~~~l~~l-~h~~i~~~~~~~~~~-~~~ 85 (299)
.+.++|.+.+.||+|++|.||++.+. +++.+|+|++............+..|+..++++ +|+||+++++++... +..
T Consensus 4 ~~~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~vK~~~~~~~~~~~~~~~~~E~~~l~~l~~h~ni~~~~~~~~~~~~~~ 83 (337)
T cd07852 4 HILRKYEILQKLGKGAYGIVWKAIDRRTKEVVALKKIFDAFRNATDAQRTFREIMFLQELGDHPNIVKLLNVIKAENDKD 83 (337)
T ss_pred hhhhHHHHhHhhcCCCCeeEEEEEEcCCCeEEEEEeeccccCcchhhhhhhHHHHHHHHhcCCCCccceeeeeccCCCce
Confidence 46789999999999999999999875 588999998864333344456677899999999 999999999977543 446
Q ss_pred eEEEEeecCCCChHHHhcCCCCCCCCCChhhHHHHHHHHHHHHHHhhcCCCCCeeeecccCCceeeCCCCcEEEeeeccc
Q 038766 86 KALILEYMENGSLESVIHGPGVDHSRWTLPKRIDVLISVANGLDYLHSGYDIPIVHCDMKPSNILLDRDFEAHVSDFGTS 165 (299)
Q Consensus 86 ~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lh~~~~~~~~H~dl~~~nil~~~~~~v~l~df~~~ 165 (299)
.++|+|++. ++|.+++.. + .+++..++.++.|++.||+|||+. +++|+||+|+||+++.++.++|+|||++
T Consensus 84 ~~lv~e~~~-~~L~~~~~~----~-~~~~~~~~~i~~qi~~~L~~LH~~---~i~H~dl~p~nill~~~~~~kl~d~g~~ 154 (337)
T cd07852 84 IYLVFEYME-TDLHAVIRA----N-ILEDVHKRYIMYQLLKALKYIHSG---NVIHRDLKPSNILLNSDCRVKLADFGLA 154 (337)
T ss_pred EEEEecccc-cCHHHHHhc----C-CCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHEEEcCCCcEEEeeccch
Confidence 799999996 599888852 2 678889999999999999999999 9999999999999999999999999998
Q ss_pred cccccccccc-cccccccccCcccCChhhhcc-cCcCccccchhhhHHHHHHHhCCCCCCCCccCCCCchhHHHHHHHHH
Q 038766 166 RMLDVHLQDL-SSLSTAFQGTIGYLAPEFAYM-RIVTTKVDVFSFGIVVMEFLTKRRPTGLDEENGLSPISLRQLVEKAL 243 (299)
Q Consensus 166 ~~~~~~~~~~-~~~~~~~~~~~~y~~PE~~~~-~~~~~~~DiwslG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~ 243 (299)
.......... ........++..|+|||.+.+ ..++.++|+||||+++|+|++|..||...... ...........
T Consensus 155 ~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~sDi~slG~~l~el~tg~~pf~~~~~~----~~~~~~~~~~~ 230 (337)
T cd07852 155 RSLSELEENPENPVLTDYVATRWYRAPEILLGSTRYTKGVDMWSVGCILGEMLLGKPLFPGTSTL----NQLEKIIEVIG 230 (337)
T ss_pred hccccccccccCcchhcccccccccCceeeeccccccccchHHHHHHHHHHHHhCCCCCCCCChH----HHHHHHHHHhC
Confidence 7654221110 112233457889999997765 45788999999999999999999998543211 00000000000
Q ss_pred -----------hcCccC-cccccCccccchhhHhHHHHHHHHHHHHHHHHhcCCCCCCCCChhhhhcC
Q 038766 244 -----------ANGING-VRQITDPKLVSSIYEEQEQHQVLEELFKLALVCTSSNPEDRPNMNELLIT 299 (299)
Q Consensus 244 -----------~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rpt~~~il~~ 299 (299)
...... ......... ... ......++.++.++|.+||..||++|||+.++++|
T Consensus 231 ~~~~~~~~~~~~~~~~~~~~~~~~~~~--~~~-~~~~~~~~~~l~~li~~~l~~~P~~Rps~~~il~~ 295 (337)
T cd07852 231 PPSAEDIESIKSPFAATMLDSLPSRPR--KPL-DELLPKASDDALDLLKKLLVFNPNKRLTAEEALEH 295 (337)
T ss_pred CCCHHHHHHHHhhhHHHhhhhcccccc--cch-hhhccCCCHHHHHHHHHhccCCcccccCHHHHhhC
Confidence 000000 000000000 000 01112256789999999999999999999999976
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 15 (MAPK15) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK15 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. Human MAPK15 is also called Extracellular signal Regulated Kinase 8 (ERK8) while the rat protein is called ERK7. ERK7 and ERK8 display both similar and different biochemical properties. They autophosphorylate and activate themselves and do not require upstream activating kinases. ERK7 is constitutively active and is not affected by extracellular stimul |
| >cd07857 STKc_MPK1 Catalytic domain of the Serine/Threonine Kinase, Fungal Mitogen-Activated Protein Kinase MPK1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-38 Score=272.30 Aligned_cols=275 Identities=23% Similarity=0.275 Sum_probs=195.1
Q ss_pred CCCCCceeecCCcceEEEEEeC-C--CcEEEEEEeccCcCChhhhHHHHHHHHHHHhcC-CcceeeeeeEEEc---CCCe
Q 038766 13 SFSENNIIGNSNLSTVYKGRLE-D--GEIVAVKKLNFHQFSAESDKSFYREAKTLKELK-HRNLVKVLGYAWE---SGKL 85 (299)
Q Consensus 13 ~y~~~~~lg~g~~~~v~~~~~~-~--~~~~~vK~~~~~~~~~~~~~~~~~e~~~l~~l~-h~~i~~~~~~~~~---~~~~ 85 (299)
+|.+.+.||+|++|.||++... . +..+|+|++............+.+|+.+++++. |+||+++++.... ....
T Consensus 1 ~y~~~~~lg~G~~g~vy~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~~~~~ 80 (332)
T cd07857 1 RYELIKELGQGAYGIVCSARNAETSEEETVAIKKITNVFSKKILAKRALRELKLLRHFRGHKNITCLYDMDIVFPGNFNE 80 (332)
T ss_pred CceEEEEccccCCeEEEEEEeCCCCcCceEEEEEeccccccchhHHHHHHHHHHHHHhcCCCChheeeeeeeeccccCCc
Confidence 5888999999999999999864 3 788999998643333334567788999999995 9999999986432 2245
Q ss_pred eEEEEeecCCCChHHHhcCCCCCCCCCChhhHHHHHHHHHHHHHHhhcCCCCCeeeecccCCceeeCCCCcEEEeeeccc
Q 038766 86 KALILEYMENGSLESVIHGPGVDHSRWTLPKRIDVLISVANGLDYLHSGYDIPIVHCDMKPSNILLDRDFEAHVSDFGTS 165 (299)
Q Consensus 86 ~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lh~~~~~~~~H~dl~~~nil~~~~~~v~l~df~~~ 165 (299)
.+++++++. ++|.+.+. ....+++..++.++.||+.||.|||++ +++|+||||+||+++.++.++|+|||++
T Consensus 81 ~~~~~e~~~-~~L~~~l~----~~~~~~~~~~~~~~~qi~~aL~~LH~~---givH~dlkp~Nili~~~~~~kl~Dfg~a 152 (332)
T cd07857 81 LYLYEELME-ADLHQIIR----SGQPLTDAHFQSFIYQILCGLKYIHSA---NVLHRDLKPGNLLVNADCELKICDFGLA 152 (332)
T ss_pred EEEEEeccc-CCHHHHHh----cCCCCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCCHHHeEEcCCCCEEeCcCCCc
Confidence 688889885 68988886 456799999999999999999999999 9999999999999999999999999999
Q ss_pred cccccccccccccccccccCcccCChhhhcc-cCcCccccchhhhHHHHHHHhCCCCCCCCccCCCCchhHHHHHHHHHh
Q 038766 166 RMLDVHLQDLSSLSTAFQGTIGYLAPEFAYM-RIVTTKVDVFSFGIVVMEFLTKRRPTGLDEENGLSPISLRQLVEKALA 244 (299)
Q Consensus 166 ~~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~-~~~~~~~DiwslG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~ 244 (299)
..+...............++..|+|||.+.+ ..++.++|+||+|+++|+|++|..||...... ..+...+.....
T Consensus 153 ~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~Di~slGv~l~~l~~g~~pf~~~~~~----~~~~~~~~~~~~ 228 (332)
T cd07857 153 RGFSENPGENAGFMTEYVATRWYRAPEIMLSFQSYTKAIDVWSVGCILAELLGRKPVFKGKDYV----DQLNQILQVLGT 228 (332)
T ss_pred eecccccccccccccCcccCccccCcHHHhCCCCCCcHHHHHHHHHHHHHHHhCCcCCCCCCHH----HHHHHHHHHhCC
Confidence 7654322211112233467889999998765 46889999999999999999999998543211 000000000000
Q ss_pred cCccCcccccCccc---------cchhhHhHHHHHHHHHHHHHHHHhcCCCCCCCCChhhhhcC
Q 038766 245 NGINGVRQITDPKL---------VSSIYEEQEQHQVLEELFKLALVCTSSNPEDRPNMNELLIT 299 (299)
Q Consensus 245 ~~~~~~~~~~~~~~---------~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rpt~~~il~~ 299 (299)
........+..+.. .............+..+.+++.+||+.||++|||+.+++.|
T Consensus 229 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~t~~~ll~~ 292 (332)
T cd07857 229 PDEETLSRIGSPKAQNYIRSLPNIPKKPFESIFPNANPLALDLLEKLLAFDPTKRISVEEALEH 292 (332)
T ss_pred CCHHHHHhhhhhhHHHHHHhccccCCcchHhhCCCCCHHHHHHHHHHccCCcccCCCHHHHhcC
Confidence 00000000000000 00000000011235689999999999999999999999986
|
Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) MPK1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MPK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs MPK1 from Saccharomyces cerevisiae, Pmk1 from Schizosaccharomyces pombe, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. MPK1 (also called Slt2) and Pmk1 (also called Spm1) are stress-activated MAPKs that regulate the cell wall integrity (CWI) pathway, and are therefore important in the maintainance of cell shape, cell wall co |
| >cd05077 PTK_Jak1_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Janus kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-38 Score=263.94 Aligned_cols=238 Identities=21% Similarity=0.325 Sum_probs=179.6
Q ss_pred ceeecCCcceEEEEEeCC-------------CcEEEEEEeccCcCChhhhHHHHHHHHHHHhcCCcceeeeeeEEEcCCC
Q 038766 18 NIIGNSNLSTVYKGRLED-------------GEIVAVKKLNFHQFSAESDKSFYREAKTLKELKHRNLVKVLGYAWESGK 84 (299)
Q Consensus 18 ~~lg~g~~~~v~~~~~~~-------------~~~~~vK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~ 84 (299)
+.||+|++|.||++.... ...+++|++... .......+..|+..++.++||||+++++++....
T Consensus 1 ~~lg~G~~~~vy~~~~~~~~~~~~~~~~~~~~~~v~~k~~~~~--~~~~~~~~~~~~~~l~~l~hp~iv~~~~~~~~~~- 77 (262)
T cd05077 1 EHLGRGTRTQIYAGILNYKDDDEDDGYSYEKEIKVILKVLDPS--HRDISLAFFETASMMRQVSHKHIVLLYGVCVRDV- 77 (262)
T ss_pred CccccCCcceEeeeecccCCCccccccchhhceeEEEeecChh--hhhHHHHHHHHHHHHHhCCCCCEeeEEEEEecCC-
Confidence 468999999999997421 235888886532 2344557788899999999999999999776644
Q ss_pred eeEEEEeecCCCChHHHhcCCCCCCCCCChhhHHHHHHHHHHHHHHhhcCCCCCeeeecccCCceeeCCCCc-------E
Q 038766 85 LKALILEYMENGSLESVIHGPGVDHSRWTLPKRIDVLISVANGLDYLHSGYDIPIVHCDMKPSNILLDRDFE-------A 157 (299)
Q Consensus 85 ~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lh~~~~~~~~H~dl~~~nil~~~~~~-------v 157 (299)
..++|+||+.+++|..++.. ....+++..++.++.||+.||+|||+. +++|+||||+||+++.++. +
T Consensus 78 ~~~lv~e~~~~~~l~~~~~~---~~~~~~~~~~~~i~~qi~~~l~~lH~~---~ivH~dlkp~Nill~~~~~~~~~~~~~ 151 (262)
T cd05077 78 ENIMVEEFVEFGPLDLFMHR---KSDVLTTPWKFKVAKQLASALSYLEDK---DLVHGNVCTKNILLAREGIDGECGPFI 151 (262)
T ss_pred CCEEEEecccCCCHHHHHHh---cCCCCCHHHHHHHHHHHHHHHHHhhhC---CeECCCCCcccEEEecCCccCCCCcee
Confidence 45899999999999888753 234689999999999999999999999 9999999999999987654 8
Q ss_pred EEeeeccccccccccccccccccccccCcccCChhhhc-ccCcCccccchhhhHHHHHHH-hCCCCCCCCccCCCCchhH
Q 038766 158 HVSDFGTSRMLDVHLQDLSSLSTAFQGTIGYLAPEFAY-MRIVTTKVDVFSFGIVVMEFL-TKRRPTGLDEENGLSPISL 235 (299)
Q Consensus 158 ~l~df~~~~~~~~~~~~~~~~~~~~~~~~~y~~PE~~~-~~~~~~~~DiwslG~~l~~l~-~g~~p~~~~~~~~~~~~~~ 235 (299)
+++|||++..... .....++..|+|||.+. +..++.++||||||+++|+|+ .|..|+..... ...
T Consensus 152 ~l~d~g~~~~~~~--------~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~el~~~~~~p~~~~~~-----~~~ 218 (262)
T cd05077 152 KLSDPGIPITVLS--------RQECVERIPWIAPECVEDSKNLSIAADKWSFGTTLWEICYNGEIPLKDKTL-----AEK 218 (262)
T ss_pred EeCCCCCCccccC--------cccccccccccChhhhcCCCCCCchhHHHHHHHHHHHHHhCCCCCCCCcch-----hHH
Confidence 9999998764321 12234567899999876 466889999999999999998 47777643211 111
Q ss_pred HHHHHHHHhcCccCcccccCccccchhhHhHHHHHHHHHHHHHHHHhcCCCCCCCCChhhhhcC
Q 038766 236 RQLVEKALANGINGVRQITDPKLVSSIYEEQEQHQVLEELFKLALVCTSSNPEDRPNMNELLIT 299 (299)
Q Consensus 236 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rpt~~~il~~ 299 (299)
.. ..... ... ....+.++.+++.+||+.||.+|||+.+|+++
T Consensus 219 ~~----~~~~~----~~~--------------~~~~~~~~~~li~~cl~~dp~~Rp~~~~il~~ 260 (262)
T cd05077 219 ER----FYEGQ----CML--------------VTPSCKELADLMTHCMNYDPNQRPFFRAIMRD 260 (262)
T ss_pred HH----HHhcC----ccC--------------CCCChHHHHHHHHHHcCCChhhCcCHHHHHHh
Confidence 11 00000 000 01123568899999999999999999999864
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic dom |
| >cd05047 PTKc_Tie Catalytic domain of Tie Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-38 Score=263.38 Aligned_cols=246 Identities=26% Similarity=0.412 Sum_probs=185.7
Q ss_pred ceeecCCcceEEEEEeCC-Cc--EEEEEEeccCcCChhhhHHHHHHHHHHHhc-CCcceeeeeeEEEcCCCeeEEEEeec
Q 038766 18 NIIGNSNLSTVYKGRLED-GE--IVAVKKLNFHQFSAESDKSFYREAKTLKEL-KHRNLVKVLGYAWESGKLKALILEYM 93 (299)
Q Consensus 18 ~~lg~g~~~~v~~~~~~~-~~--~~~vK~~~~~~~~~~~~~~~~~e~~~l~~l-~h~~i~~~~~~~~~~~~~~~lv~e~~ 93 (299)
+.||+|++|.||++.+.+ +. .+++|.+.. .........+.+|+..++++ .||||+++++.+... ...++|+||+
T Consensus 1 ~~lg~g~~g~v~~~~~~~~~~~~~~~~k~~~~-~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~-~~~~lv~e~~ 78 (270)
T cd05047 1 DVIGEGNFGQVLKARIKKDGLRMDAAIKRMKE-YASKDDHRDFAGELEVLCKLGHHPNIINLLGACEHR-GYLYLAIEYA 78 (270)
T ss_pred CcCCCCCCceEEEEEEcCCCCeeEEEEEEccc-cCCHHHHHHHHHHHHHHHhhccCCCeeeEEEEEecC-CCceEEEEeC
Confidence 468999999999998743 43 468887752 22344556788999999999 799999999977654 4569999999
Q ss_pred CCCChHHHhcCCC------------CCCCCCChhhHHHHHHHHHHHHHHhhcCCCCCeeeecccCCceeeCCCCcEEEee
Q 038766 94 ENGSLESVIHGPG------------VDHSRWTLPKRIDVLISVANGLDYLHSGYDIPIVHCDMKPSNILLDRDFEAHVSD 161 (299)
Q Consensus 94 ~~~~L~~~~~~~~------------~~~~~~~~~~~~~i~~qi~~~l~~lh~~~~~~~~H~dl~~~nil~~~~~~v~l~d 161 (299)
++++|.+++.... .....+++..++.++.|++.||+|||+. +++|+||||+||+++.++.++|+|
T Consensus 79 ~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~al~~lH~~---~i~H~dikp~nili~~~~~~kl~d 155 (270)
T cd05047 79 PHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQK---QFIHRDLAARNILVGENYVAKIAD 155 (270)
T ss_pred CCCcHHHHHHhccccccccccccccCCcCCCCHHHHHHHHHHHHHHHHHHHHC---CEeecccccceEEEcCCCeEEECC
Confidence 9999999886432 1223578999999999999999999998 999999999999999999999999
Q ss_pred eccccccccccccccccccccccCcccCChhhhcccCcCccccchhhhHHHHHHHh-CCCCCCCCccCCCCchhHHHHHH
Q 038766 162 FGTSRMLDVHLQDLSSLSTAFQGTIGYLAPEFAYMRIVTTKVDVFSFGIVVMEFLT-KRRPTGLDEENGLSPISLRQLVE 240 (299)
Q Consensus 162 f~~~~~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~DiwslG~~l~~l~~-g~~p~~~~~~~~~~~~~~~~~~~ 240 (299)
||++...... ........+..|+|||.+....++.++|+||||+++|+|++ |..||.... . .+...
T Consensus 156 fgl~~~~~~~-----~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~il~el~~~g~~pf~~~~-----~---~~~~~ 222 (270)
T cd05047 156 FGLSRGQEVY-----VKKTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMT-----C---AELYE 222 (270)
T ss_pred CCCccccchh-----hhccCCCCccccCChHHHccCCCCchhhHHHHHHHHHHHHcCCCCCccccC-----H---HHHHH
Confidence 9987532210 01111223557999999988889999999999999999997 889884321 1 11121
Q ss_pred HHHhcCccCcccccCccccchhhHhHHHHHHHHHHHHHHHHhcCCCCCCCCChhhhhc
Q 038766 241 KALANGINGVRQITDPKLVSSIYEEQEQHQVLEELFKLALVCTSSNPEDRPNMNELLI 298 (299)
Q Consensus 241 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rpt~~~il~ 298 (299)
...... .... +...+.++.+++.+|+..+|.+|||+.+++.
T Consensus 223 ~~~~~~-----~~~~------------~~~~~~~~~~li~~~l~~~p~~Rps~~~il~ 263 (270)
T cd05047 223 KLPQGY-----RLEK------------PLNCDDEVYDLMRQCWREKPYERPSFAQILV 263 (270)
T ss_pred HHhCCC-----CCCC------------CCcCCHHHHHHHHHHcccChhhCCCHHHHHH
Confidence 111100 0000 1123457899999999999999999999985
|
Protein Tyrosine Kinase (PTK) family; Tie subfamily; catalytic (c) domain. The Tie subfamily consists of Tie1 and Tie2. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie proteins are receptor tyr kinases (RTKs) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2, while no specific l |
| >cd05118 STKc_CMGC Catalytic domain of CMGC family Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.5e-38 Score=263.71 Aligned_cols=269 Identities=26% Similarity=0.312 Sum_probs=200.9
Q ss_pred CCCCceeecCCcceEEEEEeC-CCcEEEEEEeccCcCChhhhHHHHHHHHHHHhcCCcceeeeeeEEEcCCCeeEEEEee
Q 038766 14 FSENNIIGNSNLSTVYKGRLE-DGEIVAVKKLNFHQFSAESDKSFYREAKTLKELKHRNLVKVLGYAWESGKLKALILEY 92 (299)
Q Consensus 14 y~~~~~lg~g~~~~v~~~~~~-~~~~~~vK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~lv~e~ 92 (299)
|.+.+.||+|++|.||++... +++.+++|++............+.+|+..++.++|+||+++++++.. +...++|+||
T Consensus 1 y~~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~-~~~~~~v~e~ 79 (283)
T cd05118 1 YQKLGKIGEGTYGVVYKARDKLTGEIVAIKKIKLRFESEGIPKTALREIKLLKELNHPNIIKLLDVFRH-KGDLYLVFEF 79 (283)
T ss_pred CccceeeecCCCceEEEEEcCCCCcEEEEEEeccccccchhHHHHHHHHHHHHHhcCCCcchHHHhhcc-CCCEEEEEec
Confidence 678899999999999999864 68999999987655454556788899999999999999999997665 4566999999
Q ss_pred cCCCChHHHhcCCCCCCCCCChhhHHHHHHHHHHHHHHhhcCCCCCeeeecccCCceeeCCCCcEEEeeecccccccccc
Q 038766 93 MENGSLESVIHGPGVDHSRWTLPKRIDVLISVANGLDYLHSGYDIPIVHCDMKPSNILLDRDFEAHVSDFGTSRMLDVHL 172 (299)
Q Consensus 93 ~~~~~L~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lh~~~~~~~~H~dl~~~nil~~~~~~v~l~df~~~~~~~~~~ 172 (299)
+.+ +|.+.+... ...+++..++.++.|++.||.+||+. +++|+||+|+||+++.++.++|+|||.+.......
T Consensus 80 ~~~-~l~~~l~~~---~~~~~~~~~~~~~~~i~~~l~~LH~~---~i~H~dl~p~nili~~~~~~~l~df~~~~~~~~~~ 152 (283)
T cd05118 80 MDT-DLYKLIKDR---QRGLPESLIKSYLYQLLQGLAFCHSH---GILHRDLKPENLLINTEGVLKLADFGLARSFGSPV 152 (283)
T ss_pred cCC-CHHHHHHhh---cccCCHHHHHHHHHHHHHHHHHHHHC---CeeecCcCHHHEEECCCCcEEEeeeeeeEecCCCc
Confidence 965 888777532 25789999999999999999999999 99999999999999999999999999887654211
Q ss_pred ccccccccccccCcccCChhhhccc-CcCccccchhhhHHHHHHHhCCCCCCCCccCCCCchhHHHHHHHHHhcCccCcc
Q 038766 173 QDLSSLSTAFQGTIGYLAPEFAYMR-IVTTKVDVFSFGIVVMEFLTKRRPTGLDEENGLSPISLRQLVEKALANGINGVR 251 (299)
Q Consensus 173 ~~~~~~~~~~~~~~~y~~PE~~~~~-~~~~~~DiwslG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 251 (299)
.......++..|+|||.+.+. .++.++|+||||+++|+|++|..||...... ..+....+...........
T Consensus 153 ----~~~~~~~~~~~~~~PE~~~~~~~~~~~~Di~slG~~l~~l~tg~~~~~~~~~~----~~~~~~~~~~~~~~~~~~~ 224 (283)
T cd05118 153 ----RPYTHYVVTRWYRAPELLLGDKGYSTPVDIWSVGCIFAELLSRRPLFPGKSEI----DQLFKIFRTLGTPDPEVWP 224 (283)
T ss_pred ----ccccCccCcccccCcHHHhcCCCCCchhHHHHHHHHHHHHHhCCCCCCCCCHH----HHHHHHHHHcCCCchHhcc
Confidence 112233467789999988776 7889999999999999999999998543211 1111111110000000000
Q ss_pred cccC---------ccccchhhHhHHHHHHHHHHHHHHHHhcCCCCCCCCChhhhhcC
Q 038766 252 QITD---------PKLVSSIYEEQEQHQVLEELFKLALVCTSSNPEDRPNMNELLIT 299 (299)
Q Consensus 252 ~~~~---------~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rpt~~~il~~ 299 (299)
...+ +..... ........++..+.++|.+||..||.+||++++++.|
T Consensus 225 ~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~i~~~l~~~P~~Rp~~~~ll~~ 280 (283)
T cd05118 225 KFTSLARNYKFSFPKKAGM-PLPKLFPNASPQALDLLSQMLHYDPHKRITAEQALAH 280 (283)
T ss_pred cchhhhhhhhhhhcccccc-CHHHhhhhhCHHHHHHHHHHhccCcccCcCHHHHhhC
Confidence 0000 000000 0112245678899999999999999999999999986
|
Serine/Threonine Kinases (STKs), CMGC family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CMGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The CMGC family consists of Cyclin-Dependent protein Kinases (CDKs), Mitogen-activated protein kinases (MAPKs) such as Extracellular signal-regulated kinase (ERKs), c-Jun N-terminal kinases (JNKs), and p38, and similar proteins. CDKs belong to a large subfamily of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. MAPKs serve as important mediators of cellular responses to extracellular signals. They |
| >cd05057 PTKc_EGFR_like Catalytic domain of Epidermal Growth Factor Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-38 Score=265.18 Aligned_cols=253 Identities=25% Similarity=0.425 Sum_probs=194.8
Q ss_pred HhCCCCCCceeecCCcceEEEEEeC-CC----cEEEEEEeccCcCChhhhHHHHHHHHHHHhcCCcceeeeeeEEEcCCC
Q 038766 10 ATGSFSENNIIGNSNLSTVYKGRLE-DG----EIVAVKKLNFHQFSAESDKSFYREAKTLKELKHRNLVKVLGYAWESGK 84 (299)
Q Consensus 10 ~~~~y~~~~~lg~g~~~~v~~~~~~-~~----~~~~vK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~ 84 (299)
..++|++.+.||+|+||+||++.+. +| ..+++|.+.... .......+.+|+..+++++|+|++++++++.. .
T Consensus 5 ~~~~~~~~~~ig~g~~g~v~~~~~~~~~~~~~~~~aik~~~~~~-~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~--~ 81 (279)
T cd05057 5 KETELEKIKVLGSGAFGTVYKGVWIPEGEKVKIPVAIKVLREET-SPKANKEILDEAYVMASVDHPHVVRLLGICLS--S 81 (279)
T ss_pred CHHHcEEcceecCCCCccEEEEEEecCCCCcceEEEEEeccCCC-CHHHHHHHHHHHHHHHhCCCCCcceEEEEEec--C
Confidence 3578999999999999999999853 23 358999875432 34456778899999999999999999997765 4
Q ss_pred eeEEEEeecCCCChHHHhcCCCCCCCCCChhhHHHHHHHHHHHHHHhhcCCCCCeeeecccCCceeeCCCCcEEEeeecc
Q 038766 85 LKALILEYMENGSLESVIHGPGVDHSRWTLPKRIDVLISVANGLDYLHSGYDIPIVHCDMKPSNILLDRDFEAHVSDFGT 164 (299)
Q Consensus 85 ~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lh~~~~~~~~H~dl~~~nil~~~~~~v~l~df~~ 164 (299)
..++|+||+.+++|.+.+... ...+++..++.++.|++.||+|||+. +++|+||+|+||+++.++.++|+|||.
T Consensus 82 ~~~~v~e~~~~g~L~~~l~~~---~~~~~~~~~~~~~~qi~~~l~~LH~~---~i~H~di~p~nil~~~~~~~kL~dfg~ 155 (279)
T cd05057 82 QVQLITQLMPLGCLLDYVRNH---KDNIGSQYLLNWCVQIAKGMSYLEEK---RLVHRDLAARNVLVKTPQHVKITDFGL 155 (279)
T ss_pred ceEEEEecCCCCcHHHHHHhc---cCCCCHHHHHHHHHHHHHHHHHHHhC---CEEecccCcceEEEcCCCeEEECCCcc
Confidence 568999999999999988632 34589999999999999999999998 999999999999999999999999999
Q ss_pred ccccccccccccccccccccCcccCChhhhcccCcCccccchhhhHHHHHHHh-CCCCCCCCccCCCCchhHHHHHHHHH
Q 038766 165 SRMLDVHLQDLSSLSTAFQGTIGYLAPEFAYMRIVTTKVDVFSFGIVVMEFLT-KRRPTGLDEENGLSPISLRQLVEKAL 243 (299)
Q Consensus 165 ~~~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~DiwslG~~l~~l~~-g~~p~~~~~~~~~~~~~~~~~~~~~~ 243 (299)
+.......... .......+..|+|||.+....++.++|+||||++++++++ |..||... ....+...+.
T Consensus 156 ~~~~~~~~~~~--~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~-----~~~~~~~~~~--- 225 (279)
T cd05057 156 AKLLDVDEKEY--HAEGGKVPIKWMALESILHRIYTHKSDVWSYGVTVWELMTFGAKPYEGI-----PAVEIPDLLE--- 225 (279)
T ss_pred cccccCcccce--ecCCCcccccccCHHHhhcCCcCchhhHHHHHHHHHHHhcCCCCCCCCC-----CHHHHHHHHh---
Confidence 87654211111 1111223467999999988889999999999999999998 99998432 2222222211
Q ss_pred hcCccCcccccCccccchhhHhHHHHHHHHHHHHHHHHhcCCCCCCCCChhhhhc
Q 038766 244 ANGINGVRQITDPKLVSSIYEEQEQHQVLEELFKLALVCTSSNPEDRPNMNELLI 298 (299)
Q Consensus 244 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rpt~~~il~ 298 (299)
.. ..... +...+..+.+++.+||..+|.+|||+.++++
T Consensus 226 -~~----~~~~~------------~~~~~~~~~~~~~~~l~~~p~~Rp~~~~l~~ 263 (279)
T cd05057 226 -KG----ERLPQ------------PPICTIDVYMVLVKCWMIDAESRPTFKELIN 263 (279)
T ss_pred -CC----CCCCC------------CCCCCHHHHHHHHHHcCCChhhCCCHHHHHH
Confidence 11 00111 1112346889999999999999999999874
|
Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR) subfamily; catalytic (c) domain. EGFR (HER, ErbB) subfamily members include EGFR (HER1, ErbB1), HER2 (ErbB2), HER3 (ErbB3), HER4 (ErbB4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The EGFR proteins are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instea |
| >KOG0662 consensus Cyclin-dependent kinase CDK5 [Intracellular trafficking, secretion, and vesicular transport; Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-39 Score=239.52 Aligned_cols=275 Identities=23% Similarity=0.302 Sum_probs=213.8
Q ss_pred CCCCCCceeecCCcceEEEEEe-CCCcEEEEEEeccCcCChhhhHHHHHHHHHHHhcCCcceeeeeeEEEcCCCeeEEEE
Q 038766 12 GSFSENNIIGNSNLSTVYKGRL-EDGEIVAVKKLNFHQFSAESDKSFYREAKTLKELKHRNLVKVLGYAWESGKLKALIL 90 (299)
Q Consensus 12 ~~y~~~~~lg~g~~~~v~~~~~-~~~~~~~vK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~lv~ 90 (299)
.+|.-.++||+|.+|+||+++. .+++.||+|.++.....+.......+|+-+++.++|.||++++++..+ ++.+-+|+
T Consensus 2 ~~ydkmekigegtygtvfkarn~~t~eivalkrvrlddddegvpssalreicllkelkhknivrl~dvlhs-dkkltlvf 80 (292)
T KOG0662|consen 2 QKYDKMEKIGEGTYGTVFKARNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLHDVLHS-DKKLTLVF 80 (292)
T ss_pred cchHHHHhhcCCcceeeEecccCCccceEEEEEEeccCCCCCCcHHHHHHHHHHHHhhhcceeehhhhhcc-CceeEEeH
Confidence 3566778999999999999985 458999999999887777778899999999999999999999995554 55669999
Q ss_pred eecCCCChHHHhcCCCCCCCCCChhhHHHHHHHHHHHHHHhhcCCCCCeeeecccCCceeeCCCCcEEEeeecccccccc
Q 038766 91 EYMENGSLESVIHGPGVDHSRWTLPKRIDVLISVANGLDYLHSGYDIPIVHCDMKPSNILLDRDFEAHVSDFGTSRMLDV 170 (299)
Q Consensus 91 e~~~~~~L~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lh~~~~~~~~H~dl~~~nil~~~~~~v~l~df~~~~~~~~ 170 (299)
|+|.+ .|..+... -+..++.+.+.+++.|++.+|.++|+. ++.|+|+||+|.+++.+|.+||.|||+++.+.
T Consensus 81 e~cdq-dlkkyfds---lng~~d~~~~rsfmlqllrgl~fchsh---nvlhrdlkpqnllin~ngelkladfglarafg- 152 (292)
T KOG0662|consen 81 EFCDQ-DLKKYFDS---LNGDLDPEIVRSFMLQLLRGLGFCHSH---NVLHRDLKPQNLLINRNGELKLADFGLARAFG- 152 (292)
T ss_pred HHhhH-HHHHHHHh---cCCcCCHHHHHHHHHHHHhhhhhhhhh---hhhhccCCcceEEeccCCcEEecccchhhhcC-
Confidence 99954 88777652 356788899999999999999999999 99999999999999999999999999998765
Q ss_pred ccccccccccccccCcccCChhhhcccC-cCccccchhhhHHHHHHHhCCCC-CCCCccCCCCchhHHHHHHHHHhcCcc
Q 038766 171 HLQDLSSLSTAFQGTIGYLAPEFAYMRI-VTTKVDVFSFGIVVMEFLTKRRP-TGLDEENGLSPISLRQLVEKALANGIN 248 (299)
Q Consensus 171 ~~~~~~~~~~~~~~~~~y~~PE~~~~~~-~~~~~DiwslG~~l~~l~~g~~p-~~~~~~~~~~~~~~~~~~~~~~~~~~~ 248 (299)
.+..+......|.+|.||.++.+.. |+.+.|+||.||++.++.....| |..+. .+..-..+...+.......|+
T Consensus 153 ---ipvrcysaevvtlwyrppdvlfgakly~tsidmwsagcifaelanagrplfpg~d-vddqlkrif~~lg~p~ed~wp 228 (292)
T KOG0662|consen 153 ---IPVRCYSAEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGND-VDDQLKRIFRLLGTPTEDQWP 228 (292)
T ss_pred ---CceEeeeceeeeeeccCcceeeeeehhccchHhhhcchHHHHHhhcCCCCCCCCc-HHHHHHHHHHHhCCCccccCC
Confidence 2345666777899999999988765 89999999999999999985555 43321 111111122222222234455
Q ss_pred CcccccCcc----ccchhhHhHHHHHHHHHHHHHHHHhcCCCCCCCCChhhhhcC
Q 038766 249 GVRQITDPK----LVSSIYEEQEQHQVLEELFKLALVCTSSNPEDRPNMNELLIT 299 (299)
Q Consensus 249 ~~~~~~~~~----~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rpt~~~il~~ 299 (299)
.+...++.+ +..+....+.-+..+..=++++.++|.-+|.+|.+++..++|
T Consensus 229 s~t~lpdyk~yp~ypattswsqivp~lns~grdllqkll~cnp~qrisaeaalqh 283 (292)
T KOG0662|consen 229 SMTKLPDYKPYPIYPATTSWSQIVPKLNSTGRDLLQKLLKCNPAQRISAEAALQH 283 (292)
T ss_pred ccccCCCCcccCCccccchHHHHhhhhcchhHHHHHHHhccCcccccCHHHHhcC
Confidence 555555533 223333344445555667899999999999999999999987
|
|
| >cd05038 PTKc_Jak_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-38 Score=266.79 Aligned_cols=264 Identities=26% Similarity=0.411 Sum_probs=197.8
Q ss_pred hCCCCCCceeecCCcceEEEEEeC-----CCcEEEEEEeccCcCChhhhHHHHHHHHHHHhcCCcceeeeeeEEEcC-CC
Q 038766 11 TGSFSENNIIGNSNLSTVYKGRLE-----DGEIVAVKKLNFHQFSAESDKSFYREAKTLKELKHRNLVKVLGYAWES-GK 84 (299)
Q Consensus 11 ~~~y~~~~~lg~g~~~~v~~~~~~-----~~~~~~vK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~-~~ 84 (299)
.++|.+.+.||+|++|.||++... ++..+|+|++...... .....+.+|+..++.+.|+||+++++++... +.
T Consensus 3 ~~~~~~~~~ig~g~~~~v~~~~~~~~~~~~~~~~avK~~~~~~~~-~~~~~~~~ei~~l~~l~~~~i~~~~~~~~~~~~~ 81 (284)
T cd05038 3 KRHLKFIKQLGEGHFGKVELCRYDPLGDNTGEQVAVKSLNHSGEE-QHRSDFEREIEILRTLDHENIVKYKGVCEKPGGR 81 (284)
T ss_pred hhhchhheeeccCCCeeEEEeeecCCCCCCceEEEEEEeccccch-HHHHHHHHHHHHHHhCCCCChheEEeeeecCCCC
Confidence 357888899999999999999742 3788999998744322 3567889999999999999999999976542 34
Q ss_pred eeEEEEeecCCCChHHHhcCCCCCCCCCChhhHHHHHHHHHHHHHHhhcCCCCCeeeecccCCceeeCCCCcEEEeeecc
Q 038766 85 LKALILEYMENGSLESVIHGPGVDHSRWTLPKRIDVLISVANGLDYLHSGYDIPIVHCDMKPSNILLDRDFEAHVSDFGT 164 (299)
Q Consensus 85 ~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lh~~~~~~~~H~dl~~~nil~~~~~~v~l~df~~ 164 (299)
..++++||+.+++|.+++... ...++...++.++.|++.||++||++ +++|+||+|+||+++.++.++|+|||.
T Consensus 82 ~~~lv~e~~~~~~l~~~l~~~---~~~~~~~~~~~~~~~l~~aL~~lH~~---~i~H~dl~p~nil~~~~~~~~l~dfg~ 155 (284)
T cd05038 82 SLRLIMEYLPSGSLRDYLQRH---RDQINLKRLLLFSSQICKGMDYLGSQ---RYIHRDLAARNILVESEDLVKISDFGL 155 (284)
T ss_pred ceEEEEecCCCCCHHHHHHhC---ccccCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHhEEEcCCCCEEEccccc
Confidence 569999999999999998632 23589999999999999999999999 999999999999999999999999999
Q ss_pred ccccccccccccccccccccCcccCChhhhcccCcCccccchhhhHHHHHHHhCCCCCCCCccCCCCc------hhHHHH
Q 038766 165 SRMLDVHLQDLSSLSTAFQGTIGYLAPEFAYMRIVTTKVDVFSFGIVVMEFLTKRRPTGLDEENGLSP------ISLRQL 238 (299)
Q Consensus 165 ~~~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~DiwslG~~l~~l~~g~~p~~~~~~~~~~~------~~~~~~ 238 (299)
+......... .........+..|++||...+..++.++|+||||+++++|++|..|+.......... ......
T Consensus 156 ~~~~~~~~~~-~~~~~~~~~~~~~~~Pe~~~~~~~~~~~Di~slG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~ 234 (284)
T cd05038 156 AKVLPEDKDY-YYVKEPGESPIFWYAPECLRTSKFSSASDVWSFGVTLYELFTYGDPSQSPPAEFLRMIGIAQGQMIVTR 234 (284)
T ss_pred ccccccCCcc-eeccCCCCCcccccCcHHHccCCCCcccchHHHhhhhheeeccCCCcccccchhccccccccccccHHH
Confidence 8765421110 111112233456999999988889999999999999999999999875432221110 000111
Q ss_pred HHHHHhcCccCcccccCccccchhhHhHHHHHHHHHHHHHHHHhcCCCCCCCCChhhhhc
Q 038766 239 VEKALANGINGVRQITDPKLVSSIYEEQEQHQVLEELFKLALVCTSSNPEDRPNMNELLI 298 (299)
Q Consensus 239 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rpt~~~il~ 298 (299)
+........ ... .+...+.++.+++.+||+.+|++|||+.++++
T Consensus 235 ~~~~~~~~~----~~~------------~~~~~~~~~~~li~~cl~~~p~~Rpt~~ei~~ 278 (284)
T cd05038 235 LLELLKEGE----RLP------------RPPSCPDEVYDLMKLCWEAEPQDRPSFADLIL 278 (284)
T ss_pred HHHHHHcCC----cCC------------CCccCCHHHHHHHHHHhccChhhCCCHHHHHH
Confidence 111111110 000 01223467899999999999999999999975
|
Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; catalytic (c) domain (repeat 2). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Most Jaks are expressed in a wide variety of tissues, except for Jak3, which is expressed only in hematopoietic cells. Jaks are crucial for cytokine receptor signaling. They are activated by aut |
| >cd07854 STKc_MAPK4_6 Catalytic domain of the Serine/Threonine Kinases, Mitogen-Activated Protein Kinases 4 and 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-38 Score=273.96 Aligned_cols=273 Identities=23% Similarity=0.298 Sum_probs=194.6
Q ss_pred HhCCCCCCceeecCCcceEEEEEeC-CCcEEEEEEeccCcCChhhhHHHHHHHHHHHhcCCcceeeeeeEEEcCC-----
Q 038766 10 ATGSFSENNIIGNSNLSTVYKGRLE-DGEIVAVKKLNFHQFSAESDKSFYREAKTLKELKHRNLVKVLGYAWESG----- 83 (299)
Q Consensus 10 ~~~~y~~~~~lg~g~~~~v~~~~~~-~~~~~~vK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~----- 83 (299)
+.++|.+.+.||.|++|.||++.+. +|..||+|++.... ....+.+.+|+++++.++||||+++++.+...+
T Consensus 3 ~~~~y~~~~~Lg~g~~g~vy~~~~~~~~~~v~iK~i~~~~--~~~~~~~~~Ei~~l~~l~h~~i~~~~~~~~~~~~~~~~ 80 (342)
T cd07854 3 LGSRYMDLRPLGCGSNGLVFSAVDSDCDKRVAVKKIVLTD--PQSVKHALREIKIIRRLDHDNIVKVYEVLGPSGSDLTE 80 (342)
T ss_pred cCcceEEEEEecCCCCEEEEEEEECCCCcEEEEEEEecCC--CchHHHHHHHHHHHHhcCCCcchhhHhhhccccccccc
Confidence 4589999999999999999999864 58999999986443 244567888999999999999999998654432
Q ss_pred --------CeeEEEEeecCCCChHHHhcCCCCCCCCCChhhHHHHHHHHHHHHHHhhcCCCCCeeeecccCCceeeCC-C
Q 038766 84 --------KLKALILEYMENGSLESVIHGPGVDHSRWTLPKRIDVLISVANGLDYLHSGYDIPIVHCDMKPSNILLDR-D 154 (299)
Q Consensus 84 --------~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lh~~~~~~~~H~dl~~~nil~~~-~ 154 (299)
...++|+||+. ++|.+++. ...+++..++.++.||++||.|||+. +++|+||||+||+++. +
T Consensus 81 ~~~~~~~~~~~~lv~e~~~-~~L~~~~~-----~~~l~~~~~~~~~~qi~~aL~~LH~~---givH~dikp~Nili~~~~ 151 (342)
T cd07854 81 DVGSLTELNSVYIVQEYME-TDLANVLE-----QGPLSEEHARLFMYQLLRGLKYIHSA---NVLHRDLKPANVFINTED 151 (342)
T ss_pred ccccccccceEEEEeeccc-ccHHHHHH-----cCCCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCCHHHEEEcCCC
Confidence 24689999996 58888874 34689999999999999999999999 9999999999999974 5
Q ss_pred CcEEEeeeccccccccccccccccccccccCcccCChhhhcc-cCcCccccchhhhHHHHHHHhCCCCCCCCccCCCCch
Q 038766 155 FEAHVSDFGTSRMLDVHLQDLSSLSTAFQGTIGYLAPEFAYM-RIVTTKVDVFSFGIVVMEFLTKRRPTGLDEENGLSPI 233 (299)
Q Consensus 155 ~~v~l~df~~~~~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~-~~~~~~~DiwslG~~l~~l~~g~~p~~~~~~~~~~~~ 233 (299)
+.++|+|||++.......... .......++..|+|||.+.. ..++.++|||||||++|+|++|..||...... .
T Consensus 152 ~~~kl~dfg~~~~~~~~~~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwSlGvil~el~~g~~pf~~~~~~----~ 226 (342)
T cd07854 152 LVLKIGDFGLARIVDPHYSHK-GYLSEGLVTKWYRSPRLLLSPNNYTKAIDMWAAGCIFAEMLTGKPLFAGAHEL----E 226 (342)
T ss_pred ceEEECCcccceecCCccccc-cccccccccccccCHHHHhCccccCchhhHHHHHHHHHHHHhCCCCCCCCCHH----H
Confidence 578999999987553211111 11122346778999997654 56788999999999999999999999533210 0
Q ss_pred hHHHHHHHHHhcCccCccc--------cc-CccccchhhHhHHHHHHHHHHHHHHHHhcCCCCCCCCChhhhhcC
Q 038766 234 SLRQLVEKALANGINGVRQ--------IT-DPKLVSSIYEEQEQHQVLEELFKLALVCTSSNPEDRPNMNELLIT 299 (299)
Q Consensus 234 ~~~~~~~~~~~~~~~~~~~--------~~-~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rpt~~~il~~ 299 (299)
.....+............. .. ........ .......++.++.++|.+||..||++|||+++++.|
T Consensus 227 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~ell~h 300 (342)
T cd07854 227 QMQLILESVPVVREEDRNELLNVIPSFVRNDGGEPRRP-LRDLLPGVNPEALDFLEQILTFNPMDRLTAEEALMH 300 (342)
T ss_pred HHHHHHHhcCCCChHHhhhhhhhhhhhhhhcccccCCC-HHHHccCCCHHHHHHHHHHhCCCchhccCHHHHhCC
Confidence 0000000000000000000 00 00000000 001122356789999999999999999999999987
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 4 (MAPK4) and MAPK6 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK4/6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. MAPK4 is also called ERK4 or p63MAPK, while MAPK6 is also called ERK3 or p97MAPK. MAPK4 and MAPK6 are atypical MAPKs that are not regulated by MAP2Ks. MAPK6 is expressed ubiquitously with highest amounts in brain and skeletal muscle. It may be involved in the control of cell differentiation by negatively regulating cell cycle progressi |
| >PTZ00024 cyclin-dependent protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.3e-38 Score=269.68 Aligned_cols=277 Identities=23% Similarity=0.284 Sum_probs=197.9
Q ss_pred HHhCCCCC-CceeecCCcceEEEEEeC-CCcEEEEEEeccCcCChhh------------hHHHHHHHHHHHhcCCcceee
Q 038766 9 NATGSFSE-NNIIGNSNLSTVYKGRLE-DGEIVAVKKLNFHQFSAES------------DKSFYREAKTLKELKHRNLVK 74 (299)
Q Consensus 9 ~~~~~y~~-~~~lg~g~~~~v~~~~~~-~~~~~~vK~~~~~~~~~~~------------~~~~~~e~~~l~~l~h~~i~~ 74 (299)
.+.++|.. .+.||+|++|+||++.+. +++.||+|++......... ...+.+|+.+++.++|+||++
T Consensus 5 ~~~~ry~~~~~~ig~G~~g~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~ 84 (335)
T PTZ00024 5 SISERYIQKGAHLGEGTYGKVEKAYDTLTGKIVAIKKVKIIEISNDVTKDRQLVGMCGIHFTTLRELKIMNEIKHENIMG 84 (335)
T ss_pred ccccchhhhhhcccCCCceeEEEEEECCCCCeEEEEEeeccccccccccchhhhcccccchhHHHHHHHHHhCCCcceee
Confidence 46788875 577999999999999864 6899999998643322111 124678999999999999999
Q ss_pred eeeEEEcCCCeeEEEEeecCCCChHHHhcCCCCCCCCCChhhHHHHHHHHHHHHHHhhcCCCCCeeeecccCCceeeCCC
Q 038766 75 VLGYAWESGKLKALILEYMENGSLESVIHGPGVDHSRWTLPKRIDVLISVANGLDYLHSGYDIPIVHCDMKPSNILLDRD 154 (299)
Q Consensus 75 ~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lh~~~~~~~~H~dl~~~nil~~~~ 154 (299)
+++++.. +...++|+|++. ++|.+++. ....+++..+..++.|++.||++||+. +++|+||+|+||+++.+
T Consensus 85 ~~~~~~~-~~~~~lv~e~~~-~~l~~~l~----~~~~~~~~~~~~~~~ql~~aL~~LH~~---~i~H~dl~~~nill~~~ 155 (335)
T PTZ00024 85 LVDVYVE-GDFINLVMDIMA-SDLKKVVD----RKIRLTESQVKCILLQILNGLNVLHKW---YFMHRDLSPANIFINSK 155 (335)
T ss_pred eeEEEec-CCcEEEEEeccc-cCHHHHHH----hcCCCCHHHHHHHHHHHHHHHHHHHhC---CeecccccHHHeEECCC
Confidence 9997655 556799999996 58998886 445789999999999999999999999 99999999999999999
Q ss_pred CcEEEeeeccccccccccc----------cccccccccccCcccCChhhhccc-CcCccccchhhhHHHHHHHhCCCCCC
Q 038766 155 FEAHVSDFGTSRMLDVHLQ----------DLSSLSTAFQGTIGYLAPEFAYMR-IVTTKVDVFSFGIVVMEFLTKRRPTG 223 (299)
Q Consensus 155 ~~v~l~df~~~~~~~~~~~----------~~~~~~~~~~~~~~y~~PE~~~~~-~~~~~~DiwslG~~l~~l~~g~~p~~ 223 (299)
+.++|+|||++........ ..........++..|+|||.+.+. .++.++|+|||||++|+|++|..||.
T Consensus 156 ~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~el~tg~~p~~ 235 (335)
T PTZ00024 156 GICKIADFGLARRYGYPPYSDTLSKDETMQRREEMTSKVVTLWYRAPELLMGAEKYHFAVDMWSVGCIFAELLTGKPLFP 235 (335)
T ss_pred CCEEECCccceeecccccccccccccccccccccccccccccCCCCChhcccCCCCCcHHHHHHHHHHHHHHHhCCCCCC
Confidence 9999999999875431000 001111223457789999988764 46889999999999999999999986
Q ss_pred CCccCCCCchhHHHHHHHHHhcC----ccCcccccCcc---ccchhhHhHHHHHHHHHHHHHHHHhcCCCCCCCCChhhh
Q 038766 224 LDEENGLSPISLRQLVEKALANG----INGVRQITDPK---LVSSIYEEQEQHQVLEELFKLALVCTSSNPEDRPNMNEL 296 (299)
Q Consensus 224 ~~~~~~~~~~~~~~~~~~~~~~~----~~~~~~~~~~~---~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rpt~~~i 296 (299)
..... ..+..... ..... ++......... ..............+..+.++|.+||..+|++|||++++
T Consensus 236 ~~~~~----~~~~~i~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~s~~~~ 310 (335)
T PTZ00024 236 GENEI----DQLGRIFE-LLGTPNEDNWPQAKKLPLYTEFTPRKPKDLKTIFPNASDDAIDLLQSLLKLNPLERISAKEA 310 (335)
T ss_pred CCCHH----HHHHHHHH-HhCCCchhhCcchhhcccccccCcCCcccHHHhCcCCChHHHHHHHHHcCCCchhccCHHHH
Confidence 44221 11111111 11000 00100000000 000000011123346789999999999999999999999
Q ss_pred hcC
Q 038766 297 LIT 299 (299)
Q Consensus 297 l~~ 299 (299)
|.|
T Consensus 311 l~~ 313 (335)
T PTZ00024 311 LKH 313 (335)
T ss_pred hcC
Confidence 986
|
|
| >cd08528 STKc_Nek10 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 10 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.8e-38 Score=261.81 Aligned_cols=253 Identities=24% Similarity=0.388 Sum_probs=194.9
Q ss_pred CCCCCceeecCCcceEEEEEeCC--CcEEEEEEeccCc--------CChhhhHHHHHHHHHHHh-cCCcceeeeeeEEEc
Q 038766 13 SFSENNIIGNSNLSTVYKGRLED--GEIVAVKKLNFHQ--------FSAESDKSFYREAKTLKE-LKHRNLVKVLGYAWE 81 (299)
Q Consensus 13 ~y~~~~~lg~g~~~~v~~~~~~~--~~~~~vK~~~~~~--------~~~~~~~~~~~e~~~l~~-l~h~~i~~~~~~~~~ 81 (299)
.|.+.+.||+|++|.||++.+.. ++.+++|.+.... ........+..|+..+++ ++|+|++++++.+..
T Consensus 1 ~y~~~~~ig~G~~~~v~~~~~~~~~~~~~avk~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~ 80 (269)
T cd08528 1 EYAVLEHLGSGAFGCVYKVRKKNNGQNLLALKEINVHNPAFGKDKRERDKSIGDIVSEVTIIKEQLRHPNIVRYYKTFLE 80 (269)
T ss_pred CchhhhhhcCCCCceEEEEEEcCCCCceeeeeEeeccccccccccccchHHHHHHHHHHHHHhhcCCCCCeeeEEeeEcc
Confidence 48889999999999999998754 7889999886432 223334556778887865 689999999997665
Q ss_pred CCCeeEEEEeecCCCChHHHhcCCCCCCCCCChhhHHHHHHHHHHHHHHhhc-CCCCCeeeecccCCceeeCCCCcEEEe
Q 038766 82 SGKLKALILEYMENGSLESVIHGPGVDHSRWTLPKRIDVLISVANGLDYLHS-GYDIPIVHCDMKPSNILLDRDFEAHVS 160 (299)
Q Consensus 82 ~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lh~-~~~~~~~H~dl~~~nil~~~~~~v~l~ 160 (299)
+...++++||+.+++|.+++.........+++..++.++.|++.+|.+||+ . +++|+||+|+||+++.++.++|+
T Consensus 81 -~~~~~lv~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~---~i~H~dl~~~nil~~~~~~~~l~ 156 (269)
T cd08528 81 -NDRLYIVMDLIEGAPLGEHFNSLKEKKQRFTEERIWNIFVQMVLALRYLHKEK---RIVHRDLTPNNIMLGEDDKVTIT 156 (269)
T ss_pred -CCeEEEEEecCCCCcHHHHHHHHHhccCCCCHHHHHHHHHHHHHHHHHhccCC---ceeecCCCHHHEEECCCCcEEEe
Confidence 556699999999999998875322245679999999999999999999996 5 89999999999999999999999
Q ss_pred eeccccccccccccccccccccccCcccCChhhhcccCcCccccchhhhHHHHHHHhCCCCCCCCccCCCCchhHHHHHH
Q 038766 161 DFGTSRMLDVHLQDLSSLSTAFQGTIGYLAPEFAYMRIVTTKVDVFSFGIVVMEFLTKRRPTGLDEENGLSPISLRQLVE 240 (299)
Q Consensus 161 df~~~~~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~DiwslG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~ 240 (299)
|||.+...... .......++..|++||.+.+..++.++|+||||+++|+|++|..||.... .. ....
T Consensus 157 dfg~~~~~~~~-----~~~~~~~~~~~~~~Pe~~~~~~~~~~~Dv~slG~ll~~l~~g~~p~~~~~-----~~---~~~~ 223 (269)
T cd08528 157 DFGLAKQKQPE-----SKLTSVVGTILYSCPEIVKNEPYGEKADVWAFGCILYQMCTLQPPFYSTN-----ML---SLAT 223 (269)
T ss_pred cccceeecccc-----cccccccCcccCcChhhhcCCCCchHHHHHHHHHHHHHHHhCCCcccccC-----HH---HHHH
Confidence 99998754421 12234457888999999998889999999999999999999999984321 11 1111
Q ss_pred HHHhcCccCcccccCccccchhhHhHHHHHHHHHHHHHHHHhcCCCCCCCCChhhhhc
Q 038766 241 KALANGINGVRQITDPKLVSSIYEEQEQHQVLEELFKLALVCTSSNPEDRPNMNELLI 298 (299)
Q Consensus 241 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rpt~~~il~ 298 (299)
......... .. ...++..+.++|.+||..||++|||+.++.+
T Consensus 224 ~~~~~~~~~---~~-------------~~~~~~~l~~li~~cl~~~p~~Rp~~~e~~~ 265 (269)
T cd08528 224 KIVEAVYEP---LP-------------EGMYSEDVTDVITSCLTPDAEARPDIIQVSA 265 (269)
T ss_pred HHhhccCCc---CC-------------cccCCHHHHHHHHHHCCCCCccCCCHHHHHH
Confidence 111111000 00 1123467899999999999999999999875
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 10 (Nek10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek10 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. No function has yet been ascribed to Nek10. The gene encoding Nek10 is a putative causative gene for breast cancer; it is located within a breast cancer susceptibility loci on chromosome 3p24. |
| >KOG0574 consensus STE20-like serine/threonine kinase MST [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.8e-41 Score=266.83 Aligned_cols=250 Identities=24% Similarity=0.357 Sum_probs=207.5
Q ss_pred CCCCCCceeecCCcceEEEEEe-CCCcEEEEEEeccCcCChhhhHHHHHHHHHHHhcCCcceeeeeeEEEcCCCeeEEEE
Q 038766 12 GSFSENNIIGNSNLSTVYKGRL-EDGEIVAVKKLNFHQFSAESDKSFYREAKTLKELKHRNLVKVLGYAWESGKLKALIL 90 (299)
Q Consensus 12 ~~y~~~~~lg~g~~~~v~~~~~-~~~~~~~vK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~lv~ 90 (299)
+-|.++++||+|++|+||+|.+ .+|..+|||.+.. ......+.+|+.++++...|+++++||.++.+.. +++||
T Consensus 33 EVFDi~~KLGEGSYGSV~KAIH~EsG~v~AIK~VPV----~sDLQEIIKEISIMQQC~S~yVVKYYGSYFK~sD-LWIVM 107 (502)
T KOG0574|consen 33 EVFDIVGKLGEGSYGSVHKAIHRESGHVLAIKKVPV----DTDLQEIIKEISIMQQCKSKYVVKYYGSYFKHSD-LWIVM 107 (502)
T ss_pred HHHHHHHHhcCCcchHHHHHHHhccCcEEEEEecCc----cchHHHHHHHHHHHHHcCCchhhhhhhhhccCCc-eEeeh
Confidence 3477899999999999999976 5699999998753 3456778899999999999999999997776554 59999
Q ss_pred eecCCCChHHHhcCCCCCCCCCChhhHHHHHHHHHHHHHHhhcCCCCCeeeecccCCceeeCCCCcEEEeeecccccccc
Q 038766 91 EYMENGSLESVIHGPGVDHSRWTLPKRIDVLISVANGLDYLHSGYDIPIVHCDMKPSNILLDRDFEAHVSDFGTSRMLDV 170 (299)
Q Consensus 91 e~~~~~~L~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lh~~~~~~~~H~dl~~~nil~~~~~~v~l~df~~~~~~~~ 170 (299)
|||..|++.+.+.. .++++++.++..++..-+.+|+|||.. .-+|||||..|||++.+|..||.|||.+-.+-
T Consensus 108 EYCGAGSiSDI~R~---R~K~L~E~EIs~iL~~TLKGL~YLH~~---~KIHRDIKAGNILLNT~G~AKLADFGVAGQLT- 180 (502)
T KOG0574|consen 108 EYCGAGSISDIMRA---RRKPLSEQEISAVLRDTLKGLQYLHDL---KKIHRDIKAGNILLNTDGIAKLADFGVAGQLT- 180 (502)
T ss_pred hhcCCCcHHHHHHH---hcCCccHHHHHHHHHHHHhHHHHHHHH---HHHHhhcccccEEEcccchhhhhhccccchhh-
Confidence 99999999998864 578999999999999999999999998 99999999999999999999999999986543
Q ss_pred ccccccccccccccCcccCChhhhcccCcCccccchhhhHHHHHHHhCCCCCCCCccCCCCchhHHHHHHHHHhcCccCc
Q 038766 171 HLQDLSSLSTAFQGTIGYLAPEFAYMRIVTTKVDVFSFGIVVMEFLTKRRPTGLDEENGLSPISLRQLVEKALANGINGV 250 (299)
Q Consensus 171 ~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~DiwslG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 250 (299)
+.-.......|||-|+|||++..-+|..++||||||++..+|..|.+|++.- .+ ++.++ -+
T Consensus 181 ---DTMAKRNTVIGTPFWMAPEVI~EIGY~~~ADIWSLGITaIEMAEG~PPYsDI-----HP------MRAIF-----MI 241 (502)
T KOG0574|consen 181 ---DTMAKRNTVIGTPFWMAPEVIEEIGYDTKADIWSLGITAIEMAEGRPPYSDI-----HP------MRAIF-----MI 241 (502)
T ss_pred ---hhHHhhCccccCcccccHHHHHHhccchhhhHhhhcchhhhhhcCCCCcccc-----cc------cceeE-----ec
Confidence 1223456788999999999999999999999999999999999999998532 11 11111 11
Q ss_pred ccccCccccchhhHhHHHHHHHHHHHHHHHHhcCCCCCCCCChhhhhcC
Q 038766 251 RQITDPKLVSSIYEEQEQHQVLEELFKLALVCTSSNPEDRPNMNELLIT 299 (299)
Q Consensus 251 ~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rpt~~~il~~ 299 (299)
...+.|-+.. +..-++++.++|++||..+|++|-|+.++++|
T Consensus 242 PT~PPPTF~K-------PE~WS~~F~DFi~~CLiK~PE~R~TA~~L~~H 283 (502)
T KOG0574|consen 242 PTKPPPTFKK-------PEEWSSEFNDFIRSCLIKKPEERKTALRLCEH 283 (502)
T ss_pred cCCCCCCCCC-------hHhhhhHHHHHHHHHhcCCHHHHHHHHHHhhh
Confidence 1112222221 55667899999999999999999999999987
|
|
| >cd05042 PTKc_Aatyk Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.5e-38 Score=261.44 Aligned_cols=253 Identities=22% Similarity=0.328 Sum_probs=181.9
Q ss_pred ceeecCCcceEEEEEeC---CCcEEEEEEeccCcCChhhhHHHHHHHHHHHhcCCcceeeeeeEEEcCCCeeEEEEeecC
Q 038766 18 NIIGNSNLSTVYKGRLE---DGEIVAVKKLNFHQFSAESDKSFYREAKTLKELKHRNLVKVLGYAWESGKLKALILEYME 94 (299)
Q Consensus 18 ~~lg~g~~~~v~~~~~~---~~~~~~vK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~lv~e~~~ 94 (299)
+.||+|+||.||++... ....+++|.+... ........+.+|+..++.++|+||+++++.+.. +...++|+||+.
T Consensus 1 ~~lg~G~fg~v~~~~~~~~~~~~~~~~k~~~~~-~~~~~~~~~~~e~~~~~~l~h~nii~~~~~~~~-~~~~~lv~e~~~ 78 (269)
T cd05042 1 DEIGNGWFGKVLLGEAHRGMSKARVVVKELRAS-ATPDEQLLFLQEVQPYRELNHPNVLQCLGQCIE-SIPYLLVLEFCP 78 (269)
T ss_pred CcCCccCCceEEEEEEecCCCCeEEEEeecCcc-CChHHHHHHHHHHHHHHhCCCCCcceEEEEECC-CCceEEEEEeCC
Confidence 46899999999999643 2457888877532 233445667889999999999999999997665 445699999999
Q ss_pred CCChHHHhcCCCC-CCCCCChhhHHHHHHHHHHHHHHhhcCCCCCeeeecccCCceeeCCCCcEEEeeeccccccccccc
Q 038766 95 NGSLESVIHGPGV-DHSRWTLPKRIDVLISVANGLDYLHSGYDIPIVHCDMKPSNILLDRDFEAHVSDFGTSRMLDVHLQ 173 (299)
Q Consensus 95 ~~~L~~~~~~~~~-~~~~~~~~~~~~i~~qi~~~l~~lh~~~~~~~~H~dl~~~nil~~~~~~v~l~df~~~~~~~~~~~ 173 (299)
+++|.+++..... .....++..+..++.||+.||+|||+. +++|+||||+||+++.++.++|+|||++.......
T Consensus 79 ~g~L~~~l~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~---~ivH~dlkp~Nill~~~~~~kl~dfg~~~~~~~~~- 154 (269)
T cd05042 79 LGDLKNYLRSNRGMVAQMAQKDVLQRMACEVASGLLWLHQA---DFIHSDLALRNCQLTADLSVKIGDYGLALEQYPED- 154 (269)
T ss_pred CCcHHHHHHhccccccccccHHHHHHHHHHHHHHHHHHHhc---CEecccccHhheEecCCCcEEEeccccccccccch-
Confidence 9999999865321 223456778899999999999999999 99999999999999999999999999886432110
Q ss_pred cccccccccccCcccCChhhhcc-------cCcCccccchhhhHHHHHHHh-CCCCCCCCccCCCCchhHHHHHHHHHhc
Q 038766 174 DLSSLSTAFQGTIGYLAPEFAYM-------RIVTTKVDVFSFGIVVMEFLT-KRRPTGLDEENGLSPISLRQLVEKALAN 245 (299)
Q Consensus 174 ~~~~~~~~~~~~~~y~~PE~~~~-------~~~~~~~DiwslG~~l~~l~~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~ 245 (299)
.........++..|+|||.... ..++.++|||||||++|+|++ |..||.... .. +.+......
T Consensus 155 -~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l~el~~~~~~p~~~~~-----~~---~~~~~~~~~ 225 (269)
T cd05042 155 -YYITKDCHAVPLRWLAPELVEIRGQDLLPKDQTKKSNIWSLGVTMWELFTAADQPYPDLS-----DE---QVLKQVVRE 225 (269)
T ss_pred -heeccCCCCCcccccCHHHHhhccccccccccchhhHHHHHHHHHHHHHhCCCCCCCcCC-----HH---HHHHHHhhc
Confidence 0011122334667999998643 356789999999999999999 677774321 11 112121111
Q ss_pred CccCcccccCccccchhhHhHHHHHHHHHHHHHHHHhcCCCCCCCCChhhhhc
Q 038766 246 GINGVRQITDPKLVSSIYEEQEQHQVLEELFKLALVCTSSNPEDRPNMNELLI 298 (299)
Q Consensus 246 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rpt~~~il~ 298 (299)
.. .....+.. ....+..+.+++..|+ .||++|||+++|++
T Consensus 226 ~~---~~~~~~~~---------~~~~~~~~~~~~~~~~-~dp~~Rpt~~~v~~ 265 (269)
T cd05042 226 QD---IKLPKPQL---------DLKYSDRWYEVMQFCW-LDPETRPTAEEVHE 265 (269)
T ss_pred cC---ccCCCCcc---------cccCCHHHHHHHHHHh-cCcccccCHHHHHH
Confidence 11 11111111 2234556778888888 59999999999975
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase (Aatyk) subfamily; catalytic (c) domain. The Aatyk subfamily is also referred to as the lemur tyrosine kinase (Lmtk) subfamily. It consists of Aatyk1 (Lmtk1), Aatyk2 (Lmtk2, Brek), Aatyk3 (Lmtk3), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk proteins are mostly receptor tyr kinases (RTKs) containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 does not contain a transmembrane segment and is a cytoplasmic (or nonreceptor) kinase. Aatyk proteins are classified as tyr kina |
| >cd06657 STKc_PAK4 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5e-38 Score=264.64 Aligned_cols=245 Identities=24% Similarity=0.390 Sum_probs=192.5
Q ss_pred CceeecCCcceEEEEEe-CCCcEEEEEEeccCcCChhhhHHHHHHHHHHHhcCCcceeeeeeEEEcCCCeeEEEEeecCC
Q 038766 17 NNIIGNSNLSTVYKGRL-EDGEIVAVKKLNFHQFSAESDKSFYREAKTLKELKHRNLVKVLGYAWESGKLKALILEYMEN 95 (299)
Q Consensus 17 ~~~lg~g~~~~v~~~~~-~~~~~~~vK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~lv~e~~~~ 95 (299)
...||+|++|.||++.. .+++.+|+|++... .......+.+|+..++.++|+|++++++.+.. +...++|+||+++
T Consensus 25 ~~~lg~g~~g~v~~~~~~~~~~~v~iK~~~~~--~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~-~~~~~lv~e~~~~ 101 (292)
T cd06657 25 FIKIGEGSTGIVCIATVKSSGKLVAVKKMDLR--KQQRRELLFNEVVIMRDYQHENVVEMYNSYLV-GDELWVVMEFLEG 101 (292)
T ss_pred HHHcCCCCCeEEEEEEEcCCCeEEEEEEeccc--chhHHHHHHHHHHHHHhcCCcchhheeeEEEe-CCEEEEEEecCCC
Confidence 46799999999999986 46899999987532 33456678899999999999999999996655 5567999999999
Q ss_pred CChHHHhcCCCCCCCCCChhhHHHHHHHHHHHHHHhhcCCCCCeeeecccCCceeeCCCCcEEEeeeccccccccccccc
Q 038766 96 GSLESVIHGPGVDHSRWTLPKRIDVLISVANGLDYLHSGYDIPIVHCDMKPSNILLDRDFEAHVSDFGTSRMLDVHLQDL 175 (299)
Q Consensus 96 ~~L~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lh~~~~~~~~H~dl~~~nil~~~~~~v~l~df~~~~~~~~~~~~~ 175 (299)
++|.+++. ...+++..++.++.|++.+|++||+. +++|+||+|+||+++.++.++|+|||++.......
T Consensus 102 ~~L~~~~~-----~~~~~~~~~~~~~~ql~~~l~~lH~~---givH~dl~p~Nilv~~~~~~~l~dfg~~~~~~~~~--- 170 (292)
T cd06657 102 GALTDIVT-----HTRMNEEQIAAVCLAVLKALSVLHAQ---GVIHRDIKSDSILLTHDGRVKLSDFGFCAQVSKEV--- 170 (292)
T ss_pred CcHHHHHh-----cCCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHEEECCCCCEEEcccccceeccccc---
Confidence 99998874 23578999999999999999999999 99999999999999999999999999886543211
Q ss_pred cccccccccCcccCChhhhcccCcCccccchhhhHHHHHHHhCCCCCCCCccCCCCchhHHHHHHHHHhcCccCcccccC
Q 038766 176 SSLSTAFQGTIGYLAPEFAYMRIVTTKVDVFSFGIVVMEFLTKRRPTGLDEENGLSPISLRQLVEKALANGINGVRQITD 255 (299)
Q Consensus 176 ~~~~~~~~~~~~y~~PE~~~~~~~~~~~DiwslG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 255 (299)
.......++..|+|||.+....++.++|+||+|+++|+|++|..||.... .......+... .......
T Consensus 171 -~~~~~~~~~~~y~~pE~~~~~~~~~~~Dv~slGvil~el~tg~~p~~~~~-----~~~~~~~~~~~---~~~~~~~--- 238 (292)
T cd06657 171 -PRRKSLVGTPYWMAPELISRLPYGPEVDIWSLGIMVIEMVDGEPPYFNEP-----PLKAMKMIRDN---LPPKLKN--- 238 (292)
T ss_pred -ccccccccCccccCHHHhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCC-----HHHHHHHHHhh---CCcccCC---
Confidence 11233456788999999888888999999999999999999999985321 11111111110 0000000
Q ss_pred ccccchhhHhHHHHHHHHHHHHHHHHhcCCCCCCCCChhhhhcC
Q 038766 256 PKLVSSIYEEQEQHQVLEELFKLALVCTSSNPEDRPNMNELLIT 299 (299)
Q Consensus 256 ~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rpt~~~il~~ 299 (299)
...++..+.+++.+||..+|.+||+++++++|
T Consensus 239 ------------~~~~~~~l~~li~~~l~~~P~~R~~~~~ll~~ 270 (292)
T cd06657 239 ------------LHKVSPSLKGFLDRLLVRDPAQRATAAELLKH 270 (292)
T ss_pred ------------cccCCHHHHHHHHHHHhCCcccCcCHHHHhcC
Confidence 11234568899999999999999999999986
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 4, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK4 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK4 regulates cell mo |
| >cd05044 PTKc_c-ros Catalytic domain of the Protein Tyrosine Kinase, C-ros | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-38 Score=263.81 Aligned_cols=249 Identities=28% Similarity=0.436 Sum_probs=189.2
Q ss_pred ceeecCCcceEEEEEeCC-------CcEEEEEEeccCcCChhhhHHHHHHHHHHHhcCCcceeeeeeEEEcCCCeeEEEE
Q 038766 18 NIIGNSNLSTVYKGRLED-------GEIVAVKKLNFHQFSAESDKSFYREAKTLKELKHRNLVKVLGYAWESGKLKALIL 90 (299)
Q Consensus 18 ~~lg~g~~~~v~~~~~~~-------~~~~~vK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~lv~ 90 (299)
+.||+|++|.||++++.+ +..+++|.+... ........+.+|+..++.++||||+++++++... ...++|+
T Consensus 1 ~~lg~g~~g~vy~~~~~~~~~~~~~~~~~~iK~~~~~-~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~-~~~~~v~ 78 (269)
T cd05044 1 NFLGSGAFGEVYEGTATDILGPGSGPIRVAVKTLRKG-ATDQEKKEFLKEAHLMSNFNHPNIVKLLGVCLLN-EPQYIIM 78 (269)
T ss_pred CccccccceeEEeeeecccccCcccceeehhhhhhcc-cchhhHHHHHHHHHHHHhcCCCCeeeEeeeecCC-CCeEEEE
Confidence 469999999999998532 357899987532 2334566788999999999999999999977654 4569999
Q ss_pred eecCCCChHHHhcCCCC---CCCCCChhhHHHHHHHHHHHHHHhhcCCCCCeeeecccCCceeeCCCC-----cEEEeee
Q 038766 91 EYMENGSLESVIHGPGV---DHSRWTLPKRIDVLISVANGLDYLHSGYDIPIVHCDMKPSNILLDRDF-----EAHVSDF 162 (299)
Q Consensus 91 e~~~~~~L~~~~~~~~~---~~~~~~~~~~~~i~~qi~~~l~~lh~~~~~~~~H~dl~~~nil~~~~~-----~v~l~df 162 (299)
||+++++|.+++..... ....+++..+..++.|++.||+|||+. +++|+||+|+||+++.++ .++|+||
T Consensus 79 e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~---~i~H~dl~p~nil~~~~~~~~~~~~~l~df 155 (269)
T cd05044 79 ELMEGGDLLSYLRDARVERFGPPLLTLKELLDICLDVAKGCVYLEQM---HFIHRDLAARNCLVSEKGYDADRVVKIGDF 155 (269)
T ss_pred eccCCCcHHHHHHHhhhcccCCccccHHHHHHHHHHHHHHHHHHHhC---CcccCCCChheEEEecCCCCCCcceEECCc
Confidence 99999999998864221 224578899999999999999999998 999999999999999877 8999999
Q ss_pred ccccccccccccccccccccccCcccCChhhhcccCcCccccchhhhHHHHHHHh-CCCCCCCCccCCCCchhHHHHHHH
Q 038766 163 GTSRMLDVHLQDLSSLSTAFQGTIGYLAPEFAYMRIVTTKVDVFSFGIVVMEFLT-KRRPTGLDEENGLSPISLRQLVEK 241 (299)
Q Consensus 163 ~~~~~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~DiwslG~~l~~l~~-g~~p~~~~~~~~~~~~~~~~~~~~ 241 (299)
|++...... ...........+..|+|||.+.+..++.++||||||+++|+|++ |..||... ........+.
T Consensus 156 g~~~~~~~~--~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~ellt~g~~p~~~~-----~~~~~~~~~~- 227 (269)
T cd05044 156 GLARDIYKS--DYYRKEGEGLLPVRWMAPESLLDGKFTTQSDVWSFGVLMWEILTLGQQPYPAL-----NNQEVLQHVT- 227 (269)
T ss_pred ccccccccc--cccccCcccCCCccccCHHHHccCCcccchhHHHHHHHHHHHHHcCCCCCccc-----CHHHHHHHHh-
Confidence 998654311 11111122334678999999998889999999999999999998 88888532 1111111111
Q ss_pred HHhcCccCcccccCccccchhhHhHHHHHHHHHHHHHHHHhcCCCCCCCCChhhhhc
Q 038766 242 ALANGINGVRQITDPKLVSSIYEEQEQHQVLEELFKLALVCTSSNPEDRPNMNELLI 298 (299)
Q Consensus 242 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rpt~~~il~ 298 (299)
... .. ..+...+..+.++|.+||..+|++|||+.++++
T Consensus 228 --~~~-----~~------------~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~ 265 (269)
T cd05044 228 --AGG-----RL------------QKPENCPDKIYQLMTNCWAQDPSERPTFDRIQE 265 (269)
T ss_pred --cCC-----cc------------CCcccchHHHHHHHHHHcCCCcccCCCHHHHHH
Confidence 000 00 002334668899999999999999999999875
|
Protein Tyrosine Kinases (PTK) family; C-ros and Drosophila Sevenless proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The proto-oncogene c-ros encodes an orphan receptor tyr kinase (RTK) with an unknown ligand. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. C-ros is expressed in embryonic cells of the kidney, intestine and lung, but disappears soon after birth. It persists only in the adult epididymis. Male |
| >cd05606 STKc_beta_ARK Catalytic domain of the Protein Serine/Threonine Kinase, beta-adrenergic receptor kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-38 Score=264.70 Aligned_cols=244 Identities=22% Similarity=0.262 Sum_probs=184.0
Q ss_pred eeecCCcceEEEEEe-CCCcEEEEEEeccCcCChhh-hHHHHHHH---HHHHhcCCcceeeeeeEEEcCCCeeEEEEeec
Q 038766 19 IIGNSNLSTVYKGRL-EDGEIVAVKKLNFHQFSAES-DKSFYREA---KTLKELKHRNLVKVLGYAWESGKLKALILEYM 93 (299)
Q Consensus 19 ~lg~g~~~~v~~~~~-~~~~~~~vK~~~~~~~~~~~-~~~~~~e~---~~l~~l~h~~i~~~~~~~~~~~~~~~lv~e~~ 93 (299)
.||+|++|.||++.+ .+++.||+|.+......... ......|. ..++...||+++.+.+.+.. ....++|+||+
T Consensus 1 ~ig~g~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~-~~~~~~v~e~~ 79 (278)
T cd05606 1 IIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMSYAFHT-PDKLSFILDLM 79 (278)
T ss_pred CcccCCCeEEEEEEEecCCCEEEEEEeeccccccchhHHHHHHHHHHHHHHHhCCCCcEeeeeeeeec-CCEEEEEEecC
Confidence 489999999999986 45899999998754333222 22233333 34444579999999986655 45669999999
Q ss_pred CCCChHHHhcCCCCCCCCCChhhHHHHHHHHHHHHHHhhcCCCCCeeeecccCCceeeCCCCcEEEeeeccccccccccc
Q 038766 94 ENGSLESVIHGPGVDHSRWTLPKRIDVLISVANGLDYLHSGYDIPIVHCDMKPSNILLDRDFEAHVSDFGTSRMLDVHLQ 173 (299)
Q Consensus 94 ~~~~L~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lh~~~~~~~~H~dl~~~nil~~~~~~v~l~df~~~~~~~~~~~ 173 (299)
.+++|...+. ....+++..++.++.|++.||.|||+. +++|+||+|+||+++.++.++|+|||++......
T Consensus 80 ~g~~L~~~l~----~~~~l~~~~~~~~~~ql~~~l~~lH~~---~i~H~di~p~nili~~~~~~kl~dfg~~~~~~~~-- 150 (278)
T cd05606 80 NGGDLHYHLS----QHGVFSEAEMRFYAAEIILGLEHMHNR---FVVYRDLKPANILLDEHGHVRISDLGLACDFSKK-- 150 (278)
T ss_pred CCCcHHHHHH----hcCCCCHHHHHHHHHHHHHHHHHHHHC---CEEcCCCCHHHEEECCCCCEEEccCcCccccCcc--
Confidence 9999998886 445799999999999999999999999 9999999999999999999999999998654311
Q ss_pred cccccccccccCcccCChhhhccc-CcCccccchhhhHHHHHHHhCCCCCCCCccCCCCchhHHHHHHHHHhcCccCccc
Q 038766 174 DLSSLSTAFQGTIGYLAPEFAYMR-IVTTKVDVFSFGIVVMEFLTKRRPTGLDEENGLSPISLRQLVEKALANGINGVRQ 252 (299)
Q Consensus 174 ~~~~~~~~~~~~~~y~~PE~~~~~-~~~~~~DiwslG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 252 (299)
......++..|+|||.+.+. .++.++||||+|+++|+|++|..||....... .......... .
T Consensus 151 ----~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~s~G~~l~~l~~g~~p~~~~~~~~-----~~~~~~~~~~-~------ 214 (278)
T cd05606 151 ----KPHASVGTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKD-----KHEIDRMTLT-M------ 214 (278)
T ss_pred ----CCcCcCCCcCCcCcHHhcCCCCCCcccchHhHHHHHHHHHhCCCCCCCCCccc-----hHHHHHHhhc-c------
Confidence 12234578899999998754 68899999999999999999999995431111 1111111000 0
Q ss_pred ccCccccchhhHhHHHHHHHHHHHHHHHHhcCCCCCCCC-----ChhhhhcC
Q 038766 253 ITDPKLVSSIYEEQEQHQVLEELFKLALVCTSSNPEDRP-----NMNELLIT 299 (299)
Q Consensus 253 ~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rp-----t~~~il~~ 299 (299)
.. ..+...+.++.+++++||..+|++|| +++++++|
T Consensus 215 --~~---------~~~~~~s~~~~~li~~~l~~~p~~R~~~~~~~~~~ll~~ 255 (278)
T cd05606 215 --AV---------ELPDSFSPELRSLLEGLLQRDVNRRLGCLGRGAQEVKEH 255 (278)
T ss_pred --CC---------CCCCcCCHHHHHHHHHHhhcCHHhccCCCCCCHHHHHhC
Confidence 00 00223456899999999999999999 99999986
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, beta-adrenergic receptor kinase (beta-ARK) group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. The beta-ARK group is co |
| >cd05611 STKc_Rim15_like Catalytic domain of fungal Rim15-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.3e-38 Score=260.25 Aligned_cols=244 Identities=24% Similarity=0.298 Sum_probs=185.7
Q ss_pred ceeecCCcceEEEEEeC-CCcEEEEEEeccCcCCh-hhhHHHHHHHHHH-HhcCCcceeeeeeEEEcCCCeeEEEEeecC
Q 038766 18 NIIGNSNLSTVYKGRLE-DGEIVAVKKLNFHQFSA-ESDKSFYREAKTL-KELKHRNLVKVLGYAWESGKLKALILEYME 94 (299)
Q Consensus 18 ~~lg~g~~~~v~~~~~~-~~~~~~vK~~~~~~~~~-~~~~~~~~e~~~l-~~l~h~~i~~~~~~~~~~~~~~~lv~e~~~ 94 (299)
+.||.|++|.||+|.+. +++.+|+|++....... ........|...+ ....|+|++++++.+.. +...++|+||+.
T Consensus 2 ~~l~~g~~~~v~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~-~~~~~lv~e~~~ 80 (260)
T cd05611 2 KPISKGAFGSVYLAKKRSTGDYFAIKVLKKSDMIAKNQVTNVKAERAIMMIQGESPYVAKLYYSFQS-KDYLYLVMEYLN 80 (260)
T ss_pred ccCCcCCCeeEEEEEecCCCCeEEEEEecchhhhHHHHHHHHHHHHHHHhhcCCCCCeeeeeeeEEc-CCeEEEEEeccC
Confidence 57999999999999874 58899999986433211 1222344454444 44579999999996654 556799999999
Q ss_pred CCChHHHhcCCCCCCCCCChhhHHHHHHHHHHHHHHhhcCCCCCeeeecccCCceeeCCCCcEEEeeecccccccccccc
Q 038766 95 NGSLESVIHGPGVDHSRWTLPKRIDVLISVANGLDYLHSGYDIPIVHCDMKPSNILLDRDFEAHVSDFGTSRMLDVHLQD 174 (299)
Q Consensus 95 ~~~L~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lh~~~~~~~~H~dl~~~nil~~~~~~v~l~df~~~~~~~~~~~~ 174 (299)
+++|.++++ ....+++..+..++.|+++||.|||+. +++|+||+|+||+++.++.++|+|||++.....
T Consensus 81 ~~~L~~~l~----~~~~~~~~~~~~i~~qi~~aL~~lH~~---~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~---- 149 (260)
T cd05611 81 GGDCASLIK----TLGGLPEDWAKQYIAEVVLGVEDLHQR---GIIHRDIKPENLLIDQTGHLKLTDFGLSRNGLE---- 149 (260)
T ss_pred CCCHHHHHH----HcCCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHeEECCCCcEEEeecccceeccc----
Confidence 999999997 345789999999999999999999999 999999999999999999999999998864321
Q ss_pred ccccccccccCcccCChhhhcccCcCccccchhhhHHHHHHHhCCCCCCCCccCCCCchhHHHHHHHHHhcCccCccccc
Q 038766 175 LSSLSTAFQGTIGYLAPEFAYMRIVTTKVDVFSFGIVVMEFLTKRRPTGLDEENGLSPISLRQLVEKALANGINGVRQIT 254 (299)
Q Consensus 175 ~~~~~~~~~~~~~y~~PE~~~~~~~~~~~DiwslG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 254 (299)
.....++..|++||.+.+..++.++|+||||+++|+|++|..||.... .... .......... ..
T Consensus 150 ----~~~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~-----~~~~---~~~~~~~~~~----~~ 213 (260)
T cd05611 150 ----NKKFVGTPDYLAPETILGVGDDKMSDWWSLGCVIFEFLFGYPPFHAET-----PDAV---FDNILSRRIN----WP 213 (260)
T ss_pred ----cccCCCCcCccChhhhcCCCCcchhhhHHHHHHHHHHHHCCCCCCCCC-----HHHH---HHHHHhcccC----CC
Confidence 223456788999999988888999999999999999999999985331 1111 1111111000 00
Q ss_pred CccccchhhHhHHHHHHHHHHHHHHHHhcCCCCCCCCCh---hhhhcC
Q 038766 255 DPKLVSSIYEEQEQHQVLEELFKLALVCTSSNPEDRPNM---NELLIT 299 (299)
Q Consensus 255 ~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rpt~---~~il~~ 299 (299)
. .....++.++.+++.+||..+|++|||+ +|++.|
T Consensus 214 ~----------~~~~~~~~~~~~~i~~~l~~~p~~R~~~~~~~~~l~~ 251 (260)
T cd05611 214 E----------EVKEFCSPEAVDLINRLLCMDPAKRLGANGYQEIKSH 251 (260)
T ss_pred C----------cccccCCHHHHHHHHHHccCCHHHccCCCcHHHHHcC
Confidence 0 0122456789999999999999999955 688876
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, fungal Rim15-like kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include Saccharomyces cerevisiae Rim15, Schizosaccharomyces pombe cek1, and similar fungal proteins. They contain a central catalytic domain, which contains an insert relative to MAST kinases. In addition, Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. Rim15 (or Rim15p) functions as a regulator of meiosis. It acts as a do |
| >KOG0579 consensus Ste20-like serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.2e-40 Score=282.91 Aligned_cols=252 Identities=25% Similarity=0.355 Sum_probs=203.2
Q ss_pred CCCCCCceeecCCcceEEEEEeCC-CcEEEEEEeccCcCChhhhHHHHHHHHHHHhcCCcceeeeeeEEEcCCCeeEEEE
Q 038766 12 GSFSENNIIGNSNLSTVYKGRLED-GEIVAVKKLNFHQFSAESDKSFYREAKTLKELKHRNLVKVLGYAWESGKLKALIL 90 (299)
Q Consensus 12 ~~y~~~~~lg~g~~~~v~~~~~~~-~~~~~vK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~lv~ 90 (299)
+.|.|..-||.|+||.||+|..+. +-..|.|+|. ....+..+.+.-|+.+|..+.||+|+++++.++..++. +++.
T Consensus 32 d~WeIiGELGDGAFGKVyKA~nket~~lAAaKvIe--tkseEELEDylVEIeILa~CdHP~ivkLl~ayy~enkL-wili 108 (1187)
T KOG0579|consen 32 DHWEIIGELGDGAFGKVYKAVNKETKLLAAAKVIE--TKSEEELEDYLVEIEILAECDHPVIVKLLSAYYFENKL-WILI 108 (1187)
T ss_pred HHHHHHhhhcCccchhhhhhhcccchhhhhhhhhc--ccchhHHhhhhhhhhhhhcCCChHHHHHHHHHhccCce-EEEE
Confidence 345677789999999999998654 5556778775 44567788899999999999999999999987775654 9999
Q ss_pred eecCCCChHHHhcCCCCCCCCCChhhHHHHHHHHHHHHHHhhcCCCCCeeeecccCCceeeCCCCcEEEeeecccccccc
Q 038766 91 EYMENGSLESVIHGPGVDHSRWTLPKRIDVLISVANGLDYLHSGYDIPIVHCDMKPSNILLDRDFEAHVSDFGTSRMLDV 170 (299)
Q Consensus 91 e~~~~~~L~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lh~~~~~~~~H~dl~~~nil~~~~~~v~l~df~~~~~~~~ 170 (299)
|||.||-+...+-+ -+..+++.++.-++.|++.||.|||++ +|+|||||..|||++.+|.++|.|||.+....
T Consensus 109 EFC~GGAVDaimlE---L~r~LtE~QIqvvc~q~ldALn~LHs~---~iIHRDLKAGNiL~TldGdirLADFGVSAKn~- 181 (1187)
T KOG0579|consen 109 EFCGGGAVDAIMLE---LGRVLTEDQIQVVCYQVLDALNWLHSQ---NIIHRDLKAGNILLTLDGDIRLADFGVSAKNK- 181 (1187)
T ss_pred eecCCchHhHHHHH---hccccchHHHHHHHHHHHHHHHHHhhc---chhhhhccccceEEEecCcEeeecccccccch-
Confidence 99999999887654 346899999999999999999999999 99999999999999999999999999887543
Q ss_pred ccccccccccccccCcccCChhh-----hcccCcCccccchhhhHHHHHHHhCCCCCCCCccCCCCchhHHHHHHHHHhc
Q 038766 171 HLQDLSSLSTAFQGTIGYLAPEF-----AYMRIVTTKVDVFSFGIVVMEFLTKRRPTGLDEENGLSPISLRQLVEKALAN 245 (299)
Q Consensus 171 ~~~~~~~~~~~~~~~~~y~~PE~-----~~~~~~~~~~DiwslG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~ 245 (299)
........+.|||+|||||+ +.+..|+.++||||||++|.+|..+.+|-. .++++.+ +-.+...
T Consensus 182 ---~t~qkRDsFIGTPYWMAPEVvmCET~KD~PYDykaDiWSlGITLIEMAqiEPPHh-----elnpMRV---llKiaKS 250 (1187)
T KOG0579|consen 182 ---STRQKRDSFIGTPYWMAPEVVMCETFKDQPYDYKADIWSLGITLIEMAQIEPPHH-----ELNPMRV---LLKIAKS 250 (1187)
T ss_pred ---hHHhhhccccCCcccccchheeeccccCCCchhhhhHHhhhhHHHHHhccCCCcc-----ccchHHH---HHHHhhc
Confidence 23445678899999999995 556789999999999999999999988852 2333222 2111111
Q ss_pred CccCcccccCccccchhhHhHHHHHHHHHHHHHHHHhcCCCCCCCCChhhhhcC
Q 038766 246 GINGVRQITDPKLVSSIYEEQEQHQVLEELFKLALVCTSSNPEDRPNMNELLIT 299 (299)
Q Consensus 246 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rpt~~~il~~ 299 (299)
.+ ..... +..-+..+.+++++||..||..||++.++|+|
T Consensus 251 eP---PTLlq------------PS~Ws~~F~DfLk~cL~Knp~~Rp~aaqll~H 289 (1187)
T KOG0579|consen 251 EP---PTLLQ------------PSHWSRSFSDFLKRCLVKNPRNRPPAAQLLKH 289 (1187)
T ss_pred CC---CcccC------------cchhhhHHHHHHHHHHhcCCccCCCHHHHhhC
Confidence 11 11111 44456678999999999999999999999987
|
|
| >KOG0671 consensus LAMMER dual specificity kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-39 Score=263.48 Aligned_cols=269 Identities=18% Similarity=0.208 Sum_probs=201.7
Q ss_pred HHhCCCCCCceeecCCcceEEEEEeC-CCcEEEEEEeccCcCChhhhHHHHHHHHHHHhcC-C-c----ceeeeeeEEEc
Q 038766 9 NATGSFSENNIIGNSNLSTVYKGRLE-DGEIVAVKKLNFHQFSAESDKSFYREAKTLKELK-H-R----NLVKVLGYAWE 81 (299)
Q Consensus 9 ~~~~~y~~~~~lg~g~~~~v~~~~~~-~~~~~~vK~~~~~~~~~~~~~~~~~e~~~l~~l~-h-~----~i~~~~~~~~~ 81 (299)
.+.++|.++..||+|.||.|-.+.+. .+..||||+++ .-....+...-|+++++++. + | .++++.+++-.
T Consensus 86 ~l~~Ry~i~~~lGeGtFGkV~ec~D~~~~~~vAlKIik---~V~kYreAa~iEi~vLqki~~~DP~g~~rcv~m~~wFdy 162 (415)
T KOG0671|consen 86 ILTNRYEIVDLLGEGTFGKVVECWDRETKEHVALKIIK---NVDKYREAALIEIEVLQKINESDPNGKFRCVQMRDWFDY 162 (415)
T ss_pred ccccceehhhhhcCCcccceEEEeecCCCceehHHHHH---HHHHHhhHHHHHHHHHHHHHhcCCCCceEEEeeehhhhc
Confidence 45889999999999999999998764 48999999986 23345667778999999994 2 2 36677775544
Q ss_pred CCCeeEEEEeecCCCChHHHhcCCCCCCCCCChhhHHHHHHHHHHHHHHhhcCCCCCeeeecccCCceeeCC--------
Q 038766 82 SGKLKALILEYMENGSLESVIHGPGVDHSRWTLPKRIDVLISVANGLDYLHSGYDIPIVHCDMKPSNILLDR-------- 153 (299)
Q Consensus 82 ~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lh~~~~~~~~H~dl~~~nil~~~-------- 153 (299)
.+ ..|+|+|.+ |.++.+++... +-.+++...+..+..|+++++++||+. +++|.||||+||++.+
T Consensus 163 rg-hiCivfell-G~S~~dFlk~N--~y~~fpi~~ir~m~~QL~~sv~fLh~~---kl~HTDLKPENILfvss~~~~~~~ 235 (415)
T KOG0671|consen 163 RG-HICIVFELL-GLSTFDFLKEN--NYIPFPIDHIRHMGYQLLESVAFLHDL---KLTHTDLKPENILFVSSEYFKTYN 235 (415)
T ss_pred cC-ceEEEEecc-ChhHHHHhccC--CccccchHHHHHHHHHHHHHHHHHHhc---ceeecCCChheEEEeccceEEEec
Confidence 44 459999999 77999999854 456899999999999999999999999 9999999999999932
Q ss_pred ------------CCcEEEeeeccccccccccccccccccccccCcccCChhhhcccCcCccccchhhhHHHHHHHhCCCC
Q 038766 154 ------------DFEAHVSDFGTSRMLDVHLQDLSSLSTAFQGTIGYLAPEFAYMRIVTTKVDVFSFGIVVMEFLTKRRP 221 (299)
Q Consensus 154 ------------~~~v~l~df~~~~~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~DiwslG~~l~~l~~g~~p 221 (299)
+..++++|||.++.-. +.....+.|..|.|||++.+.+++.++||||+||+|+|+++|...
T Consensus 236 ~k~~~~~~r~~ks~~I~vIDFGsAtf~~-------e~hs~iVsTRHYRAPEViLgLGwS~pCDvWSiGCIL~ElytG~~L 308 (415)
T KOG0671|consen 236 PKKKVCFIRPLKSTAIKVIDFGSATFDH-------EHHSTIVSTRHYRAPEVILGLGWSQPCDVWSIGCILVELYTGETL 308 (415)
T ss_pred cCCccceeccCCCcceEEEecCCcceec-------cCcceeeeccccCCchheeccCcCCccCceeeeeEEEEeecccee
Confidence 2358999999998644 223566778999999999999999999999999999999999999
Q ss_pred CCCCccCCCCchhHHHHHHHHHhcCccCccccc--------------Cccccc--hh-------hH--hHHHHHHHHHHH
Q 038766 222 TGLDEENGLSPISLRQLVEKALANGINGVRQIT--------------DPKLVS--SI-------YE--EQEQHQVLEELF 276 (299)
Q Consensus 222 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~--------------~~~~~~--~~-------~~--~~~~~~~~~~l~ 276 (299)
|...+ ..+...+|+.+....+..+-... +..... .+ .. .......-..|+
T Consensus 309 FqtHe-----n~EHLaMMerIlGp~P~~mi~r~~~~Kyf~~~rldw~e~~~~~~~k~v~~~ckpl~~~~~~~d~e~~~Lf 383 (415)
T KOG0671|consen 309 FQTHE-----NLEHLAMMERILGPIPSRMIKKTRKEKYFRRGRLDWPEVSSKGKSKYVFEPCKPLKKYMLQDDLEHVQLF 383 (415)
T ss_pred cccCC-----cHHHHHHHHHhhCCCcHHHhhhhhhHhhhhcccccCccccccccchhhhcCCccHHHHhccCcHHHhHHH
Confidence 85432 22223455554442222221111 000000 00 00 011222335699
Q ss_pred HHHHHhcCCCCCCCCChhhhhcC
Q 038766 277 KLALVCTSSNPEDRPNMNELLIT 299 (299)
Q Consensus 277 ~li~~~l~~dP~~Rpt~~~il~~ 299 (299)
+|+++||..||.+|+|+.|+|.|
T Consensus 384 DLl~~mL~fDP~~RiTl~EAL~H 406 (415)
T KOG0671|consen 384 DLLRRMLEFDPARRITLREALSH 406 (415)
T ss_pred HHHHHHHccCccccccHHHHhcC
Confidence 99999999999999999999987
|
|
| >KOG0669 consensus Cyclin T-dependent kinase CDK9 [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.2e-41 Score=258.38 Aligned_cols=278 Identities=21% Similarity=0.293 Sum_probs=212.0
Q ss_pred HhCCCCCCceeecCCcceEEEEEeCC-CcEEEEEEeccCcCChhhhHHHHHHHHHHHhcCCcceeeeeeEEEcCC-----
Q 038766 10 ATGSFSENNIIGNSNLSTVYKGRLED-GEIVAVKKLNFHQFSAESDKSFYREAKTLKELKHRNLVKVLGYAWESG----- 83 (299)
Q Consensus 10 ~~~~y~~~~~lg~g~~~~v~~~~~~~-~~~~~vK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~----- 83 (299)
..+.|.-..++|+|.||.||+|..++ |+.||+|++-........-....+|+.+|..++|+|++.++++|....
T Consensus 15 ~~~~yek~~kigqGtfgeVFkAr~~n~~kkvalkkvlmeneKeGfpitalreikiL~~lkHenv~nliEic~tk~Tp~~r 94 (376)
T KOG0669|consen 15 EVSKYEKLAKIGQGTFGEVFKARSKNTGKKVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEICRTKATPTNR 94 (376)
T ss_pred cchHHHHHHhcCCchHHHHHHHhhcCccchhHHHHHHHhccccCCcHHHHHHHHHHHHhcchhHHHHHHHHhhccCCccc
Confidence 45677788999999999999998754 778899988765555566677889999999999999999988775322
Q ss_pred --CeeEEEEeecCCCChHHHhcCCCCCCCCCChhhHHHHHHHHHHHHHHhhcCCCCCeeeecccCCceeeCCCCcEEEee
Q 038766 84 --KLKALILEYMENGSLESVIHGPGVDHSRWTLPKRIDVLISVANGLDYLHSGYDIPIVHCDMKPSNILLDRDFEAHVSD 161 (299)
Q Consensus 84 --~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lh~~~~~~~~H~dl~~~nil~~~~~~v~l~d 161 (299)
...++||++|.. +|..++.. ...+++..++..++.+++++|.|+|++ .+.|||+|+.|++++.+|.++|.|
T Consensus 95 ~r~t~ylVf~~ceh-DLaGlLsn---~~vr~sls~Ikk~Mk~Lm~GL~~iHr~---kilHRDmKaaNvLIt~dgilklAD 167 (376)
T KOG0669|consen 95 DRATFYLVFDFCEH-DLAGLLSN---RKVRFSLSEIKKVMKGLMNGLYYIHRN---KILHRDMKAANVLITKDGILKLAD 167 (376)
T ss_pred ccceeeeeHHHhhh-hHHHHhcC---ccccccHHHHHHHHHHHHHHHHHHHHh---hHHhhcccHhhEEEcCCceEEeec
Confidence 346899999976 88888863 336899999999999999999999999 999999999999999999999999
Q ss_pred eccccccccccccccccccccccCcccCChhhhccc-CcCccccchhhhHHHHHHHhCCCCCCCCccCCCCchhHHHHHH
Q 038766 162 FGTSRMLDVHLQDLSSLSTAFQGTIGYLAPEFAYMR-IVTTKVDVFSFGIVVMEFLTKRRPTGLDEENGLSPISLRQLVE 240 (299)
Q Consensus 162 f~~~~~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~-~~~~~~DiwslG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~ 240 (299)
||+++.+..............+.|.+|.+||.+.+. .|..+.|||+.||++.+|+++.+.+.++. +..-...++
T Consensus 168 FGlar~fs~~~n~~kprytnrvvTLwYrppEllLG~r~yg~~iDiWgAgCimaeMwtrspimqgnt-----eqqql~~Is 242 (376)
T KOG0669|consen 168 FGLARAFSTSKNVVKPRYTNRVVTLWYRPPELLLGDREYGPPIDIWGAGCIMAEMWTRSPIMQGNT-----EQQQLHLIS 242 (376)
T ss_pred cccccceecccccCCCCcccceeeeecCCHHHhhcccccCCcchhHhHHHHHHHHHccCccccCCh-----HHHHHHHHH
Confidence 999987765444555556777889999999988865 68999999999999999999999886543 233334444
Q ss_pred HHHhc----CccCcccccCcc------ccchhhH---h-HHHHHHHHHHHHHHHHhcCCCCCCCCChhhhhcC
Q 038766 241 KALAN----GINGVRQITDPK------LVSSIYE---E-QEQHQVLEELFKLALVCTSSNPEDRPNMNELLIT 299 (299)
Q Consensus 241 ~~~~~----~~~~~~~~~~~~------~~~~~~~---~-~~~~~~~~~l~~li~~~l~~dP~~Rpt~~~il~~ 299 (299)
+.+.. .|+....++-.. ....... + ..+-.-.++..+|+++||..||.+|+++.++|.|
T Consensus 243 ~LcGs~tkevWP~~d~lpL~~sie~ePl~~~~~rkv~n~~kp~~kd~~a~dLle~ll~~DP~kR~~ad~alnh 315 (376)
T KOG0669|consen 243 QLCGSITKEVWPNVDNLPLYQSIELEPLPKGQKRKVKNRLKPYVKDDEALDLLEKLLKLDPTKRIDADQALNH 315 (376)
T ss_pred HHhccCCcccCCCcccchHHHhccCCCCCcchhhhhhhhcccccCChhHHHHHHHHhccCcccCcchHhhhch
Confidence 44332 222222211100 0000000 0 0001112478999999999999999999999976
|
|
| >cd05074 PTKc_Tyro3 Catalytic domain of the Protein Tyrosine Kinase, Tyro3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.1e-38 Score=262.74 Aligned_cols=255 Identities=26% Similarity=0.433 Sum_probs=193.6
Q ss_pred CCCCceeecCCcceEEEEEeC----CCcEEEEEEeccCcCChhhhHHHHHHHHHHHhcCCcceeeeeeEEEcCC-----C
Q 038766 14 FSENNIIGNSNLSTVYKGRLE----DGEIVAVKKLNFHQFSAESDKSFYREAKTLKELKHRNLVKVLGYAWESG-----K 84 (299)
Q Consensus 14 y~~~~~lg~g~~~~v~~~~~~----~~~~~~vK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~-----~ 84 (299)
|.+.+.||+|++|.||+|.+. ++..+|+|++..........+.+.+|++.++.+.|||++++++++.... .
T Consensus 1 ~~~~~~ig~g~~g~v~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~~ 80 (273)
T cd05074 1 FTLGRMLGKGEFGSVREAQLKSEDGSFQKVAVKMLKADIFSSSDIEEFLREAACMKEFDHPNVIKLIGVSLRSRAKGRLP 80 (273)
T ss_pred CcchhcccCCCCCCEEeeEeeccCCCceEEEEEEeccccCChHHHHHHHHHHHHHhcCCCCCcceEEEEEccCCCCCccc
Confidence 678899999999999999753 4688999999765555566778889999999999999999999775432 1
Q ss_pred eeEEEEeecCCCChHHHhcCC--CCCCCCCChhhHHHHHHHHHHHHHHhhcCCCCCeeeecccCCceeeCCCCcEEEeee
Q 038766 85 LKALILEYMENGSLESVIHGP--GVDHSRWTLPKRIDVLISVANGLDYLHSGYDIPIVHCDMKPSNILLDRDFEAHVSDF 162 (299)
Q Consensus 85 ~~~lv~e~~~~~~L~~~~~~~--~~~~~~~~~~~~~~i~~qi~~~l~~lh~~~~~~~~H~dl~~~nil~~~~~~v~l~df 162 (299)
..+++++|+.+++|..++... ......++...++.++.|++.||+|||+. +++|+||||+||+++.++.++|+||
T Consensus 81 ~~~~~~~~~~~~~l~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~---~i~H~dikp~nili~~~~~~kl~df 157 (273)
T cd05074 81 IPMVILPFMKHGDLHTFLLMSRIGEEPFTLPLQTLVRFMIDIASGMEYLSSK---NFIHRDLAARNCMLNENMTVCVADF 157 (273)
T ss_pred ceEEEEecCCCCcHHHHHHHhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhC---CEeecccchhhEEEcCCCCEEECcc
Confidence 346889999999998776421 11223578899999999999999999998 9999999999999999999999999
Q ss_pred ccccccccccccccccccccccCcccCChhhhcccCcCccccchhhhHHHHHHHh-CCCCCCCCccCCCCchhHHHHHHH
Q 038766 163 GTSRMLDVHLQDLSSLSTAFQGTIGYLAPEFAYMRIVTTKVDVFSFGIVVMEFLT-KRRPTGLDEENGLSPISLRQLVEK 241 (299)
Q Consensus 163 ~~~~~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~DiwslG~~l~~l~~-g~~p~~~~~~~~~~~~~~~~~~~~ 241 (299)
|.+........ ........+++.|++||...+..++.++||||||+++|+|++ |..||.... ... ....
T Consensus 158 g~~~~~~~~~~--~~~~~~~~~~~~~~~pe~~~~~~~~~~sDi~slG~il~el~~~g~~p~~~~~-----~~~---~~~~ 227 (273)
T cd05074 158 GLSKKIYSGDY--YRQGCASKLPVKWLALESLADNVYTTHSDVWAFGVTMWEIMTRGQTPYAGVE-----NSE---IYNY 227 (273)
T ss_pred cccccccCCcc--eecCCCccCchhhcCHhHHhcCccchhhhhHHHHHHHHHHhhCCCCCCCCCC-----HHH---HHHH
Confidence 98875432110 111122234567999999998889999999999999999999 777774321 111 1111
Q ss_pred HHhcCccCcccccCccccchhhHhHHHHHHHHHHHHHHHHhcCCCCCCCCChhhhhc
Q 038766 242 ALANGINGVRQITDPKLVSSIYEEQEQHQVLEELFKLALVCTSSNPEDRPNMNELLI 298 (299)
Q Consensus 242 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rpt~~~il~ 298 (299)
..... .. .. +...+..+.+++.+||+.+|++|||+.++++
T Consensus 228 ~~~~~--~~---~~------------~~~~~~~~~~l~~~~l~~~p~~Rps~~~~~~ 267 (273)
T cd05074 228 LIKGN--RL---KQ------------PPDCLEDVYELMCQCWSPEPKCRPSFQHLRD 267 (273)
T ss_pred HHcCC--cC---CC------------CCCCCHHHHHHHHHHcCCChhhCcCHHHHHH
Confidence 11100 00 00 1123457999999999999999999999975
|
Protein Tyrosine Kinase (PTK) family; Tyro3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyro3 (or Sky) is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Tyro3 is predominantly expressed in the central nervous system and the brain, and functions as a neurotrophic fac |
| >KOG4279 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.8e-39 Score=280.02 Aligned_cols=245 Identities=26% Similarity=0.396 Sum_probs=198.4
Q ss_pred ceeecCCcceEEEEEeC-CCcEEEEEEeccCcCChhhhHHHHHHHHHHHhcCCcceeeeeeEEEcCCCeeEEEEeecCCC
Q 038766 18 NIIGNSNLSTVYKGRLE-DGEIVAVKKLNFHQFSAESDKSFYREAKTLKELKHRNLVKVLGYAWESGKLKALILEYMENG 96 (299)
Q Consensus 18 ~~lg~g~~~~v~~~~~~-~~~~~~vK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~lv~e~~~~~ 96 (299)
-+||+|.+|+||-+++. +..+.|||.+. ......-..+..|+...++++|.||+++.|.+.++| +.-+.||.++||
T Consensus 581 vVLGKGTYG~VYA~RD~~tqvrIaIKEIp--ekdsr~~QPLhEEIaLH~~LrHkNIVrYLGs~senG-f~kIFMEqVPGG 657 (1226)
T KOG4279|consen 581 VVLGKGTYGTVYAARDMDTQVRIAIKEIP--EKDSREVQPLHEEIALHSTLRHKNIVRYLGSVSENG-FFKIFMEQVPGG 657 (1226)
T ss_pred EEeecCceeEEEeeccccceeEEEeeecc--cccchhhccHHHHHHHHHHHhhHhHHHHhhccCCCC-eEEEEeecCCCC
Confidence 47999999999999875 47789999874 444455567889999999999999999999665544 657999999999
Q ss_pred ChHHHhcCCCCCCCCC--ChhhHHHHHHHHHHHHHHhhcCCCCCeeeecccCCceeeC-CCCcEEEeeeccccccccccc
Q 038766 97 SLESVIHGPGVDHSRW--TLPKRIDVLISVANGLDYLHSGYDIPIVHCDMKPSNILLD-RDFEAHVSDFGTSRMLDVHLQ 173 (299)
Q Consensus 97 ~L~~~~~~~~~~~~~~--~~~~~~~i~~qi~~~l~~lh~~~~~~~~H~dl~~~nil~~-~~~~v~l~df~~~~~~~~~~~ 173 (299)
+|.+++... =+++ +|..+-.+..||+++|.|||.+ .|||||||-+|++|+ -.|.+||+|||-+..+.
T Consensus 658 SLSsLLrsk---WGPlKDNEstm~fYtkQILeGLkYLHen---~IVHRDIKGDNVLvNTySGvlKISDFGTsKRLA---- 727 (1226)
T KOG4279|consen 658 SLSSLLRSK---WGPLKDNESTMNFYTKQILEGLKYLHEN---KIVHRDIKGDNVLVNTYSGVLKISDFGTSKRLA---- 727 (1226)
T ss_pred cHHHHHHhc---cCCCccchhHHHHHHHHHHHHhhhhhhc---ceeeccccCCcEEEeeccceEEecccccchhhc----
Confidence 999998632 1355 7889999999999999999999 999999999999996 57899999999987654
Q ss_pred cccccccccccCcccCChhhhccc--CcCccccchhhhHHHHHHHhCCCCCCCCccCCCCchhHHHHHHHHHhcCccCcc
Q 038766 174 DLSSLSTAFQGTIGYLAPEFAYMR--IVTTKVDVFSFGIVVMEFLTKRRPTGLDEENGLSPISLRQLVEKALANGINGVR 251 (299)
Q Consensus 174 ~~~~~~~~~~~~~~y~~PE~~~~~--~~~~~~DiwslG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 251 (299)
..+.+..++.||..|||||++..+ +|..++|||||||+..+|.||.+||...... -..+........
T Consensus 728 ginP~TETFTGTLQYMAPEvIDqG~RGYG~aADIWS~GCT~vEMATGrPPF~Elgsp------qAAMFkVGmyKv----- 796 (1226)
T KOG4279|consen 728 GINPCTETFTGTLQYMAPEVIDQGPRGYGKAADIWSFGCTMVEMATGRPPFVELGSP------QAAMFKVGMYKV----- 796 (1226)
T ss_pred cCCccccccccchhhhChHhhccCCcCCCchhhhhhccceeEeeccCCCCeeecCCh------hHhhhhhcceec-----
Confidence 345566788899999999998865 5889999999999999999999999533211 011111111100
Q ss_pred cccCccccchhhHhHHHHHHHHHHHHHHHHhcCCCCCCCCChhhhhc
Q 038766 252 QITDPKLVSSIYEEQEQHQVLEELFKLALVCTSSNPEDRPNMNELLI 298 (299)
Q Consensus 252 ~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rpt~~~il~ 298 (299)
..+.+..++.++..+|.+|+..||.+||++.++|+
T Consensus 797 ------------HP~iPeelsaeak~FilrcFepd~~~R~sA~~LL~ 831 (1226)
T KOG4279|consen 797 ------------HPPIPEELSAEAKNFILRCFEPDPCDRPSAKDLLQ 831 (1226)
T ss_pred ------------CCCCcHHHHHHHHHHHHHHcCCCcccCccHHHhcc
Confidence 11237788899999999999999999999999986
|
|
| >KOG4278 consensus Protein tyrosine kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-39 Score=278.85 Aligned_cols=256 Identities=25% Similarity=0.396 Sum_probs=215.3
Q ss_pred hHHHHHHhCCCCCCceeecCCcceEEEEEeCC-CcEEEEEEeccCcCChhhhHHHHHHHHHHHhcCCcceeeeeeEEEcC
Q 038766 4 RTEIENATGSFSENNIIGNSNLSTVYKGRLED-GEIVAVKKLNFHQFSAESDKSFYREAKTLKELKHRNLVKVLGYAWES 82 (299)
Q Consensus 4 ~~~~~~~~~~y~~~~~lg~g~~~~v~~~~~~~-~~~~~vK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~ 82 (299)
+++||....+..+..+||.|.+|.||.+.|+. .-.||||+++ .+....+.+..|+.+|+.++|||+++++|+|-.+
T Consensus 259 ~DkWEmeRtdItMkhKLGGGQYGeVYeGvWKkyslTvAVKtLK---EDtMeveEFLkEAAvMKeikHpNLVqLLGVCT~E 335 (1157)
T KOG4278|consen 259 ADKWEMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLK---EDTMEVEEFLKEAAVMKEIKHPNLVQLLGVCTHE 335 (1157)
T ss_pred cchhhccchheeeeeccCCCcccceeeeeeeccceeeehhhhh---hcchhHHHHHHHHHHHHhhcCccHHHHhhhhccC
Confidence 47899999999999999999999999998864 6779999985 3456788999999999999999999999999886
Q ss_pred CCeeEEEEeecCCCChHHHhcCCCCCCCCCChhhHHHHHHHHHHHHHHhhcCCCCCeeeecccCCceeeCCCCcEEEeee
Q 038766 83 GKLKALILEYMENGSLESVIHGPGVDHSRWTLPKRIDVLISVANGLDYLHSGYDIPIVHCDMKPSNILLDRDFEAHVSDF 162 (299)
Q Consensus 83 ~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lh~~~~~~~~H~dl~~~nil~~~~~~v~l~df 162 (299)
..+ |||.|||..|+|.+++.+- +....+....+.++.||.+|+.||..+ +++||||...|+||..+..||+.||
T Consensus 336 pPF-YIiTEfM~yGNLLdYLRec--nr~ev~avvLlyMAtQIsSaMeYLEkk---nFIHRDLAARNCLVgEnhiVKvADF 409 (1157)
T KOG4278|consen 336 PPF-YIITEFMCYGNLLDYLREC--NRSEVPAVVLLYMATQISSAMEYLEKK---NFIHRDLAARNCLVGENHIVKVADF 409 (1157)
T ss_pred CCe-EEEEecccCccHHHHHHHh--chhhcchhHHHHHHHHHHHHHHHHHHh---hhhhhhhhhhhccccccceEEeecc
Confidence 766 9999999999999998654 455677788899999999999999999 9999999999999999999999999
Q ss_pred ccccccccccccccccccccccCcccCChhhhcccCcCccccchhhhHHHHHHHh-CCCCCCCCccCCCCchhHHHHHHH
Q 038766 163 GTSRMLDVHLQDLSSLSTAFQGTIGYLAPEFAYMRIVTTKVDVFSFGIVVMEFLT-KRRPTGLDEENGLSPISLRQLVEK 241 (299)
Q Consensus 163 ~~~~~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~DiwslG~~l~~l~~-g~~p~~~~~~~~~~~~~~~~~~~~ 241 (299)
|+++.+. .+..+.....--+..|.|||-+..+.++.++|||+||++||++.| |..|+ ......++++.++.
T Consensus 410 GLsRlMt---gDTYTAHAGAKFPIKWTAPEsLAyNtFSiKSDVWAFGVLLWEIATYGMsPY-----PGidlSqVY~LLEk 481 (1157)
T KOG4278|consen 410 GLSRLMT---GDTYTAHAGAKFPIKWTAPESLAYNTFSIKSDVWAFGVLLWEIATYGMSPY-----PGIDLSQVYGLLEK 481 (1157)
T ss_pred chhhhhc---CCceecccCccCcccccCcccccccccccchhhHHHHHHHHHHHhcCCCCC-----CCccHHHHHHHHhc
Confidence 9998765 222222222233568999999999999999999999999999997 77777 44455566666655
Q ss_pred HHhcCccCcccccCccccchhhHhHHHHHHHHHHHHHHHHhcCCCCCCCCChhhh
Q 038766 242 ALANGINGVRQITDPKLVSSIYEEQEQHQVLEELFKLALVCTSSNPEDRPNMNEL 296 (299)
Q Consensus 242 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rpt~~~i 296 (299)
..+ ...+.++++...+|++.||+++|++||++.++
T Consensus 482 gyR--------------------M~~PeGCPpkVYeLMraCW~WsPsDRPsFaei 516 (1157)
T KOG4278|consen 482 GYR--------------------MDGPEGCPPKVYELMRACWNWSPSDRPSFAEI 516 (1157)
T ss_pred ccc--------------------ccCCCCCCHHHHHHHHHHhcCCcccCccHHHH
Confidence 332 11155667789999999999999999999987
|
|
| >cd05037 PTK_Jak_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.9e-38 Score=259.70 Aligned_cols=235 Identities=24% Similarity=0.378 Sum_probs=180.8
Q ss_pred ceeecCCcceEEEEEeCCCc-----------EEEEEEeccCcCChhhhHHHHHHHHHHHhcCCcceeeeeeEEEcCCCee
Q 038766 18 NIIGNSNLSTVYKGRLEDGE-----------IVAVKKLNFHQFSAESDKSFYREAKTLKELKHRNLVKVLGYAWESGKLK 86 (299)
Q Consensus 18 ~~lg~g~~~~v~~~~~~~~~-----------~~~vK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~ 86 (299)
+.||+|+||.||++.+.+.. .+++|++.... .....+.+|+.+++.++|+||+++++.+.. + ..
T Consensus 1 ~~lg~G~~~~v~~~~~~~~~~~~~~~~~~~~~v~~k~~~~~~---~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~-~-~~ 75 (259)
T cd05037 1 EHLGQGTFTNIYKGVLRVQSDLDIVGPGQEVSVVLKVLGSDH---RDSLAFFETASLMSQLSHKHLVKLYGVCVR-D-EN 75 (259)
T ss_pred CcccccccceEEEEEEeccCCccccCCccceeeeeeccccch---hhHHHHHHHHHHHHcCCCcchhheeeEEec-C-Cc
Confidence 46899999999999875422 57777765322 226778889999999999999999997766 3 45
Q ss_pred EEEEeecCCCChHHHhcCCCCCCCCCChhhHHHHHHHHHHHHHHhhcCCCCCeeeecccCCceeeCCCC-------cEEE
Q 038766 87 ALILEYMENGSLESVIHGPGVDHSRWTLPKRIDVLISVANGLDYLHSGYDIPIVHCDMKPSNILLDRDF-------EAHV 159 (299)
Q Consensus 87 ~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lh~~~~~~~~H~dl~~~nil~~~~~-------~v~l 159 (299)
++|+||+.+++|.+++.... ..++...+..++.|++.||+|||+. +++|+||||+||+++.++ .++|
T Consensus 76 ~lv~e~~~~~~L~~~l~~~~---~~~~~~~~~~~~~~i~~~l~~LH~~---~i~H~dlkp~Nill~~~~~~~~~~~~~kl 149 (259)
T cd05037 76 IMVEEYVKFGPLDVFLHREK---NNVSLHWKLDVAKQLASALHYLEDK---KLVHGNVCGKNILVARYGLNEGYVPFIKL 149 (259)
T ss_pred EEEEEcCCCCcHHHHHHhhc---cCCCHHHHHHHHHHHHHHHHHHhhC---CeecccCccceEEEecCccccCCceeEEe
Confidence 89999999999999987432 2688999999999999999999998 999999999999999887 7999
Q ss_pred eeeccccccccccccccccccccccCcccCChhhhccc--CcCccccchhhhHHHHHHHhC-CCCCCCCccCCCCchhHH
Q 038766 160 SDFGTSRMLDVHLQDLSSLSTAFQGTIGYLAPEFAYMR--IVTTKVDVFSFGIVVMEFLTK-RRPTGLDEENGLSPISLR 236 (299)
Q Consensus 160 ~df~~~~~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~--~~~~~~DiwslG~~l~~l~~g-~~p~~~~~~~~~~~~~~~ 236 (299)
+|||++..... .....++..|+|||.+.+. .++.++|+||||+++++|++| ..||.... .....
T Consensus 150 ~Dfg~a~~~~~--------~~~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~~~~~l~~~~~~p~~~~~-----~~~~~ 216 (259)
T cd05037 150 SDPGIPITVLS--------REERVERIPWIAPECIRNGQASLTIAADKWSFGTTLLEICSNGEEPLSTLS-----SSEKE 216 (259)
T ss_pred CCCCccccccc--------ccccccCCCccChhhhcCCCCCcchhhHHHHHHHHHHHHHhCCCCCcccCC-----chhHH
Confidence 99998875431 2223356679999998876 788999999999999999994 66663321 11111
Q ss_pred HHHHHHHhcCccCcccccCccccchhhHhHHHHHHHHHHHHHHHHhcCCCCCCCCChhhhhc
Q 038766 237 QLVEKALANGINGVRQITDPKLVSSIYEEQEQHQVLEELFKLALVCTSSNPEDRPNMNELLI 298 (299)
Q Consensus 237 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rpt~~~il~ 298 (299)
.... ... ....+ ....+.+++.+||..+|++|||+.++++
T Consensus 217 ~~~~---~~~-----~~~~~--------------~~~~~~~li~~~l~~~p~~Rpt~~~il~ 256 (259)
T cd05037 217 RFYQ---DQH-----RLPMP--------------DCAELANLINQCWTYDPTKRPSFRAILR 256 (259)
T ss_pred HHHh---cCC-----CCCCC--------------CchHHHHHHHHHhccChhhCCCHHHHHH
Confidence 1111 000 00000 0157889999999999999999999985
|
Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; pseudokinase domain (repeat1). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the ki |
| >PHA02882 putative serine/threonine kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.6e-38 Score=264.65 Aligned_cols=264 Identities=16% Similarity=0.229 Sum_probs=185.1
Q ss_pred HHHhCCCCCCceeecCCcceEEEEEeCC----CcEEEEEEeccCcCChhhh---------HHHHHHHHHHHhcCCcceee
Q 038766 8 ENATGSFSENNIIGNSNLSTVYKGRLED----GEIVAVKKLNFHQFSAESD---------KSFYREAKTLKELKHRNLVK 74 (299)
Q Consensus 8 ~~~~~~y~~~~~lg~g~~~~v~~~~~~~----~~~~~vK~~~~~~~~~~~~---------~~~~~e~~~l~~l~h~~i~~ 74 (299)
++..++|.+.+.||+|+||+||++.+.+ +..+++|+........... .....+...+..+.|++++.
T Consensus 8 ~i~~~~y~i~~~LG~G~fG~Vy~~~~~~~~~~~~~~~~k~~~~~~~~~~~e~~~~~~~~~~~~~~~~~~~~~~~h~~i~~ 87 (294)
T PHA02882 8 DITGKEWKIDKLIGCGGFGCVYETQCASDHCINNQAVAKIENLENETIVMETLVYNNIYDIDKIALWKNIHNIDHLGIPK 87 (294)
T ss_pred ccCCCceEEeeEEecCCCceEEEEEEcCCcccccceEEEeccccCCchhhHHHHHHhhhhHHHHHHHHHhccCCCCCCCc
Confidence 4556899999999999999999998643 4566777643322111111 11122334455668999999
Q ss_pred eeeEEEcCC---CeeEEEEeecCCCChHHHhcCCCCCCCCCChhhHHHHHHHHHHHHHHhhcCCCCCeeeecccCCceee
Q 038766 75 VLGYAWESG---KLKALILEYMENGSLESVIHGPGVDHSRWTLPKRIDVLISVANGLDYLHSGYDIPIVHCDMKPSNILL 151 (299)
Q Consensus 75 ~~~~~~~~~---~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lh~~~~~~~~H~dl~~~nil~ 151 (299)
+++...... ...+++++.+ ..++.+.+.. ....++..++.++.|++.||+|||+. +++||||||+||++
T Consensus 88 ~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~----~~~~~~~~~~~i~~qi~~~l~~lH~~---~iiHrDiKp~Nill 159 (294)
T PHA02882 88 YYGCGSFKRCRMYYRFILLEKL-VENTKEIFKR----IKCKNKKLIKNIMKDMLTTLEYIHEH---GISHGDIKPENIMV 159 (294)
T ss_pred EEEeeeEecCCceEEEEEEehh-ccCHHHHHHh----hccCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHEEE
Confidence 998554332 2346788877 3477777652 23457888999999999999999999 99999999999999
Q ss_pred CCCCcEEEeeecccccccccccc---ccccccccccCcccCChhhhcccCcCccccchhhhHHHHHHHhCCCCCCCCccC
Q 038766 152 DRDFEAHVSDFGTSRMLDVHLQD---LSSLSTAFQGTIGYLAPEFAYMRIVTTKVDVFSFGIVVMEFLTKRRPTGLDEEN 228 (299)
Q Consensus 152 ~~~~~v~l~df~~~~~~~~~~~~---~~~~~~~~~~~~~y~~PE~~~~~~~~~~~DiwslG~~l~~l~~g~~p~~~~~~~ 228 (299)
+.++.++|+|||++..+...... .........+|+.|+|||+..+..++.++|||||||++++|++|..||......
T Consensus 160 ~~~~~~~l~DFGla~~~~~~~~~~~~~~~~~~~~~gt~~y~ape~~~~~~~~~~~DiwSlG~~l~el~~g~~P~~~~~~~ 239 (294)
T PHA02882 160 DGNNRGYIIDYGIASHFIIHGKHIEYSKEQKDLHRGTLYYAGLDAHNGACVTRRGDLESLGYCMLKWAGIKLPWKGFGHN 239 (294)
T ss_pred cCCCcEEEEEcCCceeeccCCcccccccccccccCCCccccCHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCccccc
Confidence 99999999999999765421111 111123346899999999999999999999999999999999999999644211
Q ss_pred C-CCchhHHHHHHHHHhcCccCcccccCccccchhhHhHHHHHHHHHHHHHHHHhcCCCCCCCCChhhhhc
Q 038766 229 G-LSPISLRQLVEKALANGINGVRQITDPKLVSSIYEEQEQHQVLEELFKLALVCTSSNPEDRPNMNELLI 298 (299)
Q Consensus 229 ~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rpt~~~il~ 298 (299)
. .......+.+...... + ......+..+.++++.|+..+|++||+++++++
T Consensus 240 ~~~~~~~~~~~~~~~~~~-----------~--------~~~~~~~~~~~~~~~~~~~~~~~~rp~~~~l~~ 291 (294)
T PHA02882 240 GNLIHAAKCDFIKRLHEG-----------K--------IKIKNANKFIYDFIECVTKLSYEEKPDYDALIK 291 (294)
T ss_pred hHHHHHhHHHHHHHhhhh-----------h--------hccCCCCHHHHHHHHHHHhCCCCCCCCHHHHHH
Confidence 1 0000111111111100 0 001223567999999999999999999999875
|
|
| >cd05579 STKc_MAST_like Catalytic domain of Microtubule-associated serine/threonine kinase-like proteins | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.4e-38 Score=261.10 Aligned_cols=248 Identities=25% Similarity=0.338 Sum_probs=192.3
Q ss_pred eecCCcceEEEEEeC-CCcEEEEEEeccCcC-ChhhhHHHHHHHHHHHhcCCcceeeeeeEEEcCCCeeEEEEeecCCCC
Q 038766 20 IGNSNLSTVYKGRLE-DGEIVAVKKLNFHQF-SAESDKSFYREAKTLKELKHRNLVKVLGYAWESGKLKALILEYMENGS 97 (299)
Q Consensus 20 lg~g~~~~v~~~~~~-~~~~~~vK~~~~~~~-~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~lv~e~~~~~~ 97 (299)
||+|++|.||++.+. +|+.+++|++..... .......+.+|++.+++++|+|++++++.+. .+...++++|++.+++
T Consensus 1 lg~g~~~~vy~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~-~~~~~~lv~e~~~~~~ 79 (265)
T cd05579 1 ISKGAYGRVFLAKKKSTGDIYAIKVIKKADMIRKNQVDQVLTERDILSQAQSPYVVKLYYSFQ-GKKNLYLVMEYLPGGD 79 (265)
T ss_pred CCCCCceEEEEEEECCCCCEEEEEEecchhhhhhhHHHHHHHHHHHHHhCCCcchhHHHHhee-cCcEEEEEEecCCCCc
Confidence 689999999999875 489999999864332 2244667889999999999999999998554 4666799999999999
Q ss_pred hHHHhcCCCCCCCCCChhhHHHHHHHHHHHHHHhhcCCCCCeeeecccCCceeeCCCCcEEEeeecccccccccccc---
Q 038766 98 LESVIHGPGVDHSRWTLPKRIDVLISVANGLDYLHSGYDIPIVHCDMKPSNILLDRDFEAHVSDFGTSRMLDVHLQD--- 174 (299)
Q Consensus 98 L~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lh~~~~~~~~H~dl~~~nil~~~~~~v~l~df~~~~~~~~~~~~--- 174 (299)
|.+++.. ...+++..++.++.|++.||++||+. +++|+||+|+||+++.++.++|+|||++.........
T Consensus 80 L~~~l~~----~~~~~~~~~~~i~~qi~~~L~~lH~~---~i~H~di~~~nil~~~~~~~~l~dfg~~~~~~~~~~~~~~ 152 (265)
T cd05579 80 LASLLEN----VGSLDEDVARIYIAEIVLALEYLHSN---GIIHRDLKPDNILIDSNGHLKLTDFGLSKVGLVRRQINLN 152 (265)
T ss_pred HHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHHc---CeecCCCCHHHeEEcCCCCEEEEecccchhcccCcccccc
Confidence 9999873 34789999999999999999999999 9999999999999999999999999988753311000
Q ss_pred -ccccccccccCcccCChhhhcccCcCccccchhhhHHHHHHHhCCCCCCCCccCCCCchhHHHHHHHHHhcCccCcccc
Q 038766 175 -LSSLSTAFQGTIGYLAPEFAYMRIVTTKVDVFSFGIVVMEFLTKRRPTGLDEENGLSPISLRQLVEKALANGINGVRQI 253 (299)
Q Consensus 175 -~~~~~~~~~~~~~y~~PE~~~~~~~~~~~DiwslG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 253 (299)
.........++..|+|||.......+.++|+||||+++++|++|..||.... . ............ ..
T Consensus 153 ~~~~~~~~~~~~~~~~~Pe~~~~~~~~~~~Dv~slG~~~~~l~~g~~p~~~~~-----~---~~~~~~~~~~~~-~~--- 220 (265)
T cd05579 153 DDEKEDKRIVGTPDYIAPEVILGQGHSKTVDWWSLGCILYEFLVGIPPFHGET-----P---EEIFQNILNGKI-EW--- 220 (265)
T ss_pred cccccccCcccCccccCHHHhcCCCCCcchhhHHHHHHHHHHHhCCCCCCCCC-----H---HHHHHHHhcCCc-CC---
Confidence 0112233456778999999988888999999999999999999999985332 1 111111111000 00
Q ss_pred cCccccchhhHhHHHHHHHHHHHHHHHHhcCCCCCCCCCh---hhhhcC
Q 038766 254 TDPKLVSSIYEEQEQHQVLEELFKLALVCTSSNPEDRPNM---NELLIT 299 (299)
Q Consensus 254 ~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rpt~---~~il~~ 299 (299)
.. ....+..+.+++.+||+.+|++|||+ .++|+|
T Consensus 221 ~~------------~~~~~~~~~~~i~~~l~~~p~~Rpt~~~~~~~l~~ 257 (265)
T cd05579 221 PE------------DVEVSDEAIDLISKLLVPDPEKRLGAKSIEEIKNH 257 (265)
T ss_pred Cc------------cccCCHHHHHHHHHHhcCCHhhcCCCccHHHHhcC
Confidence 00 11135688999999999999999999 888876
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MAST kinase subfamily includes MAST kinases, MAST-like (MASTL) kinases, and fungal kinases with similarity to Saccharomyces cerevisiae Rim15 and Schizosaccharomyces pombe cek1. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. MASTL kinases carry only a catalytic domain which contains a long insert re |
| >cd08222 STKc_Nek11 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 11 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-38 Score=263.97 Aligned_cols=253 Identities=23% Similarity=0.310 Sum_probs=194.4
Q ss_pred CCCCCceeecCCcceEEEEEeCC-CcEEEEEEecc---CcCChhhhHHHHHHHHHHHhcCCcceeeeeeEEEcCCCeeEE
Q 038766 13 SFSENNIIGNSNLSTVYKGRLED-GEIVAVKKLNF---HQFSAESDKSFYREAKTLKELKHRNLVKVLGYAWESGKLKAL 88 (299)
Q Consensus 13 ~y~~~~~lg~g~~~~v~~~~~~~-~~~~~vK~~~~---~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~l 88 (299)
+|.+.+.||+|++|.||++.+.. +..+++|++.. ..........+..|+..++.++|||++++++.+... ...++
T Consensus 1 ~y~i~~~ig~g~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~-~~~~l 79 (260)
T cd08222 1 RYILQQRLGKGSFGTVYLVKDKKAVAEERLKVLKEIPVGELNPNETVQANQEAQLLSKLDHPAIVKFHASFLER-DAFCI 79 (260)
T ss_pred CceeeeeecCCCCceEEEEEecCCCCcceEEEeccccccccCcchHHHHHHHHHHHHhCCCCcHHHHHHHHhcC-CceEE
Confidence 68999999999999999998643 44455555432 222333445677899999999999999999966554 45699
Q ss_pred EEeecCCCChHHHhcCCCCCCCCCChhhHHHHHHHHHHHHHHhhcCCCCCeeeecccCCceeeCCCCcEEEeeecccccc
Q 038766 89 ILEYMENGSLESVIHGPGVDHSRWTLPKRIDVLISVANGLDYLHSGYDIPIVHCDMKPSNILLDRDFEAHVSDFGTSRML 168 (299)
Q Consensus 89 v~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lh~~~~~~~~H~dl~~~nil~~~~~~v~l~df~~~~~~ 168 (299)
|+||+.+++|.+++.........+++..++.++.|++.||.+||+. +++|+||+|+||+++. +.++|+|||.+...
T Consensus 80 v~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~---~i~h~~l~~~nili~~-~~~~l~d~g~~~~~ 155 (260)
T cd08222 80 ITEYCEGRDLDCKLEELKHTGKTLSENQVCEWFIQLLLGVHYMHQR---RILHRDLKAKNIFLKN-NLLKIGDFGVSRLL 155 (260)
T ss_pred EEEeCCCCCHHHHHHHHhhcccccCHHHHHHHHHHHHHHHHHHHHc---CccccCCChhheEeec-CCEeecccCceeec
Confidence 9999999999988865433556899999999999999999999998 9999999999999975 56999999988654
Q ss_pred ccccccccccccccccCcccCChhhhcccCcCccccchhhhHHHHHHHhCCCCCCCCccCCCCchhHHHHHHHHHhcCcc
Q 038766 169 DVHLQDLSSLSTAFQGTIGYLAPEFAYMRIVTTKVDVFSFGIVVMEFLTKRRPTGLDEENGLSPISLRQLVEKALANGIN 248 (299)
Q Consensus 169 ~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~DiwslG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 248 (299)
... ........+++.|+|||.+.+..++.++|+||+|+++++|++|..||.... ............
T Consensus 156 ~~~----~~~~~~~~~~~~~~~pe~~~~~~~~~~~Dv~slG~~~~~l~~~~~~~~~~~--------~~~~~~~~~~~~-- 221 (260)
T cd08222 156 MGS----CDLATTFTGTPYYMSPEALKHQGYDSKSDIWSLGCILYEMCCLAHAFEGQN--------FLSVVLRIVEGP-- 221 (260)
T ss_pred CCC----cccccCCCCCcCccCHHHHccCCCCchhhHHHHHHHHHHHHhCCCCCCCcc--------HHHHHHHHHcCC--
Confidence 311 122233456788999999888888999999999999999999999984221 111111111100
Q ss_pred CcccccCccccchhhHhHHHHHHHHHHHHHHHHhcCCCCCCCCChhhhhcC
Q 038766 249 GVRQITDPKLVSSIYEEQEQHQVLEELFKLALVCTSSNPEDRPNMNELLIT 299 (299)
Q Consensus 249 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rpt~~~il~~ 299 (299)
.+ ..+..++.++.++|.+||..+|++||+++++++|
T Consensus 222 ------~~---------~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~ 257 (260)
T cd08222 222 ------TP---------SLPETYSRQLNSIMQSMLNKDPSLRPSAAEILRN 257 (260)
T ss_pred ------CC---------CCcchhcHHHHHHHHHHhcCChhhCcCHHHHhhC
Confidence 00 0133556789999999999999999999999987
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 11 (Nek11) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek11 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek11 is involved, through direct phosphorylation, in regulating the degradation of Cdc25A (Cell Division Cycle 25 homolog A), which plays a role in cell cycle progression and in activating cyclin dependent kinases. Nek11 is activated by CHK1 (CHeckpoint Kinase 1) and may be involved in the G2/M check |
| >KOG0983 consensus Mitogen-activated protein kinase (MAPK) kinase MKK7/JNKK2 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.9e-39 Score=250.63 Aligned_cols=251 Identities=23% Similarity=0.316 Sum_probs=197.4
Q ss_pred CCCCceeecCCcceEEEEEeC-CCcEEEEEEeccCcCChhhhHHHHHHHHHHHhcC-CcceeeeeeEEEcCCCeeEEEEe
Q 038766 14 FSENNIIGNSNLSTVYKGRLE-DGEIVAVKKLNFHQFSAESDKSFYREAKTLKELK-HRNLVKVLGYAWESGKLKALILE 91 (299)
Q Consensus 14 y~~~~~lg~g~~~~v~~~~~~-~~~~~~vK~~~~~~~~~~~~~~~~~e~~~l~~l~-h~~i~~~~~~~~~~~~~~~lv~e 91 (299)
...+..||+|+.|+||++..+ +|...|||++.... +.+..+++...+.++..-. +|.|++++|+|..+.. .++.||
T Consensus 94 l~~l~dlGsGtcG~V~k~~~rs~~~iiAVK~M~rt~-Nkee~kRILmDldvv~~s~dcpyIV~c~GyFi~n~d-V~IcMe 171 (391)
T KOG0983|consen 94 LENLGDLGSGTCGQVWKMRFRSTGHIIAVKQMRRTG-NKEENKRILMDLDVVLKSHDCPYIVQCFGYFITNTD-VFICME 171 (391)
T ss_pred hhhHHhhcCCCccceEEEEEcccceEEEEEeecccC-CHHHHHHHHHhhhHHhhccCCCeeeeeeeEEeeCch-HHHHHH
Confidence 345677999999999999865 58999999997544 4556677878887777665 8999999998776544 478888
Q ss_pred ecCCCChHHHhcCCCCCCCCCChhhHHHHHHHHHHHHHHhhcCCCCCeeeecccCCceeeCCCCcEEEeeeccccccccc
Q 038766 92 YMENGSLESVIHGPGVDHSRWTLPKRIDVLISVANGLDYLHSGYDIPIVHCDMKPSNILLDRDFEAHVSDFGTSRMLDVH 171 (299)
Q Consensus 92 ~~~~~~L~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lh~~~~~~~~H~dl~~~nil~~~~~~v~l~df~~~~~~~~~ 171 (299)
.+. ..+..++.+ ..++++|..+-++...+++||.||..+ ++++|||+||+|||+|..|++||+|||++-.+-.
T Consensus 172 lMs-~C~ekLlkr---ik~piPE~ilGk~tva~v~AL~YLKeK--H~viHRDvKPSNILlDe~GniKlCDFGIsGrlvd- 244 (391)
T KOG0983|consen 172 LMS-TCAEKLLKR---IKGPIPERILGKMTVAIVKALYYLKEK--HGVIHRDVKPSNILLDERGNIKLCDFGISGRLVD- 244 (391)
T ss_pred HHH-HHHHHHHHH---hcCCchHHhhhhhHHHHHHHHHHHHHh--cceeecccCccceEEccCCCEEeecccccceeec-
Confidence 883 355566554 346799999999999999999999987 4999999999999999999999999999976431
Q ss_pred cccccccccccccCcccCChhhhccc---CcCccccchhhhHHHHHHHhCCCCCCCCccCCCCchhHHHHHHHHHhcCcc
Q 038766 172 LQDLSSLSTAFQGTIGYLAPEFAYMR---IVTTKVDVFSFGIVVMEFLTKRRPTGLDEENGLSPISLRQLVEKALANGIN 248 (299)
Q Consensus 172 ~~~~~~~~~~~~~~~~y~~PE~~~~~---~~~~~~DiwslG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 248 (299)
........|-+.|||||.+.-. .|+.++||||||+++++|.||..||.....+ .+.+.....+..+
T Consensus 245 ----SkAhtrsAGC~~YMaPERidp~~~~kYDiRaDVWSlGITlveLaTg~yPy~~c~td-------Fe~ltkvln~ePP 313 (391)
T KOG0983|consen 245 ----SKAHTRSAGCAAYMAPERIDPPDKPKYDIRADVWSLGITLVELATGQYPYKGCKTD-------FEVLTKVLNEEPP 313 (391)
T ss_pred ----ccccccccCCccccCccccCCCCCCccchhhhhhhhccchhhhhcccCCCCCCCcc-------HHHHHHHHhcCCC
Confidence 2223444577899999987743 5889999999999999999999999765433 3445554443322
Q ss_pred CcccccCccccchhhHhHHHHHHHHHHHHHHHHhcCCCCCCCCChhhhhcC
Q 038766 249 GVRQITDPKLVSSIYEEQEQHQVLEELFKLALVCTSSNPEDRPNMNELLIT 299 (299)
Q Consensus 249 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rpt~~~il~~ 299 (299)
.... ..++++++++++..||..|+.+||...++|+|
T Consensus 314 ~L~~---------------~~gFSp~F~~fv~~CL~kd~r~RP~Y~~Ll~h 349 (391)
T KOG0983|consen 314 LLPG---------------HMGFSPDFQSFVKDCLTKDHRKRPKYNKLLEH 349 (391)
T ss_pred CCCc---------------ccCcCHHHHHHHHHHhhcCcccCcchHHHhcC
Confidence 2211 23367899999999999999999999999987
|
|
| >cd05087 PTKc_Aatyk1_Aatyk3 Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases 1 and 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.5e-38 Score=261.45 Aligned_cols=253 Identities=22% Similarity=0.334 Sum_probs=182.3
Q ss_pred ceeecCCcceEEEEEeC---CCcEEEEEEeccCcCChhhhHHHHHHHHHHHhcCCcceeeeeeEEEcCCCeeEEEEeecC
Q 038766 18 NIIGNSNLSTVYKGRLE---DGEIVAVKKLNFHQFSAESDKSFYREAKTLKELKHRNLVKVLGYAWESGKLKALILEYME 94 (299)
Q Consensus 18 ~~lg~g~~~~v~~~~~~---~~~~~~vK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~lv~e~~~ 94 (299)
+.||+|+||.||++.+. ++..+++|.+.... .......+.+|+..++.++||||+++++.+.. ....++|+||++
T Consensus 1 ~~lg~G~~g~Vy~~~~~~~~~~~~~~~k~~~~~~-~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~-~~~~~lv~e~~~ 78 (269)
T cd05087 1 KEIGNGWFGKVILGEVNSGYTPAQVVVKELRVSA-SVQEQMKFLEEAQPYRSLQHSNLLQCLGQCTE-VTPYLLVMEFCP 78 (269)
T ss_pred CcccccCCceEEEEEEcCCCCceEEEEEecCCCC-ChHHHHHHHHHHHHHHhCCCCCEeeEEEEEcC-CCCcEEEEECCC
Confidence 46899999999999753 35679999886443 23344578889999999999999999996655 445699999999
Q ss_pred CCChHHHhcCCCC-CCCCCChhhHHHHHHHHHHHHHHhhcCCCCCeeeecccCCceeeCCCCcEEEeeeccccccccccc
Q 038766 95 NGSLESVIHGPGV-DHSRWTLPKRIDVLISVANGLDYLHSGYDIPIVHCDMKPSNILLDRDFEAHVSDFGTSRMLDVHLQ 173 (299)
Q Consensus 95 ~~~L~~~~~~~~~-~~~~~~~~~~~~i~~qi~~~l~~lh~~~~~~~~H~dl~~~nil~~~~~~v~l~df~~~~~~~~~~~ 173 (299)
+++|.+++..... .....+...+..++.|++.|+.|||+. +++|+||||+||+++.++.++|+|||.+......
T Consensus 79 ~g~L~~~l~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~---~i~H~dlkp~nil~~~~~~~kL~dfg~~~~~~~~-- 153 (269)
T cd05087 79 LGDLKGYLRSCRKAELMTPDPTTLQRMACEIALGLLHLHKN---NFIHSDLALRNCLLTADLTVKIGDYGLSHNKYKE-- 153 (269)
T ss_pred CCcHHHHHHHhhhcccccccHHHHHHHHHHHHHHHHHHHHC---CEeccccCcceEEEcCCCcEEECCccccccccCc--
Confidence 9999998864221 223556677888999999999999999 9999999999999999999999999988643211
Q ss_pred cccccccccccCcccCChhhhccc-------CcCccccchhhhHHHHHHHh-CCCCCCCCccCCCCchhHHHHHHHHHhc
Q 038766 174 DLSSLSTAFQGTIGYLAPEFAYMR-------IVTTKVDVFSFGIVVMEFLT-KRRPTGLDEENGLSPISLRQLVEKALAN 245 (299)
Q Consensus 174 ~~~~~~~~~~~~~~y~~PE~~~~~-------~~~~~~DiwslG~~l~~l~~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~ 245 (299)
..........++..|+|||.+... .++.++|+||+|+++|+|++ |..||.... ...... .....
T Consensus 154 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l~el~~~g~~p~~~~~-----~~~~~~---~~~~~ 225 (269)
T cd05087 154 DYYVTPDQLWVPLRWIAPELVDEVHGNLLVVDQTKESNVWSLGVTIWELFELGSQPYRHLS-----DEQVLT---YTVRE 225 (269)
T ss_pred ceeecCCCcCCcccccCHhHhccccccccccCCCccchhHHHHHHHHHHHhCCCCCCCCCC-----hHHHHH---HHhhc
Confidence 111112233456789999987642 35789999999999999996 998985321 111111 11110
Q ss_pred CccCcccccCccccchhhHhHHHHHHHHHHHHHHHHhcCCCCCCCCChhhhhc
Q 038766 246 GINGVRQITDPKLVSSIYEEQEQHQVLEELFKLALVCTSSNPEDRPNMNELLI 298 (299)
Q Consensus 246 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rpt~~~il~ 298 (299)
.......+.. ....+..+.+++.+|+ .+|++|||+++|+.
T Consensus 226 ---~~~~~~~~~~---------~~~~~~~~~~l~~~c~-~~P~~Rpt~~~l~~ 265 (269)
T cd05087 226 ---QQLKLPKPRL---------KLPLSDRWYEVMQFCW-LQPEQRPSAEEVHL 265 (269)
T ss_pred ---ccCCCCCCcc---------CCCCChHHHHHHHHHh-cCcccCCCHHHHHH
Confidence 0111111111 1123446788999998 68999999999874
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 1 (Aatyk1) and Aatyk3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk1 and Aatyk3 are members of the Aatyk subfamily of proteins. Aatyk3 is a receptor kinase containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 has a similar domain arrangement but without the transmembrane segment and is thus, a cytoplasmic (or nonreceptor) kinase. The expression of Aatyk1 (also referred simply as Aatyk) is upregulated during growth arrest and apoptosis in myeloid cells |
| >cd05110 PTKc_HER4 Catalytic domain of the Protein Tyrosine Kinase, HER4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.3e-38 Score=265.97 Aligned_cols=252 Identities=24% Similarity=0.413 Sum_probs=192.3
Q ss_pred hCCCCCCceeecCCcceEEEEEeC-CCc----EEEEEEeccCcCChhhhHHHHHHHHHHHhcCCcceeeeeeEEEcCCCe
Q 038766 11 TGSFSENNIIGNSNLSTVYKGRLE-DGE----IVAVKKLNFHQFSAESDKSFYREAKTLKELKHRNLVKVLGYAWESGKL 85 (299)
Q Consensus 11 ~~~y~~~~~lg~g~~~~v~~~~~~-~~~----~~~vK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~ 85 (299)
.++|++.+.||+|++|.||++.+. ++. .+|+|.+... ........+.+|+..++.+.||||+++++.+... .
T Consensus 6 ~~~~~~~~~lg~G~~g~vy~~~~~~~~~~~~~~vaiK~~~~~-~~~~~~~~~~~e~~~~~~l~h~niv~~~~~~~~~--~ 82 (303)
T cd05110 6 ETELKRVKVLGSGAFGTVYKGIWVPEGETVKIPVAIKILNET-TGPKANVEFMDEALIMASMDHPHLVRLLGVCLSP--T 82 (303)
T ss_pred hhhceeccccccCCCccEEEEEEecCCCcceeeEEEEecccc-CCHHHHHHHHHHHHHHHhCCCCCcccEEEEEcCC--C
Confidence 467889999999999999999863 343 5788887532 2333445678899999999999999999977543 3
Q ss_pred eEEEEeecCCCChHHHhcCCCCCCCCCChhhHHHHHHHHHHHHHHhhcCCCCCeeeecccCCceeeCCCCcEEEeeeccc
Q 038766 86 KALILEYMENGSLESVIHGPGVDHSRWTLPKRIDVLISVANGLDYLHSGYDIPIVHCDMKPSNILLDRDFEAHVSDFGTS 165 (299)
Q Consensus 86 ~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lh~~~~~~~~H~dl~~~nil~~~~~~v~l~df~~~ 165 (299)
.++++|++++++|.+++... ...+++..++.++.|++.||+|||++ +++|+||||+||+++.++.++|+|||++
T Consensus 83 ~~~v~e~~~~g~l~~~~~~~---~~~~~~~~~~~~~~qi~~~L~~LH~~---~ivH~dikp~Nill~~~~~~kL~Dfg~~ 156 (303)
T cd05110 83 IQLVTQLMPHGCLLDYVHEH---KDNIGSQLLLNWCVQIAKGMMYLEER---RLVHRDLAARNVLVKSPNHVKITDFGLA 156 (303)
T ss_pred ceeeehhcCCCCHHHHHHhc---ccCCCHHHHHHHHHHHHHHHHHHhhc---CeeccccccceeeecCCCceEEcccccc
Confidence 47899999999999988632 34688999999999999999999999 9999999999999999999999999999
Q ss_pred cccccccccccccccccccCcccCChhhhcccCcCccccchhhhHHHHHHHh-CCCCCCCCccCCCCchhHHHHHHHHHh
Q 038766 166 RMLDVHLQDLSSLSTAFQGTIGYLAPEFAYMRIVTTKVDVFSFGIVVMEFLT-KRRPTGLDEENGLSPISLRQLVEKALA 244 (299)
Q Consensus 166 ~~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~DiwslG~~l~~l~~-g~~p~~~~~~~~~~~~~~~~~~~~~~~ 244 (299)
......... ........+..|+|||.+.+..++.++||||||+++|+|++ |..||... ........+.
T Consensus 157 ~~~~~~~~~--~~~~~~~~~~~y~~PE~~~~~~~~~~~DiwslG~~l~el~t~g~~p~~~~-----~~~~~~~~~~---- 225 (303)
T cd05110 157 RLLEGDEKE--YNADGGKMPIKWMALECIHYRKFTHQSDVWSYGVTIWELMTFGGKPYDGI-----PTREIPDLLE---- 225 (303)
T ss_pred ccccCcccc--cccCCCccccccCCHHHhccCCCChHHHHHHHHHHHHHHHhCCCCCCCCC-----CHHHHHHHHH----
Confidence 765422111 11122334678999999998889999999999999999997 88888432 1122222211
Q ss_pred cCccCcccccCccccchhhHhHHHHHHHHHHHHHHHHhcCCCCCCCCChhhhhc
Q 038766 245 NGINGVRQITDPKLVSSIYEEQEQHQVLEELFKLALVCTSSNPEDRPNMNELLI 298 (299)
Q Consensus 245 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rpt~~~il~ 298 (299)
.. ..... +...+..+.+++.+|+..+|++|||++++++
T Consensus 226 ~~----~~~~~------------~~~~~~~~~~li~~c~~~~p~~Rp~~~~l~~ 263 (303)
T cd05110 226 KG----ERLPQ------------PPICTIDVYMVMVKCWMIDADSRPKFKELAA 263 (303)
T ss_pred CC----CCCCC------------CCCCCHHHHHHHHHHcCCChhhCcCHHHHHH
Confidence 11 00000 1112346889999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; HER4 (ErbB4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER4 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as bindin |
| >cd07829 STKc_CDK_like Catalytic domain of Cyclin-Dependent protein Kinase-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.4e-38 Score=261.66 Aligned_cols=269 Identities=28% Similarity=0.352 Sum_probs=198.5
Q ss_pred CCCCceeecCCcceEEEEEeC-CCcEEEEEEeccCcCChhhhHHHHHHHHHHHhcCCcceeeeeeEEEcCCCeeEEEEee
Q 038766 14 FSENNIIGNSNLSTVYKGRLE-DGEIVAVKKLNFHQFSAESDKSFYREAKTLKELKHRNLVKVLGYAWESGKLKALILEY 92 (299)
Q Consensus 14 y~~~~~lg~g~~~~v~~~~~~-~~~~~~vK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~lv~e~ 92 (299)
|+..+.||+|++|.||+++.. +++.+++|++............+..|+..++.++|+|++++.+++... ...++|+|+
T Consensus 1 y~~~~~ig~g~~~~vy~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~-~~~~~v~e~ 79 (282)
T cd07829 1 YEKLEKLGEGTYGVVYKARDKKTGEIVALKKIRLDNEEEGIPSTALREISLLKELKHPNIVKLLDVIHTE-RKLYLVFEY 79 (282)
T ss_pred CeeehcccccCcceEEEeeecCCCcEEEEEEeccccccccccHHHHHHHHHHHhcCCCCHHHHHhhhhcC-CceEEEecC
Confidence 677889999999999999875 589999999976543444556778899999999999999999976654 566999999
Q ss_pred cCCCChHHHhcCCCCCCCCCChhhHHHHHHHHHHHHHHhhcCCCCCeeeecccCCceeeCCCCcEEEeeecccccccccc
Q 038766 93 MENGSLESVIHGPGVDHSRWTLPKRIDVLISVANGLDYLHSGYDIPIVHCDMKPSNILLDRDFEAHVSDFGTSRMLDVHL 172 (299)
Q Consensus 93 ~~~~~L~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lh~~~~~~~~H~dl~~~nil~~~~~~v~l~df~~~~~~~~~~ 172 (299)
+. ++|.+++... ...+++..++.++.|++.||++||+. +++|+||+|+||+++.++.++|+|||.+......
T Consensus 80 ~~-~~l~~~i~~~---~~~~~~~~~~~~~~~i~~~l~~LH~~---~i~H~~l~~~ni~~~~~~~~~l~d~g~~~~~~~~- 151 (282)
T cd07829 80 CD-MDLKKYLDKR---PGPLSPNLIKSIMYQLLRGLAYCHSH---RILHRDLKPQNILINRDGVLKLADFGLARAFGIP- 151 (282)
T ss_pred cC-cCHHHHHHhh---ccCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCChheEEEcCCCCEEEecCCcccccCCC-
Confidence 96 5899998742 14799999999999999999999999 9999999999999999999999999998754321
Q ss_pred ccccccccccccCcccCChhhhccc-CcCccccchhhhHHHHHHHhCCCCCCCCccCCCCchhHHHHHHHHHh---cCcc
Q 038766 173 QDLSSLSTAFQGTIGYLAPEFAYMR-IVTTKVDVFSFGIVVMEFLTKRRPTGLDEENGLSPISLRQLVEKALA---NGIN 248 (299)
Q Consensus 173 ~~~~~~~~~~~~~~~y~~PE~~~~~-~~~~~~DiwslG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~---~~~~ 248 (299)
.........+..|+|||.+... .++.++|+||||+++++|++|..||...... ............ ..+.
T Consensus 152 ---~~~~~~~~~~~~~~aPE~~~~~~~~~~~~Dv~slG~~l~~l~~~~~~~~~~~~~----~~~~~~~~~~~~~~~~~~~ 224 (282)
T cd07829 152 ---LRTYTHEVVTLWYRAPEILLGSKHYSTAVDIWSVGCIFAEMITGKPLFPGDSEI----DQLFKIFQILGTPTEESWP 224 (282)
T ss_pred ---ccccCccccCcCcCChHHhcCCcCCCccccHHHHHHHHHHHHhCCCCCCCccHH----HHHHHHHHHhCCCcHHHHH
Confidence 1112233446789999988766 7889999999999999999999988543211 111111110000 0000
Q ss_pred Ccccc-----cCccccchhhHhHHHHHHHHHHHHHHHHhcCCCCCCCCChhhhhcC
Q 038766 249 GVRQI-----TDPKLVSSIYEEQEQHQVLEELFKLALVCTSSNPEDRPNMNELLIT 299 (299)
Q Consensus 249 ~~~~~-----~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rpt~~~il~~ 299 (299)
....+ ..+......... .....+..+.++|++||..||++|||+++++.|
T Consensus 225 ~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~i~~~l~~~P~~Rp~~~~~l~~ 279 (282)
T cd07829 225 GVTKLPDYKPTFPKFPPKDLEK-VLPRLDPEGIDLLSKMLQYNPAKRISAKEALKH 279 (282)
T ss_pred hhcccccccccccccCccchHH-hcccccHHHHHHHHHhhccCcccCCCHHHHhhC
Confidence 00000 001111111111 122336789999999999999999999999986
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase (CDK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKs are partly regulated by their subcellular localization, which defines substrate phosphorylation and the resulting specific function. CDK1, CDK2, CDK4, and CDK6 have well-defined functions in the cell cycle, such as the regulation of the |
| >KOG4645 consensus MAPKKK (MAP kinase kinase kinase) SSK2 and related serine/threonine protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.9e-40 Score=302.52 Aligned_cols=260 Identities=28% Similarity=0.363 Sum_probs=212.7
Q ss_pred HHHhCCCCCCceeecCCcceEEEEEe-CCCcEEEEEEeccCcCChhhhHHHHHHHHHHHhcCCcceeeeeeEEEcCCCee
Q 038766 8 ENATGSFSENNIIGNSNLSTVYKGRL-EDGEIVAVKKLNFHQFSAESDKSFYREAKTLKELKHRNLVKVLGYAWESGKLK 86 (299)
Q Consensus 8 ~~~~~~y~~~~~lg~g~~~~v~~~~~-~~~~~~~vK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~ 86 (299)
.++.-++....+||.|.||.||.+.. .+|+..|+|.+............+.+|..++..++|||++.++|+=.+.++ .
T Consensus 1231 snV~~rWqrg~~Ig~G~fG~VYtavN~~tGellAvKEI~iq~~~~k~~~~i~eEm~vlE~lnHpNlV~YyGVEvHRek-v 1309 (1509)
T KOG4645|consen 1231 SNVTFRWQRGNFIGGGTFGKVYTAVNLDTGELLAVKEIKIQDSDHKTFKLIAEEMKVLEGLNHPNLVRYYGVEVHREK-V 1309 (1509)
T ss_pred ccceeeeccccccCCcceeeeEEeecCCccchhhhhhhhcCccccccCcchHHHHHHHHhccCccccccCceeecHHH-H
Confidence 45667888999999999999999975 569999999998777666667889999999999999999999996555444 4
Q ss_pred EEEEeecCCCChHHHhcCCCCCCCCCChhhHHHHHHHHHHHHHHhhcCCCCCeeeecccCCceeeCCCCcEEEeeecccc
Q 038766 87 ALILEYMENGSLESVIHGPGVDHSRWTLPKRIDVLISVANGLDYLHSGYDIPIVHCDMKPSNILLDRDFEAHVSDFGTSR 166 (299)
Q Consensus 87 ~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lh~~~~~~~~H~dl~~~nil~~~~~~v~l~df~~~~ 166 (299)
+|.||||.+|+|.++++ .+.-.+|.....+..|++.+++|||++ +||||||||.||+++.+|.+|++|||.+.
T Consensus 1310 ~IFMEyC~~GsLa~ll~----~gri~dE~vt~vyt~qll~gla~LH~~---gIVHRDIK~aNI~Ld~~g~iK~~DFGsa~ 1382 (1509)
T KOG4645|consen 1310 YIFMEYCEGGSLASLLE----HGRIEDEMVTRVYTKQLLEGLAYLHEH---GIVHRDIKPANILLDFNGLIKYGDFGSAV 1382 (1509)
T ss_pred HHHHHHhccCcHHHHHH----hcchhhhhHHHHHHHHHHHHHHHHHhc---CceecCCCccceeeecCCcEEeeccccee
Confidence 89999999999999997 344567777778899999999999999 99999999999999999999999999998
Q ss_pred ccccccccccccccccccCcccCChhhhcccC---cCccccchhhhHHHHHHHhCCCCCCCCccCCCCchhHHHHHHHHH
Q 038766 167 MLDVHLQDLSSLSTAFQGTIGYLAPEFAYMRI---VTTKVDVFSFGIVVMEFLTKRRPTGLDEENGLSPISLRQLVEKAL 243 (299)
Q Consensus 167 ~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~---~~~~~DiwslG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~ 243 (299)
.+..+....+.--....||+-|||||++.+.. -..++|||||||+..||+||..||+.-. ++..+...+ .
T Consensus 1383 ki~~~~~~~~~el~~~~GT~~YMAPEvit~t~~kG~~~A~DiWslGCVVlEM~tGkrPW~~~d----ne~aIMy~V---~ 1455 (1509)
T KOG4645|consen 1383 KIKNNAQTMPGELQSMMGTPMYMAPEVITGTKGKGHGGAADIWSLGCVVLEMATGKRPWAELD----NEWAIMYHV---A 1455 (1509)
T ss_pred EecCchhcCCHHHHhhcCCchhcCchhhcccccCCCCcchhhhcccceEEEeecCCCchhhcc----chhHHHhHH---h
Confidence 88755433333334667999999999888643 4568999999999999999999997432 222222211 1
Q ss_pred hcCccCcccccCccccchhhHhHHHHHHHHHHHHHHHHhcCCCCCCCCChhhhhcC
Q 038766 244 ANGINGVRQITDPKLVSSIYEEQEQHQVLEELFKLALVCTSSNPEDRPNMNELLIT 299 (299)
Q Consensus 244 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rpt~~~il~~ 299 (299)
... ..+.+..++++-+++|..||..||++|.++.|+++|
T Consensus 1456 ~gh-----------------~Pq~P~~ls~~g~dFle~Cl~~dP~~Rw~~~qlle~ 1494 (1509)
T KOG4645|consen 1456 AGH-----------------KPQIPERLSSEGRDFLEHCLEQDPKMRWTASQLLEH 1494 (1509)
T ss_pred ccC-----------------CCCCchhhhHhHHHHHHHHHhcCchhhhHHHHHHHh
Confidence 111 122244578899999999999999999999999986
|
|
| >cd05613 STKc_MSK1_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-37 Score=261.52 Aligned_cols=254 Identities=22% Similarity=0.288 Sum_probs=194.2
Q ss_pred CCCCCceeecCCcceEEEEEe----CCCcEEEEEEeccCcC--ChhhhHHHHHHHHHHHhcC-CcceeeeeeEEEcCCCe
Q 038766 13 SFSENNIIGNSNLSTVYKGRL----EDGEIVAVKKLNFHQF--SAESDKSFYREAKTLKELK-HRNLVKVLGYAWESGKL 85 (299)
Q Consensus 13 ~y~~~~~lg~g~~~~v~~~~~----~~~~~~~vK~~~~~~~--~~~~~~~~~~e~~~l~~l~-h~~i~~~~~~~~~~~~~ 85 (299)
.|++.+.||.|++|.||+|.+ .+|..||+|++..... .....+.+..|+++++.+. |++|+++++.+.. +..
T Consensus 1 ~y~~~~~lg~G~~g~v~~~~~~~~~~~g~~~aiK~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~i~~~~~~~~~-~~~ 79 (290)
T cd05613 1 NFELLKVLGTGAYGKVFLVRKVSGHDSGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSPFLVTLHYAFQT-DTK 79 (290)
T ss_pred CceeeeeeccCCcceEEEEEeccCCCCCceEEEEEeehhhhhhcchHHHHHHHHHHHHHhcccCCChhceeeEeec-CCe
Confidence 478899999999999999986 3688999999864322 1223466788999999995 8999999985544 566
Q ss_pred eEEEEeecCCCChHHHhcCCCCCCCCCChhhHHHHHHHHHHHHHHhhcCCCCCeeeecccCCceeeCCCCcEEEeeeccc
Q 038766 86 KALILEYMENGSLESVIHGPGVDHSRWTLPKRIDVLISVANGLDYLHSGYDIPIVHCDMKPSNILLDRDFEAHVSDFGTS 165 (299)
Q Consensus 86 ~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lh~~~~~~~~H~dl~~~nil~~~~~~v~l~df~~~ 165 (299)
.++|+||+++++|.+.+. ....+++..+..++.|++.||.+||+. +++|+||+|+||+++.++.++|+|||++
T Consensus 80 ~~lv~e~~~~~~L~~~l~----~~~~l~~~~~~~~~~qi~~al~~lH~~---~i~H~dl~p~nil~~~~~~~kl~dfg~~ 152 (290)
T cd05613 80 LHLILDYINGGELFTHLS----QRERFKEQEVQIYSGEIVLALEHLHKL---GIIYRDIKLENILLDSNGHVVLTDFGLS 152 (290)
T ss_pred EEEEEecCCCCcHHHHHH----HcCCCCHHHHHHHHHHHHHHHHHHHhC---CeeccCCCHHHeEECCCCCEEEeeCccc
Confidence 799999999999999886 445788999999999999999999999 9999999999999999999999999998
Q ss_pred cccccccccccccccccccCcccCChhhhccc--CcCccccchhhhHHHHHHHhCCCCCCCCccCCCCchhHHHHHHHHH
Q 038766 166 RMLDVHLQDLSSLSTAFQGTIGYLAPEFAYMR--IVTTKVDVFSFGIVVMEFLTKRRPTGLDEENGLSPISLRQLVEKAL 243 (299)
Q Consensus 166 ~~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~--~~~~~~DiwslG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~ 243 (299)
....... ........++..|+|||..... .++.++||||||+++|+|++|..||..... ............
T Consensus 153 ~~~~~~~---~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Dv~slG~~l~~ll~g~~p~~~~~~----~~~~~~~~~~~~ 225 (290)
T cd05613 153 KEFHEDE---VERAYSFCGTIEYMAPDIVRGGDGGHDKAVDWWSMGVLMYELLTGASPFTVDGE----KNSQAEISRRIL 225 (290)
T ss_pred eeccccc---ccccccccCCcccCChhhccCCCCCCCccccHHHHHHHHHHHhcCCCCCCcCCc----cccHHHHHHHhh
Confidence 7543211 1112234567889999987753 467899999999999999999999853211 111122221111
Q ss_pred hcCccCcccccCccccchhhHhHHHHHHHHHHHHHHHHhcCCCCCCCC-----ChhhhhcC
Q 038766 244 ANGINGVRQITDPKLVSSIYEEQEQHQVLEELFKLALVCTSSNPEDRP-----NMNELLIT 299 (299)
Q Consensus 244 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rp-----t~~~il~~ 299 (299)
... .. .+..++..+.+++.+||..||++|| +++++++|
T Consensus 226 ~~~-~~-----------------~~~~~~~~~~~ll~~~l~~~p~~R~~~~~~~~~~l~~~ 268 (290)
T cd05613 226 KSE-PP-----------------YPQEMSALAKDIIQRLLMKDPKKRLGCGPSDADEIKKH 268 (290)
T ss_pred ccC-CC-----------------CCccCCHHHHHHHHHHhcCCHHHhcCCCCCCHHHHHcC
Confidence 110 00 0222456788999999999999997 78888875
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK1, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydroph |
| >cd06635 STKc_TAO1 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5e-37 Score=261.60 Aligned_cols=248 Identities=26% Similarity=0.374 Sum_probs=192.6
Q ss_pred CCCCCCceeecCCcceEEEEEe-CCCcEEEEEEeccCcC-ChhhhHHHHHHHHHHHhcCCcceeeeeeEEEcCCCeeEEE
Q 038766 12 GSFSENNIIGNSNLSTVYKGRL-EDGEIVAVKKLNFHQF-SAESDKSFYREAKTLKELKHRNLVKVLGYAWESGKLKALI 89 (299)
Q Consensus 12 ~~y~~~~~lg~g~~~~v~~~~~-~~~~~~~vK~~~~~~~-~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~lv 89 (299)
..|...+.||+|++|.||++++ .++..+++|++..... ..+....+.+|++.++.++|+|++++++++.. +...++|
T Consensus 25 ~~f~~~~~lg~G~~~~v~~~~~~~~~~~valK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~-~~~~~lv 103 (317)
T cd06635 25 KLFTDLREIGHGSFGAVYFARDVRTNEVVAIKKMSYSGKQSNEKWQDIIKEVKFLQRIKHPNSIEYKGCYLR-EHTAWLV 103 (317)
T ss_pred hhhhhhheeccCCCeEEEEEEEcCCCcEEEEEEEecCCCCchHHHHHHHHHHHHHHhCCCCCEEEEEEEEee-CCeEEEE
Confidence 4478899999999999999986 4588999999864322 23345678899999999999999999997665 4556999
Q ss_pred EeecCCCChHHHhcCCCCCCCCCChhhHHHHHHHHHHHHHHhhcCCCCCeeeecccCCceeeCCCCcEEEeeeccccccc
Q 038766 90 LEYMENGSLESVIHGPGVDHSRWTLPKRIDVLISVANGLDYLHSGYDIPIVHCDMKPSNILLDRDFEAHVSDFGTSRMLD 169 (299)
Q Consensus 90 ~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lh~~~~~~~~H~dl~~~nil~~~~~~v~l~df~~~~~~~ 169 (299)
+||+.+ +|.+.+.. ...++++..+..++.|++.|+.+||+. +++|+||+|+||+++.++.++|+|||++....
T Consensus 104 ~e~~~g-~l~~~~~~---~~~~l~~~~~~~i~~~i~~~l~~lH~~---~i~H~dL~p~Nil~~~~~~~kl~dfg~~~~~~ 176 (317)
T cd06635 104 MEYCLG-SASDLLEV---HKKPLQEVEIAAITHGALQGLAYLHSH---NMIHRDIKAGNILLTEPGQVKLADFGSASIAS 176 (317)
T ss_pred EeCCCC-CHHHHHHH---hcCCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCcccEEECCCCCEEEecCCCccccC
Confidence 999965 77776643 245689999999999999999999999 99999999999999999999999999876433
Q ss_pred cccccccccccccccCcccCChhhhc---ccCcCccccchhhhHHHHHHHhCCCCCCCCccCCCCchhHHHHHHHHHhcC
Q 038766 170 VHLQDLSSLSTAFQGTIGYLAPEFAY---MRIVTTKVDVFSFGIVVMEFLTKRRPTGLDEENGLSPISLRQLVEKALANG 246 (299)
Q Consensus 170 ~~~~~~~~~~~~~~~~~~y~~PE~~~---~~~~~~~~DiwslG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~ 246 (299)
......++..|+|||.+. ...++.++|+||+|+++|+|++|..||... .. ...........
T Consensus 177 --------~~~~~~~~~~y~aPE~~~~~~~~~~~~~~Dv~slGvil~el~~g~~p~~~~-----~~---~~~~~~~~~~~ 240 (317)
T cd06635 177 --------PANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNM-----NA---MSALYHIAQNE 240 (317)
T ss_pred --------CcccccCCccccChhhhhcCCCCCCCccccHHHHHHHHHHHHhCCCCCCCc-----cH---HHHHHHHHhcc
Confidence 122345678899999874 456788999999999999999999998532 11 11111111111
Q ss_pred ccCcccccCccccchhhHhHHHHHHHHHHHHHHHHhcCCCCCCCCChhhhhcC
Q 038766 247 INGVRQITDPKLVSSIYEEQEQHQVLEELFKLALVCTSSNPEDRPNMNELLIT 299 (299)
Q Consensus 247 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rpt~~~il~~ 299 (299)
... ......+..+.+++.+||+.+|.+|||+.++++|
T Consensus 241 ~~~----------------~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~il~~ 277 (317)
T cd06635 241 SPT----------------LQSNEWSDYFRNFVDSCLQKIPQDRPTSEELLKH 277 (317)
T ss_pred CCC----------------CCCccccHHHHHHHHHHccCCcccCcCHHHHHhC
Confidence 000 0012345678999999999999999999999976
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 1 (TAO1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO1 is sometimes referred to as prostate-derived sterile 20-like kinase 2 (PSK2). TAO1 activates the p38 MAPK through direct interaction with and activation of MEK3. TAO1 is highly expressed in the brain and may play a role in neuron |
| >KOG0584 consensus Serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.8e-39 Score=275.96 Aligned_cols=249 Identities=26% Similarity=0.391 Sum_probs=198.0
Q ss_pred CCCceeecCCcceEEEEEeC-CCcEEEEEEeccCcC--ChhhhHHHHHHHHHHHhcCCcceeeeeeEEEcCC-CeeEEEE
Q 038766 15 SENNIIGNSNLSTVYKGRLE-DGEIVAVKKLNFHQF--SAESDKSFYREAKTLKELKHRNLVKVLGYAWESG-KLKALIL 90 (299)
Q Consensus 15 ~~~~~lg~g~~~~v~~~~~~-~~~~~~vK~~~~~~~--~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~-~~~~lv~ 90 (299)
+....||+|.|.+||+|.+. .|..||--.++.... .+....+++.|+.+|+.|+|+||+++++.-.+.. +...+|+
T Consensus 43 k~~evLGrGafKtVYka~De~~giEVAWnqvk~~d~~q~~~~leR~~~Ev~lLKsL~H~NIirfy~SW~d~~n~~in~iT 122 (632)
T KOG0584|consen 43 KFDEVLGRGAFKTVYKAFDEEEGIEVAWNQVKIRDVTQSPEELERLYSEVHLLKSLKHPNIIRFYDSWVDTDNKTINFIT 122 (632)
T ss_pred ehhhhcccccceeeeeccccccchhhHHHHHhHHHhhcChHHHHHHHHHHHHHccCCCCceeeeeeheecCCCceeeeee
Confidence 45678999999999999864 477777555544333 3445689999999999999999999999655433 4457899
Q ss_pred eecCCCChHHHhcCCCCCCCCCChhhHHHHHHHHHHHHHHhhcCCCCCeeeecccCCceeeC-CCCcEEEeeeccccccc
Q 038766 91 EYMENGSLESVIHGPGVDHSRWTLPKRIDVLISVANGLDYLHSGYDIPIVHCDMKPSNILLD-RDFEAHVSDFGTSRMLD 169 (299)
Q Consensus 91 e~~~~~~L~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lh~~~~~~~~H~dl~~~nil~~-~~~~v~l~df~~~~~~~ 169 (299)
|.+..|+|..+.+++ ...+...+..|+.||+.+|.|||++. ..|+|||||-+||||+ .-|.|||+|+|+++...
T Consensus 123 EL~TSGtLr~Y~kk~----~~vn~kaik~W~RQILkGL~yLHs~~-PPIIHRDLKCDNIFinG~~G~VKIGDLGLAtl~r 197 (632)
T KOG0584|consen 123 ELFTSGTLREYRKKH----RRVNIKAIKSWCRQILKGLVYLHSQD-PPIIHRDLKCDNIFVNGNLGEVKIGDLGLATLLR 197 (632)
T ss_pred ecccCCcHHHHHHHh----ccCCHHHHHHHHHHHHHHhhhhhcCC-CCccccccccceEEEcCCcCceeecchhHHHHhh
Confidence 999999999999854 47888899999999999999999984 4999999999999997 45999999999998765
Q ss_pred cccccccccccccccCcccCChhhhcccCcCccccchhhhHHHHHHHhCCCCCCCCccCCCCchhHHHHHHHHHhcCccC
Q 038766 170 VHLQDLSSLSTAFQGTIGYLAPEFAYMRIVTTKVDVFSFGIVVMEFLTKRRPTGLDEENGLSPISLRQLVEKALANGING 249 (299)
Q Consensus 170 ~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~DiwslG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 249 (299)
........|||.|||||.+. ..|+...||||||+++.+|.|+..||+...+ ..+++..+...... ..
T Consensus 198 ------~s~aksvIGTPEFMAPEmYE-E~YnE~VDVYaFGMCmLEMvT~eYPYsEC~n----~AQIYKKV~SGiKP--~s 264 (632)
T KOG0584|consen 198 ------KSHAKSVIGTPEFMAPEMYE-ENYNELVDVYAFGMCMLEMVTSEYPYSECTN----PAQIYKKVTSGIKP--AA 264 (632)
T ss_pred ------ccccceeccCccccChHHHh-hhcchhhhhhhhhHHHHHHHhccCChhhhCC----HHHHHHHHHcCCCH--HH
Confidence 23345578999999999888 7799999999999999999999999976533 33344332221110 01
Q ss_pred cccccCccccchhhHhHHHHHHHHHHHHHHHHhcCCCCCCCCChhhhhcC
Q 038766 250 VRQITDPKLVSSIYEEQEQHQVLEELFKLALVCTSSNPEDRPNMNELLIT 299 (299)
Q Consensus 250 ~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rpt~~~il~~ 299 (299)
+..+. .+++.+||.+|+.. .++|||+.|+|.|
T Consensus 265 l~kV~-----------------dPevr~fIekCl~~-~~~R~sa~eLL~d 296 (632)
T KOG0584|consen 265 LSKVK-----------------DPEVREFIEKCLAT-KSERLSAKELLKD 296 (632)
T ss_pred hhccC-----------------CHHHHHHHHHHhcC-chhccCHHHHhhC
Confidence 11111 25789999999999 9999999999986
|
|
| >KOG1035 consensus eIF-2alpha kinase GCN2 [Translation, ribosomal structure and biogenesis] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-38 Score=289.95 Aligned_cols=257 Identities=28% Similarity=0.400 Sum_probs=190.3
Q ss_pred hCCCCCCceeecCCcceEEEEEeC-CCcEEEEEEeccCcCChhhhHHHHHHHHHHHhcCCcceeeeeeEEEcC-------
Q 038766 11 TGSFSENNIIGNSNLSTVYKGRLE-DGEIVAVKKLNFHQFSAESDKSFYREAKTLKELKHRNLVKVLGYAWES------- 82 (299)
Q Consensus 11 ~~~y~~~~~lg~g~~~~v~~~~~~-~~~~~~vK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~------- 82 (299)
..+|...+.||+||||.||+|+.+ +|+.||||+|.... +......+.+|+..+.+++||||+.++..-.+.
T Consensus 478 ~~DFEEL~lLGkGGFG~VvkVRNKlDGr~YAIKKIpl~~-s~~~~skI~rEVk~LArLnHpNVVRYysAWVEs~~~~~~~ 556 (1351)
T KOG1035|consen 478 LNDFEELELLGKGGFGSVVKVRNKLDGREYAIKKIPLKA-SDKLYSKILREVKLLARLNHPNVVRYYSAWVESTAELTVL 556 (1351)
T ss_pred hhhhHHHHHhcCCCCceEEEEeecccchhhhhhhccCch-HHHHHHHHHHHHHHHhhcCCcceeeeehhhhccCCccccc
Confidence 456788899999999999999975 79999999998766 677788899999999999999999986521100
Q ss_pred --------------------------------------------------------------------------------
Q 038766 83 -------------------------------------------------------------------------------- 82 (299)
Q Consensus 83 -------------------------------------------------------------------------------- 82 (299)
T Consensus 557 ei~~~~~~~~sQs~s~~~~~~~~~q~t~~p~~~~~~~~~~~~dd~sss~~~~~~~~~~~~d~e~~d~dedg~~~S~tS~~ 636 (1351)
T KOG1035|consen 557 EIVASDSESRSQSASKYNGVDIRYQPTSSPSLTLSELDSEDEDDKSSSYTTRKASYESSTDEENDDSDEDGRNLSNTSDS 636 (1351)
T ss_pred cccccchhhhcccCCCcccceeeeccCCCcccCcchhhccccCccccccccccccccccCCccccccccccccccccccc
Confidence
Q ss_pred -----------------------C--------CeeEEEEeecCCCChHHHhcCCCCCCCCC-ChhhHHHHHHHHHHHHHH
Q 038766 83 -----------------------G--------KLKALILEYMENGSLESVIHGPGVDHSRW-TLPKRIDVLISVANGLDY 130 (299)
Q Consensus 83 -----------------------~--------~~~~lv~e~~~~~~L~~~~~~~~~~~~~~-~~~~~~~i~~qi~~~l~~ 130 (299)
+ ..+||-||||...++..++.. +... ...++|.++++|+.||+|
T Consensus 637 e~~~~~d~~~ess~s~~~~~n~~e~~~~~q~~~~LYIQMEyCE~~ll~~iI~~----N~~~~~~d~~wrLFreIlEGLaY 712 (1351)
T KOG1035|consen 637 EGSVILDDTSESSESIPKTENSSEPMVPVQKPLILYIQMEYCEKTLLRDIIRR----NHFNSQRDEAWRLFREILEGLAY 712 (1351)
T ss_pred CCccccCcchhhhhhccccCCccccccccccceEEEEEHhhhhhhHHHHHHHh----cccchhhHHHHHHHHHHHHHHHH
Confidence 0 134788888877666666653 2222 467899999999999999
Q ss_pred hhcCCCCCeeeecccCCceeeCCCCcEEEeeeccccccccc--------------cccccccccccccCcccCChhhhcc
Q 038766 131 LHSGYDIPIVHCDMKPSNILLDRDFEAHVSDFGTSRMLDVH--------------LQDLSSLSTAFQGTIGYLAPEFAYM 196 (299)
Q Consensus 131 lh~~~~~~~~H~dl~~~nil~~~~~~v~l~df~~~~~~~~~--------------~~~~~~~~~~~~~~~~y~~PE~~~~ 196 (299)
+|++ +++||||||.|||++.++.|||+|||++...... ........+..+||-.|+|||++.+
T Consensus 713 IH~~---giIHRDLKP~NIFLd~~~~VKIGDFGLAt~~~~~~~~~d~~~~~~~~~~g~~~~~~Ts~VGTalYvAPEll~~ 789 (1351)
T KOG1035|consen 713 IHDQ---GIIHRDLKPRNIFLDSRNSVKIGDFGLATDLKENLESIDQDLSFSTNRAGSNDGDLTSQVGTALYVAPELLSD 789 (1351)
T ss_pred HHhC---ceeeccCCcceeEEcCCCCeeecccccchhhhhhhhhHhhccCccccccCCCCcccccccceeeeecHHHhcc
Confidence 9999 9999999999999999999999999999873200 0011113456678999999999887
Q ss_pred cC---cCccccchhhhHHHHHHHhCCCCCCCCccCCCCchhHHHHHHHHHhcCccCcccccCccccchhhHhHHHHHHHH
Q 038766 197 RI---VTTKVDVFSFGIVVMEFLTKRRPTGLDEENGLSPISLRQLVEKALANGINGVRQITDPKLVSSIYEEQEQHQVLE 273 (299)
Q Consensus 197 ~~---~~~~~DiwslG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 273 (299)
.. |+.|.|+||||++++||+. ||.- .++....+...-....+....+.++. -+
T Consensus 790 ~~~~~Yn~KiDmYSLGIVlFEM~y---PF~T-------sMERa~iL~~LR~g~iP~~~~f~~~~--------------~~ 845 (1351)
T KOG1035|consen 790 TSSNKYNSKIDMYSLGIVLFEMLY---PFGT-------SMERASILTNLRKGSIPEPADFFDPE--------------HP 845 (1351)
T ss_pred cccccccchhhhHHHHHHHHHHhc---cCCc-------hHHHHHHHHhcccCCCCCCccccccc--------------ch
Confidence 65 9999999999999999987 3421 12222222211111111111111111 12
Q ss_pred HHHHHHHHhcCCCCCCCCChhhhhcC
Q 038766 274 ELFKLALVCTSSNPEDRPNMNELLIT 299 (299)
Q Consensus 274 ~l~~li~~~l~~dP~~Rpt~~~il~~ 299 (299)
.-..+|++|++.||++||||.|+|.|
T Consensus 846 ~e~slI~~Ll~hdP~kRPtA~eLL~s 871 (1351)
T KOG1035|consen 846 EEASLIRWLLSHDPSKRPTATELLNS 871 (1351)
T ss_pred HHHHHHHHHhcCCCccCCCHHHHhhc
Confidence 34679999999999999999999975
|
|
| >cd05086 PTKc_Aatyk2 Catalytic domain of the Protein Tyrosine Kinase, Apoptosis-associated tyrosine kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-37 Score=257.06 Aligned_cols=253 Identities=22% Similarity=0.328 Sum_probs=181.7
Q ss_pred ceeecCCcceEEEEEeCC---CcEEEEEEeccCcCChhhhHHHHHHHHHHHhcCCcceeeeeeEEEcCCCeeEEEEeecC
Q 038766 18 NIIGNSNLSTVYKGRLED---GEIVAVKKLNFHQFSAESDKSFYREAKTLKELKHRNLVKVLGYAWESGKLKALILEYME 94 (299)
Q Consensus 18 ~~lg~g~~~~v~~~~~~~---~~~~~vK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~lv~e~~~ 94 (299)
+.||+|+||.||++...+ ...+++|.+.... .....+.+.+|+..++.++||||+++++.+.. ....++|+||+.
T Consensus 1 ~~lg~G~~g~v~~~~~~~~~~~~~~~~k~~~~~~-~~~~~~~~~~e~~~~~~l~h~~iv~~~~~~~~-~~~~~lv~e~~~ 78 (268)
T cd05086 1 QEIGNGWFGKVLLSEIYTDTGVARVVVKELKANA-SSKEQNEFLQQGDPYRILQHPNILQCLGQCVE-AIPYLLVFEYCE 78 (268)
T ss_pred CcCCCCcCceEEEEEEEcCCCcceEEEEEecCCC-ChHHHHHHHHHHHHHhccCCcchhheEEEecC-CCccEEEEecCC
Confidence 469999999999997533 3456677665322 23446788899999999999999999997765 445699999999
Q ss_pred CCChHHHhcCCCCCCCCCChhhHHHHHHHHHHHHHHhhcCCCCCeeeecccCCceeeCCCCcEEEeeecccccccccccc
Q 038766 95 NGSLESVIHGPGVDHSRWTLPKRIDVLISVANGLDYLHSGYDIPIVHCDMKPSNILLDRDFEAHVSDFGTSRMLDVHLQD 174 (299)
Q Consensus 95 ~~~L~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lh~~~~~~~~H~dl~~~nil~~~~~~v~l~df~~~~~~~~~~~~ 174 (299)
+++|.+++..........++..++.++.||+.||+|||+. +++|+||||+||+++.++.++|+|||++..... ..
T Consensus 79 ~~~L~~~l~~~~~~~~~~~~~~~~~~~~~i~~al~~lH~~---~i~H~dikp~nil~~~~~~~~l~Dfg~~~~~~~--~~ 153 (268)
T cd05086 79 LGDLKSYLSQEQWHRRNSQLLLLQRMACEIAAGVTHMHKH---NFLHSDLALRNCFLTSDLTVKVGDYGIGPSRYK--ED 153 (268)
T ss_pred CCcHHHHHHhhhcccccccHHHHHHHHHHHHHHHHHHHHC---CeeccCCccceEEEcCCccEEecccccccccCc--ch
Confidence 9999999875432344567778889999999999999998 999999999999999999999999998753211 00
Q ss_pred ccccccccccCcccCChhhhcc-------cCcCccccchhhhHHHHHHHhC-CCCCCCCccCCCCchhHHHHHHHHHhcC
Q 038766 175 LSSLSTAFQGTIGYLAPEFAYM-------RIVTTKVDVFSFGIVVMEFLTK-RRPTGLDEENGLSPISLRQLVEKALANG 246 (299)
Q Consensus 175 ~~~~~~~~~~~~~y~~PE~~~~-------~~~~~~~DiwslG~~l~~l~~g-~~p~~~~~~~~~~~~~~~~~~~~~~~~~ 246 (299)
.........++..|+|||++.. ..++.++||||||+++|+|+++ ..||... .. .+.+.......
T Consensus 154 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l~el~~~~~~p~~~~-----~~---~~~~~~~~~~~ 225 (268)
T cd05086 154 YIETEDDKCVPLRWLAPELVGEFHGGLITAEQTKPSNVWALGVTLWELFENAAQPYSHL-----SD---REVLNHVIKDQ 225 (268)
T ss_pred hhhcccCCcCcccccCchhcccccCccccCCCCCcchhHHHHHHHHHHHhCCCCCCCCC-----CH---HHHHHHHHhhc
Confidence 1111223456788999998753 2356789999999999999975 5566322 11 12222221111
Q ss_pred ccCcccccCccccchhhHhHHHHHHHHHHHHHHHHhcCCCCCCCCChhhhhc
Q 038766 247 INGVRQITDPKLVSSIYEEQEQHQVLEELFKLALVCTSSNPEDRPNMNELLI 298 (299)
Q Consensus 247 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rpt~~~il~ 298 (299)
. .....+.. ...++..+.+++..|+ .+|++|||++++++
T Consensus 226 ~---~~~~~~~~---------~~~~~~~~~~l~~~c~-~~P~~Rp~~~~i~~ 264 (268)
T cd05086 226 Q---VKLFKPQL---------ELPYSERWYEVLQFCW-LSPEKRATAEEVHR 264 (268)
T ss_pred c---cccCCCcc---------CCCCcHHHHHHHHHHh-hCcccCCCHHHHHH
Confidence 1 01111111 1224467888999998 68999999999975
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 2 (Aatyk2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk2 is a member of the Aatyk subfamily of proteins, which are receptor kinases containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk2 is also called lemur tyrosine kinase 2 (Lmtk2) or brain-enriched kinase (Brek). It is expressed at high levels in early postnatal brain, and has been shown to play a role in nerve growth factor (NGF) signaling. Studies with knockout mice reveal that Aatyk2 is essential for late stage |
| >cd05076 PTK_Tyk2_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-37 Score=260.07 Aligned_cols=237 Identities=24% Similarity=0.350 Sum_probs=178.1
Q ss_pred eeecCCcceEEEEEeC-------------------------CCcEEEEEEeccCcCChhhhHHHHHHHHHHHhcCCccee
Q 038766 19 IIGNSNLSTVYKGRLE-------------------------DGEIVAVKKLNFHQFSAESDKSFYREAKTLKELKHRNLV 73 (299)
Q Consensus 19 ~lg~g~~~~v~~~~~~-------------------------~~~~~~vK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~ 73 (299)
.||+|+||.||++... ....+++|++... .......+.+|+..++.++||||+
T Consensus 2 ~lG~G~~~~vy~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~v~~k~~~~~--~~~~~~~~~~~~~~~~~l~h~niv 79 (274)
T cd05076 2 HLGQGTRTNIYDGRLRVEGGGEPEEDEMEDEDPLVEGNNNGRELRVVLKVLDPS--HRDIALAFFETASLMSQVSHIHLA 79 (274)
T ss_pred CcCcccccceecceeEeccCCCCcccccccccccccccCCCeeeeEEEEecChH--HHHHHHHHHHHHHHHhcCCCCCee
Confidence 5899999999998631 1235888887532 233345678889999999999999
Q ss_pred eeeeEEEcCCCeeEEEEeecCCCChHHHhcCCCCCCCCCChhhHHHHHHHHHHHHHHhhcCCCCCeeeecccCCceeeCC
Q 038766 74 KVLGYAWESGKLKALILEYMENGSLESVIHGPGVDHSRWTLPKRIDVLISVANGLDYLHSGYDIPIVHCDMKPSNILLDR 153 (299)
Q Consensus 74 ~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lh~~~~~~~~H~dl~~~nil~~~ 153 (299)
++++++... ...++|+||+++++|..++.. ....+++..+..++.|++.||+|||+. +++|+||||+||+++.
T Consensus 80 ~~~~~~~~~-~~~~lv~ey~~~g~L~~~l~~---~~~~~~~~~~~~i~~qi~~~l~~lH~~---~iiH~dlkp~Nill~~ 152 (274)
T cd05076 80 FVHGVCVRG-SENIMVEEFVEHGPLDVCLRK---EKGRVPVAWKITVAQQLASALSYLEDK---NLVHGNVCAKNILLAR 152 (274)
T ss_pred eEEEEEEeC-CceEEEEecCCCCcHHHHHHh---cCCCCCHHHHHHHHHHHHHHHHHHHcC---CccCCCCCcccEEEec
Confidence 999987664 455999999999999988853 235788999999999999999999999 9999999999999976
Q ss_pred CC-------cEEEeeeccccccccccccccccccccccCcccCChhhhcc-cCcCccccchhhhHHHHHHH-hCCCCCCC
Q 038766 154 DF-------EAHVSDFGTSRMLDVHLQDLSSLSTAFQGTIGYLAPEFAYM-RIVTTKVDVFSFGIVVMEFL-TKRRPTGL 224 (299)
Q Consensus 154 ~~-------~v~l~df~~~~~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~-~~~~~~~DiwslG~~l~~l~-~g~~p~~~ 224 (299)
.+ .++++|||.+..... .....++..|+|||.+.+ ..++.++||||||+++|+|+ +|..||..
T Consensus 153 ~~~~~~~~~~~kl~d~g~~~~~~~--------~~~~~~~~~~~aPe~~~~~~~~~~~~Dv~slG~~l~el~~~g~~p~~~ 224 (274)
T cd05076 153 LGLAEGTSPFIKLSDPGVSFTALS--------REERVERIPWIAPECVPGGNSLSTAADKWSFGTTLLEICFDGEVPLKE 224 (274)
T ss_pred cCcccCccceeeecCCcccccccc--------ccccccCCcccCchhhcCCCCCCcHHHHHHHHHHHHHHHhCCCCCccc
Confidence 44 379999998753221 112245678999998865 56889999999999999985 68888753
Q ss_pred CccCCCCchhHHHHHHHHHhcCccCcccccCccccchhhHhHHHHHHHHHHHHHHHHhcCCCCCCCCChhhhhcC
Q 038766 225 DEENGLSPISLRQLVEKALANGINGVRQITDPKLVSSIYEEQEQHQVLEELFKLALVCTSSNPEDRPNMNELLIT 299 (299)
Q Consensus 225 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rpt~~~il~~ 299 (299)
... ......... . ... +......+.++|.+||..+|++|||++++|++
T Consensus 225 ~~~-----~~~~~~~~~----~----~~~--------------~~~~~~~~~~li~~cl~~~p~~Rps~~~il~~ 272 (274)
T cd05076 225 RTP-----SEKERFYEK----K----HRL--------------PEPSCKELATLISQCLTYEPTQRPSFRTILRD 272 (274)
T ss_pred cCh-----HHHHHHHHh----c----cCC--------------CCCCChHHHHHHHHHcccChhhCcCHHHHHHh
Confidence 311 111111110 0 000 01122468899999999999999999999863
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalyt |
| >cd06618 PKc_MKK7 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 7 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-37 Score=261.62 Aligned_cols=258 Identities=23% Similarity=0.318 Sum_probs=193.9
Q ss_pred HHHHHhCCCCCCceeecCCcceEEEEEeCC-CcEEEEEEeccCcCChhhhHHHHHHHHHHHhcC-CcceeeeeeEEEcCC
Q 038766 6 EIENATGSFSENNIIGNSNLSTVYKGRLED-GEIVAVKKLNFHQFSAESDKSFYREAKTLKELK-HRNLVKVLGYAWESG 83 (299)
Q Consensus 6 ~~~~~~~~y~~~~~lg~g~~~~v~~~~~~~-~~~~~vK~~~~~~~~~~~~~~~~~e~~~l~~l~-h~~i~~~~~~~~~~~ 83 (299)
++....++|.+.+.||+|++|.||++.+.+ ++.+|+|.+..... ......+..|...+.... |+||+++++++.. +
T Consensus 9 ~~~~~~~~~~~~~~lg~g~~~~v~~~~~~~~~~~~avK~~~~~~~-~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~-~ 86 (296)
T cd06618 9 KYPADLNDLENLGEIGSGTCGQVYKMRFKKTGHVMAVKQMRRTGN-KEENKRILMDLDVVLKSHDCPYIVKCYGYFIT-D 86 (296)
T ss_pred eccCCcchheeeeEeeccCCeEEEEEEECCCCeEEEEEEEeccCC-hHHHHHHHHHHHHHHhccCCCchHhhheeeec-C
Confidence 445566889999999999999999998754 89999999864332 233455566776666665 9999999997765 5
Q ss_pred CeeEEEEeecCCCChHHHhcCCCCCCCCCChhhHHHHHHHHHHHHHHhhc-CCCCCeeeecccCCceeeCCCCcEEEeee
Q 038766 84 KLKALILEYMENGSLESVIHGPGVDHSRWTLPKRIDVLISVANGLDYLHS-GYDIPIVHCDMKPSNILLDRDFEAHVSDF 162 (299)
Q Consensus 84 ~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lh~-~~~~~~~H~dl~~~nil~~~~~~v~l~df 162 (299)
...++++||+. +++.+++... ...+++..+..++.|++.+++|||+ . +++|+||+|+||+++.++.++|+||
T Consensus 87 ~~~~~v~e~~~-~~l~~l~~~~---~~~l~~~~~~~i~~~i~~~l~~lH~~~---~i~H~dl~p~nill~~~~~~kL~df 159 (296)
T cd06618 87 SDVFICMELMS-TCLDKLLKRI---QGPIPEDILGKMTVAIVKALHYLKEKH---GVIHRDVKPSNILLDASGNVKLCDF 159 (296)
T ss_pred CeEEEEeeccC-cCHHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHhhC---CEecCCCcHHHEEEcCCCCEEECcc
Confidence 56699999984 4777776532 2478999999999999999999997 5 8999999999999999999999999
Q ss_pred ccccccccccccccccccccccCcccCChhhhcccC----cCccccchhhhHHHHHHHhCCCCCCCCccCCCCchhHHHH
Q 038766 163 GTSRMLDVHLQDLSSLSTAFQGTIGYLAPEFAYMRI----VTTKVDVFSFGIVVMEFLTKRRPTGLDEENGLSPISLRQL 238 (299)
Q Consensus 163 ~~~~~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~----~~~~~DiwslG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~ 238 (299)
|++..+... .......++..|+|||.+.+.. ++.++|+||||+++|+|++|..||..... ..+.
T Consensus 160 g~~~~~~~~-----~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~-------~~~~ 227 (296)
T cd06618 160 GISGRLVDS-----KAKTRSAGCAAYMAPERIDPPDPNPKYDIRADVWSLGISLVELATGQFPYKNCKT-------EFEV 227 (296)
T ss_pred ccchhccCC-----CcccCCCCCccccCHhhcCCCCCccccccchhHHHHHHHHHHHHhCCCCCCcchh-------HHHH
Confidence 998654311 1112234677899999887553 78899999999999999999999853211 1122
Q ss_pred HHHHHhcCccCcccccCccccchhhHhHHHHHHHHHHHHHHHHhcCCCCCCCCChhhhhcC
Q 038766 239 VEKALANGINGVRQITDPKLVSSIYEEQEQHQVLEELFKLALVCTSSNPEDRPNMNELLIT 299 (299)
Q Consensus 239 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rpt~~~il~~ 299 (299)
+........... .. ...++.++.+++.+||..||++|||++++++|
T Consensus 228 ~~~~~~~~~~~~---~~------------~~~~~~~l~~li~~~l~~~p~~Rp~~~~il~~ 273 (296)
T cd06618 228 LTKILQEEPPSL---PP------------NEGFSPDFCSFVDLCLTKDHRKRPKYRELLQH 273 (296)
T ss_pred HHHHhcCCCCCC---CC------------CCCCCHHHHHHHHHHccCChhhCCCHHHHhcC
Confidence 222221111110 00 01234678999999999999999999999976
|
Protein kinases (PKs), MAP kinase kinase 7 (MKK7) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK7 is a dual-specificity PK that phosphorylates and activates it |
| >cd06634 STKc_TAO2 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.4e-37 Score=260.38 Aligned_cols=249 Identities=27% Similarity=0.377 Sum_probs=192.3
Q ss_pred hCCCCCCceeecCCcceEEEEEeC-CCcEEEEEEeccCcC-ChhhhHHHHHHHHHHHhcCCcceeeeeeEEEcCCCeeEE
Q 038766 11 TGSFSENNIIGNSNLSTVYKGRLE-DGEIVAVKKLNFHQF-SAESDKSFYREAKTLKELKHRNLVKVLGYAWESGKLKAL 88 (299)
Q Consensus 11 ~~~y~~~~~lg~g~~~~v~~~~~~-~~~~~~vK~~~~~~~-~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~l 88 (299)
...|...+.||+|++|.||++.+. ++..+++|.+..... .......+.+|++.++.++|+|++++.+++.. +...++
T Consensus 14 ~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~-~~~~~l 92 (308)
T cd06634 14 EKLFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQYRGCYLR-EHTAWL 92 (308)
T ss_pred HHHHHHHHheeeCCCEEEEEEEEcCCCcEEEEEEEecccccChHHHHHHHHHHHHHHhCCCCCcccEEEEEEc-CCeeEE
Confidence 345778899999999999999874 588899998864322 33345667889999999999999999997665 456699
Q ss_pred EEeecCCCChHHHhcCCCCCCCCCChhhHHHHHHHHHHHHHHhhcCCCCCeeeecccCCceeeCCCCcEEEeeecccccc
Q 038766 89 ILEYMENGSLESVIHGPGVDHSRWTLPKRIDVLISVANGLDYLHSGYDIPIVHCDMKPSNILLDRDFEAHVSDFGTSRML 168 (299)
Q Consensus 89 v~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lh~~~~~~~~H~dl~~~nil~~~~~~v~l~df~~~~~~ 168 (299)
|+||+. +++.+.+.. ...++++..++.++.|++.++.|||+. +++|+||+|+||+++.++.++|+|||++...
T Consensus 93 v~e~~~-~~l~~~~~~---~~~~l~~~~~~~~~~~l~~~l~~LH~~---~i~H~dl~p~nil~~~~~~~kl~dfg~~~~~ 165 (308)
T cd06634 93 VMEYCL-GSASDLLEV---HKKPLQEVEIAAVTHGALQGLAYLHSH---NMIHRDVKAGNILLSEPGLVKLGDFGSASIM 165 (308)
T ss_pred EEEccC-CCHHHHHHH---cCCCCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCCHHhEEECCCCcEEECCcccceee
Confidence 999996 578776642 234689999999999999999999999 9999999999999999999999999988654
Q ss_pred ccccccccccccccccCcccCChhhhc---ccCcCccccchhhhHHHHHHHhCCCCCCCCccCCCCchhHHHHHHHHHhc
Q 038766 169 DVHLQDLSSLSTAFQGTIGYLAPEFAY---MRIVTTKVDVFSFGIVVMEFLTKRRPTGLDEENGLSPISLRQLVEKALAN 245 (299)
Q Consensus 169 ~~~~~~~~~~~~~~~~~~~y~~PE~~~---~~~~~~~~DiwslG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~ 245 (299)
.. .....++..|+|||.+. ...++.++|||||||++|+|++|..||... ... .........
T Consensus 166 ~~--------~~~~~~~~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~-----~~~---~~~~~~~~~ 229 (308)
T cd06634 166 AP--------ANXFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNM-----NAM---SALYHIAQN 229 (308)
T ss_pred cC--------cccccCCccccCHHHHhhcccCCCCcccchHHHHHHHHHHHcCCCCCccc-----cHH---HHHHHHhhc
Confidence 31 12335678899999874 345788999999999999999999997432 111 111111110
Q ss_pred CccCcccccCccccchhhHhHHHHHHHHHHHHHHHHhcCCCCCCCCChhhhhcC
Q 038766 246 GINGVRQITDPKLVSSIYEEQEQHQVLEELFKLALVCTSSNPEDRPNMNELLIT 299 (299)
Q Consensus 246 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rpt~~~il~~ 299 (299)
.... ......+..+.++|++||..+|++|||++++++|
T Consensus 230 ~~~~----------------~~~~~~~~~~~~li~~cl~~~P~~Rp~~~~ll~~ 267 (308)
T cd06634 230 ESPA----------------LQSGHWSEYFRNFVDSCLQKIPQDRPTSEVLLKH 267 (308)
T ss_pred CCCC----------------cCcccccHHHHHHHHHHhhCCcccCCCHHHHhhC
Confidence 0000 0022445678999999999999999999999986
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 2 (TAO2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Human TAO2 is also known as prostate-derived Ste20-like kinase (PSK) and was identified in a screen for overexpressed RNAs in prostate cancer. TAO2 activates both p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activatin |
| >cd05583 STKc_MSK_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.5e-37 Score=259.13 Aligned_cols=254 Identities=24% Similarity=0.306 Sum_probs=192.0
Q ss_pred CCCCCceeecCCcceEEEEEe----CCCcEEEEEEeccCcC--ChhhhHHHHHHHHHHHhcC-CcceeeeeeEEEcCCCe
Q 038766 13 SFSENNIIGNSNLSTVYKGRL----EDGEIVAVKKLNFHQF--SAESDKSFYREAKTLKELK-HRNLVKVLGYAWESGKL 85 (299)
Q Consensus 13 ~y~~~~~lg~g~~~~v~~~~~----~~~~~~~vK~~~~~~~--~~~~~~~~~~e~~~l~~l~-h~~i~~~~~~~~~~~~~ 85 (299)
+|.+.+.||+|++|.||++.+ .++..+|+|++..... .......+.+|+.++++++ |++++++.+.+. .+..
T Consensus 1 ~~~~~~~ig~G~~~~vy~~~~~~~~~~~~~~avk~~~~~~~~~~~~~~~~~~~E~~~l~~~~~~~~i~~~~~~~~-~~~~ 79 (288)
T cd05583 1 NFELLRVLGTGAYGKVFLVRKVGGHDAGKLYAMKVLKKATIVQKAKTAEHTRTERQVLEAVRRCPFLVTLHYAFQ-TDTK 79 (288)
T ss_pred CceEEEEeccCCCceEEEEEEeccccCCcEEEEEEEehHHHHhhhhHHHHHHHHHHHHHhccCCcchhhhheeee-cCCE
Confidence 478899999999999999975 2478899999864321 1223456788999999995 999999998654 4566
Q ss_pred eEEEEeecCCCChHHHhcCCCCCCCCCChhhHHHHHHHHHHHHHHhhcCCCCCeeeecccCCceeeCCCCcEEEeeeccc
Q 038766 86 KALILEYMENGSLESVIHGPGVDHSRWTLPKRIDVLISVANGLDYLHSGYDIPIVHCDMKPSNILLDRDFEAHVSDFGTS 165 (299)
Q Consensus 86 ~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lh~~~~~~~~H~dl~~~nil~~~~~~v~l~df~~~ 165 (299)
.++|+||+.+++|.+.+. ....+++..++.++.|++.+|.+||+. +++|+||+|+||+++.++.++|+|||++
T Consensus 80 ~~lv~e~~~~~~L~~~~~----~~~~~~~~~~~~~~~ql~~~l~~lH~~---~~~H~dl~p~nil~~~~~~~~l~dfg~~ 152 (288)
T cd05583 80 LHLILDYVNGGELFTHLY----QREHFTESEVRVYIAEIVLALDHLHQL---GIIYRDIKLENILLDSEGHVVLTDFGLS 152 (288)
T ss_pred EEEEEecCCCCcHHHHHh----hcCCcCHHHHHHHHHHHHHHHHHHHHC---CeeccCCCHHHeEECCCCCEEEEECccc
Confidence 799999999999998886 345789999999999999999999998 9999999999999999999999999988
Q ss_pred cccccccccccccccccccCcccCChhhhcccC--cCccccchhhhHHHHHHHhCCCCCCCCccCCCCchhHHHHHHHHH
Q 038766 166 RMLDVHLQDLSSLSTAFQGTIGYLAPEFAYMRI--VTTKVDVFSFGIVVMEFLTKRRPTGLDEENGLSPISLRQLVEKAL 243 (299)
Q Consensus 166 ~~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~--~~~~~DiwslG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~ 243 (299)
...... .........++..|++||...+.. .+.++|+||||+++|+|++|..||....... ...+......
T Consensus 153 ~~~~~~---~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Dv~slG~il~el~tg~~p~~~~~~~~----~~~~~~~~~~ 225 (288)
T cd05583 153 KEFLAE---EEERAYSFCGTIEYMAPEVIRGGSGGHDKAVDWWSLGVLTFELLTGASPFTVDGEQN----SQSEISRRIL 225 (288)
T ss_pred cccccc---cccccccccCCccccCHHHhcCCCCCCcchhhhHHHHHHHHHHHhCCCCcccCcccc----hHHHHHHHHH
Confidence 754321 111122344678999999887654 7889999999999999999999985332110 1111111111
Q ss_pred hcCccCcccccCccccchhhHhHHHHHHHHHHHHHHHHhcCCCCCCCCChh---hhhcC
Q 038766 244 ANGINGVRQITDPKLVSSIYEEQEQHQVLEELFKLALVCTSSNPEDRPNMN---ELLIT 299 (299)
Q Consensus 244 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rpt~~---~il~~ 299 (299)
... .. .+..++..+.+++.+||..||++|||+. ++|+|
T Consensus 226 ~~~-~~-----------------~~~~~~~~l~~li~~~l~~~p~~R~t~~~~~~~l~~ 266 (288)
T cd05583 226 KSK-PP-----------------FPKTMSAEARDFIQKLLEKDPKKRLGANGADEIKNH 266 (288)
T ss_pred ccC-CC-----------------CCcccCHHHHHHHHHHhcCCHhhccCcchHHHHhcC
Confidence 110 00 0223456789999999999999999964 44554
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, in response to various stimuli such as growth factors, hormones, neurotransmitters, cellular stress, and pro-inflammatory cytokines |
| >cd06633 STKc_TAO3 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-36 Score=259.06 Aligned_cols=247 Identities=26% Similarity=0.379 Sum_probs=190.8
Q ss_pred CCCCCceeecCCcceEEEEEeC-CCcEEEEEEeccCcC-ChhhhHHHHHHHHHHHhcCCcceeeeeeEEEcCCCeeEEEE
Q 038766 13 SFSENNIIGNSNLSTVYKGRLE-DGEIVAVKKLNFHQF-SAESDKSFYREAKTLKELKHRNLVKVLGYAWESGKLKALIL 90 (299)
Q Consensus 13 ~y~~~~~lg~g~~~~v~~~~~~-~~~~~~vK~~~~~~~-~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~lv~ 90 (299)
.|...+.||+|++|+||++++. ++..+++|++..... .......+..|+..++.++|+|++++.+++.. +...++|+
T Consensus 22 ~~~~~~~lg~g~~g~v~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~-~~~~~lv~ 100 (313)
T cd06633 22 IFVGLHEIGHGSFGAVYFATNSHTNEVVAVKKMSYSGKQTNEKWQDIIKEVKFLQQLKHPNTIEYKGCYLK-EHTAWLVM 100 (313)
T ss_pred HhhcceeeccCCCeEEEEEEECCCCcEEEEEEEeccccCchHHHHHHHHHHHHHHhCCCCCCccEEEEEEe-CCEEEEEE
Confidence 3667788999999999999864 588999999865433 23344678889999999999999999997665 55669999
Q ss_pred eecCCCChHHHhcCCCCCCCCCChhhHHHHHHHHHHHHHHhhcCCCCCeeeecccCCceeeCCCCcEEEeeecccccccc
Q 038766 91 EYMENGSLESVIHGPGVDHSRWTLPKRIDVLISVANGLDYLHSGYDIPIVHCDMKPSNILLDRDFEAHVSDFGTSRMLDV 170 (299)
Q Consensus 91 e~~~~~~L~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lh~~~~~~~~H~dl~~~nil~~~~~~v~l~df~~~~~~~~ 170 (299)
||+. +++.+++.. ...++++..++.++.|++.++.|||+. +++|+||+|+||+++.++.++|+|||++....
T Consensus 101 e~~~-~~l~~~l~~---~~~~l~~~~~~~~~~qi~~al~~LH~~---gi~H~dl~p~nili~~~~~~kL~dfg~~~~~~- 172 (313)
T cd06633 101 EYCL-GSASDLLEV---HKKPLQEVEIAAITHGALQGLAYLHSH---NMIHRDIKAGNILLTEPGQVKLADFGSASKSS- 172 (313)
T ss_pred ecCC-CCHHHHHHh---cCCCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCChhhEEECCCCCEEEeecCCCcccC-
Confidence 9995 577777653 235689999999999999999999999 99999999999999999999999999875322
Q ss_pred ccccccccccccccCcccCChhhhc---ccCcCccccchhhhHHHHHHHhCCCCCCCCccCCCCchhHHHHHHHHHhcCc
Q 038766 171 HLQDLSSLSTAFQGTIGYLAPEFAY---MRIVTTKVDVFSFGIVVMEFLTKRRPTGLDEENGLSPISLRQLVEKALANGI 247 (299)
Q Consensus 171 ~~~~~~~~~~~~~~~~~y~~PE~~~---~~~~~~~~DiwslG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 247 (299)
......++..|+|||.+. ...++.++|+||||+++|+|++|..||..... . ...........
T Consensus 173 -------~~~~~~~~~~y~aPE~~~~~~~~~~~~~sDv~slGvil~el~~g~~p~~~~~~-----~---~~~~~~~~~~~ 237 (313)
T cd06633 173 -------PANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNA-----M---SALYHIAQNDS 237 (313)
T ss_pred -------CCCCccccccccChhhccccCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCh-----H---HHHHHHHhcCC
Confidence 122345778899999874 35578899999999999999999999843211 1 11111111110
Q ss_pred cCcccccCccccchhhHhHHHHHHHHHHHHHHHHhcCCCCCCCCChhhhhcC
Q 038766 248 NGVRQITDPKLVSSIYEEQEQHQVLEELFKLALVCTSSNPEDRPNMNELLIT 299 (299)
Q Consensus 248 ~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rpt~~~il~~ 299 (299)
... ....++..+.+++.+||+.+|.+|||+.+++.|
T Consensus 238 ~~~----------------~~~~~~~~l~~li~~~l~~~P~~Rp~~~~~l~~ 273 (313)
T cd06633 238 PTL----------------QSNEWTDSFRGFVDYCLQKIPQERPASAELLRH 273 (313)
T ss_pred CCC----------------CccccCHHHHHHHHHHccCChhhCcCHHHHhcC
Confidence 000 012234568899999999999999999999976
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 3 (TAO3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO3 is also known as JIK (JNK inhibitory kinase) or KFC (kinase from chicken). It specifically activates c-Jun N-terminal kinase (JNK), presumably by phosphorylating and activating MKK4/MKK7. In Saccharomyces cerevisiae, TAO3 is a co |
| >cd05123 STKc_AGC Catalytic domain of AGC family Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-37 Score=255.25 Aligned_cols=242 Identities=26% Similarity=0.338 Sum_probs=193.4
Q ss_pred eecCCcceEEEEEeC-CCcEEEEEEeccCcCC-hhhhHHHHHHHHHHHhcCCcceeeeeeEEEcCCCeeEEEEeecCCCC
Q 038766 20 IGNSNLSTVYKGRLE-DGEIVAVKKLNFHQFS-AESDKSFYREAKTLKELKHRNLVKVLGYAWESGKLKALILEYMENGS 97 (299)
Q Consensus 20 lg~g~~~~v~~~~~~-~~~~~~vK~~~~~~~~-~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~lv~e~~~~~~ 97 (299)
||+|++|.||++.+. +++.+++|++...... ......+..|+..++.++|+|++++++.+. .+...++|+|++.+++
T Consensus 1 lg~G~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~-~~~~~~~v~e~~~~~~ 79 (250)
T cd05123 1 LGKGSFGKVLLVRKKDTGKLYAMKVLKKKKIIKRKEVEHTLTERNILSRINHPFIVKLHYAFQ-TEEKLYLVLEYAPGGE 79 (250)
T ss_pred CCCCCceEEEEEEECCCCcEEEEEEeehhhhcchHHHHHHHHHHHHHHHcCCCcHHHHHHHee-cCCeeEEEEecCCCCc
Confidence 689999999999875 5899999998654332 234667889999999999999999998654 4667799999999999
Q ss_pred hHHHhcCCCCCCCCCChhhHHHHHHHHHHHHHHhhcCCCCCeeeecccCCceeeCCCCcEEEeeeccccccccccccccc
Q 038766 98 LESVIHGPGVDHSRWTLPKRIDVLISVANGLDYLHSGYDIPIVHCDMKPSNILLDRDFEAHVSDFGTSRMLDVHLQDLSS 177 (299)
Q Consensus 98 L~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lh~~~~~~~~H~dl~~~nil~~~~~~v~l~df~~~~~~~~~~~~~~~ 177 (299)
|.+++. ....+++..++.++.|+++|+.+||+. +++|+||+|+||+++.++.++|+|||.+....... .
T Consensus 80 L~~~l~----~~~~l~~~~~~~~~~qi~~~l~~lh~~---~~~H~~l~p~ni~~~~~~~~~l~d~~~~~~~~~~~----~ 148 (250)
T cd05123 80 LFSHLS----KEGRFSEERARFYAAEIVLALEYLHSL---GIIYRDLKPENILLDADGHIKLTDFGLAKELSSEG----S 148 (250)
T ss_pred HHHHHH----hcCCCCHHHHHHHHHHHHHHHHHHHHC---CceecCCCcceEEEcCCCcEEEeecCcceecccCC----C
Confidence 999997 344789999999999999999999998 99999999999999999999999999987644211 1
Q ss_pred cccccccCcccCChhhhcccCcCccccchhhhHHHHHHHhCCCCCCCCccCCCCchhHHHHHHHHHhcCccCcccccCcc
Q 038766 178 LSTAFQGTIGYLAPEFAYMRIVTTKVDVFSFGIVVMEFLTKRRPTGLDEENGLSPISLRQLVEKALANGINGVRQITDPK 257 (299)
Q Consensus 178 ~~~~~~~~~~y~~PE~~~~~~~~~~~DiwslG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 257 (299)
......++..|+|||...+...+.++|+||||+++|++++|..||..... . .......... ..
T Consensus 149 ~~~~~~~~~~~~~Pe~~~~~~~~~~~D~~slG~~~~~l~~g~~p~~~~~~-----~---~~~~~~~~~~------~~--- 211 (250)
T cd05123 149 RTNTFCGTPEYLAPEVLLGKGYGKAVDWWSLGVLLYEMLTGKPPFYAEDR-----K---EIYEKILKDP------LR--- 211 (250)
T ss_pred cccCCcCCccccChHHhCCCCCCchhhHHHHHHHHHHHHHCCCCCCCCCH-----H---HHHHHHhcCC------CC---
Confidence 23344567889999999888889999999999999999999999854321 1 1111111100 00
Q ss_pred ccchhhHhHHHHHHHHHHHHHHHHhcCCCCCCCCCh---hhhhcC
Q 038766 258 LVSSIYEEQEQHQVLEELFKLALVCTSSNPEDRPNM---NELLIT 299 (299)
Q Consensus 258 ~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rpt~---~~il~~ 299 (299)
.+...+..+.+++++||..||++|||+ +++++|
T Consensus 212 ---------~~~~~~~~l~~~i~~~l~~~p~~R~~~~~~~~l~~~ 247 (250)
T cd05123 212 ---------FPEFLSPEARDLISGLLQKDPTKRLGSGGAEEIKAH 247 (250)
T ss_pred ---------CCCCCCHHHHHHHHHHhcCCHhhCCCcccHHHHHhC
Confidence 022225678999999999999999999 888876
|
Serine/Threonine Kinases (STKs), AGC (Protein Kinases A, G and C) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The AGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and Phosphoinositide 3-Kinase (PI3K). Members of this family include cAMP-dependent Protein Kinase (PKA), cGMP-dependent Protein Kinase (PKG), Protein Kinase C (PKC), Protein Kinase B (PKB), G protein-coupled Receptor Kinase (GRK), Serum- and Glucocorticoid-induced Kinase (SGK), and 70 kDa ribosomal Protein S6 Kinase (p70S6K or S6K), among others. AGC kinases share an activation mechanism based on the phosphorylation of up to three sites: the activation loop (A-loop), the hydrophobic motif (HM) and the |
| >KOG0607 consensus MAP kinase-interacting kinase and related serine/threonine protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.4e-38 Score=250.54 Aligned_cols=263 Identities=20% Similarity=0.321 Sum_probs=203.1
Q ss_pred CceeecCCcceEEEEE-eCCCcEEEEEEeccCcCChhhhHHHHHHHHHHHhcC-CcceeeeeeEEEcCCCeeEEEEeecC
Q 038766 17 NNIIGNSNLSTVYKGR-LEDGEIVAVKKLNFHQFSAESDKSFYREAKTLKELK-HRNLVKVLGYAWESGKLKALILEYME 94 (299)
Q Consensus 17 ~~~lg~g~~~~v~~~~-~~~~~~~~vK~~~~~~~~~~~~~~~~~e~~~l~~l~-h~~i~~~~~~~~~~~~~~~lv~e~~~ 94 (299)
.+.||+|+++.|..+. ..+|..||||++.. .....+.++.+|++++...+ |+||++++++|.+..++ |+|||-++
T Consensus 83 ~e~LGeGAyasVqtcv~i~t~~EYAVKiidK--q~gHsR~RvfREVe~f~~Cqgh~nilqLiefFEdd~~F-YLVfEKm~ 159 (463)
T KOG0607|consen 83 SELLGEGAYASVQTCVSIQTGKEYAVKIIDK--QPGHSRSRVFREVETFYQCQGHKNILQLIEFFEDDTRF-YLVFEKMR 159 (463)
T ss_pred HHHhcCccceeeeeeeeeccchhhhhhhhhc--CCchHHHHHHHHHHHHHHhcCCccHHHHHHHhcccceE-EEEEeccc
Confidence 3579999999999986 47899999999963 35667899999999999997 99999999966665555 99999999
Q ss_pred CCChHHHhcCCCCCCCCCChhhHHHHHHHHHHHHHHhhcCCCCCeeeecccCCceeeCCCCc---EEEeeeccccccccc
Q 038766 95 NGSLESVIHGPGVDHSRWTLPKRIDVLISVANGLDYLHSGYDIPIVHCDMKPSNILLDRDFE---AHVSDFGTSRMLDVH 171 (299)
Q Consensus 95 ~~~L~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lh~~~~~~~~H~dl~~~nil~~~~~~---v~l~df~~~~~~~~~ 171 (299)
||+|.+.|+ ...-+++.++..++..|++||.+||.+ +|.|||+||+|||..+.+. |||+||.+.......
T Consensus 160 GGplLshI~----~~~~F~E~EAs~vvkdia~aLdFlH~k---gIAHRDlKPENiLC~~pn~vsPvKiCDfDLgSg~k~~ 232 (463)
T KOG0607|consen 160 GGPLLSHIQ----KRKHFNEREASRVVKDIASALDFLHTK---GIAHRDLKPENILCESPNKVSPVKICDFDLGSGIKLN 232 (463)
T ss_pred CchHHHHHH----HhhhccHHHHHHHHHHHHHHHHHHhhc---CcccccCCccceeecCCCCcCceeeeccccccccccC
Confidence 999999998 556899999999999999999999999 9999999999999976544 799999988654322
Q ss_pred c--ccccc-cccccccCcccCChhhhc---c--cCcCccccchhhhHHHHHHHhCCCCCCCCccC--CCCchhHHHHHHH
Q 038766 172 L--QDLSS-LSTAFQGTIGYLAPEFAY---M--RIVTTKVDVFSFGIVVMEFLTKRRPTGLDEEN--GLSPISLRQLVEK 241 (299)
Q Consensus 172 ~--~~~~~-~~~~~~~~~~y~~PE~~~---~--~~~~~~~DiwslG~~l~~l~~g~~p~~~~~~~--~~~~~~~~~~~~~ 241 (299)
. ....+ .-....|+-.|||||+.. + ..|+.+.|.||||+++|-|++|.+||.+.... ++...+......+
T Consensus 233 ~~~spastP~L~tPvGSAEfMAPEVVd~fv~qA~~YDKrCDlwSLGvIlYImLsGYpPFvG~Cg~dCGWdrGe~Cr~CQ~ 312 (463)
T KOG0607|consen 233 NDCSPASTPELLTPVGSAEFMAPEVVDVFVDQATFYDKRCDLWSLGVILYIMLSGYPPFVGHCGADCGWDRGEVCRVCQN 312 (463)
T ss_pred CCCCCCCCccccCcccchhhcchhHHhhhccccccccccccHHHHHHHHHHHHhCCCCccCccCCcCCccCCCccHHHHH
Confidence 1 11111 123556788999999643 2 35889999999999999999999999765332 3334443333333
Q ss_pred HHhcCccC-cccccCccccchhhHhHHHHHHHHHHHHHHHHhcCCCCCCCCChhhhhcC
Q 038766 242 ALANGING-VRQITDPKLVSSIYEEQEQHQVLEELFKLALVCTSSNPEDRPNMNELLIT 299 (299)
Q Consensus 242 ~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rpt~~~il~~ 299 (299)
.+...+.+ ...+++.. =..++.+.-++|+.+|..||.+|.++.+++.|
T Consensus 313 ~LFesIQEGkYeFPdkd----------WahIS~eakdlisnLlvrda~~rlsa~~vlnh 361 (463)
T KOG0607|consen 313 KLFESIQEGKYEFPDKD----------WAHISSEAKDLISNLLVRDAKQRLSAAQVLNH 361 (463)
T ss_pred HHHHHHhccCCcCChhh----------hHHhhHHHHHHHHHHHhccHHhhhhhhhccCC
Confidence 22211111 12222221 34677889999999999999999999999876
|
|
| >cd05078 PTK_Jak2_Jak3_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.2e-38 Score=261.34 Aligned_cols=237 Identities=21% Similarity=0.330 Sum_probs=179.3
Q ss_pred ceeecCCcceEEEEEeCC--------CcEEEEEEeccCcCChhhhHHHHHHHHHHHhcCCcceeeeeeEEEcCCCeeEEE
Q 038766 18 NIIGNSNLSTVYKGRLED--------GEIVAVKKLNFHQFSAESDKSFYREAKTLKELKHRNLVKVLGYAWESGKLKALI 89 (299)
Q Consensus 18 ~~lg~g~~~~v~~~~~~~--------~~~~~vK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~lv 89 (299)
+.||+|+||+||++.+.. ...+++|.+.. ......+.+..|...++.+.|||++++++++.... ..++|
T Consensus 1 ~~lg~G~~~~Vy~~~~~~~~~~~~~~~~~~~~k~~~~--~~~~~~~~~~~e~~~l~~~~h~~iv~~~~~~~~~~-~~~lv 77 (258)
T cd05078 1 ESLGQGTFTKIFKGIRREVGDYGELHKTEVLLKVLDK--SHRNYSESFFEAASMMSQLSHKHLVLNYGVCVCGD-ESIMV 77 (258)
T ss_pred CCCCcccchhheeeeecccccccccccchhhHHhhcc--hhHHHHHHHHHHHHHHHhCCCCChhheeeEEEeCC-CcEEE
Confidence 479999999999997532 23477787642 22334567788999999999999999999777644 45899
Q ss_pred EeecCCCChHHHhcCCCCCCCCCChhhHHHHHHHHHHHHHHhhcCCCCCeeeecccCCceeeCCCCc--------EEEee
Q 038766 90 LEYMENGSLESVIHGPGVDHSRWTLPKRIDVLISVANGLDYLHSGYDIPIVHCDMKPSNILLDRDFE--------AHVSD 161 (299)
Q Consensus 90 ~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lh~~~~~~~~H~dl~~~nil~~~~~~--------v~l~d 161 (299)
+||+.+++|..++... ...+++..++.++.||+.||+|||+. +++|+||||+||+++.++. ++++|
T Consensus 78 ~e~~~~g~L~~~l~~~---~~~~~~~~~~~~~~qi~~~l~~lH~~---~iiH~dlkp~nili~~~~~~~~~~~~~~~l~d 151 (258)
T cd05078 78 QEYVKFGSLDTYLKKN---KNLINISWKLEVAKQLAWALHFLEDK---GLTHGNVCAKNVLLIREEDRKTGNPPFIKLSD 151 (258)
T ss_pred EecCCCCcHHHHHhcC---CCCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCccceEEEecccccccCCCceEEecc
Confidence 9999999999998643 23678899999999999999999999 9999999999999987765 68999
Q ss_pred eccccccccccccccccccccccCcccCChhhhcc-cCcCccccchhhhHHHHHHHhCC-CCCCCCccCCCCchhHHHHH
Q 038766 162 FGTSRMLDVHLQDLSSLSTAFQGTIGYLAPEFAYM-RIVTTKVDVFSFGIVVMEFLTKR-RPTGLDEENGLSPISLRQLV 239 (299)
Q Consensus 162 f~~~~~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~-~~~~~~~DiwslG~~l~~l~~g~-~p~~~~~~~~~~~~~~~~~~ 239 (299)
||.+.... ......++..|+|||.+.+ ..++.++|+||||+++|+|++|. .|+... .........
T Consensus 152 ~g~~~~~~--------~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~~l~~g~~~~~~~~-----~~~~~~~~~ 218 (258)
T cd05078 152 PGISITVL--------PKEILLERIPWVPPECIENPQNLSLAADKWSFGTTLWEIFSGGDKPLSAL-----DSQKKLQFY 218 (258)
T ss_pred cccccccC--------CchhccccCCccCchhccCCCCCCchhhHHHHHHHHHHHHcCCCCChhhc-----cHHHHHHHH
Confidence 99875432 1123446778999998886 45789999999999999999985 444321 111111111
Q ss_pred HHHHhcCccCcccccCccccchhhHhHHHHHHHHHHHHHHHHhcCCCCCCCCChhhhhc
Q 038766 240 EKALANGINGVRQITDPKLVSSIYEEQEQHQVLEELFKLALVCTSSNPEDRPNMNELLI 298 (299)
Q Consensus 240 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rpt~~~il~ 298 (299)
. . ...+ +...+.++.+++.+||+.||++|||++++++
T Consensus 219 ----~-~---~~~~--------------~~~~~~~~~~li~~~l~~~p~~Rps~~~il~ 255 (258)
T cd05078 219 ----E-D---RHQL--------------PAPKWTELANLINQCMDYEPDFRPSFRAIIR 255 (258)
T ss_pred ----H-c---cccC--------------CCCCcHHHHHHHHHHhccChhhCCCHHHHHH
Confidence 0 0 0000 1122356889999999999999999999986
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity |
| >cd07830 STKc_MAK_like Catalytic domain of Male germ cell-Associated Kinase-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.9e-37 Score=256.64 Aligned_cols=265 Identities=23% Similarity=0.317 Sum_probs=192.8
Q ss_pred CCCCceeecCCcceEEEEEeC-CCcEEEEEEeccCcCChhhhHHHHHHHHHHHhcC-CcceeeeeeEEEcCCCeeEEEEe
Q 038766 14 FSENNIIGNSNLSTVYKGRLE-DGEIVAVKKLNFHQFSAESDKSFYREAKTLKELK-HRNLVKVLGYAWESGKLKALILE 91 (299)
Q Consensus 14 y~~~~~lg~g~~~~v~~~~~~-~~~~~~vK~~~~~~~~~~~~~~~~~e~~~l~~l~-h~~i~~~~~~~~~~~~~~~lv~e 91 (299)
|.+.+.||+|++|+||+|... +++.+++|.+...... .......+|+..+++++ |+|++++++++.. +...++|+|
T Consensus 1 y~~~~~ig~g~~g~v~~~~~~~~~~~~~ik~~~~~~~~-~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~-~~~~~lv~e 78 (283)
T cd07830 1 YKVIKQLGDGTFGSVYLARNKETGELVAIKKMKKKFYS-WEECMNLREVKSLRKLNEHPNIVKLKEVFRE-NDELYFVFE 78 (283)
T ss_pred CeeheeeccCCceEEEEEEECCCCcEEEEEEehhhccc-hhHHHHHHHHHHHHhccCCCCchhHHHHhhc-CCcEEEEEe
Confidence 678899999999999999875 4889999998643322 23334557899999999 9999999997766 556699999
Q ss_pred ecCCCChHHHhcCCCCCCCCCChhhHHHHHHHHHHHHHHhhcCCCCCeeeecccCCceeeCCCCcEEEeeeccccccccc
Q 038766 92 YMENGSLESVIHGPGVDHSRWTLPKRIDVLISVANGLDYLHSGYDIPIVHCDMKPSNILLDRDFEAHVSDFGTSRMLDVH 171 (299)
Q Consensus 92 ~~~~~~L~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lh~~~~~~~~H~dl~~~nil~~~~~~v~l~df~~~~~~~~~ 171 (299)
|+ +++|.+.+... ....+++..++.++.|++.+|.|||++ +++|+||+|+||+++.++.++|+|||.+......
T Consensus 79 ~~-~~~l~~~~~~~--~~~~~~~~~~~~~~~~l~~~l~~Lh~~---~i~H~dl~~~ni~i~~~~~~~l~d~~~~~~~~~~ 152 (283)
T cd07830 79 YM-EGNLYQLMKDR--KGKPFSESVIRSIIYQILQGLAHIHKH---GFFHRDLKPENLLVSGPEVVKIADFGLAREIRSR 152 (283)
T ss_pred cC-CCCHHHHHHhc--ccccCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCChhhEEEcCCCCEEEeecccceeccCC
Confidence 99 77998887632 234789999999999999999999999 9999999999999999999999999998754321
Q ss_pred cccccccccccccCcccCChhhhc-ccCcCccccchhhhHHHHHHHhCCCCCCCCccCCCCchhHHHHHH----------
Q 038766 172 LQDLSSLSTAFQGTIGYLAPEFAY-MRIVTTKVDVFSFGIVVMEFLTKRRPTGLDEENGLSPISLRQLVE---------- 240 (299)
Q Consensus 172 ~~~~~~~~~~~~~~~~y~~PE~~~-~~~~~~~~DiwslG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~---------- 240 (299)
.......++..|+|||.+. ...++.++|+||+|+++++|++|..||....... .......
T Consensus 153 -----~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~s~G~~l~el~~g~~~~~~~~~~~----~~~~~~~~~~~~~~~~~ 223 (283)
T cd07830 153 -----PPYTDYVSTRWYRAPEILLRSTSYSSPVDIWALGCIMAELYTLRPLFPGSSEID----QLYKICSVLGTPTKQDW 223 (283)
T ss_pred -----CCcCCCCCcccccCceeeecCcCcCCccchhhHHHHHHHHHhCCCccCCCChHH----HHHHHHHhcCCCChhhh
Confidence 1122344677899999775 4457899999999999999999999985442110 0000000
Q ss_pred --HHHhcCccCcccccCccccchhhHhHHHHHHHHHHHHHHHHhcCCCCCCCCChhhhhcC
Q 038766 241 --KALANGINGVRQITDPKLVSSIYEEQEQHQVLEELFKLALVCTSSNPEDRPNMNELLIT 299 (299)
Q Consensus 241 --~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rpt~~~il~~ 299 (299)
...... ......... ..... .......+..+.++|++||..+|++|||++|++.|
T Consensus 224 ~~~~~~~~--~~~~~~~~~-~~~~~-~~~~~~~~~~~~~li~~cl~~~p~~Rpt~~ei~~~ 280 (283)
T cd07830 224 PEGYKLAS--KLGFRFPQF-APTSL-HQLIPNASPEAIDLIKDMLRWDPKKRPTASQALQH 280 (283)
T ss_pred hhHhhhhc--ccccccccc-ccccH-HHHcccCCHHHHHHHHHhcccCcccCCCHHHHhhC
Confidence 000000 000000000 00000 00011225679999999999999999999999986
|
Serine/Threonine Kinases (STKs), Male germ cell-Associated Kinase (MAK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of human MAK and MAK-related kinase (MRK), Saccharomyces cerevisiae Ime2p, Schizosaccharomyces pombe Mei4-dependent protein 3 (Mde3) and Pit1, Caenorhabditis elegans dyf-5, Arabidopsis thaliana MHK, and similar proteins. These proteins play important roles during meiosis. MAK is highly expressed in testicular cells specifically in the meiotic phase, but is not essential for spermatogenesis and fertili |
| >KOG4250 consensus TANK binding protein kinase TBK1 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.6e-38 Score=273.61 Aligned_cols=265 Identities=30% Similarity=0.415 Sum_probs=199.9
Q ss_pred CCCCCceeecCCcceEEEEEe-CCCcEEEEEEeccCcCChhhhHHHHHHHHHHHhcCCcceeeeeeEEEcC-----CCee
Q 038766 13 SFSENNIIGNSNLSTVYKGRL-EDGEIVAVKKLNFHQFSAESDKSFYREAKTLKELKHRNLVKVLGYAWES-----GKLK 86 (299)
Q Consensus 13 ~y~~~~~lg~g~~~~v~~~~~-~~~~~~~vK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~-----~~~~ 86 (299)
-|...+.||+|+||.||++++ .+|+.||||+++... .....+++-+|++++++++|+||+++.++=... ....
T Consensus 14 ~W~~~e~LG~Ga~g~V~rgrnketG~~vAvK~~~~~~-~~r~~e~~~~EieilkKLnh~NIVk~f~iee~~~~~~~~~~~ 92 (732)
T KOG4250|consen 14 LWEMDERLGKGAFGNVYRGRNKETGRLVAVKTFNKES-SLRPRERWCREIEILKKLNHPNIVKLFDIEETKFLGLVTRLP 92 (732)
T ss_pred ceeehhhhcCCccceeeeecccccccchhHHhhhhhc-ccchHHHHHHHHHHHHHcCchhhhhhcccCCccccCcccccc
Confidence 355678999999999999995 579999999997533 455678889999999999999999998843221 2345
Q ss_pred EEEEeecCCCChHHHhcCCCCCCCCCChhhHHHHHHHHHHHHHHhhcCCCCCeeeecccCCceeeCC--CC--cEEEeee
Q 038766 87 ALILEYMENGSLESVIHGPGVDHSRWTLPKRIDVLISVANGLDYLHSGYDIPIVHCDMKPSNILLDR--DF--EAHVSDF 162 (299)
Q Consensus 87 ~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lh~~~~~~~~H~dl~~~nil~~~--~~--~v~l~df 162 (299)
.+|||||.+|+|...++.+. +...+++.+.+.++..++.||.|||++ +|+||||||.||++-. +| ..||+||
T Consensus 93 vlvmEyC~gGsL~~~L~~PE-N~~GLpE~e~l~lL~d~~~al~~LrEn---~IvHRDlKP~NIvl~~Gedgq~IyKLtDf 168 (732)
T KOG4250|consen 93 VLVMEYCSGGSLRKVLNSPE-NAYGLPESEFLDLLSDLVSALRHLREN---GIVHRDLKPGNIVLQIGEDGQSIYKLTDF 168 (732)
T ss_pred eEEEeecCCCcHHHHhcCcc-cccCCCHHHHHHHHHHHHHHHHHHHHc---CceeccCCCCcEEEeecCCCceEEeeecc
Confidence 79999999999999999886 778899999999999999999999999 9999999999999943 23 4699999
Q ss_pred ccccccccccccccccccccccCcccCChhhhc-ccCcCccccchhhhHHHHHHHhCCCCCCCCccCCCCchhHHHHHHH
Q 038766 163 GTSRMLDVHLQDLSSLSTAFQGTIGYLAPEFAY-MRIVTTKVDVFSFGIVVMEFLTKRRPTGLDEENGLSPISLRQLVEK 241 (299)
Q Consensus 163 ~~~~~~~~~~~~~~~~~~~~~~~~~y~~PE~~~-~~~~~~~~DiwslG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~ 241 (299)
|.++.++ .+.......||+.|++||++. ...|+...|.||+||++|+..||..||..... +....+.+..
T Consensus 169 G~Arel~-----d~s~~~S~vGT~~YLhPel~E~q~~y~~tVDLWS~GvtlY~caTG~lPF~p~~~----pk~~~~~~~~ 239 (732)
T KOG4250|consen 169 GAARELD-----DNSLFTSLVGTEEYLHPELYERQKKYTATVDLWSFGVTLYECATGELPFIPFGG----PKNNKEIMWH 239 (732)
T ss_pred cccccCC-----CCCeeeeecCchhhcChHHHhhccCcCceeehhhhhhHHHHHhccCCCCCcCCC----ccccchhhhh
Confidence 9999876 244677888999999999999 58899999999999999999999999964322 2222333333
Q ss_pred HHhcCccCcccccCcccc-----chh--hHhHHHHHHHHHHHHHHHHhcCCCCCCCC
Q 038766 242 ALANGINGVRQITDPKLV-----SSI--YEEQEQHQVLEELFKLALVCTSSNPEDRP 291 (299)
Q Consensus 242 ~~~~~~~~~~~~~~~~~~-----~~~--~~~~~~~~~~~~l~~li~~~l~~dP~~Rp 291 (299)
.........-....+... +.. ......+.....+-..+-.||..+|.+|.
T Consensus 240 ~~tkkp~~v~i~~~~~eNgpv~~s~~lP~p~~Ls~~l~~~~~kwLa~~L~~~~~~~~ 296 (732)
T KOG4250|consen 240 IITKKPSGVAIGAQEEENGPVEWSSTLPQPNHLSRGLATRLTKWLASMLEWNPRKRG 296 (732)
T ss_pred hhccCCCceeEeeecccCCceeeeccCCCcccccHHHHhhhhHHHHHHHhhhHHHhC
Confidence 333222222111111110 000 01122344444556667778888888887
|
|
| >KOG0986 consensus G protein-coupled receptor kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.7e-38 Score=260.69 Aligned_cols=255 Identities=24% Similarity=0.343 Sum_probs=205.8
Q ss_pred HHHHhCCCCCCceeecCCcceEEEEEe-CCCcEEEEEEeccCcCChhh-hHHHHHHHHHHHhcCCcceeeeeeEEEcCCC
Q 038766 7 IENATGSFSENNIIGNSNLSTVYKGRL-EDGEIVAVKKLNFHQFSAES-DKSFYREAKTLKELKHRNLVKVLGYAWESGK 84 (299)
Q Consensus 7 ~~~~~~~y~~~~~lg~g~~~~v~~~~~-~~~~~~~vK~~~~~~~~~~~-~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~ 84 (299)
+..-.+.|+.-++||+|+||.|+-++. .+|+.||.|.+..+.+.... .....+|.++|.+++.+.|+.+ .+.++...
T Consensus 180 qpvt~n~F~~~RvlGkGGFGEV~acqvraTGKMYAcKkL~KKRiKkr~ge~maLnEk~iL~kV~s~FiVsl-aYAfeTkd 258 (591)
T KOG0986|consen 180 QPVTKNTFRVYRVLGKGGFGEVCACQVRATGKMYACKKLDKKRIKKRKGETMALNEKQILEKVSSPFIVSL-AYAFETKD 258 (591)
T ss_pred hhccccceeeeEEEecccccceeEEEEecchhhHHHHHHHHHHHHHhhhhHHhhHHHHHHHHhccCcEEEE-eeeecCCC
Confidence 344567789999999999999999975 46999999988655443333 4567789999999999987766 44667777
Q ss_pred eeEEEEeecCCCChHHHhcCCCCCCCCCChhhHHHHHHHHHHHHHHhhcCCCCCeeeecccCCceeeCCCCcEEEeeecc
Q 038766 85 LKALILEYMENGSLESVIHGPGVDHSRWTLPKRIDVLISVANGLDYLHSGYDIPIVHCDMKPSNILLDRDFEAHVSDFGT 164 (299)
Q Consensus 85 ~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lh~~~~~~~~H~dl~~~nil~~~~~~v~l~df~~ 164 (299)
.+|+|+..|+||+|.-.+...+ +..+++.++..++++|+.+|.+||+. +||+||+||+|||+|+.|+++|+|+|+
T Consensus 259 ~LClVLtlMNGGDLkfHiyn~g--~~gF~e~ra~FYAAEi~cGLehlH~~---~iVYRDLKPeNILLDd~GhvRISDLGL 333 (591)
T KOG0986|consen 259 ALCLVLTLMNGGDLKFHIYNHG--NPGFDEQRARFYAAEIICGLEHLHRR---RIVYRDLKPENILLDDHGHVRISDLGL 333 (591)
T ss_pred ceEEEEEeecCCceeEEeeccC--CCCCchHHHHHHHHHHHhhHHHHHhc---ceeeccCChhheeeccCCCeEeeccce
Confidence 8899999999999988887664 36899999999999999999999999 999999999999999999999999999
Q ss_pred ccccccccccccccccccccCcccCChhhhcccCcCccccchhhhHHHHHHHhCCCCCCCCccCCCCchhHHHHHHHHHh
Q 038766 165 SRMLDVHLQDLSSLSTAFQGTIGYLAPEFAYMRIVTTKVDVFSFGIVVMEFLTKRRPTGLDEENGLSPISLRQLVEKALA 244 (299)
Q Consensus 165 ~~~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~DiwslG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~ 244 (299)
+..+.. +..-...+||.+|||||++....|+.+.|-|||||++|+|+.|..||....+..... + +++...
T Consensus 334 Avei~~-----g~~~~~rvGT~GYMAPEvl~ne~Y~~s~Dwf~lGCllYemi~G~sPFr~~KeKvk~e-E----vdrr~~ 403 (591)
T KOG0986|consen 334 AVEIPE-----GKPIRGRVGTVGYMAPEVLQNEVYDFSPDWFSLGCLLYEMIAGHSPFRQRKEKVKRE-E----VDRRTL 403 (591)
T ss_pred EEecCC-----CCccccccCcccccCHHHHcCCcccCCccHHHHHhHHHHHHcccCchhhhhhhhhHH-H----HHHHHh
Confidence 987652 333455589999999999999999999999999999999999999997654332111 1 111111
Q ss_pred cCccCcccccCccccchhhHhHHHHHHHHHHHHHHHHhcCCCCCCCCChh
Q 038766 245 NGINGVRQITDPKLVSSIYEEQEQHQVLEELFKLALVCTSSNPEDRPNMN 294 (299)
Q Consensus 245 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rpt~~ 294 (299)
.. ....+..+++++.+|.+.+|..||++|.-..
T Consensus 404 ~~-----------------~~ey~~kFS~eakslc~~LL~Kdp~~RLGcr 436 (591)
T KOG0986|consen 404 ED-----------------PEEYSDKFSEEAKSLCEGLLTKDPEKRLGCR 436 (591)
T ss_pred cc-----------------hhhcccccCHHHHHHHHHHHccCHHHhccCC
Confidence 11 1112556788999999999999999998654
|
|
| >KOG0690 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-38 Score=254.21 Aligned_cols=245 Identities=23% Similarity=0.287 Sum_probs=201.3
Q ss_pred HhCCCCCCceeecCCcceEEEEEe-CCCcEEEEEEeccCcC-ChhhhHHHHHHHHHHHhcCCcceeeeeeEEEcCCCeeE
Q 038766 10 ATGSFSENNIIGNSNLSTVYKGRL-EDGEIVAVKKLNFHQF-SAESDKSFYREAKTLKELKHRNLVKVLGYAWESGKLKA 87 (299)
Q Consensus 10 ~~~~y~~~~~lg~g~~~~v~~~~~-~~~~~~~vK~~~~~~~-~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~ 87 (299)
-.++|...++||+|.||.|.+++. .+++.||+|+++...+ ..+..+.-..|-+.|+..+||.+..+.-.+.. ..-+|
T Consensus 166 Tm~dFdfLKvLGkGTFGKVIL~rEKat~k~YAiKIlkKeviiakdEVAHTlTE~RVL~~~~HPFLt~LKYsFQt-~drlC 244 (516)
T KOG0690|consen 166 TMEDFDFLKVLGKGTFGKVILCREKATGKLYAIKILKKEVIIAKDEVAHTLTENRVLQNCRHPFLTSLKYSFQT-QDRLC 244 (516)
T ss_pred ccchhhHHHHhcCCccceEEEEeecccCceeehhhhhhhheeehHHhhhhhhHHHHHHhccCcHHHHhhhhhcc-CceEE
Confidence 457889999999999999999986 5699999999876543 34445666789999999999998887664444 55669
Q ss_pred EEEeecCCCChHHHhcCCCCCCCCCChhhHHHHHHHHHHHHHHhhcCCCCCeeeecccCCceeeCCCCcEEEeeeccccc
Q 038766 88 LILEYMENGSLESVIHGPGVDHSRWTLPKRIDVLISVANGLDYLHSGYDIPIVHCDMKPSNILLDRDFEAHVSDFGTSRM 167 (299)
Q Consensus 88 lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lh~~~~~~~~H~dl~~~nil~~~~~~v~l~df~~~~~ 167 (299)
.||||.+||.|.-.++ ....+++.....+-..|++||.|||++ ++++||||.+|.|+|++|++|++|||+|..
T Consensus 245 FVMeyanGGeLf~HLs----rer~FsE~RtRFYGaEIvsAL~YLHs~---~ivYRDlKLENLlLDkDGHIKitDFGLCKE 317 (516)
T KOG0690|consen 245 FVMEYANGGELFFHLS----RERVFSEDRTRFYGAEIVSALGYLHSR---NIVYRDLKLENLLLDKDGHIKITDFGLCKE 317 (516)
T ss_pred EEEEEccCceEeeehh----hhhcccchhhhhhhHHHHHHhhhhhhC---CeeeeechhhhheeccCCceEeeecccchh
Confidence 9999999999988776 567899999999999999999999999 999999999999999999999999999974
Q ss_pred cccccccccccccccccCcccCChhhhcccCcCccccchhhhHHHHHHHhCCCCCCCCccCCCCchhHHHHHHHHHhcCc
Q 038766 168 LDVHLQDLSSLSTAFQGTIGYLAPEFAYMRIVTTKVDVFSFGIVVMEFLTKRRPTGLDEENGLSPISLRQLVEKALANGI 247 (299)
Q Consensus 168 ~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~DiwslG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 247 (299)
-- ..+...+...|||.|+|||++.+..|..+.|-|.+|+++|+|++|+.||.....+ .+.+.+ ...
T Consensus 318 ~I----~~g~t~kTFCGTPEYLAPEVleDnDYgraVDWWG~GVVMYEMmCGRLPFyn~dh~-----kLFeLI---l~e-- 383 (516)
T KOG0690|consen 318 EI----KYGDTTKTFCGTPEYLAPEVLEDNDYGRAVDWWGVGVVMYEMMCGRLPFYNKDHE-----KLFELI---LME-- 383 (516)
T ss_pred cc----cccceeccccCChhhcCchhhccccccceeehhhhhHHHHHHHhccCcccccchh-----HHHHHH---Hhh--
Confidence 22 2344567788999999999999999999999999999999999999999644221 111111 110
Q ss_pred cCcccccCccccchhhHhHHHHHHHHHHHHHHHHhcCCCCCCCCC
Q 038766 248 NGVRQITDPKLVSSIYEEQEQHQVLEELFKLALVCTSSNPEDRPN 292 (299)
Q Consensus 248 ~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rpt 292 (299)
+. ..++.+++++..|+..+|..||.+|..
T Consensus 384 -------d~---------kFPr~ls~eAktLLsGLL~kdP~kRLG 412 (516)
T KOG0690|consen 384 -------DL---------KFPRTLSPEAKTLLSGLLKKDPKKRLG 412 (516)
T ss_pred -------hc---------cCCccCCHHHHHHHHHHhhcChHhhcC
Confidence 11 115666788999999999999999974
|
|
| >KOG1094 consensus Discoidin domain receptor DDR1 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-37 Score=263.97 Aligned_cols=265 Identities=26% Similarity=0.388 Sum_probs=205.5
Q ss_pred HHHHhCCCCCCceeecCCcceEEEEEeCCCcEEEEEEeccCcCChhhhHHHHHHHHHHHhcCCcceeeeeeEEEcCCCee
Q 038766 7 IENATGSFSENNIIGNSNLSTVYKGRLEDGEIVAVKKLNFHQFSAESDKSFYREAKTLKELKHRNLVKVLGYAWESGKLK 86 (299)
Q Consensus 7 ~~~~~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~vK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~ 86 (299)
.|.-.+...++++||+|.||.|.++...++..||+|+++. .......+.+..|+++|.+++||||+.++++|...+..
T Consensus 533 ~EfPRs~L~~~ekiGeGqFGEVhLCeveg~lkVAVK~Lr~-~a~~~~r~~F~kEIkiLsqLkhPNIveLvGVC~~DePi- 610 (807)
T KOG1094|consen 533 VEFPRSRLRFKEKIGEGQFGEVHLCEVEGPLKVAVKILRP-DATKNARNDFLKEIKILSRLKHPNIVELLGVCVQDDPL- 610 (807)
T ss_pred hhcchhheehhhhhcCcccceeEEEEecCceEEEEeecCc-ccchhHHHHHHHHHHHHhccCCCCeeEEEeeeecCCch-
Confidence 3445677889999999999999999988789999999973 33344468899999999999999999999999886655
Q ss_pred EEEEeecCCCChHHHhcCCCCCCCCCChhhHHHHHHHHHHHHHHhhcCCCCCeeeecccCCceeeCCCCcEEEeeecccc
Q 038766 87 ALILEYMENGSLESVIHGPGVDHSRWTLPKRIDVLISVANGLDYLHSGYDIPIVHCDMKPSNILLDRDFEAHVSDFGTSR 166 (299)
Q Consensus 87 ~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lh~~~~~~~~H~dl~~~nil~~~~~~v~l~df~~~~ 166 (299)
|+++||+..|+|..++.++.... +.......|+.||+++++||.+. ++||||+.+.|+|++.++++|++|||+++
T Consensus 611 cmI~EYmEnGDLnqFl~aheapt--~~t~~~vsi~tqiasgmaYLes~---nfVHrd~a~rNcLv~~e~~iKiadfgmsR 685 (807)
T KOG1094|consen 611 CMITEYMENGDLNQFLSAHELPT--AETAPGVSICTQIASGMAYLESL---NFVHRDLATRNCLVDGEFTIKIADFGMSR 685 (807)
T ss_pred HHHHHHHhcCcHHHHHHhccCcc--cccchhHHHHHHHHHHHHHHHhh---chhhccccccceeecCcccEEecCccccc
Confidence 99999999999999998663222 44556678999999999999998 99999999999999999999999999998
Q ss_pred ccccccccccccccccccCcccCChhhhcccCcCccccchhhhHHHHHHHh--CCCCCCCCccCCCCchhHHHHHHHHHh
Q 038766 167 MLDVHLQDLSSLSTAFQGTIGYLAPEFAYMRIVTTKVDVFSFGIVVMEFLT--KRRPTGLDEENGLSPISLRQLVEKALA 244 (299)
Q Consensus 167 ~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~DiwslG~~l~~l~~--g~~p~~~~~~~~~~~~~~~~~~~~~~~ 244 (299)
.+-. ...........-+..|+|||.+..+.++.++|+|++|+++||+++ ...||+.. ...++.+-......
T Consensus 686 ~lys--g~yy~vqgr~vlpiRwmawEsillgkFttaSDvWafgvTlwE~~~~C~e~Py~~l-----t~e~vven~~~~~~ 758 (807)
T KOG1094|consen 686 NLYS--GDYYRVQGRAVLPIRWMAWESILLGKFTTASDVWAFGVTLWEVFMLCREQPYSQL-----TDEQVVENAGEFFR 758 (807)
T ss_pred cccc--CCceeeecceeeeeeehhHHHHHhccccchhhhhhhHHHHHHHHHHHhhCchhhh-----hHHHHHHhhhhhcC
Confidence 5431 222233344556789999999999999999999999999999876 45666322 22222222111111
Q ss_pred cCccCcccccCccccchhhHhHHHHHHHHHHHHHHHHhcCCCCCCCCChhhhhc
Q 038766 245 NGINGVRQITDPKLVSSIYEEQEQHQVLEELFKLALVCTSSNPEDRPNMNELLI 298 (299)
Q Consensus 245 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rpt~~~il~ 298 (299)
...... +. ..+.-.+..+.+++.+||+.+-++|||++++..
T Consensus 759 ~~~~~~-----------~l--~~P~~cp~~lyelml~Cw~~es~~RPsFe~lh~ 799 (807)
T KOG1094|consen 759 DQGRQV-----------VL--SRPPACPQGLYELMLRCWRRESEQRPSFEQLHL 799 (807)
T ss_pred CCCcce-----------ec--cCCCcCcHHHHHHHHHHhchhhhcCCCHHHHHH
Confidence 111110 00 114556678999999999999999999999853
|
|
| >KOG4257 consensus Focal adhesion tyrosine kinase FAK, contains FERM domain [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-37 Score=266.70 Aligned_cols=256 Identities=23% Similarity=0.351 Sum_probs=204.7
Q ss_pred HHHHHhCCCCCCceeecCCcceEEEEEeC---CC--cEEEEEEeccCcCChhhhHHHHHHHHHHHhcCCcceeeeeeEEE
Q 038766 6 EIENATGSFSENNIIGNSNLSTVYKGRLE---DG--EIVAVKKLNFHQFSAESDKSFYREAKTLKELKHRNLVKVLGYAW 80 (299)
Q Consensus 6 ~~~~~~~~y~~~~~lg~g~~~~v~~~~~~---~~--~~~~vK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~ 80 (299)
..|.-.+.....+.||.|.||.||.+... .| -.||||+.+.. ..++..+.+..|+.+++.+.||||++++|++.
T Consensus 383 nyel~Re~Itl~r~iG~GqFGdVy~gvYt~~~kge~iaVAvKtCK~d-~t~d~tekflqEa~iMrnfdHphIikLIGv~~ 461 (974)
T KOG4257|consen 383 NYELRRELITLKRLIGEGQFGDVYKGVYTDPEKGERIAVAVKTCKTD-CTPDDTEKFLQEASIMRNFDHPHIIKLIGVCV 461 (974)
T ss_pred cceeehhhccHHHhhcCCcccceeeeEecccccCcceeeeeehhccC-CChhhHHHHHHHHHHHHhCCCcchhheeeeee
Confidence 34555666778899999999999999742 23 34888888643 45566889999999999999999999999876
Q ss_pred cCCCeeEEEEeecCCCChHHHhcCCCCCCCCCChhhHHHHHHHHHHHHHHhhcCCCCCeeeecccCCceeeCCCCcEEEe
Q 038766 81 ESGKLKALILEYMENGSLESVIHGPGVDHSRWTLPKRIDVLISVANGLDYLHSGYDIPIVHCDMKPSNILLDRDFEAHVS 160 (299)
Q Consensus 81 ~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lh~~~~~~~~H~dl~~~nil~~~~~~v~l~ 160 (299)
+ ...++|||.++-|-|.++++. ++..++.....-++.||+.||+|||+. ++|||||...||||....-|||+
T Consensus 462 e--~P~WivmEL~~~GELr~yLq~---nk~sL~l~tL~ly~~Qi~talaYLeSk---rfVHRDIAaRNiLVsSp~CVKLa 533 (974)
T KOG4257|consen 462 E--QPMWIVMELAPLGELREYLQQ---NKDSLPLRTLTLYCYQICTALAYLESK---RFVHRDIAARNILVSSPQCVKLA 533 (974)
T ss_pred c--cceeEEEecccchhHHHHHHh---ccccchHHHHHHHHHHHHHHHHHHHhh---chhhhhhhhhheeecCcceeeec
Confidence 4 335999999999999999984 556888899999999999999999999 99999999999999998889999
Q ss_pred eeccccccccccccccccccccccCcccCChhhhcccCcCccccchhhhHHHHHHHh-CCCCCCCCccCCCCchhHHHHH
Q 038766 161 DFGTSRMLDVHLQDLSSLSTAFQGTIGYLAPEFAYMRIVTTKVDVFSFGIVVMEFLT-KRRPTGLDEENGLSPISLRQLV 239 (299)
Q Consensus 161 df~~~~~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~DiwslG~~l~~l~~-g~~p~~~~~~~~~~~~~~~~~~ 239 (299)
|||+++.+... .........-+..|+|||-+....++.++|||+||+++|+++. |..||.+-.+++..
T Consensus 534 DFGLSR~~ed~---~yYkaS~~kLPIKWmaPESINfRrFTtASDVWMFgVCmWEIl~lGvkPfqgvkNsDVI-------- 602 (974)
T KOG4257|consen 534 DFGLSRYLEDD---AYYKASRGKLPIKWMAPESINFRRFTTASDVWMFGVCMWEILSLGVKPFQGVKNSDVI-------- 602 (974)
T ss_pred ccchhhhcccc---chhhccccccceeecCccccchhcccchhhHHHHHHHHHHHHHhcCCccccccccceE--------
Confidence 99999876521 1111122223568999999999999999999999999999885 88999654333211
Q ss_pred HHHHhcCccCcccccCccccchhhHhHHHHHHHHHHHHHHHHhcCCCCCCCCChhhhhc
Q 038766 240 EKALANGINGVRQITDPKLVSSIYEEQEQHQVLEELFKLALVCTSSNPEDRPNMNELLI 298 (299)
Q Consensus 240 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rpt~~~il~ 298 (299)
...+.+...+++...++.|..|+.+||..+|.+||++.++..
T Consensus 603 -----------------~~iEnGeRlP~P~nCPp~LYslmskcWayeP~kRPrftei~~ 644 (974)
T KOG4257|consen 603 -----------------GHIENGERLPCPPNCPPALYSLMSKCWAYEPSKRPRFTEIKA 644 (974)
T ss_pred -----------------EEecCCCCCCCCCCCChHHHHHHHHHhccCcccCCcHHHHHH
Confidence 112222333446777888999999999999999999998753
|
|
| >KOG0199 consensus ACK and related non-receptor tyrosine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-37 Score=268.97 Aligned_cols=253 Identities=23% Similarity=0.393 Sum_probs=205.2
Q ss_pred hCCCCCCceeecCCcceEEEEEeCC--C--cEEEEEEeccCcCChhhhHHHHHHHHHHHhcCCcceeeeeeEEEcCCCee
Q 038766 11 TGSFSENNIIGNSNLSTVYKGRLED--G--EIVAVKKLNFHQFSAESDKSFYREAKTLKELKHRNLVKVLGYAWESGKLK 86 (299)
Q Consensus 11 ~~~y~~~~~lg~g~~~~v~~~~~~~--~--~~~~vK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~ 86 (299)
.++....++||+|+||+|+++.|.. | -.||||.+....... ....+.+|+..|.+++|+|++++||++.. .-.
T Consensus 109 ee~i~l~e~LG~GsFgvV~rg~Wt~psgk~V~VAVKclr~d~l~~-~mddflrEas~M~~L~H~hliRLyGvVl~--qp~ 185 (1039)
T KOG0199|consen 109 EEQIKLYELLGEGSFGVVKRGTWTQPSGKHVNVAVKCLRDDSLNA-IMDDFLREASHMLKLQHPHLIRLYGVVLD--QPA 185 (1039)
T ss_pred HHHHHHHHHhcCcceeeEeeccccCCCCcEEeEEEEeccCCccch-hHHHHHHHHHHHHhccCcceeEEeeeecc--chh
Confidence 3566788999999999999998742 3 468999987544333 66789999999999999999999998876 344
Q ss_pred EEEEeecCCCChHHHhcCCCCCCCCCChhhHHHHHHHHHHHHHHhhcCCCCCeeeecccCCceeeCCCCcEEEeeecccc
Q 038766 87 ALILEYMENGSLESVIHGPGVDHSRWTLPKRIDVLISVANGLDYLHSGYDIPIVHCDMKPSNILLDRDFEAHVSDFGTSR 166 (299)
Q Consensus 87 ~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lh~~~~~~~~H~dl~~~nil~~~~~~v~l~df~~~~ 166 (299)
.+|+|.+..|+|.+.+.. +....+.......++.||+.|+.||..+ ++|||||...|+++-....|||+|||+++
T Consensus 186 mMV~ELaplGSLldrLrk--a~~~~llv~~Lcdya~QiA~aM~YLesk---rlvHRDLAARNlllasprtVKI~DFGLmR 260 (1039)
T KOG0199|consen 186 MMVFELAPLGSLLDRLRK--AKKAILLVSRLCDYAMQIAKAMQYLESK---RLVHRDLAARNLLLASPRTVKICDFGLMR 260 (1039)
T ss_pred hHHhhhcccchHHHHHhh--ccccceeHHHHHHHHHHHHHHHHHHhhh---hhhhhhhhhhhheecccceeeeeccccee
Confidence 899999999999998876 2567889999999999999999999999 99999999999999988899999999999
Q ss_pred ccccccccccccccccccCcccCChhhhcccCcCccccchhhhHHHHHHHh-CCCCCCCCccCCCCchhHHHHHHHHHhc
Q 038766 167 MLDVHLQDLSSLSTAFQGTIGYLAPEFAYMRIVTTKVDVFSFGIVVMEFLT-KRRPTGLDEENGLSPISLRQLVEKALAN 245 (299)
Q Consensus 167 ~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~DiwslG~~l~~l~~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~ 245 (299)
.+...... ............|||||.+.-..++.++|+|++|+++|||++ |..|| .+.....+.+.++..
T Consensus 261 aLg~ned~-Yvm~p~rkvPfAWCaPEsLrh~kFShaSDvWmyGVTiWEMFtyGEePW-----~G~~g~qIL~~iD~~--- 331 (1039)
T KOG0199|consen 261 ALGENEDM-YVMAPQRKVPFAWCAPESLRHRKFSHASDVWMYGVTIWEMFTYGEEPW-----VGCRGIQILKNIDAG--- 331 (1039)
T ss_pred ccCCCCcc-eEecCCCcCcccccCHhHhccccccccchhhhhhhhHHhhhccCCCCC-----CCCCHHHHHHhcccc---
Confidence 77633222 122233445678999999999999999999999999999997 66777 444555544444311
Q ss_pred CccCcccccCccccchhhHhHHHHHHHHHHHHHHHHhcCCCCCCCCChhhhh
Q 038766 246 GINGVRQITDPKLVSSIYEEQEQHQVLEELFKLALVCTSSNPEDRPNMNELL 297 (299)
Q Consensus 246 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rpt~~~il 297 (299)
+.. ..+...++++.++++.||..+|.+|||+.+|.
T Consensus 332 -----erL------------pRPk~csedIY~imk~cWah~paDRptFsair 366 (1039)
T KOG0199|consen 332 -----ERL------------PRPKYCSEDIYQIMKNCWAHNPADRPTFSAIR 366 (1039)
T ss_pred -----ccC------------CCCCCChHHHHHHHHHhccCCccccccHHHHH
Confidence 111 11566788999999999999999999999885
|
|
| >cd05576 STKc_RPK118_like Catalytic domain of the Protein Serine/Threonine Kinases, RPK118 and similar proteins | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-36 Score=248.83 Aligned_cols=225 Identities=22% Similarity=0.166 Sum_probs=175.6
Q ss_pred CCcceEEEEEe-CCCcEEEEEEeccCcCChhhhHHHHHHHHHHHhcCCcceeeeeeEEEcCCCeeEEEEeecCCCChHHH
Q 038766 23 SNLSTVYKGRL-EDGEIVAVKKLNFHQFSAESDKSFYREAKTLKELKHRNLVKVLGYAWESGKLKALILEYMENGSLESV 101 (299)
Q Consensus 23 g~~~~v~~~~~-~~~~~~~vK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~lv~e~~~~~~L~~~ 101 (299)
|.+|.||++.+ .+++.+|+|++.... ....|...+....|||++++++.+.. +...++++||+.+++|.+.
T Consensus 4 g~~~~v~~~~~~~~~~~~~~K~i~~~~-------~~~~~~~~~~~~~~~~i~~~~~~~~~-~~~~~lv~e~~~~~~L~~~ 75 (237)
T cd05576 4 GVIDKVLLVMDTRTQQTFILKGLRKSS-------EYSRERLTIIPHCVPNMVCLHKYIVS-EDSVFLVLQHAEGGKLWSH 75 (237)
T ss_pred cccceEEEEEEccCCcEEEEEeecchh-------hhhhHHHHHHhcCCCceeehhhheec-CCeEEEEEecCCCCCHHHH
Confidence 89999999987 468999999986432 12234455555679999999996655 4566999999999999998
Q ss_pred hcCCCCCCCCCChhhHHHHHHHHHHHHHHhhcCCCCCeeeecccCCceeeCCCCcEEEeeeccccccccccccccccccc
Q 038766 102 IHGPGVDHSRWTLPKRIDVLISVANGLDYLHSGYDIPIVHCDMKPSNILLDRDFEAHVSDFGTSRMLDVHLQDLSSLSTA 181 (299)
Q Consensus 102 ~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lh~~~~~~~~H~dl~~~nil~~~~~~v~l~df~~~~~~~~~~~~~~~~~~~ 181 (299)
+. ...++++..+..++.|++.||.|||+. +++|+||||+||+++.++.++++|||.+..... ....
T Consensus 76 l~----~~~~l~~~~~~~~~~ql~~~l~~lH~~---~i~H~dlkp~Nil~~~~~~~~l~df~~~~~~~~-------~~~~ 141 (237)
T cd05576 76 IS----KFLNIPEECVKRWAAEMVVALDALHRE---GIVCRDLNPNNILLDDRGHIQLTYFSRWSEVED-------SCDG 141 (237)
T ss_pred HH----HhcCCCHHHHHHHHHHHHHHHHHHHhC---CeeccCCCHHHEEEcCCCCEEEecccchhcccc-------cccc
Confidence 86 334689999999999999999999999 999999999999999999999999998765432 1122
Q ss_pred cccCcccCChhhhcccCcCccccchhhhHHHHHHHhCCCCCCCCccCCCCchhHHHHHHHHHhcCccCcccccCccccch
Q 038766 182 FQGTIGYLAPEFAYMRIVTTKVDVFSFGIVVMEFLTKRRPTGLDEENGLSPISLRQLVEKALANGINGVRQITDPKLVSS 261 (299)
Q Consensus 182 ~~~~~~y~~PE~~~~~~~~~~~DiwslG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 261 (299)
..++..|+|||......++.++|+||+|+++|+|++|..|+....... . ....+.
T Consensus 142 ~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~el~~g~~~~~~~~~~~---------------~---~~~~~~------- 196 (237)
T cd05576 142 EAVENMYCAPEVGGISEETEACDWWSLGAILFELLTGKTLVECHPSGI---------------N---THTTLN------- 196 (237)
T ss_pred CCcCccccCCcccCCCCCCchhhHHHHHHHHHHHHHCcchhhcCchhc---------------c---cccccC-------
Confidence 334667999999888888999999999999999999998764221000 0 000000
Q ss_pred hhHhHHHHHHHHHHHHHHHHhcCCCCCCCCCh-----hhhhcC
Q 038766 262 IYEEQEQHQVLEELFKLALVCTSSNPEDRPNM-----NELLIT 299 (299)
Q Consensus 262 ~~~~~~~~~~~~~l~~li~~~l~~dP~~Rpt~-----~~il~~ 299 (299)
.+..++..+.++|++||+.||++|||+ ++++.|
T Consensus 197 -----~~~~~~~~~~~li~~~l~~dp~~R~~~~~~~~~~~~~h 234 (237)
T cd05576 197 -----IPEWVSEEARSLLQQLLQFNPTERLGAGVAGVEDIKSH 234 (237)
T ss_pred -----CcccCCHHHHHHHHHHccCCHHHhcCCCccchHHHHcC
Confidence 122345678999999999999999996 888876
|
Serine/Threonine Kinases (STKs), RPK118-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RPK118-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily show similarity to human RPK118, which contains an N-terminal Phox homology (PX) domain, a Microtubule Interacting and Trafficking (MIT) domain, and a kinase domain containing a long insert. Also included in the family is human RPK60 (or ribosomal protein S6 kinase-like 1), which also contains MIT and kinase domains but lacks a PX domain. RPK118 binds sphingosine kinase, a key enzyme in the synthesis of sphingosine 1-phospha |
| >KOG1151 consensus Tousled-like protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-37 Score=256.54 Aligned_cols=264 Identities=27% Similarity=0.389 Sum_probs=205.0
Q ss_pred HHhCCCCCCceeecCCcceEEEEEe-CCCcEEEEEEeccCcCChhh-----hHHHHHHHHHHHhcCCcceeeeeeEEEcC
Q 038766 9 NATGSFSENNIIGNSNLSTVYKGRL-EDGEIVAVKKLNFHQFSAES-----DKSFYREAKTLKELKHRNLVKVLGYAWES 82 (299)
Q Consensus 9 ~~~~~y~~~~~lg~g~~~~v~~~~~-~~~~~~~vK~~~~~~~~~~~-----~~~~~~e~~~l~~l~h~~i~~~~~~~~~~ 82 (299)
.+.++|-+..+||+|+|+.||+|.+ ...+.||+|+-.....+.+. -+..-+|..+.+.+.||.|+++|+++...
T Consensus 460 tLn~RYLlLhLLGrGGFSEVyKAFDl~EqRYvAvKIHqlNK~WrdEKKeNYhKHAcREyrIHKeLDHpRIVKlYDyfslD 539 (775)
T KOG1151|consen 460 TLNDRYLLLHLLGRGGFSEVYKAFDLTEQRYVAVKIHQLNKNWRDEKKENYHKHACREYRIHKELDHPRIVKLYDYFSLD 539 (775)
T ss_pred chHHHHHHHHHhccccHHHHHHhcccchhheeeEeeehhccchhhHhhhhHHHHHHHHHhhhhccCcceeeeeeeeeeec
Confidence 4678999999999999999999975 45788999987654433322 24466799999999999999999988766
Q ss_pred CCeeEEEEeecCCCChHHHhcCCCCCCCCCChhhHHHHHHHHHHHHHHhhcCCCCCeeeecccCCceeeC---CCCcEEE
Q 038766 83 GKLKALILEYMENGSLESVIHGPGVDHSRWTLPKRIDVLISVANGLDYLHSGYDIPIVHCDMKPSNILLD---RDFEAHV 159 (299)
Q Consensus 83 ~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lh~~~~~~~~H~dl~~~nil~~---~~~~v~l 159 (299)
....|-|+||++|.+|.-+++ ....+++.++..|+.||++||.||... +..|+|-||||.|||+- .-|.+||
T Consensus 540 tdsFCTVLEYceGNDLDFYLK----QhklmSEKEARSIiMQiVnAL~YLNEi-kpPIIHYDLKPgNILLv~GtacGeIKI 614 (775)
T KOG1151|consen 540 TDSFCTVLEYCEGNDLDFYLK----QHKLMSEKEARSIIMQIVNALKYLNEI-KPPIIHYDLKPGNILLVNGTACGEIKI 614 (775)
T ss_pred cccceeeeeecCCCchhHHHH----hhhhhhHHHHHHHHHHHHHHHHHHhcc-CCCeeeeccCCccEEEecCcccceeEe
Confidence 666799999999999999998 566899999999999999999999987 55999999999999994 4478999
Q ss_pred eeecccccccccccc---ccccccccccCcccCChhhhccc----CcCccccchhhhHHHHHHHhCCCCCCCCccCCCCc
Q 038766 160 SDFGTSRMLDVHLQD---LSSLSTAFQGTIGYLAPEFAYMR----IVTTKVDVFSFGIVVMEFLTKRRPTGLDEENGLSP 232 (299)
Q Consensus 160 ~df~~~~~~~~~~~~---~~~~~~~~~~~~~y~~PE~~~~~----~~~~~~DiwslG~~l~~l~~g~~p~~~~~~~~~~~ 232 (299)
+|||++..++...-+ --.......||-+|+|||.+.-. .++.+.||||+|+++|+.+.|..||+.+....
T Consensus 615 TDFGLSKIMdddSy~~vdGmeLTSQgAGTYWYLPPEcFvVgkePPKIsnKVDVWSvGVIFyQClYGrKPFGhnqsQQ--- 691 (775)
T KOG1151|consen 615 TDFGLSKIMDDDSYNSVDGMELTSQGAGTYWYLPPECFVVGKEPPKISNKVDVWSVGVIFYQCLYGRKPFGHNQSQQ--- 691 (775)
T ss_pred eecchhhhccCCccCcccceeeecccCceeeecCcceeecCCCCCccccceeeEeeehhhhhhhccCCCCCCchhHH---
Confidence 999999877633221 11334566789999999977643 47889999999999999999999998653221
Q ss_pred hhHHHHHHHHHhcCccCcccccCccccchhhHhHHHHHHHHHHHHHHHHhcCCCCCCCCChhhhh
Q 038766 233 ISLRQLVEKALANGINGVRQITDPKLVSSIYEEQEQHQVLEELFKLALVCTSSNPEDRPNMNELL 297 (299)
Q Consensus 233 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rpt~~~il 297 (299)
.+.. .+..-....... +..+.++.++..+|++||.+.-++|....++-
T Consensus 692 -dILq------eNTIlkAtEVqF----------P~KPvVsseAkaFIRRCLaYRKeDR~DV~qLA 739 (775)
T KOG1151|consen 692 -DILQ------ENTILKATEVQF----------PPKPVVSSEAKAFIRRCLAYRKEDRIDVQQLA 739 (775)
T ss_pred -HHHh------hhchhcceeccC----------CCCCccCHHHHHHHHHHHHhhhhhhhhHHHHc
Confidence 1110 000001111111 12456678899999999999999999888764
|
|
| >KOG0612 consensus Rho-associated, coiled-coil containing protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-37 Score=281.26 Aligned_cols=260 Identities=24% Similarity=0.297 Sum_probs=201.1
Q ss_pred HHHHHhCCCCCCceeecCCcceEEEEEeC-CCcEEEEEEeccCcCC-hhhhHHHHHHHHHHHhcCCcceeeeeeEEEcCC
Q 038766 6 EIENATGSFSENNIIGNSNLSTVYKGRLE-DGEIVAVKKLNFHQFS-AESDKSFYREAKTLKELKHRNLVKVLGYAWESG 83 (299)
Q Consensus 6 ~~~~~~~~y~~~~~lg~g~~~~v~~~~~~-~~~~~~vK~~~~~~~~-~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~ 83 (299)
+...-.++|.++++||+|+||.|.+++++ +++.||.|+++....- ....+-+..|-.+|-.-..+=|+.+.- .+...
T Consensus 69 ~lrl~~~DfeilKvIGrGaFGEV~lVr~k~t~~VYAMK~lnK~eMlKr~~tA~F~EERDimv~~ns~Wiv~Lhy-AFQD~ 147 (1317)
T KOG0612|consen 69 ELRLKAEDFEILKVIGRGAFGEVALVRHKSTEKVYAMKILNKWEMLKRAETACFREERDIMVFGNSEWIVQLHY-AFQDE 147 (1317)
T ss_pred HHhCCHHhhHHHHHhcccccceeEEEEeeccccchhHHHhhHHHHhhchhHHHHHHHhHHHHcCCcHHHHHHHH-HhcCc
Confidence 44556789999999999999999999875 5889999998743322 233445556666666656666666654 44556
Q ss_pred CeeEEEEeecCCCChHHHhcCCCCCCCCCChhhHHHHHHHHHHHHHHhhcCCCCCeeeecccCCceeeCCCCcEEEeeec
Q 038766 84 KLKALILEYMENGSLESVIHGPGVDHSRWTLPKRIDVLISVANGLDYLHSGYDIPIVHCDMKPSNILLDRDFEAHVSDFG 163 (299)
Q Consensus 84 ~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lh~~~~~~~~H~dl~~~nil~~~~~~v~l~df~ 163 (299)
+++|+||||++||+|..++..+ .++|+..+..++..|+.||..+|+. |+|||||||+|||+|..|++||+|||
T Consensus 148 ~~LYlVMdY~pGGDlltLlSk~----~~~pE~~ArFY~aEiVlAldslH~m---gyVHRDiKPDNvLld~~GHikLADFG 220 (1317)
T KOG0612|consen 148 RYLYLVMDYMPGGDLLTLLSKF----DRLPEDWARFYTAEIVLALDSLHSM---GYVHRDIKPDNVLLDKSGHIKLADFG 220 (1317)
T ss_pred cceEEEEecccCchHHHHHhhc----CCChHHHHHHHHHHHHHHHHHHHhc---cceeccCCcceeEecccCcEeeccch
Confidence 7789999999999999999743 4899999999999999999999999 99999999999999999999999999
Q ss_pred cccccccccccccccccccccCcccCChhhhcc-----cCcCccccchhhhHHHHHHHhCCCCCCCCccCCCCchhHHHH
Q 038766 164 TSRMLDVHLQDLSSLSTAFQGTIGYLAPEFAYM-----RIVTTKVDVFSFGIVVMEFLTKRRPTGLDEENGLSPISLRQL 238 (299)
Q Consensus 164 ~~~~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~-----~~~~~~~DiwslG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~ 238 (299)
.|-.++. +..-.+...+|||.|.+||++.. +.|...+|-||+|+++|+|+.|..||..+ .+.+.
T Consensus 221 sClkm~~---dG~V~s~~aVGTPDYISPEvLqs~~~~~g~yG~ecDwWSlGV~~YEMlyG~TPFYad--------slveT 289 (1317)
T KOG0612|consen 221 SCLKMDA---DGTVRSSVAVGTPDYISPEVLQSQGDGKGEYGRECDWWSLGVFMYEMLYGETPFYAD--------SLVET 289 (1317)
T ss_pred hHHhcCC---CCcEEeccccCCCCccCHHHHHhhcCCccccCCccchhhhHHHHHHHHcCCCcchHH--------HHHHH
Confidence 9987762 22334677889999999998773 45888999999999999999999999543 22333
Q ss_pred HHHHHhcCccCcccccCccccchhhHhHHHHHHHHHHHHHHHHhcCCCCCCCCC---hhhhhcC
Q 038766 239 VEKALANGINGVRQITDPKLVSSIYEEQEQHQVLEELFKLALVCTSSNPEDRPN---MNELLIT 299 (299)
Q Consensus 239 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rpt---~~~il~~ 299 (299)
+..+.... ..+..| ....+|.++.+||.+.+. +|+.|.. ++++-.|
T Consensus 290 Y~KIm~hk----~~l~FP----------~~~~VSeeakdLI~~ll~-~~e~RLgrngiedik~H 338 (1317)
T KOG0612|consen 290 YGKIMNHK----ESLSFP----------DETDVSEEAKDLIEALLC-DREVRLGRNGIEDIKNH 338 (1317)
T ss_pred HHHHhchh----hhcCCC----------cccccCHHHHHHHHHHhc-ChhhhcccccHHHHHhC
Confidence 33333210 001111 134478899999999876 6788888 8887665
|
|
| >KOG4236 consensus Serine/threonine protein kinase PKC mu/PKD and related proteins [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-37 Score=261.11 Aligned_cols=247 Identities=23% Similarity=0.373 Sum_probs=202.1
Q ss_pred CceeecCCcceEEEEEe-CCCcEEEEEEeccCcCChhhhHHHHHHHHHHHhcCCcceeeeeeEEEcCCCeeEEEEeecCC
Q 038766 17 NNIIGNSNLSTVYKGRL-EDGEIVAVKKLNFHQFSAESDKSFYREAKTLKELKHRNLVKVLGYAWESGKLKALILEYMEN 95 (299)
Q Consensus 17 ~~~lg~g~~~~v~~~~~-~~~~~~~vK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~lv~e~~~~ 95 (299)
.+.||+|.||+||-+++ ++|+.||||++..-...+.....+++|+.+|+.+.||.|+.+...+...+. .++|||-+.|
T Consensus 569 devLGSGQFG~VYgg~hRktGrdVAvKvIdKlrFp~kqesqlR~EVaILq~l~HPGiV~le~M~ET~er-vFVVMEKl~G 647 (888)
T KOG4236|consen 569 DEVLGSGQFGTVYGGKHRKTGRDVAVKVIDKLRFPTKQESQLRNEVAILQNLHHPGIVNLECMFETPER-VFVVMEKLHG 647 (888)
T ss_pred HhhccCCcceeeecceecccCceeeeeeeecccCCCchHHHHHHHHHHHHhcCCCCeeEEEEeecCCce-EEEEehhhcc
Confidence 57899999999999986 569999999998877777788999999999999999999999886655554 4999999955
Q ss_pred CChHHHhcCCCCCCCCCChhhHHHHHHHHHHHHHHhhcCCCCCeeeecccCCceeeCC---CCcEEEeeecccccccccc
Q 038766 96 GSLESVIHGPGVDHSRWTLPKRIDVLISVANGLDYLHSGYDIPIVHCDMKPSNILLDR---DFEAHVSDFGTSRMLDVHL 172 (299)
Q Consensus 96 ~~L~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lh~~~~~~~~H~dl~~~nil~~~---~~~v~l~df~~~~~~~~~~ 172 (299)
+..++|-.. ...++++..-..++.||+.||+|||-+ ||+|+||||+|||+.. -..+||+|||+++.+.
T Consensus 648 -DMLEMILSs--EkgRL~er~TkFlvtQIL~ALr~LH~k---nIvHCDLKPENVLLas~~~FPQvKlCDFGfARiIg--- 718 (888)
T KOG4236|consen 648 -DMLEMILSS--EKGRLPERITKFLVTQILVALRYLHFK---NIVHCDLKPENVLLASASPFPQVKLCDFGFARIIG--- 718 (888)
T ss_pred -hHHHHHHHh--hcccchHHHHHHHHHHHHHHHHHhhhc---ceeeccCCchheeeccCCCCCceeeccccceeecc---
Confidence 666655322 567899999999999999999999999 9999999999999954 3579999999999765
Q ss_pred ccccccccccccCcccCChhhhcccCcCccccchhhhHHHHHHHhCCCCCCCCccCCCCchhHHHHHHHHHhcCccCccc
Q 038766 173 QDLSSLSTAFQGTIGYLAPEFAYMRIVTTKVDVFSFGIVVMEFLTKRRPTGLDEENGLSPISLRQLVEKALANGINGVRQ 252 (299)
Q Consensus 173 ~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~DiwslG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 252 (299)
........+|||.|+|||++..++|..+.|+||.|+++|--++|..||..+++ +.+-+
T Consensus 719 --EksFRrsVVGTPAYLaPEVLrnkGyNrSLDMWSVGVIiYVsLSGTFPFNEdEd-------IndQI------------- 776 (888)
T KOG4236|consen 719 --EKSFRRSVVGTPAYLAPEVLRNKGYNRSLDMWSVGVIIYVSLSGTFPFNEDED-------INDQI------------- 776 (888)
T ss_pred --hhhhhhhhcCCccccCHHHHhhccccccccceeeeEEEEEEecccccCCCccc-------hhHHh-------------
Confidence 34567788999999999999999999999999999999999999999954311 11111
Q ss_pred ccCccccchhhHhHHHHHHHHHHHHHHHHhcCCCCCCCCChhhhhcC
Q 038766 253 ITDPKLVSSIYEEQEQHQVLEELFKLALVCTSSNPEDRPNMNELLIT 299 (299)
Q Consensus 253 ~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rpt~~~il~~ 299 (299)
.+..+.... ..-..++.++.+||..+|++.-.+|.|.+..|.|
T Consensus 777 -QNAaFMyPp---~PW~eis~~AidlIn~LLqVkm~kRysvdk~lsh 819 (888)
T KOG4236|consen 777 -QNAAFMYPP---NPWSEISPEAIDLINNLLQVKMRKRYSVDKSLSH 819 (888)
T ss_pred -hccccccCC---CchhhcCHHHHHHHHHHHHHHHHHhcchHhhccc
Confidence 111111100 1134567789999999999999999999988876
|
|
| >cd05610 STKc_MASTL Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine-like kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.2e-36 Score=277.63 Aligned_cols=148 Identities=25% Similarity=0.365 Sum_probs=129.7
Q ss_pred hCCCCCCceeecCCcceEEEEEeC-CCcEEEEEEeccCcC-ChhhhHHHHHHHHHHHhcCCcceeeeeeEEEcCCCeeEE
Q 038766 11 TGSFSENNIIGNSNLSTVYKGRLE-DGEIVAVKKLNFHQF-SAESDKSFYREAKTLKELKHRNLVKVLGYAWESGKLKAL 88 (299)
Q Consensus 11 ~~~y~~~~~lg~g~~~~v~~~~~~-~~~~~~vK~~~~~~~-~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~l 88 (299)
.++|.+.+.||+|+||+||++.+. +++.||+|++..... .......+..|+..++.++|+||+++++.+.. ....++
T Consensus 3 ~~~y~i~~~LG~G~fg~Vy~a~~~~~~~~vAiKvi~~~~~~~~~~~~~~~~E~~~l~~l~hp~Iv~~~~~~~~-~~~~~l 81 (669)
T cd05610 3 IEEFVIVKPISRGAFGKVYLGRKKNNSKLYAVKVVKKADMINKNMVHQVQAERDALALSKSPFIVHLYYSLQS-ANNVYL 81 (669)
T ss_pred cCCEEEEEEEecCCCeEEEEEEECCCCcEEEEEEEehhhccCHHHHHHHHHHHHHHHhcCCCCcCeEEEEEEE-CCEEEE
Confidence 478999999999999999999875 689999999864332 33345678899999999999999999986554 556799
Q ss_pred EEeecCCCChHHHhcCCCCCCCCCChhhHHHHHHHHHHHHHHhhcCCCCCeeeecccCCceeeCCCCcEEEeeecccc
Q 038766 89 ILEYMENGSLESVIHGPGVDHSRWTLPKRIDVLISVANGLDYLHSGYDIPIVHCDMKPSNILLDRDFEAHVSDFGTSR 166 (299)
Q Consensus 89 v~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lh~~~~~~~~H~dl~~~nil~~~~~~v~l~df~~~~ 166 (299)
||||+.+++|.+++.. ...+++..++.++.||+.||+|||+. +++|+||||+|||++.++.++|+|||++.
T Consensus 82 VmEy~~g~~L~~li~~----~~~l~~~~~~~i~~qil~aL~yLH~~---gIiHrDLKP~NILl~~~g~vkL~DFGls~ 152 (669)
T cd05610 82 VMEYLIGGDVKSLLHI----YGYFDEEMAVKYISEVALALDYLHRH---GIIHRDLKPDNMLISNEGHIKLTDFGLSK 152 (669)
T ss_pred EEeCCCCCCHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHhC---CEEeCCccHHHEEEcCCCCEEEEeCCCCc
Confidence 9999999999999873 34688999999999999999999998 99999999999999999999999999875
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST-like (MASTL) kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. The MASTL kinases in this group carry only a catalytic domain, which contains a long insertion relative to MAST kinases. The human MASTL gene has also been labelled FLJ14813. A missense mutation in FLJ1481 |
| >PLN00113 leucine-rich repeat receptor-like protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.6e-35 Score=283.33 Aligned_cols=261 Identities=26% Similarity=0.428 Sum_probs=191.1
Q ss_pred HHHHhCCCCCCceeecCCcceEEEEEe-CCCcEEEEEEeccCcCChhhhHHHHHHHHHHHhcCCcceeeeeeEEEcCCCe
Q 038766 7 IENATGSFSENNIIGNSNLSTVYKGRL-EDGEIVAVKKLNFHQFSAESDKSFYREAKTLKELKHRNLVKVLGYAWESGKL 85 (299)
Q Consensus 7 ~~~~~~~y~~~~~lg~g~~~~v~~~~~-~~~~~~~vK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~ 85 (299)
.+.+.+.|...+.||+|+||.||++.+ .++..||+|++..... ....|++.+++++||||+++++++...+ .
T Consensus 685 ~~~~~~~~~~~~~ig~G~~g~Vy~~~~~~~~~~vavK~~~~~~~------~~~~~~~~l~~l~HpnIv~~~~~~~~~~-~ 757 (968)
T PLN00113 685 INDILSSLKEENVISRGKKGASYKGKSIKNGMQFVVKEINDVNS------IPSSEIADMGKLQHPNIVKLIGLCRSEK-G 757 (968)
T ss_pred HHHHHhhCCcccEEccCCCeeEEEEEECCCCcEEEEEEccCCcc------ccHHHHHHHhhCCCCCcceEEEEEEcCC-C
Confidence 344556788889999999999999987 5689999998853221 1124578899999999999999876644 5
Q ss_pred eEEEEeecCCCChHHHhcCCCCCCCCCChhhHHHHHHHHHHHHHHhhcCCCCCeeeecccCCceeeCCCCcEEEeeeccc
Q 038766 86 KALILEYMENGSLESVIHGPGVDHSRWTLPKRIDVLISVANGLDYLHSGYDIPIVHCDMKPSNILLDRDFEAHVSDFGTS 165 (299)
Q Consensus 86 ~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lh~~~~~~~~H~dl~~~nil~~~~~~v~l~df~~~ 165 (299)
.++|+||+++++|.+++. .+++..+..++.|++.|++|||..++.+++|||+||+||+++.++..++. ++..
T Consensus 758 ~~lv~Ey~~~g~L~~~l~-------~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~dlkp~Nil~~~~~~~~~~-~~~~ 829 (968)
T PLN00113 758 AYLIHEYIEGKNLSEVLR-------NLSWERRRKIAIGIAKALRFLHCRCSPAVVVGNLSPEKIIIDGKDEPHLR-LSLP 829 (968)
T ss_pred CEEEEeCCCCCcHHHHHh-------cCCHHHHHHHHHHHHHHHHHhccCCCCCeecCCCCHHhEEECCCCceEEE-eccc
Confidence 699999999999999995 37888999999999999999995434499999999999999988887765 5443
Q ss_pred cccccccccccccccccccCcccCChhhhcccCcCccccchhhhHHHHHHHhCCCCCCCCccCCCCchhHHHHHHHHHhc
Q 038766 166 RMLDVHLQDLSSLSTAFQGTIGYLAPEFAYMRIVTTKVDVFSFGIVVMEFLTKRRPTGLDEENGLSPISLRQLVEKALAN 245 (299)
Q Consensus 166 ~~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~DiwslG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~ 245 (299)
.... ......+++.|+|||++.+..++.++||||+||++|+|++|..||...... ...+..+.......
T Consensus 830 ~~~~--------~~~~~~~t~~y~aPE~~~~~~~~~~sDv~S~Gvvl~el~tg~~p~~~~~~~---~~~~~~~~~~~~~~ 898 (968)
T PLN00113 830 GLLC--------TDTKCFISSAYVAPETRETKDITEKSDIYGFGLILIELLTGKSPADAEFGV---HGSIVEWARYCYSD 898 (968)
T ss_pred cccc--------cCCCccccccccCcccccCCCCCcccchhhHHHHHHHHHhCCCCCCcccCC---CCcHHHHHHHhcCc
Confidence 2211 112235678999999999999999999999999999999999998533211 11222222221111
Q ss_pred CccCcccccCccccchhhHhHHHHHHHHHHHHHHHHhcCCCCCCCCChhhhhc
Q 038766 246 GINGVRQITDPKLVSSIYEEQEQHQVLEELFKLALVCTSSNPEDRPNMNELLI 298 (299)
Q Consensus 246 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rpt~~~il~ 298 (299)
. ....+.++...... ........++.+++.+|+..||++|||++++++
T Consensus 899 ~--~~~~~~~~~~~~~~---~~~~~~~~~~~~l~~~Cl~~~P~~RPt~~evl~ 946 (968)
T PLN00113 899 C--HLDMWIDPSIRGDV---SVNQNEIVEVMNLALHCTATDPTARPCANDVLK 946 (968)
T ss_pred c--chhheeCccccCCC---CccHHHHHHHHHHHHhhCcCCchhCcCHHHHHH
Confidence 1 11111122111110 112334557889999999999999999999985
|
|
| >KOG0668 consensus Casein kinase II, alpha subunit [Signal transduction mechanisms; Cell cycle control, cell division, chromosome partitioning; Transcription] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.9e-37 Score=234.17 Aligned_cols=269 Identities=20% Similarity=0.280 Sum_probs=201.2
Q ss_pred hCCCCCCceeecCCcceEEEEEe-CCCcEEEEEEeccCcCChhhhHHHHHHHHHHHhcC-CcceeeeeeEEEcC-CCeeE
Q 038766 11 TGSFSENNIIGNSNLSTVYKGRL-EDGEIVAVKKLNFHQFSAESDKSFYREAKTLKELK-HRNLVKVLGYAWES-GKLKA 87 (299)
Q Consensus 11 ~~~y~~~~~lg~g~~~~v~~~~~-~~~~~~~vK~~~~~~~~~~~~~~~~~e~~~l~~l~-h~~i~~~~~~~~~~-~~~~~ 87 (299)
.++|.+++++|+|.++.||.+.. .++++++||+++ +-..+.+.+|+.+|+.+. +|||+++.+++.+. .+...
T Consensus 37 ~ddYeivrk~GRGKYSEVFeg~~~~~~eK~ViKiLK-----PVkkkKIkREikIL~nL~gg~NIi~L~DiV~Dp~Sktpa 111 (338)
T KOG0668|consen 37 QDDYEIVRKVGRGKYSEVFEGINITNNEKCVIKILK-----PVKKKKIKREIKILQNLRGGPNIIKLLDIVKDPESKTPS 111 (338)
T ss_pred cchHHHHHHHcCccHhhHhcccccCCCceEEEeeec-----hHHHHHHHHHHHHHHhccCCCCeeehhhhhcCccccCch
Confidence 57899999999999999999974 678899999985 455678999999999998 99999999987643 45678
Q ss_pred EEEeecCCCChHHHhcCCCCCCCCCChhhHHHHHHHHHHHHHHhhcCCCCCeeeecccCCceeeCCC-CcEEEeeecccc
Q 038766 88 LILEYMENGSLESVIHGPGVDHSRWTLPKRIDVLISVANGLDYLHSGYDIPIVHCDMKPSNILLDRD-FEAHVSDFGTSR 166 (299)
Q Consensus 88 lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lh~~~~~~~~H~dl~~~nil~~~~-~~v~l~df~~~~ 166 (299)
+++|+++..+...+.. .++...+..++.+++.||.|+|+. ||.|||+||.|+|++.. ..++|+|||++.
T Consensus 112 LiFE~v~n~Dfk~ly~-------tl~d~dIryY~~elLkALdyCHS~---GImHRDVKPhNvmIdh~~rkLrlIDWGLAE 181 (338)
T KOG0668|consen 112 LIFEYVNNTDFKQLYP-------TLTDYDIRYYIYELLKALDYCHSM---GIMHRDVKPHNVMIDHELRKLRLIDWGLAE 181 (338)
T ss_pred hHhhhhccccHHHHhh-------hhchhhHHHHHHHHHHHHhHHHhc---CcccccCCcceeeechhhceeeeeecchHh
Confidence 9999998777666664 688889999999999999999999 99999999999999865 579999999998
Q ss_pred ccccccccccccccccccCcccCChhhhcc-cCcCccccchhhhHHHHHHHhCCCCCCCCccCCCCchhH---------H
Q 038766 167 MLDVHLQDLSSLSTAFQGTIGYLAPEFAYM-RIVTTKVDVFSFGIVVMEFLTKRRPTGLDEENGLSPISL---------R 236 (299)
Q Consensus 167 ~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~-~~~~~~~DiwslG~~l~~l~~g~~p~~~~~~~~~~~~~~---------~ 236 (299)
++.. +.-.+-...+..|-.||++.+ ..|+.+.|+|||||++..|++...||..-..+...--.+ .
T Consensus 182 FYHp-----~~eYnVRVASRyfKGPELLVdy~~YDYSLD~WS~GcmlA~miFrkepFFhG~dN~DQLVkIakVLGt~el~ 256 (338)
T KOG0668|consen 182 FYHP-----GKEYNVRVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVKIAKVLGTDELY 256 (338)
T ss_pred hcCC-----CceeeeeeehhhcCCchheeechhccccHHHHHHHHHHHHHHhccCcccCCCCCHHHHHHHHHHhChHHHH
Confidence 7652 233445566788999998775 568999999999999999999999986443332211111 1
Q ss_pred HHHHHHHhcCccCcccccCcccc---chhhHhHHHHHHHHHHHHHHHHhcCCCCCCCCChhhhhcC
Q 038766 237 QLVEKALANGINGVRQITDPKLV---SSIYEEQEQHQVLEELFKLALVCTSSNPEDRPNMNELLIT 299 (299)
Q Consensus 237 ~~~~~~~~~~~~~~~~~~~~~~~---~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rpt~~~il~~ 299 (299)
..+......-.+....+.....+ ..........-+++++.+|++++|..|.++|||+.|.++|
T Consensus 257 ~Yl~KY~i~Ldp~~~~i~~~~~rk~w~~Fi~~~n~hl~~peaiDlldklLrYDHqeRlTakEam~H 322 (338)
T KOG0668|consen 257 AYLNKYQIDLDPQFEDILGRHSRKPWSRFINSENQHLVSPEAIDLLDKLLRYDHQERLTAKEAMAH 322 (338)
T ss_pred HHHHHHccCCChhHhhHhhccccccHHHhCCccccccCChHHHHHHHHHHhhccccccchHHHhcC
Confidence 11111111111111111111000 0111111233345789999999999999999999999987
|
|
| >KOG0614 consensus cGMP-dependent protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.3e-37 Score=259.40 Aligned_cols=247 Identities=20% Similarity=0.296 Sum_probs=205.4
Q ss_pred HHhCCCCCCceeecCCcceEEEEEeCCCc-EEEEEEeccCc-CChhhhHHHHHHHHHHHhcCCcceeeeeeEEEcCCCee
Q 038766 9 NATGSFSENNIIGNSNLSTVYKGRLEDGE-IVAVKKLNFHQ-FSAESDKSFYREAKTLKELKHRNLVKVLGYAWESGKLK 86 (299)
Q Consensus 9 ~~~~~y~~~~~lg~g~~~~v~~~~~~~~~-~~~vK~~~~~~-~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~ 86 (299)
.-.+++.++..||-|+||.|=+++..+.. .+|+|+++..- ......+.+..|-++|.....|.|+++|..+. .+++.
T Consensus 417 v~l~dl~~iaTLGvGgFGRVELV~~~~~~~~fAlKilkK~hIVdtkQqeHv~sEr~Im~~~~s~fIvrLYrTfr-d~kyv 495 (732)
T KOG0614|consen 417 VKLSDLKRIATLGVGGFGRVELVKVNSQKATFALKILKKKHIVDTKQQEHVFSERNIMMECRSDFIVRLYRTFR-DSKYV 495 (732)
T ss_pred cchhhhhhhhhcccCccceEEEEEecccchHHHHHHHhHhhccchhHHHHHHhHHHHHHhcCchHHHHHHHHhc-cchhh
Confidence 34567788889999999999999865433 48888876433 34555788999999999999999999999555 46677
Q ss_pred EEEEeecCCCChHHHhcCCCCCCCCCChhhHHHHHHHHHHHHHHhhcCCCCCeeeecccCCceeeCCCCcEEEeeecccc
Q 038766 87 ALILEYMENGSLESVIHGPGVDHSRWTLPKRIDVLISVANGLDYLHSGYDIPIVHCDMKPSNILLDRDFEAHVSDFGTSR 166 (299)
Q Consensus 87 ~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lh~~~~~~~~H~dl~~~nil~~~~~~v~l~df~~~~ 166 (299)
|+.||.|-||.||..+. +...+.+.....++.++++|+.|||++ +|++|||||+|.+++.+|-+||.|||++.
T Consensus 496 YmLmEaClGGElWTiLr----dRg~Fdd~tarF~~acv~EAfeYLH~k---~iIYRDLKPENllLd~~Gy~KLVDFGFAK 568 (732)
T KOG0614|consen 496 YMLMEACLGGELWTILR----DRGSFDDYTARFYVACVLEAFEYLHRK---GIIYRDLKPENLLLDNRGYLKLVDFGFAK 568 (732)
T ss_pred hhhHHhhcCchhhhhhh----hcCCcccchhhhhHHHHHHHHHHHHhc---CceeccCChhheeeccCCceEEeehhhHH
Confidence 99999999999999998 667899999999999999999999999 99999999999999999999999999998
Q ss_pred ccccccccccccccccccCcccCChhhhcccCcCccccchhhhHHHHHHHhCCCCCCCCccCCCCchhHHHHHHHHHhcC
Q 038766 167 MLDVHLQDLSSLSTAFQGTIGYLAPEFAYMRIVTTKVDVFSFGIVVMEFLTKRRPTGLDEENGLSPISLRQLVEKALANG 246 (299)
Q Consensus 167 ~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~DiwslG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~ 246 (299)
.+. .+....++.|||.|.|||++...+-+.+.|.||||+++|+|++|.+||+.. .++.-+..+-..+.
T Consensus 569 ki~-----~g~KTwTFcGTpEYVAPEIILnKGHD~avDyWaLGIli~ELL~G~pPFs~~-----dpmktYn~ILkGid-- 636 (732)
T KOG0614|consen 569 KIG-----SGRKTWTFCGTPEYVAPEIILNKGHDRAVDYWALGILIYELLTGSPPFSGV-----DPMKTYNLILKGID-- 636 (732)
T ss_pred Hhc-----cCCceeeecCCcccccchhhhccCcchhhHHHHHHHHHHHHHcCCCCCCCC-----chHHHHHHHHhhhh--
Confidence 765 345566788999999999999999999999999999999999999999644 33333333322111
Q ss_pred ccCcccccCccccchhhHhHHHHHHHHHHHHHHHHhcCCCCCCCCC
Q 038766 247 INGVRQITDPKLVSSIYEEQEQHQVLEELFKLALVCTSSNPEDRPN 292 (299)
Q Consensus 247 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rpt 292 (299)
....++.++....+||++++..+|.+|..
T Consensus 637 -----------------~i~~Pr~I~k~a~~Lik~LCr~~P~ERLG 665 (732)
T KOG0614|consen 637 -----------------KIEFPRRITKTATDLIKKLCRDNPTERLG 665 (732)
T ss_pred -----------------hhhcccccchhHHHHHHHHHhcCcHhhhc
Confidence 11225666778999999999999999986
|
|
| >KOG0603 consensus Ribosomal protein S6 kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.9e-36 Score=259.26 Aligned_cols=241 Identities=24% Similarity=0.252 Sum_probs=189.7
Q ss_pred HhCCCCCCceeecCCcceEEEEEe-CCCcEEEEEEeccCcCChhhhHHHHHHHHHHHhc-CCcceeeeeeEEEcCCCeeE
Q 038766 10 ATGSFSENNIIGNSNLSTVYKGRL-EDGEIVAVKKLNFHQFSAESDKSFYREAKTLKEL-KHRNLVKVLGYAWESGKLKA 87 (299)
Q Consensus 10 ~~~~y~~~~~lg~g~~~~v~~~~~-~~~~~~~vK~~~~~~~~~~~~~~~~~e~~~l~~l-~h~~i~~~~~~~~~~~~~~~ 87 (299)
..++|.....+|.|+|++|-.+.+ .++...++|++... .....+|..++... .|||+++..+++.. +...+
T Consensus 320 ~~~~y~~~~~~~~gs~s~~~~~~~~~t~~~~~vkii~~~------~~~~~~e~~~~~~~~~h~niv~~~~v~~~-~~~~~ 392 (612)
T KOG0603|consen 320 FTESYEFREELGEGSFSAVKYCESSPTDQEPAVKIISKR------ADDNQDEIPISLLVRDHPNIVKSHDVYED-GKEIY 392 (612)
T ss_pred cchhhccccccCCCCccceeeeeccccccchhheecccc------ccccccccchhhhhcCCCcceeecceecC-Cceee
Confidence 467889999999999999999875 45888999998644 12233455455554 59999999996554 66679
Q ss_pred EEEeecCCCChHHHhcCCCCCCCCCChhhHHHHHHHHHHHHHHhhcCCCCCeeeecccCCceee-CCCCcEEEeeecccc
Q 038766 88 LILEYMENGSLESVIHGPGVDHSRWTLPKRIDVLISVANGLDYLHSGYDIPIVHCDMKPSNILL-DRDFEAHVSDFGTSR 166 (299)
Q Consensus 88 lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lh~~~~~~~~H~dl~~~nil~-~~~~~v~l~df~~~~ 166 (299)
+|+|.+.|+-+.+.+- . .+....++..|+.+|+.|+.|||++ +++|||+||+|||+ +..|+++|+|||...
T Consensus 393 ~v~e~l~g~ell~ri~----~-~~~~~~e~~~w~~~lv~Av~~LH~~---gvvhRDLkp~NIL~~~~~g~lrltyFG~a~ 464 (612)
T KOG0603|consen 393 LVMELLDGGELLRRIR----S-KPEFCSEASQWAAELVSAVDYLHEQ---GVVHRDLKPGNILLDGSAGHLRLTYFGFWS 464 (612)
T ss_pred eeehhccccHHHHHHH----h-cchhHHHHHHHHHHHHHHHHHHHhc---CeeecCCChhheeecCCCCcEEEEEechhh
Confidence 9999999888777663 2 2333378888999999999999999 99999999999999 688999999999987
Q ss_pred ccccccccccccccccccCcccCChhhhcccCcCccccchhhhHHHHHHHhCCCCCCCCccCCCCchhHHHHHHHHHhcC
Q 038766 167 MLDVHLQDLSSLSTAFQGTIGYLAPEFAYMRIVTTKVDVFSFGIVVMEFLTKRRPTGLDEENGLSPISLRQLVEKALANG 246 (299)
Q Consensus 167 ~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~DiwslG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~ 246 (299)
..... +....-|..|+|||++...+|+.++|+||||++||+|++|..||...... .+.+..+.
T Consensus 465 ~~~~~-------~~tp~~t~~y~APEvl~~~~yt~acD~WSLGvlLy~ML~G~tp~~~~P~~-------~ei~~~i~--- 527 (612)
T KOG0603|consen 465 ELERS-------CDTPALTLQYVAPEVLAIQEYTEACDWWSLGVLLYEMLTGRTLFAAHPAG-------IEIHTRIQ--- 527 (612)
T ss_pred hCchh-------hcccchhhcccChhhhccCCCCcchhhHHHHHHHHHHHhCCCccccCCch-------HHHHHhhc---
Confidence 65421 34445688999999999999999999999999999999999999644222 11111110
Q ss_pred ccCcccccCccccchhhHhHHHHHHHHHHHHHHHHhcCCCCCCCCChhhhhcC
Q 038766 247 INGVRQITDPKLVSSIYEEQEQHQVLEELFKLALVCTSSNPEDRPNMNELLIT 299 (299)
Q Consensus 247 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rpt~~~il~~ 299 (299)
.+. ....+|..+.+|+.+||.+||.+||++.+++.|
T Consensus 528 --------~~~---------~s~~vS~~AKdLl~~LL~~dP~~Rl~~~~i~~h 563 (612)
T KOG0603|consen 528 --------MPK---------FSECVSDEAKDLLQQLLQVDPALRLGADEIGAH 563 (612)
T ss_pred --------CCc---------cccccCHHHHHHHHHhccCChhhCcChhhhccC
Confidence 000 025678899999999999999999999999876
|
|
| >KOG1006 consensus Mitogen-activated protein kinase (MAPK) kinase MKK4 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.4e-38 Score=243.26 Aligned_cols=258 Identities=27% Similarity=0.343 Sum_probs=196.5
Q ss_pred CCCCCceeecCCcceEEEEEe-CCCcEEEEEEeccCcCChhhhHHHHHHHHHHHhc-CCcceeeeeeEEEcCCCeeEEEE
Q 038766 13 SFSENNIIGNSNLSTVYKGRL-EDGEIVAVKKLNFHQFSAESDKSFYREAKTLKEL-KHRNLVKVLGYAWESGKLKALIL 90 (299)
Q Consensus 13 ~y~~~~~lg~g~~~~v~~~~~-~~~~~~~vK~~~~~~~~~~~~~~~~~e~~~l~~l-~h~~i~~~~~~~~~~~~~~~lv~ 90 (299)
+.+-...||.|+||+|++..+ .+|+..|||.++.... ..+..++..|.....+- ++|+|++++|..+.++.. ++.|
T Consensus 65 ~Lqdlg~iG~G~fG~V~KM~hk~sg~~mAVKrIr~~n~-~keq~rll~e~d~~mks~~cp~IVkfyGa~F~EGdc-WiCM 142 (361)
T KOG1006|consen 65 NLQDLGEIGNGAFGTVNKMLHKPSGKLMAVKRIRSNNI-EKEQKRLLMEHDTVMKSSNCPNIVKFYGALFSEGDC-WICM 142 (361)
T ss_pred hHHHHHHhcCCcchhhhhhhcCccCcEEEEEEeeeccc-hHHHHHHHHHHHHHHhhcCCcHHHHHhhhhhcCCce-eeeH
Confidence 344456799999999999876 4699999999986443 45677788888776665 589999999999987776 9999
Q ss_pred eecCCCChHHHhcC-CCCCCCCCChhhHHHHHHHHHHHHHHhhcCCCCCeeeecccCCceeeCCCCcEEEeeeccccccc
Q 038766 91 EYMENGSLESVIHG-PGVDHSRWTLPKRIDVLISVANGLDYLHSGYDIPIVHCDMKPSNILLDRDFEAHVSDFGTSRMLD 169 (299)
Q Consensus 91 e~~~~~~L~~~~~~-~~~~~~~~~~~~~~~i~~qi~~~l~~lh~~~~~~~~H~dl~~~nil~~~~~~v~l~df~~~~~~~ 169 (299)
|.++ .++..+.+. +...+..++|+.+-.|....+.||.||... .+++|||+||+|||++..|.|||+|||++-.+.
T Consensus 143 ELMd-~SlDklYk~vy~vq~~~ipE~Ilg~ItvatV~AL~yLK~~--lkiIHRDvKPSNILldr~G~vKLCDFGIcGqLv 219 (361)
T KOG1006|consen 143 ELMD-ISLDKLYKRVYSVQKSRIPENILGHITVATVDALDYLKEE--LKIIHRDVKPSNILLDRHGDVKLCDFGICGQLV 219 (361)
T ss_pred HHHh-hhHHHHHHHHHHHHhccCcHhhhhheeeeehhHHHHHHHH--hhhhhccCChhheEEecCCCEeeecccchHhHH
Confidence 9994 477665432 222456899999999999999999999976 499999999999999999999999999997543
Q ss_pred cccccccccccccccCcccCChhhhcc--cCcCccccchhhhHHHHHHHhCCCCCCCCccCCCCchhHHHHHHHHHhcCc
Q 038766 170 VHLQDLSSLSTAFQGTIGYLAPEFAYM--RIVTTKVDVFSFGIVVMEFLTKRRPTGLDEENGLSPISLRQLVEKALANGI 247 (299)
Q Consensus 170 ~~~~~~~~~~~~~~~~~~y~~PE~~~~--~~~~~~~DiwslG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 247 (299)
. +-..+.-.|-..|+|||.+.. .+|+.+||+||||+++||+.||..|+. .|...+++......
T Consensus 220 ~-----SiAkT~daGCrpYmAPERi~p~~~gyDiRSDvWSLGITL~EvAtG~fPyr----------~w~svfeql~~Vv~ 284 (361)
T KOG1006|consen 220 D-----SIAKTVDAGCRPYMAPERIDPSDKGYDIRSDVWSLGITLYEVATGNFPYR----------KWDSVFEQLCQVVI 284 (361)
T ss_pred H-----HHHhhhccCCccccChhccCCccCCcchhhhhhhhcceEeeeecCCCCcc----------hHHHHHHHHHHHHc
Confidence 1 111223346678999997663 469999999999999999999999973 34445555443221
Q ss_pred cCcccccCccccchhhHhHHHHHHHHHHHHHHHHhcCCCCCCCCChhhhhcC
Q 038766 248 NGVRQITDPKLVSSIYEEQEQHQVLEELFKLALVCTSSNPEDRPNMNELLIT 299 (299)
Q Consensus 248 ~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rpt~~~il~~ 299 (299)
-....+.... ....++..+..+|.-||..|-++||...+++++
T Consensus 285 gdpp~l~~~~---------~~~~~s~~~~~fintCl~Kd~~~Rpky~~Lk~~ 327 (361)
T KOG1006|consen 285 GDPPILLFDK---------ECVHYSFSMVRFINTCLIKDRSDRPKYDDLKKF 327 (361)
T ss_pred CCCCeecCcc---------cccccCHHHHHHHHHHhhcccccCcchhhhhcC
Confidence 1111111111 123456789999999999999999999998764
|
|
| >KOG2052 consensus Activin A type IB receptor, serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-35 Score=245.65 Aligned_cols=264 Identities=24% Similarity=0.365 Sum_probs=202.8
Q ss_pred HHHhCCCCCCceeecCCcceEEEEEeCCCcEEEEEEeccCcCChhhhHHHHHHHHHHHhc--CCcceeeeeeEEEcCC--
Q 038766 8 ENATGSFSENNIIGNSNLSTVYKGRLEDGEIVAVKKLNFHQFSAESDKSFYREAKTLKEL--KHRNLVKVLGYAWESG-- 83 (299)
Q Consensus 8 ~~~~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~vK~~~~~~~~~~~~~~~~~e~~~l~~l--~h~~i~~~~~~~~~~~-- 83 (299)
..++.+..+.+.||+|.||.||++.++ |+.||||++. ...+..+.+|.++++.. +|+||+.+++......
T Consensus 207 RTiarqI~L~e~IGkGRyGEVwrG~wr-Ge~VAVKiF~-----srdE~SWfrEtEIYqTvmLRHENILgFIaaD~~~~gs 280 (513)
T KOG2052|consen 207 RTIARQIVLQEIIGKGRFGEVWRGRWR-GEDVAVKIFS-----SRDERSWFRETEIYQTVMLRHENILGFIAADNKDNGS 280 (513)
T ss_pred HhhhheeEEEEEecCccccceeecccc-CCceEEEEec-----ccchhhhhhHHHHHHHHHhccchhhhhhhccccCCCc
Confidence 457788899999999999999999997 8999999985 34566888899888876 8999999998654332
Q ss_pred -CeeEEEEeecCCCChHHHhcCCCCCCCCCChhhHHHHHHHHHHHHHHhhcC-----CCCCeeeecccCCceeeCCCCcE
Q 038766 84 -KLKALILEYMENGSLESVIHGPGVDHSRWTLPKRIDVLISVANGLDYLHSG-----YDIPIVHCDMKPSNILLDRDFEA 157 (299)
Q Consensus 84 -~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lh~~-----~~~~~~H~dl~~~nil~~~~~~v 157 (299)
..+++|.+|.+.|+|.+++++ .+++.+..++++..++++|++||.. ++..+.|||||..||||.++|..
T Consensus 281 ~TQLwLvTdYHe~GSL~DyL~r-----~tv~~~~ml~LalS~AsGLaHLH~eI~GTqgKPaIAHRDlKSKNILVKkn~~C 355 (513)
T KOG2052|consen 281 WTQLWLVTDYHEHGSLYDYLNR-----NTVTTEGMLKLALSIASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTC 355 (513)
T ss_pred eEEEEEeeecccCCcHHHHHhh-----ccCCHHHHHHHHHHHhhhHHHHHHHHhcCCCCchhhccccccccEEEccCCcE
Confidence 347899999999999999963 5799999999999999999999963 44579999999999999999999
Q ss_pred EEeeeccccccccccccccccccccccCcccCChhhhcccCc------CccccchhhhHHHHHHHhC----------CCC
Q 038766 158 HVSDFGTSRMLDVHLQDLSSLSTAFQGTIGYLAPEFAYMRIV------TTKVDVFSFGIVVMEFLTK----------RRP 221 (299)
Q Consensus 158 ~l~df~~~~~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~------~~~~DiwslG~~l~~l~~g----------~~p 221 (299)
.|+|+|++-..........-..+..+||..|||||++..... -..+||||||.++||+.-. ..|
T Consensus 356 ~IADLGLAv~h~~~t~~idi~~N~rVGTKRYMAPEvLdetin~~~Fesyk~ADIYafgLVlWEiarRc~~ggi~eey~~P 435 (513)
T KOG2052|consen 356 CIADLGLAVRHDSDTDTIDIPPNPRVGTKRYMAPEVLDETINMKHFESYKRADIYAFGLVLWEIARRCESGGIVEEYQLP 435 (513)
T ss_pred EEeeceeeEEecccCCcccCCCCCccceeeccChHHhhhhcChhhhhhhhHHHHHHHHHHHHHHHHHhhcCCEehhhcCC
Confidence 999999998776554555556678899999999998876432 1368999999999999864 355
Q ss_pred CCCCccCCCCchhHHHHHHHHHhcCccCcccccCccccchhhHhHHHHHHHHHHHHHHHHhcCCCCCCCCChhhh
Q 038766 222 TGLDEENGLSPISLRQLVEKALANGINGVRQITDPKLVSSIYEEQEQHQVLEELFKLALVCTSSNPEDRPNMNEL 296 (299)
Q Consensus 222 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rpt~~~i 296 (299)
|..-..++.+..++.+++=. ...+......+ ........+..+++.||..+|.-|.|+-.+
T Consensus 436 yyd~Vp~DPs~eeMrkVVCv------~~~RP~ipnrW--------~s~~~l~~m~klMkeCW~~Np~aRltALri 496 (513)
T KOG2052|consen 436 YYDVVPSDPSFEEMRKVVCV------QKLRPNIPNRW--------KSDPALRVMAKLMKECWYANPAARLTALRI 496 (513)
T ss_pred cccCCCCCCCHHHHhcceee------cccCCCCCccc--------ccCHHHHHHHHHHHHhhcCCchhhhHHHHH
Confidence 54433344333343332210 01111111111 133445678889999999999999998654
|
|
| >KOG0196 consensus Tyrosine kinase, EPH (ephrin) receptor family [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.2e-37 Score=268.33 Aligned_cols=257 Identities=28% Similarity=0.456 Sum_probs=210.2
Q ss_pred HHHhCCCCCCceeecCCcceEEEEEeC----CCcEEEEEEeccCcCChhhhHHHHHHHHHHHhcCCcceeeeeeEEEcCC
Q 038766 8 ENATGSFSENNIIGNSNLSTVYKGRLE----DGEIVAVKKLNFHQFSAESDKSFYREAKTLKELKHRNLVKVLGYAWESG 83 (299)
Q Consensus 8 ~~~~~~y~~~~~lg~g~~~~v~~~~~~----~~~~~~vK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~ 83 (299)
|+-.+...|.++||.|.||.|++++.+ ....||||+++. ......+..+..|+.+|-++.||||+.+.|++ ...
T Consensus 625 EId~s~i~Ie~VIGaGEFGEVc~GrLk~pgkre~~VAIKTLK~-GytekqrrdFL~EAsIMGQFdHPNIIrLEGVV-Tks 702 (996)
T KOG0196|consen 625 EIDPSCVKIEKVIGAGEFGEVCSGRLKLPGKREITVAIKTLKA-GYTEKQRRDFLSEASIMGQFDHPNIIRLEGVV-TKS 702 (996)
T ss_pred hcChhheEEEEEEecccccceecccccCCCCcceeEEEeeecc-CccHHHHhhhhhhhhhcccCCCCcEEEEEEEE-ecC
Confidence 455667788999999999999999864 245699999963 44555567789999999999999999999954 456
Q ss_pred CeeEEEEeecCCCChHHHhcCCCCCCCCCChhhHHHHHHHHHHHHHHhhcCCCCCeeeecccCCceeeCCCCcEEEeeec
Q 038766 84 KLKALILEYMENGSLESVIHGPGVDHSRWTLPKRIDVLISVANGLDYLHSGYDIPIVHCDMKPSNILLDRDFEAHVSDFG 163 (299)
Q Consensus 84 ~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lh~~~~~~~~H~dl~~~nil~~~~~~v~l~df~ 163 (299)
+...||.|||+.|+|..++... ...++..++.-+++.|+++++||-+. ++|||||...||||+.+-..|++|||
T Consensus 703 ~PvMIiTEyMENGsLDsFLR~~---DGqftviQLVgMLrGIAsGMkYLsdm---~YVHRDLAARNILVNsnLvCKVsDFG 776 (996)
T KOG0196|consen 703 KPVMIITEYMENGSLDSFLRQN---DGQFTVIQLVGMLRGIASGMKYLSDM---NYVHRDLAARNILVNSNLVCKVSDFG 776 (996)
T ss_pred ceeEEEhhhhhCCcHHHHHhhc---CCceEeehHHHHHHHHHHHhHHHhhc---CchhhhhhhhheeeccceEEEecccc
Confidence 6779999999999999999754 35689999999999999999999998 99999999999999999999999999
Q ss_pred cccccccccccccccccccccCcccCChhhhcccCcCccccchhhhHHHHHHHh-CCCCCCCCccCCCCchhHHHHHHHH
Q 038766 164 TSRMLDVHLQDLSSLSTAFQGTIGYLAPEFAYMRIVTTKVDVFSFGIVVMEFLT-KRRPTGLDEENGLSPISLRQLVEKA 242 (299)
Q Consensus 164 ~~~~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~DiwslG~~l~~l~~-g~~p~~~~~~~~~~~~~~~~~~~~~ 242 (299)
+++.+....+...+..+.+ -+..|.|||.+.....+.+|||||+|+++||.|+ |..|+ .++.+.++...+++.
T Consensus 777 LSRvledd~~~~ytt~GGK-IPiRWTAPEAIa~RKFTsASDVWSyGIVmWEVmSyGERPY-----WdmSNQdVIkaIe~g 850 (996)
T KOG0196|consen 777 LSRVLEDDPEAAYTTLGGK-IPIRWTAPEAIAYRKFTSASDVWSYGIVMWEVMSYGERPY-----WDMSNQDVIKAIEQG 850 (996)
T ss_pred ceeecccCCCccccccCCc-cceeecChhHhhhcccCchhhccccceEEEEecccCCCcc-----cccchHHHHHHHHhc
Confidence 9997763321111111111 2468999999999999999999999999999885 77776 666777766666553
Q ss_pred HhcCccCcccccCccccchhhHhHHHHHHHHHHHHHHHHhcCCCCCCCCChhhhhc
Q 038766 243 LANGINGVRQITDPKLVSSIYEEQEQHQVLEELFKLALVCTSSNPEDRPNMNELLI 298 (299)
Q Consensus 243 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rpt~~~il~ 298 (299)
.+ .+.+.+.+..|.+|+..||+.|-.+||++.||+.
T Consensus 851 yR--------------------LPpPmDCP~aL~qLMldCWqkdR~~RP~F~qiV~ 886 (996)
T KOG0196|consen 851 YR--------------------LPPPMDCPAALYQLMLDCWQKDRNRRPKFAQIVS 886 (996)
T ss_pred cC--------------------CCCCCCCcHHHHHHHHHHHHHHhhcCCCHHHHHH
Confidence 32 1225677788999999999999999999999975
|
|
| >KOG0587 consensus Traf2- and Nck-interacting kinase and related germinal center kinase (GCK) family protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-34 Score=257.34 Aligned_cols=254 Identities=25% Similarity=0.389 Sum_probs=208.4
Q ss_pred hCCCCCCceeecCCcceEEEEEe-CCCcEEEEEEeccCcCChhhhHHHHHHHHHHHhcC-CcceeeeeeEEEc----CCC
Q 038766 11 TGSFSENNIIGNSNLSTVYKGRL-EDGEIVAVKKLNFHQFSAESDKSFYREAKTLKELK-HRNLVKVLGYAWE----SGK 84 (299)
Q Consensus 11 ~~~y~~~~~lg~g~~~~v~~~~~-~~~~~~~vK~~~~~~~~~~~~~~~~~e~~~l~~l~-h~~i~~~~~~~~~----~~~ 84 (299)
.+-|.+...+|.|.+|.||+++. ++++..|+|+... ..+..+.+..|.++++... |||+..+++++.. .++
T Consensus 18 ~d~~ei~evig~Gtygkv~k~k~~~~~~~aa~kI~~~---~~d~deEiE~eynil~~~~~hpnv~~fyg~~~k~~~~~~D 94 (953)
T KOG0587|consen 18 ADIFEIIEVIGNGTYGKVYKGRHVKTGQLAAIKIMDP---TEDEEEEIELEYNMLKKYSHHPNVATFYGAFIKKDPGNGD 94 (953)
T ss_pred CCccEEEEEEeeccceeEEEEeeeecCceeeeEeecC---CccccHHHHHHHHHHHhccCCCCcceEEEEEEEecCCCCC
Confidence 45688999999999999999985 5689999998754 3455667788999999986 9999999998863 346
Q ss_pred eeEEEEeecCCCChHHHhcCCCCCCCCCChhhHHHHHHHHHHHHHHhhcCCCCCeeeecccCCceeeCCCCcEEEeeecc
Q 038766 85 LKALILEYMENGSLESVIHGPGVDHSRWTLPKRIDVLISVANGLDYLHSGYDIPIVHCDMKPSNILLDRDFEAHVSDFGT 164 (299)
Q Consensus 85 ~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lh~~~~~~~~H~dl~~~nil~~~~~~v~l~df~~ 164 (299)
.+++|||+|.+|++.++++... +.++.|+.+..|++.++.|+++||++ .++|+|+|-.|||++.+|.|||.|||.
T Consensus 95 qLWLVMEfC~gGSVTDLVKn~~--g~rl~E~~IaYI~re~lrgl~HLH~n---kviHRDikG~NiLLT~e~~VKLvDFGv 169 (953)
T KOG0587|consen 95 QLWLVMEFCGGGSVTDLVKNTK--GNRLKEEWIAYILREILRGLAHLHNN---KVIHRDIKGQNVLLTENAEVKLVDFGV 169 (953)
T ss_pred eEEEEeeccCCccHHHHHhhhc--ccchhhHHHHHHHHHHHHHHHHHhhc---ceeeecccCceEEEeccCcEEEeeeee
Confidence 7899999999999999998764 78999999999999999999999999 999999999999999999999999999
Q ss_pred ccccccccccccccccccccCcccCChhhhcc-----cCcCccccchhhhHHHHHHHhCCCCCCCCccCCCCchhHHHHH
Q 038766 165 SRMLDVHLQDLSSLSTAFQGTIGYLAPEFAYM-----RIVTTKVDVFSFGIVVMEFLTKRRPTGLDEENGLSPISLRQLV 239 (299)
Q Consensus 165 ~~~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~-----~~~~~~~DiwslG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~ 239 (299)
+..+.. .........|||.|||||++.. ..|+.++|+||||++..+|.-|.+|+... . .+
T Consensus 170 SaQlds----T~grRnT~iGtP~WMAPEViac~e~~d~tyd~R~D~WsLGITaIEladG~PPl~Dm-----H------Pm 234 (953)
T KOG0587|consen 170 SAQLDS----TVGRRNTFIGTPYWMAPEVIACDESPDATYDYRSDLWSLGITAIEMAEGAPPLCDM-----H------PM 234 (953)
T ss_pred eeeeec----ccccccCcCCCcccccceeeecccCCCCCcccccchhhccceeehhcCCCCCccCc-----c------hh
Confidence 986652 3345667789999999997663 34778999999999999999999998432 1 11
Q ss_pred HHHHhcCccCcccccCccccchhhHhHHHHHHHHHHHHHHHHhcCCCCCCCCChhhhhcC
Q 038766 240 EKALANGINGVRQITDPKLVSSIYEEQEQHQVLEELFKLALVCTSSNPEDRPNMNELLIT 299 (299)
Q Consensus 240 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rpt~~~il~~ 299 (299)
...+ .+...+.|+... +..-++++.++|..||..|-.+||++.++|+|
T Consensus 235 raLF-----~IpRNPPPkLkr-------p~kWs~~FndFIs~cL~Kd~e~RP~~~~ll~h 282 (953)
T KOG0587|consen 235 RALF-----LIPRNPPPKLKR-------PKKWSKKFNDFISTCLVKDYEQRPSTEELLKH 282 (953)
T ss_pred hhhc-----cCCCCCCccccc-------hhhHHHHHHHHHHHHHhhccccCcchhhhccC
Confidence 1111 111122222221 45557789999999999999999999999987
|
|
| >PLN03225 Serine/threonine-protein kinase SNT7; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.3e-35 Score=263.05 Aligned_cols=269 Identities=17% Similarity=0.196 Sum_probs=166.6
Q ss_pred HhCCCCCCceeecCCcceEEEEEeC-C----CcEEEEEEeccCcCChhhhHHHHHHHHHHHhcCCcceeeeeeEE-----
Q 038766 10 ATGSFSENNIIGNSNLSTVYKGRLE-D----GEIVAVKKLNFHQFSAESDKSFYREAKTLKELKHRNLVKVLGYA----- 79 (299)
Q Consensus 10 ~~~~y~~~~~lg~g~~~~v~~~~~~-~----~~~~~vK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~----- 79 (299)
-.++|.+.+.||+|+||.||++.+. + +..||+|++.... ..+....+ .++...+.++..+...+
T Consensus 130 ~~~~y~l~~~LG~G~FG~VYka~~~~~~~~~~~~vAvK~~~~~~----~~e~~~~e--~l~~~~~~~~~~~~~~~~~~~~ 203 (566)
T PLN03225 130 KKDDFVLGKKLGEGAFGVVYKASLVNKQSKKEGKYVLKKATEYG----AVEIWMNE--RVRRACPNSCADFVYGFLEPVS 203 (566)
T ss_pred ccCCeEEeEEEeeCCCeEEEEEEEcCCccccCcEEEEEEecccc----hhHHHHHH--HHHhhchhhHHHHHHhhhcccc
Confidence 4578999999999999999999874 4 6899999875321 11111111 11111122222211111
Q ss_pred EcCCCeeEEEEeecCCCChHHHhcCCCC----------------CCCCCChhhHHHHHHHHHHHHHHhhcCCCCCeeeec
Q 038766 80 WESGKLKALILEYMENGSLESVIHGPGV----------------DHSRWTLPKRIDVLISVANGLDYLHSGYDIPIVHCD 143 (299)
Q Consensus 80 ~~~~~~~~lv~e~~~~~~L~~~~~~~~~----------------~~~~~~~~~~~~i~~qi~~~l~~lh~~~~~~~~H~d 143 (299)
...+...++|+||+.+++|.+++..... .........+..++.|++.||.|||+. +++|||
T Consensus 204 ~~~~~~~~LV~ey~~~gsL~~~l~~~~~~~~v~~~l~~~~~~l~~~~~r~~~~i~~i~~qll~aL~yLH~~---gIiHRD 280 (566)
T PLN03225 204 SKKEDEYWLVWRYEGESTLADLMQSKEFPYNVEPYLLGKVQDLPKGLERENKIIQTIMRQILFALDGLHST---GIVHRD 280 (566)
T ss_pred cccCCceEEEEEecCCCcHHHHHHhcCCchhHHHHhccchhhccccchhhHHHHHHHHHHHHHHHHHHHHC---CEEeCc
Confidence 1334567999999999999988863210 001122345678999999999999999 999999
Q ss_pred ccCCceeeCC-CCcEEEeeeccccccccccccccccccccccCcccCChhhhccc----------------------CcC
Q 038766 144 MKPSNILLDR-DFEAHVSDFGTSRMLDVHLQDLSSLSTAFQGTIGYLAPEFAYMR----------------------IVT 200 (299)
Q Consensus 144 l~~~nil~~~-~~~v~l~df~~~~~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~----------------------~~~ 200 (299)
|||+|||++. ++.+||+|||++..+... .........+++.|+|||.+... .++
T Consensus 281 LKP~NILl~~~~~~~KL~DFGlA~~l~~~---~~~~~~~~~~t~~Y~APE~~~~~~~~~~~~~~~~~~~~sp~l~~~~~~ 357 (566)
T PLN03225 281 VKPQNIIFSEGSGSFKIIDLGAAADLRVG---INYIPKEFLLDPRYAAPEQYIMSTQTPSAPSAPVATALSPVLWQLNLP 357 (566)
T ss_pred CCHHHEEEeCCCCcEEEEeCCCccccccc---cccCCcccccCCCccChHHhhccCCCCCCccccccccccchhccccCC
Confidence 9999999985 578999999999755421 12233455678999999965432 234
Q ss_pred ccccchhhhHHHHHHHhCCCCCCCCccCCCCchhHHHHHHHHHhcCcc--CcccccCccccchh-hHhHHHHHHHHHHHH
Q 038766 201 TKVDVFSFGIVVMEFLTKRRPTGLDEENGLSPISLRQLVEKALANGIN--GVRQITDPKLVSSI-YEEQEQHQVLEELFK 277 (299)
Q Consensus 201 ~~~DiwslG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~~~~-~~~~~~~~~~~~l~~ 277 (299)
.++||||+||++|+|+++..++... ...........+.+ .............. .............++
T Consensus 358 ~k~DVwSlGviL~el~~~~~~~~~~---------~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~d 428 (566)
T PLN03225 358 DRFDIYSAGLIFLQMAFPNLRSDSN---------LIQFNRQLKRNDYDLVAWRKLVEPRASPDLRRGFEVLDLDGGAGWE 428 (566)
T ss_pred CCcccHHHHHHHHHHHhCcCCCchH---------HHHHHHHHHhcCCcHHHHHHhhccccchhhhhhhhhccccchHHHH
Confidence 4679999999999999876553211 11111111110000 00000000000000 000001111234668
Q ss_pred HHHHhcCCCCCCCCChhhhhcC
Q 038766 278 LALVCTSSNPEDRPNMNELLIT 299 (299)
Q Consensus 278 li~~~l~~dP~~Rpt~~~il~~ 299 (299)
||++||..||++|||++++|+|
T Consensus 429 Li~~mL~~dP~kR~ta~e~L~H 450 (566)
T PLN03225 429 LLKSMMRFKGRQRISAKAALAH 450 (566)
T ss_pred HHHHHccCCcccCCCHHHHhCC
Confidence 9999999999999999999998
|
|
| >KOG0670 consensus U4/U6-associated splicing factor PRP4 [RNA processing and modification] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-36 Score=254.35 Aligned_cols=282 Identities=21% Similarity=0.239 Sum_probs=209.0
Q ss_pred ChHHHHHHhCCCCCCceeecCCcceEEEEEeCC-CcEEEEEEeccCcCChhhhHHHHHHHHHHHhcCC------cceeee
Q 038766 3 DRTEIENATGSFSENNIIGNSNLSTVYKGRLED-GEIVAVKKLNFHQFSAESDKSFYREAKTLKELKH------RNLVKV 75 (299)
Q Consensus 3 ~~~~~~~~~~~y~~~~~lg~g~~~~v~~~~~~~-~~~~~vK~~~~~~~~~~~~~~~~~e~~~l~~l~h------~~i~~~ 75 (299)
.+.-.|.+-++|.+....|+|=|++|..|.+.. |..||||+|.... --.+.=+.|+++|++|+. -|++.+
T Consensus 423 rv~igE~LD~RY~V~~~~GkGvFs~Vvra~D~~r~~~vAiKIIRnNE---~M~KtGl~EleiLkKL~~AD~Edk~Hclrl 499 (752)
T KOG0670|consen 423 RVRIGELLDSRYEVQGYTGKGVFSTVVRARDQARGQEVAIKIIRNNE---VMHKTGLKELEILKKLNDADPEDKFHCLRL 499 (752)
T ss_pred EEehhhhhcceeEEEeccccceeeeeeeccccCCCCeeEEEEeecch---HHhhhhhHHHHHHHHhhccCchhhhHHHHH
Confidence 344568899999999999999999999998754 7899999996322 223445679999999963 477888
Q ss_pred eeEEEcCCCeeEEEEeecCCCChHHHhcCCCCCCCCCChhhHHHHHHHHHHHHHHhhcCCCCCeeeecccCCceeeCCC-
Q 038766 76 LGYAWESGKLKALILEYMENGSLESVIHGPGVDHSRWTLPKRIDVLISVANGLDYLHSGYDIPIVHCDMKPSNILLDRD- 154 (299)
Q Consensus 76 ~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lh~~~~~~~~H~dl~~~nil~~~~- 154 (299)
+..|.. .+++|+|||.+ ..+|.++++.+| .+-.+....+..++.|++.||..|..- +++|.||||+||||+.+
T Consensus 500 ~r~F~h-knHLClVFE~L-slNLRevLKKyG-~nvGL~ikaVRsYaqQLflALklLK~c---~vlHaDIKPDNiLVNE~k 573 (752)
T KOG0670|consen 500 FRHFKH-KNHLCLVFEPL-SLNLREVLKKYG-RNVGLHIKAVRSYAQQLFLALKLLKKC---GVLHADIKPDNILVNESK 573 (752)
T ss_pred HHHhhh-cceeEEEehhh-hchHHHHHHHhC-cccceeehHHHHHHHHHHHHHHHHHhc---CeeecccCccceEeccCc
Confidence 775544 66789999999 569999999988 777899999999999999999999997 99999999999999865
Q ss_pred CcEEEeeeccccccccccccccccccccccCcccCChhhhcccCcCccccchhhhHHHHHHHhCCCCCCCCccCCCCchh
Q 038766 155 FEAHVSDFGTSRMLDVHLQDLSSLSTAFQGTIGYLAPEFAYMRIVTTKVDVFSFGIVVMEFLTKRRPTGLDEENGLSPIS 234 (299)
Q Consensus 155 ~~v~l~df~~~~~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~DiwslG~~l~~l~~g~~p~~~~~~~~~~~~~ 234 (299)
+.+||||||.+..... +. -+....+.-|.|||++.+..|+...|+||.||+||+|+||...|.+..++.+....
T Consensus 574 ~iLKLCDfGSA~~~~e-----ne-itPYLVSRFYRaPEIiLG~~yd~~iD~WSvgctLYElYtGkIlFpG~TNN~MLrl~ 647 (752)
T KOG0670|consen 574 NILKLCDFGSASFASE-----NE-ITPYLVSRFYRAPEIILGLPYDYPIDTWSVGCTLYELYTGKILFPGRTNNQMLRLF 647 (752)
T ss_pred ceeeeccCcccccccc-----cc-ccHHHHHHhccCcceeecCcccCCccceeeceeeEEeeccceecCCCCcHHHHHHH
Confidence 5679999999875441 11 12223456799999999999999999999999999999999999877665442211
Q ss_pred HH-------------HHHHHHHhcCccCccc----cc---------C--c-cccchhh-----HhHHHHHHHHHHHHHHH
Q 038766 235 LR-------------QLVEKALANGINGVRQ----IT---------D--P-KLVSSIY-----EEQEQHQVLEELFKLAL 280 (299)
Q Consensus 235 ~~-------------~~~~~~~~~~~~~~~~----~~---------~--~-~~~~~~~-----~~~~~~~~~~~l~~li~ 280 (299)
+. .+..+-+....+-+.. ++ . | +...... ..........++.+|+.
T Consensus 648 me~KGk~p~KmlRKgqF~dqHFD~d~nf~~~e~D~vT~r~~~~vm~~vkPtkdl~s~l~~~q~~~deq~~~~~~~rdLLd 727 (752)
T KOG0670|consen 648 MELKGKFPNKMLRKGQFKDQHFDQDLNFLYIEVDKVTEREKRTVMVNVKPTKDLGSELIAVQRLPDEQPKIVQQLRDLLD 727 (752)
T ss_pred HHhcCCCcHHHhhhcchhhhhcccccceEEEeccccccceeEEEecccCcchhHHHHHhccCCCCchhHHHHHHHHHHHH
Confidence 11 1111111111110000 00 0 0 0000000 01123455678999999
Q ss_pred HhcCCCCCCCCChhhhhcC
Q 038766 281 VCTSSNPEDRPNMNELLIT 299 (299)
Q Consensus 281 ~~l~~dP~~Rpt~~~il~~ 299 (299)
+||..||++|.|++++|.|
T Consensus 728 kml~LdP~KRit~nqAL~H 746 (752)
T KOG0670|consen 728 KMLILDPEKRITVNQALKH 746 (752)
T ss_pred HHhccChhhcCCHHHHhcC
Confidence 9999999999999999987
|
|
| >smart00220 S_TKc Serine/Threonine protein kinases, catalytic domain | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.8e-34 Score=234.07 Aligned_cols=240 Identities=30% Similarity=0.435 Sum_probs=188.1
Q ss_pred CcceEEEEEeC-CCcEEEEEEeccCcCChhhhHHHHHHHHHHHhcCCcceeeeeeEEEcCCCeeEEEEeecCCCChHHHh
Q 038766 24 NLSTVYKGRLE-DGEIVAVKKLNFHQFSAESDKSFYREAKTLKELKHRNLVKVLGYAWESGKLKALILEYMENGSLESVI 102 (299)
Q Consensus 24 ~~~~v~~~~~~-~~~~~~vK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~lv~e~~~~~~L~~~~ 102 (299)
++|.||++.+. +++.+++|++........ ...+.+|++.+++++|+|++++.+.+.. ....++++|++.+++|.+++
T Consensus 1 ~~g~v~~~~~~~~~~~~~~k~~~~~~~~~~-~~~~~~e~~~~~~l~~~~i~~~~~~~~~-~~~~~l~~e~~~~~~L~~~~ 78 (244)
T smart00220 1 SFGKVYLARDKKTGKLVAIKVIKKEKIKKK-RERILREISILKKLKHPNIVRLYDVFED-EDKLYLVMEYCDGGDLFDLL 78 (244)
T ss_pred CceEEEEEEECCCCcEEEEEEecccccccH-HHHHHHHHHHHHhCCCCcHHHHHhheee-CCEEEEEEeCCCCCCHHHHH
Confidence 57899999876 489999999874432221 6788999999999999999999997665 45669999999888999998
Q ss_pred cCCCCCCCCCChhhHHHHHHHHHHHHHHhhcCCCCCeeeecccCCceeeCCCCcEEEeeecccccccccccccccccccc
Q 038766 103 HGPGVDHSRWTLPKRIDVLISVANGLDYLHSGYDIPIVHCDMKPSNILLDRDFEAHVSDFGTSRMLDVHLQDLSSLSTAF 182 (299)
Q Consensus 103 ~~~~~~~~~~~~~~~~~i~~qi~~~l~~lh~~~~~~~~H~dl~~~nil~~~~~~v~l~df~~~~~~~~~~~~~~~~~~~~ 182 (299)
.. ...++...++.++.+++.++.+||+. +++|+||+|+||+++.++.++++|||.+...... ......
T Consensus 79 ~~----~~~~~~~~~~~~~~~l~~~l~~lh~~---~i~h~~i~~~ni~~~~~~~~~l~d~~~~~~~~~~-----~~~~~~ 146 (244)
T smart00220 79 KK----RGRLSEDEARFYARQILSALEYLHSN---GIIHRDLKPENILLDEDGHVKLADFGLARQLDPG-----GLLTTF 146 (244)
T ss_pred Hh----ccCCCHHHHHHHHHHHHHHHHHHHHc---CeecCCcCHHHeEECCCCcEEEccccceeeeccc-----cccccc
Confidence 63 33489999999999999999999999 9999999999999999999999999998765421 123344
Q ss_pred ccCcccCChhhhcccCcCccccchhhhHHHHHHHhCCCCCCCCccCCCCchhHHHHHHHHHhcCccCcccccCccccchh
Q 038766 183 QGTIGYLAPEFAYMRIVTTKVDVFSFGIVVMEFLTKRRPTGLDEENGLSPISLRQLVEKALANGINGVRQITDPKLVSSI 262 (299)
Q Consensus 183 ~~~~~y~~PE~~~~~~~~~~~DiwslG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 262 (299)
.++..|+|||......++.++|+|++|+++++|++|..||... .........+. ...... ...
T Consensus 147 ~~~~~~~~pE~~~~~~~~~~~Di~slG~~l~~l~~~~~p~~~~----~~~~~~~~~~~----~~~~~~---~~~------ 209 (244)
T smart00220 147 VGTPEYMAPEVLLGKGYGKAVDVWSLGVILYELLTGKPPFPGD----DQLLELFKKIG----KPKPPF---PPP------ 209 (244)
T ss_pred cCCcCCCCHHHHccCCCCchhhHHHHHHHHHHHHhCCCCCCCC----CcHHHHHHHHh----ccCCCC---ccc------
Confidence 5678899999998888899999999999999999999998532 11111111111 110000 000
Q ss_pred hHhHHHHHHHHHHHHHHHHhcCCCCCCCCChhhhhcC
Q 038766 263 YEEQEQHQVLEELFKLALVCTSSNPEDRPNMNELLIT 299 (299)
Q Consensus 263 ~~~~~~~~~~~~l~~li~~~l~~dP~~Rpt~~~il~~ 299 (299)
...++..+.+++.+|+..+|++|||+.++++|
T Consensus 210 -----~~~~~~~~~~~i~~~l~~~p~~Rp~~~~~~~~ 241 (244)
T smart00220 210 -----EWKISPEAKDLIRKLLVKDPEKRLTAEEALQH 241 (244)
T ss_pred -----cccCCHHHHHHHHHHccCCchhccCHHHHhhC
Confidence 00145689999999999999999999999986
|
Phosphotransferases. Serine or threonine-specific kinase subfamily. |
| >KOG1290 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.9e-34 Score=237.96 Aligned_cols=132 Identities=25% Similarity=0.388 Sum_probs=113.7
Q ss_pred CCCCCCceeecCCcceEEEEEe-CCCcEEEEEEeccCcCChhhhHHHHHHHHHHHhcC-C-------cceeeeeeEEEc-
Q 038766 12 GSFSENNIIGNSNLSTVYKGRL-EDGEIVAVKKLNFHQFSAESDKSFYREAKTLKELK-H-------RNLVKVLGYAWE- 81 (299)
Q Consensus 12 ~~y~~~~~lg~g~~~~v~~~~~-~~~~~~~vK~~~~~~~~~~~~~~~~~e~~~l~~l~-h-------~~i~~~~~~~~~- 81 (299)
.+|.+.++||.|-|++||++.+ .+++.||+|+.+-. ....+....|+.+|+.++ + ..|+++++.|..
T Consensus 78 gRY~v~rKLGWGHFSTVWLawDtq~~r~VAlKVvKSA---qhYtEaAlDEIklL~~v~~~Dp~~~~~~~VV~LlD~Fkhs 154 (590)
T KOG1290|consen 78 GRYHVQRKLGWGHFSTVWLAWDTQNKRYVALKVVKSA---QHYTEAALDEIKLLQQVREGDPNDPGKKCVVQLLDHFKHS 154 (590)
T ss_pred ceEEEEEeccccccceeEEEeeccCCeEEEEEEEehh---hHHHHHHHHHHHHHHHHHhcCCCCCCCceeeeeeccceec
Confidence 7899999999999999999987 45889999998632 234566788999999985 2 469999997754
Q ss_pred --CCCeeEEEEeecCCCChHHHhcCCCCCCCCCChhhHHHHHHHHHHHHHHhhcCCCCCeeeecccCCceee
Q 038766 82 --SGKLKALILEYMENGSLESVIHGPGVDHSRWTLPKRIDVLISVANGLDYLHSGYDIPIVHCDMKPSNILL 151 (299)
Q Consensus 82 --~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lh~~~~~~~~H~dl~~~nil~ 151 (299)
++.+.|+|+|++ |.+|..+|... .-..++...+.+|+.||+.||.|||+.| +|+|.||||+|||+
T Consensus 155 GpNG~HVCMVfEvL-GdnLLklI~~s--~YrGlpl~~VK~I~~qvL~GLdYLH~ec--gIIHTDlKPENvLl 221 (590)
T KOG1290|consen 155 GPNGQHVCMVFEVL-GDNLLKLIKYS--NYRGLPLSCVKEICRQVLTGLDYLHREC--GIIHTDLKPENVLL 221 (590)
T ss_pred CCCCcEEEEEehhh-hhHHHHHHHHh--CCCCCcHHHHHHHHHHHHHHHHHHHHhc--CccccCCCcceeee
Confidence 567889999999 78999999865 4567999999999999999999999986 99999999999999
|
|
| >PLN03224 probable serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.6e-33 Score=245.57 Aligned_cols=270 Identities=20% Similarity=0.252 Sum_probs=176.7
Q ss_pred hCCCCCCceeecCCcceEEEEEe-----------------CCCcEEEEEEeccCcCC------------hhhhHHHHHHH
Q 038766 11 TGSFSENNIIGNSNLSTVYKGRL-----------------EDGEIVAVKKLNFHQFS------------AESDKSFYREA 61 (299)
Q Consensus 11 ~~~y~~~~~lg~g~~~~v~~~~~-----------------~~~~~~~vK~~~~~~~~------------~~~~~~~~~e~ 61 (299)
.++|.+.++||+|+||+||++.. ..++.||||.+...... ....+....|+
T Consensus 144 ~d~F~i~~~LG~GgFG~VYkG~~~~~~~~~v~~~~~~~~~~~~r~VAVK~l~~~~~~~~~~fl~e~~~~~~~~e~~~vE~ 223 (507)
T PLN03224 144 SDDFQLRDKLGGGNFGITFEGLRLQADDQGVTQRSKLTAEQKKRRVVLKRVNMDRQGVRQDFLKTGTLAKGSAETGMVEA 223 (507)
T ss_pred ccCceEeeEeecCCCeEEEEEEecccccchhhhhccccccccCceEEEEEecccchhhHHHHHhhhhhhhcccchhHHHH
Confidence 57899999999999999999853 23568999998643211 01112234467
Q ss_pred HHHHhcCCcce-----eeeeeEEEc-------CCCeeEEEEeecCCCChHHHhcCCCC--------------------CC
Q 038766 62 KTLKELKHRNL-----VKVLGYAWE-------SGKLKALILEYMENGSLESVIHGPGV--------------------DH 109 (299)
Q Consensus 62 ~~l~~l~h~~i-----~~~~~~~~~-------~~~~~~lv~e~~~~~~L~~~~~~~~~--------------------~~ 109 (299)
..+.+++|.++ +.+++++.. .....++|+||+.+++|.+++..... ..
T Consensus 224 ~~l~~l~~~~l~~~~~~~~lg~~~~~~~~g~~~~~~~~LV~Ey~~~gsL~~~L~~~~~~~~~~L~e~l~~g~~l~~~~~~ 303 (507)
T PLN03224 224 YMCAKIKRNPIAAASCAEYLGYFTSNTADGAFTKGSQWLVWKFESDATLGDALDGKLGPFPGCLEEFMMAGKKIPDNMPQ 303 (507)
T ss_pred HHHHHhhcccchhhhhhhhhhhcccccccccccCCceEEEEEcCCCCcHHHHHhhccCCCcchHHHHHhcCCchhhhccc
Confidence 77777766544 555554432 12346899999999999998863210 11
Q ss_pred CCCChhhHHHHHHHHHHHHHHhhcCCCCCeeeecccCCceeeCCCCcEEEeeeccccccccccccccccccccccCcccC
Q 038766 110 SRWTLPKRIDVLISVANGLDYLHSGYDIPIVHCDMKPSNILLDRDFEAHVSDFGTSRMLDVHLQDLSSLSTAFQGTIGYL 189 (299)
Q Consensus 110 ~~~~~~~~~~i~~qi~~~l~~lh~~~~~~~~H~dl~~~nil~~~~~~v~l~df~~~~~~~~~~~~~~~~~~~~~~~~~y~ 189 (299)
..++...++.++.|++.+|.|||+. +++|+||||+||+++.++.++|+|||++...... ..........++.|+
T Consensus 304 ~~~~~~~~~~i~~ql~~aL~~lH~~---~ivHrDLKp~NILl~~~~~~kL~DFGla~~~~~~---~~~~~~~g~~tp~Y~ 377 (507)
T PLN03224 304 DKRDINVIKGVMRQVLTGLRKLHRI---GIVHRDIKPENLLVTVDGQVKIIDFGAAVDMCTG---INFNPLYGMLDPRYS 377 (507)
T ss_pred ccCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCchHhEEECCCCcEEEEeCcCccccccC---CccCccccCCCccee
Confidence 2345677889999999999999999 9999999999999999999999999998654311 111111223478999
Q ss_pred ChhhhcccC----------------------cCccccchhhhHHHHHHHhCCC-CCCCCccCCCCchhHHHHHHHHHhcC
Q 038766 190 APEFAYMRI----------------------VTTKVDVFSFGIVVMEFLTKRR-PTGLDEENGLSPISLRQLVEKALANG 246 (299)
Q Consensus 190 ~PE~~~~~~----------------------~~~~~DiwslG~~l~~l~~g~~-p~~~~~~~~~~~~~~~~~~~~~~~~~ 246 (299)
|||.+.... ...+.|+||+||++++|++|.. |+..... .. ..... ..... .
T Consensus 378 aPE~l~~~~~~~~~~~~~~~~~l~~~~~~yg~~~~~DvwSlGvil~em~~~~l~p~~~~~~--f~-~~~~~-~~~~~-~- 451 (507)
T PLN03224 378 PPEELVMPQSCPRAPAPAMAALLSPFAWLYGRPDLFDSYTAGVLLMQMCVPELRPVANIRL--FN-TELRQ-YDNDL-N- 451 (507)
T ss_pred ChhhhcCCCCCCccchhhhhhhhhhhHHhcCCCCccchhhHHHHHHHHHhCCCCCccchhh--hh-hHHhh-ccchH-H-
Confidence 999875432 1234799999999999999875 5531100 00 00000 00000 0
Q ss_pred ccCcccccCccccchhhHhHHHHHHHHHHHHHHHHhcCCCC---CCCCChhhhhcC
Q 038766 247 INGVRQITDPKLVSSIYEEQEQHQVLEELFKLALVCTSSNP---EDRPNMNELLIT 299 (299)
Q Consensus 247 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP---~~Rpt~~~il~~ 299 (299)
.++.+..... ........+....+|+.+||..+| .+|+|++|+|+|
T Consensus 452 --~~r~~~~~~~-----~~~~~d~~s~~~~dLi~~LL~~~~~~~~~RlSa~eaL~H 500 (507)
T PLN03224 452 --RWRMYKGQKY-----DFSLLDRNKEAGWDLACKLITKRDQANRGRLSVGQALSH 500 (507)
T ss_pred --HHHhhcccCC-----CcccccccChHHHHHHHHHhccCCCCcccCCCHHHHhCC
Confidence 0000000000 001133446789999999999876 689999999998
|
|
| >KOG0200 consensus Fibroblast/platelet-derived growth factor receptor and related receptor tyrosine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.9e-33 Score=254.46 Aligned_cols=262 Identities=28% Similarity=0.404 Sum_probs=200.9
Q ss_pred HHHHHhCCCCCCceeecCCcceEEEEEeC--------CCcEEEEEEeccCcCChhhhHHHHHHHHHHHhcC-Ccceeeee
Q 038766 6 EIENATGSFSENNIIGNSNLSTVYKGRLE--------DGEIVAVKKLNFHQFSAESDKSFYREAKTLKELK-HRNLVKVL 76 (299)
Q Consensus 6 ~~~~~~~~y~~~~~lg~g~~~~v~~~~~~--------~~~~~~vK~~~~~~~~~~~~~~~~~e~~~l~~l~-h~~i~~~~ 76 (299)
.+|.-.++..+.+.||+|.||.|+++... ....||||.+...... ...+.+..|++.++.+. |+||+.++
T Consensus 290 ~~e~~~~~l~~~~~lg~g~fG~v~~~~~~~~~~~~~~~~~~VaVK~~k~~~~~-~~~~~~~~El~~m~~~g~H~niv~ll 368 (609)
T KOG0200|consen 290 KWEIPRENLKLGKYLGEGAFGQVVKALLFGLSKALLSIYVTVAVKMLKENASS-SEKKDLMSELNVLKELGKHPNIVNLL 368 (609)
T ss_pred ceeechhhccccceeecccccceEeEEEeecccccccceEEEEEEecccccCc-HHHHHHHHHHHHHHHhcCCcchhhhe
Confidence 57777788888889999999999999732 1457999998754433 66788999999999995 99999999
Q ss_pred eEEEcCCCeeEEEEeecCCCChHHHhcCCC----------CCC--CCCChhhHHHHHHHHHHHHHHhhcCCCCCeeeecc
Q 038766 77 GYAWESGKLKALILEYMENGSLESVIHGPG----------VDH--SRWTLPKRIDVLISVANGLDYLHSGYDIPIVHCDM 144 (299)
Q Consensus 77 ~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~----------~~~--~~~~~~~~~~i~~qi~~~l~~lh~~~~~~~~H~dl 144 (299)
|.+.. ....++|.||+..|+|.+++.... ... ..++....+.++.||+.+++||++. +++||||
T Consensus 369 G~~t~-~~~~~~v~Ey~~~G~L~~~Lr~~r~~~~~~~~~~~~~~~~~L~~~dLlsfa~QIa~GMe~L~~~---~~vHRDL 444 (609)
T KOG0200|consen 369 GACTQ-DGPLYVIVEYAEHGDLLEFLRKKRVTESIDGSGVFPNERDALTTKDLLSFAYQIANGMEYLASV---PCVHRDL 444 (609)
T ss_pred eeecc-CCceEEEEEeccCCcHHHHHHhccccccccccCCCccccCCcCHHHHHHHHHHHHHHHHHHhhC---Cccchhh
Confidence 98877 555699999999999999886543 001 2388999999999999999999999 9999999
Q ss_pred cCCceeeCCCCcEEEeeeccccccccccccccccccccccCcccCChhhhcccCcCccccchhhhHHHHHHHh-CCCCCC
Q 038766 145 KPSNILLDRDFEAHVSDFGTSRMLDVHLQDLSSLSTAFQGTIGYLAPEFAYMRIVTTKVDVFSFGIVVMEFLT-KRRPTG 223 (299)
Q Consensus 145 ~~~nil~~~~~~v~l~df~~~~~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~DiwslG~~l~~l~~-g~~p~~ 223 (299)
..+||+++.+..+|++|||+++....... .........-+..|+|||.+....++.++||||+|+++|+|++ |..|+.
T Consensus 445 AaRNVLi~~~~~~kIaDFGlar~~~~~~~-y~~~~~~~~LP~kWmApEsl~~~~ft~kSDVWSfGI~L~EifsLG~~PYp 523 (609)
T KOG0200|consen 445 AARNVLITKNKVIKIADFGLARDHYNKDY-YRTKSSAGTLPVKWMAPESLFDRVFTSKSDVWSFGILLWEIFTLGGTPYP 523 (609)
T ss_pred hhhhEEecCCCEEEEccccceeccCCCCc-eEecCCCCccceeecCHHHhccCcccccchhhHHHHHHHHHhhCCCCCCC
Confidence 99999999999999999999985331100 1101111113456999999999999999999999999999998 667763
Q ss_pred CCccCCCC-chhHHHHHHHHHhcCccCcccccCccccchhhHhHHHHHHHHHHHHHHHHhcCCCCCCCCChhhhhc
Q 038766 224 LDEENGLS-PISLRQLVEKALANGINGVRQITDPKLVSSIYEEQEQHQVLEELFKLALVCTSSNPEDRPNMNELLI 298 (299)
Q Consensus 224 ~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rpt~~~il~ 298 (299)
. .. ..++.+.+ ..+. .+.. +...+.++.++++.||+.+|++||++.++.+
T Consensus 524 ~-----~~~~~~l~~~l----~~G~----r~~~------------P~~c~~eiY~iM~~CW~~~p~~RP~F~~~~~ 574 (609)
T KOG0200|consen 524 G-----IPPTEELLEFL----KEGN----RMEQ------------PEHCSDEIYDLMKSCWNADPEDRPTFSECVE 574 (609)
T ss_pred C-----CCcHHHHHHHH----hcCC----CCCC------------CCCCCHHHHHHHHHHhCCCcccCCCHHHHHH
Confidence 2 11 22222222 2111 1111 3344678999999999999999999999864
|
|
| >KOG1027 consensus Serine/threonine protein kinase and endoribonuclease ERN1/IRE1, sensor of the unfolded protein response pathway [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-34 Score=254.13 Aligned_cols=249 Identities=32% Similarity=0.397 Sum_probs=187.5
Q ss_pred CCCCceeecCCcce-EEEEEeCCCcEEEEEEeccCcCChhhhHHHHHHHHHHHhcC-CcceeeeeeEEEcCCCeeEEEEe
Q 038766 14 FSENNIIGNSNLST-VYKGRLEDGEIVAVKKLNFHQFSAESDKSFYREAKTLKELK-HRNLVKVLGYAWESGKLKALILE 91 (299)
Q Consensus 14 y~~~~~lg~g~~~~-v~~~~~~~~~~~~vK~~~~~~~~~~~~~~~~~e~~~l~~l~-h~~i~~~~~~~~~~~~~~~lv~e 91 (299)
|.-.+.+|.|+.|+ ||++.-. |+.||||++- .+....+.+|+..|+.-. ||||+++++ ......++|+..|
T Consensus 511 ~~~~eilG~Gs~Gt~Vf~G~ye-~R~VAVKrll-----~e~~~~A~rEi~lL~eSD~H~NviRyyc-~E~d~qF~YIalE 583 (903)
T KOG1027|consen 511 FSPKEILGYGSNGTVVFRGVYE-GREVAVKRLL-----EEFFDFAQREIQLLQESDEHPNVIRYYC-SEQDRQFLYIALE 583 (903)
T ss_pred eccHHHcccCCCCcEEEEEeeC-CceehHHHHh-----hHhHHHHHHHHHHHHhccCCCceEEEEe-eccCCceEEEEeh
Confidence 44456788999976 4666654 8899999874 456778899999999885 999999999 5666778899999
Q ss_pred ecCCCChHHHhcCCCCCCCCCChhhHHHHHHHHHHHHHHhhcCCCCCeeeecccCCceeeCC---CC--cEEEeeecccc
Q 038766 92 YMENGSLESVIHGPGVDHSRWTLPKRIDVLISVANGLDYLHSGYDIPIVHCDMKPSNILLDR---DF--EAHVSDFGTSR 166 (299)
Q Consensus 92 ~~~~~~L~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lh~~~~~~~~H~dl~~~nil~~~---~~--~v~l~df~~~~ 166 (299)
.|. .+|.++++..+.+.........+.++.|+++||++||+. +|+||||||+|||++. ++ .++|+|||+|.
T Consensus 584 LC~-~sL~dlie~~~~d~~~~~~i~~~~~l~q~~~GlaHLHsl---~iVHRDLkPQNILI~~~~~~~~~ra~iSDfglsK 659 (903)
T KOG1027|consen 584 LCA-CSLQDLIESSGLDVEMQSDIDPISVLSQIASGLAHLHSL---KIVHRDLKPQNILISVPSADGTLRAKISDFGLSK 659 (903)
T ss_pred Hhh-hhHHHHHhccccchhhcccccHHHHHHHHHHHHHHHHhc---ccccccCCCceEEEEccCCCcceeEEeccccccc
Confidence 994 599999986422222223256688999999999999998 9999999999999976 34 57899999999
Q ss_pred ccccccccccccccccccCcccCChhhhcccCcCccccchhhhHHHHHHHhC-CCCCCCCccCCCCchhHHHHHHHHHhc
Q 038766 167 MLDVHLQDLSSLSTAFQGTIGYLAPEFAYMRIVTTKVDVFSFGIVVMEFLTK-RRPTGLDEENGLSPISLRQLVEKALAN 245 (299)
Q Consensus 167 ~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~DiwslG~~l~~l~~g-~~p~~~~~~~~~~~~~~~~~~~~~~~~ 245 (299)
.+...-..... .....||-+|.|||++....-+.+.|||||||++|+.++| ..||+..-..+ ..+...
T Consensus 660 kl~~~~sS~~r-~s~~sGt~GW~APE~L~~~~~~~avDiFslGCvfyYvltgG~HpFGd~~~R~----------~NIl~~ 728 (903)
T KOG1027|consen 660 KLAGGKSSFSR-LSGGSGTSGWQAPEQLREDRKTQAVDIFSLGCVFYYVLTGGSHPFGDSLERQ----------ANILTG 728 (903)
T ss_pred ccCCCcchhhc-ccCCCCcccccCHHHHhccccCcccchhhcCceEEEEecCCccCCCchHHhh----------hhhhcC
Confidence 87744333333 4566789999999999999888899999999999998886 78886331110 001100
Q ss_pred CccCcccccCccccchhhHhHHHHHHHHHHHHHHHHhcCCCCCCCCChhhhhcC
Q 038766 246 GINGVRQITDPKLVSSIYEEQEQHQVLEELFKLALVCTSSNPEDRPNMNELLIT 299 (299)
Q Consensus 246 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rpt~~~il~~ 299 (299)
. ..... .... .. .++.+||.+|++.+|..||+|.+||.|
T Consensus 729 ~-~~L~~------L~~~-----~d---~eA~dLI~~ml~~dP~~RPsa~~VL~H 767 (903)
T KOG1027|consen 729 N-YTLVH------LEPL-----PD---CEAKDLISRMLNPDPQLRPSATDVLNH 767 (903)
T ss_pred c-cceee------eccC-----ch---HHHHHHHHHhcCCCcccCCCHHHHhCC
Confidence 0 00000 0000 00 178899999999999999999999987
|
|
| >KOG0664 consensus Nemo-like MAPK-related serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.5e-35 Score=229.55 Aligned_cols=270 Identities=24% Similarity=0.289 Sum_probs=197.9
Q ss_pred CCCCCCceeecCCcceEEEEEe-CCCcEEEEEEeccCcCChhhhHHHHHHHHHHHhcCCcceeeeeeEEEcCC----Cee
Q 038766 12 GSFSENNIIGNSNLSTVYKGRL-EDGEIVAVKKLNFHQFSAESDKSFYREAKTLKELKHRNLVKVLGYAWESG----KLK 86 (299)
Q Consensus 12 ~~y~~~~~lg~g~~~~v~~~~~-~~~~~~~vK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~----~~~ 86 (299)
.+..-.+.||-|.||+||.+++ ++|++|++|++..-..+-.+.+++.+|+.++..++|+|++...++..... ...
T Consensus 53 ~Di~PDRPIGYGAFGVVWsVTDPRdgrrvalkK~pnvfq~L~s~krvFre~kmLcfFkHdNVLSaLDILQPph~dfFqEi 132 (449)
T KOG0664|consen 53 QDIQPDRPIGYGAFGVVWSVTDPRSGKRVALKKMPNVFQNLASCKRVFREIKMLSSFRHDNVLSLLDILQPANPSFFQEL 132 (449)
T ss_pred ccCCCCCcccccceeEEEeccCCCCccchhHhhcchHHHHHHHHHHHHHHHHHHHhhccccHHHHHHhcCCCCchHHHHH
Confidence 4556778999999999999987 67999999987533334455688999999999999999999988554322 123
Q ss_pred EEEEeecCCCChHHHhcCCCCCCCCCChhhHHHHHHHHHHHHHHhhcCCCCCeeeecccCCceeeCCCCcEEEeeecccc
Q 038766 87 ALILEYMENGSLESVIHGPGVDHSRWTLPKRIDVLISVANGLDYLHSGYDIPIVHCDMKPSNILLDRDFEAHVSDFGTSR 166 (299)
Q Consensus 87 ~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lh~~~~~~~~H~dl~~~nil~~~~~~v~l~df~~~~ 166 (299)
|++.|.+ ..+|...+- +-+.++...+.-++.||+.+|+|||+. +|.||||||.|.+|+.++.+|++|||+++
T Consensus 133 YV~TELm-QSDLHKIIV----SPQ~Ls~DHvKVFlYQILRGLKYLHsA---~ILHRDIKPGNLLVNSNCvLKICDFGLAR 204 (449)
T KOG0664|consen 133 YVLTELM-QSDLHKIIV----SPQALTPDHVKVFVYQILRGLKYLHTA---NILHRDIKPGNLLVNSNCILKICDFGLAR 204 (449)
T ss_pred HHHHHHH-Hhhhhheec----cCCCCCcchhhhhHHHHHhhhHHHhhc---chhhccCCCccEEeccCceEEeccccccc
Confidence 6777888 457887775 667899999999999999999999999 99999999999999999999999999998
Q ss_pred ccccccccccccccccccCcccCChhhhccc-CcCccccchhhhHHHHHHHhCCCCCCCCccCCCCchhHHHHHHHHHhc
Q 038766 167 MLDVHLQDLSSLSTAFQGTIGYLAPEFAYMR-IVTTKVDVFSFGIVVMEFLTKRRPTGLDEENGLSPISLRQLVEKALAN 245 (299)
Q Consensus 167 ~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~-~~~~~~DiwslG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~ 245 (299)
... ......++....|..|.|||++.+. .|+...||||.||++.+|+..+..|... .+.+-.+.+.....
T Consensus 205 vee---~d~~~hMTqEVVTQYYRAPEiLMGaRhYs~AvDiWSVGCIFaELLgRrILFQAq-----~PiqQL~lItdLLG- 275 (449)
T KOG0664|consen 205 TWD---QRDRLNMTHEVVTQYYRAPELLMGARRYTGAVDIWSVGCIFAELLQRKILFQAA-----GPIEQLQMIIDLLG- 275 (449)
T ss_pred ccc---hhhhhhhHHHHHHHHhccHHHhhcchhhcCccceehhhHHHHHHHhhhhhhhcc-----ChHHHHHHHHHHhC-
Confidence 655 3344556677788999999998876 5999999999999999999888777422 22211111111110
Q ss_pred CccCccc---------------ccCccccchhhHhHHHHHHHHHHHHHHHHhcCCCCCCCCChhhhhcC
Q 038766 246 GINGVRQ---------------ITDPKLVSSIYEEQEQHQVLEELFKLALVCTSSNPEDRPNMNELLIT 299 (299)
Q Consensus 246 ~~~~~~~---------------~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rpt~~~il~~ 299 (299)
.+..+. -..+.-....+....+..-..+...++.+|+..||++|.+.++.+.|
T Consensus 276 -TPs~EaMr~ACEGAk~H~LR~~~k~Ps~~vLYtlsS~~~~~heav~~~~~~l~~d~dkris~~~A~~~ 343 (449)
T KOG0664|consen 276 -TPSQEAMKYACEGAKNHVLRAGLRAPDTQRLYKIASPDDKNHEAVDLLQKLLHFDPDKRISVEEALQH 343 (449)
T ss_pred -CCcHHHHHHHhhhhHHHhhccCCCCCCccceeeecCCcccchHHHHHHHHHhCCCCcccccHhhhccc
Confidence 000000 00000000001111122333467789999999999999999998865
|
|
| >KOG3653 consensus Transforming growth factor beta/activin receptor subfamily of serine/threonine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-33 Score=234.39 Aligned_cols=257 Identities=24% Similarity=0.367 Sum_probs=188.0
Q ss_pred CCCCceeecCCcceEEEEEeCCCcEEEEEEeccCcCChhhhHHHHHHHHHHHhc--CCcceeeeeeEEEcCC----CeeE
Q 038766 14 FSENNIIGNSNLSTVYKGRLEDGEIVAVKKLNFHQFSAESDKSFYREAKTLKEL--KHRNLVKVLGYAWESG----KLKA 87 (299)
Q Consensus 14 y~~~~~lg~g~~~~v~~~~~~~~~~~~vK~~~~~~~~~~~~~~~~~e~~~l~~l--~h~~i~~~~~~~~~~~----~~~~ 87 (299)
....+++|+|.||.||+|+.. ++.||||++. ....+.+.+|.++++.. +|+||++++++- ..+ ..+.
T Consensus 212 l~l~eli~~Grfg~V~KaqL~-~~~VAVKifp-----~~~kqs~~~Ek~Iy~lp~m~h~nIl~Fi~~e-kr~t~~~~eyw 284 (534)
T KOG3653|consen 212 LQLLELIGRGRFGCVWKAQLD-NRLVAVKIFP-----EQEKQSFQNEKNIYSLPGMKHENILQFIGAE-KRGTADRMEYW 284 (534)
T ss_pred hhhHHHhhcCccceeehhhcc-CceeEEEecC-----HHHHHHHHhHHHHHhccCccchhHHHhhchh-ccCCcccccee
Confidence 456788999999999999986 5899999984 45667788888877766 699999998843 222 3568
Q ss_pred EEEeecCCCChHHHhcCCCCCCCCCChhhHHHHHHHHHHHHHHhhcC------CCCCeeeecccCCceeeCCCCcEEEee
Q 038766 88 LILEYMENGSLESVIHGPGVDHSRWTLPKRIDVLISVANGLDYLHSG------YDIPIVHCDMKPSNILLDRDFEAHVSD 161 (299)
Q Consensus 88 lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lh~~------~~~~~~H~dl~~~nil~~~~~~v~l~d 161 (299)
+|++|.+.|+|.++++. ..++.....+++..++.+|+|||+- ++..|+|||||.+||||..|++..|+|
T Consensus 285 LVt~fh~kGsL~dyL~~-----ntisw~~~cria~SmarGLa~LHee~p~~d~~Kp~IaHRDlkSkNVLvK~DlTccIaD 359 (534)
T KOG3653|consen 285 LVTEFHPKGSLCDYLKA-----NTISWNSLCRIAESMARGLAHLHEELPRGDHHKPPIAHRDLKSKNVLVKNDLTCCIAD 359 (534)
T ss_pred EEeeeccCCcHHHHHHh-----ccccHHHHHHHHHHHHHHHHHhcccCCcCCCCCCccccccccccceEEccCCcEEeec
Confidence 99999999999999964 4789999999999999999999974 345799999999999999999999999
Q ss_pred eccccccccccccccccccccccCcccCChhhhcccCcC------ccccchhhhHHHHHHHhCCCCCCC-CccCCCCch-
Q 038766 162 FGTSRMLDVHLQDLSSLSTAFQGTIGYLAPEFAYMRIVT------TKVDVFSFGIVVMEFLTKRRPTGL-DEENGLSPI- 233 (299)
Q Consensus 162 f~~~~~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~------~~~DiwslG~~l~~l~~g~~p~~~-~~~~~~~~~- 233 (299)
||++..+...... ...-.-+||..|||||++.+...- .+.||||+|.++|||++.+.-+.. ...+-..++
T Consensus 360 FGLAl~~~p~~~~--~d~~~qVGT~RYMAPEvLEgainl~d~~Afkr~DvYamgLVLWEi~SRC~~~~~~~vp~Yqlpfe 437 (534)
T KOG3653|consen 360 FGLALRLEPGKPQ--GDTHGQVGTRRYMAPEVLEGAINLQDRDAFKRIDVYAMGLVLWEIASRCTDADPGPVPEYQLPFE 437 (534)
T ss_pred cceeEEecCCCCC--cchhhhhhhhhhcCHHHHhhhcccccHHHHHHHHHHHHHHHHHHHHhhcccccCCCCCcccCchh
Confidence 9999877633222 122236799999999998875422 368999999999999998765531 111111110
Q ss_pred -------hHHHHHHHHHhcCccCcccccCccccchhhHhHHHHHHHHHHHHHHHHhcCCCCCCCCChhh
Q 038766 234 -------SLRQLVEKALANGINGVRQITDPKLVSSIYEEQEQHQVLEELFKLALVCTSSNPEDRPNMNE 295 (299)
Q Consensus 234 -------~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rpt~~~ 295 (299)
.+.++........ . -|.++... ........+.+.+..||..||+.|.|+.=
T Consensus 438 ~evG~hPt~e~mq~~VV~kK--~-----RP~~p~~W----~~h~~~~~l~et~EeCWDhDaeARLTA~C 495 (534)
T KOG3653|consen 438 AEVGNHPTLEEMQELVVRKK--Q-----RPKIPDAW----RKHAGMAVLCETIEECWDHDAEARLTAGC 495 (534)
T ss_pred HHhcCCCCHHHHHHHHHhhc--c-----CCCChhhh----hcCccHHHHHHHHHHHcCCchhhhhhhHH
Confidence 1122222222111 0 11111111 12244567999999999999999999853
|
|
| >KOG1025 consensus Epidermal growth factor receptor EGFR and related tyrosine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.4e-34 Score=251.86 Aligned_cols=249 Identities=24% Similarity=0.398 Sum_probs=200.4
Q ss_pred CCCCceeecCCcceEEEEEe-CC----CcEEEEEEeccCcCChhhhHHHHHHHHHHHhcCCcceeeeeeEEEcCCCeeEE
Q 038766 14 FSENNIIGNSNLSTVYKGRL-ED----GEIVAVKKLNFHQFSAESDKSFYREAKTLKELKHRNLVKVLGYAWESGKLKAL 88 (299)
Q Consensus 14 y~~~~~lg~g~~~~v~~~~~-~~----~~~~~vK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~l 88 (299)
.+-.++||+|.||+||++.+ .. +-+||+|++. +.........+..|+..|.++.|||++++++++.... +.|
T Consensus 698 lkk~kvLGsgAfGtV~kGiw~Pege~vKipVaiKvl~-~~t~~~~s~e~LdeAl~masldHpnl~RLLgvc~~s~--~ql 774 (1177)
T KOG1025|consen 698 LKKDKVLGSGAFGTVYKGIWIPEGENVKIPVAIKVLI-EFTSPKASIELLDEALRMASLDHPNLLRLLGVCMLST--LQL 774 (1177)
T ss_pred hhhhceeccccceeEEeeeEecCCceecceeEEEEee-ccCCchhhHHHHHHHHHHhcCCCchHHHHhhhcccch--HHH
Confidence 45578999999999999976 11 5678999886 3445556778999999999999999999999887544 679
Q ss_pred EEeecCCCChHHHhcCCCCCCCCCChhhHHHHHHHHHHHHHHhhcCCCCCeeeecccCCceeeCCCCcEEEeeecccccc
Q 038766 89 ILEYMENGSLESVIHGPGVDHSRWTLPKRIDVLISVANGLDYLHSGYDIPIVHCDMKPSNILLDRDFEAHVSDFGTSRML 168 (299)
Q Consensus 89 v~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lh~~~~~~~~H~dl~~~nil~~~~~~v~l~df~~~~~~ 168 (299)
|++|+++|+|.++++. .+.++-....+.|..||++|+.|||.+ .++||||-.+|+||++...||+.|||++..+
T Consensus 775 vtq~mP~G~LlDyvr~---hr~~igsq~lLnw~~QIAkgM~YLe~q---rlVHrdLaaRNVLVksP~hvkitdfgla~ll 848 (1177)
T KOG1025|consen 775 VTQLMPLGCLLDYVRE---HRDNIGSQDLLNWCYQIAKGMKYLEEQ---RLVHRDLAARNVLVKSPNHVKITDFGLAKLL 848 (1177)
T ss_pred HHHhcccchHHHHHHH---hhccccHHHHHHHHHHHHHHHHHHHhc---chhhhhhhhhheeecCCCeEEEEecchhhcc
Confidence 9999999999999875 456888899999999999999999999 9999999999999999999999999999877
Q ss_pred ccccccccccccccccCcccCChhhhcccCcCccccchhhhHHHHHHHh-CCCCCCCCccCCCCchhHHHHHHHHHhcCc
Q 038766 169 DVHLQDLSSLSTAFQGTIGYLAPEFAYMRIVTTKVDVFSFGIVVMEFLT-KRRPTGLDEENGLSPISLRQLVEKALANGI 247 (299)
Q Consensus 169 ~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~DiwslG~~l~~l~~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 247 (299)
........... .-..+.|+|-|.+....++.++||||+|++.||++| |..|+. ...-.++.+.++...+
T Consensus 849 ~~d~~ey~~~~--gK~pikwmale~i~~~~~thqSDVWsfGVtiWElmTFGa~Py~-----gi~~~eI~dlle~geR--- 918 (1177)
T KOG1025|consen 849 APDEKEYSAPG--GKVPIKWMALESIRIRKYTHQSDVWSFGVTIWELMTFGAKPYD-----GIPAEEIPDLLEKGER--- 918 (1177)
T ss_pred Ccccccccccc--cccCcHHHHHHHhhccCCCchhhhhhhhhhHHHHHhcCCCccC-----CCCHHHhhHHHhcccc---
Confidence 64433222221 223567899999999999999999999999999997 788873 3333344444433211
Q ss_pred cCcccccCccccchhhHhHHHHHHHHHHHHHHHHhcCCCCCCCCChhhhhc
Q 038766 248 NGVRQITDPKLVSSIYEEQEQHQVLEELFKLALVCTSSNPEDRPNMNELLI 298 (299)
Q Consensus 248 ~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rpt~~~il~ 298 (299)
...++..+.++.-++.+||..|+..||+++++.+
T Consensus 919 -----------------LsqPpiCtiDVy~~mvkCwmid~~~rp~fkel~~ 952 (1177)
T KOG1025|consen 919 -----------------LSQPPICTIDVYMVMVKCWMIDADSRPTFKELAE 952 (1177)
T ss_pred -----------------CCCCCCccHHHHHHHHHHhccCcccCccHHHHHH
Confidence 1124555678999999999999999999998753
|
|
| >KOG0665 consensus Jun-N-terminal kinase (JNK) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-33 Score=225.82 Aligned_cols=271 Identities=23% Similarity=0.258 Sum_probs=200.2
Q ss_pred HhCCCCCCceeecCCcceEEEEEeC-CCcEEEEEEeccCcCChhhhHHHHHHHHHHHhcCCcceeeeeeEEEcCC-----
Q 038766 10 ATGSFSENNIIGNSNLSTVYKGRLE-DGEIVAVKKLNFHQFSAESDKSFYREAKTLKELKHRNLVKVLGYAWESG----- 83 (299)
Q Consensus 10 ~~~~y~~~~~lg~g~~~~v~~~~~~-~~~~~~vK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~----- 83 (299)
+..+|.-...+|.|.- .|..|.+. .+++|++|....+.....+.++.++|+..+..++|+||++++.++....
T Consensus 15 v~~Ry~nL~p~~~g~~-~v~~a~D~v~~~~v~ikk~~~pf~n~~~akra~rel~l~~~v~~~nii~l~n~ftP~~~l~~~ 93 (369)
T KOG0665|consen 15 VPKRYVNLKPIGSGAQ-IVVAAFDQVLGRPVAIKKLSRPFQNQTHAKRAYRELKLMKCVNHKNIISLLNVFTPQKTLEEF 93 (369)
T ss_pred eeeeeeeecccCCCCc-eEEecchhhccCceehhhhcCccccCccchhhhhhhhhhhhhcccceeeeeeccCccccHHHH
Confidence 4568888899999988 66666553 5889999999877777788999999999999999999999999664322
Q ss_pred CeeEEEEeecCCCChHHHhcCCCCCCCCCChhhHHHHHHHHHHHHHHhhcCCCCCeeeecccCCceeeCCCCcEEEeeec
Q 038766 84 KLKALILEYMENGSLESVIHGPGVDHSRWTLPKRIDVLISVANGLDYLHSGYDIPIVHCDMKPSNILLDRDFEAHVSDFG 163 (299)
Q Consensus 84 ~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lh~~~~~~~~H~dl~~~nil~~~~~~v~l~df~ 163 (299)
...++|+|++. .+|...+. -.++-..+..++.|++.|+++||+. +++||||||+||++..++.+|+.|||
T Consensus 94 ~e~y~v~e~m~-~nl~~vi~------~elDH~tis~i~yq~~~~ik~lhs~---~IihRdLkPsnivv~~~~~lKi~dfg 163 (369)
T KOG0665|consen 94 QEVYLVMELMD-ANLCQVIL------MELDHETISYILYQMLCGIKHLHSA---GIIHRDLKPSNIVVNSDCTLKILDFG 163 (369)
T ss_pred HhHHHHHHhhh-hHHHHHHH------HhcchHHHHHHHHHHHHHHHHHHhc---ceeecccCcccceecchhheeeccch
Confidence 23489999994 59988875 2467778899999999999999999 99999999999999999999999999
Q ss_pred cccccccccccccccccccccCcccCChhhhcccCcCccccchhhhHHHHHHHhCCCCCCCCcc-C---------CCCch
Q 038766 164 TSRMLDVHLQDLSSLSTAFQGTIGYLAPEFAYMRIVTTKVDVFSFGIVVMEFLTKRRPTGLDEE-N---------GLSPI 233 (299)
Q Consensus 164 ~~~~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~DiwslG~~l~~l~~g~~p~~~~~~-~---------~~~~~ 233 (299)
++.... ..-..+..+.+..|.|||++.+-.+....||||+||++.+|++|...|.+... + +-...
T Consensus 164 ~ar~e~-----~~~~mtpyVvtRyyrapevil~~~~ke~vdiwSvGci~gEli~~~Vlf~g~d~idQ~~ki~~~lgtpd~ 238 (369)
T KOG0665|consen 164 LARTED-----TDFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGELILGTVLFPGKDHIDQWNKIIEQLGTPDP 238 (369)
T ss_pred hhcccC-----cccccCchhheeeccCchheeccCCcccchhhhhhhHHHHHhhceEEecCchHHHHHHHHHHHhcCCCH
Confidence 997543 12244556778899999999998899999999999999999999988863210 0 00000
Q ss_pred hHHHHHHHHHhc---CccC------cccccCccccchhhHhHHHHHHHHHHHHHHHHhcCCCCCCCCChhhhhcC
Q 038766 234 SLRQLVEKALAN---GING------VRQITDPKLVSSIYEEQEQHQVLEELFKLALVCTSSNPEDRPNMNELLIT 299 (299)
Q Consensus 234 ~~~~~~~~~~~~---~~~~------~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rpt~~~il~~ 299 (299)
.+..-+....+. ..++ -+.+++..+...... ++--...+++++.+||..||++|.+++++|.|
T Consensus 239 ~F~~qL~~~~r~yv~~~~~y~~~~f~~~fpD~~f~~~~e~---~~~~~~~ardll~~MLvi~pe~Risv~daL~H 310 (369)
T KOG0665|consen 239 SFMKQLQPTVRNYVENRPQYQAISFSELFPDSLFPVVLEG---SKLDCSLARDLLSKMLVIDPEKRISVDDALRH 310 (369)
T ss_pred HHHHHhhHHHHHHhhcChHhhccchhhhCCcccccccccC---CccchHHHHHHHHHhhccChhhcccHHHHhcC
Confidence 111111111110 0000 011111111111100 12234568999999999999999999999988
|
|
| >KOG0695 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.2e-33 Score=222.41 Aligned_cols=254 Identities=17% Similarity=0.244 Sum_probs=198.0
Q ss_pred HhCCCCCCceeecCCcceEEEEEe-CCCcEEEEEEeccCcCChh-hhHHHHHHHHHHHhc-CCcceeeeeeEEEcCCCee
Q 038766 10 ATGSFSENNIIGNSNLSTVYKGRL-EDGEIVAVKKLNFHQFSAE-SDKSFYREAKTLKEL-KHRNLVKVLGYAWESGKLK 86 (299)
Q Consensus 10 ~~~~y~~~~~lg~g~~~~v~~~~~-~~~~~~~vK~~~~~~~~~~-~~~~~~~e~~~l~~l-~h~~i~~~~~~~~~~~~~~ 86 (299)
--++|++.+.||+|+++.|-.+.+ ++.+.||+|+++..-.+.+ ..+-.+.|-..+..- +||.++-+.. |+..+.-+
T Consensus 248 ~l~df~ll~vigrgsyakvl~~~~~~t~qiyamkvvkkel~nddedidwvqtek~vfe~asn~pflvglhs-cfqtesrl 326 (593)
T KOG0695|consen 248 GLQDFDLLRVIGRGSYAKVLLVRLKKTDQIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNNPFLVGLHS-CFQTESRL 326 (593)
T ss_pred ccccceeeeeecCcchhhhhheehcccceeeehhhHHHHhcCCcccchhHHhhHHHHHhccCCCeEEehhh-hhcccceE
Confidence 357899999999999999999986 4578899999976544433 345566677777666 4899888877 66667777
Q ss_pred EEEEeecCCCChHHHhcCCCCCCCCCChhhHHHHHHHHHHHHHHhhcCCCCCeeeecccCCceeeCCCCcEEEeeecccc
Q 038766 87 ALILEYMENGSLESVIHGPGVDHSRWTLPKRIDVLISVANGLDYLHSGYDIPIVHCDMKPSNILLDRDFEAHVSDFGTSR 166 (299)
Q Consensus 87 ~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lh~~~~~~~~H~dl~~~nil~~~~~~v~l~df~~~~ 166 (299)
++|.||++||+|--.++ ....+|++.+..+...|+.||.|||+. +|+++|+|.+|++++..|.+||+|+|++.
T Consensus 327 ffvieyv~ggdlmfhmq----rqrklpeeharfys~ei~lal~flh~r---giiyrdlkldnvlldaeghikltdygmck 399 (593)
T KOG0695|consen 327 FFVIEYVNGGDLMFHMQ----RQRKLPEEHARFYSAEICLALNFLHER---GIIYRDLKLDNVLLDAEGHIKLTDYGMCK 399 (593)
T ss_pred EEEEEEecCcceeeehh----hhhcCcHHHhhhhhHHHHHHHHHHhhc---CeeeeeccccceEEccCCceeecccchhh
Confidence 99999999999987776 556899999999999999999999999 99999999999999999999999999997
Q ss_pred ccccccccccccccccccCcccCChhhhcccCcCccccchhhhHHHHHHHhCCCCCCCCccCCCCchhHHHHHHHHHhcC
Q 038766 167 MLDVHLQDLSSLSTAFQGTIGYLAPEFAYMRIVTTKVDVFSFGIVVMEFLTKRRPTGLDEENGLSPISLRQLVEKALANG 246 (299)
Q Consensus 167 ~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~DiwslG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~ 246 (299)
.-. .......+..|||.|.|||++.+..|..+.|-|+||+++++||.|+.||.--. .+-..+.-.+.+-+.+.+.
T Consensus 400 e~l----~~gd~tstfcgtpnyiapeilrgeeygfsvdwwalgvlmfemmagrspfdivg-m~n~d~ntedylfqvilek 474 (593)
T KOG0695|consen 400 EGL----GPGDTTSTFCGTPNYIAPEILRGEEYGFSVDWWALGVLMFEMMAGRSPFDIVG-MDNPDMNTEDYLFQVILEK 474 (593)
T ss_pred cCC----CCCcccccccCCCcccchhhhcccccCceehHHHHHHHHHHHHcCCCCcceec-CCCcccchhHHHHHHHhhh
Confidence 422 23455677889999999999999999999999999999999999999996322 1111111222222322211
Q ss_pred ccCcccccCccccchhhHhHHHHHHHHHHHHHHHHhcCCCCCCCCCh
Q 038766 247 INGVRQITDPKLVSSIYEEQEQHQVLEELFKLALVCTSSNPEDRPNM 293 (299)
Q Consensus 247 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rpt~ 293 (299)
..+ .++.++-.+..+++..|+.||.+|...
T Consensus 475 qir-----------------iprslsvkas~vlkgflnkdp~erlgc 504 (593)
T KOG0695|consen 475 QIR-----------------IPRSLSVKASHVLKGFLNKDPKERLGC 504 (593)
T ss_pred ccc-----------------ccceeehhhHHHHHHhhcCCcHHhcCC
Confidence 101 133444556778999999999999753
|
|
| >KOG0696 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.7e-34 Score=234.05 Aligned_cols=247 Identities=21% Similarity=0.292 Sum_probs=192.9
Q ss_pred HHhCCCCCCceeecCCcceEEEEEe-CCCcEEEEEEeccCcCC-hhhhHHHHHHHHHHHhcC-CcceeeeeeEEEcCCCe
Q 038766 9 NATGSFSENNIIGNSNLSTVYKGRL-EDGEIVAVKKLNFHQFS-AESDKSFYREAKTLKELK-HRNLVKVLGYAWESGKL 85 (299)
Q Consensus 9 ~~~~~y~~~~~lg~g~~~~v~~~~~-~~~~~~~vK~~~~~~~~-~~~~~~~~~e~~~l~~l~-h~~i~~~~~~~~~~~~~ 85 (299)
+-..+|..+.+||+|+||.|-++.. .+.+.||||+++...+- .+..+--..|-++|.... -|.++++.. ++..-.-
T Consensus 346 i~~tDFnFl~VlGKGSFGKVlLaerkgtdELyAiKiLkKDViiQdDDvectm~EKrvLAL~~kppFL~qlHS-cFQTmDR 424 (683)
T KOG0696|consen 346 IKATDFNFLMVLGKGSFGKVLLAERKGTDELYAIKILKKDVIIQDDDVECTMVEKRVLALPGKPPFLVQLHS-CFQTMDR 424 (683)
T ss_pred eeecccceEEEeccCccceeeeecccCcchhhhhhhhccceeeecCcccceehhhhheecCCCCchHHHHHH-Hhhhhhh
Confidence 3456899999999999999999965 45788999998765432 222222334555665553 577777766 4444455
Q ss_pred eEEEEeecCCCChHHHhcCCCCCCCCCChhhHHHHHHHHHHHHHHhhcCCCCCeeeecccCCceeeCCCCcEEEeeeccc
Q 038766 86 KALILEYMENGSLESVIHGPGVDHSRWTLPKRIDVLISVANGLDYLHSGYDIPIVHCDMKPSNILLDRDFEAHVSDFGTS 165 (299)
Q Consensus 86 ~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lh~~~~~~~~H~dl~~~nil~~~~~~v~l~df~~~ 165 (299)
++.||||+.||+|-..++.. ..+.|+.+..++..|+-+|.+||++ +|++||||.+|||++.+|.+||.|||++
T Consensus 425 LyFVMEyvnGGDLMyhiQQ~----GkFKEp~AvFYAaEiaigLFFLh~k---gIiYRDLKLDNvmLd~eGHiKi~DFGmc 497 (683)
T KOG0696|consen 425 LYFVMEYVNGGDLMYHIQQV----GKFKEPVAVFYAAEIAIGLFFLHSK---GIIYRDLKLDNVMLDSEGHIKIADFGMC 497 (683)
T ss_pred eeeEEEEecCchhhhHHHHh----cccCCchhhhhhHHHHHHhhhhhcC---CeeeeeccccceEeccCCceEeeecccc
Confidence 69999999999999988844 5899999999999999999999999 9999999999999999999999999999
Q ss_pred cccccccccccccccccccCcccCChhhhcccCcCccccchhhhHHHHHHHhCCCCCCCCccCCCCchhHHHHHHHHHhc
Q 038766 166 RMLDVHLQDLSSLSTAFQGTIGYLAPEFAYMRIVTTKVDVFSFGIVVMEFLTKRRPTGLDEENGLSPISLRQLVEKALAN 245 (299)
Q Consensus 166 ~~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~DiwslG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~ 245 (299)
..-- .......+..|||.|+|||++..+.|+.+.|-||+|++||+|+.|++||....+. ..+...++.
T Consensus 498 KEni----~~~~TTkTFCGTPdYiAPEIi~YqPYgksvDWWa~GVLLyEmlaGQpPFdGeDE~----elF~aI~eh---- 565 (683)
T KOG0696|consen 498 KENI----FDGVTTKTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQPPFDGEDED----ELFQAIMEH---- 565 (683)
T ss_pred cccc----cCCcceeeecCCCcccccceEEecccccchhHHHHHHHHHHHHcCCCCCCCCCHH----HHHHHHHHc----
Confidence 7421 1233446778999999999999999999999999999999999999999654322 111111111
Q ss_pred CccCcccccCccccchhhHhHHHHHHHHHHHHHHHHhcCCCCCCCCCh
Q 038766 246 GINGVRQITDPKLVSSIYEEQEQHQVLEELFKLALVCTSSNPEDRPNM 293 (299)
Q Consensus 246 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rpt~ 293 (299)
. ...+...|.++.++.+..|...|.+|...
T Consensus 566 -----------n-------vsyPKslSkEAv~ickg~ltK~P~kRLGc 595 (683)
T KOG0696|consen 566 -----------N-------VSYPKSLSKEAVAICKGLLTKHPGKRLGC 595 (683)
T ss_pred -----------c-------CcCcccccHHHHHHHHHHhhcCCccccCC
Confidence 0 11166678899999999999999999754
|
|
| >cd00180 PKc Catalytic domain of Protein Kinases | Back alignment and domain information |
|---|
Probab=99.98 E-value=5.4e-31 Score=210.62 Aligned_cols=211 Identities=33% Similarity=0.557 Sum_probs=178.6
Q ss_pred eecCCcceEEEEEeCC-CcEEEEEEeccCcCChhhhHHHHHHHHHHHhcCCcceeeeeeEEEcCCCeeEEEEeecCCCCh
Q 038766 20 IGNSNLSTVYKGRLED-GEIVAVKKLNFHQFSAESDKSFYREAKTLKELKHRNLVKVLGYAWESGKLKALILEYMENGSL 98 (299)
Q Consensus 20 lg~g~~~~v~~~~~~~-~~~~~vK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~lv~e~~~~~~L 98 (299)
||+|++|.||++...+ ++.+++|++....... ....+.+|+..++.++|++++++++.+... ...++++|++.+++|
T Consensus 1 l~~g~~~~v~~~~~~~~~~~~~~K~~~~~~~~~-~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~-~~~~~~~e~~~~~~l 78 (215)
T cd00180 1 LGEGGFGTVYLARDKKTGKKVAIKIIKKEDSSS-LLEELLREIEILKKLNHPNIVKLYGVFEDE-NHLYLVMEYCEGGSL 78 (215)
T ss_pred CCcCCceEEEEEEecCCCcEEEEEEeccccchh-HHHHHHHHHHHHHhcCCCCeeeEeeeeecC-CeEEEEEecCCCCcH
Confidence 6899999999998754 8999999986433221 457889999999999999999999976654 566999999988999
Q ss_pred HHHhcCCCCCCCCCChhhHHHHHHHHHHHHHHhhcCCCCCeeeecccCCceeeCC-CCcEEEeeeccccccccccccccc
Q 038766 99 ESVIHGPGVDHSRWTLPKRIDVLISVANGLDYLHSGYDIPIVHCDMKPSNILLDR-DFEAHVSDFGTSRMLDVHLQDLSS 177 (299)
Q Consensus 99 ~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lh~~~~~~~~H~dl~~~nil~~~-~~~v~l~df~~~~~~~~~~~~~~~ 177 (299)
.+++.... ..++...++.++.+++.++++||+. +++|+||+|.||+++. ++.++|+||+.+........
T Consensus 79 ~~~~~~~~---~~~~~~~~~~~~~~l~~~l~~lh~~---~~~H~dl~~~ni~~~~~~~~~~l~d~~~~~~~~~~~~---- 148 (215)
T cd00180 79 KDLLKENE---GKLSEDEILRILLQILEGLEYLHSN---GIIHRDLKPENILLDSDNGKVKLADFGLSKLLTSDKS---- 148 (215)
T ss_pred HHHHHhcc---CCCCHHHHHHHHHHHHHHHHHHHhC---CeeccCCCHhhEEEeCCCCcEEEecCCceEEccCCcc----
Confidence 99986321 4689999999999999999999999 9999999999999999 89999999999876542111
Q ss_pred cccccccCcccCChhhhccc-CcCccccchhhhHHHHHHHhCCCCCCCCccCCCCchhHHHHHHHHHhcCccCcccccCc
Q 038766 178 LSTAFQGTIGYLAPEFAYMR-IVTTKVDVFSFGIVVMEFLTKRRPTGLDEENGLSPISLRQLVEKALANGINGVRQITDP 256 (299)
Q Consensus 178 ~~~~~~~~~~y~~PE~~~~~-~~~~~~DiwslG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 256 (299)
......+...|++||..... ..+.++|+|++|+++++|
T Consensus 149 ~~~~~~~~~~~~~pe~~~~~~~~~~~~D~~~lg~~~~~l----------------------------------------- 187 (215)
T cd00180 149 LLKTIVGTPAYMAPEVLLGKGYYSEKSDIWSLGVILYEL----------------------------------------- 187 (215)
T ss_pred hhhcccCCCCccChhHhcccCCCCchhhhHHHHHHHHHH-----------------------------------------
Confidence 12334567889999998877 788999999999999998
Q ss_pred cccchhhHhHHHHHHHHHHHHHHHHhcCCCCCCCCChhhhhcC
Q 038766 257 KLVSSIYEEQEQHQVLEELFKLALVCTSSNPEDRPNMNELLIT 299 (299)
Q Consensus 257 ~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rpt~~~il~~ 299 (299)
..+.+++.+|+..+|++|||+++++++
T Consensus 188 ----------------~~~~~~l~~~l~~~p~~R~~~~~l~~~ 214 (215)
T cd00180 188 ----------------PELKDLIRKMLQKDPEKRPSAKEILEH 214 (215)
T ss_pred ----------------HHHHHHHHHHhhCCcccCcCHHHHhhC
Confidence 258889999999999999999999875
|
Protein Kinases (PKs), catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The PK family is part of a larger superfamily that includes the catalytic domains of RIO kinases, aminoglycoside phosphotransferase, choline kinase, phosphoinositide 3-kinase (PI3K), and actin-fragmin kinase. PKs make up a large family of serine/threonine kinases, protein tyrosine kinases (PTKs), and dual-specificity PKs that phosphorylate both serine/threonine and tyrosine residues of target proteins. Majority of protein phosphorylation, about 95%, occurs on serine residues while only 1% occurs on tyrosine residues. Protein phosphorylation is a mechanism by which a wide variety of cellular proteins, such as enzymes and membrane channels, are reversibly regulated in response to certain stimuli. PKs often function as components of signal transduction pathways in which |
| >KOG1167 consensus Serine/threonine protein kinase of the CDC7 subfamily involved in DNA synthesis, repair and recombination [Replication, recombination and repair] | Back alignment and domain information |
|---|
Probab=99.98 E-value=1.3e-32 Score=227.26 Aligned_cols=280 Identities=24% Similarity=0.346 Sum_probs=205.1
Q ss_pred HHHHHHhCCCCCCceeecCCcceEEEEEeC----CCcEEEEEEeccCcCChhhhHHHHHHHHHHHhcC-CcceeeeeeEE
Q 038766 5 TEIENATGSFSENNIIGNSNLSTVYKGRLE----DGEIVAVKKLNFHQFSAESDKSFYREAKTLKELK-HRNLVKVLGYA 79 (299)
Q Consensus 5 ~~~~~~~~~y~~~~~lg~g~~~~v~~~~~~----~~~~~~vK~~~~~~~~~~~~~~~~~e~~~l~~l~-h~~i~~~~~~~ 79 (299)
+....+.+.|..+++||.|.|++||++.+. ..+.||+|.+.. ..+..++.+|++.|..+. +.||+++.+ +
T Consensus 29 q~~p~~~~~~~~v~kigeGsFssv~~a~~~~~~~~~~~valk~i~~----ts~p~ri~~El~~L~~~gG~~ni~~~~~-~ 103 (418)
T KOG1167|consen 29 QDIPFISNAYKVVNKIGEGSFSSVYKATDIEQDTKRRYVALKAIYR----TSSPSRILNELEMLYRLGGSDNIIKLNG-C 103 (418)
T ss_pred hhhhhhhhhhhhhccccccchhhhhhhhHhhhccccceEeeeeccc----ccCchHHHHHHHHHHHhccchhhhcchh-h
Confidence 345567789999999999999999999753 478899999863 345667999999999996 899999999 5
Q ss_pred EcCCCeeEEEEeecCCCChHHHhcCCCCCCCCCChhhHHHHHHHHHHHHHHhhcCCCCCeeeecccCCceeeCC-CCcEE
Q 038766 80 WESGKLKALILEYMENGSLESVIHGPGVDHSRWTLPKRIDVLISVANGLDYLHSGYDIPIVHCDMKPSNILLDR-DFEAH 158 (299)
Q Consensus 80 ~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lh~~~~~~~~H~dl~~~nil~~~-~~~v~ 158 (299)
..++...++|+||++.....++.. .++..++..+++.++.||+++|.+ ||+||||||.|++.+. .+.-.
T Consensus 104 ~rnnd~v~ivlp~~~H~~f~~l~~-------~l~~~~i~~Yl~~ll~Al~~~h~~---GIvHRDiKpsNFL~n~~t~rg~ 173 (418)
T KOG1167|consen 104 FRNNDQVAIVLPYFEHDRFRDLYR-------SLSLAEIRWYLRNLLKALAHLHKN---GIVHRDIKPSNFLYNRRTQRGV 173 (418)
T ss_pred hccCCeeEEEecccCccCHHHHHh-------cCCHHHHHHHHHHHHHHhhhhhcc---CccccCCCccccccccccCCce
Confidence 556667799999999988888885 467889999999999999999999 9999999999999985 46789
Q ss_pred Eeeeccccccccc-------------ccc---------------------------ccccccccccCcccCChhhhccc-
Q 038766 159 VSDFGTSRMLDVH-------------LQD---------------------------LSSLSTAFQGTIGYLAPEFAYMR- 197 (299)
Q Consensus 159 l~df~~~~~~~~~-------------~~~---------------------------~~~~~~~~~~~~~y~~PE~~~~~- 197 (299)
|+|||++...+.. ... .........||++|.|||++...
T Consensus 174 LvDFgLA~~~d~~~~~~~s~~~~~~~~~~~~g~~~~~~~~~~~~~p~g~~~~~~~~r~~~~anrAGT~GfRaPEvL~k~~ 253 (418)
T KOG1167|consen 174 LVDFGLAQRYDGYQQTEHSRSYSGRHATPAMGKDVHCQSVATASKPAGYYRRCNDGRPSERANRAGTPGFRAPEVLFRCP 253 (418)
T ss_pred EEechhHHHHHhhhhhhhhhhhhcccCCccccCcccccccccccCCCCceeccCCCccceecccCCCCCCCchHHHhhcc
Confidence 9999999722100 000 00011234589999999977754
Q ss_pred CcCccccchhhhHHHHHHHhCCCCCCCCccCCCCchhHHHHH-----HHHHh-cCc------cCcccccCcc--------
Q 038766 198 IVTTKVDVFSFGIVVMEFLTKRRPTGLDEENGLSPISLRQLV-----EKALA-NGI------NGVRQITDPK-------- 257 (299)
Q Consensus 198 ~~~~~~DiwslG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~-----~~~~~-~~~------~~~~~~~~~~-------- 257 (299)
.-+++.||||.|+++..++++..||.....+.....++.... ++... .+. .....+.+..
T Consensus 254 ~QttaiDiws~GVI~Lslls~~~PFf~a~dd~~al~ei~tifG~~~mrk~A~l~g~~~l~~ksn~~~~~e~~~~f~s~~~ 333 (418)
T KOG1167|consen 254 RQTTAIDIWSAGVILLSLLSRRYPFFKAKDDADALAEIATIFGSAEMRKCAALPGRILLWQKSNIPTIPELRVNFETLHI 333 (418)
T ss_pred CcCCccceeeccceeehhhccccccccCccccchHHHHHHHhChHHHHHHhhcCCceeeeccccccccHHHHhchhccCh
Confidence 467899999999999999999999987766555544433221 11111 111 0000000000
Q ss_pred ---cc-ch--hhHhHHHHHHHHHHHHHHHHhcCCCCCCCCChhhhhcC
Q 038766 258 ---LV-SS--IYEEQEQHQVLEELFKLALVCTSSNPEDRPNMNELLIT 299 (299)
Q Consensus 258 ---~~-~~--~~~~~~~~~~~~~l~~li~~~l~~dP~~Rpt~~~il~~ 299 (299)
.. .. ..........+..+.+|+++||..||.+|.|+++.|.|
T Consensus 334 ~~~~~~~q~n~~~~~~~d~~~~~~~dlLdk~le~np~kRitAEeALkH 381 (418)
T KOG1167|consen 334 ESIYKSRQPNTEREIGSDVFPALLLDLLDKCLELNPQKRITAEDALKH 381 (418)
T ss_pred hhcccccccceeeccccccccHHHHHHHHHHccCChhhcccHHHHhcC
Confidence 00 00 01112233445589999999999999999999999987
|
|
| >KOG0984 consensus Mitogen-activated protein kinase (MAPK) kinase MKK3/MKK6 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.98 E-value=7.8e-33 Score=208.41 Aligned_cols=207 Identities=26% Similarity=0.350 Sum_probs=170.8
Q ss_pred HHHHhCCCCCCceeecCCcceEEEEEe-CCCcEEEEEEeccCcCChhhhHHHHHHHHHHHhcC-CcceeeeeeEEEcCCC
Q 038766 7 IENATGSFSENNIIGNSNLSTVYKGRL-EDGEIVAVKKLNFHQFSAESDKSFYREAKTLKELK-HRNLVKVLGYAWESGK 84 (299)
Q Consensus 7 ~~~~~~~y~~~~~lg~g~~~~v~~~~~-~~~~~~~vK~~~~~~~~~~~~~~~~~e~~~l~~l~-h~~i~~~~~~~~~~~~ 84 (299)
.|.-.+.......||+|++|.|-+.++ .+|...|+|.+.. ..+....+++..|+.+..+.. +|.++.++|..+.+++
T Consensus 41 ~eV~ad~L~~i~elGrGayG~vekmrh~~sg~imAvKri~~-tvn~q~q~r~L~dldi~~r~~~CPf~V~FyGa~~regd 119 (282)
T KOG0984|consen 41 FEVPADDLVGIEELGRGAYGVVEKMRHIQSGTIMAVKRIRA-TVNSQEQKRLLMDLDIIMRTVDCPFTVHFYGALFREGD 119 (282)
T ss_pred cccchhhhhhhhhhcCCccchhhheeeccCCeEEEEeeehh-hcChHHHHHHHHhhhhhccCCCCCeEEEeehhhhcccc
Confidence 344556667778899999999998876 5799999999974 445667888889998887775 9999999998777776
Q ss_pred eeEEEEeecCCCChHHHhcCCCCCCCCCChhhHHHHHHHHHHHHHHhhcCCCCCeeeecccCCceeeCCCCcEEEeeecc
Q 038766 85 LKALILEYMENGSLESVIHGPGVDHSRWTLPKRIDVLISVANGLDYLHSGYDIPIVHCDMKPSNILLDRDFEAHVSDFGT 164 (299)
Q Consensus 85 ~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lh~~~~~~~~H~dl~~~nil~~~~~~v~l~df~~ 164 (299)
. ++.||.++ .+|..+-......+..++|..+-+|+..+..||.|||++ ..++|||+||+|||++.+|.||++|||+
T Consensus 120 v-wIcME~M~-tSldkfy~~v~~~g~~ipE~vlGkIa~Svv~al~~L~~k--L~vIHRDvKPsNiLIn~~GqVKiCDFGI 195 (282)
T KOG0984|consen 120 V-WICMELMD-TSLDKFYRKVLKKGGTIPEDVLGKIAVSVVHALEFLHSK--LSVIHRDVKPSNILINYDGQVKICDFGI 195 (282)
T ss_pred E-EEeHHHhh-hhHHHHHHHHHhcCCcCchHHhhHhHHHHHHHHHHHHHH--hhhhhccCCcceEEEccCCcEEEccccc
Confidence 6 99999995 488776554444778999999999999999999999987 5999999999999999999999999999
Q ss_pred ccccccccccccccccccccCcccCChhhhc----ccCcCccccchhhhHHHHHHHhCCCCCC
Q 038766 165 SRMLDVHLQDLSSLSTAFQGTIGYLAPEFAY----MRIVTTKVDVFSFGIVVMEFLTKRRPTG 223 (299)
Q Consensus 165 ~~~~~~~~~~~~~~~~~~~~~~~y~~PE~~~----~~~~~~~~DiwslG~~l~~l~~g~~p~~ 223 (299)
+-.+... -..+.-.|-..|+|||.+. ...|+.++||||||+++.||.+++.|+.
T Consensus 196 sG~L~dS-----iAkt~daGCkpYmaPEri~~e~n~~gY~vksDvWSLGItmiElA~lr~PY~ 253 (282)
T KOG0984|consen 196 SGYLVDS-----IAKTMDAGCKPYMAPERINPELNQKGYSVKSDVWSLGITMIEMAILRFPYE 253 (282)
T ss_pred ceeehhh-----hHHHHhcCCCccCChhhcCcccCcccceeehhhhhhhhhhhhhhhcccccc
Confidence 8755411 1112234667899999755 3479999999999999999999999984
|
|
| >KOG0608 consensus Warts/lats-like serine threonine kinases [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.97 E-value=3.1e-32 Score=235.00 Aligned_cols=206 Identities=21% Similarity=0.282 Sum_probs=172.3
Q ss_pred CCCCCCceeecCCcceEEEEEe-CCCcEEEEEEeccCc-CChhhhHHHHHHHHHHHhcCCcceeeeeeEEEcCCCeeEEE
Q 038766 12 GSFSENNIIGNSNLSTVYKGRL-EDGEIVAVKKLNFHQ-FSAESDKSFYREAKTLKELKHRNLVKVLGYAWESGKLKALI 89 (299)
Q Consensus 12 ~~y~~~~~lg~g~~~~v~~~~~-~~~~~~~vK~~~~~~-~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~lv 89 (299)
+-|...+.||=|+||.|.++.. .+...||.|+++..+ +.......++.|..+|..-.++=|++++-.|.+.+ .+|+|
T Consensus 629 SmFvkik~iGvGAFGeV~Lv~KvDT~~lYAmKTLrKaDVl~rnQvaHVKAERDILAEADn~WVVrLyySFQDkd-nLYFV 707 (1034)
T KOG0608|consen 629 SMFVKIKTIGVGAFGEVCLVRKVDTRALYAMKTLRKADVLMRNQVAHVKAERDILAEADNEWVVRLYYSFQDKD-NLYFV 707 (1034)
T ss_pred cceEEEeeecccccceeEEEeecchhhHHHHhhhHHHHHHhhhhhhhhhhhhhhHhhcCCcceEEEEEEeccCC-ceEEE
Confidence 4467788999999999999964 457889999987543 33444567888999999999999999998666644 55999
Q ss_pred EeecCCCChHHHhcCCCCCCCCCChhhHHHHHHHHHHHHHHhhcCCCCCeeeecccCCceeeCCCCcEEEeeeccccccc
Q 038766 90 LEYMENGSLESVIHGPGVDHSRWTLPKRIDVLISVANGLDYLHSGYDIPIVHCDMKPSNILLDRDFEAHVSDFGTSRMLD 169 (299)
Q Consensus 90 ~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lh~~~~~~~~H~dl~~~nil~~~~~~v~l~df~~~~~~~ 169 (299)
|+|++||++-+++-+ ..-|+|+.+..++..+..|+.+.|.. |++||||||+|||||.+|.+||+|||+|+-+.
T Consensus 708 MdYIPGGDmMSLLIr----mgIFeE~LARFYIAEltcAiesVHkm---GFIHRDiKPDNILIDrdGHIKLTDFGLCTGfR 780 (1034)
T KOG0608|consen 708 MDYIPGGDMMSLLIR----MGIFEEDLARFYIAELTCAIESVHKM---GFIHRDIKPDNILIDRDGHIKLTDFGLCTGFR 780 (1034)
T ss_pred EeccCCccHHHHHHH----hccCHHHHHHHHHHHHHHHHHHHHhc---cceecccCccceEEccCCceeeeeccccccce
Confidence 999999999998864 34799999999999999999999998 99999999999999999999999999998664
Q ss_pred ccccccc--------------------------------------ccccccccCcccCChhhhcccCcCccccchhhhHH
Q 038766 170 VHLQDLS--------------------------------------SLSTAFQGTIGYLAPEFAYMRIVTTKVDVFSFGIV 211 (299)
Q Consensus 170 ~~~~~~~--------------------------------------~~~~~~~~~~~y~~PE~~~~~~~~~~~DiwslG~~ 211 (299)
+...... ...-..+||+.|+|||++...+++..+|-||.|++
T Consensus 781 WTHdskYYq~gdH~RqDSmep~~e~~d~~~~lkvL~~ra~~~h~r~~ahslvgt~nyiapevl~r~g~~q~cdwws~gvi 860 (1034)
T KOG0608|consen 781 WTHDSKYYQEGDHHRQDSMEPSPEWADISKCLKVLERRAMRQHQRILAHSLVGTPNYIAPEVLARTGYTQLCDWWSVGVI 860 (1034)
T ss_pred eccccccccCCCccccccCCCchhhccccccchHHHHHHHhhhhhhhhhhhcCCCcccChHHhcccCccccchhhHhhHH
Confidence 3321100 00123468999999999999999999999999999
Q ss_pred HHHHHhCCCCCCCC
Q 038766 212 VMEFLTKRRPTGLD 225 (299)
Q Consensus 212 l~~l~~g~~p~~~~ 225 (299)
||+|+.|+.||-.+
T Consensus 861 l~em~~g~~pf~~~ 874 (1034)
T KOG0608|consen 861 LYEMLVGQPPFLAD 874 (1034)
T ss_pred HHHHhhCCCCccCC
Confidence 99999999999644
|
|
| >KOG1024 consensus Receptor-like protein tyrosine kinase RYK/derailed [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=2.9e-32 Score=223.21 Aligned_cols=262 Identities=21% Similarity=0.336 Sum_probs=210.5
Q ss_pred HHHHHHhCCCCCCceeecCCcceEEEEEeC------CCcEEEEEEeccCcCChhhhHHHHHHHHHHHhcCCcceeeeeeE
Q 038766 5 TEIENATGSFSENNIIGNSNLSTVYKGRLE------DGEIVAVKKLNFHQFSAESDKSFYREAKTLKELKHRNLVKVLGY 78 (299)
Q Consensus 5 ~~~~~~~~~y~~~~~lg~g~~~~v~~~~~~------~~~~~~vK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~ 78 (299)
.++..-..|++..-.+-+|.||.||.+.+. +.+.+.+|++++. .++-....+..|.-.+....|||++++.++
T Consensus 277 ~~l~v~r~Rv~l~~llqEGtFGri~~gI~~eEdt~n~~q~v~vKTvk~~-AS~iQv~~~L~es~lly~~sH~nll~V~~V 355 (563)
T KOG1024|consen 277 QELTVQRCRVRLSCLLQEGTFGRIYRGIWREEDTYNDCQEVLVKTVKQH-ASQIQVNLLLQESMLLYGASHPNLLSVLGV 355 (563)
T ss_pred HhhhhhhhheechhhhhcCchhheeeeeecccCCcchHHHHHHHHHHhc-ccHHHHHHHHHHHHHHhcCcCCCccceeEE
Confidence 455666788999999999999999999653 2455777877643 244445678889999999999999999999
Q ss_pred EEcCCCeeEEEEeecCCCChHHHhc-----CCCCCCCCCChhhHHHHHHHHHHHHHHhhcCCCCCeeeecccCCceeeCC
Q 038766 79 AWESGKLKALILEYMENGSLESVIH-----GPGVDHSRWTLPKRIDVLISVANGLDYLHSGYDIPIVHCDMKPSNILLDR 153 (299)
Q Consensus 79 ~~~~~~~~~lv~e~~~~~~L~~~~~-----~~~~~~~~~~~~~~~~i~~qi~~~l~~lh~~~~~~~~H~dl~~~nil~~~ 153 (299)
..+.....++.+.+..-++|..++. ... ..+.++..+...++.|++.|+.+||+. +++|.||...|+++++
T Consensus 356 ~ie~~~~P~V~y~~~~~gNLK~FL~~Cr~~~~~-~aqtvtt~qlV~masQla~am~hlh~~---~ViHkDiAaRNCvIdd 431 (563)
T KOG1024|consen 356 SIEDYATPFVLYPATGVGNLKSFLQICRGDDPS-YAQTVTTIQLVLMASQLAMAMEHLHNH---GVIHKDIAARNCVIDD 431 (563)
T ss_pred EeeccCcceEEEeccCcchHHHHHHHhccCCCc-cccchhHHHHHHHHHHHHHHHHHHHhc---Ccccchhhhhcceehh
Confidence 9988888899999999899999886 222 345678888899999999999999999 9999999999999999
Q ss_pred CCcEEEeeeccccccccccccccccccccccCcccCChhhhcccCcCccccchhhhHHHHHHHh-CCCCCCCCccCCCCc
Q 038766 154 DFEAHVSDFGTSRMLDVHLQDLSSLSTAFQGTIGYLAPEFAYMRIVTTKVDVFSFGIVVMEFLT-KRRPTGLDEENGLSP 232 (299)
Q Consensus 154 ~~~v~l~df~~~~~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~DiwslG~~l~~l~~-g~~p~~~~~~~~~~~ 232 (299)
.-.|||+|=.+++.+-. .+..........+..||+||.+....++..+|+||||+++|||++ |..|+ .+..+
T Consensus 432 ~LqVkltDsaLSRDLFP--~DYhcLGDnEnRPvkWMslEal~n~~yssasDvWsfGVllWELmtlg~~Py-----aeIDP 504 (563)
T KOG1024|consen 432 QLQVKLTDSALSRDLFP--GDYHCLGDNENRPVKWMSLEALQNSHYSSASDVWSFGVLLWELMTLGKLPY-----AEIDP 504 (563)
T ss_pred heeEEeccchhccccCc--ccccccCCCCCCcccccCHHHHhhhhhcchhhhHHHHHHHHHHHhcCCCCc-----cccCH
Confidence 99999999999875421 223333445556789999999999999999999999999999998 77777 34445
Q ss_pred hhHHHHHHHHHhcCccCcccccCccccchhhHhHHHHHHHHHHHHHHHHhcCCCCCCCCChhhhhc
Q 038766 233 ISLRQLVEKALANGINGVRQITDPKLVSSIYEEQEQHQVLEELFKLALVCTSSNPEDRPNMNELLI 298 (299)
Q Consensus 233 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rpt~~~il~ 298 (299)
.++...+.+.. +...+...+++|+.++..||..+|++||+++|+..
T Consensus 505 fEm~~ylkdGy--------------------RlaQP~NCPDeLf~vMacCWallpeeRPsf~Qlv~ 550 (563)
T KOG1024|consen 505 FEMEHYLKDGY--------------------RLAQPFNCPDELFTVMACCWALLPEERPSFSQLVI 550 (563)
T ss_pred HHHHHHHhccc--------------------eecCCCCCcHHHHHHHHHHHhcCcccCCCHHHHHH
Confidence 55555443322 11225567789999999999999999999999863
|
|
| >KOG1345 consensus Serine/threonine kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.3e-32 Score=215.23 Aligned_cols=246 Identities=18% Similarity=0.299 Sum_probs=192.7
Q ss_pred HHhCCCCCCceeecCCcceEEEEEeC-CCcEEEEEEeccCcCChhhhHHHHHHHHHHHhcC-CcceeeeeeEEEcCCCee
Q 038766 9 NATGSFSENNIIGNSNLSTVYKGRLE-DGEIVAVKKLNFHQFSAESDKSFYREAKTLKELK-HRNLVKVLGYAWESGKLK 86 (299)
Q Consensus 9 ~~~~~y~~~~~lg~g~~~~v~~~~~~-~~~~~~vK~~~~~~~~~~~~~~~~~e~~~l~~l~-h~~i~~~~~~~~~~~~~~ 86 (299)
.+.+.|.|.+.||+|.||.+-++.++ ++..+|+|-+.. .....+.+.+|...--.+. |.||+.-|++.++....+
T Consensus 21 ~l~d~y~I~k~lgeG~FgkIlL~eHr~s~t~ivlKavp~---p~tt~~dF~rEfhY~~~Ls~H~hIi~tY~vaFqt~d~Y 97 (378)
T KOG1345|consen 21 DLEDVYTINKQLGEGRFGKILLAEHRQSKTRIVLKAVPR---PQTTQADFVREFHYSFFLSPHQHIIDTYEVAFQTSDAY 97 (378)
T ss_pred chhhhhhHHHHhcccceeeEEeeeccCCceEEEeeccCc---chhhHHHHHHHhccceeeccchhhhHHHHHHhhcCceE
Confidence 46799999999999999999999875 578899998753 3355678888887776775 899999999888888888
Q ss_pred EEEEeecCCCChHHHhcCCCCCCCCCChhhHHHHHHHHHHHHHHhhcCCCCCeeeecccCCceeeC--CCCcEEEeeecc
Q 038766 87 ALILEYMENGSLESVIHGPGVDHSRWTLPKRIDVLISVANGLDYLHSGYDIPIVHCDMKPSNILLD--RDFEAHVSDFGT 164 (299)
Q Consensus 87 ~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lh~~~~~~~~H~dl~~~nil~~--~~~~v~l~df~~ 164 (299)
+.++||++.|+|.+-+... .+-|..-..++.|+++|+.|+|++ ++||||||.+|||+- +...|||+|||+
T Consensus 98 vF~qE~aP~gdL~snv~~~-----GigE~~~K~v~~ql~SAi~fMHsk---nlVHRdlK~eNiLif~~df~rvKlcDFG~ 169 (378)
T KOG1345|consen 98 VFVQEFAPRGDLRSNVEAA-----GIGEANTKKVFAQLLSAIEFMHSK---NLVHRDLKAENILIFDADFYRVKLCDFGL 169 (378)
T ss_pred EEeeccCccchhhhhcCcc-----cccHHHHHHHHHHHHHHHHHhhcc---chhhcccccceEEEecCCccEEEeeeccc
Confidence 9999999999999998644 588888999999999999999999 999999999999993 345799999999
Q ss_pred ccccccccccccccccccccCcccCChhhhccc-----CcCccccchhhhHHHHHHHhCCCCCCCCccCCCCchhHHHHH
Q 038766 165 SRMLDVHLQDLSSLSTAFQGTIGYLAPEFAYMR-----IVTTKVDVFSFGIVVMEFLTKRRPTGLDEENGLSPISLRQLV 239 (299)
Q Consensus 165 ~~~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~-----~~~~~~DiwslG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~ 239 (299)
+...... -........|.+||..... ...+.+|+|.||+++|.+++|+.||......+.....+..+.
T Consensus 170 t~k~g~t-------V~~~~~~~~y~~pe~~~~~~ne~~~~~ps~D~WqfGIi~f~cltG~~PWQka~~~d~~Y~~~~~w~ 242 (378)
T KOG1345|consen 170 TRKVGTT-------VKYLEYVNNYHAPELCDTVVNEKLVVNPSTDIWQFGIIFFYCLTGKFPWQKASIMDKPYWEWEQWL 242 (378)
T ss_pred ccccCce-------ehhhhhhcccCCcHHHhhccccceEecccccchheeeeeeeeecCCCcchhhhccCchHHHHHHHh
Confidence 8764421 2223345678999965432 246789999999999999999999975544444444444443
Q ss_pred HHHHhcCccCcccccCccccchhhHhHHHHHHHHHHHHHHHHhcCCCCCCC
Q 038766 240 EKALANGINGVRQITDPKLVSSIYEEQEQHQVLEELFKLALVCTSSNPEDR 290 (299)
Q Consensus 240 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~R 290 (299)
..... .-| ...+.+++.+..++++-|..+|++|
T Consensus 243 ~rk~~---------~~P---------~~F~~fs~~a~r~Fkk~lt~~~~dr 275 (378)
T KOG1345|consen 243 KRKNP---------ALP---------KKFNPFSEKALRLFKKSLTPRFKDR 275 (378)
T ss_pred cccCc---------cCc---------hhhcccCHHHHHHHHHhcCCccccc
Confidence 22111 001 1134556788999999999999998
|
|
| >KOG1152 consensus Signal transduction serine/threonine kinase with PAS/PAC sensor domain [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=6.7e-32 Score=230.57 Aligned_cols=199 Identities=23% Similarity=0.299 Sum_probs=167.6
Q ss_pred hCCCCCCceeecCCcceEEEEEeC-CCcEEEEEEeccCcCChhhh------HHHHHHHHHHHhcC---CcceeeeeeEEE
Q 038766 11 TGSFSENNIIGNSNLSTVYKGRLE-DGEIVAVKKLNFHQFSAESD------KSFYREAKTLKELK---HRNLVKVLGYAW 80 (299)
Q Consensus 11 ~~~y~~~~~lg~g~~~~v~~~~~~-~~~~~~vK~~~~~~~~~~~~------~~~~~e~~~l~~l~---h~~i~~~~~~~~ 80 (299)
..+|...+.||.|+||.|++|.++ +...|+||.+..+.+--+.. -.+-.|+++|..++ |+||+++++ ++
T Consensus 560 ~s~yttlq~lG~GAyGkV~lai~K~n~~eVViK~I~KeRIL~DtWvrDrkLGtVp~EIqIla~l~~~sH~NIlKlLd-fF 638 (772)
T KOG1152|consen 560 FSDYTTLQPLGEGAYGKVNLAIHKENNYEVVIKMIFKERILVDTWVRDRKLGTVPSEIQILATLNKHSHENILKLLD-FF 638 (772)
T ss_pred cccceeeeeccccccceEEEeeecccceEEEeeehhhhhhhhhhhhcccccCccchhHHHHHHhhhcCccchhhhhh-ee
Confidence 356899999999999999999864 57789999887554322221 12445999999997 999999999 45
Q ss_pred cCCCeeEEEEeec-CCCChHHHhcCCCCCCCCCChhhHHHHHHHHHHHHHHhhcCCCCCeeeecccCCceeeCCCCcEEE
Q 038766 81 ESGKLKALILEYM-ENGSLESVIHGPGVDHSRWTLPKRIDVLISVANGLDYLHSGYDIPIVHCDMKPSNILLDRDFEAHV 159 (299)
Q Consensus 81 ~~~~~~~lv~e~~-~~~~L~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lh~~~~~~~~H~dl~~~nil~~~~~~v~l 159 (299)
+++.++++++|.. +|.+|.++|+ -+..++|.++..|+.|++.|+++||++ +|+|||||-+|+.++.+|-+||
T Consensus 639 Eddd~yyl~te~hg~gIDLFd~IE----~kp~m~E~eAk~IFkQV~agi~hlh~~---~ivhrdikdenvivd~~g~~kl 711 (772)
T KOG1152|consen 639 EDDDYYYLETEVHGEGIDLFDFIE----FKPRMDEPEAKLIFKQVVAGIKHLHDQ---GIVHRDIKDENVIVDSNGFVKL 711 (772)
T ss_pred ecCCeeEEEecCCCCCcchhhhhh----ccCccchHHHHHHHHHHHhcccccccc---CceecccccccEEEecCCeEEE
Confidence 5566669999876 4568899998 567899999999999999999999999 9999999999999999999999
Q ss_pred eeeccccccccccccccccccccccCcccCChhhhcccCcCc-cccchhhhHHHHHHHhCCCCCC
Q 038766 160 SDFGTSRMLDVHLQDLSSLSTAFQGTIGYLAPEFAYMRIVTT-KVDVFSFGIVVMEFLTKRRPTG 223 (299)
Q Consensus 160 ~df~~~~~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~-~~DiwslG~~l~~l~~g~~p~~ 223 (299)
+|||.+...+ +.....++||..|.|||++-+..|-. .-|||+||+++|.+.....||.
T Consensus 712 idfgsaa~~k------sgpfd~f~gtv~~aapevl~g~~y~gk~qdiwalgillytivykenpyy 770 (772)
T KOG1152|consen 712 IDFGSAAYTK------SGPFDVFVGTVDYAAPEVLGGEKYLGKPQDIWALGILLYTIVYKENPYY 770 (772)
T ss_pred eeccchhhhc------CCCcceeeeeccccchhhhCCCccCCCcchhhhhhheeeEEEeccCCCc
Confidence 9999987654 34567788999999999999987654 5799999999999999988874
|
|
| >KOG0576 consensus Mitogen-activated protein kinase kinase kinase kinase (MAP4K), germinal center kinase family [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=5.3e-32 Score=234.57 Aligned_cols=255 Identities=26% Similarity=0.378 Sum_probs=206.9
Q ss_pred HhCCCCCCceeecCCcceEEEEEe-CCCcEEEEEEeccCcCChhhhHHHHHHHHHHHhcCCcceeeeeeEEEcCCCeeEE
Q 038766 10 ATGSFSENNIIGNSNLSTVYKGRL-EDGEIVAVKKLNFHQFSAESDKSFYREAKTLKELKHRNLVKVLGYAWESGKLKAL 88 (299)
Q Consensus 10 ~~~~y~~~~~lg~g~~~~v~~~~~-~~~~~~~vK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~l 88 (299)
=.++|...+.+|+|.+|.||++++ .+++..|+|+++.. ..+...-+++|+-+++..+||||+.+++.+....+ +++
T Consensus 13 P~ddyellqrvgsgTygdvyKaRd~~s~elaavkvVkLe--p~dd~~~iqqei~~~~dc~h~nivay~gsylr~dk-lwi 89 (829)
T KOG0576|consen 13 PQDDYELLQRVGSGTYGDVYKARDKRSGELAAVKVVKLE--PGDDFSGIQQEIGMLRDCRHPNIVAYFGSYLRRDK-LWI 89 (829)
T ss_pred CccchhheeeecCCcccchhhhcccccCchhhheeeecc--CCccccccccceeeeecCCCcChHHHHhhhhhhcC-cEE
Confidence 357899999999999999999986 56899999999753 45667888999999999999999999996655444 599
Q ss_pred EEeecCCCChHHHhcCCCCCCCCCChhhHHHHHHHHHHHHHHhhcCCCCCeeeecccCCceeeCCCCcEEEeeecccccc
Q 038766 89 ILEYMENGSLESVIHGPGVDHSRWTLPKRIDVLISVANGLDYLHSGYDIPIVHCDMKPSNILLDRDFEAHVSDFGTSRML 168 (299)
Q Consensus 89 v~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lh~~~~~~~~H~dl~~~nil~~~~~~v~l~df~~~~~~ 168 (299)
.|||+.+|+|.+.-. -..++++.++...+...+++++|||+. +-+|||||-.||+++..|.|++.|||.+..+
T Consensus 90 cMEycgggslQdiy~----~TgplselqiayvcRetl~gl~ylhs~---gk~hRdiKGanilltd~gDvklaDfgvsaqi 162 (829)
T KOG0576|consen 90 CMEYCGGGSLQDIYH----VTGPLSELQIAYVCRETLQGLKYLHSQ---GKIHRDIKGANILLTDEGDVKLADFGVSAQI 162 (829)
T ss_pred EEEecCCCcccceee----ecccchhHHHHHHHhhhhccchhhhcC---CcccccccccceeecccCceeecccCchhhh
Confidence 999999999998776 456899999999999999999999999 9999999999999999999999999988765
Q ss_pred ccccccccccccccccCcccCChhhhc---ccCcCccccchhhhHHHHHHHhCCCCCCCCccCCCCchhHHHHHHHHHhc
Q 038766 169 DVHLQDLSSLSTAFQGTIGYLAPEFAY---MRIVTTKVDVFSFGIVVMEFLTKRRPTGLDEENGLSPISLRQLVEKALAN 245 (299)
Q Consensus 169 ~~~~~~~~~~~~~~~~~~~y~~PE~~~---~~~~~~~~DiwslG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~ 245 (299)
... ......+.||+.|+|||+.. ...|...+|||++|++..++-..++|. .++.++.....+.+....
T Consensus 163 tat----i~KrksfiGtpywmapEvaaverkggynqlcdiwa~gitAiel~eLqppl-----fdlhpmr~l~LmTkS~~q 233 (829)
T KOG0576|consen 163 TAT----IAKRKSFIGTPYWMAPEVAAVERKGGYNQLCDIWALGITAIELGELQPPL-----FDLHPMRALFLMTKSGFQ 233 (829)
T ss_pred hhh----hhhhhcccCCccccchhHHHHHhcccccccccccccccchhhhhhcCCcc-----cccchHHHHHHhhccCCC
Confidence 422 23456778999999999543 567889999999999999998887775 344444444444433221
Q ss_pred CccCcccccCccccchhhHhHHHHHHHHHHHHHHHHhcCCCCCCCCChhhhhcC
Q 038766 246 GINGVRQITDPKLVSSIYEEQEQHQVLEELFKLALVCTSSNPEDRPNMNELLIT 299 (299)
Q Consensus 246 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rpt~~~il~~ 299 (299)
. +.... ...-++.+.+|++.+|..+|++|||++-+|.|
T Consensus 234 p---------p~lkD-------k~kws~~fh~fvK~altknpKkRptaeklL~h 271 (829)
T KOG0576|consen 234 P---------PTLKD-------KTKWSEFFHNFVKGALTKNPKKRPTAEKLLQH 271 (829)
T ss_pred C---------CcccC-------CccchHHHHHHHHHHhcCCCccCCChhhheec
Confidence 1 11111 22224578999999999999999999999876
|
|
| >smart00221 STYKc Protein kinase; unclassified specificity | Back alignment and domain information |
|---|
Probab=99.96 E-value=1.2e-28 Score=199.38 Aligned_cols=199 Identities=33% Similarity=0.473 Sum_probs=166.8
Q ss_pred CCCCceeecCCcceEEEEEeCC-CcEEEEEEeccCcCChhhhHHHHHHHHHHHhcCCcceeeeeeEEEcCCCeeEEEEee
Q 038766 14 FSENNIIGNSNLSTVYKGRLED-GEIVAVKKLNFHQFSAESDKSFYREAKTLKELKHRNLVKVLGYAWESGKLKALILEY 92 (299)
Q Consensus 14 y~~~~~lg~g~~~~v~~~~~~~-~~~~~vK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~lv~e~ 92 (299)
|.+.+.||.|++|+||++.... ++.+++|.+...... ...+.+.+|++.+++++|+|++++++.+.. ....++++|+
T Consensus 1 ~~~~~~i~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~-~~~~~~~~e~~~~~~~~~~~i~~~~~~~~~-~~~~~~v~e~ 78 (225)
T smart00221 1 YELGKKLGEGAFGKVYLARDKGTGELVAVKVLKKEKTE-KQREEFLREIRILKKLKHPNIVKLYGVFED-PEPLYLVMEY 78 (225)
T ss_pred CceeeEeecCCCeEEEEEEEcCCCcEEEEEeeccccch-HHHHHHHHHHHHHHhCCCCChhhheeeeec-CCceEEEEec
Confidence 6778999999999999998764 889999998754322 256788899999999999999999996554 4566999999
Q ss_pred cCCCChHHHhcCCCCCCCC-CChhhHHHHHHHHHHHHHHhhcCCCCCeeeecccCCceeeCCCCcEEEeeeccccccccc
Q 038766 93 MENGSLESVIHGPGVDHSR-WTLPKRIDVLISVANGLDYLHSGYDIPIVHCDMKPSNILLDRDFEAHVSDFGTSRMLDVH 171 (299)
Q Consensus 93 ~~~~~L~~~~~~~~~~~~~-~~~~~~~~i~~qi~~~l~~lh~~~~~~~~H~dl~~~nil~~~~~~v~l~df~~~~~~~~~ 171 (299)
+.+++|.+++... .. +++..++.++.+++.++.+||+. +++|+|++|.||+++.++.++|+|||.+......
T Consensus 79 ~~~~~L~~~~~~~----~~~~~~~~~~~~~~~l~~~l~~lh~~---~i~h~di~~~ni~v~~~~~~~l~d~g~~~~~~~~ 151 (225)
T smart00221 79 CEGGDLFDYLRKK----GGKLSEEEARFYLRQILEALEYLHSL---GIVHRDLKPENILLGMDGLVKLADFGLARFIHRD 151 (225)
T ss_pred cCCCCHHHHHHhc----ccCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHEEEcCCCCEEEeeCceeeEecCc
Confidence 9988999998743 23 88999999999999999999999 9999999999999999999999999988765421
Q ss_pred cccccccccccccCcccCChhhh-cccCcCccccchhhhHHHHHHHhCCCCCCC
Q 038766 172 LQDLSSLSTAFQGTIGYLAPEFA-YMRIVTTKVDVFSFGIVVMEFLTKRRPTGL 224 (299)
Q Consensus 172 ~~~~~~~~~~~~~~~~y~~PE~~-~~~~~~~~~DiwslG~~l~~l~~g~~p~~~ 224 (299)
. ........++..|++||.. ....++.++|+|+||+++++|++|..||..
T Consensus 152 ~---~~~~~~~~~~~~~~~pe~~~~~~~~~~~~Dv~~lG~~~~~l~~g~~pf~~ 202 (225)
T smart00221 152 L---AALLKTVKGTPFYLAPEVLLGGKGYGEAVDIWSLGVILYELLWGPEPFSG 202 (225)
T ss_pred c---cccccceeccCCcCCHhHhcCCCCCCchhhHHHHHHHHHHHHHCCCCccc
Confidence 1 0122334567789999988 666778899999999999999999999953
|
Phosphotransferases. The specificity of this class of kinases can not be predicted. Possible dual-specificity Ser/Thr/Tyr kinase. |
| >smart00750 KIND kinase non-catalytic C-lobe domain | Back alignment and domain information |
|---|
Probab=99.95 E-value=3.5e-28 Score=189.59 Aligned_cols=163 Identities=23% Similarity=0.245 Sum_probs=121.1
Q ss_pred CChHHHhcCCCCCCCCCChhhHHHHHHHHHHHHHHhhcCCCCCeeeecccCCceeeCCCCcEEEeeeccccccccccccc
Q 038766 96 GSLESVIHGPGVDHSRWTLPKRIDVLISVANGLDYLHSGYDIPIVHCDMKPSNILLDRDFEAHVSDFGTSRMLDVHLQDL 175 (299)
Q Consensus 96 ~~L~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lh~~~~~~~~H~dl~~~nil~~~~~~v~l~df~~~~~~~~~~~~~ 175 (299)
|+|.+++.. .+.++++.+++.++.|++.||+|||+. + ||+||+++.++.+++ ||.+.....
T Consensus 1 GsL~~~l~~---~~~~l~~~~~~~i~~qi~~~L~~lH~~---~------kp~Nil~~~~~~~~~--fG~~~~~~~----- 61 (176)
T smart00750 1 VSLADILEV---RGRPLNEEEIWAVCLQCLRALRELHRQ---A------KSGNILLTWDGLLKL--DGSVAFKTP----- 61 (176)
T ss_pred CcHHHHHHH---hCCCCCHHHHHHHHHHHHHHHHHHHhc---C------CcccEeEcCccceee--ccceEeecc-----
Confidence 578888863 245799999999999999999999998 6 999999999999999 998875431
Q ss_pred cccccccccCcccCChhhhcccCcCccccchhhhHHHHHHHhCCCCCCCCccCCCCchhHHHHHHHHHhcCccCcccccC
Q 038766 176 SSLSTAFQGTIGYLAPEFAYMRIVTTKVDVFSFGIVVMEFLTKRRPTGLDEENGLSPISLRQLVEKALANGINGVRQITD 255 (299)
Q Consensus 176 ~~~~~~~~~~~~y~~PE~~~~~~~~~~~DiwslG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 255 (299)
....+++.|+|||++.+..++.++||||+||++|+|++|..||..... ....+........ ...
T Consensus 62 ----~~~~g~~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~p~~~~~~-------~~~~~~~~~~~~~-~~~---- 125 (176)
T smart00750 62 ----EQSRVDPYFMAPEVIQGQSYTEKADIYSLGITLYEALDYELPYNEERE-------LSAILEILLNGMP-ADD---- 125 (176)
T ss_pred ----ccCCCcccccChHHhcCCCCcchhhHHHHHHHHHHHHhCCCCccccch-------hcHHHHHHHHHhc-cCC----
Confidence 112478999999999999999999999999999999999999853311 1111111111000 000
Q ss_pred ccccchhhHhHHHHHHHH--HHHHHHHHhcCCCCCCCCChhhhhcC
Q 038766 256 PKLVSSIYEEQEQHQVLE--ELFKLALVCTSSNPEDRPNMNELLIT 299 (299)
Q Consensus 256 ~~~~~~~~~~~~~~~~~~--~l~~li~~~l~~dP~~Rpt~~~il~~ 299 (299)
+... .....++. .+.+++++||..+|.+|||+.++++|
T Consensus 126 ~~~~------~~~~~~~~~~~~~~~i~~cl~~~p~~Rp~~~~ll~~ 165 (176)
T smart00750 126 PRDR------SNLESVSAARSFADFMRVCASRLPQRREAANHYLAH 165 (176)
T ss_pred cccc------ccHHHHHhhhhHHHHHHHHHhcccccccCHHHHHHH
Confidence 0000 01223333 69999999999999999999999875
|
It is an interaction domain identified as being similar to the C-terminal protein kinase catalytic fold (C lobe). Its presence at the N terminus of signalling proteins and the absence of the active-site residues in the catalytic and activation loops suggest that it folds independently and is likely to be non-catalytic. The occurrence of KIND only in metazoa implies that it has evolved from the catalytic protein kinase domain into an interaction domain possibly by keeping the substrate-binding features |
| >PLN00181 protein SPA1-RELATED; Provisional | Back alignment and domain information |
|---|
Probab=99.95 E-value=6.5e-28 Score=228.23 Aligned_cols=196 Identities=15% Similarity=0.120 Sum_probs=132.8
Q ss_pred cceeeeeeEEE------cCCCeeEEEEeecCCCChHHHhcCCCCCCCCCChhhHHHHHHHHHHHHHHhhcCCCCCeeeec
Q 038766 70 RNLVKVLGYAW------ESGKLKALILEYMENGSLESVIHGPGVDHSRWTLPKRIDVLISVANGLDYLHSGYDIPIVHCD 143 (299)
Q Consensus 70 ~~i~~~~~~~~------~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lh~~~~~~~~H~d 143 (299)
+||..+++++. ......+.++|++ +++|.+++.. ....+++.+++.++.||+.||.|||++ +++|||
T Consensus 33 ~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~-~~~L~~~l~~---~~~~~~~~~~~~i~~qi~~al~~lH~~---gIvHrD 105 (793)
T PLN00181 33 DYVRSLLGSHKEGNLDGLDDDSIVRALECE-DVSLRQWLDN---PDRSVDAFECFHVFRQIVEIVNAAHSQ---GIVVHN 105 (793)
T ss_pred HHHHHhhcccCCccccccccchhhhhhccC-CccHHHHHhc---ccccccHHHHHHHHHHHHHHHHHHHhC---Ceeecc
Confidence 46666666541 1123346788888 5699999963 235699999999999999999999999 999999
Q ss_pred ccCCceeeCCCCcEEEeeeccccccccc-------------------cc----c--------ccccccccccCcccCChh
Q 038766 144 MKPSNILLDRDFEAHVSDFGTSRMLDVH-------------------LQ----D--------LSSLSTAFQGTIGYLAPE 192 (299)
Q Consensus 144 l~~~nil~~~~~~v~l~df~~~~~~~~~-------------------~~----~--------~~~~~~~~~~~~~y~~PE 192 (299)
|||+|||++..|.++++|||++...... .. . .........+|+.|+|||
T Consensus 106 lKP~NiLl~~~~~~k~~d~~~~~~~~~~~~~~~ki~DfG~a~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~APE 185 (793)
T PLN00181 106 VRPSCFVMSSFNHVSFIESASCSDSGSDEDATTKSREIGSSRREEILSERRIEKLEEVKKQPFPMKQILAMEMSWYTSPE 185 (793)
T ss_pred CCchhEEEcccCcEEEeeccccCcccccccCcccccccccccccccccccchhhhhccccCCCcccccccCCCcceEChh
Confidence 9999999976555555555544321100 00 0 000011234678899999
Q ss_pred hhcccCcCccccchhhhHHHHHHHhCCCCCCCCccCCCCchhHHHHHHHHHhcCccCcccccCccccchhhHhHHHHHHH
Q 038766 193 FAYMRIVTTKVDVFSFGIVVMEFLTKRRPTGLDEENGLSPISLRQLVEKALANGINGVRQITDPKLVSSIYEEQEQHQVL 272 (299)
Q Consensus 193 ~~~~~~~~~~~DiwslG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 272 (299)
++.+..++.++|||||||++|+|++|..|+... ...+....... ..+. .....
T Consensus 186 ~~~~~~~~~~sDVwSlGviL~ELl~~~~~~~~~----------~~~~~~~~~~~-------~~~~----------~~~~~ 238 (793)
T PLN00181 186 EDNGSSSNCASDVYRLGVLLFELFCPVSSREEK----------SRTMSSLRHRV-------LPPQ----------ILLNW 238 (793)
T ss_pred hhccCCCCchhhhhhHHHHHHHHhhCCCchhhH----------HHHHHHHHHhh-------cChh----------hhhcC
Confidence 999999999999999999999999988775311 01111110000 0000 00112
Q ss_pred HHHHHHHHHhcCCCCCCCCChhhhhcC
Q 038766 273 EELFKLALVCTSSNPEDRPNMNELLIT 299 (299)
Q Consensus 273 ~~l~~li~~~l~~dP~~Rpt~~~il~~ 299 (299)
....+++.+||..+|.+|||+.++|+|
T Consensus 239 ~~~~~~~~~~L~~~P~~Rps~~eil~h 265 (793)
T PLN00181 239 PKEASFCLWLLHPEPSCRPSMSELLQS 265 (793)
T ss_pred HHHHHHHHHhCCCChhhCcChHHHhhc
Confidence 345678899999999999999999986
|
|
| >KOG1240 consensus Protein kinase containing WD40 repeats [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.94 E-value=4.7e-28 Score=220.53 Aligned_cols=250 Identities=20% Similarity=0.192 Sum_probs=179.8
Q ss_pred CCCCCceeecCCcceEEEEEeCCCcEEEEEEeccCc--CChhhhHHHHHHHHHHHhcCCcceeeeeeEEEcCCCeeEEEE
Q 038766 13 SFSENNIIGNSNLSTVYKGRLEDGEIVAVKKLNFHQ--FSAESDKSFYREAKTLKELKHRNLVKVLGYAWESGKLKALIL 90 (299)
Q Consensus 13 ~y~~~~~lg~g~~~~v~~~~~~~~~~~~vK~~~~~~--~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~lv~ 90 (299)
.|..++.||++.|=.|.++++..|. ++||++-... .+-....+-..|++ ....++||++++..+ ...++..++|-
T Consensus 24 e~~~~~~LGstRFlKv~r~k~~eG~-vVvKVFvk~~p~~sL~~~~qrL~~ik-~~l~~~pn~lPfqk~-~~t~kAAylvR 100 (1431)
T KOG1240|consen 24 ECHYVENLGSTRFLKVARAKDREGL-VVVKVFVKQDPTISLRPFKQRLEEIK-FALMKAPNCLPFQKV-LVTDKAAYLVR 100 (1431)
T ss_pred ceeeecccCchhhhhhhhccCCCce-EEEEEEeccCCCCCchHHHHHHHHHH-HHhhcCCcccchHHH-HHhhHHHHHHH
Confidence 6788999999999999999998776 8999985432 22222333333444 555689999999884 55566778999
Q ss_pred eecCCCChHHHhcCCCCCCCCCChhhHHHHHHHHHHHHHHhhcCCCCCeeeecccCCceeeCCCCcEEEeeecccccccc
Q 038766 91 EYMENGSLESVIHGPGVDHSRWTLPKRIDVLISVANGLDYLHSGYDIPIVHCDMKPSNILLDRDFEAHVSDFGTSRMLDV 170 (299)
Q Consensus 91 e~~~~~~L~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lh~~~~~~~~H~dl~~~nil~~~~~~v~l~df~~~~~~~~ 170 (299)
+|+.. +|.+.+. ....+.+.+..+|+.|++.||..+|.. ++||||||.+|||++.-+.+.|+||..-...-.
T Consensus 101 qyvkh-nLyDRlS----TRPFL~~iEKkWiaFQLL~al~qcH~~---gVcHGDIKsENILiTSWNW~~LtDFAsFKPtYL 172 (1431)
T KOG1240|consen 101 QYVKH-NLYDRLS----TRPFLVLIEKKWIAFQLLKALSQCHKL---GVCHGDIKSENILITSWNWLYLTDFASFKPTYL 172 (1431)
T ss_pred HHHhh-hhhhhhc----cchHHHHHHHHHHHHHHHHHHHHHHHc---CccccccccceEEEeeechhhhhcccccCCccC
Confidence 99955 9999997 566788899999999999999999999 999999999999999999999999987643211
Q ss_pred cccccc---ccccccccCcccCChhhhccc----------C-cCccccchhhhHHHHHHHh-CCCCCCCCccCCCCchhH
Q 038766 171 HLQDLS---SLSTAFQGTIGYLAPEFAYMR----------I-VTTKVDVFSFGIVVMEFLT-KRRPTGLDEENGLSPISL 235 (299)
Q Consensus 171 ~~~~~~---~~~~~~~~~~~y~~PE~~~~~----------~-~~~~~DiwslG~~l~~l~~-g~~p~~~~~~~~~~~~~~ 235 (299)
...++. ....+...-.+|.|||.+... . .+++.||||+||++.||++ |.+||...
T Consensus 173 PeDNPadf~fFFDTSrRRtCYiAPERFv~~~~~~~~~q~~~~L~paMDIFS~GCViaELf~Eg~PlF~LS---------- 242 (1431)
T KOG1240|consen 173 PEDNPADFTFFFDTSRRRTCYIAPERFVSALGKTSVGQDAPLLTPAMDIFSAGCVIAELFLEGRPLFTLS---------- 242 (1431)
T ss_pred CCCCcccceEEEecCCceeeecChHhhhccccccccCCcccccChhhhhhhhhHHHHHHHhcCCCcccHH----------
Confidence 111222 222344455689999976652 1 5678999999999999997 57777422
Q ss_pred HHHHHHHHhcCccCcccccCccccchhhHhHHHHHHHHHHHHHHHHhcCCCCCCCCChhhhhc
Q 038766 236 RQLVEKALANGINGVRQITDPKLVSSIYEEQEQHQVLEELFKLALVCTSSNPEDRPNMNELLI 298 (299)
Q Consensus 236 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rpt~~~il~ 298 (299)
..+..-..+. . ..+.....-....+++||..|++.||++|.+|++.|+
T Consensus 243 -QL~aYr~~~~--~------------~~e~~Le~Ied~~~Rnlil~Mi~rdPs~RlSAedyL~ 290 (1431)
T KOG1240|consen 243 -QLLAYRSGNA--D------------DPEQLLEKIEDVSLRNLILSMIQRDPSKRLSAEDYLQ 290 (1431)
T ss_pred -HHHhHhccCc--c------------CHHHHHHhCcCccHHHHHHHHHccCchhccCHHHHHH
Confidence 1110000000 0 0000001111236899999999999999999999985
|
|
| >KOG1164 consensus Casein kinase (serine/threonine/tyrosine protein kinase) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.94 E-value=4e-25 Score=188.18 Aligned_cols=205 Identities=20% Similarity=0.235 Sum_probs=164.2
Q ss_pred CCCCCceeecCCcceEEEEEeCC--CcEEEEEEeccCcCChhhhHHHHHHHHHHHhcCC----cceeeeeeEEEcCCCee
Q 038766 13 SFSENNIIGNSNLSTVYKGRLED--GEIVAVKKLNFHQFSAESDKSFYREAKTLKELKH----RNLVKVLGYAWESGKLK 86 (299)
Q Consensus 13 ~y~~~~~lg~g~~~~v~~~~~~~--~~~~~vK~~~~~~~~~~~~~~~~~e~~~l~~l~h----~~i~~~~~~~~~~~~~~ 86 (299)
+|.+.+.||+|+||.||.+.+.+ ...+|+|+........ ...+..|..++..+.. .++..+++.....+.+.
T Consensus 19 ~~~i~~~iG~G~fG~V~~v~~~~~~~~~~a~K~e~~~~~~~--~~~l~~E~~vl~~l~~~~~~~~~~~~~~~G~~~~~~~ 96 (322)
T KOG1164|consen 19 RYKLGKKIGEGGFGAVYLVSDKSEKNKEYAKKLEKKELGSK--PSVLKIEIQVLKKLEKKNGPSHFPKLLDHGRSTEDFN 96 (322)
T ss_pred ceEEeeeccccCCceEEEEEecCCCCeeEEEEEEEecccCC--CccchhHHHHHHHHhhhcCCCCCCEEEEeccCCCcee
Confidence 89999999999999999998754 3578888875432221 1267778888888862 58888888554456677
Q ss_pred EEEEeecCCCChHHHhcCCCCCCCCCChhhHHHHHHHHHHHHHHhhcCCCCCeeeecccCCceeeCCC-----CcEEEee
Q 038766 87 ALILEYMENGSLESVIHGPGVDHSRWTLPKRIDVLISVANGLDYLHSGYDIPIVHCDMKPSNILLDRD-----FEAHVSD 161 (299)
Q Consensus 87 ~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lh~~~~~~~~H~dl~~~nil~~~~-----~~v~l~d 161 (299)
++||+.+ |.+|.++..... ...++...+..++.|++.+|.++|+. +++||||||+|+++... ..+.|.|
T Consensus 97 ~iVM~l~-G~sL~dl~~~~~--~~~fs~~T~l~ia~q~l~~l~~lH~~---G~iHRDiKp~N~~~g~~~~~~~~~~~llD 170 (322)
T KOG1164|consen 97 FIVMSLL-GPSLEDLRKRNP--PGRFSRKTVLRIAIQNLNALEDLHSK---GFIHRDIKPENFVVGQSSRSEVRTLYLLD 170 (322)
T ss_pred EEEEecc-CccHHHHHHhCC--CCCcCHhHHHHHHHHHHHHHHHHHhc---CcccCCcCHHHeeecCCCCcccceEEEEe
Confidence 9999999 889999886542 57899999999999999999999999 99999999999999755 4589999
Q ss_pred eccccccc--ccccc----ccccccccccCcccCChhhhcccCcCccccchhhhHHHHHHHhCCCCCCCC
Q 038766 162 FGTSRMLD--VHLQD----LSSLSTAFQGTIGYLAPEFAYMRIVTTKVDVFSFGIVVMEFLTKRRPTGLD 225 (299)
Q Consensus 162 f~~~~~~~--~~~~~----~~~~~~~~~~~~~y~~PE~~~~~~~~~~~DiwslG~~l~~l~~g~~p~~~~ 225 (299)
||+++.+. ..... .........||..|+++....+...+.+.|+||+++++.++..|..||...
T Consensus 171 fGlar~~~~~~~~~~~~~~~r~~~~~~rGT~ry~S~~~H~~~e~~r~DDles~~Y~l~el~~g~LPW~~~ 240 (322)
T KOG1164|consen 171 FGLARRFKYVGDSGGNLRPPRPQKGLFRGTLRYASINVHLGIEQGRRDDLESLFYMLLELLKGSLPWEAL 240 (322)
T ss_pred cCCCccccccCCCCcccccCCCCccCCCCccccccHHHhCCCccCCchhhhhHHHHHHHHhcCCCCCccc
Confidence 99998332 11111 111123456999999999999999999999999999999999999998543
|
|
| >KOG0590 consensus Checkpoint kinase and related serine/threonine protein kinases [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.93 E-value=1.4e-26 Score=209.21 Aligned_cols=258 Identities=19% Similarity=0.213 Sum_probs=192.3
Q ss_pred CCCceeecCCcceEEEEEeC-CCcEEEEEEecc---CcCC-hhhhHHHHHHHHHHHhcCCcceeeeeeEEEcCCCeeEEE
Q 038766 15 SENNIIGNSNLSTVYKGRLE-DGEIVAVKKLNF---HQFS-AESDKSFYREAKTLKELKHRNLVKVLGYAWESGKLKALI 89 (299)
Q Consensus 15 ~~~~~lg~g~~~~v~~~~~~-~~~~~~vK~~~~---~~~~-~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~lv 89 (299)
...+.+|.|.+|.++.+... ..+..+.|.+.. +... ......+..|+-+-..+.|+|++.....+.+..... -+
T Consensus 321 ~~~~~~g~ga~g~~~~~~~~~~~~~~~~~~~r~~~~~~~s~~~~~~~i~sE~~i~~~l~h~~~~e~l~~~~~~~~~~-~~ 399 (601)
T KOG0590|consen 321 KPGRVLGSGAYGSVRIAKRRSDLKSFPEKEFRVRVKPTESERKYNYNITSEFCIGSSLSHPNIIETLDIVQEIDGIL-QS 399 (601)
T ss_pred CccceeeecccCceEEEEecCCCccchhhhhhcccCCcccHHHHhhhhhhheeecccccCCchhhhHHHHhhcccch-hh
Confidence 56788999999988877642 233344443321 1111 122223666777778889999988877666555443 33
Q ss_pred EeecCCCChHHHhcCCCCCCCCCChhhHHHHHHHHHHHHHHhhcCCCCCeeeecccCCceeeCCCCcEEEeeeccccccc
Q 038766 90 LEYMENGSLESVIHGPGVDHSRWTLPKRIDVLISVANGLDYLHSGYDIPIVHCDMKPSNILLDRDFEAHVSDFGTSRMLD 169 (299)
Q Consensus 90 ~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lh~~~~~~~~H~dl~~~nil~~~~~~v~l~df~~~~~~~ 169 (299)
|||++. +|..++. ....++..++..++.|++.+++|+|.. ++.|+|+|++|++++.+|.+|++|||.+....
T Consensus 400 mE~~~~-Dlf~~~~----~~~~~~~~e~~c~fKqL~~Gv~y~h~~---GiahrdlK~enll~~~~g~lki~Dfg~~~vf~ 471 (601)
T KOG0590|consen 400 MEYCPY-DLFSLVM----SNGKLTPLEADCFFKQLLRGVKYLHSM---GLAHRDLKLENLLVTENGILKIIDFGAASVFR 471 (601)
T ss_pred hhcccH-HHHHHHh----cccccchhhhhHHHHHHHHHHHHHHhc---CceeccCccccEEEecCCceEEeecCcceeec
Confidence 999988 9999997 445789999999999999999999999 99999999999999999999999999998766
Q ss_pred cccccccccccccccCcccCChhhhcccCcCc-cccchhhhHHHHHHHhCCCCCCCCccCCCCchhHHHHHHHHHhcCcc
Q 038766 170 VHLQDLSSLSTAFQGTIGYLAPEFAYMRIVTT-KVDVFSFGIVVMEFLTKRRPTGLDEENGLSPISLRQLVEKALANGIN 248 (299)
Q Consensus 170 ~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~-~~DiwslG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 248 (299)
-.............++..|+|||.+.+..|++ ..||||.|++++.|.+|+.||......+.... ....
T Consensus 472 ~~~e~~~~~~~g~~gS~pY~apE~~~~~~ydpr~vDiwS~~ii~~~m~~~~~~Wk~a~~~~~~~~----------~~~~- 540 (601)
T KOG0590|consen 472 YPWEKNIHESSGIVGSDPYLAPEVLTGKEYDPRAVDVWSCGIIYICMILGRFPWKVAKKSDNSFK----------TNNY- 540 (601)
T ss_pred cCcchhhhhhcCcccCCcCcCcccccccccCcchhhhhhccceEEEEecCCCccccccccccchh----------hhcc-
Confidence 44333334556778899999999999998887 57999999999999999999976544432220 0000
Q ss_pred CcccccCccccchhhHhHHHHHHHHHHHHHHHHhcCCCCCCCCChhhhhc
Q 038766 249 GVRQITDPKLVSSIYEEQEQHQVLEELFKLALVCTSSNPEDRPNMNELLI 298 (299)
Q Consensus 249 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rpt~~~il~ 298 (299)
.................+..-+.+|.+||+++|.+|.|+++|++
T Consensus 541 ------~~~~~~~~~~~~~~~~lp~~~~~~~~~~l~~~P~~R~ti~~i~~ 584 (601)
T KOG0590|consen 541 ------SDQRNIFEGPNRLLSLLPRETRIIIYRMLQLDPTKRITIEQILN 584 (601)
T ss_pred ------ccccccccChHHHHHhchhhHHHHHHHHccCChhheecHHHHhh
Confidence 00011112233446777888999999999999999999999986
|
|
| >PRK09188 serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.93 E-value=5.1e-25 Score=187.40 Aligned_cols=172 Identities=23% Similarity=0.235 Sum_probs=129.8
Q ss_pred HHHHhCCCCCCceeecCCcceEEEEEeC--CCcEEEEEEeccCcC---ChhhhHHHHHHHHHHHhcCCcceee-eeeEEE
Q 038766 7 IENATGSFSENNIIGNSNLSTVYKGRLE--DGEIVAVKKLNFHQF---SAESDKSFYREAKTLKELKHRNLVK-VLGYAW 80 (299)
Q Consensus 7 ~~~~~~~y~~~~~lg~g~~~~v~~~~~~--~~~~~~vK~~~~~~~---~~~~~~~~~~e~~~l~~l~h~~i~~-~~~~~~ 80 (299)
...+.++|.+.+.||+|+||+||+|.+. ++..+|||++..... .......+.+|+++++.++|+|+++ +++
T Consensus 13 ~~~~~~~Y~~~~~IG~G~fg~Vy~a~~~~~~~~~vAiK~~~~~~~~~~~~~~~~~~~~E~~iL~~L~h~~iv~~l~~--- 89 (365)
T PRK09188 13 IPALSARFVETAVLKRDVFSTVERGYFAGDPGTARAVRRRVSEVPWWSKPLARHLAAREIRALKTVRGIGVVPQLLA--- 89 (365)
T ss_pred cccccCCceEccEEeecCcEEEEEEEEcCCCCeEEEEEEecccccccccHHHHHHHHHHHHHHHhccCCCCCcEEEE---
Confidence 4567899999999999999999999764 577789998752211 2334667899999999999999985 433
Q ss_pred cCCCeeEEEEeecCCCChHHHhcCCCCCCCCCChhhHHHHHHHHHHHHHHhhcCCCCCeeeecc-cCCceeeCCCCcEEE
Q 038766 81 ESGKLKALILEYMENGSLESVIHGPGVDHSRWTLPKRIDVLISVANGLDYLHSGYDIPIVHCDM-KPSNILLDRDFEAHV 159 (299)
Q Consensus 81 ~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lh~~~~~~~~H~dl-~~~nil~~~~~~v~l 159 (299)
.+ ..++||||+.|++|.. +. . .. ...++.|++++|.+||+. +++|||| ||+||+++.++.++|
T Consensus 90 -~~-~~~LVmE~~~G~~L~~-~~----~---~~---~~~~~~~i~~aL~~lH~~---gIiHrDL~KP~NILv~~~~~ikL 153 (365)
T PRK09188 90 -TG-KDGLVRGWTEGVPLHL-AR----P---HG---DPAWFRSAHRALRDLHRA---GITHNDLAKPQNWLMGPDGEAAV 153 (365)
T ss_pred -cC-CcEEEEEccCCCCHHH-hC----c---cc---hHHHHHHHHHHHHHHHHC---CCeeCCCCCcceEEEcCCCCEEE
Confidence 13 3589999999988863 21 1 11 146788999999999999 9999999 999999999999999
Q ss_pred eeecccccccccccccc----ccccccccCcccCChhhhccc
Q 038766 160 SDFGTSRMLDVHLQDLS----SLSTAFQGTIGYLAPEFAYMR 197 (299)
Q Consensus 160 ~df~~~~~~~~~~~~~~----~~~~~~~~~~~y~~PE~~~~~ 197 (299)
+|||++..+........ ..-....+++.|.+||.+...
T Consensus 154 iDFGlA~~~~~~~~~~~~~~~~d~~~~~~~~~~~~pe~~~~~ 195 (365)
T PRK09188 154 IDFQLASVFRRRGALYRIAAYEDLRHLLKHKRTYAPDALTPR 195 (365)
T ss_pred EECccceecccCcchhhhhhhhhhhhhhccCccCCcccCChh
Confidence 99999986653221111 001244567788999977643
|
|
| >PF14531 Kinase-like: Kinase-like; PDB: 3DZO_A 2W1Z_A 3BYV_A 3Q5Z_A 3Q60_A | Back alignment and domain information |
|---|
Probab=99.92 E-value=9.5e-25 Score=178.26 Aligned_cols=236 Identities=23% Similarity=0.303 Sum_probs=152.3
Q ss_pred CCCCceeecCCcceEEEEEeC-CCcEEEEEEeccCcCC-hhhhHHHHHHHHHHHhcC----------CcceeeeeeEEEc
Q 038766 14 FSENNIIGNSNLSTVYKGRLE-DGEIVAVKKLNFHQFS-AESDKSFYREAKTLKELK----------HRNLVKVLGYAWE 81 (299)
Q Consensus 14 y~~~~~lg~g~~~~v~~~~~~-~~~~~~vK~~~~~~~~-~~~~~~~~~e~~~l~~l~----------h~~i~~~~~~~~~ 81 (299)
+..++.||.|+++.||.+++. +|+.+++|++...... ....+.+++|......+. |-.++...+....
T Consensus 14 l~~~~~i~~g~~~~v~~v~d~~t~~~~avkvf~~~~~~~~~~~~~~~~e~l~~~~~~~~~~p~~a~~~~r~l~P~d~~~i 93 (288)
T PF14531_consen 14 LVRGRIIGKGGFSIVFEVTDVETGEEFAVKVFLLPADASANEYEQLKEEQLAITLFPGVKNPKEAYRHLRFLVPLDLLRI 93 (288)
T ss_dssp EEEEEEEEEETTEEEEEEEETTTTEEEEEEEEEESSTTHTTHHHHHHHHHHGGGGSTT--SHHHHHHHH-B---SEEEEE
T ss_pred EEEccccccCCceEEEEEEEccCCceEEEEEEecccccchHHHHHHHHHHHHhhhhccCCCHHHHHHhceEEeeeEEEEE
Confidence 345789999999999999985 5999999999765532 223566766665555532 2234444443332
Q ss_pred CCC-----------e-----eEEEEeecCCCChHHHhcC---CCCCCCCCChhhHHHHHHHHHHHHHHhhcCCCCCeeee
Q 038766 82 SGK-----------L-----KALILEYMENGSLESVIHG---PGVDHSRWTLPKRIDVLISVANGLDYLHSGYDIPIVHC 142 (299)
Q Consensus 82 ~~~-----------~-----~~lv~e~~~~~~L~~~~~~---~~~~~~~~~~~~~~~i~~qi~~~l~~lh~~~~~~~~H~ 142 (299)
.++ . .+++++-+ .++|..++.. ...............+..|++..+++||.. +++|+
T Consensus 94 ~~~~~~~~~~~~~~~~~v~n~~~l~P~~-~~dL~~~~~~l~~~~~~~~~l~~~arl~lT~Q~I~lvA~Lh~~---GlVHg 169 (288)
T PF14531_consen 94 PGKPPFFERGPGQSIYWVLNRFLLMPRA-QGDLQDLVEALFSRAQTHSPLAFAARLSLTVQMIRLVANLHSY---GLVHG 169 (288)
T ss_dssp TTS-SEEEECETTEEEEEESEEEEEE---SEEHHHHHHHHHHHTTTSHHHHHHHHHHHHHHHHHHHHHHHHT---TEEES
T ss_pred cCCCcceecCCCCccceeehhhhccchh-hhcHHHHHHHHhhcccccchhHHHHHHHHHHHHHHHHHHHhhc---ceEec
Confidence 211 1 25677766 4588776542 211233455566678889999999999999 99999
Q ss_pred cccCCceeeCCCCcEEEeeeccccccccccccccccccccccCcccCChhhhcc--------cCcCccccchhhhHHHHH
Q 038766 143 DMKPSNILLDRDFEAHVSDFGTSRMLDVHLQDLSSLSTAFQGTIGYLAPEFAYM--------RIVTTKVDVFSFGIVVME 214 (299)
Q Consensus 143 dl~~~nil~~~~~~v~l~df~~~~~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~--------~~~~~~~DiwslG~~l~~ 214 (299)
||+|+|++++.+|.+.|+||+.....+ ........+..|.|||.... ..++.+.|.|+||+++|.
T Consensus 170 di~~~nfll~~~G~v~Lg~F~~~~r~g-------~~~~~~~~~~~~~PPe~~~~~~~~~~~~~~~t~~~DaW~LG~~ly~ 242 (288)
T PF14531_consen 170 DIKPENFLLDQDGGVFLGDFSSLVRAG-------TRYRCSEFPVAFTPPELESCAGQFGQNNAPYTFATDAWQLGITLYS 242 (288)
T ss_dssp T-SGGGEEE-TTS-EEE--GGGEEETT-------EEEEGGGS-TTTS-HHHHHHHTSCHHSEEEE-HHHHHHHHHHHHHH
T ss_pred ccceeeEEEcCCCCEEEcChHHHeecC-------ceeeccCCCcccCChhhhhhhcccCcccceeeeccCHHHHHHHHHH
Confidence 999999999999999999999876543 11111334578999996644 246788999999999999
Q ss_pred HHhCCCCCCCCccCCCCchhHHHHHHHHHhcCccCcccccCccccchhhHhHHHHHHHHHHHHHHHHhcCCCCCCC
Q 038766 215 FLTKRRPTGLDEENGLSPISLRQLVEKALANGINGVRQITDPKLVSSIYEEQEQHQVLEELFKLALVCTSSNPEDR 290 (299)
Q Consensus 215 l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~R 290 (299)
|+++..||........... .-..+. ++++.+..||.++|+.||.+|
T Consensus 243 lWC~~lPf~~~~~~~~~~~-----------------------------~f~~C~-~~Pe~v~~LI~~lL~~~~~~R 288 (288)
T PF14531_consen 243 LWCGRLPFGLSSPEADPEW-----------------------------DFSRCR-DMPEPVQFLIRGLLQRNPEDR 288 (288)
T ss_dssp HHHSS-STCCCGGGSTSGG-----------------------------GGTTSS----HHHHHHHHHHT-SSGGGS
T ss_pred HHHccCCCCCCCccccccc-----------------------------cchhcC-CcCHHHHHHHHHHccCCcccC
Confidence 9999999975533221111 011223 778899999999999999988
|
|
| >KOG1163 consensus Casein kinase (serine/threonine/tyrosine protein kinase) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.92 E-value=1.6e-24 Score=167.41 Aligned_cols=207 Identities=20% Similarity=0.224 Sum_probs=167.8
Q ss_pred HHHHHhCCCCCCceeecCCcceEEEEEe-CCCcEEEEEEeccCcCChhhhHHHHHHHHHHHhcCC-cceeeeeeEEEcCC
Q 038766 6 EIENATGSFSENNIIGNSNLSTVYKGRL-EDGEIVAVKKLNFHQFSAESDKSFYREAKTLKELKH-RNLVKVLGYAWESG 83 (299)
Q Consensus 6 ~~~~~~~~y~~~~~lg~g~~~~v~~~~~-~~~~~~~vK~~~~~~~~~~~~~~~~~e~~~l~~l~h-~~i~~~~~~~~~~~ 83 (299)
+..++.++|+++++||+|+||.+|.+.. .+|+.||||+-.... .-.++.-|..+.+.+++ ..|..+.. +..+.
T Consensus 9 ~~~iv~gky~lvrkiGsGSFGdIy~~~~i~~ge~VAiK~Es~~a----~hpqL~yEskvY~iL~~g~GiP~i~~-y~~e~ 83 (341)
T KOG1163|consen 9 EELIVGGKYKLVRKIGSGSFGDIYLGISITSGEEVAIKLESSKA----KHPQLLYESKVYRILQGGVGIPHIRH-YGTEK 83 (341)
T ss_pred hhheeccceEEEEeecCCchhheeeeeeccCCceEEEEeecccC----CCcchhHHHHHHHHhccCCCCchhhh-hcccc
Confidence 3456789999999999999999999974 779999999865332 33356778889999985 56666665 45556
Q ss_pred CeeEEEEeecCCCChHHHhcCCCCCCCCCChhhHHHHHHHHHHHHHHhhcCCCCCeeeecccCCceeeCC---CCcEEEe
Q 038766 84 KLKALILEYMENGSLESVIHGPGVDHSRWTLPKRIDVLISVANGLDYLHSGYDIPIVHCDMKPSNILLDR---DFEAHVS 160 (299)
Q Consensus 84 ~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lh~~~~~~~~H~dl~~~nil~~~---~~~v~l~ 160 (299)
.+..+||+.+ |.+|.++++- -+..++...++-++-|++.-++|+|.. +++||||||+|++..- .+.+.|+
T Consensus 84 ~ynvlVMdLL-GPsLEdLfnf---C~R~ftmkTvLMLaDQml~RiEyvH~r---~fiHRDIKPdNFLMGlgrh~~kl~LI 156 (341)
T KOG1163|consen 84 DYNVLVMDLL-GPSLEDLFNF---CSRRFTMKTVLMLADQMLSRIEYVHLR---NFIHRDIKPDNFLMGLGRHCNKLYLI 156 (341)
T ss_pred ccceeeeecc-CccHHHHHHH---HhhhhhHHhHHHHHHHHHHHHHHHHhh---ccccccCCccceeeccccccceEEEE
Confidence 6779999999 8899988762 345788899999999999999999999 9999999999999964 3568999
Q ss_pred eeccccccccccc---cccccccccccCcccCChhhhcccCcCccccchhhhHHHHHHHhCCCCCCC
Q 038766 161 DFGTSRMLDVHLQ---DLSSLSTAFQGTIGYLAPEFAYMRIVTTKVDVFSFGIVVMEFLTKRRPTGL 224 (299)
Q Consensus 161 df~~~~~~~~~~~---~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~DiwslG~~l~~l~~g~~p~~~ 224 (299)
|||++..+..... ..........||..|++-....+..-+.+.|+=|+|++++.+.-|..||..
T Consensus 157 DFGLaKky~d~~t~~HIpyre~r~ltGTaRYASinAh~g~eqSRRDDmeSvgYvLmYfnrG~LPWQg 223 (341)
T KOG1163|consen 157 DFGLAKKYRDIRTRQHIPYREDRNLTGTARYASINAHLGIEQSRRDDMESVGYVLMYFNRGSLPWQG 223 (341)
T ss_pred eccchhhhccccccccCccccCCccceeeeehhhhhhhhhhhhhhhhhhhhcceeeeeecCCCcccc
Confidence 9999987653221 122233466788999999888888889999999999999999999999954
|
|
| >COG0515 SPS1 Serine/threonine protein kinase [General function prediction only / Signal transduction mechanisms / Transcription / DNA replication, recombination, and repair] | Back alignment and domain information |
|---|
Probab=99.92 E-value=1.2e-22 Score=173.50 Aligned_cols=265 Identities=27% Similarity=0.390 Sum_probs=196.1
Q ss_pred CCCCceeecCCcceEEEEEeCCCcEEEEEEeccCcCChh-hhHHHHHHHHHHHhcCCc-ceeeeeeEEEcCCCeeEEEEe
Q 038766 14 FSENNIIGNSNLSTVYKGRLEDGEIVAVKKLNFHQFSAE-SDKSFYREAKTLKELKHR-NLVKVLGYAWESGKLKALILE 91 (299)
Q Consensus 14 y~~~~~lg~g~~~~v~~~~~~~~~~~~vK~~~~~~~~~~-~~~~~~~e~~~l~~l~h~-~i~~~~~~~~~~~~~~~lv~e 91 (299)
|.+.+.||.|+|+.||.+.+. ..+++|.+........ ....+.+|...++.+.|+ +++++.+.+.. ....+++++
T Consensus 2 ~~~~~~l~~g~~~~v~~~~~~--~~~~~k~~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~-~~~~~~~~~ 78 (384)
T COG0515 2 YRILRKLGEGSFGEVYLARDR--KLVALKVLAKKLESKSKEVERFLREIQILASLNHPPNIVKLYDFFQD-EGSLYLVME 78 (384)
T ss_pred ceeEEeecCCCCeEEEEEEec--cEEEEEeechhhccchhHHHHHHHHHHHHHHccCCcceeeEEEEEec-CCEEEEEEe
Confidence 778899999999999999876 7889998875544443 577888999999999988 79999997744 444689999
Q ss_pred ecCCCChHHHhcCCCCCCCCCChhhHHHHHHHHHHHHHHhhcCCCCCeeeecccCCceeeCCCC-cEEEeeecccccccc
Q 038766 92 YMENGSLESVIHGPGVDHSRWTLPKRIDVLISVANGLDYLHSGYDIPIVHCDMKPSNILLDRDF-EAHVSDFGTSRMLDV 170 (299)
Q Consensus 92 ~~~~~~L~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lh~~~~~~~~H~dl~~~nil~~~~~-~v~l~df~~~~~~~~ 170 (299)
++.++++.+++...... ..+++.....++.|++.++.++|+. +++|+|+||+||+++..+ .++++|||.+.....
T Consensus 79 ~~~~~~l~~~~~~~~~~-~~~~~~~~~~~~~~~~~~l~~~H~~---~~~hrd~kp~nil~~~~~~~~~l~dfg~~~~~~~ 154 (384)
T COG0515 79 YVDGGSLEDLLKKIGRK-GPLSESEALFILAQILSALEYLHSK---GIIHRDIKPENILLDRDGRVVKLIDFGLAKLLPD 154 (384)
T ss_pred cCCCCcHHHHHHhcccc-cCCCHHHHHHHHHHHHHHHHHHHhC---CeeccCCCHHHeeecCCCCeEEEeccCcceecCC
Confidence 99999999777633211 3789999999999999999999999 999999999999999988 799999999875442
Q ss_pred cccccc--ccccccccCcccCChhhhcc---cCcCccccchhhhHHHHHHHhCCCCCCCCccCCCCchhHHHHHHHHHhc
Q 038766 171 HLQDLS--SLSTAFQGTIGYLAPEFAYM---RIVTTKVDVFSFGIVVMEFLTKRRPTGLDEENGLSPISLRQLVEKALAN 245 (299)
Q Consensus 171 ~~~~~~--~~~~~~~~~~~y~~PE~~~~---~~~~~~~DiwslG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~ 245 (299)
...... .......++..|++||...+ ...+...|+|++|++++++++|..||...... .............
T Consensus 155 ~~~~~~~~~~~~~~~~t~~~~~pe~~~~~~~~~~~~~~D~~s~g~~~~~~~~~~~p~~~~~~~----~~~~~~~~~~~~~ 230 (384)
T COG0515 155 PGSTSSIPALPSTSVGTPGYMAPEVLLGLSLAYASSSSDIWSLGITLYELLTGLPPFEGEKNS----SATSQTLKIILEL 230 (384)
T ss_pred CCccccccccccccccccccCCHHHhcCCCCCCCCchHhHHHHHHHHHHHHhCCCCCCCCCcc----ccHHHHHHHHHhc
Confidence 211111 13456678999999999987 57888999999999999999999996433221 0111111111111
Q ss_pred CccCcccccCccccchhhHhHHHHHHHHHHHHHHHHhcCCCCCCCCChhhhhc
Q 038766 246 GINGVRQITDPKLVSSIYEEQEQHQVLEELFKLALVCTSSNPEDRPNMNELLI 298 (299)
Q Consensus 246 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rpt~~~il~ 298 (299)
............. .......+.+++.+|+..+|..|.+..+...
T Consensus 231 ~~~~~~~~~~~~~---------~~~~~~~~~~~~~~~~~~~~~~r~~~~~~~~ 274 (384)
T COG0515 231 PTPSLASPLSPSN---------PELISKAASDLLKKLLAKDPKNRLSSSSDLS 274 (384)
T ss_pred CCcccccccCccc---------cchhhHHHHHHHHHHHhcCchhcCCHHHHhh
Confidence 1110000000000 0233456889999999999999999887654
|
|
| >PRK10359 lipopolysaccharide core biosynthesis protein; Provisional | Back alignment and domain information |
|---|
Probab=99.91 E-value=2.9e-24 Score=170.41 Aligned_cols=177 Identities=14% Similarity=0.137 Sum_probs=134.4
Q ss_pred HHHhCCCCCCceeecCCcceEEEEEeCCCcEEEEEEeccCcCChhh-hHH------HHHHHHHHHhcCCcceeeeeeEEE
Q 038766 8 ENATGSFSENNIIGNSNLSTVYKGRLEDGEIVAVKKLNFHQFSAES-DKS------FYREAKTLKELKHRNLVKVLGYAW 80 (299)
Q Consensus 8 ~~~~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~vK~~~~~~~~~~~-~~~------~~~e~~~l~~l~h~~i~~~~~~~~ 80 (299)
..+.++|++.++||.|+||.||++.. ++..+|+|++......... ... +.+|++.+.++.|++|..+.+++.
T Consensus 27 ~~l~~~y~~~~~l~~~~f~~v~l~~~-~~~~~iiKvf~~~~~~~~~~~~~f~~g~~~e~Ea~~l~rL~~~GI~~~~d~~~ 105 (232)
T PRK10359 27 DFLSYNIKTIKVFRNIDDTKVSLIDT-DYGKYILKVFAPKVKRTERFLKSFVKGDYYENLIVQTDRVRSEGLASLNDFYL 105 (232)
T ss_pred HHhhCceEEEEEecCCCceEEEEEec-CCCcEEEEEechhcCchHHHHHhhhhhHHHHHHHHHHHHHHHCCCCcceEeee
Confidence 35789999999999999999999766 4678999999744322222 122 578999999999999999988755
Q ss_pred cCC-------CeeEEEEeecCCCChHHHhcCCCCCCCCCChhhHHHHHHHHHHHHHHhhcCCCCCeeeecccCCceeeCC
Q 038766 81 ESG-------KLKALILEYMENGSLESVIHGPGVDHSRWTLPKRIDVLISVANGLDYLHSGYDIPIVHCDMKPSNILLDR 153 (299)
Q Consensus 81 ~~~-------~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lh~~~~~~~~H~dl~~~nil~~~ 153 (299)
... ...++||||++|.+|.++.. +++ ....+++.++..+|+. +++|+|++|+||+++.
T Consensus 106 ~~~~~~~~~~~~~~lvmEyi~G~tL~~~~~--------~~~----~~~~~i~~~l~~lH~~---gi~H~Dikp~Nili~~ 170 (232)
T PRK10359 106 LAERKTLRYAHTYIMLIEYIEGVELNDMPE--------ISE----DVKAKIKASIESLHQH---GMVSGDPHKGNFIVSK 170 (232)
T ss_pred ecccccccccCCeEEEEEEECCccHHHhhh--------ccH----HHHHHHHHHHHHHHHc---CCccCCCChHHEEEeC
Confidence 332 23589999999999987742 233 2456999999999999 9999999999999999
Q ss_pred CCcEEEeeeccccccccccccccccccccccCcccCChhhhcccCcCccccchhhhHHHHHHHh
Q 038766 154 DFEAHVSDFGTSRMLDVHLQDLSSLSTAFQGTIGYLAPEFAYMRIVTTKVDVFSFGIVVMEFLT 217 (299)
Q Consensus 154 ~~~v~l~df~~~~~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~DiwslG~~l~~l~~ 217 (299)
+| ++|+|||........ .....+.....+..++|+|+||+++..+..
T Consensus 171 ~g-i~liDfg~~~~~~e~----------------~a~d~~vler~y~~~~di~~lg~~~~~~~~ 217 (232)
T PRK10359 171 NG-LRIIDLSGKRCTAQR----------------KAKDRIDLERHYGIKNEIKDLGYYLLIYKK 217 (232)
T ss_pred CC-EEEEECCCcccccch----------------hhHHHHHHHhHhcccccccceeEeehHHHH
Confidence 98 999999977543210 000113344456689999999999876553
|
|
| >KOG1165 consensus Casein kinase (serine/threonine/tyrosine protein kinase) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.90 E-value=6.1e-23 Score=165.54 Aligned_cols=204 Identities=21% Similarity=0.279 Sum_probs=170.5
Q ss_pred HHhCCCCCCceeecCCcceEEEEEe-CCCcEEEEEEeccCcCChhhhHHHHHHHHHHHhcC-CcceeeeeeEEEcCCCee
Q 038766 9 NATGSFSENNIIGNSNLSTVYKGRL-EDGEIVAVKKLNFHQFSAESDKSFYREAKTLKELK-HRNLVKVLGYAWESGKLK 86 (299)
Q Consensus 9 ~~~~~y~~~~~lg~g~~~~v~~~~~-~~~~~~~vK~~~~~~~~~~~~~~~~~e~~~l~~l~-h~~i~~~~~~~~~~~~~~ 86 (299)
++.-.|+++++||.|+||+.+.++. -+++.||||.-. ....+-++..|.+..+.|. .++|...+- |-.++.+.
T Consensus 25 ~VG~hyrVGkKIGeGsFG~lf~G~Nl~nne~VAIKfEP----rkS~APQLrdEYr~YKlL~g~~GIP~vYY-FGqeG~~N 99 (449)
T KOG1165|consen 25 MVGPHYRVGKKIGEGSFGVLFLGKNLYNNEPVAIKFEP----RKSEAPQLRDEYRTYKLLGGTEGIPQVYY-FGQEGKYN 99 (449)
T ss_pred EecccceeccccccCcceeeecccccccCceEEEEecc----ccCCcchHHHHHHHHHHHcCCCCCCceee-eccccchh
Confidence 4566899999999999999999974 579999999643 2334567888999999996 788888776 66778888
Q ss_pred EEEEeecCCCChHHHhcCCCCCCCCCChhhHHHHHHHHHHHHHHhhcCCCCCeeeecccCCceeeCCC-----CcEEEee
Q 038766 87 ALILEYMENGSLESVIHGPGVDHSRWTLPKRIDVLISVANGLDYLHSGYDIPIVHCDMKPSNILLDRD-----FEAHVSD 161 (299)
Q Consensus 87 ~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lh~~~~~~~~H~dl~~~nil~~~~-----~~v~l~d 161 (299)
.+|+|.+ |.+|.+++.- -+..|+...+..++.|++.-++++|++ ++++|||||+|+||... +.+.++|
T Consensus 100 iLVidLL-GPSLEDLFD~---CgR~FSvKTV~miA~Qmi~rie~vH~k---~LIYRDIKPdNFLIGrp~~k~~n~IhiiD 172 (449)
T KOG1165|consen 100 ILVIDLL-GPSLEDLFDL---CGRRFSVKTVAMIAKQMITRIEYVHEK---DLIYRDIKPDNFLIGRPGTKDANVIHIID 172 (449)
T ss_pred hhhhhhh-CcCHHHHHHH---hcCcccHHhHHHHHHHHHHHHHHHHhc---ceeecccCccceeecCCCCCCCceEEEEe
Confidence 8999999 8899998863 346899999999999999999999999 99999999999999643 4578999
Q ss_pred ecccccccccccc---ccccccccccCcccCChhhhcccCcCccccchhhhHHHHHHHhCCCCCCC
Q 038766 162 FGTSRMLDVHLQD---LSSLSTAFQGTIGYLAPEFAYMRIVTTKVDVFSFGIVVMEFLTKRRPTGL 224 (299)
Q Consensus 162 f~~~~~~~~~~~~---~~~~~~~~~~~~~y~~PE~~~~~~~~~~~DiwslG~~l~~l~~g~~p~~~ 224 (299)
||++..+...... +..-.+...||-.||+-....+.+-+.+.|+=|||-++++.+-|..||..
T Consensus 173 FGmAK~YrDp~TkqHIPYrE~KSLsGTARYMSINTHlGrEQSRRDDLEaLGHvFmYFLRGsLPWQG 238 (449)
T KOG1165|consen 173 FGMAKEYRDPKTKQHIPYREHKSLSGTARYMSINTHLGREQSRRDDLEALGHVFMYFLRGSLPWQG 238 (449)
T ss_pred ccchhhhcCccccccCccccccccccceeeeEeeccccchhhhhhhHHHhhhhhhhhccCCCcccc
Confidence 9999877533221 11223566789999999999999999999999999999999999999954
|
|
| >cd05147 RIO1_euk RIO kinase family; eukaryotic RIO1, catalytic domain | Back alignment and domain information |
|---|
Probab=99.90 E-value=3e-23 Score=162.73 Aligned_cols=142 Identities=18% Similarity=0.187 Sum_probs=108.9
Q ss_pred CCceeecCCcceEEEEEeCCCcEEEEEEeccCcCChhh------------------------hHHHHHHHHHHHhcCCcc
Q 038766 16 ENNIIGNSNLSTVYKGRLEDGEIVAVKKLNFHQFSAES------------------------DKSFYREAKTLKELKHRN 71 (299)
Q Consensus 16 ~~~~lg~g~~~~v~~~~~~~~~~~~vK~~~~~~~~~~~------------------------~~~~~~e~~~l~~l~h~~ 71 (299)
+...||+|++|.||+|.+.+|+.||+|+++........ ......|.+.+.++.+++
T Consensus 1 ~~~~ig~G~~~~Vy~a~~~~g~~vAvKv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~ 80 (190)
T cd05147 1 INGCISTGKEANVYHATTANGEERAIKIYKTSILVFKDRDRYVSGEFRFRHGYCKSNPRKMVRTWAEKEMRNLKRLVTAG 80 (190)
T ss_pred CCCccccccceEEEEEECCCCCEEEEEEEEecccccccHHHhhcCCchhhccccCCCHHHHHHHHHHHHHHHHHHHHHCC
Confidence 35789999999999999878999999999754221111 123345999999998777
Q ss_pred eeeeeeEEEcCCCeeEEEEeecCCCChHHHhcCCCCCCCCCChhhHHHHHHHHHHHHHHh-hcCCCCCeeeecccCCcee
Q 038766 72 LVKVLGYAWESGKLKALILEYMENGSLESVIHGPGVDHSRWTLPKRIDVLISVANGLDYL-HSGYDIPIVHCDMKPSNIL 150 (299)
Q Consensus 72 i~~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~l-h~~~~~~~~H~dl~~~nil 150 (299)
+..... ... ... ++||||+.++++..... ...++++..+..++.|++.+|.++ |+. +++|+||||+||+
T Consensus 81 v~~p~~-~~~-~~~-~iVmE~i~g~~l~~~~~----~~~~~~~~~~~~i~~qi~~~L~~l~H~~---giiHrDlkP~NIl 150 (190)
T cd05147 81 IPCPEP-ILL-KSH-VLVMEFIGDDGWAAPRL----KDAPLSESKARELYLQVIQIMRILYQDC---RLVHADLSEYNLL 150 (190)
T ss_pred CCCCcE-EEe-cCC-EEEEEEeCCCCCcchhh----hcCCCCHHHHHHHHHHHHHHHHHHHHhC---CcccCCCCHHHEE
Confidence 643332 222 222 79999998876654432 234788999999999999999999 688 9999999999999
Q ss_pred eCCCCcEEEeeecccccc
Q 038766 151 LDRDFEAHVSDFGTSRML 168 (299)
Q Consensus 151 ~~~~~~v~l~df~~~~~~ 168 (299)
++ ++.++|+|||++...
T Consensus 151 i~-~~~v~LiDFG~a~~~ 167 (190)
T cd05147 151 YH-DGKLYIIDVSQSVEH 167 (190)
T ss_pred EE-CCcEEEEEccccccC
Confidence 98 478999999998643
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO1 is present in archaea, bacteria and eukaryotes. This subfamily is composed of RIO1 proteins from eukaryotes. RIO1 is essential for survival and is required for 18S rRNA processing, proper cell cycle progression and c |
| >KOG0195 consensus Integrin-linked kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.89 E-value=3.5e-24 Score=168.49 Aligned_cols=246 Identities=22% Similarity=0.347 Sum_probs=185.0
Q ss_pred CCCCCCceeecCCcceEEEEEeCCCcEEEEEEeccCcCChhhhHHHHHHHHHHHhcCCcceeeeeeEEEcCCCeeEEEEe
Q 038766 12 GSFSENNIIGNSNLSTVYKGRLEDGEIVAVKKLNFHQFSAESDKSFYREAKTLKELKHRNLVKVLGYAWESGKLKALILE 91 (299)
Q Consensus 12 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~vK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~lv~e 91 (299)
++.....+|...-.|..|+++++ |..+++|++.........-..+..|.-.++.+.||||+++++.+.+.. .+.++..
T Consensus 190 ~~lnl~tkl~e~hsgelwrgrwq-gndivakil~vr~~t~risrdfneefp~lrifshpnilpvlgacnspp-nlv~isq 267 (448)
T KOG0195|consen 190 SSLNLITKLAESHSGELWRGRWQ-GNDIVAKILNVREVTARISRDFNEEFPALRIFSHPNILPVLGACNSPP-NLVIISQ 267 (448)
T ss_pred hhhhhhhhhccCCCccccccccc-CcchhhhhhhhhhcchhhcchhhhhCcceeeecCCchhhhhhhccCCC-CceEeee
Confidence 44566778889999999999997 667888988766656655667888999999999999999999887654 4589999
Q ss_pred ecCCCChHHHhcCCCCCCCCCChhhHHHHHHHHHHHHHHhhcCCCCCeeeecccCCceeeCCCCcEEE--eeeccccccc
Q 038766 92 YMENGSLESVIHGPGVDHSRWTLPKRIDVLISVANGLDYLHSGYDIPIVHCDMKPSNILLDRDFEAHV--SDFGTSRMLD 169 (299)
Q Consensus 92 ~~~~~~L~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lh~~~~~~~~H~dl~~~nil~~~~~~v~l--~df~~~~~~~ 169 (299)
|++.++|.+++.+. .+-..+..++.+++..++.+++|||+..+ -+..--+....+++|.+-+.++ +|--++
T Consensus 268 ~mp~gslynvlhe~--t~vvvd~sqav~faldiargmaflhslep-~ipr~~lns~hvmidedltarismad~kfs---- 340 (448)
T KOG0195|consen 268 YMPFGSLYNVLHEQ--TSVVVDHSQAVRFALDIARGMAFLHSLEP-MIPRFYLNSKHVMIDEDLTARISMADTKFS---- 340 (448)
T ss_pred eccchHHHHHHhcC--ccEEEecchHHHHHHHHHhhHHHHhhcch-hhhhhhcccceEEecchhhhheecccceee----
Confidence 99999999999754 45567788899999999999999999732 3444567888999998866554 332222
Q ss_pred cccccccccccccccCcccCChhhhcccCcC---ccccchhhhHHHHHHHhCCCCCCCCccCCCCchhHHHHHHHHHhcC
Q 038766 170 VHLQDLSSLSTAFQGTIGYLAPEFAYMRIVT---TKVDVFSFGIVVMEFLTKRRPTGLDEENGLSPISLRQLVEKALANG 246 (299)
Q Consensus 170 ~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~---~~~DiwslG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~ 246 (299)
-.......+|.|++||.++...-+ .++|+||+++++|+|.|...||..- .+++.. +....
T Consensus 341 -------fqe~gr~y~pawmspealqrkped~n~raadmwsfaillwel~trevpfadl-----spmecg--mkial--- 403 (448)
T KOG0195|consen 341 -------FQEVGRAYSPAWMSPEALQRKPEDLNIRAADMWSFAILLWELNTREVPFADL-----SPMECG--MKIAL--- 403 (448)
T ss_pred -------eeccccccCcccCCHHHHhcCchhcchhhhhHHHHHHHHHHhhccccccccC-----Cchhhh--hhhhh---
Confidence 123334457899999988866533 4799999999999999999999532 222211 11100
Q ss_pred ccCcccccCccccchhhHhHHHHHHHHHHHHHHHHhcCCCCCCCCChhhhh
Q 038766 247 INGVRQITDPKLVSSIYEEQEQHQVLEELFKLALVCTSSNPEDRPNMNELL 297 (299)
Q Consensus 247 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rpt~~~il 297 (299)
-......+++++..+..|+.-|++.||.+||.+..++
T Consensus 404 --------------eglrv~ippgis~hm~klm~icmnedpgkrpkfdmiv 440 (448)
T KOG0195|consen 404 --------------EGLRVHIPPGISRHMNKLMNICMNEDPGKRPKFDMIV 440 (448)
T ss_pred --------------ccccccCCCCccHHHHHHHHHHhcCCCCcCCCcceeh
Confidence 0112223667788999999999999999999998765
|
|
| >cd05145 RIO1_like RIO kinase family; RIO1, RIO3 and similar proteins, catalytic domain | Back alignment and domain information |
|---|
Probab=99.88 E-value=4.8e-22 Score=156.46 Aligned_cols=142 Identities=21% Similarity=0.232 Sum_probs=110.9
Q ss_pred CCceeecCCcceEEEEEeCCCcEEEEEEeccCcCChhh------------------------hHHHHHHHHHHHhcCCcc
Q 038766 16 ENNIIGNSNLSTVYKGRLEDGEIVAVKKLNFHQFSAES------------------------DKSFYREAKTLKELKHRN 71 (299)
Q Consensus 16 ~~~~lg~g~~~~v~~~~~~~~~~~~vK~~~~~~~~~~~------------------------~~~~~~e~~~l~~l~h~~ 71 (299)
+.+.||+|++|.||+|.+.+|+.||||+++........ ......|.+.+.++.+++
T Consensus 1 ~~~~ig~G~~~~Vy~a~~~~g~~vavKv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~ 80 (190)
T cd05145 1 INGCISTGKEANVYHARTGDGEELAVKIYKTSTLSFKDRDKYIEGDPRFRSRYSKSNPRKLVFAWAEKEFRNLKRLYEAG 80 (190)
T ss_pred CCceeecCCCcEEEEEEcCCCCEEEEEEEEcCcceEeeHHHHhcCCcccccccccCCHHHHHHHHHHHHHHHHHHHHhCC
Confidence 46789999999999999778999999998754211100 122457899999999888
Q ss_pred eeeeeeEEEcCCCeeEEEEeecCCCChHH-HhcCCCCCCCCCChhhHHHHHHHHHHHHHHhhc-CCCCCeeeecccCCce
Q 038766 72 LVKVLGYAWESGKLKALILEYMENGSLES-VIHGPGVDHSRWTLPKRIDVLISVANGLDYLHS-GYDIPIVHCDMKPSNI 149 (299)
Q Consensus 72 i~~~~~~~~~~~~~~~lv~e~~~~~~L~~-~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lh~-~~~~~~~H~dl~~~ni 149 (299)
+.....+... . .++||||+.++++.. .+. ..++++..+..++.|++.++.++|+ . +++|+||||+||
T Consensus 81 i~~p~~~~~~-~--~~lVmE~~~g~~~~~~~l~-----~~~~~~~~~~~i~~~l~~~l~~lH~~~---givHrDlkP~NI 149 (190)
T cd05145 81 VPVPEPILLK-K--NVLVMEFIGDDGSPAPRLK-----DVPLEEEEAEELYEQVVEQMRRLYQEA---GLVHGDLSEYNI 149 (190)
T ss_pred CCCceEEEec-C--CEEEEEEecCCCchhhhhh-----hccCCHHHHHHHHHHHHHHHHHHHHhC---CEecCCCChhhE
Confidence 7544443322 2 379999998875533 232 2457788999999999999999999 8 999999999999
Q ss_pred eeCCCCcEEEeeeccccccc
Q 038766 150 LLDRDFEAHVSDFGTSRMLD 169 (299)
Q Consensus 150 l~~~~~~v~l~df~~~~~~~ 169 (299)
+++ ++.++|+|||++....
T Consensus 150 ll~-~~~~~liDFG~a~~~~ 168 (190)
T cd05145 150 LYH-DGKPYIIDVSQAVELD 168 (190)
T ss_pred EEE-CCCEEEEEcccceecC
Confidence 998 8899999999987544
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO1 is present in archaea, bacteria and eukaryotes. In addition, RIO3 is present in multicellular eukaryotes. RIO1 is essential for survival and is required for 18S rRNA processing, proper cell cycle pro |
| >KOG4158 consensus BRPK/PTEN-induced protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.87 E-value=3.2e-22 Score=165.16 Aligned_cols=194 Identities=22% Similarity=0.255 Sum_probs=136.6
Q ss_pred CCcceeeeeeEEEc--------------------------CCCeeEEEEeecCCCChHHHhcCCCCCCCCCChhhHHHHH
Q 038766 68 KHRNLVKVLGYAWE--------------------------SGKLKALILEYMENGSLESVIHGPGVDHSRWTLPKRIDVL 121 (299)
Q Consensus 68 ~h~~i~~~~~~~~~--------------------------~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~i~ 121 (299)
+||||+.+.+.|.+ ++..+|+||.-++. +|..++- ....+.-...-++
T Consensus 274 ~HPNIvri~~aF~dsv~~lPda~~~YPdalp~R~~p~g~g~~~tlylvMkrY~~-tLr~yl~-----~~~~s~r~~~~~l 347 (598)
T KOG4158|consen 274 KHPNIVRIQTAFIDSVKVLPDAIERYPDALPARWYPSGAGEPKTLYLVMKRYRQ-TLREYLW-----TRHRSYRTGRVIL 347 (598)
T ss_pred CCCCEEeehhhhhhhhccCCchhhhCcccccceecccccCCCceEEEehhcchh-hHHHHHh-----cCCCchHHHHHHH
Confidence 59999999875542 23567899998855 9988884 3345556778899
Q ss_pred HHHHHHHHHhhcCCCCCeeeecccCCceeeC--CCC--cEEEeeecccccccccccccccc--ccccccCcccCChhhhc
Q 038766 122 ISVANGLDYLHSGYDIPIVHCDMKPSNILLD--RDF--EAHVSDFGTSRMLDVHLQDLSSL--STAFQGTIGYLAPEFAY 195 (299)
Q Consensus 122 ~qi~~~l~~lh~~~~~~~~H~dl~~~nil~~--~~~--~v~l~df~~~~~~~~~~~~~~~~--~~~~~~~~~y~~PE~~~ 195 (299)
.|+++|+.|||++ ++.|||+|.+||++. +|+ .++++|||.|---+.+.-..... .-..-|.-..+|||+..
T Consensus 348 aQlLEav~hL~~h---gvAhRDlKSDNiL~ElddD~~P~LVvaDFGCcLAd~~hGlqlpy~S~~Vd~GGNa~lmAPEi~t 424 (598)
T KOG4158|consen 348 AQLLEAVTHLHKH---GVAHRDLKSDNILLELDDDEIPQLVVADFGCCLADDNHGLQLPYESDEVDLGGNAKLMAPEIAT 424 (598)
T ss_pred HHHHHHHHHHHHc---cchhhcccccceEEEecCCCCcEEEEcccceeeeccccccccccccccccCCCcceecchhhhh
Confidence 9999999999999 999999999999993 443 47899999885433221111111 12233566789999876
Q ss_pred ccCc------CccccchhhhHHHHHHHhCCCCCCCCccCCCCchhHHHHHHHHHhcCccCcccccCccccchhhHhHHHH
Q 038766 196 MRIV------TTKVDVFSFGIVVMEFLTKRRPTGLDEENGLSPISLRQLVEKALANGINGVRQITDPKLVSSIYEEQEQH 269 (299)
Q Consensus 196 ~~~~------~~~~DiwslG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 269 (299)
.-.. -.++|.|+.|.+.||++....||....+..+.-... ++-.-| ..+.
T Consensus 425 a~PGp~avvny~kAD~WA~GalaYEIfg~~NPFY~rGem~L~~r~Y---------------qe~qLP---------alp~ 480 (598)
T KOG4158|consen 425 AVPGPNAVVNYEKADTWAAGALAYEIFGRSNPFYKRGEMLLDTRTY---------------QESQLP---------ALPS 480 (598)
T ss_pred cCCCCceeeccchhhhhhhhhhHHHHhccCCcccccchheechhhh---------------hhhhCC---------CCcc
Confidence 4332 247999999999999999999997543322211110 000011 1255
Q ss_pred HHHHHHHHHHHHhcCCCCCCCCChh
Q 038766 270 QVLEELFKLALVCTSSNPEDRPNMN 294 (299)
Q Consensus 270 ~~~~~l~~li~~~l~~dP~~Rpt~~ 294 (299)
.++..+++++...|+.||++|+++.
T Consensus 481 ~vpp~~rqlV~~lL~r~pskRvsp~ 505 (598)
T KOG4158|consen 481 RVPPVARQLVFDLLKRDPSKRVSPN 505 (598)
T ss_pred cCChHHHHHHHHHhcCCccccCCcc
Confidence 6677899999999999999999864
|
|
| >PRK12274 serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.85 E-value=2e-20 Score=145.49 Aligned_cols=192 Identities=18% Similarity=0.122 Sum_probs=137.7
Q ss_pred CCCCceeecCCcceEEEEEeCCCcEEEEEEeccCcCChh--hhHHHHHHHHHHHhcC-CcceeeeeeEEEcCCCeeEEEE
Q 038766 14 FSENNIIGNSNLSTVYKGRLEDGEIVAVKKLNFHQFSAE--SDKSFYREAKTLKELK-HRNLVKVLGYAWESGKLKALIL 90 (299)
Q Consensus 14 y~~~~~lg~g~~~~v~~~~~~~~~~~~vK~~~~~~~~~~--~~~~~~~e~~~l~~l~-h~~i~~~~~~~~~~~~~~~lv~ 90 (299)
+.++..|++|+||+|+.+.. .+.+++.+.+........ ....+.+|+++|+++. ++++.+++++ +. .++++
T Consensus 4 ~~~~~~l~~~~f~~v~~~~~-~~~k~~~~~l~~~~~~~~~~~~~l~~rE~~iL~~L~~~~~vP~ll~~----~~-~~lvm 77 (218)
T PRK12274 4 PAVNEPLKSDTFGRILLVRG-GERKFVRRDLSAAPWWLRGVAWWLARREALALRQLDGLPRTPRLLHW----DG-RHLDR 77 (218)
T ss_pred cccceeecCCCcceEEEeec-CCceeeecccccchhhhhhHHHHHHHHHHHHHHhcCCCCCCCEEEEE----cC-EEEEE
Confidence 34678999999999997766 678888887764433211 1235789999999996 5788888884 22 48999
Q ss_pred eecCCCChHHHhcCCCCCCCCCChhhHHHHHHHHHHHHHHhhcCCCCCeeeecc-cCCceeeCCCCcEEEeeeccccccc
Q 038766 91 EYMENGSLESVIHGPGVDHSRWTLPKRIDVLISVANGLDYLHSGYDIPIVHCDM-KPSNILLDRDFEAHVSDFGTSRMLD 169 (299)
Q Consensus 91 e~~~~~~L~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lh~~~~~~~~H~dl-~~~nil~~~~~~v~l~df~~~~~~~ 169 (299)
||+.|.+|...... ....++.|++.+|.++|++ +++|+|| ||+||+++.+|.++|+|||++....
T Consensus 78 eyI~G~~L~~~~~~-----------~~~~~~~qi~~~L~~lH~~---GIvHrDL~kp~NILv~~~g~i~LIDFG~A~~~~ 143 (218)
T PRK12274 78 SYLAGAAMYQRPPR-----------GDLAYFRAARRLLQQLHRC---GVAHNDLAKEANWLVQEDGSPAVIDFQLAVRGN 143 (218)
T ss_pred eeecCccHHhhhhh-----------hhHHHHHHHHHHHHHHHHC---cCccCCCCCcceEEEcCCCCEEEEECCCceecC
Confidence 99999888654421 1135778999999999999 9999999 7999999999999999999997543
Q ss_pred ccccc---cc-----cc-ccccccCcccCChhhhccc-CcC-ccccchhhhHHHHHHHhCCCCCCCC
Q 038766 170 VHLQD---LS-----SL-STAFQGTIGYLAPEFAYMR-IVT-TKVDVFSFGIVVMEFLTKRRPTGLD 225 (299)
Q Consensus 170 ~~~~~---~~-----~~-~~~~~~~~~y~~PE~~~~~-~~~-~~~DiwslG~~l~~l~~g~~p~~~~ 225 (299)
....- .. .. ..-...++.++.|+...-. ..+ .+.+-++.|+-+|.++|+..+.-.+
T Consensus 144 ~~~~~~r~L~~rDl~~llk~~~~y~~~~l~~~~~~~l~~~~~~~~~w~~~g~~~~~~~~~~~~~~~~ 210 (218)
T PRK12274 144 PRARWMRLLAREDLRHLLKHKRMYCPAALTPVERRVLKRTSWIRELWFATGKPVYRFVTRRVLHWED 210 (218)
T ss_pred CcchHHHHHHHHHHHHHHHHHHhcCCCCCCHHHHhhhccchhHHHHHHHhcchHHHHHhccCCcccc
Confidence 21100 00 00 0112256778888854432 233 4567778899999999998876433
|
|
| >KOG0603 consensus Ribosomal protein S6 kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.84 E-value=1e-21 Score=170.83 Aligned_cols=227 Identities=25% Similarity=0.259 Sum_probs=179.8
Q ss_pred eeecCCcceEEEEEe----CCCcEEEEEEeccCcCChhhhHHHHHHHHHHHhcC-CcceeeeeeEEEcCCCeeEEEEeec
Q 038766 19 IIGNSNLSTVYKGRL----EDGEIVAVKKLNFHQFSAESDKSFYREAKTLKELK-HRNLVKVLGYAWESGKLKALILEYM 93 (299)
Q Consensus 19 ~lg~g~~~~v~~~~~----~~~~~~~vK~~~~~~~~~~~~~~~~~e~~~l~~l~-h~~i~~~~~~~~~~~~~~~lv~e~~ 93 (299)
.+|.|++|.|+++.. ..+.-++.|+.............-..|..++...+ ||.++.+.-.+.. ...++++.++.
T Consensus 1 vlg~g~~gkvfLvrk~~g~da~~~yamkvl~k~t~~~~~~~~t~~er~il~~~~~~~f~v~lhyafqt-~~kl~l~ld~~ 79 (612)
T KOG0603|consen 1 VLGQGSYGKVFLVRKAGGADAGHLYAMKVLKKATLKVRDRTHTKQERIILAFVHNTPFLVKLHYAFQT-DGKLYLILDFL 79 (612)
T ss_pred CCCcCCCcchHHHHHhccccccchhhhhcccccccccccccccccHHHHHhhccCCCceeeeeeeecc-ccchhHhhhhc
Confidence 378999999999863 34778899988765443333335666788888887 8999988775544 55558999999
Q ss_pred CCCChHHHhcCCCCCCCCCChhhHHHHHHHHHHHHHHhhcCCCCCeeeecccCCceeeCCCCcEEEeeeccccccccccc
Q 038766 94 ENGSLESVIHGPGVDHSRWTLPKRIDVLISVANGLDYLHSGYDIPIVHCDMKPSNILLDRDFEAHVSDFGTSRMLDVHLQ 173 (299)
Q Consensus 94 ~~~~L~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lh~~~~~~~~H~dl~~~nil~~~~~~v~l~df~~~~~~~~~~~ 173 (299)
+++.|...+. ....+.+.....+...++.++..+|+. +++|+|+|++||+++.+|.+++.|||++...-..
T Consensus 80 rgg~lft~l~----~~~~f~~~~~~~~~aelaLald~lh~l---~iiyrd~k~enilld~~Ghi~~tdfglske~v~~-- 150 (612)
T KOG0603|consen 80 RGGDLFTRLS----KEVMFDELDVAFYLAELALALDHLHKL---GIAYRDYKLENVLLLLEGHIKLTDFGLSKEAVKE-- 150 (612)
T ss_pred ccchhhhccc----cCCchHHHHHHHHHHHHHHHHhhcchh---HHHHhcccccceeecccCccccCCchhhhHhHhh--
Confidence 9999988776 555788888899999999999999999 9999999999999999999999999998754311
Q ss_pred cccccccccccCcccCChhhhcccCcCccccchhhhHHHHHHHhCCCCCCCCccCCCCchhHHHHHHHHHhcCccCcccc
Q 038766 174 DLSSLSTAFQGTIGYLAPEFAYMRIVTTKVDVFSFGIVVMEFLTKRRPTGLDEENGLSPISLRQLVEKALANGINGVRQI 253 (299)
Q Consensus 174 ~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~DiwslG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 253 (299)
....|+..|+|||+.. ....++|-||+|++.++|++|..||.. +.+..+...
T Consensus 151 ------~~~cgt~eymApEI~~--gh~~a~D~ws~gvl~felltg~~pf~~------------~~~~~Il~~-------- 202 (612)
T KOG0603|consen 151 ------KIACGTYEYRAPEIIN--GHLSAADWWSFGVLAFELLTGTLPFGG------------DTMKRILKA-------- 202 (612)
T ss_pred ------hhcccchhhhhhHhhh--ccCCcccchhhhhhHHHHhhCCCCCch------------HHHHHHhhh--------
Confidence 1116799999999988 567889999999999999999999953 222222211
Q ss_pred cCccccchhhHhHHHHHHHHHHHHHHHHhcCCCCCCCCCh
Q 038766 254 TDPKLVSSIYEEQEQHQVLEELFKLALVCTSSNPEDRPNM 293 (299)
Q Consensus 254 ~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rpt~ 293 (299)
....++..+..+.+++.+++..+|..|.-.
T Consensus 203 ----------~~~~p~~l~~~a~~~~~~l~~r~p~nrLg~ 232 (612)
T KOG0603|consen 203 ----------ELEMPRELSAEARSLFRQLFKRNPENRLGA 232 (612)
T ss_pred ----------ccCCchhhhHHHHHHHHHHHhhCHHHHhcc
Confidence 112377888899999999999999999765
|
|
| >KOG1166 consensus Mitotic checkpoint serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.84 E-value=5.5e-21 Score=176.98 Aligned_cols=201 Identities=23% Similarity=0.242 Sum_probs=158.0
Q ss_pred HHHHHHhCCCCCCceeecCCcceEEEEEeCCCcEEEEEEeccCcCChhhhHHHHHHHHHHHhcC---CcceeeeeeEEEc
Q 038766 5 TEIENATGSFSENNIIGNSNLSTVYKGRLEDGEIVAVKKLNFHQFSAESDKSFYREAKTLKELK---HRNLVKVLGYAWE 81 (299)
Q Consensus 5 ~~~~~~~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~vK~~~~~~~~~~~~~~~~~e~~~l~~l~---h~~i~~~~~~~~~ 81 (299)
.+.+.-.+.|-|.+.||+|++|.||+|...+|+.+|+|+-..+..+ + ++--.+++.+|+ -+.|+.+.....-
T Consensus 691 ~~~~~~~~~~~I~~e~G~g~y~~vy~a~~~~~~~~alK~e~P~~~W-E----fYI~~q~~~RLk~~~~~~~~~~~~a~~~ 765 (974)
T KOG1166|consen 691 TEFEVGGEKFCISKEIGEGSYGSVYVATHSNGKLVALKVEKPPNPW-E----FYICLQVMERLKPQMLPSIMHISSAHVF 765 (974)
T ss_pred ceeeecceeEEEEeeeccccceEEEEeecCCCcEEEEEeecCCCce-e----eeehHHHHHhhchhhhcchHHHHHHHcc
Confidence 3556677889999999999999999999888999999987643322 2 222234444554 2334444332222
Q ss_pred CCCeeEEEEeecCCCChHHHhcCCCCCCCCCChhhHHHHHHHHHHHHHHhhcCCCCCeeeecccCCceeeCC-------C
Q 038766 82 SGKLKALILEYMENGSLESVIHGPGVDHSRWTLPKRIDVLISVANGLDYLHSGYDIPIVHCDMKPSNILLDR-------D 154 (299)
Q Consensus 82 ~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lh~~~~~~~~H~dl~~~nil~~~-------~ 154 (299)
.+.-++|+||.+.|+|.++++ ..+.+++..+..++.|++..+..||.. +|+||||||+|+++.. .
T Consensus 766 -~~~S~lv~ey~~~Gtlld~~N----~~~~m~e~lv~~~~~qml~ive~lH~~---~IIHgDiKPDNfll~~~~~~~~~~ 837 (974)
T KOG1166|consen 766 -QNASVLVSEYSPYGTLLDLIN----TNKVMDEYLVMFFSCQMLRIVEHLHAM---GIIHGDIKPDNFLLRREICADSDS 837 (974)
T ss_pred -CCcceeeeeccccccHHHhhc----cCCCCCchhhhHHHHHHHHHHHHHHhc---ceecccCCcceeEeecccCCCCcc
Confidence 223379999999999999998 677899999999999999999999999 9999999999999942 2
Q ss_pred CcEEEeeeccccccccccccccccccccccCcccCChhhhcccCcCccccchhhhHHHHHHHhCCC
Q 038766 155 FEAHVSDFGTSRMLDVHLQDLSSLSTAFQGTIGYLAPEFAYMRIVTTKVDVFSFGIVVMEFLTKRR 220 (299)
Q Consensus 155 ~~v~l~df~~~~~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~DiwslG~~l~~l~~g~~ 220 (299)
-.++|+|||.+..+..... +......++|-.+-.+|...+..++...|.|.|+.+++-|++|..
T Consensus 838 ~~l~lIDfG~siDm~lfp~--~~~F~~~~~td~f~C~EM~~grpWtYq~DyfGlAa~~h~mLFG~y 901 (974)
T KOG1166|consen 838 KGLYLIDFGRSIDMKLFPD--GTKFKAVWHTDLFDCIEMREGRPWTYQIDYFGLAATVHVMLFGKY 901 (974)
T ss_pred cceEEEecccceeeeEcCC--CcEEeeeeccccchhHHHhcCCCCchhhhhHHHHHHHHHHHHHHH
Confidence 3489999999875543222 244566778899999999999999999999999999999999864
|
|
| >smart00090 RIO RIO-like kinase | Back alignment and domain information |
|---|
Probab=99.82 E-value=1.1e-19 Score=147.29 Aligned_cols=143 Identities=17% Similarity=0.190 Sum_probs=110.3
Q ss_pred CCCCCceeecCCcceEEEEE--eCCCcEEEEEEeccCcCChh----------------------hhHHHHHHHHHHHhcC
Q 038766 13 SFSENNIIGNSNLSTVYKGR--LEDGEIVAVKKLNFHQFSAE----------------------SDKSFYREAKTLKELK 68 (299)
Q Consensus 13 ~y~~~~~lg~g~~~~v~~~~--~~~~~~~~vK~~~~~~~~~~----------------------~~~~~~~e~~~l~~l~ 68 (299)
-|.+.+.||+|++|.||+|. ..+|+.||+|++........ ....+..|+..++++.
T Consensus 29 ~~~i~~~Lg~G~~g~Vy~a~~~~~~g~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~L~~L~ 108 (237)
T smart00090 29 LSAIGGCISTGKEANVYHALDFDGSGKERAVKIYRTGTLEFKRRDRYVDGDFRFKYRKINPRKLVRLWAEKEFRNLQRLY 108 (237)
T ss_pred hHHhCCeeccCcceeEEEEEecCCCCcEEEEEEEEcCcceecchhhhcccchhhccCCCCHHHHHHHHHHHHHHHHHHHH
Confidence 48899999999999999998 46799999999875431100 1134568999999997
Q ss_pred Ccc--eeeeeeEEEcCCCeeEEEEeecCCCChHHHhcCCCCCCCCCChhhHHHHHHHHHHHHHHhhcCCCCC-eeeeccc
Q 038766 69 HRN--LVKVLGYAWESGKLKALILEYMENGSLESVIHGPGVDHSRWTLPKRIDVLISVANGLDYLHSGYDIP-IVHCDMK 145 (299)
Q Consensus 69 h~~--i~~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lh~~~~~~-~~H~dl~ 145 (299)
+.. +.++++. +. .++|+|++.+.+|..... ....+...++..++.|++.++++||+. + ++|+|||
T Consensus 109 ~~~i~~p~~~~~----~~-~~lV~E~~~g~~L~~~~~----~~~~~~~~~~~~i~~qi~~~l~~LH~~---g~iiH~Dik 176 (237)
T smart00090 109 EAGVPVPKPIAW----RR-NVLVMEFIGGDGLPAPRL----KDVEPEEEEEFELYDDILEEMRKLYKE---GELVHGDLS 176 (237)
T ss_pred hcCCCCCeeeEe----cC-ceEEEEEecCCccccccc----ccCCcchHHHHHHHHHHHHHHHHHHhc---CCEEeCCCC
Confidence 532 3333331 22 379999998877766542 233456667789999999999999999 8 9999999
Q ss_pred CCceeeCCCCcEEEeeecccccc
Q 038766 146 PSNILLDRDFEAHVSDFGTSRML 168 (299)
Q Consensus 146 ~~nil~~~~~~v~l~df~~~~~~ 168 (299)
|+||+++ ++.++|+|||.+...
T Consensus 177 p~NIli~-~~~i~LiDFg~a~~~ 198 (237)
T smart00090 177 EYNILVH-DGKVVIIDVSQSVEL 198 (237)
T ss_pred hhhEEEE-CCCEEEEEChhhhcc
Confidence 9999999 889999999988643
|
|
| >KOG1023 consensus Natriuretic peptide receptor, guanylate cyclase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.82 E-value=1.3e-19 Score=157.35 Aligned_cols=210 Identities=28% Similarity=0.454 Sum_probs=152.3
Q ss_pred HHhcCCcceeeeeeEEEcCCCeeEEEEeecCCCChHHHhcCCCCCCCCCChhhHHHHHHHHHHHHHHhhcCCCCCe-eee
Q 038766 64 LKELKHRNLVKVLGYAWESGKLKALILEYMENGSLESVIHGPGVDHSRWTLPKRIDVLISVANGLDYLHSGYDIPI-VHC 142 (299)
Q Consensus 64 l~~l~h~~i~~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lh~~~~~~~-~H~ 142 (299)
|+.+.|.|+.+++|.+... ...++|.+|+..|+|.+.+.. ....++......++..++.+|+|+|.. .+ +|+
T Consensus 1 l~~l~h~n~~~f~g~~~~~-~~~~~i~~~c~rGsl~D~i~~---~~~~~d~~F~~s~~rdi~~Gl~ylh~s---~i~~hg 73 (484)
T KOG1023|consen 1 LRQLDHDNLNKFIGASVDG-PEMIVIWEYCSRGSLLDILSN---EDIKLDYFFILSFIRDISKGLAYLHNS---PIGYHG 73 (484)
T ss_pred CcccchhhhhhheeeEecC-CceEEEEeeecCccHHhHHhc---cccCccHHHHHHHHHHHHHHHHHHhcC---cceeee
Confidence 3567899999999988875 566999999999999999874 345777788889999999999999987 44 999
Q ss_pred cccCCceeeCCCCcEEEeeeccccccccccccccccccccccCcccCChhhhcccC-------cCccccchhhhHHHHHH
Q 038766 143 DMKPSNILLDRDFEAHVSDFGTSRMLDVHLQDLSSLSTAFQGTIGYLAPEFAYMRI-------VTTKVDVFSFGIVVMEF 215 (299)
Q Consensus 143 dl~~~nil~~~~~~v~l~df~~~~~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~-------~~~~~DiwslG~~l~~l 215 (299)
.++..|++++....+|++|||+......... ............|.|||.+.... .+.++|+||+|++++++
T Consensus 74 ~l~s~nClvd~~w~lklt~~Gl~~~~~~~~~--~~~~~~~~~~~lw~aPellr~~~~~~~~~~~~~~gdiYs~~ii~~ei 151 (484)
T KOG1023|consen 74 ALKSSNCLVDSRWVLKLTDFGLNSLLEETAE--PEAHHPIRKALLWTAPELLRGALSQSLESALTQKGDIYSFGIIMYEI 151 (484)
T ss_pred eeccccceeeeeEEEEechhhhccccccccc--ccccchhHHHHhccCHHHhcccccccccccccccCCeehHHHHHHHH
Confidence 9999999999999999999999876532000 01111112345789999887642 46679999999999999
Q ss_pred HhCCCCCCCCccCCCCchhHHHHHHHHHhcCccCcccccCccccchhhHhHHHHHHHHHHHHHHHHhcCCCCCCCCChhh
Q 038766 216 LTKRRPTGLDEENGLSPISLRQLVEKALANGINGVRQITDPKLVSSIYEEQEQHQVLEELFKLALVCTSSNPEDRPNMNE 295 (299)
Q Consensus 216 ~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rpt~~~ 295 (299)
++...||......... .++...+.. .+....+ | ... . .....+++..++.+||..+|.+||++++
T Consensus 152 ~~r~~~~~~~~~~~~~-~eii~~~~~---~~~~~~r----P---~i~-~---~~e~~~~l~~l~~~cw~e~P~~rPs~~~ 216 (484)
T KOG1023|consen 152 LFRSGPFDLRNLVEDP-DEIILRVKK---GGSNPFR----P---SIE-L---LNELPPELLLLVARCWEEIPEKRPSIEQ 216 (484)
T ss_pred HhccCccccccccCCh-HHHHHHHHh---cCCCCcC----c---chh-h---hhhcchHHHHHHHHhcccChhhCccHHH
Confidence 9999999765433333 222222222 0110010 0 000 0 1133447899999999999999999998
Q ss_pred hh
Q 038766 296 LL 297 (299)
Q Consensus 296 il 297 (299)
+-
T Consensus 217 i~ 218 (484)
T KOG1023|consen 217 IR 218 (484)
T ss_pred HH
Confidence 63
|
|
| >PRK10345 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=99.81 E-value=5.5e-19 Score=139.90 Aligned_cols=138 Identities=22% Similarity=0.278 Sum_probs=103.6
Q ss_pred CCCCceeecCCcceEEEEEeCCCcEEEEEEeccCcCChhhhHHHHHHHHHHHhc-----CCcceeeeeeEEEcCCC--e-
Q 038766 14 FSENNIIGNSNLSTVYKGRLEDGEIVAVKKLNFHQFSAESDKSFYREAKTLKEL-----KHRNLVKVLGYAWESGK--L- 85 (299)
Q Consensus 14 y~~~~~lg~g~~~~v~~~~~~~~~~~~vK~~~~~~~~~~~~~~~~~e~~~l~~l-----~h~~i~~~~~~~~~~~~--~- 85 (299)
+.-.+.||+|+++.||. ...++.. +||++.... ....+.+.+|+..++.+ .||||+++++++..... .
T Consensus 4 L~~~~~LG~G~~~~Vy~-hp~~~~k-~IKv~~~~~--~~~~~~~~rEi~~l~~L~~~~~~h~nIvr~yg~~et~~g~g~v 79 (210)
T PRK10345 4 LSEQSPLGTGRHRKCYA-HPEDAQR-CIKIVYHRG--DGGDKEIRRELKYYAHLSRRLIDWSGIPRYYGTVETDCGTGYV 79 (210)
T ss_pred cCCcceecCCCceEEEE-CCCCcCe-EEEEEeccc--cchHHHHHHHHHHHHHhhccCCCCcccceeeEEEEeCCCCeEE
Confidence 34567899999999995 3233444 799886432 22456789999999999 57999999997766532 2
Q ss_pred eEEEEee--cCCCChHHHhcCCCCCCCCCChhhHHHHHHHHHHHH-HHhhcCCCCCeeeecccCCceeeCCC----CcEE
Q 038766 86 KALILEY--MENGSLESVIHGPGVDHSRWTLPKRIDVLISVANGL-DYLHSGYDIPIVHCDMKPSNILLDRD----FEAH 158 (299)
Q Consensus 86 ~~lv~e~--~~~~~L~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l-~~lh~~~~~~~~H~dl~~~nil~~~~----~~v~ 158 (299)
..+|+|| ..+++|.++++. ..+++. ..++.|++.++ +|||++ +++|+||||+||+++.. +.++
T Consensus 80 ~~~I~e~~G~~~~tL~~~l~~-----~~~~e~--~~~~~~~L~~l~~yLh~~---~IvhrDlKp~NILl~~~~~~~~~~~ 149 (210)
T PRK10345 80 YDVIADFDGKPSITLTEFAEQ-----CRYEED--VAQLRQLLKKLKRYLLDN---RIVTMELKPQNILCQRISESEVIPV 149 (210)
T ss_pred EEEEecCCCCcchhHHHHHHc-----ccccHh--HHHHHHHHHHHHHHHHHC---CEeecCCCHHHEEEeccCCCCCcEE
Confidence 3378999 446899999963 235555 35677888777 999999 99999999999999743 3799
Q ss_pred Eeeeccc
Q 038766 159 VSDFGTS 165 (299)
Q Consensus 159 l~df~~~ 165 (299)
|+|++.+
T Consensus 150 LiDg~G~ 156 (210)
T PRK10345 150 VCDNIGE 156 (210)
T ss_pred EEECCCC
Confidence 9995443
|
|
| >PRK14879 serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.78 E-value=3.4e-18 Score=137.10 Aligned_cols=137 Identities=19% Similarity=0.309 Sum_probs=110.0
Q ss_pred CceeecCCcceEEEEEeCCCcEEEEEEeccCcCChh------hhHHHHHHHHHHHhcCCcceeeeeeEEEcCCCeeEEEE
Q 038766 17 NNIIGNSNLSTVYKGRLEDGEIVAVKKLNFHQFSAE------SDKSFYREAKTLKELKHRNLVKVLGYAWESGKLKALIL 90 (299)
Q Consensus 17 ~~~lg~g~~~~v~~~~~~~~~~~~vK~~~~~~~~~~------~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~lv~ 90 (299)
.+.||+|++|.||++.+ .|..+++|+......... ......+|+..+..+.|+++.....++.... ..++++
T Consensus 1 ~~~l~~G~~~~vy~~~~-~~~~~~vK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~p~~~~~~~~-~~~lv~ 78 (211)
T PRK14879 1 MKLIKRGAEAEIYLGDF-LGIKAVIKWRIPKRYRHPELDERIRRERTRREARIMSRARKAGVNVPAVYFVDPE-NFIIVM 78 (211)
T ss_pred CcccccCceEEEEEEee-CCCceEEEEeCCcCCcChHHHHHHHHHHHHHHHHHHHHHHHCCCCCCeEEEEeCC-CCEEEE
Confidence 36799999999999987 577899998653322211 1245778999999999988876666554444 348999
Q ss_pred eecCCCChHHHhcCCCCCCCCCChhhHHHHHHHHHHHHHHhhcCCCCCeeeecccCCceeeCCCCcEEEeeeccccc
Q 038766 91 EYMENGSLESVIHGPGVDHSRWTLPKRIDVLISVANGLDYLHSGYDIPIVHCDMKPSNILLDRDFEAHVSDFGTSRM 167 (299)
Q Consensus 91 e~~~~~~L~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lh~~~~~~~~H~dl~~~nil~~~~~~v~l~df~~~~~ 167 (299)
||++|++|.+++... . . ....++.+++.+|.++|+. +++|+|++|.||+++ ++.++++|||.+..
T Consensus 79 e~~~G~~L~~~~~~~----~---~-~~~~i~~~i~~~l~~lH~~---~i~H~Dl~p~Nil~~-~~~~~liDf~~a~~ 143 (211)
T PRK14879 79 EYIEGEPLKDLINSN----G---M-EELELSREIGRLVGKLHSA---GIIHGDLTTSNMILS-GGKIYLIDFGLAEF 143 (211)
T ss_pred EEeCCcCHHHHHHhc----c---H-HHHHHHHHHHHHHHHHHhC---CcccCCCCcccEEEE-CCCEEEEECCcccC
Confidence 999999999988632 1 1 7889999999999999999 999999999999999 78899999998753
|
|
| >cd05144 RIO2_C RIO kinase family; RIO2, C-terminal catalytic domain | Back alignment and domain information |
|---|
Probab=99.78 E-value=2.8e-18 Score=136.09 Aligned_cols=138 Identities=26% Similarity=0.227 Sum_probs=107.8
Q ss_pred CCCCceeecCCcceEEEEEeCCCcEEEEEEeccCcCCh--------------------hhhHHHHHHHHHHHhcCCcc--
Q 038766 14 FSENNIIGNSNLSTVYKGRLEDGEIVAVKKLNFHQFSA--------------------ESDKSFYREAKTLKELKHRN-- 71 (299)
Q Consensus 14 y~~~~~lg~g~~~~v~~~~~~~~~~~~vK~~~~~~~~~--------------------~~~~~~~~e~~~l~~l~h~~-- 71 (299)
|.+.+.||+|++|.||++...+|+.+|||++....... ........|...+..+.+++
T Consensus 17 ~~~~~~i~~G~~g~Vy~~~~~~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~ 96 (198)
T cd05144 17 ESLGNQIGVGKESDVYLALDPDGNPVALKFHRLGRTSFRKVKRKRDYLGDRKHASWLYLSRLAAQKEFAALKALYEEGFP 96 (198)
T ss_pred hhcCCccccCcceEEEEEEcCCCCEEEEEEEecccchhhhhcchHHHHhccccchhHHHhHHHHHHHHHHHHHHHHcCCC
Confidence 88999999999999999988789999999976432110 01123567888888887764
Q ss_pred eeeeeeEEEcCCCeeEEEEeecCCCChHHHhcCCCCCCCCCChhhHHHHHHHHHHHHHHhhcCCCCCeeeecccCCceee
Q 038766 72 LVKVLGYAWESGKLKALILEYMENGSLESVIHGPGVDHSRWTLPKRIDVLISVANGLDYLHSGYDIPIVHCDMKPSNILL 151 (299)
Q Consensus 72 i~~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lh~~~~~~~~H~dl~~~nil~ 151 (299)
+...++ .+. .++|+||+++++|...... .....++.+++.++.++|+. +++|+||+|+||++
T Consensus 97 v~~~~~----~~~-~~lv~e~~~g~~L~~~~~~----------~~~~~~~~~i~~~l~~lh~~---gi~H~Dl~p~Nill 158 (198)
T cd05144 97 VPKPID----WNR-HAVVMEYIDGVELYRVRVL----------EDPEEVLDEILEEIVKAYKH---GIIHGDLSEFNILV 158 (198)
T ss_pred CCceee----cCC-ceEEEEEeCCcchhhcccc----------ccHHHHHHHHHHHHHHHHHC---CCCcCCCCcccEEE
Confidence 333333 222 3899999999888765420 34567889999999999998 99999999999999
Q ss_pred CCCCcEEEeeeccccccc
Q 038766 152 DRDFEAHVSDFGTSRMLD 169 (299)
Q Consensus 152 ~~~~~v~l~df~~~~~~~ 169 (299)
+.++.++|+|||.+....
T Consensus 159 ~~~~~~~liDfg~~~~~~ 176 (198)
T cd05144 159 DDDEKIYIIDWPQMVSTD 176 (198)
T ss_pred cCCCcEEEEECCccccCC
Confidence 999999999999986543
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO2 is present in archaea and eukaryotes. It contains an N-terminal winged helix (wHTH) domain and a C-terminal RIO kinase catalytic domain. The wHTH domain is primarily seen in DNA-binding proteins, although some wHTH dom |
| >TIGR03724 arch_bud32 Kae1-associated kinase Bud32 | Back alignment and domain information |
|---|
Probab=99.75 E-value=1.7e-17 Score=131.84 Aligned_cols=132 Identities=23% Similarity=0.365 Sum_probs=102.8
Q ss_pred eeecCCcceEEEEEeCCCcEEEEEEeccCcCChh------hhHHHHHHHHHHHhcCCcceeeeeeEEEcCCCeeEEEEee
Q 038766 19 IIGNSNLSTVYKGRLEDGEIVAVKKLNFHQFSAE------SDKSFYREAKTLKELKHRNLVKVLGYAWESGKLKALILEY 92 (299)
Q Consensus 19 ~lg~g~~~~v~~~~~~~~~~~~vK~~~~~~~~~~------~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~lv~e~ 92 (299)
.||+|++|.||++.+ ++..+++|+......... ...++.+|++.++.+.++++....-+..... ..++|+|+
T Consensus 1 ~ig~G~~~~vy~~~~-~~~~~viK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~p~~~~~~~~-~~~lv~e~ 78 (199)
T TIGR03724 1 LIAKGAEAIIYLGDF-LGLKAVIKERVPKSYRHPELDERIRRERTRNEARLLSRARKAGVNTPVVYDVDPD-NKTIVMEY 78 (199)
T ss_pred CCCCCceEEEEEeec-CCccEEEEEecCCcCcCchHHHHHHHHHHHHHHHHHHHHHHCCCCCCEEEEEECC-CCEEEEEE
Confidence 489999999999985 467899998653322111 1356778999999998876554444333333 34899999
Q ss_pred cCCCChHHHhcCCCCCCCCCChhhHHHHHHHHHHHHHHhhcCCCCCeeeecccCCceeeCCCCcEEEeeeccccc
Q 038766 93 MENGSLESVIHGPGVDHSRWTLPKRIDVLISVANGLDYLHSGYDIPIVHCDMKPSNILLDRDFEAHVSDFGTSRM 167 (299)
Q Consensus 93 ~~~~~L~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lh~~~~~~~~H~dl~~~nil~~~~~~v~l~df~~~~~ 167 (299)
++|++|.+++... .. .++.+++.+|.++|+. +++|+|++|.||+++ ++.++++|||++..
T Consensus 79 ~~g~~l~~~~~~~----~~-------~~~~~i~~~l~~lH~~---gi~H~Dl~~~Nil~~-~~~~~liDfg~a~~ 138 (199)
T TIGR03724 79 IEGKPLKDVIEEG----ND-------ELLREIGRLVGKLHKA---GIVHGDLTTSNIIVR-DDKLYLIDFGLGKY 138 (199)
T ss_pred ECCccHHHHHhhc----HH-------HHHHHHHHHHHHHHHC---CeecCCCCcceEEEE-CCcEEEEECCCCcC
Confidence 9999999887522 11 7889999999999999 999999999999999 88999999998754
|
Members of this protein family are the Bud32 protein associated with Kae1 (kinase-associated endopeptidase 1) in the Archaea. In many Archaeal genomes, Kae1 and Bud32 are fused. The complex is homologous to the Kae1 and Bud32 subunits of the eukaryotic KEOPS complex, an apparently ancient protein kinase-containing molecular machine. |
| >KOG1033 consensus eIF-2alpha kinase PEK/EIF2AK3 [Translation, ribosomal structure and biogenesis] | Back alignment and domain information |
|---|
Probab=99.74 E-value=1.2e-18 Score=149.16 Aligned_cols=126 Identities=25% Similarity=0.416 Sum_probs=106.3
Q ss_pred eeEEEEeecCCCChHHHhcCCCCCCCCCChhhHHHHHHHHHHHHHHhhcCCCCCeeeecccCCceeeCCCCcEEEeeecc
Q 038766 85 LKALILEYMENGSLESVIHGPGVDHSRWTLPKRIDVLISVANGLDYLHSGYDIPIVHCDMKPSNILLDRDFEAHVSDFGT 164 (299)
Q Consensus 85 ~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lh~~~~~~~~H~dl~~~nil~~~~~~v~l~df~~ 164 (299)
++++.|+++...+|.+++.... .....+......++.|++.++.| + +.+|+|+||.||+...+..++|+|||+
T Consensus 330 ~lyI~Mn~c~~~tledWl~rr~-~~e~~s~s~~~~~~~q~~~~~~y---k---~~ihrdlkp~nif~~~d~q~kIgDFgl 402 (516)
T KOG1033|consen 330 YLYIQMNLCEKETLEDWLRRRR-TGEERSLSLMLDIFKQIAPAVEY---K---GLIHRDLKPSNIFFSDDDQLKIGDFGL 402 (516)
T ss_pred chhhhhhhhhhhhHHHHhhCCC-cccccchhHHHHHHHhhccchhh---c---cchhhhccccccccccchhhhhhhhhh
Confidence 4689999999999999997543 34456777889999999999999 6 999999999999999999999999999
Q ss_pred cccccccccc--ccccccccccCcccCChhhhcccCcCccccchhhhHHHHHHHh
Q 038766 165 SRMLDVHLQD--LSSLSTAFQGTIGYLAPEFAYMRIVTTKVDVFSFGIVVMEFLT 217 (299)
Q Consensus 165 ~~~~~~~~~~--~~~~~~~~~~~~~y~~PE~~~~~~~~~~~DiwslG~~l~~l~~ 217 (299)
.......... .........+|..|++||++.+..|+.+.|||+||+++++++.
T Consensus 403 ~ts~~~~~~~~~~~a~~t~~~gt~~YmsPEQi~g~~y~~kvdIyaLGlil~EL~~ 457 (516)
T KOG1033|consen 403 VTSQDKDETVAPAAASHTQQVGTLLYMSPEQIRGQQYSEKVDIYALGLILAELLI 457 (516)
T ss_pred eeecccCCcccchhhhhhhcccccccCCHHHHhhhhhhhhcchhhHHHHHHHHHH
Confidence 9865532211 1223456678999999999999999999999999999999997
|
|
| >KOG0606 consensus Microtubule-associated serine/threonine kinase and related proteins [Signal transduction mechanisms; General function prediction only] | Back alignment and domain information |
|---|
Probab=99.74 E-value=9.2e-19 Score=160.22 Aligned_cols=214 Identities=24% Similarity=0.348 Sum_probs=145.7
Q ss_pred HhCCCCCCceeecCCcceEEEEEeCC-CcEEEEEEeccCcCChhhhHHHHHHHHHHHhcCCcceeeeeeEEEcCCCeeEE
Q 038766 10 ATGSFSENNIIGNSNLSTVYKGRLED-GEIVAVKKLNFHQFSAESDKSFYREAKTLKELKHRNLVKVLGYAWESGKLKAL 88 (299)
Q Consensus 10 ~~~~y~~~~~lg~g~~~~v~~~~~~~-~~~~~vK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~l 88 (299)
..++|...+.+..|++|.||+++++. .+++|.|+ +... .+++ ||..+-+ +. ++
T Consensus 81 ~e~df~~IklisngAygavylvrh~~trqrfa~ki-Nkq~-------------lilR-----nilt~a~------np-fv 134 (1205)
T KOG0606|consen 81 SESDFNTIKLISNGAYGAVYLVRHKETRQRFAMKI-NKQN-------------LILR-----NILTFAG------NP-FV 134 (1205)
T ss_pred CccccceeEeeccCCCCceeeeeccccccchhhcc-cccc-------------hhhh-----ccccccC------Cc-ce
Confidence 45789999999999999999998763 67888853 2111 1111 1221111 11 23
Q ss_pred EEeecCCCChHHHhcCCCCCCCCCChhhHHHHHHHHHHHHHHhhcCCCCCeeeecccCCceeeCCCCcEEEeeecccccc
Q 038766 89 ILEYMENGSLESVIHGPGVDHSRWTLPKRIDVLISVANGLDYLHSGYDIPIVHCDMKPSNILLDRDFEAHVSDFGTSRML 168 (299)
Q Consensus 89 v~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lh~~~~~~~~H~dl~~~nil~~~~~~v~l~df~~~~~~ 168 (299)
| |+=..+++ .-.+++. +++.+++|||+. +++|+|+||+|.+|+.-|.+|++|||++..-
T Consensus 135 v------gDc~tllk----~~g~lPv--------dmvla~Eylh~y---givhrdlkpdnllIT~mGhiKlTDfgLsk~G 193 (1205)
T KOG0606|consen 135 V------GDCATLLK----NIGPLPV--------DMVLAVEYLHSY---GIVHRDLKPDNLLITSMGHIKLTDFGLSKKG 193 (1205)
T ss_pred e------chhhhhcc----cCCCCcc--------hhhHHhHhhccC---CeecCCCCCCcceeeecccccccchhhhhhh
Confidence 3 23233343 2234454 348899999999 9999999999999999999999999998743
Q ss_pred cccc-cc---------ccc-cccccccCcccCChhhhcccCcCccccchhhhHHHHHHHhCCCCCCCCccCCCCchhHHH
Q 038766 169 DVHL-QD---------LSS-LSTAFQGTIGYLAPEFAYMRIVTTKVDVFSFGIVVMEFLTKRRPTGLDEENGLSPISLRQ 237 (299)
Q Consensus 169 ~~~~-~~---------~~~-~~~~~~~~~~y~~PE~~~~~~~~~~~DiwslG~~l~~l~~g~~p~~~~~~~~~~~~~~~~ 237 (299)
.... .+ ..+ ..++..+|+.|.|||++.-.+|....|=|+||+++|+.+-|+.||..+..+.+ +..
T Consensus 194 Lms~atnl~eg~I~k~t~Ef~dKqvcgTPeyiaPeVilrqgygkpvdwwamGiIlyeFLVgcvpffGdtpeel----fg~ 269 (1205)
T KOG0606|consen 194 LMSLATNLKEGHIEKDTHEFQDKQVCGTPEYIAPEVILRQGYGKPVDWWAMGIILYEFLVGCVPFFGDTPEEL----FGQ 269 (1205)
T ss_pred hhhccchhhhcchHHHHHHhhhccccCCccccChhhhhhhccCCCccHHHHHHHHHHHheeeeeccCCCHHHH----Hhh
Confidence 2110 00 001 12456789999999999999999999999999999999999999976644322 222
Q ss_pred HHHHHHhcCccCcccccCccccchhhHhHHHHHHHHHHHHHHHHhcCCCCCCCCCh
Q 038766 238 LVEKALANGINGVRQITDPKLVSSIYEEQEQHQVLEELFKLALVCTSSNPEDRPNM 293 (299)
Q Consensus 238 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rpt~ 293 (299)
++...+ .+.+. ....+.+++++|.++|..+|..|.-.
T Consensus 270 visd~i--------~wpE~-----------dea~p~Ea~dli~~LL~qnp~~Rlgt 306 (1205)
T KOG0606|consen 270 VISDDI--------EWPEE-----------DEALPPEAQDLIEQLLRQNPLCRLGT 306 (1205)
T ss_pred hhhhhc--------ccccc-----------CcCCCHHHHHHHHHHHHhChHhhccc
Confidence 222111 11110 22334689999999999999998654
|
|
| >PRK09605 bifunctional UGMP family protein/serine/threonine protein kinase; Validated | Back alignment and domain information |
|---|
Probab=99.73 E-value=3.1e-17 Score=148.97 Aligned_cols=139 Identities=21% Similarity=0.304 Sum_probs=108.6
Q ss_pred hCCCCCCceeecCCcceEEEEEeCCCcEEEEEEeccCcCC------hhhhHHHHHHHHHHHhcCCcceeeeeeEEEcCCC
Q 038766 11 TGSFSENNIIGNSNLSTVYKGRLEDGEIVAVKKLNFHQFS------AESDKSFYREAKTLKELKHRNLVKVLGYAWESGK 84 (299)
Q Consensus 11 ~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~vK~~~~~~~~------~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~ 84 (299)
...|...+.||+|++|+||++.+... .+++|+....... ....+++.+|++.++.++|+++.....+.....
T Consensus 332 ~~~~~~~~~iG~G~~g~Vy~~~~~~~-~~v~k~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~p~~~~~~~~- 409 (535)
T PRK09605 332 KRRKIPDHLIGKGAEADIKKGEYLGR-DAVIKERVPKGYRHPELDERLRTERTRAEARLLSEARRAGVPTPVIYDVDPE- 409 (535)
T ss_pred ccccCccceeccCCcEEEEEEeecCc-cceeEEEecccccchhHHHHHHHHHHHHHHHHHHhhcccCCCeeEEEEEeCC-
Confidence 34556789999999999999987543 3444543221111 112356889999999999999887766555433
Q ss_pred eeEEEEeecCCCChHHHhcCCCCCCCCCChhhHHHHHHHHHHHHHHhhcCCCCCeeeecccCCceeeCCCCcEEEeeecc
Q 038766 85 LKALILEYMENGSLESVIHGPGVDHSRWTLPKRIDVLISVANGLDYLHSGYDIPIVHCDMKPSNILLDRDFEAHVSDFGT 164 (299)
Q Consensus 85 ~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lh~~~~~~~~H~dl~~~nil~~~~~~v~l~df~~ 164 (299)
..++|+||+++++|.+++. ....++.+++.+|.+||+. +++|||+||+||++ .++.++|+|||+
T Consensus 410 ~~~lv~E~~~g~~L~~~l~------------~~~~~~~~i~~~L~~lH~~---giiHrDlkp~NILl-~~~~~~liDFGl 473 (535)
T PRK09605 410 EKTIVMEYIGGKDLKDVLE------------GNPELVRKVGEIVAKLHKA---GIVHGDLTTSNFIV-RDDRLYLIDFGL 473 (535)
T ss_pred CCEEEEEecCCCcHHHHHH------------HHHHHHHHHHHHHHHHHhC---CCccCCCChHHEEE-ECCcEEEEeCcc
Confidence 3489999999999998874 3467899999999999999 99999999999999 677899999999
Q ss_pred ccc
Q 038766 165 SRM 167 (299)
Q Consensus 165 ~~~ 167 (299)
+..
T Consensus 474 a~~ 476 (535)
T PRK09605 474 GKY 476 (535)
T ss_pred ccc
Confidence 864
|
|
| >KOG0590 consensus Checkpoint kinase and related serine/threonine protein kinases [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.72 E-value=4.1e-19 Score=160.97 Aligned_cols=260 Identities=25% Similarity=0.295 Sum_probs=193.9
Q ss_pred hCCCCCCceeecCCcceEEEEEeCC--CcEEEEEEeccCcCChhhhHHHHHHHHHHHhcC-CcceeeeeeEEEcCCCeeE
Q 038766 11 TGSFSENNIIGNSNLSTVYKGRLED--GEIVAVKKLNFHQFSAESDKSFYREAKTLKELK-HRNLVKVLGYAWESGKLKA 87 (299)
Q Consensus 11 ~~~y~~~~~lg~g~~~~v~~~~~~~--~~~~~vK~~~~~~~~~~~~~~~~~e~~~l~~l~-h~~i~~~~~~~~~~~~~~~ 87 (299)
...|.+.+.||+|+++.|-.+.... ...++.|.+...........++..|..+-+.+. |+|++.+++ ........+
T Consensus 19 ~~~~~~~~~ig~gs~~~~~~~~~~~~~~~~~a~~~~s~~~~~~~~~~~i~~e~~~~~~~s~h~n~~~~~~-~~~~~~~~~ 97 (601)
T KOG0590|consen 19 NSQYKLSRSIGKGSFSSSALASNSRDPESSSATKPISIPPKSEDSSEHIDTETDIQKKLSKHSNTVHMIE-PSSSPRSYL 97 (601)
T ss_pred cccccccccccccccchhhhhhhcCCCcceeeccCCCCCCCccchhhhcCccccccccccccccccccCC-ccCCCcccc
Confidence 4578899999999999998887533 445666666544444555667777888888887 999999999 455566668
Q ss_pred EEEeecCCCChHHHhcCCCCCCCCCChhhHHHHHHHHHHHHHHhh-cCCCCCeeeecccCCceeeCCCC-cEEEeeeccc
Q 038766 88 LILEYMENGSLESVIHGPGVDHSRWTLPKRIDVLISVANGLDYLH-SGYDIPIVHCDMKPSNILLDRDF-EAHVSDFGTS 165 (299)
Q Consensus 88 lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lh-~~~~~~~~H~dl~~~nil~~~~~-~v~l~df~~~ 165 (299)
+..++..++++.+.+... +....+...+-.++.|+..++.|+| .. +++|+|++|+|.+++..+ .+++.|||++
T Consensus 98 ~~~~~s~g~~~f~~i~~~--~~~~~~~~~~~~~~~ql~s~l~~~H~~~---~~~h~~ikP~n~~l~~s~~~l~~~df~~A 172 (601)
T KOG0590|consen 98 LSLSYSDGGSLFSKISHP--DSTGTSSSSASRYLPQLNSGLSYLHPEN---GVTHRDIKPSNSLLDESGSALKIADFGLA 172 (601)
T ss_pred cccCcccccccccccccC--CccCCCCcchhhhhhhhccCccccCccc---ccccCCCCCccchhccCCCcccCCCchhh
Confidence 999999899998877311 3336777788899999999999999 77 999999999999999999 9999999999
Q ss_pred ccccccccccccccccccc-CcccCChhhhccc-CcCccccchhhhHHHHHHHhCCCCCCCCccCCCCchhHHHHHHHHH
Q 038766 166 RMLDVHLQDLSSLSTAFQG-TIGYLAPEFAYMR-IVTTKVDVFSFGIVVMEFLTKRRPTGLDEENGLSPISLRQLVEKAL 243 (299)
Q Consensus 166 ~~~~~~~~~~~~~~~~~~~-~~~y~~PE~~~~~-~~~~~~DiwslG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~ 243 (299)
..+..... .........+ ++.|.|||...+. ......|+||.|+++..+++|..|+............+.+.-
T Consensus 173 t~~~~~~g-~~~~~~~~~g~s~~y~a~E~~~~~~~~~~~~d~~S~g~~l~~~~~g~~p~~~~~~~~~~~~~~~~~~---- 247 (601)
T KOG0590|consen 173 TAYRNKNG-AERSLKDRCGSSPPYGAPEHLSGKAYRGPSVDVWSLGIVLSAMLTGELPWDFPSRKDGRYSSWKSNK---- 247 (601)
T ss_pred ccccccCC-cceeeecccCCCCCCCCcccccchhhcCCCcccccccccccccccCCCCccccccccccceeecccc----
Confidence 97764222 1222334445 8999999998884 456789999999999999999999876544332211111100
Q ss_pred hcCccCcccccCccccchhhHhHHHHHHHHHHHHHHHHhcCCCCCCCCChhhhhc
Q 038766 244 ANGINGVRQITDPKLVSSIYEEQEQHQVLEELFKLALVCTSSNPEDRPNMNELLI 298 (299)
Q Consensus 244 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rpt~~~il~ 298 (299)
. ..........+....+++.+++..+|+.|.+.+++-.
T Consensus 248 -------------~----~~~~~~~~~~~~~~~~~l~k~l~~~~~~r~s~~~~~~ 285 (601)
T KOG0590|consen 248 -------------G----RFTQLPWNSISDQAHDLLHKILKENPSNRLSIEELKL 285 (601)
T ss_pred -------------c----ccccCccccCChhhhhcccccccCCchhccccccccc
Confidence 0 0001113344567888999999999999999998754
|
|
| >cd05119 RIO RIO kinase family, catalytic domain | Back alignment and domain information |
|---|
Probab=99.72 E-value=8.1e-17 Score=126.63 Aligned_cols=139 Identities=23% Similarity=0.269 Sum_probs=98.4
Q ss_pred CCceeecCCcceEEEEEeCCCcEEEEEEeccCcCChhhhHH----------------------HHHHHHHHHhcCCcc--
Q 038766 16 ENNIIGNSNLSTVYKGRLEDGEIVAVKKLNFHQFSAESDKS----------------------FYREAKTLKELKHRN-- 71 (299)
Q Consensus 16 ~~~~lg~g~~~~v~~~~~~~~~~~~vK~~~~~~~~~~~~~~----------------------~~~e~~~l~~l~h~~-- 71 (299)
+.+.||+|++|+||++.+.+++.||+|++............ ...|...+..+.+..
T Consensus 1 ~~~~lg~G~~g~Vy~a~~~~~~~vavKv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~~ 80 (187)
T cd05119 1 VGGPIGTGKEADVYLALDGDGEPVAVKIYRTGRTSFKKRKRYRTGDYRFGRKKSNWRYLSRLWAEKEFRNLKRLYEAGVP 80 (187)
T ss_pred CCcccccccceeEEEEECCCCCEEEEEEEecCccchhhhhhhhHHHHHhccCCcchhhhhhHHHHHHHHHHHHHHHcCCC
Confidence 35789999999999999888999999998643322111111 134556666654332
Q ss_pred eeeeeeEEEcCCCeeEEEEeecCCCChH-HHhcCCCCCCCCCChhhHHHHHHHHHHHHHHhhc-CCCCCeeeecccCCce
Q 038766 72 LVKVLGYAWESGKLKALILEYMENGSLE-SVIHGPGVDHSRWTLPKRIDVLISVANGLDYLHS-GYDIPIVHCDMKPSNI 149 (299)
Q Consensus 72 i~~~~~~~~~~~~~~~lv~e~~~~~~L~-~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lh~-~~~~~~~H~dl~~~ni 149 (299)
+.++++. . ..++|+||++++.+. ..+... ... .++..++.+++.++.++|. . +++|+||+|+||
T Consensus 81 ~~~~~~~----~-~~~lv~e~~~g~~~~~~~l~~~-----~~~-~~~~~~~~~~~~~l~~lh~~~---~ivH~Dl~p~Ni 146 (187)
T cd05119 81 VPKPIDL----N-RHVLVMEFIGGDGIPAPRLKDV-----RLL-EDPEELYDQILELMRKLYREA---GLVHGDLSEYNI 146 (187)
T ss_pred CCceEec----C-CCEEEEEEeCCCCccChhhhhh-----hhc-ccHHHHHHHHHHHHHHHhhcc---CcCcCCCChhhE
Confidence 3444432 1 238999999884432 112110 011 6778999999999999999 8 999999999999
Q ss_pred eeCCCCcEEEeeeccccccc
Q 038766 150 LLDRDFEAHVSDFGTSRMLD 169 (299)
Q Consensus 150 l~~~~~~v~l~df~~~~~~~ 169 (299)
+++ ++.++++|||.+....
T Consensus 147 li~-~~~~~liDfg~a~~~~ 165 (187)
T cd05119 147 LVD-DGKVYIIDVPQAVEID 165 (187)
T ss_pred EEE-CCcEEEEECccccccc
Confidence 999 8899999999986543
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases present in archaea, bacteria and eukaryotes. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. RIO kinases contain a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. Most organisms contain at least two RIO kinases, RIO1 and RIO2. A third protein, RIO3, is present in multicellular eukaryotes. In yeast, RIO1 and RIO2 are essential for survival. They funct |
| >PRK01723 3-deoxy-D-manno-octulosonic-acid kinase; Reviewed | Back alignment and domain information |
|---|
Probab=99.71 E-value=2.1e-16 Score=128.38 Aligned_cols=138 Identities=16% Similarity=0.235 Sum_probs=104.9
Q ss_pred Cceee-cCCcceEEEEEeCCCcEEEEEEeccCcC-----------ChhhhHHHHHHHHHHHhcCCcce--eeeeeEEEcC
Q 038766 17 NNIIG-NSNLSTVYKGRLEDGEIVAVKKLNFHQF-----------SAESDKSFYREAKTLKELKHRNL--VKVLGYAWES 82 (299)
Q Consensus 17 ~~~lg-~g~~~~v~~~~~~~~~~~~vK~~~~~~~-----------~~~~~~~~~~e~~~l~~l~h~~i--~~~~~~~~~~ 82 (299)
...|| .|+.|+||.+... +..++||.+..... .......+.+|+..+..+.|+++ +..+++....
T Consensus 36 ~~~lg~~~g~gtv~~v~~~-~~~~vlk~~~r~~~i~kv~~~~~~~~~~~~~r~~rE~~ll~~L~~~gi~vP~pl~~~~~~ 114 (239)
T PRK01723 36 ARVVGSAKGRGTTWFVQTP-GVNWVLRHYRRGGLIGKLSKDRYLFTGLERTRAFAEFRLLAQLYEAGLPVPRPIAARVVR 114 (239)
T ss_pred CceeecCCCCccEEEEEeC-CceEEEEEeeEcchHHhhhhhcccccchhhhHHHHHHHHHHHHHhCCCCCceeEeeeeee
Confidence 45687 8999999999875 77889998753211 11234678889999999998775 5666644333
Q ss_pred CCee---EEEEeecCC-CChHHHhcCCCCCCCCCChhhHHHHHHHHHHHHHHhhcCCCCCeeeecccCCceeeCCCCcEE
Q 038766 83 GKLK---ALILEYMEN-GSLESVIHGPGVDHSRWTLPKRIDVLISVANGLDYLHSGYDIPIVHCDMKPSNILLDRDFEAH 158 (299)
Q Consensus 83 ~~~~---~lv~e~~~~-~~L~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lh~~~~~~~~H~dl~~~nil~~~~~~v~ 158 (299)
.... ++|+|++++ .+|..++.. .++++. .+.+++.++.+||++ +++|+||||.|||++.++.++
T Consensus 115 ~~~~~~~~lV~e~l~G~~~L~~~l~~-----~~l~~~----~~~~i~~~l~~lH~~---GI~HrDlkp~NILv~~~~~v~ 182 (239)
T PRK01723 115 HGLFYRADILIERIEGARDLVALLQE-----APLSEE----QWQAIGQLIARFHDA---GVYHADLNAHNILLDPDGKFW 182 (239)
T ss_pred cCcceeeeEEEEecCCCCCHHHHHhc-----CCCCHH----HHHHHHHHHHHHHHC---CCCCCCCCchhEEEcCCCCEE
Confidence 3222 499999987 688888752 244443 356899999999999 999999999999999999999
Q ss_pred Eeeeccccc
Q 038766 159 VSDFGTSRM 167 (299)
Q Consensus 159 l~df~~~~~ 167 (299)
|+|||.+..
T Consensus 183 LIDfg~~~~ 191 (239)
T PRK01723 183 LIDFDRGEL 191 (239)
T ss_pred EEECCCccc
Confidence 999998764
|
|
| >cd05120 APH_ChoK_like Aminoglycoside 3'-phosphotransferase (APH) and Choline Kinase (ChoK) family | Back alignment and domain information |
|---|
Probab=99.65 E-value=2.7e-15 Score=113.52 Aligned_cols=135 Identities=22% Similarity=0.222 Sum_probs=107.0
Q ss_pred CCceeecCCcceEEEEEeCCCcEEEEEEeccCcCChhhhHHHHHHHHHHHhcCC--cceeeeeeEEEcCCCeeEEEEeec
Q 038766 16 ENNIIGNSNLSTVYKGRLEDGEIVAVKKLNFHQFSAESDKSFYREAKTLKELKH--RNLVKVLGYAWESGKLKALILEYM 93 (299)
Q Consensus 16 ~~~~lg~g~~~~v~~~~~~~~~~~~vK~~~~~~~~~~~~~~~~~e~~~l~~l~h--~~i~~~~~~~~~~~~~~~lv~e~~ 93 (299)
+++.||+|.++.||++...+ ..+++|....... ...+..|...++.+++ ..+.+++..... ++..++++||+
T Consensus 2 ~~~~i~~g~~~~v~~~~~~~-~~~~iK~~~~~~~----~~~~~~e~~~~~~l~~~~~~~p~~~~~~~~-~~~~~~v~e~~ 75 (155)
T cd05120 2 SIKLLKGGLTNRVYLLGTKD-EDYVLKINPSREK----GADREREVAILQLLARKGLPVPKVLASGES-DGWSYLLMEWI 75 (155)
T ss_pred cceecccccccceEEEEecC-CeEEEEecCCCCc----hhHHHHHHHHHHHHHHcCCCCCeEEEEcCC-CCccEEEEEec
Confidence 46789999999999999854 7899998753321 5678889999999976 478888774433 35569999999
Q ss_pred CCCChHHHhcCCCCCCCCCChhhHHHHHHHHHHHHHHhhcCCCCCeeeecccCCceeeCCCCcEEEeeeccccc
Q 038766 94 ENGSLESVIHGPGVDHSRWTLPKRIDVLISVANGLDYLHSGYDIPIVHCDMKPSNILLDRDFEAHVSDFGTSRM 167 (299)
Q Consensus 94 ~~~~L~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lh~~~~~~~~H~dl~~~nil~~~~~~v~l~df~~~~~ 167 (299)
.+..+..+ +......++.+++.+++.+|.....+++|+|++|.||+++..+.++++||+.+..
T Consensus 76 ~g~~~~~~-----------~~~~~~~~~~~~~~~l~~lh~~~~~~i~H~Dl~~~Nil~~~~~~~~l~Df~~~~~ 138 (155)
T cd05120 76 EGETLDEV-----------SEEEKEDIAEQLAELLAKLHQLPLLVLCHGDLHPGNILVDDGKILGIIDWEYAGY 138 (155)
T ss_pred CCeecccC-----------CHHHHHHHHHHHHHHHHHHhCCCceEEEecCCCcceEEEECCcEEEEEecccccC
Confidence 87655432 4455677889999999999986223699999999999999989999999998753
|
The APH/ChoK family is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). The family is composed of APH, ChoK, ethanolamine kinase (ETNK), macrolide 2'-phosphotransferase (MPH2'), an unusual homoserine kinase, and uncharacterized proteins with similarity to the N-terminal domain of acyl-CoA dehydrogenase 10 (ACAD10). The members of this family catalyze the transfer of the gamma-phosphoryl group from ATP (or CTP) to small molecule substrates such as aminoglycosides, macrolides, choline, ethanolamine, and homoserine. Phosphorylation of the antibiotics, aminoglycosides and macrolides, leads to their inactivation and to bacterial antibiotic resistance. Phosphorylation of choline, ethanolamine, and homoserine serves |
| >KOG1243 consensus Protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=99.62 E-value=9.3e-15 Score=128.96 Aligned_cols=167 Identities=18% Similarity=0.177 Sum_probs=128.6
Q ss_pred eCCCcEEEEEEeccCcCChhhhHHHHHHHHHHHhcCCcceeeeeeEEEcCCCeeEEEEeecCCCChHHHhcCCCCCCCCC
Q 038766 33 LEDGEIVAVKKLNFHQFSAESDKSFYREAKTLKELKHRNLVKVLGYAWESGKLKALILEYMENGSLESVIHGPGVDHSRW 112 (299)
Q Consensus 33 ~~~~~~~~vK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~ 112 (299)
..++.++.|.....+.. .....+.+-++.++.++||+|+++++ +++.....|+|+|-+ ..|...+++ +
T Consensus 34 k~~~~~vsVF~~~~~~~--~~~~~~~~A~k~lKtlRHP~Il~yL~-t~e~~~~~ylvTErV--~Pl~~~lk~-------l 101 (690)
T KOG1243|consen 34 KADGGPVSVFVYKRSNG--EVTELAKRAVKRLKTLRHPNILSYLD-TTEEEGTLYLVTERV--RPLETVLKE-------L 101 (690)
T ss_pred eccCCceEEEEEeCCCc--hhhHHHHHHHHHhhhccCchhhhhhh-hhcccCceEEEeecc--ccHHHHHHH-------h
Confidence 45688888888764332 55667888899999999999999999 555566779999998 388888863 3
Q ss_pred ChhhHHHHHHHHHHHHHHhhcCCCCCeeeecccCCceeeCCCCcEEEeeeccccccccccccccccccccccCcccCChh
Q 038766 113 TLPKRIDVLISVANGLDYLHSGYDIPIVHCDMKPSNILLDRDFEAHVSDFGTSRMLDVHLQDLSSLSTAFQGTIGYLAPE 192 (299)
Q Consensus 113 ~~~~~~~i~~qi~~~l~~lh~~~~~~~~H~dl~~~nil~~~~~~v~l~df~~~~~~~~~~~~~~~~~~~~~~~~~y~~PE 192 (299)
....+..-+.||+.||.+||+. .+++|+|++.+.|+|+..|.+||++|.++........ ..........|..|+
T Consensus 102 ~~~~v~~Gl~qIl~AL~FL~~d--~~lvHgNv~~~SVfVn~~GeWkLggle~v~~~~~~~~----~~~~~~~~~s~~~P~ 175 (690)
T KOG1243|consen 102 GKEEVCLGLFQILAALSFLNDD--CNLVHGNVCKDSVFVNESGEWKLGGLELVSKASGFNA----PAKSLYLIESFDDPE 175 (690)
T ss_pred HHHHHHHHHHHHHHHHHHHhcc--CCeeeccEeeeeEEEcCCCcEEEeeeEEEeccccCCc----ccccchhhhcccChh
Confidence 4778888999999999999865 3999999999999999999999999999875442221 111222233566676
Q ss_pred hhcccCcCccccchhhhHHHHHHHhCC
Q 038766 193 FAYMRIVTTKVDVFSFGIVVMEFLTKR 219 (299)
Q Consensus 193 ~~~~~~~~~~~DiwslG~~l~~l~~g~ 219 (299)
...... ...|.|.|||+.++++.|.
T Consensus 176 ~~~~s~--~s~D~~~Lg~li~el~ng~ 200 (690)
T KOG1243|consen 176 EIDPSE--WSIDSWGLGCLIEELFNGS 200 (690)
T ss_pred hcCccc--cchhhhhHHHHHHHHhCcc
Confidence 544333 4569999999999999993
|
|
| >KOG0601 consensus Cyclin-dependent kinase WEE1 [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.60 E-value=1.8e-15 Score=131.87 Aligned_cols=257 Identities=23% Similarity=0.223 Sum_probs=189.9
Q ss_pred HHhCCCCCCceeec--CCcceEEEEEe---CCCcEEEEEEeccCcCChhhhHHHHHHHHHHHhcC-CcceeeeeeEEEcC
Q 038766 9 NATGSFSENNIIGN--SNLSTVYKGRL---EDGEIVAVKKLNFHQFSAESDKSFYREAKTLKELK-HRNLVKVLGYAWES 82 (299)
Q Consensus 9 ~~~~~y~~~~~lg~--g~~~~v~~~~~---~~~~~~~vK~~~~~~~~~~~~~~~~~e~~~l~~l~-h~~i~~~~~~~~~~ 82 (299)
.....+.+...+|. |.+|.+|.+.. .++..+|+|.-......+....+-.+|+...+++. |++.++... .+..
T Consensus 111 ~~~~~~~~~~~~g~~~g~~~s~~~~~~~~~~s~~~~a~k~s~~p~s~p~~~~~k~~~~~s~~~i~~~~~~v~~~~-~~e~ 189 (524)
T KOG0601|consen 111 FFDQRFPISSRTGSLPGSKGSVFKSRCTNSESPHKFAVKKSKIPFSPPLDSKRKLREFLSHHKIDSHENPVRDSP-AWEG 189 (524)
T ss_pred hhhhhcccccccccCCCCCceeecccCCcccCCcccccccccCCCCCccccccccchhhcccccCccccccccCc-cccc
Confidence 45567888999999 99999999975 45888999986555544555556667777777775 899888666 5666
Q ss_pred CCeeEEEEeecCCCChHHHhcCCCCCCCCCChhhHHHHHHHHHH----HHHHhhcCCCCCeeeecccCCceeeCCC-CcE
Q 038766 83 GKLKALILEYMENGSLESVIHGPGVDHSRWTLPKRIDVLISVAN----GLDYLHSGYDIPIVHCDMKPSNILLDRD-FEA 157 (299)
Q Consensus 83 ~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~i~~qi~~----~l~~lh~~~~~~~~H~dl~~~nil~~~~-~~v 157 (299)
+..+++-+|.+ +.+|..+... ....+++..++..+.+..+ |+..+|.. +++|.|++|.||+...+ ...
T Consensus 190 ~~~lfiqtE~~-~~sl~~~~~~---~~~~~p~~~l~~~~~~~~~~~~~al~~~hs~---~~~~~~~kp~~i~~~~~~~s~ 262 (524)
T KOG0601|consen 190 SGILFIQTELC-GESLQSYCHT---PCNFLPDNLLWNSLRDWLSRDVTALSHLHSN---NIVHDDLKPANIFTTSDWTSC 262 (524)
T ss_pred CCcceeeeccc-cchhHHhhhc---ccccCCchhhhhHHhhhhhcccccccccCCC---cccccccchhheeccccccee
Confidence 77889999999 5677776653 3345889999999999999 99999999 99999999999999999 888
Q ss_pred EEeeecccccccccc-ccccccccccccCcccCChhhhcccCcCccccchhhhHHHHHHHhCCCCCCCCccCCCCchhHH
Q 038766 158 HVSDFGTSRMLDVHL-QDLSSLSTAFQGTIGYLAPEFAYMRIVTTKVDVFSFGIVVMEFLTKRRPTGLDEENGLSPISLR 236 (299)
Q Consensus 158 ~l~df~~~~~~~~~~-~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~DiwslG~~l~~l~~g~~p~~~~~~~~~~~~~~~ 236 (299)
+++|||+...+.... ...........+...|++||...+. ++..+|+++||.+..+-..+..+........
T Consensus 263 ~~~df~~v~~i~~~~~~~~~~~~~r~~~~~~Y~~ke~~~~l-~~~~~di~sl~ev~l~~~l~~~~~~~g~~~~------- 334 (524)
T KOG0601|consen 263 KLTDFGLVSKISDGNFSSVFKVSKRPEGDCIYAAKELLNGL-ATFASDIFSLGEVILEAILGSHLPSVGKNSS------- 334 (524)
T ss_pred ecCCcceeEEccCCccccceeeeecCCCCceEeChhhhccc-cchHhhhcchhhhhHhhHhhcccccCCCCCC-------
Confidence 999999998776433 1222223344677889999976654 5788999999999999888877654221111
Q ss_pred HHHHHHHhcCccCcccccCccccchhhHhHHHHHHHHHHHHHHHHhcCCCCCCCCChhhhhcC
Q 038766 237 QLVEKALANGINGVRQITDPKLVSSIYEEQEQHQVLEELFKLALVCTSSNPEDRPNMNELLIT 299 (299)
Q Consensus 237 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rpt~~~il~~ 299 (299)
|.+.+.+..+ ...-.+.+..+...+.+|+..+|-.|++++.++.+
T Consensus 335 ----------W~~~r~~~ip--------~e~~~~~s~~l~~~~~~~~d~~~~~~~~~q~~~~l 379 (524)
T KOG0601|consen 335 ----------WSQLRQGYIP--------LEFCEGGSSSLRSVTSQMLDEDPRLRLTAQILTAL 379 (524)
T ss_pred ----------ccccccccCc--------hhhhcCcchhhhhHHHHhcCcchhhhhHHHHHhcc
Confidence 1111111110 01122334566679999999999999999988754
|
|
| >TIGR01982 UbiB 2-polyprenylphenol 6-hydroxylase | Back alignment and domain information |
|---|
Probab=99.58 E-value=2.2e-14 Score=126.45 Aligned_cols=152 Identities=24% Similarity=0.310 Sum_probs=104.3
Q ss_pred HHHHhCCCCCCceeecCCcceEEEEEeCCCcEEEEEEeccCcCChhh---------------------------------
Q 038766 7 IENATGSFSENNIIGNSNLSTVYKGRLEDGEIVAVKKLNFHQFSAES--------------------------------- 53 (299)
Q Consensus 7 ~~~~~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~vK~~~~~~~~~~~--------------------------------- 53 (299)
++.+...|. .+.||+|++|.||+|+..+|+.||||+.+... ....
T Consensus 113 ~~~~F~~fd-~~plasaSigQVh~A~l~~G~~VaVKv~rp~i-~~~i~~Dl~~l~~~~~~~~~~~~~~~~~~~~~~~~e~ 190 (437)
T TIGR01982 113 LEELFAEFE-EKPLAAASIAQVHRARLVDGKEVAVKVLRPGI-EKTIAADIALLYRLARIVERLSPDSRRLRPTEVVKEF 190 (437)
T ss_pred HHHHHhhCC-CcceeeeehhheEEEEecCCCEEEEEeeCCCc-HHHHHHHHHHHHHHHHHHHHhCccccccCHHHHHHHH
Confidence 344555565 47899999999999999999999999975321 0000
Q ss_pred h------HHHHHHHHHHHhcC----CcceeeeeeEEEcCCCeeEEEEeecCCCChHHHhcCCCCCCCCCChhhHHHHHHH
Q 038766 54 D------KSFYREAKTLKELK----HRNLVKVLGYAWESGKLKALILEYMENGSLESVIHGPGVDHSRWTLPKRIDVLIS 123 (299)
Q Consensus 54 ~------~~~~~e~~~l~~l~----h~~i~~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~i~~q 123 (299)
. -.+.+|+..+.+++ +.+-+.+..++.+.....++||||++|.+|.++..... ... ....++.+
T Consensus 191 ~~~l~~Eldf~~Ea~n~~~~~~~~~~~~~v~vP~v~~~~~~~~vLvmE~i~G~~L~~~~~~~~---~~~---~~~~ia~~ 264 (437)
T TIGR01982 191 EKTLRRELDLRREAANASELGENFKNDPGVYVPEVYWDRTSERVLTMEWIDGIPLSDIAALDE---AGL---DRKALAEN 264 (437)
T ss_pred HHHHHHHHCHHHHHHHHHHHHHhcCCCCCEEeCCEehhhcCCceEEEEeECCcccccHHHHHh---cCC---CHHHHHHH
Confidence 0 01334555555552 33444555545444445689999999999987654210 111 23345555
Q ss_pred HHH-HHHHhhcCCCCCeeeecccCCceeeCCCCcEEEeeeccccccc
Q 038766 124 VAN-GLDYLHSGYDIPIVHCDMKPSNILLDRDFEAHVSDFGTSRMLD 169 (299)
Q Consensus 124 i~~-~l~~lh~~~~~~~~H~dl~~~nil~~~~~~v~l~df~~~~~~~ 169 (299)
++. .+..+|.. +++|+|++|.||+++.+|.++++|||++..+.
T Consensus 265 ~~~~~l~ql~~~---g~~H~D~hPgNilv~~~g~i~liDfG~~~~l~ 308 (437)
T TIGR01982 265 LARSFLNQVLRD---GFFHADLHPGNIFVLKDGKIIALDFGIVGRLS 308 (437)
T ss_pred HHHHHHHHHHhC---CceeCCCCcccEEECCCCcEEEEeCCCeeECC
Confidence 555 46788888 99999999999999999999999999987654
|
This model represents the enzyme (UbiB) which catalyzes the first hydroxylation step in the ubiquinone biosynthetic pathway in bacteria. It is believed that the reaction is 2-polyprenylphenol - 6-hydroxy-2-polyprenylphenol. This model finds hits primarily in the proteobacteria. The gene is also known as AarF in certain species. |
| >KOG1266 consensus Protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.56 E-value=1.9e-15 Score=122.61 Aligned_cols=210 Identities=20% Similarity=0.283 Sum_probs=141.5
Q ss_pred HHHHHHhcCCcceeeeeeEEEcC----CCeeEEEEeecCCCChHHHhcCCCCCCCCCChhhHHHHHHHHHHHHHHhhcCC
Q 038766 60 EAKTLKELKHRNLVKVLGYAWES----GKLKALILEYMENGSLESVIHGPGVDHSRWTLPKRIDVLISVANGLDYLHSGY 135 (299)
Q Consensus 60 e~~~l~~l~h~~i~~~~~~~~~~----~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lh~~~ 135 (299)
-...+..+.|.|++++..+.-+. ..-..++.||+..+++..++++.......+......+|+.||++||.|||+-
T Consensus 117 vFdnllqlvHsnlvkfH~yw~d~K~~e~~rviFiteymssgs~~~fLkrt~~~~~a~~~~~wkkw~tqIlsal~yLhs~- 195 (458)
T KOG1266|consen 117 VFDNLLQLVHSNLVKFHKYWTDKKYEEKPRVIFITEYMSSGSLKQFLKRTKKNQKALFQKAWKKWCTQILSALSYLHSC- 195 (458)
T ss_pred HHHHHHHHHHHHHHHHHHhhcccccccccceEEEEecccchhHHHHHHHHHHhhhhhhHHHHHHHHHHHHhhhhhhhcc-
Confidence 34445555688999887744321 1224678899999999999988766778899999999999999999999985
Q ss_pred CCCeeeecccCCceeeCCCCcEEEeeecccccccccccccccccc-ccccCcccCChhhhcccCcCccccchhhhHHHHH
Q 038766 136 DIPIVHCDMKPSNILLDRDFEAHVSDFGTSRMLDVHLQDLSSLST-AFQGTIGYLAPEFAYMRIVTTKVDVFSFGIVVME 214 (299)
Q Consensus 136 ~~~~~H~dl~~~nil~~~~~~v~l~df~~~~~~~~~~~~~~~~~~-~~~~~~~y~~PE~~~~~~~~~~~DiwslG~~l~~ 214 (299)
+..++|+++..+.|++..+|-+|++--.- ...........+..+ ...+.++|.+||.-........+|||++|+...+
T Consensus 196 ~PpiihgnlTc~tifiq~ngLIkig~~ap-~s~h~s~~~~~~~Ek~~~~~~~g~~a~~sg~~tn~~~a~dIy~fgmcAle 274 (458)
T KOG1266|consen 196 DPPIIHGNLTCDTIFIQHNGLIKIGSVAP-DSTHPSVNSTREAEKSVNTSLPGFSAPESGTTTNTTGASDIYKFGMCALE 274 (458)
T ss_pred CCccccCCcchhheeecCCceEEecccCc-cccchhhhhhhHhhhhccccCCccccCCcCcccccccchhhhhhhHHHHH
Confidence 66999999999999999998877642221 111111111111111 1224578999998777777889999999999999
Q ss_pred HHhCCCCCCCCccCCCCchhHHHHHHHHHhcCccCcccccCccccchhhHhHHHHHHHHHHHHHHHHhcCCCCCCCCChh
Q 038766 215 FLTKRRPTGLDEENGLSPISLRQLVEKALANGINGVRQITDPKLVSSIYEEQEQHQVLEELFKLALVCTSSNPEDRPNMN 294 (299)
Q Consensus 215 l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rpt~~ 294 (299)
|.-+..-....... ....+.+.... ....+ ..-+.+|.+|+...|..||++.
T Consensus 275 mailEiq~tnseS~----~~~ee~ia~~i-------~~len-----------------~lqr~~i~kcl~~eP~~rp~ar 326 (458)
T KOG1266|consen 275 MAILEIQSTNSESK----VEVEENIANVI-------IGLEN-----------------GLQRGSITKCLEGEPNGRPDAR 326 (458)
T ss_pred HHHheeccCCCcce----eehhhhhhhhe-------eeccC-----------------ccccCcCcccccCCCCCCcchh
Confidence 98765432211111 01111111000 00001 1124589999999999999999
Q ss_pred hhhcC
Q 038766 295 ELLIT 299 (299)
Q Consensus 295 ~il~~ 299 (299)
+++-|
T Consensus 327 ~llfH 331 (458)
T KOG1266|consen 327 LLLFH 331 (458)
T ss_pred hhhcC
Confidence 99876
|
|
| >PRK04750 ubiB putative ubiquinone biosynthesis protein UbiB; Reviewed | Back alignment and domain information |
|---|
Probab=99.55 E-value=3e-14 Score=127.11 Aligned_cols=153 Identities=24% Similarity=0.325 Sum_probs=106.7
Q ss_pred HHHHHhCCCCCCceeecCCcceEEEEEeCC-CcEEEEEEeccCcC---------------------------Ch-----h
Q 038766 6 EIENATGSFSENNIIGNSNLSTVYKGRLED-GEIVAVKKLNFHQF---------------------------SA-----E 52 (299)
Q Consensus 6 ~~~~~~~~y~~~~~lg~g~~~~v~~~~~~~-~~~~~vK~~~~~~~---------------------------~~-----~ 52 (299)
.++.+...|.. +.||+|++|.||+|+.++ |+.||||+.+.... .. +
T Consensus 114 ~~~~~F~~fd~-~PlasaSiaQVh~A~l~~~G~~VAVKV~rP~i~~~I~~Dl~~l~~~a~~l~~~~~~~~~l~~~~~v~e 192 (537)
T PRK04750 114 PVEEWFDDFDI-KPLASASIAQVHFARLKDNGREVVVKVLRPDILPVIDADLALMYRLARWVERLLPDGRRLKPREVVAE 192 (537)
T ss_pred CHHHHHHhcCh-hhhcCCCccEEEEEEECCCCCEEEEEEeCcchHHHHHHHHHHHHHHHHHHHHhCcccccCCHHHHHHH
Confidence 35667778887 899999999999999876 99999999863210 00 1
Q ss_pred hhHH------HHHHHHHHHhcC----CcceeeeeeEEEcCCCeeEEEEeecCCCChHHH--hcCCCCCCCCCChhhHHHH
Q 038766 53 SDKS------FYREAKTLKELK----HRNLVKVLGYAWESGKLKALILEYMENGSLESV--IHGPGVDHSRWTLPKRIDV 120 (299)
Q Consensus 53 ~~~~------~~~e~~~l~~l~----h~~i~~~~~~~~~~~~~~~lv~e~~~~~~L~~~--~~~~~~~~~~~~~~~~~~i 120 (299)
..+. +.+|+..+.+++ +...+.+..++++-....++||||+.|+++.+. +...+.+...+.+..+..+
T Consensus 193 ~~~~l~~ElD~~~Ea~N~~~~~~~f~~~~~v~VP~v~~d~st~~VLvmE~i~G~~l~d~~~l~~~g~d~~~la~~~v~~~ 272 (537)
T PRK04750 193 FEKTLHDELDLMREAANASQLRRNFEDSDMLYVPEVYWDYCSETVMVMERMYGIPVSDVAALRAAGTDMKLLAERGVEVF 272 (537)
T ss_pred HHHHHHHhhCHHHHHHHHHHHHHHccCCCCeecceeecccCCCceEEEeeecCccHHhHHHHHhcCCCHHHHHHHHHHHH
Confidence 1111 233444444442 455566666666555566899999999999764 3322222234555555555
Q ss_pred HHHHHHHHHHhhcCCCCCeeeecccCCceeeCCCC----cEEEeeeccccccc
Q 038766 121 LISVANGLDYLHSGYDIPIVHCDMKPSNILLDRDF----EAHVSDFGTSRMLD 169 (299)
Q Consensus 121 ~~qi~~~l~~lh~~~~~~~~H~dl~~~nil~~~~~----~v~l~df~~~~~~~ 169 (299)
+.|++ .. |++|+|++|.||+++.+| .++++|||++..++
T Consensus 273 ~~Qif-------~~---GffHaDpHPGNIlv~~~g~~~~~i~llDFGivg~l~ 315 (537)
T PRK04750 273 FTQVF-------RD---GFFHADMHPGNIFVSYDPPENPRYIALDFGIVGSLN 315 (537)
T ss_pred HHHHH-------hC---CeeeCCCChHHeEEecCCCCCCeEEEEecceEEECC
Confidence 66655 35 999999999999999888 99999999997665
|
|
| >cd05146 RIO3_euk RIO kinase family; eukaryotic RIO3, catalytic domain | Back alignment and domain information |
|---|
Probab=99.46 E-value=1.3e-12 Score=101.86 Aligned_cols=140 Identities=16% Similarity=0.175 Sum_probs=99.2
Q ss_pred CCceeecCCcceEEEEEeCC-------CcEEEEEEeccCcC--------------------ChhhhHHHH----HHHHHH
Q 038766 16 ENNIIGNSNLSTVYKGRLED-------GEIVAVKKLNFHQF--------------------SAESDKSFY----REAKTL 64 (299)
Q Consensus 16 ~~~~lg~g~~~~v~~~~~~~-------~~~~~vK~~~~~~~--------------------~~~~~~~~~----~e~~~l 64 (299)
+...||.|.-+.||.|...+ +..+|||+.+.+.. .......+. +|+..|
T Consensus 1 ~~g~i~~GKEa~V~~~~~~~~~~~~~~~~~~avKi~r~~~~~Fk~~~~y~~~~~rf~~~~~k~~~~~~~~~wa~kE~r~L 80 (197)
T cd05146 1 INGCISTGKESVVLHANGGSNETEQVIPTECAIKVFKTTLNEFKNRDKYIKDDYRFKDRFSKLNPRKIIRMWAEKEMHNL 80 (197)
T ss_pred CCCccccCcceEEEEEecCcccccccCCceEEEEEEeccceeEcChhhhccCCcccccCcCCCCHHHHHHHHHHHHHHHH
Confidence 35679999999999997542 57999998764211 011122333 799999
Q ss_pred HhcCC--cceeeeeeEEEcCCCeeEEEEeecCCCChH-HHhcCCCCCCCCCChhhHHHHHHHHHHHHHHh-hcCCCCCee
Q 038766 65 KELKH--RNLVKVLGYAWESGKLKALILEYMENGSLE-SVIHGPGVDHSRWTLPKRIDVLISVANGLDYL-HSGYDIPIV 140 (299)
Q Consensus 65 ~~l~h--~~i~~~~~~~~~~~~~~~lv~e~~~~~~L~-~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~l-h~~~~~~~~ 140 (299)
+++.. -++..++++ ... ++||||+.+..+. ..++ ...+++.....+..+++.+|..+ |+. +++
T Consensus 81 ~rl~~~Gv~vP~pi~~----~~~-~lvME~Ig~~~~~~~~Lk-----d~~~~~~~~~~i~~~i~~~l~~l~H~~---glV 147 (197)
T cd05146 81 KRMQKAGIPCPEVVVL----KKH-VLVMSFIGDDQVPAPKLK-----DAKLNDEEMKNAYYQVLSMMKQLYKEC---NLV 147 (197)
T ss_pred HHHHHcCCCCCeEEEe----cCC-EEEEEEcCCCCccchhhh-----ccccCHHHHHHHHHHHHHHHHHHHHhC---Cee
Confidence 99964 455556552 222 7999999654332 1222 12345556778889999999999 888 999
Q ss_pred eecccCCceeeCCCCcEEEeeeccccccc
Q 038766 141 HCDMKPSNILLDRDFEAHVSDFGTSRMLD 169 (299)
Q Consensus 141 H~dl~~~nil~~~~~~v~l~df~~~~~~~ 169 (299)
||||++.||+++ ++.+.++|||.+-...
T Consensus 148 HGDLs~~NIL~~-~~~v~iIDF~qav~~~ 175 (197)
T cd05146 148 HADLSEYNMLWH-DGKVWFIDVSQSVEPT 175 (197)
T ss_pred cCCCCHHHEEEE-CCcEEEEECCCceeCC
Confidence 999999999996 4679999999876543
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO3 is present only in multicellular eukaryotes. Its function is still unknown. |
| >cd05151 ChoK Choline Kinase (ChoK) | Back alignment and domain information |
|---|
Probab=99.44 E-value=8.6e-13 Score=101.96 Aligned_cols=130 Identities=21% Similarity=0.150 Sum_probs=92.9
Q ss_pred CceeecCCcceEEEEEeCCCcEEEEEEeccCcCChhhhHHHHHHHHHHHhcCCcceee-eeeEEEcCCCeeEEEEeecCC
Q 038766 17 NNIIGNSNLSTVYKGRLEDGEIVAVKKLNFHQFSAESDKSFYREAKTLKELKHRNLVK-VLGYAWESGKLKALILEYMEN 95 (299)
Q Consensus 17 ~~~lg~g~~~~v~~~~~~~~~~~~vK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~-~~~~~~~~~~~~~lv~e~~~~ 95 (299)
.+.|+.|.++.||++... +..+++|+..... ........|+..++.+...++++ ++. +.. . ..++|+|+++|
T Consensus 3 ~~~l~~G~~~~vy~~~~~-~~~~~lK~~~~~~---~~~~~~~~E~~~l~~l~~~~~~P~~~~-~~~-~-~~~lv~e~i~G 75 (170)
T cd05151 3 ISPLKGGMTNKNYRVEVA-NKKYVVRIPGNGT---ELLINRENEAENSKLAAEAGIGPKLYY-FDP-E-TGVLITEFIEG 75 (170)
T ss_pred eeecCCcccCceEEEEEC-CeEEEEEeCCCCc---ccccCHHHHHHHHHHHHHhCCCCceEE-EeC-C-CCeEEEEecCC
Confidence 467889999999999875 7789999875322 12334578888998886555443 433 222 2 23799999998
Q ss_pred CChHHHhcCCCCCCCCCChhhHHHHHHHHHHHHHHhhcCC--CCCeeeecccCCceeeCCCCcEEEeeecccc
Q 038766 96 GSLESVIHGPGVDHSRWTLPKRIDVLISVANGLDYLHSGY--DIPIVHCDMKPSNILLDRDFEAHVSDFGTSR 166 (299)
Q Consensus 96 ~~L~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lh~~~--~~~~~H~dl~~~nil~~~~~~v~l~df~~~~ 166 (299)
.++...- . ....++.+++.+|+.||+.. ...++|+|++|.||+++ ++.++++||+.+.
T Consensus 76 ~~l~~~~---------~---~~~~~~~~l~~~l~~LH~~~~~~~~~~HgD~~~~Nil~~-~~~~~liDf~~a~ 135 (170)
T cd05151 76 SELLTED---------F---SDPENLEKIAKLLKKLHSSPLPDLVPCHNDLLPGNFLLD-DGRLWLIDWEYAG 135 (170)
T ss_pred Ccccccc---------c---cCHHHHHHHHHHHHHHhCCCCCCceeecCCCCcCcEEEE-CCeEEEEeccccc
Confidence 7765320 1 11245678999999999981 11259999999999999 6689999999875
|
The ChoK subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). It is composed of bacterial and eukaryotic choline kinases, as well as eukaryotic ethanolamine kinase. ChoK catalyzes the transfer of the gamma-phosphoryl group from ATP (or CTP) to its substrate, choline, producing phosphorylcholine (PCho), a precursor to the biosynthesis of two major membrane phospholipids, phosphatidylcholine (PC), and sphingomyelin (SM). Although choline is the preferred substrate, ChoK also shows substantial activity towards ethanolamine and its N-methylated derivatives. Bacterial ChoK is also referred to as licA protein. ETNK catalyzes the transfer of the gamma-phosphoryl group from CTP to ethanolamine (Etn), the first step in the CDP-Etn pathway for the formation of the major ph |
| >KOG3087 consensus Serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=99.32 E-value=4.7e-11 Score=89.90 Aligned_cols=145 Identities=19% Similarity=0.232 Sum_probs=102.1
Q ss_pred CCceeecCCcceEEEEEeCCCcEEEEEEeccCcCC------hhhhHHHHHHHHHHHhcCCcceeeeeeEEEcCCCeeEEE
Q 038766 16 ENNIIGNSNLSTVYKGRLEDGEIVAVKKLNFHQFS------AESDKSFYREAKTLKELKHRNLVKVLGYAWESGKLKALI 89 (299)
Q Consensus 16 ~~~~lg~g~~~~v~~~~~~~~~~~~vK~~~~~~~~------~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~lv 89 (299)
...++-+|+-+.|+++.+. |+.++||.--.+... .-...+..+|++.+.++.--.|.-..=++.+..+. +++
T Consensus 11 ~l~likQGAEArv~~~~~~-Ge~~iIK~Rf~K~YRHP~LD~kLtr~Rt~~Ear~l~k~~~~GI~~P~l~~~D~~~~-~i~ 88 (229)
T KOG3087|consen 11 SLELIKQGAEARVPRGSFS-GEAAIIKERFSKRYRHPALDQKLTRKRTKQEARLLAKCRALGIPAPRLIFIDTYGG-QIY 88 (229)
T ss_pred cceeeeccceeeEeeeccC-CceeEEeecccccccchHHHHHHHHHHHHHHHHHHHHHHHhCCCCceEEEEecCCC-eEE
Confidence 6788899999999998875 777788854322211 11235678899999998754444433334444444 899
Q ss_pred EeecCC-CChHHHhcCCCCCCCCCChhhHHHHHHHHHHHHHHhhcCCCCCeeeecccCCceeeCCCC---cEEEeeeccc
Q 038766 90 LEYMEN-GSLESVIHGPGVDHSRWTLPKRIDVLISVANGLDYLHSGYDIPIVHCDMKPSNILLDRDF---EAHVSDFGTS 165 (299)
Q Consensus 90 ~e~~~~-~~L~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lh~~~~~~~~H~dl~~~nil~~~~~---~v~l~df~~~ 165 (299)
|||++| .++.+++... ............++.+|=+.+..||.+ +++||||..+||++.++| .+.++|||++
T Consensus 89 ME~~~g~~~vk~~i~~~--~~~~~~d~~~~~~~~~iG~~igklH~n---diiHGDLTTSNill~~~~~~~~~~lIdfgls 163 (229)
T KOG3087|consen 89 MEFIDGASTVKDFILST--MEDESEDEGLAELARRIGELIGKLHDN---DIIHGDLTTSNILLRSDGNQITPILIDFGLS 163 (229)
T ss_pred EEeccchhHHHHHHHHH--ccCcccchhHHHHHHHHHHHHHHhhhC---CeecccccccceEEecCCCcCceEEEeecch
Confidence 999976 3666666433 122223333378889999999999999 999999999999996554 3589999998
Q ss_pred cc
Q 038766 166 RM 167 (299)
Q Consensus 166 ~~ 167 (299)
..
T Consensus 164 ~~ 165 (229)
T KOG3087|consen 164 SV 165 (229)
T ss_pred hc
Confidence 63
|
|
| >cd05154 ACAD10_11_like Acyl-CoA dehydrogenase (ACAD) 10 and 11, N-terminal domain, and similar proteins | Back alignment and domain information |
|---|
Probab=99.30 E-value=4.3e-11 Score=96.56 Aligned_cols=144 Identities=17% Similarity=0.189 Sum_probs=105.6
Q ss_pred CceeecCCcceEEEEEeCCCcEEEEEEeccCcCChhhhHHHHHHHHHHHhcCCcc--eeeeeeEEEcCC--CeeEEEEee
Q 038766 17 NNIIGNSNLSTVYKGRLEDGEIVAVKKLNFHQFSAESDKSFYREAKTLKELKHRN--LVKVLGYAWESG--KLKALILEY 92 (299)
Q Consensus 17 ~~~lg~g~~~~v~~~~~~~~~~~~vK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~--i~~~~~~~~~~~--~~~~lv~e~ 92 (299)
.+.|+.|..+.+|++...+|+.+++|........ .....+..|+..++.+++.+ +.+++.+..... ...++|+|+
T Consensus 3 ~~~l~~G~~n~~~~v~~~~g~~~ilK~~~~~~~~-~~~~~~~~E~~~~~~l~~~~~~vp~~~~~~~~~~~~~~~~~v~e~ 81 (223)
T cd05154 3 VRQLSGGQSNLTYLLTAGGGRRLVLRRPPPGALL-PSAHDVAREYRVLRALAGTGVPVPKVLALCEDPSVLGTPFYVMER 81 (223)
T ss_pred ceecCCCccceEEEEEecCCcceEEEeCCCcccC-cccccHHHHHHHHHHhhCCCCCCCCEEEECCCCCccCCceEEEEE
Confidence 3678999999999998776789999987543321 24567889999999997533 455666433321 244899999
Q ss_pred cCCCChHHHhcCCCCCCCCCChhhHHHHHHHHHHHHHHhhcCC-------------------------------------
Q 038766 93 MENGSLESVIHGPGVDHSRWTLPKRIDVLISVANGLDYLHSGY------------------------------------- 135 (299)
Q Consensus 93 ~~~~~L~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lh~~~------------------------------------- 135 (299)
++|.++...+. ...+++.....++.+++.+|..||+..
T Consensus 82 i~G~~l~~~~~-----~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 156 (223)
T cd05154 82 VDGRVLRDRLL-----RPELSPEERRALARALADTLAALHSVDPAAVGLGDLGRPGGYLERQVARWRRQYDASRTDEPPA 156 (223)
T ss_pred eCCEecCCCCC-----CCCCCHHHHHHHHHHHHHHHHHHhCCChhhcCCcccCCCCchHHHHHHHHHHHHHhhcccccHH
Confidence 99988776552 124666677777788888888887531
Q ss_pred ----------------CCCeeeecccCCceeeCC--CCcEEEeeecccc
Q 038766 136 ----------------DIPIVHCDMKPSNILLDR--DFEAHVSDFGTSR 166 (299)
Q Consensus 136 ----------------~~~~~H~dl~~~nil~~~--~~~v~l~df~~~~ 166 (299)
...++|+|+.+.||+++. ++.+.++||+.+.
T Consensus 157 ~~~~~~~~~~~~~~~~~~~l~HgD~~~~Nil~~~~~~~~~~iID~e~~~ 205 (223)
T cd05154 157 MERLLRWLEAHLPADSRPGLVHGDYRLGNVLFHPDEPRVVAVLDWELAT 205 (223)
T ss_pred HHHHHHHHHhhCCCCCCcEEEECCCCcccEEEcCCCCcEEEEEeccccc
Confidence 135799999999999998 6678999999775
|
This subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). This subfamily is composed of bacterial and eukaryotic proteins with similarity to the N-terminal domains of vertebrate ACAD10 and ACAD11. ACADs are a family of flavoproteins that are involved in the beta-oxidation of fatty acyl-CoA derivatives. ACAD deficiency can cause metabolic disorders including muscle fatigue, hypoglycemia, and hepatic lipidosis, among them. There are at least 11 distinct ACADs, some of which show distinct substrate specificities to either straight-chain or branched-chain fatty acids. ACAD10 is widely expressed in human tissues and is highly expressed in liver, kidney, pancreas, and spleen. ACAD10 and ACAD11 contain |
| >KOG0601 consensus Cyclin-dependent kinase WEE1 [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.28 E-value=2.7e-12 Score=112.29 Aligned_cols=246 Identities=24% Similarity=0.199 Sum_probs=171.1
Q ss_pred hCCCCCCceeecCCcceEEEEEe--CCCcEEEEEEeccCcCChhhhHHHHHHHHHHHhcC-CcceeeeeeEEEcCCCeeE
Q 038766 11 TGSFSENNIIGNSNLSTVYKGRL--EDGEIVAVKKLNFHQFSAESDKSFYREAKTLKELK-HRNLVKVLGYAWESGKLKA 87 (299)
Q Consensus 11 ~~~y~~~~~lg~g~~~~v~~~~~--~~~~~~~vK~~~~~~~~~~~~~~~~~e~~~l~~l~-h~~i~~~~~~~~~~~~~~~ 87 (299)
..+|..+..||.|.|+.|+.+.. .++..|++|..............-..|+.+...+. |.+++..+.......+ .+
T Consensus 264 ~~df~~v~~i~~~~~~~~~~~~~r~~~~~~Y~~ke~~~~l~~~~~di~sl~ev~l~~~l~~~~~~~g~~~~W~~~r~-~~ 342 (524)
T KOG0601|consen 264 LTDFGLVSKISDGNFSSVFKVSKRPEGDCIYAAKELLNGLATFASDIFSLGEVILEAILGSHLPSVGKNSSWSQLRQ-GY 342 (524)
T ss_pred cCCcceeEEccCCccccceeeeecCCCCceEeChhhhccccchHhhhcchhhhhHhhHhhcccccCCCCCCcccccc-cc
Confidence 46788999999999999999763 46889999988655444444444556777777774 7777766553333333 36
Q ss_pred EEEeecCCCChHHHhcCCCCCCCCCChhhHHHHHHHHHHHHHHhhcCCCCCeeeecccCCceeeCCC-CcEEEeeecccc
Q 038766 88 LILEYMENGSLESVIHGPGVDHSRWTLPKRIDVLISVANGLDYLHSGYDIPIVHCDMKPSNILLDRD-FEAHVSDFGTSR 166 (299)
Q Consensus 88 lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lh~~~~~~~~H~dl~~~nil~~~~-~~v~l~df~~~~ 166 (299)
+-.||++++++..... ....+.+...+.+..|++.++.++|+. .++|+|++|+||++..+ +..+++||+...
T Consensus 343 ip~e~~~~~s~~l~~~----~~~~~d~~~~~~~~~q~~~~l~~i~s~---~~~~~d~~psni~i~~~~~~~~~~~~~~~t 415 (524)
T KOG0601|consen 343 IPLEFCEGGSSSLRSV----TSQMLDEDPRLRLTAQILTALNVIHSK---LFVHLDVKPSNILISNDGFFSKLGDFGCWT 415 (524)
T ss_pred CchhhhcCcchhhhhH----HHHhcCcchhhhhHHHHHhccccccch---hhhcccccccceeeccchhhhhcccccccc
Confidence 8889998888765552 345688889999999999999999998 99999999999999886 667899999876
Q ss_pred ccccccccccccccccccCccc-CChhhhcccCcCccccchhhhHHHHHHHhCCCCCCCCccCCCCchhHHHHHHHHHhc
Q 038766 167 MLDVHLQDLSSLSTAFQGTIGY-LAPEFAYMRIVTTKVDVFSFGIVVMEFLTKRRPTGLDEENGLSPISLRQLVEKALAN 245 (299)
Q Consensus 167 ~~~~~~~~~~~~~~~~~~~~~y-~~PE~~~~~~~~~~~DiwslG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~ 245 (299)
.+.... ......+..| .+|.+.....+..++|+++||..+.+..++..... ...+
T Consensus 416 ~~~~~~------~~~~~~~r~~p~~~~~~e~~~~~~~~~~~sl~~~~~e~~~~~~ls~-~~~~----------------- 471 (524)
T KOG0601|consen 416 RLAFSS------GVFHHIDRLYPIAEILLEDYPHLSKADIFSLGLSVDEAITGSPLSE-SGVQ----------------- 471 (524)
T ss_pred ccceec------ccccccccccccchhhccccccccccccccccccccccccCcccCc-cccc-----------------
Confidence 422111 1111122233 35666667778889999999999999888754321 1000
Q ss_pred CccCcccccCccccchhhHhHHHHHHHHHHHHHHHHhcCCCCCCCCChhhhhcC
Q 038766 246 GINGVRQITDPKLVSSIYEEQEQHQVLEELFKLALVCTSSNPEDRPNMNELLIT 299 (299)
Q Consensus 246 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rpt~~~il~~ 299 (299)
...+.... -....+...++..+.+.|...++..||.+.++..|
T Consensus 472 ----~~~i~~~~-------~p~~~~~~~~~q~~~kv~~~~~~~~~~l~~~l~~~ 514 (524)
T KOG0601|consen 472 ----SLTIRSGD-------TPNLPGLKLQLQVLLKVMINPDRKRRPSAVELSLH 514 (524)
T ss_pred ----ceeeeccc-------ccCCCchHHhhhhhhhhhcCCccccchhhhhhccc
Confidence 00000000 00122333678889999999999999999887543
|
|
| >COG4248 Uncharacterized protein with protein kinase and helix-hairpin-helix DNA-binding domains [General function prediction only] | Back alignment and domain information |
|---|
Probab=99.26 E-value=4.5e-10 Score=94.92 Aligned_cols=258 Identities=14% Similarity=0.122 Sum_probs=155.2
Q ss_pred CCCceeecCCcceEEEEEeCCCcEEEEEEeccCcCChhhhHHHHHHHHHHHhc-CCcceeeeeeEEE--------cCCCe
Q 038766 15 SENNIIGNSNLSTVYKGRLEDGEIVAVKKLNFHQFSAESDKSFYREAKTLKEL-KHRNLVKVLGYAW--------ESGKL 85 (299)
Q Consensus 15 ~~~~~lg~g~~~~v~~~~~~~~~~~~vK~~~~~~~~~~~~~~~~~e~~~l~~l-~h~~i~~~~~~~~--------~~~~~ 85 (299)
...+.||+|+-+.+|-.-.- ...+.|+.+.+. +. ... +.+..|... .||-+-. .+.| ..+..
T Consensus 14 ~~gr~LgqGgea~ly~l~e~--~d~VAKIYh~Pp--pa--~~a-qk~a~la~~p~~p~~~~--rvaWPqa~L~G~~~~~~ 84 (637)
T COG4248 14 PPGRPLGQGGEADLYTLGEV--RDQVAKIYHAPP--PA--AQA-QKVAELAATPDAPLLNY--RVAWPQATLHGGRRGKV 84 (637)
T ss_pred CCCccccCCccceeeecchh--hchhheeecCCC--ch--HHH-HHHHHhccCCCCcchhh--hhcccHHHhhCCCccce
Confidence 45788999999999876432 124668876432 11 121 222333333 3553322 1111 12232
Q ss_pred eEEEEeecCCCChH-HHhcCC--CCCCCCCChhhHHHHHHHHHHHHHHhhcCCCCCeeeecccCCceeeCCCCcEEEeee
Q 038766 86 KALILEYMENGSLE-SVIHGP--GVDHSRWTLPKRIDVLISVANGLDYLHSGYDIPIVHCDMKPSNILLDRDFEAHVSDF 162 (299)
Q Consensus 86 ~~lv~e~~~~~~L~-~~~~~~--~~~~~~~~~~~~~~i~~qi~~~l~~lh~~~~~~~~H~dl~~~nil~~~~~~v~l~df 162 (299)
..+.|..+++..-- .+.+.. .++..-.....+......++.+.+.||.. |.+-||++++|+||++++.|.|.|-
T Consensus 85 iGflmP~v~g~~pI~~~y~p~tRRqs~P~~~w~fllrvaRnlA~aFA~lH~~---Gh~vGDVn~~~~lVsd~~~V~LVds 161 (637)
T COG4248 85 IGFLMPKVSGKEPIHMIYSPATRRQSYPHCAWDFLLRVARNLASAFATLHEH---GHVVGDVNQNSFLVSDDSKVVLVDS 161 (637)
T ss_pred eEEecccCCCccchhhhcCchhhcccCCccccHHHHHHHHHHHHHHHHHHhc---CCcccccCccceeeecCceEEEEcc
Confidence 45677776654332 232221 12334456677888899999999999999 9999999999999999999999886
Q ss_pred ccccccccccccccccccccccCcccCChhhhc-----ccCcCccccchhhhHHHHHHHhC-CCCCCCCccCCCCchhHH
Q 038766 163 GTSRMLDVHLQDLSSLSTAFQGTIGYLAPEFAY-----MRIVTTKVDVFSFGIVVMEFLTK-RRPTGLDEENGLSPISLR 236 (299)
Q Consensus 163 ~~~~~~~~~~~~~~~~~~~~~~~~~y~~PE~~~-----~~~~~~~~DiwslG~~l~~l~~g-~~p~~~~~~~~~~~~~~~ 236 (299)
.....- ..+......++...|+|||... +..-+..+|.|.||+++++++.| +.||+.-..-...+....
T Consensus 162 Dsfqi~-----~ng~~~~cpVg~~eftPPElQ~~~sf~g~~r~~~hD~FGLavLiF~lL~ggrHPysGI~~~~~ap~p~E 236 (637)
T COG4248 162 DSFQIN-----ANGTLHLCPVGVSEFTPPELQTLPSFVGFERTANHDNFGLAVLIFHLLFGGRHPYSGIPLISDAPNPLE 236 (637)
T ss_pred cceeec-----cCCceEecccCccccCCHHHhccccccccCCCccccchhHHHHHHHHHhcCCCCCCcccccCCCCCcch
Confidence 644321 2345556778899999999654 34556789999999999999987 899976433322222222
Q ss_pred -HHHHHHHhcCccCcccccCccccchhhHhHHHHHHHHHHHHHHHHhcCCC--CCCCCChhh
Q 038766 237 -QLVEKALANGINGVRQITDPKLVSSIYEEQEQHQVLEELFKLALVCTSSN--PEDRPNMNE 295 (299)
Q Consensus 237 -~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~d--P~~Rpt~~~ 295 (299)
++....+............ ...+..-.-.++++..|+.+|+... |.-|||++.
T Consensus 237 ~~Ia~g~f~ya~~~~~g~~p------~P~~~P~~~Lpp~vqAlF~qaF~~~~~~~~RP~a~a 292 (637)
T COG4248 237 TDIAHGRFAYASDQRRGLKP------PPRSIPLSMLPPDVQALFQQAFTESGVATPRPTAKA 292 (637)
T ss_pred hhhhcceeeechhccCCCCC------CCCCCChhhcCHHHHHHHHHHhcccCCCCCCCCHHH
Confidence 1111111111001111000 0111113344567888888988754 678999874
|
|
| >KOG3741 consensus Poly(A) ribonuclease subunit [RNA processing and modification] | Back alignment and domain information |
|---|
Probab=99.26 E-value=2.9e-10 Score=98.23 Aligned_cols=216 Identities=17% Similarity=0.157 Sum_probs=147.9
Q ss_pred CcceEEEEEe-CCCcEEEEEEeccCcCChhhhHHHHHHHHHHHhcCCcceeeeeeEEEc---CCCeeEEEEeecCC-CCh
Q 038766 24 NLSTVYKGRL-EDGEIVAVKKLNFHQFSAESDKSFYREAKTLKELKHRNLVKVLGYAWE---SGKLKALILEYMEN-GSL 98 (299)
Q Consensus 24 ~~~~v~~~~~-~~~~~~~vK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~---~~~~~~lv~e~~~~-~~L 98 (299)
...+.|++.. .+|..|++|+++. ....+....-.-+++++++.|.|++++.+++.. .+..+++|++|+++ ++|
T Consensus 288 ~~~Ttyk~~s~~DG~~YvLkRlhg--~r~~~~nk~t~lve~wkkl~h~NvV~frevf~t~tF~D~SlvlvYDYyP~s~TL 365 (655)
T KOG3741|consen 288 FSITTYKATSNVDGNAYVLKRLHG--DRDQSTNKDTSLVEAWKKLCHTNVVPFREVFLTYTFGDLSLVLVYDYYPSSPTL 365 (655)
T ss_pred ccceeEeeeeccCCceeeeeeecc--ccccCcccchHHHHHHHHhccCceeehhhhhhhhccCcceEEEEEecCCCCchH
Confidence 4567888864 5799999999842 222233333456889999999999999997752 24567899999875 456
Q ss_pred HHHh--cCC---------CCCCCCCChhhHHHHHHHHHHHHHHhhcCCCCCeeeecccCCceeeCCCCcEEEeeeccccc
Q 038766 99 ESVI--HGP---------GVDHSRWTLPKRIDVLISVANGLDYLHSGYDIPIVHCDMKPSNILLDRDFEAHVSDFGTSRM 167 (299)
Q Consensus 99 ~~~~--~~~---------~~~~~~~~~~~~~~i~~qi~~~l~~lh~~~~~~~~H~dl~~~nil~~~~~~v~l~df~~~~~ 167 (299)
.+.. ... ...+...+|..+|.++.|+..||.++|+. |+..+-+.|.+|+++.+-.++++.-|....
T Consensus 366 ~d~~F~~~~~t~~~n~~~~~~~~~~~e~~lW~y~~QLtaaL~sIHss---GLAck~L~~~kIlv~G~~RIriS~C~i~Dv 442 (655)
T KOG3741|consen 366 YDLYFANPPFTKRTNSFYPSQNLKAPEEVLWSYISQLTAALYSIHSS---GLACKTLDLKKILVTGKMRIRISGCGIMDV 442 (655)
T ss_pred HHHHccCCccccccccccccCCCCchHHHHHHHHHHHHHHHHHHHhc---CceeecccHhHeEeeCcceEEEecccceee
Confidence 5532 111 11345688999999999999999999999 999999999999999888888887777655
Q ss_pred cccccccccccccccccCcccCChhhhcccCcCccccchhhhHHHHHHHhCCCCCCCCccCCCCchhHHHHHHHHHhcCc
Q 038766 168 LDVHLQDLSSLSTAFQGTIGYLAPEFAYMRIVTTKVDVFSFGIVVMEFLTKRRPTGLDEENGLSPISLRQLVEKALANGI 247 (299)
Q Consensus 168 ~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~DiwslG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 247 (299)
+.... .+| + .-..+-|.=.||.++..|.+|+.--- ..+..++.
T Consensus 443 l~~d~----------------~~~--l---e~~Qq~D~~~lG~ll~aLAt~~~ns~----~~d~~~~s------------ 485 (655)
T KOG3741|consen 443 LQEDP----------------TEP--L---ESQQQNDLRDLGLLLLALATGTENSN----RTDSTQSS------------ 485 (655)
T ss_pred ecCCC----------------Ccc--h---hHHhhhhHHHHHHHHHHHhhcccccc----cccchHHH------------
Confidence 43110 011 0 01246688899999999999964310 11111000
Q ss_pred cCcccccCccccchhhHhHHHHHHHHHHHHHHHHhcCCCCCCCCChhhhh
Q 038766 248 NGVRQITDPKLVSSIYEEQEQHQVLEELFKLALVCTSSNPEDRPNMNELL 297 (299)
Q Consensus 248 ~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rpt~~~il 297 (299)
........++.+++++|.-....++.+ -++++++
T Consensus 486 ---------------~~~~I~~~yS~D~rn~v~yl~s~~~~~-ksI~~ll 519 (655)
T KOG3741|consen 486 ---------------HLTRITTTYSTDLRNVVEYLESLNFRE-KSIQDLL 519 (655)
T ss_pred ---------------HHHHhhhhhhHHHHHHHHHHHhcCccc-ccHHHHH
Confidence 011125566777778888887777776 5666655
|
|
| >COG3642 Mn2+-dependent serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.23 E-value=2.7e-10 Score=86.15 Aligned_cols=133 Identities=23% Similarity=0.343 Sum_probs=95.0
Q ss_pred ceeecCCcceEEEEEeCCCcEEEEEEeccCcCChhh------hHHHHHHHHHHHhcCCcceeeeeeEEEcCCCeeEEEEe
Q 038766 18 NIIGNSNLSTVYKGRLEDGEIVAVKKLNFHQFSAES------DKSFYREAKTLKELKHRNLVKVLGYAWESGKLKALILE 91 (299)
Q Consensus 18 ~~lg~g~~~~v~~~~~~~~~~~~vK~~~~~~~~~~~------~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~lv~e 91 (299)
..+++|+-+.++.+.+. |..+++|.-..+...... ..+-.+|+.++.+.+--.|.-..=+..+..+ ..++||
T Consensus 2 ~~i~~GAEa~i~~~~~~-g~~av~K~Ri~K~YR~p~LD~klrr~Rt~~Earil~~a~~~GV~~P~v~dvD~~~-~~I~me 79 (204)
T COG3642 2 DLIKQGAEAIIYLTDFL-GLPAVVKERIPKRYRHPELDEKLRRERTRREARILAKAREAGVPVPIVYDVDPDN-GLIVME 79 (204)
T ss_pred chhhCCcceeEEeeecc-CcceEEEeecCcccCChHHHHHHHHHHHHHHHHHHHHHHHcCCCCCeEEEEcCCC-CEEEEE
Confidence 45788999999998764 445777764332222111 3456789999998874443332222233233 379999
Q ss_pred ecCCCChHHHhcCCCCCCCCCChhhHHHHHHHHHHHHHHhhcCCCCCeeeecccCCceeeCCCCcEEEeeeccccc
Q 038766 92 YMENGSLESVIHGPGVDHSRWTLPKRIDVLISVANGLDYLHSGYDIPIVHCDMKPSNILLDRDFEAHVSDFGTSRM 167 (299)
Q Consensus 92 ~~~~~~L~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lh~~~~~~~~H~dl~~~nil~~~~~~v~l~df~~~~~ 167 (299)
|+.|..|.+.+... ...++..+=.-+..||.+ +++||||.++|+.++.++ +.++|||++..
T Consensus 80 ~I~G~~lkd~l~~~-----------~~~~~r~vG~~vg~lH~~---givHGDLTtsNiIl~~~~-i~~IDfGLg~~ 140 (204)
T COG3642 80 YIEGELLKDALEEA-----------RPDLLREVGRLVGKLHKA---GIVHGDLTTSNIILSGGR-IYFIDFGLGEF 140 (204)
T ss_pred EeCChhHHHHHHhc-----------chHHHHHHHHHHHHHHhc---CeecCCCccceEEEeCCc-EEEEECCcccc
Confidence 99998888888632 245677888889999999 999999999999997775 99999999863
|
|
| >PF01163 RIO1: RIO1 family; InterPro: IPR018934 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases | Back alignment and domain information |
|---|
Probab=99.21 E-value=3.5e-10 Score=87.91 Aligned_cols=126 Identities=26% Similarity=0.301 Sum_probs=82.9
Q ss_pred eEEEEEeCCCcEEEEEEeccCcCC------------------------hhhhHHHHHHHHHHHhcCCc--ceeeeeeEEE
Q 038766 27 TVYKGRLEDGEIVAVKKLNFHQFS------------------------AESDKSFYREAKTLKELKHR--NLVKVLGYAW 80 (299)
Q Consensus 27 ~v~~~~~~~~~~~~vK~~~~~~~~------------------------~~~~~~~~~e~~~l~~l~h~--~i~~~~~~~~ 80 (299)
.||.|...+|..+|+|+.+....+ .-......+|.+.|.++... ++..++++
T Consensus 1 ~Vy~~~~~~~~~~a~K~~r~~~~~Fk~~~~y~~~~~r~~~~~~~~~~~~~~~~~~~~E~~~L~~l~~~Gv~vP~p~~~-- 78 (188)
T PF01163_consen 1 DVYHAIDPDGEEVAVKIYRTGRTSFKRRKKYRDYDYRFKKYRHKSSWRYLIREWAKKEFRNLKRLYEAGVPVPKPYDY-- 78 (188)
T ss_dssp EEEEEEECTTEEEEEEEE-S---SS-HHHHHTTTSTTSTTC--G--CHHHHHHHHHHHHHHHHHCCCTT-SS--EEEE--
T ss_pred CEEEEECCCCCEEEEEEeccCceEEEEeeeeecccchhcccccccCHHHHHHHHHHHHHHHHHHHHHCCccCCcEEEE--
Confidence 489999888999999987642110 00124567899999999865 45556542
Q ss_pred cCCCeeEEEEeecC--CCChHHHhcCCCCCCCCCChhhHHHHHHHHHHHHHH-hhcCCCCCeeeecccCCceeeCCCCcE
Q 038766 81 ESGKLKALILEYME--NGSLESVIHGPGVDHSRWTLPKRIDVLISVANGLDY-LHSGYDIPIVHCDMKPSNILLDRDFEA 157 (299)
Q Consensus 81 ~~~~~~~lv~e~~~--~~~L~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~-lh~~~~~~~~H~dl~~~nil~~~~~~v 157 (299)
. . . ++||||+. |..+..+... .++......++.+++..+.. +|.. +++|||+.+.||+++.+ .+
T Consensus 79 ~-~-~-~ivME~I~~~G~~~~~l~~~------~~~~~~~~~~~~~il~~~~~~~~~~---givHGDLs~~NIlv~~~-~~ 145 (188)
T PF01163_consen 79 N-R-N-VIVMEYIGEDGVPLPRLKDV------DLSPEEPKELLEEILEEIIKMLHKA---GIVHGDLSEYNILVDDG-KV 145 (188)
T ss_dssp E-T-T-EEEEE--EETTEEGGCHHHC------GGGGSTHHHHHHHHHHHHHHHHHCT---TEEESS-STTSEEEETT-CE
T ss_pred e-C-C-EEEEEecCCCccchhhHHhc------cccchhHHHHHHHHHHHHHHHHHhc---CceecCCChhhEEeecc-eE
Confidence 1 2 2 79999997 5555544431 12245667778888885555 5788 99999999999999887 89
Q ss_pred EEeeeccccc
Q 038766 158 HVSDFGTSRM 167 (299)
Q Consensus 158 ~l~df~~~~~ 167 (299)
.++|||.+..
T Consensus 146 ~iIDf~qav~ 155 (188)
T PF01163_consen 146 YIIDFGQAVD 155 (188)
T ss_dssp EE--GTTEEE
T ss_pred EEEecCccee
Confidence 9999997754
|
Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. This entry represents RIO kinase, they exhibit little sequence similarity with eukaryotic protein kinases, and are classified as atypical protein kinases []. The conformation of ATP when bound to the RIO kinases is unique when compared with ePKs, such as serine/threonine kinases or the insulin receptor tyrosine kinase, suggesting that the detailed mechanism by which the catalytic aspartate of RIO kinases participates in phosphoryl transfer may not be identical to that employed in known serine/threonine ePKs. Representatives of the RIO family are present in organisms varying from Archaea to humans, although the RIO3 proteins have only been identified in multicellular eukaryotes, to date. Yeast Rio1 and Rio2 proteins are required for proper cell cycle progression and chromosome maintenance, and are necessary for survival of the cells. These proteins are involved in the processing of 20 S pre-rRNA via late 18 S rRNA processing. ; GO: 0003824 catalytic activity, 0005524 ATP binding; PDB: 1TQP_A 1ZAR_A 1TQI_A 1ZAO_A 1TQM_A 3RE4_A 1ZTH_B 1ZP9_A 1ZTF_A. |
| >COG0478 RIO-like serine/threonine protein kinase fused to N-terminal HTH domain [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.17 E-value=3.8e-10 Score=90.39 Aligned_cols=137 Identities=24% Similarity=0.234 Sum_probs=98.0
Q ss_pred CCCCceeecCCcceEEEEEeCCCcEEEEEEeccCcC------------------C--hhhhHHHHHHHHHHHhcCCc--c
Q 038766 14 FSENNIIGNSNLSTVYKGRLEDGEIVAVKKLNFHQF------------------S--AESDKSFYREAKTLKELKHR--N 71 (299)
Q Consensus 14 y~~~~~lg~g~~~~v~~~~~~~~~~~~vK~~~~~~~------------------~--~~~~~~~~~e~~~l~~l~h~--~ 71 (299)
+.+...||-|.-+.||.+...+|.++|+|.-+.-.. + .-+...+.+|.+.|..+... .
T Consensus 93 e~iG~~IGvGKEsdVY~~~~~~g~~~~vKfHR~GrtsFrkvk~~R~y~~~~~h~sWl~~sRl~A~rEf~~L~~L~~~G~~ 172 (304)
T COG0478 93 EAIGTKIGVGKESDVYVAIDPKGRKVAVKFHRLGRTSFRKVKRNRDYLADKEHGSWLYVSRLAAEREFEALQRLYPEGVK 172 (304)
T ss_pred HhhccccccCccceEEEEECCCCCEEEEEEeecCchhhhhhcchhhhhccccCcchhhhHHHHHHHHHHHHHHhhhcCCC
Confidence 456789999999999999999999999996432111 1 11235677899999999755 6
Q ss_pred eeeeeeEEEcCCCeeEEEEeecCCCChHHHhcCCCCCCCCCChhhHHHHHHHHHHHHHHhhcCCCCCeeeecccCCceee
Q 038766 72 LVKVLGYAWESGKLKALILEYMENGSLESVIHGPGVDHSRWTLPKRIDVLISVANGLDYLHSGYDIPIVHCDMKPSNILL 151 (299)
Q Consensus 72 i~~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lh~~~~~~~~H~dl~~~nil~ 151 (299)
+.+.+++ +.+ ++|||+++|..|...- ++....-.++..|+.-+.-+-.. |++|||+++-||++
T Consensus 173 VP~P~~~----nRH-aVvMe~ieG~eL~~~r---------~~~en~~~il~~il~~~~~~~~~---GiVHGDlSefNIlV 235 (304)
T COG0478 173 VPKPIAW----NRH-AVVMEYIEGVELYRLR---------LDVENPDEILDKILEEVRKAYRR---GIVHGDLSEFNILV 235 (304)
T ss_pred CCCcccc----ccc-eeeeehcccceeeccc---------CcccCHHHHHHHHHHHHHHHHHc---CccccCCchheEEE
Confidence 6666653 333 8999999886554332 12233334444444444444455 99999999999999
Q ss_pred CCCCcEEEeeeccccc
Q 038766 152 DRDFEAHVSDFGTSRM 167 (299)
Q Consensus 152 ~~~~~v~l~df~~~~~ 167 (299)
+.+|.+.++||.-+..
T Consensus 236 ~~dg~~~vIDwPQ~v~ 251 (304)
T COG0478 236 TEDGDIVVIDWPQAVP 251 (304)
T ss_pred ecCCCEEEEeCccccc
Confidence 9999999999986643
|
|
| >KOG2137 consensus Protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.16 E-value=8.4e-12 Score=110.97 Aligned_cols=154 Identities=20% Similarity=0.266 Sum_probs=106.6
Q ss_pred HHHHHHHHHhhcCCCCCeeeecccCCceeeCCCCcEEEeeecccccccccccc-----ccccccccccCcccCChhhhcc
Q 038766 122 ISVANGLDYLHSGYDIPIVHCDMKPSNILLDRDFEAHVSDFGTSRMLDVHLQD-----LSSLSTAFQGTIGYLAPEFAYM 196 (299)
Q Consensus 122 ~qi~~~l~~lh~~~~~~~~H~dl~~~nil~~~~~~v~l~df~~~~~~~~~~~~-----~~~~~~~~~~~~~y~~PE~~~~ 196 (299)
.+++.|+.++|+. .++||++|.|++|.++.+|.+||++|+.+......... .............|.+||++..
T Consensus 106 ~~v~dgl~flh~s--Ak~VH~ni~p~~i~~na~~~wkl~Gf~f~v~~~~~~~~p~~~yd~~lp~~~~~~~~f~apE~~~~ 183 (700)
T KOG2137|consen 106 GNVADGLAFLHRS--AKVVHGNIQPEAIVVNANGDWKLAGFSFCVNANGPTEYPFSEYDPPLPLLLQPHLNFLAPEYLLG 183 (700)
T ss_pred hcccchhhhhccC--cceeecccchhheeeccCcceeeccchhhhccCCCCccccccCCCCCChhhccCcccccchhhcc
Confidence 3455999999986 69999999999999999999999999998754421110 1111122234568999999999
Q ss_pred cCcCccccchhhhHHHHHHHhCCCCCCCCccCCCCchhHHHHHHHHHhcCccCcccccCccccchhhHhHHHHHHHHHHH
Q 038766 197 RIVTTKVDVFSFGIVVMEFLTKRRPTGLDEENGLSPISLRQLVEKALANGINGVRQITDPKLVSSIYEEQEQHQVLEELF 276 (299)
Q Consensus 197 ~~~~~~~DiwslG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~ 276 (299)
.....++|+||+|++.|.+..|+.+........ .....+.... + . ........+++++.
T Consensus 184 ~~~~~~sd~fSlG~li~~i~~~gk~i~~a~~~~-----~~~~~~~~~~----~-------~-----~~~~~s~~~p~el~ 242 (700)
T KOG2137|consen 184 TTNTPASDVFSLGVLIYTIYNGGKSIIAANGGL-----LSYSFSRNLL----N-------A-----GAFGYSNNLPSELR 242 (700)
T ss_pred ccccccccceeeeeEEEEEecCCcchhhccCCc-----chhhhhhccc----c-------c-----ccccccccCcHHHH
Confidence 888999999999999999996665542221111 1111111000 0 0 00111366778999
Q ss_pred HHHHHhcCCCCCCCCChhhhhc
Q 038766 277 KLALVCTSSNPEDRPNMNELLI 298 (299)
Q Consensus 277 ~li~~~l~~dP~~Rpt~~~il~ 298 (299)
+=+.+++..++.-||++..++.
T Consensus 243 ~~l~k~l~~~~~~rp~~~~l~~ 264 (700)
T KOG2137|consen 243 ESLKKLLNGDSAVRPTLDLLLS 264 (700)
T ss_pred HHHHHHhcCCcccCcchhhhhc
Confidence 9999999999999998776653
|
|
| >KOG0606 consensus Microtubule-associated serine/threonine kinase and related proteins [Signal transduction mechanisms; General function prediction only] | Back alignment and domain information |
|---|
Probab=99.10 E-value=2e-11 Score=112.93 Aligned_cols=255 Identities=19% Similarity=0.233 Sum_probs=165.0
Q ss_pred HHhCCCCCCceeecCCcceEEEEEeC-CCcEEEEEEeccC-cCChhhhHHHHHHHHHHHhcCCcceeeeeeEEEcCCCee
Q 038766 9 NATGSFSENNIIGNSNLSTVYKGRLE-DGEIVAVKKLNFH-QFSAESDKSFYREAKTLKELKHRNLVKVLGYAWESGKLK 86 (299)
Q Consensus 9 ~~~~~y~~~~~lg~g~~~~v~~~~~~-~~~~~~vK~~~~~-~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~ 86 (299)
.-.+.+.+.+-+-+|.++.++.+... .|...++|+.... .+..........+-...-...+|.++...-. .......
T Consensus 801 sS~d~~~i~~p~qS~sp~ss~p~~pa~sgh~~~~~v~~~ap~i~~~~~~s~r~~s~~~i~p~~P~v~~~~~s-~~~rsP~ 879 (1205)
T KOG0606|consen 801 SSPDGFEITKPSQSGSPSSSFPASPAGSGHTRPSKVHGLAPKIRTNDYESIRSKSNILITPRSPAVVRSFPS-FPCRSPL 879 (1205)
T ss_pred CCCccceecccccCCCCcccccCCccccccccchhhhccchhhccccccccCCccCccccCCCCceecccCC-CCCCCCc
Confidence 34566777788889999999988753 3444444443211 1111112222222222222233433322221 1234455
Q ss_pred EEEEeecCCCChHHHhcCCCCCCCCCChhhHHHHHHHHHHHHHHhhcCCCCCeeeecccCCceeeCCCCcEEEeeecccc
Q 038766 87 ALILEYMENGSLESVIHGPGVDHSRWTLPKRIDVLISVANGLDYLHSGYDIPIVHCDMKPSNILLDRDFEAHVSDFGTSR 166 (299)
Q Consensus 87 ~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lh~~~~~~~~H~dl~~~nil~~~~~~v~l~df~~~~ 166 (299)
.+|++++.+++|.+.+... ...+++.....+..+.+++++||.. .+.|+|++|+|.+...+|...+.||+...
T Consensus 880 ~L~~~~~~~~~~~Skl~~~----~~~saepaRs~i~~~vqs~e~L~s~---~r~h~~~~p~~~l~~~~gh~~l~~~~t~~ 952 (1205)
T KOG0606|consen 880 PLVGHYLNGGDLPSKLHNS----GCLSAEPARSPILERVQSLESLHSS---LRKHRDLKPDSLLIAYDGHRPLTDFGTLS 952 (1205)
T ss_pred chhhHHhccCCchhhhhcC----CCcccccccchhHHHHhhhhccccc---hhhcccccccchhhcccCCcccCcccccc
Confidence 8999999999999888743 3566667777888899999999997 79999999999999999999999997333
Q ss_pred cccccc-----------------------cc----ccccccccccCcccCChhhhcccCcCccccchhhhHHHHHHHhCC
Q 038766 167 MLDVHL-----------------------QD----LSSLSTAFQGTIGYLAPEFAYMRIVTTKVDVFSFGIVVMEFLTKR 219 (299)
Q Consensus 167 ~~~~~~-----------------------~~----~~~~~~~~~~~~~y~~PE~~~~~~~~~~~DiwslG~~l~~l~~g~ 219 (299)
...... .. .........+++.|.+||...+..-...+|.|+.|+++++.++|.
T Consensus 953 ~vg~~~p~~~~sg~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~t~~~laPe~~lg~~hgs~ad~~~~g~~l~e~l~g~ 1032 (1205)
T KOG0606|consen 953 KVGLIPPTTDLSGPSSSGTPRRLSRSERRPQLSADEARRKHAVVGTPDYLAPEILLGRRHGSAADWWSSGVCLFEVLTGI 1032 (1205)
T ss_pred ccccccCcCCcccccccCccccccccccccccccchhhccccccCCCcccCCcccccccCCCcchhhhhhhhhhhhhcCC
Confidence 211000 00 001233456789999999999999999999999999999999999
Q ss_pred CCCCCCccCCCCchhHHHHHHHHHhcCccCcccccCccccchhhHhHHHHHHHHHHHHHHHHhcCCCCCCCCChh
Q 038766 220 RPTGLDEENGLSPISLRQLVEKALANGINGVRQITDPKLVSSIYEEQEQHQVLEELFKLALVCTSSNPEDRPNMN 294 (299)
Q Consensus 220 ~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rpt~~ 294 (299)
.||..... ....+ +-......+.. .+...+.+..+++.+.+..+|.+|..+.
T Consensus 1033 pp~na~tp-----q~~f~-------ni~~~~~~~p~-----------g~~~~s~~aq~~~~~ll~~~~~qr~~a~ 1084 (1205)
T KOG0606|consen 1033 PPFNAETP-----QQIFE-------NILNRDIPWPE-----------GPEEGSYEAQDLINRLLTEEPTQRLGAK 1084 (1205)
T ss_pred CCCCCcch-----hhhhh-------ccccCCCCCCC-----------CccccChhhhhhhhhhhccCchhccCcc
Confidence 99853322 11111 11111111111 1334456788999999999999999876
|
|
| >PRK15123 lipopolysaccharide core heptose(I) kinase RfaP; Provisional | Back alignment and domain information |
|---|
Probab=99.07 E-value=3.7e-09 Score=87.07 Aligned_cols=141 Identities=16% Similarity=0.101 Sum_probs=94.8
Q ss_pred eecCCcceEEEEEeCCCcEEEEEEeccCcCCh---------hhhHHHHHHHHHHHhcCCcce--eeeeeEEEc--C--CC
Q 038766 20 IGNSNLSTVYKGRLEDGEIVAVKKLNFHQFSA---------ESDKSFYREAKTLKELKHRNL--VKVLGYAWE--S--GK 84 (299)
Q Consensus 20 lg~g~~~~v~~~~~~~~~~~~vK~~~~~~~~~---------~~~~~~~~e~~~l~~l~h~~i--~~~~~~~~~--~--~~ 84 (299)
+-......|.++.. +|+.+.||......... .....+.+|...+.++...+| +.++.+... . ..
T Consensus 30 v~~~~~rrvvr~~~-~g~~~~vKr~~~~~~~~~~k~l~~~~~p~~~a~rE~~~l~~L~~~GIptP~pVa~~e~~~~~~~~ 108 (268)
T PRK15123 30 FRELEGRRTLRFEL-AGKSYFLKWHRGTGWGEIFKNLLSLRMPVLGADREWRAIHRLHEVGVDTMTGVAFGERGSNPATR 108 (268)
T ss_pred EecCCCceEEEEEE-CCEEEEEEEecCCcHHHHhhhhcccccccHHHHHHHHHHHHHHHcCCCCCCeeEEEEecCCCccc
Confidence 33333344556655 47789999764222110 011247789999988853332 333333321 1 12
Q ss_pred eeEEEEeecCCC-ChHHHhcCCCCCCCCCChhhHHHHHHHHHHHHHHhhcCCCCCeeeecccCCceeeCC-------CCc
Q 038766 85 LKALILEYMENG-SLESVIHGPGVDHSRWTLPKRIDVLISVANGLDYLHSGYDIPIVHCDMKPSNILLDR-------DFE 156 (299)
Q Consensus 85 ~~~lv~e~~~~~-~L~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lh~~~~~~~~H~dl~~~nil~~~-------~~~ 156 (299)
..++|+|++++. +|.+++.... ..+.+......++.+++..+..||++ |++|+|+++.|||++. ++.
T Consensus 109 ~s~LVte~l~~~~sL~~~~~~~~--~~~~~~~~~~~ll~~la~~i~~LH~~---Gi~HgDL~~~NiLl~~~~~~~~~~~~ 183 (268)
T PRK15123 109 TSFIITEDLAPTISLEDYCADWA--TNPPDPRLKRMLIKRVATMVRDMHAA---GINHRDCYICHFLLHLPFPGREEDLK 183 (268)
T ss_pred eeEEEEeeCCCCccHHHHHHhhc--ccCCCHHHHHHHHHHHHHHHHHHHHC---cCccCCCChhhEEEeccccCCCCCce
Confidence 347999999875 7888875321 23456677889999999999999999 9999999999999975 467
Q ss_pred EEEeeecccc
Q 038766 157 AHVSDFGTSR 166 (299)
Q Consensus 157 v~l~df~~~~ 166 (299)
+.|+||+.+.
T Consensus 184 ~~LIDl~r~~ 193 (268)
T PRK15123 184 LSVIDLHRAQ 193 (268)
T ss_pred EEEEECCccc
Confidence 8999999775
|
|
| >COG0661 AarF Predicted unusual protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=99.05 E-value=1e-09 Score=97.71 Aligned_cols=152 Identities=24% Similarity=0.336 Sum_probs=101.5
Q ss_pred HHHHhCCCCCCceeecCCcceEEEEEeCCCcEEEEEEeccCcC--------------------Chh-------h-----h
Q 038766 7 IENATGSFSENNIIGNSNLSTVYKGRLEDGEIVAVKKLNFHQF--------------------SAE-------S-----D 54 (299)
Q Consensus 7 ~~~~~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~vK~~~~~~~--------------------~~~-------~-----~ 54 (299)
++.+...|. .+.|+.++.|.||+|+.++|+.||||+.+..-. .+. . .
T Consensus 121 iee~F~eF~-~~PiAsASIaQVH~A~L~sG~~VAVKVqrPgi~~~i~~DL~il~~~a~~~~~~~~~~~~l~~~~vv~e~~ 199 (517)
T COG0661 121 IEELFSEFE-PEPIASASIAQVHRAVLKSGEEVAVKVQRPGIRERIEADLKLLRRLARLIKRLPPGGRRLDLVEVVDEFE 199 (517)
T ss_pred HHHHHHHcC-CCchhhhhHhhheeEEecCCCEEEEEecCCChHHHHHHHHHHHHHHHHHHHHcCCccccCChHHHHHHHH
Confidence 455556665 488999999999999999999999999763110 000 0 0
Q ss_pred H------HHHHHHHHHHhcC----CcceeeeeeEEEcCCCeeEEEEeecCCCChHHH--hcCCCCCCCCCChhhHHHHHH
Q 038766 55 K------SFYREAKTLKELK----HRNLVKVLGYAWESGKLKALILEYMENGSLESV--IHGPGVDHSRWTLPKRIDVLI 122 (299)
Q Consensus 55 ~------~~~~e~~~l~~l~----h~~i~~~~~~~~~~~~~~~lv~e~~~~~~L~~~--~~~~~~~~~~~~~~~~~~i~~ 122 (299)
+ .+..|...+.+++ +..-+.+-.++++-.+...++|||+.|..+.+. ++..+ ++...+.....
T Consensus 200 ~~l~~ElDy~~EA~n~~~~~~nf~~~~~v~VP~V~we~t~~~VLtmE~i~Gi~i~d~~~l~~~g-----~d~k~ia~~~~ 274 (517)
T COG0661 200 KRLREELDYRREAANAERFRENFKDDPDVYVPKVYWEYTTRRVLTMEWIDGIKISDIAALKSAG-----IDRKELAELLV 274 (517)
T ss_pred HHHHHHhCHHHHHHHHHHHHHHcCCCCCeEeceeehhccCCcEEEEEeeCCEecccHHHHHhcC-----CCHHHHHHHHH
Confidence 1 1334555555553 344555666676655556899999999888776 44333 34333333333
Q ss_pred HHHHHHHHhhcCCCCCeeeecccCCceeeCCCCcEEEeeeccccccc
Q 038766 123 SVANGLDYLHSGYDIPIVHCDMKPSNILLDRDFEAHVSDFGTSRMLD 169 (299)
Q Consensus 123 qi~~~l~~lh~~~~~~~~H~dl~~~nil~~~~~~v~l~df~~~~~~~ 169 (299)
++.- +.+-.. ++.|.|.+|.||+++.+|.+.+.|||+...++
T Consensus 275 ~~f~--~q~~~d---gffHaDpHpGNi~v~~~g~i~~lDfGi~g~l~ 316 (517)
T COG0661 275 RAFL--RQLLRD---GFFHADPHPGNILVRSDGRIVLLDFGIVGRLD 316 (517)
T ss_pred HHHH--HHHHhc---CccccCCCccceEEecCCcEEEEcCcceecCC
Confidence 3222 111123 99999999999999999999999999987654
|
|
| >PRK09902 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=98.90 E-value=3.6e-08 Score=77.25 Aligned_cols=142 Identities=21% Similarity=0.153 Sum_probs=100.5
Q ss_pred eecCCcceEEEEEeCCCcEEEEEEeccCc---CC-hhhhHHHHHHHHHHHhcCCcc--eeeeeeEE-E-cCC-CeeEEEE
Q 038766 20 IGNSNLSTVYKGRLEDGEIVAVKKLNFHQ---FS-AESDKSFYREAKTLKELKHRN--LVKVLGYA-W-ESG-KLKALIL 90 (299)
Q Consensus 20 lg~g~~~~v~~~~~~~~~~~~vK~~~~~~---~~-~~~~~~~~~e~~~l~~l~h~~--i~~~~~~~-~-~~~-~~~~lv~ 90 (299)
-|+||-+.|+..... |..+-+|.-.... .. +--...+.+|...++.+..-+ +.++.... . ... ...++|+
T Consensus 26 ~~rgG~SgV~r~~~~-g~~~ylKrq~nhl~~s~r~P~g~ptf~rE~~~L~~L~~~GvPVP~pvf~~~~k~~~~~rA~LVT 104 (216)
T PRK09902 26 YRRNGMSGVQCVERN-GKKLYVKRMTHHLFHSVRYPFGRPTIVREVAVIKELERAGVIVPKIVFGEAVKIEGEWRALLVT 104 (216)
T ss_pred cCCCCcceEEEEEeC-CcEEEEEeccCcccccccCCCCchHHHHHHHHHHHHHHcCCCCCccceeeeeccCCceEEEEEE
Confidence 356888999998765 3468888754111 11 335678999999999997433 33332111 1 111 1237899
Q ss_pred eecCC-CChHHHhcCCCCCCCCCChhhHHHHHHHHHHHHHHhhcCCCCCeeeecccCCceeeCCCCc--EEEeeeccccc
Q 038766 91 EYMEN-GSLESVIHGPGVDHSRWTLPKRIDVLISVANGLDYLHSGYDIPIVHCDMKPSNILLDRDFE--AHVSDFGTSRM 167 (299)
Q Consensus 91 e~~~~-~~L~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lh~~~~~~~~H~dl~~~nil~~~~~~--v~l~df~~~~~ 167 (299)
|-+.+ .+|.+++... .-.+.+......++.+++.+++.||+. ++.|+|+.+.||+++.+|. +.++||.-++.
T Consensus 105 e~L~g~~~L~~~l~~~--~~~~~~~~~k~~il~~va~~ia~LH~~---Gv~Hgdly~khIll~~~g~~~v~lIDlEk~r~ 179 (216)
T PRK09902 105 EDMAGFISIADWYAQH--AVSPYSDEVRQAMLKAVALAFKKMHSV---NRQHGCCYVRHIYVKTEGKAEAGFLDLEKSRR 179 (216)
T ss_pred EeCCCCccHHHHHhcC--CcCCcchHHHHHHHHHHHHHHHHHHHC---CCcCCCCCHhheeecCCCCeeEEEEEhhccch
Confidence 98853 4788877532 223567777889999999999999999 9999999999999987777 89999987653
|
|
| >COG1718 RIO1 Serine/threonine protein kinase involved in cell cycle control [Signal transduction mechanisms / Cell division and chromosome partitioning] | Back alignment and domain information |
|---|
Probab=98.88 E-value=5.6e-08 Score=77.32 Aligned_cols=152 Identities=18% Similarity=0.254 Sum_probs=101.4
Q ss_pred HHHHHHhCCCCCCceee---cCCcceEEEEEeCCCcEEEEEEeccCcCChhhh----------------------HHHHH
Q 038766 5 TEIENATGSFSENNIIG---NSNLSTVYKGRLEDGEIVAVKKLNFHQFSAESD----------------------KSFYR 59 (299)
Q Consensus 5 ~~~~~~~~~y~~~~~lg---~g~~~~v~~~~~~~~~~~~vK~~~~~~~~~~~~----------------------~~~~~ 59 (299)
+.+..+.++..+....| .|.-+.||+|...++..+|+|++..+....... .=..+
T Consensus 38 ~~l~~L~~rg~i~~~~g~istGKEA~Vy~a~~~~~~~~avKiyr~~t~~fk~~~~Yi~gd~Rf~~~~~~rr~lv~~W~~k 117 (268)
T COG1718 38 ETLRRLLSRGVITELVGCISTGKEANVYLAETGDGRYVAVKIYRTSTSEFKRIRRYIQGDPRFRNSRSNRRKLVFAWARK 117 (268)
T ss_pred HHHHHHhcCCceeeeEeeecCCcceEEEeeccCCCceEEEEEEehhhhhhhhHHHHHhcChhhhcCCCCHHHHHHHHHHH
Confidence 44556667777666665 577788999888889999999987543221111 11235
Q ss_pred HHHHHHhcCCc--ceeeeeeEEEcCCCeeEEEEeecCCCChHHHhcCCCCCCCCCChhhHHHHHHHHHHHHHHhhc-CCC
Q 038766 60 EAKTLKELKHR--NLVKVLGYAWESGKLKALILEYMENGSLESVIHGPGVDHSRWTLPKRIDVLISVANGLDYLHS-GYD 136 (299)
Q Consensus 60 e~~~l~~l~h~--~i~~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lh~-~~~ 136 (299)
|+..|+++... .+.+.+.+. . ..+|||++... . ...+....-++...++..+..++++.+.-|-. .
T Consensus 118 Ef~NL~R~~eAGVrvP~Pi~~~---~--nVLvMEfIg~~--g--~pAP~LkDv~~e~~e~~~~~~~~v~~~~~l~~~a-- 186 (268)
T COG1718 118 EFRNLKRAYEAGVRVPEPIAFR---N--NVLVMEFIGDD--G--LPAPRLKDVPLELEEAEGLYEDVVEYMRRLYKEA-- 186 (268)
T ss_pred HHHHHHHHHHcCCCCCCceeec---C--CeEEEEeccCC--C--CCCCCcccCCcCchhHHHHHHHHHHHHHHHHHhc--
Confidence 77777777543 334444421 1 27999999543 1 11121123334444677778888888888877 6
Q ss_pred CCeeeecccCCceeeCCCCcEEEeeeccccccc
Q 038766 137 IPIVHCDMKPSNILLDRDFEAHVSDFGTSRMLD 169 (299)
Q Consensus 137 ~~~~H~dl~~~nil~~~~~~v~l~df~~~~~~~ 169 (299)
++||+||+.-|||+. ++.+.++|++-+....
T Consensus 187 -~LVHgDLSEyNiL~~-~~~p~iID~~QaV~~~ 217 (268)
T COG1718 187 -GLVHGDLSEYNILVH-DGEPYIIDVSQAVTID 217 (268)
T ss_pred -CcccccchhhheEEE-CCeEEEEECccccccC
Confidence 999999999999998 8899999999775443
|
|
| >PF06176 WaaY: Lipopolysaccharide core biosynthesis protein (WaaY); InterPro: IPR009330 This family consists of several bacterial lipopolysaccharide core biosynthesis proteins (WaaY or RfaY) | Back alignment and domain information |
|---|
Probab=98.86 E-value=3.6e-08 Score=77.51 Aligned_cols=141 Identities=16% Similarity=0.202 Sum_probs=90.8
Q ss_pred HHhCCCCCCceeecCCcceEEEEEeCCCcEEEEEEeccCcCChhhh-------HHHHHHHHHHHhcCCc---ceeeeeeE
Q 038766 9 NATGSFSENNIIGNSNLSTVYKGRLEDGEIVAVKKLNFHQFSAESD-------KSFYREAKTLKELKHR---NLVKVLGY 78 (299)
Q Consensus 9 ~~~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~vK~~~~~~~~~~~~-------~~~~~e~~~l~~l~h~---~i~~~~~~ 78 (299)
.+.++|.+.+.+-.....-|.+.... |+.+++|..+.....++.. ..+.+.+..+.+++.. ....++-+
T Consensus 28 i~~~~~~~~kv~k~~~r~~ValIei~-~~kyIlK~pr~~~~r~er~~~sf~kg~~~~~l~~~~~~i~~~g~~~~~~~yl~ 106 (229)
T PF06176_consen 28 ILDNNYKIIKVFKNTKRNYVALIEID-GKKYILKEPREENRRPERRFKSFFKGSEYSRLINNTDKIRNEGFTEPADPYLA 106 (229)
T ss_pred HHhCCceEEEeecCCCccEEEEEEEC-CcEEEEeccchhhhhHHHHHHHHhccHHHHHHHHHHHHHHHcCccccccceee
Confidence 45678888888888888777777654 7889999886433221111 1122333333333322 22222211
Q ss_pred E----EcCCCeeEEEEeecCCCChHHHhcCCCCCCCCCChhhHHHHHHHHHHHHHHhhcCCCCCeeeecccCCceeeCCC
Q 038766 79 A----WESGKLKALILEYMENGSLESVIHGPGVDHSRWTLPKRIDVLISVANGLDYLHSGYDIPIVHCDMKPSNILLDRD 154 (299)
Q Consensus 79 ~----~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lh~~~~~~~~H~dl~~~nil~~~~ 154 (299)
. +......++++||++|..|.+... +++ .+...+.+++..+|+. |++|||..|.|++++.+
T Consensus 107 ~ekk~~~~~~~~~ll~EYIeG~~l~d~~~--------i~e----~~~~ki~~~ikqlH~~---G~~HGD~hpgNFlv~~~ 171 (229)
T PF06176_consen 107 AEKKIFRYTSSYVLLMEYIEGVELNDIED--------IDE----DLAEKIVEAIKQLHKH---GFYHGDPHPGNFLVSNN 171 (229)
T ss_pred eeeeeccceeEEEEEEEEecCeecccchh--------cCH----HHHHHHHHHHHHHHHc---CCccCCCCcCcEEEECC
Confidence 1 111234468999999987766542 232 2446688889999999 99999999999999865
Q ss_pred CcEEEeeecccc
Q 038766 155 FEAHVSDFGTSR 166 (299)
Q Consensus 155 ~~v~l~df~~~~ 166 (299)
+ ++++|++...
T Consensus 172 ~-i~iID~~~k~ 182 (229)
T PF06176_consen 172 G-IRIIDTQGKR 182 (229)
T ss_pred c-EEEEECcccc
Confidence 4 9999998653
|
The waaY, waaQ, and waaP genes are located in the central operon of the waa (formerly rfa) locus on the chromosome of Escherichia coli. This locus contains genes whose products are involved in the assembly of the core region of the lipopolysaccharide molecule. WaaY is the enzyme that phosphorylates HepII in this system [].; GO: 0009244 lipopolysaccharide core region biosynthetic process |
| >PF06293 Kdo: Lipopolysaccharide kinase (Kdo/WaaP) family; InterPro: IPR010440 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases | Back alignment and domain information |
|---|
Probab=98.83 E-value=2.8e-08 Score=79.16 Aligned_cols=137 Identities=22% Similarity=0.206 Sum_probs=93.1
Q ss_pred CcceEEEEEeC----CCcEEEEEEeccCcC-----ChhhhHHHHHHHHHHHhcCCc--ceeeeeeEEEcCC---CeeEEE
Q 038766 24 NLSTVYKGRLE----DGEIVAVKKLNFHQF-----SAESDKSFYREAKTLKELKHR--NLVKVLGYAWESG---KLKALI 89 (299)
Q Consensus 24 ~~~~v~~~~~~----~~~~~~vK~~~~~~~-----~~~~~~~~~~e~~~l~~l~h~--~i~~~~~~~~~~~---~~~~lv 89 (299)
+.+.+|..... .++.+.+|....... .+-......+|...+..+... .+..++.+..... ...++|
T Consensus 16 ~R~~~~~~~~~~~~~~~~~y~~k~~~~~~~~~~~~~~~~~~ra~~E~~~~~~L~~~Gi~tP~pva~~~~r~~~~~~s~li 95 (206)
T PF06293_consen 16 GRRGGWFGVQRVVDLVGRRYYRKRLWNKLRRDRLRFPLRRSRAKREWRNLQRLREAGIPTPEPVAYGERRKGGGYRSYLI 95 (206)
T ss_pred CCceEEEEEEccccccceEEEECCeechhccchhhhcccchHHHHHHHHHHHHHHcCCCCCcEEEEEEEcCCCceeEEEE
Confidence 34455555432 255666665322111 112345678888888888532 2334444333211 223789
Q ss_pred EeecCCC-ChHHHhcCCCCCCCCCChhhHHHHHHHHHHHHHHhhcCCCCCeeeecccCCceeeCCCC---cEEEeeeccc
Q 038766 90 LEYMENG-SLESVIHGPGVDHSRWTLPKRIDVLISVANGLDYLHSGYDIPIVHCDMKPSNILLDRDF---EAHVSDFGTS 165 (299)
Q Consensus 90 ~e~~~~~-~L~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lh~~~~~~~~H~dl~~~nil~~~~~---~v~l~df~~~ 165 (299)
+|++++. +|.+++... ...+......++.+++..++.||++ +++|+|+++.|||++.++ .+.++||+-+
T Consensus 96 te~l~~~~~L~~~~~~~----~~~~~~~~~~ll~~l~~~i~~lH~~---gi~H~Dl~~~NILv~~~~~~~~~~lIDld~~ 168 (206)
T PF06293_consen 96 TEALPGAQDLRDLLQQW----EQLDPSQRRELLRALARLIAKLHDA---GIYHGDLNPSNILVDPDDGQYRFYLIDLDRM 168 (206)
T ss_pred EEeCCCcccHHHHHHhh----cccchhhHHHHHHHHHHHHHHHHHC---cCCCCCCCcccEEEeCCCCceeEEEEcchhc
Confidence 9999874 788888632 2366677889999999999999999 999999999999999887 7899999977
Q ss_pred cc
Q 038766 166 RM 167 (299)
Q Consensus 166 ~~ 167 (299)
..
T Consensus 169 ~~ 170 (206)
T PF06293_consen 169 RF 170 (206)
T ss_pred ee
Confidence 54
|
Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. This entry represents lipopolysaccharide kinases which are related to protein kinases IPR000719 from INTERPRO. This family includes waaP (rfaP) gene product is required for the addition of phosphate to O-4 of the first heptose residue of the lipopolysaccharide (LPS) inner core region. It has previously been shown that WaaP is necessary for resistance to hydrophobic and polycationic antimicrobials in E. coli and that it is required for virulence in invasive strains of Salmonella enterica [].; GO: 0005524 ATP binding, 0016773 phosphotransferase activity, alcohol group as acceptor, 0009103 lipopolysaccharide biosynthetic process, 0016020 membrane |
| >KOG1235 consensus Predicted unusual protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=98.75 E-value=1e-07 Score=84.93 Aligned_cols=152 Identities=26% Similarity=0.335 Sum_probs=99.9
Q ss_pred HHHHhCCCCCCceeecCCcceEEEEEeCCCcEEEEEEeccCcCC-----------------------------hhhhHHH
Q 038766 7 IENATGSFSENNIIGNSNLSTVYKGRLEDGEIVAVKKLNFHQFS-----------------------------AESDKSF 57 (299)
Q Consensus 7 ~~~~~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~vK~~~~~~~~-----------------------------~~~~~~~ 57 (299)
+|.+.+.|. .+.||..+.|.|++|+.++|+.||||+-+..-.. .+..+.+
T Consensus 157 ie~if~~f~-~~piaaASlaQVhrA~L~~G~~VaVKVQ~P~l~~~~~~Dl~~~~~~~~~l~k~~p~~~~~~lvdE~~~~L 235 (538)
T KOG1235|consen 157 IEDIFSEFD-EEPIAAASLAQVHRARLKNGEDVAVKVQHPGLEKLIMLDLRNLRLLAKVLQKFFPDFDLVWLVDEIAKSL 235 (538)
T ss_pred HHHHHHhcC-cchhhhcchhheEEEEecCCCEEEEEecCcChHHHHHHHHHHHHHHHHHHHHhCcCCchhhHHHHHHhhh
Confidence 456666665 6789999999999999999999999985531100 0001111
Q ss_pred ------HHHHHHH----HhcCCcc---eeeeeeEEEcCCCeeEEEEeecCCCChHHH--hcCCCCCCCCCChhhHHHHHH
Q 038766 58 ------YREAKTL----KELKHRN---LVKVLGYAWESGKLKALILEYMENGSLESV--IHGPGVDHSRWTLPKRIDVLI 122 (299)
Q Consensus 58 ------~~e~~~l----~~l~h~~---i~~~~~~~~~~~~~~~lv~e~~~~~~L~~~--~~~~~~~~~~~~~~~~~~i~~ 122 (299)
.+|++-. +.++|-+ -+.+-.++++-.....++|||++|..+.++ +.+ ..++...+..-+.
T Consensus 236 ~~ELDF~~EA~Nae~~~~~f~~~~~~~~V~VP~Vy~~~st~RVLtME~~~G~~i~Dl~~i~~-----~gi~~~~i~~~l~ 310 (538)
T KOG1235|consen 236 PQELDFTKEAKNAERFRENFKDFSLLTYVLVPKVYWDLSTKRVLTMEYVDGIKINDLDAIDK-----RGISPHDILNKLV 310 (538)
T ss_pred HhhcchHHHHHhHHHHHHHHHhcccccceeCCeehhhcCcceEEEEEecCCccCCCHHHHHH-----cCCCHHHHHHHHH
Confidence 2233332 3334445 344566667666677999999999877654 533 3455555554444
Q ss_pred HHHHHHHHhhcCCCCCeeeecccCCceeeCC----CCcEEEeeeccccccc
Q 038766 123 SVANGLDYLHSGYDIPIVHCDMKPSNILLDR----DFEAHVSDFGTSRMLD 169 (299)
Q Consensus 123 qi~~~l~~lh~~~~~~~~H~dl~~~nil~~~----~~~v~l~df~~~~~~~ 169 (299)
+...-.-+ .. |++|+|-.|.||++++ ++.+.+.|+|+...+.
T Consensus 311 ~~~~~qIf--~~---GffHaDPHPGNilv~~~~~~~~~ivllDhGl~~~is 356 (538)
T KOG1235|consen 311 EAYLEQIF--KT---GFFHADPHPGNILVRPNPEGDEEIVLLDHGLYAVIS 356 (538)
T ss_pred HHHHHHHH--hc---CCccCCCCCCcEEEecCCCCCccEEEEccccccccc
Confidence 43332222 22 9999999999999984 6779999999987665
|
|
| >TIGR02172 Fb_sc_TIGR02172 Fibrobacter succinogenes paralogous family TIGR02172 | Back alignment and domain information |
|---|
Probab=98.67 E-value=7.1e-07 Score=72.01 Aligned_cols=138 Identities=12% Similarity=0.093 Sum_probs=79.8
Q ss_pred ceeecCCcceEEEEEeCCCcEEEEEEeccCcCChhhhHHHHHHHHHHHhcCCcce--eeeeeEEEcCCCeeEEEEeecCC
Q 038766 18 NIIGNSNLSTVYKGRLEDGEIVAVKKLNFHQFSAESDKSFYREAKTLKELKHRNL--VKVLGYAWESGKLKALILEYMEN 95 (299)
Q Consensus 18 ~~lg~g~~~~v~~~~~~~~~~~~vK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i--~~~~~~~~~~~~~~~lv~e~~~~ 95 (299)
.+||+|..+.||+. .+..+++|.... ......+.+|.+.++.+..-++ .+.+++... +....+|+|+++|
T Consensus 7 ~~i~~G~t~~~y~~---~~~~~VlR~~~~----~~~~~~i~~E~~~l~~l~~~glpvP~~~~~~~~-~~~~glv~e~i~G 78 (226)
T TIGR02172 7 TQTGEGGNGESYTH---KTGKWMLKLYNP----GFDKETIKREFDASRKVFSLGIPTPHPFDLVED-GGRLGLIYELIVG 78 (226)
T ss_pred eeecCCCCcceeEe---cCCCEEEEeCCC----CCCHHHHHHHHHHHHHHHHcCCCCCceEEEEec-CCeeeeeeeecCC
Confidence 57899999999984 255688898752 1234567889999999864333 455554433 4445789999988
Q ss_pred CC-hHHHhc--------------C-----CCCCCCCCChhhHHH-H--------------HHHHHHHHHHhhcCCCCCee
Q 038766 96 GS-LESVIH--------------G-----PGVDHSRWTLPKRID-V--------------LISVANGLDYLHSGYDIPIV 140 (299)
Q Consensus 96 ~~-L~~~~~--------------~-----~~~~~~~~~~~~~~~-i--------------~~qi~~~l~~lh~~~~~~~~ 140 (299)
.+ +..... . +...-...+...... + ...+...+..+ . ....++
T Consensus 79 ~~~~~~~~~~~~~~~~~l~~~la~~l~~lH~~~~~~~~l~~~~~~~~~~l~~~~~~~~~~~~~l~~~l~~~-~-~~~~~~ 156 (226)
T TIGR02172 79 KRSFSRIISDNPSRLEEIAKIFAEMAKKLHSTKCDTSTFQSYKEKIRKFIEEKDFVPKDYKEKARAFIKEV-P-DTSTCL 156 (226)
T ss_pred ccchhhhhcCCHHHHHHHHHHHHHHHHHHhCCCCCCCcHHHHHHHHHHHHHhccCCCHHHHHHHHHHHHhC-C-CCCceE
Confidence 53 211110 0 000000001000000 0 01111111111 1 123679
Q ss_pred eecccCCceeeCCCCcEEEeeecccc
Q 038766 141 HCDMKPSNILLDRDFEAHVSDFGTSR 166 (299)
Q Consensus 141 H~dl~~~nil~~~~~~v~l~df~~~~ 166 (299)
|||+.|.|++++.++ +.++||+.+.
T Consensus 157 HgD~~~~Nii~~~~~-~~iIDwe~a~ 181 (226)
T TIGR02172 157 HGDFQIGNLITSGKG-TYWIDLGDFG 181 (226)
T ss_pred ecCCCCCcEEEcCCC-cEEEechhcC
Confidence 999999999999888 9999999775
|
This model describes a paralogous family of five proteins, likely to be enzymes, in the rumen bacterium Fibrobacter succinogenes S85. Members show homology to proteins described by PFAM model pfam01636, a phosphotransferase enzyme family associated with resistance to aminoglycoside antibiotics. However, members of this family score below the current trusted and noise cutoffs for pfam01636. |
| >PF01636 APH: Phosphotransferase enzyme family This family is part of the larger protein kinase superfamily | Back alignment and domain information |
|---|
Probab=98.50 E-value=1.8e-06 Score=70.03 Aligned_cols=79 Identities=19% Similarity=0.303 Sum_probs=55.1
Q ss_pred CceeecCCcceEEEEEeCCCcEEEEEEeccCcCChhhhHHHHHHHHHHHhcCCcc--eeeeeeEEEc--CCCeeEEEEee
Q 038766 17 NNIIGNSNLSTVYKGRLEDGEIVAVKKLNFHQFSAESDKSFYREAKTLKELKHRN--LVKVLGYAWE--SGKLKALILEY 92 (299)
Q Consensus 17 ~~~lg~g~~~~v~~~~~~~~~~~~vK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~--i~~~~~~~~~--~~~~~~lv~e~ 92 (299)
++.|+.|..+.||++...+ ..+++|.... ......+..|...++.+.... +..++..... .....++++++
T Consensus 2 i~~l~~G~~n~~~~v~~~~-~~~vlK~~~~----~~~~~~~~~e~~~~~~l~~~~~pvP~~~~~~~~~~~~~~~~~~~~~ 76 (239)
T PF01636_consen 2 IRPLSGGFSNRVYRVTTDD-GRYVLKFYRP----PDAAERLRREAAVLRQLAEHGIPVPRVLAFDTSDEFNGFPYLLMEY 76 (239)
T ss_dssp EEEEEESSSSEEEEEEETT-SEEEEEEESS----HHHHHHHHHHHHHHHHHHHTTSBS--EEEEEEETEETSEEEEEEEE
T ss_pred CccCCCCCeeeEEEEEECC-cEEEEEEeCC----CCCHHHHHHHHHHHHHHHhcCCCCceEEeecccccccccceEEEEE
Confidence 4678999999999999876 6999998642 145677888888888886332 4445542221 22345899999
Q ss_pred cCCCChHH
Q 038766 93 MENGSLES 100 (299)
Q Consensus 93 ~~~~~L~~ 100 (299)
++|..+..
T Consensus 77 i~g~~~~~ 84 (239)
T PF01636_consen 77 IPGRPLDD 84 (239)
T ss_dssp ESSEEHHH
T ss_pred eccccccc
Confidence 98877666
|
; InterPro: IPR002575 This entry consists of bacterial antibiotic resistance proteins, which confer resistance to various aminoglycosides they include:- aminoglycoside 3'-phosphotransferase or kanamycin kinase / neomycin-kanamycin phosphotransferase and streptomycin 3''-kinase or streptomycin 3''-phosphotransferase. The aminoglycoside phosphotransferases inactivate aminoglycoside antibiotics via phosphorylation []. The proteins are found in a range of taxonomic groups.; PDB: 2PPQ_A 2Q83_B 3TDV_B 3TDW_A 3I0O_A 3I0Q_A 3I1A_B 3Q2M_A 3HAV_C 2PUI_B .... |
| >COG2112 Predicted Ser/Thr protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=98.47 E-value=1.7e-06 Score=65.40 Aligned_cols=129 Identities=21% Similarity=0.257 Sum_probs=93.5
Q ss_pred CCCCceeecCCcceEEEEEeCCCcEEEEEEeccCcCChhhhHHHHHHHHHHHhcCCcceee-eeeEEEcCCCeeEEEEee
Q 038766 14 FSENNIIGNSNLSTVYKGRLEDGEIVAVKKLNFHQFSAESDKSFYREAKTLKELKHRNLVK-VLGYAWESGKLKALILEY 92 (299)
Q Consensus 14 y~~~~~lg~g~~~~v~~~~~~~~~~~~vK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~-~~~~~~~~~~~~~lv~e~ 92 (299)
.++.+.|++|.+|.||++.++ |..+|+|+-+ .+.....+..|++++..++-.++.+ ++. +... ++.|||
T Consensus 24 ~~v~~~L~KG~~s~Vyl~~~~-~~~~a~Kvrr----~ds~r~~l~kEakiLeil~g~~~~p~vy~--yg~~---~i~me~ 93 (201)
T COG2112 24 LRVEKELAKGTTSVVYLGEWR-GGEVALKVRR----RDSPRRNLEKEAKILEILAGEGVTPEVYF--YGED---FIRMEY 93 (201)
T ss_pred hhhhhhhhcccccEEEEeecc-CceEEEEEec----CCcchhhHHHHHHHHHHhhhcCCCceEEE--echh---hhhhhh
Confidence 456789999999999999997 4588888743 5566778999999999998666554 333 2222 566999
Q ss_pred cCCCChHHHhcCCCCCCCCCChhhHHHHHHHHHHHHHHhhcCCCCCeeeecccC-CceeeCCCCcEEEeeecccc
Q 038766 93 MENGSLESVIHGPGVDHSRWTLPKRIDVLISVANGLDYLHSGYDIPIVHCDMKP-SNILLDRDFEAHVSDFGTSR 166 (299)
Q Consensus 93 ~~~~~L~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lh~~~~~~~~H~dl~~-~nil~~~~~~v~l~df~~~~ 166 (299)
+.|.+|.++.... + .+-+..++.+..-|-.. +|-|+.|+- ...++..++.+.|+||..++
T Consensus 94 i~G~~L~~~~~~~-------~----rk~l~~vlE~a~~LD~~---GI~H~El~~~~k~vlv~~~~~~iIDFd~At 154 (201)
T COG2112 94 IDGRPLGKLEIGG-------D----RKHLLRVLEKAYKLDRL---GIEHGELSRPWKNVLVNDRDVYIIDFDSAT 154 (201)
T ss_pred hcCcchhhhhhcc-------c----HHHHHHHHHHHHHHHHh---ccchhhhcCCceeEEecCCcEEEEEccchh
Confidence 9988888776411 1 22234566666667676 999999975 44555555589999999876
|
|
| >cd05150 APH Aminoglycoside 3'-phosphotransferase (APH) | Back alignment and domain information |
|---|
Probab=98.40 E-value=8.7e-06 Score=66.69 Aligned_cols=75 Identities=16% Similarity=0.107 Sum_probs=47.7
Q ss_pred eeecCCc-ceEEEEEeCCCcEEEEEEeccCcCChhhhHHHHHHHHHHHhcC-CcceeeeeeEEEcCCCeeEEEEeecCCC
Q 038766 19 IIGNSNL-STVYKGRLEDGEIVAVKKLNFHQFSAESDKSFYREAKTLKELK-HRNLVKVLGYAWESGKLKALILEYMENG 96 (299)
Q Consensus 19 ~lg~g~~-~~v~~~~~~~~~~~~vK~~~~~~~~~~~~~~~~~e~~~l~~l~-h~~i~~~~~~~~~~~~~~~lv~e~~~~~ 96 (299)
.|..|.+ ..||++... +..+++|...... ......|+..++.+. +--+.++++..... ...++|+|+++|.
T Consensus 5 ~~~~g~~~~~v~~~~~~-~~~~~vk~~~~~~-----~~~~~~E~~~l~~l~~~~~vP~v~~~~~~~-~~~~lv~e~i~G~ 77 (244)
T cd05150 5 RVTEGQSGATVYRLDGK-NPGLYLKIAPSGP-----TYELEREAERLRWLAGKLPVPEVIDYGSDD-GRAWLLTSAVPGV 77 (244)
T ss_pred ecCCCCCcCeEEEEcCC-CCcEEEEecCCCc-----ccchHHHHHHHHHHHhcCCCCeEEEEEecC-CccEEEEEeeCCc
Confidence 3444555 788998764 4788889864221 345667888888875 33344455533332 3458999999887
Q ss_pred ChHH
Q 038766 97 SLES 100 (299)
Q Consensus 97 ~L~~ 100 (299)
++..
T Consensus 78 ~l~~ 81 (244)
T cd05150 78 PAAA 81 (244)
T ss_pred cHhH
Confidence 7654
|
The APH subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). APH catalyzes the transfer of the gamma-phosphoryl group from ATP to aminoglycoside antibiotics such as kanamycin, streptomycin, neomycin, and gentamicin, among others. The aminoglycoside antibiotics target the 30S ribosome and promote miscoding, leading to the production of defective proteins which insert into the bacterial membrane, resulting in membrane damage and the ultimate demise of the bacterium. Phosphorylation of the aminoglycoside antibiotics results in their inactivation, leading to bacterial antibiotic resistance. The APH gene is found on transposons and plasmids and is thought to have originated as a self-defense mechanism used by microorganisms that produce the antibio |
| >PF12260 PIP49_C: Protein-kinase domain of FAM69; InterPro: IPR022049 Family with sequence similarity 69 has three members (A, B and C) | Back alignment and domain information |
|---|
Probab=98.34 E-value=3.6e-05 Score=60.14 Aligned_cols=105 Identities=22% Similarity=0.270 Sum_probs=80.8
Q ss_pred HHHHHHHhcCC-cceeeeeeEEEcCCCeeEEEEeecCCCChHHHhcCCCCCCCCCChhhHHHHHHHHHHHHHHhhcCCCC
Q 038766 59 REAKTLKELKH-RNLVKVLGYAWESGKLKALILEYMENGSLESVIHGPGVDHSRWTLPKRIDVLISVANGLDYLHSGYDI 137 (299)
Q Consensus 59 ~e~~~l~~l~h-~~i~~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lh~~~~~ 137 (299)
.|.-+++.+.+ +++.+++|.|.. ++|.|+...+++..... ....-...+...+..++.+++..+.+|+....+
T Consensus 8 ~E~lll~~l~~~~~~pk~lG~CG~-----~~v~E~~~~~~~~~~~~-~l~~~~~~~w~~R~~iA~~lL~~l~~l~~~~~~ 81 (188)
T PF12260_consen 8 NEPLLLQLLQGSEPFPKLLGSCGR-----FYVVEYVGAGSLYGIYR-PLSQFLQSPWEQRAKIALQLLELLEELDHGPLG 81 (188)
T ss_pred cHHHHHHHcCCCCCCCCeeeECCC-----EEEEEeecCcccccccc-ccccccccCHHHHHHHHHHHHHHHHHHhcCCCC
Confidence 47778888875 689999998732 68999997665542200 000122467889999999999999999986555
Q ss_pred CeeeecccCCceeeCCCCcEEEeeeccccccc
Q 038766 138 PIVHCDMKPSNILLDRDFEAHVSDFGTSRMLD 169 (299)
Q Consensus 138 ~~~H~dl~~~nil~~~~~~v~l~df~~~~~~~ 169 (299)
.+.-.|++++|+-++.+|.++++|...+....
T Consensus 82 ~~~lcDv~~~nfgv~~~~~lk~iDld~v~~~~ 113 (188)
T PF12260_consen 82 FFYLCDVSPDNFGVNDDGRLKLIDLDDVFVED 113 (188)
T ss_pred cEEEeecchHHeEEeCCCcEEEEechhcchhH
Confidence 78889999999999999999999999876443
|
Proteins in this uncharacterised family are described as transmembrane proteins. |
| >KOG1035 consensus eIF-2alpha kinase GCN2 [Translation, ribosomal structure and biogenesis] | Back alignment and domain information |
|---|
Probab=98.27 E-value=5e-06 Score=79.10 Aligned_cols=197 Identities=20% Similarity=0.167 Sum_probs=134.1
Q ss_pred HHHHHHHHHHhcCCcceeeeeeEEEcCCCe---eEEEEeecCCCChHHHhcCCCCCCCCCChhhHHHHHHHHHHHHHHhh
Q 038766 56 SFYREAKTLKELKHRNLVKVLGYAWESGKL---KALILEYMENGSLESVIHGPGVDHSRWTLPKRIDVLISVANGLDYLH 132 (299)
Q Consensus 56 ~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~---~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lh 132 (299)
....|...+.+..|+|+..++.+..+...- ..+..+++...++...++ .-..++....+.+..+..++++++|
T Consensus 228 ~~E~e~~~l~k~~~~n~~~~~~~~le~~~~g~~~~v~~~~~s~~~~~~~~q----~v~~i~~~~~r~~~~~~~~GL~~~h 303 (1351)
T KOG1035|consen 228 TTEIELESLSKIAHDNLGGYFVYGLERLFRGIVLDVLQEICSKVELRSLLQ----SVGSIPLETLRILHQKLLEGLAYLH 303 (1351)
T ss_pred HHHHHHHHHHhhccccccceeEEeehhhcchHHHHHHHhhcCccchHHHHh----hccccCHHHHHHHHHHHhhhHHHHH
Confidence 344577778888999999998876543221 123446777777877776 5568899999999999999999999
Q ss_pred cCCCCCeeeecccCC---ceeeCCCCcEEEe--eeccccccccccccccccccccccCcccCChhhhcccCcCc--cccc
Q 038766 133 SGYDIPIVHCDMKPS---NILLDRDFEAHVS--DFGTSRMLDVHLQDLSSLSTAFQGTIGYLAPEFAYMRIVTT--KVDV 205 (299)
Q Consensus 133 ~~~~~~~~H~dl~~~---nil~~~~~~v~l~--df~~~~~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~--~~Di 205 (299)
+. ...|.-+... +.-++..+.+..+ ||+.+..+.... .......+..+.+||.......+. ..|+
T Consensus 304 ~~---~l~~v~L~~s~~~~~~~~~e~~~~~sl~~~~ss~~l~d~~-----~~~~~~~~~~~~~~e~~~~~~~~~~r~~dL 375 (1351)
T KOG1035|consen 304 SL---SLEHVVLSASSSKESTVDGEGVVAISLSDFDSSKPLPDNE-----KSFSDLLAEIRNADEDLKENTAKKSRLTDL 375 (1351)
T ss_pred Hh---ccceeEEecccccccccCccceeecchhhhcccccCCCcc-----cchhhcCccccccccccccccchhhhhhHH
Confidence 98 6666666665 4555666777766 888877654221 122223345667777766665554 4799
Q ss_pred hhhhHHHHHHHhCCCCCCCCccCCCCchhHHHHHHHHHhcCccCcccccCccccchhhHhHHHHHHHHHHHHHHHHhcCC
Q 038766 206 FSFGIVVMEFLTKRRPTGLDEENGLSPISLRQLVEKALANGINGVRQITDPKLVSSIYEEQEQHQVLEELFKLALVCTSS 285 (299)
Q Consensus 206 wslG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~ 285 (299)
|.+|..+..+..|..+-... ......+ .......+.+...+|+..
T Consensus 376 ~~lgll~~~~~~~~~i~~~~-------~~~~~~l----------------------------~~~~~~~~~d~~~~~~~~ 420 (1351)
T KOG1035|consen 376 WCLGLLLLQLSQGEDISEKS-------AVPVSLL----------------------------DVLSTSELLDALPKCLDE 420 (1351)
T ss_pred HHHHHHHhhhhhcCcccccc-------cchhhhh----------------------------ccccchhhhhhhhhhcch
Confidence 99999999998876553111 0000000 001111567789999999
Q ss_pred CCCCCCChhhhhcC
Q 038766 286 NPEDRPNMNELLIT 299 (299)
Q Consensus 286 dP~~Rpt~~~il~~ 299 (299)
++++|+++.++++|
T Consensus 421 ~~~~Rl~~~~ll~~ 434 (1351)
T KOG1035|consen 421 DSEERLSALELLTH 434 (1351)
T ss_pred hhhhccchhhhhhc
Confidence 99999999999876
|
|
| >KOG2270 consensus Serine/threonine protein kinase involved in cell cycle control [Signal transduction mechanisms; Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=98.24 E-value=8.3e-06 Score=68.77 Aligned_cols=143 Identities=19% Similarity=0.210 Sum_probs=100.5
Q ss_pred CCceeecCCcceEEEEEeCCCcEEEEEEeccCcCChhh--------------------hHH----HHHHHHHHHhcCCcc
Q 038766 16 ENNIIGNSNLSTVYKGRLEDGEIVAVKKLNFHQFSAES--------------------DKS----FYREAKTLKELKHRN 71 (299)
Q Consensus 16 ~~~~lg~g~~~~v~~~~~~~~~~~~vK~~~~~~~~~~~--------------------~~~----~~~e~~~l~~l~h~~ 71 (299)
+...|..|.-+.||.|...+|..+|||+++-+-..... ++. +..|.+-|+++....
T Consensus 148 inGCiSTGKEANVYHat~~dG~~~AIKIYKTSILvFKDRdRYV~GEfRFRhgyck~NPRKMVk~WAEKE~RNLkRl~~aG 227 (520)
T KOG2270|consen 148 INGCISTGKEANVYHATEEDGSEFAIKIYKTSILVFKDRDRYVSGEFRFRHGYCKHNPRKMVKTWAEKEMRNLKRLNNAG 227 (520)
T ss_pred cccccccCccceeEeeecCCCceEEEEEEeeeEEEEechhhhccceeeeecccccCCcHHHHHHHHHHHHHHHHHHHhcC
Confidence 45667789999999999999999999987543211111 111 345888888887766
Q ss_pred eeeeeeEEEcCCCeeEEEEeecCCCChHHHhcCCCCCCCCCChhhHHHHHHHHHHHHHHhhcCCCCCeeeecccCCceee
Q 038766 72 LVKVLGYAWESGKLKALILEYMENGSLESVIHGPGVDHSRWTLPKRIDVLISVANGLDYLHSGYDIPIVHCDMKPSNILL 151 (299)
Q Consensus 72 i~~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lh~~~~~~~~H~dl~~~nil~ 151 (299)
| ++-....-.+ . .+||+++.+ +=+ ..+......++...+..+-++++..+.-|-+.| ++||.||+--|+|+
T Consensus 228 I-P~PePIlLk~-h-VLVM~FlGr-dgw---~aPkLKd~~ls~~ka~~~Y~~~v~~MR~lY~~c--~LVHADLSEfN~Ly 298 (520)
T KOG2270|consen 228 I-PCPEPILLKN-H-VLVMEFLGR-DGW---AAPKLKDASLSTSKARELYQQCVRIMRRLYQKC--RLVHADLSEFNLLY 298 (520)
T ss_pred C-CCCCceeeec-c-eEeeeeccC-CCC---cCcccccccCChHHHHHHHHHHHHHHHHHHHHh--ceeccchhhhhheE
Confidence 3 3333233222 2 799999943 221 112224456777888899999999999998876 99999999999999
Q ss_pred CCCCcEEEeeecccccc
Q 038766 152 DRDFEAHVSDFGTSRML 168 (299)
Q Consensus 152 ~~~~~v~l~df~~~~~~ 168 (299)
.+|.+.++|.+-+-..
T Consensus 299 -hdG~lyiIDVSQSVE~ 314 (520)
T KOG2270|consen 299 -HDGKLYIIDVSQSVEH 314 (520)
T ss_pred -ECCEEEEEEccccccC
Confidence 5668999999866443
|
|
| >PF10707 YrbL-PhoP_reg: PhoP regulatory network protein YrbL; InterPro: IPR019647 This entry represents proteins that are activated by the protein PhoP | Back alignment and domain information |
|---|
Probab=98.20 E-value=8.8e-05 Score=58.29 Aligned_cols=123 Identities=20% Similarity=0.281 Sum_probs=82.4
Q ss_pred CCceeecCCcceEEEEEeCCCcEEEEEEeccCc--------------CChhhhHHHHHHHHHHHhcC------Ccceeee
Q 038766 16 ENNIIGNSNLSTVYKGRLEDGEIVAVKKLNFHQ--------------FSAESDKSFYREAKTLKELK------HRNLVKV 75 (299)
Q Consensus 16 ~~~~lg~g~~~~v~~~~~~~~~~~~vK~~~~~~--------------~~~~~~~~~~~e~~~l~~l~------h~~i~~~ 75 (299)
-...||+|+.-.||.-- +....+||+..... ..........+|+.....+. +.+|.++
T Consensus 5 ~~~~i~~G~~R~cy~HP--~dp~~cIKV~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~E~~~y~~l~~~~~~~~~~i~r~ 82 (199)
T PF10707_consen 5 ESDLIAQGGERDCYQHP--DDPNLCIKVMRPDRGERRRPFKRWLKRLRPKSRYRQNRRELRYYKQLSLRRGVDWSHIPRF 82 (199)
T ss_pred CCcccccCCCceEEECC--CCCCeEEEEEccccccccccchhHHHhhcccchhHHHHHHHHHHHHHhhccCCcccccccE
Confidence 45689999999888543 34457889886543 11122455666776666665 7899999
Q ss_pred eeEEEcCCCeeEEEEeecCC------CChHHHhcCCCCCCCCCChhhHHHHHHHHHHHHHHhhcCCCCCeeeecccCCce
Q 038766 76 LGYAWESGKLKALILEYMEN------GSLESVIHGPGVDHSRWTLPKRIDVLISVANGLDYLHSGYDIPIVHCDMKPSNI 149 (299)
Q Consensus 76 ~~~~~~~~~~~~lv~e~~~~------~~L~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lh~~~~~~~~H~dl~~~ni 149 (299)
+|.+.. +....+|+|.+.+ .+|.+++. ...+++ +....+. .-.++|-++ +|+.+|++|.||
T Consensus 83 ~G~veT-~~G~Glv~e~I~d~dG~~s~TL~~~l~-----~~~~~~-~~~~~L~---~f~~~l~~~---~Iv~~dl~~~NI 149 (199)
T PF10707_consen 83 YGFVET-NLGLGLVVELIRDADGNISPTLEDYLK-----EGGLTE-ELRQALD---EFKRYLLDH---HIVIRDLNPHNI 149 (199)
T ss_pred eEEEec-CCceEEEEEEEECCCCCcCccHHHHHH-----cCCccH-HHHHHHH---HHHHHHHHc---CCeecCCCcccE
Confidence 996554 4445888887642 36777774 234555 4444444 444566677 999999999999
Q ss_pred eeCC
Q 038766 150 LLDR 153 (299)
Q Consensus 150 l~~~ 153 (299)
++..
T Consensus 150 v~~~ 153 (199)
T PF10707_consen 150 VVQR 153 (199)
T ss_pred EEEe
Confidence 9953
|
PhoP controls the expression of a large number of genes that mediate adaptation to low Mg2+ environments and/or virulence in several bacterial species. YbrL is proposed to be acting in a loop activity with PhoP and PrmA analogous to the multi-component loop in Salmonella sp., where the PhoP-dependent PmrD protein activates the regulatory protein PmrA, and the activated PmrA then represses transcription from the PmrD promoter which harbours binding sites for both the PhoP and PmrA proteins. Expression of YrbL is induced in low Mg2+ in a PhoP-dependent fashion and repressed by Fe3+ in a PmrA-dependent manner []. |
| >cd05155 APH_ChoK_like_1 Uncharacterized bacterial proteins with similarity to Aminoglycoside 3'-phosphotransferase (APH) and Choline kinase (ChoK) family members | Back alignment and domain information |
|---|
Probab=98.19 E-value=2.5e-05 Score=63.66 Aligned_cols=75 Identities=11% Similarity=0.086 Sum_probs=44.4
Q ss_pred CceeecCCcc-eEEEEEeCCCcEEEEEEeccCcCChhhhHHHHHHHHHHHhcCCc---ceeeeeeEEEcC--CCeeEEEE
Q 038766 17 NNIIGNSNLS-TVYKGRLEDGEIVAVKKLNFHQFSAESDKSFYREAKTLKELKHR---NLVKVLGYAWES--GKLKALIL 90 (299)
Q Consensus 17 ~~~lg~g~~~-~v~~~~~~~~~~~~vK~~~~~~~~~~~~~~~~~e~~~l~~l~h~---~i~~~~~~~~~~--~~~~~lv~ 90 (299)
++.++.|+.. .||++. ..+++|.... ......+..|.+.++.+... .+..+++..... ....++++
T Consensus 2 ~~~~~~gG~~n~vy~~~----~~~VlR~~~~----~~~~~~~~~E~~~l~~L~~~~~v~vP~~~~~~~~~~~~~~~~~l~ 73 (235)
T cd05155 2 IEPVDSGGTDNATFRLG----DDMSVRLPSA----AGYAGQVRKEQRWLPRLAPHLPLPVPEPLGKGEPGEGYPWPWSVY 73 (235)
T ss_pred ceeccCCCcccceEEcC----CceEEEcCCc----cchHHHHHHHHHHHHHHhccCCCCCCceeecCCCccCCCcceEEE
Confidence 3567777666 488763 3577887542 22345788899999888632 223333311111 12347899
Q ss_pred eecCCCChH
Q 038766 91 EYMENGSLE 99 (299)
Q Consensus 91 e~~~~~~L~ 99 (299)
++++|.++.
T Consensus 74 ~~i~G~~l~ 82 (235)
T cd05155 74 RWLEGETAT 82 (235)
T ss_pred EeecCCCCC
Confidence 999886653
|
The APH/ChoK subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). This family is composed of APH, ChoK, ethanolamine kinase (ETNK), macrolide 2'-phosphotransferase (MPH2'), an unusual homoserine kinase, and uncharacterized proteins with similarity to the N-terminal domain of acyl-CoA dehydrogenase 10 (ACAD10). The members of this family catalyze the transfer of the gamma-phosphoryl group from ATP (or CTP) to small molecule substrates, such as aminoglycosides, macrolides, choline, ethanolamine, and homoserine. Phosphorylation of the antibiotics, aminoglycosides, and macrolides leads to their inactivation and to bacterial antibiotic resista |
| >PLN02876 acyl-CoA dehydrogenase | Back alignment and domain information |
|---|
Probab=98.15 E-value=5.8e-05 Score=72.58 Aligned_cols=80 Identities=19% Similarity=0.255 Sum_probs=54.1
Q ss_pred CceeecCCcceEEEEEeCCC---cEEEEEEeccCcCChhhhHHHHHHHHHHHhcC-Ccce--eeeeeEEEcCC--CeeEE
Q 038766 17 NNIIGNSNLSTVYKGRLEDG---EIVAVKKLNFHQFSAESDKSFYREAKTLKELK-HRNL--VKVLGYAWESG--KLKAL 88 (299)
Q Consensus 17 ~~~lg~g~~~~v~~~~~~~~---~~~~vK~~~~~~~~~~~~~~~~~e~~~l~~l~-h~~i--~~~~~~~~~~~--~~~~l 88 (299)
+++++.|.+..+|++...++ ..+++|+..... .......+.+|+..++.+. |.++ .+++.++.+.. ...++
T Consensus 43 v~~l~gG~sn~ty~l~~~~~~~~~~~VLR~~p~~~-~~~~~~~~~rE~~~l~~L~~~~~vpVP~v~~~~~d~~v~G~~fl 121 (822)
T PLN02876 43 VSQFGHGQSNPTFLLEVGNGGSVKRYVLRKKPPGK-LLQSAHAVEREYQVLRALGEHTDVPVPKVYCLCTDASVIGTAFY 121 (822)
T ss_pred EEEeCCCCcCceEEEEECCCCcceeEEEEeCCCCc-cCccHHHHHHHHHHHHHHhhcCCCCCCcEEEEecCCCcCCCceE
Confidence 67788899999999886543 478888754221 1123457889999999996 6654 55555443321 23589
Q ss_pred EEeecCCCC
Q 038766 89 ILEYMENGS 97 (299)
Q Consensus 89 v~e~~~~~~ 97 (299)
|||+++|..
T Consensus 122 VME~v~G~~ 130 (822)
T PLN02876 122 IMEYLEGRI 130 (822)
T ss_pred EEEecCCcc
Confidence 999998754
|
|
| >cd05157 ETNK_euk Ethanolamine kinase (ETNK) in eukaryotes | Back alignment and domain information |
|---|
Probab=98.12 E-value=5e-05 Score=61.79 Aligned_cols=74 Identities=18% Similarity=0.184 Sum_probs=47.3
Q ss_pred CceeecCCcceEEEEEeCC--CcEEEEEEeccCcCChhhhHHHHHHHHHHHhcCCcceee-eeeEEEcCCCeeEEEEeec
Q 038766 17 NNIIGNSNLSTVYKGRLED--GEIVAVKKLNFHQFSAESDKSFYREAKTLKELKHRNLVK-VLGYAWESGKLKALILEYM 93 (299)
Q Consensus 17 ~~~lg~g~~~~v~~~~~~~--~~~~~vK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~-~~~~~~~~~~~~~lv~e~~ 93 (299)
.+.|..|-...+|++...+ ++.|++|+.... .........|...++.+...++.+ ++. ... . .+++||+
T Consensus 3 i~~l~gG~tN~~~~v~~~~~~~~~~vlR~~~~~---~~~~~d~~~E~~~~~~l~~~gl~P~v~~-~~~--~--~~l~e~i 74 (235)
T cd05157 3 FKRFTGGITNKLVKVSNKEDNQDAVLVRVYGNK---TELIIDRERELRIHKLLSKHGLAPKLYA-TFQ--N--GLIYEFI 74 (235)
T ss_pred EEEcCCcccceEEEEEcCCCCCCeEEEEEccCC---ccceecHHHHHHHHHHHHhCCCCCeEEE-EeC--C--cEEEEee
Confidence 3567778889999998764 678999976422 112223346888888886444433 333 221 2 4899999
Q ss_pred CCCCh
Q 038766 94 ENGSL 98 (299)
Q Consensus 94 ~~~~L 98 (299)
+|.++
T Consensus 75 ~G~~l 79 (235)
T cd05157 75 PGRTL 79 (235)
T ss_pred CCCcC
Confidence 88665
|
ETNK is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). ETNK catalyzes the transfer of the gamma-phosphoryl group from CTP to ethanolamine (Etn), the first step in the CDP-Etn pathway for the formation of the major phospholipid, phosphatidylethanolamine (PtdEtn). Unlike ChoK, ETNK shows specific activity for its substrate, and displays negligible activity towards N-methylated derivatives of Etn. The Drosophila ETNK is implicated in development and neuronal function. Mammals contain two ETNK proteins, ETNK1 and ETNK2. ETNK1 selectively increases Etn uptake and phosphorylation, as well as PtdEtn synthesis. ETNK2 is found primarily in the liver and reproductive tissues. It plays a critical role in regulating placental hemostasis to support late embryo |
| >cd05153 HomoserineK_II Homoserine Kinase, type II | Back alignment and domain information |
|---|
Probab=98.06 E-value=3.8e-05 Score=64.86 Aligned_cols=156 Identities=15% Similarity=0.096 Sum_probs=87.8
Q ss_pred HHHHHHhCCCCC-----CceeecCCcceEEEEEeCCCcEEEEEEeccCcCChhhhHHHHHHHHHHHhcCCcc--eeeeee
Q 038766 5 TEIENATGSFSE-----NNIIGNSNLSTVYKGRLEDGEIVAVKKLNFHQFSAESDKSFYREAKTLKELKHRN--LVKVLG 77 (299)
Q Consensus 5 ~~~~~~~~~y~~-----~~~lg~g~~~~v~~~~~~~~~~~~vK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~--i~~~~~ 77 (299)
++++.+.++|.+ .+.+..|....+|++... +..+++|+... .....+..|+..++.+...+ +.+++.
T Consensus 2 ~~l~~~l~~y~~~~~~~i~~i~~G~~n~~y~v~~~-~~~~vLr~~~~-----~~~~~~~~e~~~l~~L~~~g~~vp~~i~ 75 (296)
T cd05153 2 EELASFLADYDLGELLSFEGISAGIENTNYFVTTD-SGRYVLTLFEK-----VSAEELPFFLALLDHLAERGLPVPRPIA 75 (296)
T ss_pred HHHHHHHHHcCCCchhheecccCccccceEEEEeC-CCcEEEEEcCC-----CChHhccHHHHHHHHHHHCCCCCCcccc
Confidence 456666677775 455667888899998764 44789998752 23455667777777775333 333322
Q ss_pred E-----EEcCCCeeEEEEeecCCCChHH-----------Hh-------cCCCCCCCC-CC----hhhH--------HHHH
Q 038766 78 Y-----AWESGKLKALILEYMENGSLES-----------VI-------HGPGVDHSR-WT----LPKR--------IDVL 121 (299)
Q Consensus 78 ~-----~~~~~~~~~lv~e~~~~~~L~~-----------~~-------~~~~~~~~~-~~----~~~~--------~~i~ 121 (299)
. ....++..++++++++|..+.. .+ ......... .. .... ....
T Consensus 76 ~~~g~~~~~~~~~~~~l~~~i~G~~~~~~~~~~~~~lg~~La~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~ 155 (296)
T cd05153 76 DRDGEYLSELAGKPAALVEFLAGEHLTRPTAAHCRQIGEALARLHLAAQSFPGERNNLRGLAWIRELGKDLLPLLSAEDR 155 (296)
T ss_pred CCCCcEeeeeCCceEEEEEeCCCCCCCCCCHHHHHHHHHHHHHHHHHhccCCccCCCcCCcHHHHHHHHHhccccCHHHH
Confidence 1 1111233478999998765421 00 000000000 00 0000 0011
Q ss_pred HHHHHHHHHhhc----CCCCCeeeecccCCceeeCCCCcEEEeeecccc
Q 038766 122 ISVANGLDYLHS----GYDIPIVHCDMKPSNILLDRDFEAHVSDFGTSR 166 (299)
Q Consensus 122 ~qi~~~l~~lh~----~~~~~~~H~dl~~~nil~~~~~~v~l~df~~~~ 166 (299)
..+..++.++.+ ..+..+||+|+.|.|++++.++.+.++||+.+.
T Consensus 156 ~~~~~~~~~l~~~~~~~~~~~l~HgD~~~~Nil~~~~~~~~iIDfe~a~ 204 (296)
T cd05153 156 ALLADELARQDAFDPSDLPRGVIHADLFRDNVLFDGDELSGVIDFYFAC 204 (296)
T ss_pred HHHHHHHHHHHhhhhhcCCCcCCccCcCcccEEEeCCceEEEeehhhhc
Confidence 112233333332 112379999999999999988777899999875
|
Homoserine kinase is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). This subfamily is composed of unusual homoserine kinases, from a subset of bacteria, which have a PK fold. These proteins do not bear any similarity to the GHMP family homoserine kinases present in most bacteria and eukaryotes. Homoserine kinase catalyzes the transfer of the gamma-phosphoryl group from ATP to L-homoserine producing L-homoserine phosphate, an intermediate in the production of the amino acids threonine, methionine, and isoleucine. |
| >PRK05231 homoserine kinase; Provisional | Back alignment and domain information |
|---|
Probab=98.06 E-value=0.00014 Score=62.09 Aligned_cols=158 Identities=15% Similarity=0.155 Sum_probs=82.9
Q ss_pred ChHHHHHHhCCCCC-----CceeecCCcceEEEEEeCCCcEEEEEEeccCcCChhhhHHHHHHHHHHHhcCCcc--eeee
Q 038766 3 DRTEIENATGSFSE-----NNIIGNSNLSTVYKGRLEDGEIVAVKKLNFHQFSAESDKSFYREAKTLKELKHRN--LVKV 75 (299)
Q Consensus 3 ~~~~~~~~~~~y~~-----~~~lg~g~~~~v~~~~~~~~~~~~vK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~--i~~~ 75 (299)
+.++++.+.+.|.+ .+.|+.|...++|.+...+| .+++|++. ... .+.+..+...++.+...+ +.++
T Consensus 8 s~~~l~~~l~~y~~~~~~~~~~l~~G~~n~~y~v~t~~g-~~vLK~~~--~~~---~~~l~~~~~~l~~L~~~glpvP~~ 81 (319)
T PRK05231 8 SDDELAAFLAPYDLGELLSLKGIAEGIENSNFFLTTTQG-EYVLTLFE--RLT---AEDLPFFLGLMQHLAARGVPVPAP 81 (319)
T ss_pred CHHHHHHHHHhcCCchhhccchhccccccceEEEEeCCC-cEEEEEec--cCC---hHHhHHHHHHHHHHHHCCCCCCcc
Confidence 45667667678866 35566777789999986655 68899875 112 223334455555553212 2222
Q ss_pred eeE-----EEcCCCeeEEEEeecCCCChH-----------HHhc---CCCCCC-----CCCCh----h-----------h
Q 038766 76 LGY-----AWESGKLKALILEYMENGSLE-----------SVIH---GPGVDH-----SRWTL----P-----------K 116 (299)
Q Consensus 76 ~~~-----~~~~~~~~~lv~e~~~~~~L~-----------~~~~---~~~~~~-----~~~~~----~-----------~ 116 (299)
+.. +...+...++++++++|..+. ..+. ...... ..... . .
T Consensus 82 i~~~~G~~~~~~~g~~~~l~~~l~G~~~~~~~~~~~~~~G~~LA~lH~~~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~ 161 (319)
T PRK05231 82 VARRDGAALGELAGKPAAIVTFLEGKWPRAPTAAHCAEVGEMLARMHLAGRDFPLERPNLRGLAWWRELAPRLLPFLADE 161 (319)
T ss_pred eeCCCCCEeeeeCCEEEEEEEecCCCCCCCCCHHHHHHHHHHHHHHHhhhhcCCccCCCCCChHHHHHHHHHHhhccChh
Confidence 210 111133458999999886421 1111 000000 00000 0 0
Q ss_pred HHHHHHH-HHHHHHHhhcC----CCCCeeeecccCCceeeCCCCcEEEeeecccc
Q 038766 117 RIDVLIS-VANGLDYLHSG----YDIPIVHCDMKPSNILLDRDFEAHVSDFGTSR 166 (299)
Q Consensus 117 ~~~i~~q-i~~~l~~lh~~----~~~~~~H~dl~~~nil~~~~~~v~l~df~~~~ 166 (299)
....+.+ +...+..+.+. ...++||+|+.|+||+++.+...-++||+.+.
T Consensus 162 ~~~~l~~~~~~~~~~~~~~~~~~lp~~liHgD~~~~Nil~~~~~~~~iIDf~~~~ 216 (319)
T PRK05231 162 QAALLEAELAAQLAFLASAAWPALPRGVIHADLFRDNVLFEGDRLSGFIDFYFAC 216 (319)
T ss_pred HHHHHHHHHHHHHHhhhccccccCCcccCCCCCCCCcEEEECCceEEEEeccccc
Confidence 0011111 11122222210 23489999999999999866556899999875
|
|
| >TIGR02721 ycfN_thiK thiamine kinase | Back alignment and domain information |
|---|
Probab=98.06 E-value=5e-05 Score=62.68 Aligned_cols=140 Identities=12% Similarity=0.098 Sum_probs=76.2
Q ss_pred eeecCCcceEEEEEeCCCcEEEEEEeccCcCChhhhHHHHHHHHHHHhcCCccee-eeeeEEEcCCCeeEEEEeecCCCC
Q 038766 19 IIGNSNLSTVYKGRLEDGEIVAVKKLNFHQFSAESDKSFYREAKTLKELKHRNLV-KVLGYAWESGKLKALILEYMENGS 97 (299)
Q Consensus 19 ~lg~g~~~~v~~~~~~~~~~~~vK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~-~~~~~~~~~~~~~~lv~e~~~~~~ 97 (299)
.+..|-...+|++.. +++.+++|+..... ........+|..+++.+...++. +++.. . . -++|+||++|..
T Consensus 3 ~~~~G~tn~~y~~~~-~~~~~vlR~~~~~~--~~~~~~r~~E~~~l~~l~~~g~~P~~i~~--~-~--~~~v~e~i~G~~ 74 (256)
T TIGR02721 3 TLSGGLTNRSWRIEH-PGISFVWRPQSPVC--KALGVDRQREYQILQALSALGLAPKPILV--N-E--HWLLVEWLEGEV 74 (256)
T ss_pred cCCCcCcCCeEEEEe-CCccEEEeeCCccc--ccccCcHHHHHHHHHHHHhcCCCCceEEE--e-C--CEEEEEeccCcc
Confidence 456688889999874 46788999754221 11111346788888888643332 23332 1 2 268999998865
Q ss_pred hHHH--------------hcC-CCC--CCCCCChh-hHHHHHHHH---------HHHHHHhhcC-----CCCCeeeeccc
Q 038766 98 LESV--------------IHG-PGV--DHSRWTLP-KRIDVLISV---------ANGLDYLHSG-----YDIPIVHCDMK 145 (299)
Q Consensus 98 L~~~--------------~~~-~~~--~~~~~~~~-~~~~i~~qi---------~~~l~~lh~~-----~~~~~~H~dl~ 145 (299)
+... +.+ +.. ...+++.. .+..+..++ ...+..+-.. .+..+||+|+.
T Consensus 75 ~~~~~~~~~~~~~~la~~l~~lH~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~H~Dl~ 154 (256)
T TIGR02721 75 ITLDQFVALDLLLELAALLHQLHSQPRFGYPLSLKARIAHYWLQIDPARRTPEWLRLYKQFRSAPEPAPLPLAPLHMDVH 154 (256)
T ss_pred cccccccCchhHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHHhcccccCChHHHHHHHHHHhccCCCCCCCeeecCCCC
Confidence 4311 110 110 11121111 111111111 1111111111 12368999999
Q ss_pred CCceeeCCCCcEEEeeeccccc
Q 038766 146 PSNILLDRDFEAHVSDFGTSRM 167 (299)
Q Consensus 146 ~~nil~~~~~~v~l~df~~~~~ 167 (299)
|.||+++.++ +.++||+.+..
T Consensus 155 ~~Nil~~~~~-~~lIDwE~a~~ 175 (256)
T TIGR02721 155 AYNLVVTPQG-LKLIDWEYASD 175 (256)
T ss_pred cCcEEEeCCC-CEEEeccccCc
Confidence 9999999877 78999998753
|
Members of this family are the ycfN gene product of Escherichia coli, now identified as the salvage enzyme thiamine kinase (thiK), and additional proteobacterial homologs taken to be orthologs with equivalent function. |
| >KOG2268 consensus Serine/threonine protein kinase [Signal transduction mechanisms; General function prediction only] | Back alignment and domain information |
|---|
Probab=98.05 E-value=5e-06 Score=68.92 Aligned_cols=139 Identities=21% Similarity=0.188 Sum_probs=98.5
Q ss_pred CCCCCceeecCCcceEEEEEeCCCcEEEEEEeccCcCC------------------hh--hhHHHHHHHHHHHhcCCcc-
Q 038766 13 SFSENNIIGNSNLSTVYKGRLEDGEIVAVKKLNFHQFS------------------AE--SDKSFYREAKTLKELKHRN- 71 (299)
Q Consensus 13 ~y~~~~~lg~g~~~~v~~~~~~~~~~~~vK~~~~~~~~------------------~~--~~~~~~~e~~~l~~l~h~~- 71 (299)
-+.++++||=|.-+.+|.+.+..|+..++|.-+.-.++ +- ++-...+|+..|+.+....
T Consensus 93 v~svGnqIGVGKESDIY~v~d~~G~~~~lK~HRLGRtSFR~Vk~kRDY~r~r~~~sWlyLSRlaa~kEfafmkaL~e~gf 172 (465)
T KOG2268|consen 93 VESVGNQIGVGKESDIYVVADEEGNPLILKLHRLGRTSFRNVKNKRDYLRKRKSGSWLYLSRLAATKEFAFMKALYERGF 172 (465)
T ss_pred hhhhccccccccccceEEEecCCCCchhHHHHhhhhhhHHHhhhhhhhHhcCCccchhhhHHHHHHHHHHHHHHHHHcCC
Confidence 46788999999999999999998999999964432111 11 1234557888888886322
Q ss_pred -eeeeeeEEEcCCCeeEEEEeecCCCChHHHhcCCCCCCCCCChhhHHHHHHHHHHHHHHhhcCCCCCeeeecccCCcee
Q 038766 72 -LVKVLGYAWESGKLKALILEYMENGSLESVIHGPGVDHSRWTLPKRIDVLISVANGLDYLHSGYDIPIVHCDMKPSNIL 150 (299)
Q Consensus 72 -i~~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lh~~~~~~~~H~dl~~~nil 150 (299)
+.+.++ ...+ ++|||.+.+.+|...-.- .....+...+...+.-|-.+ |++|||..-=||+
T Consensus 173 pVPkpiD----~~RH-~Vvmelv~g~Pl~~v~~v----------~d~~~ly~~lm~~Iv~la~~---GlIHgDFNEFNim 234 (465)
T KOG2268|consen 173 PVPKPID----HNRH-CVVMELVDGYPLRQVRHV----------EDPPTLYDDLMGLIVRLANH---GLIHGDFNEFNIM 234 (465)
T ss_pred CCCCccc----ccce-eeHHHhhcccceeeeeec----------CChHHHHHHHHHHHHHHHHc---CceecccchheeE
Confidence 333333 3444 899999988777654421 11233445566667777777 9999999999999
Q ss_pred eCCCCcEEEeeeccccccc
Q 038766 151 LDRDFEAHVSDFGTSRMLD 169 (299)
Q Consensus 151 ~~~~~~v~l~df~~~~~~~ 169 (299)
++.++.++++||.-+-..+
T Consensus 235 v~dd~~i~vIDFPQmvS~s 253 (465)
T KOG2268|consen 235 VKDDDKIVVIDFPQMVSTS 253 (465)
T ss_pred EecCCCEEEeechHhhccC
Confidence 9999999999998765544
|
|
| >PRK10593 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=97.91 E-value=0.00039 Score=58.68 Aligned_cols=81 Identities=16% Similarity=0.087 Sum_probs=55.9
Q ss_pred CCCCCceeecCCcceEEEEEeCCCcEEEEEEeccCcCChhhhHHHHHHHHHHHhcCC---cceeeeeeEEEcC--CCeeE
Q 038766 13 SFSENNIIGNSNLSTVYKGRLEDGEIVAVKKLNFHQFSAESDKSFYREAKTLKELKH---RNLVKVLGYAWES--GKLKA 87 (299)
Q Consensus 13 ~y~~~~~lg~g~~~~v~~~~~~~~~~~~vK~~~~~~~~~~~~~~~~~e~~~l~~l~h---~~i~~~~~~~~~~--~~~~~ 87 (299)
.-.-.+.||.|..+.||.....++ ++++|... . ......+..|+..++.+.- -.+.++++++... ....+
T Consensus 15 ~~~~~~~i~~G~~~~vy~~~~~~~-~~~~k~~~--~--~~~~~~~~~Ea~~L~~L~~~~~vpVP~V~~~~~~~~~~g~~~ 89 (297)
T PRK10593 15 KLSRVECISEQPYAALWALYDSQG-NPMPLMAR--S--FSTPGVAQQEAWKLSMLARSGTVRMPTVYGVMTHEQSPGPDV 89 (297)
T ss_pred hhheeeecCCccceeEEEEEcCCC-CEEEEEec--c--cccchHHHHHHHHHHHHccCCCCCcCcEEEEeccCCcCCCeE
Confidence 445567899999999999987655 46777743 1 1133578889999998863 3566677654322 23359
Q ss_pred EEEeecCCCCh
Q 038766 88 LILEYMENGSL 98 (299)
Q Consensus 88 lv~e~~~~~~L 98 (299)
+|||++++.++
T Consensus 90 LVmE~i~G~~~ 100 (297)
T PRK10593 90 LLLERLRGVSV 100 (297)
T ss_pred EEEeccCCEec
Confidence 99999987654
|
|
| >TIGR00938 thrB_alt homoserine kinase, Neisseria type | Back alignment and domain information |
|---|
Probab=97.88 E-value=0.00017 Score=61.18 Aligned_cols=158 Identities=18% Similarity=0.180 Sum_probs=86.3
Q ss_pred ChHHHHHHhCCCCC-----CceeecCCcceEEEEEeCCCcEEEEEEeccCcCChhhhHHHHHHHHHHHhcCCcc--eeee
Q 038766 3 DRTEIENATGSFSE-----NNIIGNSNLSTVYKGRLEDGEIVAVKKLNFHQFSAESDKSFYREAKTLKELKHRN--LVKV 75 (299)
Q Consensus 3 ~~~~~~~~~~~y~~-----~~~lg~g~~~~v~~~~~~~~~~~~vK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~--i~~~ 75 (299)
+.+++..+.++|.+ .+.++.|....+|++...+| .+++|+..... ..+.+..+.+.+..+...+ +.++
T Consensus 8 ~~~~l~~~l~~y~~~~~~~i~~~~~G~~n~~y~v~t~~~-~~vLK~~~~~~----~~~~i~~e~~~l~~L~~~g~pvp~~ 82 (307)
T TIGR00938 8 SDEEMSSFLDGYDLGELLSLKGIAEGVENSNYLLTTDVG-RYILTLYEKRV----KAEELPFFLALTTHLAARGLPVPKP 82 (307)
T ss_pred CHHHHHHHHHhcCCCCceeccccCCccccceEEEEeCCC-cEEEEEecCCC----CHHHHHHHHHHHHHHHHCCCCCCcc
Confidence 34556666667765 45677777789999876544 68889865311 2334455666666664322 2333
Q ss_pred eeE-----EEcCCCeeEEEEeecCCCChH-----------HHh---cCCCCC--CC--C-CChhhHH-------------
Q 038766 76 LGY-----AWESGKLKALILEYMENGSLE-----------SVI---HGPGVD--HS--R-WTLPKRI------------- 118 (299)
Q Consensus 76 ~~~-----~~~~~~~~~lv~e~~~~~~L~-----------~~~---~~~~~~--~~--~-~~~~~~~------------- 118 (299)
+.. ....+...+++++|++|..+. ..+ ...... .. . ... ..|
T Consensus 83 i~t~~g~~~~~~~g~~~~l~e~i~G~~~~~~~~~~~~~~G~~LA~lH~~~~~~~~~~~~~~~~-~~w~~~~~~~~~~~~~ 161 (307)
T TIGR00938 83 VKSRDGRQLSTLAGKPACLVEFLQGLSVGRPTAMHCRPVGEVLAWMHLAGAHFPENRKNSLRL-EAWHILAEKCFEAAPQ 161 (307)
T ss_pred ccCCCCCeehhcCCeEEEEEEeCCCCCCCCCCHHHHHHHHHHHHHHHhhhccCCCCCCCCCCh-HHHHHHHHhhhhcccc
Confidence 221 111123458999999875431 111 000000 00 0 000 000
Q ss_pred ---HHHHHHHHHHHHhhc----CCCCCeeeecccCCceeeCCCCcEEEeeecccc
Q 038766 119 ---DVLISVANGLDYLHS----GYDIPIVHCDMKPSNILLDRDFEAHVSDFGTSR 166 (299)
Q Consensus 119 ---~i~~qi~~~l~~lh~----~~~~~~~H~dl~~~nil~~~~~~v~l~df~~~~ 166 (299)
.....+...++++.. ..+.++||+|+.+.|++++.++.+.++||+.+.
T Consensus 162 l~~~~~~~l~~~~~~l~~~~~~~~~~~l~HgD~~~~Nvl~~~~~~~~vIDfd~~~ 216 (307)
T TIGR00938 162 LEAHMGAELDKELDYLDKFWPRDLPRGVIHADLFPDNVLFDGDSVKGVIDFYFAC 216 (307)
T ss_pred cCHHHHHHHHHHHHHHHhhhhhcCCCccCCCCCCcCcEEEECCceEEEeeccccc
Confidence 001112334444432 123489999999999999988877899999875
|
Homoserine kinase is required in the biosynthesis of threonine from aspartate.The member of this family from Pseudomonas aeruginosa was shown by direct assay and complementation to act specifically as a homoserine kinase. |
| >KOG0576 consensus Mitogen-activated protein kinase kinase kinase kinase (MAP4K), germinal center kinase family [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=97.87 E-value=5.3e-06 Score=74.26 Aligned_cols=184 Identities=19% Similarity=0.123 Sum_probs=125.7
Q ss_pred CceeecCCcceEEEEEeCCCcEEEEEEeccCcCChhhhHHHHHHHHHHHhcCCcc-eeeeeeEEEcCCCeeEEEEeecCC
Q 038766 17 NNIIGNSNLSTVYKGRLEDGEIVAVKKLNFHQFSAESDKSFYREAKTLKELKHRN-LVKVLGYAWESGKLKALILEYMEN 95 (299)
Q Consensus 17 ~~~lg~g~~~~v~~~~~~~~~~~~vK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~-i~~~~~~~~~~~~~~~lv~e~~~~ 95 (299)
.+-+++|+++.+++.+....+....+.+.+. ....-++++|.+++||| .+..++ ..+.+.+..++++++.+
T Consensus 247 fh~fvK~altknpKkRptaeklL~h~fvs~~-------l~~rl~~eLLdK~n~P~~~v~~~~-d~~~E~~~~i~~~i~s~ 318 (829)
T KOG0576|consen 247 FHNFVKGALTKNPKKRPTAEKLLQHPFVSQT-------LSRRLAIELLDKVNNPNPVVRYLE-DYDGEDYLWIPMRICST 318 (829)
T ss_pred HHHHHHHHhcCCCccCCChhhheeceeeccc-------hhhHHHHHHHHHccCCCCcccccc-cCCcccccchhhhhhcC
Confidence 3445678888888887654445556665432 44556889999999999 443333 23445667889999876
Q ss_pred C-ChHHHhcCCCCCCCCCChhhHHHHHHHHHHHHHHhhcCCCCCeeeecccCCceeeCCCCcEEEeeecccccccccccc
Q 038766 96 G-SLESVIHGPGVDHSRWTLPKRIDVLISVANGLDYLHSGYDIPIVHCDMKPSNILLDRDFEAHVSDFGTSRMLDVHLQD 174 (299)
Q Consensus 96 ~-~L~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lh~~~~~~~~H~dl~~~nil~~~~~~v~l~df~~~~~~~~~~~~ 174 (299)
+ +....+. .....+.+.+...++..=...++++|+. .-+|+| ||+.+. +.+++.+|+....+...
T Consensus 319 ~rs~~~~~~---~se~~~~~~~~~~~~r~et~~l~~l~~~---~~~~~d----~~l~s~-~~~~~~~~~v~~~L~~~--- 384 (829)
T KOG0576|consen 319 GRSSALEMT---VSEIALEQYQFAYPLRKETRPLAELHSS---YKVHRD----NILGSE-EEVKLLDFAVPPQLTRT--- 384 (829)
T ss_pred CccccccCC---hhhHhhhhhhhhhhhhhhcccccccccc---cccCcc----cccccc-cccccccccCCcccCcc---
Confidence 5 2222221 1223344444555666667788888876 557777 666654 67899999987655421
Q ss_pred ccccccccccCcccCChhhhcccCcCccccchhhhHHHHHHHhCCCCCCC
Q 038766 175 LSSLSTAFQGTIGYLAPEFAYMRIVTTKVDVFSFGIVVMEFLTKRRPTGL 224 (299)
Q Consensus 175 ~~~~~~~~~~~~~y~~PE~~~~~~~~~~~DiwslG~~l~~l~~g~~p~~~ 224 (299)
.......+++.++|||......+...-|.|++|.-..++.-|.+|-..
T Consensus 385 --~~~~t~~~~~~~~~pev~~~~~~~~~p~~~~~~~~~~~~ap~~pPr~~ 432 (829)
T KOG0576|consen 385 --MKPRTAIGTPEPLAPEVIQENTIDGCPDSGSLAVSAIQMAPGLPPRSS 432 (829)
T ss_pred --cccccCCCCCCCCCchhhcccccccCCCccCCCcchhhcCCCCCCCCC
Confidence 134566789999999999999999999999999877777777777543
|
|
| >PRK09550 mtnK methylthioribose kinase; Reviewed | Back alignment and domain information |
|---|
Probab=97.84 E-value=0.00041 Score=60.49 Aligned_cols=78 Identities=23% Similarity=0.212 Sum_probs=53.3
Q ss_pred CceeecCCcceEEEEEeCCC-cEEEEEEeccC-----cCChhhhHHHHHHHHHHHhcC---CcceeeeeeEEEcCCCeeE
Q 038766 17 NNIIGNSNLSTVYKGRLEDG-EIVAVKKLNFH-----QFSAESDKSFYREAKTLKELK---HRNLVKVLGYAWESGKLKA 87 (299)
Q Consensus 17 ~~~lg~g~~~~v~~~~~~~~-~~~~vK~~~~~-----~~~~~~~~~~~~e~~~l~~l~---h~~i~~~~~~~~~~~~~~~ 87 (299)
.+.||.|.+..||++...+| +.++||.-... ...+...++...|.+.|+.+. ...+.+++.+ +.+ ..+
T Consensus 31 ~~elggGn~N~VyrV~~~~g~~svIVKqa~p~~r~~g~~wpl~~eR~~~Eae~L~~l~~~~p~~VPkV~~~--D~~-~~~ 107 (401)
T PRK09550 31 AREIGDGNLNLVFRVSDTEGGKSVIVKQALPYVRVVGESWPLTLDRARIEAEALKIQAKYVPDLVPKVYHY--DEE-LAV 107 (401)
T ss_pred eeEcCCCceEEEEEEEeCCCCeEEEEEecCcccccccccccccHHHHHHHHHHHHHHHhhCCCCCCeEEEE--CCC-CCE
Confidence 46789999999999998766 58999984311 111335567788888888874 2345666663 323 348
Q ss_pred EEEeecCCCC
Q 038766 88 LILEYMENGS 97 (299)
Q Consensus 88 lv~e~~~~~~ 97 (299)
+|||++++..
T Consensus 108 lVME~L~~~~ 117 (401)
T PRK09550 108 TVMEDLSDHK 117 (401)
T ss_pred EEEecCCCcc
Confidence 9999987643
|
|
| >cd05156 ChoK_euk Choline Kinase (ChoK) in eukaryotes | Back alignment and domain information |
|---|
Probab=97.76 E-value=0.00035 Score=59.13 Aligned_cols=73 Identities=26% Similarity=0.279 Sum_probs=46.4
Q ss_pred ceeecCCcceEEEEEeCC-------CcEEEEEEeccCcCChhhhHHHHHHHHHHHhcCCccee-eeeeEEEcCCCeeEEE
Q 038766 18 NIIGNSNLSTVYKGRLED-------GEIVAVKKLNFHQFSAESDKSFYREAKTLKELKHRNLV-KVLGYAWESGKLKALI 89 (299)
Q Consensus 18 ~~lg~g~~~~v~~~~~~~-------~~~~~vK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~-~~~~~~~~~~~~~~lv 89 (299)
+.|..|-...+|++...+ ++.+++|+.... .........|..+++.+...++. +++.. .. + .+|
T Consensus 4 ~~l~gGltN~~y~v~~~~~~~~~~~~~~~vlRi~~~~---~~~~~~r~~E~~~~~~l~~~g~~P~~~~~-~~-~---~~v 75 (302)
T cd05156 4 SKISGGLTNAVYKVSLPDEDALSDEPRKVLLRVYGQS---VELLIDRERELVVFARLSERNLGPKLYGI-FP-N---GRI 75 (302)
T ss_pred EEecCcccceeEEEEcCCcccccCCCCeEEEEEecCC---CcceechHHHHHHHHHHHhCCCCCceEEE-eC-C---Cch
Confidence 456667888999998654 578999986432 22334567788888888643333 33332 22 2 367
Q ss_pred EeecCCCCh
Q 038766 90 LEYMENGSL 98 (299)
Q Consensus 90 ~e~~~~~~L 98 (299)
+||++|.++
T Consensus 76 ~e~i~G~~l 84 (302)
T cd05156 76 EEFIPSRTL 84 (302)
T ss_pred hheeCCCcC
Confidence 888877655
|
The ChoK subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). It is composed of bacterial and eukaryotic choline kinases, as well as eukaryotic ethanolamine kinase. ChoK catalyzes the transfer of the gamma-phosphoryl group from ATP (or CTP) to its substrate, choline, producing phosphorylcholine (PCho), a precursor to the biosynthesis of two major membrane phospholipids, phosphatidylcholine (PC) and sphingomyelin (SM). Although choline is the preferred substrate, ChoK also shows substantial activity towards ethanolamine and its N-methylated derivatives. ChoK plays an important role in cell signaling pathways and the regulation of cell growth. Along with PCho, it is involved in malignant transformation through Ras oncogenes in various human cancer |
| >cd05152 MPH2' Macrolide 2'-Phosphotransferase (MPH2') | Back alignment and domain information |
|---|
Probab=97.67 E-value=0.0011 Score=55.29 Aligned_cols=30 Identities=30% Similarity=0.618 Sum_probs=25.2
Q ss_pred CeeeecccCCceeeCCCCcE-EEeeeccccc
Q 038766 138 PIVHCDMKPSNILLDRDFEA-HVSDFGTSRM 167 (299)
Q Consensus 138 ~~~H~dl~~~nil~~~~~~v-~l~df~~~~~ 167 (299)
.++|||+++.||+++.++.+ -++||+.+..
T Consensus 186 ~lvHGD~~~~Nilv~~~~~~~gviDWe~a~i 216 (276)
T cd05152 186 VLVHGDLHPGHILIDEDARVTGLIDWTEAKV 216 (276)
T ss_pred eeEeCCCCCCcEEEeCCCCEEEEECcHhccc
Confidence 58999999999999975554 6999998763
|
MPH2' is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). MPH2' catalyzes the transfer of the gamma-phosphoryl group from ATP to the 2'-hydroxyl of macrolide antibiotics such as erythromycin, clarithromycin, and azithromycin, among others. Macrolides penetrate the bacterial cell and bind to ribosomes, where it interrupts protein elongation, leading ultimately to the demise of the bacterium. Phosphorylation of macrolides leads to their inactivation. Based on substrate specificity and amino acid sequence, MPH2' is divided into types I and II, encoded by mphA and mphB genes, respectively. MPH2'I inactivates 14-membered ring macrolides while MPH2'II inactivates both 14- and 16-membered ring macrolides. Enzymatic inactivation of macrolides has been reported |
| >PF13095 FTA2: Kinetochore Sim4 complex subunit FTA2 | Back alignment and domain information |
|---|
Probab=97.62 E-value=0.00018 Score=56.23 Aligned_cols=128 Identities=24% Similarity=0.394 Sum_probs=88.2
Q ss_pred CCCCCCceeecCCc-ceEEEEEeCCCcEEEEEEeccCc---C-------C---h------hhhHHHHHHHHHHHhcC---
Q 038766 12 GSFSENNIIGNSNL-STVYKGRLEDGEIVAVKKLNFHQ---F-------S---A------ESDKSFYREAKTLKELK--- 68 (299)
Q Consensus 12 ~~y~~~~~lg~g~~-~~v~~~~~~~~~~~~vK~~~~~~---~-------~---~------~~~~~~~~e~~~l~~l~--- 68 (299)
.++...+.||.|.- |.||++... |+.||+|++.... . . . .....+..|-+..-+++
T Consensus 37 ~~I~flefLg~g~~~~~V~kv~I~-g~~YALKlf~~~~~~~~~~~~~~~~~~~~~~~~~~~y~~PF~~ECRAfgRLke~~ 115 (207)
T PF13095_consen 37 DDIEFLEFLGHGSHDGYVFKVEID-GRIYALKLFRFWDYTEPDYTRERFAGHETSLSTPAHYADPFNCECRAFGRLKEAG 115 (207)
T ss_pred CcEeeeeecCCCCceeEEEEEEEC-CeEEEEEEeeccccCCCccccccccccccccchhhhhcChHHHHHHhhHHHHhcc
Confidence 78888999999999 999999985 6799999943211 0 0 0 12245677888888886
Q ss_pred Ccce--eeeeeEEEcCC-----------------CeeEEEEeecCCCChHHHhcCCCCCCCCCChhhHHHHHHHHHHHHH
Q 038766 69 HRNL--VKVLGYAWESG-----------------KLKALILEYMENGSLESVIHGPGVDHSRWTLPKRIDVLISVANGLD 129 (299)
Q Consensus 69 h~~i--~~~~~~~~~~~-----------------~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~ 129 (299)
+.++ ++++|+..-.. ....||.|+..... .+. ..-+.+|.+-+.
T Consensus 116 ~e~~~Avkc~Gyl~L~~~~q~~~~~~~~~~~~~~~~~aIVKD~v~~~~-------------~~~----~~~~~~~~~dl~ 178 (207)
T PF13095_consen 116 REGLWAVKCHGYLLLTEDQQFEQLRQRGSDHRPLPIRAIVKDFVPDDP-------------PLQ----IRDIPQMLRDLK 178 (207)
T ss_pred ccCceEEEeeEEEEEchHHHHHHhhcccccCCCCccEEEEEeecCCcc-------------ccc----hhHHHHHHHHHH
Confidence 3455 88888775331 11246666654322 112 223457888888
Q ss_pred HhhcCCCCCeeeecccCCceeeCCCCcEEEeeeccc
Q 038766 130 YLHSGYDIPIVHCDMKPSNILLDRDFEAHVSDFGTS 165 (299)
Q Consensus 130 ~lh~~~~~~~~H~dl~~~nil~~~~~~v~l~df~~~ 165 (299)
.+|.. +|+-+|+++.|.. .-+|+|||.+
T Consensus 179 ~~~k~---gI~~~Dv~~~ny~-----~G~lvDfs~~ 206 (207)
T PF13095_consen 179 ILHKL---GIVPRDVKPRNYR-----GGKLVDFSSS 206 (207)
T ss_pred HHHHC---CeeeccCcccccc-----CCEEEecccC
Confidence 89998 9999999999985 2478888854
|
|
| >PLN02421 phosphotransferase, alcohol group as acceptor/kinase | Back alignment and domain information |
|---|
Probab=97.46 E-value=0.00091 Score=57.34 Aligned_cols=145 Identities=15% Similarity=0.171 Sum_probs=77.6
Q ss_pred CCCceeecCCcceEEEEEeCC----CcEEEEEEeccCcCChhhhHHHHHHHHHHHhcCCccee-eeeeEEEcCCCeeEEE
Q 038766 15 SENNIIGNSNLSTVYKGRLED----GEIVAVKKLNFHQFSAESDKSFYREAKTLKELKHRNLV-KVLGYAWESGKLKALI 89 (299)
Q Consensus 15 ~~~~~lg~g~~~~v~~~~~~~----~~~~~vK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~-~~~~~~~~~~~~~~lv 89 (299)
...+.|..|-...+|++...+ +..|++|+.... .+..-.-.+|..+++.+..-++. ++++. ..++ +|
T Consensus 17 i~i~~l~gGlTN~~~~v~~~~~~~~~~~~v~Ri~g~~---t~~~IdR~~E~~il~~l~~~gl~P~~l~~-~~~G----~i 88 (330)
T PLN02421 17 FSVERISGGITNLLLKVSVKEENGNEVSVTVRLFGPN---TDYVIDRERELQAIKYLSAAGFGAKLLGV-FGNG----MI 88 (330)
T ss_pred eEEEEeCCcccceEEEEEecCCCCCCceEEEEEecCC---cCeEechHHHHHHHHHHHhcCCCCceeEE-eCCc----Ee
Confidence 334555558888899986532 247999987532 12222335688888888654443 33442 2222 57
Q ss_pred EeecCCCChHH--------------HhcC-CCC--C-CC-CCChhhHHHHHHHH-------------------------H
Q 038766 90 LEYMENGSLES--------------VIHG-PGV--D-HS-RWTLPKRIDVLISV-------------------------A 125 (299)
Q Consensus 90 ~e~~~~~~L~~--------------~~~~-~~~--~-~~-~~~~~~~~~i~~qi-------------------------~ 125 (299)
.+|+++.++.. .+.. +.. . .. +.....+..+..++ +
T Consensus 89 ~~fi~g~~l~~~~l~~~~~~~~ia~~L~~lH~~~~~~~~~~~~~~~i~~y~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~ 168 (330)
T PLN02421 89 QSFINARTLTPSDMRKPKVAAEIAKELRRLHQVEIPGSKEPQLWNDIFKFYEKASTVKFEDPEKQKKYETISFEELRDEI 168 (330)
T ss_pred ehhhcCCCCChHHCCCHHHHHHHHHHHHHHhCCCCCCCCCCcHHHHHHHHHHHhhhcccCcHHHhhhhcccCHHHHHHHH
Confidence 88887665421 1110 100 0 00 11111222222111 1
Q ss_pred HHHHHhhc--CCCCCeeeecccCCceeeCC-CCcEEEeeeccccc
Q 038766 126 NGLDYLHS--GYDIPIVHCDMKPSNILLDR-DFEAHVSDFGTSRM 167 (299)
Q Consensus 126 ~~l~~lh~--~~~~~~~H~dl~~~nil~~~-~~~v~l~df~~~~~ 167 (299)
..+..+.. ..+..+||+|+.+.||+++. ++.++++||+.+..
T Consensus 169 ~~l~~~~~~~~~~~v~CHnDl~~~NiL~~~~~~~l~lID~EYag~ 213 (330)
T PLN02421 169 VELKEITDSLKAPVVFAHNDLLSGNLMLNEDEGKLYFIDFEYGSY 213 (330)
T ss_pred HHHHHHhccCCCCeEEEECCCCcccEEEeCCCCcEEEEcccccCC
Confidence 11122211 11235899999999999975 57899999998853
|
|
| >COG3173 Predicted aminoglycoside phosphotransferase [General function prediction only] | Back alignment and domain information |
|---|
Probab=97.45 E-value=0.0026 Score=53.67 Aligned_cols=141 Identities=18% Similarity=0.178 Sum_probs=85.5
Q ss_pred CCceeecCCcceEEEEEeCCCcEEEEEEeccCcCChhhhHHHHHHHHHHHhcCCcc--eeeeeeEEEcCC-CeeEEEEee
Q 038766 16 ENNIIGNSNLSTVYKGRLEDGEIVAVKKLNFHQFSAESDKSFYREAKTLKELKHRN--LVKVLGYAWESG-KLKALILEY 92 (299)
Q Consensus 16 ~~~~lg~g~~~~v~~~~~~~~~~~~vK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~--i~~~~~~~~~~~-~~~~lv~e~ 92 (299)
+++....|-...+|..... +++++++... ....-.......+|+..++.+.--- +...++.+.... ...+.||++
T Consensus 29 ~v~~~~~G~sn~t~~~~~~-~~~~vlR~P~-~~~~~~~~~~~~re~~~i~~l~~~~vP~p~~~~~~~~~~~g~pf~v~~~ 106 (321)
T COG3173 29 IVEEISGGWSNDTFRLGDT-GQKYVLRKPP-RGDPVESAHDEKREYRVIAALLDVDVPVPRAFGLCGEGYLGTPFYVMEW 106 (321)
T ss_pred eeeeccCCcccceEEEecC-CceEEEecCC-ccccchhhhHHHhHHHHHHHhcCCCCCCcccccccccCCCCCceEEEEE
Confidence 3444444555555655554 7888888221 1233445667778888888875322 222333333333 345899999
Q ss_pred cCCCChHHHhcCCCCCCCCCChhhHHHHH-HHHHHHHHHhhcCC------------------------------------
Q 038766 93 MENGSLESVIHGPGVDHSRWTLPKRIDVL-ISVANGLDYLHSGY------------------------------------ 135 (299)
Q Consensus 93 ~~~~~L~~~~~~~~~~~~~~~~~~~~~i~-~qi~~~l~~lh~~~------------------------------------ 135 (299)
+.|..+.+..... + ...+++ ..++..|+.||+..
T Consensus 107 veGe~~~~~~~~~-------~--~~~~~~~~~l~~~La~LH~ida~~~~~~g~~~~~~~rql~~~~~~~~~~~~~~~~~~ 177 (321)
T COG3173 107 VEGEVVWSALPPE-------S--LGRQFALDALADFLAELHSIDAAGLPDPGKPNAYRGRQLARWDDEYRRAKKELGGRI 177 (321)
T ss_pred ecceeccCcCCcc-------c--chHHHHHHHHHHHHHHHhCCCCcCCCCCCccCccccchhhHHHHHHHHHHHhccCCC
Confidence 9886544333211 1 011122 35666666666531
Q ss_pred -------------------CCCeeeecccCCceeeCCCCcEEEeeeccccc
Q 038766 136 -------------------DIPIVHCDMKPSNILLDRDFEAHVSDFGTSRM 167 (299)
Q Consensus 136 -------------------~~~~~H~dl~~~nil~~~~~~v~l~df~~~~~ 167 (299)
...++|||+.+.|++++.++-+-+.||+++..
T Consensus 178 p~~~~~~~Wl~~~~p~~~~~~~lvHGD~~~gNlii~~~~~~gVlDwe~~~l 228 (321)
T COG3173 178 PLADRLIKWLEANRPPWAGPPVLVHGDYRPGNLIIDPGRPTGVLDWELATL 228 (321)
T ss_pred chHHHHHHHHHhcCCCcCCCceeeeCCcccCCEEEeCCCeeEEEecccccc
Confidence 14599999999999999998899999999874
|
|
| >PLN02236 choline kinase | Back alignment and domain information |
|---|
Probab=97.45 E-value=0.0016 Score=56.19 Aligned_cols=143 Identities=14% Similarity=0.197 Sum_probs=78.8
Q ss_pred CCceeecCCcceEEEEEeCC-----CcEEEEEEeccCcCChhhhHHHHHHHHHHHhcCCcceee-eeeEEEcCCCeeEEE
Q 038766 16 ENNIIGNSNLSTVYKGRLED-----GEIVAVKKLNFHQFSAESDKSFYREAKTLKELKHRNLVK-VLGYAWESGKLKALI 89 (299)
Q Consensus 16 ~~~~lg~g~~~~v~~~~~~~-----~~~~~vK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~-~~~~~~~~~~~~~lv 89 (299)
-...|..|-...+|++...+ ++.+++|+.... .....+ -.+|..+++.+...++.+ +++ ...++ .|
T Consensus 40 ~i~~l~gGlTN~~y~v~~~~~~~~~~~~~v~Ri~g~~--t~~~id-R~~E~~~~~~l~~~gl~P~~~~-~~~~g----~v 111 (344)
T PLN02236 40 QVIPLKGAMTNEVFQIKWPTKEGNLGRKVLVRIYGEG--VELFFD-RDDEIRTFECMSRHGQGPRLLG-RFPNG----RV 111 (344)
T ss_pred EEEEcCCcccceeEEEEeCCCCCCCCCeEEEEEccCC--CCeeec-hHHHHHHHHHHHHcCCCCceEE-EECCc----eE
Confidence 34455558888999987432 468999987532 122223 367888888886544443 344 33322 57
Q ss_pred EeecCCCChHHH--------------hcC-CCC----CCCCCChhhHHHHHHHHH-----------------HHHHH---
Q 038766 90 LEYMENGSLESV--------------IHG-PGV----DHSRWTLPKRIDVLISVA-----------------NGLDY--- 130 (299)
Q Consensus 90 ~e~~~~~~L~~~--------------~~~-~~~----~~~~~~~~~~~~i~~qi~-----------------~~l~~--- 130 (299)
.+|+.+.++... +.+ +.. ........++..++.++. ..+..
T Consensus 112 ~efi~g~~l~~~~l~~~~~~~~ia~~L~~lH~~~~~~~~~~~~~~~i~~~~~~~~~l~~~~~~~~~~~~~l~~~~~~L~~ 191 (344)
T PLN02236 112 EEFIHARTLSAADLRDPEISALIAAKLREFHSLDMPGPKNVLLWDRLRNWLKEAKNLCSPEEAKEFRLDSLEDEINLLEK 191 (344)
T ss_pred EEeeCCCCCCHHHcCChHHHHHHHHHHHHHhCCCCCCCCCchHHHHHHHHHHHHHhhcCcchhhhcCHHHHHHHHHHHHH
Confidence 888877665311 000 100 000111222223322211 11111
Q ss_pred -hhc-CCCCCeeeecccCCceeeCC-CCcEEEeeecccc
Q 038766 131 -LHS-GYDIPIVHCDMKPSNILLDR-DFEAHVSDFGTSR 166 (299)
Q Consensus 131 -lh~-~~~~~~~H~dl~~~nil~~~-~~~v~l~df~~~~ 166 (299)
+.. ..+..+||+|+++.||+++. ++.+.++||..+.
T Consensus 192 ~~~~~~~~~~~cH~Dl~~~Nil~~~~~~~~~lID~Eya~ 230 (344)
T PLN02236 192 ELSGDDQEIGFCHNDLQYGNIMIDEETRAITIIDYEYAS 230 (344)
T ss_pred HhcccCCCceEEeCCCCcCcEEEeCCCCcEEEEeehhcc
Confidence 111 12347999999999999976 4679999999875
|
|
| >PLN02756 S-methyl-5-thioribose kinase | Back alignment and domain information |
|---|
Probab=97.37 E-value=0.0046 Score=53.96 Aligned_cols=76 Identities=18% Similarity=0.208 Sum_probs=50.6
Q ss_pred CCceeecCCcceEEEEEeCCCcEEEEEEeccC-----cCChhhhHHHHHHHHHHHhcC--C-cceeeeeeEEEcCCCeeE
Q 038766 16 ENNIIGNSNLSTVYKGRLEDGEIVAVKKLNFH-----QFSAESDKSFYREAKTLKELK--H-RNLVKVLGYAWESGKLKA 87 (299)
Q Consensus 16 ~~~~lg~g~~~~v~~~~~~~~~~~~vK~~~~~-----~~~~~~~~~~~~e~~~l~~l~--h-~~i~~~~~~~~~~~~~~~ 87 (299)
..+.||.|....||++... +..++||.-... ...+....+...|+..|+.+. . ..+.+++.++. + ..+
T Consensus 36 ~~~eiggGn~N~VyrV~~~-~~svVVKqa~p~~r~vga~wpl~~~R~~~Ea~aL~~~~~~~p~~VPkVy~~de--d-~~v 111 (418)
T PLN02756 36 KIKEVGDGNLNFVYIVVSS-SGSFVIKQALPYIRCIGESWPMTKERAYFEATALREHGRLCPDHVPEVYHFDR--T-MAL 111 (418)
T ss_pred eEEEcCCCceeeEEEEEcC-CccEEEEeCCccccCCCccccCCccHHHHHHHHHHHhhhcCCCCCCeEEEECC--C-CCE
Confidence 4678899999999999874 456899975421 111234556666777777764 2 36666766443 2 237
Q ss_pred EEEeecCC
Q 038766 88 LILEYMEN 95 (299)
Q Consensus 88 lv~e~~~~ 95 (299)
++||++++
T Consensus 112 lvME~L~~ 119 (418)
T PLN02756 112 IGMRYLEP 119 (418)
T ss_pred EEEeecCC
Confidence 89999966
|
|
| >KOG1093 consensus Predicted protein kinase (contains TBC and RHOD domains) [General function prediction only] | Back alignment and domain information |
|---|
Probab=97.31 E-value=0.00058 Score=60.37 Aligned_cols=168 Identities=21% Similarity=0.244 Sum_probs=95.4
Q ss_pred hHHHHHHHHHHHhcCCcceeeeeeEEEcCCCeeEEEEeecCCCChHHHhcCCCCCCCCCChhhHHHHHHHHHHHHHHhhc
Q 038766 54 DKSFYREAKTLKELKHRNLVKVLGYAWESGKLKALILEYMENGSLESVIHGPGVDHSRWTLPKRIDVLISVANGLDYLHS 133 (299)
Q Consensus 54 ~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lh~ 133 (299)
...+....++++.+.|+|....+++....-....+|+|++ +.+|.+...... .. ..++. -|
T Consensus 26 s~~ilgr~~~lktl~~~~l~~yl~~~r~~~~r~IVV~e~~-~~Sled~~~~~~-----l~---~~s~~---------~~- 86 (725)
T KOG1093|consen 26 SIQILGRFQYLKSLQHDNLCQYLDFSRGKHERVIVVMEHY-TMSLEDILKTGN-----LK---DESLL---------AH- 86 (725)
T ss_pred HHHHhhhhHHHHhhcCccceeeEeeecCccceEEEEehhh-ccchHHHHHhcc-----cc---hhhhc---------cc-
Confidence 4567778899999999999999885443333357899999 569988876321 11 11111 11
Q ss_pred CCCCCeeeecccCCceeeCCCCcEEEeeeccccccccccccccccccccccCcccCChhhhcccCcCccccchhhhHHHH
Q 038766 134 GYDIPIVHCDMKPSNILLDRDFEAHVSDFGTSRMLDVHLQDLSSLSTAFQGTIGYLAPEFAYMRIVTTKVDVFSFGIVVM 213 (299)
Q Consensus 134 ~~~~~~~H~dl~~~nil~~~~~~v~l~df~~~~~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~DiwslG~~l~ 213 (299)
++.|-+ + .+.+| .+... +... ..+|+|||++|.++.
T Consensus 87 ----~~~~~~-----~-------~~~td-~~~t~-----------~~~~----------------~~pKsdVwsl~~i~~ 122 (725)
T KOG1093|consen 87 ----GVLHLN-----I-------IYITD-HFLTK-----------YPSP----------------IGPKSDVWSLGFIIL 122 (725)
T ss_pred ----ccceeh-----h-------hhccc-ccccc-----------CCCC----------------CCcchhhhhHHHHHH
Confidence 333221 1 22233 11110 0000 114999999999999
Q ss_pred HHHhCCCCCCCCccCCCCchhHHHHHHHHHhcCccCcccccCccccchhhHhHHHHHHHHHHHHHHHHhcCCCCCCCCCh
Q 038766 214 EFLTKRRPTGLDEENGLSPISLRQLVEKALANGINGVRQITDPKLVSSIYEEQEQHQVLEELFKLALVCTSSNPEDRPNM 293 (299)
Q Consensus 214 ~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rpt~ 293 (299)
++.-|...+. ..... +...........+.. .....-.-..........+.+..+|+...|..||..
T Consensus 123 el~L~~~l~~-----~~~~s---~~l~~i~k~~~~d~~------~~~~a~e~~~~~~~d~~~~~~~~~c~~~~~~ir~l~ 188 (725)
T KOG1093|consen 123 ELYLGISLEA-----ELTES---EYLEILLKYYTDDQE------LLSTAMEHLIQLLADKKRLPLLKKCLWLEPIIRPLP 188 (725)
T ss_pred HHHHhhHHHH-----HHHHH---HHHHHHHHhccCchh------HHHHHHHHHHHHhhhHhHHHHhccCCccccccccch
Confidence 9999877652 11222 222222211111110 011111113356667778999999999999999987
Q ss_pred hhhhc
Q 038766 294 NELLI 298 (299)
Q Consensus 294 ~~il~ 298 (299)
.++.+
T Consensus 189 ~~~~k 193 (725)
T KOG1093|consen 189 MELSK 193 (725)
T ss_pred hHHhc
Confidence 76654
|
|
| >COG5072 ALK1 Serine/threonine kinase of the haspin family [Cell division and chromosome partitioning] | Back alignment and domain information |
|---|
Probab=97.25 E-value=0.0026 Score=54.04 Aligned_cols=75 Identities=21% Similarity=0.285 Sum_probs=59.6
Q ss_pred cCCCeeEEEEeecCCCChHHHhcCCCCCCCCCChhhHHHHHHHHHHHHHHhhcCCCCCeeeecccCCceeeCCCCcEEEe
Q 038766 81 ESGKLKALILEYMENGSLESVIHGPGVDHSRWTLPKRIDVLISVANGLDYLHSGYDIPIVHCDMKPSNILLDRDFEAHVS 160 (299)
Q Consensus 81 ~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lh~~~~~~~~H~dl~~~nil~~~~~~v~l~ 160 (299)
.++-+.+++|++- |+++. .++ ....+++..++.+.+..+.-+..+ -..-|+|+..+||+++ .|+|.|+
T Consensus 296 de~~y~yl~~kdh-gt~is-~ik-------~~~~~e~lsff~s~~sil~~lekk--f~fehrnlt~~niLId-~GnvtLI 363 (488)
T COG5072 296 DETLYLYLHFKDH-GTPIS-IIK-------ADRSEEELSFFWSCISILDILEKK--FPFEHRNLTLDNILID-EGNVTLI 363 (488)
T ss_pred CCceEEEEEEecC-Cceee-eee-------cccHHHHHHHHHHHHHHHhhhhhc--CCcccccccccceeee-cCceEEE
Confidence 4456678888886 54543 332 345678899999999999888876 4889999999999999 9999999
Q ss_pred eeccccc
Q 038766 161 DFGTSRM 167 (299)
Q Consensus 161 df~~~~~ 167 (299)
||-+++.
T Consensus 364 DfklsRl 370 (488)
T COG5072 364 DFKLSRL 370 (488)
T ss_pred Eeeeeec
Confidence 9999973
|
|
| >TIGR02904 spore_ysxE spore coat protein YsxE | Back alignment and domain information |
|---|
Probab=97.18 E-value=0.0081 Score=51.06 Aligned_cols=31 Identities=19% Similarity=0.261 Sum_probs=28.2
Q ss_pred CCCeeeecccCCceeeCCCCcEEEeeecccc
Q 038766 136 DIPIVHCDMKPSNILLDRDFEAHVSDFGTSR 166 (299)
Q Consensus 136 ~~~~~H~dl~~~nil~~~~~~v~l~df~~~~ 166 (299)
+.++||+|+.++|++++.++.+.++||..+.
T Consensus 195 ~~~lcHgD~~~~Nvl~~~~~~~~iIDfd~~~ 225 (309)
T TIGR02904 195 RTVLVHGKLSLSHFLYDETRGGYFINFEKAS 225 (309)
T ss_pred ceeeeCCCCcHHhEEEcCCCCEEEEEhhhcc
Confidence 4589999999999999999999999999875
|
Members of this family are homologs of the Bacillus subtilis spore coat protein CotS. Members of this family, designated YsxE, are found only in the family Bacillaceae, from among the endospore-forming members of the Firmicutes branch of the Bacteria. As a rule, the ysxE gene is found immediately downstream of spoVID, a gene necessary for spore coat assembly. The protein has been shown to be part of the spore coat. |
| >PF03881 Fructosamin_kin: Fructosamine kinase; InterPro: IPR016477 Ketosamines derive from a non-enzymatic reaction between a sugar and a protein [] | Back alignment and domain information |
|---|
Probab=97.17 E-value=0.0059 Score=51.11 Aligned_cols=76 Identities=24% Similarity=0.330 Sum_probs=46.1
Q ss_pred CCCCceeecCCcceEEEEEeCCCcEEEEEEeccCcCChhhhHHHHHHHHHHHhcC---CcceeeeeeEEEcCCCeeEEEE
Q 038766 14 FSENNIIGNSNLSTVYKGRLEDGEIVAVKKLNFHQFSAESDKSFYREAKTLKELK---HRNLVKVLGYAWESGKLKALIL 90 (299)
Q Consensus 14 y~~~~~lg~g~~~~v~~~~~~~~~~~~vK~~~~~~~~~~~~~~~~~e~~~l~~l~---h~~i~~~~~~~~~~~~~~~lv~ 90 (299)
..-.+.++.|....+|.+. .+++.+.||+-. ......+..|+.-|+.+. .-.+.+++++....+. .++++
T Consensus 19 i~~~~~v~GG~i~~a~~~~-~~~~~~FvK~~~-----~~~~~~f~~Ea~gL~~L~~~~~~~vP~vi~~G~~~~~-~fLll 91 (288)
T PF03881_consen 19 ITSIEPVSGGDINEAYRLD-TDGGSYFVKVNS-----ESGRDMFEGEAEGLKALAEANPIRVPKVIAWGEYDDD-AFLLL 91 (288)
T ss_dssp --EEEEE--SSSSEEEEEE-TTS-EEEEEEEE-----GGGCCHHHHHHHHHHHHCHTTTSBS--EEEEEE-SSC-CEEEE
T ss_pred eeeeEecCCCChhheEEEE-CCCccEEEEecC-----hhhHHHHHHHHHHHHHHHhcCCCCCCeEEEEEeecCC-ceEEE
Confidence 3445678889999999988 567889999854 334567788888888884 3456677775554444 38999
Q ss_pred eecCCC
Q 038766 91 EYMENG 96 (299)
Q Consensus 91 e~~~~~ 96 (299)
||++.+
T Consensus 92 e~l~~~ 97 (288)
T PF03881_consen 92 EFLEMG 97 (288)
T ss_dssp E-----
T ss_pred EeecCC
Confidence 999765
|
Ketosamine-3-kinases (KT3K), of which fructosamine-3-kinase (FN3K) is the best-known example, catalyse the phosphorylation of the ketosamine moiety of glycated proteins. The instability of a phosphorylated ketosamine leads to its degradation, and KT3K is thus thought to be involved in protein repair []. The function of the prokaryotic members of this group has not been established. However, several lines of evidence indicate that they may function as fructosamine-3-kinases (FN3K). First, they are similar to characterised FN3K from mouse and human. Second, the Escherichia coli members are found in close proximity on the genome to fructose-6-phosphate kinase (PfkB). Last, FN3K activity has been found in a Anacystis montana (Gloeocapsa montana Kutzing 1843) [], indicating such activity-directly demonstrated in eukaryotes-is nonetheless not confined to eukaryotes. This family includes eukaryotic fructosamine-3-kinase enzymes [] which may initiate a process leading to the deglycation of fructoselysine and of glycated proteins and in the phosphorylation of 1-deoxy-1-morpholinofructose, fructoselysine, fructoseglycine, fructose and glycated lysozyme. The family also includes bacterial members that have not been characterised but probably have a similar or identical function. For additional information please see [].; PDB: 3JR1_B 3F7W_A. |
| >PF01633 Choline_kinase: Choline/ethanolamine kinase; InterPro: IPR002573 Choline kinase, (ATP:choline phosphotransferase, 2 | Back alignment and domain information |
|---|
Probab=97.16 E-value=0.002 Score=51.53 Aligned_cols=30 Identities=33% Similarity=0.610 Sum_probs=21.8
Q ss_pred CCeeeecccCCceee-CCCCcEEEeeecccc
Q 038766 137 IPIVHCDMKPSNILL-DRDFEAHVSDFGTSR 166 (299)
Q Consensus 137 ~~~~H~dl~~~nil~-~~~~~v~l~df~~~~ 166 (299)
..+||+|+.+.||++ +.++.++++||..+.
T Consensus 143 ~v~cHnDl~~~Nil~~~~~~~~~lIDfEya~ 173 (211)
T PF01633_consen 143 LVFCHNDLNPGNILINNKDGEVKLIDFEYAG 173 (211)
T ss_dssp EEEE-S--SGGGEEETSSSSCEEE--GTT-E
T ss_pred ceEeeccCccccEEeccCCCeEEEecHHHHh
Confidence 379999999999999 888999999999875
|
7.1.32 from EC) belongs to the choline/ethanolamine kinase family. Ethanolamine and choline are major membrane phospholipids, in the form of glycerophosphoethanolamine and glycerophosphocholine. Ethanolamine is also a component of the glycosylphosphatidylinositol (GPI) anchor, which is necessary for cell-surface protein attachment []. The de novo synthesis of these phospholipids begins with the creation of phosphoethanolamine and phosphocholine by ethanolamine and choline kinases in the first step of the CDP-ethanolamine pathway [, ]. There are two putative choline/ethanolamine kinases (C/EKs) in the Trypanosoma brucei genome. Ethanolamine kinase has no choline kinase activity [] and its activity is inhibited by ADP []. Inositol supplementation represses ethanolamine kinase, decreasing the incorporation of ethanolamine into the CDP-ethanolamine pathway and into phosphatidylethanolamine and phosphatidylcholine []. ; GO: 0016773 phosphotransferase activity, alcohol group as acceptor; PDB: 3C5I_A 2IG7_A 3LQ3_A 3FEG_A 2QG7_E 3FI8_A 1NW1_A 3MES_A 3G15_A 2CKP_B .... |
| >TIGR01767 MTRK 5-methylthioribose kinase | Back alignment and domain information |
|---|
Probab=97.13 E-value=0.0096 Score=51.11 Aligned_cols=74 Identities=14% Similarity=0.177 Sum_probs=48.8
Q ss_pred eeecCCcceEEEEEeCCC-cEEEEEEecc-----CcCChhhhHHHHHHHHHHHhcC--Ccc-eeeeeeEEEcCCCeeEEE
Q 038766 19 IIGNSNLSTVYKGRLEDG-EIVAVKKLNF-----HQFSAESDKSFYREAKTLKELK--HRN-LVKVLGYAWESGKLKALI 89 (299)
Q Consensus 19 ~lg~g~~~~v~~~~~~~~-~~~~vK~~~~-----~~~~~~~~~~~~~e~~~l~~l~--h~~-i~~~~~~~~~~~~~~~lv 89 (299)
.+|.|....||++...+| +.++||.-.. ....+-...+..-|...|+... .|. +.+++. ++.+ ...+|
T Consensus 2 EigdGnlN~VfrV~~~~g~~svIVKQAlp~vRv~g~~wpl~~~R~~~E~~~L~~~~~~~P~~vP~vy~--~D~e-~~~~v 78 (370)
T TIGR01767 2 EVGDGNLNLVFHVYDQEGDRAAIVKQALPYVRVVGESWPLTLDRARIESSALIRQGEHVPHLVPRIFH--FDTE-MAVTV 78 (370)
T ss_pred cCCCCceEEEEEEEcCCCCeeEEEEEcCHHHhhcCCCCCCCccHHHHHHHHHHHhhccCccccCeEEE--Eccc-cceeh
Confidence 478899999999987654 5799997431 1123455677778888888874 353 444544 2323 33689
Q ss_pred EeecCC
Q 038766 90 LEYMEN 95 (299)
Q Consensus 90 ~e~~~~ 95 (299)
||+++.
T Consensus 79 MEdL~~ 84 (370)
T TIGR01767 79 MEDLSH 84 (370)
T ss_pred HhhCcc
Confidence 998854
|
This enzyme is involved in the methionine salvage pathway in certain bacteria. |
| >TIGR02906 spore_CotS spore coat protein, CotS family | Back alignment and domain information |
|---|
Probab=96.91 E-value=0.014 Score=49.51 Aligned_cols=29 Identities=34% Similarity=0.314 Sum_probs=25.3
Q ss_pred CCeeeecccCCceeeCCCCcEEEeeecccc
Q 038766 137 IPIVHCDMKPSNILLDRDFEAHVSDFGTSR 166 (299)
Q Consensus 137 ~~~~H~dl~~~nil~~~~~~v~l~df~~~~ 166 (299)
.++||||+.+.|++++. +.+.++||+.+.
T Consensus 187 ~~liHgD~~~~Nil~~~-~~i~lIDfd~~~ 215 (313)
T TIGR02906 187 RGFCHQDYAYHNILLKD-NEVYVIDFDYCT 215 (313)
T ss_pred CceEcCCCCcccEEEeC-CcEEEEECcccc
Confidence 38899999999999987 578999999664
|
Members of this family include the spore coat proteins CotS and YtaA from Bacillus subtilis and, from other endospore-forming bacteria, homologs that are more closely related to these two than to the spore coat proteins YutH and YsxE. The CotS family is more broadly distributed than YutH or YsxE, but still is not universal among spore-formers. |
| >PRK12396 5-methylribose kinase; Reviewed | Back alignment and domain information |
|---|
Probab=96.87 E-value=0.0084 Score=52.13 Aligned_cols=76 Identities=20% Similarity=0.208 Sum_probs=51.4
Q ss_pred CceeecCCcceEEEEEeCC-CcEEEEEEec----cCcCChhhhHHHHHHHHHHHhcC--Ccc-eeeeeeEEEcCCCeeEE
Q 038766 17 NNIIGNSNLSTVYKGRLED-GEIVAVKKLN----FHQFSAESDKSFYREAKTLKELK--HRN-LVKVLGYAWESGKLKAL 88 (299)
Q Consensus 17 ~~~lg~g~~~~v~~~~~~~-~~~~~vK~~~----~~~~~~~~~~~~~~e~~~l~~l~--h~~-i~~~~~~~~~~~~~~~l 88 (299)
++.||.|...-||++.+.+ ++.++||.-. .....+-..++..-|.+.|+... .|. +.+++. ++ .....+
T Consensus 34 ~~eigdGnlN~VfrV~~~~~~~svIVKQAlp~vRv~~swpL~~~R~~~E~~aL~~~~~~~P~~VP~vy~--~D-~e~~~~ 110 (409)
T PRK12396 34 CKEIGDGNLNYVFRVWDEQKNISVIVKQAGDTARISDEFKLSTNRIRIESDVLQLEEELAPGLVPKVYL--FD-SVMNCC 110 (409)
T ss_pred eeEcCCCceEEEEEEeeCCCCceEEEEeccHhhccCCCCCCChHHHHHHHHHHHHHHhhCCCcCCeEEE--EC-cHHhhH
Confidence 5688999999999998743 5679998642 22233556788888999999875 454 444554 22 223367
Q ss_pred EEeecCC
Q 038766 89 ILEYMEN 95 (299)
Q Consensus 89 v~e~~~~ 95 (299)
|||+++.
T Consensus 111 vMEdL~~ 117 (409)
T PRK12396 111 VMEDLSD 117 (409)
T ss_pred HHHhCcc
Confidence 8888743
|
|
| >KOG1826 consensus Ras GTPase activating protein RasGAP/neurofibromin [Defense mechanisms] | Back alignment and domain information |
|---|
Probab=96.72 E-value=0.0002 Score=70.68 Aligned_cols=167 Identities=11% Similarity=-0.052 Sum_probs=118.2
Q ss_pred hhhHHHHHHHHHHHhcCCcceeeeeeEEEc-CCCeeEEEEeecCCCChHHHhcCCCCCCCCCChhhHHHHHHHHHHHHHH
Q 038766 52 ESDKSFYREAKTLKELKHRNLVKVLGYAWE-SGKLKALILEYMENGSLESVIHGPGVDHSRWTLPKRIDVLISVANGLDY 130 (299)
Q Consensus 52 ~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~-~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~ 130 (299)
...+....|....+...|+++...+.-... .....+.+++++.+|.+.+.+-..........+.-+...-.+......-
T Consensus 1271 Plkemll~e~de~~~~~h~~~~~~p~rI~ps~s~ee~~r~~~~~~g~~f~iIikg~ee~~~ld~~~v~~~~kvsvl~~~~ 1350 (2724)
T KOG1826|consen 1271 PLKEMLLSERDELREAKHYLTEVDPLRIPPSESTEEYIRSLYVEFGKLFSIIIKGLEESPDLDRSPVHLRHKVSVLNRNV 1350 (2724)
T ss_pred HHHHhhhhhhhhhhhhhceeeecccccCCCCCChHHHHHHHHHHHhHHHHHHHhccccCCcchhchHHHHHHHHHhccch
Confidence 334455566667777788887765553322 2334478889999999999886554344555554444444444777777
Q ss_pred hhcCC--CCCeeeecccCCceeeCCCCcEEEeeeccccccccccccccccccccccCcccCChhhhcccCcCccccchhh
Q 038766 131 LHSGY--DIPIVHCDMKPSNILLDRDFEAHVSDFGTSRMLDVHLQDLSSLSTAFQGTIGYLAPEFAYMRIVTTKVDVFSF 208 (299)
Q Consensus 131 lh~~~--~~~~~H~dl~~~nil~~~~~~v~l~df~~~~~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Diwsl 208 (299)
.|+.. +.--+|.++++-|.++..+..|+++++|+.... .......+....++-|+.|++...-.++.++|+|..
T Consensus 1351 ~ls~tnlg~T~v~~~Lkf~lpmIVtny~v~~gk~gLdKIk----np~~sf~Gl~l~sp~~v~qli~N~ik~t~rsdilr~ 1426 (2724)
T KOG1826|consen 1351 ILSLTNLGNTNVSKSLKFTLPMIVTNYNVKLGKGGLDKIK----NPVLSFFGLELCSPIYVLQLIKNEIKFTKRSDILRR 1426 (2724)
T ss_pred hhhcccCCccchhhhhhhhccceecCCccccccccccccc----CchHhhhhhhhCCHHHHHHHHHHHHhhhhHHHHHHH
Confidence 77652 234789999999999999999999999988621 122333455566778888998887788888999999
Q ss_pred hHHHHHHHhCCCCC
Q 038766 209 GIVVMEFLTKRRPT 222 (299)
Q Consensus 209 G~~l~~l~~g~~p~ 222 (299)
|+.+|....|..+|
T Consensus 1427 s~~ly~rs~~n~~f 1440 (2724)
T KOG1826|consen 1427 SLSLYLRSDGNAYF 1440 (2724)
T ss_pred HHHHHHHhcccHHH
Confidence 99999988887765
|
|
| >PTZ00384 choline kinase; Provisional | Back alignment and domain information |
|---|
Probab=96.67 E-value=0.011 Score=51.69 Aligned_cols=77 Identities=21% Similarity=0.162 Sum_probs=44.6
Q ss_pred CCCceeecCCcceEEEEEeCCC--cE-----EEEEEeccCcCChhhhHHHHHHHHHHHhcCCcceeeeeeEEEcCCCeeE
Q 038766 15 SENNIIGNSNLSTVYKGRLEDG--EI-----VAVKKLNFHQFSAESDKSFYREAKTLKELKHRNLVKVLGYAWESGKLKA 87 (299)
Q Consensus 15 ~~~~~lg~g~~~~v~~~~~~~~--~~-----~~vK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~ 87 (299)
...+.|..|-...+|++...++ .. |.+++. .......-.-.+|.++++.+...++.+-+-.... + +
T Consensus 53 i~i~~l~gGLTN~l~~v~~~~~~~~~~~~k~Vl~R~~---g~~~~l~IdR~~E~~i~~~Ls~~glgP~l~~~f~-~---g 125 (383)
T PTZ00384 53 IEIKKMNNGITNQVYQATLVDGDKDRYPIKSVCIKKS---STYNSLVIDNDLQYNIAKLLGDNNFGPKIIGRFG-D---F 125 (383)
T ss_pred EEEEEeCCcccceEEEEEecCCCCCccccceEEEEec---cCCCceEeccHHHHHHHHHHHhCCCCCeEEEecC-C---E
Confidence 3445565588899999975432 22 344432 1122222223568888999876655554332332 1 6
Q ss_pred EEEeecCCCCh
Q 038766 88 LILEYMENGSL 98 (299)
Q Consensus 88 lv~e~~~~~~L 98 (299)
++.||++|.+|
T Consensus 126 ~l~efIeGr~l 136 (383)
T PTZ00384 126 TIQEWVEGNTM 136 (383)
T ss_pred EEEEEeccccC
Confidence 89999988665
|
|
| >PRK06148 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=96.59 E-value=0.14 Score=50.72 Aligned_cols=159 Identities=18% Similarity=0.234 Sum_probs=85.3
Q ss_pred CChHHH-HHHhCCCCCC---ceeecCCcceEEEEEeCCCcEEEEEEeccCcCChhhhHHHHHHHHHHHhcC-------Cc
Q 038766 2 FDRTEI-ENATGSFSEN---NIIGNSNLSTVYKGRLEDGEIVAVKKLNFHQFSAESDKSFYREAKTLKELK-------HR 70 (299)
Q Consensus 2 ~~~~~~-~~~~~~y~~~---~~lg~g~~~~v~~~~~~~~~~~~vK~~~~~~~~~~~~~~~~~e~~~l~~l~-------h~ 70 (299)
+|.+++ +.+.+.|-+. +.|+ |..-.+|++...+|..+++|+.+.. ........+.+.+..+. -|
T Consensus 11 ~s~~~~~~~~~~~ygl~~~~~~L~-s~~d~nf~v~~~~g~~yVLKi~~~~----~~~~~~~~q~~~L~hL~~~~~glpvP 85 (1013)
T PRK06148 11 FTTKDAEALLAQHFGISATATPLD-GERDLNFRLTTDDGADYILKIVNPS----EPRVESDFQTAALDHLAAVAPDLPVP 85 (1013)
T ss_pred CCHHHHHHHHHHHcCCceEEeecC-CcCCceEEEEeCCCCeEEEEEcCCc----cchhHHHHHHHHHHHHHhhCCCCCcC
Confidence 445555 4455566654 4554 5668889998877889999998643 12223333444554442 33
Q ss_pred ceeeeee-----EEE-cCCC-eeEEEEeecCCCChHHHh---------------------cCCCC----CCCCCC-----
Q 038766 71 NLVKVLG-----YAW-ESGK-LKALILEYMENGSLESVI---------------------HGPGV----DHSRWT----- 113 (299)
Q Consensus 71 ~i~~~~~-----~~~-~~~~-~~~lv~e~~~~~~L~~~~---------------------~~~~~----~~~~~~----- 113 (299)
.+++-.+ ... ..+. ..+.+++|++|..+.... +.... ....+.
T Consensus 86 ~~i~t~~G~~~~~v~~~~G~~~~vrLl~~l~G~~l~~~~~~t~~~~~~lG~~larlh~al~~F~~p~~~r~~~Wdl~~~~ 165 (1013)
T PRK06148 86 RLIPSLSGASLASAQDPDGEPRLLRLLSWLPGTPLAEAAPRTEALLDNLGRALGRLDRALQGFMHPGALRDLDWDLRHAG 165 (1013)
T ss_pred eeeecCCCCeEEEeecCCCceEEEEEEeccCCCcHHhccCCCHHHHHHHHHHHHHHHHHHhcCCCCCcccccccccccch
Confidence 4443221 011 1222 346789999887665411 00000 000011
Q ss_pred ----------hhhHHHHHHHHHHHHH-----HhhcCCCCCeeeecccCCceeeCCCC--cEE-Eeeecccc
Q 038766 114 ----------LPKRIDVLISVANGLD-----YLHSGYDIPIVHCDMKPSNILLDRDF--EAH-VSDFGTSR 166 (299)
Q Consensus 114 ----------~~~~~~i~~qi~~~l~-----~lh~~~~~~~~H~dl~~~nil~~~~~--~v~-l~df~~~~ 166 (299)
......++.+++.... .+.+ .+..++|+|+.+.||+++.++ .+. |+|||-+.
T Consensus 166 ~l~~~l~~i~d~~~r~~l~~~~~~~~~~v~p~l~~-Lp~~vIHgDln~~NiLv~~~~~~~isGiIDFgDa~ 235 (1013)
T PRK06148 166 RARDRLHFIDDPEDRALVERFLARFERNVAPRLAA-LPAQVIHNDANDYNILVDADDGERISGLIDFGDAV 235 (1013)
T ss_pred hhhhhhhhcCCHHHHHHHHHHHHHHHHHHHHHHhc-CCcceECCCCCcccEEEcCCCCcceEEEEECcccc
Confidence 1112222333333222 1222 234899999999999998775 555 99999875
|
|
| >COG3001 Uncharacterized protein conserved in bacteria [Function unknown] | Back alignment and domain information |
|---|
Probab=96.51 E-value=0.057 Score=43.20 Aligned_cols=76 Identities=22% Similarity=0.274 Sum_probs=47.8
Q ss_pred CceeecCCcceEEEEEeCCCcEEEEEEeccCcCChhhhHHHHHHHHHHHhcCC---cceeeeeeEEEcCCCeeEEEEeec
Q 038766 17 NNIIGNSNLSTVYKGRLEDGEIVAVKKLNFHQFSAESDKSFYREAKTLKELKH---RNLVKVLGYAWESGKLKALILEYM 93 (299)
Q Consensus 17 ~~~lg~g~~~~v~~~~~~~~~~~~vK~~~~~~~~~~~~~~~~~e~~~l~~l~h---~~i~~~~~~~~~~~~~~~lv~e~~ 93 (299)
.+.+.-|.--..|.+.+. ..++.+|+-. ......+..|+.-|+.+.- -.+.+.+.+..+ ....++|+||+
T Consensus 21 r~~v~gG~inea~~v~dg-~~~~FvK~n~-----~~~~~~f~AEa~gL~~la~s~ti~VP~vi~~G~~-~~~sylVle~L 93 (286)
T COG3001 21 REEVSGGDINEAWRLRDG-TDPFFVKCNQ-----REQLSMFTAEADGLELLARSNTITVPKVIAVGAS-RDHSYLVLEYL 93 (286)
T ss_pred ccccCCccccceeEeecC-CcceEEEecc-----hhhHHHHHHHHHHHHHHHhcCCccccceEEecCC-CCeeEEEEeec
Confidence 344555666666766653 5678888742 2334556677777777753 456666664444 44559999999
Q ss_pred CCCChH
Q 038766 94 ENGSLE 99 (299)
Q Consensus 94 ~~~~L~ 99 (299)
+.+.+.
T Consensus 94 ~~~~~d 99 (286)
T COG3001 94 PTGPLD 99 (286)
T ss_pred cCCCCC
Confidence 876543
|
|
| >KOG1236 consensus Predicted unusual protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=96.45 E-value=0.0094 Score=51.58 Aligned_cols=59 Identities=20% Similarity=0.148 Sum_probs=42.0
Q ss_pred EEEEeecCCCChHHHhcCCCCCCCCCChhhHHHHHHHHHHHHHHhhcCCCCCeeeecccCCceeeC
Q 038766 87 ALILEYMENGSLESVIHGPGVDHSRWTLPKRIDVLISVANGLDYLHSGYDIPIVHCDMKPSNILLD 152 (299)
Q Consensus 87 ~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lh~~~~~~~~H~dl~~~nil~~ 152 (299)
.++-+|..|.++..+++. ...+++....++.-.++|+..+--.. |++|.|+.|.||++.
T Consensus 321 vl~E~~~~Gl~v~~~v~~-----~~~pe~l~kkva~lg~~AllkMl~vD--NFvHaDlHPGNVlir 379 (565)
T KOG1236|consen 321 VLVETYERGLSVLRFVKW-----KSQPEALVKKVAKLGVNALLKMLIVD--NFVHADLHPGNVLIR 379 (565)
T ss_pred eeeeeccccccHHhhhhc-----ccChHHHHHHHHHHHHHHHHHHHHhh--cceecccCCCcEEEE
Confidence 577788888899888853 33455556666666666655444321 999999999999994
|
|
| >PRK11768 serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=96.39 E-value=0.23 Score=42.55 Aligned_cols=72 Identities=24% Similarity=0.179 Sum_probs=43.1
Q ss_pred CCcceEEEEEeCCCcEEEEEEeccCcCChhhhHHHHHHHHHHHhcCCcce--eeee---e-EEEcCCCeeEEEEeecCCC
Q 038766 23 SNLSTVYKGRLEDGEIVAVKKLNFHQFSAESDKSFYREAKTLKELKHRNL--VKVL---G-YAWESGKLKALILEYMENG 96 (299)
Q Consensus 23 g~~~~v~~~~~~~~~~~~vK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i--~~~~---~-~~~~~~~~~~lv~e~~~~~ 96 (299)
+.-..||.+...++..+++|+.+... .....+..|...+..+....+ +... | .....+...+.+++++.|.
T Consensus 36 s~eN~vy~v~~~~~~~~vlKv~r~~~---~~~~~i~~E~~~l~~L~~~gipv~~p~~~~G~~~~~~~g~~~~l~~~~~G~ 112 (325)
T PRK11768 36 SYENRVYQFGDEDGRRVVAKFYRPER---WSDAQILEEHAFALELAEAEIPVVAPLAFNGQTLHEHQGFRFALFPRRGGR 112 (325)
T ss_pred cccceEEEEecCCCCEEEEEEcCccc---CCHHHHHHHHHHHHHHHHCCCCCCCCccCCCCEEEEECCEEEEEEeeeCCC
Confidence 45567899988778899999875221 244566677777776642221 2211 1 0112234567899998775
Q ss_pred C
Q 038766 97 S 97 (299)
Q Consensus 97 ~ 97 (299)
.
T Consensus 113 ~ 113 (325)
T PRK11768 113 A 113 (325)
T ss_pred C
Confidence 3
|
|
| >PF07387 Seadorna_VP7: Seadornavirus VP7; InterPro: IPR009973 This family consists of several Seadornavirus specific VP7 proteins of around 305 residues in length | Back alignment and domain information |
|---|
Probab=96.38 E-value=0.033 Score=44.30 Aligned_cols=104 Identities=15% Similarity=0.153 Sum_probs=66.1
Q ss_pred EEEEEEeccCcCChhhhHHHHHHHHHHHhcCCcceeeeeeEEEcCCCeeEEEEeecCCCChHHHhcCCCCCCCCCChhhH
Q 038766 38 IVAVKKLNFHQFSAESDKSFYREAKTLKELKHRNLVKVLGYAWESGKLKALILEYMENGSLESVIHGPGVDHSRWTLPKR 117 (299)
Q Consensus 38 ~~~vK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~ 117 (299)
+..+|++...... -....++++..++.++ ..|+++.. +++..+.++.|.|-.... ...
T Consensus 87 ~L~lKKi~slp~~-~~~~~y~nky~v~Arm--hGilrL~N---Dn~~~yGvIlE~Cy~~~i----------------~~~ 144 (308)
T PF07387_consen 87 PLFLKKIRSLPCC-INDALYFNKYRVFARM--HGILRLKN---DNNYKYGVILERCYKIKI----------------NFS 144 (308)
T ss_pred hhhhhhccCCCcc-cchhhhhhhhhHHHHh--hheeEeec---CCCceeEEEEeeccCccc----------------chh
Confidence 3455555422221 1334567787777775 46777764 245455788998833111 111
Q ss_pred HHHHHHHHHHHHHhhcCCCCCeeeecccCCceeeCCCCcEEEeeeccc
Q 038766 118 IDVLISVANGLDYLHSGYDIPIVHCDMKPSNILLDRDFEAHVSDFGTS 165 (299)
Q Consensus 118 ~~i~~qi~~~l~~lh~~~~~~~~H~dl~~~nil~~~~~~v~l~df~~~ 165 (299)
-.+... +++|.-+|+. +.+..|||-.|+|||-|+.|.+||.|.+..
T Consensus 145 N~i~ag-i~~L~~fH~~-~~~~lHGD~np~NiM~D~~G~lKlVDP~~L 190 (308)
T PF07387_consen 145 NFITAG-IKDLMDFHSE-NQHCLHGDCNPDNIMCDKFGYLKLVDPVCL 190 (308)
T ss_pred HHHHHh-HHHHHHhhcc-CCCeecCCCChhheeecCCCCEEecChhhh
Confidence 111222 4567788854 349999999999999999999999999865
|
The function of this family is unknown. |
| >PTZ00296 choline kinase; Provisional | Back alignment and domain information |
|---|
Probab=96.26 E-value=0.096 Score=46.78 Aligned_cols=29 Identities=28% Similarity=0.392 Sum_probs=25.0
Q ss_pred CCeeeecccCCceeeCCCCcEEEeeecccc
Q 038766 137 IPIVHCDMKPSNILLDRDFEAHVSDFGTSR 166 (299)
Q Consensus 137 ~~~~H~dl~~~nil~~~~~~v~l~df~~~~ 166 (299)
..+||+|+.+.||+.+.++ +.|+||..+.
T Consensus 284 ~VfCHNDl~~~NiL~~~~~-l~LIDfEYAg 312 (442)
T PTZ00296 284 IVFCHNDLQENNIINTNKC-LRLIDFEYSG 312 (442)
T ss_pred eeEEeCCCCccceeecCCC-EEEEeecccc
Confidence 4799999999999886554 9999999875
|
|
Homologous Structure Templates
Structure Templates Detected by BLAST
Original result of BLAST against Protein Data Bank
| ID | Alignment Graph | Length |
Definition |
E-value | |
| Query | 299 | ||||
| 3tl8_A | 349 | The Avrptob-Bak1 Complex Reveals Two Structurally S | 8e-37 | ||
| 3uim_A | 326 | Structural Basis For The Impact Of Phosphorylation | 8e-36 | ||
| 2qkw_B | 321 | Structural Basis For Activation Of Plant Immunity B | 9e-31 | ||
| 3hgk_A | 327 | Crystal Structure Of Effect Protein Avrptob Complex | 3e-30 | ||
| 3p86_A | 309 | Crystal Structure Of Ctr1 Kinase Domain Mutant D676 | 1e-23 | ||
| 2nry_A | 307 | Crystal Structure Of Irak-4 Length = 307 | 1e-23 | ||
| 2nru_A | 307 | Crystal Structure Of Irak-4 Length = 307 | 2e-23 | ||
| 2oib_A | 301 | Crystal Structure Of Irak4 Kinase Domain Apo Form L | 2e-23 | ||
| 3ppz_A | 309 | Crystal Structure Of Ctr1 Kinase Domain In Complex | 3e-23 | ||
| 2o8y_A | 298 | Apo Irak4 Kinase Domain Length = 298 | 4e-21 | ||
| 4gs6_A | 315 | Irreversible Inhibition Of Tak1 Kinase By 5z-7-oxoz | 3e-20 | ||
| 2eva_A | 307 | Structural Basis For The Interaction Of Tak1 Kinase | 4e-20 | ||
| 3dqw_A | 286 | C-Src Kinase Domain Thr338ile Mutant In Complex Wit | 7e-20 | ||
| 3g6h_A | 286 | Src Thr338ile Inhibited In The Dfg-Asp-Out Conforma | 9e-20 | ||
| 1yi6_A | 276 | C-Term Tail Segment Of Human Tyrosine Kinase (258-5 | 1e-19 | ||
| 3svv_A | 286 | Crystal Structure Of T338c C-Src Covalently Bound T | 1e-19 | ||
| 2qq7_A | 286 | Crystal Structure Of Drug Resistant Src Kinase Doma | 2e-19 | ||
| 3u4w_A | 275 | Src In Complex With Dna-Templated Macrocyclic Inhib | 2e-19 | ||
| 2oiq_A | 286 | Crystal Structure Of Chicken C-Src Kinase Domain In | 2e-19 | ||
| 3d7u_B | 277 | Structural Basis For The Recognition Of C-Src By It | 2e-19 | ||
| 1y57_A | 452 | Structure Of Unphosphorylated C-Src In Complex With | 2e-19 | ||
| 1fmk_A | 452 | Crystal Structure Of Human Tyrosine-Protein Kinase | 2e-19 | ||
| 2bdf_A | 279 | Src Kinase In Complex With Inhibitor Ap23451 Length | 3e-19 | ||
| 2ptk_A | 453 | Chicken Src Tyrosine Kinase Length = 453 | 3e-19 | ||
| 2h8h_A | 535 | Src Kinase In Complex With A Quinazoline Inhibitor | 3e-19 | ||
| 1uwh_A | 276 | The Complex Of Wild Type B-Raf And Bay439006 Length | 3e-19 | ||
| 1yoj_A | 283 | Crystal Structure Of Src Kinase Domain Length = 283 | 3e-19 | ||
| 1yol_A | 283 | Crystal Structure Of Src Kinase Domain In Complex W | 3e-19 | ||
| 3oez_A | 286 | Crystal Structure Of The L317i Mutant Of The Chicke | 3e-19 | ||
| 3geq_A | 286 | Structural Basis For The Chemical Rescue Of Src Kin | 4e-19 | ||
| 1ksw_A | 452 | Structure Of Human C-Src Tyrosine Kinase (Thr338gly | 5e-19 | ||
| 2hwo_A | 286 | Crystal Structure Of Src Kinase Domain In Complex W | 5e-19 | ||
| 4h58_A | 275 | Braf In Complex With Compound 3 Length = 275 | 5e-19 | ||
| 2fb8_A | 281 | Structure Of The B-Raf Kinase Domain Bound To Sb-59 | 5e-19 | ||
| 3kul_B | 325 | Kinase Domain Of Human Ephrin Type-A Receptor 8 (Ep | 5e-19 | ||
| 4dbn_A | 284 | Crystal Structure Of The Kinase Domain Of Human B-R | 5e-19 | ||
| 3q96_A | 282 | B-Raf Kinase Domain In Complex With A Tetrahydronap | 5e-19 | ||
| 1uwj_A | 276 | The Complex Of Mutant V599e B-raf And Bay439006 Len | 6e-19 | ||
| 3idp_A | 300 | B-Raf V600e Kinase Domain In Complex With An Aminoi | 7e-19 | ||
| 3d4q_A | 307 | Pyrazole-Based Inhibitors Of B-Raf Kinase Length = | 7e-19 | ||
| 3ii5_A | 306 | The Complex Of Wild-Type B-Raf With Pyrazolo Pyrimi | 7e-19 | ||
| 3og7_A | 289 | B-Raf Kinase V600e Oncogenic Mutant In Complex With | 7e-19 | ||
| 4g9r_A | 307 | B-Raf V600e Kinase Domain Bound To A Type Ii Dihydr | 7e-19 | ||
| 3kul_A | 325 | Kinase Domain Of Human Ephrin Type-A Receptor 8 (Ep | 8e-19 | ||
| 4fk3_A | 292 | B-Raf Kinase V600e Oncogenic Mutant In Complex With | 1e-18 | ||
| 3c4c_A | 280 | B-Raf Kinase In Complex With Plx4720 Length = 280 | 1e-18 | ||
| 3s95_A | 310 | Crystal Structure Of The Human Limk1 Kinase Domain | 6e-18 | ||
| 2dq7_X | 283 | Crystal Structure Of Fyn Kinase Domain Complexed Wi | 1e-17 | ||
| 2qoo_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f: | 3e-17 | ||
| 3dzq_A | 361 | Human Epha3 Kinase Domain In Complex With Inhibitor | 3e-17 | ||
| 2qoc_A | 344 | Human Epha3 Kinase Domain, Phosphorylated, Amp-Pnp | 4e-17 | ||
| 2vwu_A | 302 | Ephb4 Kinase Domain Inhibitor Complex Length = 302 | 4e-17 | ||
| 2qoi_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f: | 4e-17 | ||
| 2qof_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f | 4e-17 | ||
| 2qod_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y602f | 4e-17 | ||
| 2gsf_A | 373 | The Human Epha3 Receptor Tyrosine Kinase And Juxtam | 4e-17 | ||
| 3fxx_A | 371 | Human Epha3 Kinase And Juxtamembrane Region Bound T | 5e-17 | ||
| 4aw5_A | 291 | Complex Of The Ephb4 Kinase Domain With An Oxindole | 7e-17 | ||
| 1qpe_A | 279 | Structural Analysis Of The Lymphocyte-Specific Kina | 7e-17 | ||
| 3bym_A | 272 | X-Ray Co-Crystal Structure Aminobenzimidazole Triaz | 8e-17 | ||
| 2zm1_A | 285 | Crystal Structure Of Imidazo Pyrazin 1 Bound To The | 8e-17 | ||
| 3lck_A | 271 | The Kinase Domain Of Human Lymphocyte Kinase (Lck), | 8e-17 | ||
| 3kmm_A | 288 | Structure Of Human Lck Kinase With A Small Molecule | 8e-17 | ||
| 3kxz_A | 287 | The Complex Crystal Structure Of Lck With A Probe M | 8e-17 | ||
| 2ofu_A | 273 | X-Ray Crystal Structure Of 2-Aminopyrimidine Carbam | 8e-17 | ||
| 2qok_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f: | 9e-17 | ||
| 2of2_A | 271 | Crystal Structure Of Furanopyrimidine 8 Bound To Lc | 9e-17 | ||
| 2og8_A | 265 | Crystal Structure Of Aminoquinazoline 36 Bound To L | 9e-17 | ||
| 3f69_A | 311 | Crystal Structure Of The Mycobacterium Tuberculosis | 1e-16 | ||
| 3ori_A | 311 | Mycobacterium Tuberculosis Pknb Kinase Domain L33d | 1e-16 | ||
| 3bys_A | 277 | Co-Crystal Structure Of Lck And Aminopyrimidine Ami | 1e-16 | ||
| 2pl0_A | 289 | Lck Bound To Imatinib Length = 289 | 1e-16 | ||
| 2ofv_A | 277 | Crystal Structure Of Aminoquinazoline 1 Bound To Lc | 1e-16 | ||
| 2hel_A | 306 | Crystal Structure Of A Mutant Epha4 Kinase Domain ( | 1e-16 | ||
| 2y6m_A | 291 | Crystal Structure Of Epha4 Kinase Domain Length = 2 | 1e-16 | ||
| 2qol_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596:y | 1e-16 | ||
| 1qpd_A | 279 | Structural Analysis Of The Lymphocyte-specific Kina | 1e-16 | ||
| 2xyu_A | 285 | Crystal Structure Of Epha4 Kinase Domain In Complex | 1e-16 | ||
| 3omv_A | 307 | Crystal Structure Of C-Raf (Raf-1) Length = 307 | 2e-16 | ||
| 3q6w_A | 307 | Structure Of Dually-phosphorylated Met Receptor Kin | 2e-16 | ||
| 3dkg_A | 317 | Sgx Clone 5698a109kfg1h1 Length = 317 | 2e-16 | ||
| 3f61_A | 311 | Crystal Structure Of M. Tuberculosis Pknb Leu33aspV | 2e-16 | ||
| 3sls_A | 304 | Crystal Structure Of Human Mek-1 Kinase In Complex | 2e-16 | ||
| 2g15_A | 318 | Structural Characterization Of Autoinhibited C-Met | 3e-16 | ||
| 1jpa_A | 312 | Crystal Structure Of Unphosphorylated Ephb2 Recepto | 3e-16 | ||
| 2wd1_A | 292 | Human C-Met Kinase In Complex With Azaindole Inhibi | 3e-16 | ||
| 3orn_A | 307 | Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In | 3e-16 | ||
| 4gg5_A | 319 | Crystal Structure Of Cmet In Complex With Novel Inh | 3e-16 | ||
| 2wgj_A | 306 | X-Ray Structure Of Pf-02341066 Bound To The Kinase | 3e-16 | ||
| 3q6u_A | 308 | Structure Of The Apo Met Receptor Kinase In The Dua | 3e-16 | ||
| 3i5n_A | 309 | Crystal Structure Of C-Met With Triazolopyridazine | 3e-16 | ||
| 3coh_A | 268 | Crystal Structure Of Aurora-A In Complex With A Pen | 3e-16 | ||
| 2qon_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f: | 4e-16 | ||
| 3lq8_A | 302 | Structure Of The Kinase Domain Of C-Met Bound To Xl | 4e-16 | ||
| 3c1x_A | 373 | Crystal Structure Of The Tyrosine Kinase Domain Of | 4e-16 | ||
| 2qob_A | 344 | Human Epha3 Kinase Domain, Base Structure Length = | 4e-16 | ||
| 2rfn_A | 310 | X-ray Structure Of C-met With Inhibitor. Length = 3 | 4e-16 | ||
| 3f66_A | 298 | Human C-Met Kinase In Complex With Quinoxaline Inhi | 4e-16 | ||
| 2wtw_A | 285 | Aurora-A Inhibitor Structure (2nd Crystal Form) Len | 4e-16 | ||
| 2qo7_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Dephos | 4e-16 | ||
| 3mpm_A | 267 | Lck Complexed With A Pyrazolopyrimidine Length = 26 | 4e-16 | ||
| 1r0p_A | 312 | Crystal Structure Of The Tyrosine Kinase Domain Of | 4e-16 | ||
| 3dkc_A | 317 | Sgx Clone 5698a65kfg1h1 Length = 317 | 4e-16 | ||
| 3cth_A | 314 | Crystal Structure Of The Tyrosine Kinase Domain Of | 5e-16 | ||
| 2xa4_A | 298 | Inhibitors Of Jak2 Kinase Domain Length = 298 | 5e-16 | ||
| 3qup_A | 323 | Inhibitor Bound Structure Of The Kinase Domain Of T | 5e-16 | ||
| 3qti_A | 314 | C-Met Kinase In Complex With Nvp-Bvu972 Length = 31 | 5e-16 | ||
| 3a4p_A | 319 | Human C-Met Kinase Domain Complexed With 6-Benzylox | 5e-16 | ||
| 2j4z_A | 306 | Structure Of Aurora-2 In Complex With Pha-680626 Le | 5e-16 | ||
| 2rei_A | 318 | Kinase Domain Of Human Ephrin Type-a Receptor 7 (ep | 6e-16 | ||
| 3sxr_A | 268 | Crystal Structure Of Bmx Non-Receptor Tyrosine Kina | 6e-16 | ||
| 2j50_A | 280 | Structure Of Aurora-2 In Complex With Pha-739358 Le | 6e-16 | ||
| 2b7a_A | 293 | The Structural Basis Of Janus Kinase 2 Inhibition B | 7e-16 | ||
| 3e62_A | 293 | Fragment Based Discovery Of Jak-2 Inhibitors Length | 7e-16 | ||
| 1muo_A | 297 | Crystal Structure Of Aurora-2, An Oncogenic Serine- | 7e-16 | ||
| 3q32_A | 301 | Structure Of Janus Kinase 2 With A Pyrrolotriazine | 7e-16 | ||
| 3rvg_A | 303 | Crystals Structure Of Jak2 With A 1-Amino-5h-Pyrido | 7e-16 | ||
| 2r2p_A | 295 | Kinase Domain Of Human Ephrin Type-A Receptor 5 (Ep | 7e-16 | ||
| 3nrm_A | 283 | Imidazo[1,2-A]pyrazine-Based Aurora Kinase Inhibito | 8e-16 | ||
| 2x6d_A | 285 | Aurora-A Bound To An Inhibitor Length = 285 | 8e-16 | ||
| 2xru_A | 280 | Aurora-A T288e Complexed With Pha-828300 Length = 2 | 8e-16 | ||
| 4aqc_A | 301 | Triazolopyridine-Based Inhibitor Of Janus Kinase 2 | 8e-16 | ||
| 2xng_A | 283 | Structure Of Aurora-A Bound To A Selective Imidazop | 8e-16 | ||
| 3lpb_A | 295 | Crystal Structure Of Jak2 Complexed With A Potent 2 | 8e-16 | ||
| 4hge_A | 300 | Jak2 Kinase (Jh1 Domain) In Complex With Compound 8 | 8e-16 | ||
| 3d14_A | 272 | Crystal Structure Of Mouse Aurora A (Asn186->gly, L | 8e-16 | ||
| 1mq4_A | 272 | Crystal Structure Of Aurora-A Protein Kinase Length | 8e-16 | ||
| 3h0y_A | 268 | Aurora A In Complex With A Bisanilinopyrimidine Len | 8e-16 | ||
| 3tjc_A | 298 | Co-Crystal Structure Of Jak2 With Thienopyridine 8 | 8e-16 | ||
| 2w1i_A | 326 | Structure Determination Of Aurora Kinase In Complex | 9e-16 | ||
| 4e4m_A | 302 | Jak2 Kinase (Jh1 Domain) In Complex With Compound 3 | 9e-16 | ||
| 3o50_A | 267 | Crystal Structure Of Benzamide 9 Bound To Auroraa L | 9e-16 | ||
| 3ugc_A | 295 | Structural Basis Of Jak2 Inhibition By The Type Ii | 9e-16 | ||
| 3qbn_A | 281 | Structure Of Human Aurora A In Complex With A Diami | 9e-16 | ||
| 3e5a_A | 268 | Crystal Structure Of Aurora A In Complex With Vx-68 | 9e-16 | ||
| 2w1d_A | 275 | Structure Determination Of Aurora Kinase In Complex | 9e-16 | ||
| 1mqb_A | 333 | Crystal Structure Of Ephrin A2 (Epha2) Receptor Pro | 1e-15 | ||
| 3orm_A | 311 | Mycobacterium Tuberculosis Pknb Kinase Domain D76a | 1e-15 | ||
| 3fdn_A | 279 | Structure-Based Drug Design Of Novel Aurora Kinase | 1e-15 | ||
| 2c6d_A | 275 | Aurora A Kinase Activated Mutant (T287d) In Complex | 1e-15 | ||
| 2wtv_A | 285 | Aurora-A Inhibitor Structure Length = 285 | 1e-15 | ||
| 3lau_A | 287 | Crystal Structure Of Aurora2 Kinase In Complex With | 1e-15 | ||
| 2wqe_A | 262 | Structure Of S155r Aurora-A Somatic Mutant Length = | 1e-15 | ||
| 3jy9_A | 311 | Janus Kinase 2 Inhibitors Length = 311 | 1e-15 | ||
| 3io7_A | 313 | 2-Aminopyrazolo[1,5-A]pyrimidines As Potent And Sel | 1e-15 | ||
| 2c6e_A | 283 | Aurora A Kinase Activated Mutant (T287d) In Complex | 1e-15 | ||
| 4apc_A | 350 | Crystal Structure Of Human Nima-Related Kinase 1 (N | 2e-15 | ||
| 1mru_A | 311 | Intracellular SerTHR PROTEIN KINASE DOMAIN OF Mycob | 2e-15 | ||
| 4asz_A | 299 | Crystal Structure Of Apo Trkb Kinase Domain Length | 2e-15 | ||
| 2hen_A | 286 | Crystal Structure Of The Ephb2 Receptor Kinase Doma | 2e-15 | ||
| 1o6y_A | 299 | Catalytic Domain Of Pknb Kinase From Mycobacterium | 2e-15 | ||
| 2dwb_A | 285 | Aurora-A Kinase Complexed With Amppnp Length = 285 | 2e-15 | ||
| 4e6d_A | 298 | Jak2 Kinase (Jh1 Domain) Triple Mutant In Complex W | 3e-15 | ||
| 2xne_A | 272 | Structure Of Aurora-A Bound To An Imidazopyrazine I | 3e-15 | ||
| 1ol6_A | 282 | Structure Of Unphosphorylated D274n Mutant Of Auror | 3e-15 | ||
| 3v5q_A | 297 | Discovery Of A Selective Trk Inhibitor With Efficac | 3e-15 | ||
| 3dtc_A | 271 | Crystal Structure Of Mixed-Lineage Kinase Mlk1 Comp | 3e-15 | ||
| 1ol5_A | 282 | Structure Of Aurora-A 122-403, Phosphorylated On Th | 4e-15 | ||
| 3unz_A | 279 | Aurora A In Complex With Rpm1679 Length = 279 | 4e-15 | ||
| 3ha6_A | 268 | Crystal Structure Of Aurora A In Complex With Tpx2 | 4e-15 | ||
| 4bbe_A | 298 | Aminoalkylpyrimidine Inhibitor Complexes With Jak2 | 4e-15 | ||
| 3say_A | 430 | Crystal Structure Of Human Glycogen Synthase Kinase | 4e-15 | ||
| 3daj_A | 272 | Crystal Structure Of Aurora A Complexed With An Inh | 4e-15 | ||
| 2y4i_C | 395 | Ksr2-Mek1 Heterodimer Length = 395 | 4e-15 | ||
| 4an2_A | 301 | Crystal Structures Of Human Mek1 With Carboxamide-B | 4e-15 | ||
| 2bmc_A | 306 | Aurora-2 T287d T288d Complexed With Pha-680632 Leng | 4e-15 | ||
| 2w1c_A | 275 | Structure Determination Of Aurora Kinase In Complex | 5e-15 | ||
| 1s9j_A | 341 | X-Ray Structure Of The Human Mitogen-Activated Prot | 5e-15 | ||
| 2p55_A | 333 | X-Ray Structure Of The Human Mitogen-Activated Prot | 5e-15 | ||
| 3eqc_A | 360 | X-Ray Structure Of The Human Mitogen-Activated Prot | 5e-15 | ||
| 3mbl_A | 328 | Crystal Structure Of The Human Mitogen-Activated Pr | 5e-15 | ||
| 3dv3_A | 322 | Mek1 With Pf-04622664 Bound Length = 322 | 5e-15 | ||
| 1ua2_A | 346 | Crystal Structure Of Human Cdk7 Length = 346 | 5e-15 | ||
| 3r21_A | 271 | Design, Synthesis, And Biological Evaluation Of Pyr | 6e-15 | ||
| 1i09_A | 420 | Structure Of Glycogen Synthase Kinase-3 (Gsk3b) Len | 6e-15 | ||
| 1q3d_A | 424 | Gsk-3 Beta Complexed With Staurosporine Length = 42 | 6e-15 | ||
| 1pyx_A | 422 | Gsk-3 Beta Complexed With Amp-Pnp Length = 422 | 6e-15 | ||
| 3zrk_A | 371 | Identification Of 2-(4-Pyridyl)thienopyridinones As | 6e-15 | ||
| 4acc_A | 465 | Gsk3b In Complex With Inhibitor Length = 465 | 6e-15 | ||
| 4dit_A | 382 | Crystal Structure Of Gsk3beta In Complex With A Imi | 6e-15 | ||
| 1q5k_A | 414 | Crystal Structure Of Glycogen Synthase Kinase 3 In | 7e-15 | ||
| 3f88_A | 349 | Glycogen Synthase Kinase 3beta Inhibitor Complex Le | 7e-15 | ||
| 3gb2_A | 353 | Gsk3beta Inhibitor Complex Length = 353 | 7e-15 | ||
| 1gng_A | 378 | Glycogen Synthase Kinase-3 Beta (Gsk3) Complex With | 7e-15 | ||
| 2ow3_A | 352 | Glycogen Synthase Kinase-3 Beta In Complex With Bis | 7e-15 | ||
| 4afj_A | 367 | 5-Aryl-4-Carboxamide-1,3-Oxazoles: Potent And Selec | 7e-15 | ||
| 1r0e_A | 391 | Glycogen Synthase Kinase-3 Beta In Complex With 3-I | 7e-15 | ||
| 3zdi_A | 350 | Glycogen Synthase Kinase 3 Beta Complexed With Axin | 7e-15 | ||
| 3f7z_A | 350 | X-ray Co-crystal Structure Of Glycogen Synthase Kin | 8e-15 | ||
| 2o5k_A | 372 | Crystal Structure Of Gsk3beta In Complex With A Ben | 9e-15 | ||
| 2hak_A | 328 | Catalytic And Ubiqutin-Associated Domains Of Mark1P | 1e-14 | ||
| 3sd0_A | 350 | Identification Of A Glycogen Synthase Kinase-3b Inh | 1e-14 | ||
| 4eqm_A | 294 | Structural Analysis Of Staphylococcus Aureus Serine | 1e-14 | ||
| 4aoj_A | 329 | Human Trka In Complex With The Inhibitor Az-23 Leng | 1e-14 | ||
| 4f0i_A | 300 | Crystal Structure Of Apo Trka Length = 300 | 1e-14 | ||
| 4gt5_A | 306 | Crystal Structure Of The Inactive Trka Kinase Domai | 1e-14 | ||
| 3miy_A | 266 | X-Ray Crystal Structure Of Itk Complexed With Sunit | 2e-14 | ||
| 3v5j_A | 266 | Crystal Structure Of Interleukin-2 Inducible T-Cell | 2e-14 | ||
| 1oit_A | 299 | Imidazopyridines: A Potent And Selective Class Of C | 2e-14 | ||
| 4ic7_A | 442 | Crystal Structure Of The Erk5 Kinase Domain In Comp | 2e-14 | ||
| 1sm2_A | 264 | Crystal Structure Of The Phosphorylated Interleukin | 2e-14 | ||
| 1s9i_A | 354 | X-Ray Structure Of The Human Mitogen-Activated Prot | 2e-14 | ||
| 4b99_A | 398 | Crystal Structure Of Mapk7 (Erk5) With Inhibitor Le | 2e-14 | ||
| 1yvj_A | 290 | Crystal Structure Of The Jak3 Kinase Domain In Comp | 3e-14 | ||
| 4hct_A | 269 | Crystal Structure Of Itk In Complex With Compound 5 | 3e-14 | ||
| 3pxf_A | 306 | Cdk2 In Complex With Two Molecules Of 8-Anilino-1-N | 3e-14 | ||
| 4hvd_A | 314 | Jak3 Kinase Domain In Complex With 2-cyclopropyl-5h | 3e-14 | ||
| 1pf8_A | 298 | Crystal Structure Of Human Cyclin-dependent Kinase | 3e-14 | ||
| 4erw_A | 306 | Cdk2 In Complex With Staurosporine Length = 306 | 3e-14 | ||
| 2w17_A | 299 | Cdk2 In Complex With The Imidazole Pyrimidine Amide | 3e-14 | ||
| 3lxk_A | 327 | Structural And Thermodynamic Characterization Of Th | 3e-14 | ||
| 1fin_A | 298 | Cyclin A-Cyclin-Dependent Kinase 2 Complex Length = | 3e-14 | ||
| 1o9u_A | 350 | Glycogen Synthase Kinase 3 Beta Complexed With Axin | 3e-14 | ||
| 3pj8_A | 299 | Structure Of Cdk2 In Complex With A Pyrazolo[4,3-D] | 3e-14 | ||
| 1uv5_A | 350 | Glycogen Synthase Kinase 3 Beta Complexed With 6-Br | 3e-14 | ||
| 1vyw_A | 309 | Structure Of Cdk2CYCLIN A WITH PNU-292137 Length = | 3e-14 | ||
| 1h8f_A | 352 | Glycogen Synthase Kinase 3 Beta. Length = 352 | 3e-14 | ||
| 3ezr_A | 300 | Cdk-2 With Indazole Inhibitor 17 Bound At Its Activ | 3e-14 | ||
| 1gz8_A | 299 | Human Cyclin Dependent Kinase 2 Complexed With The | 3e-14 | ||
| 2iw6_A | 302 | Structure Of Human Thr160-Phospho Cdk2-Cyclin A Com | 3e-14 | ||
| 1zmw_A | 327 | Catalytic And Ubiqutin-Associated Domains Of Mark2P | 4e-14 | ||
| 3t9t_A | 267 | Crystal Structure Of Btk Mutant (F435t,K596r) Compl | 5e-14 | ||
| 1gii_A | 298 | Human Cyclin Dependent Kinase 2 Complexed With The | 5e-14 | ||
| 3pjc_A | 315 | Crystal Structure Of Jak3 Complexed With A Potent A | 5e-14 | ||
| 1qmz_A | 299 | Phosphorylated Cdk2-Cyclyin A-Substrate Peptide Com | 5e-14 | ||
| 1ogu_A | 302 | Structure Of Human Thr160-phospho Cdk2/cyclin A Com | 5e-14 | ||
| 1jst_A | 298 | Phosphorylated Cyclin-Dependent Kinase-2 Bound To C | 5e-14 | ||
| 4eoq_A | 301 | Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Co | 5e-14 | ||
| 4bcq_A | 301 | Structure Of Cdk2 In Complex With Cyclin A And A 2- | 5e-14 | ||
| 4i3z_A | 296 | Structure Of Pcdk2CYCLINA BOUND TO ADP AND 2 MAGNES | 5e-14 | ||
| 1w98_A | 298 | The Structural Basis Of Cdk2 Activation By Cyclin E | 5e-14 | ||
| 4eos_A | 300 | Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Co | 5e-14 | ||
| 3bht_A | 300 | Structure Of Phosphorylated Thr160 Cdk2CYCLIN A IN | 5e-14 | ||
| 1h1p_A | 303 | Structure Of Human Thr160-Phospho Cdk2CYCLIN A COMP | 6e-14 | ||
| 2jgz_A | 289 | Crystal Structure Of Phospho-Cdk2 In Complex With C | 6e-14 | ||
| 3qhr_A | 298 | Structure Of A Pcdk2CYCLINA TRANSITION-State Mimic | 6e-14 | ||
| 1e9h_A | 297 | Thr 160 Phosphorylated Cdk2-Human Cyclin A3 Complex | 6e-14 | ||
| 4eop_A | 300 | Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 | 6e-14 | ||
| 4eoo_A | 299 | Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 | 6e-14 | ||
| 4eoi_A | 299 | Thr 160 Phosphorylated Cdk2 K89d, Q131e - Human Cyc | 7e-14 | ||
| 2iw8_A | 302 | Structure Of Human Thr160-Phospho Cdk2-Cyclin A F82 | 7e-14 | ||
| 2clq_A | 295 | Structure Of Mitogen-Activated Protein Kinase Kinas | 7e-14 | ||
| 2r0i_A | 327 | Crystal Structure Of A Kinase Mark2PAR-1 Mutant Len | 7e-14 | ||
| 1zmu_A | 327 | Catalytic And Ubiqutin-Associated Domains Of Mark2P | 7e-14 | ||
| 3vw6_A | 269 | Crystal Structure Of Human Apoptosis Signal-Regulat | 8e-14 | ||
| 3qgw_A | 286 | Crystal Structure Of Itk Kinase Bound To An Inhibit | 8e-14 | ||
| 4eom_A | 301 | Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Hum | 1e-13 | ||
| 4eok_A | 300 | Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Huma | 1e-13 | ||
| 4eoj_A | 302 | Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Huma | 1e-13 | ||
| 4eon_A | 300 | Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Hum | 1e-13 | ||
| 3fe3_A | 328 | Crystal Structure Of The Kinase Mark3PAR-1: T211a-S | 1e-13 | ||
| 1oir_A | 299 | Imidazopyridines: A Potent And Selective Class Of C | 1e-13 | ||
| 1h01_A | 298 | Cdk2 In Complex With A Disubstituted 2, 4-Bis Anili | 1e-13 | ||
| 1zmv_A | 327 | Catalytic And Ubiqutin-Associated Domains Of Mark2P | 2e-13 | ||
| 2qnj_A | 328 | Kinase And Ubiquitin-Associated Domains Of Mark3PAR | 2e-13 | ||
| 3dk7_A | 277 | Crystal Structure Of Mutant Abl Kinase Domain In Co | 2e-13 | ||
| 3a4o_X | 286 | Lyn Kinase Domain Length = 286 | 2e-13 | ||
| 2wzj_A | 327 | Catalytic And Uba Domain Of Kinase Mark2(PAR-1) K82 | 2e-13 | ||
| 3t8o_A | 543 | Rhodopsin Kinase (grk1) L166k Mutant At 2.5a Resolu | 3e-13 | ||
| 3c4x_A | 543 | Crystal Structure Of G Protein Coupled Receptor Kin | 3e-13 | ||
| 3c4w_A | 543 | Crystal Structure Of G Protein Coupled Receptor Kin | 3e-13 | ||
| 3qc9_A | 543 | Crystal Structure Of Cross-Linked Bovine Grk1 T8cN4 | 3e-13 | ||
| 2hk5_A | 270 | Hck Kinase In Complex With Lck Targetted Inhibitor | 3e-13 | ||
| 3dk6_A | 293 | Crystal Structure Of Mutant Abl Kinase Domain In Co | 3e-13 | ||
| 1qcf_A | 454 | Crystal Structure Of Hck In Complex With A Src Fami | 3e-13 | ||
| 1v0o_A | 288 | Structure Of P. Falciparum Pfpk5-Indirubin-5-Sulpho | 3e-13 | ||
| 3rhx_B | 306 | Crystal Structure Of The Catalytic Domain Of Fgfr1 | 3e-13 | ||
| 3pls_A | 298 | Ron In Complex With Ligand Amp-Pnp Length = 298 | 3e-13 | ||
| 1v0b_A | 288 | Crystal Structure Of The T198a Mutant Of Pfpk5 Leng | 4e-13 | ||
| 1fgk_A | 310 | Crystal Structure Of The Tyrosine Kinase Domain Of | 4e-13 | ||
| 3iec_A | 319 | Helicobacter Pylori Caga Inhibits Par1MARK FAMILY K | 4e-13 | ||
| 2v7a_A | 286 | Crystal Structure Of The T315i Abl Mutant In Comple | 4e-13 | ||
| 3tt0_A | 382 | Co-Structure Of Fibroblast Growth Factor Receptor 1 | 4e-13 | ||
| 3kxx_A | 317 | Structure Of The Mutant Fibroblast Growth Factor Re | 4e-13 | ||
| 4f63_A | 309 | Crystal Structure Of Human Fibroblast Growth Factor | 4e-13 | ||
| 3js2_A | 317 | Crystal Structure Of Minimal Kinase Domain Of Fibro | 4e-13 | ||
| 1a06_A | 332 | Calmodulin-Dependent Protein Kinase From Rat Length | 4e-13 | ||
| 4fg7_A | 293 | Crystal Structure Of Human Calcium/calmodulin-depen | 4e-13 | ||
| 1ob3_A | 288 | Structure Of P. Falciparum Pfpk5 Length = 288 | 4e-13 | ||
| 3i81_A | 315 | Crystal Structure Of Insulin-Like Growth Factor 1 R | 4e-13 | ||
| 2oj9_A | 307 | Structure Of Igf-1r Kinase Domain Complexed With A | 4e-13 | ||
| 1y8g_A | 327 | Catalytic And Ubiqutin-Associated Domains Of Mark2P | 4e-13 | ||
| 1jqh_A | 308 | Igf-1 Receptor Kinase Domain Length = 308 | 4e-13 | ||
| 4f1o_A | 287 | Crystal Structure Of The L1180t Mutant Roco4 Kinase | 5e-13 | ||
| 3o23_A | 305 | Human Unphosphorylated Igf1-R Kinase Domain In Comp | 5e-13 | ||
| 4fg8_A | 315 | Crystal Structure Of Human Calcium/calmodulin-depen | 5e-13 | ||
| 3qqu_A | 301 | Cocrystal Structure Of Unphosphorylated Igf With Py | 5e-13 | ||
| 3lvp_A | 336 | Crystal Structure Of Bisphosphorylated Igf1-R Kinas | 5e-13 | ||
| 1m7n_A | 322 | Crystal Structure Of Unactivated Apo Insulin-Like G | 5e-13 | ||
| 3gqi_A | 326 | Crystal Structure Of Activated Receptor Tyrosine Ki | 5e-13 | ||
| 4fg9_A | 320 | Crystal Structure Of Human Calcium/calmodulin-depen | 5e-13 | ||
| 3qrj_A | 277 | The Crystal Structure Of Human Abl1 Kinase Domain T | 6e-13 | ||
| 3rzf_A | 677 | Crystal Structure Of Inhibitor Of Kappab Kinase Bet | 6e-13 | ||
| 3qa8_A | 676 | Crystal Structure Of Inhibitor Of Kappa B Kinase Be | 6e-13 | ||
| 3lw0_A | 304 | Igf-1rk In Complex With Ligand Msc1609119a-1 Length | 6e-13 | ||
| 2z60_A | 288 | Crystal Structure Of The T315i Mutant Of Abl Kinase | 6e-13 | ||
| 1f3m_C | 297 | Crystal Structure Of Human SerineTHREONINE KINASE P | 6e-13 | ||
| 2wqm_A | 310 | Structure Of Apo Human Nek7 Length = 310 | 6e-13 | ||
| 1p4o_A | 322 | Structure Of Apo Unactivated Igf-1r Kinase Domain A | 6e-13 | ||
| 3q52_A | 306 | Structure Of Phosphorylated Pak1 Kinase Domain Leng | 6e-13 | ||
| 3fxz_A | 297 | Crystal Structure Of Pak1 Kinase Domain With Ruthen | 7e-13 | ||
| 2jav_A | 279 | Human Kinase With Pyrrole-Indolinone Ligand Length | 7e-13 | ||
| 3dk3_A | 293 | Crystal Structure Of Mutant Abl Kinase Domain In Co | 7e-13 | ||
| 2zm3_A | 308 | Complex Structure Of Insulin-Like Growth Factor Rec | 8e-13 | ||
| 1yhv_A | 297 | Crystal Structure Of Pak1 Kinase Domain With Two Po | 8e-13 | ||
| 3p4k_A | 370 | The Third Conformation Of P38a Map Kinase Observed | 8e-13 | ||
| 3oy3_A | 284 | Crystal Structure Of Abl T315i Mutant Kinase Domain | 8e-13 | ||
| 2gqg_A | 278 | X-Ray Crystal Structure Of Dasatinib (Bms-354825) B | 8e-13 | ||
| 2f4j_A | 287 | Structure Of The Kinase Domain Of An Imatinib-Resis | 8e-13 | ||
| 1lew_A | 360 | Crystal Structure Of Map Kinase P38 Complexed To Th | 8e-13 | ||
| 2pk9_A | 317 | Structure Of The Pho85-pho80 Cdk-cyclin Complex Of | 8e-13 | ||
| 1bmk_A | 379 | The Complex Structure Of The Map Kinase P38SB218655 | 9e-13 | ||
| 2puu_A | 348 | Crystal Structure Of P38 Complex With 1-(5-Tert-But | 9e-13 | ||
| 2g2f_A | 287 | A Src-Like Inactive Conformation In The Abl Tyrosin | 9e-13 | ||
| 2e2b_A | 293 | Crystal Structure Of The C-Abl Kinase Domain In Com | 9e-13 | ||
| 3gql_A | 326 | Crystal Structure Of Activated Receptor Tyrosine Ki | 1e-12 | ||
| 2gtm_A | 348 | Mutated Mouse P38 Map Kinase Domain In Complex With | 1e-12 | ||
| 3c4f_A | 302 | Fgfr Tyrosine Kinase Domain In Complex With 3-(3- M | 1e-12 | ||
| 3g51_A | 325 | Structural Diversity Of The Active Conformation Of | 1e-12 | ||
| 3tg1_A | 380 | Crystal Structure Of P38alpha In Complex With A Map | 1e-12 | ||
| 2hiw_A | 287 | Crystal Structure Of Inactive Conformation Abl Kina | 1e-12 | ||
| 2g1t_A | 287 | A Src-Like Inactive Conformation In The Abl Tyrosin | 1e-12 | ||
| 2oza_B | 366 | Structure Of P38alpha Complex Length = 366 | 1e-12 | ||
| 3ubd_A | 304 | Structure Of N-Terminal Domain Of Rsk2 Kinase In Co | 1e-12 | ||
| 2hzi_A | 277 | Abl Kinase Domain In Complex With Pd180970 Length = | 1e-12 | ||
| 1h4l_A | 292 | Structure And Regulation Of The Cdk5-P25(Nck5a) Com | 1e-12 | ||
| 4el9_A | 305 | Structure Of N-Terminal Kinase Domain Of Rsk2 With | 1e-12 | ||
| 1ywr_A | 360 | Crystal Structure Analysis Of Inactive P38 Kinase D | 1e-12 | ||
| 3qri_A | 277 | The Crystal Structure Of Human Abl1 Kinase Domain I | 1e-12 | ||
| 1yw2_A | 360 | Mutated Mus Musculus P38 Kinase (Mp38) Length = 360 | 1e-12 | ||
| 3pyy_A | 298 | Discovery And Characterization Of A Cell-Permeable, | 1e-12 | ||
| 2hyy_A | 273 | Human Abl Kinase Domain In Complex With Imatinib (S | 1e-12 | ||
| 2qoh_A | 288 | Crystal Structure Of Abl Kinase Bound With Ppy-a Le | 1e-12 | ||
| 1fpu_A | 293 | Crystal Structure Of Abl Kinase Domain In Complex W | 1e-12 | ||
| 2hz0_A | 270 | Abl Kinase Domain In Complex With Nvp-Aeg082 Length | 1e-12 | ||
| 3odz_X | 360 | Crystal Structure Of P38alpha Y323r Active Mutant L | 2e-12 | ||
| 3ody_X | 360 | Crystal Structure Of P38alpha Y323q Active Mutant L | 2e-12 | ||
| 2ghl_A | 348 | Mutant Mus Musculus P38 Kinase Domain In Complex Wi | 2e-12 | ||
| 3od6_X | 360 | Crystal Structure Of P38alpha Y323t Active Mutant L | 2e-12 | ||
| 2baq_A | 365 | P38alpha Bound To Ro3201195 Length = 365 | 2e-12 | ||
| 3k3j_A | 362 | P38alpha Bound To Novel Dfg-Out Compound Pf-0041612 | 2e-12 | ||
| 1zzl_A | 351 | Crystal Structure Of P38 With Triazolopyridine Leng | 2e-12 | ||
| 3nnu_A | 354 | Crystal Structure Of P38 Alpha In Complex With Dp13 | 2e-12 | ||
| 1oz1_A | 372 | P38 Mitogen-Activated Kinase In Complex With 4-Azai | 2e-12 | ||
| 2gfs_A | 372 | P38 Kinase Crystal Structure In Complex With Ro3201 | 2e-12 | ||
| 3oxz_A | 284 | Crystal Structure Of Abl Kinase Domain Bound With A | 2e-12 | ||
| 2baj_A | 365 | P38alpha Bound To Pyrazolourea Length = 365 | 2e-12 | ||
| 3oef_X | 360 | Crystal Structure Of Y323f Inactive Mutant Of P38al | 2e-12 | ||
| 3hrb_A | 359 | P38 Kinase Crystal Structure In Complex With Small | 2e-12 | ||
| 3mpt_A | 371 | Crystal Structure Of P38 Kinase In Complex With A P | 2e-12 | ||
| 3hvc_A | 362 | Crystal Structure Of Human P38alpha Map Kinase Leng | 2e-12 | ||
| 1m7q_A | 366 | Crystal Structure Of P38 Map Kinase In Complex With | 2e-12 | ||
| 1di9_A | 360 | The Structure Of P38 Mitogen-Activated Protein Kina | 2e-12 | ||
| 3k3i_A | 350 | P38alpha Bound To Novel Dgf-Out Compound Pf-0021595 | 2e-12 | ||
| 2npq_A | 367 | A Novel Lipid Binding Site In The P38 Alpha Map Kin | 2e-12 | ||
| 2bal_A | 365 | P38alpha Map Kinase Bound To Pyrazoloamine Length = | 2e-12 | ||
| 1bl6_A | 379 | The Complex Structure Of The Map Kinase P38SB216995 | 2e-12 | ||
| 3gcu_A | 360 | Human P38 Map Kinase In Complex With Rl48 Length = | 2e-12 | ||
| 3dt1_A | 383 | P38 Complexed With A Quinazoline Inhibitor Length = | 2e-12 | ||
| 3zsg_A | 362 | X-Ray Structure Of P38alpha Bound To Tak-715 Length | 2e-12 | ||
| 3d83_A | 360 | Crystal Structure Of P38 Kinase In Complex With A B | 2e-12 | ||
| 3d7z_A | 360 | Crystal Structure Of P38 Kinase In Complex With A B | 2e-12 | ||
| 2zv7_A | 279 | Lyn Tyrosine Kinase Domain, Apo Form Length = 279 | 2e-12 | ||
| 3e92_A | 371 | Crystal Structure Of P38 Kinase In Complex With A B | 2e-12 | ||
| 2lgc_A | 359 | Joint Nmr And X-Ray Refinement Reveals The Structur | 2e-12 | ||
| 3oht_A | 389 | Crystal Structure Of Salmo Salar P38alpha Length = | 2e-12 | ||
| 3kq7_A | 380 | Structure Of Human P38alpha With N-[4-Methyl-3-(6-{ | 2e-12 | ||
| 3s3i_A | 349 | P38 Kinase Crystal Structure In Complex With Small | 2e-12 | ||
| 3fi4_A | 372 | P38 Kinase Crystal Structure In Complex With Ro4499 | 2e-12 | ||
| 3hec_A | 348 | P38 In Complex With Imatinib Length = 348 | 2e-12 | ||
| 3q4z_A | 306 | Structure Of Unphosphorylated Pak1 Kinase Domain Le | 2e-12 | ||
| 1ian_A | 366 | Human P38 Map Kinase Inhibitor Complex Length = 366 | 2e-12 | ||
| 3gcp_A | 360 | Human P38 Map Kinase In Complex With Sb203580 Lengt | 2e-12 | ||
| 1ove_A | 366 | The Structure Of P38 Alpha In Complex With A Dihydr | 2e-12 | ||
| 1k3a_A | 299 | Structure Of The Insulin-Like Growth Factor 1 Recep | 2e-12 | ||
| 2y8o_A | 362 | Crystal Structure Of Human P38alpha Complexed With | 2e-12 | ||
| 2w5a_A | 279 | Human Nek2 Kinase Adp-Bound Length = 279 | 2e-12 | ||
| 4f0f_A | 287 | Crystal Structure Of The Roco4 Kinase Domain Bound | 3e-12 | ||
| 2vrx_A | 285 | Structure Of Aurora B Kinase In Complex With Zm4474 | 3e-12 | ||
| 4e5a_X | 360 | The W197a Mutant Of P38a Map Kinase Length = 360 | 3e-12 | ||
| 4a4x_A | 279 | Nek2-Ede Bound To Cct248662 Length = 279 | 3e-12 | ||
| 2bfx_B | 284 | Mechanism Of Aurora-B Activation By Incenp And Inhi | 3e-12 | ||
| 3cly_A | 334 | Crystal Structure Of Fgf Receptor 2 (Fgfr2) Kinase | 3e-12 | ||
| 2psq_A | 370 | Crystal Structure Of Unphosphorylated Unactivated W | 3e-12 | ||
| 2ydj_A | 276 | Discovery Of Checkpoint Kinase Inhibitor Azd7762 By | 3e-12 | ||
| 2ivt_A | 314 | Crystal Structure Of Phosphorylated Ret Tyrosine Ki | 3e-12 | ||
| 4fsz_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 4e-12 | ||
| 2bfy_A | 284 | Complex Of Aurora-B With Incenp And Hesperidin. Len | 4e-12 | ||
| 2pzp_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 4e-12 | ||
| 2pzr_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 4e-12 | ||
| 1irk_A | 306 | Crystal Structure Of The Tyrosine Kinase Domain Of | 4e-12 | ||
| 2fo0_A | 495 | Organization Of The Sh3-Sh2 Unit In Active And Inac | 4e-12 | ||
| 3b2t_A | 311 | Structure Of Phosphotransferase Length = 311 | 4e-12 | ||
| 3mh2_A | 360 | Mutagenesis Of P38 Map Kinase Establishes Key Roles | 4e-12 | ||
| 2ivv_A | 314 | Crystal Structure Of Phosphorylated Ret Tyrosine Ki | 4e-12 | ||
| 1opl_A | 537 | Structural Basis For The Auto-Inhibition Of C-Abl T | 4e-12 | ||
| 1gjo_A | 316 | The Fgfr2 Tyrosine Kinase Domain Length = 316 | 4e-12 | ||
| 3ri1_A | 313 | Crystal Structure Of The Catalytic Domain Of Fgfr2 | 4e-12 | ||
| 4fsy_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 5e-12 | ||
| 3eta_A | 317 | Kinase Domain Of Insulin Receptor Complexed With A | 5e-12 | ||
| 3d94_A | 301 | Crystal Structure Of The Insulin-Like Growth Factor | 5e-12 | ||
| 1ir3_A | 306 | Phosphorylated Insulin Receptor Tyrosine Kinase In | 5e-12 | ||
| 4fsw_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 5e-12 | ||
| 4exu_A | 371 | Mapk13, Inactive Form Length = 371 | 5e-12 | ||
| 1rqq_A | 306 | Crystal Structure Of The Insulin Receptor Kinase In | 5e-12 | ||
| 2pz5_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 5e-12 | ||
| 2ivs_A | 314 | Crystal Structure Of Non-Phosphorylated Ret Tyrosin | 5e-12 | ||
| 4ft3_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 5e-12 | ||
| 2p0c_A | 313 | Catalytic Domain Of The Proto-Oncogene Tyrosine-Pro | 5e-12 | ||
| 2pvy_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 5e-12 | ||
| 2z8c_A | 303 | Phosphorylated Insulin Receptor Tyrosine Kinase In | 5e-12 | ||
| 2br1_A | 297 | Structure-Based Design Of Novel Chk1 Inhibitors: In | 5e-12 | ||
| 1ia8_A | 289 | The 1.7 A Crystal Structure Of Human Cell Cycle Che | 5e-12 | ||
| 4fst_A | 269 | Crystal Structure Of The Chk1 Length = 269 | 5e-12 | ||
| 2pwl_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 5e-12 | ||
| 1zlt_A | 295 | Crystal Structure Of Chk1 Complexed With A Hymenald | 5e-12 | ||
| 4fsu_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 6e-12 | ||
| 1ung_A | 292 | Structural Mechanism For The Inhibition Of Cdk5-P25 | 6e-12 | ||
| 4e7w_A | 394 | Structure Of Gsk3 From Ustilago Maydis Length = 394 | 6e-12 | ||
| 1ad5_A | 438 | Src Family Kinase Hck-Amp-Pnp Complex Length = 438 | 6e-12 | ||
| 2hog_A | 322 | Crystal Structure Of Chek1 In Complex With Inhibito | 6e-12 | ||
| 3nnx_A | 354 | Crystal Structure Of Phosphorylated P38 Alpha In Co | 6e-12 | ||
| 3ot3_A | 273 | X-Ray Crystal Structure Of Compound 22k Bound To Hu | 6e-12 | ||
| 3jvr_A | 271 | Characterization Of The Chk1 Allosteric Inhibitor B | 6e-12 | ||
| 2z7q_A | 321 | Crystal Structure Of The N-Terminal Kinase Domain O | 6e-12 | ||
| 2ayp_A | 269 | Crystal Structure Of Chk1 With An Indol Inhibitor L | 6e-12 | ||
| 4fsm_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 6e-12 | ||
| 3dak_A | 290 | Crystal Structure Of Domain-Swapped Osr1 Kinase Dom | 6e-12 | ||
| 2e9v_A | 268 | Structure Of H-Chk1 Complexed With A859017 Length = | 6e-12 | ||
| 2ghg_A | 269 | H-Chk1 Complexed With A431994 Length = 269 | 6e-12 | ||
| 2vwi_A | 303 | Structure Of The Osr1 Kinase, A Hypertension Drug T | 7e-12 | ||
| 4fsn_A | 278 | Crystal Structure Of The Chk1 Length = 278 | 7e-12 | ||
| 2x8e_A | 276 | Discovery Of A Novel Class Of Triazolones As Checkp | 7e-12 | ||
| 2fsl_X | 367 | Mitogen Activated Protein Kinase P38alpha (D176a+f3 | 7e-12 | ||
| 4eut_A | 396 | Structure Of Bx-795 Complexed With Unphosphorylated | 7e-12 | ||
| 2pvf_A | 334 | Crystal Structure Of Tyrosine Phosphorylated Activa | 7e-12 | ||
| 2r0u_A | 323 | Crystal Structure Of Chek1 In Complex With Inhibito | 7e-12 | ||
| 1opk_A | 495 | Structural Basis For The Auto-Inhibition Of C-Abl T | 7e-12 | ||
| 2fst_X | 367 | Mitogen Activated Protein Kinase P38alpha (d176a+f3 | 7e-12 | ||
| 4ewq_A | 383 | Human P38 Alpha Mapk In Complex With A Pyridazine B | 7e-12 | ||
| 2fso_X | 367 | Mitogen Activated Protein Kinase P38alpha (D176a) A | 8e-12 | ||
| 3gi3_A | 360 | Crystal Structure Of A N-Phenyl-N'-Naphthylurea Ana | 9e-12 | ||
| 3coi_A | 353 | Crystal Structure Of P38delta Kinase Length = 353 | 1e-11 | ||
| 3cd3_A | 377 | Crystal Structure Of Phosphorylated Human Feline Sa | 1e-11 | ||
| 3oz6_A | 388 | Crystal Structure Of Mapk From Cryptosporidium Parv | 1e-11 | ||
| 1fot_A | 318 | Structure Of The Unliganded Camp-Dependent Protein | 1e-11 | ||
| 2a19_B | 284 | Pkr Kinase Domain- Eif2alpha- Amp-Pnp Complex. Leng | 1e-11 | ||
| 1p14_A | 306 | Crystal Structure Of A Catalytic-Loop Mutant Of The | 1e-11 | ||
| 3py3_A | 380 | Crystal Structure Of Phosphorylated P38alpha Map Ki | 1e-11 | ||
| 3ekk_A | 307 | Insulin Receptor Kinase Complexed With An Inhibitor | 1e-11 | ||
| 3bkb_A | 377 | Crystal Structure Of Human Feline Sarcoma Viral Onc | 1e-11 | ||
| 4f1m_A | 287 | Crystal Structure Of The G1179s Roco4 Kinase Domain | 1e-11 | ||
| 3o8p_A | 360 | Conformational Plasticity Of P38 Map Kinase Dfg Mot | 1e-11 | ||
| 2biy_A | 310 | Structure Of Pdk1-S241a Mutant Kinase Domain Length | 1e-11 | ||
| 1luf_A | 343 | Crystal Structure Of The Musk Tyrosine Kinase: Insi | 2e-11 | ||
| 2xik_A | 294 | Structure Of Human Ysk1 (Yeast Sps1-Ste20-Related K | 2e-11 | ||
| 3mh0_A | 360 | Mutagenesis Of P38 Map Kinase Eshtablishes Key Role | 2e-11 | ||
| 3fpq_A | 290 | Crystal Structure Of The Kinase Domain Of Wnk1 Leng | 2e-11 | ||
| 1byg_A | 278 | Kinase Domain Of Human C-Terminal Src Kinase (Csk) | 2e-11 | ||
| 3mh3_A | 360 | Mutagenesis Of P38 Map Kinase Establishes Key Roles | 2e-11 | ||
| 2q0b_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 2e-11 | ||
| 4e4l_A | 302 | Jak1 Kinase (Jh1 Domain) In Complex With Compound 3 | 2e-11 | ||
| 1i44_A | 306 | Crystallographic Studies Of An Activation Loop Muta | 2e-11 | ||
| 3d7u_A | 263 | Structural Basis For The Recognition Of C-Src By It | 2e-11 | ||
| 1k9a_A | 450 | Crystal Structure Analysis Of Full-Length Carboxyl- | 2e-11 | ||
| 3eyg_A | 290 | Crystal Structures Of Jak1 And Jak2 Inhibitor Compl | 2e-11 | ||
| 3mh1_A | 360 | Mutagenesis Of P38 Map Kinase Establishes Key Roles | 2e-11 | ||
| 4euu_A | 319 | Structure Of Bx-795 Complexed With Human Tbk1 Kinas | 2e-11 | ||
| 2f57_A | 317 | Crystal Structure Of The Human P21-activated Kinase | 2e-11 | ||
| 2qkr_A | 313 | Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5 | 3e-11 | ||
| 3pwy_A | 311 | Crystal Structure Of An Extender (Spd28345)-Modifie | 3e-11 | ||
| 3niz_A | 311 | Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5 | 3e-11 | ||
| 1zys_A | 273 | Co-Crystal Structure Of Checkpoint Kinase Chk1 With | 3e-11 | ||
| 3d7t_A | 269 | Structural Basis For The Recognition Of C-Src By It | 3e-11 | ||
| 2py3_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 3e-11 | ||
| 2r7b_A | 312 | Crystal Structure Of The Phosphoinositide-Dependent | 4e-11 | ||
| 2y94_A | 476 | Structure Of An Active Form Of Mammalian Ampk Lengt | 4e-11 | ||
| 4fif_A | 346 | Catalytic Domain Of Human Pak4 With Rpkplvdp Peptid | 4e-11 | ||
| 3orx_A | 316 | Pdk1 Mutant Bound To Allosteric Disulfide Fragment | 5e-11 | ||
| 3nax_A | 311 | Pdk1 In Complex With Inhibitor Mp7 Length = 311 | 5e-11 | ||
| 2cdz_A | 303 | Crystal Structure Of The Human P21-Activated Kinase | 5e-11 | ||
| 3gvu_A | 292 | The Crystal Structure Of Human Abl2 In Complex With | 5e-11 | ||
| 3uiu_A | 306 | Crystal Structure Of Apo-Pkr Kinase Domain Length = | 5e-11 | ||
| 1h1w_A | 289 | High Resolution Crystal Structure Of The Human Pdk1 | 5e-11 | ||
| 3h9o_A | 311 | Phosphoinositide-Dependent Protein Kinase 1 (Pdk-1) | 5e-11 | ||
| 2bva_A | 292 | Crystal Structure Of The Human P21-Activated Kinase | 5e-11 | ||
| 3gp0_A | 348 | Crystal Structure Of Human Mitogen Activated Protei | 6e-11 | ||
| 4fie_A | 423 | Full-Length Human Pak4 Length = 423 | 6e-11 | ||
| 2q0n_A | 301 | Structure Of Human P21 Activating Kinase 4 (Pak4) I | 6e-11 | ||
| 2jam_A | 304 | Crystal Structure Of Human Calmodulin-Dependent Pro | 6e-11 | ||
| 3iop_A | 312 | Pdk-1 In Complex With The Inhibitor Compound-8i Len | 6e-11 | ||
| 4fr4_A | 384 | Crystal Structure Of Human SerineTHREONINE-Protein | 6e-11 | ||
| 3qc4_A | 314 | Pdk1 In Complex With Dfg-Out Inhibitor Xxx Length = | 6e-11 | ||
| 2x4z_A | 296 | Crystal Structure Of The Human P21-Activated Kinase | 6e-11 | ||
| 1uu9_A | 286 | Structure Of Human Pdk1 Kinase Domain In Complex Wi | 6e-11 | ||
| 3nus_A | 286 | Phosphoinositide-Dependent Kinase-1 (Pdk1) With Fra | 6e-11 | ||
| 3sc1_A | 311 | Novel Isoquinolone Pdk1 Inhibitors Discovered Throu | 6e-11 | ||
| 1z5m_A | 286 | Crystal Structure Of N1-[3-[[5-bromo-2-[[3-[(1-pyrr | 6e-11 | ||
| 1uu3_A | 310 | Structure Of Human Pdk1 Kinase Domain In Complex Wi | 6e-11 | ||
| 3rwp_A | 311 | Discovery Of A Novel, Potent And Selective Inhibito | 6e-11 | ||
| 2xch_A | 309 | Crystal Structure Of Pdk1 In Complex With A Pyrazol | 6e-11 | ||
| 3nun_A | 292 | Phosphoinositide-Dependent Kinase-1 (Pdk1) With Lea | 6e-11 | ||
| 3hrc_A | 311 | Crystal Structure Of A Mutant Of Human Pdk1 Kinase | 6e-11 | ||
| 3gc9_A | 370 | The Structure Of P38beta C119s, C162s In Complex Wi | 6e-11 | ||
| 3nay_A | 311 | Pdk1 In Complex With Inhibitor Mp6 Length = 311 | 7e-11 | ||
| 3ku2_A | 507 | Crystal Structure Of Inactivated Form Of Cdpk1 From | 7e-11 | ||
| 3hx4_A | 508 | Crystal Structure Of Cdpk1 Of Toxoplasma Gondii, Tg | 7e-11 | ||
| 4a07_A | 311 | Human Pdk1 Kinase Domain In Complex With Allosteric | 8e-11 | ||
| 3ma6_A | 298 | Crystal Structure Of Kinase Domain Of Tgcdpk1 In Pr | 8e-11 | ||
| 3com_A | 314 | Crystal Structure Of Mst1 Kinase Length = 314 | 8e-11 | ||
| 3i79_A | 484 | Calcium-Dependent Protein Kinase 1 From Toxoplasma | 9e-11 | ||
| 1pme_A | 380 | Structure Of Penta Mutant Human Erk2 Map Kinase Com | 1e-10 | ||
| 3gc8_A | 370 | The Structure Of P38beta C162s In Complex With A Di | 1e-10 | ||
| 3ggf_A | 301 | Crystal Structure Of Human SerineTHREONINE-Protein | 1e-10 | ||
| 4af3_A | 292 | Human Aurora B Kinase In Complex With Incenp And Vx | 1e-10 | ||
| 3h9r_A | 330 | Crystal Structure Of The Kinase Domain Of Type I Ac | 2e-10 | ||
| 2xck_A | 309 | Crystal Structure Of Pdk1 In Complex With A Pyrazol | 2e-10 | ||
| 4dym_A | 301 | Crystal Structure Of The Acvr1 Kinase Domain In Com | 2e-10 | ||
| 3mtf_A | 301 | Crystal Structure Of The Acvr1 Kinase In Complex Wi | 2e-10 | ||
| 3i7c_A | 484 | Calcium-Dependent Protein Kinase 1 From Toxoplasma | 2e-10 | ||
| 2r4b_A | 321 | Erbb4 Kinase Domain Complexed With A Thienopyrimidi | 2e-10 | ||
| 3zhp_C | 294 | Human Mst3 (stk24) In Complex With Mo25beta Length | 2e-10 | ||
| 2h6d_A | 276 | Protein Kinase Domain Of The Human 5'-Amp-Activated | 2e-10 | ||
| 4aaa_A | 331 | Crystal Structure Of The Human Cdkl2 Kinase Domain | 2e-10 | ||
| 3ika_A | 331 | Crystal Structure Of Egfr 696-1022 T790m Mutant Cov | 2e-10 | ||
| 4i24_A | 329 | Structure Of T790m Egfr Kinase Domain Co-crystalliz | 2e-10 | ||
| 4i21_A | 329 | Crystal Structure Of L858r + T790m Egfr Kinase Doma | 2e-10 | ||
| 3w2o_A | 331 | Egfr Kinase Domain T790m/l858r Mutant With Tak-285 | 2e-10 | ||
| 4g5p_A | 330 | Crystal Structure Of Egfr Kinase T790m In Complex W | 2e-10 | ||
| 3ckw_A | 304 | Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3 | 2e-10 | ||
| 3a7f_A | 303 | Human Mst3 Kinase Length = 303 | 2e-10 | ||
| 3bbt_B | 328 | Crystal Structure Of The Erbb4 Kinase In Complex Wi | 2e-10 | ||
| 2jiu_A | 328 | Crystal Structure Of Egfr Kinase Domain T790m Mutat | 2e-10 | ||
| 1zy4_A | 303 | Crystal Structure Of Eif2alpha Protein Kinase Gcn2: | 3e-10 | ||
| 3npc_A | 364 | Crystal Structure Of Jnk2 Complexed With Birb796 Le | 3e-10 | ||
| 2jit_A | 327 | Crystal Structure Of Egfr Kinase Domain T790m Mutat | 3e-10 | ||
| 2v55_A | 406 | Mechanism Of Multi-site Phosphorylation From A Rock | 3e-10 | ||
| 3v8s_A | 410 | Human Rho-Associated Protein Kinase 1 (Rock 1) In C | 3e-10 | ||
| 3ckx_A | 304 | Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3 | 3e-10 | ||
| 2esm_A | 415 | Crystal Structure Of Rock 1 Bound To Fasudil Length | 3e-10 | ||
| 3e7o_A | 360 | Crystal Structure Of Jnk2 Length = 360 | 3e-10 | ||
| 2jiv_A | 328 | Crystal Structure Of Egfr Kinase Domain T790m Mutat | 3e-10 | ||
| 4bc6_A | 293 | Crystal Structure Of Human Serine Threonine Kinase- | 4e-10 | ||
| 2eb3_A | 334 | Crystal Structure Of Mutated Egfr Kinase Domain (L8 | 5e-10 | ||
| 4i1z_A | 329 | Crystal Structure Of The Monomeric (v948r) Form Of | 5e-10 | ||
| 1u5q_A | 348 | Crystal Structure Of The Tao2 Kinase Domain: Activa | 5e-10 | ||
| 2j7t_A | 302 | Crystal Structure Of Human Serine Threonine Kinase- | 5e-10 | ||
| 2gcd_A | 309 | Tao2 Kinase Domain-Staurosporine Structure Length = | 6e-10 | ||
| 1m14_A | 333 | Tyrosine Kinase Domain From Epidermal Growth Factor | 6e-10 | ||
| 3vjo_A | 334 | Crystal Structure Of The Wild-Type Egfr Kinase Doma | 6e-10 | ||
| 4i23_A | 329 | Crystal Structure Of The Wild-type Egfr Kinase Doma | 6e-10 | ||
| 2gs2_A | 330 | Crystal Structure Of The Active Egfr Kinase Domain | 6e-10 | ||
| 3bel_A | 315 | X-Ray Structure Of Egfr In Complex With Oxime Inhib | 6e-10 | ||
| 2itt_A | 327 | Crystal Structure Of Egfr Kinase Domain L858r Mutat | 6e-10 | ||
| 1xkk_A | 352 | Egfr Kinase Domain Complexed With A Quinazoline Inh | 7e-10 | ||
| 2jfm_A | 325 | Crystal Structure Of Human Ste20-Like Kinase (Unlig | 7e-10 | ||
| 4g5j_A | 330 | Crystal Structure Of Egfr Kinase In Complex With Bi | 7e-10 | ||
| 2j5f_A | 327 | Crystal Structure Of Egfr Kinase Domain In Complex | 7e-10 | ||
| 3a60_A | 327 | Crystal Structure Of Unphosphorylated P70s6k1 (Form | 7e-10 | ||
| 2rfd_A | 324 | Crystal Structure Of The Complex Between The Egfr K | 7e-10 | ||
| 2j51_A | 325 | Crystal Structure Of Human Ste20-Like Kinase Bound | 7e-10 | ||
| 3q5i_A | 504 | Crystal Structure Of Pbanka_031420 Length = 504 | 8e-10 | ||
| 3a62_A | 327 | Crystal Structure Of Phosphorylated P70s6k1 Length | 8e-10 | ||
| 2j5e_A | 327 | Crystal Structure Of Egfr Kinase Domain In Complex | 9e-10 | ||
| 1fvr_A | 327 | Tie2 Kinase Domain Length = 327 | 9e-10 | ||
| 3fi3_A | 364 | Crystal Structure Of Jnk3 With Indazole Inhibitor, | 1e-09 | ||
| 2oo8_X | 317 | Synthesis, Structural Analysis, And Sar Studies Of | 1e-09 | ||
| 2w9f_B | 306 | Crystal Structure Of Cdk4 In Complex With A D-Type | 1e-09 | ||
| 2w99_B | 306 | Crystal Structure Of Cdk4 In Complex With A D-Type | 1e-09 | ||
| 2yza_A | 276 | Crystal Structure Of Kinase Domain Of Human 5'-Amp- | 1e-09 | ||
| 4i20_A | 329 | Crystal Structure Of Monomeric (v948r) Primary Onco | 1e-09 | ||
| 3lzb_A | 327 | Egfr Kinase Domain Complexed With An Imidazo[2,1-B] | 1e-09 | ||
| 2gs7_A | 330 | Crystal Structure Of The Inactive Egfr Kinase Domai | 1e-09 | ||
| 4hjo_A | 337 | Crystal Structure Of The Inactive Egfr Tyrosine Kin | 1e-09 | ||
| 3g2f_A | 336 | Crystal Structure Of The Kinase Domain Of Bone Morp | 1e-09 | ||
| 3fv8_A | 355 | Jnk3 Bound To Piperazine Amide Inhibitor, Sr2774 Le | 1e-09 | ||
| 3ug1_A | 334 | Crystal Structure Of The Mutated Egfr Kinase Domain | 1e-09 | ||
| 3cok_A | 278 | Crystal Structure Of Plk4 Kinase Length = 278 | 2e-09 | ||
| 1bi8_A | 326 | Mechanism Of G1 Cyclin Dependent Kinase Inhibition | 2e-09 | ||
| 3kvx_A | 364 | Jnk3 Bound To Aminopyrimidine Inhibitor, Sr-3562 Le | 2e-09 | ||
| 1cm8_A | 367 | Phosphorylated Map Kinase P38-Gamma Length = 367 | 2e-09 | ||
| 2r9s_A | 356 | C-Jun N-Terminal Kinase 3 With 3,5-Disubstituted Qu | 2e-09 | ||
| 2r5t_A | 373 | Crystal Structure Of Inactive Serum And Glucocortic | 2e-09 | ||
| 2f2u_A | 402 | Crystal Structure Of The Rho-Kinase Kinase Domain L | 2e-09 | ||
| 3pp0_A | 338 | Crystal Structure Of The Kinase Domain Of Human Her | 2e-09 | ||
| 2jfl_A | 325 | Crystal Structure Of Human Ste20-Like Kinase ( Diph | 2e-09 | ||
| 1jow_B | 308 | Crystal Structure Of A Complex Of Human Cdk6 And A | 2e-09 | ||
| 2w96_B | 306 | Crystal Structure Of Cdk4 In Complex With A D-Type | 2e-09 | ||
| 3nup_A | 307 | Cdk6 (Monomeric) In Complex With Inhibitor Length = | 2e-09 | ||
| 3is5_A | 285 | Crystal Structure Of Cdpk Kinase Domain From Toxopl | 2e-09 | ||
| 2b9f_A | 353 | Crystal Structure Of Non-Phosphorylated Fus3 Length | 2e-09 | ||
| 2jed_A | 352 | The Crystal Structure Of The Kinase Domain Of The P | 2e-09 | ||
| 3nyn_A | 576 | Crystal Structure Of G Protein-Coupled Receptor Kin | 2e-09 | ||
| 3bhh_A | 295 | Crystal Structure Of Human Calcium/calmodulin-depen | 2e-09 | ||
| 2acx_A | 576 | Crystal Structure Of G Protein Coupled Receptor Kin | 2e-09 | ||
| 3fi2_A | 353 | Crystal Structure Of Jnk3 With Amino-Pyrazole Inhib | 2e-09 | ||
| 1zyc_A | 303 | Crystal Structure Of Eif2alpha Protein Kinase Gcn2: | 2e-09 | ||
| 1xjd_A | 345 | Crystal Structure Of Pkc-Theta Complexed With Staur | 2e-09 | ||
| 3g33_A | 308 | Crystal Structure Of Cdk4CYCLIN D3 Length = 308 | 2e-09 | ||
| 4agu_A | 311 | Crystal Structure Of The Human Cdkl1 Kinase Domain | 3e-09 | ||
| 3vul_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M1 | 3e-09 | ||
| 3ttj_A | 464 | Crystal Structure Of Jnk3 Complexed With Cc-359, A | 3e-09 | ||
| 3vum_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M7 | 3e-09 | ||
| 3k54_A | 283 | Structures Of Human Bruton's Tyrosine Kinase In Act | 3e-09 | ||
| 2b1p_A | 355 | Inhibitor Complex Of Jnk3 Length = 355 | 3e-09 | ||
| 4h36_A | 356 | Crystal Structure Of Jnk3 In Complex With Atf2 Pept | 3e-09 | ||
| 2exc_X | 356 | Inhibitor Complex Of Jnk3 Length = 356 | 3e-09 | ||
| 2ok1_A | 365 | Crystal Structure Of Jnk3 Bound To N-Benzyl-4-(4-(3 | 3e-09 | ||
| 3oxi_A | 362 | Design And Synthesis Of Disubstituted Thiophene And | 3e-09 | ||
| 3ptg_A | 363 | Design And Synthesis Of A Novel, Orally Efficacious | 3e-09 | ||
| 2o0u_A | 364 | Crystal Structure Of Human Jnk3 Complexed With N-{3 | 3e-09 | ||
| 3kmw_A | 271 | Crystal Structure Of The IlkALPHA-Parvin Core Compl | 3e-09 | ||
| 1pmn_A | 364 | Crystal Structure Of Jnk3 In Complex With An Imidaz | 3e-09 | ||
| 2b9h_A | 353 | Crystal Structure Of Fus3 With A Docking Motif From | 3e-09 | ||
| 2c30_A | 321 | Crystal Structure Of The Human P21-Activated Kinase | 3e-09 | ||
| 2wqb_A | 324 | Structure Of The Tie2 Kinase Domain In Complex With | 3e-09 | ||
| 4gt4_A | 308 | Structure Of Unliganded, Inactive Ror2 Kinase Domai | 4e-09 | ||
| 1jnk_A | 423 | The C-Jun N-Terminal Kinase (Jnk3s) Complexed With | 4e-09 | ||
| 3vug_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M2 | 4e-09 | ||
| 2eb2_A | 334 | Crystal Structure Of Mutated Egfr Kinase Domain (G7 | 4e-09 | ||
| 3gop_A | 361 | Crystal Structure Of The Egf Receptor Juxtamembrane | 4e-09 | ||
| 2jc6_A | 334 | Crystal Structure Of Human Calmodulin-Dependent Pro | 4e-09 | ||
| 1rw8_A | 301 | Crystal Structure Of Tgf-Beta Receptor I Kinase Wit | 4e-09 | ||
| 1vjy_A | 303 | Crystal Structure Of A Naphthyridine Inhibitor Of H | 4e-09 | ||
| 3gen_A | 283 | The 1.6 A Crystal Structure Of Human Bruton's Tyros | 4e-09 | ||
| 3ocs_A | 271 | Crystal Structure Of Bruton's Tyrosine Kinase In Co | 4e-09 | ||
| 1k2p_A | 263 | Crystal Structure Of Bruton's Tyrosine Kinase Domai | 4e-09 | ||
| 3zzw_A | 289 | Crystal Structure Of The Kinase Domain Of Ror2 Leng | 4e-09 | ||
| 2wot_A | 306 | Alk5 In Complex With 4-((5,6-Dimethyl-2-(2-Pyridyl) | 4e-09 | ||
| 3p08_A | 267 | Crystal Structure Of The Human Btk Kinase Domain Le | 4e-09 | ||
| 3pix_A | 274 | Crystal Structure Of Btk Kinase Domain Complexed Wi | 4e-09 | ||
| 2itn_A | 327 | Crystal Structure Of Egfr Kinase Domain G719s Mutat | 5e-09 | ||
| 1b6c_B | 342 | Crystal Structure Of The Cytoplasmic Domain Of The | 5e-09 | ||
| 3uto_A | 573 | Twitchin Kinase Region From C.Elegans (Fn31-Nl-Kin- | 5e-09 | ||
| 3vui_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M2 | 5e-09 | ||
| 4fnw_A | 327 | Crystal Structure Of The Apo F1174l Anaplastic Lymp | 5e-09 | ||
| 3vuh_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M3 | 5e-09 | ||
| 3tzm_A | 309 | Tgf-Beta Receptor Type 1 In Complex With Sb431542 L | 5e-09 | ||
| 1koa_A | 491 | Twitchin Kinase Fragment (C.Elegans), Autoregulated | 5e-09 | ||
| 2yjr_A | 342 | Structure Of F1174l Mutant Anaplastic Lymphoma Kina | 5e-09 | ||
| 1py5_A | 326 | Crystal Structure Of Tgf-Beta Receptor I Kinase Wit | 5e-09 | ||
| 3oct_A | 265 | Crystal Structure Of Bruton's Tyrosine Kinase Mutan | 5e-09 | ||
| 4g31_A | 299 | Crystal Structure Of Gsk6414 Bound To Perk (R587-R1 | 6e-09 | ||
| 2buj_A | 317 | Crystal Structure Of The Human Serine-Threonine Kin | 6e-09 | ||
| 2gph_A | 364 | Docking Motif Interactions In The Map Kinase Erk2 L | 6e-09 | ||
| 2i6l_A | 320 | Crystal Structure Of Human Mitogen Activated Protei | 6e-09 | ||
| 2xrw_A | 371 | Linear Binding Motifs For Jnk And For Calcineurin A | 6e-09 | ||
| 3vuk_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M5 | 6e-09 | ||
| 3vud_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M1 | 7e-09 | ||
| 3zu7_A | 365 | Crystal Structure Of A Designed Selected Ankyrin Re | 7e-09 | ||
| 2z7l_A | 366 | Unphosphorylated Mitogen Activated Protein Kinase E | 7e-09 | ||
| 3c9w_A | 357 | Crystal Structure Of Erk-2 With Hypothemycin Covale | 7e-09 | ||
| 2fys_B | 364 | Crystal Structure Of Erk2 Complex With Kim Peptide | 7e-09 | ||
| 1ukh_A | 369 | Structural Basis For The Selective Inhibition Of Jn | 7e-09 | ||
| 4bcf_A | 331 | Structure Of Cdk9 In Complex With Cyclin T And A 2- | 7e-09 | ||
| 2uv2_A | 287 | Crystal Structure Of Human Ste20-Like Kinase Bound | 7e-09 | ||
| 3o71_A | 358 | Crystal Structure Of Erk2DCC PEPTIDE COMPLEX Length | 7e-09 | ||
| 4fv6_A | 360 | Crystal Structure Of The Erk2 Complexed With E57 Le | 7e-09 | ||
| 3r63_A | 358 | Structure Of Erk2 (Spe) Mutant (S246e) Length = 358 | 7e-09 | ||
| 3gbz_A | 329 | Structure Of The Cmgc Cdk Kinase From Giardia Lambl | 7e-09 | ||
| 2f9g_A | 353 | Crystal Structure Of Fus3 Phosphorylated On Tyr182 | 7e-09 | ||
| 4fv7_A | 360 | Crystal Structure Of The Erk2 Complexed With E94 Le | 8e-09 | ||
| 4fux_A | 360 | Crystal Structure Of The Erk2 Complexed With E75 Le | 8e-09 | ||
| 3qyw_A | 364 | Crystal Structure Of Erk2 In Complex With An Inhibi | 8e-09 | ||
| 2y9q_A | 362 | Crystal Structure Of Human Erk2 Complexed With A Ma | 8e-09 | ||
| 2xs0_A | 386 | Linear Binding Motifs For Jnk And For Calcineurin A | 8e-09 | ||
| 2ojg_A | 380 | Crystal Structure Of Erk2 In Complex With N,n-dimet | 8e-09 | ||
| 3elj_A | 369 | Jnk1 Complexed With A Bis-Anilino-Pyrrolopyrimidine | 8e-09 | ||
| 1wzy_A | 368 | Crystal Structure Of Human Erk2 Complexed With A Py | 8e-09 | ||
| 1tvo_A | 368 | The Structure Of Erk2 In Complex With A Small Molec | 8e-09 | ||
| 3pze_A | 358 | Jnk1 In Complex With Inhibitor Length = 358 | 8e-09 | ||
| 3lij_A | 494 | Crystal Structure Of Full Length Cpcdpk3 (Cgd5_820) | 9e-09 | ||
| 2xuu_A | 334 | Crystal Structure Of A Dap-Kinase 1 Mutant Length = | 9e-09 | ||
| 2y0a_A | 326 | Structure Of Dapk1 Construct Residues 1-304 Length | 9e-09 | ||
| 3tei_A | 362 | Crystal Structure Of Human Erk2 Complexed With A Ma | 1e-08 | ||
| 4gsb_A | 364 | Monoclinic Crystal Form Of The Apo-Erk2 Length = 36 | 1e-08 | ||
| 3sa0_A | 360 | Complex Of Erk2 With Norathyriol Length = 360 | 1e-08 | ||
| 1u59_A | 287 | Crystal Structure Of The Zap-70 Kinase Domain In Co | 1e-08 | ||
| 2w4j_A | 277 | X-Ray Structure Of A Dap-Kinase 2-277 Length = 277 | 1e-08 | ||
| 2yjs_A | 342 | Structure Of C1156y Mutant Anaplastic Lymphoma Kina | 1e-08 | ||
| 1wvw_A | 278 | Crystal Structures Of Kinase Domain Of Dap Kinase I | 1e-08 | ||
| 2yak_A | 285 | Structure Of Death-Associated Protein Kinase 1 (Dap | 1e-08 | ||
| 2w4k_A | 302 | X-Ray Structure Of A Dap-Kinase 2-302 Length = 302 | 1e-08 | ||
| 1p4f_A | 293 | Death Associated Protein Kinase Catalytic Domain Wi | 1e-08 | ||
| 3blh_A | 331 | Crystal Structure Of Human Cdk9CYCLINT1 Length = 33 | 1e-08 | ||
| 2xp2_A | 327 | Structure Of The Human Anaplastic Lymphoma Kinase I | 1e-08 | ||
| 4fnz_A | 327 | Crystal Structure Of Human Anaplastic Lymphoma Kina | 1e-08 | ||
| 4ec8_A | 373 | Structure Of Full Length Cdk9 In Complex With Cycli | 1e-08 | ||
| 2xzs_A | 312 | Death Associated Protein Kinase 1 Residues 1-312 Le | 1e-08 | ||
| 1gol_A | 364 | Coordinates Of Rat Map Kinase Erk2 With An Arginine | 1e-08 | ||
| 2xb7_A | 315 | Structure Of Human Anaplastic Lymphoma Kinase In Co | 1e-08 | ||
| 3gu4_A | 295 | Crystal Structure Of Dapkq23v-Amppnp Length = 295 | 1e-08 | ||
| 2x7f_A | 326 | Crystal Structure Of The Kinase Domain Of Human Tra | 1e-08 | ||
| 3mi9_A | 351 | Crystal Structure Of Hiv-1 Tat Complexed With Human | 1e-08 | ||
| 1ig1_A | 294 | 1.8a X-Ray Structure Of Ternary Complex Of A Cataly | 1e-08 | ||
| 4dce_A | 333 | Crystal Structure Of Human Anaplastic Lymphoma Kina | 1e-08 | ||
| 3aox_A | 344 | X-Ray Crystal Structure Of Human Anaplastic Lymphom | 1e-08 | ||
| 3f5u_A | 295 | Crystal Structure Of The Death Associated Protein K | 1e-08 | ||
| 2vn9_A | 301 | Crystal Structure Of Human Calcium Calmodulin Depen | 1e-08 | ||
| 3dfc_B | 295 | Crystal Structure Of A Glycine-Rich Loop Mutant Of | 1e-08 | ||
| 3lct_A | 344 | Crystal Structure Of The Anaplastic Lymphoma Kinase | 1e-08 | ||
| 2wel_A | 327 | Crystal Structure Of Su6656-Bound CalciumCALMODULIN | 2e-08 | ||
| 3l9p_A | 367 | Crystal Structure Of The Anaplastic Lymphoma Kinase | 2e-08 | ||
| 4g3d_A | 371 | Crystal Structure Of Human Nf-kappab Inducing Kinas | 2e-08 | ||
| 1zxe_A | 303 | Crystal Structure Of Eif2alpha Protein Kinase Gcn2: | 2e-08 | ||
| 4fob_A | 353 | Crystal Structure Of Human Anaplastic Lymphoma Kina | 2e-08 | ||
| 4h3q_A | 362 | Crystal Structure Of Human Erk2 Complexed With A Ma | 2e-08 | ||
| 3hyh_A | 275 | Crystal Structure Of The Protein Kinase Domain Of Y | 2e-08 | ||
| 3v3v_A | 379 | Structural And Functional Analysis Of Quercetagetin | 2e-08 | ||
| 2x0g_A | 334 | X-ray Structure Of A Dap-kinase Calmodulin Complex | 2e-08 | ||
| 2fh9_A | 274 | Structure And Dimerization Of The Kinase Domain Fro | 2e-08 | ||
| 3dae_A | 283 | Crystal Structure Of Phosphorylated Snf1 Kinase Dom | 2e-08 | ||
| 2yhv_A | 342 | Structure Of L1196m Mutant Anaplastic Lymphoma Kina | 2e-08 | ||
| 3mn3_A | 271 | An Inhibited Conformation For The Protein Kinase Do | 2e-08 | ||
| 2x4f_A | 373 | The Crystal Structure Of The Human Myosin Light Cha | 2e-08 | ||
| 2yfx_A | 327 | Structure Of L1196m Mutant Anaplastic Lymphoma Kina | 2e-08 | ||
| 2v7o_A | 336 | Crystal Structure Of Human Calcium-Calmodulin-Depen | 2e-08 | ||
| 2y7j_A | 365 | Structure Of Human Phosphorylase Kinase, Gamma 2 Le | 2e-08 | ||
| 2zoq_A | 382 | Structural Dissection Of Human Mitogen-Activated Ki | 3e-08 | ||
| 3h4j_B | 336 | Crystal Structure Of Pombe Ampk Kdaid Fragment Leng | 3e-08 | ||
| 3o17_A | 370 | Crystal Structure Of Jnk1-Alpha1 Isoform Length = 3 | 3e-08 | ||
| 4ejn_A | 446 | Crystal Structure Of Autoinhibited Form Of Akt1 In | 3e-08 | ||
| 3o96_A | 446 | Crystal Structure Of Human Akt1 With An Allosteric | 3e-08 | ||
| 4e1z_A | 291 | Structure Of Mouse Tyk-2 Complexed To A 3-Aminoinda | 3e-08 | ||
| 2ozo_A | 613 | Autoinhibited Intact Human Zap-70 Length = 613 | 4e-08 | ||
| 4e20_A | 290 | Structure Of Mouse Tyk-2 Complexed To A 3-Aminoinda | 4e-08 | ||
| 1vzo_A | 355 | The Structure Of The N-Terminal Kinase Domain Of Ms | 4e-08 | ||
| 2wei_A | 287 | Crystal Structure Of The Kinase Domain Of Cryptospo | 4e-08 | ||
| 2pml_X | 348 | Crystal Structure Of Pfpk7 In Complex With An Atp A | 4e-08 | ||
| 3my0_A | 305 | Crystal Structure Of The Acvrl1 (Alk1) Kinase Domai | 4e-08 | ||
| 3igo_A | 486 | Crystal Structure Of Cryptosporidium Parvum Cdpk1, | 4e-08 | ||
| 2qlu_A | 314 | Crystal Structure Of Activin Receptor Type Ii Kinas | 4e-08 | ||
| 3dfa_A | 286 | Crystal Structure Of Kinase Domain Of Calcium-depen | 4e-08 | ||
| 2dyl_A | 318 | Crystal Structure Of Human Mitogen-Activated Protei | 5e-08 | ||
| 4fnx_A | 327 | Crystal Structure Of The Apo R1275q Anaplastic Lymp | 5e-08 | ||
| 3nyx_A | 302 | Non-Phosphorylated Tyk2 Jh1 Domain With Quinoline-T | 5e-08 | ||
| 4dn5_A | 356 | Crystal Structure Of Nf-kb-inducing Kinase (nik) Le | 5e-08 | ||
| 2g01_A | 370 | Pyrazoloquinolones As Novel, Selective Jnk1 Inhibit | 5e-08 | ||
| 3lxn_A | 318 | Structural And Thermodynamic Characterization Of Th | 5e-08 | ||
| 2bdw_A | 362 | Crystal Structure Of The Auto-Inhibited Kinase Doma | 5e-08 | ||
| 2wtk_C | 305 | Structure Of The Heterotrimeric Lkb1-Stradalpha-Mo2 | 5e-08 | ||
| 3p23_A | 432 | Crystal Structure Of The Human Kinase And Rnase Dom | 6e-08 | ||
| 3zgw_A | 347 | Crystal Structure Of Maternal Embryonic Leucine Zip | 6e-08 | ||
| 1omw_A | 689 | Crystal Structure Of The Complex Between G Protein- | 6e-08 | ||
| 3psc_A | 695 | Bovine Grk2 In Complex With Gbetagamma Subunits Len | 6e-08 | ||
| 3krw_A | 688 | Human Grk2 In Complex With Gbetgamma Subunits And B | 6e-08 | ||
| 3cik_A | 689 | Human Grk2 In Complex With Gbetagamma Subunits Leng | 6e-08 | ||
| 3lm0_A | 327 | Crystal Structure Of Human SerineTHREONINE KINASE 1 | 6e-08 | ||
| 1mrv_A | 339 | Crystal Structure Of An Inactive Akt2 Kinase Domain | 7e-08 | ||
| 1gzk_A | 315 | Molecular Mechanism For The Regulation Of Protein K | 7e-08 | ||
| 1gzn_A | 335 | Structure Of Pkb Kinase Domain Length = 335 | 7e-08 | ||
| 2j0l_A | 276 | Crystal Structure Of A The Active Conformation Of T | 8e-08 | ||
| 2vz6_A | 313 | Structure Of Human Calcium Calmodulin Dependent Pro | 8e-08 | ||
| 3cjg_A | 309 | Crystal Structure Of Vegfr2 In Complex With A 3,4,5 | 8e-08 | ||
| 1jbp_E | 350 | Crystal Structure Of The Catalytic Subunit Of Camp- | 8e-08 | ||
| 3cjf_A | 309 | Crystal Structure Of Vegfr2 In Complex With A 3,4,5 | 9e-08 | ||
| 4ebw_A | 304 | Structure Of Focal Adhesion Kinase Catalytic Domain | 9e-08 | ||
| 1mp8_A | 281 | Crystal Structure Of Focal Adhesion Kinase (Fak) Le | 9e-08 | ||
| 3dxn_A | 287 | Crystal Structure Of The Calcium-dependent Kinase F | 9e-08 | ||
| 2jkm_A | 276 | Focal Adhesion Kinase Catalytic Domain In Complex W | 9e-08 | ||
| 2etm_A | 281 | Crystal Structure Of Focal Adhesion Kinase Domain C | 9e-08 | ||
| 2j0m_B | 276 | Crystal Structure A Two-Chain Complex Between The F | 1e-07 | ||
| 3nz0_A | 302 | Non-Phosphorylated Tyk2 Kinase With Cmp6 Length = 3 | 1e-07 | ||
| 3pxk_A | 282 | Focal Adhesion Kinase Catalytic Domain In Complex W | 1e-07 | ||
| 3gu8_A | 295 | Crystal Structure Of Dapkl93g With N6-Cyclopentylad | 1e-07 | ||
| 3hzt_A | 467 | Crystal Structure Of Toxoplasma Gondii Cdpk3, Tgme4 | 1e-07 | ||
| 3bz3_A | 276 | Crystal Structure Analysis Of Focal Adhesion Kinase | 1e-07 | ||
| 3zuv_A | 364 | Crystal Structure Of A Designed Selected Ankyrin Re | 1e-07 | ||
| 2erk_A | 365 | Phosphorylated Map Kinase Erk2 Length = 365 | 1e-07 | ||
| 3iw4_A | 360 | Crystal Structure Of Pkc Alpha In Complex With Nvp- | 1e-07 | ||
| 3fhi_A | 350 | Crystal Structure Of A Complex Between The Catalyti | 1e-07 | ||
| 3qd2_B | 332 | Crsytal Structure Of Mouse Perk Kinase Domain Lengt | 1e-07 | ||
| 3cqu_A | 342 | Crystal Structure Of Akt-1 Complexed With Substrate | 1e-07 | ||
| 3ocb_A | 341 | Akt1 Kinase Domain With Pyrrolopyrimidine Inhibitor | 1e-07 | ||
| 4gv1_A | 340 | Pkb Alpha In Complex With Azd5363 Length = 340 | 1e-07 | ||
| 3q4t_A | 322 | Crystal Structure Of Activin Receptor Type-Iia (Acv | 2e-07 | ||
| 2gnf_A | 350 | Protein Kinase A Fivefold Mutant Model Of Rho-Kinas | 2e-07 | ||
| 2i0e_A | 353 | Structure Of Catalytic Domain Of Human Protein Kina | 2e-07 | ||
| 2gng_A | 350 | Protein Kinase A Fivefold Mutant Model Of Rho-Kinas | 2e-07 | ||
| 3pfq_A | 674 | Crystal Structure And Allosteric Activation Of Prot | 2e-07 | ||
| 3kb7_A | 311 | Crystal Structure Of Polo-Like Kinase 1 In Complex | 2e-07 | ||
| 2v5q_A | 315 | Crystal Structure Of Wild-type Plk-1 Kinase Domain | 2e-07 | ||
| 2yac_A | 311 | Crystal Structure Of Polo-Like Kinase 1 In Complex | 2e-07 | ||
| 2j0j_A | 656 | Crystal Structure Of A Fragment Of Focal Adhesion K | 2e-07 | ||
| 3rgf_A | 405 | Crystal Structure Of Human Cdk8CYCC Length = 405 | 2e-07 | ||
| 2oh4_A | 316 | Crystal Structure Of Vegfr2 With A Benzimidazole-Ur | 2e-07 | ||
| 1bkx_A | 350 | A Binary Complex Of The Catalytic Subunit Of Camp-D | 2e-07 | ||
| 2erz_E | 351 | Crystal Structure Of C-amp Dependent Kinase (pka) B | 2e-07 | ||
| 1fmo_E | 350 | Crystal Structure Of A Polyhistidine-Tagged Recombi | 2e-07 | ||
| 2qur_A | 350 | Crystal Structure Of F327aK285P MUTANT OF CAMP-Depe | 2e-07 | ||
| 2w4o_A | 349 | Crystal Structure Of Human Camk4 In Complex With 4- | 2e-07 | ||
| 3qal_E | 350 | Crystal Structure Of Arg280ala Mutant Of Catalytic | 2e-07 | ||
| 3sdj_A | 448 | Structure Of Rnase-Inactive Point Mutant Of Oligome | 2e-07 | ||
| 1j3h_A | 350 | Crystal Structure Of Apoenzyme Camp-Dependent Prote | 2e-07 | ||
| 3c7q_A | 316 | Structure Of Vegfr2 Kinase Domain In Complex With B | 2e-07 | ||
| 4dfy_A | 371 | Crystal Structure Of R194a Mutant Of Camp-Dependent | 2e-07 | ||
| 1cdk_A | 350 | Camp-Dependent Protein Kinase Catalytic Subunit (E. | 2e-07 | ||
| 1ctp_E | 350 | Structure Of The Mammalian Catalytic Subunit Of Cam | 2e-07 | ||
| 1cmk_E | 350 | Crystal Structures Of The Myristylated Catalytic Su | 2e-07 | ||
| 2jkk_A | 276 | Focal Adhesion Kinase Catalytic Domain In Complex W | 2e-07 | ||
| 2vd5_A | 412 | Structure Of Human Myotonic Dystrophy Protein Kinas | 2e-07 | ||
| 3fbv_A | 448 | Crystal Structure Of The Oligomer Formed By The Kin | 2e-07 | ||
| 4ae6_A | 343 | Structure And Function Of The Human Sperm-specific | 2e-07 | ||
| 3kk9_A | 282 | Camkii Substrate Complex B Length = 282 | 2e-07 | ||
| 1vr2_A | 316 | Human Vascular Endothelial Growth Factor Receptor 2 | 2e-07 | ||
| 3kl8_A | 269 | Camkiintide Inhibitor Complex Length = 269 | 3e-07 | ||
| 4dg3_E | 371 | Crystal Structure Of R336a Mutant Of Camp-dependent | 3e-07 | ||
| 1apm_E | 350 | 2.0 Angstrom Refined Crystal Structure Of The Catal | 3e-07 | ||
| 3pvb_A | 345 | Crystal Structure Of (73-244)ria:c Holoenzyme Of Ca | 3e-07 | ||
| 3agm_A | 351 | Complex Of Pka With The Bisubstrate Protein Kinase | 3e-07 | ||
| 3kk8_A | 284 | Camkii Substrate Complex A Length = 284 | 3e-07 | ||
| 2jdo_A | 342 | Structure Of Pkb-Beta (Akt2) Complexed With Isoquin | 3e-07 | ||
| 3agl_A | 351 | Complex Of Pka With The Bisubstrate Protein Kinase | 3e-07 | ||
| 1o6l_A | 337 | Crystal Structure Of An Activated Akt/protein Kinas | 3e-07 | ||
| 1o6k_A | 336 | Structure Of Activated Form Of Pkb Kinase Domain S4 | 3e-07 | ||
| 4dfx_E | 350 | Crystal Structure Of Myristoylated K7c Catalytic Su | 3e-07 | ||
| 4agc_A | 353 | Crystal Structure Of Vegfr2 (Juxtamembrane And Kina | 3e-07 | ||
| 3nx8_A | 351 | Human Camp Dependent Protein Kinase In Complex With | 3e-07 | ||
| 3cc6_A | 281 | Crystal Structure Of Kinase Domain Of Protein Tyros | 3e-07 | ||
| 2gu8_A | 337 | Discovery Of 2-pyrimidyl-5-amidothiophenes As Novel | 3e-07 | ||
| 3e87_A | 335 | Crystal Structures Of The Kinase Domain Of Akt2 In | 3e-07 | ||
| 3fzo_A | 277 | Crystal Structure Of Pyk2-Apo, Proline-Rich Tyrosin | 3e-07 | ||
| 4h1j_A | 293 | Crystal Structure Of Pyk2 With The Pyrazole 13a Len | 3e-07 | ||
| 2qcs_A | 350 | A Complex Structure Between The Catalytic And Regul | 3e-07 | ||
| 2xir_A | 316 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 3e-07 | ||
| 1l3r_E | 350 | Crystal Structure Of A Transition State Mimic Of Th | 3e-07 | ||
| 3vnt_A | 318 | Crystal Structure Of The Kinase Domain Of Human Veg | 3e-07 | ||
| 3mvj_A | 371 | Human Cyclic Amp-Dependent Protein Kinase Pka Inhib | 3e-07 | ||
| 3hng_A | 360 | Crystal Structure Of Vegfr1 In Complex With N-(4-ch | 3e-07 | ||
| 2j0k_A | 656 | Crystal Structure Of A Fragment Of Focal Adhesion K | 3e-07 | ||
| 3o7l_B | 350 | Crystal Structure Of Phospholamban (1-19):pka C-Sub | 4e-07 | ||
| 1ql6_A | 298 | The Catalytic Mechanism Of Phosphorylase Kinase Pro | 4e-07 | ||
| 3thb_A | 333 | Structure Of Plk1 Kinase Domain In Complex With A B | 4e-07 | ||
| 2uzt_A | 336 | Pka Structures Of Akt, Indazole-Pyridine Inhibitors | 4e-07 | ||
| 2rio_A | 434 | Structure Of The Dual Enzyme Ire1 Reveals The Basis | 4e-07 | ||
| 2ou7_A | 335 | Structure Of The Catalytic Domain Of Human Polo-Lik | 4e-07 | ||
| 1syk_A | 350 | Crystal Structure Of E230q Mutant Of Camp-Dependent | 4e-07 | ||
| 1ydt_E | 350 | Structure Of Camp-Dependent Protein Kinase, Alpha-C | 4e-07 | ||
| 2c1a_A | 351 | Structure Of Camp-Dependent Protein Kinase Complexe | 4e-07 | ||
| 2f7e_E | 351 | Pka Complexed With (S)-2-(1h-Indol-3-Yl)-1-(5-Isoqu | 4e-07 | ||
| 4ae9_A | 343 | Structure And Function Of The Human Sperm-specific | 4e-07 | ||
| 1stc_E | 350 | Camp-Dependent Protein Kinase, Alpha-Catalytic Subu | 4e-07 | ||
| 1svh_A | 350 | Crystal Structure Of Protein Kinase A In Complex Wi | 4e-07 | ||
| 3dnd_A | 350 | Camp-Dependent Protein Kinase Pka Catalytic Subunit | 4e-07 | ||
| 2rku_A | 294 | Structure Of Plk1 In Complex With Bi2536 Length = 2 | 5e-07 | ||
| 3lmg_A | 344 | Crystal Structure Of The Erbb3 Kinase Domain In Com | 5e-07 | ||
| 3kex_A | 325 | Crystal Structure Of The Catalytically Inactive Kin | 5e-07 | ||
| 3u6j_A | 314 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 5e-07 | ||
| 3ewh_A | 314 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 6e-07 | ||
| 1ywn_A | 316 | Vegfr2 In Complex With A Novel 4-amino-furo[2,3-d]p | 6e-07 | ||
| 2p2i_A | 314 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 6e-07 | ||
| 2gnj_A | 350 | Pka Three Fold Mutant Model Of Rho-Kinase With Y-27 | 6e-07 | ||
| 3fme_A | 290 | Crystal Structure Of Human Mitogen-Activated Protei | 6e-07 | ||
| 3p1a_A | 311 | Structure Of Human Membrane-Associated Tyrosine- An | 7e-07 | ||
| 3vn9_A | 340 | Rifined Crystal Structure Of Non-Phosphorylated Map | 7e-07 | ||
| 1q8w_A | 350 | The Catalytic Subunit Of Camp-Dependent Protein Kin | 7e-07 | ||
| 2jds_A | 351 | Structure Of Camp-Dependent Protein Kinase Complexe | 7e-07 | ||
| 1xh7_A | 350 | Crystal Structures Of Protein Kinase B Selective In | 8e-07 | ||
| 3lj0_A | 434 | Ire1 Complexed With Adp And Quercetin Length = 434 | 8e-07 | ||
| 3mtl_A | 324 | Crystal Structure Of The Pctaire1 Kinase In Complex | 8e-07 | ||
| 3ama_A | 351 | Protein Kinase A Sixfold Mutant Model Of Aurora B W | 9e-07 | ||
| 2phk_A | 277 | The Crystal Structure Of A Phosphorylase Kinase Pep | 9e-07 | ||
| 3qam_E | 350 | Crystal Structure Of Glu208ala Mutant Of Catalytic | 9e-07 | ||
| 2p2h_A | 314 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 9e-07 | ||
| 3dls_A | 335 | Crystal Structure Of Human Pas Kinase Bound To Adp | 1e-06 | ||
| 1q24_A | 350 | Pka Double Mutant Model Of Pkb In Complex With Mgat | 1e-06 | ||
| 3l9m_A | 351 | Crystal Structure Of Pkab3 (Pka Triple Mutant V123a | 1e-06 | ||
| 1phk_A | 298 | Two Structures Of The Catalytic Domain Of Phosphory | 1e-06 | ||
| 3soa_A | 444 | Full-Length Human Camkii Length = 444 | 1e-06 | ||
| 3mfr_A | 351 | Cask-4m Cam Kinase Domain, Native Length = 351 | 1e-06 | ||
| 1smh_A | 350 | Protein Kinase A Variant Complex With Completely Or | 1e-06 | ||
| 4g3f_A | 336 | Crystal Structure Of Murine Nf-kappab Inducing Kina | 1e-06 | ||
| 3bhy_A | 283 | Crystal Structure Of Human Death Associated Protein | 1e-06 | ||
| 4g3c_A | 352 | Crystal Structure Of Apo Murine Nf-kappab Inducing | 2e-06 | ||
| 1yrp_A | 278 | Catalytic Domain Of Human Zip Kinase Phosphorylated | 2e-06 | ||
| 1q61_A | 350 | Pka Triple Mutant Model Of Pkb Length = 350 | 2e-06 | ||
| 3emg_A | 291 | Discovery And Sar Of Novel 4-Thiazolyl-2- Phenylami | 2e-06 | ||
| 4f4p_A | 273 | Syk In Complex With Ligand Lasw836 Length = 273 | 2e-06 | ||
| 3tub_A | 293 | Crystal Structure Of Syk Kinase Domain With 1-(5-(6 | 2e-06 | ||
| 3vf8_A | 299 | Crystal Structure Of Spleen Tyrosine Kinase Syk Cat | 2e-06 | ||
| 4dfl_A | 274 | Crystal Structure Of Spleen Tyrosine Kinase Complex | 2e-06 | ||
| 1xba_A | 291 | Crystal Structure Of Apo Syk Tyrosine Kinase Domain | 2e-06 | ||
| 3srv_B | 277 | Crystal Structure Of Spleen Tyrosine Kinase (Syk) I | 2e-06 | ||
| 4g3g_A | 350 | Crystal Structure Of Murine Nf-kappab Inducing Kina | 2e-06 | ||
| 3srv_A | 277 | Crystal Structure Of Spleen Tyrosine Kinase (Syk) I | 2e-06 | ||
| 4fl3_A | 635 | Structural And Biophysical Characterization Of The | 2e-06 | ||
| 1xh9_A | 350 | Crystal Structures Of Protein Kinase B Selective In | 2e-06 | ||
| 4fl2_A | 636 | Structural And Biophysical Characterization Of The | 2e-06 | ||
| 1rdq_E | 350 | Hydrolysis Of Atp In The Crystal Of Y204a Mutant Of | 2e-06 | ||
| 3aln_A | 327 | Crystal Structure Of Human Non-Phosphorylated Mkk4 | 2e-06 | ||
| 4aw2_A | 437 | Crystal Structure Of Cdc42 Binding Protein Kinase A | 2e-06 | ||
| 2j90_A | 304 | Crystal Structure Of Human Zip Kinase In Complex Wi | 2e-06 | ||
| 1szm_A | 350 | Dual Binding Mode Of Bisindolylmaleimide 2 To Prote | 3e-06 | ||
| 2vo0_A | 351 | Structure Of Pka-Pkb Chimera Complexed With C-(4-(4 | 3e-06 | ||
| 2jdt_A | 351 | Structure Of Pka-Pkb Chimera Complexed With Isoquin | 3e-06 | ||
| 2ycr_A | 323 | Crystal Structure Of Checkpoint Kinase 2 In Complex | 4e-06 | ||
| 2zv2_A | 298 | Crystal Structure Of Human CalciumCALMODULIN-Depend | 4e-06 | ||
| 2ycf_A | 322 | Crystal Structure Of Checkpoint Kinase 2 In Complex | 4e-06 | ||
| 2xk9_A | 322 | Structural Analysis Of Checkpoint Kinase 2 (Chk2) I | 4e-06 | ||
| 2w0j_A | 323 | Crystal Structure Of Chk2 In Complex With Nsc 10955 | 4e-06 | ||
| 2z2w_A | 285 | Humand Wee1 Kinase Complexed With Inhibitor Pf03357 | 4e-06 | ||
| 2in6_A | 287 | Wee1 Kinase Complex With Inhibitor Pd311839 Length | 4e-06 | ||
| 2cn5_A | 329 | Crystal Structure Of Human Chk2 In Complex With Adp | 4e-06 | ||
| 1x8b_A | 289 | Structure Of Human Wee1a Kinase: Kinase Domain Comp | 4e-06 | ||
| 3bi6_A | 287 | Wee1 Kinase Complex With Inhibitor Pd352396 Length | 4e-06 | ||
| 2uvy_A | 351 | Structure Of Pka-pkb Chimera Complexed With Methyl- | 4e-06 | ||
| 3kmu_A | 271 | Crystal Structure Of The IlkALPHA-Parvin Core Compl | 4e-06 | ||
| 3i6w_A | 443 | Structure And Activation Mechanism Of The Chk2 Dna- | 5e-06 | ||
| 3i6u_A | 419 | Structure And Activation Mechanism Of The Chk2 Dna- | 5e-06 | ||
| 2y4i_B | 319 | Ksr2-Mek1 Heterodimer Length = 319 | 5e-06 | ||
| 3txo_A | 353 | Pkc Eta Kinase In Complex With A Naphthyridine Leng | 6e-06 | ||
| 2i0v_A | 335 | C-Fms Tyrosine Kinase In Complex With A Quinolone I | 6e-06 | ||
| 3bea_A | 333 | Cfms Tyrosine Kinase (Tie2 Kid) In Complex With A P | 6e-06 | ||
| 1u54_A | 291 | Crystal Structures Of The Phosphorylated And Unphos | 7e-06 | ||
| 4ewh_B | 275 | Co-Crystal Structure Of Ack1 With Inhibitor Length | 7e-06 | ||
| 4hzs_A | 341 | Crystal Structure Of Ack1 Kinase Domain With C-term | 8e-06 | ||
| 1u46_A | 291 | Crystal Structure Of The Unphosphorylated Kinase Do | 9e-06 | ||
| 3eqp_B | 276 | Crystal Structure Of Ack1 With Compound T95 Length | 1e-05 | ||
| 4hzr_A | 277 | Crystal Structure Of Ack1 Kinase Domain Length = 27 | 1e-05 | ||
| 3enm_A | 316 | The Structure Of The Map2k Mek6 Reveals An Autoinhi | 1e-05 | ||
| 3vid_A | 356 | Crystal Structure Of Human Vegfr2 Kinase Domain Wit | 1e-05 | ||
| 4id7_A | 273 | Ack1 Kinase In Complex With The Inhibitor Cis-3-[8- | 1e-05 | ||
| 3qfv_A | 415 | Mrck Beta In Complex With Tpca-1 Length = 415 | 1e-05 | ||
| 1y6a_A | 366 | Crystal Structure Of Vegfr2 In Complex With A 2-Ani | 1e-05 | ||
| 3vhk_A | 368 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 1e-05 | ||
| 3vhe_A | 359 | Crystal Structure Of Human Vegfr2 Kinase Domain Wit | 1e-05 | ||
| 3rp9_A | 458 | Crystal Structure Of The Apo Mapk From Toxoplasma G | 1e-05 | ||
| 3tku_A | 433 | Mrck Beta In Complex With Fasudil Length = 433 | 1e-05 | ||
| 1rjb_A | 344 | Crystal Structure Of Flt3 Length = 344 | 2e-05 | ||
| 3mdy_A | 337 | Crystal Structure Of The Cytoplasmic Domain Of The | 2e-05 | ||
| 3d5u_A | 317 | Crystal Structure Of A Wildtype Polo-Like Kinase 1 | 2e-05 | ||
| 2a27_A | 321 | Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal | 2e-05 | ||
| 1zws_A | 288 | Crystal Structure Of The Catalytic Domain Of Human | 3e-05 | ||
| 2ogv_A | 317 | Crystal Structure Of The Autoinhibited Human C-Fms | 3e-05 | ||
| 3kvw_A | 429 | Crystal Structure Of Dual-Specificity Tyrosine Phos | 3e-05 | ||
| 2i1m_A | 333 | Cfms Tyrosine Kinase (Tie2 Kid) In Complex With An | 3e-05 | ||
| 3db6_A | 301 | Crystal Structure Of An Activated (Thr->asp) Polo-L | 3e-05 | ||
| 3d5w_A | 317 | Crystal Structure Of A Phosphorylated Polo-Like Kin | 3e-05 | ||
| 1z9x_A | 321 | Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal | 3e-05 | ||
| 3d5v_A | 317 | Crystal Structure Of An Activated (Thr->asp) Polo-L | 3e-05 | ||
| 3lcd_A | 329 | Inhibitor Bound To A Dfg-In Structure Of The Kinase | 3e-05 | ||
| 3n9x_A | 432 | Crystal Structure Of Map Kinase From Plasmodium Ber | 3e-05 | ||
| 1wmk_A | 321 | Human Death-Associated Kinase Drp-1, Mutant S308d D | 3e-05 | ||
| 4azf_A | 417 | Human Dyrk2 In Complex With Leucettine L41 Length = | 3e-05 | ||
| 2a2a_A | 321 | High-resolution Crystallographic Analysis Of The Au | 4e-05 | ||
| 3lco_A | 324 | Inhibitor Bound To A Dfg-Out Structure Of The Kinas | 4e-05 | ||
| 3k2l_A | 429 | Crystal Structure Of Dual-Specificity Tyrosine Phos | 5e-05 | ||
| 2ac5_A | 316 | Structure Of Human Mnk2 Kinase Domain Mutant D228g | 6e-05 | ||
| 2ya9_A | 361 | Crystal Structure Of The Autoinhibited Form Of Mous | 6e-05 | ||
| 3tac_A | 361 | Crystal Structure Of The Liprin-AlphaCASK COMPLEX L | 7e-05 | ||
| 3c0g_A | 351 | Cask Cam-kinase Domain- 3'-amp Complex, P1 Form Len | 8e-05 | ||
| 4dc2_A | 396 | Structure Of Pkc In Complex With A Substrate Peptid | 1e-04 | ||
| 3nie_A | 429 | Crystal Structure Of Pf11_0147 Length = 429 | 1e-04 | ||
| 2qr8_A | 342 | 2.0a X-ray Structure Of C-terminal Kinase Domain Of | 3e-04 | ||
| 1zrz_A | 364 | Crystal Structure Of The Catalytic Domain Of Atypic | 5e-04 | ||
| 2ac3_A | 316 | Structure Of Human Mnk2 Kinase Domain Length = 316 | 5e-04 | ||
| 3kn5_A | 325 | Crystal Structure Of The C-Terminal Kinase Domain O | 5e-04 | ||
| 1kwp_A | 400 | Crystal Structure Of Mapkap2 Length = 400 | 5e-04 | ||
| 2onl_C | 406 | Crystal Structure Of The P38a-Mapkap Kinase 2 Heter | 5e-04 | ||
| 2oza_A | 356 | Structure Of P38alpha Complex Length = 356 | 6e-04 | ||
| 3gok_A | 334 | Binding Site Mapping Of Protein Ligands Length = 33 | 6e-04 | ||
| 2hw6_A | 307 | Crystal Structure Of Mnk1 Catalytic Domain Length = | 6e-04 | ||
| 3zh8_A | 349 | A Novel Small Molecule Apkc Inhibitor Length = 349 | 6e-04 | ||
| 2pzy_A | 324 | Structure Of Mk2 Complexed With Compound 76 Length | 6e-04 | ||
| 3e3p_A | 360 | Glycogen Synthase Kinase From Leishmania Major Leng | 6e-04 | ||
| 2p3g_X | 327 | Crystal Structure Of A Pyrrolopyridine Inhibitor Bo | 6e-04 | ||
| 2h34_A | 309 | Apoenzyme Crystal Structure Of The Tuberculosis Ser | 6e-04 | ||
| 3r2b_A | 318 | Mk2 Kinase Bound To Compound 5b Length = 318 | 7e-04 | ||
| 3fpm_A | 325 | Crystal Structure Of A Squarate Inhibitor Bound To | 7e-04 | ||
| 1kob_A | 387 | Twitchin Kinase Fragment (Aplysia), Autoregulated P | 7e-04 | ||
| 3r2y_A | 319 | Mk2 Kinase Bound To Compound 1 Length = 319 | 7e-04 | ||
| 3a8w_A | 345 | Crystal Structure Of Pkciota Kinase Domain Length = | 7e-04 | ||
| 2jbo_A | 326 | Protein Kinase Mk2 In Complex With An Inhibitor (Cr | 7e-04 | ||
| 2x9e_A | 317 | Human Mps1 In Complex With Nms-P715 Length = 317 | 7e-04 | ||
| 3vqu_A | 320 | Crystal Structure Of Human Mps1 Catalytic Domain In | 8e-04 | ||
| 3cek_A | 313 | Crystal Structure Of Human Dual Specificity Protein | 9e-04 |
| >pdb|3TL8|A Chain A, The Avrptob-Bak1 Complex Reveals Two Structurally Similar Kinaseinteracting Domains In A Single Type Iii Effector Length = 349 | Back alignment and structure |
|
| >pdb|3UIM|A Chain A, Structural Basis For The Impact Of Phosphorylation On Plant Receptor- Like Kinase Bak1 Activation Length = 326 | Back alignment and structure |
|
| >pdb|2QKW|B Chain B, Structural Basis For Activation Of Plant Immunity By Bacterial Effector Protein Avrpto Length = 321 | Back alignment and structure |
|
| >pdb|3HGK|A Chain A, Crystal Structure Of Effect Protein Avrptob Complexed With Kinase Pto Length = 327 | Back alignment and structure |
|
| >pdb|3P86|A Chain A, Crystal Structure Of Ctr1 Kinase Domain Mutant D676n In Complex With Staurosporine Length = 309 | Back alignment and structure |
|
| >pdb|2NRY|A Chain A, Crystal Structure Of Irak-4 Length = 307 | Back alignment and structure |
|
| >pdb|2NRU|A Chain A, Crystal Structure Of Irak-4 Length = 307 | Back alignment and structure |
|
| >pdb|2OIB|A Chain A, Crystal Structure Of Irak4 Kinase Domain Apo Form Length = 301 | Back alignment and structure |
|
| >pdb|3PPZ|A Chain A, Crystal Structure Of Ctr1 Kinase Domain In Complex With Staurosporine Length = 309 | Back alignment and structure |
|
| >pdb|2O8Y|A Chain A, Apo Irak4 Kinase Domain Length = 298 | Back alignment and structure |
|
| >pdb|4GS6|A Chain A, Irreversible Inhibition Of Tak1 Kinase By 5z-7-oxozeaenol Length = 315 | Back alignment and structure |
|
| >pdb|2EVA|A Chain A, Structural Basis For The Interaction Of Tak1 Kinase With Its Activating Protein Tab1 Length = 307 | Back alignment and structure |
|
| >pdb|3DQW|A Chain A, C-Src Kinase Domain Thr338ile Mutant In Complex With Atpgs Length = 286 | Back alignment and structure |
|
| >pdb|3G6H|A Chain A, Src Thr338ile Inhibited In The Dfg-Asp-Out Conformation Length = 286 | Back alignment and structure |
|
| >pdb|1YI6|A Chain A, C-Term Tail Segment Of Human Tyrosine Kinase (258-533) Length = 276 | Back alignment and structure |
|
| >pdb|3SVV|A Chain A, Crystal Structure Of T338c C-Src Covalently Bound To Vinylsulfonamide- Pyrazolopyrimidine 9 Length = 286 | Back alignment and structure |
|
| >pdb|2QQ7|A Chain A, Crystal Structure Of Drug Resistant Src Kinase Domain With Irreversible Inhibitor Length = 286 | Back alignment and structure |
|
| >pdb|3U4W|A Chain A, Src In Complex With Dna-Templated Macrocyclic Inhibitor Mc4b Length = 275 | Back alignment and structure |
|
| >pdb|2OIQ|A Chain A, Crystal Structure Of Chicken C-Src Kinase Domain In Complex With The Cancer Drug Imatinib. Length = 286 | Back alignment and structure |
|
| >pdb|3D7U|B Chain B, Structural Basis For The Recognition Of C-Src By Its Inactivator Csk Length = 277 | Back alignment and structure |
|
| >pdb|1Y57|A Chain A, Structure Of Unphosphorylated C-Src In Complex With An Inhibitor Length = 452 | Back alignment and structure |
|
| >pdb|1FMK|A Chain A, Crystal Structure Of Human Tyrosine-Protein Kinase C-Src Length = 452 | Back alignment and structure |
|
| >pdb|2BDF|A Chain A, Src Kinase In Complex With Inhibitor Ap23451 Length = 279 | Back alignment and structure |
|
| >pdb|2PTK|A Chain A, Chicken Src Tyrosine Kinase Length = 453 | Back alignment and structure |
|
| >pdb|2H8H|A Chain A, Src Kinase In Complex With A Quinazoline Inhibitor Length = 535 | Back alignment and structure |
|
| >pdb|1UWH|A Chain A, The Complex Of Wild Type B-Raf And Bay439006 Length = 276 | Back alignment and structure |
|
| >pdb|1YOJ|A Chain A, Crystal Structure Of Src Kinase Domain Length = 283 | Back alignment and structure |
|
| >pdb|1YOL|A Chain A, Crystal Structure Of Src Kinase Domain In Complex With Cgp77675 Length = 283 | Back alignment and structure |
|
| >pdb|3OEZ|A Chain A, Crystal Structure Of The L317i Mutant Of The Chicken C-Src Tyrosine Kinase Domain Complexed With Imatinib Length = 286 | Back alignment and structure |
|
| >pdb|3GEQ|A Chain A, Structural Basis For The Chemical Rescue Of Src Kinase Activity Length = 286 | Back alignment and structure |
|
| >pdb|1KSW|A Chain A, Structure Of Human C-Src Tyrosine Kinase (Thr338gly Mutant) In Complex With N6-Benzyl Adp Length = 452 | Back alignment and structure |
|
| >pdb|2HWO|A Chain A, Crystal Structure Of Src Kinase Domain In Complex With Covalent Inhibitor Length = 286 | Back alignment and structure |
|
| >pdb|4H58|A Chain A, Braf In Complex With Compound 3 Length = 275 | Back alignment and structure |
|
| >pdb|2FB8|A Chain A, Structure Of The B-Raf Kinase Domain Bound To Sb-590885 Length = 281 | Back alignment and structure |
|
| >pdb|3KUL|B Chain B, Kinase Domain Of Human Ephrin Type-A Receptor 8 (Epha8) Length = 325 | Back alignment and structure |
|
| >pdb|4DBN|A Chain A, Crystal Structure Of The Kinase Domain Of Human B-Raf With A [1, 3]thiazolo[5,4-B]pyridine Derivative Length = 284 | Back alignment and structure |
|
| >pdb|3Q96|A Chain A, B-Raf Kinase Domain In Complex With A Tetrahydronaphthalene Inhibitor Length = 282 | Back alignment and structure |
|
| >pdb|1UWJ|A Chain A, The Complex Of Mutant V599e B-raf And Bay439006 Length = 276 | Back alignment and structure |
|
| >pdb|3IDP|A Chain A, B-Raf V600e Kinase Domain In Complex With An Aminoisoquinoline Inhibitor Length = 300 | Back alignment and structure |
|
| >pdb|3D4Q|A Chain A, Pyrazole-Based Inhibitors Of B-Raf Kinase Length = 307 | Back alignment and structure |
|
| >pdb|3II5|A Chain A, The Complex Of Wild-Type B-Raf With Pyrazolo Pyrimidine Inhibitor Length = 306 | Back alignment and structure |
|
| >pdb|3OG7|A Chain A, B-Raf Kinase V600e Oncogenic Mutant In Complex With Plx4032 Length = 289 | Back alignment and structure |
|
| >pdb|4G9R|A Chain A, B-Raf V600e Kinase Domain Bound To A Type Ii Dihydroquinazoline Inhibitor Length = 307 | Back alignment and structure |
|
| >pdb|3KUL|A Chain A, Kinase Domain Of Human Ephrin Type-A Receptor 8 (Epha8) Length = 325 | Back alignment and structure |
|
| >pdb|4FK3|A Chain A, B-Raf Kinase V600e Oncogenic Mutant In Complex With Plx3203 Length = 292 | Back alignment and structure |
|
| >pdb|3C4C|A Chain A, B-Raf Kinase In Complex With Plx4720 Length = 280 | Back alignment and structure |
|
| >pdb|3S95|A Chain A, Crystal Structure Of The Human Limk1 Kinase Domain In Complex With Staurosporine Length = 310 | Back alignment and structure |
|
| >pdb|2DQ7|X Chain X, Crystal Structure Of Fyn Kinase Domain Complexed With Staurosporine Length = 283 | Back alignment and structure |
|
| >pdb|2QOO|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f:y742f Triple Mutant Length = 373 | Back alignment and structure |
|
| >pdb|3DZQ|A Chain A, Human Epha3 Kinase Domain In Complex With Inhibitor Awl-Ii- 38.3 Length = 361 | Back alignment and structure |
|
| >pdb|2QOC|A Chain A, Human Epha3 Kinase Domain, Phosphorylated, Amp-Pnp Bound Structure Length = 344 | Back alignment and structure |
|
| >pdb|2VWU|A Chain A, Ephb4 Kinase Domain Inhibitor Complex Length = 302 | Back alignment and structure |
|
| >pdb|2QOI|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f Double Mutant Length = 373 | Back alignment and structure |
|
| >pdb|2QOF|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f Mutant Length = 373 | Back alignment and structure |
|
| >pdb|2QOD|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y602f Mutant Length = 373 | Back alignment and structure |
|
| >pdb|2GSF|A Chain A, The Human Epha3 Receptor Tyrosine Kinase And Juxtamembrane Region Length = 373 | Back alignment and structure |
|
| >pdb|3FXX|A Chain A, Human Epha3 Kinase And Juxtamembrane Region Bound To Substrate Kqwdnye[ptyr]iw Length = 371 | Back alignment and structure |
|
| >pdb|4AW5|A Chain A, Complex Of The Ephb4 Kinase Domain With An Oxindole Inhibitor Length = 291 | Back alignment and structure |
|
| >pdb|1QPE|A Chain A, Structural Analysis Of The Lymphocyte-Specific Kinase Lck In Complex With Non-Selective And Src Family Selective Kinase Inhibitors Length = 279 | Back alignment and structure |
|
| >pdb|3BYM|A Chain A, X-Ray Co-Crystal Structure Aminobenzimidazole Triazine 1 Bound To Lck Length = 272 | Back alignment and structure |
|
| >pdb|2ZM1|A Chain A, Crystal Structure Of Imidazo Pyrazin 1 Bound To The Kinase Domain Of Human Lck, (Auto-Phosphorylated On Tyr394) Length = 285 | Back alignment and structure |
|
| >pdb|3LCK|A Chain A, The Kinase Domain Of Human Lymphocyte Kinase (Lck), Activated Form (Auto-Phosphorylated On Tyr394) Length = 271 | Back alignment and structure |
|
| >pdb|3KMM|A Chain A, Structure Of Human Lck Kinase With A Small Molecule Inhibitor Length = 288 | Back alignment and structure |
|
| >pdb|3KXZ|A Chain A, The Complex Crystal Structure Of Lck With A Probe Molecule W259 Length = 287 | Back alignment and structure |
|
| >pdb|2OFU|A Chain A, X-Ray Crystal Structure Of 2-Aminopyrimidine Carbamate 43 Bound To Lck Length = 273 | Back alignment and structure |
|
| >pdb|2QOK|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f:s768a Triple Mutant Length = 373 | Back alignment and structure |
|
| >pdb|2OF2|A Chain A, Crystal Structure Of Furanopyrimidine 8 Bound To Lck Length = 271 | Back alignment and structure |
|
| >pdb|2OG8|A Chain A, Crystal Structure Of Aminoquinazoline 36 Bound To Lck Length = 265 | Back alignment and structure |
|
| >pdb|3F69|A Chain A, Crystal Structure Of The Mycobacterium Tuberculosis Pknb Mutant Kinase Domain In Complex With Kt5720 Length = 311 | Back alignment and structure |
|
| >pdb|3ORI|A Chain A, Mycobacterium Tuberculosis Pknb Kinase Domain L33d Mutant (Crystal Form 1) Length = 311 | Back alignment and structure |
|
| >pdb|3BYS|A Chain A, Co-Crystal Structure Of Lck And Aminopyrimidine Amide 10b Length = 277 | Back alignment and structure |
|
| >pdb|2PL0|A Chain A, Lck Bound To Imatinib Length = 289 | Back alignment and structure |
|
| >pdb|2OFV|A Chain A, Crystal Structure Of Aminoquinazoline 1 Bound To Lck Length = 277 | Back alignment and structure |
|
| >pdb|2HEL|A Chain A, Crystal Structure Of A Mutant Epha4 Kinase Domain (Y742a) Length = 306 | Back alignment and structure |
|
| >pdb|2Y6M|A Chain A, Crystal Structure Of Epha4 Kinase Domain Length = 291 | Back alignment and structure |
|
| >pdb|2QOL|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596:y602:s768g Triple Mutant Length = 373 | Back alignment and structure |
|
| >pdb|1QPD|A Chain A, Structural Analysis Of The Lymphocyte-specific Kinase Lck In Complex With Non-selective And Src Family Selective Kinase Inhibitors Length = 279 | Back alignment and structure |
|
| >pdb|2XYU|A Chain A, Crystal Structure Of Epha4 Kinase Domain In Complex With Vuf 12058 Length = 285 | Back alignment and structure |
|
| >pdb|3OMV|A Chain A, Crystal Structure Of C-Raf (Raf-1) Length = 307 | Back alignment and structure |
|
| >pdb|3Q6W|A Chain A, Structure Of Dually-phosphorylated Met Receptor Kinase In Complex With An Mk-2461 Analog With Specificity For The Activated Receptor Length = 307 | Back alignment and structure |
|
| >pdb|3DKG|A Chain A, Sgx Clone 5698a109kfg1h1 Length = 317 | Back alignment and structure |
|
| >pdb|3F61|A Chain A, Crystal Structure Of M. Tuberculosis Pknb Leu33aspVAL222ASP DOUBLE MUTANT IN COMPLEX WITH ADP Length = 311 | Back alignment and structure |
|
| >pdb|3SLS|A Chain A, Crystal Structure Of Human Mek-1 Kinase In Complex With Ucb1353770 And Amppnp Length = 304 | Back alignment and structure |
|
| >pdb|2G15|A Chain A, Structural Characterization Of Autoinhibited C-Met Kinase Length = 318 | Back alignment and structure |
|
| >pdb|1JPA|A Chain A, Crystal Structure Of Unphosphorylated Ephb2 Receptor Tyrosine Kinase And Juxtamembrane Region Length = 312 | Back alignment and structure |
|
| >pdb|2WD1|A Chain A, Human C-Met Kinase In Complex With Azaindole Inhibitor Length = 292 | Back alignment and structure |
|
| >pdb|3ORN|A Chain A, Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In Complex With Ch4987655 And Mgamp-Pnp Length = 307 | Back alignment and structure |
|
| >pdb|4GG5|A Chain A, Crystal Structure Of Cmet In Complex With Novel Inhibitor Length = 319 | Back alignment and structure |
|
| >pdb|2WGJ|A Chain A, X-Ray Structure Of Pf-02341066 Bound To The Kinase Domain Of C-Met Length = 306 | Back alignment and structure |
|
| >pdb|3Q6U|A Chain A, Structure Of The Apo Met Receptor Kinase In The Dually-Phosphorylated, Activated State Length = 308 | Back alignment and structure |
|
| >pdb|3I5N|A Chain A, Crystal Structure Of C-Met With Triazolopyridazine Inhibitor 13 Length = 309 | Back alignment and structure |
|
| >pdb|3COH|A Chain A, Crystal Structure Of Aurora-A In Complex With A Pentacyclic Inhibitor Length = 268 | Back alignment and structure |
|
| >pdb|2QON|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f:y742a Triple Mutant Length = 373 | Back alignment and structure |
|
| >pdb|3LQ8|A Chain A, Structure Of The Kinase Domain Of C-Met Bound To Xl880 (Gsk1 Length = 302 | Back alignment and structure |
|
| >pdb|3C1X|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Hepatocyte Growth Factor Receptor C-Met In Complex With A Pyrrolotriazine Based Inhibitor Length = 373 | Back alignment and structure |
|
| >pdb|2QOB|A Chain A, Human Epha3 Kinase Domain, Base Structure Length = 344 | Back alignment and structure |
|
| >pdb|2RFN|A Chain A, X-ray Structure Of C-met With Inhibitor. Length = 310 | Back alignment and structure |
|
| >pdb|3F66|A Chain A, Human C-Met Kinase In Complex With Quinoxaline Inhibitor Length = 298 | Back alignment and structure |
|
| >pdb|2WTW|A Chain A, Aurora-A Inhibitor Structure (2nd Crystal Form) Length = 285 | Back alignment and structure |
|
| >pdb|2QO7|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Dephosphorylated, Amp-Pnp Bound Length = 373 | Back alignment and structure |
|
| >pdb|3MPM|A Chain A, Lck Complexed With A Pyrazolopyrimidine Length = 267 | Back alignment and structure |
|
| >pdb|1R0P|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Hepatocyte Growth Factor Receptor C-Met In Complex With The Microbial Alkaloid K-252a Length = 312 | Back alignment and structure |
|
| >pdb|3DKC|A Chain A, Sgx Clone 5698a65kfg1h1 Length = 317 | Back alignment and structure |
|
| >pdb|3CTH|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Hepatocyte Growth Factor Receptor C-Met In Complex With A Aminopyridine Based Inhibitor Length = 314 | Back alignment and structure |
|
| >pdb|2XA4|A Chain A, Inhibitors Of Jak2 Kinase Domain Length = 298 | Back alignment and structure |
|
| >pdb|3QUP|A Chain A, Inhibitor Bound Structure Of The Kinase Domain Of The Murine Receptor Tyrosine Kinase Tyro3 (Sky) Length = 323 | Back alignment and structure |
|
| >pdb|3QTI|A Chain A, C-Met Kinase In Complex With Nvp-Bvu972 Length = 314 | Back alignment and structure |
|
| >pdb|3A4P|A Chain A, Human C-Met Kinase Domain Complexed With 6-Benzyloxyquinoline Inhibitor Length = 319 | Back alignment and structure |
|
| >pdb|2J4Z|A Chain A, Structure Of Aurora-2 In Complex With Pha-680626 Length = 306 | Back alignment and structure |
|
| >pdb|2REI|A Chain A, Kinase Domain Of Human Ephrin Type-a Receptor 7 (epha7) Length = 318 | Back alignment and structure |
|
| >pdb|3SXR|A Chain A, Crystal Structure Of Bmx Non-Receptor Tyrosine Kinase Complex With Dasatinib Length = 268 | Back alignment and structure |
|
| >pdb|2J50|A Chain A, Structure Of Aurora-2 In Complex With Pha-739358 Length = 280 | Back alignment and structure |
|
| >pdb|2B7A|A Chain A, The Structural Basis Of Janus Kinase 2 Inhibition By A Potent And Specific Pan-Janus Kinase Inhibitor Length = 293 | Back alignment and structure |
|
| >pdb|3E62|A Chain A, Fragment Based Discovery Of Jak-2 Inhibitors Length = 293 | Back alignment and structure |
|
| >pdb|1MUO|A Chain A, Crystal Structure Of Aurora-2, An Oncogenic Serine- Threonine Kinase Length = 297 | Back alignment and structure |
|
| >pdb|3Q32|A Chain A, Structure Of Janus Kinase 2 With A Pyrrolotriazine Inhibitor Length = 301 | Back alignment and structure |
|
| >pdb|3RVG|A Chain A, Crystals Structure Of Jak2 With A 1-Amino-5h-Pyrido[4,3-B]indol-4- Carboxamide Inhibitor Length = 303 | Back alignment and structure |
|
| >pdb|2R2P|A Chain A, Kinase Domain Of Human Ephrin Type-A Receptor 5 (Epha5) Length = 295 | Back alignment and structure |
|
| >pdb|3NRM|A Chain A, Imidazo[1,2-A]pyrazine-Based Aurora Kinase Inhibitors Length = 283 | Back alignment and structure |
|
| >pdb|2X6D|A Chain A, Aurora-A Bound To An Inhibitor Length = 285 | Back alignment and structure |
|
| >pdb|2XRU|A Chain A, Aurora-A T288e Complexed With Pha-828300 Length = 280 | Back alignment and structure |
|
| >pdb|4AQC|A Chain A, Triazolopyridine-Based Inhibitor Of Janus Kinase 2 Length = 301 | Back alignment and structure |
|
| >pdb|2XNG|A Chain A, Structure Of Aurora-A Bound To A Selective Imidazopyrazine Inhibitor Length = 283 | Back alignment and structure |
|
| >pdb|3LPB|A Chain A, Crystal Structure Of Jak2 Complexed With A Potent 2,8-Diaryl Quinoxaline Inhibitor Length = 295 | Back alignment and structure |
|
| >pdb|4HGE|A Chain A, Jak2 Kinase (Jh1 Domain) In Complex With Compound 8 Length = 300 | Back alignment and structure |
|
| >pdb|3D14|A Chain A, Crystal Structure Of Mouse Aurora A (Asn186->gly, Lys240->arg, Met302- >leu) In Complex With 1-{5-[2-(Thieno[3,2-D]pyrimidin-4-Ylamino)- Ethyl]- Thiazol-2-Yl}-3-(3-Trifluoromethyl-Phenyl)-Urea Length = 272 | Back alignment and structure |
|
| >pdb|1MQ4|A Chain A, Crystal Structure Of Aurora-A Protein Kinase Length = 272 | Back alignment and structure |
|
| >pdb|3H0Y|A Chain A, Aurora A In Complex With A Bisanilinopyrimidine Length = 268 | Back alignment and structure |
|
| >pdb|3TJC|A Chain A, Co-Crystal Structure Of Jak2 With Thienopyridine 8 Length = 298 | Back alignment and structure |
|
| >pdb|2W1I|A Chain A, Structure Determination Of Aurora Kinase In Complex With Inhibitor Length = 326 | Back alignment and structure |
|
| >pdb|4E4M|A Chain A, Jak2 Kinase (Jh1 Domain) In Complex With Compound 30 Length = 302 | Back alignment and structure |
|
| >pdb|3O50|A Chain A, Crystal Structure Of Benzamide 9 Bound To Auroraa Length = 267 | Back alignment and structure |
|
| >pdb|3UGC|A Chain A, Structural Basis Of Jak2 Inhibition By The Type Ii Inhibtor Nvp-Bbt594 Length = 295 | Back alignment and structure |
|
| >pdb|3QBN|A Chain A, Structure Of Human Aurora A In Complex With A Diaminopyrimidine Length = 281 | Back alignment and structure |
|
| >pdb|3E5A|A Chain A, Crystal Structure Of Aurora A In Complex With Vx-680 And Tpx2 Length = 268 | Back alignment and structure |
|
| >pdb|2W1D|A Chain A, Structure Determination Of Aurora Kinase In Complex With Inhibitor Length = 275 | Back alignment and structure |
|
| >pdb|1MQB|A Chain A, Crystal Structure Of Ephrin A2 (Epha2) Receptor Protein Kinase Length = 333 | Back alignment and structure |
|
| >pdb|3ORM|A Chain A, Mycobacterium Tuberculosis Pknb Kinase Domain D76a Mutant Length = 311 | Back alignment and structure |
|
| >pdb|3FDN|A Chain A, Structure-Based Drug Design Of Novel Aurora Kinase A Inhibitors: Structure Basis For Potency And Specificity Length = 279 | Back alignment and structure |
|
| >pdb|2C6D|A Chain A, Aurora A Kinase Activated Mutant (T287d) In Complex With Adpnp Length = 275 | Back alignment and structure |
|
| >pdb|2WTV|A Chain A, Aurora-A Inhibitor Structure Length = 285 | Back alignment and structure |
|
| >pdb|3LAU|A Chain A, Crystal Structure Of Aurora2 Kinase In Complex With A Gsk3beta Inhibitor Length = 287 | Back alignment and structure |
|
| >pdb|2WQE|A Chain A, Structure Of S155r Aurora-A Somatic Mutant Length = 262 | Back alignment and structure |
|
| >pdb|3JY9|A Chain A, Janus Kinase 2 Inhibitors Length = 311 | Back alignment and structure |
|
| >pdb|3IO7|A Chain A, 2-Aminopyrazolo[1,5-A]pyrimidines As Potent And Selective Inhibitors Of Jak2 Length = 313 | Back alignment and structure |
|
| >pdb|2C6E|A Chain A, Aurora A Kinase Activated Mutant (T287d) In Complex With A 5-Aminopyrimidinyl Quinazoline Inhibitor Length = 283 | Back alignment and structure |
|
| >pdb|4APC|A Chain A, Crystal Structure Of Human Nima-Related Kinase 1 (Nek1) Length = 350 | Back alignment and structure |
|
| >pdb|1MRU|A Chain A, Intracellular SerTHR PROTEIN KINASE DOMAIN OF Mycobacterium Tuberculosis Pknb. Length = 311 | Back alignment and structure |
|
| >pdb|4ASZ|A Chain A, Crystal Structure Of Apo Trkb Kinase Domain Length = 299 | Back alignment and structure |
|
| >pdb|2HEN|A Chain A, Crystal Structure Of The Ephb2 Receptor Kinase Domain In Complex With Adp Length = 286 | Back alignment and structure |
|
| >pdb|1O6Y|A Chain A, Catalytic Domain Of Pknb Kinase From Mycobacterium Tuberculosis Length = 299 | Back alignment and structure |
|
| >pdb|2DWB|A Chain A, Aurora-A Kinase Complexed With Amppnp Length = 285 | Back alignment and structure |
|
| >pdb|4E6D|A Chain A, Jak2 Kinase (Jh1 Domain) Triple Mutant In Complex With Compound 7 Length = 298 | Back alignment and structure |
|
| >pdb|2XNE|A Chain A, Structure Of Aurora-A Bound To An Imidazopyrazine Inhibitor Length = 272 | Back alignment and structure |
|
| >pdb|1OL6|A Chain A, Structure Of Unphosphorylated D274n Mutant Of Aurora-a Length = 282 | Back alignment and structure |
|
| >pdb|3V5Q|A Chain A, Discovery Of A Selective Trk Inhibitor With Efficacy In Rodent Cancer Tumor Models Length = 297 | Back alignment and structure |
|
| >pdb|3DTC|A Chain A, Crystal Structure Of Mixed-Lineage Kinase Mlk1 Complexed With Compound 16 Length = 271 | Back alignment and structure |
|
| >pdb|1OL5|A Chain A, Structure Of Aurora-A 122-403, Phosphorylated On Thr287, Thr288 And Bound To Tpx2 1-43 Length = 282 | Back alignment and structure |
|
| >pdb|3UNZ|A Chain A, Aurora A In Complex With Rpm1679 Length = 279 | Back alignment and structure |
|
| >pdb|3HA6|A Chain A, Crystal Structure Of Aurora A In Complex With Tpx2 And Compound 10 Length = 268 | Back alignment and structure |
|
| >pdb|4BBE|A Chain A, Aminoalkylpyrimidine Inhibitor Complexes With Jak2 Length = 298 | Back alignment and structure |
|
| >pdb|3SAY|A Chain A, Crystal Structure Of Human Glycogen Synthase Kinase 3 Beta (Gsk3b) In Complex With Inhibitor 142 Length = 430 | Back alignment and structure |
|
| >pdb|3DAJ|A Chain A, Crystal Structure Of Aurora A Complexed With An Inhibitor Discovered Through Site-Directed Dynamic Tethering Length = 272 | Back alignment and structure |
|
| >pdb|2Y4I|C Chain C, Ksr2-Mek1 Heterodimer Length = 395 | Back alignment and structure |
|
| >pdb|4AN2|A Chain A, Crystal Structures Of Human Mek1 With Carboxamide-Based Allosteric Inhibitor Xl518 (Gdc-0973), Or Related Analogs. Length = 301 | Back alignment and structure |
|
| >pdb|2BMC|A Chain A, Aurora-2 T287d T288d Complexed With Pha-680632 Length = 306 | Back alignment and structure |
|
| >pdb|2W1C|A Chain A, Structure Determination Of Aurora Kinase In Complex With Inhibitor Length = 275 | Back alignment and structure |
|
| >pdb|1S9J|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In A Complex With Ligand And Mgatp Length = 341 | Back alignment and structure |
|
| >pdb|2P55|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In A Complex With Ligand And Mgatp Length = 333 | Back alignment and structure |
|
| >pdb|3EQC|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In A Ternary Complex With Compound 1, Atp-Gs And Mg2p Length = 360 | Back alignment and structure |
|
| >pdb|3MBL|A Chain A, Crystal Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek 1) In Complex With Ligand And Mgadp Length = 328 | Back alignment and structure |
|
| >pdb|3DV3|A Chain A, Mek1 With Pf-04622664 Bound Length = 322 | Back alignment and structure |
|
| >pdb|1UA2|A Chain A, Crystal Structure Of Human Cdk7 Length = 346 | Back alignment and structure |
|
| >pdb|3R21|A Chain A, Design, Synthesis, And Biological Evaluation Of Pyrazolopyridine- Sulfonamides As Potent Multiple-Mitotic Kinase (Mmk) Inhibitors (Part I) Length = 271 | Back alignment and structure |
|
| >pdb|1I09|A Chain A, Structure Of Glycogen Synthase Kinase-3 (Gsk3b) Length = 420 | Back alignment and structure |
|
| >pdb|1Q3D|A Chain A, Gsk-3 Beta Complexed With Staurosporine Length = 424 | Back alignment and structure |
|
| >pdb|1PYX|A Chain A, Gsk-3 Beta Complexed With Amp-Pnp Length = 422 | Back alignment and structure |
|
| >pdb|3ZRK|A Chain A, Identification Of 2-(4-Pyridyl)thienopyridinones As Gsk-3beta Inhibitors Length = 371 | Back alignment and structure |
|
| >pdb|4ACC|A Chain A, Gsk3b In Complex With Inhibitor Length = 465 | Back alignment and structure |
|
| >pdb|4DIT|A Chain A, Crystal Structure Of Gsk3beta In Complex With A Imidazopyridine Inhibitor Length = 382 | Back alignment and structure |
|
| >pdb|1Q5K|A Chain A, Crystal Structure Of Glycogen Synthase Kinase 3 In Complexed With Inhibitor Length = 414 | Back alignment and structure |
|
| >pdb|3F88|A Chain A, Glycogen Synthase Kinase 3beta Inhibitor Complex Length = 349 | Back alignment and structure |
|
| >pdb|3GB2|A Chain A, Gsk3beta Inhibitor Complex Length = 353 | Back alignment and structure |
|
| >pdb|1GNG|A Chain A, Glycogen Synthase Kinase-3 Beta (Gsk3) Complex With Frattide Peptide Length = 378 | Back alignment and structure |
|
| >pdb|2OW3|A Chain A, Glycogen Synthase Kinase-3 Beta In Complex With Bis- (Indole)maleimide Pyridinophane Inhibitor Length = 352 | Back alignment and structure |
|
| >pdb|4AFJ|A Chain A, 5-Aryl-4-Carboxamide-1,3-Oxazoles: Potent And Selective Gsk-3 Inhibitors Length = 367 | Back alignment and structure |
|
| >pdb|1R0E|A Chain A, Glycogen Synthase Kinase-3 Beta In Complex With 3-Indolyl-4- Arylmaleimide Inhibitor Length = 391 | Back alignment and structure |
|
| >pdb|3ZDI|A Chain A, Glycogen Synthase Kinase 3 Beta Complexed With Axin Peptide And Inhibitor 7d Length = 350 | Back alignment and structure |
|
| >pdb|3F7Z|A Chain A, X-ray Co-crystal Structure Of Glycogen Synthase Kinase 3beta In Complex With An Inhibitor Length = 350 | Back alignment and structure |
|
| >pdb|2O5K|A Chain A, Crystal Structure Of Gsk3beta In Complex With A Benzoimidazol Inhibitor Length = 372 | Back alignment and structure |
|
| >pdb|2HAK|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark1PAR-1 Length = 328 | Back alignment and structure |
|
| >pdb|3SD0|A Chain A, Identification Of A Glycogen Synthase Kinase-3b Inhibitor That Attenuates Hyperactivity In Clock Mutant Mice Length = 350 | Back alignment and structure |
|
| >pdb|4EQM|A Chain A, Structural Analysis Of Staphylococcus Aureus SerineTHREONINE KINASE Pknb Length = 294 | Back alignment and structure |
|
| >pdb|4AOJ|A Chain A, Human Trka In Complex With The Inhibitor Az-23 Length = 329 | Back alignment and structure |
|
| >pdb|4F0I|A Chain A, Crystal Structure Of Apo Trka Length = 300 | Back alignment and structure |
|
| >pdb|4GT5|A Chain A, Crystal Structure Of The Inactive Trka Kinase Domain Length = 306 | Back alignment and structure |
|
| >pdb|3MIY|A Chain A, X-Ray Crystal Structure Of Itk Complexed With Sunitinib Length = 266 | Back alignment and structure |
|
| >pdb|3V5J|A Chain A, Crystal Structure Of Interleukin-2 Inducible T-Cell Kinase Itk Catalytic Domain With Thienopyrazolylindole Inhibitor 090 Length = 266 | Back alignment and structure |
|
| >pdb|1OIT|A Chain A, Imidazopyridines: A Potent And Selective Class Of Cyclin-dependent Kinase Inhibitors Identified Through Structure-based Hybridisation Length = 299 | Back alignment and structure |
|
| >pdb|4IC7|A Chain A, Crystal Structure Of The Erk5 Kinase Domain In Complex With An Mkk5 Binding Fragment Length = 442 | Back alignment and structure |
|
| >pdb|1SM2|A Chain A, Crystal Structure Of The Phosphorylated Interleukin-2 Tyrosine Kinase Catalytic Domain Length = 264 | Back alignment and structure |
|
| >pdb|1S9I|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 2 (Mek2)in A Complex With Ligand And Mgatp Length = 354 | Back alignment and structure |
|
| >pdb|4B99|A Chain A, Crystal Structure Of Mapk7 (Erk5) With Inhibitor Length = 398 | Back alignment and structure |
|
| >pdb|1YVJ|A Chain A, Crystal Structure Of The Jak3 Kinase Domain In Complex With A Staurosporine Analogue Length = 290 | Back alignment and structure |
|
| >pdb|4HCT|A Chain A, Crystal Structure Of Itk In Complex With Compound 52 Length = 269 | Back alignment and structure |
|
| >pdb|3PXF|A Chain A, Cdk2 In Complex With Two Molecules Of 8-Anilino-1-Naphthalene Sulfonate Length = 306 | Back alignment and structure |
|
| >pdb|4HVD|A Chain A, Jak3 Kinase Domain In Complex With 2-cyclopropyl-5h-pyrrolo[2,3- B]pyrazine-7-carboxylic Acid ((s)-1,2,2-trimethyl-propyl)-amide Length = 314 | Back alignment and structure |
|
| >pdb|1PF8|A Chain A, Crystal Structure Of Human Cyclin-dependent Kinase 2 Complexed With A Nucleoside Inhibitor Length = 298 | Back alignment and structure |
|
| >pdb|4ERW|A Chain A, Cdk2 In Complex With Staurosporine Length = 306 | Back alignment and structure |
|
| >pdb|2W17|A Chain A, Cdk2 In Complex With The Imidazole Pyrimidine Amide, Compound (S)-8b Length = 299 | Back alignment and structure |
|
| >pdb|3LXK|A Chain A, Structural And Thermodynamic Characterization Of The Tyk2 And Jak3 Kinase Domains In Complex With Cp-690550 And Cmp-6 Length = 327 | Back alignment and structure |
|
| >pdb|1FIN|A Chain A, Cyclin A-Cyclin-Dependent Kinase 2 Complex Length = 298 | Back alignment and structure |
|
| >pdb|1O9U|A Chain A, Glycogen Synthase Kinase 3 Beta Complexed With Axin Peptide Length = 350 | Back alignment and structure |
|
| >pdb|3PJ8|A Chain A, Structure Of Cdk2 In Complex With A Pyrazolo[4,3-D]pyrimidine Bioisostere Of Roscovitine Length = 299 | Back alignment and structure |
|
| >pdb|1UV5|A Chain A, Glycogen Synthase Kinase 3 Beta Complexed With 6-Bromoindirubin-3'-Oxime Length = 350 | Back alignment and structure |
|
| >pdb|1VYW|A Chain A, Structure Of Cdk2CYCLIN A WITH PNU-292137 Length = 309 | Back alignment and structure |
|
| >pdb|1H8F|A Chain A, Glycogen Synthase Kinase 3 Beta. Length = 352 | Back alignment and structure |
|
| >pdb|3EZR|A Chain A, Cdk-2 With Indazole Inhibitor 17 Bound At Its Active Site Length = 300 | Back alignment and structure |
|
| >pdb|1GZ8|A Chain A, Human Cyclin Dependent Kinase 2 Complexed With The Inhibitor 2-Amino-6-(3'-Methyl-2'-Oxo)butoxypurine Length = 299 | Back alignment and structure |
|
| >pdb|2IW6|A Chain A, Structure Of Human Thr160-Phospho Cdk2-Cyclin A Complexed With A Bisanilinopyrimidine Inhibitor Length = 302 | Back alignment and structure |
|
| >pdb|1ZMW|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: T208aS212A INACTIVE DOUBLE MUTANT Length = 327 | Back alignment and structure |
|
| >pdb|3T9T|A Chain A, Crystal Structure Of Btk Mutant (F435t,K596r) Complexed With Imidazo[1,5-A]quinoxaline Length = 267 | Back alignment and structure |
|
| >pdb|1GII|A Chain A, Human Cyclin Dependent Kinase 2 Complexed With The Cdk4 Inhibitor Length = 298 | Back alignment and structure |
|
| >pdb|3PJC|A Chain A, Crystal Structure Of Jak3 Complexed With A Potent Atp Site Inhibitor Showing High Selectivity Within The Janus Kinase Family Length = 315 | Back alignment and structure |
|
| >pdb|1QMZ|A Chain A, Phosphorylated Cdk2-Cyclyin A-Substrate Peptide Complex Length = 299 | Back alignment and structure |
|
| >pdb|1OGU|A Chain A, Structure Of Human Thr160-phospho Cdk2/cyclin A Complexed With A 2-arylamino-4-cyclohexylmethyl-5-nitroso-6- aminopyrimidine Inhibitor Length = 302 | Back alignment and structure |
|
| >pdb|1JST|A Chain A, Phosphorylated Cyclin-Dependent Kinase-2 Bound To Cyclin A Length = 298 | Back alignment and structure |
|
| >pdb|4EOQ|A Chain A, Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Complex With Atp Length = 301 | Back alignment and structure |
|
| >pdb|4BCQ|A Chain A, Structure Of Cdk2 In Complex With Cyclin A And A 2-amino-4- Heteroaryl-pyrimidine Inhibitor Length = 301 | Back alignment and structure |
|
| >pdb|4I3Z|A Chain A, Structure Of Pcdk2CYCLINA BOUND TO ADP AND 2 MAGNESIUM IONS Length = 296 | Back alignment and structure |
|
| >pdb|1W98|A Chain A, The Structural Basis Of Cdk2 Activation By Cyclin E Length = 298 | Back alignment and structure |
|
| >pdb|4EOS|A Chain A, Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 300 | Back alignment and structure |
|
| >pdb|3BHT|A Chain A, Structure Of Phosphorylated Thr160 Cdk2CYCLIN A IN COMPLEX WITH THE Inhibitor Meriolin 3 Length = 300 | Back alignment and structure |
|
| >pdb|1H1P|A Chain A, Structure Of Human Thr160-Phospho Cdk2CYCLIN A COMPLEXED With The Inhibitor Nu2058 Length = 303 | Back alignment and structure |
|
| >pdb|2JGZ|A Chain A, Crystal Structure Of Phospho-Cdk2 In Complex With Cyclin B Length = 289 | Back alignment and structure |
|
| >pdb|3QHR|A Chain A, Structure Of A Pcdk2CYCLINA TRANSITION-State Mimic Length = 298 | Back alignment and structure |
|
| >pdb|1E9H|A Chain A, Thr 160 Phosphorylated Cdk2-Human Cyclin A3 Complex With The Inhibitor Indirubin-5-Sulphonate Bound Length = 297 | Back alignment and structure |
|
| >pdb|4EOP|A Chain A, Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 300 | Back alignment and structure |
|
| >pdb|4EOO|A Chain A, Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 Complex With Atp Length = 299 | Back alignment and structure |
|
| >pdb|4EOI|A Chain A, Thr 160 Phosphorylated Cdk2 K89d, Q131e - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 299 | Back alignment and structure |
|
| >pdb|2IW8|A Chain A, Structure Of Human Thr160-Phospho Cdk2-Cyclin A F82h-L83v- H84d Mutant With An O6-Cyclohexylmethylguanine Inhibitor Length = 302 | Back alignment and structure |
|
| >pdb|2CLQ|A Chain A, Structure Of Mitogen-Activated Protein Kinase Kinase Kinase 5 Length = 295 | Back alignment and structure |
|
| >pdb|2R0I|A Chain A, Crystal Structure Of A Kinase Mark2PAR-1 Mutant Length = 327 | Back alignment and structure |
|
| >pdb|1ZMU|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: Wild Type Length = 327 | Back alignment and structure |
|
| >pdb|3VW6|A Chain A, Crystal Structure Of Human Apoptosis Signal-Regulating Kinase 1 (Ask1) With Imidazopyridine Inhibitor Length = 269 | Back alignment and structure |
|
| >pdb|3QGW|A Chain A, Crystal Structure Of Itk Kinase Bound To An Inhibitor Length = 286 | Back alignment and structure |
|
| >pdb|4EOM|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Human Cyclin A3 Complex With Atp Length = 301 | Back alignment and structure |
|
| >pdb|4EOK|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Human Cyclin A3 Complex With The Inhibitor Nu6102 Length = 300 | Back alignment and structure |
|
| >pdb|4EOJ|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Human Cyclin A3 Complex With Atp Length = 302 | Back alignment and structure |
|
| >pdb|4EON|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 300 | Back alignment and structure |
|
| >pdb|3FE3|A Chain A, Crystal Structure Of The Kinase Mark3PAR-1: T211a-S215a Double Mutant Length = 328 | Back alignment and structure |
|
| >pdb|1OIR|A Chain A, Imidazopyridines: A Potent And Selective Class Of Cyclin-Dependent Kinase Inhibitors Identified Through Structure-Based Hybridisation Length = 299 | Back alignment and structure |
|
| >pdb|1H01|A Chain A, Cdk2 In Complex With A Disubstituted 2, 4-Bis Anilino Pyrimidine Cdk4 Inhibitor Length = 298 | Back alignment and structure |
|
| >pdb|1ZMV|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: K82r Mutant Length = 327 | Back alignment and structure |
|
| >pdb|2QNJ|A Chain A, Kinase And Ubiquitin-Associated Domains Of Mark3PAR-1 Length = 328 | Back alignment and structure |
|
| >pdb|3DK7|A Chain A, Crystal Structure Of Mutant Abl Kinase Domain In Complex With Small Molecule Fragment Length = 277 | Back alignment and structure |
|
| >pdb|3A4O|X Chain X, Lyn Kinase Domain Length = 286 | Back alignment and structure |
|
| >pdb|2WZJ|A Chain A, Catalytic And Uba Domain Of Kinase Mark2(PAR-1) K82r, T208e Double Mutant Length = 327 | Back alignment and structure |
|
| >pdb|3T8O|A Chain A, Rhodopsin Kinase (grk1) L166k Mutant At 2.5a Resolution Length = 543 | Back alignment and structure |
|
| >pdb|3C4X|A Chain A, Crystal Structure Of G Protein Coupled Receptor Kinase 1 Bound To Atp And Magnesium Chloride At 2.9a Length = 543 | Back alignment and structure |
|
| >pdb|3C4W|A Chain A, Crystal Structure Of G Protein Coupled Receptor Kinase 1 Bound To Atp And Magnesium Chloride At 2.7a Length = 543 | Back alignment and structure |
|
| >pdb|3QC9|A Chain A, Crystal Structure Of Cross-Linked Bovine Grk1 T8cN480C DOUBLE MUTANT Complexed With Adp And Mg Length = 543 | Back alignment and structure |
|
| >pdb|2HK5|A Chain A, Hck Kinase In Complex With Lck Targetted Inhibitor Pg- 1009247 Length = 270 | Back alignment and structure |
|
| >pdb|3DK6|A Chain A, Crystal Structure Of Mutant Abl Kinase Domain In Complex With Small Molecule Fragment Length = 293 | Back alignment and structure |
|
| >pdb|1QCF|A Chain A, Crystal Structure Of Hck In Complex With A Src Family- Selective Tyrosine Kinase Inhibitor Length = 454 | Back alignment and structure |
|
| >pdb|1V0O|A Chain A, Structure Of P. Falciparum Pfpk5-Indirubin-5-Sulphonate Ligand Complex Length = 288 | Back alignment and structure |
|
| >pdb|3RHX|B Chain B, Crystal Structure Of The Catalytic Domain Of Fgfr1 Kinase In Complex With Arq 069 Length = 306 | Back alignment and structure |
|
| >pdb|3PLS|A Chain A, Ron In Complex With Ligand Amp-Pnp Length = 298 | Back alignment and structure |
|
| >pdb|1V0B|A Chain A, Crystal Structure Of The T198a Mutant Of Pfpk5 Length = 288 | Back alignment and structure |
|
| >pdb|1FGK|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of Fibroblast Growth Factor Receptor 1 Length = 310 | Back alignment and structure |
|
| >pdb|3IEC|A Chain A, Helicobacter Pylori Caga Inhibits Par1MARK FAMILY KINASES BY Mimicking Host Substrates Length = 319 | Back alignment and structure |
|
| >pdb|2V7A|A Chain A, Crystal Structure Of The T315i Abl Mutant In Complex With The Inhibitor Pha-739358 Length = 286 | Back alignment and structure |
|
| >pdb|3TT0|A Chain A, Co-Structure Of Fibroblast Growth Factor Receptor 1 Kinase Domain With 3-(2,6-Dichloro-3, 5-Dimethoxy-Phenyl)-1-{6-[4-(4-Ethyl-Piperazin-1- Yl)-Phenylamino]-Pyrimidin-4-Yl}-1-Methyl-Urea (Bgj398) Length = 382 | Back alignment and structure |
|
| >pdb|3KXX|A Chain A, Structure Of The Mutant Fibroblast Growth Factor Receptor 1 Length = 317 | Back alignment and structure |
|
| >pdb|4F63|A Chain A, Crystal Structure Of Human Fibroblast Growth Factor Receptor 1 Kinase Domain In Complex With Compound 1 Length = 309 | Back alignment and structure |
|
| >pdb|3JS2|A Chain A, Crystal Structure Of Minimal Kinase Domain Of Fibroblast Growth Factor Receptor 1 In Complex With 5-(2-Thienyl) Nicotinic Acid Length = 317 | Back alignment and structure |
|
| >pdb|1A06|A Chain A, Calmodulin-Dependent Protein Kinase From Rat Length = 332 | Back alignment and structure |
|
| >pdb|4FG7|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase I 1-293 In Complex With Atp Length = 293 | Back alignment and structure |
|
| >pdb|1OB3|A Chain A, Structure Of P. Falciparum Pfpk5 Length = 288 | Back alignment and structure |
|
| >pdb|3I81|A Chain A, Crystal Structure Of Insulin-Like Growth Factor 1 Receptor (Igf-1r-Wt) Complex With Bms-754807 [1-(4-((5-Cyclopropyl- 1h-Pyrazol-3-Yl)amino)pyrrolo[2,1-F][1,2, 4]triazin-2-Yl)-N- (6-Fluoro-3-Pyridinyl)-2-Methyl-L-Prolinamide] Length = 315 | Back alignment and structure |
|
| >pdb|2OJ9|A Chain A, Structure Of Igf-1r Kinase Domain Complexed With A Benzimidazole Inhibitor Length = 307 | Back alignment and structure |
|
| >pdb|1Y8G|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: Inactive Double Mutant With Selenomethionine Length = 327 | Back alignment and structure |
|
| >pdb|1JQH|A Chain A, Igf-1 Receptor Kinase Domain Length = 308 | Back alignment and structure |
|
| >pdb|4F1O|A Chain A, Crystal Structure Of The L1180t Mutant Roco4 Kinase Domain From D. Discoideum Bound To Appcp Length = 287 | Back alignment and structure |
|
| >pdb|3O23|A Chain A, Human Unphosphorylated Igf1-R Kinase Domain In Complex With An Hydantoin Inhibitor Length = 305 | Back alignment and structure |
|
| >pdb|4FG8|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase I 1-315 In Complex With Atp Length = 315 | Back alignment and structure |
|
| >pdb|3QQU|A Chain A, Cocrystal Structure Of Unphosphorylated Igf With Pyrimidine 8 Length = 301 | Back alignment and structure |
|
| >pdb|3LVP|A Chain A, Crystal Structure Of Bisphosphorylated Igf1-R Kinase Domain (2p) In Complex With A Bis-Azaindole Inhibitor Length = 336 | Back alignment and structure |
|
| >pdb|1M7N|A Chain A, Crystal Structure Of Unactivated Apo Insulin-Like Growth Factor-1 Receptor Kinase Domain Length = 322 | Back alignment and structure |
|
| >pdb|3GQI|A Chain A, Crystal Structure Of Activated Receptor Tyrosine Kinase In Complex With Substrates Length = 326 | Back alignment and structure |
|
| >pdb|4FG9|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase I 1-320 In Complex With Atp Length = 320 | Back alignment and structure |
|
| >pdb|3QRJ|A Chain A, The Crystal Structure Of Human Abl1 Kinase Domain T315i Mutant In Complex With Dcc-2036 Length = 277 | Back alignment and structure |
|
| >pdb|3RZF|A Chain A, Crystal Structure Of Inhibitor Of Kappab Kinase Beta (I4122) Length = 677 | Back alignment and structure |
|
| >pdb|3QA8|A Chain A, Crystal Structure Of Inhibitor Of Kappa B Kinase Beta Length = 676 | Back alignment and structure |
|
| >pdb|3LW0|A Chain A, Igf-1rk In Complex With Ligand Msc1609119a-1 Length = 304 | Back alignment and structure |
|
| >pdb|2Z60|A Chain A, Crystal Structure Of The T315i Mutant Of Abl Kinase Bound With Ppy-A Length = 288 | Back alignment and structure |
|
| >pdb|1F3M|C Chain C, Crystal Structure Of Human SerineTHREONINE KINASE PAK1 Length = 297 | Back alignment and structure |
|
| >pdb|2WQM|A Chain A, Structure Of Apo Human Nek7 Length = 310 | Back alignment and structure |
|
| >pdb|1P4O|A Chain A, Structure Of Apo Unactivated Igf-1r Kinase Domain At 1.5a Resolution. Length = 322 | Back alignment and structure |
|
| >pdb|3Q52|A Chain A, Structure Of Phosphorylated Pak1 Kinase Domain Length = 306 | Back alignment and structure |
|
| >pdb|3FXZ|A Chain A, Crystal Structure Of Pak1 Kinase Domain With Ruthenium Complex Lambda-Fl172 Length = 297 | Back alignment and structure |
|
| >pdb|2JAV|A Chain A, Human Kinase With Pyrrole-Indolinone Ligand Length = 279 | Back alignment and structure |
|
| >pdb|3DK3|A Chain A, Crystal Structure Of Mutant Abl Kinase Domain In Complex With Small Molecule Fragment Length = 293 | Back alignment and structure |
|
| >pdb|2ZM3|A Chain A, Complex Structure Of Insulin-Like Growth Factor Receptor And Isoquinolinedione Inhibitor Length = 308 | Back alignment and structure |
|
| >pdb|1YHV|A Chain A, Crystal Structure Of Pak1 Kinase Domain With Two Point Mutations (K299r, T423e) Length = 297 | Back alignment and structure |
|
| >pdb|3P4K|A Chain A, The Third Conformation Of P38a Map Kinase Observed In Phosphorylated P38a And In Solution Length = 370 | Back alignment and structure |
|
| >pdb|3OY3|A Chain A, Crystal Structure Of Abl T315i Mutant Kinase Domain Bound With A Dfg- Out Inhibitor Ap24589 Length = 284 | Back alignment and structure |
|
| >pdb|2GQG|A Chain A, X-Ray Crystal Structure Of Dasatinib (Bms-354825) Bound To Activated Abl Kinase Domain Length = 278 | Back alignment and structure |
|
| >pdb|2F4J|A Chain A, Structure Of The Kinase Domain Of An Imatinib-Resistant Abl Mutant In Complex With The Aurora Kinase Inhibitor Vx-680 Length = 287 | Back alignment and structure |
|
| >pdb|1LEW|A Chain A, Crystal Structure Of Map Kinase P38 Complexed To The Docking Site On Its Nuclear Substrate Mef2a Length = 360 | Back alignment and structure |
|
| >pdb|2PK9|A Chain A, Structure Of The Pho85-pho80 Cdk-cyclin Complex Of The Phosphate-responsive Signal Transduction Pathway Length = 317 | Back alignment and structure |
|
| >pdb|1BMK|A Chain A, The Complex Structure Of The Map Kinase P38SB218655 Length = 379 | Back alignment and structure |
|
| >pdb|2PUU|A Chain A, Crystal Structure Of P38 Complex With 1-(5-Tert-Butyl-2-P- Tolyl-2h-Pyrazol-3-Yl)-3-[4-(6-Morpholin-4-Ylmethyl- Pyridin-3-Yl)naphthalen-1-Yl]urea Length = 348 | Back alignment and structure |
|
| >pdb|2G2F|A Chain A, A Src-Like Inactive Conformation In The Abl Tyrosine Kinase Domain Length = 287 | Back alignment and structure |
|
| >pdb|2E2B|A Chain A, Crystal Structure Of The C-Abl Kinase Domain In Complex With Inno-406 Length = 293 | Back alignment and structure |
|
| >pdb|3GQL|A Chain A, Crystal Structure Of Activated Receptor Tyrosine Kinase In Complex With Substrates Length = 326 | Back alignment and structure |
|
| >pdb|2GTM|A Chain A, Mutated Mouse P38 Map Kinase Domain In Complex With Inhibitor Pg-892579 Length = 348 | Back alignment and structure |
|
| >pdb|3C4F|A Chain A, Fgfr Tyrosine Kinase Domain In Complex With 3-(3- Methoxybenzyl)-7-Azaindole Length = 302 | Back alignment and structure |
|
| >pdb|3G51|A Chain A, Structural Diversity Of The Active Conformation Of The N- Terminal Kinase Domain Of P90 Ribosomal S6 Kinase 2 Length = 325 | Back alignment and structure |
|
| >pdb|3TG1|A Chain A, Crystal Structure Of P38alpha In Complex With A Mapk Docking Partner Length = 380 | Back alignment and structure |
|
| >pdb|2HIW|A Chain A, Crystal Structure Of Inactive Conformation Abl Kinase Catalytic Domain Complexed With Type Ii Inhibitor Length = 287 | Back alignment and structure |
|
| >pdb|2G1T|A Chain A, A Src-Like Inactive Conformation In The Abl Tyrosine Kinase Domain Length = 287 | Back alignment and structure |
|
| >pdb|2OZA|B Chain B, Structure Of P38alpha Complex Length = 366 | Back alignment and structure |
|
| >pdb|3UBD|A Chain A, Structure Of N-Terminal Domain Of Rsk2 Kinase In Complex With Flavonoid Glycoside Sl0101 Length = 304 | Back alignment and structure |
|
| >pdb|2HZI|A Chain A, Abl Kinase Domain In Complex With Pd180970 Length = 277 | Back alignment and structure |
|
| >pdb|1H4L|A Chain A, Structure And Regulation Of The Cdk5-P25(Nck5a) Complex Length = 292 | Back alignment and structure |
|
| >pdb|4EL9|A Chain A, Structure Of N-Terminal Kinase Domain Of Rsk2 With Afzelin Length = 305 | Back alignment and structure |
|
| >pdb|1YWR|A Chain A, Crystal Structure Analysis Of Inactive P38 Kinase Domain In Complex With A Monocyclic Pyrazolone Inhibitor Length = 360 | Back alignment and structure |
|
| >pdb|3QRI|A Chain A, The Crystal Structure Of Human Abl1 Kinase Domain In Complex With Dcc- 2036 Length = 277 | Back alignment and structure |
|
| >pdb|1YW2|A Chain A, Mutated Mus Musculus P38 Kinase (Mp38) Length = 360 | Back alignment and structure |
|
| >pdb|3PYY|A Chain A, Discovery And Characterization Of A Cell-Permeable, Small-Molecule C- Abl Kinase Activator That Binds To The Myristoyl Binding Site Length = 298 | Back alignment and structure |
|
| >pdb|2HYY|A Chain A, Human Abl Kinase Domain In Complex With Imatinib (Sti571, Glivec) Length = 273 | Back alignment and structure |
|
| >pdb|2QOH|A Chain A, Crystal Structure Of Abl Kinase Bound With Ppy-a Length = 288 | Back alignment and structure |
|
| >pdb|1FPU|A Chain A, Crystal Structure Of Abl Kinase Domain In Complex With A Small Molecule Inhibitor Length = 293 | Back alignment and structure |
|
| >pdb|2HZ0|A Chain A, Abl Kinase Domain In Complex With Nvp-Aeg082 Length = 270 | Back alignment and structure |
|
| >pdb|3ODZ|X Chain X, Crystal Structure Of P38alpha Y323r Active Mutant Length = 360 | Back alignment and structure |
|
| >pdb|3ODY|X Chain X, Crystal Structure Of P38alpha Y323q Active Mutant Length = 360 | Back alignment and structure |
|
| >pdb|2GHL|A Chain A, Mutant Mus Musculus P38 Kinase Domain In Complex With Inhibitor Pg-874743 Length = 348 | Back alignment and structure |
|
| >pdb|3OD6|X Chain X, Crystal Structure Of P38alpha Y323t Active Mutant Length = 360 | Back alignment and structure |
|
| >pdb|2BAQ|A Chain A, P38alpha Bound To Ro3201195 Length = 365 | Back alignment and structure |
|
| >pdb|3K3J|A Chain A, P38alpha Bound To Novel Dfg-Out Compound Pf-00416121 Length = 362 | Back alignment and structure |
|
| >pdb|1ZZL|A Chain A, Crystal Structure Of P38 With Triazolopyridine Length = 351 | Back alignment and structure |
|
| >pdb|3NNU|A Chain A, Crystal Structure Of P38 Alpha In Complex With Dp1376 Length = 354 | Back alignment and structure |
|
| >pdb|1OZ1|A Chain A, P38 Mitogen-Activated Kinase In Complex With 4-Azaindole Inhibitor Length = 372 | Back alignment and structure |
|
| >pdb|2GFS|A Chain A, P38 Kinase Crystal Structure In Complex With Ro3201195 Length = 372 | Back alignment and structure |
|
| >pdb|3OXZ|A Chain A, Crystal Structure Of Abl Kinase Domain Bound With A Dfg-Out Inhibitor Ap24534 Length = 284 | Back alignment and structure |
|
| >pdb|2BAJ|A Chain A, P38alpha Bound To Pyrazolourea Length = 365 | Back alignment and structure |
|
| >pdb|3OEF|X Chain X, Crystal Structure Of Y323f Inactive Mutant Of P38alpha Map Kinase Length = 360 | Back alignment and structure |
|
| >pdb|3HRB|A Chain A, P38 Kinase Crystal Structure In Complex With Small Molecule Inhibitor Length = 359 | Back alignment and structure |
|
| >pdb|3MPT|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Pyrrole-2- Carboxamide Inhibitor Length = 371 | Back alignment and structure |
|
| >pdb|3HVC|A Chain A, Crystal Structure Of Human P38alpha Map Kinase Length = 362 | Back alignment and structure |
|
| >pdb|1M7Q|A Chain A, Crystal Structure Of P38 Map Kinase In Complex With A Dihydroquinazolinone Inhibitor Length = 366 | Back alignment and structure |
|
| >pdb|1DI9|A Chain A, The Structure Of P38 Mitogen-Activated Protein Kinase In Complex With 4-[3-Methylsulfanylanilino]-6,7- Dimethoxyquinazoline Length = 360 | Back alignment and structure |
|
| >pdb|3K3I|A Chain A, P38alpha Bound To Novel Dgf-Out Compound Pf-00215955 Length = 350 | Back alignment and structure |
|
| >pdb|2NPQ|A Chain A, A Novel Lipid Binding Site In The P38 Alpha Map Kinase Length = 367 | Back alignment and structure |
|
| >pdb|2BAL|A Chain A, P38alpha Map Kinase Bound To Pyrazoloamine Length = 365 | Back alignment and structure |
|
| >pdb|1BL6|A Chain A, The Complex Structure Of The Map Kinase P38SB216995 Length = 379 | Back alignment and structure |
|
| >pdb|3GCU|A Chain A, Human P38 Map Kinase In Complex With Rl48 Length = 360 | Back alignment and structure |
|
| >pdb|3DT1|A Chain A, P38 Complexed With A Quinazoline Inhibitor Length = 383 | Back alignment and structure |
|
| >pdb|3ZSG|A Chain A, X-Ray Structure Of P38alpha Bound To Tak-715 Length = 362 | Back alignment and structure |
|
| >pdb|3D83|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Biphenyl Amide Inhibitor Length = 360 | Back alignment and structure |
|
| >pdb|3D7Z|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Biphenyl Amide Inhibitor Length = 360 | Back alignment and structure |
|
| >pdb|2ZV7|A Chain A, Lyn Tyrosine Kinase Domain, Apo Form Length = 279 | Back alignment and structure |
|
| >pdb|3E92|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Biaryl Amide Inhibitor Length = 371 | Back alignment and structure |
|
| >pdb|2LGC|A Chain A, Joint Nmr And X-Ray Refinement Reveals The Structure Of A Novel Dibenzo[a,D]cycloheptenone InhibitorP38 MAP KINASE COMPLEX IN Solution Length = 359 | Back alignment and structure |
|
| >pdb|3OHT|A Chain A, Crystal Structure Of Salmo Salar P38alpha Length = 389 | Back alignment and structure |
|
| >pdb|3KQ7|A Chain A, Structure Of Human P38alpha With N-[4-Methyl-3-(6-{[2-(1- Methylpyrrolidin-2-Yl)ethyl]amino}pyridine-3- Amido)phenyl]- 2-(Morpholin-4-Yl)pyridine-4-Carboxamide Length = 380 | Back alignment and structure |
|
| >pdb|3S3I|A Chain A, P38 Kinase Crystal Structure In Complex With Small Molecule Inhibitor Length = 349 | Back alignment and structure |
|
| >pdb|3FI4|A Chain A, P38 Kinase Crystal Structure In Complex With Ro4499 Length = 372 | Back alignment and structure |
|
| >pdb|3HEC|A Chain A, P38 In Complex With Imatinib Length = 348 | Back alignment and structure |
|
| >pdb|3Q4Z|A Chain A, Structure Of Unphosphorylated Pak1 Kinase Domain Length = 306 | Back alignment and structure |
|
| >pdb|1IAN|A Chain A, Human P38 Map Kinase Inhibitor Complex Length = 366 | Back alignment and structure |
|
| >pdb|3GCP|A Chain A, Human P38 Map Kinase In Complex With Sb203580 Length = 360 | Back alignment and structure |
|
| >pdb|1OVE|A Chain A, The Structure Of P38 Alpha In Complex With A Dihydroquinolinone Length = 366 | Back alignment and structure |
|
| >pdb|1K3A|A Chain A, Structure Of The Insulin-Like Growth Factor 1 Receptor Kinase Length = 299 | Back alignment and structure |
|
| >pdb|2Y8O|A Chain A, Crystal Structure Of Human P38alpha Complexed With A Mapk Docking Peptide Length = 362 | Back alignment and structure |
|
| >pdb|2W5A|A Chain A, Human Nek2 Kinase Adp-Bound Length = 279 | Back alignment and structure |
|
| >pdb|4F0F|A Chain A, Crystal Structure Of The Roco4 Kinase Domain Bound To Appcp From D. Discoideum Length = 287 | Back alignment and structure |
|
| >pdb|2VRX|A Chain A, Structure Of Aurora B Kinase In Complex With Zm447439 Length = 285 | Back alignment and structure |
|
| >pdb|4E5A|X Chain X, The W197a Mutant Of P38a Map Kinase Length = 360 | Back alignment and structure |
|
| >pdb|4A4X|A Chain A, Nek2-Ede Bound To Cct248662 Length = 279 | Back alignment and structure |
|
| >pdb|3CLY|A Chain A, Crystal Structure Of Fgf Receptor 2 (Fgfr2) Kinase Domains Trapped In Trans-Phosphorylation Reaction Length = 334 | Back alignment and structure |
|
| >pdb|2PSQ|A Chain A, Crystal Structure Of Unphosphorylated Unactivated Wild Type Fgf Receptor 2 (Fgfr2) Kinase Domain Length = 370 | Back alignment and structure |
|
| >pdb|2YDJ|A Chain A, Discovery Of Checkpoint Kinase Inhibitor Azd7762 By Structure Based Design And Optimization Of Thiophene Carboxamide Ureas Length = 276 | Back alignment and structure |
|
| >pdb|2IVT|A Chain A, Crystal Structure Of Phosphorylated Ret Tyrosine Kinase Domain Length = 314 | Back alignment and structure |
|
| >pdb|4FSZ|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|2BFY|A Chain A, Complex Of Aurora-B With Incenp And Hesperidin. Length = 284 | Back alignment and structure |
|
| >pdb|2PZP|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic K526e Mutation Responsible For Crouzon Syndrome Length = 324 | Back alignment and structure |
|
| >pdb|2PZR|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic K641r Mutation Responsible For Pfeiffer Syndrome Length = 324 | Back alignment and structure |
|
| >pdb|1IRK|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Human Insulin Receptor Length = 306 | Back alignment and structure |
|
| >pdb|3B2T|A Chain A, Structure Of Phosphotransferase Length = 311 | Back alignment and structure |
|
| >pdb|3MH2|A Chain A, Mutagenesis Of P38 Map Kinase Establishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360 | Back alignment and structure |
|
| >pdb|2IVV|A Chain A, Crystal Structure Of Phosphorylated Ret Tyrosine Kinase Domain Complexed With The Inhibitor Pp1 Length = 314 | Back alignment and structure |
|
| >pdb|1OPL|A Chain A, Structural Basis For The Auto-Inhibition Of C-Abl Tyrosine Kinase Length = 537 | Back alignment and structure |
|
| >pdb|1GJO|A Chain A, The Fgfr2 Tyrosine Kinase Domain Length = 316 | Back alignment and structure |
|
| >pdb|3RI1|A Chain A, Crystal Structure Of The Catalytic Domain Of Fgfr2 Kinase In Complex With Arq 069 Length = 313 | Back alignment and structure |
|
| >pdb|4FSY|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|3ETA|A Chain A, Kinase Domain Of Insulin Receptor Complexed With A Pyrrolo Pyridine Inhibitor Length = 317 | Back alignment and structure |
|
| >pdb|3D94|A Chain A, Crystal Structure Of The Insulin-Like Growth Factor-1 Receptor Kinase In Complex With Pqip Length = 301 | Back alignment and structure |
|
| >pdb|1IR3|A Chain A, Phosphorylated Insulin Receptor Tyrosine Kinase In Complex With Peptide Substrate And Atp Analog Length = 306 | Back alignment and structure |
|
| >pdb|4FSW|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|4EXU|A Chain A, Mapk13, Inactive Form Length = 371 | Back alignment and structure |
|
| >pdb|1RQQ|A Chain A, Crystal Structure Of The Insulin Receptor Kinase In Complex With The Sh2 Domain Of Aps Length = 306 | Back alignment and structure |
|
| >pdb|2PZ5|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic N549t Mutation Responsible For Pfeiffer Syndrome Length = 324 | Back alignment and structure |
|
| >pdb|2IVS|A Chain A, Crystal Structure Of Non-Phosphorylated Ret Tyrosine Kinase Domain Length = 314 | Back alignment and structure |
|
| >pdb|4FT3|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|2P0C|A Chain A, Catalytic Domain Of The Proto-Oncogene Tyrosine-Protein Kina Length = 313 | Back alignment and structure |
|
| >pdb|2PVY|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic K659n Mutation Responsible For An Unclassified Craniosynostosis Syndrome. Length = 324 | Back alignment and structure |
|
| >pdb|2Z8C|A Chain A, Phosphorylated Insulin Receptor Tyrosine Kinase In Complex With (4-{[5-Carbamoyl-4-(3-Methylanilino)pyrimidin-2- Yl]amino}phenyl)acetic Acid Length = 303 | Back alignment and structure |
|
| >pdb|2BR1|A Chain A, Structure-Based Design Of Novel Chk1 Inhibitors: Insights Into Hydrogen Bonding And Protein-Ligand Affinity Length = 297 | Back alignment and structure |
|
| >pdb|1IA8|A Chain A, The 1.7 A Crystal Structure Of Human Cell Cycle Checkpoint Kinase Chk1 Length = 289 | Back alignment and structure |
|
| >pdb|4FST|A Chain A, Crystal Structure Of The Chk1 Length = 269 | Back alignment and structure |
|
| >pdb|2PWL|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic N549h Mutation Responsible For Crouzon Syndrome. Length = 324 | Back alignment and structure |
|
| >pdb|1ZLT|A Chain A, Crystal Structure Of Chk1 Complexed With A Hymenaldisine Analog Length = 295 | Back alignment and structure |
|
| >pdb|4FSU|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|1UNG|A Chain A, Structural Mechanism For The Inhibition Of Cdk5-P25 By Roscovitine, Aloisine And Indirubin. Length = 292 | Back alignment and structure |
|
| >pdb|4E7W|A Chain A, Structure Of Gsk3 From Ustilago Maydis Length = 394 | Back alignment and structure |
|
| >pdb|1AD5|A Chain A, Src Family Kinase Hck-Amp-Pnp Complex Length = 438 | Back alignment and structure |
|
| >pdb|2HOG|A Chain A, Crystal Structure Of Chek1 In Complex With Inhibitor 20 Length = 322 | Back alignment and structure |
|
| >pdb|3NNX|A Chain A, Crystal Structure Of Phosphorylated P38 Alpha In Complex With Dp802 Length = 354 | Back alignment and structure |
|
| >pdb|3OT3|A Chain A, X-Ray Crystal Structure Of Compound 22k Bound To Human Chk1 Kinase Domain Length = 273 | Back alignment and structure |
|
| >pdb|3JVR|A Chain A, Characterization Of The Chk1 Allosteric Inhibitor Binding Site Length = 271 | Back alignment and structure |
|
| >pdb|2Z7Q|A Chain A, Crystal Structure Of The N-Terminal Kinase Domain Of Human Rsk-1 Bound To Amp-Pcp Length = 321 | Back alignment and structure |
|
| >pdb|2AYP|A Chain A, Crystal Structure Of Chk1 With An Indol Inhibitor Length = 269 | Back alignment and structure |
|
| >pdb|4FSM|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|3DAK|A Chain A, Crystal Structure Of Domain-Swapped Osr1 Kinase Domain Length = 290 | Back alignment and structure |
|
| >pdb|2E9V|A Chain A, Structure Of H-Chk1 Complexed With A859017 Length = 268 | Back alignment and structure |
|
| >pdb|2GHG|A Chain A, H-Chk1 Complexed With A431994 Length = 269 | Back alignment and structure |
|
| >pdb|2VWI|A Chain A, Structure Of The Osr1 Kinase, A Hypertension Drug Target Length = 303 | Back alignment and structure |
|
| >pdb|4FSN|A Chain A, Crystal Structure Of The Chk1 Length = 278 | Back alignment and structure |
|
| >pdb|2X8E|A Chain A, Discovery Of A Novel Class Of Triazolones As Checkpoint Kinase Inhibitors - Hit To Lead Exploration Length = 276 | Back alignment and structure |
|
| >pdb|2FSL|X Chain X, Mitogen Activated Protein Kinase P38alpha (D176a+f327s) Activating Mutant Form-A Length = 367 | Back alignment and structure |
|
| >pdb|4EUT|A Chain A, Structure Of Bx-795 Complexed With Unphosphorylated Human Tbk1 Kinase- Uld Domain Length = 396 | Back alignment and structure |
|
| >pdb|2PVF|A Chain A, Crystal Structure Of Tyrosine Phosphorylated Activated Fgf Receptor 2 (Fgfr2) Kinase Domain In Complex With Atp Analog And Substrate Peptide Length = 334 | Back alignment and structure |
|
| >pdb|2R0U|A Chain A, Crystal Structure Of Chek1 In Complex With Inhibitor 54 Length = 323 | Back alignment and structure |
|
| >pdb|1OPK|A Chain A, Structural Basis For The Auto-Inhibition Of C-Abl Tyrosine Kinase Length = 495 | Back alignment and structure |
|
| >pdb|2FST|X Chain X, Mitogen Activated Protein Kinase P38alpha (d176a+f327l) Activating Mutant Length = 367 | Back alignment and structure |
|
| >pdb|4EWQ|A Chain A, Human P38 Alpha Mapk In Complex With A Pyridazine Based Inhibitor Length = 383 | Back alignment and structure |
|
| >pdb|2FSO|X Chain X, Mitogen Activated Protein Kinase P38alpha (D176a) Activating Mutant Length = 367 | Back alignment and structure |
|
| >pdb|3GI3|A Chain A, Crystal Structure Of A N-Phenyl-N'-Naphthylurea Analog In Complex With P38 Map Kinase Length = 360 | Back alignment and structure |
|
| >pdb|3COI|A Chain A, Crystal Structure Of P38delta Kinase Length = 353 | Back alignment and structure |
|
| >pdb|3CD3|A Chain A, Crystal Structure Of Phosphorylated Human Feline Sarcoma Viral Oncogene Homologue (V-Fes) In Complex With Staurosporine And A Consensus Peptide Length = 377 | Back alignment and structure |
|
| >pdb|3OZ6|A Chain A, Crystal Structure Of Mapk From Cryptosporidium Parvum, Cgd2_1960 Length = 388 | Back alignment and structure |
|
| >pdb|1FOT|A Chain A, Structure Of The Unliganded Camp-Dependent Protein Kinase Catalytic Subunit From Saccharomyces Cerevisiae Length = 318 | Back alignment and structure |
|
| >pdb|2A19|B Chain B, Pkr Kinase Domain- Eif2alpha- Amp-Pnp Complex. Length = 284 | Back alignment and structure |
|
| >pdb|1P14|A Chain A, Crystal Structure Of A Catalytic-Loop Mutant Of The Insulin Receptor Tyrosine Kinase Length = 306 | Back alignment and structure |
|
| >pdb|3PY3|A Chain A, Crystal Structure Of Phosphorylated P38alpha Map Kinase Length = 380 | Back alignment and structure |
|
| >pdb|3EKK|A Chain A, Insulin Receptor Kinase Complexed With An Inhibitor Length = 307 | Back alignment and structure |
|
| >pdb|3BKB|A Chain A, Crystal Structure Of Human Feline Sarcoma Viral Oncogene Homologue (V- Fes) Length = 377 | Back alignment and structure |
|
| >pdb|4F1M|A Chain A, Crystal Structure Of The G1179s Roco4 Kinase Domain Bound To Appcp From D. Discoideum Length = 287 | Back alignment and structure |
|
| >pdb|3O8P|A Chain A, Conformational Plasticity Of P38 Map Kinase Dfg Motif Mutants In Response To Inhibitor Binding Length = 360 | Back alignment and structure |
|
| >pdb|2BIY|A Chain A, Structure Of Pdk1-S241a Mutant Kinase Domain Length = 310 | Back alignment and structure |
|
| >pdb|1LUF|A Chain A, Crystal Structure Of The Musk Tyrosine Kinase: Insights Into Receptor Autoregulation Length = 343 | Back alignment and structure |
|
| >pdb|2XIK|A Chain A, Structure Of Human Ysk1 (Yeast Sps1-Ste20-Related Kinase 1) Length = 294 | Back alignment and structure |
|
| >pdb|3MH0|A Chain A, Mutagenesis Of P38 Map Kinase Eshtablishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360 | Back alignment and structure |
|
| >pdb|3FPQ|A Chain A, Crystal Structure Of The Kinase Domain Of Wnk1 Length = 290 | Back alignment and structure |
|
| >pdb|1BYG|A Chain A, Kinase Domain Of Human C-Terminal Src Kinase (Csk) In Complex With Inhibitor Staurosporine Length = 278 | Back alignment and structure |
|
| >pdb|3MH3|A Chain A, Mutagenesis Of P38 Map Kinase Establishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360 | Back alignment and structure |
|
| >pdb|2Q0B|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic E565a Mutation Responsible For Pfeiffer Syndrome Length = 324 | Back alignment and structure |
|
| >pdb|4E4L|A Chain A, Jak1 Kinase (Jh1 Domain) In Complex With Compound 30 Length = 302 | Back alignment and structure |
|
| >pdb|1I44|A Chain A, Crystallographic Studies Of An Activation Loop Mutant Of The Insulin Receptor Tyrosine Kinase Length = 306 | Back alignment and structure |
|
| >pdb|3D7U|A Chain A, Structural Basis For The Recognition Of C-Src By Its Inactivator Csk Length = 263 | Back alignment and structure |
|
| >pdb|1K9A|A Chain A, Crystal Structure Analysis Of Full-Length Carboxyl-Terminal Src Kinase At 2.5 A Resolution Length = 450 | Back alignment and structure |
|
| >pdb|3EYG|A Chain A, Crystal Structures Of Jak1 And Jak2 Inhibitor Complexes Length = 290 | Back alignment and structure |
|
| >pdb|3MH1|A Chain A, Mutagenesis Of P38 Map Kinase Establishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360 | Back alignment and structure |
|
| >pdb|4EUU|A Chain A, Structure Of Bx-795 Complexed With Human Tbk1 Kinase Domain Phosphorylated On Ser172 Length = 319 | Back alignment and structure |
|
| >pdb|2F57|A Chain A, Crystal Structure Of The Human P21-activated Kinase 5 Length = 317 | Back alignment and structure |
|
| >pdb|2QKR|A Chain A, Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5_2510 With Indirubin 3'-Monoxime Bound Length = 313 | Back alignment and structure |
|
| >pdb|3PWY|A Chain A, Crystal Structure Of An Extender (Spd28345)-Modified Human Pdk1 Complex 2 Length = 311 | Back alignment and structure |
|
| >pdb|3NIZ|A Chain A, Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5_2510 With Adp Bound Length = 311 | Back alignment and structure |
|
| >pdb|1ZYS|A Chain A, Co-Crystal Structure Of Checkpoint Kinase Chk1 With A Pyrrolo-Pyridine Inhibitor Length = 273 | Back alignment and structure |
|
| >pdb|3D7T|A Chain A, Structural Basis For The Recognition Of C-Src By Its Inactivator Csk Length = 269 | Back alignment and structure |
|
| >pdb|2PY3|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic E565g Mutation Responsible For Pfeiffer Syndrome Length = 324 | Back alignment and structure |
|
| >pdb|2R7B|A Chain A, Crystal Structure Of The Phosphoinositide-Dependent Kinase- 1 (Pdk-1)catalytic Domain Bound To A Dibenzonaphthyridine Inhibitor Length = 312 | Back alignment and structure |
|
| >pdb|2Y94|A Chain A, Structure Of An Active Form Of Mammalian Ampk Length = 476 | Back alignment and structure |
|
| >pdb|4FIF|A Chain A, Catalytic Domain Of Human Pak4 With Rpkplvdp Peptide Length = 346 | Back alignment and structure |
|
| >pdb|3ORX|A Chain A, Pdk1 Mutant Bound To Allosteric Disulfide Fragment Inhibitor 1f8 Length = 316 | Back alignment and structure |
|
| >pdb|3NAX|A Chain A, Pdk1 In Complex With Inhibitor Mp7 Length = 311 | Back alignment and structure |
|
| >pdb|2CDZ|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 4 In Complex With Cgp74514a Length = 303 | Back alignment and structure |
|
| >pdb|3GVU|A Chain A, The Crystal Structure Of Human Abl2 In Complex With Gleevec Length = 292 | Back alignment and structure |
|
| >pdb|3UIU|A Chain A, Crystal Structure Of Apo-Pkr Kinase Domain Length = 306 | Back alignment and structure |
|
| >pdb|1H1W|A Chain A, High Resolution Crystal Structure Of The Human Pdk1 Catalytic Domain Length = 289 | Back alignment and structure |
|
| >pdb|3H9O|A Chain A, Phosphoinositide-Dependent Protein Kinase 1 (Pdk-1) In Complex With Compound 9 Length = 311 | Back alignment and structure |
|
| >pdb|2BVA|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 4 Length = 292 | Back alignment and structure |
|
| >pdb|3GP0|A Chain A, Crystal Structure Of Human Mitogen Activated Protein Kinase 11 (p38 Beta) In Complex With Nilotinib Length = 348 | Back alignment and structure |
|
| >pdb|4FIE|A Chain A, Full-Length Human Pak4 Length = 423 | Back alignment and structure |
|
| >pdb|2Q0N|A Chain A, Structure Of Human P21 Activating Kinase 4 (Pak4) In Complex With A Consensus Peptide Length = 301 | Back alignment and structure |
|
| >pdb|2JAM|A Chain A, Crystal Structure Of Human Calmodulin-Dependent Protein Kinase I G Length = 304 | Back alignment and structure |
|
| >pdb|3IOP|A Chain A, Pdk-1 In Complex With The Inhibitor Compound-8i Length = 312 | Back alignment and structure |
|
| >pdb|4FR4|A Chain A, Crystal Structure Of Human SerineTHREONINE-Protein Kinase 32a (Yank1) Length = 384 | Back alignment and structure |
|
| >pdb|3QC4|A Chain A, Pdk1 In Complex With Dfg-Out Inhibitor Xxx Length = 314 | Back alignment and structure |
|
| >pdb|2X4Z|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 4 In Complex With Pf-03758309 Length = 296 | Back alignment and structure |
|
| >pdb|1UU9|A Chain A, Structure Of Human Pdk1 Kinase Domain In Complex With Bim-3 Length = 286 | Back alignment and structure |
|
| >pdb|3NUS|A Chain A, Phosphoinositide-Dependent Kinase-1 (Pdk1) With Fragment8 Length = 286 | Back alignment and structure |
|
| >pdb|3SC1|A Chain A, Novel Isoquinolone Pdk1 Inhibitors Discovered Through Fragment-Based Lead Discovery Length = 311 | Back alignment and structure |
|
| >pdb|1Z5M|A Chain A, Crystal Structure Of N1-[3-[[5-bromo-2-[[3-[(1-pyrrolidinylcarbonyl) Amino]phenyl]amino]-4-pyrimidinyl]amino]propyl]-2,2- Dimethylpropanediamide Complexed With Human Pdk1 Length = 286 | Back alignment and structure |
|
| >pdb|1UU3|A Chain A, Structure Of Human Pdk1 Kinase Domain In Complex With Ly333531 Length = 310 | Back alignment and structure |
|
| >pdb|3RWP|A Chain A, Discovery Of A Novel, Potent And Selective Inhibitor Of 3- Phosphoinositide Dependent Kinase (Pdk1) Length = 311 | Back alignment and structure |
|
| >pdb|2XCH|A Chain A, Crystal Structure Of Pdk1 In Complex With A Pyrazoloquinazoline Inhibitor Length = 309 | Back alignment and structure |
|
| >pdb|3NUN|A Chain A, Phosphoinositide-Dependent Kinase-1 (Pdk1) With Lead Compound Length = 292 | Back alignment and structure |
|
| >pdb|3HRC|A Chain A, Crystal Structure Of A Mutant Of Human Pdk1 Kinase Domain In Complex With Atp Length = 311 | Back alignment and structure |
|
| >pdb|3GC9|A Chain A, The Structure Of P38beta C119s, C162s In Complex With A Dihydroquinazolinone Inhibitor Length = 370 | Back alignment and structure |
|
| >pdb|3NAY|A Chain A, Pdk1 In Complex With Inhibitor Mp6 Length = 311 | Back alignment and structure |
|
| >pdb|3KU2|A Chain A, Crystal Structure Of Inactivated Form Of Cdpk1 From Toxoplasma Gondii, Tgme49.101440 Length = 507 | Back alignment and structure |
|
| >pdb|3HX4|A Chain A, Crystal Structure Of Cdpk1 Of Toxoplasma Gondii, Tgme49_101440, In Presence Of Calcium Length = 508 | Back alignment and structure |
|
| >pdb|4A07|A Chain A, Human Pdk1 Kinase Domain In Complex With Allosteric Activator Ps171 Bound To The Pif-Pocket Length = 311 | Back alignment and structure |
|
| >pdb|3MA6|A Chain A, Crystal Structure Of Kinase Domain Of Tgcdpk1 In Presence Of 3brb-Pp1 Length = 298 | Back alignment and structure |
|
| >pdb|3COM|A Chain A, Crystal Structure Of Mst1 Kinase Length = 314 | Back alignment and structure |
|
| >pdb|3I79|A Chain A, Calcium-Dependent Protein Kinase 1 From Toxoplasma Gondii (Tgcdpk1) Length = 484 | Back alignment and structure |
|
| >pdb|1PME|A Chain A, Structure Of Penta Mutant Human Erk2 Map Kinase Complexed With A Specific Inhibitor Of Human P38 Map Kinase Length = 380 | Back alignment and structure |
|
| >pdb|3GC8|A Chain A, The Structure Of P38beta C162s In Complex With A Dihydroquinazolinone Length = 370 | Back alignment and structure |
|
| >pdb|3GGF|A Chain A, Crystal Structure Of Human SerineTHREONINE-Protein Kinase Mst4 In Complex With An Quinazolin Length = 301 | Back alignment and structure |
|
| >pdb|4AF3|A Chain A, Human Aurora B Kinase In Complex With Incenp And Vx-680 Length = 292 | Back alignment and structure |
|
| >pdb|3H9R|A Chain A, Crystal Structure Of The Kinase Domain Of Type I Activin Receptor (Acvr1) In Complex With Fkbp12 And Dorsomorphin Length = 330 | Back alignment and structure |
|
| >pdb|2XCK|A Chain A, Crystal Structure Of Pdk1 In Complex With A Pyrazoloquinazoline Inhibitor Length = 309 | Back alignment and structure |
|
| >pdb|4DYM|A Chain A, Crystal Structure Of The Acvr1 Kinase Domain In Complex With The Imidazo[1,2-B]pyridazine Inhibitor K00135 Length = 301 | Back alignment and structure |
|
| >pdb|3MTF|A Chain A, Crystal Structure Of The Acvr1 Kinase In Complex With A 2- Aminopyridine Inhibitor Length = 301 | Back alignment and structure |
|
| >pdb|3I7C|A Chain A, Calcium-Dependent Protein Kinase 1 From Toxoplasma Gondii (Tgcdpk1) In Complex With Bumped Kinase Inhibitor Na-Pp2 Length = 484 | Back alignment and structure |
|
| >pdb|2R4B|A Chain A, Erbb4 Kinase Domain Complexed With A Thienopyrimidine Inhibitor Length = 321 | Back alignment and structure |
|
| >pdb|3ZHP|C Chain C, Human Mst3 (stk24) In Complex With Mo25beta Length = 294 | Back alignment and structure |
|
| >pdb|2H6D|A Chain A, Protein Kinase Domain Of The Human 5'-Amp-Activated Protein Kinase Catalytic Subunit Alpha-2 (Ampk Alpha-2 Chain) Length = 276 | Back alignment and structure |
|
| >pdb|4AAA|A Chain A, Crystal Structure Of The Human Cdkl2 Kinase Domain Length = 331 | Back alignment and structure |
|
| >pdb|3IKA|A Chain A, Crystal Structure Of Egfr 696-1022 T790m Mutant Covalently Binding To Wz4002 Length = 331 | Back alignment and structure |
|
| >pdb|4I24|A Chain A, Structure Of T790m Egfr Kinase Domain Co-crystallized With Dacomitinib Length = 329 | Back alignment and structure |
|
| >pdb|4I21|A Chain A, Crystal Structure Of L858r + T790m Egfr Kinase Domain In Complex With Mig6 Peptide Length = 329 | Back alignment and structure |
|
| >pdb|3W2O|A Chain A, Egfr Kinase Domain T790m/l858r Mutant With Tak-285 Length = 331 | Back alignment and structure |
|
| >pdb|4G5P|A Chain A, Crystal Structure Of Egfr Kinase T790m In Complex With Bibw2992 Length = 330 | Back alignment and structure |
|
| >pdb|3CKW|A Chain A, Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3, Stk24) Length = 304 | Back alignment and structure |
|
| >pdb|3A7F|A Chain A, Human Mst3 Kinase Length = 303 | Back alignment and structure |
|
| >pdb|3BBT|B Chain B, Crystal Structure Of The Erbb4 Kinase In Complex With Lapatinib Length = 328 | Back alignment and structure |
|
| >pdb|2JIU|A Chain A, Crystal Structure Of Egfr Kinase Domain T790m Mutation In Complex With Aee788 Length = 328 | Back alignment and structure |
|
| >pdb|1ZY4|A Chain A, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: R794g Hyperactivating Mutant In Apo Form. Length = 303 | Back alignment and structure |
|
| >pdb|3NPC|A Chain A, Crystal Structure Of Jnk2 Complexed With Birb796 Length = 364 | Back alignment and structure |
|
| >pdb|2JIT|A Chain A, Crystal Structure Of Egfr Kinase Domain T790m Mutation Length = 327 | Back alignment and structure |
|
| >pdb|2V55|A Chain A, Mechanism Of Multi-site Phosphorylation From A Rock-i:rhoe Complex Structure Length = 406 | Back alignment and structure |
|
| >pdb|3V8S|A Chain A, Human Rho-Associated Protein Kinase 1 (Rock 1) In Complex With Indazole Derivative (Compound 18) Length = 410 | Back alignment and structure |
|
| >pdb|3CKX|A Chain A, Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3, Stk24) In Complex With Staurosporine Length = 304 | Back alignment and structure |
|
| >pdb|2ESM|A Chain A, Crystal Structure Of Rock 1 Bound To Fasudil Length = 415 | Back alignment and structure |
|
| >pdb|3E7O|A Chain A, Crystal Structure Of Jnk2 Length = 360 | Back alignment and structure |
|
| >pdb|2JIV|A Chain A, Crystal Structure Of Egfr Kinase Domain T790m Mutation In Compex With Hki-272 Length = 328 | Back alignment and structure |
|
| >pdb|4BC6|A Chain A, Crystal Structure Of Human Serine Threonine Kinase-10 Bound To Novel Bosutinib Isoform 1, Previously Thought To Be Bosutinib Length = 293 | Back alignment and structure |
|
| >pdb|2EB3|A Chain A, Crystal Structure Of Mutated Egfr Kinase Domain (L858r) In Complex With Amppnp Length = 334 | Back alignment and structure |
|
| >pdb|4I1Z|A Chain A, Crystal Structure Of The Monomeric (v948r) Form Of The Gefitinib/erlotinib Resistant Egfr Kinase Domain L858r+t790m Length = 329 | Back alignment and structure |
|
| >pdb|1U5Q|A Chain A, Crystal Structure Of The Tao2 Kinase Domain: Activation And Specifity Of A Ste20p Map3k Length = 348 | Back alignment and structure |
|
| >pdb|2J7T|A Chain A, Crystal Structure Of Human Serine Threonine Kinase-10 Bound To Su11274 Length = 302 | Back alignment and structure |
|
| >pdb|2GCD|A Chain A, Tao2 Kinase Domain-Staurosporine Structure Length = 309 | Back alignment and structure |
|
| >pdb|1M14|A Chain A, Tyrosine Kinase Domain From Epidermal Growth Factor Receptor Length = 333 | Back alignment and structure |
|
| >pdb|3VJO|A Chain A, Crystal Structure Of The Wild-Type Egfr Kinase Domain In Complex With Amppnp Length = 334 | Back alignment and structure |
|
| >pdb|4I23|A Chain A, Crystal Structure Of The Wild-type Egfr Kinase Domain In Complex With Dacomitinib (soaked) Length = 329 | Back alignment and structure |
|
| >pdb|2GS2|A Chain A, Crystal Structure Of The Active Egfr Kinase Domain Length = 330 | Back alignment and structure |
|
| >pdb|3BEL|A Chain A, X-Ray Structure Of Egfr In Complex With Oxime Inhibitor Length = 315 | Back alignment and structure |
|
| >pdb|2ITT|A Chain A, Crystal Structure Of Egfr Kinase Domain L858r Mutation In Complex With Aee788 Length = 327 | Back alignment and structure |
|
| >pdb|1XKK|A Chain A, Egfr Kinase Domain Complexed With A Quinazoline Inhibitor- Gw572016 Length = 352 | Back alignment and structure |
|
| >pdb|2JFM|A Chain A, Crystal Structure Of Human Ste20-Like Kinase (Unliganded Form) Length = 325 | Back alignment and structure |
|
| >pdb|4G5J|A Chain A, Crystal Structure Of Egfr Kinase In Complex With Bibw2992 Length = 330 | Back alignment and structure |
|
| >pdb|2J5F|A Chain A, Crystal Structure Of Egfr Kinase Domain In Complex With An Irreversible Inhibitor 34-Jab Length = 327 | Back alignment and structure |
|
| >pdb|3A60|A Chain A, Crystal Structure Of Unphosphorylated P70s6k1 (Form I) Length = 327 | Back alignment and structure |
|
| >pdb|2RFD|A Chain A, Crystal Structure Of The Complex Between The Egfr Kinase Domain And A Mig6 Peptide Length = 324 | Back alignment and structure |
|
| >pdb|2J51|A Chain A, Crystal Structure Of Human Ste20-Like Kinase Bound To 5- Amino-3-((4-(Aminosulfonyl)phenyl)amino)-N-(2,6- Difluorophenyl)-1h-1,2,4-Triazole-1-Carbothioamide Length = 325 | Back alignment and structure |
|
| >pdb|3Q5I|A Chain A, Crystal Structure Of Pbanka_031420 Length = 504 | Back alignment and structure |
|
| >pdb|3A62|A Chain A, Crystal Structure Of Phosphorylated P70s6k1 Length = 327 | Back alignment and structure |
|
| >pdb|2J5E|A Chain A, Crystal Structure Of Egfr Kinase Domain In Complex With An Irreversible Inhibitor 13-Jab Length = 327 | Back alignment and structure |
|
| >pdb|1FVR|A Chain A, Tie2 Kinase Domain Length = 327 | Back alignment and structure |
|
| >pdb|3FI3|A Chain A, Crystal Structure Of Jnk3 With Indazole Inhibitor, Sr-3737 Length = 364 | Back alignment and structure |
|
| >pdb|2OO8|X Chain X, Synthesis, Structural Analysis, And Sar Studies Of Triazine Derivatives As Potent, Selective Tie-2 Inhibitors Length = 317 | Back alignment and structure |
|
| >pdb|2W9F|B Chain B, Crystal Structure Of Cdk4 In Complex With A D-Type Cyclin Length = 306 | Back alignment and structure |
|
| >pdb|2W99|B Chain B, Crystal Structure Of Cdk4 In Complex With A D-Type Cyclin Length = 306 | Back alignment and structure |
|
| >pdb|2YZA|A Chain A, Crystal Structure Of Kinase Domain Of Human 5'-Amp-Activated Protein Kinase Alpha-2 Subunit Mutant (T172d) Length = 276 | Back alignment and structure |
|
| >pdb|4I20|A Chain A, Crystal Structure Of Monomeric (v948r) Primary Oncogenic Mutant L858r Egfr Kinase Domain Length = 329 | Back alignment and structure |
|
| >pdb|3LZB|A Chain A, Egfr Kinase Domain Complexed With An Imidazo[2,1-B]thiazole Inhibitor Length = 327 | Back alignment and structure |
|
| >pdb|2GS7|A Chain A, Crystal Structure Of The Inactive Egfr Kinase Domain In Complex With Amp-Pnp Length = 330 | Back alignment and structure |
|
| >pdb|4HJO|A Chain A, Crystal Structure Of The Inactive Egfr Tyrosine Kinase Domain With Erlotinib Length = 337 | Back alignment and structure |
|
| >pdb|3G2F|A Chain A, Crystal Structure Of The Kinase Domain Of Bone Morphogenetic Protein Receptor Type Ii (Bmpr2) At 2.35 A Resolution Length = 336 | Back alignment and structure |
|
| >pdb|3FV8|A Chain A, Jnk3 Bound To Piperazine Amide Inhibitor, Sr2774 Length = 355 | Back alignment and structure |
|
| >pdb|3UG1|A Chain A, Crystal Structure Of The Mutated Egfr Kinase Domain (G719sT790M) IN The Apo Form Length = 334 | Back alignment and structure |
|
| >pdb|3COK|A Chain A, Crystal Structure Of Plk4 Kinase Length = 278 | Back alignment and structure |
|
| >pdb|1BI8|A Chain A, Mechanism Of G1 Cyclin Dependent Kinase Inhibition From The Structures Cdk6-P19ink4d Inhibitor Complex Length = 326 | Back alignment and structure |
|
| >pdb|3KVX|A Chain A, Jnk3 Bound To Aminopyrimidine Inhibitor, Sr-3562 Length = 364 | Back alignment and structure |
|
| >pdb|1CM8|A Chain A, Phosphorylated Map Kinase P38-Gamma Length = 367 | Back alignment and structure |
|
| >pdb|2R9S|A Chain A, C-Jun N-Terminal Kinase 3 With 3,5-Disubstituted Quinoline Inhibitor Length = 356 | Back alignment and structure |
|
| >pdb|2R5T|A Chain A, Crystal Structure Of Inactive Serum And Glucocorticoid- Regulated Kinase 1 In Complex With Amp-Pnp Length = 373 | Back alignment and structure |
|
| >pdb|2F2U|A Chain A, Crystal Structure Of The Rho-Kinase Kinase Domain Length = 402 | Back alignment and structure |
|
| >pdb|3PP0|A Chain A, Crystal Structure Of The Kinase Domain Of Human Her2 (Erbb2). Length = 338 | Back alignment and structure |
|
| >pdb|2JFL|A Chain A, Crystal Structure Of Human Ste20-Like Kinase ( Diphosphorylated Form) Bound To 5- Amino-3-((4-( Aminosulfonyl)phenyl)amino)-N-(2,6- Difluorophenyl)-1h-1,2, 4-Triazole-1-Carbothioamide Length = 325 | Back alignment and structure |
|
| >pdb|1JOW|B Chain B, Crystal Structure Of A Complex Of Human Cdk6 And A Viral Cyclin Length = 308 | Back alignment and structure |
|
| >pdb|2W96|B Chain B, Crystal Structure Of Cdk4 In Complex With A D-Type Cyclin Length = 306 | Back alignment and structure |
|
| >pdb|3NUP|A Chain A, Cdk6 (Monomeric) In Complex With Inhibitor Length = 307 | Back alignment and structure |
|
| >pdb|3IS5|A Chain A, Crystal Structure Of Cdpk Kinase Domain From Toxoplasma Gondii, Tgme49_018720 Length = 285 | Back alignment and structure |
|
| >pdb|2B9F|A Chain A, Crystal Structure Of Non-Phosphorylated Fus3 Length = 353 | Back alignment and structure |
|
| >pdb|2JED|A Chain A, The Crystal Structure Of The Kinase Domain Of The Protein Kinase C Theta In Complex With Nvp-Xaa228 At 2.32a Resolution. Length = 352 | Back alignment and structure |
|
| >pdb|3NYN|A Chain A, Crystal Structure Of G Protein-Coupled Receptor Kinase 6 In Complex With Sangivamycin Length = 576 | Back alignment and structure |
|
| >pdb|3BHH|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase Iib Isoform 1 (camk2b) Length = 295 | Back alignment and structure |
|
| >pdb|2ACX|A Chain A, Crystal Structure Of G Protein Coupled Receptor Kinase 6 Bound To Amppnp Length = 576 | Back alignment and structure |
|
| >pdb|3FI2|A Chain A, Crystal Structure Of Jnk3 With Amino-Pyrazole Inhibitor, Sr- 3451 Length = 353 | Back alignment and structure |
|
| >pdb|1ZYC|A Chain A, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: Wild- Type In Apo Form. Length = 303 | Back alignment and structure |
|
| >pdb|1XJD|A Chain A, Crystal Structure Of Pkc-Theta Complexed With Staurosporine At 2a Resolution Length = 345 | Back alignment and structure |
|
| >pdb|3G33|A Chain A, Crystal Structure Of Cdk4CYCLIN D3 Length = 308 | Back alignment and structure |
|
| >pdb|4AGU|A Chain A, Crystal Structure Of The Human Cdkl1 Kinase Domain Length = 311 | Back alignment and structure |
|
| >pdb|3VUL|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M1 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|3TTJ|A Chain A, Crystal Structure Of Jnk3 Complexed With Cc-359, A Jnk Inhibitor For The Prevention Of Ischemia-Reperfusion Injury Length = 464 | Back alignment and structure |
|
| >pdb|3VUM|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M7 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|3K54|A Chain A, Structures Of Human Bruton's Tyrosine Kinase In Active And Inactive Conformations Suggests A Mechanism Of Activation For Tec Family Kinases Length = 283 | Back alignment and structure |
|
| >pdb|2B1P|A Chain A, Inhibitor Complex Of Jnk3 Length = 355 | Back alignment and structure |
|
| >pdb|4H36|A Chain A, Crystal Structure Of Jnk3 In Complex With Atf2 Peptide Length = 356 | Back alignment and structure |
|
| >pdb|2EXC|X Chain X, Inhibitor Complex Of Jnk3 Length = 356 | Back alignment and structure |
|
| >pdb|2OK1|A Chain A, Crystal Structure Of Jnk3 Bound To N-Benzyl-4-(4-(3- Chlorophenyl)-1h-Pyrazol-3-Yl)-1h-Pyrrole-2-Carboxamide Length = 365 | Back alignment and structure |
|
| >pdb|3OXI|A Chain A, Design And Synthesis Of Disubstituted Thiophene And Thiazole Based Inhibitors Of Jnk For The Treatment Of Neurodegenerative Diseases Length = 362 | Back alignment and structure |
|
| >pdb|3PTG|A Chain A, Design And Synthesis Of A Novel, Orally Efficacious Tri-Substituted Thiophene Based Jnk Inhibitor Length = 363 | Back alignment and structure |
|
| >pdb|2O0U|A Chain A, Crystal Structure Of Human Jnk3 Complexed With N-{3-Cyano-6-[3-(1- Piperidinyl)propanoyl]-4,5,6,7-Tetrahydrothieno[2, 3-C]pyridin-2-Yl}- 1-Naphthalenecarboxamide Length = 364 | Back alignment and structure |
|
| >pdb|3KMW|A Chain A, Crystal Structure Of The IlkALPHA-Parvin Core Complex (Mgatp) Length = 271 | Back alignment and structure |
|
| >pdb|1PMN|A Chain A, Crystal Structure Of Jnk3 In Complex With An Imidazole- Pyrimidine Inhibitor Length = 364 | Back alignment and structure |
|
| >pdb|2B9H|A Chain A, Crystal Structure Of Fus3 With A Docking Motif From Ste7 Length = 353 | Back alignment and structure |
|
| >pdb|2C30|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 6 Length = 321 | Back alignment and structure |
|
| >pdb|2WQB|A Chain A, Structure Of The Tie2 Kinase Domain In Complex With A Thiazolopyrimidine Inhibitor Length = 324 | Back alignment and structure |
|
| >pdb|4GT4|A Chain A, Structure Of Unliganded, Inactive Ror2 Kinase Domain Length = 308 | Back alignment and structure |
|
| >pdb|1JNK|A Chain A, The C-Jun N-Terminal Kinase (Jnk3s) Complexed With Mgamp-Pnp Length = 423 | Back alignment and structure |
|
| >pdb|3VUG|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M2 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|2EB2|A Chain A, Crystal Structure Of Mutated Egfr Kinase Domain (G719s) Length = 334 | Back alignment and structure |
|
| >pdb|3GOP|A Chain A, Crystal Structure Of The Egf Receptor Juxtamembrane And Kinase Domains Length = 361 | Back alignment and structure |
|
| >pdb|2JC6|A Chain A, Crystal Structure Of Human Calmodulin-Dependent Protein Kinase 1d Length = 334 | Back alignment and structure |
|
| >pdb|1RW8|A Chain A, Crystal Structure Of Tgf-Beta Receptor I Kinase With Atp Site Inhibitor Length = 301 | Back alignment and structure |
|
| >pdb|1VJY|A Chain A, Crystal Structure Of A Naphthyridine Inhibitor Of Human Tgf- Beta Type I Receptor Length = 303 | Back alignment and structure |
|
| >pdb|3GEN|A Chain A, The 1.6 A Crystal Structure Of Human Bruton's Tyrosine Kinase Bound To A Pyrrolopyrimidine-Containing Compound Length = 283 | Back alignment and structure |
|
| >pdb|3OCS|A Chain A, Crystal Structure Of Bruton's Tyrosine Kinase In Complex With Inhibitor Cgi1746 Length = 271 | Back alignment and structure |
|
| >pdb|1K2P|A Chain A, Crystal Structure Of Bruton's Tyrosine Kinase Domain Length = 263 | Back alignment and structure |
|
| >pdb|3ZZW|A Chain A, Crystal Structure Of The Kinase Domain Of Ror2 Length = 289 | Back alignment and structure |
|
| >pdb|2WOT|A Chain A, Alk5 In Complex With 4-((5,6-Dimethyl-2-(2-Pyridyl)-3- Pyridyl)oxy)-N-(3,4,5-Trimethoxyphenyl)pyridin-2-Amine Length = 306 | Back alignment and structure |
|
| >pdb|3P08|A Chain A, Crystal Structure Of The Human Btk Kinase Domain Length = 267 | Back alignment and structure |
|
| >pdb|3PIX|A Chain A, Crystal Structure Of Btk Kinase Domain Complexed With 2-Isopropyl-7- (4-Methyl-Piperazin-1-Yl)-4-(5-Methyl-2h-Pyrazol-3- Ylamino)-2h- Phthalazin-1-One Length = 274 | Back alignment and structure |
|
| >pdb|2ITN|A Chain A, Crystal Structure Of Egfr Kinase Domain G719s Mutation In Complex With Amp-Pnp Length = 327 | Back alignment and structure |
|
| >pdb|1B6C|B Chain B, Crystal Structure Of The Cytoplasmic Domain Of The Type I Tgf-Beta Receptor In Complex With Fkbp12 Length = 342 | Back alignment and structure |
|
| >pdb|3UTO|A Chain A, Twitchin Kinase Region From C.Elegans (Fn31-Nl-Kin-Crd-Ig26) Length = 573 | Back alignment and structure |
|
| >pdb|3VUI|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M2 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|4FNW|A Chain A, Crystal Structure Of The Apo F1174l Anaplastic Lymphoma Kinase Catalytic Domain Length = 327 | Back alignment and structure |
|
| >pdb|3VUH|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M3 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|3TZM|A Chain A, Tgf-Beta Receptor Type 1 In Complex With Sb431542 Length = 309 | Back alignment and structure |
|
| >pdb|1KOA|A Chain A, Twitchin Kinase Fragment (C.Elegans), Autoregulated Protein Kinase And Immunoglobulin Domains Length = 491 | Back alignment and structure |
|
| >pdb|2YJR|A Chain A, Structure Of F1174l Mutant Anaplastic Lymphoma Kinase Length = 342 | Back alignment and structure |
|
| >pdb|1PY5|A Chain A, Crystal Structure Of Tgf-Beta Receptor I Kinase With Inhibitor Length = 326 | Back alignment and structure |
|
| >pdb|3OCT|A Chain A, Crystal Structure Of Bruton's Tyrosine Kinase Mutant V555r In Complex With Dasatinib Length = 265 | Back alignment and structure |
|
| >pdb|4G31|A Chain A, Crystal Structure Of Gsk6414 Bound To Perk (R587-R1092, Delete A660- T867) At 2.28 A Resolution Length = 299 | Back alignment and structure |
|
| >pdb|2BUJ|A Chain A, Crystal Structure Of The Human Serine-Threonine Kinase 16 In Complex With Staurosporine Length = 317 | Back alignment and structure |
|
| >pdb|2GPH|A Chain A, Docking Motif Interactions In The Map Kinase Erk2 Length = 364 | Back alignment and structure |
|
| >pdb|2I6L|A Chain A, Crystal Structure Of Human Mitogen Activated Protein Kinase 6 (Mapk6) Length = 320 | Back alignment and structure |
|
| >pdb|2XRW|A Chain A, Linear Binding Motifs For Jnk And For Calcineurin Antagonistically Control The Nuclear Shuttling Of Nfat4 Length = 371 | Back alignment and structure |
|
| >pdb|3VUK|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M5 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|3VUD|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M1 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|3ZU7|A Chain A, Crystal Structure Of A Designed Selected Ankyrin Repeat Protein In Complex With The Map Kinase Erk2 Length = 365 | Back alignment and structure |
|
| >pdb|2Z7L|A Chain A, Unphosphorylated Mitogen Activated Protein Kinase Erk2 In Complex With (4-{[5-Carbamoyl-4-(3-Methylanilino)pyrimidin 2-Yl]amino}phenyl)acetic Acid Length = 366 | Back alignment and structure |
|
| >pdb|3C9W|A Chain A, Crystal Structure Of Erk-2 With Hypothemycin Covalently Bound Length = 357 | Back alignment and structure |
|
| >pdb|2FYS|B Chain B, Crystal Structure Of Erk2 Complex With Kim Peptide Derived From Mkp3 Length = 364 | Back alignment and structure |
|
| >pdb|1UKH|A Chain A, Structural Basis For The Selective Inhibition Of Jnk1 By The Scaffolding Protein Jip1 And Sp600125 Length = 369 | Back alignment and structure |
|
| >pdb|4BCF|A Chain A, Structure Of Cdk9 In Complex With Cyclin T And A 2-amino-4- Heteroaryl-pyrimidine Inhibitor Length = 331 | Back alignment and structure |
|
| >pdb|3O71|A Chain A, Crystal Structure Of Erk2DCC PEPTIDE COMPLEX Length = 358 | Back alignment and structure |
|
| >pdb|4FV6|A Chain A, Crystal Structure Of The Erk2 Complexed With E57 Length = 360 | Back alignment and structure |
|
| >pdb|3R63|A Chain A, Structure Of Erk2 (Spe) Mutant (S246e) Length = 358 | Back alignment and structure |
|
| >pdb|3GBZ|A Chain A, Structure Of The Cmgc Cdk Kinase From Giardia Lamblia Length = 329 | Back alignment and structure |
|
| >pdb|2F9G|A Chain A, Crystal Structure Of Fus3 Phosphorylated On Tyr182 Length = 353 | Back alignment and structure |
|
| >pdb|4FV7|A Chain A, Crystal Structure Of The Erk2 Complexed With E94 Length = 360 | Back alignment and structure |
|
| >pdb|4FUX|A Chain A, Crystal Structure Of The Erk2 Complexed With E75 Length = 360 | Back alignment and structure |
|
| >pdb|3QYW|A Chain A, Crystal Structure Of Erk2 In Complex With An Inhibitor Length = 364 | Back alignment and structure |
|
| >pdb|2Y9Q|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Mapk Docking Peptide Length = 362 | Back alignment and structure |
|
| >pdb|2XS0|A Chain A, Linear Binding Motifs For Jnk And For Calcineurin Antagonistically Control The Nuclear Shuttling Of Nfat4 Length = 386 | Back alignment and structure |
|
| >pdb|2OJG|A Chain A, Crystal Structure Of Erk2 In Complex With N,n-dimethyl-4-(4- Phenyl-1h-pyrazol-3-yl)-1h-pyrrole-2-carboxamide Length = 380 | Back alignment and structure |
|
| >pdb|3ELJ|A Chain A, Jnk1 Complexed With A Bis-Anilino-Pyrrolopyrimidine Inhibitor Length = 369 | Back alignment and structure |
|
| >pdb|1WZY|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Pyrazolopyridazine Derivative Length = 368 | Back alignment and structure |
|
| >pdb|1TVO|A Chain A, The Structure Of Erk2 In Complex With A Small Molecule Inhibitor Length = 368 | Back alignment and structure |
|
| >pdb|3PZE|A Chain A, Jnk1 In Complex With Inhibitor Length = 358 | Back alignment and structure |
|
| >pdb|3LIJ|A Chain A, Crystal Structure Of Full Length Cpcdpk3 (Cgd5_820) In Complex With Ca2+ And Amppnp Length = 494 | Back alignment and structure |
|
| >pdb|2XUU|A Chain A, Crystal Structure Of A Dap-Kinase 1 Mutant Length = 334 | Back alignment and structure |
|
| >pdb|2Y0A|A Chain A, Structure Of Dapk1 Construct Residues 1-304 Length = 326 | Back alignment and structure |
|
| >pdb|3TEI|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Mapk Docking Peptide Length = 362 | Back alignment and structure |
|
| >pdb|4GSB|A Chain A, Monoclinic Crystal Form Of The Apo-Erk2 Length = 364 | Back alignment and structure |
|
| >pdb|3SA0|A Chain A, Complex Of Erk2 With Norathyriol Length = 360 | Back alignment and structure |
|
| >pdb|1U59|A Chain A, Crystal Structure Of The Zap-70 Kinase Domain In Complex With Staurosporine Length = 287 | Back alignment and structure |
|
| >pdb|2W4J|A Chain A, X-Ray Structure Of A Dap-Kinase 2-277 Length = 277 | Back alignment and structure |
|
| >pdb|2YJS|A Chain A, Structure Of C1156y Mutant Anaplastic Lymphoma Kinase Length = 342 | Back alignment and structure |
|
| >pdb|1WVW|A Chain A, Crystal Structures Of Kinase Domain Of Dap Kinase In Complex With Small Molecular Inhibitors Length = 278 | Back alignment and structure |
|
| >pdb|2YAK|A Chain A, Structure Of Death-Associated Protein Kinase 1 (Dapk1) In Complex With A Ruthenium Octasporine Ligand (Osv) Length = 285 | Back alignment and structure |
|
| >pdb|2W4K|A Chain A, X-Ray Structure Of A Dap-Kinase 2-302 Length = 302 | Back alignment and structure |
|
| >pdb|1P4F|A Chain A, Death Associated Protein Kinase Catalytic Domain With Bound Inhibitor Fragment Length = 293 | Back alignment and structure |
|
| >pdb|3BLH|A Chain A, Crystal Structure Of Human Cdk9CYCLINT1 Length = 331 | Back alignment and structure |
|
| >pdb|2XP2|A Chain A, Structure Of The Human Anaplastic Lymphoma Kinase In Complex With Crizotinib (Pf-02341066) Length = 327 | Back alignment and structure |
|
| >pdb|4FNZ|A Chain A, Crystal Structure Of Human Anaplastic Lymphoma Kinase In Complex With Piperidine-Carboxamide Inhibitor 2 Length = 327 | Back alignment and structure |
|
| >pdb|4EC8|A Chain A, Structure Of Full Length Cdk9 In Complex With Cyclint And Drb Length = 373 | Back alignment and structure |
|
| >pdb|2XZS|A Chain A, Death Associated Protein Kinase 1 Residues 1-312 Length = 312 | Back alignment and structure |
|
| >pdb|1GOL|A Chain A, Coordinates Of Rat Map Kinase Erk2 With An Arginine Mutation At Position 52 Length = 364 | Back alignment and structure |
|
| >pdb|2XB7|A Chain A, Structure Of Human Anaplastic Lymphoma Kinase In Complex With Nvp- Tae684 Length = 315 | Back alignment and structure |
|
| >pdb|3GU4|A Chain A, Crystal Structure Of Dapkq23v-Amppnp Length = 295 | Back alignment and structure |
|
| >pdb|2X7F|A Chain A, Crystal Structure Of The Kinase Domain Of Human Traf2- And Nck-Interacting Kinase With Wee1chk1 Inhibitor Length = 326 | Back alignment and structure |
|
| >pdb|3MI9|A Chain A, Crystal Structure Of Hiv-1 Tat Complexed With Human P-Tefb Length = 351 | Back alignment and structure |
|
| >pdb|1IG1|A Chain A, 1.8a X-Ray Structure Of Ternary Complex Of A Catalytic Domain Of Death-Associated Protein Kinase With Atp Analogue And Mn. Length = 294 | Back alignment and structure |
|
| >pdb|4DCE|A Chain A, Crystal Structure Of Human Anaplastic Lymphoma Kinase In Complex With A Piperidine-Carboxamide Inhibitor Length = 333 | Back alignment and structure |
|
| >pdb|3AOX|A Chain A, X-Ray Crystal Structure Of Human Anaplastic Lymphoma Kinase In Complex With Ch5424802 Length = 344 | Back alignment and structure |
|
| >pdb|3F5U|A Chain A, Crystal Structure Of The Death Associated Protein Kinase In Complex With Amppnp And Mg2+ Length = 295 | Back alignment and structure |
|
| >pdb|2VN9|A Chain A, Crystal Structure Of Human Calcium Calmodulin Dependent Protein Kinase Ii Delta Isoform 1, Camkd Length = 301 | Back alignment and structure |
|
| >pdb|3DFC|B Chain B, Crystal Structure Of A Glycine-Rich Loop Mutant Of The Death Associated Protein Kinase Catalytic Domain With Amppnp Length = 295 | Back alignment and structure |
|
| >pdb|3LCT|A Chain A, Crystal Structure Of The Anaplastic Lymphoma Kinase Catalytic Domain Length = 344 | Back alignment and structure |
|
| >pdb|2WEL|A Chain A, Crystal Structure Of Su6656-Bound CalciumCALMODULIN- Dependent Protein Kinase Ii Delta In Complex With Calmodulin Length = 327 | Back alignment and structure |
|
| >pdb|3L9P|A Chain A, Crystal Structure Of The Anaplastic Lymphoma Kinase Catalytic Domain Length = 367 | Back alignment and structure |
|
| >pdb|4G3D|A Chain A, Crystal Structure Of Human Nf-kappab Inducing Kinase (nik) Length = 371 | Back alignment and structure |
|
| >pdb|1ZXE|A Chain A, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: D835n Inactivating Mutant In Apo Form Length = 303 | Back alignment and structure |
|
| >pdb|4FOB|A Chain A, Crystal Structure Of Human Anaplastic Lymphoma Kinase In Complex With Acyliminobenzimidazole Inhibitor 1 Length = 353 | Back alignment and structure |
|
| >pdb|4H3Q|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Mapk Docking Peptide Length = 362 | Back alignment and structure |
|
| >pdb|3HYH|A Chain A, Crystal Structure Of The Protein Kinase Domain Of Yeast Amp-Activated Protein Kinase Snf1 Length = 275 | Back alignment and structure |
|
| >pdb|3V3V|A Chain A, Structural And Functional Analysis Of Quercetagetin, A Natural Jnk1 Inhibitor Length = 379 | Back alignment and structure |
|
| >pdb|2X0G|A Chain A, X-ray Structure Of A Dap-kinase Calmodulin Complex Length = 334 | Back alignment and structure |
|
| >pdb|2FH9|A Chain A, Structure And Dimerization Of The Kinase Domain From Yeast Snf1 Length = 274 | Back alignment and structure |
|
| >pdb|3DAE|A Chain A, Crystal Structure Of Phosphorylated Snf1 Kinase Domain Length = 283 | Back alignment and structure |
|
| >pdb|2YHV|A Chain A, Structure Of L1196m Mutant Anaplastic Lymphoma Kinase Length = 342 | Back alignment and structure |
|
| >pdb|3MN3|A Chain A, An Inhibited Conformation For The Protein Kinase Domain Of The Saccharomyces Cerevisiae Ampk Homolog Snf1 Length = 271 | Back alignment and structure |
|
| >pdb|2X4F|A Chain A, The Crystal Structure Of The Human Myosin Light Chain Kinase Loc340156. Length = 373 | Back alignment and structure |
|
| >pdb|2YFX|A Chain A, Structure Of L1196m Mutant Anaplastic Lymphoma Kinase In Complex With Crizotinib Length = 327 | Back alignment and structure |
|
| >pdb|2V7O|A Chain A, Crystal Structure Of Human Calcium-Calmodulin-Dependent Protein Kinase Ii Gamma Length = 336 | Back alignment and structure |
|
| >pdb|2Y7J|A Chain A, Structure Of Human Phosphorylase Kinase, Gamma 2 Length = 365 | Back alignment and structure |
|
| >pdb|2ZOQ|A Chain A, Structural Dissection Of Human Mitogen-Activated Kinase Erk1 Length = 382 | Back alignment and structure |
|
| >pdb|3H4J|B Chain B, Crystal Structure Of Pombe Ampk Kdaid Fragment Length = 336 | Back alignment and structure |
|
| >pdb|3O17|A Chain A, Crystal Structure Of Jnk1-Alpha1 Isoform Length = 370 | Back alignment and structure |
|
| >pdb|4EJN|A Chain A, Crystal Structure Of Autoinhibited Form Of Akt1 In Complex With N-(4- (5-(3-Acetamidophenyl)-2-(2-Aminopyridin-3-Yl)-3h- Imidazo[4,5- B]pyridin-3-Yl)benzyl)-3-Fluorobenzamide Length = 446 | Back alignment and structure |
|
| >pdb|3O96|A Chain A, Crystal Structure Of Human Akt1 With An Allosteric Inhibitor Length = 446 | Back alignment and structure |
|
| >pdb|4E1Z|A Chain A, Structure Of Mouse Tyk-2 Complexed To A 3-Aminoindazole Inhibitor Length = 291 | Back alignment and structure |
|
| >pdb|2OZO|A Chain A, Autoinhibited Intact Human Zap-70 Length = 613 | Back alignment and structure |
|
| >pdb|4E20|A Chain A, Structure Of Mouse Tyk-2 Complexed To A 3-Aminoindazole Inhibitor Length = 290 | Back alignment and structure |
|
| >pdb|1VZO|A Chain A, The Structure Of The N-Terminal Kinase Domain Of Msk1 Reveals A Novel Autoinhibitory Conformation For A Dual Kinase Protein Length = 355 | Back alignment and structure |
|
| >pdb|2WEI|A Chain A, Crystal Structure Of The Kinase Domain Of Cryptosporidium Parvum Calcium Dependent Protein Kinase In Complex With 3- Mb-Pp1 Length = 287 | Back alignment and structure |
|
| >pdb|2PML|X Chain X, Crystal Structure Of Pfpk7 In Complex With An Atp Analogue Length = 348 | Back alignment and structure |
|
| >pdb|3MY0|A Chain A, Crystal Structure Of The Acvrl1 (Alk1) Kinase Domain Bound To Ldn- 193189 Length = 305 | Back alignment and structure |
|
| >pdb|3IGO|A Chain A, Crystal Structure Of Cryptosporidium Parvum Cdpk1, Cgd3_920 Length = 486 | Back alignment and structure |
|
| >pdb|2QLU|A Chain A, Crystal Structure Of Activin Receptor Type Ii Kinase Domain From Human Length = 314 | Back alignment and structure |
|
| >pdb|3DFA|A Chain A, Crystal Structure Of Kinase Domain Of Calcium-dependent Protein Kinase Cgd3_920 From Cryptosporidium Parvum Length = 286 | Back alignment and structure |
|
| >pdb|2DYL|A Chain A, Crystal Structure Of Human Mitogen-Activated Protein Kinase Kinase 7 Activated Mutant (S287d, T291d) Length = 318 | Back alignment and structure |
|
| >pdb|4FNX|A Chain A, Crystal Structure Of The Apo R1275q Anaplastic Lymphoma Kinase Catalytic Domain Length = 327 | Back alignment and structure |
|
| >pdb|3NYX|A Chain A, Non-Phosphorylated Tyk2 Jh1 Domain With Quinoline-Thiadiazole- Thiophene Inhibitor Length = 302 | Back alignment and structure |
|
| >pdb|4DN5|A Chain A, Crystal Structure Of Nf-kb-inducing Kinase (nik) Length = 356 | Back alignment and structure |
|
| >pdb|2G01|A Chain A, Pyrazoloquinolones As Novel, Selective Jnk1 Inhibitors Length = 370 | Back alignment and structure |
|
| >pdb|3LXN|A Chain A, Structural And Thermodynamic Characterization Of The Tyk2 And Jak3 Kinase Domains In Complex With Cp-690550 And Cmp-6 Length = 318 | Back alignment and structure |
|
| >pdb|2BDW|A Chain A, Crystal Structure Of The Auto-Inhibited Kinase Domain Of CalciumCALMODULIN ACTIVATED KINASE II Length = 362 | Back alignment and structure |
|
| >pdb|2WTK|C Chain C, Structure Of The Heterotrimeric Lkb1-Stradalpha-Mo25alpha Complex Length = 305 | Back alignment and structure |
|
| >pdb|3P23|A Chain A, Crystal Structure Of The Human Kinase And Rnase Domains In Complex With Adp Length = 432 | Back alignment and structure |
|
| >pdb|1OMW|A Chain A, Crystal Structure Of The Complex Between G Protein-Coupled Receptor Kinase 2 And Heterotrimeric G Protein Beta 1 And Gamma 2 Subunits Length = 689 | Back alignment and structure |
|
| >pdb|3PSC|A Chain A, Bovine Grk2 In Complex With Gbetagamma Subunits Length = 695 | Back alignment and structure |
|
| >pdb|3KRW|A Chain A, Human Grk2 In Complex With Gbetgamma Subunits And Balanol (Soak) Length = 688 | Back alignment and structure |
|
| >pdb|3CIK|A Chain A, Human Grk2 In Complex With Gbetagamma Subunits Length = 689 | Back alignment and structure |
|
| >pdb|3LM0|A Chain A, Crystal Structure Of Human SerineTHREONINE KINASE 17B (STK17B) Length = 327 | Back alignment and structure |
|
| >pdb|1MRV|A Chain A, Crystal Structure Of An Inactive Akt2 Kinase Domain Length = 339 | Back alignment and structure |
|
| >pdb|1GZK|A Chain A, Molecular Mechanism For The Regulation Of Protein Kinase B Akt By Hydrophobic Motif Phosphorylation Length = 315 | Back alignment and structure |
|
| >pdb|1GZN|A Chain A, Structure Of Pkb Kinase Domain Length = 335 | Back alignment and structure |
|
| >pdb|2J0L|A Chain A, Crystal Structure Of A The Active Conformation Of The Kinase Domain Of Focal Adhesion Kinase With A Phosphorylated Activation Loop Length = 276 | Back alignment and structure |
|
| >pdb|2VZ6|A Chain A, Structure Of Human Calcium Calmodulin Dependent Protein Kinase Type Ii Alpha (Camk2a) In Complex With Indirubin E804 Length = 313 | Back alignment and structure |
|
| >pdb|3CJG|A Chain A, Crystal Structure Of Vegfr2 In Complex With A 3,4,5-Trimethoxy Aniline Containing Pyrimidine Length = 309 | Back alignment and structure |
|
| >pdb|1JBP|E Chain E, Crystal Structure Of The Catalytic Subunit Of Camp- Dependent Protein Kinase Complexed With A Substrate Peptide, Adp And Detergent Length = 350 | Back alignment and structure |
|
| >pdb|3CJF|A Chain A, Crystal Structure Of Vegfr2 In Complex With A 3,4,5-Trimethoxy Aniline Containing Pyrimidine Length = 309 | Back alignment and structure |
|
| >pdb|4EBW|A Chain A, Structure Of Focal Adhesion Kinase Catalytic Domain In Complex With Novel Allosteric Inhibitor Length = 304 | Back alignment and structure |
|
| >pdb|1MP8|A Chain A, Crystal Structure Of Focal Adhesion Kinase (Fak) Length = 281 | Back alignment and structure |
|
| >pdb|3DXN|A Chain A, Crystal Structure Of The Calcium-dependent Kinase From Toxoplasma Gondii, 541.m00134, Kinase Domain Length = 287 | Back alignment and structure |
|
| >pdb|2JKM|A Chain A, Focal Adhesion Kinase Catalytic Domain In Complex With Bis- Anilino Pyrimidine Inhibitor Length = 276 | Back alignment and structure |
|
| >pdb|2ETM|A Chain A, Crystal Structure Of Focal Adhesion Kinase Domain Complexed With 7h-Pyrrolo [2,3-D] Pyrimidine Derivative Length = 281 | Back alignment and structure |
|
| >pdb|2J0M|B Chain B, Crystal Structure A Two-Chain Complex Between The Ferm And Kinase Domains Of Focal Adhesion Kinase. Length = 276 | Back alignment and structure |
|
| >pdb|3NZ0|A Chain A, Non-Phosphorylated Tyk2 Kinase With Cmp6 Length = 302 | Back alignment and structure |
|
| >pdb|3PXK|A Chain A, Focal Adhesion Kinase Catalytic Domain In Complex With Pyrrolo[2,3- D]thiazole Length = 282 | Back alignment and structure |
|
| >pdb|3GU8|A Chain A, Crystal Structure Of Dapkl93g With N6-Cyclopentyladenosine Length = 295 | Back alignment and structure |
|
| >pdb|3HZT|A Chain A, Crystal Structure Of Toxoplasma Gondii Cdpk3, Tgme49_105860 Length = 467 | Back alignment and structure |
|
| >pdb|3BZ3|A Chain A, Crystal Structure Analysis Of Focal Adhesion Kinase With A Methanesulfonamide Diaminopyrimidine Inhibitor Length = 276 | Back alignment and structure |
|
| >pdb|3ZUV|A Chain A, Crystal Structure Of A Designed Selected Ankyrin Repeat Protein In Complex With The Phosphorylated Map Kinase Erk2 Length = 364 | Back alignment and structure |
|
| >pdb|2ERK|A Chain A, Phosphorylated Map Kinase Erk2 Length = 365 | Back alignment and structure |
|
| >pdb|3IW4|A Chain A, Crystal Structure Of Pkc Alpha In Complex With Nvp-Aeb071 Length = 360 | Back alignment and structure |
|
| >pdb|3FHI|A Chain A, Crystal Structure Of A Complex Between The Catalytic And Regulatory (Ri{alpha}) Subunits Of Pka Length = 350 | Back alignment and structure |
|
| >pdb|3QD2|B Chain B, Crsytal Structure Of Mouse Perk Kinase Domain Length = 332 | Back alignment and structure |
|
| >pdb|3CQU|A Chain A, Crystal Structure Of Akt-1 Complexed With Substrate Peptide And Inhibitor Length = 342 | Back alignment and structure |
|
| >pdb|3OCB|A Chain A, Akt1 Kinase Domain With Pyrrolopyrimidine Inhibitor Length = 341 | Back alignment and structure |
|
| >pdb|4GV1|A Chain A, Pkb Alpha In Complex With Azd5363 Length = 340 | Back alignment and structure |
|
| >pdb|3Q4T|A Chain A, Crystal Structure Of Activin Receptor Type-Iia (Acvr2a) Kinase Domain In Complex With Dorsomorphin Length = 322 | Back alignment and structure |
|
| >pdb|2GNF|A Chain A, Protein Kinase A Fivefold Mutant Model Of Rho-Kinase With Y- 27632 Length = 350 | Back alignment and structure |
|
| >pdb|2I0E|A Chain A, Structure Of Catalytic Domain Of Human Protein Kinase C Beta Ii Complexed With A Bisindolylmaleimide Inhibitor Length = 353 | Back alignment and structure |
|
| >pdb|2GNG|A Chain A, Protein Kinase A Fivefold Mutant Model Of Rho-Kinase Length = 350 | Back alignment and structure |
|
| >pdb|3PFQ|A Chain A, Crystal Structure And Allosteric Activation Of Protein Kinase C Beta Ii Length = 674 | Back alignment and structure |
|
| >pdb|3KB7|A Chain A, Crystal Structure Of Polo-Like Kinase 1 In Complex With A Pyrazoloquinazoline Inhibitor Length = 311 | Back alignment and structure |
|
| >pdb|2V5Q|A Chain A, Crystal Structure Of Wild-type Plk-1 Kinase Domain In Complex With A Selective Darpin Length = 315 | Back alignment and structure |
|
| >pdb|2YAC|A Chain A, Crystal Structure Of Polo-Like Kinase 1 In Complex With Nms-P937 Length = 311 | Back alignment and structure |
|
| >pdb|2J0J|A Chain A, Crystal Structure Of A Fragment Of Focal Adhesion Kinase Containing The Ferm And Kinase Domains Length = 656 | Back alignment and structure |
|
| >pdb|3RGF|A Chain A, Crystal Structure Of Human Cdk8CYCC Length = 405 | Back alignment and structure |
|
| >pdb|2OH4|A Chain A, Crystal Structure Of Vegfr2 With A Benzimidazole-Urea Inhibitor Length = 316 | Back alignment and structure |
|
| >pdb|1BKX|A Chain A, A Binary Complex Of The Catalytic Subunit Of Camp-Dependent Protein Kinase And Adenosine Further Defines Conformational Flexibility Length = 350 | Back alignment and structure |
|
| >pdb|2ERZ|E Chain E, Crystal Structure Of C-amp Dependent Kinase (pka) Bound To Hydroxyfasudil Length = 351 | Back alignment and structure |
|
| >pdb|1FMO|E Chain E, Crystal Structure Of A Polyhistidine-Tagged Recombinant Catalytic Subunit Of Camp-Dependent Protein Kinase Complexed With The Peptide Inhibitor Pki(5-24) And Adenosine Length = 350 | Back alignment and structure |
|
| >pdb|2QUR|A Chain A, Crystal Structure Of F327aK285P MUTANT OF CAMP-Dependent Protein Kinase Length = 350 | Back alignment and structure |
|
| >pdb|2W4O|A Chain A, Crystal Structure Of Human Camk4 In Complex With 4-Amino( Sulfamoyl-Phenylamino)-Triazole-Carbothioic Acid (2,6- Difluoro-Phenyl)-Amide) Length = 349 | Back alignment and structure |
|
| >pdb|3QAL|E Chain E, Crystal Structure Of Arg280ala Mutant Of Catalytic Subunit Of Camp- Dependent Protein Kinase Length = 350 | Back alignment and structure |
|
| >pdb|3SDJ|A Chain A, Structure Of Rnase-Inactive Point Mutant Of Oligomeric KinaseRNASE Ire1 Length = 448 | Back alignment and structure |
|
| >pdb|1J3H|A Chain A, Crystal Structure Of Apoenzyme Camp-Dependent Protein Kinase Catalytic Subunit Length = 350 | Back alignment and structure |
|
| >pdb|3C7Q|A Chain A, Structure Of Vegfr2 Kinase Domain In Complex With Bibf1120 Length = 316 | Back alignment and structure |
|
| >pdb|4DFY|A Chain A, Crystal Structure Of R194a Mutant Of Camp-Dependent Protein Kinase With Unphosphorylated Activation Loop Length = 371 | Back alignment and structure |
|
| >pdb|1CDK|A Chain A, Camp-Dependent Protein Kinase Catalytic Subunit (E.C.2.7.1.37) (Protein Kinase A) Complexed With Protein Kinase Inhibitor Peptide Fragment 5-24 (Pki(5-24) Isoelectric Variant Ca) And Mn2+ Adenylyl Imidodiphosphate (Mnamp-Pnp) At Ph 5.6 And 7c And 4c Length = 350 | Back alignment and structure |
|
| >pdb|1CTP|E Chain E, Structure Of The Mammalian Catalytic Subunit Of Camp-Dependent Protein Kinase And An Inhibitor Peptide Displays An Open Conformation Length = 350 | Back alignment and structure |
|
| >pdb|1CMK|E Chain E, Crystal Structures Of The Myristylated Catalytic Subunit Of Camp- Dependent Protein Kinase Reveal Open And Closed Conformations Length = 350 | Back alignment and structure |
|
| >pdb|2JKK|A Chain A, Focal Adhesion Kinase Catalytic Domain In Complex With Bis- Anilino Pyrimidine Inhibitor Length = 276 | Back alignment and structure |
|
| >pdb|2VD5|A Chain A, Structure Of Human Myotonic Dystrophy Protein Kinase In Complex With The Bisindoylmaleide Inhibitor Bim Viii Length = 412 | Back alignment and structure |
|
| >pdb|3FBV|A Chain A, Crystal Structure Of The Oligomer Formed By The Kinase-Ribonuclease Domain Of Ire1 Length = 448 | Back alignment and structure |
|
| >pdb|4AE6|A Chain A, Structure And Function Of The Human Sperm-specific Isoform Of Protein Kinase A (pka) Catalytic Subunit Calpha 2 Length = 343 | Back alignment and structure |
|
| >pdb|3KK9|A Chain A, Camkii Substrate Complex B Length = 282 | Back alignment and structure |
|
| >pdb|1VR2|A Chain A, Human Vascular Endothelial Growth Factor Receptor 2 (Kdr) Kinase Domain Length = 316 | Back alignment and structure |
|
| >pdb|3KL8|A Chain A, Camkiintide Inhibitor Complex Length = 269 | Back alignment and structure |
|
| >pdb|4DG3|E Chain E, Crystal Structure Of R336a Mutant Of Camp-dependent Protein Kinase With Unphosphorylated Turn Motif Length = 371 | Back alignment and structure |
|
| >pdb|1APM|E Chain E, 2.0 Angstrom Refined Crystal Structure Of The Catalytic Subunit Of Camp-Dependent Protein Kinase Complexed With A Peptide Inhibitor And Detergent Length = 350 | Back alignment and structure |
|
| >pdb|3PVB|A Chain A, Crystal Structure Of (73-244)ria:c Holoenzyme Of Camp-Dependent Protein Kinase Length = 345 | Back alignment and structure |
|
| >pdb|3AGM|A Chain A, Complex Of Pka With The Bisubstrate Protein Kinase Inhibitor Arc-670 Length = 351 | Back alignment and structure |
|
| >pdb|3KK8|A Chain A, Camkii Substrate Complex A Length = 284 | Back alignment and structure |
|
| >pdb|2JDO|A Chain A, Structure Of Pkb-Beta (Akt2) Complexed With Isoquinoline-5- Sulfonic Acid (2-(2-(4-Chlorobenzyloxy) Ethylamino)ethyl) Amide Length = 342 | Back alignment and structure |
|
| >pdb|3AGL|A Chain A, Complex Of Pka With The Bisubstrate Protein Kinase Inhibitor Arc-1039 Length = 351 | Back alignment and structure |
|
| >pdb|1O6L|A Chain A, Crystal Structure Of An Activated Akt/protein Kinase B (pkb-pif Chimera) Ternary Complex With Amp-pnp And Gsk3 Peptide Length = 337 | Back alignment and structure |
|
| >pdb|1O6K|A Chain A, Structure Of Activated Form Of Pkb Kinase Domain S474d With Gsk3 Peptide And Amp-Pnp Length = 336 | Back alignment and structure |
|
| >pdb|4DFX|E Chain E, Crystal Structure Of Myristoylated K7c Catalytic Subunit Of Camp- Dependent Protein Kinase In Complex With Sp20 And Amp-Pnp Length = 350 | Back alignment and structure |
|
| >pdb|4AGC|A Chain A, Crystal Structure Of Vegfr2 (Juxtamembrane And Kinase Domains) In Complex With Axitinib (Ag-013736) (N-Methyl-2-( 3-((E)-2-Pyridin-2-Yl-Vinyl)-1h-Indazol-6-Ylsulfanyl)- Benzamide) Length = 353 | Back alignment and structure |
|
| >pdb|3NX8|A Chain A, Human Camp Dependent Protein Kinase In Complex With Phenol Length = 351 | Back alignment and structure |
|
| >pdb|3CC6|A Chain A, Crystal Structure Of Kinase Domain Of Protein Tyrosine Kinase 2 Beta (ptk2b) Length = 281 | Back alignment and structure |
|
| >pdb|2GU8|A Chain A, Discovery Of 2-pyrimidyl-5-amidothiophenes As Novel And Potent Inhibitors For Akt: Synthesis And Sar Studies Length = 337 | Back alignment and structure |
|
| >pdb|3E87|A Chain A, Crystal Structures Of The Kinase Domain Of Akt2 In Complex With Atp- Competitive Inhibitors Length = 335 | Back alignment and structure |
|
| >pdb|3FZO|A Chain A, Crystal Structure Of Pyk2-Apo, Proline-Rich Tyrosine Kinase Length = 277 | Back alignment and structure |
|
| >pdb|4H1J|A Chain A, Crystal Structure Of Pyk2 With The Pyrazole 13a Length = 293 | Back alignment and structure |
|
| >pdb|2QCS|A Chain A, A Complex Structure Between The Catalytic And Regulatory Subunit Of Protein Kinase A That Represents The Inhibited State Length = 350 | Back alignment and structure |
|
| >pdb|2XIR|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With Pf-00337210 (N,2-Dimethyl-6-(7-(2-Morpholinoethoxy) Quinolin-4-Yloxy)benzofuran-3-Carboxamide) Length = 316 | Back alignment and structure |
|
| >pdb|1L3R|E Chain E, Crystal Structure Of A Transition State Mimic Of The Catalytic Subunit Of Camp-Dependent Protein Kinase Length = 350 | Back alignment and structure |
|
| >pdb|3VNT|A Chain A, Crystal Structure Of The Kinase Domain Of Human Vegfr2 With A [1, 3]thiazolo[5,4-B]pyridine Derivative Length = 318 | Back alignment and structure |
|
| >pdb|3MVJ|A Chain A, Human Cyclic Amp-Dependent Protein Kinase Pka Inhibitor Complex Length = 371 | Back alignment and structure |
|
| >pdb|3HNG|A Chain A, Crystal Structure Of Vegfr1 In Complex With N-(4-chlorophenyl)-2- ((pyridin-4-ylmethyl)amino)benzamide Length = 360 | Back alignment and structure |
|
| >pdb|2J0K|A Chain A, Crystal Structure Of A Fragment Of Focal Adhesion Kinase Containing The Ferm And Kinase Domains. Length = 656 | Back alignment and structure |
|
| >pdb|3O7L|B Chain B, Crystal Structure Of Phospholamban (1-19):pka C-Subunit:amp-Pnp:mg2+ Complex Length = 350 | Back alignment and structure |
|
| >pdb|1QL6|A Chain A, The Catalytic Mechanism Of Phosphorylase Kinase Probed By Mutational Studies Length = 298 | Back alignment and structure |
|
| >pdb|3THB|A Chain A, Structure Of Plk1 Kinase Domain In Complex With A Benzolactam-Derived Inhibitor Length = 333 | Back alignment and structure |
|
| >pdb|2UZT|A Chain A, Pka Structures Of Akt, Indazole-Pyridine Inhibitors Length = 336 | Back alignment and structure |
|
| >pdb|2RIO|A Chain A, Structure Of The Dual Enzyme Ire1 Reveals The Basis For Catalysis And Regulation Of Non-conventional Splicing Length = 434 | Back alignment and structure |
|
| >pdb|2OU7|A Chain A, Structure Of The Catalytic Domain Of Human Polo-Like Kinase 1 Length = 335 | Back alignment and structure |
|
| >pdb|1SYK|A Chain A, Crystal Structure Of E230q Mutant Of Camp-Dependent Protein Kinase Reveals Unexpected Apoenzyme Conformation Length = 350 | Back alignment and structure |
|
| >pdb|1YDT|E Chain E, Structure Of Camp-Dependent Protein Kinase, Alpha-Catalytic Subunit In Complex With H89 Protein Kinase Inhibitor N-[2- (4-Bromocinnamylamino)ethyl]-5-Isoquinoline Length = 350 | Back alignment and structure |
|
| >pdb|2C1A|A Chain A, Structure Of Camp-Dependent Protein Kinase Complexed With Isoquinoline-5-Sulfonic Acid (2-(2-(4-Chlorobenzyloxy) Ethylamino)ethyl)amide Length = 351 | Back alignment and structure |
|
| >pdb|2F7E|E Chain E, Pka Complexed With (S)-2-(1h-Indol-3-Yl)-1-(5-Isoquinolin-6- Yl-Pyridin-3-Yloxymethyl-Etylamine Length = 351 | Back alignment and structure |
|
| >pdb|4AE9|A Chain A, Structure And Function Of The Human Sperm-specific Isoform Of Protein Kinase A (pka) Catalytic Subunit C Alpha 2 Length = 343 | Back alignment and structure |
|
| >pdb|1STC|E Chain E, Camp-Dependent Protein Kinase, Alpha-Catalytic Subunit In Complex With Staurosporine Length = 350 | Back alignment and structure |
|
| >pdb|1SVH|A Chain A, Crystal Structure Of Protein Kinase A In Complex With Azepane Derivative 8 Length = 350 | Back alignment and structure |
|
| >pdb|3DND|A Chain A, Camp-Dependent Protein Kinase Pka Catalytic Subunit With Pki-5-24 Length = 350 | Back alignment and structure |
|
| >pdb|2RKU|A Chain A, Structure Of Plk1 In Complex With Bi2536 Length = 294 | Back alignment and structure |
|
| >pdb|3LMG|A Chain A, Crystal Structure Of The Erbb3 Kinase Domain In Complex With Amp-Pnp Length = 344 | Back alignment and structure |
|
| >pdb|3KEX|A Chain A, Crystal Structure Of The Catalytically Inactive Kinase Domain Of The Human Epidermal Growth Factor Receptor 3 (Her3) Length = 325 | Back alignment and structure |
|
| >pdb|3U6J|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Pyrazolone Inhibitor Length = 314 | Back alignment and structure |
|
| >pdb|3EWH|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Pyridyl-Pyrimidine Benzimidazole Inhibitor Length = 314 | Back alignment and structure |
|
| >pdb|1YWN|A Chain A, Vegfr2 In Complex With A Novel 4-amino-furo[2,3-d]pyrimidine Length = 316 | Back alignment and structure |
|
| >pdb|2P2I|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Nicotinamide Inhibitor Length = 314 | Back alignment and structure |
|
| >pdb|2GNJ|A Chain A, Pka Three Fold Mutant Model Of Rho-Kinase With Y-27632 Length = 350 | Back alignment and structure |
|
| >pdb|3FME|A Chain A, Crystal Structure Of Human Mitogen-Activated Protein Kinase Kinase 6 (Mek6) Activated Mutant (S207d, T211d) Length = 290 | Back alignment and structure |
|
| >pdb|3P1A|A Chain A, Structure Of Human Membrane-Associated Tyrosine- And Threonine- Specific Cdc2-Inhibitory Kinase Myt1 (Pkmyt1) Length = 311 | Back alignment and structure |
|
| >pdb|3VN9|A Chain A, Rifined Crystal Structure Of Non-Phosphorylated Map2k6 In A Putative Auto-Inhibition State Length = 340 | Back alignment and structure |
|
| >pdb|1Q8W|A Chain A, The Catalytic Subunit Of Camp-Dependent Protein Kinase In Complex With Rho-Kinase Inhibitor Fasudil (Ha-1077) Length = 350 | Back alignment and structure |
|
| >pdb|2JDS|A Chain A, Structure Of Camp-Dependent Protein Kinase Complexed With A- 443654 Length = 351 | Back alignment and structure |
|
| >pdb|1XH7|A Chain A, Crystal Structures Of Protein Kinase B Selective Inhibitors In Complex With Protein Kinase A And Mutants Length = 350 | Back alignment and structure |
|
| >pdb|3LJ0|A Chain A, Ire1 Complexed With Adp And Quercetin Length = 434 | Back alignment and structure |
|
| >pdb|3MTL|A Chain A, Crystal Structure Of The Pctaire1 Kinase In Complex With Ind E804 Length = 324 | Back alignment and structure |
|
| >pdb|3AMA|A Chain A, Protein Kinase A Sixfold Mutant Model Of Aurora B With Inhibitor Jnj- 7706621 Length = 351 | Back alignment and structure |
|
| >pdb|2PHK|A Chain A, The Crystal Structure Of A Phosphorylase Kinase Peptide Substrate Complex: Kinase Substrate Recognition Length = 277 | Back alignment and structure |
|
| >pdb|3QAM|E Chain E, Crystal Structure Of Glu208ala Mutant Of Catalytic Subunit Of Camp- Dependent Protein Kinase Length = 350 | Back alignment and structure |
|
| >pdb|2P2H|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Pyridinyl-Triazine Inhibitor Length = 314 | Back alignment and structure |
|
| >pdb|3DLS|A Chain A, Crystal Structure Of Human Pas Kinase Bound To Adp Length = 335 | Back alignment and structure |
|
| >pdb|1Q24|A Chain A, Pka Double Mutant Model Of Pkb In Complex With Mgatp Length = 350 | Back alignment and structure |
|
| >pdb|3L9M|A Chain A, Crystal Structure Of Pkab3 (Pka Triple Mutant V123a, L173m, Q181k) With Compound 18 Length = 351 | Back alignment and structure |
|
| >pdb|1PHK|A Chain A, Two Structures Of The Catalytic Domain Of Phosphorylase, Kinase: An Active Protein Kinase Complexed With Nucleotide, Substrate-Analogue And Product Length = 298 | Back alignment and structure |
|
| >pdb|3SOA|A Chain A, Full-Length Human Camkii Length = 444 | Back alignment and structure |
|
| >pdb|3MFR|A Chain A, Cask-4m Cam Kinase Domain, Native Length = 351 | Back alignment and structure |
|
| >pdb|1SMH|A Chain A, Protein Kinase A Variant Complex With Completely Ordered N- Terminal Helix Length = 350 | Back alignment and structure |
|
| >pdb|4G3F|A Chain A, Crystal Structure Of Murine Nf-kappab Inducing Kinase (nik) Bound To A 2-(aminothiazoly)phenol (cmp2) Length = 336 | Back alignment and structure |
|
| >pdb|3BHY|A Chain A, Crystal Structure Of Human Death Associated Protein Kinase 3 (Dapk3) In Complex With A Beta-Carboline Ligand Length = 283 | Back alignment and structure |
|
| >pdb|4G3C|A Chain A, Crystal Structure Of Apo Murine Nf-kappab Inducing Kinase (nik) Length = 352 | Back alignment and structure |
|
| >pdb|1YRP|A Chain A, Catalytic Domain Of Human Zip Kinase Phosphorylated At Thr265 Length = 278 | Back alignment and structure |
|
| >pdb|1Q61|A Chain A, Pka Triple Mutant Model Of Pkb Length = 350 | Back alignment and structure |
|
| >pdb|3EMG|A Chain A, Discovery And Sar Of Novel 4-Thiazolyl-2- Phenylaminopyrimidines As Potent Inhibitors Of Spleen Tyrosine Kinase (Syk) Length = 291 | Back alignment and structure |
|
| >pdb|4F4P|A Chain A, Syk In Complex With Ligand Lasw836 Length = 273 | Back alignment and structure |
|
| >pdb|3TUB|A Chain A, Crystal Structure Of Syk Kinase Domain With 1-(5-(6,7- Dimethoxyquinolin-4-Yloxy)pyridin-2-Yl)-3-((1r,2s)-2- Phenylcyclopropyl)urea Length = 293 | Back alignment and structure |
|
| >pdb|3VF8|A Chain A, Crystal Structure Of Spleen Tyrosine Kinase Syk Catalytic Domain With Pyrazolylbenzimidazole Inhibitor 416 Length = 299 | Back alignment and structure |
|
| >pdb|4DFL|A Chain A, Crystal Structure Of Spleen Tyrosine Kinase Complexed With A Sulfonamidopyrazine Piperidine Inhibitor Length = 274 | Back alignment and structure |
|
| >pdb|1XBA|A Chain A, Crystal Structure Of Apo Syk Tyrosine Kinase Domain Length = 291 | Back alignment and structure |
|
| >pdb|3SRV|B Chain B, Crystal Structure Of Spleen Tyrosine Kinase (Syk) In Complex With A Diaminopyrimidine Carboxamide Inhibitor Length = 277 | Back alignment and structure |
|
| >pdb|4G3G|A Chain A, Crystal Structure Of Murine Nf-kappab Inducing Kinase (nik) V408l Bound To A 2-(aminothiazolyl)phenol (cmp3) Length = 350 | Back alignment and structure |
|
| >pdb|3SRV|A Chain A, Crystal Structure Of Spleen Tyrosine Kinase (Syk) In Complex With A Diaminopyrimidine Carboxamide Inhibitor Length = 277 | Back alignment and structure |
|
| >pdb|4FL3|A Chain A, Structural And Biophysical Characterization Of The Syk Activation Switch Length = 635 | Back alignment and structure |
|
| >pdb|1XH9|A Chain A, Crystal Structures Of Protein Kinase B Selective Inhibitors In Complex With Protein Kinase A And Mutants Length = 350 | Back alignment and structure |
|
| >pdb|4FL2|A Chain A, Structural And Biophysical Characterization Of The Syk Activation Switch Length = 636 | Back alignment and structure |
|
| >pdb|1RDQ|E Chain E, Hydrolysis Of Atp In The Crystal Of Y204a Mutant Of Camp-Dependent Protein Kinase Length = 350 | Back alignment and structure |
|
| >pdb|3ALN|A Chain A, Crystal Structure Of Human Non-Phosphorylated Mkk4 Kinase Domain Complexed With Amp-Pnp Length = 327 | Back alignment and structure |
|
| >pdb|4AW2|A Chain A, Crystal Structure Of Cdc42 Binding Protein Kinase Alpha (Mrck Alpha) Length = 437 | Back alignment and structure |
|
| >pdb|2J90|A Chain A, Crystal Structure Of Human Zip Kinase In Complex With A Tetracyclic Pyridone Inhibitor (pyridone 6) Length = 304 | Back alignment and structure |
|
| >pdb|1SZM|A Chain A, Dual Binding Mode Of Bisindolylmaleimide 2 To Protein Kinase A (Pka) Length = 350 | Back alignment and structure |
|
| >pdb|2VO0|A Chain A, Structure Of Pka-Pkb Chimera Complexed With C-(4-(4- Chlorophenyl)-1-(7h-Pyrrolo(2, 3-D)pyrimidin-4-Yl)piperidin- 4-Yl)methylamine Length = 351 | Back alignment and structure |
|
| >pdb|2JDT|A Chain A, Structure Of Pka-Pkb Chimera Complexed With Isoquinoline-5- Sulfonic Acid (2-(2-(4-Chlorobenzyloxy) Ethylamino)ethyl) Amide Length = 351 | Back alignment and structure |
|
| >pdb|2YCR|A Chain A, Crystal Structure Of Checkpoint Kinase 2 In Complex With Inhibitor Pv976 Length = 323 | Back alignment and structure |
|
| >pdb|2ZV2|A Chain A, Crystal Structure Of Human CalciumCALMODULIN-Dependent Protein Kinase Kinase 2, Beta, Camkk2 Kinase Domain In Complex With Sto-609 Length = 298 | Back alignment and structure |
|
| >pdb|2YCF|A Chain A, Crystal Structure Of Checkpoint Kinase 2 In Complex With Inhibitor Pv1531 Length = 322 | Back alignment and structure |
|
| >pdb|2XK9|A Chain A, Structural Analysis Of Checkpoint Kinase 2 (Chk2) In Complex With Inhibitor Pv1533 Length = 322 | Back alignment and structure |
|
| >pdb|2W0J|A Chain A, Crystal Structure Of Chk2 In Complex With Nsc 109555, A Specific Inhibitor Length = 323 | Back alignment and structure |
|
| >pdb|2Z2W|A Chain A, Humand Wee1 Kinase Complexed With Inhibitor Pf0335770 Length = 285 | Back alignment and structure |
|
| >pdb|2IN6|A Chain A, Wee1 Kinase Complex With Inhibitor Pd311839 Length = 287 | Back alignment and structure |
|
| >pdb|2CN5|A Chain A, Crystal Structure Of Human Chk2 In Complex With Adp Length = 329 | Back alignment and structure |
|
| >pdb|1X8B|A Chain A, Structure Of Human Wee1a Kinase: Kinase Domain Complexed With Inhibitor Pd0407824 Length = 289 | Back alignment and structure |
|
| >pdb|3BI6|A Chain A, Wee1 Kinase Complex With Inhibitor Pd352396 Length = 287 | Back alignment and structure |
|
| >pdb|2UVY|A Chain A, Structure Of Pka-pkb Chimera Complexed With Methyl-(4-(9h- Purin-6-yl)-benzyl)-amine Length = 351 | Back alignment and structure |
|
| >pdb|3KMU|A Chain A, Crystal Structure Of The IlkALPHA-Parvin Core Complex (Apo) Length = 271 | Back alignment and structure |
|
| >pdb|3I6W|A Chain A, Structure And Activation Mechanism Of The Chk2 Dna-Damage Checkpoint Kinase Length = 443 | Back alignment and structure |
|
| >pdb|3I6U|A Chain A, Structure And Activation Mechanism Of The Chk2 Dna-Damage Checkpoint Kinase Length = 419 | Back alignment and structure |
|
| >pdb|2Y4I|B Chain B, Ksr2-Mek1 Heterodimer Length = 319 | Back alignment and structure |
|
| >pdb|3TXO|A Chain A, Pkc Eta Kinase In Complex With A Naphthyridine Length = 353 | Back alignment and structure |
|
| >pdb|2I0V|A Chain A, C-Fms Tyrosine Kinase In Complex With A Quinolone Inhibitor Length = 335 | Back alignment and structure |
|
| >pdb|3BEA|A Chain A, Cfms Tyrosine Kinase (Tie2 Kid) In Complex With A Pyrimidinopyridone Inhibitor Length = 333 | Back alignment and structure |
|
| >pdb|1U54|A Chain A, Crystal Structures Of The Phosphorylated And Unphosphorylated Kinase Domains Of The Cdc42-Associated Tyrosine Kinase Ack1 Bound To Amp-Pcp Length = 291 | Back alignment and structure |
|
| >pdb|4EWH|B Chain B, Co-Crystal Structure Of Ack1 With Inhibitor Length = 275 | Back alignment and structure |
|
| >pdb|4HZS|A Chain A, Crystal Structure Of Ack1 Kinase Domain With C-terminal Sh3 Domain Length = 341 | Back alignment and structure |
|
| >pdb|1U46|A Chain A, Crystal Structure Of The Unphosphorylated Kinase Domain Of The Tyrosine Kinase Ack1 Length = 291 | Back alignment and structure |
|
| >pdb|3EQP|B Chain B, Crystal Structure Of Ack1 With Compound T95 Length = 276 | Back alignment and structure |
|
| >pdb|4HZR|A Chain A, Crystal Structure Of Ack1 Kinase Domain Length = 277 | Back alignment and structure |
|
| >pdb|3ENM|A Chain A, The Structure Of The Map2k Mek6 Reveals An Autoinhibitory Dimer Length = 316 | Back alignment and structure |
|
| >pdb|3VID|A Chain A, Crystal Structure Of Human Vegfr2 Kinase Domain With Compound A Length = 356 | Back alignment and structure |
|
| >pdb|4ID7|A Chain A, Ack1 Kinase In Complex With The Inhibitor Cis-3-[8-amino-1-(4- Phenoxyphenyl)imidazo[1,5-a]pyrazin-3-yl]cyclobutanol Length = 273 | Back alignment and structure |
|
| >pdb|3QFV|A Chain A, Mrck Beta In Complex With Tpca-1 Length = 415 | Back alignment and structure |
|
| >pdb|1Y6A|A Chain A, Crystal Structure Of Vegfr2 In Complex With A 2-Anilino-5-Aryl-Oxazole Inhibitor Length = 366 | Back alignment and structure |
|
| >pdb|3VHK|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Back Pocket Binder Length = 368 | Back alignment and structure |
|
| >pdb|3VHE|A Chain A, Crystal Structure Of Human Vegfr2 Kinase Domain With A Novel Pyrrolopyrimidine Inhibitor Length = 359 | Back alignment and structure |
|
| >pdb|3RP9|A Chain A, Crystal Structure Of The Apo Mapk From Toxoplasma Gondii, 25.M01780 Or Tgme49_007820 Length = 458 | Back alignment and structure |
|
| >pdb|3TKU|A Chain A, Mrck Beta In Complex With Fasudil Length = 433 | Back alignment and structure |
|
| >pdb|1RJB|A Chain A, Crystal Structure Of Flt3 Length = 344 | Back alignment and structure |
|
| >pdb|3MDY|A Chain A, Crystal Structure Of The Cytoplasmic Domain Of The Bone Morp Protein Receptor Type-1b (Bmpr1b) In Complex With Fkbp12 An 193189 Length = 337 | Back alignment and structure |
|
| >pdb|3D5U|A Chain A, Crystal Structure Of A Wildtype Polo-Like Kinase 1 (Plk1) Catalytic Domain Length = 317 | Back alignment and structure |
|
| >pdb|2A27|A Chain A, Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal Form With 8 Monomers In The Asymmetric Unit Length = 321 | Back alignment and structure |
|
| >pdb|1ZWS|A Chain A, Crystal Structure Of The Catalytic Domain Of Human Drp-1 Kinase Length = 288 | Back alignment and structure |
|
| >pdb|2OGV|A Chain A, Crystal Structure Of The Autoinhibited Human C-Fms Kinase Domain Length = 317 | Back alignment and structure |
|
| >pdb|3KVW|A Chain A, Crystal Structure Of Dual-Specificity Tyrosine Phosphorylation Regulated Kinase 2 (Dyrk2) In Complex With An Indirubin Ligand Length = 429 | Back alignment and structure |
|
| >pdb|2I1M|A Chain A, Cfms Tyrosine Kinase (Tie2 Kid) In Complex With An Arylamide Inhibitor Length = 333 | Back alignment and structure |
|
| >pdb|3DB6|A Chain A, Crystal Structure Of An Activated (Thr->asp) Polo-Like Kinase 1 (Plk1) Catalytic Domain In Complex With Compound 902 Length = 301 | Back alignment and structure |
|
| >pdb|3D5W|A Chain A, Crystal Structure Of A Phosphorylated Polo-Like Kinase 1 (Plk1) Catalytic Domain In Complex With Adp Length = 317 | Back alignment and structure |
|
| >pdb|1Z9X|A Chain A, Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal Form With 3 Monomers In The Asymmetric Unit Length = 321 | Back alignment and structure |
|
| >pdb|3D5V|A Chain A, Crystal Structure Of An Activated (Thr->asp) Polo-Like Kinase 1 (Plk1) Catalytic Domain. Length = 317 | Back alignment and structure |
|
| >pdb|3LCD|A Chain A, Inhibitor Bound To A Dfg-In Structure Of The Kinase Domain Of Csf-1r Length = 329 | Back alignment and structure |
|
| >pdb|3N9X|A Chain A, Crystal Structure Of Map Kinase From Plasmodium Berghei, Pb000659.00.0 Length = 432 | Back alignment and structure |
|
| >pdb|1WMK|A Chain A, Human Death-Associated Kinase Drp-1, Mutant S308d D40 Length = 321 | Back alignment and structure |
|
| >pdb|4AZF|A Chain A, Human Dyrk2 In Complex With Leucettine L41 Length = 417 | Back alignment and structure |
|
| >pdb|2A2A|A Chain A, High-resolution Crystallographic Analysis Of The Autoinhibited Conformation Of A Human Death-associated Protein Kinase Length = 321 | Back alignment and structure |
|
| >pdb|3LCO|A Chain A, Inhibitor Bound To A Dfg-Out Structure Of The Kinase Domain Of Csf-1r Length = 324 | Back alignment and structure |
|
| >pdb|3K2L|A Chain A, Crystal Structure Of Dual-Specificity Tyrosine Phosphorylation Regulated Kinase 2 (Dyrk2) Length = 429 | Back alignment and structure |
|
| >pdb|2AC5|A Chain A, Structure Of Human Mnk2 Kinase Domain Mutant D228g Length = 316 | Back alignment and structure |
|
| >pdb|2YA9|A Chain A, Crystal Structure Of The Autoinhibited Form Of Mouse Dapk2 Length = 361 | Back alignment and structure |
|
| >pdb|3TAC|A Chain A, Crystal Structure Of The Liprin-AlphaCASK COMPLEX Length = 361 | Back alignment and structure |
|
| >pdb|3C0G|A Chain A, Cask Cam-kinase Domain- 3'-amp Complex, P1 Form Length = 351 | Back alignment and structure |
|
| >pdb|4DC2|A Chain A, Structure Of Pkc In Complex With A Substrate Peptide From Par-3 Length = 396 | Back alignment and structure |
|
| >pdb|3NIE|A Chain A, Crystal Structure Of Pf11_0147 Length = 429 | Back alignment and structure |
|
| >pdb|2QR8|A Chain A, 2.0a X-ray Structure Of C-terminal Kinase Domain Of P90 Ribosomal S6 Kinase 2 (rsk2) Length = 342 | Back alignment and structure |
|
| >pdb|1ZRZ|A Chain A, Crystal Structure Of The Catalytic Domain Of Atypical Protein Kinase C-Iota Length = 364 | Back alignment and structure |
|
| >pdb|2AC3|A Chain A, Structure Of Human Mnk2 Kinase Domain Length = 316 | Back alignment and structure |
|
| >pdb|3KN5|A Chain A, Crystal Structure Of The C-Terminal Kinase Domain Of Msk1 In With Amp-Pnp Length = 325 | Back alignment and structure |
|
| >pdb|1KWP|A Chain A, Crystal Structure Of Mapkap2 Length = 400 | Back alignment and structure |
|
| >pdb|2ONL|C Chain C, Crystal Structure Of The P38a-Mapkap Kinase 2 Heterodimer Length = 406 | Back alignment and structure |
|
| >pdb|2OZA|A Chain A, Structure Of P38alpha Complex Length = 356 | Back alignment and structure |
|
| >pdb|3GOK|A Chain A, Binding Site Mapping Of Protein Ligands Length = 334 | Back alignment and structure |
|
| >pdb|2HW6|A Chain A, Crystal Structure Of Mnk1 Catalytic Domain Length = 307 | Back alignment and structure |
|
| >pdb|3ZH8|A Chain A, A Novel Small Molecule Apkc Inhibitor Length = 349 | Back alignment and structure |
|
| >pdb|2PZY|A Chain A, Structure Of Mk2 Complexed With Compound 76 Length = 324 | Back alignment and structure |
|
| >pdb|3E3P|A Chain A, Glycogen Synthase Kinase From Leishmania Major Length = 360 | Back alignment and structure |
|
| >pdb|2P3G|X Chain X, Crystal Structure Of A Pyrrolopyridine Inhibitor Bound To Mapkap Kinase-2 Length = 327 | Back alignment and structure |
|
| >pdb|2H34|A Chain A, Apoenzyme Crystal Structure Of The Tuberculosis SerineTHREONINE Kinase, Pkne Length = 309 | Back alignment and structure |
|
| >pdb|3R2B|A Chain A, Mk2 Kinase Bound To Compound 5b Length = 318 | Back alignment and structure |
|
| >pdb|3FPM|A Chain A, Crystal Structure Of A Squarate Inhibitor Bound To Mapkap Kinase-2 Length = 325 | Back alignment and structure |
|
| >pdb|1KOB|A Chain A, Twitchin Kinase Fragment (Aplysia), Autoregulated Protein Kinase Domain Length = 387 | Back alignment and structure |
|
| >pdb|3R2Y|A Chain A, Mk2 Kinase Bound To Compound 1 Length = 319 | Back alignment and structure |
|
| >pdb|3A8W|A Chain A, Crystal Structure Of Pkciota Kinase Domain Length = 345 | Back alignment and structure |
|
| >pdb|2JBO|A Chain A, Protein Kinase Mk2 In Complex With An Inhibitor (Crystal Form-1, Soaking) Length = 326 | Back alignment and structure |
|
| >pdb|2X9E|A Chain A, Human Mps1 In Complex With Nms-P715 Length = 317 | Back alignment and structure |
|
| >pdb|3VQU|A Chain A, Crystal Structure Of Human Mps1 Catalytic Domain In Complex With 4- [(4-Amino-5-Cyano-6-Ethoxypyridin-2- Yl)amino]benzamide Length = 320 | Back alignment and structure |
|
| >pdb|3CEK|A Chain A, Crystal Structure Of Human Dual Specificity Protein Kinase (ttk) Length = 313 | Back alignment and structure |
|
Structure Templates Detected by RPS-BLAST
Original result of RPS-BLAST against PDB70 database
| >3uim_A Brassinosteroid insensitive 1-associated receptor; kinase, protein kinase, transferase; HET: SEP TPO ANP; 2.20A {Arabidopsis thaliana} PDB: 3tl8_A* Length = 326 | Back alignment and structure |
|---|
Score = 256 bits (657), Expect = 9e-85
Identities = 99/295 (33%), Positives = 159/295 (53%), Gaps = 12/295 (4%)
Query: 1 RFDRTEIENATGSFSENNIIGNSNLSTVYKGRLEDGEIVAVKKLNFHQFSAESDKSFYRE 60
RF E++ A+ +FS NI+G VYKGRL DG +VAVK+L + + F E
Sbjct: 19 RFSLRELQVASDNFSNKNILGRGGFGKVYKGRLADGTLVAVKRLKEERTQG-GELQFQTE 77
Query: 61 AKTLKELKHRNLVKVLGYAWESGKLKALILEYMENGSLESVIHGPGVDHSRWTLPKRIDV 120
+ + HRNL+++ G+ + L+ YM NGS+ S + PKR +
Sbjct: 78 VEMISMAVHRNLLRLRGFCMT-PTERLLVYPYMANGSVASCLRERPESQPPLDWPKRQRI 136
Query: 121 LISVANGLDYLHSGYDIPIVHCDMKPSNILLDRDFEAHVSDFGTSRMLDVHLQDLSSLST 180
+ A GL YLH D I+H D+K +NILLD +FEA V DFG ++++D + ++T
Sbjct: 137 ALGSARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDY---KDTHVTT 193
Query: 181 AFQGTIGYLAPEFAYMRIVTTKVDVFSFGIVVMEFLTKRRPTGLDEENGLSPISLRQLVE 240
A +GTIG++APE+ + K DVF +G++++E +T +R L + L V+
Sbjct: 194 AVRGTIGHIAPEYLSTGKSSEKTDVFGYGVMLLELITGQRAFDLARLANDDDVMLLDWVK 253
Query: 241 KALANGINGVRQITDPKLVSSIYEEQEQHQVLEELFKLALVCTSSNPEDRPNMNE 295
L + + D L + Y+++E Q++ ++AL+CT S+P +RP M+E
Sbjct: 254 GLLKEK--KLEALVDVDLQGN-YKDEEVEQLI----QVALLCTQSSPMERPKMSE 301
|
| >2qkw_B Protein kinase; three-helix bundle motif, AVRPTO-PTO duplex, layered beta- sheets, transferas; HET: SEP TPO; 3.20A {Solanum pimpinellifolium} PDB: 3hgk_A* Length = 321 | Back alignment and structure |
|---|
Score = 245 bits (628), Expect = 1e-80
Identities = 95/297 (31%), Positives = 157/297 (52%), Gaps = 17/297 (5%)
Query: 1 RFDRTEIENATGSFSENNIIGNSNLSTVYKGRLEDGEIVAVKKLNFHQFSAESDKSFYRE 60
R ++E AT +F +IG+ VYKG L DG VA+K+ S++ + F E
Sbjct: 28 RVPLVDLEEATNNFDHKFLIGHGVFGKVYKGVLRDGAKVALKRRT--PESSQGIEEFETE 85
Query: 61 AKTLKELKHRNLVKVLGYAWESGKLKALILEYMENGSLESVIHGPGVDHSRWTLPKRIDV 120
+TL +H +LV ++G+ E ++ LI +YMENG+L+ ++G + + +R+++
Sbjct: 86 IETLSFCRHPHLVSLIGFCDERNEM-ILIYKYMENGNLKRHLYGSDLPTMSMSWEQRLEI 144
Query: 121 LISVANGLDYLHSGYDIPIVHCDMKPSNILLDRDFEAHVSDFGTSRMLDVHLQDLSSLST 180
I A GL YLH+ I+H D+K NILLD +F ++DFG S+ D + LST
Sbjct: 145 CIGAARGLHYLHTR---AIIHRDVKSINILLDENFVPKITDFGISKKGTE--LDQTHLST 199
Query: 181 AFQGTIGYLAPEFAYMRIVTTKVDVFSFGIVVMEFLTKRRPTGLDEENGLSPISLRQLVE 240
+GT+GY+ PE+ +T K DV+SFG+V+ E L R + + ++L +
Sbjct: 200 VVKGTLGYIDPEYFIKGRLTEKSDVYSFGVVLFEVLCARSA--IVQSLPREMVNLAEWAV 257
Query: 241 KALANGINGVRQITDPKLVSSIYEEQEQHQVLEELFKLALVCTSSNPEDRPNMNELL 297
++ NG + QI DP L + + + A+ C + + EDRP+M ++L
Sbjct: 258 ESHNNG--QLEQIVDPNLADK-IRPESLRKFGD----TAVKCLALSSEDRPSMGDVL 307
|
| >2nru_A Interleukin-1 receptor-associated kinase 4; inhibitor, IRAK, transferase; HET: TPO SEP T12; 2.00A {Homo sapiens} PDB: 2nry_A* 2oib_A* 2oic_A* 2oid_A* 2o8y_A* Length = 307 | Back alignment and structure |
|---|
Score = 228 bits (583), Expect = 6e-74
Identities = 81/310 (26%), Positives = 136/310 (43%), Gaps = 42/310 (13%)
Query: 1 RFDRTEIENATGSFSENNIIGNSNL------STVYKGRLEDGEIVAVKKLNFHQF--SAE 52
F E++N T +F E I N VYKG + + VAVKKL + E
Sbjct: 14 SFSFYELKNVTNNFDERPISVGGNKMGEGGFGVVYKGYV-NNTTVAVKKLAAMVDITTEE 72
Query: 53 SDKSFYREAKTLKELKHRNLVKVLGYAWESGKLKALILEYMENGSLESVIHGPGVDHSRW 112
+ F +E K + + +H NLV++LG++ + G L+ YM NGSL +
Sbjct: 73 LKQQFDQEIKVMAKCQHENLVELLGFSSD-GDDLCLVYVYMPNGSLLDRLSCL---DGTP 128
Query: 113 TL--PKRIDVLISVANGLDYLHSGYDIPIVHCDMKPSNILLDRDFEAHVSDFGTSRMLDV 170
L R + ANG+++LH +H D+K +NILLD F A +SDFG +R +
Sbjct: 129 PLSWHMRCKIAQGAANGINFLHEN---HHIHRDIKSANILLDEAFTAKISDFGLARASEK 185
Query: 171 HLQDLSSLSTAFQGTIGYLAPEFAYMR-IVTTKVDVFSFGIVVMEFLTKRRP--TGLDEE 227
+ +++ GT Y+APE +R +T K D++SFG+V++E +T + +
Sbjct: 186 --FAQTVMTSRIVGTTAYMAPE--ALRGEITPKSDIYSFGVVLLEIITGLPAVDEHREPQ 241
Query: 228 NGLSPISLRQLVEKA--LANGINGVRQITDPKLVSSIYEEQEQHQVLEELFKLALVCTSS 285
L++ + + + D K+ + + +A C
Sbjct: 242 L---------LLDIKEEIEDEEKTIEDYIDKKMND--ADSTSVEAMYS----VASQCLHE 286
Query: 286 NPEDRPNMNE 295
RP++ +
Sbjct: 287 KKNKRPDIKK 296
|
| >3soc_A Activin receptor type-2A; structural genomics consortium, SGC, transferase, protein KI; HET: GVD; 1.95A {Homo sapiens} PDB: 3q4t_A* 2qlu_A* Length = 322 | Back alignment and structure |
|---|
Score = 198 bits (504), Expect = 7e-62
Identities = 61/314 (19%), Positives = 116/314 (36%), Gaps = 35/314 (11%)
Query: 2 FDRTEIENATGSFSENNIIGNSNLSTVYKGRLEDGEIVAVKKLNFHQFSAESDKSFYREA 61
+ + + V+K +L E VAVK F + +S+ E
Sbjct: 14 LGTENLYFQSMPLQLLEVKARGRFGCVWKAQL-LNEYVAVKI-----FPIQDKQSWQNEY 67
Query: 62 K--TLKELKHRNLVKVLGYAWESGKLKA---LILEYMENGSLESVIHGPGVDHSRWTLPK 116
+ +L +KH N+++ +G + LI + E GSL + V +
Sbjct: 68 EVYSLPGMKHENILQFIGAEKRGTSVDVDLWLITAFHEKGSLSDFLKANVVS-----WNE 122
Query: 117 RIDVLISVANGLDYLHS-------GYDIPIVHCDMKPSNILLDRDFEAHVSDFGTSRMLD 169
+ ++A GL YLH G+ I H D+K N+LL + A ++DFG + +
Sbjct: 123 LCHIAETMARGLAYLHEDIPGLKDGHKPAISHRDIKSKNVLLKNNLTACIADFGLALKFE 182
Query: 170 VHLQDLSSLSTAFQGTIGYLAPEFAYMRI-----VTTKVDVFSFGIVVMEFLTKRRPTGL 224
+ GT Y+APE I ++D+++ G+V+ E ++
Sbjct: 183 AGKSAGD--THGQVGTRRYMAPEVLEGAINFQRDAFLRIDMYAMGLVLWELASRCTAADG 240
Query: 225 DEENGLSPISLRQLVEKALANGINGV-RQITDPKLVSSIYEEQEQHQVLEELFKLALVCT 283
+ + P +L + V + P + + ++H + L + C
Sbjct: 241 PVDEYMLPFEEEIGQHPSLEDMQEVVVHKKKRP----VLRDYWQKHAGMAMLCETIEECW 296
Query: 284 SSNPEDRPNMNELL 297
+ E R + +
Sbjct: 297 DHDAEARLSAGCVG 310
|
| >3p86_A Serine/threonine-protein kinase CTR1; ETR1, ERS1, ETR2, phosphorylation, transferase; HET: STU; 2.50A {Arabidopsis thaliana} PDB: 3ppz_A* Length = 309 | Back alignment and structure |
|---|
Score = 194 bits (496), Expect = 7e-61
Identities = 75/280 (26%), Positives = 128/280 (45%), Gaps = 32/280 (11%)
Query: 18 NIIGNSNLSTVYKGRLEDGEIVAVKKLNFHQFSAESDKSFYREAKTLKELKHRNLVKVLG 77
IG + TV++ G VAVK L F AE F RE +K L+H N+V +G
Sbjct: 43 EKIGAGSFGTVHRAEW-HGSDVAVKILMEQDFHAERVNEFLREVAIMKRLRHPNIVLFMG 101
Query: 78 YAWESGKLKALILEYMENGSLESVIHGPGVDHSRWTLPKRIDVLISVANGLDYLHSGYDI 137
+ L +++ EY+ GSL ++H G + +R+ + VA G++YLH+ +
Sbjct: 102 AVTQPPNL-SIVTEYLSRGSLYRLLHKSG-AREQLDERRRLSMAYDVAKGMNYLHN-RNP 158
Query: 138 PIVHCDMKPSNILLDRDFEAHVSDFGTSRMLDVHLQDLSSLSTAFQGTIGYLAPEFAYMR 197
PIVH ++K N+L+D+ + V DFG SR+ S + GT ++APE
Sbjct: 159 PIVHRNLKSPNLLVDKKYTVKVCDFGLSRLKA----STFLSSKSAAGTPEWMAPEVLRDE 214
Query: 198 IVTTKVDVFSFGIVVMEFLTKRRPTGLDEENGLSPISLRQLVEKALANGINGVRQITDPK 257
K DV+SFG+++ E T ++P L+P + V G R +
Sbjct: 215 PSNEKSDVYSFGVILWELATLQQPW-----GNLNPAQVVAAV------GFKCKR----LE 259
Query: 258 LVSSIYEEQEQHQVLEELFKLALVCTSSNPEDRPNMNELL 297
+ ++ + + + + C ++ P RP+ ++
Sbjct: 260 IPRNL------NPQVAAIIEG---CWTNEPWKRPSFATIM 290
|
| >3dtc_A Mitogen-activated protein kinase kinase kinase 9; mixed-lineage kinase, MLK family, MLK1 and MLK3 subtype selective inhibitors; HET: VIN; 2.60A {Homo sapiens} Length = 271 | Back alignment and structure |
|---|
Score = 184 bits (470), Expect = 2e-57
Identities = 68/290 (23%), Positives = 123/290 (42%), Gaps = 47/290 (16%)
Query: 18 NIIGNSNLSTVYKGRLEDGEIVAVKKLNFH--QFSAESDKSFYREAKTLKELKHRNLVKV 75
IIG VY+ G+ VAVK + +++ ++ +EAK LKH N++ +
Sbjct: 13 EIIGIGGFGKVYRAFW-IGDEVAVKAARHDPDEDISQTIENVRQEAKLFAMLKHPNIIAL 71
Query: 76 LGYAWESGKLKALILEYMENGSLESVIHGPGVDHSRWTLPKRIDVLISVANGLDYLHSGY 135
G + L L++E+ G L V+ G + ++ + +A G++YLH
Sbjct: 72 RGVCLKEPNL-CLVMEFARGGPLNRVLSGKRIP-----PDILVNWAVQIARGMNYLHDEA 125
Query: 136 DIPIVHCDMKPSNILLDRDFEAH--------VSDFGTSRMLDVHLQDLSSLSTAFQGTIG 187
+PI+H D+K SNIL+ + E ++DFG +R + + G
Sbjct: 126 IVPIIHRDLKSSNILILQKVENGDLSNKILKITDFGLAREWH------RTTKMSAAGAYA 179
Query: 188 YLAPEFAYMRIVTTKVDVFSFGIVVMEFLTKRRPTGLDEENGLSPISLRQLVEKALANGI 247
++APE + + DV+S+G+++ E LT P G+ +++ V +
Sbjct: 180 WMAPEVIRASMFSKGSDVWSYGVLLWELLTGEVPF-----RGIDGLAVAYGV------AM 228
Query: 248 NGVRQITDPKLVSSIYEEQEQHQVLEELFKLALVCTSSNPEDRPNMNELL 297
N + + S+ E KL C + +P RP+ +L
Sbjct: 229 NKLA----LPIPSTC---------PEPFAKLMEDCWNPDPHSRPSFTNIL 265
|
| >3kmu_A ILK, integrin-linked kinase; cell adhesion, ANK repeat, ATP-binding, cell junction, cell membrane, integrin-binding protein, membrane, nucleotide- binding; 1.80A {Homo sapiens} PDB: 3kmw_A* 3rep_A* Length = 271 | Back alignment and structure |
|---|
Score = 183 bits (466), Expect = 9e-57
Identities = 56/284 (19%), Positives = 107/284 (37%), Gaps = 41/284 (14%)
Query: 18 NIIGNSNLSTVYKGRLEDGEIVAVKKLNFHQFSAESDKSFYREAKTLKELKHRNLVKVLG 77
+ ++ ++KGR G + VK L +S + F E L+ H N++ VLG
Sbjct: 16 TKLNENHSGELWKGRW-QGNDIVVKVLKVRDWSTRKSRDFNEECPRLRIFSHPNVLPVLG 74
Query: 78 YAWESGKLK-ALILEYMENGSLESVIHGPGVDHSRWTLPKRIDVLISVANGLDYLHSGYD 136
LI +M GSL +V+H + + + + +A G+ +LH+ +
Sbjct: 75 ACQSPPAPHPTLITHWMPYGSLYNVLHEGT--NFVVDQSQAVKFALDMARGMAFLHT-LE 131
Query: 137 IPIVHCDMKPSNILLDRDFEAHVSDFGTSRMLDVHLQDLSSLSTAFQGTIGYLAPEF--- 193
I + ++++D D A +S S ++APE
Sbjct: 132 PLIPRHALNSRSVMIDEDMTARISMADVKFSFQ---------SPGRMYAPAWVAPEALQK 182
Query: 194 AYMRIVTTKVDVFSFGIVVMEFLTKRRPTGLDEENGLSPISLRQLVEKALANGINGVRQI 253
D++SF +++ E +T+ P LS + + V + G+R
Sbjct: 183 KPEDTNRRSADMWSFAVLLWELVTREVPF-----ADLSNMEIGMKV------ALEGLR-- 229
Query: 254 TDPKLVSSIYEEQEQHQVLEELFKLALVCTSSNPEDRPNMNELL 297
P + I + +L K+ C + +P RP + ++
Sbjct: 230 --PTIPPGI------SPHVSKLMKI---CMNEDPAKRPKFDMIV 262
|
| >3og7_A AKAP9-BRAF fusion protein; proto-oncogene, V600E, kinase, transferase; HET: 032; 2.45A {Homo sapiens} PDB: 3c4c_A* 3c4d_A* 3idp_A* 3ii5_A* 3d4q_A* 3ppj_A* 3ppk_A* 3prf_A* 3pri_A* 3psb_A* 3psd_A* 3q4c_A* 3skc_A* 3tv4_A* 3tv6_A* 2fb8_A* 4dbn_A* 1uwj_A* 1uwh_A* 3q96_A* Length = 289 | Back alignment and structure |
|---|
Score = 183 bits (467), Expect = 9e-57
Identities = 69/281 (24%), Positives = 128/281 (45%), Gaps = 35/281 (12%)
Query: 20 IGNSNLSTVYKGRLEDGEIVAVKKLNFHQFSAESDKSFYREAKTLKELKHRNLVKVLGYA 79
IG+ + TVYKG+ G+ VAVK LN + + ++F E L++ +H N++ +G
Sbjct: 32 IGSGSFGTVYKGKW-HGD-VAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMG-Y 88
Query: 80 WESGKLKALILEYMENGSLESVIHGPGVDHSRWTLPKRIDVLISVANGLDYLHSGYDIPI 139
+ +L A++ ++ E SL +H +++ + K ID+ A G+DYLH+ I
Sbjct: 89 STAPQL-AIVTQWCEGSSLYHHLHASE---TKFEMKKLIDIARQTARGMDYLHA---KSI 141
Query: 140 VHCDMKPSNILLDRDFEAHVSDFGTSRMLDVHLQDLSSLSTAFQGTIGYLAPEFAYMRI- 198
+H D+K +NI L D + DFG + S G+I ++APE M+
Sbjct: 142 IHRDLKSNNIFLHEDNTVKIGDFGLATE--KSRWSGSHQFEQLSGSILWMAPEVIRMQDS 199
Query: 199 --VTTKVDVFSFGIVVMEFLTKRRPTGLDEENGLSPISLRQLVEKALANGINGVRQITDP 256
+ + DV++FGIV+ E +T + P + ++ ++ + G
Sbjct: 200 NPYSFQSDVYAFGIVLYELMTGQLPY-----SNINN------RDQIIEMVGRGSLSPDLS 248
Query: 257 KLVSSIYEEQEQHQVLEELFKLALVCTSSNPEDRPNMNELL 297
K+ + + + +L C ++RP+ +L
Sbjct: 249 KV---------RSNCPKRMKRLMAECLKKKRDERPSFPRIL 280
|
| >2eva_A TAK1 kinase - TAB1 chimera fusion protein; transferase/transferase activator complex; HET: ADN; 2.00A {Homo sapiens} Length = 307 | Back alignment and structure |
|---|
Score = 183 bits (467), Expect = 2e-56
Identities = 76/281 (27%), Positives = 127/281 (45%), Gaps = 40/281 (14%)
Query: 18 NIIGNSNLSTVYKGRLEDGEIVAVKKLNFHQFSAESDKSFYREAKTLKELKHRNLVKVLG 77
++G V K + + VA+K++ S K+F E + L + H N+VK+ G
Sbjct: 14 EVVGRGAFGVVCKAKW-RAKDVAIKQIE----SESERKAFIVELRQLSRVNHPNIVKLYG 68
Query: 78 YAWESGKLKALILEYMENGSLESVIHGPGVDHSRWTLPKRIDVLISVANGLDYLHSGYDI 137
L++EY E GSL +V+HG +T + + + G+ YLHS
Sbjct: 69 ACLNP---VCLVMEYAEGGSLYNVLHGAEP-LPYYTAAHAMSWCLQCSQGVAYLHSMQPK 124
Query: 138 PIVHCDMKPSNILLDRDFE-AHVSDFGTSRMLDVHLQDLSSLSTAFQGTIGYLAPEFAYM 196
++H D+KP N+LL + DFGT+ D+ + T +G+ ++APE
Sbjct: 125 ALIHRDLKPPNLLLVAGGTVLKICDFGTAC-------DIQTHMTNNKGSAAWMAPEVFEG 177
Query: 197 RIVTTKVDVFSFGIVVMEFLTKRRPTGLDEENGLSPISLRQLVEKALANGINGVRQITDP 256
+ K DVFS+GI++ E +T+R+P +E G + V G R P
Sbjct: 178 SNYSEKCDVFSWGIILWEVITRRKPF---DEIGGPAFRIMWAVHN-------GTR----P 223
Query: 257 KLVSSIYEEQEQHQVLEELFKLALVCTSSNPEDRPNMNELL 297
L+ ++ + +E L C S +P RP+M E++
Sbjct: 224 PLIKNL------PKPIESLMTR---CWSKDPSQRPSMEEIV 255
|
| >4f0f_A Serine/threonine-protein kinase ROCO4; LRRK2, ATP-binding, nucleotide serine/threonine-protein kinase, transferase, signaling Pro; HET: ACP; 1.80A {Dictyostelium discoideum} PDB: 4f0g_A 4f1t_A* 4f1m_A* 4f1o_A* Length = 287 | Back alignment and structure |
|---|
Score = 179 bits (457), Expect = 3e-55
Identities = 63/293 (21%), Positives = 115/293 (39%), Gaps = 49/293 (16%)
Query: 18 NIIGNSNLSTVYKGR-LEDGEIVAVKKLNFHQFSAESD-----KSFYREAKTLKELKHRN 71
IG V+KGR ++D +VA+K L E++ + F RE + L H N
Sbjct: 25 KQIGKGGFGLVHKGRLVKDKSVVAIKSLILGDSEGETEMIEKFQEFQREVFIMSNLNHPN 84
Query: 72 LVKVLGYAWESGKLKALILEYMENGSLESVIHGPGVDHSRWTLPKRIDVLISVANGLDYL 131
+VK+ G +++E++ G L + ++ +++ +A G++Y+
Sbjct: 85 IVKLYGLMHNP---PRMVMEFVPCGDLYHRLLDK---AHPIKWSVKLRLMLDIALGIEYM 138
Query: 132 HSGYDIPIVHCDMKPSNILLD-----RDFEAHVSDFGTSRMLDVHLQDLSSLSTAFQGTI 186
+ + PIVH D++ NI L A V+DFG S+ + G
Sbjct: 139 QN-QNPPIVHRDLRSPNIFLQSLDENAPVCAKVADFGLSQQS-------VHSVSGLLGNF 190
Query: 187 GYLAPEFAYMR--IVTTKVDVFSFGIVVMEFLTKRRPTGLDEENGLSPISLRQLVEKALA 244
++APE T K D +SF +++ LT P + S ++
Sbjct: 191 QWMAPETIGAEEESYTEKADTYSFAMILYTILTGEGPF-----DEYSYGK----IKFINM 241
Query: 245 NGINGVRQITDPKLVSSIYEEQEQHQVLEELFKLALVCTSSNPEDRPNMNELL 297
G+R P + L + +C S +P+ RP+ + ++
Sbjct: 242 IREEGLR----PTIPEDC---------PPRLRNVIELCWSGDPKKRPHFSYIV 281
|
| >2y4i_B KSR2, HKSR2, kinase suppressor of RAS 2; transferase, KSR1; HET: ATP; 3.46A {Homo sapiens} Length = 319 | Back alignment and structure |
|---|
Score = 177 bits (452), Expect = 3e-54
Identities = 59/290 (20%), Positives = 109/290 (37%), Gaps = 44/290 (15%)
Query: 18 NIIGNSNLSTVYKGRLEDGEIVAVKKLNFHQFSAESDKSFYREAKTLKELKHRNLVKVLG 77
+IG VY GR GE VA++ ++ + + + K+F RE ++ +H N+V +G
Sbjct: 39 ELIGKGRFGQVYHGRW-HGE-VAIRLIDIERDNEDQLKAFKREVMAYRQTRHENVVLFMG 96
Query: 78 YAWESGKLKALILEYMENGSLESVIHGPGVDHSRWTLPKRIDVLISVANGLDYLHSGYDI 137
L A+I + +L SV+ + K + + G+ YLH+
Sbjct: 97 ACMSPPHL-AIITSLCKGRTLYSVVRDA---KIVLDVNKTRQIAQEIVKGMGYLHA---K 149
Query: 138 PIVHCDMKPSNILLDRDFEAHVSDFGTSRMLDV-HLQDLSSLSTAFQGTIGYLAPE---- 192
I+H D+K N+ D + + ++DFG + V G + +LAPE
Sbjct: 150 GILHKDLKSKNVFYD-NGKVVITDFGLFSISGVLQAGRREDKLRIQNGWLCHLAPEIIRQ 208
Query: 193 -----FAYMRIVTTKVDVFSFGIVVMEFLTKRRPTGLDEENGLSPISLRQLVEKALANGI 247
+ DVF+ G + E + P ++ +
Sbjct: 209 LSPDTEEDKLPFSKHSDVFALGTIWYELHAREWPF-----KTQPAEAIIWQMGT------ 257
Query: 248 NGVRQITDPKLVSSIYEEQEQHQVLEELFKLALVCTSSNPEDRPNMNELL 297
G++ Q + +E+ + L C + E+RP +L+
Sbjct: 258 -GMKP------------NLSQIGMGKEISDILLFCWAFEQEERPTFTKLM 294
|
| >3s95_A LIMK-1, LIM domain kinase 1; structural genomics, structural genomics consortium, SGC, PR kinase, transferase-antibiotic complex; HET: STU GOL; 1.65A {Homo sapiens} Length = 310 | Back alignment and structure |
|---|
Score = 175 bits (446), Expect = 2e-53
Identities = 69/291 (23%), Positives = 121/291 (41%), Gaps = 43/291 (14%)
Query: 18 NIIGNSNLSTVYKGRL-EDGEIVAVKKLNFHQFSAESDKSFYREAKTLKELKHRNLVKVL 76
++G K E GE++ +K+L +F E+ ++F +E K ++ L+H N++K +
Sbjct: 16 EVLGKGCFGQAIKVTHRETGEVMVMKEL--IRFDEETQRTFLKEVKVMRCLEHPNVLKFI 73
Query: 77 GYAWESGKLKALILEYMENGSLESVIHGPGVDHSRWTLPKRIDVLISVANGLDYLHSGYD 136
G ++ +L I EY++ G+L +I S++ +R+ +A+G+ YLHS
Sbjct: 74 GVLYKDKRL-NFITEYIKGGTLRGIIKSMD---SQYPWSQRVSFAKDIASGMAYLHS--- 126
Query: 137 IPIVHCDMKPSNILLDRDFEAHVSDFGTSRMLDVHLQDLSSL----------STAFQGTI 186
+ I+H D+ N L+ + V+DFG +R++ L G
Sbjct: 127 MNIIHRDLNSHNCLVRENKNVVVADFGLARLMVDEKTQPEGLRSLKKPDRKKRYTVVGNP 186
Query: 187 GYLAPEFAYMRIVTTKVDVFSFGIVVMEFLTKRRPTGLDEENGLSPISLRQLVEKALANG 246
++APE R KVDVFSFGIV+ E + + P +
Sbjct: 187 YWMAPEMINGRSYDEKVDVFSFGIVLCEIIGRVNAD-----PDYLPRT------MDFGLN 235
Query: 247 INGVRQITDPKLVSSIYEEQEQHQVLEELFKLALVCTSSNPEDRPNMNELL 297
+ G P F + + C +PE RP+ +L
Sbjct: 236 VRGFLDRYCPP------------NCPPSFFPITVRCCDLDPEKRPSFVKLE 274
|
| >3q4u_A Activin receptor type-1; structural genomics consortium, SGC, protein kinase, transfe; HET: LDN FLC; 1.82A {Homo sapiens} PDB: 3mtf_A* 3oom_A* 4dym_A* 3h9r_A* 3my0_A* Length = 301 | Back alignment and structure |
|---|
Score = 170 bits (434), Expect = 9e-52
Identities = 71/303 (23%), Positives = 118/303 (38%), Gaps = 45/303 (14%)
Query: 18 NIIGNSNLSTVYKGRLEDGEIVAVKKLNFHQFSAESDKSFYREAK--TLKELKHRNLVKV 75
+G V++G GE VAVK FS+ +KS++RE + L+H N++
Sbjct: 14 ECVGKGRYGEVWRGSW-QGENVAVKI-----FSSRDEKSWFRETELYNTVMLRHENILGF 67
Query: 76 LGYAWESGKLKA---LILEYMENGSLESVIHGPGVDHSRWTLPKRIDVLISVANGLDYLH 132
+ S LI Y E GSL + +D + +++S+A+GL +LH
Sbjct: 68 IASDMTSRHSSTQLWLITHYHEMGSLYDYLQLTTLD-----TVSCLRIVLSIASGLAHLH 122
Query: 133 S-----GYDIPIVHCDMKPSNILLDRDFEAHVSDFGTSRMLDVHLQDLSSLSTAFQGTIG 187
I H D+K NIL+ ++ + ++D G + M L + GT
Sbjct: 123 IEIFGTQGKPAIAHRDLKSKNILVKKNGQCCIADLGLAVMHSQSTNQLDVGNNPRVGTKR 182
Query: 188 YLAPE------FAYMRIVTTKVDVFSFGIVVMEFLTKRRPTGLDEE-----NGLSPI--S 234
Y+APE +VD+++FG+V+ E + G+ E+ + P S
Sbjct: 183 YMAPEVLDETIQVDCFDSYKRVDIWAFGLVLWEVARRMVSNGIVEDYKPPFYDVVPNDPS 242
Query: 235 LRQLVEKALANGINGVRQITDPKLVSSIYEEQEQHQVLEELFKLALVCTSSNPEDRPNMN 294
+ + ++ R P +I L L KL C NP R
Sbjct: 243 FEDMRK---VVCVDQQR----P----NIPNRWFSDPTLTSLAKLMKECWYQNPSARLTAL 291
Query: 295 ELL 297
+
Sbjct: 292 RIK 294
|
| >3mdy_A Bone morphogenetic protein receptor type-1B; complex (isomerase-protein kinase), receptor serine/threonin structural genomics consortium, SGC; HET: LDN; 2.05A {Homo sapiens} Length = 337 | Back alignment and structure |
|---|
Score = 171 bits (434), Expect = 3e-51
Identities = 67/303 (22%), Positives = 113/303 (37%), Gaps = 45/303 (14%)
Query: 18 NIIGNSNLSTVYKGRLEDGEIVAVKKLNFHQFSAESDKSFYREAK--TLKELKHRNLVKV 75
IG V+ G+ GE VAVK F + S++RE + ++H N++
Sbjct: 43 KQIGKGRYGEVWMGKW-RGEKVAVKV-----FFTTEEASWFRETEIYQTVLMRHENILGF 96
Query: 76 LGYAWESGKLKA---LILEYMENGSLESVIHGPGVDHSRWTLPKRIDVLISVANGLDYLH 132
+ + LI +Y ENGSL + +D + + S +GL +LH
Sbjct: 97 IAADIKGTGSWTQLYLITDYHENGSLYDYLKSTTLD-----AKSMLKLAYSSVSGLCHLH 151
Query: 133 S-----GYDIPIVHCDMKPSNILLDRDFEAHVSDFGTSRMLDVHLQDLSSLSTAFQGTIG 187
+ I H D+K NIL+ ++ ++D G + ++ GT
Sbjct: 152 TEIFSTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVKFISDTNEVDIPPNTRVGTKR 211
Query: 188 YLAPEFAYMRI------VTTKVDVFSFGIVVMEFLTKRRPTGLDEE-----NGLSPI--S 234
Y+ PE + D++SFG+++ E + G+ EE + L P S
Sbjct: 212 YMPPEVLDESLNRNHFQSYIMADMYSFGLILWEVARRCVSGGIVEEYQLPYHDLVPSDPS 271
Query: 235 LRQLVEKALANGINGVRQITDPKLVSSIYEEQEQHQVLEELFKLALVCTSSNPEDRPNMN 294
+ E I +R P S + L ++ KL C + NP R
Sbjct: 272 YEDMREIV---CIKKLR----P----SFPNRWSSDECLRQMGKLMTECWAHNPASRLTAL 320
Query: 295 ELL 297
+
Sbjct: 321 RVK 323
|
| >3g2f_A Bone morphogenetic protein receptor type-2; kinase, structural genomics, structural genomics consortium, ATP-binding, disease mutation; HET: ADP; 2.35A {Homo sapiens} Length = 336 | Back alignment and structure |
|---|
Score = 170 bits (431), Expect = 6e-51
Identities = 70/320 (21%), Positives = 110/320 (34%), Gaps = 44/320 (13%)
Query: 2 FDRTEIENATGSFSENNIIGNSNLSTVYKGRLEDGEIVAVKKLNFHQFSAESDKSFYREA 61
+E + +IG VYKG L D VAVK FS + ++F E
Sbjct: 3 AAASEPSLDLDNLKLLELIGRGRYGAVYKGSL-DERPVAVKV-----FSFANRQNFINEK 56
Query: 62 K--TLKELKHRNLVKVLGYAWESGKLKA----LILEYMENGSLESVIHGPGVDHSRWTLP 115
+ ++H N+ + + L++EY NGSL + D
Sbjct: 57 NIYRVPLMEHDNIARFIVGDERVTADGRMEYLLVMEYYPNGSLXKYLSLHTSD-----WV 111
Query: 116 KRIDVLISVANGLDYLHS------GYDIPIVHCDMKPSNILLDRDFEAHVSDFGTSRMLD 169
+ SV GL YLH+ Y I H D+ N+L+ D +SDFG S L
Sbjct: 112 SSCRLAHSVTRGLAYLHTELPRGDHYKPAISHRDLNSRNVLVKNDGTCVISDFGLSMRLT 171
Query: 170 ----VHLQDLSSLSTAFQGTIGYLAPE-------FAYMRIVTTKVDVFSFGIVVMEFLTK 218
V + + + + GTI Y+APE +VD+++ G++ E
Sbjct: 172 GNRLVRPGEEDNAAISEVGTIRYMAPEVLEGAVNLRDXESALKQVDMYALGLIYWEIFM- 230
Query: 219 RRPTGLDEENGLSPISLRQLVEKALANGINGVRQITDP----KLVSSIYEE-QEQHQVLE 273
R T L + Q+ + + K E +E +
Sbjct: 231 -RCTDLFPGESVPEY---QMAFQTEVGNHPTFEDMQVLVSREKQRPKFPEAWKENSLAVR 286
Query: 274 ELFKLALVCTSSNPEDRPNM 293
L + C + E R
Sbjct: 287 SLKETIEDCWDQDAEARLTA 306
|
| >1b6c_B TGF-B superfamily receptor type I; complex (isomerase/protein kinase), receptor serine/threonine kinase; 2.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1ias_A 2x7o_A* 3faa_A* 3kcf_A* Length = 342 | Back alignment and structure |
|---|
Score = 162 bits (412), Expect = 5e-48
Identities = 65/304 (21%), Positives = 118/304 (38%), Gaps = 47/304 (15%)
Query: 18 NIIGNSNLSTVYKGRLEDGEIVAVKKLNFHQFSAESDKSFYREAK--TLKELKHRNLVKV 75
IG V++G+ GE VAVK FS+ ++S++REA+ L+H N++
Sbjct: 48 ESIGKGRFGEVWRGKW-RGEEVAVKI-----FSSREERSWFREAEIYQTVMLRHENILGF 101
Query: 76 LGYAWESGKLK---ALILEYMENGSLESVIHGPGVDHSRWTLPKRIDVLISVANGLDYLH 132
+ + L+ +Y E+GSL ++ V + I + +S A+GL +LH
Sbjct: 102 IAADNKDNGTWTQLWLVSDYHEHGSLFDYLNRYTVT-----VEGMIKLALSTASGLAHLH 156
Query: 133 S-----GYDIPIVHCDMKPSNILLDRDFEAHVSDFGTSRMLDVHLQDLSSLSTAFQGTIG 187
I H D+K NIL+ ++ ++D G + D + GT
Sbjct: 157 MEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVRHDSATDTIDIAPNHRVGTKR 216
Query: 188 YLAPE------FAYMRIVTTKVDVFSFGIVVMEFLTKRRPTGLDEE--------NGLSPI 233
Y+APE + D+++ G+V E + G+ E+ P
Sbjct: 217 YMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHEDYQLPYYDLVPSDP- 275
Query: 234 SLRQLVEKALANGINGVRQITDPKLVSSIYEEQEQHQVLEELFKLALVCTSSNPEDRPNM 293
S+ ++ + +R P +I + + L + K+ C +N R
Sbjct: 276 SVEEMRKVV---CEQKLR----P----NIPNRWQSCEALRVMAKIMRECWYANGAARLTA 324
Query: 294 NELL 297
+
Sbjct: 325 LRIK 328
|
| >2wqm_A Serine/threonine-protein kinase NEK7; ATP-binding, polymorphism, metal-binding, cell cycle kinase, mitosis, cytoplasm, magnesium, transferase; 2.10A {Homo sapiens} PDB: 2wqn_A* Length = 310 | Back alignment and structure |
|---|
Score = 138 bits (349), Expect = 6e-39
Identities = 67/280 (23%), Positives = 110/280 (39%), Gaps = 32/280 (11%)
Query: 20 IGNSNLSTVYKGR-LEDGEIVAVKKLNFHQFSAESDK-SFYREAKTLKELKHRNLVKVLG 77
IG S VY+ L DG VA+KK+ + +E LK+L H N++K
Sbjct: 40 IGRGQFSEVYRAACLLDGVPVALKKVQIFDLMDAKARADCIKEIDLLKQLNHPNVIKYYA 99
Query: 78 YAWESGKLKALILEYMENGSLESVIHGPGVDHSRWTLPKRIDVLISVANGLDYLHSGYDI 137
E +L ++LE + G L +I + + + L+++HS
Sbjct: 100 SFIEDNELN-IVLELADAGDLSRMIKHFKKQKRLIPERTVWKYFVQLCSALEHMHSRR-- 156
Query: 138 PIVHCDMKPSNILLDRDFEAHVSDFGTSRMLDVHLQDLSSLSTAFQGTIGYLAPEFAYMR 197
++H D+KP+N+ + + D G R S GT Y++PE +
Sbjct: 157 -VMHRDIKPANVFITATGVVKLGDLGLGRFFSSKTTAAHS----LVGTPYYMSPERIHEN 211
Query: 198 IVTTKVDVFSFGIVVMEFLTKRRPTGLDEENGLSPISLRQLVEKALANGINGVRQITDPK 257
K D++S G ++ E + P D+ N L L +K P
Sbjct: 212 GYNFKSDIWSLGCLLYEMAALQSPFYGDKMN------LYSLCKK----IEQCDY----PP 257
Query: 258 LVSSIYEEQEQHQVLEELFKLALVCTSSNPEDRPNMNELL 297
L S Y EEL +L +C + +PE RP++ +
Sbjct: 258 LPSDHYS--------EELRQLVNMCINPDPEKRPDVTYVY 289
|
| >1t4h_A Serine/threonine-protein kinase WNK1; protein serine/threonine kinase, transferase; 1.80A {Rattus norvegicus} SCOP: d.144.1.7 PDB: 3fpq_A Length = 290 | Back alignment and structure |
|---|
Score = 135 bits (343), Expect = 2e-38
Identities = 68/286 (23%), Positives = 117/286 (40%), Gaps = 40/286 (13%)
Query: 17 NNIIGNSNLSTVYKGR-LEDGEIVAVKKLNFHQFSAESDKSFYREAKTLKELKHRNLVKV 75
+ IG + TVYKG E VA +L + + + F EA+ LK L+H N+V+
Sbjct: 31 DIEIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQHPNIVRF 90
Query: 76 LGYAWESGKLKA---LILEYMENGSLESVIHGPGVDHSRWTLPKRIDVLISVANGLDYLH 132
+ K K L+ E M +G+L++ + + + GL +LH
Sbjct: 91 YDSWESTVKGKKCIVLVTELMTSGTLKTYLK----RFKVMKIKVLRSWCRQILKGLQFLH 146
Query: 133 SGYDIPIVHCDMKPSNILLD-RDFEAHVSDFGTSRMLDVHLQDLSSLSTAFQGTIGYLAP 191
+ PI+H D+K NI + + D G + + +S + A GT ++AP
Sbjct: 147 T-RTPPIIHRDLKCDNIFITGPTGSVKIGDLGLATLKR------ASFAKAVIGTPEFMAP 199
Query: 192 EFAYMRIVTTKVDVFSFGIVVMEFLTKRRPTGLDEENGLSPISLRQLVEKALANGINGVR 251
E Y VDV++FG+ ++E T P E + I R +GV+
Sbjct: 200 EM-YEEKYDESVDVYAFGMCMLEMATSEYP--YSECQNAAQIYRR---------VTSGVK 247
Query: 252 QITDPKLVSSIYEEQEQHQVLEELFKLALVCTSSNPEDRPNMNELL 297
+ K+ E+ ++ C N ++R ++ +LL
Sbjct: 248 PASFDKVAI------------PEVKEIIEGCIRQNKDERYSIKDLL 281
|
| >2clq_A Mitogen-activated protein kinase kinase kinase 5; transferase, metal-binding, apoptosis; HET: STU; 2.3A {Homo sapiens} Length = 295 | Back alignment and structure |
|---|
Score = 131 bits (332), Expect = 1e-36
Identities = 62/229 (27%), Positives = 104/229 (45%), Gaps = 27/229 (11%)
Query: 3 DRTEIENATGSFSENNIIGNSNLSTVYKGR-LEDGEIVAVKKLNFHQFSAESDKSFYREA 61
D E + + ++G VY GR L + +A+K++ + + + E
Sbjct: 13 DLLEYDYEYDENGDRVVLGKGTYGIVYAGRDLSNQVRIAIKEIPER--DSRYSQPLHEEI 70
Query: 62 KTLKELKHRNLVKVLGYAWESGKLKALILEYMENGSLESVIHGPGVDHSRWTLPKRIDVL 121
K LKH+N+V+ LG E+G +K + +E + GSL +++ S+W K +
Sbjct: 71 ALHKHLKHKNIVQYLGSFSENGFIK-IFMEQVPGGSLSALL------RSKWGPLKDNEQT 123
Query: 122 IS-----VANGLDYLHS-GYDIPIVHCDMKPSNILLD-RDFEAHVSDFGTSRMLDVHLQD 174
I + GL YLH IVH D+K N+L++ +SDFGTS+ L
Sbjct: 124 IGFYTKQILEGLKYLHDNQ----IVHRDIKGDNVLINTYSGVLKISDFGTSK----RLAG 175
Query: 175 LSSLSTAFQGTIGYLAPEFAYMRIV--TTKVDVFSFGIVVMEFLTKRRP 221
++ + F GT+ Y+APE D++S G ++E T + P
Sbjct: 176 INPCTETFTGTLQYMAPEIIDKGPRGYGKAADIWSLGCTIIEMATGKPP 224
|
| >4apc_A Serine/threonine-protein kinase NEK1; transferase; 2.10A {Homo sapiens} Length = 350 | Back alignment and structure |
|---|
Score = 132 bits (334), Expect = 2e-36
Identities = 66/282 (23%), Positives = 112/282 (39%), Gaps = 40/282 (14%)
Query: 19 IIGNSNLSTVYKGR-LEDGEIVAVKKLNFHQFSAESDKSFYREAKTLKELKHRNLVKVLG 77
IG + + EDG +K++N + S++ + RE L +KH N+V+
Sbjct: 31 KIGEGSFGKAILVKSTEDGRQYVIKEINISRMSSKEREESRREVAVLANMKHPNIVQYRE 90
Query: 78 YAWESGKLKALILEYMENGSLESVIHGPGVDHSRWTLP-KRI-DVLISVANGLDYLHSGY 135
E+G L ++++Y E G L I+ +I D + + L ++H
Sbjct: 91 SFEENGSLY-IVMDYCEGGDLFKRIN----AQKGVLFQEDQILDWFVQICLALKHVHDRK 145
Query: 136 DIPIVHCDMKPSNILLDRDFEAHVSDFGTSRMLDVHLQDLSSLSTAFQGTIGYLAPEFAY 195
I+H D+K NI L +D + DFG +R+L+ ++ + GT YL+PE
Sbjct: 146 ---ILHRDIKSQNIFLTKDGTVQLGDFGIARVLNSTVELARA----CIGTPYYLSPEICE 198
Query: 196 MRIVTTKVDVFSFGIVVMEFLTKRRPTGLDEENGLSPISLRQLVEKALANGINGVRQITD 255
+ K D+++ G V+ E T + S +L +
Sbjct: 199 NKPYNNKSDIWALGCVLYELCTLKHA-----FEAGSMKNLVLKIISG------------S 241
Query: 256 PKLVSSIYEEQEQHQVLEELFKLALVCTSSNPEDRPNMNELL 297
VS Y +L L NP DRP++N +L
Sbjct: 242 FPPVSLHYS--------YDLRSLVSQLFKRNPRDRPSVNSIL 275
|
| >2w5a_A Serine/threonine-protein kinase NEK2; Ser/Thr protein kinase, nucleus, meiosis, mitosis, cytoplasm, metal-binding, phosphoprotein; HET: ADP; 1.55A {Homo sapiens} PDB: 2wqo_A* 2xk3_A* 2xk4_A* 2xk6_A* 2xk7_A* 2xk8_A* 2xkc_A* 2xkd_A* 2xke_A* 2xkf_A* 2xnm_A* 2xnn_A* 2xno_A* 2xnp_A* 4afe_A* 2jav_A* 2w5b_A* 2w5h_A 4a4x_A* Length = 279 | Back alignment and structure |
|---|
Score = 130 bits (329), Expect = 2e-36
Identities = 65/283 (22%), Positives = 112/283 (39%), Gaps = 33/283 (11%)
Query: 19 IIGNSNLSTVYKGR-LEDGEIVAVKKLNFHQFSAESDKSFYREAKTLKELKHRNLVKVLG 77
IG + K R DG+I+ K+L++ + + E L+ELKH N+V+
Sbjct: 13 TIGTGSYGRCQKIRRKSDGKILVWKELDYGSMTEAEKQMLVSEVNLLRELKHPNIVRYYD 72
Query: 78 -YAWESGKLKALILEYMENGSLESVIHGPGVDHSRWTLPKRIDVLISVANGLDYLHS--G 134
+ +++EY E G L SVI + + V+ + L H
Sbjct: 73 RIIDRTNTTLYIVMEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLALKECHRRSD 132
Query: 135 YDIPIVHCDMKPSNILLDRDFEAHVSDFGTSRMLDVHLQDLSSLSTAFQGTIGYLAPEFA 194
++H D+KP+N+ LD + DFG +R+L+ +S + F GT Y++PE
Sbjct: 133 GGHTVLHRDLKPANVFLDGKQNVKLGDFGLARILNHD----TSFAKTFVGTPYYMSPEQM 188
Query: 195 YMRIVTTKVDVFSFGIVVMEFLTKRRPTGLDEENGLSPISLRQLVEKALANGINGVRQIT 254
K D++S G ++ E P + S ++L K I +
Sbjct: 189 NRMSYNEKSDIWSLGCLLYELCALMPP--------FTAFSQKELAGK-----IREGKFRR 235
Query: 255 DPKLVSSIYEEQEQHQVLEELFKLALVCTSSNPEDRPNMNELL 297
P S +EL ++ + RP++ E+L
Sbjct: 236 IPYRYS------------DELNEIITRMLNLKDYHRPSVEEIL 266
|
| >3cbl_A C-FES, proto-oncogene tyrosine-protein kinase FES/FPS; V-FES, fujinami, avian sarcoma, viral, feline virus, SGC; HET: STU; 1.75A {Homo sapiens} PDB: 3bkb_A* 3cd3_A* 4e93_A* Length = 377 | Back alignment and structure |
|---|
Score = 126 bits (320), Expect = 4e-34
Identities = 63/274 (22%), Positives = 115/274 (41%), Gaps = 41/274 (14%)
Query: 28 VYKGRLEDGEI-VAVKKLNFHQFSAESDKSFYREAKTLKELKHRNLVKVLGYAWESGKLK 86
V+ GRL VAVK + F +EA+ LK+ H N+V+++G + +
Sbjct: 130 VFSGRLRADNTLVAVKSCR-ETLPPDLKAKFLQEARILKQYSHPNIVRLIGVCTQKQPI- 187
Query: 87 ALILEYMENGSLESVIHGPGVDHSRWTLPKRIDVLISVANGLDYLHSGYDIPIVHCDMKP 146
+++E ++ G + + G +R + + ++ A G++YL S +H D+
Sbjct: 188 YIVMELVQGGDFLTFLRTEG---ARLRVKTLLQMVGDAAAGMEYLES---KCCIHRDLAA 241
Query: 147 SNILLDRDFEAHVSDFGTSRMLDVHLQDLSSLSTAFQGTIGYLAPEFAYMRIVTTKVDVF 206
N L+ +SDFG SR + ++ Q + + APE +++ DV+
Sbjct: 242 RNCLVTEKNVLKISDFGMSR--EEADGVYAASGGLRQVPVKWTAPEALNYGRYSSESDVW 299
Query: 207 SFGIVVMEFLTKRRPTGLDEENGLSP---ISLRQLVEKALANGINGVRQITDPKLVSSIY 263
SFGI++ E + G SP +S +Q E G R + P+L
Sbjct: 300 SFGILLWETFS----------LGASPYPNLSNQQTREFV----EKGGR-LPCPELCP--- 341
Query: 264 EEQEQHQVLEELFKLALVCTSSNPEDRPNMNELL 297
+ +F+L C + P RP+ + +
Sbjct: 342 ---------DAVFRLMEQCWAYEPGQRPSFSTIY 366
|
| >4g3f_A NF-kappa-beta-inducing kinase; non-RD kinase, protein serine/threonine kinase, S based drug design, MAP3K14, transferase; HET: 0WB; 1.64A {Mus musculus} PDB: 4g3g_A* 4g3c_A 4dn5_A* Length = 336 | Back alignment and structure |
|---|
Score = 126 bits (317), Expect = 4e-34
Identities = 52/200 (26%), Positives = 81/200 (40%), Gaps = 22/200 (11%)
Query: 27 TVYKGR-LEDGEIVAVKKLNFHQFSAESDKSFYREAKTLKELKHRNLVKVLGYAWESGKL 85
V++ + + G AVKK+ F E E L +V + G E +
Sbjct: 73 EVHRMKDKQTGFQCAVKKVRLEVFRVE-------ELVACAGLSSPRIVPLYGAVREGPWV 125
Query: 86 KALILEYMENGSLESVIHGPGVDHSRWTLP-KRIDVLIS-VANGLDYLHSGYDIPIVHCD 143
+ +E +E GSL +I G LP R + GL+YLH+ I+H D
Sbjct: 126 N-IFMELLEGGSLGQLIKQMG------CLPEDRALYYLGQALEGLEYLHTRR---ILHGD 175
Query: 144 MKPSNILLDRD-FEAHVSDFGTS-RMLDVHLQDLSSLSTAFQGTIGYLAPEFAYMRIVTT 201
+K N+LL D A + DFG + + L GT ++APE +
Sbjct: 176 VKADNVLLSSDGSRAALCDFGHALCLQPDGLGKSLLTGDYIPGTETHMAPEVVMGKPCDA 235
Query: 202 KVDVFSFGIVVMEFLTKRRP 221
KVD++S +++ L P
Sbjct: 236 KVDIWSSCCMMLHMLNGCHP 255
|
| >3ork_A Serine/threonine protein kinase; structural genomics, TB structural genomics consortium, TBSG domain, signal transduction; HET: AGS; 1.60A {Mycobacterium tuberculosis} PDB: 3ori_A* 3orl_A* 3oro_A* 3orp_A* 3ort_A* 3f61_A* 1mru_A* 3f69_A* 3orm_A* 1o6y_A* 2fum_A* Length = 311 | Back alignment and structure |
|---|
Score = 122 bits (308), Expect = 5e-33
Identities = 74/288 (25%), Positives = 119/288 (41%), Gaps = 44/288 (15%)
Query: 20 IGNSNLSTVYKGR-LEDGEIVAVKKLNFHQFSAESD--KSFYREAKTLKELKHRNLVKVL 76
+G +S V+ R L D VAVK L + + F REA+ L H +V V
Sbjct: 20 LGFGGMSEVHLARDLRDHRDVAVKVLRAD-LARDPSFYLRFRREAQNAAALNHPAIVAVY 78
Query: 77 GYAWESGKLKA---LILEYMENGSLESVIHGPGVDHSRWTLPKRIDVLISVANGLDYLHS 133
+++EY++ +L ++H T + I+V+ L++ H
Sbjct: 79 DTGEAETPAGPLPYIVMEYVDGVTLRDIVH----TEGPMTPKRAIEVIADACQALNFSHQ 134
Query: 134 -GYDIPIVHCDMKPSNILLDRDFEAHVSDFGTSRMLDVHLQDLSSLSTAFQGTIGYLAPE 192
G I+H D+KP+NI++ V DFG +R + ++ + GT YL+PE
Sbjct: 135 NG----IIHRDVKPANIMISATNAVKVMDFGIARAIADSGNSVTQTAAVI-GTAQYLSPE 189
Query: 193 FAYMRIVTTKVDVFSFGIVVMEFLTKRRPTGLDEENGLSPIS--LRQLVEKALANGINGV 250
A V + DV+S G V+ E LT P G SP+S + + E
Sbjct: 190 QARGDSVDARSDVYSLGCVLYEVLTGEPPF-----TGDSPVSVAYQHVRE---------- 234
Query: 251 RQITDPKLVSSIYEEQEQHQVLEELFKLALVCTSSNPEDRP-NMNELL 297
DP S+ +E + +L + L + NPE+R E+
Sbjct: 235 ----DPIPPSARHEG-----LSADLDAVVLKALAKNPENRYQTAAEMR 273
|
| >3cek_A Dual specificity protein kinase TTK; HMPS1, PYT, ESK, phosphotyros picked threonine kinase, SGC, structural genomics consortiu binding; HET: 7PE; 2.30A {Homo sapiens} PDB: 3gfw_A* 3h9f_A* 2x9e_A* 3hmp_A* 3hmn_A* 3hmo_A* Length = 313 | Back alignment and structure |
|---|
Score = 122 bits (308), Expect = 6e-33
Identities = 55/294 (18%), Positives = 107/294 (36%), Gaps = 50/294 (17%)
Query: 18 NIIGNSNLSTVYKGRLEDGEIVAVKKLNFHQFSAESDKSFYREAKTLKELKHRNL--VKV 75
IG+ S V++ E +I A+K +N + ++ S+ E L +L+ + +++
Sbjct: 34 KQIGSGGSSKVFQVLNEKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRL 93
Query: 76 LGYAWESGKLKALILEYMENGSLESVIHGPGVDHSRWTLPKRIDVLISVANGLDYLHS-G 134
Y + +++E N L S + +R ++ + +H G
Sbjct: 94 YDYEITDQYIY-MVMEC-GNIDLNSWL----KKKKSIDPWERKSYWKNMLEAVHTIHQHG 147
Query: 135 YDIPIVHCDMKPSNILLDRDFEAHVSDFGTSRMLDVHLQDLSSLSTAFQGTIGYLAPE-- 192
IVH D+KP+N L+ + DFG + + S + + GT+ Y+ PE
Sbjct: 148 ----IVHSDLKPANFLIVDG-MLKLIDFGIANQMQPD--TTSVVKDSQVGTVNYMPPEAI 200
Query: 193 ---------FAYMRIVTTKVDVFSFGIVVMEFLTKRRPTGLDEENGLSPISLRQLVEKAL 243
++ K DV+S G ++ + P L
Sbjct: 201 KDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIINQ-----------ISKL 249
Query: 244 ANGINGVRQITDPKLVSSIYEEQEQHQVLEELFKLALVCTSSNPEDRPNMNELL 297
I+ +I P + ++L + C +P+ R ++ ELL
Sbjct: 250 HAIIDPNHEIEFPDIPE------------KDLQDVLKCCLKRDPKQRISIPELL 291
|
| >2pzi_A Probable serine/threonine-protein kinase PKNG; ATP-recognition, kinase-INH complex, rubredoxin fold, TPR domain, transferase; HET: AXX; 2.40A {Mycobacterium tuberculosis} Length = 681 | Back alignment and structure |
|---|
Score = 126 bits (319), Expect = 6e-33
Identities = 49/234 (20%), Positives = 91/234 (38%), Gaps = 34/234 (14%)
Query: 25 LSTVYKGR--LEDGEIVAVKKLNFHQFSAESDKSFYREAKTLKELKHRNLVKVLGYAWES 82
L +Y +G V +K L H AE+ E + L E+ H ++V++ + +
Sbjct: 93 LGWIYLALDRNVNGRPVVLKGLV-HSGDAEAQAMAMAERQFLAEVVHPSIVQIFNFVEHT 151
Query: 83 GKLKA----LILEYMENGSLESVIHGPGVDHSRWTLPKRIDVLISVANGLDYLHSGYDIP 138
+ +++EY+ SL+ + + I L+ + L YLHS I
Sbjct: 152 DRHGDPVGYIVMEYVGGQSLKRSKGQKL------PVAEAIAYLLEILPALSYLHS---IG 202
Query: 139 IVHCDMKPSNILLDRDFEAHVSDFGTSRMLDVHLQDLSSLSTAFQGTIGYLAPEFAYMRI 198
+V+ D+KP NI+L + + + D G ++ GT G+ APE
Sbjct: 203 LVYNDLKPENIMLTEE-QLKLIDLGAVSRINS--------FGYLYGTPGFQAPEIV-RTG 252
Query: 199 VTTKVDVFSFGIVVMEFLTKRRPTGLDEENGL--------SPISLRQLVEKALA 244
T D+++ G + +GL + S +L+ +A+
Sbjct: 253 PTVATDIYTVGRTLAALTLDLPTRNGRYVDGLPEDDPVLKTYDSYGRLLRRAID 306
|
| >4eqm_A Protein kinase; transferase; HET: ANP; 3.00A {Staphylococcus aureus subsp} Length = 294 | Back alignment and structure |
|---|
Score = 121 bits (305), Expect = 9e-33
Identities = 66/286 (23%), Positives = 118/286 (41%), Gaps = 45/286 (15%)
Query: 20 IGNSNLSTVYKGR-LEDGEIVAVKKLNFHQFSAESD--KSFYREAKTLKELKHRNLVKVL 76
+G +STVY VA+K + + + K F RE +L H+N+V ++
Sbjct: 19 LGGGGMSTVYLAEDTILNIKVAIKAIFIP-PREKEETLKRFEREVHNSSQLSHQNIVSMI 77
Query: 77 GYAWESGKLKALILEYMENGSLESVIHGPGVDHSRWTLPKRIDVLISVANGLDYLHS-GY 135
E L++EY+E +L I H ++ I+ + +G+ + H
Sbjct: 78 DVDEEDD-CYYLVMEYIEGPTLSEYIE----SHGPLSVDTAINFTNQILDGIKHAHDMR- 131
Query: 136 DIPIVHCDMKPSNILLDRDFEAHVSDFGTSRMLDVHLQDLSSLST-AFQGTIGYLAPEFA 194
IVH D+KP NIL+D + + DFG ++ L + S T GT+ Y +PE A
Sbjct: 132 ---IVHRDIKPQNILIDSNKTLKIFDFGIAKALS----ETSLTQTNHVLGTVQYFSPEQA 184
Query: 195 YMRIVTTKVDVFSFGIVVMEFLTKRRPTGLDEENGLSPIS--LRQLVEKALANGINGVRQ 252
D++S GIV+ E L P NG + +S ++ + +
Sbjct: 185 KGEATDECTDIYSIGIVLYEMLVGEPPF-----NGETAVSIAIKHIQDSV---------- 229
Query: 253 ITDPKLVSSIYEEQEQHQVLEELFKLALVCTSSNPEDRP-NMNELL 297
P + + + ++ + + L + L T + +R + E+
Sbjct: 230 ---PNVTTDVRKD-----IPQSLSNVILRATEKDKANRYKTIQEMK 267
|
| >3dbq_A Dual specificity protein kinase TTK; MPS1 structure, kinase activation, phosphorylation, ATP- binding, nucleotide-binding, phosphoprotein; 2.70A {Homo sapiens} Length = 343 | Back alignment and structure |
|---|
Score = 122 bits (308), Expect = 9e-33
Identities = 56/294 (19%), Positives = 109/294 (37%), Gaps = 50/294 (17%)
Query: 18 NIIGNSNLSTVYKGRLEDGEIVAVKKLNFHQFSAESDKSFYREAKTLKELKHRNL--VKV 75
IG+ S V++ E +I A+K +N + ++ S+ E L +L+ + +++
Sbjct: 15 KQIGSGGSSKVFQVLNEKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRL 74
Query: 76 LGYAWESGKLKALILEYMENGSLESVIHGPGVDHSRWTLPKRIDVLISVANGLDYLHS-G 134
Y + +++E N L S + +R ++ + +H G
Sbjct: 75 YDYEITDQYIY-MVMEC-GNIDLNSWL----KKKKSIDPWERKSYWKNMLEAVHTIHQHG 128
Query: 135 YDIPIVHCDMKPSNILLDRDFEAHVSDFGTSRMLDVHLQDLSSLSTAFQGTIGYLAPE-- 192
IVH D+KP+N L+ + DFG + + S + + GT+ Y+ PE
Sbjct: 129 ----IVHSDLKPANFLIVDG-MLKLIDFGIANQMQPD--TTSVVKDSQVGTVNYMPPEAI 181
Query: 193 ---------FAYMRIVTTKVDVFSFGIVVMEFLTKRRPTGLDEENGLSPISLRQLVEKAL 243
++ K DV+S G ++ + P L
Sbjct: 182 KDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIINQ-----------ISKL 230
Query: 244 ANGINGVRQITDPKLVSSIYEEQEQHQVLEELFKLALVCTSSNPEDRPNMNELL 297
I+ +I P + + L+++ K L +P+ R ++ ELL
Sbjct: 231 HAIIDPNHEIEFPDIPE---------KDLQDVLKCCLK---RDPKQRISIPELL 272
|
| >2a19_B Interferon-induced, double-stranded RNA-activated kinase; transferase, protein biosynthesis, protein synthesis transferase complex; HET: TPO ANP; 2.50A {Homo sapiens} PDB: 2a1a_B* Length = 284 | Back alignment and structure |
|---|
Score = 120 bits (304), Expect = 1e-32
Identities = 64/303 (21%), Positives = 119/303 (39%), Gaps = 68/303 (22%)
Query: 14 FSENNIIGNSNLSTVYKGR-LEDGEIVAVKKLNFHQFSAESDKSFYREAKTLKELKHRNL 72
F E +IG+ V+K + DG+ +K++ + +++ RE K L +L H N+
Sbjct: 13 FKEIELIGSGGFGQVFKAKHRIDGKTYVIKRVKY------NNEKAEREVKALAKLDHVNI 66
Query: 73 VKVLGYAWESGKLKA----------------LILEYMENGSLESVIHGPGVDHSRWTLPK 116
V G W+ + +E+ + G+LE I L K
Sbjct: 67 VHYNG-CWDGFDYDPETSSKNSSRSKTKCLFIQMEFCDKGTLEQWIE----KRRGEKLDK 121
Query: 117 R--IDVLISVANGLDYLHSGYDIPIVHCDMKPSNILLDRDFEAHVSDFGTSRMLDVHLQD 174
+++ + G+DY+HS +++ D+KPSNI L + + DFG L
Sbjct: 122 VLALELFEQITKGVDYIHSKK---LINRDLKPSNIFLVDTKQVKIGDFGLVTSLKN---- 174
Query: 175 LSSLSTAFQGTIGYLAPEFAYMRIVTTKVDVFSFGIVVMEFLTKRRPTGLDEENGLSPIS 234
T +GT+ Y++PE + +VD+++ G+++ E L
Sbjct: 175 -DGKRTRSKGTLRYMSPEQISSQDYGKEVDLYALGLILAELLHVCDT----------AFE 223
Query: 235 LRQLVEKALANGINGVRQITDPKLVSSIYEEQEQHQVLEELFKLALVCTSSNPEDRPNMN 294
+ +R + +++ +L++L PEDRPN +
Sbjct: 224 TSKFFTD--------LRDGIISDIFD-----KKEKTLLQKLLSK-------KPEDRPNTS 263
Query: 295 ELL 297
E+L
Sbjct: 264 EIL 266
|
| >2buj_A Serine/threonine-protein kinase 16; transferase, ATP-binding, lipoprotein, myristate, PA phosphorylation; HET: STU; 2.6A {Homo sapiens} Length = 317 | Back alignment and structure |
|---|
Score = 120 bits (303), Expect = 3e-32
Identities = 63/285 (22%), Positives = 114/285 (40%), Gaps = 42/285 (14%)
Query: 26 STVYKGR-LEDGEIVAVKKLNFHQFSAESDKSFYREAKTLKELKHRNLVKVLGYAWESGK 84
S V L DG A+K++ H + + REA + H N+++++ Y
Sbjct: 43 SYVDLVEGLHDGHFYALKRILCH--EQQDREEAQREADMHRLFNHPNILRLVAYCLRERG 100
Query: 85 LKA---LILEYMENGSLESVIHGPGVDHSRWTLPKRIDVLISVANGLDYLHSGYDIPIVH 141
K L+L + + G+L + I + T + + +L+ + GL+ +H+ H
Sbjct: 101 AKHEAWLLLPFFKRGTLWNEIERLKDKGNFLTEDQILWLLLGICRGLEAIHA---KGYAH 157
Query: 142 CDMKPSNILLDRDFEAHVSDFGTSRMLDVHLQDLSSLST-----AFQGTIGYLAPE---- 192
D+KP+NILL + + + D G+ +H++ T A + TI Y APE
Sbjct: 158 RDLKPTNILLGDEGQPVLMDLGSMNQACIHVEGSRQALTLQDWAAQRCTISYRAPELFSV 217
Query: 193 FAYMRIVTTKVDVFSFGIVVMEFLTKRRPTGLDEENGLSPISLRQLVEKALANGINGVRQ 252
++ I + DV+S G V+ + P + + G S +A +
Sbjct: 218 QSHCVI-DERTDVWSLGCVLYAMMFGEGPYDMVFQKGDS-----------VALAVQNQLS 265
Query: 253 ITDPKLVSSIYEEQEQHQVLEELFKLALVCTSSNPEDRPNMNELL 297
I S Q+L + + +P RP++ LL
Sbjct: 266 IPQSPRHS-----SALWQLLNSMMTV-------DPHQRPHIPLLL 298
|
| >3p1a_A MYT1 kinase, membrane-associated tyrosine- and threonine-speci inhibitory kinase; structural genomics, structural genomics consortium, SGC; 1.70A {Homo sapiens} Length = 311 | Back alignment and structure |
|---|
Score = 119 bits (301), Expect = 6e-32
Identities = 67/293 (22%), Positives = 107/293 (36%), Gaps = 55/293 (18%)
Query: 13 SFSENNIIGNSNLSTVYKGR-LEDGEIVAVKKLNFHQFSAESDKSFYREAKTLKEL-KHR 70
SF + +G+ + V+K R EDG + AVK+ + E + +++ +H
Sbjct: 58 SFQRLSRLGHGSYGEVFKVRSKEDGRLYAVKRSMSPFRGPKDRARKLAEVGSHEKVGQHP 117
Query: 71 NLVKVLGYAWESGKLKALILEYMENGSLESVIHGPGVDHSRWTLP-KRI-DVLISVANGL 128
V+ L AWE G + L E SL+ G +LP ++ L L
Sbjct: 118 CCVR-LEQAWEEGGILYLQTELCG-PSLQQHCEAWGA-----SLPEAQVWGYLRDTLLAL 170
Query: 129 DYLHSGYDIPIVHCDMKPSNILLDRDFEAHVSDFGTSRMLDVHLQDLSSLSTAFQGTIGY 188
+LHS +VH D+KP+NI L + DFG L + +G Y
Sbjct: 171 AHLHSQG---LVHLDVKPANIFLGPRGRCKLGDFGLLVELGT-----AGAGEVQEGDPRY 222
Query: 189 LAPEFAYMRIV----TTKVDVFSFGIVVMEFLTKRRPTGLDEENGLSPISLRQLVEKALA 244
+APE ++ T DVFS G+ ++E P
Sbjct: 223 MAPE-----LLQGSYGTAADVFSLGLTILEVACNMEL----------PHG---------G 258
Query: 245 NGINGVRQITDPKLVSSIYEEQEQHQVLEELFKLALVCTSSNPEDRPNMNELL 297
G +RQ P ++ EL + ++ +P+ R LL
Sbjct: 259 EGWQQLRQGYLPPEFTAGLS--------SELRSVLVMMLEPDPKLRATAEALL 303
|
| >3eqc_A Dual specificity mitogen-activated protein kinase; MEK1 kinase, ATP-binding, disease mutation, nucleoti binding, phosphoprotein; HET: 3BM AGS; 1.80A {Homo sapiens} PDB: 3eqd_A* 3eqf_A* 3eqg_A* 3eqh_A* 3eqi_A* 2y4i_C* 3eqb_A* 2p55_A* 1s9j_A* 3dy7_A* 3e8n_A* 3dv3_A* 3mbl_A* 3pp1_A* 3orn_A* 3os3_A* 3sls_A* 1s9i_A* Length = 360 | Back alignment and structure |
|---|
Score = 120 bits (303), Expect = 6e-32
Identities = 73/309 (23%), Positives = 123/309 (39%), Gaps = 45/309 (14%)
Query: 14 FSENNIIGNSNLSTVYKGRL-EDGEIVAVKKLNFHQFSAESDKSFYREAKTLKELKHRNL 72
F + + +G N V+K G ++A K ++ RE + L E +
Sbjct: 35 FEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEI-KPAIRNQIIRELQVLHECNSPYI 93
Query: 73 VKVLGYAWESGKLKALILEYMENGSLESVIHGPGVDHSRWTLPKRI--DVLISVANGLDY 130
V G + G++ + +E+M+ GSL+ V+ G +P++I V I+V GL Y
Sbjct: 94 VGFYGAFYSDGEIS-ICMEHMDGGSLDQVLKKAG------RIPEQILGKVSIAVIKGLTY 146
Query: 131 LHSGYDIPIVHCDMKPSNILLDRDFEAHVSDFGTSRMLDVHLQDLSSLSTAFQGTIGYLA 190
L I+H D+KPSNIL++ E + DFG S L S++ +F GT Y++
Sbjct: 147 LRE--KHKIMHRDVKPSNILVNSRGEIKLCDFGVSGQLI------DSMANSFVGTRSYMS 198
Query: 191 PEFAYMRIV----TTKVDVFSFGIVVMEFLTKRRPTGLDEENGLSPISLRQLVEKALANG 246
PE R+ + + D++S G+ ++E R P + L + Q+ A
Sbjct: 199 PE----RLQGTHYSVQSDIWSMGLSLVEMAVGRYPIPPPDAKELELMFGCQVEGDAAETP 254
Query: 247 INGVRQITDPKLVSSIYE------EQEQHQVLEELFKLAL------------VCTSSNPE 288
E + V E KL C NP
Sbjct: 255 PRPRTPGRPLNKFGMDSRPPMAIFELLDYIVNEPPPKLPSGVFSLEFQDFVNKCLIKNPA 314
Query: 289 DRPNMNELL 297
+R ++ +L+
Sbjct: 315 ERADLKQLM 323
|
| >1opk_A P150, C-ABL, proto-oncogene tyrosine-protein kinase ABL1; transferase; HET: MYR P16; 1.80A {Mus musculus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1opl_A* 2fo0_A* 2abl_A Length = 495 | Back alignment and structure |
|---|
Score = 122 bits (308), Expect = 7e-32
Identities = 65/283 (22%), Positives = 119/283 (42%), Gaps = 41/283 (14%)
Query: 18 NIIGNSNLSTVYKGRLEDGEI-VAVKKLNFHQFSAESDKSFYREAKTLKELKHRNLVKVL 76
+ +G VY+G + + VAVK L + F +EA +KE+KH NLV++L
Sbjct: 226 HKLGGGQYGEVYEGVWKKYSLTVAVKTLKE---DTMEVEEFLKEAAVMKEIKHPNLVQLL 282
Query: 77 GYAWESGKLKALILEYMENGSLESVIHGPGVDHSRWTLPKRIDVLISVANGLDYLHS-GY 135
G +I E+M G+L + + + + + +++ ++YL +
Sbjct: 283 GVCTREPPFY-IITEFMTYGNLLDYLREC--NRQEVSAVVLLYMATQISSAMEYLEKKNF 339
Query: 136 DIPIVHCDMKPSNILLDRDFEAHVSDFGTSRMLDVHLQDLSSLSTAFQGTIGYLAPEFAY 195
+H ++ N L+ + V+DFG SR++ D + + I + APE
Sbjct: 340 ----IHRNLAARNCLVGENHLVKVADFGLSRLMT---GDTYTAHAGAKFPIKWTAPESLA 392
Query: 196 MRIVTTKVDVFSFGIVVMEFLTK-RRPTGLDEENGLSPISLRQLVEKALANGINGVRQIT 254
+ K DV++FG+++ E T P G+ + +L+EK R +
Sbjct: 393 YNKFSIKSDVWAFGVLLWEIATYGMSPYP-----GIDLSQVYELLEK-------DYR-ME 439
Query: 255 DPKLVSSIYEEQEQHQVLEELFKLALVCTSSNPEDRPNMNELL 297
P+ E++++L C NP DRP+ E+
Sbjct: 440 RPEGCP------------EKVYELMRACWQWNPSDRPSFAEIH 470
|
| >2zmd_A Dual specificity protein kinase TTK; MPS1, T686A, ATP-binding, nucleotide-bindi phosphoprotein, serine/threonine-protein kinase; HET: 537 7PE; 2.88A {Homo sapiens} PDB: 2zmc_A* Length = 390 | Back alignment and structure |
|---|
Score = 120 bits (303), Expect = 1e-31
Identities = 55/295 (18%), Positives = 110/295 (37%), Gaps = 52/295 (17%)
Query: 18 NIIGNSNLSTVYKGRLEDGEIVAVKKLNFHQFSAESDKSFYREAKTLKELKHRNL--VKV 75
IG+ S V++ E +I A+K +N + ++ S+ E L +L+ + +++
Sbjct: 62 KQIGSGGSSKVFQVLNEKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRL 121
Query: 76 LGYAWESGKLKALILEYMENGSLESVIHGPGVDHSRWTLPKRIDVLISVANGLDYLHS-G 134
Y + +++E N L S + +R ++ + +H G
Sbjct: 122 YDYEITDQYIY-MVMEC-GNIDLNSWL----KKKKSIDPWERKSYWKNMLEAVHTIHQHG 175
Query: 135 YDIPIVHCDMKPSNILLDRDFEAHVSDFGTSRMLDVHLQDLSSLSTAFQGTIGYLAPE-- 192
IVH D+KP+N L+ + DFG + + S + + G + Y+ PE
Sbjct: 176 ----IVHSDLKPANFLIVDG-MLKLIDFGIANQMQPD--TTSVVKDSQVGAVNYMPPEAI 228
Query: 193 ---------FAYMRIVTTKVDVFSFGIVVMEFLTKRRP-TGLDEENGLSPISLRQLVEKA 242
++ K DV+S G ++ + P + +
Sbjct: 229 KDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIINQI------------SK 276
Query: 243 LANGINGVRQITDPKLVSSIYEEQEQHQVLEELFKLALVCTSSNPEDRPNMNELL 297
L I+ +I P + + L+++ K L +P+ R ++ ELL
Sbjct: 277 LHAIIDPNHEIEFPDIPE---------KDLQDVLKCCLK---RDPKQRISIPELL 319
|
| >1x8b_A WEE1HU, WEE1-like protein kinase; cell cycle, transferase; HET: 824; 1.81A {Homo sapiens} PDB: 3bi6_A* 3biz_A* 3cqe_A* 3cr0_A* 2in6_A* 2io6_A* 2z2w_A* Length = 289 | Back alignment and structure |
|---|
Score = 118 bits (297), Expect = 1e-31
Identities = 68/302 (22%), Positives = 112/302 (37%), Gaps = 54/302 (17%)
Query: 14 FSENNIIGNSNLSTVYKGR-LEDGEIVAVKKLNFHQFSAESDKSFYREAKTLKEL-KHRN 71
F E IG+ +V+K DG I A+K+ + +++ RE L +H +
Sbjct: 13 FHELEKIGSGEFGSVFKCVKRLDGCIYAIKRSKKPLAGSVDEQNALREVYAHAVLGQHSH 72
Query: 72 LVKVLGYAWESGKLKALILEYMENGSLESVIHGPGVDHSRWTLPKRIDVLISVANGLDYL 131
+V+ AW + EY GSL I S + + D+L+ V GL Y+
Sbjct: 73 VVRYFS-AWAEDDHMLIQNEYCNGGSLADAISENYRIMSYFKEAELKDLLLQVGRGLRYI 131
Query: 132 HSGYDIPIVHCDMKPSNILLDRD------FEAHVSDFGTSRMLDVHLQDLS-----SLST 180
HS +VH D+KPSNI + R E D S + + DL S
Sbjct: 132 HSMS---LVHMDIKPSNIFISRTSIPNAASEEGDEDDWASNKVMFKIGDLGHVTRISSPQ 188
Query: 181 AFQGTIGYLAPE-----FAYMRIVTTKVDVFSFGIVVMEFLTKRRPTGLDEENGLSPISL 235
+G +LA E + + K D+F+ + V+ ++
Sbjct: 189 VEEGDSRFLANEVLQENYTH----LPKADIFALALTVVCAAGAEPLPRNGDQ-------- 236
Query: 236 RQLVEKALANGINGVRQITDPKLVSSIYEEQEQHQVLEELFKLALVCTSSNPEDRPNMNE 295
+ +RQ P++ + +E EL K+ +PE RP+
Sbjct: 237 -----------WHEIRQGRLPRIPQVLSQE------FTELLKV---MIHPDPERRPSAMA 276
Query: 296 LL 297
L+
Sbjct: 277 LV 278
|
| >3pls_A Macrophage-stimulating protein receptor; protein kinase, CIS autophosphorylation conformation, recept tyrosine kinase, AMP-PNP, unphosphorylated; HET: ANP; 2.24A {Homo sapiens} Length = 298 | Back alignment and structure |
|---|
Score = 118 bits (297), Expect = 1e-31
Identities = 71/299 (23%), Positives = 120/299 (40%), Gaps = 41/299 (13%)
Query: 6 EIENATGSFSENNIIGNSNLSTVYKGRLEDGE----IVAVKKLNFHQFSAESDKSFYREA 61
I + + +IG + VY G D A+K L+ + ++F RE
Sbjct: 15 LIPHERVVTHSDRVIGKGHFGVVYHGEYIDQAQNRIQCAIKSLS-RITEMQQVEAFLREG 73
Query: 62 KTLKELKHRNLVKVLGYAWESGKLKALILEYMENGSLESVIHGPGVDHSRWTLPKRIDVL 121
++ L H N++ ++G L ++L YM +G L I P T+ I
Sbjct: 74 LLMRGLNHPNVLALIGIMLPPEGLPHVLLPYMCHGDLLQFIRSPQ---RNPTVKDLISFG 130
Query: 122 ISVANGLDYLHSGYDIPIVHCDMKPSNILLDRDFEAHVSDFGTSRMLDVHLQDLSSLSTA 181
+ VA G++YL VH D+ N +LD F V+DFG +R D+ ++ S+
Sbjct: 131 LQVARGMEYLAE---QKFVHRDLAARNCMLDESFTVKVADFGLAR--DILDREYYSVQQH 185
Query: 182 FQGT--IGYLAPEFAYMRIVTTKVDVFSFGIVVMEFLTK-RRPTGLDEENGLSPISLRQL 238
+ + A E TTK DV+SFG+++ E LT+ P + P L
Sbjct: 186 RHARLPVKWTALESLQTYRFTTKSDVWSFGVLLWELLTRGAPPYR-----HIDPFDLTHF 240
Query: 239 VEKALANGINGVRQITDPKLVSSIYEEQEQHQVLEELFKLALVCTSSNPEDRPNMNELL 297
+ + G R + P+ + L+++ C ++P RP L+
Sbjct: 241 LAQ-------GRR-LPQPEYCP------------DSLYQVMQQCWEADPAVRPTFRVLV 279
|
| >3brb_A Proto-oncogene tyrosine-protein kinase MER; ATP-binding, disease mutation, glycoprotein, nucleot binding, phosphorylation, receptor; HET: ADP; 1.90A {Homo sapiens} PDB: 3bpr_A* 2p0c_A* Length = 313 | Back alignment and structure |
|---|
Score = 118 bits (297), Expect = 2e-31
Identities = 65/288 (22%), Positives = 120/288 (41%), Gaps = 55/288 (19%)
Query: 28 VYKGRLEDGE----IVAVKKLNFHQFSAESDKSFYREAKTLKELKHRNLVKVLGYAWESG 83
V +G L+ + VAVK + S + F EA +K+ H N++++LG E
Sbjct: 50 VMEGNLKQEDGTSLKVAVKTMKLDNSSQREIEEFLSEAACMKDFSHPNVIRLLGVCIEMS 109
Query: 84 KLKA----LILEYMENGSLESVI--HGPGVDHSRWTLPKRIDVLISVANGLDYLHSGYDI 137
+IL +M+ G L + + L + ++ +A G++YL +
Sbjct: 110 SQGIPKPMVILPFMKYGDLHTYLLYSRLETGPKHIPLQTLLKFMVDIALGMEYLSN---R 166
Query: 138 PIVHCDMKPSNILLDRDFEAHVSDFGTSRMLDVHLQDLSSLSTAFQGTIGYL-----APE 192
+H D+ N +L D V+DFG S+ ++ D QG I + A E
Sbjct: 167 NFLHRDLAARNCMLRDDMTVCVADFGLSK--KIYSGDYYR-----QGRIAKMPVKWIAIE 219
Query: 193 FAYMRIVTTKVDVFSFGIVVMEFLTKRRPTGLDEENGLSP---ISLRQLVEKALANGING 249
R+ T+K DV++FG+ + E T+ G++P + ++ + L +G
Sbjct: 220 SLADRVYTSKSDVWAFGVTMWEIATR----------GMTPYPGVQNHEMYDY-LLHG--- 265
Query: 250 VRQITDPKLVSSIYEEQEQHQVLEELFKLALVCTSSNPEDRPNMNELL 297
++ P+ +EL+++ C ++P DRP + L
Sbjct: 266 -HRLKQPEDCL------------DELYEIMYSCWRTDPLDRPTFSVLR 300
|
| >1k9a_A Carboxyl-terminal SRC kinase; COOH-terminal SRC kinase, CSK, SFK, signal transduction, SH2, SH3, SRC homology, tyrosine kinase; 2.50A {Rattus norvegicus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1jeg_A Length = 450 | Back alignment and structure |
|---|
Score = 120 bits (303), Expect = 3e-31
Identities = 66/287 (22%), Positives = 108/287 (37%), Gaps = 55/287 (19%)
Query: 18 NIIGNSNLSTVYKGRLEDGEIVAVKKLNFHQFSAESDKSFYREAKTLKELKHRNLVKVLG 77
IG V G G VAVK + + + ++F EA + +L+H NLV++LG
Sbjct: 199 QTIGKGEFGDVMLGDYR-GNKVAVKCIK----NDATAQAFLAEASVMTQLRHSNLVQLLG 253
Query: 78 YAWESGKLKALILEYMENGSLESVIHGPGVDHSRWTLPKRIDVLISVANGLDYLHS-GYD 136
E ++ EYM GSL + G S + + V ++YL +
Sbjct: 254 VIVEEKGGLYIVTEYMAKGSLVDYLRSRG--RSVLGGDCLLKFSLDVCEAMEYLEGNNF- 310
Query: 137 IPIVHCDMKPSNILLDRDFEAHVSDFGTSRMLDVHLQDLSSLSTAFQGT---IGYLAPEF 193
VH D+ N+L+ D A VSDFG ++ + + + APE
Sbjct: 311 ---VHRDLAARNVLVSEDNVAKVSDFGLTKEAS----------STQDTGKLPVKWTAPEA 357
Query: 194 AYMRIVTTKVDVFSFGIVVMEFLTKRRPTGLDEENGLSP---ISLRQLVEKALANGINGV 250
+ +TK DV+SFGI++ E + G P I L+ +V + G
Sbjct: 358 LREKKFSTKSDVWSFGILLWEIYSF----------GRVPYPRIPLKDVVPRVE----KGY 403
Query: 251 RQITDPKLVSSIYEEQEQHQVLEELFKLALVCTSSNPEDRPNMNELL 297
+ + P ++ + C + RP +L
Sbjct: 404 K-MDAPDGCP------------PAVYDVMKNCWHLDAATRPTFLQLR 437
|
| >3gni_B Strad alpha; kinase fold, pseudokinase, alpha helical repeat protein, ADA protein, ATP-binding, cell cycle, kinase, nucleotide-bindin nucleus; HET: ATP CIT; 2.35A {Homo sapiens} PDB: 2wtk_B* Length = 389 | Back alignment and structure |
|---|
Score = 119 bits (299), Expect = 3e-31
Identities = 64/314 (20%), Positives = 107/314 (34%), Gaps = 54/314 (17%)
Query: 21 GNSNLSTVYKGR-LEDGEIVAVKKLNFHQFSAESDKSFYREAKTLKELKHRNLVKVLGYA 79
G +L TV R GE V V+++N S E E K H N+V
Sbjct: 36 GFEDLMTVNLARYKPTGEYVTVRRINLEACSNEMVTFLQGELHVSKLFNHPNIVPYRATF 95
Query: 80 WESGKLKALILEYMENGSLESVIHGPGVDHSRWTLPKRID------VLISVANGLDYLHS 133
+L ++ +M GS + +I ++ +L V LDY+H
Sbjct: 96 IADNEL-WVVTSFMAYGSAKDLI--------CTHFMDGMNELAIAYILQGVLKALDYIHH 146
Query: 134 -GYDIPIVHCDMKPSNILLDRDFEAHVSDFGTSRMLDVHLQDLSSLSTAFQGTIG---YL 189
GY VH +K S+IL+ D + ++S ++ + H Q + + ++ +L
Sbjct: 147 MGY----VHRSVKASHILISVDGKVYLSGLRSNLSMISHGQRQRVVHDFPKYSVKVLPWL 202
Query: 190 APE------FAYMRIVTTKVDVFSFGIVVME-----------------FLTKRR--PTGL 224
+PE Y K D++S GI E P L
Sbjct: 203 SPEVLQQNLQGY----DAKSDIYSVGITACELANGHVPFKDMPATQMLLEKLNGTVPCLL 258
Query: 225 DEENGLSPISLRQLVEKALANGINGVRQITDPKLVSSIYEEQEQHQVLEELFK-LALVCT 283
D + +G++ + P+ + H+ F C
Sbjct: 259 DTSTIPAEELTMSPSRSVANSGLSDSLTTSTPRPSNGDSPSHPYHRTFSPHFHHFVEQCL 318
Query: 284 SSNPEDRPNMNELL 297
NP+ RP+ + LL
Sbjct: 319 QRNPDARPSASTLL 332
|
| >4e5w_A Tyrosine-protein kinase JAK1; kinase domain, transferase-transferase inhibit complex; HET: PTR 0NT; 1.86A {Homo sapiens} PDB: 4e4l_A* 4e4n_A* 3eyg_A* 3eyh_A* Length = 302 | Back alignment and structure |
|---|
Score = 117 bits (295), Expect = 3e-31
Identities = 69/311 (22%), Positives = 119/311 (38%), Gaps = 48/311 (15%)
Query: 3 DRTEIENATGSFSENNIIGNSNLSTVYKGRLE-----DGEIVAVKKLNFHQFSAESDKSF 57
D T E +G + V R + GE VAVK L
Sbjct: 14 DPTHFEKR--FLKRIRDLGEGHFGKVELCRYDPEGDNTGEQVAVKSLKPES-GGNHIADL 70
Query: 58 YREAKTLKELKHRNLVKVLGYAWESGKLKA-LILEYMENGSLESVIHGPGVDHSRWTLPK 116
+E + L+ L H N+VK G E G LI+E++ +GSL+ + ++ L +
Sbjct: 71 KKEIEILRNLYHENIVKYKGICTEDGGNGIKLIMEFLPSGSLKEYLPKNK---NKINLKQ 127
Query: 117 RIDVLISVANGLDYLHS-GYDIPIVHCDMKPSNILLDRDFEAHVSDFGTSRMLDVHLQDL 175
++ + + G+DYL S Y VH D+ N+L++ + + + DFG ++ ++
Sbjct: 128 QLKYAVQICKGMDYLGSRQY----VHRDLAARNVLVESEHQVKIGDFGLTKAIETD---- 179
Query: 176 SSLSTAFQGT---IGYLAPEFAYMRIVTTKVDVFSFGIVVMEFLTKRRPTGLDEENGLSP 232
T + + APE DV+SFG+ + E LT L
Sbjct: 180 KEYYTVKDDRDSPVFWYAPECLMQSKFYIASDVWSFGVTLHELLTYCDSDSSPMALFLKM 239
Query: 233 ISLRQLVEKALANGINGVRQITDPKLVSSIYEEQEQHQVLE-------ELFKLALVCTSS 285
I Q+T +LV+++ ++ + L E+++L C
Sbjct: 240 IGPTH-------------GQMTVTRLVNTL----KEGKRLPCPPNCPDEVYQLMRKCWEF 282
Query: 286 NPEDRPNMNEL 296
P +R + L
Sbjct: 283 QPSNRTSFQNL 293
|
| >3qup_A Tyrosine-protein kinase receptor TYRO3; protein kinase inhibitor, receptor tyrosine kinase, spirocyc kinase domain, phosphotransfer, GAS6 ligand; HET: LUN; 1.90A {Mus musculus} Length = 323 | Back alignment and structure |
|---|
Score = 117 bits (296), Expect = 4e-31
Identities = 69/300 (23%), Positives = 122/300 (40%), Gaps = 56/300 (18%)
Query: 17 NNIIGNSNLSTVYKGRLEDGE----IVAVKKLNFHQFSAESDKSFYREAKTLKELKHRNL 72
++G +V + +L+ + VAVK L ++ + F REA +KE H ++
Sbjct: 28 GRMLGKGEFGSVREAQLKQEDGSFVKVAVKMLKADIIASSDIEEFLREAACMKEFDHPHV 87
Query: 73 VKVLGYAWESGKLKA-----LILEYMENGSLESVI--HGPGVDHSRWTLPKRIDVLISVA 125
K++G + S +IL +M++G L + + G + L + ++ +A
Sbjct: 88 AKLVGVSLRSRAKGRLPIPMVILPFMKHGDLHAFLLASRIGENPFNLPLQTLVRFMVDIA 147
Query: 126 NGLDYLHSGYDIPIVHCDMKPSNILLDRDFEAHVSDFGTSRMLDVHLQDLSSLSTAFQGT 185
G++YL S +H D+ N +L D V+DFG SR ++ D QG
Sbjct: 148 CGMEYLSS---RNFIHRDLAARNCMLAEDMTVCVADFGLSR--KIYSGDYYR-----QGC 197
Query: 186 IGYL-----APEFAYMRIVTTKVDVFSFGIVVMEFLTKRRPTGLDEENGLSP---ISLRQ 237
L A E + T DV++FG+ + E +T+ G +P I +
Sbjct: 198 ASKLPVKWLALESLADNLYTVHSDVWAFGVTMWEIMTR----------GQTPYAGIENAE 247
Query: 238 LVEKALANGINGVRQITDPKLVSSIYEEQEQHQVLEELFKLALVCTSSNPEDRPNMNELL 297
+ L G ++ P EE++ L C S++P+ RP+ L
Sbjct: 248 IYNY-LIGG----NRLKQPPECM------------EEVYDLMYQCWSADPKQRPSFTCLR 290
|
| >3p23_A Serine/threonine-protein kinase/endoribonuclease; kinase domain, kinase and RNAse function, ATP binding ssRNA dephosphorylated, hydrolase; HET: ADP; 2.70A {Homo sapiens} Length = 432 | Back alignment and structure |
|---|
Score = 118 bits (298), Expect = 9e-31
Identities = 58/218 (26%), Positives = 94/218 (43%), Gaps = 23/218 (10%)
Query: 13 SFSENNIIGNSNLSTVYKGRLEDGEIVAVKKLNFHQFSAESDKSFYREAKTLKEL-KHRN 71
SF +++G+ T+ + D VAVK++ FS RE + L+E +H N
Sbjct: 25 SFCPKDVLGHGAEGTIVYRGMFDNRDVAVKRILPECFSFAD-----REVQLLRESDEHPN 79
Query: 72 LVKVLGYAWESGKLKALILEYMENGSLESVIHGPGVDHSRWTLPKRIDVLISVANGLDYL 131
+++ + + +E +L+ + H + I +L +GL +L
Sbjct: 80 VIRYFCTEKDRQFQ-YIAIELCA-ATLQEYVEQKDFAHLG---LEPITLLQQTTSGLAHL 134
Query: 132 HSGYDIPIVHCDMKPSNILL-----DRDFEAHVSDFGTSRMLDVHLQDLSSLSTAFQGTI 186
HS + IVH D+KP NIL+ +A +SDFG + L V S S GT
Sbjct: 135 HS---LNIVHRDLKPHNILISMPNAHGKIKAMISDFGLCKKLAVGRHSFSRRSGV-PGTE 190
Query: 187 GYLAPE---FAYMRIVTTKVDVFSFGIVVMEFLTKRRP 221
G++APE T VD+FS G V +++
Sbjct: 191 GWIAPEMLSEDCKENPTYTVDIFSAGCVFYYVISEGSH 228
|
| >2h34_A Serine/threonine-protein kinase PKNE; apoenzyme, transferase; 2.80A {Mycobacterium tuberculosis} Length = 309 | Back alignment and structure |
|---|
Score = 115 bits (291), Expect = 1e-30
Identities = 51/250 (20%), Positives = 100/250 (40%), Gaps = 42/250 (16%)
Query: 20 IGNSNLSTVYKGRLED---GEIVAVKKLNFHQFSAESD--KSFYREAKTLKELKHRNLVK 74
+G + VY+ D IVA+K ++ S++ REA+T L+ ++V
Sbjct: 42 VGRGGMGDVYEAE--DTVRERIVALKLMSET-LSSDPVFRTRMQREARTAGRLQEPHVVP 98
Query: 75 VLGYAW-ESGKLKALILEYMENGSLESVIHGPGVDHSRWTLPKRIDVLISVANGLDYLHS 133
+ + + E + + + L +++ P+ + ++ + + LD H+
Sbjct: 99 I--HDFGEIDGQLYVDMRLINGVDLAAMLR----RQGPLAPPRAVAIVRQIGSALDAAHA 152
Query: 134 -GYDIPIVHCDMKPSNILLDRDFEAHVSDFGTSRMLDVHLQDLSSLST-AFQGTIGYLAP 191
G H D+KP NIL+ D A++ DFG + D GT+ Y+AP
Sbjct: 153 AG----ATHRDVKPENILVSADDFAYLVDFGIASATT----DEKLTQLGNTVGTLYYMAP 204
Query: 192 EFAYMRIVTTKVDVFSFGIVVMEFLTKRRP-TG---------LDEE-------NGLSPIS 234
E T + D+++ V+ E LT P G +++ P++
Sbjct: 205 ERFSESHATYRADIYALTCVLYECLTGSPPYQGDQLSVMGAHINQAIPRPSTVRPGIPVA 264
Query: 235 LRQLVEKALA 244
++ + +A
Sbjct: 265 FDAVIARGMA 274
|
| >3lxl_A Tyrosine-protein kinase JAK3; TYK2, inflammation, cancer, PAN inhibitor, ATP-binding mutation, membrane, nucleotide-binding, phosphoprot SCID; HET: IZA; 1.74A {Homo sapiens} PDB: 3lxk_A* 3pjc_A* 1yvj_A* Length = 327 | Back alignment and structure |
|---|
Score = 115 bits (291), Expect = 2e-30
Identities = 70/311 (22%), Positives = 124/311 (39%), Gaps = 49/311 (15%)
Query: 3 DRTEIENATGSFSENNIIGNSNLSTVYKGRL-----EDGEIVAVKKLNFHQFSAESDKSF 57
D T E + +G N +V R G +VAVK+L + + F
Sbjct: 16 DPTIFEER--HLKYISQLGKGNFGSVELCRYDPLGDNTGALVAVKQL--QHSGPDQQRDF 71
Query: 58 YREAKTLKELKHRNLVKVLGYAWESGKLKA-LILEYMENGSLESVIHGPGVDHSRWTLPK 116
RE + LK L +VK G ++ G+ L++EY+ +G L + +R +
Sbjct: 72 QREIQILKALHSDFIVKYRGVSYGPGRQSLRLVMEYLPSGCLRDFLQRHR---ARLDASR 128
Query: 117 RIDVLISVANGLDYLHS-GYDIPIVHCDMKPSNILLDRDFEAHVSDFGTSRMLDVHLQDL 175
+ + G++YL S VH D+ NIL++ + ++DFG +++L +
Sbjct: 129 LLLYSSQICKGMEYLGSRRC----VHRDLAARNILVESEAHVKIADFGLAKLLPLD---- 180
Query: 176 SSLSTAFQGT---IGYLAPEFAYMRIVTTKVDVFSFGIVVMEFLTKRRPTGLDEENGLSP 232
+ I + APE I + + DV+SFG+V+ E T
Sbjct: 181 KDYYVVREPGQSPIFWYAPESLSDNIFSRQSDVWSFGVVLYELFTY----------CDKS 230
Query: 233 ISLRQLVEKALANGINGVRQITDPKLVSSIYEEQEQHQVLE-------ELFKLALVCTSS 285
S + + + +S + E E+ Q L E+ +L +C +
Sbjct: 231 CSPSAEFLRMMGCERDVPA-------LSRLLELLEEGQRLPAPPACPAEVHELMKLCWAP 283
Query: 286 NPEDRPNMNEL 296
+P+DRP+ + L
Sbjct: 284 SPQDRPSFSAL 294
|
| >1qcf_A Haematopoetic cell kinase (HCK); tyrosine kinase-inhibitor complex, DOWN-regulated kinase, ordered activation loop; HET: PTR PP1; 2.00A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 2c0i_A* 2c0o_A* 2c0t_A* 1ad5_A* 2hck_A* 3nhn_A 3hck_A 1bu1_A 3rea_B 3rbb_B Length = 454 | Back alignment and structure |
|---|
Score = 117 bits (296), Expect = 2e-30
Identities = 74/285 (25%), Positives = 124/285 (43%), Gaps = 47/285 (16%)
Query: 18 NIIGNSNLSTVYKGRLEDGEIVAVKKLNFHQFSAESDKSFYREAKTLKELKHRNLVKVLG 77
+G V+ VAVK + + S ++F EA +K L+H LVK+
Sbjct: 194 KKLGAGQFGEVWMATYNKHTKVAVKTMKP---GSMSVEAFLAEANVMKTLQHDKLVKLHA 250
Query: 78 YAWESGKLKALILEYMENGSLESVIHGPGVDHSRWTLPKRIDVLISVANGLDYLHS-GYD 136
+ +I E+M GSL + + S+ LPK ID +A G+ ++ Y
Sbjct: 251 VVTKEPIY--IITEFMAKGSLLDFLKSD--EGSKQPLPKLIDFSAQIAEGMAFIEQRNY- 305
Query: 137 IPIVHCDMKPSNILLDRDFEAHVSDFGTSRMLDVHLQDLSSLSTAFQGT---IGYLAPEF 193
+H D++ +NIL+ ++DFG +R+++ + TA +G I + APE
Sbjct: 306 ---IHRDLRAANILVSASLVCKIADFGLARVIE------DNEYTAREGAKFPIKWTAPEA 356
Query: 194 AYMRIVTTKVDVFSFGIVVMEFLTK-RRPTGLDEENGLSPISLRQLVEKALANGINGVRQ 252
T K DV+SFGI++ME +T R P G+S + + +E+ G R
Sbjct: 357 INFGSFTIKSDVWSFGILLMEIVTYGRIPYP-----GMSNPEVIRALER-------GYR- 403
Query: 253 ITDPKLVSSIYEEQEQHQVLEELFKLALVCTSSNPEDRPNMNELL 297
+ P+ EEL+ + + C + PE+RP +
Sbjct: 404 MPRPENCP------------EELYNIMMRCWKNRPEERPTFEYIQ 436
|
| >3ugc_A Tyrosine-protein kinase JAK2; small molecule inhibitor, ATP binding, transferase-transfera inhibitor complex; HET: 046; 1.34A {} PDB: 3krr_A* 3lpb_A* 4aqc_A* 3q32_A* 3rvg_A* 3tjc_A* 3tjd_A* 2b7a_A* 3fup_A* 3e64_A* 3e62_A* 3e63_A* 2xa4_A* 3iok_A* 3io7_A* 3kck_A* 3jy9_A* Length = 295 | Back alignment and structure |
|---|
Score = 114 bits (288), Expect = 3e-30
Identities = 77/319 (24%), Positives = 124/319 (38%), Gaps = 64/319 (20%)
Query: 3 DRTEIENATGSFSENNIIGNSNLSTVYKGRLE-----DGEIVAVKKLNFHQFSAESDKSF 57
D T+ E F + +G N +V R + GE+VAVKKL + E + F
Sbjct: 3 DPTQFEERHLKFLQ--QLGKGNFGSVEMCRYDPLQDNTGEVVAVKKL--QHSTEEHLRDF 58
Query: 58 YREAKTLKELKHRNLVKVLGYAWESGKLKA-LILEYMENGSLESVIHGPGVDHSRWTLPK 116
RE + LK L+H N+VK G + +G+ LI+EY+ GSL + R K
Sbjct: 59 EREIEILKSLQHDNIVKYKGVCYSAGRRNLKLIMEYLPYGSLRDYLQKHK---ERIDHIK 115
Query: 117 RIDVLISVANGLDYLHS-GYDIPIVHCDMKPSNILLDRDFEAHVSDFGTSRMLDVHLQDL 175
+ + G++YL + Y +H D+ NIL++ + + DFG +++L
Sbjct: 116 LLQYTSQICKGMEYLGTKRY----IHRDLATRNILVENENRVKIGDFGLTKVLPQD---- 167
Query: 176 SSLSTAFQGT---IGYLAPEFAYMRIVTTKVDVFSFGIVVMEFLT-----KRRPTGLDEE 227
+ I + APE + DV+SFG+V+ E T K P
Sbjct: 168 KEFFKVKEPGESPIFWYAPESLTESKFSVASDVWSFGVVLYELFTYIEKSKSPPAEFMRM 227
Query: 228 NGLSP---ISLRQLVEKALANGINGVRQITDPKLVSSIYEEQEQHQVLE-------ELFK 277
G + + L+E L N L E++
Sbjct: 228 IGNDKQGQMIVFHLIEL-LKNN-----------------------GRLPRPDGCPDEIYM 263
Query: 278 LALVCTSSNPEDRPNMNEL 296
+ C ++N RP+ +L
Sbjct: 264 IMTECWNNNVNQRPSFRDL 282
|
| >3f66_A Hepatocyte growth factor receptor; C-Met, protein kinase, quinoxaline, alternative splicing, ATP-binding, chromosomal rearrangement; HET: IHX; 1.40A {Homo sapiens} PDB: 3i5n_A* 3u6h_A* 3u6i_A* 3ccn_A* 2rfn_A* 2rfs_A* 3cd8_A* 3efj_A* 3efk_A* 3lq8_A* 3zxz_A* 2wkm_A* 2wgj_A* 3zze_A* 3q6w_A* 3r7o_A* 3q6u_A* 3cth_A* 3ce3_A* 3ctj_A* ... Length = 298 | Back alignment and structure |
|---|
Score = 114 bits (287), Expect = 5e-30
Identities = 72/287 (25%), Positives = 121/287 (42%), Gaps = 41/287 (14%)
Query: 18 NIIGNSNLSTVYKGRLEDGE----IVAVKKLNFHQFSAESDKSFYREAKTLKELKHRNLV 73
+IG + VY G L D + AVK LN F E +K+ H N++
Sbjct: 31 EVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLN-RITDIGEVSQFLTEGIIMKDFSHPNVL 89
Query: 74 KVLGYAWESGKLKALILEYMENGSLESVIHGPGVDHSRWTLPKRIDVLISVANGLDYLHS 133
+LG S ++L YM++G L + I T+ I + VA G+ YL S
Sbjct: 90 SLLGICLRSEGSPLVVLPYMKHGDLRNFIRNET---HNPTVKDLIGFGLQVAKGMKYLAS 146
Query: 134 GYDIPIVHCDMKPSNILLDRDFEAHVSDFGTSRMLDVHLQDLSSLSTAFQGT--IGYLAP 191
VH D+ N +LD F V+DFG +R D++ ++ S+ + ++A
Sbjct: 147 ---KKFVHRDLAARNCMLDEKFTVKVADFGLAR--DMYDKEYYSVHNKTGAKLPVKWMAL 201
Query: 192 EFAYMRIVTTKVDVFSFGIVVMEFLTK-RRPTGLDEENGLSPISLRQLVEKALANGINGV 250
E + TTK DV+SFG+++ E +T+ P ++ + + + G
Sbjct: 202 ESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYP-----DVNTFDITVYLLQ-------GR 249
Query: 251 RQITDPKLVSSIYEEQEQHQVLEELFKLALVCTSSNPEDRPNMNELL 297
R + P+ + L+++ L C E RP+ +EL+
Sbjct: 250 R-LLQPEYCP------------DPLYEVMLKCWHPKAEMRPSFSELV 283
|
| >1fmk_A C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyrosine kinase, phosphorylation, SH2, SH3, phosphotyrosine, proto-oncogene, phosphotransferase; HET: PTR; 1.50A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1y57_A* 2src_A* 1ksw_A* 2ptk_A* 1yol_A* 2oiq_A* 3d7t_B* 3dqx_A* 3el7_A* 3el8_A* 3en4_A* 3en5_A* 3en6_A* 3en7_A* 3f6x_A* 3g6g_A* 3uqf_A* 3uqg_A* 4agw_A* 3oez_A* ... Length = 452 | Back alignment and structure |
|---|
Score = 116 bits (293), Expect = 6e-30
Identities = 75/282 (26%), Positives = 119/282 (42%), Gaps = 41/282 (14%)
Query: 18 NIIGNSNLSTVYKGRLEDGEIVAVKKLNFHQFSAESDKSFYREAKTLKELKHRNLVKVLG 77
+G V+ G VA+K L S ++F +EA+ +K+L+H LV++
Sbjct: 190 VKLGQGCFGEVWMGTWNGTTRVAIKTLKP---GTMSPEAFLQEAQVMKKLRHEKLVQLYA 246
Query: 78 YAWESGKLKALILEYMENGSLESVIHGPGVDHSRWTLPKRIDVLISVANGLDYLHS-GYD 136
E ++ EYM GSL + G LP+ +D+ +A+G+ Y+ Y
Sbjct: 247 VVSEEPIY--IVTEYMSKGSLLDFLKGE--TGKYLRLPQLVDMAAQIASGMAYVERMNY- 301
Query: 137 IPIVHCDMKPSNILLDRDFEAHVSDFGTSRMLDVHLQDLSSLSTAFQGTIGYLAPEFAYM 196
VH D++ +NIL+ + V+DFG +R+++ + + + I + APE A
Sbjct: 302 ---VHRDLRAANILVGENLVCKVADFGLARLIE---DNEYTARQGAKFPIKWTAPEAALY 355
Query: 197 RIVTTKVDVFSFGIVVMEFLTK-RRPTGLDEENGLSPISLRQLVEKALANGINGVRQITD 255
T K DV+SFGI++ E TK R P G+ + VE+ G R +
Sbjct: 356 GRFTIKSDVWSFGILLTELTTKGRVPYP-----GMVNREVLDQVER-------GYR-MPC 402
Query: 256 PKLVSSIYEEQEQHQVLEELFKLALVCTSSNPEDRPNMNELL 297
P E L L C PE+RP L
Sbjct: 403 PPECP------------ESLHDLMCQCWRKEPEERPTFEYLQ 432
|
| >2h8h_A Proto-oncogene tyrosine-protein kinase SRC; SRC kinase, transferase; HET: PTR H8H; 2.20A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 Length = 535 | Back alignment and structure |
|---|
Score = 117 bits (294), Expect = 7e-30
Identities = 78/297 (26%), Positives = 123/297 (41%), Gaps = 43/297 (14%)
Query: 3 DRTEIENATGSFSENNIIGNSNLSTVYKGRLEDGEIVAVKKLNFHQFSAESDKSFYREAK 62
D EI + +G V+ G VA+K L S ++F +EA+
Sbjct: 260 DAWEIPRESLRLEV--KLGQGCFGEVWMGTWNGTTRVAIKTLKP---GTMSPEAFLQEAQ 314
Query: 63 TLKELKHRNLVKVLGYAWESGKLKALILEYMENGSLESVIHGPGVDHSRWTLPKRIDVLI 122
+K+L+H LV++ E ++ EYM GSL + G LP+ +D+
Sbjct: 315 VMKKLRHEKLVQLYAVVSEEPIY--IVTEYMSKGSLLDFLKGE--TGKYLRLPQLVDMAA 370
Query: 123 SVANGLDYLHS-GYDIPIVHCDMKPSNILLDRDFEAHVSDFGTSRMLDVHLQDLSSLSTA 181
+A+G+ Y+ Y VH D++ +NIL+ + V+DFG +R+++ + +
Sbjct: 371 QIASGMAYVERMNY----VHRDLRAANILVGENLVCKVADFGLARLIE---DNEYTARQG 423
Query: 182 FQGTIGYLAPEFAYMRIVTTKVDVFSFGIVVMEFLTK-RRPTGLDEENGLSPISLRQLVE 240
+ I + APE A T K DV+SFGI++ E TK R P G+ + VE
Sbjct: 424 AKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYP-----GMVNREVLDQVE 478
Query: 241 KALANGINGVRQITDPKLVSSIYEEQEQHQVLEELFKLALVCTSSNPEDRPNMNELL 297
+ G R + P E L L C PE+RP L
Sbjct: 479 R-------GYR-MPCPPECP------------ESLHDLMCQCWRKEPEERPTFEYLQ 515
|
| >3c1x_A Hepatocyte growth factor receptor; receptor tyrosine kinase, signal transduction, GRB2, SHC, ATP-binding, glycoprotein, membrane; HET: CKK; 2.17A {Homo sapiens} SCOP: d.144.1.7 Length = 373 | Back alignment and structure |
|---|
Score = 115 bits (289), Expect = 8e-30
Identities = 73/290 (25%), Positives = 119/290 (41%), Gaps = 47/290 (16%)
Query: 18 NIIGNSNLSTVYKGRLEDGE----IVAVKKLNFHQFSAESDKSFYREAKTLKELKHRNLV 73
+IG + VY G L D + AVK LN F E +K+ H N++
Sbjct: 95 EVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLN-RITDIGEVSQFLTEGIIMKDFSHPNVL 153
Query: 74 KVLGYAWESGKLKALILEYMENGSLESVIHGPGVDHSRWTLPKRIDVLISVANGLDYLHS 133
+LG S ++L YM++G L + I T+ I + VA G+ +L S
Sbjct: 154 SLLGICLRSEGSPLVVLPYMKHGDLRNFIRNET---HNPTVKDLIGFGLQVAKGMKFLAS 210
Query: 134 GYDIPIVHCDMKPSNILLDRDFEAHVSDFGTSRMLDVHLQDLSSLSTAFQGTIGYL---- 189
VH D+ N +LD F V+DFG +R D++ ++ S T L
Sbjct: 211 ---KKFVHRDLAARNCMLDEKFTVKVADFGLAR--DMYDKEFDS---VHNKTGAKLPVKW 262
Query: 190 -APEFAYMRIVTTKVDVFSFGIVVMEFLTK-RRPTGLDEENGLSPISLRQLVEKALANGI 247
A E + TTK DV+SFG+++ E +T+ P ++ + + +
Sbjct: 263 MALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYP-----DVNTFDITVYLLQ------ 311
Query: 248 NGVRQITDPKLVSSIYEEQEQHQVLEELFKLALVCTSSNPEDRPNMNELL 297
G R + P+ + L+++ L C E RP+ +EL+
Sbjct: 312 -GRR-LLQPEYCP------------DPLYEVMLKCWHPKAEMRPSFSELV 347
|
| >1byg_A CSK, protein (C-terminal SRC kinase); protein kinase, phosphorylation, staurosporine, transferase; HET: STU; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 3d7u_A 3d7t_A* Length = 278 | Back alignment and structure |
|---|
Score = 111 bits (281), Expect = 2e-29
Identities = 66/287 (22%), Positives = 111/287 (38%), Gaps = 55/287 (19%)
Query: 18 NIIGNSNLSTVYKGRLEDGEIVAVKKLNFHQFSAESDKSFYREAKTLKELKHRNLVKVLG 77
IG V G G VAVK + + + ++F EA + +L+H NLV++LG
Sbjct: 27 QTIGKGEFGDVMLGDYR-GNKVAVKCIK----NDATAQAFLAEASVMTQLRHSNLVQLLG 81
Query: 78 YAWESGKLKALILEYMENGSLESVIHGPGVDHSRWTLPKRIDVLISVANGLDYLHS-GYD 136
E ++ EYM GSL + G S + + V ++YL +
Sbjct: 82 VIVEEKGGLYIVTEYMAKGSLVDYLRSRG--RSVLGGDCLLKFSLDVCEAMEYLEGNNF- 138
Query: 137 IPIVHCDMKPSNILLDRDFEAHVSDFGTSRMLDVHLQDLSSLSTAFQGT---IGYLAPEF 193
VH D+ N+L+ D A VSDFG ++ + + + + APE
Sbjct: 139 ---VHRDLAARNVLVSEDNVAKVSDFGLTK--EAS--------STQDTGKLPVKWTAPEA 185
Query: 194 AYMRIVTTKVDVFSFGIVVMEFLTKRRPTGLDEENGLSP---ISLRQLVEKALANGINGV 250
+ +TK DV+SFGI++ E + G P I L+ +V + G
Sbjct: 186 LREKKFSTKSDVWSFGILLWEIYSF----------GRVPYPRIPLKDVVPRV----EKGY 231
Query: 251 RQITDPKLVSSIYEEQEQHQVLEELFKLALVCTSSNPEDRPNMNELL 297
+ + P ++++ C + RP+ +L
Sbjct: 232 K-MDAPDGCP------------PAVYEVMKNCWHLDAAMRPSFLQLR 265
|
| >1qpc_A LCK kinase; alpha beta fold, transferase; HET: PTR ANP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1qpe_A* 1qpj_A* 2pl0_A* 3kxz_A* 3ac1_A* 2zm4_A* 2zyb_A* 2zm1_A* 3ac2_A* 3ac3_A* 3ac4_A* 3ac5_A* 3ac8_A* 3acj_A* 3ack_A* 3ad4_A* 3ad5_A* 3ad6_A* 3kmm_A* 1qpd_A* ... Length = 279 | Back alignment and structure |
|---|
Score = 111 bits (281), Expect = 2e-29
Identities = 78/285 (27%), Positives = 127/285 (44%), Gaps = 47/285 (16%)
Query: 18 NIIGNSNLSTVYKGRLEDGEIVAVKKLNFHQFSAESDKSFYREAKTLKELKHRNLVKVLG 77
+G V+ G VAVK L + S +F EA +K+L+H+ LV++
Sbjct: 19 ERLGAGQFGEVWMGYYNGHTKVAVKSLKQ---GSMSPDAFLAEANLMKQLQHQRLVRLYA 75
Query: 78 YAWESGKLKALILEYMENGSLESVIHGPGVDHSRWTLPKRIDVLISVANGLDYLHS-GYD 136
+ +I EYMENGSL + P + T+ K +D+ +A G+ ++ Y
Sbjct: 76 VVTQEPIY--IITEYMENGSLVDFLKTP--SGIKLTINKLLDMAAQIAEGMAFIEERNY- 130
Query: 137 IPIVHCDMKPSNILLDRDFEAHVSDFGTSRMLDVHLQDLSSLSTAFQGT---IGYLAPEF 193
+H D++ +NIL+ ++DFG +R+++ + TA +G I + APE
Sbjct: 131 ---IHRDLRAANILVSDTLSCKIADFGLARLIE------DNEYTAREGAKFPIKWTAPEA 181
Query: 194 AYMRIVTTKVDVFSFGIVVMEFLTK-RRPTGLDEENGLSPISLRQLVEKALANGINGVRQ 252
T K DV+SFGI++ E +T R P G++ + Q +E+ G R
Sbjct: 182 INYGTFTIKSDVWSFGILLTEIVTHGRIPYP-----GMTNPEVIQNLER-------GYR- 228
Query: 253 ITDPKLVSSIYEEQEQHQVLEELFKLALVCTSSNPEDRPNMNELL 297
+ P EEL++L +C PEDRP + L
Sbjct: 229 MVRPDNCP------------EELYQLMRLCWKERPEDRPTFDYLR 261
|
| >2w1i_A JAK2; chromosomal rearrangement, nucleotide-binding, tyrosine-protein kinase, proto-oncogene, phosphoprotein, disease mutation, SH2 domain; HET: PTR L0I; 2.60A {Homo sapiens} Length = 326 | Back alignment and structure |
|---|
Score = 112 bits (283), Expect = 2e-29
Identities = 77/319 (24%), Positives = 122/319 (38%), Gaps = 64/319 (20%)
Query: 3 DRTEIENATGSFSENNIIGNSNLSTVYKGRLE-----DGEIVAVKKLNFHQFSAESDKSF 57
D T+ E F + +G N +V R + GE+VAVKKL D F
Sbjct: 34 DPTQFEERHLKFLQ--QLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRD--F 89
Query: 58 YREAKTLKELKHRNLVKVLGYAWESGKLKA-LILEYMENGSLESVIHGPGVDHSRWTLPK 116
RE + LK L+H N+VK G + +G+ LI+EY+ GSL + R K
Sbjct: 90 EREIEILKSLQHDNIVKYKGVCYSAGRRNLKLIMEYLPYGSLRDYLQKHK---ERIDHIK 146
Query: 117 RIDVLISVANGLDYLHS-GYDIPIVHCDMKPSNILLDRDFEAHVSDFGTSRMLDVHLQDL 175
+ + G++YL + Y +H D+ NIL++ + + DFG +++L
Sbjct: 147 LLQYTSQICKGMEYLGTKRY----IHRDLATRNILVENENRVKIGDFGLTKVLPQD---- 198
Query: 176 SSLSTAFQGT---IGYLAPEFAYMRIVTTKVDVFSFGIVVMEFLT-----KRRPTGLDEE 227
+ I + APE + DV+SFG+V+ E T K P
Sbjct: 199 KEYYKVKEPGESPIFWYAPESLTESKFSVASDVWSFGVVLYELFTYIEKSKSPPAEFMRM 258
Query: 228 NGLSP---ISLRQLVEKALANGINGVRQITDPKLVSSIYEEQEQHQVLE-------ELFK 277
G + + L+E L N L E++
Sbjct: 259 IGNDKQGQMIVFHLIEL-LKNN-----------------------GRLPRPDGCPDEIYM 294
Query: 278 LALVCTSSNPEDRPNMNEL 296
+ C ++N RP+ +L
Sbjct: 295 IMTECWNNNVNQRPSFRDL 313
|
| >3kfa_A Tyrosine-protein kinase ABL1; CML, drug resistance, inhibitor, ATP-binding, nucleotide-binding, oncogene, TRAN; HET: B91; 1.22A {Mus musculus} PDB: 2qoh_A* 3kf4_A* 3k5v_A* 1fpu_A* 1m52_A* 1iep_A* 2hzn_A* 1opj_A* 3ms9_A* 3mss_A* 3ik3_A* 2z60_A* 2e2b_A* 3pyy_A* 3oxz_A* 2g1t_A* 3ue4_A* 3oy3_A* 2hiw_A* 2v7a_A* ... Length = 288 | Back alignment and structure |
|---|
Score = 111 bits (281), Expect = 3e-29
Identities = 71/288 (24%), Positives = 118/288 (40%), Gaps = 51/288 (17%)
Query: 18 NIIGNSNLSTVYKGRLEDGEI-VAVKKLNFHQFSAESDKSFYREAKTLKELKHRNLVKVL 76
+ +G VY+G + + VAVK L E F +EA +KE+KH NLV++L
Sbjct: 19 HKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEE---FLKEAAVMKEIKHPNLVQLL 75
Query: 77 GYAWESGKLKALILEYMENGSLESVIHGPGVDHSRWTLPKRIDVLISVANGLDYLHS-GY 135
G +I E+M G+L + + + + +++ ++YL +
Sbjct: 76 GVCTREPPF-YIITEFMTYGNLLDYLRECN--RQEVSAVVLLYMATQISSAMEYLEKKNF 132
Query: 136 DIPIVHCDMKPSNILLDRDFEAHVSDFGTSRMLDVHLQDLSSLSTAFQGT---IGYLAPE 192
+H D+ N L+ + V+DFG SR++ TA G I + APE
Sbjct: 133 ----IHRDLAARNCLVGENHLVKVADFGLSRLMT------GDTYTAHAGAKFPIKWTAPE 182
Query: 193 FAYMRIVTTKVDVFSFGIVVMEFLTKRRPTGLDEENGLSP---ISLRQLVEKALANGING 249
+ K DV++FG+++ E T G+SP I L Q+ E
Sbjct: 183 SLAYNKFSIKSDVWAFGVLLWEIATY----------GMSPYPGIDLSQVYELL----EKD 228
Query: 250 VRQITDPKLVSSIYEEQEQHQVLEELFKLALVCTSSNPEDRPNMNELL 297
R + P+ E++++L C NP DRP+ E+
Sbjct: 229 YR-MERPEGCP------------EKVYELMRACWQWNPSDRPSFAEIH 263
|
| >4g31_A Eukaryotic translation initiation factor 2-alpha; deletion mutant, catalytic domain, synthetic inhibitor, TRAN transferase inhibitor complex; HET: 0WH; 2.28A {Homo sapiens} PDB: 4g34_A* Length = 299 | Back alignment and structure |
|---|
Score = 111 bits (280), Expect = 4e-29
Identities = 58/299 (19%), Positives = 111/299 (37%), Gaps = 54/299 (18%)
Query: 20 IGNSNLSTVYKGR-LEDGEIVAVKKLNFHQFSAESDKSFYREAKTLKELKHRNLVKVLGY 78
+G V++ + D A+K++ + + RE K L +L+H +V+
Sbjct: 13 LGRGGFGVVFEAKNKVDDCNYAIKRIRLPN-RELAREKVMREVKALAKLEHPGIVRYFNA 71
Query: 79 AWESGKLKA-----------LILEYMENGSLESVIHG-PGVDHSRWTLPKRIDVLISVAN 126
E + + ++ +L+ ++G ++ ++ I + +A
Sbjct: 72 WLEKNTTEKLQPSSPKVYLYIQMQLCRKENLKDWMNGRCTIEERERSVCLHI--FLQIAE 129
Query: 127 GLDYLHSGYDIPIVHCDMKPSNILLDRDFEAHVSDFGTSRMLD--------VHLQDLSSL 178
+++LHS ++H D+KPSNI D V DFG +D + +
Sbjct: 130 AVEFLHS---KGLMHRDLKPSNIFFTMDDVVKVGDFGLVTAMDQDEEEQTVLTPMPAYAR 186
Query: 179 STAFQGTIGYLAPEFAYMRIVTTKVDVFSFGIVVMEFLTKRRPTGLDEENGLSPISLRQL 238
T GT Y++PE + + KVD+FS G+++ E L S R
Sbjct: 187 HTGQVGTKLYMSPEQIHGNSYSHKVDIFSLGLILFELLYP-----------FSTQMERVR 235
Query: 239 VEKALANGINGVRQITDPKLVSSIYEEQEQHQVLEELFKLALVCTSSNPEDRPNMNELL 297
+ VR + P L + Y + + S +P +RP ++
Sbjct: 236 T-------LTDVRNLKFPPLFTQKY---------PCEYVMVQDMLSPSPMERPEAINII 278
|
| >3lxp_A Non-receptor tyrosine-protein kinase TYK2; JAK3, inflammation, cancer, PAN inhibitor, ATP-binding nucleotide-binding, phosphoprotein, SH2 domain; HET: PTR IZA; 1.65A {Homo sapiens} PDB: 3lxn_A* 3nz0_A* 3nyx_A* Length = 318 | Back alignment and structure |
|---|
Score = 112 bits (281), Expect = 5e-29
Identities = 64/307 (20%), Positives = 111/307 (36%), Gaps = 42/307 (13%)
Query: 3 DRTEIENATGSFSENNIIGNSNLSTVYKGRLED-----GEIVAVKKLNFHQFSAESDKSF 57
D T + +G + V + GE+VAVK L + +
Sbjct: 24 DPTVFHKR--YLKKIRDLGEGHFGKVSLYCYDPTNDGTGEMVAVKALKADA-GPQHRSGW 80
Query: 58 YREAKTLKELKHRNLVKVLGYAWESGKLKA-LILEYMENGSLESVIHGPGVDHSRWTLPK 116
+E L+ L H +++K G ++G L++EY+ GSL + L +
Sbjct: 81 KQEIDILRTLYHEHIIKYKGCCEDAGAASLQLVMEYVPLGSLRDYLPR-----HSIGLAQ 135
Query: 117 RIDVLISVANGLDYLHSGYDIPIVHCDMKPSNILLDRDFEAHVSDFGTSRMLDVHLQDLS 176
+ + G+ YLH+ +H D+ N+LLD D + DFG ++ + +
Sbjct: 136 LLLFAQQICEGMAYLHA---QHYIHRDLAARNVLLDNDRLVKIGDFGLAKAVPEG-HEYY 191
Query: 177 SLSTAFQGTIGYLAPEFAYMRIVTTKVDVFSFGIVVMEFLTKRRPTGLDEENGLSPISLR 236
+ + + APE DV+SFG+ + E LT + L I +
Sbjct: 192 RVREDGDSPVFWYAPECLKEYKFYYASDVWSFGVTLYELLTHCDSSQSPPTKFLELIGIA 251
Query: 237 QLVEKALANGINGVRQITDPKLVSSIYEEQEQHQVLE-------ELFKLALVCTSSNPED 289
Q Q+T +L + E+ + L E++ L C +
Sbjct: 252 Q-------------GQMTVLRLTELL----ERGERLPRPDKCPAEVYHLMKNCWETEASF 294
Query: 290 RPNMNEL 296
RP L
Sbjct: 295 RPTFENL 301
|
| >3t9t_A Tyrosine-protein kinase ITK/TSK; kinase domain, alpha/beta, ATP binding, phosphorylation, intracellular, transferase-transferase inhibitor complex; HET: IAQ; 1.65A {Homo sapiens} PDB: 3v5l_A* 3v5j_A* 3v8t_A* 3v8w_A* 1sm2_A* 1snu_A* 1snx_A 3qgw_A* 3qgy_A* 3miy_A* 3mj1_A* 3mj2_A* Length = 267 | Back alignment and structure |
|---|
Score = 110 bits (278), Expect = 5e-29
Identities = 68/287 (23%), Positives = 118/287 (41%), Gaps = 51/287 (17%)
Query: 18 NIIGNSNLSTVYKGRLEDGEIVAVKKLNFHQFSAESDKSFYREAKTLKELKHRNLVKVLG 77
IG+ V+ G + + VA+K + A S++ F EA+ + +L H LV++ G
Sbjct: 14 QEIGSGQFGLVHLGYWLNKDKVAIKTIRE---GAMSEEDFIEEAEVMMKLSHPKLVQLYG 70
Query: 78 YAWESGKLKALILEYMENGSLESVIHGPGVDHSRWTLPKRIDVLISVANGLDYLHS-GYD 136
E + L+ E+ME+G L + + + + + V G+ YL
Sbjct: 71 VCLEQAPI-CLVTEFMEHGCLSDYLRTQR---GLFAAETLLGMCLDVCEGMAYLEEACV- 125
Query: 137 IPIVHCDMKPSNILLDRDFEAHVSDFGTSRMLDVHLQDLSSLSTAFQGT---IGYLAPEF 193
+H D+ N L+ + VSDFG +R + T+ GT + + +PE
Sbjct: 126 ---IHRDLAARNCLVGENQVIKVSDFGMTRFVL------DDQYTSSTGTKFPVKWASPEV 176
Query: 194 AYMRIVTTKVDVFSFGIVVMEFLTKRRPTGLDEENGLSP---ISLRQLVEKALANGINGV 250
++K DV+SFG+++ E ++ G P S ++VE G
Sbjct: 177 FSFSRYSSKSDVWSFGVLMWEVFSE----------GKIPYENRSNSEVVEDIS----TGF 222
Query: 251 RQITDPKLVSSIYEEQEQHQVLEELFKLALVCTSSNPEDRPNMNELL 297
R + P+L S ++++ C PEDRP + LL
Sbjct: 223 R-LYKPRLAS------------THVYQIMNHCWRERPEDRPAFSRLL 256
|
| >3sxs_A Cytoplasmic tyrosine-protein kinase BMX; transferase-transferase inhibitor complex; HET: PP2; 1.89A {Homo sapiens} PDB: 3sxr_A* Length = 268 | Back alignment and structure |
|---|
Score = 110 bits (277), Expect = 7e-29
Identities = 69/286 (24%), Positives = 121/286 (42%), Gaps = 51/286 (17%)
Query: 19 IIGNSNLSTVYKGRLEDGEIVAVKKLNFHQFSAESDKSFYREAKTLKELKHRNLVKVLGY 78
+G+ V G+ + VAVK + + S+ F++EA+T+ +L H LVK G
Sbjct: 15 ELGSGQFGVVKLGKWKGQYDVAVKMIKE---GSMSEDEFFQEAQTMMKLSHPKLVKFYGV 71
Query: 79 AWESGKLKALILEYMENGSLESVIHGPGVDHSRWTLPKRIDVLISVANGLDYLHS-GYDI 137
+ + ++ EY+ NG L + + G + +++ V G+ +L S +
Sbjct: 72 CSKEYPI-YIVTEYISNGCLLNYLRSHG---KGLEPSQLLEMCYDVCEGMAFLESHQF-- 125
Query: 138 PIVHCDMKPSNILLDRDFEAHVSDFGTSRMLDVHLQDLSSLSTAFQGT---IGYLAPEFA 194
+H D+ N L+DRD VSDFG +R + + GT + + APE
Sbjct: 126 --IHRDLAARNCLVDRDLCVKVSDFGMTRYVL------DDQYVSSVGTKFPVKWSAPEVF 177
Query: 195 YMRIVTTKVDVFSFGIVVMEFLTKRRPTGLDEENGLSP---ISLRQLVEKALANGINGVR 251
+ ++K DV++FGI++ E + G P + ++V K G R
Sbjct: 178 HYFKYSSKSDVWAFGILMWEVFSL----------GKMPYDLYTNSEVVLKV----SQGHR 223
Query: 252 QITDPKLVSSIYEEQEQHQVLEELFKLALVCTSSNPEDRPNMNELL 297
+ P L S + ++++ C PE RP +LL
Sbjct: 224 -LYRPHLAS------------DTIYQIMYSCWHELPEKRPTFQQLL 256
|
| >1mqb_A Ephrin type-A receptor 2; tyrosine protein kinase, transferase; HET: ANP; 2.30A {Homo sapiens} SCOP: d.144.1.7 Length = 333 | Back alignment and structure |
|---|
Score = 111 bits (280), Expect = 9e-29
Identities = 65/213 (30%), Positives = 104/213 (48%), Gaps = 23/213 (10%)
Query: 19 IIGNSNLSTVYKGRL----EDGEI-VAVKKLNFHQFSAESDKSFYREAKTLKELKHRNLV 73
+IG VYKG L E+ VA+K L ++ + F EA + + H N++
Sbjct: 51 VIGAGEFGEVYKGMLKTSSGKKEVPVAIKTLK-AGYTEKQRVDFLGEAGIMGQFSHHNII 109
Query: 74 KVLGYAWESGKLKALILEYMENGSLESVIHGPGVDHSRWTLPKRIDVLISVANGLDYLHS 133
++ G + + +I EYMENG+L+ + +++ + + +L +A G+ YL +
Sbjct: 110 RLEGVISKYKPM-MIITEYMENGALDKFLREKD---GEFSVLQLVGMLRGIAAGMKYLAN 165
Query: 134 -GYDIPIVHCDMKPSNILLDRDFEAHVSDFGTSRMLDVHLQDLSSLSTAFQGT---IGYL 189
Y VH D+ NIL++ + VSDFG SR+L +D + G I +
Sbjct: 166 MNY----VHRDLAARNILVNSNLVCKVSDFGLSRVL----EDDPEATYTTSGGKIPIRWT 217
Query: 190 APEFAYMRIVTTKVDVFSFGIVVMEFLTK-RRP 221
APE R T+ DV+SFGIV+ E +T RP
Sbjct: 218 APEAISYRKFTSASDVWSFGIVMWEVMTYGERP 250
|
| >3kul_A Ephrin type-A receptor 8; ATP-binding, kinase, nucleotide-binding, transfera phosphorylation, transmembrane, tyrosine-protein kinase; HET: PTR; 2.15A {Homo sapiens} Length = 325 | Back alignment and structure |
|---|
Score = 111 bits (279), Expect = 9e-29
Identities = 64/213 (30%), Positives = 103/213 (48%), Gaps = 22/213 (10%)
Query: 18 NIIGNSNLSTVYKGRL---EDGEI-VAVKKLNFHQFSAESDKSFYREAKTLKELKHRNLV 73
IIG+ + V GRL ++ VA+K L ++ + F EA + + H N++
Sbjct: 55 KIIGSGDSGEVCYGRLRVPGQRDVPVAIKALK-AGYTERQRRDFLSEASIMGQFDHPNII 113
Query: 74 KVLGYAWESGKLKALILEYMENGSLESVIHGPGVDHSRWTLPKRIDVLISVANGLDYLHS 133
++ G ++ EYMENGSL++ + ++T+ + + +L V G+ YL
Sbjct: 114 RLEGVVTRGRLA-MIVTEYMENGSLDTFLRTHD---GQFTIMQLVGMLRGVGAGMRYLSD 169
Query: 134 -GYDIPIVHCDMKPSNILLDRDFEAHVSDFGTSRMLDVHLQDLSSLSTAFQGT---IGYL 189
GY VH D+ N+L+D + VSDFG SR+L +D + G I +
Sbjct: 170 LGY----VHRDLAARNVLVDSNLVCKVSDFGLSRVL----EDDPDAAYTTTGGKIPIRWT 221
Query: 190 APEFAYMRIVTTKVDVFSFGIVVMEFLTK-RRP 221
APE R ++ DV+SFG+V+ E L RP
Sbjct: 222 APEAIAFRTFSSASDVWSFGVVMWEVLAYGERP 254
|
| >2qol_A Ephrin receptor; receptor tyrosine kinase, juxtamembrane segment, structural genomics, mutant, structural genomics consortium, SGC, ATP- binding; 1.07A {Homo sapiens} PDB: 2qok_A 2qoi_A 2qoo_A 2qof_A 2qod_A 2qo9_A* 2gsf_A 2qo7_A* 2qo2_A* 2qoq_A* 2qon_A* 3fxx_A* 3fy2_A 2qoc_A* 2qob_A* 3dzq_A* 2r2p_A 2hel_A 2rei_A 3dko_A* ... Length = 373 | Back alignment and structure |
|---|
Score = 112 bits (281), Expect = 1e-28
Identities = 64/213 (30%), Positives = 108/213 (50%), Gaps = 22/213 (10%)
Query: 18 NIIGNSNLSTVYKGRL---EDGEI-VAVKKLNFHQFSAESDKSFYREAKTLKELKHRNLV 73
++G V GRL EI VA+K L ++ + + F EA + + H N++
Sbjct: 51 KVVGAGEFGEVCSGRLKLPSKKEISVAIKTLK-VGYTEKQRRDFLGEASIMGQFDHPNII 109
Query: 74 KVLGYAWESGKLKALILEYMENGSLESVIHGPGVDHSRWTLPKRIDVLISVANGLDYLHS 133
++ G + K ++ EYMENGSL+S + +++T+ + + +L +A+G+ YL
Sbjct: 110 RLEGVVTK-SKPVMIVTEYMENGSLDSFLRKHD---AQFTVIQLVGMLRGIASGMKYLSD 165
Query: 134 -GYDIPIVHCDMKPSNILLDRDFEAHVSDFGTSRMLDVHLQDLSSLSTAFQGT---IGYL 189
GY VH D+ NIL++ + VSDFG R+L+ D + +G I +
Sbjct: 166 MGY----VHRDLAARNILINSNLVCKVSDFGLGRVLE----DDPEAAYTTRGGKIPIRWT 217
Query: 190 APEFAYMRIVTTKVDVFSFGIVVMEFLTK-RRP 221
+PE R T+ DV+S+GIV+ E ++ RP
Sbjct: 218 SPEAIAYRKFTSASDVWSYGIVLWEVMSYGERP 250
|
| >3gen_A Tyrosine-protein kinase BTK; bruton'S tyrosine kinase, 4-amino-5-(4-phenoxyphenyl)-5H- pyrrolo[3, 2-D]pyrimidin-7-YL-cyclopentane, TEC-family; HET: B43; 1.60A {Homo sapiens} PDB: 3k54_A* 3pj2_A* 3piy_A* 3piz_A* 3pj1_A* 3pix_A* 3pj3_A* 3p08_A 3ocs_A* 3oct_A* 1k2p_A Length = 283 | Back alignment and structure |
|---|
Score = 110 bits (277), Expect = 1e-28
Identities = 51/225 (22%), Positives = 95/225 (42%), Gaps = 24/225 (10%)
Query: 2 FDRTEIENATGSFSENNIIGNSNLSTVYKGRLEDGEIVAVKKLNFHQFSAESDKSFYREA 61
+ EI+ + +G V G+ VA+K + + S+ F EA
Sbjct: 16 YGSWEIDPK--DLTFLKELGTGQFGVVKYGKWRGQYDVAIKMIKE---GSMSEDEFIEEA 70
Query: 62 KTLKELKHRNLVKVLGYAWESGKLKALILEYMENGSLESVIHGPGVDHSRWTLPKRIDVL 121
K + L H LV++ G + + +I EYM NG L + + R+ + +++
Sbjct: 71 KVMMNLSHEKLVQLYGVCTKQRPI-FIITEYMANGCLLNYLREMR---HRFQTQQLLEMC 126
Query: 122 ISVANGLDYLHS-GYDIPIVHCDMKPSNILLDRDFEAHVSDFGTSRMLDVHLQDLSSLST 180
V ++YL S + +H D+ N L++ VSDFG SR + T
Sbjct: 127 KDVCEAMEYLESKQF----LHRDLAARNCLVNDQGVVKVSDFGLSRYVL------DDEYT 176
Query: 181 AFQGT---IGYLAPEFAYMRIVTTKVDVFSFGIVVMEFLTK-RRP 221
+ G+ + + PE ++K D+++FG+++ E + + P
Sbjct: 177 SSVGSKFPVRWSPPEVLMYSKFSSKSDIWAFGVLMWEIYSLGKMP 221
|
| >1zy4_A Serine/threonine-protein kinase GCN2; translation regulator, signal transduction, acid starvation, starvation stress response; 1.95A {Saccharomyces cerevisiae} PDB: 1zy5_A* 1zyd_A* 1zyc_A* 1zxe_A Length = 303 | Back alignment and structure |
|---|
Score = 109 bits (275), Expect = 3e-28
Identities = 68/311 (21%), Positives = 106/311 (34%), Gaps = 63/311 (20%)
Query: 14 FSENNIIGNSNLSTVYKGR-LEDGEIVAVKKLNFHQFSAESDKSFYREAKTLKELKHRNL 72
F E ++G V K R D A+KK+ + E + E L L H+ +
Sbjct: 8 FEEIAVLGQGAFGQVVKARNALDSRYYAIKKIRH---TEEKLSTILSEVMLLASLNHQYV 64
Query: 73 VKVLGYAWESGKLKA-------------LILEYMENGSLESVIHGPGVDHSRWTLPKRID 119
V+ AW + + +EY ENG+L +I +
Sbjct: 65 VRYYA-AWLERRNFVKPMTAVKKKSTLFIQMEYCENGTLYDLI----HSENLNQQRDEYW 119
Query: 120 VLIS-VANGLDYLHS-GYDIPIVHCDMKPSNILLDRDFEAHVSDFGTSRMLDVHLQDLSS 177
L + L Y+HS G I+H D+KP NI +D + DFG ++ + L L
Sbjct: 120 RLFRQILEALSYIHSQG----IIHRDLKPMNIFIDESRNVKIGDFGLAKNVHRSLDILKL 175
Query: 178 LSTAFQ----------GTIGYLAPE-FAYMRIVTTKVDVFSFGIVVMEFLTKRRPTGLDE 226
S GT Y+A E K+D++S GI+ E +
Sbjct: 176 DSQNLPGSSDNLTSAIGTAMYVATEVLDGTGHYNEKIDMYSLGIIFFEMIY--------- 226
Query: 227 ENGLSPISLRQLVEKALANGINGVRQITDPKLVSSIYEEQEQHQVLEELFKLALVCTSSN 286
S R + K L + I P + + +++ L +
Sbjct: 227 --PFSTGMERVNILKKLRSV-----SIEFPPDFDDNKMK-VEKKIIRLLIDH-------D 271
Query: 287 PEDRPNMNELL 297
P RP LL
Sbjct: 272 PNKRPGARTLL 282
|
| >1xbb_A Tyrosine-protein kinase SYK; gleevec, STI-571, imatinib, spleen typrosine kinase, active conformation, structural genomics, structural genomix; HET: STI; 1.57A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xba_A* 1xbc_A* 3fqe_A* 3fqh_A* 3fqs_A* 3emg_A* 3srv_A* 4dfl_A* 4dfn_A* 3vf8_A* 3vf9_A* Length = 291 | Back alignment and structure |
|---|
Score = 109 bits (274), Expect = 3e-28
Identities = 52/214 (24%), Positives = 91/214 (42%), Gaps = 22/214 (10%)
Query: 16 ENNIIGNSNLSTVYKGRL--EDGEI-VAVKKLNFHQFSAESDKSFYREAKTLKELKHRNL 72
E+ +G+ N TV KG + VAVK L EA +++L + +
Sbjct: 21 EDKELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYI 80
Query: 73 VKVLGYAWESGKLKALILEYMENGSLESVIHGPGVDHSRWTLPKRIDVLISVANGLDYLH 132
V+++G + L++E E G L + + I+++ V+ G+ YL
Sbjct: 81 VRMIGICEAESWM--LVMEMAELGPLNKYLQ----QNRHVKDKNIIELVHQVSMGMKYLE 134
Query: 133 S-GYDIPIVHCDMKPSNILLDRDFEAHVSDFGTSRMLDVHLQDLSSLSTAFQGT---IGY 188
+ VH D+ N+LL A +SDFG S+ L + A + +
Sbjct: 135 ESNF----VHRDLAARNVLLVTQHYAKISDFGLSKALR----ADENYYKAQTHGKWPVKW 186
Query: 189 LAPEFAYMRIVTTKVDVFSFGIVVMEFLTK-RRP 221
APE ++K DV+SFG+++ E + ++P
Sbjct: 187 YAPECINYYKFSSKSDVWSFGVLMWEAFSYGQKP 220
|
| >3qa8_A MGC80376 protein; kinase ubiquitin-like domain, phosphorylation, kinase domain ubiquitin-like domain, kinase, substrate binding; 3.60A {Xenopus laevis} PDB: 3qad_A* 3rzf_A* Length = 676 | Back alignment and structure |
|---|
Score = 112 bits (281), Expect = 5e-28
Identities = 68/303 (22%), Positives = 113/303 (37%), Gaps = 35/303 (11%)
Query: 11 TGSFSENNIIGNSNLSTVYKGR-LEDGEIVAVKKLNFHQFSAESDKSFYREAKTLKELKH 69
G + +G V + + GE VA+K+ + S ++ + + E + +K+L H
Sbjct: 13 CGPWEMKERLGTGGFGYVLRWIHQDTGEQVAIKQCR-QELSPKNRERWCLEIQIMKKLNH 71
Query: 70 RNLVKVL-----GYAWESGKLKALILEYMENGSLESVIHGPGVDHSRWTLPKRI--DVLI 122
N+V L L +EY E G L ++ + L + +L
Sbjct: 72 PNVVSAREVPDGLQKLAPNDLPLLAMEYCEGGDLRKYLNQFE---NCCGLKEGPIRTLLS 128
Query: 123 SVANGLDYLHSGYDIPIVHCDMKPSNILLDRDFEAH---VSDFGTSRMLDVHLQDLSSLS 179
+++ L YLH I+H D+KP NI+L + + D G ++ LD +
Sbjct: 129 DISSALRYLHENR---IIHRDLKPENIVLQPGPQRLIHKIIDLGYAKELD----QGELCT 181
Query: 180 TAFQGTIGYLAPEFAYMRIVTTKVDVFSFGIVVMEFLTKRRPTGLDEENGLSPISLRQLV 239
F GT+ YLAPE + T VD +SFG + E +T RP P+ V
Sbjct: 182 E-FVGTLQYLAPELLEQKKYTVTVDYWSFGTLAFECITGFRPF----LPNWQPVQWHGKV 236
Query: 240 EKALANGINGVRQITDPKLVSSIYEEQEQ-----HQVLEELFKLALVCTSSNPEDRPNMN 294
+ I +T SS+ LE + L+ + R
Sbjct: 237 REKSNEHIVVYDDLTGAVKFSSVLPTPNHLSGILAGKLERWLQCMLMW---HQRQRGTDP 293
Query: 295 ELL 297
+
Sbjct: 294 QNP 296
|
| >4euu_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: SEP BX7; 1.80A {Homo sapiens} Length = 319 | Back alignment and structure |
|---|
Score = 109 bits (273), Expect = 7e-28
Identities = 66/302 (21%), Positives = 119/302 (39%), Gaps = 39/302 (12%)
Query: 19 IIGNSNLSTVYKGR-LEDGEIVAVKKLNFHQFSAESDKSFYREAKTLKELKHRNLVKVLG 77
I+G + V++GR + G++ A+K N F D RE + LK+L H+N+VK+
Sbjct: 16 ILGQGATANVFRGRHKKTGDLFAIKVFNNISFLRPVDV-QMREFEVLKKLNHKNIVKLFA 74
Query: 78 -YAWESGKLKALILEYMENGSLESVIHGPGVDHSRWTLPKR--IDVLISVANGLDYLHSG 134
+ + K LI+E+ GSL +V+ P + + LP+ + VL V G+++L
Sbjct: 75 IEEETTTRHKVLIMEFCPCGSLYTVLEEPS---NAYGLPESEFLIVLRDVVGGMNHLRE- 130
Query: 135 YDIPIVHCDMKPSNILLDRDFEAH----VSDFGTSRMLDVHLQDLSSLSTAFQGTIGYLA 190
IVH ++KP NI+ + ++DFG +R L+ D + + GT YL
Sbjct: 131 --NGIVHRNIKPGNIMRVIGEDGQSVYKLTDFGAARELE----DDEQFVSLY-GTEEYLH 183
Query: 191 PE--------FAYMRIVTTKVDVFSFGIVVMEFLTKRRPTGLDEENGLSPISLRQLVEKA 242
P+ + + VD++S G+ T P E + +
Sbjct: 184 PDMYERAVLRKDHQKKYGATVDLWSIGVTFYHAATGSLPF-RPFEGPRRNKEVMYKIITG 242
Query: 243 LANGINGVRQITDPKLVSSIYEEQEQHQV-------LEELFKLALVCTSSNPEDRPNMNE 295
+G Q + + + + L + L + E ++
Sbjct: 243 KPSGAISGVQKAENGPIDWSGDMPVSCSLSRGLQVLLTPVLANILEA---DQEKCWGFDQ 299
Query: 296 LL 297
Sbjct: 300 FF 301
|
| >2rio_A Serine/threonine-protein kinase/endoribonuclease IRE1; protein-nucleotide complex, ATP-binding, endoplasmic reticulum, glycoprotein; HET: ADP; 2.40A {Saccharomyces cerevisiae} PDB: 3lj0_A* 3lj1_A* 3lj2_A* 3fbv_A* 3sdm_A* 3sdj_A* Length = 434 | Back alignment and structure |
|---|
Score = 110 bits (276), Expect = 1e-27
Identities = 58/244 (23%), Positives = 93/244 (38%), Gaps = 38/244 (15%)
Query: 6 EIENATGSFSE----NNIIGNSNLSTVYKGRLEDGEIVAVKKLNFHQFSAESDKSFYREA 61
I N S I+G + TV G VAVK++ + E
Sbjct: 5 NIPNFEQSLKNLVVSEKILGYGSSGTVVFQGSFQGRPVAVKRML-----IDFCDIALMEI 59
Query: 62 KTLKELK-HRNLVKVLGYAWESGKLKALILEYMENGSLESVIHGPGV---DHSRWTLPKR 117
K L E H N+++ + + + LE +L+ ++ V +
Sbjct: 60 KLLTESDDHPNVIRYYCS-ETTDRFLYIALELCN-LNLQDLVESKNVSDENLKLQKEYNP 117
Query: 118 IDVLISVANGLDYLHSGYDIPIVHCDMKPSNILLD-------------RDFEAHVSDFGT 164
I +L +A+G+ +LHS + I+H D+KP NIL+ + +SDFG
Sbjct: 118 ISLLRQIASGVAHLHS---LKIIHRDLKPQNILVSTSSRFTADQQTGAENLRILISDFGL 174
Query: 165 SRMLDVHLQDLSSLSTAFQGTIGYLAPE-------FAYMRIVTTKVDVFSFGIVVMEFLT 217
+ LD + GT G+ APE R +T +D+FS G V L+
Sbjct: 175 CKKLDSGQSSFRTNLNNPSGTSGWRAPELLEESNNLQTKRRLTRSIDIFSMGCVFYYILS 234
Query: 218 KRRP 221
K +
Sbjct: 235 KGKH 238
|
| >3cc6_A Protein tyrosine kinase 2 beta; focal adhesion kinase, structural genomics, structural genom consortium, SGC, ATP-binding, membrane; 1.60A {Homo sapiens} PDB: 3fzs_A* 3et7_A 3fzo_A* 3fzr_A* 3fzp_A* 3fzt_A* 3h3c_A* Length = 281 | Back alignment and structure |
|---|
Score = 107 bits (269), Expect = 1e-27
Identities = 49/212 (23%), Positives = 86/212 (40%), Gaps = 25/212 (11%)
Query: 19 IIGNSNLSTVYKGRLEDGEI----VAVKKLNFHQFSAESDKSFYREAKTLKELKHRNLVK 74
I+G VY+G + + VAVK + ++ + F EA +K L H ++VK
Sbjct: 19 ILGEGFFGEVYEGVYTNHKGEKINVAVKTCK-KDCTLDNKEKFMSEAVIMKNLDHPHIVK 77
Query: 75 VLGYAWESGKLKALILEYMENGSLESVIHGPGVDHSRWTLPKRIDVLISVANGLDYLHS- 133
++G + +I+E G L + + + + + + + YL S
Sbjct: 78 LIGII--EEEPTWIIMELYPYGELGHYLERNK---NSLKVLTLVLYSLQICKAMAYLESI 132
Query: 134 GYDIPIVHCDMKPSNILLDRDFEAHVSDFGTSRMLDVHLQDLSSLSTAFQGT---IGYLA 190
VH D+ NIL+ + DFG SR ++ T I +++
Sbjct: 133 NC----VHRDIAVRNILVASPECVKLGDFGLSRYIE------DEDYYKASVTRLPIKWMS 182
Query: 191 PEFAYMRIVTTKVDVFSFGIVVMEFLTK-RRP 221
PE R TT DV+ F + + E L+ ++P
Sbjct: 183 PESINFRRFTTASDVWMFAVCMWEILSFGKQP 214
|
| >1p4o_A Insulin-like growth factor I receptor protein; IGF-1R, kinase domain, hormone-growth factor complex; 1.50A {Homo sapiens} SCOP: d.144.1.7 PDB: 1m7n_A 3lvp_A* 3lw0_A* 1jqh_A* 2zm3_A* 3f5p_A* 3i81_A* 2oj9_A* 3nw5_A* 3nw6_A* 3nw7_A* 3o23_A* 3qqu_A* 3d94_A* 1k3a_A* 2z8c_A* 1ir3_A* 1gag_A* 1irk_A 3bu3_A* ... Length = 322 | Back alignment and structure |
|---|
Score = 108 bits (271), Expect = 1e-27
Identities = 69/291 (23%), Positives = 123/291 (42%), Gaps = 61/291 (20%)
Query: 28 VYKGRLEDGE------IVAVKKLNFHQFSAESDKS-FYREAKTLKELKHRNLVKVLGYAW 80
VY+G + VA+K +N + ++ ++ F EA +KE ++V++LG
Sbjct: 41 VYEGVAKGVVKDEPETRVAIKTVN--EAASMRERIEFLNEASVMKEFNCHHVVRLLGVVS 98
Query: 81 ESGKLKALILEYMENGSLESVI--HGPGVDHSRWTLPKRIDVLIS----VANGLDYLHSG 134
+ +I+E M G L+S + P + ++ P + +I +A+G+ YL++
Sbjct: 99 QGQPT-LVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQMAGEIADGMAYLNA- 156
Query: 135 YDIPIVHCDMKPSNILLDRDFEAHVSDFGTSRMLDVHLQDLSSLSTAFQGTIGYL----- 189
VH D+ N ++ DF + DFG +R D++ D +G G L
Sbjct: 157 --NKFVHRDLAARNCMVAEDFTVKIGDFGMTR--DIYETD-----YYRKGGKGLLPVRWM 207
Query: 190 APEFAYMRIVTTKVDVFSFGIVVMEFLTKRRPTGLDEENGLSP---ISLRQLVEKALANG 246
+PE + TT DV+SFG+V+ E T P +S Q++ + G
Sbjct: 208 SPESLKDGVFTTYSDVWSFGVVLWEIATL----------AEQPYQGLSNEQVLRF-VMEG 256
Query: 247 INGVRQITDPKLVSSIYEEQEQHQVLEELFKLALVCTSSNPEDRPNMNELL 297
+ P + LF+L +C NP+ RP+ E++
Sbjct: 257 ----GLLDKPDNCP------------DMLFELMRMCWQYNPKMRPSFLEII 291
|
| >1u46_A ACK-1, activated CDC42 kinase 1; tyrosine kinase, transferase; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 1u4d_A* 1u54_A* 3eqr_A* 3eqp_B* Length = 291 | Back alignment and structure |
|---|
Score = 107 bits (269), Expect = 1e-27
Identities = 62/289 (21%), Positives = 103/289 (35%), Gaps = 47/289 (16%)
Query: 19 IIGNSNLSTVYKGRLEDGEI----VAVKKLNFHQFSAESDKS-FYREAKTLKELKHRNLV 73
+G+ + V +G + VAVK L S F RE + L HRNL+
Sbjct: 25 KLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNLI 84
Query: 74 KVLGYAWESGKLKALILEYMENGSLESVIHGPGVDHSRWTLPKRIDVLISVANGLDYLHS 133
++ G ++ E GSL + + L + VA G+ YL S
Sbjct: 85 RLYGVV--LTPPMKMVTELAPLGSLLDRLRKHQ---GHFLLGTLSRYAVQVAEGMGYLES 139
Query: 134 -GYDIPIVHCDMKPSNILLDRDFEAHVSDFGTSRMLDVHLQDLSSLSTAFQGT---IGYL 189
+ +H D+ N+LL + DFG R L + + +
Sbjct: 140 KRF----IHRDLAARNLLLATRDLVKIGDFGLMRALPQN----DDHYVMQEHRKVPFAWC 191
Query: 190 APEFAYMRIVTTKVDVFSFGIVVMEFLTK-RRPTGLDEENGLSPISLRQLVEKALANGIN 248
APE R + D + FG+ + E T + P GL+ + ++K
Sbjct: 192 APESLKTRTFSHASDTWMFGVTLWEMFTYGQEPWI-----GLNGSQILHKIDK------E 240
Query: 249 GVRQITDPKLVSSIYEEQEQHQVLEELFKLALVCTSSNPEDRPNMNELL 297
G R + P+ ++++ + + C + PEDRP L
Sbjct: 241 GER-LPRPEDCP------------QDIYNVMVQCWAHKPEDRPTFVALR 276
|
| >1u59_A Tyrosine-protein kinase ZAP-70; transferase; HET: STU; 2.30A {Homo sapiens} SCOP: d.144.1.7 Length = 287 | Back alignment and structure |
|---|
Score = 107 bits (269), Expect = 1e-27
Identities = 52/210 (24%), Positives = 92/210 (43%), Gaps = 22/210 (10%)
Query: 20 IGNSNLSTVYKGRL--EDGEI-VAVKKLNFHQFSAESDKSFYREAKTLKELKHRNLVKVL 76
+G N +V +G +I VA+K L + REA+ + +L + +V+++
Sbjct: 18 LGCGNFGSVRQGVYRMRKKQIDVAIKVLK-QGTEKADTEEMMREAQIMHQLDNPYIVRLI 76
Query: 77 GYAWESGKLKALILEYMENGSLESVIHGPGVDHSRWTLPKRIDVLISVANGLDYLHS-GY 135
G + L++E G L + G + ++L V+ G+ YL +
Sbjct: 77 GVCQAEALM--LVMEMAGGGPLHKFLVGKR---EEIPVSNVAELLHQVSMGMKYLEEKNF 131
Query: 136 DIPIVHCDMKPSNILLDRDFEAHVSDFGTSRMLDVHLQDLSSLSTAFQGT---IGYLAPE 192
VH D+ N+LL A +SDFG S+ L S TA + + APE
Sbjct: 132 ----VHRDLAARNVLLVNRHYAKISDFGLSKAL----GADDSYYTARSAGKWPLKWYAPE 183
Query: 193 FAYMRIVTTKVDVFSFGIVVMEFLTK-RRP 221
R +++ DV+S+G+ + E L+ ++P
Sbjct: 184 CINFRKFSSRSDVWSYGVTMWEALSYGQKP 213
|
| >4aoj_A High affinity nerve growth factor receptor; transferase, inhibitor; HET: V4Z; 2.75A {Homo sapiens} Length = 329 | Back alignment and structure |
|---|
Score = 108 bits (271), Expect = 2e-27
Identities = 71/295 (24%), Positives = 115/295 (38%), Gaps = 65/295 (22%)
Query: 28 VYKGRLEDGE------IVAVKKLNFHQFSAESDKSFYREAKTLKELKHRNLVKVLGYAWE 81
V+ + +VAVK L SA D F REA+ L L+H+++V+ G E
Sbjct: 57 VFLAECHNLLPEQDKMLVAVKALKEASESARQD--FQREAELLTMLQHQHIVRFFGVCTE 114
Query: 82 SGKLKALILEYMENGSL-----------ESVIHGPGVDHSRWTLPKRIDVLISVANGLDY 130
L ++ EYM +G L + + G V L + + V VA G+ Y
Sbjct: 115 GRPL-LMVFEYMRHGDLNRFLRSHGPDAKLLAGGEDVAPGPLGLGQLLAVASQVAAGMVY 173
Query: 131 LHSGYDIPIVHCDMKPSNILLDRDFEAHVSDFGTSRMLDVHLQDLSSLSTAFQGTIGYL- 189
L + VH D+ N L+ + + DFG SR D++ D G L
Sbjct: 174 LAG---LHFVHRDLATRNCLVGQGLVVKIGDFGMSR--DIYSTDYYR-----VGGRTMLP 223
Query: 190 ----APEFAYMRIVTTKVDVFSFGIVVMEFLTKRRPTGLDEENGLSP---ISLRQLVEKA 242
PE R TT+ DV+SFG+V+ E T G P +S + ++
Sbjct: 224 IRWMPPESILYRKFTTESDVWSFGVVLWEIFTY----------GKQPWYQLSNTEAID-C 272
Query: 243 LANGINGVRQITDPKLVSSIYEEQEQHQVLEELFKLALVCTSSNPEDRPNMNELL 297
+ G R++ P+ E++ + C P+ R ++ ++
Sbjct: 273 ITQG----RELERPRACP------------PEVYAIMRGCWQREPQQRHSIKDVH 311
|
| >3v5q_A NT-3 growth factor receptor; kinase domain, kinase, phosphorylation, transferase-transfer inhibitor complex; HET: 0F4; 2.20A {Homo sapiens} Length = 297 | Back alignment and structure |
|---|
Score = 107 bits (269), Expect = 2e-27
Identities = 71/295 (24%), Positives = 117/295 (39%), Gaps = 64/295 (21%)
Query: 28 VYKGRLEDGE------IVAVKKLNFHQFSAESDKSFYREAKTLKELKHRNLVKVLGYAWE 81
V+ + +VAVK L +A D F REA+ L L+H ++VK G +
Sbjct: 31 VFLAECYNLSPTKDKMLVAVKALKDPTLAARKD--FQREAELLTNLQHEHIVKFYGVCGD 88
Query: 82 SGKLKALILEYMENGSL------------ESVIHGPGVDHSRWTLPKRIDVLISVANGLD 129
L ++ EYM++G L V P L + + + +A+G+
Sbjct: 89 GDPL-IMVFEYMKHGDLNKFLRAHGPDAMILVDGQPRQAKGELGLSQMLHIASQIASGMV 147
Query: 130 YLHSGYDIPIVHCDMKPSNILLDRDFEAHVSDFGTSRMLDVHLQDLSSLSTAFQGT---- 185
YL S VH D+ N L+ + + DFG SR DV+ D G
Sbjct: 148 YLAS---QHFVHRDLATRNCLVGANLLVKIGDFGMSR--DVYSTDY----YRVGGHTMLP 198
Query: 186 IGYLAPEFAYMRIVTTKVDVFSFGIVVMEFLTKRRPTGLDEENGLSP---ISLRQLVEKA 242
I ++ PE R TT+ DV+SFG+++ E T G P +S +++E
Sbjct: 199 IRWMPPESIMYRKFTTESDVWSFGVILWEIFTY----------GKQPWFQLSNTEVIECI 248
Query: 243 LANGINGVRQITDPKLVSSIYEEQEQHQVLEELFKLALVCTSSNPEDRPNMNELL 297
+ + P++ +E++ + L C P+ R N+ E+
Sbjct: 249 TQGRV-----LERPRVCP------------KEVYDVMLGCWQREPQQRLNIKEIY 286
|
| >3lzb_A Epidermal growth factor receptor; epidermal growth factor kinase domain, multitargeted small M kinase inhibitor; HET: ITI; 2.70A {Homo sapiens} Length = 327 | Back alignment and structure |
|---|
Score = 107 bits (269), Expect = 3e-27
Identities = 63/290 (21%), Positives = 118/290 (40%), Gaps = 50/290 (17%)
Query: 18 NIIGNSNLSTVYKGRL----EDGEI-VAVKKLNFHQFSAESDKSFYREAKTLKELKHRNL 72
++G+ TVYKG E +I VA+K+L S +++K EA + + + ++
Sbjct: 21 KVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELR-EATSPKANKEILDEAYVMASVDNPHV 79
Query: 73 VKVLGYAWESGKLKALILEYMENGSLESVIHGPGVDHSRWTLPKRIDVLISVANGLDYLH 132
++LG S LI + M G L + ++ + +A G++YL
Sbjct: 80 CRLLGICLTSTVQ--LITQLMPFGCLLDYVREHK---DNIGSQYLLNWCVQIAKGMNYLE 134
Query: 133 S-GYDIPIVHCDMKPSNILLDRDFEAHVSDFGTSRMLDVHLQDLSSLSTAFQGT---IGY 188
VH D+ N+L+ ++DFG +++L +G I +
Sbjct: 135 DRRL----VHRDLAARNVLVKTPQHVKITDFGLAKLLGA-----EEKEYHAEGGKVPIKW 185
Query: 189 LAPEFAYMRIVTTKVDVFSFGIVVMEFLTK-RRPTGLDEENGLSPISLRQLVEKALANGI 247
+A E RI T + DV+S+G+ V E +T +P G+ + ++EK
Sbjct: 186 MALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYD-----GIPASEISSILEK------ 234
Query: 248 NGVRQITDPKLVSSIYEEQEQHQVLEELFKLALVCTSSNPEDRPNMNELL 297
G R + P + + +++ + C + + RP EL+
Sbjct: 235 -GER-LPQPPICT------------IDVYMIMRKCWMIDADSRPKFRELI 270
|
| >2ozo_A Tyrosine-protein kinase ZAP-70; inactive ZAP-70, tandem SH2, autoinhibition, ITAM, hydrogen bonding network, TCR signaling, transferase; HET: ANP; 2.60A {Homo sapiens} Length = 613 | Back alignment and structure |
|---|
Score = 109 bits (274), Expect = 5e-27
Identities = 51/210 (24%), Positives = 92/210 (43%), Gaps = 22/210 (10%)
Query: 20 IGNSNLSTVYKGRL--EDGEI-VAVKKLNFHQFSAESDKSFYREAKTLKELKHRNLVKVL 76
+G N +V +G +I VA+K L + REA+ + +L + +V+++
Sbjct: 344 LGCGNFGSVRQGVYRMRKKQIDVAIKVLK-QGTEKADTEEMMREAQIMHQLDNPYIVRLI 402
Query: 77 GYAWESGKLKALILEYMENGSLESVIHGPGVDHSRWTLPKRIDVLISVANGLDYLHS-GY 135
G + L++E G L + G + ++L V+ G+ YL +
Sbjct: 403 GVCQAEALM--LVMEMAGGGPLHKFLVGKR---EEIPVSNVAELLHQVSMGMKYLEEKNF 457
Query: 136 DIPIVHCDMKPSNILLDRDFEAHVSDFGTSRMLDVHLQDLSSLSTAFQGT---IGYLAPE 192
VH ++ N+LL A +SDFG S+ L S TA + + APE
Sbjct: 458 ----VHRNLAARNVLLVNRHYAKISDFGLSKAL----GADDSYYTARSAGKWPLKWYAPE 509
Query: 193 FAYMRIVTTKVDVFSFGIVVMEFLTK-RRP 221
R +++ DV+S+G+ + E L+ ++P
Sbjct: 510 CINFRKFSSRSDVWSYGVTMWEALSYGQKP 539
|
| >1mp8_A Focal adhesion kinase 1; tyrosine protein kinase, transferase; HET: ADP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 2ijm_A* 2etm_A* 3pxk_A* 2jkq_A* 2j0m_B* 2jkm_A* 2j0l_A* 3bz3_A* 2jko_A* 2jkk_A* Length = 281 | Back alignment and structure |
|---|
Score = 105 bits (264), Expect = 7e-27
Identities = 53/212 (25%), Positives = 89/212 (41%), Gaps = 25/212 (11%)
Query: 19 IIGNSNLSTVYKGRL---EDGEI-VAVKKLNFHQFSAESDKSFYREAKTLKELKHRNLVK 74
IG V++G E+ + VA+K + S + F +EA T+++ H ++VK
Sbjct: 22 CIGEGQFGDVHQGIYMSPENPALAVAIKTCK-NCTSDSVREKFLQEALTMRQFDHPHIVK 80
Query: 75 VLGYAWESGKLKALILEYMENGSLESVIHGPGVDHSRWTLPKRIDVLISVANGLDYLHS- 133
++G E+ +I+E G L S + L I ++ L YL S
Sbjct: 81 LIGVITENPVW--IIMELCTLGELRSFLQVRK---YSLDLASLILYAYQLSTALAYLESK 135
Query: 134 GYDIPIVHCDMKPSNILLDRDFEAHVSDFGTSRMLDVHLQDLSSLSTAFQGT---IGYLA 190
+ VH D+ N+L+ + + DFG SR ++ S I ++A
Sbjct: 136 RF----VHRDIAARNVLVSSNDCVKLGDFGLSRYME------DSTYYKASKGKLPIKWMA 185
Query: 191 PEFAYMRIVTTKVDVFSFGIVVMEFLTK-RRP 221
PE R T+ DV+ FG+ + E L +P
Sbjct: 186 PESINFRRFTSASDVWMFGVCMWEILMHGVKP 217
|
| >4eut_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: BX7; 2.60A {Homo sapiens} Length = 396 | Back alignment and structure |
|---|
Score = 107 bits (268), Expect = 9e-27
Identities = 68/301 (22%), Positives = 126/301 (41%), Gaps = 37/301 (12%)
Query: 19 IIGNSNLSTVYKGR-LEDGEIVAVKKLNFHQFSAESDKSFYREAKTLKELKHRNLVKVLG 77
I+G + V++GR + G++ A+K N F D RE + LK+L H+N+VK+
Sbjct: 16 ILGQGATANVFRGRHKKTGDLFAIKVFNNISFLRPVDV-QMREFEVLKKLNHKNIVKLFA 74
Query: 78 -YAWESGKLKALILEYMENGSLESVIHGPGVDHSRWTLPKR--IDVLISVANGLDYLHSG 134
+ + K LI+E+ GSL +V+ P + + LP+ + VL V G+++L
Sbjct: 75 IEEETTTRHKVLIMEFCPCGSLYTVLEEPS---NAYGLPESEFLIVLRDVVGGMNHLRE- 130
Query: 135 YDIPIVHCDMKPSNILLDRDFEAH----VSDFGTSRMLDVHLQDLSSLSTAFQGTIGYLA 190
IVH ++KP NI+ + ++DFG +R L+ D + + GT YL
Sbjct: 131 --NGIVHRNIKPGNIMRVIGEDGQSVYKLTDFGAARELE----DDEQFVSLY-GTEEYLH 183
Query: 191 PE--------FAYMRIVTTKVDVFSFGIVVMEFLTKRRPTGLDEENGLSPISLRQLVEKA 242
P+ + + VD++S G+ T P E + + +++
Sbjct: 184 PDMYERAVLRKDHQKKYGATVDLWSIGVTFYHAATGSLPFRPFEGPRRNKEVMYKIITGK 243
Query: 243 LANGINGVRQITDPKLVSSIYEEQEQH------QVLEELFKLALVCTSSNPEDRPNMNEL 296
+ I+GV++ + + S +L + L + E ++
Sbjct: 244 PSGAISGVQKAENGPIDWSGDMPVSCSLSRGLQVLLTPVLANILEA---DQEKCWGFDQF 300
Query: 297 L 297
Sbjct: 301 F 301
|
| >2xir_A Vascular endothelial growth factor receptor 2; angiogenesis, nucleotide-binding, inhibitor, phosphorylation receptor, transferase, transmembrane; HET: 00J; 1.50A {Homo sapiens} PDB: 1vr2_A* 1ywn_A* 3vnt_A* 3c7q_A* 2oh4_A* 3u6j_A* 3efl_A* 2p2i_A* 3cjf_A* 3cjg_A* 3ewh_A* 2qu5_A* 2qu6_A* 2rl5_A* 3b8q_A* 3b8r_A* 2p2h_A* 3cp9_A* 3cpb_A* 3cpc_A* ... Length = 316 | Back alignment and structure |
|---|
Score = 104 bits (261), Expect = 4e-26
Identities = 64/296 (21%), Positives = 108/296 (36%), Gaps = 64/296 (21%)
Query: 28 VYKGRL------EDGEIVAVKKLNFHQFSAESDKSFYREAKTLKEL-KHRNLVKVLGYAW 80
V + VAVK L + ++ E K L + H N+V +LG
Sbjct: 43 VIEADAFGIDKTATCRTVAVKMLK-EGATHSEHRALMSELKILIHIGHHLNVVNLLGACT 101
Query: 81 ESGKLKALILEYMENGSL------------ESVIHGPGVDHSRWTLPKRIDVLISVANGL 128
+ G +I+E+ + G+L + + TL I VA G+
Sbjct: 102 KPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGM 161
Query: 129 DYLHSGYDIPIVHCDMKPSNILLDRDFEAHVSDFGTSRMLDVHLQDLSSLSTAFQGTIGY 188
++L S +H D+ NILL + DFG +R D++ +
Sbjct: 162 EFLAS---RKCIHRDLAARNILLSEKNVVKICDFGLAR--DIYKDP-----DYVRKGDAR 211
Query: 189 L-----APEFAYMRIVTTKVDVFSFGIVVMEFLTKRRPTGLDEENGLSP---ISLRQLVE 240
L APE + R+ T + DV+SFG+++ E + G SP + + +
Sbjct: 212 LPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSL----------GASPYPGVKIDEEFC 261
Query: 241 KALANGINGVRQITDPKLVSSIYEEQEQHQVLEELFKLALVCTSSNPEDRPNMNEL 296
+ L G ++ P + E+++ L C P RP +EL
Sbjct: 262 RRLKEG----TRMRAPDYTT------------PEMYQTMLDCWHGEPSQRPTFSEL 301
|
| >3l9p_A Anaplastic lymphoma kinase; kinase domain, ATP-binding, glycoprotein, membrane, nucleotide-binding, phosphoprotein, proto-oncogene; 1.80A {Homo sapiens} Length = 367 | Back alignment and structure |
|---|
Score = 104 bits (262), Expect = 4e-26
Identities = 67/290 (23%), Positives = 112/290 (38%), Gaps = 59/290 (20%)
Query: 28 VYKGRLEDGE------IVAVKKLNFHQFSAESDKSFYREAKTLKELKHRNLVKVLGYAWE 81
VY+G++ VAVK L S + + F EA + + H+N+V+ +G + +
Sbjct: 87 VYEGQVSGMPNDPSPLQVAVKTLPEV-CSEQDELDFLMEALIISKFNHQNIVRCIGVSLQ 145
Query: 82 SGKLKALILEYMENGSLESVI--HGPGVDH-SRWTLPKRIDVLISVANGLDYLHSGYDIP 138
S ++LE M G L+S + P S + + V +A G YL +
Sbjct: 146 SLPR-FILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYLEENH--- 201
Query: 139 IVHCDMKPSNILLDRDFEAHV---SDFGTSRMLDVHLQDLSSLSTAFQGTIGYL-----A 190
+H D+ N LL V DFG +R D++ +G L
Sbjct: 202 FIHRDIAARNCLLTCPGPGRVAKIGDFGMAR--DIYRAG-----YYRKGGCAMLPVKWMP 254
Query: 191 PEFAYMRIVTTKVDVFSFGIVVMEFLTKRRPTGLDEENGLSP---ISLRQLVEKALANGI 247
PE I T+K D +SFG+++ E + G P S ++++E +
Sbjct: 255 PEAFMEGIFTSKTDTWSFGVLLWEIFSL----------GYMPYPSKSNQEVLEF-----V 299
Query: 248 NGVRQITDPKLVSSIYEEQEQHQVLEELFKLALVCTSSNPEDRPNMNELL 297
++ PK ++++ C PEDRPN +L
Sbjct: 300 TSGGRMDPPKNCP------------GPVYRIMTQCWQHQPEDRPNFAIIL 337
|
| >3kex_A Receptor tyrosine-protein kinase ERBB-3; kinase domain, inactive kinase, HER3, ATP-binding, cell membrane, membrane, nucleotide-binding; HET: ANP; 2.80A {Homo sapiens} PDB: 3lmg_A* Length = 325 | Back alignment and structure |
|---|
Score = 103 bits (260), Expect = 5e-26
Identities = 51/230 (22%), Positives = 93/230 (40%), Gaps = 32/230 (13%)
Query: 2 FDRTEIENATGSFSENNIIGNSNLSTVYKGRL----EDGEI-VAVKKLNFHQFSAESDKS 56
F TE+ ++G+ TV+KG E +I V +K + + +S ++
Sbjct: 10 FKETELRK-------LKVLGSGVFGTVHKGVWIPEGESIKIPVCIKVIE-DKSGRQSFQA 61
Query: 57 FYREAKTLKELKHRNLVKVLGYAWESGKLKALILEYMENGSLESVIHGPGVDHSRWTLPK 116
+ L H ++V++LG S L+ +Y+ GSL +
Sbjct: 62 VTDHMLAIGSLDHAHIVRLLGLCPGSSLQ--LVTQYLPLGSLLDHVRQHR---GALGPQL 116
Query: 117 RIDVLISVANGLDYLHS-GYDIPIVHCDMKPSNILLDRDFEAHVSDFGTSRMLDVHLQDL 175
++ + +A G+ YL G VH ++ N+LL + V+DFG + +L
Sbjct: 117 LLNWGVQIAKGMYYLEEHGM----VHRNLAARNVLLKSPSQVQVADFGVADLLPP----- 167
Query: 176 SSLSTAFQGT---IGYLAPEFAYMRIVTTKVDVFSFGIVVMEFLTK-RRP 221
+ I ++A E + T + DV+S+G+ V E +T P
Sbjct: 168 DDKQLLYSEAKTPIKWMALESIHFGKYTHQSDVWSYGVTVWELMTFGAEP 217
|
| >3q60_A ROP5B; pseudokinase, transferase; HET: ATP; 1.72A {Toxoplasma gondii} PDB: 3q5z_A* Length = 371 | Back alignment and structure |
|---|
Score = 104 bits (261), Expect = 5e-26
Identities = 35/305 (11%), Positives = 73/305 (23%), Gaps = 62/305 (20%)
Query: 26 STVYKGR-LEDGEIVAVKKLNFHQFSAESD-KSFYREAKTLKELKHRNLVKVLGYAWESG 83
S V+ R +E E A+K ++ S+ + + L + +
Sbjct: 76 SVVFLVRDVERLEDFALKVFTMGAENSRSELERLHEATFAAARLLGESPEEARDRRRLLL 135
Query: 84 KLKA-------------------------LILEYMENGSLESVI---HGPGVDHSRWTLP 115
A L++ LE + V +
Sbjct: 136 PSDAVAVQSQPPFAQLSPGQDDYAVANYLLLMPAAS-VDLELLFSTLDFVYVFRGDEGIL 194
Query: 116 KRIDVLISVANGLDYLHS-GYDIPIVHCDMKPSNILLDRDFEAHVSDFGTSRMLDVHLQD 174
+ + L S G +VH P N+ + D + D +
Sbjct: 195 ALHILTAQLIRLAANLQSKG----LVHGHFTPDNLFIMPDGRLMLGDVSALWKVG----- 245
Query: 175 LSSLSTAFQGTIGYLAPEFAYMR--IVTTKVDVFSFGIVVMEFLTKRRPTGLDEENGLSP 232
+ A + Y EF T ++ + G+ + P GL
Sbjct: 246 --TRGPASSVPVTYAPREFLNASTATFTHALNAWQLGLSIYRVWCLFLPFGLVTPGIKGS 303
Query: 233 ISLRQLVEKALANGINGVRQITDPKLVSSIYEEQEQHQVLEELFKLALVCTSSNPEDRPN 292
++ + + + + + L + + R
Sbjct: 304 W-----------------KRPSLRVPGTDSLAFGSCTPLPDFVKTLIGRFLNFDRRRRLL 346
Query: 293 MNELL 297
E +
Sbjct: 347 PLEAM 351
|
| >2pml_X PFPK7, Ser/Thr protein kinase; phosphorylati transferase, transferase; HET: ANP; 2.60A {Plasmodium falciparum} PDB: 2pmn_X* 2pmo_X* Length = 348 | Back alignment and structure |
|---|
Score = 104 bits (260), Expect = 6e-26
Identities = 51/228 (22%), Positives = 89/228 (39%), Gaps = 41/228 (17%)
Query: 20 IGNSNLSTVYKGRLEDGEIVAVKKLNFHQFSAESDKS---------------FYREAKTL 64
+ + + +D + A+KK + D + F E + +
Sbjct: 39 LNQGKFNKIILCE-KDNKFYALKKYEKSLLEKKRDFTKSNNDKISIKSKYDDFKNELQII 97
Query: 65 KELKHRNLVKVLGYAWESGKLKALILEYMENGSLESVIHGPGVDHSRWTLPKRIDVLI-- 122
++K+ + G + +I EYMEN S+ V +T I V+
Sbjct: 98 TDIKNEYCLTCEGI-ITNYDEVYIIYEYMENDSILKFDEYFFVLDKNYTCFIPIQVIKCI 156
Query: 123 --SVANGLDYLHSGYDIPIVHCDMKPSNILLDRDFEAHVSDFGTSRMLDVHLQDLSSLST 180
SV N Y+H+ +I H D+KPSNIL+D++ +SDFG S ++ D +
Sbjct: 157 IKSVLNSFSYIHNEKNI--CHRDVKPSNILMDKNGRVKLSDFGES----EYMVD-KKIKG 209
Query: 181 AFQGTIGYLAPEFAYMRIVTTK-------VDVFSFGIVVMEFLTKRRP 221
+GT ++ PE + + VD++S GI + P
Sbjct: 210 -SRGTYEFMPPE-----FFSNESSYNGAKVDIWSLGICLYVMFYNVVP 251
|
| >2yfx_A Tyrosine-protein kinase receptor; nucleotide-binding, transferase; HET: VGH; 1.70A {Homo sapiens} PDB: 2xp2_A* 3aox_A* 2yhv_A 3lcs_A* 3lct_A* 4dce_A* 2xba_A* 2xb7_A* Length = 327 | Back alignment and structure |
|---|
Score = 103 bits (258), Expect = 1e-25
Identities = 66/290 (22%), Positives = 112/290 (38%), Gaps = 59/290 (20%)
Query: 28 VYKGRLEDGE------IVAVKKLNFHQFSAESDKSFYREAKTLKELKHRNLVKVLGYAWE 81
VY+G++ VAVK L S + + F EA + + H+N+V+ +G + +
Sbjct: 46 VYEGQVSGMPNDPSPLQVAVKTLPEV-CSEQDELDFLMEALIISKFNHQNIVRCIGVSLQ 104
Query: 82 SGKLKALILEYMENGSLESVI--HGPGVDH-SRWTLPKRIDVLISVANGLDYLHSGYDIP 138
S +++E M G L+S + P S + + V +A G YL +
Sbjct: 105 SLPR-FILMELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYLEENH--- 160
Query: 139 IVHCDMKPSNILLDRDFEAHV---SDFGTSRMLDVHLQDLSSLSTAFQGTIGYL-----A 190
+H D+ N LL V DFG +R D++ +G L
Sbjct: 161 FIHRDIAARNCLLTCPGPGRVAKIGDFGMAR--DIYRASYYR-----KGGCAMLPVKWMP 213
Query: 191 PEFAYMRIVTTKVDVFSFGIVVMEFLTKRRPTGLDEENGLSP---ISLRQLVEKALANGI 247
PE I T+K D +SFG+++ E + G P S ++++E +
Sbjct: 214 PEAFMEGIFTSKTDTWSFGVLLWEIFSL----------GYMPYPSKSNQEVLEF-----V 258
Query: 248 NGVRQITDPKLVSSIYEEQEQHQVLEELFKLALVCTSSNPEDRPNMNELL 297
++ PK ++++ C PEDRPN +L
Sbjct: 259 TSGGRMDPPKNCP------------GPVYRIMTQCWQHQPEDRPNFAIIL 296
|
| >3fme_A Dual specificity mitogen-activated protein kinase; active mutant, structural genomics consortium, SCG, binding, nucleotide-binding, phosphoprotein; HET: STU; 2.26A {Homo sapiens} PDB: 3enm_A Length = 290 | Back alignment and structure |
|---|
Score = 101 bits (253), Expect = 3e-25
Identities = 64/291 (21%), Positives = 122/291 (41%), Gaps = 53/291 (18%)
Query: 20 IGNSNLSTVYKGR-LEDGEIVAVKKLNFHQFSAESDKSFYREAK-TLKELKHRNLVKVLG 77
+G V K R + G+I+AVK++ +++ K + +++ + V G
Sbjct: 15 LGRGAYGVVEKMRHVPSGQIMAVKRIRA-TVNSQEQKRLLMDLDISMRTVDCPFTVTFYG 73
Query: 78 YAWESGKLKALILEYMENGSLESVIHGPGVDHSRWTLPKRI--DVLISVANGLDYLHSGY 135
+ G + + +E M + SL+ V T+P+ I + +S+ L++LHS
Sbjct: 74 ALFREGDVW-ICMELM-DTSLDKFYKQ--VIDKGQTIPEDILGKIAVSIVKALEHLHS-- 127
Query: 136 DIPIVHCDMKPSNILLDRDFEAHVSDFGTSRMLDVHLQDLSSLS-TAFQGTIGYLAPEFA 194
+ ++H D+KPSN+L++ + + DFG S L ++ G Y+APE
Sbjct: 128 KLSVIHRDVKPSNVLINALGQVKMCDFGISGYLV------DDVAKDIDAGCKPYMAPE-- 179
Query: 195 YMRIV--------TTKVDVFSFGIVVMEFLTKRRPTGLDEENGLSPISLRQLVEKALANG 246
RI + K D++S GI ++E R P ++ +P + V + +
Sbjct: 180 --RINPELNQKGYSVKSDIWSLGITMIELAILRFPY----DSWGTPFQQLKQVVEEPS-- 231
Query: 247 INGVRQITDPKLVSSIYEEQEQHQVLEELFKLALVCTSSNPEDRPNMNELL 297
P+L + + + + L K N ++RP EL+
Sbjct: 232 ---------PQLPADKFSAEFVDFTSQCLKK--------NSKERPTYPELM 265
|
| >2pvf_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; HET: PTR ACP; 1.80A {Homo sapiens} PDB: 3cly_A* 2pzr_A* 2pzp_A* 2pvy_A* 2pz5_A* 2q0b_A* 2pwl_A* 2py3_A* 3ri1_A* 1gjo_A 1oec_A* 3b2t_A* 3gql_A* 3gqi_A* 1fgk_A 1fgi_A* 1agw_A 2fgi_A* 3js2_A* 3ky2_A ... Length = 334 | Back alignment and structure |
|---|
Score = 101 bits (255), Expect = 3e-25
Identities = 71/300 (23%), Positives = 117/300 (39%), Gaps = 70/300 (23%)
Query: 27 TVYKGRLEDGE--------IVAVKKLNFHQFSAESDKS-FYREAKTLKEL-KHRNLVKVL 76
V + VAVK L + E D S E + +K + KH+N++ +L
Sbjct: 50 QVVMAEAVGIDKDKPKEAVTVAVKMLK--DDATEKDLSDLVSEMEMMKMIGKHKNIINLL 107
Query: 77 GYAWESGKLKALILEYMENGSL------------ESVIHGPGVDHSRWTLPKRIDVLISV 124
G + G L +I+EY G+L E V + T + +
Sbjct: 108 GACTQDGPL-YVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSCTYQL 166
Query: 125 ANGLDYLHSGYDIPIVHCDMKPSNILLDRDFEAHVSDFGTSRMLDVHLQDLSSLSTAFQG 184
A G++YL S +H D+ N+L+ + ++DFG +R D++ D +
Sbjct: 167 ARGMEYLAS---QKCIHRDLAARNVLVTENNVMKIADFGLAR--DINNIDYYK-----KT 216
Query: 185 TIGYL-----APEFAYMRIVTTKVDVFSFGIVVMEFLTKRRPTGLDEENGLSP---ISLR 236
T G L APE + R+ T + DV+SFG+++ E T G SP I +
Sbjct: 217 TNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTL----------GGSPYPGIPVE 266
Query: 237 QLVEKALANGINGVRQITDPKLVSSIYEEQEQHQVLEELFKLALVCTSSNPEDRPNMNEL 296
+L + L G ++ P + EL+ + C + P RP +L
Sbjct: 267 ELFKL-LKEG----HRMDKPANCT------------NELYMMMRDCWHAVPSQRPTFKQL 309
|
| >1fvr_A Tyrosine-protein kinase TIE-2; tyrosine kinase, transferase; 2.20A {Homo sapiens} SCOP: d.144.1.7 PDB: 2oo8_X* 2osc_A* 2p4i_A* 3l8p_A* 2wqb_A* Length = 327 | Back alignment and structure |
|---|
Score = 101 bits (254), Expect = 4e-25
Identities = 71/312 (22%), Positives = 126/312 (40%), Gaps = 82/312 (26%)
Query: 18 NIIGNSNLSTVYKGRLEDGE---IVAVKKLNFHQFSAESDKS-FYREAKTLKEL-KHRNL 72
++IG N V K R++ A+K++ +++++ D F E + L +L H N+
Sbjct: 31 DVIGEGNFGQVLKARIKKDGLRMDAAIKRMK--EYASKDDHRDFAGELEVLCKLGHHPNI 88
Query: 73 VKVLGYAWESGKLKALILEYMENGSL------------ESVIHGPGVDHSRWTLPKRIDV 120
+ +LG G L L +EY +G+L + S + + +
Sbjct: 89 INLLGACEHRGYL-YLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHF 147
Query: 121 LISVANGLDYLHSGYDIPIVHCDMKPSNILLDRDFEAHVSDFGTSRMLDVHLQDLSSLST 180
VA G+DYL +H D+ NIL+ ++ A ++DFG SR +V+++
Sbjct: 148 AADVARGMDYLSQ---KQFIHRDLAARNILVGENYVAKIADFGLSRGQEVYVK------- 197
Query: 181 AFQGTIGYL-----APEFAYMRIVTTKVDVFSFGIVVMEFLTKRRPTGLDEENGLSP--- 232
T+G L A E + TT DV+S+G+++ E ++ G +P
Sbjct: 198 ---KTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSL----------GGTPYCG 244
Query: 233 ISLRQLVEKALANGINGVRQITDPKLVSSIYEEQEQHQVLE-------ELFKLALVCTSS 285
++ +L EK L G LE E++ L C
Sbjct: 245 MTCAELYEK-LPQG-----------------------YRLEKPLNCDDEVYDLMRQCWRE 280
Query: 286 NPEDRPNMNELL 297
P +RP+ ++L
Sbjct: 281 KPYERPSFAQIL 292
|
| >3zzw_A Tyrosine-protein kinase transmembrane receptor RO; transferase, neurotrophic tyrosine kinase, receptor-related NTRKR2; 2.90A {Homo sapiens} Length = 289 | Back alignment and structure |
|---|
Score = 100 bits (252), Expect = 4e-25
Identities = 64/305 (20%), Positives = 101/305 (33%), Gaps = 83/305 (27%)
Query: 28 VYKGRLEDGE------IVAVKKLNFHQFSAESDKS-FYREAKTLKELKHRNLVKVLGYAW 80
VYKG L VA+K L + + F EA L+H N+V +LG
Sbjct: 25 VYKGHLFGPAPGEQTQAVAIKTLK--DKAEGPLREEFRHEAMLRARLQHPNVVCLLGVVT 82
Query: 81 ESGKLKALILEYMENGSL------------ESVIHGPGVDHSRWTLPKRIDVLISVANGL 128
+ L ++I Y +G L S P + ++ +A G+
Sbjct: 83 KDQPL-SMIFSYCSHGDLHEFLVMRSPHSDVGSTDDDRTVKSALEPPDFVHLVAQIAAGM 141
Query: 129 DYLHS-GYDIPIVHCDMKPSNILLDRDFEAHVSDFGTSRMLDVHLQDLSSLSTAFQGTIG 187
+YL S VH D+ N+L+ +SD G R +V+ D
Sbjct: 142 EYLSSHHV----VHKDLATRNVLVYDKLNVKISDLGLFR--EVYAAD-----YYKLLGNS 190
Query: 188 YL-----APEFAYMRIVTTKVDVFSFGIVVMEFLTKRRPTGLDEENGLSP---ISLRQLV 239
L APE + D++S+G+V+ E + GL P S + +V
Sbjct: 191 LLPIRWMAPEAIMYGKFSIDSDIWSYGVVLWEVFSY----------GLQPYCGYSNQDVV 240
Query: 240 EKALANGINGVRQITDPKLVSSIYEEQEQHQVLE-------ELFKLALVCTSSNPEDRPN 292
E QVL ++ L + C + P RP
Sbjct: 241 EMI------------------------RNRQVLPCPDDCPAWVYALMIECWNEFPSRRPR 276
Query: 293 MNELL 297
++
Sbjct: 277 FKDIH 281
|
| >1t46_A HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcoma viral oncogene homolog; kinase, structure, inhibitor, STI-571, gleevec, transferase activator; HET: STI; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1pkg_A* 1t45_A 3g0e_A* 3g0f_A* Length = 313 | Back alignment and structure |
|---|
Score = 100 bits (252), Expect = 6e-25
Identities = 60/294 (20%), Positives = 104/294 (35%), Gaps = 59/294 (20%)
Query: 28 VYKGRL------EDGEIVAVKKLNFHQFSAESDKS-FYREAKTLKEL-KHRNLVKVLGYA 79
V + + VAVK L + +++ E K L L H N+V +LG
Sbjct: 39 VVEATAYGLIKSDAAMTVAVKMLK--PSAHLTEREALMSELKVLSYLGNHMNIVNLLGAC 96
Query: 80 WESGKLKALILEYMENGSL--------------ESVIHGPGVDHSRWTLPKRIDVLISVA 125
G +I EY G L ++ D L + VA
Sbjct: 97 TIGGPT-LVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALDLEDLLSFSYQVA 155
Query: 126 NGLDYLHSGYDIPIVHCDMKPSNILLDRDFEAHVSDFGTSRMLDVHLQDLSSLSTAFQGT 185
G+ +L S +H D+ NILL + DFG +R D+ + +
Sbjct: 156 KGMAFLAS---KNCIHRDLAARNILLTHGRITKICDFGLAR--DIKNDSNYVVKGNARLP 210
Query: 186 IGYLAPEFAYMRIVTTKVDVFSFGIVVMEFLTKRRPTGLDEENGLSP---ISLRQLVEKA 242
+ ++APE + + T + DV+S+GI + E + G SP + + K
Sbjct: 211 VKWMAPESIFNCVYTFESDVWSYGIFLWELFSL----------GSSPYPGMPVDSKFYKM 260
Query: 243 LANGINGVRQITDPKLVSSIYEEQEQHQVLEELFKLALVCTSSNPEDRPNMNEL 296
+ G ++ P+ E++ + C ++P RP ++
Sbjct: 261 IKEG----FRMLSPEHAP------------AEMYDIMKTCWDADPLKRPTFKQI 298
|
| >2psq_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xr0_A Length = 370 | Back alignment and structure |
|---|
Score = 101 bits (254), Expect = 6e-25
Identities = 71/300 (23%), Positives = 117/300 (39%), Gaps = 70/300 (23%)
Query: 27 TVYKGRLEDGE--------IVAVKKLNFHQFSAESDKS-FYREAKTLKEL-KHRNLVKVL 76
V + VAVK L + E D S E + +K + KH+N++ +L
Sbjct: 96 QVVMAEAVGIDKDKPKEAVTVAVKMLK--DDATEKDLSDLVSEMEMMKMIGKHKNIINLL 153
Query: 77 GYAWESGKLKALILEYMENGSL------------ESVIHGPGVDHSRWTLPKRIDVLISV 124
G + G L +I+EY G+L E V + T + +
Sbjct: 154 GACTQDGPL-YVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSCTYQL 212
Query: 125 ANGLDYLHSGYDIPIVHCDMKPSNILLDRDFEAHVSDFGTSRMLDVHLQDLSSLSTAFQG 184
A G++YL S +H D+ N+L+ + ++DFG +R D++ D +
Sbjct: 213 ARGMEYLAS---QKCIHRDLAARNVLVTENNVMKIADFGLAR--DINNID-----YYKKT 262
Query: 185 TIGYL-----APEFAYMRIVTTKVDVFSFGIVVMEFLTKRRPTGLDEENGLSP---ISLR 236
T G L APE + R+ T + DV+SFG+++ E T G SP I +
Sbjct: 263 TNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTL----------GGSPYPGIPVE 312
Query: 237 QLVEKALANGINGVRQITDPKLVSSIYEEQEQHQVLEELFKLALVCTSSNPEDRPNMNEL 296
+L + L G ++ P + EL+ + C + P RP +L
Sbjct: 313 ELFKL-LKEG----HRMDKPANCT------------NELYMMMRDCWHAVPSQRPTFKQL 355
|
| >4fvq_A Tyrosine-protein kinase JAK2; janus protein kinase, pseudokinase, ATP binding, phosphoryla transferase; HET: ATP; 1.75A {Homo sapiens} PDB: 4fvp_A* 4fvr_A* Length = 289 | Back alignment and structure |
|---|
Score = 100 bits (250), Expect = 8e-25
Identities = 55/305 (18%), Positives = 108/305 (35%), Gaps = 78/305 (25%)
Query: 19 IIGNSNLSTVYKGRLEDGEI--------VAVKKLNFHQFSAESDKSFYREAKTLKELKHR 70
+G + ++KG + V +K L+ + +SF+ A + +L H+
Sbjct: 15 SLGQGTFTKIFKGVRREVGDYGQLHETEVLLKVLD--KAHRNYSESFFEAASMMSKLSHK 72
Query: 71 NLVKVLGYAWESGKLKALILEYMENGSLESVIHGPGVDHSRWTLPKRIDVLISVANGLDY 130
+LV G G L+ E+++ GSL++ + + + +++V +A + +
Sbjct: 73 HLVLNYGVCVC-GDENILVQEFVKFGSLDTYLKKNK---NCINILWKLEVAKQLAAAMHF 128
Query: 131 LHS-GYDIPIVHCDMKPSNILLDRDFEAH--------VSDFGTSRMLDVHLQDLSSLSTA 181
L +H ++ NILL R+ + +SD G S V +D+
Sbjct: 129 LEENTL----IHGNVCAKNILLIREEDRKTGNPPFIKLSDPGISI--TVLPKDI------ 176
Query: 182 FQGTIGYLAPE-FAYMRIVTTKVDVFSFGIVVMEFLTKRRPTGLDEENGLSP---ISLRQ 237
Q I ++ PE + + D +SFG + E + G P + ++
Sbjct: 177 LQERIPWVPPECIENPKNLNLATDKWSFGTTLWEICSG----------GDKPLSALDSQR 226
Query: 238 LVEKALANGINGVRQITDPKLVSSIYEEQEQHQVLE-----ELFKLALVCTSSNPEDRPN 292
++ E L EL L C P+ RP+
Sbjct: 227 KLQFY------------------------EDRHQLPAPKAAELANLINNCMDYEPDHRPS 262
Query: 293 MNELL 297
++
Sbjct: 263 FRAII 267
|
| >3poz_A Epidermal growth factor receptor; kinase domain, anti-oncogene, ATP-binding, cell cycle, disea mutation, glycoprotein, membrane, nucleotide-binding; HET: 03P; 1.50A {Homo sapiens} PDB: 2itx_A* 2ity_A* 2j5f_A* 2j6m_A* 2itw_A* 1m14_A 1m17_A* 3vjo_A* 2gs6_A* 2gs2_A* 2rf9_A 1xkk_A* 2eb2_A 3gop_A 2eb3_A* 2itn_A* 2ito_A* 2itp_A* 2itq_A* 2jiu_A* ... Length = 327 | Back alignment and structure |
|---|
Score = 100 bits (251), Expect = 9e-25
Identities = 52/214 (24%), Positives = 93/214 (43%), Gaps = 25/214 (11%)
Query: 18 NIIGNSNLSTVYKGRL----EDGEI-VAVKKLNFHQFSAESDKSFYREAKTLKELKHRNL 72
++G+ TVYKG E +I VA+K+L S +++K EA + + + ++
Sbjct: 21 KVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELR-EATSPKANKEILDEAYVMASVDNPHV 79
Query: 73 VKVLGYAWESGKLKALILEYMENGSLESVIHGPGVDHSRWTLPKRIDVLISVANGLDYLH 132
++LG S LI + M G L + ++ + +A G++YL
Sbjct: 80 CRLLGICLTSTVQ--LITQLMPFGCLLDYVREHK---DNIGSQYLLNWCVQIAKGMNYLE 134
Query: 133 S-GYDIPIVHCDMKPSNILLDRDFEAHVSDFGTSRMLDVHLQDLSSLSTAFQGT---IGY 188
VH D+ N+L+ ++DFG +++L +G I +
Sbjct: 135 DRRL----VHRDLAARNVLVKTPQHVKITDFGLAKLLGA-----EEKEYHAEGGKVPIKW 185
Query: 189 LAPEFAYMRIVTTKVDVFSFGIVVMEFLTK-RRP 221
+A E RI T + DV+S+G+ V E +T +P
Sbjct: 186 MALESILHRIYTHQSDVWSYGVTVWELMTFGSKP 219
|
| >2j0j_A Focal adhesion kinase 1; cell migration, FERM, transferase, integrin signaling; HET: 4ST; 2.80A {Gallus gallus} PDB: 2j0k_A* Length = 656 | Back alignment and structure |
|---|
Score = 102 bits (255), Expect = 2e-24
Identities = 66/287 (22%), Positives = 109/287 (37%), Gaps = 50/287 (17%)
Query: 19 IIGNSNLSTVYKGRL---EDGEI-VAVKKLNFHQFSAESDKSFYREAKTLKELKHRNLVK 74
IG V++G E+ + VA+K + S + F +EA T+++ H ++VK
Sbjct: 397 CIGEGQFGDVHQGIYMSPENPAMAVAIKTCK-NCTSDSVREKFLQEALTMRQFDHPHIVK 455
Query: 75 VLGYAWESGKLKALILEYMENGSLESVIHGPGVDHSRWTLPKRIDVLISVANGLDYLHS- 133
++G E+ +I+E G L S + L I ++ L YL S
Sbjct: 456 LIGVITENPVW--IIMELCTLGELRSFLQVRK---FSLDLASLILYAYQLSTALAYLESK 510
Query: 134 GYDIPIVHCDMKPSNILLDRDFEAHVSDFGTSRMLDVHLQDLSSLSTAFQGT---IGYLA 190
+ VH D+ N+L+ + + DFG SR ++ S I ++A
Sbjct: 511 RF----VHRDIAARNVLVSSNDCVKLGDFGLSRYME------DSTYYKASKGKLPIKWMA 560
Query: 191 PEFAYMRIVTTKVDVFSFGIVVMEFLTK-RRPTGLDEENGLSPISLRQLVEKALANGING 249
PE R T+ DV+ FG+ + E L +P G+ + +E G
Sbjct: 561 PESINFRRFTSASDVWMFGVCMWEILMHGVKPFQ-----GVKNNDVIGRIEN-------G 608
Query: 250 VRQITDPKLVSSIYEEQEQHQVLEELFKLALVCTSSNPEDRPNMNEL 296
R + P L+ L C + +P RP EL
Sbjct: 609 ER-LPMPPNCP------------PTLYSLMTKCWAYDPSRRPRFTEL 642
|
| >3tt0_A Basic fibroblast growth factor receptor 1; kinase domain, transferase, transferase-transferase inhibito; HET: 07J; 2.80A {Homo sapiens} Length = 382 | Back alignment and structure |
|---|
Score = 100 bits (251), Expect = 2e-24
Identities = 72/299 (24%), Positives = 116/299 (38%), Gaps = 70/299 (23%)
Query: 28 VYKGRL--------EDGEIVAVKKLNFHQFSAESDKS-FYREAKTLKEL-KHRNLVKVLG 77
V VAVK L + E D S E + +K + KH+N++ +LG
Sbjct: 85 VVLAEAIGLDKDKPNRVTKVAVKMLK--SDATEKDLSDLISEMEMMKMIGKHKNIINLLG 142
Query: 78 YAWESGKLKALILEYMENGSL------------ESVIHGPGVDHSRWTLPKRIDVLISVA 125
+ G L +I+EY G+L E + + + + VA
Sbjct: 143 ACTQDGPL-YVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDLVSCAYQVA 201
Query: 126 NGLDYLHSGYDIPIVHCDMKPSNILLDRDFEAHVSDFGTSRMLDVHLQDLSSLSTAFQGT 185
G++YL S +H D+ N+L+ D ++DFG +R D+H D + T
Sbjct: 202 RGMEYLAS---KKCIHRDLAARNVLVTEDNVMKIADFGLAR--DIHHID-----YYKKTT 251
Query: 186 IGYL-----APEFAYMRIVTTKVDVFSFGIVVMEFLTKRRPTGLDEENGLSP---ISLRQ 237
G L APE + RI T + DV+SFG+++ E T G SP + + +
Sbjct: 252 NGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTL----------GGSPYPGVPVEE 301
Query: 238 LVEKALANGINGVRQITDPKLVSSIYEEQEQHQVLEELFKLALVCTSSNPEDRPNMNEL 296
L + L G ++ P + EL+ + C + P RP +L
Sbjct: 302 LFKL-LKEG----HRMDKPSNCT------------NELYMMMRDCWHAVPSQRPTFKQL 343
|
| >2ivs_A Proto-oncogene tyrosine-protein kinase receptor RET; nucleotide-binding, hirschsprung disease, phosphorylation, disease mutation; HET: ACK; 2.00A {Homo sapiens} PDB: 2ivt_A* 2ivu_A* 2x2k_A* 2x2l_A* 2x2m_A* 2ivv_A* Length = 314 | Back alignment and structure |
|---|
Score = 99.2 bits (248), Expect = 2e-24
Identities = 73/305 (23%), Positives = 121/305 (39%), Gaps = 75/305 (24%)
Query: 27 TVYKGRLEDGE------IVAVKKLNFHQFSAESDKS-FYREAKTLKELKHRNLVKVLGYA 79
V K + VAVK L + ++ S+ E LK++ H +++K+ G
Sbjct: 38 KVVKATAFHLKGRAGYTTVAVKMLK--ENASPSELRDLLSEFNVLKQVNHPHVIKLYGAC 95
Query: 80 WESGKLKALILEYMENGSL--------------------ESVIHGPGVDHSRWTLPKRID 119
+ G L LI+EY + GSL + D T+ I
Sbjct: 96 SQDGPL-LLIVEYAKYGSLRGFLRESRKVGPGYLGSGGSRNSSSLDHPDERALTMGDLIS 154
Query: 120 VLISVANGLDYLHSGYDIPIVHCDMKPSNILLDRDFEAHVSDFGTSRMLDVHLQDLSSLS 179
++ G+ YL + +VH D+ NIL+ + +SDFG SR DV+ +D
Sbjct: 155 FAWQISQGMQYLAE---MKLVHRDLAARNILVAEGRKMKISDFGLSR--DVYEED----- 204
Query: 180 TAFQGTIGYL-----APEFAYMRIVTTKVDVFSFGIVVMEFLTKRRPTGLDEENGLSP-- 232
+ + + G + A E + I TT+ DV+SFG+++ E +T G +P
Sbjct: 205 SYVKRSQGRIPVKWMAIESLFDHIYTTQSDVWSFGVLLWEIVTL----------GGNPYP 254
Query: 233 -ISLRQLVEKALANGINGVRQITDPKLVSSIYEEQEQHQVLEELFKLALVCTSSNPEDRP 291
I +L L G ++ P S EE+++L L C P+ RP
Sbjct: 255 GIPPERLFNL-LKTG----HRMERPDNCS------------EEMYRLMLQCWKQEPDKRP 297
Query: 292 NMNEL 296
++
Sbjct: 298 VFADI 302
|
| >3fdn_A Serine/threonine-protein kinase 6; aurora kinase inhibitors, virtual screening, X-RAY CO- crystal analysis, structure-based drug design (SBDD); HET: MMH; 1.90A {Homo sapiens} PDB: 3k5u_A* 3m11_A* 2c6e_A* 1muo_A* 2bmc_A* 2j4z_A* 1ol6_A* 3up2_A* 3unz_A* 3uo5_A* 3uo6_A* 3uod_A* 3uoh_A* 3uoj_A* 3uok_A* 3uo4_A* 3uol_A* 3up7_A* 3lau_A* 2wtv_A* ... Length = 279 | Back alignment and structure |
|---|
Score = 98.1 bits (245), Expect = 3e-24
Identities = 61/204 (29%), Positives = 98/204 (48%), Gaps = 16/204 (7%)
Query: 20 IGNSNLSTVYKGR-LEDGEIVAVKKLNFHQ-FSAESDKSFYREAKTLKELKHRNLVKVLG 77
+G VY R + I+A+K L Q A + RE + L+H N++++ G
Sbjct: 17 LGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLYG 76
Query: 78 YAWESGKLKALILEYMENGSLESVIHGPGVDHSRWTLPKRIDVLISVANGLDYLHSGYDI 137
Y ++ ++ LILEY G++ + S++ + + +AN L Y HS
Sbjct: 77 YFHDATRV-YLILEYAPLGTVYREL----QKLSKFDEQRTATYITELANALSYCHSKR-- 129
Query: 138 PIVHCDMKPSNILLDRDFEAHVSDFGTSRMLDVHLQDLSSLSTAFQGTIGYLAPEFAYMR 197
++H D+KP N+LL E ++DFG S VH S + GT+ YL PE R
Sbjct: 130 -VIHRDIKPENLLLGSAGELKIADFGWS----VHAPS-SRRTD-LCGTLDYLPPEMIEGR 182
Query: 198 IVTTKVDVFSFGIVVMEFLTKRRP 221
+ KVD++S G++ EFL + P
Sbjct: 183 MHDEKVDLWSLGVLCYEFLVGKPP 206
|
| >3fxz_A Serine/threonine-protein kinase PAK 1; transferase, ATP-binding, phosphorylation, allosteric enzyme, alternative splicing, apoptosis, cell junction; HET: TPO FLL; 1.64A {Homo sapiens} PDB: 3fy0_A* 4daw_A* 3q52_A* 3q53_A* 1yhw_A 1f3m_C 1yhv_A 2hy8_1* 3q4z_A* Length = 297 | Back alignment and structure |
|---|
Score = 98.5 bits (246), Expect = 3e-24
Identities = 68/297 (22%), Positives = 119/297 (40%), Gaps = 51/297 (17%)
Query: 8 ENATGSFSENNIIGNSNLSTVYKGR-LEDGEIVAVKKLNFHQFSAESDKSFYREAKTLKE 66
+ ++ IG TVY + G+ VA++++N Q + E ++E
Sbjct: 16 GDPKKKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQ--QPKKELIINEILVMRE 73
Query: 67 LKHRNLVKVLGYAWESGKLKALILEYMENGSLESVIHGPGVDHSRWTLPKRID------V 120
K+ N+V L +L +++EY+ GSL V+ +D V
Sbjct: 74 NKNPNIVNYLDSYLVGDEL-WVVMEYLAGGSLTDVVT-----------ETCMDEGQIAAV 121
Query: 121 LISVANGLDYLHSGYDIPIVHCDMKPSNILLDRDFEAHVSDFGTSRMLDVHLQDLSSLST 180
L++LHS ++H D+K NILL D ++DFG + S+
Sbjct: 122 CRECLQALEFLHSNQ---VIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSKRST--- 175
Query: 181 AFQGTIGYLAPEFAYMRIVTTKVDVFSFGIVVMEFLTKRRPTGLDEENGLSPISLRQLVE 240
GT ++APE + KVD++S GI+ +E + + P L+E P+ L+
Sbjct: 176 -MVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIE-MIEGEPPYLNEN----PLRALYLIA 229
Query: 241 KALANGINGVRQITDPKLVSSIYEEQEQHQVLEELFKLALVCTSSNPEDRPNMNELL 297
NG ++ +P+ +S + + L + E R + ELL
Sbjct: 230 T------NGTPELQNPEKLS---------AIFRDFLNRCLE---MDVEKRGSAKELL 268
|
| >2vwi_A Serine/threonine-protein kinase OSR1; STE kinase, hypertension, transferase; HET: ANP; 2.15A {Homo sapiens} PDB: 3dak_A* Length = 303 | Back alignment and structure |
|---|
Score = 98.2 bits (245), Expect = 4e-24
Identities = 71/289 (24%), Positives = 115/289 (39%), Gaps = 36/289 (12%)
Query: 20 IGNSNLSTVYKGR-LEDGEIVAVKKLNFHQFSAESDKSFYREAKTLKELKHRNLVKVLGY 78
IG+ + V E VA+K++N + D +E + + + H N+V
Sbjct: 23 IGSGATAVVQAAYCAPKKEKVAIKRINLEKCQTSMD-ELLKEIQAMSQCHHPNIVSYYTS 81
Query: 79 AWESGKLKALILEYMENGSLESVI--HGPGVDHSRWTLPKRI--DVLISVANGLDYLHSG 134
+L L+++ + GS+ +I +H L + +L V GL+YLH
Sbjct: 82 FVVKDEL-WLVMKLLSGGSVLDIIKHIVAKGEHKSGVLDESTIATILREVLEGLEYLHKN 140
Query: 135 YDIPIVHCDMKPSNILLDRDFEAHVSDFGTSRML-DVHLQDLSSLSTAFQGTIGYLAPE- 192
I H D+K NILL D ++DFG S L + + F GT ++APE
Sbjct: 141 GQI---HRDVKAGNILLGEDGSVQIADFGVSAFLATGGDITRNKVRKTFVGTPCWMAPEV 197
Query: 193 ----FAYMRIVTTKVDVFSFGIVVMEFLTKRRPTGLDEENGLSPISLRQLVEKALANGIN 248
Y K D++SFGI +E T P + + K L
Sbjct: 198 MEQVRGY----DFKADIWSFGITAIELATGAAP--YHKYPPM----------KVLML--- 238
Query: 249 GVRQITDPKLVSSIYEEQEQHQVLEELFKLALVCTSSNPEDRPNMNELL 297
Q P L + + +++ + + K+ +C +PE RP ELL
Sbjct: 239 -TLQNDPPSLETGVQDKEMLKKYGKSFRKMISLCLQKDPEKRPTAAELL 286
|
| >1luf_A Muscle-specific tyrosine kinase receptor MUSK; phosphorylation, signal transduction, MASS spectrometry, transferase; 2.05A {Rattus norvegicus} SCOP: d.144.1.7 Length = 343 | Back alignment and structure |
|---|
Score = 98.5 bits (246), Expect = 5e-24
Identities = 64/304 (21%), Positives = 110/304 (36%), Gaps = 73/304 (24%)
Query: 28 VYKGRLEDGE------IVAVKKLNFHQFSAESDKSFYREAKTLKELKHRNLVKVLGYAWE 81
V++ R +VAVK L + SA+ F REA + E + N+VK+LG
Sbjct: 63 VFQARAPGLLPYEPFTMVAVKMLK-EEASADMQADFQREAALMAEFDNPNIVKLLGVCAV 121
Query: 82 SGKLKALILEYMENGSL--------------------ESVIHGPGVDHSRWTLPKRIDVL 121
+ L+ EYM G L + + +++ +
Sbjct: 122 GKPM-CLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVSSPGPPPLSCAEQLCIA 180
Query: 122 ISVANGLDYLHSGYDIPIVHCDMKPSNILLDRDFEAHVSDFGTSRMLDVHLQDLSSLSTA 181
VA G+ YL VH D+ N L+ + ++DFG SR +++ D
Sbjct: 181 RQVAAGMAYLSE---RKFVHRDLATRNCLVGENMVVKIADFGLSR--NIYSAD-----YY 230
Query: 182 FQGTIGYL-----APEFAYMRIVTTKVDVFSFGIVVMEFLTKRRPTGLDEENGLSP---I 233
+ PE + TT+ DV+++G+V+ E + GL P +
Sbjct: 231 KADGNDAIPIRWMPPESIFYNRYTTESDVWAYGVVLWEIFSY----------GLQPYYGM 280
Query: 234 SLRQLVEKALANGINGVRQITDPKLVSSIYEEQEQHQVLEELFKLALVCTSSNPEDRPNM 293
+ +++ I + P+ EL+ L +C S P DRP+
Sbjct: 281 AHEEVIYYVRDGNI-----LACPENCP------------LELYNLMRLCWSKLPADRPSF 323
Query: 294 NELL 297
+
Sbjct: 324 CSIH 327
|
| >3aln_A Dual specificity mitogen-activated protein kinase; protein AMP-PNP complex, transferase; HET: ANP; 2.30A {Homo sapiens} PDB: 3alo_A* Length = 327 | Back alignment and structure |
|---|
Score = 98.2 bits (245), Expect = 7e-24
Identities = 53/212 (25%), Positives = 85/212 (40%), Gaps = 37/212 (17%)
Query: 20 IGNSNLSTVYKGR-LEDGEIVAVKKLNFHQFSAESDKSFYREAKT-LKELKHRNLVKVLG 77
IG +V K G+I+AVK++ E K + ++ +V+ G
Sbjct: 30 IGRGAYGSVNKMVHKPSGQIMAVKRIRSTVDEKEQ-KQLLMDLDVVMRSSDCPYIVQFYG 88
Query: 78 YAWESGKLKALILEYMENGSLESVIHGPGVDHSRWTLPKRID------VLISVANGLDYL 131
+ G + +E M + S + + L I + ++ L++L
Sbjct: 89 ALFREGDCW-ICMELM-STSFDKF-----YKYVYSVLDDVIPEEILGKITLATVKALNHL 141
Query: 132 HSGYDIPIVHCDMKPSNILLDRDFEAHVSDFGTSRMLDVHLQDLSSLS-TAFQGTIGYLA 190
++ I+H D+KPSNILLDR + DFG S L S++ T G Y+A
Sbjct: 142 KE--NLKIIHRDIKPSNILLDRSGNIKLCDFGISGQLV------DSIAKTRDAGCRPYMA 193
Query: 191 PEFAYMRIV--------TTKVDVFSFGIVVME 214
PE RI + DV+S GI + E
Sbjct: 194 PE----RIDPSASRQGYDVRSDVWSLGITLYE 221
|
| >3o0g_A Cell division protein kinase 5; kinase activator complex, kinase inhibitor complex, transferase-transferase activator complex; HET: 3O0; 1.95A {Homo sapiens} PDB: 1unh_A* 1ung_A* 1unl_A* 1h4l_A Length = 292 | Back alignment and structure |
|---|
Score = 97.2 bits (243), Expect = 8e-24
Identities = 54/198 (27%), Positives = 96/198 (48%), Gaps = 16/198 (8%)
Query: 27 TVYKGR-LEDGEIVAVKKLNFHQFSAESDKSFYREAKTLKELKHRNLVKVLGYAWESGKL 85
TV+K + E EIVA+K++ S RE LKELKH+N+V++ KL
Sbjct: 17 TVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLHDVLHSDKKL 76
Query: 86 KALILEYMENGSLESVIHGPGVDHSRWTLPKRI-DVLISVANGLDYLHSGYDIPIVHCDM 144
L+ E+ + L+ D P+ + L + GL + HS ++H D+
Sbjct: 77 -TLVFEFCDQ-DLKKYFDSCNGDLD----PEIVKSFLFQLLKGLGFCHSRN---VLHRDL 127
Query: 145 KPSNILLDRDFEAHVSDFGTSRMLDVHLQDLSSLSTAFQGTIGYLAPEFAY-MRIVTTKV 203
KP N+L++R+ E +++FG +R + ++ S+ T+ Y P+ + ++ +T +
Sbjct: 128 KPQNLLINRNGELKLANFGLARAFGIPVRCYSAEVV----TLWYRPPDVLFGAKLYSTSI 183
Query: 204 DVFSFGIVVMEFLTKRRP 221
D++S G + E RP
Sbjct: 184 DMWSAGCIFAELANAGRP 201
|
| >3dzo_A Rhoptry kinase domain; parasitic disease, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} Length = 413 | Back alignment and structure |
|---|
Score = 98.6 bits (245), Expect = 1e-23
Identities = 41/265 (15%), Positives = 74/265 (27%), Gaps = 53/265 (20%)
Query: 26 STVYKGR-LEDGEIVAVKKLNFHQFSAESD-KSFYREAKTLKELK--------------- 68
+ E GE V F + + K E L+ L+
Sbjct: 92 YAYLEATDQETGESFEVHVPYFTERPPSNAIKQMKEEVLRLRLLRGIKNQKQAKVHLRFI 151
Query: 69 ----------HRNLVKVLGYAWESGKLKALILEYMENGSLESV---IHGPGVDHSRWTLP 115
+ +++V + L L +L++ + H
Sbjct: 152 FPFDLVKDPQKKKMIRVRLDERDMWVLSRFFLYPRMQSNLQTFGEVLLSHSSTHKSLVHH 211
Query: 116 KRIDVLISVANGLDYLHS-GYDIPIVHCDMKPSNILLDRDFEAHVSDFGTSRMLDVHLQD 174
R+ + + V L LH G +VH ++P +I+LD+ ++ F
Sbjct: 212 ARLQLTLQVIRLLASLHHYG----LVHTYLRPVDIVLDQRGGVFLTGFEHLVRDG---AS 264
Query: 175 LSSLSTAFQGTIGYLAPEFAYMR-----IVTTKVDVFSFGIVVMEFLTKRRPTGLDEENG 229
S A ++T D ++ G+ + P D G
Sbjct: 265 AVSPIGRGFAPPETTAERMLPFGQHHPTLMTFAFDTWTLGLAIYWIWCADLPNTDDAALG 324
Query: 230 LS----------PISLRQLVEKALA 244
S P +R L+E L
Sbjct: 325 GSEWIFRSCKNIPQPVRALLEGFLR 349
|
| >1rjb_A FL cytokine receptor; kinase, structure, autoinhibition, juxtamembrane domain, transferase; 2.10A {Homo sapiens} SCOP: d.144.1.7 Length = 344 | Back alignment and structure |
|---|
Score = 97.8 bits (244), Expect = 1e-23
Identities = 66/299 (22%), Positives = 113/299 (37%), Gaps = 64/299 (21%)
Query: 28 VYKGRLEDGE------IVAVKKLNFHQFSAESDKS-FYREAKTLKEL-KHRNLVKVLGYA 79
V VAVK L + + S++ E K + +L H N+V +LG
Sbjct: 61 VMNATAYGISKTGVSIQVAVKMLK--EKADSSEREALMSELKMMTQLGSHENIVNLLGAC 118
Query: 80 WESGKLKALILEYMENGSL--------ESVIHGPGVDHSRWTLPKRIDV-------LIS- 123
SG + LI EY G L E ++ L + D+ L+
Sbjct: 119 TLSGPI-YLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEEDLNVLTFEDLLCF 177
Query: 124 ---VANGLDYLHSGYDIPIVHCDMKPSNILLDRDFEAHVSDFGTSRMLDVHLQDLSSLST 180
VA G+++L VH D+ N+L+ + DFG +R D+ +
Sbjct: 178 AYQVAKGMEFLEF---KSCVHRDLAARNVLVTHGKVVKICDFGLAR--DIMSDSNYVVRG 232
Query: 181 AFQGTIGYLAPEFAYMRIVTTKVDVFSFGIVVMEFLTKRRPTGLDEENGLSP---ISLRQ 237
+ + ++APE + I T K DV+S+GI++ E + G++P I +
Sbjct: 233 NARLPVKWMAPESLFEGIYTIKSDVWSYGILLWEIFSL----------GVNPYPGIPVDA 282
Query: 238 LVEKALANGINGVRQITDPKLVSSIYEEQEQHQVLEELFKLALVCTSSNPEDRPNMNEL 296
K + NG ++ P + EE++ + C + + RP+ L
Sbjct: 283 NFYKLIQNG----FKMDQPFYAT------------EEIYIIMQSCWAFDSRKRPSFPNL 325
|
| >3cok_A Serine/threonine-protein kinase PLK4; POLO-like kinase 4, SAK, STK18, PSI, structural genomics, protein structure initiative; HET: ANP; 2.25A {Homo sapiens} Length = 278 | Back alignment and structure |
|---|
Score = 96.1 bits (240), Expect = 2e-23
Identities = 50/202 (24%), Positives = 80/202 (39%), Gaps = 25/202 (12%)
Query: 28 VYKGR-LEDGEIVAVKKLNFHQFSAESDKS-FYREAKTLKELKHRNLVKVLGYAWESGKL 85
VY+ + G VA+K ++ E K +LKH +++++ Y +E
Sbjct: 27 VYRAESIHTGLEVAIKMIDKKAMYKAGMVQRVQNEVKIHCQLKHPSILELYNY-FEDSNY 85
Query: 86 KALILEYMENGSLESVIHGPGVDHSRWTLPKRID------VLISVANGLDYLHSGYDIPI 139
L+LE NG + + K + + G+ YLHS I
Sbjct: 86 VYLVLEMCHNGEMNRYLKNRV---------KPFSENEARHFMHQIITGMLYLHSHG---I 133
Query: 140 VHCDMKPSNILLDRDFEAHVSDFGTSRMLDVHLQDLSSLSTAFQGTIGYLAPEFAYMRIV 199
+H D+ SN+LL R+ ++DFG L L+ GT Y++PE A
Sbjct: 134 LHRDLTLSNLLLTRNMNIKIADFG----LATQLKMPHEKHYTLCGTPNYISPEIATRSAH 189
Query: 200 TTKVDVFSFGIVVMEFLTKRRP 221
+ DV+S G + L R P
Sbjct: 190 GLESDVWSLGCMFYTLLIGRPP 211
|
| >3byv_A Rhoptry kinase; malaria, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} PDB: 2w1z_A Length = 377 | Back alignment and structure |
|---|
Score = 97.8 bits (243), Expect = 2e-23
Identities = 44/271 (16%), Positives = 79/271 (29%), Gaps = 64/271 (23%)
Query: 26 STVYKGR-LEDGEIVAVKKLNF--------------------------HQFSAESDKSFY 58
+ E GE V F +Q A+ F
Sbjct: 87 YAYLEATDQETGESFEVHVPYFTERPPSNAIKQMKEEVLRLRLLRGIKNQKQAKVHLRFI 146
Query: 59 REAKTLKELKHRNLVKVLGYAWESGKLKALILEYMENGSLESV---IHGPGVDHSRWTLP 115
+K+ + + +++V + L L +L++ + H
Sbjct: 147 FPFDLVKDPQKKKMIRVRLDERDMWVLSRFFLYPRMQSNLQTFGEVLLSHSSTHKSLVHH 206
Query: 116 KRIDVLISVANGLDYLHS-GYDIPIVHCDMKPSNILLDRDFEAHVSDFGTSRMLDVHLQD 174
R+ + + V L LH G +VH ++P +I+LD+ ++ F
Sbjct: 207 ARLQLTLQVIRLLASLHHYG----LVHTYLRPVDIVLDQRGGVFLTGFEHLVRDGA---- 258
Query: 175 LSSLSTAFQGTIGYLAPEFAYMRI-----------VTTKVDVFSFGIVVMEFLTKRRPTG 223
+ G+ PE R +T D ++ G+V+ P
Sbjct: 259 ----RVVSSVSRGFEPPELEARRATISYHRDRRTLMTFSFDAWALGLVIYWIWCADLPIT 314
Query: 224 LDEENGLS----------PISLRQLVEKALA 244
D G S P +R L+E L
Sbjct: 315 KDAALGGSEWIFRSCKNIPQPVRALLEGFLR 345
|
| >2c30_A Serine/threonine-protein kinase PAK 6; CRIB domain, ATP-binding, transferase, nucleotide-binding; HET: SEP; 1.6A {Homo sapiens} PDB: 2f57_A* 2j0i_A* 2cdz_A* 2q0n_A* 2x4z_A* 2bva_A* Length = 321 | Back alignment and structure |
|---|
Score = 96.7 bits (241), Expect = 2e-23
Identities = 62/291 (21%), Positives = 119/291 (40%), Gaps = 39/291 (13%)
Query: 8 ENATGSFSENNIIGNSNLSTVYKGR-LEDGEIVAVKKLNFHQFSAESDKSFYREAKTLKE 66
+ IG + V R G VAVK ++ + + + + E +++
Sbjct: 41 GDPRLLLDSYVKIGEGSTGIVCLAREKHSGRQVAVKMMDLRK--QQRRELLFNEVVIMRD 98
Query: 67 LKHRNLVKVLGYAWESGKLKALILEYMENGSLESVIHGPGVDHSRWTLPKRIDVLISVAN 126
+H N+V++ +L +++E+++ G+L ++ R + V +V
Sbjct: 99 YQHFNVVEMYKSYLVGEEL-WVLMEFLQGGALTDIVS-----QVRLNEEQIATVCEAVLQ 152
Query: 127 GLDYLHSGYDIPIVHCDMKPSNILLDRDFEAHVSDFGTSRMLDVHLQDLSSLSTAFQGTI 186
L YLH+ ++H D+K +ILL D +SDFG + + S GT
Sbjct: 153 ALAYLHAQG---VIHRDIKSDSILLTLDGRVKLSDFGFCAQISKDVPKRKS----LVGTP 205
Query: 187 GYLAPEFAYMRIVTTKVDVFSFGIVVMEFLTKRRPTGLDEENGLSPISLRQLVEKALANG 246
++APE + T+VD++S GI+V+E + P + P+ + +
Sbjct: 206 YWMAPEVISRSLYATEVDIWSLGIMVIE-MVDGEPPYFSDS----PVQAMKRLRD----- 255
Query: 247 INGVRQITDPKLVSSIYEEQEQHQVLEELFKLALVCTSSNPEDRPNMNELL 297
+ ++ + VS VL + + LV +P++R ELL
Sbjct: 256 -SPPPKLKNSHKVS---------PVLRDFLERMLV---RDPQERATAQELL 293
|
| >2dyl_A Dual specificity mitogen-activated protein kinase kinase 7; MKK7, activated mutant, ATP-binding, structural genomics, NPPSFA; 2.45A {Homo sapiens} Length = 318 | Back alignment and structure |
|---|
Score = 96.7 bits (241), Expect = 2e-23
Identities = 52/216 (24%), Positives = 90/216 (41%), Gaps = 34/216 (15%)
Query: 20 IGNSNLSTVYKGR-LEDGEIVAVKKLNFHQFSAESDKSFYREAKTL-KELKHRNLVKVLG 77
+G+ V+K R + G ++AVK++ + E +K + + K +V+ G
Sbjct: 33 MGSGTCGQVWKMRFRKTGHVIAVKQMRR-SGNKEENKRILMDLDVVLKSHDCPYIVQCFG 91
Query: 78 YAWESGKLKALILEYMENGSLESVIHGPGVDHSRWTLPKRI--DVLISVANGLDYLHSGY 135
+ + + +E M + + G +P+RI + +++ L YL
Sbjct: 92 TFITNTDVF-IAMELMGTCAEKLKKRMQG------PIPERILGKMTVAIVKALYYLKE-- 142
Query: 136 DIPIVHCDMKPSNILLDRDFEAHVSDFGTSRMLDVHLQDLSSLS-TAFQGTIGYLAPEFA 194
++H D+KPSNILLD + + DFG S L + G Y+APE
Sbjct: 143 KHGVIHRDVKPSNILLDERGQIKLCDFGISGRLV------DDKAKDRSAGCAAYMAPE-- 194
Query: 195 YMRIV---------TTKVDVFSFGIVVMEFLTKRRP 221
RI + DV+S GI ++E T + P
Sbjct: 195 --RIDPPDPTKPDYDIRADVWSLGISLVELATGQFP 228
|
| >2vgo_A Serine/threonine-protein kinase 12-A; nucleotide-binding, serine/threonine-protein kinase, ATP-binding, transferase, coiled coil, cell division, kinase; HET: TPO AD5; 1.7A {Xenopus laevis} PDB: 2bfx_A* 2vgp_A* 3ztx_A* 2vrx_A* 2bfy_A* 4af3_A* 3dj6_A* 3d15_A* 3d2i_A* 3d2k_A* 3d14_A* 3dj5_A* 3dj7_A* 3daj_A* 1ol5_A* 1ol7_A* 2x6d_A* 2x6e_A* 2xng_A* 2dwb_A* ... Length = 284 | Back alignment and structure |
|---|
Score = 95.7 bits (239), Expect = 2e-23
Identities = 54/204 (26%), Positives = 90/204 (44%), Gaps = 16/204 (7%)
Query: 20 IGNSNLSTVYKGR-LEDGEIVAVKKLNFHQ-FSAESDKSFYREAKTLKELKHRNLVKVLG 77
+G VY R ++ I+A+K L Q + RE + L+H N++++
Sbjct: 22 LGKGKFGNVYLAREKQNKFIMALKVLFKSQLEKEGVEHQLRREIEIQSHLRHPNILRMYN 81
Query: 78 YAWESGKLKALILEYMENGSLESVIHGPGVDHSRWTLPKRIDVLISVANGLDYLHSGYDI 137
Y + ++ L+LE+ G L + H R+ + + +A+ L Y H
Sbjct: 82 YFHDRKRI-YLMLEFAPRGELYKEL----QKHGRFDEQRSATFMEELADALHYCHE---R 133
Query: 138 PIVHCDMKPSNILLDRDFEAHVSDFGTSRMLDVHLQDLSSLSTAFQGTIGYLAPEFAYMR 197
++H D+KP N+L+ E ++DFG S VH T GT+ YL PE +
Sbjct: 134 KVIHRDIKPENLLMGYKGELKIADFGWS----VHAPS-LRRRT-MCGTLDYLPPEMIEGK 187
Query: 198 IVTTKVDVFSFGIVVMEFLTKRRP 221
KVD++ G++ EFL P
Sbjct: 188 THDEKVDLWCAGVLCYEFLVGMPP 211
|
| >3rgf_A Cyclin-dependent kinase 8; protein kinase complex, transferase,transcription; HET: BAX; 2.20A {Homo sapiens} Length = 405 | Back alignment and structure |
|---|
Score = 97.6 bits (243), Expect = 2e-23
Identities = 52/216 (24%), Positives = 92/216 (42%), Gaps = 41/216 (18%)
Query: 27 TVYKGR---LEDGEIVAVKKLNFHQFSAESDKSFYREAKTLKELKHRNLVKVLGYAWESG 83
VYK + +D + A+K++ S + RE L+ELKH N++ +
Sbjct: 36 HVYKAKRKDGKDDKDYALKQIEGTGISMSA----CREIALLRELKHPNVISLQKVFLSHA 91
Query: 84 KLKA-LILEYMENGSLESVIHGPGVDHSRWTLPKRIDVLISVA----------NGLDYLH 132
K L+ +Y E+ L +I R + + V + +G+ YLH
Sbjct: 92 DRKVWLLFDYAEH-DLWHII-----KFHRASKANKKPVQLPRGMVKSLLYQILDGIHYLH 145
Query: 133 SGYDIPIVHCDMKPSNILLDRDFEAH----VSDFGTSRMLDVHLQDLSSLSTAFQGTIGY 188
+ + ++H D+KP+NIL+ + ++D G +R+ + L+ L+ L T Y
Sbjct: 146 ANW---VLHRDLKPANILVMGEGPERGRVKIADMGFARLFNSPLKPLADLDPVVV-TFWY 201
Query: 189 LAPEF-----AYMRIVTTKVDVFSFGIVVMEFLTKR 219
APE Y T +D+++ G + E LT
Sbjct: 202 RAPELLLGARHY----TKAIDIWAIGCIFAELLTSE 233
|
| >1ua2_A CAK, cell division protein kinase 7; cell cycle, phosphorylation, protein-protein interaction, PR kinase, cell cycle, transferase; HET: TPO ATP; 3.02A {Homo sapiens} SCOP: d.144.1.7 Length = 346 | Back alignment and structure |
|---|
Score = 96.5 bits (241), Expect = 3e-23
Identities = 56/198 (28%), Positives = 95/198 (47%), Gaps = 17/198 (8%)
Query: 27 TVYKGR-LEDGEIVAVKKLNFHQFSAESD---KSFYREAKTLKELKHRNLVKVLGYAWES 82
TVYK R +IVA+KK+ S D ++ RE K L+EL H N++ +L
Sbjct: 25 TVYKARDKNTNQIVAIKKIKLGHRSEAKDGINRTALREIKLLQELSHPNIIGLLDAFGHK 84
Query: 83 GKLKALILEYMENGSLESVIHGPGVDHSRWTLPKRIDVLISVANGLDYLHSGYDIPIVHC 142
+ +L+ ++ME LE +I + T ++ GL+YLH + I+H
Sbjct: 85 SNI-SLVFDFMET-DLEVIIKDNSL---VLTPSHIKAYMLMTLQGLEYLHQHW---ILHR 136
Query: 143 DMKPSNILLDRDFEAHVSDFGTSRMLDVHLQDLSSLSTAFQGTIGYLAPEFAY-MRIVTT 201
D+KP+N+LLD + ++DFG ++ + + T Y APE + R+
Sbjct: 137 DLKPNNLLLDENGVLKLADFGLAKSFGSPNRAYTHQVV----TRWYRAPELLFGARMYGV 192
Query: 202 KVDVFSFGIVVMEFLTKR 219
VD+++ G ++ E L +
Sbjct: 193 GVDMWAVGCILAELLLRV 210
|
| >3e7e_A HBUB1, BUB1A, mitotic checkpoint serine/threonine-protein kinas; spindle assembly checkpoint, mitosis, kinase, activation, KE CDC20, ATP-binding; HET: ATP; 2.31A {Homo sapiens} Length = 365 | Back alignment and structure |
|---|
Score = 97.0 bits (241), Expect = 3e-23
Identities = 40/239 (16%), Positives = 78/239 (32%), Gaps = 32/239 (13%)
Query: 4 RTEIENATGSFSENNIIGNSNLSTVYKGR------LEDGEIVAVKKLNFHQFSAESDKSF 57
+TE + + ++++G + VY+ ++ + +K + F
Sbjct: 57 KTEFQLGSKLVYVHHLLGEGAFAQVYEATQGDLNDAKNKQKFVLKVQK-----PANPWEF 111
Query: 58 Y---REAKTLKELKHRNLVKVLGYAWESGKLKALILEYMENGSLESVIHGPGVDHSRW-T 113
Y + + LK +K L+ E G+L + I+ +
Sbjct: 112 YIGTQLMERLKPSMQHMFMKFYSAHLFQNGS-VLVGELYSYGTLLNAINLYKNTPEKVMP 170
Query: 114 LPKRIDVLISVANGLDYLHSGYDIPIVHCDMKPSNILLDRDFEAH-----------VSDF 162
I + + ++ +H I+H D+KP N +L F + D
Sbjct: 171 QGLVISFAMRMLYMIEQVHD---CEIIHGDIKPDNFILGNGFLEQDDEDDLSAGLALIDL 227
Query: 163 GTSRMLDVHLQDLSSLSTAFQGTIGYLAPEFAYMRIVTTKVDVFSFGIVVMEFLTKRRP 221
G S D+ L ++ TA T G+ E + ++D F V L
Sbjct: 228 GQSI--DMKLFPKGTIFTAKCETSGFQCVEMLSNKPWNYQIDYFGVAATVYCMLFGTYM 284
|
| >2i1m_A Macrophage colony-stimulating factor 1 receptor; kinase domain, kinase inhibitor complex, transferase; HET: 5CN; 1.80A {Homo sapiens} PDB: 3bea_A* 3lcd_A* 2i0y_A* 2i0v_A* 3dpk_A* 3krj_A* 3krl_A* 2ogv_A 3lco_A* Length = 333 | Back alignment and structure |
|---|
Score = 96.2 bits (240), Expect = 4e-23
Identities = 62/290 (21%), Positives = 109/290 (37%), Gaps = 55/290 (18%)
Query: 28 VYKGRL-----EDGEI-VAVKKLNFHQFSAESDKS-FYREAKTLKEL-KHRNLVKVLGYA 79
V + ED + VAVK L + +K E K + L +H N+V +LG
Sbjct: 62 VVEATAFGLGKEDAVLKVAVKMLK--STAHADEKEALMSELKIMSHLGQHENIVNLLGAC 119
Query: 80 WESGKLKALILEYMENGSL----------ESVIHGPGVDHSRWTLPKRIDVLISVANGLD 129
G + +I EY G L + +S + + VA G+
Sbjct: 120 THGGPV-LVITEYCCYGDLLNFLRRKSRVLETDPAFAIANSTASTRDLLHFSSQVAQGMA 178
Query: 130 YLHSGYDIPIVHCDMKPSNILLDRDFEAHVSDFGTSRMLDVHLQDLSSLSTAFQGTIGYL 189
+L S +H D+ N+LL A + DFG +R D+ + + + ++
Sbjct: 179 FLAS---KNCIHRDVAARNVLLTNGHVAKIGDFGLAR--DIMNDSNYIVKGNARLPVKWM 233
Query: 190 APEFAYMRIVTTKVDVFSFGIVVMEFLTKRRPTGLDEENGLSP---ISLRQLVEKALANG 246
APE + + T + DV+S+GI++ E + GL+P I + K + +G
Sbjct: 234 APESIFDCVYTVQSDVWSYGILLWEIFSL----------GLNPYPGILVNSKFYKLVKDG 283
Query: 247 INGVRQITDPKLVSSIYEEQEQHQVLEELFKLALVCTSSNPEDRPNMNEL 296
Q+ P + ++ + C + P RP ++
Sbjct: 284 ----YQMAQPAFAP------------KNIYSIMQACWALEPTHRPTFQQI 317
|
| >3mi9_A Cell division protein kinase 9; P-TEFB, HIV-1, protein binding; HET: TPO; 2.10A {Homo sapiens} PDB: 3mia_A* 3blh_A* 3blq_A* 3blr_A* 3lq5_A* 3my1_A* 3tn8_A* 3tnh_A* 3tni_A* Length = 351 | Back alignment and structure |
|---|
Score = 96.1 bits (240), Expect = 5e-23
Identities = 58/219 (26%), Positives = 95/219 (43%), Gaps = 32/219 (14%)
Query: 18 NIIGNSNLSTVYKGR-LEDGEIVAVKKLNFHQFSAESDKSF----YREAKTLKELKHRNL 72
IG V+K R + G+ VA+KK+ E + F RE K L+ LKH N+
Sbjct: 23 AKIGQGTFGEVFKARHRKTGQKVALKKVLMEN---EKE-GFPITALREIKILQLLKHENV 78
Query: 73 VK----VLGYAWESGKLKA---LILEYMENGSLESVIHGPGVDHSRWTLPKRIDVLISVA 125
V A + K L+ ++ E+ L ++ V ++TL + V+ +
Sbjct: 79 VNLIEICRTKASPYNRCKGSIYLVFDFCEH-DLAGLLSNVLV---KFTLSEIKRVMQMLL 134
Query: 126 NGLDYLHSGYDIPIVHCDMKPSNILLDRDFEAHVSDFGTSRMLDVHLQDLSSLSTAFQGT 185
NGL Y+H I+H DMK +N+L+ RD ++DFG +R + + T T
Sbjct: 135 NGLYYIHRNK---ILHRDMKAANVLITRDGVLKLADFGLARAFSLAKNSQPNRYTNRVVT 191
Query: 186 IGYLAPEF-----AYMRIVTTKVDVFSFGIVVMEFLTKR 219
+ Y PE Y +D++ G ++ E T+
Sbjct: 192 LWYRPPELLLGERDY----GPPIDLWGAGCIMAEMWTRS 226
|
| >3niz_A Rhodanese family protein; structural genomics, structural genomics consortium, SGC, phosphotransferase, cyclin dependent kinase; HET: ADP; 2.40A {Cryptosporidium parvum} PDB: 2qkr_A* Length = 311 | Back alignment and structure |
|---|
Score = 94.9 bits (237), Expect = 7e-23
Identities = 52/196 (26%), Positives = 90/196 (45%), Gaps = 17/196 (8%)
Query: 27 TVYKGRLEDGEIVAVKKLNFHQFSAESDKSFYREAKTLKELKHRNLVKVLGYAWESGKLK 86
VYK + G IVA+K++ + RE LKEL H N+V ++ L
Sbjct: 36 VVYKAKDSQGRIVALKRIRLDAEDEGIPSTAIREISLLKELHHPNIVSLIDVIHSERCL- 94
Query: 87 ALILEYMENGSLESVIHGPGVDHSRWTLPKRI--DVLISVANGLDYLHSGYDIPIVHCDM 144
L+ E+ME L+ V+ D ++ L L + G+ + H I+H D+
Sbjct: 95 TLVFEFMEK-DLKKVL-----DENKTGLQDSQIKIYLYQLLRGVAHCHQHR---ILHRDL 145
Query: 145 KPSNILLDRDFEAHVSDFGTSRMLDVHLQDLSSLSTAFQGTIGYLAPEFAY-MRIVTTKV 203
KP N+L++ D ++DFG +R + ++ + T+ Y AP+ + +T V
Sbjct: 146 KPQNLLINSDGALKLADFGLARAFGIPVRSYTHEVV----TLWYRAPDVLMGSKKYSTSV 201
Query: 204 DVFSFGIVVMEFLTKR 219
D++S G + E +T +
Sbjct: 202 DIWSIGCIFAEMITGK 217
|
| >2rku_A Serine/threonine-protein kinase PLK1; structure of PLK1, selectivity residues, POLO-like K structure based drug design, ATP-binding; HET: R78 TLA SRT TAR; 1.95A {Homo sapiens} PDB: 2v5q_A 2yac_A* 4a4l_A* 4a4o_A* 3kb7_A* 3d5w_A* 3d5u_A* 3d5v_A 3db8_A* 3dbc_A* 3dbd_A* 3d5x_A* 3db6_A* 3dbe_A* 3dbf_A* Length = 294 | Back alignment and structure |
|---|
Score = 94.2 bits (235), Expect = 1e-22
Identities = 43/196 (21%), Positives = 79/196 (40%), Gaps = 14/196 (7%)
Query: 28 VYKGR-LEDGEIVAVKKLNFHQFSAESDKS-FYREAKTLKELKHRNLVKVLGYAWESGKL 85
++ + E+ A K + + E + L H+++V G+ ++ +
Sbjct: 31 CFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAHQHVVGFHGFFEDNDFV 90
Query: 86 KALILEYMENGSLESVIHGPGVDHSRWTLPKRIDVLISVANGLDYLHSGYDIPIVHCDMK 145
++LE SL + T P+ L + G YLH ++H D+K
Sbjct: 91 -FVVLELCRRRSLLELH----KRRKALTEPEARYYLRQIVLGCQYLHRNR---VIHRDLK 142
Query: 146 PSNILLDRDFEAHVSDFGTSRMLDVHLQDLSSLSTAFQGTIGYLAPEFAYMRIVTTKVDV 205
N+ L+ D E + DFG + ++ D GT Y+APE + + +VDV
Sbjct: 143 LGNLFLNEDLEVKIGDFGLATKVE---YDGERKKV-LCGTPNYIAPEVLSKKGHSFEVDV 198
Query: 206 FSFGIVVMEFLTKRRP 221
+S G ++ L + P
Sbjct: 199 WSIGCIMYTLLVGKPP 214
|
| >2pmi_A Negative RE, cyclin-dependent protein kinase PHO85; cyclin-dependent kinase, signaling protein,transfera cycle complex; HET: MES AGS; 2.90A {Saccharomyces cerevisiae} PDB: 2pk9_A* Length = 317 | Back alignment and structure |
|---|
Score = 94.6 bits (236), Expect = 1e-22
Identities = 55/206 (26%), Positives = 94/206 (45%), Gaps = 32/206 (15%)
Query: 27 TVYKGR-LEDGEIVAVKKLNFHQ-----FSAESDKSFYREAKTLKELKHRNLVKVLGYAW 80
TVYKG G VA+K++ +A RE +KELKH N+V++
Sbjct: 20 TVYKGLNKTTGVYVALKEVKLDSEEGTPSTA------IREISLMKELKHENIVRLYDVIH 73
Query: 81 ESGKLKALILEYMENGSLESVIHGPGVDHSRWTLPKRI--DVLISVANGLDYLHSGYDIP 138
KL L+ E+M+N L+ + V ++ L + + GL + H
Sbjct: 74 TENKL-TLVFEFMDN-DLKKYMDSRTVGNTPRGLELNLVKYFQWQLLQGLAFCHENK--- 128
Query: 139 IVHCDMKPSNILLDRDFEAHVSDFGTSRMLDVHLQDLSSLSTAFQGTIGYLAPEF----- 193
I+H D+KP N+L+++ + + DFG +R + + SS T+ Y AP+
Sbjct: 129 ILHRDLKPQNLLINKRGQLKLGDFGLARAFGIPVNTFSSEVV----TLWYRAPDVLMGSR 184
Query: 194 AYMRIVTTKVDVFSFGIVVMEFLTKR 219
Y +T +D++S G ++ E +T +
Sbjct: 185 TY----STSIDIWSCGCILAEMITGK 206
|
| >3lij_A Calcium/calmodulin dependent protein kinase with A kinase domain and 4 calmodulin...; transferase, calcium dependent protein kinase; HET: ANP; 1.90A {Cryptosporidium parvum} PDB: 3hzt_A* 3dxn_A 3l19_A* Length = 494 | Back alignment and structure |
|---|
Score = 96.3 bits (240), Expect = 1e-22
Identities = 57/232 (24%), Positives = 95/232 (40%), Gaps = 22/232 (9%)
Query: 7 IENATGSFSEN----NIIGNSNLSTVYKGR-LEDGEIVAVKKLNFHQFSAESDKSFYREA 61
I + G SE +G+ V R A+K + S S+ E
Sbjct: 28 ITSKKGHLSEMYQRVKKLGSGAYGEVLLCRDKVTHVERAIKIIRKTSVSTSSNSKLLEEV 87
Query: 62 KTLKELKHRNLVKVLGYAWESGKLKALILEYMENGSLESVIHGPGVDHSRWTLPKRIDVL 121
LK L H N++K+ +E + L++E + G L I + ++ ++
Sbjct: 88 AVLKLLDHPNIMKLYD-FFEDKRNYYLVMECYKGGELFDEI----IHRMKFNEVDAAVII 142
Query: 122 ISVANGLDYLHSGYDIPIVHCDMKPSNILL---DRDFEAHVSDFGTSRMLDVHLQDLSSL 178
V +G+ YLH IVH D+KP N+LL ++D + DFG S + + + +
Sbjct: 143 KQVLSGVTYLHK---HNIVHRDLKPENLLLESKEKDALIKIVDFGLSAVFE----NQKKM 195
Query: 179 STAFQGTIGYLAPEFAYMRIVTTKVDVFSFGIVVMEFLTKRRPTGLDEENGL 230
GT Y+APE + K DV+S G+++ L P G + +
Sbjct: 196 KERL-GTAYYIAPE-VLRKKYDEKCDVWSIGVILFILLAGYPPFGGQTDQEI 245
|
| >3com_A Serine/threonine-protein kinase 4; MST1, STE20-like kinase, PSI, structural genomics, protein structure initiative; HET: TPO; 2.20A {Homo sapiens} Length = 314 | Back alignment and structure |
|---|
Score = 94.4 bits (235), Expect = 1e-22
Identities = 66/291 (22%), Positives = 116/291 (39%), Gaps = 51/291 (17%)
Query: 14 FSENNIIGNSNLSTVYKGR-LEDGEIVAVKKLNFHQFSAESDKSFYREAKTLKELKHRNL 72
F +G + +VYK E G+IVA+K++ + +E +++ ++
Sbjct: 31 FDVLEKLGEGSYGSVYKAIHKETGQIVAIKQVPV----ESDLQEIIKEISIMQQCDSPHV 86
Query: 73 VKVLGYAWESGKLKALILEYMENGSLESVIHGPGVDHSRWTLPKRID------VLISVAN 126
VK G +++ L +++EY GS+ +I K + +L S
Sbjct: 87 VKYYGSYFKNTDL-WIVMEYCGAGSVSDIIR---------LRNKTLTEDEIATILQSTLK 136
Query: 127 GLDYLHSGYDIPIVHCDMKPSNILLDRDFEAHVSDFGTSRMLDVHLQDLSSLSTAFQGTI 186
GL+YLH +H D+K NILL+ + A ++DFG + L D + GT
Sbjct: 137 GLEYLHFMR---KIHRDIKAGNILLNTEGHAKLADFGVA----GQLTDTMAKRNTVIGTP 189
Query: 187 GYLAPEFAYMRIVTTKVDVFSFGIVVMEFLTKRRPTGLDEENGLSPISLRQLVEKALANG 246
++APE D++S GI +E + + +P D P+ ++
Sbjct: 190 FWMAPEVIQEIGYNCVADIWSLGITAIE-MAEGKPPYADIH----PMRAIFMIPT----- 239
Query: 247 INGVRQITDPKLVSSIYEEQEQHQVLEELFKLALVCTSSNPEDRPNMNELL 297
N P+L S + + F + C +PE R +LL
Sbjct: 240 -NPPPTFRKPELWSDNFTD----------F-VKQ-CLVKSPEQRATATQLL 277
|
| >1ob3_A PFPK5, cell division control protein 2 homolog; transferase, serine/threonine-protein kinase, ATP-binding, phosphorylation, CDK; 1.9A {Plasmodium falciparum} SCOP: d.144.1.7 PDB: 1v0p_A* 1v0o_A* 1v0b_A Length = 288 | Back alignment and structure |
|---|
Score = 93.7 bits (234), Expect = 2e-22
Identities = 51/196 (26%), Positives = 92/196 (46%), Gaps = 17/196 (8%)
Query: 27 TVYKGRLEDGEIVAVKKLNFHQFSAESDKSFYREAKTLKELKHRNLVKVLGYAWESGKLK 86
VYK + GE A+KK+ + + RE LKELKH N+VK+ +L
Sbjct: 17 VVYKAQNNYGETFALKKIRLEKEDEGIPSTTIREISILKELKHSNIVKLYDVIHTKKRL- 75
Query: 87 ALILEYMENGSLESVIHGPGVDHSRWTLPKRI--DVLISVANGLDYLHSGYDIPIVHCDM 144
L+ E+++ L+ ++ D L L+ + NG+ Y H ++H D+
Sbjct: 76 VLVFEHLDQ-DLKKLL-----DVCEGGLESVTAKSFLLQLLNGIAYCHDRR---VLHRDL 126
Query: 145 KPSNILLDRDFEAHVSDFGTSRMLDVHLQDLSSLSTAFQGTIGYLAPEFAY-MRIVTTKV 203
KP N+L++R+ E ++DFG +R + ++ + T+ Y AP+ + +T +
Sbjct: 127 KPQNLLINREGELKIADFGLARAFGIPVRKYTHEIV----TLWYRAPDVLMGSKKYSTTI 182
Query: 204 DVFSFGIVVMEFLTKR 219
D++S G + E +
Sbjct: 183 DIWSVGCIFAEMVNGT 198
|
| >3a7i_A MST3 kinase, serine/threonine kinase 24 (STE20 homolog, yeast); two-LOBE protein kinase fold, ATP-binding, nucleotid binding, transferase; HET: TPO ADE; 1.45A {Homo sapiens} PDB: 3a7g_A* 3a7h_A* 3a7f_A* 3a7j_A* 3ckw_A 3ckx_A* 3ggf_A* 2xik_A* Length = 303 | Back alignment and structure |
|---|
Score = 93.5 bits (233), Expect = 2e-22
Identities = 55/214 (25%), Positives = 93/214 (43%), Gaps = 27/214 (12%)
Query: 8 ENATGSFSENNIIGNSNLSTVYKGR-LEDGEIVAVKKLNFHQFSAESDKSFYREAKTLKE 66
+ F++ IG + V+KG ++VA+K ++ + + + + +E L +
Sbjct: 18 ADPEELFTKLEKIGKGSFGEVFKGIDNRTQKVVAIKIIDLEE-AEDEIEDIQQEITVLSQ 76
Query: 67 LKHRNLVKVLGYAWESGKLKALILEYMENGSLESVIHGPGVDHSRWTLPKRID------V 120
+ K G + KL +I+EY+ GS ++ P +D +
Sbjct: 77 CDSPYVTKYYGSYLKDTKL-WIIMEYLGGGSALDLLE-----------PGPLDETQIATI 124
Query: 121 LISVANGLDYLHSGYDIPIVHCDMKPSNILLDRDFEAHVSDFGTSRMLDVHLQDLSSLST 180
L + GLDYLHS I H D+K +N+LL E ++DFG + L D
Sbjct: 125 LREILKGLDYLHSEKKI---HRDIKAANVLLSEHGEVKLADFGVA----GQLTDTQIKRN 177
Query: 181 AFQGTIGYLAPEFAYMRIVTTKVDVFSFGIVVME 214
F GT ++APE +K D++S GI +E
Sbjct: 178 TFVGTPFWMAPEVIKQSAYDSKADIWSLGITAIE 211
|
| >2owb_A Serine/threonine-protein kinase PLK1; catalytic domain, POLO-like kinase1, transfera; HET: 626; 2.10A {Homo sapiens} PDB: 2ou7_A* 3fc2_A* 3thb_A* Length = 335 | Back alignment and structure |
|---|
Score = 93.9 bits (234), Expect = 2e-22
Identities = 43/196 (21%), Positives = 79/196 (40%), Gaps = 14/196 (7%)
Query: 28 VYKGR-LEDGEIVAVKKLNFHQFSAESDKS-FYREAKTLKELKHRNLVKVLGYAWESGKL 85
++ + E+ A K + + E + L H+++V G+ ++ +
Sbjct: 57 CFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAHQHVVGFHGFFEDNDFV 116
Query: 86 KALILEYMENGSLESVIHGPGVDHSRWTLPKRIDVLISVANGLDYLHSGYDIPIVHCDMK 145
++LE SL + T P+ L + G YLH ++H D+K
Sbjct: 117 -FVVLELCRRRSLLELH----KRRKALTEPEARYYLRQIVLGCQYLHRNR---VIHRDLK 168
Query: 146 PSNILLDRDFEAHVSDFGTSRMLDVHLQDLSSLSTAFQGTIGYLAPEFAYMRIVTTKVDV 205
N+ L+ D E + DFG + ++ D GT Y+APE + + +VDV
Sbjct: 169 LGNLFLNEDLEVKIGDFGLATKVE---YDGERKKV-LCGTPNYIAPEVLSKKGHSFEVDV 224
Query: 206 FSFGIVVMEFLTKRRP 221
+S G ++ L + P
Sbjct: 225 WSIGCIMYTLLVGKPP 240
|
| >3ll6_A Cyclin G-associated kinase; transferase, protein kinase, serine/threonine kinase, cyclin clathrine, membrane trafficking, structural genomics; 2.10A {Homo sapiens} Length = 337 | Back alignment and structure |
|---|
Score = 94.1 bits (234), Expect = 2e-22
Identities = 49/300 (16%), Positives = 105/300 (35%), Gaps = 57/300 (19%)
Query: 20 IGNSNLSTVYKGR-LEDGEIVAVKKLNFHQFSAESDKSFYREAKTLKELK-HRNLVKVLG 77
+ + VY+ + + G A+K+L + E +++ +E +K+L H N+V+
Sbjct: 36 LAEGGFAFVYEAQDVGSGREYALKRLLSN--EEEKNRAIIQEVCFMKKLSGHPNIVQFCS 93
Query: 78 YAW------ESGKLKALILEYMENGSLESVIHGPGVDHSRWTLPKRIDVLISVANGLDYL 131
A ++G+ + L+L + G L + + + + + ++
Sbjct: 94 AASIGKEESDTGQAEFLLLTELCKGQLVEFLK-KMESRGPLSCDTVLKIFYQTCRAVQHM 152
Query: 132 HSGYDIPIVHCDMKPSNILLDRDFEAHVSDFGTSRMLDVHLQDLSSLST--------AFQ 183
H PI+H D+K N+LL + DFG++ + + S
Sbjct: 153 HR-QKPPIIHRDLKVENLLLSNQGTIKLCDFGSATTISHYPDYSWSAQRRALVEEEITRN 211
Query: 184 GTIGYLAPEFAYM------RIVTTKVDVFSFGIVVMEFLTKRRPTGLDEENGLSPISLRQ 237
T Y PE + + K D+++ G ++ ++ P ++ L
Sbjct: 212 TTPMYRTPE---IIDLYSNFPIGEKQDIWALGCILYLLCFRQHP--FEDGAKL------- 259
Query: 238 LVEKALANGINGVRQITDPKLVSSIYEEQEQHQVLEELFKLALVCTSSNPEDRPNMNELL 297
++V+ Y L NPE+R ++ E++
Sbjct: 260 -------------------RIVNGKYSIPPHDTQYTVFHSLIRAMLQVNPEERLSIAEVV 300
|
| >2xrw_A Mitogen-activated protein kinase 8; transcription, MAPK signaling pathways, linear binding motif; HET: ANP; 1.33A {Homo sapiens} PDB: 1ukh_A 1uki_A* 2xs0_A* 3elj_A* 2h96_A* 2gmx_A* 2g01_A* 2no3_A* 3o2m_A* 3o17_A* 3pze_A* 3g9l_X* 2p33_A* 3cgf_A* 3cgo_A* 3g90_X* 2ok1_A* 3g9n_A* 1pmn_A* 1pmq_A* ... Length = 371 | Back alignment and structure |
|---|
Score = 93.6 bits (233), Expect = 6e-22
Identities = 50/191 (26%), Positives = 84/191 (43%), Gaps = 24/191 (12%)
Query: 36 GEIVAVKKLNFHQFSAESD-KSFYREAKTLKELKHRNLVKVL-----GYAWESGKLKALI 89
VA+KKL F ++ K YRE +K + H+N++ +L + E + ++
Sbjct: 50 ERNVAIKKL-SRPFQNQTHAKRAYRELVLMKCVNHKNIIGLLNVFTPQKSLEEFQDVYIV 108
Query: 90 LEYMENGSLESVIHGPGVD-HSRWTLPKRIDVLISVANGLDYLHSGYDIPIVHCDMKPSN 148
+E M+ +L VI + +L + G+ +LHS I+H D+KPSN
Sbjct: 109 MELMDA-NLCQVIQMELDHERMSY-------LLYQMLCGIKHLHSA---GIIHRDLKPSN 157
Query: 149 ILLDRDFEAHVSDFGTSRMLDVHLQDLSSLSTAFQGTIGYLAPEFAYMRIVTTKVDVFSF 208
I++ D + DFG +R S + T + T Y APE VD++S
Sbjct: 158 IVVKSDCTLKILDFGLARTA-----GTSFMMTPYVVTRYYRAPEVILGMGYKENVDIWSV 212
Query: 209 GIVVMEFLTKR 219
G ++ E +
Sbjct: 213 GCIMGEMIKGG 223
|
| >3mtl_A Cell division protein kinase 16; pctaire1, indirubin, structural genomics, structural consortium, SGC, transferase; HET: FEF; 2.40A {Homo sapiens} Length = 324 | Back alignment and structure |
|---|
Score = 92.3 bits (230), Expect = 7e-22
Identities = 51/214 (23%), Positives = 94/214 (43%), Gaps = 25/214 (11%)
Query: 13 SFSENNIIGNSNLSTVYKGR-LEDGEIVAVKKLNFHQ-----FSAESDKSFYREAKTLKE 66
++ + + +G +TVYKG+ +VA+K++ +A RE LK+
Sbjct: 3 TYIKLDKLGEGTYATVYKGKSKLTDNLVALKEIRLEHEEGAPCTA------IREVSLLKD 56
Query: 67 LKHRNLVKVLGYAWESGKLKALILEYMENGSLESVIHGPGVDHSRWTLPKRIDVLISVAN 126
LKH N+V + L L+ EY++ L+ + G + + K L +
Sbjct: 57 LKHANIVTLHDIIHTEKSL-TLVFEYLDK-DLKQYLDDCGNIINMHNV-KLF--LFQLLR 111
Query: 127 GLDYLHSGYDIPIVHCDMKPSNILLDRDFEAHVSDFGTSRMLDVHLQDLSSLSTAFQGTI 186
GL Y H ++H D+KP N+L++ E ++DFG +R + + + T+
Sbjct: 112 GLAYCHRQK---VLHRDLKPQNLLINERGELKLADFGLARAKSIPTKTYDNEVV----TL 164
Query: 187 GYLAPEFAY-MRIVTTKVDVFSFGIVVMEFLTKR 219
Y P+ +T++D++ G + E T R
Sbjct: 165 WYRPPDILLGSTDYSTQIDMWGVGCIFYEMATGR 198
|
| >3hko_A Calcium/calmodulin-dependent protein kinase with domain and 2 calmodulin-like EF...; structural genomics, protist parasite; HET: ANP; 1.80A {Cryptosporidium parvum iowa II} Length = 345 | Back alignment and structure |
|---|
Score = 92.6 bits (230), Expect = 1e-21
Identities = 46/246 (18%), Positives = 82/246 (33%), Gaps = 48/246 (19%)
Query: 20 IGNSNLSTVYKGR-LEDGEIVAVK---KLNFHQFSAESDKSFYREAKTLKELKHRNLVKV 75
IG + V + I A+K K Q + + + E + +K+L H N+ ++
Sbjct: 34 IGQGSYGVVRVAIENQTRAIRAIKIMNKNKIRQINPKDVERIKTEVRLMKKLHHPNIARL 93
Query: 76 LGYAWESGKLKALILEYMENGSLESVIHGPGVDHSRWTLPKRI----------------- 118
+E + L++E G L ++ D + +
Sbjct: 94 YE-VYEDEQYICLVMELCHGGHLLDKLNVFIDDSTGKCAMDVVKTQICPCPECNEEAING 152
Query: 119 -------------------DVLISVANGLDYLHSGYDIPIVHCDMKPSNILLDRDFEAHV 159
+++ + + L YLH+ I H D+KP N L + +
Sbjct: 153 SIHGFRESLDFVQREKLISNIMRQIFSALHYLHNQG---ICHRDIKPENFLFSTNKSFEI 209
Query: 160 --SDFGTSRMLDVHLQDLSSLSTAFQGTIGYLAPE--FAYMRIVTTKVDVFSFGIVVMEF 215
DFG S+ T GT ++APE K D +S G+++
Sbjct: 210 KLVDFGLSKEFYKLNNGEYYGMTTKAGTPYFVAPEVLNTTNESYGPKCDAWSAGVLLHLL 269
Query: 216 LTKRRP 221
L P
Sbjct: 270 LMGAVP 275
|
| >3qd2_B Eukaryotic translation initiation factor 2-alpha; EIF2A kinase, phosphoryalation, gene regulation; HET: TPO; 2.81A {Mus musculus} Length = 332 | Back alignment and structure |
|---|
Score = 91.9 bits (228), Expect = 1e-21
Identities = 53/258 (20%), Positives = 99/258 (38%), Gaps = 44/258 (17%)
Query: 50 SAESDKSFYREAKTLKELKHRNLVKVLGYAWESGKLKALILEYMENGSLESVI-HGPGVD 108
S + + + + +N V L + L + ++ +L+ + ++
Sbjct: 101 SPSPMDAPSVKIRRMDPFSTKNTVGQLQPSSPKVYLY-IQMQLCRKENLKDWMNRRCSLE 159
Query: 109 HSRWTLPKRIDVLISVANGLDYLHS-GYDIPIVHCDMKPSNILLDRDFEAHVSDFGTSRM 167
+ I I +A +++LHS G ++H D+KPSNI D V DFG
Sbjct: 160 DREHGVCLHI--FIQIAEAVEFLHSKG----LMHRDLKPSNIFFTMDDVVKVGDFGLVTA 213
Query: 168 LDVHLQDLSSLS--------TAFQGTIGYLAPEFAYMRIVTTKVDVFSFGIVVMEFLTKR 219
+D ++ + L+ T GT Y++PE + + KVD+FS G+++ E L
Sbjct: 214 MDQDEEEQTVLTPMPAYATHTGQVGTKLYMSPEQIHGNNYSHKVDIFSLGLILFELLY-- 271
Query: 220 RPTGLDEENGLSPISLRQLVEKALANGINGVRQITDPKLVSSIYEEQEQHQVLEELFKLA 279
S R + I VR + P L + Y ++ +
Sbjct: 272 ---------SFSTQMERVRI-------ITDVRNLKFPLLFTQKYPQEH---------MMV 306
Query: 280 LVCTSSNPEDRPNMNELL 297
S +P +RP +++
Sbjct: 307 QDMLSPSPTERPEATDII 324
|
| >3qd2_B Eukaryotic translation initiation factor 2-alpha; EIF2A kinase, phosphoryalation, gene regulation; HET: TPO; 2.81A {Mus musculus} Length = 332 | Back alignment and structure |
|---|
Score = 40.3 bits (94), Expect = 5e-04
Identities = 19/111 (17%), Positives = 34/111 (30%), Gaps = 2/111 (1%)
Query: 14 FSENNIIGNSNLSTVYKGR-LEDGEIVAVKKLNFHQFSAESDKSFYREAKTLKELKHRNL 72
F +G V++ + D A+K++ +K RE K L +L+H +
Sbjct: 8 FEPIQCMGRGGFGVVFEAKNKVDDCNYAIKRIRLPNRELAREK-VMREVKALAKLEHPGI 66
Query: 73 VKVLGYAWESGKLKALILEYMENGSLESVIHGPGVDHSRWTLPKRIDVLIS 123
V+ E+ K ES +I +
Sbjct: 67 VRYFNAWLETPPEKWQEEMDEIWLKDESTDWPLSSPSPMDAPSVKIRRMDP 117
|
| >3uqc_A Probable conserved transmembrane protein; structural genomics, TB structural genomics consortium, TBSG fold, FHAA, transferase; 2.26A {Mycobacterium tuberculosis} PDB: 3oun_B* 3otv_A 3ouk_A Length = 286 | Back alignment and structure |
|---|
Score = 90.6 bits (225), Expect = 2e-21
Identities = 34/277 (12%), Positives = 70/277 (25%), Gaps = 68/277 (24%)
Query: 20 IGNSNLSTVYKGRLED---GEIVAVKKLNFHQFSAESDKS-FYREAKTLKELKHRNLVKV 75
G ++ D VA+ ++ + L + + +V
Sbjct: 39 HGGVPPLQFWQAL--DTALDRQVALTFVDPQGVLPDDVLQETLSRTLRLSRIDKPGVARV 96
Query: 76 LGYAWESGKLKALILEYMENGSLESVIHGPGVDHSRWTLPKR-IDVLISVANGLDYLHSG 134
L + ++ E++ GSL+ V P I + S+A D H
Sbjct: 97 LDVV-HTRAGGLVVAEWIRGGSLQEVADTSP-------SPVGAIRAMQSLAAAADAAH-- 146
Query: 135 YDIPIVHCDMKPSNILLDRDFEAHVSDFGTSRMLDVHLQDLSSLSTAFQGTIGYLAPEFA 194
+ PS + + D + ++ +
Sbjct: 147 -RAGVALSIDHPSRVRVSIDGDVVLAYP------------------------ATMPD--- 178
Query: 195 YMRIVTTKVDVFSFGIVVMEFLTKRRPTGLDEENGLSPISLRQLVEKALANGINGVRQIT 254
+ D+ G + L R P L E S ++ G Q
Sbjct: 179 ----ANPQDDIRGIGASLYALLVNRWP--LPEAGVRSGLA-------PAERDTAG--QPI 223
Query: 255 DPKLVSSIYEEQEQHQVLEELFKLALVCTSSNPEDRP 291
+P + + ++ +A + R
Sbjct: 224 EPADI--------DRDIPFQISAVAARSVQGDGGIRS 252
|
| >2j7t_A Serine/threonine-protein kinase 10; transferase, ATP-binding, cell cycle progression, phosphorylation, disease mutation, nucleotide- binding; HET: 274; 2.0A {Homo sapiens} PDB: 4aot_A* 3zz2_A* 2j51_A* 2jfl_A* 2jfm_A* 2uv2_A* Length = 302 | Back alignment and structure |
|---|
Score = 90.5 bits (225), Expect = 3e-21
Identities = 60/260 (23%), Positives = 105/260 (40%), Gaps = 50/260 (19%)
Query: 14 FSENNIIGNSNLSTVYKGR-LEDGEIVAVKKLNFHQFSAESDKSFYREAKTLKELKHRNL 72
+ +G+ VYK + E G + A K + S E + + E + L H +
Sbjct: 21 WEIVGELGDGAFGKVYKAKNKETGALAAAKVIETK--SEEELEDYIVEIEILATCDHPYI 78
Query: 73 VKVLGYAWESGKLKALILEYMENGSLESVIHGPGVDHSRWTLPKRID------VLISVAN 126
VK+LG + GKL +++E+ G++++++ L + + V +
Sbjct: 79 VKLLGAYYHDGKL-WIMIEFCPGGAVDAIML---------ELDRGLTEPQIQVVCRQMLE 128
Query: 127 GLDYLHSGYDIPIVHCDMKPSNILLDRDFEAHVSDFGTSRMLDVHLQDLSSLSTAFQGTI 186
L++LHS I+H D+K N+L+ + + ++DFG S LQ S F GT
Sbjct: 129 ALNFLHSKR---IIHRDLKAGNVLMTLEGDIRLADFGVSAKNLKTLQKRDS----FIGTP 181
Query: 187 GYLAPEFAYMRIVT-----TKVDVFSFGIVVME-----------------FL-TKRRPTG 223
++APE + K D++S GI ++E K P
Sbjct: 182 YWMAPEVVMCETMKDTPYDYKADIWSLGITLIEMAQIEPPHHELNPMRVLLKIAKSDPPT 241
Query: 224 LDEENGLSPISLRQLVEKAL 243
L + S R ++ AL
Sbjct: 242 LLTPSKWSV-EFRDFLKIAL 260
|
| >2x7f_A TRAF2 and NCK-interacting protein kinase; serine/threonine-protein kinase, phosphoprotein; HET: 824; 2.80A {Homo sapiens} Length = 326 | Back alignment and structure |
|---|
Score = 90.1 bits (224), Expect = 5e-21
Identities = 55/232 (23%), Positives = 100/232 (43%), Gaps = 36/232 (15%)
Query: 1 RFDRTEIENATGSFSENNIIGNSNLSTVYKGR-LEDGEIVAVKKLNFHQFSAESDKSFYR 59
D + + + G F ++GN VYKGR ++ G++ A+K ++ + + ++ +
Sbjct: 13 EIDLSALRDPAGIFELVELVGNGTYGQVYKGRHVKTGQLAAIKVMDV---TGDEEEEIKQ 69
Query: 60 EAKTLKEL-KHRNLVKVLG-YAWESGKLKA----LILEYMENGSLESVIHGPGVDHSRWT 113
E LK+ HRN+ G + ++ L++E+ GS+ +I T
Sbjct: 70 EINMLKKYSHHRNIATYYGAFIKKNPPGMDDQLWLVMEFCGAGSVTDLIKN--------T 121
Query: 114 LPKRID------VLISVANGLDYLHSGYDIPIVHCDMKPSNILLDRDFEAHVSDFGTSRM 167
+ + + GL +LH ++H D+K N+LL + E + DFG S
Sbjct: 122 KGNTLKEEWIAYICREILRGLSHLHQHK---VIHRDIKGQNVLLTENAEVKLVDFGVSAQ 178
Query: 168 LDVHLQDLSSLSTAFQGTIGYLAPEFAYMRIVT-----TKVDVFSFGIVVME 214
LD + ++ F GT ++APE K D++S GI +E
Sbjct: 179 LDRTVGRRNT----FIGTPYWMAPEVIACDENPDATYDFKSDLWSLGITAIE 226
|
| >3gbz_A Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; 1.85A {Giardia lamblia} PDB: 3gc0_A* Length = 329 | Back alignment and structure |
|---|
Score = 89.6 bits (223), Expect = 7e-21
Identities = 54/205 (26%), Positives = 88/205 (42%), Gaps = 30/205 (14%)
Query: 27 TVYKGR-LEDGEIVAVKKLNFHQFSAESDKSFYREAKTLKELKHRNLVKVLGYAWESGKL 85
VYK E VA+K++ + RE LKEL+HRN++++ + +L
Sbjct: 49 EVYKAIDTVTNETVAIKRIRLEHEEEGVPGTAIREVSLLKELQHRNIIELKSVIHHNHRL 108
Query: 86 KALILEYMENGSLESVIHGPGVDHSRWTLPKRI-DVLISVANGLDYLHSGYDIPIVHCDM 144
LI EY EN L+ + D + + I L + NG+++ HS +H D+
Sbjct: 109 -HLIFEYAEN-DLKKYM-----DKNPDVSMRVIKSFLYQLINGVNFCHSRR---CLHRDL 158
Query: 145 KPSNILLDRDFEAH-----VSDFGTSRMLDVHLQDLSSLSTAFQGTIGYLAPEF-----A 194
KP N+LL + + DFG +R + ++ + T+ Y PE
Sbjct: 159 KPQNLLLSVSDASETPVLKIGDFGLARAFGIPIRQFTHEII----TLWYRPPEILLGSRH 214
Query: 195 YMRIVTTKVDVFSFGIVVMEFLTKR 219
Y +T VD++S + E L K
Sbjct: 215 Y----STSVDIWSIACIWAEMLMKT 235
|
| >3nyv_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, EF hand, bumped kinase inhibitor; HET: MSE DTQ; 1.88A {Toxoplasma gondii} PDB: 3i79_A* 3i7b_A* 3n51_A* 3i7c_A* 3sx9_A* 3sxf_A* 3t3u_A* 3t3v_A* 3upx_A* 3upz_A* 3v51_A* 3v5p_A* 3v5t_A* 3ku2_A* 3hx4_A* Length = 484 | Back alignment and structure |
|---|
Score = 90.9 bits (226), Expect = 9e-21
Identities = 58/224 (25%), Positives = 101/224 (45%), Gaps = 23/224 (10%)
Query: 7 IENATGSFSEN----NIIGNSNLSTVYKGR-LEDGEIVAVKKLNFHQFSAESD-KSFYRE 60
++++T FS+ ++G + V + G+ AVK ++ Q ++D +S RE
Sbjct: 17 VQHSTAIFSDRYKGQRVLGKGSFGEVILCKDKITGQECAVKVISKRQVKQKTDKESLLRE 76
Query: 61 AKTLKELKHRNLVKVLGYAWESGKLKALILEYMENGSLESVIHGPGVDHSRWTLPKRIDV 120
+ LK+L H N++K+ + +E L+ E G L I + R++ +
Sbjct: 77 VQLLKQLDHPNIMKLYEF-FEDKGYFYLVGEVYTGGELFDEI----ISRKRFSEVDAARI 131
Query: 121 LISVANGLDYLHSGYDIPIVHCDMKPSNILL---DRDFEAHVSDFGTSRMLDVHLQDLSS 177
+ V +G+ Y+H IVH D+KP N+LL +D + DFG S +
Sbjct: 132 IRQVLSGITYMHK---NKIVHRDLKPENLLLESKSKDANIRIIDFGLSTHFE----ASKK 184
Query: 178 LSTAFQGTIGYLAPEFAYMRIVTTKVDVFSFGIVVMEFLTKRRP 221
+ GT Y+APE K DV+S G+++ L+ P
Sbjct: 185 MKDKI-GTAYYIAPE-VLHGTYDEKCDVWSTGVILYILLSGCPP 226
|
| >4agu_A Cyclin-dependent kinase-like 1; transferase, phospho-mimetic; HET: D15; 2.40A {Homo sapiens} Length = 311 | Back alignment and structure |
|---|
Score = 89.2 bits (222), Expect = 1e-20
Identities = 52/201 (25%), Positives = 86/201 (42%), Gaps = 26/201 (12%)
Query: 27 TVYKGR-LEDGEIVAVKKLNFHQFSAESDKSFYREAKTLKELKHRNLVKVLGYAWESGKL 85
V+K R + G+IVA+KK + K RE + LK+LKH NLV +L +L
Sbjct: 18 VVFKCRNRDTGQIVAIKKFLESEDDPVIKKIALREIRMLKQLKHPNLVNLLEVFRRKRRL 77
Query: 86 KALILEYMENGSLESVIHGPGVDHSRWTLPKRI--DVLISVANGLDYLHSGYDIPIVHCD 143
L+ EY ++ ++ + D + +P+ + + +++ H +H D
Sbjct: 78 -HLVFEYCDH-TVLHEL-----DRYQRGVPEHLVKSITWQTLQAVNFCHKHN---CIHRD 127
Query: 144 MKPSNILLDRDFEAHVSDFGTSRMLDVHLQDLSSLSTAFQGTIGYLAPEF-----AYMRI 198
+KP NIL+ + + DFG +R+L T Y +PE Y
Sbjct: 128 VKPENILITKHSVIKLCDFGFARLLTGPSDYY----DDEVATRWYRSPELLVGDTQY--- 180
Query: 199 VTTKVDVFSFGIVVMEFLTKR 219
VDV++ G V E L+
Sbjct: 181 -GPPVDVWAIGCVFAELLSGV 200
|
| >3kk8_A Calcium/calmodulin dependent protein kinase II; ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; HET: TPO; 1.72A {Caenorhabditis elegans} PDB: 3kk9_A* 3kl8_A 2vn9_A* 3bhh_A* Length = 284 | Back alignment and structure |
|---|
Score = 88.4 bits (220), Expect = 1e-20
Identities = 51/209 (24%), Positives = 91/209 (43%), Gaps = 21/209 (10%)
Query: 11 TGSFSEN----NIIGNSNLSTVYKGR-LEDGEIVAVKKLNFHQFSAESDKSFYREAKTLK 65
+ FS+N +G S V + G A K +N + SA + REA+ +
Sbjct: 1 STKFSDNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICR 60
Query: 66 ELKHRNLVKVLGYAWESGKLKALILEYMENGSLESVIHGPGVDHSRWTLPKRIDVLISVA 125
+L+H N+V++ + + L+ + + G L I V ++ + +
Sbjct: 61 KLQHPNIVRLHD-SIQEESFHYLVFDLVTGGELFEDI----VAREFYSEADASHCIQQIL 115
Query: 126 NGLDYLHSGYDIPIVHCDMKPSNILL-DRDFEAHV--SDFGTSRMLDVHLQDLSSLSTAF 182
+ Y HS IVH ++KP N+LL + A V +DFG + + + D +
Sbjct: 116 ESIAYCHS---NGIVHRNLKPENLLLASKAKGAAVKLADFGLA----IEVNDSEAWHGFA 168
Query: 183 QGTIGYLAPEFAYMRIVTTKVDVFSFGIV 211
GT GYL+PE + VD+++ G++
Sbjct: 169 -GTPGYLSPEVLKKDPYSKPVDIWACGVI 196
|
| >3mwu_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, bumped kinase inhibitor, BKI; HET: BK3; 1.98A {Cryptosporidium parvum} PDB: 3igo_A* 3ncg_A* Length = 486 | Back alignment and structure |
|---|
Score = 90.5 bits (225), Expect = 1e-20
Identities = 57/220 (25%), Positives = 95/220 (43%), Gaps = 24/220 (10%)
Query: 11 TGSFSEN----NIIGNSNLSTVYKGR-LEDGEIVAVKKLNFHQFSAESDKSFYREAKTLK 65
G+F+E ++G + V K + + AVK +N + + RE + LK
Sbjct: 17 QGTFAERYNIVCMLGKGSFGEVLKCKDRITQQEYAVKVINKASAKNKDTSTILREVELLK 76
Query: 66 ELKHRNLVKVLGYAWESGKLKALILEYMENGSLESVIHGPGVDHSRWTLPKRIDVLISVA 125
+L H N++K+ E ++ E G L I + R++ ++ V
Sbjct: 77 KLDHPNIMKLFE-ILEDSSSFYIVGELYTGGELFDEI----IKRKRFSEHDAARIIKQVF 131
Query: 126 NGLDYLHS-GYDIPIVHCDMKPSNILL---DRDFEAHVSDFGTSRMLDVHLQDLSSLSTA 181
+G+ Y+H IVH D+KP NILL ++D + + DFG S Q + +
Sbjct: 132 SGITYMHKHN----IVHRDLKPENILLESKEKDCDIKIIDFGLS----TCFQQNTKMKDR 183
Query: 182 FQGTIGYLAPEFAYMRIVTTKVDVFSFGIVVMEFLTKRRP 221
GT Y+APE K DV+S G+++ L+ P
Sbjct: 184 I-GTAYYIAPE-VLRGTYDEKCDVWSAGVILYILLSGTPP 221
|
| >3coi_A Mitogen-activated protein kinase 13; P38D, P38delta, ERK, MAP kinase, PMK, STK26, stress-activated protein kinase, structural genomics, PSI; 2.09A {Homo sapiens} Length = 353 | Back alignment and structure |
|---|
Score = 89.3 bits (222), Expect = 1e-20
Identities = 55/218 (25%), Positives = 98/218 (44%), Gaps = 31/218 (14%)
Query: 14 FSENNIIGNSNLSTVYKGR-LEDGEIVAVKKLNFHQFSAESD-KSFYREAKTLKELKHRN 71
+ +G+ +V GE VA+KKL F +E K YRE LK ++H N
Sbjct: 26 YVSPTHVGSGAYGSVCSAIDKRSGEKVAIKKL-SRPFQSEIFAKRAYRELLLLKHMQHEN 84
Query: 72 LVKVL-----GYAWESGKLKALILEYMENGSLESVIHGPGVD-HSRWTLPKRIDVLISVA 125
++ +L + + L++ +M+ L+ ++ + ++ ++ +
Sbjct: 85 VIGLLDVFTPASSLRNFYDFYLVMPFMQT-DLQKIMGLKFSEEKIQY-------LVYQML 136
Query: 126 NGLDYLHSGYDIPIVHCDMKPSNILLDRDFEAHVSDFGTSRMLDVHLQDLSSLSTAFQGT 185
GL Y+HS +VH D+KP N+ ++ D E + DFG +R D + T + T
Sbjct: 137 KGLKYIHSA---GVVHRDLKPGNLAVNEDCELKILDFGLARHADAEM-------TGYVVT 186
Query: 186 IGYLAPE--FAYMRIVTTKVDVFSFGIVVMEFLTKRRP 221
Y APE ++M VD++S G ++ E LT +
Sbjct: 187 RWYRAPEVILSWMH-YNQTVDIWSVGCIMAEMLT-GKT 222
|
| >3ttj_A Mitogen-activated protein kinase 10; JNK3, protein kinase in transferase-transferase inhibitor complex; HET: JBI; 2.10A {Homo sapiens} PDB: 3tti_A* 1jnk_A* Length = 464 | Back alignment and structure |
|---|
Score = 89.9 bits (223), Expect = 2e-20
Identities = 51/191 (26%), Positives = 85/191 (44%), Gaps = 24/191 (12%)
Query: 36 GEIVAVKKLNFHQFSAESD-KSFYREAKTLKELKHRNLVKVL-----GYAWESGKLKALI 89
VA+KKL F ++ K YRE +K + H+N++ +L E + L+
Sbjct: 87 DRNVAIKKL-SRPFQNQTHAKRAYRELVLMKCVNHKNIISLLNVFTPQKTLEEFQDVYLV 145
Query: 90 LEYMENGSLESVIHGP-GVDHSRWTLPKRIDVLISVANGLDYLHSGYDIPIVHCDMKPSN 148
+E M+ +L VI + + +L + G+ +LHS I+H D+KPSN
Sbjct: 146 MELMDA-NLCQVIQMELDHERMSY-------LLYQMLCGIKHLHSA---GIIHRDLKPSN 194
Query: 149 ILLDRDFEAHVSDFGTSRMLDVHLQDLSSLSTAFQGTIGYLAPEFAYMRIVTTKVDVFSF 208
I++ D + DFG +R S + T + T Y APE VD++S
Sbjct: 195 IVVKSDCTLKILDFGLARTAGT-----SFMMTPYVVTRYYRAPEVILGMGYKENVDIWSV 249
Query: 209 GIVVMEFLTKR 219
G ++ E + +
Sbjct: 250 GCIMGEMVRHK 260
|
| >2bdw_A Hypothetical protein K11E8.1D; kinase, calmodulin activated, transferase; 1.80A {Caenorhabditis elegans} PDB: 2wel_A* 2v7o_A* 2vz6_A* 1cdm_B 1cm1_B 1cm4_B Length = 362 | Back alignment and structure |
|---|
Score = 88.9 bits (221), Expect = 2e-20
Identities = 53/213 (24%), Positives = 94/213 (44%), Gaps = 21/213 (9%)
Query: 7 IENATGSFSEN----NIIGNSNLSTVYKGR-LEDGEIVAVKKLNFHQFSAESDKSFYREA 61
+ NA+ FS+N +G S V + G A K +N + SA + REA
Sbjct: 20 MMNASTKFSDNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREA 79
Query: 62 KTLKELKHRNLVKVLGYAWESGKLKALILEYMENGSLESVIHGPGVDHSRWTLPKRIDVL 121
+ ++L+H N+V++ + + L+ + + G L I V ++ +
Sbjct: 80 RICRKLQHPNIVRLHD-SIQEESFHYLVFDLVTGGELFEDI----VAREFYSEADASHCI 134
Query: 122 ISVANGLDYLHSGYDIPIVHCDMKPSNILL-DRDFEAHV--SDFGTSRMLDVHLQDLSSL 178
+ + Y HS IVH ++KP N+LL + A V +DFG + + + D +
Sbjct: 135 QQILESIAYCHS---NGIVHRNLKPENLLLASKAKGAAVKLADFGLA----IEVNDSEAW 187
Query: 179 STAFQGTIGYLAPEFAYMRIVTTKVDVFSFGIV 211
GT GYL+PE + VD+++ G++
Sbjct: 188 HGFA-GTPGYLSPEVLKKDPYSKPVDIWACGVI 219
|
| >4aaa_A Cyclin-dependent kinase-like 2; transferase, phospho-mimetic; HET: DKI; 1.53A {Homo sapiens} Length = 331 | Back alignment and structure |
|---|
Score = 87.7 bits (218), Expect = 4e-20
Identities = 54/201 (26%), Positives = 85/201 (42%), Gaps = 26/201 (12%)
Query: 27 TVYKGR-LEDGEIVAVKKLNFHQFSAESDKSFYREAKTLKELKHRNLVKVLGYAWESGKL 85
V K R + G IVA+KK K RE K LK+L+H NLV +L + +
Sbjct: 40 MVMKCRNKDTGRIVAIKKFLESDDDKMVKKIAMREIKLLKQLRHENLVNLLEVCKKKKRW 99
Query: 86 KALILEYMENGSLESVIHGPGVDHSRWTLPKRI--DVLISVANGLDYLHSGYDIPIVHCD 143
L+ E++++ ++ + + L ++ L + NG+ + HS I+H D
Sbjct: 100 -YLVFEFVDH-TILDDL-----ELFPNGLDYQVVQKYLFQIINGIGFCHSHN---IIHRD 149
Query: 144 MKPSNILLDRDFEAHVSDFGTSRMLDVHLQDLSSLSTAFQGTIGYLAPEF-----AYMRI 198
+KP NIL+ + + DFG +R L + T Y APE Y
Sbjct: 150 IKPENILVSQSGVVKLCDFGFARTLAAPGEVYDDEVA----TRWYRAPELLVGDVKY--- 202
Query: 199 VTTKVDVFSFGIVVMEFLTKR 219
VDV++ G +V E
Sbjct: 203 -GKAVDVWAIGCLVTEMFMGE 222
|
| >3c0i_A Peripheral plasma membrane protein CASK; neurexin, Ca2+/calmodulin dependent protein kinase, Mg synaptic plasticity, pseudokinase, maguk; HET: 3AM; 1.85A {Homo sapiens} PDB: 3c0h_A* 3c0g_A* 3mfr_A* 3mfs_A* 3mft_A 3mfu_A* 3tac_A Length = 351 | Back alignment and structure |
|---|
Score = 87.7 bits (218), Expect = 5e-20
Identities = 48/201 (23%), Positives = 81/201 (40%), Gaps = 17/201 (8%)
Query: 19 IIGNSNLSTVYKGR-LEDGEIVAVK---KLNFHQFSAESDKSFYREAKTLKELKHRNLVK 74
+IG S V + E G+ AVK F S + REA LKH ++V+
Sbjct: 31 VIGKGPFSVVRRCINRETGQQFAVKIVDVAKFTSSPGLSTEDLKREASICHMLKHPHIVE 90
Query: 75 VLGYAWESGKLKALILEYMENGSLESVIHGPGVDHSRWTLPKRIDVLISVANGLDYLHS- 133
+L + S + ++ E+M+ L I ++ + + L Y H
Sbjct: 91 LLE-TYSSDGMLYMVFEFMDGADLCFEIVKRADAGFVYSEAVASHYMRQILEALRYCHDN 149
Query: 134 GYDIPIVHCDMKPSNILL-DRDFEAHV--SDFGTSRMLDVHLQDLSSLSTAFQGTIGYLA 190
I+H D+KP +LL ++ A V FG + + L + ++ GT ++A
Sbjct: 150 N----IIHRDVKPHCVLLASKENSAPVKLGGFGVA----IQLGESGLVAGGRVGTPHFMA 201
Query: 191 PEFAYMRIVTTKVDVFSFGIV 211
PE VDV+ G++
Sbjct: 202 PEVVKREPYGKPVDVWGCGVI 222
|
| >1u5q_A Serine/threonine protein kinase TAO2; transferase; HET: SEP; 2.10A {Rattus norvegicus} SCOP: d.144.1.7 PDB: 1u5r_A* 2gcd_A* Length = 348 | Back alignment and structure |
|---|
Score = 87.1 bits (216), Expect = 8e-20
Identities = 57/219 (26%), Positives = 98/219 (44%), Gaps = 35/219 (15%)
Query: 8 ENATGSFSENNIIGNSNLSTVYKGR-LEDGEIVAVKKLNFHQFSAESD-KSFYREAKTLK 65
++ FS+ IG+ + VY R + + E+VA+KK+++ + + +E + L+
Sbjct: 50 DDPEKLFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQ 109
Query: 66 ELKHRNLVKVLG-YAWESGKLKALILEYMENGSLESVIHGPGVDHSRWTLPKRID----- 119
+L+H N ++ G Y E L++EY GS ++ K +
Sbjct: 110 KLRHPNTIQYRGCYLREH-TA-WLVMEYCL-GSASDLLE---------VHKKPLQEVEIA 157
Query: 120 -VLISVANGLDYLHSGYDIPIVHCDMKPSNILLDRDFEAHVSDFGTSRMLDVHLQDLSSL 178
V GL YLHS ++H D+K NILL + DFG++ ++ +
Sbjct: 158 AVTHGALQGLAYLHSHN---MIHRDVKAGNILLSEPGLVKLGDFGSASIM--------AP 206
Query: 179 STAFQGTIGYLAPEFAYMRIVTT---KVDVFSFGIVVME 214
+ +F GT ++APE KVDV+S GI +E
Sbjct: 207 ANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIE 245
|
| >3qyz_A Mitogen-activated protein kinase 1; transferase, serine/threonine-protein kinase, ATP-binding CE phosphorylation; HET: CME Z8B SO4; 1.46A {Rattus norvegicus} PDB: 2fys_B 1erk_A* 3qyi_A* 3erk_A* 3qyw_A* 4erk_A* 2z7l_A* 2erk_A* 1gol_A* 2gph_A 3o71_A 3r63_A 3c9w_A* 2y9q_A* 3sa0_A* 1wzy_A* 2e14_A* 1tvo_A* 2ojg_A* 2oji_A* ... Length = 364 | Back alignment and structure |
|---|
Score = 87.0 bits (216), Expect = 1e-19
Identities = 55/218 (25%), Positives = 97/218 (44%), Gaps = 26/218 (11%)
Query: 14 FSENNIIGNSNLSTVYKGR-LEDGEIVAVKKLNFHQFSAESD-KSFYREAKTLKELKHRN 71
++ + IG V + VA+KK++ F ++ + RE K L +H N
Sbjct: 29 YTNLSYIGEGAYGMVCSAYDNLNKVRVAIKKIS--PFEHQTYCQRTLREIKILLRFRHEN 86
Query: 72 LVKVLG--YAWESGKLKA--LILEYMENGSLESVIHGPGV--DHSRWTLPKRIDVLISVA 125
++ + A ++K ++ + ME L ++ + DH + L +
Sbjct: 87 IIGINDIIRAPTIEQMKDVYIVQDLMET-DLYKLLKTQHLSNDHICY-------FLYQIL 138
Query: 126 NGLDYLHSGYDIPIVHCDMKPSNILLDRDFEAHVSDFGTSRMLDVHLQDLSSLSTAFQGT 185
GL Y+HS ++H D+KPSN+LL+ + + DFG +R+ D D + T + T
Sbjct: 139 RGLKYIHSA---NVLHRDLKPSNLLLNTTCDLKICDFGLARVADPD-HDHTGFLTEYVAT 194
Query: 186 IGYLAPE--FAYMRIVTTKVDVFSFGIVVMEFLTKRRP 221
Y APE T +D++S G ++ E L+ RP
Sbjct: 195 RWYRAPEIMLNSKG-YTKSIDIWSVGCILAEMLS-NRP 230
|
| >3q5i_A Protein kinase; CDPK, malaria, phosphotransferase, structural genomics, structural genomic consortium, SGC, transferase; HET: ANP; 2.10A {Plasmodium berghei} Length = 504 | Back alignment and structure |
|---|
Score = 87.8 bits (218), Expect = 1e-19
Identities = 54/235 (22%), Positives = 93/235 (39%), Gaps = 35/235 (14%)
Query: 7 IENATGSFSEN----NIIGNSNLSTVYKGR-LEDGEIVAVKKLN-----------FHQFS 50
+ G E+ +G+ V + A+K + ++
Sbjct: 27 VRKKEGKIGESYFKVRKLGSGAYGEVLLCKEKNGHSEKAIKVIKKSQFDKGRYSDDNKNI 86
Query: 51 AESDKSFYREAKTLKELKHRNLVKVLGYAWESGKLKALILEYMENGSLESVIHGPGVDHS 110
+ + Y E LK L H N++K+ +E K L+ E+ E G L I ++
Sbjct: 87 EKFHEEIYNEISLLKSLDHPNIIKLFDV-FEDKKYFYLVTEFYEGGELFEQI----INRH 141
Query: 111 RWTLPKRIDVLISVANGLDYLHS-GYDIPIVHCDMKPSNILL-DRDFEAH--VSDFGTSR 166
++ +++ + +G+ YLH IVH D+KP NILL +++ + + DFG S
Sbjct: 142 KFDECDAANIMKQILSGICYLHKHN----IVHRDIKPENILLENKNSLLNIKIVDFGLSS 197
Query: 167 MLDVHLQDLSSLSTAFQGTIGYLAPEFAYMRIVTTKVDVFSFGIVVMEFLTKRRP 221
L GT Y+APE + K DV+S G+++ L P
Sbjct: 198 FFS----KDYKLRDRL-GTAYYIAPE-VLKKKYNEKCDVWSCGVIMYILLCGYPP 246
|
| >1cm8_A Phosphorylated MAP kinase P38-gamma; phosphorylation, transferase; HET: TPO PTR ANP; 2.40A {Homo sapiens} SCOP: d.144.1.7 Length = 367 | Back alignment and structure |
|---|
Score = 86.6 bits (215), Expect = 1e-19
Identities = 55/213 (25%), Positives = 96/213 (45%), Gaps = 32/213 (15%)
Query: 20 IGNSNLSTVYKGR-LEDGEIVAVKKLNFHQFSAESD-KSFYREAKTLKELKHRNLVKVL- 76
+G+ V G VA+KKL + F +E K YRE + LK ++H N++ +L
Sbjct: 33 VGSGAYGAVCSAVDGRTGAKVAIKKL-YRPFQSELFAKRAYRELRLLKHMRHENVIGLLD 91
Query: 77 ----GYAWESGKLKALILEYMENGSLESVIHGPGV--DHSRWTLPKRIDVLISVANGLDY 130
+ L++ +M L ++ + D ++ ++ + GL Y
Sbjct: 92 VFTPDETLDDFTDFYLVMPFMGT-DLGKLMKHEKLGEDRIQF-------LVYQMLKGLRY 143
Query: 131 LHSGYDIPIVHCDMKPSNILLDRDFEAHVSDFGTSRMLDVHLQDLSSLSTAFQGTIGYLA 190
+H+ I+H D+KP N+ ++ D E + DFG +R D + T + T Y A
Sbjct: 144 IHAA---GIIHRDLKPGNLAVNEDCELKILDFGLARQADSEM-------TGYVVTRWYRA 193
Query: 191 PE--FAYMRIVTTKVDVFSFGIVVMEFLTKRRP 221
PE +MR T VD++S G ++ E +T +
Sbjct: 194 PEVILNWMR-YTQTVDIWSVGCIMAEMIT-GKT 224
|
| >3pg1_A Mitogen-activated protein kinase, putative (MAP K protein); EPK Ser/Thr protein kinase fold, Ser/Thr protein kinase, TRA; 1.95A {Leishmania major} Length = 362 | Back alignment and structure |
|---|
Score = 86.6 bits (215), Expect = 2e-19
Identities = 48/214 (22%), Positives = 78/214 (36%), Gaps = 37/214 (17%)
Query: 27 TVYKGRLEDGEIVAVKKLNFHQFSAESDKSF---------YREAKTLKELKHRNLVKVLG 77
V G +G VA+K++ + RE + L H N++ +
Sbjct: 37 AVCAGVDSEGIPVAIKRVFNTVSDGRTVNILSDSFLCKRVLREIRLLNHFHHPNILGLRD 96
Query: 78 --YAWESGKLKA--LILEYMENGSLESVIHGPGV----DHSRWTLPKRIDVLISVANGLD 129
+E + L+ E M L VIH + H ++ + + GL
Sbjct: 97 IFVHFEEPAMHKLYLVTELMRT-DLAQVIHDQRIVISPQHIQY-------FMYHILLGLH 148
Query: 130 YLHSGYDIPIVHCDMKPSNILLDRDFEAHVSDFGTSRMLDVHLQDLSSLSTAFQGTIGYL 189
LH +VH D+ P NILL + + + DF +R + T + Y
Sbjct: 149 VLHEA---GVVHRDLHPGNILLADNNDITICDFNLAREDTA-----DANKTHYVTHRWYR 200
Query: 190 APE--FAYMRIVTTKVDVFSFGIVVMEFLTKRRP 221
APE + T VD++S G V+ E R+
Sbjct: 201 APELVMQFKG-FTKLVDMWSAGCVMAEMFN-RKA 232
|
| >1j1b_A Glycogen synthase kinase-3 beta; complex, TAU, AMPPNP, transferase; HET: ANP; 1.80A {Homo sapiens} SCOP: d.144.1.7 PDB: 1i09_A* 1j1c_A* 2jld_A* 3m1s_A* 3pup_A* 3du8_A* 1pyx_A* 1q41_A* 1q3w_A* 1q3d_A* 1q4l_A* 3q3b_A* 1q5k_A* 3i4b_A* 3l1s_A* 1r0e_A* 3zrk_A* 3zrl_A* 3zrm_A* 4dit_A* ... Length = 420 | Back alignment and structure |
|---|
Score = 86.7 bits (215), Expect = 2e-19
Identities = 64/225 (28%), Positives = 112/225 (49%), Gaps = 43/225 (19%)
Query: 13 SFSENNIIGNSNLSTVYKGRL-EDGEIVAVKKLNFHQFSAESDKSF-YREAKTLKELKHR 70
S+++ +IGN + VY+ +L + GE+VA+KK+ DK F RE + +++L H
Sbjct: 55 SYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKV-------LQDKRFKNRELQIMRKLDHC 107
Query: 71 NLVKVLGYAWESGKLKA-----LILEYMENGSLESVIHGPGVDHSRWTLPKRIDVLIS-- 123
N+V++ + + SG+ K L+L+Y+ ++ V ++ TLP + +
Sbjct: 108 NIVRLRYFFYSSGEKKDEVYLNLVLDYVPE-TVYRVARH--YSRAKQTLP---VIYVKLY 161
Query: 124 ---VANGLDYLHSGYDIPIVHCDMKPSNILLDRD-FEAHVSDFGTSRMLDVHLQDLSSLS 179
+ L Y+HS I H D+KP N+LLD D + DFG+++ L ++S +
Sbjct: 162 MYQLFRSLAYIHS---FGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVSYIC 218
Query: 180 TAFQGTIGYLAPEF-----AYMRIVTTKVDVFSFGIVVMEFLTKR 219
+ + Y APE Y T+ +DV+S G V+ E L +
Sbjct: 219 SRY-----YRAPELIFGATDY----TSSIDVWSAGCVLAELLLGQ 254
|
| >1phk_A Phosphorylase kinase; glycogen metabolism, transferase, serine/threonine-protein, ATP-binding, calmodulin-binding; HET: ATP; 2.20A {Oryctolagus cuniculus} SCOP: d.144.1.7 PDB: 1ql6_A* 2phk_A* Length = 298 | Back alignment and structure |
|---|
Score = 85.4 bits (212), Expect = 2e-19
Identities = 53/223 (23%), Positives = 93/223 (41%), Gaps = 34/223 (15%)
Query: 9 NATGSFSEN----NIIGNSNLSTVYKGR-LEDGEIVAVKKLNFHQFSAESDK-------S 56
++T F EN I+G S V + + AVK ++ + S + +
Sbjct: 10 HSTHGFYENYEPKEILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREA 69
Query: 57 FYREAKTLKELK-HRNLVKVLGYAWESGKLKALILEYMENGSLESVIHGPGVDHSRWTLP 115
+E L+++ H N++++ +E+ L+ + M+ G L + + +
Sbjct: 70 TLKEVDILRKVSGHPNIIQLKD-TYETNTFFFLVFDLMKKGELFDYL----TEKVTLSEK 124
Query: 116 KRIDVLISVANGLDYLHS-GYDIPIVHCDMKPSNILLDRDFEAHVSDFGTSRMLDVHLQD 174
+ ++ ++ + LH IVH D+KP NILLD D ++DFG S LD
Sbjct: 125 ETRKIMRALLEVICALHKLN----IVHRDLKPENILLDDDMNIKLTDFGFSCQLD----P 176
Query: 175 LSSLSTAFQGTIGYLAPE------FAYMRIVTTKVDVFSFGIV 211
L GT YLAPE +VD++S G++
Sbjct: 177 GEKLREVC-GTPSYLAPEIIECSMNDNHPGYGKEVDMWSTGVI 218
|
| >3soa_A Calcium/calmodulin-dependent protein kinase type alpha with A beta 7 linker; phosphorylation, cytosolic, transferase-transferase inhibitor complex; HET: DB8; 3.55A {Homo sapiens} Length = 444 | Back alignment and structure |
|---|
Score = 86.6 bits (215), Expect = 2e-19
Identities = 47/197 (23%), Positives = 84/197 (42%), Gaps = 16/197 (8%)
Query: 19 IIGNSNLSTVYKGR-LEDGEIVAVKKLNFHQFSAESDKSFYREAKTLKELKHRNLVKVLG 77
+G S V + + G+ A +N + SA + REA+ + LKH N+V++
Sbjct: 18 ELGKGAFSVVRRCVKVLAGQEYAAMIINTKKLSARDHQKLEREARICRLLKHPNIVRLHD 77
Query: 78 YAWESGKLKALILEYMENGSLESVIHGPGVDHSRWTLPKRIDVLISVANGLDYLHSGYDI 137
+ LI + + G L I V ++ + + + + H +
Sbjct: 78 -SISEEGHHYLIFDLVTGGELFEDI----VAREYYSEADASHCIQQILEAVLHCHQ---M 129
Query: 138 PIVHCDMKPSNILL-DRDFEAHV--SDFGTSRMLDVHLQDLSSLSTAFQGTIGYLAPEFA 194
+VH ++KP N+LL + A V +DFG + ++ Q F GT GYL+PE
Sbjct: 130 GVVHRNLKPENLLLASKLKGAAVKLADFGLAIEVEGEQQAWFG----FAGTPGYLSPEVL 185
Query: 195 YMRIVTTKVDVFSFGIV 211
VD+++ G++
Sbjct: 186 RKDPYGKPVDLWACGVI 202
|
| >2wtk_C Serine/threonine-protein kinase 11; transferase-metal-binding protein complex, transferase metal protein complex, nucleus; HET: ANP; 2.65A {Homo sapiens} Length = 305 | Back alignment and structure |
|---|
Score = 85.4 bits (212), Expect = 2e-19
Identities = 59/239 (24%), Positives = 94/239 (39%), Gaps = 44/239 (18%)
Query: 20 IGNSNLSTVYKGR-LEDGEIVAVKKLNFHQFSAESD--KSFYREAKTLKELKHRNLVK-- 74
+G + V + E AVK L + + + +E + L+ L+H+N+++
Sbjct: 13 LGEGSYGKVKEVLDSETLCRRAVKILKKKKLRRIPNGEANVKKEIQLLRRLRHKNVIQLV 72
Query: 75 -VLGYAWESGKLKALILEYMENGSLE---SVIHGP-GVDHSRWTLPKRIDVLISVANGLD 129
VL E + +++EY G E SV V + LI GL+
Sbjct: 73 DVLYN--EEKQKMYMVMEYCVCGMQEMLDSVPEKRFPVCQAH----GYFCQLID---GLE 123
Query: 130 YLHSGYDIPIVHCDMKPSNILLDRDFEAHVSDFGTSRMLDVHLQDLSSLSTAFQGTIGYL 189
YLHS IVH D+KP N+LL +S G + L D + T QG+ +
Sbjct: 124 YLHSQG---IVHKDIKPGNLLLTTGGTLKISALGVAEALHPFAAD-DTCRT-SQGSPAFQ 178
Query: 190 APEFAYMRIVT-------TKVDVFSFGIVVMEFLTKRRPTGLDEENGLSPISLRQLVEK 241
PE I KVD++S G+ + T P + +N + +L E
Sbjct: 179 PPE-----IANGLDTFSGFKVDIWSAGVTLYNITTGLYP--FEGDN------IYKLFEN 224
|
| >2wei_A Calmodulin-domain protein kinase 1, putative; nucleotide-binding, serine/threonine-protein kinase, CGD3_920, transferase; HET: VGG; 1.65A {Cryptosporidium parvum iowa II} PDB: 3dfa_A 3ma6_A* Length = 287 | Back alignment and structure |
|---|
Score = 84.2 bits (209), Expect = 4e-19
Identities = 55/212 (25%), Positives = 91/212 (42%), Gaps = 28/212 (13%)
Query: 11 TGSFSEN----NIIGNSNLSTVYKGR-LEDGEIVAVKKLNFHQFSAESDKSFYREAKTLK 65
G+F+E ++G + V K + + AVK +N + + RE + LK
Sbjct: 17 QGTFAERYNIVCMLGKGSFGEVLKCKDRITQQEYAVKVINKASAKNKDTSTILREVELLK 76
Query: 66 ELKHRNLVKVLGYAWESGKLKALILEYMENGSLESVIHGPGVDHSRWTLPKRIDVLISVA 125
+L H N++K+ E ++ E G L I + R++ ++ V
Sbjct: 77 KLDHPNIMKLFE-ILEDSSSFYIVGELYTGGELFDEI----IKRKRFSEHDAARIIKQVF 131
Query: 126 NGLDYLHSGYDIPIVHCDMKPSNILL---DRDFEAHVSDFGTSRMLDVHLQDLSSLSTAF 182
+G+ Y+H IVH D+KP NILL ++D + + DFG S + +
Sbjct: 132 SGITYMHK---HNIVHRDLKPENILLESKEKDCDIKIIDFGLSTCFQ----QNTKMKDRI 184
Query: 183 QGTIGYLAPEF---AYMRIVTTKVDVFSFGIV 211
GT Y+APE Y K DV+S G++
Sbjct: 185 -GTAYYIAPEVLRGTY----DEKCDVWSAGVI 211
|
| >2i6l_A Mitogen-activated protein kinase 6; MAPK6, ERK3, extracellular signal regulated kinase 3, serine phosphorylation, threonine phosphorylation; 2.25A {Homo sapiens} Length = 320 | Back alignment and structure |
|---|
Score = 84.2 bits (209), Expect = 6e-19
Identities = 52/207 (25%), Positives = 90/207 (43%), Gaps = 36/207 (17%)
Query: 34 EDGEIVAVKKLNF-HQFSAESDKSFYREAKTLKELKHRNLVKVL--------GYAWESGK 84
+ + VA+KK+ S K RE K ++ L H N+VKV + G
Sbjct: 34 DCDKRVAIKKIVLTDPQSV---KHALREIKIIRRLDHDNIVKVFEILGPSGSQLTDDVGS 90
Query: 85 LKA-----LILEYMENGSLESVIHGPGV--DHSRWTLPKRIDVLISVANGLDYLHSGYDI 137
L ++ EYME L +V+ + +H+R + + GL Y+HS
Sbjct: 91 LTELNSVYIVQEYMET-DLANVLEQGPLLEEHARL-------FMYQLLRGLKYIHSA--- 139
Query: 138 PIVHCDMKPSNILLD-RDFEAHVSDFGTSRMLDVHLQDLSSLSTAFQGTIGYLAPE--FA 194
++H D+KP+N+ ++ D + DFG +R++D H L + T Y +P +
Sbjct: 140 NVLHRDLKPANLFINTEDLVLKIGDFGLARIMDPHYSHKGHL-SEGLVTKWYRSPRLLLS 198
Query: 195 YMRIVTTKVDVFSFGIVVMEFLTKRRP 221
T +D+++ G + E LT +
Sbjct: 199 PNN-YTKAIDMWAAGCIFAEMLT-GKT 223
|
| >3uto_A Twitchin; kinase, muscle sarcomere, transferase; HET: FLC P33; 2.40A {Caenorhabditis elegans} PDB: 1koa_A Length = 573 | Back alignment and structure |
|---|
Score = 85.7 bits (212), Expect = 6e-19
Identities = 49/218 (22%), Positives = 88/218 (40%), Gaps = 23/218 (10%)
Query: 1 RFDRTEIENATGSFSE----NNIIGNSNLSTVYKGR-LEDGEIVAVKKLNFHQFSAESDK 55
++ +E + + +G V++ G A K + +
Sbjct: 142 QYYPQPVEIKHDHVLDHYDIHEELGTGAFGVVHRVTERATGNNFAAKFVM--TPHESDKE 199
Query: 56 SFYREAKTLKELKHRNLVKVLGYAWESGKLKALILEYMENGSL-ESVIHGPGVDHSRWTL 114
+ +E +T+ L+H LV + A+E +I E+M G L E V +H++ +
Sbjct: 200 TVRKEIQTMSVLRHPTLVNLHD-AFEDDNEMVMIYEFMSGGELFEKVAD----EHNKMSE 254
Query: 115 PKRIDVLISVANGLDYLHSGYDIPIVHCDMKPSNILLDRDFEAHV--SDFGTSRMLDVHL 172
+ ++ + V GL ++H VH D+KP NI+ + DFG + LD
Sbjct: 255 DEAVEYMRQVCKGLCHMHENN---YVHLDLKPENIMFTTKRSNELKLIDFGLTAHLDPK- 310
Query: 173 QDLSSLSTAFQGTIGYLAPEFAYMRIVTTKVDVFSFGI 210
S+ GT + APE A + V D++S G+
Sbjct: 311 ---QSVKVTT-GTAEFAAPEVAEGKPVGYYTDMWSVGV 344
|
| >3bhy_A Death-associated protein kinase 3; death associated kinase, DAPK3, ZIP kinase, ZIPK, DAP kinase like kinase, DLK, structural genomics consortium; HET: 7CP; 1.24A {Homo sapiens} PDB: 3bqr_A* 2j90_A* 1yrp_A* 2yak_A* 2y4p_A* 3f5u_A* 1jks_A 1jkk_A* 1ig1_A* 1jkl_A 1jkt_A 3eh9_A* 3eha_A* 3f5g_A* 1p4f_A* 1wvw_A 1wvx_A* 1wvy_A* 2w4j_A* 3dgk_A ... Length = 283 | Back alignment and structure |
|---|
Score = 83.8 bits (208), Expect = 6e-19
Identities = 49/201 (24%), Positives = 86/201 (42%), Gaps = 22/201 (10%)
Query: 20 IGNSNLSTVYKGR-LEDGEIVAVK---KLNFHQFSAESDK-SFYREAKTLKELKHRNLVK 74
+G+ + V K R G+ A K K + RE L+E++H N++
Sbjct: 13 LGSGQFAIVRKCRQKGTGKEYAAKFIKKRRLSSSRRGVSREEIEREVNILREIRHPNIIT 72
Query: 75 VLGYAWESGKLKALILEYMENGSLESVIHGPGVDHSRWTLPKRIDVLISVANGLDYLHSG 134
+ +E+ LILE + G L + + T + L + +G+ YLHS
Sbjct: 73 LHD-IFENKTDVVLILELVSGGELFDFL----AEKESLTEDEATQFLKQILDGVHYLHSK 127
Query: 135 YDIPIVHCDMKPSNILL-DRDFEAH---VSDFGTSRMLDVHLQDLSSLSTAFQGTIGYLA 190
I H D+KP NI+L D++ + DFG + ++ + F GT ++A
Sbjct: 128 R---IAHFDLKPENIMLLDKNVPNPRIKLIDFGIAHKIE----AGNEFKNIF-GTPEFVA 179
Query: 191 PEFAYMRIVTTKVDVFSFGIV 211
PE + + D++S G++
Sbjct: 180 PEIVNYEPLGLEADMWSIGVI 200
|
| >2fst_X Mitogen-activated protein kinase 14; active mutants, lipids, MAP kinase insertion, autophosphorylation, transferase; HET: BOG; 1.45A {Homo sapiens} PDB: 2fso_X* 2fsl_X* 2fsm_X* 2npq_A* 2bal_A* 2baj_A* 2bak_A* 2baq_A* 2qd9_A* 1ian_A* 2rg5_A* 2rg6_A* 3bv2_A* 3bv3_A* 3bx5_A* 3c5u_A* 3cg2_A* 3l8x_A* 3mvl_A* 3mvm_A* ... Length = 367 | Back alignment and structure |
|---|
Score = 84.3 bits (209), Expect = 9e-19
Identities = 59/213 (27%), Positives = 95/213 (44%), Gaps = 32/213 (15%)
Query: 20 IGNSNLSTVYKGR-LEDGEIVAVKKLNFHQFSAESD-KSFYREAKTLKELKHRNLVKVL- 76
+G+ +V + G VAVKKL F + K YRE + LK +KH N++ +L
Sbjct: 37 VGSGAYGSVCAAFDTKTGLRVAVKKL-SRPFQSIIHAKRTYRELRLLKHMKHENVIGLLD 95
Query: 77 ----GYAWESGKLKALILEYMENGSLESVIHGPGV--DHSRWTLPKRIDVLISVANGLDY 130
+ E L+ M L +++ + DH ++ ++ + GL Y
Sbjct: 96 VFTPARSLEEFNDVYLVTHLMGA-DLNNIVKCQKLTDDHVQF-------LIYQILRGLKY 147
Query: 131 LHSGYDIPIVHCDMKPSNILLDRDFEAHVSDFGTSRMLDVHLQDLSSLSTAFQGTIGYLA 190
+HS I+H D+KPSN+ ++ D E + DFG +R + T + T Y A
Sbjct: 148 IHSA---DIIHRDLKPSNLAVNEDCELKILDFGLARHTADEM-------TGYVATRWYRA 197
Query: 191 PE--FAYMRIVTTKVDVFSFGIVVMEFLTKRRP 221
PE +M VD++S G ++ E LT R
Sbjct: 198 PEIMLNWMH-YNQTVDIWSVGCIMAELLT-GRT 228
|
| >2jam_A Calcium/calmodulin-dependent protein kinase type 1G; transferase, kinase, membrane, ATP-binding, prenylation, serine/threonine-protein kinase, alternative splicing; HET: J60; 1.7A {Homo sapiens} PDB: 2jc6_A* 1a06_A Length = 304 | Back alignment and structure |
|---|
Score = 83.4 bits (207), Expect = 9e-19
Identities = 56/210 (26%), Positives = 98/210 (46%), Gaps = 24/210 (11%)
Query: 11 TGSFSEN----NIIGNSNLSTVYKGR-LEDGEIVAVKKLNFHQFSAESDKSFYREAKTLK 65
T + + ++G+ S V+ + G++ A+K + + A D S E LK
Sbjct: 4 TTNIRKTFIFMEVLGSGAFSEVFLVKQRLTGKLFALKCIK--KSPAFRDSSLENEIAVLK 61
Query: 66 ELKHRNLVKVLGYAWESGKLKALILEYMENGSLESVIHGPGVDHSRWTLPKRIDVLISVA 125
++KH N+V + +ES L+++ + G L I ++ +T V+ V
Sbjct: 62 KIKHENIVTLEDI-YESTTHYYLVMQLVSGGELFDRI----LERGVYTEKDASLVIQQVL 116
Query: 126 NGLDYLHSGYDIPIVHCDMKPSNILL-DRDFEAHV--SDFGTSRMLDVHLQDLSSLSTAF 182
+ + YLH IVH D+KP N+L + + + +DFG S+M + +STA
Sbjct: 117 SAVKYLHE---NGIVHRDLKPENLLYLTPEENSKIMITDFGLSKMEQNGI-----MSTAC 168
Query: 183 QGTIGYLAPEFAYMRIVTTKVDVFSFGIVV 212
GT GY+APE + + VD +S G++
Sbjct: 169 -GTPGYVAPEVLAQKPYSKAVDCWSIGVIT 197
|
| >2a2a_A Death-associated protein kinase 2; autoinhibition, transferase; 1.47A {Homo sapiens} PDB: 2cke_A* 1wmk_A 1z9x_A 2a27_A 2x0g_A 2xuu_A* 2w4k_A* 2xzs_A Length = 321 | Back alignment and structure |
|---|
Score = 83.5 bits (207), Expect = 1e-18
Identities = 46/202 (22%), Positives = 84/202 (41%), Gaps = 22/202 (10%)
Query: 19 IIGNSNLSTVYKGR-LEDGEIVAVK---KLNFHQFSAESDK-SFYREAKTLKELKHRNLV 73
+G+ + V K R G A K K + RE L+++ H N++
Sbjct: 19 ELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVSREEIEREVSILRQVLHHNVI 78
Query: 74 KVLGYAWESGKLKALILEYMENGSLESVIHGPGVDHSRWTLPKRIDVLISVANGLDYLHS 133
+ +E+ LILE + G L + + + + + +G++YLH+
Sbjct: 79 TLHD-VYENRTDVVLILELVSGGELFDFL----AQKESLSEEEATSFIKQILDGVNYLHT 133
Query: 134 GYDIPIVHCDMKPSNILL-DRDFEAH---VSDFGTSRMLDVHLQDLSSLSTAFQGTIGYL 189
I H D+KP NI+L D++ + DFG + ++ D F GT ++
Sbjct: 134 KK---IAHFDLKPENIMLLDKNIPIPHIKLIDFGLAHEIE----DGVEFKNIF-GTPEFV 185
Query: 190 APEFAYMRIVTTKVDVFSFGIV 211
APE + + D++S G++
Sbjct: 186 APEIVNYEPLGLEADMWSIGVI 207
|
| >3i6u_A CDS1, serine/threonine-protein kinase CHK2; Ser/Thr protein kinase, FHA domain, ATP-binding, cell cycle, mutation, LI-fraumeni syndrome, magnesium; 3.00A {Homo sapiens} PDB: 3i6w_A Length = 419 | Back alignment and structure |
|---|
Score = 84.4 bits (209), Expect = 1e-18
Identities = 50/206 (24%), Positives = 91/206 (44%), Gaps = 27/206 (13%)
Query: 20 IGNSNLSTVYKGR-LEDGEIVAVKKLNFHQFSAESDK------SFYREAKTLKELKHRNL 72
+G+ V + + VA++ ++ +F+ S + + E + LK+L H +
Sbjct: 143 LGSGACGEVKLAFERKTCKKVAIRIISKRKFAIGSAREADPALNVETEIEILKKLNHPCI 202
Query: 73 VKVLGYAWESGKLKALILEYMENGSLESVIHGPGVDHSRWTLPKRIDVLISVANGLDYLH 132
+K+ + +++ ++LE ME G L + V + R + + YLH
Sbjct: 203 IKIKNF-FDAEDY-YIVLELMEGGELFDKV----VGNKRLKEATCKLYFYQMLLAVQYLH 256
Query: 133 SGYDIPIVHCDMKPSNILL---DRDFEAHVSDFGTSRMLDVHLQDLSSLSTAFQGTIGYL 189
I+H D+KP N+LL + D ++DFG S++L + S + T GT YL
Sbjct: 257 E---NGIIHRDLKPENVLLSSQEEDCLIKITDFGHSKILG----ETSLMRTLC-GTPTYL 308
Query: 190 APE---FAYMRIVTTKVDVFSFGIVV 212
APE VD +S G+++
Sbjct: 309 APEVLVSVGTAGYNRAVDCWSLGVIL 334
|
| >2b9h_A MAP kinase FUS3, mitogen-activated protein kinase FUS3; transferase; HET: ADP; 1.55A {Saccharomyces cerevisiae} PDB: 2b9i_A* 2b9j_A* 2f49_A 2fa2_A 2b9f_A* 2f9g_A* Length = 353 | Back alignment and structure |
|---|
Score = 83.8 bits (208), Expect = 1e-18
Identities = 55/203 (27%), Positives = 85/203 (41%), Gaps = 30/203 (14%)
Query: 34 EDGEIVAVKKLNFHQFSAESD-KSFYREAKTLKELKHRNLVKVLG--YAWESGKLKA--L 88
GEIVA+KK+ F RE K LK KH N++ + +
Sbjct: 34 PTGEIVAIKKIE--PFDKPLFALRTLREIKILKHFKHENIITIFNIQRPDSFENFNEVYI 91
Query: 89 ILEYMENGSLESVIHGPGV--DHSRWTLPKRIDVLISVANGLDYLHSGYDIPIVHCDMKP 146
I E M+ L VI + DH ++ + + LH ++H D+KP
Sbjct: 92 IQELMQT-DLHRVISTQMLSDDHIQY-------FIYQTLRAVKVLHGS---NVIHRDLKP 140
Query: 147 SNILLDRDFEAHVSDFGTSRMLDVHLQDLSSLSTAFQG------TIGYLAPE--FAYMRI 198
SN+L++ + + V DFG +R++D D S + G T Y APE +
Sbjct: 141 SNLLINSNCDLKVCDFGLARIIDESAADNSEPTGQQSGMVEFVATRWYRAPEVMLTSAK- 199
Query: 199 VTTKVDVFSFGIVVMEFLTKRRP 221
+ +DV+S G ++ E RRP
Sbjct: 200 YSRAMDVWSCGCILAELFL-RRP 221
|
| >3lm5_A Serine/threonine-protein kinase 17B; STK17B, serine/threonine kinase 17B, DRAK2, DAP kinase relat apoptosis-inducing protein kinase 2; HET: QUE; 2.29A {Homo sapiens} PDB: 3lm0_A* Length = 327 | Back alignment and structure |
|---|
Score = 83.5 bits (207), Expect = 1e-18
Identities = 48/192 (25%), Positives = 75/192 (39%), Gaps = 18/192 (9%)
Query: 26 STVYKGR-LEDGEIVAVKKLNFHQFSAESDKSFYREAKTLKELKHR-NLVKVLGYAWESG 83
+ V + G+ A K L + + E L+ K ++ + +E+
Sbjct: 43 AVVRQCISKSTGQEYAAKFLKKRRRGQDCRAEILHEIAVLELAKSCPRVINLHE-VYENT 101
Query: 84 KLKALILEYMENGSL-ESVIHGPGVDHSRWTLPKRIDVLISVANGLDYLHSGYDIPIVHC 142
LILEY G + + + I ++ + G+ YLH IVH
Sbjct: 102 SEIILILEYAAGGEIFSLCLP---ELAEMVSENDVIRLIKQILEGVYYLHQNN---IVHL 155
Query: 143 DMKPSNILLDRDFEAH---VSDFGTSRMLDVHLQDLSSLSTAFQGTIGYLAPEFAYMRIV 199
D+KP NILL + + DFG SR + L GT YLAPE +
Sbjct: 156 DLKPQNILLSSIYPLGDIKIVDFGMSRKIG----HACELREIM-GTPEYLAPEILNYDPI 210
Query: 200 TTKVDVFSFGIV 211
TT D+++ GI+
Sbjct: 211 TTATDMWNIGII 222
|
| >3g33_A Cell division protein kinase 4; Ser/Thr protein kinase, cell cycle, phosphorylation, ATP-BIN cell division, disease mutation, kinase; 3.00A {Homo sapiens} Length = 308 | Back alignment and structure |
|---|
Score = 83.0 bits (206), Expect = 2e-18
Identities = 50/205 (24%), Positives = 84/205 (40%), Gaps = 24/205 (11%)
Query: 27 TVYKGR-LEDGEIVAVKKLNFHQFSAESDKSF----YREAKTLKELK---HRNLVKVL-- 76
TVYK R G VA+K + RE L+ L+ H N+V+++
Sbjct: 24 TVYKARDPHSGHFVALKSVRVPN-GGGGGGGLPISTVREVALLRRLEAFEHPNVVRLMDV 82
Query: 77 --GYAWESGKLKALILEYMENGSLESVIHGPGVDHSRWTLPKRIDVLISVANGLDYLHSG 134
+ L+ E+++ L + + K + + GLD+LH+
Sbjct: 83 CATSRTDREIKVTLVFEHVDQ-DLRTYLDKAPPPGLPAETIKDL--MRQFLRGLDFLHAN 139
Query: 135 YDIPIVHCDMKPSNILLDRDFEAHVSDFGTSRMLDVHLQDLSSLSTAFQGTIGYLAPEFA 194
IVH D+KP NIL+ ++DFG +R+ + L+ + T+ Y APE
Sbjct: 140 C---IVHRDLKPENILVTSGGTVKLADFGLARIYSYQMA-LTPVVV----TLWYRAPEVL 191
Query: 195 YMRIVTTKVDVFSFGIVVMEFLTKR 219
T VD++S G + E ++
Sbjct: 192 LQSTYATPVDMWSVGCIFAEMFRRK 216
|
| >2w4o_A Calcium/calmodulin-dependent protein kinase type IV; calmodulin-binding, nucleotide-binding, serine/threonine-protein kinase, ATP-binding; HET: DKI; 2.17A {Homo sapiens} Length = 349 | Back alignment and structure |
|---|
Score = 83.1 bits (206), Expect = 2e-18
Identities = 52/197 (26%), Positives = 85/197 (43%), Gaps = 21/197 (10%)
Query: 19 IIGNSNLSTVYKGR-LEDGEIVAVKKLNFHQFSAESDKSFYREAKTLKELKHRNLVKVLG 77
+G S VY+ + + A+K L K E L L H N++K+
Sbjct: 60 ELGRGATSIVYRCKQKGTQKPYALKVLK----KTVDKKIVRTEIGVLLRLSHPNIIKLKE 115
Query: 78 YAWESGKLKALILEYMENGSLESVIHGPGVDHSRWTLPKRIDVLISVANGLDYLHSGYDI 137
+E+ +L+LE + G L I V+ ++ D + + + YLH
Sbjct: 116 -IFETPTEISLVLELVTGGELFDRI----VEKGYYSERDAADAVKQILEAVAYLHE---N 167
Query: 138 PIVHCDMKPSNILL-DRDFEAHV--SDFGTSRMLDVHLQDLSSLSTAFQGTIGYLAPEFA 194
IVH D+KP N+L +A + +DFG S++++ + T GT GY APE
Sbjct: 168 GIVHRDLKPENLLYATPAPDAPLKIADFGLSKIVE----HQVLMKTVC-GTPGYCAPEIL 222
Query: 195 YMRIVTTKVDVFSFGIV 211
+VD++S GI+
Sbjct: 223 RGCAYGPEVDMWSVGII 239
|
| >2y0a_A Death-associated protein kinase 1; transferase, calmodulin, esprit; HET: MES; 2.60A {Homo sapiens} Length = 326 | Back alignment and structure |
|---|
Score = 82.7 bits (205), Expect = 2e-18
Identities = 53/214 (24%), Positives = 88/214 (41%), Gaps = 26/214 (12%)
Query: 11 TGSFSEN----NIIGNSNLSTVYKGR-LEDGEIVAVK---KLNFHQFSAESDK-SFYREA 61
+ + +G+ + V K R G A K K + RE
Sbjct: 6 QENVDDYYDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREV 65
Query: 62 KTLKELKHRNLVKVLGYAWESGKLKALILEYMENGSLESVIHGPGVDHSRWTLPKRIDVL 121
LKE++H N++ + +E+ LILE + G L + + T + + L
Sbjct: 66 SILKEIQHPNVITLHE-VYENKTDVILILELVAGGELFDFL----AEKESLTEEEATEFL 120
Query: 122 ISVANGLDYLHSGYDIPIVHCDMKPSNILL-DRDFEAH---VSDFGTSRMLDVHLQDLSS 177
+ NG+ YLHS I H D+KP NI+L DR+ + DFG + +D +
Sbjct: 121 KQILNGVYYLHSLQ---IAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKID----FGNE 173
Query: 178 LSTAFQGTIGYLAPEFAYMRIVTTKVDVFSFGIV 211
F GT ++APE + + D++S G++
Sbjct: 174 FKNIF-GTPEFVAPEIVNYEPLGLEADMWSIGVI 206
|
| >2yab_A Death-associated protein kinase 2; apoptosis, transferase; HET: AMP; 1.90A {Mus musculus} PDB: 2yaa_A* 2ya9_A* Length = 361 | Back alignment and structure |
|---|
Score = 83.2 bits (206), Expect = 2e-18
Identities = 46/201 (22%), Positives = 84/201 (41%), Gaps = 22/201 (10%)
Query: 20 IGNSNLSTVYKGR-LEDGEIVAVK---KLNFHQFSAESDK-SFYREAKTLKELKHRNLVK 74
+G+ + V K R G A K K + RE L+++ H N++
Sbjct: 20 LGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVCREEIEREVSILRQVLHPNIIT 79
Query: 75 VLGYAWESGKLKALILEYMENGSLESVIHGPGVDHSRWTLPKRIDVLISVANGLDYLHSG 134
+ +E+ LILE + G L + + + + + +G++YLH+
Sbjct: 80 LHD-VYENRTDVVLILELVSGGELFDFL----AQKESLSEEEATSFIKQILDGVNYLHTK 134
Query: 135 YDIPIVHCDMKPSNILL-DRDFEAH---VSDFGTSRMLDVHLQDLSSLSTAFQGTIGYLA 190
I H D+KP NI+L D++ + DFG + ++ D F GT ++A
Sbjct: 135 K---IAHFDLKPENIMLLDKNIPIPHIKLIDFGLAHEIE----DGVEFKNIF-GTPEFVA 186
Query: 191 PEFAYMRIVTTKVDVFSFGIV 211
PE + + D++S G++
Sbjct: 187 PEIVNYEPLGLEADMWSIGVI 207
|
| >2x4f_A Myosin light chain kinase family member 4; LUNG, breast cancer, transferase, serine/threonine-protein kinase, nucleotide-binding; HET: 16X 1PE; 2.67A {Homo sapiens} Length = 373 | Back alignment and structure |
|---|
Score = 83.2 bits (206), Expect = 3e-18
Identities = 53/219 (24%), Positives = 89/219 (40%), Gaps = 25/219 (11%)
Query: 2 FDRTEIENATGSFSEN------NIIGNSNLSTVYKGR-LEDGEIVAVKKLNFHQFSAESD 54
FD + G+ + I+G V+K G +A K + +
Sbjct: 73 FDHRIVTAKQGAVNSFYTVSKTEILGGGRFGQVHKCEETATGLKLAAKII--KTRGMKDK 130
Query: 55 KSFYREAKTLKELKHRNLVKVLGYAWESGKLKALILEYMENGSL-ESVIHGPGVDHSRWT 113
+ E + +L H NL+++ A+ES L++EY++ G L + +I + T
Sbjct: 131 EEVKNEISVMNQLDHANLIQLYD-AFESKNDIVLVMEYVDGGELFDRIID----ESYNLT 185
Query: 114 LPKRIDVLISVANGLDYLHSGYDIPIVHCDMKPSNILLDRDFEAHV--SDFGTSRMLDVH 171
I + + G+ ++H Y I+H D+KP NIL + DFG +R
Sbjct: 186 ELDTILFMKQICEGIRHMHQMY---ILHLDLKPENILCVNRDAKQIKIIDFGLARRYK-- 240
Query: 172 LQDLSSLSTAFQGTIGYLAPEFAYMRIVTTKVDVFSFGI 210
L F GT +LAPE V+ D++S G+
Sbjct: 241 --PREKLKVNF-GTPEFLAPEVVNYDFVSFPTDMWSVGV 276
|
| >3is5_A Calcium-dependent protein kinase; CDPK, structural genomics, parasitology, structural genomics consortium, SGC, ATP-binding, nucleotide-binding; HET: ANP; 2.55A {Toxoplasma gondii} Length = 285 | Back alignment and structure |
|---|
Score = 81.9 bits (203), Expect = 3e-18
Identities = 49/190 (25%), Positives = 79/190 (41%), Gaps = 15/190 (7%)
Query: 26 STVYKGR-LEDGEIVAVKKLNFHQFSAESDKSFYREAKTLKELKHRNLVKVLGYAWESGK 84
V+ G +K +N + S + E + LK L H N++K+ +E
Sbjct: 36 GDVHLVEERSSGLERVIKTINKDR-SQVPMEQIEAEIEVLKSLDHPNIIKIFE-VFEDYH 93
Query: 85 LKALILEYMENGSLESVIHGPGVDHSRWTLPKRIDVLISVANGLDYLHSGYDIPIVHCDM 144
+++E E G L I + +++ + N L Y HS + +VH D+
Sbjct: 94 NMYIVMETCEGGELLERIVSAQARGKALSEGYVAELMKQMMNALAYFHSQH---VVHKDL 150
Query: 145 KPSNILL---DRDFEAHVSDFGTSRMLDVHLQDLSSLSTAFQGTIGYLAPEFAYMRIVTT 201
KP NIL + DFG + + + A GT Y+APE + R VT
Sbjct: 151 KPENILFQDTSPHSPIKIIDFGLAELFK----SDEHSTNAA-GTALYMAPE-VFKRDVTF 204
Query: 202 KVDVFSFGIV 211
K D++S G+V
Sbjct: 205 KCDIWSAGVV 214
|
| >4e7w_A Glycogen synthase kinase 3; GSK3, PTyr195, transferase; HET: PTR; 3.30A {Ustilago maydis} Length = 394 | Back alignment and structure |
|---|
Score = 82.8 bits (205), Expect = 4e-18
Identities = 57/225 (25%), Positives = 106/225 (47%), Gaps = 44/225 (19%)
Query: 13 SFSENNIIGNSNLSTVYKGRLEDGEIVAVKKLNFHQFSAESDKSF-YREAKTLKELKHRN 71
+++ +IGN + V++ +L + + VA+KK+ DK F RE + ++ +KH N
Sbjct: 41 AYTNCKVIGNGSFGVVFQAKLVESDEVAIKKV-------LQDKRFKNRELQIMRIVKHPN 93
Query: 72 LVKVLGYAWESGKLKA-----LILEYMENGSLESVIHGPGVDHSRWTLPKRIDVLIS--- 123
+V + + + +G K L+LEY+ ++ L + + +L+
Sbjct: 94 VVDLKAFFYSNGDKKDEVFLNLVLEYVPE-TVYRASR------HYAKLKQTMPMLLIKLY 146
Query: 124 ---VANGLDYLHSGYDIPIVHCDMKPSNILLDRD-FEAHVSDFGTSRMLDVHLQDLSSLS 179
+ L Y+HS I I H D+KP N+LLD + DFG++++L ++S +
Sbjct: 147 MYQLLRSLAYIHS---IGICHRDIKPQNLLLDPPSGVLKLIDFGSAKILIAGEPNVSYIC 203
Query: 180 TAFQGTIGYLAPEF-----AYMRIVTTKVDVFSFGIVVMEFLTKR 219
+ + Y APE Y TT +D++S G V+ E + +
Sbjct: 204 SRY-----YRAPELIFGATNY----TTNIDIWSTGCVMAELMQGQ 239
|
| >3fe3_A MAP/microtubule affinity-regulating kinase 3; serine/threonine protein kinase, MARK;PAR-1, UBA domai TAK1;P78;MARK3, ATP-binding; 1.90A {Homo sapiens} PDB: 2qnj_A 1y8g_A* 1zmw_A 1zmu_A 1zmv_A 2wzj_A 2r0i_A 2hak_A 3iec_A Length = 328 | Back alignment and structure |
|---|
Score = 81.2 bits (201), Expect = 9e-18
Identities = 59/194 (30%), Positives = 87/194 (44%), Gaps = 15/194 (7%)
Query: 20 IGNSNLSTVYKGR-LEDGEIVAVKKLNFHQFSAESDKSFYREAKTLKELKHRNLVKVLGY 78
IG N + V R + G VA+K ++ Q + S + +RE + +K L H N+VK L
Sbjct: 23 IGKGNFAKVKLARHILTGREVAIKIIDKTQLNPTSLQKLFREVRIMKILNHPNIVK-LFE 81
Query: 79 AWESGKLKALILEYMENGSLESVIHGPGVDHSRWTLPKRIDVLISVANGLDYLHSGYDIP 138
E+ K LI+EY G + + V H R + + + + Y H
Sbjct: 82 VIETEKTLYLIMEYASGGEVFDYL----VAHGRMKEKEARSKFRQIVSAVQYCHQ---KR 134
Query: 139 IVHCDMKPSNILLDRDFEAHVSDFGTSRMLDVHLQDLSSLSTAFQGTIGYLAPE-FAYMR 197
IVH D+K N+LLD D ++DFG S L F G Y APE F +
Sbjct: 135 IVHRDLKAENLLLDADMNIKIADFGFSNE----FTVGGKLDA-FCGAPPYAAPELFQGKK 189
Query: 198 IVTTKVDVFSFGIV 211
+VDV+S G++
Sbjct: 190 YDGPEVDVWSLGVI 203
|
| >2ycf_A Serine/threonine-protein kinase CHK2; transferase, anticancer, anticancer drug design; HET: YCF; 1.77A {Homo sapiens} PDB: 2yiq_A* 2w7x_A* 2ycq_A* 2ycs_A* 2w0j_A* 2yir_A* 2yit_A* 2wtj_A* 2cn8_A* 2wtc_A* 2wtd_A* 2wti_A* 2cn5_A* 2xbj_A* 2xm8_A* 2xm9_A* 2xk9_A* 2ycr_A* Length = 322 | Back alignment and structure |
|---|
Score = 80.8 bits (200), Expect = 9e-18
Identities = 50/206 (24%), Positives = 91/206 (44%), Gaps = 27/206 (13%)
Query: 19 IIGNSNLSTVYKGR-LEDGEIVAVKKLNFHQFSAESDK------SFYREAKTLKELKHRN 71
+G+ V + + VA+K ++ +F+ S + + E + LK+L H
Sbjct: 17 TLGSGACGEVKLAFERKTCKKVAIKIISKRKFAIGSAREADPALNVETEIEILKKLNHPC 76
Query: 72 LVKVLGYAWESGKLKALILEYMENGSLESVIHGPGVDHSRWTLPKRIDVLISVANGLDYL 131
++K+ + +++ ++LE ME G L + V + R + + YL
Sbjct: 77 IIKIKNF-FDAEDY-YIVLELMEGGELFDKV----VGNKRLKEATCKLYFYQMLLAVQYL 130
Query: 132 HSGYDIPIVHCDMKPSNILLD-RDFEAHV--SDFGTSRMLDVHLQDLSSLSTAFQGTIGY 188
H I+H D+KP N+LL ++ + + +DFG S++L + S + T GT Y
Sbjct: 131 HE---NGIIHRDLKPENVLLSSQEEDCLIKITDFGHSKILG----ETSLMRTLC-GTPTY 182
Query: 189 LAPE---FAYMRIVTTKVDVFSFGIV 211
LAPE VD +S G++
Sbjct: 183 LAPEVLVSVGTAGYNRAVDCWSLGVI 208
|
| >2y7j_A Phosphorylase B kinase gamma catalytic chain, testis/liver isoform; transferase; HET: B49; 2.50A {Homo sapiens} PDB: 1h0t_A 1lp1_B 1q2n_A 2spz_A 3mzw_B* 1ss1_A 2jwd_A 1bdc_A 1bdd_A 1fc2_C* 2b87_A 2b88_A 1h0t_B 1lp1_A 2b87_B 2b89_A 3s1k_A Length = 365 | Back alignment and structure |
|---|
Score = 80.9 bits (200), Expect = 1e-17
Identities = 51/208 (24%), Positives = 88/208 (42%), Gaps = 29/208 (13%)
Query: 19 IIGNSNLSTVYKGR-LEDGEIVAVK-----KLNFHQFSAESDK-SFYREAKTLKELK-HR 70
+IG S V + G AVK E + + RE L+++ H
Sbjct: 101 VIGRGVSSVVRRCVHRATGHEFAVKIMEVTAERLSPEQLEEVREATRRETHILRQVAGHP 160
Query: 71 NLVKVLGYAWESGKLKALILEYMENGSLESVIHGPGVDHSRWTLPKRIDVLISVANGLDY 130
+++ ++ ++ES L+ + M G L + + + + ++ S+ + +
Sbjct: 161 HIITLID-SYESSSFMFLVFDLMRKGELFDYL----TEKVALSEKETRSIMRSLLEAVSF 215
Query: 131 LHS-GYDIPIVHCDMKPSNILLDRDFEAHVSDFGTSRMLDVHLQDLSSLSTAFQGTIGYL 189
LH+ IVH D+KP NILLD + + +SDFG S L+ L GT GYL
Sbjct: 216 LHANN----IVHRDLKPENILLDDNMQIRLSDFGFSCH----LEPGEKLRELC-GTPGYL 266
Query: 190 APE------FAYMRIVTTKVDVFSFGIV 211
APE +VD+++ G++
Sbjct: 267 APEILKCSMDETHPGYGKEVDLWACGVI 294
|
| >1tki_A Titin; serine kinase, muscle, autoinhibition; 2.00A {Homo sapiens} SCOP: d.144.1.7 Length = 321 | Back alignment and structure |
|---|
Score = 80.4 bits (199), Expect = 1e-17
Identities = 38/195 (19%), Positives = 72/195 (36%), Gaps = 20/195 (10%)
Query: 20 IGNSNLSTVYKGR-LEDGEIVAVKKLNFHQFSAESDKSFYREAKTLKELKHRNLVKVLGY 78
+G V++ + K + +E L +HRN++ +
Sbjct: 13 LGRGEFGIVHRCVETSSKKTYMAKFVKV---KGTDQVLVKKEISILNIARHRNILHLHE- 68
Query: 79 AWESGKLKALILEYMENGSL-ESVIHGPGVDHSRWTLPKRIDVLISVANGLDYLHSGYDI 137
++ES + +I E++ + E + + + + V L +LHS
Sbjct: 69 SFESMEELVMIFEFISGLDIFERINT----SAFELNEREIVSYVHQVCEALQFLHSHN-- 122
Query: 138 PIVHCDMKPSNILLDRDFEAHV--SDFGTSRMLDVHLQDLSSLSTAFQGTIGYLAPEFAY 195
I H D++P NI+ + + +FG +R L + F Y APE
Sbjct: 123 -IGHFDIRPENIIYQTRRSSTIKIIEFGQARQLK----PGDNFRLLF-TAPEYYAPEVHQ 176
Query: 196 MRIVTTKVDVFSFGI 210
+V+T D++S G
Sbjct: 177 HDVVSTATDMWSLGT 191
|
| >1blx_A Cyclin-dependent kinase 6; inhibitor protein, cyclin-dependent kinase, cell cycle control, alpha/beta, complex (inhibitor protein/kinase); 1.90A {Homo sapiens} SCOP: d.144.1.7 PDB: 1bi7_A 1bi8_A 1g3n_A 2f2c_B* 1jow_B* 2euf_B* 1xo2_B* 3nup_A* 3nux_A* 2w9z_B 2w99_B 2w96_B 2w9f_B Length = 326 | Back alignment and structure |
|---|
Score = 80.3 bits (199), Expect = 1e-17
Identities = 50/205 (24%), Positives = 88/205 (42%), Gaps = 26/205 (12%)
Query: 27 TVYKGR--LEDGEIVAVKKLNFHQFSAESD---KSFYREAKTLKELK---HRNLVKVL-- 76
V+K R G VA+K++ + S RE L+ L+ H N+V++
Sbjct: 26 KVFKARDLKNGGRFVALKRVRVQT---GEEGMPLSTIREVAVLRHLETFEHPNVVRLFDV 82
Query: 77 --GYAWESGKLKALILEYMENGSLESVIHGPGVDHSRWTLPKRIDVLISVANGLDYLHSG 134
+ L+ E+++ L + + K + + + GLD+LHS
Sbjct: 83 CTVSRTDRETKLTLVFEHVDQ-DLTTYLDKVPEPGVPTETIKDM--MFQLLRGLDFLHSH 139
Query: 135 YDIPIVHCDMKPSNILLDRDFEAHVSDFGTSRMLDVHLQDLSSLSTAFQGTIGYLAPEFA 194
+VH D+KP NIL+ + ++DFG +R+ + L+S+ T+ Y APE
Sbjct: 140 R---VVHRDLKPQNILVTSSGQIKLADFGLARIYSFQMA-LTSVVV----TLWYRAPEVL 191
Query: 195 YMRIVTTKVDVFSFGIVVMEFLTKR 219
T VD++S G + E ++
Sbjct: 192 LQSSYATPVDLWSVGCIFAEMFRRK 216
|
| >1kob_A Twitchin; kinase, intrasteric regulation; 2.30A {Aplysia californica} SCOP: d.144.1.7 Length = 387 | Back alignment and structure |
|---|
Score = 80.9 bits (200), Expect = 2e-17
Identities = 44/219 (20%), Positives = 85/219 (38%), Gaps = 23/219 (10%)
Query: 1 RFDRTEIENATGSFSEN----NIIGNSNLSTVYKGR-LEDGEIVAVKKLNFHQFSAESDK 55
++ +E GS + +G+ V++ G + K +N
Sbjct: 36 KYVPQPVEVKQGSVYDYYDILEELGSGAFGVVHRCVEKATGRVFVAKFIN--TPYPLDKY 93
Query: 56 SFYREAKTLKELKHRNLVKVLGYAWESGKLKALILEYMENGSL-ESVIHGPGVDHSRWTL 114
+ E + +L H L+ + A+E LILE++ G L + + + + +
Sbjct: 94 TVKNEISIMNQLHHPKLINLHD-AFEDKYEMVLILEFLSGGELFDRIAA----EDYKMSE 148
Query: 115 PKRIDVLISVANGLDYLHSGYDIPIVHCDMKPSNILLDRDFEAHV--SDFGTSRMLDVHL 172
+ I+ + GL ++H IVH D+KP NI+ + + V DFG + L+
Sbjct: 149 AEVINYMRQACEGLKHMHEHS---IVHLDIKPENIMCETKKASSVKIIDFGLATKLN--- 202
Query: 173 QDLSSLSTAFQGTIGYLAPEFAYMRIVTTKVDVFSFGIV 211
+ T + APE V D+++ G++
Sbjct: 203 -PDEIVKVTT-ATAEFAAPEIVDREPVGFYTDMWAIGVL 239
|
| >3f3z_A Calcium/calmodulin-dependent protein kinase with domain and 4 calmodulin like EF...; calcium dependent protein kinase; HET: SEP DRK; 1.84A {Cryptosporidium parvum iowa II} PDB: 2qg5_A* Length = 277 | Back alignment and structure |
|---|
Score = 79.2 bits (196), Expect = 2e-17
Identities = 41/200 (20%), Positives = 74/200 (37%), Gaps = 26/200 (13%)
Query: 19 IIGNSNLSTVYKGR-LEDGEIVAVKKLNFHQFSAESDKSFYREAKTLKELKHRNLVKVLG 77
IG + V A KK+ ++ E F +E + +K L H N++++
Sbjct: 16 TIGRGSWGEVKIAVQKGTRIRRAAKKIP--KYFVEDVDRFKQEIEIMKSLDHPNIIRLYE 73
Query: 78 YAWESGKLKALILEYMENGSLESVIHGPGVDHSRWTLPKRIDVLISVANGLDYLHSGYDI 137
+E L++E G L + V + ++ V + + Y H +
Sbjct: 74 -TFEDNTDIYLVMELCTGGELFERV----VHKRVFRESDAARIMKDVLSAVAYCHK---L 125
Query: 138 PIVHCDMKPSNILL---DRDFEAHVSDFGTSRMLDVHLQDLSSLSTAFQGTIGYLAPEF- 193
+ H D+KP N L D + DFG + + T GT Y++P+
Sbjct: 126 NVAHRDLKPENFLFLTDSPDSPLKLIDFGLAARFK----PGKMMRTKV-GTPYYVSPQVL 180
Query: 194 --AYMRIVTTKVDVFSFGIV 211
Y + D +S G++
Sbjct: 181 EGLY----GPECDEWSAGVM 196
|
| >3n9x_A Phosphotransferase; malaria kinase, structural genomics, structural genomics CON SGC; 2.05A {Plasmodium berghei} PDB: 3nie_A* Length = 432 | Back alignment and structure |
|---|
Score = 80.2 bits (198), Expect = 4e-17
Identities = 52/255 (20%), Positives = 90/255 (35%), Gaps = 47/255 (18%)
Query: 34 EDGEIVAVKKLNFHQFSAESD-KSFYREAKTLKELKHRNLVKVLG--YAWESGKLKA--L 88
+ VA+KK+ F D K RE L LK ++++ + K +
Sbjct: 49 NTEKNVAIKKV-NRMFEDLIDCKRILREITILNRLKSDYIIRLYDLIIPDDLLKFDELYI 107
Query: 89 ILEYMENGSLESVIHGPGV---DHSRWTLPKRIDVLISVANGLDYLHSGYDIPIVHCDMK 145
+LE ++ L+ + P +H + +L ++ G +++H I+H D+K
Sbjct: 108 VLEIADS-DLKKLFKTPIFLTEEHIKT-------ILYNLLLGENFIHES---GIIHRDLK 156
Query: 146 PSNILLDRDFEAHVSDFGTSRMLDVHLQDLSSLSTAFQGTIG------------------ 187
P+N LL++D V DFG +R ++ G
Sbjct: 157 PANCLLNQDCSVKVCDFGLARTINSEKDTNIVNDLEENEEPGPHNKNLKKQLTSHVVTRW 216
Query: 188 YLAPE--FAYMRIVTTKVDVFSFGIVVMEFLTKRRPTGLDEEN------GLSPISLRQLV 239
Y APE T +D++S G + E L + D N G S L
Sbjct: 217 YRAPELILLQEN-YTKSIDIWSTGCIFAELLNMLQSHINDPTNRFPLFPGSSCFPLSPDR 275
Query: 240 EKALANGINGVRQIT 254
+ + Q+
Sbjct: 276 NSKKVHEKSNRDQLN 290
|
| >2h6d_A 5'-AMP-activated protein kinase catalytic subunit alpha-2; ATP-binding, cholesterol biosynthesis, fatty acid biosynthesis;kinase, lipid synthesis; 1.85A {Homo sapiens} PDB: 3aqv_A* 2yza_A* Length = 276 | Back alignment and structure |
|---|
Score = 78.4 bits (194), Expect = 4e-17
Identities = 60/225 (26%), Positives = 96/225 (42%), Gaps = 24/225 (10%)
Query: 20 IGNSNLSTVYKGR-LEDGEIVAVKKLNFHQFSAESDKS-FYREAKTLKELKHRNLVKVLG 77
+G V G G VAVK LN + + RE + LK +H +++K L
Sbjct: 19 LGVGTFGKVKIGEHQLTGHKVAVKILNRQKIRSLDVVGKIKREIQNLKLFRHPHIIK-LY 77
Query: 78 YAWESGKLKALILEYMENGSLESVIHGPGVDHSRWTLPKRIDVLISVANGLDYLHSGYDI 137
+ +++EY+ G L I H R + + + + +DY H
Sbjct: 78 QVISTPTDFFMVMEYVSGGELFDYI----CKHGRVEEMEARRLFQQILSAVDYCHRHM-- 131
Query: 138 PIVHCDMKPSNILLDRDFEAHVSDFGTSRMLDVHLQDLSSLSTAFQGTIGYLAPE-FAYM 196
+VH D+KP N+LLD A ++DFG S M + D L T G+ Y APE +
Sbjct: 132 -VVHRDLKPENVLLDAHMNAKIADFGLSNM----MSDGEFLRT-SCGSPNYAAPEVISGR 185
Query: 197 RIVTTKVDVFSFGIVVMEFLTKRRPTGLDEENGLSPISLRQLVEK 241
+VD++S G+++ L P D+E+ + L +K
Sbjct: 186 LYAGPEVDIWSCGVILYALLCGTLP--FDDEH------VPTLFKK 222
|
| >2yex_A Serine/threonine-protein kinase CHK1; transferase, cell cycle; HET: YEX; 1.30A {Homo sapiens} PDB: 2x8e_A* 2ydk_A* 2ydj_A* 2yer_A* 2ydi_A* 1nvq_A* 1nvr_A* 1nvs_A* 2wmq_A* 2wmr_A* 2wms_A* 2wmt_A* 2wmu_A* 2wmv_A* 2wmw_A* 2wmx_A* 2x8d_A* 2x8i_A* 2xey_A* 2xez_A* ... Length = 276 | Back alignment and structure |
|---|
Score = 78.0 bits (193), Expect = 7e-17
Identities = 57/199 (28%), Positives = 84/199 (42%), Gaps = 23/199 (11%)
Query: 20 IGNSNLSTVYKGR-LEDGEIVAVKKLNFHQFSAESDKSFYREAKTLKELKHRNLVKVLGY 78
+G V E VAVK ++ + + +E K L H N+VK G+
Sbjct: 15 LGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPEN-IKKEICINKMLNHENVVKFYGH 73
Query: 79 AWESGKLKALILEYMENGSLESVIHGPGVDHSRWTLPKRIDV-----LISVANGLDYLHS 133
G ++ L LEY G L I +P+ L++ G+ YLH
Sbjct: 74 -RREGNIQYLFLEYCSGGELFDRI----EPDIG--MPEPDAQRFFHQLMA---GVVYLHG 123
Query: 134 GYDIPIVHCDMKPSNILLDRDFEAHVSDFGTSRMLDVHLQDLSSLSTAFQGTIGYLAPE- 192
I I H D+KP N+LLD +SDFG + + + ++ L+ GT+ Y+APE
Sbjct: 124 ---IGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRE-RLLNK-MCGTLPYVAPEL 178
Query: 193 FAYMRIVTTKVDVFSFGIV 211
VDV+S GIV
Sbjct: 179 LKRREFHAEPVDVWSCGIV 197
|
| >2zv2_A Calcium/calmodulin-dependent protein kinase kinas; beta, camkk2, E.C.2.7.11.17, phosphorylation, AMPKK, metabolism, binding, calmodulin-binding; HET: 609; 2.40A {Homo sapiens} Length = 298 | Back alignment and structure |
|---|
Score = 77.7 bits (192), Expect = 1e-16
Identities = 57/225 (25%), Positives = 84/225 (37%), Gaps = 49/225 (21%)
Query: 20 IGNSNLSTVYKGR-LEDGEIVAVK-----KLNFHQFSAESDKSF---------------- 57
IG + V D A+K KL
Sbjct: 21 IGKGSYGVVKLAYNENDNTYYAMKVLSKKKLIRQAGFPRRPPPRGTRPAPGGCIQPRGPI 80
Query: 58 ---YREAKTLKELKHRNLVK---VLGYAWESGKLKALILEYMENGSL-ESVIHGP-GVDH 109
Y+E LK+L H N+VK VL E L ++ E + G + E P D
Sbjct: 81 EQVYQEIAILKKLDHPNVVKLVEVLDDPNED-HL-YMVFELVNQGPVMEVPTLKPLSEDQ 138
Query: 110 SRWTLPKRIDVLISVANGLDYLHSGYDIPIVHCDMKPSNILLDRDFEAHVSDFGTSRMLD 169
+R LI G++YLH I+H D+KPSN+L+ D ++DFG S
Sbjct: 139 AR----FYFQDLIK---GIEYLHY---QKIIHRDIKPSNLLVGEDGHIKIADFGVSNEFK 188
Query: 170 VHLQDLSSLSTAFQGTIGYLAPEF--AYMRIVT-TKVDVFSFGIV 211
+ LS GT ++APE +I + +DV++ G+
Sbjct: 189 ---GSDALLSN-TVGTPAFMAPESLSETRKIFSGKALDVWAMGVT 229
|
| >3c4z_A Rhodopsin kinase; Ser/Thr kinase, RGS homology domain, G protein coupled recep kinase, GRK, GRK1, P-loop, autophosphoryl ADP, ATP-binding; HET: ADP; 1.84A {Bos taurus} PDB: 3c4x_A* 3c4y_A 3c4w_A* 3c50_A* 3c51_A* 3qc9_A* 2i94_B Length = 543 | Back alignment and structure |
|---|
Score = 78.7 bits (194), Expect = 2e-16
Identities = 55/196 (28%), Positives = 94/196 (47%), Gaps = 10/196 (5%)
Query: 28 VYKGRLED-GEIVAVKKLNFHQFSAESD-KSFYREAKTLKELKHRNLVKVLGYAWESGKL 85
V+ +++ G++ A KKLN + + E K L ++ R +V L YA+E+
Sbjct: 201 VFACQMKATGKLYACKKLNKKRLKKRKGYQGAMVEKKILAKVHSRFIVS-LAYAFETKTD 259
Query: 86 KALILEYMENGSLESVIHGPGVDHSRWTLPKRIDVLISVANGLDYLHSGYDIPIVHCDMK 145
L++ M G + I+ D+ + P+ I + +GL++LH I++ D+K
Sbjct: 260 LCLVMTIMNGGDIRYHIYNVDEDNPGFQEPRAIFYTAQIVSGLEHLHQ---RNIIYRDLK 316
Query: 146 PSNILLDRDFEAHVSDFGTSRMLDVHLQDLSSLSTAFQGTIGYLAPEFAYMRIVTTKVDV 205
P N+LLD D +SD G L V L+ + + + GT G++APE VD
Sbjct: 317 PENVLLDDDGNVRISDLG----LAVELKAGQTKTKGYAGTPGFMAPELLLGEEYDFSVDY 372
Query: 206 FSFGIVVMEFLTKRRP 221
F+ G+ + E + R P
Sbjct: 373 FALGVTLYEMIAARGP 388
|
| >3tki_A Serine/threonine-protein kinase CHK1; cell checkpoint, transferase-transferase inhib complex; HET: S25; 1.60A {Homo sapiens} PDB: 2qhm_A* 2r0u_A* 3tkh_A* 2qhn_A* 2hy0_A* 2hog_A* 2hxq_A* 2hxl_A* 3f9n_A* Length = 323 | Back alignment and structure |
|---|
Score = 77.0 bits (190), Expect = 2e-16
Identities = 57/197 (28%), Positives = 82/197 (41%), Gaps = 19/197 (9%)
Query: 20 IGNSNLSTVYKGR-LEDGEIVAVKKLNFHQFSAESDKSFYREAKTLKELKHRNLVKVLGY 78
+G V E VAVK ++ + + +E K L H N+VK G+
Sbjct: 15 LGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPEN-IKKEICINKMLNHENVVKFYGH 73
Query: 79 AWESGKLKALILEYMENGSLESVIHGPGVDHSRWTLPKRIDV---LISVANGLDYLHSGY 135
G ++ L LEY G L I P L++ G+ YLH
Sbjct: 74 -RREGNIQYLFLEYCSGGELFDRI----EPDIGMPEPDAQRFFHQLMA---GVVYLHG-- 123
Query: 136 DIPIVHCDMKPSNILLDRDFEAHVSDFGTSRMLDVHLQDLSSLSTAFQGTIGYLAPE-FA 194
I I H D+KP N+LLD +SDFG + + + ++ L+ GT+ Y+APE
Sbjct: 124 -IGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRE-RLLNK-MCGTLPYVAPELLK 180
Query: 195 YMRIVTTKVDVFSFGIV 211
VDV+S GIV
Sbjct: 181 RREFHAEPVDVWSCGIV 197
|
| >3rp9_A Mitogen-activated protein kinase; structural genomics, structural genomics consortium, SGC, TR; 2.40A {Toxoplasma gondii} Length = 458 | Back alignment and structure |
|---|
Score = 77.6 bits (191), Expect = 3e-16
Identities = 55/240 (22%), Positives = 89/240 (37%), Gaps = 53/240 (22%)
Query: 27 TVYKGR-LEDGEIVAVKKLNFHQFSAESD-KSFYREAKTLKELKHRNLVKVL----GYAW 80
V + + +VA+KK+ F D K RE L L H ++VKVL
Sbjct: 68 HVCEAYDKLEKRVVAIKKI-LRVFEDLIDCKRILREIAILNRLNHDHVVKVLDIVIPKDV 126
Query: 81 ESGKLKALILEYMENGSLESVIHGPGV---DHSRWTLPKRIDVLISVANGLDYLHSGYDI 137
E ++LE ++ + + P H + +L ++ G+ Y+HS
Sbjct: 127 EKFDELYVVLEIADS-DFKKLFRTPVYLTELHIKT-------LLYNLLVGVKYVHSA--- 175
Query: 138 PIVHCDMKPSNILLDRDFEAHVSDFGTSRMLDVHLQDLSSLSTAFQGTIG---------- 187
I+H D+KP+N L+++D V DFG +R +D S L + +
Sbjct: 176 GILHRDLKPANCLVNQDCSVKVCDFGLARTVDYPENGNSQLPISPREDDMNLVTFPHTKN 235
Query: 188 -------------YLAPEF-----AYMRIVTTKVDVFSFGIVVMEFLTKRRPTGLDEENG 229
Y APE Y T +DV+S G + E L + +
Sbjct: 236 LKRQLTGHVVTRWYRAPELILLQENY----TEAIDVWSIGCIFAELLNMIKENVAYHADR 291
|
| >3nsz_A CK II alpha, casein kinase II subunit alpha; inhibitor, transferase-transferase inhibitor CO; HET: ANP; 1.30A {Homo sapiens} PDB: 2r7i_A 3pe1_A* 1jwh_A* 3pe2_A* 3r0t_A* 3h30_A* 3q9w_A* 3q9x_A* 3q9y_A* 3q9z_A* 3qa0_A 3bqc_A* 2rkp_A* 3c13_A* 3fwq_A 3rps_A* 3mb7_A* 3mb6_A* 3owj_A* 3owk_A* ... Length = 330 | Back alignment and structure |
|---|
Score = 76.2 bits (188), Expect = 5e-16
Identities = 45/221 (20%), Positives = 88/221 (39%), Gaps = 27/221 (12%)
Query: 20 IGNSNLSTVYKGR-LEDGEIVAVKKLNFHQFSAESDKSFYREAKTLKELK-HRNLVKVLG 77
+G S V++ + + E V VK L K RE K L+ L+ N++ +
Sbjct: 44 LGRGKYSEVFEAINITNNEKVVVKILK-----PVKKKKIKREIKILENLRGGPNIITLAD 98
Query: 78 YAWESGKLK-ALILEYMENGSLESVIHGPGVDHSRWTLPKRIDVLISVANGLDYLHSGYD 136
+ AL+ E++ N + + R+ + + LDY HS
Sbjct: 99 IVKDPVSRTPALVFEHVNNTDFKQLYQTLTDYDIRF-------YMYEILKALDYCHSM-- 149
Query: 137 IPIVHCDMKPSNILLDRDF-EAHVSDFGTSRMLDVHLQDLSSLSTAFQGTIGYLAPE-FA 194
I+H D+KP N+++D + + + D+G + Q+ + + PE
Sbjct: 150 -GIMHRDVKPHNVMIDHEHRKLRLIDWGLAEFYH-PGQEY----NVRVASRYFKGPELLV 203
Query: 195 YMRIVTTKVDVFSFGIVVMEFLTKRRP--TGLDEENGLSPI 233
++ +D++S G ++ + ++ P G D + L I
Sbjct: 204 DYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVRI 244
|
| >3oz6_A Mitogen-activated protein kinase 1, serine/threon protein kinase; structural genomics consortium, SGC, transferase; 2.37A {Cryptosporidium parvum iowa II} Length = 388 | Back alignment and structure |
|---|
Score = 76.6 bits (189), Expect = 5e-16
Identities = 60/212 (28%), Positives = 96/212 (45%), Gaps = 38/212 (17%)
Query: 34 EDGEIVAVKKLNFHQFSAESD-KSFYREAKTLKELK-HRNLVKVLG-YAWESGKLKALIL 90
GE+VAVKK+ F F +D + +RE L EL H N+V +L ++ + L+
Sbjct: 32 RTGEVVAVKKI-FDAFQNSTDAQRTFREIMILTELSGHENIVNLLNVLRADNDRDVYLVF 90
Query: 91 EYMENGSLESVIHGPGV--DHSRWTLPKRIDVLISVANGLDYLHSGYDIPIVHCDMKPSN 148
+YME L +VI + H ++ V+ + + YLHSG ++H DMKPSN
Sbjct: 91 DYMET-DLHAVIRANILEPVHKQY-------VVYQLIKVIKYLHSG---GLLHRDMKPSN 139
Query: 149 ILLDRDFEAHVSDFGTSRMLDVHLQDLSSLSTAFQGTIG-----------------YLAP 191
ILL+ + V+DFG SR + +++ + Y AP
Sbjct: 140 ILLNAECHVKVADFGLSRSFVNIRRVTNNIPLSINENTENFDDDQPILTDYVATRWYRAP 199
Query: 192 E--FAYMRIVTTKVDVFSFGIVVMEFLTKRRP 221
E + T +D++S G ++ E L +P
Sbjct: 200 EILLGSTK-YTKGIDMWSLGCILGEILC-GKP 229
|
| >2ac3_A MAP kinase-interacting serine/threonine kinase 2; DFD motif, transferase; 2.10A {Homo sapiens} PDB: 2hw7_A* 2ac5_A* 2hw6_A Length = 316 | Back alignment and structure |
|---|
Score = 74.6 bits (184), Expect = 1e-15
Identities = 50/220 (22%), Positives = 92/220 (41%), Gaps = 30/220 (13%)
Query: 11 TGSFSE-----NNIIGNSNLSTVYKGR-LEDGEIVAVKKLNFHQFSAESDKSFYREAKTL 64
+G F + +++G + V L + AVK + S +RE + L
Sbjct: 7 SGRFEDVYQLQEDVLGEGAHARVQTCINLITSQEYAVKIIEKQPGHIRSR--VFREVEML 64
Query: 65 KELK-HRNLVKVLGYAWESGKLKALILEYMENGSLESVIHGPGVDHSRWTLPKRIDVLIS 123
+ + HRN+++++ + +E L+ E M GS+ S I + + V+
Sbjct: 65 YQCQGHRNVLELIEF-FEEEDRFYLVFEKMRGGSILSHI----HKRRHFNELEASVVVQD 119
Query: 124 VANGLDYLHS-GYDIPIVHCDMKPSNILL---DRDFEAHVSDFGTSRMLDVHLQDLSSLS 179
VA+ LD+LH+ G I H D+KP NIL ++ + DF + ++ +
Sbjct: 120 VASALDFLHNKG----IAHRDLKPENILCEHPNQVSPVKICDFDLGSGIKLNGDCSPIST 175
Query: 180 TAFQ---GTIGYLAPE-----FAYMRIVTTKVDVFSFGIV 211
G+ Y+APE I + D++S G++
Sbjct: 176 PELLTPCGSAEYMAPEVVEAFSEEASIYDKRCDLWSLGVI 215
|
| >3kn6_A Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1, MSK, ATP-binding, metal-binding, NUCL binding, serine/threonine-protein kinase, transferase; 2.00A {Homo sapiens} PDB: 3kn5_A Length = 325 | Back alignment and structure |
|---|
Score = 74.6 bits (184), Expect = 2e-15
Identities = 43/214 (20%), Positives = 84/214 (39%), Gaps = 31/214 (14%)
Query: 11 TGSFSE-------NNIIGNSNLSTVYKGR-LEDGEIVAVKKLNFHQFSAESDKSFYREAK 62
F + + +G + S K + + AVK ++ + +E
Sbjct: 3 DSPFYQHYDLDLKDKPLGEGSFSICRKCVHKKSNQAFAVKIISKRMEANTQ-----KEIT 57
Query: 63 TLKELK-HRNLVKVLGYAWESGKLKALILEYMENGSLESVIHGPGVDHSRWTLPKRIDVL 121
LK + H N+VK+ + L++E + G L I ++ + ++
Sbjct: 58 ALKLCEGHPNIVKLHE-VFHDQLHTFLVMELLNGGELFERI----KKKKHFSETEASYIM 112
Query: 122 ISVANGLDYLHS-GYDIPIVHCDMKPSNILL---DRDFEAHVSDFGTSRMLDVHLQDLSS 177
+ + + ++H G +VH D+KP N+L + + E + DFG +R+ Q L +
Sbjct: 113 RKLVSAVSHMHDVG----VVHRDLKPENLLFTDENDNLEIKIIDFGFARLKPPDNQPLKT 168
Query: 178 LSTAFQGTIGYLAPEFAYMRIVTTKVDVFSFGIV 211
T+ Y APE D++S G++
Sbjct: 169 ----PCFTLHYAAPELLNQNGYDESCDLWSLGVI 198
|
| >4fr4_A YANK1, serine/threonine-protein kinase 32A; structural genomics, structural genomics consortium, SGC, TR; HET: STU; 2.29A {Homo sapiens} Length = 384 | Back alignment and structure |
|---|
Score = 74.7 bits (184), Expect = 2e-15
Identities = 36/101 (35%), Positives = 49/101 (48%), Gaps = 11/101 (10%)
Query: 124 VANGLDYLHSGYDIPIVHCDMKPSNILLDRDFEAHVSDFGTSRMLDVHLQDLSSLSTAFQ 183
+ LDYL + I+H DMKP NILLD H++DF + L + ++T
Sbjct: 124 LVMALDYLQN---QRIIHRDMKPDNILLDEHGHVHITDFNIAA----MLPRETQITT-MA 175
Query: 184 GTIGYLAPEFAYMRIV---TTKVDVFSFGIVVMEFLTKRRP 221
GT Y+APE R + VD +S G+ E L RRP
Sbjct: 176 GTKPYMAPEMFSSRKGAGYSFAVDWWSLGVTAYELLRGRRP 216
|
| >2y94_A 5'-AMP-activated protein kinase catalytic subunit; transferase, nucleotide-binding, staurosporine-binding, serine/threonine-protein kinase; HET: TPO STU AMP; 3.24A {Rattus norvegicus} Length = 476 | Back alignment and structure |
|---|
Score = 74.8 bits (184), Expect = 3e-15
Identities = 59/225 (26%), Positives = 98/225 (43%), Gaps = 24/225 (10%)
Query: 20 IGNSNLSTVYKGR-LEDGEIVAVKKLNFHQFSAESDKS-FYREAKTLKELKHRNLVKVLG 77
+G V G+ G VAVK LN + + RE + LK +H +++K L
Sbjct: 24 LGVGTFGKVKVGKHELTGHKVAVKILNRQKIRSLDVVGKIRREIQNLKLFRHPHIIK-LY 82
Query: 78 YAWESGKLKALILEYMENGSLESVIHGPGVDHSRWTLPKRIDVLISVANGLDYLHSGYDI 137
+ +++EY+ G L I + R + + + +G+DY H
Sbjct: 83 QVISTPSDIFMVMEYVSGGELFDYI----CKNGRLDEKESRRLFQQILSGVDYCHRHM-- 136
Query: 138 PIVHCDMKPSNILLDRDFEAHVSDFGTSRMLDVHLQDLSSLSTAFQGTIGYLAPE-FAYM 196
+VH D+KP N+LLD A ++DFG S M + D L T G+ Y APE +
Sbjct: 137 -VVHRDLKPENVLLDAHMNAKIADFGLSNM----MSDGEFLRT-SCGSPNYAAPEVISGR 190
Query: 197 RIVTTKVDVFSFGIVVMEFLTKRRPTGLDEENGLSPISLRQLVEK 241
+VD++S G+++ L P D+++ + L +K
Sbjct: 191 LYAGPEVDIWSSGVILYALLCGTLP--FDDDH------VPTLFKK 227
|
| >3dls_A PAS domain-containing serine/threonine-protein KI; PAS kinase, PASK, protein kinase, drug discovery, ATP-bindin kinase, nucleotide-binding; HET: ADP; 2.30A {Homo sapiens} Length = 335 | Back alignment and structure |
|---|
Score = 72.8 bits (179), Expect = 7e-15
Identities = 47/207 (22%), Positives = 80/207 (38%), Gaps = 34/207 (16%)
Query: 20 IGNSNLSTVYKGR-LEDGEIVAVKKLNFHQFSAESDKSF------YREAKTLKELKHRNL 72
+G+ V+ E + V VK + + + E L ++H N+
Sbjct: 32 LGSGAFGFVWTAVDKEKNKEVVVKFIKKEKVLEDCWIEDPKLGKVTLEIAILSRVEHANI 91
Query: 73 VKVLGYAWESGKLKALILEYMENGSLESVIHGPG-------VDHSRWTLPKRIDVLISVA 125
+KVL +E+ L++E HG G H R P + +
Sbjct: 92 IKVLD-IFENQGFFQLVMEK----------HGSGLDLFAFIDRHPRLDEPLASYIFRQLV 140
Query: 126 NGLDYLHSGYDIPIVHCDMKPSNILLDRDFEAHVSDFGTSRMLDVHLQDLSSLSTAFQGT 185
+ + YL I+H D+K NI++ DF + DFG++ L+ T F GT
Sbjct: 141 SAVGYLRLKD---IIHRDIKDENIVIAEDFTIKLIDFGSAAY----LERGKLFYT-FCGT 192
Query: 186 IGYLAPE-FAYMRIVTTKVDVFSFGIV 211
I Y APE +++++S G+
Sbjct: 193 IEYCAPEVLMGNPYRGPELEMWSLGVT 219
|
| >3a99_A Proto-oncogene serine/threonine-protein kinase PI; PIM-1, P27KIP1, peptide drug, prostate cancer, transferase; HET: ANP; 1.60A {Homo sapiens} PDB: 3bgq_A* 3bgp_A* 2obj_A* 3bgz_A* 3t9i_A* 3dcv_A* 1xws_A* 2xj1_A* 2xix_A* 2xiz_A* 2xj0_A* 2xiy_A* 2xj2_A* 3f2a_A* 1xr1_A* 1xqz_A* 3cy2_A* 3cxw_A* 3cy3_A* 2bik_B* ... Length = 320 | Back alignment and structure |
|---|
Score = 72.4 bits (178), Expect = 8e-15
Identities = 48/202 (23%), Positives = 81/202 (40%), Gaps = 24/202 (11%)
Query: 20 IGNSNLSTVYKGR-LEDGEIVAVKKLNFHQFSAESDKSF----YREAKTLKELKHR--NL 72
+G+ +VY G + D VA+K + + S + E LK++ +
Sbjct: 51 LGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGV 110
Query: 73 VKVLGYAWESGKLKALILEYMEN-GSLESVIHGPGVDHSRWTLPKRIDVLISVANGLDYL 131
+++L + +E LILE E L I + V + +
Sbjct: 111 IRLLDW-FERPDSFVLILERPEPVQDLFDFI----TERGALQEELARSFFWQVLEAVRHC 165
Query: 132 HSGYDIPIVHCDMKPSNILLDRD-FEAHVSDFGTSRMLDVHLQDLSSLSTAFQGTIGYLA 190
H+ ++H D+K NIL+D + E + DFG+ + L+D + + F GT Y
Sbjct: 166 HNCG---VLHRDIKDENILIDLNRGELKLIDFGSGAL----LKD-TVYTD-FDGTRVYSP 216
Query: 191 PE-FAYMRIVTTKVDVFSFGIV 211
PE Y R V+S GI+
Sbjct: 217 PEWIRYHRYHGRSAAVWSLGIL 238
|
| >3h4j_B AMPK kdaid, SNF1-like protein kinase SSP2; ATP-binding, nucleotide-binding, phosphoprotei serine/threonine-protein kinase, transferase; 2.80A {Schizosaccharomyces pombe} Length = 336 | Back alignment and structure |
|---|
Score = 72.3 bits (178), Expect = 1e-14
Identities = 59/225 (26%), Positives = 94/225 (41%), Gaps = 25/225 (11%)
Query: 20 IGNSNLSTVYKGR-LEDGEIVAVKKLNFHQFSAESDKS-FYREAKTLKELKHRNLVKVLG 77
+G + V + + VA+K ++ RE LK L+H +++K L
Sbjct: 17 LGEGSFGKVKLATHYKTQQKVALKFISRQLLKKSDMHMRVEREISYLKLLRHPHIIK-LY 75
Query: 78 YAWESGKLKALILEYMENGSLESVIHGPGVDHSRWTLPKRIDVLISVANGLDYLHSGYDI 137
+ +++EY G L I V+ R T + + ++Y H
Sbjct: 76 DVITTPTDIVMVIEYA-GGELFDYI----VEKKRMTEDEGRRFFQQIICAIEYCHRHK-- 128
Query: 138 PIVHCDMKPSNILLDRDFEAHVSDFGTSRMLDVHLQDLSSLSTAFQGTIGYLAPE-FAYM 196
IVH D+KP N+LLD + ++DFG S + + D + L T G+ Y APE
Sbjct: 129 -IVHRDLKPENLLLDDNLNVKIADFGLSNI----MTDGNFLKT-SCGSPNYAAPEVINGK 182
Query: 197 RIVTTKVDVFSFGIVVMEFLTKRRPTGLDEENGLSPISLRQLVEK 241
+VDV+S GIV+ L R P D+E + L +K
Sbjct: 183 LYAGPEVDVWSCGIVLYVMLVGRLP--FDDEF------IPNLFKK 219
|
| >3e3p_A Protein kinase, putative glycogen synthase kinase; leishmaniasis, transferase; 2.00A {Leishmania major} Length = 360 | Back alignment and structure |
|---|
Score = 71.9 bits (177), Expect = 1e-14
Identities = 49/233 (21%), Positives = 91/233 (39%), Gaps = 40/233 (17%)
Query: 8 ENATGSFSENNIIGNSNLSTVYKGRL-EDGEIVAVKKLNFHQFSAESDKSF----YREAK 62
F + G TV G+ G VA+KK+ D F + +
Sbjct: 19 RKEMDRFQVERMAGQGTFGTVQLGKEKSTGMSVAIKKV----IQ---DPRFRNRELQIMQ 71
Query: 63 TLKELKHRNLVKVLGYAWESGKLK------ALILEYMENGSLESVIHGPGVDHSRWTLPK 116
L L H N+V++ Y + G+ +++EY+ + +L + P
Sbjct: 72 DLAVLHHPNIVQLQSYFYTLGERDRRDIYLNVVMEYVPD-TLHRCCRN--YYRRQVAPPP 128
Query: 117 RIDVLIS--VANGLDYLHSGYDIPIVHCDMKPSNILLDR-DFEAHVSDFGTSRMLDVHLQ 173
+ + + + LH + + H D+KP N+L++ D + DFG+++ L
Sbjct: 129 ILIKVFLFQLIRSIGCLHL-PSVNVCHRDIKPHNVLVNEADGTLKLCDFGSAKKLSPSEP 187
Query: 174 DLSSLSTAFQGTIGYLAPE-----FAYMRIVTTKVDVFSFGIVVMEFLTKRRP 221
+++ + + + Y APE Y TT VD++S G + E + P
Sbjct: 188 NVAYICSRY-----YRAPELIFGNQHY----TTAVDIWSVGCIFAEMML-GEP 230
|
| >3eb0_A Putative uncharacterized protein; kinase cryptosporidium parvum, ATP-binding, kinase, nucleoti binding; HET: PTR DRK; 2.65A {Cryptosporidium parvum iowa II} Length = 383 | Back alignment and structure |
|---|
Score = 71.3 bits (175), Expect = 3e-14
Identities = 56/264 (21%), Positives = 106/264 (40%), Gaps = 76/264 (28%)
Query: 8 ENATGSFSENNIIGNSNLSTVYKGR-LEDGEIVAVKKLNFHQFSAESDKSF-YREAKTLK 65
E ++ +S +G + V + +E G+ A+KK+ D + RE +K
Sbjct: 3 ETSSKKYSLGKTLGTGSFGIVCEVFDIESGKRFALKKV-------LQDPRYKNRELDIMK 55
Query: 66 ELKHRNLVKVLGYAWESGKLKA-------------------------------------L 88
L H N++K++ Y + +G + +
Sbjct: 56 VLDHVNIIKLVDYFYTTGDEEPKPPQPPDDHNKLGGKNNGVNNHHKSVIVNPSQNKYLNV 115
Query: 89 ILEYMENGSLESVIHGPGVDHSRWTLPKRIDVLIS-----VANGLDYLHSGYDIPIVHCD 143
I+EY+ + +L V+ S ++P LIS + + ++HS + I H D
Sbjct: 116 IMEYVPD-TLHKVLKS--FIRSGRSIP---MNLISIYIYQLFRAVGFIHS---LGICHRD 166
Query: 144 MKPSNILLD-RDFEAHVSDFGTSRMLDVHLQDLSSLSTAFQGTIGYLAPEF-----AYMR 197
+KP N+L++ +D + DFG+++ L ++ + + F Y APE Y
Sbjct: 167 IKPQNLLVNSKDNTLKLCDFGSAKKLIPSEPSVAYICSRF-----YRAPELMLGATEY-- 219
Query: 198 IVTTKVDVFSFGIVVMEFLTKRRP 221
T +D++S G V E + +P
Sbjct: 220 --TPSIDLWSIGCVFGELIL-GKP 240
|
| >3fhr_A MAP kinase-activated protein kinase 3; kinase-inhibitor complex, ATP-binding, cytoplasm, nucleotide-binding, nucleus, phosphoprotein, polymorphism; HET: P4O; 1.90A {Homo sapiens} PDB: 3fxw_A* 3r1n_A* 3she_A* 2oza_A 3fyk_X* 3fyj_X* 2p3g_X* 3ka0_A* 3fpm_A* 2pzy_A* 3a2c_A* 3kc3_A* 3gok_A* 2jbo_A* 2jbp_A* 3r2y_A* 3r30_A* 3r2b_A* Length = 336 | Back alignment and structure |
|---|
Score = 70.8 bits (174), Expect = 3e-14
Identities = 43/214 (20%), Positives = 83/214 (38%), Gaps = 31/214 (14%)
Query: 11 TGSFSENNIIGNSNL-----STVYKGR-LEDGEIVAVKKLNFHQFSAESDKSFYREAKTL 64
+ +++ + L V + G+ A+K L +E
Sbjct: 23 KYAVTDDYQLSKQVLGLGVNGKVLECFHRRTGQKCALKLLY-------DSPKARQEVDHH 75
Query: 65 KEL-KHRNLVKVLGY---AWESGKLKALILEYMENGSLESVIHGPGVDHSRWTLPKRIDV 120
+ ++V +L + +I+E ME G L S I G +T + ++
Sbjct: 76 WQASGGPHIVCILDVYENMHHGKRCLLIIMECMEGGELFSRIQERG--DQAFTEREAAEI 133
Query: 121 LISVANGLDYLHSGYDIPIVHCDMKPSNILL-DRDFEAHV--SDFGTSRMLDVHLQDLSS 177
+ + + +LHS I H D+KP N+L ++ +A + +DFG ++ + +
Sbjct: 134 MRDIGTAIQFLHS---HNIAHRDVKPENLLYTSKEKDAVLKLTDFGFAKETTQN-----A 185
Query: 178 LSTAFQGTIGYLAPEFAYMRIVTTKVDVFSFGIV 211
L T T Y+APE D++S G++
Sbjct: 186 LQTP-CYTPYYVAPEVLGPEKYDKSCDMWSLGVI 218
|
| >2acx_A G protein-coupled receptor kinase 6; GRK, G transferase; HET: ANP; 2.60A {Homo sapiens} PDB: 3nyn_A* 3nyo_A* Length = 576 | Back alignment and structure |
|---|
Score = 71.7 bits (176), Expect = 3e-14
Identities = 54/198 (27%), Positives = 90/198 (45%), Gaps = 17/198 (8%)
Query: 28 VYKGRLED-GEIVAVKKLNFHQFSAESD-KSFYREAKTLKELKHRNLVKVLGYAWESGKL 85
V ++ G++ A KKL + E + L+++ R +V L YA+E+
Sbjct: 200 VCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKQILEKVNSRFVVS-LAYAYETKDA 258
Query: 86 KALILEYMENGSLESVIHGPGVDHSRWTLPKRIDVLISVANGLDYLHSGYDIPIVHCDMK 145
L+L M G L+ I+ G + + + + + GL+ LH IV+ D+K
Sbjct: 259 LCLVLTLMNGGDLKFHIYHMG--QAGFPEARAVFYAAEICCGLEDLHRER---IVYRDLK 313
Query: 146 PSNILLDRDFEAHV--SDFGTSRMLDVHLQDLSSLSTAFQGTIGYLAPEFAYMRIVTTKV 203
P NILLD H+ SD G L VH+ + ++ GT+GY+APE T
Sbjct: 314 PENILLDDH--GHIRISDLG----LAVHVPEGQTIKG-RVGTVGYMAPEVVKNERYTFSP 366
Query: 204 DVFSFGIVVMEFLTKRRP 221
D ++ G ++ E + + P
Sbjct: 367 DWWALGCLLYEMIAGQSP 384
|
| >3pvu_A Beta-adrenergic receptor kinase 1; transferase, serine/threonine-protein kinase, ATP-binding, I membrane; HET: QRW; 2.48A {Bos taurus} PDB: 3psc_A* 3pvw_A* 1omw_A 1ym7_A 2bcj_A* 3cik_A 3krw_A* 3krx_A* 1bak_A Length = 695 | Back alignment and structure |
|---|
Score = 71.5 bits (175), Expect = 4e-14
Identities = 45/201 (22%), Positives = 77/201 (38%), Gaps = 39/201 (19%)
Query: 36 GEIVAVKKLNFHQFSAESDKSFYREAKTLKE---------LKHRNLVKVLGYAWESGKLK 86
G++ A+K L+ + + E L E +V + YA+ +
Sbjct: 214 GKMYAMKCLDKKRIKMKQG-----ETLALNERIMLSLVSTGDCPFIVC-MSYAFHTPDKL 267
Query: 87 ALILEYMENGSLESVIHGPGVDHSRWTLPKRIDVLISVANGLDYLHSGYDIPIVHCDMKP 146
+ IL+ M G L + H ++ + GL+++H+ +V+ D+KP
Sbjct: 268 SFILDLMNGGDLHYHLS----QHGVFSEADMRFYAAEIILGLEHMHN---RFVVYRDLKP 320
Query: 147 SNILLDRDFEAHVSDFGTSRMLDVHLQDLSSLSTAFQGTIGYLAPEFAYMRIVTTK---- 202
+NILLD +SD G + A GT GY+APE ++
Sbjct: 321 ANILLDEHGHVRISDLGLACDFS------KKKPHASVGTHGYMAPE-----VLQKGVAYD 369
Query: 203 --VDVFSFGIVVMEFLTKRRP 221
D FS G ++ + L P
Sbjct: 370 SSADWFSLGCMLFKLLRGHSP 390
|
| >1uu3_A HPDK1, 3-phosphoinositide dependent protein kinase-1; PKB, inhibitor, LY333531, diabetes, cancer, transferase, serine/threonine-protein kinase; HET: SEP LY4; 1.7A {Homo sapiens} SCOP: d.144.1.7 PDB: 1okz_A* 1oky_A* 1uu7_A* 1uu8_A* 2biy_A* 3rwp_A* 2xch_A* 3rwq_A* 3sc1_A* 3qd0_A* 2r7b_A* 3ion_A* 3qcq_A* 3qcs_A* 3qcx_A* 3qcy_A* 3iop_A* 3qd3_A* 3qd4_A* 3h9o_A* ... Length = 310 | Back alignment and structure |
|---|
Score = 70.3 bits (173), Expect = 4e-14
Identities = 56/220 (25%), Positives = 89/220 (40%), Gaps = 45/220 (20%)
Query: 11 TGSFSENNIIGNSNLSTVYKGRL-EDGEIVAVKKLNFHQFSAESD-KSFYREAKTLKELK 68
GSFS TV R A+K L E+ RE + L
Sbjct: 40 EGSFS-----------TVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLD 88
Query: 69 HRNLVKVLGYAWESGKLKALILEYMENGSLESVIHGPGVDHSRWTLPKRIDVLIS----- 123
H VK L + ++ + L Y +NG L I G D +
Sbjct: 89 HPFFVK-LYFTFQDDEKLYFGLSYAKNGELLKYIRKIG----------SFDETCTRFYTA 137
Query: 124 -VANGLDYLHSGYDIPIVHCDMKPSNILLDRDFEAHVSDFGTSRMLDVHLQDLSSLSTAF 182
+ + L+YLH I+H D+KP NILL+ D ++DFGT+++L + + S F
Sbjct: 138 EIVSALEYLHG---KGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANS--F 192
Query: 183 QGTIGYLAPEFAYMRIVTTK-----VDVFSFGIVVMEFLT 217
GT Y++PE ++T K D+++ G ++ + +
Sbjct: 193 VGTAQYVSPE-----LLTEKSACKSSDLWALGCIIYQLVA 227
|
| >2iwi_A Serine/threonine-protein kinase PIM-2; nucleotide-binding, cancer, leukemia, transferase, ATP-binding, proto- oncogene, phosphorylation; HET: HB1; 2.80A {Homo sapiens} Length = 312 | Back alignment and structure |
|---|
Score = 70.0 bits (172), Expect = 6e-14
Identities = 46/204 (22%), Positives = 76/204 (37%), Gaps = 26/204 (12%)
Query: 20 IGNSNLSTVYKGR-LEDGEIVAVKKLN----FHQFSAESDKSFYREAKTLKEL----KHR 70
+G TV+ G L D VA+K + + E L ++ H
Sbjct: 39 LGKGGFGTVFAGHRLTDRLQVAIKVIPRNRVLGWSPLSDSVTCPLEVALLWKVGAGGGHP 98
Query: 71 NLVKVLGYAWESGKLKALILEYMENGS-LESVIHGPGVDHSRWTLPKRIDVLISVANGLD 129
++++L + +E+ + L+LE L I + V +
Sbjct: 99 GVIRLLDW-FETQEGFMLVLERPLPAQDLFDYI----TEKGPLGEGPSRCFFGQVVAAIQ 153
Query: 130 YLHSGYDIPIVHCDMKPSNILLDRD-FEAHVSDFGTSRMLDVHLQDLSSLSTAFQGTIGY 188
+ HS +VH D+K NIL+D A + DFG+ + L D + F GT Y
Sbjct: 154 HCHSRG---VVHRDIKDENILIDLRRGCAKLIDFGSGAL----LHD-EPYTD-FDGTRVY 204
Query: 189 LAPE-FAYMRIVTTKVDVFSFGIV 211
PE + + V+S GI+
Sbjct: 205 SPPEWISRHQYHALPATVWSLGIL 228
|
| >3uc3_A Serine/threonine-protein kinase SRK2I; SNRK2, ABA signaling, transferase; 1.90A {Arabidopsis thaliana} PDB: 3zut_A 3zuu_A 3uc4_A 3ujg_A 3udb_A Length = 361 | Back alignment and structure |
|---|
Score = 69.3 bits (170), Expect = 1e-13
Identities = 54/199 (27%), Positives = 80/199 (40%), Gaps = 26/199 (13%)
Query: 20 IGNSNLSTVYKGR-LEDGEIVAVKKLNFHQFSAESDKSFYREAKTLKELKHRNLVKVLGY 78
IG+ N R E+VAVK + D++ RE + L+H N+V+
Sbjct: 28 IGSGNFGVARLMRDKLTKELVAVKYIERGAAI---DENVQREIINHRSLRHPNIVR-FKE 83
Query: 79 AWESGKLKALILEYMENGSLESVIHGPGVDHSRWTLP---KRIDVLISVANGLDYLHSGY 135
+ A+I+EY G L I + R++ L+S G+ Y HS
Sbjct: 84 VILTPTHLAIIMEYASGGELYERI----CNAGRFSEDEARFFFQQLLS---GVSYCHS-- 134
Query: 136 DIPIVHCDMKPSNILLDRDFEAH--VSDFGTSRMLDVHLQDLSSLSTAFQGTIGYLAPE- 192
+ I H D+K N LLD + DFG S+ +H S + GT Y+APE
Sbjct: 135 -MQICHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLH----SQPKS-TVGTPAYIAPEV 188
Query: 193 FAYMRIVTTKVDVFSFGIV 211
DV+S G+
Sbjct: 189 LLRQEYDGKIADVWSCGVT 207
|
| >1nxk_A MAP kinase-activated protein kinase 2; MK2, phosphorylation, staurosporine, transfe; HET: STU; 2.70A {Homo sapiens} SCOP: d.144.1.7 PDB: 1kwp_A* 1ny3_A* 2onl_C Length = 400 | Back alignment and structure |
|---|
Score = 69.0 bits (169), Expect = 2e-13
Identities = 45/201 (22%), Positives = 84/201 (41%), Gaps = 25/201 (12%)
Query: 19 IIGNSNLSTVYKGR-LEDGEIVAVKKLNFHQFSAESDKSFYREAKTLKEL-KHRNLVKVL 76
++G V + E A+K L + RE + + ++V+++
Sbjct: 69 VLGLGINGKVLQIFNKRTQEKFALKML-------QDCPKARREVELHWRASQCPHIVRIV 121
Query: 77 GYAWESGKLKA---LILEYMENGSLESVIHGPGVDHSRWTLPKRIDVLISVANGLDYLHS 133
+ +++E ++ G L S I G +T + +++ S+ + YLHS
Sbjct: 122 DVYENLYAGRKCLLIVMECLDGGELFSRIQDRG--DQAFTEREASEIMKSIGEAIQYLHS 179
Query: 134 GYDIPIVHCDMKPSNILL-DRDFEAHV--SDFGTSRMLDVHLQDLSSLSTAFQGTIGYLA 190
I I H D+KP N+L + A + +DFG ++ H +SL+T T Y+A
Sbjct: 180 ---INIAHRDVKPENLLYTSKRPNAILKLTDFGFAKETTSH----NSLTT-PCYTPYYVA 231
Query: 191 PEFAYMRIVTTKVDVFSFGIV 211
PE D++S G++
Sbjct: 232 PEVLGPEKYDKSCDMWSLGVI 252
|
| >2qr7_A Ribosomal protein S6 kinase alpha-3; kinase domain, RSK2, autoinhibitory, ATP-binding, nucleotide phosphorylation, serine/threonine-protein kinase; 2.00A {Mus musculus} PDB: 2qr8_A 4d9t_A* 4d9u_A* 3rny_A 2wnt_A Length = 342 | Back alignment and structure |
|---|
Score = 68.1 bits (167), Expect = 3e-13
Identities = 47/212 (22%), Positives = 90/212 (42%), Gaps = 30/212 (14%)
Query: 11 TGSFSEN----NIIGNSNLSTVYKGR-LEDGEIVAVKKLNFHQFSAESDKSFYREAKTL- 64
+ F++ IG + S + AVK ++ +S + E + L
Sbjct: 17 SIQFTDGYEVKEDIGVGSYSVCKRCIHKATNMEFAVKIID------KSKRDPTEEIEILL 70
Query: 65 KELKHRNLVKVLGYAWESGKLKALILEYMENGSLESVIHGPGVDHSRWTLPKRIDVLISV 124
+ +H N++ + ++ GK ++ E M+ G L I + ++ + VL ++
Sbjct: 71 RYGQHPNIITLKD-VYDDGKYVYVVTELMKGGELLDKI----LRQKFFSEREASAVLFTI 125
Query: 125 ANGLDYLHS-GYDIPIVHCDMKPSNILLDRDFEAH----VSDFGTSRMLDVHLQDLSSLS 179
++YLH+ G +VH D+KPSNIL + + DFG ++ L + L
Sbjct: 126 TKTVEYLHAQG----VVHRDLKPSNILYVDESGNPESIRICDFGFAKQLR---AENGLLM 178
Query: 180 TAFQGTIGYLAPEFAYMRIVTTKVDVFSFGIV 211
T T ++APE + D++S G++
Sbjct: 179 TPC-YTANFVAPEVLERQGYDAACDIWSLGVL 209
|
| >2vd5_A DMPK protein; serine/threonine-protein kinase, kinase, transferase, ATP-BI nucleotide-binding, cardiac contractility, muscle different; HET: BI8; 2.80A {Homo sapiens} Length = 412 | Back alignment and structure |
|---|
Score = 67.8 bits (166), Expect = 5e-13
Identities = 53/224 (23%), Positives = 87/224 (38%), Gaps = 43/224 (19%)
Query: 19 IIGNSNLSTVYKGRLED-GEIVAVKKLNFHQFSAESDKSFYREAKT-LKELKHRNLVKVL 76
+IG S V +++ G++ A+K +N + S +RE + L R + + L
Sbjct: 68 VIGRGAFSEVAVVKMKQTGQVYAMKIMNKWDMLKRGEVSCFREERDVLVNGDRRWITQ-L 126
Query: 77 GYAWESGKLKALILEYMENGSLESVIHGPGVDHSRWTLPKRIDVLIS----------VAN 126
+A++ L++EY G L TL + I +
Sbjct: 127 HFAFQDENYLYLVMEYYVGGDL-------------LTLLSKFGERIPAEMARFYLAEIVM 173
Query: 127 GLDYLHSGYDIPIVHCDMKPSNILLDRDFEAHV--SDFGTSRMLDVHLQDLSSLSTAFQG 184
+D +H + VH D+KP NILLDR H+ +DFG+ L D + S G
Sbjct: 174 AIDSVHR---LGYVHRDIKPDNILLDRC--GHIRLADFGSCLKLRA---DGTVRSLVAVG 225
Query: 185 TIGYLAPE-------FAYMRIVTTKVDVFSFGIVVMEFLTKRRP 221
T YL+PE + D ++ G+ E + P
Sbjct: 226 TPDYLSPEILQAVGGGPGTGSYGPECDWWALGVFAYEMFYGQTP 269
|
| >4aw2_A Serine/threonine-protein kinase MRCK alpha; transferase, CDC42BPA; HET: 22E; 1.70A {Rattus norvegicus} PDB: 3tku_A* 3qfv_A* Length = 437 | Back alignment and structure |
|---|
Score = 67.9 bits (166), Expect = 5e-13
Identities = 46/211 (21%), Positives = 85/211 (40%), Gaps = 50/211 (23%)
Query: 34 EDGEIVAVKKLNFHQFSAESDKSFYREAKT-LKELKHRNLVKVLGYAWESGKLKALILEY 92
++ A+K LN + ++ + +RE + L + + L YA++ L+++Y
Sbjct: 97 NADKVFAMKILNKWEMLKRAETACFREERDVLVNGDSKWITT-LHYAFQDDNNLYLVMDY 155
Query: 93 MENGSLESVIHGPGVDHSRWTLPKRIDVLIS----------VANGLDYLHSGYDIPIVHC 142
G L TL + + + + +D +H + VH
Sbjct: 156 YVGGDL-------------LTLLSKFEDRLPEEMARFYLAEMVIAIDSVHQ---LHYVHR 199
Query: 143 DMKPSNILLDRDFEAHV--SDFGTSRMLDVHLQDLSSLSTAFQGTIGYLAPEFAYMRIVT 200
D+KP NIL+D + H+ +DFG+ L ++D + S+ GT Y++PE I+
Sbjct: 200 DIKPDNILMDMN--GHIRLADFGSCLKL---MEDGTVQSSVAVGTPDYISPE-----ILQ 249
Query: 201 TK----------VDVFSFGIVVMEFLTKRRP 221
D +S G+ + E L P
Sbjct: 250 AMEGGKGRYGPECDWWSLGVCMYEMLYGETP 280
|
| >3vhe_A Vascular endothelial growth factor receptor 2; kinase domain, kinase, transferase-transferase inhibitor COM; HET: 42Q; 1.55A {Homo sapiens} PDB: 1y6a_A* 1y6b_A* 3vid_A* 3hng_A* Length = 359 | Back alignment and structure |
|---|
Score = 67.3 bits (164), Expect = 6e-13
Identities = 42/182 (23%), Positives = 71/182 (39%), Gaps = 44/182 (24%)
Query: 124 VANGLDYLHSGYDIPIVHCDMKPSNILLDRDFEAHVSDFGTSRMLDVHLQDLSSLSTAFQ 183
VA G+++L S +H D+ NILL + DFG +R D+ +
Sbjct: 202 VAKGMEFLAS---RKCIHRDLAARNILLSEKNVVKICDFGLAR-------DIYKDPDYVR 251
Query: 184 GTIGYL-----APEFAYMRIVTTKVDVFSFGIVVMEFLTKRRPTGLDEENGLSP---ISL 235
L APE + R+ T + DV+SFG+++ E + G SP + +
Sbjct: 252 KGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSL----------GASPYPGVKI 301
Query: 236 RQLVEKALANGINGVRQITDPKLVSSIYEEQEQHQVLEELFKLALVCTSSNPEDRPNMNE 295
+ + L G ++ P + E+++ L C P RP +E
Sbjct: 302 DEEFCRRLKEG----TRMRAPDYTT------------PEMYQTMLDCWHGEPSQRPTFSE 345
Query: 296 LL 297
L+
Sbjct: 346 LV 347
|
| >3vhe_A Vascular endothelial growth factor receptor 2; kinase domain, kinase, transferase-transferase inhibitor COM; HET: 42Q; 1.55A {Homo sapiens} PDB: 1y6a_A* 1y6b_A* 3vid_A* 3hng_A* Length = 359 | Back alignment and structure |
|---|
Score = 52.2 bits (125), Expect = 6e-08
Identities = 33/204 (16%), Positives = 60/204 (29%), Gaps = 37/204 (18%)
Query: 27 TVYKGRL------EDGEIVAVKKLNFHQFSAESDKSFYREAKTLKEL-KHRNLVKVLGYA 79
V + VAVK L + ++ E K L + H N+V +LG
Sbjct: 37 QVIEADAFGIDKTATCRTVAVKMLK-EGATHSEHRALMSELKILIHIGHHLNVVNLLGAC 95
Query: 80 WESGKLKALILEYMENGSLESVIHGPGVDHSRWTLPKRIDVLISVANGLDYLHSGYDIPI 139
+ G +I+E+ + G+L + + R G DY+ +
Sbjct: 96 TKPGGPLMVIVEFCKFGNLSTYLR-----SKRNEFVPYKTKGARFRQGKDYVGA------ 144
Query: 140 VHCDMKPSNILLDRDFEAHVSDFGTSRMLDVHLQDLSSLSTAFQGTIGYLAPEFAYMRIV 199
+ D+K + + G + + +
Sbjct: 145 IPVDLKRRLDSI--TSSQSSASSGFVEEKSLSDVE-------------EEEAPEDLYKDF 189
Query: 200 TTKVDVFSFGIVV---MEFLTKRR 220
T + + V MEFL R+
Sbjct: 190 LTLEHLICYSFQVAKGMEFLASRK 213
|
| >3v8s_A RHO-associated protein kinase 1; dimerization, myosin, transferase, inhibitor, transf transferase inhibitor complex; HET: 0HD; 2.29A {Homo sapiens} PDB: 3tv7_A* 2etr_A* 2esm_A* 2eto_A* 2etk_A* 3d9v_A* 3ncz_A* 3ndm_A* 2v55_A* 2f2u_A* 2h9v_A* Length = 410 | Back alignment and structure |
|---|
Score = 67.0 bits (164), Expect = 9e-13
Identities = 52/230 (22%), Positives = 92/230 (40%), Gaps = 55/230 (23%)
Query: 11 TGSFSENNIIGNSNLSTVYKGRLED-GEIVAVKKLNFHQFSAESDKSFYREAKT-LKELK 68
G+F E V R + ++ A+K L+ + SD +F+ E + +
Sbjct: 79 RGAFGE-----------VQLVRHKSTRKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFAN 127
Query: 69 HRNLVKVLGYAWESGKLKALILEYMENGSLESVIHGPGVDHSRWTLPKRIDVLISVAN-- 126
+V+ L YA++ + +++EYM G L L DV A
Sbjct: 128 SPWVVQ-LFYAFQDDRYLYMVMEYMPGGDL-------------VNLMSNYDVPEKWARFY 173
Query: 127 ------GLDYLHSGYDIPIVHCDMKPSNILLDRDFEAHVSDFGTSRMLDVHLQDLSSLST 180
LD +HS + +H D+KP N+LLD+ ++DFGT ++ ++
Sbjct: 174 TAEVVLALDAIHS---MGFIHRDVKPDNMLLDKSGHLKLADFGTCMKMN---KEGMVRCD 227
Query: 181 AFQGTIGYLAPEFAYMRIVTTK---------VDVFSFGIVVMEFLTKRRP 221
GT Y++PE ++ ++ D +S G+ + E L P
Sbjct: 228 TAVGTPDYISPE-----VLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTP 272
|
| >4ejn_A RAC-alpha serine/threonine-protein kinase; AKT1, autoinhibition, allosteric inhibitor, kinase inhibitor hydrophobic collapase, ATPase; HET: 0R4; 2.19A {Homo sapiens} PDB: 3o96_A* Length = 446 | Back alignment and structure |
|---|
Score = 63.2 bits (154), Expect = 2e-11
Identities = 50/196 (25%), Positives = 87/196 (44%), Gaps = 13/196 (6%)
Query: 34 EDGEIVAVKKLNFHQFSAESD-KSFYREAKTLKELKHRNLVKVLGYAWESGKLKALILEY 92
G A+K L A+ + E + L+ +H L L Y++++ ++EY
Sbjct: 171 ATGRYYAMKILKKEVIVAKDEVAHTLTENRVLQNSRHPFLTA-LKYSFQTHDRLCFVMEY 229
Query: 93 MENGSLESVIHGPGVDHSRWTLPKRIDVLISVANGLDYLHSGYDIPIVHCDMKPSNILLD 152
G L + ++ + + + LDYLHS ++ V+ D+K N++LD
Sbjct: 230 ANGGELFFHLSRER----VFSEDRARFYGAEIVSALDYLHSEKNV--VYRDLKLENLMLD 283
Query: 153 RDFEAHVSDFGTSRMLDVHLQDLSSLSTAFQGTIGYLAPEFAYMRIVTTKVDVFSFGIVV 212
+D ++DFG + ++D +++ T F GT YLAPE VD + G+V+
Sbjct: 284 KDGHIKITDFGLCKE---GIKDGATMKT-FCGTPEYLAPEVLEDNDYGRAVDWWGLGVVM 339
Query: 213 MEFLTKRRP-TGLDEE 227
E + R P D E
Sbjct: 340 YEMMCGRLPFYNQDHE 355
|
| >1vzo_A Ribosomal protein S6 kinase alpha 5; protein kinase, transferase, phosphorylation, serine/threonine protein kinase; 1.8A {Homo sapiens} SCOP: d.144.1.7 Length = 355 | Back alignment and structure |
|---|
Score = 58.5 bits (142), Expect = 5e-10
Identities = 38/112 (33%), Positives = 57/112 (50%), Gaps = 23/112 (20%)
Query: 127 GLDYLHSGYDIPIVHCDMKPSNILLDRDFEAHV--SDFGTSRMLDVHLQDLSSLSTAFQG 184
L++LH + I++ D+K NILLD + HV +DFG S+ + D + + F G
Sbjct: 171 ALEHLHK---LGIIYRDIKLENILLDSN--GHVVLTDFGLSK---EFVADETERAYDFCG 222
Query: 185 TIGYLAPEFAYMRIVTTK-------VDVFSFGIVVMEFLTKRRP-TGLDEEN 228
TI Y+AP+ IV VD +S G+++ E LT P T E+N
Sbjct: 223 TIEYMAPD-----IVRGGDSGHDKAVDWWSLGVLMYELLTGASPFTVDGEKN 269
|
| >3pfq_A PKC-B, PKC-beta, protein kinase C beta type; phosphorylation, transferase; HET: TPO SEP ANP; 4.00A {Rattus norvegicus} PDB: 1tbn_A 1tbo_A 2e73_A Length = 674 | Back alignment and structure |
|---|
Score = 58.9 bits (142), Expect = 7e-10
Identities = 42/143 (29%), Positives = 70/143 (48%), Gaps = 16/143 (11%)
Query: 88 LILEYMENGSLESVIHGPGVDHSRWTLPKRIDVLISVANGLDYLHSGYDIPIVHCDMKPS 147
++EY+ G L I G R+ P + +A GL +L S I++ D+K
Sbjct: 419 FVMEYVNGGDLMYHIQQVG----RFKEPHAVFYAAEIAIGLFFLQS---KGIIYRDLKLD 471
Query: 148 NILLDRDFEAHV--SDFGTSRMLDVHLQDLSSLSTAFQGTIGYLAPEFAYMRIVTTKVDV 205
N++LD + H+ +DFG + ++ D + T F GT Y+APE + VD
Sbjct: 472 NVMLDSE--GHIKIADFGMCKE---NIWDGVTTKT-FCGTPDYIAPEIIAYQPYGKSVDW 525
Query: 206 FSFGIVVMEFLTKRRP-TGLDEE 227
++FG+++ E L + P G DE+
Sbjct: 526 WAFGVLLYEMLAGQAPFEGEDED 548
|
| >1o6l_A RAC-beta serine/threonine protein kinase; protein kinase, transferase, serine/threonine-protein kinase; HET: TPO ANP; 1.6A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jdo_A* 2jdr_A* 2uw9_A* 2x37_A* 2x39_A* 2xh5_A* 3d0e_A* 3e87_A* 3e88_A* 3e8d_A* 1o6k_A* 1mrv_A 1mry_A 1gzn_A 1gzk_A 1gzo_A 3qkl_A* 3ocb_A* 3ow4_A* 3qkk_A* ... Length = 337 | Back alignment and structure |
|---|
Score = 58.0 bits (141), Expect = 8e-10
Identities = 35/112 (31%), Positives = 57/112 (50%), Gaps = 22/112 (19%)
Query: 124 VANGLDYLHSGYDIPIVHCDMKPSNILLDRDFEAHV--SDFGTSRMLDVHLQDLSSLSTA 181
+ + L+YLHS +V+ D+K N++LD+D H+ +DFG + + D +++ T
Sbjct: 114 IVSALEYLHS---RDVVYRDIKLENLMLDKD--GHIKITDFGLCKE---GISDGATMKT- 164
Query: 182 FQGTIGYLAPEFAYMRIVTTK-----VDVFSFGIVVMEFLTKRRP-TGLDEE 227
F GT YLAPE ++ VD + G+V+ E + R P D E
Sbjct: 165 FCGTPEYLAPE-----VLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHE 211
|
| >3a62_A Ribosomal protein S6 kinase beta-1; kinase domain, inactive, active, ribosomal S6 kinase, activation, alternative initiation, ATP-binding; HET: TPO STU; 2.35A {Homo sapiens} PDB: 3a61_A* 3a60_A* Length = 327 | Back alignment and structure |
|---|
Score = 56.8 bits (138), Expect = 2e-09
Identities = 35/109 (32%), Positives = 53/109 (48%), Gaps = 22/109 (20%)
Query: 127 GLDYLHSGYDIPIVHCDMKPSNILLDRDFEAHV--SDFGTSRMLDVHLQDLSSLSTAFQG 184
L +LH I++ D+KP NI+L+ HV +DFG + + D + T F G
Sbjct: 133 ALGHLHQ---KGIIYRDLKPENIMLNHQ--GHVKLTDFGLCK---ESIHDGTVTHT-FCG 183
Query: 185 TIGYLAPEFAYMRIVTTK-----VDVFSFGIVVMEFLTKRRP-TGLDEE 227
TI Y+APE I+ VD +S G ++ + LT P TG + +
Sbjct: 184 TIEYMAPE-----ILMRSGHNRAVDWWSLGALMYDMLTGAPPFTGENRK 227
|
| >3g51_A Ribosomal protein S6 kinase alpha-3; N-terminal kinase domain of P90 ribosomal S6 kinase 2, ATP- binding, nucleotide-binding, phosphoprotein; HET: ANP; 1.80A {Mus musculus} PDB: 2z7q_A* 2z7r_A* 2z7s_A* Length = 325 | Back alignment and structure |
|---|
Score = 56.8 bits (138), Expect = 2e-09
Identities = 37/109 (33%), Positives = 57/109 (52%), Gaps = 22/109 (20%)
Query: 127 GLDYLHSGYDIPIVHCDMKPSNILLDRDFEAHV--SDFGTSRMLDVHLQDLSSLSTAFQG 184
LD+LHS + I++ D+KP NILLD + H+ +DFG S+ + + F G
Sbjct: 138 ALDHLHS---LGIIYRDLKPENILLDEE--GHIKLTDFGLSK---ESIDHEKKAYS-FCG 188
Query: 185 TIGYLAPEFAYMRIVTTK-----VDVFSFGIVVMEFLTKRRP-TGLDEE 227
T+ Y+APE +V + D +SFG+++ E LT P G D +
Sbjct: 189 TVEYMAPE-----VVNRRGHTQSADWWSFGVLMFEMLTGTLPFQGKDRK 232
|
| >1rdq_E PKA C-alpha, CAMP-dependent protein kinase, alpha-catalytic SU; CAMP-dependent protein kinase,catalytic mechanism, ATP hydro two nucleotide states; HET: TPO SEP ADP ATP; 1.26A {Mus musculus} SCOP: d.144.1.7 PDB: 2erz_E* 3fjq_E* 1bkx_A* 1atp_E* 1fmo_E* 1j3h_A* 1jlu_E* 1bx6_A* 1re8_A* 1rej_A* 1rek_A* 2cpk_E* 2qcs_A* 2qvs_E* 1l3r_E* 3idb_A* 3idc_A* 3o7l_D* 3ow3_A* 3tnp_C* ... Length = 350 | Back alignment and structure |
|---|
Score = 56.9 bits (138), Expect = 2e-09
Identities = 39/166 (23%), Positives = 76/166 (45%), Gaps = 31/166 (18%)
Query: 60 EAKTLKELKHRNLVKVLGYAWESGKLKALILEYMENGSLESVIHGPGV---DHSRWTLPK 116
E + L+ + LVK L ++++ +++EY+ G + S + G H+R+
Sbjct: 91 EKRILQAVNFPFLVK-LEFSFKDNSNLYMVMEYVAGGEMFSHLRRIGRFSEPHARF---- 145
Query: 117 RIDVLISVANGLDYLHSGYDIPIVHCDMKPSNILLDRDFEAHVSDFGTSRMLDVHLQDLS 176
+ +YLHS + +++ D+KP N+L+D+ V+DFG ++ +
Sbjct: 146 ---YAAQIVLTFEYLHS---LDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVK------- 192
Query: 177 SLSTAFQGTIGYLAPEFAYMRIVTTK-----VDVFSFGIVVMEFLT 217
+ GT LAPE I+ +K VD ++ G+++ E
Sbjct: 193 GRTWTLCGTPEALAPE-----IILSKGYNKAVDWWALGVLIYEMAA 233
|
| >1xjd_A Protein kinase C, theta type; PKC-theta, ATP, AMP,, transferase; HET: TPO SEP STU; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jed_A* Length = 345 | Back alignment and structure |
|---|
Score = 56.5 bits (137), Expect = 2e-09
Identities = 44/143 (30%), Positives = 70/143 (48%), Gaps = 16/143 (11%)
Query: 88 LILEYMENGSLESVIHGPGVDHSRWTLPKRIDVLISVANGLDYLHSGYDIPIVHCDMKPS 147
++EY+ G L I ++ L + + GL +LHS IV+ D+K
Sbjct: 95 FVMEYLNGGDLMYHIQSCH----KFDLSRATFYAAEIILGLQFLHS---KGIVYRDLKLD 147
Query: 148 NILLDRDFEAHV--SDFGTSRMLDVHLQDLSSLSTAFQGTIGYLAPEFAYMRIVTTKVDV 205
NILLD+ + H+ +DFG + ++ + +T F GT Y+APE + VD
Sbjct: 148 NILLDK--DGHIKIADFGMCKE---NMLGDAKTNT-FCGTPDYIAPEILLGQKYNHSVDW 201
Query: 206 FSFGIVVMEFLTKRRP-TGLDEE 227
+SFG+++ E L + P G DEE
Sbjct: 202 WSFGVLLYEMLIGQSPFHGQDEE 224
|
| >1fot_A TPK1 delta, CAMP-dependent protein kinase type 1; open conformation, transferase; HET: TPO; 2.80A {Saccharomyces cerevisiae} SCOP: d.144.1.7 Length = 318 | Back alignment and structure |
|---|
Score = 56.0 bits (136), Expect = 3e-09
Identities = 35/101 (34%), Positives = 55/101 (54%), Gaps = 24/101 (23%)
Query: 124 VANGLDYLHSGYDIPIVHCDMKPSNILLDRDFEAHV--SDFGTSRMLDVHLQDLSSLSTA 181
V L+YLHS I++ D+KP NILLD++ H+ +DFG ++ + ++
Sbjct: 115 VCLALEYLHS---KDIIYRDLKPENILLDKN--GHIKITDFGFAKYVP-------DVTYT 162
Query: 182 FQGTIGYLAPEFAYMRIVTTK-----VDVFSFGIVVMEFLT 217
GT Y+APE +V+TK +D +SFGI++ E L
Sbjct: 163 LCGTPDYIAPE-----VVSTKPYNKSIDWWSFGILIYEMLA 198
|
| >2r5t_A Serine/threonine-protein kinase SGK1; AGC protein kinase, apoptosis, ATP-binding, cytoplasm, endoplasmic reticulum, nucleotide-binding, nucleus; HET: ANP; 1.90A {Homo sapiens} PDB: 3hdm_A* 3hdn_A* Length = 373 | Back alignment and structure |
|---|
Score = 56.1 bits (136), Expect = 3e-09
Identities = 38/100 (38%), Positives = 54/100 (54%), Gaps = 11/100 (11%)
Query: 124 VANGLDYLHSGYDIPIVHCDMKPSNILLDRDFEAHV--SDFGTSRMLDVHLQDLSSLSTA 181
+A+ L YLHS + IV+ D+KP NILLD H+ +DFG + +++ S+ ST
Sbjct: 148 IASALGYLHS---LNIVYRDLKPENILLDSQ--GHIVLTDFGLCKE---NIEHNSTTST- 198
Query: 182 FQGTIGYLAPEFAYMRIVTTKVDVFSFGIVVMEFLTKRRP 221
F GT YLAPE + + VD + G V+ E L P
Sbjct: 199 FCGTPEYLAPEVLHKQPYDRTVDWWCLGAVLYEMLYGLPP 238
|
| >2i0e_A Protein kinase C-beta II; serine/threonine protein kinase, transferase; HET: TPO SEP PDS; 2.60A {Homo sapiens} PDB: 3iw4_A* Length = 353 | Back alignment and structure |
|---|
Score = 55.7 bits (135), Expect = 4e-09
Identities = 34/107 (31%), Positives = 57/107 (53%), Gaps = 12/107 (11%)
Query: 124 VANGLDYLHSGYDIPIVHCDMKPSNILLDRDFEAHV--SDFGTSRMLDVHLQDLSSLSTA 181
+A GL +L S I++ D+K N++LD + H+ +DFG + ++ D + T
Sbjct: 130 IAIGLFFLQS---KGIIYRDLKLDNVMLDSE--GHIKIADFGMCKE---NIWDGVTTKT- 180
Query: 182 FQGTIGYLAPEFAYMRIVTTKVDVFSFGIVVMEFLTKRRP-TGLDEE 227
F GT Y+APE + VD ++FG+++ E L + P G DE+
Sbjct: 181 FCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQAPFEGEDED 227
|
| >1q8y_A SR protein kinase; transferase; HET: ADP ADE; 2.05A {Saccharomyces cerevisiae} SCOP: d.144.1.7 PDB: 1q8z_A 1q97_A* 1q99_A* 1how_A 2jd5_A Length = 373 | Back alignment and structure |
|---|
Score = 55.9 bits (135), Expect = 4e-09
Identities = 24/101 (23%), Positives = 42/101 (41%), Gaps = 23/101 (22%)
Query: 127 GLDYLHSGYDIPIVHCDMKPSNILLDRDFEAH------VSDFGTSRMLDVHLQDLSSLST 180
GLDY+H I+H D+KP N+L++ ++D G + D H + + T
Sbjct: 143 GLDYMHR--RCGIIHTDIKPENVLMEIVDSPENLIQIKIADLGNACWYDEHYTNS--IQT 198
Query: 181 AFQGTIGYLAPE----FAYMRIVTTKVDVFSFGIVVMEFLT 217
Y +PE + D++S ++ E +T
Sbjct: 199 RE-----YRSPEVLLGAPW----GCGADIWSTACLIFELIT 230
|
| >4dc2_A Protein kinase C IOTA type; kinase, substrate, cell polarity, atypical PKC, trans transferase substrate complex; HET: TPO ADE; 2.40A {Mus musculus} Length = 396 | Back alignment and structure |
|---|
Score = 54.7 bits (132), Expect = 1e-08
Identities = 38/170 (22%), Positives = 71/170 (41%), Gaps = 30/170 (17%)
Query: 124 VANGLDYLHSGYDIPIVHCDMKPSNILLDRDFEAHV--SDFGTSRMLDVHLQDLSSLSTA 181
++ L+YLH I++ D+K N+LLD E H+ +D+G + L+ + ST
Sbjct: 162 ISLALNYLHE---RGIIYRDLKLDNVLLDS--EGHIKLTDYGMCKE---GLRPGDTTST- 212
Query: 182 FQGTIGYLAPEFAYMRIVTTKVDVFSFGIVVMEFLTKRRPTGLDEENGLSPISLRQLVEK 241
F GT Y+APE VD ++ G+++ E + G SP + +
Sbjct: 213 FCGTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMA-----------GRSPFDIVGSSDN 261
Query: 242 ALANGINGV-RQITDPKLVSSIYEEQEQHQVLEELFKLALVCTSSNPEDR 290
N + + + I + ++ + VL+ +P++R
Sbjct: 262 PDQNTEDYLFQVILEKQIRIPRSLSVKAASVLKSFLN-------KDPKER 304
|
| >3txo_A PKC-L, NPKC-ETA, protein kinase C ETA type; phosphotransferase, transferase-transferase inhibito; HET: TPO 07U; 2.05A {Homo sapiens} Length = 353 | Back alignment and structure |
|---|
Score = 54.2 bits (131), Expect = 1e-08
Identities = 30/112 (26%), Positives = 53/112 (47%), Gaps = 22/112 (19%)
Query: 124 VANGLDYLHSGYDIPIVHCDMKPSNILLDRDFEAHV--SDFGTSRMLDVHLQDLSSLSTA 181
+ + L +LH I++ D+K N+LLD + H +DFG + + + + +T
Sbjct: 133 IISALMFLHDK---GIIYRDLKLDNVLLDHE--GHCKLADFGMCKE---GICNGVTTAT- 183
Query: 182 FQGTIGYLAPEFAYMRIVTTK-----VDVFSFGIVVMEFLTKRRP-TGLDEE 227
F GT Y+APE I+ VD ++ G+++ E L P +E+
Sbjct: 184 FCGTPDYIAPE-----ILQEMLYGPAVDWWAMGVLLYEMLCGHAPFEAENED 230
|
| >3a8x_A Protein kinase C IOTA type; transferase; HET: TPO; 2.00A {Homo sapiens} PDB: 3a8w_A* 1zrz_A* Length = 345 | Back alignment and structure |
|---|
Score = 54.2 bits (131), Expect = 2e-08
Identities = 38/167 (22%), Positives = 69/167 (41%), Gaps = 30/167 (17%)
Query: 127 GLDYLHSGYDIPIVHCDMKPSNILLDRDFEAHV--SDFGTSRMLDVHLQDLSSLSTAFQG 184
L+YLH I++ D+K N+LLD E H+ +D+G + L+ + ST F G
Sbjct: 122 ALNYLHE---RGIIYRDLKLDNVLLDS--EGHIKLTDYGMCKE---GLRPGDTTST-FCG 172
Query: 185 TIGYLAPEFAYMRIVTTKVDVFSFGIVVMEFLTKRRPTGLDEENGLSPISLRQLVEKALA 244
T Y+APE VD ++ G+++ E + G SP + +
Sbjct: 173 TPNYIAPEILRGEDYGFSVDWWALGVLMFEMMA-----------GRSPFDIVGSSDNPDQ 221
Query: 245 NGINGV-RQITDPKLVSSIYEEQEQHQVLEELFKLALVCTSSNPEDR 290
N + + + I + ++ + VL+ +P++R
Sbjct: 222 NTEDYLFQVILEKQIRIPRSLSVKAASVLKSFLN-------KDPKER 261
|
| >3m2w_A MAP kinase-activated protein kinase 2; small molecule inhibitor, spiroazetidine-tetracycle, ATP-SIT inhibitor, novartis compound NVP-BXS169; HET: L8I; 2.41A {Homo sapiens} PDB: 3kga_A* 3m42_A* Length = 299 | Back alignment and structure |
|---|
Score = 52.3 bits (126), Expect = 4e-08
Identities = 33/153 (21%), Positives = 63/153 (41%), Gaps = 20/153 (13%)
Query: 19 IIGNSNLSTVYKGR-LEDGEIVAVKKLNFHQFSAESDKSFYREAKTLKEL-KHRNLVKVL 76
++G V + E A+K L + RE + + ++V+++
Sbjct: 25 VLGLGINGKVLQIFNKRTQEKFALKML-------QDCPKARREVELHWRASQCPHIVRIV 77
Query: 77 GYAWESGKLKA---LILEYMENGSLESVIHGPGVDHSRWTLPKRIDVLISVANGLDYLHS 133
+ +++E ++ G L S I G +T + +++ S+ + YLHS
Sbjct: 78 DVYENLYAGRKCLLIVMECLDGGELFSRIQDRG--DQAFTEREASEIMKSIGEAIQYLHS 135
Query: 134 GYDIPIVHCDMKPSNILL-DRDFEAHV--SDFG 163
I I H D+KP N+L + A + +DFG
Sbjct: 136 ---INIAHRDVKPENLLYTSKRPNAILKLTDFG 165
|
| >2vx3_A Dual specificity tyrosine-phosphorylation- regula kinase 1A; serine/threonine-protein kinase, minibrain homolog, nucleotide-binding, transferase; HET: PTR D15 P6G; 2.40A {Homo sapiens} PDB: 2wo6_A* 3anq_A* 3anr_A* Length = 382 | Back alignment and structure |
|---|
Score = 50.9 bits (122), Expect = 2e-07
Identities = 28/102 (27%), Positives = 48/102 (47%), Gaps = 20/102 (19%)
Query: 123 SVANGLDYLHSGYDIPIVHCDMKPSNILLDRDFEAH--VSDFGTSRMLDVHLQDLSS-LS 179
+ L +L + ++ I+HCD+KP NILL + + DFG+S L Q + +
Sbjct: 165 QMCTALLFLATP-ELSIIHCDLKPENILLCNPKRSAIKIVDFGSSCQLG---QRIYQYIQ 220
Query: 180 TAFQGTIGYLAPE----FAYMRIVTTKVDVFSFGIVVMEFLT 217
+ F Y +PE Y +D++S G +++E T
Sbjct: 221 SRF-----YRSPEVLLGMPY----DLAIDMWSLGCILVEMHT 253
|
| >3kvw_A DYRK2, dual specificity tyrosine-phosphorylation-regulat 2; KI-(Y)-phosphorylation REG kinase 2, PSK-H2, kinase, structural genomics consortium; HET: SEP PTR IRB; 2.28A {Homo sapiens} PDB: 3k2l_A* Length = 429 | Back alignment and structure |
|---|
Score = 50.9 bits (122), Expect = 2e-07
Identities = 32/98 (32%), Positives = 45/98 (45%), Gaps = 14/98 (14%)
Query: 123 SVANGLDYLHSGYDIPIVHCDMKPSNILL--DRDFEAHVSDFGTSRMLDVHLQDLSS-LS 179
S+ LD LH I+HCD+KP NILL V DFG+S Q + + +
Sbjct: 208 SILQCLDALH---KNRIIHCDLKPENILLKQQGRSGIKVIDFGSSCYEH---QRVYTYIQ 261
Query: 180 TAFQGTIGYLAPEFAYMRIVTTKVDVFSFGIVVMEFLT 217
+ F Y APE +D++S G ++ E LT
Sbjct: 262 SRF-----YRAPEVILGARYGMPIDMWSLGCILAELLT 294
|
| >2vuw_A Serine/threonine-protein kinase haspin; cell cycle, transferase, CAsp8, nucleotide binding; HET: MSE 5ID MPD; 1.80A {Homo sapiens} PDB: 3f2n_A* 3e7v_A* 3dlz_A* 3fmd_A* 3iq7_A* 2wb8_A Length = 336 | Back alignment and structure |
|---|
Score = 45.6 bits (107), Expect = 8e-06
Identities = 28/225 (12%), Positives = 55/225 (24%), Gaps = 59/225 (26%)
Query: 20 IGNSNLSTVYKGRLEDGEIVAVKKLNFHQFSAE------SDKSFYREAKTLKEL------ 67
IG V++ D VA+K + + + E KEL
Sbjct: 28 IGEGVFGEVFQTIA-DHTPVAIKIIAIEGPDLVNGSHQKTFEEILPEIIISKELSLLSGE 86
Query: 68 ---KHRNLVKVLG-------------YAWESGKLKA----------------LILEYMEN 95
+ + + AW+ ++LE+
Sbjct: 87 VCNRTEGFIGLNSVHCVQGSYPPLLLKAWDHYNSTKGSANDRPDFFKDDQLFIVLEFEFG 146
Query: 96 GSLESVIHGPGVDHSRWTLPKRIDVLISVANGLDYLHSGYDIPIVHCDMKPSNILLDRDF 155
G + +L +L + L + H D+ N+LL +
Sbjct: 147 GIDLEQMR-----TKLSSLATAKSILHQLTASLAVAEASLR--FEHRDLHWGNVLLKKTS 199
Query: 156 EAHVSDFGTSRM-------LDVHLQDLSSLSTAFQGTIGYLAPEF 193
+ + L V + D + G + +
Sbjct: 200 LKKLHYTLNGKSSTIPSCGLQVSIIDYTLSRLERDGIVVFCDVSM 244
|
| >2eu9_A Dual specificity protein kinase CLK3; kinase domain, transferase; 1.53A {Homo sapiens} PDB: 2wu6_A* 2wu7_A* 3raw_A* 2exe_A 3nr9_A* Length = 355 | Back alignment and structure |
|---|
Score = 45.0 bits (107), Expect = 1e-05
Identities = 23/117 (19%), Positives = 42/117 (35%), Gaps = 41/117 (35%)
Query: 126 NGLDYLHSGYDIPIVHCDMKPSNILLDRDFEAH-------------------VSDFGTSR 166
+ L +LH + + H D+KP NIL V+DFG++
Sbjct: 134 HALRFLH---ENQLTHTDLKPENILFVNSEFETLYNEHKSCEEKSVKNTSIRVADFGSAT 190
Query: 167 MLDVHLQDLSS-LSTAFQGTIGYLAPEFAYMRIV-----TTKVDVFSFGIVVMEFLT 217
+ ++ ++T Y PE ++ DV+S G ++ E+
Sbjct: 191 FDH---EHHTTIVATRH-----YRPPE-----VILELGWAQPCDVWSIGCILFEYYR 234
|
| >2izr_A Casein kinase I isoform gamma-3; serine/threonine-protein kinase, transferase, ATP- binding, phosphorylation, nucleotide-binding; HET: BRK; 1.3A {Homo sapiens} PDB: 2izs_A* 2izt_A* 2izu_A* 2chl_A* 2c47_A* 2cmw_A* Length = 330 | Back alignment and structure |
|---|
Score = 44.7 bits (106), Expect = 1e-05
Identities = 42/160 (26%), Positives = 66/160 (41%), Gaps = 31/160 (19%)
Query: 20 IGNSNLSTVYKGR-LEDGEIVAVKKLNFHQFSAESDKS----FYREAKTLKELKH-RNLV 73
IG N + G+ L E VA+K E KS + E + K+L +
Sbjct: 17 IGCGNFGELRLGKNLYTNEYVAIK--------LEPMKSRAPQLHLEYRFYKQLGSGDGIP 68
Query: 74 KVLGYAWESGKLKALILEYMENG-SLESVIHGPGVDHSRWTLPKRIDVLISVANGLDYLH 132
+V + GK A++LE + G SLE + S T+ LIS ++Y+H
Sbjct: 69 QVYYFGPC-GKYNAMVLELL--GPSLEDLFDLCDRTFSLKTVLMIAIQLISR---MEYVH 122
Query: 133 S-GYDIPIVHCDMKPSNILLDRDFEA-----HVSDFGTSR 166
S ++ D+KP N L+ R H+ DF ++
Sbjct: 123 SKNL----IYRDVKPENFLIGRPGNKTQQVIHIIDFALAK 158
|
| >3uzp_A CKI-delta, CKID, casein kinase I isoform delta; CK1D, inhibitor, PF670462, transferase-transferase I complex; HET: 0CK; 1.94A {Homo sapiens} PDB: 3uys_A* 3uyt_A* 1cki_A 1ckj_A Length = 296 | Back alignment and structure |
|---|
Score = 44.7 bits (106), Expect = 2e-05
Identities = 34/158 (21%), Positives = 70/158 (44%), Gaps = 27/158 (17%)
Query: 20 IGNSNLSTVYKGR-LEDGEIVAVKKLNFHQFSAESDKS----FYREAKTLKELKH-RNLV 73
IG+ + +Y G + GE VA+K E K+ + E+K K ++ +
Sbjct: 17 IGSGSFGDIYLGTDIAAGEEVAIKL--------ECVKTKHPQLHIESKIYKMMQGGVGIP 68
Query: 74 KVLGYAWESGKLKALILEYMENG-SLESVIHGPGVDHSRWTLPKRIDVLISVANGLDYLH 132
+ E G +++E + G SLE + + +++L + + + + ++Y+H
Sbjct: 69 TIRWCGAE-GDYNVMVMELL--GPSLEDLFNFCSR---KFSLKTVLLLADQMISRIEYIH 122
Query: 133 SGYDIPIVHCDMKPSNILLDRDFEAH---VSDFGTSRM 167
S +H D+KP N L+ + + + DFG ++
Sbjct: 123 SKN---FIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKK 157
|
| >1z57_A Dual specificity protein kinase CLK1; protein tyrosine kinase, splicing, human, 10Z-hymendialdisine, structural genomics; HET: DBQ; 1.70A {Homo sapiens} PDB: 2vag_A* Length = 339 | Back alignment and structure |
|---|
Score = 44.6 bits (106), Expect = 2e-05
Identities = 25/117 (21%), Positives = 44/117 (37%), Gaps = 41/117 (35%)
Query: 126 NGLDYLHSGYDIPIVHCDMKPSNILLDRDFEAHVS-------------------DFGTSR 166
+++LH + H D+KP NIL + DFG++
Sbjct: 129 KSVNFLH---SNKLTHTDLKPENILFVQSDYTEAYNPKIKRDERTLINPDIKVVDFGSAT 185
Query: 167 MLDVHLQDLSS-LSTAFQGTIGYLAPEFAYMRIV-----TTKVDVFSFGIVVMEFLT 217
D + S+ +ST Y APE ++ + DV+S G +++E+
Sbjct: 186 YDD---EHHSTLVSTRH-----YRAPE-----VILALGWSQPCDVWSIGCILIEYYL 229
|
| >2jii_A Serine/threonine-protein kinase VRK3 molecule: VA related kinase 3; transferase, pseudo kinase domain, vaccinia related kinase, ATP-binding; 2.00A {Homo sapiens} Length = 352 | Back alignment and structure |
|---|
Score = 44.0 bits (104), Expect = 3e-05
Identities = 33/199 (16%), Positives = 73/199 (36%), Gaps = 39/199 (19%)
Query: 12 GSFSENNIIGNSNLSTVYKGRLEDGEIVAVK----------KLNFHQFSAESDKSFYREA 61
+ + + ST+ + ++K + NF Q +A+ + +
Sbjct: 53 DNQGI--LYEAAPTSTLTCDSGPQKQKFSLKLDAKDGRLFNEQNFFQRAAKPLQ--VNKW 108
Query: 62 KTLKELKHRNLVKVLGYAWESGKLKALILEYMENG-SLESVIHGPGVDHSRWTLPKR--- 117
K L + +G+ K + L+L + G SL+S + + L +R
Sbjct: 109 KKLYSTPLLAIPTCMGFGVHQDKYRFLVLPSL--GRSLQSALD----VSPKHVLSERSVL 162
Query: 118 --IDVLISVANGLDYLHS-GYDIPIVHCDMKPSNILLDRDFEAHV--SDFGTS---RMLD 169
L+ L++LH Y VH ++ NI +D + ++ V + +G +
Sbjct: 163 QVACRLLDA---LEFLHENEY----VHGNVTAENIFVDPEDQSQVTLAGYGFAFRYCPSG 215
Query: 170 VHLQDLSSLSTAFQGTIGY 188
H+ + + +G + +
Sbjct: 216 KHVAYVEGSRSPHEGDLEF 234
|
| >1wak_A Serine/threonine-protein kinase SPRK1; SRPK, transferase, alternative splicing, ATP-binding, chromosome partition, differentiation, mRNA processing; 1.73A {Homo sapiens} PDB: 1wbp_A* 3beg_A* 2x7g_A* Length = 397 | Back alignment and structure |
|---|
Score = 43.4 bits (102), Expect = 5e-05
Identities = 28/156 (17%), Positives = 46/156 (29%), Gaps = 44/156 (28%)
Query: 108 DHSRWTLPKRIDVLISVANGLDYLHSGYDIPIVHCDMKPSNILLDRD------------- 154
++ LP ++ V GLDYLH+ I+H D+KP NILL +
Sbjct: 139 NYQGLPLPCVKKIIQQVLQGLDYLHT--KCRIIHTDIKPENILLSVNEQYIRRLAAEATE 196
Query: 155 --------------------FEAHVSDFGTSRMLDVHLQDLSSLSTAFQG---------T 185
+ + + + ++ L A T
Sbjct: 197 WQRSGAPPPSGSAVSTAPATAGNFLVNPLEPKNAEKLKVKIADLGNACWVHKHFTEDIQT 256
Query: 186 IGYLAPEFAYMRIVTTKVDVFSFGIVVMEFLTKRRP 221
Y + E T D++S + E T
Sbjct: 257 RQYRSLEVLIGSGYNTPADIWSTACMAFELATGDYL 292
|
| >3sv0_A Casein kinase I-like; typical kinase domain fold, cytosol, transferase; 2.00A {Oryza sativa japonica group} Length = 483 | Back alignment and structure |
|---|
Score = 43.1 bits (101), Expect = 7e-05
Identities = 35/156 (22%), Positives = 69/156 (44%), Gaps = 25/156 (16%)
Query: 20 IGNSNLSTVYKGR-LEDGEIVAVKKLNFHQFSAESDKS----FYREAKTLKELKHRNLVK 74
IG+ + +Y G ++ E VA+K E+ K+ E+K + L+ +
Sbjct: 15 IGSGSFGEIYLGTNIQTNEEVAIKL--------ENVKTKHPQLLYESKIYRILQGGTGIP 66
Query: 75 VLGYAWESGKLKALILEYMENG-SLESVIHGPGVDHSRWTLPKRIDVLISVANGLDYLHS 133
+ + G L+++ + G SLE + + S T+ D +I+ ++++HS
Sbjct: 67 NVRWFGVEGDYNVLVMDLL--GPSLEDLFNFCSRKLSLKTVLMLADQMINR---VEFVHS 121
Query: 134 GYDIPIVHCDMKPSNILLDRDFEAH---VSDFGTSR 166
+H D+KP N L+ A+ + DFG ++
Sbjct: 122 ---KSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAK 154
|
| >3llt_A Serine/threonine kinase-1, pflammer; lammer kinase, malaria, structural GE structural genomics consortium, SGC, transferase; HET: ANP; 2.50A {Plasmodium falciparum 3D7} Length = 360 | Back alignment and structure |
|---|
Score = 41.9 bits (99), Expect = 1e-04
Identities = 28/123 (22%), Positives = 41/123 (33%), Gaps = 47/123 (38%)
Query: 126 NGLDYLHSGYDIPIVHCDMKPSNILLDRDFEAHVS------------------------- 160
L+YL + + H D+KP NILLD +
Sbjct: 148 KALNYLR---KMSLTHTDLKPENILLDDPYFEKSLITVRRVTDGKKIQIYRTKSTGIKLI 204
Query: 161 DFGTSRMLDVHLQDLSS-LSTAFQGTIGYLAPEFAYMRIV-----TTKVDVFSFGIVVME 214
DFG + S ++T Y APE ++ D++SFG V+ E
Sbjct: 205 DFGCATFKS---DYHGSIINTRQ-----YRAPE-----VILNLGWDVSSDMWSFGCVLAE 251
Query: 215 FLT 217
T
Sbjct: 252 LYT 254
|
| >1csn_A Casein kinase-1; phosphotransferase; HET: ATP; 2.00A {Schizosaccharomyces pombe} SCOP: d.144.1.7 PDB: 1eh4_A* 2csn_A* Length = 298 | Back alignment and structure |
|---|
Score = 40.4 bits (95), Expect = 3e-04
Identities = 36/161 (22%), Positives = 64/161 (39%), Gaps = 31/161 (19%)
Query: 20 IGNSNLSTVYKGR-LEDGEIVAVKKLNFHQFSAESDKS----FYREAKTLKELKH-RNLV 73
IG + +++G L + + VA+K E +S E +T K L +
Sbjct: 18 IGEGSFGVIFEGTNLLNNQQVAIKF--------EPRRSDAPQLRDEYRTYKLLAGCTGIP 69
Query: 74 KVLGYAWESGKLKALILEYMENG-SLESVIHGPGVDHSRWTLPKRIDVLISVANGLDYLH 132
V + E G L+++ + G SLE ++ G S T+ +++ + +H
Sbjct: 70 NVYYFGQE-GLHNVLVIDLL--GPSLEDLLDLCGRKFSVKTVAMAAKQMLAR---VQSIH 123
Query: 133 S-GYDIPIVHCDMKPSNILLDRDFEA-----HVSDFGTSRM 167
V+ D+KP N L+ R +V DFG +
Sbjct: 124 EKSL----VYRDIKPDNFLIGRPNSKNANMIYVVDFGMVKF 160
|
| >3op5_A Serine/threonine-protein kinase VRK1; adenosine triphosphate, amino acid sequence, binding sites, domain, models, molecular; HET: REB; 2.40A {Homo sapiens} PDB: 2lav_A 2kty_A 2kul_A Length = 364 | Back alignment and structure |
|---|
Score = 39.8 bits (93), Expect = 7e-04
Identities = 31/169 (18%), Positives = 55/169 (32%), Gaps = 31/169 (18%)
Query: 20 IGNSNLSTVYKGRLEDGEIVAVKKLNFHQFSAESDKSFYREAKTLKELKHRNLV------ 73
IG +Y + E V + + + E K + +
Sbjct: 43 IGQGGFGCIYLADMNSSESVGSDAPCVVKVEPSDNGPLFTELKFYQRAAKPEQIQKWIRT 102
Query: 74 ---------KVLGYAWESGKLK---ALILEYMENG-SLESVIHGPGVDHSRWTLPKRIDV 120
K G K +I++ G L+ + SR T+ +
Sbjct: 103 RKLKYLGVPKYWGSGLHDKNGKSYRFMIMDRF--GSDLQKIYEANAKRFSRKTVLQLSLR 160
Query: 121 LISVANGLDYLHS-GYDIPIVHCDMKPSNILLDRDFEAHV--SDFGTSR 166
++ + L+Y+H Y VH D+K SN+LL+ V D+G +
Sbjct: 161 ILDI---LEYIHEHEY----VHGDIKASNLLLNYKNPDQVYLVDYGLAY 202
|
Structure Templates Detected by HHsearch
Original result of HHsearch against PDB70 database
| ID | Alignment Graph | Length |
Definition |
Probability |
| Query | 299 | |||
| 4b9d_A | 350 | Serine/threonine-protein kinase NEK1; transferase, | 100.0 | |
| 4fih_A | 346 | Serine/threonine-protein kinase PAK 4; kinase doma | 100.0 | |
| 4aw0_A | 311 | HPDK1, 3-phosphoinositide-dependent protein kinase | 100.0 | |
| 3fpq_A | 290 | Serine/threonine-protein kinase WNK1; protein seri | 100.0 | |
| 3hyh_A | 275 | Carbon catabolite-derepressing protein kinase; kin | 100.0 | |
| 4fie_A | 423 | Serine/threonine-protein kinase PAK 4; kinase doma | 100.0 | |
| 3ubd_A | 304 | Ribosomal protein S6 kinase alpha-3; kinase-inhibi | 100.0 | |
| 3omv_A | 307 | RAF proto-oncogene serine/threonine-protein kinas; | 100.0 | |
| 4g3f_A | 336 | NF-kappa-beta-inducing kinase; non-RD kinase, prot | 100.0 | |
| 4asz_A | 299 | BDNF/NT-3 growth factors receptor; transferase, TR | 100.0 | |
| 4b99_A | 398 | Mitogen-activated protein kinase 7; transferase, i | 100.0 | |
| 4aoj_A | 329 | High affinity nerve growth factor receptor; transf | 100.0 | |
| 4g31_A | 299 | Eukaryotic translation initiation factor 2-alpha; | 100.0 | |
| 4gt4_A | 308 | Tyrosine-protein kinase transmembrane receptor RO; | 100.0 | |
| 4ase_A | 353 | Vascular endothelial growth factor receptor 2; tra | 100.0 | |
| 4f9c_A | 361 | Cell division cycle 7-related protein kinase; Ser/ | 100.0 | |
| 3hmm_A | 303 | TGF-beta receptor type-1; ALK5, kinase, inhibitor, | 100.0 | |
| 3v5w_A | 689 | G-protein coupled receptor kinase 2; inhibitor com | 100.0 | |
| 3uto_A | 573 | Twitchin; kinase, muscle sarcomere, transferase; H | 100.0 | |
| 3fe3_A | 328 | MAP/microtubule affinity-regulating kinase 3; seri | 100.0 | |
| 3uim_A | 326 | Brassinosteroid insensitive 1-associated receptor; | 100.0 | |
| 3zgw_A | 347 | Maternal embryonic leucine zipper kinase; transfer | 100.0 | |
| 3fxz_A | 297 | Serine/threonine-protein kinase PAK 1; transferase | 100.0 | |
| 3niz_A | 311 | Rhodanese family protein; structural genomics, str | 100.0 | |
| 2qkw_B | 321 | Protein kinase; three-helix bundle motif, AVRPTO-P | 100.0 | |
| 2yab_A | 361 | Death-associated protein kinase 2; apoptosis, tran | 100.0 | |
| 3o0g_A | 292 | Cell division protein kinase 5; kinase activator c | 100.0 | |
| 2bdw_A | 362 | Hypothetical protein K11E8.1D; kinase, calmodulin | 100.0 | |
| 3soa_A | 444 | Calcium/calmodulin-dependent protein kinase type a | 100.0 | |
| 3p86_A | 309 | Serine/threonine-protein kinase CTR1; ETR1, ERS1, | 100.0 | |
| 2y0a_A | 326 | Death-associated protein kinase 1; transferase, ca | 100.0 | |
| 1tki_A | 321 | Titin; serine kinase, muscle, autoinhibition; 2.00 | 100.0 | |
| 3gni_B | 389 | Strad alpha; kinase fold, pseudokinase, alpha heli | 100.0 | |
| 1o6l_A | 337 | RAC-beta serine/threonine protein kinase; protein | 100.0 | |
| 3tki_A | 323 | Serine/threonine-protein kinase CHK1; cell checkpo | 100.0 | |
| 4dc2_A | 396 | Protein kinase C IOTA type; kinase, substrate, cel | 100.0 | |
| 2c30_A | 321 | Serine/threonine-protein kinase PAK 6; CRIB domain | 100.0 | |
| 1ob3_A | 288 | PFPK5, cell division control protein 2 homolog; tr | 100.0 | |
| 3c0i_A | 351 | Peripheral plasma membrane protein CASK; neurexin, | 100.0 | |
| 4agu_A | 311 | Cyclin-dependent kinase-like 1; transferase, phosp | 100.0 | |
| 4euu_A | 319 | Serine/threonine-protein kinase TBK1; ATP binding, | 100.0 | |
| 3a8x_A | 345 | Protein kinase C IOTA type; transferase; HET: TPO; | 100.0 | |
| 3oz6_A | 388 | Mitogen-activated protein kinase 1, serine/threon | 100.0 | |
| 2zv2_A | 298 | Calcium/calmodulin-dependent protein kinase kinas; | 100.0 | |
| 3qd2_B | 332 | Eukaryotic translation initiation factor 2-alpha; | 100.0 | |
| 3kk8_A | 284 | Calcium/calmodulin dependent protein kinase II; AT | 100.0 | |
| 3h4j_B | 336 | AMPK kdaid, SNF1-like protein kinase SSP2; ATP-bin | 100.0 | |
| 3g33_A | 308 | Cell division protein kinase 4; Ser/Thr protein ki | 100.0 | |
| 3s95_A | 310 | LIMK-1, LIM domain kinase 1; structural genomics, | 100.0 | |
| 1fot_A | 318 | TPK1 delta, CAMP-dependent protein kinase type 1; | 100.0 | |
| 3mi9_A | 351 | Cell division protein kinase 9; P-TEFB, HIV-1, pro | 100.0 | |
| 3txo_A | 353 | PKC-L, NPKC-ETA, protein kinase C ETA type; phosph | 100.0 | |
| 4fr4_A | 384 | YANK1, serine/threonine-protein kinase 32A; struct | 100.0 | |
| 3ttj_A | 464 | Mitogen-activated protein kinase 10; JNK3, protein | 100.0 | |
| 1xjd_A | 345 | Protein kinase C, theta type; PKC-theta, ATP, AMP, | 100.0 | |
| 3llt_A | 360 | Serine/threonine kinase-1, pflammer; lammer kinase | 100.0 | |
| 2eue_A | 275 | Carbon catabolite derepressing protein kinase; kin | 100.0 | |
| 2pmi_A | 317 | Negative RE, cyclin-dependent protein kinase PHO85 | 100.0 | |
| 1rdq_E | 350 | PKA C-alpha, CAMP-dependent protein kinase, alpha- | 100.0 | |
| 3n9x_A | 432 | Phosphotransferase; malaria kinase, structural gen | 100.0 | |
| 3q4u_A | 301 | Activin receptor type-1; structural genomics conso | 100.0 | |
| 4aaa_A | 331 | Cyclin-dependent kinase-like 2; transferase, phosp | 100.0 | |
| 2nru_A | 307 | Interleukin-1 receptor-associated kinase 4; inhibi | 100.0 | |
| 2a2a_A | 321 | Death-associated protein kinase 2; autoinhibition, | 100.0 | |
| 3uc3_A | 361 | Serine/threonine-protein kinase SRK2I; SNRK2, ABA | 100.0 | |
| 3hko_A | 345 | Calcium/calmodulin-dependent protein kinase with d | 100.0 | |
| 4eqm_A | 294 | Protein kinase; transferase; HET: ANP; 3.00A {Stap | 100.0 | |
| 2y94_A | 476 | 5'-AMP-activated protein kinase catalytic subunit; | 100.0 | |
| 3vhe_A | 359 | Vascular endothelial growth factor receptor 2; kin | 100.0 | |
| 3rp9_A | 458 | Mitogen-activated protein kinase; structural genom | 100.0 | |
| 4hcu_A | 269 | Tyrosine-protein kinase ITK/TSK; transferase-trans | 100.0 | |
| 3a62_A | 327 | Ribosomal protein S6 kinase beta-1; kinase domain, | 100.0 | |
| 2w5a_A | 279 | Serine/threonine-protein kinase NEK2; Ser/Thr prot | 100.0 | |
| 3p1a_A | 311 | MYT1 kinase, membrane-associated tyrosine- and thr | 100.0 | |
| 1kob_A | 387 | Twitchin; kinase, intrasteric regulation; 2.30A {A | 100.0 | |
| 3gbz_A | 329 | Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide- | 100.0 | |
| 3fdn_A | 279 | Serine/threonine-protein kinase 6; aurora kinase i | 100.0 | |
| 1cm8_A | 367 | Phosphorylated MAP kinase P38-gamma; phosphorylati | 100.0 | |
| 2w4o_A | 349 | Calcium/calmodulin-dependent protein kinase type I | 100.0 | |
| 1t4h_A | 290 | Serine/threonine-protein kinase WNK1; protein seri | 100.0 | |
| 3sxs_A | 268 | Cytoplasmic tyrosine-protein kinase BMX; transfera | 100.0 | |
| 3kn6_A | 325 | Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1 | 100.0 | |
| 2i0e_A | 353 | Protein kinase C-beta II; serine/threonine protein | 100.0 | |
| 3f3z_A | 277 | Calcium/calmodulin-dependent protein kinase with d | 100.0 | |
| 2qr7_A | 342 | Ribosomal protein S6 kinase alpha-3; kinase domain | 100.0 | |
| 3dls_A | 335 | PAS domain-containing serine/threonine-protein KI; | 100.0 | |
| 3mwu_A | 486 | Calmodulin-domain protein kinase 1; serine/threoni | 100.0 | |
| 3lb7_A | 307 | RAF proto-oncogene serine/threonine-protein kinas; | 100.0 | |
| 3dbq_A | 343 | Dual specificity protein kinase TTK; MPS1 structur | 100.0 | |
| 3v8s_A | 410 | RHO-associated protein kinase 1; dimerization, myo | 100.0 | |
| 2psq_A | 370 | Fibroblast growth factor receptor 2; kinase domain | 100.0 | |
| 3is5_A | 285 | Calcium-dependent protein kinase; CDPK, structural | 100.0 | |
| 2yex_A | 276 | Serine/threonine-protein kinase CHK1; transferase, | 100.0 | |
| 3gen_A | 283 | Tyrosine-protein kinase BTK; bruton'S tyrosine kin | 100.0 | |
| 3q5i_A | 504 | Protein kinase; CDPK, malaria, phosphotransferase, | 100.0 | |
| 3nyv_A | 484 | Calmodulin-domain protein kinase 1; serine/threoni | 100.0 | |
| 3lij_A | 494 | Calcium/calmodulin dependent protein kinase with A | 100.0 | |
| 3kul_A | 325 | Ephrin type-A receptor 8; ATP-binding, kinase, nuc | 100.0 | |
| 3lm5_A | 327 | Serine/threonine-protein kinase 17B; STK17B, serin | 100.0 | |
| 3eqc_A | 360 | Dual specificity mitogen-activated protein kinase; | 100.0 | |
| 3bhy_A | 283 | Death-associated protein kinase 3; death associate | 100.0 | |
| 4aw2_A | 437 | Serine/threonine-protein kinase MRCK alpha; transf | 100.0 | |
| 2fst_X | 367 | Mitogen-activated protein kinase 14; active mutant | 100.0 | |
| 3cok_A | 278 | Serine/threonine-protein kinase PLK4; POLO-like ki | 100.0 | |
| 2xrw_A | 371 | Mitogen-activated protein kinase 8; transcription, | 100.0 | |
| 3ork_A | 311 | Serine/threonine protein kinase; structural genomi | 100.0 | |
| 2ivs_A | 314 | Proto-oncogene tyrosine-protein kinase receptor RE | 100.0 | |
| 2rku_A | 294 | Serine/threonine-protein kinase PLK1; structure of | 100.0 | |
| 3soc_A | 322 | Activin receptor type-2A; structural genomics cons | 100.0 | |
| 4ejn_A | 446 | RAC-alpha serine/threonine-protein kinase; AKT1, a | 100.0 | |
| 1qpc_A | 279 | LCK kinase; alpha beta fold, transferase; HET: PTR | 100.0 | |
| 3i6u_A | 419 | CDS1, serine/threonine-protein kinase CHK2; Ser/Th | 100.0 | |
| 2owb_A | 335 | Serine/threonine-protein kinase PLK1; catalytic do | 100.0 | |
| 3ugc_A | 295 | Tyrosine-protein kinase JAK2; small molecule inhib | 100.0 | |
| 3c4z_A | 543 | Rhodopsin kinase; Ser/Thr kinase, RGS homology dom | 100.0 | |
| 2vgo_A | 284 | Serine/threonine-protein kinase 12-A; nucleotide-b | 100.0 | |
| 1ua2_A | 346 | CAK, cell division protein kinase 7; cell cycle, p | 100.0 | |
| 1nxk_A | 400 | MAP kinase-activated protein kinase 2; MK2, phosph | 100.0 | |
| 1qcf_A | 454 | Haematopoetic cell kinase (HCK); tyrosine kinase-i | 100.0 | |
| 3cbl_A | 377 | C-FES, proto-oncogene tyrosine-protein kinase FES/ | 100.0 | |
| 3eb0_A | 383 | Putative uncharacterized protein; kinase cryptospo | 100.0 | |
| 2y7j_A | 365 | Phosphorylase B kinase gamma catalytic chain, test | 100.0 | |
| 3kfa_A | 288 | Tyrosine-protein kinase ABL1; CML, drug resistance | 100.0 | |
| 1x8b_A | 289 | WEE1HU, WEE1-like protein kinase; cell cycle, tran | 100.0 | |
| 2xir_A | 316 | Vascular endothelial growth factor receptor 2; ang | 100.0 | |
| 2ac3_A | 316 | MAP kinase-interacting serine/threonine kinase 2; | 100.0 | |
| 3kmu_A | 271 | ILK, integrin-linked kinase; cell adhesion, ANK re | 100.0 | |
| 2jam_A | 304 | Calcium/calmodulin-dependent protein kinase type 1 | 100.0 | |
| 2vd5_A | 412 | DMPK protein; serine/threonine-protein kinase, kin | 100.0 | |
| 2r3i_A | 299 | Cell division protein kinase 2; serine/threonine-p | 100.0 | |
| 3tt0_A | 382 | Basic fibroblast growth factor receptor 1; kinase | 100.0 | |
| 3mtl_A | 324 | Cell division protein kinase 16; pctaire1, indirub | 100.0 | |
| 3pg1_A | 362 | Mitogen-activated protein kinase, putative (MAP K | 100.0 | |
| 1mp8_A | 281 | Focal adhesion kinase 1; tyrosine protein kinase, | 100.0 | |
| 3qyz_A | 364 | Mitogen-activated protein kinase 1; transferase, s | 100.0 | |
| 1k9a_A | 450 | Carboxyl-terminal SRC kinase; COOH-terminal SRC ki | 100.0 | |
| 2r5t_A | 373 | Serine/threonine-protein kinase SGK1; AGC protein | 100.0 | |
| 3dtc_A | 271 | Mitogen-activated protein kinase kinase kinase 9; | 100.0 | |
| 2zmd_A | 390 | Dual specificity protein kinase TTK; MPS1, T686A, | 100.0 | |
| 2h6d_A | 276 | 5'-AMP-activated protein kinase catalytic subunit | 100.0 | |
| 2acx_A | 576 | G protein-coupled receptor kinase 6; GRK, G transf | 100.0 | |
| 4exu_A | 371 | Mitogen-activated protein kinase 13; P38 kinase, t | 100.0 | |
| 3qup_A | 323 | Tyrosine-protein kinase receptor TYRO3; protein ki | 100.0 | |
| 3l9p_A | 367 | Anaplastic lymphoma kinase; kinase domain, ATP-bin | 100.0 | |
| 2ycf_A | 322 | Serine/threonine-protein kinase CHK2; transferase, | 100.0 | |
| 3byv_A | 377 | Rhoptry kinase; malaria, transferase, structural g | 100.0 | |
| 4f0f_A | 287 | Serine/threonine-protein kinase ROCO4; LRRK2, ATP- | 100.0 | |
| 2wtk_C | 305 | Serine/threonine-protein kinase 11; transferase-me | 100.0 | |
| 3a7i_A | 303 | MST3 kinase, serine/threonine kinase 24 (STE20 hom | 100.0 | |
| 3og7_A | 289 | AKAP9-BRAF fusion protein; proto-oncogene, V600E, | 100.0 | |
| 1rjb_A | 344 | FL cytokine receptor; kinase, structure, autoinhib | 100.0 | |
| 3nsz_A | 330 | CK II alpha, casein kinase II subunit alpha; inhib | 100.0 | |
| 1luf_A | 343 | Muscle-specific tyrosine kinase receptor MUSK; pho | 100.0 | |
| 4eut_A | 396 | Serine/threonine-protein kinase TBK1; ATP binding, | 100.0 | |
| 2x7f_A | 326 | TRAF2 and NCK-interacting protein kinase; serine/t | 100.0 | |
| 3f66_A | 298 | Hepatocyte growth factor receptor; C-Met, protein | 100.0 | |
| 2x4f_A | 373 | Myosin light chain kinase family member 4; LUNG, b | 100.0 | |
| 3kvw_A | 429 | DYRK2, dual specificity tyrosine-phosphorylation-r | 100.0 | |
| 1t46_A | 313 | HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcom | 100.0 | |
| 3t9t_A | 267 | Tyrosine-protein kinase ITK/TSK; kinase domain, al | 100.0 | |
| 1vzo_A | 355 | Ribosomal protein S6 kinase alpha 5; protein kinas | 100.0 | |
| 3com_A | 314 | Serine/threonine-protein kinase 4; MST1, STE20-lik | 100.0 | |
| 2qol_A | 373 | Ephrin receptor; receptor tyrosine kinase, juxtame | 100.0 | |
| 3fme_A | 290 | Dual specificity mitogen-activated protein kinase; | 100.0 | |
| 1xbb_A | 291 | Tyrosine-protein kinase SYK; gleevec, STI-571, ima | 100.0 | |
| 2wei_A | 287 | Calmodulin-domain protein kinase 1, putative; nucl | 100.0 | |
| 1u5q_A | 348 | Serine/threonine protein kinase TAO2; transferase; | 100.0 | |
| 1fmk_A | 452 | C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyros | 100.0 | |
| 2izr_A | 330 | Casein kinase I isoform gamma-3; serine/threonine- | 100.0 | |
| 3brb_A | 313 | Proto-oncogene tyrosine-protein kinase MER; ATP-bi | 100.0 | |
| 4hgt_A | 296 | Casein kinase I isoform delta; CK1D, inhibitor, tr | 100.0 | |
| 4e5w_A | 302 | Tyrosine-protein kinase JAK1; kinase domain, trans | 100.0 | |
| 1csn_A | 298 | Casein kinase-1; phosphotransferase; HET: ATP; 2.0 | 100.0 | |
| 3mdy_A | 337 | Bone morphogenetic protein receptor type-1B; compl | 100.0 | |
| 1p4o_A | 322 | Insulin-like growth factor I receptor protein; IGF | 100.0 | |
| 3lxp_A | 318 | Non-receptor tyrosine-protein kinase TYK2; JAK3, i | 100.0 | |
| 2wqm_A | 310 | Serine/threonine-protein kinase NEK7; ATP-binding, | 100.0 | |
| 1phk_A | 298 | Phosphorylase kinase; glycogen metabolism, transfe | 100.0 | |
| 3gxj_A | 303 | TGF-beta receptor type-1; ALK5, kinase, inhibitor, | 100.0 | |
| 2j7t_A | 302 | Serine/threonine-protein kinase 10; transferase, A | 100.0 | |
| 2pvf_A | 334 | Fibroblast growth factor receptor 2; kinase domain | 100.0 | |
| 1opk_A | 495 | P150, C-ABL, proto-oncogene tyrosine-protein kinas | 100.0 | |
| 1b6c_B | 342 | TGF-B superfamily receptor type I; complex (isomer | 100.0 | |
| 3uzp_A | 296 | CKI-delta, CKID, casein kinase I isoform delta; CK | 100.0 | |
| 3rgf_A | 405 | Cyclin-dependent kinase 8; protein kinase complex, | 100.0 | |
| 1u59_A | 287 | Tyrosine-protein kinase ZAP-70; transferase; HET: | 100.0 | |
| 3coi_A | 353 | Mitogen-activated protein kinase 13; P38D, P38delt | 100.0 | |
| 1z57_A | 339 | Dual specificity protein kinase CLK1; protein tyro | 100.0 | |
| 2pml_X | 348 | PFPK7, Ser/Thr protein kinase; phosphorylati trans | 100.0 | |
| 1blx_A | 326 | Cyclin-dependent kinase 6; inhibitor protein, cycl | 100.0 | |
| 4e7w_A | 394 | Glycogen synthase kinase 3; GSK3, PTyr195, transfe | 100.0 | |
| 1byg_A | 278 | CSK, protein (C-terminal SRC kinase); protein kina | 100.0 | |
| 1j1b_A | 420 | Glycogen synthase kinase-3 beta; complex, TAU, AMP | 100.0 | |
| 3lxl_A | 327 | Tyrosine-protein kinase JAK3; TYK2, inflammation, | 100.0 | |
| 2h34_A | 309 | Serine/threonine-protein kinase PKNE; apoenzyme, t | 100.0 | |
| 3q60_A | 371 | ROP5B; pseudokinase, transferase; HET: ATP; 1.72A | 100.0 | |
| 3e3p_A | 360 | Protein kinase, putative glycogen synthase kinase; | 100.0 | |
| 3poz_A | 327 | Epidermal growth factor receptor; kinase domain, a | 100.0 | |
| 3pls_A | 298 | Macrophage-stimulating protein receptor; protein k | 100.0 | |
| 3kex_A | 325 | Receptor tyrosine-protein kinase ERBB-3; kinase do | 100.0 | |
| 2eva_A | 307 | TAK1 kinase - TAB1 chimera fusion protein; transfe | 100.0 | |
| 3cc6_A | 281 | Protein tyrosine kinase 2 beta; focal adhesion kin | 100.0 | |
| 3pfq_A | 674 | PKC-B, PKC-beta, protein kinase C beta type; phosp | 100.0 | |
| 2b9h_A | 353 | MAP kinase FUS3, mitogen-activated protein kinase | 100.0 | |
| 2v62_A | 345 | Serine/threonine-protein kinase VRK2; transferase, | 100.0 | |
| 3c1x_A | 373 | Hepatocyte growth factor receptor; receptor tyrosi | 100.0 | |
| 2clq_A | 295 | Mitogen-activated protein kinase kinase kinase 5; | 100.0 | |
| 3an0_A | 340 | Dual specificity mitogen-activated protein kinase; | 100.0 | |
| 1wak_A | 397 | Serine/threonine-protein kinase SPRK1; SRPK, trans | 100.0 | |
| 3cek_A | 313 | Dual specificity protein kinase TTK; HMPS1, PYT, E | 100.0 | |
| 2buj_A | 317 | Serine/threonine-protein kinase 16; transferase, A | 100.0 | |
| 3op5_A | 364 | Serine/threonine-protein kinase VRK1; adenosine tr | 100.0 | |
| 2vwi_A | 303 | Serine/threonine-protein kinase OSR1; STE kinase, | 100.0 | |
| 3fhr_A | 336 | MAP kinase-activated protein kinase 3; kinase-inhi | 100.0 | |
| 2a19_B | 284 | Interferon-induced, double-stranded RNA-activated | 100.0 | |
| 2h8h_A | 535 | Proto-oncogene tyrosine-protein kinase SRC; SRC ki | 100.0 | |
| 1fvr_A | 327 | Tyrosine-protein kinase TIE-2; tyrosine kinase, tr | 100.0 | |
| 2jii_A | 352 | Serine/threonine-protein kinase VRK3 molecule: VA | 100.0 | |
| 3lzb_A | 327 | Epidermal growth factor receptor; epidermal growth | 100.0 | |
| 2vx3_A | 382 | Dual specificity tyrosine-phosphorylation- regula | 100.0 | |
| 2i1m_A | 333 | Macrophage colony-stimulating factor 1 receptor; k | 100.0 | |
| 2i6l_A | 320 | Mitogen-activated protein kinase 6; MAPK6, ERK3, e | 100.0 | |
| 2rio_A | 434 | Serine/threonine-protein kinase/endoribonuclease I | 100.0 | |
| 2yfx_A | 327 | Tyrosine-protein kinase receptor; nucleotide-bindi | 100.0 | |
| 2w1i_A | 326 | JAK2; chromosomal rearrangement, nucleotide-bindin | 100.0 | |
| 2eu9_A | 355 | Dual specificity protein kinase CLK3; kinase domai | 100.0 | |
| 4fvq_A | 289 | Tyrosine-protein kinase JAK2; janus protein kinase | 100.0 | |
| 3a99_A | 320 | Proto-oncogene serine/threonine-protein kinase PI; | 100.0 | |
| 1mqb_A | 333 | Ephrin type-A receptor 2; tyrosine protein kinase, | 100.0 | |
| 3ll6_A | 337 | Cyclin G-associated kinase; transferase, protein k | 100.0 | |
| 2iwi_A | 312 | Serine/threonine-protein kinase PIM-2; nucleotide- | 100.0 | |
| 1zy4_A | 303 | Serine/threonine-protein kinase GCN2; translation | 100.0 | |
| 3sv0_A | 483 | Casein kinase I-like; typical kinase domain fold, | 100.0 | |
| 1q8y_A | 373 | SR protein kinase; transferase; HET: ADP ADE; 2.05 | 100.0 | |
| 4fl3_A | 635 | Tyrosine-protein kinase SYK; transferase; HET: ANP | 100.0 | |
| 3g2f_A | 336 | Bone morphogenetic protein receptor type-2; kinase | 100.0 | |
| 2ozo_A | 613 | Tyrosine-protein kinase ZAP-70; inactive ZAP-70, t | 100.0 | |
| 2dyl_A | 318 | Dual specificity mitogen-activated protein kinase | 100.0 | |
| 1u46_A | 291 | ACK-1, activated CDC42 kinase 1; tyrosine kinase, | 100.0 | |
| 3qa8_A | 676 | MGC80376 protein; kinase ubiquitin-like domain, ph | 100.0 | |
| 3e7e_A | 365 | HBUB1, BUB1A, mitotic checkpoint serine/threonine- | 100.0 | |
| 2y4i_B | 319 | KSR2, HKSR2, kinase suppressor of RAS 2; transfera | 100.0 | |
| 3aln_A | 327 | Dual specificity mitogen-activated protein kinase; | 100.0 | |
| 2j0j_A | 656 | Focal adhesion kinase 1; cell migration, FERM, tra | 100.0 | |
| 3p23_A | 432 | Serine/threonine-protein kinase/endoribonuclease; | 100.0 | |
| 3m2w_A | 299 | MAP kinase-activated protein kinase 2; small molec | 100.0 | |
| 2pzi_A | 681 | Probable serine/threonine-protein kinase PKNG; ATP | 100.0 | |
| 3uqc_A | 286 | Probable conserved transmembrane protein; structur | 100.0 | |
| 3dzo_A | 413 | Rhoptry kinase domain; parasitic disease, transfer | 100.0 | |
| 2vuw_A | 336 | Serine/threonine-protein kinase haspin; cell cycle | 100.0 | |
| 4azs_A | 569 | Methyltransferase WBDD; kinase; HET: AMP SAM; 2.15 | 99.96 | |
| 3en9_A | 540 | Glycoprotease, O-sialoglycoprotein endopeptidase/p | 99.94 | |
| 1zar_A | 282 | RIO2 kinase; serine kinase, winged-helix, RIO doma | 99.91 | |
| 1zth_A | 258 | RIO1 serine protein kinase; ribosome biogenesis, r | 99.84 | |
| 4gyi_A | 397 | RIO2 kinase; protein kinase, ADP complex, phosphoa | 99.76 | |
| 3tm0_A | 263 | Aminoglycoside 3'-phosphotransferase; protein kina | 99.44 | |
| 1nd4_A | 264 | Aminoglycoside 3'-phosphotransferase; protein kina | 99.33 | |
| 3dxp_A | 359 | Putative acyl-COA dehydrogenase; protein kinase-li | 99.16 | |
| 3sg8_A | 304 | APH(2'')-ID; antibiotic resistance enzyme, transfe | 99.07 | |
| 3r70_A | 320 | Aminoglycoside phosphotransferase; structural geno | 98.92 | |
| 3tdw_A | 306 | Gentamicin resistance protein; kinase, phosphoryl | 98.78 | |
| 4gkh_A | 272 | Aminoglycoside 3'-phosphotransferase APHA1-IAB; py | 98.7 | |
| 3ovc_A | 362 | Hygromycin-B 4-O-kinase; aminoglycoside phosphotra | 98.5 | |
| 3d1u_A | 288 | Putative fructosamine-3-kinase; YP_290396.1, struc | 98.5 | |
| 3ats_A | 357 | Putative uncharacterized protein; hypothetical pro | 98.33 | |
| 3f7w_A | 288 | Putative fructosamine-3-kinase; YP_290396.1, struc | 98.19 | |
| 2yle_A | 229 | Protein spire homolog 1; actin-binding protein, ac | 98.16 | |
| 2olc_A | 397 | MTR kinase, methylthioribose kinase; kinase ADP-2H | 98.14 | |
| 2q83_A | 346 | YTAA protein; 2635576, structural genomics, joint | 98.14 | |
| 3dxq_A | 301 | Choline/ethanolamine kinase family protein; NP_106 | 97.93 | |
| 3jr1_A | 312 | Putative fructosamine-3-kinase; YP_719053.1, struc | 97.82 | |
| 2ppq_A | 322 | HSK, HK, homoserine kinase; structural genomics, M | 97.8 | |
| 2pyw_A | 420 | Uncharacterized protein; 5-methylthioribose kinase | 97.72 | |
| 3feg_A | 379 | Choline/ethanolamine kinase; non-protein kinase, c | 97.61 | |
| 3csv_A | 333 | Aminoglycoside phosphotransferase; YP_614837.1, ph | 97.6 | |
| 1nw1_A | 429 | Choline kinase (49.2 KD); phospholipid synthesis, | 97.57 | |
| 2qg7_A | 458 | Ethanolamine kinase PV091845; malaria, SGC, struct | 97.48 | |
| 3c5i_A | 369 | Choline kinase; choline, kinase, malaria, transfer | 97.34 | |
| 1zyl_A | 328 | Hypothetical protein YIHE; putative protein kinase | 97.33 | |
| 3i1a_A | 339 | Spectinomycin phosphotransferase; protein kinase, | 97.16 | |
| 3f2s_A | 401 | CK, chetk-alpha, choline kinase alpha; non-protein | 96.95 | |
| 3mes_A | 424 | Choline kinase; malaria, structural genomics, stru | 96.71 | |
| 3g15_A | 401 | CK, chetk-alpha, choline kinase alpha; non-protein | 96.36 | |
| 4ano_A | 219 | ESSB; membrane protein, membrane secretion, ESS ty | 90.62 | |
| 4ann_A | 215 | ESSB; membrane protein, membrane secretion, ESS ty | 90.23 | |
| 3cxl_A | 463 | N-chimerin; SH2, RHO-GAP, structural genomics cons | 83.03 | |
| 3eps_A | 578 | Isocitrate dehydrogenase kinase/phosphatase; ATP-b | 80.22 |
| >4b9d_A Serine/threonine-protein kinase NEK1; transferase, inhibitor; HET: CK7; 1.90A {Homo sapiens} PDB: 4apc_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-59 Score=398.12 Aligned_cols=253 Identities=25% Similarity=0.383 Sum_probs=207.1
Q ss_pred CCCCCCceeecCCcceEEEEEe-CCCcEEEEEEeccCcCChhhhHHHHHHHHHHHhcCCcceeeeeeEEEcCCCeeEEEE
Q 038766 12 GSFSENNIIGNSNLSTVYKGRL-EDGEIVAVKKLNFHQFSAESDKSFYREAKTLKELKHRNLVKVLGYAWESGKLKALIL 90 (299)
Q Consensus 12 ~~y~~~~~lg~g~~~~v~~~~~-~~~~~~~vK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~lv~ 90 (299)
++|++.+.||+|+||+||+|.+ .+|+.||||++..........+.+.+|+.++++++||||+++++++.+ +..+++||
T Consensus 24 e~Y~~~~~lG~G~fg~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~E~~il~~l~HpnIV~~~~~~~~-~~~~yiVm 102 (350)
T 4b9d_A 24 EKYVRLQKIGEGSFGKAILVKSTEDGRQYVIKEINISRMSSKEREESRREVAVLANMKHPNIVQYRESFEE-NGSLYIVM 102 (350)
T ss_dssp CCEEEEEEC------CEEEEEETTTCCEEEEEEEECTTSCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEE-TTEEEEEE
T ss_pred cceEEeEEEecCCCeEEEEEEECCCCCEEEEEEEehHHCCHHHHHHHHHHHHHHHHCCCCCCCcEEEEEEE-CCEEEEEE
Confidence 6899999999999999999987 469999999998777677778889999999999999999999997665 55669999
Q ss_pred eecCCCChHHHhcCCCCCCCCCChhhHHHHHHHHHHHHHHhhcCCCCCeeeecccCCceeeCCCCcEEEeeecccccccc
Q 038766 91 EYMENGSLESVIHGPGVDHSRWTLPKRIDVLISVANGLDYLHSGYDIPIVHCDMKPSNILLDRDFEAHVSDFGTSRMLDV 170 (299)
Q Consensus 91 e~~~~~~L~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lh~~~~~~~~H~dl~~~nil~~~~~~v~l~df~~~~~~~~ 170 (299)
||++||+|.+++... ....+++.+++.++.||+.||+|||++ +|+||||||+|||++.+|.+||+|||++..+..
T Consensus 103 Ey~~gg~L~~~i~~~--~~~~~~e~~~~~~~~qi~~aL~ylH~~---~IiHRDlKp~NILl~~~g~vKl~DFGla~~~~~ 177 (350)
T 4b9d_A 103 DYCEGGDLFKRINAQ--KGVLFQEDQILDWFVQICLALKHVHDR---KILHRDIKSQNIFLTKDGTVQLGDFGIARVLNS 177 (350)
T ss_dssp ECCTTCBHHHHHHHT--TTCCCCHHHHHHHHHHHHHHHHHHHHT---TCEETTCCGGGEEECTTCCEEECSTTEESCCCH
T ss_pred eCCCCCcHHHHHHHc--CCCCCCHHHHHHHHHHHHHHHHHHHHC---CeeeccCCHHHEEECCCCCEEEcccccceeecC
Confidence 999999999998632 345689999999999999999999999 999999999999999999999999999986542
Q ss_pred ccccccccccccccCcccCChhhhcccCcCccccchhhhHHHHHHHhCCCCCCCCccCCCCchhHHHHHHHHHhcCccCc
Q 038766 171 HLQDLSSLSTAFQGTIGYLAPEFAYMRIVTTKVDVFSFGIVVMEFLTKRRPTGLDEENGLSPISLRQLVEKALANGINGV 250 (299)
Q Consensus 171 ~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~DiwslG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 250 (299)
. ........||+.|+|||++.+..|+.++|||||||++|+|++|..||.... ..+.+........+..
T Consensus 178 ~----~~~~~~~~GT~~YmAPE~l~~~~y~~~~DiwSlGvilyemltG~~PF~~~~--------~~~~~~~i~~~~~~~~ 245 (350)
T 4b9d_A 178 T----VELARACIGTPYYLSPEICENKPYNNKSDIWALGCVLYELCTLKHAFEAGS--------MKNLVLKIISGSFPPV 245 (350)
T ss_dssp H----HHHHHHHHSCCTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCSCCCSS--------HHHHHHHHHHTCCCCC
T ss_pred C----cccccccCCCccccCHHHHCCCCCCcHHHHHHHHHHHHHHHHCCCCCCCcC--------HHHHHHHHHcCCCCCC
Confidence 1 122345679999999999999999999999999999999999999995431 2233333333222111
Q ss_pred ccccCccccchhhHhHHHHHHHHHHHHHHHHhcCCCCCCCCChhhhhcC
Q 038766 251 RQITDPKLVSSIYEEQEQHQVLEELFKLALVCTSSNPEDRPNMNELLIT 299 (299)
Q Consensus 251 ~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rpt~~~il~~ 299 (299)
+..++.++.+||.+||..||++|||++|+|+|
T Consensus 246 -----------------~~~~s~~~~~li~~~L~~dP~~R~s~~e~l~h 277 (350)
T 4b9d_A 246 -----------------SLHYSYDLRSLVSQLFKRNPRDRPSVNSILEK 277 (350)
T ss_dssp -----------------CTTSCHHHHHHHHHHTCSSGGGSCCHHHHHTS
T ss_pred -----------------CccCCHHHHHHHHHHccCChhHCcCHHHHhcC
Confidence 12345689999999999999999999999987
|
| >4fih_A Serine/threonine-protein kinase PAK 4; kinase domain, protein ATP binding, phosphorylation, transferase; HET: SEP; 1.97A {Homo sapiens} PDB: 4fig_A* 4fif_A* 4fii_A* 4fij_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7.5e-58 Score=387.31 Aligned_cols=250 Identities=24% Similarity=0.376 Sum_probs=207.6
Q ss_pred CCCCCCceeecCCcceEEEEEeC-CCcEEEEEEeccCcCChhhhHHHHHHHHHHHhcCCcceeeeeeEEEcCCCeeEEEE
Q 038766 12 GSFSENNIIGNSNLSTVYKGRLE-DGEIVAVKKLNFHQFSAESDKSFYREAKTLKELKHRNLVKVLGYAWESGKLKALIL 90 (299)
Q Consensus 12 ~~y~~~~~lg~g~~~~v~~~~~~-~~~~~~vK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~lv~ 90 (299)
++|.+.+.||+|+||+||+|.+. +|+.||||++.... ....+.+.+|+.+++.++||||+++++++.. ++.+|+||
T Consensus 74 ~~y~~~~~iG~G~fG~V~~a~~~~tg~~vAiK~i~~~~--~~~~~~~~~Ei~il~~l~HpnIV~l~~~~~~-~~~~~ivm 150 (346)
T 4fih_A 74 SYLDNFIKIGEGSTGIVCIATVRSSGKLVAVKKMDLRK--QQRRELLFNEVVIMRDYQHENVVEMYNSYLV-GDELWVVM 150 (346)
T ss_dssp GTEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEGGG--CSSGGGGHHHHHHHHHCCCTTBCCEEEEEEE-TTEEEEEE
T ss_pred HhcEEeEEeecCcCeEEEEEEECCCCCEEEEEEEecCc--hhHHHHHHHHHHHHHhCCCCCCCcEEEEEEE-CCEEEEEE
Confidence 57999999999999999999875 69999999997433 3345668899999999999999999997665 55669999
Q ss_pred eecCCCChHHHhcCCCCCCCCCChhhHHHHHHHHHHHHHHhhcCCCCCeeeecccCCceeeCCCCcEEEeeecccccccc
Q 038766 91 EYMENGSLESVIHGPGVDHSRWTLPKRIDVLISVANGLDYLHSGYDIPIVHCDMKPSNILLDRDFEAHVSDFGTSRMLDV 170 (299)
Q Consensus 91 e~~~~~~L~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lh~~~~~~~~H~dl~~~nil~~~~~~v~l~df~~~~~~~~ 170 (299)
||++||+|.+++. ..++++.+++.++.||+.||+|||++ +|+||||||+|||++.+|.+||+|||++..+..
T Consensus 151 Ey~~gg~L~~~l~-----~~~l~e~~~~~~~~qi~~aL~ylH~~---~IiHRDlKp~NILl~~~g~vKl~DFGla~~~~~ 222 (346)
T 4fih_A 151 EFLEGGALTDIVT-----HTRMNEEQIAAVCLAVLQALSVLHAQ---GVIHRDIKSDSILLTHDGRVKLSDFGFCAQVSK 222 (346)
T ss_dssp CCCTTEEHHHHHH-----HSCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECTTCCEEECCCTTCEECCS
T ss_pred eCCCCCcHHHHHH-----cCCCCHHHHHHHHHHHHHHHHHHHHC---CcccccCCHHHEEECCCCCEEEecCcCceecCC
Confidence 9999999999985 34699999999999999999999999 999999999999999999999999999986542
Q ss_pred ccccccccccccccCcccCChhhhcccCcCccccchhhhHHHHHHHhCCCCCCCCccCCCCchhHHHHHHHHHhcCccCc
Q 038766 171 HLQDLSSLSTAFQGTIGYLAPEFAYMRIVTTKVDVFSFGIVVMEFLTKRRPTGLDEENGLSPISLRQLVEKALANGINGV 250 (299)
Q Consensus 171 ~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~DiwslG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 250 (299)
.........||+.|+|||++.+..|+.++|||||||++|+|++|..||... ... +.+..+........
T Consensus 223 ----~~~~~~~~~GTp~YmAPEvl~~~~y~~~~DiWSlGvilyeml~G~~PF~~~-----~~~---~~~~~i~~~~~~~~ 290 (346)
T 4fih_A 223 ----EVPRRKSLVGTPYWMAPELISRLPYGPEVDIWSLGIMVIEMVDGEPPYFNE-----PPL---KAMKMIRDNLPPRL 290 (346)
T ss_dssp ----SSCCBCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCTTTTS-----CHH---HHHHHHHHSSCCCC
T ss_pred ----CCCcccccccCcCcCCHHHHCCCCCCcHHHHHHHHHHHHHHHHCCCCCCCc-----CHH---HHHHHHHcCCCCCC
Confidence 223345678999999999999999999999999999999999999999533 222 22222222211111
Q ss_pred ccccCccccchhhHhHHHHHHHHHHHHHHHHhcCCCCCCCCChhhhhcC
Q 038766 251 RQITDPKLVSSIYEEQEQHQVLEELFKLALVCTSSNPEDRPNMNELLIT 299 (299)
Q Consensus 251 ~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rpt~~~il~~ 299 (299)
.. ...+++++.+||.+||..||++|||++|+|+|
T Consensus 291 ~~---------------~~~~s~~~~dli~~~L~~dP~~R~ta~e~l~H 324 (346)
T 4fih_A 291 KN---------------LHKVSPSLKGFLDRLLVRDPAQRATAAELLKH 324 (346)
T ss_dssp SC---------------GGGSCHHHHHHHHHHSCSSTTTSCCHHHHTTC
T ss_pred Cc---------------cccCCHHHHHHHHHHcCCChhHCcCHHHHhcC
Confidence 10 22356789999999999999999999999987
|
| >4aw0_A HPDK1, 3-phosphoinositide-dependent protein kinase 1; transferase, allosteric regulation, allosteric site, phosphorylation, AGC protein kinase; HET: SEP ATP MJF; 1.43A {Homo sapiens} PDB: 3hrc_A* 3hrf_A* 4a06_A* 4a07_A* 3rcj_A* 4aw1_A* 3rwq_A* 3sc1_A* 3qd0_A* 2r7b_A* 3ion_A* 3qcq_A* 3qcs_A* 3qcx_A* 3qcy_A* 3iop_A* 3qd3_A* 3qd4_A* 3h9o_A* 1uu3_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-58 Score=386.14 Aligned_cols=251 Identities=22% Similarity=0.316 Sum_probs=207.6
Q ss_pred hCCCCCCceeecCCcceEEEEEe-CCCcEEEEEEeccCcC-ChhhhHHHHHHHHHHHhcCCcceeeeeeEEEcCCCeeEE
Q 038766 11 TGSFSENNIIGNSNLSTVYKGRL-EDGEIVAVKKLNFHQF-SAESDKSFYREAKTLKELKHRNLVKVLGYAWESGKLKAL 88 (299)
Q Consensus 11 ~~~y~~~~~lg~g~~~~v~~~~~-~~~~~~~vK~~~~~~~-~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~l 88 (299)
.++|.+.+.||+|+||+||+|.+ .+|+.||+|++..... .....+.+.+|++++++++||||+++++++.+ ++.+++
T Consensus 31 ~~dy~i~~~lG~G~fg~V~~a~~~~~~~~~AiK~i~k~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~-~~~~yi 109 (311)
T 4aw0_A 31 PEDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPFFVKLYFTFQD-DEKLYF 109 (311)
T ss_dssp GGGEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTCCCTTBCCEEEEEEC-SSEEEE
T ss_pred ccccEEEEEEecccCeEEEEEEECCCCCEEEEEEEEHHHCCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEEe-CCEEEE
Confidence 35799999999999999999987 4699999999964332 23446789999999999999999999996655 556799
Q ss_pred EEeecCCCChHHHhcCCCCCCCCCChhhHHHHHHHHHHHHHHhhcCCCCCeeeecccCCceeeCCCCcEEEeeecccccc
Q 038766 89 ILEYMENGSLESVIHGPGVDHSRWTLPKRIDVLISVANGLDYLHSGYDIPIVHCDMKPSNILLDRDFEAHVSDFGTSRML 168 (299)
Q Consensus 89 v~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lh~~~~~~~~H~dl~~~nil~~~~~~v~l~df~~~~~~ 168 (299)
||||++||+|.+++. ....+++.+++.++.||+.||+|||++ +++||||||+|||++.+|.+||+|||++..+
T Consensus 110 vmEy~~gG~L~~~i~----~~~~l~e~~~~~~~~qi~~al~ylH~~---~IiHRDlKPeNILl~~~g~vKl~DFGla~~~ 182 (311)
T 4aw0_A 110 GLSYAKNGELLKYIR----KIGSFDETCTRFYTAEIVSALEYLHGK---GIIHRDLKPENILLNEDMHIQITDFGTAKVL 182 (311)
T ss_dssp EECCCTTEEHHHHHH----HHSSCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEECTTSCEEECCCTTCEEC
T ss_pred EEecCCCCCHHHHHH----HcCCCCHHHHHHHHHHHHHHHHHHHHC---CCccCCCCHHHeEEcCCCCEEEEEcCCceec
Confidence 999999999999997 456899999999999999999999999 9999999999999999999999999999866
Q ss_pred ccccccccccccccccCcccCChhhhcccCcCccccchhhhHHHHHHHhCCCCCCCCccCCCCchhHHHHHHHHHhcCcc
Q 038766 169 DVHLQDLSSLSTAFQGTIGYLAPEFAYMRIVTTKVDVFSFGIVVMEFLTKRRPTGLDEENGLSPISLRQLVEKALANGIN 248 (299)
Q Consensus 169 ~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~DiwslG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 248 (299)
... ..........||+.|+|||++.+..|+.++|||||||++|+|++|..||.... ..+.+..+.....
T Consensus 183 ~~~--~~~~~~~~~~GTp~YmAPEvl~~~~y~~~~DiWSlGvilyeml~G~~PF~~~~--------~~~~~~~i~~~~~- 251 (311)
T 4aw0_A 183 SPE--SKQARANSFVGTAQYVSPELLTEKSACKSSDLWALGCIIYQLVAGLPPFRAGN--------EGLIFAKIIKLEY- 251 (311)
T ss_dssp CTT--TTCCCBCCCCSCGGGCCHHHHHHSCBCHHHHHHHHHHHHHHHHHSSCSSCCSS--------HHHHHHHHHHTCC-
T ss_pred CCC--CCcccccCcccCcccCCHHHHcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCC--------HHHHHHHHHcCCC-
Confidence 421 11233456689999999999999999999999999999999999999995431 2233333332111
Q ss_pred CcccccCccccchhhHhHHHHHHHHHHHHHHHHhcCCCCCCCCChhhhh
Q 038766 249 GVRQITDPKLVSSIYEEQEQHQVLEELFKLALVCTSSNPEDRPNMNELL 297 (299)
Q Consensus 249 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rpt~~~il 297 (299)
. + +..+++++.+||++||..||++|||++|++
T Consensus 252 ~---~--------------p~~~s~~~~dli~~lL~~dp~~R~t~~e~~ 283 (311)
T 4aw0_A 252 D---F--------------PEKFFPKARDLVEKLLVLDATKRLGCEEME 283 (311)
T ss_dssp C---C--------------CTTCCHHHHHHHHHHSCSSGGGSTTSGGGT
T ss_pred C---C--------------CcccCHHHHHHHHHHccCCHhHCcChHHHc
Confidence 1 1 122456799999999999999999999964
|
| >3fpq_A Serine/threonine-protein kinase WNK1; protein serine/threonine kinase, transferase, ATP-BIND kinase, nucleotide-binding, phosphoprotein; 1.80A {Rattus norvegicus} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.5e-58 Score=381.32 Aligned_cols=251 Identities=25% Similarity=0.381 Sum_probs=203.5
Q ss_pred CCC-CCCceeecCCcceEEEEEeC-CCcEEEEEEeccCcCChhhhHHHHHHHHHHHhcCCcceeeeeeEEEc---CCCee
Q 038766 12 GSF-SENNIIGNSNLSTVYKGRLE-DGEIVAVKKLNFHQFSAESDKSFYREAKTLKELKHRNLVKVLGYAWE---SGKLK 86 (299)
Q Consensus 12 ~~y-~~~~~lg~g~~~~v~~~~~~-~~~~~~vK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~---~~~~~ 86 (299)
++| ++.+.||+|+||+||+|.+. ++..||+|++..........+.+.+|+.++++++||||+++++++.. .+..+
T Consensus 25 gr~~~~~~~iG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~E~~il~~l~HpnIV~~~~~~~~~~~~~~~~ 104 (290)
T 3fpq_A 25 GRFLKFDIEIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQHPNIVRFYDSWESTVKGKKCI 104 (290)
T ss_dssp SSEEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEEEEETTEEEE
T ss_pred CceEEeeeEEecCcCcEEEEEEECCCCeEEEEEEEchhhCCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEeeccCCCcEE
Confidence 344 66778999999999999874 58999999998766667777889999999999999999999997754 23557
Q ss_pred EEEEeecCCCChHHHhcCCCCCCCCCChhhHHHHHHHHHHHHHHhhcCCCCC--eeeecccCCceeeC-CCCcEEEeeec
Q 038766 87 ALILEYMENGSLESVIHGPGVDHSRWTLPKRIDVLISVANGLDYLHSGYDIP--IVHCDMKPSNILLD-RDFEAHVSDFG 163 (299)
Q Consensus 87 ~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lh~~~~~~--~~H~dl~~~nil~~-~~~~v~l~df~ 163 (299)
++||||+++|+|.+++. ....+++..+..++.||+.||+|||++ + ++||||||+|||++ .+|.+||+|||
T Consensus 105 ~lvmEy~~gg~L~~~l~----~~~~l~~~~~~~~~~qi~~aL~ylH~~---~~~IiHRDlKp~NILl~~~~g~vKl~DFG 177 (290)
T 3fpq_A 105 VLVTELMTSGTLKTYLK----RFKVMKIKVLRSWCRQILKGLQFLHTR---TPPIIHRDLKCDNIFITGPTGSVKIGDLG 177 (290)
T ss_dssp EEEEECCCSCBHHHHHH----HHSSCCHHHHHHHHHHHHHHHHHHHTS---SSCCCCCCCCGGGEEESSTTSCEEECCTT
T ss_pred EEEEeCCCCCCHHHHHH----hcCCCCHHHHHHHHHHHHHHHHHHHHC---CCCEEecccChhheeEECCCCCEEEEeCc
Confidence 99999999999999997 456899999999999999999999998 7 99999999999998 47999999999
Q ss_pred cccccccccccccccccccccCcccCChhhhcccCcCccccchhhhHHHHHHHhCCCCCCCCccCCCCchhHHHHHHHHH
Q 038766 164 TSRMLDVHLQDLSSLSTAFQGTIGYLAPEFAYMRIVTTKVDVFSFGIVVMEFLTKRRPTGLDEENGLSPISLRQLVEKAL 243 (299)
Q Consensus 164 ~~~~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~DiwslG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~ 243 (299)
++.... ........||+.|+|||++.+ .|+.++|||||||++|+|++|..||..... . ...... .
T Consensus 178 la~~~~------~~~~~~~~GTp~YmAPE~~~~-~y~~~~DiwSlGvilyelltg~~Pf~~~~~----~---~~~~~~-i 242 (290)
T 3fpq_A 178 LATLKR------ASFAKAVIGTPEFMAPEMYEE-KYDESVDVYAFGMCMLEMATSEYPYSECQN----A---AQIYRR-V 242 (290)
T ss_dssp GGGGCC------TTSBEESCSSCCCCCGGGGGT-CCCTHHHHHHHHHHHHHHHHSSCTTTTCSS----H---HHHHHH-H
T ss_pred CCEeCC------CCccCCcccCccccCHHHcCC-CCCcHHHHHHHHHHHHHHHHCCCCCCCCCc----H---HHHHHH-H
Confidence 997533 233455679999999998865 599999999999999999999999953211 1 111111 1
Q ss_pred hcCccCcccccCccccchhhHhHHHHHHHHHHHHHHHHhcCCCCCCCCChhhhhcC
Q 038766 244 ANGINGVRQITDPKLVSSIYEEQEQHQVLEELFKLALVCTSSNPEDRPNMNELLIT 299 (299)
Q Consensus 244 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rpt~~~il~~ 299 (299)
..+... +. .+...++++.+||.+||..||++|||++|+|+|
T Consensus 243 ~~~~~~------~~---------~~~~~~~~~~~li~~~L~~dP~~R~s~~e~l~H 283 (290)
T 3fpq_A 243 TSGVKP------AS---------FDKVAIPEVKEIIEGCIRQNKDERYSIKDLLNH 283 (290)
T ss_dssp TTTCCC------GG---------GGGCCCHHHHHHHHHHSCSSGGGSCCHHHHHTS
T ss_pred HcCCCC------CC---------CCccCCHHHHHHHHHHccCChhHCcCHHHHhcC
Confidence 111000 00 022234578999999999999999999999988
|
| >3hyh_A Carbon catabolite-derepressing protein kinase; kinase domain, transferase, ATP-binding, carbohydrate metabo kinase, membrane; 2.20A {Saccharomyces cerevisiae} PDB: 3dae_A 2fh9_A 3mn3_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-57 Score=376.04 Aligned_cols=248 Identities=22% Similarity=0.349 Sum_probs=191.6
Q ss_pred CCCCCCceeecCCcceEEEEEe-CCCcEEEEEEeccCcCC-hhhhHHHHHHHHHHHhcCCcceeeeeeEEEcCCCeeEEE
Q 038766 12 GSFSENNIIGNSNLSTVYKGRL-EDGEIVAVKKLNFHQFS-AESDKSFYREAKTLKELKHRNLVKVLGYAWESGKLKALI 89 (299)
Q Consensus 12 ~~y~~~~~lg~g~~~~v~~~~~-~~~~~~~vK~~~~~~~~-~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~lv 89 (299)
++|++.+.||+|+||+||+|.+ .+|+.||+|++...... ......+.+|+.++++++||||+++++++.. .+..++|
T Consensus 13 g~Y~i~~~lG~G~fg~V~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~~~~~~~~-~~~~~iv 91 (275)
T 3hyh_A 13 GNYQIVKTLGEGSFGKVKLAYHTTTGQKVALKIINKKVLAKSDMQGRIEREISYLRLLRHPHIIKLYDVIKS-KDEIIMV 91 (275)
T ss_dssp -CCEEEEEEEC---CCEEEEECTTTCCEEEEEEEECC------CHHHHHHHHHHHHHCCCTTBCCEEEEEEC-SSEEEEE
T ss_pred eCeEEEEEEecCcCeEEEEEEECCCCCEEEEEEEeHHHcCCHHHHHHHHHHHHHHHHCCCCCCCeEEEEEEE-CCEEEEE
Confidence 6899999999999999999987 46999999999755433 3446778999999999999999999997655 5567999
Q ss_pred EeecCCCChHHHhcCCCCCCCCCChhhHHHHHHHHHHHHHHhhcCCCCCeeeecccCCceeeCCCCcEEEeeeccccccc
Q 038766 90 LEYMENGSLESVIHGPGVDHSRWTLPKRIDVLISVANGLDYLHSGYDIPIVHCDMKPSNILLDRDFEAHVSDFGTSRMLD 169 (299)
Q Consensus 90 ~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lh~~~~~~~~H~dl~~~nil~~~~~~v~l~df~~~~~~~ 169 (299)
|||+ +|+|.+.+. ...++++.++..++.||+.||+|||++ +++||||||+|||++.++.+||+|||++....
T Consensus 92 mEy~-~g~L~~~l~----~~~~l~e~~~~~~~~qi~~al~ylH~~---~IiHRDiKP~NILl~~~~~vkl~DFGla~~~~ 163 (275)
T 3hyh_A 92 IEYA-GNELFDYIV----QRDKMSEQEARRFFQQIISAVEYCHRH---KIVHRDLKPENLLLDEHLNVKIADFGLSNIMT 163 (275)
T ss_dssp EECC-CEEHHHHHH----HSCSCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCTTTEEECTTCCEEECCSSCC----
T ss_pred EeCC-CCCHHHHHH----HcCCCCHHHHHHHHHHHHHHHHHHHHC---CcccccCChHHeEECCCCCEEEeecCCCeecC
Confidence 9999 679999887 456899999999999999999999999 99999999999999999999999999997644
Q ss_pred cccccccccccccccCcccCChhhhcccCc-CccccchhhhHHHHHHHhCCCCCCCCccCCCCchhHHHHHHHHHhcCcc
Q 038766 170 VHLQDLSSLSTAFQGTIGYLAPEFAYMRIV-TTKVDVFSFGIVVMEFLTKRRPTGLDEENGLSPISLRQLVEKALANGIN 248 (299)
Q Consensus 170 ~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~-~~~~DiwslG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 248 (299)
. ........||+.|+|||++.+..+ +.++|||||||++|+|++|..||... . ....+....... .
T Consensus 164 ~-----~~~~~~~~GT~~Y~APE~~~~~~y~~~~~DiwSlGvily~lltg~~PF~~~-----~---~~~~~~~i~~~~-~ 229 (275)
T 3hyh_A 164 D-----GNFLKTSCGSPNYAAPEVISGKLYAGPEVDVWSCGVILYVMLCRRLPFDDE-----S---IPVLFKNISNGV-Y 229 (275)
T ss_dssp ----------------CTTSCHHHHSSSSCCCTHHHHHHHHHHHHHHHHSSCSSCCS-----S---HHHHHHHHHHTC-C
T ss_pred C-----CCccCCeeECcccCChhhhcCCCCCCChhhhHHHHHHHHHHHHCCCCCCCC-----C---HHHHHHHHHcCC-C
Confidence 2 223345679999999999998876 57999999999999999999999533 1 122222222211 1
Q ss_pred CcccccCccccchhhHhHHHHHHHHHHHHHHHHhcCCCCCCCCChhhhhcC
Q 038766 249 GVRQITDPKLVSSIYEEQEQHQVLEELFKLALVCTSSNPEDRPNMNELLIT 299 (299)
Q Consensus 249 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rpt~~~il~~ 299 (299)
.. +..+++++.+||++||..||++|||++|+++|
T Consensus 230 ~~-----------------p~~~s~~~~~li~~~L~~dP~~R~s~~eil~h 263 (275)
T 3hyh_A 230 TL-----------------PKFLSPGAAGLIKRMLIVNPLNRISIHEIMQD 263 (275)
T ss_dssp CC-----------------CTTSCHHHHHHHHHHSCSSGGGSCCHHHHHHC
T ss_pred CC-----------------CCCCCHHHHHHHHHHccCChhHCcCHHHHHcC
Confidence 10 12345689999999999999999999999987
|
| >4fie_A Serine/threonine-protein kinase PAK 4; kinase domain, protein ATP binding, phosphorylation, transferase; HET: SEP ANP; 3.11A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-56 Score=388.68 Aligned_cols=251 Identities=24% Similarity=0.374 Sum_probs=208.5
Q ss_pred hCCCCCCceeecCCcceEEEEEeC-CCcEEEEEEeccCcCChhhhHHHHHHHHHHHhcCCcceeeeeeEEEcCCCeeEEE
Q 038766 11 TGSFSENNIIGNSNLSTVYKGRLE-DGEIVAVKKLNFHQFSAESDKSFYREAKTLKELKHRNLVKVLGYAWESGKLKALI 89 (299)
Q Consensus 11 ~~~y~~~~~lg~g~~~~v~~~~~~-~~~~~~vK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~lv 89 (299)
.++|.+.+.||+|+||+||+|.+. +|+.||||++.... ....+.+.+|+.+|+.++||||+++++++.. ++.+|+|
T Consensus 150 ~~~y~~~~~iG~G~fG~V~~a~~~~tg~~vAiK~i~~~~--~~~~~~~~~Ei~il~~l~HpnIV~l~~~~~~-~~~~~iV 226 (423)
T 4fie_A 150 RSYLDNFIKIGEGSTGIVCIATVRSSGKLVAVKKMDLRK--QQRRELLFNEVVIMRDYQHENVVEMYNSYLV-GDELWVV 226 (423)
T ss_dssp GGTEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEESTT--CSSGGGHHHHHHHHHHCCCTTBCCEEEEEEE-TTEEEEE
T ss_pred hHhcEeeeEeccCcCcEEEEEEECCCCCEEEEEEEeccc--hhHHHHHHHHHHHHHhCCCCCCCceEEEEEE-CCEEEEE
Confidence 367999999999999999999874 69999999997543 3345678899999999999999999997765 5567999
Q ss_pred EeecCCCChHHHhcCCCCCCCCCChhhHHHHHHHHHHHHHHhhcCCCCCeeeecccCCceeeCCCCcEEEeeeccccccc
Q 038766 90 LEYMENGSLESVIHGPGVDHSRWTLPKRIDVLISVANGLDYLHSGYDIPIVHCDMKPSNILLDRDFEAHVSDFGTSRMLD 169 (299)
Q Consensus 90 ~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lh~~~~~~~~H~dl~~~nil~~~~~~v~l~df~~~~~~~ 169 (299)
|||++||+|.+++. ...+++.+++.++.||+.||+|||++ +|+||||||+|||++.+|.+||+|||++..+.
T Consensus 227 mEy~~gG~L~~~i~-----~~~l~e~~~~~~~~qil~aL~ylH~~---~IiHRDiKp~NILl~~~g~vKl~DFGla~~~~ 298 (423)
T 4fie_A 227 MEFLEGGALTDIVT-----HTRMNEEQIAAVCLAVLQALSVLHAQ---GVIHRDIKSDSILLTHDGRVKLSDFGFCAQVS 298 (423)
T ss_dssp EECCTTEEHHHHHH-----HSCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSTTTEEECTTCCEEECCCTTCEECC
T ss_pred EeCCCCCcHHHHHh-----ccCCCHHHHHHHHHHHHHHHHHHHHC---CeecccCCHHHEEEcCCCCEEEecCccceECC
Confidence 99999999999985 34699999999999999999999999 99999999999999999999999999998654
Q ss_pred cccccccccccccccCcccCChhhhcccCcCccccchhhhHHHHHHHhCCCCCCCCccCCCCchhHHHHHHHHHhcCccC
Q 038766 170 VHLQDLSSLSTAFQGTIGYLAPEFAYMRIVTTKVDVFSFGIVVMEFLTKRRPTGLDEENGLSPISLRQLVEKALANGING 249 (299)
Q Consensus 170 ~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~DiwslG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 249 (299)
. .........||+.|+|||++.+..|+.++|||||||++|+|++|..||... ... +.+..+.......
T Consensus 299 ~----~~~~~~~~~GTp~YmAPEvl~~~~y~~~~DiWSlGvilyeml~G~~PF~~~-----~~~---~~~~~i~~~~~~~ 366 (423)
T 4fie_A 299 K----EVPRRKSLVGTPYWMAPELISRLPYGPEVDIWSLGIMVIEMVDGEPPYFNE-----PPL---KAMKMIRDNLPPR 366 (423)
T ss_dssp S----SCCCBCCCEECTTTCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCTTTTS-----CHH---HHHHHHHHSCCCC
T ss_pred C----CCccccccccCcCcCCHHHHCCCCCCcHHHHHHHHHHHHHHHHCCCCCCCc-----CHH---HHHHHHHcCCCCC
Confidence 2 223345678999999999999999999999999999999999999999533 222 2222222222111
Q ss_pred cccccCccccchhhHhHHHHHHHHHHHHHHHHhcCCCCCCCCChhhhhcC
Q 038766 250 VRQITDPKLVSSIYEEQEQHQVLEELFKLALVCTSSNPEDRPNMNELLIT 299 (299)
Q Consensus 250 ~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rpt~~~il~~ 299 (299)
... ...++.++.+||.+||..||++|||++|+|+|
T Consensus 367 ~~~---------------~~~~s~~~~dli~~~L~~dP~~R~ta~ell~H 401 (423)
T 4fie_A 367 LKN---------------LHKVSPSLKGFLDRLLVRDPAQRATAAELLKH 401 (423)
T ss_dssp CSC---------------TTSSCHHHHHHHHHHSCSSTTTSCCHHHHTTC
T ss_pred Ccc---------------cccCCHHHHHHHHHHcCCChhHCcCHHHHhcC
Confidence 111 22345689999999999999999999999988
|
| >3ubd_A Ribosomal protein S6 kinase alpha-3; kinase-inhibitor complex, induced FIT, transferase-transfera inhibitor complex; HET: SL0; 1.53A {Mus musculus} PDB: 4el9_A* 3g51_A* 2z7q_A* 2z7r_A* 2z7s_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.4e-58 Score=383.17 Aligned_cols=251 Identities=25% Similarity=0.296 Sum_probs=201.4
Q ss_pred hCCCCCCceeecCCcceEEEEEeC----CCcEEEEEEeccCcCChhhhHHHHHHHHHHHhcCCcceeeeeeEEEcCCCee
Q 038766 11 TGSFSENNIIGNSNLSTVYKGRLE----DGEIVAVKKLNFHQFSAESDKSFYREAKTLKELKHRNLVKVLGYAWESGKLK 86 (299)
Q Consensus 11 ~~~y~~~~~lg~g~~~~v~~~~~~----~~~~~~vK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~ 86 (299)
.++|++.+.||+|+||+||+|++. +++.||+|++............+.+|+.++++++||||+++++++.. ++.+
T Consensus 23 p~~Y~i~~~lG~G~fg~Vy~a~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~-~~~~ 101 (304)
T 3ubd_A 23 PSQFELLKVLGQGSFGKVFLVKKISGSDARQLYAMKVLKKATLKVRDRVRTKMERDILVEVNHPFIVKLHYAFQT-EGKL 101 (304)
T ss_dssp GGGEEEEEEEECGGGCEEEEEEECSSTTTTCEEEEEEEESEEEEEEECC------CCCCCCCCTTEECEEEEEEE-TTEE
T ss_pred ccccEEEEEEecCCCeEEEEEEEccCCCCCEEEEEEEEehHHcChHHHHHHHHHHHHHHHCCCCCCCeEEEEEEE-CCEE
Confidence 367999999999999999999862 47899999997655444555678899999999999999999997665 5566
Q ss_pred EEEEeecCCCChHHHhcCCCCCCCCCChhhHHHHHHHHHHHHHHhhcCCCCCeeeecccCCceeeCCCCcEEEeeecccc
Q 038766 87 ALILEYMENGSLESVIHGPGVDHSRWTLPKRIDVLISVANGLDYLHSGYDIPIVHCDMKPSNILLDRDFEAHVSDFGTSR 166 (299)
Q Consensus 87 ~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lh~~~~~~~~H~dl~~~nil~~~~~~v~l~df~~~~ 166 (299)
++||||++||+|.+++. ....+++.++..++.||+.||+|||++ +++||||||+|||++.+|.+||+|||++.
T Consensus 102 ~ivmEy~~gg~L~~~l~----~~~~l~e~~~~~~~~qi~~aL~ylH~~---~IiHRDlKp~NILl~~~g~vKl~DFGla~ 174 (304)
T 3ubd_A 102 YLILDFLRGGDLFTRLS----KEVMFTEEDVKFYLAELALALDHLHSL---GIIYRDLKPENILLDEEGHIKLTDFGLSK 174 (304)
T ss_dssp EEEECCCTTCEEHHHHH----HHCCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSSCCGGGEEECTTSCEEEESSEEEE
T ss_pred EEEEEcCCCCCHHHHHH----hcCCCCHHHHHHHHHHHHHHHHHHHHC---CCcCCCCCHHHeEEcCCCCEEecccccce
Confidence 99999999999999997 456899999999999999999999999 99999999999999999999999999997
Q ss_pred ccccccccccccccccccCcccCChhhhcccCcCccccchhhhHHHHHHHhCCCCCCCCccCCCCchhHHHHHHHHHhcC
Q 038766 167 MLDVHLQDLSSLSTAFQGTIGYLAPEFAYMRIVTTKVDVFSFGIVVMEFLTKRRPTGLDEENGLSPISLRQLVEKALANG 246 (299)
Q Consensus 167 ~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~DiwslG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~ 246 (299)
.... .........||+.|+|||++.+..++.++|||||||++|+|++|..||... .. .+.+..+....
T Consensus 175 ~~~~----~~~~~~~~~GT~~YmAPE~~~~~~y~~~~DiwSlGvilyemltG~~PF~~~-----~~---~~~~~~i~~~~ 242 (304)
T 3ubd_A 175 ESID----HEKKAYSFCGTVEYMAPEVVNRRGHTQSADWWSFGVLMFEMLTGTLPFQGK-----DR---KETMTMILKAK 242 (304)
T ss_dssp C---------CCCCSCCCCGGGCCHHHHHTSCCCTHHHHHHHHHHHHHHHHSSCSSCCS-----SH---HHHHHHHHHCC
T ss_pred eccC----CCccccccccCcccCCHHHhccCCCCCCCcccchHHHHHHHHhCCCCCCCc-----CH---HHHHHHHHcCC
Confidence 5431 123344567999999999999999999999999999999999999999543 12 22333332211
Q ss_pred ccCcccccCccccchhhHhHHHHHHHHHHHHHHHHhcCCCCCCCCCh-----hhhhcC
Q 038766 247 INGVRQITDPKLVSSIYEEQEQHQVLEELFKLALVCTSSNPEDRPNM-----NELLIT 299 (299)
Q Consensus 247 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rpt~-----~~il~~ 299 (299)
. . . +..+++++.+||++||..||++|||+ +|+++|
T Consensus 243 ~-~-----~------------p~~~s~~~~~li~~~L~~dP~~R~ta~~~~~~eil~H 282 (304)
T 3ubd_A 243 L-G-----M------------PQFLSPEAQSLLRMLFKRNPANRLGAGPDGVEEIKRH 282 (304)
T ss_dssp C-C-----C------------CTTSCHHHHHHHHHHTCSSGGGSTTCSTTTHHHHHTS
T ss_pred C-C-----C------------CCcCCHHHHHHHHHHcccCHHHCCCCCcCCHHHHHcC
Confidence 1 1 0 12345689999999999999999995 789887
|
| >3omv_A RAF proto-oncogene serine/threonine-protein kinas; serine/threonine-protein kinase, transferase; HET: SM5; 4.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.4e-56 Score=372.63 Aligned_cols=261 Identities=26% Similarity=0.410 Sum_probs=203.6
Q ss_pred HHHHHhCCCCCCceeecCCcceEEEEEeCCCcEEEEEEeccCcCChhhhHHHHHHHHHHHhcCCcceeeeeeEEEcCCCe
Q 038766 6 EIENATGSFSENNIIGNSNLSTVYKGRLEDGEIVAVKKLNFHQFSAESDKSFYREAKTLKELKHRNLVKVLGYAWESGKL 85 (299)
Q Consensus 6 ~~~~~~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~vK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~ 85 (299)
.||+-.+++.+.+.||+|+||+||+|++.+ .||||+++.........+.+.+|+.++++++||||+++++++. .+ .
T Consensus 30 ~Wei~~~~l~l~~~iG~G~fG~Vy~~~~~~--~vAvK~~~~~~~~~~~~~~f~~E~~il~~l~HpNIV~l~g~~~-~~-~ 105 (307)
T 3omv_A 30 YWEIEASEVMLSTRIGSGSFGTVYKGKWHG--DVAVKILKVVDPTPEQFQAFRNEVAVLRKTRHVNILLFMGYMT-KD-N 105 (307)
T ss_dssp CCBCCTTSCCEEEECCCCSSSEEEEEESSS--EEEEEECCCSSCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEEC-SS-S
T ss_pred CcEEcHHHeEEeeEEeeCCCcEEEEEEECC--cEEEEEEEecCCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEE-CC-e
Confidence 467778899999999999999999998753 5999999866666677788999999999999999999999654 33 4
Q ss_pred eEEEEeecCCCChHHHhcCCCCCCCCCChhhHHHHHHHHHHHHHHhhcCCCCCeeeecccCCceeeCCCCcEEEeeeccc
Q 038766 86 KALILEYMENGSLESVIHGPGVDHSRWTLPKRIDVLISVANGLDYLHSGYDIPIVHCDMKPSNILLDRDFEAHVSDFGTS 165 (299)
Q Consensus 86 ~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lh~~~~~~~~H~dl~~~nil~~~~~~v~l~df~~~ 165 (299)
+++||||+++|+|.+++.. ...++++.++..++.||+.||+|||++ +++||||||+|||++.++.+||+|||++
T Consensus 106 ~~iVmEy~~gGsL~~~l~~---~~~~l~~~~~~~i~~qia~gL~yLH~~---~IiHRDlKp~NILl~~~~~~Ki~DFGla 179 (307)
T 3omv_A 106 LAIVTQWCEGSSLYKHLHV---QETKFQMFQLIDIARQTAQGMDYLHAK---NIIHRDMKSNNIFLHEGLTVKIGDFGLA 179 (307)
T ss_dssp CEEEEECCSSCBHHHHHHT---SCCCCCHHHHHHHHHHHHHHHHHHHHT---TCBCSCCCSSSEEEETTEEEEECCCSSC
T ss_pred EEEEEEcCCCCCHHHHHhh---cCCCCCHHHHHHHHHHHHHHHHHHHHC---CccCCccCHHHEEECCCCcEEEeeccCc
Confidence 5999999999999999863 235799999999999999999999999 9999999999999999999999999999
Q ss_pred cccccccccccccccccccCcccCChhhhccc---CcCccccchhhhHHHHHHHhCCCCCCCCccCCCCchhHHHHHHHH
Q 038766 166 RMLDVHLQDLSSLSTAFQGTIGYLAPEFAYMR---IVTTKVDVFSFGIVVMEFLTKRRPTGLDEENGLSPISLRQLVEKA 242 (299)
Q Consensus 166 ~~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~---~~~~~~DiwslG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~ 242 (299)
....... .........||+.|+|||++.+. .++.++|||||||++|+|++|..||.... .. ..+...
T Consensus 180 ~~~~~~~--~~~~~~~~~GT~~ymAPE~l~~~~~~~y~~ksDVwS~Gvvl~Elltg~~Pf~~~~-----~~---~~~~~~ 249 (307)
T 3omv_A 180 TVKSRWS--GSQQVEQPTGSVLWMAPEVIRMQDNNPFSFQSDVYSYGIVLYELMTGELPYSHIN-----NR---DQIIFM 249 (307)
T ss_dssp BC--------------CCCCTTSCCHHHHHCCSSCCCCHHHHHHHHHHHHHHHHHSSCTTTTCC-----CH---HHHHHH
T ss_pred eecccCC--cceeecccccCCCccCHHHhhccCCCCCCcHHHhHhHHHHHHHHHHCCCCCCCCC-----hH---HHHHHH
Confidence 7654211 12233456799999999998643 58899999999999999999999995331 11 111111
Q ss_pred HhcCccCcccccCccccchhhHhHHHHHHHHHHHHHHHHhcCCCCCCCCChhhhhc
Q 038766 243 LANGINGVRQITDPKLVSSIYEEQEQHQVLEELFKLALVCTSSNPEDRPNMNELLI 298 (299)
Q Consensus 243 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rpt~~~il~ 298 (299)
...+.. .+... ..+..++.++.+|+.+||..||++|||+.+|++
T Consensus 250 ~~~~~~------~p~~~------~~~~~~~~~l~~li~~cl~~dP~~RPs~~ei~~ 293 (307)
T 3omv_A 250 VGRGYA------SPDLS------KLYKNCPKAMKRLVADCVKKVKEERPLFPQILS 293 (307)
T ss_dssp HHTTCC------CCCST------TSCTTSCHHHHHHHHHHTCSSSTTSCCHHHHHH
T ss_pred HhcCCC------CCCcc------cccccchHHHHHHHHHHcCCCHhHCcCHHHHHH
Confidence 211110 00000 002234568999999999999999999999875
|
| >4g3f_A NF-kappa-beta-inducing kinase; non-RD kinase, protein serine/threonine kinase, S based drug design, MAP3K14, transferase; HET: 0WB; 1.64A {Mus musculus} PDB: 4g3g_A* 4g3c_A 4dn5_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=8.1e-57 Score=379.90 Aligned_cols=250 Identities=23% Similarity=0.264 Sum_probs=198.4
Q ss_pred hCCCCCCceeecCCcceEEEEEeC-CCcEEEEEEeccCcCChhhhHHHHHHHHHHHhcCCcceeeeeeEEEcCCCeeEEE
Q 038766 11 TGSFSENNIIGNSNLSTVYKGRLE-DGEIVAVKKLNFHQFSAESDKSFYREAKTLKELKHRNLVKVLGYAWESGKLKALI 89 (299)
Q Consensus 11 ~~~y~~~~~lg~g~~~~v~~~~~~-~~~~~~vK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~lv 89 (299)
.+.|.+.++||+|+||+||+|.+. +|+.||||+++..... .+|+.+++.++||||+++++++.+ ++.+++|
T Consensus 57 ~~~~~~~~~lG~G~fG~Vy~a~~~~~g~~vAiK~i~~~~~~-------~~E~~il~~l~HpnIV~l~~~~~~-~~~~~iv 128 (336)
T 4g3f_A 57 VHWMTHQPRVGRGSFGEVHRMKDKQTGFQCAVKKVRLEVFR-------VEELVACAGLSSPRIVPLYGAVRE-GPWVNIF 128 (336)
T ss_dssp TTEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEETTTCC-------THHHHTTTTCCCTTBCCEEEEEEE-TTEEEEE
T ss_pred hhheEeCcEeccCCCeEEEEEEECCCCCEEEEEEECHHHhH-------HHHHHHHHhCCCCCCCcEEEEEEE-CCEEEEE
Confidence 345777889999999999999874 5999999999754322 369999999999999999997665 5567999
Q ss_pred EeecCCCChHHHhcCCCCCCCCCChhhHHHHHHHHHHHHHHhhcCCCCCeeeecccCCceeeCCCC-cEEEeeecccccc
Q 038766 90 LEYMENGSLESVIHGPGVDHSRWTLPKRIDVLISVANGLDYLHSGYDIPIVHCDMKPSNILLDRDF-EAHVSDFGTSRML 168 (299)
Q Consensus 90 ~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lh~~~~~~~~H~dl~~~nil~~~~~-~v~l~df~~~~~~ 168 (299)
|||++|++|.++++ ...++++.+++.++.||+.||+|||++ +++||||||+|||++.+| .+||+|||++..+
T Consensus 129 mEy~~gg~L~~~l~----~~~~l~e~~~~~~~~qi~~aL~ylH~~---~IiHRDlKp~NILl~~~g~~vKl~DFGla~~~ 201 (336)
T 4g3f_A 129 MELLEGGSLGQLIK----QMGCLPEDRALYYLGQALEGLEYLHTR---RILHGDVKADNVLLSSDGSRAALCDFGHALCL 201 (336)
T ss_dssp ECCCTTCBHHHHHH----HHSSCCHHHHHHHHHHHHHHHHHHHTT---TEECSCCCGGGEEECTTSCCEEECCCTTCEEC
T ss_pred EeccCCCcHHHHHH----HcCCCCHHHHHHHHHHHHHHHHHHHHC---CceecccCHHHEEEeCCCCEEEEeeCCCCeEc
Confidence 99999999999997 445899999999999999999999999 999999999999999987 5999999999866
Q ss_pred cccccccc-ccccccccCcccCChhhhcccCcCccccchhhhHHHHHHHhCCCCCCCCccCCCCchhHHHHHHHHHhcCc
Q 038766 169 DVHLQDLS-SLSTAFQGTIGYLAPEFAYMRIVTTKVDVFSFGIVVMEFLTKRRPTGLDEENGLSPISLRQLVEKALANGI 247 (299)
Q Consensus 169 ~~~~~~~~-~~~~~~~~~~~y~~PE~~~~~~~~~~~DiwslG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 247 (299)
........ .......||+.|+|||++.+..++.++|||||||++|+|++|..||....... +.. .+....
T Consensus 202 ~~~~~~~~~~~~~~~~GT~~YmAPE~~~~~~y~~~~DiwSlGvilyemltG~~Pf~~~~~~~-----~~~---~i~~~~- 272 (336)
T 4g3f_A 202 QPDGLGKSLLTGDYIPGTETHMAPEVVMGKPCDAKVDIWSSCCMMLHMLNGCHPWTQYFRGP-----LCL---KIASEP- 272 (336)
T ss_dssp ------------CCCCCCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSSTTTCCSC-----CHH---HHHHSC-
T ss_pred cCCCcccceecCCccccCccccCHHHHCCCCCCcHHHHHHHHHHHHHHHHCcCCCCCCCHHH-----HHH---HHHcCC-
Confidence 43211111 12234579999999999999999999999999999999999999996543221 111 111111
Q ss_pred cCcccccCccccchhhHhHHHHHHHHHHHHHHHHhcCCCCCCCCChhhhhc
Q 038766 248 NGVRQITDPKLVSSIYEEQEQHQVLEELFKLALVCTSSNPEDRPNMNELLI 298 (299)
Q Consensus 248 ~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rpt~~~il~ 298 (299)
..... .+..+++++.++|.+||..||++|||++|+++
T Consensus 273 ~~~~~--------------~~~~~s~~~~~li~~~L~~dP~~R~sa~el~~ 309 (336)
T 4g3f_A 273 PPIRE--------------IPPSCAPLTAQAIQEGLRKEPVHRASAMELRR 309 (336)
T ss_dssp CGGGG--------------SCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred CCchh--------------cCccCCHHHHHHHHHHccCCHhHCcCHHHHHH
Confidence 01100 12345678999999999999999999999875
|
| >4asz_A BDNF/NT-3 growth factors receptor; transferase, TRKA, TRKB; 1.70A {Homo sapiens} PDB: 4at3_A* 4at4_A* 4at5_A* 3v5q_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.8e-56 Score=372.20 Aligned_cols=255 Identities=26% Similarity=0.382 Sum_probs=203.0
Q ss_pred hCCCCCCceeecCCcceEEEEEeC------CCcEEEEEEeccCcCChhhhHHHHHHHHHHHhcCCcceeeeeeEEEcCCC
Q 038766 11 TGSFSENNIIGNSNLSTVYKGRLE------DGEIVAVKKLNFHQFSAESDKSFYREAKTLKELKHRNLVKVLGYAWESGK 84 (299)
Q Consensus 11 ~~~y~~~~~lg~g~~~~v~~~~~~------~~~~~~vK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~ 84 (299)
.++|.+.+.||+|+||+||+|.+. ++..||||++.. ......+.+.+|++++++++||||+++++++.+. +
T Consensus 12 r~~~~l~~~lG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~l~~--~~~~~~~~f~~E~~il~~l~HpnIV~l~g~~~~~-~ 88 (299)
T 4asz_A 12 RHNIVLKRELGEGAFGKVFLAECYNLCPEQDKILVAVKTLKD--ASDNARKDFHREAELLTNLQHEHIVKFYGVCVEG-D 88 (299)
T ss_dssp GGGEEEEEEEEC--CCCEEEEEECSCC----CEEEEEEEECS--CCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECSS-S
T ss_pred HHHeEEeeEEeeCCCcEEEEEEECCcccCCCCEEEEEEEeCC--CChHHHHHHHHHHHHHHhCCCCCCccEEEEEeeC-C
Confidence 467889999999999999999863 477899999863 3455677899999999999999999999977664 4
Q ss_pred eeEEEEeecCCCChHHHhcCCC---------CCCCCCChhhHHHHHHHHHHHHHHhhcCCCCCeeeecccCCceeeCCCC
Q 038766 85 LKALILEYMENGSLESVIHGPG---------VDHSRWTLPKRIDVLISVANGLDYLHSGYDIPIVHCDMKPSNILLDRDF 155 (299)
Q Consensus 85 ~~~lv~e~~~~~~L~~~~~~~~---------~~~~~~~~~~~~~i~~qi~~~l~~lh~~~~~~~~H~dl~~~nil~~~~~ 155 (299)
..++||||+++|+|.+++...+ .....+++.+++.++.||+.||+|||++ +++||||||+|||++.++
T Consensus 89 ~~~lV~Ey~~~G~L~~~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gl~yLH~~---~iiHRDlKp~NILl~~~~ 165 (299)
T 4asz_A 89 PLIMVFEYMKHGDLNKFLRAHGPDAVLMAEGNPPTELTQSQMLHIAQQIAAGMVYLASQ---HFVHRDLATRNCLVGENL 165 (299)
T ss_dssp SEEEEEECCTTCBHHHHHHHTSHHHHHC----CCCCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEECGGG
T ss_pred EEEEEEEcCCCCcHHHHHHhcCcccccccccCCCCCCCHHHHHHHHHHHHHHHHHHHhC---CcccCccCHhhEEECCCC
Confidence 5699999999999999986431 2345799999999999999999999999 999999999999999999
Q ss_pred cEEEeeeccccccccccccccccccccccCcccCChhhhcccCcCccccchhhhHHHHHHHh-CCCCCCCCccCCCCchh
Q 038766 156 EAHVSDFGTSRMLDVHLQDLSSLSTAFQGTIGYLAPEFAYMRIVTTKVDVFSFGIVVMEFLT-KRRPTGLDEENGLSPIS 234 (299)
Q Consensus 156 ~v~l~df~~~~~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~DiwslG~~l~~l~~-g~~p~~~~~~~~~~~~~ 234 (299)
.+||+|||++...... ..........+|+.|+|||++.+..++.++|||||||++|||+| |..||... ...+
T Consensus 166 ~~Ki~DFGla~~~~~~--~~~~~~~~~~gt~~ymAPE~~~~~~~~~k~DVwS~Gvvl~Ellt~G~~Pf~~~-----~~~~ 238 (299)
T 4asz_A 166 LVKIGDFGMSRDVYST--DYYRVGGHTMLPIRWMPPESIMYRKFTTESDVWSLGVVLWEIFTYGKQPWYQL-----SNNE 238 (299)
T ss_dssp CEEECCCSCHHHHTGG--GCEEETTTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCTTTTS-----CHHH
T ss_pred cEEECCcccceecCCC--CceeecCceecChhhcCHHHHcCCCCCchhhHHHHHHHHHHHHcCCCCCCCCC-----CHHH
Confidence 9999999999754321 11122334568999999999999999999999999999999998 89999533 2223
Q ss_pred HHHHHHHHHhcCccCcccccCccccchhhHhHHHHHHHHHHHHHHHHhcCCCCCCCCChhhhhc
Q 038766 235 LRQLVEKALANGINGVRQITDPKLVSSIYEEQEQHQVLEELFKLALVCTSSNPEDRPNMNELLI 298 (299)
Q Consensus 235 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rpt~~~il~ 298 (299)
+. .......... . +..+++++.+|+.+||+.||++|||+++|++
T Consensus 239 ~~---~~i~~~~~~~-----~------------p~~~~~~~~~li~~cl~~dP~~RPs~~~i~~ 282 (299)
T 4asz_A 239 VI---ECITQGRVLQ-----R------------PRTCPQEVYELMLGCWQREPHMRKNIKGIHT 282 (299)
T ss_dssp HH---HHHHHTCCCC-----C------------CTTCCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred HH---HHHHcCCCCC-----C------------CccchHHHHHHHHHHcCCChhHCcCHHHHHH
Confidence 22 2222211100 0 2234567999999999999999999999863
|
| >4b99_A Mitogen-activated protein kinase 7; transferase, inhibitor; HET: R4L; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-54 Score=377.21 Aligned_cols=277 Identities=25% Similarity=0.307 Sum_probs=209.7
Q ss_pred HhCCCCCCceeecCCcceEEEEEe-CCCcEEEEEEeccCcCChhhhHHHHHHHHHHHhcCCcceeeeeeEEEc-----CC
Q 038766 10 ATGSFSENNIIGNSNLSTVYKGRL-EDGEIVAVKKLNFHQFSAESDKSFYREAKTLKELKHRNLVKVLGYAWE-----SG 83 (299)
Q Consensus 10 ~~~~y~~~~~lg~g~~~~v~~~~~-~~~~~~~vK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~-----~~ 83 (299)
+.++|.+.+.||+|+||+||+|.+ .+|+.||||++..........+.+.+|+++|+.++||||+++++++.. ..
T Consensus 52 i~~~Y~~~~~lG~G~fG~V~~a~~~~t~~~vAiK~i~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~~~ 131 (398)
T 4b99_A 52 VGDEYEIIETIGNGAYGVVSSARRRLTGQQVAIKKIPNAFDVVTNAKRTLRELKILKHFKHDNIIAIKDILRPTVPYGEF 131 (398)
T ss_dssp CCSSEEEEEEEEECSSCEEEEEEETTTCCEEEEEEETTTTSSHHHHHHHHHHHHHHHHCCCTTBCCEEEECCCSSCTTTC
T ss_pred CCCCeEEEEEEecccCeEEEEEEECCCCCEEEEEEECccccchHHHHHHHHHHHHHHhcCCCCcceEeeeeecccccccC
Confidence 457899999999999999999987 469999999997665556667788899999999999999999997643 23
Q ss_pred CeeEEEEeecCCCChHHHhcCCCCCCCCCChhhHHHHHHHHHHHHHHhhcCCCCCeeeecccCCceeeCCCCcEEEeeec
Q 038766 84 KLKALILEYMENGSLESVIHGPGVDHSRWTLPKRIDVLISVANGLDYLHSGYDIPIVHCDMKPSNILLDRDFEAHVSDFG 163 (299)
Q Consensus 84 ~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lh~~~~~~~~H~dl~~~nil~~~~~~v~l~df~ 163 (299)
..+|+||||+. |+|.+++. ...++++.++..++.||+.||+|||++ +++||||||+|||++.+|.+||+|||
T Consensus 132 ~~~~ivmE~~~-g~L~~~i~----~~~~l~~~~~~~~~~qil~al~ylH~~---~iiHRDlKP~NIl~~~~~~~Ki~DFG 203 (398)
T 4b99_A 132 KSVYVVLDLME-SDLHQIIH----SSQPLTLEHVRYFLYQLLRGLKYMHSA---QVIHRDLKPSNLLVNENCELKIGDFG 203 (398)
T ss_dssp CCEEEEEECCS-EEHHHHHT----SSSCCCHHHHHHHHHHHHHHHHHHHHT---TCBCCCCCGGGEEECTTCCEEECCCT
T ss_pred CEEEEEEeCCC-CCHHHHHH----hcCCCCHHHHHHHHHHHHHHHHHHHHC---cCcCCCcCccccccCCCCCEEEeecc
Confidence 56799999995 58999997 556899999999999999999999999 99999999999999999999999999
Q ss_pred cccccccccccccccccccccCcccCChhhhccc-CcCccccchhhhHHHHHHHhCCCCCCCCccCCCCchhHHHHHHHH
Q 038766 164 TSRMLDVHLQDLSSLSTAFQGTIGYLAPEFAYMR-IVTTKVDVFSFGIVVMEFLTKRRPTGLDEENGLSPISLRQLVEKA 242 (299)
Q Consensus 164 ~~~~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~-~~~~~~DiwslG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~ 242 (299)
++..+...............||+.|+|||++.+. .++.++||||+||++|+|++|..||.... .......+...
T Consensus 204 la~~~~~~~~~~~~~~~~~~GT~~Y~APEv~~~~~~~~~~~DiWSlG~il~ell~G~~pF~g~~-----~~~~l~~I~~~ 278 (398)
T 4b99_A 204 MARGLCTSPAEHQYFMTEYVATRWYRAPELMLSLHEYTQAIDLWSVGCIFGEMLARRQLFPGKN-----YVHQLQLIMMV 278 (398)
T ss_dssp TCBCC-------CCCCCSSCCCCTTCCHHHHTTCSCCCTHHHHHHHHHHHHHHHHTSCSSCCSS-----HHHHHHHHHHH
T ss_pred eeeecccCccccccccccceeChHhcCHHHhcCCCCCCChhheehhHHHHHHHHHCCCCCCCCC-----HHHHHHHHHHh
Confidence 9986543222233345567899999999998875 56899999999999999999999995432 22222222111
Q ss_pred HhcCccCc-ccccCccc---------cchhhHhHHHHHHHHHHHHHHHHhcCCCCCCCCChhhhhcC
Q 038766 243 LANGINGV-RQITDPKL---------VSSIYEEQEQHQVLEELFKLALVCTSSNPEDRPNMNELLIT 299 (299)
Q Consensus 243 ~~~~~~~~-~~~~~~~~---------~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rpt~~~il~~ 299 (299)
........ ........ ............++.++.+||.+||..||++|||++|+|+|
T Consensus 279 ~g~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLl~~mL~~dP~~R~ta~e~L~H 345 (398)
T 4b99_A 279 LGTPSPAVIQAVGAERVRAYIQSLPPRQPVPWETVYPGADRQALSLLGRMLRFEPSARISAAAALRH 345 (398)
T ss_dssp HCCCCGGGTC-----CHHHHHHSSCCCCCCCHHHHSTTCCHHHHHHHHHHSCSSTTTSCCHHHHTTS
T ss_pred cCCCChHHhhhhhhhhhhhhhhcCCCcCCCCHHHhCCCCCHHHHHHHHHHCcCChhHCcCHHHHhcC
Confidence 11110000 00000000 00000011123456789999999999999999999999998
|
| >4aoj_A High affinity nerve growth factor receptor; transferase, inhibitor; HET: V4Z; 2.75A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.3e-55 Score=371.31 Aligned_cols=255 Identities=25% Similarity=0.365 Sum_probs=197.9
Q ss_pred hCCCCCCceeecCCcceEEEEEeC------CCcEEEEEEeccCcCChhhhHHHHHHHHHHHhcCCcceeeeeeEEEcCCC
Q 038766 11 TGSFSENNIIGNSNLSTVYKGRLE------DGEIVAVKKLNFHQFSAESDKSFYREAKTLKELKHRNLVKVLGYAWESGK 84 (299)
Q Consensus 11 ~~~y~~~~~lg~g~~~~v~~~~~~------~~~~~~vK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~ 84 (299)
.++|.+.+.||+|+||+||+|.+. ++..||||++.. ......+.+.+|++++++++||||+++++++.+. .
T Consensus 40 ~~d~~l~~~LG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~l~~--~~~~~~~~f~~E~~il~~l~HpnIV~l~g~~~~~-~ 116 (329)
T 4aoj_A 40 RRDIVLKWELGEGAFGKVFLAECHNLLPEQDKMLVAVKALKE--ASESARQDFQREAELLTMLQHQHIVRFFGVCTEG-R 116 (329)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEESSSCC---CEEEEEEEESC--CSHHHHHHHHHHHHHHTTCCCTTBCCEEEEECSS-S
T ss_pred HHHeEEEEEEccCCCcEEEEEEECCcccCCCCeEEEEEEECc--CCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEEC-C
Confidence 456778899999999999999863 478899999863 3455667899999999999999999999977654 4
Q ss_pred eeEEEEeecCCCChHHHhcCCCC-----------CCCCCChhhHHHHHHHHHHHHHHhhcCCCCCeeeecccCCceeeCC
Q 038766 85 LKALILEYMENGSLESVIHGPGV-----------DHSRWTLPKRIDVLISVANGLDYLHSGYDIPIVHCDMKPSNILLDR 153 (299)
Q Consensus 85 ~~~lv~e~~~~~~L~~~~~~~~~-----------~~~~~~~~~~~~i~~qi~~~l~~lh~~~~~~~~H~dl~~~nil~~~ 153 (299)
..++||||+++|+|.+++..... ...++++.+++.++.||+.||+|||+. +++||||||+|||++.
T Consensus 117 ~~~lV~Ey~~~G~L~~~l~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gl~yLH~~---~iiHRDLKp~NILl~~ 193 (329)
T 4aoj_A 117 PLLMVFEYMRHGDLNRFLRSHGPDAKLLAGGEDVAPGPLGLGQLLAVASQVAAGMVYLAGL---HFVHRDLATRNCLVGQ 193 (329)
T ss_dssp SEEEEEECCTTCBHHHHHHTSSCC-----------CCSCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEEET
T ss_pred EEEEEEEcCCCCcHHHHHHhcCcccccccccccccCCCCCHHHHHHHHHHHHHHHHHHhcC---CeecccccHhhEEECC
Confidence 56999999999999999875421 234699999999999999999999999 9999999999999999
Q ss_pred CCcEEEeeeccccccccccccccccccccccCcccCChhhhcccCcCccccchhhhHHHHHHHh-CCCCCCCCccCCCCc
Q 038766 154 DFEAHVSDFGTSRMLDVHLQDLSSLSTAFQGTIGYLAPEFAYMRIVTTKVDVFSFGIVVMEFLT-KRRPTGLDEENGLSP 232 (299)
Q Consensus 154 ~~~v~l~df~~~~~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~DiwslG~~l~~l~~-g~~p~~~~~~~~~~~ 232 (299)
++.+||+|||++...... ..........+|+.|+|||++.+..++.++|||||||++|||+| |..||... ..
T Consensus 194 ~~~~Ki~DFGla~~~~~~--~~~~~~~~~~gt~~ymAPE~~~~~~~~~~sDvwS~Gvvl~Ellt~G~~Pf~~~-----~~ 266 (329)
T 4aoj_A 194 GLVVKIGDFGMSRDIYST--DYYRVGGRTMLPIRWMPPESILYRKFTTESDVWSFGVVLWEIFTYGKQPWYQL-----SN 266 (329)
T ss_dssp TTEEEECCCC------------------CCCCGGGCCHHHHTTCCCCHHHHHHHHHHHHHHHHTTSCCTTCSS-----CH
T ss_pred CCcEEEcccccceeccCC--CcceecCcccccccccChhhhcCCCCCccccccchHHHHHHHHcCCCCCCCCC-----CH
Confidence 999999999999755321 11222344568999999999999999999999999999999998 89999533 22
Q ss_pred hhHHHHHHHHHhcCccCcccccCccccchhhHhHHHHHHHHHHHHHHHHhcCCCCCCCCChhhhhc
Q 038766 233 ISLRQLVEKALANGINGVRQITDPKLVSSIYEEQEQHQVLEELFKLALVCTSSNPEDRPNMNELLI 298 (299)
Q Consensus 233 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rpt~~~il~ 298 (299)
.++.. ....... ... +..+++++.+|+.+||..||++|||++||++
T Consensus 267 ~~~~~---~i~~g~~-----~~~------------p~~~~~~~~~li~~cl~~dP~~RPs~~ei~~ 312 (329)
T 4aoj_A 267 TEAID---CITQGRE-----LER------------PRACPPEVYAIMRGCWQREPQQRHSIKDVHA 312 (329)
T ss_dssp HHHHH---HHHHTCC-----CCC------------CTTCCHHHHHHHHHHCCSSTTTSCCHHHHHH
T ss_pred HHHHH---HHHcCCC-----CCC------------cccccHHHHHHHHHHcCcChhHCcCHHHHHH
Confidence 22222 2221110 011 2234567999999999999999999999975
|
| >4g31_A Eukaryotic translation initiation factor 2-alpha; deletion mutant, catalytic domain, synthetic inhibitor, TRAN transferase inhibitor complex; HET: 0WH; 2.28A {Homo sapiens} PDB: 4g34_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-54 Score=363.90 Aligned_cols=256 Identities=21% Similarity=0.335 Sum_probs=191.2
Q ss_pred CCCCCCceeecCCcceEEEEEeC-CCcEEEEEEeccCcCChhhhHHHHHHHHHHHhcCCcceeeeeeEEEcCCC------
Q 038766 12 GSFSENNIIGNSNLSTVYKGRLE-DGEIVAVKKLNFHQFSAESDKSFYREAKTLKELKHRNLVKVLGYAWESGK------ 84 (299)
Q Consensus 12 ~~y~~~~~lg~g~~~~v~~~~~~-~~~~~~vK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~------ 84 (299)
++|.+.+.||+|+||+||+|.+. +|+.||||++.... .....+.+.+|+.++++++||||+++++++...+.
T Consensus 5 ~dy~~~~~lG~G~fg~V~~a~~~~~~~~vAiK~i~~~~-~~~~~~~~~~E~~il~~l~HpnIV~~~~~~~~~~~~~~~~~ 83 (299)
T 4g31_A 5 TDFEPIQCLGRGGFGVVFEAKNKVDDCNYAIKRIRLPN-RELAREKVMREVKALAKLEHPGIVRYFNAWLEKNTTEKLQP 83 (299)
T ss_dssp HHEEEEEEEEECC--EEEEEEETTTCCEEEEEEEEECS-SHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEEEC-------
T ss_pred hhCEEeeEEecCCCeEEEEEEECCCCCEEEEEEEeccC-CHHHHHHHHHHHHHHHhCCCCCCCeEEEEEEecCccccccc
Confidence 46899999999999999999874 68999999997543 34456788999999999999999999998765432
Q ss_pred -----eeEEEEeecCCCChHHHhcCCCCCCCCCChhhHHHHHHHHHHHHHHhhcCCCCCeeeecccCCceeeCCCCcEEE
Q 038766 85 -----LKALILEYMENGSLESVIHGPGVDHSRWTLPKRIDVLISVANGLDYLHSGYDIPIVHCDMKPSNILLDRDFEAHV 159 (299)
Q Consensus 85 -----~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lh~~~~~~~~H~dl~~~nil~~~~~~v~l 159 (299)
.+++||||+++++|.+++...+ .....+...++.++.||++||+|||++ +++||||||+|||++.+|.+||
T Consensus 84 ~~~~~~l~ivmE~~~gg~L~~~l~~~~-~~~~~~~~~~~~i~~qi~~al~ylH~~---~IiHRDlKp~NILl~~~~~vKl 159 (299)
T 4g31_A 84 SSPKVYLYIQMQLCRKENLKDWMNGRC-TIEERERSVCLHIFLQIAEAVEFLHSK---GLMHRDLKPSNIFFTMDDVVKV 159 (299)
T ss_dssp ---CEEEEEEEECCCSCCHHHHHHTCC-SGGGSCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEECTTCCEEE
T ss_pred cCCCcEEEEEEecCCCCcHHHHHHhcC-CCChhHHHHHHHHHHHHHHHHHHHHHC---cCccccCcHHHeEECCCCcEEE
Confidence 3689999999999999997443 222344566889999999999999999 9999999999999999999999
Q ss_pred eeeccccccccccccc--------cccccccccCcccCChhhhcccCcCccccchhhhHHHHHHHhCCCCCCCCccCCCC
Q 038766 160 SDFGTSRMLDVHLQDL--------SSLSTAFQGTIGYLAPEFAYMRIVTTKVDVFSFGIVVMEFLTKRRPTGLDEENGLS 231 (299)
Q Consensus 160 ~df~~~~~~~~~~~~~--------~~~~~~~~~~~~y~~PE~~~~~~~~~~~DiwslG~~l~~l~~g~~p~~~~~~~~~~ 231 (299)
+|||++..+....... ........||+.|+|||++.+..|+.++|||||||++|+|++ ||...
T Consensus 160 ~DFGla~~~~~~~~~~~~~~~~~~~~~~~~~~GT~~YmAPE~~~~~~y~~~~DiwSlGvilyell~---Pf~~~------ 230 (299)
T 4g31_A 160 GDFGLVTAMDQDEEEQTVLTPMPAYARHTGQVGTKLYMSPEQIHGNSYSHKVDIFSLGLILFELLY---PFSTQ------ 230 (299)
T ss_dssp CCCCCC--------------------------CCCTTSCHHHHTTCCCCTHHHHHHHHHHHHHHHS---CCSSH------
T ss_pred ccCccceecCCCccccccccccccccccCCcccCccccCHHHHcCCCCCCHHHHHHHHHHHHHHcc---CCCCc------
Confidence 9999998665322111 112234579999999999999999999999999999999996 66321
Q ss_pred chhHHHHHHHHHhcCccCcccccCccccchhhHhHHHHHHHHHHHHHHHHhcCCCCCCCCChhhhhcC
Q 038766 232 PISLRQLVEKALANGINGVRQITDPKLVSSIYEEQEQHQVLEELFKLALVCTSSNPEDRPNMNELLIT 299 (299)
Q Consensus 232 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rpt~~~il~~ 299 (299)
......+....... .+ ......++.+.+||.+||..||++|||++|+|+|
T Consensus 231 -~~~~~~~~~~~~~~--------~p---------~~~~~~~~~~~~li~~~L~~dP~~Rps~~eil~h 280 (299)
T 4g31_A 231 -MERVRTLTDVRNLK--------FP---------PLFTQKYPCEYVMVQDMLSPSPMERPEAINIIEN 280 (299)
T ss_dssp -HHHHHHHHHHHTTC--------CC---------HHHHHHCHHHHHHHHHHTCSSGGGSCCHHHHHTS
T ss_pred -cHHHHHHHHHhcCC--------CC---------CCCcccCHHHHHHHHHHcCCChhHCcCHHHHhcC
Confidence 11111111111100 00 1134455677899999999999999999999987
|
| >4gt4_A Tyrosine-protein kinase transmembrane receptor RO; ATP binding, phosphorylation, transferase; 2.41A {Homo sapiens} PDB: 3zzw_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2.4e-55 Score=368.89 Aligned_cols=257 Identities=22% Similarity=0.327 Sum_probs=203.8
Q ss_pred HhCCCCCCceeecCCcceEEEEEeC------CCcEEEEEEeccCcCChhhhHHHHHHHHHHHhcCCcceeeeeeEEEcCC
Q 038766 10 ATGSFSENNIIGNSNLSTVYKGRLE------DGEIVAVKKLNFHQFSAESDKSFYREAKTLKELKHRNLVKVLGYAWESG 83 (299)
Q Consensus 10 ~~~~y~~~~~lg~g~~~~v~~~~~~------~~~~~~vK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~ 83 (299)
-.+++++.+.||+|+||+||+|.+. +++.||||++... ......+.+.+|+.++++++||||++++|++...+
T Consensus 24 ~~~~~~~~~~lG~G~fG~Vykg~~~~~~~~~~~~~VAvK~l~~~-~~~~~~~~f~~E~~il~~l~HpNIV~l~g~~~~~~ 102 (308)
T 4gt4_A 24 SLSAVRFMEELGEDRFGKVYKGHLFGPAPGEQTQAVAIKTLKDK-AEGPLREEFRHEAMLRARLQHPNVVCLLGVVTKDQ 102 (308)
T ss_dssp CGGGEEEEEEEEECSSCEEEEEEEC-------CEEEEEEECCC--CCC-CHHHHHHHHHHHHHCCCTTBCCEEEEECSSS
T ss_pred CHHHCeEeeEeccCCCcEEEEEEEcCCccCCCCeEEEEEEECcc-cChHHHHHHHHHHHHHHhCCCCCCCCcceEEEECC
Confidence 3456777889999999999999852 4678999999643 33445678999999999999999999999776644
Q ss_pred CeeEEEEeecCCCChHHHhcCCC------------CCCCCCChhhHHHHHHHHHHHHHHhhcCCCCCeeeecccCCceee
Q 038766 84 KLKALILEYMENGSLESVIHGPG------------VDHSRWTLPKRIDVLISVANGLDYLHSGYDIPIVHCDMKPSNILL 151 (299)
Q Consensus 84 ~~~~lv~e~~~~~~L~~~~~~~~------------~~~~~~~~~~~~~i~~qi~~~l~~lh~~~~~~~~H~dl~~~nil~ 151 (299)
..++|+||+++|+|.+++.... .....+++..++.++.||+.||+|||++ +++||||||+|||+
T Consensus 103 -~~~lV~Ey~~~G~L~~~L~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gl~yLH~~---~iiHRDLK~~NILl 178 (308)
T 4gt4_A 103 -PLSMIFSYCSHGDLHEFLVMRSPHSDVGSTDDDRTVKSALEPPDFVHLVAQIAAGMEYLSSH---HVVHKDLATRNVLV 178 (308)
T ss_dssp -SCEEEEECCSSCBHHHHHHTTCSSCCCC-----CCEECCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEE
T ss_pred -EEEEEEEcCCCCcHHHHHHhhCccccccccccccccccCCCHHHHHHHHHHHHHHHHHHHhC---CCCCCCccccceEE
Confidence 5599999999999999985421 1134689999999999999999999999 99999999999999
Q ss_pred CCCCcEEEeeeccccccccccccccccccccccCcccCChhhhcccCcCccccchhhhHHHHHHHh-CCCCCCCCccCCC
Q 038766 152 DRDFEAHVSDFGTSRMLDVHLQDLSSLSTAFQGTIGYLAPEFAYMRIVTTKVDVFSFGIVVMEFLT-KRRPTGLDEENGL 230 (299)
Q Consensus 152 ~~~~~v~l~df~~~~~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~DiwslG~~l~~l~~-g~~p~~~~~~~~~ 230 (299)
+.++.+||+|||++...... ..........+|+.|+|||++.+..++.++|||||||++|||+| |..||...
T Consensus 179 ~~~~~~Ki~DFGlar~~~~~--~~~~~~~~~~gt~~ymAPE~l~~~~~s~ksDVwSfGvvl~El~t~g~~Pf~~~----- 251 (308)
T 4gt4_A 179 YDKLNVKISDLGLFREVYAA--DYYKLLGNSLLPIRWMAPEAIMYGKFSIDSDIWSYGVVLWEVFSYGLQPYCGY----- 251 (308)
T ss_dssp CGGGCEEECCSCCBCGGGGG--GCBCSSSSSCBCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCTTTTC-----
T ss_pred CCCCCEEECCcccceeccCC--CceeEecccccCCcccCHHHHhCCCCCccchhhhHHHHHHHHHhCCCCCCCCC-----
Confidence 99999999999999765421 12223445678999999999999999999999999999999998 88998533
Q ss_pred CchhHHHHHHHHHhcCccCcccccCccccchhhHhHHHHHHHHHHHHHHHHhcCCCCCCCCChhhhhc
Q 038766 231 SPISLRQLVEKALANGINGVRQITDPKLVSSIYEEQEQHQVLEELFKLALVCTSSNPEDRPNMNELLI 298 (299)
Q Consensus 231 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rpt~~~il~ 298 (299)
...++.. ........ +. +..++.++.+|+.+||..||++|||++||++
T Consensus 252 ~~~~~~~---~i~~~~~~-----~~------------p~~~~~~~~~li~~C~~~dP~~RPs~~ei~~ 299 (308)
T 4gt4_A 252 SNQDVVE---MIRNRQVL-----PC------------PDDCPAWVYALMIECWNEFPSRRPRFKDIHS 299 (308)
T ss_dssp CHHHHHH---HHHTTCCC-----CC------------CTTCCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred CHHHHHH---HHHcCCCC-----CC------------cccchHHHHHHHHHHcCCChhHCcCHHHHHH
Confidence 2223322 22211100 00 2234567999999999999999999999975
|
| >4ase_A Vascular endothelial growth factor receptor 2; transferase, angiogenesis, signaling protein, phosphorylatio receptor, inhibitor; HET: AV9; 1.83A {Homo sapiens} PDB: 4agd_A* 4asd_A* 4agc_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-54 Score=371.20 Aligned_cols=268 Identities=23% Similarity=0.338 Sum_probs=213.1
Q ss_pred CChHHHHHHhCCCCCCceeecCCcceEEEEEeCC------CcEEEEEEeccCcCChhhhHHHHHHHHHHHhcCC-cceee
Q 038766 2 FDRTEIENATGSFSENNIIGNSNLSTVYKGRLED------GEIVAVKKLNFHQFSAESDKSFYREAKTLKELKH-RNLVK 74 (299)
Q Consensus 2 ~~~~~~~~~~~~y~~~~~lg~g~~~~v~~~~~~~------~~~~~vK~~~~~~~~~~~~~~~~~e~~~l~~l~h-~~i~~ 74 (299)
|+..+||+-.++|.+.+.||+|+||+||+|.+.. ++.||||++... ......+.+.+|+.+++++.| |||++
T Consensus 54 ~~~~~wEi~~~~~~l~~~LG~G~fG~Vy~a~~~~~~~~~~~k~VAvK~l~~~-~~~~~~~~~~~E~~il~~l~hhpnIV~ 132 (353)
T 4ase_A 54 YDASKWEFPRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEG-ATHSEHRALMSELKILIHIGHHLNVVN 132 (353)
T ss_dssp CCHHHHBCCGGGEEEEEEEEECSSEEEEEEEEETSSSTTCEEEEEEEEECTT-CCHHHHHHHHHHHHHHHHHCCCTTBCC
T ss_pred CCCcccEecHHHeEEeeEEecCCCeEEEEEEEcCCCcccCCeEEEEEEEccc-cChHHHHHHHHHHHHHHHcCCCCcEEE
Confidence 4556788889999999999999999999998532 467999998643 334456778999999999975 89999
Q ss_pred eeeEEEcCCCeeEEEEeecCCCChHHHhcCCC------------CCCCCCChhhHHHHHHHHHHHHHHhhcCCCCCeeee
Q 038766 75 VLGYAWESGKLKALILEYMENGSLESVIHGPG------------VDHSRWTLPKRIDVLISVANGLDYLHSGYDIPIVHC 142 (299)
Q Consensus 75 ~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~------------~~~~~~~~~~~~~i~~qi~~~l~~lh~~~~~~~~H~ 142 (299)
+++++...+..+++||||+++|+|.+++.... .....+++..+..++.||+.||+|||++ +++||
T Consensus 133 l~g~~~~~~~~~~iV~Ey~~~G~L~~~L~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qia~gl~yLH~~---~iiHR 209 (353)
T 4ase_A 133 LLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLASR---KCIHR 209 (353)
T ss_dssp EEEEECCTTSCCEEEEECCTTEEHHHHHHHTGGGBCCC-------CTTCBCHHHHHHHHHHHHHHHHHHHHT---TCCCS
T ss_pred EEEEEEecCCEEEEEEEcCCCCCHHHHHHhcccccccccccchhhccccCCHHHHHHHHHHHHHHHHhHhhC---CeecC
Confidence 99988776777799999999999999986321 1235689999999999999999999999 99999
Q ss_pred cccCCceeeCCCCcEEEeeeccccccccccccccccccccccCcccCChhhhcccCcCccccchhhhHHHHHHHh-CCCC
Q 038766 143 DMKPSNILLDRDFEAHVSDFGTSRMLDVHLQDLSSLSTAFQGTIGYLAPEFAYMRIVTTKVDVFSFGIVVMEFLT-KRRP 221 (299)
Q Consensus 143 dl~~~nil~~~~~~v~l~df~~~~~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~DiwslG~~l~~l~~-g~~p 221 (299)
||||+|||++.++.+||+|||++..+... ..........+|+.|+|||++.+..++.++|||||||++|||+| |..|
T Consensus 210 DLK~~NILl~~~~~vKi~DFGlar~~~~~--~~~~~~~~~~gt~~ymAPE~l~~~~y~~ksDVwS~Gv~l~El~t~G~~P 287 (353)
T 4ase_A 210 DLAARNILLSEKNVVKICDFGLARDIYKD--PDYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASP 287 (353)
T ss_dssp CCSGGGEEECGGGCEEECCCGGGSCTTTC--TTSEEETTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHTTTSCCS
T ss_pred ccCccceeeCCCCCEEECcchhhhhcccC--CCceeeccccccccccCHHHHhcCCCCCcccEeehHHHHHHHHhCCCCC
Confidence 99999999999999999999999765421 11122345568999999999999999999999999999999998 8999
Q ss_pred CCCCccCCCCchhHHHHHHHHHhcCccCcccccCccccchhhHhHHHHHHHHHHHHHHHHhcCCCCCCCCChhhhhcC
Q 038766 222 TGLDEENGLSPISLRQLVEKALANGINGVRQITDPKLVSSIYEEQEQHQVLEELFKLALVCTSSNPEDRPNMNELLIT 299 (299)
Q Consensus 222 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rpt~~~il~~ 299 (299)
|..... ...+...+ ..+.. ... +...++++.+++.+||..||++|||+++|++|
T Consensus 288 f~~~~~----~~~~~~~i----~~g~~----~~~------------p~~~~~~~~~li~~c~~~dP~~RPt~~eil~~ 341 (353)
T 4ase_A 288 YPGVKI----DEEFCRRL----KEGTR----MRA------------PDYTTPEMYQTMLDCWHGEPSQRPTFSELVEH 341 (353)
T ss_dssp STTCCC----SHHHHHHH----HHTCC----CCC------------CTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred CCCCCH----HHHHHHHH----HcCCC----CCC------------CccCCHHHHHHHHHHcCcChhHCcCHHHHHHH
Confidence 954321 11222222 11110 001 22335679999999999999999999999875
|
| >4f9c_A Cell division cycle 7-related protein kinase; Ser/Thr protein kinase, transferase, phosphorylation, cell C cell division, mitosis, S phase; HET: 0SX; 2.08A {Homo sapiens} PDB: 4f99_A* 4f9b_A* 4f9a_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7.4e-53 Score=361.83 Aligned_cols=206 Identities=22% Similarity=0.305 Sum_probs=170.4
Q ss_pred HHHHHHhCCCCCCceeecCCcceEEEEEeC----CCcEEEEEEeccCcCChhhhHHHHHHHHHHHhc-CCcceeeeeeEE
Q 038766 5 TEIENATGSFSENNIIGNSNLSTVYKGRLE----DGEIVAVKKLNFHQFSAESDKSFYREAKTLKEL-KHRNLVKVLGYA 79 (299)
Q Consensus 5 ~~~~~~~~~y~~~~~lg~g~~~~v~~~~~~----~~~~~~vK~~~~~~~~~~~~~~~~~e~~~l~~l-~h~~i~~~~~~~ 79 (299)
+.++.+.++|++.+.||+|+||+||+|+++ +++.||+|++... ....++.+|+++++.+ .||||+++++++
T Consensus 14 ~~~p~l~~~Y~i~~~lG~G~fg~Vy~a~~~~~~~~~~~vAiK~i~~~----~~~~~~~~E~~~l~~~~~h~nIv~l~~~~ 89 (361)
T 4f9c_A 14 EAVPQLSNVFKIEDKIGEGTFSSVYLATAQLQVGPEEKIALKHLIPT----SHPIRIAAELQCLTVAGGQDNVMGVKYCF 89 (361)
T ss_dssp HHSGGGGGTCEEEEEEEECSSEEEEEEEEEBTTSCEEEEEEEEECTT----SCHHHHHHHHHHHHHTCSBTTBCCCSEEE
T ss_pred HhcCCccCcEEEEEEEecccCcEEEEEEEcccCCCCCEEEEEEEccc----cCHHHHHHHHHHHHHhcCCCCCceEEEEE
Confidence 445667899999999999999999999753 4788999998532 3445678899999998 599999999966
Q ss_pred EcCCCeeEEEEeecCCCChHHHhcCCCCCCCCCChhhHHHHHHHHHHHHHHhhcCCCCCeeeecccCCceeeCCC-CcEE
Q 038766 80 WESGKLKALILEYMENGSLESVIHGPGVDHSRWTLPKRIDVLISVANGLDYLHSGYDIPIVHCDMKPSNILLDRD-FEAH 158 (299)
Q Consensus 80 ~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lh~~~~~~~~H~dl~~~nil~~~~-~~v~ 158 (299)
.. .+..++||||+++++|.++++ .+++.++..++.|++.||+|||++ +++||||||+|||++.+ +.+|
T Consensus 90 ~~-~~~~~lvmE~~~g~~L~~~~~-------~l~~~~~~~~~~qll~al~ylH~~---gIiHRDiKPeNiLl~~~~~~~k 158 (361)
T 4f9c_A 90 RK-NDHVVIAMPYLEHESFLDILN-------SLSFQEVREYMLNLFKALKRIHQF---GIVHRDVKPSNFLYNRRLKKYA 158 (361)
T ss_dssp EE-TTEEEEEEECCCCCCHHHHHT-------TCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEEETTTTEEE
T ss_pred EE-CCEEEEEEeCCCcccHHHHHc-------CCCHHHHHHHHHHHHHHHHHHHHC---CeEeCcCCHHHeEEeCCCCeEE
Confidence 65 556799999999999999995 589999999999999999999999 99999999999999876 8999
Q ss_pred Eeeecccccccccccc------------------------ccccccccccCcccCChhhhccc-CcCccccchhhhHHHH
Q 038766 159 VSDFGTSRMLDVHLQD------------------------LSSLSTAFQGTIGYLAPEFAYMR-IVTTKVDVFSFGIVVM 213 (299)
Q Consensus 159 l~df~~~~~~~~~~~~------------------------~~~~~~~~~~~~~y~~PE~~~~~-~~~~~~DiwslG~~l~ 213 (299)
|+|||++......... .........||+.|+|||++.+. .++.++||||+||++|
T Consensus 159 l~DFGla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~y~~~~DiWSlG~il~ 238 (361)
T 4f9c_A 159 LVDFGLAQGTHDTKIELLKFVQSEAQQERCSQNKCSICLSRRQQVAPRAGTPGFRAPEVLTKCPNQTTAIDMWSAGVIFL 238 (361)
T ss_dssp ECCCTTCEECTTCSCGGGGGC--------------------------CCCCGGGCCHHHHTTCSCCCTHHHHHHHHHHHH
T ss_pred ECcCCCCcccCCccccccccccccccccccccccccccccccccccccccCccccCHHHHcCCCCCCCccchhhhHHHHH
Confidence 9999999754321110 01112345689999999998875 5899999999999999
Q ss_pred HHHhCCCCCCCC
Q 038766 214 EFLTKRRPTGLD 225 (299)
Q Consensus 214 ~l~~g~~p~~~~ 225 (299)
+|++|..||...
T Consensus 239 ell~G~~Pf~~~ 250 (361)
T 4f9c_A 239 SLLSGRYPFYKA 250 (361)
T ss_dssp HHHHTCSSSSCC
T ss_pred HHHHCCCCCCCC
Confidence 999999999543
|
| >3hmm_A TGF-beta receptor type-1; ALK5, kinase, inhibitor, quinazoline, aortic aneurysm, ATP-binding, craniosynostosis, disease mutation, disulfide bond; HET: 855; 1.70A {Homo sapiens} PDB: 1vjy_A* 3gxl_A* 3tzm_A* 2wot_A* 2wou_A* 1py5_A* 1rw8_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7.7e-53 Score=354.20 Aligned_cols=269 Identities=22% Similarity=0.290 Sum_probs=196.5
Q ss_pred HhCCCCCCceeecCCcceEEEEEeCCCcEEEEEEeccCcCChhhhHHHHHHHHHHHhcCCcceeeeeeEEEcCCC---ee
Q 038766 10 ATGSFSENNIIGNSNLSTVYKGRLEDGEIVAVKKLNFHQFSAESDKSFYREAKTLKELKHRNLVKVLGYAWESGK---LK 86 (299)
Q Consensus 10 ~~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~vK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~---~~ 86 (299)
+..+|.+.+.||+|+||+||+|++. |+.||||++.... ........|+..+.+++||||+++++++...+. .+
T Consensus 1 Iar~i~L~~~iG~G~fG~Vy~~~~~-g~~VAvK~l~~~~---~~~~~~e~Ei~~~~~l~HpNIv~l~g~~~~~~~~~~~~ 76 (303)
T 3hmm_A 1 IARTIVLQESIGKGRFGEVWRGKWR-GEEVAVKIFSSRE---ERSWFREAEIYQTVMLRHENILGFIAADNKDNGTWTQL 76 (303)
T ss_dssp CGGGEEEEEEEEECSSSEEEEEEET-TEEEEEEEECGGG---HHHHHHHHHHHTSTTCCCTTBCCEEEEEEEECSSSEEE
T ss_pred CCcEEEEEEEEeeCCCeEEEEEEEC-CEEEEEEEECccc---hhhHHHHHHHHHHhcCCCCCCCcEEEEEEecCCCceEE
Confidence 3567889999999999999999984 8899999985321 222223346666678899999999998876542 46
Q ss_pred EEEEeecCCCChHHHhcCCCCCCCCCChhhHHHHHHHHHHHHHHhhcC-----CCCCeeeecccCCceeeCCCCcEEEee
Q 038766 87 ALILEYMENGSLESVIHGPGVDHSRWTLPKRIDVLISVANGLDYLHSG-----YDIPIVHCDMKPSNILLDRDFEAHVSD 161 (299)
Q Consensus 87 ~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lh~~-----~~~~~~H~dl~~~nil~~~~~~v~l~d 161 (299)
++||||+++|+|.+++. ..+++++.+..++.|++.||+|||++ ++.+++||||||+|||++.++.+||+|
T Consensus 77 ~lV~Ey~~~gsL~~~l~-----~~~l~~~~~~~i~~~ia~gl~ylH~~~~~~~~~~~IiHRDlKp~NILl~~~~~~Ki~D 151 (303)
T 3hmm_A 77 WLVSDYHEHGSLFDYLN-----RYTVTVEGMIKLALSTASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIAD 151 (303)
T ss_dssp EEEEECCTTCBHHHHHH-----HCCBCHHHHHHHHHHHHHHHHHHHCCBCSTTCBCCEECSCCCGGGEEECTTSCEEECC
T ss_pred EEEecCCCCCcHHHHHH-----hCCCCHHHHHHHHHHHHHHHHHHHHhhhhccCCCCEeeccCCcccEEECCCCCEEEEe
Confidence 99999999999999995 34689999999999999999999974 123899999999999999999999999
Q ss_pred eccccccccccccccccccccccCcccCChhhhccc------CcCccccchhhhHHHHHHHhCCCCCCCCccCCCCch--
Q 038766 162 FGTSRMLDVHLQDLSSLSTAFQGTIGYLAPEFAYMR------IVTTKVDVFSFGIVVMEFLTKRRPTGLDEENGLSPI-- 233 (299)
Q Consensus 162 f~~~~~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~------~~~~~~DiwslG~~l~~l~~g~~p~~~~~~~~~~~~-- 233 (299)
||++..................||+.|+|||++.+. .++.++|||||||++|||++|..|+...........
T Consensus 152 FGla~~~~~~~~~~~~~~~~~~GT~~ymAPE~l~~~~~~~~~~~~~k~DVwS~Gvvl~El~tg~~~~~~~~~~~~p~~~~ 231 (303)
T 3hmm_A 152 LGLAVRHDSATDTIDIAPNHRVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHEDYQLPYYDL 231 (303)
T ss_dssp CTTCEEEETTTTEESCC-----CCGGGCCHHHHTTCSCTTCHHHHHHHHHHHHHHHHHHHHHTBCBTTBCCCCCCTTTTT
T ss_pred CCCCccccCCCCceeeecccccccccccCHHHhcccccccCCccChhHhhhhHHHHHHHHHHCCCCCCccccccccchhc
Confidence 999976553222222233456799999999998764 467899999999999999999888764432221111
Q ss_pred -----hHHHHHHHHHhcCccCcccccCccccchhhHhHHHHHHHHHHHHHHHHhcCCCCCCCCChhhhhc
Q 038766 234 -----SLRQLVEKALANGINGVRQITDPKLVSSIYEEQEQHQVLEELFKLALVCTSSNPEDRPNMNELLI 298 (299)
Q Consensus 234 -----~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rpt~~~il~ 298 (299)
.............. .+..... ......+..+.+|+.+||..||++|||+.+|++
T Consensus 232 ~~~~~~~~~~~~~~~~~~~-------rp~~p~~----~~~~~~~~~l~~li~~cl~~dP~~RPt~~ei~~ 290 (303)
T 3hmm_A 232 VPSDPSVEEMRKVVCEQKL-------RPNIPNR----WQSCEALRVMAKIMRECWYANGAARLTALRIKK 290 (303)
T ss_dssp SCSSCCHHHHHHHHTTSCC-------CCCCCGG----GGSSHHHHHHHHHHHTTCCSSGGGSCCHHHHHH
T ss_pred ccccchHHHHHHHHhcccC-------CCCCCcc----ccchHHHHHHHHHHHHHcccCHhHCcCHHHHHH
Confidence 11222221111111 1111110 112345667899999999999999999999975
|
| >3v5w_A G-protein coupled receptor kinase 2; inhibitor complex, protein kinase, beta propeller, RGS homol domain; HET: 8PR; 2.07A {Homo sapiens} PDB: 3cik_A* 3krw_A* 3krx_A* 1omw_A 1ym7_A 2bcj_A* 3uzs_A 3uzt_A 3pvu_A* 3psc_A* 3pvw_A* 1bak_A | Back alignment and structure |
|---|
Probab=100.00 E-value=5e-51 Score=369.09 Aligned_cols=252 Identities=21% Similarity=0.264 Sum_probs=200.9
Q ss_pred hCCCCCCceeecCCcceEEEEEeC-CCcEEEEEEeccCcCCh-hhhHHHHH---HHHHHHhcCCcceeeeeeEEEcCCCe
Q 038766 11 TGSFSENNIIGNSNLSTVYKGRLE-DGEIVAVKKLNFHQFSA-ESDKSFYR---EAKTLKELKHRNLVKVLGYAWESGKL 85 (299)
Q Consensus 11 ~~~y~~~~~lg~g~~~~v~~~~~~-~~~~~~vK~~~~~~~~~-~~~~~~~~---e~~~l~~l~h~~i~~~~~~~~~~~~~ 85 (299)
.++|.+.+.||+|+||.||+|++. +|+.||+|++....... ........ ++.+++.++||||+++++++.+ ...
T Consensus 188 lddf~i~k~LG~G~fG~V~la~~~~tg~~~AiK~i~K~~i~~~~~~~~~~~E~~~l~ll~~~~HP~IV~l~~~f~~-~~~ 266 (689)
T 3v5w_A 188 MNDFSVHRIIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMSYAFHT-PDK 266 (689)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHHSSSCCTTBCCEEEEEEC-SSE
T ss_pred hHHeEEEEEEecccCeEEEEEEECCCCCEEEEEEEeHHHcchhhhHHHHHHHHHHHHHHhhCCCCCEeEEEEEEEE-CCE
Confidence 468999999999999999999874 59999999996433221 12223333 4566677789999999996655 556
Q ss_pred eEEEEeecCCCChHHHhcCCCCCCCCCChhhHHHHHHHHHHHHHHhhcCCCCCeeeecccCCceeeCCCCcEEEeeeccc
Q 038766 86 KALILEYMENGSLESVIHGPGVDHSRWTLPKRIDVLISVANGLDYLHSGYDIPIVHCDMKPSNILLDRDFEAHVSDFGTS 165 (299)
Q Consensus 86 ~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lh~~~~~~~~H~dl~~~nil~~~~~~v~l~df~~~ 165 (299)
+|+||||++||+|.+++. ....+++..+..++.||+.||.|||++ +|+||||||+|||++.+|.+||+|||++
T Consensus 267 lylVmEy~~GGdL~~~l~----~~~~l~E~~a~~y~~qIl~aL~yLH~~---gIiHRDLKPeNILld~~G~vKL~DFGlA 339 (689)
T 3v5w_A 267 LSFILDLMNGGDLHYHLS----QHGVFSEADMRFYAAEIILGLEHMHNR---FVVYRDLKPANILLDEHGHVRISDLGLA 339 (689)
T ss_dssp EEEEECCCCSCBHHHHHH----HHCCCCHHHHHHHHHHHHHHHHHHHTT---TEECCCCSGGGEEECTTSCEEECCCTTC
T ss_pred EEEEEecCCCCcHHHHHH----hcCCCCHHHHHHHHHHHHHHHHHHHHC---CccccCCchHHeEEeCCCCEEeccccee
Confidence 799999999999999997 445899999999999999999999999 9999999999999999999999999999
Q ss_pred cccccccccccccccccccCcccCChhhhc-ccCcCccccchhhhHHHHHHHhCCCCCCCCccCCCCchhHHHHHHHHHh
Q 038766 166 RMLDVHLQDLSSLSTAFQGTIGYLAPEFAY-MRIVTTKVDVFSFGIVVMEFLTKRRPTGLDEENGLSPISLRQLVEKALA 244 (299)
Q Consensus 166 ~~~~~~~~~~~~~~~~~~~~~~y~~PE~~~-~~~~~~~~DiwslG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~ 244 (299)
..+.. .......||+.|+|||++. +..|+.++|+|||||++|+|++|..||....... ..........
T Consensus 340 ~~~~~------~~~~t~~GTp~YmAPEvl~~~~~y~~~vDiWSLGvilYEmLtG~~PF~~~~~~~-----~~~i~~~i~~ 408 (689)
T 3v5w_A 340 CDFSK------KKPHASVGTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKD-----KHEIDRMTLT 408 (689)
T ss_dssp EECSS------CCCCSCCSCGGGCCHHHHSTTCCCCTHHHHHHHHHHHHHHHHSSCTTCGGGCCC-----HHHHHHHHHH
T ss_pred eecCC------CCCCCccCCcCccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHH-----HHHHHHhhcC
Confidence 76542 2234567999999999986 4679999999999999999999999996543221 1222222221
Q ss_pred cCccCcccccCccccchhhHhHHHHHHHHHHHHHHHHhcCCCCCCCCC-----hhhhhcC
Q 038766 245 NGINGVRQITDPKLVSSIYEEQEQHQVLEELFKLALVCTSSNPEDRPN-----MNELLIT 299 (299)
Q Consensus 245 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rpt-----~~~il~~ 299 (299)
... .. +..++.++.+||.+||..||++|++ ++||++|
T Consensus 409 ~~~-~~-----------------p~~~S~~a~dLI~~lL~~dP~~Rl~~~~~ga~ei~~H 450 (689)
T 3v5w_A 409 MAV-EL-----------------PDSFSPELRSLLEGLLQRDVNRRLGCLGRGAQEVKES 450 (689)
T ss_dssp CCC-CC-----------------CTTSCHHHHHHHHHHTCSCGGGCTTCSSSTHHHHTTS
T ss_pred CCC-CC-----------------CccCCHHHHHHHHHHccCCHhHCCCCCCCCHHHHhcC
Confidence 110 00 2234678999999999999999998 6999987
|
| >3uto_A Twitchin; kinase, muscle sarcomere, transferase; HET: FLC P33; 2.40A {Caenorhabditis elegans} PDB: 1koa_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-50 Score=367.99 Aligned_cols=254 Identities=20% Similarity=0.300 Sum_probs=208.0
Q ss_pred HhCCCCCCceeecCCcceEEEEEeC-CCcEEEEEEeccCcCChhhhHHHHHHHHHHHhcCCcceeeeeeEEEcCCCeeEE
Q 038766 10 ATGSFSENNIIGNSNLSTVYKGRLE-DGEIVAVKKLNFHQFSAESDKSFYREAKTLKELKHRNLVKVLGYAWESGKLKAL 88 (299)
Q Consensus 10 ~~~~y~~~~~lg~g~~~~v~~~~~~-~~~~~~vK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~l 88 (299)
+.++|.+.+.||+|+||+||+|.++ +|+.||+|++... .....+.+.+|+.+|+.++||||+++++++.. ...+++
T Consensus 155 il~~Y~i~~~lG~G~fg~V~~~~~~~tg~~~AiK~i~~~--~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~-~~~~~i 231 (573)
T 3uto_A 155 VLDHYDIHEELGTGAFGVVHRVTERATGNNFAAKFVMTP--HESDKETVRKEIQTMSVLRHPTLVNLHDAFED-DNEMVM 231 (573)
T ss_dssp GGGTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECC--SHHHHHHHHHHHHHHHHTCCTTBCCEEEEEEC-SSEEEE
T ss_pred CccccEEEEEEeeccCeEEEEEEECCCCCEEEEEEEecc--chhhHHHHHHHHHHHHhCCCCCCCeEEEEEEE-CCEEEE
Confidence 4578999999999999999999874 6999999998643 33446778899999999999999999996655 566799
Q ss_pred EEeecCCCChHHHhcCCCCCCCCCChhhHHHHHHHHHHHHHHhhcCCCCCeeeecccCCceeeCCC--CcEEEeeecccc
Q 038766 89 ILEYMENGSLESVIHGPGVDHSRWTLPKRIDVLISVANGLDYLHSGYDIPIVHCDMKPSNILLDRD--FEAHVSDFGTSR 166 (299)
Q Consensus 89 v~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lh~~~~~~~~H~dl~~~nil~~~~--~~v~l~df~~~~ 166 (299)
||||+.||+|.+++.. ....+++.++..++.||+.||+|||++ +++||||||+|||++.+ +.+||+|||++.
T Consensus 232 v~E~~~gg~L~~~i~~---~~~~l~e~~~~~~~~qi~~al~ylH~~---~iiHRDlKp~Nill~~~~~~~vKl~DFG~a~ 305 (573)
T 3uto_A 232 IYEFMSGGELFEKVAD---EHNKMSEDEAVEYMRQVCKGLCHMHEN---NYVHLDLKPENIMFTTKRSNELKLIDFGLTA 305 (573)
T ss_dssp EEECCCCCBHHHHHTC---TTSCEEHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEESSSSCCCEEECCCSSCE
T ss_pred EEeecCCCcHHHHHHH---hCCCCCHHHHHHHHHHHHHHHHHHHHC---CeeeccCChhhccccCCCCCCEEEeecccee
Confidence 9999999999998853 235799999999999999999999999 99999999999999854 899999999998
Q ss_pred ccccccccccccccccccCcccCChhhhcccCcCccccchhhhHHHHHHHhCCCCCCCCccCCCCchhHHHHHHHHHhcC
Q 038766 167 MLDVHLQDLSSLSTAFQGTIGYLAPEFAYMRIVTTKVDVFSFGIVVMEFLTKRRPTGLDEENGLSPISLRQLVEKALANG 246 (299)
Q Consensus 167 ~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~DiwslG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~ 246 (299)
.+.. ........||+.|+|||++.+..|+.++|||||||++|+|++|..||.... . .+.+..+....
T Consensus 306 ~~~~-----~~~~~~~~GT~~y~APEv~~~~~y~~~~DiWSlGvilyeml~G~~Pf~~~~-----~---~~~~~~i~~~~ 372 (573)
T 3uto_A 306 HLDP-----KQSVKVTTGTAEFAAPEVAEGKPVGYYTDMWSVGVLSYILLSGLSPFGGEN-----D---DETLRNVKSCD 372 (573)
T ss_dssp ECCT-----TSEEEEECSSGGGCCHHHHTTCCBCHHHHHHHHHHHHHHHHHSCCSSCCSS-----H---HHHHHHHHTTC
T ss_pred EccC-----CCceeeeEECccccCHHHhCCCCCCcHHHHHHHHHHHHHHHHCCCCCCCcC-----H---HHHHHHHHhCC
Confidence 7542 222345578999999999999999999999999999999999999995432 1 22232222211
Q ss_pred ccCcccccCccccchhhHhHHHHHHHHHHHHHHHHhcCCCCCCCCChhhhhcC
Q 038766 247 INGVRQITDPKLVSSIYEEQEQHQVLEELFKLALVCTSSNPEDRPNMNELLIT 299 (299)
Q Consensus 247 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rpt~~~il~~ 299 (299)
. .+... ....++.++.+||++||..||.+|||++|+|+|
T Consensus 373 ~----~~~~~----------~~~~~s~~~~dli~~~L~~dp~~R~t~~e~l~H 411 (573)
T 3uto_A 373 W----NMDDS----------AFSGISEDGKDFIRKLLLADPNTRMTIHQALEH 411 (573)
T ss_dssp C----CCCSG----------GGTTSCHHHHHHHHTTSCSSGGGSCCHHHHHHS
T ss_pred C----CCCcc----------cccCCCHHHHHHHHHHccCChhHCcCHHHHhcC
Confidence 1 01111 123456789999999999999999999999987
|
| >3fe3_A MAP/microtubule affinity-regulating kinase 3; serine/threonine protein kinase, MARK;PAR-1, UBA domai TAK1;P78;MARK3, ATP-binding; 1.90A {Homo sapiens} PDB: 2qnj_A 1y8g_A* 1zmw_A 1zmu_A 1zmv_A 2wzj_A 2r0i_A 2hak_A 3iec_A | Back alignment and structure |
|---|
Probab=100.00 E-value=6.6e-50 Score=340.76 Aligned_cols=255 Identities=25% Similarity=0.382 Sum_probs=210.6
Q ss_pred HHHHHhCCCCCCceeecCCcceEEEEEe-CCCcEEEEEEeccCcCChhhhHHHHHHHHHHHhcCCcceeeeeeEEEcCCC
Q 038766 6 EIENATGSFSENNIIGNSNLSTVYKGRL-EDGEIVAVKKLNFHQFSAESDKSFYREAKTLKELKHRNLVKVLGYAWESGK 84 (299)
Q Consensus 6 ~~~~~~~~y~~~~~lg~g~~~~v~~~~~-~~~~~~~vK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~ 84 (299)
+.....++|++.+.||+|+||.||+|.+ .+|+.||+|++............+.+|+.+++.++||||+++++++.. .+
T Consensus 9 ~~~~~~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~-~~ 87 (328)
T 3fe3_A 9 DEQPHIGNYRLLKTIGKGNFAKVKLARHILTGREVAIKIIDKTQLNPTSLQKLFREVRIMKILNHPNIVKLFEVIET-EK 87 (328)
T ss_dssp --CCEETTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEC-SS
T ss_pred ccCCccCCEEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEhhcCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEE-CC
Confidence 3445678999999999999999999987 579999999998766667777889999999999999999999997654 55
Q ss_pred eeEEEEeecCCCChHHHhcCCCCCCCCCChhhHHHHHHHHHHHHHHhhcCCCCCeeeecccCCceeeCCCCcEEEeeecc
Q 038766 85 LKALILEYMENGSLESVIHGPGVDHSRWTLPKRIDVLISVANGLDYLHSGYDIPIVHCDMKPSNILLDRDFEAHVSDFGT 164 (299)
Q Consensus 85 ~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lh~~~~~~~~H~dl~~~nil~~~~~~v~l~df~~ 164 (299)
..++|+||+.+++|.+++. ...++++.+++.++.|++.||+|||++ +++||||||+||+++.++.++|+|||+
T Consensus 88 ~~~lv~e~~~~~~L~~~l~----~~~~l~~~~~~~~~~qi~~al~~lH~~---~ivHrDlkp~NIll~~~~~~kl~DFG~ 160 (328)
T 3fe3_A 88 TLYLIMEYASGGEVFDYLV----AHGRMKEKEARSKFRQIVSAVQYCHQK---RIVHRDLKAENLLLDADMNIKIADFGF 160 (328)
T ss_dssp EEEEEECCCTTCBHHHHHH----HHCCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEECTTSCEEECSTTC
T ss_pred EEEEEEECCCCCcHHHHHH----HcCCCCHHHHHHHHHHHHHHHHHHHHC---CEeccCCCHHHEEEcCCCCEEEeeccC
Confidence 6799999999999999986 445799999999999999999999999 999999999999999999999999999
Q ss_pred ccccccccccccccccccccCcccCChhhhcccCcC-ccccchhhhHHHHHHHhCCCCCCCCccCCCCchhHHHHHHHHH
Q 038766 165 SRMLDVHLQDLSSLSTAFQGTIGYLAPEFAYMRIVT-TKVDVFSFGIVVMEFLTKRRPTGLDEENGLSPISLRQLVEKAL 243 (299)
Q Consensus 165 ~~~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~-~~~DiwslG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~ 243 (299)
+..... ........+|+.|+|||++.+..+. .++|||||||++|+|++|..||.... . ........
T Consensus 161 a~~~~~-----~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~-----~---~~~~~~i~ 227 (328)
T 3fe3_A 161 SNEFTV-----GGKLDAFCGAPPYAAPELFQGKKYDGPEVDVWSLGVILYTLVSGSLPFDGQN-----L---KELRERVL 227 (328)
T ss_dssp CGGGSS-----SCGGGTTSSSGGGCCHHHHHTCCCCSHHHHHHHHHHHHHHHHHSSCSSCCSS-----H---HHHHHHHH
T ss_pred ceecCC-----CCccccccCCcceeCcccccCCCcCCchhhhhhhHHHHHHHHhCCCCCCCCC-----H---HHHHHHHH
Confidence 875442 2233455689999999999888765 78999999999999999999995431 1 22222222
Q ss_pred hcCccCcccccCccccchhhHhHHHHHHHHHHHHHHHHhcCCCCCCCCChhhhhcC
Q 038766 244 ANGINGVRQITDPKLVSSIYEEQEQHQVLEELFKLALVCTSSNPEDRPNMNELLIT 299 (299)
Q Consensus 244 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rpt~~~il~~ 299 (299)
.... .. +..++.++.+|+++||..||.+|||++|+++|
T Consensus 228 ~~~~-~~-----------------p~~~s~~~~~li~~~L~~dP~~R~t~~eil~h 265 (328)
T 3fe3_A 228 RGKY-RI-----------------PFYMSTDCENLLKRFLVLNPIKRGTLEQIMKD 265 (328)
T ss_dssp HCCC-CC-----------------CTTSCHHHHHHHHHHCCSSTTTSCCHHHHTTC
T ss_pred hCCC-CC-----------------CCCCCHHHHHHHHHHCCCChhHCcCHHHHhcC
Confidence 1110 00 11235678999999999999999999999987
|
| >3uim_A Brassinosteroid insensitive 1-associated receptor; kinase, protein kinase, transferase; HET: SEP TPO ANP; 2.20A {Arabidopsis thaliana} PDB: 3ulz_A* 3tl8_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-49 Score=339.89 Aligned_cols=287 Identities=34% Similarity=0.590 Sum_probs=224.3
Q ss_pred CCChHHHHHHhCCCCCCceeecCCcceEEEEEeCCCcEEEEEEeccCcCChhhhHHHHHHHHHHHhcCCcceeeeeeEEE
Q 038766 1 RFDRTEIENATGSFSENNIIGNSNLSTVYKGRLEDGEIVAVKKLNFHQFSAESDKSFYREAKTLKELKHRNLVKVLGYAW 80 (299)
Q Consensus 1 ~~~~~~~~~~~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~vK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~ 80 (299)
+|+.++++...++|.+.+.||+|+||+||++.+.+++.||+|++.... .......+.+|+.+++.++||||+++++++.
T Consensus 19 ~~~~~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~-~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~ 97 (326)
T 3uim_A 19 RFSLRELQVASDNFSNKNILGRGGFGKVYKGRLADGTLVAVKRLKEER-TQGGELQFQTEVEMISMAVHRNLLRLRGFCM 97 (326)
T ss_dssp ECCTHHHHTTTTSSCSTTEEECCSSSEEEEECCSSSCCEEEEECCC------CCCHHHHHHHGGGTCCCTTBCCCCEEEC
T ss_pred eecHHHHHHHhhccccceeEecCCCcEEEEEEecCCCEEEEEEecccc-CchHHHHHHHHHHHHHhccCCCccceEEEEe
Confidence 488999999999999999999999999999998889999999987433 2233446889999999999999999999766
Q ss_pred cCCCeeEEEEeecCCCChHHHhcCCCCCCCCCChhhHHHHHHHHHHHHHHhhcCCCCCeeeecccCCceeeCCCCcEEEe
Q 038766 81 ESGKLKALILEYMENGSLESVIHGPGVDHSRWTLPKRIDVLISVANGLDYLHSGYDIPIVHCDMKPSNILLDRDFEAHVS 160 (299)
Q Consensus 81 ~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lh~~~~~~~~H~dl~~~nil~~~~~~v~l~ 160 (299)
. ....++|+||+.+++|.+++........++++..++.++.|++.||+|||+.++.+++|+||||+||+++.++.++|+
T Consensus 98 ~-~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~ivH~Dlkp~Nil~~~~~~~kl~ 176 (326)
T 3uim_A 98 T-PTERLLVYPYMANGSVASCLRERPESQPPLDWPKRQRIALGSARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVG 176 (326)
T ss_dssp C-SSCCEEEEECCTTCBHHHHHHCCSTTCCCCCHHHHHHHHHHHHHHHHHHHHSSSSCEECCCCSGGGEEECTTCCEEEC
T ss_pred c-CCceEEEEEeccCCCHHHHHHhccccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCchhhEEECCCCCEEec
Confidence 5 445599999999999999998765566679999999999999999999999755589999999999999999999999
Q ss_pred eeccccccccccccccccccccccCcccCChhhhcccCcCccccchhhhHHHHHHHhCCCCCCCCccCCCCchhHHHHHH
Q 038766 161 DFGTSRMLDVHLQDLSSLSTAFQGTIGYLAPEFAYMRIVTTKVDVFSFGIVVMEFLTKRRPTGLDEENGLSPISLRQLVE 240 (299)
Q Consensus 161 df~~~~~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~DiwslG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~ 240 (299)
|||++...... .........+++.|+|||.+.+..++.++||||||+++|+|++|..||................+.
T Consensus 177 Dfg~~~~~~~~---~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~ 253 (326)
T 3uim_A 177 DFGLAKLMDYK---DTHVTTAVRGTIGHIAPEYLSTGKSSEKTDVFGYGVMLLELITGQRAFDLARLANDDDVMLLDWVK 253 (326)
T ss_dssp CCSSCEECCSS---SSCEECCCCSCGGGCCHHHHHHSEECHHHHHHHHHHHHHHHHHCCCSBCHHHHTTTSCSBHHHHHT
T ss_pred cCccccccCcc---cccccccccCCcCccCHHHhccCCCCccccchhHHHHHHHHHhCCCcccccccccccchhHHHHHH
Confidence 99999765421 122234455899999999999888999999999999999999999999633222222222222222
Q ss_pred HHHhcCccCcccccCccccchhhHhHHHHHHHHHHHHHHHHhcCCCCCCCCChhhhhcC
Q 038766 241 KALANGINGVRQITDPKLVSSIYEEQEQHQVLEELFKLALVCTSSNPEDRPNMNELLIT 299 (299)
Q Consensus 241 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rpt~~~il~~ 299 (299)
...... ......+..... ......+..+.+++.+||..||++|||+++++++
T Consensus 254 ~~~~~~--~~~~~~~~~~~~-----~~~~~~~~~l~~li~~cl~~dP~~Rps~~ell~~ 305 (326)
T 3uim_A 254 GLLKEK--KLEALVDVDLQG-----NYKDEEVEQLIQVALLCTQSSPMERPKMSEVVRM 305 (326)
T ss_dssp TTTSSC--CSTTSSCTTCTT-----SCCHHHHHHHHHHHHHHTCSCGGGSCCHHHHHHH
T ss_pred HHhhch--hhhhhcChhhcc-----ccCHHHHHHHHHHHHHHhCcCCccCCCHHHHHHH
Confidence 111111 111222211111 2245667889999999999999999999999874
|
| >3fxz_A Serine/threonine-protein kinase PAK 1; transferase, ATP-binding, phosphorylation, allosteric enzyme, alternative splicing, apoptosis, cell junction; HET: TPO FLL; 1.64A {Homo sapiens} SCOP: d.144.1.7 PDB: 3fy0_A* 4daw_A* 3q52_A* 3q53_A* 1yhw_A 1f3m_C 1yhv_A 2hy8_1* 3q4z_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3e-48 Score=326.51 Aligned_cols=252 Identities=25% Similarity=0.379 Sum_probs=205.2
Q ss_pred HhCCCCCCceeecCCcceEEEEEe-CCCcEEEEEEeccCcCChhhhHHHHHHHHHHHhcCCcceeeeeeEEEcCCCeeEE
Q 038766 10 ATGSFSENNIIGNSNLSTVYKGRL-EDGEIVAVKKLNFHQFSAESDKSFYREAKTLKELKHRNLVKVLGYAWESGKLKAL 88 (299)
Q Consensus 10 ~~~~y~~~~~lg~g~~~~v~~~~~-~~~~~~~vK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~l 88 (299)
..++|++.+.||+|+||+||+|.+ .+++.||+|++.... ....+.+.+|+..++.++||||+++++++.. +...++
T Consensus 18 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~--~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~-~~~~~l 94 (297)
T 3fxz_A 18 PKKKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQ--QPKKELIINEILVMRENKNPNIVNYLDSYLV-GDELWV 94 (297)
T ss_dssp GGGTBCCCEEEEEETTEEEEEEEBTTTCCEEEEEEEEGGG--CSCHHHHHHHHHHHHHCCCTTBCCEEEEEEE-TTEEEE
T ss_pred hhhceeeeeeeccCCCeEEEEEEECCCCcEEEEEEeeccc--ccHHHHHHHHHHHHhcCCCCCCCeEeEEEEE-CCEEEE
Confidence 457899999999999999999986 568999999986433 3345678899999999999999999997665 456699
Q ss_pred EEeecCCCChHHHhcCCCCCCCCCChhhHHHHHHHHHHHHHHhhcCCCCCeeeecccCCceeeCCCCcEEEeeecccccc
Q 038766 89 ILEYMENGSLESVIHGPGVDHSRWTLPKRIDVLISVANGLDYLHSGYDIPIVHCDMKPSNILLDRDFEAHVSDFGTSRML 168 (299)
Q Consensus 89 v~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lh~~~~~~~~H~dl~~~nil~~~~~~v~l~df~~~~~~ 168 (299)
|+||+.+++|.+++.. ..+++..++.++.|++.||+|||++ +++|+||||+||+++.++.++|+|||++...
T Consensus 95 v~e~~~~~~L~~~~~~-----~~~~~~~~~~~~~qi~~~l~~lH~~---~i~H~Dlkp~Nil~~~~~~~kl~Dfg~~~~~ 166 (297)
T 3fxz_A 95 VMEYLAGGSLTDVVTE-----TCMDEGQIAAVCRECLQALEFLHSN---QVIHRDIKSDNILLGMDGSVKLTDFGFCAQI 166 (297)
T ss_dssp EEECCTTCBHHHHHHH-----SCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECTTCCEEECCCTTCEEC
T ss_pred EEECCCCCCHHHHHhh-----cCCCHHHHHHHHHHHHHHHHHHHhC---CceeCCCCHHHEEECCCCCEEEeeCCCceec
Confidence 9999999999999853 3689999999999999999999999 9999999999999999999999999998765
Q ss_pred ccccccccccccccccCcccCChhhhcccCcCccccchhhhHHHHHHHhCCCCCCCCccCCCCchhHHHHHHHHHhcCcc
Q 038766 169 DVHLQDLSSLSTAFQGTIGYLAPEFAYMRIVTTKVDVFSFGIVVMEFLTKRRPTGLDEENGLSPISLRQLVEKALANGIN 248 (299)
Q Consensus 169 ~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~DiwslG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 248 (299)
... ........+++.|+|||++.+..++.++||||||+++|+|++|..||.... .. ............
T Consensus 167 ~~~----~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~-----~~---~~~~~~~~~~~~ 234 (297)
T 3fxz_A 167 TPE----QSKRSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMIEGEPPYLNEN-----PL---RALYLIATNGTP 234 (297)
T ss_dssp CST----TCCBCCCCSCGGGCCHHHHHCSCBCTHHHHHHHHHHHHHHHHSSCTTTTSC-----HH---HHHHHHHHHCSC
T ss_pred CCc----ccccCCccCCcCccChhhhcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCC-----HH---HHHHHHHhCCCC
Confidence 421 222344568999999999999999999999999999999999999995331 11 111111111111
Q ss_pred CcccccCccccchhhHhHHHHHHHHHHHHHHHHhcCCCCCCCCChhhhhcC
Q 038766 249 GVRQITDPKLVSSIYEEQEQHQVLEELFKLALVCTSSNPEDRPNMNELLIT 299 (299)
Q Consensus 249 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rpt~~~il~~ 299 (299)
.. .. +..++..+.++|.+||..||++|||++++|+|
T Consensus 235 ~~---~~------------~~~~~~~~~~li~~~l~~dp~~Rps~~ell~h 270 (297)
T 3fxz_A 235 EL---QN------------PEKLSAIFRDFLNRCLEMDVEKRGSAKELLQH 270 (297)
T ss_dssp CC---SC------------GGGSCHHHHHHHHHHSCSSTTTSCCHHHHTTC
T ss_pred CC---CC------------ccccCHHHHHHHHHHccCChhHCcCHHHHhhC
Confidence 11 11 22345678999999999999999999999987
|
| >3niz_A Rhodanese family protein; structural genomics, structural genomics consortium, SGC, phosphotransferase, cyclin dependent kinase; HET: ADP; 2.40A {Cryptosporidium parvum} SCOP: d.144.1.7 PDB: 2qkr_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2e-48 Score=329.75 Aligned_cols=278 Identities=21% Similarity=0.280 Sum_probs=207.1
Q ss_pred HHHHHhCCCCCCceeecCCcceEEEEEeCCCcEEEEEEeccCcCChhhhHHHHHHHHHHHhcCCcceeeeeeEEEcCCCe
Q 038766 6 EIENATGSFSENNIIGNSNLSTVYKGRLEDGEIVAVKKLNFHQFSAESDKSFYREAKTLKELKHRNLVKVLGYAWESGKL 85 (299)
Q Consensus 6 ~~~~~~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~vK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~ 85 (299)
..+.+.++|++.+.||+|+||+||+|.+.+++.||+|++............+.+|+.++++++||||+++++++.. +..
T Consensus 15 ~~q~l~~~y~~~~~lG~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~-~~~ 93 (311)
T 3niz_A 15 YFQGLMEKYQKLEKVGEGTYGVVYKAKDSQGRIVALKRIRLDAEDEGIPSTAIREISLLKELHHPNIVSLIDVIHS-ERC 93 (311)
T ss_dssp CEECSSCEEEEEEEEEECSSCEEEEEEETTSCEEEEEEEC------CHHHHHHHHHHHHHHCCCTTBCCEEEEECC-SSC
T ss_pred eecchHhhhHhhhhccCCCCeEEEEEEECCCCEEEEEEEecccccchhhHHHHHHHHHHHHcCCCCEeeeeeEEcc-CCE
Confidence 3456789999999999999999999999889999999997655555556788899999999999999999996654 556
Q ss_pred eEEEEeecCCCChHHHhcCCCCCCCCCChhhHHHHHHHHHHHHHHhhcCCCCCeeeecccCCceeeCCCCcEEEeeeccc
Q 038766 86 KALILEYMENGSLESVIHGPGVDHSRWTLPKRIDVLISVANGLDYLHSGYDIPIVHCDMKPSNILLDRDFEAHVSDFGTS 165 (299)
Q Consensus 86 ~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lh~~~~~~~~H~dl~~~nil~~~~~~v~l~df~~~ 165 (299)
.++|+||+.+ +|.+.+.. ....+++..++.++.|++.||+|||+. +++|+||||+||+++.++.++|+|||++
T Consensus 94 ~~lv~e~~~~-~l~~~~~~---~~~~~~~~~~~~~~~qi~~~l~~LH~~---~ivH~Dikp~NIl~~~~~~~kl~Dfg~a 166 (311)
T 3niz_A 94 LTLVFEFMEK-DLKKVLDE---NKTGLQDSQIKIYLYQLLRGVAHCHQH---RILHRDLKPQNLLINSDGALKLADFGLA 166 (311)
T ss_dssp EEEEEECCSE-EHHHHHHT---CTTCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEECTTCCEEECCCTTC
T ss_pred EEEEEcCCCC-CHHHHHHh---ccCCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCchHhEEECCCCCEEEccCcCc
Confidence 6999999975 88877753 335699999999999999999999999 9999999999999999999999999999
Q ss_pred cccccccccccccccccccCcccCChhhhcc-cCcCccccchhhhHHHHHHHhCCCCCCCCccCCCCchhHHHHHHHHHh
Q 038766 166 RMLDVHLQDLSSLSTAFQGTIGYLAPEFAYM-RIVTTKVDVFSFGIVVMEFLTKRRPTGLDEENGLSPISLRQLVEKALA 244 (299)
Q Consensus 166 ~~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~-~~~~~~~DiwslG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~ 244 (299)
...... ........+++.|+|||.+.+ ..++.++|||||||++|+|++|..||....... ...........
T Consensus 167 ~~~~~~----~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~----~~~~i~~~~~~ 238 (311)
T 3niz_A 167 RAFGIP----VRSYTHEVVTLWYRAPDVLMGSKKYSTSVDIWSIGCIFAEMITGKPLFPGVTDDD----QLPKIFSILGT 238 (311)
T ss_dssp EETTSC----CC---CCCCCCTTCCHHHHTTCCSCCTHHHHHHHHHHHHHHHHSSCSCCCSSTTT----HHHHHHHHHCC
T ss_pred eecCCC----cccccCCcccCCcCCHHHhcCCCCCCchHHhHHHHHHHHHHHhCCCCCCCCChHH----HHHHHHHHHCC
Confidence 765421 122334467899999999876 568999999999999999999999996442221 11122211111
Q ss_pred cCccCcccccCc--------cccchhhHhHHHHHHHHHHHHHHHHhcCCCCCCCCChhhhhcC
Q 038766 245 NGINGVRQITDP--------KLVSSIYEEQEQHQVLEELFKLALVCTSSNPEDRPNMNELLIT 299 (299)
Q Consensus 245 ~~~~~~~~~~~~--------~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rpt~~~il~~ 299 (299)
............ ..............++.++.+||++||..||++|||++|+|+|
T Consensus 239 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~h 301 (311)
T 3niz_A 239 PNPREWPQVQELPLWKQRTFQVFEKKPWSSIIPGFCQEGIDLLSNMLCFDPNKRISARDAMNH 301 (311)
T ss_dssp CCTTTSGGGTTSHHHHSCCCCCCCCCCHHHHSTTCCHHHHHHHHHHSCSCTTTSCCHHHHHTS
T ss_pred CChHHhhhhhccchhhhcccccccCCcHHHhCcccCHHHHHHHHHHcCCChhHCCCHHHHhcC
Confidence 111111111000 0000001111233456789999999999999999999999987
|
| >2qkw_B Protein kinase; three-helix bundle motif, AVRPTO-PTO duplex, layered beta- sheets, transferas; HET: SEP TPO; 3.20A {Solanum pimpinellifolium} PDB: 3hgk_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.3e-48 Score=329.16 Aligned_cols=281 Identities=33% Similarity=0.539 Sum_probs=219.7
Q ss_pred CChHHHHHHhCCCCCCceeecCCcceEEEEEeCCCcEEEEEEeccCcCChhhhHHHHHHHHHHHhcCCcceeeeeeEEEc
Q 038766 2 FDRTEIENATGSFSENNIIGNSNLSTVYKGRLEDGEIVAVKKLNFHQFSAESDKSFYREAKTLKELKHRNLVKVLGYAWE 81 (299)
Q Consensus 2 ~~~~~~~~~~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~vK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~ 81 (299)
|...+++...++|.+.+.||+|+||+||++.+.+++.||+|++... .....+.+.+|+..++.++||||+++++++..
T Consensus 29 ~~~~~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~ 106 (321)
T 2qkw_B 29 VPLVDLEEATNNFDHKFLIGHGVFGKVYKGVLRDGAKVALKRRTPE--SSQGIEEFETEIETLSFCRHPHLVSLIGFCDE 106 (321)
T ss_dssp -CCSCCCCCCCCCSCCCCSCBCSSSEEEEEECTTCCEEEEEECCSC--CSSHHHHHHHHHHGGGSCCCTTBCCEEEECCC
T ss_pred ecHHHHHHHHhccCccceeecCCCeeEEEEEECCCCEEEEEEeccc--ChHHHHHHHHHHHHHHhCCCCCEeeEEEEEcC
Confidence 4445566778999999999999999999999888999999988643 34456788999999999999999999996654
Q ss_pred CCCeeEEEEeecCCCChHHHhcCCCCCCCCCChhhHHHHHHHHHHHHHHhhcCCCCCeeeecccCCceeeCCCCcEEEee
Q 038766 82 SGKLKALILEYMENGSLESVIHGPGVDHSRWTLPKRIDVLISVANGLDYLHSGYDIPIVHCDMKPSNILLDRDFEAHVSD 161 (299)
Q Consensus 82 ~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lh~~~~~~~~H~dl~~~nil~~~~~~v~l~d 161 (299)
++..++|+||+.+++|.+++.........+++..++.++.|++.||.|||++ +++|+||||+||+++.++.++|+|
T Consensus 107 -~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~---~ivH~dlkp~Nil~~~~~~~kl~D 182 (321)
T 2qkw_B 107 -RNEMILIYKYMENGNLKRHLYGSDLPTMSMSWEQRLEICIGAARGLHYLHTR---AIIHRDVKSINILLDENFVPKITD 182 (321)
T ss_dssp -TTCCEEEEECCTTCBTGGGSSSSCCCSCCCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCCSTTEEECTTCCEEECC
T ss_pred -CCeEEEEEEcCCCCcHHHHHhccCCCccccCHHHHHHHHHHHHHHHHHhcCC---CeecCCCCHHHEEECCCCCEEEee
Confidence 5556999999999999999976544556799999999999999999999999 999999999999999999999999
Q ss_pred eccccccccccccccccccccccCcccCChhhhcccCcCccccchhhhHHHHHHHhCCCCCCCCccCCCCchhHHHHHHH
Q 038766 162 FGTSRMLDVHLQDLSSLSTAFQGTIGYLAPEFAYMRIVTTKVDVFSFGIVVMEFLTKRRPTGLDEENGLSPISLRQLVEK 241 (299)
Q Consensus 162 f~~~~~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~DiwslG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~ 241 (299)
||++....... .........+++.|+|||.+.+..++.++||||||+++|+|++|..||.......... .......
T Consensus 183 fg~~~~~~~~~--~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~ell~g~~p~~~~~~~~~~~--~~~~~~~ 258 (321)
T 2qkw_B 183 FGISKKGTELD--QTHLSTVVKGTLGYIDPEYFIKGRLTEKSDVYSFGVVLFEVLCARSAIVQSLPREMVN--LAEWAVE 258 (321)
T ss_dssp CTTCEECSSSS--CCCCBCCCEEETTTCCHHHHHHCBCCTHHHHHHHHHHHHHHHHCCTTCSCSSSSSCCC--HHHHTHH
T ss_pred ccccccccccc--ccccccccCCCccccCHHHhcCCCCCcccchHhHHHHHHHHHhCCCcccccCcHHHHH--HHHHhhh
Confidence 99987543211 1122334457899999999998899999999999999999999999997554332221 1111111
Q ss_pred HHhcCccCcccccCccccchhhHhHHHHHHHHHHHHHHHHhcCCCCCCCCChhhhhcC
Q 038766 242 ALANGINGVRQITDPKLVSSIYEEQEQHQVLEELFKLALVCTSSNPEDRPNMNELLIT 299 (299)
Q Consensus 242 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rpt~~~il~~ 299 (299)
..... ......++.... ......+..+.+++.+||..||++|||+++++++
T Consensus 259 ~~~~~--~~~~~~~~~~~~-----~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~ 309 (321)
T 2qkw_B 259 SHNNG--QLEQIVDPNLAD-----KIRPESLRKFGDTAVKCLALSSEDRPSMGDVLWK 309 (321)
T ss_dssp HHTTT--CCCSSSSSSCTT-----CSCHHHHHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred ccccc--cHHHhcChhhcc-----ccCHHHHHHHHHHHHHHcCCCcccCcCHHHHHHH
Confidence 11111 122222222211 1245677889999999999999999999999863
|
| >2yab_A Death-associated protein kinase 2; apoptosis, transferase; HET: AMP; 1.90A {Mus musculus} PDB: 2yaa_A* 2ya9_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=9.9e-48 Score=331.11 Aligned_cols=257 Identities=21% Similarity=0.275 Sum_probs=209.1
Q ss_pred HHHhCCCCCCceeecCCcceEEEEEeC-CCcEEEEEEeccCcCCh----hhhHHHHHHHHHHHhcCCcceeeeeeEEEcC
Q 038766 8 ENATGSFSENNIIGNSNLSTVYKGRLE-DGEIVAVKKLNFHQFSA----ESDKSFYREAKTLKELKHRNLVKVLGYAWES 82 (299)
Q Consensus 8 ~~~~~~y~~~~~lg~g~~~~v~~~~~~-~~~~~~vK~~~~~~~~~----~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~ 82 (299)
..+.++|.+.+.||+|+||+||++.+. +|+.||+|++....... ...+.+.+|+.+++.++||||+++++++..
T Consensus 8 ~~~~~~y~~~~~LG~G~fg~V~~~~~~~~~~~~avK~i~~~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~- 86 (361)
T 2yab_A 8 QKVEDFYDIGEELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVCREEIEREVSILRQVLHPNIITLHDVYEN- 86 (361)
T ss_dssp SCGGGTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEBCSSTTCSSSBCHHHHHHHHHHHTTCCCTTBCCEEEEEEC-
T ss_pred CChhhceEEeeEEeeCcCEEEEEEEECCCCCEEEEEEEEccccccccchhHHHHHHHHHHHHHhCCCcCCCcEEEEEEe-
Confidence 356789999999999999999999875 58999999997544322 235788999999999999999999996654
Q ss_pred CCeeEEEEeecCCCChHHHhcCCCCCCCCCChhhHHHHHHHHHHHHHHhhcCCCCCeeeecccCCceeeCCCC----cEE
Q 038766 83 GKLKALILEYMENGSLESVIHGPGVDHSRWTLPKRIDVLISVANGLDYLHSGYDIPIVHCDMKPSNILLDRDF----EAH 158 (299)
Q Consensus 83 ~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lh~~~~~~~~H~dl~~~nil~~~~~----~v~ 158 (299)
+...++|+||+.+++|.+++. ....+++..++.++.||+.||.|||+. +++|+||||+||+++.++ .++
T Consensus 87 ~~~~~lv~e~~~gg~L~~~l~----~~~~l~~~~~~~i~~qi~~aL~~LH~~---givHrDlkp~NIll~~~~~~~~~vk 159 (361)
T 2yab_A 87 RTDVVLILELVSGGELFDFLA----QKESLSEEEATSFIKQILDGVNYLHTK---KIAHFDLKPENIMLLDKNIPIPHIK 159 (361)
T ss_dssp SSEEEEEEECCCSCBHHHHHT----TCSCCBHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEESCTTSSSCCEE
T ss_pred CCEEEEEEEcCCCCcHHHHHH----hcCCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCHHHEEEeCCCCCccCEE
Confidence 566799999999999999997 456799999999999999999999999 999999999999998776 799
Q ss_pred EeeeccccccccccccccccccccccCcccCChhhhcccCcCccccchhhhHHHHHHHhCCCCCCCCccCCCCchhHHHH
Q 038766 159 VSDFGTSRMLDVHLQDLSSLSTAFQGTIGYLAPEFAYMRIVTTKVDVFSFGIVVMEFLTKRRPTGLDEENGLSPISLRQL 238 (299)
Q Consensus 159 l~df~~~~~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~DiwslG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~ 238 (299)
|+|||++..... ........+|+.|+|||++.+..++.++||||||+++|+|++|..||.... . .+.
T Consensus 160 l~DFG~a~~~~~-----~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~~ll~g~~Pf~~~~-----~---~~~ 226 (361)
T 2yab_A 160 LIDFGLAHEIED-----GVEFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGDT-----K---QET 226 (361)
T ss_dssp ECCCSSCEECCT-----TCCCCCCCSCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSCCSSCCSS-----H---HHH
T ss_pred EEecCCceEcCC-----CCccccCCCCccEECchHHcCCCCCccccHHHHHHHHHHHHhCCCCCCCCC-----H---HHH
Confidence 999999976542 122344568999999999999999999999999999999999999995431 1 122
Q ss_pred HHHHHhcCccCcccccCccccchhhHhHHHHHHHHHHHHHHHHhcCCCCCCCCChhhhhcC
Q 038766 239 VEKALANGINGVRQITDPKLVSSIYEEQEQHQVLEELFKLALVCTSSNPEDRPNMNELLIT 299 (299)
Q Consensus 239 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rpt~~~il~~ 299 (299)
+........ . + .......++..+.+||++||..||++|||++|+|+|
T Consensus 227 ~~~i~~~~~-~--------~-----~~~~~~~~s~~~~~li~~~L~~dP~~R~t~~e~l~h 273 (361)
T 2yab_A 227 LANITAVSY-D--------F-----DEEFFSQTSELAKDFIRKLLVKETRKRLTIQEALRH 273 (361)
T ss_dssp HHHHHTTCC-C--------C-----CHHHHTTSCHHHHHHHHHHSCSSTTTSCCHHHHHTS
T ss_pred HHHHHhcCC-C--------C-----CchhccCCCHHHHHHHHHHCCCChhHCcCHHHHhcC
Confidence 222211110 0 0 011133456789999999999999999999999987
|
| >3o0g_A Cell division protein kinase 5; kinase activator complex, kinase inhibitor complex, transferase-transferase activator complex; HET: 3O0; 1.95A {Homo sapiens} SCOP: d.144.1.7 PDB: 1unh_A* 1ung_A* 1unl_A* 1h4l_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-48 Score=327.37 Aligned_cols=272 Identities=22% Similarity=0.292 Sum_probs=204.9
Q ss_pred CCCCCCceeecCCcceEEEEEeC-CCcEEEEEEeccCcCChhhhHHHHHHHHHHHhcCCcceeeeeeEEEcCCCeeEEEE
Q 038766 12 GSFSENNIIGNSNLSTVYKGRLE-DGEIVAVKKLNFHQFSAESDKSFYREAKTLKELKHRNLVKVLGYAWESGKLKALIL 90 (299)
Q Consensus 12 ~~y~~~~~lg~g~~~~v~~~~~~-~~~~~~vK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~lv~ 90 (299)
++|++.+.||+|+||+||+|.+. +++.||+|++............+.+|+.++++++||||+++++++.. +...++|+
T Consensus 2 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~-~~~~~lv~ 80 (292)
T 3o0g_A 2 QKYEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLHDVLHS-DKKLTLVF 80 (292)
T ss_dssp CSEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEESSCSSTTHHHHHHHHHHHHTTCCCTTBCCEEEEEEE-TTEEEEEE
T ss_pred CCceeeeEecCCCCeEEEEEEECCCCceEEEEeeeccCCcCCcchHHHHHHHHHhcCCCCCEeeEEeEEEe-CCEEEEEE
Confidence 68999999999999999999875 58999999998766666667888999999999999999999997665 55669999
Q ss_pred eecCCCChHHHhcCCCCCCCCCChhhHHHHHHHHHHHHHHhhcCCCCCeeeecccCCceeeCCCCcEEEeeecccccccc
Q 038766 91 EYMENGSLESVIHGPGVDHSRWTLPKRIDVLISVANGLDYLHSGYDIPIVHCDMKPSNILLDRDFEAHVSDFGTSRMLDV 170 (299)
Q Consensus 91 e~~~~~~L~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lh~~~~~~~~H~dl~~~nil~~~~~~v~l~df~~~~~~~~ 170 (299)
||+.+ ++.+.+.. ....+++..++.++.|++.||+|||++ +++|+||||+||+++.++.++|+|||++.....
T Consensus 81 e~~~~-~l~~~~~~---~~~~l~~~~~~~~~~ql~~~l~~lH~~---~ivH~dikp~Nil~~~~~~~kl~Dfg~~~~~~~ 153 (292)
T 3o0g_A 81 EFCDQ-DLKKYFDS---CNGDLDPEIVKSFLFQLLKGLGFCHSR---NVLHRDLKPQNLLINRNGELKLANFGLARAFGI 153 (292)
T ss_dssp ECCSE-EHHHHHHH---TTTCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECTTSCEEECCCTTCEECCS
T ss_pred ecCCC-CHHHHHHh---CCCCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHEEEcCCCCEEEeecccceecCC
Confidence 99976 66555432 345799999999999999999999999 999999999999999999999999999976541
Q ss_pred ccccccccccccccCcccCChhhhcccC-cCccccchhhhHHHHHHHhCCCCCCCCccCCCCchhHHHHHHHHHhcC---
Q 038766 171 HLQDLSSLSTAFQGTIGYLAPEFAYMRI-VTTKVDVFSFGIVVMEFLTKRRPTGLDEENGLSPISLRQLVEKALANG--- 246 (299)
Q Consensus 171 ~~~~~~~~~~~~~~~~~y~~PE~~~~~~-~~~~~DiwslG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~--- 246 (299)
.........+|+.|+|||.+.+.. ++.++|||||||++|+|++|..||.... ........+.......
T Consensus 154 ----~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~~~~p~~~~~----~~~~~~~~i~~~~~~~~~~ 225 (292)
T 3o0g_A 154 ----PVRCYSAEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGN----DVDDQLKRIFRLLGTPTEE 225 (292)
T ss_dssp ----CCSCCCSCCSCGGGCCHHHHTTCSCCCTHHHHHHHHHHHHHHTTTSCCSCCCS----SHHHHHHHHHHHHCCCCTT
T ss_pred ----ccccccCCccccCCcChHHHcCCCCcCchHHHHHHHHHHHHHHHcCCCCcCCC----CHHHHHHHHHHHhCCCChh
Confidence 122334456789999999988765 7999999999999999999988864221 1111111111111111
Q ss_pred -ccCcccccCc----cccchhhHhHHHHHHHHHHHHHHHHhcCCCCCCCCChhhhhcC
Q 038766 247 -INGVRQITDP----KLVSSIYEEQEQHQVLEELFKLALVCTSSNPEDRPNMNELLIT 299 (299)
Q Consensus 247 -~~~~~~~~~~----~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rpt~~~il~~ 299 (299)
+......... ..............++.++.+||++||..||++|||++|+|+|
T Consensus 226 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~h 283 (292)
T 3o0g_A 226 QWPSMTKLPDYKPYPMYPATTSLVNVVPKLNATGRDLLQNLLKCNPVQRISAEEALQH 283 (292)
T ss_dssp TCTTGGGSTTCCCCCCCCTTCCCTTTSTTCCHHHHHHHHHHSCSSGGGSCCHHHHHTS
T ss_pred hhhhhcccccccccccccCCcchhhcccccChHHHHHHHHHhccChhhCCCHHHHhcC
Confidence 0000000000 0000000011123456788999999999999999999999987
|
| >2bdw_A Hypothetical protein K11E8.1D; kinase, calmodulin activated, transferase; 1.80A {Caenorhabditis elegans} PDB: 2wel_A* 2v7o_A* 2vz6_A* 1cdm_B 1cm1_B 1cm4_B | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-47 Score=330.64 Aligned_cols=258 Identities=23% Similarity=0.335 Sum_probs=209.8
Q ss_pred HHHHhCCCCCCceeecCCcceEEEEEeC-CCcEEEEEEeccCcCChhhhHHHHHHHHHHHhcCCcceeeeeeEEEcCCCe
Q 038766 7 IENATGSFSENNIIGNSNLSTVYKGRLE-DGEIVAVKKLNFHQFSAESDKSFYREAKTLKELKHRNLVKVLGYAWESGKL 85 (299)
Q Consensus 7 ~~~~~~~y~~~~~lg~g~~~~v~~~~~~-~~~~~~vK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~ 85 (299)
...+.++|.+.+.||+|+||.||++.+. +++.||+|++..........+.+.+|+.+++.++||||+++++++.. +..
T Consensus 24 ~~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~-~~~ 102 (362)
T 2bdw_A 24 STKFSDNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVRLHDSIQE-ESF 102 (362)
T ss_dssp CCHHHHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEETTTCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEC-SSE
T ss_pred CCCcccCeEEeeEEecCCCeEEEEEEECCCCCEEEEEEEEcccCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEEe-CCE
Confidence 3456788999999999999999999874 58999999998766666667889999999999999999999996655 556
Q ss_pred eEEEEeecCCCChHHHhcCCCCCCCCCChhhHHHHHHHHHHHHHHhhcCCCCCeeeecccCCceeeCCC---CcEEEeee
Q 038766 86 KALILEYMENGSLESVIHGPGVDHSRWTLPKRIDVLISVANGLDYLHSGYDIPIVHCDMKPSNILLDRD---FEAHVSDF 162 (299)
Q Consensus 86 ~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lh~~~~~~~~H~dl~~~nil~~~~---~~v~l~df 162 (299)
.++|+||+.+++|.+.+. ....+++..++.++.||+.||.|||++ +++|+||||+||+++.+ +.+||+||
T Consensus 103 ~~lv~e~~~gg~L~~~l~----~~~~~~~~~~~~~~~qi~~al~~lH~~---~ivH~Dlkp~NIll~~~~~~~~~kl~Df 175 (362)
T 2bdw_A 103 HYLVFDLVTGGELFEDIV----AREFYSEADASHCIQQILESIAYCHSN---GIVHRNLKPENLLLASKAKGAAVKLADF 175 (362)
T ss_dssp EEEEECCCCSCBHHHHHT----TCSCCCHHHHHHHHHHHHHHHHHHHHT---TCBCCCCSGGGEEESCSSTTCCEEECCC
T ss_pred EEEEEecCCCCCHHHHHH----HcCCCCHHHHHHHHHHHHHHHHHHHHC---CeEeccCchHHEEEecCCCCCCEEEeec
Confidence 699999999999999887 446799999999999999999999999 99999999999999865 45999999
Q ss_pred ccccccccccccccccccccccCcccCChhhhcccCcCccccchhhhHHHHHHHhCCCCCCCCccCCCCchhHHHHHHHH
Q 038766 163 GTSRMLDVHLQDLSSLSTAFQGTIGYLAPEFAYMRIVTTKVDVFSFGIVVMEFLTKRRPTGLDEENGLSPISLRQLVEKA 242 (299)
Q Consensus 163 ~~~~~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~DiwslG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~ 242 (299)
|++..... ........+|+.|+|||++.+..++.++|||||||++|+|++|..||.... .. ......
T Consensus 176 G~a~~~~~-----~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~Pf~~~~-----~~---~~~~~i 242 (362)
T 2bdw_A 176 GLAIEVND-----SEAWHGFAGTPGYLSPEVLKKDPYSKPVDIWACGVILYILLVGYPPFWDED-----QH---RLYAQI 242 (362)
T ss_dssp TTCBCCTT-----CCSCCCSCSCTTTCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSSCCSS-----HH---HHHHHH
T ss_pred CcceEecC-----CcccccCCCCccccCHHHHccCCCCchhhHHHHHHHHHHHHHCCCCCCCCC-----HH---HHHHHH
Confidence 99976541 122334568999999999999899999999999999999999999995331 11 222222
Q ss_pred HhcCccCcccccCccccchhhHhHHHHHHHHHHHHHHHHhcCCCCCCCCChhhhhcC
Q 038766 243 LANGINGVRQITDPKLVSSIYEEQEQHQVLEELFKLALVCTSSNPEDRPNMNELLIT 299 (299)
Q Consensus 243 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rpt~~~il~~ 299 (299)
..... ....+. ...++.++.+||.+||..||++|||++++|+|
T Consensus 243 ~~~~~----~~~~~~----------~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~h 285 (362)
T 2bdw_A 243 KAGAY----DYPSPE----------WDTVTPEAKSLIDSMLTVNPKKRITADQALKV 285 (362)
T ss_dssp HHTCC----CCCTTG----------GGGSCHHHHHHHHHHSCSSGGGSCCHHHHTTS
T ss_pred HhCCC----CCCccc----------ccCCCHHHHHHHHHHcCCChhhCcCHHHHhcC
Confidence 11110 011110 12345679999999999999999999999987
|
| >3soa_A Calcium/calmodulin-dependent protein kinase type alpha with A beta 7 linker; phosphorylation, cytosolic, transferase-transferase inhibitor complex; HET: DB8; 3.55A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-47 Score=338.75 Aligned_cols=259 Identities=22% Similarity=0.280 Sum_probs=208.7
Q ss_pred HHHHhCCCCCCceeecCCcceEEEEEe-CCCcEEEEEEeccCcCChhhhHHHHHHHHHHHhcCCcceeeeeeEEEcCCCe
Q 038766 7 IENATGSFSENNIIGNSNLSTVYKGRL-EDGEIVAVKKLNFHQFSAESDKSFYREAKTLKELKHRNLVKVLGYAWESGKL 85 (299)
Q Consensus 7 ~~~~~~~y~~~~~lg~g~~~~v~~~~~-~~~~~~~vK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~ 85 (299)
...+.++|.+.+.||+|+||+||++.+ .+|+.+|+|++............+.+|+.+++.++||||+++++++.. +..
T Consensus 6 ~~~~~~~Y~i~~~LG~G~fg~V~~~~~~~~~~~~a~K~i~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~-~~~ 84 (444)
T 3soa_A 6 CTRFTEEYQLFEELGKGAFSVVRRCVKVLAGQEYAAMIINTKKLSARDHQKLEREARICRLLKHPNIVRLHDSISE-EGH 84 (444)
T ss_dssp -CHHHHHEEEEEEEEEC--CEEEEEEETTTTEEEEEEEEESCSCHHHHHHHHHHHHHHHHHCCBTTBCCEEEEEEC-SSE
T ss_pred cccccCCeEEEEEeccCCCeEEEEEEECCCCcEEEEEEEEcccCCHHHHHHHHHHHHHHHhCCCcCCCeEEEEEEE-CCE
Confidence 346778999999999999999999986 468999999998766666667789999999999999999999996654 556
Q ss_pred eEEEEeecCCCChHHHhcCCCCCCCCCChhhHHHHHHHHHHHHHHhhcCCCCCeeeecccCCceeeC---CCCcEEEeee
Q 038766 86 KALILEYMENGSLESVIHGPGVDHSRWTLPKRIDVLISVANGLDYLHSGYDIPIVHCDMKPSNILLD---RDFEAHVSDF 162 (299)
Q Consensus 86 ~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lh~~~~~~~~H~dl~~~nil~~---~~~~v~l~df 162 (299)
.++|+||+.+++|.+.+. ....+++..++.++.||+.||.|||++ +++||||||+||+++ .++.+||+||
T Consensus 85 ~~lv~E~~~gg~L~~~i~----~~~~~~e~~~~~i~~qil~aL~~lH~~---givHrDlKp~NIll~~~~~~~~vkL~DF 157 (444)
T 3soa_A 85 HYLIFDLVTGGELFEDIV----AREYYSEADASHCIQQILEAVLHCHQM---GVVHRNLKPENLLLASKLKGAAVKLADF 157 (444)
T ss_dssp EEEEECCCBCCBHHHHHH----HCSCCCHHHHHHHHHHHHHHHHHHHHT---TCBCCCCSSTTEEESBSSTTCCEEECCC
T ss_pred EEEEEEeCCCCCHHHHHH----HcCCCCHHHHHHHHHHHHHHHHHHHHC---CccccCCCHHHEEEeccCCCCcEEEccC
Confidence 699999999999999887 445799999999999999999999999 999999999999998 5688999999
Q ss_pred ccccccccccccccccccccccCcccCChhhhcccCcCccccchhhhHHHHHHHhCCCCCCCCccCCCCchhHHHHHHHH
Q 038766 163 GTSRMLDVHLQDLSSLSTAFQGTIGYLAPEFAYMRIVTTKVDVFSFGIVVMEFLTKRRPTGLDEENGLSPISLRQLVEKA 242 (299)
Q Consensus 163 ~~~~~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~DiwslG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~ 242 (299)
|++..... .........+|+.|+|||++.+..++.++|||||||++|+|++|..||... ... ......
T Consensus 158 G~a~~~~~----~~~~~~~~~gt~~Y~APE~l~~~~~~~~~DIwSlGvilyell~G~~Pf~~~-----~~~---~~~~~i 225 (444)
T 3soa_A 158 GLAIEVEG----EQQAWFGFAGTPGYLSPEVLRKDPYGKPVDLWACGVILYILLVGYPPFWDE-----DQH---RLYQQI 225 (444)
T ss_dssp SSCBCCCT----TCCBCCCSCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSCCCS-----SHH---HHHHHH
T ss_pred ceeEEecC----CCceeecccCCcccCCHHHhcCCCCCCccccHHHHHHHHHHHhCCCCCCCc-----cHH---HHHHHH
Confidence 99976542 122234457899999999999999999999999999999999999999533 111 222222
Q ss_pred HhcCccCcccccCccccchhhHhHHHHHHHHHHHHHHHHhcCCCCCCCCChhhhhcC
Q 038766 243 LANGINGVRQITDPKLVSSIYEEQEQHQVLEELFKLALVCTSSNPEDRPNMNELLIT 299 (299)
Q Consensus 243 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rpt~~~il~~ 299 (299)
..... ....+. ...+++++.+||.+||..||++|||++|+|+|
T Consensus 226 ~~~~~----~~~~~~----------~~~~s~~~~~li~~~L~~dP~~Rpta~e~L~h 268 (444)
T 3soa_A 226 KAGAY----DFPSPE----------WDTVTPEAKDLINKMLTINPSKRITAAEALKH 268 (444)
T ss_dssp HHTCC----CCCTTT----------TTTSCHHHHHHHHHHSCSSTTTSCCHHHHHHS
T ss_pred HhCCC----CCCccc----------cccCCHHHHHHHHHHcCCChhHCCCHHHHhcC
Confidence 21111 111111 12345679999999999999999999999987
|
| >3p86_A Serine/threonine-protein kinase CTR1; ETR1, ERS1, ETR2, phosphorylation, transferase; HET: STU; 2.50A {Arabidopsis thaliana} PDB: 3ppz_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.1e-48 Score=327.40 Aligned_cols=262 Identities=27% Similarity=0.442 Sum_probs=201.3
Q ss_pred ChHHHHHHhCCCCCCceeecCCcceEEEEEeCCCcEEEEEEeccCcCChhhhHHHHHHHHHHHhcCCcceeeeeeEEEcC
Q 038766 3 DRTEIENATGSFSENNIIGNSNLSTVYKGRLEDGEIVAVKKLNFHQFSAESDKSFYREAKTLKELKHRNLVKVLGYAWES 82 (299)
Q Consensus 3 ~~~~~~~~~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~vK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~ 82 (299)
+.++++...++|++.+.||+|+||+||++.+ +|..||+|++..........+.+.+|+.++++++||||+++++++..
T Consensus 28 ~~~~~~i~~~~y~i~~~lG~G~~g~V~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~- 105 (309)
T 3p86_A 28 DGDDMDIPWCDLNIKEKIGAGSFGTVHRAEW-HGSDVAVKILMEQDFHAERVNEFLREVAIMKRLRHPNIVLFMGAVTQ- 105 (309)
T ss_dssp ----CBCCGGGEEEEEEEEECSSEEEEEEEE-TTEEEEEEEECCCCCSHHHHHHHHHHHHHHHHCCCTTBCCEEEEECS-
T ss_pred CcccccCChhHceeeeEeecCCCeEEEEEEE-CCCcEEEEEecCCCCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEE-
Confidence 3455667788999999999999999999987 48889999998766666777889999999999999999999997655
Q ss_pred CCeeEEEEeecCCCChHHHhcCCCCCCCCCChhhHHHHHHHHHHHHHHhhcCCCCC--eeeecccCCceeeCCCCcEEEe
Q 038766 83 GKLKALILEYMENGSLESVIHGPGVDHSRWTLPKRIDVLISVANGLDYLHSGYDIP--IVHCDMKPSNILLDRDFEAHVS 160 (299)
Q Consensus 83 ~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lh~~~~~~--~~H~dl~~~nil~~~~~~v~l~ 160 (299)
....++|+||+.+++|.+++...+ ....+++..++.++.|++.||+|||+. + ++||||||+||+++.++.++|+
T Consensus 106 ~~~~~lv~e~~~~~~L~~~l~~~~-~~~~~~~~~~~~i~~qi~~aL~~LH~~---~~~ivH~Dikp~NIll~~~~~~kL~ 181 (309)
T 3p86_A 106 PPNLSIVTEYLSRGSLYRLLHKSG-AREQLDERRRLSMAYDVAKGMNYLHNR---NPPIVHRNLKSPNLLVDKKYTVKVC 181 (309)
T ss_dssp TTCCEEEEECCTTCBHHHHHHSTT-HHHHSCHHHHHHHHHHHHHHHHHHHTS---SSCCCCTTCCGGGEEECTTCCEEEC
T ss_pred CCceEEEEecCCCCcHHHHHhhcC-CCCCCCHHHHHHHHHHHHHHHHHHHcC---CCCEECCCCChhhEEEeCCCcEEEC
Confidence 445699999999999999997432 223499999999999999999999998 8 9999999999999999999999
Q ss_pred eeccccccccccccccccccccccCcccCChhhhcccCcCccccchhhhHHHHHHHhCCCCCCCCccCCCCchhHHHHHH
Q 038766 161 DFGTSRMLDVHLQDLSSLSTAFQGTIGYLAPEFAYMRIVTTKVDVFSFGIVVMEFLTKRRPTGLDEENGLSPISLRQLVE 240 (299)
Q Consensus 161 df~~~~~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~DiwslG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~ 240 (299)
|||++..... .........+++.|+|||++.+..++.++||||||+++|+|++|..||... ..... ..
T Consensus 182 Dfg~a~~~~~----~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~Pf~~~-----~~~~~---~~ 249 (309)
T 3p86_A 182 DFGLSRLKAS----TFLSSKSAAGTPEWMAPEVLRDEPSNEKSDVYSFGVILWELATLQQPWGNL-----NPAQV---VA 249 (309)
T ss_dssp CCC---------------------CCTTSCHHHHTTCCCCTTHHHHHHHHHHHHHHHCCCTTTTS-----CHHHH---HH
T ss_pred CCCCCccccc----cccccccCCCCccccChhhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCC-----CHHHH---HH
Confidence 9999875331 112234456899999999999999999999999999999999999999533 12111 11
Q ss_pred HHHhcCccCcccccCccccchhhHhHHHHHHHHHHHHHHHHhcCCCCCCCCChhhhhc
Q 038766 241 KALANGINGVRQITDPKLVSSIYEEQEQHQVLEELFKLALVCTSSNPEDRPNMNELLI 298 (299)
Q Consensus 241 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rpt~~~il~ 298 (299)
...... ..... +..++.++.++|++||..||++|||++++++
T Consensus 250 ~~~~~~----~~~~~------------~~~~~~~l~~li~~~l~~dP~~Rps~~~ll~ 291 (309)
T 3p86_A 250 AVGFKC----KRLEI------------PRNLNPQVAAIIEGCWTNEPWKRPSFATIMD 291 (309)
T ss_dssp HHHHSC----CCCCC------------CTTSCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred HHHhcC----CCCCC------------CccCCHHHHHHHHHHccCChhhCcCHHHHHH
Confidence 111111 00000 2234567999999999999999999999975
|
| >2y0a_A Death-associated protein kinase 1; transferase, calmodulin, esprit; HET: MES; 2.60A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.5e-47 Score=324.10 Aligned_cols=257 Identities=23% Similarity=0.307 Sum_probs=208.1
Q ss_pred HHHhCCCCCCceeecCCcceEEEEEeC-CCcEEEEEEeccCcCCh----hhhHHHHHHHHHHHhcCCcceeeeeeEEEcC
Q 038766 8 ENATGSFSENNIIGNSNLSTVYKGRLE-DGEIVAVKKLNFHQFSA----ESDKSFYREAKTLKELKHRNLVKVLGYAWES 82 (299)
Q Consensus 8 ~~~~~~y~~~~~lg~g~~~~v~~~~~~-~~~~~~vK~~~~~~~~~----~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~ 82 (299)
+.+.++|.+.+.||+|+||.||++.+. +|+.||+|++....... ...+.+.+|+.+++.++||||+++++++..
T Consensus 7 ~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~- 85 (326)
T 2y0a_A 7 ENVDDYYDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQHPNVITLHEVYEN- 85 (326)
T ss_dssp SCHHHHEEEEEEEECCSSEEEEEEEETTTCCEEEEEEEEBCCSTTCSSSBCHHHHHHHHHHHHHCCCTTBCCEEEEEEC-
T ss_pred CCcccceEeceEEeeCCCeEEEEEEECCCCcEEEEEEEEccccccccchhhHHHHHHHHHHHHhCCCCCCCcEEEEEEe-
Confidence 356788999999999999999999875 58999999997543322 246778999999999999999999996655
Q ss_pred CCeeEEEEeecCCCChHHHhcCCCCCCCCCChhhHHHHHHHHHHHHHHhhcCCCCCeeeecccCCceeeCCCC----cEE
Q 038766 83 GKLKALILEYMENGSLESVIHGPGVDHSRWTLPKRIDVLISVANGLDYLHSGYDIPIVHCDMKPSNILLDRDF----EAH 158 (299)
Q Consensus 83 ~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lh~~~~~~~~H~dl~~~nil~~~~~----~v~ 158 (299)
+...++|+||+.+++|.+++. ....+++..++.++.|++.||.|||+. +++|+||||+||+++.++ .++
T Consensus 86 ~~~~~lv~e~~~~~~L~~~l~----~~~~~~~~~~~~i~~qi~~al~~lH~~---~ivH~Dlkp~NIll~~~~~~~~~~k 158 (326)
T 2y0a_A 86 KTDVILILELVAGGELFDFLA----EKESLTEEEATEFLKQILNGVYYLHSL---QIAHFDLKPENIMLLDRNVPKPRIK 158 (326)
T ss_dssp SSEEEEEEECCCSCBHHHHHT----TSSCCBHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEESCSSSSSCCEE
T ss_pred CCEEEEEEEcCCCCCHHHHHH----hcCCcCHHHHHHHHHHHHHHHHHHHHC---CeEcCCCCHHHEEEecCCCCCCCEE
Confidence 556799999999999999997 456799999999999999999999999 999999999999999887 799
Q ss_pred EeeeccccccccccccccccccccccCcccCChhhhcccCcCccccchhhhHHHHHHHhCCCCCCCCccCCCCchhHHHH
Q 038766 159 VSDFGTSRMLDVHLQDLSSLSTAFQGTIGYLAPEFAYMRIVTTKVDVFSFGIVVMEFLTKRRPTGLDEENGLSPISLRQL 238 (299)
Q Consensus 159 l~df~~~~~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~DiwslG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~ 238 (299)
|+|||++..... ........+++.|+|||++.+..++.++|||||||++|+|++|..||.... . .+.
T Consensus 159 l~Dfg~a~~~~~-----~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~-----~---~~~ 225 (326)
T 2y0a_A 159 IIDFGLAHKIDF-----GNEFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGDT-----K---QET 225 (326)
T ss_dssp ECCCTTCEECCT-----TSCCCCCCSCTTTCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSCCSSCCSS-----H---HHH
T ss_pred EEECCCCeECCC-----CCccccccCCcCcCCceeecCCCCCcHHHHHHHHHHHHHHHHCcCCCCCCC-----H---HHH
Confidence 999999976542 122334568999999999999999999999999999999999999995431 1 122
Q ss_pred HHHHHhcCccCcccccCccccchhhHhHHHHHHHHHHHHHHHHhcCCCCCCCCChhhhhcC
Q 038766 239 VEKALANGINGVRQITDPKLVSSIYEEQEQHQVLEELFKLALVCTSSNPEDRPNMNELLIT 299 (299)
Q Consensus 239 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rpt~~~il~~ 299 (299)
+........ . . .......++..+.+||++||..||++|||++++|+|
T Consensus 226 ~~~~~~~~~-~---~----------~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~h 272 (326)
T 2y0a_A 226 LANVSAVNY-E---F----------EDEYFSNTSALAKDFIRRLLVKDPKKRMTIQDSLQH 272 (326)
T ss_dssp HHHHHHTCC-C---C----------CHHHHTTSCHHHHHHHHHHSCSSGGGSCCHHHHHHS
T ss_pred HHHHHhcCC-C---c----------CccccccCCHHHHHHHHHHccCChhhCCCHHHHhcC
Confidence 222111110 0 0 001123456789999999999999999999999987
|
| >1tki_A Titin; serine kinase, muscle, autoinhibition; 2.00A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-47 Score=324.95 Aligned_cols=254 Identities=18% Similarity=0.233 Sum_probs=206.9
Q ss_pred HHhCCCCCCceeecCCcceEEEEEeC-CCcEEEEEEeccCcCChhhhHHHHHHHHHHHhcCCcceeeeeeEEEcCCCeeE
Q 038766 9 NATGSFSENNIIGNSNLSTVYKGRLE-DGEIVAVKKLNFHQFSAESDKSFYREAKTLKELKHRNLVKVLGYAWESGKLKA 87 (299)
Q Consensus 9 ~~~~~y~~~~~lg~g~~~~v~~~~~~-~~~~~~vK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~ 87 (299)
.+.++|.+.+.||+|+||+||++.+. +++.+|+|++... ......+.+|+.+++.++||||+++++++.. ....+
T Consensus 2 ~~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~a~K~~~~~---~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~-~~~~~ 77 (321)
T 1tki_A 2 ELYEKYMIAEDLGRGEFGIVHRCVETSSKKTYMAKFVKVK---GTDQVLVKKEISILNIARHRNILHLHESFES-MEELV 77 (321)
T ss_dssp CCTTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECCC---THHHHHHHHHHHHHHHSCCTTBCCEEEEEEE-TTEEE
T ss_pred chhhceEeeeEEecCCCeEEEEEEECCCCcEEEEEEEecC---cccHHHHHHHHHHHHhCCCCCCCeEeEEEec-CCEEE
Confidence 35789999999999999999999875 5889999998633 3455678899999999999999999997655 55679
Q ss_pred EEEeecCCCChHHHhcCCCCCCCCCChhhHHHHHHHHHHHHHHhhcCCCCCeeeecccCCceeeCC--CCcEEEeeeccc
Q 038766 88 LILEYMENGSLESVIHGPGVDHSRWTLPKRIDVLISVANGLDYLHSGYDIPIVHCDMKPSNILLDR--DFEAHVSDFGTS 165 (299)
Q Consensus 88 lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lh~~~~~~~~H~dl~~~nil~~~--~~~v~l~df~~~ 165 (299)
+|+||+.+++|.+.+.. ....+++..++.++.|++.||.|||+. +++|+||||+||+++. ++.++|+|||++
T Consensus 78 lv~e~~~g~~L~~~l~~---~~~~~~~~~~~~i~~qi~~al~~lH~~---givH~Dlkp~NIl~~~~~~~~~kl~Dfg~a 151 (321)
T 1tki_A 78 MIFEFISGLDIFERINT---SAFELNEREIVSYVHQVCEALQFLHSH---NIGHFDIRPENIIYQTRRSSTIKIIEFGQA 151 (321)
T ss_dssp EEECCCCCCBHHHHHTS---SSCCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEESSSSCCCEEECCCTTC
T ss_pred EEEEeCCCCCHHHHHHh---cCCCCCHHHHHHHHHHHHHHHHHHHHC---CCCcCCCCHHHEEEccCCCCCEEEEECCCC
Confidence 99999999999999863 234799999999999999999999999 9999999999999987 789999999999
Q ss_pred cccccccccccccccccccCcccCChhhhcccCcCccccchhhhHHHHHHHhCCCCCCCCccCCCCchhHHHHHHHHHhc
Q 038766 166 RMLDVHLQDLSSLSTAFQGTIGYLAPEFAYMRIVTTKVDVFSFGIVVMEFLTKRRPTGLDEENGLSPISLRQLVEKALAN 245 (299)
Q Consensus 166 ~~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~DiwslG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~ 245 (299)
..... ........+++.|+|||++.+..++.++||||||+++|+|++|..||.... . ...+......
T Consensus 152 ~~~~~-----~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~-----~---~~~~~~i~~~ 218 (321)
T 1tki_A 152 RQLKP-----GDNFRLLFTAPEYYAPEVHQHDVVSTATDMWSLGTLVYVLLSGINPFLAET-----N---QQIIENIMNA 218 (321)
T ss_dssp EECCT-----TCEEEEEESCGGGSCHHHHTTCEECHHHHHHHHHHHHHHHHHSSCTTCCSS-----H---HHHHHHHHHT
T ss_pred eECCC-----CCccccccCChhhcCcHHhcCCCCCchhhHHHHHHHHHHHHhCCCCCcCCC-----H---HHHHHHHHcC
Confidence 76542 122344568999999999999889999999999999999999999995432 1 1222222221
Q ss_pred CccCcccccCccccchhhHhHHHHHHHHHHHHHHHHhcCCCCCCCCChhhhhcC
Q 038766 246 GINGVRQITDPKLVSSIYEEQEQHQVLEELFKLALVCTSSNPEDRPNMNELLIT 299 (299)
Q Consensus 246 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rpt~~~il~~ 299 (299)
.... .......++.++.++|.+||..||++|||++|+|+|
T Consensus 219 ~~~~--------------~~~~~~~~s~~~~~li~~~L~~dp~~Rpt~~e~l~h 258 (321)
T 1tki_A 219 EYTF--------------DEEAFKEISIEAMDFVDRLLVKERKSRMTASEALQH 258 (321)
T ss_dssp CCCC--------------CHHHHTTSCHHHHHHHHTTSCSSGGGSCCHHHHHHS
T ss_pred CCCC--------------ChhhhccCCHHHHHHHHHHcCCChhHCcCHHHHhcC
Confidence 1100 011123456789999999999999999999999987
|
| >3gni_B Strad alpha; kinase fold, pseudokinase, alpha helical repeat protein, ADA protein, ATP-binding, cell cycle, kinase, nucleotide-bindin nucleus; HET: ATP CIT; 2.35A {Homo sapiens} PDB: 2wtk_B* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.1e-47 Score=332.15 Aligned_cols=284 Identities=21% Similarity=0.227 Sum_probs=208.2
Q ss_pred HhCCCCCCceeecC--CcceEEEEEeC-CCcEEEEEEeccCcCChhhhHHHHHHHHHHHhcCCcceeeeeeEEEcCCCee
Q 038766 10 ATGSFSENNIIGNS--NLSTVYKGRLE-DGEIVAVKKLNFHQFSAESDKSFYREAKTLKELKHRNLVKVLGYAWESGKLK 86 (299)
Q Consensus 10 ~~~~y~~~~~lg~g--~~~~v~~~~~~-~~~~~~vK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~ 86 (299)
..++|++.+.||+| ++|+||++.+. +++.||+|++............+.+|+.+++.++||||+++++++.. ++..
T Consensus 23 ~~~~y~~~~~lG~G~~~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~-~~~~ 101 (389)
T 3gni_B 23 EGGCYELLTVIGKGFEDLMTVNLARYKPTGEYVTVRRINLEACSNEMVTFLQGELHVSKLFNHPNIVPYRATFIA-DNEL 101 (389)
T ss_dssp CGGGEEEEEEEEEETTTTEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEE-TTEE
T ss_pred CCCcEEEEecccCCcCCceEEEEEEEcCCCCEEEEEEecccccChHHHHHHHHHHHHHHhCCCCCCCcEeEEEEE-CCEE
Confidence 46789999999999 99999999875 69999999998766666677888999999999999999999997765 5566
Q ss_pred EEEEeecCCCChHHHhcCCCCCCCCCChhhHHHHHHHHHHHHHHhhcCCCCCeeeecccCCceeeCCCCcEEEeeecccc
Q 038766 87 ALILEYMENGSLESVIHGPGVDHSRWTLPKRIDVLISVANGLDYLHSGYDIPIVHCDMKPSNILLDRDFEAHVSDFGTSR 166 (299)
Q Consensus 87 ~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lh~~~~~~~~H~dl~~~nil~~~~~~v~l~df~~~~ 166 (299)
++|+||+.+++|.+++... ....+++..++.++.||+.||+|||++ +++||||||+||+++.++.++|+|||.+.
T Consensus 102 ~lv~e~~~~~~L~~~l~~~--~~~~~~~~~~~~~~~qi~~~l~~LH~~---~ivHrDlkp~NIll~~~~~~kl~dfg~~~ 176 (389)
T 3gni_B 102 WVVTSFMAYGSAKDLICTH--FMDGMNELAIAYILQGVLKALDYIHHM---GYVHRSVKASHILISVDGKVYLSGLRSNL 176 (389)
T ss_dssp EEEEECCTTCBHHHHHHHT--CTTCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECTTCCEEECCGGGCE
T ss_pred EEEEEccCCCCHHHHHhhh--cccCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHEEEcCCCCEEEcccccce
Confidence 9999999999999998643 235699999999999999999999999 99999999999999999999999999886
Q ss_pred cccccccc---ccccccccccCcccCChhhhcc--cCcCccccchhhhHHHHHHHhCCCCCCCCccCCCCchhHHHHHHH
Q 038766 167 MLDVHLQD---LSSLSTAFQGTIGYLAPEFAYM--RIVTTKVDVFSFGIVVMEFLTKRRPTGLDEENGLSPISLRQLVEK 241 (299)
Q Consensus 167 ~~~~~~~~---~~~~~~~~~~~~~y~~PE~~~~--~~~~~~~DiwslG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~ 241 (299)
........ .........+++.|+|||++.+ ..++.++|||||||++|+|++|..||............+......
T Consensus 177 ~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~ 256 (389)
T 3gni_B 177 SMISHGQRQRVVHDFPKYSVKVLPWLSPEVLQQNLQGYDAKSDIYSVGITACELANGHVPFKDMPATQMLLEKLNGTVPC 256 (389)
T ss_dssp ECEETTEECSCBCCCCTTCTTTGGGSCHHHHSTTSSCBCTHHHHHHHHHHHHHHHHSSCTTTTCCSTTHHHHC-------
T ss_pred eeccccccccccccccccccccccccCHHHHhccCCCCCcHhHHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHhcCCCCc
Confidence 54321111 1122233467889999999987 578999999999999999999999996543221111111000000
Q ss_pred HHhcCccCcc--------------------cccCccccchhhHhHHHHHHHHHHHHHHHHhcCCCCCCCCChhhhhcC
Q 038766 242 ALANGINGVR--------------------QITDPKLVSSIYEEQEQHQVLEELFKLALVCTSSNPEDRPNMNELLIT 299 (299)
Q Consensus 242 ~~~~~~~~~~--------------------~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rpt~~~il~~ 299 (299)
.......... ...................++.++.+||++||..||++|||++|+|+|
T Consensus 257 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpta~ell~h 334 (389)
T 3gni_B 257 LLDTSTIPAEELTMSPSRSVANSGLSDSLTTSTPRPSNGDSPSHPYHRTFSPHFHHFVEQCLQRNPDARPSASTLLNH 334 (389)
T ss_dssp -------------------------------------------------CCHHHHHHHHHHTCSCTTTSCCHHHHTTS
T ss_pred cccccccccccccccccccccccccccccccCccccccCCCCCCccccccCHHHHHHHHHHhhcCcccCCCHHHHhcC
Confidence 0000000000 000000000001112345567889999999999999999999999987
|
| >1o6l_A RAC-beta serine/threonine protein kinase; protein kinase, transferase, serine/threonine-protein kinase; HET: TPO ANP; 1.6A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jdo_A* 2jdr_A* 2uw9_A* 2x37_A* 2x39_A* 2xh5_A* 3d0e_A* 3e87_A* 3e88_A* 3e8d_A* 1o6k_A* 1mrv_A 1mry_A 1gzn_A 1gzk_A 1gzo_A 3qkl_A* 3ocb_A* 3ow4_A* 3qkk_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-47 Score=327.44 Aligned_cols=251 Identities=22% Similarity=0.266 Sum_probs=205.3
Q ss_pred hCCCCCCceeecCCcceEEEEEeC-CCcEEEEEEeccCcC-ChhhhHHHHHHHHHHHhcCCcceeeeeeEEEcCCCeeEE
Q 038766 11 TGSFSENNIIGNSNLSTVYKGRLE-DGEIVAVKKLNFHQF-SAESDKSFYREAKTLKELKHRNLVKVLGYAWESGKLKAL 88 (299)
Q Consensus 11 ~~~y~~~~~lg~g~~~~v~~~~~~-~~~~~~vK~~~~~~~-~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~l 88 (299)
.++|.+.+.||+|+||.||+|.+. +|+.||+|++..... .......+.+|..+++.++||||+++++++.. ....++
T Consensus 4 ~~~y~~~~~lG~G~fg~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~l~~~~~~-~~~~~l 82 (337)
T 1o6l_A 4 MNDFDYLKLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTALKYAFQT-HDRLCF 82 (337)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCCCTTBCCEEEEEEC-SSEEEE
T ss_pred hHHeEEEEEEecCCCeEEEEEEECCCCCEEEEEEEeHHHhhhhhHHHHHHHHHHHHHhCCCCcCcceEEEEEe-CCEEEE
Confidence 478999999999999999999875 689999999864321 23345678899999999999999999997665 456699
Q ss_pred EEeecCCCChHHHhcCCCCCCCCCChhhHHHHHHHHHHHHHHhhcCCCCCeeeecccCCceeeCCCCcEEEeeecccccc
Q 038766 89 ILEYMENGSLESVIHGPGVDHSRWTLPKRIDVLISVANGLDYLHSGYDIPIVHCDMKPSNILLDRDFEAHVSDFGTSRML 168 (299)
Q Consensus 89 v~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lh~~~~~~~~H~dl~~~nil~~~~~~v~l~df~~~~~~ 168 (299)
||||+.+++|..++. ....+++..++.++.||+.||.|||++ +++||||||+||+++.+|.++|+|||++...
T Consensus 83 v~E~~~gg~L~~~l~----~~~~~~~~~~~~~~~qi~~aL~~LH~~---~ivHrDlkp~NIll~~~g~vkL~DFG~a~~~ 155 (337)
T 1o6l_A 83 VMEYANGGELFFHLS----RERVFTEERARFYGAEIVSALEYLHSR---DVVYRDIKLENLMLDKDGHIKITDFGLCKEG 155 (337)
T ss_dssp EEECCTTCBHHHHHH----HHSCCCHHHHHHHHHHHHHHHHHHHHT---TCBCCCCCGGGEEECTTSCEEECCCTTCBCS
T ss_pred EEeCCCCCcHHHHHH----hcCCCCHHHHHHHHHHHHHHHHHHHHC---CeecCcCCHHHEEECCCCCEEEeeccchhhc
Confidence 999999999999887 445799999999999999999999999 9999999999999999999999999998753
Q ss_pred ccccccccccccccccCcccCChhhhcccCcCccccchhhhHHHHHHHhCCCCCCCCccCCCCchhHHHHHHHHHhcCcc
Q 038766 169 DVHLQDLSSLSTAFQGTIGYLAPEFAYMRIVTTKVDVFSFGIVVMEFLTKRRPTGLDEENGLSPISLRQLVEKALANGIN 248 (299)
Q Consensus 169 ~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~DiwslG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 248 (299)
.. .........+|+.|+|||++.+..++.++|+|||||++|+|++|..||.... . ............
T Consensus 156 ~~----~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~-----~---~~~~~~i~~~~~- 222 (337)
T 1o6l_A 156 IS----DGATMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQD-----H---ERLFELILMEEI- 222 (337)
T ss_dssp CC----TTCCBCCCEECGGGCCGGGGSSSCBCTTHHHHHHHHHHHHHHHSSCSSCCSS-----H---HHHHHHHHHCCC-
T ss_pred cc----CCCcccccccChhhCChhhhcCCCCCchhhcccchhHHHHHhcCCCCCCCCC-----H---HHHHHHHHcCCC-
Confidence 21 1223345678999999999999999999999999999999999999995331 1 122222222110
Q ss_pred CcccccCccccchhhHhHHHHHHHHHHHHHHHHhcCCCCCCCC-----ChhhhhcC
Q 038766 249 GVRQITDPKLVSSIYEEQEQHQVLEELFKLALVCTSSNPEDRP-----NMNELLIT 299 (299)
Q Consensus 249 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rp-----t~~~il~~ 299 (299)
. . +..++.++.++|.+||..||++|| +++++++|
T Consensus 223 ~-----~------------p~~~s~~~~~li~~lL~~dP~~R~g~~~~~~~ei~~h 261 (337)
T 1o6l_A 223 R-----F------------PRTLSPEAKSLLAGLLKKDPKQRLGGGPSDAKEVMEH 261 (337)
T ss_dssp C-----C------------CTTSCHHHHHHHHHHTCSSTTTSTTCSTTTHHHHHTS
T ss_pred C-----C------------CCCCCHHHHHHHHHHhhcCHHHhcCCCCCCHHHHHcC
Confidence 0 0 123456899999999999999999 99999987
|
| >3tki_A Serine/threonine-protein kinase CHK1; cell checkpoint, transferase-transferase inhib complex; HET: S25; 1.60A {Homo sapiens} PDB: 2qhm_A* 2r0u_A* 3tkh_A* 2qhn_A* 2hy0_A* 2hog_A* 2hxq_A* 2hxl_A* 3f9n_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=8.2e-48 Score=327.52 Aligned_cols=256 Identities=25% Similarity=0.346 Sum_probs=202.3
Q ss_pred HhCCCCCCceeecCCcceEEEEEeC-CCcEEEEEEeccCcCChhhhHHHHHHHHHHHhcCCcceeeeeeEEEcCCCeeEE
Q 038766 10 ATGSFSENNIIGNSNLSTVYKGRLE-DGEIVAVKKLNFHQFSAESDKSFYREAKTLKELKHRNLVKVLGYAWESGKLKAL 88 (299)
Q Consensus 10 ~~~~y~~~~~lg~g~~~~v~~~~~~-~~~~~~vK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~l 88 (299)
+.++|++.+.||+|+||+||++.+. +++.||+|++.... .....+.+.+|+.+++.++||||+++++++.. +...++
T Consensus 5 ~~~~y~i~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~-~~~~~l 82 (323)
T 3tki_A 5 FVEDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKR-AVDCPENIKKEICINKMLNHENVVKFYGHRRE-GNIQYL 82 (323)
T ss_dssp TTTCEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECC--------CHHHHHHHHHHCCCTTBCCEEEEEEC-SSEEEE
T ss_pred HhhhceeeeEEecCCCEEEEEEEECCCCcEEEEEEEEccc-ccchHHHHHHHHHHHHhCCCCCCCeEEEEEec-CCeEEE
Confidence 5689999999999999999999875 68999999986433 22334668899999999999999999996654 566799
Q ss_pred EEeecCCCChHHHhcCCCCCCCCCChhhHHHHHHHHHHHHHHhhcCCCCCeeeecccCCceeeCCCCcEEEeeecccccc
Q 038766 89 ILEYMENGSLESVIHGPGVDHSRWTLPKRIDVLISVANGLDYLHSGYDIPIVHCDMKPSNILLDRDFEAHVSDFGTSRML 168 (299)
Q Consensus 89 v~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lh~~~~~~~~H~dl~~~nil~~~~~~v~l~df~~~~~~ 168 (299)
|+||+.+++|.+++. ....+++..++.++.|++.||+|||+. +++|+||||+||+++.++.++|+|||++..+
T Consensus 83 v~e~~~~~~L~~~l~----~~~~~~~~~~~~i~~qi~~aL~~LH~~---givH~Dlkp~NIll~~~~~~kl~Dfg~a~~~ 155 (323)
T 3tki_A 83 FLEYCSGGELFDRIE----PDIGMPEPDAQRFFHQLMAGVVYLHGI---GITHRDIKPENLLLDERDNLKISDFGLATVF 155 (323)
T ss_dssp EEECCTTEEGGGGSB----TTTBCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEECTTCCEEECCCTTCEEC
T ss_pred EEEcCCCCcHHHHHh----hcCCCCHHHHHHHHHHHHHHHHHHHHC---CccccccchHHEEEeCCCCEEEEEeecccee
Confidence 999999999999997 456799999999999999999999999 9999999999999999999999999999765
Q ss_pred ccccccccccccccccCcccCChhhhcccCc-CccccchhhhHHHHHHHhCCCCCCCCccCCCCchhHHHHHHHHHhcCc
Q 038766 169 DVHLQDLSSLSTAFQGTIGYLAPEFAYMRIV-TTKVDVFSFGIVVMEFLTKRRPTGLDEENGLSPISLRQLVEKALANGI 247 (299)
Q Consensus 169 ~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~-~~~~DiwslG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 247 (299)
.... .........+++.|+|||++.+..+ +.++|||||||++|+|++|..||....... ....... . .
T Consensus 156 ~~~~--~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~---~~~~~~~----~-~- 224 (323)
T 3tki_A 156 RYNN--RERLLNKMCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSC---QEYSDWK----E-K- 224 (323)
T ss_dssp EETT--EECCBCSCCSCGGGSCHHHHHCSSBCHHHHHHHHHHHHHHHHHHSSCSCSSSCTTS---HHHHHHH----T-T-
T ss_pred ccCC--cccccCCCccCcCccCcHHhccCCCCCCcccHHHHHHHHHHHHhCCCCCCCCchHH---HHHHHHh----c-c-
Confidence 4211 1222345568999999999987765 778999999999999999999996442211 1111110 0 0
Q ss_pred cCcccccCccccchhhHhHHHHHHHHHHHHHHHHhcCCCCCCCCChhhhhcC
Q 038766 248 NGVRQITDPKLVSSIYEEQEQHQVLEELFKLALVCTSSNPEDRPNMNELLIT 299 (299)
Q Consensus 248 ~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rpt~~~il~~ 299 (299)
.....+ ...++..+.+||.+||..||++|||++|+++|
T Consensus 225 ---~~~~~~-----------~~~~~~~~~~li~~~L~~dP~~R~t~~eil~h 262 (323)
T 3tki_A 225 ---KTYLNP-----------WKKIDSAPLALLHKILVENPSARITIPDIKKD 262 (323)
T ss_dssp ---CTTSTT-----------GGGSCHHHHHHHHHHSCSSTTTSCCHHHHTTC
T ss_pred ---cccCCc-----------cccCCHHHHHHHHHHccCChhhCcCHHHHhhC
Confidence 000000 12345678899999999999999999999987
|
| >4dc2_A Protein kinase C IOTA type; kinase, substrate, cell polarity, atypical PKC, trans transferase substrate complex; HET: TPO ADE; 2.40A {Mus musculus} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.4e-47 Score=331.71 Aligned_cols=261 Identities=17% Similarity=0.236 Sum_probs=204.2
Q ss_pred HhCCCCCCceeecCCcceEEEEEeC-CCcEEEEEEeccCcCC-hhhhHHHHHHHHHHHhc-CCcceeeeeeEEEcCCCee
Q 038766 10 ATGSFSENNIIGNSNLSTVYKGRLE-DGEIVAVKKLNFHQFS-AESDKSFYREAKTLKEL-KHRNLVKVLGYAWESGKLK 86 (299)
Q Consensus 10 ~~~~y~~~~~lg~g~~~~v~~~~~~-~~~~~~vK~~~~~~~~-~~~~~~~~~e~~~l~~l-~h~~i~~~~~~~~~~~~~~ 86 (299)
-.++|.+.+.||+|+||.||+|++. +++.||+|++...... ......+..|..+++++ +||||+++++++.. ...+
T Consensus 50 ~~~~y~~~~~LG~G~fG~V~~~~~~~~~~~~AvK~~~k~~~~~~~~~~~~~~E~~il~~~~~hp~Iv~l~~~~~~-~~~~ 128 (396)
T 4dc2_A 50 GLQDFDLLRVIGRGSYAKVLLVRLKKTDRIYAMRVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGLHSCFQT-ESRL 128 (396)
T ss_dssp CGGGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEEGGGTC----CCHHHHHHHHHHHHTTCTTBCCEEEEEEC-SSEE
T ss_pred ChhHcEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEEhhhccCHHHHHHHHHHHHHHHhcCCCCCcCeeEEEEEE-CCEE
Confidence 3568999999999999999999875 5889999999754332 33456688899999887 79999999996655 5567
Q ss_pred EEEEeecCCCChHHHhcCCCCCCCCCChhhHHHHHHHHHHHHHHhhcCCCCCeeeecccCCceeeCCCCcEEEeeecccc
Q 038766 87 ALILEYMENGSLESVIHGPGVDHSRWTLPKRIDVLISVANGLDYLHSGYDIPIVHCDMKPSNILLDRDFEAHVSDFGTSR 166 (299)
Q Consensus 87 ~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lh~~~~~~~~H~dl~~~nil~~~~~~v~l~df~~~~ 166 (299)
++|+||+.+++|..++. ....+++..++.++.||+.||.|||++ +++||||||+||+++.+|.+||+|||++.
T Consensus 129 ~lV~E~~~gg~L~~~l~----~~~~l~~~~~~~~~~qi~~aL~~LH~~---givHrDLKp~NILl~~~g~ikL~DFGla~ 201 (396)
T 4dc2_A 129 FFVIEYVNGGDLMFHMQ----RQRKLPEEHARFYSAEISLALNYLHER---GIIYRDLKLDNVLLDSEGHIKLTDYGMCK 201 (396)
T ss_dssp EEEEECCTTCBHHHHHH----HHSSCCHHHHHHHHHHHHHHHHHHHHT---TCBCCCCCGGGEEECTTSCEEECCCTTCB
T ss_pred EEEEEcCCCCcHHHHHH----HcCCCCHHHHHHHHHHHHHHHHHHHHC---CEEeccCCHHHEEECCCCCEEEeecceee
Confidence 99999999999999887 445799999999999999999999999 99999999999999999999999999987
Q ss_pred ccccccccccccccccccCcccCChhhhcccCcCccccchhhhHHHHHHHhCCCCCCCCccCCCCchhHHHHHHHHHhcC
Q 038766 167 MLDVHLQDLSSLSTAFQGTIGYLAPEFAYMRIVTTKVDVFSFGIVVMEFLTKRRPTGLDEENGLSPISLRQLVEKALANG 246 (299)
Q Consensus 167 ~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~DiwslG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~ 246 (299)
... ..........+|+.|+|||++.+..++.++|+|||||++|+|++|..||................+.......
T Consensus 202 ~~~----~~~~~~~~~~gt~~Y~aPE~l~~~~~~~~~DiwslGvllyell~G~~Pf~~~~~~~~~~~~~~~~~~~~i~~~ 277 (396)
T 4dc2_A 202 EGL----RPGDTTSTFCGTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFDIVGSSDNPDQNTEDYLFQVILEK 277 (396)
T ss_dssp CCC----CTTCCBCCCCBCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSTTTTC------CCHHHHHHHHHHC
T ss_pred ecc----cCCCccccccCCcccCCchhhcCCCCChHHHHHHHHHHHHHHHhCCCCCcccccccccchhhHHHHHHHHhcc
Confidence 422 1123344567899999999999999999999999999999999999999644322222111112222211111
Q ss_pred ccCcccccCccccchhhHhHHHHHHHHHHHHHHHHhcCCCCCCCCCh------hhhhcC
Q 038766 247 INGVRQITDPKLVSSIYEEQEQHQVLEELFKLALVCTSSNPEDRPNM------NELLIT 299 (299)
Q Consensus 247 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rpt~------~~il~~ 299 (299)
.... +..++.++.+||++||..||++||++ +|+++|
T Consensus 278 ~~~~-----------------p~~~s~~~~~li~~lL~~dP~~R~~~~~~~~~~ei~~H 319 (396)
T 4dc2_A 278 QIRI-----------------PRSLSVKAASVLKSFLNKDPKERLGCHPQTGFADIQGH 319 (396)
T ss_dssp CCCC-----------------CTTSCHHHHHHHHHHTCSCTTTSTTCSTTTHHHHHHHS
T ss_pred ccCC-----------------CCcCCHHHHHHHHHHhcCCHhHcCCCCCCCCHHHHhcC
Confidence 1111 22345679999999999999999996 688876
|
| >2c30_A Serine/threonine-protein kinase PAK 6; CRIB domain, ATP-binding, transferase, nucleotide-binding; HET: SEP; 1.6A {Homo sapiens} PDB: 2f57_A* 2j0i_A* 2cdz_A* 2q0n_A* 2x4z_A* 2bva_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=8.8e-47 Score=320.96 Aligned_cols=260 Identities=23% Similarity=0.376 Sum_probs=208.9
Q ss_pred CChHHHHHHhCC----------CCCCceeecCCcceEEEEEeC-CCcEEEEEEeccCcCChhhhHHHHHHHHHHHhcCCc
Q 038766 2 FDRTEIENATGS----------FSENNIIGNSNLSTVYKGRLE-DGEIVAVKKLNFHQFSAESDKSFYREAKTLKELKHR 70 (299)
Q Consensus 2 ~~~~~~~~~~~~----------y~~~~~lg~g~~~~v~~~~~~-~~~~~~vK~~~~~~~~~~~~~~~~~e~~~l~~l~h~ 70 (299)
|+.++++...+. |...+.||+|+||.||+|.+. +|+.||||++... .....+.+.+|+..++.++||
T Consensus 25 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~lg~G~~g~V~~a~~~~~g~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~ 102 (321)
T 2c30_A 25 VTHEQFKAALRMVVDQGDPRLLLDSYVKIGEGSTGIVCLAREKHSGRQVAVKMMDLR--KQQRRELLFNEVVIMRDYQHF 102 (321)
T ss_dssp CCHHHHHHHHHTTSCSSCHHHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEETT--TCCSHHHHHHHHHHHTTCCCT
T ss_pred CcHHHHHHHHhhccCCCCchhhhhccEEeccCCCeEEEEEEECCCCcEEEEEEEecc--chhHHHHHHHHHHHHHhCCCC
Confidence 566666665543 677789999999999999875 6999999998643 234466788999999999999
Q ss_pred ceeeeeeEEEcCCCeeEEEEeecCCCChHHHhcCCCCCCCCCChhhHHHHHHHHHHHHHHhhcCCCCCeeeecccCCcee
Q 038766 71 NLVKVLGYAWESGKLKALILEYMENGSLESVIHGPGVDHSRWTLPKRIDVLISVANGLDYLHSGYDIPIVHCDMKPSNIL 150 (299)
Q Consensus 71 ~i~~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lh~~~~~~~~H~dl~~~nil 150 (299)
||+++++++.. +...++|+||+.+++|.+++. ...+++..++.++.|++.||.|||+. +++|+||||+||+
T Consensus 103 niv~~~~~~~~-~~~~~lv~e~~~~~~L~~~l~-----~~~l~~~~~~~i~~qi~~~L~~LH~~---~ivH~Dlkp~NIl 173 (321)
T 2c30_A 103 NVVEMYKSYLV-GEELWVLMEFLQGGALTDIVS-----QVRLNEEQIATVCEAVLQALAYLHAQ---GVIHRDIKSDSIL 173 (321)
T ss_dssp TBCCEEEEEEE-TTEEEEEECCCCSCBHHHHHT-----TCCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEE
T ss_pred CcceEEEEEEE-CCEEEEEEecCCCCCHHHHHH-----hcCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHEE
Confidence 99999997665 456699999999999999985 34689999999999999999999999 9999999999999
Q ss_pred eCCCCcEEEeeeccccccccccccccccccccccCcccCChhhhcccCcCccccchhhhHHHHHHHhCCCCCCCCccCCC
Q 038766 151 LDRDFEAHVSDFGTSRMLDVHLQDLSSLSTAFQGTIGYLAPEFAYMRIVTTKVDVFSFGIVVMEFLTKRRPTGLDEENGL 230 (299)
Q Consensus 151 ~~~~~~v~l~df~~~~~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~DiwslG~~l~~l~~g~~p~~~~~~~~~ 230 (299)
++.++.++|+|||++...... ........+++.|+|||.+.+..++.++||||||+++|+|++|..||....
T Consensus 174 l~~~~~~kl~Dfg~~~~~~~~----~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~g~~pf~~~~---- 245 (321)
T 2c30_A 174 LTLDGRVKLSDFGFCAQISKD----VPKRKSLVGTPYWMAPEVISRSLYATEVDIWSLGIMVIEMVDGEPPYFSDS---- 245 (321)
T ss_dssp ECTTCCEEECCCTTCEECCSS----SCCBCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCTTTTSC----
T ss_pred ECCCCcEEEeeeeeeeecccC----ccccccccCCccccCHhhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCC----
Confidence 999999999999998765421 112344568999999999999999999999999999999999999995331
Q ss_pred CchhHHHHHHHHHhcCccCcccccCccccchhhHhHHHHHHHHHHHHHHHHhcCCCCCCCCChhhhhcC
Q 038766 231 SPISLRQLVEKALANGINGVRQITDPKLVSSIYEEQEQHQVLEELFKLALVCTSSNPEDRPNMNELLIT 299 (299)
Q Consensus 231 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rpt~~~il~~ 299 (299)
.. ..+........+... . ...++..+.++|.+||..||++|||++++++|
T Consensus 246 -~~---~~~~~~~~~~~~~~~---~------------~~~~~~~l~~li~~~l~~dp~~Rps~~ell~h 295 (321)
T 2c30_A 246 -PV---QAMKRLRDSPPPKLK---N------------SHKVSPVLRDFLERMLVRDPQERATAQELLDH 295 (321)
T ss_dssp -HH---HHHHHHHHSSCCCCT---T------------GGGSCHHHHHHHHHHSCSSTTTSCCHHHHHTS
T ss_pred -HH---HHHHHHhcCCCCCcC---c------------cccCCHHHHHHHHHHccCChhhCcCHHHHhcC
Confidence 11 122222211111100 0 12345678999999999999999999999987
|
| >1ob3_A PFPK5, cell division control protein 2 homolog; transferase, serine/threonine-protein kinase, ATP-binding, phosphorylation, CDK; 1.9A {Plasmodium falciparum} SCOP: d.144.1.7 PDB: 1v0p_A* 1v0o_A* 1v0b_A | Back alignment and structure |
|---|
Probab=100.00 E-value=3.4e-47 Score=318.84 Aligned_cols=271 Identities=23% Similarity=0.301 Sum_probs=202.1
Q ss_pred CCCCCCceeecCCcceEEEEEeCCCcEEEEEEeccCcCChhhhHHHHHHHHHHHhcCCcceeeeeeEEEcCCCeeEEEEe
Q 038766 12 GSFSENNIIGNSNLSTVYKGRLEDGEIVAVKKLNFHQFSAESDKSFYREAKTLKELKHRNLVKVLGYAWESGKLKALILE 91 (299)
Q Consensus 12 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~vK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~lv~e 91 (299)
++|.+.+.||+|+||+||+|.+.+++.+|+|++............+.+|+.+++.++||||+++++++.. +...++|+|
T Consensus 2 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~-~~~~~lv~e 80 (288)
T 1ob3_A 2 EKYHGLEKIGEGTYGVVYKAQNNYGETFALKKIRLEKEDEGIPSTTIREISILKELKHSNIVKLYDVIHT-KKRLVLVFE 80 (288)
T ss_dssp CSEEEEEEEEEETTEEEEEEEETTSCEEEEEEECCSSGGGCCCHHHHHHHHGGGGCCCTTBCCEEEEEEC-SSCEEEEEE
T ss_pred ccchhhhhcccCCCEEEEEEEcCCCCEEEEEEEeccccccccchhHHHHHHHHHhcCCCCEeeeeeEEcc-CCeEEEEEE
Confidence 6899999999999999999998889999999997655444556788899999999999999999997665 455699999
Q ss_pred ecCCCChHHHhcCCCCCCCCCChhhHHHHHHHHHHHHHHhhcCCCCCeeeecccCCceeeCCCCcEEEeeeccccccccc
Q 038766 92 YMENGSLESVIHGPGVDHSRWTLPKRIDVLISVANGLDYLHSGYDIPIVHCDMKPSNILLDRDFEAHVSDFGTSRMLDVH 171 (299)
Q Consensus 92 ~~~~~~L~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lh~~~~~~~~H~dl~~~nil~~~~~~v~l~df~~~~~~~~~ 171 (299)
++.+ +|.+++.. ....+++..++.++.|++.||+|||++ +++|+||||+||+++.++.+||+|||++......
T Consensus 81 ~~~~-~l~~~~~~---~~~~~~~~~~~~~~~qi~~~l~~lH~~---~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~ 153 (288)
T 1ob3_A 81 HLDQ-DLKKLLDV---CEGGLESVTAKSFLLQLLNGIAYCHDR---RVLHRDLKPQNLLINREGELKIADFGLARAFGIP 153 (288)
T ss_dssp CCSE-EHHHHHHT---STTCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEECTTSCEEECCTTHHHHHCC-
T ss_pred ecCC-CHHHHHHh---cccCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHEEEcCCCCEEEeECccccccCcc
Confidence 9965 99888863 235789999999999999999999999 9999999999999999999999999998754311
Q ss_pred cccccccccccccCcccCChhhhccc-CcCccccchhhhHHHHHHHhCCCCCCCCccCCCCchhHHHHHHHHHhcC----
Q 038766 172 LQDLSSLSTAFQGTIGYLAPEFAYMR-IVTTKVDVFSFGIVVMEFLTKRRPTGLDEENGLSPISLRQLVEKALANG---- 246 (299)
Q Consensus 172 ~~~~~~~~~~~~~~~~y~~PE~~~~~-~~~~~~DiwslG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~---- 246 (299)
........+++.|+|||++.+. .++.++|||||||++|+|++|..||.... .......+.......
T Consensus 154 ----~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~-----~~~~~~~~~~~~~~~~~~~ 224 (288)
T 1ob3_A 154 ----VRKYTHEIVTLWYRAPDVLMGSKKYSTTIDIWSVGCIFAEMVNGTPLFPGVS-----EADQLMRIFRILGTPNSKN 224 (288)
T ss_dssp ------------CCCTTCCHHHHTTCCSCCTHHHHHHHHHHHHHHHHSSCSCCCSS-----HHHHHHHHHHHHCCCCTTT
T ss_pred ----ccccccccccccccCchheeCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCC-----HHHHHHHHHHHHCCCChhh
Confidence 1222344678999999998764 58999999999999999999999995431 111111111111110
Q ss_pred ccCcccccC--cccc--chhhHhHHHHHHHHHHHHHHHHhcCCCCCCCCChhhhhcC
Q 038766 247 INGVRQITD--PKLV--SSIYEEQEQHQVLEELFKLALVCTSSNPEDRPNMNELLIT 299 (299)
Q Consensus 247 ~~~~~~~~~--~~~~--~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rpt~~~il~~ 299 (299)
++....... +... ...........++.++.+||.+||..||++|||++|+|+|
T Consensus 225 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~h 281 (288)
T 1ob3_A 225 WPNVTELPKYDPNFTVYEPLPWESFLKGLDESGIDLLSKMLKLDPNQRITAKQALEH 281 (288)
T ss_dssp STTGGGSTTCCTTCCCCCCCCGGGTCCSCCHHHHHHHHHHTCSSTTTSCCHHHHHTS
T ss_pred chhhhcccccccccccccCccHHHHhhhcCHHHHHHHHHHcCCCcccCCCHHHHhcC
Confidence 000000000 0000 0000011123356788999999999999999999999987
|
| >3c0i_A Peripheral plasma membrane protein CASK; neurexin, Ca2+/calmodulin dependent protein kinase, Mg synaptic plasticity, pseudokinase, maguk; HET: 3AM; 1.85A {Homo sapiens} PDB: 3c0h_A* 3c0g_A* 3mfr_A* 3mfs_A* 3mft_A 3mfu_A* 3tac_A | Back alignment and structure |
|---|
Probab=100.00 E-value=5e-48 Score=332.55 Aligned_cols=260 Identities=21% Similarity=0.268 Sum_probs=206.1
Q ss_pred HHhCCCCCCceeecCCcceEEEEEeC-CCcEEEEEEeccCcC---ChhhhHHHHHHHHHHHhcCCcceeeeeeEEEcCCC
Q 038766 9 NATGSFSENNIIGNSNLSTVYKGRLE-DGEIVAVKKLNFHQF---SAESDKSFYREAKTLKELKHRNLVKVLGYAWESGK 84 (299)
Q Consensus 9 ~~~~~y~~~~~lg~g~~~~v~~~~~~-~~~~~~vK~~~~~~~---~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~ 84 (299)
.+.++|.+.+.||+|+||+||++.+. +++.||+|++..... .....+.+.+|+.+++.++||||+++++++.. +.
T Consensus 21 ~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~-~~ 99 (351)
T 3c0i_A 21 LFEDVYELCEVIGKGPFSVVRRCINRETGQQFAVKIVDVAKFTSSPGLSTEDLKREASICHMLKHPHIVELLETYSS-DG 99 (351)
T ss_dssp CHHHHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHTSSSCCHHHHHHHHHHHHHCCCTTBCCEEEEEEE-TT
T ss_pred ccccceEEeeEEeeCCCEEEEEEEECCCCCEEEEEEEEhhhccccccchHHHHHHHHHHHHhCCCCCCCcEEEEEEe-CC
Confidence 46688999999999999999999874 689999999864321 12246778999999999999999999997665 55
Q ss_pred eeEEEEeecCCCChHHHhcCCCCCCCCCChhhHHHHHHHHHHHHHHhhcCCCCCeeeecccCCceeeCCCCc---EEEee
Q 038766 85 LKALILEYMENGSLESVIHGPGVDHSRWTLPKRIDVLISVANGLDYLHSGYDIPIVHCDMKPSNILLDRDFE---AHVSD 161 (299)
Q Consensus 85 ~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lh~~~~~~~~H~dl~~~nil~~~~~~---v~l~d 161 (299)
..++|+||+.+++|.+.+.........+++..++.++.||+.||+|||++ +++|+||||+||+++.++. ++|+|
T Consensus 100 ~~~lv~e~~~g~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~al~~lH~~---~ivHrDlkp~NIl~~~~~~~~~vkl~D 176 (351)
T 3c0i_A 100 MLYMVFEFMDGADLCFEIVKRADAGFVYSEAVASHYMRQILEALRYCHDN---NIIHRDVKPHCVLLASKENSAPVKLGG 176 (351)
T ss_dssp EEEEEEECCSSCBHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEECSSSTTCCEEECC
T ss_pred EEEEEEeCCCCCCHHHHHHHhcccCCCCCHHHHHHHHHHHHHHHHHHHHC---CceeccCChHHeEEecCCCCCcEEEec
Confidence 67999999999999877653322344689999999999999999999999 9999999999999986654 99999
Q ss_pred eccccccccccccccccccccccCcccCChhhhcccCcCccccchhhhHHHHHHHhCCCCCCCCccCCCCchhHHHHHHH
Q 038766 162 FGTSRMLDVHLQDLSSLSTAFQGTIGYLAPEFAYMRIVTTKVDVFSFGIVVMEFLTKRRPTGLDEENGLSPISLRQLVEK 241 (299)
Q Consensus 162 f~~~~~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~DiwslG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~ 241 (299)
||++...... ........+|+.|+|||++.+..++.++|||||||++|+|++|..||.... ......
T Consensus 177 fg~a~~~~~~----~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~---------~~~~~~ 243 (351)
T 3c0i_A 177 FGVAIQLGES----GLVAGGRVGTPHFMAPEVVKREPYGKPVDVWGCGVILFILLSGCLPFYGTK---------ERLFEG 243 (351)
T ss_dssp CTTCEECCTT----SCBCCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCSSH---------HHHHHH
T ss_pred CcceeEecCC----CeeecCCcCCcCccCHHHHcCCCCCchHhhHHHHHHHHHHHHCCCCCCCcH---------HHHHHH
Confidence 9999765421 122344568999999999999999999999999999999999999996431 112222
Q ss_pred HHhcCccCcccccCccccchhhHhHHHHHHHHHHHHHHHHhcCCCCCCCCChhhhhcC
Q 038766 242 ALANGINGVRQITDPKLVSSIYEEQEQHQVLEELFKLALVCTSSNPEDRPNMNELLIT 299 (299)
Q Consensus 242 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rpt~~~il~~ 299 (299)
........ . ......++.++.+||++||..||++|||+.++|+|
T Consensus 244 i~~~~~~~-----~---------~~~~~~~s~~~~~li~~~L~~dP~~R~s~~e~l~h 287 (351)
T 3c0i_A 244 IIKGKYKM-----N---------PRQWSHISESAKDLVRRMLMLDPAERITVYEALNH 287 (351)
T ss_dssp HHHTCCCC-----C---------HHHHTTSCHHHHHHHHHHTCSSTTTSCCHHHHHTS
T ss_pred HHcCCCCC-----C---------ccccccCCHHHHHHHHHHCCCChhHCcCHHHHhcC
Confidence 21111000 0 01123456789999999999999999999999987
|
| >4agu_A Cyclin-dependent kinase-like 1; transferase, phospho-mimetic; HET: D15; 2.40A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-46 Score=319.26 Aligned_cols=271 Identities=24% Similarity=0.287 Sum_probs=203.1
Q ss_pred HhCCCCCCceeecCCcceEEEEEeC-CCcEEEEEEeccCcCChhhhHHHHHHHHHHHhcCCcceeeeeeEEEcCCCeeEE
Q 038766 10 ATGSFSENNIIGNSNLSTVYKGRLE-DGEIVAVKKLNFHQFSAESDKSFYREAKTLKELKHRNLVKVLGYAWESGKLKAL 88 (299)
Q Consensus 10 ~~~~y~~~~~lg~g~~~~v~~~~~~-~~~~~~vK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~l 88 (299)
+.++|++.+.||+|++|+||++.+. +|+.||+|++..........+.+.+|+.++++++||||+++++++.. +...++
T Consensus 1 l~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~-~~~~~l 79 (311)
T 4agu_A 1 MMEKYEKIGKIGEGSYGVVFKCRNRDTGQIVAIKKFLESEDDPVIKKIALREIRMLKQLKHPNLVNLLEVFRR-KRRLHL 79 (311)
T ss_dssp --CCEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECCCCC-HHHHHHHHHHHHHHHHCCCTTBCCEEEEEEE-TTEEEE
T ss_pred CcccceEeeEEeecCCeEEEEEEeCCCCcEEEEEEeeccccchHHHHHHHHHHHHHHhCCCCCccchhheeec-CCeEEE
Confidence 3578999999999999999999875 58999999997666556667788899999999999999999997665 556699
Q ss_pred EEeecCCCChHHHhcCCCCCCCCCChhhHHHHHHHHHHHHHHhhcCCCCCeeeecccCCceeeCCCCcEEEeeecccccc
Q 038766 89 ILEYMENGSLESVIHGPGVDHSRWTLPKRIDVLISVANGLDYLHSGYDIPIVHCDMKPSNILLDRDFEAHVSDFGTSRML 168 (299)
Q Consensus 89 v~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lh~~~~~~~~H~dl~~~nil~~~~~~v~l~df~~~~~~ 168 (299)
|+||+.+++|..++. ....+++..++.++.|++.||+|||+. +++|+||||+||+++.++.++|+|||++...
T Consensus 80 v~e~~~~~~l~~~~~----~~~~~~~~~~~~i~~~l~~~l~~lH~~---~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~ 152 (311)
T 4agu_A 80 VFEYCDHTVLHELDR----YQRGVPEHLVKSITWQTLQAVNFCHKH---NCIHRDVKPENILITKHSVIKLCDFGFARLL 152 (311)
T ss_dssp EEECCSEEHHHHHHH----TSSCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECTTSCEEECCCTTCEEC
T ss_pred EEEeCCCchHHHHHh----hhcCCCHHHHHHHHHHHHHHHHHHHHC---CCcCCCCChhhEEEcCCCCEEEeeCCCchhc
Confidence 999999988988886 445799999999999999999999999 9999999999999999999999999999765
Q ss_pred ccccccccccccccccCcccCChhhhcc-cCcCccccchhhhHHHHHHHhCCCCCCCCccCCCCchhHHHHHHHHHhc--
Q 038766 169 DVHLQDLSSLSTAFQGTIGYLAPEFAYM-RIVTTKVDVFSFGIVVMEFLTKRRPTGLDEENGLSPISLRQLVEKALAN-- 245 (299)
Q Consensus 169 ~~~~~~~~~~~~~~~~~~~y~~PE~~~~-~~~~~~~DiwslG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~-- 245 (299)
.. .........+++.|+|||.+.+ ..++.++||||||+++|+|++|..||.... .......+......
T Consensus 153 ~~----~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~-----~~~~~~~~~~~~~~~~ 223 (311)
T 4agu_A 153 TG----PSDYYDDEVATRWYRSPELLVGDTQYGPPVDVWAIGCVFAELLSGVPLWPGKS-----DVDQLYLIRKTLGDLI 223 (311)
T ss_dssp C----------------GGGCCHHHHHTCSCCCTHHHHHHHHHHHHHHHHSSCSCCCSS-----HHHHHHHHHHHHCSCC
T ss_pred cC----cccccCCCcCCccccChHHHhcCCCCCcchhhHHHHHHHHHHHhCCCCCCCCC-----HHHHHHHHHHHhcccc
Confidence 42 1222334567889999999876 567999999999999999999999995432 11111111111110
Q ss_pred ----------CccCcccccCccccchhhHhHHHHHHHHHHHHHHHHhcCCCCCCCCChhhhhcC
Q 038766 246 ----------GINGVRQITDPKLVSSIYEEQEQHQVLEELFKLALVCTSSNPEDRPNMNELLIT 299 (299)
Q Consensus 246 ----------~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rpt~~~il~~ 299 (299)
.......+..+..... .......++..+.+||++||..||++|||++|+|+|
T Consensus 224 ~~~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~h 285 (311)
T 4agu_A 224 PRHQQVFSTNQYFSGVKIPDPEDMEP--LELKFPNISYPALGLLKGCLHMDPTERLTCEQLLHH 285 (311)
T ss_dssp HHHHHHHHTCGGGTTCCCCCCSSCCC--HHHHCTTCCHHHHHHHHHHCCSSTTTSCCHHHHHTS
T ss_pred cccccccccccccccCcCCCccccch--hhhhcccccHHHHHHHHHHccCChhhcCCHHHHhcC
Confidence 0000111111111100 111123456789999999999999999999999987
|
| >4euu_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: SEP BX7; 1.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.9e-47 Score=323.00 Aligned_cols=276 Identities=23% Similarity=0.321 Sum_probs=209.9
Q ss_pred HhCCCCCCceeecCCcceEEEEEeC-CCcEEEEEEeccCcCChhhhHHHHHHHHHHHhcCCcceeeeeeEEEcCC-CeeE
Q 038766 10 ATGSFSENNIIGNSNLSTVYKGRLE-DGEIVAVKKLNFHQFSAESDKSFYREAKTLKELKHRNLVKVLGYAWESG-KLKA 87 (299)
Q Consensus 10 ~~~~y~~~~~lg~g~~~~v~~~~~~-~~~~~~vK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~-~~~~ 87 (299)
..++|.+.+.||+|+||+||++.+. +++.||+|++.... .....+.+.+|++++++++||||+++++++.... ...+
T Consensus 7 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~ 85 (319)
T 4euu_A 7 SNHLWLLSDILGQGATANVFRGRHKKTGDLFAIKVFNNIS-FLRPVDVQMREFEVLKKLNHKNIVKLFAIEEETTTRHKV 85 (319)
T ss_dssp SSEEEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECGGG-GGSCHHHHHHHHHHHHHCCCTTBCCEEEEEECTTTCCEE
T ss_pred CCCCEEEEEEecCCCCeEEEEEEECCCCcEEEEEEecccc-ccchHHHHHHHHHHHHhcCCCCcceEEEEeecCCCceEE
Confidence 4578999999999999999999875 48999999986432 2334567789999999999999999999776544 3669
Q ss_pred EEEeecCCCChHHHhcCCCCCCCCCChhhHHHHHHHHHHHHHHhhcCCCCCeeeecccCCceee----CCCCcEEEeeec
Q 038766 88 LILEYMENGSLESVIHGPGVDHSRWTLPKRIDVLISVANGLDYLHSGYDIPIVHCDMKPSNILL----DRDFEAHVSDFG 163 (299)
Q Consensus 88 lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lh~~~~~~~~H~dl~~~nil~----~~~~~v~l~df~ 163 (299)
+|+||+.+++|.+++.... ....+++..++.++.|++.||+|||+. +++|+||||+||++ +.++.+||+|||
T Consensus 86 lv~e~~~~~~L~~~l~~~~-~~~~~~~~~~~~i~~qi~~~L~~LH~~---~ivH~Dlkp~NIll~~~~~~~~~~kL~Dfg 161 (319)
T 4euu_A 86 LIMEFCPCGSLYTVLEEPS-NAYGLPESEFLIVLRDVVGGMNHLREN---GIVHRNIKPGNIMRVIGEDGQSVYKLTDFG 161 (319)
T ss_dssp EEEECCTTCBHHHHHHSGG-GTTCCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEEEECTTSCEEEEECCCT
T ss_pred EEEeCCCCCCHHHHHHHhc-cccCCCHHHHHHHHHHHHHHHHHHHHC---CEecCCCCHHHEEEeccCCCCceEEEccCC
Confidence 9999999999999997542 233499999999999999999999999 99999999999999 777889999999
Q ss_pred cccccccccccccccccccccCcccCChhhhc--------ccCcCccccchhhhHHHHHHHhCCCCCCCCccCCCCchhH
Q 038766 164 TSRMLDVHLQDLSSLSTAFQGTIGYLAPEFAY--------MRIVTTKVDVFSFGIVVMEFLTKRRPTGLDEENGLSPISL 235 (299)
Q Consensus 164 ~~~~~~~~~~~~~~~~~~~~~~~~y~~PE~~~--------~~~~~~~~DiwslG~~l~~l~~g~~p~~~~~~~~~~~~~~ 235 (299)
++..... ........+++.|+|||++. +..++.++|||||||++|+|++|..||........ .
T Consensus 162 ~a~~~~~-----~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~----~ 232 (319)
T 4euu_A 162 AARELED-----DEQFVSLYGTEEYLHPDMYERAVLRKDHQKKYGATVDLWSIGVTFYHAATGSLPFRPFEGPRR----N 232 (319)
T ss_dssp TCEECCT-----TCCBCCCCSCGGGCCHHHHHHHTSCCCCCCCBCTTHHHHHHHHHHHHHHHSSCSEECTTCGGG----C
T ss_pred CceecCC-----CCceeecccCCCccCHHHhhhccccccccCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCccch----h
Confidence 9976542 12223456899999999876 46788999999999999999999999964322222 2
Q ss_pred HHHHHHHHhcCccC----cccccCccc--c-chhhHhHHHHHHHHHHHHHHHHhcCCCCCCCCChhhhhcC
Q 038766 236 RQLVEKALANGING----VRQITDPKL--V-SSIYEEQEQHQVLEELFKLALVCTSSNPEDRPNMNELLIT 299 (299)
Q Consensus 236 ~~~~~~~~~~~~~~----~~~~~~~~~--~-~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rpt~~~il~~ 299 (299)
.+.+.......... ......... . ...........++..+.+++++||..||++|||++|+|+|
T Consensus 233 ~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~ll~~~L~~dP~~R~s~~ell~h 303 (319)
T 4euu_A 233 KEVMYKIITGKPSGAISGVQKAENGPIDWSGDMPVSCSLSRGLQVLLTPVLANILEADQEKCWGFDQFFAE 303 (319)
T ss_dssp HHHHHHHHHHCCTTCCEEEECSTTCCEEEESSCCTTCSSCHHHHHHHHHHHHHHSCCCTTTSCCHHHHHHH
T ss_pred HHHHHHHhcCCCcccchhhhcccCCccccCccCCcccccchhHHHHhHHHHHHhccCChhhhccHHHhhhc
Confidence 22333332222111 100000000 0 0000112256778899999999999999999999999976
|
| >3a8x_A Protein kinase C IOTA type; transferase; HET: TPO; 2.00A {Homo sapiens} PDB: 3a8w_A* 1zrz_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7.6e-47 Score=324.06 Aligned_cols=259 Identities=19% Similarity=0.239 Sum_probs=204.7
Q ss_pred hCCCCCCceeecCCcceEEEEEeC-CCcEEEEEEeccCcC-ChhhhHHHHHHHHHHHhc-CCcceeeeeeEEEcCCCeeE
Q 038766 11 TGSFSENNIIGNSNLSTVYKGRLE-DGEIVAVKKLNFHQF-SAESDKSFYREAKTLKEL-KHRNLVKVLGYAWESGKLKA 87 (299)
Q Consensus 11 ~~~y~~~~~lg~g~~~~v~~~~~~-~~~~~~vK~~~~~~~-~~~~~~~~~~e~~~l~~l-~h~~i~~~~~~~~~~~~~~~ 87 (299)
.++|.+.+.||+|+||.||+|.+. +++.||+|++..... .......+..|..+++++ +||||+++++++.. ....+
T Consensus 8 ~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~~~~hp~iv~l~~~~~~-~~~~~ 86 (345)
T 3a8x_A 8 LQDFDLLRVIGRGSYAKVLLVRLKKTDRIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGLHSCFQT-ESRLF 86 (345)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEEGGGSCSHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEEC-SSEEE
T ss_pred hhheEEEEEEEecCCeEEEEEEECCCCCEEEEEEEEhHHhcchHHHHHHHHHHHHHHhcCCCCccCeEEEEEEe-CCEEE
Confidence 578999999999999999999875 589999999975443 334466788999999988 79999999997655 55679
Q ss_pred EEEeecCCCChHHHhcCCCCCCCCCChhhHHHHHHHHHHHHHHhhcCCCCCeeeecccCCceeeCCCCcEEEeeeccccc
Q 038766 88 LILEYMENGSLESVIHGPGVDHSRWTLPKRIDVLISVANGLDYLHSGYDIPIVHCDMKPSNILLDRDFEAHVSDFGTSRM 167 (299)
Q Consensus 88 lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lh~~~~~~~~H~dl~~~nil~~~~~~v~l~df~~~~~ 167 (299)
+|+||+.+++|..++. ....+++..++.++.||+.||.|||++ +++||||||+||+++.+|.++|+|||++..
T Consensus 87 lv~e~~~gg~L~~~l~----~~~~l~~~~~~~~~~qi~~aL~~LH~~---~ivHrDlkp~NIll~~~g~~kL~DFG~a~~ 159 (345)
T 3a8x_A 87 FVIEYVNGGDLMFHMQ----RQRKLPEEHARFYSAEISLALNYLHER---GIIYRDLKLDNVLLDSEGHIKLTDYGMCKE 159 (345)
T ss_dssp EEECCCCSCBHHHHHH----HHSSCCHHHHHHHHHHHHHHHHHHHHT---TCBCCCCCGGGEEECTTSCEEECCGGGCBC
T ss_pred EEEeCCCCCcHHHHHH----HcCCCCHHHHHHHHHHHHHHHHHHHHC---CceecCCCHHHEEECCCCCEEEEecccccc
Confidence 9999999999999887 445799999999999999999999999 999999999999999999999999999875
Q ss_pred cccccccccccccccccCcccCChhhhcccCcCccccchhhhHHHHHHHhCCCCCCCCccCCCCchh-HHHHHHHHHhcC
Q 038766 168 LDVHLQDLSSLSTAFQGTIGYLAPEFAYMRIVTTKVDVFSFGIVVMEFLTKRRPTGLDEENGLSPIS-LRQLVEKALANG 246 (299)
Q Consensus 168 ~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~DiwslG~~l~~l~~g~~p~~~~~~~~~~~~~-~~~~~~~~~~~~ 246 (299)
... .........+|+.|+|||++.+..++.++|+|||||++|+|++|..||............ ............
T Consensus 160 ~~~----~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~i~~~~ 235 (345)
T 3a8x_A 160 GLR----PGDTTSTFCGTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFDIVGSSDNPDQNTEDYLFQVILEKQ 235 (345)
T ss_dssp SCC----TTCCBCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCTTTTTTC-------CHHHHHHHHHHCC
T ss_pred ccC----CCCcccccCCCccccCccccCCCCCChHHhHHHHHHHHHHHHhCCCCcCCcccccccccccHHHHHHHHHcCC
Confidence 321 122334557899999999999999999999999999999999999999643222111111 111122221111
Q ss_pred ccCcccccCccccchhhHhHHHHHHHHHHHHHHHHhcCCCCCCCCCh------hhhhcC
Q 038766 247 INGVRQITDPKLVSSIYEEQEQHQVLEELFKLALVCTSSNPEDRPNM------NELLIT 299 (299)
Q Consensus 247 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rpt~------~~il~~ 299 (299)
... +..++.++.++|++||..||++||++ +++++|
T Consensus 236 -~~~-----------------p~~~s~~~~~li~~lL~~dP~~R~~~~~~~~~~~i~~h 276 (345)
T 3a8x_A 236 -IRI-----------------PRSLSVKAASVLKSFLNKDPKERLGCHPQTGFADIQGH 276 (345)
T ss_dssp -CCC-----------------CTTSCHHHHHHHHHHTCSSTTTSTTCCTTTHHHHHHTS
T ss_pred -CCC-----------------CCCCCHHHHHHHHHHhcCCHhHCCCCCCcCCHHHHhcC
Confidence 010 12345679999999999999999996 788876
|
| >3oz6_A Mitogen-activated protein kinase 1, serine/threon protein kinase; structural genomics consortium, SGC, transferase; 2.37A {Cryptosporidium parvum iowa II} | Back alignment and structure |
|---|
Probab=100.00 E-value=7e-47 Score=329.82 Aligned_cols=278 Identities=26% Similarity=0.334 Sum_probs=198.1
Q ss_pred HHHhCCCCCCceeecCCcceEEEEEe-CCCcEEEEEEeccCcCChhhhHHHHHHHHHHHhcC-CcceeeeeeEEEcC-CC
Q 038766 8 ENATGSFSENNIIGNSNLSTVYKGRL-EDGEIVAVKKLNFHQFSAESDKSFYREAKTLKELK-HRNLVKVLGYAWES-GK 84 (299)
Q Consensus 8 ~~~~~~y~~~~~lg~g~~~~v~~~~~-~~~~~~~vK~~~~~~~~~~~~~~~~~e~~~l~~l~-h~~i~~~~~~~~~~-~~ 84 (299)
..+.++|.+.+.||+|+||+||+|.+ .+|+.||+|++..............+|+..++.+. ||||+++++++... ..
T Consensus 5 ~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~i~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~~ 84 (388)
T 3oz6_A 5 RHVLRKYELVKKLGKGAYGIVWKSIDRRTGEVVAVKKIFDAFQNSTDAQRTFREIMILTELSGHENIVNLLNVLRADNDR 84 (388)
T ss_dssp HHHHTTEEEEEC-------CEEEEEETTTCCEEEEEEECC--CCHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECTTSS
T ss_pred CcccCceEEEEEeeeCCCeEEEEEEECCCCCEEEEEEecccccChHHHHHHHHHHHHHHhccCCCCCCeeeeEEecCCCC
Confidence 45789999999999999999999987 46899999999765556667788889999999998 99999999987643 34
Q ss_pred eeEEEEeecCCCChHHHhcCCCCCCCCCChhhHHHHHHHHHHHHHHhhcCCCCCeeeecccCCceeeCCCCcEEEeeecc
Q 038766 85 LKALILEYMENGSLESVIHGPGVDHSRWTLPKRIDVLISVANGLDYLHSGYDIPIVHCDMKPSNILLDRDFEAHVSDFGT 164 (299)
Q Consensus 85 ~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lh~~~~~~~~H~dl~~~nil~~~~~~v~l~df~~ 164 (299)
..++|+||+. ++|..++. ...+++..+..++.|++.||+|||+. +++||||||+||+++.++.+||+|||+
T Consensus 85 ~~~lv~e~~~-~~L~~~~~-----~~~~~~~~~~~i~~qi~~~L~~LH~~---~ivHrDlkp~NIll~~~~~~kl~DFG~ 155 (388)
T 3oz6_A 85 DVYLVFDYME-TDLHAVIR-----ANILEPVHKQYVVYQLIKVIKYLHSG---GLLHRDMKPSNILLNAECHVKVADFGL 155 (388)
T ss_dssp CEEEEEECCS-EEHHHHHH-----HTCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEECTTCCEEECCCTT
T ss_pred EEEEEecccC-cCHHHHHH-----cCCCCHHHHHHHHHHHHHHHHHHHhC---CEEeCCCCHHHeEEcCCCCEEecCCcc
Confidence 6799999996 58998885 24789999999999999999999999 999999999999999999999999999
Q ss_pred ccccccccc-----------------cccccccccccCcccCChhhhcc-cCcCccccchhhhHHHHHHHhCCCCCCCCc
Q 038766 165 SRMLDVHLQ-----------------DLSSLSTAFQGTIGYLAPEFAYM-RIVTTKVDVFSFGIVVMEFLTKRRPTGLDE 226 (299)
Q Consensus 165 ~~~~~~~~~-----------------~~~~~~~~~~~~~~y~~PE~~~~-~~~~~~~DiwslG~~l~~l~~g~~p~~~~~ 226 (299)
+..+..... ..........+|+.|+|||++.+ ..++.++|||||||++|+|++|..||....
T Consensus 156 a~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~ 235 (388)
T 3oz6_A 156 SRSFVNIRRVTNNIPLSINENTENFDDDQPILTDYVATRWYRAPEILLGSTKYTKGIDMWSLGCILGEILCGKPIFPGSS 235 (388)
T ss_dssp CEESSSCCCCCCCGGGCCC---------------CCCGGGGCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHSSCSCCCSS
T ss_pred cccccccccccccccccccccccccccccccccCCcccCCcCCHHHhcCCCCCCChhhHHHHHHHHHHHHhCCCCCCCCC
Confidence 976532100 01122334568999999999886 678999999999999999999999996432
Q ss_pred cCCCCchhHHHHHHHHHhcCc-cCcccccCcc------------------ccchh--hHh-----HHHHHHHHHHHHHHH
Q 038766 227 ENGLSPISLRQLVEKALANGI-NGVRQITDPK------------------LVSSI--YEE-----QEQHQVLEELFKLAL 280 (299)
Q Consensus 227 ~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~------------------~~~~~--~~~-----~~~~~~~~~l~~li~ 280 (299)
.......+........ .....+..+. ..... +.. .....++.++.+||+
T Consensus 236 -----~~~~~~~i~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~ 310 (388)
T 3oz6_A 236 -----TMNQLERIIGVIDFPSNEDVESIQSPFAKTMIESLKEKVEIRQSNKRDIFTKWKNLLLKINPKADCNEEALDLLD 310 (388)
T ss_dssp -----HHHHHHHHHHHHCCCCHHHHHTSCCSSHHHHHHHHHHHCC-----CCCCHHHHHHHHHHHCTTCCCCHHHHHHHH
T ss_pred -----HHHHHHHHHHhcCCCCHHHHHhccCHHHHHHHHhCcccccccCCCHHHhCcchhhhcccccccccCCHHHHHHHH
Confidence 1111111111111000 0000000000 00000 000 000134678999999
Q ss_pred HhcCCCCCCCCChhhhhcC
Q 038766 281 VCTSSNPEDRPNMNELLIT 299 (299)
Q Consensus 281 ~~l~~dP~~Rpt~~~il~~ 299 (299)
+||..||++|||++|+|+|
T Consensus 311 ~~L~~dP~~R~t~~e~l~H 329 (388)
T 3oz6_A 311 KLLQFNPNKRISANDALKH 329 (388)
T ss_dssp HHCCSSGGGSCCHHHHTTS
T ss_pred HhhccCcccCCCHHHHhCC
Confidence 9999999999999999987
|
| >2zv2_A Calcium/calmodulin-dependent protein kinase kinas; beta, camkk2, E.C.2.7.11.17, phosphorylation, AMPKK, metabolism, binding, calmodulin-binding; HET: 609; 2.40A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=8.7e-47 Score=317.84 Aligned_cols=254 Identities=24% Similarity=0.327 Sum_probs=198.0
Q ss_pred HhCCCCCCceeecCCcceEEEEEeC-CCcEEEEEEeccCcCCh------------------------hhhHHHHHHHHHH
Q 038766 10 ATGSFSENNIIGNSNLSTVYKGRLE-DGEIVAVKKLNFHQFSA------------------------ESDKSFYREAKTL 64 (299)
Q Consensus 10 ~~~~y~~~~~lg~g~~~~v~~~~~~-~~~~~~vK~~~~~~~~~------------------------~~~~~~~~e~~~l 64 (299)
..++|.+.+.||+|+||+||+|.+. +++.||+|++....... ...+.+.+|+.++
T Consensus 11 ~~~~y~~~~~lG~G~~g~Vy~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l 90 (298)
T 2zv2_A 11 QLNQYTLKDEIGKGSYGVVKLAYNENDNTYYAMKVLSKKKLIRQAGFPRRPPPRGTRPAPGGCIQPRGPIEQVYQEIAIL 90 (298)
T ss_dssp EETTEEEEEEEEC--CCEEEEEEETTTTEEEEEEEEECC-------------------------------CHHHHHHHHH
T ss_pred eecceEEEeEEeecCCEEEEEEEECCCCcEEEEEEeehhhhhhhcccccccccccccccccccccccchHHHHHHHHHHH
Confidence 4579999999999999999999874 58999999986543211 1245688999999
Q ss_pred HhcCCcceeeeeeEEEc-CCCeeEEEEeecCCCChHHHhcCCCCCCCCCChhhHHHHHHHHHHHHHHhhcCCCCCeeeec
Q 038766 65 KELKHRNLVKVLGYAWE-SGKLKALILEYMENGSLESVIHGPGVDHSRWTLPKRIDVLISVANGLDYLHSGYDIPIVHCD 143 (299)
Q Consensus 65 ~~l~h~~i~~~~~~~~~-~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lh~~~~~~~~H~d 143 (299)
+.++||||+++++++.. .+...++|+||+++++|.++. ...++++..++.++.|++.||+|||++ +++|+|
T Consensus 91 ~~l~h~~iv~~~~~~~~~~~~~~~lv~e~~~~~~l~~~~-----~~~~~~~~~~~~~~~qi~~~l~~lH~~---~ivH~D 162 (298)
T 2zv2_A 91 KKLDHPNVVKLVEVLDDPNEDHLYMVFELVNQGPVMEVP-----TLKPLSEDQARFYFQDLIKGIEYLHYQ---KIIHRD 162 (298)
T ss_dssp HTCCCTTBCCEEEEEECSSSSEEEEEEECCTTCBSCCSS-----CSSCCCHHHHHHHHHHHHHHHHHHHHT---TEECCC
T ss_pred HhCCCCCCCeEEEEEEcCCCCEEEEEEecCCCCcHHHHh-----hcCCCCHHHHHHHHHHHHHHHHHHHHC---CeeccC
Confidence 99999999999998765 356779999999999988765 345799999999999999999999999 999999
Q ss_pred ccCCceeeCCCCcEEEeeeccccccccccccccccccccccCcccCChhhhcccC---cCccccchhhhHHHHHHHhCCC
Q 038766 144 MKPSNILLDRDFEAHVSDFGTSRMLDVHLQDLSSLSTAFQGTIGYLAPEFAYMRI---VTTKVDVFSFGIVVMEFLTKRR 220 (299)
Q Consensus 144 l~~~nil~~~~~~v~l~df~~~~~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~---~~~~~DiwslG~~l~~l~~g~~ 220 (299)
|||+||+++.++.++|+|||++...... ........+++.|+|||.+.+.. ++.++||||||+++|+|++|..
T Consensus 163 lkp~Nil~~~~~~~kl~Dfg~~~~~~~~----~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~~l~~l~~g~~ 238 (298)
T 2zv2_A 163 IKPSNLLVGEDGHIKIADFGVSNEFKGS----DALLSNTVGTPAFMAPESLSETRKIFSGKALDVWAMGVTLYCFVFGQC 238 (298)
T ss_dssp CCGGGEEECTTSCEEECCCTTCEECSSS----SCEECCCCSCGGGCCGGGCCTTCCCEESHHHHHHHHHHHHHHHHHSSC
T ss_pred CCHHHEEECCCCCEEEecCCCccccccc----cccccCCcCCccccChhhhccCCCCCCCchhhhHhHHHHHHHHHHCCC
Confidence 9999999999999999999998765421 12233456899999999988765 4778999999999999999999
Q ss_pred CCCCCccCCCCchhHHHHHHHHHhcCccCcccccCccccchhhHhHHHHHHHHHHHHHHHHhcCCCCCCCCChhhhhcC
Q 038766 221 PTGLDEENGLSPISLRQLVEKALANGINGVRQITDPKLVSSIYEEQEQHQVLEELFKLALVCTSSNPEDRPNMNELLIT 299 (299)
Q Consensus 221 p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rpt~~~il~~ 299 (299)
||.... . ............ . ... ...++.++.++|.+||..||++|||++|+++|
T Consensus 239 pf~~~~-----~---~~~~~~~~~~~~-~---~~~------------~~~~~~~l~~li~~~l~~dp~~R~s~~e~l~h 293 (298)
T 2zv2_A 239 PFMDER-----I---MCLHSKIKSQAL-E---FPD------------QPDIAEDLKDLITRMLDKNPESRIVVPEIKLH 293 (298)
T ss_dssp SSCCSS-----H---HHHHHHHHHCCC-C---CCS------------SSCCCHHHHHHHHHHTCSCTTTSCCHHHHTTC
T ss_pred CCCCcc-----H---HHHHHHHhcccC-C---CCC------------ccccCHHHHHHHHHHhhcChhhCCCHHHHhcC
Confidence 995331 1 122222111110 0 000 11234679999999999999999999999987
|
| >3qd2_B Eukaryotic translation initiation factor 2-alpha; EIF2A kinase, phosphoryalation, gene regulation; HET: TPO; 2.81A {Mus musculus} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.1e-47 Score=324.27 Aligned_cols=258 Identities=20% Similarity=0.300 Sum_probs=202.1
Q ss_pred HhCCCCCCceeecCCcceEEEEEeC-CCcEEEEEEeccCcCChhhhHHHHHHHHHHHhcCCcceeeeeeEEEcCCC----
Q 038766 10 ATGSFSENNIIGNSNLSTVYKGRLE-DGEIVAVKKLNFHQFSAESDKSFYREAKTLKELKHRNLVKVLGYAWESGK---- 84 (299)
Q Consensus 10 ~~~~y~~~~~lg~g~~~~v~~~~~~-~~~~~~vK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~---- 84 (299)
..++|.+.+.||+|+||.||+|.+. +|+.||||++.... .....+.+.+|+.++++++||||+++++++.....
T Consensus 4 ~~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vavK~~~~~~-~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~ 82 (332)
T 3qd2_B 4 YLTDFEPIQCMGRGGFGVVFEAKNKVDDCNYAIKRIRLPN-RELAREKVMREVKALAKLEHPGIVRYFNAWLETPPEKWQ 82 (332)
T ss_dssp HHHHEEEEEEEECC-CSEEEEEEETTTCCEEEEEEEECCS-TTTHHHHHHHHHHHHTSCCCTTBCCEEEEEEECCSCHHH
T ss_pred hhhcCceeeEecCCCCeEEEEEEEcCCCcEEEEEEeecCC-chhHHHHHHHHHHHHHhCCCCCEeeEEEEEEEeccchhh
Confidence 4578999999999999999999975 69999999997543 44456789999999999999999999998755332
Q ss_pred ----------------------------------------------------eeEEEEeecCCCChHHHhcCCCCCCCCC
Q 038766 85 ----------------------------------------------------LKALILEYMENGSLESVIHGPGVDHSRW 112 (299)
Q Consensus 85 ----------------------------------------------------~~~lv~e~~~~~~L~~~~~~~~~~~~~~ 112 (299)
..++|+||+.+++|.+++.... .....
T Consensus 83 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~-~~~~~ 161 (332)
T 3qd2_B 83 EEMDEIWLKDESTDWPLSSPSPMDAPSVKIRRMDPFSTKNTVGQLQPSSPKVYLYIQMQLCRKENLKDWMNRRC-SLEDR 161 (332)
T ss_dssp HHHHC--------------------------------------------CCCEEEEEEECCCSSCHHHHHHTCC-SGGGS
T ss_pred hhhhhhhhccccccccccCCCcccccccceeeccccCcccccccccCCCCCceEEEEEEecCCCCHHHHHhccc-Cccch
Confidence 3699999999999999998653 33445
Q ss_pred ChhhHHHHHHHHHHHHHHhhcCCCCCeeeecccCCceeeCCCCcEEEeeeccccccccccccc--------ccccccccc
Q 038766 113 TLPKRIDVLISVANGLDYLHSGYDIPIVHCDMKPSNILLDRDFEAHVSDFGTSRMLDVHLQDL--------SSLSTAFQG 184 (299)
Q Consensus 113 ~~~~~~~i~~qi~~~l~~lh~~~~~~~~H~dl~~~nil~~~~~~v~l~df~~~~~~~~~~~~~--------~~~~~~~~~ 184 (299)
++..++.++.|++.||+|||++ +++|+||||+||+++.++.++|+|||++.......... ........+
T Consensus 162 ~~~~~~~i~~qi~~aL~~LH~~---~ivH~Dlkp~NIll~~~~~~kL~DfG~a~~~~~~~~~~~~~~~~~~~~~~~~~~g 238 (332)
T 3qd2_B 162 EHGVCLHIFIQIAEAVEFLHSK---GLMHRDLKPSNIFFTMDDVVKVGDFGLVTAMDQDEEEQTVLTPMPAYATHTGQVG 238 (332)
T ss_dssp CHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEECTTCCEEECCCTTCEECSCC--------------CCCSCC-
T ss_pred hhHHHHHHHHHHHHHHHHHHhC---CeeecCCCcccEEEeCCCCEEEeecCcccccccchhhccccccccccccccccCC
Confidence 6667899999999999999999 99999999999999999999999999998665321111 112234568
Q ss_pred CcccCChhhhcccCcCccccchhhhHHHHHHHhCCCCCCCCccCCCCchhHHHHHHHHHhcCccCcccccCccccchhhH
Q 038766 185 TIGYLAPEFAYMRIVTTKVDVFSFGIVVMEFLTKRRPTGLDEENGLSPISLRQLVEKALANGINGVRQITDPKLVSSIYE 264 (299)
Q Consensus 185 ~~~y~~PE~~~~~~~~~~~DiwslG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 264 (299)
|+.|+|||.+.+..++.++||||||+++|+|++|..|+. ........... . . .
T Consensus 239 t~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~~~~~~----------~~~~~~~~~~~-~-------~---------~ 291 (332)
T 3qd2_B 239 TKLYMSPEQIHGNNYSHKVDIFSLGLILFELLYSFSTQM----------ERVRIITDVRN-L-------K---------F 291 (332)
T ss_dssp CGGGSCHHHHHCCCCCTHHHHHHHHHHHHHHHSCCCCHH----------HHHHHHHHHHT-T-------C---------C
T ss_pred CcCccChHHhcCCCCcchhhHHHHHHHHHHHHHcCCChh----------HHHHHHHHhhc-c-------C---------C
Confidence 999999999999999999999999999999999876641 11111111110 0 0 0
Q ss_pred hHHHHHHHHHHHHHHHHhcCCCCCCCCChhhhhcC
Q 038766 265 EQEQHQVLEELFKLALVCTSSNPEDRPNMNELLIT 299 (299)
Q Consensus 265 ~~~~~~~~~~l~~li~~~l~~dP~~Rpt~~~il~~ 299 (299)
.......++++.++|.+||..||++|||++|+|+|
T Consensus 292 ~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~~l~~ 326 (332)
T 3qd2_B 292 PLLFTQKYPQEHMMVQDMLSPSPTERPEATDIIEN 326 (332)
T ss_dssp CHHHHHHCHHHHHHHHHHHCSSGGGSCCHHHHHHS
T ss_pred CcccccCChhHHHHHHHHccCCCCcCCCHHHHhhc
Confidence 11144556778999999999999999999999987
|
| >3kk8_A Calcium/calmodulin dependent protein kinase II; ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; HET: TPO; 1.72A {Caenorhabditis elegans} PDB: 3kk9_A* 3kl8_A 2vn9_A* 3bhh_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-46 Score=314.86 Aligned_cols=256 Identities=23% Similarity=0.336 Sum_probs=208.0
Q ss_pred HHhCCCCCCceeecCCcceEEEEEeC-CCcEEEEEEeccCcCChhhhHHHHHHHHHHHhcCCcceeeeeeEEEcCCCeeE
Q 038766 9 NATGSFSENNIIGNSNLSTVYKGRLE-DGEIVAVKKLNFHQFSAESDKSFYREAKTLKELKHRNLVKVLGYAWESGKLKA 87 (299)
Q Consensus 9 ~~~~~y~~~~~lg~g~~~~v~~~~~~-~~~~~~vK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~ 87 (299)
.+.++|++.+.||+|++|+||++.+. +++.||+|++............+.+|+.++++++||||+++++++.. +...+
T Consensus 3 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~-~~~~~ 81 (284)
T 3kk8_A 3 KFSDNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVRLHDSIQE-ESFHY 81 (284)
T ss_dssp TTTTTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEC-SSEEE
T ss_pred hhhhhhhhhhhhcCcCCeEEEEEEEcCCCceEEEEEeecccCCHHHHHHHHHHHHHHHHcCCCCcCeEEEEEEc-CCEEE
Confidence 35789999999999999999999874 58999999998766666677889999999999999999999997654 55669
Q ss_pred EEEeecCCCChHHHhcCCCCCCCCCChhhHHHHHHHHHHHHHHhhcCCCCCeeeecccCCceeeCCCCc---EEEeeecc
Q 038766 88 LILEYMENGSLESVIHGPGVDHSRWTLPKRIDVLISVANGLDYLHSGYDIPIVHCDMKPSNILLDRDFE---AHVSDFGT 164 (299)
Q Consensus 88 lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lh~~~~~~~~H~dl~~~nil~~~~~~---v~l~df~~ 164 (299)
+|+||+.+++|.+.+. ....+++..++.++.|++.||.|||+. +++|+||||+||+++.++. ++|+|||+
T Consensus 82 ~v~e~~~~~~l~~~~~----~~~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dikp~Nil~~~~~~~~~~kl~Dfg~ 154 (284)
T 3kk8_A 82 LVFDLVTGGELFEDIV----AREFYSEADASHCIQQILESIAYCHSN---GIVHRNLKPENLLLASKAKGAAVKLADFGL 154 (284)
T ss_dssp EEECCCCSCBHHHHHH----HHSSCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCCGGGEEESSSSTTCCEEECCCTT
T ss_pred EEEecCCCCCHHHHHH----hcCCCCHHHHHHHHHHHHHHHHHHHHC---CcCcCCCCHHHEEEecCCCCCcEEEeecee
Confidence 9999999999988876 445799999999999999999999999 9999999999999986655 99999999
Q ss_pred ccccccccccccccccccccCcccCChhhhcccCcCccccchhhhHHHHHHHhCCCCCCCCccCCCCchhHHHHHHHHHh
Q 038766 165 SRMLDVHLQDLSSLSTAFQGTIGYLAPEFAYMRIVTTKVDVFSFGIVVMEFLTKRRPTGLDEENGLSPISLRQLVEKALA 244 (299)
Q Consensus 165 ~~~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~DiwslG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~ 244 (299)
+..... ........+++.|+|||.+.+..++.++||||||+++|+|++|..||... .... .......
T Consensus 155 ~~~~~~-----~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~-----~~~~---~~~~~~~ 221 (284)
T 3kk8_A 155 AIEVND-----SEAWHGFAGTPGYLSPEVLKKDPYSKPVDIWACGVILYILLVGYPPFWDE-----DQHR---LYAQIKA 221 (284)
T ss_dssp CEECCS-----SCBCCCSCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCS-----SHHH---HHHHHHH
T ss_pred eEEccc-----CccccCCCCCcCCcCchhhcCCCCCcccchHHHHHHHHHHHHCCCCCCCC-----chhH---HHHHHHh
Confidence 975442 22233456899999999999999999999999999999999999999533 1111 2222111
Q ss_pred cCccCcccccCccccchhhHhHHHHHHHHHHHHHHHHhcCCCCCCCCChhhhhcC
Q 038766 245 NGINGVRQITDPKLVSSIYEEQEQHQVLEELFKLALVCTSSNPEDRPNMNELLIT 299 (299)
Q Consensus 245 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rpt~~~il~~ 299 (299)
... ....+. ...++.++.++|.+||..||++|||++|+|+|
T Consensus 222 ~~~----~~~~~~----------~~~~~~~~~~li~~~l~~dp~~Rps~~~~l~h 262 (284)
T 3kk8_A 222 GAY----DYPSPE----------WDTVTPEAKSLIDSMLTVNPKKRITADQALKV 262 (284)
T ss_dssp TCC----CCCTTT----------TTTSCHHHHHHHHHHSCSSTTTSCCHHHHTTS
T ss_pred ccc----cCCchh----------hcccCHHHHHHHHHHcccChhhCCCHHHHhcC
Confidence 111 011100 12335678999999999999999999999987
|
| >3h4j_B AMPK kdaid, SNF1-like protein kinase SSP2; ATP-binding, nucleotide-binding, phosphoprotei serine/threonine-protein kinase, transferase; 2.80A {Schizosaccharomyces pombe} | Back alignment and structure |
|---|
Probab=100.00 E-value=8.8e-48 Score=328.30 Aligned_cols=250 Identities=22% Similarity=0.318 Sum_probs=201.8
Q ss_pred HhCCCCCCceeecCCcceEEEEEe-CCCcEEEEEEeccCcCC-hhhhHHHHHHHHHHHhcCCcceeeeeeEEEcCCCeeE
Q 038766 10 ATGSFSENNIIGNSNLSTVYKGRL-EDGEIVAVKKLNFHQFS-AESDKSFYREAKTLKELKHRNLVKVLGYAWESGKLKA 87 (299)
Q Consensus 10 ~~~~y~~~~~lg~g~~~~v~~~~~-~~~~~~~vK~~~~~~~~-~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~ 87 (299)
..++|.+.+.||+|+||.||+|.+ .+++.||+|++...... ......+.+|+..++.++||||+++++++.. ....+
T Consensus 7 ~i~~Y~i~~~lG~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~-~~~~~ 85 (336)
T 3h4j_B 7 HIGPYIIRETLGEGSFGKVKLATHYKTQQKVALKFISRQLLKKSDMHMRVEREISYLKLLRHPHIIKLYDVITT-PTDIV 85 (336)
T ss_dssp EETTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHHHTTCSHHHHHHHHHHTTCCCTTBCCEEEEEEC-SSEEE
T ss_pred ccCCEEEEEEEecCCCeEEEEEEECCCCCEEEEEEEehHHccchhHHHHHHHHHHHHHhCCCCCCCeEEEEEEe-CCEEE
Confidence 457899999999999999999987 56899999998643221 2234678899999999999999999997665 55669
Q ss_pred EEEeecCCCChHHHhcCCCCCCCCCChhhHHHHHHHHHHHHHHhhcCCCCCeeeecccCCceeeCCCCcEEEeeeccccc
Q 038766 88 LILEYMENGSLESVIHGPGVDHSRWTLPKRIDVLISVANGLDYLHSGYDIPIVHCDMKPSNILLDRDFEAHVSDFGTSRM 167 (299)
Q Consensus 88 lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lh~~~~~~~~H~dl~~~nil~~~~~~v~l~df~~~~~ 167 (299)
+|+||+ +++|.+.+. ....+++.+++.++.|++.||.|||+. +++||||||+||+++.++.++|+|||++..
T Consensus 86 lv~E~~-~g~l~~~l~----~~~~l~~~~~~~i~~qi~~aL~~LH~~---givH~Dlkp~NIll~~~~~~kl~DFG~s~~ 157 (336)
T 3h4j_B 86 MVIEYA-GGELFDYIV----EKKRMTEDEGRRFFQQIICAIEYCHRH---KIVHRDLKPENLLLDDNLNVKIADFGLSNI 157 (336)
T ss_dssp EEECCC-CEEHHHHHH----HHCSCCHHHHHHHHHHHHHHHHHHHHH---TCCCCCCSTTTEEECTTCCEEECCSSCTBT
T ss_pred EEEECC-CCcHHHHHH----HcCCCCHHHHHHHHHHHHHHHHHHHHC---CeEecCCchhhEEEcCCCCEEEEEecccee
Confidence 999999 678988876 445799999999999999999999999 999999999999999999999999999875
Q ss_pred cccccccccccccccccCcccCChhhhcccCc-CccccchhhhHHHHHHHhCCCCCCCCccCCCCchhHHHHHHHHHhcC
Q 038766 168 LDVHLQDLSSLSTAFQGTIGYLAPEFAYMRIV-TTKVDVFSFGIVVMEFLTKRRPTGLDEENGLSPISLRQLVEKALANG 246 (299)
Q Consensus 168 ~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~-~~~~DiwslG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~ 246 (299)
... ........+++.|+|||++.+..+ +.++||||||+++|+|++|..||..........
T Consensus 158 ~~~-----~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~Pf~~~~~~~~~~-------------- 218 (336)
T 3h4j_B 158 MTD-----GNFLKTSCGSPNYAAPEVINGKLYAGPEVDVWSCGIVLYVMLVGRLPFDDEFIPNLFK-------------- 218 (336)
T ss_dssp TTT-----SBTTCCCTTSTTTSCGGGSCCSGGGCHHHHHHHHHHHHHHHHHSSCSSBCSSSTTCBC--------------
T ss_pred ccC-----CcccccccCCcCcCCHHHHcCCCCCCCccchhHHHHHHHHHHhCCCCCCCccHHHHHH--------------
Confidence 432 222344568999999999988776 689999999999999999999996442221100
Q ss_pred ccCcccccCccccchhhHhHHHHHHHHHHHHHHHHhcCCCCCCCCChhhhhcC
Q 038766 247 INGVRQITDPKLVSSIYEEQEQHQVLEELFKLALVCTSSNPEDRPNMNELLIT 299 (299)
Q Consensus 247 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rpt~~~il~~ 299 (299)
.+..... ..+..++.++.+||++||..||.+|||++|+++|
T Consensus 219 -----~i~~~~~-------~~p~~~s~~~~~li~~~L~~dP~~Rpt~~eil~h 259 (336)
T 3h4j_B 219 -----KVNSCVY-------VMPDFLSPGAQSLIRRMIVADPMQRITIQEIRRD 259 (336)
T ss_dssp -----CCCSSCC-------CCCTTSCHHHHHHHHTTSCSSGGGSCCHHHHTTC
T ss_pred -----HHHcCCC-------CCcccCCHHHHHHHHHHcCCChhHCcCHHHHHhC
Confidence 0000000 0022345678999999999999999999999987
|
| >3g33_A Cell division protein kinase 4; Ser/Thr protein kinase, cell cycle, phosphorylation, ATP-BIN cell division, disease mutation, kinase; 3.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.5e-46 Score=316.51 Aligned_cols=276 Identities=23% Similarity=0.259 Sum_probs=202.8
Q ss_pred HHHhCCCCCCceeecCCcceEEEEEe-CCCcEEEEEEeccCcC---ChhhhHHHHHHHHHHHhcC---CcceeeeeeEEE
Q 038766 8 ENATGSFSENNIIGNSNLSTVYKGRL-EDGEIVAVKKLNFHQF---SAESDKSFYREAKTLKELK---HRNLVKVLGYAW 80 (299)
Q Consensus 8 ~~~~~~y~~~~~lg~g~~~~v~~~~~-~~~~~~~vK~~~~~~~---~~~~~~~~~~e~~~l~~l~---h~~i~~~~~~~~ 80 (299)
..+.++|++.+.||+|+||+||+|.+ .+++.||+|++..... .........+|+..++.++ ||||+++++++.
T Consensus 5 ~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~h~niv~~~~~~~ 84 (308)
T 3g33_A 5 SMATSRYEPVAEIGVGAYGTVYKARDPHSGHFVALKSVRVPNGGGGGGGLPISTVREVALLRRLEAFEHPNVVRLMDVCA 84 (308)
T ss_dssp -----CCEEEEEECCSSSCCEEEEECTTTCCEEEEEEEEEECCCTTSSCCCHHHHHHHHHHHHHHHHCCTTBCCEEEEEE
T ss_pred cccccceEEEEEEecCCCeEEEEEEECCCCcEEEEEEEecccccccccccchhHHHHHHHHHHHhhcCCCCeEEeeeeee
Confidence 45678999999999999999999997 5689999999874332 1222346667777777765 999999999887
Q ss_pred cCCC----eeEEEEeecCCCChHHHhcCCCCCCCCCChhhHHHHHHHHHHHHHHhhcCCCCCeeeecccCCceeeCCCCc
Q 038766 81 ESGK----LKALILEYMENGSLESVIHGPGVDHSRWTLPKRIDVLISVANGLDYLHSGYDIPIVHCDMKPSNILLDRDFE 156 (299)
Q Consensus 81 ~~~~----~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lh~~~~~~~~H~dl~~~nil~~~~~~ 156 (299)
.... ..++|+|++. ++|.+++... ....+++..++.++.|++.||+|||++ +++|+||||+||+++.++.
T Consensus 85 ~~~~~~~~~~~lv~e~~~-~~L~~~~~~~--~~~~~~~~~~~~i~~qi~~al~~lH~~---~ivH~Dlkp~Nil~~~~~~ 158 (308)
T 3g33_A 85 TSRTDREIKVTLVFEHVD-QDLRTYLDKA--PPPGLPAETIKDLMRQFLRGLDFLHAN---CIVHRDLKPENILVTSGGT 158 (308)
T ss_dssp ECCSSSEEEEEEEEECCC-CBHHHHHHTC--CTTCSCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCTTTEEECTTSC
T ss_pred ccCCCCceeEEEEehhhh-cCHHHHHhhc--cCCCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCHHHEEEcCCCC
Confidence 6443 4689999996 5999998754 233499999999999999999999999 9999999999999999999
Q ss_pred EEEeeeccccccccccccccccccccccCcccCChhhhcccCcCccccchhhhHHHHHHHhCCCCCCCCccCCCCchhHH
Q 038766 157 AHVSDFGTSRMLDVHLQDLSSLSTAFQGTIGYLAPEFAYMRIVTTKVDVFSFGIVVMEFLTKRRPTGLDEENGLSPISLR 236 (299)
Q Consensus 157 v~l~df~~~~~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~DiwslG~~l~~l~~g~~p~~~~~~~~~~~~~~~ 236 (299)
++|+|||++..... ........+|+.|+|||++.+..++.++|||||||++|+|++|..||.... .....
T Consensus 159 ~kl~Dfg~a~~~~~-----~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~-----~~~~~ 228 (308)
T 3g33_A 159 VKLADFGLARIYSY-----QMALTPVVVTLWYRAPEVLLQSTYATPVDMWSVGCIFAEMFRRKPLFCGNS-----EADQL 228 (308)
T ss_dssp EEECSCSCTTTSTT-----CCCSGGGGCCCSSCCHHHHHTSCCCSTHHHHHHHHHHHHTTTSSCSCCCSS-----HHHHH
T ss_pred EEEeeCccccccCC-----CcccCCccccccccCchHHcCCCCCchHHHHHHHHHHHHHHhCCCCCCCCC-----HHHHH
Confidence 99999999975441 222344567999999999999999999999999999999999999995432 22222
Q ss_pred HHHHHHHhcC----ccCcccccCccccc--hhhHhHHHHHHHHHHHHHHHHhcCCCCCCCCChhhhhcC
Q 038766 237 QLVEKALANG----INGVRQITDPKLVS--SIYEEQEQHQVLEELFKLALVCTSSNPEDRPNMNELLIT 299 (299)
Q Consensus 237 ~~~~~~~~~~----~~~~~~~~~~~~~~--~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rpt~~~il~~ 299 (299)
..+....... +..........+.. ..........++..+.+||.+||..||++|||++|+|+|
T Consensus 229 ~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~h 297 (308)
T 3g33_A 229 GKIFDLIGLPPEDDWPRDVSLPRGAFPPRGPRPVQSVVPEMEESGAQLLLEMLTFNPHKRISAFRALQH 297 (308)
T ss_dssp HHHHHHHCCCCTTTSCSSCSSCGGGSCCCCCCCHHHHSCSCCHHHHHHHHHHTCSSTTTSCCHHHHHTS
T ss_pred HHHHHHhCCCChhhccchhhccccccCCCCCCcHHHhCccccHHHHHHHHHHhcCCCccCCCHHHHhcC
Confidence 2221111111 00000000000000 000111223456789999999999999999999999987
|
| >3s95_A LIMK-1, LIM domain kinase 1; structural genomics, structural genomics consortium, SGC, PR kinase, transferase-antibiotic complex; HET: STU GOL; 1.65A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=6.4e-47 Score=320.38 Aligned_cols=255 Identities=25% Similarity=0.465 Sum_probs=204.0
Q ss_pred hCCCCCCceeecCCcceEEEEEeC-CCcEEEEEEeccCcCChhhhHHHHHHHHHHHhcCCcceeeeeeEEEcCCCeeEEE
Q 038766 11 TGSFSENNIIGNSNLSTVYKGRLE-DGEIVAVKKLNFHQFSAESDKSFYREAKTLKELKHRNLVKVLGYAWESGKLKALI 89 (299)
Q Consensus 11 ~~~y~~~~~lg~g~~~~v~~~~~~-~~~~~~vK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~lv 89 (299)
.++|.+.+.||+|+||+||++.+. +++.||+|++. .......+.+.+|+.+++.++||||+++++++.. +...++|
T Consensus 9 ~~~~~~~~~lG~G~~g~V~~~~~~~~~~~va~K~~~--~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~-~~~~~lv 85 (310)
T 3s95_A 9 PSDLIHGEVLGKGCFGQAIKVTHRETGEVMVMKELI--RFDEETQRTFLKEVKVMRCLEHPNVLKFIGVLYK-DKRLNFI 85 (310)
T ss_dssp GGGEEEEEEEECCSSEEEEEEEETTTCCEEEEEEES--CCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEE-TTEEEEE
T ss_pred hhHeeccceecCCCCEEEEEEEECCCCcEEEEEEec--cCCHHHHHHHHHHHHHHHhCCCcCcccEEEEEec-CCeeEEE
Confidence 578999999999999999999874 58999999885 3456667889999999999999999999997766 4566999
Q ss_pred EeecCCCChHHHhcCCCCCCCCCChhhHHHHHHHHHHHHHHhhcCCCCCeeeecccCCceeeCCCCcEEEeeeccccccc
Q 038766 90 LEYMENGSLESVIHGPGVDHSRWTLPKRIDVLISVANGLDYLHSGYDIPIVHCDMKPSNILLDRDFEAHVSDFGTSRMLD 169 (299)
Q Consensus 90 ~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lh~~~~~~~~H~dl~~~nil~~~~~~v~l~df~~~~~~~ 169 (299)
+||+.+++|.+++... ...+++.+++.++.|++.||+|||+. +++|+||||+||+++.++.++|+|||++....
T Consensus 86 ~e~~~~~~L~~~l~~~---~~~~~~~~~~~i~~qi~~al~~lH~~---~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~ 159 (310)
T 3s95_A 86 TEYIKGGTLRGIIKSM---DSQYPWSQRVSFAKDIASGMAYLHSM---NIIHRDLNSHNCLVRENKNVVVADFGLARLMV 159 (310)
T ss_dssp EECCTTCBHHHHHHHC---CTTSCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSTTSEEECTTSCEEECCCTTCEECC
T ss_pred EEecCCCcHHHHHHhc---cCCCCHHHHHHHHHHHHHHHHHHHhC---CccCCCCCcCeEEECCCCCEEEeecccceecc
Confidence 9999999999998742 45789999999999999999999999 99999999999999999999999999997654
Q ss_pred ccccccc----------ccccccccCcccCChhhhcccCcCccccchhhhHHHHHHHhCCCCCCCCccCCCCc-hhHHHH
Q 038766 170 VHLQDLS----------SLSTAFQGTIGYLAPEFAYMRIVTTKVDVFSFGIVVMEFLTKRRPTGLDEENGLSP-ISLRQL 238 (299)
Q Consensus 170 ~~~~~~~----------~~~~~~~~~~~y~~PE~~~~~~~~~~~DiwslG~~l~~l~~g~~p~~~~~~~~~~~-~~~~~~ 238 (299)
....... .......+|+.|+|||++.+..++.++||||||+++|+|++|..|+.......... ......
T Consensus 160 ~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~g~~~~~~~~~~~~~~~~~~~~~ 239 (310)
T 3s95_A 160 DEKTQPEGLRSLKKPDRKKRYTVVGNPYWMAPEMINGRSYDEKVDVFSFGIVLCEIIGRVNADPDYLPRTMDFGLNVRGF 239 (310)
T ss_dssp --------------------CCCCSCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHTCCSSTTTSCBCTTSSBCHHHH
T ss_pred cccccccccccccccccccccccCCCcceeCHHHhcCCCCCcHHHHHHHHHHHHHHhcCCCCCcchhhhHHHHhhhhhcc
Confidence 2221110 11124568999999999999999999999999999999999999986432222111 111111
Q ss_pred HHHHHhcCccCcccccCccccchhhHhHHHHHHHHHHHHHHHHhcCCCCCCCCChhhhhc
Q 038766 239 VEKALANGINGVRQITDPKLVSSIYEEQEQHQVLEELFKLALVCTSSNPEDRPNMNELLI 298 (299)
Q Consensus 239 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rpt~~~il~ 298 (299)
... ..+..++..+.+++.+||..||++|||++++++
T Consensus 240 ~~~------------------------~~~~~~~~~l~~li~~~l~~dP~~Rps~~~l~~ 275 (310)
T 3s95_A 240 LDR------------------------YCPPNCPPSFFPITVRCCDLDPEKRPSFVKLEH 275 (310)
T ss_dssp HHH------------------------TCCTTCCTTHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred ccc------------------------cCCCCCCHHHHHHHHHHccCChhhCcCHHHHHH
Confidence 111 002233457899999999999999999999875
|
| >1fot_A TPK1 delta, CAMP-dependent protein kinase type 1; open conformation, transferase; HET: TPO; 2.80A {Saccharomyces cerevisiae} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=6.3e-47 Score=321.03 Aligned_cols=248 Identities=23% Similarity=0.323 Sum_probs=204.2
Q ss_pred hCCCCCCceeecCCcceEEEEEeC-CCcEEEEEEeccCcC-ChhhhHHHHHHHHHHHhcCCcceeeeeeEEEcCCCeeEE
Q 038766 11 TGSFSENNIIGNSNLSTVYKGRLE-DGEIVAVKKLNFHQF-SAESDKSFYREAKTLKELKHRNLVKVLGYAWESGKLKAL 88 (299)
Q Consensus 11 ~~~y~~~~~lg~g~~~~v~~~~~~-~~~~~~vK~~~~~~~-~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~l 88 (299)
.++|.+.+.||+|+||.||+|.+. +|+.||+|++..... .....+.+.+|..+++.++||||+++++++.. ....++
T Consensus 5 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~Iv~~~~~~~~-~~~~~l 83 (318)
T 1fot_A 5 LQDFQILRTLGTGSFGRVHLIRSRHNGRYYAMKVLKKEIVVRLKQVEHTNDERLMLSIVTHPFIIRMWGTFQD-AQQIFM 83 (318)
T ss_dssp GGGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCCBTTBCCEEEEEEC-SSEEEE
T ss_pred hHHcEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHhhCCCCCCceEeEEEEe-CCEEEE
Confidence 478999999999999999999875 689999999864322 12345677889999999999999999996655 556799
Q ss_pred EEeecCCCChHHHhcCCCCCCCCCChhhHHHHHHHHHHHHHHhhcCCCCCeeeecccCCceeeCCCCcEEEeeecccccc
Q 038766 89 ILEYMENGSLESVIHGPGVDHSRWTLPKRIDVLISVANGLDYLHSGYDIPIVHCDMKPSNILLDRDFEAHVSDFGTSRML 168 (299)
Q Consensus 89 v~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lh~~~~~~~~H~dl~~~nil~~~~~~v~l~df~~~~~~ 168 (299)
|+||+.+++|.+++. ....+++..++.++.||+.||.|||++ +++||||||+||+++.+|.++|+|||++...
T Consensus 84 v~e~~~gg~L~~~l~----~~~~~~~~~~~~~~~qi~~aL~~LH~~---~ivHrDlkp~NIll~~~g~~kL~Dfg~a~~~ 156 (318)
T 1fot_A 84 IMDYIEGGELFSLLR----KSQRFPNPVAKFYAAEVCLALEYLHSK---DIIYRDLKPENILLDKNGHIKITDFGFAKYV 156 (318)
T ss_dssp EECCCCSCBHHHHHH----HTSSCCHHHHHHHHHHHHHHHHHHHTT---TEECCCCCGGGEEECTTSCEEECCCSSCEEC
T ss_pred EEeCCCCCCHHHHHH----HcCCCCHHHHHHHHHHHHHHHHHHHHC---CccccCCChheEEEcCCCCEEEeecCcceec
Confidence 999999999999997 445799999999999999999999999 9999999999999999999999999999754
Q ss_pred ccccccccccccccccCcccCChhhhcccCcCccccchhhhHHHHHHHhCCCCCCCCccCCCCchhHHHHHHHHHhcCcc
Q 038766 169 DVHLQDLSSLSTAFQGTIGYLAPEFAYMRIVTTKVDVFSFGIVVMEFLTKRRPTGLDEENGLSPISLRQLVEKALANGIN 248 (299)
Q Consensus 169 ~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~DiwslG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 248 (299)
. .......+|+.|+|||++.+..++.++|+|||||++|+|++|..||.... . ............
T Consensus 157 ~-------~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~-----~---~~~~~~i~~~~~- 220 (318)
T 1fot_A 157 P-------DVTYTLCGTPDYIAPEVVSTKPYNKSIDWWSFGILIYEMLAGYTPFYDSN-----T---MKTYEKILNAEL- 220 (318)
T ss_dssp S-------SCBCCCCSCTTTCCHHHHTTCCBCTTHHHHHHHHHHHHHHHSSCTTCCSS-----H---HHHHHHHHHCCC-
T ss_pred C-------CccccccCCccccCHhHhcCCCCCcccchhhhHHHHHHHHhCCCCCCCCC-----H---HHHHHHHHhCCC-
Confidence 3 22334568999999999999999999999999999999999999995431 1 122222222110
Q ss_pred CcccccCccccchhhHhHHHHHHHHHHHHHHHHhcCCCCCCCC-----ChhhhhcC
Q 038766 249 GVRQITDPKLVSSIYEEQEQHQVLEELFKLALVCTSSNPEDRP-----NMNELLIT 299 (299)
Q Consensus 249 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rp-----t~~~il~~ 299 (299)
. . +..++.++.++|.+||..||++|| +++++++|
T Consensus 221 ~-----~------------p~~~~~~~~~li~~lL~~dp~~R~~~~~~~~~~i~~h 259 (318)
T 1fot_A 221 R-----F------------PPFFNEDVKDLLSRLITRDLSQRLGNLQNGTEDVKNH 259 (318)
T ss_dssp C-----C------------CTTSCHHHHHHHHHHTCSCTTTCTTSSTTTTHHHHTS
T ss_pred C-----C------------CCCCCHHHHHHHHHHhccCHHHcCCCcCCCHHHHhcC
Confidence 0 0 122356799999999999999999 99999987
|
| >3mi9_A Cell division protein kinase 9; P-TEFB, HIV-1, protein binding; HET: TPO; 2.10A {Homo sapiens} PDB: 3mia_A* 4ec9_A* 4ec8_A* 3blh_A* 3blq_A* 3blr_A* 3lq5_A* 3my1_A* 3tn8_A* 3tnh_A* 3tni_A* 4bch_A* 4bci_A* 4bcj_A* 4bcf_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.4e-46 Score=320.58 Aligned_cols=278 Identities=22% Similarity=0.278 Sum_probs=210.4
Q ss_pred HhCCCCCCceeecCCcceEEEEEe-CCCcEEEEEEeccCcCChhhhHHHHHHHHHHHhcCCcceeeeeeEEEcC------
Q 038766 10 ATGSFSENNIIGNSNLSTVYKGRL-EDGEIVAVKKLNFHQFSAESDKSFYREAKTLKELKHRNLVKVLGYAWES------ 82 (299)
Q Consensus 10 ~~~~y~~~~~lg~g~~~~v~~~~~-~~~~~~~vK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~------ 82 (299)
..++|++.+.||+|+||+||+|.+ .+|+.||+|++............+.+|+.+++.++||||+++++++...
T Consensus 15 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~ 94 (351)
T 3mi9_A 15 EVSKYEKLAKIGQGTFGEVFKARHRKTGQKVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEICRTKASPYNR 94 (351)
T ss_dssp BGGGEEEEEECSSCSTTSEEEEEETTTCCEEEEEECCCSSCSSSSCHHHHHHHHHHHHCCCTTBCCEEEEEEEC------
T ss_pred cccceeEEEEEecCCCcEEEEEEECCCCCEEEEEEEecccccccchHHHHHHHHHHHhccCCCcccHhheeecccccccc
Confidence 357899999999999999999987 5689999999976665555667788999999999999999999987654
Q ss_pred -CCeeEEEEeecCCCChHHHhcCCCCCCCCCChhhHHHHHHHHHHHHHHhhcCCCCCeeeecccCCceeeCCCCcEEEee
Q 038766 83 -GKLKALILEYMENGSLESVIHGPGVDHSRWTLPKRIDVLISVANGLDYLHSGYDIPIVHCDMKPSNILLDRDFEAHVSD 161 (299)
Q Consensus 83 -~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lh~~~~~~~~H~dl~~~nil~~~~~~v~l~d 161 (299)
+...++|+||+.+ +|.+.+.. ....+++.+++.++.|++.||+|||+. +++|+||||+||+++.++.++|+|
T Consensus 95 ~~~~~~lv~e~~~~-~l~~~l~~---~~~~~~~~~~~~i~~qi~~~l~~LH~~---~ivH~Dlkp~NIl~~~~~~~kl~D 167 (351)
T 3mi9_A 95 CKGSIYLVFDFCEH-DLAGLLSN---VLVKFTLSEIKRVMQMLLNGLYYIHRN---KILHRDMKAANVLITRDGVLKLAD 167 (351)
T ss_dssp --CEEEEEEECCSE-EHHHHHHC---TTSCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECTTSCEEECC
T ss_pred CCceEEEEEeccCC-CHHHHHhh---ccCCCCHHHHHHHHHHHHHHHHHHHHC---CeeCCCCCHHHEEEcCCCCEEEcc
Confidence 3457999999965 77776653 235699999999999999999999999 999999999999999999999999
Q ss_pred eccccccccccccccccccccccCcccCChhhhcc-cCcCccccchhhhHHHHHHHhCCCCCCCCccCCCCchhHHHHHH
Q 038766 162 FGTSRMLDVHLQDLSSLSTAFQGTIGYLAPEFAYM-RIVTTKVDVFSFGIVVMEFLTKRRPTGLDEENGLSPISLRQLVE 240 (299)
Q Consensus 162 f~~~~~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~-~~~~~~~DiwslG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~ 240 (299)
||++..................+++.|+|||++.+ ..++.++|||||||++|+|++|..||... ........+.
T Consensus 168 fg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~-----~~~~~~~~i~ 242 (351)
T 3mi9_A 168 FGLARAFSLAKNSQPNRYTNRVVTLWYRPPELLLGERDYGPPIDLWGAGCIMAEMWTRSPIMQGN-----TEQHQLALIS 242 (351)
T ss_dssp CTTCEECCCCSSSSCCCCCSSCSCGGGCCHHHHTTCCSCCTHHHHHHHHHHHHHHHHSSCSCCCS-----SHHHHHHHHH
T ss_pred chhcccccccccccccccCCcccccCccCchhhcCCCCCCcHhHHHHHHHHHHHHHhCCCCCCCC-----ChHHHHHHHH
Confidence 99998665333333334455667999999998876 45799999999999999999999999543 2222223332
Q ss_pred HHHhcCccCc-ccccCc---------cc-cchhhHhHHHHHHHHHHHHHHHHhcCCCCCCCCChhhhhcC
Q 038766 241 KALANGINGV-RQITDP---------KL-VSSIYEEQEQHQVLEELFKLALVCTSSNPEDRPNMNELLIT 299 (299)
Q Consensus 241 ~~~~~~~~~~-~~~~~~---------~~-~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rpt~~~il~~ 299 (299)
.......... ...... .. .............++.+.+||.+||..||++|||++|+|+|
T Consensus 243 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~h 312 (351)
T 3mi9_A 243 QLCGSITPEVWPNVDNYELYEKLELVKGQKRKVKDRLKAYVRDPYALDLIDKLLVLDPAQRIDSDDALNH 312 (351)
T ss_dssp HHHCCCCTTTSTTGGGCGGGTSSCCCSSCCCCHHHHHHHHHCCHHHHHHHHHHSCSSGGGSCCHHHHHTS
T ss_pred HHhCCCChhhccccccchhhcccccccccccCHHHHhhhccCChHHHHHHHHHhcCChhhCCCHHHHhCC
Confidence 2222111111 000000 00 00011111122235678999999999999999999999987
|
| >3txo_A PKC-L, NPKC-ETA, protein kinase C ETA type; phosphotransferase, transferase-transferase inhibito; HET: TPO 07U; 2.05A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-47 Score=328.69 Aligned_cols=253 Identities=21% Similarity=0.295 Sum_probs=200.2
Q ss_pred HHhCCCCCCceeecCCcceEEEEEeC-CCcEEEEEEeccCcC-ChhhhHHHHHHHHHHHhc-CCcceeeeeeEEEcCCCe
Q 038766 9 NATGSFSENNIIGNSNLSTVYKGRLE-DGEIVAVKKLNFHQF-SAESDKSFYREAKTLKEL-KHRNLVKVLGYAWESGKL 85 (299)
Q Consensus 9 ~~~~~y~~~~~lg~g~~~~v~~~~~~-~~~~~~vK~~~~~~~-~~~~~~~~~~e~~~l~~l-~h~~i~~~~~~~~~~~~~ 85 (299)
.-.++|.+.+.||+|+||.||+|.+. +++.||+|++..... ..........|..+++.+ .||||+++++++.. ...
T Consensus 20 ~~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~AvK~~~~~~~~~~~~~~~~~~E~~il~~~~~hp~Iv~l~~~~~~-~~~ 98 (353)
T 3txo_A 20 LGIDNFEFIRVLGKGSFGKVMLARVKETGDLYAVKVLKKDVILQDDDVECTMTEKRILSLARNHPFLTQLFCCFQT-PDR 98 (353)
T ss_dssp ---CCEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHHHHTTHHHHHHHHHHHHHTTTCTTBCCEEEEEEC-SSE
T ss_pred CchhheEEEEEEeeCCCEEEEEEEEcCCCCEEEEEEEEHHHhcchhHHHHHHHHHHHHHhccCCCceeeEEEEEEe-CCE
Confidence 44688999999999999999999875 589999999864322 233456778899999988 69999999996655 556
Q ss_pred eEEEEeecCCCChHHHhcCCCCCCCCCChhhHHHHHHHHHHHHHHhhcCCCCCeeeecccCCceeeCCCCcEEEeeeccc
Q 038766 86 KALILEYMENGSLESVIHGPGVDHSRWTLPKRIDVLISVANGLDYLHSGYDIPIVHCDMKPSNILLDRDFEAHVSDFGTS 165 (299)
Q Consensus 86 ~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lh~~~~~~~~H~dl~~~nil~~~~~~v~l~df~~~ 165 (299)
.++||||+.+++|..++. ....+++..++.++.||+.||+|||++ +++||||||+||+++.+|.++|+|||++
T Consensus 99 ~~lv~E~~~gg~L~~~l~----~~~~~~~~~~~~~~~qi~~aL~~LH~~---givHrDlkp~NILl~~~g~ikL~DFG~a 171 (353)
T 3txo_A 99 LFFVMEFVNGGDLMFHIQ----KSRRFDEARARFYAAEIISALMFLHDK---GIIYRDLKLDNVLLDHEGHCKLADFGMC 171 (353)
T ss_dssp EEEEEECCCSCBHHHHHH----HHSSCCHHHHHHHHHHHHHHHHHHHHT---TCBCCCCCGGGEEECTTSCEEECCCTTC
T ss_pred EEEEEeCCCCCcHHHHHH----HcCCCCHHHHHHHHHHHHHHHHHHHHC---CCcccCCCHHHEEECCCCCEEEccccce
Confidence 799999999999999987 446799999999999999999999999 9999999999999999999999999998
Q ss_pred cccccccccccccccccccCcccCChhhhcccCcCccccchhhhHHHHHHHhCCCCCCCCccCCCCchhHHHHHHHHHhc
Q 038766 166 RMLDVHLQDLSSLSTAFQGTIGYLAPEFAYMRIVTTKVDVFSFGIVVMEFLTKRRPTGLDEENGLSPISLRQLVEKALAN 245 (299)
Q Consensus 166 ~~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~DiwslG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~ 245 (299)
..... .........+|+.|+|||++.+..++.++|+|||||++|+|++|..||.... . .+....+...
T Consensus 172 ~~~~~----~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~G~~Pf~~~~-----~---~~~~~~i~~~ 239 (353)
T 3txo_A 172 KEGIC----NGVTTATFCGTPDYIAPEILQEMLYGPAVDWWAMGVLLYEMLCGHAPFEAEN-----E---DDLFEAILND 239 (353)
T ss_dssp BCSCC-------------CCGGGCCHHHHHHHHCTTHHHHHHHHHHHHHHHHSSCSSCCSS-----H---HHHHHHHHHC
T ss_pred eeccc----CCccccccCCCcCeEChhhcCCCCcCCccCCCcchHHHHHHHhCCCCCCCCC-----H---HHHHHHHHcC
Confidence 74321 1223345568999999999999999999999999999999999999995432 1 2222222221
Q ss_pred CccCcccccCccccchhhHhHHHHHHHHHHHHHHHHhcCCCCCCCCCh------hhhhcC
Q 038766 246 GINGVRQITDPKLVSSIYEEQEQHQVLEELFKLALVCTSSNPEDRPNM------NELLIT 299 (299)
Q Consensus 246 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rpt~------~~il~~ 299 (299)
.. . . +..++.++.++|++||..||++||++ +++++|
T Consensus 240 ~~-~-----~------------p~~~~~~~~~li~~lL~~dP~~R~~~~~~~~~~~il~h 281 (353)
T 3txo_A 240 EV-V-----Y------------PTWLHEDATGILKSFMTKNPTMRLGSLTQGGEHAILRH 281 (353)
T ss_dssp CC-C-----C------------CTTSCHHHHHHHHHHTCSSGGGSTTSGGGTCTHHHHTS
T ss_pred CC-C-----C------------CCCCCHHHHHHHHHHhhhCHHHccCCcccCCHHHHhhC
Confidence 10 0 0 11235678999999999999999999 888887
|
| >4fr4_A YANK1, serine/threonine-protein kinase 32A; structural genomics, structural genomics consortium, SGC, TR; HET: STU; 2.29A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-46 Score=326.31 Aligned_cols=256 Identities=22% Similarity=0.323 Sum_probs=205.8
Q ss_pred HHHhCCCCCCceeecCCcceEEEEEeC-CCcEEEEEEeccCc-CChhhhHHHHHHHHHHHhcCCcceeeeeeEEEcCCCe
Q 038766 8 ENATGSFSENNIIGNSNLSTVYKGRLE-DGEIVAVKKLNFHQ-FSAESDKSFYREAKTLKELKHRNLVKVLGYAWESGKL 85 (299)
Q Consensus 8 ~~~~~~y~~~~~lg~g~~~~v~~~~~~-~~~~~~vK~~~~~~-~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~ 85 (299)
+...++|.+.+.||+|+||.||+|.+. +++.||+|++.... ........+.+|+.+++.++||||+++++++.. ...
T Consensus 11 ~v~~~~y~i~~~LG~G~fG~V~~~~~~~~~~~~AiK~~~~~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~-~~~ 89 (384)
T 4fr4_A 11 DVNFDHFEILRAIGKGSFGKVCIVQKNDTKKMYAMKYMNKQKCVERNEVRNVFKELQIMQGLEHPFLVNLWYSFQD-EED 89 (384)
T ss_dssp CCCGGGEEEEEEEECCTTCCEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTCCCTTBCCEEEEEEC-SSE
T ss_pred CCChHHeEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEehhhcccHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEe-CCE
Confidence 345688999999999999999999875 58899999986432 123345678899999999999999999997665 456
Q ss_pred eEEEEeecCCCChHHHhcCCCCCCCCCChhhHHHHHHHHHHHHHHhhcCCCCCeeeecccCCceeeCCCCcEEEeeeccc
Q 038766 86 KALILEYMENGSLESVIHGPGVDHSRWTLPKRIDVLISVANGLDYLHSGYDIPIVHCDMKPSNILLDRDFEAHVSDFGTS 165 (299)
Q Consensus 86 ~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lh~~~~~~~~H~dl~~~nil~~~~~~v~l~df~~~ 165 (299)
.++|+||+.+++|..++. ....+++..++.++.||+.||.|||+. +++||||||+||+++.+|.++|+|||++
T Consensus 90 ~~lv~e~~~gg~L~~~l~----~~~~l~~~~~~~~~~qi~~aL~~LH~~---givHrDlkp~NIll~~~g~vkL~DFG~a 162 (384)
T 4fr4_A 90 MFMVVDLLLGGDLRYHLQ----QNVHFKEETVKLFICELVMALDYLQNQ---RIIHRDMKPDNILLDEHGHVHITDFNIA 162 (384)
T ss_dssp EEEEECCCTTEEHHHHHH----TTCCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECTTSCEEECCCTTC
T ss_pred EEEEEecCCCCcHHHHHH----hcCCCCHHHHHHHHHHHHHHHHHHHHC---CceeccCcHHHeEECCCCCEEEecccee
Confidence 699999999999999997 456799999999999999999999999 9999999999999999999999999999
Q ss_pred cccccccccccccccccccCcccCChhhhcc---cCcCccccchhhhHHHHHHHhCCCCCCCCccCCCCchhHHHHHHHH
Q 038766 166 RMLDVHLQDLSSLSTAFQGTIGYLAPEFAYM---RIVTTKVDVFSFGIVVMEFLTKRRPTGLDEENGLSPISLRQLVEKA 242 (299)
Q Consensus 166 ~~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~---~~~~~~~DiwslG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~ 242 (299)
..... ........+|+.|+|||++.. ..++.++|+|||||++|+|++|..||..... ..........
T Consensus 163 ~~~~~-----~~~~~~~~gt~~Y~aPE~~~~~~~~~~~~~~DiwSlG~il~elltG~~Pf~~~~~-----~~~~~~~~~~ 232 (384)
T 4fr4_A 163 AMLPR-----ETQITTMAGTKPYMAPEMFSSRKGAGYSFAVDWWSLGVTAYELLRGRRPYHIRSS-----TSSKEIVHTF 232 (384)
T ss_dssp EECCT-----TCCBCCCCSCGGGCCGGGTCCCSSCCBCTTHHHHHHHHHHHHHHHSSCSSCCCTT-----SCHHHHHHHH
T ss_pred eeccC-----CCceeccCCCccccCCeeeccCCCCCCCccceeechHHHHHHHHhCCCCCCCCCC-----ccHHHHHHHH
Confidence 76541 223445678999999999874 4588999999999999999999999964322 1122222222
Q ss_pred HhcCccCcccccCccccchhhHhHHHHHHHHHHHHHHHHhcCCCCCCCCC-hhhhhcC
Q 038766 243 LANGINGVRQITDPKLVSSIYEEQEQHQVLEELFKLALVCTSSNPEDRPN-MNELLIT 299 (299)
Q Consensus 243 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rpt-~~~il~~ 299 (299)
..... . . +..++.++.+||.+||..||++||+ ++++++|
T Consensus 233 ~~~~~-~-----~------------p~~~s~~~~~li~~lL~~dP~~R~s~~~~l~~h 272 (384)
T 4fr4_A 233 ETTVV-T-----Y------------PSAWSQEMVSLLKKLLEPNPDQRFSQLSDVQNF 272 (384)
T ss_dssp HHCCC-C-----C------------CTTSCHHHHHHHHHHSCSSGGGSCCSHHHHHTS
T ss_pred hhccc-C-----C------------CCcCCHHHHHHHHHHhcCCHhHhcccHHHHHcC
Confidence 21110 0 0 1233568999999999999999999 8888775
|
| >3ttj_A Mitogen-activated protein kinase 10; JNK3, protein kinase in transferase-transferase inhibitor complex; HET: JBI; 2.10A {Homo sapiens} PDB: 3tti_A* 1jnk_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.7e-46 Score=331.58 Aligned_cols=271 Identities=23% Similarity=0.250 Sum_probs=202.2
Q ss_pred HhCCCCCCceeecCCcceEEEEEeC-CCcEEEEEEeccCcCChhhhHHHHHHHHHHHhcCCcceeeeeeEEEcCC-----
Q 038766 10 ATGSFSENNIIGNSNLSTVYKGRLE-DGEIVAVKKLNFHQFSAESDKSFYREAKTLKELKHRNLVKVLGYAWESG----- 83 (299)
Q Consensus 10 ~~~~y~~~~~lg~g~~~~v~~~~~~-~~~~~~vK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~----- 83 (299)
+.++|++.+.||+|+||+||+|.+. +++.||||++............+.+|+.+++.++||||+++++++...+
T Consensus 60 ~~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vAiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~~~ 139 (464)
T 3ttj_A 60 VLKRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISLLNVFTPQKTLEEF 139 (464)
T ss_dssp EETTEEEEEEEEECSSCEEEEEEETTTTEEEEEEEEESGGGSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCCSTTTC
T ss_pred ecCCeEEEEEeecCCCeEEEEEEECCCCCEEEEEEECccccChHHHHHHHHHHHHHHhCCCCCCCcEEEEEccCCccccC
Confidence 4578999999999999999999864 5899999999765556666788999999999999999999999775433
Q ss_pred CeeEEEEeecCCCChHHHhcCCCCCCCCCChhhHHHHHHHHHHHHHHhhcCCCCCeeeecccCCceeeCCCCcEEEeeec
Q 038766 84 KLKALILEYMENGSLESVIHGPGVDHSRWTLPKRIDVLISVANGLDYLHSGYDIPIVHCDMKPSNILLDRDFEAHVSDFG 163 (299)
Q Consensus 84 ~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lh~~~~~~~~H~dl~~~nil~~~~~~v~l~df~ 163 (299)
...++|+||+.+ +|...+. ..+++..++.++.|++.||+|||++ +++||||||+||+++.++.+||+|||
T Consensus 140 ~~~~lv~E~~~~-~l~~~~~------~~l~~~~~~~~~~qil~aL~~lH~~---~iiHrDlkp~NIll~~~~~~kl~DFG 209 (464)
T 3ttj_A 140 QDVYLVMELMDA-NLCQVIQ------MELDHERMSYLLYQMLCGIKHLHSA---GIIHRDLKPSNIVVKSDCTLKILDFG 209 (464)
T ss_dssp CEEEEEEECCSE-EHHHHHT------SCCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEECTTSCEEECCCC
T ss_pred CeEEEEEeCCCC-CHHHHHh------hcCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCChHhEEEeCCCCEEEEEEE
Confidence 456999999965 6777774 2489999999999999999999999 99999999999999999999999999
Q ss_pred cccccccccccccccccccccCcccCChhhhcccCcCccccchhhhHHHHHHHhCCCCCCCCccCCCCchhHHHHHHHHH
Q 038766 164 TSRMLDVHLQDLSSLSTAFQGTIGYLAPEFAYMRIVTTKVDVFSFGIVVMEFLTKRRPTGLDEENGLSPISLRQLVEKAL 243 (299)
Q Consensus 164 ~~~~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~DiwslG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~ 243 (299)
++..... ........+|+.|+|||++.+..++.++|||||||++|+|++|..||...... ..+...+....
T Consensus 210 ~a~~~~~-----~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~ell~g~~pF~g~~~~----~~~~~i~~~lg 280 (464)
T 3ttj_A 210 LARTAGT-----SFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMVRHKILFPGRDYI----DQWNKVIEQLG 280 (464)
T ss_dssp CC----------CCCC----CCCTTCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCSSCCSSHH----HHHHHHHHHHC
T ss_pred eeeecCC-----CcccCCCcccccccCHHHHcCCCCCHHHHHHHHHHHHHHHHhCCCCCCCCCHH----HHHHHHHHhcC
Confidence 9976442 22334567899999999999999999999999999999999999999643211 11111111100
Q ss_pred h-----------------cCccCcccccCccccch---hhHhHHHHHHHHHHHHHHHHhcCCCCCCCCChhhhhcC
Q 038766 244 A-----------------NGINGVRQITDPKLVSS---IYEEQEQHQVLEELFKLALVCTSSNPEDRPNMNELLIT 299 (299)
Q Consensus 244 ~-----------------~~~~~~~~~~~~~~~~~---~~~~~~~~~~~~~l~~li~~~l~~dP~~Rpt~~~il~~ 299 (299)
. ...........+..... ..........+.++.+||++||..||++|||++|+|+|
T Consensus 281 ~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLl~~mL~~dP~~R~ta~e~L~H 356 (464)
T 3ttj_A 281 TPCPEFMKKLQPTVRNYVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRISVDDALQH 356 (464)
T ss_dssp SCCHHHHTTSCHHHHHHHTTSCCCCCCCHHHHSCGGGSCCSSHHHHHHHHHHHHHHHHHSCSSTTTSCCHHHHHTS
T ss_pred CCCHHHHHHcchhhhhHhhcccccCCCChHHhCcccccccccccccccCHHHHHHHHHHcCCChhhCCCHHHHhcC
Confidence 0 00000000000000000 00011234457889999999999999999999999987
|
| >1xjd_A Protein kinase C, theta type; PKC-theta, ATP, AMP,, transferase; HET: TPO SEP STU; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jed_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.8e-47 Score=324.39 Aligned_cols=254 Identities=22% Similarity=0.308 Sum_probs=204.0
Q ss_pred HHHhCCCCCCceeecCCcceEEEEEeC-CCcEEEEEEeccCcC-ChhhhHHHHHHHHHHHhc-CCcceeeeeeEEEcCCC
Q 038766 8 ENATGSFSENNIIGNSNLSTVYKGRLE-DGEIVAVKKLNFHQF-SAESDKSFYREAKTLKEL-KHRNLVKVLGYAWESGK 84 (299)
Q Consensus 8 ~~~~~~y~~~~~lg~g~~~~v~~~~~~-~~~~~~vK~~~~~~~-~~~~~~~~~~e~~~l~~l-~h~~i~~~~~~~~~~~~ 84 (299)
..-.++|.+.+.||+|+||.||+|.+. +|+.||+|++..... ..........|..+++.+ +||||+++++++.. ..
T Consensus 13 ~~~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~il~~~~~hp~iv~l~~~~~~-~~ 91 (345)
T 1xjd_A 13 KLKIEDFILHKMLGKGSFGKVFLAEFKKTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTHMFCTFQT-KE 91 (345)
T ss_dssp ---CTTEEEEEEEEECSSSEEEEEEETTTTEEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHHTTCTTBCCEEEEEEC-SS
T ss_pred CCChHHeEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEEhHHhhhhhhHHHHHHHHHHHHhcCCCCCCCcEEEEEEe-CC
Confidence 455689999999999999999999875 589999999864321 123456678899999877 89999999997665 55
Q ss_pred eeEEEEeecCCCChHHHhcCCCCCCCCCChhhHHHHHHHHHHHHHHhhcCCCCCeeeecccCCceeeCCCCcEEEeeecc
Q 038766 85 LKALILEYMENGSLESVIHGPGVDHSRWTLPKRIDVLISVANGLDYLHSGYDIPIVHCDMKPSNILLDRDFEAHVSDFGT 164 (299)
Q Consensus 85 ~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lh~~~~~~~~H~dl~~~nil~~~~~~v~l~df~~ 164 (299)
..++|+||+.+++|.+++. ....+++..++.++.||+.||+|||++ +++||||||+||+++.+|.++|+|||+
T Consensus 92 ~~~lv~E~~~gg~L~~~l~----~~~~~~~~~~~~~~~qi~~aL~~LH~~---~ivHrDlkp~NIll~~~g~vkL~DFG~ 164 (345)
T 1xjd_A 92 NLFFVMEYLNGGDLMYHIQ----SCHKFDLSRATFYAAEIILGLQFLHSK---GIVYRDLKLDNILLDKDGHIKIADFGM 164 (345)
T ss_dssp EEEEEEECCTTCBHHHHHH----HHSSCCHHHHHHHHHHHHHHHHHHHHT---TCBCCCCCGGGEEECTTSCEEECCCTT
T ss_pred EEEEEEeCCCCCcHHHHHH----HcCCCCHHHHHHHHHHHHHHHHHHHHC---CeEeCCCChhhEEECCCCCEEEeEChh
Confidence 6799999999999999987 445799999999999999999999999 999999999999999999999999999
Q ss_pred ccccccccccccccccccccCcccCChhhhcccCcCccccchhhhHHHHHHHhCCCCCCCCccCCCCchhHHHHHHHHHh
Q 038766 165 SRMLDVHLQDLSSLSTAFQGTIGYLAPEFAYMRIVTTKVDVFSFGIVVMEFLTKRRPTGLDEENGLSPISLRQLVEKALA 244 (299)
Q Consensus 165 ~~~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~DiwslG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~ 244 (299)
+..... .........+|+.|+|||++.+..++.++|+|||||++|+|++|..||.... .. +.......
T Consensus 165 a~~~~~----~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~-----~~---~~~~~i~~ 232 (345)
T 1xjd_A 165 CKENML----GDAKTNTFCGTPDYIAPEILLGQKYNHSVDWWSFGVLLYEMLIGQSPFHGQD-----EE---ELFHSIRM 232 (345)
T ss_dssp CBCCCC----TTCCBCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSS-----HH---HHHHHHHH
T ss_pred hhhccc----CCCcccCCCCCcccCChhhhcCCCCCChhhhHHHHHHHHHHhcCCCCCCCCC-----HH---HHHHHHHh
Confidence 875321 1122345678999999999999999999999999999999999999995432 11 22222221
Q ss_pred cCccCcccccCccccchhhHhHHHHHHHHHHHHHHHHhcCCCCCCCCChh-hhhcC
Q 038766 245 NGINGVRQITDPKLVSSIYEEQEQHQVLEELFKLALVCTSSNPEDRPNMN-ELLIT 299 (299)
Q Consensus 245 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rpt~~-~il~~ 299 (299)
.. ... +..++.++.+||.+||..||++||++. ++++|
T Consensus 233 ~~-~~~-----------------p~~~s~~~~~li~~lL~~dp~~R~~~~~~i~~h 270 (345)
T 1xjd_A 233 DN-PFY-----------------PRWLEKEAKDLLVKLFVREPEKRLGVRGDIRQH 270 (345)
T ss_dssp CC-CCC-----------------CTTSCHHHHHHHHHHSCSSGGGSBTTBSCGGGS
T ss_pred CC-CCC-----------------CcccCHHHHHHHHHHhcCCHhHcCCChHHHHcC
Confidence 11 000 112456799999999999999999998 88876
|
| >3llt_A Serine/threonine kinase-1, pflammer; lammer kinase, malaria, structural GE structural genomics consortium, SGC, transferase; HET: ANP; 2.50A {Plasmodium falciparum 3D7} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.5e-46 Score=322.30 Aligned_cols=276 Identities=22% Similarity=0.227 Sum_probs=208.5
Q ss_pred CChHHHHHHhCCCCCCceeecCCcceEEEEEe-CCCcEEEEEEeccCcCChhhhHHHHHHHHHHHhcC-----Ccceeee
Q 038766 2 FDRTEIENATGSFSENNIIGNSNLSTVYKGRL-EDGEIVAVKKLNFHQFSAESDKSFYREAKTLKELK-----HRNLVKV 75 (299)
Q Consensus 2 ~~~~~~~~~~~~y~~~~~lg~g~~~~v~~~~~-~~~~~~~vK~~~~~~~~~~~~~~~~~e~~~l~~l~-----h~~i~~~ 75 (299)
|+.++.+.+.++|.+.+.||+|+||+||+|.+ .+++.||+|++.. ..........|+.+++.+. ||||+++
T Consensus 25 ~~~~~g~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~---~~~~~~~~~~e~~~l~~l~~~~~~h~~iv~~ 101 (360)
T 3llt_A 25 FSWKKGMLLNNAFLVIRKMGDGTFGRVLLCQHIDNKKYYAVKVVRN---IKKYTRSAKIEADILKKIQNDDINNNNIVKY 101 (360)
T ss_dssp CCCCTTCEETTTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECS---CHHHHHHHHHHHHHHHHTCCCSTTGGGBCCE
T ss_pred eeeecceEecCEEEEEEEEcccCCeEEEEEEECCCCeEEEEEEecc---chhhhhhhHHHHHHHHHhcccCCCCCCeecc
Confidence 56667778899999999999999999999987 4689999999852 3345567788999999997 9999999
Q ss_pred eeEEEcCCCeeEEEEeecCCCChHHHhcCCCCCCCCCChhhHHHHHHHHHHHHHHhhcCCCCCeeeecccCCceeeCC--
Q 038766 76 LGYAWESGKLKALILEYMENGSLESVIHGPGVDHSRWTLPKRIDVLISVANGLDYLHSGYDIPIVHCDMKPSNILLDR-- 153 (299)
Q Consensus 76 ~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lh~~~~~~~~H~dl~~~nil~~~-- 153 (299)
++++.. ....++|+|++ +++|.+++... ....+++..++.++.||+.||+|||+. +++|+||||+||+++.
T Consensus 102 ~~~~~~-~~~~~lv~e~~-~~~L~~~~~~~--~~~~~~~~~~~~i~~qi~~aL~~LH~~---~ivHrDlkp~NIll~~~~ 174 (360)
T 3llt_A 102 HGKFMY-YDHMCLIFEPL-GPSLYEIITRN--NYNGFHIEDIKLYCIEILKALNYLRKM---SLTHTDLKPENILLDDPY 174 (360)
T ss_dssp EEEEEE-TTEEEEEECCC-CCBHHHHHHHT--TTCCCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEESCTT
T ss_pred cceeeE-CCeeEEEEcCC-CCCHHHHHHhc--CCCCCCHHHHHHHHHHHHHHHHHHHHC---CeeeCCCCcccEEEcccc
Confidence 997665 45679999999 88999998743 234589999999999999999999999 9999999999999975
Q ss_pred -----------------------CCcEEEeeeccccccccccccccccccccccCcccCChhhhcccCcCccccchhhhH
Q 038766 154 -----------------------DFEAHVSDFGTSRMLDVHLQDLSSLSTAFQGTIGYLAPEFAYMRIVTTKVDVFSFGI 210 (299)
Q Consensus 154 -----------------------~~~v~l~df~~~~~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~DiwslG~ 210 (299)
++.++|+|||++.... .......+|+.|+|||++.+..++.++|||||||
T Consensus 175 ~~~~~~~~~~~~~~~~~~~~~~~~~~~kl~DFG~a~~~~-------~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~ 247 (360)
T 3llt_A 175 FEKSLITVRRVTDGKKIQIYRTKSTGIKLIDFGCATFKS-------DYHGSIINTRQYRAPEVILNLGWDVSSDMWSFGC 247 (360)
T ss_dssp CCEEEEEEECTTTCCEEEEEEESCCCEEECCCTTCEETT-------SCCCSCCSCGGGCCHHHHTTCCCCTTHHHHHHHH
T ss_pred ccccccchhcccccccccccccCCCCEEEEeccCceecC-------CCCcCccCcccccCcHHHcCCCCCCccchHHHHH
Confidence 7889999999997533 2234456799999999999999999999999999
Q ss_pred HHHHHHhCCCCCCCCccCCCCchhHHHHHHHHHhcCccC----------cccccCccccchhh---------------Hh
Q 038766 211 VVMEFLTKRRPTGLDEENGLSPISLRQLVEKALANGING----------VRQITDPKLVSSIY---------------EE 265 (299)
Q Consensus 211 ~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~----------~~~~~~~~~~~~~~---------------~~ 265 (299)
++|+|++|..||.... .......+.......... .............. ..
T Consensus 248 il~ell~g~~pf~~~~-----~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~ 322 (360)
T 3llt_A 248 VLAELYTGSLLFRTHE-----HMEHLAMMESIIQPIPKNMLYEATKTNGSKYVNKDELKLAWPENASSINSIKHVKKCLP 322 (360)
T ss_dssp HHHHHHHSSCSCCCSS-----HHHHHHHHHHHTCCCCHHHHHHHTTSGGGGGEETTTTEECTTTTCSCHHHHHHHHTCCC
T ss_pred HHHHHHHCCCCCCCCc-----HHHHHHHHHHhcCCCCHHHHhhhhhccCccccCcccceecCcccccchhhhhhhhhccc
Confidence 9999999999995432 112222221111100000 00000000000000 00
Q ss_pred HHHHHHHHHHHHHHHHhcCCCCCCCCChhhhhcC
Q 038766 266 QEQHQVLEELFKLALVCTSSNPEDRPNMNELLIT 299 (299)
Q Consensus 266 ~~~~~~~~~l~~li~~~l~~dP~~Rpt~~~il~~ 299 (299)
......++.+.+||++||..||++|||++|+|+|
T Consensus 323 ~~~~~~~~~l~~li~~~L~~dP~~Rpta~elL~h 356 (360)
T 3llt_A 323 LYKIIKHELFCDFLYSILQIDPTLRPSPAELLKH 356 (360)
T ss_dssp HHHHCCCHHHHHHHHHHCCSSGGGSCCHHHHTTS
T ss_pred ccccchHHHHHHHHHHHhcCChhhCCCHHHHhcC
Confidence 0111123678899999999999999999999987
|
| >2pmi_A Negative RE, cyclin-dependent protein kinase PHO85; cyclin-dependent kinase, signaling protein,transfera cycle complex; HET: MES AGS; 2.90A {Saccharomyces cerevisiae} PDB: 2pk9_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.3e-46 Score=315.22 Aligned_cols=275 Identities=22% Similarity=0.350 Sum_probs=190.2
Q ss_pred HhCCCCCCceeecCCcceEEEEEeC-CCcEEEEEEeccCcCChhhhHHHHHHHHHHHhcCCcceeeeeeEEEcCCCeeEE
Q 038766 10 ATGSFSENNIIGNSNLSTVYKGRLE-DGEIVAVKKLNFHQFSAESDKSFYREAKTLKELKHRNLVKVLGYAWESGKLKAL 88 (299)
Q Consensus 10 ~~~~y~~~~~lg~g~~~~v~~~~~~-~~~~~~vK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~l 88 (299)
..++|++.+.||+|+||+||+|.+. +|+.||+|++.... .......+.+|+.+++.++||||+++++++.. ++..++
T Consensus 3 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~-~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~-~~~~~l 80 (317)
T 2pmi_A 3 SSSQFKQLEKLGNGTYATVYKGLNKTTGVYVALKEVKLDS-EEGTPSTAIREISLMKELKHENIVRLYDVIHT-ENKLTL 80 (317)
T ss_dssp ----------------CEEEEEECSSSCCEEEEEEEECCS-TTCSCHHHHHHHHHHTTCCBTTBCCEEEEECC-TTEEEE
T ss_pred cccceeEeeEECCCCCEEEEEEEECCCCcEEEEEEeeccc-ccccHHHHHHHHHHHHhcCCCCcceEEEEEEE-CCeEEE
Confidence 4578999999999999999999874 58999999997543 33445678899999999999999999996554 556799
Q ss_pred EEeecCCCChHHHhcCC--CCCCCCCChhhHHHHHHHHHHHHHHhhcCCCCCeeeecccCCceeeCCCCcEEEeeecccc
Q 038766 89 ILEYMENGSLESVIHGP--GVDHSRWTLPKRIDVLISVANGLDYLHSGYDIPIVHCDMKPSNILLDRDFEAHVSDFGTSR 166 (299)
Q Consensus 89 v~e~~~~~~L~~~~~~~--~~~~~~~~~~~~~~i~~qi~~~l~~lh~~~~~~~~H~dl~~~nil~~~~~~v~l~df~~~~ 166 (299)
|+||+. ++|.+++... ......+++..++.++.|++.||.|||+. +++|+||||+||+++.++.+||+|||++.
T Consensus 81 v~e~~~-~~L~~~l~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~lH~~---~ivH~Dlkp~NIl~~~~~~~kl~Dfg~~~ 156 (317)
T 2pmi_A 81 VFEFMD-NDLKKYMDSRTVGNTPRGLELNLVKYFQWQLLQGLAFCHEN---KILHRDLKPQNLLINKRGQLKLGDFGLAR 156 (317)
T ss_dssp EEECCC-CBHHHHHHHHHSSSCCCCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEECTTCCEEECCCSSCE
T ss_pred EEEecC-CCHHHHHHhccccccccCCCHHHHHHHHHHHHHHHHHHHHC---CeeeCCCChHHeEEcCCCCEEECcCccce
Confidence 999997 5998887532 11234689999999999999999999999 99999999999999999999999999997
Q ss_pred ccccccccccccccccccCcccCChhhhcc-cCcCccccchhhhHHHHHHHhCCCCCCCCccCCCCchhHHHHHHHHHhc
Q 038766 167 MLDVHLQDLSSLSTAFQGTIGYLAPEFAYM-RIVTTKVDVFSFGIVVMEFLTKRRPTGLDEENGLSPISLRQLVEKALAN 245 (299)
Q Consensus 167 ~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~-~~~~~~~DiwslG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~ 245 (299)
..... ........+++.|+|||++.+ ..++.++|||||||++|+|++|..||.... .......+......
T Consensus 157 ~~~~~----~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~-----~~~~~~~i~~~~~~ 227 (317)
T 2pmi_A 157 AFGIP----VNTFSSEVVTLWYRAPDVLMGSRTYSTSIDIWSCGCILAEMITGKPLFPGTN-----DEEQLKLIFDIMGT 227 (317)
T ss_dssp ETTSC----CCCCCCCCSCCTTCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHSSCSCCCSS-----HHHHHHHHHHHHCS
T ss_pred ecCCC----cccCCCCcccccccCchHhhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCC-----hHHHHHHHHHHhCC
Confidence 65421 122334467899999999876 468999999999999999999999995432 12222222111111
Q ss_pred Ccc----CcccccC---------ccccchhhHhHHHHHHHHHHHHHHHHhcCCCCCCCCChhhhhcC
Q 038766 246 GIN----GVRQITD---------PKLVSSIYEEQEQHQVLEELFKLALVCTSSNPEDRPNMNELLIT 299 (299)
Q Consensus 246 ~~~----~~~~~~~---------~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rpt~~~il~~ 299 (299)
... ....... +..............++.++.+||.+||..||++|||++|+|+|
T Consensus 228 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rpt~~e~l~h 294 (317)
T 2pmi_A 228 PNESLWPSVTKLPKYNPNIQQRPPRDLRQVLQPHTKEPLDGNLMDFLHGLLQLNPDMRLSAKQALHH 294 (317)
T ss_dssp CCTTTCGGGGGCTTCCTTCCCCCCCCSHHHHGGGCSSCCCHHHHHHHHHHSCSSGGGSCCHHHHTTS
T ss_pred CChhHhhhhhhhhhcccccccccchhHHHhhcccccccCCHHHHHHHHHHCCCCcccCCCHHHHhCC
Confidence 100 0000000 00000000011112356789999999999999999999999987
|
| >1rdq_E PKA C-alpha, CAMP-dependent protein kinase, alpha-catalytic SU; CAMP-dependent protein kinase,catalytic mechanism, ATP hydro two nucleotide states; HET: TPO SEP ADP ATP; 1.26A {Mus musculus} SCOP: d.144.1.7 PDB: 2erz_E* 3fjq_E* 1bkx_A* 1atp_E* 1fmo_E* 1j3h_A* 1jlu_E* 1bx6_A* 1re8_A* 1rej_A* 1rek_A* 2cpk_E* 2qcs_A* 2qvs_E* 1l3r_E* 3idb_A* 3idc_A* 3o7l_D* 3ow3_A* 3tnp_C* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=9.3e-47 Score=324.00 Aligned_cols=249 Identities=21% Similarity=0.283 Sum_probs=204.8
Q ss_pred HhCCCCCCceeecCCcceEEEEEeC-CCcEEEEEEeccCcC-ChhhhHHHHHHHHHHHhcCCcceeeeeeEEEcCCCeeE
Q 038766 10 ATGSFSENNIIGNSNLSTVYKGRLE-DGEIVAVKKLNFHQF-SAESDKSFYREAKTLKELKHRNLVKVLGYAWESGKLKA 87 (299)
Q Consensus 10 ~~~~y~~~~~lg~g~~~~v~~~~~~-~~~~~~vK~~~~~~~-~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~ 87 (299)
..++|.+.+.||+|+||.||+|.+. +|+.||+|++..... .....+.+.+|+.+++.++||||+++++++.. +...+
T Consensus 39 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~-~~~~~ 117 (350)
T 1rdq_E 39 QLDQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEFSFKD-NSNLY 117 (350)
T ss_dssp CGGGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTCCCTTBCCEEEEEEC-SSEEE
T ss_pred CHHHCEEEEEeecCcCcEEEEEEECCCCCEEEEEEEEhHHhccHHHHHHHHHHHHHHHhCCCCCCCeEEEEEEc-CCEEE
Confidence 3478999999999999999999875 689999999864322 22345678899999999999999999996655 55679
Q ss_pred EEEeecCCCChHHHhcCCCCCCCCCChhhHHHHHHHHHHHHHHhhcCCCCCeeeecccCCceeeCCCCcEEEeeeccccc
Q 038766 88 LILEYMENGSLESVIHGPGVDHSRWTLPKRIDVLISVANGLDYLHSGYDIPIVHCDMKPSNILLDRDFEAHVSDFGTSRM 167 (299)
Q Consensus 88 lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lh~~~~~~~~H~dl~~~nil~~~~~~v~l~df~~~~~ 167 (299)
+||||+.+++|.+++. ....+++..++.++.||+.||.|||++ +++||||||+||+++.+|.++|+|||++..
T Consensus 118 lv~e~~~gg~L~~~l~----~~~~~~~~~~~~~~~qi~~aL~~LH~~---~ivHrDlkp~NIll~~~g~~kL~DFg~a~~ 190 (350)
T 1rdq_E 118 MVMEYVAGGEMFSHLR----RIGRFSEPHARFYAAQIVLTFEYLHSL---DLIYRDLKPENLLIDQQGYIQVTDFGFAKR 190 (350)
T ss_dssp EEEECCTTCBHHHHHH----HHCCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECTTSCEEECCCTTCEE
T ss_pred EEEcCCCCCcHHHHHH----HcCCCCHHHHHHHHHHHHHHHHHHHHC---CcccccCccceEEECCCCCEEEccccccee
Confidence 9999999999999987 345799999999999999999999999 999999999999999999999999999976
Q ss_pred cccccccccccccccccCcccCChhhhcccCcCccccchhhhHHHHHHHhCCCCCCCCccCCCCchhHHHHHHHHHhcCc
Q 038766 168 LDVHLQDLSSLSTAFQGTIGYLAPEFAYMRIVTTKVDVFSFGIVVMEFLTKRRPTGLDEENGLSPISLRQLVEKALANGI 247 (299)
Q Consensus 168 ~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~DiwslG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 247 (299)
... ......+|+.|+|||++.+..++.++|+|||||++|+|++|..||.... . ............
T Consensus 191 ~~~-------~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~-----~---~~~~~~i~~~~~ 255 (350)
T 1rdq_E 191 VKG-------RTWTLCGTPEALAPEIILSKGYNKAVDWWALGVLIYEMAAGYPPFFADQ-----P---IQIYEKIVSGKV 255 (350)
T ss_dssp CSS-------CBCCCEECGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSS-----H---HHHHHHHHHCCC
T ss_pred ccC-------CcccccCCccccCHHHhcCCCCCCcCCEecccHhHhHHhhCCCCCCCCC-----H---HHHHHHHHcCCC
Confidence 431 2334568999999999999999999999999999999999999995431 1 122222222110
Q ss_pred cCcccccCccccchhhHhHHHHHHHHHHHHHHHHhcCCCCCCCCC-----hhhhhcC
Q 038766 248 NGVRQITDPKLVSSIYEEQEQHQVLEELFKLALVCTSSNPEDRPN-----MNELLIT 299 (299)
Q Consensus 248 ~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rpt-----~~~il~~ 299 (299)
. + +..++.++.++|++||..||++||+ ++++++|
T Consensus 256 -~---~--------------p~~~~~~~~~li~~lL~~dp~~R~~~~~~~~~ei~~h 294 (350)
T 1rdq_E 256 -R---F--------------PSHFSSDLKDLLRNLLQVDLTKRFGNLKNGVNDIKNH 294 (350)
T ss_dssp -C---C--------------CTTCCHHHHHHHHHHSCSCTTTCTTSSTTTTHHHHTS
T ss_pred -C---C--------------CCCCCHHHHHHHHHHhhcCHHhccCCccCCHHHHHhC
Confidence 0 0 1223567999999999999999999 9999887
|
| >3n9x_A Phosphotransferase; malaria kinase, structural genomics, structural genomics CON SGC; 2.05A {Plasmodium berghei} PDB: 3nie_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-46 Score=332.63 Aligned_cols=282 Identities=22% Similarity=0.289 Sum_probs=204.7
Q ss_pred HhCCCCCCceeecCCcceEEEEEeC-CCcEEEEEEeccCcCChhhhHHHHHHHHHHHhcCCcceeeeeeEEEcCC----C
Q 038766 10 ATGSFSENNIIGNSNLSTVYKGRLE-DGEIVAVKKLNFHQFSAESDKSFYREAKTLKELKHRNLVKVLGYAWESG----K 84 (299)
Q Consensus 10 ~~~~y~~~~~lg~g~~~~v~~~~~~-~~~~~~vK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~----~ 84 (299)
+.++|.+.+.||+|+||+||+|.+. +++.||||++..........+.+.+|+.+++.++||||+++++++...+ .
T Consensus 24 i~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vAiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~~~ 103 (432)
T 3n9x_A 24 VPDNYIIKHLIGRGSYGYVYLAYDKNTEKNVAIKKVNRMFEDLIDCKRILREITILNRLKSDYIIRLYDLIIPDDLLKFD 103 (432)
T ss_dssp CCTTEEEEEEEEEETTEEEEEEEETTTTEEEEEEEECSTTTSHHHHHHHHHHHHHHHHCCCTTBCCEEEECCCSCTTTCC
T ss_pred ecCCEEEEEEEeecCCEEEEEEEECCCCcEEEEEEeCchhcChHHHHHHHHHHHHHHHcCCCCcceEEEEEecCCCCcCC
Confidence 5789999999999999999999874 5889999999765555666788999999999999999999999776543 4
Q ss_pred eeEEEEeecCCCChHHHhcCCCCCCCCCChhhHHHHHHHHHHHHHHhhcCCCCCeeeecccCCceeeCCCCcEEEeeecc
Q 038766 85 LKALILEYMENGSLESVIHGPGVDHSRWTLPKRIDVLISVANGLDYLHSGYDIPIVHCDMKPSNILLDRDFEAHVSDFGT 164 (299)
Q Consensus 85 ~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lh~~~~~~~~H~dl~~~nil~~~~~~v~l~df~~ 164 (299)
..++|+|++. ++|.+++. ....+++..++.++.||+.||+|||++ +++||||||+||+++.++.+||+|||+
T Consensus 104 ~~~lv~e~~~-~~L~~~~~----~~~~l~~~~~~~i~~qil~aL~~LH~~---givHrDlkp~NILl~~~~~~kL~DFGl 175 (432)
T 3n9x_A 104 ELYIVLEIAD-SDLKKLFK----TPIFLTEEHIKTILYNLLLGENFIHES---GIIHRDLKPANCLLNQDCSVKVCDFGL 175 (432)
T ss_dssp CEEEEEECCS-EEHHHHHH----SSCCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEECTTCCEEECCCTT
T ss_pred eEEEEEecCC-cCHHHHHh----ccCCCCHHHHHHHHHHHHHHHHHHHHC---CCCCCCCCHHHeEECCCCCEEEccCCC
Confidence 5799999995 59999997 456799999999999999999999999 999999999999999999999999999
Q ss_pred cccccccccc------------------ccccccccccCcccCChhhh-cccCcCccccchhhhHHHHHHHhCCCCCCCC
Q 038766 165 SRMLDVHLQD------------------LSSLSTAFQGTIGYLAPEFA-YMRIVTTKVDVFSFGIVVMEFLTKRRPTGLD 225 (299)
Q Consensus 165 ~~~~~~~~~~------------------~~~~~~~~~~~~~y~~PE~~-~~~~~~~~~DiwslG~~l~~l~~g~~p~~~~ 225 (299)
+......... .........+|+.|+|||++ ....++.++|||||||++|+|++|..||...
T Consensus 176 a~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~APE~~~~~~~~~~~~DiwSlG~il~ell~g~~p~~~~ 255 (432)
T 3n9x_A 176 ARTINSEKDTNIVNDLEENEEPGPHNKNLKKQLTSHVVTRWYRAPELILLQENYTKSIDIWSTGCIFAELLNMLQSHIND 255 (432)
T ss_dssp CEEC-------------------------------CCCCCTTCCHHHHTTCSCCCTHHHHHHHHHHHHHHHTTCTTTCSS
T ss_pred cccccccccccccccccccccccccccchhccccCCCCCccccCHHHHhcCCCCCcccccchHHHHHHHHHhcccccccc
Confidence 9865422110 00123556789999999985 5667999999999999999999876665432
Q ss_pred ccCCCCc--------------------hhHHHHHHHHHh-cCccCcc---cccCccc---------cchhhHhHHHHHHH
Q 038766 226 EENGLSP--------------------ISLRQLVEKALA-NGINGVR---QITDPKL---------VSSIYEEQEQHQVL 272 (299)
Q Consensus 226 ~~~~~~~--------------------~~~~~~~~~~~~-~~~~~~~---~~~~~~~---------~~~~~~~~~~~~~~ 272 (299)
....... ....+.+..+.. .+.+... .+..... ............++
T Consensus 256 ~~~~~p~f~g~~~~~~~~~~~~~~~~~~~~~~ql~~i~~~~g~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s 335 (432)
T 3n9x_A 256 PTNRFPLFPGSSCFPLSPDRNSKKVHEKSNRDQLNIIFNIIGTPTEDDLKNINKPEVIKYIKLFPHRKPINLKQKYPSIS 335 (432)
T ss_dssp GGGCCCSCCCSCSCC----------CHHHHHHHHHHHHHHHCSCCHHHHHTCCCHHHHHHHHTSCCCCCCCHHHHSTTSC
T ss_pred cccccccCCCccccccCcccccccccccchHHHHHHHHHhcCCCCHHHHHhccCHHHHHHHHhCCCCCCCCHHHHCCCCC
Confidence 2111110 001111111111 1111100 0000000 00000001123467
Q ss_pred HHHHHHHHHhcCCCCCCCCChhhhhcC
Q 038766 273 EELFKLALVCTSSNPEDRPNMNELLIT 299 (299)
Q Consensus 273 ~~l~~li~~~l~~dP~~Rpt~~~il~~ 299 (299)
+++.+||++||..||++|||++|+|+|
T Consensus 336 ~~~~dLl~~mL~~dP~~R~ta~e~L~H 362 (432)
T 3n9x_A 336 DDGINLLESMLKFNPNKRITIDQALDH 362 (432)
T ss_dssp HHHHHHHHHHSCSSTTTSCCHHHHHTC
T ss_pred HHHHHHHHHHhcCCcccCCCHHHHhcC
Confidence 889999999999999999999999987
|
| >3q4u_A Activin receptor type-1; structural genomics consortium, SGC, protein kinase, transfe; HET: LDN FLC; 1.82A {Homo sapiens} PDB: 3mtf_A* 3oom_A* 4dym_A* 3h9r_A* 3my0_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.4e-46 Score=313.27 Aligned_cols=263 Identities=25% Similarity=0.350 Sum_probs=200.1
Q ss_pred HHHhCCCCCCceeecCCcceEEEEEeCCCcEEEEEEeccCcCChhhhHHHHHHHHHHHh--cCCcceeeeeeEEEcC---
Q 038766 8 ENATGSFSENNIIGNSNLSTVYKGRLEDGEIVAVKKLNFHQFSAESDKSFYREAKTLKE--LKHRNLVKVLGYAWES--- 82 (299)
Q Consensus 8 ~~~~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~vK~~~~~~~~~~~~~~~~~e~~~l~~--l~h~~i~~~~~~~~~~--- 82 (299)
+.+.++|.+.+.||+|+||+||++.+ +++.||+|++.. ........|.+++.. ++||||+++++++...
T Consensus 4 ~~~~~~y~~~~~lg~G~~g~V~~~~~-~~~~vavK~~~~-----~~~~~~~~e~~~~~~~~l~h~niv~~~~~~~~~~~~ 77 (301)
T 3q4u_A 4 RTVARDITLLECVGKGRYGEVWRGSW-QGENVAVKIFSS-----RDEKSWFRETELYNTVMLRHENILGFIASDMTSRHS 77 (301)
T ss_dssp CCCGGGCEEEEEEEECSSEEEEEEEE-TTEEEEEEEECG-----GGHHHHHHHHHHHHHTCCCCTTBCCEEEEEEEEETT
T ss_pred ccccCcEEEEEeeccCCCcEEEEEEE-CCEEEEEEEecc-----ccchhhHHHHHHHHHhhccCcCeeeEEEeeccccCC
Confidence 45678999999999999999999988 588999999853 234455666666666 7899999999976542
Q ss_pred CCeeEEEEeecCCCChHHHhcCCCCCCCCCChhhHHHHHHHHHHHHHHhh--------cCCCCCeeeecccCCceeeCCC
Q 038766 83 GKLKALILEYMENGSLESVIHGPGVDHSRWTLPKRIDVLISVANGLDYLH--------SGYDIPIVHCDMKPSNILLDRD 154 (299)
Q Consensus 83 ~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lh--------~~~~~~~~H~dl~~~nil~~~~ 154 (299)
....++|+||+.+++|.++++ ...+++..++.++.|++.||+||| +. +++|+||||+||+++.+
T Consensus 78 ~~~~~lv~e~~~~g~L~~~l~-----~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~---~ivH~Dlkp~Nill~~~ 149 (301)
T 3q4u_A 78 STQLWLITHYHEMGSLYDYLQ-----LTTLDTVSCLRIVLSIASGLAHLHIEIFGTQGKP---AIAHRDLKSKNILVKKN 149 (301)
T ss_dssp EEEEEEEECCCTTCBHHHHHT-----TCCBCHHHHHHHHHHHHHHHHHHHSCBCSTTCBC---EEECSCCCGGGEEECTT
T ss_pred CceeEEehhhccCCCHHHHHh-----hcccCHHHHHHHHHHHHHHHHHHHHhhhhccCCC---CeecCCCChHhEEEcCC
Confidence 345789999999999999995 347999999999999999999999 87 99999999999999999
Q ss_pred CcEEEeeeccccccccccccccccccccccCcccCChhhhccc------CcCccccchhhhHHHHHHHhC----------
Q 038766 155 FEAHVSDFGTSRMLDVHLQDLSSLSTAFQGTIGYLAPEFAYMR------IVTTKVDVFSFGIVVMEFLTK---------- 218 (299)
Q Consensus 155 ~~v~l~df~~~~~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~------~~~~~~DiwslG~~l~~l~~g---------- 218 (299)
+.+||+|||++..................+|+.|+|||.+.+. .++.++||||||+++|+|++|
T Consensus 150 ~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~DvwslG~il~el~tg~~~~~~~~~~ 229 (301)
T 3q4u_A 150 GQCCIADLGLAVMHSQSTNQLDVGNNPRVGTKRYMAPEVLDETIQVDCFDSYKRVDIWAFGLVLWEVARRMVSNGIVEDY 229 (301)
T ss_dssp SCEEECCCTTCEEEETTTTEEECCCCCCCCCGGGCCHHHHTTCCCTTCHHHHHHHHHHHHHHHHHHHHTTBCBTTBCCCC
T ss_pred CCEEEeeCCCeeecccccccccccccccccccceeChhhhcCcCCCCcccCCchhhHHHHHHHHHHHHhhhcCccccccc
Confidence 9999999999976543222222223344789999999998876 456799999999999999999
Q ss_pred CCCCCCCccCCCCchhHHHHHHHHHhcCccCcccccCccccchhhHhHHHHHHHHHHHHHHHHhcCCCCCCCCChhhhhc
Q 038766 219 RRPTGLDEENGLSPISLRQLVEKALANGINGVRQITDPKLVSSIYEEQEQHQVLEELFKLALVCTSSNPEDRPNMNELLI 298 (299)
Q Consensus 219 ~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rpt~~~il~ 298 (299)
..||............+. ....... ....+.. .......+..+.+++.+||..||++|||++++++
T Consensus 230 ~~pf~~~~~~~~~~~~~~----~~~~~~~-~~~~~~~---------~~~~~~~~~~l~~li~~cl~~dP~~Rps~~~i~~ 295 (301)
T 3q4u_A 230 KPPFYDVVPNDPSFEDMR----KVVCVDQ-QRPNIPN---------RWFSDPTLTSLAKLMKECWYQNPSARLTALRIKK 295 (301)
T ss_dssp CCTTTTTSCSSCCHHHHH----HHHTTSC-CCCCCCG---------GGGGSHHHHHHHHHHHHHCCSSGGGSCCHHHHHH
T ss_pred cccccccCCCCcchhhhh----HHHhccC-CCCCCCh---------hhccCccHHHHHHHHHHHhhcChhhCCCHHHHHH
Confidence 677654322222222211 1111110 0001110 1113456788999999999999999999999985
|
| >4aaa_A Cyclin-dependent kinase-like 2; transferase, phospho-mimetic; HET: DKI; 1.53A {Homo sapiens} PDB: 4bbm_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-46 Score=321.71 Aligned_cols=273 Identities=26% Similarity=0.326 Sum_probs=205.1
Q ss_pred HhCCCCCCceeecCCcceEEEEEeC-CCcEEEEEEeccCcCChhhhHHHHHHHHHHHhcCCcceeeeeeEEEcCCCeeEE
Q 038766 10 ATGSFSENNIIGNSNLSTVYKGRLE-DGEIVAVKKLNFHQFSAESDKSFYREAKTLKELKHRNLVKVLGYAWESGKLKAL 88 (299)
Q Consensus 10 ~~~~y~~~~~lg~g~~~~v~~~~~~-~~~~~~vK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~l 88 (299)
..++|++.+.||+|++|.||++.+. +|+.||+|++..........+.+.+|+.+++.++||||+++++++.. +...++
T Consensus 23 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~-~~~~~l 101 (331)
T 4aaa_A 23 SMEKYENLGLVGEGSYGMVMKCRNKDTGRIVAIKKFLESDDDKMVKKIAMREIKLLKQLRHENLVNLLEVCKK-KKRWYL 101 (331)
T ss_dssp CGGGEEEEEEGGGGTTSSEEEEEETTTCCEEEEEEEESCSSCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEE-TTEEEE
T ss_pred hhhhheeeeEEeecCCEEEEEEEECCCCceEEEEEEecCCCchHHHHHHHHHHHHHhhCCCCCEeeEEEEeec-CCEEEE
Confidence 4678999999999999999999875 58999999997666556667778899999999999999999997665 556699
Q ss_pred EEeecCCCChHHHhcCCCCCCCCCChhhHHHHHHHHHHHHHHhhcCCCCCeeeecccCCceeeCCCCcEEEeeecccccc
Q 038766 89 ILEYMENGSLESVIHGPGVDHSRWTLPKRIDVLISVANGLDYLHSGYDIPIVHCDMKPSNILLDRDFEAHVSDFGTSRML 168 (299)
Q Consensus 89 v~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lh~~~~~~~~H~dl~~~nil~~~~~~v~l~df~~~~~~ 168 (299)
|+||+.+++|..+.. ....+++..++.++.|++.||.|||+. +++|+||||+||+++.++.++|+|||++...
T Consensus 102 v~e~~~~~~l~~~~~----~~~~~~~~~~~~~~~qi~~~l~~LH~~---~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~ 174 (331)
T 4aaa_A 102 VFEFVDHTILDDLEL----FPNGLDYQVVQKYLFQIINGIGFCHSH---NIIHRDIKPENILVSQSGVVKLCDFGFARTL 174 (331)
T ss_dssp EEECCSEEHHHHHHH----STTCCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEECTTSCEEECCCTTC---
T ss_pred EEecCCcchHHHHHh----hccCCCHHHHHHHHHHHHHHHHHHHHC---CEEccCcChheEEEcCCCcEEEEeCCCceee
Confidence 999999888888876 445799999999999999999999999 9999999999999999999999999998754
Q ss_pred ccccccccccccccccCcccCChhhhccc-CcCccccchhhhHHHHHHHhCCCCCCCCccCCCCchhHHHHHHHHHhc--
Q 038766 169 DVHLQDLSSLSTAFQGTIGYLAPEFAYMR-IVTTKVDVFSFGIVVMEFLTKRRPTGLDEENGLSPISLRQLVEKALAN-- 245 (299)
Q Consensus 169 ~~~~~~~~~~~~~~~~~~~y~~PE~~~~~-~~~~~~DiwslG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~-- 245 (299)
... ........+++.|+|||.+.+. .++.++|||||||++|+|++|..||...... ......+. ....
T Consensus 175 ~~~----~~~~~~~~~t~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~----~~~~~~~~-~~~~~~ 245 (331)
T 4aaa_A 175 AAP----GEVYDDEVATRWYRAPELLVGDVKYGKAVDVWAIGCLVTEMFMGEPLFPGDSDI----DQLYHIMM-CLGNLI 245 (331)
T ss_dssp -------------CCCCCTTCCHHHHTTCTTCCTHHHHHHHHHHHHHHHHSSCSCCCSSHH----HHHHHHHH-HHCSCC
T ss_pred cCC----ccccCCCcCCccccCcccccCCCCcchHHHHHHHHHHHHHHHhCCCCCCCCCcH----HHHHHHHH-HhCCCC
Confidence 421 1223345678999999998875 6889999999999999999999999543211 11111110 0000
Q ss_pred --------CccCcccccCccccchhhHhHHHHHHHHHHHHHHHHhcCCCCCCCCChhhhhcC
Q 038766 246 --------GINGVRQITDPKLVSSIYEEQEQHQVLEELFKLALVCTSSNPEDRPNMNELLIT 299 (299)
Q Consensus 246 --------~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rpt~~~il~~ 299 (299)
..+.......+..............++..+.+||.+||..||++|||++|+|+|
T Consensus 246 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rpt~~ell~h 307 (331)
T 4aaa_A 246 PRHQELFNKNPVFAGVRLPEIKEREPLERRYPKLSEVVIDLAKKCLHIDPDKRPFCAELLHH 307 (331)
T ss_dssp HHHHHHHHHCGGGTTCCCCCCSSCCCHHHHSTTSCHHHHHHHHHHTCSSGGGSCCGGGGGGS
T ss_pred hhhhhHhhhccccccccCccccccchhhhcccchhHHHHHHHHHHhccCcccCCCHHHHhcC
Confidence 000001111111111111112233567889999999999999999999999987
|
| >2nru_A Interleukin-1 receptor-associated kinase 4; inhibitor, IRAK, transferase; HET: TPO SEP T12; 2.00A {Homo sapiens} PDB: 2nry_A* 2oib_A* 2oic_A* 2oid_A* 2o8y_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.3e-45 Score=310.41 Aligned_cols=277 Identities=30% Similarity=0.505 Sum_probs=213.9
Q ss_pred CChHHHHHHhCCCCCC------ceeecCCcceEEEEEeCCCcEEEEEEeccCc--CChhhhHHHHHHHHHHHhcCCccee
Q 038766 2 FDRTEIENATGSFSEN------NIIGNSNLSTVYKGRLEDGEIVAVKKLNFHQ--FSAESDKSFYREAKTLKELKHRNLV 73 (299)
Q Consensus 2 ~~~~~~~~~~~~y~~~------~~lg~g~~~~v~~~~~~~~~~~~vK~~~~~~--~~~~~~~~~~~e~~~l~~l~h~~i~ 73 (299)
|+..+++.+.+.|... +.||+|++|+||++.. +++.+|+|++.... ......+.+.+|+..++.++||||+
T Consensus 15 ~~~~~l~~~~~~f~~~~~~~~~~~lg~G~~g~Vy~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~ 93 (307)
T 2nru_A 15 FSFYELKNVTNNFDERPISVGGNKMGEGGFGVVYKGYV-NNTTVAVKKLAAMVDITTEELKQQFDQEIKVMAKCQHENLV 93 (307)
T ss_dssp CCHHHHHHHTTTTCCSBTTTTCCEEEECSSEEEEEEES-SSCEEEEEEECCCTTSCTTTHHHHHHHHHHHHHHCCCTTBC
T ss_pred ccHHHHHHHHcccccccccccCCccccCCCeEEEEEEE-CCceEEEEEEecccCcchHHHHHHHHHHHHHHHhcCCCCeE
Confidence 7888999999998877 9999999999999987 47899999986432 2334467889999999999999999
Q ss_pred eeeeEEEcCCCeeEEEEeecCCCChHHHhcCCCCCCCCCChhhHHHHHHHHHHHHHHhhcCCCCCeeeecccCCceeeCC
Q 038766 74 KVLGYAWESGKLKALILEYMENGSLESVIHGPGVDHSRWTLPKRIDVLISVANGLDYLHSGYDIPIVHCDMKPSNILLDR 153 (299)
Q Consensus 74 ~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lh~~~~~~~~H~dl~~~nil~~~ 153 (299)
++++++.. +...++|+||+.+++|.+++.... ...++++..++.++.|++.||.|||+. +++|+||||+||+++.
T Consensus 94 ~~~~~~~~-~~~~~lv~e~~~~~~L~~~l~~~~-~~~~~~~~~~~~i~~~i~~~l~~lH~~---~i~H~dlkp~Nili~~ 168 (307)
T 2nru_A 94 ELLGFSSD-GDDLCLVYVYMPNGSLLDRLSCLD-GTPPLSWHMRCKIAQGAANGINFLHEN---HHIHRDIKSANILLDE 168 (307)
T ss_dssp CEEEEECS-SSSCEEEEECCTTCBHHHHHHTGG-GCCCCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCCGGGEEECT
T ss_pred EEEEEEec-CCceEEEEEecCCCcHHHHHHhcc-CCCCCCHHHHHHHHHHHHHHHHHHhcC---CeecCCCCHHHEEEcC
Confidence 99996655 445699999999999999886432 345689999999999999999999999 9999999999999999
Q ss_pred CCcEEEeeeccccccccccccccccccccccCcccCChhhhcccCcCccccchhhhHHHHHHHhCCCCCCCCccCCCCch
Q 038766 154 DFEAHVSDFGTSRMLDVHLQDLSSLSTAFQGTIGYLAPEFAYMRIVTTKVDVFSFGIVVMEFLTKRRPTGLDEENGLSPI 233 (299)
Q Consensus 154 ~~~v~l~df~~~~~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~DiwslG~~l~~l~~g~~p~~~~~~~~~~~~ 233 (299)
++.++|+|||++........ ........+++.|+|||.+.+ .++.++||||||+++|+|++|..||..........
T Consensus 169 ~~~~kl~Dfg~~~~~~~~~~--~~~~~~~~g~~~y~aPE~~~~-~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~- 244 (307)
T 2nru_A 169 AFTAKISDFGLARASEKFAQ--TVMTSRIVGTTAYMAPEALRG-EITPKSDIYSFGVVLLEIITGLPAVDEHREPQLLL- 244 (307)
T ss_dssp TCCEEECCCTTCEECCSCSS--CEECSSCCSCGGGCCHHHHTT-EECTHHHHHHHHHHHHHHHHCCCSBCTTBSSSBTT-
T ss_pred CCcEEEeecccccccccccc--cccccccCCCcCcCChHHhcC-CCCccchhHHHHHHHHHHHHCCCCcccCcchHHHH-
Confidence 99999999999876542111 112234567899999998875 47899999999999999999999997543322111
Q ss_pred hHHHHHHHHHhcCccCcccccCccccchhhHhHHHHHHHHHHHHHHHHhcCCCCCCCCChhhhhc
Q 038766 234 SLRQLVEKALANGINGVRQITDPKLVSSIYEEQEQHQVLEELFKLALVCTSSNPEDRPNMNELLI 298 (299)
Q Consensus 234 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rpt~~~il~ 298 (299)
.+.. . ............+.... ......+..+.+++.+||..||++|||++++++
T Consensus 245 ~~~~---~-~~~~~~~~~~~~~~~~~------~~~~~~~~~l~~li~~cl~~~p~~Rps~~~l~~ 299 (307)
T 2nru_A 245 DIKE---E-IEDEEKTIEDYIDKKMN------DADSTSVEAMYSVASQCLHEKKNKRPDIKKVQQ 299 (307)
T ss_dssp HHHH---H-HHTTSCCHHHHSCSSCS------CCCHHHHHHHHHHHHHHTCSSTTTSCCHHHHHH
T ss_pred HHHH---H-hhhhhhhhhhhcccccc------ccchHHHHHHHHHHHHHcCCCcccCcCHHHHHH
Confidence 1111 1 11111111111111111 114456788999999999999999999999986
|
| >2a2a_A Death-associated protein kinase 2; autoinhibition, transferase; 1.47A {Homo sapiens} PDB: 2cke_A* 1wmk_A 1z9x_A 2a27_A 2x0g_A 2xuu_A* 2w4k_A* 2xzs_A | Back alignment and structure |
|---|
Probab=100.00 E-value=5.3e-46 Score=316.29 Aligned_cols=256 Identities=20% Similarity=0.272 Sum_probs=207.2
Q ss_pred HHhCCCCCCceeecCCcceEEEEEeC-CCcEEEEEEeccCcCCh----hhhHHHHHHHHHHHhcCCcceeeeeeEEEcCC
Q 038766 9 NATGSFSENNIIGNSNLSTVYKGRLE-DGEIVAVKKLNFHQFSA----ESDKSFYREAKTLKELKHRNLVKVLGYAWESG 83 (299)
Q Consensus 9 ~~~~~y~~~~~lg~g~~~~v~~~~~~-~~~~~~vK~~~~~~~~~----~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~ 83 (299)
.+.++|.+.+.||+|+||.||++.+. +|+.||+|++....... ...+.+.+|+.+++.++||||+++++++.. +
T Consensus 9 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~-~ 87 (321)
T 2a2a_A 9 KVEDFYDIGEELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVSREEIEREVSILRQVLHHNVITLHDVYEN-R 87 (321)
T ss_dssp CHHHHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEBCSSSSCSSSBCHHHHHHHHHHHHHCCCTTBCCEEEEEEC-S
T ss_pred hhhccEEEeeEeeecCCEEEEEEEECCCCeEEEEEEEecccccccccchhHHHHHHHHHHHHhCCCCCcceEEEEEec-C
Confidence 46778999999999999999999875 58999999997543322 236778999999999999999999996654 5
Q ss_pred CeeEEEEeecCCCChHHHhcCCCCCCCCCChhhHHHHHHHHHHHHHHhhcCCCCCeeeecccCCceeeCCCC----cEEE
Q 038766 84 KLKALILEYMENGSLESVIHGPGVDHSRWTLPKRIDVLISVANGLDYLHSGYDIPIVHCDMKPSNILLDRDF----EAHV 159 (299)
Q Consensus 84 ~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lh~~~~~~~~H~dl~~~nil~~~~~----~v~l 159 (299)
...++|+||+.+++|.+++. ....+++..++.++.|++.||+|||+. +++|+||||+||+++.++ .++|
T Consensus 88 ~~~~lv~e~~~~~~L~~~l~----~~~~~~~~~~~~i~~qi~~aL~~lH~~---~ivH~dikp~NIl~~~~~~~~~~~kl 160 (321)
T 2a2a_A 88 TDVVLILELVSGGELFDFLA----QKESLSEEEATSFIKQILDGVNYLHTK---KIAHFDLKPENIMLLDKNIPIPHIKL 160 (321)
T ss_dssp SEEEEEECCCCSCBHHHHHH----TCSCEEHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEESCTTSSSCCEEE
T ss_pred CEEEEEEEcCCCCcHHHHHH----hcCCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCChHHEEEecCCCCcCCEEE
Confidence 56799999999999999997 456799999999999999999999999 999999999999999887 7999
Q ss_pred eeeccccccccccccccccccccccCcccCChhhhcccCcCccccchhhhHHHHHHHhCCCCCCCCccCCCCchhHHHHH
Q 038766 160 SDFGTSRMLDVHLQDLSSLSTAFQGTIGYLAPEFAYMRIVTTKVDVFSFGIVVMEFLTKRRPTGLDEENGLSPISLRQLV 239 (299)
Q Consensus 160 ~df~~~~~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~DiwslG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~ 239 (299)
+|||++..... ........+++.|+|||.+.+..++.++||||||+++|+|++|..||.... . .+.+
T Consensus 161 ~Dfg~~~~~~~-----~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~-----~---~~~~ 227 (321)
T 2a2a_A 161 IDFGLAHEIED-----GVEFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGDT-----K---QETL 227 (321)
T ss_dssp CCCTTCEECCT-----TCCCCCCCSCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSCCSSCCSS-----H---HHHH
T ss_pred ccCccceecCc-----cccccccCCCCCccCcccccCCCCCCccccHHHHHHHHHHHHCCCCCCCCC-----H---HHHH
Confidence 99999976542 122234568899999999999999999999999999999999999995431 1 1122
Q ss_pred HHHHhcCccCcccccCccccchhhHhHHHHHHHHHHHHHHHHhcCCCCCCCCChhhhhcC
Q 038766 240 EKALANGINGVRQITDPKLVSSIYEEQEQHQVLEELFKLALVCTSSNPEDRPNMNELLIT 299 (299)
Q Consensus 240 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rpt~~~il~~ 299 (299)
........ . . .......++..+.++|++||..||++|||++++++|
T Consensus 228 ~~i~~~~~-~---~----------~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~e~l~h 273 (321)
T 2a2a_A 228 ANITSVSY-D---F----------DEEFFSHTSELAKDFIRKLLVKETRKRLTIQEALRH 273 (321)
T ss_dssp HHHHTTCC-C---C----------CHHHHTTCCHHHHHHHHTTSCSSTTTSCCHHHHHHS
T ss_pred HHHHhccc-c---c----------ChhhhcccCHHHHHHHHHHcCCChhhCcCHHHHhcC
Confidence 21111100 0 0 011123456789999999999999999999999987
|
| >3uc3_A Serine/threonine-protein kinase SRK2I; SNRK2, ABA signaling, transferase; 1.90A {Arabidopsis thaliana} PDB: 3zut_A 3zuu_A 3uc4_A 3ujg_A 3udb_A | Back alignment and structure |
|---|
Probab=100.00 E-value=5.7e-46 Score=320.70 Aligned_cols=254 Identities=26% Similarity=0.325 Sum_probs=194.8
Q ss_pred HhCCCCCCceeecCCcceEEEEEeC-CCcEEEEEEeccCcCChhhhHHHHHHHHHHHhcCCcceeeeeeEEEcCCCeeEE
Q 038766 10 ATGSFSENNIIGNSNLSTVYKGRLE-DGEIVAVKKLNFHQFSAESDKSFYREAKTLKELKHRNLVKVLGYAWESGKLKAL 88 (299)
Q Consensus 10 ~~~~y~~~~~lg~g~~~~v~~~~~~-~~~~~~vK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~l 88 (299)
..++|.+.+.||+|+||+||++.+. +++.||+|++.... ...+.+.+|+..++.++||||+++++++.. ....++
T Consensus 18 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~---~~~~~~~~E~~~l~~l~hpniv~~~~~~~~-~~~~~l 93 (361)
T 3uc3_A 18 DSDRYDFVKDIGSGNFGVARLMRDKLTKELVAVKYIERGA---AIDENVQREIINHRSLRHPNIVRFKEVILT-PTHLAI 93 (361)
T ss_dssp CTTTEEEEEEESSSTTSSEEEEEETTTCCEEEEEEEESST---TSCHHHHHHHHHHHHCCCTTBCCEEEEEEC-SSEEEE
T ss_pred CCCcEEEEEEeccCCCEEEEEEEECCCCcEEEEEEEecCc---cccHHHHHHHHHHHhCCCCCCCcEEEEEee-CCEEEE
Confidence 4579999999999999999999875 68999999986432 334678899999999999999999997665 556699
Q ss_pred EEeecCCCChHHHhcCCCCCCCCCChhhHHHHHHHHHHHHHHhhcCCCCCeeeecccCCceeeCCCCc--EEEeeecccc
Q 038766 89 ILEYMENGSLESVIHGPGVDHSRWTLPKRIDVLISVANGLDYLHSGYDIPIVHCDMKPSNILLDRDFE--AHVSDFGTSR 166 (299)
Q Consensus 89 v~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lh~~~~~~~~H~dl~~~nil~~~~~~--v~l~df~~~~ 166 (299)
|+||+.+++|.+++. ...++++..++.++.|++.||+|||++ +++||||||+||+++.++. +||+|||++.
T Consensus 94 v~e~~~~~~L~~~l~----~~~~~~~~~~~~i~~ql~~~L~~LH~~---~ivH~Dlkp~Nill~~~~~~~~kl~Dfg~a~ 166 (361)
T 3uc3_A 94 IMEYASGGELYERIC----NAGRFSEDEARFFFQQLLSGVSYCHSM---QICHRDLKLENTLLDGSPAPRLKICDFGYSK 166 (361)
T ss_dssp EEECCCSCBHHHHHH----HHSSCCHHHHHHHHHHHHHHHHHHHHT---TCCSCCCCGGGEEECSSSSCCEEECCCCCC-
T ss_pred EEEeCCCCCHHHHHH----hcCCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCHHHEEEcCCCCceEEEeecCccc
Confidence 999999999999986 445799999999999999999999999 9999999999999987765 9999999986
Q ss_pred ccccccccccccccccccCcccCChhhhcccCcCcc-ccchhhhHHHHHHHhCCCCCCCCccCCCCchhHHHHHHHHHhc
Q 038766 167 MLDVHLQDLSSLSTAFQGTIGYLAPEFAYMRIVTTK-VDVFSFGIVVMEFLTKRRPTGLDEENGLSPISLRQLVEKALAN 245 (299)
Q Consensus 167 ~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~-~DiwslG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~ 245 (299)
.... ........+|+.|+|||++.+..++.+ +|||||||++|+|++|..||....... .....+......
T Consensus 167 ~~~~-----~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~----~~~~~~~~~~~~ 237 (361)
T 3uc3_A 167 SSVL-----HSQPKSTVGTPAYIAPEVLLRQEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPR----DYRKTIQRILSV 237 (361)
T ss_dssp -------------------CTTSCHHHHHCSSCCHHHHHHHHHHHHHHHHHHSSCSCC----CC----CHHHHHHHHHTT
T ss_pred cccc-----cCCCCCCcCCCCcCChhhhcCCCCCCCeeeeehhHHHHHHHHhCCCCCCCCccHH----HHHHHHHHHhcC
Confidence 4321 122344568999999999988877665 899999999999999999996442221 222222222211
Q ss_pred CccCcccccCccccchhhHhHHHHHHHHHHHHHHHHhcCCCCCCCCChhhhhcC
Q 038766 246 GINGVRQITDPKLVSSIYEEQEQHQVLEELFKLALVCTSSNPEDRPNMNELLIT 299 (299)
Q Consensus 246 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rpt~~~il~~ 299 (299)
.. .+.. ...++.++.+||++||..||++|||++++++|
T Consensus 238 ~~----~~~~------------~~~~s~~~~~li~~~L~~dP~~Rps~~ell~h 275 (361)
T 3uc3_A 238 KY----SIPD------------DIRISPECCHLISRIFVADPATRISIPEIKTH 275 (361)
T ss_dssp CC----CCCT------------TSCCCHHHHHHHHHHSCSCTTTSCCHHHHHTS
T ss_pred CC----CCCC------------cCCCCHHHHHHHHHHccCChhHCcCHHHHHhC
Confidence 10 0000 11234678999999999999999999999987
|
| >3hko_A Calcium/calmodulin-dependent protein kinase with domain and 2 calmodulin-like EF...; structural genomics, protist parasite; HET: ANP; 1.80A {Cryptosporidium parvum iowa II} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-46 Score=323.43 Aligned_cols=268 Identities=19% Similarity=0.199 Sum_probs=204.8
Q ss_pred HHHHHhCCCCCCceeecCCcceEEEEEe-CCCcEEEEEEeccCc---CChhhhHHHHHHHHHHHhcCCcceeeeeeEEEc
Q 038766 6 EIENATGSFSENNIIGNSNLSTVYKGRL-EDGEIVAVKKLNFHQ---FSAESDKSFYREAKTLKELKHRNLVKVLGYAWE 81 (299)
Q Consensus 6 ~~~~~~~~y~~~~~lg~g~~~~v~~~~~-~~~~~~~vK~~~~~~---~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~ 81 (299)
++..+.++|.+.+.||+|+||+||++.+ .++..||+|++.... ......+.+.+|+.+++.++||||+++++++..
T Consensus 20 ~~~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~ 99 (345)
T 3hko_A 20 SLLELQKKYHLKGAIGQGSYGVVRVAIENQTRAIRAIKIMNKNKIRQINPKDVERIKTEVRLMKKLHHPNIARLYEVYED 99 (345)
T ss_dssp CHHHHHHHEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHC---CHHHHHHHHHHHHHHCCCTTBCCEEEEEEC
T ss_pred hhhhhhhheeecceeeecCCeEEEEEEECCCCceEEEeehhhhhhcccCHHHHHHHHHHHHHHHhCCCCCcceeehhhcc
Confidence 4567889999999999999999999987 458899999986432 234556789999999999999999999997655
Q ss_pred CCCeeEEEEeecCCCChHHHhcCCCC------------------------------------CCCCCChhhHHHHHHHHH
Q 038766 82 SGKLKALILEYMENGSLESVIHGPGV------------------------------------DHSRWTLPKRIDVLISVA 125 (299)
Q Consensus 82 ~~~~~~lv~e~~~~~~L~~~~~~~~~------------------------------------~~~~~~~~~~~~i~~qi~ 125 (299)
+...++|+||+.+++|.+++..... ....+++..++.++.|++
T Consensus 100 -~~~~~lv~e~~~gg~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~ 178 (345)
T 3hko_A 100 -EQYICLVMELCHGGHLLDKLNVFIDDSTGKCAMDVVKTQICPCPECNEEAINGSIHGFRESLDFVQREKLISNIMRQIF 178 (345)
T ss_dssp -SSEEEEEEECCCSCBHHHHEEEEEETTTTEEEEEEECCCCCCSHHHHHHHHHSCC--CEEECCHHHHHHHHHHHHHHHH
T ss_pred -CCeEEEEEeCCCCCcHHHHHHHhhcccccccccccccccccccccccccccccccccccccccccccHHHHHHHHHHHH
Confidence 5667999999999999998852110 122457888999999999
Q ss_pred HHHHHhhcCCCCCeeeecccCCceeeCCCC--cEEEeeeccccccccccccccccccccccCcccCChhhhcc--cCcCc
Q 038766 126 NGLDYLHSGYDIPIVHCDMKPSNILLDRDF--EAHVSDFGTSRMLDVHLQDLSSLSTAFQGTIGYLAPEFAYM--RIVTT 201 (299)
Q Consensus 126 ~~l~~lh~~~~~~~~H~dl~~~nil~~~~~--~v~l~df~~~~~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~--~~~~~ 201 (299)
.||+|||+. +++|+||||+||+++.++ .++|+|||++..+...............+++.|+|||.+.+ ..++.
T Consensus 179 ~~l~~LH~~---~ivH~Dlkp~NIll~~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~ 255 (345)
T 3hko_A 179 SALHYLHNQ---GICHRDIKPENFLFSTNKSFEIKLVDFGLSKEFYKLNNGEYYGMTTKAGTPYFVAPEVLNTTNESYGP 255 (345)
T ss_dssp HHHHHHHHT---TEECCCCCGGGEEESCSSSCCEEECCCTTCEEGGGTTCC--------CCCGGGCCHHHHTCSSSCCCT
T ss_pred HHHHHHHHC---CccccCCChhhEEEecCCCceEEEeeccccccccccCccccccccccCCCccccCchhhccCCCCCCc
Confidence 999999999 999999999999998776 89999999998654322222223345668999999999875 67889
Q ss_pred cccchhhhHHHHHHHhCCCCCCCCccCCCCchhHHHHHHHHHhcCccCcccccCccccchhhHhHHHHHHHHHHHHHHHH
Q 038766 202 KVDVFSFGIVVMEFLTKRRPTGLDEENGLSPISLRQLVEKALANGINGVRQITDPKLVSSIYEEQEQHQVLEELFKLALV 281 (299)
Q Consensus 202 ~~DiwslG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~ 281 (299)
++||||||+++|+|++|..||..... .+......... .....+. ...++..+.++|.+
T Consensus 256 ~~DiwslG~il~el~~g~~pf~~~~~--------~~~~~~~~~~~----~~~~~~~----------~~~~~~~~~~li~~ 313 (345)
T 3hko_A 256 KCDAWSAGVLLHLLLMGAVPFPGVND--------ADTISQVLNKK----LCFENPN----------YNVLSPLARDLLSN 313 (345)
T ss_dssp HHHHHHHHHHHHHHHHSSCSSCCSSH--------HHHHHHHHHCC----CCTTSGG----------GGGSCHHHHHHHHH
T ss_pred HHHHHHHHHHHHHHHHCCCCCCCCCh--------HHHHHHHHhcc----cccCCcc----------cccCCHHHHHHHHH
Confidence 99999999999999999999954321 12222222211 0111111 22345689999999
Q ss_pred hcCCCCCCCCChhhhhcC
Q 038766 282 CTSSNPEDRPNMNELLIT 299 (299)
Q Consensus 282 ~l~~dP~~Rpt~~~il~~ 299 (299)
||..||++|||+.++|+|
T Consensus 314 ~l~~~p~~Rps~~~~l~h 331 (345)
T 3hko_A 314 LLNRNVDERFDAMRALQH 331 (345)
T ss_dssp HSCSCTTTSCCHHHHHHS
T ss_pred HcCCChhHCCCHHHHhcC
Confidence 999999999999999987
|
| >4eqm_A Protein kinase; transferase; HET: ANP; 3.00A {Staphylococcus aureus subsp} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-47 Score=321.38 Aligned_cols=257 Identities=25% Similarity=0.372 Sum_probs=199.5
Q ss_pred HHhCCCCCCceeecCCcceEEEEEeC-CCcEEEEEEeccCcC-ChhhhHHHHHHHHHHHhcCCcceeeeeeEEEcCCCee
Q 038766 9 NATGSFSENNIIGNSNLSTVYKGRLE-DGEIVAVKKLNFHQF-SAESDKSFYREAKTLKELKHRNLVKVLGYAWESGKLK 86 (299)
Q Consensus 9 ~~~~~y~~~~~lg~g~~~~v~~~~~~-~~~~~~vK~~~~~~~-~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~ 86 (299)
.+.++|++.+.||+|+||+||++.+. ++..||+|++..... .....+.+.+|+..++.++||||+++++++.. ++..
T Consensus 8 ~~~~~y~i~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~hp~iv~~~~~~~~-~~~~ 86 (294)
T 4eqm_A 8 IINERYKIVDKLGGGGMSTVYLAEDTILNIKVAIKAIFIPPREKEETLKRFEREVHNSSQLSHQNIVSMIDVDEE-DDCY 86 (294)
T ss_dssp CEETTEEEEEEEEEETTEEEEEEEETTTCSEEEEEEEECCSSCCHHHHHHHHHHHHHHTTCCBTTBCCEEEEEEC-SSEE
T ss_pred HhhccEEEEEEEccCCCEEEEEEEECCCCCeEEEEEeccCccccHHHHHHHHHHHHHHhcCCCCCCceEEEeeee-CCeE
Confidence 45789999999999999999999864 589999999865433 34446788999999999999999999996654 5667
Q ss_pred EEEEeecCCCChHHHhcCCCCCCCCCChhhHHHHHHHHHHHHHHhhcCCCCCeeeecccCCceeeCCCCcEEEeeecccc
Q 038766 87 ALILEYMENGSLESVIHGPGVDHSRWTLPKRIDVLISVANGLDYLHSGYDIPIVHCDMKPSNILLDRDFEAHVSDFGTSR 166 (299)
Q Consensus 87 ~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lh~~~~~~~~H~dl~~~nil~~~~~~v~l~df~~~~ 166 (299)
++|+||+++++|.+++. ...++++..++.++.|++.||+|||++ +++|+||||+||+++.++.++|+|||++.
T Consensus 87 ~lv~e~~~g~~L~~~l~----~~~~~~~~~~~~~~~qi~~~l~~lH~~---~i~H~Dlkp~Nil~~~~~~~kl~Dfg~~~ 159 (294)
T 4eqm_A 87 YLVMEYIEGPTLSEYIE----SHGPLSVDTAINFTNQILDGIKHAHDM---RIVHRDIKPQNILIDSNKTLKIFDFGIAK 159 (294)
T ss_dssp EEEEECCCSCBHHHHHH----HHCSCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEECTTSCEEECCCSSST
T ss_pred EEEEeCCCCCCHHHHHH----hcCCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCHHHEEECCCCCEEEEeCCCcc
Confidence 99999999999999997 445799999999999999999999999 99999999999999999999999999997
Q ss_pred ccccccccccccccccccCcccCChhhhcccCcCccccchhhhHHHHHHHhCCCCCCCCccCCCCchhHHHHHHHHHhcC
Q 038766 167 MLDVHLQDLSSLSTAFQGTIGYLAPEFAYMRIVTTKVDVFSFGIVVMEFLTKRRPTGLDEENGLSPISLRQLVEKALANG 246 (299)
Q Consensus 167 ~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~DiwslG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~ 246 (299)
.... ..........+++.|+|||.+.+..++.++||||||+++|+|++|..||..... ...........
T Consensus 160 ~~~~---~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~~l~~ll~g~~pf~~~~~--------~~~~~~~~~~~ 228 (294)
T 4eqm_A 160 ALSE---TSLTQTNHVLGTVQYFSPEQAKGEATDECTDIYSIGIVLYEMLVGEPPFNGETA--------VSIAIKHIQDS 228 (294)
T ss_dssp TC----------------CCSSCCHHHHHTCCCCTTHHHHHHHHHHHHHHHSSCSSCSSCH--------HHHHHHHHSSC
T ss_pred cccc---ccccccCccccCccccCHhHhcCCCCCchHhHHHHHHHHHHHHhCCCCCCCCCh--------HHHHHHHhhcc
Confidence 6542 111223345689999999999999999999999999999999999999954311 11111111111
Q ss_pred ccCcccccCccccchhhHhHHHHHHHHHHHHHHHHhcCCCCCCCC-Chhhhh
Q 038766 247 INGVRQITDPKLVSSIYEEQEQHQVLEELFKLALVCTSSNPEDRP-NMNELL 297 (299)
Q Consensus 247 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rp-t~~~il 297 (299)
.+.. .......+++.+.++|.+||..||++|| +++++.
T Consensus 229 ~~~~-------------~~~~~~~~~~~l~~li~~~l~~dp~~R~~~~~~l~ 267 (294)
T 4eqm_A 229 VPNV-------------TTDVRKDIPQSLSNVILRATEKDKANRYKTIQEMK 267 (294)
T ss_dssp CCCH-------------HHHSCTTSCHHHHHHHHHHSCSSGGGSCSSHHHHH
T ss_pred CCCc-------------chhcccCCCHHHHHHHHHHhcCCHhHccccHHHHH
Confidence 0000 0011234567899999999999999999 555554
|
| >2y94_A 5'-AMP-activated protein kinase catalytic subunit; transferase, nucleotide-binding, staurosporine-binding, serine/threonine-protein kinase; HET: TPO STU AMP; 3.24A {Rattus norvegicus} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-46 Score=333.19 Aligned_cols=251 Identities=24% Similarity=0.365 Sum_probs=204.7
Q ss_pred HhCCCCCCceeecCCcceEEEEEeC-CCcEEEEEEeccCcCC-hhhhHHHHHHHHHHHhcCCcceeeeeeEEEcCCCeeE
Q 038766 10 ATGSFSENNIIGNSNLSTVYKGRLE-DGEIVAVKKLNFHQFS-AESDKSFYREAKTLKELKHRNLVKVLGYAWESGKLKA 87 (299)
Q Consensus 10 ~~~~y~~~~~lg~g~~~~v~~~~~~-~~~~~~vK~~~~~~~~-~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~ 87 (299)
..++|.+.+.||+|+||.||+|.+. +|+.||+|++...... ......+.+|+.+++.++||||+++++++.. ....+
T Consensus 14 ~~~~Y~l~~~LG~G~fg~V~~a~~~~~g~~vAvK~i~~~~~~~~~~~~~~~~Ei~~l~~l~HpnIv~l~~~~~~-~~~~~ 92 (476)
T 2y94_A 14 KIGHYILGDTLGVGTFGKVKVGKHELTGHKVAVKILNRQKIRSLDVVGKIRREIQNLKLFRHPHIIKLYQVIST-PSDIF 92 (476)
T ss_dssp EETTEEEEEEEECCSSSCEEEEEETTTCCEEEEEEEEHHHHHHTTTHHHHHHHHHHHTTCCCTTBCCEEEEEEC-SSEEE
T ss_pred eecCEEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEEhhhccCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEE-CCEEE
Confidence 4678999999999999999999875 6999999998643221 2335678899999999999999999997655 55679
Q ss_pred EEEeecCCCChHHHhcCCCCCCCCCChhhHHHHHHHHHHHHHHhhcCCCCCeeeecccCCceeeCCCCcEEEeeeccccc
Q 038766 88 LILEYMENGSLESVIHGPGVDHSRWTLPKRIDVLISVANGLDYLHSGYDIPIVHCDMKPSNILLDRDFEAHVSDFGTSRM 167 (299)
Q Consensus 88 lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lh~~~~~~~~H~dl~~~nil~~~~~~v~l~df~~~~~ 167 (299)
+|+||+.+++|.+++. ....+++.+++.++.||+.||+|||++ +++||||||+||+++.++.+||+|||++..
T Consensus 93 lv~E~~~gg~L~~~l~----~~~~l~~~~~~~i~~qi~~aL~~LH~~---givHrDLkp~NIll~~~~~vkL~DFG~a~~ 165 (476)
T 2y94_A 93 MVMEYVSGGELFDYIC----KNGRLDEKESRRLFQQILSGVDYCHRH---MVVHRDLKPENVLLDAHMNAKIADFGLSNM 165 (476)
T ss_dssp EEEECCSSEEHHHHTT----SSSSCCHHHHHHHHHHHHHHHHHHHTT---TEECSCCSGGGEEECTTCCEEECCCSSCEE
T ss_pred EEEeCCCCCcHHHHHH----hcCCCCHHHHHHHHHHHHHHHHHHHHC---CCCcccccHHHEEEecCCCeEEEeccchhh
Confidence 9999999999999997 456799999999999999999999999 999999999999999999999999999976
Q ss_pred cccccccccccccccccCcccCChhhhcccCc-CccccchhhhHHHHHHHhCCCCCCCCccCCCCchhHHHHHHHHHhcC
Q 038766 168 LDVHLQDLSSLSTAFQGTIGYLAPEFAYMRIV-TTKVDVFSFGIVVMEFLTKRRPTGLDEENGLSPISLRQLVEKALANG 246 (299)
Q Consensus 168 ~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~-~~~~DiwslG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~ 246 (299)
... ........+++.|+|||++.+..+ +.++|||||||++|+|++|..||.... .. ..........
T Consensus 166 ~~~-----~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGvil~elltG~~Pf~~~~-----~~---~~~~~i~~~~ 232 (476)
T 2y94_A 166 MSD-----GEFLRTSCGSPNYAAPEVISGRLYAGPEVDIWSSGVILYALLCGTLPFDDDH-----VP---TLFKKICDGI 232 (476)
T ss_dssp CCT-----TCCBCCCCSCSTTCCHHHHTTCCBCSHHHHHHHHHHHHHHHHHSSCSSCCSS-----SH---HHHHHHHTTC
T ss_pred ccc-----cccccccCCCcCeEChhhccCCCCCCCcceehhhHHHHHHHhhCCCCCCCCC-----HH---HHHHHHhcCC
Confidence 542 222344568999999999988765 679999999999999999999995432 11 2222221111
Q ss_pred ccCcccccCccccchhhHhHHHHHHHHHHHHHHHHhcCCCCCCCCChhhhhcC
Q 038766 247 INGVRQITDPKLVSSIYEEQEQHQVLEELFKLALVCTSSNPEDRPNMNELLIT 299 (299)
Q Consensus 247 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rpt~~~il~~ 299 (299)
. .. +..++.++.+||++||..||++|||++++++|
T Consensus 233 -~-----~~------------p~~~s~~~~~Li~~~L~~dP~~Rpt~~eil~h 267 (476)
T 2y94_A 233 -F-----YT------------PQYLNPSVISLLKHMLQVDPMKRATIKDIREH 267 (476)
T ss_dssp -C-----CC------------CTTCCHHHHHHHHHHTCSSTTTSCCHHHHHTC
T ss_pred -c-----CC------------CccCCHHHHHHHHHHcCCCchhCcCHHHHHhC
Confidence 0 00 11234578999999999999999999999987
|
| >3vhe_A Vascular endothelial growth factor receptor 2; kinase domain, kinase, transferase-transferase inhibitor COM; HET: 42Q; 1.55A {Homo sapiens} PDB: 1y6a_A* 1y6b_A* 3vhk_A* 3vid_A* 3hng_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=8.7e-47 Score=325.89 Aligned_cols=268 Identities=22% Similarity=0.329 Sum_probs=212.0
Q ss_pred CChHHHHHHhCCCCCCceeecCCcceEEEEEe------CCCcEEEEEEeccCcCChhhhHHHHHHHHHHHhc-CCcceee
Q 038766 2 FDRTEIENATGSFSENNIIGNSNLSTVYKGRL------EDGEIVAVKKLNFHQFSAESDKSFYREAKTLKEL-KHRNLVK 74 (299)
Q Consensus 2 ~~~~~~~~~~~~y~~~~~lg~g~~~~v~~~~~------~~~~~~~vK~~~~~~~~~~~~~~~~~e~~~l~~l-~h~~i~~ 74 (299)
|+..+++.-.++|.+.+.||+|+||.||++.+ .+++.||+|++... ......+.+.+|+++++++ .||||++
T Consensus 12 ~~~~~~~~~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~-~~~~~~~~~~~E~~~l~~l~~hpniv~ 90 (359)
T 3vhe_A 12 YDASKWEFPRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEG-ATHSEHRALMSELKILIHIGHHLNVVN 90 (359)
T ss_dssp CCHHHHBCCGGGEEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTT-CCHHHHHHHHHHHHHHHHHCCCTTBCC
T ss_pred CCcccccccccceeeceeecCCCCceEEEEEeccccccccceEEEEEEecCc-CCHHHHHHHHHHHHHHHhhcCCcceee
Confidence 56778889999999999999999999999973 24688999999643 3444567789999999999 6899999
Q ss_pred eeeEEEcCCCeeEEEEeecCCCChHHHhcCCCCC----------------------------------------------
Q 038766 75 VLGYAWESGKLKALILEYMENGSLESVIHGPGVD---------------------------------------------- 108 (299)
Q Consensus 75 ~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~---------------------------------------------- 108 (299)
+++++...+...++|+||+.+++|.+++......
T Consensus 91 ~~~~~~~~~~~~~iv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 170 (359)
T 3vhe_A 91 LLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKTKGARFRQGKDYVGAIPVDLKRRLDSITSSQSSASSGFVEE 170 (359)
T ss_dssp EEEEECSTTSCCEEEEECCTTEEHHHHHHTTTTSBCSCC-----------------------------------------
T ss_pred eeeeeecCCCceEEEEEecCCCcHHHHHHhccccccccccccchhhcccccccccchhhhccccccCccccccccccccc
Confidence 9998877677679999999999999998754211
Q ss_pred ----------------CCCCChhhHHHHHHHHHHHHHHhhcCCCCCeeeecccCCceeeCCCCcEEEeeecccccccccc
Q 038766 109 ----------------HSRWTLPKRIDVLISVANGLDYLHSGYDIPIVHCDMKPSNILLDRDFEAHVSDFGTSRMLDVHL 172 (299)
Q Consensus 109 ----------------~~~~~~~~~~~i~~qi~~~l~~lh~~~~~~~~H~dl~~~nil~~~~~~v~l~df~~~~~~~~~~ 172 (299)
...+++..++.++.|++.||+|||++ +++|+||||+||+++.++.++|+|||++......
T Consensus 171 ~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~ql~~aL~~LH~~---~ivH~Dikp~NIll~~~~~~kl~Dfg~a~~~~~~- 246 (359)
T 3vhe_A 171 KSLSDVEEEEAPEDLYKDFLTLEHLICYSFQVAKGMEFLASR---KCIHRDLAARNILLSEKNVVKICDFGLARDIYKD- 246 (359)
T ss_dssp -------------CTTTTCBCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEECGGGCEEECCCGGGSCTTSC-
T ss_pred cccchhhhcccccchhccccCHHHHHHHHHHHHHHHHHHHHC---CcccCCCChhhEEEcCCCcEEEEeccceeeeccc-
Confidence 12289999999999999999999999 9999999999999999999999999999755321
Q ss_pred ccccccccccccCcccCChhhhcccCcCccccchhhhHHHHHHHh-CCCCCCCCccCCCCchhHHHHHHHHHhcCccCcc
Q 038766 173 QDLSSLSTAFQGTIGYLAPEFAYMRIVTTKVDVFSFGIVVMEFLT-KRRPTGLDEENGLSPISLRQLVEKALANGINGVR 251 (299)
Q Consensus 173 ~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~DiwslG~~l~~l~~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 251 (299)
..........+++.|+|||++.+..++.++||||||+++|+|++ |..||...... ..+...+ .......
T Consensus 247 -~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~----~~~~~~~---~~~~~~~-- 316 (359)
T 3vhe_A 247 -PDYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKID----EEFCRRL---KEGTRMR-- 316 (359)
T ss_dssp -TTCEEC--CEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHTTTSCCSSTTCCCS----HHHHHHH---HHTCCCC--
T ss_pred -ccchhccccCCCceeEChhhhcCCCCCchhhhhhHHHHHHHHHhcCCCCCCccchh----HHHHHHH---HcCCCCC--
Confidence 11122344567889999999999999999999999999999998 99998543221 1111111 1111000
Q ss_pred cccCccccchhhHhHHHHHHHHHHHHHHHHhcCCCCCCCCChhhhhcC
Q 038766 252 QITDPKLVSSIYEEQEQHQVLEELFKLALVCTSSNPEDRPNMNELLIT 299 (299)
Q Consensus 252 ~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rpt~~~il~~ 299 (299)
. +..++.++.+++.+||..||++|||++++++|
T Consensus 317 ---~------------~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~ 349 (359)
T 3vhe_A 317 ---A------------PDYTTPEMYQTMLDCWHGEPSQRPTFSELVEH 349 (359)
T ss_dssp ---C------------CTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred ---C------------CCCCCHHHHHHHHHHccCChhhCCCHHHHHHH
Confidence 0 11234579999999999999999999999875
|
| >3rp9_A Mitogen-activated protein kinase; structural genomics, structural genomics consortium, SGC, TR; 2.40A {Toxoplasma gondii} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.1e-46 Score=333.53 Aligned_cols=201 Identities=26% Similarity=0.339 Sum_probs=158.5
Q ss_pred HhCCCCCCceeecCCcceEEEEEeC-CCcEEEEEEeccCcCChhhhHHHHHHHHHHHhcCCcceeeeeeEEEcC----CC
Q 038766 10 ATGSFSENNIIGNSNLSTVYKGRLE-DGEIVAVKKLNFHQFSAESDKSFYREAKTLKELKHRNLVKVLGYAWES----GK 84 (299)
Q Consensus 10 ~~~~y~~~~~lg~g~~~~v~~~~~~-~~~~~~vK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~----~~ 84 (299)
+.++|.+.+.||+|+||+||+|.+. +++.||||++..........+.+.+|+.+++.++||||+++++++... ..
T Consensus 51 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~i~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~ 130 (458)
T 3rp9_A 51 IPDRYEIRHLIGTGSYGHVCEAYDKLEKRVVAIKKILRVFEDLIDCKRILREIAILNRLNHDHVVKVLDIVIPKDVEKFD 130 (458)
T ss_dssp SCTTEEECCC-------CEEEEEECC--CEEEEEEECSTTSSHHHHHHHHHHHHHHHHCCCTTBCCEEEECCCSCTTTCC
T ss_pred cCCCeEEeeEeeecCCeEEEEEEECCCCcEEEEEEechhhcCHHHHHHHHHHHHHHHhCCCCCCCceEEEEecCCcccCc
Confidence 4578999999999999999999864 689999999976555566678899999999999999999999977533 24
Q ss_pred eeEEEEeecCCCChHHHhcCCCCCCCCCChhhHHHHHHHHHHHHHHhhcCCCCCeeeecccCCceeeCCCCcEEEeeecc
Q 038766 85 LKALILEYMENGSLESVIHGPGVDHSRWTLPKRIDVLISVANGLDYLHSGYDIPIVHCDMKPSNILLDRDFEAHVSDFGT 164 (299)
Q Consensus 85 ~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lh~~~~~~~~H~dl~~~nil~~~~~~v~l~df~~ 164 (299)
..++|+|++ +++|..++. ....+++..++.++.||+.||+|||++ +++||||||+|||++.++.+||+|||+
T Consensus 131 ~~~lv~e~~-~~~L~~~~~----~~~~l~~~~~~~~~~qi~~aL~~LH~~---~iiHrDlKp~NILl~~~~~~kl~DFGl 202 (458)
T 3rp9_A 131 ELYVVLEIA-DSDFKKLFR----TPVYLTELHIKTLLYNLLVGVKYVHSA---GILHRDLKPANCLVNQDCSVKVCDFGL 202 (458)
T ss_dssp CEEEEECCC-SEEHHHHHH----SSCCCCHHHHHHHHHHHHHHHHHHHHT---TCBCCCCCGGGEEECTTCCEEECCCTT
T ss_pred eEEEEEecc-ccchhhhcc----cCCCCCHHHHHHHHHHHHHHHHHHHhC---CcCCCCCChhhEEECCCCCEeeccccc
Confidence 579999998 569999987 456799999999999999999999999 999999999999999999999999999
Q ss_pred ccccccccccc-----------------------cccccccccCcccCChhhh-cccCcCccccchhhhHHHHHHHhC
Q 038766 165 SRMLDVHLQDL-----------------------SSLSTAFQGTIGYLAPEFA-YMRIVTTKVDVFSFGIVVMEFLTK 218 (299)
Q Consensus 165 ~~~~~~~~~~~-----------------------~~~~~~~~~~~~y~~PE~~-~~~~~~~~~DiwslG~~l~~l~~g 218 (299)
+.......... ........+|+.|+|||++ .+..++.++|||||||++|+|++|
T Consensus 203 a~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~~DiwSlG~il~elltg 280 (458)
T 3rp9_A 203 ARTVDYPENGNSQLPISPREDDMNLVTFPHTKNLKRQLTGHVVTRWYRAPELILLQENYTEAIDVWSIGCIFAELLNM 280 (458)
T ss_dssp CBCTTSCTTCCCCCC---------------------------CCCTTCCHHHHTTCCCCCTHHHHHHHHHHHHHHHTT
T ss_pred chhccCccccccccccCccccccccccccccccccccccCCcccccccChHHhhCCCCCCcHhHHHHHHHHHHHHHHh
Confidence 98654221100 1123445679999999976 566799999999999999999994
|
| >4hcu_A Tyrosine-protein kinase ITK/TSK; transferase-transferase inhibitor complex; HET: 13L; 1.43A {Homo sapiens} PDB: 4hct_A* 4hcv_A* 3t9t_A* 1sm2_A* 1snu_A* 1snx_A 3v5l_A* 3v5j_A* 3v8t_A* 3v8w_A* 3qgw_A* 3qgy_A* 3miy_A* 3mj1_A* 3mj2_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=8.4e-47 Score=313.33 Aligned_cols=255 Identities=24% Similarity=0.375 Sum_probs=204.6
Q ss_pred HHHHhCCCCCCceeecCCcceEEEEEeCCCcEEEEEEeccCcCChhhhHHHHHHHHHHHhcCCcceeeeeeEEEcCCCee
Q 038766 7 IENATGSFSENNIIGNSNLSTVYKGRLEDGEIVAVKKLNFHQFSAESDKSFYREAKTLKELKHRNLVKVLGYAWESGKLK 86 (299)
Q Consensus 7 ~~~~~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~vK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~ 86 (299)
+..-.++|++.+.||+|+||+||++.+.+++.||+|++.... ...+.+.+|+..+++++||||+++++++.. +...
T Consensus 5 ~~i~~~~y~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~---~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~-~~~~ 80 (269)
T 4hcu_A 5 WVIDPSELTFVQEIGSGQFGLVHLGYWLNKDKVAIKTIREGA---MSEEDFIEEAEVMMKLSHPKLVQLYGVCLE-QAPI 80 (269)
T ss_dssp CBCCGGGEEEEEEEEECSSCEEEEEEETTTEEEEEEEECTTS---BCHHHHHHHHHHHHTCCCTTBCCEEEEECS-SSSE
T ss_pred EEeChhhceeeheecCCCccEEEEEEecCCCeEEEEEecccc---cCHHHHHHHHHHHHhCCCCCEeeEEEEEec-CCce
Confidence 445568899999999999999999999888999999997433 234678899999999999999999997655 4556
Q ss_pred EEEEeecCCCChHHHhcCCCCCCCCCChhhHHHHHHHHHHHHHHhhcCCCCCeeeecccCCceeeCCCCcEEEeeecccc
Q 038766 87 ALILEYMENGSLESVIHGPGVDHSRWTLPKRIDVLISVANGLDYLHSGYDIPIVHCDMKPSNILLDRDFEAHVSDFGTSR 166 (299)
Q Consensus 87 ~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lh~~~~~~~~H~dl~~~nil~~~~~~v~l~df~~~~ 166 (299)
++|+||+++++|.+++.. ....+++..++.++.|++.||++||+. +++|+||||+||+++.++.++|+|||++.
T Consensus 81 ~lv~e~~~~~~L~~~l~~---~~~~~~~~~~~~i~~~i~~~l~~lH~~---~i~H~dikp~Nil~~~~~~~kl~Dfg~~~ 154 (269)
T 4hcu_A 81 CLVFEFMEHGCLSDYLRT---QRGLFAAETLLGMCLDVCEGMAYLEEA---CVIHRDLAARNCLVGENQVIKVSDFGMTR 154 (269)
T ss_dssp EEEEECCTTCBHHHHHHT---TTTCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEECGGGCEEECCTTGGG
T ss_pred EEEEEeCCCCcHHHHHHh---cCcccCHHHHHHHHHHHHHHHHHHHhC---CeecCCcchheEEEcCCCCEEeccccccc
Confidence 999999999999999863 334689999999999999999999999 99999999999999999999999999997
Q ss_pred ccccccccccccccccccCcccCChhhhcccCcCccccchhhhHHHHHHHh-CCCCCCCCccCCCCchhHHHHHHHHHhc
Q 038766 167 MLDVHLQDLSSLSTAFQGTIGYLAPEFAYMRIVTTKVDVFSFGIVVMEFLT-KRRPTGLDEENGLSPISLRQLVEKALAN 245 (299)
Q Consensus 167 ~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~DiwslG~~l~~l~~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~ 245 (299)
..... .........+++.|+|||.+.+..++.++||||||+++|+|++ |..||... ... +........
T Consensus 155 ~~~~~---~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~ll~~g~~p~~~~-----~~~---~~~~~~~~~ 223 (269)
T 4hcu_A 155 FVLDD---QYTSSTGTKFPVKWASPEVFSFSRYSSKSDVWSFGVLMWEVFSEGKIPYENR-----SNS---EVVEDISTG 223 (269)
T ss_dssp GBCCH---HHHSTTSTTCCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTC-----CHH---HHHHHHHTT
T ss_pred ccccc---ccccccCcccccccCCHHHhcCCCCCchhhhHHHHHHHHHHhcCCCCCCCCC-----CHH---HHHHHHhcC
Confidence 55421 1122334445778999999999999999999999999999999 88998533 111 222222111
Q ss_pred CccCcccccCccccchhhHhHHHHHHHHHHHHHHHHhcCCCCCCCCChhhhhcC
Q 038766 246 GINGVRQITDPKLVSSIYEEQEQHQVLEELFKLALVCTSSNPEDRPNMNELLIT 299 (299)
Q Consensus 246 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rpt~~~il~~ 299 (299)
. .... +...+..+.+++.+||..||++|||+++++++
T Consensus 224 ~-----~~~~------------~~~~~~~~~~li~~~l~~~p~~Rps~~~ll~~ 260 (269)
T 4hcu_A 224 F-----RLYK------------PRLASTHVYQIMNHCWRERPEDRPAFSRLLRQ 260 (269)
T ss_dssp C-----CCCC------------CTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred c-----cCCC------------CCcCCHHHHHHHHHHccCCcccCcCHHHHHHH
Confidence 0 0000 11234579999999999999999999999864
|
| >3a62_A Ribosomal protein S6 kinase beta-1; kinase domain, inactive, active, ribosomal S6 kinase, activation, alternative initiation, ATP-binding; HET: TPO STU; 2.35A {Homo sapiens} PDB: 3a61_A* 3a60_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-46 Score=319.93 Aligned_cols=255 Identities=24% Similarity=0.310 Sum_probs=196.2
Q ss_pred HHHHhCCCCCCceeecCCcceEEEEEe----CCCcEEEEEEeccCcC--ChhhhHHHHHHHHHHHhcCCcceeeeeeEEE
Q 038766 7 IENATGSFSENNIIGNSNLSTVYKGRL----EDGEIVAVKKLNFHQF--SAESDKSFYREAKTLKELKHRNLVKVLGYAW 80 (299)
Q Consensus 7 ~~~~~~~y~~~~~lg~g~~~~v~~~~~----~~~~~~~vK~~~~~~~--~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~ 80 (299)
.+...++|.+.+.||+|+||.||++.+ .+++.||+|++..... .......+.+|+.+++.++||||+++++++.
T Consensus 12 ~~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~ 91 (327)
T 3a62_A 12 EKIRPECFELLRVLGKGGYGKVFQVRKVTGANTGKIFAMKVLKKAMIVRNAKDTAHTKAERNILEEVKHPFIVDLIYAFQ 91 (327)
T ss_dssp -CCCGGGEEEEEEEEEETTEEEEEEEECSSTTTTCEEEEEEECCC--------------HHHHHHHCCCTTBCCEEEEEE
T ss_pred CCCCHHHeEEEEEEEeCCCEEEEEEEEeccCCCCcEEEEEEEEHHHhhhhhhHHHHHHHHHHHHHhCCCCCccceeEEEE
Confidence 345578999999999999999999986 4689999999975432 2234556788999999999999999999766
Q ss_pred cCCCeeEEEEeecCCCChHHHhcCCCCCCCCCChhhHHHHHHHHHHHHHHhhcCCCCCeeeecccCCceeeCCCCcEEEe
Q 038766 81 ESGKLKALILEYMENGSLESVIHGPGVDHSRWTLPKRIDVLISVANGLDYLHSGYDIPIVHCDMKPSNILLDRDFEAHVS 160 (299)
Q Consensus 81 ~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lh~~~~~~~~H~dl~~~nil~~~~~~v~l~ 160 (299)
. +...++|+||+.+++|.+++. ....+++..++.++.||+.||.|||++ +++|+||||+||+++.++.++|+
T Consensus 92 ~-~~~~~lv~e~~~~~~L~~~l~----~~~~~~~~~~~~~~~qi~~al~~lH~~---~ivH~Dlkp~Nill~~~~~~kl~ 163 (327)
T 3a62_A 92 T-GGKLYLILEYLSGGELFMQLE----REGIFMEDTACFYLAEISMALGHLHQK---GIIYRDLKPENIMLNHQGHVKLT 163 (327)
T ss_dssp C-SSCEEEEEECCTTEEHHHHHH----HHSSCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCTTTEEECTTSCEEEC
T ss_pred c-CCEEEEEEeCCCCCcHHHHHH----hCCCCCHHHHHHHHHHHHHHHHHHHhC---CEEcccCCHHHeEECCCCcEEEE
Confidence 5 455699999999999999987 445789999999999999999999999 99999999999999999999999
Q ss_pred eeccccccccccccccccccccccCcccCChhhhcccCcCccccchhhhHHHHHHHhCCCCCCCCccCCCCchhHHHHHH
Q 038766 161 DFGTSRMLDVHLQDLSSLSTAFQGTIGYLAPEFAYMRIVTTKVDVFSFGIVVMEFLTKRRPTGLDEENGLSPISLRQLVE 240 (299)
Q Consensus 161 df~~~~~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~DiwslG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~ 240 (299)
|||++..... .........+++.|+|||.+.+..++.++||||||+++|+|++|..||.... . ...+.
T Consensus 164 Dfg~~~~~~~----~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~-----~---~~~~~ 231 (327)
T 3a62_A 164 DFGLCKESIH----DGTVTHTFCGTIEYMAPEILMRSGHNRAVDWWSLGALMYDMLTGAPPFTGEN-----R---KKTID 231 (327)
T ss_dssp CCSCC--------------CTTSSCCTTSCHHHHTTSCCCTHHHHHHHHHHHHHHHHSSCSCCCSS-----H---HHHHH
T ss_pred eCCccccccc----CCccccccCCCcCccCHhhCcCCCCCCcccchhHHHHHHHHHHCCCCCCCCC-----H---HHHHH
Confidence 9999864331 1122344568999999999999999999999999999999999999995431 1 12222
Q ss_pred HHHhcCccCcccccCccccchhhHhHHHHHHHHHHHHHHHHhcCCCCCCCC-----ChhhhhcC
Q 038766 241 KALANGINGVRQITDPKLVSSIYEEQEQHQVLEELFKLALVCTSSNPEDRP-----NMNELLIT 299 (299)
Q Consensus 241 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rp-----t~~~il~~ 299 (299)
....... . + +..++.++.++|.+||..||++|| +++++++|
T Consensus 232 ~i~~~~~-~---~--------------p~~~~~~~~~li~~~L~~dp~~R~~~~~~~~~e~l~h 277 (327)
T 3a62_A 232 KILKCKL-N---L--------------PPYLTQEARDLLKKLLKRNAASRLGAGPGDAGEVQAH 277 (327)
T ss_dssp HHHHTCC-C---C--------------CTTSCHHHHHHHHHHSCSCGGGSTTSSTTTHHHHHHS
T ss_pred HHHhCCC-C---C--------------CCCCCHHHHHHHHHHHhcCHhhccCCCCCCHHHHHcC
Confidence 2222110 0 0 112356799999999999999999 78899887
|
| >2w5a_A Serine/threonine-protein kinase NEK2; Ser/Thr protein kinase, nucleus, meiosis, mitosis, cytoplasm, metal-binding, phosphoprotein; HET: ADP; 1.55A {Homo sapiens} PDB: 2wqo_A* 2xk3_A* 2xk4_A* 2xk6_A* 2xk7_A* 2xk8_A* 2xkc_A* 2xkd_A* 2xke_A* 2xkf_A* 2xnm_A* 2xnn_A* 2xno_A* 2xnp_A* 4afe_A* 2jav_A* 2w5b_A* 2w5h_A 4a4x_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.9e-47 Score=315.42 Aligned_cols=259 Identities=24% Similarity=0.364 Sum_probs=208.1
Q ss_pred HHhCCCCCCceeecCCcceEEEEEeC-CCcEEEEEEeccCcCChhhhHHHHHHHHHHHhcCCcceeeeeeEEEc-CCCee
Q 038766 9 NATGSFSENNIIGNSNLSTVYKGRLE-DGEIVAVKKLNFHQFSAESDKSFYREAKTLKELKHRNLVKVLGYAWE-SGKLK 86 (299)
Q Consensus 9 ~~~~~y~~~~~lg~g~~~~v~~~~~~-~~~~~~vK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~-~~~~~ 86 (299)
...++|++.+.||+|++|+||++.+. +++.||+|++..........+.+.+|+..++.++||||+++++++.. .+...
T Consensus 3 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~ 82 (279)
T 2w5a_A 3 SRAEDYEVLYTIGTGSYGRCQKIRRKSDGKILVWKELDYGSMTEAEKQMLVSEVNLLRELKHPNIVRYYDRIIDRTNTTL 82 (279)
T ss_dssp CCGGGEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEECTTCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEEGGGTEE
T ss_pred CchhheeeehhccCCCCcEEEEEEECCCCcEEEEEEEEcccCCHHHHHHHHHHHHHHHhcCCCCCCeEEEEEecCCCceE
Confidence 34679999999999999999999875 68999999998766666677889999999999999999999997754 45677
Q ss_pred EEEEeecCCCChHHHhcCCCCCCCCCChhhHHHHHHHHHHHHHHhhcCCCCC-----eeeecccCCceeeCCCCcEEEee
Q 038766 87 ALILEYMENGSLESVIHGPGVDHSRWTLPKRIDVLISVANGLDYLHSGYDIP-----IVHCDMKPSNILLDRDFEAHVSD 161 (299)
Q Consensus 87 ~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lh~~~~~~-----~~H~dl~~~nil~~~~~~v~l~d 161 (299)
++|+||+++++|.+++.........+++..++.++.|++.||+|||+. + ++|+||+|+||+++.++.++|+|
T Consensus 83 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~---~~~~~~ivH~dl~p~NIl~~~~~~~kl~d 159 (279)
T 2w5a_A 83 YIVMEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLALKECHRR---SDGGHTVLHRDLKPANVFLDGKQNVKLGD 159 (279)
T ss_dssp EEEEECCTTEEHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHHH---C------CCCCCSGGGEEECSSSCEEECC
T ss_pred EEEEeCCCCCCHHHHHHhhcccCCCCCHHHHHHHHHHHHHHHHHHhcc---cCCCCeeEEeccchhhEEEcCCCCEEEec
Confidence 999999999999999864332345699999999999999999999998 7 99999999999999999999999
Q ss_pred eccccccccccccccccccccccCcccCChhhhcccCcCccccchhhhHHHHHHHhCCCCCCCCccCCCCchhHHHHHHH
Q 038766 162 FGTSRMLDVHLQDLSSLSTAFQGTIGYLAPEFAYMRIVTTKVDVFSFGIVVMEFLTKRRPTGLDEENGLSPISLRQLVEK 241 (299)
Q Consensus 162 f~~~~~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~DiwslG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~ 241 (299)
||++...... ........+++.|+|||.+.+..++.++||||||+++|+|++|..||... ....+ ...
T Consensus 160 fg~~~~~~~~----~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~-----~~~~~---~~~ 227 (279)
T 2w5a_A 160 FGLARILNHD----TSFAKTFVGTPYYMSPEQMNRMSYNEKSDIWSLGCLLYELCALMPPFTAF-----SQKEL---AGK 227 (279)
T ss_dssp CCHHHHC-------CHHHHHHHSCCTTCCHHHHHCC-CCHHHHHHHHHHHHHHHHHSSCSSCCS-----SHHHH---HHH
T ss_pred Cchheeeccc----cccccccCCCccccChHHhccCCCCchhhHHHHHHHHHHHHHCCCCCccc-----CHHHH---HHH
Confidence 9998765421 11123346789999999999988999999999999999999999998543 12222 222
Q ss_pred HHhcCccCcccccCccccchhhHhHHHHHHHHHHHHHHHHhcCCCCCCCCChhhhhcC
Q 038766 242 ALANGINGVRQITDPKLVSSIYEEQEQHQVLEELFKLALVCTSSNPEDRPNMNELLIT 299 (299)
Q Consensus 242 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rpt~~~il~~ 299 (299)
........ + +..++.++.++|.+||..||++|||++++|+|
T Consensus 228 i~~~~~~~---~--------------~~~~~~~l~~li~~~l~~~p~~Rps~~~ll~~ 268 (279)
T 2w5a_A 228 IREGKFRR---I--------------PYRYSDELNEIITRMLNLKDYHRPSVEEILEN 268 (279)
T ss_dssp HHHTCCCC---C--------------CTTSCHHHHHHHHHHTCSSGGGSCCHHHHHTS
T ss_pred Hhhccccc---C--------------CcccCHHHHHHHHHHcCCCcccCCCHHHHHhC
Confidence 21111110 0 11235679999999999999999999999986
|
| >3p1a_A MYT1 kinase, membrane-associated tyrosine- and threonine-speci inhibitory kinase; structural genomics, structural genomics consortium, SGC; 1.70A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=7.9e-47 Score=319.96 Aligned_cols=249 Identities=23% Similarity=0.250 Sum_probs=196.3
Q ss_pred HhCCCCCCceeecCCcceEEEEEeC-CCcEEEEEEeccCcCChhhhHHHHHHHHHHHhc-CCcceeeeeeEEEcCCCeeE
Q 038766 10 ATGSFSENNIIGNSNLSTVYKGRLE-DGEIVAVKKLNFHQFSAESDKSFYREAKTLKEL-KHRNLVKVLGYAWESGKLKA 87 (299)
Q Consensus 10 ~~~~y~~~~~lg~g~~~~v~~~~~~-~~~~~~vK~~~~~~~~~~~~~~~~~e~~~l~~l-~h~~i~~~~~~~~~~~~~~~ 87 (299)
+.++|++.+.||+|+||+||+|.+. +++.||||++...............|+..+..+ .||||+++++++.. +...+
T Consensus 55 ~~~~y~~~~~LG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~~~~~~~h~~iv~l~~~~~~-~~~~~ 133 (311)
T 3p1a_A 55 FQQSFQRLSRLGHGSYGEVFKVRSKEDGRLYAVKRSMSPFRGPKDRARKLAEVGSHEKVGQHPCCVRLEQAWEE-GGILY 133 (311)
T ss_dssp HHHHEEEEEEEEEETTEEEEEEEETTTSCEEEEEEESSSCCSHHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEE-TTEEE
T ss_pred hhhheeeeheeccCCCeEEEEEEECCCCeEEEEEEecccccChHHHHHHHHHHHHHHHhcCCCcEEEEEEEEEe-CCEEE
Confidence 4478999999999999999999875 699999999876555555555666666666666 89999999997654 56679
Q ss_pred EEEeecCCCChHHHhcCCCCCCCCCChhhHHHHHHHHHHHHHHhhcCCCCCeeeecccCCceeeCCCCcEEEeeeccccc
Q 038766 88 LILEYMENGSLESVIHGPGVDHSRWTLPKRIDVLISVANGLDYLHSGYDIPIVHCDMKPSNILLDRDFEAHVSDFGTSRM 167 (299)
Q Consensus 88 lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lh~~~~~~~~H~dl~~~nil~~~~~~v~l~df~~~~~ 167 (299)
+|+|++ +++|.+.+... ...+++..++.++.|++.||+|||+. +++|+||||+||+++.++.+||+|||++..
T Consensus 134 lv~e~~-~~~L~~~~~~~---~~~l~~~~~~~i~~qi~~aL~~LH~~---~ivH~Dikp~NIll~~~~~~kl~DFG~a~~ 206 (311)
T 3p1a_A 134 LQTELC-GPSLQQHCEAW---GASLPEAQVWGYLRDTLLALAHLHSQ---GLVHLDVKPANIFLGPRGRCKLGDFGLLVE 206 (311)
T ss_dssp EEEECC-CCBHHHHHHHH---CSCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECGGGCEEECCCTTCEE
T ss_pred EEEecc-CCCHHHHHHhc---CCCCCHHHHHHHHHHHHHHHHHHHHC---CEecCCCCHHHEEECCCCCEEEccceeeee
Confidence 999999 66898877532 34699999999999999999999999 999999999999999999999999999875
Q ss_pred cccccccccccccccccCcccCChhhhcccCcCccccchhhhHHHHHHHhCCCCCCCCccCCCCchhHHHHHHHHHhcCc
Q 038766 168 LDVHLQDLSSLSTAFQGTIGYLAPEFAYMRIVTTKVDVFSFGIVVMEFLTKRRPTGLDEENGLSPISLRQLVEKALANGI 247 (299)
Q Consensus 168 ~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~DiwslG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 247 (299)
... ........+|+.|+|||++.+ .++.++|||||||++|+|++|..|+.... .... ....
T Consensus 207 ~~~-----~~~~~~~~gt~~y~aPE~~~~-~~~~~~DiwslG~il~el~~g~~~~~~~~-----------~~~~-~~~~- 267 (311)
T 3p1a_A 207 LGT-----AGAGEVQEGDPRYMAPELLQG-SYGTAADVFSLGLTILEVACNMELPHGGE-----------GWQQ-LRQG- 267 (311)
T ss_dssp CC-----------CCCCCGGGCCGGGGGT-CCSTHHHHHHHHHHHHHHHHTCCCCSSHH-----------HHHH-HTTT-
T ss_pred ccc-----CCCCcccCCCccccCHhHhcC-CCCchhhHHHHHHHHHHHHhCCCCCCCcc-----------HHHH-Hhcc-
Confidence 442 122334458999999998876 68999999999999999999977663220 0111 0000
Q ss_pred cCcccccCccccchhhHhHHHHHHHHHHHHHHHHhcCCCCCCCCChhhhhcC
Q 038766 248 NGVRQITDPKLVSSIYEEQEQHQVLEELFKLALVCTSSNPEDRPNMNELLIT 299 (299)
Q Consensus 248 ~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rpt~~~il~~ 299 (299)
.. .......++.++.++|.+||..||++|||++++|+|
T Consensus 268 -----~~---------~~~~~~~~~~~l~~li~~~L~~dP~~Rpt~~ell~h 305 (311)
T 3p1a_A 268 -----YL---------PPEFTAGLSSELRSVLVMMLEPDPKLRATAEALLAL 305 (311)
T ss_dssp -----CC---------CHHHHTTSCHHHHHHHHHHSCSSTTTSCCHHHHHTS
T ss_pred -----CC---------CcccccCCCHHHHHHHHHHcCCChhhCcCHHHHHhC
Confidence 00 011234456789999999999999999999999987
|
| >1kob_A Twitchin; kinase, intrasteric regulation; 2.30A {Aplysia californica} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=7.1e-46 Score=322.28 Aligned_cols=254 Identities=18% Similarity=0.259 Sum_probs=204.3
Q ss_pred HhCCCCCCceeecCCcceEEEEEeC-CCcEEEEEEeccCcCChhhhHHHHHHHHHHHhcCCcceeeeeeEEEcCCCeeEE
Q 038766 10 ATGSFSENNIIGNSNLSTVYKGRLE-DGEIVAVKKLNFHQFSAESDKSFYREAKTLKELKHRNLVKVLGYAWESGKLKAL 88 (299)
Q Consensus 10 ~~~~y~~~~~lg~g~~~~v~~~~~~-~~~~~~vK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~l 88 (299)
+.++|.+.+.||+|+||+||+|.+. +++.+|+|++... .......+.+|+.+++.++||||+++++++.. +...++
T Consensus 49 ~~~~y~i~~~LG~G~~g~Vy~~~~~~~~~~~a~K~~~~~--~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~-~~~~~l 125 (387)
T 1kob_A 49 VYDYYDILEELGSGAFGVVHRCVEKATGRVFVAKFINTP--YPLDKYTVKNEISIMNQLHHPKLINLHDAFED-KYEMVL 125 (387)
T ss_dssp GGGTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECC--SHHHHHHHHHHHHHHTTCCSTTBCCEEEEEEC-SSEEEE
T ss_pred cccceEEEEEEecCCCEEEEEEEECCCCCEEEEEEeccc--chhhHHHHHHHHHHHHhCCCcCCCeEEEEEEe-CCEEEE
Confidence 5678999999999999999999874 6899999998643 23445678899999999999999999997655 556799
Q ss_pred EEeecCCCChHHHhcCCCCCCCCCChhhHHHHHHHHHHHHHHhhcCCCCCeeeecccCCceeeCC--CCcEEEeeecccc
Q 038766 89 ILEYMENGSLESVIHGPGVDHSRWTLPKRIDVLISVANGLDYLHSGYDIPIVHCDMKPSNILLDR--DFEAHVSDFGTSR 166 (299)
Q Consensus 89 v~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lh~~~~~~~~H~dl~~~nil~~~--~~~v~l~df~~~~ 166 (299)
|+||+.+++|.+++.. ....+++..++.++.||+.||+|||+. +++|+||||+||+++. ++.++|+|||++.
T Consensus 126 v~E~~~gg~L~~~l~~---~~~~l~~~~~~~i~~qi~~aL~~LH~~---givHrDlkp~NIll~~~~~~~vkL~DFG~a~ 199 (387)
T 1kob_A 126 ILEFLSGGELFDRIAA---EDYKMSEAEVINYMRQACEGLKHMHEH---SIVHLDIKPENIMCETKKASSVKIIDFGLAT 199 (387)
T ss_dssp EEECCCCCBHHHHTTC---TTCCBCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEESSTTCCCEEECCCTTCE
T ss_pred EEEcCCCCcHHHHHHh---hcCCCCHHHHHHHHHHHHHHHHHHHhC---CeeecccchHHeEEecCCCCceEEEecccce
Confidence 9999999999998863 234799999999999999999999999 9999999999999974 4779999999997
Q ss_pred ccccccccccccccccccCcccCChhhhcccCcCccccchhhhHHHHHHHhCCCCCCCCccCCCCchhHHHHHHHHHhcC
Q 038766 167 MLDVHLQDLSSLSTAFQGTIGYLAPEFAYMRIVTTKVDVFSFGIVVMEFLTKRRPTGLDEENGLSPISLRQLVEKALANG 246 (299)
Q Consensus 167 ~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~DiwslG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~ 246 (299)
.... ........+|+.|+|||++.+..++.++|||||||++|+|++|..||.... . .+.+.......
T Consensus 200 ~~~~-----~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~Pf~~~~-----~---~~~~~~i~~~~ 266 (387)
T 1kob_A 200 KLNP-----DEIVKVTTATAEFAAPEIVDREPVGFYTDMWAIGVLGYVLLSGLSPFAGED-----D---LETLQNVKRCD 266 (387)
T ss_dssp ECCT-----TSCEEEECSSGGGCCHHHHTTCCBCHHHHHHHHHHHHHHHHHSCCSSCCSS-----H---HHHHHHHHHCC
T ss_pred ecCC-----CcceeeeccCCCccCchhccCCCCCCcccEeeHhHHHHHHHhCCCCCCCCC-----H---HHHHHHHHhCC
Confidence 6542 122234468999999999999999999999999999999999999995431 1 12222222211
Q ss_pred ccCcccccCccccchhhHhHHHHHHHHHHHHHHHHhcCCCCCCCCChhhhhcC
Q 038766 247 INGVRQITDPKLVSSIYEEQEQHQVLEELFKLALVCTSSNPEDRPNMNELLIT 299 (299)
Q Consensus 247 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rpt~~~il~~ 299 (299)
.. ..... ...++.++.++|++||..||++|||++++|+|
T Consensus 267 ~~----~~~~~----------~~~~s~~~~~li~~~L~~dP~~Rpt~~ell~h 305 (387)
T 1kob_A 267 WE----FDEDA----------FSSVSPEAKDFIKNLLQKEPRKRLTVHDALEH 305 (387)
T ss_dssp CC----CCSST----------TTTSCHHHHHHHHTTSCSSGGGSCCHHHHHTS
T ss_pred CC----CCccc----------cccCCHHHHHHHHHHcCCChhHCcCHHHHhhC
Confidence 11 00000 12345689999999999999999999999987
|
| >3gbz_A Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; 1.85A {Giardia lamblia} PDB: 3gc0_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3e-46 Score=318.84 Aligned_cols=276 Identities=23% Similarity=0.272 Sum_probs=197.4
Q ss_pred HHHHhCCCCCCceeecCCcceEEEEEe-CCCcEEEEEEeccCcCChhhhHHHHHHHHHHHhcCCcceeeeeeEEEcCCCe
Q 038766 7 IENATGSFSENNIIGNSNLSTVYKGRL-EDGEIVAVKKLNFHQFSAESDKSFYREAKTLKELKHRNLVKVLGYAWESGKL 85 (299)
Q Consensus 7 ~~~~~~~y~~~~~lg~g~~~~v~~~~~-~~~~~~~vK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~ 85 (299)
.....++|++.+.||+|+||+||++.+ .+++.||+|++............+.+|+.+++.++||||+++++++.. +..
T Consensus 29 ~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~-~~~ 107 (329)
T 3gbz_A 29 SATSIDRYRRITKLGEGTYGEVYKAIDTVTNETVAIKRIRLEHEEEGVPGTAIREVSLLKELQHRNIIELKSVIHH-NHR 107 (329)
T ss_dssp ---CGGGEEEEEEEEECSSSEEEEEEETTTTEEEEEEECCCCC--------CHHHHHHGGGCCCTTBCCEEEEEEE-TTE
T ss_pred cccchhhEEEEEEEEecCCeEEEEEEECCCCceEEEEEEcccccccccchhHHHHHHHHHHcCCCCcceEEEEEec-CCE
Confidence 345678999999999999999999986 468999999997665555556678899999999999999999997665 556
Q ss_pred eEEEEeecCCCChHHHhcCCCCCCCCCChhhHHHHHHHHHHHHHHhhcCCCCCeeeecccCCceeeC-----CCCcEEEe
Q 038766 86 KALILEYMENGSLESVIHGPGVDHSRWTLPKRIDVLISVANGLDYLHSGYDIPIVHCDMKPSNILLD-----RDFEAHVS 160 (299)
Q Consensus 86 ~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lh~~~~~~~~H~dl~~~nil~~-----~~~~v~l~ 160 (299)
.++|+||+.+ +|.+++. ....+++..++.++.|++.||+|||++ +++|+||||+||+++ ..+.++|+
T Consensus 108 ~~lv~e~~~~-~L~~~~~----~~~~~~~~~~~~i~~ql~~~l~~LH~~---~ivH~Dlkp~NIll~~~~~~~~~~~kl~ 179 (329)
T 3gbz_A 108 LHLIFEYAEN-DLKKYMD----KNPDVSMRVIKSFLYQLINGVNFCHSR---RCLHRDLKPQNLLLSVSDASETPVLKIG 179 (329)
T ss_dssp EEEEEECCSE-EHHHHHH----HCTTCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEEEC-----CCEEEEC
T ss_pred EEEEEecCCC-CHHHHHh----hcCCCCHHHHHHHHHHHHHHHHHHHhC---CEECCCCCHHHEEEecCCCCccceEEEC
Confidence 6999999965 9999887 445799999999999999999999999 999999999999994 45569999
Q ss_pred eeccccccccccccccccccccccCcccCChhhhccc-CcCccccchhhhHHHHHHHhCCCCCCCCccCCCCchhHHHHH
Q 038766 161 DFGTSRMLDVHLQDLSSLSTAFQGTIGYLAPEFAYMR-IVTTKVDVFSFGIVVMEFLTKRRPTGLDEENGLSPISLRQLV 239 (299)
Q Consensus 161 df~~~~~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~-~~~~~~DiwslG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~ 239 (299)
|||++...... ........+++.|+|||++.+. .++.++|||||||++|+|++|..||..... ...+....
T Consensus 180 Dfg~a~~~~~~----~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~----~~~~~~~~ 251 (329)
T 3gbz_A 180 DFGLARAFGIP----IRQFTHEIITLWYRPPEILLGSRHYSTSVDIWSIACIWAEMLMKTPLFPGDSE----IDQLFKIF 251 (329)
T ss_dssp CTTHHHHHC---------------CCTTCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHSSCSSCCSSH----HHHHHHHH
T ss_pred cCCCccccCCc----ccccCCCcCCccccCHHHhcCCCCCCcHHHHHHHHHHHHHHHHCCCCcCCCCH----HHHHHHHH
Confidence 99999765421 1223344578999999998874 489999999999999999999999954321 11111111
Q ss_pred HHHHhcCccCccc---c-----cCccccchhhHhHHHHHHHHHHHHHHHHhcCCCCCCCCChhhhhcC
Q 038766 240 EKALANGINGVRQ---I-----TDPKLVSSIYEEQEQHQVLEELFKLALVCTSSNPEDRPNMNELLIT 299 (299)
Q Consensus 240 ~~~~~~~~~~~~~---~-----~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rpt~~~il~~ 299 (299)
............. . ..+..............++.++.+||.+||..||++|||++|+|+|
T Consensus 252 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~h 319 (329)
T 3gbz_A 252 EVLGLPDDTTWPGVTALPDWKQSFPKFRGKTLKRVLGALLDDEGLDLLTAMLEMDPVKRISAKNALEH 319 (329)
T ss_dssp HHHCCCCTTTSTTGGGSTTCCTTCCCCCCCCHHHHHGGGSCHHHHHHHHHHTCSSGGGSCCHHHHHTS
T ss_pred HHhCCCchhhhhhhhhhhhhhhhhhhhccccHhhhcccccCHHHHHHHHHHccCChhhCCCHHHHhCC
Confidence 1110000000000 0 0011111222222333466789999999999999999999999987
|
| >3fdn_A Serine/threonine-protein kinase 6; aurora kinase inhibitors, virtual screening, X-RAY CO- crystal analysis, structure-based drug design (SBDD); HET: MMH; 1.90A {Homo sapiens} SCOP: d.144.1.7 PDB: 3k5u_A* 3m11_A* 2c6e_A* 1muo_A* 2bmc_A* 2j4z_A* 1ol6_A* 3up2_A* 3unz_A* 3uo5_A* 3uo6_A* 3uod_A* 3uoh_A* 3uoj_A* 3uok_A* 3uo4_A* 3uol_A* 3up7_A* 4dea_A* 4deb_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=2e-46 Score=312.72 Aligned_cols=250 Identities=29% Similarity=0.417 Sum_probs=200.1
Q ss_pred HhCCCCCCceeecCCcceEEEEEeC-CCcEEEEEEeccCcCC-hhhhHHHHHHHHHHHhcCCcceeeeeeEEEcCCCeeE
Q 038766 10 ATGSFSENNIIGNSNLSTVYKGRLE-DGEIVAVKKLNFHQFS-AESDKSFYREAKTLKELKHRNLVKVLGYAWESGKLKA 87 (299)
Q Consensus 10 ~~~~y~~~~~lg~g~~~~v~~~~~~-~~~~~~vK~~~~~~~~-~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~ 87 (299)
..++|.+.+.||+|++|+||++.+. ++..||+|++...... ......+.+|+.+++.++||||+++++++.. +...+
T Consensus 7 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~-~~~~~ 85 (279)
T 3fdn_A 7 ALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLYGYFHD-ATRVY 85 (279)
T ss_dssp CGGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHHTCHHHHHHHHHHHTTCCCTTBCCEEEEEEC-SSEEE
T ss_pred ecccEEEeeEEecCCCeEEEEEEEccCCcEEEEEEEeccccchhhHHHHHHHHHHHHHcCCCCCCcchhheEec-CCEEE
Confidence 4678999999999999999999875 5789999998643221 2235678899999999999999999997655 55669
Q ss_pred EEEeecCCCChHHHhcCCCCCCCCCChhhHHHHHHHHHHHHHHhhcCCCCCeeeecccCCceeeCCCCcEEEeeeccccc
Q 038766 88 LILEYMENGSLESVIHGPGVDHSRWTLPKRIDVLISVANGLDYLHSGYDIPIVHCDMKPSNILLDRDFEAHVSDFGTSRM 167 (299)
Q Consensus 88 lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lh~~~~~~~~H~dl~~~nil~~~~~~v~l~df~~~~~ 167 (299)
+|+||+.+++|.+.+. ....+++..++.++.|++.||.|||+. +++|+||||+||+++.++.++|+|||++..
T Consensus 86 lv~e~~~~~~l~~~l~----~~~~~~~~~~~~~~~qi~~~l~~LH~~---~i~H~dlkp~Nili~~~~~~~l~Dfg~~~~ 158 (279)
T 3fdn_A 86 LILEYAPLGTVYRELQ----KLSKFDEQRTATYITELANALSYCHSK---RVIHRDIKPENLLLGSAGELKIADFGWSVH 158 (279)
T ss_dssp EEECCCTTEEHHHHHH----HHSSCCHHHHHHHHHHHHHHHHHHHTT---TCEECCCCGGGEEECTTSCEEECSCCEESC
T ss_pred EEEecCCCCcHHHHHH----hcCCCCHHHHHHHHHHHHHHHHHHHhC---CEecccCChHhEEEcCCCCEEEEecccccc
Confidence 9999999999999886 445799999999999999999999999 999999999999999999999999998854
Q ss_pred cccccccccccccccccCcccCChhhhcccCcCccccchhhhHHHHHHHhCCCCCCCCccCCCCchhHHHHHHHHHhcCc
Q 038766 168 LDVHLQDLSSLSTAFQGTIGYLAPEFAYMRIVTTKVDVFSFGIVVMEFLTKRRPTGLDEENGLSPISLRQLVEKALANGI 247 (299)
Q Consensus 168 ~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~DiwslG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 247 (299)
.. ........+++.|+|||.+.+..++.++||||||+++|+|++|..||.... .. +..........
T Consensus 159 ~~------~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~-----~~---~~~~~~~~~~~ 224 (279)
T 3fdn_A 159 AP------SSRRTDLCGTLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEANT-----YQ---ETYKRISRVEF 224 (279)
T ss_dssp C--------------CCCCTTCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCTTCCSS-----HH---HHHHHHHHTCC
T ss_pred CC------cccccccCCCCCccCHhHhccCCCCccchhHhHHHHHHHHHHCCCCCCCCc-----HH---HHHHHHHhCCC
Confidence 33 122334567899999999999999999999999999999999999995331 11 12211111110
Q ss_pred cCcccccCccccchhhHhHHHHHHHHHHHHHHHHhcCCCCCCCCChhhhhcC
Q 038766 248 NGVRQITDPKLVSSIYEEQEQHQVLEELFKLALVCTSSNPEDRPNMNELLIT 299 (299)
Q Consensus 248 ~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rpt~~~il~~ 299 (299)
.. +..++..+.+||.+||..||++|||++++++|
T Consensus 225 -~~-----------------~~~~~~~~~~li~~~l~~~p~~Rps~~e~l~h 258 (279)
T 3fdn_A 225 -TF-----------------PDFVTEGARDLISRLLKHNPSQRPMLREVLEH 258 (279)
T ss_dssp -CC-----------------CTTSCHHHHHHHHHHCCSSGGGSCCHHHHHHC
T ss_pred -CC-----------------CCcCCHHHHHHHHHHhccChhhCCCHHHHhhC
Confidence 00 11234678999999999999999999999987
|
| >1cm8_A Phosphorylated MAP kinase P38-gamma; phosphorylation, transferase; HET: TPO PTR ANP; 2.40A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=2.6e-46 Score=323.51 Aligned_cols=263 Identities=22% Similarity=0.278 Sum_probs=199.2
Q ss_pred HhCCCCCCceeecCCcceEEEEEe-CCCcEEEEEEeccCcCChhhhHHHHHHHHHHHhcCCcceeeeeeEEEcCC-----
Q 038766 10 ATGSFSENNIIGNSNLSTVYKGRL-EDGEIVAVKKLNFHQFSAESDKSFYREAKTLKELKHRNLVKVLGYAWESG----- 83 (299)
Q Consensus 10 ~~~~y~~~~~lg~g~~~~v~~~~~-~~~~~~~vK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~----- 83 (299)
+.++|++.+.||+|+||.||+|.+ .+|+.||+|++..........+.+.+|+.+++.++||||+++++++...+
T Consensus 23 ~~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~~~ 102 (367)
T 1cm8_A 23 VRAVYRDLQPVGSGAYGAVCSAVDGRTGAKVAIKKLYRPFQSELFAKRAYRELRLLKHMRHENVIGLLDVFTPDETLDDF 102 (367)
T ss_dssp CBSSEEEEEEC------CEEEEEETTTCCEEEEEECSSTTSSHHHHHHHHHHHHHHHHCCBTTBCCCSEEECSCSSTTTC
T ss_pred ecceEEEeEEeeecCCeEEEEEEECCCCCEEEEEEeCccccCHHHHHHHHHHHHHHHhCCCcCCCCceeeEecCCccccC
Confidence 467899999999999999999987 46999999999765555566778899999999999999999999776543
Q ss_pred CeeEEEEeecCCCChHHHhcCCCCCCCCCChhhHHHHHHHHHHHHHHhhcCCCCCeeeecccCCceeeCCCCcEEEeeec
Q 038766 84 KLKALILEYMENGSLESVIHGPGVDHSRWTLPKRIDVLISVANGLDYLHSGYDIPIVHCDMKPSNILLDRDFEAHVSDFG 163 (299)
Q Consensus 84 ~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lh~~~~~~~~H~dl~~~nil~~~~~~v~l~df~ 163 (299)
...++|+|++ +++|.+++.. ..+++..++.++.|++.||+|||++ +++|+||||+||+++.++.+||+|||
T Consensus 103 ~~~~lv~e~~-~~~L~~~~~~-----~~l~~~~~~~~~~qi~~~L~~LH~~---~ivH~Dlkp~NIll~~~~~~kl~Dfg 173 (367)
T 1cm8_A 103 TDFYLVMPFM-GTDLGKLMKH-----EKLGEDRIQFLVYQMLKGLRYIHAA---GIIHRDLKPGNLAVNEDCELKILDFG 173 (367)
T ss_dssp CCCEEEEECC-SEEHHHHHHH-----CCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEECTTCCEEECCCT
T ss_pred ceEEEEEecC-CCCHHHHHhc-----CCCCHHHHHHHHHHHHHHHHHHHHC---CccccCcCHHHEEEcCCCCEEEEeee
Confidence 3358999999 7799999852 4689999999999999999999999 99999999999999999999999999
Q ss_pred cccccccccccccccccccccCcccCChhhhcc-cCcCccccchhhhHHHHHHHhCCCCCCCCccCCCCchhHHHHHHHH
Q 038766 164 TSRMLDVHLQDLSSLSTAFQGTIGYLAPEFAYM-RIVTTKVDVFSFGIVVMEFLTKRRPTGLDEENGLSPISLRQLVEKA 242 (299)
Q Consensus 164 ~~~~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~-~~~~~~~DiwslG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~ 242 (299)
++..... ......+|+.|+|||++.+ ..++.++|||||||++|+|++|..||..... ......+...
T Consensus 174 ~a~~~~~-------~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~-----~~~l~~i~~~ 241 (367)
T 1cm8_A 174 LARQADS-------EMTGYVVTRWYRAPEVILNWMRYTQTVDIWSVGCIMAEMITGKTLFKGSDH-----LDQLKEIMKV 241 (367)
T ss_dssp TCEECCS-------SCCSSCSCGGGCCTHHHHTTTCCCTTHHHHHHHHHHHHHHHSSCSSCCSSH-----HHHHHHHHHH
T ss_pred ccccccc-------ccCcCcCCCCcCCHHHHhCCCCCChhhhHHHHHHHHHHHHhCCCCCCCCCH-----HHHHHHHHHh
Confidence 9976431 2334567899999998887 6789999999999999999999999964321 1111111111
Q ss_pred HhcCccC----------------cccccCccccchhhHhHHHHHHHHHHHHHHHHhcCCCCCCCCChhhhhcC
Q 038766 243 LANGING----------------VRQITDPKLVSSIYEEQEQHQVLEELFKLALVCTSSNPEDRPNMNELLIT 299 (299)
Q Consensus 243 ~~~~~~~----------------~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rpt~~~il~~ 299 (299)
....... ........+. ......+..+.+||.+||..||++|||++++|+|
T Consensus 242 ~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~------~~~~~~~~~~~~ll~~mL~~dP~~R~t~~e~l~h 308 (367)
T 1cm8_A 242 TGTPPAEFVQRLQSDEAKNYMKGLPELEKKDFA------SILTNASPLAVNLLEKMLVLDAEQRVTAGEALAH 308 (367)
T ss_dssp HCCCCHHHHHTCSCHHHHHHHHHSCCCCCCCGG------GTCTTCCHHHHHHHHHHSCSSTTTSCCHHHHHHS
T ss_pred cCCCCHHHHHHhhhHHHHHHHHhCCCCCCCCHH------HHCCCCCHHHHHHHHHHccCChhHCCCHHHHhcC
Confidence 1000000 0000000000 0122346789999999999999999999999987
|
| >2w4o_A Calcium/calmodulin-dependent protein kinase type IV; calmodulin-binding, nucleotide-binding, serine/threonine-protein kinase, ATP-binding; HET: DKI; 2.17A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.6e-46 Score=319.98 Aligned_cols=255 Identities=24% Similarity=0.302 Sum_probs=190.9
Q ss_pred HHHHhCCCCCCceeecCCcceEEEEEeC-CCcEEEEEEeccCcCChhhhHHHHHHHHHHHhcCCcceeeeeeEEEcCCCe
Q 038766 7 IENATGSFSENNIIGNSNLSTVYKGRLE-DGEIVAVKKLNFHQFSAESDKSFYREAKTLKELKHRNLVKVLGYAWESGKL 85 (299)
Q Consensus 7 ~~~~~~~y~~~~~lg~g~~~~v~~~~~~-~~~~~~vK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~ 85 (299)
.+.+.++|.+.+.||+|+||+||++.+. +++.||+|++... ...+.+.+|+.++++++||||+++++++.. +..
T Consensus 48 ~~~~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~----~~~~~~~~E~~~l~~l~h~niv~~~~~~~~-~~~ 122 (349)
T 2w4o_A 48 RDALSDFFEVESELGRGATSIVYRCKQKGTQKPYALKVLKKT----VDKKIVRTEIGVLLRLSHPNIIKLKEIFET-PTE 122 (349)
T ss_dssp CSCGGGTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEC--------------CHHHHHCCCTTBCCEEEEEEC-SSE
T ss_pred cccccCcEEEeeEEeeCCCEEEEEEEECCCCcEEEEEEeccc----hhHHHHHHHHHHHHhCCCCCCcceeeeEec-CCe
Confidence 3456788999999999999999999875 5889999998643 234567889999999999999999997655 556
Q ss_pred eEEEEeecCCCChHHHhcCCCCCCCCCChhhHHHHHHHHHHHHHHhhcCCCCCeeeecccCCceeeCC---CCcEEEeee
Q 038766 86 KALILEYMENGSLESVIHGPGVDHSRWTLPKRIDVLISVANGLDYLHSGYDIPIVHCDMKPSNILLDR---DFEAHVSDF 162 (299)
Q Consensus 86 ~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lh~~~~~~~~H~dl~~~nil~~~---~~~v~l~df 162 (299)
.++|+||+.+++|.+++. ....+++.+++.++.|++.||.|||+. +++|+||||+||+++. ++.++|+||
T Consensus 123 ~~lv~e~~~~~~L~~~l~----~~~~~~~~~~~~i~~qi~~~L~~LH~~---~ivH~Dikp~NIll~~~~~~~~~kl~Df 195 (349)
T 2w4o_A 123 ISLVLELVTGGELFDRIV----EKGYYSERDAADAVKQILEAVAYLHEN---GIVHRDLKPENLLYATPAPDAPLKIADF 195 (349)
T ss_dssp EEEEECCCCSCBHHHHHT----TCSSCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEESSSSTTCCEEECCC
T ss_pred EEEEEEeCCCCCHHHHHH----hcCCCCHHHHHHHHHHHHHHHHHHHHC---CeEecCCCcccEEEecCCCCCCEEEccC
Confidence 799999999999999987 445799999999999999999999999 9999999999999975 889999999
Q ss_pred ccccccccccccccccccccccCcccCChhhhcccCcCccccchhhhHHHHHHHhCCCCCCCCccCCCCchhHHHHHHHH
Q 038766 163 GTSRMLDVHLQDLSSLSTAFQGTIGYLAPEFAYMRIVTTKVDVFSFGIVVMEFLTKRRPTGLDEENGLSPISLRQLVEKA 242 (299)
Q Consensus 163 ~~~~~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~DiwslG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~ 242 (299)
|++..... ........+++.|+|||++.+..++.++|||||||++|+|++|..||...... .......
T Consensus 196 g~a~~~~~-----~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~-------~~~~~~i 263 (349)
T 2w4o_A 196 GLSKIVEH-----QVLMKTVCGTPGYCAPEILRGCAYGPEVDMWSVGIITYILLCGFEPFYDERGD-------QFMFRRI 263 (349)
T ss_dssp C---------------------CGGGSCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCTTCCTTCH-------HHHHHHH
T ss_pred ccccccCc-----ccccccccCCCCccCHHHhcCCCCCcccchHHHHHHHHHHHhCCCCCCCCccc-------HHHHHHH
Confidence 99875432 12233456899999999999999999999999999999999999998533111 1112222
Q ss_pred HhcCccCcccccCccccchhhHhHHHHHHHHHHHHHHHHhcCCCCCCCCChhhhhcC
Q 038766 243 LANGINGVRQITDPKLVSSIYEEQEQHQVLEELFKLALVCTSSNPEDRPNMNELLIT 299 (299)
Q Consensus 243 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rpt~~~il~~ 299 (299)
..... ....+ ....++.++.+||++||..||++|||++++|+|
T Consensus 264 ~~~~~----~~~~~----------~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~h 306 (349)
T 2w4o_A 264 LNCEY----YFISP----------WWDEVSLNAKDLVRKLIVLDPKKRLTTFQALQH 306 (349)
T ss_dssp HTTCC----CCCTT----------TTTTSCHHHHHHHHTTSCSSGGGSCCHHHHHHS
T ss_pred HhCCC----ccCCc----------hhhhCCHHHHHHHHHHccCChhhCcCHHHHhcC
Confidence 11110 00000 012345679999999999999999999999987
|
| >1t4h_A Serine/threonine-protein kinase WNK1; protein serine/threonine kinase, transferase; 1.80A {Rattus norvegicus} PDB: 3fpq_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2.6e-46 Score=313.68 Aligned_cols=251 Identities=24% Similarity=0.360 Sum_probs=202.1
Q ss_pred CCCCCCceeecCCcceEEEEEeC-CCcEEEEEEeccCcCChhhhHHHHHHHHHHHhcCCcceeeeeeEEEcC---CCeeE
Q 038766 12 GSFSENNIIGNSNLSTVYKGRLE-DGEIVAVKKLNFHQFSAESDKSFYREAKTLKELKHRNLVKVLGYAWES---GKLKA 87 (299)
Q Consensus 12 ~~y~~~~~lg~g~~~~v~~~~~~-~~~~~~vK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~---~~~~~ 87 (299)
..|++.+.||+|+||+||+|.+. ++..||+|++............+.+|+.+++.++||||+++++++... +...+
T Consensus 26 ~~~~~~~~lg~G~~g~Vy~~~~~~~~~~va~k~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~ 105 (290)
T 1t4h_A 26 RFLKFDIEIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQHPNIVRFYDSWESTVKGKKCIV 105 (290)
T ss_dssp CEEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEEESSSCEEEE
T ss_pred eeEEeeeeccCCCCeEEEEeEecCCceEEEEEEecchhhCHHHHHHHHHHHHHHHhCCCCCeeeeeeeeccccCCCceEE
Confidence 34788889999999999999874 588999999987666777788899999999999999999999977542 45679
Q ss_pred EEEeecCCCChHHHhcCCCCCCCCCChhhHHHHHHHHHHHHHHhhcCCCCC--eeeecccCCceeeC-CCCcEEEeeecc
Q 038766 88 LILEYMENGSLESVIHGPGVDHSRWTLPKRIDVLISVANGLDYLHSGYDIP--IVHCDMKPSNILLD-RDFEAHVSDFGT 164 (299)
Q Consensus 88 lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lh~~~~~~--~~H~dl~~~nil~~-~~~~v~l~df~~ 164 (299)
+|+||+.+++|.+++. ....+++..++.++.|++.||.|||+. + ++|+||||+||+++ .++.++|+|||+
T Consensus 106 lv~e~~~~~~L~~~l~----~~~~~~~~~~~~~~~qi~~~l~~lH~~---~~~i~H~dikp~Nil~~~~~~~~kl~Dfg~ 178 (290)
T 1t4h_A 106 LVTELMTSGTLKTYLK----RFKVMKIKVLRSWCRQILKGLQFLHTR---TPPIIHRDLKCDNIFITGPTGSVKIGDLGL 178 (290)
T ss_dssp EEEECCCSCBHHHHHH----HHSSCCHHHHHHHHHHHHHHHHHHHTS---SSCCCCSCCCGGGEEESSTTSCEEECCTTG
T ss_pred EEEEecCCCCHHHHHH----HccCCCHHHHHHHHHHHHHHHHHHHcC---CCCEEECCCCHHHEEEECCCCCEEEeeCCC
Confidence 9999999999999997 446789999999999999999999998 8 99999999999998 789999999999
Q ss_pred ccccccccccccccccccccCcccCChhhhcccCcCccccchhhhHHHHHHHhCCCCCCCCccCCCCchhHHHHHHHHHh
Q 038766 165 SRMLDVHLQDLSSLSTAFQGTIGYLAPEFAYMRIVTTKVDVFSFGIVVMEFLTKRRPTGLDEENGLSPISLRQLVEKALA 244 (299)
Q Consensus 165 ~~~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~DiwslG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~ 244 (299)
+.... ........+++.|+|||.+.+ .++.++||||||+++|+|++|..||..... ....... ..
T Consensus 179 ~~~~~------~~~~~~~~~t~~y~aPE~~~~-~~~~~~Di~slG~~l~~l~~g~~pf~~~~~-------~~~~~~~-~~ 243 (290)
T 1t4h_A 179 ATLKR------ASFAKAVIGTPEFMAPEMYEE-KYDESVDVYAFGMCMLEMATSEYPYSECQN-------AAQIYRR-VT 243 (290)
T ss_dssp GGGCC------TTSBEESCSSCCCCCGGGGGT-CCCTHHHHHHHHHHHHHHHHSSCTTTTCSS-------HHHHHHH-HT
T ss_pred ccccc------ccccccccCCcCcCCHHHHhc-cCCCcchHHHHHHHHHHHHhCCCCCCCcCc-------HHHHHHH-Hh
Confidence 86433 122334568899999998774 489999999999999999999999953211 1111111 11
Q ss_pred cCccCcccccCccccchhhHhHHHHHHHHHHHHHHHHhcCCCCCCCCChhhhhcC
Q 038766 245 NGINGVRQITDPKLVSSIYEEQEQHQVLEELFKLALVCTSSNPEDRPNMNELLIT 299 (299)
Q Consensus 245 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rpt~~~il~~ 299 (299)
..... . ......++++.++|.+||..||++|||++++|+|
T Consensus 244 ~~~~~------~---------~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~h 283 (290)
T 1t4h_A 244 SGVKP------A---------SFDKVAIPEVKEIIEGCIRQNKDERYSIKDLLNH 283 (290)
T ss_dssp TTCCC------G---------GGGGCCCHHHHHHHHHHSCSSGGGSCCHHHHHTS
T ss_pred ccCCc------c---------ccCCCCCHHHHHHHHHHccCChhhCCCHHHHhhC
Confidence 11000 0 0012223579999999999999999999999987
|
| >3sxs_A Cytoplasmic tyrosine-protein kinase BMX; transferase-transferase inhibitor complex; HET: PP2; 1.89A {Homo sapiens} SCOP: d.144.1.7 PDB: 3sxr_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-46 Score=312.01 Aligned_cols=255 Identities=25% Similarity=0.387 Sum_probs=203.7
Q ss_pred HHHHhCCCCCCceeecCCcceEEEEEeCCCcEEEEEEeccCcCChhhhHHHHHHHHHHHhcCCcceeeeeeEEEcCCCee
Q 038766 7 IENATGSFSENNIIGNSNLSTVYKGRLEDGEIVAVKKLNFHQFSAESDKSFYREAKTLKELKHRNLVKVLGYAWESGKLK 86 (299)
Q Consensus 7 ~~~~~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~vK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~ 86 (299)
++...++|++.+.||+|+||+||++.+.++..||+|++.... ...+.+.+|+..+++++||||+++++++.. +...
T Consensus 3 ~~l~~~~y~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~---~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~-~~~~ 78 (268)
T 3sxs_A 3 MELKREEITLLKELGSGQFGVVKLGKWKGQYDVAVKMIKEGS---MSEDEFFQEAQTMMKLSHPKLVKFYGVCSK-EYPI 78 (268)
T ss_dssp TBCCGGGEEEEEEEEEETTEEEEEEEETTTEEEEEEEECBTT---BCHHHHHHHHHHHHHCCCTTBCCEEEEECS-SSSE
T ss_pred eEechhheeeeeeeccCCCceEEEEEecCceeEEEEEeccCC---CcHHHHHHHHHHHHhCCCCCEeeEEEEEcc-CCce
Confidence 455678999999999999999999999888899999986433 334678899999999999999999996654 5556
Q ss_pred EEEEeecCCCChHHHhcCCCCCCCCCChhhHHHHHHHHHHHHHHhhcCCCCCeeeecccCCceeeCCCCcEEEeeecccc
Q 038766 87 ALILEYMENGSLESVIHGPGVDHSRWTLPKRIDVLISVANGLDYLHSGYDIPIVHCDMKPSNILLDRDFEAHVSDFGTSR 166 (299)
Q Consensus 87 ~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lh~~~~~~~~H~dl~~~nil~~~~~~v~l~df~~~~ 166 (299)
++|+||+++++|.+++.. ....+++..++.++.|++.||+|||+. +++|+||||+||+++.++.++|+|||++.
T Consensus 79 ~lv~e~~~~~~L~~~l~~---~~~~~~~~~~~~i~~qi~~~l~~lH~~---~i~H~dikp~Nil~~~~~~~~l~Dfg~~~ 152 (268)
T 3sxs_A 79 YIVTEYISNGCLLNYLRS---HGKGLEPSQLLEMCYDVCEGMAFLESH---QFIHRDLAARNCLVDRDLCVKVSDFGMTR 152 (268)
T ss_dssp EEEEECCTTCBHHHHHHH---HGGGCCHHHHHHHHHHHHHHHHHHHHT---TEEESSCSGGGEEECTTCCEEECCTTCEE
T ss_pred EEEEEccCCCcHHHHHHH---cCCCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCcCcceEEECCCCCEEEccCccce
Confidence 999999999999998863 234689999999999999999999999 99999999999999999999999999987
Q ss_pred ccccccccccccccccccCcccCChhhhcccCcCccccchhhhHHHHHHHh-CCCCCCCCccCCCCchhHHHHHHHHHhc
Q 038766 167 MLDVHLQDLSSLSTAFQGTIGYLAPEFAYMRIVTTKVDVFSFGIVVMEFLT-KRRPTGLDEENGLSPISLRQLVEKALAN 245 (299)
Q Consensus 167 ~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~DiwslG~~l~~l~~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~ 245 (299)
..... .........+++.|+|||.+.+..++.++||||||+++|+|++ |..||.... .. .........
T Consensus 153 ~~~~~---~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~-----~~---~~~~~~~~~ 221 (268)
T 3sxs_A 153 YVLDD---QYVSSVGTKFPVKWSAPEVFHYFKYSSKSDVWAFGILMWEVFSLGKMPYDLYT-----NS---EVVLKVSQG 221 (268)
T ss_dssp ECCTT---CEEECCSCCCCGGGCCHHHHHHSEEETTHHHHHHHHHHHHHHTTTCCTTTTSC-----HH---HHHHHHHTT
T ss_pred ecchh---hhhcccCCCcCcccCCHHHHhccCCchhhhhHHHHHHHHHHHcCCCCCccccC-----hH---HHHHHHHcC
Confidence 55421 1112233445678999999999899999999999999999998 999985331 11 111111111
Q ss_pred CccCcccccCccccchhhHhHHHHHHHHHHHHHHHHhcCCCCCCCCChhhhhcC
Q 038766 246 GINGVRQITDPKLVSSIYEEQEQHQVLEELFKLALVCTSSNPEDRPNMNELLIT 299 (299)
Q Consensus 246 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rpt~~~il~~ 299 (299)
. .... +...++.+.+++.+||..||++|||+++++++
T Consensus 222 ~-----~~~~------------~~~~~~~l~~li~~~l~~~p~~Rps~~~ll~~ 258 (268)
T 3sxs_A 222 H-----RLYR------------PHLASDTIYQIMYSCWHELPEKRPTFQQLLSS 258 (268)
T ss_dssp C-----CCCC------------CTTSCHHHHHHHHHTTCSSGGGSCCHHHHHHH
T ss_pred C-----CCCC------------CCcChHHHHHHHHHHcCCChhhCcCHHHHHHH
Confidence 1 0000 11124578999999999999999999999864
|
| >3kn6_A Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1, MSK, ATP-binding, metal-binding, NUCL binding, serine/threonine-protein kinase, transferase; 2.00A {Homo sapiens} PDB: 3kn5_A | Back alignment and structure |
|---|
Probab=100.00 E-value=4.7e-46 Score=316.94 Aligned_cols=257 Identities=20% Similarity=0.273 Sum_probs=183.6
Q ss_pred hCCCCC---CceeecCCcceEEEEEeC-CCcEEEEEEeccCcCChhhhHHHHHHHHHHHhcC-CcceeeeeeEEEcCCCe
Q 038766 11 TGSFSE---NNIIGNSNLSTVYKGRLE-DGEIVAVKKLNFHQFSAESDKSFYREAKTLKELK-HRNLVKVLGYAWESGKL 85 (299)
Q Consensus 11 ~~~y~~---~~~lg~g~~~~v~~~~~~-~~~~~~vK~~~~~~~~~~~~~~~~~e~~~l~~l~-h~~i~~~~~~~~~~~~~ 85 (299)
.++|.+ .+.||+|+||+||++.+. +++.||+|++.. .......+|+..++.+. ||||+++++++.. +..
T Consensus 7 ~~~y~~~~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~-----~~~~~~~~e~~~l~~l~~h~niv~~~~~~~~-~~~ 80 (325)
T 3kn6_A 7 YQHYDLDLKDKPLGEGSFSICRKCVHKKSNQAFAVKIISK-----RMEANTQKEITALKLCEGHPNIVKLHEVFHD-QLH 80 (325)
T ss_dssp HHHEEECTTSCCSEEETTEEEEEEEETTTCCEEEEEEEEG-----GGHHHHHHHHHHHHHTTTCTTBCCEEEEEEC-SSE
T ss_pred hhccccccCCCccccCCCeEEEEEEECCCCCEEEEEEECh-----hhhhhHHHHHHHHHHhcCCCCeeEEEEEEEc-CCE
Confidence 344554 488999999999999874 589999999852 34567788999999997 9999999997655 556
Q ss_pred eEEEEeecCCCChHHHhcCCCCCCCCCChhhHHHHHHHHHHHHHHhhcCCCCCeeeecccCCceeeCCCC---cEEEeee
Q 038766 86 KALILEYMENGSLESVIHGPGVDHSRWTLPKRIDVLISVANGLDYLHSGYDIPIVHCDMKPSNILLDRDF---EAHVSDF 162 (299)
Q Consensus 86 ~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lh~~~~~~~~H~dl~~~nil~~~~~---~v~l~df 162 (299)
.++|+||+.+++|.+++. ....+++.+++.++.|++.||+|||++ +++|+||||+||+++.++ .++|+||
T Consensus 81 ~~lv~e~~~~~~L~~~l~----~~~~~~~~~~~~i~~qi~~~l~~LH~~---~ivH~Dlkp~NIll~~~~~~~~~kl~Df 153 (325)
T 3kn6_A 81 TFLVMELLNGGELFERIK----KKKHFSETEASYIMRKLVSAVSHMHDV---GVVHRDLKPENLLFTDENDNLEIKIIDF 153 (325)
T ss_dssp EEEEECCCCSCBHHHHHH----HCSCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEEEC----CEEEECCC
T ss_pred EEEEEEccCCCcHHHHHH----hcCCCCHHHHHHHHHHHHHHHHHHHHC---CCeecCCCHHHEEEecCCCcccEEEecc
Confidence 699999999999999987 456799999999999999999999999 999999999999998765 7999999
Q ss_pred ccccccccccccccccccccccCcccCChhhhcccCcCccccchhhhHHHHHHHhCCCCCCCCccCCCCchhHHHHHHHH
Q 038766 163 GTSRMLDVHLQDLSSLSTAFQGTIGYLAPEFAYMRIVTTKVDVFSFGIVVMEFLTKRRPTGLDEENGLSPISLRQLVEKA 242 (299)
Q Consensus 163 ~~~~~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~DiwslG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~ 242 (299)
|++...... ........+++.|+|||++.+..++.++||||||+++|+|++|..||........ .....+.+...
T Consensus 154 g~a~~~~~~----~~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~-~~~~~~~~~~i 228 (325)
T 3kn6_A 154 GFARLKPPD----NQPLKTPCFTLHYAAPELLNQNGYDESCDLWSLGVILYTMLSGQVPFQSHDRSLT-CTSAVEIMKKI 228 (325)
T ss_dssp TTCEECCC--------------------------CCCCHHHHHHHHHHHHHHHHHSSCTTC--------CCCHHHHHHHH
T ss_pred ccceecCCC----CCcccccCCCcCccCHHHhcCCCCCCccchHHHHHHHHHHHhCCCCCCCCccccc-cccHHHHHHHH
Confidence 999754321 2223345578999999999999999999999999999999999999965432211 11122222222
Q ss_pred HhcCccCcccccCccccchhhHhHHHHHHHHHHHHHHHHhcCCCCCCCCChhhhhcC
Q 038766 243 LANGINGVRQITDPKLVSSIYEEQEQHQVLEELFKLALVCTSSNPEDRPNMNELLIT 299 (299)
Q Consensus 243 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rpt~~~il~~ 299 (299)
..... .. .......+++++.+||.+||..||++|||++++++|
T Consensus 229 ~~~~~----~~----------~~~~~~~~s~~~~~li~~~L~~dP~~Rpt~~ell~h 271 (325)
T 3kn6_A 229 KKGDF----SF----------EGEAWKNVSQEAKDLIQGLLTVDPNKRLKMSGLRYN 271 (325)
T ss_dssp TTTCC----CC----------CSHHHHTSCHHHHHHHHHHHCCCTTTCCCTTTSTTC
T ss_pred HcCCC----CC----------CcccccCCCHHHHHHHHHHCCCChhHCCCHHHHhcC
Confidence 11110 00 011134567789999999999999999999999987
|
| >2i0e_A Protein kinase C-beta II; serine/threonine protein kinase, transferase; HET: TPO SEP PDS; 2.60A {Homo sapiens} PDB: 3iw4_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.2e-46 Score=321.76 Aligned_cols=253 Identities=20% Similarity=0.280 Sum_probs=203.4
Q ss_pred HHhCCCCCCceeecCCcceEEEEEeCC-CcEEEEEEeccCcC-ChhhhHHHHHHHHHHHhc-CCcceeeeeeEEEcCCCe
Q 038766 9 NATGSFSENNIIGNSNLSTVYKGRLED-GEIVAVKKLNFHQF-SAESDKSFYREAKTLKEL-KHRNLVKVLGYAWESGKL 85 (299)
Q Consensus 9 ~~~~~y~~~~~lg~g~~~~v~~~~~~~-~~~~~vK~~~~~~~-~~~~~~~~~~e~~~l~~l-~h~~i~~~~~~~~~~~~~ 85 (299)
.-.++|.+.+.||+|+||.||+|.+.. ++.||+|++..... .....+.+..|..+++.+ .||+|+++++++.. ...
T Consensus 17 ~~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~AiK~~~~~~~~~~~~~~~~~~E~~~l~~~~~hp~iv~l~~~~~~-~~~ 95 (353)
T 2i0e_A 17 MKLTDFNFLMVLGKGSFGKVMLSERKGTDELYAVKILKKDVVIQDDDVECTMVEKRVLALPGKPPFLTQLHSCFQT-MDR 95 (353)
T ss_dssp --CTTEEEEEEEEEETTEEEEEEEETTEEEEEEEEEEEHHHHHHTTCHHHHHHHHHHHTCTTCCTTBCCEEEEEEC-SSE
T ss_pred CchHHcEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhcchHHHHHHHHHHHHHhcCCCCEEeeEEEEEEc-CCE
Confidence 346889999999999999999998754 88999999864322 223456778899999888 69999999996654 556
Q ss_pred eEEEEeecCCCChHHHhcCCCCCCCCCChhhHHHHHHHHHHHHHHhhcCCCCCeeeecccCCceeeCCCCcEEEeeeccc
Q 038766 86 KALILEYMENGSLESVIHGPGVDHSRWTLPKRIDVLISVANGLDYLHSGYDIPIVHCDMKPSNILLDRDFEAHVSDFGTS 165 (299)
Q Consensus 86 ~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lh~~~~~~~~H~dl~~~nil~~~~~~v~l~df~~~ 165 (299)
.++||||+.+++|.+++. ....+++..++.++.||+.||.|||++ +++||||||+||+++.+|.++|+|||++
T Consensus 96 ~~lv~E~~~gg~L~~~l~----~~~~~~~~~~~~~~~qi~~aL~~LH~~---givHrDlkp~NIll~~~g~vkL~DFG~a 168 (353)
T 2i0e_A 96 LYFVMEYVNGGDLMYHIQ----QVGRFKEPHAVFYAAEIAIGLFFLQSK---GIIYRDLKLDNVMLDSEGHIKIADFGMC 168 (353)
T ss_dssp EEEEEECCCSCBHHHHHH----HHSSCCHHHHHHHHHHHHHHHHHHHHT---TCBCCCCCGGGEEECTTSCEEECCCTTC
T ss_pred EEEEEeCCCCCcHHHHHH----hcCCCCHHHHHHHHHHHHHHHHHHHHC---CEEeccCCHHHEEEcCCCcEEEEeCCcc
Confidence 799999999999999987 345799999999999999999999999 9999999999999999999999999998
Q ss_pred cccccccccccccccccccCcccCChhhhcccCcCccccchhhhHHHHHHHhCCCCCCCCccCCCCchhHHHHHHHHHhc
Q 038766 166 RMLDVHLQDLSSLSTAFQGTIGYLAPEFAYMRIVTTKVDVFSFGIVVMEFLTKRRPTGLDEENGLSPISLRQLVEKALAN 245 (299)
Q Consensus 166 ~~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~DiwslG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~ 245 (299)
..... .........+|+.|+|||++.+..++.++|+|||||++|+|++|..||.... . .+....+...
T Consensus 169 ~~~~~----~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~G~~Pf~~~~-----~---~~~~~~i~~~ 236 (353)
T 2i0e_A 169 KENIW----DGVTTKTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQAPFEGED-----E---DELFQSIMEH 236 (353)
T ss_dssp BCCCC----TTCCBCCCCSCGGGCCHHHHTTCCBSTHHHHHHHHHHHHHHHHSSCSSCCSS-----H---HHHHHHHHHC
T ss_pred ccccc----CCcccccccCCccccChhhhcCCCcCCcccccchHHHHHHHHcCCCCCCCCC-----H---HHHHHHHHhC
Confidence 75321 1223345578999999999999999999999999999999999999995431 1 1222222221
Q ss_pred CccCcccccCccccchhhHhHHHHHHHHHHHHHHHHhcCCCCCCCCC-----hhhhhcC
Q 038766 246 GINGVRQITDPKLVSSIYEEQEQHQVLEELFKLALVCTSSNPEDRPN-----MNELLIT 299 (299)
Q Consensus 246 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rpt-----~~~il~~ 299 (299)
.. . + +..++.++.+||++||..||++||+ ++++++|
T Consensus 237 ~~-~---~--------------p~~~s~~~~~li~~lL~~dP~~R~~~~~~~~~~i~~h 277 (353)
T 2i0e_A 237 NV-A---Y--------------PKSMSKEAVAICKGLMTKHPGKRLGCGPEGERDIKEH 277 (353)
T ss_dssp CC-C---C--------------CTTSCHHHHHHHHHHTCSCTTSCTTCSTTHHHHHHTS
T ss_pred CC-C---C--------------CCCCCHHHHHHHHHHhhcCHHHcCCCCCCCHHHHhcC
Confidence 10 0 0 1234568999999999999999995 5888876
|
| >3f3z_A Calcium/calmodulin-dependent protein kinase with domain and 4 calmodulin like EF...; calcium dependent protein kinase; HET: SEP DRK; 1.84A {Cryptosporidium parvum iowa II} PDB: 2qg5_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-45 Score=307.12 Aligned_cols=254 Identities=19% Similarity=0.222 Sum_probs=203.8
Q ss_pred HHHhCCCCCCceeecCCcceEEEEEeC-CCcEEEEEEeccCcCChhhhHHHHHHHHHHHhcCCcceeeeeeEEEcCCCee
Q 038766 8 ENATGSFSENNIIGNSNLSTVYKGRLE-DGEIVAVKKLNFHQFSAESDKSFYREAKTLKELKHRNLVKVLGYAWESGKLK 86 (299)
Q Consensus 8 ~~~~~~y~~~~~lg~g~~~~v~~~~~~-~~~~~~vK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~ 86 (299)
..+.++|++.+.||+|+||+||++.+. ++..+|+|++.... ....+.+.+|+++++.++||||+++++++.. +...
T Consensus 5 ~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~a~k~~~~~~--~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~-~~~~ 81 (277)
T 3f3z_A 5 GDINQYYTLENTIGRGSWGEVKIAVQKGTRIRRAAKKIPKYF--VEDVDRFKQEIEIMKSLDHPNIIRLYETFED-NTDI 81 (277)
T ss_dssp -CHHHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGG--CSCHHHHHHHHHHHHTCCCTTBCCEEEEEEC-SSEE
T ss_pred hhhhhhEEeeeEEeecCCEEEEEEEeCCCCcEEEEEeehhhc--cchHHHHHHHHHHHHhCCCCCEeeEEEEEec-CCeE
Confidence 456789999999999999999999875 47899999986432 3346788999999999999999999997655 5566
Q ss_pred EEEEeecCCCChHHHhcCCCCCCCCCChhhHHHHHHHHHHHHHHhhcCCCCCeeeecccCCceee---CCCCcEEEeeec
Q 038766 87 ALILEYMENGSLESVIHGPGVDHSRWTLPKRIDVLISVANGLDYLHSGYDIPIVHCDMKPSNILL---DRDFEAHVSDFG 163 (299)
Q Consensus 87 ~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lh~~~~~~~~H~dl~~~nil~---~~~~~v~l~df~ 163 (299)
++|+||+.+++|.+.+. ....+++..++.++.|++.||+|||++ +++|+||||+||++ +.++.++|+|||
T Consensus 82 ~lv~e~~~~~~L~~~~~----~~~~~~~~~~~~i~~~i~~~l~~lH~~---~i~H~dlkp~Nil~~~~~~~~~~~l~Dfg 154 (277)
T 3f3z_A 82 YLVMELCTGGELFERVV----HKRVFRESDAARIMKDVLSAVAYCHKL---NVAHRDLKPENFLFLTDSPDSPLKLIDFG 154 (277)
T ss_dssp EEEEECCCSCBHHHHHH----HHCSCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEESSSSTTCCEEECCCT
T ss_pred EEEEeccCCCcHHHHHH----HcCCCCHHHHHHHHHHHHHHHHHHHHC---CccCCCCCHHHEEEecCCCCCcEEEEecc
Confidence 99999999999999886 445799999999999999999999999 99999999999999 788999999999
Q ss_pred cccccccccccccccccccccCcccCChhhhcccCcCccccchhhhHHHHHHHhCCCCCCCCccCCCCchhHHHHHHHHH
Q 038766 164 TSRMLDVHLQDLSSLSTAFQGTIGYLAPEFAYMRIVTTKVDVFSFGIVVMEFLTKRRPTGLDEENGLSPISLRQLVEKAL 243 (299)
Q Consensus 164 ~~~~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~DiwslG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~ 243 (299)
++..... ........+++.|+|||.+.+. ++.++||||||+++|+|++|..||.... . .+......
T Consensus 155 ~~~~~~~-----~~~~~~~~~t~~y~aPE~~~~~-~~~~~Di~slG~~l~~l~~g~~p~~~~~-----~---~~~~~~~~ 220 (277)
T 3f3z_A 155 LAARFKP-----GKMMRTKVGTPYYVSPQVLEGL-YGPECDEWSAGVMMYVLLCGYPPFSAPT-----D---SEVMLKIR 220 (277)
T ss_dssp TCEECCT-----TSCBCCCCSCTTTCCHHHHTTC-BCTTHHHHHHHHHHHHHHHSSCSSCCSS-----H---HHHHHHHH
T ss_pred cceeccC-----ccchhccCCCCCccChHHhccc-CCchhhehhHHHHHHHHHHCCCCCCCCC-----H---HHHHHHHH
Confidence 9876542 2223445689999999988765 8999999999999999999999995432 1 12222211
Q ss_pred hcCccCcccccCccccchhhHhHHHHHHHHHHHHHHHHhcCCCCCCCCChhhhhcC
Q 038766 244 ANGINGVRQITDPKLVSSIYEEQEQHQVLEELFKLALVCTSSNPEDRPNMNELLIT 299 (299)
Q Consensus 244 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rpt~~~il~~ 299 (299)
.... . .. ......++..+.++|.+||..||++|||+.++|+|
T Consensus 221 ~~~~-~---~~----------~~~~~~~~~~~~~li~~~l~~dp~~R~s~~~~l~h 262 (277)
T 3f3z_A 221 EGTF-T---FP----------EKDWLNVSPQAESLIRRLLTKSPKQRITSLQALEH 262 (277)
T ss_dssp HCCC-C---CC----------HHHHTTSCHHHHHHHHHHTCSSTTTSCCHHHHTTS
T ss_pred hCCC-C---CC----------chhhhcCCHHHHHHHHHHccCChhhCcCHHHHhcC
Confidence 1110 0 00 00122356789999999999999999999999987
|
| >2qr7_A Ribosomal protein S6 kinase alpha-3; kinase domain, RSK2, autoinhibitory, ATP-binding, nucleotide phosphorylation, serine/threonine-protein kinase; 2.00A {Mus musculus} PDB: 2qr8_A 4d9t_A* 4d9u_A* 3rny_A 2wnt_A | Back alignment and structure |
|---|
Probab=100.00 E-value=6.6e-46 Score=317.86 Aligned_cols=256 Identities=20% Similarity=0.258 Sum_probs=200.1
Q ss_pred HHHHhCCCCCCceeecCCcceEEEEEeC-CCcEEEEEEeccCcCChhhhHHHHHHHHHHHhc-CCcceeeeeeEEEcCCC
Q 038766 7 IENATGSFSENNIIGNSNLSTVYKGRLE-DGEIVAVKKLNFHQFSAESDKSFYREAKTLKEL-KHRNLVKVLGYAWESGK 84 (299)
Q Consensus 7 ~~~~~~~y~~~~~lg~g~~~~v~~~~~~-~~~~~~vK~~~~~~~~~~~~~~~~~e~~~l~~l-~h~~i~~~~~~~~~~~~ 84 (299)
...+.++|.+.+.||+|+||.||++.+. +++.||+|++..... ...+|++++.++ +||||+++++++. .+.
T Consensus 17 ~~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~avK~~~~~~~------~~~~E~~~l~~~~~hp~iv~~~~~~~-~~~ 89 (342)
T 2qr7_A 17 SIQFTDGYEVKEDIGVGSYSVCKRCIHKATNMEFAVKIIDKSKR------DPTEEIEILLRYGQHPNIITLKDVYD-DGK 89 (342)
T ss_dssp --CHHHHEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEETTTC------CCHHHHHHHHHHTTSTTBCCEEEEEE-CSS
T ss_pred ccCccccEEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEcccC------ChHHHHHHHHHhcCCCCcCeEEEEEE-cCC
Confidence 3456788999999999999999999875 589999999964332 234677888887 6999999999665 466
Q ss_pred eeEEEEeecCCCChHHHhcCCCCCCCCCChhhHHHHHHHHHHHHHHhhcCCCCCeeeecccCCceeeCCC----CcEEEe
Q 038766 85 LKALILEYMENGSLESVIHGPGVDHSRWTLPKRIDVLISVANGLDYLHSGYDIPIVHCDMKPSNILLDRD----FEAHVS 160 (299)
Q Consensus 85 ~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lh~~~~~~~~H~dl~~~nil~~~~----~~v~l~ 160 (299)
..++||||+.+++|.+.+. ....+++.+++.++.||+.||+|||++ +++||||||+||++..+ +.++|+
T Consensus 90 ~~~lv~E~~~gg~L~~~i~----~~~~~~~~~~~~~~~qi~~al~~lH~~---givHrDlkp~NIl~~~~~~~~~~~kl~ 162 (342)
T 2qr7_A 90 YVYVVTELMKGGELLDKIL----RQKFFSEREASAVLFTITKTVEYLHAQ---GVVHRDLKPSNILYVDESGNPESIRIC 162 (342)
T ss_dssp EEEEEECCCCSCBHHHHHH----TCTTCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCCGGGEEESSSSCSGGGEEEC
T ss_pred EEEEEEeCCCCCcHHHHHH----HcCCCCHHHHHHHHHHHHHHHHHHHHC---CcEeccCCHHHEEEecCCCCcCeEEEE
Confidence 7799999999999999887 445799999999999999999999999 99999999999998543 359999
Q ss_pred eeccccccccccccccccccccccCcccCChhhhcccCcCccccchhhhHHHHHHHhCCCCCCCCccCCCCchhHHHHHH
Q 038766 161 DFGTSRMLDVHLQDLSSLSTAFQGTIGYLAPEFAYMRIVTTKVDVFSFGIVVMEFLTKRRPTGLDEENGLSPISLRQLVE 240 (299)
Q Consensus 161 df~~~~~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~DiwslG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~ 240 (299)
|||++...... ........+|+.|+|||++.+..++.++|||||||++|+|++|..||..... . ...+.+.
T Consensus 163 Dfg~a~~~~~~----~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~--~---~~~~~~~ 233 (342)
T 2qr7_A 163 DFGFAKQLRAE----NGLLMTPCYTANFVAPEVLERQGYDAACDIWSLGVLLYTMLTGYTPFANGPD--D---TPEEILA 233 (342)
T ss_dssp CCTTCEECBCT----TCCBCCSSCCSSCCCHHHHHHHHHHHHHHHHHHHHHHHHHHHSSCSSCSSTT--S---CHHHHHH
T ss_pred ECCCcccCcCC----CCceeccCCCccccCHHHhcCCCCCCccCeeeHhHHHHHHhcCCCCCCCCCc--C---CHHHHHH
Confidence 99999765421 1223345679999999999988899999999999999999999999964321 1 1222222
Q ss_pred HHHhcCccCcccccCccccchhhHhHHHHHHHHHHHHHHHHhcCCCCCCCCChhhhhcC
Q 038766 241 KALANGINGVRQITDPKLVSSIYEEQEQHQVLEELFKLALVCTSSNPEDRPNMNELLIT 299 (299)
Q Consensus 241 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rpt~~~il~~ 299 (299)
........ .... ....++.++.+||++||..||++|||++++++|
T Consensus 234 ~i~~~~~~----~~~~----------~~~~~s~~~~~li~~~L~~dP~~R~t~~~il~h 278 (342)
T 2qr7_A 234 RIGSGKFS----LSGG----------YWNSVSDTAKDLVSKMLHVDPHQRLTAALVLRH 278 (342)
T ss_dssp HHHHCCCC----CCST----------TTTTSCHHHHHHHHHHTCSSTTTSCCHHHHTTS
T ss_pred HHccCCcc----cCcc----------ccccCCHHHHHHHHHHCCCChhHCcCHHHHhcC
Confidence 22221110 0000 012345689999999999999999999999987
|
| >3dls_A PAS domain-containing serine/threonine-protein KI; PAS kinase, PASK, protein kinase, drug discovery, ATP-bindin kinase, nucleotide-binding; HET: ADP; 2.30A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-46 Score=320.54 Aligned_cols=246 Identities=24% Similarity=0.338 Sum_probs=201.2
Q ss_pred HHhCCCCCCceeecCCcceEEEEEe-CCCcEEEEEEeccCcCChh------hhHHHHHHHHHHHhcCCcceeeeeeEEEc
Q 038766 9 NATGSFSENNIIGNSNLSTVYKGRL-EDGEIVAVKKLNFHQFSAE------SDKSFYREAKTLKELKHRNLVKVLGYAWE 81 (299)
Q Consensus 9 ~~~~~y~~~~~lg~g~~~~v~~~~~-~~~~~~~vK~~~~~~~~~~------~~~~~~~e~~~l~~l~h~~i~~~~~~~~~ 81 (299)
.+.++|.+.+.||+|+||+||++.+ .+++.||+|++........ ....+.+|+.+++.++||||+++++++..
T Consensus 21 ~~~~~y~~~~~lG~G~~g~Vy~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~Iv~~~~~~~~ 100 (335)
T 3dls_A 21 EYSQKYSTMSPLGSGAFGFVWTAVDKEKNKEVVVKFIKKEKVLEDCWIEDPKLGKVTLEIAILSRVEHANIIKVLDIFEN 100 (335)
T ss_dssp HHHHHEEEEEECSSSSSCSEEEEEETTTTEEEEEEEEESTTSCTTSEEEETTTEEEEHHHHHHTTCCCTTBCCEEEEEEC
T ss_pred ccccceEEEeEEEecCCEEEEEEEECCCCcEEEEEEEehhhcccccccchHHHHHHHHHHHHHHhCCCCCEeeEEEEEee
Confidence 3567899999999999999999986 4689999999976543222 34567789999999999999999996654
Q ss_pred CCCeeEEEEeecCCC-ChHHHhcCCCCCCCCCChhhHHHHHHHHHHHHHHhhcCCCCCeeeecccCCceeeCCCCcEEEe
Q 038766 82 SGKLKALILEYMENG-SLESVIHGPGVDHSRWTLPKRIDVLISVANGLDYLHSGYDIPIVHCDMKPSNILLDRDFEAHVS 160 (299)
Q Consensus 82 ~~~~~~lv~e~~~~~-~L~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lh~~~~~~~~H~dl~~~nil~~~~~~v~l~ 160 (299)
....++|+|++.++ +|.+++. ....+++..++.++.|++.||.|||+. +++|+||||+||+++.++.++|+
T Consensus 101 -~~~~~lv~e~~~~g~~l~~~~~----~~~~l~~~~~~~i~~qi~~~L~~LH~~---~ivH~Dlkp~NIll~~~~~~kL~ 172 (335)
T 3dls_A 101 -QGFFQLVMEKHGSGLDLFAFID----RHPRLDEPLASYIFRQLVSAVGYLRLK---DIIHRDIKDENIVIAEDFTIKLI 172 (335)
T ss_dssp -SSEEEEEEECCTTSCBHHHHHH----TCCCCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEECTTSCEEEC
T ss_pred -CCEEEEEEEeCCCCccHHHHHH----hcCCCCHHHHHHHHHHHHHHHHHHHhC---CeEEeccCHHHEEEcCCCcEEEe
Confidence 55669999998665 9999997 445799999999999999999999999 99999999999999999999999
Q ss_pred eeccccccccccccccccccccccCcccCChhhhcccCc-CccccchhhhHHHHHHHhCCCCCCCCccCCCCchhHHHHH
Q 038766 161 DFGTSRMLDVHLQDLSSLSTAFQGTIGYLAPEFAYMRIV-TTKVDVFSFGIVVMEFLTKRRPTGLDEENGLSPISLRQLV 239 (299)
Q Consensus 161 df~~~~~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~-~~~~DiwslG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~ 239 (299)
|||++..... ........+++.|+|||++.+..+ +.++||||||+++|+|++|..||.......
T Consensus 173 Dfg~a~~~~~-----~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~---------- 237 (335)
T 3dls_A 173 DFGSAAYLER-----GKLFYTFCGTIEYCAPEVLMGNPYRGPELEMWSLGVTLYTLVFEENPFCELEETV---------- 237 (335)
T ss_dssp CCTTCEECCT-----TCCBCEECSCGGGCCHHHHTTCCBCSHHHHHHHHHHHHHHHHHSSCSCSSGGGGT----------
T ss_pred ecccceECCC-----CCceeccCCCccccChhhhcCCCCCCCcccchhHHHHHHHHHhCCCchhhHHHHH----------
Confidence 9999976542 122334568999999999988776 789999999999999999999995321100
Q ss_pred HHHHhcCccCcccccCccccchhhHhHHHHHHHHHHHHHHHHhcCCCCCCCCChhhhhcC
Q 038766 240 EKALANGINGVRQITDPKLVSSIYEEQEQHQVLEELFKLALVCTSSNPEDRPNMNELLIT 299 (299)
Q Consensus 240 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rpt~~~il~~ 299 (299)
...... +..++.++.+||.+||..||++|||++++++|
T Consensus 238 ----------~~~~~~------------~~~~~~~l~~li~~~L~~dP~~Rps~~ell~h 275 (335)
T 3dls_A 238 ----------EAAIHP------------PYLVSKELMSLVSGLLQPVPERRTTLEKLVTD 275 (335)
T ss_dssp ----------TTCCCC------------SSCCCHHHHHHHHHHTCSSGGGSCCHHHHHHC
T ss_pred ----------hhccCC------------CcccCHHHHHHHHHHccCChhhCcCHHHHhcC
Confidence 000000 11235679999999999999999999999987
|
| >3mwu_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, bumped kinase inhibitor, BKI; HET: BK3; 1.98A {Cryptosporidium parvum} PDB: 3igo_A* 3ncg_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.6e-46 Score=333.58 Aligned_cols=255 Identities=22% Similarity=0.316 Sum_probs=204.5
Q ss_pred HHhCCCCCCceeecCCcceEEEEEeC-CCcEEEEEEeccCcCChhhhHHHHHHHHHHHhcCCcceeeeeeEEEcCCCeeE
Q 038766 9 NATGSFSENNIIGNSNLSTVYKGRLE-DGEIVAVKKLNFHQFSAESDKSFYREAKTLKELKHRNLVKVLGYAWESGKLKA 87 (299)
Q Consensus 9 ~~~~~y~~~~~lg~g~~~~v~~~~~~-~~~~~~vK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~ 87 (299)
.+.++|++.+.||+|+||+||+|.+. +++.||+|++............+.+|+.+++.++||||+++++++.. ....+
T Consensus 19 ~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~-~~~~~ 97 (486)
T 3mwu_A 19 TFAERYNIVCMLGKGSFGEVLKCKDRITQQEYAVKVINKASAKNKDTSTILREVELLKKLDHPNIMKLFEILED-SSSFY 97 (486)
T ss_dssp HHHHHEEEEEEEECCSSSEEEEEEETTTCCEEEEEEEEHHHHBCSCHHHHHHHHHHHHHCCCTTBCCEEEEEEC-SSEEE
T ss_pred ChhcceEEeEEEeecCCEEEEEEEECCCCCEEEEEEEecccccchHHHHHHHHHHHHHhCCCCCcCeEEEEEEc-CCEEE
Confidence 46789999999999999999999875 68999999986544444556788999999999999999999997655 55669
Q ss_pred EEEeecCCCChHHHhcCCCCCCCCCChhhHHHHHHHHHHHHHHhhcCCCCCeeeecccCCceeeC---CCCcEEEeeecc
Q 038766 88 LILEYMENGSLESVIHGPGVDHSRWTLPKRIDVLISVANGLDYLHSGYDIPIVHCDMKPSNILLD---RDFEAHVSDFGT 164 (299)
Q Consensus 88 lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lh~~~~~~~~H~dl~~~nil~~---~~~~v~l~df~~ 164 (299)
+|+||+.+++|.+.+. ....+++..++.++.|++.||.|||++ +++||||||+||+++ .++.++|+|||+
T Consensus 98 lv~e~~~~~~L~~~~~----~~~~~~~~~~~~i~~qi~~al~~lH~~---~ivH~Dlkp~Nil~~~~~~~~~~kl~Dfg~ 170 (486)
T 3mwu_A 98 IVGELYTGGELFDEII----KRKRFSEHDAARIIKQVFSGITYMHKH---NIVHRDLKPENILLESKEKDCDIKIIDFGL 170 (486)
T ss_dssp EEECCCCSCBHHHHHH----HHSSCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEESSSSTTCCEEECSCSC
T ss_pred EEEEcCCCCcHHHHHH----hcCCCCHHHHHHHHHHHHHHHHHHHHC---CeEeccCchHHEEEecCCCCCCEEEEECCc
Confidence 9999999999998886 445799999999999999999999999 999999999999995 456799999999
Q ss_pred ccccccccccccccccccccCcccCChhhhcccCcCccccchhhhHHHHHHHhCCCCCCCCccCCCCchhHHHHHHHHHh
Q 038766 165 SRMLDVHLQDLSSLSTAFQGTIGYLAPEFAYMRIVTTKVDVFSFGIVVMEFLTKRRPTGLDEENGLSPISLRQLVEKALA 244 (299)
Q Consensus 165 ~~~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~DiwslG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~ 244 (299)
+..... ........+|+.|+|||++.+ .++.++|||||||++|+|++|..||.... . .+.+.....
T Consensus 171 a~~~~~-----~~~~~~~~gt~~y~aPE~~~~-~~~~~~DiwslG~il~~ll~g~~pf~~~~-----~---~~~~~~i~~ 236 (486)
T 3mwu_A 171 STCFQQ-----NTKMKDRIGTAYYIAPEVLRG-TYDEKCDVWSAGVILYILLSGTPPFYGKN-----E---YDILKRVET 236 (486)
T ss_dssp TTTBCC-----C----CCTTGGGGCCGGGGGS-CCCHHHHHHHHHHHHHHHHHSSCSSCCSS-----H---HHHHHHHHH
T ss_pred CeECCC-----CCccCCCcCCCCCCCHHHhCC-CCCchhhHHHHHHHHHHHHhCCCCCCCCC-----H---HHHHHHHHh
Confidence 976542 122344568999999999876 48999999999999999999999995431 1 222222221
Q ss_pred cCccCcccccCccccchhhHhHHHHHHHHHHHHHHHHhcCCCCCCCCChhhhhcC
Q 038766 245 NGINGVRQITDPKLVSSIYEEQEQHQVLEELFKLALVCTSSNPEDRPNMNELLIT 299 (299)
Q Consensus 245 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rpt~~~il~~ 299 (299)
.... ...+. ...+++++.+||++||..||++|||+.++|+|
T Consensus 237 ~~~~----~~~~~----------~~~~s~~~~~li~~~L~~dp~~R~t~~~~l~h 277 (486)
T 3mwu_A 237 GKYA----FDLPQ----------WRTISDDAKDLIRKMLTFHPSLRITATQCLEH 277 (486)
T ss_dssp TCCC----SCSGG----------GGGSCHHHHHHHHHHTCSSTTTSCCHHHHHHC
T ss_pred CCCC----CCCcc----------cCCCCHHHHHHHHHHcCCChhhCcCHHHHhcC
Confidence 1110 00010 22346789999999999999999999999987
|
| >3dbq_A Dual specificity protein kinase TTK; MPS1 structure, kinase activation, phosphorylation, ATP- binding, nucleotide-binding, phosphoprotein; 2.70A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=7.7e-46 Score=318.05 Aligned_cols=257 Identities=21% Similarity=0.286 Sum_probs=199.5
Q ss_pred HHHhCCCCCCceeecCCcceEEEEEeCCCcEEEEEEeccCcCChhhhHHHHHHHHHHHhcCC--cceeeeeeEEEcCCCe
Q 038766 8 ENATGSFSENNIIGNSNLSTVYKGRLEDGEIVAVKKLNFHQFSAESDKSFYREAKTLKELKH--RNLVKVLGYAWESGKL 85 (299)
Q Consensus 8 ~~~~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~vK~~~~~~~~~~~~~~~~~e~~~l~~l~h--~~i~~~~~~~~~~~~~ 85 (299)
+...++|.+.+.||+|+||.||++.+.+++.||+|++..........+.+.+|+.+++.++| +||+++++++.. +..
T Consensus 5 ~~~~~~y~i~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~~iv~~~~~~~~-~~~ 83 (343)
T 3dbq_A 5 SVKGRIYSILKQIGSGGSSKVFQVLNEKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRLYDYEIT-DQY 83 (343)
T ss_dssp ESSSCEEEEEEEESCCSSEEEEEEECTTSCEEEEEEEECTTCCHHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEEC-SSE
T ss_pred eeecCEEEEEEEEecCCCeEEEEEEeCCCCEEEEEEeeccccchHHHHHHHHHHHHHHhhhhcCCceEEEeeeEee-CCE
Confidence 34567899999999999999999998889999999998766666677889999999999986 999999996655 556
Q ss_pred eEEEEeecCCCChHHHhcCCCCCCCCCChhhHHHHHHHHHHHHHHhhcCCCCCeeeecccCCceeeCCCCcEEEeeeccc
Q 038766 86 KALILEYMENGSLESVIHGPGVDHSRWTLPKRIDVLISVANGLDYLHSGYDIPIVHCDMKPSNILLDRDFEAHVSDFGTS 165 (299)
Q Consensus 86 ~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lh~~~~~~~~H~dl~~~nil~~~~~~v~l~df~~~ 165 (299)
.++|||+. +++|.+++. ....+++.+++.++.|++.||.|||+. +++||||||+||+++ ++.++|+|||++
T Consensus 84 ~~lv~e~~-~~~L~~~l~----~~~~~~~~~~~~i~~qi~~al~~lH~~---~iiHrDikp~NIll~-~~~~kl~DFG~a 154 (343)
T 3dbq_A 84 IYMVMECG-NIDLNSWLK----KKKSIDPWERKSYWKNMLEAVHTIHQH---GIVHSDLKPANFLIV-DGMLKLIDFGIA 154 (343)
T ss_dssp EEEEECCC-SEEHHHHHH----HSCCCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEEE-TTEEEECCCSSS
T ss_pred EEEEEeCC-CCCHHHHHH----hcCCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCcceEEEE-CCcEEEeecccc
Confidence 79999955 779999997 456799999999999999999999999 999999999999997 678999999999
Q ss_pred cccccccccccccccccccCcccCChhhhcc-----------cCcCccccchhhhHHHHHHHhCCCCCCCCccCCCCchh
Q 038766 166 RMLDVHLQDLSSLSTAFQGTIGYLAPEFAYM-----------RIVTTKVDVFSFGIVVMEFLTKRRPTGLDEENGLSPIS 234 (299)
Q Consensus 166 ~~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~-----------~~~~~~~DiwslG~~l~~l~~g~~p~~~~~~~~~~~~~ 234 (299)
....... .........+|+.|+|||++.+ ..++.++|||||||++|+|++|..||.....
T Consensus 155 ~~~~~~~--~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~------- 225 (343)
T 3dbq_A 155 NQMQPDT--TSVVKDSQVGTVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIIN------- 225 (343)
T ss_dssp CCC--------------CCCCSSCCHHHHHHCC-----------CCHHHHHHHHHHHHHHHHHSSCTTTTCCS-------
T ss_pred cccCccc--ccccCCCCcCCcCcCCHHHHhhccccccccccccCCCchhhHHHHHHHHHHHHhCCCcchhhhh-------
Confidence 7654211 1112334568999999999865 6688899999999999999999999953211
Q ss_pred HHHHHHHHHhcCccCcccccCccccchhhHhHHHHHHHHHHHHHHHHhcCCCCCCCCChhhhhcC
Q 038766 235 LRQLVEKALANGINGVRQITDPKLVSSIYEEQEQHQVLEELFKLALVCTSSNPEDRPNMNELLIT 299 (299)
Q Consensus 235 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rpt~~~il~~ 299 (299)
....+........ .... +...+.++.++|.+||..||.+|||++++|+|
T Consensus 226 ~~~~~~~~~~~~~----~~~~------------~~~~~~~l~~li~~~L~~dp~~Rpt~~e~l~h 274 (343)
T 3dbq_A 226 QISKLHAIIDPNH----EIEF------------PDIPEKDLQDVLKCCLKRDPKQRISIPELLAH 274 (343)
T ss_dssp HHHHHHHHHCTTS----CCCC------------CCCSCHHHHHHHHHHTCSSTTTSCCHHHHHTS
T ss_pred HHHHHHHHhcCCc----ccCC------------cccCCHHHHHHHHHHcCCChhHCCCHHHHHhC
Confidence 1111111111110 0000 11113468899999999999999999999987
|
| >3v8s_A RHO-associated protein kinase 1; dimerization, myosin, transferase, inhibitor, transf transferase inhibitor complex; HET: 0HD; 2.29A {Homo sapiens} PDB: 3twj_A* 3tv7_A* 2etr_A* 2esm_A* 2eto_A* 2etk_A* 3d9v_A* 3ncz_A* 3ndm_A* 2v55_A* 2f2u_A* 2h9v_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.7e-46 Score=325.19 Aligned_cols=260 Identities=20% Similarity=0.261 Sum_probs=204.6
Q ss_pred HHHHHhCCCCCCceeecCCcceEEEEEeC-CCcEEEEEEeccCcC-ChhhhHHHHHHHHHHHhcCCcceeeeeeEEEcCC
Q 038766 6 EIENATGSFSENNIIGNSNLSTVYKGRLE-DGEIVAVKKLNFHQF-SAESDKSFYREAKTLKELKHRNLVKVLGYAWESG 83 (299)
Q Consensus 6 ~~~~~~~~y~~~~~lg~g~~~~v~~~~~~-~~~~~~vK~~~~~~~-~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~ 83 (299)
+.+...++|.+.+.||+|+||.||+|.+. +++.||+|++..... .......+.+|..+++.++||||+++++++.. +
T Consensus 63 ~~~~~~~~y~~~~~LG~G~fG~V~~~~~~~~~~~~AiK~~~k~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~-~ 141 (410)
T 3v8s_A 63 DLRMKAEDYEVVKVIGRGAFGEVQLVRHKSTRKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPWVVQLFYAFQD-D 141 (410)
T ss_dssp HHSCCGGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTCCCSTHHHHHHHHHHCCCTTBCCEEEEEEC-S
T ss_pred hcccCccccEEEEEEEcCCCEEEEEEEECCCCcEEEEEEEehhhhhhhHHHHHHHHHHHHHHhCCCCCCCeEEEEEEE-C
Confidence 34455689999999999999999999875 589999999864221 12234457889999999999999999996655 5
Q ss_pred CeeEEEEeecCCCChHHHhcCCCCCCCCCChhhHHHHHHHHHHHHHHhhcCCCCCeeeecccCCceeeCCCCcEEEeeec
Q 038766 84 KLKALILEYMENGSLESVIHGPGVDHSRWTLPKRIDVLISVANGLDYLHSGYDIPIVHCDMKPSNILLDRDFEAHVSDFG 163 (299)
Q Consensus 84 ~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lh~~~~~~~~H~dl~~~nil~~~~~~v~l~df~ 163 (299)
...++||||+++++|.+++.. ..+++..++.++.||+.||.|||+. +++||||||+||+++.+|.+||+|||
T Consensus 142 ~~~~lV~E~~~gg~L~~~l~~-----~~~~e~~~~~~~~qi~~aL~~LH~~---givHrDLKp~NILl~~~g~ikL~DFG 213 (410)
T 3v8s_A 142 RYLYMVMEYMPGGDLVNLMSN-----YDVPEKWARFYTAEVVLALDAIHSM---GFIHRDVKPDNMLLDKSGHLKLADFG 213 (410)
T ss_dssp SEEEEEECCCTTEEHHHHHHH-----CCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECTTSCEEECCCT
T ss_pred CEEEEEEeCCCCCcHHHHHHc-----CCCCHHHHHHHHHHHHHHHHHHHHC---CeEeccCCHHHeeECCCCCEEEeccc
Confidence 667999999999999999853 3689999999999999999999999 99999999999999999999999999
Q ss_pred cccccccccccccccccccccCcccCChhhhcccC----cCccccchhhhHHHHHHHhCCCCCCCCccCCCCchhHHHHH
Q 038766 164 TSRMLDVHLQDLSSLSTAFQGTIGYLAPEFAYMRI----VTTKVDVFSFGIVVMEFLTKRRPTGLDEENGLSPISLRQLV 239 (299)
Q Consensus 164 ~~~~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~----~~~~~DiwslG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~ 239 (299)
++...... .........+|+.|+|||++.+.. ++.++|+|||||++|+|++|..||.... .. ...
T Consensus 214 ~a~~~~~~---~~~~~~~~~gt~~Y~APE~l~~~~~~~~~~~~~DiwSlGvilyell~G~~Pf~~~~-----~~---~~~ 282 (410)
T 3v8s_A 214 TCMKMNKE---GMVRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPFYADS-----LV---GTY 282 (410)
T ss_dssp TCEECCTT---SEEECCSCCSCGGGCCHHHHHTTTTTCEEETHHHHHHHHHHHHHHHHSSCTTCCSS-----HH---HHH
T ss_pred eeEeeccC---CcccccCCcCCccccCHHHhhccCCCcCCCCcceEecchHHHHHHHhCCCCCCCCC-----hh---hHH
Confidence 99765421 112234567899999999988765 7899999999999999999999995431 11 222
Q ss_pred HHHHhcCccCcccccCccccchhhHhHHHHHHHHHHHHHHHHhcCCCCCC--CCChhhhhcC
Q 038766 240 EKALANGINGVRQITDPKLVSSIYEEQEQHQVLEELFKLALVCTSSNPED--RPNMNELLIT 299 (299)
Q Consensus 240 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~--Rpt~~~il~~ 299 (299)
..+.... .....+. ...++.++.+||.+||..+|.+ ||+++||++|
T Consensus 283 ~~i~~~~----~~~~~p~----------~~~~s~~~~~li~~lL~~~~~rlgR~~~~ei~~H 330 (410)
T 3v8s_A 283 SKIMNHK----NSLTFPD----------DNDISKEAKNLICAFLTDREVRLGRNGVEEIKRH 330 (410)
T ss_dssp HHHHTHH----HHCCCCT----------TCCCCHHHHHHHHHHSSCGGGCTTSSCHHHHHTS
T ss_pred HHHHhcc----ccccCCC----------cccccHHHHHHHHHHccChhhhCCCCCHHHHhcC
Confidence 2211100 0000000 1124568999999999999988 9999999987
|
| >2psq_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xr0_A | Back alignment and structure |
|---|
Probab=100.00 E-value=7.6e-46 Score=320.99 Aligned_cols=258 Identities=22% Similarity=0.354 Sum_probs=202.5
Q ss_pred HHhCCCCCCceeecCCcceEEEEEeC--------CCcEEEEEEeccCcCChhhhHHHHHHHHHHHhc-CCcceeeeeeEE
Q 038766 9 NATGSFSENNIIGNSNLSTVYKGRLE--------DGEIVAVKKLNFHQFSAESDKSFYREAKTLKEL-KHRNLVKVLGYA 79 (299)
Q Consensus 9 ~~~~~y~~~~~lg~g~~~~v~~~~~~--------~~~~~~vK~~~~~~~~~~~~~~~~~e~~~l~~l-~h~~i~~~~~~~ 79 (299)
...++|.+.+.||+|+||.||+|.+. ++..||+|++... ........+.+|+.+++.+ +||||+++++++
T Consensus 78 ~~~~~~~~~~~LG~G~fg~Vy~a~~~~~~~~~~~~~~~vavK~~~~~-~~~~~~~~~~~E~~~l~~l~~hpnIv~~~~~~ 156 (370)
T 2psq_A 78 FPRDKLTLGKPLGEGCFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDD-ATEKDLSDLVSEMEMMKMIGKHKNIINLLGAC 156 (370)
T ss_dssp CCGGGEEEEEEESCCSSSEEEEEEEETCSTTCTTCEEEEEEEECCTT-CBHHHHHHHHHHHHHHHHSCCCTTBCCEEEEE
T ss_pred ccHHHCEeeeEEeeCCCeeEEEEEEecccCcCcCcceeEEEEEecCC-cCHHHHHHHHHHHHHHHHhcCCCCEeeEEEEE
Confidence 34578999999999999999999752 3567999998643 3445567889999999999 899999999976
Q ss_pred EcCCCeeEEEEeecCCCChHHHhcCCCC------------CCCCCChhhHHHHHHHHHHHHHHhhcCCCCCeeeecccCC
Q 038766 80 WESGKLKALILEYMENGSLESVIHGPGV------------DHSRWTLPKRIDVLISVANGLDYLHSGYDIPIVHCDMKPS 147 (299)
Q Consensus 80 ~~~~~~~~lv~e~~~~~~L~~~~~~~~~------------~~~~~~~~~~~~i~~qi~~~l~~lh~~~~~~~~H~dl~~~ 147 (299)
.. ....++|+||+.+++|.+++..... ....+++.+++.++.||+.||+|||++ +++|+||||+
T Consensus 157 ~~-~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~---~ivHrDlkp~ 232 (370)
T 2psq_A 157 TQ-DGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSCTYQLARGMEYLASQ---KCIHRDLAAR 232 (370)
T ss_dssp CS-SSSCEEEEECCTTCBHHHHHHHTCCC-----------CCCCCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCCGG
T ss_pred cc-CCCEEEEEEcCCCCCHHHHHHhhCCccccccccccccccccCCHHHHHHHHHHHHHHHHHHHhC---Ceeccccchh
Confidence 55 4456999999999999999864321 234689999999999999999999999 9999999999
Q ss_pred ceeeCCCCcEEEeeeccccccccccccccccccccccCcccCChhhhcccCcCccccchhhhHHHHHHHh-CCCCCCCCc
Q 038766 148 NILLDRDFEAHVSDFGTSRMLDVHLQDLSSLSTAFQGTIGYLAPEFAYMRIVTTKVDVFSFGIVVMEFLT-KRRPTGLDE 226 (299)
Q Consensus 148 nil~~~~~~v~l~df~~~~~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~DiwslG~~l~~l~~-g~~p~~~~~ 226 (299)
||+++.++.+||+|||++....... .........+++.|+|||++.+..++.++|||||||++|+|++ |..||...
T Consensus 233 NIll~~~~~~kl~DFG~a~~~~~~~--~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DvwslG~il~ellt~g~~p~~~~- 309 (370)
T 2psq_A 233 NVLVTENNVMKIADFGLARDINNID--YYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSPYPGI- 309 (370)
T ss_dssp GEEECTTCCEEECCCSSCEETTCCC--TTCTTTTTTSCGGGCCHHHHHTCCCCHHHHHHHHHHHHHHHHTTSCCSSTTC-
T ss_pred hEEECCCCCEEEccccCCcccCccc--ceecccCCCcccceECHhHhcCCCCCcHHHHHHHHHHHHHHHcCCCCCCCCC-
Confidence 9999999999999999997554211 1112233445788999999999999999999999999999999 99998543
Q ss_pred cCCCCchhHHHHHHHHHhcCccCcccccCccccchhhHhHHHHHHHHHHHHHHHHhcCCCCCCCCChhhhhc
Q 038766 227 ENGLSPISLRQLVEKALANGINGVRQITDPKLVSSIYEEQEQHQVLEELFKLALVCTSSNPEDRPNMNELLI 298 (299)
Q Consensus 227 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rpt~~~il~ 298 (299)
....+...+. .+.. ... +..++.++.++|.+||..||++|||++++++
T Consensus 310 ----~~~~~~~~~~----~~~~----~~~------------~~~~~~~l~~li~~~l~~dP~~Rpt~~ell~ 357 (370)
T 2psq_A 310 ----PVEELFKLLK----EGHR----MDK------------PANCTNELYMMMRDCWHAVPSQRPTFKQLVE 357 (370)
T ss_dssp ----CGGGHHHHHH----TTCC----CCC------------CTTSCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred ----CHHHHHHHHh----cCCC----CCC------------CCCCCHHHHHHHHHHcCCChhhCcCHHHHHH
Confidence 2222222211 1100 000 1234567999999999999999999999986
|
| >3is5_A Calcium-dependent protein kinase; CDPK, structural genomics, parasitology, structural genomics consortium, SGC, ATP-binding, nucleotide-binding; HET: ANP; 2.55A {Toxoplasma gondii} | Back alignment and structure |
|---|
Probab=100.00 E-value=9.4e-46 Score=309.58 Aligned_cols=256 Identities=25% Similarity=0.300 Sum_probs=198.5
Q ss_pred HhCCCCCCceeecCCcceEEEEEeC-CCcEEEEEEeccCcCChhhhHHHHHHHHHHHhcCCcceeeeeeEEEcCCCeeEE
Q 038766 10 ATGSFSENNIIGNSNLSTVYKGRLE-DGEIVAVKKLNFHQFSAESDKSFYREAKTLKELKHRNLVKVLGYAWESGKLKAL 88 (299)
Q Consensus 10 ~~~~y~~~~~lg~g~~~~v~~~~~~-~~~~~~vK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~l 88 (299)
+.++|.+.+.||+|+||+||++.+. ++..+|+|++.... .....+.+.+|+++++.++||||+++++++.. ....++
T Consensus 20 i~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~-~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~-~~~~~l 97 (285)
T 3is5_A 20 IDDLFIFKRKLGSGAFGDVHLVEERSSGLERVIKTINKDR-SQVPMEQIEAEIEVLKSLDHPNIIKIFEVFED-YHNMYI 97 (285)
T ss_dssp HHHHEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEGGG-CCSCHHHHHHHHHHHHTCCCTTBCCEEEEEEC-SSEEEE
T ss_pred hhhheeecceeccCCCeEEEEEEEccCCceEEEEEeeccc-cchhHHHHHHHHHHHHhCCCchHHhHHHheec-CCeEEE
Confidence 5688999999999999999999874 58999999987533 33456788999999999999999999997654 556699
Q ss_pred EEeecCCCChHHHhcCCCCCCCCCChhhHHHHHHHHHHHHHHhhcCCCCCeeeecccCCceee---CCCCcEEEeeeccc
Q 038766 89 ILEYMENGSLESVIHGPGVDHSRWTLPKRIDVLISVANGLDYLHSGYDIPIVHCDMKPSNILL---DRDFEAHVSDFGTS 165 (299)
Q Consensus 89 v~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lh~~~~~~~~H~dl~~~nil~---~~~~~v~l~df~~~ 165 (299)
|+||+.+++|.+.+.........+++..++.++.|++.||+|||+. +++|+||||+||++ +.++.++|+|||++
T Consensus 98 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~---~ivH~dikp~NIl~~~~~~~~~~kl~Dfg~a 174 (285)
T 3is5_A 98 VMETCEGGELLERIVSAQARGKALSEGYVAELMKQMMNALAYFHSQ---HVVHKDLKPENILFQDTSPHSPIKIIDFGLA 174 (285)
T ss_dssp EECCCSCCBHHHHHHHHHHHTCCCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCSGGGEEESSSSTTCCEEECCCCCC
T ss_pred EEEeCCCCcHHHHHHhhhhcccCCCHHHHHHHHHHHHHHHHHHHhC---CEEECCCCHHHEEEecCCCCCCEEEEeeecc
Confidence 9999999999988753222346799999999999999999999999 99999999999999 45688999999999
Q ss_pred cccccccccccccccccccCcccCChhhhcccCcCccccchhhhHHHHHHHhCCCCCCCCccCCCCchhHHHHHHHHHhc
Q 038766 166 RMLDVHLQDLSSLSTAFQGTIGYLAPEFAYMRIVTTKVDVFSFGIVVMEFLTKRRPTGLDEENGLSPISLRQLVEKALAN 245 (299)
Q Consensus 166 ~~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~DiwslG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~ 245 (299)
..... ........+++.|+|||.+. ..++.++||||||+++|+|++|..||.... ..+........
T Consensus 175 ~~~~~-----~~~~~~~~~t~~y~aPE~~~-~~~~~~~Di~slG~il~~ll~g~~pf~~~~--------~~~~~~~~~~~ 240 (285)
T 3is5_A 175 ELFKS-----DEHSTNAAGTALYMAPEVFK-RDVTFKCDIWSAGVVMYFLLTGCLPFTGTS--------LEEVQQKATYK 240 (285)
T ss_dssp CC---------------CTTGGGCCHHHHT-TCCCHHHHHHHHHHHHHHHHHSSCSSCCSS--------HHHHHHHHHHC
T ss_pred eecCC-----cccCcCcccccCcCChHHhc-cCCCcccCeehHHHHHHHHHhCCCCCCCCC--------HHHHHhhhccC
Confidence 75442 12234456789999999876 467899999999999999999999995431 11222111111
Q ss_pred CccCcccccCccccchhhHhHHHHHHHHHHHHHHHHhcCCCCCCCCChhhhhcC
Q 038766 246 GINGVRQITDPKLVSSIYEEQEQHQVLEELFKLALVCTSSNPEDRPNMNELLIT 299 (299)
Q Consensus 246 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rpt~~~il~~ 299 (299)
...... . ...+++++.++|++||..||++|||++|+|+|
T Consensus 241 ~~~~~~--~-------------~~~~~~~~~~li~~~L~~dP~~Rps~~e~l~h 279 (285)
T 3is5_A 241 EPNYAV--E-------------CRPLTPQAVDLLKQMLTKDPERRPSAAQVLHH 279 (285)
T ss_dssp CCCCCC-----------------CCCCHHHHHHHHHHTCSCTTTSCCHHHHHTS
T ss_pred Cccccc--c-------------cCcCCHHHHHHHHHHccCChhhCcCHHHHhcC
Confidence 100000 0 11134678899999999999999999999987
|
| >2yex_A Serine/threonine-protein kinase CHK1; transferase, cell cycle; HET: YEX; 1.30A {Homo sapiens} PDB: 2x8e_A* 2ydk_A* 2ydj_A* 2yer_A* 2ydi_A* 1nvq_A* 1nvr_A* 1nvs_A* 2wmq_A* 2wmr_A* 2wms_A* 2wmt_A* 2wmu_A* 2wmv_A* 2wmw_A* 2wmx_A* 2x8d_A* 2x8i_A* 2xey_A* 2xez_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=9.3e-46 Score=308.03 Aligned_cols=257 Identities=25% Similarity=0.328 Sum_probs=205.2
Q ss_pred HHhCCCCCCceeecCCcceEEEEEeC-CCcEEEEEEeccCcCChhhhHHHHHHHHHHHhcCCcceeeeeeEEEcCCCeeE
Q 038766 9 NATGSFSENNIIGNSNLSTVYKGRLE-DGEIVAVKKLNFHQFSAESDKSFYREAKTLKELKHRNLVKVLGYAWESGKLKA 87 (299)
Q Consensus 9 ~~~~~y~~~~~lg~g~~~~v~~~~~~-~~~~~~vK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~ 87 (299)
...++|.+.+.||+|++|.||+|.+. +++.||+|++.... .....+.+.+|+..++.++||||+++++++.. ++..+
T Consensus 4 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~-~~~~~ 81 (276)
T 2yex_A 4 PFVEDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKR-AVDCPENIKKEICINKMLNHENVVKFYGHRRE-GNIQY 81 (276)
T ss_dssp HHHHHEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEEGGG-CTTHHHHHHHHHHHHHTCCCTTBCCEEEEEEE-TTEEE
T ss_pred ceecceEEEEEeecCCCcEEEEEEECCCCcEEEEEEeeecc-chhhhHHHHHHHHHHHhcCCCCceeeeeEEEc-CCEEE
Confidence 35688999999999999999999875 68999999986433 23456788899999999999999999997655 55669
Q ss_pred EEEeecCCCChHHHhcCCCCCCCCCChhhHHHHHHHHHHHHHHhhcCCCCCeeeecccCCceeeCCCCcEEEeeeccccc
Q 038766 88 LILEYMENGSLESVIHGPGVDHSRWTLPKRIDVLISVANGLDYLHSGYDIPIVHCDMKPSNILLDRDFEAHVSDFGTSRM 167 (299)
Q Consensus 88 lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lh~~~~~~~~H~dl~~~nil~~~~~~v~l~df~~~~~ 167 (299)
+|+|++.+++|.+++. ....+++..++.++.|++.||.+||++ +++|+||+|+||+++.++.++|+|||.+..
T Consensus 82 lv~e~~~~~~L~~~l~----~~~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dl~p~Nil~~~~~~~kl~dfg~~~~ 154 (276)
T 2yex_A 82 LFLEYCSGGELFDRIE----PDIGMPEPDAQRFFHQLMAGVVYLHGI---GITHRDIKPENLLLDERDNLKISDFGLATV 154 (276)
T ss_dssp EEEECCTTEEGGGGSB----TTTBCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEECTTCCEEECCCTTCEE
T ss_pred EEEEecCCCcHHHHHh----hccCCCHHHHHHHHHHHHHHHHHHHhC---CeeccCCChHHEEEccCCCEEEeeCCCccc
Confidence 9999999999999987 456799999999999999999999999 999999999999999999999999999876
Q ss_pred cccccccccccccccccCcccCChhhhcccCc-CccccchhhhHHHHHHHhCCCCCCCCccCCCCchhHHHHHHHHHhcC
Q 038766 168 LDVHLQDLSSLSTAFQGTIGYLAPEFAYMRIV-TTKVDVFSFGIVVMEFLTKRRPTGLDEENGLSPISLRQLVEKALANG 246 (299)
Q Consensus 168 ~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~-~~~~DiwslG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~ 246 (299)
..... .........+++.|+|||.+.+..+ +.++||||||+++|+|++|..||....... ...... .. .
T Consensus 155 ~~~~~--~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~---~~~~~~----~~-~ 224 (276)
T 2yex_A 155 FRYNN--RERLLNKMCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSC---QEYSDW----KE-K 224 (276)
T ss_dssp CEETT--EECCBCCCCSCGGGCCGGGGTCSSBCHHHHHHHHHHHHHHHHHHSSCCCSCSCTTS---HHHHHH----HT-T
T ss_pred cCCCc--chhcccCCccccCccChHHHhcCCCCCCcchHHHHHHHHHHHHhCCCCCCCCchHH---HHHHHh----hh-c
Confidence 54211 1122344567899999999887665 778999999999999999999996442211 111111 10 0
Q ss_pred ccCcccccCccccchhhHhHHHHHHHHHHHHHHHHhcCCCCCCCCChhhhhcC
Q 038766 247 INGVRQITDPKLVSSIYEEQEQHQVLEELFKLALVCTSSNPEDRPNMNELLIT 299 (299)
Q Consensus 247 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rpt~~~il~~ 299 (299)
... . . ....++..+.++|.+||..||++|||++++++|
T Consensus 225 ~~~---~-~-----------~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~ 262 (276)
T 2yex_A 225 KTY---L-N-----------PWKKIDSAPLALLHKILVENPSARITIPDIKKD 262 (276)
T ss_dssp CTT---S-T-----------TGGGSCHHHHHHHHHHSCSSTTTSCCHHHHTTC
T ss_pred ccc---c-C-----------chhhcCHHHHHHHHHHCCCCchhCCCHHHHhcC
Confidence 000 0 0 012345678999999999999999999999987
|
| >3gen_A Tyrosine-protein kinase BTK; bruton'S tyrosine kinase, 4-amino-5-(4-phenoxyphenyl)-5H- pyrrolo[3, 2-D]pyrimidin-7-YL-cyclopentane, TEC-family; HET: B43; 1.60A {Homo sapiens} PDB: 3k54_A* 3pj2_A* 3piy_A* 3piz_A* 3pj1_A* 3pix_A* 3pj3_A* 3p08_A 3ocs_A* 3oct_A* 1k2p_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2.2e-46 Score=313.03 Aligned_cols=256 Identities=22% Similarity=0.326 Sum_probs=202.0
Q ss_pred HHHHHhCCCCCCceeecCCcceEEEEEeCCCcEEEEEEeccCcCChhhhHHHHHHHHHHHhcCCcceeeeeeEEEcCCCe
Q 038766 6 EIENATGSFSENNIIGNSNLSTVYKGRLEDGEIVAVKKLNFHQFSAESDKSFYREAKTLKELKHRNLVKVLGYAWESGKL 85 (299)
Q Consensus 6 ~~~~~~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~vK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~ 85 (299)
.++.-.++|++.+.||+|+||+||++.+.++..||+|++.... ...+.+.+|+..++.++||||+++++++.. +..
T Consensus 18 ~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~---~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~-~~~ 93 (283)
T 3gen_A 18 SWEIDPKDLTFLKELGTGQFGVVKYGKWRGQYDVAIKMIKEGS---MSEDEFIEEAKVMMNLSHEKLVQLYGVCTK-QRP 93 (283)
T ss_dssp TTBCCGGGEEEEEECC---CEEEEEEEETTTEEEEEEEECTTS---BCHHHHHHHHHHHHTCCCTTBCCEEEEECS-SSS
T ss_pred CccCCHHHHHhHhhcCCCCCceEEEEEEcCCCeEEEEEecCCC---CCHHHHHHHHHHHhcCCCCCEeeEEEEEec-CCC
Confidence 4556678999999999999999999999888899999997433 234678899999999999999999996654 555
Q ss_pred eEEEEeecCCCChHHHhcCCCCCCCCCChhhHHHHHHHHHHHHHHhhcCCCCCeeeecccCCceeeCCCCcEEEeeeccc
Q 038766 86 KALILEYMENGSLESVIHGPGVDHSRWTLPKRIDVLISVANGLDYLHSGYDIPIVHCDMKPSNILLDRDFEAHVSDFGTS 165 (299)
Q Consensus 86 ~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lh~~~~~~~~H~dl~~~nil~~~~~~v~l~df~~~ 165 (299)
.++|+||+.+++|.+++... ...+++..++.++.|++.||+|||++ +++|+||||+||+++.++.++|+|||++
T Consensus 94 ~~lv~e~~~~~~L~~~l~~~---~~~~~~~~~~~i~~qi~~~l~~lH~~---~i~H~dikp~Nili~~~~~~kl~Dfg~~ 167 (283)
T 3gen_A 94 IFIITEYMANGCLLNYLREM---RHRFQTQQLLEMCKDVCEAMEYLESK---QFLHRDLAARNCLVNDQGVVKVSDFGLS 167 (283)
T ss_dssp EEEEECCCTTCBHHHHHHCG---GGCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSSCSGGGEEECTTSCEEECSTTGG
T ss_pred eEEEEeccCCCcHHHHHHHh---ccCCCHHHHHHHHHHHHHHHHHHHHC---CccCCCCccceEEEcCCCCEEEcccccc
Confidence 69999999999999998742 35799999999999999999999999 9999999999999999999999999999
Q ss_pred cccccccccccccccccccCcccCChhhhcccCcCccccchhhhHHHHHHHh-CCCCCCCCccCCCCchhHHHHHHHHHh
Q 038766 166 RMLDVHLQDLSSLSTAFQGTIGYLAPEFAYMRIVTTKVDVFSFGIVVMEFLT-KRRPTGLDEENGLSPISLRQLVEKALA 244 (299)
Q Consensus 166 ~~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~DiwslG~~l~~l~~-g~~p~~~~~~~~~~~~~~~~~~~~~~~ 244 (299)
...... .........+++.|+|||.+.+..++.++||||||+++|+|++ |..||... .... .......
T Consensus 168 ~~~~~~---~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~~l~t~g~~p~~~~-----~~~~---~~~~~~~ 236 (283)
T 3gen_A 168 RYVLDD---EYTSSVGSKFPVRWSPPEVLMYSKFSSKSDIWAFGVLMWEIYSLGKMPYERF-----TNSE---TAEHIAQ 236 (283)
T ss_dssp GGBCCH---HHHSTTSTTSCGGGCCHHHHHHCCCSHHHHHHHHHHHHHHHHTTTCCTTTTS-----CHHH---HHHHHHT
T ss_pred cccccc---ccccccCCccCcccCCHHHhccCCCCchhhHHHHHHHHHHHHhCCCCCcccc-----ChhH---HHHHHhc
Confidence 765421 1122233345778999999998899999999999999999998 99998532 2222 2222111
Q ss_pred cCccCcccccCccccchhhHhHHHHHHHHHHHHHHHHhcCCCCCCCCChhhhhcC
Q 038766 245 NGINGVRQITDPKLVSSIYEEQEQHQVLEELFKLALVCTSSNPEDRPNMNELLIT 299 (299)
Q Consensus 245 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rpt~~~il~~ 299 (299)
... . .. +...++.+.+++.+||..||++|||+++++++
T Consensus 237 ~~~-~----~~------------~~~~~~~l~~li~~~l~~~p~~Rps~~~ll~~ 274 (283)
T 3gen_A 237 GLR-L----YR------------PHLASEKVYTIMYSCWHEKADERPTFKILLSN 274 (283)
T ss_dssp TCC-C----CC------------CTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHH
T ss_pred ccC-C----CC------------CCcCCHHHHHHHHHHccCChhHCcCHHHHHHH
Confidence 100 0 00 11224578999999999999999999999864
|
| >3q5i_A Protein kinase; CDPK, malaria, phosphotransferase, structural genomics, structural genomic consortium, SGC, transferase; HET: ANP; 2.10A {Plasmodium berghei} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.6e-45 Score=330.03 Aligned_cols=256 Identities=23% Similarity=0.329 Sum_probs=202.4
Q ss_pred HHHhCCCCCCceeecCCcceEEEEEeC-CCcEEEEEEeccCcCCh-----------hhhHHHHHHHHHHHhcCCcceeee
Q 038766 8 ENATGSFSENNIIGNSNLSTVYKGRLE-DGEIVAVKKLNFHQFSA-----------ESDKSFYREAKTLKELKHRNLVKV 75 (299)
Q Consensus 8 ~~~~~~y~~~~~lg~g~~~~v~~~~~~-~~~~~~vK~~~~~~~~~-----------~~~~~~~~e~~~l~~l~h~~i~~~ 75 (299)
..+.++|.+.+.||+|+||+||+|.+. ++..+|+|++....... ...+.+.+|+.+++.++||||+++
T Consensus 32 ~~i~~~Y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~ 111 (504)
T 3q5i_A 32 GKIGESYFKVRKLGSGAYGEVLLCKEKNGHSEKAIKVIKKSQFDKGRYSDDNKNIEKFHEEIYNEISLLKSLDHPNIIKL 111 (504)
T ss_dssp SCGGGTEEEEEEEEC--CEEEEEEEETTTCCEEEEEEEEC----------------CTHHHHHHHHHHHHTCCCTTBCCE
T ss_pred CCcccceEEEeEecccCCeEEEEEEECCCCcEEEEEEEEhhhcccccccccchhhHHHHHHHHHHHHHHHhCCCCCCCeE
Confidence 357789999999999999999999875 58899999997544322 345678899999999999999999
Q ss_pred eeEEEcCCCeeEEEEeecCCCChHHHhcCCCCCCCCCChhhHHHHHHHHHHHHHHhhcCCCCCeeeecccCCceeeCCCC
Q 038766 76 LGYAWESGKLKALILEYMENGSLESVIHGPGVDHSRWTLPKRIDVLISVANGLDYLHSGYDIPIVHCDMKPSNILLDRDF 155 (299)
Q Consensus 76 ~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lh~~~~~~~~H~dl~~~nil~~~~~ 155 (299)
++++.. +...++|+||+.+++|.+.+. ....+++..++.++.||+.||+|||+. +++||||||+||+++.++
T Consensus 112 ~~~~~~-~~~~~lv~e~~~gg~L~~~l~----~~~~~~~~~~~~i~~qi~~~l~~lH~~---~ivH~Dlkp~Nil~~~~~ 183 (504)
T 3q5i_A 112 FDVFED-KKYFYLVTEFYEGGELFEQII----NRHKFDECDAANIMKQILSGICYLHKH---NIVHRDIKPENILLENKN 183 (504)
T ss_dssp EEEEEC-SSEEEEEEECCTTCBHHHHHH----HHSCCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEESSTT
T ss_pred EEEEEc-CCEEEEEEecCCCCcHHHHHH----HcCCCCHHHHHHHHHHHHHHHHHHHHC---CeEeCCCcHHHEEEecCC
Confidence 997654 566799999999999998886 445799999999999999999999999 999999999999998776
Q ss_pred ---cEEEeeeccccccccccccccccccccccCcccCChhhhcccCcCccccchhhhHHHHHHHhCCCCCCCCccCCCCc
Q 038766 156 ---EAHVSDFGTSRMLDVHLQDLSSLSTAFQGTIGYLAPEFAYMRIVTTKVDVFSFGIVVMEFLTKRRPTGLDEENGLSP 232 (299)
Q Consensus 156 ---~v~l~df~~~~~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~DiwslG~~l~~l~~g~~p~~~~~~~~~~~ 232 (299)
.++|+|||++..... ........+++.|+|||++.+ .++.++|||||||++|+|++|..||.... .
T Consensus 184 ~~~~~kl~Dfg~a~~~~~-----~~~~~~~~gt~~y~aPE~~~~-~~~~~~DiwslG~il~~ll~g~~pf~~~~-----~ 252 (504)
T 3q5i_A 184 SLLNIKIVDFGLSSFFSK-----DYKLRDRLGTAYYIAPEVLKK-KYNEKCDVWSCGVIMYILLCGYPPFGGQN-----D 252 (504)
T ss_dssp CCSSEEECCCTTCEECCT-----TSCBCCCCSCTTTCCHHHHTT-CBCTHHHHHHHHHHHHHHHHSSCSSCCSS-----H
T ss_pred CCccEEEEECCCCEEcCC-----CCccccccCCcCCCCHHHhcc-CCCchHHHHHHHHHHHHHHhCCCCCCCCC-----H
Confidence 699999999976542 122344568999999998874 58999999999999999999999995432 1
Q ss_pred hhHHHHHHHHHhcCccCcccccCccccchhhHhHHHHHHHHHHHHHHHHhcCCCCCCCCChhhhhcC
Q 038766 233 ISLRQLVEKALANGINGVRQITDPKLVSSIYEEQEQHQVLEELFKLALVCTSSNPEDRPNMNELLIT 299 (299)
Q Consensus 233 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rpt~~~il~~ 299 (299)
. +.+........ .. .......++.++.+||++||..||.+|||++++|+|
T Consensus 253 ~---~~~~~i~~~~~----~~----------~~~~~~~~s~~~~~li~~~L~~dp~~R~t~~e~l~h 302 (504)
T 3q5i_A 253 Q---DIIKKVEKGKY----YF----------DFNDWKNISDEAKELIKLMLTYDYNKRCTAEEALNS 302 (504)
T ss_dssp H---HHHHHHHHCCC----CC----------CHHHHTTSCHHHHHHHHHHTCSSTTTSCCHHHHHTS
T ss_pred H---HHHHHHHcCCC----CC----------CccccCCCCHHHHHHHHHHcCCChhHCCCHHHHhcC
Confidence 1 22222221110 00 001123456789999999999999999999999987
|
| >3nyv_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, EF hand, bumped kinase inhibitor; HET: MSE DTQ; 1.88A {Toxoplasma gondii} PDB: 3i79_A* 3i7b_A* 3n51_A* 3i7c_A* 3sx9_A* 3sxf_A* 3t3u_A* 3t3v_A* 3upx_A* 3upz_A* 3v51_A* 3v5p_A* 3v5t_A* 3ku2_A* 3hx4_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.2e-46 Score=333.21 Aligned_cols=256 Identities=24% Similarity=0.336 Sum_probs=207.2
Q ss_pred HHHhCCCCCCceeecCCcceEEEEEeC-CCcEEEEEEeccCcCC-hhhhHHHHHHHHHHHhcCCcceeeeeeEEEcCCCe
Q 038766 8 ENATGSFSENNIIGNSNLSTVYKGRLE-DGEIVAVKKLNFHQFS-AESDKSFYREAKTLKELKHRNLVKVLGYAWESGKL 85 (299)
Q Consensus 8 ~~~~~~y~~~~~lg~g~~~~v~~~~~~-~~~~~~vK~~~~~~~~-~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~ 85 (299)
..+.++|++.+.||+|+||+||++.+. +++.||+|++...... ......+.+|+.+++.++||||+++++++.. ...
T Consensus 22 ~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~-~~~ 100 (484)
T 3nyv_A 22 AIFSDRYKGQRVLGKGSFGEVILCKDKITGQECAVKVISKRQVKQKTDKESLLREVQLLKQLDHPNIMKLYEFFED-KGY 100 (484)
T ss_dssp CCHHHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEETTTCCBSSCHHHHHHHHHHHTTCCCTTBCCEEEEEEC-SSE
T ss_pred CcccCceEEeeEEecCCCEEEEEEEECCCCCEEEEEEEEhhhcccchHHHHHHHHHHHHHhCCCCCCCcEEEEEEe-CCE
Confidence 456789999999999999999999875 6899999999754433 3456788999999999999999999997655 556
Q ss_pred eEEEEeecCCCChHHHhcCCCCCCCCCChhhHHHHHHHHHHHHHHhhcCCCCCeeeecccCCceee---CCCCcEEEeee
Q 038766 86 KALILEYMENGSLESVIHGPGVDHSRWTLPKRIDVLISVANGLDYLHSGYDIPIVHCDMKPSNILL---DRDFEAHVSDF 162 (299)
Q Consensus 86 ~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lh~~~~~~~~H~dl~~~nil~---~~~~~v~l~df 162 (299)
.++|+|++.+++|.+.+. ....+++..++.++.|++.||.|||++ +++|+||||+||++ +.++.++|+||
T Consensus 101 ~~lv~e~~~~~~L~~~~~----~~~~~~~~~~~~i~~qi~~~l~~lH~~---~ivH~Dlkp~Nil~~~~~~~~~~kl~Df 173 (484)
T 3nyv_A 101 FYLVGEVYTGGELFDEII----SRKRFSEVDAARIIRQVLSGITYMHKN---KIVHRDLKPENLLLESKSKDANIRIIDF 173 (484)
T ss_dssp EEEEECCCCSCBHHHHHH----TCSCCBHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEESSSSTTCCEEECCT
T ss_pred EEEEEecCCCCCHHHHHH----hcCCCCHHHHHHHHHHHHHHHHHHHHC---CeeeCCCCHHHEEEecCCCCCcEEEEee
Confidence 799999999999999887 456799999999999999999999999 99999999999999 56789999999
Q ss_pred ccccccccccccccccccccccCcccCChhhhcccCcCccccchhhhHHHHHHHhCCCCCCCCccCCCCchhHHHHHHHH
Q 038766 163 GTSRMLDVHLQDLSSLSTAFQGTIGYLAPEFAYMRIVTTKVDVFSFGIVVMEFLTKRRPTGLDEENGLSPISLRQLVEKA 242 (299)
Q Consensus 163 ~~~~~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~DiwslG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~ 242 (299)
|++..+.. ........+|+.|+|||++.+ .++.++|||||||++|+|++|..||.... .. +.+...
T Consensus 174 g~a~~~~~-----~~~~~~~~gt~~y~aPE~~~~-~~~~~~DiwslG~il~~ll~g~~pf~~~~-----~~---~~~~~i 239 (484)
T 3nyv_A 174 GLSTHFEA-----SKKMKDKIGTAYYIAPEVLHG-TYDEKCDVWSTGVILYILLSGCPPFNGAN-----EY---DILKKV 239 (484)
T ss_dssp THHHHBCC-----CCSHHHHTTGGGTCCHHHHHT-CCCTHHHHHHHHHHHHHHHHSSCSSCCSS-----HH---HHHHHH
T ss_pred eeeEEccc-----ccccccCCCCccccCceeecC-CCCCcceeHHHHHHHHHHHHCCCCCCCCC-----HH---HHHHHH
Confidence 99876542 122334568999999999876 58999999999999999999999995431 22 222222
Q ss_pred HhcCccCcccccCccccchhhHhHHHHHHHHHHHHHHHHhcCCCCCCCCChhhhhcC
Q 038766 243 LANGINGVRQITDPKLVSSIYEEQEQHQVLEELFKLALVCTSSNPEDRPNMNELLIT 299 (299)
Q Consensus 243 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rpt~~~il~~ 299 (299)
..... ....+ ....++.++.+||++||..||++|||++++|+|
T Consensus 240 ~~~~~----~~~~~----------~~~~~s~~~~~li~~~L~~dp~~R~s~~e~l~h 282 (484)
T 3nyv_A 240 EKGKY----TFELP----------QWKKVSESAKDLIRKMLTYVPSMRISARDALDH 282 (484)
T ss_dssp HHCCC----CCCSG----------GGGGSCHHHHHHHHHHTCSSGGGSCCHHHHHTS
T ss_pred HcCCC----CCCCc----------ccccCCHHHHHHHHHHCCCChhHCcCHHHHhhC
Confidence 22111 00111 022346789999999999999999999999987
|
| >3lij_A Calcium/calmodulin dependent protein kinase with A kinase domain and 4 calmodulin...; transferase, calcium dependent protein kinase; HET: ANP; 1.90A {Cryptosporidium parvum} PDB: 3hzt_A* 3dxn_A 3l19_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.2e-45 Score=329.75 Aligned_cols=255 Identities=23% Similarity=0.321 Sum_probs=200.2
Q ss_pred HHhCCCCCCceeecCCcceEEEEEeC-CCcEEEEEEeccCcCChhhhHHHHHHHHHHHhcCCcceeeeeeEEEcCCCeeE
Q 038766 9 NATGSFSENNIIGNSNLSTVYKGRLE-DGEIVAVKKLNFHQFSAESDKSFYREAKTLKELKHRNLVKVLGYAWESGKLKA 87 (299)
Q Consensus 9 ~~~~~y~~~~~lg~g~~~~v~~~~~~-~~~~~~vK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~ 87 (299)
.+.++|++.+.||+|+||+||+|.+. ++..+|+|++............+.+|+.+++.++||||+++++++.. ....+
T Consensus 34 ~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~-~~~~~ 112 (494)
T 3lij_A 34 HLSEMYQRVKKLGSGAYGEVLLCRDKVTHVERAIKIIRKTSVSTSSNSKLLEEVAVLKLLDHPNIMKLYDFFED-KRNYY 112 (494)
T ss_dssp CHHHHEEEEEEEECC---EEEEEEETTTCCEEEEEEEEC-----CTTHHHHHHHHHHTTCCCTTBCCEEEEEEC-SSEEE
T ss_pred chhcCeEEeeEEecCCCEEEEEEEECCCCcEEEEEEEeccccCchHHHHHHHHHHHHHhCCCCCCCeEEEEEEe-CCEEE
Confidence 45678999999999999999999875 68999999998665555667889999999999999999999997655 55669
Q ss_pred EEEeecCCCChHHHhcCCCCCCCCCChhhHHHHHHHHHHHHHHhhcCCCCCeeeecccCCceeeCC---CCcEEEeeecc
Q 038766 88 LILEYMENGSLESVIHGPGVDHSRWTLPKRIDVLISVANGLDYLHSGYDIPIVHCDMKPSNILLDR---DFEAHVSDFGT 164 (299)
Q Consensus 88 lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lh~~~~~~~~H~dl~~~nil~~~---~~~v~l~df~~ 164 (299)
+|+||+.+++|.+.+. ....+++..++.++.||+.||.|||+. +++||||||+||+++. ++.++|+|||+
T Consensus 113 lv~e~~~~g~L~~~~~----~~~~~~~~~~~~i~~qi~~~l~~lH~~---~ivH~Dlkp~Nil~~~~~~~~~~kl~DfG~ 185 (494)
T 3lij_A 113 LVMECYKGGELFDEII----HRMKFNEVDAAVIIKQVLSGVTYLHKH---NIVHRDLKPENLLLESKEKDALIKIVDFGL 185 (494)
T ss_dssp EEEECCCSCBHHHHHH----HHSSCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEESCSSTTCCEEECCCTT
T ss_pred EEEecCCCCcHHHHHH----HcCCCCHHHHHHHHHHHHHHHHHHHHC---CceeccCChhhEEEeCCCCCCcEEEEECCC
Confidence 9999999999998876 445799999999999999999999999 9999999999999976 45599999999
Q ss_pred ccccccccccccccccccccCcccCChhhhcccCcCccccchhhhHHHHHHHhCCCCCCCCccCCCCchhHHHHHHHHHh
Q 038766 165 SRMLDVHLQDLSSLSTAFQGTIGYLAPEFAYMRIVTTKVDVFSFGIVVMEFLTKRRPTGLDEENGLSPISLRQLVEKALA 244 (299)
Q Consensus 165 ~~~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~DiwslG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~ 244 (299)
+..... ........+|+.|+|||++. ..++.++|||||||++|+|++|..||.... .. +.+.....
T Consensus 186 a~~~~~-----~~~~~~~~gt~~y~aPE~l~-~~~~~~~DiwslG~il~~ll~g~~pf~~~~-----~~---~~~~~i~~ 251 (494)
T 3lij_A 186 SAVFEN-----QKKMKERLGTAYYIAPEVLR-KKYDEKCDVWSIGVILFILLAGYPPFGGQT-----DQ---EILRKVEK 251 (494)
T ss_dssp CEECBT-----TBCBCCCCSCTTTCCHHHHT-TCBCTHHHHHHHHHHHHHHHHSSCSSCCSS-----HH---HHHHHHHH
T ss_pred CeECCC-----CccccccCCCcCeeCHHHHc-ccCCCchhHHHHHHHHHHHHhCCCCCCCCC-----HH---HHHHHHHh
Confidence 876542 12234456899999999876 458999999999999999999999995432 11 22222221
Q ss_pred cCccCcccccCccccchhhHhHHHHHHHHHHHHHHHHhcCCCCCCCCChhhhhcC
Q 038766 245 NGINGVRQITDPKLVSSIYEEQEQHQVLEELFKLALVCTSSNPEDRPNMNELLIT 299 (299)
Q Consensus 245 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rpt~~~il~~ 299 (299)
... ....+. ...++..+.+||++||..||.+|||++++|+|
T Consensus 252 ~~~----~~~~~~----------~~~~s~~~~~li~~~L~~dp~~R~s~~e~l~h 292 (494)
T 3lij_A 252 GKY----TFDSPE----------WKNVSEGAKDLIKQMLQFDSQRRISAQQALEH 292 (494)
T ss_dssp TCC----CCCSGG----------GTTSCHHHHHHHHHHTCSSTTTSCCHHHHHTC
T ss_pred CCC----CCCchh----------cccCCHHHHHHHHHHCCCChhhCccHHHHhcC
Confidence 111 111111 12345679999999999999999999999987
|
| >3kul_A Ephrin type-A receptor 8; ATP-binding, kinase, nucleotide-binding, transfera phosphorylation, transmembrane, tyrosine-protein kinase; HET: PTR; 2.15A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=6.3e-46 Score=316.22 Aligned_cols=256 Identities=27% Similarity=0.442 Sum_probs=200.6
Q ss_pred HHhCCCCCCceeecCCcceEEEEEeC----CCcEEEEEEeccCcCChhhhHHHHHHHHHHHhcCCcceeeeeeEEEcCCC
Q 038766 9 NATGSFSENNIIGNSNLSTVYKGRLE----DGEIVAVKKLNFHQFSAESDKSFYREAKTLKELKHRNLVKVLGYAWESGK 84 (299)
Q Consensus 9 ~~~~~y~~~~~lg~g~~~~v~~~~~~----~~~~~~vK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~ 84 (299)
...++|.+.+.||+|+||+||++.+. .+..||||++... ......+.+.+|+.+++.++||||+++++++.. +.
T Consensus 46 ~~~~~y~i~~~lG~G~~g~V~~~~~~~~~~~~~~vavK~~~~~-~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~-~~ 123 (325)
T 3kul_A 46 IEASRIHIEKIIGSGDSGEVCYGRLRVPGQRDVPVAIKALKAG-YTERQRRDFLSEASIMGQFDHPNIIRLEGVVTR-GR 123 (325)
T ss_dssp CCGGGEEEEEEEEETTTEEEEEEEECCTTSCCEEEEEEEECTT-CCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECG-GG
T ss_pred cChhHeEEeeEEEeCCCcEEEEEEEecCCCCCceEEEEecCCC-CCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEe-CC
Confidence 45678999999999999999999874 3456999998642 345556788999999999999999999997654 55
Q ss_pred eeEEEEeecCCCChHHHhcCCCCCCCCCChhhHHHHHHHHHHHHHHhhcCCCCCeeeecccCCceeeCCCCcEEEeeecc
Q 038766 85 LKALILEYMENGSLESVIHGPGVDHSRWTLPKRIDVLISVANGLDYLHSGYDIPIVHCDMKPSNILLDRDFEAHVSDFGT 164 (299)
Q Consensus 85 ~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lh~~~~~~~~H~dl~~~nil~~~~~~v~l~df~~ 164 (299)
..++|+||+.+++|.+++.. ....+++..++.++.|++.||.|||+. +++|+||||+||+++.++.++|+|||+
T Consensus 124 ~~~lv~e~~~~~~L~~~l~~---~~~~~~~~~~~~i~~qi~~~L~~LH~~---~ivH~Dlkp~NIll~~~~~~kl~Dfg~ 197 (325)
T 3kul_A 124 LAMIVTEYMENGSLDTFLRT---HDGQFTIMQLVGMLRGVGAGMRYLSDL---GYVHRDLAARNVLVDSNLVCKVSDFGL 197 (325)
T ss_dssp CCEEEEECCTTCBHHHHHHT---TTTCSCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEECTTCCEEECCCSS
T ss_pred ccEEEeeCCCCCcHHHHHHh---cccCCCHHHHHHHHHHHHHHHHHHHHC---CeeCCCCCcceEEECCCCCEEECCCCc
Confidence 56999999999999999863 235799999999999999999999999 999999999999999999999999999
Q ss_pred ccccccccccccccccccccCcccCChhhhcccCcCccccchhhhHHHHHHHh-CCCCCCCCccCCCCchhHHHHHHHHH
Q 038766 165 SRMLDVHLQDLSSLSTAFQGTIGYLAPEFAYMRIVTTKVDVFSFGIVVMEFLT-KRRPTGLDEENGLSPISLRQLVEKAL 243 (299)
Q Consensus 165 ~~~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~DiwslG~~l~~l~~-g~~p~~~~~~~~~~~~~~~~~~~~~~ 243 (299)
+......... ........+++.|+|||++.+..++.++||||||+++|+|++ |..||... .... ......
T Consensus 198 a~~~~~~~~~-~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~ell~~g~~p~~~~-----~~~~---~~~~~~ 268 (325)
T 3kul_A 198 SRVLEDDPDA-AYTTTGGKIPIRWTAPEAIAFRTFSSASDVWSFGVVMWEVLAYGERPYWNM-----TNRD---VISSVE 268 (325)
T ss_dssp CEECC----C-CEECC---CCGGGSCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCTTTTS-----CHHH---HHHHHH
T ss_pred ccccccCccc-eeeccCCCCcccccCHhHhcCCCCCcHHHHHHHHHHHHHHHcCCCCCcccC-----CHHH---HHHHHH
Confidence 9865422111 111223345678999999999999999999999999999998 99998432 2222 222211
Q ss_pred hcCccCcccccCccccchhhHhHHHHHHHHHHHHHHHHhcCCCCCCCCChhhhhc
Q 038766 244 ANGINGVRQITDPKLVSSIYEEQEQHQVLEELFKLALVCTSSNPEDRPNMNELLI 298 (299)
Q Consensus 244 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rpt~~~il~ 298 (299)
.... ... +..++..+.++|.+||..||++|||++++++
T Consensus 269 ~~~~-----~~~------------~~~~~~~l~~li~~~l~~dp~~Rps~~eil~ 306 (325)
T 3kul_A 269 EGYR-----LPA------------PMGCPHALHQLMLDCWHKDRAQRPRFSQIVS 306 (325)
T ss_dssp TTCC-----CCC------------CTTCCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred cCCC-----CCC------------CCCcCHHHHHHHHHHccCChhhCcCHHHHHH
Confidence 1110 000 1234567999999999999999999999975
|
| >3lm5_A Serine/threonine-protein kinase 17B; STK17B, serine/threonine kinase 17B, DRAK2, DAP kinase relat apoptosis-inducing protein kinase 2; HET: QUE; 2.29A {Homo sapiens} PDB: 3lm0_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-45 Score=313.93 Aligned_cols=262 Identities=23% Similarity=0.276 Sum_probs=207.7
Q ss_pred HHHHHHhCCCCCC-ceeecCCcceEEEEEeC-CCcEEEEEEeccCcCChhhhHHHHHHHHHHHhcC-CcceeeeeeEEEc
Q 038766 5 TEIENATGSFSEN-NIIGNSNLSTVYKGRLE-DGEIVAVKKLNFHQFSAESDKSFYREAKTLKELK-HRNLVKVLGYAWE 81 (299)
Q Consensus 5 ~~~~~~~~~y~~~-~~lg~g~~~~v~~~~~~-~~~~~~vK~~~~~~~~~~~~~~~~~e~~~l~~l~-h~~i~~~~~~~~~ 81 (299)
...+.+.++|.+. +.||+|+||+||++.+. +++.||+|++............+.+|+..++.+. ||||+++++++..
T Consensus 21 ~~~~~~~~~y~~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~iv~~~~~~~~ 100 (327)
T 3lm5_A 21 QSMENFNNFYILTSKELGRGKFAVVRQCISKSTGQEYAAKFLKKRRRGQDCRAEILHEIAVLELAKSCPRVINLHEVYEN 100 (327)
T ss_dssp BCHHHHHHHEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEESEETTEECHHHHHHHHHHHHHTTTCTTBCCEEEEEEC
T ss_pred HHHHhhhhEEeeccceeCCCCCeEEEEEEECCCCCEEEEEEEehhhcchHHHHHHHHHHHHHHhccCCCCEEEEEEEEEe
Confidence 3467888899998 89999999999999875 5899999999866555666788999999999996 6999999997654
Q ss_pred CCCeeEEEEeecCCCChHHHhcCCCCCCCCCChhhHHHHHHHHHHHHHHhhcCCCCCeeeecccCCceeeCC---CCcEE
Q 038766 82 SGKLKALILEYMENGSLESVIHGPGVDHSRWTLPKRIDVLISVANGLDYLHSGYDIPIVHCDMKPSNILLDR---DFEAH 158 (299)
Q Consensus 82 ~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lh~~~~~~~~H~dl~~~nil~~~---~~~v~ 158 (299)
+...++|+||+.+++|.+++... ....+++..++.++.|++.||+|||+. +++|+||||+||+++. ++.++
T Consensus 101 -~~~~~lv~e~~~~~~L~~~~~~~--~~~~~~~~~~~~i~~ql~~~L~~LH~~---givH~Dikp~NIl~~~~~~~~~~k 174 (327)
T 3lm5_A 101 -TSEIILILEYAAGGEIFSLCLPE--LAEMVSENDVIRLIKQILEGVYYLHQN---NIVHLDLKPQNILLSSIYPLGDIK 174 (327)
T ss_dssp -SSEEEEEEECCTTEEGGGGGSSC--C-CCCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCCGGGEEESCBTTBCCEE
T ss_pred -CCeEEEEEEecCCCcHHHHHHHh--cccCCCHHHHHHHHHHHHHHHHHHHHC---CeecCcCChHHEEEecCCCCCcEE
Confidence 55679999999999999988532 346799999999999999999999999 9999999999999987 78999
Q ss_pred EeeeccccccccccccccccccccccCcccCChhhhcccCcCccccchhhhHHHHHHHhCCCCCCCCccCCCCchhHHHH
Q 038766 159 VSDFGTSRMLDVHLQDLSSLSTAFQGTIGYLAPEFAYMRIVTTKVDVFSFGIVVMEFLTKRRPTGLDEENGLSPISLRQL 238 (299)
Q Consensus 159 l~df~~~~~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~DiwslG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~ 238 (299)
|+|||++..... ........+++.|+|||++.+..++.++||||||+++|+|++|..||.... .. +.
T Consensus 175 L~Dfg~a~~~~~-----~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~-----~~---~~ 241 (327)
T 3lm5_A 175 IVDFGMSRKIGH-----ACELREIMGTPEYLAPEILNYDPITTATDMWNIGIIAYMLLTHTSPFVGED-----NQ---ET 241 (327)
T ss_dssp ECCGGGCEEC--------------CCCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSSCCSS-----HH---HH
T ss_pred EeeCccccccCC-----ccccccccCCcCccCCeeecCCCCCchhhHHHHHHHHHHHHhCCCCCCCCC-----ch---HH
Confidence 999999976542 112234568999999999999999999999999999999999999995431 11 11
Q ss_pred HHHHHhcCccCcccccCccccchhhHhHHHHHHHHHHHHHHHHhcCCCCCCCCChhhhhcC
Q 038766 239 VEKALANGINGVRQITDPKLVSSIYEEQEQHQVLEELFKLALVCTSSNPEDRPNMNELLIT 299 (299)
Q Consensus 239 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rpt~~~il~~ 299 (299)
......... ..... ....++..+.++|.+||..||++|||++++|+|
T Consensus 242 ~~~i~~~~~----~~~~~----------~~~~~~~~~~~li~~~L~~dP~~Rpt~~~ll~h 288 (327)
T 3lm5_A 242 YLNISQVNV----DYSEE----------TFSSVSQLATDFIQSLLVKNPEKRPTAEICLSH 288 (327)
T ss_dssp HHHHHHTCC----CCCTT----------TTTTSCHHHHHHHHHHSCSSGGGSCCHHHHTTC
T ss_pred HHHHHhccc----ccCch----------hhcccCHHHHHHHHHHcCCChhhCcCHHHHhCC
Confidence 111111110 00000 012345678999999999999999999999987
|
| >3eqc_A Dual specificity mitogen-activated protein kinase; MEK1 kinase, ATP-binding, disease mutation, nucleoti binding, phosphoprotein; HET: 3BM AGS; 1.80A {Homo sapiens} PDB: 3eqd_A* 3eqf_A* 3eqg_A* 3eqh_A* 3eqi_A* 2y4i_C* 3eqb_A* 2p55_A* 1s9j_A* 3dy7_A* 3e8n_A* 3v01_A* 3v04_A* 3dv3_A* 3mbl_A* 3pp1_A* 3orn_A* 3os3_A* 3sls_A* 1s9i_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=8.7e-46 Score=319.81 Aligned_cols=270 Identities=24% Similarity=0.354 Sum_probs=203.1
Q ss_pred HhCCCCCCceeecCCcceEEEEEeC-CCcEEEEEEeccCcCChhhhHHHHHHHHHHHhcCCcceeeeeeEEEcCCCeeEE
Q 038766 10 ATGSFSENNIIGNSNLSTVYKGRLE-DGEIVAVKKLNFHQFSAESDKSFYREAKTLKELKHRNLVKVLGYAWESGKLKAL 88 (299)
Q Consensus 10 ~~~~y~~~~~lg~g~~~~v~~~~~~-~~~~~~vK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~l 88 (299)
..++|.+.+.||+|+||+||++.+. ++..||+|++... ........+.+|+.+++.++||||+++++++.. +...++
T Consensus 31 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~va~K~~~~~-~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~-~~~~~l 108 (360)
T 3eqc_A 31 KDDDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLE-IKPAIRNQIIRELQVLHECNSPYIVGFYGAFYS-DGEISI 108 (360)
T ss_dssp CGGGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEECC-CCHHHHHHHHHHHGGGGGCCCTTBCCEEEEEEE-TTEEEE
T ss_pred ccccceeeeeecCCCCeEEEEEEECCCCcEEEEEEeccc-cCHHHHHHHHHHHHHHHHCCCCCEEEEeEEEEE-CCEEEE
Confidence 4678999999999999999999875 6899999998753 345567789999999999999999999997765 556699
Q ss_pred EEeecCCCChHHHhcCCCCCCCCCChhhHHHHHHHHHHHHHHhhc-CCCCCeeeecccCCceeeCCCCcEEEeeeccccc
Q 038766 89 ILEYMENGSLESVIHGPGVDHSRWTLPKRIDVLISVANGLDYLHS-GYDIPIVHCDMKPSNILLDRDFEAHVSDFGTSRM 167 (299)
Q Consensus 89 v~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lh~-~~~~~~~H~dl~~~nil~~~~~~v~l~df~~~~~ 167 (299)
|+||+.+++|.+++. ....+++..++.++.|++.||.|||+ . +++|+||||+||+++.++.++|+|||++..
T Consensus 109 v~e~~~~~~L~~~l~----~~~~~~~~~~~~i~~~i~~~l~~lh~~~---~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~ 181 (360)
T 3eqc_A 109 CMEHMDGGSLDQVLK----KAGRIPEQILGKVSIAVIKGLTYLREKH---KIMHRDVKPSNILVNSRGEIKLCDFGVSGQ 181 (360)
T ss_dssp EECCCTTCBHHHHHH----HHSSCCHHHHHHHHHHHHHHHHHHHHHH---CCCCSCCSGGGEEECTTCCEEECCCCCCHH
T ss_pred EEECCCCCCHHHHHH----HcCCCCHHHHHHHHHHHHHHHHHHHHhC---CEEcCCccHHHEEECCCCCEEEEECCCCcc
Confidence 999999999999997 44579999999999999999999998 4 899999999999999999999999999865
Q ss_pred cccccccccccccccccCcccCChhhhcccCcCccccchhhhHHHHHHHhCCCCCCCCccCCCCchhHHHHHHHHHhcCc
Q 038766 168 LDVHLQDLSSLSTAFQGTIGYLAPEFAYMRIVTTKVDVFSFGIVVMEFLTKRRPTGLDEENGLSPISLRQLVEKALANGI 247 (299)
Q Consensus 168 ~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~DiwslG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 247 (299)
... .......+++.|+|||++.+..++.++|||||||++|+|++|..||...... .....+........
T Consensus 182 ~~~------~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~-----~~~~~~~~~~~~~~ 250 (360)
T 3eqc_A 182 LID------SMANSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAVGRYPIPPPDAK-----ELELMFGCQVEGDA 250 (360)
T ss_dssp HHH------HC----CCCCTTCCHHHHTTCCCSHHHHHHHHHHHHHHHHHTSCCSSCCCHH-----HHHHHHC-------
T ss_pred ccc------ccccCCCCCCCeECHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHH-----HHHHHhcccccccC
Confidence 431 1233456899999999999999999999999999999999999999643211 11110000000000
Q ss_pred cCc-----------ccccC-ccccchh-----------hHhHHHHHHHHHHHHHHHHhcCCCCCCCCChhhhhcC
Q 038766 248 NGV-----------RQITD-PKLVSSI-----------YEEQEQHQVLEELFKLALVCTSSNPEDRPNMNELLIT 299 (299)
Q Consensus 248 ~~~-----------~~~~~-~~~~~~~-----------~~~~~~~~~~~~l~~li~~~l~~dP~~Rpt~~~il~~ 299 (299)
... ..... ....... ........++.++.+||++||..||++|||++++|+|
T Consensus 251 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~h 325 (360)
T 3eqc_A 251 AETPPRPRTPGRPLNKFGMDSRPPMAIFELLDYIVNEPPPKLPSGVFSLEFQDFVNKCLIKNPAERADLKQLMVH 325 (360)
T ss_dssp -----------------------CCCHHHHHHHHHHSCCCCCCTTTSCHHHHHHHHHHHCSSTTTSCCHHHHHTS
T ss_pred CCCCCCcccCCCcccccccCCCCcccchhhhhHHhccCCCCCCcccccHHHHHHHHHHhhcChhhCCCHHHHhhC
Confidence 000 00000 0000000 0000011245689999999999999999999999987
|
| >3bhy_A Death-associated protein kinase 3; death associated kinase, DAPK3, ZIP kinase, ZIPK, DAP kinase like kinase, DLK, structural genomics consortium; HET: 7CP; 1.24A {Homo sapiens} PDB: 3bqr_A* 2j90_A* 1yrp_A* 2yak_A* 2y4p_A* 3f5u_A* 1jks_A 1jkk_A* 1ig1_A* 1jkl_A 1jkt_A 3eh9_A* 3eha_A* 3f5g_A* 1p4f_A* 1wvw_A 1wvx_A* 1wvy_A* 2w4j_A* 3dgk_A ... | Back alignment and structure |
|---|
Probab=100.00 E-value=2.3e-45 Score=306.78 Aligned_cols=255 Identities=22% Similarity=0.315 Sum_probs=203.5
Q ss_pred HhCCCCCCceeecCCcceEEEEEeC-CCcEEEEEEeccCcCCh----hhhHHHHHHHHHHHhcCCcceeeeeeEEEcCCC
Q 038766 10 ATGSFSENNIIGNSNLSTVYKGRLE-DGEIVAVKKLNFHQFSA----ESDKSFYREAKTLKELKHRNLVKVLGYAWESGK 84 (299)
Q Consensus 10 ~~~~y~~~~~lg~g~~~~v~~~~~~-~~~~~~vK~~~~~~~~~----~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~ 84 (299)
+.++|++.+.||+|+||+||++.+. +++.+|+|++....... ...+.+.+|+..++.++||||+++++++.. +.
T Consensus 3 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~-~~ 81 (283)
T 3bhy_A 3 VEDHYEMGEELGSGQFAIVRKCRQKGTGKEYAAKFIKKRRLSSSRRGVSREEIEREVNILREIRHPNIITLHDIFEN-KT 81 (283)
T ss_dssp HHHHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEBCSSTTCSSSBCHHHHHHHHHHHHHCCCTTBCCEEEEEEC-SS
T ss_pred hhhhhhhHHhhcccCceEEEEEEEcCCCCeeehHHhhhccccccccchHHHHHHHHHHHHHhCCCCCeeehhheecC-CC
Confidence 5678999999999999999999875 68999999987543322 236788999999999999999999997665 55
Q ss_pred eeEEEEeecCCCChHHHhcCCCCCCCCCChhhHHHHHHHHHHHHHHhhcCCCCCeeeecccCCceeeCCCC----cEEEe
Q 038766 85 LKALILEYMENGSLESVIHGPGVDHSRWTLPKRIDVLISVANGLDYLHSGYDIPIVHCDMKPSNILLDRDF----EAHVS 160 (299)
Q Consensus 85 ~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lh~~~~~~~~H~dl~~~nil~~~~~----~v~l~ 160 (299)
..++|+|++.+++|.+++. ....+++..++.++.|++.||.+||+. +++|+||+|+||+++.++ .++|+
T Consensus 82 ~~~lv~e~~~~~~L~~~l~----~~~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dl~p~Nil~~~~~~~~~~~kl~ 154 (283)
T 3bhy_A 82 DVVLILELVSGGELFDFLA----EKESLTEDEATQFLKQILDGVHYLHSK---RIAHFDLKPENIMLLDKNVPNPRIKLI 154 (283)
T ss_dssp EEEEEEECCCSCBHHHHHH----HHSSCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEESCSSSSSCCEEEC
T ss_pred eEEEEEeecCCCcHHHHHH----hcCCCCHHHHHHHHHHHHHHHHHHHhC---CccCCCCChHHEEEecCCCCCCceEEE
Confidence 6799999999999999986 445799999999999999999999999 999999999999998877 79999
Q ss_pred eeccccccccccccccccccccccCcccCChhhhcccCcCccccchhhhHHHHHHHhCCCCCCCCccCCCCchhHHHHHH
Q 038766 161 DFGTSRMLDVHLQDLSSLSTAFQGTIGYLAPEFAYMRIVTTKVDVFSFGIVVMEFLTKRRPTGLDEENGLSPISLRQLVE 240 (299)
Q Consensus 161 df~~~~~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~DiwslG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~ 240 (299)
|||++...... .......+++.|+|||.+.+..++.++||||||+++|+|++|..||.... . .+...
T Consensus 155 dfg~~~~~~~~-----~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~-----~---~~~~~ 221 (283)
T 3bhy_A 155 DFGIAHKIEAG-----NEFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGET-----K---QETLT 221 (283)
T ss_dssp CCTTCEECC-------------CCCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCTTCCSS-----H---HHHHH
T ss_pred ecccceeccCC-----CcccccCCCcCccCcceecCCCCCcchhhhhHHHHHHHHHHCCCCCCCcc-----h---HHHHH
Confidence 99998765421 12234457899999999998899999999999999999999999985431 1 11111
Q ss_pred HHHhcCccCcccccCccccchhhHhHHHHHHHHHHHHHHHHhcCCCCCCCCChhhhhcC
Q 038766 241 KALANGINGVRQITDPKLVSSIYEEQEQHQVLEELFKLALVCTSSNPEDRPNMNELLIT 299 (299)
Q Consensus 241 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rpt~~~il~~ 299 (299)
....... . . .......++..+.+++.+||..||++|||++++++|
T Consensus 222 ~~~~~~~-~--------~-----~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~~l~h 266 (283)
T 3bhy_A 222 NISAVNY-D--------F-----DEEYFSNTSELAKDFIRRLLVKDPKRRMTIAQSLEH 266 (283)
T ss_dssp HHHTTCC-C--------C-----CHHHHTTCCHHHHHHHHTTSCSSGGGSCCHHHHHHC
T ss_pred HhHhccc-C--------C-----cchhcccCCHHHHHHHHHHccCCHhHCcCHHHHHhC
Confidence 1111100 0 0 011133456789999999999999999999999987
|
| >4aw2_A Serine/threonine-protein kinase MRCK alpha; transferase, CDC42BPA; HET: 22E; 1.70A {Rattus norvegicus} PDB: 3tku_A* 3qfv_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.1e-46 Score=327.35 Aligned_cols=264 Identities=20% Similarity=0.239 Sum_probs=205.5
Q ss_pred HHHHHHhCCCCCCceeecCCcceEEEEEeC-CCcEEEEEEeccCcC-ChhhhHHHHHHHHHHHhcCCcceeeeeeEEEcC
Q 038766 5 TEIENATGSFSENNIIGNSNLSTVYKGRLE-DGEIVAVKKLNFHQF-SAESDKSFYREAKTLKELKHRNLVKVLGYAWES 82 (299)
Q Consensus 5 ~~~~~~~~~y~~~~~lg~g~~~~v~~~~~~-~~~~~~vK~~~~~~~-~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~ 82 (299)
.+.+...++|.+.+.||+|+||+||++++. +++.||+|++..... .......+..|..+++.++||||+++++++..
T Consensus 67 ~~~~~~~~~y~~~~~LG~G~fG~V~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~~~E~~il~~~~hp~Iv~l~~~~~~- 145 (437)
T 4aw2_A 67 KQMRLHREDFEILKVIGRGAFGEVAVVKLKNADKVFAMKILNKWEMLKRAETACFREERDVLVNGDSKWITTLHYAFQD- 145 (437)
T ss_dssp HHHSCCGGGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEEHHHHHHTTTTCCHHHHHHHHHHSCTTTBCCEEEEEEC-
T ss_pred hcccCChhheEEEEEEEeCCCEEEEEEEEcCCCcEEEEEEEEHHHhhhHHHHHHHHHHHHHHHhCCCCCEEEEEEEEee-
Confidence 344556789999999999999999999875 488999999864221 12223447889999999999999999996665
Q ss_pred CCeeEEEEeecCCCChHHHhcCCCCCCCCCChhhHHHHHHHHHHHHHHhhcCCCCCeeeecccCCceeeCCCCcEEEeee
Q 038766 83 GKLKALILEYMENGSLESVIHGPGVDHSRWTLPKRIDVLISVANGLDYLHSGYDIPIVHCDMKPSNILLDRDFEAHVSDF 162 (299)
Q Consensus 83 ~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lh~~~~~~~~H~dl~~~nil~~~~~~v~l~df 162 (299)
+..+++||||+.+++|.+++... ...+++..++.++.||+.||.|||+. +++||||||+|||++.+|.+||+||
T Consensus 146 ~~~~~lV~Ey~~gg~L~~~l~~~---~~~l~e~~~~~~~~qi~~aL~~LH~~---giiHrDLKp~NILl~~~g~vkL~DF 219 (437)
T 4aw2_A 146 DNNLYLVMDYYVGGDLLTLLSKF---EDRLPEEMARFYLAEMVIAIDSVHQL---HYVHRDIKPDNILMDMNGHIRLADF 219 (437)
T ss_dssp SSEEEEEECCCTTCBHHHHHHTT---TTCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECTTSCEEECCC
T ss_pred CCEEEEEEecCCCCcHHHHHHHc---cCCCCHHHHHHHHHHHHHHHHHHHhC---CeEecccCHHHeeEcCCCCEEEcch
Confidence 55679999999999999999742 45799999999999999999999999 9999999999999999999999999
Q ss_pred ccccccccccccccccccccccCcccCChhhhc-----ccCcCccccchhhhHHHHHHHhCCCCCCCCccCCCCchhHHH
Q 038766 163 GTSRMLDVHLQDLSSLSTAFQGTIGYLAPEFAY-----MRIVTTKVDVFSFGIVVMEFLTKRRPTGLDEENGLSPISLRQ 237 (299)
Q Consensus 163 ~~~~~~~~~~~~~~~~~~~~~~~~~y~~PE~~~-----~~~~~~~~DiwslG~~l~~l~~g~~p~~~~~~~~~~~~~~~~ 237 (299)
|++..... ..........||+.|+|||++. ...++.++|||||||++|+|++|..||.... .. +
T Consensus 220 Gla~~~~~---~~~~~~~~~~GT~~Y~APE~l~~~~~~~~~~~~~~DvwSlGvil~elltG~~Pf~~~~-----~~---~ 288 (437)
T 4aw2_A 220 GSCLKLME---DGTVQSSVAVGTPDYISPEILQAMEGGKGRYGPECDWWSLGVCMYEMLYGETPFYAES-----LV---E 288 (437)
T ss_dssp TTCEECCT---TSCEECCSCCSCGGGCCHHHHHHHHTSCCEECTHHHHHHHHHHHHHHHHSSCTTCCSS-----HH---H
T ss_pred hhhhhccc---CCCcccccccCCcCeeChHHHhhcccCCCCCCCcCeeHHHHHHHHHHHhCCCCCCCCC-----hh---H
Confidence 99975442 1112233457899999999987 4568999999999999999999999995431 11 2
Q ss_pred HHHHHHhcCccCcccccCccccchhhHhHHHHHHHHHHHHHHHHhcCCCCCC--CCChhhhhcC
Q 038766 238 LVEKALANGINGVRQITDPKLVSSIYEEQEQHQVLEELFKLALVCTSSNPED--RPNMNELLIT 299 (299)
Q Consensus 238 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~--Rpt~~~il~~ 299 (299)
....+.... .....+.. ...++.++.+||++||..+|++ ||+++|+++|
T Consensus 289 ~~~~i~~~~----~~~~~p~~---------~~~~s~~~~dLi~~lL~~~~~r~~r~~~~eil~H 339 (437)
T 4aw2_A 289 TYGKIMNHK----ERFQFPTQ---------VTDVSENAKDLIRRLICSREHRLGQNGIEDFKKH 339 (437)
T ss_dssp HHHHHHTHH----HHCCCCSS---------CCCSCHHHHHHHHTTSSCGGGCTTTTTTHHHHTS
T ss_pred HHHhhhhcc----ccccCCcc---------cccCCHHHHHHHHHHhcccccccCCCCHHHHhCC
Confidence 222211100 00000000 0124567999999999999888 9999999987
|
| >2fst_X Mitogen-activated protein kinase 14; active mutants, lipids, MAP kinase insertion, autophosphorylation, transferase; HET: BOG; 1.45A {Homo sapiens} PDB: 2fso_X* 2fsl_X* 2fsm_X* 2npq_A* 2bal_A* 2baj_A* 2bak_A* 2baq_A* 2qd9_A* 1ian_A* 2rg5_A* 2rg6_A* 3bv2_A* 3bv3_A* 3bx5_A* 3c5u_A* 3cg2_A* 3l8x_A* 3mvl_A* 3mvm_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=8e-46 Score=320.28 Aligned_cols=269 Identities=23% Similarity=0.277 Sum_probs=189.3
Q ss_pred HhCCCCCCceeecCCcceEEEEEe-CCCcEEEEEEeccCcCChhhhHHHHHHHHHHHhcCCcceeeeeeEEEcC-----C
Q 038766 10 ATGSFSENNIIGNSNLSTVYKGRL-EDGEIVAVKKLNFHQFSAESDKSFYREAKTLKELKHRNLVKVLGYAWES-----G 83 (299)
Q Consensus 10 ~~~~y~~~~~lg~g~~~~v~~~~~-~~~~~~~vK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~-----~ 83 (299)
+.++|.+.+.||+|+||.||+|.+ .+|+.||||++............+.+|+.+++.++||||+++++++... .
T Consensus 27 ~~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~~~ 106 (367)
T 2fst_X 27 VPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEF 106 (367)
T ss_dssp EETTEEEEEECC----CCEEEEEETTTTEEEEEEECSSTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCSSGGGC
T ss_pred CCCceEEeeEEeecCCeEEEEEEECCCCCEEEEEEeCccccCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEecCCccccC
Confidence 468999999999999999999986 4689999999976555556678889999999999999999999977543 2
Q ss_pred CeeEEEEeecCCCChHHHhcCCCCCCCCCChhhHHHHHHHHHHHHHHhhcCCCCCeeeecccCCceeeCCCCcEEEeeec
Q 038766 84 KLKALILEYMENGSLESVIHGPGVDHSRWTLPKRIDVLISVANGLDYLHSGYDIPIVHCDMKPSNILLDRDFEAHVSDFG 163 (299)
Q Consensus 84 ~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lh~~~~~~~~H~dl~~~nil~~~~~~v~l~df~ 163 (299)
...++|+|++ +++|.+++. ...+++..++.++.||+.||+|||++ +++||||||+||+++.++.+||+|||
T Consensus 107 ~~~~lv~e~~-~~~L~~~~~-----~~~l~~~~~~~i~~qi~~aL~~LH~~---givH~Dlkp~NIll~~~~~~kL~DFG 177 (367)
T 2fst_X 107 NDVYLVTHLM-GADLNNIVK-----CQKLTDDHVQFLIYQILRGLKYIHSA---DIIHRDLKPSNLAVNEDCELKILDFG 177 (367)
T ss_dssp CCCEEEEECC-CEECC----------CCCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEECTTCCEEECC--
T ss_pred CeEEEEeccc-CCCHHHHHh-----cCCCCHHHHHHHHHHHHHHHHHHHHC---CeeeCCCCHhhEEECCCCCEEEeecc
Confidence 4469999999 679988885 35799999999999999999999999 99999999999999999999999999
Q ss_pred cccccccccccccccccccccCcccCChhhhcc-cCcCccccchhhhHHHHHHHhCCCCCCCCccCCCCchhHHHHHHHH
Q 038766 164 TSRMLDVHLQDLSSLSTAFQGTIGYLAPEFAYM-RIVTTKVDVFSFGIVVMEFLTKRRPTGLDEENGLSPISLRQLVEKA 242 (299)
Q Consensus 164 ~~~~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~-~~~~~~~DiwslG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~ 242 (299)
++.... .......+|+.|+|||++.+ ..++.++|||||||++|+|++|..||.... .......+...
T Consensus 178 ~a~~~~-------~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~-----~~~~l~~i~~~ 245 (367)
T 2fst_X 178 LARHTA-------DEMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTD-----HIDQLKLILRL 245 (367)
T ss_dssp --------------------CCCTTCCHHHHTTCCSCCTTHHHHHHHHHHHHHHHSSCSCCCSS-----HHHHHHHHHHH
T ss_pred cccccc-------ccCCCcCcCcCccChHHHcCCcCCCchhhHHHHHHHHHHHHhCCCCCCCCC-----HHHHHHHHHHH
Confidence 987543 12334568999999999887 678999999999999999999999995432 11111111111
Q ss_pred HhcCccC-cccccCccc---------cchhhHhHHHHHHHHHHHHHHHHhcCCCCCCCCChhhhhcC
Q 038766 243 LANGING-VRQITDPKL---------VSSIYEEQEQHQVLEELFKLALVCTSSNPEDRPNMNELLIT 299 (299)
Q Consensus 243 ~~~~~~~-~~~~~~~~~---------~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rpt~~~il~~ 299 (299)
....... ...+..... .............+..+.+||++||..||++|||++++|+|
T Consensus 246 ~g~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dLl~~mL~~dP~~R~t~~e~L~h 312 (367)
T 2fst_X 246 VGTPGAELLKKISSESARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAH 312 (367)
T ss_dssp HCSCCHHHHTTCCCHHHHHHHHTSCCCCCCCHHHHTTTCCHHHHHHHHHHSCSSGGGSCCHHHHHTS
T ss_pred hCCCCHHHHHHhhhHHHHHHHhccCCCCCCCHHHHCCCCCHHHHHHHHHhCCCCcccCcCHHHHhcC
Confidence 1100000 000000000 00000001122346789999999999999999999999987
|
| >3cok_A Serine/threonine-protein kinase PLK4; POLO-like kinase 4, SAK, STK18, PSI, structural genomics, protein structure initiative; HET: ANP; 2.25A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.9e-46 Score=310.16 Aligned_cols=254 Identities=24% Similarity=0.351 Sum_probs=184.0
Q ss_pred HHhCCCCCCceeecCCcceEEEEEe-CCCcEEEEEEeccCcCC-hhhhHHHHHHHHHHHhcCCcceeeeeeEEEcCCCee
Q 038766 9 NATGSFSENNIIGNSNLSTVYKGRL-EDGEIVAVKKLNFHQFS-AESDKSFYREAKTLKELKHRNLVKVLGYAWESGKLK 86 (299)
Q Consensus 9 ~~~~~y~~~~~lg~g~~~~v~~~~~-~~~~~~~vK~~~~~~~~-~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~ 86 (299)
...++|.+.+.||+|++|.||++.+ .+++.||+|++...... ......+.+|+..++.++||||+++++++.. +...
T Consensus 8 ~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~-~~~~ 86 (278)
T 3cok_A 8 EKIEDFKVGNLLGKGSFAGVYRAESIHTGLEVAIKMIDKKAMYKAGMVQRVQNEVKIHCQLKHPSILELYNYFED-SNYV 86 (278)
T ss_dssp SSGGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTBCCTTBCCEEEEEEC-SSEE
T ss_pred cccccceeeeeecCCCceEEEEEEEccCCceEEEEEeehhhhhhhhHHHHHHHHHHHHHhCCCCCeEeEEEEEcc-CCeE
Confidence 3457899999999999999999987 46899999998643221 2234678899999999999999999997655 5667
Q ss_pred EEEEeecCCCChHHHhcCCCCCCCCCChhhHHHHHHHHHHHHHHhhcCCCCCeeeecccCCceeeCCCCcEEEeeecccc
Q 038766 87 ALILEYMENGSLESVIHGPGVDHSRWTLPKRIDVLISVANGLDYLHSGYDIPIVHCDMKPSNILLDRDFEAHVSDFGTSR 166 (299)
Q Consensus 87 ~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lh~~~~~~~~H~dl~~~nil~~~~~~v~l~df~~~~ 166 (299)
++|+||+.+++|.+++.. ...++++..++.++.|++.||.|||+. +++|+||+|+||+++.++.++|+|||++.
T Consensus 87 ~lv~e~~~~~~L~~~l~~---~~~~~~~~~~~~~~~qi~~~l~~lH~~---~i~H~dl~p~Nili~~~~~~kl~dfg~~~ 160 (278)
T 3cok_A 87 YLVLEMCHNGEMNRYLKN---RVKPFSENEARHFMHQIITGMLYLHSH---GILHRDLTLSNLLLTRNMNIKIADFGLAT 160 (278)
T ss_dssp EEEEECCTTEEHHHHHHT---CSSCCCHHHHHHHHHHHHHHHHHHHHT---TEECSSCCGGGEEECTTCCEEECCCTTCE
T ss_pred EEEEecCCCCcHHHHHhh---ccCCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHEEEcCCCCEEEEeeccee
Confidence 999999999999999873 235789999999999999999999999 99999999999999999999999999987
Q ss_pred ccccccccccccccccccCcccCChhhhcccCcCccccchhhhHHHHHHHhCCCCCCCCccCCCCchhHHHHHHHHHhcC
Q 038766 167 MLDVHLQDLSSLSTAFQGTIGYLAPEFAYMRIVTTKVDVFSFGIVVMEFLTKRRPTGLDEENGLSPISLRQLVEKALANG 246 (299)
Q Consensus 167 ~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~DiwslG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~ 246 (299)
..... ........+++.|+|||.+.+..++.++||||||+++|+|++|..||......... ...
T Consensus 161 ~~~~~----~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~--------~~~---- 224 (278)
T 3cok_A 161 QLKMP----HEKHYTLCGTPNYISPEIATRSAHGLESDVWSLGCMFYTLLIGRPPFDTDTVKNTL--------NKV---- 224 (278)
T ss_dssp ECC--------------------------------CTHHHHHHHHHHHHHHSSCSSCCCSCC-------------C----
T ss_pred eccCC----CCcceeccCCCCcCCcchhcCCCCCchhhHHHHHHHHHHHHhCCCCCCChhHHHHH--------HHH----
Confidence 65421 11223346789999999999988999999999999999999999999654222100 000
Q ss_pred ccCcccccCccccchhhHhHHHHHHHHHHHHHHHHhcCCCCCCCCChhhhhcC
Q 038766 247 INGVRQITDPKLVSSIYEEQEQHQVLEELFKLALVCTSSNPEDRPNMNELLIT 299 (299)
Q Consensus 247 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rpt~~~il~~ 299 (299)
....... +..++.++.++|.+||..||++|||++++++|
T Consensus 225 --~~~~~~~------------~~~~~~~~~~li~~~l~~dp~~Rps~~~~l~h 263 (278)
T 3cok_A 225 --VLADYEM------------PSFLSIEAKDLIHQLLRRNPADRLSLSSVLDH 263 (278)
T ss_dssp --CSSCCCC------------CTTSCHHHHHHHHHHSCSSGGGSCCHHHHTTS
T ss_pred --hhcccCC------------ccccCHHHHHHHHHHcccCHhhCCCHHHHhcC
Confidence 0000000 12245678999999999999999999999987
|
| >2xrw_A Mitogen-activated protein kinase 8; transcription, MAPK signaling pathways, linear binding motif; HET: ANP; 1.33A {Homo sapiens} PDB: 1ukh_A 1uki_A* 2xs0_A* 3elj_A* 2h96_A* 2gmx_A* 2g01_A* 2no3_A* 3o2m_A* 3o17_A* 3pze_A* 3g9l_X* 2p33_A* 3cgf_A* 3cgo_A* 3g90_X* 2ok1_A* 3g9n_A* 1pmn_A* 1pmq_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-45 Score=318.74 Aligned_cols=270 Identities=21% Similarity=0.224 Sum_probs=198.3
Q ss_pred HhCCCCCCceeecCCcceEEEEEeC-CCcEEEEEEeccCcCChhhhHHHHHHHHHHHhcCCcceeeeeeEEEcCC-----
Q 038766 10 ATGSFSENNIIGNSNLSTVYKGRLE-DGEIVAVKKLNFHQFSAESDKSFYREAKTLKELKHRNLVKVLGYAWESG----- 83 (299)
Q Consensus 10 ~~~~y~~~~~lg~g~~~~v~~~~~~-~~~~~~vK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~----- 83 (299)
+.++|.+.+.||+|+||+||+|.+. +++.||+|++............+.+|+.+++.++||||+++++++...+
T Consensus 23 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~ 102 (371)
T 2xrw_A 23 VLKRYQNLKPIGSGAQGIVCAAYDAILERNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIIGLLNVFTPQKSLEEF 102 (371)
T ss_dssp EETTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEECTTSSHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSCCSTTTC
T ss_pred hhhheeEeeeeEecCCEEEEEEEECCCCceEEEEEeccccCChHHHHHHHHHHHHHHhcCCCCccceEEeeccccccccc
Confidence 4579999999999999999999874 5899999999765555666778899999999999999999999776543
Q ss_pred CeeEEEEeecCCCChHHHhcCCCCCCCCCChhhHHHHHHHHHHHHHHhhcCCCCCeeeecccCCceeeCCCCcEEEeeec
Q 038766 84 KLKALILEYMENGSLESVIHGPGVDHSRWTLPKRIDVLISVANGLDYLHSGYDIPIVHCDMKPSNILLDRDFEAHVSDFG 163 (299)
Q Consensus 84 ~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lh~~~~~~~~H~dl~~~nil~~~~~~v~l~df~ 163 (299)
...++|+||+.+ +|.+.+. ..+++..++.++.|++.||.|||++ +++|+||||+||+++.++.+||+|||
T Consensus 103 ~~~~lv~e~~~~-~l~~~~~------~~~~~~~~~~i~~qi~~al~~lH~~---~ivH~Dlkp~NIl~~~~~~~kl~Dfg 172 (371)
T 2xrw_A 103 QDVYIVMELMDA-NLCQVIQ------MELDHERMSYLLYQMLCGIKHLHSA---GIIHRDLKPSNIVVKSDCTLKILDFG 172 (371)
T ss_dssp CEEEEEEECCSE-EHHHHHH------SCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEECTTSCEEECCCC
T ss_pred cceEEEEEcCCC-CHHHHHh------hccCHHHHHHHHHHHHHHHHHHHHC---CeecccCCHHHEEEcCCCCEEEEEee
Confidence 367999999965 8888875 2488999999999999999999999 99999999999999999999999999
Q ss_pred cccccccccccccccccccccCcccCChhhhcccCcCccccchhhhHHHHHHHhCCCCCCCCccCCCCchhHHHHHH---
Q 038766 164 TSRMLDVHLQDLSSLSTAFQGTIGYLAPEFAYMRIVTTKVDVFSFGIVVMEFLTKRRPTGLDEENGLSPISLRQLVE--- 240 (299)
Q Consensus 164 ~~~~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~DiwslG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~--- 240 (299)
++..... ........+++.|+|||++.+..++.++|||||||++|+|++|..||...... ..+...+.
T Consensus 173 ~a~~~~~-----~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~----~~~~~i~~~~~ 243 (371)
T 2xrw_A 173 LARTAGT-----SFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIKGGVLFPGTDHI----DQWNKVIEQLG 243 (371)
T ss_dssp C---------------------CTTCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCSSCCSSHH----HHHHHHHC-CC
T ss_pred ccccccc-----ccccCCceecCCccCHHHhcCCCCCchHhHHHHHHHHHHHHhCCCCCCCCCHH----HHHHHHHHHhC
Confidence 9975431 11233456789999999999999999999999999999999999999643211 00111100
Q ss_pred ---------------HHHhcCccCcccccCcc-ccc--hhhHhHHHHHHHHHHHHHHHHhcCCCCCCCCChhhhhcC
Q 038766 241 ---------------KALANGINGVRQITDPK-LVS--SIYEEQEQHQVLEELFKLALVCTSSNPEDRPNMNELLIT 299 (299)
Q Consensus 241 ---------------~~~~~~~~~~~~~~~~~-~~~--~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rpt~~~il~~ 299 (299)
...... +......... ... ...........+.++.+||++||..||++|||++|+|+|
T Consensus 244 ~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~R~t~~e~l~h 319 (371)
T 2xrw_A 244 TPCPEFMKKLQPTVRTYVENR-PKYAGYSFEKLFPDVLFPADSEHNKLKASQARDLLSKMLVIDASKRISVDEALQH 319 (371)
T ss_dssp CCCHHHHTTSCHHHHHHHHSS-CCCCCCCHHHHSCGGGSCCSSHHHHHHHHHHHHHHHHHSCSSGGGSCCHHHHHHS
T ss_pred CCCHHHHHHhhhHHHHHHhhC-ccccccchhhhcccccCcccccccccccHHHHHHHHHHCcCChhhCCCHHHHhCC
Confidence 000000 0000000000 000 000011234557889999999999999999999999987
|
| >3ork_A Serine/threonine protein kinase; structural genomics, TB structural genomics consortium, TBSG domain, signal transduction; HET: AGS; 1.60A {Mycobacterium tuberculosis} PDB: 3ori_A* 3orl_A* 3oro_A* 3orp_A* 3ort_A* 3f61_A* 1mru_A* 3f69_A* 3orm_A* 1o6y_A* 2fum_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.7e-46 Score=316.67 Aligned_cols=262 Identities=25% Similarity=0.345 Sum_probs=200.9
Q ss_pred HHHhCCCCCCceeecCCcceEEEEEe-CCCcEEEEEEeccCcC-ChhhhHHHHHHHHHHHhcCCcceeeeeeEEEcCCC-
Q 038766 8 ENATGSFSENNIIGNSNLSTVYKGRL-EDGEIVAVKKLNFHQF-SAESDKSFYREAKTLKELKHRNLVKVLGYAWESGK- 84 (299)
Q Consensus 8 ~~~~~~y~~~~~lg~g~~~~v~~~~~-~~~~~~~vK~~~~~~~-~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~- 84 (299)
..+.++|.+.+.||+|+||.||++.+ .+++.||+|++..... .......+.+|+..++.++||||+++++++.....
T Consensus 8 ~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~ 87 (311)
T 3ork_A 8 SHLSDRYELGEILGFGGMSEVHLARDLRDHRDVAVKVLRADLARDPSFYLRFRREAQNAAALNHPAIVAVYDTGEAETPA 87 (311)
T ss_dssp SEETTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECTTTTTSHHHHHHHHHHHTTCCCCCCTTBCCEEEEEEEEETT
T ss_pred ceecCcEEEEEEEccCCCEEEEEEEECCCCceEEEEEeCccccCCHHHHHHHHHHHHHHHcCCCCCcceEEEeeeccCCC
Confidence 45678999999999999999999987 5689999999975433 33445678899999999999999999997764432
Q ss_pred --eeEEEEeecCCCChHHHhcCCCCCCCCCChhhHHHHHHHHHHHHHHhhcCCCCCeeeecccCCceeeCCCCcEEEeee
Q 038766 85 --LKALILEYMENGSLESVIHGPGVDHSRWTLPKRIDVLISVANGLDYLHSGYDIPIVHCDMKPSNILLDRDFEAHVSDF 162 (299)
Q Consensus 85 --~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lh~~~~~~~~H~dl~~~nil~~~~~~v~l~df 162 (299)
..++|+||+++++|.+++. ...++++.+++.++.|++.||+|||++ +++|+||||+||+++.++.++|+||
T Consensus 88 ~~~~~lv~e~~~g~~L~~~l~----~~~~~~~~~~~~~~~qi~~~l~~lH~~---~ivH~dlkp~Nil~~~~~~~kl~Df 160 (311)
T 3ork_A 88 GPLPYIVMEYVDGVTLRDIVH----TEGPMTPKRAIEVIADACQALNFSHQN---GIIHRDVKPANIMISATNAVKVMDF 160 (311)
T ss_dssp EEEEEEEEECCCEEEHHHHHH----HHCSCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEEETTSCEEECCC
T ss_pred CcccEEEEecCCCCCHHHHHH----hcCCCCHHHHHHHHHHHHHHHHHHHHC---CCCcCCCCHHHEEEcCCCCEEEeec
Confidence 3589999999999999997 445799999999999999999999999 9999999999999999999999999
Q ss_pred ccccccccccccccccccccccCcccCChhhhcccCcCccccchhhhHHHHHHHhCCCCCCCCccCCCCchhHHHHHHHH
Q 038766 163 GTSRMLDVHLQDLSSLSTAFQGTIGYLAPEFAYMRIVTTKVDVFSFGIVVMEFLTKRRPTGLDEENGLSPISLRQLVEKA 242 (299)
Q Consensus 163 ~~~~~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~DiwslG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~ 242 (299)
|++........ .........+++.|+|||++.+..++.++||||||+++|+|++|..||..... .......
T Consensus 161 g~a~~~~~~~~-~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~~l~~ll~g~~pf~~~~~--------~~~~~~~ 231 (311)
T 3ork_A 161 GIARAIADSGN-SVTQTAAVIGTAQYLSPEQARGDSVDARSDVYSLGCVLYEVLTGEPPFTGDSP--------VSVAYQH 231 (311)
T ss_dssp SCC-------------------CCTTCCHHHHHTCCCCHHHHHHHHHHHHHHHHHSSCSCCCSSH--------HHHHHHH
T ss_pred cCccccccccc-ccccccccCcCcccCCHHHhcCCCCCchHhHHHHHHHHHHHHhCCCCCCCCCh--------HHHHHHH
Confidence 99976542211 11223345689999999999999999999999999999999999999954311 1111111
Q ss_pred HhcCccCcccccCccccchhhHhHHHHHHHHHHHHHHHHhcCCCCCCCCChhhhhcC
Q 038766 243 LANGINGVRQITDPKLVSSIYEEQEQHQVLEELFKLALVCTSSNPEDRPNMNELLIT 299 (299)
Q Consensus 243 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rpt~~~il~~ 299 (299)
....... .......++.++.++|.+||..||++||++.+++.|
T Consensus 232 ~~~~~~~--------------~~~~~~~~~~~l~~li~~~l~~dP~~R~~~~~~l~~ 274 (311)
T 3ork_A 232 VREDPIP--------------PSARHEGLSADLDAVVLKALAKNPENRYQTAAEMRA 274 (311)
T ss_dssp HHCCCCC--------------HHHHSTTCCHHHHHHHHHHTCSSGGGSCSSHHHHHH
T ss_pred hcCCCCC--------------cccccCCCCHHHHHHHHHHHhcCHhhChhhHHHHHH
Confidence 1111000 001122356789999999999999999999988753
|
| >2ivs_A Proto-oncogene tyrosine-protein kinase receptor RET; nucleotide-binding, hirschsprung disease, phosphorylation, disease mutation; HET: ACK; 2.00A {Homo sapiens} PDB: 2ivt_A* 2ivu_A* 2x2k_A* 2x2l_A* 2x2m_A* 2ivv_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.5e-46 Score=316.23 Aligned_cols=264 Identities=25% Similarity=0.351 Sum_probs=206.8
Q ss_pred hHHHHHHhCCCCCCceeecCCcceEEEEEe------CCCcEEEEEEeccCcCChhhhHHHHHHHHHHHhcCCcceeeeee
Q 038766 4 RTEIENATGSFSENNIIGNSNLSTVYKGRL------EDGEIVAVKKLNFHQFSAESDKSFYREAKTLKELKHRNLVKVLG 77 (299)
Q Consensus 4 ~~~~~~~~~~y~~~~~lg~g~~~~v~~~~~------~~~~~~~vK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~ 77 (299)
..+++...++|.+.+.||+|+||.||++.+ .++..||+|++... ......+.+.+|+.+++.++||||+++++
T Consensus 15 ~~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~-~~~~~~~~~~~E~~~l~~l~hp~iv~~~~ 93 (314)
T 2ivs_A 15 DPKWEFPRKNLVLGKTLGEGEFGKVVKATAFHLKGRAGYTTVAVKMLKEN-ASPSELRDLLSEFNVLKQVNHPHVIKLYG 93 (314)
T ss_dssp CTTTBCCGGGEEEEEEEEECSSSEEEEEEEETGGGCSSEEEEEEEECCTT-CCHHHHHHHHHHHHHHTTCCCTTBCCEEE
T ss_pred CcccccchhheeeeeeecccCCeeEEEEEEeccCcccCcceEEEEeccCC-CCHHHHHHHHHHHHHHhhCCCCceeeEEE
Confidence 345566678999999999999999999985 23578999998643 34555678899999999999999999999
Q ss_pred EEEcCCCeeEEEEeecCCCChHHHhcCCCC--------------------CCCCCChhhHHHHHHHHHHHHHHhhcCCCC
Q 038766 78 YAWESGKLKALILEYMENGSLESVIHGPGV--------------------DHSRWTLPKRIDVLISVANGLDYLHSGYDI 137 (299)
Q Consensus 78 ~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~--------------------~~~~~~~~~~~~i~~qi~~~l~~lh~~~~~ 137 (299)
++.. +...++|+||+.+++|.+++..... ....+++..++.++.|++.||.|||++
T Consensus 94 ~~~~-~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~--- 169 (314)
T 2ivs_A 94 ACSQ-DGPLLLIVEYAKYGSLRGFLRESRKVGPGYLGSGGSRNSSSLDHPDERALTMGDLISFAWQISQGMQYLAEM--- 169 (314)
T ss_dssp EECS-SSSCEEEEECCTTCBHHHHHHHTTTSTTEEC----------------CEECHHHHHHHHHHHHHHHHHHHHT---
T ss_pred EEec-CCceEEEEeecCCCCHHHHHHHHhhccCCcccccccccccccccccccCcCHHHHHHHHHHHHHHHHHHHHC---
Confidence 7655 4456999999999999999875431 123589999999999999999999999
Q ss_pred CeeeecccCCceeeCCCCcEEEeeeccccccccccccccccccccccCcccCChhhhcccCcCccccchhhhHHHHHHHh
Q 038766 138 PIVHCDMKPSNILLDRDFEAHVSDFGTSRMLDVHLQDLSSLSTAFQGTIGYLAPEFAYMRIVTTKVDVFSFGIVVMEFLT 217 (299)
Q Consensus 138 ~~~H~dl~~~nil~~~~~~v~l~df~~~~~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~DiwslG~~l~~l~~ 217 (299)
+++|+||||+||+++.++.++|+|||++........ ........+++.|+|||.+.+..++.++||||||+++|+|++
T Consensus 170 ~ivH~dikp~NIli~~~~~~kl~Dfg~~~~~~~~~~--~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~t 247 (314)
T 2ivs_A 170 KLVHRDLAARNILVAEGRKMKISDFGLSRDVYEEDS--YVKRSQGRIPVKWMAIESLFDHIYTTQSDVWSFGVLLWEIVT 247 (314)
T ss_dssp TEECCCCSGGGEEEETTTEEEECCCTTCEECTTTSC--EECSSCCCSCGGGCCHHHHHHCEECHHHHHHHHHHHHHHHHT
T ss_pred CCcccccchheEEEcCCCCEEEcccccccccccccc--ceeccCCCCcccccChhhhcCCCcCchhhHHHHHHHHHHHHh
Confidence 999999999999999999999999999875542111 112233445788999999999889999999999999999999
Q ss_pred -CCCCCCCCccCCCCchhHHHHHHHHHhcCccCcccccCccccchhhHhHHHHHHHHHHHHHHHHhcCCCCCCCCChhhh
Q 038766 218 -KRRPTGLDEENGLSPISLRQLVEKALANGINGVRQITDPKLVSSIYEEQEQHQVLEELFKLALVCTSSNPEDRPNMNEL 296 (299)
Q Consensus 218 -g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rpt~~~i 296 (299)
|..||.... ...+...+.. ... ... +..++..+.++|.+||..||++|||++++
T Consensus 248 ~g~~p~~~~~-----~~~~~~~~~~---~~~-----~~~------------~~~~~~~~~~li~~~l~~dp~~Rps~~~l 302 (314)
T 2ivs_A 248 LGGNPYPGIP-----PERLFNLLKT---GHR-----MER------------PDNCSEEMYRLMLQCWKQEPDKRPVFADI 302 (314)
T ss_dssp TSCCSSTTCC-----GGGHHHHHHT---TCC-----CCC------------CTTCCHHHHHHHHHHTCSSGGGSCCHHHH
T ss_pred CCCCCCCCCC-----HHHHHHHhhc---CCc-----CCC------------CccCCHHHHHHHHHHccCChhhCcCHHHH
Confidence 999985432 2222222211 000 000 12345679999999999999999999999
Q ss_pred hcC
Q 038766 297 LIT 299 (299)
Q Consensus 297 l~~ 299 (299)
+++
T Consensus 303 ~~~ 305 (314)
T 2ivs_A 303 SKD 305 (314)
T ss_dssp HHH
T ss_pred HHH
Confidence 863
|
| >2rku_A Serine/threonine-protein kinase PLK1; structure of PLK1, selectivity residues, POLO-like K structure based drug design, ATP-binding; HET: R78 TLA SRT TAR; 1.95A {Homo sapiens} PDB: 2v5q_A 2yac_A* 4a4l_A* 4a4o_A* 3kb7_A* 3d5w_A* 3d5u_A* 3d5v_A 3db8_A* 3dbc_A* 3dbd_A* 3d5x_A* 3db6_A* 3dbe_A* 3dbf_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.6e-45 Score=308.19 Aligned_cols=252 Identities=21% Similarity=0.319 Sum_probs=205.4
Q ss_pred HhCCCCCCceeecCCcceEEEEEeC-CCcEEEEEEeccCcC-ChhhhHHHHHHHHHHHhcCCcceeeeeeEEEcCCCeeE
Q 038766 10 ATGSFSENNIIGNSNLSTVYKGRLE-DGEIVAVKKLNFHQF-SAESDKSFYREAKTLKELKHRNLVKVLGYAWESGKLKA 87 (299)
Q Consensus 10 ~~~~y~~~~~lg~g~~~~v~~~~~~-~~~~~~vK~~~~~~~-~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~ 87 (299)
..++|.+.+.||+|+||.||++.+. +++.+|+|++..... .....+.+.+|+..++.++||||+++++++.. ++..+
T Consensus 13 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~-~~~~~ 91 (294)
T 2rku_A 13 SRRRYVRGRFLGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAHQHVVGFHGFFED-NDFVF 91 (294)
T ss_dssp TTEEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCCSHHHHHHHHHHHHHHHTCCCTTBCCEEEEEEC-SSEEE
T ss_pred cccceEEEEEEeecCCEEEEEEEECCCCceEEEEEechhhccCHHHHHHHHHHHHHHHhCCCCCEeeeeeeecc-CCEEE
Confidence 4578999999999999999999875 588999999865432 34456778899999999999999999997655 55679
Q ss_pred EEEeecCCCChHHHhcCCCCCCCCCChhhHHHHHHHHHHHHHHhhcCCCCCeeeecccCCceeeCCCCcEEEeeeccccc
Q 038766 88 LILEYMENGSLESVIHGPGVDHSRWTLPKRIDVLISVANGLDYLHSGYDIPIVHCDMKPSNILLDRDFEAHVSDFGTSRM 167 (299)
Q Consensus 88 lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lh~~~~~~~~H~dl~~~nil~~~~~~v~l~df~~~~~ 167 (299)
+|+||+.+++|.+++. ....+++.+++.++.|++.||+|||+. +++|+||+|+||+++.++.++|+|||++..
T Consensus 92 lv~e~~~~~~L~~~~~----~~~~~~~~~~~~i~~qi~~~l~~lH~~---~i~H~dl~p~Nil~~~~~~~kl~dfg~~~~ 164 (294)
T 2rku_A 92 VVLELCRRRSLLELHK----RRKALTEPEARYYLRQIVLGCQYLHRN---RVIHRDLKLGNLFLNEDLEVKIGDFGLATK 164 (294)
T ss_dssp EEEECCTTCBHHHHHH----HHCSCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEECTTCCEEECCCTTCEE
T ss_pred EEEecCCCCCHHHHHH----hcCCCCHHHHHHHHHHHHHHHHHHHHC---CccccCCChHhEEEcCCCCEEEEeccCcee
Confidence 9999999999999886 445799999999999999999999999 999999999999999999999999999876
Q ss_pred cccccccccccccccccCcccCChhhhcccCcCccccchhhhHHHHHHHhCCCCCCCCccCCCCchhHHHHHHHHHhcCc
Q 038766 168 LDVHLQDLSSLSTAFQGTIGYLAPEFAYMRIVTTKVDVFSFGIVVMEFLTKRRPTGLDEENGLSPISLRQLVEKALANGI 247 (299)
Q Consensus 168 ~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~DiwslG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 247 (299)
.... ........+++.|+|||.+.+..++.++||||||+++|+|++|..||..... .+..........
T Consensus 165 ~~~~----~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~--------~~~~~~~~~~~~ 232 (294)
T 2rku_A 165 VEYD----GERKKVLCGTPNYIAPEVLSKKGHSFEVDVWSIGCIMYTLLVGKPPFETSCL--------KETYLRIKKNEY 232 (294)
T ss_dssp CCST----TCCBCCCCSCCSSCCHHHHTTSCBCTHHHHHHHHHHHHHHHHSSCTTCCSSH--------HHHHHHHHTTCC
T ss_pred cccC----ccccccccCCCCcCCcchhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCH--------HHHHHHHhhccC
Confidence 5421 1223345678999999999998899999999999999999999999954321 111111111110
Q ss_pred cCcccccCccccchhhHhHHHHHHHHHHHHHHHHhcCCCCCCCCChhhhhcC
Q 038766 248 NGVRQITDPKLVSSIYEEQEQHQVLEELFKLALVCTSSNPEDRPNMNELLIT 299 (299)
Q Consensus 248 ~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rpt~~~il~~ 299 (299)
. . +..++..+.++|.+||..||++|||++++++|
T Consensus 233 -~-----~------------~~~~~~~~~~li~~~l~~~p~~Rps~~~ll~~ 266 (294)
T 2rku_A 233 -S-----I------------PKHINPVAASLIQKMLQTDPTARPTINELLND 266 (294)
T ss_dssp -C-----C------------CTTSCHHHHHHHHHHTCSSGGGSCCGGGGGGS
T ss_pred -C-----C------------ccccCHHHHHHHHHHcccChhhCcCHHHHhhC
Confidence 0 0 11234578999999999999999999999987
|
| >3soc_A Activin receptor type-2A; structural genomics consortium, SGC, transferase, protein KI; HET: GVD; 1.95A {Homo sapiens} PDB: 3q4t_A* 4asx_A* 2qlu_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.2e-45 Score=312.59 Aligned_cols=268 Identities=22% Similarity=0.294 Sum_probs=202.1
Q ss_pred HHhCCCCCCceeecCCcceEEEEEeCCCcEEEEEEeccCcCChhhhHHHHHHHHHHHhcCCcceeeeeeEEEcCCC---e
Q 038766 9 NATGSFSENNIIGNSNLSTVYKGRLEDGEIVAVKKLNFHQFSAESDKSFYREAKTLKELKHRNLVKVLGYAWESGK---L 85 (299)
Q Consensus 9 ~~~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~vK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~---~ 85 (299)
.-.++|++.+.||+|+||+||++++. ++.||||++... .........|+..+++++||||+++++++..... .
T Consensus 21 ~~~~~y~~~~~lg~G~~g~Vy~~~~~-~~~vavK~~~~~---~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~ 96 (322)
T 3soc_A 21 FQSMPLQLLEVKARGRFGCVWKAQLL-NEYVAVKIFPIQ---DKQSWQNEYEVYSLPGMKHENILQFIGAEKRGTSVDVD 96 (322)
T ss_dssp ETTEEEEEEEEEECSTTCEEEEEEET-TEEEEEEEECGG---GHHHHHHHHHHHTSTTCCCTTBCCEEEEEEEECSSSEE
T ss_pred cchhhchhhheecccCceEEEEEEEC-CCEEEEEEeecC---chHHHHHHHHHHHHhcCCCCCchhhcceeccCCCCCce
Confidence 34578999999999999999999886 789999998532 2334455668888999999999999998776432 3
Q ss_pred eEEEEeecCCCChHHHhcCCCCCCCCCChhhHHHHHHHHHHHHHHhhcC-------CCCCeeeecccCCceeeCCCCcEE
Q 038766 86 KALILEYMENGSLESVIHGPGVDHSRWTLPKRIDVLISVANGLDYLHSG-------YDIPIVHCDMKPSNILLDRDFEAH 158 (299)
Q Consensus 86 ~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lh~~-------~~~~~~H~dl~~~nil~~~~~~v~ 158 (299)
.++|+||+.+++|.+++.. ..+++..++.++.|++.||+|||+. ++.+++|+||||+||+++.++.+|
T Consensus 97 ~~lv~e~~~~g~L~~~l~~-----~~~~~~~~~~i~~qi~~al~~LH~~~~~l~~~~~~~ivH~Dlkp~Nill~~~~~~k 171 (322)
T 3soc_A 97 LWLITAFHEKGSLSDFLKA-----NVVSWNELCHIAETMARGLAYLHEDIPGLKDGHKPAISHRDIKSKNVLLKNNLTAC 171 (322)
T ss_dssp EEEEEECCTTCBHHHHHHH-----CCBCHHHHHHHHHHHHHHHHHHTCCEEEETTEEECEEECSCCSGGGEEECTTCCEE
T ss_pred EEEEEecCCCCCHHHHHHh-----cCCCHHHHHHHHHHHHHHHHHHHhhccccccccCCCEEeCCCChHhEEECCCCeEE
Confidence 6899999999999999953 4589999999999999999999974 122899999999999999999999
Q ss_pred EeeeccccccccccccccccccccccCcccCChhhhcc-----cCcCccccchhhhHHHHHHHhCCCCCCCCccCCCCch
Q 038766 159 VSDFGTSRMLDVHLQDLSSLSTAFQGTIGYLAPEFAYM-----RIVTTKVDVFSFGIVVMEFLTKRRPTGLDEENGLSPI 233 (299)
Q Consensus 159 l~df~~~~~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~-----~~~~~~~DiwslG~~l~~l~~g~~p~~~~~~~~~~~~ 233 (299)
|+|||++....... .........+|+.|+|||++.+ ..++.++|||||||++|+|++|..||...........
T Consensus 172 L~DFg~a~~~~~~~--~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwslG~il~el~tg~~pf~~~~~~~~~~~ 249 (322)
T 3soc_A 172 IADFGLALKFEAGK--SAGDTHGQVGTRRYMAPEVLEGAINFQRDAFLRIDMYAMGLVLWELASRCTAADGPVDEYMLPF 249 (322)
T ss_dssp ECCCTTCEEECTTS--CCCCCTTCCCCGGGCCHHHHTTCCCCCHHHHHHHHHHHHHHHHHHHHTTBTTSSSCCCCCCCTT
T ss_pred EccCCccccccccc--CccccccCccCccccCHhhcccccccCcCCCccchhHHHHHHHHHHHhCCCCCCCCcchhccch
Confidence 99999997654221 1122334568999999999886 3566789999999999999999999976543322222
Q ss_pred h--------HHHHHHHHHhcCccCcccccCccccchhhHhHHHHHHHHHHHHHHHHhcCCCCCCCCChhhhhc
Q 038766 234 S--------LRQLVEKALANGINGVRQITDPKLVSSIYEEQEQHQVLEELFKLALVCTSSNPEDRPNMNELLI 298 (299)
Q Consensus 234 ~--------~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rpt~~~il~ 298 (299)
. ............ . .+..... ......+..+.+||.+||..||++|||++++++
T Consensus 250 ~~~~~~~~~~~~~~~~~~~~~---~----~~~~~~~----~~~~~~~~~l~~li~~cl~~dP~~Rps~~ell~ 311 (322)
T 3soc_A 250 EEEIGQHPSLEDMQEVVVHKK---K----RPVLRDY----WQKHAGMAMLCETIEECWDHDAEARLSAGCVGE 311 (322)
T ss_dssp HHHHCSSCCHHHHHHHHTTSC---C----CCCCCGG----GGSSHHHHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred hhhhccCCchhhhhhhhhccc---C----CCCcccc----ccccchHHHHHHHHHHHccCChhhCcCHHHHHH
Confidence 1 111111111111 0 0110000 012244567999999999999999999999985
|
| >4ejn_A RAC-alpha serine/threonine-protein kinase; AKT1, autoinhibition, allosteric inhibitor, kinase inhibitor hydrophobic collapase, ATPase; HET: 0R4; 2.19A {Homo sapiens} PDB: 3o96_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.3e-46 Score=332.14 Aligned_cols=252 Identities=22% Similarity=0.260 Sum_probs=195.3
Q ss_pred HhCCCCCCceeecCCcceEEEEEeC-CCcEEEEEEeccCcC-ChhhhHHHHHHHHHHHhcCCcceeeeeeEEEcCCCeeE
Q 038766 10 ATGSFSENNIIGNSNLSTVYKGRLE-DGEIVAVKKLNFHQF-SAESDKSFYREAKTLKELKHRNLVKVLGYAWESGKLKA 87 (299)
Q Consensus 10 ~~~~y~~~~~lg~g~~~~v~~~~~~-~~~~~~vK~~~~~~~-~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~ 87 (299)
..++|.+.+.||+|+||.||++.+. +|+.||+|++..... .......+.+|+.+++.++||||+++++++.. ....+
T Consensus 146 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~l~~~~~~-~~~~~ 224 (446)
T 4ejn_A 146 TMNEFEYLKLLGKGTFGKVILVKEKATGRYYAMKILKKEVIVAKDEVAHTLTENRVLQNSRHPFLTALKYSFQT-HDRLC 224 (446)
T ss_dssp CGGGEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHC-------------CCCCCSCTTSCCEEEEEEE-TTEEE
T ss_pred ChHHcEEeEEEeeCcCEEEEEEEEcCCCCEEEEEEEEhhhhhhhHHHHHHHHHHHHHHhCCCCeEeeEEEEEee-CCEEE
Confidence 4578999999999999999999874 689999999864322 23345667789999999999999999997765 45569
Q ss_pred EEEeecCCCChHHHhcCCCCCCCCCChhhHHHHHHHHHHHHHHhhc-CCCCCeeeecccCCceeeCCCCcEEEeeecccc
Q 038766 88 LILEYMENGSLESVIHGPGVDHSRWTLPKRIDVLISVANGLDYLHS-GYDIPIVHCDMKPSNILLDRDFEAHVSDFGTSR 166 (299)
Q Consensus 88 lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lh~-~~~~~~~H~dl~~~nil~~~~~~v~l~df~~~~ 166 (299)
+||||+.+++|...+. ....+++..++.++.|++.||+|||+ . +++||||||+||+++.++.++|+|||++.
T Consensus 225 lv~e~~~~~~L~~~l~----~~~~~~~~~~~~~~~qi~~aL~~LH~~~---giiHrDlkp~NIll~~~~~~kl~DFG~a~ 297 (446)
T 4ejn_A 225 FVMEYANGGELFFHLS----RERVFSEDRARFYGAEIVSALDYLHSEK---NVVYRDLKLENLMLDKDGHIKITDFGLCK 297 (446)
T ss_dssp EEECCCSSCBHHHHHH----HHSCCCHHHHHHHHHHHHHHHHHHHHHT---CCCCCCCCGGGEEECSSSCEEECCCCCCC
T ss_pred EEEeeCCCCcHHHHHH----hcCCCCHHHHHHHHHHHHHHHHHHhhcC---CEEECCCCHHHEEECCCCCEEEccCCCce
Confidence 9999999999999886 44579999999999999999999998 8 99999999999999999999999999987
Q ss_pred ccccccccccccccccccCcccCChhhhcccCcCccccchhhhHHHHHHHhCCCCCCCCccCCCCchhHHHHHHHHHhcC
Q 038766 167 MLDVHLQDLSSLSTAFQGTIGYLAPEFAYMRIVTTKVDVFSFGIVVMEFLTKRRPTGLDEENGLSPISLRQLVEKALANG 246 (299)
Q Consensus 167 ~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~DiwslG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~ 246 (299)
.... .........+|+.|+|||++.+..++.++|||||||++|+|++|..||.... . ...........
T Consensus 298 ~~~~----~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~-----~---~~~~~~i~~~~ 365 (446)
T 4ejn_A 298 EGIK----DGATMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQD-----H---EKLFELILMEE 365 (446)
T ss_dssp TTCC---------CCSSSCGGGCCHHHHHTSCCCTHHHHHHHHHHHHHHHHSSCSSCCSS-----H---HHHHHHHHHCC
T ss_pred eccC----CCcccccccCCccccCHhhcCCCCCCCccchhhhHHHHHHHhhCCCCCCCCC-----H---HHHHHHHHhCC
Confidence 5321 1223345678999999999999999999999999999999999999995431 1 12222222211
Q ss_pred ccCcccccCccccchhhHhHHHHHHHHHHHHHHHHhcCCCCCCCC-----ChhhhhcC
Q 038766 247 INGVRQITDPKLVSSIYEEQEQHQVLEELFKLALVCTSSNPEDRP-----NMNELLIT 299 (299)
Q Consensus 247 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rp-----t~~~il~~ 299 (299)
. . . +..++.++.+||.+||..||.+|| |++++++|
T Consensus 366 ~-~-----~------------p~~~~~~~~~li~~~L~~dP~~R~~~~~~t~~ell~h 405 (446)
T 4ejn_A 366 I-R-----F------------PRTLGPEAKSLLSGLLKKDPKQRLGGGSEDAKEIMQH 405 (446)
T ss_dssp C-C-----C------------CTTSCHHHHHHHHHHTCSSTTTSTTCSTTTHHHHHTS
T ss_pred C-C-----C------------CccCCHHHHHHHHHHcccCHHHhCCCCCCCHHHHHhC
Confidence 1 0 0 122356799999999999999999 99999987
|
| >1qpc_A LCK kinase; alpha beta fold, transferase; HET: PTR ANP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1qpe_A* 1qpj_A* 2pl0_A* 3kxz_A* 3ac1_A* 2zm4_A* 2zyb_A* 2zm1_A* 3ac2_A* 3ac3_A* 3ac4_A* 3ac5_A* 3ac8_A* 3acj_A* 3ack_A* 3ad4_A* 3ad5_A* 3ad6_A* 3kmm_A* 1qpd_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=8.4e-46 Score=308.89 Aligned_cols=259 Identities=27% Similarity=0.425 Sum_probs=207.4
Q ss_pred CChHHHHHHhCCCCCCceeecCCcceEEEEEeCCCcEEEEEEeccCcCChhhhHHHHHHHHHHHhcCCcceeeeeeEEEc
Q 038766 2 FDRTEIENATGSFSENNIIGNSNLSTVYKGRLEDGEIVAVKKLNFHQFSAESDKSFYREAKTLKELKHRNLVKVLGYAWE 81 (299)
Q Consensus 2 ~~~~~~~~~~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~vK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~ 81 (299)
|..++++...++|++.+.||+|++|+||++.+.++..||+|++.... ...+.+.+|++.++.++||||+++++++.
T Consensus 3 ~~~~~~~v~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~---~~~~~~~~E~~~l~~l~h~~i~~~~~~~~- 78 (279)
T 1qpc_A 3 WWEDEWEVPRETLKLVERLGAGQFGEVWMGYYNGHTKVAVKSLKQGS---MSPDAFLAEANLMKQLQHQRLVRLYAVVT- 78 (279)
T ss_dssp TTTCTTBCCGGGEEEEEEEEEETTEEEEEEEETTTEEEEEEEECTTS---SCHHHHHHHHHHHHHCCCTTBCCEEEEEC-
T ss_pred cchhhcccCHHhhhheeeecCCCCeEEEEEEEcCCcEEEEEEecCCc---ccHHHHHHHHHHHHhCCCcCcceEEEEEc-
Confidence 56678899999999999999999999999998888899999986433 34567889999999999999999999654
Q ss_pred CCCeeEEEEeecCCCChHHHhcCCCCCCCCCChhhHHHHHHHHHHHHHHhhcCCCCCeeeecccCCceeeCCCCcEEEee
Q 038766 82 SGKLKALILEYMENGSLESVIHGPGVDHSRWTLPKRIDVLISVANGLDYLHSGYDIPIVHCDMKPSNILLDRDFEAHVSD 161 (299)
Q Consensus 82 ~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lh~~~~~~~~H~dl~~~nil~~~~~~v~l~d 161 (299)
.+ ..++|+|++.+++|.+++... ....+++..++.++.|++.||.+||++ +++|+||||+||+++.++.++|+|
T Consensus 79 ~~-~~~~v~e~~~~~~L~~~l~~~--~~~~~~~~~~~~i~~qi~~~l~~lH~~---~i~H~dikp~Nil~~~~~~~kl~D 152 (279)
T 1qpc_A 79 QE-PIYIITEYMENGSLVDFLKTP--SGIKLTINKLLDMAAQIAEGMAFIEER---NYIHRDLRAANILVSDTLSCKIAD 152 (279)
T ss_dssp SS-SCEEEEECCTTCBHHHHTTSH--HHHTCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEECTTSCEEECC
T ss_pred CC-CcEEEEecCCCCCHHHHHhcC--CCCCCCHHHHHHHHHHHHHHHHHHHHC---CeeccCCCHhhEEEcCCCCEEECC
Confidence 33 458999999999999999632 123689999999999999999999999 999999999999999999999999
Q ss_pred eccccccccccccccccccccccCcccCChhhhcccCcCccccchhhhHHHHHHHh-CCCCCCCCccCCCCchhHHHHHH
Q 038766 162 FGTSRMLDVHLQDLSSLSTAFQGTIGYLAPEFAYMRIVTTKVDVFSFGIVVMEFLT-KRRPTGLDEENGLSPISLRQLVE 240 (299)
Q Consensus 162 f~~~~~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~DiwslG~~l~~l~~-g~~p~~~~~~~~~~~~~~~~~~~ 240 (299)
||++...... .........++..|+|||.+.+..++.++||||||+++|+|++ |..||... ..... ..
T Consensus 153 fg~~~~~~~~---~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~-----~~~~~---~~ 221 (279)
T 1qpc_A 153 FGLARLIEDN---EYTAREGAKFPIKWTAPEAINYGTFTIKSDVWSFGILLTEIVTHGRIPYPGM-----TNPEV---IQ 221 (279)
T ss_dssp CTTCEECSSS---CEECCTTCCCCTTTSCHHHHHHCEECHHHHHHHHHHHHHHHHTTTCCSSTTC-----CHHHH---HH
T ss_pred CcccccccCc---ccccccCCCCccCccChhhhccCCCCchhhhHHHHHHHHHHHhCCCCCCccc-----CHHHH---HH
Confidence 9999765421 1112233445778999999998889999999999999999999 88888532 11121 21
Q ss_pred HHHhcCccCcccccCccccchhhHhHHHHHHHHHHHHHHHHhcCCCCCCCCChhhhhc
Q 038766 241 KALANGINGVRQITDPKLVSSIYEEQEQHQVLEELFKLALVCTSSNPEDRPNMNELLI 298 (299)
Q Consensus 241 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rpt~~~il~ 298 (299)
.... .... .. +..++..+.+++.+||..||++|||++++++
T Consensus 222 ~~~~-~~~~----~~------------~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~ 262 (279)
T 1qpc_A 222 NLER-GYRM----VR------------PDNCPEELYQLMRLCWKERPEDRPTFDYLRS 262 (279)
T ss_dssp HHHT-TCCC----CC------------CTTCCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred HHhc-ccCC----CC------------cccccHHHHHHHHHHhccChhhCCCHHHHHH
Confidence 1111 1000 00 1233467999999999999999999999875
|
| >3i6u_A CDS1, serine/threonine-protein kinase CHK2; Ser/Thr protein kinase, FHA domain, ATP-binding, cell cycle, mutation, LI-fraumeni syndrome, magnesium; 3.00A {Homo sapiens} PDB: 3i6w_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2.5e-45 Score=322.70 Aligned_cols=257 Identities=23% Similarity=0.336 Sum_probs=195.2
Q ss_pred HHHhCCCCCCceeecCCcceEEEEEeC-CCcEEEEEEeccCcCC------hhhhHHHHHHHHHHHhcCCcceeeeeeEEE
Q 038766 8 ENATGSFSENNIIGNSNLSTVYKGRLE-DGEIVAVKKLNFHQFS------AESDKSFYREAKTLKELKHRNLVKVLGYAW 80 (299)
Q Consensus 8 ~~~~~~y~~~~~lg~g~~~~v~~~~~~-~~~~~~vK~~~~~~~~------~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~ 80 (299)
..+.++|.+.+.||+|+||+||+|.+. +++.||+|++...... ......+.+|+.++++++||||+++++++
T Consensus 131 ~~~~~~y~~~~~LG~G~~g~V~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~- 209 (419)
T 3i6u_A 131 KALRDEYIMSKTLGSGACGEVKLAFERKTCKKVAIRIISKRKFAIGSAREADPALNVETEIEILKKLNHPCIIKIKNFF- 209 (419)
T ss_dssp HHHHTTEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEEGGGGTTC--------CCHHHHHHHHHHCCCTTBCCCCEEE-
T ss_pred hhhhccEEEEeEEeeCCCeEEEEEEECCCCcEEEEEEEEechhcccccccchhHHHHHHHHHHHHhCCCCCEeeEEEEE-
Confidence 457899999999999999999999874 5899999998753321 12233578999999999999999999965
Q ss_pred cCCCeeEEEEeecCCCChHHHhcCCCCCCCCCChhhHHHHHHHHHHHHHHhhcCCCCCeeeecccCCceeeCCCC---cE
Q 038766 81 ESGKLKALILEYMENGSLESVIHGPGVDHSRWTLPKRIDVLISVANGLDYLHSGYDIPIVHCDMKPSNILLDRDF---EA 157 (299)
Q Consensus 81 ~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lh~~~~~~~~H~dl~~~nil~~~~~---~v 157 (299)
..+ ..++|+||+.+++|.+.+. ....+++..++.++.|++.||+|||++ +++|+||||+||+++.++ .+
T Consensus 210 ~~~-~~~lv~e~~~~g~L~~~l~----~~~~~~~~~~~~i~~qi~~~l~~LH~~---~ivHrDlkp~NIll~~~~~~~~~ 281 (419)
T 3i6u_A 210 DAE-DYYIVLELMEGGELFDKVV----GNKRLKEATCKLYFYQMLLAVQYLHEN---GIIHRDLKPENVLLSSQEEDCLI 281 (419)
T ss_dssp ESS-EEEEEEECCTTCBGGGGTS----SSCCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEESSSSSSCCE
T ss_pred ecC-ceEEEEEcCCCCcHHHHHh----ccCCCCHHHHHHHHHHHHHHHHHHHHC---CccccCCChHhEEEecCCCcceE
Confidence 333 4589999999999999887 456899999999999999999999999 999999999999997544 59
Q ss_pred EEeeeccccccccccccccccccccccCcccCChhhhcc---cCcCccccchhhhHHHHHHHhCCCCCCCCccCCCCchh
Q 038766 158 HVSDFGTSRMLDVHLQDLSSLSTAFQGTIGYLAPEFAYM---RIVTTKVDVFSFGIVVMEFLTKRRPTGLDEENGLSPIS 234 (299)
Q Consensus 158 ~l~df~~~~~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~---~~~~~~~DiwslG~~l~~l~~g~~p~~~~~~~~~~~~~ 234 (299)
||+|||++..... ........+|+.|+|||++.+ ..++.++|||||||++|+|++|..||...... ..
T Consensus 282 kl~DFG~a~~~~~-----~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~DiwslG~il~~lltg~~pf~~~~~~----~~ 352 (419)
T 3i6u_A 282 KITDFGHSKILGE-----TSLMRTLCGTPTYLAPEVLVSVGTAGYNRAVDCWSLGVILFICLSGYPPFSEHRTQ----VS 352 (419)
T ss_dssp EECCSSTTTSCC----------------CTTCCTTTTC----CTTHHHHHHHHHHHHHHHHHHSSCSSCCCSSS----CC
T ss_pred EEeecccceecCC-----CccccccCCCCCccCceeeecCCCCCCCchhhhHhHHHHHHHHHHCCCCCCCCcch----HH
Confidence 9999999976542 222345568999999998764 56788999999999999999999999643221 11
Q ss_pred HHHHHHHHHhcCccCcccccCccccchhhHhHHHHHHHHHHHHHHHHhcCCCCCCCCChhhhhcC
Q 038766 235 LRQLVEKALANGINGVRQITDPKLVSSIYEEQEQHQVLEELFKLALVCTSSNPEDRPNMNELLIT 299 (299)
Q Consensus 235 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rpt~~~il~~ 299 (299)
+...+. ...... .......++..+.+||++||..||++|||++++|+|
T Consensus 353 ~~~~i~----~~~~~~-------------~~~~~~~~~~~~~~li~~~L~~dP~~Rps~~e~l~h 400 (419)
T 3i6u_A 353 LKDQIT----SGKYNF-------------IPEVWAEVSEKALDLVKKLLVVDPKARFTTEEALRH 400 (419)
T ss_dssp HHHHHH----TTCCCC-------------CHHHHTTSCHHHHHHHHHHSCSSTTTSCCHHHHHHS
T ss_pred HHHHHh----cCCCCC-------------CchhhcccCHHHHHHHHHHccCChhHCcCHHHHhCC
Confidence 111111 000000 001123456789999999999999999999999987
|
| >2owb_A Serine/threonine-protein kinase PLK1; catalytic domain, POLO-like kinase1, transfera; HET: 626; 2.10A {Homo sapiens} PDB: 2ou7_A* 3fc2_A* 3thb_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.2e-45 Score=313.24 Aligned_cols=252 Identities=21% Similarity=0.330 Sum_probs=205.3
Q ss_pred HhCCCCCCceeecCCcceEEEEEeC-CCcEEEEEEeccCcC-ChhhhHHHHHHHHHHHhcCCcceeeeeeEEEcCCCeeE
Q 038766 10 ATGSFSENNIIGNSNLSTVYKGRLE-DGEIVAVKKLNFHQF-SAESDKSFYREAKTLKELKHRNLVKVLGYAWESGKLKA 87 (299)
Q Consensus 10 ~~~~y~~~~~lg~g~~~~v~~~~~~-~~~~~~vK~~~~~~~-~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~ 87 (299)
..++|.+.+.||+|+||.||++.+. +++.+|+|++..... .....+.+.+|+.+++.++|+||+++++++.. +...+
T Consensus 39 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~-~~~~~ 117 (335)
T 2owb_A 39 SRRRYVRGRFLGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAHQHVVGFHGFFED-NDFVF 117 (335)
T ss_dssp TTEEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCCSHHHHHHHHHHHHHHHTCCCTTBCCEEEEEEC-SSEEE
T ss_pred cCCceEEEEEEeeCCCeEEEEEEECCCCCEEEEEEechhhhcCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEec-CCeEE
Confidence 3568999999999999999999875 588999999865432 34456778899999999999999999997665 55679
Q ss_pred EEEeecCCCChHHHhcCCCCCCCCCChhhHHHHHHHHHHHHHHhhcCCCCCeeeecccCCceeeCCCCcEEEeeeccccc
Q 038766 88 LILEYMENGSLESVIHGPGVDHSRWTLPKRIDVLISVANGLDYLHSGYDIPIVHCDMKPSNILLDRDFEAHVSDFGTSRM 167 (299)
Q Consensus 88 lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lh~~~~~~~~H~dl~~~nil~~~~~~v~l~df~~~~~ 167 (299)
+|+||+.+++|.+++. ....+++.+++.++.|++.||.|||++ +++|+||||+||+++.++.++|+|||++..
T Consensus 118 lv~e~~~~~~L~~~~~----~~~~l~~~~~~~i~~qi~~aL~~LH~~---~ivH~dlkp~NIl~~~~~~~kl~Dfg~~~~ 190 (335)
T 2owb_A 118 VVLELCRRRSLLELHK----RRKALTEPEARYYLRQIVLGCQYLHRN---RVIHRDLKLGNLFLNEDLEVKIGDFGLATK 190 (335)
T ss_dssp EEECCCTTCBHHHHHH----HHCSCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCCGGGEEECTTCCEEECCCTTCEE
T ss_pred EEEecCCCCCHHHHHh----ccCCCCHHHHHHHHHHHHHHHHHHHHC---CCEecCCCchhEEEcCCCCEEEeeccCcee
Confidence 9999999999999886 445799999999999999999999999 999999999999999999999999999976
Q ss_pred cccccccccccccccccCcccCChhhhcccCcCccccchhhhHHHHHHHhCCCCCCCCccCCCCchhHHHHHHHHHhcCc
Q 038766 168 LDVHLQDLSSLSTAFQGTIGYLAPEFAYMRIVTTKVDVFSFGIVVMEFLTKRRPTGLDEENGLSPISLRQLVEKALANGI 247 (299)
Q Consensus 168 ~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~DiwslG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 247 (299)
.... ........+++.|+|||.+.+..++.++||||||+++|+|++|..||.... . .+..........
T Consensus 191 ~~~~----~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~-----~---~~~~~~~~~~~~ 258 (335)
T 2owb_A 191 VEYD----GERKKVLCGTPNYIAPEVLSKKGHSFEVDVWSIGCIMYTLLVGKPPFETSC-----L---KETYLRIKKNEY 258 (335)
T ss_dssp CCST----TCCBCCCCSCCSSCCHHHHHTSCBCTHHHHHHHHHHHHHHHHSSCTTCCSS-----H---HHHHHHHHHTCC
T ss_pred cccC----cccccccCCCccccCHHHhccCCCCchhhHHHHHHHHHHHHHCcCCCCCCC-----H---HHHHHHHhcCCC
Confidence 5421 122334567899999999999999999999999999999999999995431 1 111111111110
Q ss_pred cCcccccCccccchhhHhHHHHHHHHHHHHHHHHhcCCCCCCCCChhhhhcC
Q 038766 248 NGVRQITDPKLVSSIYEEQEQHQVLEELFKLALVCTSSNPEDRPNMNELLIT 299 (299)
Q Consensus 248 ~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rpt~~~il~~ 299 (299)
. + +..++..+.++|.+||..||++|||++++++|
T Consensus 259 -~---~--------------~~~~~~~~~~li~~~l~~dp~~Rps~~ell~~ 292 (335)
T 2owb_A 259 -S---I--------------PKHINPVAASLIQKMLQTDPTARPTINELLND 292 (335)
T ss_dssp -C---C--------------CTTSCHHHHHHHHHHTCSSGGGSCCGGGGGGS
T ss_pred -C---C--------------CccCCHHHHHHHHHHccCChhHCcCHHHHhcC
Confidence 0 0 11234578899999999999999999999987
|
| >3ugc_A Tyrosine-protein kinase JAK2; small molecule inhibitor, ATP binding, transferase-transfera inhibitor complex; HET: 046; 1.34A {} PDB: 3krr_A* 3lpb_A* 4aqc_A* 4e4m_A* 4f08_A* 4f09_A* 3q32_A* 3rvg_A* 4hge_A* 3tjc_A* 3tjd_A* 4bbe_A* 4bbf_A* 2b7a_A* 3fup_A* 3e64_A* 3e62_A* 3e63_A* 2xa4_A* 3iok_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=9.4e-46 Score=311.07 Aligned_cols=266 Identities=25% Similarity=0.404 Sum_probs=201.2
Q ss_pred HHHHhCCCCCCceeecCCcceEEEEEe-----CCCcEEEEEEeccCcCChhhhHHHHHHHHHHHhcCCcceeeeeeEEEc
Q 038766 7 IENATGSFSENNIIGNSNLSTVYKGRL-----EDGEIVAVKKLNFHQFSAESDKSFYREAKTLKELKHRNLVKVLGYAWE 81 (299)
Q Consensus 7 ~~~~~~~y~~~~~lg~g~~~~v~~~~~-----~~~~~~~vK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~ 81 (299)
.+...++|++.+.||+|+||+||++.. .+++.||+|++.. ......+.+.+|+.+++.++||||+++++++..
T Consensus 5 ~~~~~~~~~~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~--~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~ 82 (295)
T 3ugc_A 5 TQFEERHLKFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQH--STEEHLRDFEREIEILKSLQHDNIVKYKGVCYS 82 (295)
T ss_dssp -CCCGGGEEEEEEEEECSSEEEEEEEECTTCSSCCEEEEEEEESC--CCHHHHHHHHHHHHHHHTCCCTTBCCEEEEECH
T ss_pred CcCCHHHhhhhheeeccCCEEEEEEEEecccCCCCcEEEEEEccc--CCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEec
Confidence 345678999999999999999999973 3588999999863 345556788999999999999999999997764
Q ss_pred C-CCeeEEEEeecCCCChHHHhcCCCCCCCCCChhhHHHHHHHHHHHHHHhhcCCCCCeeeecccCCceeeCCCCcEEEe
Q 038766 82 S-GKLKALILEYMENGSLESVIHGPGVDHSRWTLPKRIDVLISVANGLDYLHSGYDIPIVHCDMKPSNILLDRDFEAHVS 160 (299)
Q Consensus 82 ~-~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lh~~~~~~~~H~dl~~~nil~~~~~~v~l~ 160 (299)
. ....++|+||+.+++|.+++... ...+++..++.++.|++.||+|||+. +++|+||||+||+++.++.++|+
T Consensus 83 ~~~~~~~lv~e~~~~~~L~~~l~~~---~~~~~~~~~~~~~~qi~~~l~~lH~~---~ivH~Dikp~Nil~~~~~~~kl~ 156 (295)
T 3ugc_A 83 AGRRNLKLIMEYLPYGSLRDYLQKH---KERIDHIKLLQYTSQICKGMEYLGTK---RYIHRDLATRNILVENENRVKIG 156 (295)
T ss_dssp HHHTSCEEEEECCTTCBHHHHHHHC---GGGCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEEEETTEEEEC
T ss_pred CCCCceEEEEEeCCCCCHHHHHHhc---ccccCHHHHHHHHHHHHHHHHHHhcC---CcccCCCCHhhEEEcCCCeEEEc
Confidence 3 24568999999999999998632 34689999999999999999999999 99999999999999999999999
Q ss_pred eeccccccccccccccccccccccCcccCChhhhcccCcCccccchhhhHHHHHHHhCCCCCCCCccC--------CCCc
Q 038766 161 DFGTSRMLDVHLQDLSSLSTAFQGTIGYLAPEFAYMRIVTTKVDVFSFGIVVMEFLTKRRPTGLDEEN--------GLSP 232 (299)
Q Consensus 161 df~~~~~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~DiwslG~~l~~l~~g~~p~~~~~~~--------~~~~ 232 (299)
|||++........ .........++..|+|||.+.+..++.++||||||+++|+|++|..|+...... ....
T Consensus 157 Dfg~~~~~~~~~~-~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~~~~~~~~~~~~~~~~~~~~~ 235 (295)
T 3ugc_A 157 DFGLTKVLPQDKE-FFKVKEPGESPIFWYAPESLTESKFSVASDVWSFGVVLYELFTYIEKSKSPPAEFMRMIGNDKQGQ 235 (295)
T ss_dssp CCCSCC--------------CTTCGGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHHTTCTTCSHHHHHHHHHCTTCCTH
T ss_pred cCcccccccCCcc-eeeeccCCCCccceeCcHHhcCCCCChHHHHHHHHHHHHHHHhcccccCCChHHHHhhhcCccccc
Confidence 9999976542211 111223334567799999999999999999999999999999999988543211 0011
Q ss_pred hhHHHHHHHHHhcCccCcccccCccccchhhHhHHHHHHHHHHHHHHHHhcCCCCCCCCChhhhhc
Q 038766 233 ISLRQLVEKALANGINGVRQITDPKLVSSIYEEQEQHQVLEELFKLALVCTSSNPEDRPNMNELLI 298 (299)
Q Consensus 233 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rpt~~~il~ 298 (299)
............... . ..+..++.++.+++.+||..||++|||++++++
T Consensus 236 ~~~~~~~~~~~~~~~-----~------------~~~~~~~~~l~~li~~~l~~dp~~Rps~~el~~ 284 (295)
T 3ugc_A 236 MIVFHLIELLKNNGR-----L------------PRPDGCPDEIYMIMTECWNNNVNQRPSFRDLAL 284 (295)
T ss_dssp HHHHHHHHHHHTTCC-----C------------CCCTTCCHHHHHHHHHHSCSSGGGSCCHHHHHH
T ss_pred hhHHHHHHHHhccCc-----C------------CCCcCcCHHHHHHHHHHcCCChhhCCCHHHHHH
Confidence 111111111111110 0 002234568999999999999999999999975
|
| >3c4z_A Rhodopsin kinase; Ser/Thr kinase, RGS homology domain, G protein coupled recep kinase, GRK, GRK1, P-loop, autophosphoryl ADP, ATP-binding; HET: ADP; 1.84A {Bos taurus} PDB: 3c4x_A* 3c4y_A 3c4w_A* 3c50_A* 3c51_A* 3qc9_A* 2i94_B | Back alignment and structure |
|---|
Probab=100.00 E-value=3.7e-45 Score=328.62 Aligned_cols=260 Identities=22% Similarity=0.344 Sum_probs=207.9
Q ss_pred HhCCCCCCceeecCCcceEEEEEeC-CCcEEEEEEeccCcCC-hhhhHHHHHHHHHHHhcCCcceeeeeeEEEcCCCeeE
Q 038766 10 ATGSFSENNIIGNSNLSTVYKGRLE-DGEIVAVKKLNFHQFS-AESDKSFYREAKTLKELKHRNLVKVLGYAWESGKLKA 87 (299)
Q Consensus 10 ~~~~y~~~~~lg~g~~~~v~~~~~~-~~~~~~vK~~~~~~~~-~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~ 87 (299)
..++|.+.+.||+|+||.||++.+. +|+.||+|++...... ......+..|..+++.++||||+++++++.. ...++
T Consensus 183 ~~~~f~~~~~LG~G~fG~Vy~a~~~~tg~~vAiK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~~~~-~~~l~ 261 (543)
T 3c4z_A 183 GEDWFLDFRVLGRGGFGEVFACQMKATGKLYACKKLNKKRLKKRKGYQGAMVEKKILAKVHSRFIVSLAYAFET-KTDLC 261 (543)
T ss_dssp CGGGEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHCCCTTBCCEEEEEEC-SSEEE
T ss_pred ChhheEEEEEEeeCCCeEEEEEEECCCCcEEEEEEEEhHHhhhhHHHHHHHHHHHHHHhcCCCCEeeEEEEEee-CCEEE
Confidence 3478999999999999999999875 6999999998643322 2335678899999999999999999996654 56679
Q ss_pred EEEeecCCCChHHHhcCCCCCCCCCChhhHHHHHHHHHHHHHHhhcCCCCCeeeecccCCceeeCCCCcEEEeeeccccc
Q 038766 88 LILEYMENGSLESVIHGPGVDHSRWTLPKRIDVLISVANGLDYLHSGYDIPIVHCDMKPSNILLDRDFEAHVSDFGTSRM 167 (299)
Q Consensus 88 lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lh~~~~~~~~H~dl~~~nil~~~~~~v~l~df~~~~~ 167 (299)
+||||+.|++|..++.........+++..++.++.||+.||.|||++ +++||||||+||+++.+|.+||+|||++..
T Consensus 262 lVmE~~~gg~L~~~l~~~~~~~~~l~e~~~~~~~~qi~~aL~~LH~~---gIvHrDLKP~NILl~~~g~vkL~DFGla~~ 338 (543)
T 3c4z_A 262 LVMTIMNGGDIRYHIYNVDEDNPGFQEPRAIFYTAQIVSGLEHLHQR---NIIYRDLKPENVLLDDDGNVRISDLGLAVE 338 (543)
T ss_dssp EEECCCTTCBHHHHHHTSSTTSCSCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEECTTSCEEECCCTTCEE
T ss_pred EEEEeccCCCHHHHHHHhhcccccccHHHHHHHHHHHHHHHHHHHHc---CCcccCCChHHEEEeCCCCEEEeecceeee
Confidence 99999999999999876544566899999999999999999999999 999999999999999999999999999976
Q ss_pred cccccccccccccccccCcccCChhhhcccCcCccccchhhhHHHHHHHhCCCCCCCCccCCCCchhHHHHHHHHHhcCc
Q 038766 168 LDVHLQDLSSLSTAFQGTIGYLAPEFAYMRIVTTKVDVFSFGIVVMEFLTKRRPTGLDEENGLSPISLRQLVEKALANGI 247 (299)
Q Consensus 168 ~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~DiwslG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 247 (299)
.... ........+|+.|+|||++.+..++.++|+|||||++|+|++|..||....... . ............
T Consensus 339 ~~~~----~~~~~~~~GT~~Y~APE~l~~~~~~~~~DiwSlGvilyelltG~~PF~~~~~~~-~---~~~~~~~i~~~~- 409 (543)
T 3c4z_A 339 LKAG----QTKTKGYAGTPGFMAPELLLGEEYDFSVDYFALGVTLYEMIAARGPFRARGEKV-E---NKELKQRVLEQA- 409 (543)
T ss_dssp CCTT----CCCBCCCCSCTTTSCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCTTCCC-C---HHHHHHHHHHCC-
T ss_pred ccCC----CcccccccCCccccChhhhcCCCCChHHhcCcchHHHHHHHhCCCCCCCCccch-h---HHHHHHHHhhcc-
Confidence 5421 122334578999999999999999999999999999999999999996542211 1 122222222111
Q ss_pred cCcccccCccccchhhHhHHHHHHHHHHHHHHHHhcCCCCCCCCCh-----hhhhcC
Q 038766 248 NGVRQITDPKLVSSIYEEQEQHQVLEELFKLALVCTSSNPEDRPNM-----NELLIT 299 (299)
Q Consensus 248 ~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rpt~-----~~il~~ 299 (299)
.. + +..++.++.+||++||..||++||++ +++++|
T Consensus 410 ~~---~--------------p~~~s~~~~~li~~lL~~dP~~R~~~~~~~a~ei~~H 449 (543)
T 3c4z_A 410 VT---Y--------------PDKFSPASKDFCEALLQKDPEKRLGFRDGSCDGLRTH 449 (543)
T ss_dssp CC---C--------------CTTSCHHHHHHHHHHSCSSGGGSCCCBTTBSHHHHTS
T ss_pred cC---C--------------CcccCHHHHHHHHHhccCCHhHCCCCcccCHHHHHcC
Confidence 00 0 12345689999999999999999964 778776
|
| >2vgo_A Serine/threonine-protein kinase 12-A; nucleotide-binding, serine/threonine-protein kinase, ATP-binding, transferase, coiled coil, cell division, kinase; HET: TPO AD5; 1.7A {Xenopus laevis} PDB: 2bfx_A* 2vgp_A* 3ztx_A* 2vrx_A* 2bfy_A* 4af3_A* 3dj6_A* 3d15_A* 3d2i_A* 3d2k_A* 3d14_A* 3dj5_A* 3dj7_A* 3daj_A* 1ol5_A* 1ol7_A* 2x6d_A* 2x6e_A* 2xng_A* 2dwb_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-45 Score=308.28 Aligned_cols=251 Identities=22% Similarity=0.342 Sum_probs=203.6
Q ss_pred HHhCCCCCCceeecCCcceEEEEEeC-CCcEEEEEEeccCcCC-hhhhHHHHHHHHHHHhcCCcceeeeeeEEEcCCCee
Q 038766 9 NATGSFSENNIIGNSNLSTVYKGRLE-DGEIVAVKKLNFHQFS-AESDKSFYREAKTLKELKHRNLVKVLGYAWESGKLK 86 (299)
Q Consensus 9 ~~~~~y~~~~~lg~g~~~~v~~~~~~-~~~~~~vK~~~~~~~~-~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~ 86 (299)
...++|.+.+.||+|++|+||++.+. ++..||+|++...... ......+.+|+..++.++||||+++++++.. ++..
T Consensus 11 ~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~-~~~~ 89 (284)
T 2vgo_A 11 FTIDDFDIGRPLGKGKFGNVYLAREKQNKFIMALKVLFKSQLEKEGVEHQLRREIEIQSHLRHPNILRMYNYFHD-RKRI 89 (284)
T ss_dssp CCGGGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTCCCTTBCCEEEEEEC-SSEE
T ss_pred hhhhhceeeheecCCCCeEEEEEEEcCCCcEEEEEEEcccccchHHHHHHHHHHHHHHhcCCCCCEeeEEEEEEc-CCEE
Confidence 34578999999999999999999875 5789999998643221 2235678899999999999999999997655 5567
Q ss_pred EEEEeecCCCChHHHhcCCCCCCCCCChhhHHHHHHHHHHHHHHhhcCCCCCeeeecccCCceeeCCCCcEEEeeecccc
Q 038766 87 ALILEYMENGSLESVIHGPGVDHSRWTLPKRIDVLISVANGLDYLHSGYDIPIVHCDMKPSNILLDRDFEAHVSDFGTSR 166 (299)
Q Consensus 87 ~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lh~~~~~~~~H~dl~~~nil~~~~~~v~l~df~~~~ 166 (299)
++|+||+.+++|.+++. ....+++..++.++.|++.||.|||++ +++|+||+|+||+++.++.++|+|||++.
T Consensus 90 ~lv~e~~~~~~L~~~l~----~~~~~~~~~~~~~~~qi~~~l~~lH~~---~i~H~dl~p~Nil~~~~~~~kl~Dfg~~~ 162 (284)
T 2vgo_A 90 YLMLEFAPRGELYKELQ----KHGRFDEQRSATFMEELADALHYCHER---KVIHRDIKPENLLMGYKGELKIADFGWSV 162 (284)
T ss_dssp EEEECCCTTEEHHHHHH----HHSSCCHHHHHHHHHHHHHHHHHHHTT---TEECCCCSGGGEEECTTCCEEECCCTTCE
T ss_pred EEEEEeCCCCcHHHHHH----hcCCCCHHHHHHHHHHHHHHHHHHHHC---CceecCCCHHHEEEcCCCCEEEecccccc
Confidence 99999999999999987 345789999999999999999999999 99999999999999999999999999886
Q ss_pred ccccccccccccccccccCcccCChhhhcccCcCccccchhhhHHHHHHHhCCCCCCCCccCCCCchhHHHHHHHHHhcC
Q 038766 167 MLDVHLQDLSSLSTAFQGTIGYLAPEFAYMRIVTTKVDVFSFGIVVMEFLTKRRPTGLDEENGLSPISLRQLVEKALANG 246 (299)
Q Consensus 167 ~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~DiwslG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~ 246 (299)
.... .......+++.|+|||.+.+..++.++||||||+++|+|++|..||.... . .+.........
T Consensus 163 ~~~~------~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~-----~---~~~~~~~~~~~ 228 (284)
T 2vgo_A 163 HAPS------LRRRTMCGTLDYLPPEMIEGKTHDEKVDLWCAGVLCYEFLVGMPPFDSPS-----H---TETHRRIVNVD 228 (284)
T ss_dssp ECSS------SCBCCCCSCGGGCCHHHHTTCCBCTTHHHHHHHHHHHHHHHSSCTTCCSS-----H---HHHHHHHHTTC
T ss_pred cCcc------cccccccCCCCcCCHHHhccCCCCcccchhhHHHHHHHHHHCCCCCCCCC-----H---hHHHHHHhccc
Confidence 5431 12234567899999999999999999999999999999999999995431 1 11111111110
Q ss_pred ccCcccccCccccchhhHhHHHHHHHHHHHHHHHHhcCCCCCCCCChhhhhcC
Q 038766 247 INGVRQITDPKLVSSIYEEQEQHQVLEELFKLALVCTSSNPEDRPNMNELLIT 299 (299)
Q Consensus 247 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rpt~~~il~~ 299 (299)
. . . +..++.++.++|.+||..||++|||++++++|
T Consensus 229 ~-~-----~------------~~~~~~~~~~li~~~l~~~p~~Rps~~~ll~h 263 (284)
T 2vgo_A 229 L-K-----F------------PPFLSDGSKDLISKLLRYHPPQRLPLKGVMEH 263 (284)
T ss_dssp C-C-----C------------CTTSCHHHHHHHHHHSCSSGGGSCCHHHHHTC
T ss_pred c-C-----C------------CCcCCHHHHHHHHHHhhcCHhhCCCHHHHhhC
Confidence 0 0 0 12245678999999999999999999999987
|
| >1ua2_A CAK, cell division protein kinase 7; cell cycle, phosphorylation, protein-protein interaction, PR kinase, cell cycle, transferase; HET: TPO ATP; 3.02A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=8.8e-45 Score=311.83 Aligned_cols=277 Identities=24% Similarity=0.320 Sum_probs=197.0
Q ss_pred HHHHhCCCCCCceeecCCcceEEEEEeC-CCcEEEEEEeccCcCCh---hhhHHHHHHHHHHHhcCCcceeeeeeEEEcC
Q 038766 7 IENATGSFSENNIIGNSNLSTVYKGRLE-DGEIVAVKKLNFHQFSA---ESDKSFYREAKTLKELKHRNLVKVLGYAWES 82 (299)
Q Consensus 7 ~~~~~~~y~~~~~lg~g~~~~v~~~~~~-~~~~~~vK~~~~~~~~~---~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~ 82 (299)
+....++|.+.+.||+|+||.||++.+. +|+.||+|++....... .....+.+|+.+++.++||||+++++++..
T Consensus 5 ~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~- 83 (346)
T 1ua2_A 5 VKSRAKRYEKLDFLGEGQFATVYKARDKNTNQIVAIKKIKLGHRSEAKDGINRTALREIKLLQELSHPNIIGLLDAFGH- 83 (346)
T ss_dssp --------CEEEEEEEETTEEEEEEECSSCCSEEEEEEC------------CTHHHHHHHHHHHCCCTTBCCEEEEECC-
T ss_pred hHHHhcccEEEeEEeecCCEEEEEEEECCCCcEEEEEEEecCCcchhhhhhhHHHHHHHHHHhhCCCCCCCeEEEEEee-
Confidence 4556789999999999999999999875 58999999986533221 223567899999999999999999997655
Q ss_pred CCeeEEEEeecCCCChHHHhcCCCCCCCCCChhhHHHHHHHHHHHHHHhhcCCCCCeeeecccCCceeeCCCCcEEEeee
Q 038766 83 GKLKALILEYMENGSLESVIHGPGVDHSRWTLPKRIDVLISVANGLDYLHSGYDIPIVHCDMKPSNILLDRDFEAHVSDF 162 (299)
Q Consensus 83 ~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lh~~~~~~~~H~dl~~~nil~~~~~~v~l~df 162 (299)
....++|+||+.+ +|...+.. ....+++..++.++.|++.||+|||++ +++|+||||+||+++.++.++|+||
T Consensus 84 ~~~~~lv~e~~~~-~l~~~~~~---~~~~~~~~~~~~~~~qi~~~l~~lH~~---~ivH~Dlkp~Nil~~~~~~~kl~Df 156 (346)
T 1ua2_A 84 KSNISLVFDFMET-DLEVIIKD---NSLVLTPSHIKAYMLMTLQGLEYLHQH---WILHRDLKPNNLLLDENGVLKLADF 156 (346)
T ss_dssp TTCCEEEEECCSE-EHHHHHTT---CCSSCCSSHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEECTTCCEEECCC
T ss_pred CCceEEEEEcCCC-CHHHHHHh---cCcCCCHHHHHHHHHHHHHHHHHHHHC---CEECCCCCHHHEEEcCCCCEEEEec
Confidence 4556999999975 88888863 335789999999999999999999999 9999999999999999999999999
Q ss_pred ccccccccccccccccccccccCcccCChhhhccc-CcCccccchhhhHHHHHHHhCCCCCCCCccCCCCchhHHHHHHH
Q 038766 163 GTSRMLDVHLQDLSSLSTAFQGTIGYLAPEFAYMR-IVTTKVDVFSFGIVVMEFLTKRRPTGLDEENGLSPISLRQLVEK 241 (299)
Q Consensus 163 ~~~~~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~-~~~~~~DiwslG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~ 241 (299)
|++..... .........+++.|+|||++.+. .++.++|||||||++|+|++|..||..... ...+......
T Consensus 157 g~a~~~~~----~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~~~~~~~~----~~~~~~i~~~ 228 (346)
T 1ua2_A 157 GLAKSFGS----PNRAYTHQVVTRWYRAPELLFGARMYGVGVDMWAVGCILAELLLRVPFLPGDSD----LDQLTRIFET 228 (346)
T ss_dssp GGGSTTTS----CCCCCCCSCCCCTTCCHHHHTTCSCCCHHHHHHHHHHHHHHHHHSSCSSCCSSH----HHHHHHHHHH
T ss_pred ccceeccC----CcccCCcccccccccCchHhhCCCCCCchhhhHhHHHHHHHHHHCCCCCCCCCH----HHHHHHHHHH
Confidence 99976542 12223445679999999998764 478999999999999999999999854311 1111111111
Q ss_pred HHhcC---ccCcccccCcc---ccchhhHhHHHHHHHHHHHHHHHHhcCCCCCCCCChhhhhcC
Q 038766 242 ALANG---INGVRQITDPK---LVSSIYEEQEQHQVLEELFKLALVCTSSNPEDRPNMNELLIT 299 (299)
Q Consensus 242 ~~~~~---~~~~~~~~~~~---~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rpt~~~il~~ 299 (299)
..... ++......+.. .............++.++.+||++||..||++|||++|+|+|
T Consensus 229 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~h 292 (346)
T 1ua2_A 229 LGTPTEEQWPDMCSLPDYVTFKSFPGIPLHHIFSAAGDDLLDLIQGLFLFNPCARITATQALKM 292 (346)
T ss_dssp HCCCCTTTSSSTTSSTTCCCCCCCCCCCHHHHCTTCCHHHHHHHHHHHCSSTTTSCCHHHHHTS
T ss_pred cCCCChhhhhhhccCcccccccccCCCChHHhhccCCHHHHHHHHHHhccChhhCCCHHHHhcC
Confidence 11110 11111110000 000000111123456789999999999999999999999987
|
| >1nxk_A MAP kinase-activated protein kinase 2; MK2, phosphorylation, staurosporine, transfe; HET: STU; 2.70A {Homo sapiens} SCOP: d.144.1.7 PDB: 1kwp_A* 1ny3_A* 2onl_C | Back alignment and structure |
|---|
Probab=100.00 E-value=4.8e-45 Score=318.94 Aligned_cols=255 Identities=21% Similarity=0.259 Sum_probs=191.9
Q ss_pred HhCCCCCC-ceeecCCcceEEEEEeC-CCcEEEEEEeccCcCChhhhHHHHHHHHHHHh-cCCcceeeeeeEEEc---CC
Q 038766 10 ATGSFSEN-NIIGNSNLSTVYKGRLE-DGEIVAVKKLNFHQFSAESDKSFYREAKTLKE-LKHRNLVKVLGYAWE---SG 83 (299)
Q Consensus 10 ~~~~y~~~-~~lg~g~~~~v~~~~~~-~~~~~~vK~~~~~~~~~~~~~~~~~e~~~l~~-l~h~~i~~~~~~~~~---~~ 83 (299)
+.++|.+. +.||+|+||+||++.+. +++.||+|++.. .....+|+..+.+ .+||||+++++++.. .+
T Consensus 59 ~~~~y~~~~~~LG~G~~g~V~~~~~~~~~~~vAiK~~~~-------~~~~~~E~~~~~~~~~hp~iv~l~~~~~~~~~~~ 131 (400)
T 1nxk_A 59 IIDDYKVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQD-------CPKARREVELHWRASQCPHIVRIVDVYENLYAGR 131 (400)
T ss_dssp GGGTEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEC-------SHHHHHHHHHHHHHTTSTTBCCEEEEEEEEETTE
T ss_pred ccccceeccceeeeccCeEEEEEEECCCCCEEEEEEeCc-------chhHHHHHHHHHHhcCCCCcceEeEEEeecccCC
Confidence 34566665 78999999999999875 589999999852 2356678887744 479999999997643 24
Q ss_pred CeeEEEEeecCCCChHHHhcCCCCCCCCCChhhHHHHHHHHHHHHHHhhcCCCCCeeeecccCCceeeCC---CCcEEEe
Q 038766 84 KLKALILEYMENGSLESVIHGPGVDHSRWTLPKRIDVLISVANGLDYLHSGYDIPIVHCDMKPSNILLDR---DFEAHVS 160 (299)
Q Consensus 84 ~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lh~~~~~~~~H~dl~~~nil~~~---~~~v~l~ 160 (299)
...++|+||+.+++|.+++... ....+++.+++.++.||+.||.|||+. +++||||||+||+++. ++.+||+
T Consensus 132 ~~~~lv~E~~~gg~L~~~l~~~--~~~~l~~~~~~~i~~qi~~aL~~LH~~---~ivHrDlkp~Nill~~~~~~~~~kl~ 206 (400)
T 1nxk_A 132 KCLLIVMECLDGGELFSRIQDR--GDQAFTEREASEIMKSIGEAIQYLHSI---NIAHRDVKPENLLYTSKRPNAILKLT 206 (400)
T ss_dssp EEEEEEEECCCSEEHHHHHHCC-----CCBHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEESSSSTTCCEEEC
T ss_pred cEEEEEEEeCCCCcHHHHHHHh--CCCCCCHHHHHHHHHHHHHHHHHHHHC---CccccCcCcceEEEecCCCCccEEEE
Confidence 5679999999999999999743 234699999999999999999999999 9999999999999987 7899999
Q ss_pred eeccccccccccccccccccccccCcccCChhhhcccCcCccccchhhhHHHHHHHhCCCCCCCCccCCCCchhHHHHHH
Q 038766 161 DFGTSRMLDVHLQDLSSLSTAFQGTIGYLAPEFAYMRIVTTKVDVFSFGIVVMEFLTKRRPTGLDEENGLSPISLRQLVE 240 (299)
Q Consensus 161 df~~~~~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~DiwslG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~ 240 (299)
|||++..... ........+|+.|+|||++.+..++.++|||||||++|+|++|..||............ ...+.
T Consensus 207 DFG~a~~~~~-----~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~-~~~i~ 280 (400)
T 1nxk_A 207 DFGFAKETTS-----HNSLTTPCYTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAISPGM-KTRIR 280 (400)
T ss_dssp CCTTCEECC----------------CTTCCGGGSCCCCSSSHHHHHHHHHHHHHHHHSSCSCCCCTTCSSCCSH-HHHHH
T ss_pred ecccccccCC-----CCccccCCCCCCccCHhhcCCCCCCCcccHHHHHHHHHHHHhCCCCCCCCccccccHHH-HHHHH
Confidence 9999875432 12233456799999999999999999999999999999999999999655332222111 11111
Q ss_pred HHHhcCccCcccccCccccchhhHhHHHHHHHHHHHHHHHHhcCCCCCCCCChhhhhcC
Q 038766 241 KALANGINGVRQITDPKLVSSIYEEQEQHQVLEELFKLALVCTSSNPEDRPNMNELLIT 299 (299)
Q Consensus 241 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rpt~~~il~~ 299 (299)
. + ......+. ...++.++.+||++||..||++|||++++++|
T Consensus 281 ---~-~---~~~~~~~~----------~~~~s~~~~~li~~~L~~dP~~Rpt~~eil~h 322 (400)
T 1nxk_A 281 ---M-G---QYEFPNPE----------WSEVSEEVKMLIRNLLKTEPTQRMTITEFMNH 322 (400)
T ss_dssp ---H-T---CCCCCTTT----------TTTSCHHHHHHHHTTSCSSGGGSCCHHHHHHS
T ss_pred ---c-C---cccCCCcc----------cccCCHHHHHHHHHHCCCChhHCcCHHHHhcC
Confidence 1 1 00011100 12345689999999999999999999999987
|
| >1qcf_A Haematopoetic cell kinase (HCK); tyrosine kinase-inhibitor complex, DOWN-regulated kinase, ordered activation loop; HET: PTR PP1; 2.00A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 2c0i_A* 2c0o_A* 2c0t_A* 1ad5_A* 2hck_A* 3nhn_A 3hck_A 1bu1_A 3rea_B 3rbb_B | Back alignment and structure |
|---|
Probab=100.00 E-value=3.3e-46 Score=331.62 Aligned_cols=258 Identities=26% Similarity=0.415 Sum_probs=206.8
Q ss_pred ChHHHHHHhCCCCCCceeecCCcceEEEEEeCCCcEEEEEEeccCcCChhhhHHHHHHHHHHHhcCCcceeeeeeEEEcC
Q 038766 3 DRTEIENATGSFSENNIIGNSNLSTVYKGRLEDGEIVAVKKLNFHQFSAESDKSFYREAKTLKELKHRNLVKVLGYAWES 82 (299)
Q Consensus 3 ~~~~~~~~~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~vK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~ 82 (299)
..+++++-.++|.+.+.||+|+||.||++.+.++..||||++.... ...+.+.+|+.+++.++||||+++++++.
T Consensus 179 ~~~~~~i~~~~~~~~~~lG~G~fg~V~~~~~~~~~~vavK~~~~~~---~~~~~~~~E~~~l~~l~h~~iv~l~~~~~-- 253 (454)
T 1qcf_A 179 EKDAWEIPRESLKLEKKLGAGQFGEVWMATYNKHTKVAVKTMKPGS---MSVEAFLAEANVMKTLQHDKLVKLHAVVT-- 253 (454)
T ss_dssp CTTCSBCCGGGEEEEEEEECCSSEEEEEEEETTTEEEEEEEECTTS---BCHHHHHHHHHHHTTCCCTTBCCEEEEEC--
T ss_pred cccceeechHHeEEEEEcccCCceEEEEEEECCccEEEEEEecCCC---ccHHHHHHHHHHHhhCCCCCEeeEEEEEe--
Confidence 3456777888999999999999999999999888899999987432 34678899999999999999999999764
Q ss_pred CCeeEEEEeecCCCChHHHhcCCCCCCCCCChhhHHHHHHHHHHHHHHhhcCCCCCeeeecccCCceeeCCCCcEEEeee
Q 038766 83 GKLKALILEYMENGSLESVIHGPGVDHSRWTLPKRIDVLISVANGLDYLHSGYDIPIVHCDMKPSNILLDRDFEAHVSDF 162 (299)
Q Consensus 83 ~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lh~~~~~~~~H~dl~~~nil~~~~~~v~l~df 162 (299)
....++|+||+.+++|.+++... ....+++..++.++.|++.||+|||++ +++||||||+|||++.++.+||+||
T Consensus 254 ~~~~~lv~e~~~~g~L~~~l~~~--~~~~~~~~~~~~~~~qi~~~l~~LH~~---~ivHrDlkp~Nill~~~~~~kl~DF 328 (454)
T 1qcf_A 254 KEPIYIITEFMAKGSLLDFLKSD--EGSKQPLPKLIDFSAQIAEGMAFIEQR---NYIHRDLRAANILVSASLVCKIADF 328 (454)
T ss_dssp SSSCEEEECCCTTCBHHHHHHSH--HHHTCCHHHHHHHHHHHHHHHHHHHHT---TCCCSSCSGGGEEECTTCCEEECST
T ss_pred CCccEEEEeecCCCcHHHHHHhc--cCCCCCHHHHHHHHHHHHHHHHHHHhC---CccCCCCCHHHEEECCCCcEEEeeC
Confidence 44569999999999999998632 123688899999999999999999999 9999999999999999999999999
Q ss_pred ccccccccccccccccccccccCcccCChhhhcccCcCccccchhhhHHHHHHHh-CCCCCCCCccCCCCchhHHHHHHH
Q 038766 163 GTSRMLDVHLQDLSSLSTAFQGTIGYLAPEFAYMRIVTTKVDVFSFGIVVMEFLT-KRRPTGLDEENGLSPISLRQLVEK 241 (299)
Q Consensus 163 ~~~~~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~DiwslG~~l~~l~~-g~~p~~~~~~~~~~~~~~~~~~~~ 241 (299)
|++...... .........+++.|+|||.+....++.++||||||+++|+|++ |..||... ....+...+..
T Consensus 329 G~a~~~~~~---~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~el~t~g~~P~~~~-----~~~~~~~~i~~ 400 (454)
T 1qcf_A 329 GLARVIEDN---EYTAREGAKFPIKWTAPEAINFGSFTIKSDVWSFGILLMEIVTYGRIPYPGM-----SNPEVIRALER 400 (454)
T ss_dssp TGGGGBCCH---HHHTTCSSSSCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTC-----CHHHHHHHHHH
T ss_pred CCceEcCCC---ceeccCCCcccccccCHHHhccCCCCcHHHHHhHHHHHHHHHhCCCCCCCCC-----CHHHHHHHHHc
Confidence 999765421 1111223345678999999998999999999999999999999 99998532 22222222211
Q ss_pred HHhcCccCcccccCccccchhhHhHHHHHHHHHHHHHHHHhcCCCCCCCCChhhhhc
Q 038766 242 ALANGINGVRQITDPKLVSSIYEEQEQHQVLEELFKLALVCTSSNPEDRPNMNELLI 298 (299)
Q Consensus 242 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rpt~~~il~ 298 (299)
.. .... +..++.++.++|.+||..||++|||+++|++
T Consensus 401 ---~~-----~~~~------------~~~~~~~l~~li~~cl~~dp~~RPt~~~i~~ 437 (454)
T 1qcf_A 401 ---GY-----RMPR------------PENCPEELYNIMMRCWKNRPEERPTFEYIQS 437 (454)
T ss_dssp ---TC-----CCCC------------CTTSCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred ---CC-----CCCC------------CCCCCHHHHHHHHHHccCChhHCcCHHHHHH
Confidence 10 0001 1234567999999999999999999999874
|
| >3cbl_A C-FES, proto-oncogene tyrosine-protein kinase FES/FPS; V-FES, fujinami, avian sarcoma, viral, feline virus, SGC; HET: STU; 1.75A {Homo sapiens} PDB: 3bkb_A* 3cd3_A* 4e93_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.3e-46 Score=325.19 Aligned_cols=259 Identities=24% Similarity=0.376 Sum_probs=204.1
Q ss_pred HHHHHHhCCCCCCceeecCCcceEEEEEeC-CCcEEEEEEeccCcCChhhhHHHHHHHHHHHhcCCcceeeeeeEEEcCC
Q 038766 5 TEIENATGSFSENNIIGNSNLSTVYKGRLE-DGEIVAVKKLNFHQFSAESDKSFYREAKTLKELKHRNLVKVLGYAWESG 83 (299)
Q Consensus 5 ~~~~~~~~~y~~~~~lg~g~~~~v~~~~~~-~~~~~~vK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~ 83 (299)
+.++.-.++|.+.+.||+|+||.||++.+. +++.||+|++.. .........+.+|+.+++.++||||+++++++.. +
T Consensus 107 ~~~~~~~~~~~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~-~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~-~ 184 (377)
T 3cbl_A 107 DKWVLNHEDLVLGEQIGRGNFGEVFSGRLRADNTLVAVKSCRE-TLPPDLKAKFLQEARILKQYSHPNIVRLIGVCTQ-K 184 (377)
T ss_dssp CTTBCCGGGEEEEEEEEEETTEEEEEEEETTTCCEEEEEECCT-TSCHHHHTTTTHHHHHHTTCCCTTBCCEEEEECS-S
T ss_pred cccEEchHHeEEeeEeccCCCCeEEEEEEecCCeEEEEEEccc-cCCHHHHHHHHHHHHHHHhCCCCCEEEEEEEEec-C
Confidence 345566788999999999999999999975 689999999863 2344455678899999999999999999997755 4
Q ss_pred CeeEEEEeecCCCChHHHhcCCCCCCCCCChhhHHHHHHHHHHHHHHhhcCCCCCeeeecccCCceeeCCCCcEEEeeec
Q 038766 84 KLKALILEYMENGSLESVIHGPGVDHSRWTLPKRIDVLISVANGLDYLHSGYDIPIVHCDMKPSNILLDRDFEAHVSDFG 163 (299)
Q Consensus 84 ~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lh~~~~~~~~H~dl~~~nil~~~~~~v~l~df~ 163 (299)
...++|+||+++++|.+++.. ....+++..++.++.|++.||+|||++ +++||||||+||+++.++.+||+|||
T Consensus 185 ~~~~lv~e~~~~g~L~~~l~~---~~~~~~~~~~~~~~~qi~~~l~~LH~~---~ivHrDlkp~Nil~~~~~~~kl~DfG 258 (377)
T 3cbl_A 185 QPIYIVMELVQGGDFLTFLRT---EGARLRVKTLLQMVGDAAAGMEYLESK---CCIHRDLAARNCLVTEKNVLKISDFG 258 (377)
T ss_dssp SSCEEEEECCTTCBHHHHHHH---HGGGCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEECTTCCEEECCGG
T ss_pred CCcEEEEEcCCCCCHHHHHHh---cCCCCCHHHHHHHHHHHHHHHHHHHHC---CcCCcccCHHHEEEcCCCcEEECcCC
Confidence 456999999999999998863 234689999999999999999999999 99999999999999999999999999
Q ss_pred cccccccccccccccccccccCcccCChhhhcccCcCccccchhhhHHHHHHHh-CCCCCCCCccCCCCchhHHHHHHHH
Q 038766 164 TSRMLDVHLQDLSSLSTAFQGTIGYLAPEFAYMRIVTTKVDVFSFGIVVMEFLT-KRRPTGLDEENGLSPISLRQLVEKA 242 (299)
Q Consensus 164 ~~~~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~DiwslG~~l~~l~~-g~~p~~~~~~~~~~~~~~~~~~~~~ 242 (299)
++...... ..........+++.|+|||.+.+..++.++||||||+++|+|++ |..||... ........+.
T Consensus 259 ~s~~~~~~--~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~el~t~g~~p~~~~-----~~~~~~~~~~-- 329 (377)
T 3cbl_A 259 MSREEADG--VYAASGGLRQVPVKWTAPEALNYGRYSSESDVWSFGILLWETFSLGASPYPNL-----SNQQTREFVE-- 329 (377)
T ss_dssp GCEECTTS--EEECCSSCCEEEGGGSCHHHHHHCEEEHHHHHHHHHHHHHHHHTTSCCSSTTS-----CHHHHHHHHH--
T ss_pred CceecCCC--ceeecCCCCCCCcCcCCHhHhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCC-----CHHHHHHHHH--
Confidence 98753311 01111122335678999999998899999999999999999998 88888533 2222222221
Q ss_pred HhcCccCcccccCccccchhhHhHHHHHHHHHHHHHHHHhcCCCCCCCCChhhhhc
Q 038766 243 LANGINGVRQITDPKLVSSIYEEQEQHQVLEELFKLALVCTSSNPEDRPNMNELLI 298 (299)
Q Consensus 243 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rpt~~~il~ 298 (299)
.+. .... +..++..+.+++.+||..||++|||++++++
T Consensus 330 --~~~----~~~~------------~~~~~~~l~~li~~cl~~dP~~Rps~~~i~~ 367 (377)
T 3cbl_A 330 --KGG----RLPC------------PELCPDAVFRLMEQCWAYEPGQRPSFSTIYQ 367 (377)
T ss_dssp --TTC----CCCC------------CTTCCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred --cCC----CCCC------------CCCCCHHHHHHHHHHcCCCchhCcCHHHHHH
Confidence 110 0111 1223467899999999999999999999975
|
| >3eb0_A Putative uncharacterized protein; kinase cryptosporidium parvum, ATP-binding, kinase, nucleoti binding; HET: PTR DRK; 2.65A {Cryptosporidium parvum iowa II} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.5e-45 Score=319.42 Aligned_cols=274 Identities=21% Similarity=0.257 Sum_probs=200.1
Q ss_pred HHHHhCCCCCCceeecCCcceEEEEEe-CCCcEEEEEEeccCcCChhhhHHHHHHHHHHHhcCCcceeeeeeEEEcC---
Q 038766 7 IENATGSFSENNIIGNSNLSTVYKGRL-EDGEIVAVKKLNFHQFSAESDKSFYREAKTLKELKHRNLVKVLGYAWES--- 82 (299)
Q Consensus 7 ~~~~~~~y~~~~~lg~g~~~~v~~~~~-~~~~~~~vK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~--- 82 (299)
++...++|.+.+.||+|+||+||+|.+ .+|+.||+|++..... ...+|+.+++.++||||+++++++...
T Consensus 2 l~~~~~~y~~~~~lG~G~fg~V~~a~~~~~~~~vAiK~~~~~~~------~~~~E~~il~~l~hpnIv~l~~~~~~~~~~ 75 (383)
T 3eb0_A 2 LETSSKKYSLGKTLGTGSFGIVCEVFDIESGKRFALKKVLQDPR------YKNRELDIMKVLDHVNIIKLVDYFYTTGDE 75 (383)
T ss_dssp ----CTTEEEEEEEECC-CEEEEEEEETTTCCEEEEEEEECCTT------SCCHHHHHHTTCCCTTBCCEEEEEEEC---
T ss_pred CccccceEEEEEEEEeccCEEEEEEEECCCCCEEEEEEEecCcc------hHHHHHHHHHHcCCCCccchhheeeecCcc
Confidence 466788999999999999999999986 5699999999864321 123699999999999999999987543
Q ss_pred ----------------------------------CCeeEEEEeecCCCChHHHhcCCCCCCCCCChhhHHHHHHHHHHHH
Q 038766 83 ----------------------------------GKLKALILEYMENGSLESVIHGPGVDHSRWTLPKRIDVLISVANGL 128 (299)
Q Consensus 83 ----------------------------------~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l 128 (299)
+...++||||+.+ +|.+.+......+..+++..++.++.||+.||
T Consensus 76 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~~-~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL 154 (383)
T 3eb0_A 76 EPKPPQPPDDHNKLGGKNNGVNNHHKSVIVNPSQNKYLNVIMEYVPD-TLHKVLKSFIRSGRSIPMNLISIYIYQLFRAV 154 (383)
T ss_dssp ----------------------------------CCEEEEEECCCSE-EHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHH
T ss_pred cccccccccccccccccccccccccccccccCCCceEEEEEEecCCc-cHHHHHHHHHhcCCCCCHHHHHHHHHHHHHHH
Confidence 2347899999974 87766643222456899999999999999999
Q ss_pred HHhhcCCCCCeeeecccCCceeeC-CCCcEEEeeeccccccccccccccccccccccCcccCChhhhccc-CcCccccch
Q 038766 129 DYLHSGYDIPIVHCDMKPSNILLD-RDFEAHVSDFGTSRMLDVHLQDLSSLSTAFQGTIGYLAPEFAYMR-IVTTKVDVF 206 (299)
Q Consensus 129 ~~lh~~~~~~~~H~dl~~~nil~~-~~~~v~l~df~~~~~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~-~~~~~~Diw 206 (299)
+|||+. +++|+||||+||+++ .++.++|+|||++..... ........+++.|+|||.+.+. .++.++|||
T Consensus 155 ~~LH~~---gi~H~Dikp~Nil~~~~~~~~kl~Dfg~a~~~~~-----~~~~~~~~~t~~y~aPE~~~~~~~~~~~~Diw 226 (383)
T 3eb0_A 155 GFIHSL---GICHRDIKPQNLLVNSKDNTLKLCDFGSAKKLIP-----SEPSVAYICSRFYRAPELMLGATEYTPSIDLW 226 (383)
T ss_dssp HHHHTT---TEECSCCCGGGEEEETTTTEEEECCCTTCEECCT-----TSCCCCCCCCSSCCCHHHHTTCSSCCTHHHHH
T ss_pred HHHHHC---cCccCccCHHHEEEcCCCCcEEEEECCCCcccCC-----CCCCcCcccCCCccCHHHhcCCCCCCcchhhh
Confidence 999999 999999999999997 688999999999976542 1223344678899999988875 489999999
Q ss_pred hhhHHHHHHHhCCCCCCCCccCCCCchhHHHHHHHHHhcC-------ccCcccccCccccchhhHhHHHHHHHHHHHHHH
Q 038766 207 SFGIVVMEFLTKRRPTGLDEENGLSPISLRQLVEKALANG-------INGVRQITDPKLVSSIYEEQEQHQVLEELFKLA 279 (299)
Q Consensus 207 slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~-------~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li 279 (299)
|+||++|+|++|..||...... ..+...+....... .........+......+....+...+.++.+||
T Consensus 227 slG~il~ell~g~~pf~~~~~~----~~~~~i~~~~g~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li 302 (383)
T 3eb0_A 227 SIGCVFGELILGKPLFSGETSI----DQLVRIIQIMGTPTKEQMIRMNPHYTEVRFPTLKAKDWRKILPEGTPSLAIDLL 302 (383)
T ss_dssp HHHHHHHHHHHSSCSSCCSSHH----HHHHHHHHHHCCCCHHHHHHHCTTC--CCCCCCCCCCHHHHSCTTCCHHHHHHH
T ss_pred hHHHHHHHHHhCCCCCCCCChH----HHHHHHHHHhCCCCHHHHHHhCcccccccCCccCcccHHhhCCCCCCHHHHHHH
Confidence 9999999999999999643211 11111111100000 000111111111222222233445677899999
Q ss_pred HHhcCCCCCCCCChhhhhcC
Q 038766 280 LVCTSSNPEDRPNMNELLIT 299 (299)
Q Consensus 280 ~~~l~~dP~~Rpt~~~il~~ 299 (299)
.+||..||++|||+.|+|+|
T Consensus 303 ~~~L~~dP~~R~t~~e~l~h 322 (383)
T 3eb0_A 303 EQILRYEPDLRINPYEAMAH 322 (383)
T ss_dssp HHHCCSSGGGSCCHHHHHTS
T ss_pred HHHccCChhhCCCHHHHhcC
Confidence 99999999999999999987
|
| >2y7j_A Phosphorylase B kinase gamma catalytic chain, testis/liver isoform; transferase; HET: B49; 2.50A {Homo sapiens} PDB: 1h0t_A 1lp1_B 1q2n_A 2spz_A 3mzw_B* 1ss1_A 2jwd_A 1bdc_A 1bdd_A 1fc2_C* 2b87_A 2b88_A 1h0t_B 1lp1_A 2b87_B 2b89_A 3s1k_A | Back alignment and structure |
|---|
Probab=100.00 E-value=8.8e-45 Score=313.83 Aligned_cols=258 Identities=22% Similarity=0.337 Sum_probs=204.5
Q ss_pred HHHHhCCCCCCceeecCCcceEEEEEeC-CCcEEEEEEeccCcCC------hhhhHHHHHHHHHHHhc-CCcceeeeeeE
Q 038766 7 IENATGSFSENNIIGNSNLSTVYKGRLE-DGEIVAVKKLNFHQFS------AESDKSFYREAKTLKEL-KHRNLVKVLGY 78 (299)
Q Consensus 7 ~~~~~~~y~~~~~lg~g~~~~v~~~~~~-~~~~~~vK~~~~~~~~------~~~~~~~~~e~~~l~~l-~h~~i~~~~~~ 78 (299)
...+.++|.+.+.||+|++|.||+|.+. +|+.||||++...... ....+.+.+|+.+++.+ .||||++++++
T Consensus 89 ~~~~~~~y~~~~~lg~G~~g~Vy~a~~~~~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~ 168 (365)
T 2y7j_A 89 AKEFYQKYDPKDVIGRGVSSVVRRCVHRATGHEFAVKIMEVTAERLSPEQLEEVREATRRETHILRQVAGHPHIITLIDS 168 (365)
T ss_dssp HHHHHHHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEETTSSCCCHHHHHHHHHHHHHHHHHHHHHTTCTTBCCEEEE
T ss_pred hhhhhhhcccceEEecCCCEEEEEEEECCCCcEEEEEEEEccccccCHHHHHHHHHHHHHHHHHHHHhcCCCCEeEEEEE
Confidence 3456688999999999999999999875 6999999998754321 12245678899999999 79999999996
Q ss_pred EEcCCCeeEEEEeecCCCChHHHhcCCCCCCCCCChhhHHHHHHHHHHHHHHhhcCCCCCeeeecccCCceeeCCCCcEE
Q 038766 79 AWESGKLKALILEYMENGSLESVIHGPGVDHSRWTLPKRIDVLISVANGLDYLHSGYDIPIVHCDMKPSNILLDRDFEAH 158 (299)
Q Consensus 79 ~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lh~~~~~~~~H~dl~~~nil~~~~~~v~ 158 (299)
+.. ....++|+||+.+++|.+++. ....+++..++.++.|++.||.|||+. +++|+||||+||+++.+|.++
T Consensus 169 ~~~-~~~~~lv~e~~~g~~L~~~l~----~~~~l~~~~~~~i~~qi~~~L~~LH~~---gi~H~Dlkp~NIl~~~~~~ik 240 (365)
T 2y7j_A 169 YES-SSFMFLVFDLMRKGELFDYLT----EKVALSEKETRSIMRSLLEAVSFLHAN---NIVHRDLKPENILLDDNMQIR 240 (365)
T ss_dssp EEB-SSEEEEEECCCTTCBHHHHHH----HHSSCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEECTTCCEE
T ss_pred Eee-CCEEEEEEEeCCCCcHHHHHH----hcCCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHEEECCCCCEE
Confidence 654 566799999999999999986 445799999999999999999999999 999999999999999999999
Q ss_pred EeeeccccccccccccccccccccccCcccCChhhhccc------CcCccccchhhhHHHHHHHhCCCCCCCCccCCCCc
Q 038766 159 VSDFGTSRMLDVHLQDLSSLSTAFQGTIGYLAPEFAYMR------IVTTKVDVFSFGIVVMEFLTKRRPTGLDEENGLSP 232 (299)
Q Consensus 159 l~df~~~~~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~------~~~~~~DiwslG~~l~~l~~g~~p~~~~~~~~~~~ 232 (299)
|+|||++..+.. ........+++.|+|||++.+. .++.++|||||||++|+|++|..||.... .
T Consensus 241 l~DfG~~~~~~~-----~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~Di~slG~il~ell~g~~pf~~~~-----~ 310 (365)
T 2y7j_A 241 LSDFGFSCHLEP-----GEKLRELCGTPGYLAPEILKCSMDETHPGYGKEVDLWACGVILFTLLAGSPPFWHRR-----Q 310 (365)
T ss_dssp ECCCTTCEECCT-----TCCBCCCCSCGGGCCHHHHHHTTCTTSCCBCTTHHHHHHHHHHHHHHHSSCSSCCSS-----H
T ss_pred EEecCcccccCC-----CcccccCCCCCCccChhhccccccccCcCCCchhhHHhHHHHHHHHHHCCCCCCCCC-----H
Confidence 999999876542 1223445689999999988643 57889999999999999999999995431 1
Q ss_pred hhHHHHHHHHHhcCccCcccccCccccchhhHhHHHHHHHHHHHHHHHHhcCCCCCCCCChhhhhcC
Q 038766 233 ISLRQLVEKALANGINGVRQITDPKLVSSIYEEQEQHQVLEELFKLALVCTSSNPEDRPNMNELLIT 299 (299)
Q Consensus 233 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rpt~~~il~~ 299 (299)
. ..+........ . .. .......+..+.++|.+||..||++|||++++|+|
T Consensus 311 ~---~~~~~i~~~~~-~---~~----------~~~~~~~~~~~~~li~~~L~~dP~~Rps~~ell~h 360 (365)
T 2y7j_A 311 I---LMLRMIMEGQY-Q---FS----------SPEWDDRSSTVKDLISRLLQVDPEARLTAEQALQH 360 (365)
T ss_dssp H---HHHHHHHHTCC-C---CC----------HHHHSSSCHHHHHHHHHHSCSSTTTSCCHHHHHHS
T ss_pred H---HHHHHHHhCCC-C---CC----------CcccccCCHHHHHHHHHHcCCChhHCcCHHHHhcC
Confidence 1 11111111110 0 00 00112345679999999999999999999999987
|
| >3kfa_A Tyrosine-protein kinase ABL1; CML, drug resistance, inhibitor, ATP-binding, nucleotide-binding, oncogene, TRAN; HET: B91; 1.22A {Mus musculus} SCOP: d.144.1.7 PDB: 2qoh_A* 3kf4_A* 3k5v_A* 1fpu_A* 1m52_A* 1iep_A* 2hzn_A* 1opj_A* 3ms9_A* 3mss_A* 3ik3_A* 2z60_A* 2e2b_A* 3pyy_A* 3oxz_A* 2g1t_A* 3ue4_A* 3oy3_A* 2hiw_A* 2v7a_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=4.1e-46 Score=312.16 Aligned_cols=258 Identities=25% Similarity=0.364 Sum_probs=208.6
Q ss_pred hHHHHHHhCCCCCCceeecCCcceEEEEEeC-CCcEEEEEEeccCcCChhhhHHHHHHHHHHHhcCCcceeeeeeEEEcC
Q 038766 4 RTEIENATGSFSENNIIGNSNLSTVYKGRLE-DGEIVAVKKLNFHQFSAESDKSFYREAKTLKELKHRNLVKVLGYAWES 82 (299)
Q Consensus 4 ~~~~~~~~~~y~~~~~lg~g~~~~v~~~~~~-~~~~~~vK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~ 82 (299)
+++++...++|.+.+.||+|++|+||++.+. ++..||+|++.. .....+.+.+|+..++.++||||+++++++..
T Consensus 5 ~~~~~~~~~~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~---~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~- 80 (288)
T 3kfa_A 5 YDKWEMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKE---DTMEVEEFLKEAAVMKEIKHPNLVQLLGVCTR- 80 (288)
T ss_dssp CCTTBCCGGGEEEEEESGGGTTCSEEEEEEGGGTEEEEEEEECS---CSTHHHHHHHHHHHHHHCCCTTBCCEEEEECS-
T ss_pred hhcccccccceeEEeecCCCCceeEEEeEecCCCEEEEEEecCc---CHHHHHHHHHHHHHHHhCCCCCEeeEEEEEcc-
Confidence 4577888999999999999999999999875 488999999863 33456788899999999999999999996654
Q ss_pred CCeeEEEEeecCCCChHHHhcCCCCCCCCCChhhHHHHHHHHHHHHHHhhcCCCCCeeeecccCCceeeCCCCcEEEeee
Q 038766 83 GKLKALILEYMENGSLESVIHGPGVDHSRWTLPKRIDVLISVANGLDYLHSGYDIPIVHCDMKPSNILLDRDFEAHVSDF 162 (299)
Q Consensus 83 ~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lh~~~~~~~~H~dl~~~nil~~~~~~v~l~df 162 (299)
+...++|+|++.+++|.+++... ....+++..++.++.|++.||.+||+. +++|+||||+||+++.++.++|+||
T Consensus 81 ~~~~~~v~e~~~~~~L~~~~~~~--~~~~~~~~~~~~i~~~i~~~l~~lH~~---~i~H~dikp~Nil~~~~~~~~l~Df 155 (288)
T 3kfa_A 81 EPPFYIITEFMTYGNLLDYLREC--NRQEVSAVVLLYMATQISSAMEYLEKK---NFIHRDLAARNCLVGENHLVKVADF 155 (288)
T ss_dssp SSSEEEEEECCTTEEHHHHHHHC--CTTTSCHHHHHHHHHHHHHHHHHHHHH---TCCCSCCSGGGEEECGGGCEEECCC
T ss_pred CCCEEEEEEcCCCCcHHHHHHhc--ccCCccHhHHHHHHHHHHHHHHHHHHC---CccCCCCCcceEEEcCCCCEEEccC
Confidence 55569999999999999998643 345689999999999999999999999 9999999999999999999999999
Q ss_pred ccccccccccccccccccccccCcccCChhhhcccCcCccccchhhhHHHHHHHh-CCCCCCCCccCCCCchhHHHHHHH
Q 038766 163 GTSRMLDVHLQDLSSLSTAFQGTIGYLAPEFAYMRIVTTKVDVFSFGIVVMEFLT-KRRPTGLDEENGLSPISLRQLVEK 241 (299)
Q Consensus 163 ~~~~~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~DiwslG~~l~~l~~-g~~p~~~~~~~~~~~~~~~~~~~~ 241 (299)
|++..... ..........+++.|+|||.+.+..++.++||||||+++|+|++ |..||... ........+..
T Consensus 156 g~~~~~~~---~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~ll~~g~~p~~~~-----~~~~~~~~~~~ 227 (288)
T 3kfa_A 156 GLSRLMTG---DTYTAHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGI-----DLSQVYELLEK 227 (288)
T ss_dssp CGGGTSCS---SSSEEETTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTC-----CGGGHHHHHHT
T ss_pred ccceeccC---CccccccCCccccCcCChhhhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCC-----CHHHHHHHHhc
Confidence 99976542 11222334456788999999999999999999999999999999 88888543 22222222211
Q ss_pred HHhcCccCcccccCccccchhhHhHHHHHHHHHHHHHHHHhcCCCCCCCCChhhhhc
Q 038766 242 ALANGINGVRQITDPKLVSSIYEEQEQHQVLEELFKLALVCTSSNPEDRPNMNELLI 298 (299)
Q Consensus 242 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rpt~~~il~ 298 (299)
.. .... +..++..+.+++++||..||++|||++++++
T Consensus 228 ---~~-----~~~~------------~~~~~~~l~~li~~~l~~dp~~Rps~~~~~~ 264 (288)
T 3kfa_A 228 ---DY-----RMER------------PEGCPEKVYELMRACWQWNPSDRPSFAEIHQ 264 (288)
T ss_dssp ---TC-----CCCC------------CTTCCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred ---cC-----CCCC------------CCCCCHHHHHHHHHHhCCChhhCcCHHHHHH
Confidence 00 0000 1233467999999999999999999999975
|
| >1x8b_A WEE1HU, WEE1-like protein kinase; cell cycle, transferase; HET: 824; 1.81A {Homo sapiens} PDB: 3bi6_A* 3biz_A* 3cqe_A* 3cr0_A* 2in6_A* 2io6_A* 2z2w_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-45 Score=307.91 Aligned_cols=251 Identities=24% Similarity=0.316 Sum_probs=200.7
Q ss_pred HHhCCCCCCceeecCCcceEEEEEeC-CCcEEEEEEeccCcCChhhhHHHHHHHHHHHhc-CCcceeeeeeEEEcCCCee
Q 038766 9 NATGSFSENNIIGNSNLSTVYKGRLE-DGEIVAVKKLNFHQFSAESDKSFYREAKTLKEL-KHRNLVKVLGYAWESGKLK 86 (299)
Q Consensus 9 ~~~~~y~~~~~lg~g~~~~v~~~~~~-~~~~~~vK~~~~~~~~~~~~~~~~~e~~~l~~l-~h~~i~~~~~~~~~~~~~~ 86 (299)
...++|.+.+.||+|++|+||++.+. +++.||+|++............+.+|+..+..+ +||||+++++++.. ....
T Consensus 8 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~~~~l~~h~~iv~~~~~~~~-~~~~ 86 (289)
T 1x8b_A 8 RYTTEFHELEKIGSGEFGSVFKCVKRLDGCIYAIKRSKKPLAGSVDEQNALREVYAHAVLGQHSHVVRYFSAWAE-DDHM 86 (289)
T ss_dssp HHHHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCCTTSHHHHHHHHHHHHHHHSCSCTTBCCEEEEEEE-TTEE
T ss_pred cccchhhhhhhhcCCCceEEEEEEEcCCCceEEEEEecccccccHHHHHHHHHHHHHHHhCCCCCeeeeeeeeec-CCeE
Confidence 35678999999999999999999875 699999999986655566677888999999999 89999999997665 4566
Q ss_pred EEEEeecCCCChHHHhcCCCCCCCCCChhhHHHHHHHHHHHHHHhhcCCCCCeeeecccCCceeeCCC------------
Q 038766 87 ALILEYMENGSLESVIHGPGVDHSRWTLPKRIDVLISVANGLDYLHSGYDIPIVHCDMKPSNILLDRD------------ 154 (299)
Q Consensus 87 ~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lh~~~~~~~~H~dl~~~nil~~~~------------ 154 (299)
++|+||+++++|.+++.........+++..++.++.|++.||+|||++ +++|+||||+||+++.+
T Consensus 87 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~al~~lH~~---~ivH~Dikp~NIl~~~~~~~~~~~~~~~~ 163 (289)
T 1x8b_A 87 LIQNEYCNGGSLADAISENYRIMSYFKEAELKDLLLQVGRGLRYIHSM---SLVHMDIKPSNIFISRTSIPNAASEEGDE 163 (289)
T ss_dssp EEEEECCTTCBHHHHHHHHHHHTCCCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEEC--------------
T ss_pred EEEEEecCCCcHHHHHHhhcccccCCCHHHHHHHHHHHHHHHHHHHhC---CEeecCCCHHHEEEcCCCCCccccccccc
Confidence 999999999999999864321235789999999999999999999999 99999999999999844
Q ss_pred -------CcEEEeeeccccccccccccccccccccccCcccCChhhhccc-CcCccccchhhhHHHHHHHhCCCCCCCCc
Q 038766 155 -------FEAHVSDFGTSRMLDVHLQDLSSLSTAFQGTIGYLAPEFAYMR-IVTTKVDVFSFGIVVMEFLTKRRPTGLDE 226 (299)
Q Consensus 155 -------~~v~l~df~~~~~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~-~~~~~~DiwslG~~l~~l~~g~~p~~~~~ 226 (299)
..++|+|||.+..... .....+++.|+|||.+.+. .++.++||||||+++|+|++|..++...
T Consensus 164 ~~~~~~~~~~kl~Dfg~~~~~~~--------~~~~~gt~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~~~~~~~~~- 234 (289)
T 1x8b_A 164 DDWASNKVMFKIGDLGHVTRISS--------PQVEEGDSRFLANEVLQENYTHLPKADIFALALTVVCAAGAEPLPRNG- 234 (289)
T ss_dssp ------CCCEEECCCTTCEETTC--------SCCCCCCGGGCCHHHHTTCCTTHHHHHHHHHHHHHHHHTTCCCCCSSS-
T ss_pred ccccCCceEEEEcccccccccCC--------ccccCCCccccChhHhcCCCCCCchhhHHHHHHHHHHHhcCCCCCcch-
Confidence 4799999999876442 1223478999999998876 5668999999999999999998775322
Q ss_pred cCCCCchhHHHHHHHHHhcCccCcccccCccccchhhHhHHHHHHHHHHHHHHHHhcCCCCCCCCChhhhhcC
Q 038766 227 ENGLSPISLRQLVEKALANGINGVRQITDPKLVSSIYEEQEQHQVLEELFKLALVCTSSNPEDRPNMNELLIT 299 (299)
Q Consensus 227 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rpt~~~il~~ 299 (299)
........... ..+ +..++.++.++|.+||..||++|||++++++|
T Consensus 235 ----------~~~~~~~~~~~---~~~--------------~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~h 280 (289)
T 1x8b_A 235 ----------DQWHEIRQGRL---PRI--------------PQVLSQEFTELLKVMIHPDPERRPSAMALVKH 280 (289)
T ss_dssp ----------HHHHHHHTTCC---CCC--------------SSCCCHHHHHHHHHHTCSSGGGSCCHHHHHTC
T ss_pred ----------hHHHHHHcCCC---CCC--------------CcccCHHHHHHHHHHhCCCcccCCCHHHHhhC
Confidence 11111111111 000 11235679999999999999999999999987
|
| >2xir_A Vascular endothelial growth factor receptor 2; angiogenesis, nucleotide-binding, inhibitor, phosphorylation receptor, transferase, transmembrane; HET: 00J; 1.50A {Homo sapiens} PDB: 1vr2_A* 1ywn_A* 3vnt_A* 3c7q_A* 2oh4_A* 3u6j_A* 3efl_A* 2p2i_A* 3cjf_A* 3cjg_A* 3ewh_A* 2qu5_A* 2qu6_A* 2rl5_A* 3b8q_A* 3b8r_A* 2p2h_A* 3cp9_A* 3cpb_A* 3cpc_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=2.1e-45 Score=311.79 Aligned_cols=268 Identities=22% Similarity=0.329 Sum_probs=211.5
Q ss_pred CChHHHHHHhCCCCCCceeecCCcceEEEEEe------CCCcEEEEEEeccCcCChhhhHHHHHHHHHHHhc-CCcceee
Q 038766 2 FDRTEIENATGSFSENNIIGNSNLSTVYKGRL------EDGEIVAVKKLNFHQFSAESDKSFYREAKTLKEL-KHRNLVK 74 (299)
Q Consensus 2 ~~~~~~~~~~~~y~~~~~lg~g~~~~v~~~~~------~~~~~~~vK~~~~~~~~~~~~~~~~~e~~~l~~l-~h~~i~~ 74 (299)
++..+++...++|++.+.||+|+||+||+|.+ .+++.||+|++... ........+.+|+..++.+ +||||++
T Consensus 17 ~~~~~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~-~~~~~~~~~~~E~~~l~~l~~hp~iv~ 95 (316)
T 2xir_A 17 YDASKWEFPRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEG-ATHSEHRALMSELKILIHIGHHLNVVN 95 (316)
T ss_dssp CCHHHHBCCGGGEEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTT-CCHHHHHHHHHHHHHHHHHCCCTTBCC
T ss_pred ccccceecchhheeeeeEEcCCCceeEEEEEEecCCccccceEEEEEecccC-CCcHHHHHHHHHHHHHHhcccCCCeee
Confidence 55667888889999999999999999999974 34688999998643 3444566788999999999 6899999
Q ss_pred eeeEEEcCCCeeEEEEeecCCCChHHHhcCCCCC------------CCCCChhhHHHHHHHHHHHHHHhhcCCCCCeeee
Q 038766 75 VLGYAWESGKLKALILEYMENGSLESVIHGPGVD------------HSRWTLPKRIDVLISVANGLDYLHSGYDIPIVHC 142 (299)
Q Consensus 75 ~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~------------~~~~~~~~~~~i~~qi~~~l~~lh~~~~~~~~H~ 142 (299)
+++++...+...++|+||+.+++|.+++...... ...+++..++.++.|++.||.|||+. +++|+
T Consensus 96 ~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~---~i~H~ 172 (316)
T 2xir_A 96 LLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLASR---KCIHR 172 (316)
T ss_dssp EEEEECCTTSCCEEEEECCTTEEHHHHHHTCTTSEECC-------CTTCEEHHHHHHHHHHHHHHHHHHHHT---TCCCS
T ss_pred EEEEEecCCCceEEEEEcCCCCcHHHHHHhcccccccccccchhhhccccCHHHHHHHHHHHHHHHHHHHhC---Ccccc
Confidence 9998877666679999999999999999754321 22389999999999999999999999 99999
Q ss_pred cccCCceeeCCCCcEEEeeeccccccccccccccccccccccCcccCChhhhcccCcCccccchhhhHHHHHHHh-CCCC
Q 038766 143 DMKPSNILLDRDFEAHVSDFGTSRMLDVHLQDLSSLSTAFQGTIGYLAPEFAYMRIVTTKVDVFSFGIVVMEFLT-KRRP 221 (299)
Q Consensus 143 dl~~~nil~~~~~~v~l~df~~~~~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~DiwslG~~l~~l~~-g~~p 221 (299)
||||+||+++.++.++|+|||++....... .........+++.|+|||++.+..++.++||||||+++|+|++ |..|
T Consensus 173 dikp~Nil~~~~~~~kl~Dfg~~~~~~~~~--~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~~l~t~g~~p 250 (316)
T 2xir_A 173 DLAARNILLSEKNVVKICDFGLARDIYKDP--DYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASP 250 (316)
T ss_dssp CCSGGGEEECGGGCEEECCCGGGSCTTTCT--TSEEETTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCS
T ss_pred cCccceEEECCCCCEEECCCccccccccCc--cceeccCCCcceeecCchhhccccccchhHHHHHHHHHHHHHhCCCCC
Confidence 999999999999999999999997654211 1122234456789999999999999999999999999999998 9999
Q ss_pred CCCCccCCCCchhHHHHHHHHHhcCccCcccccCccccchhhHhHHHHHHHHHHHHHHHHhcCCCCCCCCChhhhhcC
Q 038766 222 TGLDEENGLSPISLRQLVEKALANGINGVRQITDPKLVSSIYEEQEQHQVLEELFKLALVCTSSNPEDRPNMNELLIT 299 (299)
Q Consensus 222 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rpt~~~il~~ 299 (299)
|...... ..+.. ......... . +..++..+.+++.+||..||.+|||++++++|
T Consensus 251 ~~~~~~~----~~~~~---~~~~~~~~~-----~------------~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~ 304 (316)
T 2xir_A 251 YPGVKID----EEFCR---RLKEGTRMR-----A------------PDYTTPEMYQTMLDCWHGEPSQRPTFSELVEH 304 (316)
T ss_dssp STTCCCS----HHHHH---HHHHTCCCC-----C------------CTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred Ccccchh----HHHHH---HhccCccCC-----C------------CCCCCHHHHHHHHHHcCCChhhCcCHHHHHHH
Confidence 8543211 11111 111111000 0 11234579999999999999999999999864
|
| >2ac3_A MAP kinase-interacting serine/threonine kinase 2; DFD motif, transferase; 2.10A {Homo sapiens} PDB: 2hw7_A* 2ac5_A* 2hw6_A | Back alignment and structure |
|---|
Probab=100.00 E-value=6.8e-45 Score=308.69 Aligned_cols=266 Identities=20% Similarity=0.259 Sum_probs=198.8
Q ss_pred HhCCCCCC-ceeecCCcceEEEEEe-CCCcEEEEEEeccCcCChhhhHHHHHHHHHHHhc-CCcceeeeeeEEEcCCCee
Q 038766 10 ATGSFSEN-NIIGNSNLSTVYKGRL-EDGEIVAVKKLNFHQFSAESDKSFYREAKTLKEL-KHRNLVKVLGYAWESGKLK 86 (299)
Q Consensus 10 ~~~~y~~~-~~lg~g~~~~v~~~~~-~~~~~~~vK~~~~~~~~~~~~~~~~~e~~~l~~l-~h~~i~~~~~~~~~~~~~~ 86 (299)
+.++|.+. +.||+|+||+||++.+ .+++.||+|++... .......+.+|+..++++ +||||+++++++.. ++..
T Consensus 10 ~~~~y~i~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~~~~h~~i~~~~~~~~~-~~~~ 86 (316)
T 2ac3_A 10 FEDVYQLQEDVLGEGAHARVQTCINLITSQEYAVKIIEKQ--PGHIRSRVFREVEMLYQCQGHRNVLELIEFFEE-EDRF 86 (316)
T ss_dssp TTTSCEECCCCCCCCSSEEEEEEECSSSCCEEEEEEEECC--SSCCHHHHHHHHHHHHHTCCCTTBCCEEEEEEE-TTEE
T ss_pred cceeEEecCceecCCceEEEEEEEEcCCCcEEEEEEEeeC--cchhHHHHHHHHHHHHHhcCCCCeeeEEEEEee-CCEE
Confidence 45788885 7899999999999986 46899999998643 334567888999999985 69999999997665 5566
Q ss_pred EEEEeecCCCChHHHhcCCCCCCCCCChhhHHHHHHHHHHHHHHhhcCCCCCeeeecccCCceeeCCCCc---EEEeeec
Q 038766 87 ALILEYMENGSLESVIHGPGVDHSRWTLPKRIDVLISVANGLDYLHSGYDIPIVHCDMKPSNILLDRDFE---AHVSDFG 163 (299)
Q Consensus 87 ~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lh~~~~~~~~H~dl~~~nil~~~~~~---v~l~df~ 163 (299)
++|+||+.+++|.+++. ....+++..++.++.|++.||+|||++ +++|+||||+||+++.++. ++|+|||
T Consensus 87 ~lv~e~~~~~~L~~~l~----~~~~~~~~~~~~i~~qi~~~l~~lH~~---~ivH~dlkp~Nil~~~~~~~~~~kl~Dfg 159 (316)
T 2ac3_A 87 YLVFEKMRGGSILSHIH----KRRHFNELEASVVVQDVASALDFLHNK---GIAHRDLKPENILCEHPNQVSPVKICDFD 159 (316)
T ss_dssp EEEEECCTTCBHHHHHH----HHSSCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEESCSSSSCSEEECCTT
T ss_pred EEEEEcCCCCcHHHHHh----ccCCCCHHHHHHHHHHHHHHHHHHHhC---CceeCCCCHHHEEEccCCCcCceEEEEcc
Confidence 99999999999999987 445799999999999999999999999 9999999999999998776 9999999
Q ss_pred ccccccccccc---ccccccccccCcccCChhhhcc-----cCcCccccchhhhHHHHHHHhCCCCCCCCccCCCCch--
Q 038766 164 TSRMLDVHLQD---LSSLSTAFQGTIGYLAPEFAYM-----RIVTTKVDVFSFGIVVMEFLTKRRPTGLDEENGLSPI-- 233 (299)
Q Consensus 164 ~~~~~~~~~~~---~~~~~~~~~~~~~y~~PE~~~~-----~~~~~~~DiwslG~~l~~l~~g~~p~~~~~~~~~~~~-- 233 (299)
++......... .........+++.|+|||++.+ ..++.++|||||||++|+|++|..||...........
T Consensus 160 ~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~ 239 (316)
T 2ac3_A 160 LGSGIKLNGDCSPISTPELLTPCGSAEYMAPEVVEAFSEEASIYDKRCDLWSLGVILYILLSGYPPFVGRCGSDCGWDRG 239 (316)
T ss_dssp CCC-------------------CCSGGGCCHHHHHHTSHHHHHHTTTHHHHHHHHHHHHHHHSSCSCCCCCCSCSCC---
T ss_pred CccccccCCccccccccccccccCCcCccChHHhhcccccccCCCcccccHhHHHHHHHHHHCCCCCccccccccccccc
Confidence 98754321110 0111223458899999999875 5588999999999999999999999975533221100
Q ss_pred -----hHHHHHHHHHhcCccCcccccCccccchhhHhHHHHHHHHHHHHHHHHhcCCCCCCCCChhhhhcC
Q 038766 234 -----SLRQLVEKALANGINGVRQITDPKLVSSIYEEQEQHQVLEELFKLALVCTSSNPEDRPNMNELLIT 299 (299)
Q Consensus 234 -----~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rpt~~~il~~ 299 (299)
........... .... .. ......++..+.+||++||..||++|||++|+|+|
T Consensus 240 ~~~~~~~~~~~~~i~~-~~~~---~~----------~~~~~~~~~~~~~li~~~L~~dP~~Rps~~e~l~h 296 (316)
T 2ac3_A 240 EACPACQNMLFESIQE-GKYE---FP----------DKDWAHISCAAKDLISKLLVRDAKQRLSAAQVLQH 296 (316)
T ss_dssp -CCHHHHHHHHHHHHH-CCCC---CC----------HHHHTTSCHHHHHHHHHHSCSSTTTSCCHHHHHHS
T ss_pred ccchhHHHHHHHHHhc-cCcc---cC----------chhcccCCHHHHHHHHHHhhCChhhCCCHHHHhcC
Confidence 01111111111 1000 00 00122356789999999999999999999999987
|
| >3kmu_A ILK, integrin-linked kinase; cell adhesion, ANK repeat, ATP-binding, cell junction, cell membrane, integrin-binding protein, membrane, nucleotide- binding; 1.80A {Homo sapiens} SCOP: d.144.1.0 PDB: 3kmw_A* 3rep_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.9e-45 Score=302.72 Aligned_cols=252 Identities=21% Similarity=0.348 Sum_probs=203.7
Q ss_pred HHHhCCCCCCceeecCCcceEEEEEeCCCcEEEEEEeccCcCChhhhHHHHHHHHHHHhcCCcceeeeeeEEEcC-CCee
Q 038766 8 ENATGSFSENNIIGNSNLSTVYKGRLEDGEIVAVKKLNFHQFSAESDKSFYREAKTLKELKHRNLVKVLGYAWES-GKLK 86 (299)
Q Consensus 8 ~~~~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~vK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~-~~~~ 86 (299)
+...++|.+.+.||+|++|+||++.+. ++.+|+|++..........+.+.+|+..++.++||||+++++++... +...
T Consensus 6 ~i~~~~y~~~~~lg~G~~g~V~~~~~~-~~~~avK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~ 84 (271)
T 3kmu_A 6 GIDFKQLNFLTKLNENHSGELWKGRWQ-GNDIVVKVLKVRDWSTRKSRDFNEECPRLRIFSHPNVLPVLGACQSPPAPHP 84 (271)
T ss_dssp CCCGGGCEEEEEEEEETTEEEEEEEET-TEEEEEEEECCTTCCHHHHHHHHHHGGGGCCCSCTTEECEEEEECTTTSSSC
T ss_pred CCCHHHhHHHHHhcCCCcceEEEEEEC-CeeEEEEEecccccCHHHHHHHHHHHHHHHhcCCCchhheEEEEccCCCCCe
Confidence 345688999999999999999999986 88999999987666677778899999999999999999999977654 2566
Q ss_pred EEEEeecCCCChHHHhcCCCCCCCCCChhhHHHHHHHHHHHHHHhhcCCCCC--eeeecccCCceeeCCCCcEEEeeecc
Q 038766 87 ALILEYMENGSLESVIHGPGVDHSRWTLPKRIDVLISVANGLDYLHSGYDIP--IVHCDMKPSNILLDRDFEAHVSDFGT 164 (299)
Q Consensus 87 ~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lh~~~~~~--~~H~dl~~~nil~~~~~~v~l~df~~ 164 (299)
++|+||+.+++|.+++... ....+++..++.++.|++.||+|||+. + ++|+||||+||+++.++.++++||++
T Consensus 85 ~lv~e~~~~~~L~~~l~~~--~~~~~~~~~~~~i~~qi~~~l~~lH~~---~~~i~H~dikp~Nil~~~~~~~~l~~~~~ 159 (271)
T 3kmu_A 85 TLITHWMPYGSLYNVLHEG--TNFVVDQSQAVKFALDMARGMAFLHTL---EPLIPRHALNSRSVMIDEDMTARISMADV 159 (271)
T ss_dssp EEEEECCTTCBHHHHHHSC--SSCCCCHHHHHHHHHHHHHHHHHHTTS---SSCCTTCCCSGGGEEECTTSCEEEEGGGS
T ss_pred EeeecccCCCcHHHHHhhc--ccCCCCHHHHHHHHHHHHHHHHHHhcC---CCceecCCCccceEEEcCCcceeEEeccc
Confidence 9999999999999999743 233689999999999999999999998 8 99999999999999999999999987
Q ss_pred ccccccccccccccccccccCcccCChhhhcccCcCc---cccchhhhHHHHHHHhCCCCCCCCccCCCCchhHHHHHHH
Q 038766 165 SRMLDVHLQDLSSLSTAFQGTIGYLAPEFAYMRIVTT---KVDVFSFGIVVMEFLTKRRPTGLDEENGLSPISLRQLVEK 241 (299)
Q Consensus 165 ~~~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~---~~DiwslG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~ 241 (299)
..... .....+++.|+|||.+.+..++. ++||||||+++|+|++|..||... .. ......
T Consensus 160 ~~~~~---------~~~~~~t~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~-----~~---~~~~~~ 222 (271)
T 3kmu_A 160 KFSFQ---------SPGRMYAPAWVAPEALQKKPEDTNRRSADMWSFAVLLWELVTREVPFADL-----SN---MEIGMK 222 (271)
T ss_dssp CCTTS---------CTTCBSCGGGSCHHHHHSCGGGSCHHHHHHHHHHHHHHHHHHCSCTTTTS-----CH---HHHHHH
T ss_pred eeeec---------ccCccCCccccChhhhccCCCCCCCchhhHHHHHHHHHHHHhCCCCcccc-----Ch---HHHHHH
Confidence 65422 23345789999999988765554 799999999999999999999532 11 111122
Q ss_pred HHhcCccCcccccCccccchhhHhHHHHHHHHHHHHHHHHhcCCCCCCCCChhhhhc
Q 038766 242 ALANGINGVRQITDPKLVSSIYEEQEQHQVLEELFKLALVCTSSNPEDRPNMNELLI 298 (299)
Q Consensus 242 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rpt~~~il~ 298 (299)
........ .+ +..++.++.+++.+||..||++|||++++++
T Consensus 223 ~~~~~~~~--~~--------------~~~~~~~~~~li~~~l~~~p~~Rps~~~il~ 263 (271)
T 3kmu_A 223 VALEGLRP--TI--------------PPGISPHVSKLMKICMNEDPAKRPKFDMIVP 263 (271)
T ss_dssp HHHSCCCC--CC--------------CTTCCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred HHhcCCCC--CC--------------CCCCCHHHHHHHHHHcCCChhhCcCHHHHHH
Confidence 22111100 00 1234567999999999999999999999985
|
| >2jam_A Calcium/calmodulin-dependent protein kinase type 1G; transferase, kinase, membrane, ATP-binding, prenylation, serine/threonine-protein kinase, alternative splicing; HET: J60; 1.7A {Homo sapiens} PDB: 2jc6_A* 1a06_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2e-45 Score=310.37 Aligned_cols=254 Identities=24% Similarity=0.344 Sum_probs=202.0
Q ss_pred HHHhCCCCCCceeecCCcceEEEEEeC-CCcEEEEEEeccCcCChhhhHHHHHHHHHHHhcCCcceeeeeeEEEcCCCee
Q 038766 8 ENATGSFSENNIIGNSNLSTVYKGRLE-DGEIVAVKKLNFHQFSAESDKSFYREAKTLKELKHRNLVKVLGYAWESGKLK 86 (299)
Q Consensus 8 ~~~~~~y~~~~~lg~g~~~~v~~~~~~-~~~~~~vK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~ 86 (299)
..+.++|.+.+.||+|++|+||++.+. +|+.||+|++.... ......+.+|+..++.++||||+++++++.. +...
T Consensus 5 ~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~--~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~-~~~~ 81 (304)
T 2jam_A 5 TNIRKTFIFMEVLGSGAFSEVFLVKQRLTGKLFALKCIKKSP--AFRDSSLENEIAVLKKIKHENIVTLEDIYES-TTHY 81 (304)
T ss_dssp -CHHHHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEECC--------HHHHHHHHHHHCCCTTBCCEEEEEEC-SSEE
T ss_pred cchhccceeeeeccCCCCceEEEEEECCCCCEEEEEEEeccc--ccchHHHHHHHHHHHhCCCCCeeehhhhccc-CCEE
Confidence 457789999999999999999999875 68999999987432 2334578899999999999999999996655 5566
Q ss_pred EEEEeecCCCChHHHhcCCCCCCCCCChhhHHHHHHHHHHHHHHhhcCCCCCeeeecccCCceee---CCCCcEEEeeec
Q 038766 87 ALILEYMENGSLESVIHGPGVDHSRWTLPKRIDVLISVANGLDYLHSGYDIPIVHCDMKPSNILL---DRDFEAHVSDFG 163 (299)
Q Consensus 87 ~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lh~~~~~~~~H~dl~~~nil~---~~~~~v~l~df~ 163 (299)
++|+|++.+++|.+++. ....+++..++.++.|++.||.|||+. +++|+||||+||++ +.++.++|+|||
T Consensus 82 ~lv~e~~~~~~L~~~l~----~~~~~~~~~~~~~~~qi~~~l~~lH~~---~i~H~dikp~NIl~~~~~~~~~~kl~Dfg 154 (304)
T 2jam_A 82 YLVMQLVSGGELFDRIL----ERGVYTEKDASLVIQQVLSAVKYLHEN---GIVHRDLKPENLLYLTPEENSKIMITDFG 154 (304)
T ss_dssp EEEECCCCSCBHHHHHH----HHSCCCHHHHHHHHHHHHHHHHHHHHT---TCCCCSCCGGGCEESSSSTTCCEEBCSCS
T ss_pred EEEEEcCCCccHHHHHH----HcCCCCHHHHHHHHHHHHHHHHHHHHC---CccccCCCHHHEEEecCCCCCCEEEccCC
Confidence 99999999999999886 345789999999999999999999999 99999999999999 778899999999
Q ss_pred cccccccccccccccccccccCcccCChhhhcccCcCccccchhhhHHHHHHHhCCCCCCCCccCCCCchhHHHHHHHHH
Q 038766 164 TSRMLDVHLQDLSSLSTAFQGTIGYLAPEFAYMRIVTTKVDVFSFGIVVMEFLTKRRPTGLDEENGLSPISLRQLVEKAL 243 (299)
Q Consensus 164 ~~~~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~DiwslG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~ 243 (299)
++.... ........+++.|+|||.+.+..++.++||||||+++|+|++|..||.... .. .......
T Consensus 155 ~~~~~~------~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~-----~~---~~~~~i~ 220 (304)
T 2jam_A 155 LSKMEQ------NGIMSTACGTPGYVAPEVLAQKPYSKAVDCWSIGVITYILLCGYPPFYEET-----ES---KLFEKIK 220 (304)
T ss_dssp TTCCCC------CBTTHHHHSCCCBCCTTTBSSCSCCHHHHHHHHHHHHHHHHHSSCTTTTSC-----HH---HHHHHHH
T ss_pred cceecC------CCccccccCCCCccChHHhccCCCCchhhHHHHHHHHHHHHHCCCCCCCCC-----HH---HHHHHHH
Confidence 986433 112234457899999999999999999999999999999999999995431 11 1222221
Q ss_pred hcCccCcccccCccccchhhHhHHHHHHHHHHHHHHHHhcCCCCCCCCChhhhhcC
Q 038766 244 ANGINGVRQITDPKLVSSIYEEQEQHQVLEELFKLALVCTSSNPEDRPNMNELLIT 299 (299)
Q Consensus 244 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rpt~~~il~~ 299 (299)
.... . ...+ ....++..+.++|.+||..||++|||++++++|
T Consensus 221 ~~~~-~---~~~~----------~~~~~~~~~~~li~~~l~~dp~~Rps~~~~l~h 262 (304)
T 2jam_A 221 EGYY-E---FESP----------FWDDISESAKDFICHLLEKDPNERYTCEKALSH 262 (304)
T ss_dssp HCCC-C---CCTT----------TTTTSCHHHHHHHHHHHCSSTTTSCCHHHHHTS
T ss_pred cCCC-C---CCcc----------ccccCCHHHHHHHHHHcCCChhHCcCHHHHhcC
Confidence 1110 0 0000 012345689999999999999999999999987
|
| >2vd5_A DMPK protein; serine/threonine-protein kinase, kinase, transferase, ATP-BI nucleotide-binding, cardiac contractility, muscle different; HET: BI8; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-45 Score=322.92 Aligned_cols=263 Identities=22% Similarity=0.259 Sum_probs=204.7
Q ss_pred HHHHHHhCCCCCCceeecCCcceEEEEEeC-CCcEEEEEEeccCcC-ChhhhHHHHHHHHHHHhcCCcceeeeeeEEEcC
Q 038766 5 TEIENATGSFSENNIIGNSNLSTVYKGRLE-DGEIVAVKKLNFHQF-SAESDKSFYREAKTLKELKHRNLVKVLGYAWES 82 (299)
Q Consensus 5 ~~~~~~~~~y~~~~~lg~g~~~~v~~~~~~-~~~~~~vK~~~~~~~-~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~ 82 (299)
++.+...++|.+.+.||+|+||.||++.+. +|+.||+|++..... .......+..|..++..++||||+++++++..
T Consensus 54 ~~~~~~~~~f~~~~~lG~G~fG~V~~~~~~~~~~~vAiK~l~k~~~~~~~~~~~~~~E~~il~~~~hp~Iv~l~~~~~~- 132 (412)
T 2vd5_A 54 KEVRLQRDDFEILKVIGRGAFSEVAVVKMKQTGQVYAMKIMNKWDMLKRGEVSCFREERDVLVNGDRRWITQLHFAFQD- 132 (412)
T ss_dssp HHHSCCGGGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHHGGGCCHHHHHHHHHHSCTTTBCCEEEEEEC-
T ss_pred hhccCChhhEEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEeHHHhhhHHHHHHHHHHHHHHHhcCCCCeeeEEEEEee-
Confidence 445566789999999999999999999874 699999999864221 22334567889999999999999999996655
Q ss_pred CCeeEEEEeecCCCChHHHhcCCCCCCCCCChhhHHHHHHHHHHHHHHhhcCCCCCeeeecccCCceeeCCCCcEEEeee
Q 038766 83 GKLKALILEYMENGSLESVIHGPGVDHSRWTLPKRIDVLISVANGLDYLHSGYDIPIVHCDMKPSNILLDRDFEAHVSDF 162 (299)
Q Consensus 83 ~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lh~~~~~~~~H~dl~~~nil~~~~~~v~l~df 162 (299)
...+++||||+.+++|.+++... +..+++..++.++.||+.||.|||+. +++||||||+||+++.+|.+||+||
T Consensus 133 ~~~~~lVmE~~~gg~L~~~l~~~---~~~l~~~~~~~~~~qi~~aL~~LH~~---giiHrDLKp~NILld~~g~vkL~DF 206 (412)
T 2vd5_A 133 ENYLYLVMEYYVGGDLLTLLSKF---GERIPAEMARFYLAEIVMAIDSVHRL---GYVHRDIKPDNILLDRCGHIRLADF 206 (412)
T ss_dssp SSEEEEEECCCCSCBHHHHHHHH---SSCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECTTSCEEECCC
T ss_pred CCEEEEEEcCCCCCcHHHHHHhc---CCCCCHHHHHHHHHHHHHHHHHHHHC---CeeecccCHHHeeecCCCCEEEeec
Confidence 55679999999999999998632 24799999999999999999999999 9999999999999999999999999
Q ss_pred ccccccccccccccccccccccCcccCChhhhc-------ccCcCccccchhhhHHHHHHHhCCCCCCCCccCCCCchhH
Q 038766 163 GTSRMLDVHLQDLSSLSTAFQGTIGYLAPEFAY-------MRIVTTKVDVFSFGIVVMEFLTKRRPTGLDEENGLSPISL 235 (299)
Q Consensus 163 ~~~~~~~~~~~~~~~~~~~~~~~~~y~~PE~~~-------~~~~~~~~DiwslG~~l~~l~~g~~p~~~~~~~~~~~~~~ 235 (299)
|++...... .........+|+.|+|||++. ...++.++|+|||||++|+|++|..||.... ...
T Consensus 207 Gla~~~~~~---~~~~~~~~~Gt~~Y~APE~l~~~~~~~~~~~~~~~~DiwSlGvilyelltG~~Pf~~~~-----~~~- 277 (412)
T 2vd5_A 207 GSCLKLRAD---GTVRSLVAVGTPDYLSPEILQAVGGGPGTGSYGPECDWWALGVFAYEMFYGQTPFYADS-----TAE- 277 (412)
T ss_dssp TTCEECCTT---SCEECSSCCSCGGGCCHHHHHHHHTCTTCSEECTHHHHHHHHHHHHHHHHSSCTTCCSS-----HHH-
T ss_pred hhheeccCC---CccccceeccccCcCCHHHHhhcccCcCCCCCChHHhhhHHhHHHHHHHhCCCCCCCCC-----HHH-
Confidence 999765421 111223457899999999887 3568999999999999999999999995431 111
Q ss_pred HHHHHHHHhcCccCcccccCccccchhhHhHHHHHHHHHHHHHHHHhcCCCCCCC---CChhhhhcC
Q 038766 236 RQLVEKALANGINGVRQITDPKLVSSIYEEQEQHQVLEELFKLALVCTSSNPEDR---PNMNELLIT 299 (299)
Q Consensus 236 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~R---pt~~~il~~ 299 (299)
....+.... .....+. ....++.++.+||++||. +|++| |+++++++|
T Consensus 278 --~~~~i~~~~----~~~~~p~---------~~~~~s~~~~dli~~lL~-~p~~Rlgr~~~~ei~~H 328 (412)
T 2vd5_A 278 --TYGKIVHYK----EHLSLPL---------VDEGVPEEARDFIQRLLC-PPETRLGRGGAGDFRTH 328 (412)
T ss_dssp --HHHHHHTHH----HHCCCC-------------CCCHHHHHHHHTTSS-CGGGCTTTTTHHHHHTS
T ss_pred --HHHHHHhcc----cCcCCCc---------cccCCCHHHHHHHHHHcC-ChhhcCCCCCHHHHhcC
Confidence 111111100 0000000 023456789999999999 99998 599999987
|
| >3tt0_A Basic fibroblast growth factor receptor 1; kinase domain, transferase, transferase-transferase inhibito; HET: 07J; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-45 Score=321.09 Aligned_cols=261 Identities=22% Similarity=0.317 Sum_probs=205.3
Q ss_pred HHHHhCCCCCCceeecCCcceEEEEEeC--------CCcEEEEEEeccCcCChhhhHHHHHHHHHHHhc-CCcceeeeee
Q 038766 7 IENATGSFSENNIIGNSNLSTVYKGRLE--------DGEIVAVKKLNFHQFSAESDKSFYREAKTLKEL-KHRNLVKVLG 77 (299)
Q Consensus 7 ~~~~~~~y~~~~~lg~g~~~~v~~~~~~--------~~~~~~vK~~~~~~~~~~~~~~~~~e~~~l~~l-~h~~i~~~~~ 77 (299)
++...++|.+.+.||+|+||+||+|.+. .+..||+|++... ........+.+|+++++.+ +||||+++++
T Consensus 64 ~~i~~~~y~i~~~LG~G~~g~Vy~a~~~~~~~~~~~~~~~vavK~~~~~-~~~~~~~~~~~E~~~l~~l~~hpnIv~~~~ 142 (382)
T 3tt0_A 64 WELPRDRLVLGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSD-ATEKDLSDLISEMEMMKMIGKHKNIINLLG 142 (382)
T ss_dssp TBCCGGGEEEEEEEEECSSEEEEEEEEETSSTTCTTCEEEEEEEEECTT-CCHHHHHHHHHHHHHHHHHCCCTTBCCEEE
T ss_pred cccchhheEeeeEEecCCCeEEEEEEEccccccccccceEEEEEeeccc-cCHHHHHHHHHHHHHHHHhcCCchhhhhee
Confidence 4566789999999999999999999852 2457999998643 3455567889999999999 8999999999
Q ss_pred EEEcCCCeeEEEEeecCCCChHHHhcCCCC------------CCCCCChhhHHHHHHHHHHHHHHhhcCCCCCeeeeccc
Q 038766 78 YAWESGKLKALILEYMENGSLESVIHGPGV------------DHSRWTLPKRIDVLISVANGLDYLHSGYDIPIVHCDMK 145 (299)
Q Consensus 78 ~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~------------~~~~~~~~~~~~i~~qi~~~l~~lh~~~~~~~~H~dl~ 145 (299)
++.. +...++|+||+.+++|.+++..... ....+++..++.++.|++.||+|||+. +++|+|||
T Consensus 143 ~~~~-~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~---~ivH~Dlk 218 (382)
T 3tt0_A 143 ACTQ-DGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDLVSCAYQVARGMEYLASK---KCIHRDLA 218 (382)
T ss_dssp EECS-SSSCEEEEECCTTCBHHHHHHHTCCSSSSSCCCCCSSCCCCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCC
T ss_pred eecc-CCceEEEEEecCCCcHHHHHHHhcccccccccccccccccccCHHHHHHHHHHHHHHHHHHHhC---CEecCCCC
Confidence 7655 4556999999999999999864321 134699999999999999999999999 99999999
Q ss_pred CCceeeCCCCcEEEeeeccccccccccccccccccccccCcccCChhhhcccCcCccccchhhhHHHHHHHh-CCCCCCC
Q 038766 146 PSNILLDRDFEAHVSDFGTSRMLDVHLQDLSSLSTAFQGTIGYLAPEFAYMRIVTTKVDVFSFGIVVMEFLT-KRRPTGL 224 (299)
Q Consensus 146 ~~nil~~~~~~v~l~df~~~~~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~DiwslG~~l~~l~~-g~~p~~~ 224 (299)
|+||+++.++.+||+|||++....... .........+++.|+|||++.+..++.++|||||||++|+|++ |..||..
T Consensus 219 p~NIll~~~~~~kL~DFG~a~~~~~~~--~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwslG~il~ellt~g~~p~~~ 296 (382)
T 3tt0_A 219 ARNVLVTEDNVMKIADFGLARDIHHID--YYKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPYPG 296 (382)
T ss_dssp GGGEEECTTCCEEECSCSCCCCSSCCC--TTCCCTTCCCGGGGSCHHHHHSCCCCHHHHHHHHHHHHHHHHTTSCCSSTT
T ss_pred cceEEEcCCCcEEEcccCccccccccc--ccccccCCCCCcceeCHHHhcCCCCCchhHHHHHHHHHHHHHhCCCCCCCC
Confidence 999999999999999999997654211 1122233456788999999999999999999999999999999 9999853
Q ss_pred CccCCCCchhHHHHHHHHHhcCccCcccccCccccchhhHhHHHHHHHHHHHHHHHHhcCCCCCCCCChhhhhcC
Q 038766 225 DEENGLSPISLRQLVEKALANGINGVRQITDPKLVSSIYEEQEQHQVLEELFKLALVCTSSNPEDRPNMNELLIT 299 (299)
Q Consensus 225 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rpt~~~il~~ 299 (299)
. ... +............ . +..++.++.+++++||..||++|||+++++++
T Consensus 297 ~-----~~~---~~~~~~~~~~~~~-----~------------~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~ 346 (382)
T 3tt0_A 297 V-----PVE---ELFKLLKEGHRMD-----K------------PSNCTNELYMMMRDCWHAVPSQRPTFKQLVED 346 (382)
T ss_dssp C-----CHH---HHHHHHHTTCCCC-----C------------CSSCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred C-----CHH---HHHHHHHcCCCCC-----C------------CccCCHHHHHHHHHHcCCChhhCcCHHHHHHH
Confidence 3 112 2222221111000 0 11234679999999999999999999999863
|
| >3mtl_A Cell division protein kinase 16; pctaire1, indirubin, structural genomics, structural consortium, SGC, transferase; HET: FEF; 2.40A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-45 Score=313.87 Aligned_cols=269 Identities=20% Similarity=0.285 Sum_probs=194.8
Q ss_pred CCCCCCceeecCCcceEEEEEeC-CCcEEEEEEeccCcCChhhhHHHHHHHHHHHhcCCcceeeeeeEEEcCCCeeEEEE
Q 038766 12 GSFSENNIIGNSNLSTVYKGRLE-DGEIVAVKKLNFHQFSAESDKSFYREAKTLKELKHRNLVKVLGYAWESGKLKALIL 90 (299)
Q Consensus 12 ~~y~~~~~lg~g~~~~v~~~~~~-~~~~~~vK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~lv~ 90 (299)
++|++.+.||+|+||+||++.+. +++.||+|++.... .......+.+|+.+++.++||||+++++++.. +...++|+
T Consensus 2 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~-~~~~~lv~ 79 (324)
T 3mtl_A 2 ETYIKLDKLGEGTYATVYKGKSKLTDNLVALKEIRLEH-EEGAPCTAIREVSLLKDLKHANIVTLHDIIHT-EKSLTLVF 79 (324)
T ss_dssp CSEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECC-------CCCCCCCHHHHSCCCCTTBCCEEEEEEC-SSCEEEEE
T ss_pred CceEEEEEEcCCCCEEEEEEEECCCCcEEEEEEEeccc-ccccchhHHHHHHHHHhcCCCCCCeeeeEEee-CCEEEEEe
Confidence 68999999999999999999875 68999999986433 22222244579999999999999999997665 45569999
Q ss_pred eecCCCChHHHhcCCCCCCCCCChhhHHHHHHHHHHHHHHhhcCCCCCeeeecccCCceeeCCCCcEEEeeecccccccc
Q 038766 91 EYMENGSLESVIHGPGVDHSRWTLPKRIDVLISVANGLDYLHSGYDIPIVHCDMKPSNILLDRDFEAHVSDFGTSRMLDV 170 (299)
Q Consensus 91 e~~~~~~L~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lh~~~~~~~~H~dl~~~nil~~~~~~v~l~df~~~~~~~~ 170 (299)
||+. ++|.+++.. ....+++..++.++.|++.||.|||+. +++|+||||+||+++.++.++|+|||++.....
T Consensus 80 e~~~-~~l~~~~~~---~~~~~~~~~~~~~~~qi~~aL~~LH~~---~ivH~Dikp~NIl~~~~~~~kl~Dfg~a~~~~~ 152 (324)
T 3mtl_A 80 EYLD-KDLKQYLDD---CGNIINMHNVKLFLFQLLRGLAYCHRQ---KVLHRDLKPQNLLINERGELKLADFGLARAKSI 152 (324)
T ss_dssp ECCS-EEHHHHHHH---TTTCCCHHHHHHHHHHHHHHHHHHHHT---TEEESSCCGGGEEECTTCCEEECSSSEEECC--
T ss_pred cccc-cCHHHHHHh---cCCCCCHHHHHHHHHHHHHHHHHHHHC---CccCCCcCHHHEEECCCCCEEEccCcccccccC
Confidence 9996 488887763 234689999999999999999999999 999999999999999999999999999875431
Q ss_pred ccccccccccccccCcccCChhhhcc-cCcCccccchhhhHHHHHHHhCCCCCCCCccCCCCchhHHHHHHHHHhcCcc-
Q 038766 171 HLQDLSSLSTAFQGTIGYLAPEFAYM-RIVTTKVDVFSFGIVVMEFLTKRRPTGLDEENGLSPISLRQLVEKALANGIN- 248 (299)
Q Consensus 171 ~~~~~~~~~~~~~~~~~y~~PE~~~~-~~~~~~~DiwslG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~- 248 (299)
.........+++.|+|||.+.+ ..++.++|||||||++|+|++|..||... ........+.........
T Consensus 153 ----~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~-----~~~~~~~~i~~~~~~~~~~ 223 (324)
T 3mtl_A 153 ----PTKTYDNEVVTLWYRPPDILLGSTDYSTQIDMWGVGCIFYEMATGRPLFPGS-----TVEEQLHFIFRILGTPTEE 223 (324)
T ss_dssp --------------CGGGCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHSSCSCCCS-----SHHHHHHHHHHHHCCCCTT
T ss_pred ----CccccccccCcccccChhhhcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCC-----CHHHHHHHHHHHhCCCChH
Confidence 1222334467899999999876 56899999999999999999999999543 222222222222211110
Q ss_pred CcccccC---------ccccchhhHhHHHHHHHHHHHHHHHHhcCCCCCCCCChhhhhcC
Q 038766 249 GVRQITD---------PKLVSSIYEEQEQHQVLEELFKLALVCTSSNPEDRPNMNELLIT 299 (299)
Q Consensus 249 ~~~~~~~---------~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rpt~~~il~~ 299 (299)
....... +..... ........++.++.+||.+||..||++|||++|+|+|
T Consensus 224 ~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~h 282 (324)
T 3mtl_A 224 TWPGILSNEEFKTYNYPKYRAE-ALLSHAPRLDSDGADLLTKLLQFEGRNRISAEDAMKH 282 (324)
T ss_dssp TSTTGGGCHHHHHTCCCCCCCC-CHHHHCTTSCHHHHHHHHHHSCSSGGGSCCHHHHTTS
T ss_pred hchhhhcchhhcccccccccch-hhhhhcCCCCHHHHHHHHHHcCcCcccCCCHHHHhcC
Confidence 0010000 000000 0011123456789999999999999999999999987
|
| >3pg1_A Mitogen-activated protein kinase, putative (MAP K protein); EPK Ser/Thr protein kinase fold, Ser/Thr protein kinase, TRA; 1.95A {Leishmania major} PDB: 3uib_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4e-45 Score=315.90 Aligned_cols=273 Identities=20% Similarity=0.215 Sum_probs=202.5
Q ss_pred hHHHHHHhCCCCCCceeecCCcceEEEEEeCCCcEEEEEEeccCcCC---------hhhhHHHHHHHHHHHhcCCcceee
Q 038766 4 RTEIENATGSFSENNIIGNSNLSTVYKGRLEDGEIVAVKKLNFHQFS---------AESDKSFYREAKTLKELKHRNLVK 74 (299)
Q Consensus 4 ~~~~~~~~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~vK~~~~~~~~---------~~~~~~~~~e~~~l~~l~h~~i~~ 74 (299)
..+++.+.++|.+.+.||+|+||.||++.+.+|..||+|++...... ....+.+.+|+.+++.++||||++
T Consensus 14 ~~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~ 93 (362)
T 3pg1_A 14 IAELHAMQSPYTVQRFISSGSYGAVCAGVDSEGIPVAIKRVFNTVSDGRTVNILSDSFLCKRVLREIRLLNHFHHPNILG 93 (362)
T ss_dssp HHHHHHTTCSCEEEEEEEEETTEEEEEEECTTSCEEEEEEECEECCTTSCEEGGGSHHHHHHHHHHHHHHHHCCCTTBCC
T ss_pred HHHHHHhccceEEeEEeccCCCEEEEEEECCCCCeEEEEeccccCCccchhhhhhhhhHHHHHHHHHHHHHhCCCcCccc
Confidence 46788999999999999999999999999888999999998643322 122478899999999999999999
Q ss_pred eeeEEEcC----CCeeEEEEeecCCCChHHHhcCCCCCCCCCChhhHHHHHHHHHHHHHHhhcCCCCCeeeecccCCcee
Q 038766 75 VLGYAWES----GKLKALILEYMENGSLESVIHGPGVDHSRWTLPKRIDVLISVANGLDYLHSGYDIPIVHCDMKPSNIL 150 (299)
Q Consensus 75 ~~~~~~~~----~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lh~~~~~~~~H~dl~~~nil 150 (299)
+++++... ....++|+||+. ++|.+.+.. ....+++..++.++.|++.||.|||+. +++|+||||+||+
T Consensus 94 ~~~~~~~~~~~~~~~~~lv~e~~~-~~l~~~~~~---~~~~~~~~~~~~~~~qi~~~l~~lH~~---~ivH~Dlkp~NIl 166 (362)
T 3pg1_A 94 LRDIFVHFEEPAMHKLYLVTELMR-TDLAQVIHD---QRIVISPQHIQYFMYHILLGLHVLHEA---GVVHRDLHPGNIL 166 (362)
T ss_dssp CSEEEEECCTTTCCEEEEEEECCS-EEHHHHHHC---TTSCCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEE
T ss_pred eeeeEEeccCCCcceEEEEEccCC-CCHHHHHHh---cccCCCHHHHHHHHHHHHHHHHHHHHC---cCEecCCChHHEE
Confidence 99987543 346799999996 588877763 345799999999999999999999999 9999999999999
Q ss_pred eCCCCcEEEeeeccccccccccccccccccccccCcccCChhhhcc-cCcCccccchhhhHHHHHHHhCCCCCCCCccCC
Q 038766 151 LDRDFEAHVSDFGTSRMLDVHLQDLSSLSTAFQGTIGYLAPEFAYM-RIVTTKVDVFSFGIVVMEFLTKRRPTGLDEENG 229 (299)
Q Consensus 151 ~~~~~~v~l~df~~~~~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~-~~~~~~~DiwslG~~l~~l~~g~~p~~~~~~~~ 229 (299)
++.++.++|+|||++..... ........+++.|+|||++.+ ..++.++|||||||++|+|++|..||....
T Consensus 167 ~~~~~~~kl~Dfg~~~~~~~-----~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~--- 238 (362)
T 3pg1_A 167 LADNNDITICDFNLAREDTA-----DANKTHYVTHRWYRAPELVMQFKGFTKLVDMWSAGCVMAEMFNRKALFRGST--- 238 (362)
T ss_dssp ECTTCCEEECCTTC--------------------CGGGCCHHHHTTCTTCCTHHHHHHHHHHHHHHHHSSCSCCCSS---
T ss_pred EcCCCCEEEEecCccccccc-----ccccceecccceecCcHHhcCCCCCCcHhHHHhHHHHHHHHHhCCCCCCCCC---
Confidence 99999999999999974331 122334567889999998877 678999999999999999999999995432
Q ss_pred CCchhHHHHHHHHHhcCc-----------------cCcccccCccccchhhHhHHHHHHHHHHHHHHHHhcCCCCCCCCC
Q 038766 230 LSPISLRQLVEKALANGI-----------------NGVRQITDPKLVSSIYEEQEQHQVLEELFKLALVCTSSNPEDRPN 292 (299)
Q Consensus 230 ~~~~~~~~~~~~~~~~~~-----------------~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rpt 292 (299)
.......+........ ......... .........+..+.+||.+||..||++|||
T Consensus 239 --~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~------~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt 310 (362)
T 3pg1_A 239 --FYNQLNKIVEVVGTPKIEDVVMFSSPSARDYLRNSLSNVPAR------AWTAVVPTADPVALDLIAKMLEFNPQRRIS 310 (362)
T ss_dssp --HHHHHHHHHHHHCCCCHHHHHHTSCHHHHHHTTTCCCCCCCC------CHHHHSTTSCHHHHHHHHHHTCSSGGGSCC
T ss_pred --HHHHHHHHHHHcCCCChHHhhhccchhhhHHHHhhcccCChh------hHHhhCCCCCHHHHHHHHHHhcCChhhCCC
Confidence 1111111111100000 000000000 011112344677999999999999999999
Q ss_pred hhhhhcC
Q 038766 293 MNELLIT 299 (299)
Q Consensus 293 ~~~il~~ 299 (299)
++++|+|
T Consensus 311 ~~ell~h 317 (362)
T 3pg1_A 311 TEQALRH 317 (362)
T ss_dssp HHHHHTS
T ss_pred HHHHHcC
Confidence 9999987
|
| >1mp8_A Focal adhesion kinase 1; tyrosine protein kinase, transferase; HET: ADP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 2ijm_A* 2etm_A* 3pxk_A* 2jkq_A* 2j0m_B* 2jkm_A* 2j0l_A* 3bz3_A* 2jko_A* 2jkk_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.7e-46 Score=310.27 Aligned_cols=258 Identities=23% Similarity=0.296 Sum_probs=194.0
Q ss_pred hHHHHHHhCCCCCCceeecCCcceEEEEEeCC----CcEEEEEEeccCcCChhhhHHHHHHHHHHHhcCCcceeeeeeEE
Q 038766 4 RTEIENATGSFSENNIIGNSNLSTVYKGRLED----GEIVAVKKLNFHQFSAESDKSFYREAKTLKELKHRNLVKVLGYA 79 (299)
Q Consensus 4 ~~~~~~~~~~y~~~~~lg~g~~~~v~~~~~~~----~~~~~vK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~ 79 (299)
..+++...++|.+.+.||+|+||+||++.+.. +..+|+|++... ......+.+.+|+..++.++||||+++++++
T Consensus 7 ~~~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~vaiK~~~~~-~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~ 85 (281)
T 1mp8_A 7 TRDYEIQRERIELGRCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNC-TSDSVREKFLQEALTMRQFDHPHIVKLIGVI 85 (281)
T ss_dssp --CCBCCGGGEEEEEEEEECSSSEEEEEEECCC--CCEEEEEEECTTT-TSHHHHHHHHHHHHHHHTCCCTTBCCEEEEE
T ss_pred ccceEEehHHeEEEeEeeecCCeeEEEEEEecCCCCceEEEEEecccc-CCHHHHHHHHHHHHHHHhCCCCccceEEEEE
Confidence 34567778999999999999999999998642 457999998642 3445567889999999999999999999965
Q ss_pred EcCCCeeEEEEeecCCCChHHHhcCCCCCCCCCChhhHHHHHHHHHHHHHHhhcCCCCCeeeecccCCceeeCCCCcEEE
Q 038766 80 WESGKLKALILEYMENGSLESVIHGPGVDHSRWTLPKRIDVLISVANGLDYLHSGYDIPIVHCDMKPSNILLDRDFEAHV 159 (299)
Q Consensus 80 ~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lh~~~~~~~~H~dl~~~nil~~~~~~v~l 159 (299)
. ++..++|+||+.+++|.+++.. ....+++..++.++.|++.||.|||+. +++|+||||+||+++.++.++|
T Consensus 86 -~-~~~~~lv~e~~~~~~L~~~l~~---~~~~~~~~~~~~~~~qi~~~l~~lH~~---~i~H~dlkp~Nil~~~~~~~kl 157 (281)
T 1mp8_A 86 -T-ENPVWIIMELCTLGELRSFLQV---RKYSLDLASLILYAYQLSTALAYLESK---RFVHRDIAARNVLVSSNDCVKL 157 (281)
T ss_dssp -C-SSSCEEEEECCTTEEHHHHHHH---TTTTSCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEEEETTEEEE
T ss_pred -c-cCccEEEEecCCCCCHHHHHHh---cCCCCCHHHHHHHHHHHHHHHHHHHhC---CeecccccHHHEEECCCCCEEE
Confidence 3 3445899999999999999863 234689999999999999999999999 9999999999999999999999
Q ss_pred eeeccccccccccccccccccccccCcccCChhhhcccCcCccccchhhhHHHHHHHh-CCCCCCCCccCCCCchhHHHH
Q 038766 160 SDFGTSRMLDVHLQDLSSLSTAFQGTIGYLAPEFAYMRIVTTKVDVFSFGIVVMEFLT-KRRPTGLDEENGLSPISLRQL 238 (299)
Q Consensus 160 ~df~~~~~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~DiwslG~~l~~l~~-g~~p~~~~~~~~~~~~~~~~~ 238 (299)
+|||++...... .........+++.|+|||.+.+..++.++||||||+++|+|++ |..||.... .......
T Consensus 158 ~Dfg~~~~~~~~---~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~ell~~g~~pf~~~~-----~~~~~~~ 229 (281)
T 1mp8_A 158 GDFGLSRYMEDS---TYYKASKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMHGVKPFQGVK-----NNDVIGR 229 (281)
T ss_dssp CC----------------------CCGGGCCHHHHHHCCCSHHHHHHHHHHHHHHHHTTSCCTTTTCC-----GGGHHHH
T ss_pred CccccccccCcc---cccccccCCCcccccChhhcccCCCCCccCchHHHHHHHHHHhcCCCCCCcCC-----HHHHHHH
Confidence 999999765421 1111223345678999999998899999999999999999996 888985432 2222221
Q ss_pred HHHHHhcCccCcccccCccccchhhHhHHHHHHHHHHHHHHHHhcCCCCCCCCChhhhhc
Q 038766 239 VEKALANGINGVRQITDPKLVSSIYEEQEQHQVLEELFKLALVCTSSNPEDRPNMNELLI 298 (299)
Q Consensus 239 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rpt~~~il~ 298 (299)
+ ....... . +..++..+.+++.+||..||++|||+.++++
T Consensus 230 i---~~~~~~~-----~------------~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~ 269 (281)
T 1mp8_A 230 I---ENGERLP-----M------------PPNCPPTLYSLMTKCWAYDPSRRPRFTELKA 269 (281)
T ss_dssp H---HTTCCCC-----C------------CTTCCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred H---HcCCCCC-----C------------CCCCCHHHHHHHHHHccCChhhCcCHHHHHH
Confidence 1 1111000 0 1234567999999999999999999999985
|
| >3qyz_A Mitogen-activated protein kinase 1; transferase, serine/threonine-protein kinase, ATP-binding CE phosphorylation; HET: CME Z8B SO4; 1.46A {Rattus norvegicus} PDB: 2fys_B 1erk_A* 3qyi_A* 3erk_A* 3qyw_A* 4erk_A* 4gsb_A* 4gt3_A* 4gva_A* 2z7l_A* 2erk_A* 1gol_A* 2gph_A 3zu7_A 3zuv_A* 3o71_A 3r63_A 3c9w_A* 2y9q_A* 4fmq_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=6.1e-45 Score=314.92 Aligned_cols=275 Identities=20% Similarity=0.261 Sum_probs=204.7
Q ss_pred HHhCCCCCCceeecCCcceEEEEEeC-CCcEEEEEEeccCcCChhhhHHHHHHHHHHHhcCCcceeeeeeEEEcCC----
Q 038766 9 NATGSFSENNIIGNSNLSTVYKGRLE-DGEIVAVKKLNFHQFSAESDKSFYREAKTLKELKHRNLVKVLGYAWESG---- 83 (299)
Q Consensus 9 ~~~~~y~~~~~lg~g~~~~v~~~~~~-~~~~~~vK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~---- 83 (299)
.+.++|++.+.||+|+||.||++.+. ++..||+|++.. .........+.+|+.++++++||||+++++++....
T Consensus 24 ~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~-~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~ 102 (364)
T 3qyz_A 24 DVGPRYTNLSYIGEGAYGMVCSAYDNLNKVRVAIKKISP-FEHQTYCQRTLREIKILLRFRHENIIGINDIIRAPTIEQM 102 (364)
T ss_dssp CCTTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECC-TTCHHHHHHHHHHHHHHHHCCCTTBCCCCEEECCSSTTTC
T ss_pred cccccEEEEEEeecCCCeEEEEEEECCCCeEEEEEEecc-ccCcHHHHHHHHHHHHHHhcCCCCCccceeEEecCCcccc
Confidence 35679999999999999999999874 688999999863 224445678889999999999999999999775432
Q ss_pred CeeEEEEeecCCCChHHHhcCCCCCCCCCChhhHHHHHHHHHHHHHHhhcCCCCCeeeecccCCceeeCCCCcEEEeeec
Q 038766 84 KLKALILEYMENGSLESVIHGPGVDHSRWTLPKRIDVLISVANGLDYLHSGYDIPIVHCDMKPSNILLDRDFEAHVSDFG 163 (299)
Q Consensus 84 ~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lh~~~~~~~~H~dl~~~nil~~~~~~v~l~df~ 163 (299)
...++|+|++. ++|.++++ ...+++..++.++.|++.||+|||++ +++|+||||+||+++.++.++|+|||
T Consensus 103 ~~~~iv~e~~~-~~L~~~l~-----~~~~~~~~~~~i~~qi~~aL~~LH~~---~ivH~Dikp~NIl~~~~~~~kl~Dfg 173 (364)
T 3qyz_A 103 KDVYIVQDLME-TDLYKLLK-----TQHLSNDHICYFLYQILRGLKYIHSA---NVLHRDLKPSNLLLNTTCDLKICDFG 173 (364)
T ss_dssp CCEEEEEECCS-EEHHHHHH-----HCCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEECTTCCEEECCCT
T ss_pred ceEEEEEcccC-cCHHHHHH-----hCCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCChHhEEECCCCCEEEEeCc
Confidence 45699999996 59999885 34699999999999999999999999 99999999999999999999999999
Q ss_pred cccccccccccccccccccccCcccCChhhhcc-cCcCccccchhhhHHHHHHHhCCCCCCCCccCCCCchhHHHHHHHH
Q 038766 164 TSRMLDVHLQDLSSLSTAFQGTIGYLAPEFAYM-RIVTTKVDVFSFGIVVMEFLTKRRPTGLDEENGLSPISLRQLVEKA 242 (299)
Q Consensus 164 ~~~~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~-~~~~~~~DiwslG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~ 242 (299)
++........ .........+|+.|+|||++.+ ..++.++|||||||++|+|++|..||.... .......+...
T Consensus 174 ~a~~~~~~~~-~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~-----~~~~~~~i~~~ 247 (364)
T 3qyz_A 174 LARVADPDHD-HTGFLTEYVATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKH-----YLDQLNHILGI 247 (364)
T ss_dssp TCEECCGGGC-BCCTTCCCCSCGGGCCHHHHHTBCSCSTHHHHHHHHHHHHHHHHSSCSSCCSS-----GGGHHHHHHHH
T ss_pred ceEecCCCCC-ccccccccccccCCCCCHHhcCCCCCCcchhHHHHHHHHHHHHHCCCCCCCCC-----hHHHHHHHHHH
Confidence 9976542211 1112344578999999998654 458999999999999999999999995432 22222211111
Q ss_pred HhcCccC-cccccCc---------cccchhhHhHHHHHHHHHHHHHHHHhcCCCCCCCCChhhhhcC
Q 038766 243 LANGING-VRQITDP---------KLVSSIYEEQEQHQVLEELFKLALVCTSSNPEDRPNMNELLIT 299 (299)
Q Consensus 243 ~~~~~~~-~~~~~~~---------~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rpt~~~il~~ 299 (299)
....... ...+... ..............++.++.+||++||..||++|||++|+|+|
T Consensus 248 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~h 314 (364)
T 3qyz_A 248 LGSPSQEDLNCIINLKARNYLLSLPHKNKVPWNRLFPNADSKALDLLDKMLTFNPHKRIEVEQALAH 314 (364)
T ss_dssp HCSCCHHHHHTCCCHHHHHHHHTSCCCCCCCHHHHCTTSCHHHHHHHHHHTCSSTTTSCCHHHHHTS
T ss_pred hCCCCHHHHHHhhhhhHHHHHHhcCCccCCCHHHhCCCCCHHHHHHHHHHcCCChhhCCCHHHHhcC
Confidence 1110000 0000000 0000000111123456789999999999999999999999987
|
| >1k9a_A Carboxyl-terminal SRC kinase; COOH-terminal SRC kinase, CSK, SFK, signal transduction, SH2, SH3, SRC homology, tyrosine kinase; 2.50A {Rattus norvegicus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1jeg_A | Back alignment and structure |
|---|
Probab=100.00 E-value=9.4e-46 Score=328.27 Aligned_cols=252 Identities=25% Similarity=0.351 Sum_probs=203.2
Q ss_pred HHHHHHhCCCCCCceeecCCcceEEEEEeCCCcEEEEEEeccCcCChhhhHHHHHHHHHHHhcCCcceeeeeeEEEcCCC
Q 038766 5 TEIENATGSFSENNIIGNSNLSTVYKGRLEDGEIVAVKKLNFHQFSAESDKSFYREAKTLKELKHRNLVKVLGYAWESGK 84 (299)
Q Consensus 5 ~~~~~~~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~vK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~ 84 (299)
..++.-.++|.+.+.||+|+||.||++.+. ++.||||++... ...+.+.+|+.++++++||||+++++++.....
T Consensus 186 ~~~~i~~~~~~~~~~lG~G~fg~V~~~~~~-~~~vavK~~~~~----~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~ 260 (450)
T 1k9a_A 186 SGWALNMKELKLLQTIGKGEFGDVMLGDYR-GNKVAVKCIKND----ATAQAFLAEASVMTQLRHSNLVQLLGVIVEEKG 260 (450)
T ss_dssp TTCBCCGGGEEEEEEEEECSSEEEEEEEET-TEEEEEEEESSC----TTSHHHHHHHHHHHTCCCTTBCCEEEEEECTTS
T ss_pred cccccChHHeEEEeeecCcCCeeEEEEEec-CCeEEEEEeCCc----hHHHHHHHHHHHHHhccCCCEEEEEEEEEcCCC
Confidence 345566788999999999999999999886 779999998643 255678999999999999999999998877666
Q ss_pred eeEEEEeecCCCChHHHhcCCCCCCCCCChhhHHHHHHHHHHHHHHhhcCCCCCeeeecccCCceeeCCCCcEEEeeecc
Q 038766 85 LKALILEYMENGSLESVIHGPGVDHSRWTLPKRIDVLISVANGLDYLHSGYDIPIVHCDMKPSNILLDRDFEAHVSDFGT 164 (299)
Q Consensus 85 ~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lh~~~~~~~~H~dl~~~nil~~~~~~v~l~df~~ 164 (299)
..++|+||+.+++|.+++... ....+++..++.++.|++.||+|||++ +++||||||+||+++.++.+||+|||+
T Consensus 261 ~~~iv~e~~~~g~L~~~l~~~--~~~~~~~~~~~~~~~qi~~~l~~LH~~---~ivHrDlkp~Nill~~~~~~kl~DfG~ 335 (450)
T 1k9a_A 261 GLYIVTEYMAKGSLVDYLRSR--GRSVLGGDCLLKFSLDVCEAMEYLEGN---NFVHRDLAARNVLVSEDNVAKVSDFGL 335 (450)
T ss_dssp CEEEEEECCTTCBHHHHHHHH--CTTTCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCCGGGEEECTTSCEEECCCTT
T ss_pred ceEEEEEecCCCcHHHHHHhc--CCCCCCHHHHHHHHHHHHHHHHHHHhC---CeeCCCCCHhhEEECCCCCEEEeeCCC
Confidence 679999999999999998743 223478999999999999999999999 999999999999999999999999999
Q ss_pred ccccccccccccccccccccCcccCChhhhcccCcCccccchhhhHHHHHHHh-CCCCCCCCccCCCCchhHHHHHHHHH
Q 038766 165 SRMLDVHLQDLSSLSTAFQGTIGYLAPEFAYMRIVTTKVDVFSFGIVVMEFLT-KRRPTGLDEENGLSPISLRQLVEKAL 243 (299)
Q Consensus 165 ~~~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~DiwslG~~l~~l~~-g~~p~~~~~~~~~~~~~~~~~~~~~~ 243 (299)
+..... ......+++.|+|||.+.+..++.++||||||+++|+|++ |..||..... ......+..
T Consensus 336 a~~~~~-------~~~~~~~~~~y~aPE~~~~~~~~~~sDvwslG~~l~el~t~g~~P~~~~~~-----~~~~~~i~~-- 401 (450)
T 1k9a_A 336 TKEASS-------TQDTGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPL-----KDVVPRVEK-- 401 (450)
T ss_dssp CEECC-------------CCCTTTSCHHHHHSSCCCHHHHHHHHHHHHHHHHTTTCCSSTTSCT-----TTHHHHHHT--
T ss_pred cccccc-------cccCCCCCcceeCHHHhcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCCH-----HHHHHHHHc--
Confidence 874331 1122245788999999999999999999999999999998 9999854322 222222211
Q ss_pred hcCccCcccccCccccchhhHhHHHHHHHHHHHHHHHHhcCCCCCCCCChhhhhc
Q 038766 244 ANGINGVRQITDPKLVSSIYEEQEQHQVLEELFKLALVCTSSNPEDRPNMNELLI 298 (299)
Q Consensus 244 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rpt~~~il~ 298 (299)
+. .... +..++..+.++|.+||..||++|||++++++
T Consensus 402 --~~----~~~~------------p~~~~~~l~~li~~cl~~dp~~Rpt~~~l~~ 438 (450)
T 1k9a_A 402 --GY----KMDA------------PDGCPPAVYDVMKNCWHLDAATRPTFLQLRE 438 (450)
T ss_dssp --TC----CCCC------------CTTCCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred --CC----CCCC------------CCcCCHHHHHHHHHHcCCChhHCcCHHHHHH
Confidence 10 0001 2234568999999999999999999999874
|
| >2r5t_A Serine/threonine-protein kinase SGK1; AGC protein kinase, apoptosis, ATP-binding, cytoplasm, endoplasmic reticulum, nucleotide-binding, nucleus; HET: ANP; 1.90A {Homo sapiens} PDB: 3hdm_A* 3hdn_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-45 Score=319.12 Aligned_cols=252 Identities=24% Similarity=0.288 Sum_probs=194.1
Q ss_pred HhCCCCCCceeecCCcceEEEEEeC-CCcEEEEEEeccCcCC-hhhhHHHHHHHHH-HHhcCCcceeeeeeEEEcCCCee
Q 038766 10 ATGSFSENNIIGNSNLSTVYKGRLE-DGEIVAVKKLNFHQFS-AESDKSFYREAKT-LKELKHRNLVKVLGYAWESGKLK 86 (299)
Q Consensus 10 ~~~~y~~~~~lg~g~~~~v~~~~~~-~~~~~~vK~~~~~~~~-~~~~~~~~~e~~~-l~~l~h~~i~~~~~~~~~~~~~~ 86 (299)
..++|.+.+.||+|+||.||++++. +++.||+|++...... ......+..|... ++.++||||+++++++.. ....
T Consensus 36 ~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~AiK~~~~~~~~~~~~~~~~~~e~~~ll~~~~hp~Iv~l~~~~~~-~~~~ 114 (373)
T 2r5t_A 36 KPSDFHFLKVIGKGSFGKVLLARHKAEEVFYAVKVLQKKAILKKKEEKHIMSERNVLLKNVKHPFLVGLHFSFQT-ADKL 114 (373)
T ss_dssp CGGGEEEEEEEECCTTCEEEEEEETTTCCEEEEEEEEGGGBC-------------CCBCCCCCTTBCCEEEEEEC-SSEE
T ss_pred ChhheEEEEEEeeCCCeEEEEEEEcCCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHHhCCCCCCCCEEEEEEe-CCEE
Confidence 3578999999999999999999875 5889999999754432 2334556667666 467889999999997665 5567
Q ss_pred EEEEeecCCCChHHHhcCCCCCCCCCChhhHHHHHHHHHHHHHHhhcCCCCCeeeecccCCceeeCCCCcEEEeeecccc
Q 038766 87 ALILEYMENGSLESVIHGPGVDHSRWTLPKRIDVLISVANGLDYLHSGYDIPIVHCDMKPSNILLDRDFEAHVSDFGTSR 166 (299)
Q Consensus 87 ~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lh~~~~~~~~H~dl~~~nil~~~~~~v~l~df~~~~ 166 (299)
++||||+.+++|.+++. ....+++..++.++.||+.||.|||++ +++||||||+||+++.+|.+||+|||++.
T Consensus 115 ~lv~E~~~gg~L~~~l~----~~~~~~~~~~~~~~~qi~~aL~~LH~~---givHrDlkp~NIll~~~g~ikL~DFG~a~ 187 (373)
T 2r5t_A 115 YFVLDYINGGELFYHLQ----RERCFLEPRARFYAAEIASALGYLHSL---NIVYRDLKPENILLDSQGHIVLTDFGLCK 187 (373)
T ss_dssp EEEEECCCSCBHHHHHH----HHSSCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEECTTSCEEECCCCBCG
T ss_pred EEEEeCCCCCcHHHHHH----hcCCCCHHHHHHHHHHHHHHHHHHHHC---CceecCCCHHHEEECCCCCEEEeeCcccc
Confidence 99999999999999987 445789999999999999999999999 99999999999999999999999999987
Q ss_pred ccccccccccccccccccCcccCChhhhcccCcCccccchhhhHHHHHHHhCCCCCCCCccCCCCchhHHHHHHHHHhcC
Q 038766 167 MLDVHLQDLSSLSTAFQGTIGYLAPEFAYMRIVTTKVDVFSFGIVVMEFLTKRRPTGLDEENGLSPISLRQLVEKALANG 246 (299)
Q Consensus 167 ~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~DiwslG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~ 246 (299)
.... .........+|+.|+|||++.+..++.++|+|||||++|+|++|..||.... . .+....+....
T Consensus 188 ~~~~----~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~G~~Pf~~~~-----~---~~~~~~i~~~~ 255 (373)
T 2r5t_A 188 ENIE----HNSTTSTFCGTPEYLAPEVLHKQPYDRTVDWWCLGAVLYEMLYGLPPFYSRN-----T---AEMYDNILNKP 255 (373)
T ss_dssp GGBC----CCCCCCSBSCCCCCCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCTTCCSB-----H---HHHHHHHHHSC
T ss_pred cccc----CCCccccccCCccccCHHHhCCCCCCchhhhHHHHHHHHHHHcCCCCCCCCC-----H---HHHHHHHHhcc
Confidence 5321 1223445678999999999999999999999999999999999999995432 1 22222222211
Q ss_pred ccCcccccCccccchhhHhHHHHHHHHHHHHHHHHhcCCCCCCCCCh----hhhhcC
Q 038766 247 INGVRQITDPKLVSSIYEEQEQHQVLEELFKLALVCTSSNPEDRPNM----NELLIT 299 (299)
Q Consensus 247 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rpt~----~~il~~ 299 (299)
. .. +..++.++.+||++||..||++||++ +++++|
T Consensus 256 ~-~~-----------------~~~~~~~~~~li~~lL~~dp~~R~~~~~~~~~i~~h 294 (373)
T 2r5t_A 256 L-QL-----------------KPNITNSARHLLEGLLQKDRTKRLGAKDDFMEIKSH 294 (373)
T ss_dssp C-CC-----------------CSSSCHHHHHHHHHHTCSSGGGSTTTTTTHHHHHTS
T ss_pred c-CC-----------------CCCCCHHHHHHHHHHcccCHHhCCCCCCCHHHHhCC
Confidence 0 00 11234678999999999999999998 466665
|
| >3dtc_A Mitogen-activated protein kinase kinase kinase 9; mixed-lineage kinase, MLK family, MLK1 and MLK3 subtype selective inhibitors; HET: VIN; 2.60A {Homo sapiens} SCOP: d.144.1.0 | Back alignment and structure |
|---|
Probab=100.00 E-value=2.3e-45 Score=304.95 Aligned_cols=251 Identities=25% Similarity=0.396 Sum_probs=191.3
Q ss_pred HHhCCCCCCceeecCCcceEEEEEeCCCcEEEEEEeccCcCC--hhhhHHHHHHHHHHHhcCCcceeeeeeEEEcCCCee
Q 038766 9 NATGSFSENNIIGNSNLSTVYKGRLEDGEIVAVKKLNFHQFS--AESDKSFYREAKTLKELKHRNLVKVLGYAWESGKLK 86 (299)
Q Consensus 9 ~~~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~vK~~~~~~~~--~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~ 86 (299)
.-.++|.+.+.||+|+||+||++.+. +..+|+|++...... ....+.+.+|+..++.++||||+++++++.. +...
T Consensus 4 ~~~~~~~~~~~lg~G~~g~V~~~~~~-~~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~-~~~~ 81 (271)
T 3dtc_A 4 IDFAELTLEEIIGIGGFGKVYRAFWI-GDEVAVKAARHDPDEDISQTIENVRQEAKLFAMLKHPNIIALRGVCLK-EPNL 81 (271)
T ss_dssp CCTTSEEEEEEEEEETTEEEEEEEET-TEEEEEEEC----------CHHHHHHHHHHHHHCCCTTBCCEEEEECC-C--C
T ss_pred cchhheeeeeeeccCCCeEEEEEEEc-CCeEEEEEEecCCcccHHHHHHHHHHHHHHHHhcCCCCEeeEEEEEec-CCce
Confidence 34678999999999999999999985 889999998654322 2335778899999999999999999997655 4556
Q ss_pred EEEEeecCCCChHHHhcCCCCCCCCCChhhHHHHHHHHHHHHHHhhcCCCCC---eeeecccCCceeeCC--------CC
Q 038766 87 ALILEYMENGSLESVIHGPGVDHSRWTLPKRIDVLISVANGLDYLHSGYDIP---IVHCDMKPSNILLDR--------DF 155 (299)
Q Consensus 87 ~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lh~~~~~~---~~H~dl~~~nil~~~--------~~ 155 (299)
++|+||+.+++|.+++. ..++++..++.++.|++.||+|||++ + ++|+||||+||+++. ++
T Consensus 82 ~lv~e~~~~~~L~~~~~-----~~~~~~~~~~~i~~~l~~~l~~lH~~---~~~~i~H~dikp~Nil~~~~~~~~~~~~~ 153 (271)
T 3dtc_A 82 CLVMEFARGGPLNRVLS-----GKRIPPDILVNWAVQIARGMNYLHDE---AIVPIIHRDLKSSNILILQKVENGDLSNK 153 (271)
T ss_dssp EEEEECCTTEEHHHHHT-----SSCCCHHHHHHHHHHHHHHHHHHHHS---SSSCCCCSCCSGGGEEESSCCSSSCCSSC
T ss_pred EEEEEcCCCCCHHHHhh-----cCCCCHHHHHHHHHHHHHHHHHHHhC---CCCceeecCCchHHEEEecccccccccCc
Confidence 99999999999999984 45799999999999999999999998 7 999999999999986 67
Q ss_pred cEEEeeeccccccccccccccccccccccCcccCChhhhcccCcCccccchhhhHHHHHHHhCCCCCCCCccCCCCchhH
Q 038766 156 EAHVSDFGTSRMLDVHLQDLSSLSTAFQGTIGYLAPEFAYMRIVTTKVDVFSFGIVVMEFLTKRRPTGLDEENGLSPISL 235 (299)
Q Consensus 156 ~v~l~df~~~~~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~DiwslG~~l~~l~~g~~p~~~~~~~~~~~~~~ 235 (299)
.++|+|||++..... .......+++.|+|||.+.+..++.++||||||+++|+|++|..||.... ..
T Consensus 154 ~~kl~Dfg~~~~~~~------~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~-----~~-- 220 (271)
T 3dtc_A 154 ILKITDFGLAREWHR------TTKMSAAGAYAWMAPEVIRASMFSKGSDVWSYGVLLWELLTGEVPFRGID-----GL-- 220 (271)
T ss_dssp CEEECCCCC-------------------CCGGGSCHHHHHHCCCSHHHHHHHHHHHHHHHHHCCCTTTTSC-----HH--
T ss_pred ceEEccCCccccccc------ccccCCCCccceeCHHHhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCC-----HH--
Confidence 899999999975442 11224467899999999999999999999999999999999999995331 11
Q ss_pred HHHHHHHHhcCccCcccccCccccchhhHhHHHHHHHHHHHHHHHHhcCCCCCCCCChhhhhcC
Q 038766 236 RQLVEKALANGINGVRQITDPKLVSSIYEEQEQHQVLEELFKLALVCTSSNPEDRPNMNELLIT 299 (299)
Q Consensus 236 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rpt~~~il~~ 299 (299)
............ ... +..++..+.+++.+||..||++|||+++++++
T Consensus 221 -~~~~~~~~~~~~----~~~------------~~~~~~~~~~li~~~l~~~p~~Rps~~e~l~~ 267 (271)
T 3dtc_A 221 -AVAYGVAMNKLA----LPI------------PSTCPEPFAKLMEDCWNPDPHSRPSFTNILDQ 267 (271)
T ss_dssp -HHHHHHHTSCCC----CCC------------CTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred -HHHHhhhcCCCC----CCC------------CcccCHHHHHHHHHHhcCCcccCcCHHHHHHH
Confidence 111111111100 000 12334679999999999999999999999864
|
| >2zmd_A Dual specificity protein kinase TTK; MPS1, T686A, ATP-binding, nucleotide-bindi phosphoprotein, serine/threonine-protein kinase; HET: 537 7PE; 2.88A {Homo sapiens} PDB: 2zmc_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-44 Score=314.70 Aligned_cols=253 Identities=21% Similarity=0.308 Sum_probs=197.1
Q ss_pred CCCCCCceeecCCcceEEEEEeCCCcEEEEEEeccCcCChhhhHHHHHHHHHHHhcC--CcceeeeeeEEEcCCCeeEEE
Q 038766 12 GSFSENNIIGNSNLSTVYKGRLEDGEIVAVKKLNFHQFSAESDKSFYREAKTLKELK--HRNLVKVLGYAWESGKLKALI 89 (299)
Q Consensus 12 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~vK~~~~~~~~~~~~~~~~~e~~~l~~l~--h~~i~~~~~~~~~~~~~~~lv 89 (299)
.+|.+.+.||+|+||.||++.+.+++.||||++............+.+|+.+++.++ ||||+++++++.. +...++|
T Consensus 56 ~~y~~~~~LG~G~fg~Vy~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~Ei~~l~~l~~~~~~iv~~~~~~~~-~~~~~lv 134 (390)
T 2zmd_A 56 RIYSILKQIGSGGSSKVFQVLNEKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRLYDYEIT-DQYIYMV 134 (390)
T ss_dssp EEEEEEEEEECCSSEEEEEEECTTCCEEEEEEEECTTCCHHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEEC-SSEEEEE
T ss_pred CceEEEEEEccCCCeEEEEEEcCCCCEEEEEEEecccccHHHHHHHHHHHHHHHHcccCCCeEEEEEEEEec-CCEEEEE
Confidence 459999999999999999999888999999999876666667788999999999997 5999999996665 5567999
Q ss_pred EeecCCCChHHHhcCCCCCCCCCChhhHHHHHHHHHHHHHHhhcCCCCCeeeecccCCceeeCCCCcEEEeeeccccccc
Q 038766 90 LEYMENGSLESVIHGPGVDHSRWTLPKRIDVLISVANGLDYLHSGYDIPIVHCDMKPSNILLDRDFEAHVSDFGTSRMLD 169 (299)
Q Consensus 90 ~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lh~~~~~~~~H~dl~~~nil~~~~~~v~l~df~~~~~~~ 169 (299)
||+ .+++|.+++. ....+++.+++.++.||+.||.|||+. +++||||||+||+++ ++.+||+|||++..+.
T Consensus 135 ~E~-~~~~L~~~l~----~~~~~~~~~~~~i~~qi~~aL~~lH~~---~ivHrDlkp~NIll~-~~~~kl~DFG~a~~~~ 205 (390)
T 2zmd_A 135 MEC-GNIDLNSWLK----KKKSIDPWERKSYWKNMLEAVHTIHQH---GIVHSDLKPANFLIV-DGMLKLIDFGIANQMQ 205 (390)
T ss_dssp EEC-CSEEHHHHHH----HCSSCCHHHHHHHHHHHHHHHHHHHTT---TCCCCCCCGGGEEES-SSCEEECCCSSSCCC-
T ss_pred Eec-CCCCHHHHHH----hcCCCCHHHHHHHHHHHHHHHHHHHHC---CeeecCCCHHHEEEE-CCeEEEEecCcccccc
Confidence 995 4779999987 345789999999999999999999999 999999999999995 5789999999997654
Q ss_pred cccccccccccccccCcccCChhhhcc-----------cCcCccccchhhhHHHHHHHhCCCCCCCCccCCCCchhHHHH
Q 038766 170 VHLQDLSSLSTAFQGTIGYLAPEFAYM-----------RIVTTKVDVFSFGIVVMEFLTKRRPTGLDEENGLSPISLRQL 238 (299)
Q Consensus 170 ~~~~~~~~~~~~~~~~~~y~~PE~~~~-----------~~~~~~~DiwslG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~ 238 (299)
... .........+|+.|+|||++.+ ..++.++|||||||++|+|++|..||..... ....
T Consensus 206 ~~~--~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~~~~DiwSlGvil~ell~G~~Pf~~~~~-------~~~~ 276 (390)
T 2zmd_A 206 PDT--TSVVKDSQVGAVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIIN-------QISK 276 (390)
T ss_dssp ----------CCSCCCGGGCCHHHHHCC------------CCHHHHHHHHHHHHHHHHHSSCTTTTCCC-------HHHH
T ss_pred CCC--ccccCCCCCcCCCccChHHhhhccccccccccccCCCChhhHHHHHHHHHHHHHCCCcchhhhH-------HHHH
Confidence 211 1112344568999999999875 3688899999999999999999999953211 1111
Q ss_pred HHHHHhcCccCcccccCccccchhhHhHHHHHHHHHHHHHHHHhcCCCCCCCCChhhhhcC
Q 038766 239 VEKALANGINGVRQITDPKLVSSIYEEQEQHQVLEELFKLALVCTSSNPEDRPNMNELLIT 299 (299)
Q Consensus 239 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rpt~~~il~~ 299 (299)
+....... .....+. ..+.++.+||++||..||++|||++++|+|
T Consensus 277 ~~~~~~~~----~~~~~~~------------~~~~~~~~li~~~L~~dP~~Rps~~ell~h 321 (390)
T 2zmd_A 277 LHAIIDPN----HEIEFPD------------IPEKDLQDVLKCCLKRDPKQRISIPELLAH 321 (390)
T ss_dssp HHHHHCTT----SCCCCCC------------CSCHHHHHHHHHHTCSSTTTSCCHHHHHTS
T ss_pred HHHHhCcc----ccCCCCc------------cchHHHHHHHHHHcccChhhCCCHHHHhhC
Confidence 11111111 0001111 113578899999999999999999999987
|
| >2h6d_A 5'-AMP-activated protein kinase catalytic subunit alpha-2; ATP-binding, cholesterol biosynthesis, fatty acid biosynthesis;kinase, lipid synthesis; 1.85A {Homo sapiens} PDB: 3aqv_A* 2yza_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-45 Score=307.71 Aligned_cols=255 Identities=24% Similarity=0.349 Sum_probs=196.7
Q ss_pred HHHHHhCCCCCCceeecCCcceEEEEEeC-CCcEEEEEEeccCcC-ChhhhHHHHHHHHHHHhcCCcceeeeeeEEEcCC
Q 038766 6 EIENATGSFSENNIIGNSNLSTVYKGRLE-DGEIVAVKKLNFHQF-SAESDKSFYREAKTLKELKHRNLVKVLGYAWESG 83 (299)
Q Consensus 6 ~~~~~~~~y~~~~~lg~g~~~~v~~~~~~-~~~~~~vK~~~~~~~-~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~ 83 (299)
+.....++|.+.+.||+|++|.||++.+. +++.||+|++..... .......+.+|+..++.++||||+++++++.. .
T Consensus 5 ~g~~~~~~y~i~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~-~ 83 (276)
T 2h6d_A 5 DGRVKIGHYVLGDTLGVGTFGKVKIGEHQLTGHKVAVKILNRQKIRSLDVVGKIKREIQNLKLFRHPHIIKLYQVIST-P 83 (276)
T ss_dssp --CCEETTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTCCCTTBCCEEEEEEC-S
T ss_pred cCcceeccEEEEeeecCCCCeEEEEEEECCCCceEEEEEeccccccchhHHHHHHHHHHHHhcCCCCCEeEEEEEEec-C
Confidence 34456789999999999999999999875 689999999864322 22345678899999999999999999997655 5
Q ss_pred CeeEEEEeecCCCChHHHhcCCCCCCCCCChhhHHHHHHHHHHHHHHhhcCCCCCeeeecccCCceeeCCCCcEEEeeec
Q 038766 84 KLKALILEYMENGSLESVIHGPGVDHSRWTLPKRIDVLISVANGLDYLHSGYDIPIVHCDMKPSNILLDRDFEAHVSDFG 163 (299)
Q Consensus 84 ~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lh~~~~~~~~H~dl~~~nil~~~~~~v~l~df~ 163 (299)
...++|+|++.+++|.+++. ....+++..++.++.|++.||.+||++ +++|+||+|+||+++.++.++|+|||
T Consensus 84 ~~~~lv~e~~~~~~L~~~l~----~~~~~~~~~~~~~~~qi~~~l~~lH~~---~i~H~dl~p~Nil~~~~~~~~l~dfg 156 (276)
T 2h6d_A 84 TDFFMVMEYVSGGELFDYIC----KHGRVEEMEARRLFQQILSAVDYCHRH---MVVHRDLKPENVLLDAHMNAKIADFG 156 (276)
T ss_dssp SEEEEEEECCCSCBHHHHHH----HHCSCCHHHHHHHHHHHHHHHHHHHHH---CSSCCCCCGGGEEECTTSCEEECCCC
T ss_pred CeEEEEEeccCCCcHHHHHh----ccCCCCHHHHHHHHHHHHHHHHHHHHC---CCccCCCChhhEEECCCCCEEEeecc
Confidence 56799999999999999987 345789999999999999999999999 99999999999999999999999999
Q ss_pred cccccccccccccccccccccCcccCChhhhcccCc-CccccchhhhHHHHHHHhCCCCCCCCccCCCCchhHHHHHHHH
Q 038766 164 TSRMLDVHLQDLSSLSTAFQGTIGYLAPEFAYMRIV-TTKVDVFSFGIVVMEFLTKRRPTGLDEENGLSPISLRQLVEKA 242 (299)
Q Consensus 164 ~~~~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~-~~~~DiwslG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~ 242 (299)
++..... ........+++.|+|||.+.+..+ +.++||||||+++|+|++|..||.... .. ......
T Consensus 157 ~~~~~~~-----~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~-----~~---~~~~~~ 223 (276)
T 2h6d_A 157 LSNMMSD-----GEFLRTSCGSPNYAAPEVISGRLYAGPEVDIWSCGVILYALLCGTLPFDDEH-----VP---TLFKKI 223 (276)
T ss_dssp GGGCCCC------------------CCTGGGTTSCCCHHHHHHHHHHHHHHHHHHSSCSSCCSS-----HH---HHHHHH
T ss_pred cccccCC-----CcceecccCCccccCHHHHcCCCCCCccchHHHHHHHHHHHHhCCCCCCCCc-----HH---HHHHHh
Confidence 9876542 122234457889999999887765 689999999999999999999985321 11 222221
Q ss_pred HhcCccCcccccCccccchhhHhHHHHHHHHHHHHHHHHhcCCCCCCCCChhhhhcC
Q 038766 243 LANGINGVRQITDPKLVSSIYEEQEQHQVLEELFKLALVCTSSNPEDRPNMNELLIT 299 (299)
Q Consensus 243 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rpt~~~il~~ 299 (299)
.... .. . +..++..+.++|.+||..||++|||++++++|
T Consensus 224 ~~~~-~~---~--------------~~~~~~~l~~li~~~l~~~p~~Rps~~~~l~h 262 (276)
T 2h6d_A 224 RGGV-FY---I--------------PEYLNRSVATLLMHMLQVDPLKRATIKDIREH 262 (276)
T ss_dssp HHCC-CC---C--------------CTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHS
T ss_pred hcCc-cc---C--------------chhcCHHHHHHHHHHccCChhhCCCHHHHHhC
Confidence 1111 00 0 11234578999999999999999999999987
|
| >2acx_A G protein-coupled receptor kinase 6; GRK, G transferase; HET: ANP; 2.60A {Homo sapiens} PDB: 3nyn_A* 3nyo_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.5e-45 Score=329.73 Aligned_cols=258 Identities=20% Similarity=0.276 Sum_probs=206.6
Q ss_pred HHhCCCCCCceeecCCcceEEEEEeC-CCcEEEEEEeccCcC-ChhhhHHHHHHHHHHHhcCCcceeeeeeEEEcCCCee
Q 038766 9 NATGSFSENNIIGNSNLSTVYKGRLE-DGEIVAVKKLNFHQF-SAESDKSFYREAKTLKELKHRNLVKVLGYAWESGKLK 86 (299)
Q Consensus 9 ~~~~~y~~~~~lg~g~~~~v~~~~~~-~~~~~~vK~~~~~~~-~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~ 86 (299)
...++|.+.+.||+|+||.||++.+. +|+.||+|++..... .......+.+|+.+++.++||||+++++++.. ....
T Consensus 181 ~~~~~f~~~~~LG~G~fG~Vy~a~~~~tg~~vAvK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~~~~-~~~l 259 (576)
T 2acx_A 181 VTKNTFRQYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKQILEKVNSRFVVSLAYAYET-KDAL 259 (576)
T ss_dssp CCGGGEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHCCCTTBCCEEEEEEC-SSEE
T ss_pred ccccceEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEhHhhhhhHHHHHHHHHHHHHHHcCCCCEeeEEEEEee-CCEE
Confidence 34577999999999999999999874 699999999864322 22335667899999999999999999996655 5567
Q ss_pred EEEEeecCCCChHHHhcCCCCCCCCCChhhHHHHHHHHHHHHHHhhcCCCCCeeeecccCCceeeCCCCcEEEeeecccc
Q 038766 87 ALILEYMENGSLESVIHGPGVDHSRWTLPKRIDVLISVANGLDYLHSGYDIPIVHCDMKPSNILLDRDFEAHVSDFGTSR 166 (299)
Q Consensus 87 ~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lh~~~~~~~~H~dl~~~nil~~~~~~v~l~df~~~~ 166 (299)
++||||+.+++|.+++... ....+++..++.++.||+.||.|||++ +++||||||+||+++.+|.+||+|||++.
T Consensus 260 ~lVmEy~~gg~L~~~l~~~--~~~~l~e~~~~~i~~qIl~aL~yLH~~---gIvHrDLKPeNILld~~g~vKL~DFGla~ 334 (576)
T 2acx_A 260 CLVLTLMNGGDLKFHIYHM--GQAGFPEARAVFYAAEICCGLEDLHRE---RIVYRDLKPENILLDDHGHIRISDLGLAV 334 (576)
T ss_dssp EEEECCCCSCBHHHHHHSS--SSCCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEECTTSCEEECCCTTCE
T ss_pred EEEEEcCCCCcHHHHHHhc--CCCCCCHHHHHHHHHHHHHHHHHHHHC---CEeccCCchheEEEeCCCCeEEEecccce
Confidence 9999999999999988743 234599999999999999999999999 99999999999999999999999999997
Q ss_pred ccccccccccccccccccCcccCChhhhcccCcCccccchhhhHHHHHHHhCCCCCCCCccCCCCchhHHHHHHHHHhcC
Q 038766 167 MLDVHLQDLSSLSTAFQGTIGYLAPEFAYMRIVTTKVDVFSFGIVVMEFLTKRRPTGLDEENGLSPISLRQLVEKALANG 246 (299)
Q Consensus 167 ~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~DiwslG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~ 246 (299)
.... ........+|+.|+|||++.+..++.++|+|||||++|+|++|..||....... ....+... .. ..
T Consensus 335 ~~~~-----~~~~~~~~GT~~Y~APEvl~~~~~~~~~DiwSLGvilyeLltG~~PF~~~~~~~-~~~~i~~~---i~-~~ 404 (576)
T 2acx_A 335 HVPE-----GQTIKGRVGTVGYMAPEVVKNERYTFSPDWWALGCLLYEMIAGQSPFQQRKKKI-KREEVERL---VK-EV 404 (576)
T ss_dssp ECCT-----TCCEECCCSCGGGCCHHHHTTCEESSHHHHHHHHHHHHHHHHSSCSSSCSSSCC-CHHHHHHH---HH-HC
T ss_pred eccc-----CccccccCCCccccCHHHHcCCCCCccchHHHHHHHHHHHHhCCCCCcccccch-hHHHHHHH---hh-cc
Confidence 6542 112234578999999999999999999999999999999999999996542211 11112211 11 11
Q ss_pred ccCcccccCccccchhhHhHHHHHHHHHHHHHHHHhcCCCCCCCC-----ChhhhhcC
Q 038766 247 INGVRQITDPKLVSSIYEEQEQHQVLEELFKLALVCTSSNPEDRP-----NMNELLIT 299 (299)
Q Consensus 247 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rp-----t~~~il~~ 299 (299)
.... +..++.++.+||++||..||++|| +++|+++|
T Consensus 405 ~~~~-----------------p~~~s~~~~dLI~~lL~~dP~~R~g~~~~sa~eil~H 445 (576)
T 2acx_A 405 PEEY-----------------SERFSPQARSLCSQLLCKDPAERLGCRGGSAREVKEH 445 (576)
T ss_dssp CCCC-----------------CTTSCHHHHHHHHHHTCSSGGGSTTCSSSHHHHHHTS
T ss_pred cccC-----------------CccCCHHHHHHHHHhccCCHHHcCCCCCCCHHHHHhC
Confidence 1010 123456899999999999999999 78999987
|
| >4exu_A Mitogen-activated protein kinase 13; P38 kinase, transferase; 1.70A {Homo sapiens} PDB: 4eyj_A* 4eym_A* 3coi_A | Back alignment and structure |
|---|
Probab=100.00 E-value=9e-45 Score=314.57 Aligned_cols=268 Identities=23% Similarity=0.280 Sum_probs=200.8
Q ss_pred HhCCCCCCceeecCCcceEEEEEeC-CCcEEEEEEeccCcCChhhhHHHHHHHHHHHhcCCcceeeeeeEEEcCCCe---
Q 038766 10 ATGSFSENNIIGNSNLSTVYKGRLE-DGEIVAVKKLNFHQFSAESDKSFYREAKTLKELKHRNLVKVLGYAWESGKL--- 85 (299)
Q Consensus 10 ~~~~y~~~~~lg~g~~~~v~~~~~~-~~~~~~vK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~--- 85 (299)
+.++|.+.+.||+|+||+||+|.+. +|+.||+|++............+.+|+.+++.++||||+++++++...+..
T Consensus 40 l~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~ 119 (371)
T 4exu_A 40 LPKTYVSPTHVGSGAYGSVCSAIDKRSGEKVAIKKLSRPFQSEIFAKRAYRELLLLKHMQHENVIGLLDVFTPASSLRNF 119 (371)
T ss_dssp EETTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCSSSTTC
T ss_pred ccccEEEEeEEecCCCeEEEEEEECCCCCEEEEEEecccccchhHHHHHHHHHHHHHhcCCCCchhhhhheeccCCcccc
Confidence 5689999999999999999999874 689999999976655666678889999999999999999999977654432
Q ss_pred --eEEEEeecCCCChHHHhcCCCCCCCCCChhhHHHHHHHHHHHHHHhhcCCCCCeeeecccCCceeeCCCCcEEEeeec
Q 038766 86 --KALILEYMENGSLESVIHGPGVDHSRWTLPKRIDVLISVANGLDYLHSGYDIPIVHCDMKPSNILLDRDFEAHVSDFG 163 (299)
Q Consensus 86 --~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lh~~~~~~~~H~dl~~~nil~~~~~~v~l~df~ 163 (299)
.++|+|++. ++|.+.+. ..+++..++.++.|++.||+|||+. +++|+||||+||+++.++.++|+|||
T Consensus 120 ~~~~lv~e~~~-~~l~~~~~------~~~~~~~~~~i~~qi~~aL~~LH~~---~ivH~Dikp~NIll~~~~~~kL~Dfg 189 (371)
T 4exu_A 120 YDFYLVMPFMQ-TDLQKIMG------MEFSEEKIQYLVYQMLKGLKYIHSA---GVVHRDLKPGNLAVNEDCELKILDFG 189 (371)
T ss_dssp CCCEEEEECCC-EEHHHHTT------SCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEECTTCCEEECSTT
T ss_pred eeEEEEEcccc-ccHHHHhh------cCCCHHHHHHHHHHHHHHHHHHHHC---CCcCCCcCHHHeEECCCCCEEEEecC
Confidence 389999996 58888874 3489999999999999999999999 99999999999999999999999999
Q ss_pred cccccccccccccccccccccCcccCChhhhcc-cCcCccccchhhhHHHHHHHhCCCCCCCCccCCCCchhHHHHHHHH
Q 038766 164 TSRMLDVHLQDLSSLSTAFQGTIGYLAPEFAYM-RIVTTKVDVFSFGIVVMEFLTKRRPTGLDEENGLSPISLRQLVEKA 242 (299)
Q Consensus 164 ~~~~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~-~~~~~~~DiwslG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~ 242 (299)
++.... .......+++.|+|||.+.+ ..++.++|||||||++|+|++|..||.... .......+...
T Consensus 190 ~a~~~~-------~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~-----~~~~~~~i~~~ 257 (371)
T 4exu_A 190 LARHAD-------AEMTGYVVTRWYRAPEVILSWMHYNQTVDIWSVGCIMAEMLTGKTLFKGKD-----YLDQLTQILKV 257 (371)
T ss_dssp CC---------------CTTCCCTTSCHHHHSCCSCCCTTHHHHHHHHHHHHHHHSSCSCCCSS-----HHHHHHHHHHH
T ss_pred cccccc-------cCcCCcccCccccCHHHhcCCCCCCcHHhHHHHHHHHHHHHhCCCCCCCCC-----hHHHHHHHHHH
Confidence 987543 22334567899999999887 678999999999999999999999995432 11111111111
Q ss_pred HhcCccCc-ccccCccc---------cchhhHhHHHHHHHHHHHHHHHHhcCCCCCCCCChhhhhcC
Q 038766 243 LANGINGV-RQITDPKL---------VSSIYEEQEQHQVLEELFKLALVCTSSNPEDRPNMNELLIT 299 (299)
Q Consensus 243 ~~~~~~~~-~~~~~~~~---------~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rpt~~~il~~ 299 (299)
........ ..+..... ............++.++.+||++||..||++|||++|+|+|
T Consensus 258 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~h 324 (371)
T 4exu_A 258 TGVPGTEFVQKLNDKAAKSYIQSLPQTPRKDFTQLFPRASPQAADLLEKMLELDVDKRLTAAQALTH 324 (371)
T ss_dssp HCCCCHHHHTTCSCHHHHHHHHHSCCCCCCCHHHHSTTSCHHHHHHHHHHSCSCTTTSCCHHHHHTS
T ss_pred hCCCcHHHHHHhhhhhhhhhhhccCCCcchhHHHhccccChHHHHHHHHHCCCChhhcCCHHHHhcC
Confidence 10000000 00000000 00000001122346789999999999999999999999987
|
| >3qup_A Tyrosine-protein kinase receptor TYRO3; protein kinase inhibitor, receptor tyrosine kinase, spirocyc kinase domain, phosphotransfer, GAS6 ligand; HET: LUN; 1.90A {Mus musculus} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-45 Score=314.11 Aligned_cols=263 Identities=24% Similarity=0.415 Sum_probs=189.5
Q ss_pred HHHHHhCCCCCCceeecCCcceEEEEEeCC-C---cEEEEEEeccCcCChhhhHHHHHHHHHHHhcCCcceeeeeeEEEc
Q 038766 6 EIENATGSFSENNIIGNSNLSTVYKGRLED-G---EIVAVKKLNFHQFSAESDKSFYREAKTLKELKHRNLVKVLGYAWE 81 (299)
Q Consensus 6 ~~~~~~~~y~~~~~lg~g~~~~v~~~~~~~-~---~~~~vK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~ 81 (299)
++....++|.+.+.||+|+||+||+|.+.. + ..||+|++..........+.+.+|+.+++.++||||+++++++..
T Consensus 17 ~~~i~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~ 96 (323)
T 3qup_A 17 DVLIPEQQFTLGRMLGKGEFGSVREAQLKQEDGSFVKVAVKMLKADIIASSDIEEFLREAACMKEFDHPHVAKLVGVSLR 96 (323)
T ss_dssp TTBCC---CEEEEEEEEETTEEEEEEEC-------CEEEEEEC------CHHHHHHHHHHHHHTTCCCTTBCCCCEEEEC
T ss_pred hcccChhHeEEeceecccCCeEEEEEEEcccCCcceeEEEEEecccccCHHHHHHHHHHHHHHHHCCCCceehhhceeec
Confidence 344557889999999999999999998653 3 379999997655566667889999999999999999999997765
Q ss_pred CCCe-----eEEEEeecCCCChHHHhcCC--CCCCCCCChhhHHHHHHHHHHHHHHhhcCCCCCeeeecccCCceeeCCC
Q 038766 82 SGKL-----KALILEYMENGSLESVIHGP--GVDHSRWTLPKRIDVLISVANGLDYLHSGYDIPIVHCDMKPSNILLDRD 154 (299)
Q Consensus 82 ~~~~-----~~lv~e~~~~~~L~~~~~~~--~~~~~~~~~~~~~~i~~qi~~~l~~lh~~~~~~~~H~dl~~~nil~~~~ 154 (299)
.... .++|+||+.+++|.+++... +.....+++..++.++.|++.||+|||++ +++|+||||+||+++.+
T Consensus 97 ~~~~~~~~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~qi~~al~~LH~~---~ivH~Dikp~NIli~~~ 173 (323)
T 3qup_A 97 SRAKGRLPIPMVILPFMKHGDLHAFLLASRIGENPFNLPLQTLVRFMVDIACGMEYLSSR---NFIHRDLAARNCMLAED 173 (323)
T ss_dssp C-------CEEEEEECCTTCBHHHHHHHHHC---CCCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEECTT
T ss_pred cccccCCCccEEEEEeccCCcHHHHHHhhhccccccccCHHHHHHHHHHHHHHHHHHHcC---CcccCCCCcceEEEcCC
Confidence 4332 38999999999999988532 11233689999999999999999999999 99999999999999999
Q ss_pred CcEEEeeeccccccccccccccccccccccCcccCChhhhcccCcCccccchhhhHHHHHHHh-CCCCCCCCccCCCCch
Q 038766 155 FEAHVSDFGTSRMLDVHLQDLSSLSTAFQGTIGYLAPEFAYMRIVTTKVDVFSFGIVVMEFLT-KRRPTGLDEENGLSPI 233 (299)
Q Consensus 155 ~~v~l~df~~~~~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~DiwslG~~l~~l~~-g~~p~~~~~~~~~~~~ 233 (299)
+.++|+|||++....... .........+++.|+|||.+.+..++.++|||||||++|+|++ |..||.... ..
T Consensus 174 ~~~kl~Dfg~a~~~~~~~--~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ell~~g~~p~~~~~-----~~ 246 (323)
T 3qup_A 174 MTVCVADFGLSRKIYSGD--YYRQGCASKLPVKWLALESLADNLYTVHSDVWAFGVTMWEIMTRGQTPYAGIE-----NA 246 (323)
T ss_dssp SCEEECCCCC-------------------CCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCC-----GG
T ss_pred CCEEEeeccccccccccc--cccccccccCcccccCchhhcCCCCCCccchhhHHHHHHHHHhCCCCCccccC-----hH
Confidence 999999999997654211 1112223445778999999999999999999999999999999 889985432 22
Q ss_pred hHHHHHHHHHhcCccCcccccCccccchhhHhHHHHHHHHHHHHHHHHhcCCCCCCCCChhhhhc
Q 038766 234 SLRQLVEKALANGINGVRQITDPKLVSSIYEEQEQHQVLEELFKLALVCTSSNPEDRPNMNELLI 298 (299)
Q Consensus 234 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rpt~~~il~ 298 (299)
..... ...... ... +..++.++.+++.+||..||++|||+.++++
T Consensus 247 ~~~~~---~~~~~~-----~~~------------~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~ 291 (323)
T 3qup_A 247 EIYNY---LIGGNR-----LKQ------------PPECMEEVYDLMYQCWSADPKQRPSFTCLRM 291 (323)
T ss_dssp GHHHH---HHTTCC-----CCC------------CTTCCHHHHHHHHHTTCSSGGGSCCHHHHHH
T ss_pred HHHHH---HhcCCC-----CCC------------CCccCHHHHHHHHHHccCChhhCcCHHHHHH
Confidence 22221 111110 000 1233467999999999999999999777653
|
| >3l9p_A Anaplastic lymphoma kinase; kinase domain, ATP-binding, glycoprotein, membrane, nucleotide-binding, phosphoprotein, proto-oncogene; 1.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=7.6e-46 Score=320.71 Aligned_cols=259 Identities=24% Similarity=0.362 Sum_probs=202.0
Q ss_pred HHhCCCCCCceeecCCcceEEEEEeC------CCcEEEEEEeccCcCChhhhHHHHHHHHHHHhcCCcceeeeeeEEEcC
Q 038766 9 NATGSFSENNIIGNSNLSTVYKGRLE------DGEIVAVKKLNFHQFSAESDKSFYREAKTLKELKHRNLVKVLGYAWES 82 (299)
Q Consensus 9 ~~~~~y~~~~~lg~g~~~~v~~~~~~------~~~~~~vK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~ 82 (299)
...++|.+.+.||+|+||+||+|.+. ++..||+|++.. .........+.+|+.+++.++||||+++++++..
T Consensus 68 ~~~~~~~~~~~LG~G~fg~Vy~~~~~~~~~~~~~~~vavK~~~~-~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~- 145 (367)
T 3l9p_A 68 VPRKNITLIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPE-VCSEQDELDFLMEALIISKFNHQNIVRCIGVSLQ- 145 (367)
T ss_dssp CCGGGEEEEEECCCCSSSCEEEEEECC-----CCEEEEEEECCS-SCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEECS-
T ss_pred cCHhHeEEeeEeeeCCCEEEEEEEEccCCCCCcceeEEEEeccc-ccChhhHHHHHHHHHHHHhCCCCCCCeEEEEEec-
Confidence 34578999999999999999999842 467899999863 3345556678899999999999999999997655
Q ss_pred CCeeEEEEeecCCCChHHHhcCCC---CCCCCCChhhHHHHHHHHHHHHHHhhcCCCCCeeeecccCCceeeCCCC---c
Q 038766 83 GKLKALILEYMENGSLESVIHGPG---VDHSRWTLPKRIDVLISVANGLDYLHSGYDIPIVHCDMKPSNILLDRDF---E 156 (299)
Q Consensus 83 ~~~~~lv~e~~~~~~L~~~~~~~~---~~~~~~~~~~~~~i~~qi~~~l~~lh~~~~~~~~H~dl~~~nil~~~~~---~ 156 (299)
+...++|+||+.+++|.+++.... .....+++..++.++.|++.||+|||++ +++||||||+||+++.++ .
T Consensus 146 ~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~---~ivHrDlkp~NIll~~~~~~~~ 222 (367)
T 3l9p_A 146 SLPRFILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYLEEN---HFIHRDIAARNCLLTCPGPGRV 222 (367)
T ss_dssp SSSCEEEEECCTTEEHHHHHHHHSCCSSSCCCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEESCSSTTCC
T ss_pred CCCCEEEEEeCCCCCHHHHHHhhccccCccccccHHHHHHHHHHHHHHHHHHHhC---CeeCCCCChhhEEEecCCCCce
Confidence 445599999999999999986432 1234689999999999999999999999 999999999999999554 5
Q ss_pred EEEeeeccccccccccccccccccccccCcccCChhhhcccCcCccccchhhhHHHHHHHh-CCCCCCCCccCCCCchhH
Q 038766 157 AHVSDFGTSRMLDVHLQDLSSLSTAFQGTIGYLAPEFAYMRIVTTKVDVFSFGIVVMEFLT-KRRPTGLDEENGLSPISL 235 (299)
Q Consensus 157 v~l~df~~~~~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~DiwslG~~l~~l~~-g~~p~~~~~~~~~~~~~~ 235 (299)
++|+|||++...... ..........+++.|+|||++.+..++.++|||||||++|+|++ |..||... ...
T Consensus 223 ~kL~DFG~a~~~~~~--~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DvwslG~il~ellt~g~~pf~~~-----~~~-- 293 (367)
T 3l9p_A 223 AKIGDFGMARDIYRA--GYYRKGGCAMLPVKWMPPEAFMEGIFTSKTDTWSFGVLLWEIFSLGYMPYPSK-----SNQ-- 293 (367)
T ss_dssp EEECCCHHHHHHHHH--SSCTTCCGGGSCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTC-----CHH--
T ss_pred EEECCCccccccccc--cccccCCCcCCcccEECHHHhcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCC-----CHH--
Confidence 999999999754321 11222334557889999999999999999999999999999998 88998533 122
Q ss_pred HHHHHHHHhcCccCcccccCccccchhhHhHHHHHHHHHHHHHHHHhcCCCCCCCCChhhhhcC
Q 038766 236 RQLVEKALANGINGVRQITDPKLVSSIYEEQEQHQVLEELFKLALVCTSSNPEDRPNMNELLIT 299 (299)
Q Consensus 236 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rpt~~~il~~ 299 (299)
+............ . +..++..+.+|+.+||..||++|||+++++++
T Consensus 294 -~~~~~i~~~~~~~-----~------------~~~~~~~l~~li~~~l~~dP~~Rps~~eil~~ 339 (367)
T 3l9p_A 294 -EVLEFVTSGGRMD-----P------------PKNCPGPVYRIMTQCWQHQPEDRPNFAIILER 339 (367)
T ss_dssp -HHHHHHHTTCCCC-----C------------CTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred -HHHHHHHcCCCCC-----C------------CccCCHHHHHHHHHHcCCCHhHCcCHHHHHHH
Confidence 2222222111000 0 12234578999999999999999999999864
|
| >2ycf_A Serine/threonine-protein kinase CHK2; transferase, anticancer, anticancer drug design; HET: YCF; 1.77A {Homo sapiens} PDB: 2yiq_A* 2w7x_A* 2ycq_A* 2ycs_A* 2w0j_A* 2yir_A* 2yit_A* 2wtj_A* 2cn8_A* 2wtc_A* 2wtd_A* 2wti_A* 2cn5_A* 2xbj_A* 2xm8_A* 2xm9_A* 2xk9_A* 2ycr_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.5e-45 Score=310.12 Aligned_cols=256 Identities=24% Similarity=0.324 Sum_probs=198.3
Q ss_pred HHhCCCCCCceeecCCcceEEEEEeC-CCcEEEEEEeccCcC------ChhhhHHHHHHHHHHHhcCCcceeeeeeEEEc
Q 038766 9 NATGSFSENNIIGNSNLSTVYKGRLE-DGEIVAVKKLNFHQF------SAESDKSFYREAKTLKELKHRNLVKVLGYAWE 81 (299)
Q Consensus 9 ~~~~~y~~~~~lg~g~~~~v~~~~~~-~~~~~~vK~~~~~~~------~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~ 81 (299)
.+.++|.+.+.||+|+||.||++.+. +++.||+|++..... .......+.+|+.+++.++||||+++++++..
T Consensus 7 ~l~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~ 86 (322)
T 2ycf_A 7 ALRDEYIMSKTLGSGACGEVKLAFERKTCKKVAIKIISKRKFAIGSAREADPALNVETEIEILKKLNHPCIIKIKNFFDA 86 (322)
T ss_dssp HHHHHEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECC---------------CHHHHHHHHHHCCCTTBCCEEEEEES
T ss_pred hhhhceeEeeEEecCCCEEEEEEEEcCCCcEEEEEEeehhhhhhcccccchhhhhHHHHHHHHHhCCCCCCceEeeEEcC
Confidence 46789999999999999999999874 588999999865332 12223457899999999999999999996654
Q ss_pred CCCeeEEEEeecCCCChHHHhcCCCCCCCCCChhhHHHHHHHHHHHHHHhhcCCCCCeeeecccCCceeeCCCCc---EE
Q 038766 82 SGKLKALILEYMENGSLESVIHGPGVDHSRWTLPKRIDVLISVANGLDYLHSGYDIPIVHCDMKPSNILLDRDFE---AH 158 (299)
Q Consensus 82 ~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lh~~~~~~~~H~dl~~~nil~~~~~~---v~ 158 (299)
+. .++|+||+.+++|.+.+. ....+++..++.++.|++.||.|||++ +++|+||||+||+++.++. ++
T Consensus 87 -~~-~~lv~e~~~~~~L~~~~~----~~~~~~~~~~~~~~~qi~~~l~~lH~~---~ivH~dlkp~NIl~~~~~~~~~~k 157 (322)
T 2ycf_A 87 -ED-YYIVLELMEGGELFDKVV----GNKRLKEATCKLYFYQMLLAVQYLHEN---GIIHRDLKPENVLLSSQEEDCLIK 157 (322)
T ss_dssp -SS-EEEEEECCTTEETHHHHS----TTCCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEESSSSSSCCEE
T ss_pred -Cc-eEEEEecCCCCcHHHHHh----ccCCCCHHHHHHHHHHHHHHHHHHHHC---CeeccCCCHHHEEEecCCCCCeEE
Confidence 33 599999999999999887 456899999999999999999999999 9999999999999987654 99
Q ss_pred EeeeccccccccccccccccccccccCcccCChhhhc---ccCcCccccchhhhHHHHHHHhCCCCCCCCccCCCCchhH
Q 038766 159 VSDFGTSRMLDVHLQDLSSLSTAFQGTIGYLAPEFAY---MRIVTTKVDVFSFGIVVMEFLTKRRPTGLDEENGLSPISL 235 (299)
Q Consensus 159 l~df~~~~~~~~~~~~~~~~~~~~~~~~~y~~PE~~~---~~~~~~~~DiwslG~~l~~l~~g~~p~~~~~~~~~~~~~~ 235 (299)
|+|||++..... ........+++.|+|||++. ...++.++||||||+++|+|++|..||....... .+
T Consensus 158 l~Dfg~~~~~~~-----~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~----~~ 228 (322)
T 2ycf_A 158 ITDFGHSKILGE-----TSLMRTLCGTPTYLAPEVLVSVGTAGYNRAVDCWSLGVILFICLSGYPPFSEHRTQV----SL 228 (322)
T ss_dssp ECCCTTCEECCC-----CHHHHHHHSCCTTCCHHHHHHTTTTTCTTHHHHHHHHHHHHHHHHSSCSSCSTTCSS----CH
T ss_pred EccCccceeccc-----ccccccccCCcCccCchhhccCCCCCCCchhhHHHHHHHHHHHHhCCCCCcccchHH----HH
Confidence 999999876531 11223445789999999874 4568899999999999999999999996432221 11
Q ss_pred HHHHHHHHhcCccCcccccCccccchhhHhHHHHHHHHHHHHHHHHhcCCCCCCCCChhhhhcC
Q 038766 236 RQLVEKALANGINGVRQITDPKLVSSIYEEQEQHQVLEELFKLALVCTSSNPEDRPNMNELLIT 299 (299)
Q Consensus 236 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rpt~~~il~~ 299 (299)
...+.. ... .. .......++..+.++|.+||..||++|||++++|+|
T Consensus 229 ~~~~~~---~~~-~~-------------~~~~~~~~~~~~~~li~~~l~~dP~~Rps~~~~l~h 275 (322)
T 2ycf_A 229 KDQITS---GKY-NF-------------IPEVWAEVSEKALDLVKKLLVVDPKARFTTEEALRH 275 (322)
T ss_dssp HHHHHH---TCC-CC-------------CHHHHTTSCHHHHHHHHHHSCSSTTTSCCHHHHHTS
T ss_pred HHHHHh---Ccc-cc-------------CchhhhhcCHHHHHHHHHHcccCHhhCCCHHHHhhC
Confidence 121111 000 00 001123456789999999999999999999999987
|
| >3byv_A Rhoptry kinase; malaria, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} PDB: 2w1z_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-46 Score=326.24 Aligned_cols=247 Identities=19% Similarity=0.205 Sum_probs=190.1
Q ss_pred hCCCCCCceeecCCcceEEEEEe-CCCcEEEEEEeccCcC-ChhhhHHHHHHH---HHHHhcCCcceeeee-------eE
Q 038766 11 TGSFSENNIIGNSNLSTVYKGRL-EDGEIVAVKKLNFHQF-SAESDKSFYREA---KTLKELKHRNLVKVL-------GY 78 (299)
Q Consensus 11 ~~~y~~~~~lg~g~~~~v~~~~~-~~~~~~~vK~~~~~~~-~~~~~~~~~~e~---~~l~~l~h~~i~~~~-------~~ 78 (299)
.++|.+.+.||+|+||+||+|.+ .+|+.||||++..... .....+.+.+|+ +.++.++||||++++ ++
T Consensus 72 ~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~l~hpniv~~~~~~~~~~~~ 151 (377)
T 3byv_A 72 PRTLVRGTVLGQEDPYAYLEATDQETGESFEVHVPYFTERPPSNAIKQMKEEVLRLRLLRGIKNQKQAKVHLRFIFPFDL 151 (377)
T ss_dssp CEEEEEEEEEEEETTEEEEEEEC-CCCCEEEEEEEEECC-CCTTHHHHHHHHHHGGGGSTTCCSHHHHHHHHCBCCCSEE
T ss_pred CceEEEcceeecCCCEEEEEEEECCCCcEEEEEEEeeccccchHHHHHHHHHHHHHHhccccCCHHHHHHHhhhhhhhhh
Confidence 46789999999999999999996 5699999999975432 344567888999 455555799999988 55
Q ss_pred EEcCCC----------------eeEEEEeecCCCChHHHhcCCC---CCCCCCChhhHHHHHHHHHHHHHHhhcCCCCCe
Q 038766 79 AWESGK----------------LKALILEYMENGSLESVIHGPG---VDHSRWTLPKRIDVLISVANGLDYLHSGYDIPI 139 (299)
Q Consensus 79 ~~~~~~----------------~~~lv~e~~~~~~L~~~~~~~~---~~~~~~~~~~~~~i~~qi~~~l~~lh~~~~~~~ 139 (299)
+...+. ..++||||+ +++|.+++...+ .....+++..++.++.||+.||+|||++ ++
T Consensus 152 ~~~~~~~~~~~~~~~~~~~~i~~~~lv~E~~-~g~L~~~l~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~---~i 227 (377)
T 3byv_A 152 VKDPQKKKMIRVRLDERDMWVLSRFFLYPRM-QSNLQTFGEVLLSHSSTHKSLVHHARLQLTLQVIRLLASLHHY---GL 227 (377)
T ss_dssp EECTTSCSEEEC------CEEESEEEEEECC-SEEHHHHHHHHHHTTTTTHHHHHHHHHHHHHHHHHHHHHHHHT---TE
T ss_pred hhccCCccccccccCCCceEEEEEEEEEecc-CCCHHHHHHhccccccccccccHHHHHHHHHHHHHHHHHHHhC---Ce
Confidence 443322 268999999 579999886321 0122344588889999999999999999 99
Q ss_pred eeecccCCceeeCCCCcEEEeeeccccccccccccccccccccccCcccCChhhhccc-----------CcCccccchhh
Q 038766 140 VHCDMKPSNILLDRDFEAHVSDFGTSRMLDVHLQDLSSLSTAFQGTIGYLAPEFAYMR-----------IVTTKVDVFSF 208 (299)
Q Consensus 140 ~H~dl~~~nil~~~~~~v~l~df~~~~~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~-----------~~~~~~Diwsl 208 (299)
+|+||||+|||++.++.+||+|||++.... .......+ +.|+|||++.+. .++.++|||||
T Consensus 228 vHrDikp~NIll~~~~~~kL~DFG~a~~~~-------~~~~~~~g-~~y~aPE~~~~~~~~~~~~~~~~~~~~~~DvwSl 299 (377)
T 3byv_A 228 VHTYLRPVDIVLDQRGGVFLTGFEHLVRDG-------ARVVSSVS-RGFEPPELEARRATISYHRDRRTLMTFSFDAWAL 299 (377)
T ss_dssp ECSCCCGGGEEECTTCCEEECCGGGCEETT-------CEEECCCC-TTCCCHHHHHHHTSTHHHHCCEEECCHHHHHHHH
T ss_pred ecCCCCHHHEEEcCCCCEEEEechhheecC-------CcccCCCC-cCccChhhhcccccccccccccccCChhhhHHHH
Confidence 999999999999999999999999987532 22334456 899999999887 89999999999
Q ss_pred hHHHHHHHhCCCCCCCCccCCCCchhHHHHHHHHHhcCccCcccccCccccchhhHhHHHHHHHHHHHHHHHHhcCCCCC
Q 038766 209 GIVVMEFLTKRRPTGLDEENGLSPISLRQLVEKALANGINGVRQITDPKLVSSIYEEQEQHQVLEELFKLALVCTSSNPE 288 (299)
Q Consensus 209 G~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~ 288 (299)
||++|+|++|..||.......... .+... ...++.++.+||.+||..||+
T Consensus 300 G~il~elltg~~Pf~~~~~~~~~~-------------------~~~~~-----------~~~~~~~~~~li~~~L~~dp~ 349 (377)
T 3byv_A 300 GLVIYWIWCADLPITKDAALGGSE-------------------WIFRS-----------CKNIPQPVRALLEGFLRYPKE 349 (377)
T ss_dssp HHHHHHHHHSSCCC------CCSG-------------------GGGSS-----------CCCCCHHHHHHHHHHTCSSGG
T ss_pred HHHHHHHHHCCCCCcccccccchh-------------------hhhhh-----------ccCCCHHHHHHHHHHcCCCch
Confidence 999999999999995432211110 00000 112356799999999999999
Q ss_pred CCCChhhhhcC
Q 038766 289 DRPNMNELLIT 299 (299)
Q Consensus 289 ~Rpt~~~il~~ 299 (299)
+|||+.++++|
T Consensus 350 ~Rpt~~e~l~h 360 (377)
T 3byv_A 350 DRLLPLQAMET 360 (377)
T ss_dssp GCCCHHHHHTS
T ss_pred hCCCHHHHhhC
Confidence 99999999987
|
| >4f0f_A Serine/threonine-protein kinase ROCO4; LRRK2, ATP-binding, nucleotide serine/threonine-protein kinase, transferase, signaling Pro; HET: ACP; 1.80A {Dictyostelium discoideum} PDB: 4f0g_A 4f1t_A* 4f1m_A* 4f1o_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-44 Score=302.21 Aligned_cols=251 Identities=25% Similarity=0.433 Sum_probs=197.2
Q ss_pred HhCCCCCCceeecCCcceEEEEEe-CCCcEEEEEEeccCcCChhhh-----HHHHHHHHHHHhcCCcceeeeeeEEEcCC
Q 038766 10 ATGSFSENNIIGNSNLSTVYKGRL-EDGEIVAVKKLNFHQFSAESD-----KSFYREAKTLKELKHRNLVKVLGYAWESG 83 (299)
Q Consensus 10 ~~~~y~~~~~lg~g~~~~v~~~~~-~~~~~~~vK~~~~~~~~~~~~-----~~~~~e~~~l~~l~h~~i~~~~~~~~~~~ 83 (299)
..++|.+.+.||+|+||+||++.+ .+++.||+|++.......... +.+.+|+.+++.++||||+++++++.. .
T Consensus 17 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~-~ 95 (287)
T 4f0f_A 17 ADNEIEYEKQIGKGGFGLVHKGRLVKDKSVVAIKSLILGDSEGETEMIEKFQEFQREVFIMSNLNHPNIVKLYGLMHN-P 95 (287)
T ss_dssp CSTTEEEEEECCCCSSSCEEEEEETTTCCEEEEEECCCCTTTCCHHHHCCSHHHHHHHHHHTTCCCTTBCCEEEEETT-T
T ss_pred hhccceehhccccCCceeEEEEEEcCCceEEEEEEeeccccccchhHHHHHHHHHHHHHHHHhCCCCCchhhheeecC-C
Confidence 457899999999999999999987 468999999986544332222 678899999999999999999996533 3
Q ss_pred CeeEEEEeecCCCChHHHhcCCCCCCCCCChhhHHHHHHHHHHHHHHhhcCCCCC--eeeecccCCceeeCCCCc-----
Q 038766 84 KLKALILEYMENGSLESVIHGPGVDHSRWTLPKRIDVLISVANGLDYLHSGYDIP--IVHCDMKPSNILLDRDFE----- 156 (299)
Q Consensus 84 ~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lh~~~~~~--~~H~dl~~~nil~~~~~~----- 156 (299)
. ++|+||+.+++|.+.+.. ...++++..++.++.|++.||+|||+. + ++|+||||+||+++.++.
T Consensus 96 ~--~lv~e~~~~~~L~~~l~~---~~~~~~~~~~~~~~~~l~~~l~~lH~~---~~~ivH~dikp~Nil~~~~~~~~~~~ 167 (287)
T 4f0f_A 96 P--RMVMEFVPCGDLYHRLLD---KAHPIKWSVKLRLMLDIALGIEYMQNQ---NPPIVHRDLRSPNIFLQSLDENAPVC 167 (287)
T ss_dssp T--EEEEECCTTCBHHHHHHC---TTSCCCHHHHHHHHHHHHHHHHHHHTS---SSCCBCSCCSGGGEEESCCCTTCSCC
T ss_pred C--eEEEEecCCCCHHHHHhc---ccCCccHHHHHHHHHHHHHHHHHHHhC---CCCeecCCCCcceEEEeccCCCCcee
Confidence 2 799999999999887753 345799999999999999999999998 8 999999999999988776
Q ss_pred EEEeeeccccccccccccccccccccccCcccCChhhhc--ccCcCccccchhhhHHHHHHHhCCCCCCCCccCCCCchh
Q 038766 157 AHVSDFGTSRMLDVHLQDLSSLSTAFQGTIGYLAPEFAY--MRIVTTKVDVFSFGIVVMEFLTKRRPTGLDEENGLSPIS 234 (299)
Q Consensus 157 v~l~df~~~~~~~~~~~~~~~~~~~~~~~~~y~~PE~~~--~~~~~~~~DiwslG~~l~~l~~g~~p~~~~~~~~~~~~~ 234 (299)
++|+|||++.... .......+++.|+|||.+. ...++.++||||||+++|+|++|..||...... .
T Consensus 168 ~kl~Dfg~~~~~~-------~~~~~~~g~~~y~aPE~~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~-----~ 235 (287)
T 4f0f_A 168 AKVADFGLSQQSV-------HSVSGLLGNFQWMAPETIGAEEESYTEKADTYSFAMILYTILTGEGPFDEYSYG-----K 235 (287)
T ss_dssp EEECCCTTCBCCS-------SCEECCCCCCTTSCGGGSSCSSCEECHHHHHHHHHHHHHHHHHSSCTTTTCCCC-----H
T ss_pred EEeCCCCcccccc-------ccccccCCCccccCchhhccCCCCcCchhhHHHHHHHHHHHHcCCCCCcccccc-----H
Confidence 9999999986433 2233456889999999984 455788999999999999999999999543211 1
Q ss_pred HHHHHHHHHhcCccCcccccCccccchhhHhHHHHHHHHHHHHHHHHhcCCCCCCCCChhhhhc
Q 038766 235 LRQLVEKALANGINGVRQITDPKLVSSIYEEQEQHQVLEELFKLALVCTSSNPEDRPNMNELLI 298 (299)
Q Consensus 235 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rpt~~~il~ 298 (299)
. ............. .. +..+++.+.++|.+||..||++|||++++++
T Consensus 236 ~-~~~~~~~~~~~~~-------~~---------~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~ 282 (287)
T 4f0f_A 236 I-KFINMIREEGLRP-------TI---------PEDCPPRLRNVIELCWSGDPKKRPHFSYIVK 282 (287)
T ss_dssp H-HHHHHHHHSCCCC-------CC---------CTTSCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred H-HHHHHHhccCCCC-------CC---------CcccCHHHHHHHHHHhcCChhhCcCHHHHHH
Confidence 1 1111111111100 00 1234567999999999999999999999985
|
| >2wtk_C Serine/threonine-protein kinase 11; transferase-metal-binding protein complex, transferase metal protein complex, nucleus; HET: ANP; 2.65A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=9.1e-45 Score=306.39 Aligned_cols=257 Identities=21% Similarity=0.300 Sum_probs=198.9
Q ss_pred HHhCCCCCCceeecCCcceEEEEEeC-CCcEEEEEEeccCcC--ChhhhHHHHHHHHHHHhcCCcceeeeeeEEEc-CCC
Q 038766 9 NATGSFSENNIIGNSNLSTVYKGRLE-DGEIVAVKKLNFHQF--SAESDKSFYREAKTLKELKHRNLVKVLGYAWE-SGK 84 (299)
Q Consensus 9 ~~~~~y~~~~~lg~g~~~~v~~~~~~-~~~~~~vK~~~~~~~--~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~-~~~ 84 (299)
.+.++|.+.+.||+|+||.||++.+. +++.+|+|++..... .......+.+|+..++.++||||+++++++.. .+.
T Consensus 2 ~l~~~y~i~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~ 81 (305)
T 2wtk_C 2 KLIGKYLMGDLLGEGSYGKVKEVLDSETLCRRAVKILKKKKLRRIPNGEANVKKEIQLLRRLRHKNVIQLVDVLYNEEKQ 81 (305)
T ss_dssp ---CCBCCCCEEEECSSCEEEEEEBTTTCCEEEEEEECHHHHHHSTTHHHHHHHHHHHHTTCCCTTBCCEEEEEECC---
T ss_pred ccccceeEeeEEecCCCeEEEEEEECCCCcEEEEEEeccccccccchhHHHHHHHHHHHHhcCCCCeeEEEEEEEcCCCC
Confidence 46789999999999999999999874 589999999864322 12446778999999999999999999998753 345
Q ss_pred eeEEEEeecCCCChHHHhcCCCCCCCCCChhhHHHHHHHHHHHHHHhhcCCCCCeeeecccCCceeeCCCCcEEEeeecc
Q 038766 85 LKALILEYMENGSLESVIHGPGVDHSRWTLPKRIDVLISVANGLDYLHSGYDIPIVHCDMKPSNILLDRDFEAHVSDFGT 164 (299)
Q Consensus 85 ~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lh~~~~~~~~H~dl~~~nil~~~~~~v~l~df~~ 164 (299)
..++|+||+.++ |.+++... ....+++..++.++.|++.||.|||++ +++|+||||+||+++.++.++|+|||+
T Consensus 82 ~~~lv~e~~~~~-l~~~~~~~--~~~~~~~~~~~~~~~qi~~al~~LH~~---~i~H~dlkp~NIl~~~~~~~kl~dfg~ 155 (305)
T 2wtk_C 82 KMYMVMEYCVCG-MQEMLDSV--PEKRFPVCQAHGYFCQLIDGLEYLHSQ---GIVHKDIKPGNLLLTTGGTLKISALGV 155 (305)
T ss_dssp CEEEEEECCSEE-HHHHHHHS--TTCSCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEECTTCCEEECCCTT
T ss_pred eEEEEehhccCC-HHHHHHhC--cccccCHHHHHHHHHHHHHHHHHHHHC---CeeecCCCcccEEEcCCCcEEeecccc
Confidence 679999999764 77766533 345799999999999999999999999 999999999999999999999999999
Q ss_pred ccccccccccccccccccccCcccCChhhhcccC--cCccccchhhhHHHHHHHhCCCCCCCCccCCCCchhHHHHHHHH
Q 038766 165 SRMLDVHLQDLSSLSTAFQGTIGYLAPEFAYMRI--VTTKVDVFSFGIVVMEFLTKRRPTGLDEENGLSPISLRQLVEKA 242 (299)
Q Consensus 165 ~~~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~--~~~~~DiwslG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~ 242 (299)
+....... .........+++.|+|||++.+.. ++.++||||||+++|+|++|..||.... . .......
T Consensus 156 ~~~~~~~~--~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~-----~---~~~~~~i 225 (305)
T 2wtk_C 156 AEALHPFA--ADDTCRTSQGSPAFQPPEIANGLDTFSGFKVDIWSAGVTLYNITTGLYPFEGDN-----I---YKLFENI 225 (305)
T ss_dssp CEECCTTC--SSCEECCCCSCGGGCCHHHHTCCSCEESHHHHHHHHHHHHHHHHHSSCSCCCSS-----H---HHHHHHH
T ss_pred ccccCccc--cccccccCCCCCCCcChhhccCcccCCcchhhHHHHHHHHHHHHhCCCCCCCch-----H---HHHHHHH
Confidence 97654211 112233456889999999987644 4779999999999999999999995431 1 2222222
Q ss_pred HhcCccCcccccCccccchhhHhHHHHHHHHHHHHHHHHhcCCCCCCCCChhhhhcC
Q 038766 243 LANGINGVRQITDPKLVSSIYEEQEQHQVLEELFKLALVCTSSNPEDRPNMNELLIT 299 (299)
Q Consensus 243 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rpt~~~il~~ 299 (299)
..... . + +..++..+.++|++||..||++|||++++++|
T Consensus 226 ~~~~~-~---~--------------~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~ 264 (305)
T 2wtk_C 226 GKGSY-A---I--------------PGDCGPPLSDLLKGMLEYEPAKRFSIRQIRQH 264 (305)
T ss_dssp HHCCC-C---C--------------CSSSCHHHHHHHHHHTCSSTTTSCCHHHHHHS
T ss_pred hcCCC-C---C--------------CCccCHHHHHHHHHHccCChhhCCCHHHHhcC
Confidence 11110 0 0 11234578899999999999999999999986
|
| >3a7i_A MST3 kinase, serine/threonine kinase 24 (STE20 homolog, yeast); two-LOBE protein kinase fold, ATP-binding, nucleotid binding, transferase; HET: TPO ADE; 1.45A {Homo sapiens} PDB: 3a7g_A* 3a7h_A* 3a7f_A* 3a7j_A* 3ckw_A 3ckx_A* 3ggf_A* 2xik_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-44 Score=304.91 Aligned_cols=251 Identities=24% Similarity=0.369 Sum_probs=204.2
Q ss_pred HhCCCCCCceeecCCcceEEEEEe-CCCcEEEEEEeccCcCChhhhHHHHHHHHHHHhcCCcceeeeeeEEEcCCCeeEE
Q 038766 10 ATGSFSENNIIGNSNLSTVYKGRL-EDGEIVAVKKLNFHQFSAESDKSFYREAKTLKELKHRNLVKVLGYAWESGKLKAL 88 (299)
Q Consensus 10 ~~~~y~~~~~lg~g~~~~v~~~~~-~~~~~~~vK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~l 88 (299)
..++|.+.+.||+|++|.||++.+ .+++.||+|++.... .....+.+.+|+..++.+.||||+++++++.. +...++
T Consensus 20 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~-~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~-~~~~~l 97 (303)
T 3a7i_A 20 PEELFTKLEKIGKGSFGEVFKGIDNRTQKVVAIKIIDLEE-AEDEIEDIQQEITVLSQCDSPYVTKYYGSYLK-DTKLWI 97 (303)
T ss_dssp GGGTEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEETTT-CSTTHHHHHHHHHHHHHCCCTTBCCEEEEEEE-TTEEEE
T ss_pred hHHHHHHhhhhcccCCeEEEEEEECCCCcEEEEEEecccc-cHHHHHHHHHHHHHHHhCCCCCEeEEEEEEec-CCeEEE
Confidence 356799999999999999999986 468999999987543 23456788999999999999999999997765 456699
Q ss_pred EEeecCCCChHHHhcCCCCCCCCCChhhHHHHHHHHHHHHHHhhcCCCCCeeeecccCCceeeCCCCcEEEeeecccccc
Q 038766 89 ILEYMENGSLESVIHGPGVDHSRWTLPKRIDVLISVANGLDYLHSGYDIPIVHCDMKPSNILLDRDFEAHVSDFGTSRML 168 (299)
Q Consensus 89 v~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lh~~~~~~~~H~dl~~~nil~~~~~~v~l~df~~~~~~ 168 (299)
|+||+.+++|.+++. ..++++..++.++.|++.||.+||+. +++|+||+|+||+++.++.++|+|||++...
T Consensus 98 v~e~~~~~~L~~~~~-----~~~~~~~~~~~~~~qi~~~l~~lH~~---~i~H~dl~p~Nil~~~~~~~kl~Dfg~~~~~ 169 (303)
T 3a7i_A 98 IMEYLGGGSALDLLE-----PGPLDETQIATILREILKGLDYLHSE---KKIHRDIKAANVLLSEHGEVKLADFGVAGQL 169 (303)
T ss_dssp EEECCTTEEHHHHHT-----TSCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECTTSCEEECCCTTCEEC
T ss_pred EEEeCCCCcHHHHHh-----cCCCCHHHHHHHHHHHHHHHHHHHHC---CCccCCCChheEEECCCCCEEEeecccceec
Confidence 999999999999995 35789999999999999999999999 9999999999999999999999999998765
Q ss_pred ccccccccccccccccCcccCChhhhcccCcCccccchhhhHHHHHHHhCCCCCCCCccCCCCchhHHHHHHHHHhcCcc
Q 038766 169 DVHLQDLSSLSTAFQGTIGYLAPEFAYMRIVTTKVDVFSFGIVVMEFLTKRRPTGLDEENGLSPISLRQLVEKALANGIN 248 (299)
Q Consensus 169 ~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~DiwslG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 248 (299)
... ........+++.|+|||.+.+..++.++||||||+++|+|++|..||... ....... ........
T Consensus 170 ~~~----~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~-----~~~~~~~---~~~~~~~~ 237 (303)
T 3a7i_A 170 TDT----QIKRNTFVGTPFWMAPEVIKQSAYDSKADIWSLGITAIELARGEPPHSEL-----HPMKVLF---LIPKNNPP 237 (303)
T ss_dssp BTT----BCCBCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCTTTTS-----CHHHHHH---HHHHSCCC
T ss_pred Ccc----ccccCccCCCcCccCHHHHhcCCCCchhhhHHHHHHHHHHccCCCCCCCc-----CHHHHHH---HhhcCCCC
Confidence 421 11233456789999999999999999999999999999999999998532 1222111 11111110
Q ss_pred CcccccCccccchhhHhHHHHHHHHHHHHHHHHhcCCCCCCCCChhhhhcC
Q 038766 249 GVRQITDPKLVSSIYEEQEQHQVLEELFKLALVCTSSNPEDRPNMNELLIT 299 (299)
Q Consensus 249 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rpt~~~il~~ 299 (299)
.. ...++..+.++|.+||..||++|||++++++|
T Consensus 238 ~~-----------------~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~ 271 (303)
T 3a7i_A 238 TL-----------------EGNYSKPLKEFVEACLNKEPSFRPTAKELLKH 271 (303)
T ss_dssp CC-----------------CSSCCHHHHHHHHHHCCSSGGGSCCHHHHTTC
T ss_pred CC-----------------ccccCHHHHHHHHHHcCCChhhCcCHHHHhhC
Confidence 00 11234578999999999999999999999986
|
| >3og7_A AKAP9-BRAF fusion protein; proto-oncogene, V600E, kinase, transferase; HET: 032; 2.45A {Homo sapiens} SCOP: d.144.1.7 PDB: 4fk3_A* 3c4c_A* 3c4d_A* 3idp_A* 4g9r_A* 3ii5_A* 4e26_A* 3ppj_A* 3ppk_A* 3prf_A* 3pri_A* 3psb_A* 3psd_A* 3q4c_A* 3skc_A* 3tv4_A* 3tv6_A* 3d4q_A* 4e4x_A* 4g9c_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-44 Score=303.90 Aligned_cols=262 Identities=26% Similarity=0.445 Sum_probs=196.2
Q ss_pred HHHHHHhCCCCCCceeecCCcceEEEEEeCCCcEEEEEEeccCcCChhhhHHHHHHHHHHHhcCCcceeeeeeEEEcCCC
Q 038766 5 TEIENATGSFSENNIIGNSNLSTVYKGRLEDGEIVAVKKLNFHQFSAESDKSFYREAKTLKELKHRNLVKVLGYAWESGK 84 (299)
Q Consensus 5 ~~~~~~~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~vK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~ 84 (299)
+.+|+..++|++.+.||+|+||+||++.+.+ .+|+|++..........+.+.+|+..++.++||||++++++. . ..
T Consensus 17 ~~~ei~~~~y~~~~~lG~G~~g~Vy~~~~~~--~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~-~-~~ 92 (289)
T 3og7_A 17 DDWEIPDGQITVGQRIGSGSFGTVYKGKWHG--DVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGYS-T-AP 92 (289)
T ss_dssp -CCBCCTTSCEEEEEEEECSSEEEEEEESSS--EEEEEEESCSSCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEE-C-SS
T ss_pred CCCccCccceeeeeEecCCCCeEEEEEEEcC--ceEEEEEeccCCCHHHHHHHHHHHHHHHhCCCCcEEEEEeec-c-CC
Confidence 3457788999999999999999999998653 599999987766677778899999999999999999999943 3 34
Q ss_pred eeEEEEeecCCCChHHHhcCCCCCCCCCChhhHHHHHHHHHHHHHHhhcCCCCCeeeecccCCceeeCCCCcEEEeeecc
Q 038766 85 LKALILEYMENGSLESVIHGPGVDHSRWTLPKRIDVLISVANGLDYLHSGYDIPIVHCDMKPSNILLDRDFEAHVSDFGT 164 (299)
Q Consensus 85 ~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lh~~~~~~~~H~dl~~~nil~~~~~~v~l~df~~ 164 (299)
..++|+||+.+++|.+++.. ....+++..++.++.|++.||.|||+. +++|+||||+||+++.++.++|+|||+
T Consensus 93 ~~~lv~e~~~~~~L~~~l~~---~~~~~~~~~~~~i~~qi~~~L~~lH~~---~i~H~Dlkp~Nil~~~~~~~kl~Dfg~ 166 (289)
T 3og7_A 93 QLAIVTQWCEGSSLYHHLHA---SETKFEMKKLIDIARQTARGMDYLHAK---SIIHRDLKSNNIFLHEDNTVKIGDFGL 166 (289)
T ss_dssp SCEEEEECCCEEEHHHHHTT---C---CCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEEETTTEEEECCCC-
T ss_pred ccEEEEEecCCCcHHHHHhh---ccCCCCHHHHHHHHHHHHHHHHHHHhC---CcccccCccceEEECCCCCEEEcccee
Confidence 45899999999999998863 345789999999999999999999999 999999999999999999999999999
Q ss_pred ccccccccccccccccccccCcccCChhhhc---ccCcCccccchhhhHHHHHHHhCCCCCCCCccCCCCchhHHHHHHH
Q 038766 165 SRMLDVHLQDLSSLSTAFQGTIGYLAPEFAY---MRIVTTKVDVFSFGIVVMEFLTKRRPTGLDEENGLSPISLRQLVEK 241 (299)
Q Consensus 165 ~~~~~~~~~~~~~~~~~~~~~~~y~~PE~~~---~~~~~~~~DiwslG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~ 241 (299)
+....... .........+++.|+|||.+. +..++.++||||||+++|+|++|..||..... ...+...+
T Consensus 167 ~~~~~~~~--~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~----~~~~~~~~-- 238 (289)
T 3og7_A 167 ATEKSRWS--GSHQFEQLSGSILWMAPEVIRMQDSNPYSFQSDVYAFGIVLYELMTGQLPYSNINN----RDQIIEMV-- 238 (289)
T ss_dssp -------------------CCCTTCCHHHHC----CCSCHHHHHHHHHHHHHHHHHSSCTTSSCCC----HHHHHHHH--
T ss_pred cccccccc--ccccccccCCCccccCchhhcccCCCCCCcccchHHHHHHHHHHHHCCCCccccch----HHHHHHHh--
Confidence 87544211 112233456899999999886 56678899999999999999999999954311 11122211
Q ss_pred HHhcCccCcccccCccccchhhHhHHHHHHHHHHHHHHHHhcCCCCCCCCChhhhhc
Q 038766 242 ALANGINGVRQITDPKLVSSIYEEQEQHQVLEELFKLALVCTSSNPEDRPNMNELLI 298 (299)
Q Consensus 242 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rpt~~~il~ 298 (299)
........ . ... ...++..+.+++.+||..||++|||++++++
T Consensus 239 -~~~~~~~~--~--~~~---------~~~~~~~l~~li~~~l~~~p~~Rps~~ell~ 281 (289)
T 3og7_A 239 -GRGSLSPD--L--SKV---------RSNCPKRMKRLMAECLKKKRDERPSFPRILA 281 (289)
T ss_dssp -HHTSCCCC--T--TSS---------CTTSCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred -cccccCcc--h--hhc---------cccCCHHHHHHHHHHccCChhhCCCHHHHHH
Confidence 11111000 0 000 1233567999999999999999999999985
|
| >1rjb_A FL cytokine receptor; kinase, structure, autoinhibition, juxtamembrane domain, transferase; 2.10A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=4.8e-45 Score=313.26 Aligned_cols=263 Identities=22% Similarity=0.304 Sum_probs=202.9
Q ss_pred HHHHHhCCCCCCceeecCCcceEEEEEe------CCCcEEEEEEeccCcCChhhhHHHHHHHHHHHhc-CCcceeeeeeE
Q 038766 6 EIENATGSFSENNIIGNSNLSTVYKGRL------EDGEIVAVKKLNFHQFSAESDKSFYREAKTLKEL-KHRNLVKVLGY 78 (299)
Q Consensus 6 ~~~~~~~~y~~~~~lg~g~~~~v~~~~~------~~~~~~~vK~~~~~~~~~~~~~~~~~e~~~l~~l-~h~~i~~~~~~ 78 (299)
+++.-.++|.+.+.||+|+||+||+|.+ .++..||+|++... ......+.+.+|+.+++++ .||||++++++
T Consensus 39 ~~~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~-~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~ 117 (344)
T 1rjb_A 39 KWEFPRENLEFGKVLGSGAFGKVMNATAYGISKTGVSIQVAVKMLKEK-ADSSEREALMSELKMMTQLGSHENIVNLLGA 117 (344)
T ss_dssp GGBCCGGGEEEEEEEEECSSEEEEEEEEESCSSSSCEEEEEEEEECC-------CHHHHHHHHHHHHHCCCTTBCCEEEE
T ss_pred CcccCHHHceeeeeecCCCCceeEEeeeeccccCCcceEEEEEecccc-cCHHHHHHHHHHHHHHHhhcCCCCeeeEEEE
Confidence 4666778999999999999999999985 23668999999743 2344567889999999999 89999999997
Q ss_pred EEcCCCeeEEEEeecCCCChHHHhcCCCCC-------------------CCCCChhhHHHHHHHHHHHHHHhhcCCCCCe
Q 038766 79 AWESGKLKALILEYMENGSLESVIHGPGVD-------------------HSRWTLPKRIDVLISVANGLDYLHSGYDIPI 139 (299)
Q Consensus 79 ~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~-------------------~~~~~~~~~~~i~~qi~~~l~~lh~~~~~~~ 139 (299)
+.. +...++|+||+++++|.+++...... ...+++..++.++.|++.||.|||+. ++
T Consensus 118 ~~~-~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~---~i 193 (344)
T 1rjb_A 118 CTL-SGPIYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEEDLNVLTFEDLLCFAYQVAKGMEFLEFK---SC 193 (344)
T ss_dssp ECS-SSSCEEEEECCTTCBHHHHHHTTTTCC---------------------CCHHHHHHHHHHHHHHHHHHHHT---TE
T ss_pred Eee-CCccEEEEecCCCCcHHHHHhhccccccccccchhhhcccccccccccCCHHHHHHHHHHHHHHHHHHHhC---Cc
Confidence 665 44569999999999999998753211 13489999999999999999999999 99
Q ss_pred eeecccCCceeeCCCCcEEEeeeccccccccccccccccccccccCcccCChhhhcccCcCccccchhhhHHHHHHHh-C
Q 038766 140 VHCDMKPSNILLDRDFEAHVSDFGTSRMLDVHLQDLSSLSTAFQGTIGYLAPEFAYMRIVTTKVDVFSFGIVVMEFLT-K 218 (299)
Q Consensus 140 ~H~dl~~~nil~~~~~~v~l~df~~~~~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~DiwslG~~l~~l~~-g 218 (299)
+|+||||+||+++.++.++|+|||++....... .........+++.|+|||.+.+..++.++||||||+++|+|++ |
T Consensus 194 vH~Dikp~NIll~~~~~~kL~Dfg~~~~~~~~~--~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g 271 (344)
T 1rjb_A 194 VHRDLAARNVLVTHGKVVKICDFGLARDIMSDS--NYVVRGNARLPVKWMAPESLFEGIYTIKSDVWSYGILLWEIFSLG 271 (344)
T ss_dssp EETTCSGGGEEEETTTEEEECCCGGGSCGGGCT--TSEEETTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHTTTS
T ss_pred ccCCCChhhEEEcCCCcEEeCCCccCcccccCc--cceeccCccCccCccCHHHhccCCCChhHhHHHHHHHHHHHHcCC
Confidence 999999999999999999999999997654211 1122334456788999999999999999999999999999998 9
Q ss_pred CCCCCCCccCCCCchhHHHHHHHHHhcCccCcccccCccccchhhHhHHHHHHHHHHHHHHHHhcCCCCCCCCChhhhhc
Q 038766 219 RRPTGLDEENGLSPISLRQLVEKALANGINGVRQITDPKLVSSIYEEQEQHQVLEELFKLALVCTSSNPEDRPNMNELLI 298 (299)
Q Consensus 219 ~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rpt~~~il~ 298 (299)
..||...... ..+.. ........ .. +...+.++.++|.+||..||.+|||++++++
T Consensus 272 ~~p~~~~~~~----~~~~~----~~~~~~~~----~~------------~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~ 327 (344)
T 1rjb_A 272 VNPYPGIPVD----ANFYK----LIQNGFKM----DQ------------PFYATEEIYIIMQSCWAFDSRKRPSFPNLTS 327 (344)
T ss_dssp CCSSTTCCCS----HHHHH----HHHTTCCC----CC------------CTTCCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred CCCcccCCcH----HHHHH----HHhcCCCC----CC------------CCCCCHHHHHHHHHHcCCCchhCcCHHHHHH
Confidence 9998543211 11111 11111000 00 1123467999999999999999999999986
Q ss_pred C
Q 038766 299 T 299 (299)
Q Consensus 299 ~ 299 (299)
+
T Consensus 328 ~ 328 (344)
T 1rjb_A 328 F 328 (344)
T ss_dssp H
T ss_pred H
Confidence 3
|
| >3nsz_A CK II alpha, casein kinase II subunit alpha; inhibitor, transferase-transferase inhibitor CO; HET: ANP; 1.30A {Homo sapiens} SCOP: d.144.1.7 PDB: 2r7i_A 3pe1_A* 1jwh_A* 3pe2_A* 3r0t_A* 3h30_A* 3q9w_A* 3q9x_A* 3q9y_A* 3q9z_A* 3qa0_A 3bqc_A* 2rkp_A* 3c13_A* 3fwq_A 3rps_A* 3u9c_A* 4fbx_A* 3mb7_A* 3mb6_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-44 Score=308.96 Aligned_cols=266 Identities=19% Similarity=0.255 Sum_probs=199.9
Q ss_pred hCCCCCCceeecCCcceEEEEEe-CCCcEEEEEEeccCcCChhhhHHHHHHHHHHHhcC-CcceeeeeeEEEcC-CCeeE
Q 038766 11 TGSFSENNIIGNSNLSTVYKGRL-EDGEIVAVKKLNFHQFSAESDKSFYREAKTLKELK-HRNLVKVLGYAWES-GKLKA 87 (299)
Q Consensus 11 ~~~y~~~~~lg~g~~~~v~~~~~-~~~~~~~vK~~~~~~~~~~~~~~~~~e~~~l~~l~-h~~i~~~~~~~~~~-~~~~~ 87 (299)
.++|++.+.||+|+||+||+|.+ .+++.||+|++.. ...+.+.+|+.+++.++ ||||+++++++... ....+
T Consensus 35 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~-----~~~~~~~~E~~~l~~l~~~~~i~~~~~~~~~~~~~~~~ 109 (330)
T 3nsz_A 35 QDDYQLVRKLGRGKYSEVFEAINITNNEKVVVKILKP-----VKKKKIKREIKILENLRGGPNIITLADIVKDPVSRTPA 109 (330)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECS-----CCHHHHHHHHHHHHHHTTSTTBCCEEEEEECTTTCCEE
T ss_pred CCceEEEEEecccCCeEEEEEEECCCCcEEEEEEecc-----cchHHHHHHHHHHHHcCCCCCEEEeeeeeccCCCCceE
Confidence 46899999999999999999986 5689999999852 33567889999999998 99999999977653 45569
Q ss_pred EEEeecCCCChHHHhcCCCCCCCCCChhhHHHHHHHHHHHHHHhhcCCCCCeeeecccCCceeeCCCC-cEEEeeecccc
Q 038766 88 LILEYMENGSLESVIHGPGVDHSRWTLPKRIDVLISVANGLDYLHSGYDIPIVHCDMKPSNILLDRDF-EAHVSDFGTSR 166 (299)
Q Consensus 88 lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lh~~~~~~~~H~dl~~~nil~~~~~-~v~l~df~~~~ 166 (299)
+|+||+.+++|..++. .+++..++.++.|++.||+|||++ +++|+||||+||+++.++ .++|+|||++.
T Consensus 110 lv~e~~~~~~l~~~~~-------~~~~~~~~~~~~qi~~~l~~lH~~---~ivH~Dikp~Nil~~~~~~~~kl~Dfg~a~ 179 (330)
T 3nsz_A 110 LVFEHVNNTDFKQLYQ-------TLTDYDIRFYMYEILKALDYCHSM---GIMHRDVKPHNVMIDHEHRKLRLIDWGLAE 179 (330)
T ss_dssp EEEECCCCCCHHHHGG-------GCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEEETTTTEEEECCCTTCE
T ss_pred EEEeccCchhHHHHHH-------hCCHHHHHHHHHHHHHHHHHHHhC---CeeeCCCCHHHEEEcCCCCEEEEEeCCCce
Confidence 9999999999999885 589999999999999999999999 999999999999999776 89999999997
Q ss_pred ccccccccccccccccccCcccCChhhhcc-cCcCccccchhhhHHHHHHHhCCCCCCCCccCCCCchhHHHHHHH----
Q 038766 167 MLDVHLQDLSSLSTAFQGTIGYLAPEFAYM-RIVTTKVDVFSFGIVVMEFLTKRRPTGLDEENGLSPISLRQLVEK---- 241 (299)
Q Consensus 167 ~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~-~~~~~~~DiwslG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~---- 241 (299)
.... ........+++.|+|||.+.+ ..++.++|||||||++|+|++|..||....... ..+......
T Consensus 180 ~~~~-----~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~p~~~~~~~~---~~l~~~~~~~~~~ 251 (330)
T 3nsz_A 180 FYHP-----GQEYNVRVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNY---DQLVRIAKVLGTE 251 (330)
T ss_dssp ECCT-----TCCCCSCCSCGGGCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHTCSSSSCCSSHH---HHHHHHHHHHCHH
T ss_pred EcCC-----CCccccccccccccChhhhcCCCcCCchhhHHHHHHHHHHHHhCCCCcccCCchH---HHHHHHHHhcCCc
Confidence 6442 122344567889999999877 668999999999999999999999985332110 011110000
Q ss_pred ----HHhcCccCcc----cc---cCccccchhhHhHHHHHHHHHHHHHHHHhcCCCCCCCCChhhhhcC
Q 038766 242 ----ALANGINGVR----QI---TDPKLVSSIYEEQEQHQVLEELFKLALVCTSSNPEDRPNMNELLIT 299 (299)
Q Consensus 242 ----~~~~~~~~~~----~~---~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rpt~~~il~~ 299 (299)
.......... .. .................++.++.+||++||..||++|||++|+|+|
T Consensus 252 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpta~e~l~h 320 (330)
T 3nsz_A 252 DLYDYIDKYNIELDPRFNDILGRHSRKRWERFVHSENQHLVSPEALDFLDKLLRYDHQSRLTAREAMEH 320 (330)
T ss_dssp HHHHHHHHTTCCCCTHHHHHHCCCCCCCGGGGCCTTTGGGCCHHHHHHHHTTSCSSGGGSCCHHHHHTS
T ss_pred hhhhHHHHhccccccchhhhhhhccccchhhhccccccccCCHHHHHHHHHHhcCCcccCCCHHHHhcC
Confidence 0000000000 00 0000000000011123356789999999999999999999999987
|
| >1luf_A Muscle-specific tyrosine kinase receptor MUSK; phosphorylation, signal transduction, MASS spectrometry, transferase; 2.05A {Rattus norvegicus} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=2.3e-45 Score=315.07 Aligned_cols=260 Identities=26% Similarity=0.374 Sum_probs=204.0
Q ss_pred HHHHhCCCCCCceeecCCcceEEEEEeC------CCcEEEEEEeccCcCChhhhHHHHHHHHHHHhcCCcceeeeeeEEE
Q 038766 7 IENATGSFSENNIIGNSNLSTVYKGRLE------DGEIVAVKKLNFHQFSAESDKSFYREAKTLKELKHRNLVKVLGYAW 80 (299)
Q Consensus 7 ~~~~~~~y~~~~~lg~g~~~~v~~~~~~------~~~~~~vK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~ 80 (299)
++...++|.+.+.||+|+||.||++.+. +++.||+|++... ........+.+|+.+++.++||||+++++++.
T Consensus 42 ~~~~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~-~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~ 120 (343)
T 1luf_A 42 LEYPRNNIEYVRDIGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEE-ASADMQADFQREAALMAEFDNPNIVKLLGVCA 120 (343)
T ss_dssp TBCCGGGCEEEEEEEECSSCEEEEEEEETSSTTSSEEEEEEEECCTT-CCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEC
T ss_pred eEecHHHCeeeeeeeecCCeeEEEEEecCcCCCCCceeEEEEEeccc-cCHHHHHHHHHHHHHHHhCCCCCEEEEEEEEc
Confidence 3456789999999999999999999874 3488999998643 34455678899999999999999999999765
Q ss_pred cCCCeeEEEEeecCCCChHHHhcCCCC--------------------CCCCCChhhHHHHHHHHHHHHHHhhcCCCCCee
Q 038766 81 ESGKLKALILEYMENGSLESVIHGPGV--------------------DHSRWTLPKRIDVLISVANGLDYLHSGYDIPIV 140 (299)
Q Consensus 81 ~~~~~~~lv~e~~~~~~L~~~~~~~~~--------------------~~~~~~~~~~~~i~~qi~~~l~~lh~~~~~~~~ 140 (299)
. +...++|+||+.+++|.+++..... ....+++.+++.++.||+.||.|||++ +++
T Consensus 121 ~-~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~---~iv 196 (343)
T 1luf_A 121 V-GKPMCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVSSPGPPPLSCAEQLCIARQVAAGMAYLSER---KFV 196 (343)
T ss_dssp S-SSSCEEEEECCTTCBHHHHHHHTCC----------------------CCCCHHHHHHHHHHHHHHHHHHHHT---TCC
T ss_pred c-CCceEEEEecCCCCcHHHHHHHhCcccccccccccccccccccccCCCCCCHHHHHHHHHHHHHHHHHHHhC---Cee
Confidence 5 5556999999999999998864321 125799999999999999999999999 999
Q ss_pred eecccCCceeeCCCCcEEEeeeccccccccccccccccccccccCcccCChhhhcccCcCccccchhhhHHHHHHHh-CC
Q 038766 141 HCDMKPSNILLDRDFEAHVSDFGTSRMLDVHLQDLSSLSTAFQGTIGYLAPEFAYMRIVTTKVDVFSFGIVVMEFLT-KR 219 (299)
Q Consensus 141 H~dl~~~nil~~~~~~v~l~df~~~~~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~DiwslG~~l~~l~~-g~ 219 (299)
|+||||+||+++.++.++|+|||++...... ..........+++.|+|||.+.+..++.++||||||+++|+|++ |.
T Consensus 197 H~Dlkp~NIl~~~~~~~kl~Dfg~~~~~~~~--~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~ 274 (343)
T 1luf_A 197 HRDLATRNCLVGENMVVKIADFGLSRNIYSA--DYYKADGNDAIPIRWMPPESIFYNRYTTESDVWAYGVVLWEIFSYGL 274 (343)
T ss_dssp CSCCSGGGEEECGGGCEEECCCSCHHHHTGG--GCBC----CCBCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTC
T ss_pred cCCCCcceEEECCCCeEEEeecCCCcccccC--ccccccCCCcccceecChhhhccCCcCcccccHHHHHHHHHHHhcCC
Confidence 9999999999999999999999998755321 11122234456889999999999899999999999999999998 98
Q ss_pred CCCCCCccCCCCchhHHHHHHHHHhcCccCcccccCccccchhhHhHHHHHHHHHHHHHHHHhcCCCCCCCCChhhhhc
Q 038766 220 RPTGLDEENGLSPISLRQLVEKALANGINGVRQITDPKLVSSIYEEQEQHQVLEELFKLALVCTSSNPEDRPNMNELLI 298 (299)
Q Consensus 220 ~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rpt~~~il~ 298 (299)
.||... ... +............ . +..++..+.+++++||..||++|||++++++
T Consensus 275 ~p~~~~-----~~~---~~~~~~~~~~~~~---~--------------~~~~~~~l~~li~~~l~~~p~~Rps~~~~~~ 328 (343)
T 1luf_A 275 QPYYGM-----AHE---EVIYYVRDGNILA---C--------------PENCPLELYNLMRLCWSKLPADRPSFCSIHR 328 (343)
T ss_dssp CTTTTS-----CHH---HHHHHHHTTCCCC---C--------------CTTCCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred CcCCCC-----ChH---HHHHHHhCCCcCC---C--------------CCCCCHHHHHHHHHHcccCcccCCCHHHHHH
Confidence 898532 111 2222221111100 0 1233467999999999999999999999975
|
| >4eut_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: BX7; 2.60A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.2e-45 Score=319.22 Aligned_cols=275 Identities=23% Similarity=0.317 Sum_probs=208.3
Q ss_pred HhCCCCCCceeecCCcceEEEEEeC-CCcEEEEEEeccCcCChhhhHHHHHHHHHHHhcCCcceeeeeeEEEcCC-CeeE
Q 038766 10 ATGSFSENNIIGNSNLSTVYKGRLE-DGEIVAVKKLNFHQFSAESDKSFYREAKTLKELKHRNLVKVLGYAWESG-KLKA 87 (299)
Q Consensus 10 ~~~~y~~~~~lg~g~~~~v~~~~~~-~~~~~~vK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~-~~~~ 87 (299)
..++|.+.+.||+|+||+||+|.+. +|+.||+|++.... .....+.+.+|+++++.++||||+++++++...+ ...+
T Consensus 7 ~~~~y~i~~~LG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~-~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~~~ 85 (396)
T 4eut_A 7 SNHLWLLSDILGQGATANVFRGRHKKTGDLFAIKVFNNIS-FLRPVDVQMREFEVLKKLNHKNIVKLFAIEEETTTRHKV 85 (396)
T ss_dssp SSEEEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECGGG-GGSCHHHHHHHHHHHHHCCCTTBCCEEEEEECTTTCCEE
T ss_pred CCCceEEEEEEEcCCCeEEEEEEECCCCcEEEEEEecccc-ccchHHHHHHHHHHHHhcCCCCCCeEEEeeccCCCCeeE
Confidence 4578999999999999999999875 48999999986432 2334567789999999999999999999776544 3569
Q ss_pred EEEeecCCCChHHHhcCCCCCCCCCChhhHHHHHHHHHHHHHHhhcCCCCCeeeecccCCceee----CCCCcEEEeeec
Q 038766 88 LILEYMENGSLESVIHGPGVDHSRWTLPKRIDVLISVANGLDYLHSGYDIPIVHCDMKPSNILL----DRDFEAHVSDFG 163 (299)
Q Consensus 88 lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lh~~~~~~~~H~dl~~~nil~----~~~~~v~l~df~ 163 (299)
+|+||+.+++|.+++.... ....+++..++.++.|++.||+|||+. +++|+||||+||++ +.++.+||+|||
T Consensus 86 lv~e~~~~g~L~~~l~~~~-~~~~l~~~~~~~i~~qi~~aL~~LH~~---~ivH~Dlkp~NIll~~~~~~~~~~kL~DFG 161 (396)
T 4eut_A 86 LIMEFCPCGSLYTVLEEPS-NAYGLPESEFLIVLRDVVGGMNHLREN---GIVHRNIKPGNIMRVIGEDGQSVYKLTDFG 161 (396)
T ss_dssp EEECCCTTEEHHHHTTSGG-GTTCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEEEECTTSCEEEEECCGG
T ss_pred EEEecCCCCCHHHHHHhhh-cccCCCHHHHHHHHHHHHHHHHHHHHC---CEEECCcCHHHEEEeecCCCceeEEEecCC
Confidence 9999999999999997542 223499999999999999999999999 99999999999999 777889999999
Q ss_pred cccccccccccccccccccccCcccCChhhhcc--------cCcCccccchhhhHHHHHHHhCCCCCCCCccCCCCchhH
Q 038766 164 TSRMLDVHLQDLSSLSTAFQGTIGYLAPEFAYM--------RIVTTKVDVFSFGIVVMEFLTKRRPTGLDEENGLSPISL 235 (299)
Q Consensus 164 ~~~~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~--------~~~~~~~DiwslG~~l~~l~~g~~p~~~~~~~~~~~~~~ 235 (299)
++..... ........+++.|+|||++.+ ..++.++|||||||++|+|++|..||.........
T Consensus 162 ~a~~~~~-----~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~DiwSlG~il~el~tg~~Pf~~~~~~~~~---- 232 (396)
T 4eut_A 162 AARELED-----DEQFVSLYGTEEYLHPDMYERAVLRKDHQKKYGATVDLWSIGVTFYHAATGSLPFRPFEGPRRN---- 232 (396)
T ss_dssp GCEECCC-----GGGSSCSSSCCTTCCHHHHHHHCC--CHHHHHHHHHHHHHHHHHHHHHHHSSCSEECTTCTTTC----
T ss_pred CceEccC-----CCccccccCCccccCHHHhhccccccccccCCCcHHHHHHHHHHHHHHHHCCCCCCCCCcccch----
Confidence 9976542 122334568999999998875 56788999999999999999999999644322222
Q ss_pred HHHHHHHHhcCccCc-ccc---cCcc--ccc-hhhHhHHHHHHHHHHHHHHHHhcCCCCCCCCChhhhhc
Q 038766 236 RQLVEKALANGINGV-RQI---TDPK--LVS-SIYEEQEQHQVLEELFKLALVCTSSNPEDRPNMNELLI 298 (299)
Q Consensus 236 ~~~~~~~~~~~~~~~-~~~---~~~~--~~~-~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rpt~~~il~ 298 (299)
.+.+........... ... .... +.. ..........++..+.+++++||..||++|||++++++
T Consensus 233 ~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~l~~ll~~~L~~dP~~R~s~~e~l~ 302 (396)
T 4eut_A 233 KEVMYKIITGKPSGAISGVQKAENGPIDWSGDMPVSCSLSRGLQVLLTPVLANILEADQEKCWGFDQFFA 302 (396)
T ss_dssp HHHHHHHHHSCCTTCCEEEECSTTCCEEEESSCCTTCSSCHHHHHHHHHHHHHHSCCCTTTSCCHHHHHH
T ss_pred HHHHHHHhcCCCcccchhheeccCCCcccCccCCcccccchHHHhhchHHHHHhhccChhhhccHHHHHH
Confidence 233333332221110 000 0000 000 00011224677889999999999999999999999875
|
| >2x7f_A TRAF2 and NCK-interacting protein kinase; serine/threonine-protein kinase, phosphoprotein; HET: 824; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=5e-45 Score=310.86 Aligned_cols=261 Identities=24% Similarity=0.377 Sum_probs=200.2
Q ss_pred ChHHHHHHhCCCCCCceeecCCcceEEEEEe-CCCcEEEEEEeccCcCChhhhHHHHHHHHHHHhc-CCcceeeeeeEEE
Q 038766 3 DRTEIENATGSFSENNIIGNSNLSTVYKGRL-EDGEIVAVKKLNFHQFSAESDKSFYREAKTLKEL-KHRNLVKVLGYAW 80 (299)
Q Consensus 3 ~~~~~~~~~~~y~~~~~lg~g~~~~v~~~~~-~~~~~~~vK~~~~~~~~~~~~~~~~~e~~~l~~l-~h~~i~~~~~~~~ 80 (299)
+..++....++|++.+.||+|+||.||++.+ .+++.||+|++.... .....+.+|+..++++ .||||+++++++.
T Consensus 15 ~~~~l~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~---~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~ 91 (326)
T 2x7f_A 15 DLSALRDPAGIFELVELVGNGTYGQVYKGRHVKTGQLAAIKVMDVTG---DEEEEIKQEINMLKKYSHHRNIATYYGAFI 91 (326)
T ss_dssp -CCCCCCCTTTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCS---STTHHHHHHHHHHHHHCCSTTBCCEEEEEE
T ss_pred cchhccCCCCcEEEEEEeccCCCEEEEEEEECCCCCeEEEEEEecCc---ccHHHHHHHHHHHHhccCCCCeeeeeeEEe
Confidence 3445556788999999999999999999987 468999999986432 3456788999999999 7999999999876
Q ss_pred cC-----CCeeEEEEeecCCCChHHHhcCCCCCCCCCChhhHHHHHHHHHHHHHHhhcCCCCCeeeecccCCceeeCCCC
Q 038766 81 ES-----GKLKALILEYMENGSLESVIHGPGVDHSRWTLPKRIDVLISVANGLDYLHSGYDIPIVHCDMKPSNILLDRDF 155 (299)
Q Consensus 81 ~~-----~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lh~~~~~~~~H~dl~~~nil~~~~~ 155 (299)
.. ....++|+||+.+++|.+++... ....+++..++.++.|++.||.|||++ +++|+||+|+||+++.++
T Consensus 92 ~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~--~~~~~~~~~~~~i~~qi~~~l~~lH~~---~ivH~dlkp~NIl~~~~~ 166 (326)
T 2x7f_A 92 KKNPPGMDDQLWLVMEFCGAGSVTDLIKNT--KGNTLKEEWIAYICREILRGLSHLHQH---KVIHRDIKGQNVLLTENA 166 (326)
T ss_dssp ECC--CCCCEEEEEEECCTTEEHHHHHHHS--GGGCCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCSGGGEEECTTC
T ss_pred eccCccccceEEEEEEcCCCCcHHHHHHhc--ccCCCCHHHHHHHHHHHHHHHHHHHHC---CccccCCcHHHEEEcCCC
Confidence 53 45679999999999999998643 235789999999999999999999999 999999999999999999
Q ss_pred cEEEeeeccccccccccccccccccccccCcccCChhhhc-----ccCcCccccchhhhHHHHHHHhCCCCCCCCccCCC
Q 038766 156 EAHVSDFGTSRMLDVHLQDLSSLSTAFQGTIGYLAPEFAY-----MRIVTTKVDVFSFGIVVMEFLTKRRPTGLDEENGL 230 (299)
Q Consensus 156 ~v~l~df~~~~~~~~~~~~~~~~~~~~~~~~~y~~PE~~~-----~~~~~~~~DiwslG~~l~~l~~g~~p~~~~~~~~~ 230 (299)
.++|+|||++...... ........+++.|+|||++. +..++.++||||||+++|+|++|..||....
T Consensus 167 ~~kl~Dfg~~~~~~~~----~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~---- 238 (326)
T 2x7f_A 167 EVKLVDFGVSAQLDRT----VGRRNTFIGTPYWMAPEVIACDENPDATYDFKSDLWSLGITAIEMAEGAPPLCDMH---- 238 (326)
T ss_dssp CEEECCCTTTC-----------------CCGGGCCHHHHC--------CCTTHHHHHHHHHHHHHHHSSCTTTTSC----
T ss_pred CEEEeeCcCceecCcC----ccccccccCCccccChhhhccccccCcCCCccchHHHHHHHHHHHHhCCCCCCCCc----
Confidence 9999999998765421 11223446789999999987 5568899999999999999999999985321
Q ss_pred CchhHHHHHHHHHhcCccCcccccCccccchhhHhHHHHHHHHHHHHHHHHhcCCCCCCCCChhhhhcC
Q 038766 231 SPISLRQLVEKALANGINGVRQITDPKLVSSIYEEQEQHQVLEELFKLALVCTSSNPEDRPNMNELLIT 299 (299)
Q Consensus 231 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rpt~~~il~~ 299 (299)
.. ..+........... . ...++..+.++|.+||..||++|||++++++|
T Consensus 239 -~~---~~~~~~~~~~~~~~---~-------------~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~h 287 (326)
T 2x7f_A 239 -PM---RALFLIPRNPAPRL---K-------------SKKWSKKFQSFIESCLVKNHSQRPATEQLMKH 287 (326)
T ss_dssp -HH---HHHHHHHHSCCCCC---S-------------CSCSCHHHHHHHHHHCCSSGGGSCCHHHHHTS
T ss_pred -HH---HHHHHhhcCccccC---C-------------ccccCHHHHHHHHHHhccChhhCCCHHHHhhC
Confidence 11 11111111111110 0 11224578999999999999999999999987
|
| >3f66_A Hepatocyte growth factor receptor; C-Met, protein kinase, quinoxaline, alternative splicing, ATP-binding, chromosomal rearrangement; HET: IHX; 1.40A {Homo sapiens} PDB: 3i5n_A* 3u6h_A* 3u6i_A* 4deg_A* 4deh_A* 4dei_A* 3ccn_A* 2rfn_A* 2rfs_A* 3cd8_A* 3efj_A* 3efk_A* 3lq8_A* 3zxz_A* 2wkm_A* 2wgj_A* 3zze_A* 4aoi_A* 4ap7_A* 3q6w_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=8.1e-45 Score=305.75 Aligned_cols=256 Identities=27% Similarity=0.399 Sum_probs=198.5
Q ss_pred hCCCCCCceeecCCcceEEEEEeCC----CcEEEEEEeccCcCChhhhHHHHHHHHHHHhcCCcceeeeeeEEEcCCCee
Q 038766 11 TGSFSENNIIGNSNLSTVYKGRLED----GEIVAVKKLNFHQFSAESDKSFYREAKTLKELKHRNLVKVLGYAWESGKLK 86 (299)
Q Consensus 11 ~~~y~~~~~lg~g~~~~v~~~~~~~----~~~~~vK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~ 86 (299)
..+|.+.+.||+|+||+||++.+.+ +..+|+|.+.. .......+.+.+|+..+++++||||+++++++...+...
T Consensus 24 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~avk~~~~-~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~ 102 (298)
T 3f66_A 24 SLIVHFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNR-ITDIGEVSQFLTEGIIMKDFSHPNVLSLLGICLRSEGSP 102 (298)
T ss_dssp GEEEEEEEEEEEETTEEEEEEEEC-----CEEEEEEEETT-CCSHHHHHHHHHHHHHHHTCCCTTBCCCCEEECCSSSCC
T ss_pred ceehhhcceeeecCCceEEEEEEecCCCceeEEEEEeccc-CCCHHHHHHHHHHHHHHHhCCCCCEeeeeeEEEcCCCce
Confidence 4568889999999999999998532 33589998863 334455678899999999999999999999877777777
Q ss_pred EEEEeecCCCChHHHhcCCCCCCCCCChhhHHHHHHHHHHHHHHhhcCCCCCeeeecccCCceeeCCCCcEEEeeecccc
Q 038766 87 ALILEYMENGSLESVIHGPGVDHSRWTLPKRIDVLISVANGLDYLHSGYDIPIVHCDMKPSNILLDRDFEAHVSDFGTSR 166 (299)
Q Consensus 87 ~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lh~~~~~~~~H~dl~~~nil~~~~~~v~l~df~~~~ 166 (299)
++|+||+.+++|.+++.. ....+++..++.++.|++.||+|||++ +++|+||||+||+++.++.++|+|||++.
T Consensus 103 ~~v~e~~~~~~L~~~l~~---~~~~~~~~~~~~i~~ql~~~l~~lH~~---~i~H~dikp~Nil~~~~~~~kl~Dfg~a~ 176 (298)
T 3f66_A 103 LVVLPYMKHGDLRNFIRN---ETHNPTVKDLIGFGLQVAKGMKYLASK---KFVHRDLAARNCMLDEKFTVKVADFGLAR 176 (298)
T ss_dssp EEEEECCTTCBHHHHHHC---TTCCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEECTTCCEEECSCGGGC
T ss_pred EEEEeCCCCCCHHHHHHh---cccCCCHHHHHHHHHHHHHHHHHHHhC---CccCCCCchheEEECCCCCEEECcccccc
Confidence 999999999999999964 345689999999999999999999999 99999999999999999999999999998
Q ss_pred ccccccccccccccccccCcccCChhhhcccCcCccccchhhhHHHHHHHhCC-CCCCCCccCCCCchhHHHHHHHHHhc
Q 038766 167 MLDVHLQDLSSLSTAFQGTIGYLAPEFAYMRIVTTKVDVFSFGIVVMEFLTKR-RPTGLDEENGLSPISLRQLVEKALAN 245 (299)
Q Consensus 167 ~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~DiwslG~~l~~l~~g~-~p~~~~~~~~~~~~~~~~~~~~~~~~ 245 (299)
.................+++.|+|||.+.+..++.++||||||+++|+|++|. +||.... ........ ...
T Consensus 177 ~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~~~~~~~~~~-----~~~~~~~~---~~~ 248 (298)
T 3f66_A 177 DMYDKEYYSVHNKTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVN-----TFDITVYL---LQG 248 (298)
T ss_dssp CCSCGGGCBC-----CCBCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTSC-----TTTHHHHH---HTT
T ss_pred cccccchhccccccCCCCCccccChHHhcCCCCChHHHHHHHHHHHHHHHhCCCCCCccCC-----HHHHHHHH---hcC
Confidence 65432222222234445678899999999999999999999999999999954 4553221 11111111 110
Q ss_pred CccCcccccCccccchhhHhHHHHHHHHHHHHHHHHhcCCCCCCCCChhhhhc
Q 038766 246 GINGVRQITDPKLVSSIYEEQEQHQVLEELFKLALVCTSSNPEDRPNMNELLI 298 (299)
Q Consensus 246 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rpt~~~il~ 298 (299)
. .... +..++..+.+++.+||..||++|||++++++
T Consensus 249 ~-----~~~~------------~~~~~~~l~~li~~~l~~~p~~Rps~~ell~ 284 (298)
T 3f66_A 249 R-----RLLQ------------PEYCPDPLYEVMLKCWHPKAEMRPSFSELVS 284 (298)
T ss_dssp C-----CCCC------------CTTCCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred C-----CCCC------------CccCCHHHHHHHHHHcCCChhhCcCHHHHHH
Confidence 0 0000 1123457999999999999999999999985
|
| >2x4f_A Myosin light chain kinase family member 4; LUNG, breast cancer, transferase, serine/threonine-protein kinase, nucleotide-binding; HET: 16X 1PE; 2.67A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=9.7e-45 Score=314.18 Aligned_cols=247 Identities=23% Similarity=0.287 Sum_probs=193.4
Q ss_pred CceeecCCcceEEEEEe-CCCcEEEEEEeccCcCChhhhHHHHHHHHHHHhcCCcceeeeeeEEEcCCCeeEEEEeecCC
Q 038766 17 NNIIGNSNLSTVYKGRL-EDGEIVAVKKLNFHQFSAESDKSFYREAKTLKELKHRNLVKVLGYAWESGKLKALILEYMEN 95 (299)
Q Consensus 17 ~~~lg~g~~~~v~~~~~-~~~~~~~vK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~lv~e~~~~ 95 (299)
.+.||+|+||.||++.+ .+|+.||+|++... .....+.+.+|+.++++++||||+++++++.. ....++|+||+++
T Consensus 94 ~~~lG~G~~g~Vy~a~~~~~g~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~-~~~~~lv~E~~~~ 170 (373)
T 2x4f_A 94 TEILGGGRFGQVHKCEETATGLKLAAKIIKTR--GMKDKEEVKNEISVMNQLDHANLIQLYDAFES-KNDIVLVMEYVDG 170 (373)
T ss_dssp EEECC-----CEEEEEETTTCCEEEEEEEECC--SHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEC-SSEEEEEEECCTT
T ss_pred ceEEecCcCEEEEEEEEcCCCcEEEEEEEccc--ccccHHHHHHHHHHHHhCCCCCCCeEEEEEEE-CCEEEEEEeCCCC
Confidence 56799999999999986 46899999998743 33456788999999999999999999997655 5567999999999
Q ss_pred CChHHHhcCCCCCCCCCChhhHHHHHHHHHHHHHHhhcCCCCCeeeecccCCceee--CCCCcEEEeeeccccccccccc
Q 038766 96 GSLESVIHGPGVDHSRWTLPKRIDVLISVANGLDYLHSGYDIPIVHCDMKPSNILL--DRDFEAHVSDFGTSRMLDVHLQ 173 (299)
Q Consensus 96 ~~L~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lh~~~~~~~~H~dl~~~nil~--~~~~~v~l~df~~~~~~~~~~~ 173 (299)
++|.+.+.. ....+++..++.++.||+.||+|||+. +++|+||||+||++ +.++.++|+|||++.....
T Consensus 171 ~~L~~~l~~---~~~~l~~~~~~~i~~qi~~aL~~LH~~---~ivH~Dlkp~NIll~~~~~~~~kl~DFG~a~~~~~--- 241 (373)
T 2x4f_A 171 GELFDRIID---ESYNLTELDTILFMKQICEGIRHMHQM---YILHLDLKPENILCVNRDAKQIKIIDFGLARRYKP--- 241 (373)
T ss_dssp CEEHHHHHH---TGGGCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEEEETTTTEEEECCCSSCEECCT---
T ss_pred CcHHHHHHh---cCCCCCHHHHHHHHHHHHHHHHHHHHC---CcccccCCHHHEEEecCCCCcEEEEeCCCceecCC---
Confidence 999887752 335689999999999999999999999 99999999999999 5678899999999976542
Q ss_pred cccccccccccCcccCChhhhcccCcCccccchhhhHHHHHHHhCCCCCCCCccCCCCchhHHHHHHHHHhcCccCcccc
Q 038766 174 DLSSLSTAFQGTIGYLAPEFAYMRIVTTKVDVFSFGIVVMEFLTKRRPTGLDEENGLSPISLRQLVEKALANGINGVRQI 253 (299)
Q Consensus 174 ~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~DiwslG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 253 (299)
........+++.|+|||++.+..++.++|||||||++|+|++|..||..... .+.+.......+..
T Consensus 242 --~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~--------~~~~~~i~~~~~~~---- 307 (373)
T 2x4f_A 242 --REKLKVNFGTPEFLAPEVVNYDFVSFPTDMWSVGVIAYMLLSGLSPFLGDND--------AETLNNILACRWDL---- 307 (373)
T ss_dssp --TCBCCCCCSSCTTCCHHHHTTCBCCHHHHHHHHHHHHHHHHHSSCTTCCSSH--------HHHHHHHHHTCCCS----
T ss_pred --ccccccccCCCcEeChhhccCCCCCcHHhHHHHHHHHHHHHhCCCCCCCCCH--------HHHHHHHHhccCCC----
Confidence 1223344689999999999988999999999999999999999999954321 12222222221110
Q ss_pred cCccccchhhHhHHHHHHHHHHHHHHHHhcCCCCCCCCChhhhhcC
Q 038766 254 TDPKLVSSIYEEQEQHQVLEELFKLALVCTSSNPEDRPNMNELLIT 299 (299)
Q Consensus 254 ~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rpt~~~il~~ 299 (299)
... ....++.++.+||.+||..||++|||++++|+|
T Consensus 308 ~~~----------~~~~~~~~~~~li~~~L~~dp~~Rps~~e~l~h 343 (373)
T 2x4f_A 308 EDE----------EFQDISEEAKEFISKLLIKEKSWRISASEALKH 343 (373)
T ss_dssp CSG----------GGTTSCHHHHHHHHTTSCSSGGGSCCHHHHHHS
T ss_pred Chh----------hhccCCHHHHHHHHHHcCCChhhCCCHHHHhcC
Confidence 000 012345689999999999999999999999987
|
| >3kvw_A DYRK2, dual specificity tyrosine-phosphorylation-regulat 2; KI-(Y)-phosphorylation REG kinase 2, PSK-H2, kinase, structural genomics consortium; HET: SEP PTR IRB; 2.28A {Homo sapiens} PDB: 3k2l_A* 4azf_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4e-44 Score=315.83 Aligned_cols=200 Identities=24% Similarity=0.293 Sum_probs=169.0
Q ss_pred HHhCCCCCCceeecCCcceEEEEEeC-CCcEEEEEEeccCcCChhhhHHHHHHHHHHHhc------CCcceeeeeeEEEc
Q 038766 9 NATGSFSENNIIGNSNLSTVYKGRLE-DGEIVAVKKLNFHQFSAESDKSFYREAKTLKEL------KHRNLVKVLGYAWE 81 (299)
Q Consensus 9 ~~~~~y~~~~~lg~g~~~~v~~~~~~-~~~~~~vK~~~~~~~~~~~~~~~~~e~~~l~~l------~h~~i~~~~~~~~~ 81 (299)
.+..+|.+.+.||+|+||+||+|.+. +++.||||++.. .......+..|+.+++.+ .|+||+.+++++..
T Consensus 94 ~~~~ry~~~~~LG~G~fg~V~~a~~~~~~~~vAvK~~~~---~~~~~~~~~~E~~~l~~l~~~~~~~~~~iv~~~~~~~~ 170 (429)
T 3kvw_A 94 HVAYRYEVLKVIGKGSFGQVVKAYDHKVHQHVALKMVRN---EKRFHRQAAEEIRILEHLRKQDKDNTMNVIHMLENFTF 170 (429)
T ss_dssp EETTTEEEEEEEEESSSEEEEEEEETTTTEEEEEEEECS---CHHHHHHHHHHHHHHHHHHTTCTTSCSCBCCEEEEEEE
T ss_pred cccCcEEEEEEcccCccEEEEEEEECCCCcEEEEEEECC---ccchHHHHHHHHHHHHHHhhccccCCcCEEEEEeeccc
Confidence 45678999999999999999999875 589999999863 234456677788888877 46799999996655
Q ss_pred CCCeeEEEEeecCCCChHHHhcCCCCCCCCCChhhHHHHHHHHHHHHHHhhcCCCCCeeeecccCCceeeCCCCc--EEE
Q 038766 82 SGKLKALILEYMENGSLESVIHGPGVDHSRWTLPKRIDVLISVANGLDYLHSGYDIPIVHCDMKPSNILLDRDFE--AHV 159 (299)
Q Consensus 82 ~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lh~~~~~~~~H~dl~~~nil~~~~~~--v~l 159 (299)
....++|+|++. ++|.+++... ....+++..++.++.||+.||+|||+. +++||||||+||+++.++. +||
T Consensus 171 -~~~~~lv~e~~~-~~L~~~l~~~--~~~~~~~~~~~~i~~qi~~aL~~LH~~---~ivHrDlKp~NILl~~~~~~~vkL 243 (429)
T 3kvw_A 171 -RNHICMTFELLS-MNLYELIKKN--KFQGFSLPLVRKFAHSILQCLDALHKN---RIIHCDLKPENILLKQQGRSGIKV 243 (429)
T ss_dssp -TTEEEEEECCCC-CBHHHHHHHT--TTCCCCHHHHHHHHHHHHHHHHHHHHH---TEECSCCSGGGEEESSTTSCCEEE
T ss_pred -CCeEEEEEeccC-CCHHHHHHhc--cCCCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHeEEccCCCcceEE
Confidence 556799999995 5999888643 234589999999999999999999999 9999999999999999887 999
Q ss_pred eeeccccccccccccccccccccccCcccCChhhhcccCcCccccchhhhHHHHHHHhCCCCCCCC
Q 038766 160 SDFGTSRMLDVHLQDLSSLSTAFQGTIGYLAPEFAYMRIVTTKVDVFSFGIVVMEFLTKRRPTGLD 225 (299)
Q Consensus 160 ~df~~~~~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~DiwslG~~l~~l~~g~~p~~~~ 225 (299)
+|||++.... .......+|+.|+|||++.+..++.++|||||||++|+|++|..||...
T Consensus 244 ~DFG~a~~~~-------~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltG~~pf~~~ 302 (429)
T 3kvw_A 244 IDFGSSCYEH-------QRVYTYIQSRFYRAPEVILGARYGMPIDMWSLGCILAELLTGYPLLPGE 302 (429)
T ss_dssp CCCTTCEETT-------CCCCSSCSCGGGCCHHHHHTBCCCTHHHHHHHHHHHHHHHHSSCSSCCS
T ss_pred eecccceecC-------CcccccCCCCCccChHHHhCCCCCchHHHHhHHHHHHHHHhCCCCCCCC
Confidence 9999986533 2233456789999999999999999999999999999999999999644
|
| >1t46_A HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcoma viral oncogene homolog; kinase, structure, inhibitor, STI-571, gleevec, transferase activator; HET: STI; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1pkg_A* 1t45_A 3g0e_A* 3g0f_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.1e-45 Score=308.51 Aligned_cols=263 Identities=22% Similarity=0.335 Sum_probs=206.0
Q ss_pred HHHHHHhCCCCCCceeecCCcceEEEEEe------CCCcEEEEEEeccCcCChhhhHHHHHHHHHHHhc-CCcceeeeee
Q 038766 5 TEIENATGSFSENNIIGNSNLSTVYKGRL------EDGEIVAVKKLNFHQFSAESDKSFYREAKTLKEL-KHRNLVKVLG 77 (299)
Q Consensus 5 ~~~~~~~~~y~~~~~lg~g~~~~v~~~~~------~~~~~~~vK~~~~~~~~~~~~~~~~~e~~~l~~l-~h~~i~~~~~ 77 (299)
++++...++|.+.+.||+|+||+||++.+ .++..||+|++... ......+.+.+|+..++++ +||||+++++
T Consensus 16 ~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~-~~~~~~~~~~~E~~~l~~l~~h~~i~~~~~ 94 (313)
T 1t46_A 16 HKWEFPRNRLSFGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPS-AHLTEREALMSELKVLSYLGNHMNIVNLLG 94 (313)
T ss_dssp GGGBCCGGGEEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTT-CCHHHHHHHHHHHHHHHHHCCCTTBCCEEE
T ss_pred cccccChhhhhHHHhhCccCCcceEEEEEeeccccchhhhhHHHhcCcc-hhHHHHHHHHHHHHHHhhcccCCCeeeEEE
Confidence 45566778999999999999999999974 34788999998743 2344567889999999999 8999999999
Q ss_pred EEEcCCCeeEEEEeecCCCChHHHhcCCCC--------------CCCCCChhhHHHHHHHHHHHHHHhhcCCCCCeeeec
Q 038766 78 YAWESGKLKALILEYMENGSLESVIHGPGV--------------DHSRWTLPKRIDVLISVANGLDYLHSGYDIPIVHCD 143 (299)
Q Consensus 78 ~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~--------------~~~~~~~~~~~~i~~qi~~~l~~lh~~~~~~~~H~d 143 (299)
++.. +...++|+||+.+++|.+++..... ....+++..++.++.|++.||.|||++ +++|+|
T Consensus 95 ~~~~-~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~---~i~H~d 170 (313)
T 1t46_A 95 ACTI-GGPTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALDLEDLLSFSYQVAKGMAFLASK---NCIHRD 170 (313)
T ss_dssp EECS-SSSCEEEEECCTTEEHHHHHHHTTTTC--------------CCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSC
T ss_pred EEec-CCCcEEEEecCCCCCHHHHHHhcccccccccccccccccccccCCHHHHHHHHHHHHHHHHHHHHC---CeecCC
Confidence 7655 4455999999999999998864321 123589999999999999999999999 999999
Q ss_pred ccCCceeeCCCCcEEEeeeccccccccccccccccccccccCcccCChhhhcccCcCccccchhhhHHHHHHHh-CCCCC
Q 038766 144 MKPSNILLDRDFEAHVSDFGTSRMLDVHLQDLSSLSTAFQGTIGYLAPEFAYMRIVTTKVDVFSFGIVVMEFLT-KRRPT 222 (299)
Q Consensus 144 l~~~nil~~~~~~v~l~df~~~~~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~DiwslG~~l~~l~~-g~~p~ 222 (299)
|||+||+++.++.++|+|||++....... .........+++.|+|||.+.+..++.++||||||+++|+|++ |..||
T Consensus 171 lkp~Nil~~~~~~~kl~Dfg~~~~~~~~~--~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~ 248 (313)
T 1t46_A 171 LAARNILLTHGRITKICDFGLARDIKNDS--NYVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGIFLWELFSLGSSPY 248 (313)
T ss_dssp CSGGGEEEETTTEEEECCCGGGSCTTSCT--TSEECSSSEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCSS
T ss_pred CccceEEEcCCCCEEEccccccccccccc--cceeccCCCCcceeeChHHhcCCCCChHHHHHHHHHHHHHHHhCCCCCC
Confidence 99999999999999999999997654221 1112234456788999999999999999999999999999998 99998
Q ss_pred CCCccCCCCchhHHHHHHHHHhcCccCcccccCccccchhhHhHHHHHHHHHHHHHHHHhcCCCCCCCCChhhhhc
Q 038766 223 GLDEENGLSPISLRQLVEKALANGINGVRQITDPKLVSSIYEEQEQHQVLEELFKLALVCTSSNPEDRPNMNELLI 298 (299)
Q Consensus 223 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rpt~~~il~ 298 (299)
...... ......+. ...... . +..++..+.++|.+||..||.+|||++++++
T Consensus 249 ~~~~~~----~~~~~~~~----~~~~~~----~------------~~~~~~~l~~li~~~l~~dp~~Rps~~ell~ 300 (313)
T 1t46_A 249 PGMPVD----SKFYKMIK----EGFRML----S------------PEHAPAEMYDIMKTCWDADPLKRPTFKQIVQ 300 (313)
T ss_dssp TTCCSS----HHHHHHHH----HTCCCC----C------------CTTSCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred Ccccch----hHHHHHhc----cCCCCC----C------------cccCCHHHHHHHHHHcCCCchhCcCHHHHHH
Confidence 543221 11111111 111000 0 1223467999999999999999999999986
|
| >3t9t_A Tyrosine-protein kinase ITK/TSK; kinase domain, alpha/beta, ATP binding, phosphorylation, intracellular, transferase-transferase inhibitor complex; HET: IAQ; 1.65A {Homo sapiens} PDB: 3v5l_A* 3v5j_A* 3v8t_A* 3v8w_A* 1sm2_A* 1snu_A* 1snx_A 3qgw_A* 3qgy_A* 3miy_A* 3mj1_A* 3mj2_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2e-45 Score=304.56 Aligned_cols=253 Identities=24% Similarity=0.375 Sum_probs=202.2
Q ss_pred HHHhCCCCCCceeecCCcceEEEEEeCCCcEEEEEEeccCcCChhhhHHHHHHHHHHHhcCCcceeeeeeEEEcCCCeeE
Q 038766 8 ENATGSFSENNIIGNSNLSTVYKGRLEDGEIVAVKKLNFHQFSAESDKSFYREAKTLKELKHRNLVKVLGYAWESGKLKA 87 (299)
Q Consensus 8 ~~~~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~vK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~ 87 (299)
..-.++|.+.+.||+|++|.||++.+.+++.||+|++.... ...+.+.+|+..++.++||||+++++++.. +...+
T Consensus 4 ~i~~~~y~~~~~lg~G~~g~V~~~~~~~~~~vaiK~~~~~~---~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~-~~~~~ 79 (267)
T 3t9t_A 4 VIDPSELTFVQEIGSGQFGLVHLGYWLNKDKVAIKTIREGA---MSEEDFIEEAEVMMKLSHPKLVQLYGVCLE-QAPIC 79 (267)
T ss_dssp BCCGGGEEEEEEEEEETTEEEEEEEETTTEEEEEEEECTTT---BCHHHHHHHHHHHHTCCCTTBCCEEEEECS-SSSCE
T ss_pred EEchhheeeeeEecCCCceeEEEEEecCCCeEEEEEccccC---CCHHHHHHHHHHHHhCCCCCEeeEEEEEcc-CCCeE
Confidence 34467899999999999999999999888899999997433 234678899999999999999999997655 44569
Q ss_pred EEEeecCCCChHHHhcCCCCCCCCCChhhHHHHHHHHHHHHHHhhcCCCCCeeeecccCCceeeCCCCcEEEeeeccccc
Q 038766 88 LILEYMENGSLESVIHGPGVDHSRWTLPKRIDVLISVANGLDYLHSGYDIPIVHCDMKPSNILLDRDFEAHVSDFGTSRM 167 (299)
Q Consensus 88 lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lh~~~~~~~~H~dl~~~nil~~~~~~v~l~df~~~~~ 167 (299)
+|+|++++++|.+++.. ....+++..++.++.|++.||.+||+. +++|+||||+||+++.++.++|+|||++..
T Consensus 80 lv~e~~~~~~L~~~~~~---~~~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dl~p~Nili~~~~~~kl~dfg~~~~ 153 (267)
T 3t9t_A 80 LVTEFMEHGCLSDYLRT---QRGLFAAETLLGMCLDVCEGMAYLEEA---CVIHRDLAARNCLVGENQVIKVSDFGMTRF 153 (267)
T ss_dssp EEECCCTTCBHHHHHHH---TTTCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSSCCGGGEEECGGGCEEECCTTGGGG
T ss_pred EEEeCCCCCcHHHHHhh---CcccCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCchheEEECCCCCEEEcccccccc
Confidence 99999999999998863 234689999999999999999999999 999999999999999999999999999875
Q ss_pred cccccccccccccccccCcccCChhhhcccCcCccccchhhhHHHHHHHh-CCCCCCCCccCCCCchhHHHHHHHHHhcC
Q 038766 168 LDVHLQDLSSLSTAFQGTIGYLAPEFAYMRIVTTKVDVFSFGIVVMEFLT-KRRPTGLDEENGLSPISLRQLVEKALANG 246 (299)
Q Consensus 168 ~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~DiwslG~~l~~l~~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~ 246 (299)
.... .........+++.|+|||.+.+..++.++||||||+++|+|++ |..||... ... ..........
T Consensus 154 ~~~~---~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~-----~~~---~~~~~i~~~~ 222 (267)
T 3t9t_A 154 VLDD---QYTSSTGTKFPVKWASPEVFSFSRYSSKSDVWSFGVLMWEVFSEGKIPYENR-----SNS---EVVEDISTGF 222 (267)
T ss_dssp BCCH---HHHSTTSTTCCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTC-----CHH---HHHHHHHTTC
T ss_pred cccc---cccccccccccccccChhhhcCCCccchhchhhhHHHHHHHhccCCCCCCCC-----CHH---HHHHHHhcCC
Confidence 4321 1112233445778999999998889999999999999999999 88888532 111 2222221110
Q ss_pred ccCcccccCccccchhhHhHHHHHHHHHHHHHHHHhcCCCCCCCCChhhhhc
Q 038766 247 INGVRQITDPKLVSSIYEEQEQHQVLEELFKLALVCTSSNPEDRPNMNELLI 298 (299)
Q Consensus 247 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rpt~~~il~ 298 (299)
. ... +...+..+.+++.+||..||++|||++++++
T Consensus 223 -~----~~~------------~~~~~~~l~~li~~~l~~~p~~Rps~~~ll~ 257 (267)
T 3t9t_A 223 -R----LYK------------PRLASTHVYQIMNHCWRERPEDRPAFSRLLR 257 (267)
T ss_dssp -C----CCC------------CTTSCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred -c----CCC------------CccCcHHHHHHHHHHccCChhhCcCHHHHHH
Confidence 0 000 1123457899999999999999999999986
|
| >1vzo_A Ribosomal protein S6 kinase alpha 5; protein kinase, transferase, phosphorylation, serine/threonine protein kinase; 1.8A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=3.4e-45 Score=315.30 Aligned_cols=256 Identities=23% Similarity=0.295 Sum_probs=200.2
Q ss_pred hCCCCCCceeecCCcceEEEEEe----CCCcEEEEEEeccCcC--ChhhhHHHHHHHHHHHhc-CCcceeeeeeEEEcCC
Q 038766 11 TGSFSENNIIGNSNLSTVYKGRL----EDGEIVAVKKLNFHQF--SAESDKSFYREAKTLKEL-KHRNLVKVLGYAWESG 83 (299)
Q Consensus 11 ~~~y~~~~~lg~g~~~~v~~~~~----~~~~~~~vK~~~~~~~--~~~~~~~~~~e~~~l~~l-~h~~i~~~~~~~~~~~ 83 (299)
.++|.+.+.||+|+||+||++.+ .+++.||+|++..... .......+.+|+++++.+ .||||+++++++.. +
T Consensus 53 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~-~ 131 (355)
T 1vzo_A 53 IENFELLKVLGTGAYGKVFLVRKISGHDTGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSPFLVTLHYAFQT-E 131 (355)
T ss_dssp GGGEEEEEEEEETTTEEEEEEEECSSTTTTCEEEEEEESEEEEEEEESSGGGCCCHHHHHHHHHTCTTBCCEEEEEEE-T
T ss_pred ccceEEEEEeccCCCEEEEEEEEcccCCCCeEEEEEEEeHHHhhhhhhHHHHHHHHHHHHHHccCCCceeEEEEEEee-C
Confidence 37899999999999999999987 3689999999864322 123345667799999999 59999999996655 5
Q ss_pred CeeEEEEeecCCCChHHHhcCCCCCCCCCChhhHHHHHHHHHHHHHHhhcCCCCCeeeecccCCceeeCCCCcEEEeeec
Q 038766 84 KLKALILEYMENGSLESVIHGPGVDHSRWTLPKRIDVLISVANGLDYLHSGYDIPIVHCDMKPSNILLDRDFEAHVSDFG 163 (299)
Q Consensus 84 ~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lh~~~~~~~~H~dl~~~nil~~~~~~v~l~df~ 163 (299)
...++|+||+.+++|.+++. ....+++..++.++.|++.||.|||++ +++|+||||+||+++.++.++|+|||
T Consensus 132 ~~~~lv~e~~~~~~L~~~l~----~~~~~~~~~~~~~~~qi~~aL~~LH~~---~ivH~Dlkp~NIll~~~~~~kl~DfG 204 (355)
T 1vzo_A 132 TKLHLILDYINGGELFTHLS----QRERFTEHEVQIYVGEIVLALEHLHKL---GIIYRDIKLENILLDSNGHVVLTDFG 204 (355)
T ss_dssp TEEEEEECCCCSCBHHHHHH----HHSCCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEECTTSCEEESCSS
T ss_pred ceEEEEeecCCCCCHHHHHH----HcCCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCHHHEEECCCCcEEEeeCC
Confidence 56699999999999999987 445799999999999999999999999 99999999999999999999999999
Q ss_pred cccccccccccccccccccccCcccCChhhhcc--cCcCccccchhhhHHHHHHHhCCCCCCCCccCCCCchhHHHHHHH
Q 038766 164 TSRMLDVHLQDLSSLSTAFQGTIGYLAPEFAYM--RIVTTKVDVFSFGIVVMEFLTKRRPTGLDEENGLSPISLRQLVEK 241 (299)
Q Consensus 164 ~~~~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~--~~~~~~~DiwslG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~ 241 (299)
++...... .........+|+.|+|||++.+ ..++.++|||||||++|+|++|..||....... ........
T Consensus 205 ~a~~~~~~---~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DvwslG~il~ell~g~~pf~~~~~~~----~~~~~~~~ 277 (355)
T 1vzo_A 205 LSKEFVAD---ETERAYDFCGTIEYMAPDIVRGGDSGHDKAVDWWSLGVLMYELLTGASPFTVDGEKN----SQAEISRR 277 (355)
T ss_dssp EEEECCGG---GGGGGCGGGSCCTTCCHHHHTTCC---CTHHHHHHHHHHHHHHHHSSCTTSCTTSCC----CHHHHHHH
T ss_pred CCeecccC---CCCcccCcccCcCccChhhhcCCCCCCCchhhHHHHHHHHHHHHHCCCCCccCCccc----hHHHHHHH
Confidence 99765321 1222334568999999999885 347889999999999999999999996442221 11222222
Q ss_pred HHhcCccCcccccCccccchhhHhHHHHHHHHHHHHHHHHhcCCCCCCCC-----ChhhhhcC
Q 038766 242 ALANGINGVRQITDPKLVSSIYEEQEQHQVLEELFKLALVCTSSNPEDRP-----NMNELLIT 299 (299)
Q Consensus 242 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rp-----t~~~il~~ 299 (299)
...... .. +..++..+.+||.+||..||++|| |++++++|
T Consensus 278 ~~~~~~-~~-----------------~~~~~~~~~~li~~~L~~dP~~R~~~~~~s~~ell~h 322 (355)
T 1vzo_A 278 ILKSEP-PY-----------------PQEMSALAKDLIQRLLMKDPKKRLGCGPRDADEIKEH 322 (355)
T ss_dssp HHHCCC-CC-----------------CTTSCHHHHHHHHHHTCSSGGGSTTSSTTTHHHHHTS
T ss_pred HhccCC-CC-----------------CcccCHHHHHHHHHHhhhCHHHhcCCCCCCHHHHHcC
Confidence 221110 00 122345789999999999999999 99999987
|
| >3com_A Serine/threonine-protein kinase 4; MST1, STE20-like kinase, PSI, structural genomics, protein structure initiative; HET: TPO; 2.20A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.2e-44 Score=305.28 Aligned_cols=254 Identities=23% Similarity=0.337 Sum_probs=197.6
Q ss_pred HHHhCCCCCCceeecCCcceEEEEEeC-CCcEEEEEEeccCcCChhhhHHHHHHHHHHHhcCCcceeeeeeEEEcCCCee
Q 038766 8 ENATGSFSENNIIGNSNLSTVYKGRLE-DGEIVAVKKLNFHQFSAESDKSFYREAKTLKELKHRNLVKVLGYAWESGKLK 86 (299)
Q Consensus 8 ~~~~~~y~~~~~lg~g~~~~v~~~~~~-~~~~~~vK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~ 86 (299)
....++|.+.+.||+|++|.||++.+. +|+.||+|++... .....+.+|+..++.++||||+++++++.. +...
T Consensus 25 ~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~----~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~-~~~~ 99 (314)
T 3com_A 25 KQPEEVFDVLEKLGEGSYGSVYKAIHKETGQIVAIKQVPVE----SDLQEIIKEISIMQQCDSPHVVKYYGSYFK-NTDL 99 (314)
T ss_dssp -----CEEEEEECC----CEEEEEEETTTCCEEEEEEEETT----SCCHHHHHHHHHHHTCCCTTBCCEEEEEEE-TTEE
T ss_pred hcchhhhhhheeeccCCCeEEEEEEECCCCCEEEEEecCch----HHHHHHHHHHHHHHhCCCCCCccEEEEEEe-CCEE
Confidence 456788999999999999999999875 5899999998643 245678899999999999999999997765 4566
Q ss_pred EEEEeecCCCChHHHhcCCCCCCCCCChhhHHHHHHHHHHHHHHhhcCCCCCeeeecccCCceeeCCCCcEEEeeecccc
Q 038766 87 ALILEYMENGSLESVIHGPGVDHSRWTLPKRIDVLISVANGLDYLHSGYDIPIVHCDMKPSNILLDRDFEAHVSDFGTSR 166 (299)
Q Consensus 87 ~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lh~~~~~~~~H~dl~~~nil~~~~~~v~l~df~~~~ 166 (299)
++|+||+.+++|.+++.. ....+++..++.++.|++.||.|||+. +++|+||+|+||+++.++.++|+|||++.
T Consensus 100 ~lv~e~~~~~~L~~~~~~---~~~~~~~~~~~~i~~~i~~~l~~lH~~---~i~H~dl~p~Nil~~~~~~~kl~dfg~~~ 173 (314)
T 3com_A 100 WIVMEYCGAGSVSDIIRL---RNKTLTEDEIATILQSTLKGLEYLHFM---RKIHRDIKAGNILLNTEGHAKLADFGVAG 173 (314)
T ss_dssp EEEEECCTTEEHHHHHHH---HTCCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECTTCCEEECCCTTCE
T ss_pred EEEeecCCCCCHHHHHHh---cCCCCCHHHHHHHHHHHHHHHHHHHhC---CCcCCCcCHHHEEECCCCCEEEeecccch
Confidence 999999999999998852 245789999999999999999999999 99999999999999999999999999987
Q ss_pred ccccccccccccccccccCcccCChhhhcccCcCccccchhhhHHHHHHHhCCCCCCCCccCCCCchhHHHHHHHHHhcC
Q 038766 167 MLDVHLQDLSSLSTAFQGTIGYLAPEFAYMRIVTTKVDVFSFGIVVMEFLTKRRPTGLDEENGLSPISLRQLVEKALANG 246 (299)
Q Consensus 167 ~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~DiwslG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~ 246 (299)
..... ........+++.|+|||.+.+..++.++||||||+++|+|++|..||.... ... .........
T Consensus 174 ~~~~~----~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~-----~~~---~~~~~~~~~ 241 (314)
T 3com_A 174 QLTDT----MAKRNTVIGTPFWMAPEVIQEIGYNCVADIWSLGITAIEMAEGKPPYADIH-----PMR---AIFMIPTNP 241 (314)
T ss_dssp ECBTT----BSCBCCCCSCGGGCCHHHHSSSCBCTTHHHHHHHHHHHHHHHSSCTTTTSC-----HHH---HHHHHHHSC
T ss_pred hhhhh----ccccCccCCCCCccChhhcCCCCCCccccHHHHHHHHHHHHhCCCCCCCCC-----hHH---HHHHHhcCC
Confidence 65421 122334567899999999999999999999999999999999999985331 111 111111111
Q ss_pred ccCcccccCccccchhhHhHHHHHHHHHHHHHHHHhcCCCCCCCCChhhhhcC
Q 038766 247 INGVRQITDPKLVSSIYEEQEQHQVLEELFKLALVCTSSNPEDRPNMNELLIT 299 (299)
Q Consensus 247 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rpt~~~il~~ 299 (299)
... ... +..++..+.++|.+||..||.+|||++++++|
T Consensus 242 ~~~---~~~------------~~~~~~~l~~li~~~l~~dp~~Rpt~~~ll~~ 279 (314)
T 3com_A 242 PPT---FRK------------PELWSDNFTDFVKQCLVKSPEQRATATQLLQH 279 (314)
T ss_dssp CCC---CSS------------GGGSCHHHHHHHHHHTCSCTTTSCCHHHHTTS
T ss_pred Ccc---cCC------------cccCCHHHHHHHHHHccCChhhCcCHHHHHhC
Confidence 100 000 12235679999999999999999999999987
|
| >2qol_A Ephrin receptor; receptor tyrosine kinase, juxtamembrane segment, structural genomics, mutant, structural genomics consortium, SGC, ATP- binding; 1.07A {Homo sapiens} PDB: 2qok_A 2qoi_A 2qoo_A 2qof_A 2qod_A 2qo9_A* 2gsf_A 2qo7_A* 2qo2_A* 2qoq_A* 2qon_A* 3fxx_A* 3fy2_A 2qoc_A* 2qob_A* 3dzq_A* 2r2p_A 2hel_A 2rei_A 3dko_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=8.4e-45 Score=314.65 Aligned_cols=255 Identities=27% Similarity=0.463 Sum_probs=190.6
Q ss_pred HhCCCCCCceeecCCcceEEEEEeC----CCcEEEEEEeccCcCChhhhHHHHHHHHHHHhcCCcceeeeeeEEEcCCCe
Q 038766 10 ATGSFSENNIIGNSNLSTVYKGRLE----DGEIVAVKKLNFHQFSAESDKSFYREAKTLKELKHRNLVKVLGYAWESGKL 85 (299)
Q Consensus 10 ~~~~y~~~~~lg~g~~~~v~~~~~~----~~~~~~vK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~ 85 (299)
..++|.+.+.||+|+||.||++.+. ++..||||++... ........+.+|+.++++++||||+++++++.. +..
T Consensus 43 ~~~~~~~~~~lG~G~fg~Vy~~~~~~~~~~~~~vaiK~~~~~-~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~-~~~ 120 (373)
T 2qol_A 43 DATNISIDKVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVG-YTEKQRRDFLGEASIMGQFDHPNIIRLEGVVTK-SKP 120 (373)
T ss_dssp CGGGCCCCEEEEECSSSEEEEC-CBCTTSCBCCEEEEECCTT-CCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECS-SSS
T ss_pred CHhhceeeeEEeeCCCeEEEEEEEecCCCCceeEEEEEecCc-cCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEee-CCc
Confidence 3468999999999999999999864 4778999998643 244556788999999999999999999997655 455
Q ss_pred eEEEEeecCCCChHHHhcCCCCCCCCCChhhHHHHHHHHHHHHHHhhcCCCCCeeeecccCCceeeCCCCcEEEeeeccc
Q 038766 86 KALILEYMENGSLESVIHGPGVDHSRWTLPKRIDVLISVANGLDYLHSGYDIPIVHCDMKPSNILLDRDFEAHVSDFGTS 165 (299)
Q Consensus 86 ~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lh~~~~~~~~H~dl~~~nil~~~~~~v~l~df~~~ 165 (299)
.++|+||+.+++|.+++... ...+++.+++.++.|++.||+|||+. +++|+||||+||+++.++.+||+|||++
T Consensus 121 ~~lv~e~~~~~sL~~~l~~~---~~~~~~~~~~~i~~qi~~aL~~LH~~---~ivH~Dlkp~NIll~~~~~~kl~Dfg~a 194 (373)
T 2qol_A 121 VMIVTEYMENGSLDSFLRKH---DAQFTVIQLVGMLRGIASGMKYLSDM---GYVHRDLAARNILINSNLVCKVSDFGLG 194 (373)
T ss_dssp CEEEEECCTTCBHHHHHHTT---TTCSCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEECTTCCEEECCC---
T ss_pred eEEEEeCCCCCcHHHHHHhC---CCCCCHHHHHHHHHHHHHHHHHHHHC---CeeCCCCCcceEEEcCCCCEEECcCccc
Confidence 69999999999999999742 34789999999999999999999999 9999999999999999999999999999
Q ss_pred cccccccccccccccccccCcccCChhhhcccCcCccccchhhhHHHHHHHh-CCCCCCCCccCCCCchhHHHHHHHHHh
Q 038766 166 RMLDVHLQDLSSLSTAFQGTIGYLAPEFAYMRIVTTKVDVFSFGIVVMEFLT-KRRPTGLDEENGLSPISLRQLVEKALA 244 (299)
Q Consensus 166 ~~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~DiwslG~~l~~l~~-g~~p~~~~~~~~~~~~~~~~~~~~~~~ 244 (299)
......... ........+++.|+|||.+.+..++.++||||||+++|+|++ |..||... ........+ .
T Consensus 195 ~~~~~~~~~-~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~SlG~il~ellt~g~~P~~~~-----~~~~~~~~i---~- 264 (373)
T 2qol_A 195 RVLEDDPEA-AYTTRGGKIPIRWTSPEAIAYRKFTSASDVWSYGIVLWEVMSYGERPYWEM-----SNQDVIKAV---D- 264 (373)
T ss_dssp --------------------CTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTC-CTTTTC-----CHHHHHHHH---H-
T ss_pred cccccCCcc-ceeccCCCcCCCccChhhhccCCcCchhcHHHHHHHHHHHHhCCCCCCCCC-----CHHHHHHHH---H-
Confidence 765422111 111112234678999999999999999999999999999997 99998432 222222211 1
Q ss_pred cCccCcccccCccccchhhHhHHHHHHHHHHHHHHHHhcCCCCCCCCChhhhhc
Q 038766 245 NGINGVRQITDPKLVSSIYEEQEQHQVLEELFKLALVCTSSNPEDRPNMNELLI 298 (299)
Q Consensus 245 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rpt~~~il~ 298 (299)
... .... +..++..+.+++.+||..||++|||++++++
T Consensus 265 ~~~----~~~~------------~~~~~~~l~~li~~cl~~dp~~RPs~~~i~~ 302 (373)
T 2qol_A 265 EGY----RLPP------------PMDCPAALYQLMLDCWQKDRNNRPKFEQIVS 302 (373)
T ss_dssp TTE----ECCC------------CTTCBHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred cCC----CCCC------------CccccHHHHHHHHHHhCcChhhCcCHHHHHH
Confidence 110 0000 1123467999999999999999999999875
|
| >3fme_A Dual specificity mitogen-activated protein kinase; active mutant, structural genomics consortium, SCG, binding, nucleotide-binding, phosphoprotein; HET: STU; 2.26A {Homo sapiens} PDB: 3enm_A | Back alignment and structure |
|---|
Probab=100.00 E-value=4.4e-45 Score=306.09 Aligned_cols=260 Identities=22% Similarity=0.271 Sum_probs=190.1
Q ss_pred HHHhCCCCCCceeecCCcceEEEEEe-CCCcEEEEEEeccCcCChhhhHHHHHHHHHHHhcCCcceeeeeeEEEcCCCee
Q 038766 8 ENATGSFSENNIIGNSNLSTVYKGRL-EDGEIVAVKKLNFHQFSAESDKSFYREAKTLKELKHRNLVKVLGYAWESGKLK 86 (299)
Q Consensus 8 ~~~~~~y~~~~~lg~g~~~~v~~~~~-~~~~~~~vK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~ 86 (299)
+...++|++.+.||+|+||+||++.+ .+++.||+|++............+..+...++.+.||||+++++++.. +...
T Consensus 3 ~i~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~h~~iv~~~~~~~~-~~~~ 81 (290)
T 3fme_A 3 EVKADDLEPIMELGRGAYGVVEKMRHVPSGQIMAVKRIRATVNSQEQKRLLMDLDISMRTVDCPFTVTFYGALFR-EGDV 81 (290)
T ss_dssp CCCGGGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEC---CHHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEC-SSSE
T ss_pred cccHHhhhhHHhcCCCCCeEEEEEEecCCCeEEEEEEeecccCcHHHHHHHHHHHHHHHhCCCCeEEEEeeeeec-cCCE
Confidence 45678999999999999999999987 468999999997544344444555566666888899999999997765 4456
Q ss_pred EEEEeecCCCChHHHhcCCCCCCCCCChhhHHHHHHHHHHHHHHhhcCCCCCeeeecccCCceeeCCCCcEEEeeecccc
Q 038766 87 ALILEYMENGSLESVIHGPGVDHSRWTLPKRIDVLISVANGLDYLHSGYDIPIVHCDMKPSNILLDRDFEAHVSDFGTSR 166 (299)
Q Consensus 87 ~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lh~~~~~~~~H~dl~~~nil~~~~~~v~l~df~~~~ 166 (299)
++|+||+.+ +|.+++.........+++..++.++.|++.||+|||++ .+++|+||||+||+++.++.++|+|||++.
T Consensus 82 ~lv~e~~~~-~l~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~--~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~ 158 (290)
T 3fme_A 82 WICMELMDT-SLDKFYKQVIDKGQTIPEDILGKIAVSIVKALEHLHSK--LSVIHRDVKPSNVLINALGQVKMCDFGISG 158 (290)
T ss_dssp EEEEECCSE-EHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHHH--SCCCCCCCSGGGCEECTTCCEEBCCC----
T ss_pred EEEEehhcc-chHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHhhc--CCeecCCCCHHHEEECCCCCEEEeecCCcc
Confidence 999999964 88776643222456899999999999999999999983 299999999999999999999999999987
Q ss_pred ccccccccccccccccccCcccCChhhh----cccCcCccccchhhhHHHHHHHhCCCCCCCCccCCCCchhHHHHHHHH
Q 038766 167 MLDVHLQDLSSLSTAFQGTIGYLAPEFA----YMRIVTTKVDVFSFGIVVMEFLTKRRPTGLDEENGLSPISLRQLVEKA 242 (299)
Q Consensus 167 ~~~~~~~~~~~~~~~~~~~~~y~~PE~~----~~~~~~~~~DiwslG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~ 242 (299)
.... ........+++.|+|||.+ .+..++.++||||||+++|+|++|..||..... ....+...
T Consensus 159 ~~~~-----~~~~~~~~~t~~y~aPE~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~-------~~~~~~~~ 226 (290)
T 3fme_A 159 YLVD-----DVAKDIDAGCKPYMAPERINPELNQKGYSVKSDIWSLGITMIELAILRFPYDSWGT-------PFQQLKQV 226 (290)
T ss_dssp ----------------CCCCCCSCHHHHSCCTTC--CCHHHHHHHHHHHHHHHHHTSCSSCCCSC-------HHHHHHHH
T ss_pred cccc-----cccccccCCCccccChhhcChhhcCcCCCcHHHHHHHHHHHHHHHHCCCCccccCc-------hHHHHHHH
Confidence 6542 1222334578999999996 556788999999999999999999999953211 11122222
Q ss_pred HhcCccCcccccCccccchhhHhHHHHHHHHHHHHHHHHhcCCCCCCCCChhhhhcC
Q 038766 243 LANGINGVRQITDPKLVSSIYEEQEQHQVLEELFKLALVCTSSNPEDRPNMNELLIT 299 (299)
Q Consensus 243 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rpt~~~il~~ 299 (299)
......... ...++.++.++|.+||..||++|||++++++|
T Consensus 227 ~~~~~~~~~----------------~~~~~~~~~~li~~~l~~~p~~Rpt~~e~l~h 267 (290)
T 3fme_A 227 VEEPSPQLP----------------ADKFSAEFVDFTSQCLKKNSKERPTYPELMQH 267 (290)
T ss_dssp HHSCCCCCC----------------TTTSCHHHHHHHHHHTCSSGGGSCCHHHHTTS
T ss_pred hccCCCCcc----------------cccCCHHHHHHHHHHhhcChhhCcCHHHHHhC
Confidence 221111110 11235679999999999999999999999987
|
| >1xbb_A Tyrosine-protein kinase SYK; gleevec, STI-571, imatinib, spleen typrosine kinase, active conformation, structural genomics, structural genomix; HET: STI; 1.57A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xba_A* 1xbc_A* 3fqe_A* 3fqh_A* 3fqs_A* 3emg_A* 3srv_A* 4dfl_A* 4dfn_A* 3vf8_A* 3vf9_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.4e-45 Score=308.02 Aligned_cols=259 Identities=23% Similarity=0.338 Sum_probs=200.1
Q ss_pred HHHHHHhCCCCCCc-eeecCCcceEEEEEe---CCCcEEEEEEeccCcCChhhhHHHHHHHHHHHhcCCcceeeeeeEEE
Q 038766 5 TEIENATGSFSENN-IIGNSNLSTVYKGRL---EDGEIVAVKKLNFHQFSAESDKSFYREAKTLKELKHRNLVKVLGYAW 80 (299)
Q Consensus 5 ~~~~~~~~~y~~~~-~lg~g~~~~v~~~~~---~~~~~~~vK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~ 80 (299)
++++.-.++|.+.+ .||+|+||+||++.+ .+++.||+|++..........+.+.+|+..++.++||||+++++++
T Consensus 9 ~~~~~~~~~y~~~~~~lg~G~~g~Vy~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~- 87 (291)
T 1xbb_A 9 KEVYLDRKLLTLEDKELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRMIGIC- 87 (291)
T ss_dssp --CBCCGGGEEEEEEEEEECSSEEEEEEEEECSSSEEEEEEEEEC-----CHHHHHHHHHHHHHHTCCCTTBCCEEEEE-
T ss_pred ceeeecchhhhhccCccccccCeeeEeeeecCCCceeeEEEEeecccccCHHHHHHHHHHHHHHHhCCCCCEEEEEEEE-
Confidence 34455567888888 999999999999954 3478899999976555555578899999999999999999999976
Q ss_pred cCCCeeEEEEeecCCCChHHHhcCCCCCCCCCChhhHHHHHHHHHHHHHHhhcCCCCCeeeecccCCceeeCCCCcEEEe
Q 038766 81 ESGKLKALILEYMENGSLESVIHGPGVDHSRWTLPKRIDVLISVANGLDYLHSGYDIPIVHCDMKPSNILLDRDFEAHVS 160 (299)
Q Consensus 81 ~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lh~~~~~~~~H~dl~~~nil~~~~~~v~l~ 160 (299)
. ....++|+|++.+++|.+++. ....+++..++.++.|++.||.|||+. +++|+||||+||+++.++.++|+
T Consensus 88 ~-~~~~~lv~e~~~~~~L~~~l~----~~~~~~~~~~~~i~~qi~~~l~~LH~~---~i~H~dikp~Nil~~~~~~~kl~ 159 (291)
T 1xbb_A 88 E-AESWMLVMEMAELGPLNKYLQ----QNRHVKDKNIIELVHQVSMGMKYLEES---NFVHRDLAARNVLLVTQHYAKIS 159 (291)
T ss_dssp E-SSSEEEEEECCTTEEHHHHHH----HCTTCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEEEETTEEEEC
T ss_pred C-CCCcEEEEEeCCCCCHHHHHH----hCcCCCHHHHHHHHHHHHHHHHHHHhC---CeEcCCCCcceEEEeCCCcEEEc
Confidence 3 445689999999999999997 345799999999999999999999999 99999999999999999999999
Q ss_pred eeccccccccccccccccccccccCcccCChhhhcccCcCccccchhhhHHHHHHHh-CCCCCCCCccCCCCchhHHHHH
Q 038766 161 DFGTSRMLDVHLQDLSSLSTAFQGTIGYLAPEFAYMRIVTTKVDVFSFGIVVMEFLT-KRRPTGLDEENGLSPISLRQLV 239 (299)
Q Consensus 161 df~~~~~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~DiwslG~~l~~l~~-g~~p~~~~~~~~~~~~~~~~~~ 239 (299)
|||++......... ........+++.|+|||.+.+..++.++||||||+++|+|++ |..||... ........+
T Consensus 160 Dfg~~~~~~~~~~~-~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~-----~~~~~~~~~ 233 (291)
T 1xbb_A 160 DFGLSKALRADENY-YKAQTHGKWPVKWYAPECINYYKFSSKSDVWSFGVLMWEAFSYGQKPYRGM-----KGSEVTAML 233 (291)
T ss_dssp CCTTCEECCTTCSE-EEC----CCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTTCCSSTTC-----CHHHHHHHH
T ss_pred cCCcceeeccCCCc-ccccccCCCCceeeChHHhccCCCChhhhHHHHHHHHHHHHhcCCCCCCCC-----CHHHHHHHH
Confidence 99998765422111 111222335678999999998889999999999999999999 99998533 222222221
Q ss_pred HHHHhcCccCcccccCccccchhhHhHHHHHHHHHHHHHHHHhcCCCCCCCCChhhhhc
Q 038766 240 EKALANGINGVRQITDPKLVSSIYEEQEQHQVLEELFKLALVCTSSNPEDRPNMNELLI 298 (299)
Q Consensus 240 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rpt~~~il~ 298 (299)
....... . +..++..+.++|.+||..||++|||+.++++
T Consensus 234 ---~~~~~~~-----~------------~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~ 272 (291)
T 1xbb_A 234 ---EKGERMG-----C------------PAGCPREMYDLMNLCWTYDVENRPGFAAVEL 272 (291)
T ss_dssp ---HTTCCCC-----C------------CTTCCHHHHHHHHHHTCSSTTTSCCHHHHHH
T ss_pred ---HcCCCCC-----C------------CCCCCHHHHHHHHHHcCCChhhCcCHHHHHH
Confidence 1111000 0 1234567999999999999999999999875
|
| >2wei_A Calmodulin-domain protein kinase 1, putative; nucleotide-binding, serine/threonine-protein kinase, CGD3_920, transferase; HET: VGG; 1.65A {Cryptosporidium parvum iowa II} PDB: 3dfa_A 3ma6_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-44 Score=302.65 Aligned_cols=257 Identities=22% Similarity=0.303 Sum_probs=205.6
Q ss_pred HHHHhCCCCCCceeecCCcceEEEEEeC-CCcEEEEEEeccCcCChhhhHHHHHHHHHHHhcCCcceeeeeeEEEcCCCe
Q 038766 7 IENATGSFSENNIIGNSNLSTVYKGRLE-DGEIVAVKKLNFHQFSAESDKSFYREAKTLKELKHRNLVKVLGYAWESGKL 85 (299)
Q Consensus 7 ~~~~~~~y~~~~~lg~g~~~~v~~~~~~-~~~~~~vK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~ 85 (299)
...+.++|++.+.||+|++|+||++.+. +++.||+|++............+.+|+..+++++||||+++++++.. ...
T Consensus 17 ~~~~~~~y~i~~~lg~G~~g~V~~~~~~~~~~~valK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~-~~~ 95 (287)
T 2wei_A 17 QGTFAERYNIVCMLGKGSFGEVLKCKDRITQQEYAVKVINKASAKNKDTSTILREVELLKKLDHPNIMKLFEILED-SSS 95 (287)
T ss_dssp THHHHHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGBSSSCHHHHHHHHHHHHTCCCTTBCCEEEEEEC-SSE
T ss_pred HHHHhhcceeeEEEcCCCCEEEEEEEEcCCCcEEEEEEecccccchHHHHHHHHHHHHHHhccCCCccEEEEEEeC-CCe
Confidence 3567789999999999999999999875 68999999997655555667889999999999999999999997665 556
Q ss_pred eEEEEeecCCCChHHHhcCCCCCCCCCChhhHHHHHHHHHHHHHHhhcCCCCCeeeecccCCceeeCCC---CcEEEeee
Q 038766 86 KALILEYMENGSLESVIHGPGVDHSRWTLPKRIDVLISVANGLDYLHSGYDIPIVHCDMKPSNILLDRD---FEAHVSDF 162 (299)
Q Consensus 86 ~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lh~~~~~~~~H~dl~~~nil~~~~---~~v~l~df 162 (299)
.++|+|++.+++|.+.+. ....+++..++.++.|++.||.+||++ +++|+||+|+||+++.+ +.++|+||
T Consensus 96 ~~lv~e~~~~~~L~~~l~----~~~~~~~~~~~~i~~qi~~~l~~LH~~---~i~H~dl~p~NIlv~~~~~~~~~kL~Df 168 (287)
T 2wei_A 96 FYIVGELYTGGELFDEII----KRKRFSEHDAARIIKQVFSGITYMHKH---NIVHRDLKPENILLESKEKDCDIKIIDF 168 (287)
T ss_dssp EEEEECCCCSCBHHHHHH----HHSSCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEESCSSTTCCEEECST
T ss_pred EEEEEEccCCCCHHHHHH----hcCCCCHHHHHHHHHHHHHHHHHHHHC---CeeccCCChhhEEEecCCCcccEEEecc
Confidence 699999999999988876 345789999999999999999999999 99999999999999754 46999999
Q ss_pred ccccccccccccccccccccccCcccCChhhhcccCcCccccchhhhHHHHHHHhCCCCCCCCccCCCCchhHHHHHHHH
Q 038766 163 GTSRMLDVHLQDLSSLSTAFQGTIGYLAPEFAYMRIVTTKVDVFSFGIVVMEFLTKRRPTGLDEENGLSPISLRQLVEKA 242 (299)
Q Consensus 163 ~~~~~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~DiwslG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~ 242 (299)
|++..... ........+++.|+|||.+.+. ++.++||||||+++|+|++|..||.... .. +.....
T Consensus 169 g~~~~~~~-----~~~~~~~~~~~~y~aPE~~~~~-~~~~~Di~slG~~l~~l~~g~~p~~~~~-----~~---~~~~~~ 234 (287)
T 2wei_A 169 GLSTCFQQ-----NTKMKDRIGTAYYIAPEVLRGT-YDEKCDVWSAGVILYILLSGTPPFYGKN-----EY---DILKRV 234 (287)
T ss_dssp TGGGTBCC-----CSSCSCHHHHHTTCCHHHHTTC-CCTHHHHHHHHHHHHHHHHSSCSSCCSS-----HH---HHHHHH
T ss_pred CcceeecC-----CCccccccCcccccChHHhcCC-CCCchhhHhHHHHHHHHHhCCCCCCCCC-----HH---HHHHHH
Confidence 99875442 1122334578899999988764 8899999999999999999999985431 11 222222
Q ss_pred HhcCccCcccccCccccchhhHhHHHHHHHHHHHHHHHHhcCCCCCCCCChhhhhcC
Q 038766 243 LANGINGVRQITDPKLVSSIYEEQEQHQVLEELFKLALVCTSSNPEDRPNMNELLIT 299 (299)
Q Consensus 243 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rpt~~~il~~ 299 (299)
..... ....+. ...++.++.++|++||..||++|||++++|+|
T Consensus 235 ~~~~~----~~~~~~----------~~~~~~~~~~li~~~l~~dp~~Rps~~ell~h 277 (287)
T 2wei_A 235 ETGKY----AFDLPQ----------WRTISDDAKDLIRKMLTFHPSLRITATQCLEH 277 (287)
T ss_dssp HHCCC----CCCSGG----------GTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHS
T ss_pred HcCCC----CCCchh----------hhhcCHHHHHHHHHHcccChhhCcCHHHHhcC
Confidence 11110 000000 12345679999999999999999999999986
|
| >1u5q_A Serine/threonine protein kinase TAO2; transferase; HET: SEP; 2.10A {Rattus norvegicus} SCOP: d.144.1.7 PDB: 1u5r_A* 2gcd_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-44 Score=310.65 Aligned_cols=249 Identities=26% Similarity=0.376 Sum_probs=198.7
Q ss_pred hCCCCCCceeecCCcceEEEEEe-CCCcEEEEEEeccCcCC-hhhhHHHHHHHHHHHhcCCcceeeeeeEEEcCCCeeEE
Q 038766 11 TGSFSENNIIGNSNLSTVYKGRL-EDGEIVAVKKLNFHQFS-AESDKSFYREAKTLKELKHRNLVKVLGYAWESGKLKAL 88 (299)
Q Consensus 11 ~~~y~~~~~lg~g~~~~v~~~~~-~~~~~~~vK~~~~~~~~-~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~l 88 (299)
.++|.+.+.||+|+||+||+|.+ .+++.||||++...... ......+.+|+.++++++||||+++++++.. +...++
T Consensus 53 ~~~y~~~~~lG~G~~g~Vy~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~-~~~~~l 131 (348)
T 1u5q_A 53 EKLFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQYRGCYLR-EHTAWL 131 (348)
T ss_dssp HHHEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEESCSSCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEE-TTEEEE
T ss_pred hhheeeeeEEccCCCEEEEEEEEccCCeEEEEEEEccccccchHHHHHHHHHHHHHHhCCCCCEeeEEEEEEE-CCeEEE
Confidence 35689999999999999999986 56899999999754332 3345678899999999999999999997665 556699
Q ss_pred EEeecCCCChHHHhcCCCCCCCCCChhhHHHHHHHHHHHHHHhhcCCCCCeeeecccCCceeeCCCCcEEEeeecccccc
Q 038766 89 ILEYMENGSLESVIHGPGVDHSRWTLPKRIDVLISVANGLDYLHSGYDIPIVHCDMKPSNILLDRDFEAHVSDFGTSRML 168 (299)
Q Consensus 89 v~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lh~~~~~~~~H~dl~~~nil~~~~~~v~l~df~~~~~~ 168 (299)
|+||+. ++|.+++.. ...++++..++.++.|++.||.|||++ +++|+||||+||+++.++.++|+|||++...
T Consensus 132 v~e~~~-g~l~~~l~~---~~~~l~~~~~~~i~~qi~~aL~~LH~~---~ivH~Dlkp~NIll~~~~~~kL~DfG~a~~~ 204 (348)
T 1u5q_A 132 VMEYCL-GSASDLLEV---HKKPLQEVEIAAVTHGALQGLAYLHSH---NMIHRDVKAGNILLSEPGLVKLGDFGSASIM 204 (348)
T ss_dssp EEECCS-EEHHHHHHH---HTSCCCHHHHHHHHHHHHHHHHHHHHT---TCBCCCCSGGGEEEETTTEEEECCCTTCBSS
T ss_pred EEecCC-CCHHHHHHH---hcCCCCHHHHHHHHHHHHHHHHHHHhC---CeeeCCCCHHHEEECCCCCEEEeeccCceec
Confidence 999996 588777642 235789999999999999999999999 9999999999999999999999999998754
Q ss_pred ccccccccccccccccCcccCChhhhc---ccCcCccccchhhhHHHHHHHhCCCCCCCCccCCCCchhHHHHHHHHHhc
Q 038766 169 DVHLQDLSSLSTAFQGTIGYLAPEFAY---MRIVTTKVDVFSFGIVVMEFLTKRRPTGLDEENGLSPISLRQLVEKALAN 245 (299)
Q Consensus 169 ~~~~~~~~~~~~~~~~~~~y~~PE~~~---~~~~~~~~DiwslG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~ 245 (299)
.. .....+++.|+|||++. ...++.++|||||||++|+|++|..||.... . ...+......
T Consensus 205 ~~--------~~~~~gt~~y~aPE~~~~~~~~~~~~~~DiwslG~il~ell~g~~p~~~~~-----~---~~~~~~~~~~ 268 (348)
T 1u5q_A 205 AP--------ANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMN-----A---MSALYHIAQN 268 (348)
T ss_dssp SS--------BCCCCSCGGGCCHHHHHTTSSCCBCTHHHHHHHHHHHHHHHHSSCTTTTSC-----H---HHHHHHHHHS
T ss_pred CC--------CCcccCCcceeCHhhhccccCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCC-----h---HHHHHHHHhc
Confidence 31 23446899999999885 4668899999999999999999999985331 1 1122222221
Q ss_pred CccCcccccCccccchhhHhHHHHHHHHHHHHHHHHhcCCCCCCCCChhhhhcC
Q 038766 246 GINGVRQITDPKLVSSIYEEQEQHQVLEELFKLALVCTSSNPEDRPNMNELLIT 299 (299)
Q Consensus 246 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rpt~~~il~~ 299 (299)
..+.. . ....+..+.++|.+||..||++|||++++++|
T Consensus 269 ~~~~~---~-------------~~~~~~~l~~li~~~l~~dP~~Rps~~~ll~h 306 (348)
T 1u5q_A 269 ESPAL---Q-------------SGHWSEYFRNFVDSCLQKIPQDRPTSEVLLKH 306 (348)
T ss_dssp CCCCC---C-------------CTTSCHHHHHHHHHHTCSSGGGSCCHHHHTTC
T ss_pred CCCCC---C-------------CCCCCHHHHHHHHHHcccChhhCcCHHHHhhC
Confidence 11110 0 11234578999999999999999999999987
|
| >1fmk_A C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyrosine kinase, phosphorylation, SH2, SH3, phosphotyrosine, proto-oncogene, phosphotransferase; HET: PTR; 1.50A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1y57_A* 2src_A* 1ksw_A* 2ptk_A* 1yol_A* 2oiq_A* 3d7t_B* 3dqx_A* 3el7_A* 3el8_A* 3en4_A* 3en5_A* 3en6_A* 3en7_A* 3f6x_A* 3g6g_A* 3uqf_A* 3uqg_A* 4agw_A* 3oez_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-45 Score=327.96 Aligned_cols=257 Identities=27% Similarity=0.418 Sum_probs=201.2
Q ss_pred hHHHHHHhCCCCCCceeecCCcceEEEEEeCCCcEEEEEEeccCcCChhhhHHHHHHHHHHHhcCCcceeeeeeEEEcCC
Q 038766 4 RTEIENATGSFSENNIIGNSNLSTVYKGRLEDGEIVAVKKLNFHQFSAESDKSFYREAKTLKELKHRNLVKVLGYAWESG 83 (299)
Q Consensus 4 ~~~~~~~~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~vK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~ 83 (299)
.+.++.-.++|++.+.||+|+||.||++.+.++..||||++.... ...+.+.+|+.++++++||||+++++++..
T Consensus 176 ~~~~~i~~~~~~~~~~lG~G~fg~Vy~~~~~~~~~vavK~~~~~~---~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~-- 250 (452)
T 1fmk_A 176 KDAWEIPRESLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTLKPGT---MSPEAFLQEAQVMKKLRHEKLVQLYAVVSE-- 250 (452)
T ss_dssp TTCSBCCGGGEEEEEEEEECSSCEEEEEEETTTEEEEEEECCTTS---SCHHHHHHHHHHHHHCCCTTBCCEEEEECS--
T ss_pred ccccccChhHceeeeeecCCCCeEEEEEEECCCceEEEEEeccCC---CCHHHHHHHHHHHHhCCCCCEeeEEEEEcC--
Confidence 456677788999999999999999999999888889999987433 335678999999999999999999997644
Q ss_pred CeeEEEEeecCCCChHHHhcCCCCCCCCCChhhHHHHHHHHHHHHHHhhcCCCCCeeeecccCCceeeCCCCcEEEeeec
Q 038766 84 KLKALILEYMENGSLESVIHGPGVDHSRWTLPKRIDVLISVANGLDYLHSGYDIPIVHCDMKPSNILLDRDFEAHVSDFG 163 (299)
Q Consensus 84 ~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lh~~~~~~~~H~dl~~~nil~~~~~~v~l~df~ 163 (299)
...++|+||+.+++|.+++... ....+++..++.++.|++.||+|||++ +++||||||+||+++.++.+||+|||
T Consensus 251 ~~~~iv~e~~~~gsL~~~l~~~--~~~~~~~~~~~~i~~qi~~~l~~LH~~---~ivHrDlkp~Nill~~~~~~kl~DfG 325 (452)
T 1fmk_A 251 EPIYIVTEYMSKGSLLDFLKGE--TGKYLRLPQLVDMAAQIASGMAYVERM---NYVHRDLRAANILVGENLVCKVADFG 325 (452)
T ss_dssp SSCEEEECCCTTCBHHHHHSHH--HHTTCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEECGGGCEEECCCC
T ss_pred CceEEEehhhcCCCHHHHHHhc--CCCCCCHHHHHHHHHHHHHHHHHHHhC---CeeCCCCChhhEEECCCCCEEECCCc
Confidence 4458999999999999998632 224589999999999999999999999 99999999999999999999999999
Q ss_pred cccccccccccccccccccccCcccCChhhhcccCcCccccchhhhHHHHHHHh-CCCCCCCCccCCCCchhHHHHHHHH
Q 038766 164 TSRMLDVHLQDLSSLSTAFQGTIGYLAPEFAYMRIVTTKVDVFSFGIVVMEFLT-KRRPTGLDEENGLSPISLRQLVEKA 242 (299)
Q Consensus 164 ~~~~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~DiwslG~~l~~l~~-g~~p~~~~~~~~~~~~~~~~~~~~~ 242 (299)
++...... .........++..|+|||.+.+..++.++||||||+++|+|++ |..||... .... .+...
T Consensus 326 ~a~~~~~~---~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDvwslG~~l~el~t~g~~P~~~~-----~~~~---~~~~i 394 (452)
T 1fmk_A 326 LARLIEDN---EYTARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGM-----VNRE---VLDQV 394 (452)
T ss_dssp TTC-----------------CCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCSSTTC-----CHHH---HHHHH
T ss_pred cceecCCC---ceecccCCcccccccCHhHHhcCCCCccccHHhHHHHHHHHHhCCCCCCCCC-----CHHH---HHHHH
Confidence 99765421 1112223345778999999999999999999999999999999 88998532 2222 22222
Q ss_pred HhcCccCcccccCccccchhhHhHHHHHHHHHHHHHHHHhcCCCCCCCCChhhhhc
Q 038766 243 LANGINGVRQITDPKLVSSIYEEQEQHQVLEELFKLALVCTSSNPEDRPNMNELLI 298 (299)
Q Consensus 243 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rpt~~~il~ 298 (299)
.. +. .... +..++..+.++|.+||..||++|||++++++
T Consensus 395 ~~-~~----~~~~------------~~~~~~~l~~li~~cl~~dP~~Rpt~~~l~~ 433 (452)
T 1fmk_A 395 ER-GY----RMPC------------PPECPESLHDLMCQCWRKEPEERPTFEYLQA 433 (452)
T ss_dssp HT-TC----CCCC------------CTTSCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred Hc-CC----CCCC------------CCCCCHHHHHHHHHHccCChhhCcCHHHHHH
Confidence 11 10 0000 1234567999999999999999999999874
|
| >2izr_A Casein kinase I isoform gamma-3; serine/threonine-protein kinase, transferase, ATP- binding, phosphorylation, nucleotide-binding; HET: BRK; 1.3A {Homo sapiens} PDB: 2izs_A* 2izt_A* 2izu_A* 2chl_A* 2c47_A* 2cmw_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2e-44 Score=307.76 Aligned_cols=258 Identities=19% Similarity=0.211 Sum_probs=201.1
Q ss_pred HhCCCCCCceeecCCcceEEEEEe-CCCcEEEEEEeccCcCChhhhHHHHHHHHHHHhc-CCcceeeeeeEEEcCCCeeE
Q 038766 10 ATGSFSENNIIGNSNLSTVYKGRL-EDGEIVAVKKLNFHQFSAESDKSFYREAKTLKEL-KHRNLVKVLGYAWESGKLKA 87 (299)
Q Consensus 10 ~~~~y~~~~~lg~g~~~~v~~~~~-~~~~~~~vK~~~~~~~~~~~~~~~~~e~~~l~~l-~h~~i~~~~~~~~~~~~~~~ 87 (299)
+.++|.+.+.||+|+||+||++.+ .+++.||+|++.... ....+.+|+.+++.+ .||||+++++++.. +...+
T Consensus 7 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~----~~~~~~~E~~~l~~l~~h~~i~~~~~~~~~-~~~~~ 81 (330)
T 2izr_A 7 VGPNFRVGKKIGCGNFGELRLGKNLYTNEYVAIKLEPMKS----RAPQLHLEYRFYKQLGSGDGIPQVYYFGPC-GKYNA 81 (330)
T ss_dssp ETTTEEEEEECCC-CTTSEEEEEETTTTEEEEEEEEETTC----SSCCHHHHHHHHHHHCSCTTSCCEEEEEEE-TTEEE
T ss_pred EcCCeEEEEEeeccCCceEEEEEECCCCcEEEEEEecccc----chHHHHHHHHHHHHhhCCCCCCEEEEEEec-CCccE
Confidence 568899999999999999999986 568999999986432 234578899999999 89999999996655 56679
Q ss_pred EEEeecCCCChHHHhcCCCCCCCCCChhhHHHHHHHHHHHHHHhhcCCCCCeeeecccCCceeeCCCCc-----EEEeee
Q 038766 88 LILEYMENGSLESVIHGPGVDHSRWTLPKRIDVLISVANGLDYLHSGYDIPIVHCDMKPSNILLDRDFE-----AHVSDF 162 (299)
Q Consensus 88 lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lh~~~~~~~~H~dl~~~nil~~~~~~-----v~l~df 162 (299)
+|+|++ +++|.+++... ...+++..++.++.|++.||+|||+. +++|+||||+||+++.++. ++|+||
T Consensus 82 lv~e~~-~~~L~~~~~~~---~~~~~~~~~~~i~~qi~~~l~~LH~~---~iiHrDlkp~Nill~~~~~~~~~~~kl~DF 154 (330)
T 2izr_A 82 MVLELL-GPSLEDLFDLC---DRTFSLKTVLMIAIQLISRMEYVHSK---NLIYRDVKPENFLIGRPGNKTQQVIHIIDF 154 (330)
T ss_dssp EEEECC-CCBHHHHHHHT---TTCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEECCGGGTCTTSEEECCC
T ss_pred EEEEeC-CCCHHHHHHHc---CCCCCHHHHHHHHHHHHHHHHHHHhC---CeeccCCCHHHeeeccCCCCCCceEEEEEc
Confidence 999999 88999998642 35799999999999999999999999 9999999999999998887 999999
Q ss_pred ccccccccccccc---cccccccccCcccCChhhhcccCcCccccchhhhHHHHHHHhCCCCCCCCccCCCCchhHHHHH
Q 038766 163 GTSRMLDVHLQDL---SSLSTAFQGTIGYLAPEFAYMRIVTTKVDVFSFGIVVMEFLTKRRPTGLDEENGLSPISLRQLV 239 (299)
Q Consensus 163 ~~~~~~~~~~~~~---~~~~~~~~~~~~y~~PE~~~~~~~~~~~DiwslG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~ 239 (299)
|++..+....... ........+|+.|+|||++.+..++.++|||||||++|+|++|..||.... .....+.+
T Consensus 155 g~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~ell~g~~Pf~~~~-----~~~~~~~~ 229 (330)
T 2izr_A 155 ALAKEYIDPETKKHIPYREHKSLTGTARYMSINTHLGKEQSRRDDLEALGHMFMYFLRGSLPWQGLK-----ADTLKERY 229 (330)
T ss_dssp TTCEESBCTTTCCBCCCCCCCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTTTCC-----CSSHHHHH
T ss_pred ccceeeecCCCCccccccccCCcCCCccccChHHHcCCCCCchhHHHHHHHHHHHHhcCCCCccccc-----cccHHHHH
Confidence 9998654221111 111245678999999999999999999999999999999999999996442 22222222
Q ss_pred HHHHhcCccCcccccCccccchhhHhHHHHHHHHHHHHHHHHhcCCCCCCCCChhhhhc
Q 038766 240 EKALANGINGVRQITDPKLVSSIYEEQEQHQVLEELFKLALVCTSSNPEDRPNMNELLI 298 (299)
Q Consensus 240 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rpt~~~il~ 298 (299)
.......... .........+ ++.+++.+||..||.+|||++++++
T Consensus 230 ~~i~~~~~~~-------------~~~~~~~~~p-~~~~li~~~l~~~p~~RP~~~~l~~ 274 (330)
T 2izr_A 230 QKIGDTKRAT-------------PIEVLCENFP-EMATYLRYVRRLDFFEKPDYDYLRK 274 (330)
T ss_dssp HHHHHHHHHS-------------CHHHHTTTCH-HHHHHHHHHHHCCTTCCCCHHHHHH
T ss_pred HHHHhhhccC-------------CHHHHhccCh-HHHHHHHHHHhCCCCCCCCHHHHHH
Confidence 2211100000 0000011233 8999999999999999999999864
|
| >3brb_A Proto-oncogene tyrosine-protein kinase MER; ATP-binding, disease mutation, glycoprotein, nucleot binding, phosphorylation, receptor; HET: ADP; 1.90A {Homo sapiens} PDB: 3bpr_A* 2p0c_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.5e-45 Score=309.44 Aligned_cols=264 Identities=23% Similarity=0.380 Sum_probs=197.5
Q ss_pred HHHHHhCCCCCCceeecCCcceEEEEEeC----CCcEEEEEEeccCcCChhhhHHHHHHHHHHHhcCCcceeeeeeEEEc
Q 038766 6 EIENATGSFSENNIIGNSNLSTVYKGRLE----DGEIVAVKKLNFHQFSAESDKSFYREAKTLKELKHRNLVKVLGYAWE 81 (299)
Q Consensus 6 ~~~~~~~~y~~~~~lg~g~~~~v~~~~~~----~~~~~~vK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~ 81 (299)
++....++|.+.+.||+|+||.||+|.+. ++..||+|++..........+.+.+|+..+++++||||+++++++..
T Consensus 28 ~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~ 107 (313)
T 3brb_A 28 DVVIDRNLLILGKILGEGEFGSVMEGNLKQEDGTSLKVAVKTMKLDNSSQREIEEFLSEAACMKDFSHPNVIRLLGVCIE 107 (313)
T ss_dssp TTBCCGGGEEEEEEEEC-CCCCEEEEEEECTTSCEEEEEEEEC---CCCHHHHHHHHHHHHHHHTCCCTTBCCCCEEEEC
T ss_pred hcccCHHHeeeccceeecCCeEEEEEEEeccCCceeEEEEEEEeccccchhHHHHHHHHHHHHhcCCCCCeeeeeEEEee
Confidence 34455678999999999999999999753 35589999998666666667889999999999999999999998775
Q ss_pred CCC----eeEEEEeecCCCChHHHhcCC--CCCCCCCChhhHHHHHHHHHHHHHHhhcCCCCCeeeecccCCceeeCCCC
Q 038766 82 SGK----LKALILEYMENGSLESVIHGP--GVDHSRWTLPKRIDVLISVANGLDYLHSGYDIPIVHCDMKPSNILLDRDF 155 (299)
Q Consensus 82 ~~~----~~~lv~e~~~~~~L~~~~~~~--~~~~~~~~~~~~~~i~~qi~~~l~~lh~~~~~~~~H~dl~~~nil~~~~~ 155 (299)
.+. ..++|+||+.+++|.+++... ......+++..++.++.|++.||.|||++ +++|+||||+||+++.++
T Consensus 108 ~~~~~~~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~---~ivH~dikp~NIli~~~~ 184 (313)
T 3brb_A 108 MSSQGIPKPMVILPFMKYGDLHTYLLYSRLETGPKHIPLQTLLKFMVDIALGMEYLSNR---NFLHRDLAARNCMLRDDM 184 (313)
T ss_dssp -------CEEEEEECCTTCBHHHHHHHTTBTTSCCCCCHHHHHHHHHHHHHHHHHHHTT---TCCCCCCSGGGEEECTTS
T ss_pred ccccCCcccEEEEecccCCCHHHHHHHhhhhcCCccCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCCcceEEEcCCC
Confidence 442 358999999999999987321 12446799999999999999999999999 999999999999999999
Q ss_pred cEEEeeeccccccccccccccccccccccCcccCChhhhcccCcCccccchhhhHHHHHHHh-CCCCCCCCccCCCCchh
Q 038766 156 EAHVSDFGTSRMLDVHLQDLSSLSTAFQGTIGYLAPEFAYMRIVTTKVDVFSFGIVVMEFLT-KRRPTGLDEENGLSPIS 234 (299)
Q Consensus 156 ~v~l~df~~~~~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~DiwslG~~l~~l~~-g~~p~~~~~~~~~~~~~ 234 (299)
.++|+|||++....... .........+++.|+|||.+.+..++.++||||||+++|+|++ |..||.... ...
T Consensus 185 ~~kl~Dfg~~~~~~~~~--~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~-----~~~ 257 (313)
T 3brb_A 185 TVCVADFGLSKKIYSGD--YYRQGRIAKMPVKWIAIESLADRVYTSKSDVWAFGVTMWEIATRGMTPYPGVQ-----NHE 257 (313)
T ss_dssp CEEECSCSCC------------------CCGGGSCHHHHHSSCCCHHHHHHHHHHHHHHHHTTSCCSSTTCC-----GGG
T ss_pred cEEEeecCcceeccccc--ccCcccccCCCccccCchhhcCCCccchhhhHHHHHHHHHHHhcCCCCCccCC-----HHH
Confidence 99999999987654211 1112233446778999999999999999999999999999999 888885432 222
Q ss_pred HHHHHHHHHhcCccCcccccCccccchhhHhHHHHHHHHHHHHHHHHhcCCCCCCCCChhhhhcC
Q 038766 235 LRQLVEKALANGINGVRQITDPKLVSSIYEEQEQHQVLEELFKLALVCTSSNPEDRPNMNELLIT 299 (299)
Q Consensus 235 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rpt~~~il~~ 299 (299)
....+ ....... . +..++..+.++|.+||..||++|||+++++++
T Consensus 258 ~~~~~---~~~~~~~-----~------------~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~ 302 (313)
T 3brb_A 258 MYDYL---LHGHRLK-----Q------------PEDCLDELYEIMYSCWRTDPLDRPTFSVLRLQ 302 (313)
T ss_dssp HHHHH---HTTCCCC-----C------------BTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHH
T ss_pred HHHHH---HcCCCCC-----C------------CccccHHHHHHHHHHcCCChhhCcCHHHHHHH
Confidence 22211 1111000 0 12334679999999999999999999999863
|
| >4hgt_A Casein kinase I isoform delta; CK1D, inhibitor, transferase-transferase inhibitor C; HET: 15G; 1.80A {Homo sapiens} PDB: 3uys_A* 3uyt_A* 3uzp_A* 4hnf_A* 1cki_A 1ckj_A 4hni_A* 4hok_A | Back alignment and structure |
|---|
Probab=100.00 E-value=5.6e-44 Score=300.16 Aligned_cols=261 Identities=19% Similarity=0.237 Sum_probs=200.7
Q ss_pred HHhCCCCCCceeecCCcceEEEEEe-CCCcEEEEEEeccCcCChhhhHHHHHHHHHHHhcCCcceeeeeeEEEcCCCeeE
Q 038766 9 NATGSFSENNIIGNSNLSTVYKGRL-EDGEIVAVKKLNFHQFSAESDKSFYREAKTLKELKHRNLVKVLGYAWESGKLKA 87 (299)
Q Consensus 9 ~~~~~y~~~~~lg~g~~~~v~~~~~-~~~~~~~vK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~ 87 (299)
.+.++|.+.+.||+|+||+||++.+ .+++.||+|++.... ....+.+|+.+++.++|++++..+..+...+...+
T Consensus 6 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~----~~~~~~~e~~~l~~l~~~~~i~~~~~~~~~~~~~~ 81 (296)
T 4hgt_A 6 RVGNRYRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKT----KHPQLHIESKIYKMMQGGVGIPTIRWCGAEGDYNV 81 (296)
T ss_dssp -----CEEEEEEEECSSSEEEEEEETTTTEEEEEEEEEC-------CCCHHHHHHHHHHHTTSTTCCCEEEEEEETTEEE
T ss_pred ccCCceEEeeeecCCCCeEEEEEEEcCCCceEEEEeecccc----cchHHHHHHHHHHHhcCCCCCCeeeeecCCCCceE
Confidence 5678999999999999999999987 568999999875432 23357889999999999988888887877788889
Q ss_pred EEEeecCCCChHHHhcCCCCCCCCCChhhHHHHHHHHHHHHHHhhcCCCCCeeeecccCCceee---CCCCcEEEeeecc
Q 038766 88 LILEYMENGSLESVIHGPGVDHSRWTLPKRIDVLISVANGLDYLHSGYDIPIVHCDMKPSNILL---DRDFEAHVSDFGT 164 (299)
Q Consensus 88 lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lh~~~~~~~~H~dl~~~nil~---~~~~~v~l~df~~ 164 (299)
+|+|++ +++|.+++... ...+++..++.++.|++.||+|||+. +++|+||||+||++ +.++.++|+|||+
T Consensus 82 lv~e~~-~~~L~~~~~~~---~~~~~~~~~~~i~~qi~~~l~~LH~~---~ivH~Dlkp~NIl~~~~~~~~~~kL~Dfg~ 154 (296)
T 4hgt_A 82 MVMELL-GPSLEDLFNFC---SRKFSLKTVLLLADQMISRIEYIHSK---NFIHRDVKPDNFLMGLGKKGNLVYIIDFGL 154 (296)
T ss_dssp EEEECC-CCBHHHHHHHT---TSCCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEECCGGGTTCEEECCCTT
T ss_pred EEEEcc-CCCHHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHeeeeccCCCCeEEEecCcc
Confidence 999999 88999998632 34699999999999999999999999 99999999999999 7889999999999
Q ss_pred ccccccccccc---cccccccccCcccCChhhhcccCcCccccchhhhHHHHHHHhCCCCCCCCccCCCCchhHHHHHHH
Q 038766 165 SRMLDVHLQDL---SSLSTAFQGTIGYLAPEFAYMRIVTTKVDVFSFGIVVMEFLTKRRPTGLDEENGLSPISLRQLVEK 241 (299)
Q Consensus 165 ~~~~~~~~~~~---~~~~~~~~~~~~y~~PE~~~~~~~~~~~DiwslG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~ 241 (299)
+.......... ........+++.|+|||.+.+..++.++|||||||++|+|++|..||......... ..+......
T Consensus 155 a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~-~~~~~~~~~ 233 (296)
T 4hgt_A 155 AKKYRDARTHQHIPYRENKNLTGTARYASINTHLGIEQSRRDDLESLGYVLMYFNLGSLPWQGLKAATKR-QKYERISEK 233 (296)
T ss_dssp CEECBCTTTCCBCCCCCSCCCCSCGGGCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTSSCCCSSSS-SHHHHHHHH
T ss_pred ceeccCcccCccCCCCcccccCCCccccchHHhcCCCCCchhHHHHHHHHHHHHhcCCCCCcccchhhhh-hhhhhhhcc
Confidence 98655322111 11233556899999999999999999999999999999999999999654322211 111111111
Q ss_pred HHhcCccCcccccCccccchhhHhHHHHHHHHHHHHHHHHhcCCCCCCCCChhhhhc
Q 038766 242 ALANGINGVRQITDPKLVSSIYEEQEQHQVLEELFKLALVCTSSNPEDRPNMNELLI 298 (299)
Q Consensus 242 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rpt~~~il~ 298 (299)
..... .......++.++.++|.+||..||++|||++++++
T Consensus 234 ~~~~~-----------------~~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~l~~ 273 (296)
T 4hgt_A 234 KMSTP-----------------IEVLCKGYPSEFATYLNFCRSLRFDDKPDYSYLRQ 273 (296)
T ss_dssp HHHSC-----------------HHHHTTTSCHHHHHHHHHHHTSCTTCCCCHHHHHH
T ss_pred cccch-----------------hhhhhccCCHHHHHHHHHHHhcCCCCCCCHHHHHH
Confidence 11100 00111334678999999999999999999999875
|
| >4e5w_A Tyrosine-protein kinase JAK1; kinase domain, transferase-transferase inhibit complex; HET: PTR 0NT; 1.86A {Homo sapiens} PDB: 4e4l_A* 4e4n_A* 4ehz_A* 4ei4_A* 4fk6_A* 3eyg_A* 3eyh_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.1e-45 Score=309.84 Aligned_cols=263 Identities=22% Similarity=0.386 Sum_probs=200.6
Q ss_pred hCCCCCCceeecCCcceEEEEEe-----CCCcEEEEEEeccCcCChhhhHHHHHHHHHHHhcCCcceeeeeeEEEcCC-C
Q 038766 11 TGSFSENNIIGNSNLSTVYKGRL-----EDGEIVAVKKLNFHQFSAESDKSFYREAKTLKELKHRNLVKVLGYAWESG-K 84 (299)
Q Consensus 11 ~~~y~~~~~lg~g~~~~v~~~~~-----~~~~~~~vK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~-~ 84 (299)
.++|++.+.||+|+||.||++.+ .+++.||+|++.... .......+.+|+..++.++||||+++++++...+ .
T Consensus 20 ~~~~~~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~ 98 (302)
T 4e5w_A 20 KRFLKRIRDLGEGHFGKVELCRYDPEGDNTGEQVAVKSLKPES-GGNHIADLKKEIEILRNLYHENIVKYKGICTEDGGN 98 (302)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEECTTSSSCSEEEEEEEEC------CCHHHHHHHHHHHHTCCCTTBCCEEEEEEC---C
T ss_pred hhhhhhhhccCCCCceEEEEEEEccccCccCeEEEEEEecccc-cchhHHHHHHHHHHHHhCCCCCeeeeeeEEecCCCc
Confidence 46689999999999999999983 358999999987433 3445678899999999999999999999877643 5
Q ss_pred eeEEEEeecCCCChHHHhcCCCCCCCCCChhhHHHHHHHHHHHHHHhhcCCCCCeeeecccCCceeeCCCCcEEEeeecc
Q 038766 85 LKALILEYMENGSLESVIHGPGVDHSRWTLPKRIDVLISVANGLDYLHSGYDIPIVHCDMKPSNILLDRDFEAHVSDFGT 164 (299)
Q Consensus 85 ~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lh~~~~~~~~H~dl~~~nil~~~~~~v~l~df~~ 164 (299)
..++|+||+.+++|.+++.. ....+++..++.++.|++.||++||++ +++|+||||+||+++.++.++|+|||+
T Consensus 99 ~~~lv~e~~~~~~L~~~l~~---~~~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dikp~Nil~~~~~~~kl~Dfg~ 172 (302)
T 4e5w_A 99 GIKLIMEFLPSGSLKEYLPK---NKNKINLKQQLKYAVQICKGMDYLGSR---QYVHRDLAARNVLVESEHQVKIGDFGL 172 (302)
T ss_dssp CEEEEEECCTTCBHHHHHHH---HTTTCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEEEETTEEEECCCTT
T ss_pred eEEEEEEeCCCCcHHHHHHh---ccccCCHHHHHHHHHHHHHHHHHhhcC---CcccCCCchheEEEcCCCCEEECcccc
Confidence 56899999999999999853 234689999999999999999999999 999999999999999999999999999
Q ss_pred ccccccccccccccccccccCcccCChhhhcccCcCccccchhhhHHHHHHHhCCCCCCCCcc------CCCCc-hhHHH
Q 038766 165 SRMLDVHLQDLSSLSTAFQGTIGYLAPEFAYMRIVTTKVDVFSFGIVVMEFLTKRRPTGLDEE------NGLSP-ISLRQ 237 (299)
Q Consensus 165 ~~~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~DiwslG~~l~~l~~g~~p~~~~~~------~~~~~-~~~~~ 237 (299)
+........ .........++..|+|||.+.+..++.++||||||+++|+|++|..|+..... ..... .....
T Consensus 173 ~~~~~~~~~-~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~ 251 (302)
T 4e5w_A 173 TKAIETDKE-YYTVKDDRDSPVFWYAPECLMQSKFYIASDVWSFGVTLHELLTYCDSDSSPMALFLKMIGPTHGQMTVTR 251 (302)
T ss_dssp CEECCTTCC-EEECCCCTTCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTTCGGGSHHHHHHHHHCSCCGGGHHHH
T ss_pred cccccCCCc-ceeccCCCCCCccccCCeeecCCCCCcchhHHHHHHHHHHHHHccCCCcchhhHHhhccCCcccccCHHH
Confidence 976542211 11223345577889999999999999999999999999999999988642210 00011 11111
Q ss_pred HHHHHHhcCccCcccccCccccchhhHhHHHHHHHHHHHHHHHHhcCCCCCCCCChhhhhc
Q 038766 238 LVEKALANGINGVRQITDPKLVSSIYEEQEQHQVLEELFKLALVCTSSNPEDRPNMNELLI 298 (299)
Q Consensus 238 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rpt~~~il~ 298 (299)
......... .. ..+..++..+.++|++||..||++|||++++++
T Consensus 252 ~~~~~~~~~-----~~------------~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~ 295 (302)
T 4e5w_A 252 LVNTLKEGK-----RL------------PCPPNCPDEVYQLMRKCWEFQPSNRTSFQNLIE 295 (302)
T ss_dssp HHHHHHTTC-----CC------------CCCTTCCHHHHHHHHHTTCSSGGGSCCHHHHHH
T ss_pred HHHHHhccC-----CC------------CCCCCCCHHHHHHHHHHcCCCCCCCCCHHHHHH
Confidence 111111100 00 002234568999999999999999999999985
|
| >1csn_A Casein kinase-1; phosphotransferase; HET: ATP; 2.00A {Schizosaccharomyces pombe} SCOP: d.144.1.7 PDB: 1eh4_A* 2csn_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.4e-44 Score=301.19 Aligned_cols=261 Identities=17% Similarity=0.194 Sum_probs=202.9
Q ss_pred HHHhCCCCCCceeecCCcceEEEEEe-CCCcEEEEEEeccCcCChhhhHHHHHHHHHHHhc-CCcceeeeeeEEEcCCCe
Q 038766 8 ENATGSFSENNIIGNSNLSTVYKGRL-EDGEIVAVKKLNFHQFSAESDKSFYREAKTLKEL-KHRNLVKVLGYAWESGKL 85 (299)
Q Consensus 8 ~~~~~~y~~~~~lg~g~~~~v~~~~~-~~~~~~~vK~~~~~~~~~~~~~~~~~e~~~l~~l-~h~~i~~~~~~~~~~~~~ 85 (299)
..+.++|.+.+.||+|++|+||++.+ .+++.||+|++... .....+.+|+..++.+ .|++++++++++. .+..
T Consensus 6 ~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~----~~~~~~~~e~~~~~~l~~~~~i~~~~~~~~-~~~~ 80 (298)
T 1csn_A 6 NVVGVHYKVGRRIGEGSFGVIFEGTNLLNNQQVAIKFEPRR----SDAPQLRDEYRTYKLLAGCTGIPNVYYFGQ-EGLH 80 (298)
T ss_dssp CEETTTEEEEEEEEECSSCEEEEEEETTTTEEEEEEEEECC----TTSCCHHHHHHHHHHTTTCTTCCCEEEEEE-ETTE
T ss_pred cccccceEEEEEEeecCCEEEEEEEECCCCcEEEEEEeccC----CccHHHHHHHHHHHHHhcCCCCCeEEeecC-CCce
Confidence 45678999999999999999999986 56899999998633 2334578899999999 6999999999654 4666
Q ss_pred eEEEEeecCCCChHHHhcCCCCCCCCCChhhHHHHHHHHHHHHHHhhcCCCCCeeeecccCCceeeCCCCc-----EEEe
Q 038766 86 KALILEYMENGSLESVIHGPGVDHSRWTLPKRIDVLISVANGLDYLHSGYDIPIVHCDMKPSNILLDRDFE-----AHVS 160 (299)
Q Consensus 86 ~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lh~~~~~~~~H~dl~~~nil~~~~~~-----v~l~ 160 (299)
.++|+|++ +++|.+++... ..++++..++.++.|++.||+|||++ +++|+||||+||+++.++. ++|+
T Consensus 81 ~~lv~e~~-~~~L~~~l~~~---~~~~~~~~~~~i~~qi~~~l~~lH~~---~ivH~Dlkp~NIl~~~~~~~~~~~~kl~ 153 (298)
T 1csn_A 81 NVLVIDLL-GPSLEDLLDLC---GRKFSVKTVAMAAKQMLARVQSIHEK---SLVYRDIKPDNFLIGRPNSKNANMIYVV 153 (298)
T ss_dssp EEEEEECC-CCBHHHHHHHT---TTCCCHHHHHHHHHHHHHHHHHHHTT---TEECCCCCGGGEEECCSSSTTTTCEEEC
T ss_pred eEEEEEec-CCCHHHHHHHh---ccCCCHHHHHHHHHHHHHHHHHHHhC---CEecCCCCHHHEEeccCCCCCCCeEEEE
Confidence 79999999 88999998742 34699999999999999999999999 9999999999999987766 9999
Q ss_pred eecccccccccccccc---ccccccccCcccCChhhhcccCcCccccchhhhHHHHHHHhCCCCCCCCccCCCCchhHHH
Q 038766 161 DFGTSRMLDVHLQDLS---SLSTAFQGTIGYLAPEFAYMRIVTTKVDVFSFGIVVMEFLTKRRPTGLDEENGLSPISLRQ 237 (299)
Q Consensus 161 df~~~~~~~~~~~~~~---~~~~~~~~~~~y~~PE~~~~~~~~~~~DiwslG~~l~~l~~g~~p~~~~~~~~~~~~~~~~ 237 (299)
|||++........... .......+++.|+|||.+.+..++.++||||||+++|+|++|..||...... .......
T Consensus 154 Dfg~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~--~~~~~~~ 231 (298)
T 1csn_A 154 DFGMVKFYRDPVTKQHIPYREKKNLSGTARYMSINTHLGREQSRRDDLEALGHVFMYFLRGSLPWQGLKAA--TNKQKYE 231 (298)
T ss_dssp CCTTCEESBCTTTCCBCCCCCCCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTSSCCSC--CHHHHHH
T ss_pred ECccccccccccccccccccCccCCCCCcccCCchhhcCCCCChHHHHHHHHHHHHHHHcCCCCcchhhcc--ccHHHHH
Confidence 9999986553221111 1234556899999999999999999999999999999999999999653211 1111111
Q ss_pred HHHHHHhcCccCcccccCccccchhhHhHHHHHHHHHHHHHHHHhcCCCCCCCCChhhhhc
Q 038766 238 LVEKALANGINGVRQITDPKLVSSIYEEQEQHQVLEELFKLALVCTSSNPEDRPNMNELLI 298 (299)
Q Consensus 238 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rpt~~~il~ 298 (299)
.+....... ........++.++.+++.+||..||++|||++++++
T Consensus 232 ~~~~~~~~~----------------~~~~~~~~~~~~l~~li~~~l~~dp~~RP~~~~l~~ 276 (298)
T 1csn_A 232 RIGEKKQST----------------PLRELCAGFPEEFYKYMHYARNLAFDATPDYDYLQG 276 (298)
T ss_dssp HHHHHHHHS----------------CHHHHTTTSCHHHHHHHHHHHHCCTTCCCCHHHHHH
T ss_pred HHHhhccCc----------------cHHHHHhhCcHHHHHHHHHHhcCCcccCCCHHHHHH
Confidence 111110000 000112245678999999999999999999999875
|
| >3mdy_A Bone morphogenetic protein receptor type-1B; complex (isomerase-protein kinase), receptor serine/threonin structural genomics consortium, SGC; HET: LDN; 2.05A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-43 Score=303.88 Aligned_cols=269 Identities=22% Similarity=0.310 Sum_probs=197.2
Q ss_pred HHHHHhCCCCCCceeecCCcceEEEEEeCCCcEEEEEEeccCcCChhhhHHHHHHHHHHHhc--CCcceeeeeeEEEcCC
Q 038766 6 EIENATGSFSENNIIGNSNLSTVYKGRLEDGEIVAVKKLNFHQFSAESDKSFYREAKTLKEL--KHRNLVKVLGYAWESG 83 (299)
Q Consensus 6 ~~~~~~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~vK~~~~~~~~~~~~~~~~~e~~~l~~l--~h~~i~~~~~~~~~~~ 83 (299)
....+.++|++.+.||+|+||.||++++. ++.||+|++.. ........|.+++... +||||+++++++....
T Consensus 31 ~~~~~~~~y~~~~~lg~G~~g~V~~~~~~-~~~vavK~~~~-----~~~~~~~~e~~~~~~~~~~h~~i~~~~~~~~~~~ 104 (337)
T 3mdy_A 31 VQRTIAKQIQMVKQIGKGRYGEVWMGKWR-GEKVAVKVFFT-----TEEASWFRETEIYQTVLMRHENILGFIAADIKGT 104 (337)
T ss_dssp HHTTHHHHCEEEEEEEEETTEEEEEEEET-TEEEEEEEEEG-----GGHHHHHHHHHHHTSTTCCCTTBCCEEEEEEESC
T ss_pred cccccccceEEEeEeecCCCeEEEEEEEC-CceEEEEEEec-----cccchhhhHHHHHHHHhhcCCCeeeEEEEEccCC
Confidence 45567789999999999999999999886 89999999852 2234445555666554 8999999999877653
Q ss_pred ---CeeEEEEeecCCCChHHHhcCCCCCCCCCChhhHHHHHHHHHHHHHHhhcCC-----CCCeeeecccCCceeeCCCC
Q 038766 84 ---KLKALILEYMENGSLESVIHGPGVDHSRWTLPKRIDVLISVANGLDYLHSGY-----DIPIVHCDMKPSNILLDRDF 155 (299)
Q Consensus 84 ---~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lh~~~-----~~~~~H~dl~~~nil~~~~~ 155 (299)
...++|+||+.+++|.++++ ...+++..++.++.|++.||.|||+.. ..+++|+||||+||+++.++
T Consensus 105 ~~~~~~~lv~e~~~~g~L~~~l~-----~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~~ivH~Dikp~Nill~~~~ 179 (337)
T 3mdy_A 105 GSWTQLYLITDYHENGSLYDYLK-----STTLDAKSMLKLAYSSVSGLCHLHTEIFSTQGKPAIAHRDLKSKNILVKKNG 179 (337)
T ss_dssp GGGCEEEEEECCCTTCBHHHHHH-----HCCBCHHHHHHHHHHHHHHHHHHHSCBCSTTCBCCEECSCCCGGGEEECTTS
T ss_pred CCCCceEEEEeccCCCcHHHHhh-----ccCCCHHHHHHHHHHHHHHHHHHHHhhhhhccCCCEEecccchHHEEECCCC
Confidence 56799999999999999995 336899999999999999999999741 22899999999999999999
Q ss_pred cEEEeeeccccccccccccccccccccccCcccCChhhhcccCcCcc------ccchhhhHHHHHHHhCC----------
Q 038766 156 EAHVSDFGTSRMLDVHLQDLSSLSTAFQGTIGYLAPEFAYMRIVTTK------VDVFSFGIVVMEFLTKR---------- 219 (299)
Q Consensus 156 ~v~l~df~~~~~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~------~DiwslG~~l~~l~~g~---------- 219 (299)
.+||+|||++..................+++.|+|||++.+...... +|||||||++|+|++|.
T Consensus 180 ~~kl~Dfg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~DiwslG~il~el~tg~~~~~~~~~~~ 259 (337)
T 3mdy_A 180 TCCIADLGLAVKFISDTNEVDIPPNTRVGTKRYMPPEVLDESLNRNHFQSYIMADMYSFGLILWEVARRCVSGGIVEEYQ 259 (337)
T ss_dssp CEEECCCTTCEECC---------CCSSCSCGGGCCHHHHTTCCCTTCTHHHHHHHHHHHHHHHHHHHTTBCBTTBCCCCC
T ss_pred CEEEEeCCCceeeccccccccCCCCCCccCcceeChhhcccccCCccccCccccchHHHHHHHHHHHhccCccccccccc
Confidence 99999999997654322222222335568999999999987766655 99999999999999994
Q ss_pred CCCCCCccCCCCchhHHHHHHHHHhcCccCcccccCccccchhhHhHHHHHHHHHHHHHHHHhcCCCCCCCCChhhhhcC
Q 038766 220 RPTGLDEENGLSPISLRQLVEKALANGINGVRQITDPKLVSSIYEEQEQHQVLEELFKLALVCTSSNPEDRPNMNELLIT 299 (299)
Q Consensus 220 ~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rpt~~~il~~ 299 (299)
.||............. ....... .. .+.. ........++.++.+++.+||..||++|||+++++++
T Consensus 260 ~p~~~~~~~~~~~~~~----~~~~~~~--~~----~~~~----~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~ 325 (337)
T 3mdy_A 260 LPYHDLVPSDPSYEDM----REIVCIK--KL----RPSF----PNRWSSDECLRQMGKLMTECWAHNPASRLTALRVKKT 325 (337)
T ss_dssp CTTTTTSCSSCCHHHH----HHHHTTS--CC----CCCC----CGGGGGSHHHHHHHHHHHHHSCSSGGGSCCHHHHHHH
T ss_pred ccHhhhcCCCCchhhh----HHHHhhh--cc----Cccc----cccchhhHHHHHHHHHHHHhhhhChhhCCCHHHHHHH
Confidence 4443222221111111 1111100 00 0000 0111134677889999999999999999999999864
|
| >1p4o_A Insulin-like growth factor I receptor protein; IGF-1R, kinase domain, hormone-growth factor complex; 1.50A {Homo sapiens} SCOP: d.144.1.7 PDB: 1m7n_A 3lvp_A* 3lw0_A* 1jqh_A* 2zm3_A* 3f5p_A* 3i81_A* 2oj9_A* 3nw5_A* 3nw6_A* 3nw7_A* 3o23_A* 3qqu_A* 3d94_A* 1k3a_A* 2z8c_A* 1ir3_A* 1gag_A* 1irk_A 3bu3_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=2.6e-45 Score=312.08 Aligned_cols=266 Identities=26% Similarity=0.379 Sum_probs=208.0
Q ss_pred CChHHHHHHhCCCCCCceeecCCcceEEEEEeC------CCcEEEEEEeccCcCChhhhHHHHHHHHHHHhcCCcceeee
Q 038766 2 FDRTEIENATGSFSENNIIGNSNLSTVYKGRLE------DGEIVAVKKLNFHQFSAESDKSFYREAKTLKELKHRNLVKV 75 (299)
Q Consensus 2 ~~~~~~~~~~~~y~~~~~lg~g~~~~v~~~~~~------~~~~~~vK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~ 75 (299)
|..++++...++|.+.+.||+|+||.||+|.+. +++.||+|++... ........+.+|+.+++.++||||+++
T Consensus 15 ~~~~~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vaiK~~~~~-~~~~~~~~~~~E~~~l~~l~h~~i~~~ 93 (322)
T 1p4o_A 15 YVPDEWEVAREKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEA-ASMRERIEFLNEASVMKEFNCHHVVRL 93 (322)
T ss_dssp CCCCTTBCCGGGEEEEEEEEECSSSEEEEEEEEEEETTEEEEEEEEEECCTT-SCHHHHHHHHHHHHHGGGCCCTTBCCE
T ss_pred cChhhhcchhhheeeeeEeccCCceEEEeeeecCccCCCCceEEEEEecccc-cCHHHHHHHHHHHHHHHhcCCCCEeee
Confidence 455678888999999999999999999999754 3788999998633 334456678899999999999999999
Q ss_pred eeEEEcCCCeeEEEEeecCCCChHHHhcCCC------CCCCCCChhhHHHHHHHHHHHHHHhhcCCCCCeeeecccCCce
Q 038766 76 LGYAWESGKLKALILEYMENGSLESVIHGPG------VDHSRWTLPKRIDVLISVANGLDYLHSGYDIPIVHCDMKPSNI 149 (299)
Q Consensus 76 ~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~------~~~~~~~~~~~~~i~~qi~~~l~~lh~~~~~~~~H~dl~~~ni 149 (299)
++++.. +...++|+|++.+++|.+++.... .....+++..++.++.|++.||.|||++ +++|+||||+||
T Consensus 94 ~~~~~~-~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~---~i~H~dikp~NI 169 (322)
T 1p4o_A 94 LGVVSQ-GQPTLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQMAGEIADGMAYLNAN---KFVHRDLAARNC 169 (322)
T ss_dssp EEEECS-SSSCEEEEECCTTCBHHHHHHHHHHHHHHCTTCCCCCHHHHHHHHHHHHHHHHHHHHT---TCBCSCCSGGGE
T ss_pred EEEEcc-CCccEEEEEeCCCCcHHHHHHHhchhhccCCCCCCcCHHHHHHHHHHHHHHHHHHHHC---CCccCCCccceE
Confidence 996655 455699999999999999886321 0124678999999999999999999999 999999999999
Q ss_pred eeCCCCcEEEeeeccccccccccccccccccccccCcccCChhhhcccCcCccccchhhhHHHHHHHh-CCCCCCCCccC
Q 038766 150 LLDRDFEAHVSDFGTSRMLDVHLQDLSSLSTAFQGTIGYLAPEFAYMRIVTTKVDVFSFGIVVMEFLT-KRRPTGLDEEN 228 (299)
Q Consensus 150 l~~~~~~v~l~df~~~~~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~DiwslG~~l~~l~~-g~~p~~~~~~~ 228 (299)
+++.++.++|+|||++....... .........+++.|+|||.+.+..++.++||||||+++|+|++ |..||...
T Consensus 170 li~~~~~~kl~Dfg~~~~~~~~~--~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~--- 244 (322)
T 1p4o_A 170 MVAEDFTVKIGDFGMTRDIYETD--YYRKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGL--- 244 (322)
T ss_dssp EECTTCCEEECCTTCCCGGGGGG--CEEGGGSSEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHHTSCCTTTTS---
T ss_pred EEcCCCeEEECcCcccccccccc--ccccccCCCCCCCccChhhhccCCCCchhhHHHHHHHHHHHHhcCCCccccC---
Confidence 99999999999999987543211 1112233456788999999999899999999999999999999 78888432
Q ss_pred CCCchhHHHHHHHHHhcCccCcccccCccccchhhHhHHHHHHHHHHHHHHHHhcCCCCCCCCChhhhhcC
Q 038766 229 GLSPISLRQLVEKALANGINGVRQITDPKLVSSIYEEQEQHQVLEELFKLALVCTSSNPEDRPNMNELLIT 299 (299)
Q Consensus 229 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rpt~~~il~~ 299 (299)
... .............. +..++..+.++|.+||..||++|||+++++++
T Consensus 245 --~~~---~~~~~~~~~~~~~~-----------------~~~~~~~l~~li~~~l~~dp~~Rps~~e~l~~ 293 (322)
T 1p4o_A 245 --SNE---QVLRFVMEGGLLDK-----------------PDNCPDMLFELMRMCWQYNPKMRPSFLEIISS 293 (322)
T ss_dssp --CHH---HHHHHHHTTCCCCC-----------------CTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred --CHH---HHHHHHHcCCcCCC-----------------CCCCCHHHHHHHHHHcCCCcccCcCHHHHHHH
Confidence 111 22222211111000 12345679999999999999999999999863
|
| >3lxp_A Non-receptor tyrosine-protein kinase TYK2; JAK3, inflammation, cancer, PAN inhibitor, ATP-binding nucleotide-binding, phosphoprotein, SH2 domain; HET: PTR IZA; 1.65A {Homo sapiens} PDB: 3lxn_A* 3nz0_A* 3nyx_A* 4e20_A* 4e1z_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-44 Score=306.37 Aligned_cols=263 Identities=22% Similarity=0.346 Sum_probs=202.5
Q ss_pred HHhCCC-CCCceeecCCcceEEEEEe-----CCCcEEEEEEeccCcCChhhhHHHHHHHHHHHhcCCcceeeeeeEEEcC
Q 038766 9 NATGSF-SENNIIGNSNLSTVYKGRL-----EDGEIVAVKKLNFHQFSAESDKSFYREAKTLKELKHRNLVKVLGYAWES 82 (299)
Q Consensus 9 ~~~~~y-~~~~~lg~g~~~~v~~~~~-----~~~~~~~vK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~ 82 (299)
.+.++| ++.+.||+|+||+||++.. .+++.||+|++... ........+.+|+.+++.++||||+++++++...
T Consensus 27 ~~~~r~~~~~~~lG~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~-~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~ 105 (318)
T 3lxp_A 27 VFHKRYLKKIRDLGEGHFGKVSLYCYDPTNDGTGEMVAVKALKAD-AGPQHRSGWKQEIDILRTLYHEHIIKYKGCCEDA 105 (318)
T ss_dssp BCCGGGEEEEEEEEECSSEEEEEEEECSCC--CCEEEEEEEECTT-CCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEET
T ss_pred eecHHHHhhhheecCCCCeEEEEEEEccCCCCCCcEEEEEEeccc-cChHHHHHHHHHHHHHHhCCCcchhhEEEEEecC
Confidence 355667 9999999999999998853 25889999999743 3455677899999999999999999999988765
Q ss_pred -CCeeEEEEeecCCCChHHHhcCCCCCCCCCChhhHHHHHHHHHHHHHHhhcCCCCCeeeecccCCceeeCCCCcEEEee
Q 038766 83 -GKLKALILEYMENGSLESVIHGPGVDHSRWTLPKRIDVLISVANGLDYLHSGYDIPIVHCDMKPSNILLDRDFEAHVSD 161 (299)
Q Consensus 83 -~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lh~~~~~~~~H~dl~~~nil~~~~~~v~l~d 161 (299)
....++|+||+++++|.+++.. ..+++..++.++.|++.||++||+. +++|+||||+||+++.++.++|+|
T Consensus 106 ~~~~~~lv~e~~~~~~L~~~l~~-----~~~~~~~~~~i~~~l~~~l~~LH~~---~ivH~Dikp~Nil~~~~~~~kl~D 177 (318)
T 3lxp_A 106 GAASLQLVMEYVPLGSLRDYLPR-----HSIGLAQLLLFAQQICEGMAYLHAQ---HYIHRDLAARNVLLDNDRLVKIGD 177 (318)
T ss_dssp TTTEEEEEECCCTTCBHHHHGGG-----SCCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEECTTCCEEECC
T ss_pred CCceEEEEEecccCCcHHHHHhh-----CCCCHHHHHHHHHHHHHHHHHHHhC---CccCCCCchheEEEcCCCCEEECC
Confidence 3667999999999999999963 3589999999999999999999999 999999999999999999999999
Q ss_pred eccccccccccccccccccccccCcccCChhhhcccCcCccccchhhhHHHHHHHhCCCCCCCCccC-----CCCch--h
Q 038766 162 FGTSRMLDVHLQDLSSLSTAFQGTIGYLAPEFAYMRIVTTKVDVFSFGIVVMEFLTKRRPTGLDEEN-----GLSPI--S 234 (299)
Q Consensus 162 f~~~~~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~DiwslG~~l~~l~~g~~p~~~~~~~-----~~~~~--~ 234 (299)
||++........ .........++..|+|||.+.+..++.++||||||+++|+|++|..||...... ..... .
T Consensus 178 fg~a~~~~~~~~-~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~ll~g~~p~~~~~~~~~~~~~~~~~~~~ 256 (318)
T 3lxp_A 178 FGLAKAVPEGHE-YYRVREDGDSPVFWYAPECLKEYKFYYASDVWSFGVTLYELLTHCDSSQSPPTKFLELIGIAQGQMT 256 (318)
T ss_dssp GGGCEECCTTCS-EEEC---CCCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTTCGGGSHHHHHHHHHCSCCHHHH
T ss_pred cccccccccccc-ccccccCCCCCceeeChHHhcCCCCCcHHHHHHHHHHHHHHHhCCCcccccchhhhhhhcccccchh
Confidence 999986542211 111233445677899999999989999999999999999999999998543111 00000 0
Q ss_pred HHHHHHHHHhcCccCcccccCccccchhhHhHHHHHHHHHHHHHHHHhcCCCCCCCCChhhhhc
Q 038766 235 LRQLVEKALANGINGVRQITDPKLVSSIYEEQEQHQVLEELFKLALVCTSSNPEDRPNMNELLI 298 (299)
Q Consensus 235 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rpt~~~il~ 298 (299)
...... ...... ... .+..++.++.++|++||..||++|||++++++
T Consensus 257 ~~~~~~-~~~~~~----~~~------------~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~ 303 (318)
T 3lxp_A 257 VLRLTE-LLERGE----RLP------------RPDKCPAEVYHLMKNCWETEASFRPTFENLIP 303 (318)
T ss_dssp HHHHHH-HHHTTC----CCC------------CCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred HHHHHH-HHhccc----CCC------------CCccccHHHHHHHHHHcCCCcccCcCHHHHHH
Confidence 111111 111110 000 02234568999999999999999999999975
|
| >2wqm_A Serine/threonine-protein kinase NEK7; ATP-binding, polymorphism, metal-binding, cell cycle kinase, mitosis, cytoplasm, magnesium, transferase; 2.10A {Homo sapiens} PDB: 2wqn_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-44 Score=305.41 Aligned_cols=261 Identities=24% Similarity=0.360 Sum_probs=195.9
Q ss_pred HHHhCCCCCCceeecCCcceEEEEEe-CCCcEEEEEEeccCc-CChhhhHHHHHHHHHHHhcCCcceeeeeeEEEcCCCe
Q 038766 8 ENATGSFSENNIIGNSNLSTVYKGRL-EDGEIVAVKKLNFHQ-FSAESDKSFYREAKTLKELKHRNLVKVLGYAWESGKL 85 (299)
Q Consensus 8 ~~~~~~y~~~~~lg~g~~~~v~~~~~-~~~~~~~vK~~~~~~-~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~ 85 (299)
....++|++.+.||+|++|.||++.+ .+|+.||+|++.... ........+.+|+..++.++||||+++++++.. ++.
T Consensus 28 ~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~-~~~ 106 (310)
T 2wqm_A 28 YNTLANFRIEKKIGRGQFSEVYRAACLLDGVPVALKKVQIFDLMDAKARADCIKEIDLLKQLNHPNVIKYYASFIE-DNE 106 (310)
T ss_dssp TSSGGGEEEEEEEECC--CEEEEEEETTTCCEEEEEEECTTSSCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEEE-TTE
T ss_pred cccccceEEEEeecCCCCceEEEEEEcCCCceEEEEeeehhhccCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEc-CCc
Confidence 34567899999999999999999986 468999999997533 234556778899999999999999999997766 456
Q ss_pred eEEEEeecCCCChHHHhcCCCCCCCCCChhhHHHHHHHHHHHHHHhhcCCCCCeeeecccCCceeeCCCCcEEEeeeccc
Q 038766 86 KALILEYMENGSLESVIHGPGVDHSRWTLPKRIDVLISVANGLDYLHSGYDIPIVHCDMKPSNILLDRDFEAHVSDFGTS 165 (299)
Q Consensus 86 ~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lh~~~~~~~~H~dl~~~nil~~~~~~v~l~df~~~ 165 (299)
.++|+|++.+++|.+++.........+++..++.++.|++.||.|||+. +++|+||+|+||+++.++.++|+|||++
T Consensus 107 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~---~i~H~dl~p~NIl~~~~~~~kl~Dfg~~ 183 (310)
T 2wqm_A 107 LNIVLELADAGDLSRMIKHFKKQKRLIPERTVWKYFVQLCSALEHMHSR---RVMHRDIKPANVFITATGVVKLGDLGLG 183 (310)
T ss_dssp EEEEEECCCSCBHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEECTTSCEEECCC---
T ss_pred EEEEEecCCCCCHHHHHHHhcccccCCCHHHHHHHHHHHHHHHHHHhhC---CeeCCCCcHHHEEEcCCCCEEEEeccce
Confidence 6999999999999998864322356789999999999999999999999 9999999999999999999999999998
Q ss_pred cccccccccccccccccccCcccCChhhhcccCcCccccchhhhHHHHHHHhCCCCCCCCccCCCCchhHHHHHHHHHhc
Q 038766 166 RMLDVHLQDLSSLSTAFQGTIGYLAPEFAYMRIVTTKVDVFSFGIVVMEFLTKRRPTGLDEENGLSPISLRQLVEKALAN 245 (299)
Q Consensus 166 ~~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~DiwslG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~ 245 (299)
...... ........+++.|+|||.+.+..++.++||||||+++|+|++|..||..... ............
T Consensus 184 ~~~~~~----~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~------~~~~~~~~~~~~ 253 (310)
T 2wqm_A 184 RFFSSK----TTAAHSLVGTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSPFYGDKM------NLYSLCKKIEQC 253 (310)
T ss_dssp -------------------CCSSCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTC---C------CHHHHHHHHHTT
T ss_pred eeecCC----CccccccCCCeeEeChHHhCCCCCCchhhHHHHHHHHHHHHhCCCCCcccch------hHHHHHHHhhcc
Confidence 754421 1122344678899999999999999999999999999999999999854321 112222221111
Q ss_pred CccCcccccCccccchhhHhHHHHHHHHHHHHHHHHhcCCCCCCCCChhhhhc
Q 038766 246 GINGVRQITDPKLVSSIYEEQEQHQVLEELFKLALVCTSSNPEDRPNMNELLI 298 (299)
Q Consensus 246 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rpt~~~il~ 298 (299)
..... . ...++.++.+++.+||..||++|||++++++
T Consensus 254 ~~~~~---~-------------~~~~~~~l~~li~~~l~~dp~~Rps~~~il~ 290 (310)
T 2wqm_A 254 DYPPL---P-------------SDHYSEELRQLVNMCINPDPEKRPDVTYVYD 290 (310)
T ss_dssp CSCCC---C-------------TTTSCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred cCCCC---c-------------ccccCHHHHHHHHHHcCCChhhCCCHHHHHH
Confidence 11100 0 1233567999999999999999999999985
|
| >1phk_A Phosphorylase kinase; glycogen metabolism, transferase, serine/threonine-protein, ATP-binding, calmodulin-binding; HET: ATP; 2.20A {Oryctolagus cuniculus} SCOP: d.144.1.7 PDB: 1ql6_A* 2phk_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.9e-44 Score=300.91 Aligned_cols=258 Identities=22% Similarity=0.296 Sum_probs=203.2
Q ss_pred HHHHhCCCCCCceeecCCcceEEEEEeC-CCcEEEEEEeccCcCC-------hhhhHHHHHHHHHHHhcC-Ccceeeeee
Q 038766 7 IENATGSFSENNIIGNSNLSTVYKGRLE-DGEIVAVKKLNFHQFS-------AESDKSFYREAKTLKELK-HRNLVKVLG 77 (299)
Q Consensus 7 ~~~~~~~y~~~~~lg~g~~~~v~~~~~~-~~~~~~vK~~~~~~~~-------~~~~~~~~~e~~~l~~l~-h~~i~~~~~ 77 (299)
.....++|.+.+.||+|++|.||++.+. +++.||+|++...... ....+.+.+|+.+++++. ||||+++++
T Consensus 12 ~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~ 91 (298)
T 1phk_A 12 THGFYENYEPKEILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDILRKVSGHPNIIQLKD 91 (298)
T ss_dssp ---CTTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEETTCSTTCCHHHHHHHHHHHHHHHHHHHHHTTCTTBCCEEE
T ss_pred CcchhhccceeeeecCCCceEEEEEEEcCcCceEEEEEEecccccccCHHHHHHHHHHHHHHHHHHHHhcCCCCEeeeee
Confidence 4456789999999999999999999875 5899999999754311 123466789999999996 999999999
Q ss_pred EEEcCCCeeEEEEeecCCCChHHHhcCCCCCCCCCChhhHHHHHHHHHHHHHHhhcCCCCCeeeecccCCceeeCCCCcE
Q 038766 78 YAWESGKLKALILEYMENGSLESVIHGPGVDHSRWTLPKRIDVLISVANGLDYLHSGYDIPIVHCDMKPSNILLDRDFEA 157 (299)
Q Consensus 78 ~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lh~~~~~~~~H~dl~~~nil~~~~~~v 157 (299)
++.. +...++|+|++.+++|.+++. ....+++..++.++.|++.||.|||+. +++|+||+|+||+++.++.+
T Consensus 92 ~~~~-~~~~~lv~e~~~~~~L~~~l~----~~~~~~~~~~~~~~~qi~~~l~~lH~~---~i~H~dl~p~Nil~~~~~~~ 163 (298)
T 1phk_A 92 TYET-NTFFFLVFDLMKKGELFDYLT----EKVTLSEKETRKIMRALLEVICALHKL---NIVHRDLKPENILLDDDMNI 163 (298)
T ss_dssp EEEC-SSEEEEEEECCTTCBHHHHHH----HHSSCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEECTTCCE
T ss_pred eecc-CCeEEEEEeccCCCcHHHHHh----ccCCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCcceEEEcCCCcE
Confidence 6654 566799999999999999987 445799999999999999999999999 99999999999999999999
Q ss_pred EEeeeccccccccccccccccccccccCcccCChhhhc------ccCcCccccchhhhHHHHHHHhCCCCCCCCccCCCC
Q 038766 158 HVSDFGTSRMLDVHLQDLSSLSTAFQGTIGYLAPEFAY------MRIVTTKVDVFSFGIVVMEFLTKRRPTGLDEENGLS 231 (299)
Q Consensus 158 ~l~df~~~~~~~~~~~~~~~~~~~~~~~~~y~~PE~~~------~~~~~~~~DiwslG~~l~~l~~g~~p~~~~~~~~~~ 231 (299)
+|+|||++..... ........+++.|+|||.+. ...++.++||||||+++|+|++|..||....
T Consensus 164 kl~dfg~~~~~~~-----~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~----- 233 (298)
T 1phk_A 164 KLTDFGFSCQLDP-----GEKLREVCGTPSYLAPEIIECSMNDNHPGYGKEVDMWSTGVIMYTLLAGSPPFWHRK----- 233 (298)
T ss_dssp EECCCTTCEECCT-----TCCBCCCCSCGGGCCHHHHHHHHCTTSCCBCTHHHHHHHHHHHHHHHHSSCSSCCSS-----
T ss_pred EEecccchhhcCC-----CcccccccCCccccCHHHhccccccccccCCcccccHhHHHHHHHHHHCCCCCcCcc-----
Confidence 9999999876542 12233456789999999875 3457889999999999999999999985331
Q ss_pred chhHHHHHHHHHhcCccCcccccCccccchhhHhHHHHHHHHHHHHHHHHhcCCCCCCCCChhhhhcC
Q 038766 232 PISLRQLVEKALANGINGVRQITDPKLVSSIYEEQEQHQVLEELFKLALVCTSSNPEDRPNMNELLIT 299 (299)
Q Consensus 232 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rpt~~~il~~ 299 (299)
.. ........... ....+. ...++..+.++|.+||..||++|||++++++|
T Consensus 234 ~~---~~~~~~~~~~~----~~~~~~----------~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~h 284 (298)
T 1phk_A 234 QM---LMLRMIMSGNY----QFGSPE----------WDDYSDTVKDLVSRFLVVQPQKRYTAEEALAH 284 (298)
T ss_dssp HH---HHHHHHHHTCC----CCCTTT----------GGGSCHHHHHHHHHHCCSSGGGSCCHHHHTTS
T ss_pred HH---HHHHHHhcCCc----ccCccc----------ccccCHHHHHHHHHHccCCcccCCCHHHHHhC
Confidence 11 12222111110 001100 12345679999999999999999999999987
|
| >2j7t_A Serine/threonine-protein kinase 10; transferase, ATP-binding, cell cycle progression, phosphorylation, disease mutation, nucleotide- binding; HET: 274; 2.0A {Homo sapiens} PDB: 4aot_A* 3zz2_A* 2j51_A* 2jfl_A* 2jfm_A* 2uv2_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.6e-44 Score=302.32 Aligned_cols=255 Identities=23% Similarity=0.348 Sum_probs=198.2
Q ss_pred HHhCCCCCCceeecCCcceEEEEEeC-CCcEEEEEEeccCcCChhhhHHHHHHHHHHHhcCCcceeeeeeEEEcCCCeeE
Q 038766 9 NATGSFSENNIIGNSNLSTVYKGRLE-DGEIVAVKKLNFHQFSAESDKSFYREAKTLKELKHRNLVKVLGYAWESGKLKA 87 (299)
Q Consensus 9 ~~~~~y~~~~~lg~g~~~~v~~~~~~-~~~~~~vK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~ 87 (299)
...++|++.+.||+|++|.||++.+. +++.+|+|++... .......+.+|+..++.++||||+++++++... ...+
T Consensus 16 ~~~~~y~i~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~--~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~-~~~~ 92 (302)
T 2j7t_A 16 DPNEVWEIVGELGDGAFGKVYKAKNKETGALAAAKVIETK--SEEELEDYIVEIEILATCDHPYIVKLLGAYYHD-GKLW 92 (302)
T ss_dssp CGGGTEEEEEEEECSTTCCEEEEEETTTCCEEEEEEEC------CCHHHHHHHHHHHHHCCCTTBCCEEEEEECC--CEE
T ss_pred CCccceeecceeccCCCeEEEEEEEcCCCcEEEEEEecCC--CHHHHHHHHHHHHHHhcCCCCCEeeeeeeeeeC-CeEE
Confidence 35678999999999999999999875 5899999998643 344567888999999999999999999977664 4569
Q ss_pred EEEeecCCCChHHHhcCCCCCCCCCChhhHHHHHHHHHHHHHHhhcCCCCCeeeecccCCceeeCCCCcEEEeeeccccc
Q 038766 88 LILEYMENGSLESVIHGPGVDHSRWTLPKRIDVLISVANGLDYLHSGYDIPIVHCDMKPSNILLDRDFEAHVSDFGTSRM 167 (299)
Q Consensus 88 lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lh~~~~~~~~H~dl~~~nil~~~~~~v~l~df~~~~~ 167 (299)
+|+||+.+++|.+++.. ....+++..++.++.|++.||.|||+. +++|+||||+||+++.++.++|+|||++..
T Consensus 93 lv~e~~~~~~l~~~~~~---~~~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~ 166 (302)
T 2j7t_A 93 IMIEFCPGGAVDAIMLE---LDRGLTEPQIQVVCRQMLEALNFLHSK---RIIHRDLKAGNVLMTLEGDIRLADFGVSAK 166 (302)
T ss_dssp EEEECCTTEEHHHHHHH---HTSCCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCSGGGEEECTTSCEEECCCHHHHH
T ss_pred EEEEeCCCCcHHHHHHh---hccCCCHHHHHHHHHHHHHHHHHHhcC---CcccCCCCHHHEEECCCCCEEEEECCCCcc
Confidence 99999999999988753 235689999999999999999999999 999999999999999999999999998754
Q ss_pred cccccccccccccccccCcccCChhhhc-----ccCcCccccchhhhHHHHHHHhCCCCCCCCccCCCCchhHHHHHHHH
Q 038766 168 LDVHLQDLSSLSTAFQGTIGYLAPEFAY-----MRIVTTKVDVFSFGIVVMEFLTKRRPTGLDEENGLSPISLRQLVEKA 242 (299)
Q Consensus 168 ~~~~~~~~~~~~~~~~~~~~y~~PE~~~-----~~~~~~~~DiwslG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~ 242 (299)
.... ........+++.|+|||.+. +..++.++||||||+++|+|++|..||.... .. ..+...
T Consensus 167 ~~~~----~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~-----~~---~~~~~~ 234 (302)
T 2j7t_A 167 NLKT----LQKRDSFIGTPYWMAPEVVMCETMKDTPYDYKADIWSLGITLIEMAQIEPPHHELN-----PM---RVLLKI 234 (302)
T ss_dssp HHHH----HHC-----CCGGGCCHHHHHHHHTTSTTTTTHHHHHHHHHHHHHHHHSSCTTTTSC-----HH---HHHHHH
T ss_pred cccc----ccccccccCChhhcCCeeeccccCCCCCCchhhhHHHHHHHHHHHhcCCCCCccCC-----HH---HHHHHH
Confidence 3211 11223446789999999874 5668899999999999999999999985331 11 112222
Q ss_pred HhcCccCcccccCccccchhhHhHHHHHHHHHHHHHHHHhcCCCCCCCCChhhhhcC
Q 038766 243 LANGINGVRQITDPKLVSSIYEEQEQHQVLEELFKLALVCTSSNPEDRPNMNELLIT 299 (299)
Q Consensus 243 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rpt~~~il~~ 299 (299)
....... ... +..++..+.++|.+||..||++|||++++++|
T Consensus 235 ~~~~~~~---~~~------------~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~h 276 (302)
T 2j7t_A 235 AKSDPPT---LLT------------PSKWSVEFRDFLKIALDKNPETRPSAAQLLEH 276 (302)
T ss_dssp HHSCCCC---CSS------------GGGSCHHHHHHHHHHSCSCTTTSCCHHHHTTS
T ss_pred hccCCcc---cCC------------ccccCHHHHHHHHHHcccChhhCCCHHHHhcC
Confidence 2111100 000 22335678999999999999999999999987
|
| >2pvf_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; HET: PTR ACP; 1.80A {Homo sapiens} PDB: 3cly_A* 2pzr_A* 2pzp_A* 2pvy_A* 2pz5_A* 2q0b_A* 2pwl_A* 2py3_A* 3ri1_A* 1gjo_A 1oec_A* 3b2t_A* 3gql_A* 3gqi_A* 1fgk_A 1fgi_A* 1agw_A 2fgi_A* 3js2_A* 3ky2_A ... | Back alignment and structure |
|---|
Probab=100.00 E-value=9.4e-45 Score=310.23 Aligned_cols=261 Identities=21% Similarity=0.324 Sum_probs=203.0
Q ss_pred HHHHHhCCCCCCceeecCCcceEEEEEeC--------CCcEEEEEEeccCcCChhhhHHHHHHHHHHHhc-CCcceeeee
Q 038766 6 EIENATGSFSENNIIGNSNLSTVYKGRLE--------DGEIVAVKKLNFHQFSAESDKSFYREAKTLKEL-KHRNLVKVL 76 (299)
Q Consensus 6 ~~~~~~~~y~~~~~lg~g~~~~v~~~~~~--------~~~~~~vK~~~~~~~~~~~~~~~~~e~~~l~~l-~h~~i~~~~ 76 (299)
.++...++|++.+.||+|+||.||+|.+. ++..||+|++... ........+.+|+.+++.+ +||||++++
T Consensus 29 ~~~~~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~~~vavK~~~~~-~~~~~~~~~~~E~~~l~~l~~hp~iv~~~ 107 (334)
T 2pvf_A 29 KWEFPRDKLTLGKPLGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDD-ATEKDLSDLVSEMEMMKMIGKHKNIINLL 107 (334)
T ss_dssp TTBCCGGGEEEEEEEEECSSCEEEEEEETTCSTTCC---CEEEEEECCTT-CCHHHHHHHHHHHHHHHHHCCCTTBCCEE
T ss_pred cccCCHhHeEEeeEEeecCceeEEEeEeccccccccccceEEEEeeeccC-CcHHHHHHHHHHHHHHHHhhcCCCEeeEE
Confidence 34556789999999999999999999863 4678999998643 3445567889999999999 899999999
Q ss_pred eEEEcCCCeeEEEEeecCCCChHHHhcCCCC------------CCCCCChhhHHHHHHHHHHHHHHhhcCCCCCeeeecc
Q 038766 77 GYAWESGKLKALILEYMENGSLESVIHGPGV------------DHSRWTLPKRIDVLISVANGLDYLHSGYDIPIVHCDM 144 (299)
Q Consensus 77 ~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~------------~~~~~~~~~~~~i~~qi~~~l~~lh~~~~~~~~H~dl 144 (299)
+++.. +...++|+||+.+++|.+++..... ....+++..++.++.|++.||.|||+. +++|+||
T Consensus 108 ~~~~~-~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~---~ivH~Dl 183 (334)
T 2pvf_A 108 GACTQ-DGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSCTYQLARGMEYLASQ---KCIHRDL 183 (334)
T ss_dssp EEECS-SSCCEEEEECCTTCBHHHHHHTTSCTTCCSCC--------CCCHHHHHHHHHHHHHHHHHHHHT---TEECSCC
T ss_pred EEEcc-CCceEEEEECCCCCcHHHHHHHhccccccccccccccccccCCHHHHHHHHHHHHHHHHHHHhC---CeeCCCC
Confidence 97655 4556999999999999999875431 123589999999999999999999999 9999999
Q ss_pred cCCceeeCCCCcEEEeeeccccccccccccccccccccccCcccCChhhhcccCcCccccchhhhHHHHHHHh-CCCCCC
Q 038766 145 KPSNILLDRDFEAHVSDFGTSRMLDVHLQDLSSLSTAFQGTIGYLAPEFAYMRIVTTKVDVFSFGIVVMEFLT-KRRPTG 223 (299)
Q Consensus 145 ~~~nil~~~~~~v~l~df~~~~~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~DiwslG~~l~~l~~-g~~p~~ 223 (299)
||+||+++.++.++|+|||++........ ........+++.|+|||.+.+..++.++||||||+++|+|++ |..||.
T Consensus 184 kp~NIll~~~~~~kL~Dfg~~~~~~~~~~--~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~ 261 (334)
T 2pvf_A 184 AARNVLVTENNVMKIADFGLARDINNIDY--YKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSPYP 261 (334)
T ss_dssp SGGGEEECTTCCEEECCCTTCEECTTTSS--EECCSCCCCCGGGCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCSST
T ss_pred ccceEEEcCCCCEEEcccccccccccccc--ccccCCCCcccceeChHHhcCCCcChHHHHHHHHHHHHHHHhCCCCCcC
Confidence 99999999999999999999976542111 111223345778999999998889999999999999999999 999985
Q ss_pred CCccCCCCchhHHHHHHHHHhcCccCcccccCccccchhhHhHHHHHHHHHHHHHHHHhcCCCCCCCCChhhhhc
Q 038766 224 LDEENGLSPISLRQLVEKALANGINGVRQITDPKLVSSIYEEQEQHQVLEELFKLALVCTSSNPEDRPNMNELLI 298 (299)
Q Consensus 224 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rpt~~~il~ 298 (299)
.. ....+ ........... . +..++..+.++|.+||..||.+|||++++++
T Consensus 262 ~~-----~~~~~---~~~~~~~~~~~-----~------------~~~~~~~l~~li~~~l~~dp~~Rps~~ell~ 311 (334)
T 2pvf_A 262 GI-----PVEEL---FKLLKEGHRMD-----K------------PANCTNELYMMMRDCWHAVPSQRPTFKQLVE 311 (334)
T ss_dssp TC-----CHHHH---HHHHHHTCCCC-----C------------CTTCCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred cC-----CHHHH---HHHHhcCCCCC-----C------------CccCCHHHHHHHHHHccCChhhCcCHHHHHH
Confidence 33 22222 22211111000 0 1223467899999999999999999999986
|
| >1opk_A P150, C-ABL, proto-oncogene tyrosine-protein kinase ABL1; transferase; HET: MYR P16; 1.80A {Mus musculus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1opl_A* 2fo0_A* 2abl_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2.6e-45 Score=328.97 Aligned_cols=257 Identities=24% Similarity=0.366 Sum_probs=205.7
Q ss_pred HHHHHHhCCCCCCceeecCCcceEEEEEeCC-CcEEEEEEeccCcCChhhhHHHHHHHHHHHhcCCcceeeeeeEEEcCC
Q 038766 5 TEIENATGSFSENNIIGNSNLSTVYKGRLED-GEIVAVKKLNFHQFSAESDKSFYREAKTLKELKHRNLVKVLGYAWESG 83 (299)
Q Consensus 5 ~~~~~~~~~y~~~~~lg~g~~~~v~~~~~~~-~~~~~vK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~ 83 (299)
+.++...++|.+.+.||+|+||.||++.+.. +..||||++.... ...+.+.+|+.++++++||||+++++++...
T Consensus 213 ~~~~~~~~~~~~~~~lG~G~fg~Vy~~~~~~~~~~vavK~~~~~~---~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~- 288 (495)
T 1opk_A 213 DKWEMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDT---MEVEEFLKEAAVMKEIKHPNLVQLLGVCTRE- 288 (495)
T ss_dssp SCCBCCGGGEEEEEESGGGTTSSEEEEEEGGGTEEEEEEECCSSS---SCHHHHHHHHHHHHHCCCTTBCCEEEEECSS-
T ss_pred cccccCHHHceeeeEecCCCCeEEEEEEEcCCCeEEEEEEecCcc---cchHHHHHHHHHHHhcCCCCEeeEEEEEecC-
Confidence 4566677889999999999999999998764 8899999986432 3467789999999999999999999976654
Q ss_pred CeeEEEEeecCCCChHHHhcCCCCCCCCCChhhHHHHHHHHHHHHHHhhcCCCCCeeeecccCCceeeCCCCcEEEeeec
Q 038766 84 KLKALILEYMENGSLESVIHGPGVDHSRWTLPKRIDVLISVANGLDYLHSGYDIPIVHCDMKPSNILLDRDFEAHVSDFG 163 (299)
Q Consensus 84 ~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lh~~~~~~~~H~dl~~~nil~~~~~~v~l~df~ 163 (299)
...++|+||+.+++|.+++... ....+++..++.++.|++.||+|||++ +++||||||+||+++.++.+||+|||
T Consensus 289 ~~~~lv~E~~~~g~L~~~l~~~--~~~~~~~~~~~~i~~qi~~~L~~LH~~---~ivHrDlkp~NIll~~~~~~kl~DFG 363 (495)
T 1opk_A 289 PPFYIITEFMTYGNLLDYLREC--NRQEVSAVVLLYMATQISSAMEYLEKK---NFIHRNLAARNCLVGENHLVKVADFG 363 (495)
T ss_dssp SSCEEEEECCTTCBHHHHHHHS--CTTTSCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEECGGGCEEECCTT
T ss_pred CcEEEEEEccCCCCHHHHHHhc--CcCCCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCChhhEEECCCCcEEEeecc
Confidence 4559999999999999998643 235689999999999999999999999 99999999999999999999999999
Q ss_pred cccccccccccccccccccccCcccCChhhhcccCcCccccchhhhHHHHHHHh-CCCCCCCCccCCCCchhHHHHHHHH
Q 038766 164 TSRMLDVHLQDLSSLSTAFQGTIGYLAPEFAYMRIVTTKVDVFSFGIVVMEFLT-KRRPTGLDEENGLSPISLRQLVEKA 242 (299)
Q Consensus 164 ~~~~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~DiwslG~~l~~l~~-g~~p~~~~~~~~~~~~~~~~~~~~~ 242 (299)
++...... .........++..|+|||.+.+..++.++||||||+++|+|++ |..||... ....+...+..
T Consensus 364 ~a~~~~~~---~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDvwSlG~~l~el~t~g~~p~~~~-----~~~~~~~~~~~- 434 (495)
T 1opk_A 364 LSRLMTGD---TYTAHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGI-----DLSQVYELLEK- 434 (495)
T ss_dssp CEECCTTC---CEECCTTCCCCGGGCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCSSTTC-----CGGGHHHHHHT-
T ss_pred cceeccCC---ceeecCCCcCCcceeCHhHHhcCCCCcHHhHHhHHHHHHHHHhCCCCCCCCC-----CHHHHHHHHHc-
Confidence 99765421 1112223345678999999999999999999999999999999 88888543 22233332211
Q ss_pred HhcCccCcccccCccccchhhHhHHHHHHHHHHHHHHHHhcCCCCCCCCChhhhhc
Q 038766 243 LANGINGVRQITDPKLVSSIYEEQEQHQVLEELFKLALVCTSSNPEDRPNMNELLI 298 (299)
Q Consensus 243 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rpt~~~il~ 298 (299)
.. .... +..++..+.+||.+||..||++|||++++++
T Consensus 435 ---~~----~~~~------------~~~~~~~l~~li~~cl~~dP~~RPs~~el~~ 471 (495)
T 1opk_A 435 ---DY----RMER------------PEGCPEKVYELMRACWQWNPSDRPSFAEIHQ 471 (495)
T ss_dssp ---TC----CCCC------------CTTCCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred ---CC----CCCC------------CCCCCHHHHHHHHHHcCcChhHCcCHHHHHH
Confidence 10 0000 1234567999999999999999999999875
|
| >1b6c_B TGF-B superfamily receptor type I; complex (isomerase/protein kinase), receptor serine/threonine kinase; 2.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1ias_A 2x7o_A* 3faa_A* 3kcf_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4e-44 Score=307.23 Aligned_cols=265 Identities=23% Similarity=0.325 Sum_probs=202.9
Q ss_pred HHHHhCCCCCCceeecCCcceEEEEEeCCCcEEEEEEeccCcCChhhhHHHHHHHHHHHh--cCCcceeeeeeEEEcCC-
Q 038766 7 IENATGSFSENNIIGNSNLSTVYKGRLEDGEIVAVKKLNFHQFSAESDKSFYREAKTLKE--LKHRNLVKVLGYAWESG- 83 (299)
Q Consensus 7 ~~~~~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~vK~~~~~~~~~~~~~~~~~e~~~l~~--l~h~~i~~~~~~~~~~~- 83 (299)
.+.+.++|.+.+.||+|+||+||++.+. ++.||+|++.. .....+..|.++++. ++||||+++++++....
T Consensus 37 ~~~~~~~y~~~~~lg~G~~g~Vy~~~~~-~~~vavK~~~~-----~~~~~~~~e~~~~~~~~l~h~ni~~~~~~~~~~~~ 110 (342)
T 1b6c_B 37 QRTIARTIVLQESIGKGRFGEVWRGKWR-GEEVAVKIFSS-----REERSWFREAEIYQTVMLRHENILGFIAADNKDNG 110 (342)
T ss_dssp HHHHHHHCEEEEEEEEETTEEEEEEEET-TEEEEEEEECG-----GGHHHHHHHHHHHHHSCCCCTTBCCEEEEEECCCS
T ss_pred cccccccEEEEeeecCCCCcEEEEEEEc-CccEEEEEeCc-----hhHHHHHHHHHHHHHhhcCCCcEEEEEeeecccCC
Confidence 4567889999999999999999999984 88999999852 344567788888887 68999999999877654
Q ss_pred --CeeEEEEeecCCCChHHHhcCCCCCCCCCChhhHHHHHHHHHHHHHHhh--------cCCCCCeeeecccCCceeeCC
Q 038766 84 --KLKALILEYMENGSLESVIHGPGVDHSRWTLPKRIDVLISVANGLDYLH--------SGYDIPIVHCDMKPSNILLDR 153 (299)
Q Consensus 84 --~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lh--------~~~~~~~~H~dl~~~nil~~~ 153 (299)
...++|+||+.+++|.++++. ..+++..++.++.|++.||.||| +. +++|+||||+||+++.
T Consensus 111 ~~~~~~lv~e~~~~g~L~~~l~~-----~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~---~ivH~Dlkp~NIll~~ 182 (342)
T 1b6c_B 111 TWTQLWLVSDYHEHGSLFDYLNR-----YTVTVEGMIKLALSTASGLAHLHMEIVGTQGKP---AIAHRDLKSKNILVKK 182 (342)
T ss_dssp SCCCEEEEECCCTTCBHHHHHHH-----CCBCHHHHHHHHHHHHHHHHHHHCCBCSTTCBC---EEECSCCSGGGEEECT
T ss_pred ccceeEEEEeecCCCcHHHHHhc-----cCccHHHHHHHHHHHHHHHHHHHHHHhhhcccC---CeeeCCCCHHHEEECC
Confidence 267999999999999999953 46899999999999999999999 77 9999999999999999
Q ss_pred CCcEEEeeeccccccccccccccccccccccCcccCChhhhccc------CcCccccchhhhHHHHHHHhC---------
Q 038766 154 DFEAHVSDFGTSRMLDVHLQDLSSLSTAFQGTIGYLAPEFAYMR------IVTTKVDVFSFGIVVMEFLTK--------- 218 (299)
Q Consensus 154 ~~~v~l~df~~~~~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~------~~~~~~DiwslG~~l~~l~~g--------- 218 (299)
++.++|+|||++..................+++.|+|||++.+. .++.++||||||+++|+|++|
T Consensus 183 ~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~Di~slG~il~el~tg~~~~~~~~~ 262 (342)
T 1b6c_B 183 NGTCCIADLGLAVRHDSATDTIDIAPNHRVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHED 262 (342)
T ss_dssp TSCEEECCCTTCEEEETTTTEEEECCCSCCCCGGGCCHHHHTSCCCTTCHHHHHHHHHHHHHHHHHHHHTTBCBTTBCCC
T ss_pred CCCEEEEECCCceeccccccccccccccCCcCcccCCHhhhcccccccccccCCcccHHHHHHHHHHHHhccCcCCcccc
Confidence 99999999999976543222111123455689999999998865 344689999999999999999
Q ss_pred -CCCCCCCccCCCCchhHHHHHHHHHhcCccCcccccCccccchhhHhHHHHHHHHHHHHHHHHhcCCCCCCCCChhhhh
Q 038766 219 -RRPTGLDEENGLSPISLRQLVEKALANGINGVRQITDPKLVSSIYEEQEQHQVLEELFKLALVCTSSNPEDRPNMNELL 297 (299)
Q Consensus 219 -~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rpt~~~il 297 (299)
..||............+.. ...... ..+..... ......+..+.+|+.+||..||++|||+++++
T Consensus 263 ~~~p~~~~~~~~~~~~~~~~---~~~~~~-------~~~~~~~~----~~~~~~~~~l~~li~~cl~~dp~~Rps~~~i~ 328 (342)
T 1b6c_B 263 YQLPYYDLVPSDPSVEEMRK---VVCEQK-------LRPNIPNR----WQSCEALRVMAKIMRECWYANGAARLTALRIK 328 (342)
T ss_dssp CCCTTTTTSCSSCCHHHHHH---HHTTSC-------CCCCCCGG----GGTSHHHHHHHHHHHHHCCSSGGGSCCHHHHH
T ss_pred cccCccccCcCcccHHHHHH---HHHHHH-------hCCCCccc----ccchhHHHHHHHHHHHHhccChhhCCCHHHHH
Confidence 5666543222222222221 111111 00111110 01335667899999999999999999999998
Q ss_pred cC
Q 038766 298 IT 299 (299)
Q Consensus 298 ~~ 299 (299)
++
T Consensus 329 ~~ 330 (342)
T 1b6c_B 329 KT 330 (342)
T ss_dssp HH
T ss_pred HH
Confidence 64
|
| >3uzp_A CKI-delta, CKID, casein kinase I isoform delta; CK1D, inhibitor, PF670462, transferase-transferase I complex; HET: 0CK; 1.94A {Homo sapiens} PDB: 3uys_A* 3uyt_A* 1cki_A 1ckj_A | Back alignment and structure |
|---|
Probab=100.00 E-value=4.3e-44 Score=300.93 Aligned_cols=261 Identities=19% Similarity=0.236 Sum_probs=205.0
Q ss_pred HHhCCCCCCceeecCCcceEEEEEe-CCCcEEEEEEeccCcCChhhhHHHHHHHHHHHhcCCcceeeeeeEEEcCCCeeE
Q 038766 9 NATGSFSENNIIGNSNLSTVYKGRL-EDGEIVAVKKLNFHQFSAESDKSFYREAKTLKELKHRNLVKVLGYAWESGKLKA 87 (299)
Q Consensus 9 ~~~~~y~~~~~lg~g~~~~v~~~~~-~~~~~~~vK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~ 87 (299)
.+.++|++.+.||+|++|.||++.+ .+++.||+|++.... ....+.+|+.+++.++|+++++.+..+...+...+
T Consensus 6 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~----~~~~~~~e~~~l~~l~~~~~i~~~~~~~~~~~~~~ 81 (296)
T 3uzp_A 6 RVGNRYRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKT----KHPQLHIESKIYKMMQGGVGIPTIRWCGAEGDYNV 81 (296)
T ss_dssp EETTTEEEEEEEEEETTEEEEEEEETTTTEEEEEEEEESCS----SCCHHHHHHHHHHHHTTSTTCCCEEEEEEETTEEE
T ss_pred eeccEEEEEEEEccCCCeEEEEEEEcCCCcEEEEEEecCCc----chhHHHHHHHHHHHhhcCCCCCccccccCCCCceE
Confidence 3578999999999999999999987 569999999986433 23468899999999999888887887777788889
Q ss_pred EEEeecCCCChHHHhcCCCCCCCCCChhhHHHHHHHHHHHHHHhhcCCCCCeeeecccCCceeeC---CCCcEEEeeecc
Q 038766 88 LILEYMENGSLESVIHGPGVDHSRWTLPKRIDVLISVANGLDYLHSGYDIPIVHCDMKPSNILLD---RDFEAHVSDFGT 164 (299)
Q Consensus 88 lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lh~~~~~~~~H~dl~~~nil~~---~~~~v~l~df~~ 164 (299)
+|+||+ +++|.+++.. ....+++..++.++.|++.||+|||++ +++|+||||+||+++ .++.++|+|||+
T Consensus 82 lv~e~~-~~~L~~~~~~---~~~~~~~~~~~~i~~qi~~~l~~lH~~---~ivH~dlkp~NIl~~~~~~~~~~kl~Dfg~ 154 (296)
T 3uzp_A 82 MVMELL-GPSLEDLFNF---CSRKFSLKTVLLLADQMISRIEYIHSK---NFIHRDVKPDNFLMGLGKKGNLVYIIDFGL 154 (296)
T ss_dssp EEEECC-CCBHHHHHHH---TTTCCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCCGGGEEECCGGGTTCEEECCCTT
T ss_pred EEEEec-CCCHHHHHHh---hccCCCHHHHHHHHHHHHHHHHHHHhC---CeeeCCCCHHHeEEecCCCCCeEEEeeCCC
Confidence 999999 8899999863 234799999999999999999999999 999999999999994 788999999999
Q ss_pred ccccccccccc---cccccccccCcccCChhhhcccCcCccccchhhhHHHHHHHhCCCCCCCCccCCCCchhHHHHHHH
Q 038766 165 SRMLDVHLQDL---SSLSTAFQGTIGYLAPEFAYMRIVTTKVDVFSFGIVVMEFLTKRRPTGLDEENGLSPISLRQLVEK 241 (299)
Q Consensus 165 ~~~~~~~~~~~---~~~~~~~~~~~~y~~PE~~~~~~~~~~~DiwslG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~ 241 (299)
+.......... ........+++.|+|||.+.+..++.++||||||+++|+|++|..||......... ..+......
T Consensus 155 ~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~-~~~~~~~~~ 233 (296)
T 3uzp_A 155 AKKYRDARTHQHIPYRENKNLTGTARYASINTHLGIEQSRRDDLESLGYVLMYFNLGSLPWQGLKAATKR-QKYERISEK 233 (296)
T ss_dssp CEECBCTTTCCBCCCCCSCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTSSCCCSSSS-SHHHHHHHH
T ss_pred cccccccccccccccccccccccccccCChhhhcCCCCCcchhhHHHHHHHHHHHhCCCCCCCcCchhhh-hhhhhhccc
Confidence 98655322111 11234556899999999999999999999999999999999999999654222111 111111111
Q ss_pred HHhcCccCcccccCccccchhhHhHHHHHHHHHHHHHHHHhcCCCCCCCCChhhhhc
Q 038766 242 ALANGINGVRQITDPKLVSSIYEEQEQHQVLEELFKLALVCTSSNPEDRPNMNELLI 298 (299)
Q Consensus 242 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rpt~~~il~ 298 (299)
..... .......++.++.+++.+||..||++|||++++++
T Consensus 234 ~~~~~-----------------~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~ 273 (296)
T 3uzp_A 234 KMSTP-----------------IEVLCKGYPSEFATYLNFCRSLRFDDKPDYSYLRQ 273 (296)
T ss_dssp HHHSC-----------------HHHHTTTSCHHHHHHHHHHHTSCTTCCCCHHHHHH
T ss_pred ccCCc-----------------hHHHHhhCCHHHHHHHHHHHhcCcCcCCCHHHHHH
Confidence 11100 00112334578999999999999999999999875
|
| >3rgf_A Cyclin-dependent kinase 8; protein kinase complex, transferase,transcription; HET: BAX; 2.20A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-44 Score=316.84 Aligned_cols=284 Identities=20% Similarity=0.240 Sum_probs=188.8
Q ss_pred HHHHhCCCCC-CceeecCCcceEEEEEeC---CCcEEEEEEeccCcCChhhhHHHHHHHHHHHhcCCcceeeeeeEEEc-
Q 038766 7 IENATGSFSE-NNIIGNSNLSTVYKGRLE---DGEIVAVKKLNFHQFSAESDKSFYREAKTLKELKHRNLVKVLGYAWE- 81 (299)
Q Consensus 7 ~~~~~~~y~~-~~~lg~g~~~~v~~~~~~---~~~~~~vK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~- 81 (299)
.+.+.+.|.+ .++||+|+||+||+|.+. +++.||+|++.... ....+.+|+.+++.++||||+++++++..
T Consensus 15 ~~~~~~~y~~~g~~lG~G~~g~Vy~~~~~~~~~~~~vaiK~~~~~~----~~~~~~~E~~~l~~l~hpniv~~~~~~~~~ 90 (405)
T 3rgf_A 15 RERVEDLFEYEGCKVGRGTYGHVYKAKRKDGKDDKDYALKQIEGTG----ISMSACREIALLRELKHPNVISLQKVFLSH 90 (405)
T ss_dssp CCCHHHHEECSSCCCC-----EEEEEEESSSSCCCCEEEEECSSSS----CCHHHHHHHHHHHHCCCTTBCCCCEEEEET
T ss_pred hhhhhhhhhhcCcEeeecCCeEEEEEEEccCCCCeEEEEEEECCCC----CCHHHHHHHHHHHhcCCCCeeeEeeEEecC
Confidence 3455667777 558999999999999864 57899999986432 33467889999999999999999998764
Q ss_pred CCCeeEEEEeecCCCChHHHhcCC-----CCCCCCCChhhHHHHHHHHHHHHHHhhcCCCCCeeeecccCCceee----C
Q 038766 82 SGKLKALILEYMENGSLESVIHGP-----GVDHSRWTLPKRIDVLISVANGLDYLHSGYDIPIVHCDMKPSNILL----D 152 (299)
Q Consensus 82 ~~~~~~lv~e~~~~~~L~~~~~~~-----~~~~~~~~~~~~~~i~~qi~~~l~~lh~~~~~~~~H~dl~~~nil~----~ 152 (299)
.+...++|+||+. ++|.+++... ......+++..++.++.||+.||+|||+. +++||||||+||++ +
T Consensus 91 ~~~~~~lv~e~~~-~~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~---~ivH~Dlkp~NIll~~~~~ 166 (405)
T 3rgf_A 91 ADRKVWLLFDYAE-HDLWHIIKFHRASKANKKPVQLPRGMVKSLLYQILDGIHYLHAN---WVLHRDLKPANILVMGEGP 166 (405)
T ss_dssp TTTEEEEEEECCS-EEHHHHHHHHHHHC-------CCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEECCSST
T ss_pred CCCeEEEEEeCCC-CCHHHHHHHhccccccccccCCCHHHHHHHHHHHHHHHHHHHhC---CEeCCCcCHHHeEEecCCC
Confidence 4567799999996 4887776421 11223599999999999999999999999 99999999999999 6
Q ss_pred CCCcEEEeeeccccccccccccccccccccccCcccCChhhhccc-CcCccccchhhhHHHHHHHhCCCCCCCCccCCC-
Q 038766 153 RDFEAHVSDFGTSRMLDVHLQDLSSLSTAFQGTIGYLAPEFAYMR-IVTTKVDVFSFGIVVMEFLTKRRPTGLDEENGL- 230 (299)
Q Consensus 153 ~~~~v~l~df~~~~~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~-~~~~~~DiwslG~~l~~l~~g~~p~~~~~~~~~- 230 (299)
.++.++|+|||++........ .........+|+.|+|||++.+. .++.++|||||||++|+|++|..||........
T Consensus 167 ~~~~~kl~Dfg~a~~~~~~~~-~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~ 245 (405)
T 3rgf_A 167 ERGRVKIADMGFARLFNSPLK-PLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCRQEDIKT 245 (405)
T ss_dssp TTTCEEECCTTCCC-----------------CCCTTCCHHHHTTCCSCCHHHHHHHHHHHHHHHHHSSCTTCCCC-----
T ss_pred CCCcEEEEECCCceecCCCCc-ccccCCCceecCcccCchhhcCCCcccchhhhHHHHHHHHHHHhCCCCCCCccccccc
Confidence 778999999999976542111 11223445689999999998874 589999999999999999999999965433211
Q ss_pred ----CchhHHHHHHHHHhcCccCcccccCc---cc-----cchhhH-hHHH-------HHHHHHHHHHHHHhcCCCCCCC
Q 038766 231 ----SPISLRQLVEKALANGINGVRQITDP---KL-----VSSIYE-EQEQ-------HQVLEELFKLALVCTSSNPEDR 290 (299)
Q Consensus 231 ----~~~~~~~~~~~~~~~~~~~~~~~~~~---~~-----~~~~~~-~~~~-------~~~~~~l~~li~~~l~~dP~~R 290 (299)
....+...+.............+... .. ...... .... ...+..+.+||++||..||++|
T Consensus 246 ~~~~~~~~l~~i~~~~g~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Ll~~~L~~dP~~R 325 (405)
T 3rgf_A 246 SNPYHHDQLDRIFNVMGFPADKDWEDIKKMPEHSTLMKDFRRNTYTNCSLIKYMEKHKVKPDSKAFHLLQKLLTMDPIKR 325 (405)
T ss_dssp -CCCCHHHHHHHHHHHCCCCTTTCGGGGGSTTHHHHHHHCCGGGGTTCCHHHHHHTTTCCTTSHHHHHHHHHSCSSGGGS
T ss_pred cccchHHHHHHHHHhhCCCChhhcchhhcCcchhhhhhhccccCCCcchhhhhHhhcCCCCCHHHHHHHHHHccCCcccC
Confidence 11122222221111111111111000 00 000000 0000 0115678999999999999999
Q ss_pred CChhhhhcC
Q 038766 291 PNMNELLIT 299 (299)
Q Consensus 291 pt~~~il~~ 299 (299)
||++|+|+|
T Consensus 326 ~ta~e~L~h 334 (405)
T 3rgf_A 326 ITSEQAMQD 334 (405)
T ss_dssp CCHHHHHTS
T ss_pred CCHHHHhcC
Confidence 999999987
|
| >1u59_A Tyrosine-protein kinase ZAP-70; transferase; HET: STU; 2.30A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=6.7e-45 Score=304.68 Aligned_cols=258 Identities=22% Similarity=0.324 Sum_probs=203.1
Q ss_pred HHHHhCCCCCCc-eeecCCcceEEEEEeC---CCcEEEEEEeccCcCChhhhHHHHHHHHHHHhcCCcceeeeeeEEEcC
Q 038766 7 IENATGSFSENN-IIGNSNLSTVYKGRLE---DGEIVAVKKLNFHQFSAESDKSFYREAKTLKELKHRNLVKVLGYAWES 82 (299)
Q Consensus 7 ~~~~~~~y~~~~-~lg~g~~~~v~~~~~~---~~~~~~vK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~ 82 (299)
++...++|.+.+ .||+|+||+||++.+. ++..||+|++... ......+.+.+|+..++.++||||+++++++ .
T Consensus 4 ~~~~~~~~~i~~~~lg~G~~g~Vy~~~~~~~~~~~~vavK~~~~~-~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~-~- 80 (287)
T 1u59_A 4 LFLKRDNLLIADIELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQG-TEKADTEEMMREAQIMHQLDNPYIVRLIGVC-Q- 80 (287)
T ss_dssp CBCCGGGEEEEEEEEECCTTEEEEEEEEC---CCEEEEEEEECSS-CCHHHHHHHHHHHHHHHHCCCTTBCCEEEEE-E-
T ss_pred ccccHHHhhhhhccccccCceeEEEeEeccCCCcceEEEEecCCc-cchhHHHHHHHHHHHHHhCCCCCEeEEEEEe-c-
Confidence 344567777777 9999999999999753 5788999999743 3445677889999999999999999999977 3
Q ss_pred CCeeEEEEeecCCCChHHHhcCCCCCCCCCChhhHHHHHHHHHHHHHHhhcCCCCCeeeecccCCceeeCCCCcEEEeee
Q 038766 83 GKLKALILEYMENGSLESVIHGPGVDHSRWTLPKRIDVLISVANGLDYLHSGYDIPIVHCDMKPSNILLDRDFEAHVSDF 162 (299)
Q Consensus 83 ~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lh~~~~~~~~H~dl~~~nil~~~~~~v~l~df 162 (299)
....++|+|++.+++|.+++.. ....+++..++.++.|++.||.+||+. +++|+||||+||+++.++.++|+||
T Consensus 81 ~~~~~lv~e~~~~~~L~~~l~~---~~~~~~~~~~~~~~~qi~~~l~~lH~~---~i~H~dlkp~Nili~~~~~~kl~Df 154 (287)
T 1u59_A 81 AEALMLVMEMAGGGPLHKFLVG---KREEIPVSNVAELLHQVSMGMKYLEEK---NFVHRDLAARNVLLVNRHYAKISDF 154 (287)
T ss_dssp SSSEEEEEECCTTEEHHHHHTT---CTTTSCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEEEETTEEEECCC
T ss_pred CCCcEEEEEeCCCCCHHHHHHh---CCccCCHHHHHHHHHHHHHHHHHHHHC---CEeeCCCchheEEEcCCCCEEECcc
Confidence 3446999999999999999863 345699999999999999999999999 9999999999999999999999999
Q ss_pred ccccccccccccccccccccccCcccCChhhhcccCcCccccchhhhHHHHHHHh-CCCCCCCCccCCCCchhHHHHHHH
Q 038766 163 GTSRMLDVHLQDLSSLSTAFQGTIGYLAPEFAYMRIVTTKVDVFSFGIVVMEFLT-KRRPTGLDEENGLSPISLRQLVEK 241 (299)
Q Consensus 163 ~~~~~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~DiwslG~~l~~l~~-g~~p~~~~~~~~~~~~~~~~~~~~ 241 (299)
|++........ .........+++.|+|||.+.+..++.++||||||+++|+|++ |..||... ........+
T Consensus 155 g~~~~~~~~~~-~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~-----~~~~~~~~i-- 226 (287)
T 1u59_A 155 GLSKALGADDS-YYTARSAGKWPLKWYAPECINFRKFSSRSDVWSYGVTMWEALSYGQKPYKKM-----KGPEVMAFI-- 226 (287)
T ss_dssp TTCEECTTCSC-EECCCCSSCCCGGGCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCTTTTC-----CTHHHHHHH--
T ss_pred cceeeeccCcc-eeeccccccccccccCHHHhccCCCCchhhHHHHHHHHHHHHcCCCCCcccC-----CHHHHHHHH--
Confidence 99976542211 1111233345788999999998889999999999999999998 99998533 222222211
Q ss_pred HHhcCccCcccccCccccchhhHhHHHHHHHHHHHHHHHHhcCCCCCCCCChhhhhcC
Q 038766 242 ALANGINGVRQITDPKLVSSIYEEQEQHQVLEELFKLALVCTSSNPEDRPNMNELLIT 299 (299)
Q Consensus 242 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rpt~~~il~~ 299 (299)
....... . +..++..+.++|.+||..||++|||+++++++
T Consensus 227 -~~~~~~~-----~------------~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~ 266 (287)
T 1u59_A 227 -EQGKRME-----C------------PPECPPELYALMSDCWIYKWEDRPDFLTVEQR 266 (287)
T ss_dssp -HTTCCCC-----C------------CTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHH
T ss_pred -hcCCcCC-----C------------CCCcCHHHHHHHHHHcCCChhhCcCHHHHHHH
Confidence 1111000 0 12345689999999999999999999999863
|
| >3coi_A Mitogen-activated protein kinase 13; P38D, P38delta, ERK, MAP kinase, PMK, STK26, stress-activated protein kinase, structural genomics, PSI; 2.09A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.4e-44 Score=310.00 Aligned_cols=267 Identities=22% Similarity=0.273 Sum_probs=199.8
Q ss_pred HhCCCCCCceeecCCcceEEEEEeC-CCcEEEEEEeccCcCChhhhHHHHHHHHHHHhcCCcceeeeeeEEEcCCC----
Q 038766 10 ATGSFSENNIIGNSNLSTVYKGRLE-DGEIVAVKKLNFHQFSAESDKSFYREAKTLKELKHRNLVKVLGYAWESGK---- 84 (299)
Q Consensus 10 ~~~~y~~~~~lg~g~~~~v~~~~~~-~~~~~~vK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~---- 84 (299)
+.++|.+.+.||+|+||.||+|.+. +|+.||||++............+.+|+.+++.++||||+++++++...+.
T Consensus 22 l~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~ 101 (353)
T 3coi_A 22 LPKTYVSPTHVGSGAYGSVCSAIDKRSGEKVAIKKLSRPFQSEIFAKRAYRELLLLKHMQHENVIGLLDVFTPASSLRNF 101 (353)
T ss_dssp EETTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEESSTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCSSGGGC
T ss_pred cCceEEEeeeEecCCCeEEEEEEECCCCCEEEEEEecccccchHHHHHHHHHHHHHHhcCCCCcccHhheEecccccccc
Confidence 4688999999999999999999874 68999999997655555667788999999999999999999997765443
Q ss_pred -eeEEEEeecCCCChHHHhcCCCCCCCCCChhhHHHHHHHHHHHHHHhhcCCCCCeeeecccCCceeeCCCCcEEEeeec
Q 038766 85 -LKALILEYMENGSLESVIHGPGVDHSRWTLPKRIDVLISVANGLDYLHSGYDIPIVHCDMKPSNILLDRDFEAHVSDFG 163 (299)
Q Consensus 85 -~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lh~~~~~~~~H~dl~~~nil~~~~~~v~l~df~ 163 (299)
..++|+|++. ++|.+++. ..+++..++.++.|++.||.|||++ +++|+||||+||+++.++.++|+|||
T Consensus 102 ~~~~lv~e~~~-~~l~~~~~------~~~~~~~~~~i~~qi~~al~~LH~~---~ivH~dlkp~NIl~~~~~~~kl~Dfg 171 (353)
T 3coi_A 102 YDFYLVMPFMQ-TDLQKIMG------LKFSEEKIQYLVYQMLKGLKYIHSA---GVVHRDLKPGNLAVNEDCELKILDFG 171 (353)
T ss_dssp CCCEEEEECCS-EEGGGTTT------SCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSSCCGGGEEECTTCCEEECSTT
T ss_pred eeEEEEecccc-CCHHHHhc------CCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCHHHEeECCCCcEEEeecc
Confidence 2489999996 58887774 2489999999999999999999999 99999999999999999999999999
Q ss_pred cccccccccccccccccccccCcccCChhhhcc-cCcCccccchhhhHHHHHHHhCCCCCCCCccCCCCchhHHHHHHHH
Q 038766 164 TSRMLDVHLQDLSSLSTAFQGTIGYLAPEFAYM-RIVTTKVDVFSFGIVVMEFLTKRRPTGLDEENGLSPISLRQLVEKA 242 (299)
Q Consensus 164 ~~~~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~-~~~~~~~DiwslG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~ 242 (299)
++..... ......+++.|+|||.+.+ ..++.++||||||+++|+|++|..||.... .......+...
T Consensus 172 ~~~~~~~-------~~~~~~~t~~y~aPE~~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~-----~~~~~~~i~~~ 239 (353)
T 3coi_A 172 LARHADA-------EMTGYVVTRWYRAPEVILSWMHYNQTVDIWSVGCIMAEMLTGKTLFKGKD-----YLDQLTQILKV 239 (353)
T ss_dssp CTTC---------------CCSBCCSCHHHHSCCSCCCTTHHHHHHHHHHHHHHHSSCSSBSSC-----HHHHHHHHHHH
T ss_pred cccCCCC-------CccccccCcCcCCHHHHhCcCCCCchhhHHHHHHHHHHHHhCCCCCCCCC-----HHHHHHHHHHH
Confidence 9875431 1234467899999998877 678999999999999999999999995432 11111111111
Q ss_pred HhcCccCc-ccccCc----------cccchhhHhHHHHHHHHHHHHHHHHhcCCCCCCCCChhhhhcC
Q 038766 243 LANGINGV-RQITDP----------KLVSSIYEEQEQHQVLEELFKLALVCTSSNPEDRPNMNELLIT 299 (299)
Q Consensus 243 ~~~~~~~~-~~~~~~----------~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rpt~~~il~~ 299 (299)
........ ..+.+. ...... .......++.++.+||.+||..||++|||++++|+|
T Consensus 240 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~li~~~L~~dp~~Rpt~~e~l~h 306 (353)
T 3coi_A 240 TGVPGTEFVQKLNDKAAKSYIQSLPQTPRKD-FTQLFPRASPQAADLLEKMLELDVDKRLTAAQALTH 306 (353)
T ss_dssp HCBCCHHHHTTCSCHHHHHHHHTSCBCSSCC-TTTTCTTSCHHHHHHHHHHSCSCTTTSCCHHHHHTS
T ss_pred hCCCCHHHHHHHhhHHHHHHHHhCcCCCCcc-HHHhcCCcCHHHHHHHHHHcCCCcccCCCHHHHhcC
Confidence 10000000 000000 000000 000122446789999999999999999999999987
|
| >1z57_A Dual specificity protein kinase CLK1; protein tyrosine kinase, splicing, human, 10Z-hymendialdisine, structural genomics; HET: DBQ; 1.70A {Homo sapiens} PDB: 2vag_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-43 Score=304.05 Aligned_cols=271 Identities=19% Similarity=0.224 Sum_probs=203.7
Q ss_pred HHHHhCCCCCCceeecCCcceEEEEEe--CCCcEEEEEEeccCcCChhhhHHHHHHHHHHHhcCCcc------eeeeeeE
Q 038766 7 IENATGSFSENNIIGNSNLSTVYKGRL--EDGEIVAVKKLNFHQFSAESDKSFYREAKTLKELKHRN------LVKVLGY 78 (299)
Q Consensus 7 ~~~~~~~y~~~~~lg~g~~~~v~~~~~--~~~~~~~vK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~------i~~~~~~ 78 (299)
.+.+.++|++.+.||+|+||+||++.+ .+++.||+|++.. .....+.+.+|+.+++.++|++ +++++++
T Consensus 9 g~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~vavK~~~~---~~~~~~~~~~e~~~l~~l~~~~~~~~~~i~~~~~~ 85 (339)
T 1z57_A 9 GDVLSARYEIVDTLGEGAFGKVVECIDHKAGGRHVAVKIVKN---VDRYCEAARSEIQVLEHLNTTDPNSTFRCVQMLEW 85 (339)
T ss_dssp TCEETTTEEEEEEEEEETTEEEEEEEETTTTTEEEEEEEECS---SHHHHHHHHHHHHHHHHHHHHCTTCTTCBCCEEEE
T ss_pred CCCccCceEEEEEEecCCCeEEEEEEecCCCCcEEEEEEEec---CCchhHHHHHHHHHHHHhhhcCCCCceeeEeeecc
Confidence 345678999999999999999999986 3588999999863 2345677889999999987664 8999996
Q ss_pred EEcCCCeeEEEEeecCCCChHHHhcCCCCCCCCCChhhHHHHHHHHHHHHHHhhcCCCCCeeeecccCCceeeCC-----
Q 038766 79 AWESGKLKALILEYMENGSLESVIHGPGVDHSRWTLPKRIDVLISVANGLDYLHSGYDIPIVHCDMKPSNILLDR----- 153 (299)
Q Consensus 79 ~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lh~~~~~~~~H~dl~~~nil~~~----- 153 (299)
+.. ....++|+|++ +++|.+++... ...++++..++.++.|++.||+|||++ +++|+||||+||+++.
T Consensus 86 ~~~-~~~~~lv~e~~-~~~l~~~l~~~--~~~~~~~~~~~~~~~qi~~~l~~lH~~---~ivH~Dlkp~Nil~~~~~~~~ 158 (339)
T 1z57_A 86 FEH-HGHICIVFELL-GLSTYDFIKEN--GFLPFRLDHIRKMAYQICKSVNFLHSN---KLTHTDLKPENILFVQSDYTE 158 (339)
T ss_dssp EEE-TTEEEEEEECC-CCBHHHHHHHT--TTCCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEESCCCEEE
T ss_pred ccc-CCcEEEEEcCC-CCCHHHHHHhc--CCCCCcHHHHHHHHHHHHHHHHHHHHC---CCcCCCCCHHHEEEecccccc
Confidence 655 45679999999 78999988643 234689999999999999999999999 9999999999999987
Q ss_pred --------------CCcEEEeeeccccccccccccccccccccccCcccCChhhhcccCcCccccchhhhHHHHHHHhCC
Q 038766 154 --------------DFEAHVSDFGTSRMLDVHLQDLSSLSTAFQGTIGYLAPEFAYMRIVTTKVDVFSFGIVVMEFLTKR 219 (299)
Q Consensus 154 --------------~~~v~l~df~~~~~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~DiwslG~~l~~l~~g~ 219 (299)
++.++|+|||++.... .......+++.|+|||++.+..++.++|||||||++|+|++|.
T Consensus 159 ~~~~~~~~~~~~~~~~~~kl~Dfg~~~~~~-------~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~ 231 (339)
T 1z57_A 159 AYNPKIKRDERTLINPDIKVVDFGSATYDD-------EHHSTLVSTRHYRAPEVILALGWSQPCDVWSIGCILIEYYLGF 231 (339)
T ss_dssp EEC----CEEEEESCCCEEECCCSSCEETT-------SCCCSSCSCGGGCCHHHHTTSCCCTHHHHHHHHHHHHHHHHSS
T ss_pred ccCCccccccccccCCCceEeeCcccccCc-------cccccccCCccccChHHhhCCCCCcchhhHHHHHHHHHHHhCC
Confidence 6689999999987533 2233456799999999999999999999999999999999999
Q ss_pred CCCCCCccCCCCchhHHHHHHHHHhcCccCcc--------------cccCccccch---------hhHhHHHHHHHHHHH
Q 038766 220 RPTGLDEENGLSPISLRQLVEKALANGINGVR--------------QITDPKLVSS---------IYEEQEQHQVLEELF 276 (299)
Q Consensus 220 ~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~--------------~~~~~~~~~~---------~~~~~~~~~~~~~l~ 276 (299)
.||... ........+............ .+........ ..........+.++.
T Consensus 232 ~pf~~~-----~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~ 306 (339)
T 1z57_A 232 TVFPTH-----DSKEHLAMMERILGPLPKHMIQKTRKRKYFHHDRLDWDEHSSAGRYVSRACKPLKEFMLSQDVEHERLF 306 (339)
T ss_dssp CSCCCS-----CHHHHHHHHHHHHCSCCHHHHHHCSCGGGEETTEECCCTTSHHHHHHHHHCCCGGGGCSCCSHHHHHHH
T ss_pred CCCCCC-----ChHHHHHHHHHHhCCCCHHHHhhccchhHHhhccccccccccccchhhhcCcchhhhcccchhhHHHHH
Confidence 999543 222222222222211100000 0000000000 000001234567899
Q ss_pred HHHHHhcCCCCCCCCChhhhhcC
Q 038766 277 KLALVCTSSNPEDRPNMNELLIT 299 (299)
Q Consensus 277 ~li~~~l~~dP~~Rpt~~~il~~ 299 (299)
+||.+||..||++|||++|+++|
T Consensus 307 ~li~~~L~~dP~~Rpt~~ell~h 329 (339)
T 1z57_A 307 DLIQKMLEYDPAKRITLREALKH 329 (339)
T ss_dssp HHHHHHTCSSTTTSCCHHHHTTS
T ss_pred HHHHHHhCcCcccccCHHHHhcC
Confidence 99999999999999999999987
|
| >2pml_X PFPK7, Ser/Thr protein kinase; phosphorylati transferase, transferase; HET: ANP; 2.60A {Plasmodium falciparum} PDB: 2pmn_X* 2pmo_X* | Back alignment and structure |
|---|
Probab=100.00 E-value=8.4e-45 Score=312.18 Aligned_cols=269 Identities=20% Similarity=0.251 Sum_probs=204.5
Q ss_pred HhCCCCCCceeecCCcceEEEEEeCCCcEEEEEEeccCcCChhh---------------hHHHHHHHHHHHhcCCcceee
Q 038766 10 ATGSFSENNIIGNSNLSTVYKGRLEDGEIVAVKKLNFHQFSAES---------------DKSFYREAKTLKELKHRNLVK 74 (299)
Q Consensus 10 ~~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~vK~~~~~~~~~~~---------------~~~~~~e~~~l~~l~h~~i~~ 74 (299)
..++|.+.+.||+|++|.||++.+ +++.||+|++......... ...+.+|+.+++.++||||++
T Consensus 29 ~~~~y~~~~~lg~G~~g~V~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~ 107 (348)
T 2pml_X 29 YINDYRIIRTLNQGKFNKIILCEK-DNKFYALKKYEKSLLEKKRDFTKSNNDKISIKSKYDDFKNELQIITDIKNEYCLT 107 (348)
T ss_dssp EETTEEEEEEEECCSSCCEEEEEE-TTEEEEEEEEEHHHHSSCEEECCCSSSSCCEEEHHHHHHHHHHHHTTCCCTTBCC
T ss_pred ccCceEEEEEEcCCCCeEEEEEEc-CCceEEEEEeecccccchhhhccccchhhhHHhHHHHHHHHHHHHHhCCCCCcce
Confidence 457999999999999999999999 8999999998754322211 178899999999999999999
Q ss_pred eeeEEEcCCCeeEEEEeecCCCChHHH------hcCCCCCCCCCChhhHHHHHHHHHHHHHHhhc-CCCCCeeeecccCC
Q 038766 75 VLGYAWESGKLKALILEYMENGSLESV------IHGPGVDHSRWTLPKRIDVLISVANGLDYLHS-GYDIPIVHCDMKPS 147 (299)
Q Consensus 75 ~~~~~~~~~~~~~lv~e~~~~~~L~~~------~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lh~-~~~~~~~H~dl~~~ 147 (299)
+++++.. ....++|+||+.+++|.++ +... ....+++..++.++.|++.||.|||+ . +++|+||+|+
T Consensus 108 ~~~~~~~-~~~~~lv~e~~~~~~L~~~~~~~~~l~~~--~~~~~~~~~~~~i~~qi~~~l~~lH~~~---~i~H~dl~p~ 181 (348)
T 2pml_X 108 CEGIITN-YDEVYIIYEYMENDSILKFDEYFFVLDKN--YTCFIPIQVIKCIIKSVLNSFSYIHNEK---NICHRDVKPS 181 (348)
T ss_dssp CSEEEES-SSEEEEEEECCTTCBSSEESSSEESSCSS--SCCCCCHHHHHHHHHHHHHHHHHHHHTS---CEECCCCCGG
T ss_pred EEEEEee-CCeEEEEEeccCCCcHHHHHHHhhhhhhc--cccCCCHHHHHHHHHHHHHHHHHHhccC---CEeecCCChH
Confidence 9997665 4566999999999999998 4421 25689999999999999999999998 8 9999999999
Q ss_pred ceeeCCCCcEEEeeeccccccccccccccccccccccCcccCChhhhccc-CcCc-cccchhhhHHHHHHHhCCCCCCCC
Q 038766 148 NILLDRDFEAHVSDFGTSRMLDVHLQDLSSLSTAFQGTIGYLAPEFAYMR-IVTT-KVDVFSFGIVVMEFLTKRRPTGLD 225 (299)
Q Consensus 148 nil~~~~~~v~l~df~~~~~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~-~~~~-~~DiwslG~~l~~l~~g~~p~~~~ 225 (299)
||+++.++.++|+|||.+..... .......+++.|+|||.+.+. .++. ++||||||+++|+|++|..||...
T Consensus 182 Nil~~~~~~~kl~dfg~~~~~~~------~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~ 255 (348)
T 2pml_X 182 NILMDKNGRVKLSDFGESEYMVD------KKIKGSRGTYEFMPPEFFSNESSYNGAKVDIWSLGICLYVMFYNVVPFSLK 255 (348)
T ss_dssp GEEECTTSCEEECCCTTCEECBT------TEECSSCSCGGGCCGGGGSSCCCEEHHHHHHHHHHHHHHHHHHSSCSSCCS
T ss_pred hEEEcCCCcEEEecccccccccc------ccccCCCCCcCccCchhhcCCCCCCcchhhHHHHHHHHHHHHhCCCCCCCC
Confidence 99999999999999999876542 123445678999999999877 5666 999999999999999999999644
Q ss_pred ccCCCCchhHHHHHHHHHhcCccCcccccCc--cccchhhHhHHHHHHHHHHHHHHHHhcCCCCCCCCChhhhhcC
Q 038766 226 EENGLSPISLRQLVEKALANGINGVRQITDP--KLVSSIYEEQEQHQVLEELFKLALVCTSSNPEDRPNMNELLIT 299 (299)
Q Consensus 226 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rpt~~~il~~ 299 (299)
... .+....... ........... ..............++.++.++|.+||..||++|||++++++|
T Consensus 256 ~~~-------~~~~~~i~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rps~~e~l~h 323 (348)
T 2pml_X 256 ISL-------VELFNNIRT-KNIEYPLDRNHFLYPLTNKKSTCSNNFLSNEDIDFLKLFLRKNPAERITSEDALKH 323 (348)
T ss_dssp SCS-------HHHHHHHTS-CCCCCCCSSSSSTTTTCC--------CCCHHHHHHHHHHCCSSGGGSCCHHHHHTS
T ss_pred CcH-------HHHHHHHhc-cCcCCccchhhhhccccccccccchhhcCHHHHHHHHHHccCChhhCCCHHHHhcC
Confidence 221 112221111 11111000000 0000000011124566789999999999999999999999987
|
| >1blx_A Cyclin-dependent kinase 6; inhibitor protein, cyclin-dependent kinase, cell cycle control, alpha/beta, complex (inhibitor protein/kinase); 1.90A {Homo sapiens} SCOP: d.144.1.7 PDB: 1bi7_A 1bi8_A 1g3n_A 2f2c_B* 1jow_B* 2euf_B* 1xo2_B* 3nup_A* 3nux_A* 2w9z_B 2w99_B 2w96_B 2w9f_B | Back alignment and structure |
|---|
Probab=100.00 E-value=5.3e-44 Score=304.47 Aligned_cols=275 Identities=23% Similarity=0.294 Sum_probs=204.1
Q ss_pred HHhCCCCCCceeecCCcceEEEEEe--CCCcEEEEEEeccCcCChhhhHHHHHHHHHHHhc---CCcceeeeeeEEEc--
Q 038766 9 NATGSFSENNIIGNSNLSTVYKGRL--EDGEIVAVKKLNFHQFSAESDKSFYREAKTLKEL---KHRNLVKVLGYAWE-- 81 (299)
Q Consensus 9 ~~~~~y~~~~~lg~g~~~~v~~~~~--~~~~~~~vK~~~~~~~~~~~~~~~~~e~~~l~~l---~h~~i~~~~~~~~~-- 81 (299)
...++|++.+.||+|+||.||++.+ .+++.||+|++............+.+|+..++.+ .||||+++++++..
T Consensus 8 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~h~~i~~~~~~~~~~~ 87 (326)
T 1blx_A 8 RADQQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETFEHPNVVRLFDVCTVSR 87 (326)
T ss_dssp CGGGTEEEEEEEEEETTEEEEEEEETTTTTEEEEEEEEEEEBCTTSCBCTHHHHHHHHHHHHHTCCTTBCCEEEEEEEEE
T ss_pred CchhceeeeeeecccccEEEEEEEecCCCCEEEEEEEeccCcccccCCchhhHHHHHHHhhhccCCCCeEeeeeeeeecc
Confidence 4568999999999999999999987 3588999999875544444445566777777766 79999999997762
Q ss_pred --CCCeeEEEEeecCCCChHHHhcCCCCCCCCCChhhHHHHHHHHHHHHHHhhcCCCCCeeeecccCCceeeCCCCcEEE
Q 038766 82 --SGKLKALILEYMENGSLESVIHGPGVDHSRWTLPKRIDVLISVANGLDYLHSGYDIPIVHCDMKPSNILLDRDFEAHV 159 (299)
Q Consensus 82 --~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lh~~~~~~~~H~dl~~~nil~~~~~~v~l 159 (299)
.....++|+|++. ++|.+++... ....+++..++.++.|++.||.|||+. +++|+||||+||+++.++.++|
T Consensus 88 ~~~~~~~~lv~e~~~-~~L~~~l~~~--~~~~~~~~~~~~~~~qi~~~l~~lH~~---gi~H~dlkp~Nili~~~~~~kl 161 (326)
T 1blx_A 88 TDRETKLTLVFEHVD-QDLTTYLDKV--PEPGVPTETIKDMMFQLLRGLDFLHSH---RVVHRDLKPQNILVTSSGQIKL 161 (326)
T ss_dssp CSSEEEEEEEEECCS-CBHHHHHHHS--CTTCSCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEECTTCCEEE
T ss_pred cCCCceEEEEEecCC-CCHHHHHHhc--ccCCCCHHHHHHHHHHHHHHHHHHHHC---CceeccCCHHHeEEcCCCCEEE
Confidence 4456799999997 5999988643 234589999999999999999999999 9999999999999999999999
Q ss_pred eeeccccccccccccccccccccccCcccCChhhhcccCcCccccchhhhHHHHHHHhCCCCCCCCccCCCCchhHHHHH
Q 038766 160 SDFGTSRMLDVHLQDLSSLSTAFQGTIGYLAPEFAYMRIVTTKVDVFSFGIVVMEFLTKRRPTGLDEENGLSPISLRQLV 239 (299)
Q Consensus 160 ~df~~~~~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~DiwslG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~ 239 (299)
+|||++...... .......+++.|+|||.+.+..++.++||||||+++|+|++|..||.... .......+
T Consensus 162 ~Dfg~~~~~~~~-----~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~-----~~~~~~~i 231 (326)
T 1blx_A 162 ADFGLARIYSFQ-----MALTSVVVTLWYRAPEVLLQSSYATPVDLWSVGCIFAEMFRRKPLFRGSS-----DVDQLGKI 231 (326)
T ss_dssp CSCCSCCCCCGG-----GGGCCCCCCCTTCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSCCCSS-----HHHHHHHH
T ss_pred ecCcccccccCC-----CCccccccccceeCHHHHhcCCCCcchhHHHHHHHHHHHHcCCCCCCCCC-----HHHHHHHH
Confidence 999998765421 12334567899999999999999999999999999999999999995432 11111111
Q ss_pred HHHHhc-C---ccCcccccCcccc--chhhHhHHHHHHHHHHHHHHHHhcCCCCCCCCChhhhhcC
Q 038766 240 EKALAN-G---INGVRQITDPKLV--SSIYEEQEQHQVLEELFKLALVCTSSNPEDRPNMNELLIT 299 (299)
Q Consensus 240 ~~~~~~-~---~~~~~~~~~~~~~--~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rpt~~~il~~ 299 (299)
...... . +............ ...........++..+.+||.+||..||++|||++++++|
T Consensus 232 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~h 297 (326)
T 1blx_A 232 LDVIGLPGEEDWPRDVALPRQAFHSKSAQPIEKFVTDIDELGKDLLLKCLTFNPAKRISAYSALSH 297 (326)
T ss_dssp HHHHCCCCGGGSCTTCSSCGGGSCCCCCCCGGGTCCSCCHHHHHHHHHHSCSSTTTSCCHHHHHTS
T ss_pred HHHcCCCCcccCccccccchhhhcccCcchhhhccccCCHHHHHHHHHHcCCCcccCCCHHHHhcC
Confidence 111110 0 0000000000000 0000011123456789999999999999999999999987
|
| >4e7w_A Glycogen synthase kinase 3; GSK3, PTyr195, transferase; HET: PTR; 3.30A {Ustilago maydis} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-44 Score=315.83 Aligned_cols=271 Identities=20% Similarity=0.277 Sum_probs=196.6
Q ss_pred HhCCCCCCceeecCCcceEEEEEeCCCcEEEEEEeccCcCChhhhHHHHHHHHHHHhcCCcceeeeeeEEEcCCC-----
Q 038766 10 ATGSFSENNIIGNSNLSTVYKGRLEDGEIVAVKKLNFHQFSAESDKSFYREAKTLKELKHRNLVKVLGYAWESGK----- 84 (299)
Q Consensus 10 ~~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~vK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~----- 84 (299)
...+|.+.+.||+|+||+||+|++..+..+|+|++..... ...+|+++++.++||||+++++++...+.
T Consensus 38 ~~~~Y~~~~~lG~G~~g~V~~a~~~~~~~~aikk~~~~~~------~~~~E~~il~~l~h~niv~l~~~~~~~~~~~~~~ 111 (394)
T 4e7w_A 38 REIAYTNCKVIGNGSFGVVFQAKLVESDEVAIKKVLQDKR------FKNRELQIMRIVKHPNVVDLKAFFYSNGDKKDEV 111 (394)
T ss_dssp EEEEEEEEEEEEEETTEEEEEEEETTTEEEEEEEEECCTT------SCCHHHHHHHTCCCTTBCCEEEEEEEESSSSSCE
T ss_pred ccceEEEeEEEeeCCCeEEEEEEECCCCeEEEEEEecCcc------hHHHHHHHHHhCCCCCcceEEEEEEecCCCCCce
Confidence 4567999999999999999999987777799998864321 12269999999999999999998865432
Q ss_pred eeEEEEeecCCCChHHHhcCCCCCCCCCChhhHHHHHHHHHHHHHHhhcCCCCCeeeecccCCceeeC-CCCcEEEeeec
Q 038766 85 LKALILEYMENGSLESVIHGPGVDHSRWTLPKRIDVLISVANGLDYLHSGYDIPIVHCDMKPSNILLD-RDFEAHVSDFG 163 (299)
Q Consensus 85 ~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lh~~~~~~~~H~dl~~~nil~~-~~~~v~l~df~ 163 (299)
..++|+||+.+ ++...+.........+++..++.++.|++.||+|||+. +++||||||+||+++ .++.+||+|||
T Consensus 112 ~~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~LH~~---~ivHrDlkp~Nill~~~~~~~kL~DFG 187 (394)
T 4e7w_A 112 FLNLVLEYVPE-TVYRASRHYAKLKQTMPMLLIKLYMYQLLRSLAYIHSI---GICHRDIKPQNLLLDPPSGVLKLIDFG 187 (394)
T ss_dssp EEEEEEECCSE-EHHHHHHHHHHTTSCCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEEETTTTEEEECCCT
T ss_pred EEEEEeeccCc-cHHHHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHHC---CccCCCCCHHHEEEcCCCCcEEEeeCC
Confidence 36899999976 55443321111356799999999999999999999999 999999999999998 78999999999
Q ss_pred cccccccccccccccccccccCcccCChhhhccc-CcCccccchhhhHHHHHHHhCCCCCCCCccCCCCchhHHHHHHHH
Q 038766 164 TSRMLDVHLQDLSSLSTAFQGTIGYLAPEFAYMR-IVTTKVDVFSFGIVVMEFLTKRRPTGLDEENGLSPISLRQLVEKA 242 (299)
Q Consensus 164 ~~~~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~-~~~~~~DiwslG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~ 242 (299)
++..... ........+++.|+|||++.+. .++.++|||||||++|+|++|..||...... ..+...+...
T Consensus 188 ~a~~~~~-----~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~----~~l~~i~~~~ 258 (394)
T 4e7w_A 188 SAKILIA-----GEPNVSYICSRYYRAPELIFGATNYTTNIDIWSTGCVMAELMQGQPLFPGESGI----DQLVEIIKVL 258 (394)
T ss_dssp TCEECCT-----TCCCCSSCSCGGGCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSSCCSSHH----HHHHHHHHHH
T ss_pred CcccccC-----CCCCcccccCcCccCHHHHcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHH----HHHHHHHHHh
Confidence 9976532 1223345678999999988765 5899999999999999999999999543211 1111111110
Q ss_pred HhcC-------ccCcccccCccccchhhHhHHHHHHHHHHHHHHHHhcCCCCCCCCChhhhhcC
Q 038766 243 LANG-------INGVRQITDPKLVSSIYEEQEQHQVLEELFKLALVCTSSNPEDRPNMNELLIT 299 (299)
Q Consensus 243 ~~~~-------~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rpt~~~il~~ 299 (299)
.... .........+..............++.++.+||.+||..||++|||+.++++|
T Consensus 259 g~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~h 322 (394)
T 4e7w_A 259 GTPSREQIKTMNPNYMEHKFPQIRPHPFSKVFRPRTPPDAIDLISRLLEYTPSARLTAIEALCH 322 (394)
T ss_dssp CCCCHHHHHHHCGGGSSSCCCCCCCCCHHHHSCTTCCHHHHHHHHHHCCSSGGGSCCHHHHHTS
T ss_pred CCCCHHHHHhhChhhhhhccccccCCcHHHhccccCCHHHHHHHHHHhCCChhhCCCHHHHhcC
Confidence 0000 00000001111111111112223456789999999999999999999999987
|
| >1byg_A CSK, protein (C-terminal SRC kinase); protein kinase, phosphorylation, staurosporine, transferase; HET: STU; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 3d7u_A 3d7t_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-45 Score=307.06 Aligned_cols=252 Identities=25% Similarity=0.346 Sum_probs=195.1
Q ss_pred HHHHHHhCCCCCCceeecCCcceEEEEEeCCCcEEEEEEeccCcCChhhhHHHHHHHHHHHhcCCcceeeeeeEEEcCCC
Q 038766 5 TEIENATGSFSENNIIGNSNLSTVYKGRLEDGEIVAVKKLNFHQFSAESDKSFYREAKTLKELKHRNLVKVLGYAWESGK 84 (299)
Q Consensus 5 ~~~~~~~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~vK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~ 84 (299)
..+....++|++.+.||+|++|+||++.+. |+.||+|++... ...+.+.+|+..++.++||||+++++++...+.
T Consensus 14 ~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~-~~~vavK~~~~~----~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~ 88 (278)
T 1byg_A 14 SGWALNMKELKLLQTIGKGEFGDVMLGDYR-GNKVAVKCIKND----ATAQAFLAEASVMTQLRHSNLVQLLGVIVEEKG 88 (278)
T ss_dssp -CCBCCGGGEEEEEEEEECSSCEEEEEEET-TEEEEEEECCCC----C--HHHHHTHHHHTTCCCTTBCCEEEEECCC--
T ss_pred ccccCChhhceEEeEEecCCCceEEEEEEc-CCEEEEEEecch----hHHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCC
Confidence 344566789999999999999999999875 889999998632 345678899999999999999999998776666
Q ss_pred eeEEEEeecCCCChHHHhcCCCCCCCCCChhhHHHHHHHHHHHHHHhhcCCCCCeeeecccCCceeeCCCCcEEEeeecc
Q 038766 85 LKALILEYMENGSLESVIHGPGVDHSRWTLPKRIDVLISVANGLDYLHSGYDIPIVHCDMKPSNILLDRDFEAHVSDFGT 164 (299)
Q Consensus 85 ~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lh~~~~~~~~H~dl~~~nil~~~~~~v~l~df~~ 164 (299)
..++|+||+.+++|.+++... ....+++..++.++.|++.||.+||++ +++|+||||+||+++.++.++|+|||+
T Consensus 89 ~~~lv~e~~~~~~L~~~l~~~--~~~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dlkp~Nil~~~~~~~~l~Dfg~ 163 (278)
T 1byg_A 89 GLYIVTEYMAKGSLVDYLRSR--GRSVLGGDCLLKFSLDVCEAMEYLEGN---NFVHRDLAARNVLVSEDNVAKVSDFGL 163 (278)
T ss_dssp CCEEEECCCTTEEHHHHHHHH--HHHHCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEECTTSCEEECCCCC
T ss_pred ceEEEEecCCCCCHHHHHHhc--ccccCCHHHHHHHHHHHHHHHHHHHhC---CccccCCCcceEEEeCCCcEEEeeccc
Confidence 679999999999999998632 112378999999999999999999999 999999999999999999999999999
Q ss_pred ccccccccccccccccccccCcccCChhhhcccCcCccccchhhhHHHHHHHh-CCCCCCCCccCCCCchhHHHHHHHHH
Q 038766 165 SRMLDVHLQDLSSLSTAFQGTIGYLAPEFAYMRIVTTKVDVFSFGIVVMEFLT-KRRPTGLDEENGLSPISLRQLVEKAL 243 (299)
Q Consensus 165 ~~~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~DiwslG~~l~~l~~-g~~p~~~~~~~~~~~~~~~~~~~~~~ 243 (299)
+..... ......+++.|+|||.+.+..++.++||||||+++|+|++ |..||.... .......+.
T Consensus 164 ~~~~~~-------~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~t~g~~p~~~~~-----~~~~~~~~~--- 228 (278)
T 1byg_A 164 TKEASS-------TQDTGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIP-----LKDVVPRVE--- 228 (278)
T ss_dssp -------------------CCTTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSCTTSC-----GGGHHHHHT---
T ss_pred cccccc-------cccCCCccccccCHHHhCCCCCCchhcHHHHHHHHHHHHhCCCCCCCCCC-----HHHHHHHHh---
Confidence 875431 1223346788999999999899999999999999999998 999985432 122221111
Q ss_pred hcCccCcccccCccccchhhHhHHHHHHHHHHHHHHHHhcCCCCCCCCChhhhhc
Q 038766 244 ANGINGVRQITDPKLVSSIYEEQEQHQVLEELFKLALVCTSSNPEDRPNMNELLI 298 (299)
Q Consensus 244 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rpt~~~il~ 298 (299)
.+. .... +..++..+.++|++||..||++|||++++++
T Consensus 229 -~~~----~~~~------------~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~ 266 (278)
T 1byg_A 229 -KGY----KMDA------------PDGCPPAVYEVMKNCWHLDAAMRPSFLQLRE 266 (278)
T ss_dssp -TTC----CCCC------------CTTCCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred -cCC----CCCC------------cccCCHHHHHHHHHHhcCChhhCCCHHHHHH
Confidence 110 0000 1234567999999999999999999999975
|
| >1j1b_A Glycogen synthase kinase-3 beta; complex, TAU, AMPPNP, transferase; HET: ANP; 1.80A {Homo sapiens} SCOP: d.144.1.7 PDB: 1i09_A* 1j1c_A* 2jld_A* 3m1s_A* 3pup_A* 3du8_A* 1pyx_A* 1q41_A* 1q3w_A* 1q3d_A* 1q4l_A* 3q3b_A* 1q5k_A* 3i4b_A* 3l1s_A* 1r0e_A* 3zrk_A* 3zrl_A* 3zrm_A* 4dit_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-44 Score=317.62 Aligned_cols=269 Identities=23% Similarity=0.310 Sum_probs=196.6
Q ss_pred CCCCCCceeecCCcceEEEEEeC-CCcEEEEEEeccCcCChhhhHHHHHHHHHHHhcCCcceeeeeeEEEcCC-----Ce
Q 038766 12 GSFSENNIIGNSNLSTVYKGRLE-DGEIVAVKKLNFHQFSAESDKSFYREAKTLKELKHRNLVKVLGYAWESG-----KL 85 (299)
Q Consensus 12 ~~y~~~~~lg~g~~~~v~~~~~~-~~~~~~vK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~-----~~ 85 (299)
.+|.+.+.||+|+||+||++.+. +|+.||||++.... ....+|+++++.++||||+++++++...+ ..
T Consensus 54 ~~y~~~~~lG~G~fg~Vy~~~~~~~~~~vaiK~~~~~~------~~~~~E~~il~~l~hpniv~l~~~~~~~~~~~~~~~ 127 (420)
T 1j1b_A 54 VSYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDK------RFKNRELQIMRKLDHCNIVRLRYFFYSSGEKKDEVY 127 (420)
T ss_dssp EEEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEECCT------TSCCHHHHHHHTCCCTTBCCEEEEEEEEETTTTEEE
T ss_pred ceEEeeeEEeeCCCEEEEEEEECCCCcEEEEEEecccc------hhHHHHHHHHHHcCCCCccceeeEEeccCCCCccee
Confidence 46999999999999999999875 58999999986432 12236999999999999999999876422 23
Q ss_pred eEEEEeecCCCChHHHhcCCCCCCCCCChhhHHHHHHHHHHHHHHhhcCCCCCeeeecccCCceeeCCC-CcEEEeeecc
Q 038766 86 KALILEYMENGSLESVIHGPGVDHSRWTLPKRIDVLISVANGLDYLHSGYDIPIVHCDMKPSNILLDRD-FEAHVSDFGT 164 (299)
Q Consensus 86 ~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lh~~~~~~~~H~dl~~~nil~~~~-~~v~l~df~~ 164 (299)
+++|+||+.+ +|.+.+.........+++..++.++.||+.||+|||++ +++||||||+|||++.+ +.+||+|||+
T Consensus 128 ~~lv~e~~~~-~l~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~---~ivHrDlkp~NILl~~~~~~~kl~DFG~ 203 (420)
T 1j1b_A 128 LNLVLDYVPE-TVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAYIHSF---GICHRDIKPQNLLLDPDTAVLKLCDFGS 203 (420)
T ss_dssp EEEEEECCCE-EHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHTT---TEECSCCSGGGEEEETTTTEEEECCCTT
T ss_pred EEeehhcccc-cHHHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHHC---CccccCCChhhEEEeCCCCeEEeccchh
Confidence 5799999965 67665542222456799999999999999999999999 99999999999999965 5689999999
Q ss_pred ccccccccccccccccccccCcccCChhhhccc-CcCccccchhhhHHHHHHHhCCCCCCCCccCCCCchhHHHHHHHHH
Q 038766 165 SRMLDVHLQDLSSLSTAFQGTIGYLAPEFAYMR-IVTTKVDVFSFGIVVMEFLTKRRPTGLDEENGLSPISLRQLVEKAL 243 (299)
Q Consensus 165 ~~~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~-~~~~~~DiwslG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~ 243 (299)
+..+... .......+++.|+|||++.+. .++.++|||||||++|+|++|..||..... ...+...+....
T Consensus 204 a~~~~~~-----~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~G~~pf~~~~~----~~~l~~i~~~lg 274 (420)
T 1j1b_A 204 AKQLVRG-----EPNVSYICSRYYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQPIFPGDSG----VDQLVEIIKVLG 274 (420)
T ss_dssp CEECCTT-----CCCCSCCSCTTSCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSSCCSSH----HHHHHHHHHHHC
T ss_pred hhhcccC-----CCceeeeeCCCcCCHHHHcCCCCCCchhhhHHHHHHHHHHHhCCCCCCCCCH----HHHHHHHHHHhC
Confidence 9765321 222345678999999998765 789999999999999999999999964321 111222221110
Q ss_pred -------hcCccCcccccCccccchhhHhHHHHHHHHHHHHHHHHhcCCCCCCCCChhhhhcC
Q 038766 244 -------ANGINGVRQITDPKLVSSIYEEQEQHQVLEELFKLALVCTSSNPEDRPNMNELLIT 299 (299)
Q Consensus 244 -------~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rpt~~~il~~ 299 (299)
.........+..+......+........+.++.+||++||..||++|||+.|+++|
T Consensus 275 ~p~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~Li~~~L~~dP~~R~t~~e~l~h 337 (420)
T 1j1b_A 275 TPTREQIREMNPNYTEFKFPQIKAHPWTKVFRPRTPPEAIALCSRLLEYTPTARLTPLEACAH 337 (420)
T ss_dssp SCCHHHHHHHCSCCCCCCCCCCCCCCHHHHSCTTSCHHHHHHHHHHSCSSGGGSCCHHHHHTS
T ss_pred CCCHHHHHhhChhhhhhccCccCCCCHHHhcCCCCCHHHHHHHHHhccCChhHCCCHHHHhCC
Confidence 00000111111111111111111223456789999999999999999999999987
|
| >3lxl_A Tyrosine-protein kinase JAK3; TYK2, inflammation, cancer, PAN inhibitor, ATP-binding mutation, membrane, nucleotide-binding, phosphoprot SCID; HET: IZA; 1.74A {Homo sapiens} PDB: 3lxk_A* 4hvd_A* 4hvg_A* 4hvh_A* 4hvi_A* 3pjc_A* 1yvj_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-44 Score=308.63 Aligned_cols=262 Identities=24% Similarity=0.385 Sum_probs=203.9
Q ss_pred hCCCCCCceeecCCcceEEEEEe-----CCCcEEEEEEeccCcCChhhhHHHHHHHHHHHhcCCcceeeeeeEEEc-CCC
Q 038766 11 TGSFSENNIIGNSNLSTVYKGRL-----EDGEIVAVKKLNFHQFSAESDKSFYREAKTLKELKHRNLVKVLGYAWE-SGK 84 (299)
Q Consensus 11 ~~~y~~~~~lg~g~~~~v~~~~~-----~~~~~~~vK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~-~~~ 84 (299)
.++|++.+.||+|+||.||++.+ .+++.||+|++... .....+.+.+|+++++.++||||+++++++.. ...
T Consensus 22 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~ 99 (327)
T 3lxl_A 22 ERHLKYISQLGKGNFGSVELCRYDPLGDNTGALVAVKQLQHS--GPDQQRDFQREIQILKALHSDFIVKYRGVSYGPGRQ 99 (327)
T ss_dssp GGGEEEEEEEEEETTEEEEEEEECTTSSSCSEEEEEEEESSC--CHHHHHHHHHHHHHHHTCCCTTBCCEEEEEECSSSC
T ss_pred hhhhhhhhhccCCCCeEEEEEEeccCCCCcceEEEEEEeccC--CHHHHHHHHHHHHHHHhcCCCceeEEEEEEecCCCc
Confidence 46899999999999999999983 35889999998632 45556778999999999999999999998774 445
Q ss_pred eeEEEEeecCCCChHHHhcCCCCCCCCCChhhHHHHHHHHHHHHHHhhcCCCCCeeeecccCCceeeCCCCcEEEeeecc
Q 038766 85 LKALILEYMENGSLESVIHGPGVDHSRWTLPKRIDVLISVANGLDYLHSGYDIPIVHCDMKPSNILLDRDFEAHVSDFGT 164 (299)
Q Consensus 85 ~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lh~~~~~~~~H~dl~~~nil~~~~~~v~l~df~~ 164 (299)
..++|+||+++++|.+++... ...+++..++.++.|++.||+|||+. +++|+||||+||+++.++.++|+|||+
T Consensus 100 ~~~lv~e~~~~~~L~~~l~~~---~~~~~~~~~~~i~~qi~~al~~lH~~---~ivH~Dikp~NIl~~~~~~~kl~Dfg~ 173 (327)
T 3lxl_A 100 SLRLVMEYLPSGCLRDFLQRH---RARLDASRLLLYSSQICKGMEYLGSR---RCVHRDLAARNILVESEAHVKIADFGL 173 (327)
T ss_dssp EEEEEEECCTTCBHHHHHHHH---GGGCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEEEETTEEEECCGGG
T ss_pred eEEEEEeecCCCCHHHHHHhc---ccCCCHHHHHHHHHHHHHHHHHHHhC---CccCCCCChhhEEECCCCCEEEccccc
Confidence 678999999999999998632 34699999999999999999999999 999999999999999999999999999
Q ss_pred ccccccccccccccccccccCcccCChhhhcccCcCccccchhhhHHHHHHHhCCCCCCCCccCC-------CCchhHHH
Q 038766 165 SRMLDVHLQDLSSLSTAFQGTIGYLAPEFAYMRIVTTKVDVFSFGIVVMEFLTKRRPTGLDEENG-------LSPISLRQ 237 (299)
Q Consensus 165 ~~~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~DiwslG~~l~~l~~g~~p~~~~~~~~-------~~~~~~~~ 237 (299)
+........ .........+++.|+|||.+.+..++.++||||||+++|+|++|..||....... ........
T Consensus 174 ~~~~~~~~~-~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~ 252 (327)
T 3lxl_A 174 AKLLPLDKD-YYVVREPGQSPIFWYAPESLSDNIFSRQSDVWSFGVVLYELFTYCDKSCSPSAEFLRMMGCERDVPALSR 252 (327)
T ss_dssp CEECCTTCS-EEECSSCCCSCGGGSCHHHHHHCEEEHHHHHHHHHHHHHHHHTTTCGGGSHHHHHHHHCC----CCHHHH
T ss_pred ceecccCCc-cceeeccCCccccccCHHHhccCCCChHHhHHHHHHHHHHHHhCCCCCccccchhhhhcccccccccHHH
Confidence 986542211 1112234456788999999999999999999999999999999999985432110 00000111
Q ss_pred HHHHHHhcCccCcccccCccccchhhHhHHHHHHHHHHHHHHHHhcCCCCCCCCChhhhhc
Q 038766 238 LVEKALANGINGVRQITDPKLVSSIYEEQEQHQVLEELFKLALVCTSSNPEDRPNMNELLI 298 (299)
Q Consensus 238 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rpt~~~il~ 298 (299)
.......... . ..+..++..+.++|.+||..||++|||++++++
T Consensus 253 ~~~~~~~~~~-----~------------~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~ 296 (327)
T 3lxl_A 253 LLELLEEGQR-----L------------PAPPACPAEVHELMKLCWAPSPQDRPSFSALGP 296 (327)
T ss_dssp HHHHHHTTCC-----C------------CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred HHHHhhcccC-----C------------CCCCcccHHHHHHHHHHcCCChhhCcCHHHHHH
Confidence 1111111000 0 002234568999999999999999999999976
|
| >2h34_A Serine/threonine-protein kinase PKNE; apoenzyme, transferase; 2.80A {Mycobacterium tuberculosis} | Back alignment and structure |
|---|
Probab=100.00 E-value=5.9e-45 Score=308.20 Aligned_cols=256 Identities=20% Similarity=0.267 Sum_probs=193.2
Q ss_pred HHhCCCCCCceeecCCcceEEEEEeC-CCcEEEEEEeccCcC-ChhhhHHHHHHHHHHHhcCCcceeeeeeEEEcCCCee
Q 038766 9 NATGSFSENNIIGNSNLSTVYKGRLE-DGEIVAVKKLNFHQF-SAESDKSFYREAKTLKELKHRNLVKVLGYAWESGKLK 86 (299)
Q Consensus 9 ~~~~~y~~~~~lg~g~~~~v~~~~~~-~~~~~~vK~~~~~~~-~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~ 86 (299)
...++|++.+.||+|+||.||++.+. +++.||+|++..... .....+.+.+|+..++.++||||+++++++.. ++..
T Consensus 31 ~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~hp~iv~~~~~~~~-~~~~ 109 (309)
T 2h34_A 31 TQFGPYRLRRLVGRGGMGDVYEAEDTVRERIVALKLMSETLSSDPVFRTRMQREARTAGRLQEPHVVPIHDFGEI-DGQL 109 (309)
T ss_dssp ---CCEEEEEEEEECSSSEEEEEEETTTTEEEEEEECGGGGGGSHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEE-TTEE
T ss_pred cEeccEEEEEEEcCCCCeeEEEEEEcCCCeEEEEEecCcccccCHHHHHHHHHHHHHHhhcCCCCeeEEEEEEee-CCeE
Confidence 45689999999999999999999875 688999999865432 23345778899999999999999999997765 5566
Q ss_pred EEEEeecCCCChHHHhcCCCCCCCCCChhhHHHHHHHHHHHHHHhhcCCCCCeeeecccCCceeeCCCCcEEEeeecccc
Q 038766 87 ALILEYMENGSLESVIHGPGVDHSRWTLPKRIDVLISVANGLDYLHSGYDIPIVHCDMKPSNILLDRDFEAHVSDFGTSR 166 (299)
Q Consensus 87 ~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lh~~~~~~~~H~dl~~~nil~~~~~~v~l~df~~~~ 166 (299)
++|+|++.+++|.+++. ...++++..++.++.|++.||.|||+. +++|+||+|+||+++.++.++|+|||++.
T Consensus 110 ~lv~e~~~~~~L~~~l~----~~~~~~~~~~~~i~~qi~~~l~~lH~~---~i~H~dlkp~NIl~~~~~~~kl~Dfg~~~ 182 (309)
T 2h34_A 110 YVDMRLINGVDLAAMLR----RQGPLAPPRAVAIVRQIGSALDAAHAA---GATHRDVKPENILVSADDFAYLVDFGIAS 182 (309)
T ss_dssp EEEEECCCCEEHHHHHH----HHCSCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEECTTSCEEECSCCC--
T ss_pred EEEEEecCCCCHHHHHH----hcCCCCHHHHHHHHHHHHHHHHHHHHC---cCCcCCCChHHEEEcCCCCEEEecCccCc
Confidence 99999999999999987 345799999999999999999999999 99999999999999999999999999987
Q ss_pred ccccccccccccccccccCcccCChhhhcccCcCccccchhhhHHHHHHHhCCCCCCCCccCCCCchhHHHHHHHHHhcC
Q 038766 167 MLDVHLQDLSSLSTAFQGTIGYLAPEFAYMRIVTTKVDVFSFGIVVMEFLTKRRPTGLDEENGLSPISLRQLVEKALANG 246 (299)
Q Consensus 167 ~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~DiwslG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~ 246 (299)
..... .........+++.|+|||.+.+..++.++||||||+++|+|++|..||..... ..+.......
T Consensus 183 ~~~~~---~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~---------~~~~~~~~~~ 250 (309)
T 2h34_A 183 ATTDE---KLTQLGNTVGTLYYMAPERFSESHATYRADIYALTCVLYECLTGSPPYQGDQL---------SVMGAHINQA 250 (309)
T ss_dssp -----------------CCGGGCCGGGTCC----CCCHHHHHHHHHHHHHHSSCSSCSCHH---------HHHHHHHHSC
T ss_pred ccccc---ccccccccCCCcCccCHHHHcCCCCCchHhHHHHHHHHHHHHHCCCCCCCchH---------HHHHHHhccC
Confidence 54421 11222345678999999999999999999999999999999999999954311 1111212111
Q ss_pred ccCcccccCccccchhhHhHHHHHHHHHHHHHHHHhcCCCCCCCC-Chhhhhc
Q 038766 247 INGVRQITDPKLVSSIYEEQEQHQVLEELFKLALVCTSSNPEDRP-NMNELLI 298 (299)
Q Consensus 247 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rp-t~~~il~ 298 (299)
..... .....++..+.++|.+||..||++|| |++++++
T Consensus 251 ~~~~~--------------~~~~~~~~~l~~li~~~l~~dP~~Rp~s~~~l~~ 289 (309)
T 2h34_A 251 IPRPS--------------TVRPGIPVAFDAVIARGMAKNPEDRYVTCGDLSA 289 (309)
T ss_dssp CCCGG--------------GTSTTCCTHHHHHHHHHTCSSGGGSCSSHHHHHH
T ss_pred CCCcc--------------ccCCCCCHHHHHHHHHhccCCHHHHHHhHHHHHH
Confidence 11100 01223456799999999999999999 8888764
|
| >3q60_A ROP5B; pseudokinase, transferase; HET: ATP; 1.72A {Toxoplasma gondii} PDB: 3q5z_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7.8e-45 Score=315.04 Aligned_cols=256 Identities=13% Similarity=0.039 Sum_probs=182.1
Q ss_pred CCCCCceeecCCcceEEEEEeC-CCcEEEEEEeccCcC-ChhhhHHHHHHHHHHHhc--CCcceeeee-------eEEEc
Q 038766 13 SFSENNIIGNSNLSTVYKGRLE-DGEIVAVKKLNFHQF-SAESDKSFYREAKTLKEL--KHRNLVKVL-------GYAWE 81 (299)
Q Consensus 13 ~y~~~~~lg~g~~~~v~~~~~~-~~~~~~vK~~~~~~~-~~~~~~~~~~e~~~l~~l--~h~~i~~~~-------~~~~~ 81 (299)
+|.+.+.||+|+||+||++.+. +++.||+|++..... .......+.+|+.+++.+ +||||++++ +++..
T Consensus 63 ~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~~~~l~~~hp~iv~~~~~~~~p~d~~~~ 142 (371)
T 3q60_A 63 KLKLVEPLRVGDRSVVFLVRDVERLEDFALKVFTMGAENSRSELERLHEATFAAARLLGESPEEARDRRRLLLPSDAVAV 142 (371)
T ss_dssp EEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEECCSTTHHHHHHHHHHHHHHHHHHHC----------CBCCCCEEEEE
T ss_pred eeeeeeeccCCCCEEEEEEEECCCCceeEEEEEEecccccccHHHHHHHHHHHHHHhcccChhhhhhceeEEeeehheec
Confidence 4889999999999999999874 689999999986544 234456677785555555 699988755 44433
Q ss_pred CC----------------CeeEEEEeecCCCChHHHhcCCCCCCCCCChhhH------HHHHHHHHHHHHHhhcCCCCCe
Q 038766 82 SG----------------KLKALILEYMENGSLESVIHGPGVDHSRWTLPKR------IDVLISVANGLDYLHSGYDIPI 139 (299)
Q Consensus 82 ~~----------------~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~------~~i~~qi~~~l~~lh~~~~~~~ 139 (299)
.+ ...++||||+. ++|.+++... +..++...+ +.++.||+.||+|||++ ++
T Consensus 143 ~~~~~~~~~~~~~~~~~~~~~~lv~e~~~-~~L~~~l~~~---~~~~~~~~~~~~~vk~~i~~qi~~aL~~LH~~---~i 215 (371)
T 3q60_A 143 QSQPPFAQLSPGQDDYAVANYLLLMPAAS-VDLELLFSTL---DFVYVFRGDEGILALHILTAQLIRLAANLQSK---GL 215 (371)
T ss_dssp TTSCSSSBCSCC---CCEEEEEEEECCCS-EEHHHHHHHH---HHSCCCCHHHHHHHHHHHHHHHHHHHHHHHHT---TE
T ss_pred CCCCCeeeccCCcccceeeeEEEEecCCC-CCHHHHHHHh---ccccchhhhhhhhhHHHHHHHHHHHHHHHHHC---CC
Confidence 22 23699999997 7999998632 223455555 67789999999999999 99
Q ss_pred eeecccCCceeeCCCCcEEEeeeccccccccccccccccccccccCcccCChhhhcc--cCcCccccchhhhHHHHHHHh
Q 038766 140 VHCDMKPSNILLDRDFEAHVSDFGTSRMLDVHLQDLSSLSTAFQGTIGYLAPEFAYM--RIVTTKVDVFSFGIVVMEFLT 217 (299)
Q Consensus 140 ~H~dl~~~nil~~~~~~v~l~df~~~~~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~--~~~~~~~DiwslG~~l~~l~~ 217 (299)
+||||||+|||++.++.+||+|||++.... .......+++.|+|||++.+ ..++.++|||||||++|+|++
T Consensus 216 vHrDikp~NIll~~~~~~kL~DFG~a~~~~-------~~~~~~~~t~~y~aPE~~~~~~~~~~~~~DiwSlG~il~ellt 288 (371)
T 3q60_A 216 VHGHFTPDNLFIMPDGRLMLGDVSALWKVG-------TRGPASSVPVTYAPREFLNASTATFTHALNAWQLGLSIYRVWC 288 (371)
T ss_dssp EETTCSGGGEEECTTSCEEECCGGGEEETT-------CEEEGGGSCGGGCCHHHHTCSEEECCHHHHHHHHHHHHHHHHH
T ss_pred ccCcCCHHHEEECCCCCEEEEecceeeecC-------CCccCccCCcCCcChhhccCCCCCcCccccHHHHHHHHHHHHh
Confidence 999999999999999999999999997543 11213445699999999987 678999999999999999999
Q ss_pred CCCCCCCCccCCCCchhHHHHHHHHHhcCccCcccccCccccchhhHhHHHHHHHHHHHHHHHHhcCCCCCCCCChhhhh
Q 038766 218 KRRPTGLDEENGLSPISLRQLVEKALANGINGVRQITDPKLVSSIYEEQEQHQVLEELFKLALVCTSSNPEDRPNMNELL 297 (299)
Q Consensus 218 g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rpt~~~il 297 (299)
|..||.............. ............ .....++..+.+||.+||..||++|||++++|
T Consensus 289 g~~Pf~~~~~~~~~~~~~~------------~~~~~~~~~~~~-----~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l 351 (371)
T 3q60_A 289 LFLPFGLVTPGIKGSWKRP------------SLRVPGTDSLAF-----GSCTPLPDFVKTLIGRFLNFDRRRRLLPLEAM 351 (371)
T ss_dssp SSCSTTBCCTTCTTCCCBC------------CTTSCCCCSCCC-----TTSSCCCHHHHHHHHHHTCSSTTTCCCHHHHT
T ss_pred CCCCCCCcCcccccchhhh------------hhhhccccccch-----hhccCCCHHHHHHHHHHcCCChhhCCCHHHHh
Confidence 9999975532211100000 000000000000 00124467899999999999999999999999
Q ss_pred cC
Q 038766 298 IT 299 (299)
Q Consensus 298 ~~ 299 (299)
+|
T Consensus 352 ~h 353 (371)
T 3q60_A 352 ET 353 (371)
T ss_dssp TS
T ss_pred cC
Confidence 87
|
| >3e3p_A Protein kinase, putative glycogen synthase kinase; leishmaniasis, transferase; 2.00A {Leishmania major} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.5e-44 Score=310.64 Aligned_cols=278 Identities=21% Similarity=0.256 Sum_probs=191.5
Q ss_pred HHHHHHhCCCCCCceeecCCcceEEEEEeC-CCcEEEEEEeccCcCChhhhHHHHHHHHHHHhcCCcceeeeeeEEEcCC
Q 038766 5 TEIENATGSFSENNIIGNSNLSTVYKGRLE-DGEIVAVKKLNFHQFSAESDKSFYREAKTLKELKHRNLVKVLGYAWESG 83 (299)
Q Consensus 5 ~~~~~~~~~y~~~~~lg~g~~~~v~~~~~~-~~~~~~vK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~ 83 (299)
+......++|.+.+.||+|+||+||++.+. +++.||||++... ........++++.++.++||||+++++++...+
T Consensus 16 ~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~---~~~~~~~~~~~~~l~~l~h~niv~~~~~~~~~~ 92 (360)
T 3e3p_A 16 ERSRKEMDRFQVERMAGQGTFGTVQLGKEKSTGMSVAIKKVIQD---PRFRNRELQIMQDLAVLHHPNIVQLQSYFYTLG 92 (360)
T ss_dssp HHHHHHHTTEEEC----------CEEEEETTTCCEEEEEEEECC---TTCCCHHHHHHHHHHHHCCTTBCCEEEEEEEEC
T ss_pred hhchhhccceEEEEEEecCCCeEEEEEEECCCCCEEEEEEEecC---ccccHHHHHHHHHHHhcCCCCcccHHHhhhccc
Confidence 456677899999999999999999999874 5899999998543 233446667888889999999999999886533
Q ss_pred C------eeEEEEeecCCCChHHHhcCCCCCCCCCChhhHHHHHHHHHHHHHHhh--cCCCCCeeeecccCCceeeCC-C
Q 038766 84 K------LKALILEYMENGSLESVIHGPGVDHSRWTLPKRIDVLISVANGLDYLH--SGYDIPIVHCDMKPSNILLDR-D 154 (299)
Q Consensus 84 ~------~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lh--~~~~~~~~H~dl~~~nil~~~-~ 154 (299)
. ..++|+||+.+ +|...+.........+++..++.++.|++.||.||| +. +++|+||||+||+++. +
T Consensus 93 ~~~~~~~~~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~~---~ivH~Dlkp~NIll~~~~ 168 (360)
T 3e3p_A 93 ERDRRDIYLNVVMEYVPD-TLHRCCRNYYRRQVAPPPILIKVFLFQLIRSIGCLHLPSV---NVCHRDIKPHNVLVNEAD 168 (360)
T ss_dssp SSCTTCEEEEEEEECCSC-BHHHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHTSTTT---CCBCSCCCGGGEEEETTT
T ss_pred cccccceeEEEEeecccc-cHHHHHHHHhhcccCCCHHHHHHHHHHHHHHHHHHhCCCC---CeecCcCCHHHEEEeCCC
Confidence 2 36899999976 655443321125567899999999999999999999 87 9999999999999996 8
Q ss_pred CcEEEeeeccccccccccccccccccccccCcccCChhhhcccC-cCccccchhhhHHHHHHHhCCCCCCCCccCCCCch
Q 038766 155 FEAHVSDFGTSRMLDVHLQDLSSLSTAFQGTIGYLAPEFAYMRI-VTTKVDVFSFGIVVMEFLTKRRPTGLDEENGLSPI 233 (299)
Q Consensus 155 ~~v~l~df~~~~~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~-~~~~~DiwslG~~l~~l~~g~~p~~~~~~~~~~~~ 233 (299)
+.++|+|||++..... ........+++.|+|||++.+.. ++.++|||||||++|+|++|..||.... ..
T Consensus 169 ~~~kl~Dfg~a~~~~~-----~~~~~~~~gt~~y~aPE~~~~~~~~~~~~Di~slG~il~ell~g~~pf~~~~-----~~ 238 (360)
T 3e3p_A 169 GTLKLCDFGSAKKLSP-----SEPNVAYICSRYYRAPELIFGNQHYTTAVDIWSVGCIFAEMMLGEPIFRGDN-----SA 238 (360)
T ss_dssp TEEEECCCTTCBCCCT-----TSCCCSTTSCGGGCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSSCCSS-----HH
T ss_pred CcEEEeeCCCceecCC-----CCCcccccCCcceeCHHHHcCCCCCCcHHHHHHHHHHHHHHHhCCCCcCCCC-----hH
Confidence 9999999999976542 12223445789999999887654 8999999999999999999999995432 11
Q ss_pred hHHHHHHHHHhcCccC--------cccccCccccchhhHh---HHHHHHHHHHHHHHHHhcCCCCCCCCChhhhhcC
Q 038766 234 SLRQLVEKALANGING--------VRQITDPKLVSSIYEE---QEQHQVLEELFKLALVCTSSNPEDRPNMNELLIT 299 (299)
Q Consensus 234 ~~~~~~~~~~~~~~~~--------~~~~~~~~~~~~~~~~---~~~~~~~~~l~~li~~~l~~dP~~Rpt~~~il~~ 299 (299)
.....+.......... ................ ......+.++.+||.+||..||.+|||+.|+|+|
T Consensus 239 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~h 315 (360)
T 3e3p_A 239 GQLHEIVRVLGCPSREVLRKLNPSHTDVDLYNSKGIPWSNVFSDHSLKDAKEAYDLLSALLQYLPEERMKPYEALCH 315 (360)
T ss_dssp HHHHHHHHHHCCCCHHHHHHHCTTCCCGGGGCCCCCCHHHHTTTCCCTTHHHHHHHHHHHTCSSGGGSCCHHHHTTS
T ss_pred HHHHHHHHHcCCCCHHHHHhcccchhhccccccccCCcccccchhhccccHHHHHHHHHHhccCccccCCHHHHhcC
Confidence 1111111111100000 0000000000000000 0011246789999999999999999999999987
|
| >3poz_A Epidermal growth factor receptor; kinase domain, anti-oncogene, ATP-binding, cell cycle, disea mutation, glycoprotein, membrane, nucleotide-binding; HET: 03P; 1.50A {Homo sapiens} SCOP: d.144.1.7 PDB: 2itx_A* 2ity_A* 2j5f_A* 2j6m_A* 2itw_A* 1m14_A 1m17_A* 3vjo_A* 2gs6_A* 2gs2_A* 2rf9_A 4g5j_A* 1xkk_A* 2eb2_A 3gop_A 2eb3_A* 2itn_A* 2ito_A* 2itp_A* 2itq_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=8.6e-45 Score=309.55 Aligned_cols=252 Identities=24% Similarity=0.423 Sum_probs=193.2
Q ss_pred hCCCCCCceeecCCcceEEEEEeC-CCc----EEEEEEeccCcCChhhhHHHHHHHHHHHhcCCcceeeeeeEEEcCCCe
Q 038766 11 TGSFSENNIIGNSNLSTVYKGRLE-DGE----IVAVKKLNFHQFSAESDKSFYREAKTLKELKHRNLVKVLGYAWESGKL 85 (299)
Q Consensus 11 ~~~y~~~~~lg~g~~~~v~~~~~~-~~~----~~~vK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~ 85 (299)
.++|++.+.||+|+||+||++.+. +++ +||+|.+.. .........+.+|+.++++++||||+++++++... .
T Consensus 14 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~vaiK~~~~-~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~-~- 90 (327)
T 3poz_A 14 ETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELRE-ATSPKANKEILDEAYVMASVDNPHVCRLLGICLTS-T- 90 (327)
T ss_dssp GGGEEEEEEEEEETTEEEEEEEECC----CCEEEEEEEC--------CHHHHHHHHHHHHHCCBTTBCCEEEEEESS-S-
T ss_pred HHHcccceEEeeCCCeEEEEEEEcCCCceEEEEEEEeeccc-ccCHHHHHHHHHHHHHHHhCCCCCEeEEEEEEecC-C-
Confidence 468999999999999999999864 344 368888753 22445567889999999999999999999977653 3
Q ss_pred eEEEEeecCCCChHHHhcCCCCCCCCCChhhHHHHHHHHHHHHHHhhcCCCCCeeeecccCCceeeCCCCcEEEeeeccc
Q 038766 86 KALILEYMENGSLESVIHGPGVDHSRWTLPKRIDVLISVANGLDYLHSGYDIPIVHCDMKPSNILLDRDFEAHVSDFGTS 165 (299)
Q Consensus 86 ~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lh~~~~~~~~H~dl~~~nil~~~~~~v~l~df~~~ 165 (299)
.++|++++.+++|.+++.. ....+++..++.++.|++.||.|||+. +++||||||+||+++.++.+||+|||++
T Consensus 91 ~~~v~e~~~~g~L~~~l~~---~~~~~~~~~~~~~~~qi~~~l~~LH~~---~ivH~Dikp~NIll~~~~~~kl~Dfg~a 164 (327)
T 3poz_A 91 VQLITQLMPFGCLLDYVRE---HKDNIGSQYLLNWCVQIAKGMNYLEDR---RLVHRDLAARNVLVKTPQHVKITDFGLA 164 (327)
T ss_dssp EEEEEECCTTCBHHHHHHH---STTSCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEEEETTEEEECCTTHH
T ss_pred eEEEEEecCCCcHHHHHHh---cCCCCCHHHHHHHHHHHHHHHHHHhhC---CeeCCCCChheEEECCCCCEEEccCcce
Confidence 5799999999999998863 235789999999999999999999999 9999999999999999999999999999
Q ss_pred cccccccccccccccccccCcccCChhhhcccCcCccccchhhhHHHHHHHh-CCCCCCCCccCCCCchhHHHHHHHHHh
Q 038766 166 RMLDVHLQDLSSLSTAFQGTIGYLAPEFAYMRIVTTKVDVFSFGIVVMEFLT-KRRPTGLDEENGLSPISLRQLVEKALA 244 (299)
Q Consensus 166 ~~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~DiwslG~~l~~l~~-g~~p~~~~~~~~~~~~~~~~~~~~~~~ 244 (299)
........ ........+++.|+|||.+.+..++.++||||||+++|+|++ |..||... ....+...+..
T Consensus 165 ~~~~~~~~--~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~-----~~~~~~~~~~~--- 234 (327)
T 3poz_A 165 KLLGAEEK--EYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGI-----PASEISSILEK--- 234 (327)
T ss_dssp HHHTTTCC---------CCCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTC-----CGGGHHHHHHT---
T ss_pred eEccCCcc--cccccCCCccccccChHHhccCCCCchhhhhhhHHHHHHHHhcCCCCccCC-----CHHHHHHHHHc---
Confidence 76542211 111223345778999999999999999999999999999999 99998543 22223222221
Q ss_pred cCccCcccccCccccchhhHhHHHHHHHHHHHHHHHHhcCCCCCCCCChhhhhc
Q 038766 245 NGINGVRQITDPKLVSSIYEEQEQHQVLEELFKLALVCTSSNPEDRPNMNELLI 298 (299)
Q Consensus 245 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rpt~~~il~ 298 (299)
.. .... +...+.++.+++.+||..||++|||++++++
T Consensus 235 -~~----~~~~------------~~~~~~~~~~li~~~l~~~p~~Rps~~ell~ 271 (327)
T 3poz_A 235 -GE----RLPQ------------PPICTIDVYMIMVKCWMIDADSRPKFRELII 271 (327)
T ss_dssp -TC----CCCC------------CTTBCHHHHHHHHHHTCSCGGGSCCHHHHHH
T ss_pred -CC----CCCC------------CccCCHHHHHHHHHHcCCChhhCCCHHHHHH
Confidence 10 0000 1123457899999999999999999999985
|
| >3pls_A Macrophage-stimulating protein receptor; protein kinase, CIS autophosphorylation conformation, recept tyrosine kinase, AMP-PNP, unphosphorylated; HET: ANP; 2.24A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=3.8e-44 Score=301.52 Aligned_cols=255 Identities=25% Similarity=0.394 Sum_probs=199.2
Q ss_pred CCCCCceeecCCcceEEEEEeC-C---CcEEEEEEeccCcCChhhhHHHHHHHHHHHhcCCcceeeeeeEEEcCCCeeEE
Q 038766 13 SFSENNIIGNSNLSTVYKGRLE-D---GEIVAVKKLNFHQFSAESDKSFYREAKTLKELKHRNLVKVLGYAWESGKLKAL 88 (299)
Q Consensus 13 ~y~~~~~lg~g~~~~v~~~~~~-~---~~~~~vK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~l 88 (299)
.|.+.+.||+|+||+||++.+. + +..+|+|++.. .......+.+.+|+..++.++||||+++++++...+...++
T Consensus 22 ~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~-~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~ 100 (298)
T 3pls_A 22 VTHSDRVIGKGHFGVVYHGEYIDQAQNRIQCAIKSLSR-ITEMQQVEAFLREGLLMRGLNHPNVLALIGIMLPPEGLPHV 100 (298)
T ss_dssp EEEEEEEEEEETTEEEEEEEEECSSSCEEEEEEEEETT-CCSHHHHHHHHHHHHHHHTCCCTTBCCCCEEECCSSSCCEE
T ss_pred EEccCceeccCCCceEEEEEEecCCCceeeeeeeeccc-cccHHHHHHHHHHHHHHHhCCCCCeeeEEEEEecCCCCcEE
Confidence 4555689999999999999853 2 33799999863 33445567888999999999999999999988776666689
Q ss_pred EEeecCCCChHHHhcCCCCCCCCCChhhHHHHHHHHHHHHHHhhcCCCCCeeeecccCCceeeCCCCcEEEeeecccccc
Q 038766 89 ILEYMENGSLESVIHGPGVDHSRWTLPKRIDVLISVANGLDYLHSGYDIPIVHCDMKPSNILLDRDFEAHVSDFGTSRML 168 (299)
Q Consensus 89 v~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lh~~~~~~~~H~dl~~~nil~~~~~~v~l~df~~~~~~ 168 (299)
|+|++.+++|.+++.. ....+++..++.++.|++.||+|||+. +++|+||||+||+++.++.++|+|||++...
T Consensus 101 v~e~~~~~~L~~~~~~---~~~~~~~~~~~~i~~qi~~~l~~LH~~---~i~H~dikp~Nili~~~~~~kl~Dfg~~~~~ 174 (298)
T 3pls_A 101 LLPYMCHGDLLQFIRS---PQRNPTVKDLISFGLQVARGMEYLAEQ---KFVHRDLAARNCMLDESFTVKVADFGLARDI 174 (298)
T ss_dssp EECCCTTCBHHHHHHC---TTCCCBHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEECTTCCEEECCTTSSCTT
T ss_pred EEecccCCCHHHHHhc---cccCCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCCcceEEEcCCCcEEeCcCCCcccc
Confidence 9999999999999874 245789999999999999999999999 9999999999999999999999999999765
Q ss_pred ccccccccccccccccCcccCChhhhcccCcCccccchhhhHHHHHHHhCCCCCCCCccCCCCchhHHHHHHHHHhcCcc
Q 038766 169 DVHLQDLSSLSTAFQGTIGYLAPEFAYMRIVTTKVDVFSFGIVVMEFLTKRRPTGLDEENGLSPISLRQLVEKALANGIN 248 (299)
Q Consensus 169 ~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~DiwslG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 248 (299)
...............+++.|+|||.+.+..++.++||||||+++|+|++|..|+... .........+.. ..
T Consensus 175 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~~~~~~----~~~~~~~~~~~~---~~-- 245 (298)
T 3pls_A 175 LDREYYSVQQHRHARLPVKWTALESLQTYRFTTKSDVWSFGVLLWELLTRGAPPYRH----IDPFDLTHFLAQ---GR-- 245 (298)
T ss_dssp TTGGGGCSCCSSCTTCGGGGSCHHHHTTCCCCHHHHHHHHHHHHHHHHHTSCCTTTT----SCGGGHHHHHHT---TC--
T ss_pred cCCcccccccCcCCCCCccccChhhhccCCCChhhchhhHHHHHHHHhhCCCCCCcc----CCHHHHHHHhhc---CC--
Confidence 432222223334456788999999999999999999999999999999966664322 122222222211 10
Q ss_pred CcccccCccccchhhHhHHHHHHHHHHHHHHHHhcCCCCCCCCChhhhhc
Q 038766 249 GVRQITDPKLVSSIYEEQEQHQVLEELFKLALVCTSSNPEDRPNMNELLI 298 (299)
Q Consensus 249 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rpt~~~il~ 298 (299)
.... +..++..+.+++.+||..||.+|||++++++
T Consensus 246 ---~~~~------------~~~~~~~l~~li~~~l~~~p~~Rps~~~ll~ 280 (298)
T 3pls_A 246 ---RLPQ------------PEYCPDSLYQVMQQCWEADPAVRPTFRVLVG 280 (298)
T ss_dssp ---CCCC------------CTTCCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred ---CCCC------------CccchHHHHHHHHHHccCChhhCcCHHHHHH
Confidence 0000 1123457999999999999999999999875
|
| >3kex_A Receptor tyrosine-protein kinase ERBB-3; kinase domain, inactive kinase, HER3, ATP-binding, cell membrane, membrane, nucleotide-binding; HET: ANP; 2.80A {Homo sapiens} PDB: 3lmg_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7.9e-45 Score=309.55 Aligned_cols=253 Identities=22% Similarity=0.333 Sum_probs=195.5
Q ss_pred hCCCCCCceeecCCcceEEEEEeC-CCcE----EEEEEeccCcCChhhhHHHHHHHHHHHhcCCcceeeeeeEEEcCCCe
Q 038766 11 TGSFSENNIIGNSNLSTVYKGRLE-DGEI----VAVKKLNFHQFSAESDKSFYREAKTLKELKHRNLVKVLGYAWESGKL 85 (299)
Q Consensus 11 ~~~y~~~~~lg~g~~~~v~~~~~~-~~~~----~~vK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~ 85 (299)
.++|++.+.||+|+||+||+|.+. +++. +++|++... ........+.+|+..++.++||||+++++++. +..
T Consensus 12 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~kv~~K~~~~~-~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~--~~~ 88 (325)
T 3kex_A 12 ETELRKLKVLGSGVFGTVHKGVWIPEGESIKIPVCIKVIEDK-SGRQSFQAVTDHMLAIGSLDHAHIVRLLGLCP--GSS 88 (325)
T ss_dssp TTTEEEEEEEECCSSCEEEEEEECCTTCSCCEEEEEEEECCT-TSCSCBCSCCHHHHHHHTCCCTTBCCEEEEEC--BSS
T ss_pred HhHceeeeeeeecCCceEEEEEEcCCCceEEEEEEEEecccc-ccHHHHHHHHHHHHHHhcCCCCCcCeEEEEEc--CCc
Confidence 468999999999999999999864 3443 788877532 23334556778999999999999999999653 344
Q ss_pred eEEEEeecCCCChHHHhcCCCCCCCCCChhhHHHHHHHHHHHHHHhhcCCCCCeeeecccCCceeeCCCCcEEEeeeccc
Q 038766 86 KALILEYMENGSLESVIHGPGVDHSRWTLPKRIDVLISVANGLDYLHSGYDIPIVHCDMKPSNILLDRDFEAHVSDFGTS 165 (299)
Q Consensus 86 ~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lh~~~~~~~~H~dl~~~nil~~~~~~v~l~df~~~ 165 (299)
.++|+||+.+++|.+++.. ....+++..++.++.|++.||.|||+. +++|+||||+||+++.++.++|+|||++
T Consensus 89 ~~~v~e~~~~~~L~~~l~~---~~~~~~~~~~~~~~~qi~~~l~~lH~~---~ivH~Dikp~Nil~~~~~~~kl~Dfg~a 162 (325)
T 3kex_A 89 LQLVTQYLPLGSLLDHVRQ---HRGALGPQLLLNWGVQIAKGMYYLEEH---GMVHRNLAARNVLLKSPSQVQVADFGVA 162 (325)
T ss_dssp EEEEEECCTTCBSHHHHHS---SGGGSCTTHHHHHHHHHHHHHHHHHHT---TCCCSCCSSTTEEESSSSCEEECSCSGG
T ss_pred cEEEEEeCCCCCHHHHHHH---ccccCCHHHHHHHHHHHHHHHHHHHhC---CCCCCccchheEEECCCCeEEECCCCcc
Confidence 6899999999999998863 235799999999999999999999999 9999999999999999999999999999
Q ss_pred cccccccccccccccccccCcccCChhhhcccCcCccccchhhhHHHHHHHh-CCCCCCCCccCCCCchhHHHHHHHHHh
Q 038766 166 RMLDVHLQDLSSLSTAFQGTIGYLAPEFAYMRIVTTKVDVFSFGIVVMEFLT-KRRPTGLDEENGLSPISLRQLVEKALA 244 (299)
Q Consensus 166 ~~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~DiwslG~~l~~l~~-g~~p~~~~~~~~~~~~~~~~~~~~~~~ 244 (299)
....... .........++..|+|||.+.+..++.++||||||+++|+|++ |..||.... ...+...+..
T Consensus 163 ~~~~~~~--~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~-----~~~~~~~~~~--- 232 (325)
T 3kex_A 163 DLLPPDD--KQLLYSEAKTPIKWMALESIHFGKYTHQSDVWSYGVTVWELMTFGAEPYAGLR-----LAEVPDLLEK--- 232 (325)
T ss_dssp GGSCCCT--TCCC-----CCTTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTSC-----TTHHHHHHHT---
T ss_pred cccCccc--ccccccCCCCcccccChHHhccCCCChhhHhHHhHHHHHHHHhCCCCCccccC-----HHHHHHHHHc---
Confidence 8654221 1122344556789999999999999999999999999999999 999996432 2222222211
Q ss_pred cCccCcccccCccccchhhHhHHHHHHHHHHHHHHHHhcCCCCCCCCChhhhhcC
Q 038766 245 NGINGVRQITDPKLVSSIYEEQEQHQVLEELFKLALVCTSSNPEDRPNMNELLIT 299 (299)
Q Consensus 245 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rpt~~~il~~ 299 (299)
.. .... +...+.++.+++.+||..||++|||+++++++
T Consensus 233 ~~-----~~~~------------~~~~~~~~~~li~~~l~~dp~~Rps~~el~~~ 270 (325)
T 3kex_A 233 GE-----RLAQ------------PQICTIDVYMVMVKCWMIDENIRPTFKELANE 270 (325)
T ss_dssp TC-----BCCC------------CTTBCTTTTHHHHHHTCSCTTTSCCHHHHHHH
T ss_pred CC-----CCCC------------CCcCcHHHHHHHHHHcCCChhhCcCHHHHHHH
Confidence 10 0001 11123468889999999999999999999863
|
| >2eva_A TAK1 kinase - TAB1 chimera fusion protein; transferase/transferase activator complex; HET: ADN; 2.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=8.7e-44 Score=300.73 Aligned_cols=249 Identities=27% Similarity=0.431 Sum_probs=190.9
Q ss_pred hCCCCCCceeecCCcceEEEEEeCCCcEEEEEEeccCcCChhhhHHHHHHHHHHHhcCCcceeeeeeEEEcCCCeeEEEE
Q 038766 11 TGSFSENNIIGNSNLSTVYKGRLEDGEIVAVKKLNFHQFSAESDKSFYREAKTLKELKHRNLVKVLGYAWESGKLKALIL 90 (299)
Q Consensus 11 ~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~vK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~lv~ 90 (299)
.++|.+.+.||+|+||+||++.+. ++.||+|++.. ....+.+.+|+..+++++||||+++++++.. ..++|+
T Consensus 7 ~~~~~~~~~lg~G~~g~V~~~~~~-~~~vavK~~~~----~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~---~~~lv~ 78 (307)
T 2eva_A 7 YKEIEVEEVVGRGAFGVVCKAKWR-AKDVAIKQIES----ESERKAFIVELRQLSRVNHPNIVKLYGACLN---PVCLVM 78 (307)
T ss_dssp GGGEEEEEEEECCSSSEEEEEEET-TEEEEEEECSS----TTHHHHHHHHHHHHHHCCCTTBCCEEEBCTT---TTEEEE
T ss_pred HhHeeeeeEeecCCCceEEEEEEC-CeeEEEEEecC----hhHHHHHHHHHHHHhcCCCCCcCeEEEEEcC---CcEEEE
Confidence 468999999999999999999885 78899999852 3456778899999999999999999996542 358999
Q ss_pred eecCCCChHHHhcCCCCCCCCCChhhHHHHHHHHHHHHHHhhcCCCCCeeeecccCCceeeCCCCc-EEEeeeccccccc
Q 038766 91 EYMENGSLESVIHGPGVDHSRWTLPKRIDVLISVANGLDYLHSGYDIPIVHCDMKPSNILLDRDFE-AHVSDFGTSRMLD 169 (299)
Q Consensus 91 e~~~~~~L~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lh~~~~~~~~H~dl~~~nil~~~~~~-v~l~df~~~~~~~ 169 (299)
||+.+++|.+++.... ....+++..++.++.|+++||+|||+.+..+++|+||||+||+++.++. +||+|||++....
T Consensus 79 e~~~~~~L~~~l~~~~-~~~~~~~~~~~~~~~qi~~~l~~LH~~~~~~ivH~dlkp~NIll~~~~~~~kl~Dfg~~~~~~ 157 (307)
T 2eva_A 79 EYAEGGSLYNVLHGAE-PLPYYTAAHAMSWCLQCSQGVAYLHSMQPKALIHRDLKPPNLLLVAGGTVLKICDFGTACDIQ 157 (307)
T ss_dssp ECCTTCBHHHHHHCSS-SEECCCHHHHHHHHHHHHHHHHHHHTCSSSCCCCCCCSGGGEEEETTTTEEEECCCCC-----
T ss_pred EcCCCCCHHHHHhccC-CCCccCHHHHHHHHHHHHHHHHHHHhCCCCCeecCCCChhHEEEeCCCCEEEEcccccccccc
Confidence 9999999999997432 2235788999999999999999999921129999999999999998886 7999999987543
Q ss_pred cccccccccccccccCcccCChhhhcccCcCccccchhhhHHHHHHHhCCCCCCCCccCCCCchhHHHHHHHHHhcCccC
Q 038766 170 VHLQDLSSLSTAFQGTIGYLAPEFAYMRIVTTKVDVFSFGIVVMEFLTKRRPTGLDEENGLSPISLRQLVEKALANGING 249 (299)
Q Consensus 170 ~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~DiwslG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 249 (299)
. ......+++.|+|||.+.+..++.++||||||+++|+|++|..||...... ...............
T Consensus 158 ~-------~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~------~~~~~~~~~~~~~~~ 224 (307)
T 2eva_A 158 T-------HMTNNKGSAAWMAPEVFEGSNYSEKCDVFSWGIILWEVITRRKPFDEIGGP------AFRIMWAVHNGTRPP 224 (307)
T ss_dssp --------------CCTTSSCHHHHTCCCCCTHHHHHHHHHHHHHHHHTCCTTTTTCSS------HHHHHHHHHTTCCCC
T ss_pred c-------ccccCCCCCceEChhhhCCCCCCcHHHHHHHHHHHHHHHHCCCCchhhCcc------HHHHHHHHhcCCCCC
Confidence 1 123345789999999999999999999999999999999999999533211 111111111111000
Q ss_pred cccccCccccchhhHhHHHHHHHHHHHHHHHHhcCCCCCCCCChhhhhc
Q 038766 250 VRQITDPKLVSSIYEEQEQHQVLEELFKLALVCTSSNPEDRPNMNELLI 298 (299)
Q Consensus 250 ~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rpt~~~il~ 298 (299)
. ...++..+.+++.+||..||++|||++++++
T Consensus 225 --------~---------~~~~~~~l~~li~~~l~~dp~~Rps~~ell~ 256 (307)
T 2eva_A 225 --------L---------IKNLPKPIESLMTRCWSKDPSQRPSMEEIVK 256 (307)
T ss_dssp --------C---------BTTCCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred --------c---------ccccCHHHHHHHHHHhcCChhhCcCHHHHHH
Confidence 0 1123457899999999999999999999985
|
| >3cc6_A Protein tyrosine kinase 2 beta; focal adhesion kinase, structural genomics, structural genom consortium, SGC, ATP-binding, membrane; 1.60A {Homo sapiens} PDB: 3fzs_A* 3et7_A 3fzo_A* 3fzr_A* 3fzp_A* 3fzt_A* 3h3c_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.2e-44 Score=300.61 Aligned_cols=256 Identities=24% Similarity=0.344 Sum_probs=199.2
Q ss_pred HHHHhCCCCCCceeecCCcceEEEEEeCC----CcEEEEEEeccCcCChhhhHHHHHHHHHHHhcCCcceeeeeeEEEcC
Q 038766 7 IENATGSFSENNIIGNSNLSTVYKGRLED----GEIVAVKKLNFHQFSAESDKSFYREAKTLKELKHRNLVKVLGYAWES 82 (299)
Q Consensus 7 ~~~~~~~y~~~~~lg~g~~~~v~~~~~~~----~~~~~vK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~ 82 (299)
+....++|.+.+.||+|++|+||++.+.+ +..||+|++... ......+.+.+|+..++.++||||+++++++. .
T Consensus 7 ~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~-~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~-~ 84 (281)
T 3cc6_A 7 YGIAREDVVLNRILGEGFFGEVYEGVYTNHKGEKINVAVKTCKKD-CTLDNKEKFMSEAVIMKNLDHPHIVKLIGIIE-E 84 (281)
T ss_dssp CSCCGGGEEEEEEEEECSSSEEEEEEEECTTCCEEEEEEEECCTT-SCHHHHHHHHHHHHHHHHHCCTTBCCEEEEEC-S
T ss_pred ceecccceEEEEEEEecCCeeEEEeEEcCCCCCcceEEEEecccc-cCchHHHHHHHHHHHHHhCCCCCcceEEEEEc-C
Confidence 34557889999999999999999997532 346999998643 24455678899999999999999999999654 3
Q ss_pred CCeeEEEEeecCCCChHHHhcCCCCCCCCCChhhHHHHHHHHHHHHHHhhcCCCCCeeeecccCCceeeCCCCcEEEeee
Q 038766 83 GKLKALILEYMENGSLESVIHGPGVDHSRWTLPKRIDVLISVANGLDYLHSGYDIPIVHCDMKPSNILLDRDFEAHVSDF 162 (299)
Q Consensus 83 ~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lh~~~~~~~~H~dl~~~nil~~~~~~v~l~df 162 (299)
+. .++|+|++.+++|.+++.. ....+++..++.++.|++.||.|||++ +++|+||||+||+++.++.++|+||
T Consensus 85 ~~-~~~v~e~~~~~~L~~~l~~---~~~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dlkp~Nil~~~~~~~kl~Df 157 (281)
T 3cc6_A 85 EP-TWIIMELYPYGELGHYLER---NKNSLKVLTLVLYSLQICKAMAYLESI---NCVHRDIAVRNILVASPECVKLGDF 157 (281)
T ss_dssp SS-CEEEEECCTTCBHHHHHHH---HTTTCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCSGGGEEEEETTEEEECCC
T ss_pred CC-CEEEEecCCCCCHHHHHHh---ccccCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCccceEEECCCCcEEeCcc
Confidence 33 4899999999999999863 234689999999999999999999999 9999999999999999999999999
Q ss_pred ccccccccccccccccccccccCcccCChhhhcccCcCccccchhhhHHHHHHHh-CCCCCCCCccCCCCchhHHHHHHH
Q 038766 163 GTSRMLDVHLQDLSSLSTAFQGTIGYLAPEFAYMRIVTTKVDVFSFGIVVMEFLT-KRRPTGLDEENGLSPISLRQLVEK 241 (299)
Q Consensus 163 ~~~~~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~DiwslG~~l~~l~~-g~~p~~~~~~~~~~~~~~~~~~~~ 241 (299)
|++...... .........+++.|+|||.+.+..++.++||||||+++|+|++ |..||.... .......+..
T Consensus 158 g~~~~~~~~---~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~llt~g~~p~~~~~-----~~~~~~~~~~ 229 (281)
T 3cc6_A 158 GLSRYIEDE---DYYKASVTRLPIKWMSPESINFRRFTTASDVWMFAVCMWEILSFGKQPFFWLE-----NKDVIGVLEK 229 (281)
T ss_dssp CGGGCC------------CCCCCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCTTTTSC-----GGGHHHHHHH
T ss_pred CCCcccccc---cccccccCCCCcceeCchhhccCCCCchhccHHHHHHHHHHHhCCCCCcccCC-----hHHHHHHHhc
Confidence 998765421 1112233445778999999998899999999999999999998 999985332 2222222211
Q ss_pred HHhcCccCcccccCccccchhhHhHHHHHHHHHHHHHHHHhcCCCCCCCCChhhhhcC
Q 038766 242 ALANGINGVRQITDPKLVSSIYEEQEQHQVLEELFKLALVCTSSNPEDRPNMNELLIT 299 (299)
Q Consensus 242 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rpt~~~il~~ 299 (299)
... ... +..++..+.++|.+||..||++|||+++++++
T Consensus 230 ---~~~-----~~~------------~~~~~~~l~~li~~~l~~~p~~Rps~~ell~~ 267 (281)
T 3cc6_A 230 ---GDR-----LPK------------PDLCPPVLYTLMTRCWDYDPSDRPRFTELVCS 267 (281)
T ss_dssp ---TCC-----CCC------------CTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred ---CCC-----CCC------------CCCCCHHHHHHHHHHccCCchhCcCHHHHHHH
Confidence 110 000 11234679999999999999999999999863
|
| >3pfq_A PKC-B, PKC-beta, protein kinase C beta type; phosphorylation, transferase; HET: TPO SEP ANP; 4.00A {Rattus norvegicus} PDB: 1tbn_A 1tbo_A 2e73_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2.2e-44 Score=333.11 Aligned_cols=253 Identities=20% Similarity=0.287 Sum_probs=204.4
Q ss_pred HHhCCCCCCceeecCCcceEEEEEeC-CCcEEEEEEeccCcC-ChhhhHHHHHHHHHHHhc-CCcceeeeeeEEEcCCCe
Q 038766 9 NATGSFSENNIIGNSNLSTVYKGRLE-DGEIVAVKKLNFHQF-SAESDKSFYREAKTLKEL-KHRNLVKVLGYAWESGKL 85 (299)
Q Consensus 9 ~~~~~y~~~~~lg~g~~~~v~~~~~~-~~~~~~vK~~~~~~~-~~~~~~~~~~e~~~l~~l-~h~~i~~~~~~~~~~~~~ 85 (299)
.-.++|.+.+.||+|+||.||++.+. +++.||+|++..... ..........|..++..+ .||+|+++++++ .....
T Consensus 338 ~~~~~f~~~~~LG~G~fG~V~~~~~~~~~~~vAvK~l~~~~~~~~~~~~~~~~E~~~l~~~~~~~~i~~l~~~~-~~~~~ 416 (674)
T 3pfq_A 338 MKLTDFNFLMVLGKGSFGKVMLSERKGTDELYAVKILKKDVVIQDDDVECTMVEKRVLALPGKPPFLTQLHSCF-QTMDR 416 (674)
T ss_dssp --CTTEEEEEESSBTTTBCEEEEEESSSCCEEEEEEEEHHHHHHTTTTHHHHHHHHHHTCTTCCTTBCCEEEEC-BCSSE
T ss_pred ccccceEEEEEEccCCCEEEEEEEECCCCcEEEEEEEeccccccHHHHHHHHHHHHHHHhccCCCeEEEEEEEE-EeCCE
Confidence 34578999999999999999999875 588999999864321 233456778899999888 599999999955 44566
Q ss_pred eEEEEeecCCCChHHHhcCCCCCCCCCChhhHHHHHHHHHHHHHHhhcCCCCCeeeecccCCceeeCCCCcEEEeeeccc
Q 038766 86 KALILEYMENGSLESVIHGPGVDHSRWTLPKRIDVLISVANGLDYLHSGYDIPIVHCDMKPSNILLDRDFEAHVSDFGTS 165 (299)
Q Consensus 86 ~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lh~~~~~~~~H~dl~~~nil~~~~~~v~l~df~~~ 165 (299)
+++||||+.+++|..++. ....+++..++.++.||+.||+|||+. +++||||||+|||++.+|.+||+|||++
T Consensus 417 ~~lV~E~~~gg~L~~~l~----~~~~~~~~~~~~~~~qi~~aL~~LH~~---gIiHrDLKp~NILl~~~g~ikL~DFGla 489 (674)
T 3pfq_A 417 LYFVMEYVNGGDLMYHIQ----QVGRFKEPHAVFYAAEIAIGLFFLQSK---GIIYRDLKLDNVMLDSEGHIKIADFGMC 489 (674)
T ss_dssp EEEEEECCCSCBHHHHHH----HHSSCCHHHHHHHHHHHHHHHHHHHHT---SEECCCCCSTTEEECSSSCEEECCCTTC
T ss_pred EEEEEeCcCCCcHHHHHH----hcCCCCHHHHHHHHHHHHHHHHHHHhC---CeEeccCChhhEEEcCCCcEEEeeccee
Confidence 799999999999999997 445799999999999999999999999 9999999999999999999999999998
Q ss_pred cccccccccccccccccccCcccCChhhhcccCcCccccchhhhHHHHHHHhCCCCCCCCccCCCCchhHHHHHHHHHhc
Q 038766 166 RMLDVHLQDLSSLSTAFQGTIGYLAPEFAYMRIVTTKVDVFSFGIVVMEFLTKRRPTGLDEENGLSPISLRQLVEKALAN 245 (299)
Q Consensus 166 ~~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~DiwslG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~ 245 (299)
..... .........+|+.|+|||++.+..++.++|+||||+++|+|++|..||.... . .+.+..+...
T Consensus 490 ~~~~~----~~~~~~~~~GT~~Y~APE~l~~~~~~~~~DvwSlGvilyelltG~~Pf~~~~-----~---~~~~~~i~~~ 557 (674)
T 3pfq_A 490 KENIW----DGVTTKTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQAPFEGED-----E---DELFQSIMEH 557 (674)
T ss_dssp EECCC----TTCCBCCCCSCSSSCCHHHHTCCCBSTHHHHHHHHHHHHHHHHSSCSSCCSS-----H---HHHHHHHHSS
T ss_pred ecccc----CCcccccccCCCcccCHhhhcCCCCCccceEechHHHHHHHHcCCCCCCCCC-----H---HHHHHHHHhC
Confidence 74321 1223445678999999999999999999999999999999999999995432 1 2223222221
Q ss_pred CccCcccccCccccchhhHhHHHHHHHHHHHHHHHHhcCCCCCCCCCh-----hhhhcC
Q 038766 246 GINGVRQITDPKLVSSIYEEQEQHQVLEELFKLALVCTSSNPEDRPNM-----NELLIT 299 (299)
Q Consensus 246 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rpt~-----~~il~~ 299 (299)
.. . . +..++.++.+||++||..||++||++ ++|++|
T Consensus 558 ~~-~-----~------------p~~~s~~~~~li~~lL~~dP~~R~~~~~~~~~ei~~h 598 (674)
T 3pfq_A 558 NV-A-----Y------------PKSMSKEAVAICKGLMTKHPGKRLGCGPEGERDIKEH 598 (674)
T ss_dssp CC-C-----C------------CTTSCHHHHHHHHHHSCSSSTTCTTCSTTHHHHHHSS
T ss_pred CC-C-----C------------CccCCHHHHHHHHHHccCCHHHCCCCCCCcHHHHhcC
Confidence 10 0 0 12345789999999999999999998 889876
|
| >2b9h_A MAP kinase FUS3, mitogen-activated protein kinase FUS3; transferase; HET: ADP; 1.55A {Saccharomyces cerevisiae} PDB: 2b9i_A* 2b9j_A* 2f49_A 2fa2_A 2b9f_A* 2f9g_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.2e-44 Score=307.37 Aligned_cols=276 Identities=24% Similarity=0.285 Sum_probs=202.8
Q ss_pred HHhCCCCCCceeecCCcceEEEEEeC-CCcEEEEEEeccCcCChhhhHHHHHHHHHHHhcCCcceeeeeeEEEcC----C
Q 038766 9 NATGSFSENNIIGNSNLSTVYKGRLE-DGEIVAVKKLNFHQFSAESDKSFYREAKTLKELKHRNLVKVLGYAWES----G 83 (299)
Q Consensus 9 ~~~~~y~~~~~lg~g~~~~v~~~~~~-~~~~~~vK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~----~ 83 (299)
.+.++|.+.+.||+|+||.||++.+. +|+.||||++.. .........+.+|+.+++.++||||+++++++... .
T Consensus 8 ~i~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~-~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~ 86 (353)
T 2b9h_A 8 NISSDFQLKSLLGEGAYGVVCSATHKPTGEIVAIKKIEP-FDKPLFALRTLREIKILKHFKHENIITIFNIQRPDSFENF 86 (353)
T ss_dssp CSCTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECC-CSSHHHHHHHHHHHHHHHHCCCTTBCCEEEECCCSCSTTC
T ss_pred ccccceEEeeEEcCCCCeEEEEEEECCCCcEEEEEeecc-cccchHHHHHHHHHHHHHhCcCCCcCCeeeeecccccCcc
Confidence 46789999999999999999999875 689999999863 23445566788999999999999999999966543 2
Q ss_pred CeeEEEEeecCCCChHHHhcCCCCCCCCCChhhHHHHHHHHHHHHHHhhcCCCCCeeeecccCCceeeCCCCcEEEeeec
Q 038766 84 KLKALILEYMENGSLESVIHGPGVDHSRWTLPKRIDVLISVANGLDYLHSGYDIPIVHCDMKPSNILLDRDFEAHVSDFG 163 (299)
Q Consensus 84 ~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lh~~~~~~~~H~dl~~~nil~~~~~~v~l~df~ 163 (299)
...++|+|++. ++|.+++.. ..+++..++.++.|++.||+|||++ +++|+||||+||+++.++.++|+|||
T Consensus 87 ~~~~lv~e~~~-~~L~~~~~~-----~~~~~~~~~~~~~qi~~~L~~LH~~---~ivH~Dlkp~Nil~~~~~~~kl~Dfg 157 (353)
T 2b9h_A 87 NEVYIIQELMQ-TDLHRVIST-----QMLSDDHIQYFIYQTLRAVKVLHGS---NVIHRDLKPSNLLINSNCDLKVCDFG 157 (353)
T ss_dssp CCEEEEECCCS-EEHHHHHHH-----CCCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCCGGGEEECTTCCEEECCCT
T ss_pred ceEEEEEeccC-ccHHHHHhh-----cCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHeEEcCCCcEEEEecc
Confidence 56799999996 589998852 4689999999999999999999999 99999999999999999999999999
Q ss_pred cccccccccccccc------cccccccCcccCChhhhcc-cCcCccccchhhhHHHHHHHhCCCCCCCCccCCCCchhHH
Q 038766 164 TSRMLDVHLQDLSS------LSTAFQGTIGYLAPEFAYM-RIVTTKVDVFSFGIVVMEFLTKRRPTGLDEENGLSPISLR 236 (299)
Q Consensus 164 ~~~~~~~~~~~~~~------~~~~~~~~~~y~~PE~~~~-~~~~~~~DiwslG~~l~~l~~g~~p~~~~~~~~~~~~~~~ 236 (299)
++............ ......+++.|+|||++.. ..++.++|||||||++|+|++|..||..... ....
T Consensus 158 ~a~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~-----~~~~ 232 (353)
T 2b9h_A 158 LARIIDESAADNSEPTGQQSGMVEFVATRWYRAPEVMLTSAKYSRAMDVWSCGCILAELFLRRPIFPGRDY-----RHQL 232 (353)
T ss_dssp TCEECC----------------CCCCCCGGGCCHHHHHSCCCCCHHHHHHHHHHHHHHHHHSSCSCCCSSH-----HHHH
T ss_pred cccccccccccccCccccccchhhccccccccCCeeeccCCCccchhhHHHHHHHHHHHHhCCCCCCCCCc-----HHHH
Confidence 99865422111110 1223467899999998764 6789999999999999999999999964321 1111
Q ss_pred HHHHHHHhcCc-c-CcccccCccccc---------hhhHhHHHHHHHHHHHHHHHHhcCCCCCCCCChhhhhcC
Q 038766 237 QLVEKALANGI-N-GVRQITDPKLVS---------SIYEEQEQHQVLEELFKLALVCTSSNPEDRPNMNELLIT 299 (299)
Q Consensus 237 ~~~~~~~~~~~-~-~~~~~~~~~~~~---------~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rpt~~~il~~ 299 (299)
..+........ . ....+....... ..........++.++.+||.+||..||++|||++++|+|
T Consensus 233 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~h 306 (353)
T 2b9h_A 233 LLIFGIIGTPHSDNDLRCIESPRAREYIKSLPMYPAAPLEKMFPRVNPKGIDLLQRMLVFDPAKRITAKEALEH 306 (353)
T ss_dssp HHHHHHHCCCCSTTTTTTCCCHHHHHHHHTSCCCCCCCHHHHSTTSCHHHHHHHHHHSCSSGGGSCCHHHHHTS
T ss_pred HHHHHHhCCCchhccccccccchhhHHhhcccCCCCcchhhhcccCCHHHHHHHHHhcCcCcccCCCHHHHhcC
Confidence 11111111000 0 000000000000 000011123456789999999999999999999999987
|
| >2v62_A Serine/threonine-protein kinase VRK2; transferase, ATP-binding, membrane, nucleotide-binding, TRAN; 1.7A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=8.5e-45 Score=311.80 Aligned_cols=266 Identities=15% Similarity=0.193 Sum_probs=195.0
Q ss_pred HhCCCCCCceeecCCcceEEEEEeC----CCcEEEEEEeccCcCChh---------hhHHHHHHHHHHHhcCCcceeeee
Q 038766 10 ATGSFSENNIIGNSNLSTVYKGRLE----DGEIVAVKKLNFHQFSAE---------SDKSFYREAKTLKELKHRNLVKVL 76 (299)
Q Consensus 10 ~~~~y~~~~~lg~g~~~~v~~~~~~----~~~~~~vK~~~~~~~~~~---------~~~~~~~e~~~l~~l~h~~i~~~~ 76 (299)
..++|.+.+.||+|+||+||+|.+. ++..+|+|++........ ....+.+|+..++.++||||++++
T Consensus 35 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~~~~~e~~~~~~~~~~~~~~e~~~~~~l~h~ni~~~~ 114 (345)
T 2v62_A 35 EGNQWVLGKKIGSGGFGLIYLAFPTNKPEKDARHVVKVEYQENGPLFSELKFYQRVAKKDCIKKWIERKQLDYLGIPLFY 114 (345)
T ss_dssp TSCEEEEEEEC------CEEEEEESSSCGGGCCEEEEEEECC-CHHHHHHHHHHHHCCHHHHHHHHHHHTCSCCCCCCEE
T ss_pred cCceEEEEeeEeecCCeEEEEEEecCCCCccceEEEEeeecCCcchHHHHHHHHHHhhhHHHHHHHhhccccccCcceee
Confidence 3468999999999999999999874 578899999874432111 123356788889999999999999
Q ss_pred eEEEcC---CCeeEEEEeecCCCChHHHhcCCCCCCCCCChhhHHHHHHHHHHHHHHhhcCCCCCeeeecccCCceeeCC
Q 038766 77 GYAWES---GKLKALILEYMENGSLESVIHGPGVDHSRWTLPKRIDVLISVANGLDYLHSGYDIPIVHCDMKPSNILLDR 153 (299)
Q Consensus 77 ~~~~~~---~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lh~~~~~~~~H~dl~~~nil~~~ 153 (299)
+++... +...++|+|++ +++|.+++. ....+++.+++.++.||+.||+|||++ +++|+||||+||+++.
T Consensus 115 ~~~~~~~~~~~~~~lv~e~~-~~~L~~~l~----~~~~~~~~~~~~i~~qi~~aL~~LH~~---~ivH~Dlkp~NIll~~ 186 (345)
T 2v62_A 115 GSGLTEFKGRSYRFMVMERL-GIDLQKISG----QNGTFKKSTVLQLGIRMLDVLEYIHEN---EYVHGDIKAANLLLGY 186 (345)
T ss_dssp EEEEEESSSCEEEEEEEECE-EEEHHHHCB----GGGBCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEEES
T ss_pred cccccccCCCcEEEEEEecc-CCCHHHHHH----hcCCCCHHHHHHHHHHHHHHHHHHHhC---CeeCCCcCHHHEEEcc
Confidence 987663 56679999999 889999997 344899999999999999999999999 9999999999999988
Q ss_pred CC--cEEEeeecccccccccccc---ccccccccccCcccCChhhhcccCcCccccchhhhHHHHHHHhCCCCCCCCccC
Q 038766 154 DF--EAHVSDFGTSRMLDVHLQD---LSSLSTAFQGTIGYLAPEFAYMRIVTTKVDVFSFGIVVMEFLTKRRPTGLDEEN 228 (299)
Q Consensus 154 ~~--~v~l~df~~~~~~~~~~~~---~~~~~~~~~~~~~y~~PE~~~~~~~~~~~DiwslG~~l~~l~~g~~p~~~~~~~ 228 (299)
++ .++|+|||++..+...... .........+++.|+|||++.+..++.++|||||||++|+|++|..||.....
T Consensus 187 ~~~~~~kL~Dfg~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~ell~g~~pf~~~~~- 265 (345)
T 2v62_A 187 KNPDQVYLADYGLSYRYCPNGNHKQYQENPRKGHNGTIEFTSLDAHKGVALSRRSDVEILGYCMLRWLCGKLPWEQNLK- 265 (345)
T ss_dssp SSTTSEEECCCTTCEESSGGGCCCCCCCCGGGCSCSCTTTCCHHHHHTCCCCHHHHHHHHHHHHHHHHHSSCTTGGGTT-
T ss_pred CCCCcEEEEeCCCceecccccccccchhccccccCCCccccCHHHhcCCCCCchhhHHHHHHHHHHHHhCCCCcccccc-
Confidence 77 9999999999765432111 11122455689999999999999999999999999999999999999953211
Q ss_pred CCCchhHHHHHHHHHhcCccCcccccCccccchhhHhHHHHHHHHHHHHHHHHhcCCCCCCCCChhhhhc
Q 038766 229 GLSPISLRQLVEKALANGINGVRQITDPKLVSSIYEEQEQHQVLEELFKLALVCTSSNPEDRPNMNELLI 298 (299)
Q Consensus 229 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rpt~~~il~ 298 (299)
...................... ......++.++.++|.+||..||++|||++++++
T Consensus 266 --~~~~~~~~~~~~~~~~~~~~~~------------~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~ 321 (345)
T 2v62_A 266 --DPVAVQTAKTNLLDELPQSVLK------------WAPSGSSCCEIAQFLVCAHSLAYDEKPNYQALKK 321 (345)
T ss_dssp --CHHHHHHHHHHHHHTTTHHHHH------------HSCTTSCCHHHHHHHHHHHTCCTTCCCCHHHHHH
T ss_pred --ccHHHHHHHHhhcccccHHHHh------------hccccccHHHHHHHHHHHhhcCcccCCCHHHHHH
Confidence 1111111111111100000000 0001145568999999999999999999999975
|
| >3c1x_A Hepatocyte growth factor receptor; receptor tyrosine kinase, signal transduction, GRB2, SHC, ATP-binding, glycoprotein, membrane; HET: CKK; 2.17A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-44 Score=313.39 Aligned_cols=254 Identities=28% Similarity=0.405 Sum_probs=188.7
Q ss_pred CCCCCceeecCCcceEEEEEeC--C--CcEEEEEEeccCcCChhhhHHHHHHHHHHHhcCCcceeeeeeEEEcCCCeeEE
Q 038766 13 SFSENNIIGNSNLSTVYKGRLE--D--GEIVAVKKLNFHQFSAESDKSFYREAKTLKELKHRNLVKVLGYAWESGKLKAL 88 (299)
Q Consensus 13 ~y~~~~~lg~g~~~~v~~~~~~--~--~~~~~vK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~l 88 (299)
+|.+.+.||+|+||+||++.+. + +..+|+|++.. .......+.+.+|+.++++++||||+++++++...+...++
T Consensus 90 ~~~~~~~LG~G~fg~Vy~~~~~~~~~~~~~vavK~~~~-~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~~l 168 (373)
T 3c1x_A 90 IVHFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNR-ITDIGEVSQFLTEGIIMKDFSHPNVLSLLGICLRSEGSPLV 168 (373)
T ss_dssp EEEEEEEEECCSSSEEEEEEEEETTTEEEEEEEEECCS-CSCSHHHHHHHHHHTTSTTCCCTTBCCCCEEECCCSSCCEE
T ss_pred eeecCcEeeeCCCeEEEEEEEECCCCcEEEEEEEEcCC-CCCHHHHHHHHHHHHHHHhCCCCCcceEEEEEEcCCCCeEE
Confidence 3566789999999999999753 2 24689998863 23445567889999999999999999999987766667799
Q ss_pred EEeecCCCChHHHhcCCCCCCCCCChhhHHHHHHHHHHHHHHhhcCCCCCeeeecccCCceeeCCCCcEEEeeecccccc
Q 038766 89 ILEYMENGSLESVIHGPGVDHSRWTLPKRIDVLISVANGLDYLHSGYDIPIVHCDMKPSNILLDRDFEAHVSDFGTSRML 168 (299)
Q Consensus 89 v~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lh~~~~~~~~H~dl~~~nil~~~~~~v~l~df~~~~~~ 168 (299)
|+||+.+++|.+++.. ....+++..++.++.|++.||+|||++ +++|+||||+||+++.++.+||+|||++...
T Consensus 169 v~e~~~~g~L~~~l~~---~~~~~~~~~~~~i~~qi~~aL~~LH~~---~ivHrDlkp~NIll~~~~~~kL~DFG~a~~~ 242 (373)
T 3c1x_A 169 VLPYMKHGDLRNFIRN---ETHNPTVKDLIGFGLQVAKGMKFLASK---KFVHRDLAARNCMLDEKFTVKVADFGLARDM 242 (373)
T ss_dssp EEECCTTCBHHHHHHC---TTCCCBHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEECTTCCEEECCC------
T ss_pred EEECCCCCCHHHHHhh---cccCCCHHHHHHHHHHHHHHHHHHHHC---CEecCccchheEEECCCCCEEEeeccccccc
Confidence 9999999999999974 234688999999999999999999999 9999999999999999999999999999755
Q ss_pred ccccccccccccccccCcccCChhhhcccCcCccccchhhhHHHHHHHh-CCCCCCCCccCCCCchhHHHHHHHHHhcCc
Q 038766 169 DVHLQDLSSLSTAFQGTIGYLAPEFAYMRIVTTKVDVFSFGIVVMEFLT-KRRPTGLDEENGLSPISLRQLVEKALANGI 247 (299)
Q Consensus 169 ~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~DiwslG~~l~~l~~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 247 (299)
...............+++.|+|||.+.+..++.++||||||+++|+|++ |.+||..... ......+. .+.
T Consensus 243 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwSlG~il~ellt~~~~p~~~~~~-----~~~~~~~~----~~~ 313 (373)
T 3c1x_A 243 YDKEFDSVHNKTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVNT-----FDITVYLL----QGR 313 (373)
T ss_dssp ---------------CCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSCTTSCS-----SCHHHHHH----TTC
T ss_pred cccccccccccCCCCCcccccChHHhcCCCCCcHHHHHHHHHHHHHHHhCcCCCCCCCCH-----HHHHHHHH----cCC
Confidence 4221111112233456778999999999999999999999999999999 5666643321 12222111 110
Q ss_pred cCcccccCccccchhhHhHHHHHHHHHHHHHHHHhcCCCCCCCCChhhhhc
Q 038766 248 NGVRQITDPKLVSSIYEEQEQHQVLEELFKLALVCTSSNPEDRPNMNELLI 298 (299)
Q Consensus 248 ~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rpt~~~il~ 298 (299)
.... +..++..+.+++.+||..||++|||++++++
T Consensus 314 ----~~~~------------p~~~~~~l~~li~~cl~~dp~~RPs~~ell~ 348 (373)
T 3c1x_A 314 ----RLLQ------------PEYCPDPLYEVMLKCWHPKAEMRPSFSELVS 348 (373)
T ss_dssp ----CCCC------------CTTCCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred ----CCCC------------CCCCCHHHHHHHHHHcCCChhhCcCHHHHHH
Confidence 0001 1123457999999999999999999999985
|
| >2clq_A Mitogen-activated protein kinase kinase kinase 5; transferase, metal-binding, apoptosis; HET: STU; 2.3A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-43 Score=296.80 Aligned_cols=254 Identities=24% Similarity=0.363 Sum_probs=195.0
Q ss_pred CCCCCCceeecCCcceEEEEEe-CCCcEEEEEEeccCcCChhhhHHHHHHHHHHHhcCCcceeeeeeEEEcCCCeeEEEE
Q 038766 12 GSFSENNIIGNSNLSTVYKGRL-EDGEIVAVKKLNFHQFSAESDKSFYREAKTLKELKHRNLVKVLGYAWESGKLKALIL 90 (299)
Q Consensus 12 ~~y~~~~~lg~g~~~~v~~~~~-~~~~~~~vK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~lv~ 90 (299)
++|.....||+|+||+||++.+ .++..||+|++... .....+.+.+|+..++.++||||+++++++.. ....++|+
T Consensus 22 ~~~~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~--~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~-~~~~~lv~ 98 (295)
T 2clq_A 22 DENGDRVVLGKGTYGIVYAGRDLSNQVRIAIKEIPER--DSRYSQPLHEEIALHKHLKHKNIVQYLGSFSE-NGFIKIFM 98 (295)
T ss_dssp CTTSSBCEEEECSSSEEEEEEETTTCCEEEEEEEECC--CC---HHHHHHHHHHHTCCCTTBCCEEEEEEE-TTEEEEEE
T ss_pred cCCCCcEEEeecCcEEEEEEEECCCCeEEEEEEccCC--chHHHHHHHHHHHHHHhCCCCCEeeEeeEEEe-CCcEEEEE
Confidence 4455566999999999999987 45889999998643 34456778899999999999999999997765 45669999
Q ss_pred eecCCCChHHHhcCCCCCCCCCChhhHHHHHHHHHHHHHHhhcCCCCCeeeecccCCceeeCC-CCcEEEeeeccccccc
Q 038766 91 EYMENGSLESVIHGPGVDHSRWTLPKRIDVLISVANGLDYLHSGYDIPIVHCDMKPSNILLDR-DFEAHVSDFGTSRMLD 169 (299)
Q Consensus 91 e~~~~~~L~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lh~~~~~~~~H~dl~~~nil~~~-~~~v~l~df~~~~~~~ 169 (299)
|++.+++|.+++.... ....+++..++.++.|++.||.|||+. +++|+||+|+||+++. ++.++|+|||++....
T Consensus 99 e~~~~~~L~~~l~~~~-~~~~~~~~~~~~~~~qi~~~l~~lH~~---~i~H~dl~p~Nil~~~~~~~~kl~Dfg~~~~~~ 174 (295)
T 2clq_A 99 EQVPGGSLSALLRSKW-GPLKDNEQTIGFYTKQILEGLKYLHDN---QIVHRDIKGDNVLINTYSGVLKISDFGTSKRLA 174 (295)
T ss_dssp ECCSEEEHHHHHHHTT-CCCTTCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEEETTTCCEEECCTTTCEESC
T ss_pred EeCCCCCHHHHHHhhc-cCCCccHHHHHHHHHHHHHHHHHHHhC---CEEccCCChhhEEEECCCCCEEEeecccccccC
Confidence 9999999999886432 234567889999999999999999999 9999999999999987 8999999999987654
Q ss_pred cccccccccccccccCcccCChhhhcccC--cCccccchhhhHHHHHHHhCCCCCCCCccCCCCchhHHHHHHHHHhcCc
Q 038766 170 VHLQDLSSLSTAFQGTIGYLAPEFAYMRI--VTTKVDVFSFGIVVMEFLTKRRPTGLDEENGLSPISLRQLVEKALANGI 247 (299)
Q Consensus 170 ~~~~~~~~~~~~~~~~~~y~~PE~~~~~~--~~~~~DiwslG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 247 (299)
.. ........+++.|+|||.+.+.. ++.++||||||+++|+|++|..||...... . ............
T Consensus 175 ~~----~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~-----~-~~~~~~~~~~~~ 244 (295)
T 2clq_A 175 GI----NPCTETFTGTLQYMAPEIIDKGPRGYGKAADIWSLGCTIIEMATGKPPFYELGEP-----Q-AAMFKVGMFKVH 244 (295)
T ss_dssp C---------CCCCCCGGGCCHHHHHHGGGGCSHHHHHHHHHHHHHHHHHTSCTTGGGSSH-----H-HHHHHHHHHCCC
T ss_pred CC----CCcccccCCCccccChhhhcCCCCCCCcHHHHHHHHHHHHHHHHCCCCccCCCch-----h-HHHHhhcccccc
Confidence 21 12233456789999999987653 788999999999999999999998532110 0 111111111110
Q ss_pred cCcccccCccccchhhHhHHHHHHHHHHHHHHHHhcCCCCCCCCChhhhhcC
Q 038766 248 NGVRQITDPKLVSSIYEEQEQHQVLEELFKLALVCTSSNPEDRPNMNELLIT 299 (299)
Q Consensus 248 ~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rpt~~~il~~ 299 (299)
.. . +..++.++.++|.+||..||++|||++++|+|
T Consensus 245 ~~--------~---------~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~~ 279 (295)
T 2clq_A 245 PE--------I---------PESMSAEAKAFILKCFEPDPDKRACANDLLVD 279 (295)
T ss_dssp CC--------C---------CTTSCHHHHHHHHHTTCSSTTTSCCHHHHHTS
T ss_pred cc--------c---------cccCCHHHHHHHHHHccCChhhCCCHHHHhcC
Confidence 00 0 12335678999999999999999999999986
|
| >1wak_A Serine/threonine-protein kinase SPRK1; SRPK, transferase, alternative splicing, ATP-binding, chromosome partition, differentiation, mRNA processing; 1.73A {Homo sapiens} PDB: 1wbp_A* 3beg_A* 2x7g_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-43 Score=309.10 Aligned_cols=276 Identities=21% Similarity=0.218 Sum_probs=204.5
Q ss_pred HHhCCCCCCceeecCCcceEEEEEe-CCCcEEEEEEeccCcCChhhhHHHHHHHHHHHhcC--------CcceeeeeeEE
Q 038766 9 NATGSFSENNIIGNSNLSTVYKGRL-EDGEIVAVKKLNFHQFSAESDKSFYREAKTLKELK--------HRNLVKVLGYA 79 (299)
Q Consensus 9 ~~~~~y~~~~~lg~g~~~~v~~~~~-~~~~~~~vK~~~~~~~~~~~~~~~~~e~~~l~~l~--------h~~i~~~~~~~ 79 (299)
.+.++|.+.+.||+|+||+||+|.+ .+++.||+|++.. .......+.+|+.+++.++ |+||+++++++
T Consensus 34 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~---~~~~~~~~~~E~~~l~~l~~~~~~~~~~~~iv~~~~~~ 110 (397)
T 1wak_A 34 LFNGRYHVIRKLGWGHFSTVWLSWDIQGKKFVAMKVVKS---AEHYTETALDEIRLLKSVRNSDPNDPNREMVVQLLDDF 110 (397)
T ss_dssp EETTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECS---CHHHHHHHHHHHHHHHHHHHSCTTCGGGGGBCCEEEEE
T ss_pred hcCCeEEEEEEeeecCCeeEEEEEecCCCeEEEEEEEec---CCcchHHHHHHHHHHHHHhhcCCCCCCcceeeeeecce
Confidence 3568899999999999999999986 4588999999863 2345677889999999996 78899999977
Q ss_pred Ec---CCCeeEEEEeecCCCChHHHhcCCCCCCCCCChhhHHHHHHHHHHHHHHhhcCCCCCeeeecccCCceeeCCCC-
Q 038766 80 WE---SGKLKALILEYMENGSLESVIHGPGVDHSRWTLPKRIDVLISVANGLDYLHSGYDIPIVHCDMKPSNILLDRDF- 155 (299)
Q Consensus 80 ~~---~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lh~~~~~~~~H~dl~~~nil~~~~~- 155 (299)
.. .+...++|+|++ +++|.+.+... ....+++..++.++.||+.||+|||+++ +++||||||+|||++.++
T Consensus 111 ~~~~~~~~~~~lv~e~~-~~~l~~~~~~~--~~~~~~~~~~~~i~~qi~~aL~~lH~~~--givHrDikp~NIll~~~~~ 185 (397)
T 1wak_A 111 KISGVNGTHICMVFEVL-GHHLLKWIIKS--NYQGLPLPCVKKIIQQVLQGLDYLHTKC--RIIHTDIKPENILLSVNEQ 185 (397)
T ss_dssp EEEETTEEEEEEEECCC-CCBHHHHHHHT--TTSCCCHHHHHHHHHHHHHHHHHHHHTT--CEECCCCSGGGEEECCCHH
T ss_pred eecCCCCceEEEEEecc-CccHHHHHHhc--ccCCCCHHHHHHHHHHHHHHHHHHHHhC--CEecCCCCHHHeeEeccch
Confidence 63 455679999999 55776655422 2357999999999999999999999842 899999999999999775
Q ss_pred ------------------------------------------------cEEEeeeccccccccccccccccccccccCcc
Q 038766 156 ------------------------------------------------EAHVSDFGTSRMLDVHLQDLSSLSTAFQGTIG 187 (299)
Q Consensus 156 ------------------------------------------------~v~l~df~~~~~~~~~~~~~~~~~~~~~~~~~ 187 (299)
.++|+|||++..... ......+|+.
T Consensus 186 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~kl~DfG~a~~~~~-------~~~~~~gt~~ 258 (397)
T 1wak_A 186 YIRRLAAEATEWQRSGAPPPSGSAVSTAPATAGNFLVNPLEPKNAEKLKVKIADLGNACWVHK-------HFTEDIQTRQ 258 (397)
T ss_dssp HHHHHHHHHC---------------------CCTTSCCTTSGGGGGGCCEEECCGGGCEETTB-------CSCSCCSCGG
T ss_pred hhhhhhhhhHHHhhcCCCCCCCCccccCCcccccccccccccccccccceEeccccccccccc-------cCccCCCCCc
Confidence 799999999976541 2334467999
Q ss_pred cCChhhhcccCcCccccchhhhHHHHHHHhCCCCCCCCccCCCCch-hHHHHHHHHHhcCcc-----------------C
Q 038766 188 YLAPEFAYMRIVTTKVDVFSFGIVVMEFLTKRRPTGLDEENGLSPI-SLRQLVEKALANGIN-----------------G 249 (299)
Q Consensus 188 y~~PE~~~~~~~~~~~DiwslG~~l~~l~~g~~p~~~~~~~~~~~~-~~~~~~~~~~~~~~~-----------------~ 249 (299)
|+|||++.+..++.++|||||||++|+|++|..||........... .....+......... .
T Consensus 259 y~aPE~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~ 338 (397)
T 1wak_A 259 YRSLEVLIGSGYNTPADIWSTACMAFELATGDYLFEPHSGEEYTRDEDHIALIIELLGKVPRKLIVAGKYSKEFFTKKGD 338 (397)
T ss_dssp GCCHHHHHTSCCCTHHHHHHHHHHHHHHHHSSCSCCCCCCSSSCHHHHHHHHHHHHHCSCCHHHHHHCTTGGGTBCTTSS
T ss_pred ccCChhhcCCCCCcHHHHHHHHHHHHHHhhCCCCCCCCcccccCchHHHHHHHHHhcCCCChHHhhcccccccccCCccc
Confidence 9999999999999999999999999999999999975543332211 111111111111000 0
Q ss_pred cccccCccccc--h--hhHhHHHHHHHHHHHHHHHHhcCCCCCCCCChhhhhcC
Q 038766 250 VRQITDPKLVS--S--IYEEQEQHQVLEELFKLALVCTSSNPEDRPNMNELLIT 299 (299)
Q Consensus 250 ~~~~~~~~~~~--~--~~~~~~~~~~~~~l~~li~~~l~~dP~~Rpt~~~il~~ 299 (299)
...+....... . ..........+..+.+||.+||..||++|||++|+|+|
T Consensus 339 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~h 392 (397)
T 1wak_A 339 LKHITKLKPWGLFEVLVEKYEWSQEEAAGFTDFLLPMLELIPEKRATAAECLRH 392 (397)
T ss_dssp BSSCCCCCCCCHHHHHHHTSCCCHHHHHHHHHHHGGGGCSSGGGSCCHHHHHTS
T ss_pred cccccccCCcchhHhhhhhcccchhhHHHHHHHHHHHhccChhhcCCHHHHhhC
Confidence 00000000000 0 00001245677889999999999999999999999987
|
| >3cek_A Dual specificity protein kinase TTK; HMPS1, PYT, ESK, phosphotyros picked threonine kinase, SGC, structural genomics consortiu binding; HET: 7PE; 2.30A {Homo sapiens} PDB: 3gfw_A* 3h9f_A* 2x9e_A* 3hmp_A* 3hmn_A* 3hmo_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4e-45 Score=309.77 Aligned_cols=262 Identities=20% Similarity=0.282 Sum_probs=200.5
Q ss_pred ChHHHHHHhCCCCCCceeecCCcceEEEEEeCCCcEEEEEEeccCcCChhhhHHHHHHHHHHHhcC--CcceeeeeeEEE
Q 038766 3 DRTEIENATGSFSENNIIGNSNLSTVYKGRLEDGEIVAVKKLNFHQFSAESDKSFYREAKTLKELK--HRNLVKVLGYAW 80 (299)
Q Consensus 3 ~~~~~~~~~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~vK~~~~~~~~~~~~~~~~~e~~~l~~l~--h~~i~~~~~~~~ 80 (299)
+.+.++...++|.+.+.||+|+||.||++.+.+++.||+|++............+.+|+..+++++ |+||+++++++.
T Consensus 19 ~~~~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~~iv~~~~~~~ 98 (313)
T 3cek_A 19 YFQSMSVKGRIYSILKQIGSGGSSKVFQVLNEKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRLYDYEI 98 (313)
T ss_dssp -CCEEEETTEEEEEEEEEECCSSEEEEEEECTTCCEEEEEEEECSSCCHHHHHHHHHHHHHHHHHGGGCTTBCCEEEEEE
T ss_pred CeeeeeeccceEEEEEEecCCCCEEEEEEEcCCCcEEEEEEeccccccccchHHHHHHHHHHHhccccCCceEEEEEEee
Confidence 344455667889999999999999999999888999999999876666667788999999999997 599999999665
Q ss_pred cCCCeeEEEEeecCCCChHHHhcCCCCCCCCCChhhHHHHHHHHHHHHHHhhcCCCCCeeeecccCCceeeCCCCcEEEe
Q 038766 81 ESGKLKALILEYMENGSLESVIHGPGVDHSRWTLPKRIDVLISVANGLDYLHSGYDIPIVHCDMKPSNILLDRDFEAHVS 160 (299)
Q Consensus 81 ~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lh~~~~~~~~H~dl~~~nil~~~~~~v~l~ 160 (299)
. +...++|+|+. +++|.+++. ....+++..++.++.|++.||.|||+. +++|+||||+||+++ ++.++|+
T Consensus 99 ~-~~~~~lv~e~~-~~~L~~~l~----~~~~~~~~~~~~i~~qi~~aL~~LH~~---~ivH~dlkp~NIl~~-~~~~kL~ 168 (313)
T 3cek_A 99 T-DQYIYMVMECG-NIDLNSWLK----KKKSIDPWERKSYWKNMLEAVHTIHQH---GIVHSDLKPANFLIV-DGMLKLI 168 (313)
T ss_dssp C-SSEEEEEECCC-SEEHHHHHH----HCSSCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEEE-TTEEEEC
T ss_pred c-CCEEEEEEecC-CCcHHHHHH----hcCCCCHHHHHHHHHHHHHHHHHHHHC---CceecCCCcccEEEE-CCeEEEe
Confidence 5 55679999954 779999987 445789999999999999999999999 999999999999996 4899999
Q ss_pred eeccccccccccccccccccccccCcccCChhhhcc-----------cCcCccccchhhhHHHHHHHhCCCCCCCCccCC
Q 038766 161 DFGTSRMLDVHLQDLSSLSTAFQGTIGYLAPEFAYM-----------RIVTTKVDVFSFGIVVMEFLTKRRPTGLDEENG 229 (299)
Q Consensus 161 df~~~~~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~-----------~~~~~~~DiwslG~~l~~l~~g~~p~~~~~~~~ 229 (299)
|||++........ ........+++.|+|||.+.+ ..++.++||||||+++|+|++|..||.....
T Consensus 169 Dfg~~~~~~~~~~--~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~-- 244 (313)
T 3cek_A 169 DFGIANQMQPDTT--SVVKDSQVGTVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIIN-- 244 (313)
T ss_dssp CCSSSCC----------------CCGGGCCHHHHTTCC----------CCCHHHHHHHHHHHHHHHHHSSCTTTTCCS--
T ss_pred eccccccccCccc--cccccCCCCCCCcCCHHHHhhcccccccccccccCCchHHHHHHHHHHHHHHhCCCchhhHHH--
Confidence 9999976542111 112234467999999999875 4678899999999999999999999953211
Q ss_pred CCchhHHHHHHHHHhcCccCcccccCccccchhhHhHHHHHHHHHHHHHHHHhcCCCCCCCCChhhhhcC
Q 038766 230 LSPISLRQLVEKALANGINGVRQITDPKLVSSIYEEQEQHQVLEELFKLALVCTSSNPEDRPNMNELLIT 299 (299)
Q Consensus 230 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rpt~~~il~~ 299 (299)
. ...+....... ..... +...+.++.++|.+||..||++|||++++|+|
T Consensus 245 ----~-~~~~~~~~~~~----~~~~~------------~~~~~~~l~~li~~~l~~dp~~Rps~~ell~h 293 (313)
T 3cek_A 245 ----Q-ISKLHAIIDPN----HEIEF------------PDIPEKDLQDVLKCCLKRDPKQRISIPELLAH 293 (313)
T ss_dssp ----H-HHHHHHHHCTT----SCCCC------------CCCSCHHHHHHHHHHTCSSTTTSCCHHHHHTS
T ss_pred ----H-HHHHHHHHhcc----cccCC------------cccchHHHHHHHHHHccCCcccCcCHHHHhcC
Confidence 1 11111111111 00000 01113578999999999999999999999987
|
| >2buj_A Serine/threonine-protein kinase 16; transferase, ATP-binding, lipoprotein, myristate, PA phosphorylation; HET: STU; 2.6A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=9.2e-45 Score=308.03 Aligned_cols=263 Identities=22% Similarity=0.317 Sum_probs=200.7
Q ss_pred HHhCCCCCCceeecCCcceEEEEEe-CCCcEEEEEEeccCcCChhhhHHHHHHHHHHHhcCCcceeeeeeEEEc---CCC
Q 038766 9 NATGSFSENNIIGNSNLSTVYKGRL-EDGEIVAVKKLNFHQFSAESDKSFYREAKTLKELKHRNLVKVLGYAWE---SGK 84 (299)
Q Consensus 9 ~~~~~y~~~~~lg~g~~~~v~~~~~-~~~~~~~vK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~---~~~ 84 (299)
...++|.+.+.||+|+||.||++.+ .+++.||+|++.. ......+.+.+|+.+++.++||||+++++++.. ...
T Consensus 26 i~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~--~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~ 103 (317)
T 2buj_A 26 IDNKHYLFIQKLGEGGFSYVDLVEGLHDGHFYALKRILC--HEQQDREEAQREADMHRLFNHPNILRLVAYCLRERGAKH 103 (317)
T ss_dssp ETTEEEEEEEEEEC--CEEEEEEEETTTCCEEEEEEEEE--SSHHHHHHHHHHHHHHHTCCCTTBCCCCEEEEEEETTEE
T ss_pred ECCeEEEEEEEecCCCCeEEEEEEecCCCcEEEEEEEec--CCHHHHHHHHHHHHHHhhcCCCCeeeEEEEEEeccCCCc
Confidence 3457899999999999999999987 5689999999864 344567788999999999999999999998763 234
Q ss_pred eeEEEEeecCCCChHHHhcCCCCCCCCCChhhHHHHHHHHHHHHHHhhcCCCCCeeeecccCCceeeCCCCcEEEeeecc
Q 038766 85 LKALILEYMENGSLESVIHGPGVDHSRWTLPKRIDVLISVANGLDYLHSGYDIPIVHCDMKPSNILLDRDFEAHVSDFGT 164 (299)
Q Consensus 85 ~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lh~~~~~~~~H~dl~~~nil~~~~~~v~l~df~~ 164 (299)
..++|+||+.+++|.+++.........+++.+++.++.|++.||.|||++ +++|+||||+||+++.++.++|+|||+
T Consensus 104 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~---~ivH~dlkp~NIl~~~~~~~kl~dfg~ 180 (317)
T 2buj_A 104 EAWLLLPFFKRGTLWNEIERLKDKGNFLTEDQILWLLLGICRGLEAIHAK---GYAHRDLKPTNILLGDEGQPVLMDLGS 180 (317)
T ss_dssp EEEEEEECCTTCBHHHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEECTTSCEEECCCSS
T ss_pred eeEEEEEeCCCCcHHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCCHHHEEEcCCCCEEEEecCc
Confidence 67899999999999998865333456899999999999999999999999 999999999999999999999999998
Q ss_pred cccccccccccc-----ccccccccCcccCChhhhcccC---cCccccchhhhHHHHHHHhCCCCCCCCccCCCCchhHH
Q 038766 165 SRMLDVHLQDLS-----SLSTAFQGTIGYLAPEFAYMRI---VTTKVDVFSFGIVVMEFLTKRRPTGLDEENGLSPISLR 236 (299)
Q Consensus 165 ~~~~~~~~~~~~-----~~~~~~~~~~~y~~PE~~~~~~---~~~~~DiwslG~~l~~l~~g~~p~~~~~~~~~~~~~~~ 236 (299)
+........... .......+++.|+|||.+.+.. ++.++||||||+++|+|++|..||........ ...
T Consensus 181 ~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~---~~~ 257 (317)
T 2buj_A 181 MNQACIHVEGSRQALTLQDWAAQRCTISYRAPELFSVQSHCVIDERTDVWSLGCVLYAMMFGEGPYDMVFQKGD---SVA 257 (317)
T ss_dssp CEESCEEEESHHHHHHHHHHHHHHSCGGGCCGGGSSCCSEEEECTHHHHHHHHHHHHHHHHSSCTTHHHHHTTS---CHH
T ss_pred chhcccccccccccccccccccccCCcccCCHhHhccCCCcCCCchhhHHHHHHHHHHHHhCCCChhhhhcccc---hhh
Confidence 875432111100 0112334688999999987554 68899999999999999999999843211110 011
Q ss_pred HHHHHHHhcCccCcccccCccccchhhHhHHHHHHHHHHHHHHHHhcCCCCCCCCChhhhhcC
Q 038766 237 QLVEKALANGINGVRQITDPKLVSSIYEEQEQHQVLEELFKLALVCTSSNPEDRPNMNELLIT 299 (299)
Q Consensus 237 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rpt~~~il~~ 299 (299)
.. .... ..... ...++..+.++|.+||..||.+|||+++++++
T Consensus 258 ~~----~~~~----~~~~~------------~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~ 300 (317)
T 2buj_A 258 LA----VQNQ----LSIPQ------------SPRHSSALWQLLNSMMTVDPHQRPHIPLLLSQ 300 (317)
T ss_dssp HH----HHCC------CCC------------CTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred HH----hhcc----CCCCc------------cccCCHHHHHHHHHHhhcChhhCCCHHHHHHH
Confidence 10 0000 00000 12335679999999999999999999999863
|
| >3op5_A Serine/threonine-protein kinase VRK1; adenosine triphosphate, amino acid sequence, binding sites, domain, models, molecular; HET: REB; 2.40A {Homo sapiens} PDB: 2lav_A 2kty_A 2kul_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2.9e-44 Score=310.68 Aligned_cols=267 Identities=15% Similarity=0.183 Sum_probs=195.8
Q ss_pred HhCCCCCCceeecCCcceEEEEEeCC------CcEEEEEEeccCcCChhh---------hHHHHHHHHHHHhcCCcceee
Q 038766 10 ATGSFSENNIIGNSNLSTVYKGRLED------GEIVAVKKLNFHQFSAES---------DKSFYREAKTLKELKHRNLVK 74 (299)
Q Consensus 10 ~~~~y~~~~~lg~g~~~~v~~~~~~~------~~~~~vK~~~~~~~~~~~---------~~~~~~e~~~l~~l~h~~i~~ 74 (299)
..++|.+.+.||+|+||+||++.+.+ ++.||+|++......... ......|+..++.++||||++
T Consensus 33 ~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~e~~~~~~~~~~~~~~e~~~~~~l~h~~iv~ 112 (364)
T 3op5_A 33 AAAAWKVGLPIGQGGFGCIYLADMNSSESVGSDAPCVVKVEPSDNGPLFTELKFYQRAAKPEQIQKWIRTRKLKYLGVPK 112 (364)
T ss_dssp TCCEEEEEEECCCC-CCEEEEEEECCSSCCCTTCSEEEEEEETTCHHHHHHHHHHHHHCCHHHHHHHHHHTTCSCCCSCC
T ss_pred CCCeEEEEEEEecCCCeEEEEeeecCccccccccceEEEEeeccchhHHHHHHHHHhhhhhHHHHHHHHHhhccCCCCCe
Confidence 34589999999999999999998753 478999998643211100 122344566677888999999
Q ss_pred eeeEEEcC---CCeeEEEEeecCCCChHHHhcCCCCCCCCCChhhHHHHHHHHHHHHHHhhcCCCCCeeeecccCCceee
Q 038766 75 VLGYAWES---GKLKALILEYMENGSLESVIHGPGVDHSRWTLPKRIDVLISVANGLDYLHSGYDIPIVHCDMKPSNILL 151 (299)
Q Consensus 75 ~~~~~~~~---~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lh~~~~~~~~H~dl~~~nil~ 151 (299)
+++++... ....++||||+ +++|.+++.. ....+++..++.++.||+.||+|||+. +++||||||+||++
T Consensus 113 ~~~~~~~~~~~~~~~~lv~e~~-g~~L~~~~~~---~~~~l~~~~~~~i~~qi~~~l~~lH~~---~iiHrDlkp~Nill 185 (364)
T 3op5_A 113 YWGSGLHDKNGKSYRFMIMDRF-GSDLQKIYEA---NAKRFSRKTVLQLSLRILDILEYIHEH---EYVHGDIKASNLLL 185 (364)
T ss_dssp EEEEEEEEETTEEEEEEEEECE-EEEHHHHHHH---TTSCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEE
T ss_pred EEeeeeeccCCcceEEEEEeCC-CCCHHHHHHh---ccCCCCHHHHHHHHHHHHHHHHHHHHC---CeEEecCCHHHEEE
Confidence 99987654 24569999999 8899999863 235799999999999999999999999 99999999999999
Q ss_pred C--CCCcEEEeeeccccccccccccc---cccccccccCcccCChhhhcccCcCccccchhhhHHHHHHHhCCCCCCCCc
Q 038766 152 D--RDFEAHVSDFGTSRMLDVHLQDL---SSLSTAFQGTIGYLAPEFAYMRIVTTKVDVFSFGIVVMEFLTKRRPTGLDE 226 (299)
Q Consensus 152 ~--~~~~v~l~df~~~~~~~~~~~~~---~~~~~~~~~~~~y~~PE~~~~~~~~~~~DiwslG~~l~~l~~g~~p~~~~~ 226 (299)
+ .++.++|+|||++..+....... ........+|+.|+|||++.+..++.++|||||||++|+|++|..||....
T Consensus 186 ~~~~~~~~kl~DFG~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~g~~Pf~~~~ 265 (364)
T 3op5_A 186 NYKNPDQVYLVDYGLAYRYCPEGVHKAYAADPKRCHDGTIEFTSIDAHNGVAPSRRGDLEILGYCMIQWLTGHLPWEDNL 265 (364)
T ss_dssp ESSCTTCEEECCCTTCEESSGGGCCCCSSCCSSCCCCCCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSCCTTGGGT
T ss_pred ecCCCCeEEEEECCcceecccCCcccccccCcccccCCCCCccCHHHhCCCCCCchhhHHHHHHHHHHHHhCCCCccccc
Confidence 8 88999999999997654321111 111234458999999999999999999999999999999999999996432
Q ss_pred cCCCCchhHHHHHHHHHhcCccCcccccCccccchhhHhHHHHHHHHHHHHHHHHhcCCCCCCCCChhhhhc
Q 038766 227 ENGLSPISLRQLVEKALANGINGVRQITDPKLVSSIYEEQEQHQVLEELFKLALVCTSSNPEDRPNMNELLI 298 (299)
Q Consensus 227 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rpt~~~il~ 298 (299)
.. .............. ...+.+..+ ....++.++.+++.+||..||++|||++++++
T Consensus 266 ~~----~~~~~~~~~~~~~~---~~~~~~~~~--------~~~~~~~~~~~li~~cl~~~p~~RP~~~~l~~ 322 (364)
T 3op5_A 266 KD----PKYVRDSKIRYREN---IASLMDKCF--------PAANAPGEIAKYMETVKLLDYTEKPLYENLRD 322 (364)
T ss_dssp TC----HHHHHHHHHHHHHC---HHHHHHHHS--------CTTCCCHHHHHHHHHHHTCCTTCCCCHHHHHH
T ss_pred cC----HHHHHHHHHHhhhh---HHHHHHHhc--------ccccCHHHHHHHHHHHhcCCCCCCCCHHHHHH
Confidence 11 11111111111000 000000000 00233678999999999999999999999874
|
| >2vwi_A Serine/threonine-protein kinase OSR1; STE kinase, hypertension, transferase; HET: ANP; 2.15A {Homo sapiens} PDB: 3dak_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.9e-45 Score=306.74 Aligned_cols=272 Identities=24% Similarity=0.352 Sum_probs=186.0
Q ss_pred HHHHHhCCCCCCceeecCCcceEEEEEeC-CCcEEEEEEeccCcCChhhhHHHHHHHHHHHhcCCcceeeeeeEEEcCCC
Q 038766 6 EIENATGSFSENNIIGNSNLSTVYKGRLE-DGEIVAVKKLNFHQFSAESDKSFYREAKTLKELKHRNLVKVLGYAWESGK 84 (299)
Q Consensus 6 ~~~~~~~~y~~~~~lg~g~~~~v~~~~~~-~~~~~~vK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~ 84 (299)
.+....++|.+.+.||+|++|+||++.+. +++.||+|++.... .......+.+|+..++.++||||+++++++...+
T Consensus 9 p~~i~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~-~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~- 86 (303)
T 2vwi_A 9 PWSINRDDYELQEVIGSGATAVVQAAYCAPKKEKVAIKRINLEK-CQTSMDELLKEIQAMSQCHHPNIVSYYTSFVVKD- 86 (303)
T ss_dssp ----CCCCCEEEEECC---CCCEEEEEC----CEEEEECCC-----------------CCCCCCCTTBCCEEEEEESSS-
T ss_pred ccccchhhhhhhheeccccceEEEEEEECCCCcEEEEEEEEhhh-cchhHHHHHHHHHHHhhcCCCCEeeEEEEEeecC-
Confidence 45667889999999999999999999864 68999999986432 2344567889999999999999999999776644
Q ss_pred eeEEEEeecCCCChHHHhcC----CCCCCCCCChhhHHHHHHHHHHHHHHhhcCCCCCeeeecccCCceeeCCCCcEEEe
Q 038766 85 LKALILEYMENGSLESVIHG----PGVDHSRWTLPKRIDVLISVANGLDYLHSGYDIPIVHCDMKPSNILLDRDFEAHVS 160 (299)
Q Consensus 85 ~~~lv~e~~~~~~L~~~~~~----~~~~~~~~~~~~~~~i~~qi~~~l~~lh~~~~~~~~H~dl~~~nil~~~~~~v~l~ 160 (299)
..++|+||+.+++|.+++.. .......+++..++.++.|++.||.|||+. +++|+||+|+||+++.++.++|+
T Consensus 87 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~---~i~H~dl~p~Nil~~~~~~~kl~ 163 (303)
T 2vwi_A 87 ELWLVMKLLSGGSVLDIIKHIVAKGEHKSGVLDESTIATILREVLEGLEYLHKN---GQIHRDVKAGNILLGEDGSVQIA 163 (303)
T ss_dssp CEEEEEECCTTCBHHHHHHHHHHTTTTTTCSSCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCSGGGEEECTTCCEEEC
T ss_pred CcEEEehhccCCchHHHHHHHhhccccccCCCCHHHHHHHHHHHHHHHHHHHhC---CCCCCCCChhhEEEcCCCCEEEE
Confidence 56999999999999998753 111345689999999999999999999999 99999999999999999999999
Q ss_pred eeccccccccccc-cccccccccccCcccCChhhhcc-cCcCccccchhhhHHHHHHHhCCCCCCCCccCCCCchhHHHH
Q 038766 161 DFGTSRMLDVHLQ-DLSSLSTAFQGTIGYLAPEFAYM-RIVTTKVDVFSFGIVVMEFLTKRRPTGLDEENGLSPISLRQL 238 (299)
Q Consensus 161 df~~~~~~~~~~~-~~~~~~~~~~~~~~y~~PE~~~~-~~~~~~~DiwslG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~ 238 (299)
|||++........ ..........+++.|+|||.+.+ ..++.++||||||+++|+|++|..||..... ....
T Consensus 164 dfg~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~-----~~~~-- 236 (303)
T 2vwi_A 164 DFGVSAFLATGGDITRNKVRKTFVGTPCWMAPEVMEQVRGYDFKADIWSFGITAIELATGAAPYHKYPP-----MKVL-- 236 (303)
T ss_dssp CCHHHHHCC---------------CCCTTCCHHHHHHHHCCCTHHHHHHHHHHHHHHHHSSCTTTTSCG-----GGHH--
T ss_pred eccchheeccCCCccchhhhcccCCCccccCHHHhccccCCCchhhHHHHHHHHHHHHhCCCCCccCch-----hhHH--
Confidence 9999875542111 01112234568899999998876 5689999999999999999999999964321 1111
Q ss_pred HHHHHhcCccCccc-ccCccccchhhHhHHHHHHHHHHHHHHHHhcCCCCCCCCChhhhhcC
Q 038766 239 VEKALANGINGVRQ-ITDPKLVSSIYEEQEQHQVLEELFKLALVCTSSNPEDRPNMNELLIT 299 (299)
Q Consensus 239 ~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rpt~~~il~~ 299 (299)
............. ...... ...++.++.++|.+||..||++|||++++++|
T Consensus 237 -~~~~~~~~~~~~~~~~~~~~---------~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~h 288 (303)
T 2vwi_A 237 -MLTLQNDPPSLETGVQDKEM---------LKKYGKSFRKMISLCLQKDPEKRPTAAELLRH 288 (303)
T ss_dssp -HHHHTSSCCCTTC-----CC---------CCCCCHHHHHHHHHHCCSSGGGSCCHHHHHTS
T ss_pred -HHHhccCCCccccccccchh---------hhhhhHHHHHHHHHHccCChhhCcCHHHHhhC
Confidence 1111111111100 000000 12234678999999999999999999999987
|
| >3fhr_A MAP kinase-activated protein kinase 3; kinase-inhibitor complex, ATP-binding, cytoplasm, nucleotide-binding, nucleus, phosphoprotein, polymorphism; HET: P4O; 1.90A {Homo sapiens} PDB: 3fxw_A* 3r1n_A* 3she_A* 2oza_A 3fyk_X* 3fyj_X* 2p3g_X* 3ka0_A* 3fpm_A* 2pzy_A* 3a2c_A* 3kc3_A* 3gok_A* 2jbo_A* 2jbp_A* 3r2y_A* 3r30_A* 3r2b_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.2e-44 Score=305.29 Aligned_cols=256 Identities=21% Similarity=0.272 Sum_probs=174.7
Q ss_pred HHhCCCCCCc-eeecCCcceEEEEEeC-CCcEEEEEEeccCcCChhhhHHHHHHHHHHHhcCCcceeeeeeEEEc---CC
Q 038766 9 NATGSFSENN-IIGNSNLSTVYKGRLE-DGEIVAVKKLNFHQFSAESDKSFYREAKTLKELKHRNLVKVLGYAWE---SG 83 (299)
Q Consensus 9 ~~~~~y~~~~-~lg~g~~~~v~~~~~~-~~~~~~vK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~---~~ 83 (299)
.+.++|.+.+ .||+|+||+||++.+. +++.||+|++... ..........++.+.||||+++++++.. .+
T Consensus 25 ~~~~~y~i~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~------~~~~~e~~~~~~~~~h~~i~~~~~~~~~~~~~~ 98 (336)
T 3fhr_A 25 AVTDDYQLSKQVLGLGVNGKVLECFHRRTGQKCALKLLYDS------PKARQEVDHHWQASGGPHIVCILDVYENMHHGK 98 (336)
T ss_dssp CGGGTEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEESS------HHHHHHHHHHHHHTTSTTBCCEEEEEEEEETTE
T ss_pred cccceeEecceeeeeCCCeEEEEEEECCCCCEEEEEEecCc------HHHHHHHHHHHHhcCCCChHHHHHHHhhccCCC
Confidence 4678899955 6999999999999875 6899999998532 1222233344566789999999997754 24
Q ss_pred CeeEEEEeecCCCChHHHhcCCCCCCCCCChhhHHHHHHHHHHHHHHhhcCCCCCeeeecccCCceeeCC---CCcEEEe
Q 038766 84 KLKALILEYMENGSLESVIHGPGVDHSRWTLPKRIDVLISVANGLDYLHSGYDIPIVHCDMKPSNILLDR---DFEAHVS 160 (299)
Q Consensus 84 ~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lh~~~~~~~~H~dl~~~nil~~~---~~~v~l~ 160 (299)
...++|+||+.+++|.+++... ....+++.+++.++.|++.||.|||++ +++|+||||+||+++. ++.++|+
T Consensus 99 ~~~~lv~e~~~gg~L~~~l~~~--~~~~l~~~~~~~i~~ql~~~l~~LH~~---~ivH~dlkp~NIll~~~~~~~~~kl~ 173 (336)
T 3fhr_A 99 RCLLIIMECMEGGELFSRIQER--GDQAFTEREAAEIMRDIGTAIQFLHSH---NIAHRDVKPENLLYTSKEKDAVLKLT 173 (336)
T ss_dssp EEEEEEEECCTTEEHHHHHHTC---CCCCBHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEESCSSTTCCEEEC
T ss_pred ceEEEEEeccCCCCHHHHHHhc--CCCCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHEEEEecCCCceEEEe
Confidence 4578999999999999999754 235799999999999999999999999 9999999999999976 4559999
Q ss_pred eeccccccccccccccccccccccCcccCChhhhcccCcCccccchhhhHHHHHHHhCCCCCCCCccCCCCchhHHHHHH
Q 038766 161 DFGTSRMLDVHLQDLSSLSTAFQGTIGYLAPEFAYMRIVTTKVDVFSFGIVVMEFLTKRRPTGLDEENGLSPISLRQLVE 240 (299)
Q Consensus 161 df~~~~~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~DiwslG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~ 240 (299)
|||++..... .......+++.|+|||++.+..++.++||||||+++|+|++|..||................
T Consensus 174 Dfg~~~~~~~------~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~-- 245 (336)
T 3fhr_A 174 DFGFAKETTQ------NALQTPCYTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGFPPFYSNTGQAISPGMKRRI-- 245 (336)
T ss_dssp CCTTCEEC----------------------------CHHHHHHHHHHHHHHHHHHHHSSCCC------------------
T ss_pred ccccceeccc------cccccCCCCcCccChhhhCCCCCCchhhHHHHHHHHHHHHHCCCCCCCccchhhhhhHHHhh--
Confidence 9999875431 22234457899999999988889999999999999999999999996443221111100000
Q ss_pred HHHhcCccCcccccCccccchhhHhHHHHHHHHHHHHHHHHhcCCCCCCCCChhhhhcC
Q 038766 241 KALANGINGVRQITDPKLVSSIYEEQEQHQVLEELFKLALVCTSSNPEDRPNMNELLIT 299 (299)
Q Consensus 241 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rpt~~~il~~ 299 (299)
... ......+. ...++.++.+||.+||..||++|||++++|+|
T Consensus 246 ---~~~---~~~~~~~~----------~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~h 288 (336)
T 3fhr_A 246 ---RLG---QYGFPNPE----------WSEVSEDAKQLIRLLLKTDPTERLTITQFMNH 288 (336)
T ss_dssp -----------CCCTTT----------STTCCHHHHHHHHHHSCSSGGGSCCHHHHHHS
T ss_pred ---hcc---ccccCchh----------hccCCHHHHHHHHHHCCCChhHCcCHHHHhcC
Confidence 000 00000000 12345679999999999999999999999987
|
| >2a19_B Interferon-induced, double-stranded RNA-activated kinase; transferase, protein biosynthesis, protein synthesis transferase complex; HET: TPO ANP; 2.50A {Homo sapiens} PDB: 2a1a_B* | Back alignment and structure |
|---|
Probab=100.00 E-value=7.1e-45 Score=303.87 Aligned_cols=245 Identities=26% Similarity=0.410 Sum_probs=198.1
Q ss_pred HHhCCCCCCceeecCCcceEEEEEeC-CCcEEEEEEeccCcCChhhhHHHHHHHHHHHhcCCcceeeeeeEEEc------
Q 038766 9 NATGSFSENNIIGNSNLSTVYKGRLE-DGEIVAVKKLNFHQFSAESDKSFYREAKTLKELKHRNLVKVLGYAWE------ 81 (299)
Q Consensus 9 ~~~~~y~~~~~lg~g~~~~v~~~~~~-~~~~~~vK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~------ 81 (299)
.+.++|.+.+.||+|++|.||++.+. +++.||+|++.... ..+.+|+++++.++||||+++++++..
T Consensus 8 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~------~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~ 81 (284)
T 2a19_B 8 RFGMDFKEIELIGSGGFGQVFKAKHRIDGKTYVIKRVKYNN------EKAEREVKALAKLDHVNIVHYNGCWDGFDYDPE 81 (284)
T ss_dssp HHHHHEEEEEEEECSSSCCEEEEEETTTCCEEEEEEEECCS------GGGHHHHHHHHHCCCTTBCCEEEEEEEEEEC--
T ss_pred hhccccceeeeeccCCceEEEEEEEcCCCeEEEEEEecccc------HHHHHHHHHHHhCCCCCEEEEeeeEeccccCcc
Confidence 46788999999999999999999875 69999999986432 356689999999999999999996643
Q ss_pred ---------CCCeeEEEEeecCCCChHHHhcCCCCCCCCCChhhHHHHHHHHHHHHHHhhcCCCCCeeeecccCCceeeC
Q 038766 82 ---------SGKLKALILEYMENGSLESVIHGPGVDHSRWTLPKRIDVLISVANGLDYLHSGYDIPIVHCDMKPSNILLD 152 (299)
Q Consensus 82 ---------~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lh~~~~~~~~H~dl~~~nil~~ 152 (299)
.....++|+||+.+++|.+++... ....+++..++.++.|++.||.|||+. +++|+||||+||+++
T Consensus 82 ~~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~--~~~~~~~~~~~~i~~qi~~~l~~lH~~---~i~H~dlkp~Nil~~ 156 (284)
T 2a19_B 82 TSSKNSSRSKTKCLFIQMEFCDKGTLEQWIEKR--RGEKLDKVLALELFEQITKGVDYIHSK---KLINRDLKPSNIFLV 156 (284)
T ss_dssp -------CCEEEEEEEEECCCCSCBHHHHHHHG--GGSCCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEEE
T ss_pred cccccccccCcceEEEEEeccCCCCHHHHHhhc--cCCCCCHHHHHHHHHHHHHHHHHHHhC---CeeeccCCHHHEEEc
Confidence 134468999999999999998632 235789999999999999999999999 999999999999999
Q ss_pred CCCcEEEeeeccccccccccccccccccccccCcccCChhhhcccCcCccccchhhhHHHHHHHhCCCCCCCCccCCCCc
Q 038766 153 RDFEAHVSDFGTSRMLDVHLQDLSSLSTAFQGTIGYLAPEFAYMRIVTTKVDVFSFGIVVMEFLTKRRPTGLDEENGLSP 232 (299)
Q Consensus 153 ~~~~v~l~df~~~~~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~DiwslG~~l~~l~~g~~p~~~~~~~~~~~ 232 (299)
.++.++|+|||++...... .......+++.|+|||.+.+..++.++||||||+++|+|++|..|+...
T Consensus 157 ~~~~~kl~Dfg~~~~~~~~-----~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~~~~~~~~------- 224 (284)
T 2a19_B 157 DTKQVKIGDFGLVTSLKND-----GKRTRSKGTLRYMSPEQISSQDYGKEVDLYALGLILAELLHVCDTAFET------- 224 (284)
T ss_dssp ETTEEEECCCTTCEESSCC-----SCCCCCCSCCTTSCHHHHHCSCCCTHHHHHHHHHHHHHHHSCCSSHHHH-------
T ss_pred CCCCEEECcchhheecccc-----ccccccCCcccccChhhhccCCCcchhhhHHHHHHHHHHHhcCCcchhH-------
Confidence 9999999999998765421 1223445789999999999999999999999999999999998886211
Q ss_pred hhHHHHHHHHHhcCccCcccccCccccchhhHhHHHHHHHHHHHHHHHHhcCCCCCCCCChhhhhcC
Q 038766 233 ISLRQLVEKALANGINGVRQITDPKLVSSIYEEQEQHQVLEELFKLALVCTSSNPEDRPNMNELLIT 299 (299)
Q Consensus 233 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rpt~~~il~~ 299 (299)
........ .. . + +..++..+.++|.+||..||++|||+.+++++
T Consensus 225 ---~~~~~~~~-~~--~---~--------------~~~~~~~~~~li~~~l~~dp~~Rps~~e~l~~ 268 (284)
T 2a19_B 225 ---SKFFTDLR-DG--I---I--------------SDIFDKKEKTLLQKLLSKKPEDRPNTSEILRT 268 (284)
T ss_dssp ---HHHHHHHH-TT--C---C--------------CTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred ---HHHHHHhh-cc--c---c--------------cccCCHHHHHHHHHHccCChhhCcCHHHHHHH
Confidence 11111111 10 0 0 11234568899999999999999999999864
|
| >2h8h_A Proto-oncogene tyrosine-protein kinase SRC; SRC kinase, transferase; HET: PTR H8H; 2.20A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=4.8e-45 Score=329.97 Aligned_cols=258 Identities=27% Similarity=0.416 Sum_probs=205.9
Q ss_pred ChHHHHHHhCCCCCCceeecCCcceEEEEEeCCCcEEEEEEeccCcCChhhhHHHHHHHHHHHhcCCcceeeeeeEEEcC
Q 038766 3 DRTEIENATGSFSENNIIGNSNLSTVYKGRLEDGEIVAVKKLNFHQFSAESDKSFYREAKTLKELKHRNLVKVLGYAWES 82 (299)
Q Consensus 3 ~~~~~~~~~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~vK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~ 82 (299)
..+.+++..++|++.+.||+|+||.||++.+.++..||||++.... ...+.+.+|+++++.++|+||+++++++..
T Consensus 258 ~~~~~~i~~~~~~~~~~lG~G~fg~Vy~~~~~~~~~vavK~~~~~~---~~~~~~~~E~~~l~~l~hpniv~~~~~~~~- 333 (535)
T 2h8h_A 258 AKDAWEIPRESLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTLKPGT---MSPEAFLQEAQVMKKLRHEKLVQLYAVVSE- 333 (535)
T ss_dssp STTCSBCCGGGEEEEEEEEECSSEEEEEEEETTTEEEEEEEECTTS---SCHHHHHHHHHHHHHCCCTTBCCEEEEECS-
T ss_pred CccceecchhhhhhheecccCCCeEEEEEEECCCceEEEEEeCCCC---CCHHHHHHHHHHHHhCCCCCEeeEEEEEee-
Confidence 3556777888999999999999999999999888889999997433 335678999999999999999999997644
Q ss_pred CCeeEEEEeecCCCChHHHhcCCCCCCCCCChhhHHHHHHHHHHHHHHhhcCCCCCeeeecccCCceeeCCCCcEEEeee
Q 038766 83 GKLKALILEYMENGSLESVIHGPGVDHSRWTLPKRIDVLISVANGLDYLHSGYDIPIVHCDMKPSNILLDRDFEAHVSDF 162 (299)
Q Consensus 83 ~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lh~~~~~~~~H~dl~~~nil~~~~~~v~l~df 162 (299)
...++|+||+.+++|.+++... ....+++..++.++.||+.||+|||++ +++||||||+|||++.++.+||+||
T Consensus 334 -~~~~lv~e~~~~gsL~~~l~~~--~~~~l~~~~~~~i~~qi~~~L~~LH~~---~ivHrDlkp~NIll~~~~~~kl~DF 407 (535)
T 2h8h_A 334 -EPIYIVTEYMSKGSLLDFLKGE--TGKYLRLPQLVDMAAQIASGMAYVERM---NYVHRDLRAANILVGENLVCKVADF 407 (535)
T ss_dssp -SSCEEEECCCTTEEHHHHHSHH--HHTTCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEECGGGCEEECCT
T ss_pred -ccceEeeehhcCCcHHHHHhhc--CCCCCCHHHHHHHHHHHHHHHHHHHhC---CeeCCCCCHhhEEEcCCCcEEEccc
Confidence 4469999999999999999632 124589999999999999999999999 9999999999999999999999999
Q ss_pred ccccccccccccccccccccccCcccCChhhhcccCcCccccchhhhHHHHHHHh-CCCCCCCCccCCCCchhHHHHHHH
Q 038766 163 GTSRMLDVHLQDLSSLSTAFQGTIGYLAPEFAYMRIVTTKVDVFSFGIVVMEFLT-KRRPTGLDEENGLSPISLRQLVEK 241 (299)
Q Consensus 163 ~~~~~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~DiwslG~~l~~l~~-g~~p~~~~~~~~~~~~~~~~~~~~ 241 (299)
|++...... .........++..|+|||.+.+..++.++||||||+++|+|++ |..||... .... .+..
T Consensus 408 G~a~~~~~~---~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDvwSlGv~l~el~t~g~~P~~~~-----~~~~---~~~~ 476 (535)
T 2h8h_A 408 GLARLIEDN---EYTARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGM-----VNRE---VLDQ 476 (535)
T ss_dssp TSTTTCCCH---HHHTTCSTTSCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHTTTTCCSSTTC-----CHHH---HHHH
T ss_pred ccceecCCC---ceecccCCcCcccccCHHHhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCC-----CHHH---HHHH
Confidence 999765421 1111223345678999999999899999999999999999999 88888432 2222 2222
Q ss_pred HHhcCccCcccccCccccchhhHhHHHHHHHHHHHHHHHHhcCCCCCCCCChhhhhc
Q 038766 242 ALANGINGVRQITDPKLVSSIYEEQEQHQVLEELFKLALVCTSSNPEDRPNMNELLI 298 (299)
Q Consensus 242 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rpt~~~il~ 298 (299)
... +. .... +..++..+.+||.+||..||++|||+++|++
T Consensus 477 i~~-~~----~~~~------------~~~~~~~l~~li~~cl~~dP~~RPt~~~l~~ 516 (535)
T 2h8h_A 477 VER-GY----RMPC------------PPECPESLHDLMCQCWRKEPEERPTFEYLQA 516 (535)
T ss_dssp HHT-TC----CCCC------------CTTCCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred HHc-CC----CCCC------------CCCCCHHHHHHHHHHcCCChhHCcCHHHHHH
Confidence 211 10 0000 1234567899999999999999999999875
|
| >1fvr_A Tyrosine-protein kinase TIE-2; tyrosine kinase, transferase; 2.20A {Homo sapiens} SCOP: d.144.1.7 PDB: 2oo8_X* 2osc_A* 2p4i_A* 3l8p_A* 2wqb_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.6e-44 Score=306.59 Aligned_cols=254 Identities=26% Similarity=0.415 Sum_probs=196.0
Q ss_pred hCCCCCCceeecCCcceEEEEEeC-CCcE--EEEEEeccCcCChhhhHHHHHHHHHHHhc-CCcceeeeeeEEEcCCCee
Q 038766 11 TGSFSENNIIGNSNLSTVYKGRLE-DGEI--VAVKKLNFHQFSAESDKSFYREAKTLKEL-KHRNLVKVLGYAWESGKLK 86 (299)
Q Consensus 11 ~~~y~~~~~lg~g~~~~v~~~~~~-~~~~--~~vK~~~~~~~~~~~~~~~~~e~~~l~~l-~h~~i~~~~~~~~~~~~~~ 86 (299)
.++|.+.+.||+|+||.||++.+. ++.. +++|.+.. .........+.+|+.+++++ +||||+++++++.. +...
T Consensus 24 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~v~iK~~~~-~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~-~~~~ 101 (327)
T 1fvr_A 24 WNDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKE-YASKDDHRDFAGELEVLCKLGHHPNIINLLGACEH-RGYL 101 (327)
T ss_dssp GGGCEEEEEEECGGGCEEEEEEEEETTEEEEEEEEEEEC-C------CHHHHHHHHHTTCCCCTTBCCEEEEEEE-TTEE
T ss_pred HHHccceeeeecCCCceEEEEEEccCCcccceeeeeecc-ccchHHHHHHHHHHHHHHhccCCCchhhhceeeee-CCce
Confidence 478999999999999999999864 4554 48998863 23344567788999999999 89999999997655 5567
Q ss_pred EEEEeecCCCChHHHhcCCC------------CCCCCCChhhHHHHHHHHHHHHHHhhcCCCCCeeeecccCCceeeCCC
Q 038766 87 ALILEYMENGSLESVIHGPG------------VDHSRWTLPKRIDVLISVANGLDYLHSGYDIPIVHCDMKPSNILLDRD 154 (299)
Q Consensus 87 ~lv~e~~~~~~L~~~~~~~~------------~~~~~~~~~~~~~i~~qi~~~l~~lh~~~~~~~~H~dl~~~nil~~~~ 154 (299)
++|+||+++++|.+++.... .....+++..++.++.|++.||.|||++ +++|+||||+||+++.+
T Consensus 102 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~---~ivH~dlkp~NIl~~~~ 178 (327)
T 1fvr_A 102 YLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQK---QFIHRDLAARNILVGEN 178 (327)
T ss_dssp EEEECCCTTCBHHHHHHTTCHHHHCHHHHHHTTBSCSSCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEECGG
T ss_pred EEEEecCCCCCHHHHHHhcccccccccccccccccccCCHHHHHHHHHHHHHHHHHHHhC---CccCCCCccceEEEcCC
Confidence 99999999999999997542 2345799999999999999999999999 99999999999999999
Q ss_pred CcEEEeeeccccccccccccccccccccccCcccCChhhhcccCcCccccchhhhHHHHHHHh-CCCCCCCCccCCCCch
Q 038766 155 FEAHVSDFGTSRMLDVHLQDLSSLSTAFQGTIGYLAPEFAYMRIVTTKVDVFSFGIVVMEFLT-KRRPTGLDEENGLSPI 233 (299)
Q Consensus 155 ~~v~l~df~~~~~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~DiwslG~~l~~l~~-g~~p~~~~~~~~~~~~ 233 (299)
+.++|+|||++..... ........+++.|+|||.+.+..++.++||||||+++|+|++ |..||.... ..
T Consensus 179 ~~~kL~Dfg~~~~~~~-----~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~pf~~~~-----~~ 248 (327)
T 1fvr_A 179 YVAKIADFGLSRGQEV-----YVKKTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMT-----CA 248 (327)
T ss_dssp GCEEECCTTCEESSCE-----ECCC----CCTTTCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCTTTTCC-----HH
T ss_pred CeEEEcccCcCccccc-----cccccCCCCCccccChhhhccccCCchhcchHHHHHHHHHHcCCCCCCCCCc-----HH
Confidence 9999999999864321 112233345788999999998889999999999999999998 999985331 11
Q ss_pred hHHHHHHHHHhcCccCcccccCccccchhhHhHHHHHHHHHHHHHHHHhcCCCCCCCCChhhhhcC
Q 038766 234 SLRQLVEKALANGINGVRQITDPKLVSSIYEEQEQHQVLEELFKLALVCTSSNPEDRPNMNELLIT 299 (299)
Q Consensus 234 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rpt~~~il~~ 299 (299)
+...... ... .... +..++..+.++|.+||..||++|||+++++++
T Consensus 249 ---~~~~~~~-~~~----~~~~------------~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~ 294 (327)
T 1fvr_A 249 ---ELYEKLP-QGY----RLEK------------PLNCDDEVYDLMRQCWREKPYERPSFAQILVS 294 (327)
T ss_dssp ---HHHHHGG-GTC----CCCC------------CTTBCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred ---HHHHHhh-cCC----CCCC------------CCCCCHHHHHHHHHHccCChhhCcCHHHHHHH
Confidence 1111111 110 0000 11234679999999999999999999999863
|
| >2jii_A Serine/threonine-protein kinase VRK3 molecule: VA related kinase 3; transferase, pseudo kinase domain, vaccinia related kinase, ATP-binding; 2.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.4e-44 Score=308.23 Aligned_cols=260 Identities=14% Similarity=0.177 Sum_probs=199.4
Q ss_pred hCCCCCCceeecCCcceEEEEEeC---------CCcEEEEEEeccCcCChhhhHHHHHHHHHHHhcCCcceee-------
Q 038766 11 TGSFSENNIIGNSNLSTVYKGRLE---------DGEIVAVKKLNFHQFSAESDKSFYREAKTLKELKHRNLVK------- 74 (299)
Q Consensus 11 ~~~y~~~~~lg~g~~~~v~~~~~~---------~~~~~~vK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~------- 74 (299)
.++|.+.+.||+|+||+||+|.+. +++.||+|++... ..+.+|+.++++++||||++
T Consensus 41 ~~~y~~~~~lg~G~~g~Vy~~~~~~t~~~~~~~~~~~vavK~~~~~-------~~~~~E~~~l~~l~h~niv~~~~~~~~ 113 (352)
T 2jii_A 41 GRQWKLKSFQTRDNQGILYEAAPTSTLTCDSGPQKQKFSLKLDAKD-------GRLFNEQNFFQRAAKPLQVNKWKKLYS 113 (352)
T ss_dssp SCEEEEEEEEEEETTEEEEEEEECC-----------CEEEEEEETT-------STHHHHHHHHHHHCCHHHHHHHHHHTT
T ss_pred CCeEEEEEEecCCCCeEEEEEeecCCccccccccCceEEEEEeccc-------chHHHHHHHHHHhcccchhhhhhhhcc
Confidence 478999999999999999999875 3789999998632 46788999999999999887
Q ss_pred --------eeeEEEcCCCeeEEEEeecCCCChHHHhcCCCCCCCCCChhhHHHHHHHHHHHHHHhhcCCCCCeeeecccC
Q 038766 75 --------VLGYAWESGKLKALILEYMENGSLESVIHGPGVDHSRWTLPKRIDVLISVANGLDYLHSGYDIPIVHCDMKP 146 (299)
Q Consensus 75 --------~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lh~~~~~~~~H~dl~~ 146 (299)
+++++...+...++|+||+ +++|.+++... ....+++..++.++.|++.||+|||++ +++|+||||
T Consensus 114 ~~~~~i~~~~~~~~~~~~~~~lv~e~~-~~~L~~~l~~~--~~~~l~~~~~~~i~~qi~~~L~~LH~~---~ivH~Dikp 187 (352)
T 2jii_A 114 TPLLAIPTCMGFGVHQDKYRFLVLPSL-GRSLQSALDVS--PKHVLSERSVLQVACRLLDALEFLHEN---EYVHGNVTA 187 (352)
T ss_dssp CTTCSCCCCCEEEEETTTEEEEEEECC-CEEHHHHHHHS--GGGCCCHHHHHHHHHHHHHHHHHHHHT---TCBCSCCCG
T ss_pred CCccCccchhhccccCCcEEEEEecCC-CcCHHHHHHhC--CcCCCCHHHHHHHHHHHHHHHHHHHhC---CccCCCCCH
Confidence 5676666677889999999 89999999732 236799999999999999999999999 999999999
Q ss_pred CceeeCCCC--cEEEeeeccccccccccccc---cccccccccCcccCChhhhcccCcCccccchhhhHHHHHHHhCCCC
Q 038766 147 SNILLDRDF--EAHVSDFGTSRMLDVHLQDL---SSLSTAFQGTIGYLAPEFAYMRIVTTKVDVFSFGIVVMEFLTKRRP 221 (299)
Q Consensus 147 ~nil~~~~~--~v~l~df~~~~~~~~~~~~~---~~~~~~~~~~~~y~~PE~~~~~~~~~~~DiwslG~~l~~l~~g~~p 221 (299)
+||+++.++ .++|+|||++..+....... ........+++.|+|||++.+..++.++||||||+++|+|++|..|
T Consensus 188 ~NIl~~~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~p 267 (352)
T 2jii_A 188 ENIFVDPEDQSQVTLAGYGFAFRYCPSGKHVAYVEGSRSPHEGDLEFISMDLHKGCGPSRRSDLQSLGYCMLKWLYGFLP 267 (352)
T ss_dssp GGEEEETTEEEEEEECCGGGCBCSSGGGCCCCCCTTSSCTTCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSCCT
T ss_pred HHEEEcCCCCceEEEecCcceeeccCCCccccccccccccccCCccccCHHHHccCCCCchhhHHHHHHHHHHHHhCCCC
Confidence 999999998 89999999997655322111 1122344689999999999999999999999999999999999999
Q ss_pred CCCCccCCCCchhHHHHHHHHHhcCccCcccccCccccchhhHhHHHHHHHHHHHHHHHHhcCCCCCCCCChhhhhc
Q 038766 222 TGLDEENGLSPISLRQLVEKALANGINGVRQITDPKLVSSIYEEQEQHQVLEELFKLALVCTSSNPEDRPNMNELLI 298 (299)
Q Consensus 222 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rpt~~~il~ 298 (299)
|..... ....+........... .. +...... ...++..+.++|.+||..||++|||++++++
T Consensus 268 f~~~~~---~~~~~~~~~~~~~~~~-~~---~~~~~~~--------~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~ 329 (352)
T 2jii_A 268 WTNCLP---NTEDIMKQKQKFVDKP-GP---FVGPCGH--------WIRPSETLQKYLKVVMALTYEEKPPYAMLRN 329 (352)
T ss_dssp TGGGTT---CHHHHHHHHHHHHHSC-CC---EECTTSC--------EECCCHHHHHHHHHHHTCCTTCCCCHHHHHH
T ss_pred cccCCc---CHHHHHHHHHhccCCh-hh---hhhhccc--------cCCCcHHHHHHHHHHHhCChhhCCCHHHHHH
Confidence 964321 1122222222211111 11 1000000 0123467999999999999999999999975
|
| >3lzb_A Epidermal growth factor receptor; epidermal growth factor kinase domain, multitargeted small M kinase inhibitor; HET: ITI; 2.70A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.2e-44 Score=305.24 Aligned_cols=252 Identities=24% Similarity=0.413 Sum_probs=193.0
Q ss_pred hCCCCCCceeecCCcceEEEEEeC-CCcE----EEEEEeccCcCChhhhHHHHHHHHHHHhcCCcceeeeeeEEEcCCCe
Q 038766 11 TGSFSENNIIGNSNLSTVYKGRLE-DGEI----VAVKKLNFHQFSAESDKSFYREAKTLKELKHRNLVKVLGYAWESGKL 85 (299)
Q Consensus 11 ~~~y~~~~~lg~g~~~~v~~~~~~-~~~~----~~vK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~ 85 (299)
.++|++.+.||+|+||+||++.+. +++. +++|.+.. .........+.+|+.+++.++||||+++++++... .
T Consensus 14 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~kv~iK~~~~-~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~-~- 90 (327)
T 3lzb_A 14 ETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELRE-ATSPKANKEILDEAYVMASVDNPHVCRLLGICLTS-T- 90 (327)
T ss_dssp TTTEEEEEEEEECSSEEEEEEEECCTTCSCCEEEEEEEECC-CSSCCCHHHHHHHHHHHTTCCBTTBCCCCEEEESS-S-
T ss_pred HhHceEEEEeeeCCCeEEEEEEEcCCCceEEEEEEEEeecc-ccCHHHHHHHHHHHHHHHhCCCCCeeEEEEEEecC-C-
Confidence 578999999999999999999864 3443 57777653 23445677889999999999999999999977653 3
Q ss_pred eEEEEeecCCCChHHHhcCCCCCCCCCChhhHHHHHHHHHHHHHHhhcCCCCCeeeecccCCceeeCCCCcEEEeeeccc
Q 038766 86 KALILEYMENGSLESVIHGPGVDHSRWTLPKRIDVLISVANGLDYLHSGYDIPIVHCDMKPSNILLDRDFEAHVSDFGTS 165 (299)
Q Consensus 86 ~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lh~~~~~~~~H~dl~~~nil~~~~~~v~l~df~~~ 165 (299)
.++|++++.+++|.+++.. ....+++..++.++.|++.||.|||+. +++|+||||+||+++.++.++|+|||++
T Consensus 91 ~~~v~~~~~~g~L~~~l~~---~~~~~~~~~~~~i~~qi~~aL~~LH~~---~ivH~Dikp~NIl~~~~~~~kL~DfG~a 164 (327)
T 3lzb_A 91 VQLITQLMPFGCLLDYVRE---HKDNIGSQYLLNWCVQIAKGMNYLEDR---RLVHRDLAARNVLVKTPQHVKITDFGLA 164 (327)
T ss_dssp EEEEECCCSSCBHHHHHHH---TTTCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEEEETTEEEECCTTC-
T ss_pred ceEEEEecCCCcHHHHHHh---cCCCCCHHHHHHHHHHHHHHHHHHhhC---CCcCCCCCHHHEEEcCCCCEEEccCcce
Confidence 5899999999999998863 235689999999999999999999999 9999999999999999999999999999
Q ss_pred cccccccccccccccccccCcccCChhhhcccCcCccccchhhhHHHHHHHh-CCCCCCCCccCCCCchhHHHHHHHHHh
Q 038766 166 RMLDVHLQDLSSLSTAFQGTIGYLAPEFAYMRIVTTKVDVFSFGIVVMEFLT-KRRPTGLDEENGLSPISLRQLVEKALA 244 (299)
Q Consensus 166 ~~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~DiwslG~~l~~l~~-g~~p~~~~~~~~~~~~~~~~~~~~~~~ 244 (299)
........ ........+++.|+|||.+.+..++.++||||||+++|+|++ |..||... ....+...+..
T Consensus 165 ~~~~~~~~--~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~ell~~g~~p~~~~-----~~~~~~~~~~~--- 234 (327)
T 3lzb_A 165 KLLGAEEK--EYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGI-----PASEISSILEK--- 234 (327)
T ss_dssp -----------------CCCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTC-----CGGGHHHHHHT---
T ss_pred eEccCccc--cccccCCCccccccCHHHHcCCCCChHHHHHHHHHHHHHHHHCCCCCCCCC-----CHHHHHHHHHc---
Confidence 76542211 111223345778999999999999999999999999999999 99999543 22222222211
Q ss_pred cCccCcccccCccccchhhHhHHHHHHHHHHHHHHHHhcCCCCCCCCChhhhhc
Q 038766 245 NGINGVRQITDPKLVSSIYEEQEQHQVLEELFKLALVCTSSNPEDRPNMNELLI 298 (299)
Q Consensus 245 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rpt~~~il~ 298 (299)
.. .... +..++.++.++|++||..||.+|||++++++
T Consensus 235 ~~-----~~~~------------~~~~~~~l~~li~~~l~~dp~~Rps~~ell~ 271 (327)
T 3lzb_A 235 GE-----RLPQ------------PPICTIDVYMIMRKCWMIDADSRPKFRELII 271 (327)
T ss_dssp TC-----CCCC------------CTTBCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred CC-----CCCC------------CccCCHHHHHHHHHHcCCChhHCcCHHHHHH
Confidence 00 0000 1123457899999999999999999999985
|
| >2vx3_A Dual specificity tyrosine-phosphorylation- regula kinase 1A; serine/threonine-protein kinase, minibrain homolog, nucleotide-binding, transferase; HET: PTR D15 P6G; 2.40A {Homo sapiens} PDB: 2wo6_A* 3anq_A* 3anr_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5e-43 Score=304.81 Aligned_cols=205 Identities=20% Similarity=0.268 Sum_probs=168.8
Q ss_pred HHHHHhCCCCCCceeecCCcceEEEEEeC-CCcEEEEEEeccCcCChhhhHHHHHHHHHHHhcC-Cc-----ceeeeeeE
Q 038766 6 EIENATGSFSENNIIGNSNLSTVYKGRLE-DGEIVAVKKLNFHQFSAESDKSFYREAKTLKELK-HR-----NLVKVLGY 78 (299)
Q Consensus 6 ~~~~~~~~y~~~~~lg~g~~~~v~~~~~~-~~~~~~vK~~~~~~~~~~~~~~~~~e~~~l~~l~-h~-----~i~~~~~~ 78 (299)
..+.+.++|.+.+.||+|+||+||+|.+. +++.||||++.. .......+..|+.+++.++ |+ +++.++++
T Consensus 48 ~~~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~---~~~~~~~~~~e~~~l~~l~~~~~~~~~~iv~~~~~ 124 (382)
T 2vx3_A 48 NGEKWMDRYEIDSLIGKGSFGQVVKAYDRVEQEWVAIKIIKN---KKAFLNQAQIEVRLLELMNKHDTEMKYYIVHLKRH 124 (382)
T ss_dssp TTCEETTTEEEEEEEEEETTEEEEEEEETTTTEEEEEEEECS---SHHHHHHHHHHHHHHHHHHHCSSGGGGGBCCEEEE
T ss_pred cCCEeeeeEEEEEEEeecCCEEEEEEEEcCCCcEEEEEEEec---cHHHHHHHHHHHHHHHHHHhcccccceeEEEeeee
Confidence 34556789999999999999999999875 588999999863 2344567778888888885 44 49999996
Q ss_pred EEcCCCeeEEEEeecCCCChHHHhcCCCCCCCCCChhhHHHHHHHHHHHHHHhhcCCCCCeeeecccCCceeeC--CCCc
Q 038766 79 AWESGKLKALILEYMENGSLESVIHGPGVDHSRWTLPKRIDVLISVANGLDYLHSGYDIPIVHCDMKPSNILLD--RDFE 156 (299)
Q Consensus 79 ~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lh~~~~~~~~H~dl~~~nil~~--~~~~ 156 (299)
+.. ....++|+|++. ++|.+++... ....+++..++.++.|++.||.|||++ ..+++||||||+||+++ .++.
T Consensus 125 ~~~-~~~~~lv~e~~~-~~L~~~l~~~--~~~~~~~~~~~~i~~qi~~al~~lH~~-~~~ivHrDlkp~NIll~~~~~~~ 199 (382)
T 2vx3_A 125 FMF-RNHLCLVFEMLS-YNLYDLLRNT--NFRGVSLNLTRKFAQQMCTALLFLATP-ELSIIHCDLKPENILLCNPKRSA 199 (382)
T ss_dssp EEE-TTEEEEEEECCC-CBHHHHHHHT--TTSCCCHHHHHHHHHHHHHHHHHHTST-TTCEECCCCSGGGEEESSTTSCC
T ss_pred ecc-CCceEEEEecCC-CCHHHHHhhc--CcCCCCHHHHHHHHHHHHHHHHHhccC-CCCEEcCCCCcccEEEecCCCCc
Confidence 665 456799999995 5999988643 234689999999999999999999942 12999999999999995 4778
Q ss_pred EEEeeeccccccccccccccccccccccCcccCChhhhcccCcCccccchhhhHHHHHHHhCCCCCCCC
Q 038766 157 AHVSDFGTSRMLDVHLQDLSSLSTAFQGTIGYLAPEFAYMRIVTTKVDVFSFGIVVMEFLTKRRPTGLD 225 (299)
Q Consensus 157 v~l~df~~~~~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~DiwslG~~l~~l~~g~~p~~~~ 225 (299)
+||+|||++.... .......+|+.|+|||++.+..++.++|||||||++|+|++|..||...
T Consensus 200 ~kL~DFG~a~~~~-------~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~pf~~~ 261 (382)
T 2vx3_A 200 IKIVDFGSSCQLG-------QRIYQYIQSRFYRSPEVLLGMPYDLAIDMWSLGCILVEMHTGEPLFSGA 261 (382)
T ss_dssp EEECCCTTCEETT-------CCCCSSCSCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSSCCS
T ss_pred EEEEeccCceecc-------cccccccCCccccChHHHcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCC
Confidence 9999999997653 2233456789999999999999999999999999999999999999643
|
| >2i1m_A Macrophage colony-stimulating factor 1 receptor; kinase domain, kinase inhibitor complex, transferase; HET: 5CN; 1.80A {Homo sapiens} PDB: 3bea_A* 3lcd_A* 2i0y_A* 2i0v_A* 3dpk_A* 3krj_A* 3krl_A* 2ogv_A 3lco_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.1e-44 Score=305.52 Aligned_cols=262 Identities=22% Similarity=0.313 Sum_probs=203.2
Q ss_pred HHHHHhCCCCCCceeecCCcceEEEEEeCC------CcEEEEEEeccCcCChhhhHHHHHHHHHHHhc-CCcceeeeeeE
Q 038766 6 EIENATGSFSENNIIGNSNLSTVYKGRLED------GEIVAVKKLNFHQFSAESDKSFYREAKTLKEL-KHRNLVKVLGY 78 (299)
Q Consensus 6 ~~~~~~~~y~~~~~lg~g~~~~v~~~~~~~------~~~~~vK~~~~~~~~~~~~~~~~~e~~~l~~l-~h~~i~~~~~~ 78 (299)
+++...++|.+.+.||+|+||+||++.+.. ...||+|++... ........+.+|+.+++.+ +||||++++++
T Consensus 40 ~~~~~~~~~~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~-~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~ 118 (333)
T 2i1m_A 40 KWEFPRNNLQFGKTLGAGAFGKVVEATAFGLGKEDAVLKVAVKMLKST-AHADEKEALMSELKIMSHLGQHENIVNLLGA 118 (333)
T ss_dssp GGBCCTTSEEEEEEEEECSSEEEEEEEETTCSSSCCCCEEEEEEECTT-CCHHHHHHHHHHHHHHHHHCCCTTBCCEEEE
T ss_pred cccCCHHHceeeeEeccCCCcceEEEEecCCCcccchhHHHHHhcccc-cChHHHHHHHHHHHHHHhhcCCCCeeeEEEE
Confidence 466677899999999999999999998642 247999998643 2445567889999999999 89999999997
Q ss_pred EEcCCCeeEEEEeecCCCChHHHhcCCC----------CCCCCCChhhHHHHHHHHHHHHHHhhcCCCCCeeeecccCCc
Q 038766 79 AWESGKLKALILEYMENGSLESVIHGPG----------VDHSRWTLPKRIDVLISVANGLDYLHSGYDIPIVHCDMKPSN 148 (299)
Q Consensus 79 ~~~~~~~~~lv~e~~~~~~L~~~~~~~~----------~~~~~~~~~~~~~i~~qi~~~l~~lh~~~~~~~~H~dl~~~n 148 (299)
+.. +...++|+||+.+++|.+++.... .....+++..++.++.|++.||.|||++ +++|+||||+|
T Consensus 119 ~~~-~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~---~ivH~Dlkp~N 194 (333)
T 2i1m_A 119 CTH-GGPVLVITEYCCYGDLLNFLRRKSRVLETDPAFAIANSTASTRDLLHFSSQVAQGMAFLASK---NCIHRDVAARN 194 (333)
T ss_dssp ECS-SSSCEEEEECCTTEEHHHHHHHHHHHHSCC-------CCCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGG
T ss_pred Eec-CCceEEEEecCCCCcHHHHHHHhcccccccccccccccccCHHHHHHHHHHHHHHHHHHhcC---CcccCCcccce
Confidence 655 445699999999999999885321 0134689999999999999999999999 99999999999
Q ss_pred eeeCCCCcEEEeeeccccccccccccccccccccccCcccCChhhhcccCcCccccchhhhHHHHHHHh-CCCCCCCCcc
Q 038766 149 ILLDRDFEAHVSDFGTSRMLDVHLQDLSSLSTAFQGTIGYLAPEFAYMRIVTTKVDVFSFGIVVMEFLT-KRRPTGLDEE 227 (299)
Q Consensus 149 il~~~~~~v~l~df~~~~~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~DiwslG~~l~~l~~-g~~p~~~~~~ 227 (299)
|+++.++.++|+|||++....... .........+++.|+|||.+.+..++.++||||||+++|+|++ |..||.....
T Consensus 195 Il~~~~~~~kl~Dfg~~~~~~~~~--~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~~~~~~ 272 (333)
T 2i1m_A 195 VLLTNGHVAKIGDFGLARDIMNDS--NYIVKGNARLPVKWMAPESIFDCVYTVQSDVWSYGILLWEIFSLGLNPYPGILV 272 (333)
T ss_dssp CEEEGGGEEEBCCCGGGCCGGGCT--TSEECSSCEECGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHTTTSCCSSTTCCS
T ss_pred EEECCCCeEEECcccccccccccc--ceeecCCCCCCccccCHHHhccCCCChHHHHHHHHHHHHHHHcCCCCCCcccch
Confidence 999999999999999997654211 1112234456788999999999899999999999999999998 8888854321
Q ss_pred CCCCchhHHHHHHHHHhcCccCcccccCccccchhhHhHHHHHHHHHHHHHHHHhcCCCCCCCCChhhhhc
Q 038766 228 NGLSPISLRQLVEKALANGINGVRQITDPKLVSSIYEEQEQHQVLEELFKLALVCTSSNPEDRPNMNELLI 298 (299)
Q Consensus 228 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rpt~~~il~ 298 (299)
.......... .... .. +...+..+.+++.+||..||++|||++++++
T Consensus 273 ----~~~~~~~~~~----~~~~----~~------------~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~ 319 (333)
T 2i1m_A 273 ----NSKFYKLVKD----GYQM----AQ------------PAFAPKNIYSIMQACWALEPTHRPTFQQICS 319 (333)
T ss_dssp ----SHHHHHHHHH----TCCC----CC------------CTTCCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred ----hHHHHHHHhc----CCCC----CC------------CCCCCHHHHHHHHHHhccChhhCcCHHHHHH
Confidence 1111121111 1000 00 1112457899999999999999999999985
|
| >2i6l_A Mitogen-activated protein kinase 6; MAPK6, ERK3, extracellular signal regulated kinase 3, serine phosphorylation, threonine phosphorylation; 2.25A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.8e-43 Score=299.01 Aligned_cols=271 Identities=22% Similarity=0.287 Sum_probs=195.6
Q ss_pred HHhCCCCCCceeecCCcceEEEEEeC-CCcEEEEEEeccCcCChhhhHHHHHHHHHHHhcCCcceeeeeeEEEc------
Q 038766 9 NATGSFSENNIIGNSNLSTVYKGRLE-DGEIVAVKKLNFHQFSAESDKSFYREAKTLKELKHRNLVKVLGYAWE------ 81 (299)
Q Consensus 9 ~~~~~y~~~~~lg~g~~~~v~~~~~~-~~~~~~vK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~------ 81 (299)
.+.++|.+.+.||+|++|.||++.+. +++.||+|++... .....+.+.+|+.+++.++||||+++++++..
T Consensus 8 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~--~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~ 85 (320)
T 2i6l_A 8 DLGSRYMDLKPLGCGGNGLVFSAVDNDCDKRVAIKKIVLT--DPQSVKHALREIKIIRRLDHDNIVKVFEILGPSGSQLT 85 (320)
T ss_dssp EETTTEEEEEECC-----CEEEEEETTTTEEEEEEEEECC--SHHHHHHHHHHHHHHHTCCCTTBCCEEEEECTTSCBCC
T ss_pred ccCCceeEEEEeccCCCeEEEEEEECCCCeEEEEEEEecC--ChHHHHHHHHHHHHHHhcCCCCeeEEEEeccccccccc
Confidence 45789999999999999999999875 4899999998633 45566788999999999999999999997642
Q ss_pred -------CCCeeEEEEeecCCCChHHHhcCCCCCCCCCChhhHHHHHHHHHHHHHHhhcCCCCCeeeecccCCceeeC-C
Q 038766 82 -------SGKLKALILEYMENGSLESVIHGPGVDHSRWTLPKRIDVLISVANGLDYLHSGYDIPIVHCDMKPSNILLD-R 153 (299)
Q Consensus 82 -------~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lh~~~~~~~~H~dl~~~nil~~-~ 153 (299)
.....++|+||+. ++|.+++. ..++++..++.++.|++.||+|||++ +++|+||||+||+++ .
T Consensus 86 ~~~~~~~~~~~~~lv~e~~~-~~L~~~~~-----~~~~~~~~~~~~~~qi~~~l~~lH~~---~i~H~dlkp~Nil~~~~ 156 (320)
T 2i6l_A 86 DDVGSLTELNSVYIVQEYME-TDLANVLE-----QGPLLEEHARLFMYQLLRGLKYIHSA---NVLHRDLKPANLFINTE 156 (320)
T ss_dssp C----CCSCSEEEEEEECCS-EEHHHHHT-----TCCCCHHHHHHHHHHHHHHHHHHHHT---TCBCCCCSGGGEEEETT
T ss_pred cccccccccCceeEEeeccC-CCHHHHhh-----cCCccHHHHHHHHHHHHHHHHHHHhC---CEecCCCCHHHEEEcCC
Confidence 3356799999997 59999985 35689999999999999999999999 999999999999997 5
Q ss_pred CCcEEEeeeccccccccccccccccccccccCcccCChhhhcc-cCcCccccchhhhHHHHHHHhCCCCCCCCccCCCCc
Q 038766 154 DFEAHVSDFGTSRMLDVHLQDLSSLSTAFQGTIGYLAPEFAYM-RIVTTKVDVFSFGIVVMEFLTKRRPTGLDEENGLSP 232 (299)
Q Consensus 154 ~~~v~l~df~~~~~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~-~~~~~~~DiwslG~~l~~l~~g~~p~~~~~~~~~~~ 232 (299)
++.++|+|||++........ .........++..|+|||.+.+ ..++.++||||||+++|+|++|..||.....
T Consensus 157 ~~~~kl~Dfg~~~~~~~~~~-~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~----- 230 (320)
T 2i6l_A 157 DLVLKIGDFGLARIMDPHYS-HKGHLSEGLVTKWYRSPRLLLSPNNYTKAIDMWAAGCIFAEMLTGKTLFAGAHE----- 230 (320)
T ss_dssp TTEEEECCCTTCBCC---------CCCGGGSCCTTCCHHHHHCTTCCCHHHHHHHHHHHHHHHHHSSCSSCCSSH-----
T ss_pred CCeEEEccCccccccCCCcc-cccccccccccccccCcHHhcCcccCCchhhhHhHHHHHHHHHhCCCCCCCCCH-----
Confidence 67899999999976542111 1112233456889999998765 6788999999999999999999999964321
Q ss_pred hhHHHHHHHHHhcCccCc----ccccC--cc-----cc-chhhHhHHHHHHHHHHHHHHHHhcCCCCCCCCChhhhhcC
Q 038766 233 ISLRQLVEKALANGINGV----RQITD--PK-----LV-SSIYEEQEQHQVLEELFKLALVCTSSNPEDRPNMNELLIT 299 (299)
Q Consensus 233 ~~~~~~~~~~~~~~~~~~----~~~~~--~~-----~~-~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rpt~~~il~~ 299 (299)
. +.+........... ..... +. .. ...........++.++.++|++||..||++|||++++|+|
T Consensus 231 ~---~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~h 306 (320)
T 2i6l_A 231 L---EQMQLILESIPVVHEEDRQELLSVIPVYIRNDMTEPHKPLTQLLPGISREAVDFLEQILTFSPMDRLTAEEALSH 306 (320)
T ss_dssp H---HHHHHHHHHSCCCCHHHHHHHHTTSCHHHHHHTTSCCCCHHHHSTTCCHHHHHHHHTTSCSSGGGSCCHHHHHTS
T ss_pred H---HHHHHHHHhcCCCchhhhhhhhhcCcccccccccCCCCChhHhcchhhHHHHHHHHHHcCCCccccCCHHHHhCC
Confidence 1 11111111000000 00000 00 00 0000001123457789999999999999999999999987
|
| >2rio_A Serine/threonine-protein kinase/endoribonuclease IRE1; protein-nucleotide complex, ATP-binding, endoplasmic reticulum, glycoprotein; HET: ADP; 2.40A {Saccharomyces cerevisiae} PDB: 3lj0_A* 3lj1_A* 3lj2_A* 3fbv_A* 3sdm_A* 3sdj_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.1e-43 Score=311.79 Aligned_cols=259 Identities=25% Similarity=0.328 Sum_probs=186.7
Q ss_pred HhCCCCCCceeecCCcceEEEEEeCCCcEEEEEEeccCcCChhhhHHHHHHHHHHHhc-CCcceeeeeeEEEcCCCeeEE
Q 038766 10 ATGSFSENNIIGNSNLSTVYKGRLEDGEIVAVKKLNFHQFSAESDKSFYREAKTLKEL-KHRNLVKVLGYAWESGKLKAL 88 (299)
Q Consensus 10 ~~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~vK~~~~~~~~~~~~~~~~~e~~~l~~l-~h~~i~~~~~~~~~~~~~~~l 88 (299)
+.+.|.+.+.||+|+||+||.+...+|+.||||++.. +..+.+.+|+.+++.+ +||||+++++++. .+...++
T Consensus 13 l~~~~~~~~~LG~G~~g~V~~~~~~~g~~vAvK~~~~-----~~~~~~~~E~~~l~~l~~HpnIv~~~~~~~-~~~~~~l 86 (434)
T 2rio_A 13 LKNLVVSEKILGYGSSGTVVFQGSFQGRPVAVKRMLI-----DFCDIALMEIKLLTESDDHPNVIRYYCSET-TDRFLYI 86 (434)
T ss_dssp CSSCEEEEEEEEECSTTCEEEEEESSSSEEEEEEEEG-----GGHHHHHHHHHHHHHHTTSTTBCCEEEEEE-CSSEEEE
T ss_pred hhheeeccCeEeeCCCeEEEEEEEECCeEEEEEEEcH-----HHHHHHHHHHHHHHhccCCCCcCeEEEEEe-cCCeEEE
Confidence 4455666789999999999887777799999999853 2345678899999876 7999999999654 4567799
Q ss_pred EEeecCCCChHHHhcCCCCCCC---CCChhhHHHHHHHHHHHHHHhhcCCCCCeeeecccCCceeeCCC-----------
Q 038766 89 ILEYMENGSLESVIHGPGVDHS---RWTLPKRIDVLISVANGLDYLHSGYDIPIVHCDMKPSNILLDRD----------- 154 (299)
Q Consensus 89 v~e~~~~~~L~~~~~~~~~~~~---~~~~~~~~~i~~qi~~~l~~lh~~~~~~~~H~dl~~~nil~~~~----------- 154 (299)
|+|++. ++|.+++........ ..++..++.++.||+.||+|||++ +++||||||+||+++.+
T Consensus 87 v~E~~~-gsL~~~l~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~---~ivHrDLkp~NILl~~~~~~~~~~~~~~ 162 (434)
T 2rio_A 87 ALELCN-LNLQDLVESKNVSDENLKLQKEYNPISLLRQIASGVAHLHSL---KIIHRDLKPQNILVSTSSRFTADQQTGA 162 (434)
T ss_dssp EECCCS-EEHHHHHHTC------------CCHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEEECCHHHHSCCTTCC
T ss_pred EEecCC-CCHHHHHhccCCCchhhhhccchhHHHHHHHHHHHHHHHHHC---CccccCCChHhEEEecCcccccccccCC
Confidence 999995 599999975432221 124556788999999999999999 99999999999999754
Q ss_pred --CcEEEeeeccccccccccccccccccccccCcccCChhhhcc-------cCcCccccchhhhHHHHHHHh-CCCCCCC
Q 038766 155 --FEAHVSDFGTSRMLDVHLQDLSSLSTAFQGTIGYLAPEFAYM-------RIVTTKVDVFSFGIVVMEFLT-KRRPTGL 224 (299)
Q Consensus 155 --~~v~l~df~~~~~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~-------~~~~~~~DiwslG~~l~~l~~-g~~p~~~ 224 (299)
+.++|+|||++..................+|+.|+|||++.+ ..++.++|||||||++|+|++ |..||..
T Consensus 163 ~~~~~kL~DFG~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~DiwSlG~il~ellt~g~~Pf~~ 242 (434)
T 2rio_A 163 ENLRILISDFGLCKKLDSGQSSFRTNLNNPSGTSGWRAPELLEESNNLQTKRRLTRSIDIFSMGCVFYYILSKGKHPFGD 242 (434)
T ss_dssp CSCEEEECCCTTCEECCC--------------CCTTSCHHHHSCCCTTSCCCCCCTHHHHHHHHHHHHHHHTTSCCTTCS
T ss_pred CceEEEEcccccceecCCCCccceeeecCCCCCCCccCHHHhccccccccccCcchhhhhHhHHHHHHHHHhCCCCCCCC
Confidence 479999999998665322111222334578999999999876 568899999999999999998 8899853
Q ss_pred CccCCCCchhHHHHHHHHHhcCccCcccccCccccchhhHhHHHHHHHHHHHHHHHHhcCCCCCCCCChhhhhcC
Q 038766 225 DEENGLSPISLRQLVEKALANGINGVRQITDPKLVSSIYEEQEQHQVLEELFKLALVCTSSNPEDRPNMNELLIT 299 (299)
Q Consensus 225 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rpt~~~il~~ 299 (299)
.... ... ... .......... .....++.++.++|.+||..||++|||+.++++|
T Consensus 243 ~~~~------~~~----i~~-~~~~~~~~~~----------~~~~~~~~~~~~li~~~L~~dP~~Rps~~eil~h 296 (434)
T 2rio_A 243 KYSR------ESN----IIR-GIFSLDEMKC----------LHDRSLIAEATDLISQMIDHDPLKRPTAMKVLRH 296 (434)
T ss_dssp TTTH------HHH----HHH-TCCCCCCCTT----------CCCHHHHHHHHHHHHHHTCSSGGGSCCHHHHHTS
T ss_pred chhh------HHH----Hhc-CCCCcccccc----------cccccchHHHHHHHHHHhhCChhhCCCHHHHHhC
Confidence 3110 011 111 1101111100 0134567889999999999999999999999987
|
| >2yfx_A Tyrosine-protein kinase receptor; nucleotide-binding, transferase; HET: VGH; 1.70A {Homo sapiens} PDB: 2xp2_A* 3aox_A* 2yhv_A 3lcs_A* 3lct_A* 4dce_A* 2xba_A* 2xb7_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.6e-44 Score=305.11 Aligned_cols=260 Identities=23% Similarity=0.365 Sum_probs=198.6
Q ss_pred HHHhCCCCCCceeecCCcceEEEEEe------CCCcEEEEEEeccCcCChhhhHHHHHHHHHHHhcCCcceeeeeeEEEc
Q 038766 8 ENATGSFSENNIIGNSNLSTVYKGRL------EDGEIVAVKKLNFHQFSAESDKSFYREAKTLKELKHRNLVKVLGYAWE 81 (299)
Q Consensus 8 ~~~~~~y~~~~~lg~g~~~~v~~~~~------~~~~~~~vK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~ 81 (299)
+...++|.+.+.||+|+||.||++.+ .++..||+|++.. .........+.+|+..+++++||||+++++++..
T Consensus 26 ~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~-~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~ 104 (327)
T 2yfx_A 26 EVPRKNITLIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPE-VCSEQDELDFLMEALIISKFNHQNIVRCIGVSLQ 104 (327)
T ss_dssp BCCGGGCEEEEECC--CSSCEEEEEC--------CCEEEEEECCS-SCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEECS
T ss_pred cCChhheEEEEEEcCCCCeeEEEEEEcCCCCCCccceEEEEEecc-ccchhhHHHHHHHHHHHhhCCCCCCCeEEEEEcC
Confidence 45678999999999999999999984 3477899999863 3344556778899999999999999999997665
Q ss_pred CCCeeEEEEeecCCCChHHHhcCCCC---CCCCCChhhHHHHHHHHHHHHHHhhcCCCCCeeeecccCCceeeCC---CC
Q 038766 82 SGKLKALILEYMENGSLESVIHGPGV---DHSRWTLPKRIDVLISVANGLDYLHSGYDIPIVHCDMKPSNILLDR---DF 155 (299)
Q Consensus 82 ~~~~~~lv~e~~~~~~L~~~~~~~~~---~~~~~~~~~~~~i~~qi~~~l~~lh~~~~~~~~H~dl~~~nil~~~---~~ 155 (299)
....++|+||+.+++|.+++..... ....+++..++.++.|++.||.|||+. +++|+||||+||+++. ++
T Consensus 105 -~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~i~~qi~~al~~LH~~---~i~H~dlkp~NIli~~~~~~~ 180 (327)
T 2yfx_A 105 -SLPRFILMELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYLEEN---HFIHRDIAARNCLLTCPGPGR 180 (327)
T ss_dssp -SSSCEEEEECCTTEEHHHHHHHTSCCSSSTTSCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEESCSSTTC
T ss_pred -CCCcEEEEecCCCCcHHHHHHhhcccccccccccHHHHHHHHHHHHHHHHHHhhC---CeecCcCCHhHEEEecCCCcc
Confidence 4455999999999999999875321 224589999999999999999999999 9999999999999984 44
Q ss_pred cEEEeeeccccccccccccccccccccccCcccCChhhhcccCcCccccchhhhHHHHHHHh-CCCCCCCCccCCCCchh
Q 038766 156 EAHVSDFGTSRMLDVHLQDLSSLSTAFQGTIGYLAPEFAYMRIVTTKVDVFSFGIVVMEFLT-KRRPTGLDEENGLSPIS 234 (299)
Q Consensus 156 ~v~l~df~~~~~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~DiwslG~~l~~l~~-g~~p~~~~~~~~~~~~~ 234 (299)
.++|+|||++...... ..........+++.|+|||.+.+..++.++||||||+++|+|++ |..||... ...
T Consensus 181 ~~kl~Dfg~~~~~~~~--~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~-----~~~- 252 (327)
T 2yfx_A 181 VAKIGDFGMARDIYRA--SYYRKGGCAMLPVKWMPPEAFMEGIFTSKTDTWSFGVLLWEIFSLGYMPYPSK-----SNQ- 252 (327)
T ss_dssp CEEECCCHHHHHHHC--------CCGGGSCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTC-----CHH-
T ss_pred eEEECccccccccccc--cccccCCCcCCCcceeCHhHhcCCCCCchhhHHHHHHHHHHHHcCCCCCCCCc-----CHH-
Confidence 6999999998754321 11122334456889999999998899999999999999999998 88888533 111
Q ss_pred HHHHHHHHHhcCccCcccccCccccchhhHhHHHHHHHHHHHHHHHHhcCCCCCCCCChhhhhcC
Q 038766 235 LRQLVEKALANGINGVRQITDPKLVSSIYEEQEQHQVLEELFKLALVCTSSNPEDRPNMNELLIT 299 (299)
Q Consensus 235 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rpt~~~il~~ 299 (299)
............. . +..++..+.++|.+||..||.+|||+++++++
T Consensus 253 --~~~~~~~~~~~~~-----~------------~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~ 298 (327)
T 2yfx_A 253 --EVLEFVTSGGRMD-----P------------PKNCPGPVYRIMTQCWQHQPEDRPNFAIILER 298 (327)
T ss_dssp --HHHHHHHTTCCCC-----C------------CTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred --HHHHHHhcCCCCC-----C------------CCCCCHHHHHHHHHHhcCChhhCcCHHHHHHH
Confidence 2222221111000 0 11234578999999999999999999999864
|
| >2w1i_A JAK2; chromosomal rearrangement, nucleotide-binding, tyrosine-protein kinase, proto-oncogene, phosphoprotein, disease mutation, SH2 domain; HET: PTR L0I; 2.60A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=8e-44 Score=303.47 Aligned_cols=266 Identities=25% Similarity=0.389 Sum_probs=201.8
Q ss_pred HHHhCCCCCCceeecCCcceEEEEEe-----CCCcEEEEEEeccCcCChhhhHHHHHHHHHHHhcCCcceeeeeeEEEcC
Q 038766 8 ENATGSFSENNIIGNSNLSTVYKGRL-----EDGEIVAVKKLNFHQFSAESDKSFYREAKTLKELKHRNLVKVLGYAWES 82 (299)
Q Consensus 8 ~~~~~~y~~~~~lg~g~~~~v~~~~~-----~~~~~~~vK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~ 82 (299)
....++|++.+.||+|++|.||++.. .+++.||+|++.. ........+.+|+..++.++||||+++++++...
T Consensus 37 ~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~--~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~ 114 (326)
T 2w1i_A 37 QFEERHLKFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQH--STEEHLRDFEREIEILKSLQHDNIVKYKGVCYSA 114 (326)
T ss_dssp CCCGGGEEEEEEEECCSSEEEEEEEECTTSSSCCEEEEEEEESS--CCSHHHHHHHHHHHHHHTCCCTTBCCEEEEECC-
T ss_pred ccCHHHceeeeeeccCCCeEEEEEEeccccCCCceEEEEEEecc--CCHHHHHHHHHHHHHHHhCCCCCeeeEEEEEEec
Confidence 34456799999999999999999983 3589999999864 2445567889999999999999999999977654
Q ss_pred C-CeeEEEEeecCCCChHHHhcCCCCCCCCCChhhHHHHHHHHHHHHHHhhcCCCCCeeeecccCCceeeCCCCcEEEee
Q 038766 83 G-KLKALILEYMENGSLESVIHGPGVDHSRWTLPKRIDVLISVANGLDYLHSGYDIPIVHCDMKPSNILLDRDFEAHVSD 161 (299)
Q Consensus 83 ~-~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lh~~~~~~~~H~dl~~~nil~~~~~~v~l~d 161 (299)
+ ...++|+|++.+++|.+++... ...+++..++.++.|++.||.+||+. +++|+||||+||+++.++.++|+|
T Consensus 115 ~~~~~~lv~e~~~~~~L~~~l~~~---~~~~~~~~~~~i~~qi~~aL~~LH~~---~ivH~dikp~NIli~~~~~~kL~D 188 (326)
T 2w1i_A 115 GRRNLKLIMEYLPYGSLRDYLQKH---KERIDHIKLLQYTSQICKGMEYLGTK---RYIHRDLATRNILVENENRVKIGD 188 (326)
T ss_dssp ---CCEEEECCCTTCBHHHHHHHS---TTSSCHHHHHHHHHHHHHHHHHHHHT---TEECSCCCGGGEEEEETTEEEECC
T ss_pred CCCceEEEEECCCCCCHHHHHHhc---ccCCCHHHHHHHHHHHHHHHHHHHhC---CEeccCCCcceEEEcCCCcEEEec
Confidence 3 3568999999999999998632 34689999999999999999999999 999999999999999999999999
Q ss_pred eccccccccccccccccccccccCcccCChhhhcccCcCccccchhhhHHHHHHHhCCCCCCCCcc-------CCCCchh
Q 038766 162 FGTSRMLDVHLQDLSSLSTAFQGTIGYLAPEFAYMRIVTTKVDVFSFGIVVMEFLTKRRPTGLDEE-------NGLSPIS 234 (299)
Q Consensus 162 f~~~~~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~DiwslG~~l~~l~~g~~p~~~~~~-------~~~~~~~ 234 (299)
||++......... ........++..|+|||.+.+..++.++||||||+++|+|++|..|+..... .......
T Consensus 189 fg~~~~~~~~~~~-~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~tg~~~~~~~~~~~~~~~~~~~~~~~ 267 (326)
T 2w1i_A 189 FGLTKVLPQDKEY-YKVKEPGESPIFWYAPESLTESKFSVASDVWSFGVVLYELFTYIEKSKSPPAEFMRMIGNDKQGQM 267 (326)
T ss_dssp CTTCEECCSSCSE-EECSSCCSCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHHTTCGGGSHHHHHHHHHCTTCCTHH
T ss_pred Ccchhhccccccc-cccccCCCCceeEECchhhcCCCCCchhhHHHHHHHHHHHHhcCCCCCCCHHHHHHhhccccchhh
Confidence 9999765422110 1112233456789999999988899999999999999999999988753210 0000000
Q ss_pred HHHHHHHHHhcCccCcccccCccccchhhHhHHHHHHHHHHHHHHHHhcCCCCCCCCChhhhhc
Q 038766 235 LRQLVEKALANGINGVRQITDPKLVSSIYEEQEQHQVLEELFKLALVCTSSNPEDRPNMNELLI 298 (299)
Q Consensus 235 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rpt~~~il~ 298 (299)
....+......... ... +..++.++.++|++||..||++|||++++++
T Consensus 268 ~~~~~~~~~~~~~~----~~~------------~~~~~~~l~~li~~cl~~dP~~Rps~~el~~ 315 (326)
T 2w1i_A 268 IVFHLIELLKNNGR----LPR------------PDGCPDEIYMIMTECWNNNVNQRPSFRDLAL 315 (326)
T ss_dssp HHHHHHHHHHTTCC----CCC------------CTTCCHHHHHHHHHHSCSSGGGSCCHHHHHH
T ss_pred hHHHHHHHhhcCCC----CCC------------CCcccHHHHHHHHHHcCCChhhCcCHHHHHH
Confidence 11111111111100 000 1234567999999999999999999999975
|
| >2eu9_A Dual specificity protein kinase CLK3; kinase domain, transferase; 1.53A {Homo sapiens} PDB: 2wu6_A* 2wu7_A* 3raw_A* 2exe_A 3nr9_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=8.3e-43 Score=300.32 Aligned_cols=270 Identities=18% Similarity=0.219 Sum_probs=199.8
Q ss_pred HHHhCCCCCCceeecCCcceEEEEEeC-CC-cEEEEEEeccCcCChhhhHHHHHHHHHHHhcCCcc------eeeeeeEE
Q 038766 8 ENATGSFSENNIIGNSNLSTVYKGRLE-DG-EIVAVKKLNFHQFSAESDKSFYREAKTLKELKHRN------LVKVLGYA 79 (299)
Q Consensus 8 ~~~~~~y~~~~~lg~g~~~~v~~~~~~-~~-~~~~vK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~------i~~~~~~~ 79 (299)
..+.++|.+.+.||+|+||+||++.+. ++ ..||+|++.. .......+.+|+..++.++|++ ++.+.+++
T Consensus 15 ~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~vavK~~~~---~~~~~~~~~~E~~~l~~l~~~~~~~~~~~~~~~~~~ 91 (355)
T 2eu9_A 15 DWLQERYEIVGNLGEGTFGKVVECLDHARGKSQVALKIIRN---VGKYREAARLEINVLKKIKEKDKENKFLCVLMSDWF 91 (355)
T ss_dssp CEETTTEEEEEEEEEETTEEEEEEEETTTTTEEEEEEEECS---CHHHHHHHHHHHHHHHHHHHHCTTSCSCBCCEEEEE
T ss_pred ceecccEEEEEEeeccCCeEEEEEEecCCCceEEEEEEEcc---cccchhHHHHHHHHHHHHhhcCCCCceeEEEeeeee
Confidence 456789999999999999999999874 34 6899999863 3345677888999999998765 88888865
Q ss_pred EcCCCeeEEEEeecCCCChHHHhcCCCCCCCCCChhhHHHHHHHHHHHHHHhhcCCCCCeeeecccCCceee--------
Q 038766 80 WESGKLKALILEYMENGSLESVIHGPGVDHSRWTLPKRIDVLISVANGLDYLHSGYDIPIVHCDMKPSNILL-------- 151 (299)
Q Consensus 80 ~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lh~~~~~~~~H~dl~~~nil~-------- 151 (299)
.. ....++|+|++ +++|.+.+... ...++++..++.++.||+.||+|||++ +++|+||||+||++
T Consensus 92 ~~-~~~~~lv~e~~-~~~l~~~l~~~--~~~~~~~~~~~~i~~qi~~~L~~lH~~---~ivH~Dlkp~NIll~~~~~~~~ 164 (355)
T 2eu9_A 92 NF-HGHMCIAFELL-GKNTFEFLKEN--NFQPYPLPHVRHMAYQLCHALRFLHEN---QLTHTDLKPENILFVNSEFETL 164 (355)
T ss_dssp EE-TTEEEEEEECC-CCBHHHHHHHT--TTCCCCHHHHHHHHHHHHHHHHHHHTT---TEECCCCCGGGEEESCCCEEEE
T ss_pred ee-CCeEEEEEecc-CCChHHHHHhc--cCCCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCHHHEEEeccccccc
Confidence 55 45669999999 56777766532 234789999999999999999999999 99999999999999
Q ss_pred -----------CCCCcEEEeeeccccccccccccccccccccccCcccCChhhhcccCcCccccchhhhHHHHHHHhCCC
Q 038766 152 -----------DRDFEAHVSDFGTSRMLDVHLQDLSSLSTAFQGTIGYLAPEFAYMRIVTTKVDVFSFGIVVMEFLTKRR 220 (299)
Q Consensus 152 -----------~~~~~v~l~df~~~~~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~DiwslG~~l~~l~~g~~ 220 (299)
+.++.++|+|||++.... .......+|+.|+|||++.+..++.++|||||||++|+|++|..
T Consensus 165 ~~~~~~~~~~~~~~~~~kl~Dfg~~~~~~-------~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~ 237 (355)
T 2eu9_A 165 YNEHKSCEEKSVKNTSIRVADFGSATFDH-------EHHTTIVATRHYRPPEVILELGWAQPCDVWSIGCILFEYYRGFT 237 (355)
T ss_dssp ECCC-CCCEEEESCCCEEECCCTTCEETT-------SCCCSSCSCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSC
T ss_pred ccccccccccccCCCcEEEeecCcccccc-------ccccCCcCCCcccCCeeeecCCCCCccchHHHHHHHHHHHhCCC
Confidence 567899999999987533 22344568999999999999999999999999999999999999
Q ss_pred CCCCCccCCCCchhHHHHHHHHHhcCccCc-------ccccCc--cccchh--------------hHhHHHHHHHHHHHH
Q 038766 221 PTGLDEENGLSPISLRQLVEKALANGINGV-------RQITDP--KLVSSI--------------YEEQEQHQVLEELFK 277 (299)
Q Consensus 221 p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-------~~~~~~--~~~~~~--------------~~~~~~~~~~~~l~~ 277 (299)
||.... .......+........... ...... .+.... .........+.++.+
T Consensus 238 pf~~~~-----~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~ 312 (355)
T 2eu9_A 238 LFQTHE-----NREHLVMMEKILGPIPSHMIHRTRKQKYFYKGGLVWDENSSDGRYVKENCKPLKSYMLQDSLEHVQLFD 312 (355)
T ss_dssp SCCCSS-----HHHHHHHHHHHHCCCCHHHHHHCSCGGGEETTEECCCTTSHHHHHHHHHCCCGGGGCSCCSHHHHHHHH
T ss_pred CCCCCC-----HHHHHHHHHHHcCCCcHHHhhhccchhhhcccccccccccchhccccccCCcccccccccchhHHHHHH
Confidence 995432 2222222222211110000 000000 000000 000012234568999
Q ss_pred HHHHhcCCCCCCCCChhhhhcC
Q 038766 278 LALVCTSSNPEDRPNMNELLIT 299 (299)
Q Consensus 278 li~~~l~~dP~~Rpt~~~il~~ 299 (299)
||++||..||++|||++++|+|
T Consensus 313 li~~~L~~dP~~Rpt~~e~l~h 334 (355)
T 2eu9_A 313 LMRRMLEFDPAQRITLAEALLH 334 (355)
T ss_dssp HHHHHTCSSTTTSCCHHHHTTS
T ss_pred HHHHHhcCChhhCcCHHHHhcC
Confidence 9999999999999999999987
|
| >4fvq_A Tyrosine-protein kinase JAK2; janus protein kinase, pseudokinase, ATP binding, phosphoryla transferase; HET: ATP; 1.75A {Homo sapiens} PDB: 4fvp_A* 4fvr_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=8.1e-44 Score=298.30 Aligned_cols=248 Identities=22% Similarity=0.340 Sum_probs=193.7
Q ss_pred HHhCCCCCCceeecCCcceEEEEEeCC-C-------cEEEEEEeccCcCChhhhHHHHHHHHHHHhcCCcceeeeeeEEE
Q 038766 9 NATGSFSENNIIGNSNLSTVYKGRLED-G-------EIVAVKKLNFHQFSAESDKSFYREAKTLKELKHRNLVKVLGYAW 80 (299)
Q Consensus 9 ~~~~~y~~~~~lg~g~~~~v~~~~~~~-~-------~~~~vK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~ 80 (299)
...++|.+.+.||+|+||+||++.+.. + ..||+|++.. ......+.+.+|+..++.++||||+++++++.
T Consensus 5 i~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~va~K~~~~--~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~ 82 (289)
T 4fvq_A 5 IRNEDLIFNESLGQGTFTKIFKGVRREVGDYGQLHETEVLLKVLDK--AHRNYSESFFEAASMMSKLSHKHLVLNYGVCV 82 (289)
T ss_dssp CCGGGEEEEEEEEEETTEEEEEEEEEEECGGGCEEEEEEEEEEECG--GGGGGHHHHHHHHHHHHTSCCTTBCCEEEEEC
T ss_pred echhHeeeeeeeccCCCceEEEEEEecccccccccchhhhhhhccc--ccHHHHHHHHHHHHHHHhCCCCCEeEEEEEEE
Confidence 346789999999999999999998642 3 5799999853 23455678899999999999999999999766
Q ss_pred cCCCeeEEEEeecCCCChHHHhcCCCCCCCCCChhhHHHHHHHHHHHHHHhhcCCCCCeeeecccCCceeeCCCCc----
Q 038766 81 ESGKLKALILEYMENGSLESVIHGPGVDHSRWTLPKRIDVLISVANGLDYLHSGYDIPIVHCDMKPSNILLDRDFE---- 156 (299)
Q Consensus 81 ~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lh~~~~~~~~H~dl~~~nil~~~~~~---- 156 (299)
. +...++|+||+.+++|.+++... ...+++..++.++.|++.||.|||++ +++|+||||+||+++.++.
T Consensus 83 ~-~~~~~lv~e~~~~~~L~~~l~~~---~~~~~~~~~~~i~~qi~~~L~~LH~~---~ivH~Dlkp~NIll~~~~~~~~~ 155 (289)
T 4fvq_A 83 C-GDENILVQEFVKFGSLDTYLKKN---KNCINILWKLEVAKQLAAAMHFLEEN---TLIHGNVCAKNILLIREEDRKTG 155 (289)
T ss_dssp C-TTCCEEEEECCTTCBHHHHHHHT---GGGCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEEEECCBGGGT
T ss_pred e-CCCCEEEEECCCCCCHHHHHHhC---CCCCCHHHHHHHHHHHHHHHHHHhhC---CeECCCcCcceEEEecCCccccc
Confidence 5 44559999999999999998732 23489999999999999999999999 9999999999999998877
Q ss_pred ----EEEeeeccccccccccccccccccccccCcccCChhhhcc-cCcCccccchhhhHHHHHHHhCCCCCCCCccCCCC
Q 038766 157 ----AHVSDFGTSRMLDVHLQDLSSLSTAFQGTIGYLAPEFAYM-RIVTTKVDVFSFGIVVMEFLTKRRPTGLDEENGLS 231 (299)
Q Consensus 157 ----v~l~df~~~~~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~-~~~~~~~DiwslG~~l~~l~~g~~p~~~~~~~~~~ 231 (299)
++|+|||++..... .....+++.|+|||.+.+ ..++.++||||||+++|+|++|..|+... ..
T Consensus 156 ~~~~~kl~Dfg~~~~~~~--------~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~~~~~~----~~ 223 (289)
T 4fvq_A 156 NPPFIKLSDPGISITVLP--------KDILQERIPWVPPECIENPKNLNLATDKWSFGTTLWEICSGGDKPLSA----LD 223 (289)
T ss_dssp BCCEEEECCCCSCTTTSC--------HHHHHHTTTTSCHHHHHCGGGCCHHHHHHHHHHHHHHHHTTTCCTTTT----SC
T ss_pred ccceeeeccCcccccccC--------ccccCCcCcccCHHHhCCCCCCCchhHHHHHHHHHHHHHcCCCCCccc----cc
Confidence 99999999864331 123346788999999887 67899999999999999999966554322 11
Q ss_pred chhHHHHHHHHHhcCccCcccccCccccchhhHhHHHHHHHHHHHHHHHHhcCCCCCCCCChhhhhcC
Q 038766 232 PISLRQLVEKALANGINGVRQITDPKLVSSIYEEQEQHQVLEELFKLALVCTSSNPEDRPNMNELLIT 299 (299)
Q Consensus 232 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rpt~~~il~~ 299 (299)
....... .... .... ...+.++.+++.+||..||++|||+++++++
T Consensus 224 ~~~~~~~----~~~~----~~~~--------------~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~ 269 (289)
T 4fvq_A 224 SQRKLQF----YEDR----HQLP--------------APKAAELANLINNCMDYEPDHRPSFRAIIRD 269 (289)
T ss_dssp HHHHHHH----HHTT----CCCC--------------CCSSCTTHHHHHHHSCSSGGGSCCHHHHHHH
T ss_pred hHHHHHH----hhcc----CCCC--------------CCCCHHHHHHHHHHcCCChhHCcCHHHHHHH
Confidence 1111111 1100 0000 0113458899999999999999999999864
|
| >3a99_A Proto-oncogene serine/threonine-protein kinase PI; PIM-1, P27KIP1, peptide drug, prostate cancer, transferase; HET: ANP; 1.60A {Homo sapiens} PDB: 3bgq_A* 3bgp_A* 2obj_A* 3bgz_A* 3t9i_A* 3dcv_A* 1xws_A* 2xj1_A* 2xix_A* 2xiz_A* 2xj0_A* 2xiy_A* 2xj2_A* 3f2a_A* 1xr1_A* 1xqz_A* 3cy2_A* 3cxw_A* 3cy3_A* 2bik_B* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-44 Score=307.93 Aligned_cols=249 Identities=24% Similarity=0.335 Sum_probs=198.8
Q ss_pred HHHHHHhCCCCCCceeecCCcceEEEEEe-CCCcEEEEEEeccCcCCh----hhhHHHHHHHHHHHhcC--Ccceeeeee
Q 038766 5 TEIENATGSFSENNIIGNSNLSTVYKGRL-EDGEIVAVKKLNFHQFSA----ESDKSFYREAKTLKELK--HRNLVKVLG 77 (299)
Q Consensus 5 ~~~~~~~~~y~~~~~lg~g~~~~v~~~~~-~~~~~~~vK~~~~~~~~~----~~~~~~~~e~~~l~~l~--h~~i~~~~~ 77 (299)
.+.+.+.++|++.+.||+|+||+||++.+ .+++.||+|++....... .....+.+|+.++++++ |+||+++++
T Consensus 36 ~~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~~i~~~~~ 115 (320)
T 3a99_A 36 KEKEPLESQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGVIRLLD 115 (320)
T ss_dssp ----CCTTTEEEEEECSSSSSCEEEEEEETTTTEEEEEEEEEGGGCCCEEECTTCCEEEHHHHHHHHHCSSSCSBCCEEE
T ss_pred cccCCccCceEEEEEEeeCCCeEEEEEEECCCCcEEEEEEEecccchhhhhhhhhhHHHHHHHHHHhhccCCCCceEEEE
Confidence 56678899999999999999999999986 468999999997544322 12345677999999996 599999999
Q ss_pred EEEcCCCeeEEEEeecCC-CChHHHhcCCCCCCCCCChhhHHHHHHHHHHHHHHhhcCCCCCeeeecccCCceeeC-CCC
Q 038766 78 YAWESGKLKALILEYMEN-GSLESVIHGPGVDHSRWTLPKRIDVLISVANGLDYLHSGYDIPIVHCDMKPSNILLD-RDF 155 (299)
Q Consensus 78 ~~~~~~~~~~lv~e~~~~-~~L~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lh~~~~~~~~H~dl~~~nil~~-~~~ 155 (299)
++.. ....++|+|++.+ ++|.+++. ....+++..++.++.|++.||+|||+. +++|+||||+||+++ .++
T Consensus 116 ~~~~-~~~~~lv~e~~~~~~~L~~~l~----~~~~l~~~~~~~i~~qi~~~L~~LH~~---~ivH~Dlkp~NIll~~~~~ 187 (320)
T 3a99_A 116 WFER-PDSFVLILERPEPVQDLFDFIT----ERGALQEELARSFFWQVLEAVRHCHNC---GVLHRDIKDENILIDLNRG 187 (320)
T ss_dssp EEEC-SSEEEEEEECCSSEEEHHHHHH----HHCSCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEEETTTT
T ss_pred EEec-CCcEEEEEEcCCCCccHHHHHh----ccCCCCHHHHHHHHHHHHHHHHHHHHC---CcEeCCCCHHHEEEeCCCC
Confidence 7665 5566999999975 79999987 445789999999999999999999999 999999999999998 788
Q ss_pred cEEEeeeccccccccccccccccccccccCcccCChhhhcccCc-CccccchhhhHHHHHHHhCCCCCCCCccCCCCchh
Q 038766 156 EAHVSDFGTSRMLDVHLQDLSSLSTAFQGTIGYLAPEFAYMRIV-TTKVDVFSFGIVVMEFLTKRRPTGLDEENGLSPIS 234 (299)
Q Consensus 156 ~v~l~df~~~~~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~-~~~~DiwslG~~l~~l~~g~~p~~~~~~~~~~~~~ 234 (299)
.++|+|||++..... .......+++.|+|||++.+..+ +.++||||||+++|+|++|..||....
T Consensus 188 ~~kL~Dfg~~~~~~~------~~~~~~~gt~~y~aPE~~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~-------- 253 (320)
T 3a99_A 188 ELKLIDFGSGALLKD------TVYTDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHDE-------- 253 (320)
T ss_dssp EEEECCCTTCEECCS------SCBCCCCSCGGGSCHHHHHHSCBCHHHHHHHHHHHHHHHHHHSSCSCCSHH--------
T ss_pred CEEEeeCcccccccc------ccccCCCCCccCCChHHhccCCCCCccchHHhHHHHHHHHHHCCCCCCChh--------
Confidence 999999999876542 22334568899999999887665 678999999999999999999985321
Q ss_pred HHHHHHHHHhcCccCcccccCccccchhhHhHHHHHHHHHHHHHHHHhcCCCCCCCCChhhhhcC
Q 038766 235 LRQLVEKALANGINGVRQITDPKLVSSIYEEQEQHQVLEELFKLALVCTSSNPEDRPNMNELLIT 299 (299)
Q Consensus 235 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rpt~~~il~~ 299 (299)
. ...... . . ...++.++.++|++||..||++|||++++++|
T Consensus 254 --~----~~~~~~-~-----~------------~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~h 294 (320)
T 3a99_A 254 --E----IIRGQV-F-----F------------RQRVSSECQHLIRWCLALRPSDRPTFEEIQNH 294 (320)
T ss_dssp --H----HHHCCC-C-----C------------SSCCCHHHHHHHHHHTCSSGGGSCCHHHHHTS
T ss_pred --h----hhcccc-c-----c------------cccCCHHHHHHHHHHccCChhhCcCHHHHhcC
Confidence 0 011000 0 0 11234678999999999999999999999986
|
| >1mqb_A Ephrin type-A receptor 2; tyrosine protein kinase, transferase; HET: ANP; 2.30A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-43 Score=302.34 Aligned_cols=257 Identities=26% Similarity=0.436 Sum_probs=194.6
Q ss_pred HHHhCCCCCCceeecCCcceEEEEEeCC-----CcEEEEEEeccCcCChhhhHHHHHHHHHHHhcCCcceeeeeeEEEcC
Q 038766 8 ENATGSFSENNIIGNSNLSTVYKGRLED-----GEIVAVKKLNFHQFSAESDKSFYREAKTLKELKHRNLVKVLGYAWES 82 (299)
Q Consensus 8 ~~~~~~y~~~~~lg~g~~~~v~~~~~~~-----~~~~~vK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~ 82 (299)
+...++|.+.+.||+|+||+||++.+.. +..||+|++... ........+.+|+.+++.++||||+++++++..
T Consensus 40 ~i~~~~~~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~vavK~~~~~-~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~- 117 (333)
T 1mqb_A 40 EIHPSCVTRQKVIGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAG-YTEKQRVDFLGEAGIMGQFSHHNIIRLEGVISK- 117 (333)
T ss_dssp BCCTTTEEEEEEEEECSSSEEEEEEEEC---CCEEEEEEEEECTT-CCHHHHHHHHHHHHHHHTCCCTTBCCEEEEECS-
T ss_pred cCChHHhhcccEEecCCCeEEEEEEEecCCCCccccEEEEEcCCC-CCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEec-
Confidence 3445678889999999999999997632 346999998643 344556678899999999999999999996654
Q ss_pred CCeeEEEEeecCCCChHHHhcCCCCCCCCCChhhHHHHHHHHHHHHHHhhcCCCCCeeeecccCCceeeCCCCcEEEeee
Q 038766 83 GKLKALILEYMENGSLESVIHGPGVDHSRWTLPKRIDVLISVANGLDYLHSGYDIPIVHCDMKPSNILLDRDFEAHVSDF 162 (299)
Q Consensus 83 ~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lh~~~~~~~~H~dl~~~nil~~~~~~v~l~df 162 (299)
....++|+|++.+++|.+++.. ....+++..++.++.|++.||.|||+. +++|+||||+||+++.++.++|+||
T Consensus 118 ~~~~~lv~e~~~~~~L~~~l~~---~~~~~~~~~~~~i~~qi~~aL~~LH~~---~ivH~Dikp~NIl~~~~~~~kl~Df 191 (333)
T 1mqb_A 118 YKPMMIITEYMENGALDKFLRE---KDGEFSVLQLVGMLRGIAAGMKYLANM---NYVHRDLAARNILVNSNLVCKVSDF 191 (333)
T ss_dssp SSSEEEEEECCTTEEHHHHHHH---TTTCSCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEECTTCCEEECCC
T ss_pred CCCcEEEEeCCCCCcHHHHHHh---CCCCCCHHHHHHHHHHHHHHHHHHHhC---CeeCCCCChheEEECCCCcEEECCC
Confidence 5566999999999999999863 235789999999999999999999999 9999999999999999999999999
Q ss_pred ccccccccccccccccccccccCcccCChhhhcccCcCccccchhhhHHHHHHHh-CCCCCCCCccCCCCchhHHHHHHH
Q 038766 163 GTSRMLDVHLQDLSSLSTAFQGTIGYLAPEFAYMRIVTTKVDVFSFGIVVMEFLT-KRRPTGLDEENGLSPISLRQLVEK 241 (299)
Q Consensus 163 ~~~~~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~DiwslG~~l~~l~~-g~~p~~~~~~~~~~~~~~~~~~~~ 241 (299)
|++......... ........+++.|+|||.+.+..++.++||||||+++|+|++ |..||... ... +.+..
T Consensus 192 g~~~~~~~~~~~-~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~pf~~~-----~~~---~~~~~ 262 (333)
T 1mqb_A 192 GLSRVLEDDPEA-TYTTSGGKIPIRWTAPEAISYRKFTSASDVWSFGIVMWEVMTYGERPYWEL-----SNH---EVMKA 262 (333)
T ss_dssp CC------------------CCCGGGSCHHHHHSCCCCHHHHHHHHHHHHHHHHTTSCCTTTTC-----CHH---HHHHH
T ss_pred Ccchhhcccccc-ccccCCCCccccccCchhcccCCCCchhhhHHHHHHHHHHHcCCCCCcccC-----CHH---HHHHH
Confidence 999765422111 111122335678999999998899999999999999999998 99998432 122 22222
Q ss_pred HHhcCccCcccccCccccchhhHhHHHHHHHHHHHHHHHHhcCCCCCCCCChhhhhc
Q 038766 242 ALANGINGVRQITDPKLVSSIYEEQEQHQVLEELFKLALVCTSSNPEDRPNMNELLI 298 (299)
Q Consensus 242 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rpt~~~il~ 298 (299)
..... .... +..++..+.+++.+||..||++|||+.++++
T Consensus 263 ~~~~~-----~~~~------------~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~ 302 (333)
T 1mqb_A 263 INDGF-----RLPT------------PMDCPSAIYQLMMQCWQQERARRPKFADIVS 302 (333)
T ss_dssp HHTTC-----CCCC------------CTTCBHHHHHHHHHHTCSSTTTSCCHHHHHH
T ss_pred HHCCC-----cCCC------------cccCCHHHHHHHHHHcCCChhhCcCHHHHHH
Confidence 11110 0000 1123467899999999999999999999875
|
| >3ll6_A Cyclin G-associated kinase; transferase, protein kinase, serine/threonine kinase, cyclin clathrine, membrane trafficking, structural genomics; 2.10A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-44 Score=308.81 Aligned_cols=261 Identities=18% Similarity=0.241 Sum_probs=185.6
Q ss_pred hHHHHHHhCCCCCCceeecCCcceEEEEEeC-CCcEEEEEEeccCcCChhhhHHHHHHHHHHHhcC-CcceeeeeeEEE-
Q 038766 4 RTEIENATGSFSENNIIGNSNLSTVYKGRLE-DGEIVAVKKLNFHQFSAESDKSFYREAKTLKELK-HRNLVKVLGYAW- 80 (299)
Q Consensus 4 ~~~~~~~~~~y~~~~~lg~g~~~~v~~~~~~-~~~~~~vK~~~~~~~~~~~~~~~~~e~~~l~~l~-h~~i~~~~~~~~- 80 (299)
.+.++....+|++.+.||+|+||.||++.+. +++.||+|++.. ........+.+|+..++++. ||||+++++++.
T Consensus 20 ~~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~--~~~~~~~~~~~e~~~l~~l~~h~~iv~~~~~~~~ 97 (337)
T 3ll6_A 20 GQTVELGELRLRVRRVLAEGGFAFVYEAQDVGSGREYALKRLLS--NEEEKNRAIIQEVCFMKKLSGHPNIVQFCSAASI 97 (337)
T ss_dssp TCEEEETTEEEEEEEEEECCSSEEEEEEEETTTCCEEEEEEEEE--SSHHHHHHHHHHHHHHHHHTTSTTBCCEEEEEEE
T ss_pred cceeeccCceEEEEEEEccCCceEEEEEEECCCCcEEEEEEecC--CchHHHHHHHHHHHHHHHhccCCChhhccccccc
Confidence 3445556679999999999999999999874 689999999853 24455677889999999996 999999999774
Q ss_pred ------cCCCeeEEEEeecCCCChHHHhcCCCCCCCCCChhhHHHHHHHHHHHHHHhhcCCCCC--eeeecccCCceeeC
Q 038766 81 ------ESGKLKALILEYMENGSLESVIHGPGVDHSRWTLPKRIDVLISVANGLDYLHSGYDIP--IVHCDMKPSNILLD 152 (299)
Q Consensus 81 ------~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lh~~~~~~--~~H~dl~~~nil~~ 152 (299)
......++|+||+. ++|.+++.... ...++++..++.++.|++.||+|||+. + ++|+||||+||+++
T Consensus 98 ~~~~~~~~~~~~~lv~e~~~-g~L~~~l~~~~-~~~~~~~~~~~~i~~qi~~~l~~LH~~---~~~ivH~Dikp~NIl~~ 172 (337)
T 3ll6_A 98 GKEESDTGQAEFLLLTELCK-GQLVEFLKKME-SRGPLSCDTVLKIFYQTCRAVQHMHRQ---KPPIIHRDLKVENLLLS 172 (337)
T ss_dssp CTTTSTTSSEEEEEEEECCS-EEHHHHHHHHH-TTCSCCHHHHHHHHHHHHHHHHHHHTS---SSCCBCCCCCGGGCEEC
T ss_pred cccccccCCceEEEEEEecC-CCHHHHHHHhh-ccCCCCHHHHHHHHHHHHHHHHHHHhC---CCCEEEccCCcccEEEC
Confidence 33445689999995 68988775321 345699999999999999999999998 8 99999999999999
Q ss_pred CCCcEEEeeeccccccccccccc--------cccccccccCcccCChhhh---cccCcCccccchhhhHHHHHHHhCCCC
Q 038766 153 RDFEAHVSDFGTSRMLDVHLQDL--------SSLSTAFQGTIGYLAPEFA---YMRIVTTKVDVFSFGIVVMEFLTKRRP 221 (299)
Q Consensus 153 ~~~~v~l~df~~~~~~~~~~~~~--------~~~~~~~~~~~~y~~PE~~---~~~~~~~~~DiwslG~~l~~l~~g~~p 221 (299)
.++.++|+|||++.......... ........+++.|+|||++ .+..++.++||||||+++|+|++|..|
T Consensus 173 ~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~~~Dv~slG~il~el~~g~~p 252 (337)
T 3ll6_A 173 NQGTIKLCDFGSATTISHYPDYSWSAQRRALVEEEITRNTTPMYRTPEIIDLYSNFPIGEKQDIWALGCILYLLCFRQHP 252 (337)
T ss_dssp TTSCEEBCCCTTCBCCSSCC-------------------------------CCTTSCSSHHHHHHHHHHHHHHHHHSSCC
T ss_pred CCCCEEEecCccceeccccCcccccccccccchhhccccCCCCcCChhhhhccccCCCChHHhHHHHHHHHHHHHhCCCC
Confidence 99999999999997654221110 0111234578899999988 566788999999999999999999999
Q ss_pred CCCCccCCCCchhHHHHHHHHHhcCccCcccccCccccchhhHhHHHHHHHHHHHHHHHHhcCCCCCCCCChhhhhcC
Q 038766 222 TGLDEENGLSPISLRQLVEKALANGINGVRQITDPKLVSSIYEEQEQHQVLEELFKLALVCTSSNPEDRPNMNELLIT 299 (299)
Q Consensus 222 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rpt~~~il~~ 299 (299)
|...... ..... ...... ....+..+.++|++||..||++|||+++++++
T Consensus 253 ~~~~~~~--------~~~~~--------~~~~~~------------~~~~~~~~~~li~~~l~~~p~~Rps~~e~l~~ 302 (337)
T 3ll6_A 253 FEDGAKL--------RIVNG--------KYSIPP------------HDTQYTVFHSLIRAMLQVNPEERLSIAEVVHQ 302 (337)
T ss_dssp C----------------------------CCCCT------------TCCSSGGGHHHHHHHSCSSGGGSCCHHHHHHH
T ss_pred CcchhHH--------HhhcC--------cccCCc------------ccccchHHHHHHHHHccCChhhCcCHHHHHHH
Confidence 8532111 00000 000000 11112357889999999999999999999863
|
| >2iwi_A Serine/threonine-protein kinase PIM-2; nucleotide-binding, cancer, leukemia, transferase, ATP-binding, proto- oncogene, phosphorylation; HET: HB1; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.8e-44 Score=303.61 Aligned_cols=249 Identities=23% Similarity=0.331 Sum_probs=189.8
Q ss_pred HHHHHHhCCCCCCceeecCCcceEEEEEe-CCCcEEEEEEeccCcCCh----hhhHHHHHHHHHHHhc----CCcceeee
Q 038766 5 TEIENATGSFSENNIIGNSNLSTVYKGRL-EDGEIVAVKKLNFHQFSA----ESDKSFYREAKTLKEL----KHRNLVKV 75 (299)
Q Consensus 5 ~~~~~~~~~y~~~~~lg~g~~~~v~~~~~-~~~~~~~vK~~~~~~~~~----~~~~~~~~e~~~l~~l----~h~~i~~~ 75 (299)
.+.+.+.++|++.+.||+|+||.||++.+ .+++.||+|++....... .....+.+|+..++++ +|+||+++
T Consensus 24 ~~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~h~~i~~~ 103 (312)
T 2iwi_A 24 KDREAFEAEYRLGPLLGKGGFGTVFAGHRLTDRLQVAIKVIPRNRVLGWSPLSDSVTCPLEVALLWKVGAGGGHPGVIRL 103 (312)
T ss_dssp ---------CEEEEEEEEETTEEEEEEECTTTCCEEEEEECCSTTTC--------CCCCHHHHHHHHHHSSCCCSSBCCE
T ss_pred cchhhhhhceEEeeEEEcCCCEEEEEEEEccCCeEEEEEEEecccccccccchhhHHHHHHHHHHHhhcccCCCCCeeeE
Confidence 35677889999999999999999999986 468899999986543222 1233456788999888 89999999
Q ss_pred eeEEEcCCCeeEEEEee-cCCCChHHHhcCCCCCCCCCChhhHHHHHHHHHHHHHHhhcCCCCCeeeecccCCceeeC-C
Q 038766 76 LGYAWESGKLKALILEY-MENGSLESVIHGPGVDHSRWTLPKRIDVLISVANGLDYLHSGYDIPIVHCDMKPSNILLD-R 153 (299)
Q Consensus 76 ~~~~~~~~~~~~lv~e~-~~~~~L~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lh~~~~~~~~H~dl~~~nil~~-~ 153 (299)
++++... +..++|+|+ +.+++|.+++. ....+++..++.++.|++.||.|||++ +++|+||||+||+++ .
T Consensus 104 ~~~~~~~-~~~~~v~e~~~~~~~L~~~l~----~~~~~~~~~~~~~~~qi~~~l~~lH~~---~i~H~dlkp~Nil~~~~ 175 (312)
T 2iwi_A 104 LDWFETQ-EGFMLVLERPLPAQDLFDYIT----EKGPLGEGPSRCFFGQVVAAIQHCHSR---GVVHRDIKDENILIDLR 175 (312)
T ss_dssp EEEC------CEEEEECCSSEEEHHHHHH----HHCSCCHHHHHHHHHHHHHHHHHHHHH---TEECCCCSGGGEEEETT
T ss_pred EEEEecC-CeEEEEEEecCCCCCHHHHHH----hcCCCCHHHHHHHHHHHHHHHHHHHHC---CeeecCCChhhEEEeCC
Confidence 9976554 455899998 77889999987 345799999999999999999999999 999999999999999 8
Q ss_pred CCcEEEeeeccccccccccccccccccccccCcccCChhhhcccCcC-ccccchhhhHHHHHHHhCCCCCCCCccCCCCc
Q 038766 154 DFEAHVSDFGTSRMLDVHLQDLSSLSTAFQGTIGYLAPEFAYMRIVT-TKVDVFSFGIVVMEFLTKRRPTGLDEENGLSP 232 (299)
Q Consensus 154 ~~~v~l~df~~~~~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~-~~~DiwslG~~l~~l~~g~~p~~~~~~~~~~~ 232 (299)
++.++|+|||++..... .......+++.|+|||++.+..+. .++||||||+++|+|++|..||....
T Consensus 176 ~~~~kl~dfg~~~~~~~------~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~------ 243 (312)
T 2iwi_A 176 RGCAKLIDFGSGALLHD------EPYTDFDGTRVYSPPEWISRHQYHALPATVWSLGILLYDMVCGDIPFERDQ------ 243 (312)
T ss_dssp TTEEEECCCSSCEECCS------SCBCCCCSCTTTSCHHHHHHSCBCHHHHHHHHHHHHHHHHHHSSCSCCSHH------
T ss_pred CCeEEEEEcchhhhccc------CcccccCCcccccCceeeecCCCCCccchHHHHHHHHHHHHHCCCCCCChH------
Confidence 89999999999876542 123345578999999988876654 58999999999999999999985321
Q ss_pred hhHHHHHHHHHhcCccCcccccCccccchhhHhHHHHHHHHHHHHHHHHhcCCCCCCCCChhhhhcC
Q 038766 233 ISLRQLVEKALANGINGVRQITDPKLVSSIYEEQEQHQVLEELFKLALVCTSSNPEDRPNMNELLIT 299 (299)
Q Consensus 233 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rpt~~~il~~ 299 (299)
.. .... ..+ +..++..+.++|.+||..||++|||++++++|
T Consensus 244 ----~~----~~~~----~~~--------------~~~~~~~~~~li~~~l~~~p~~Rps~~e~l~~ 284 (312)
T 2iwi_A 244 ----EI----LEAE----LHF--------------PAHVSPDCCALIRRCLAPKPSSRPSLEEILLD 284 (312)
T ss_dssp ----HH----HHTC----CCC--------------CTTSCHHHHHHHHHHTCSSTTTSCCHHHHHHS
T ss_pred ----HH----hhhc----cCC--------------cccCCHHHHHHHHHHccCChhhCcCHHHHhcC
Confidence 11 0000 000 12235678999999999999999999999986
|
| >1zy4_A Serine/threonine-protein kinase GCN2; translation regulator, signal transduction, acid starvation, starvation stress response; 1.95A {Saccharomyces cerevisiae} PDB: 1zy5_A* 1zyd_A* 1zyc_A* 1zxe_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-42 Score=292.09 Aligned_cols=257 Identities=24% Similarity=0.367 Sum_probs=193.4
Q ss_pred HhCCCCCCceeecCCcceEEEEEeC-CCcEEEEEEeccCcCChhhhHHHHHHHHHHHhcCCcceeeeeeEEEcC------
Q 038766 10 ATGSFSENNIIGNSNLSTVYKGRLE-DGEIVAVKKLNFHQFSAESDKSFYREAKTLKELKHRNLVKVLGYAWES------ 82 (299)
Q Consensus 10 ~~~~y~~~~~lg~g~~~~v~~~~~~-~~~~~~vK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~------ 82 (299)
+.++|.+.+.||+|+||+||++.+. +++.||+|++.. .......+.+|+..++.++||||+++++++...
T Consensus 4 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~---~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~ 80 (303)
T 1zy4_A 4 YASDFEEIAVLGQGAFGQVVKARNALDSRYYAIKKIRH---TEEKLSTILSEVMLLASLNHQYVVRYYAAWLERRNFVKP 80 (303)
T ss_dssp HHHHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEE---EHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEECCCCCC-
T ss_pred ccccchhhheeccCCcEEEEEEEEcCCCeEEEEEEEec---cHHHHHHHHHHHHHHHhcCchHHHHHHHHHHhhcchhhh
Confidence 4678999999999999999999874 689999999853 334567788999999999999999999977543
Q ss_pred ------CCeeEEEEeecCCCChHHHhcCCCCCCCCCChhhHHHHHHHHHHHHHHhhcCCCCCeeeecccCCceeeCCCCc
Q 038766 83 ------GKLKALILEYMENGSLESVIHGPGVDHSRWTLPKRIDVLISVANGLDYLHSGYDIPIVHCDMKPSNILLDRDFE 156 (299)
Q Consensus 83 ------~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lh~~~~~~~~H~dl~~~nil~~~~~~ 156 (299)
....++|+||+.+++|.+++.. ....+++..++.++.|++.||+|||++ +++|+||||+||+++.++.
T Consensus 81 ~~~~~~~~~~~lv~e~~~~~~L~~~l~~---~~~~~~~~~~~~i~~qi~~~l~~LH~~---~i~H~dlkp~Nil~~~~~~ 154 (303)
T 1zy4_A 81 MTAVKKKSTLFIQMEYCENGTLYDLIHS---ENLNQQRDEYWRLFRQILEALSYIHSQ---GIIHRDLKPMNIFIDESRN 154 (303)
T ss_dssp -----CEEEEEEEEECCCSCBHHHHHHH---SCGGGCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEECTTSC
T ss_pred hcccccCCceEEEEecCCCCCHHHhhhc---cccccchHHHHHHHHHHHHHHHHHHhC---CeecccCCHHhEEEcCCCC
Confidence 3456899999999999999863 234678899999999999999999999 9999999999999999999
Q ss_pred EEEeeeccccccccccc----------cccccccccccCcccCChhhhccc-CcCccccchhhhHHHHHHHhCCCCCCCC
Q 038766 157 AHVSDFGTSRMLDVHLQ----------DLSSLSTAFQGTIGYLAPEFAYMR-IVTTKVDVFSFGIVVMEFLTKRRPTGLD 225 (299)
Q Consensus 157 v~l~df~~~~~~~~~~~----------~~~~~~~~~~~~~~y~~PE~~~~~-~~~~~~DiwslG~~l~~l~~g~~p~~~~ 225 (299)
++|+|||++........ ..........+++.|+|||.+.+. .++.++||||||+++|+|++ ||...
T Consensus 155 ~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~---p~~~~ 231 (303)
T 1zy4_A 155 VKIGDFGLAKNVHRSLDILKLDSQNLPGSSDNLTSAIGTAMYVATEVLDGTGHYNEKIDMYSLGIIFFEMIY---PFSTG 231 (303)
T ss_dssp EEECCCCCCSCTTC-------------------------CTTSCHHHHTSCSCCCTHHHHHHHHHHHHHHHS---CCSSH
T ss_pred EEEeeCcchhhcccccchhccccccccccccccccCCCcccccCcccccCCCCCcchhhHHHHHHHHHHHHh---ccCCc
Confidence 99999999876542110 001222345678999999998865 68999999999999999998 44211
Q ss_pred ccCCCCchhHHHHHHHHHhcCccCcccccCccccchhhHhHHHHHHHHHHHHHHHHhcCCCCCCCCChhhhhcC
Q 038766 226 EENGLSPISLRQLVEKALANGINGVRQITDPKLVSSIYEEQEQHQVLEELFKLALVCTSSNPEDRPNMNELLIT 299 (299)
Q Consensus 226 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rpt~~~il~~ 299 (299)
............ ..... .. .. ....+..+.++|++||..||++|||++++++|
T Consensus 232 -------~~~~~~~~~~~~-~~~~~---~~-~~---------~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~h 284 (303)
T 1zy4_A 232 -------MERVNILKKLRS-VSIEF---PP-DF---------DDNKMKVEKKIIRLLIDHDPNKRPGARTLLNS 284 (303)
T ss_dssp -------HHHHHHHHHHHS-TTCCC---CT-TC---------CTTTSHHHHHHHHHHTCSSGGGSCCHHHHHHS
T ss_pred -------hhHHHHHHhccc-ccccc---Cc-cc---------cccchHHHHHHHHHHHhcCcccCcCHHHHhCC
Confidence 111122222111 10000 00 00 12334568899999999999999999999987
|
| >3sv0_A Casein kinase I-like; typical kinase domain fold, cytosol, transferase; 2.00A {Oryza sativa japonica group} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.2e-42 Score=307.68 Aligned_cols=261 Identities=20% Similarity=0.242 Sum_probs=201.9
Q ss_pred HHhCCCCCCceeecCCcceEEEEEe-CCCcEEEEEEeccCcCChhhhHHHHHHHHHHHhcCCcceeeeeeEEEcCCCeeE
Q 038766 9 NATGSFSENNIIGNSNLSTVYKGRL-EDGEIVAVKKLNFHQFSAESDKSFYREAKTLKELKHRNLVKVLGYAWESGKLKA 87 (299)
Q Consensus 9 ~~~~~y~~~~~lg~g~~~~v~~~~~-~~~~~~~vK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~ 87 (299)
.+.++|.+.+.||+|+||.||++.+ .+++.||||++..... ...+..|+++++.++|++.+..+..+...+...+
T Consensus 4 ~i~~~y~i~~~LG~G~fG~Vy~a~~~~~~~~vAvK~~~~~~~----~~~~~~E~~il~~L~~~~~i~~i~~~~~~~~~~~ 79 (483)
T 3sv0_A 4 RVGNKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKTK----HPQLLYESKIYRILQGGTGIPNVRWFGVEGDYNV 79 (483)
T ss_dssp EETTTEECCCCCEECSSCEEEEEEETTTCCEEEEEEEETTCS----SCCHHHHHHHHHHTTTSTTCCCEEEEEEETTEEE
T ss_pred CcCCcEEEEEEEeeCCCEEEEEEEECCCCcEEEEEEeccccc----cHHHHHHHHHHHHhcCCCCCCeEEEEEeeCCEEE
Confidence 4678999999999999999999986 5689999998864432 2347789999999997665555555666677889
Q ss_pred EEEeecCCCChHHHhcCCCCCCCCCChhhHHHHHHHHHHHHHHhhcCCCCCeeeecccCCceee---CCCCcEEEeeecc
Q 038766 88 LILEYMENGSLESVIHGPGVDHSRWTLPKRIDVLISVANGLDYLHSGYDIPIVHCDMKPSNILL---DRDFEAHVSDFGT 164 (299)
Q Consensus 88 lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lh~~~~~~~~H~dl~~~nil~---~~~~~v~l~df~~ 164 (299)
+|+||+ +++|.+++... ...+++..++.++.||+.||+|||++ +++|+||||+|||+ +.++.++|+|||+
T Consensus 80 lvme~~-g~sL~~ll~~~---~~~l~~~~~~~i~~qi~~aL~yLH~~---gIvHrDIKP~NILl~~~~~~~~vkL~DFGl 152 (483)
T 3sv0_A 80 LVMDLL-GPSLEDLFNFC---SRKLSLKTVLMLADQMINRVEFVHSK---SFLHRDIKPDNFLMGLGRRANQVYIIDFGL 152 (483)
T ss_dssp EEEECC-CCBHHHHHHHT---TTCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEECCGGGTTCEEECCCTT
T ss_pred EEEECC-CCCHHHHHHhh---cCCCCHHHHHHHHHHHHHHHHHHHHC---CEeecccCcceEEEecCCCCCeEEEEeCCc
Confidence 999999 88999998632 35799999999999999999999999 99999999999999 5889999999999
Q ss_pred ccccccccccc---cccccccccCcccCChhhhcccCcCccccchhhhHHHHHHHhCCCCCCCCccCCCCchhHHHHHHH
Q 038766 165 SRMLDVHLQDL---SSLSTAFQGTIGYLAPEFAYMRIVTTKVDVFSFGIVVMEFLTKRRPTGLDEENGLSPISLRQLVEK 241 (299)
Q Consensus 165 ~~~~~~~~~~~---~~~~~~~~~~~~y~~PE~~~~~~~~~~~DiwslG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~ 241 (299)
+..+....... ........+++.|+|||.+.+..++.++|||||||++|+|++|..||..... ......+..
T Consensus 153 a~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~s~~sDvwSlGvil~elltG~~Pf~~~~~-----~~~~~~~~~ 227 (483)
T 3sv0_A 153 AKKYRDTSTHQHIPYRENKNLTGTARYASVNTHLGIEQSRRDDLESLGYVLMYFLRGSLPWQGLKA-----GTKKQKYEK 227 (483)
T ss_dssp CEECBCTTTCCBCCCCCCCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTSSCCC-----SSHHHHHHH
T ss_pred ceeccCCccccccccccccccCCCccccCHHHhcCCCCChHHHHHHHHHHHHHHHhCCCCCccccc-----hhHHHHHHH
Confidence 98655322111 1122356789999999999999999999999999999999999999964321 111111111
Q ss_pred HHhcCccCcccccCccccchhhHhHHHHHHHHHHHHHHHHhcCCCCCCCCChhhhhc
Q 038766 242 ALANGINGVRQITDPKLVSSIYEEQEQHQVLEELFKLALVCTSSNPEDRPNMNELLI 298 (299)
Q Consensus 242 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rpt~~~il~ 298 (299)
...... ..........++.++.++|.+||..||++||++++|++
T Consensus 228 i~~~~~-------------~~~~~~l~~~~p~~l~~li~~cl~~dP~~RPs~~el~~ 271 (483)
T 3sv0_A 228 ISEKKV-------------ATSIEALCRGYPTEFASYFHYCRSLRFDDKPDYSYLKR 271 (483)
T ss_dssp HHHHHH-------------HSCHHHHHTTSCHHHHHHHHHHHTCCTTCCCCHHHHHH
T ss_pred Hhhccc-------------cccHHHHhcCCcHHHHHHHHHHhcCChhhCcCHHHHHH
Confidence 111000 00001113345678999999999999999999999874
|
| >1q8y_A SR protein kinase; transferase; HET: ADP ADE; 2.05A {Saccharomyces cerevisiae} SCOP: d.144.1.7 PDB: 1q8z_A 1q97_A* 1q99_A* 1how_A 2jd5_A | Back alignment and structure |
|---|
Probab=100.00 E-value=8.5e-43 Score=302.39 Aligned_cols=273 Identities=20% Similarity=0.238 Sum_probs=200.0
Q ss_pred hCCCCCCceeecCCcceEEEEEe-CCCcEEEEEEeccCcCChhhhHHHHHHHHHHHhcC-----------CcceeeeeeE
Q 038766 11 TGSFSENNIIGNSNLSTVYKGRL-EDGEIVAVKKLNFHQFSAESDKSFYREAKTLKELK-----------HRNLVKVLGY 78 (299)
Q Consensus 11 ~~~y~~~~~lg~g~~~~v~~~~~-~~~~~~~vK~~~~~~~~~~~~~~~~~e~~~l~~l~-----------h~~i~~~~~~ 78 (299)
.++|.+.+.||+|+||+||+|.+ .+++.||+|++.. .......+.+|+..+++++ |+||++++++
T Consensus 18 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~---~~~~~~~~~~e~~~l~~l~~~~~~~~~~~~~~~i~~~~~~ 94 (373)
T 1q8y_A 18 DARYILVRKLGWGHFSTVWLAKDMVNNTHVAMKIVRG---DKVYTEAAEDEIKLLQRVNDADNTKEDSMGANHILKLLDH 94 (373)
T ss_dssp TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECS---CHHHHHHHHHHHHHHHHHHHTCCSHHHHHHHTTBCCCCEE
T ss_pred CCeEEEEEeeeecCCeEEEEEEecCCCcEEEEEEecC---CccchhhhhHHHHHHHHhhcccccchhccccchHHHHHHH
Confidence 57899999999999999999987 4689999999863 3345567888999998886 7899999998
Q ss_pred EEcCC---CeeEEEEeecCCCChHHHhcCCCCCCCCCChhhHHHHHHHHHHHHHHhhcCCCCCeeeecccCCceeeC---
Q 038766 79 AWESG---KLKALILEYMENGSLESVIHGPGVDHSRWTLPKRIDVLISVANGLDYLHSGYDIPIVHCDMKPSNILLD--- 152 (299)
Q Consensus 79 ~~~~~---~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lh~~~~~~~~H~dl~~~nil~~--- 152 (299)
+...+ ...++|+|++ +++|.+++... ....+++..++.++.||+.||+|||++ .+++|+||||+||+++
T Consensus 95 ~~~~~~~~~~~~lv~e~~-~~~L~~~~~~~--~~~~~~~~~~~~i~~qi~~aL~~lH~~--~~ivH~Dikp~NIll~~~~ 169 (373)
T 1q8y_A 95 FNHKGPNGVHVVMVFEVL-GENLLALIKKY--EHRGIPLIYVKQISKQLLLGLDYMHRR--CGIIHTDIKPENVLMEIVD 169 (373)
T ss_dssp EEEEETTEEEEEEEECCC-CEEHHHHHHHT--TTSCCCHHHHHHHHHHHHHHHHHHHHT--TCEECSCCSGGGEEEEEEE
T ss_pred hhccCCCCceEEEEEecC-CCCHHHHHHHh--hccCCcHHHHHHHHHHHHHHHHHHHhc--CCEEecCCChHHeEEeccC
Confidence 76533 3678999999 88999988643 234689999999999999999999984 2899999999999994
Q ss_pred ---CCCcEEEeeeccccccccccccccccccccccCcccCChhhhcccCcCccccchhhhHHHHHHHhCCCCCCCCccCC
Q 038766 153 ---RDFEAHVSDFGTSRMLDVHLQDLSSLSTAFQGTIGYLAPEFAYMRIVTTKVDVFSFGIVVMEFLTKRRPTGLDEENG 229 (299)
Q Consensus 153 ---~~~~v~l~df~~~~~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~DiwslG~~l~~l~~g~~p~~~~~~~~ 229 (299)
..+.++|+|||++..... ......+|+.|+|||++.+..++.++|||||||++|+|++|..||.......
T Consensus 170 ~~~~~~~~kl~Dfg~a~~~~~-------~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~ 242 (373)
T 1q8y_A 170 SPENLIQIKIADLGNACWYDE-------HYTNSIQTREYRSPEVLLGAPWGCGADIWSTACLIFELITGDFLFEPDEGHS 242 (373)
T ss_dssp TTTTEEEEEECCCTTCEETTB-------CCCSCCSCGGGCCHHHHHTCCCCTHHHHHHHHHHHHHHHHSSCCC-------
T ss_pred CCcCcceEEEcccccccccCC-------CCCCCCCCccccCcHHHhCCCCCchHhHHHHHHHHHHHHhCCCCCCCCcccc
Confidence 344799999999976541 2334467899999999999999999999999999999999999997543222
Q ss_pred CCc-h-hHHHHHHHHHhcCcc-----------------CcccccCcccc--ch--hhHhHHHHHHHHHHHHHHHHhcCCC
Q 038766 230 LSP-I-SLRQLVEKALANGIN-----------------GVRQITDPKLV--SS--IYEEQEQHQVLEELFKLALVCTSSN 286 (299)
Q Consensus 230 ~~~-~-~~~~~~~~~~~~~~~-----------------~~~~~~~~~~~--~~--~~~~~~~~~~~~~l~~li~~~l~~d 286 (299)
... . .+..... ....... ....+...... .. ......+...+.++.+||++||..|
T Consensus 243 ~~~~~~~~~~~~~-~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~d 321 (373)
T 1q8y_A 243 YTKDDDHIAQIIE-LLGELPSYLLRNGKYTRTFFNSRGLLRNISKLKFWPLEDVLTEKYKFSKDEAKEISDFLSPMLQLD 321 (373)
T ss_dssp --CHHHHHHHHHH-HHCSCCHHHHHHCTTHHHHBCC--CBSSCCCCCBCCHHHHHHHTTCCCHHHHHHHHHHHGGGGCSS
T ss_pred cCChHHHHHHHHH-hcCCCCHHHHhccchhhhhcCCcchhcccccccccchhhhhhhcccCCcchHHHHHHHHHHHhccC
Confidence 111 1 1111111 1110000 00000000000 00 0001124567889999999999999
Q ss_pred CCCCCChhhhhcC
Q 038766 287 PEDRPNMNELLIT 299 (299)
Q Consensus 287 P~~Rpt~~~il~~ 299 (299)
|++|||++++|+|
T Consensus 322 P~~Rpt~~ell~h 334 (373)
T 1q8y_A 322 PRKRADAGGLVNH 334 (373)
T ss_dssp TTTCBCHHHHHTC
T ss_pred ccccCCHHHHhhC
Confidence 9999999999987
|
| >4fl3_A Tyrosine-protein kinase SYK; transferase; HET: ANP; 1.90A {Homo sapiens} PDB: 4fl2_A* 1a81_A* 1csy_A* 1csz_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.8e-43 Score=323.64 Aligned_cols=246 Identities=24% Similarity=0.361 Sum_probs=193.4
Q ss_pred ceeecCCcceEEEEEe---CCCcEEEEEEeccCcCChhhhHHHHHHHHHHHhcCCcceeeeeeEEEcCCCeeEEEEeecC
Q 038766 18 NIIGNSNLSTVYKGRL---EDGEIVAVKKLNFHQFSAESDKSFYREAKTLKELKHRNLVKVLGYAWESGKLKALILEYME 94 (299)
Q Consensus 18 ~~lg~g~~~~v~~~~~---~~~~~~~vK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~lv~e~~~ 94 (299)
+.||+|+||+||++.+ ..++.||||++..........+.+.+|++++++++||||+++++++. .+ ..++||||+.
T Consensus 375 ~~LG~G~fG~Vy~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~-~~-~~~lv~E~~~ 452 (635)
T 4fl3_A 375 KELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRMIGICE-AE-SWMLVMEMAE 452 (635)
T ss_dssp EEEEECSSEEEEEEEEECSSCEEEEEEEEECGGGGCGGGHHHHHHHHHHHHHCCCTTBCCEEEEEE-SS-SEEEEEECCT
T ss_pred CEeccCCCEEEEEEEEcCCCcceEEEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEe-cC-CEEEEEEccC
Confidence 4799999999999964 34688999999765555566788999999999999999999999764 33 3589999999
Q ss_pred CCChHHHhcCCCCCCCCCChhhHHHHHHHHHHHHHHhhcCCCCCeeeecccCCceeeCCCCcEEEeeecccccccccccc
Q 038766 95 NGSLESVIHGPGVDHSRWTLPKRIDVLISVANGLDYLHSGYDIPIVHCDMKPSNILLDRDFEAHVSDFGTSRMLDVHLQD 174 (299)
Q Consensus 95 ~~~L~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lh~~~~~~~~H~dl~~~nil~~~~~~v~l~df~~~~~~~~~~~~ 174 (299)
+++|.+++. ....+++..++.++.||+.||+|||++ +++||||||+||+++.++.+||+|||++..+.....
T Consensus 453 ~g~L~~~l~----~~~~l~~~~~~~i~~qi~~~L~yLH~~---~iiHrDLkp~NILl~~~~~~kL~DFGla~~~~~~~~- 524 (635)
T 4fl3_A 453 LGPLNKYLQ----QNRHVKDKNIIELVHQVSMGMKYLEES---NFVHRDLAARNVLLVTQHYAKISDFGLSKALRADEN- 524 (635)
T ss_dssp TEEHHHHHH----HCTTCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEEEETTEEEECCTTHHHHTTC----
T ss_pred CCCHHHHHh----hCCCCCHHHHHHHHHHHHHHHHHHHHC---CEeCCCCChHhEEEeCCCCEEEEEcCCccccccCcc-
Confidence 999999997 456799999999999999999999999 999999999999999999999999999976542211
Q ss_pred ccccccccccCcccCChhhhcccCcCccccchhhhHHHHHHHh-CCCCCCCCccCCCCchhHHHHHHHHHhcCccCcccc
Q 038766 175 LSSLSTAFQGTIGYLAPEFAYMRIVTTKVDVFSFGIVVMEFLT-KRRPTGLDEENGLSPISLRQLVEKALANGINGVRQI 253 (299)
Q Consensus 175 ~~~~~~~~~~~~~y~~PE~~~~~~~~~~~DiwslG~~l~~l~~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 253 (299)
.........+++.|+|||++.+..++.++|||||||++|+|++ |..||... ....+...+.. .. ..
T Consensus 525 ~~~~~~~~~~t~~y~APE~~~~~~~~~~sDvwSlGv~l~ellt~G~~Pf~~~-----~~~~~~~~i~~---~~-----~~ 591 (635)
T 4fl3_A 525 YYKAQTHGKWPVKWYAPECINYYKFSSKSDVWSFGVLMWEAFSYGQKPYRGM-----KGSEVTAMLEK---GE-----RM 591 (635)
T ss_dssp ----------CGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCSSTTC-----CHHHHHHHHHT---TC-----CC
T ss_pred ccccccCCCCceeeeChhhhcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCC-----CHHHHHHHHHc---CC-----CC
Confidence 1112233345678999999999999999999999999999998 99999533 22222222211 11 00
Q ss_pred cCccccchhhHhHHHHHHHHHHHHHHHHhcCCCCCCCCChhhhhc
Q 038766 254 TDPKLVSSIYEEQEQHQVLEELFKLALVCTSSNPEDRPNMNELLI 298 (299)
Q Consensus 254 ~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rpt~~~il~ 298 (299)
.. +..++.++.+||.+||..||++|||++++++
T Consensus 592 ~~------------p~~~~~~l~~li~~cl~~dP~~RPs~~~l~~ 624 (635)
T 4fl3_A 592 GC------------PAGCPREMYDLMNLCWTYDVENRPGFAAVEL 624 (635)
T ss_dssp CC------------CTTCCHHHHHHHHHHTCSSTTTSCCHHHHHH
T ss_pred CC------------CCCCCHHHHHHHHHHcCCCHhHCcCHHHHHH
Confidence 00 1234568999999999999999999999875
|
| >3g2f_A Bone morphogenetic protein receptor type-2; kinase, structural genomics, structural genomics consortium, ATP-binding, disease mutation; HET: ADP; 2.35A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.8e-44 Score=306.00 Aligned_cols=273 Identities=22% Similarity=0.286 Sum_probs=191.6
Q ss_pred HHHHHhCCCCCCceeecCCcceEEEEEeCCCcEEEEEEeccCcCChhhhHHHHHHHHH--HHhcCCcceeeeeeEEEc--
Q 038766 6 EIENATGSFSENNIIGNSNLSTVYKGRLEDGEIVAVKKLNFHQFSAESDKSFYREAKT--LKELKHRNLVKVLGYAWE-- 81 (299)
Q Consensus 6 ~~~~~~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~vK~~~~~~~~~~~~~~~~~e~~~--l~~l~h~~i~~~~~~~~~-- 81 (299)
+...-.++|.+.+.||+|+||+||+++. +++.||+|++... .......|.++ ++.++||||+++++.+..
T Consensus 7 ~~~~~~~~y~~~~~lg~G~~g~Vy~~~~-~~~~vavK~~~~~-----~~~~~~~e~~~~~~~~~~h~~i~~~~~~~~~~~ 80 (336)
T 3g2f_A 7 EPSLDLDNLKLLELIGRGRYGAVYKGSL-DERPVAVKVFSFA-----NRQNFINEKNIYRVPLMEHDNIARFIVGDERVT 80 (336)
T ss_dssp --CCCTTSEEEEEEEEECSSEEEEEEEE-TTEEEEEEEEEGG-----GHHHHHHHHHHHTSTTCCCTTBCCEEEEEEEEC
T ss_pred CCCcChHHhheeeecccCCCeEEEEEEE-CCeEEEEEEeecc-----chhhHHHHHHHHHHHhccCcchhhheecccccc
Confidence 3445578999999999999999999987 5889999998632 22333344444 445789999999975432
Q ss_pred --CCCeeEEEEeecCCCChHHHhcCCCCCCCCCChhhHHHHHHHHHHHHHHhhcCC------CCCeeeecccCCceeeCC
Q 038766 82 --SGKLKALILEYMENGSLESVIHGPGVDHSRWTLPKRIDVLISVANGLDYLHSGY------DIPIVHCDMKPSNILLDR 153 (299)
Q Consensus 82 --~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lh~~~------~~~~~H~dl~~~nil~~~ 153 (299)
.....++|+||+++++|.+++.. ...++..++.++.|++.||+|||+.. ..+++|+||||+||+++.
T Consensus 81 ~~~~~~~~lv~e~~~~g~L~~~l~~-----~~~~~~~~~~i~~qi~~~L~~LH~~~~~~~~~~~~ivH~Dikp~Nill~~ 155 (336)
T 3g2f_A 81 ADGRMEYLLVMEYYPNGSLXKYLSL-----HTSDWVSSCRLAHSVTRGLAYLHTELPRGDHYKPAISHRDLNSRNVLVKN 155 (336)
T ss_dssp TTSCEEEEEEECCCTTCBHHHHHHH-----CCBCHHHHHHHHHHHHHHHHHHHCCBCCGGGCBCCEECSSCSGGGEEECT
T ss_pred cCCCceEEEEEecCCCCcHHHHHhh-----cccchhHHHHHHHHHHHHHHHHHhhhccccccccceeecccccceEEEcC
Confidence 23356899999999999999953 34588899999999999999999751 128999999999999999
Q ss_pred CCcEEEeeeccccccccccc----cccccccccccCcccCChhhhcc-------cCcCccccchhhhHHHHHHHhCCCCC
Q 038766 154 DFEAHVSDFGTSRMLDVHLQ----DLSSLSTAFQGTIGYLAPEFAYM-------RIVTTKVDVFSFGIVVMEFLTKRRPT 222 (299)
Q Consensus 154 ~~~v~l~df~~~~~~~~~~~----~~~~~~~~~~~~~~y~~PE~~~~-------~~~~~~~DiwslG~~l~~l~~g~~p~ 222 (299)
++.+||+|||++..+..... ..........+|+.|+|||++.+ ..++.++|||||||++|+|++|..||
T Consensus 156 ~~~~kL~DFG~a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~il~ell~g~~p~ 235 (336)
T 3g2f_A 156 DGTCVISDFGLSMRLTGNRLVRPGEEDNAAISEVGTIRYMAPEVLEGAVNLRDXESALKQVDMYALGLIYWEIFMRCTDL 235 (336)
T ss_dssp TSCEEECCCTTCEECSSSSCC---------CCTTSCGGGCCHHHHTTCCCGGGHHHHHHHHHHHHHHHHHHHHHTTBGGG
T ss_pred CCcEEEeeccceeecccccccCccccccccccCCCccceeCchhhcCCcccccccccccccchHHHHHHHHHHHhcCCcC
Confidence 99999999999976542111 11122234468999999999886 45677899999999999999998776
Q ss_pred CCCccCCCCchhH---------HHHHHHHHhcCccCcccccCccccchhhHhHHHHHHHHHHHHHHHHhcCCCCCCCCCh
Q 038766 223 GLDEENGLSPISL---------RQLVEKALANGINGVRQITDPKLVSSIYEEQEQHQVLEELFKLALVCTSSNPEDRPNM 293 (299)
Q Consensus 223 ~~~~~~~~~~~~~---------~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rpt~ 293 (299)
............+ ...+........ ....+.. .. ......+..+.++|.+||..||++|||+
T Consensus 236 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~-~~-------~~~~~~~~~l~~li~~cl~~dP~~Rps~ 306 (336)
T 3g2f_A 236 FPGESVPEYQMAFQTEVGNHPTFEDMQVLVSREK-QRPKFPE-AW-------KENSLAVRSLKETIEDCWDQDAEARLTA 306 (336)
T ss_dssp STTSCCCCCCCTTHHHHCSSCCHHHHHHHHTTSC-CCCCCCT-TC-------CCCSHHHHHHHHHHHHHSCSSGGGSCCH
T ss_pred CCccchhHHHHhhhcccCCCchHHHHHhhhcccc-cCCCCCc-cc-------ccccchHHHHHHHHHHHhcCChhhCcch
Confidence 4332221111111 011111111000 0001110 00 0023456789999999999999999999
Q ss_pred hhhhc
Q 038766 294 NELLI 298 (299)
Q Consensus 294 ~~il~ 298 (299)
+++++
T Consensus 307 ~e~l~ 311 (336)
T 3g2f_A 307 QXAEE 311 (336)
T ss_dssp HHHHH
T ss_pred HHHHH
Confidence 99975
|
| >2ozo_A Tyrosine-protein kinase ZAP-70; inactive ZAP-70, tandem SH2, autoinhibition, ITAM, hydrogen bonding network, TCR signaling, transferase; HET: ANP; 2.60A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.6e-43 Score=321.39 Aligned_cols=245 Identities=24% Similarity=0.369 Sum_probs=191.1
Q ss_pred eeecCCcceEEEEEeC---CCcEEEEEEeccCcCChhhhHHHHHHHHHHHhcCCcceeeeeeEEEcCCCeeEEEEeecCC
Q 038766 19 IIGNSNLSTVYKGRLE---DGEIVAVKKLNFHQFSAESDKSFYREAKTLKELKHRNLVKVLGYAWESGKLKALILEYMEN 95 (299)
Q Consensus 19 ~lg~g~~~~v~~~~~~---~~~~~~vK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~lv~e~~~~ 95 (299)
.||+|+||.||++.+. ++..||||++... ......+.+.+|+++++.++||||+++++++.. ...++|+||+.+
T Consensus 343 ~LG~G~fG~Vy~~~~~~~~~~~~vAvK~~~~~-~~~~~~~~~~~E~~il~~l~hpniv~l~~~~~~--~~~~lv~E~~~~ 419 (613)
T 2ozo_A 343 ELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQG-TEKADTEEMMREAQIMHQLDNPYIVRLIGVCQA--EALMLVMEMAGG 419 (613)
T ss_dssp EEEECSSSEEEEEEEECSSCEEEEEEEECCCC-CSSTTHHHHHHHHHHHTTCCCTTBCCEEEEEES--SSEEEEEECCTT
T ss_pred EEecCCCcEEEEEEEecCCCcEEEEEEEcCCC-CChHHHHHHHHHHHHHHhCCCCCEeeEEEEecc--CCeEEEEEeCCC
Confidence 7999999999999753 4667999998743 334456789999999999999999999997754 346999999999
Q ss_pred CChHHHhcCCCCCCCCCChhhHHHHHHHHHHHHHHhhcCCCCCeeeecccCCceeeCCCCcEEEeeeccccccccccccc
Q 038766 96 GSLESVIHGPGVDHSRWTLPKRIDVLISVANGLDYLHSGYDIPIVHCDMKPSNILLDRDFEAHVSDFGTSRMLDVHLQDL 175 (299)
Q Consensus 96 ~~L~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lh~~~~~~~~H~dl~~~nil~~~~~~v~l~df~~~~~~~~~~~~~ 175 (299)
++|.+++.. ....+++..++.++.||+.||+|||++ +++||||||+||+++.++.+||+|||++........ .
T Consensus 420 g~L~~~l~~---~~~~l~~~~~~~i~~qi~~~L~~LH~~---~iiHrDlkp~NILl~~~~~vkL~DFGla~~~~~~~~-~ 492 (613)
T 2ozo_A 420 GPLHKFLVG---KREEIPVSNVAELLHQVSMGMKYLEEK---NFVHRNLAARNVLLVNRHYAKISDFGLSKALGADDS-Y 492 (613)
T ss_dssp CBHHHHHTT---CTTTSCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEEEETTEEEECCCSTTTTCC------
T ss_pred CcHHHHHhh---ccCCCCHHHHHHHHHHHHHHHHHHHHC---CEEcCcCCHHHEEEcCCCcEEEeeccCcccccCCCc-e
Confidence 999999863 345699999999999999999999999 999999999999999999999999999976542111 1
Q ss_pred cccccccccCcccCChhhhcccCcCccccchhhhHHHHHHHh-CCCCCCCCccCCCCchhHHHHHHHHHhcCccCccccc
Q 038766 176 SSLSTAFQGTIGYLAPEFAYMRIVTTKVDVFSFGIVVMEFLT-KRRPTGLDEENGLSPISLRQLVEKALANGINGVRQIT 254 (299)
Q Consensus 176 ~~~~~~~~~~~~y~~PE~~~~~~~~~~~DiwslG~~l~~l~~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 254 (299)
........+++.|+|||++.+..++.++|||||||++|+|++ |..||... ....+...+.. +. ...
T Consensus 493 ~~~~~~~~~~~~y~APE~~~~~~~~~~sDvwSlGv~l~ellt~G~~Pf~~~-----~~~~~~~~i~~----~~----~~~ 559 (613)
T 2ozo_A 493 YTARSAGKWPLKWYAPECINFRKFSSRSDVWSYGVTMWEALSYGQKPYKKM-----KGPEVMAFIEQ----GK----RME 559 (613)
T ss_dssp ---------CCTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTC-----CSHHHHHHHHT----TC----CCC
T ss_pred eeeccCCCCccceeCHhhhcCCCCCcHHHHHHHHHHHHHHHHCCCCCCCCC-----CHHHHHHHHHc----CC----CCC
Confidence 111122334678999999999999999999999999999998 99999533 22222222211 10 000
Q ss_pred CccccchhhHhHHHHHHHHHHHHHHHHhcCCCCCCCCChhhhhc
Q 038766 255 DPKLVSSIYEEQEQHQVLEELFKLALVCTSSNPEDRPNMNELLI 298 (299)
Q Consensus 255 ~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rpt~~~il~ 298 (299)
. +..++.++.++|.+||..||++|||++++++
T Consensus 560 ~------------p~~~~~~l~~li~~cl~~dP~~RPs~~~l~~ 591 (613)
T 2ozo_A 560 C------------PPECPPELYALMSDCWIYKWEDRPDFLTVEQ 591 (613)
T ss_dssp C------------CTTCCHHHHHHHHHTTCSSTTTSCCHHHHHH
T ss_pred C------------CCcCCHHHHHHHHHHcCCChhHCcCHHHHHH
Confidence 0 2234568999999999999999999999864
|
| >2dyl_A Dual specificity mitogen-activated protein kinase kinase 7; MKK7, activated mutant, ATP-binding, structural genomics, NPPSFA; 2.45A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-42 Score=294.00 Aligned_cols=257 Identities=21% Similarity=0.271 Sum_probs=183.8
Q ss_pred HHHhCCCCCCceeecCCcceEEEEEeC-CCcEEEEEEeccCcCChhhhHHHHHHHHHHHhcCCcceeeeeeEEEcCCCee
Q 038766 8 ENATGSFSENNIIGNSNLSTVYKGRLE-DGEIVAVKKLNFHQFSAESDKSFYREAKTLKELKHRNLVKVLGYAWESGKLK 86 (299)
Q Consensus 8 ~~~~~~y~~~~~lg~g~~~~v~~~~~~-~~~~~~vK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~ 86 (299)
....++|.+.+.||+|+||.||++.+. +|+.||+|++............+..+...++.++||||+++++++.. +...
T Consensus 21 ~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~h~~i~~~~~~~~~-~~~~ 99 (318)
T 2dyl_A 21 QAEINDLENLGEMGSGTCGQVWKMRFRKTGHVIAVKQMRRSGNKEENKRILMDLDVVLKSHDCPYIVQCFGTFIT-NTDV 99 (318)
T ss_dssp ECCGGGEEEEEEC------CEEEEEETTTCCEEEEEEEETTSCHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEEC-SSEE
T ss_pred hhhhccccccceeeecCCeeEEEEEEecCCeEEEEEEecccccchHHHHHHHHHHHHHHhcCCCceeeEEEEEec-CCcE
Confidence 344678999999999999999999875 68999999997554434444455556667888899999999997665 5567
Q ss_pred EEEEeecCCCChHHHhcCCCCCCCCCChhhHHHHHHHHHHHHHHhhc-CCCCCeeeecccCCceeeCCCCcEEEeeeccc
Q 038766 87 ALILEYMENGSLESVIHGPGVDHSRWTLPKRIDVLISVANGLDYLHS-GYDIPIVHCDMKPSNILLDRDFEAHVSDFGTS 165 (299)
Q Consensus 87 ~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lh~-~~~~~~~H~dl~~~nil~~~~~~v~l~df~~~ 165 (299)
++|+||+ ++.+..+... ....+++..++.++.|++.||.|||+ . +++|+||||+||+++.++.++|+|||++
T Consensus 100 ~lv~e~~-~~~~~~l~~~---~~~~~~~~~~~~~~~~i~~~l~~lH~~~---~i~H~dlkp~Nil~~~~~~~kl~dfg~~ 172 (318)
T 2dyl_A 100 FIAMELM-GTCAEKLKKR---MQGPIPERILGKMTVAIVKALYYLKEKH---GVIHRDVKPSNILLDERGQIKLCDFGIS 172 (318)
T ss_dssp EEEECCC-SEEHHHHHHH---HTSCCCHHHHHHHHHHHHHHHHHHHHHH---CCCCCCCCGGGEEECTTSCEEECCCTTC
T ss_pred EEEEecc-CCcHHHHHHH---hccCCCHHHHHHHHHHHHHHHHHHHhhC---CEEeCCCCHHHEEECCCCCEEEEECCCc
Confidence 9999999 5566655542 23578999999999999999999998 6 8999999999999999999999999998
Q ss_pred cccccccccccccccccccCcccCChhhhc-----ccCcCccccchhhhHHHHHHHhCCCCCCCCccCCCCchhHHHHHH
Q 038766 166 RMLDVHLQDLSSLSTAFQGTIGYLAPEFAY-----MRIVTTKVDVFSFGIVVMEFLTKRRPTGLDEENGLSPISLRQLVE 240 (299)
Q Consensus 166 ~~~~~~~~~~~~~~~~~~~~~~y~~PE~~~-----~~~~~~~~DiwslG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~ 240 (299)
..... ........+++.|+|||.+. ...++.++||||||+++|+|++|..||..... ....+.
T Consensus 173 ~~~~~-----~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~-------~~~~~~ 240 (318)
T 2dyl_A 173 GRLVD-----DKAKDRSAGCAAYMAPERIDPPDPTKPDYDIRADVWSLGISLVELATGQFPYKNCKT-------DFEVLT 240 (318)
T ss_dssp -------------------CCTTCCHHHHC--------CCTHHHHHHHHHHHHHHHHSSCTTTTCCS-------HHHHHH
T ss_pred hhccC-----CccccccCCCccccChhhcccccccccCCccccchhhHHHHHHHHHhCCCCCCCCCc-------cHHHHH
Confidence 75432 11223446789999999984 45678899999999999999999999953211 122222
Q ss_pred HHHhcCccCcccccCccccchhhHhHHHHHHHHHHHHHHHHhcCCCCCCCCChhhhhcC
Q 038766 241 KALANGINGVRQITDPKLVSSIYEEQEQHQVLEELFKLALVCTSSNPEDRPNMNELLIT 299 (299)
Q Consensus 241 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rpt~~~il~~ 299 (299)
............ ...++.++.++|.+||..||.+|||++++++|
T Consensus 241 ~~~~~~~~~~~~---------------~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~h 284 (318)
T 2dyl_A 241 KVLQEEPPLLPG---------------HMGFSGDFQSFVKDCLTKDHRKRPKYNKLLEH 284 (318)
T ss_dssp HHHHSCCCCCCS---------------SSCCCHHHHHHHHHHTCSCTTTSCCHHHHTTS
T ss_pred HHhccCCCCCCc---------------cCCCCHHHHHHHHHHccCChhHCcCHHHHhhC
Confidence 222222111110 01234578999999999999999999999987
|
| >1u46_A ACK-1, activated CDC42 kinase 1; tyrosine kinase, transferase; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 1u4d_A* 1u54_A* 3eqr_A* 3eqp_B* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.8e-43 Score=293.83 Aligned_cols=256 Identities=23% Similarity=0.369 Sum_probs=190.6
Q ss_pred HhCCCCCCceeecCCcceEEEEEeC--CCc--EEEEEEeccCcC-ChhhhHHHHHHHHHHHhcCCcceeeeeeEEEcCCC
Q 038766 10 ATGSFSENNIIGNSNLSTVYKGRLE--DGE--IVAVKKLNFHQF-SAESDKSFYREAKTLKELKHRNLVKVLGYAWESGK 84 (299)
Q Consensus 10 ~~~~y~~~~~lg~g~~~~v~~~~~~--~~~--~~~vK~~~~~~~-~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~ 84 (299)
..++|++.+.||+|++|+||++.+. ++. .||+|++..... .....+.+.+|+..++.++||||+++++++... .
T Consensus 16 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~-~ 94 (291)
T 1u46_A 16 GEKDLRLLEKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNLIRLYGVVLTP-P 94 (291)
T ss_dssp CGGGEEEEEECC----CCCEEEEEECTTSCEEEEEEEC--------CHHHHHHHHHHHHHHHCCCTTBCCEEEEECSS-S
T ss_pred chhHeeeeeeecCCCceeEEEEEeccCCCceeEEEEEEEccCccCCHHHHHHHHHHHHHHHhCCCCCcccEEEEEccC-C
Confidence 3578999999999999999999752 233 689998865432 334567889999999999999999999976543 3
Q ss_pred eeEEEEeecCCCChHHHhcCCCCCCCCCChhhHHHHHHHHHHHHHHhhcCCCCCeeeecccCCceeeCCCCcEEEeeecc
Q 038766 85 LKALILEYMENGSLESVIHGPGVDHSRWTLPKRIDVLISVANGLDYLHSGYDIPIVHCDMKPSNILLDRDFEAHVSDFGT 164 (299)
Q Consensus 85 ~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lh~~~~~~~~H~dl~~~nil~~~~~~v~l~df~~ 164 (299)
.++|+|++.+++|.+++.. ....+++..++.++.|++.||.+||++ +++|+||||+||+++.++.++|+|||+
T Consensus 95 -~~~v~e~~~~~~L~~~l~~---~~~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dikp~Nili~~~~~~kl~Dfg~ 167 (291)
T 1u46_A 95 -MKMVTELAPLGSLLDRLRK---HQGHFLLGTLSRYAVQVAEGMGYLESK---RFIHRDLAARNLLLATRDLVKIGDFGL 167 (291)
T ss_dssp -CEEEEECCTTCBHHHHHHH---HGGGSCHHHHHHHHHHHHHHHHHHHHT---TEECSCCCGGGEEEEETTEEEECCCTT
T ss_pred -ceeeEecccCCCHHHHHHh---ccCCcCHHHHHHHHHHHHHHHHHHHhC---CcccCCCchheEEEcCCCCEEEccccc
Confidence 5899999999999998863 235689999999999999999999999 999999999999999999999999999
Q ss_pred ccccccccccccccccccccCcccCChhhhcccCcCccccchhhhHHHHHHHh-CCCCCCCCccCCCCchhHHHHHHHHH
Q 038766 165 SRMLDVHLQDLSSLSTAFQGTIGYLAPEFAYMRIVTTKVDVFSFGIVVMEFLT-KRRPTGLDEENGLSPISLRQLVEKAL 243 (299)
Q Consensus 165 ~~~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~DiwslG~~l~~l~~-g~~p~~~~~~~~~~~~~~~~~~~~~~ 243 (299)
+........ .........+++.|+|||.+.+..++.++||||||+++|+|++ |..||.... .. +.+....
T Consensus 168 ~~~~~~~~~-~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~-----~~---~~~~~~~ 238 (291)
T 1u46_A 168 MRALPQNDD-HYVMQEHRKVPFAWCAPESLKTRTFSHASDTWMFGVTLWEMFTYGQEPWIGLN-----GS---QILHKID 238 (291)
T ss_dssp CEECCC-CC-EEEC-----CCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTSCCTTTTCC-----HH---HHHHHHH
T ss_pred ccccccccc-chhhhccCCCCceeeCchhhcCCCCCchhhHHHHHHHHHHHHhCCCCCcccCC-----HH---HHHHHHH
Confidence 876542211 1112233446778999999998889999999999999999999 999985331 11 2222222
Q ss_pred hcCccCcccccCccccchhhHhHHHHHHHHHHHHHHHHhcCCCCCCCCChhhhhc
Q 038766 244 ANGINGVRQITDPKLVSSIYEEQEQHQVLEELFKLALVCTSSNPEDRPNMNELLI 298 (299)
Q Consensus 244 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rpt~~~il~ 298 (299)
.... . ... +..++..+.++|.+||..||++|||++++++
T Consensus 239 ~~~~-~---~~~------------~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~ 277 (291)
T 1u46_A 239 KEGE-R---LPR------------PEDCPQDIYNVMVQCWAHKPEDRPTFVALRD 277 (291)
T ss_dssp TSCC-C---CCC------------CTTCCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred ccCC-C---CCC------------CcCcCHHHHHHHHHHccCCcccCcCHHHHHH
Confidence 1110 0 000 1234567999999999999999999999985
|
| >3qa8_A MGC80376 protein; kinase ubiquitin-like domain, phosphorylation, kinase domain ubiquitin-like domain, kinase, substrate binding; 3.60A {Xenopus laevis} PDB: 3qad_A* 3rzf_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.6e-43 Score=319.82 Aligned_cols=277 Identities=23% Similarity=0.301 Sum_probs=200.2
Q ss_pred HHhCCCCCCceeecCCcceEEEEEe-CCCcEEEEEEeccCcCChhhhHHHHHHHHHHHhcCCcceeeeeeEEEc-----C
Q 038766 9 NATGSFSENNIIGNSNLSTVYKGRL-EDGEIVAVKKLNFHQFSAESDKSFYREAKTLKELKHRNLVKVLGYAWE-----S 82 (299)
Q Consensus 9 ~~~~~y~~~~~lg~g~~~~v~~~~~-~~~~~~~vK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~-----~ 82 (299)
...++|++.+.||+|+||+||++.+ .+|+.||+|++... ......+.+.+|+.+++.++||||+++++++.. .
T Consensus 11 ~~~grY~i~~~LG~G~fG~Vyla~~~~tg~~VAVKvi~~~-~~~~~~~~~~~Ei~iL~~L~HpnIV~l~~v~~~~~~~~~ 89 (676)
T 3qa8_A 11 QTCGPWEMKERLGTGGFGYVLRWIHQDTGEQVAIKQCRQE-LSPKNRERWCLEIQIMKKLNHPNVVSAREVPDGLQKLAP 89 (676)
T ss_dssp ------CCCCCCCBCSSSBCCCCCCTTTTCCEEECCCCSC-CCHHHHHHHHHHHHHHHHCCBTTBCCEEECCTTTCCCCT
T ss_pred CCCCCeEEEEEEeeCCCeEEEEEEECCCCcEEEEEEeccc-CCHHHHHHHHHHHHHHHhCCCCCCCceeeeecccccccC
Confidence 3458999999999999999999987 45899999998643 355567789999999999999999999996533 2
Q ss_pred CCeeEEEEeecCCCChHHHhcCCCCCCCCCChhhHHHHHHHHHHHHHHhhcCCCCCeeeecccCCceeeCCCCc---EEE
Q 038766 83 GKLKALILEYMENGSLESVIHGPGVDHSRWTLPKRIDVLISVANGLDYLHSGYDIPIVHCDMKPSNILLDRDFE---AHV 159 (299)
Q Consensus 83 ~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lh~~~~~~~~H~dl~~~nil~~~~~~---v~l 159 (299)
+...++|+||+.+++|.+++.... ....+++..++.++.|++.||+|||+. +++|+||||+||+++.++. ++|
T Consensus 90 ~~~~~LVmEy~~ggsL~~~L~~~~-~~~~lse~~i~~I~~QLl~aL~yLHs~---gIVHrDLKP~NILl~~~g~~~~vKL 165 (676)
T 3qa8_A 90 NDLPLLAMEYCEGGDLRKYLNQFE-NCCGLKEGPIRTLLSDISSALRYLHEN---RIIHRDLKPENIVLQPGPQRLIHKI 165 (676)
T ss_dssp TSSCCCEEECCSSCBHHHHHHSSS-CTTCCCSSHHHHHHHHHHHHHHHHHHT---TBCCCCCCSTTEEEECCSSSCEEEE
T ss_pred CCeEEEEEEeCCCCCHHHHHHhcc-cCCCCCHHHHHHHHHHHHHHHHHHHHC---CCccCCCCHHHeEeecCCCceeEEE
Confidence 455689999999999999997543 344699999999999999999999999 9999999999999987765 899
Q ss_pred eeeccccccccccccccccccccccCcccCChhhhcccCcCccccchhhhHHHHHHHhCCCCCCCCccCC-CCchhHHHH
Q 038766 160 SDFGTSRMLDVHLQDLSSLSTAFQGTIGYLAPEFAYMRIVTTKVDVFSFGIVVMEFLTKRRPTGLDEENG-LSPISLRQL 238 (299)
Q Consensus 160 ~df~~~~~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~DiwslG~~l~~l~~g~~p~~~~~~~~-~~~~~~~~~ 238 (299)
+|||++..... ........+++.|+|||.+.+..++.++||||||+++|+|++|..||....... .........
T Consensus 166 ~DFG~a~~~~~-----~~~~~~~~gt~~Y~APE~l~~~~~s~ksDIwSLGviLyeLltG~~Pf~~~~~~~~~~~~i~~~~ 240 (676)
T 3qa8_A 166 IDLGYAKELDQ-----GELCTEFVGTLQYLAPELLEQKKYTVTVDYWSFGTLAFECITGFRPFLPNWQPVQWHGKVREKS 240 (676)
T ss_dssp CSCCCCCBTTS-----CCCCCCCCSCCTTCSSCSSCCSCCSTTHHHHHHHHHHHHHHSSCSSCCSSCHHHHSSTTCC---
T ss_pred ccccccccccc-----ccccccccCCcccCChHHhccCCCCchhHHHHHHHHHHHHHHCCCCCCcccchhhhhhhhhccc
Confidence 99999976542 122344568999999999999999999999999999999999999996431100 000000000
Q ss_pred HHH-HHhcCccCcccccCccccchhhHhHHHHHHHHHHHHHHHHhcCCCCCCCCChhhhhcC
Q 038766 239 VEK-ALANGINGVRQITDPKLVSSIYEEQEQHQVLEELFKLALVCTSSNPEDRPNMNELLIT 299 (299)
Q Consensus 239 ~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rpt~~~il~~ 299 (299)
... ...........+.... .........++..+.++|.+||..||++|||++++++|
T Consensus 241 ~~~~~~~~~l~g~~~~~~~l----p~p~~l~~~ls~~L~dLI~~mL~~DP~kRPTa~elL~h 298 (676)
T 3qa8_A 241 NEHIVVYDDLTGAVKFSSVL----PTPNHLSGILAGKLERWLQCMLMWHQRQRGTDPQNPNV 298 (676)
T ss_dssp ---CCSCCCCSSSCCCCSSS----CCSCCCCGGGHHHHHHHHHHHSCSSCC---CCTTCCCC
T ss_pred chhhhhhhhhcccccccccc----CCchhhchhhhHHHHHHHHHHccCCHhhCcCHHHHhcC
Confidence 000 0000000000000000 00011133467889999999999999999999999876
|
| >3e7e_A HBUB1, BUB1A, mitotic checkpoint serine/threonine-protein kinas; spindle assembly checkpoint, mitosis, kinase, activation, KE CDC20, ATP-binding; HET: ATP; 2.31A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=5.9e-43 Score=302.63 Aligned_cols=249 Identities=16% Similarity=0.145 Sum_probs=193.2
Q ss_pred HHHHhCCCCCCceeecCCcceEEEEE------eCCCcEEEEEEeccCcCChhhhHHHHHHHHHHHhcC---Ccceeeeee
Q 038766 7 IENATGSFSENNIIGNSNLSTVYKGR------LEDGEIVAVKKLNFHQFSAESDKSFYREAKTLKELK---HRNLVKVLG 77 (299)
Q Consensus 7 ~~~~~~~y~~~~~lg~g~~~~v~~~~------~~~~~~~~vK~~~~~~~~~~~~~~~~~e~~~l~~l~---h~~i~~~~~ 77 (299)
++...++|.+.+.||+|+||+||+|. ..+++.||+|++.. .....+..|.+.++.++ |+||+.+++
T Consensus 60 ~~~~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~-----~~~~~~~~e~~~~~~l~~~~~~~iv~~~~ 134 (365)
T 3e7e_A 60 FQLGSKLVYVHHLLGEGAFAQVYEATQGDLNDAKNKQKFVLKVQKP-----ANPWEFYIGTQLMERLKPSMQHMFMKFYS 134 (365)
T ss_dssp EECSSSEEEEEEEEEECSSEEEEEEEC-------CCCCEEEEEESS-----CCHHHHHHHHHHHHHSCGGGGGGBCCEEE
T ss_pred EEECCEEEEEEEEeeccCCEEEEEEEecCCcccccCcEEEEEEeCC-----CChhHHHHHHHHHHHhhhhhhhhhhhhhe
Confidence 34456789999999999999999994 34688999999863 23446677888888876 899999999
Q ss_pred EEEcCCCeeEEEEeecCCCChHHHhcCCCC-CCCCCChhhHHHHHHHHHHHHHHhhcCCCCCeeeecccCCceeeCC---
Q 038766 78 YAWESGKLKALILEYMENGSLESVIHGPGV-DHSRWTLPKRIDVLISVANGLDYLHSGYDIPIVHCDMKPSNILLDR--- 153 (299)
Q Consensus 78 ~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~-~~~~~~~~~~~~i~~qi~~~l~~lh~~~~~~~~H~dl~~~nil~~~--- 153 (299)
++...+ ..++||||+.+++|.+++..... ....+++..++.++.|++.||+|||+. +++||||||+|||++.
T Consensus 135 ~~~~~~-~~~lv~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~qi~~~L~~lH~~---~ivHrDiKp~NIll~~~~~ 210 (365)
T 3e7e_A 135 AHLFQN-GSVLVGELYSYGTLLNAINLYKNTPEKVMPQGLVISFAMRMLYMIEQVHDC---EIIHGDIKPDNFILGNGFL 210 (365)
T ss_dssp EEECSS-CEEEEECCCCSCBHHHHHHHHHTSTTCSCCHHHHHHHHHHHHHHHHHHHTT---TEECCCCSGGGEEECGGGT
T ss_pred eeecCC-CcEEEEeccCCCcHHHHHHHhhcccccCCCHHHHHHHHHHHHHHHHHHhhC---CeecCCCCHHHEEeccccc
Confidence 776644 55999999999999999864211 345799999999999999999999999 9999999999999998
Q ss_pred --------CCcEEEeeeccccccccccccccccccccccCcccCChhhhcccCcCccccchhhhHHHHHHHhCCCCCCCC
Q 038766 154 --------DFEAHVSDFGTSRMLDVHLQDLSSLSTAFQGTIGYLAPEFAYMRIVTTKVDVFSFGIVVMEFLTKRRPTGLD 225 (299)
Q Consensus 154 --------~~~v~l~df~~~~~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~DiwslG~~l~~l~~g~~p~~~~ 225 (299)
++.+||+|||++..+... ..........+|+.|+|||++.+..++.++|||||||++|+|++|..||...
T Consensus 211 ~~~~~~~~~~~~kl~DFG~a~~~~~~--~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~pf~~~ 288 (365)
T 3e7e_A 211 EQDDEDDLSAGLALIDLGQSIDMKLF--PKGTIFTAKCETSGFQCVEMLSNKPWNYQIDYFGVAATVYCMLFGTYMKVKN 288 (365)
T ss_dssp CC------CTTEEECCCTTCEEGGGS--CTTEEECCSSCTTSCCCHHHHTTCCBSTHHHHHHHHHHHHHHHHSSCCCEEE
T ss_pred CccccccccCCEEEeeCchhhhhhcc--CCCceeeeecCCCCCCChHHhcCCCCCccccHHHHHHHHHHHHhCCCccccC
Confidence 899999999999754421 1122334566899999999999999999999999999999999999998533
Q ss_pred ccCCCCchhHHHHHHHHHhcCccCcccccCccccchhhHhHHHHHHHHHHHHHHHHhcCCCCCCCCChhhh
Q 038766 226 EENGLSPISLRQLVEKALANGINGVRQITDPKLVSSIYEEQEQHQVLEELFKLALVCTSSNPEDRPNMNEL 296 (299)
Q Consensus 226 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rpt~~~i 296 (299)
..... ....... . ...++.+.+++.+||+.+|.+|++..+.
T Consensus 289 ~~~~~------------------~~~~~~~----~--------~~~~~~~~~~~~~~l~~~p~~r~~~~~~ 329 (365)
T 3e7e_A 289 EGGEC------------------KPEGLFR----R--------LPHLDMWNEFFHVMLNIPDCHHLPSLDL 329 (365)
T ss_dssp ETTEE------------------EECSCCT----T--------CSSHHHHHHHHHHHHCCCCTTCCCCHHH
T ss_pred CCCce------------------eechhcc----c--------cCcHHHHHHHHHHHcCCCCCCcchHHHH
Confidence 21100 0000000 0 0124567889999999999999665443
|
| >2y4i_B KSR2, HKSR2, kinase suppressor of RAS 2; transferase, KSR1; HET: ATP; 3.46A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=6e-43 Score=297.09 Aligned_cols=261 Identities=21% Similarity=0.325 Sum_probs=199.6
Q ss_pred hHHHHHHhCCCCCCceeecCCcceEEEEEeCCCcEEEEEEeccCcCChhhhHHHHHHHHHHHhcCCcceeeeeeEEEcCC
Q 038766 4 RTEIENATGSFSENNIIGNSNLSTVYKGRLEDGEIVAVKKLNFHQFSAESDKSFYREAKTLKELKHRNLVKVLGYAWESG 83 (299)
Q Consensus 4 ~~~~~~~~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~vK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~ 83 (299)
.++++...++|.+.+.||+|++|+||++.+.+ .+|+|++..........+.+.+|+..++.++||||+++++++...+
T Consensus 25 ~~~~~i~~~~~~~~~~lg~G~~g~V~~~~~~~--~~avk~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~ 102 (319)
T 2y4i_B 25 LQEWDIPFEQLEIGELIGKGRFGQVYHGRWHG--EVAIRLIDIERDNEDQLKAFKREVMAYRQTRHENVVLFMGACMSPP 102 (319)
T ss_dssp GGGSSSCCSCEECCCBCCCSSSSEEEEEEESS--SEEEEECCCCSCCCCCCCCCCTTGGGGTTCCCTTBCCCCEEEECSS
T ss_pred cccccCCHHHeEEeeEeccCCceEEEEEEEcC--eEEEEEeecCCCCHHHHHHHHHHHHHHhcCCCCCEeEEEEEEecCC
Confidence 45677778999999999999999999998754 4999999766555555667788999999999999999999776644
Q ss_pred CeeEEEEeecCCCChHHHhcCCCCCCCCCChhhHHHHHHHHHHHHHHhhcCCCCCeeeecccCCceeeCCCCcEEEeeec
Q 038766 84 KLKALILEYMENGSLESVIHGPGVDHSRWTLPKRIDVLISVANGLDYLHSGYDIPIVHCDMKPSNILLDRDFEAHVSDFG 163 (299)
Q Consensus 84 ~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lh~~~~~~~~H~dl~~~nil~~~~~~v~l~df~ 163 (299)
..++|+||+.+++|.+++... ...+++..++.++.|++.||+|||+. +++|+||||+||+++ ++.++|+|||
T Consensus 103 -~~~iv~e~~~~~~L~~~l~~~---~~~~~~~~~~~i~~qi~~al~~lH~~---~i~H~dlkp~NIl~~-~~~~~l~Dfg 174 (319)
T 2y4i_B 103 -HLAIITSLCKGRTLYSVVRDA---KIVLDVNKTRQIAQEIVKGMGYLHAK---GILHKDLKSKNVFYD-NGKVVITDFG 174 (319)
T ss_dssp -CEEEECBCCCSEEHHHHTTSS---CCCCCSHHHHHHHHHHHHHHHHHHHT---TCCCCCCCSTTEEEC---CCEECCCS
T ss_pred -ceEEEeecccCCcHHHHHHhc---CCCCCHHHHHHHHHHHHHHHHHHHhC---CccccCCChhhEEEe-CCCEEEeecC
Confidence 569999999999999999642 34789999999999999999999999 999999999999998 6799999999
Q ss_pred cccccccccc-cccccccccccCcccCChhhhcc---------cCcCccccchhhhHHHHHHHhCCCCCCCCccCCCCch
Q 038766 164 TSRMLDVHLQ-DLSSLSTAFQGTIGYLAPEFAYM---------RIVTTKVDVFSFGIVVMEFLTKRRPTGLDEENGLSPI 233 (299)
Q Consensus 164 ~~~~~~~~~~-~~~~~~~~~~~~~~y~~PE~~~~---------~~~~~~~DiwslG~~l~~l~~g~~p~~~~~~~~~~~~ 233 (299)
++........ ..........+++.|+|||.+.+ ..++.++||||||+++|+|++|..||.... ..
T Consensus 175 ~~~~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~-----~~ 249 (319)
T 2y4i_B 175 LFSISGVLQAGRREDKLRIQNGWLCHLAPEIIRQLSPDTEEDKLPFSKHSDVFALGTIWYELHAREWPFKTQP-----AE 249 (319)
T ss_dssp CCC----------CCSCBCCSGGGGTSCHHHHSCBSCC--CCCSCCCHHHHHHHHHHHHHHHHHSSCSSSSCC-----HH
T ss_pred CccccccccccccccccccCCCcccccChHHhhhccccccccccCCCchhhHHHHHHHHHHHHhCCCCCCCCC-----HH
Confidence 9865432111 11122334457889999998875 347889999999999999999999985331 11
Q ss_pred hHHHHHHHHHhcCccCcccccCccccchhhHhHHHHHHHHHHHHHHHHhcCCCCCCCCChhhhhc
Q 038766 234 SLRQLVEKALANGINGVRQITDPKLVSSIYEEQEQHQVLEELFKLALVCTSSNPEDRPNMNELLI 298 (299)
Q Consensus 234 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rpt~~~il~ 298 (299)
.............. .. ..++.++.+++.+||..||++|||++++++
T Consensus 250 ---~~~~~~~~~~~~~~---~~-------------~~~~~~l~~li~~~l~~~p~~Rpt~~~l~~ 295 (319)
T 2y4i_B 250 ---AIIWQMGTGMKPNL---SQ-------------IGMGKEISDILLFCWAFEQEERPTFTKLMD 295 (319)
T ss_dssp ---HHHHHHHTTCCCCC---CC-------------SSCCTTHHHHHHHHHCSSTTTSCCHHHHHH
T ss_pred ---HHHHHhccCCCCCC---Cc-------------CCCCHHHHHHHHHHhcCChhhCcCHHHHHH
Confidence 22222211111010 00 012346889999999999999999999975
|
| >3aln_A Dual specificity mitogen-activated protein kinase; protein AMP-PNP complex, transferase; HET: ANP; 2.30A {Homo sapiens} PDB: 3alo_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=9.4e-43 Score=296.97 Aligned_cols=262 Identities=22% Similarity=0.299 Sum_probs=178.3
Q ss_pred HHHhCCCCCCceeecCCcceEEEEEeC-CCcEEEEEEeccCcCChhhhHHHHHHHH-HHHhcCCcceeeeeeEEEcCCCe
Q 038766 8 ENATGSFSENNIIGNSNLSTVYKGRLE-DGEIVAVKKLNFHQFSAESDKSFYREAK-TLKELKHRNLVKVLGYAWESGKL 85 (299)
Q Consensus 8 ~~~~~~y~~~~~lg~g~~~~v~~~~~~-~~~~~~vK~~~~~~~~~~~~~~~~~e~~-~l~~l~h~~i~~~~~~~~~~~~~ 85 (299)
+...++|.+.+.||+|+||.||++.+. +|+.||+|++.... .......+..|+. .++.++||||+++++++.. +..
T Consensus 18 ~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~-~~~~~~~~~~e~~~~~~~~~h~niv~~~~~~~~-~~~ 95 (327)
T 3aln_A 18 DFTAEDLKDLGEIGRGAYGSVNKMVHKPSGQIMAVKRIRSTV-DEKEQKQLLMDLDVVMRSSDCPYIVQFYGALFR-EGD 95 (327)
T ss_dssp CCCSCSEEC-CEEEECSSEEEEEEEETTTTEEEEEEEEECCC-CHHHHHHHHHHHHHHHSSCCCTTBCCEEEEEEC-SSE
T ss_pred ccCHHHhhehheeccCCCEEEEEEEEcCCCCEEEEEEeeccc-CchHHHHHHHHHHHHHHcCCCCcEeeeeeEEEe-CCc
Confidence 445689999999999999999999874 68999999997543 3334445555555 6777899999999997765 456
Q ss_pred eEEEEeecCCCChHHHhcCC-CCCCCCCChhhHHHHHHHHHHHHHHhhcCCCCCeeeecccCCceeeCCCCcEEEeeecc
Q 038766 86 KALILEYMENGSLESVIHGP-GVDHSRWTLPKRIDVLISVANGLDYLHSGYDIPIVHCDMKPSNILLDRDFEAHVSDFGT 164 (299)
Q Consensus 86 ~~lv~e~~~~~~L~~~~~~~-~~~~~~~~~~~~~~i~~qi~~~l~~lh~~~~~~~~H~dl~~~nil~~~~~~v~l~df~~ 164 (299)
.++|+||+.+ +|.+++... ......+++..++.++.|++.||.|||+. .+++|+||||+||+++.++.++|+|||+
T Consensus 96 ~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~--~~ivH~dlkp~NIll~~~~~~kl~Dfg~ 172 (327)
T 3aln_A 96 CWICMELMST-SFDKFYKYVYSVLDDVIPEEILGKITLATVKALNHLKEN--LKIIHRDIKPSNILLDRSGNIKLCDFGI 172 (327)
T ss_dssp EEEEECCCSE-EHHHHHHHHHHTTCCCCCHHHHHHHHHHHHHHHHHHHHH--HSCCCSCCCGGGEEEETTTEEEECCCSS
T ss_pred eEEEEeecCC-ChHHHHHHHHhhhcccCcHHHHHHHHHHHHHHHHHHhcc--CCEeECCCCHHHEEEcCCCCEEEccCCC
Confidence 6999999975 887776421 01245789999999999999999999984 2899999999999999999999999999
Q ss_pred ccccccccccccccccccccCcccCChhhh----cccCcCccccchhhhHHHHHHHhCCCCCCCCccCCCCchhHHHHHH
Q 038766 165 SRMLDVHLQDLSSLSTAFQGTIGYLAPEFA----YMRIVTTKVDVFSFGIVVMEFLTKRRPTGLDEENGLSPISLRQLVE 240 (299)
Q Consensus 165 ~~~~~~~~~~~~~~~~~~~~~~~y~~PE~~----~~~~~~~~~DiwslG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~ 240 (299)
+...... .......+++.|+|||++ .+..++.++||||||+++|+|++|..||...... .+.+.
T Consensus 173 ~~~~~~~-----~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~-------~~~~~ 240 (327)
T 3aln_A 173 SGQLVDS-----IAKTRDAGCRPYMAPERIDPSASRQGYDVRSDVWSLGITLYELATGRFPYPKWNSV-------FDQLT 240 (327)
T ss_dssp SCC-----------------------------------CCSHHHHHHHHHHHHHHHHSCCCSSCC--------------C
T ss_pred ceecccc-----cccccCCCCccccCceeeccccCcCCCCchhhHHHHHHHHHHHHHCCCCCCCcchH-------HHHHH
Confidence 8765421 112233578999999998 4566889999999999999999999999543111 00000
Q ss_pred HHHhcCccCcccccCccccchhhHhHHHHHHHHHHHHHHHHhcCCCCCCCCChhhhhcC
Q 038766 241 KALANGINGVRQITDPKLVSSIYEEQEQHQVLEELFKLALVCTSSNPEDRPNMNELLIT 299 (299)
Q Consensus 241 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rpt~~~il~~ 299 (299)
...... ...+... ....++..+.++|.+||..||++|||++++++|
T Consensus 241 ~~~~~~---~~~~~~~----------~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~h 286 (327)
T 3aln_A 241 QVVKGD---PPQLSNS----------EEREFSPSFINFVNLCLTKDESKRPKYKELLKH 286 (327)
T ss_dssp CCCCSC---CCCCCCC----------SSCCCCHHHHHHHHHHTCSSGGGSCCHHHHTTS
T ss_pred HHhcCC---CCCCCCc----------ccccCCHHHHHHHHHHhhCChhhCcCHHHHHhC
Confidence 000000 0000000 012235679999999999999999999999987
|
| >2j0j_A Focal adhesion kinase 1; cell migration, FERM, transferase, integrin signaling; HET: 4ST; 2.80A {Gallus gallus} PDB: 2j0k_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.3e-42 Score=318.64 Aligned_cols=257 Identities=23% Similarity=0.309 Sum_probs=199.5
Q ss_pred HHHHHHhCCCCCCceeecCCcceEEEEEeCC----CcEEEEEEeccCcCChhhhHHHHHHHHHHHhcCCcceeeeeeEEE
Q 038766 5 TEIENATGSFSENNIIGNSNLSTVYKGRLED----GEIVAVKKLNFHQFSAESDKSFYREAKTLKELKHRNLVKVLGYAW 80 (299)
Q Consensus 5 ~~~~~~~~~y~~~~~lg~g~~~~v~~~~~~~----~~~~~vK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~ 80 (299)
.+.+...++|.+.+.||+|+||+||++.+.. +..+|+|++.. .......+.+.+|+..++.++||||+++++++
T Consensus 383 ~~~~i~~~~y~i~~~LG~G~fG~Vy~a~~~~~~~~~~~vaiK~~~~-~~~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~- 460 (656)
T 2j0j_A 383 RDYEIQRERIELGRCIGEGQFGDVHQGIYMSPENPAMAVAIKTCKN-CTSDSVREKFLQEALTMRQFDHPHIVKLIGVI- 460 (656)
T ss_dssp GGTBCCGGGEEEEEEEECCSSCCEEEEEECCSSSCCEEEEEEECSS-TTCHHHHHHHHHHHHHHHHCCCTTBCCEEEEE-
T ss_pred cccccccccEEEeeEEeeCCCEEEEEEEEecCCCccEEEEEEEecc-cCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEE-
Confidence 3455667889999999999999999998632 56799998863 23445567889999999999999999999976
Q ss_pred cCCCeeEEEEeecCCCChHHHhcCCCCCCCCCChhhHHHHHHHHHHHHHHhhcCCCCCeeeecccCCceeeCCCCcEEEe
Q 038766 81 ESGKLKALILEYMENGSLESVIHGPGVDHSRWTLPKRIDVLISVANGLDYLHSGYDIPIVHCDMKPSNILLDRDFEAHVS 160 (299)
Q Consensus 81 ~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lh~~~~~~~~H~dl~~~nil~~~~~~v~l~ 160 (299)
. ++..++|+||+.+++|.+++.. ....+++..++.++.|++.||.|||++ +++||||||+||+++.++.++|+
T Consensus 461 ~-~~~~~lv~E~~~~g~L~~~l~~---~~~~l~~~~~~~i~~qi~~aL~~LH~~---givHrDikp~NILl~~~~~vkL~ 533 (656)
T 2j0j_A 461 T-ENPVWIIMELCTLGELRSFLQV---RKFSLDLASLILYAYQLSTALAYLESK---RFVHRDIAARNVLVSSNDCVKLG 533 (656)
T ss_dssp C-SSSCEEEEECCTTCBHHHHHHH---TTTTCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEEEETTEEEEC
T ss_pred e-cCceEEEEEcCCCCcHHHHHHh---ccCCCCHHHHHHHHHHHHHHHHHHHhC---CccccccchHhEEEeCCCCEEEE
Confidence 3 3346899999999999999863 234689999999999999999999999 99999999999999999999999
Q ss_pred eeccccccccccccccccccccccCcccCChhhhcccCcCccccchhhhHHHHHHHh-CCCCCCCCccCCCCchhHHHHH
Q 038766 161 DFGTSRMLDVHLQDLSSLSTAFQGTIGYLAPEFAYMRIVTTKVDVFSFGIVVMEFLT-KRRPTGLDEENGLSPISLRQLV 239 (299)
Q Consensus 161 df~~~~~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~DiwslG~~l~~l~~-g~~p~~~~~~~~~~~~~~~~~~ 239 (299)
|||++...... .........+++.|+|||.+.+..++.++||||||+++|+|++ |..||... .... .+
T Consensus 534 DFG~a~~~~~~---~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwSlG~il~ellt~g~~Pf~~~-----~~~~---~~ 602 (656)
T 2j0j_A 534 DFGLSRYMEDS---TYYKASKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMHGVKPFQGV-----KNND---VI 602 (656)
T ss_dssp CCCCCCSCCC-------------CCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTC-----CHHH---HH
T ss_pred ecCCCeecCCC---cceeccCCCCCcceeCHHHhcCCCCCchhhHHHHHHHHHHHHHcCCCCCCCC-----CHHH---HH
Confidence 99999765421 1111223345678999999998899999999999999999997 88898533 2222 22
Q ss_pred HHHHhcCccCcccccCccccchhhHhHHHHHHHHHHHHHHHHhcCCCCCCCCChhhhhc
Q 038766 240 EKALANGINGVRQITDPKLVSSIYEEQEQHQVLEELFKLALVCTSSNPEDRPNMNELLI 298 (299)
Q Consensus 240 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rpt~~~il~ 298 (299)
........... +..++..+.++|.+||..||++|||+.++++
T Consensus 603 ~~i~~~~~~~~-----------------~~~~~~~l~~li~~~l~~dP~~RPs~~el~~ 644 (656)
T 2j0j_A 603 GRIENGERLPM-----------------PPNCPPTLYSLMTKCWAYDPSRRPRFTELKA 644 (656)
T ss_dssp HHHHHTCCCCC-----------------CTTCCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred HHHHcCCCCCC-----------------CccccHHHHHHHHHHcCCChhHCcCHHHHHH
Confidence 22221111000 1233567999999999999999999999975
|
| >3p23_A Serine/threonine-protein kinase/endoribonuclease; kinase domain, kinase and RNAse function, ATP binding ssRNA dephosphorylated, hydrolase; HET: ADP; 2.70A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=6.2e-42 Score=301.74 Aligned_cols=251 Identities=25% Similarity=0.307 Sum_probs=183.9
Q ss_pred CCCCCCceeecCCcceEEEEEeCCCcEEEEEEeccCcCChhhhHHHHHHHHHHHhc-CCcceeeeeeEEEcCCCeeEEEE
Q 038766 12 GSFSENNIIGNSNLSTVYKGRLEDGEIVAVKKLNFHQFSAESDKSFYREAKTLKEL-KHRNLVKVLGYAWESGKLKALIL 90 (299)
Q Consensus 12 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~vK~~~~~~~~~~~~~~~~~e~~~l~~l-~h~~i~~~~~~~~~~~~~~~lv~ 90 (299)
.+|.+.+.||+|+||+|+.....+++.||||++... ......+|+.+++.+ +||||+++++++.. +...++|+
T Consensus 24 ~~y~~~~~LG~G~~G~V~~~~~~~~~~vAvK~~~~~-----~~~~~~~E~~~l~~l~~HpnIv~l~~~~~~-~~~~~lv~ 97 (432)
T 3p23_A 24 ISFCPKDVLGHGAEGTIVYRGMFDNRDVAVKRILPE-----CFSFADREVQLLRESDEHPNVIRYFCTEKD-RQFQYIAI 97 (432)
T ss_dssp EEEEEEEEEEECGGGCEEEEEESSSSEEEEEEECTT-----TEEECHHHHHHHHHSCCCTTBCCEEEEEEE-TTEEEEEE
T ss_pred EEEecCCeeecCcCEEEEEEEEeCCeEEEEEEECHH-----HHHHHHHHHHHHHhccCCCCcCeEEEEEec-CCEEEEEE
Confidence 468889999999999987666667999999998532 223356799999999 79999999996654 56679999
Q ss_pred eecCCCChHHHhcCCCCCCCCCChhhHHHHHHHHHHHHHHhhcCCCCCeeeecccCCceeeCCC-----CcEEEeeeccc
Q 038766 91 EYMENGSLESVIHGPGVDHSRWTLPKRIDVLISVANGLDYLHSGYDIPIVHCDMKPSNILLDRD-----FEAHVSDFGTS 165 (299)
Q Consensus 91 e~~~~~~L~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lh~~~~~~~~H~dl~~~nil~~~~-----~~v~l~df~~~ 165 (299)
|++. ++|.+++... ....++..++.++.||+.||.|||+. +++||||||+||+++.+ ..++|+|||++
T Consensus 98 E~~~-g~L~~~l~~~---~~~~~~~~~~~i~~qi~~aL~~LH~~---~ivHrDlKp~NIll~~~~~~~~~~~kL~DFG~a 170 (432)
T 3p23_A 98 ELCA-ATLQEYVEQK---DFAHLGLEPITLLQQTTSGLAHLHSL---NIVHRDLKPHNILISMPNAHGKIKAMISDFGLC 170 (432)
T ss_dssp ECCS-EEHHHHHHSS---SCCCCSSCHHHHHHHHHHHHHHHHHT---TCCCCCCSTTSEEECCCBTTTBCCEEECCTTEE
T ss_pred ECCC-CCHHHHHHhc---CCCccchhHHHHHHHHHHHHHHHHHC---cCEeCCCCHHHEEEecCCCCCceeEEEecccce
Confidence 9995 5999988743 23456667889999999999999999 99999999999999532 35789999999
Q ss_pred cccccccccccccccccccCcccCChhhhc---ccCcCccccchhhhHHHHHHHh-CCCCCCCCccCCCCchhHHHHHHH
Q 038766 166 RMLDVHLQDLSSLSTAFQGTIGYLAPEFAY---MRIVTTKVDVFSFGIVVMEFLT-KRRPTGLDEENGLSPISLRQLVEK 241 (299)
Q Consensus 166 ~~~~~~~~~~~~~~~~~~~~~~y~~PE~~~---~~~~~~~~DiwslG~~l~~l~~-g~~p~~~~~~~~~~~~~~~~~~~~ 241 (299)
........ .........+|+.|+|||++. ...++.++|||||||++|+|++ |..||..... .. ...
T Consensus 171 ~~~~~~~~-~~~~~~~~~gt~~y~APE~l~~~~~~~~t~~~DiwSlG~il~ellt~g~~pf~~~~~-----~~----~~~ 240 (432)
T 3p23_A 171 KKLAVGRH-SFSRRSGVPGTEGWIAPEMLSEDCKENPTYTVDIFSAGCVFYYVISEGSHPFGKSLQ-----RQ----ANI 240 (432)
T ss_dssp ECC-------------CCSCTTSCCGGGTSCC---CCCTHHHHHHHHHHHHHHHTTSCBTTBSTTT-----HH----HHH
T ss_pred eeccCCCc-ceeeccccCCCcCccChhhhhcccccCCCcHHHHHHHHHHHHHHHcCCCCCcchhhH-----HH----HHH
Confidence 76542111 112234456899999999987 4567789999999999999999 8888843211 00 111
Q ss_pred HHhcCccCcccccCccccchhhHhHHHHHHHHHHHHHHHHhcCCCCCCCCChhhhhcC
Q 038766 242 ALANGINGVRQITDPKLVSSIYEEQEQHQVLEELFKLALVCTSSNPEDRPNMNELLIT 299 (299)
Q Consensus 242 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rpt~~~il~~ 299 (299)
..... ....... ....+..+.+||.+||..||++|||++++++|
T Consensus 241 ~~~~~--~~~~~~~------------~~~~~~~~~~li~~~L~~dP~~Rps~~evl~h 284 (432)
T 3p23_A 241 LLGAC--SLDCLHP------------EKHEDVIARELIEKMIAMDPQKRPSAKHVLKH 284 (432)
T ss_dssp HTTCC--CCTTSCT------------TCHHHHHHHHHHHHHSCSSGGGSCCHHHHHTS
T ss_pred HhccC--CccccCc------------cccccHHHHHHHHHHHhCCHhhCCCHHHHHhC
Confidence 11000 0100000 12345668899999999999999999999987
|
| >3m2w_A MAP kinase-activated protein kinase 2; small molecule inhibitor, spiroazetidine-tetracycle, ATP-SIT inhibitor, novartis compound NVP-BXS169; HET: L8I; 2.41A {Homo sapiens} PDB: 3kga_A* 3m42_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-40 Score=280.64 Aligned_cols=234 Identities=21% Similarity=0.278 Sum_probs=179.7
Q ss_pred HhCCCCCC-ceeecCCcceEEEEEe-CCCcEEEEEEeccCcCChhhhHHHHHHHHHH-HhcCCcceeeeeeEEEc---CC
Q 038766 10 ATGSFSEN-NIIGNSNLSTVYKGRL-EDGEIVAVKKLNFHQFSAESDKSFYREAKTL-KELKHRNLVKVLGYAWE---SG 83 (299)
Q Consensus 10 ~~~~y~~~-~~lg~g~~~~v~~~~~-~~~~~~~vK~~~~~~~~~~~~~~~~~e~~~l-~~l~h~~i~~~~~~~~~---~~ 83 (299)
+.++|.+. +.||+|+||.||++.+ .+++.||+|++.. .....+|+..+ +...||||+++++++.. .+
T Consensus 15 ~~~~y~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~-------~~~~~~e~~~~~~~~~h~~i~~~~~~~~~~~~~~ 87 (299)
T 3m2w_A 15 IIDDYKVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQD-------CPKARREVELHWRASQCPHIVRIVDVYENLYAGR 87 (299)
T ss_dssp GGGTEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEC-------SHHHHHHHHHHHHHTTSTTBCCEEEEEEEEETTE
T ss_pred cccchhhcCcccccCCCeEEEEEEEcCCCcEEEEEEecc-------cHHHHHHHHHHHHhccCCCchhHHhhhhhhcCCC
Confidence 55677777 7899999999999987 4689999999852 24566788887 55589999999997654 24
Q ss_pred CeeEEEEeecCCCChHHHhcCCCCCCCCCChhhHHHHHHHHHHHHHHhhcCCCCCeeeecccCCceeeCC---CCcEEEe
Q 038766 84 KLKALILEYMENGSLESVIHGPGVDHSRWTLPKRIDVLISVANGLDYLHSGYDIPIVHCDMKPSNILLDR---DFEAHVS 160 (299)
Q Consensus 84 ~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lh~~~~~~~~H~dl~~~nil~~~---~~~v~l~ 160 (299)
...++|+||+.+++|.+++... ....+++..++.++.|++.||.|||+. +++|+||||+||+++. ++.++|+
T Consensus 88 ~~~~lv~e~~~~~~L~~~l~~~--~~~~~~~~~~~~i~~qi~~~l~~lH~~---~i~H~dlkp~Nil~~~~~~~~~~kl~ 162 (299)
T 3m2w_A 88 KCLLIVMECLDGGELFSRIQDR--GDQAFTEREASEIMKSIGEAIQYLHSI---NIAHRDVKPENLLYTSKRPNAILKLT 162 (299)
T ss_dssp EEEEEEECCCCSCBHHHHHHHC--TTCCCBHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEESSSSTTCCEEEC
T ss_pred ceEEEEEeecCCCcHHHHHHhc--cCCCCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCCHHHEEEecCCCCCcEEEe
Confidence 5679999999999999998743 234799999999999999999999999 9999999999999998 7889999
Q ss_pred eeccccccccccccccccccccccCcccCChhhhcccCcCccccchhhhHHHHHHHhCCCCCCCCccCCCCchhHHHHHH
Q 038766 161 DFGTSRMLDVHLQDLSSLSTAFQGTIGYLAPEFAYMRIVTTKVDVFSFGIVVMEFLTKRRPTGLDEENGLSPISLRQLVE 240 (299)
Q Consensus 161 df~~~~~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~DiwslG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~ 240 (299)
|||++.... +..++.++|||||||++|+|++|..||..........
T Consensus 163 Dfg~a~~~~--------------------------~~~~~~~~DiwslG~il~el~tg~~pf~~~~~~~~~~-------- 208 (299)
T 3m2w_A 163 DFGFAKETT--------------------------GEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAISP-------- 208 (299)
T ss_dssp CCTTCEECT--------------------------TCGGGGHHHHHHHHHHHHHHHHSSCSCCC-------C--------
T ss_pred ccccccccc--------------------------cccCCchhhHHHHHHHHHHHHHCCCCCCCCcchhhhH--------
Confidence 999885432 1345789999999999999999999995432111000
Q ss_pred HHHhcCccCcccccCccccchhhHhHHHHHHHHHHHHHHHHhcCCCCCCCCChhhhhcC
Q 038766 241 KALANGINGVRQITDPKLVSSIYEEQEQHQVLEELFKLALVCTSSNPEDRPNMNELLIT 299 (299)
Q Consensus 241 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rpt~~~il~~ 299 (299)
. ....+...... ........++.++.++|.+||..||++|||++++|+|
T Consensus 209 -----~--~~~~~~~~~~~---~~~~~~~~~~~~~~~li~~~l~~dP~~Rps~~e~l~h 257 (299)
T 3m2w_A 209 -----G--MKTRIRMGQYE---FPNPEWSEVSEEVKMLIRNLLKTEPTQRMTITEFMNH 257 (299)
T ss_dssp -----C--SCCSSCTTCCS---SCHHHHTTSCHHHHHHHHHHTCSSTTTSCCHHHHHTS
T ss_pred -----H--HHHHHhhcccc---CCchhcccCCHHHHHHHHHHcccChhhCCCHHHHhcC
Confidence 0 00000000000 0111124467789999999999999999999999987
|
| >2pzi_A Probable serine/threonine-protein kinase PKNG; ATP-recognition, kinase-INH complex, rubredoxin fold, TPR domain, transferase; HET: AXX; 2.40A {Mycobacterium tuberculosis} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.8e-41 Score=312.94 Aligned_cols=239 Identities=21% Similarity=0.329 Sum_probs=192.4
Q ss_pred HHHhCCCCCCceeecCCcceEEEEEeC--CCcEEEEEEeccCcCChhhhHHHHHHHHHHHhcCCcceeeeeeEEEcCCCe
Q 038766 8 ENATGSFSENNIIGNSNLSTVYKGRLE--DGEIVAVKKLNFHQFSAESDKSFYREAKTLKELKHRNLVKVLGYAWESGKL 85 (299)
Q Consensus 8 ~~~~~~y~~~~~lg~g~~~~v~~~~~~--~~~~~~vK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~ 85 (299)
+.+.++|++.+.||+|+||+||++.+. +++.||||++... ........+.+|+..++.++||||+++++++...+..
T Consensus 76 ~~~~~~y~i~~~lg~G~~g~Vy~a~~~~~~~~~vaiK~~~~~-~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~ 154 (681)
T 2pzi_A 76 DIVAGQYEVKGCIAHGGLGWIYLALDRNVNGRPVVLKGLVHS-GDAEAQAMAMAERQFLAEVVHPSIVQIFNFVEHTDRH 154 (681)
T ss_dssp CEETTTEEEEEEEEEETTEEEEEEEEGGGTTEEEEEEESCSS-CCHHHHHHHHHHHGGGGGCCCTTBCCEEEEEEEECTT
T ss_pred CEeCCceEEEEEEeeCCCeEEEEEEEcCCCCcEEEEEEeCcc-CCHHHHHHHHHHHHHHHhcCCCCcCeEeeeEeecCCC
Confidence 346689999999999999999999874 5899999998642 3445567788999999999999999999988765442
Q ss_pred ----eEEEEeecCCCChHHHhcCCCCCCCCCChhhHHHHHHHHHHHHHHhhcCCCCCeeeecccCCceeeCCCCcEEEee
Q 038766 86 ----KALILEYMENGSLESVIHGPGVDHSRWTLPKRIDVLISVANGLDYLHSGYDIPIVHCDMKPSNILLDRDFEAHVSD 161 (299)
Q Consensus 86 ----~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lh~~~~~~~~H~dl~~~nil~~~~~~v~l~d 161 (299)
.++||||+.+++|.+++.. .+++.+++.++.||+.||.|||++ +++|+||||+||+++.+ .+||+|
T Consensus 155 ~~~~~~lv~E~~~g~~L~~~~~~------~l~~~~~~~~~~qi~~aL~~lH~~---giiHrDlkp~NIll~~~-~~kl~D 224 (681)
T 2pzi_A 155 GDPVGYIVMEYVGGQSLKRSKGQ------KLPVAEAIAYLLEILPALSYLHSI---GLVYNDLKPENIMLTEE-QLKLID 224 (681)
T ss_dssp SCEEEEEEEECCCCEECC----C------CCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECSS-CEEECC
T ss_pred CCceeEEEEEeCCCCcHHHHHhC------CCCHHHHHHHHHHHHHHHHHHHHC---CCeecccChHHeEEeCC-cEEEEe
Confidence 5999999999999887642 689999999999999999999999 99999999999999875 899999
Q ss_pred eccccccccccccccccccccccCcccCChhhhcccCcCccccchhhhHHHHHHHhCCCCCCCCccCCCCchhHHHHHHH
Q 038766 162 FGTSRMLDVHLQDLSSLSTAFQGTIGYLAPEFAYMRIVTTKVDVFSFGIVVMEFLTKRRPTGLDEENGLSPISLRQLVEK 241 (299)
Q Consensus 162 f~~~~~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~DiwslG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~ 241 (299)
||++..... .....+|+.|+|||++.+.. +.++|||||||++|+|++|..||........
T Consensus 225 FG~a~~~~~--------~~~~~gt~~y~aPE~~~~~~-~~~sDi~slG~~l~~l~~g~~~~~~~~~~~~----------- 284 (681)
T 2pzi_A 225 LGAVSRINS--------FGYLYGTPGFQAPEIVRTGP-TVATDIYTVGRTLAALTLDLPTRNGRYVDGL----------- 284 (681)
T ss_dssp CTTCEETTC--------CSCCCCCTTTSCTTHHHHCS-CHHHHHHHHHHHHHHHHSCCCEETTEECSSC-----------
T ss_pred cccchhccc--------CCccCCCccccCHHHHcCCC-CCceehhhhHHHHHHHHhCCCCCcccccccc-----------
Confidence 999876442 13456899999999887654 8899999999999999999888753211110
Q ss_pred HHhcCccCcccccCccccchhhHhHHHHHHHHHHHHHHHHhcCCCCCCCCChhhhhc
Q 038766 242 ALANGINGVRQITDPKLVSSIYEEQEQHQVLEELFKLALVCTSSNPEDRPNMNELLI 298 (299)
Q Consensus 242 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rpt~~~il~ 298 (299)
.. .......+..+.++|.+||..||++||+..+.+.
T Consensus 285 ------------~~---------~~~~~~~~~~l~~li~~~l~~dP~~R~~~~~~l~ 320 (681)
T 2pzi_A 285 ------------PE---------DDPVLKTYDSYGRLLRRAIDPDPRQRFTTAEEMS 320 (681)
T ss_dssp ------------CT---------TCHHHHHCHHHHHHHHHHTCSSGGGSCSSHHHHH
T ss_pred ------------cc---------cccccccCHHHHHHHhhhccCChhhCCCHHHHHH
Confidence 00 0012334567899999999999999998777654
|
| >3uqc_A Probable conserved transmembrane protein; structural genomics, TB structural genomics consortium, TBSG fold, FHAA, transferase; 2.26A {Mycobacterium tuberculosis} PDB: 3oun_B* 3otv_A 3ouk_A | Back alignment and structure |
|---|
Probab=100.00 E-value=3e-40 Score=276.04 Aligned_cols=229 Identities=15% Similarity=0.113 Sum_probs=179.0
Q ss_pred HHhCCCCCCceeecCCcceEEEEEeC-CCcEEEEEEeccCcCC-hhhhHHHHHHHHHHHhcCCcceeeeeeEEEcCCCee
Q 038766 9 NATGSFSENNIIGNSNLSTVYKGRLE-DGEIVAVKKLNFHQFS-AESDKSFYREAKTLKELKHRNLVKVLGYAWESGKLK 86 (299)
Q Consensus 9 ~~~~~y~~~~~lg~g~~~~v~~~~~~-~~~~~~vK~~~~~~~~-~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~ 86 (299)
.+.++|++.+.||+|+||.||++.+. +++.||+|++...... ......+.+|+..++.++||||+++++++.. ++..
T Consensus 28 ~~~~~y~i~~~lg~G~~g~Vy~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~hp~iv~~~~~~~~-~~~~ 106 (286)
T 3uqc_A 28 IANGRYRLLIFHGGVPPLQFWQALDTALDRQVALTFVDPQGVLPDDVLQETLSRTLRLSRIDKPGVARVLDVVHT-RAGG 106 (286)
T ss_dssp ETTTTEEEEEEEEBSTTCEEEEEEETTTTEEEEEEESCTTCCSCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEEE-TTEE
T ss_pred EecCcEEEEEEEcccCCeEEEEEEecCCCceEEEEEECcccccCHHHHHHHHHHHHHHhcCCCCCcceeeEEEEE-CCcE
Confidence 45688999999999999999999875 4899999999754433 3445788999999999999999999997665 4566
Q ss_pred EEEEeecCCCChHHHhcCCCCCCCCCChhhHHHHHHHHHHHHHHhhcCCCCCeeeecccCCceeeCCCCcEEEeeecccc
Q 038766 87 ALILEYMENGSLESVIHGPGVDHSRWTLPKRIDVLISVANGLDYLHSGYDIPIVHCDMKPSNILLDRDFEAHVSDFGTSR 166 (299)
Q Consensus 87 ~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lh~~~~~~~~H~dl~~~nil~~~~~~v~l~df~~~~ 166 (299)
++||||+.+++|.++++. . ....++..++.|++.||+|||++ +++|+||||+||+++.+|.++|++++.
T Consensus 107 ~lv~e~~~g~~L~~~l~~-----~-~~~~~~~~i~~ql~~aL~~lH~~---givH~Dikp~NIll~~~g~~kl~~~~~-- 175 (286)
T 3uqc_A 107 LVVAEWIRGGSLQEVADT-----S-PSPVGAIRAMQSLAAAADAAHRA---GVALSIDHPSRVRVSIDGDVVLAYPAT-- 175 (286)
T ss_dssp EEEEECCCEEEHHHHHTT-----C-CCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCSGGGEEEETTSCEEECSCCC--
T ss_pred EEEEEecCCCCHHHHHhc-----C-CChHHHHHHHHHHHHHHHHHHHC---CCccCCCCcccEEEcCCCCEEEEeccc--
Confidence 999999999999999952 2 35557889999999999999999 999999999999999999999985442
Q ss_pred ccccccccccccccccccCcccCChhhhcccCcCccccchhhhHHHHHHHhCCCCCCCCccCCCCchhHHHHHHHHHhcC
Q 038766 167 MLDVHLQDLSSLSTAFQGTIGYLAPEFAYMRIVTTKVDVFSFGIVVMEFLTKRRPTGLDEENGLSPISLRQLVEKALANG 246 (299)
Q Consensus 167 ~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~DiwslG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~ 246 (299)
++ .++.++|||||||++|+|++|..||............
T Consensus 176 ----------------------~~-------~~~~~~Di~slG~il~elltg~~Pf~~~~~~~~~~~~------------ 214 (286)
T 3uqc_A 176 ----------------------MP-------DANPQDDIRGIGASLYALLVNRWPLPEAGVRSGLAPA------------ 214 (286)
T ss_dssp ----------------------CT-------TCCHHHHHHHHHHHHHHHHHSEECSCCCSBCCCSEEC------------
T ss_pred ----------------------cC-------CCCchhHHHHHHHHHHHHHHCCCCCCcCCcchhhHHH------------
Confidence 22 2578999999999999999999999754322100000
Q ss_pred ccCcccccCccccchhhHhHHHHHHHHHHHHHHHHhcCCCCCCCCChhhhhc
Q 038766 247 INGVRQITDPKLVSSIYEEQEQHQVLEELFKLALVCTSSNPEDRPNMNELLI 298 (299)
Q Consensus 247 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rpt~~~il~ 298 (299)
....... ..........++.++.++|.+||..||++| |++++++
T Consensus 215 ---~~~~~~~----~~~~~~~~~~~~~~l~~li~~~l~~dP~~R-s~~el~~ 258 (286)
T 3uqc_A 215 ---ERDTAGQ----PIEPADIDRDIPFQISAVAARSVQGDGGIR-SASTLLN 258 (286)
T ss_dssp ---CBCTTSC----BCCHHHHCTTSCHHHHHHHHHHHCTTSSCC-CHHHHHH
T ss_pred ---HHHhccC----CCChhhcccCCCHHHHHHHHHHcccCCccC-CHHHHHH
Confidence 0000000 000011123456789999999999999999 9999975
|
| >3dzo_A Rhoptry kinase domain; parasitic disease, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} | Back alignment and structure |
|---|
Probab=100.00 E-value=7.2e-41 Score=293.79 Aligned_cols=245 Identities=18% Similarity=0.190 Sum_probs=181.6
Q ss_pred CCCCCceeecCCcceEEEEEe-CCCcEEEEEEeccCc-CChhhhHHHHHHHHHHHhcCC-cc---------eeeeeeEEE
Q 038766 13 SFSENNIIGNSNLSTVYKGRL-EDGEIVAVKKLNFHQ-FSAESDKSFYREAKTLKELKH-RN---------LVKVLGYAW 80 (299)
Q Consensus 13 ~y~~~~~lg~g~~~~v~~~~~-~~~~~~~vK~~~~~~-~~~~~~~~~~~e~~~l~~l~h-~~---------i~~~~~~~~ 80 (299)
.|...+.||+|+||+||+|.+ .+|+.||||++.... ......+.+.+|+..++.++| ++ ++...+...
T Consensus 79 ~~~~~~~LG~G~fG~Vy~a~~~~~g~~vAvK~~~~~~~~~~~~~~~~~~E~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~ 158 (413)
T 3dzo_A 79 TLVRGTVLGQEDPYAYLEATDQETGESFEVHVPYFTERPPSNAIKQMKEEVLRLRLLRGIKNQKQAKVHLRFIFPFDLVK 158 (413)
T ss_dssp EEEEEEEEEEETTEEEEEEEETTTCCEEEEEEECCSCC----CCHHHHHHHHGGGGSTTCCSHHHHHHHTCBCCCCEEEE
T ss_pred eEEEecccccCCCEEEEEEEecCCCCceEEEEEecCCCccHHHHHHHHHHHHHHHhhccCCCHHHHHHhcccccchhhcc
Confidence 367788999999999999986 469999999987332 223346778899999999976 21 111111111
Q ss_pred ------------cC----CCeeEEEEeecCCCChHHHhcCC---CCCCCCCChhhHHHHHHHHHHHHHHhhcCCCCCeee
Q 038766 81 ------------ES----GKLKALILEYMENGSLESVIHGP---GVDHSRWTLPKRIDVLISVANGLDYLHSGYDIPIVH 141 (299)
Q Consensus 81 ------------~~----~~~~~lv~e~~~~~~L~~~~~~~---~~~~~~~~~~~~~~i~~qi~~~l~~lh~~~~~~~~H 141 (299)
.. ....+++++.. +++|.++++.. ......+++..++.++.|++.||+|||++ +++|
T Consensus 159 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~L~~ll~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~---~iiH 234 (413)
T 3dzo_A 159 DPQKKKMIRVRLDERDMWVLSRFFLYPRM-QSNLQTFGEVLLSHSSTHKSLVHHARLQLTLQVIRLLASLHHY---GLVH 234 (413)
T ss_dssp CCC---------------CCSEEEEEECC-SEEHHHHHHHHHHHTTTSHHHHHHHHHHHHHHHHHHHHHHHHT---TEEC
T ss_pred cCCCCccccccCCCccccccceEEEeehh-cCCHHHHHHHhhcccccCCCCCHHHHHHHHHHHHHHHHHHHhC---Cccc
Confidence 10 12346777776 67999888411 11355788999999999999999999999 9999
Q ss_pred ecccCCceeeCCCCcEEEeeeccccccccccccccccccccccCcccCChhhh----------cccCcCccccchhhhHH
Q 038766 142 CDMKPSNILLDRDFEAHVSDFGTSRMLDVHLQDLSSLSTAFQGTIGYLAPEFA----------YMRIVTTKVDVFSFGIV 211 (299)
Q Consensus 142 ~dl~~~nil~~~~~~v~l~df~~~~~~~~~~~~~~~~~~~~~~~~~y~~PE~~----------~~~~~~~~~DiwslG~~ 211 (299)
|||||+|||++.++.+||+|||++..... ......+ +.|+|||++ ....++.++|||||||+
T Consensus 235 rDiKp~NILl~~~~~~kL~DFG~a~~~~~-------~~~~~~g-~~y~aPE~~~~~~~~~~~~~~~~~~~~~DvwSlGvi 306 (413)
T 3dzo_A 235 TYLRPVDIVLDQRGGVFLTGFEHLVRDGA-------SAVSPIG-RGFAPPETTAERMLPFGQHHPTLMTFAFDTWTLGLA 306 (413)
T ss_dssp SCCCGGGEEECTTCCEEECCGGGCEETTE-------EECCCCC-TTTCCHHHHHHHTSTTGGGCCEEECHHHHHHHHHHH
T ss_pred CCcccceEEEecCCeEEEEeccceeecCC-------ccccCCC-CceeCchhhhccccccccccCcCCCchhhHHHHHHH
Confidence 99999999999999999999999875442 1334456 899999998 55568889999999999
Q ss_pred HHHHHhCCCCCCCCccCCCCchhHHHHHHHHHhcCccCcccccCccccchhhHhHHHHHHHHHHHHHHHHhcCCCCCCCC
Q 038766 212 VMEFLTKRRPTGLDEENGLSPISLRQLVEKALANGINGVRQITDPKLVSSIYEEQEQHQVLEELFKLALVCTSSNPEDRP 291 (299)
Q Consensus 212 l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rp 291 (299)
+|+|++|..||........... +... ...++..+.+||.+||..||++||
T Consensus 307 l~elltg~~Pf~~~~~~~~~~~-------------------~~~~-----------~~~~~~~~~~li~~~l~~dP~~Rp 356 (413)
T 3dzo_A 307 IYWIWCADLPNTDDAALGGSEW-------------------IFRS-----------CKNIPQPVRALLEGFLRYPKEDRL 356 (413)
T ss_dssp HHHHHHSSCCCCTTGGGSCSGG-------------------GGSS-----------CCCCCHHHHHHHHHHTCSSGGGSC
T ss_pred HHHHHHCCCCCCCcchhhhHHH-------------------HHhh-----------cccCCHHHHHHHHHHccCChhhCc
Confidence 9999999999965432211110 0000 012346799999999999999999
Q ss_pred ChhhhhcC
Q 038766 292 NMNELLIT 299 (299)
Q Consensus 292 t~~~il~~ 299 (299)
|+.++++|
T Consensus 357 t~~~~l~~ 364 (413)
T 3dzo_A 357 LPLQAMET 364 (413)
T ss_dssp CHHHHTTS
T ss_pred CHHHHHhC
Confidence 99999976
|
| >2vuw_A Serine/threonine-protein kinase haspin; cell cycle, transferase, CAsp8, nucleotide binding; HET: MSE 5ID MPD; 1.80A {Homo sapiens} PDB: 3f2n_A* 3e7v_A* 3dlz_A* 3fmd_A* 3iq7_A* 2wb8_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-39 Score=278.53 Aligned_cols=247 Identities=14% Similarity=0.104 Sum_probs=188.5
Q ss_pred HhCCCCCCceeecCCcceEEEEEeCCCcEEEEEEeccCcC------ChhhhHHHHHHHHHHHhcC---------Ccceee
Q 038766 10 ATGSFSENNIIGNSNLSTVYKGRLEDGEIVAVKKLNFHQF------SAESDKSFYREAKTLKELK---------HRNLVK 74 (299)
Q Consensus 10 ~~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~vK~~~~~~~------~~~~~~~~~~e~~~l~~l~---------h~~i~~ 74 (299)
..++|.+.+.||+|+||+||+|.+ +|+.||+|++..... .....+.+.+|+.+++.++ ||||++
T Consensus 18 ~~~~y~~~~~lG~G~~g~V~~~~~-~~~~vAvK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~l~~~~~~~h~niv~ 96 (336)
T 2vuw_A 18 PTEKLQRCEKIGEGVFGEVFQTIA-DHTPVAIKIIAIEGPDLVNGSHQKTFEEILPEIIISKELSLLSGEVCNRTEGFIG 96 (336)
T ss_dssp CHHHHHTCEEEEEETTEEEEEEEE-TTEEEEEEEEEESCSSCBTTBCCBCHHHHHHHHHHHHHHHHGGGCSSSBCCCBCC
T ss_pred ccccchheeeecccCceEEEEEEe-CCceEEEEEEecCCccccccccchhHHHHHHHHHHHHHHHHhhccccccCCchhh
Confidence 357899999999999999999998 589999999975432 2333477889999998886 777777
Q ss_pred eeeEEEc-----------------------------CCCeeEEEEeecCCCChHHHhcCCCCCCCCCChhhHHHHHHHHH
Q 038766 75 VLGYAWE-----------------------------SGKLKALILEYMENGSLESVIHGPGVDHSRWTLPKRIDVLISVA 125 (299)
Q Consensus 75 ~~~~~~~-----------------------------~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~i~~qi~ 125 (299)
+.++... .+...++||||+.++++.+.+. ...+++..++.++.||+
T Consensus 97 l~~~~~~~~~~hp~iv~~~~~~~~~~~~~~~~~~~~~~~~~~lv~E~~~~g~ll~~~~-----~~~~~~~~~~~i~~qi~ 171 (336)
T 2vuw_A 97 LNSVHCVQGSYPPLLLKAWDHYNSTKGSANDRPDFFKDDQLFIVLEFEFGGIDLEQMR-----TKLSSLATAKSILHQLT 171 (336)
T ss_dssp EEEEEEEESSCCHHHHHHHHHHHHHTCCSSCCSCCCCTTCEEEEEEEECCCEETGGGT-----TTCCCHHHHHHHHHHHH
T ss_pred hcceeEecCCCcHHHHHHHHHHhhhccccccCccccccCeEEEEEEecCCCccHHHHH-----hcCCCHHHHHHHHHHHH
Confidence 7775431 1566799999999887766663 24689999999999999
Q ss_pred HHHHHhh-cCCCCCeeeecccCCceeeCCCC--------------------cEEEeeecccccccccccccccccccccc
Q 038766 126 NGLDYLH-SGYDIPIVHCDMKPSNILLDRDF--------------------EAHVSDFGTSRMLDVHLQDLSSLSTAFQG 184 (299)
Q Consensus 126 ~~l~~lh-~~~~~~~~H~dl~~~nil~~~~~--------------------~v~l~df~~~~~~~~~~~~~~~~~~~~~~ 184 (299)
.||+||| +. +++||||||+|||++.++ .+||+|||++..... ....+
T Consensus 172 ~aL~~lH~~~---~ivHrDlKp~NILl~~~~~~~~~~~~~~~~~~~~~~~~~vkL~DFG~a~~~~~---------~~~~g 239 (336)
T 2vuw_A 172 ASLAVAEASL---RFEHRDLHWGNVLLKKTSLKKLHYTLNGKSSTIPSCGLQVSIIDYTLSRLERD---------GIVVF 239 (336)
T ss_dssp HHHHHHHHHH---CCBCSCCCGGGEEEEECSCSEEEEEETTEEEEEECTTEEEEECCCTTCBEEET---------TEEEC
T ss_pred HHHHHHHHhC---CEeECCCCHHHEEEeccCCcceeeeccCccccccCCCceEEEeeccccEecCC---------CcEEE
Confidence 9999999 88 999999999999999887 899999999986541 23468
Q ss_pred CcccCChhhhcccCcCccccchhhhHH-HHHHHhCCCCCCCCccCCCCchhH-HHHHHHHHhcCccCcccccCccccchh
Q 038766 185 TIGYLAPEFAYMRIVTTKVDVFSFGIV-VMEFLTKRRPTGLDEENGLSPISL-RQLVEKALANGINGVRQITDPKLVSSI 262 (299)
Q Consensus 185 ~~~y~~PE~~~~~~~~~~~DiwslG~~-l~~l~~g~~p~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~ 262 (299)
|+.|+|||++.+.. +.++||||||++ .+++++|..||... .+ ........... .....
T Consensus 240 t~~y~aPE~~~g~~-~~~~Diwsl~~~~~~~~~~g~~p~~~~--------~~~~~~~~~~~~~~--~~~~~--------- 299 (336)
T 2vuw_A 240 CDVSMDEDLFTGDG-DYQFDIYRLMKKENNNRWGEYHPYSNV--------LWLHYLTDKMLKQM--TFKTK--------- 299 (336)
T ss_dssp CCCTTCSGGGCCCS-SHHHHHHHHHHHHHTTCTTSCCTHHHH--------HHHHHHHHHHHHTC--CCSSC---------
T ss_pred eecccChhhhcCCC-ccceehhhhhCCCCcccccccCCCcch--------hhhhHHHHhhhhhh--ccCcc---------
Confidence 99999999998776 889999998777 77788888887210 01 11111111110 00000
Q ss_pred hHhHHHHHHHHHHHHHHHHhcCCCCCCCCChhhhh-cC
Q 038766 263 YEEQEQHQVLEELFKLALVCTSSNPEDRPNMNELL-IT 299 (299)
Q Consensus 263 ~~~~~~~~~~~~l~~li~~~l~~dP~~Rpt~~~il-~~ 299 (299)
........+++++.+||++||..| |++|+| +|
T Consensus 300 ~~~~~~~~~s~~~~dli~~~L~~d-----sa~e~l~~H 332 (336)
T 2vuw_A 300 CNTPAMKQIKRKIQEFHRTMLNFS-----SATDLLCQH 332 (336)
T ss_dssp CCSHHHHHHHHHHHHHHHHGGGSS-----SHHHHHHHC
T ss_pred cchhhhhhcCHHHHHHHHHHhccC-----CHHHHHhcC
Confidence 011225678899999999999977 999999 77
|
| >4azs_A Methyltransferase WBDD; kinase; HET: AMP SAM; 2.15A {Escherichia coli} PDB: 4azt_A* 4azv_A* 4azw_A* | Back alignment and structure |
|---|
Probab=99.96 E-value=9.7e-31 Score=237.25 Aligned_cols=184 Identities=16% Similarity=0.074 Sum_probs=125.3
Q ss_pred cCCcceEEEEE-eCCCcEEEEEEeccCcC--------ChhhhHHHHHHHHHHHhc-CCcceeeeeeEEEcCCCeeEEEEe
Q 038766 22 NSNLSTVYKGR-LEDGEIVAVKKLNFHQF--------SAESDKSFYREAKTLKEL-KHRNLVKVLGYAWESGKLKALILE 91 (299)
Q Consensus 22 ~g~~~~v~~~~-~~~~~~~~vK~~~~~~~--------~~~~~~~~~~e~~~l~~l-~h~~i~~~~~~~~~~~~~~~lv~e 91 (299)
.|+.|.+..++ .-.|+.+++|++..... .....+.+.+|+++|+++ .|+||+++++++.+ +...|||||
T Consensus 244 ~~~~~~h~~~rr~~fg~~~~~K~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~~~~~~~i~~~~~~~ed-~~~~yLVME 322 (569)
T 4azs_A 244 AGAGLAHKRSRRYFFGEDYVCKFFYYDMPHGILTAEESQRNKYELHNEIKFLTQPPAGFDAPAVLAHGEN-AQSGWLVME 322 (569)
T ss_dssp --------CCEEEEECSSEEEEEEESSCSTTCSCHHHHHHHHHHHHHHHHHHHSCCTTCCCCCEEEEEEC-SSEEEEEEE
T ss_pred cCCcccccccccccccceeEEEEEecccccccchhhhhHHHHHHHHHHHHHHHhcCCCCCeeEEEEEEEE-CCEEEEEEe
Confidence 34444444433 22478899999975421 123345689999999999 59999999996554 556699999
Q ss_pred ecCCCChHHHhcCCCCCCCCCChhhHHHHHHHHHHHHHHhhcCCCCCeeeecccCCceeeCCCCcEEEeeeccccccccc
Q 038766 92 YMENGSLESVIHGPGVDHSRWTLPKRIDVLISVANGLDYLHSGYDIPIVHCDMKPSNILLDRDFEAHVSDFGTSRMLDVH 171 (299)
Q Consensus 92 ~~~~~~L~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lh~~~~~~~~H~dl~~~nil~~~~~~v~l~df~~~~~~~~~ 171 (299)
|++|++|.+++. ...++++. .|+.||+.||+|+|++ ||+||||||+|||++.+|.+||+|||++.....
T Consensus 323 yv~G~~L~d~i~----~~~~l~~~---~I~~QIl~AL~ylH~~---GIIHRDIKPeNILL~~dg~vKL~DFGlAr~~~~- 391 (569)
T 4azs_A 323 KLPGRLLSDMLA----AGEEIDRE---KILGSLLRSLAALEKQ---GFWHDDVRPWNVMVDARQHARLIDFGSIVTTPQ- 391 (569)
T ss_dssp CCCSEEHHHHHH----TTCCCCHH---HHHHHHHHHHHHHHHT---TCEESCCCGGGEEECTTSCEEECCCTTEESCC--
T ss_pred cCCCCcHHHHHH----hCCCCCHH---HHHHHHHHHHHHHHHC---CceeccCchHhEEECCCCCEEEeecccCeeCCC-
Confidence 999999999998 44566654 5789999999999999 999999999999999999999999999876542
Q ss_pred cccccccccccccCcccCChhhhcccCcCccccchhhhHHHHHHHhCCCC
Q 038766 172 LQDLSSLSTAFQGTIGYLAPEFAYMRIVTTKVDVFSFGIVVMEFLTKRRP 221 (299)
Q Consensus 172 ~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~DiwslG~~l~~l~~g~~p 221 (299)
.........||+.|+|||++.+. +..++|+|++|++++.+.++..+
T Consensus 392 ---~~~~~~t~vGTp~YmAPE~l~g~-~~~~~d~~s~g~~~~~l~~~~~~ 437 (569)
T 4azs_A 392 ---DCSWPTNLVQSFFVFVNELFAEN-KSWNGFWRSAPVHPFNLPQPWSN 437 (569)
T ss_dssp -----CCSHHHHHHHHHHHHHHC------------------CCCCTTHHH
T ss_pred ---CCccccCceechhhccHHHhCCC-CCCcccccccccchhhhccccch
Confidence 12334456789999999998764 56789999999988777655433
|
| >3en9_A Glycoprotease, O-sialoglycoprotein endopeptidase/protein kinase; endopeptidase activity, protein kinase activity; HET: TBR; 2.67A {Methanocaldococcus jannaschii} PDB: 3enh_A* 2vwb_A* | Back alignment and structure |
|---|
Probab=99.94 E-value=1.3e-27 Score=215.55 Aligned_cols=189 Identities=16% Similarity=0.221 Sum_probs=140.8
Q ss_pred CCCceeecCCcceEEEEEeCCCcEEEEEEeccCcCChh------hhHHHHHHHHHHHhcCCcceeeeeeEEEcCCCeeEE
Q 038766 15 SENNIIGNSNLSTVYKGRLEDGEIVAVKKLNFHQFSAE------SDKSFYREAKTLKELKHRNLVKVLGYAWESGKLKAL 88 (299)
Q Consensus 15 ~~~~~lg~g~~~~v~~~~~~~~~~~~vK~~~~~~~~~~------~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~l 88 (299)
...+.||+|+||+||++.. .+..+++|+......... ..+++.+|++++++++||||+++..+....+. .++
T Consensus 339 ~~~~~LG~G~fg~Vy~~~~-~~~~~~~k~~~~~~~~~~~~~~~~~~~~~~~E~~il~~l~h~nIv~~~~~~~~~~~-~~l 416 (540)
T 3en9_A 339 IPEHLIGKGAEADIKRDSY-LDFDVIIKERVKKGYRDERLDENIRKSRTAREARYLALVKDFGIPAPYIFDVDLDN-KRI 416 (540)
T ss_dssp ---------CCEEEEEEEC-SSCEEEEEEECCCTTSCHHHHHHHHHHHHHHHHHHHHHGGGGTCCCCCEEEEETTT-TEE
T ss_pred CCCCEEeeCCCEEEEEEEE-CCCeEEEEEEecccccchhhhhHHHHHHHHHHHHHHHhcCCCCcCceEEEEEeCCc-cEE
Confidence 4467999999999999954 478889998754332221 13457899999999999999954444444343 499
Q ss_pred EEeecCCCChHHHhcCCCCCCCCCChhhHHHHHHHHHHHHHHhhcCCCCCeeeecccCCceeeCCCCcEEEeeecccccc
Q 038766 89 ILEYMENGSLESVIHGPGVDHSRWTLPKRIDVLISVANGLDYLHSGYDIPIVHCDMKPSNILLDRDFEAHVSDFGTSRML 168 (299)
Q Consensus 89 v~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lh~~~~~~~~H~dl~~~nil~~~~~~v~l~df~~~~~~ 168 (299)
||||+++++|.+++.. +..++.|++++|+|||++ +++|+||||+||+++. .+||+|||++...
T Consensus 417 VmE~~~ggsL~~~l~~------------~~~i~~qi~~aL~~LH~~---gIiHrDiKp~NILl~~--~~kL~DFGla~~~ 479 (540)
T 3en9_A 417 MMSYINGKLAKDVIED------------NLDIAYKIGEIVGKLHKN---DVIHNDLTTSNFIFDK--DLYIIDFGLGKIS 479 (540)
T ss_dssp EEECCCSEEHHHHSTT------------CTHHHHHHHHHHHHHHHT---TEECTTCCTTSEEESS--SEEECCCTTCEEC
T ss_pred EEECCCCCCHHHHHHH------------HHHHHHHHHHHHHHHHHC---cCccCCCCHHHEEECC--eEEEEECccCEEC
Confidence 9999999999999962 568999999999999999 9999999999999998 9999999999876
Q ss_pred ccccccc---cccccccccCcccCChhhhcc--cCcCccccchhhhHHHHHHHhCCCCC
Q 038766 169 DVHLQDL---SSLSTAFQGTIGYLAPEFAYM--RIVTTKVDVFSFGIVVMEFLTKRRPT 222 (299)
Q Consensus 169 ~~~~~~~---~~~~~~~~~~~~y~~PE~~~~--~~~~~~~DiwslG~~l~~l~~g~~p~ 222 (299)
....... ........+|+.|+|||++.. ..|+...|+|+..+-..+-..+..++
T Consensus 480 ~~~~~~~~~~~~~~~~~~GT~~y~APEv~~~~~~~Y~~~~d~ws~vl~~l~~v~~r~rY 538 (540)
T 3en9_A 480 NLDEDKAVDLIVFKKAVLSTHHEKFDEIWERFLEGYKSVYDRWEIILELMKDVERRARY 538 (540)
T ss_dssp CCHHHHHHHHHHHHHHHHHHCGGGHHHHHHHHHHHHHHHCTTHHHHHHHHHHHHTCSCC
T ss_pred CCccccccchhhhhhhhcCCCCcCCHHHHHHHHHHHHHHHhHHHHHHHHHHHHHhcccc
Confidence 4211100 001235678999999999887 66888899999988887777666554
|
| >1zar_A RIO2 kinase; serine kinase, winged-helix, RIO domain, ADP-Mn complex, rRNA processing, transferase; HET: ADP; 1.75A {Archaeoglobus fulgidus} SCOP: a.4.5.56 d.144.1.9 PDB: 1tqi_A* 1tqp_A* 1tqm_A* 1zao_A* | Back alignment and structure |
|---|
Probab=99.91 E-value=9.3e-25 Score=181.45 Aligned_cols=149 Identities=18% Similarity=0.112 Sum_probs=116.7
Q ss_pred hCCCCCCceeecCCcceEEEEEeCCCcEEEEEEeccCcCCh----------------hhhHHHHHHHHHHHhcCCcceee
Q 038766 11 TGSFSENNIIGNSNLSTVYKGRLEDGEIVAVKKLNFHQFSA----------------ESDKSFYREAKTLKELKHRNLVK 74 (299)
Q Consensus 11 ~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~vK~~~~~~~~~----------------~~~~~~~~e~~~l~~l~h~~i~~ 74 (299)
...|.+.+.||+|++|.||++.+.+|+.||+|++....... .....+.+|+.++++++ | ++
T Consensus 89 ~~~~~~~~~iG~G~~g~Vy~~~~~~g~~valK~~~~~~~~~~~~~~~~~~~~~~w~~~~~~~~~~E~~~l~~l~--~-~~ 165 (282)
T 1zar_A 89 GKVDAIGKLMGEGKESAVFNCYSEKFGECVVKFHKVGHTSFKKVKEKRDYGDLHFSVLAIRSARNEFRALQKLQ--G-LA 165 (282)
T ss_dssp TSCSEEEEEEEECSSEEEEEEEETTTEEEEEEEECC------CCCC-------CHHHHHHHHHHHHHHHHHHTT--T-SS
T ss_pred CeEEEecCEeccCCCceEEEEEeCCCCEEEEEEEECCCCchhhhhhhhhhcchhhHHHHHHHHHHHHHHHHhcc--C-CC
Confidence 34555669999999999999998779999999986432211 23567889999999999 4 56
Q ss_pred eeeEEEcCCCeeEEEEeecCCCChHHHhcCCCCCCCCCChhhHHHHHHHHHHHHHHhhcCCCCCeeeecccCCceeeCCC
Q 038766 75 VLGYAWESGKLKALILEYMENGSLESVIHGPGVDHSRWTLPKRIDVLISVANGLDYLHSGYDIPIVHCDMKPSNILLDRD 154 (299)
Q Consensus 75 ~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lh~~~~~~~~H~dl~~~nil~~~~ 154 (299)
+.+++ ..+ ..++||||+++++|.+ +. ......++.|++.||.+||+. +++|+||||+||+++ +
T Consensus 166 v~~~~-~~~-~~~lvmE~~~g~~L~~-l~----------~~~~~~i~~qi~~~l~~lH~~---giiHrDlkp~NILl~-~ 228 (282)
T 1zar_A 166 VPKVY-AWE-GNAVLMELIDAKELYR-VR----------VENPDEVLDMILEEVAKFYHR---GIVHGDLSQYNVLVS-E 228 (282)
T ss_dssp SCCEE-EEE-TTEEEEECCCCEEGGG-CC----------CSCHHHHHHHHHHHHHHHHHT---TEECSCCSTTSEEEE-T
T ss_pred cCeEE-ecc-ceEEEEEecCCCcHHH-cc----------hhhHHHHHHHHHHHHHHHHHC---CCEeCCCCHHHEEEE-C
Confidence 66633 223 3489999999999988 42 123557999999999999999 999999999999999 9
Q ss_pred CcEEEeeeccccccccccccccccccccccCcccCChhhhcc
Q 038766 155 FEAHVSDFGTSRMLDVHLQDLSSLSTAFQGTIGYLAPEFAYM 196 (299)
Q Consensus 155 ~~v~l~df~~~~~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~ 196 (299)
+.++|+|||++.. +..+.|||++..
T Consensus 229 ~~vkl~DFG~a~~-----------------~~~~~a~e~l~r 253 (282)
T 1zar_A 229 EGIWIIDFPQSVE-----------------VGEEGWREILER 253 (282)
T ss_dssp TEEEECCCTTCEE-----------------TTSTTHHHHHHH
T ss_pred CcEEEEECCCCeE-----------------CCCCCHHHHHHH
Confidence 9999999998863 334678887653
|
| >1zth_A RIO1 serine protein kinase; ribosome biogenesis, rRNA, ADP, manganese, transferase; HET: ADP; 1.89A {Archaeoglobus fulgidus} PDB: 1zp9_A* 1ztf_A* | Back alignment and structure |
|---|
Probab=99.84 E-value=9.3e-21 Score=155.48 Aligned_cols=137 Identities=17% Similarity=0.189 Sum_probs=105.6
Q ss_pred CCCCceeecCCcceEEEEEe-CCCcE--EEEEEeccCcCCh----------------------hhhHHHHHHHHHHHhcC
Q 038766 14 FSENNIIGNSNLSTVYKGRL-EDGEI--VAVKKLNFHQFSA----------------------ESDKSFYREAKTLKELK 68 (299)
Q Consensus 14 y~~~~~lg~g~~~~v~~~~~-~~~~~--~~vK~~~~~~~~~----------------------~~~~~~~~e~~~l~~l~ 68 (299)
|.+.+.||+|++|.||+|.+ .+|+. ||||++....... .....+.+|+..++.+.
T Consensus 49 ~~i~~~ig~G~~g~Vy~a~~~~~g~~~~vAvK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~ 128 (258)
T 1zth_A 49 TAMGGVISTGKEANVFYADGVFDGKPVAMAVKIYRIETSEFDKMDEYLYGDERFDMRRISPKEKVFIWTEKEFRNLERAK 128 (258)
T ss_dssp EEEEEEEEECSSEEEEEEEEEETTEEEEEEEEEECCC-------GGGTTTCTTSCC----CHHHHHHHHHHHHHHHHHHH
T ss_pred hhhCCEEeecceEEEEEEEEcCCCcEeeEEEEEEECCccchhhHHHhhcccchhhhhccChHHHHHHHHHHHHHHHHHHH
Confidence 56789999999999999987 67888 9999975432111 11236788999999998
Q ss_pred Ccce--eeeeeEEEcCCCeeEEEEeecCC-C----ChHHHhcCCCCCCCCCChhhHHHHHHHHHHHHHHhh-cCCCCCee
Q 038766 69 HRNL--VKVLGYAWESGKLKALILEYMEN-G----SLESVIHGPGVDHSRWTLPKRIDVLISVANGLDYLH-SGYDIPIV 140 (299)
Q Consensus 69 h~~i--~~~~~~~~~~~~~~~lv~e~~~~-~----~L~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lh-~~~~~~~~ 140 (299)
|+++ ..+++. + ..++||||+.+ + +|.++.. ..++..+..++.|++.+|.+|| +. +++
T Consensus 129 ~~~i~~p~~~~~----~-~~~lVmE~~g~~g~~~~~L~~~~~-------~~~~~~~~~i~~qi~~~l~~lH~~~---giv 193 (258)
T 1zth_A 129 EAGVSVPQPYTY----M-KNVLLMEFIGEDELPAPTLVELGR-------ELKELDVEGIFNDVVENVKRLYQEA---ELV 193 (258)
T ss_dssp HTTCCCCCEEEE----E-TTEEEEECCEETTEECCBHHHHGG-------GGGGSCHHHHHHHHHHHHHHHHHTS---CEE
T ss_pred hCCCCCCeEEEc----C-CCEEEEEecCCCCCccccHHHHhh-------ccChHHHHHHHHHHHHHHHHHHHHC---CEE
Confidence 8764 333331 2 23899999932 2 6666553 1346678899999999999999 88 999
Q ss_pred eecccCCceeeCCCCcEEEeeeccccc
Q 038766 141 HCDMKPSNILLDRDFEAHVSDFGTSRM 167 (299)
Q Consensus 141 H~dl~~~nil~~~~~~v~l~df~~~~~ 167 (299)
|+||||+|||++. .++|+|||++..
T Consensus 194 HrDlkp~NILl~~--~~~liDFG~a~~ 218 (258)
T 1zth_A 194 HADLSEYNIMYID--KVYFIDMGQAVT 218 (258)
T ss_dssp CSSCSTTSEEESS--SEEECCCTTCEE
T ss_pred eCCCCHHHEEEcC--cEEEEECccccc
Confidence 9999999999988 899999999864
|
| >4gyi_A RIO2 kinase; protein kinase, ADP complex, phosphoaspartate, acyl-phosphat ribosome biogenesis, Ser/Thr protein kinase; HET: PHD ADP; 2.20A {Chaetomium thermophilum} PDB: 4gyg_A | Back alignment and structure |
|---|
Probab=99.76 E-value=1.3e-18 Score=148.56 Aligned_cols=138 Identities=15% Similarity=0.159 Sum_probs=100.2
Q ss_pred CCCCceeecCCcceEEEEEeCCCcEEEEEEeccCcCCh------------hh--------hHHHHHHHHHHHhcCCccee
Q 038766 14 FSENNIIGNSNLSTVYKGRLEDGEIVAVKKLNFHQFSA------------ES--------DKSFYREAKTLKELKHRNLV 73 (299)
Q Consensus 14 y~~~~~lg~g~~~~v~~~~~~~~~~~~vK~~~~~~~~~------------~~--------~~~~~~e~~~l~~l~h~~i~ 73 (299)
|.+.+.||.|++|.||+|.+.+|+.||||+++...... .. ......|...+.++.+.++.
T Consensus 97 Y~I~~~IG~Gk~a~VY~a~d~~G~~vAvKi~r~~~~sfr~v~~~r~~~~~~~~~~~~~~~rl~A~kE~~nL~rL~~~gv~ 176 (397)
T 4gyi_A 97 YSVGSRIGVGKESDIMIVADEKGKQKVLKIHRLGRISFRTVKANRDYLRNRSTGSWMYLSRLAAIKEFAFMKALYEEGFP 176 (397)
T ss_dssp SEEEEEEEECSSEEEEEEECTTCCEEEEEEECTTEECCCCCC--CEECTTSCHHHHHHHHHHHHHHHHHHHHHHHHTTCS
T ss_pred EEecCEeeeCCceEEEEEECCCCCEEEEEEEecccccHHHHHHHHHHHHhhccccHHHHHHHHHHHHHHHHHHHHhcCCC
Confidence 88999999999999999999889999999976421110 00 01123566777777544432
Q ss_pred eeeeEEEcCCCeeEEEEeecCCCChHHHhcCCCCCCCCCChhhHHHHHHHHHHHHHHhhcCCCCCeeeecccCCceeeCC
Q 038766 74 KVLGYAWESGKLKALILEYMENGSLESVIHGPGVDHSRWTLPKRIDVLISVANGLDYLHSGYDIPIVHCDMKPSNILLDR 153 (299)
Q Consensus 74 ~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lh~~~~~~~~H~dl~~~nil~~~ 153 (299)
...- +.. ... ++||||+.|.+|..+.. .+....++.|++.+|.+||+. +++||||||.|||++.
T Consensus 177 vp~p-~~~-~~~-~LVME~i~G~~L~~l~~----------~~~~~~l~~qll~~l~~lH~~---gIVHrDLKp~NILl~~ 240 (397)
T 4gyi_A 177 VPEP-IAQ-SRH-TIVMSLVDALPMRQVSS----------VPDPASLYADLIALILRLAKH---GLIHGDFNEFNILIRE 240 (397)
T ss_dssp CCCE-EEE-ETT-EEEEECCSCEEGGGCCC----------CSCHHHHHHHHHHHHHHHHHT---TEECSCCSTTSEEEEE
T ss_pred CCee-eec-cCc-eEEEEecCCccHhhhcc----------cHHHHHHHHHHHHHHHHHHHC---CCcCCCCCHHHEEEeC
Confidence 2111 111 122 79999999888765542 124467889999999999999 9999999999999987
Q ss_pred CC----------cEEEeeeccccc
Q 038766 154 DF----------EAHVSDFGTSRM 167 (299)
Q Consensus 154 ~~----------~v~l~df~~~~~ 167 (299)
+| .+.++||+-+-.
T Consensus 241 dgd~~d~~~~~~~~~iID~~Q~V~ 264 (397)
T 4gyi_A 241 EKDAEDPSSITLTPIIIXFPQMVS 264 (397)
T ss_dssp EECSSCTTSEEEEEEECCCTTCEE
T ss_pred CCCcccccccccceEEEEeCCccc
Confidence 76 389999996644
|
| >3tm0_A Aminoglycoside 3'-phosphotransferase; protein kinase, phosphorylation, transferase-antibiotic COMP; HET: ANP B31; 2.10A {Enterococcus faecalis} SCOP: d.144.1.6 PDB: 2b0q_A* 1l8t_A* 3q2j_A* 1j7i_A* 1j7u_A* 3h8p_A* 1j7l_A* 2bkk_A* | Back alignment and structure |
|---|
Probab=99.44 E-value=6.2e-13 Score=109.05 Aligned_cols=147 Identities=16% Similarity=0.121 Sum_probs=110.9
Q ss_pred HHHHhCCCCCCceeecCCcceEEEEEeCCCcEEEEEEeccCcCChhhhHHHHHHHHHHHhcC-CcceeeeeeEEEcCCCe
Q 038766 7 IENATGSFSENNIIGNSNLSTVYKGRLEDGEIVAVKKLNFHQFSAESDKSFYREAKTLKELK-HRNLVKVLGYAWESGKL 85 (299)
Q Consensus 7 ~~~~~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~vK~~~~~~~~~~~~~~~~~e~~~l~~l~-h~~i~~~~~~~~~~~~~ 85 (299)
+....+.|++...++.|+.+.||++... +..+++|+...... .....+..|+..++.+. +..+.+++++... +..
T Consensus 9 l~~~l~~~~~~~~~~g~s~~~v~~~~~~-~~~~vlK~~~~~~~--~~~~~~~~E~~~l~~l~~~~~vP~v~~~~~~-~~~ 84 (263)
T 3tm0_A 9 LKKLIEKYRCVKDTEGMSPAKVYKLVGE-NENLYLKMTDSRYK--GTTYDVEREKDMMLWLEGKLPVPKVLHFERH-DGW 84 (263)
T ss_dssp HHHHHTTSEEEECCSCCSSSEEEEEECS-SCEEEEEEECGGGT--TSTTCHHHHHHHHHHHTTTSCCCCEEEEEEE-TTE
T ss_pred HHHHhccceeEeeccCCCCCeEEEEECC-CCcEEEEeCCcccC--CCHHHHHHHHHHHHHHhcCCCCCeEEEEEec-CCc
Confidence 3445678998999999999999999865 68899999853211 22346888999999885 5667778886554 455
Q ss_pred eEEEEeecCCCChHHHhcCCCCCCCCCChhhHHHHHHHHHHHHHHhhcCC------------------------------
Q 038766 86 KALILEYMENGSLESVIHGPGVDHSRWTLPKRIDVLISVANGLDYLHSGY------------------------------ 135 (299)
Q Consensus 86 ~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lh~~~------------------------------ 135 (299)
.++|||+++|.+|..... +......++.+++.+++.||+..
T Consensus 85 ~~lv~e~i~G~~l~~~~~---------~~~~~~~~~~~l~~~l~~LH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 155 (263)
T 3tm0_A 85 SNLLMSEADGVLCSEEYE---------DEQSPEKIIELYAECIRLFHSIDISDCPYTNSLDSRLAELDYLLNNDLADVDC 155 (263)
T ss_dssp EEEEEECCSSEEHHHHCC---------TTTCHHHHHHHHHHHHHHHHHSCCTTCSCBCCHHHHHHHHHHHHHTTCSCCSG
T ss_pred eEEEEEecCCeehhhccC---------CcccHHHHHHHHHHHHHHHhCCCcccCCCcchHHHHHHHHHHHHhcccccccc
Confidence 699999999999887642 12234577889999999999810
Q ss_pred --------------------------CCCeeeecccCCceeeCCCCcEEEeeecccc
Q 038766 136 --------------------------DIPIVHCDMKPSNILLDRDFEAHVSDFGTSR 166 (299)
Q Consensus 136 --------------------------~~~~~H~dl~~~nil~~~~~~v~l~df~~~~ 166 (299)
...++|||++|.||+++.++.+.++||+.+.
T Consensus 156 ~~~~~~~~~~~~~~l~~~l~~~~~~~~~~l~HgDl~~~Nil~~~~~~~~lIDwe~a~ 212 (263)
T 3tm0_A 156 ENWEEDTPFKDPRELYDFLKTEKPEEELVFSHGDLGDSNIFVKDGKVSGFIDLGRSG 212 (263)
T ss_dssp GGGSTTCSSSSHHHHHHHHHHCCCCCCEEEECSSCCTTSEEEETTEEEEECCCTTCE
T ss_pred ccccccccCCCHHHHHHHHHhcCCCCCceEECCCCCcCcEEEECCcEEEEEEchhcc
Confidence 0259999999999999876666799999764
|
| >1nd4_A Aminoglycoside 3'-phosphotransferase; protein kinase, ATPase, kanamycin; HET: KAN; 2.10A {Klebsiella pneumoniae} SCOP: d.144.1.6 | Back alignment and structure |
|---|
Probab=99.33 E-value=4.3e-12 Score=103.77 Aligned_cols=137 Identities=17% Similarity=0.097 Sum_probs=96.3
Q ss_pred CCCCCCceeecCCcceEEEEEeCCCcEEEEEEeccCcCChhhhHHHHHHHHHHHhcCCcc--eeeeeeEEEcCCCeeEEE
Q 038766 12 GSFSENNIIGNSNLSTVYKGRLEDGEIVAVKKLNFHQFSAESDKSFYREAKTLKELKHRN--LVKVLGYAWESGKLKALI 89 (299)
Q Consensus 12 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~vK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~--i~~~~~~~~~~~~~~~lv 89 (299)
..+.+....+.|..+.||++...+|..+++|+.... ....+..|+..++.+.+.+ +.+++++.... ...++|
T Consensus 20 ~~~~~~~~~~gg~~~~v~~~~~~~g~~~vlK~~~~~-----~~~~~~~E~~~l~~l~~~~~~vP~~~~~~~~~-~~~~~v 93 (264)
T 1nd4_A 20 FGYDWAQQTIGCSDAAVFRLSAQGRPVLFVKTDLSG-----ALNELQDEAARLSWLATTGVPCAAVLDVVTEA-GRDWLL 93 (264)
T ss_dssp TTCEEEECSCTTSSCEEEEEECTTSCCEEEEEECSC-----TTSCHHHHHHHHHHHHTTTCCBCCEEEEEECS-SCEEEE
T ss_pred CCCceEecccCCCCceEEEEecCCCCeEEEEeCCcc-----cchhhhHHHHHHHHHHhCCCCCCeEEEeccCC-CCCEEE
Confidence 345544444456679999998777888999987532 2345778999998886444 44577755443 445999
Q ss_pred EeecCCCChHHHhcCCCCCCCCCChhhHHHHHHHHHHHHHHhhcCC----------------------------------
Q 038766 90 LEYMENGSLESVIHGPGVDHSRWTLPKRIDVLISVANGLDYLHSGY---------------------------------- 135 (299)
Q Consensus 90 ~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lh~~~---------------------------------- 135 (299)
+|+++|.+|. ... . ....++.+++.+|..||+..
T Consensus 94 ~e~i~G~~l~--~~~-------~---~~~~~~~~l~~~l~~lh~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 161 (264)
T 1nd4_A 94 LGEVPGQDLL--SSH-------L---APAEKVSIMADAMRRLHTLDPATCPFDHQAKHRIERARTRMEAGLVDQDDLDEE 161 (264)
T ss_dssp EECCSSEETT--TSC-------C---CHHHHHHHHHHHHHHHTTSCGGGCCCBCCHHHHHHHHHHHHHTTCCCTTSCCGG
T ss_pred EEecCCcccC--cCc-------C---CHhHHHHHHHHHHHHHhCCCCCCCCCchHHHHHHHHHHHHHhcCCccchhhhhh
Confidence 9999988773 220 1 12356677888888888751
Q ss_pred ---------------------CCCeeeecccCCceeeCCCCcEEEeeecccc
Q 038766 136 ---------------------DIPIVHCDMKPSNILLDRDFEAHVSDFGTSR 166 (299)
Q Consensus 136 ---------------------~~~~~H~dl~~~nil~~~~~~v~l~df~~~~ 166 (299)
...++|+|++|.||+++.++.+.|+||+.+.
T Consensus 162 ~~~~~~~~~~~~l~~~~~~~~~~~l~HgDl~~~Nil~~~~~~~~liD~~~a~ 213 (264)
T 1nd4_A 162 HQGLAPAELFARLKARMPDGEDLVVTHGDACLPNIMVENGRFSGFIDCGRLG 213 (264)
T ss_dssp GTTCCHHHHHHHHHHTCCSSCCEEEECSSCCGGGEEEETTEEEEECCCTTCE
T ss_pred ccCccHHHHHHHHHHhcCCCCCeEEECCCCCCCcEEEECCcEEEEEcchhcc
Confidence 0129999999999999877666799999875
|
| >3dxp_A Putative acyl-COA dehydrogenase; protein kinase-like fold, structural genomics, joint center structural genomics, JCSG; 2.32A {Ralstonia eutropha JMP134} | Back alignment and structure |
|---|
Probab=99.16 E-value=1.7e-10 Score=98.82 Aligned_cols=146 Identities=14% Similarity=0.122 Sum_probs=103.2
Q ss_pred CCCCceeecCCcceEEEEEeCCCcEEEEEEec--cCcCChhhhHHHHHHHHHHHhcCC--cceeeeeeEEEcCC--CeeE
Q 038766 14 FSENNIIGNSNLSTVYKGRLEDGEIVAVKKLN--FHQFSAESDKSFYREAKTLKELKH--RNLVKVLGYAWESG--KLKA 87 (299)
Q Consensus 14 y~~~~~lg~g~~~~v~~~~~~~~~~~~vK~~~--~~~~~~~~~~~~~~e~~~l~~l~h--~~i~~~~~~~~~~~--~~~~ 87 (299)
....+.|+.|.++.||++... +..+++|+.. ... .......+..|+..++.+.. ..+.+++..+.... ...+
T Consensus 40 ~~~~~~l~~G~sn~~y~v~~~-~~~~vlr~~~~p~~~-~~~~~~~~~~E~~~l~~L~~~~vpvP~~~~~~~~~~~~g~~~ 117 (359)
T 3dxp_A 40 PLSVEQFKGGQSNPTFKLVTP-GQTYVMRAKPGPKSK-LLPSAHAIEREYRVMDALAGTDVPVAKMYALCEDESVIGRAF 117 (359)
T ss_dssp CCEEEECCC-CCSCEEEEECS-SCEEEEECCCC-----------CHHHHHHHHHHHTTSSSCCCCEEEEECCTTTTSSCE
T ss_pred CceEEEcCCcccceEEEEEEC-CceEEEEeCCCCCCC-CCCcHHHHHHHHHHHHHhhcCCCCCCcEEEECCCCCccCCeE
Confidence 344678899999999999876 4678888764 211 11234577889999999973 45677777554331 2358
Q ss_pred EEEeecCCCChHHHhcCCCCCCCCCChhhHHHHHHHHHHHHHHhhcCC--------------------------------
Q 038766 88 LILEYMENGSLESVIHGPGVDHSRWTLPKRIDVLISVANGLDYLHSGY-------------------------------- 135 (299)
Q Consensus 88 lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lh~~~-------------------------------- 135 (299)
+|||+++|.++.+.. -..++......++.+++.+|+.||+..
T Consensus 118 ~vme~v~G~~l~~~~------~~~l~~~~~~~~~~~l~~~La~LH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 191 (359)
T 3dxp_A 118 YIMEFVSGRVLWDQS------LPGMSPAERTAIYDEMNRVIAAMHTVDYQAIGLGDYGKPGNYFQRQIERWTKQYKLSET 191 (359)
T ss_dssp EEEECCCCBCCCCTT------CTTCCHHHHHHHHHHHHHHHHHHHHSCTTTTTCTTSSCCSCHHHHHHHHHHHHHHHHCC
T ss_pred EEEEecCCeecCCCc------cccCCHHHHHHHHHHHHHHHHHHhCCCchhccccccCCCCCchHHHHHHHHHHHHhcCC
Confidence 999999987774321 124677788889999999999999730
Q ss_pred -----------------------CCCeeeecccCCceeeCCCCc--EEEeeeccccc
Q 038766 136 -----------------------DIPIVHCDMKPSNILLDRDFE--AHVSDFGTSRM 167 (299)
Q Consensus 136 -----------------------~~~~~H~dl~~~nil~~~~~~--v~l~df~~~~~ 167 (299)
...++|||+++.||+++.++. +.++||+.+..
T Consensus 192 ~~~~~~~~~~~~l~~~~~~~~~~~~~lvHgD~~~~Nil~~~~~~~v~~viDwe~a~~ 248 (359)
T 3dxp_A 192 ESIPAMDSLMDWLPQHIPQEDADLTSIVHGDYRLDNLMFHPTEPRVLAVLDWELSTL 248 (359)
T ss_dssp SCCHHHHHHHHHGGGCCCSTTSSCCEEECSSCSGGGEEECSSSSCEEEECCCTTCEE
T ss_pred cCChHHHHHHHHHHhcCCCccCCCceEEeCCCCCCcEEEeCCCCcEEEEECcccccc
Confidence 137999999999999987753 68999998863
|
| >3sg8_A APH(2'')-ID; antibiotic resistance enzyme, transferase, aminoglycoside, phosphorylation, transferase-antibiotic complex; HET: TOY; 1.80A {Enterococcus casseliflavus} PDB: 3sg9_A* 3n4v_A 3n4t_A 3n4u_A 3r81_A* 3r80_A* 3r7z_A* 3r82_A* 3vcq_A* 4dbx_A 4de4_A* 4dfb_A* 4dfu_A* 4dt9_A* 4dt8_A* 4dtb_A* 3sgc_A 4dta_A* 3lzh_A | Back alignment and structure |
|---|
Probab=99.07 E-value=2.1e-10 Score=96.03 Aligned_cols=188 Identities=18% Similarity=0.151 Sum_probs=118.0
Q ss_pred CCceeecCCcceEEEEEeCCCcEEEEEEeccCcCChhhhHHHHHHHHHHHhcC-Ccc--eeeeeeEEEcCC--CeeEEEE
Q 038766 16 ENNIIGNSNLSTVYKGRLEDGEIVAVKKLNFHQFSAESDKSFYREAKTLKELK-HRN--LVKVLGYAWESG--KLKALIL 90 (299)
Q Consensus 16 ~~~~lg~g~~~~v~~~~~~~~~~~~vK~~~~~~~~~~~~~~~~~e~~~l~~l~-h~~--i~~~~~~~~~~~--~~~~lv~ 90 (299)
-.+.++.|....||++. ..+++|+.. .......+..|...++.+. +.. +..++......+ ...++||
T Consensus 24 ~i~~~~~G~~n~v~~v~----~~~vlR~~~----~~~~~~~~~~E~~~l~~l~~~~~v~vP~~~~~~~~~~~~~~~~~vm 95 (304)
T 3sg8_A 24 TIEISGEGNDCIAYEIN----RDFIFKFPK----HSRGSTNLFNEVNILKRIHNKLPLPIPEVVFTGMPSETYQMSFAGF 95 (304)
T ss_dssp CCCEEEECSSEEEEEST----TSEEEEEES----SHHHHHHHHHHHHHHHHHTTSSSSCCCCEEEECCCCSSCSCSCEEE
T ss_pred eeEecCCCCcceEEEEC----CEEEEEecC----CcchHHHHHHHHHHHHHHHhcCCCCCCceEeecCCCCCCCcceEEE
Confidence 35678999999999875 458999864 2245677889999998884 322 223333211111 1237899
Q ss_pred eecCCCChHHHhcCCCCCCCCCChhhHHHHHHHHHHHHHHhhcCC-----------------------------------
Q 038766 91 EYMENGSLESVIHGPGVDHSRWTLPKRIDVLISVANGLDYLHSGY----------------------------------- 135 (299)
Q Consensus 91 e~~~~~~L~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lh~~~----------------------------------- 135 (299)
++++|.++..... ..++..+...++.+++..++.||+..
T Consensus 96 ~~i~G~~l~~~~~------~~l~~~~~~~~~~~l~~~la~LH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 169 (304)
T 3sg8_A 96 TKIKGVPLTPLLL------NNLPKQSQNQAAKDLARFLSELHSINISGFKSNLVLDFREKINEDNKKIKKLLSRELKGPQ 169 (304)
T ss_dssp ECCCCEECCHHHH------HTSCHHHHHHHHHHHHHHHHHHHHSCCTTSCGGGBCCHHHHHHHHHHHHHHHHTTTSCHHH
T ss_pred cccCCeECCcccc------ccCCHHHHHHHHHHHHHHHHHHHcCCCCCCCccchhhHHHHHHHHHHHHHHHhcccCCccc
Confidence 9999988764321 14566677778888888888888520
Q ss_pred --------------------CCCeeeecccCCceeeCC--CCcEEEeeeccccccccccccccccccccccCcccCChhh
Q 038766 136 --------------------DIPIVHCDMKPSNILLDR--DFEAHVSDFGTSRMLDVHLQDLSSLSTAFQGTIGYLAPEF 193 (299)
Q Consensus 136 --------------------~~~~~H~dl~~~nil~~~--~~~v~l~df~~~~~~~~~~~~~~~~~~~~~~~~~y~~PE~ 193 (299)
...++|||++|.||+++. ++.+.++||+.+..-.... +....... . .-.+|+.
T Consensus 170 ~~~l~~~~~~~l~~~~~~~~~~~~~HgD~~~~N~l~~~~~~~~~~~iD~~~~~~~~~~~-Dl~~~~~~---~-~~~~~~~ 244 (304)
T 3sg8_A 170 MKKVDDFYRDILENEIYFKYYPCLIHNDFSSDHILFDTEKNTICGIIDFGDAAISDPDN-DFISLMED---D-EEYGMEF 244 (304)
T ss_dssp HHHHHHHHHHHHTCGGGTCCCCEEECSCCCGGGEEEETTTTEEEEECCCTTCEEECTTH-HHHTTCCT---T-TSCCHHH
T ss_pred HHHHHHHHHHHHhccccccCCceeEeCCCCcccEEEeCCCCCEEEEEeCCCCccCChHH-HHHHHHhh---c-cccCHHH
Confidence 124799999999999988 5567899999876422100 00000000 0 0022321
Q ss_pred hcc----c----------CcCccccchhhhHHHHHHHhCCCCC
Q 038766 194 AYM----R----------IVTTKVDVFSFGIVVMEFLTKRRPT 222 (299)
Q Consensus 194 ~~~----~----------~~~~~~DiwslG~~l~~l~~g~~p~ 222 (299)
... . ......+.|+++.+++.+.+|..+|
T Consensus 245 ~~~~l~~Y~~~~~~~~~~r~~~~~~~~~l~~~~~~~~~g~~~~ 287 (304)
T 3sg8_A 245 VSKILNHYKHKDIPTVLEKYRMKEKYWSFEKIIYGKEYGYMDW 287 (304)
T ss_dssp HHHHHHHHTCSCHHHHHHHHHHHHHHHHHHHHHHHHHTTCHHH
T ss_pred HHHHHHHcCCCCcHHHHHHHHHHHHHHHHHHHHHHHHcCCHHH
Confidence 110 0 0112368999999999999998765
|
| >3tdw_A Gentamicin resistance protein; kinase, phosphoryl transfer, antibiotic resistance, transfer; HET: GDP; 1.70A {Enterococcus gallinarum} PDB: 3tdv_A* | Back alignment and structure |
|---|
Probab=98.78 E-value=1e-07 Score=79.68 Aligned_cols=137 Identities=12% Similarity=0.061 Sum_probs=93.5
Q ss_pred CceeecCCcceEEEEEeCCCcEEEEEEeccCcCChhhhHHHHHHHHHHHhcCCc---ceeeeeeEEEcCCCeeEEEEeec
Q 038766 17 NNIIGNSNLSTVYKGRLEDGEIVAVKKLNFHQFSAESDKSFYREAKTLKELKHR---NLVKVLGYAWESGKLKALILEYM 93 (299)
Q Consensus 17 ~~~lg~g~~~~v~~~~~~~~~~~~vK~~~~~~~~~~~~~~~~~e~~~l~~l~h~---~i~~~~~~~~~~~~~~~lv~e~~ 93 (299)
.+.++.|....||++ +..+++|+.. .......+..|...++.+.+. .+...+.+........++|||++
T Consensus 24 v~~l~~G~~n~v~~v----g~~~VlR~~~----~~~~~~~~~~E~~~L~~L~~~~~v~VP~~~~~~~~~~g~~~~v~e~i 95 (306)
T 3tdw_A 24 VESLGEGFRNYAILV----NGDWVFRFPK----SQQGADELNKEIQLLPLLVGCVKVNIPQYVYIGKRSDGNPFVGYRKV 95 (306)
T ss_dssp EEEEEECSSEEEEEE----TTTEEEEEES----SHHHHHHHHHHHHHHHHHTTTCSSBCCCEEEEEECTTSCEEEEEECC
T ss_pred eeecCCCcceeEEEE----CCEEEEEecC----CchHHHHHHHHHHHHHHHHhcCCCCCCCeEeecccCCCceEEEEecc
Confidence 456888888899988 5678899852 234567889999999999742 24455554433344568999999
Q ss_pred CCCChHHHhcCCCCCCCCCChhhHHHHHHHHHHHHHHhhcCC--------------------------------------
Q 038766 94 ENGSLESVIHGPGVDHSRWTLPKRIDVLISVANGLDYLHSGY-------------------------------------- 135 (299)
Q Consensus 94 ~~~~L~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lh~~~-------------------------------------- 135 (299)
+|.++....- ..++......++.++...|+.||+..
T Consensus 96 ~G~~l~~~~~------~~l~~~~~~~~~~~lg~~La~LH~~~~~~~~~~g~p~~~w~~~~~~~~~~~~~~~~~~l~~~~~ 169 (306)
T 3tdw_A 96 QGQILGEDGM------AVLPDDAKDRLALQLAEFMNELSAFPVETAISAGVPVTNLKNKILLLSEAVEDQVFPLLDESLR 169 (306)
T ss_dssp CSEECHHHHH------TTSCHHHHHHHHHHHHHHHHHHHHSCHHHHHHTTCCBCCHHHHHHHHHHHHHHHTGGGSCHHHH
T ss_pred CCeECchhhh------hhCCHHHHHHHHHHHHHHHHHHhcCCcccccccCCChHHHHHHHHHHHHHHHHhcccccchhhH
Confidence 9988765321 12344445555555555555555431
Q ss_pred -------------------CCCeeeecccCCceeeCC---CCc-EEEeeeccccc
Q 038766 136 -------------------DIPIVHCDMKPSNILLDR---DFE-AHVSDFGTSRM 167 (299)
Q Consensus 136 -------------------~~~~~H~dl~~~nil~~~---~~~-v~l~df~~~~~ 167 (299)
...++|+|+++.||+++. ++. +.|+||+.+..
T Consensus 170 ~~l~~~~~~~l~~~~~~~~~~~~~HgD~~~~N~l~~~~~~~~~~~~~iD~~~a~~ 224 (306)
T 3tdw_A 170 DYLTLRFQSYMTHPVYTRYTPRLIHGDLSPDHFLTNLNSRQTPLTGIIDFGDAAI 224 (306)
T ss_dssp HHHHHHHHHHHHCHHHHCCCCEEECSCCSGGGEEECTTCSSCCEEEECCCTTCEE
T ss_pred HHHHHHHHHHHhCcccccCCCeeEeCCCCcccEEEecCCCCCceEEEEehhhcCC
Confidence 124699999999999987 455 47999998764
|
| >4gkh_A Aminoglycoside 3'-phosphotransferase APHA1-IAB; pyrazolopyrimidine, 1-Na-PP1, bumped kinase inhibitor, BKI, kinase inhibitor; HET: KAN 0J9; 1.86A {Acinetobacter baumannii} PDB: 4feu_A* 4few_A* 4fex_A* 4fev_A* 4gki_A* 4ej7_A* 3r78_A* | Back alignment and structure |
|---|
Probab=98.70 E-value=2.7e-07 Score=75.57 Aligned_cols=134 Identities=16% Similarity=0.083 Sum_probs=94.4
Q ss_pred eeecCCcc-eEEEEEeC-CCcEEEEEEeccCcCChhhhHHHHHHHHHHHhcC-CcceeeeeeEEEcCCCeeEEEEeecCC
Q 038766 19 IIGNSNLS-TVYKGRLE-DGEIVAVKKLNFHQFSAESDKSFYREAKTLKELK-HRNLVKVLGYAWESGKLKALILEYMEN 95 (299)
Q Consensus 19 ~lg~g~~~-~v~~~~~~-~~~~~~vK~~~~~~~~~~~~~~~~~e~~~l~~l~-h~~i~~~~~~~~~~~~~~~lv~e~~~~ 95 (299)
.+..|..+ .||+.... ++..+++|+-. ......+..|...++.+. +--+.+++.++... ...++|||+++|
T Consensus 31 ~~~~G~S~~~v~rl~~~~~~~~~~lk~~~-----~~~~~~~~~E~~~l~~l~~~vPVP~v~~~~~~~-~~~~lvme~l~G 104 (272)
T 4gkh_A 31 RDNVGQSGATIYRLYGKPNAPELFLKHGK-----GSVANDVTDEMVRLNWLTAFMPLPTIKHFIRTP-DDAWLLTTAIPG 104 (272)
T ss_dssp EEECSSSSCEEEEEECCTTCCCEEEEEEE-----THHHHHHHHHHHHHHHHTTTSCCCCEEEEEEET-TEEEEEEECCCS
T ss_pred EccCCCcCCeEEEEEecCCCeEEEEEECC-----CCCHhHHHHHHHHHHHhccCCCcCeEEEEEEEC-CeEEEEEEeeCC
Confidence 44556655 68988764 46789999853 235667888999999886 32355566655444 456999999999
Q ss_pred CChHHHhcCCCCCCCCCChhhHHHHHHHHHHHHHHhhcCC----------------------------------------
Q 038766 96 GSLESVIHGPGVDHSRWTLPKRIDVLISVANGLDYLHSGY---------------------------------------- 135 (299)
Q Consensus 96 ~~L~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lh~~~---------------------------------------- 135 (299)
.++.+.... .......+..++...|+.||+..
T Consensus 105 ~~~~~~~~~--------~~~~~~~~~~~l~~~L~~Lh~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 176 (272)
T 4gkh_A 105 KTAFQVLEE--------YPDSGENIVDALAVFLRRLHSIPVCNCPFNSDRVFRLAQAQSRMNNGLVDASDFDDERNGWPV 176 (272)
T ss_dssp EEHHHHHHH--------CGGGHHHHHHHHHHHHHHHHTSCGGGCCBBCCHHHHHHHHHHHHHTTCCCGGGCCGGGTTCCH
T ss_pred ccccccccC--------CHHHHHHHHHHHHHHHHHhcCCCcccCCcCcccccchhhHHHHHHHhhhhhhhccccccchHH
Confidence 888776531 22334456677777777777631
Q ss_pred ---------------CCCeeeecccCCceeeCCCCcEEEeeecccc
Q 038766 136 ---------------DIPIVHCDMKPSNILLDRDFEAHVSDFGTSR 166 (299)
Q Consensus 136 ---------------~~~~~H~dl~~~nil~~~~~~v~l~df~~~~ 166 (299)
...++|||+.+.||+++.++.+-|+||+.+.
T Consensus 177 ~~~~~~l~~~~~~~~~~~l~HGDl~~~Nil~~~~~~~~viDwe~a~ 222 (272)
T 4gkh_A 177 EQVWKEMHKLLPFSPDSVVTHGDFSLDNLIFDEGKLIGCIDVGRVG 222 (272)
T ss_dssp HHHHHHHHTTCCCCCCEEEECSCCCTTSEEEETTEEEEECCCTTCE
T ss_pred HHHHHHHHhcccccCCcEEEcCCCCCCeEEEECCeEEEEEECcccc
Confidence 0128999999999999987777799999875
|
| >3ats_A Putative uncharacterized protein; hypothetical protein, putative aminoglycoside phosphortransf transferase; 1.67A {Mycobacterium tuberculosis} PDB: 3att_A* | Back alignment and structure |
|---|
Probab=98.33 E-value=1.1e-06 Score=75.07 Aligned_cols=83 Identities=5% Similarity=-0.059 Sum_probs=52.1
Q ss_pred Ccee-ecCCcceEEEEEeC-------CCcEEEEEEeccCcC-ChhhhHHHHHHHHHHHhcCC---cceeeeeeEEEcCC-
Q 038766 17 NNII-GNSNLSTVYKGRLE-------DGEIVAVKKLNFHQF-SAESDKSFYREAKTLKELKH---RNLVKVLGYAWESG- 83 (299)
Q Consensus 17 ~~~l-g~g~~~~v~~~~~~-------~~~~~~vK~~~~~~~-~~~~~~~~~~e~~~l~~l~h---~~i~~~~~~~~~~~- 83 (299)
.+.| +.|....+|++... ++..+++|+...... .......+..|+..++.+.. -.+.+++.+.....
T Consensus 25 ~~~l~~~G~~n~~y~v~~~~~~~~~~~~~~~vlR~~~~~~~~~~~~~~~~~~E~~~l~~L~~~~~vpvP~v~~~~~~~~~ 104 (357)
T 3ats_A 25 ESGVDSTGMSSETIILTARWQQDGRSIQQKLVARVAPAAEDVPVFPTYRLDHQFEVIRLVGELTDVPVPRVRWIETTGDV 104 (357)
T ss_dssp EEEECTTSSEEEEEEEEEEEEETTEEEEEEEEEEECCCGGGCCSSSCCCHHHHHHHHHHHHHHCCSCCCCEEEEECSSTT
T ss_pred EEECCCCCccceEEEEEEecccCCCCCCceEEEEeCCCCCccccCchhHHHHHHHHHHHHhhcCCCCCCcEEEEccCCCc
Confidence 3567 78888999998754 267899997642110 00012456778888888752 23555666443321
Q ss_pred -CeeEEEEeecCCCChH
Q 038766 84 -KLKALILEYMENGSLE 99 (299)
Q Consensus 84 -~~~~lv~e~~~~~~L~ 99 (299)
...++|||+++|.++.
T Consensus 105 ~g~~~~v~e~l~G~~l~ 121 (357)
T 3ats_A 105 LGTPFFLMDYVEGVVPP 121 (357)
T ss_dssp TSSCEEEEECCCCBCCC
T ss_pred cCCceEEEEecCCCChh
Confidence 2348999999886654
|
| >3f7w_A Putative fructosamine-3-kinase; YP_290396.1, structural GENO joint center for structural genomics, JCSG, protein structu initiative, PSI-2; 1.85A {Thermobifida fusca YX} | Back alignment and structure |
|---|
Probab=98.19 E-value=6.1e-06 Score=68.17 Aligned_cols=81 Identities=23% Similarity=0.257 Sum_probs=57.4
Q ss_pred HhCCCCCCceeecCCcceEEEEEeCCCcEEEEEEeccCcCChhhhHHHHHHHHHHHhcCCc---ceeeeeeEEEcCCCee
Q 038766 10 ATGSFSENNIIGNSNLSTVYKGRLEDGEIVAVKKLNFHQFSAESDKSFYREAKTLKELKHR---NLVKVLGYAWESGKLK 86 (299)
Q Consensus 10 ~~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~vK~~~~~~~~~~~~~~~~~e~~~l~~l~h~---~i~~~~~~~~~~~~~~ 86 (299)
...+..-++.+|.|..+.||++...+|+.+++|+... ........+..|+..|+.+... -+.+++++ +..
T Consensus 13 ~G~~v~~v~~~g~G~~~~vyrv~l~DG~~~~vK~~~~--~~~~~~~~~~~Ea~~L~~L~~~~~vpvP~v~~~----~~~- 85 (288)
T 3f7w_A 13 TGREVAAVAERGHSHRWHLYRVELADGTPLFVKALPD--DAPALDGLFRAEALGLDWLGRSFGSPVPQVAGW----DDR- 85 (288)
T ss_dssp HCCCEEEEEEEEEETTEEEEEEEETTSCEEEEEECCT--TCCCCTTHHHHHHHHHHHHTCSTTCCSCCEEEE----ETT-
T ss_pred cCCCeEEEEecCCCCCeEEEEEEECCCCEEEEEEeCC--CCcchhhHHHHHHHHHHHHHhhCCCCcceEEec----cCc-
Confidence 3456677889999999999999999999999998642 2233345678899999988532 23334432 222
Q ss_pred EEEEeecCCCC
Q 038766 87 ALILEYMENGS 97 (299)
Q Consensus 87 ~lv~e~~~~~~ 97 (299)
++|+|++.+..
T Consensus 86 ~lv~e~l~~~~ 96 (288)
T 3f7w_A 86 TLAMEWVDERP 96 (288)
T ss_dssp EEEEECCCCCC
T ss_pred eEEEEeecccC
Confidence 78999987654
|
| >2yle_A Protein spire homolog 1; actin-binding protein, actin polymerization; 1.80A {Homo sapiens} PDB: 2ylf_A 3r7g_A 3rbw_A | Back alignment and structure |
|---|
Probab=98.16 E-value=2.6e-06 Score=66.12 Aligned_cols=99 Identities=16% Similarity=0.113 Sum_probs=65.1
Q ss_pred ChHHHhcCCCCCCCCCChhhHHHHHHHHHHHHHHhhc-CCCCCeeeecccCCceeeCCCCcEEEeeeccccccccccccc
Q 038766 97 SLESVIHGPGVDHSRWTLPKRIDVLISVANGLDYLHS-GYDIPIVHCDMKPSNILLDRDFEAHVSDFGTSRMLDVHLQDL 175 (299)
Q Consensus 97 ~L~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lh~-~~~~~~~H~dl~~~nil~~~~~~v~l~df~~~~~~~~~~~~~ 175 (299)
+|.+.++. .+.+++|+++|.++.|.+.+|..+-. + .-...=+.|..|++..+|.|.+.+ ..+.
T Consensus 34 SL~eIL~~---~~~PlsEEqaWALc~Qc~~~L~~~~~~~---~~~~~i~~~~~i~l~~dG~V~f~~-~~s~--------- 97 (229)
T 2yle_A 34 SLEEILRL---YNQPINEEQAWAVCYQCCGSLRAAARRR---QPRHRVRSAAQIRVWRDGAVTLAP-AADD--------- 97 (229)
T ss_dssp EHHHHHHH---HTSCCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCSGGGEEEETTSCEEECC-C------------
T ss_pred cHHHHHHH---cCCCcCHHHHHHHHHHHHHHHHhhhhcc---cCCceecCCcceEEecCCceeccc-cccc---------
Confidence 68888774 35799999999999999999988722 2 112334457899999999998864 1110
Q ss_pred cccccccccCcccCChhhhcccCcCccccchhhhHHHHHHHhCC
Q 038766 176 SSLSTAFQGTIGYLAPEFAYMRIVTTKVDVFSFGIVVMEFLTKR 219 (299)
Q Consensus 176 ~~~~~~~~~~~~y~~PE~~~~~~~~~~~DiwslG~~l~~l~~g~ 219 (299)
.....+.|||... ...+.+.=|||||+++|.-+--.
T Consensus 98 -------~~~~~~~~pe~~~-~~~te~~~IysLG~tLY~ALDyg 133 (229)
T 2yle_A 98 -------AGEPPPVAGKLGY-SQCMETEVIESLGIIIYKALDYG 133 (229)
T ss_dssp ----------------CCSS-SSSCHHHHHHHHHHHHHHHHTTT
T ss_pred -------ccccCCCChhhcc-ccchHHHHHHHHHHHHHHHhhcC
Confidence 0122456777653 34457788999999999988633
|
| >2olc_A MTR kinase, methylthioribose kinase; kinase ADP-2HO complex, transferase; HET: CPS ADP; 2.00A {Bacillus subtilis} SCOP: d.144.1.6 PDB: 2pu8_A* 2pui_A* 2pul_A* 2pun_A* 2pup_A* | Back alignment and structure |
|---|
Probab=98.14 E-value=1e-05 Score=70.04 Aligned_cols=77 Identities=13% Similarity=0.075 Sum_probs=48.7
Q ss_pred CceeecCCcceEEEEEeC-CCcEEEEEEeccCcC--C---hhhhHHHHHHHHHHHhcCC--cc-eeeeeeEEEcCCCeeE
Q 038766 17 NNIIGNSNLSTVYKGRLE-DGEIVAVKKLNFHQF--S---AESDKSFYREAKTLKELKH--RN-LVKVLGYAWESGKLKA 87 (299)
Q Consensus 17 ~~~lg~g~~~~v~~~~~~-~~~~~~vK~~~~~~~--~---~~~~~~~~~e~~~l~~l~h--~~-i~~~~~~~~~~~~~~~ 87 (299)
.+.||.|..+.||++... +++.+++|....... . .....++..|.+.++.+.. +. +.+++.+ ..+. .+
T Consensus 35 ~~~lg~G~~n~vyrv~~~~~~~~~vvK~~~~~~r~~~~~~~~~~~r~~~E~~~L~~l~~~~~~~vP~~~~~--d~~~-~~ 111 (397)
T 2olc_A 35 CQEIGDGNLNYVFHIYDQEHDRALIIKQAVPYAKVVGESWPLTIDRARIESSALIRQGEHVPHLVPRVFYS--DTEM-AV 111 (397)
T ss_dssp EEECCSSSSEEEEEEEC----CEEEEEEECCC-------CCCCTTHHHHHHHHHHHHHTTCGGGSCCEEEE--ETTT-TE
T ss_pred EEECCCCceEEEEEEEECCCCcEEEEEecchhhcccCCCCcCcHHHHHHHHHHHHHhhhhCCCCcCeEEEE--cCCc-cE
Confidence 568899999999999754 468899998642211 1 1234567778888887742 33 3345442 2233 37
Q ss_pred EEEeecCCC
Q 038766 88 LILEYMENG 96 (299)
Q Consensus 88 lv~e~~~~~ 96 (299)
+|||++.+.
T Consensus 112 lvmE~l~g~ 120 (397)
T 2olc_A 112 TVMEDLSHL 120 (397)
T ss_dssp EEECCCTTS
T ss_pred EEEEeCCCc
Confidence 999999763
|
| >2q83_A YTAA protein; 2635576, structural genomics, joint center for structu genomics, JCSG, protein structure initiative, PSI-2, transf; HET: ADN CIT UNL; 2.50A {Bacillus subtilis} | Back alignment and structure |
|---|
Probab=98.14 E-value=7.2e-06 Score=69.31 Aligned_cols=30 Identities=27% Similarity=0.297 Sum_probs=27.3
Q ss_pred CCeeeecccCCceeeCCCCcEEEeeecccc
Q 038766 137 IPIVHCDMKPSNILLDRDFEAHVSDFGTSR 166 (299)
Q Consensus 137 ~~~~H~dl~~~nil~~~~~~v~l~df~~~~ 166 (299)
..+||||+++.||+++.++.+.++||+.+.
T Consensus 222 ~~l~HgD~~~~Nil~~~~~~~~lIDfe~a~ 251 (346)
T 2q83_A 222 PNLCHQDYGTGNTLLGENEQIWVIDLDTVS 251 (346)
T ss_dssp CCEECSSCSTTSEEECGGGCEEECCCTTCE
T ss_pred CceecCCCCcccEEEeCCCcEEEEehhhcc
Confidence 389999999999999888899999999774
|
| >3dxq_A Choline/ethanolamine kinase family protein; NP_106042.1, STR genomics, joint center for structural genomics, JCSG, prote structure initiative; HET: MSE; 2.55A {Mesorhizobium loti} | Back alignment and structure |
|---|
Probab=97.93 E-value=4.6e-05 Score=63.26 Aligned_cols=74 Identities=11% Similarity=0.111 Sum_probs=44.8
Q ss_pred CCCCceeecCCcceEEEEEeCCCcEEEEEEeccCcCChhhhHHHHHHHHHHHhcCCcce-eeeeeEEEcCCCeeEEEEee
Q 038766 14 FSENNIIGNSNLSTVYKGRLEDGEIVAVKKLNFHQFSAESDKSFYREAKTLKELKHRNL-VKVLGYAWESGKLKALILEY 92 (299)
Q Consensus 14 y~~~~~lg~g~~~~v~~~~~~~~~~~~vK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i-~~~~~~~~~~~~~~~lv~e~ 92 (299)
+.-.+.|+.|....+|++ ..+++|+.... .........|+..++.+...++ .+++.. ..+. -++++||
T Consensus 20 ~~~i~~l~gG~tN~~~~~-----~~~vlR~~~~~---~~~~~~r~~E~~~l~~l~~~g~~P~~~~~--~~~~-~~~v~e~ 88 (301)
T 3dxq_A 20 YTGPLERLGGLTNLVFRA-----GDLCLRIPGKG---TEEYINRANEAVAAREAAKAGVSPEVLHV--DPAT-GVMVTRY 88 (301)
T ss_dssp CCSCEEEESCSSEEEEEE-----TTEEEEEECC-------CCCHHHHHHHHHHHHHTTSSCCEEEE--CTTT-CCEEEEC
T ss_pred ccceeEcCCcccccccee-----eeEEEECCCCC---ccceeCHHHHHHHHHHHHHcCCCCceEEE--ECCC-CEEEEee
Confidence 444788999999999999 45889987532 1111223457777777753333 334432 2222 2689999
Q ss_pred c-CCCCh
Q 038766 93 M-ENGSL 98 (299)
Q Consensus 93 ~-~~~~L 98 (299)
+ +|.++
T Consensus 89 i~~g~~l 95 (301)
T 3dxq_A 89 IAGAQTM 95 (301)
T ss_dssp CTTCEEC
T ss_pred cCCCccC
Confidence 9 66544
|
| >3jr1_A Putative fructosamine-3-kinase; YP_719053.1, structural genomics, joint center for structural genomics, JCSG; HET: MSE UNL; 2.32A {Haemophilus somnus 129PT} | Back alignment and structure |
|---|
Probab=97.82 E-value=0.00017 Score=60.13 Aligned_cols=76 Identities=20% Similarity=0.134 Sum_probs=55.8
Q ss_pred CCceeecCCcceEEEEEeCCCcEEEEEEeccCcCChhhhHHHHHHHHHHHhcC---CcceeeeeeEEEcCCCeeEEEEee
Q 038766 16 ENNIIGNSNLSTVYKGRLEDGEIVAVKKLNFHQFSAESDKSFYREAKTLKELK---HRNLVKVLGYAWESGKLKALILEY 92 (299)
Q Consensus 16 ~~~~lg~g~~~~v~~~~~~~~~~~~vK~~~~~~~~~~~~~~~~~e~~~l~~l~---h~~i~~~~~~~~~~~~~~~lv~e~ 92 (299)
-.+.|+.|....+|++... +..+++|+... .....+..|+..|+.+. ...+.+++...... ...++|||+
T Consensus 40 ~~~~l~gG~~n~~y~v~~~-~~~~vlK~~~~-----~~~~~~~~E~~~L~~L~~~~~v~VP~vl~~~~~~-g~~~lvme~ 112 (312)
T 3jr1_A 40 HKEKLYSGEMNEIWLINDE-VQTVFVKINER-----SYRSMFRAEADQLALLAKTNSINVPLVYGIGNSQ-GHSFLLLEA 112 (312)
T ss_dssp EEEEECCSSSSEEEEEESS-SCEEEEEEEEG-----GGHHHHHHHHHHHHHHHHTTSSBCCCEEEEEECS-SEEEEEEEC
T ss_pred eeEEeCCccceeeeEEEEC-CCeEEEEeCCc-----ccHHHHHHHHHHHHHHHhhCCCCcceEEEEeecC-CceEEEEEe
Confidence 3467899999999999864 67889998642 23567888988888885 24566677755443 456999999
Q ss_pred cCCCCh
Q 038766 93 MENGSL 98 (299)
Q Consensus 93 ~~~~~L 98 (299)
+++..+
T Consensus 113 l~G~~~ 118 (312)
T 3jr1_A 113 LNKSKN 118 (312)
T ss_dssp CCCCCC
T ss_pred ccCCCC
Confidence 988654
|
| >2ppq_A HSK, HK, homoserine kinase; structural genomics, MCSG, PSI-2, protein structure initiative; 2.00A {Agrobacterium tumefaciens str} SCOP: d.144.1.6 | Back alignment and structure |
|---|
Probab=97.80 E-value=0.00025 Score=59.23 Aligned_cols=160 Identities=13% Similarity=0.103 Sum_probs=85.5
Q ss_pred CChHHHHHHhCCCCCC-----ceeecCCcceEEEEEeCCCcEEEEEEeccCcCChhhhHHHHHHHHHHHhcCCcce--ee
Q 038766 2 FDRTEIENATGSFSEN-----NIIGNSNLSTVYKGRLEDGEIVAVKKLNFHQFSAESDKSFYREAKTLKELKHRNL--VK 74 (299)
Q Consensus 2 ~~~~~~~~~~~~y~~~-----~~lg~g~~~~v~~~~~~~~~~~~vK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i--~~ 74 (299)
++.+++..+..+|.+. +.|+.|....+|++...+| .+++|+.... .....+..|...++.+...++ .+
T Consensus 7 ~~~~~l~~~l~~~~~~~~~~~~~i~~G~~n~~~~v~~~~g-~~vlk~~~~~----~~~~~l~~e~~~l~~L~~~g~~vP~ 81 (322)
T 2ppq_A 7 ITEDELRNFLTQYDVGSLTSYKGIAEGVENSNFLLHTTKD-PLILTLYEKR----VEKNDLPFFLGLMQHLAAKGLSCPL 81 (322)
T ss_dssp CCHHHHHHHHTTBCCCCEEEEEEECC---EEEEEEEESSC-CEEEEEECC-------CCHHHHHHHHHHHHHHTTCCCCC
T ss_pred CCHHHHHHHHHhCCCCcceEeeccCCCcccceEEEEeCCc-cEEEEEeCCC----CCHHHHHHHHHHHHHHHHCCCCCCc
Confidence 4677788888888763 3455688889999987655 6889987531 123345567777776642222 22
Q ss_pred eeeE-----EEcCCCeeEEEEeecCCCChHH------------------HhcCCCCCC-CCCChhhHHH-----------
Q 038766 75 VLGY-----AWESGKLKALILEYMENGSLES------------------VIHGPGVDH-SRWTLPKRID----------- 119 (299)
Q Consensus 75 ~~~~-----~~~~~~~~~lv~e~~~~~~L~~------------------~~~~~~~~~-~~~~~~~~~~----------- 119 (299)
++.. +...+...++++++++|..+.. ......... ..........
T Consensus 82 ~~~~~~g~~~~~~~g~~~~l~~~l~G~~~~~~~~~~~~~~g~~La~lH~~~~~~~~~~~~~~~~~~w~~~~~~~~~~~~~ 161 (322)
T 2ppq_A 82 PLPRKDGELLGELSGRPAALISFLEGMWLRKPEAKHCREVGKALAAMHLASEGFEIKRPNALSVDGWKVLWDKSEERADE 161 (322)
T ss_dssp BCCBTTCCSCEEETTEEEEEEECCCCBCCSSCCHHHHHHHHHHHHHHHHHTTTCCCCCBCTTSHHHHHHHHHHHGGGGGG
T ss_pred ccCCCCCCEEEEECCEEEEEEEeCCCcCCCCCCHHHHHHHHHHHHHHHHHhccCCCcccCccChHHHHHHHHHHHHHHHh
Confidence 2211 0011234589999998754310 111100000 0000000000
Q ss_pred ----HHHHHHHHHHHhhcC----CCCCeeeecccCCceeeCCCCcEEEeeecccc
Q 038766 120 ----VLISVANGLDYLHSG----YDIPIVHCDMKPSNILLDRDFEAHVSDFGTSR 166 (299)
Q Consensus 120 ----i~~qi~~~l~~lh~~----~~~~~~H~dl~~~nil~~~~~~v~l~df~~~~ 166 (299)
+...+...++.+.+. ....++|+|+.+.||+++.++.+.++||+.+.
T Consensus 162 ~~~~l~~~l~~~~~~l~~~~~~~~~~~liHgDl~~~Nil~~~~~~~~lIDf~~a~ 216 (322)
T 2ppq_A 162 VEKGLREEIRPEIDYLAAHWPKDLPAGVIHADLFQDNVFFLGDELSGLIDFYFAC 216 (322)
T ss_dssp TSTTHHHHHHHHHHHHHHHCCCSSCEEEECSCCCGGGEEEETTEEEEECCCTTCE
T ss_pred hhhhhHHHHHHHHHHHHhhCcccCCcccCCCCCCccCEEEeCCceEEEecchhcc
Confidence 001123334444321 12379999999999999887666899999775
|
| >2pyw_A Uncharacterized protein; 5-methylthioribose kinase, plant methionine recycling, refol transferase; HET: SR1 ADP; 1.90A {Arabidopsis thaliana} | Back alignment and structure |
|---|
Probab=97.72 E-value=0.0002 Score=62.38 Aligned_cols=29 Identities=21% Similarity=0.356 Sum_probs=26.4
Q ss_pred CeeeecccCCceeeCCCCcEEEeeeccccc
Q 038766 138 PIVHCDMKPSNILLDRDFEAHVSDFGTSRM 167 (299)
Q Consensus 138 ~~~H~dl~~~nil~~~~~~v~l~df~~~~~ 167 (299)
.++|||+++.||+++.++ +.++||+.+..
T Consensus 233 ~liHGDl~~~Nil~~~~~-~~lID~e~a~~ 261 (420)
T 2pyw_A 233 ALIHGDLHTGSVMVTQDS-TQVIDPEFSFY 261 (420)
T ss_dssp EEECSCCSGGGEEECSSC-EEECCCTTCEE
T ss_pred eEEecCCCCCcEEEeCCC-CEEEeCccccc
Confidence 899999999999998876 99999998764
|
| >3feg_A Choline/ethanolamine kinase; non-protein kinase, choline kinase, structural genomics CONS SGC, hemicholinium-3, phosphorylation; HET: HC7 ADP AMP; 1.30A {Homo sapiens} PDB: 3lq3_A* 2ig7_A* | Back alignment and structure |
|---|
Probab=97.61 E-value=0.00021 Score=61.16 Aligned_cols=142 Identities=16% Similarity=0.182 Sum_probs=80.0
Q ss_pred CceeecCCcceEEEEEeC--------CCcEEEEEEeccCcCChhhhHHHHHHHHHHHhcCCcce-eeeeeEEEcCCCeeE
Q 038766 17 NNIIGNSNLSTVYKGRLE--------DGEIVAVKKLNFHQFSAESDKSFYREAKTLKELKHRNL-VKVLGYAWESGKLKA 87 (299)
Q Consensus 17 ~~~lg~g~~~~v~~~~~~--------~~~~~~vK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i-~~~~~~~~~~~~~~~ 87 (299)
.+.|..|-...+|++... +++.+++|+... .......+.+|..+++.+...++ .++++.+ . + .
T Consensus 55 v~~lsGG~TN~~y~v~~~~~~~~~~~~~~~~vlR~~g~---~~~~~~~~~rE~~vl~~L~~~gv~P~ll~~~-~-~---g 126 (379)
T 3feg_A 55 VYPVSGGLSNLLFRCSLPDHLPSVGEEPREVLLRLYGA---ILQGVDSLVLESVMFAILAERSLGPQLYGVF-P-E---G 126 (379)
T ss_dssp CEEC-----CCEEEEECCTTSCCCSSCCSEEEEEECC------CCHHHHHHHHHHHHHHHHTTSSCCEEEEE-T-T---E
T ss_pred EEEcCCcccccEEEEEeCCCccccCCCCCeEEEEECCC---ccchHHHHHHHHHHHHHHHhcCCCCeEEEEc-C-C---c
Confidence 566777888999999864 257899998531 22345666789999988863233 3444432 2 2 3
Q ss_pred EEEeecCCCChHH--------------HhcC-CCC--C-CCCC--ChhhHHHHHHHHHH-------------------HH
Q 038766 88 LILEYMENGSLES--------------VIHG-PGV--D-HSRW--TLPKRIDVLISVAN-------------------GL 128 (299)
Q Consensus 88 lv~e~~~~~~L~~--------------~~~~-~~~--~-~~~~--~~~~~~~i~~qi~~-------------------~l 128 (299)
+|+||++|.+|.. .+.+ +.. . .... ....+..++.++.. .+
T Consensus 127 ~v~e~i~G~~l~~~~l~~p~~~~~ia~~La~LH~~~~~~~~~~~~l~~~i~~w~~~~~~~~~~~~~~~~~~~~~~l~~~~ 206 (379)
T 3feg_A 127 RLEQYIPSRPLKTQELREPVLSAAIATKMAQFHGMEMPFTKEPHWLFGTMERYLKQIQDLPPTGLPEMNLLEMYSLKDEM 206 (379)
T ss_dssp EEEECCSEEECCGGGGGCHHHHHHHHHHHHHHHTCCCSSCCSCCHHHHHHHHHHHHHHHCCCCSCCSCCHHHHTTHHHHH
T ss_pred cEEEEecCccCChhHhCCHHHHHHHHHHHHHHhCCCCCCCCCcccHHHHHHHHHHHHHhccCcccchhhhhhhHHHHHHH
Confidence 8999998755421 0000 000 0 1111 12344444444322 11
Q ss_pred HH----hhcC-CCCCeeeecccCCceeeCCC----CcEEEeeecccc
Q 038766 129 DY----LHSG-YDIPIVHCDMKPSNILLDRD----FEAHVSDFGTSR 166 (299)
Q Consensus 129 ~~----lh~~-~~~~~~H~dl~~~nil~~~~----~~v~l~df~~~~ 166 (299)
.. |... ....+||+|+.+.||+++.+ +.+.++||..+.
T Consensus 207 ~~L~~~L~~~~~~~~~~H~D~~~~Nil~~~~~~~~~~~~~IDwE~a~ 253 (379)
T 3feg_A 207 GNLRKLLESTPSPVVFCHNDIQEGNILLLSEPENADSLMLVDFEYSS 253 (379)
T ss_dssp HHHHHHHHTSCCCEEEECSCCCGGGEEEESCC---CCEEECCCTTCE
T ss_pred HHHHHHHhhcCCCcEEEcCCCCCCeEEEcCCCCccCcEEEEecccCC
Confidence 22 2211 23479999999999999876 789999999875
|
| >3csv_A Aminoglycoside phosphotransferase; YP_614837.1, phosphotransferase enzyme family, structural genomics, JOIN for structural genomics, JCSG; HET: MSE; 2.15A {Silicibacter SP} | Back alignment and structure |
|---|
Probab=97.60 E-value=0.00032 Score=58.97 Aligned_cols=31 Identities=26% Similarity=0.428 Sum_probs=27.0
Q ss_pred CCeeeecccCCceeeCCC----CcEEEeeeccccc
Q 038766 137 IPIVHCDMKPSNILLDRD----FEAHVSDFGTSRM 167 (299)
Q Consensus 137 ~~~~H~dl~~~nil~~~~----~~v~l~df~~~~~ 167 (299)
..++|||+.+.||+++.+ +.+.++||+.+..
T Consensus 183 ~~lvHgD~~~~Nil~~~~~~~~~~~~lIDf~~a~~ 217 (333)
T 3csv_A 183 MVFVHRDFHAQNLLWLPEREGLARVGVIDFQDAKL 217 (333)
T ss_dssp CEEECSCCSGGGEEECTTSCGGGGEEECCCTTCEE
T ss_pred CeeEeCCcCcccEEeccCcCCCCCeEEEeCCCcCc
Confidence 389999999999999874 6789999998763
|
| >1nw1_A Choline kinase (49.2 KD); phospholipid synthesis, protein kinase fold, transferase; 2.02A {Caenorhabditis elegans} SCOP: d.144.1.8 | Back alignment and structure |
|---|
Probab=97.57 E-value=0.00038 Score=60.78 Aligned_cols=73 Identities=18% Similarity=0.217 Sum_probs=47.7
Q ss_pred CCceeecCCcceEEEEEeCC--------CcEEEEEEeccCcCChhhhHHHHHHHHHHHhcCCcce-eeeeeEEEcCCCee
Q 038766 16 ENNIIGNSNLSTVYKGRLED--------GEIVAVKKLNFHQFSAESDKSFYREAKTLKELKHRNL-VKVLGYAWESGKLK 86 (299)
Q Consensus 16 ~~~~lg~g~~~~v~~~~~~~--------~~~~~vK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i-~~~~~~~~~~~~~~ 86 (299)
-.+.|+.|-...+|++...+ +..+++|+.... ...+.+..|...++.+...++ .++++.+ . +
T Consensus 77 ~v~~l~gG~tN~~y~v~~~~~~~~~~~~~~~~vlRi~~~~----~~~~~li~E~~~l~~L~~~g~~P~l~~~~-~--~-- 147 (429)
T 1nw1_A 77 RISRIKGGMSNMLFLCRLSEVYPPIRNEPNKVLLRVYFNP----ETESHLVAESVIFTLLSERHLGPKLYGIF-S--G-- 147 (429)
T ss_dssp EEEEECCCTTEEEEEEEECTTSCCSSSCCSEEEEEEECSC----CCHHHHHHHHHHHHHHHHTTSSSCEEEEE-T--T--
T ss_pred EEEEeCCCcccceEEEEeCCCccccCCCCceEEEEEeCCC----CcHHHHHHHHHHHHHHHhCCCCCcEEEEe-C--C--
Confidence 35677888889999998642 578999987421 112455578888888864333 4455532 2 2
Q ss_pred EEEEeecCCCC
Q 038766 87 ALILEYMENGS 97 (299)
Q Consensus 87 ~lv~e~~~~~~ 97 (299)
.+|+||++|.+
T Consensus 148 g~v~e~l~G~~ 158 (429)
T 1nw1_A 148 GRLEEYIPSRP 158 (429)
T ss_dssp EEEECCCCEEE
T ss_pred CEEEEEeCCcc
Confidence 38899997643
|
| >2qg7_A Ethanolamine kinase PV091845; malaria, SGC, structural genomics consortium, transferase; 2.41A {Plasmodium vivax} | Back alignment and structure |
|---|
Probab=97.48 E-value=0.00076 Score=59.27 Aligned_cols=74 Identities=18% Similarity=0.120 Sum_probs=46.3
Q ss_pred CceeecCCcceEEEEEeCC-CcEEEEEEeccCcCChhhhHHHHHHHHHHHhcCCcce-eeeeeEEEcCCCeeEEEEeecC
Q 038766 17 NNIIGNSNLSTVYKGRLED-GEIVAVKKLNFHQFSAESDKSFYREAKTLKELKHRNL-VKVLGYAWESGKLKALILEYME 94 (299)
Q Consensus 17 ~~~lg~g~~~~v~~~~~~~-~~~~~vK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i-~~~~~~~~~~~~~~~lv~e~~~ 94 (299)
.+.|+.|-...+|++...+ +..+++|+.... .........|...++.+...++ .++++.+ . + .+|+||++
T Consensus 113 i~~lsgG~tN~~y~v~~~~~~~~~vLRi~g~~---~~~~idR~~E~~vl~~L~~~gl~P~ll~~~-~--~--G~v~e~I~ 184 (458)
T 2qg7_A 113 FQIINGGITNILIKVKDMSKQAKYLIRLYGPK---TDEIINREREKKISCILYNKNIAKKIYVFF-T--N--GRIEEFMD 184 (458)
T ss_dssp EEEECC--CEEEEEEEETTTTEEEEEEEECC----CCSCSCHHHHHHHHHHHTTSSSBCCEEEEE-T--T--EEEEECCC
T ss_pred EEEcCCCeEeEEEEEEECCCCceEEEEECCCC---hhhhcCHHHHHHHHHHHHhcCCCCCEEEEe-C--C--eEEEEeeC
Confidence 4577788889999998764 578899986421 1111122578888988875444 3455533 2 2 36999998
Q ss_pred CCCh
Q 038766 95 NGSL 98 (299)
Q Consensus 95 ~~~L 98 (299)
|.+|
T Consensus 185 G~~l 188 (458)
T 2qg7_A 185 GYAL 188 (458)
T ss_dssp SEEC
T ss_pred CccC
Confidence 7443
|
| >3c5i_A Choline kinase; choline, kinase, malaria, transferase, structural genomics, structural genomics consortium; 2.20A {Plasmodium knowlesi} PDB: 3fi8_A* | Back alignment and structure |
|---|
Probab=97.34 E-value=0.0005 Score=58.71 Aligned_cols=73 Identities=14% Similarity=0.127 Sum_probs=42.7
Q ss_pred CceeecCCcceEEEEEeCC---------CcEEEEEEeccCcCChhhhHHHHHHHHHHHhcCCcc-eeeeeeEEEcCCCee
Q 038766 17 NNIIGNSNLSTVYKGRLED---------GEIVAVKKLNFHQFSAESDKSFYREAKTLKELKHRN-LVKVLGYAWESGKLK 86 (299)
Q Consensus 17 ~~~lg~g~~~~v~~~~~~~---------~~~~~vK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~-i~~~~~~~~~~~~~~ 86 (299)
.+.|+.|....+|++...+ +..+++|+.... .........|...++.+...+ ..++++.. .+
T Consensus 38 ~~~l~~G~~N~~y~v~~~~~~~~~~~~~~~~~vlRi~~~~---~~~~~~~~~E~~~l~~L~~~g~~P~~~~~~--~~--- 109 (369)
T 3c5i_A 38 VKQILSGLTNQLFEVGLKEETANNYNSIRTRVLFRIYGKH---VDELYNTISEFEVYKTMSKYKIAPQLLNTF--NG--- 109 (369)
T ss_dssp EEEC----CCEEEEEEECHHHHTTCTTSCCEEEEEECCTT---GGGTSCHHHHHHHHHHHHHTTSSCCEEEEE--TT---
T ss_pred EEEeCCcccceEEEEEeCCCCcccccCCCceEEEEecCCC---ccceecHHHHHHHHHHHHhcCCCCceEEec--CC---
Confidence 4567778889999998653 268899986421 122222456888888775333 33455432 22
Q ss_pred EEEEeecCCCC
Q 038766 87 ALILEYMENGS 97 (299)
Q Consensus 87 ~lv~e~~~~~~ 97 (299)
++|+|+++|.+
T Consensus 110 ~~v~e~i~G~~ 120 (369)
T 3c5i_A 110 GRIEEWLYGDP 120 (369)
T ss_dssp EEEEECCCSEE
T ss_pred cEEEEEecCCc
Confidence 68999998754
|
| >1zyl_A Hypothetical protein YIHE; putative protein kinase, structural genomics, PSI, protein structure initiative; 2.80A {Escherichia coli} SCOP: d.144.1.6 | Back alignment and structure |
|---|
Probab=97.33 E-value=0.0044 Score=51.73 Aligned_cols=156 Identities=13% Similarity=0.092 Sum_probs=83.8
Q ss_pred HHHHHHhCCCCC-----CceeecCCcceEEEEEeCCCcEEEEEEeccCcCChhhhHHHHHHHHHHHhcCCcc--eeeeee
Q 038766 5 TEIENATGSFSE-----NNIIGNSNLSTVYKGRLEDGEIVAVKKLNFHQFSAESDKSFYREAKTLKELKHRN--LVKVLG 77 (299)
Q Consensus 5 ~~~~~~~~~y~~-----~~~lg~g~~~~v~~~~~~~~~~~~vK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~--i~~~~~ 77 (299)
+.+..+.++|.+ ...|+ |....||++...+|+.+++|...... .....+..|...++.+...+ +.+++.
T Consensus 14 ~~i~~~l~~~g~~~~~~~~~l~-g~~n~~y~v~~~~g~~~vlK~~~~~~---~~~~~~~~E~~~~~~L~~~g~~vp~~~~ 89 (328)
T 1zyl_A 14 DTIMDALFEHGIRVDSGLTPLN-SYENRVYQFQDEDRRRFVVKFYRPER---WTADQILEEHQFALQLVNDEVPVAAPVA 89 (328)
T ss_dssp HHHHHHHHHTTCCCCSCCEEEC-CSSSEEEEECCTTCCCEEEEEECTTT---SCHHHHHHHHHHHHHHHHTTCSBCCCCC
T ss_pred HHHHHHHHHcCCCCCceEEeec-CcccceEEEEcCCCCEEEEEEcCCCC---CCHHHHHHHHHHHHHHHHcCCeecceee
Confidence 344444444533 34566 88889999887777789999975221 13445666777777775222 333333
Q ss_pred E----EEcCCCeeEEEEeecCCCChH-----------H-------HhcCCCC-CCCCCChh-------------------
Q 038766 78 Y----AWESGKLKALILEYMENGSLE-----------S-------VIHGPGV-DHSRWTLP------------------- 115 (299)
Q Consensus 78 ~----~~~~~~~~~lv~e~~~~~~L~-----------~-------~~~~~~~-~~~~~~~~------------------- 115 (299)
. ....+...++++++++|.++. . ....... ....++..
T Consensus 90 ~~g~~~~~~~g~~~~l~~~i~G~~~~~~~~~~~~~~g~~La~lH~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~ 169 (328)
T 1zyl_A 90 FNGQTLLNHQGFYFAVFPSVGGRQFEADNIDQMEAVGRYLGRMHQTGRKQLFIHRPTIGLNEYLIEPRKLFEDATLIPSG 169 (328)
T ss_dssp BTTBSCEEETTEEEEEEECCCCEECCSSCHHHHHHHHHHHHHHHHHHTSSCCSSSCBCSHHHHTHHHHHHHHTCSSSCTT
T ss_pred cCCcEEEEECCEEEEEEEecCCCCCCCCCHHHHHHHHHHHHHHHHhhccCCCccCCCCCHHHHHhhHHHHHhhcCcCCHH
Confidence 1 011123447899999774321 0 0010000 00111110
Q ss_pred h---HHHHHHHHHHHHHHhhc-CCCCCeeeecccCCceeeCCCCcEEEeeecccc
Q 038766 116 K---RIDVLISVANGLDYLHS-GYDIPIVHCDMKPSNILLDRDFEAHVSDFGTSR 166 (299)
Q Consensus 116 ~---~~~i~~qi~~~l~~lh~-~~~~~~~H~dl~~~nil~~~~~~v~l~df~~~~ 166 (299)
. ....+..++..+..+-. .....++|||+++.||+++ + .+.++||+.+.
T Consensus 170 ~~~~~~~~~~~~~~~l~~~~~~~~~~~l~HgD~~~~Nil~~-~-~~~lIDfe~a~ 222 (328)
T 1zyl_A 170 LKAAFLKATDELIAAVTAHWREDFTVLRLHGDCHAGNILWR-D-GPMFVDLDDAR 222 (328)
T ss_dssp THHHHHHHHHHHHHHHHHHCCSCSCCEECCSSCSGGGEEES-S-SEEECCCTTCC
T ss_pred HHHHHHHHHHHHHHHHHHHhhhcCCeeeeeCCCCcccEeEc-C-CCEEEECCCCC
Confidence 0 11122222222222211 1123789999999999998 4 89999998775
|
| >3i1a_A Spectinomycin phosphotransferase; protein kinase, aminoglycoside phosphotransferase, antibiotic resistance; HET: MES PG4; 1.70A {Legionella pneumophila} PDB: 3i0q_A* 3i0o_A* 3q2m_A* | Back alignment and structure |
|---|
Probab=97.16 E-value=0.0046 Score=52.07 Aligned_cols=31 Identities=16% Similarity=0.379 Sum_probs=27.5
Q ss_pred CCeeeecccCCceeeCCCCcEEEeeeccccc
Q 038766 137 IPIVHCDMKPSNILLDRDFEAHVSDFGTSRM 167 (299)
Q Consensus 137 ~~~~H~dl~~~nil~~~~~~v~l~df~~~~~ 167 (299)
..++|+|+.+.||+++.++.+.++||+.+..
T Consensus 206 ~~~~HgD~~~~N~l~~~~~~~~~iD~e~~~~ 236 (339)
T 3i1a_A 206 YVLCHSDIHAGNVLVGNEESIYIIDWDEPML 236 (339)
T ss_dssp CEEECSCCCGGGEEECGGGCEEECCCSSCEE
T ss_pred ceeEeCCCCcCCEEEeCCCeEEEEECCCCee
Confidence 3799999999999999888899999987753
|
| >3mes_A Choline kinase; malaria, structural genomics, structural genomics consortium, SGC, transferase; HET: ADP DME PT3; 2.35A {Cryptosporidium parvum} | Back alignment and structure |
|---|
Probab=96.71 E-value=0.0055 Score=53.20 Aligned_cols=74 Identities=9% Similarity=0.054 Sum_probs=46.8
Q ss_pred CceeecCCcceEEEEEeCC--------CcEEEEEEeccCcCChhhhHHHHHHHHHHHhcCCcce-eeeeeEEEcCCCeeE
Q 038766 17 NNIIGNSNLSTVYKGRLED--------GEIVAVKKLNFHQFSAESDKSFYREAKTLKELKHRNL-VKVLGYAWESGKLKA 87 (299)
Q Consensus 17 ~~~lg~g~~~~v~~~~~~~--------~~~~~vK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i-~~~~~~~~~~~~~~~ 87 (299)
.+.|..|-...+|++...+ +..+++|+... ..+......+|...++.+...++ .++++.+ .+ +
T Consensus 75 v~~lsGG~TN~~y~v~~~~~~~~~~~~~~~~vlRi~g~---~t~~~idR~~E~~~l~~L~~~gi~P~l~~~~--~~---~ 146 (424)
T 3mes_A 75 VKQIFSGLTNQLFVVSIVNESMSLSLKHPRILFRIYGK---HVGKFYDSKVELDVFRYLSNINIAPNIIADF--PE---G 146 (424)
T ss_dssp EEEECCCSSSEEEEEEECCC-----CCCSEEEEEECCC---CC-CCCCHHHHHHHHHHHHHTTSSCCEEEEE--TT---E
T ss_pred EEEcCCCcccceEEEEeCCCcccccCCCCeEEEEECCC---CcchhcCHHHHHHHHHHHHhcCCCCCEEEEc--CC---C
Confidence 4567678889999998653 57899998632 22233334578888888753233 3444422 22 6
Q ss_pred EEEeecCCCCh
Q 038766 88 LILEYMENGSL 98 (299)
Q Consensus 88 lv~e~~~~~~L 98 (299)
+|+||++|.+|
T Consensus 147 ~I~efI~G~~l 157 (424)
T 3mes_A 147 RIEEFIDGEPL 157 (424)
T ss_dssp EEEECCCSEEC
T ss_pred EEEEEeCCccC
Confidence 89999988653
|
| >3g15_A CK, chetk-alpha, choline kinase alpha; non-protein kinase, structural genomics CONS SGC, hemicholinium-3, transferase; HET: ADP HC6; 1.70A {Homo sapiens} PDB: 3f2r_A* 2i7q_A 2cko_A 2ckp_A* 2ckq_A* | Back alignment and structure |
|---|
Probab=96.36 E-value=0.015 Score=50.10 Aligned_cols=30 Identities=30% Similarity=0.365 Sum_probs=25.6
Q ss_pred CeeeecccCCceee------CCCCcEEEeeeccccc
Q 038766 138 PIVHCDMKPSNILL------DRDFEAHVSDFGTSRM 167 (299)
Q Consensus 138 ~~~H~dl~~~nil~------~~~~~v~l~df~~~~~ 167 (299)
.+||+|+.+.||++ +.++.+.++||.++..
T Consensus 245 vfcHnDl~~gNil~~~~~~~~~~~~l~vIDwEya~~ 280 (401)
T 3g15_A 245 VFCHNDCQEGNILLLEGRENSEKQKLMLIDFEYSSY 280 (401)
T ss_dssp EEECSCCCGGGEEEETTGGGCSSCCEEECCCTTCEE
T ss_pred eeEEecCCCCeEEEecCcccCcCCeEEEechHhccC
Confidence 47899999999999 4567799999998863
|
| >4ano_A ESSB; membrane protein, membrane secretion, ESS type V secretion S; HET: MSE; 1.70A {Geobacillus thermodenitrificans ng80-2organism_taxid} | Back alignment and structure |
|---|
Probab=90.62 E-value=1.3 Score=34.33 Aligned_cols=83 Identities=16% Similarity=0.134 Sum_probs=57.6
Q ss_pred CCcceeeeeeEEEcCCCeeEEEEeecCCCChHHHhcCCCCCCCCCChhhHHHHHHHHHHHHH-HhhcCCCCCeeeecccC
Q 038766 68 KHRNLVKVLGYAWESGKLKALILEYMENGSLESVIHGPGVDHSRWTLPKRIDVLISVANGLD-YLHSGYDIPIVHCDMKP 146 (299)
Q Consensus 68 ~h~~i~~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~-~lh~~~~~~~~H~dl~~ 146 (299)
.||++ -..+. ..++.+.+.++.-.+..-+..++ .++..+.++++.+|+.... +++ .-+|--++|
T Consensus 48 ~~~~f--~~~I~-~~eD~~~i~y~~~~~~~~f~~i~-------~~~~~eKlrll~nl~~L~~~~~~-----~r~tf~l~P 112 (219)
T 4ano_A 48 VDPCI--VRDID-VSEDEVKVVIKPPSSFLTFAAIR-------KTTLLSRIRAAIHLVSKVKHHSA-----RRLIFIVCP 112 (219)
T ss_dssp SCSSS--EEEEE-ECSSEEEEEEECCTTCEEHHHHH-------TSCHHHHHHHHHHHHHHHSSCCS-----SSEECCCCG
T ss_pred cCCCC--CeEEE-EeCCEEEEEEEcCcccCcHHHHH-------hcCHHHHHHHHHHHHHHHHHhhh-----CceeEEEeC
Confidence 46777 33323 33445455555543333344443 5788999999999998666 443 567889999
Q ss_pred CceeeCCCCcEEEeeeccc
Q 038766 147 SNILLDRDFEAHVSDFGTS 165 (299)
Q Consensus 147 ~nil~~~~~~v~l~df~~~ 165 (299)
+|+++|.++.+++.=.|+-
T Consensus 113 ~NL~f~~~~~p~i~hRGi~ 131 (219)
T 4ano_A 113 ENLMFNRALEPFFLHVGVK 131 (219)
T ss_dssp GGEEECTTCCEEESCCEET
T ss_pred ceEEEeCCCcEEEEEcCCc
Confidence 9999999999999877753
|
| >4ann_A ESSB; membrane protein, membrane secretion, ESS type VII secretion virulence; 1.05A {Staphylococcus aureus subsp} | Back alignment and structure |
|---|
Probab=90.23 E-value=0.84 Score=35.28 Aligned_cols=84 Identities=11% Similarity=0.087 Sum_probs=57.8
Q ss_pred CCcceeeeeeEEEcCCCeeEEEEeecCCCChHHHhcCCCCCCCCCChhhHHHHHHHHHHHHHHhhcCCCCCeeeecccCC
Q 038766 68 KHRNLVKVLGYAWESGKLKALILEYMENGSLESVIHGPGVDHSRWTLPKRIDVLISVANGLDYLHSGYDIPIVHCDMKPS 147 (299)
Q Consensus 68 ~h~~i~~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lh~~~~~~~~H~dl~~~ 147 (299)
.||++++. .+... ...+.+.++.-..+.-+..++ ..+..+.+.++.+|+....+++ .-+|--++|+
T Consensus 43 ~~~~Fl~~-~I~e~-eD~v~~~y~~~~~~~~f~~ik-------~~~~~eKlr~l~ni~~l~~~~~-----~r~tf~L~P~ 108 (215)
T 4ann_A 43 HSPYFIDA-ELTEL-RDSFQIHYDINDNHTPFDNIK-------SFTKNEKLRYLLNIKNLEEVNR-----TRYTFVLAPD 108 (215)
T ss_dssp CCTTBCCE-EEEEC-SSEEEEEECCCTTSEEGGGGG-------GSCHHHHHHHHHHGGGGGGGGG-----SSEECCCSGG
T ss_pred cCCcccce-EEEEc-ccEEEEEEEcCcccCCHHHHH-------hcCHHHHHHHHHHHHHHHHHhc-----CceEEEEecc
Confidence 47888876 43333 444345554433222223343 5788999999999999775554 4578899999
Q ss_pred ceeeCCCCcEEEeeeccc
Q 038766 148 NILLDRDFEAHVSDFGTS 165 (299)
Q Consensus 148 nil~~~~~~v~l~df~~~ 165 (299)
|++++.++.+++.=.|+-
T Consensus 109 NL~f~~~~~p~i~~RGik 126 (215)
T 4ann_A 109 ELFFTRDGLPIAKTRGLQ 126 (215)
T ss_dssp GEEECTTSCEEESCCEET
T ss_pred eEEEcCCCCEEEEEccCc
Confidence 999999999999877653
|
| >3cxl_A N-chimerin; SH2, RHO-GAP, structural genomics consortium, SGC, gtpas activation, metal-binding, phorbol-ester binding, SH2 domai finger; 2.60A {Homo sapiens} PDB: 1xa6_A | Back alignment and structure |
|---|
Probab=83.03 E-value=0.17 Score=44.46 Aligned_cols=63 Identities=13% Similarity=0.044 Sum_probs=17.7
Q ss_pred CCCceeecCCcceEEEEEeCC-CcEEEE------EEeccCcCChhhhHHHHHHHHHHHhcCCcceeeeeeEEE
Q 038766 15 SENNIIGNSNLSTVYKGRLED-GEIVAV------KKLNFHQFSAESDKSFYREAKTLKELKHRNLVKVLGYAW 80 (299)
Q Consensus 15 ~~~~~lg~g~~~~v~~~~~~~-~~~~~v------K~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~ 80 (299)
.+.+.|| ||.||.+.+.. ..+||+ |+........+....+.++...++.++|||+++..++..
T Consensus 145 ~l~~~lG---fG~v~~g~~~~~~~~Vav~~~~~~K~~~~~~~~~e~~~~~~rea~l~~~~~H~niv~~h~f~~ 214 (463)
T 3cxl_A 145 PIYEHVG---YTTLNREPAYKKHMPVLKETHDERDSTGQDGVSEKRLTSLVRRATLKENEQIPKYEKIHNFKV 214 (463)
T ss_dssp CSTTTSS---BCCC---------CCBGGGC-----------------------------------CBCCCEEE
T ss_pred cccccCC---chhhhcccccccCCchhhhhccCccccccccccccccccccccccccccccccccCCCcceEE
Confidence 4566776 99999998753 467888 766543444444556778888888899999999887543
|
| >3eps_A Isocitrate dehydrogenase kinase/phosphatase; ATP-binding, glyoxylate bypass, nucleotide-binding, protein phosphatase; HET: AMP ATP; 2.80A {Escherichia coli O157} PDB: 3lcb_A* 3lc6_A* | Back alignment and structure |
|---|
Probab=80.22 E-value=27 Score=30.95 Aligned_cols=137 Identities=15% Similarity=0.044 Sum_probs=90.9
Q ss_pred eeecCCcceEEEEEeCCCcEEEEEEeccCcC--ChhhhHHHHHHHHHHHhcCCcceeeeee------EEE----------
Q 038766 19 IIGNSNLSTVYKGRLEDGEIVAVKKLNFHQF--SAESDKSFYREAKTLKELKHRNLVKVLG------YAW---------- 80 (299)
Q Consensus 19 ~lg~g~~~~v~~~~~~~~~~~~vK~~~~~~~--~~~~~~~~~~e~~~l~~l~h~~i~~~~~------~~~---------- 80 (299)
.+.-|--|.|=.+-.-.+-++|.|+|+.... .+...+.++...+..++ |+.+=++-+ +.+
T Consensus 313 i~APGikGmVM~VFTLPSf~~VFKvIKD~F~p~K~~tr~~Vk~KY~LVK~--hDRVGRMADT~Efsn~~fp~~Rfs~eLL 390 (578)
T 3eps_A 313 IEAPGIRGMVMLVFTLPGFDRVFKVIKDKFAPQKEMSAAHVRACYQLVKE--HDRVGRMADTQEFENFVLEKRHISPALM 390 (578)
T ss_dssp EECSSCCCSSEEEEECTTCSEEEEEECSSCCTTCCCCHHHHHHHHHHHHT--SCCTTTBCCCEEEEEEEEEGGGBCHHHH
T ss_pred EECCCCCceEEEEEcCCCCceEEEEEccCCCCccccCHHHHHHHHHHHHh--hhhhhhhhhhhhhhcccCchhhCCHHHH
Confidence 3566888999888766688899999986422 23335555555555554 433322222 111
Q ss_pred ------------cCCCee---EEEEeecCCCChHHHhcCCCCCCCCCChhhHHHHHHHHHHHHHHhhcCCCCCeeeeccc
Q 038766 81 ------------ESGKLK---ALILEYMENGSLESVIHGPGVDHSRWTLPKRIDVLISVANGLDYLHSGYDIPIVHCDMK 145 (299)
Q Consensus 81 ------------~~~~~~---~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lh~~~~~~~~H~dl~ 145 (299)
..++.+ .+..|-- ...|.-+++ .-+++++...+...-.|++.|-.. ||.-||+=
T Consensus 391 ~EL~~~~ps~le~~gd~liIkHlYiERR-MtPLNLYL~-------~a~~~~~~~av~eYG~AIKqLAaA---NIFPGDML 459 (578)
T 3eps_A 391 ELLLQEAAEKITDLGEQIVIRHLYIERR-MVPLNIWLE-------QVEGQQLRDAIEEYGNAIRQLAAA---NIFPGDML 459 (578)
T ss_dssp HHHHHHSGGGEEEETTEEEEEEEEEEEC-CEEHHHHHH-------HCCTHHHHHHHHHHHHHHHHHHHT---TEECSCCC
T ss_pred HHHHHhCCccEEEcCCeeEeeeeeeecc-ccchhHHHh-------hCCHHHHHHHHHHHHHHHHHHHHh---cCCCcccc
Confidence 112221 1122221 335655665 235677888899999999999999 99999999
Q ss_pred CCceeeCCCCcEEEeeecccccc
Q 038766 146 PSNILLDRDFEAHVSDFGTSRML 168 (299)
Q Consensus 146 ~~nil~~~~~~v~l~df~~~~~~ 168 (299)
..|+=||..|.|..-|+.-.+.+
T Consensus 460 ~KNFGVTRhgRVVFYDYDEI~yl 482 (578)
T 3eps_A 460 FKNFGVTRHGRVVFYDYDEICYM 482 (578)
T ss_dssp GGGEEECTTCCEEECCGGGCEES
T ss_pred cccCCccccceEEEecccceeee
Confidence 99999999999999999876643
|
Homologous Structure Domains
Structure Domains Detected by RPS-BLAST
Original result of RPS-BLAST against SCOP70(version1.75) database
| ID | Alignment Graph | Length |
Definition |
E-value |
| 299 | ||||
| d1uwha_ | 276 | d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens) | 2e-61 | |
| d1s9ja_ | 322 | d.144.1.7 (A:) Dual specificity mitogen-activated | 1e-55 | |
| d1fmka3 | 285 | d.144.1.7 (A:249-533) c-src tyrosine kinase {Human | 2e-55 | |
| d1qpca_ | 272 | d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Hom | 2e-55 | |
| d1sm2a_ | 263 | d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Hu | 1e-54 | |
| d2java1 | 269 | d.144.1.7 (A:3-271) Serine/threonine-protein kinas | 2e-54 | |
| d1k2pa_ | 258 | d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Hum | 4e-53 | |
| d1vjya_ | 303 | d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human | 1e-52 | |
| d1byga_ | 262 | d.144.1.7 (A:) Carboxyl-terminal src kinase (csk) | 1e-52 | |
| d1t4ha_ | 270 | d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sa | 2e-51 | |
| d1r0pa_ | 311 | d.144.1.7 (A:) Hepatocyte growth factor receptor, | 6e-51 | |
| d1xbba_ | 277 | d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human | 6e-51 | |
| d1jpaa_ | 299 | d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mou | 7e-51 | |
| d2j4za1 | 263 | d.144.1.7 (A:126-388) Aurora-related kinase 1 (aur | 2e-50 | |
| d1u59a_ | 285 | d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Hum | 5e-50 | |
| d1u5ra_ | 309 | d.144.1.7 (A:) Serine/threonine protein kinase TAO | 1e-49 | |
| d1yhwa1 | 293 | d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [ | 4e-49 | |
| d1lufa_ | 301 | d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus n | 6e-49 | |
| d1mqba_ | 283 | d.144.1.7 (A:) epha2 receptor tyrosine kinase {Hum | 1e-48 | |
| d1opja_ | 287 | d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mou | 5e-48 | |
| d1nvra_ | 271 | d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 { | 4e-47 | |
| d2jfla1 | 288 | d.144.1.7 (A:21-308) STE20-like serine/threonine-p | 6e-47 | |
| d1u46a_ | 273 | d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Hum | 3e-46 | |
| d1t46a_ | 311 | d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens | 3e-45 | |
| d1xkka_ | 317 | d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb- | 3e-45 | |
| d1rjba_ | 325 | d.144.1.7 (A:) Fl cytokine receptor {Human (Homo s | 3e-45 | |
| d1fvra_ | 309 | d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [ | 2e-44 | |
| d1mp8a_ | 273 | d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Huma | 2e-43 | |
| d1uu3a_ | 288 | d.144.1.7 (A:) 3-phosphoinositide dependent protei | 7e-43 | |
| d1a06a_ | 307 | d.144.1.7 (A:) Calmodulin-dependent protein kinase | 9e-43 | |
| d1koaa2 | 350 | d.144.1.7 (A:5915-6264) Twitchin, kinase domain {C | 1e-42 | |
| d1o6ya_ | 277 | d.144.1.7 (A:) Mycobacterial protein kinase PknB, | 3e-42 | |
| d1ua2a_ | 299 | d.144.1.7 (A:) Cell division protein kinase 7, CDK | 2e-41 | |
| d1p4oa_ | 308 | d.144.1.7 (A:) Insulin-like growth factor 1 recept | 3e-41 | |
| d1ob3a_ | 286 | d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmod | 5e-41 | |
| d1koba_ | 352 | d.144.1.7 (A:) Twitchin, kinase domain {California | 8e-41 | |
| d1q5ka_ | 350 | d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gs | 1e-39 | |
| d1ywna1 | 299 | d.144.1.7 (A:818-1166) Vascular endothelial growth | 1e-39 | |
| d1fgka_ | 299 | d.144.1.7 (A:) Fibroblast growth factor receptor 1 | 3e-39 | |
| d1tkia_ | 321 | d.144.1.7 (A:) Titin, kinase domain {Human (Homo s | 5e-39 | |
| d3blha1 | 318 | d.144.1.7 (A:8-325) Cell division protein kinase 9 | 2e-38 | |
| d1phka_ | 277 | d.144.1.7 (A:) gamma-subunit of glycogen phosphory | 2e-38 | |
| d1gz8a_ | 298 | d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (H | 3e-38 | |
| d1blxa_ | 305 | d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (H | 4e-38 | |
| d1xjda_ | 320 | d.144.1.7 (A:) Protein kinase C, theta type {Human | 2e-37 | |
| d1ckia_ | 299 | d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus n | 2e-37 | |
| d1fota_ | 316 | d.144.1.7 (A:) cAMP-dependent PK, catalytic subuni | 7e-37 | |
| d1omwa3 | 364 | d.144.1.7 (A:186-549) G-protein coupled receptor k | 9e-37 | |
| d1unla_ | 292 | d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (H | 1e-36 | |
| d1xwsa_ | 273 | d.144.1.7 (A:) Proto-oncogene serine/threonine-pro | 3e-36 | |
| d1csna_ | 293 | d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast | 3e-36 | |
| d2ozaa1 | 335 | d.144.1.7 (A:51-385) MAP kinase activated protein | 6e-36 | |
| d1pmea_ | 345 | d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapien | 3e-35 | |
| d1jksa_ | 293 | d.144.1.7 (A:) Death-associated protein kinase, Da | 1e-34 | |
| d1cm8a_ | 346 | d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo s | 1e-32 | |
| d3bqca1 | 328 | d.144.1.7 (A:3-330) Protein kinase CK2, alpha subu | 2e-31 | |
| d1o6la_ | 337 | d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sap | 3e-31 | |
| d1rdqe_ | 350 | d.144.1.7 (E:) cAMP-dependent PK, catalytic subuni | 1e-29 | |
| d2b1pa1 | 355 | d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3 | 4e-29 | |
| d1vzoa_ | 322 | d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5 | 4e-29 | |
| d2gfsa1 | 348 | d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sa | 9e-29 | |
| d1q8ya_ | 362 | d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces | 7e-22 | |
| d1zara2 | 191 | d.144.1.9 (A:91-281) Rio2 serine protein kinase C- | 5e-18 |
| >d1uwha_ d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 276 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: B-Raf kinase species: Human (Homo sapiens) [TaxId: 9606]
Score = 194 bits (494), Expect = 2e-61
Identities = 74/295 (25%), Positives = 130/295 (44%), Gaps = 35/295 (11%)
Query: 6 EIENATGSFSENNIIGNSNLSTVYKGRLEDGEIVAVKKLNFHQFSAESDKSFYREAKTLK 65
+ E G + IG+ + TVYKG+ VAVK LN + + ++F E L+
Sbjct: 2 DWEIPDGQITVGQRIGSGSFGTVYKGKWHGD--VAVKMLNVTAPTPQQLQAFKNEVGVLR 59
Query: 66 ELKHRNLVKVLGYAWESGKLKALILEYMENGSLESVIHGPGVDHSRWTLPKRIDVLISVA 125
+ +H N++ +GY + A++ ++ E SL +H +++ + K ID+ A
Sbjct: 60 KTRHVNILLFMGY--STAPQLAIVTQWCEGSSLYHHLHII---ETKFEMIKLIDIARQTA 114
Query: 126 NGLDYLHSGYDIPIVHCDMKPSNILLDRDFEAHVSDFGTSRMLDVHLQDLSSLSTAFQGT 185
G+DYLH I+H D+K +NI L D + DFG + + S G+
Sbjct: 115 QGMDYLH---AKSIIHRDLKSNNIFLHEDLTVKIGDFGLATVKSR--WSGSHQFEQLSGS 169
Query: 186 IGYLAPEFAYMR---IVTTKVDVFSFGIVVMEFLTKRRPTGLDEENGLSPISLRQLVEKA 242
I ++APE M+ + + DV++FGIV+ E +T + P S I+ R +
Sbjct: 170 ILWMAPEVIRMQDKNPYSFQSDVYAFGIVLYELMTGQLP--------YSNINNRDQIIFM 221
Query: 243 LANGINGVRQITDPKLVSSIYEEQEQHQVLEELFKLALVCTSSNPEDRPNMNELL 297
+ G P L + + + + +L C ++RP ++L
Sbjct: 222 VGRG------YLSPDL------SKVRSNCPKAMKRLMAECLKKKRDERPLFPQIL 264
|
| >d1s9ja_ d.144.1.7 (A:) Dual specificity mitogen-activated protein kinase kinase 1, Mek1 {Human (Homo sapiens) [TaxId: 9606]} Length = 322 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Dual specificity mitogen-activated protein kinase kinase 1, Mek1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 180 bits (458), Expect = 1e-55
Identities = 70/310 (22%), Positives = 125/310 (40%), Gaps = 33/310 (10%)
Query: 7 IENATGSFSENNIIGNSNLSTVYKGR-LEDGEIVAVKKLNFHQFSAESDKSFYREAKTLK 65
+E F + + +G N V+K G ++A K ++ + RE + L
Sbjct: 1 MELKDDDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIH-LEIKPAIRNQIIRELQVLH 59
Query: 66 ELKHRNLVKVLGYAWESGKLKALILEYMENGSLESVIHGPGVDHSRWTLPKRIDVLISVA 125
E +V G + G++ ++ +E+M+ GSL+ V+ R V I+V
Sbjct: 60 ECNSPYIVGFYGAFYSDGEI-SICMEHMDGGSLDQVLK----KAGRIPEQILGKVSIAVI 114
Query: 126 NGLDYLHSGYDIPIVHCDMKPSNILLDRDFEAHVSDFGTSRMLDVHLQDLSSLSTAFQGT 185
GL YL I+H D+KPSNIL++ E + DFG S L S++ +F GT
Sbjct: 115 KGLTYLRE--KHKIMHRDVKPSNILVNSRGEIKLCDFGVSGQLI------DSMANSFVGT 166
Query: 186 IGYLAPEFAYMRIVTTKVDVFSFGIVVMEFLTKRRP--------------TGLDEENGLS 231
Y++PE + + D++S G+ ++E R P ++ + +
Sbjct: 167 RSYMSPERLQGTHYSVQSDIWSMGLSLVEMAVGRYPIPPPDAKELELMFGCQVEGDAAET 226
Query: 232 PISLRQLVEKALANGINGVRQITDPKLVSSIYEEQ----EQHQVLEELFKLALVCTSSNP 287
P R + G++ + +L+ I E E C NP
Sbjct: 227 PPRPRTPGRPLSSYGMDSRPPMAIFELLDYIVNEPPPKLPSGVFSLEFQDFVNKCLIKNP 286
Query: 288 EDRPNMNELL 297
+R ++ +L+
Sbjct: 287 AERADLKQLM 296
|
| >d1fmka3 d.144.1.7 (A:249-533) c-src tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 285 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-src tyrosine kinase species: Human (Homo sapiens) [TaxId: 9606]
Score = 179 bits (455), Expect = 2e-55
Identities = 72/285 (25%), Positives = 118/285 (41%), Gaps = 37/285 (12%)
Query: 13 SFSENNIIGNSNLSTVYKGRLEDGEIVAVKKLNFHQFSAESDKSFYREAKTLKELKHRNL 72
S +G V+ G VA+K L S ++F +EA+ +K+L+H L
Sbjct: 18 SLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTLKP---GTMSPEAFLQEAQVMKKLRHEKL 74
Query: 73 VKVLGYAWESGKLKALILEYMENGSLESVIHGPGVDHSRWTLPKRIDVLISVANGLDYLH 132
V++ E ++ EYM GSL + G + R P+ +D+ +A+G+ Y+
Sbjct: 75 VQLYAVVSEEPIY--IVTEYMSKGSLLDFLKGETGKYLRL--PQLVDMAAQIASGMAYVE 130
Query: 133 SGYDIPIVHCDMKPSNILLDRDFEAHVSDFGTSRMLDVHLQDLSSLSTAFQGTIGYLAPE 192
+ VH D++ +NIL+ + V+DFG +R+++ + + + I + APE
Sbjct: 131 ---RMNYVHRDLRAANILVGENLVCKVADFGLARLIE---DNEYTARQGAKFPIKWTAPE 184
Query: 193 FAYMRIVTTKVDVFSFGIVVMEFLTKRRPTGLDEENGLSPISLRQLVEKALANGINGVRQ 252
A T K DV+SFGI++ E TK R G+ + VE+
Sbjct: 185 AALYGRFTIKSDVWSFGILLTELTTKGRVP----YPGMVNREVLDQVERG---------- 230
Query: 253 ITDPKLVSSIYEEQEQHQVLEELFKLALVCTSSNPEDRPNMNELL 297
Y + E L L C PE+RP L
Sbjct: 231 ----------YRMPCPPECPESLHDLMCQCWRKEPEERPTFEYLQ 265
|
| >d1qpca_ d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Homo sapiens) [TaxId: 9606]} Length = 272 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Lymphocyte kinase (lck) species: Human (Homo sapiens) [TaxId: 9606]
Score = 178 bits (453), Expect = 2e-55
Identities = 71/284 (25%), Positives = 122/284 (42%), Gaps = 37/284 (13%)
Query: 14 FSENNIIGNSNLSTVYKGRLEDGEIVAVKKLNFHQFSAESDKSFYREAKTLKELKHRNLV 73
+G V+ G VAVK L + S +F EA +K+L+H+ LV
Sbjct: 15 LKLVERLGAGQFGEVWMGYYNGHTKVAVKSLKQ---GSMSPDAFLAEANLMKQLQHQRLV 71
Query: 74 KVLGYAWESGKLKALILEYMENGSLESVIHGPGVDHSRWTLPKRIDVLISVANGLDYLHS 133
++ + +I EYMENGSL + P + T+ K +D+ +A G+ ++
Sbjct: 72 RLYAVVTQEPIY--IITEYMENGSLVDFLKTPS--GIKLTINKLLDMAAQIAEGMAFIEE 127
Query: 134 GYDIPIVHCDMKPSNILLDRDFEAHVSDFGTSRMLDVHLQDLSSLSTAFQGTIGYLAPEF 193
+H D++ +NIL+ ++DFG +R+++ + + + I + APE
Sbjct: 128 R---NYIHRDLRAANILVSDTLSCKIADFGLARLIE---DNEYTAREGAKFPIKWTAPEA 181
Query: 194 AYMRIVTTKVDVFSFGIVVMEFLTKRRPTGLDEENGLSPISLRQLVEKALANGINGVRQI 253
T K DV+SFGI++ E +T R G++ + Q +E+ ++
Sbjct: 182 INYGTFTIKSDVWSFGILLTEIVTHGRIP----YPGMTNPEVIQNLERGY--------RM 229
Query: 254 TDPKLVSSIYEEQEQHQVLEELFKLALVCTSSNPEDRPNMNELL 297
P EEL++L +C PEDRP + L
Sbjct: 230 VRPDNCP------------EELYQLMRLCWKERPEDRPTFDYLR 261
|
| >d1sm2a_ d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Human (Homo sapiens) [TaxId: 9606]} Length = 263 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase Itk/Tsk species: Human (Homo sapiens) [TaxId: 9606]
Score = 176 bits (446), Expect = 1e-54
Identities = 65/284 (22%), Positives = 122/284 (42%), Gaps = 37/284 (13%)
Query: 14 FSENNIIGNSNLSTVYKGRLEDGEIVAVKKLNFHQFSAESDKSFYREAKTLKELKHRNLV 73
+ IG+ V+ G + + VA+K + A S++ F EA+ + +L H LV
Sbjct: 7 LTFVQEIGSGQFGLVHLGYWLNKDKVAIKTIRE---GAMSEEDFIEEAEVMMKLSHPKLV 63
Query: 74 KVLGYAWESGKLKALILEYMENGSLESVIHGPGVDHSRWTLPKRIDVLISVANGLDYLHS 133
++ G E + L+ E+ME+G L + + + + + V G+ YL
Sbjct: 64 QLYGVCLEQAPI-CLVFEFMEHGCLSDYLRTQ---RGLFAAETLLGMCLDVCEGMAYLEE 119
Query: 134 GYDIPIVHCDMKPSNILLDRDFEAHVSDFGTSRMLDVHLQDLSSLSTAFQGTIGYLAPEF 193
++H D+ N L+ + VSDFG +R + D + ST + + + +PE
Sbjct: 120 A---CVIHRDLAARNCLVGENQVIKVSDFGMTRFVL---DDQYTSSTGTKFPVKWASPEV 173
Query: 194 AYMRIVTTKVDVFSFGIVVMEFLTKRRPTGLDEENGLSPISLRQLVEKALANGINGVRQI 253
++K DV+SFG+++ E ++ + + N ++VE I+ ++
Sbjct: 174 FSFSRYSSKSDVWSFGVLMWEVFSEGKIPYENRSN-------SEVVED-----ISTGFRL 221
Query: 254 TDPKLVSSIYEEQEQHQVLEELFKLALVCTSSNPEDRPNMNELL 297
P+L S ++++ C PEDRP + LL
Sbjct: 222 YKPRLAS------------THVYQIMNHCWKERPEDRPAFSRLL 253
|
| >d2java1 d.144.1.7 (A:3-271) Serine/threonine-protein kinase Nek2 {Human (Homo sapiens) [TaxId: 9606]} Length = 269 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Serine/threonine-protein kinase Nek2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 175 bits (446), Expect = 2e-54
Identities = 66/284 (23%), Positives = 111/284 (39%), Gaps = 33/284 (11%)
Query: 18 NIIGNSNLSTVYKGR-LEDGEIVAVKKLNFHQFSAESDKSFYREAKTLKELKHRNLVKVL 76
IG + K R DG+I+ K+L++ + + E L+ELKH N+V+
Sbjct: 10 YTIGTGSYGRCQKIRRKSDGKILVWKELDYGSMTEAEKQMLVSEVNLLRELKHPNIVRYY 69
Query: 77 GYAW-ESGKLKALILEYMENGSLESVIHGPGVDHSRWTLPKRIDVLISVANGLDYLHSGY 135
+ +++EY E G L SVI + + V+ + L H
Sbjct: 70 DRIIDRTNTTLYIVMEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLALKECHRRS 129
Query: 136 DI--PIVHCDMKPSNILLDRDFEAHVSDFGTSRMLDVHLQDLSSLSTAFQGTIGYLAPEF 193
D ++H D+KP+N+ LD + DFG +R+L+ +S + AF GT Y++PE
Sbjct: 130 DGGHTVLHRDLKPANVFLDGKQNVKLGDFGLARILN----HDTSFAKAFVGTPYYMSPEQ 185
Query: 194 AYMRIVTTKVDVFSFGIVVMEFLTKRRPTGLDEENGLSPISLRQLVEKALANGINGVRQI 253
K D++S G ++ E P S L + + I
Sbjct: 186 MNRMSYNEKSDIWSLGCLLYELCALMPPF-----TAFSQKELAGKIREGKFRRI------ 234
Query: 254 TDPKLVSSIYEEQEQHQVLEELFKLALVCTSSNPEDRPNMNELL 297
P S +EL ++ + RP++ E+L
Sbjct: 235 --PYRYS------------DELNEIITRMLNLKDYHRPSVEEIL 264
|
| >d1k2pa_ d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Human (Homo sapiens) [TaxId: 9606]} Length = 258 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Bruton's tyrosine kinase (Btk) species: Human (Homo sapiens) [TaxId: 9606]
Score = 172 bits (436), Expect = 4e-53
Identities = 57/284 (20%), Positives = 110/284 (38%), Gaps = 37/284 (13%)
Query: 14 FSENNIIGNSNLSTVYKGRLEDGEIVAVKKLNFHQFSAESDKSFYREAKTLKELKHRNLV 73
+ +G V G+ VA+K + + S+ F EAK + L H LV
Sbjct: 6 LTFLKELGTGQFGVVKYGKWRGQYDVAIKMIKE---GSMSEDEFIEEAKVMMNLSHEKLV 62
Query: 74 KVLGYAWESGKLKALILEYMENGSLESVIHGPGVDHSRWTLPKRIDVLISVANGLDYLHS 133
++ G + + +I EYM NG L + + R+ + +++ V ++YL
Sbjct: 63 QLYGVCTKQRPI-FIITEYMANGCLLNYLREM---RHRFQTQQLLEMCKDVCEAMEYLE- 117
Query: 134 GYDIPIVHCDMKPSNILLDRDFEAHVSDFGTSRMLDVHLQDLSSLSTAFQGTIGYLAPEF 193
+H D+ N L++ VSDFG SR + D + S + + + PE
Sbjct: 118 --SKQFLHRDLAARNCLVNDQGVVKVSDFGLSRYVL---DDEYTSSVGSKFPVRWSPPEV 172
Query: 194 AYMRIVTTKVDVFSFGIVVMEFLTKRRPTGLDEENGLSPISLRQLVEKALANGINGVRQI 253
++K D+++FG+++ E + + + + + + L ++
Sbjct: 173 LMYSKFSSKSDIWAFGVLMWEIYSLGKMP----YERFTNSETAEHIAQGL--------RL 220
Query: 254 TDPKLVSSIYEEQEQHQVLEELFKLALVCTSSNPEDRPNMNELL 297
P L S E+++ + C ++RP LL
Sbjct: 221 YRPHLAS------------EKVYTIMYSCWHEKADERPTFKILL 252
|
| >d1vjya_ d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human (Homo sapiens) [TaxId: 9606]} Length = 303 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Type I TGF-beta receptor R4 species: Human (Homo sapiens) [TaxId: 9606]
Score = 172 bits (437), Expect = 1e-52
Identities = 62/292 (21%), Positives = 111/292 (38%), Gaps = 27/292 (9%)
Query: 20 IGNSNLSTVYKGRLEDGEIVAVKKLNFHQFSAESDKSFYREAKTLKELKHRNLVKVLGYA 79
IG V++G+ GE VAVK + + E E L+H N++ +
Sbjct: 11 IGKGRFGEVWRGKW-RGEEVAVKIFSSRE---ERSWFREAEIYQTVMLRHENILGFIAAD 66
Query: 80 WESGKLKA---LILEYMENGSLESVIHGPGVDHSRWTLPKRIDVLISVANGLDYLHSGY- 135
+ L+ +Y E+GSL ++ V T+ I + +S A+GL +LH
Sbjct: 67 NKDNGTWTQLWLVSDYHEHGSLFDYLNRYTV-----TVEGMIKLALSTASGLAHLHMEIV 121
Query: 136 ----DIPIVHCDMKPSNILLDRDFEAHVSDFGTSRMLDVHLQDLSSLSTAFQGTIGYLAP 191
I H D+K NIL+ ++ ++D G + D + GT Y+AP
Sbjct: 122 GTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVRHDSATDTIDIAPNHRVGTKRYMAP 181
Query: 192 EFAYMRI------VTTKVDVFSFGIVVMEFLTKRRPTGLDEENGLSPISLRQLVEKALAN 245
E I + D+++ G+V E + G+ E+ P + ++
Sbjct: 182 EVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHED-YQLPYYDLVPSDPSVEE 240
Query: 246 GINGVRQITDPKLVSSIYEEQEQHQVLEELFKLALVCTSSNPEDRPNMNELL 297
+ + KL +I + + L + K+ C +N R +
Sbjct: 241 MRKV---VCEQKLRPNIPNRWQSCEALRVMAKIMRECWYANGAARLTALRIK 289
|
| >d1byga_ d.144.1.7 (A:) Carboxyl-terminal src kinase (csk) {Human (Homo sapiens) [TaxId: 9606]} Length = 262 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Carboxyl-terminal src kinase (csk) species: Human (Homo sapiens) [TaxId: 9606]
Score = 170 bits (433), Expect = 1e-52
Identities = 66/280 (23%), Positives = 108/280 (38%), Gaps = 41/280 (14%)
Query: 18 NIIGNSNLSTVYKGRLEDGEIVAVKKLNFHQFSAESDKSFYREAKTLKELKHRNLVKVLG 77
IG V G G VAVK + + + ++F EA + +L+H NLV++LG
Sbjct: 13 QTIGKGEFGDVMLGDY-RGNKVAVKCIK----NDATAQAFLAEASVMTQLRHSNLVQLLG 67
Query: 78 YAWESGKLKALILEYMENGSLESVIHGPGVDHSRWTLPKRIDVLISVANGLDYLHSGYDI 137
E ++ EYM GSL + G S + + V ++YL
Sbjct: 68 VIVEEKGGLYIVTEYMAKGSLVDYLRSRG--RSVLGGDCLLKFSLDVCEAMEYLEG---N 122
Query: 138 PIVHCDMKPSNILLDRDFEAHVSDFGTSRMLDVHLQDLSSLSTAFQGTIGYLAPEFAYMR 197
VH D+ N+L+ D A VSDFG ++ + SS + + + APE +
Sbjct: 123 NFVHRDLAARNVLVSEDNVAKVSDFGLTK-------EASSTQDTGKLPVKWTAPEALREK 175
Query: 198 IVTTKVDVFSFGIVVMEFLTKRRPTGLDEENGLSPISLRQLVEKALANGINGVRQITDPK 257
+TK DV+SFGI++ E + R + + VEK
Sbjct: 176 KFSTKSDVWSFGILLWEIYSFGRVP----YPRIPLKDVVPRVEKG--------------- 216
Query: 258 LVSSIYEEQEQHQVLEELFKLALVCTSSNPEDRPNMNELL 297
Y+ ++++ C + RP+ +L
Sbjct: 217 -----YKMDAPDGCPPAVYEVMKNCWHLDAAMRPSFLQLR 251
|
| >d1t4ha_ d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 270 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase wnk1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 168 bits (426), Expect = 2e-51
Identities = 67/286 (23%), Positives = 116/286 (40%), Gaps = 40/286 (13%)
Query: 17 NNIIGNSNLSTVYKGRL-EDGEIVAVKKLNFHQFSAESDKSFYREAKTLKELKHRNLVKV 75
+ IG + TVYKG E VA +L + + + F EA+ LK L+H N+V+
Sbjct: 14 DIEIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQHPNIVRF 73
Query: 76 LGYAWESGKLK---ALILEYMENGSLESVIHGPGVDHSRWTLPKRIDVLISVANGLDYLH 132
+ K K L+ E M +G+L++ + + + GL +LH
Sbjct: 74 YDSWESTVKGKKCIVLVTELMTSGTLKTYLK----RFKVMKIKVLRSWCRQILKGLQFLH 129
Query: 133 SGYDIPIVHCDMKPSNILL-DRDFEAHVSDFGTSRMLDVHLQDLSSLSTAFQGTIGYLAP 191
+ PI+H D+K NI + + D G + + +S + A GT ++AP
Sbjct: 130 T-RTPPIIHRDLKCDNIFITGPTGSVKIGDLGLATLKR------ASFAKAVIGTPEFMAP 182
Query: 192 EFAYMRIVTTKVDVFSFGIVVMEFLTKRRPTGLDEENGLSPISLRQLVEKALANGINGVR 251
E Y VDV++FG+ ++E T P S Q + +GV+
Sbjct: 183 E-MYEEKYDESVDVYAFGMCMLEMATSEY-----------PYSECQNAAQIYRRVTSGVK 230
Query: 252 QITDPKLVSSIYEEQEQHQVLEELFKLALVCTSSNPEDRPNMNELL 297
+ K+ E+ ++ C N ++R ++ +LL
Sbjct: 231 PASFDKVAI------------PEVKEIIEGCIRQNKDERYSIKDLL 264
|
| >d1r0pa_ d.144.1.7 (A:) Hepatocyte growth factor receptor, c-MET {Human (Homo sapiens) [TaxId: 9606]} Length = 311 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Hepatocyte growth factor receptor, c-MET species: Human (Homo sapiens) [TaxId: 9606]
Score = 168 bits (426), Expect = 6e-51
Identities = 72/285 (25%), Positives = 116/285 (40%), Gaps = 35/285 (12%)
Query: 17 NNIIGNSNLSTVYKGRLED----GEIVAVKKLNFHQFSAESDKSFYREAKTLKELKHRNL 72
N +IG + VY G L D AVK LN F E +K+ H N+
Sbjct: 32 NEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLN-RITDIGEVSQFLTEGIIMKDFSHPNV 90
Query: 73 VKVLGYAWESGKLKALILEYMENGSLESVIHGPGVDHSRWTLPKRIDVLISVANGLDYLH 132
+ +LG S ++L YM++G L + I T+ I + VA G+ +L
Sbjct: 91 LSLLGICLRSEGSPLVVLPYMKHGDLRNFIRNET---HNPTVKDLIGFGLQVAKGMKFLA 147
Query: 133 SGYDIPIVHCDMKPSNILLDRDFEAHVSDFGTSRMLDVHLQDLSSLSTAFQGTIGYLAPE 192
VH D+ N +LD F V+DFG +R + D T + + ++A E
Sbjct: 148 ---SKKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEFDSVHNKTGAKLPVKWMALE 204
Query: 193 FAYMRIVTTKVDVFSFGIVVMEFLTKRRPTGLDEENGLSPISLRQLVEKALANGINGVRQ 252
+ TTK DV+SFG+++ E +T+ P D + + L R+
Sbjct: 205 SLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDV-------NTFDITVYLLQG-----RR 252
Query: 253 ITDPKLVSSIYEEQEQHQVLEELFKLALVCTSSNPEDRPNMNELL 297
+ P+ + L+++ L C E RP+ +EL+
Sbjct: 253 LLQPEYCP------------DPLYEVMLKCWHPKAEMRPSFSELV 285
|
| >d1xbba_ d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human (Homo sapiens) [TaxId: 9606]} Length = 277 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase SYK species: Human (Homo sapiens) [TaxId: 9606]
Score = 167 bits (423), Expect = 6e-51
Identities = 61/285 (21%), Positives = 115/285 (40%), Gaps = 37/285 (12%)
Query: 16 ENNIIGNSNLSTVYKGRLED---GEIVAVKKLNFHQFSAESDKSFYREAKTLKELKHRNL 72
E+ +G+ N TV KG + + VAVK L EA +++L + +
Sbjct: 11 EDKELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYI 70
Query: 73 VKVLGYAWESGKLKALILEYMENGSLESVIHGPGVDHSRWTLPKRIDVLISVANGLDYLH 132
V+++G + L++E E G L + + I+++ V+ G+ YL
Sbjct: 71 VRMIGICEAESWM--LVMEMAELGPLNKYLQ----QNRHVKDKNIIELVHQVSMGMKYLE 124
Query: 133 SGYDIPIVHCDMKPSNILLDRDFEAHVSDFGTSRMLDVHLQDLSSLSTAFQGTIGYLAPE 192
+ VH D+ N+LL A +SDFG S+ L ++ T + + + APE
Sbjct: 125 ---ESNFVHRDLAARNVLLVTQHYAKISDFGLSKALRAD-ENYYKAQTHGKWPVKWYAPE 180
Query: 193 FAYMRIVTTKVDVFSFGIVVMEFLTKRRPTGLDEENGLSPISLRQLVEKALANGINGVRQ 252
++K DV+SFG+++ E + + G+ + ++EK +
Sbjct: 181 CINYYKFSSKSDVWSFGVLMWEAFSYGQKP----YRGMKGSEVTAMLEKG--------ER 228
Query: 253 ITDPKLVSSIYEEQEQHQVLEELFKLALVCTSSNPEDRPNMNELL 297
+ P E++ L +C + + E+RP +
Sbjct: 229 MGCPAGCP------------REMYDLMNLCWTYDVENRPGFAAVE 261
|
| >d1jpaa_ d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mouse (Mus musculus) [TaxId: 10090]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: ephb2 receptor tyrosine kinase species: Mouse (Mus musculus) [TaxId: 10090]
Score = 168 bits (425), Expect = 7e-51
Identities = 70/306 (22%), Positives = 125/306 (40%), Gaps = 46/306 (15%)
Query: 6 EIENATGSFSEN---------NIIGNSNLSTVYKGRL----EDGEIVAVKKLNFHQFSAE 52
+ A F++ +IG V G L + VA+K L ++ +
Sbjct: 11 DPNEAVREFAKEIDISCVKIEQVIGAGEFGEVCSGHLKLPGKREIFVAIKTLK-SGYTEK 69
Query: 53 SDKSFYREAKTLKELKHRNLVKVLGYAWESGKLKALILEYMENGSLESVIHGPGVDHSRW 112
+ F EA + + H N++ + G +S + +I E+MENGSL+S + + ++
Sbjct: 70 QRRDFLSEASIMGQFDHPNVIHLEGVVTKSTPV-MIITEFMENGSLDSFLRQ---NDGQF 125
Query: 113 TLPKRIDVLISVANGLDYLHSGYDIPIVHCDMKPSNILLDRDFEAHVSDFGTSRML-DVH 171
T+ + + +L +A G+ YL D+ VH D+ NIL++ + VSDFG SR L D
Sbjct: 126 TVIQLVGMLRGIAAGMKYLA---DMNYVHRDLAARNILVNSNLVCKVSDFGLSRFLEDDT 182
Query: 172 LQDLSSLSTAFQGTIGYLAPEFAYMRIVTTKVDVFSFGIVVMEFLTKRRPTGLDEENGLS 231
+ + + I + APE R T+ DV+S+GIV+ E ++ ++
Sbjct: 183 SDPTYTSALGGKIPIRWTAPEAIQYRKFTSASDVWSYGIVMWEVMSYGERP----YWDMT 238
Query: 232 PISLRQLVEKALANGINGVRQITDPKLVSSIYEEQEQHQVLEELFKLALVCTSSNPEDRP 291
+ +E+ Y L +L L C + RP
Sbjct: 239 NQDVINAIEQD--------------------YRLPPPMDCPSALHQLMLDCWQKDRNHRP 278
Query: 292 NMNELL 297
+++
Sbjct: 279 KFGQIV 284
|
| >d2j4za1 d.144.1.7 (A:126-388) Aurora-related kinase 1 (aurora-2) {Human (Homo sapiens) [TaxId: 9606]} Length = 263 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Aurora-related kinase 1 (aurora-2) species: Human (Homo sapiens) [TaxId: 9606]
Score = 165 bits (419), Expect = 2e-50
Identities = 71/282 (25%), Positives = 114/282 (40%), Gaps = 42/282 (14%)
Query: 18 NIIGNSNLSTVYKGRL-EDGEIVAVKKLNFHQFSAESD-KSFYREAKTLKELKHRNLVKV 75
+G VY R + I+A+K L Q RE + L+H N++++
Sbjct: 12 RPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRL 71
Query: 76 LGYAWESGKLKALILEYMENGSLESVIHGPGVDHSRWTLPKRIDVLISVANGLDYLHSGY 135
GY ++ ++ LILEY G++ + S++ + + +AN L Y HS
Sbjct: 72 YGYFHDATRV-YLILEYAPLGTVYRELQ----KLSKFDEQRTATYITELANALSYCHSK- 125
Query: 136 DIPIVHCDMKPSNILLDRDFEAHVSDFGTSRMLDVHLQDLSSLSTAFQGTIGYLAPEFAY 195
++H D+KP N+LL E ++DFG S SS T GT+ YL PE
Sbjct: 126 --RVIHRDIKPENLLLGSAGELKIADFGWSVHAP------SSRRTTLCGTLDYLPPEMIE 177
Query: 196 MRIVTTKVDVFSFGIVVMEFLTKRRPTGLDEENGLSPISLRQLVEKALANGINGVRQITD 255
R+ KVD++S G++ EFL + P + + + + + T
Sbjct: 178 GRMHDEKVDLWSLGVLCYEFLVGKPPF-----EANTYQETYKRISRV---------EFTF 223
Query: 256 PKLVSSIYEEQEQHQVLEELFKLALVCTSSNPEDRPNMNELL 297
P V+ E L NP RP + E+L
Sbjct: 224 PDFVT------------EGARDLISRLLKHNPSQRPMLREVL 253
|
| >d1u59a_ d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Human (Homo sapiens) [TaxId: 9606]} Length = 285 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase ZAP-70 species: Human (Homo sapiens) [TaxId: 9606]
Score = 165 bits (418), Expect = 5e-50
Identities = 58/285 (20%), Positives = 111/285 (38%), Gaps = 37/285 (12%)
Query: 16 ENNIIGNSNLSTVYKGRL---EDGEIVAVKKLNFHQFSAESDKSFYREAKTLKELKHRNL 72
+ +G N +V +G + VA+K L + REA+ + +L + +
Sbjct: 13 ADIELGCGNFGSVRQGVYRMRKKQIDVAIKVLK-QGTEKADTEEMMREAQIMHQLDNPYI 71
Query: 73 VKVLGYAWESGKLKALILEYMENGSLESVIHGPGVDHSRWTLPKRIDVLISVANGLDYLH 132
V+++G + L++E G L + G + ++L V+ G+ YL
Sbjct: 72 VRLIGVCQAEALM--LVMEMAGGGPLHKFLVGK---REEIPVSNVAELLHQVSMGMKYLE 126
Query: 133 SGYDIPIVHCDMKPSNILLDRDFEAHVSDFGTSRMLDVHLQDLSSLSTAFQGTIGYLAPE 192
+ VH D+ N+LL A +SDFG S+ L + +A + + + APE
Sbjct: 127 ---EKNFVHRDLAARNVLLVNRHYAKISDFGLSKALGAD-DSYYTARSAGKWPLKWYAPE 182
Query: 193 FAYMRIVTTKVDVFSFGIVVMEFLTKRRPTGLDEENGLSPISLRQLVEKALANGINGVRQ 252
R +++ DV+S+G+ + E L+ + + + +E+ ++
Sbjct: 183 CINFRKFSSRSDVWSYGVTMWEALSYGQK----PYKKMKGPEVMAFIEQG--------KR 230
Query: 253 ITDPKLVSSIYEEQEQHQVLEELFKLALVCTSSNPEDRPNMNELL 297
+ P EL+ L C EDRP+ +
Sbjct: 231 MECPPECP------------PELYALMSDCWIYKWEDRPDFLTVE 263
|
| >d1u5ra_ d.144.1.7 (A:) Serine/threonine protein kinase TAO2 {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 309 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Serine/threonine protein kinase TAO2 species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 164 bits (417), Expect = 1e-49
Identities = 66/295 (22%), Positives = 113/295 (38%), Gaps = 45/295 (15%)
Query: 8 ENATGSFSENNIIGNSNLSTVYKGR-LEDGEIVAVKKLNFHQF-SAESDKSFYREAKTLK 65
++ FS+ IG+ + VY R + + E+VA+KK+++ S E + +E + L+
Sbjct: 11 DDPEKLFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQ 70
Query: 66 ELKHRNLVKVLGYAWESGKLKALILEYMENGSLESVIHGPGVDHSRWTLPKRIDVLISVA 125
+L+H N ++ G L++EY + + + + V
Sbjct: 71 KLRHPNTIQYRGCYLREHTA-WLVMEYCLGSASDLLEVHKK----PLQEVEIAAVTHGAL 125
Query: 126 NGLDYLHSGYDIPIVHCDMKPSNILLDRDFEAHVSDFGTSRMLDVHLQDLSSLSTAFQGT 185
GL YLHS ++H D+K NILL + DFG++ ++ + +F GT
Sbjct: 126 QGLAYLHS---HNMIHRDVKAGNILLSEPGLVKLGDFGSASIMAP--------ANSFVGT 174
Query: 186 IGYLAPEFA---YMRIVTTKVDVFSFGIVVMEFLTKRRPTGLDEENGLSPISLRQLVEKA 242
++APE KVDV+S GI +E ++ P ++ +S
Sbjct: 175 PYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPL-----FNMNAMSA------- 222
Query: 243 LANGINGVRQITDPKLVSSIYEEQEQHQVLEELFKLALVCTSSNPEDRPNMNELL 297
L + S E C P+DRP LL
Sbjct: 223 LYHIAQNESPALQSGHWS------------EYFRNFVDSCLQKIPQDRPTSEVLL 265
|
| >d1yhwa1 d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [TaxId: 9606]} Length = 293 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: pak1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 163 bits (413), Expect = 4e-49
Identities = 65/293 (22%), Positives = 115/293 (39%), Gaps = 39/293 (13%)
Query: 6 EIENATGSFSENNIIGNSNLSTVYKGR-LEDGEIVAVKKLNFHQFSAESDKSFYREAKTL 64
+ + ++ IG TVY + G+ VA++++N Q + E +
Sbjct: 14 SVGDPKKKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQ--QPKKELIINEILVM 71
Query: 65 KELKHRNLVKVLGYAWESGKLKALILEYMENGSLESVIHGPGVDHSRWTLPKRIDVLISV 124
+E K+ N+V L +L +++EY+ GSL V+ + + V
Sbjct: 72 RENKNPNIVNYLDSYLVGDEL-WVVMEYLAGGSLTDVVT-----ETCMDEGQIAAVCREC 125
Query: 125 ANGLDYLHSGYDIPIVHCDMKPSNILLDRDFEAHVSDFGTSRMLDVHLQDLSSLSTAFQG 184
L++LHS ++H D+K NILL D ++DFG + S + G
Sbjct: 126 LQALEFLHS---NQVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPE----QSKRSTMVG 178
Query: 185 TIGYLAPEFAYMRIVTTKVDVFSFGIVVMEFLTKRRPTGLDEENGLSPISLRQLVEKALA 244
T ++APE + KVD++S GI+ +E + P +P+ L+
Sbjct: 179 TPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMIEGEPPY-----LNENPLRALYLIAT--- 230
Query: 245 NGINGVRQITDPKLVSSIYEEQEQHQVLEELFKLALVCTSSNPEDRPNMNELL 297
NG ++ +P+ +S C + E R + ELL
Sbjct: 231 ---NGTPELQNPEKLS------------AIFRDFLNRCLDMDVEKRGSAKELL 268
|
| >d1lufa_ d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 301 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Musk tyrosine kinase species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 162 bits (411), Expect = 6e-49
Identities = 67/318 (21%), Positives = 112/318 (35%), Gaps = 57/318 (17%)
Query: 6 EIENATGSFSENNIIGNSNLSTVYKGRL------EDGEIVAVKKLNFHQFSAESDKSFYR 59
+E + IG V++ R E +VAVK L + SA+ F R
Sbjct: 7 SLEYPRNNIEYVRDIGEGAFGRVFQARAPGLLPYEPFTMVAVKMLK-EEASADMQADFQR 65
Query: 60 EAKTLKELKHRNLVKVLGYAWESGKLKALILEYMENGSLESVIHGPGVD----------- 108
EA + E + N+VK+LG + L+ EYM G L +
Sbjct: 66 EAALMAEFDNPNIVKLLGVCAVGKPM-CLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLS 124
Query: 109 ---------HSRWTLPKRIDVLISVANGLDYLHSGYDIPIVHCDMKPSNILLDRDFEAHV 159
+ +++ + VA G+ YL VH D+ N L+ + +
Sbjct: 125 TRARVSSPGPPPLSCAEQLCIARQVAAGMAYLSE---RKFVHRDLATRNCLVGENMVVKI 181
Query: 160 SDFGTSRMLDVHLQDLSSLSTAFQGTIGYLAPEFAYMRIVTTKVDVFSFGIVVMEFLTKR 219
+DFG SR + D I ++ PE + TT+ DV+++G+V+ E +
Sbjct: 182 ADFGLSRNIYS--ADYYKADGNDAIPIRWMPPESIFYNRYTTESDVWAYGVVLWEIFSYG 239
Query: 220 RPTGLDEENGLSPISLRQLVEKALANGINGVRQITDPKLVSSIYEEQEQHQVLEELFKLA 279
G++ + V + P+ EL+ L
Sbjct: 240 LQP----YYGMAHEEVIYYVRDG--------NILACPENCP------------LELYNLM 275
Query: 280 LVCTSSNPEDRPNMNELL 297
+C S P DRP+ +
Sbjct: 276 RLCWSKLPADRPSFCSIH 293
|
| >d1mqba_ d.144.1.7 (A:) epha2 receptor tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 283 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: epha2 receptor tyrosine kinase species: Human (Homo sapiens) [TaxId: 9606]
Score = 161 bits (408), Expect = 1e-48
Identities = 68/298 (22%), Positives = 124/298 (41%), Gaps = 40/298 (13%)
Query: 5 TEIENATGSFSENNIIGNSNLSTVYKGRLEDGE-----IVAVKKLNFHQFSAESDKSFYR 59
TEI + +IG VYKG L+ VA+K L ++ + F
Sbjct: 2 TEIH--PSCVTRQKVIGAGEFGEVYKGMLKTSSGKKEVPVAIKTLK-AGYTEKQRVDFLG 58
Query: 60 EAKTLKELKHRNLVKVLGYAWESGKLKALILEYMENGSLESVIHGPGVDHSRWTLPKRID 119
EA + + H N++++ G + + +I EYMENG+L+ + +++ + +
Sbjct: 59 EAGIMGQFSHHNIIRLEGVISKYKPM-MIITEYMENGALDKFLREK---DGEFSVLQLVG 114
Query: 120 VLISVANGLDYLHSGYDIPIVHCDMKPSNILLDRDFEAHVSDFGTSRMLDVHLQDLSSLS 179
+L +A G+ YL + + VH D+ NIL++ + VSDFG SR+L+ + + +
Sbjct: 115 MLRGIAAGMKYLAN---MNYVHRDLAARNILVNSNLVCKVSDFGLSRVLE-DDPEATYTT 170
Query: 180 TAFQGTIGYLAPEFAYMRIVTTKVDVFSFGIVVMEFLTKRRPTGLDEENGLSPISLRQLV 239
+ + I + APE R T+ DV+SFGIV+ E +T LS + + +
Sbjct: 171 SGGKIPIRWTAPEAISYRKFTSASDVWSFGIVMWEVMTYGERP----YWELSNHEVMKAI 226
Query: 240 EKALANGINGVRQITDPKLVSSIYEEQEQHQVLEELFKLALVCTSSNPEDRPNMNELL 297
+ +++L + C RP +++
Sbjct: 227 NDG--------------------FRLPTPMDCPSAIYQLMMQCWQQERARRPKFADIV 264
|
| >d1opja_ d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mouse (Mus musculus) [TaxId: 10090]} Length = 287 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Abelsone tyrosine kinase (abl) species: Mouse (Mus musculus) [TaxId: 10090]
Score = 159 bits (404), Expect = 5e-48
Identities = 67/297 (22%), Positives = 122/297 (41%), Gaps = 39/297 (13%)
Query: 2 FDRTEIENATGSFSENNIIGNSNLSTVYKGRLED-GEIVAVKKLNFHQFSAESDKSFYRE 60
+D+ E+E + + +G VY+G + VAVK L + F +E
Sbjct: 9 YDKWEMERT--DITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKE---DTMEVEEFLKE 63
Query: 61 AKTLKELKHRNLVKVLGYAWESGKLKALILEYMENGSLESVIHGPGVDHSRWTLPKRIDV 120
A +KE+KH NLV++LG +I E+M G+L + + + +
Sbjct: 64 AAVMKEIKHPNLVQLLGVCTREPPFY-IITEFMTYGNLLDYLRECN--RQEVSAVVLLYM 120
Query: 121 LISVANGLDYLHSGYDIPIVHCDMKPSNILLDRDFEAHVSDFGTSRMLDVHLQDLSSLST 180
+++ ++YL +H D+ N L+ + V+DFG SR++ D +
Sbjct: 121 ATQISSAMEYLEK---KNFIHRDLAARNCLVGENHLVKVADFGLSRLMT---GDTYTAHA 174
Query: 181 AFQGTIGYLAPEFAYMRIVTTKVDVFSFGIVVMEFLTKRRPTGLDEENGLSPISLRQLVE 240
+ I + APE + K DV++FG+++ E T G+ + +L+E
Sbjct: 175 GAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSP----YPGIDLSQVYELLE 230
Query: 241 KALANGINGVRQITDPKLVSSIYEEQEQHQVLEELFKLALVCTSSNPEDRPNMNELL 297
K ++ P+ E++++L C NP DRP+ E+
Sbjct: 231 KDY--------RMERPEGCP------------EKVYELMRACWQWNPSDRPSFAEIH 267
|
| >d1nvra_ d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 271 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell cycle checkpoint kinase chk1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 157 bits (397), Expect = 4e-47
Identities = 65/290 (22%), Positives = 101/290 (34%), Gaps = 40/290 (13%)
Query: 14 FSEN----NIIGNSNLSTVYKGR-LEDGEIVAVKKLNFHQFSAESDKSFYREAKTLKELK 68
F E+ +G V E VAVK ++ + + + ++ +E K L
Sbjct: 3 FVEDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKR-AVDCPENIKKEICINKMLN 61
Query: 69 HRNLVKVLGYAWESGKLKALILEYMENGSLESVIHGPGVDHSRWTLPKRIDVLISVANGL 128
H N+VK G+ E L LEY G L I P + G+
Sbjct: 62 HENVVKFYGHRREGNIQ-YLFLEYCSGGELFDRIE----PDIGMPEPDAQRFFHQLMAGV 116
Query: 129 DYLHSGYDIPIVHCDMKPSNILLDRDFEAHVSDFGTSRMLDVHLQDLSSLSTAFQGTIGY 188
YLH I I H D+KP N+LLD +SDFG + + + ++ L GT+ Y
Sbjct: 117 VYLHG---IGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRE--RLLNKMCGTLPY 171
Query: 189 LAPE-FAYMRIVTTKVDVFSFGIVVMEFLTKRRPTGLDEENGLSPISLRQLVEKALANGI 247
+APE VDV+S GIV+ L P ++ + ++
Sbjct: 172 VAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDS-----------CQEYSDWK 220
Query: 248 NGVRQITDPKLVSSIYEEQEQHQVLEELFKLALVCTSSNPEDRPNMNELL 297
+ K + L NP R + ++
Sbjct: 221 EKKTYLNPWKKID------------SAPLALLHKILVENPSARITIPDIK 258
|
| >d2jfla1 d.144.1.7 (A:21-308) STE20-like serine/threonine-protein kinase, SLK {Human (Homo sapiens) [TaxId: 9606]} Length = 288 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: STE20-like serine/threonine-protein kinase, SLK species: Human (Homo sapiens) [TaxId: 9606]
Score = 157 bits (398), Expect = 6e-47
Identities = 63/284 (22%), Positives = 107/284 (37%), Gaps = 42/284 (14%)
Query: 20 IGNSNLSTVYKGR-LEDGEIVAVKKLNFHQFSAESDKSFYREAKTLKELKHRNLVKVLGY 78
+G+ VYK + E + A K ++ S E + + E L H N+VK+L
Sbjct: 20 LGDGAFGKVYKAQNKETSVLAAAKVIDTK--SEEELEDYMVEIDILASCDHPNIVKLLDA 77
Query: 79 AWESGKLKALILEYMENGSLESVIHGPGVDHSRWTLPKRIDVLISVANGLDYLHSGYDIP 138
+ L +++E+ G++++V+ T + V + L+YLH
Sbjct: 78 FYYENNL-WILIEFCAGGAVDAVMLEL---ERPLTESQIQVVCKQTLDALNYLHDN---K 130
Query: 139 IVHCDMKPSNILLDRDFEAHVSDFGTSRMLDVHLQDLSSLSTAFQGTIGYLAPEFAYM-- 196
I+H D+K NIL D + ++DFG S +F GT ++APE
Sbjct: 131 IIHRDLKAGNILFTLDGDIKLADFGVSAKNT----RTIQRRDSFIGTPYWMAPEVVMCET 186
Query: 197 ---RIVTTKVDVFSFGIVVMEFLTKRRPTGLDEENGLSPISLRQLVEKALANGINGVRQI 253
R K DV+S GI ++E P + L+P+ + + K + +
Sbjct: 187 SKDRPYDYKADVWSLGITLIEMAEIEPP-----HHELNPMRVLLKIAK------SEPPTL 235
Query: 254 TDPKLVSSIYEEQEQHQVLEELFKLALVCTSSNPEDRPNMNELL 297
P S C N + R ++LL
Sbjct: 236 AQPSRWS------------SNFKDFLKKCLEKNVDARWTTSQLL 267
|
| >d1u46a_ d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Human (Homo sapiens) [TaxId: 9606]} Length = 273 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Activated CDC42 kinase 1, ACK1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 155 bits (392), Expect = 3e-46
Identities = 61/283 (21%), Positives = 104/283 (36%), Gaps = 37/283 (13%)
Query: 20 IGNSNLSTVYKGRLE----DGEIVAVKKLNFHQFSAESD-KSFYREAKTLKELKHRNLVK 74
+G+ + V +G + VAVK L S F RE + L HRNL++
Sbjct: 16 LGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNLIR 75
Query: 75 VLGYAWESGKLKALILEYMENGSLESVIHGPGVDHSRWTLPKRIDVLISVANGLDYLHSG 134
+ G + +K ++ E GSL + + L + VA G+ YL S
Sbjct: 76 LYGV-VLTPPMK-MVTELAPLGSLLDRLRK---HQGHFLLGTLSRYAVQVAEGMGYLES- 129
Query: 135 YDIPIVHCDMKPSNILLDRDFEAHVSDFGTSRMLDVHLQDLSSLSTAFQGTIGYLAPEFA 194
+H D+ N+LL + DFG R L D + + + APE
Sbjct: 130 --KRFIHRDLAARNLLLATRDLVKIGDFGLMRALP-QNDDHYVMQEHRKVPFAWCAPESL 186
Query: 195 YMRIVTTKVDVFSFGIVVMEFLTKRRPTGLDEENGLSPISLRQLVEKALANGINGVRQIT 254
R + D + FG+ + E T + + + Q++ K G ++
Sbjct: 187 KTRTFSHASDTWMFGVTLWEMFTYGQEPWIGL-------NGSQILHKIDKEG----ERLP 235
Query: 255 DPKLVSSIYEEQEQHQVLEELFKLALVCTSSNPEDRPNMNELL 297
P+ ++++ + + C + PEDRP L
Sbjct: 236 RPEDCP------------QDIYNVMVQCWAHKPEDRPTFVALR 266
|
| >d1t46a_ d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 311 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-KIT receptor species: Human (Homo sapiens) [TaxId: 9606]
Score = 153 bits (387), Expect = 3e-45
Identities = 59/305 (19%), Positives = 101/305 (33%), Gaps = 51/305 (16%)
Query: 14 FSENNIIGNSNLSTVYKGRL------EDGEIVAVKKLNFHQFSAESDKSFYREAKTLKEL 67
S +G V + + VAVK L E ++ E K L L
Sbjct: 25 LSFGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAHLTE-REALMSELKVLSYL 83
Query: 68 K-HRNLVKVLGYAWESGKLKALILEYMENGSLESVIHGPG--------------VDHSRW 112
H N+V +LG G +I EY G L + + D
Sbjct: 84 GNHMNIVNLLGACTIGGPT-LVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELAL 142
Query: 113 TLPKRIDVLISVANGLDYLHSGYDIPIVHCDMKPSNILLDRDFEAHVSDFGTSRMLDVHL 172
L + VA G+ +L S +H D+ NILL + DFG +R +
Sbjct: 143 DLEDLLSFSYQVAKGMAFLASK---NCIHRDLAARNILLTHGRITKICDFGLARDIKN-- 197
Query: 173 QDLSSLSTAFQGTIGYLAPEFAYMRIVTTKVDVFSFGIVVMEFLTKRRPTGLDEENGLSP 232
+ + + ++APE + + T + DV+S+GI + E +
Sbjct: 198 DSNYVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGIFLWELFSLGSSPYPGMP----- 252
Query: 233 ISLRQLVEKALANGINGVRQITDPKLVSSIYEEQEQHQVLEELFKLALVCTSSNPEDRPN 292
V+ I ++ P+ E++ + C ++P RP
Sbjct: 253 ------VDSKFYKMIKEGFRMLSPEHAP------------AEMYDIMKTCWDADPLKRPT 294
Query: 293 MNELL 297
+++
Sbjct: 295 FKQIV 299
|
| >d1xkka_ d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb-1 {Human (Homo sapiens) [TaxId: 9606]} Length = 317 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: EGF receptor tyrosine kinase, Erbb-1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 153 bits (388), Expect = 3e-45
Identities = 61/289 (21%), Positives = 123/289 (42%), Gaps = 40/289 (13%)
Query: 14 FSENNIIGNSNLSTVYKGR-LEDGE----IVAVKKLNFHQFSAESDKSFYREAKTLKELK 68
F + ++G+ TVYKG + +GE VA+K+L S +++K EA + +
Sbjct: 11 FKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELR-EATSPKANKEILDEAYVMASVD 69
Query: 69 HRNLVKVLGYAWESGKLKALILEYMENGSLESVIHGPGVDHSRWTLPKRIDVLISVANGL 128
+ ++ ++LG S LI + M G L + ++ + +A G+
Sbjct: 70 NPHVCRLLGICLTSTVQ--LITQLMPFGCLLDYVRE---HKDNIGSQYLLNWCVQIAKGM 124
Query: 129 DYLHSGYDIPIVHCDMKPSNILLDRDFEAHVSDFGTSRMLDVHLQDLSSLSTAFQGTIGY 188
+YL D +VH D+ N+L+ ++DFG +++L + + + I +
Sbjct: 125 NYLE---DRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAE--EKEYHAEGGKVPIKW 179
Query: 189 LAPEFAYMRIVTTKVDVFSFGIVVMEFLTKRRPTGLDEENGLSPISLRQLVEKALANGIN 248
+A E RI T + DV+S+G+ V E +T +G+ + ++EK
Sbjct: 180 MALESILHRIYTHQSDVWSYGVTVWELMTFGSKP----YDGIPASEISSILEKGE----- 230
Query: 249 GVRQITDPKLVSSIYEEQEQHQVLEELFKLALVCTSSNPEDRPNMNELL 297
++ P + + +++ + + C + + RP EL+
Sbjct: 231 ---RLPQPPICT------------IDVYMIMVKCWMIDADSRPKFRELI 264
|
| >d1rjba_ d.144.1.7 (A:) Fl cytokine receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 325 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Fl cytokine receptor species: Human (Homo sapiens) [TaxId: 9606]
Score = 153 bits (388), Expect = 3e-45
Identities = 61/305 (20%), Positives = 108/305 (35%), Gaps = 56/305 (18%)
Query: 19 IIGNSNLSTVYKGRLED------GEIVAVKKLNFHQFSAESDKSFYREAKTLKEL-KHRN 71
++G+ V VAVK L + + ++ E K + +L H N
Sbjct: 44 VLGSGAFGKVMNATAYGISKTGVSIQVAVKMLK-EKADSSEREALMSELKMMTQLGSHEN 102
Query: 72 LVKVLGYAWESGKLKALILEYMENGSLESVIHGPG-------------------VDHSRW 112
+V +LG SG + LI EY G L + + D +
Sbjct: 103 IVNLLGACTLSGPI-YLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEEDLNVL 161
Query: 113 TLPKRIDVLISVANGLDYLHSGYDIPIVHCDMKPSNILLDRDFEAHVSDFGTSRMLDVHL 172
T + VA G+++L VH D+ N+L+ + DFG +R +
Sbjct: 162 TFEDLLCFAYQVAKGMEFLEFK---SCVHRDLAARNVLVTHGKVVKICDFGLARDIMSD- 217
Query: 173 QDLSSLSTAFQGTIGYLAPEFAYMRIVTTKVDVFSFGIVVMEFLTKRRPTGLDEENGLSP 232
+ + + ++APE + I T K DV+S+GI++ E +
Sbjct: 218 -SNYVVRGNARLPVKWMAPESLFEGIYTIKSDVWSYGILLWEIFSLGVNP-------YPG 269
Query: 233 ISLRQLVEKALANGINGVRQITDPKLVSSIYEEQEQHQVLEELFKLALVCTSSNPEDRPN 292
I + K + NG ++ P + EE++ + C + + RP+
Sbjct: 270 IPVDANFYKLIQNGF----KMDQPFYAT------------EEIYIIMQSCWAFDSRKRPS 313
Query: 293 MNELL 297
L
Sbjct: 314 FPNLT 318
|
| >d1fvra_ d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 309 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tie2 kinase species: Human (Homo sapiens) [TaxId: 9606]
Score = 151 bits (382), Expect = 2e-44
Identities = 64/300 (21%), Positives = 124/300 (41%), Gaps = 50/300 (16%)
Query: 14 FSENNIIGNSNLSTVYKGRLEDG---EIVAVKKLNFHQFSAESDKSFYREAKTLKEL-KH 69
++IG N V K R++ A+K++ + S + + F E + L +L H
Sbjct: 12 IKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEY-ASKDDHRDFAGELEVLCKLGHH 70
Query: 70 RNLVKVLGYAWESGKLKALILEYMENGSLESVIHGPGVDH------------SRWTLPKR 117
N++ +LG G L L +EY +G+L + V S + +
Sbjct: 71 PNIINLLGACEHRGYL-YLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQL 129
Query: 118 IDVLISVANGLDYLHSGYDIPIVHCDMKPSNILLDRDFEAHVSDFGTSRMLDVHLQDLSS 177
+ VA G+DYL +H D+ NIL+ ++ A ++DFG SR +V+++
Sbjct: 130 LHFAADVARGMDYLSQ---KQFIHRDLAARNILVGENYVAKIADFGLSRGQEVYVK---- 182
Query: 178 LSTAFQGTIGYLAPEFAYMRIVTTKVDVFSFGIVVMEFLTKRRPTGLDEENGLSPISLRQ 237
T + + ++A E + TT DV+S+G+++ E ++ G++ L +
Sbjct: 183 -KTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTP----YCGMTCAELYE 237
Query: 238 LVEKALANGINGVRQITDPKLVSSIYEEQEQHQVLEELFKLALVCTSSNPEDRPNMNELL 297
+ + ++ P +E++ L C P +RP+ ++L
Sbjct: 238 KLPQGY--------RLEKPLNCD------------DEVYDLMRQCWREKPYERPSFAQIL 277
|
| >d1mp8a_ d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Human (Homo sapiens) [TaxId: 9606]} Length = 273 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Focal adhesion kinase 1 (fak) species: Human (Homo sapiens) [TaxId: 9606]
Score = 147 bits (372), Expect = 2e-43
Identities = 61/283 (21%), Positives = 104/283 (36%), Gaps = 40/283 (14%)
Query: 19 IIGNSNLSTVYKGRL----EDGEIVAVKKLNFHQFSAESDKSFYREAKTLKELKHRNLVK 74
IG V++G VA+K + S + F +EA T+++ H ++VK
Sbjct: 14 CIGEGQFGDVHQGIYMSPENPALAVAIKTCK-NCTSDSVREKFLQEALTMRQFDHPHIVK 72
Query: 75 VLGYAWESGKLKALILEYMENGSLESVIHGPGVDHSRWTLPKRIDVLISVANGLDYLHSG 134
++G E+ +I+E G L S + L I ++ L YL S
Sbjct: 73 LIGVITENPVW--IIMELCTLGELRSFLQV---RKYSLDLASLILYAYQLSTALAYLES- 126
Query: 135 YDIPIVHCDMKPSNILLDRDFEAHVSDFGTSRMLDVHLQDLSSLSTAFQGTIGYLAPEFA 194
VH D+ N+L+ + + DFG SR ++ ++ + I ++APE
Sbjct: 127 --KRFVHRDIAARNVLVSSNDCVKLGDFGLSRYME---DSTYYKASKGKLPIKWMAPESI 181
Query: 195 YMRIVTTKVDVFSFGIVVMEFLTKRRPTGLDEENGLSPISLRQLVEKALANGINGVRQIT 254
R T+ DV+ FG+ + E L G+ + +E ++
Sbjct: 182 NFRRFTSASDVWMFGVCMWEILMHGVKP----FQGVKNNDVIGRIENG--------ERLP 229
Query: 255 DPKLVSSIYEEQEQHQVLEELFKLALVCTSSNPEDRPNMNELL 297
P L+ L C + +P RP EL
Sbjct: 230 MPPNCP------------PTLYSLMTKCWAYDPSRRPRFTELK 260
|
| >d1uu3a_ d.144.1.7 (A:) 3-phosphoinositide dependent protein kinase-1 Pdk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 288 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: 3-phosphoinositide dependent protein kinase-1 Pdk1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 146 bits (370), Expect = 7e-43
Identities = 61/286 (21%), Positives = 102/286 (35%), Gaps = 38/286 (13%)
Query: 14 FSENNIIGNSNLSTVYKGR-LEDGEIVAVKKLNFHQFSAESD-KSFYREAKTLKELKHRN 71
F I+G + STV R L A+K L E+ RE + L H
Sbjct: 10 FKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPF 69
Query: 72 LVKVLGYAWESGKLKALILEYMENGSLESVIHGPGVDHSRWTLPKRIDVLISVANGLDYL 131
VK+ + KL L Y +NG L I G + + + L+YL
Sbjct: 70 FVKLYFTFQDDEKL-YFGLSYAKNGELLKYIRKIG----SFDETCTRFYTAEIVSALEYL 124
Query: 132 HSGYDIPIVHCDMKPSNILLDRDFEAHVSDFGTSRMLDVHLQDLSSLSTAFQGTIGYLAP 191
H I+H D+KP NILL+ D ++DFGT+++L + + +F GT Y++P
Sbjct: 125 HGKG---IIHRDLKPENILLNEDMHIQITDFGTAKVLSPE--SKQARANSFVGTAQYVSP 179
Query: 192 EFAYMRIVTTKVDVFSFGIVVMEFLTKRRPTGLDEENGLSPISLRQLVEKALANGINGVR 251
E + D+++ G ++ + + P + + Q + K
Sbjct: 180 ELLTEKSACKSSDLWALGCIIYQLVAGLPPF-----RAGNEYLIFQKIIKL--------- 225
Query: 252 QITDPKLVSSIYEEQEQHQVLEELFKLALVCTSSNPEDRPNMNELL 297
+ P+ + L + R E+
Sbjct: 226 EYDFPEKFF------------PKARDLVEKLLVLDATKRLGCEEME 259
|
| >d1a06a_ d.144.1.7 (A:) Calmodulin-dependent protein kinase {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 307 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Calmodulin-dependent protein kinase species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 147 bits (371), Expect = 9e-43
Identities = 58/293 (19%), Positives = 107/293 (36%), Gaps = 34/293 (11%)
Query: 6 EIENATGSFSENNIIGNSNLSTVYKGR-LEDGEIVAVKKLNFHQFSAESDKSFYREAKTL 64
+ E+ + +++G S V ++VA+K + + + S E L
Sbjct: 3 QAEDIRDIYDFRDVLGTGAFSEVILAEDKRTQKLVAIKCIAKKALEGK-EGSMENEIAVL 61
Query: 65 KELKHRNLVKVLGYAWESGKLKALILEYMENGSLESVIHGPGVDHSRWTLPKRIDVLISV 124
++KH N+V + G L LI++ + G L I + +T ++ V
Sbjct: 62 HKIKHPNIVALDDIYESGGHL-YLIMQLVSGGELFDRIV----EKGFYTERDASRLIFQV 116
Query: 125 ANGLDYLHSGYDIPIVHCDMKPSNILLDRDFEAHVSDFGTSRMLDVHLQDLSSLSTAFQG 184
+ + YLH + LD D + +SDFG S+M D S+ + G
Sbjct: 117 LDAVKYLHDLGIVHRDLKPENLLYYSLDEDSKIMISDFGLSKMEDPG-----SVLSTACG 171
Query: 185 TIGYLAPEFAYMRIVTTKVDVFSFGIVVMEFLTKRRPTGLDEENGLSPISLRQLVEKALA 244
T GY+APE + + VD +S G++ L P + L + + KA
Sbjct: 172 TPGYVAPEVLAQKPYSKAVDCWSIGVIAYILLCGYPPF-----YDENDAKLFEQILKA-- 224
Query: 245 NGINGVRQITDPKLVSSIYEEQEQHQVLEELFKLALVCTSSNPEDRPNMNELL 297
+ + S +++ + + +PE R + L
Sbjct: 225 ----------EYEFDSPYWDD-----ISDSAKDFIRHLMEKDPEKRFTCEQAL 262
|
| >d1koaa2 d.144.1.7 (A:5915-6264) Twitchin, kinase domain {Caenorhabditis elegans, pjk4 [TaxId: 6239]} Length = 350 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Twitchin, kinase domain species: Caenorhabditis elegans, pjk4 [TaxId: 6239]
Score = 147 bits (373), Expect = 1e-42
Identities = 53/282 (18%), Positives = 103/282 (36%), Gaps = 39/282 (13%)
Query: 19 IIGNSNLSTVYKGR-LEDGEIVAVKKLNFHQFSAESDKSFYREAKTLKELKHRNLVKVLG 77
+G V++ G A K + ++ +E +T+ L+H LV +
Sbjct: 33 ELGTGAFGVVHRVTERATGNNFAAKFVMTP--HESDKETVRKEIQTMSVLRHPTLVNLHD 90
Query: 78 YAWESGKLKALILEYMENGSLESVIHGPGVDHSRWTLPKRIDVLISVANGLDYLHSGYDI 137
+ ++ +I E+M G L + +H++ + + ++ + V GL ++H
Sbjct: 91 AFEDDNEM-VMIYEFMSGGELFEKVAD---EHNKMSEDEAVEYMRQVCKGLCHMHEN--- 143
Query: 138 PIVHCDMKPSNILLDRDFEAHV--SDFGTSRMLDVHLQDLSSLSTAFQGTIGYLAPEFAY 195
VH D+KP NI+ + DFG + LD GT + APE A
Sbjct: 144 NYVHLDLKPENIMFTTKRSNELKLIDFGLTAHLDPKQSVKV-----TTGTAEFAAPEVAE 198
Query: 196 MRIVTTKVDVFSFGIVVMEFLTKRRPTGLDEENGLSPISLRQLVEKALANGINGVRQITD 255
+ V D++S G++ L+ P G G + + V+ N
Sbjct: 199 GKPVGYYTDMWSVGVLSYILLSGLSPFG-----GENDDETLRNVKSCDWN---------- 243
Query: 256 PKLVSSIYEEQEQHQVLEELFKLALVCTSSNPEDRPNMNELL 297
++ + E+ ++P R +++ L
Sbjct: 244 -------MDDSAFSGISEDGKDFIRKLLLADPNTRMTIHQAL 278
|
| >d1o6ya_ d.144.1.7 (A:) Mycobacterial protein kinase PknB, catalytic domain {Mycobacterium tuberculosis [TaxId: 1773]} Length = 277 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Mycobacterial protein kinase PknB, catalytic domain species: Mycobacterium tuberculosis [TaxId: 1773]
Score = 144 bits (365), Expect = 3e-42
Identities = 70/285 (24%), Positives = 113/285 (39%), Gaps = 36/285 (12%)
Query: 19 IIGNSNLSTVYKGR-LEDGEIVAVKKLNFHQFSAESD-KSFYREAKTLKELKHRNLVKVL 76
I+G +S V+ R L VAVK L S F REA+ L H +V V
Sbjct: 14 ILGFGGMSEVHLARDLRLHRDVAVKVLRADLARDPSFYLRFRREAQNAAALNHPAIVAVY 73
Query: 77 GYAWE---SGKLKALILEYMENGSLESVIHGPGVDHSRWTLPKRIDVLISVANGLDYLHS 133
+G L +++EY++ +L ++H G T + I+V+ L++ H
Sbjct: 74 DTGEAETPAGPLPYIVMEYVDGVTLRDIVHTEG----PMTPKRAIEVIADACQALNFSHQ 129
Query: 134 GYDIPIVHCDMKPSNILLDRDFEAHVSDFGTSRMLDVHLQDLSSLSTAFQGTIGYLAPEF 193
I+H D+KP+NI++ V DFG +R + ++ + GT YL+PE
Sbjct: 130 ---NGIIHRDVKPANIMISATNAVKVMDFGIARAIADSGNSVTQTAA-VIGTAQYLSPEQ 185
Query: 194 AYMRIVTTKVDVFSFGIVVMEFLTKRRPTGLDEENGLSPISLRQLVEKALANGINGVRQI 253
A V + DV+S G V+ E LT P + S + + +
Sbjct: 186 ARGDSVDARSDVYSLGCVLYEVLTGEPP--------FTGDSPVSVAYQHVREDP------ 231
Query: 254 TDPKLVSSIYEEQEQHQVLEELFKLALVCTSSNPEDRP-NMNELL 297
I + +L + L + NPE+R E+
Sbjct: 232 --------IPPSARHEGLSADLDAVVLKALAKNPENRYQTAAEMR 268
|
| >d1ua2a_ d.144.1.7 (A:) Cell division protein kinase 7, CDK7 {Human (Homo sapiens) [TaxId: 9606]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell division protein kinase 7, CDK7 species: Human (Homo sapiens) [TaxId: 9606]
Score = 143 bits (360), Expect = 2e-41
Identities = 66/287 (22%), Positives = 115/287 (40%), Gaps = 19/287 (6%)
Query: 18 NIIGNSNLSTVYKGR-LEDGEIVAVKKLNFHQFSAESD---KSFYREAKTLKELKHRNLV 73
+ +G +TVYK R +IVA+KK+ S D ++ RE K L+EL H N++
Sbjct: 4 DFLGEGQFATVYKARDKNTNQIVAIKKIKLGHRSEAKDGINRTALREIKLLQELSHPNII 63
Query: 74 KVLGYAWESGKLKALILEYMENGSLESVIHGPGVDHSRWTLPKRIDVLISVANGLDYLHS 133
+L + +L+ ++ME + V ++ GL+YLH
Sbjct: 64 GLLDAFGHKSNI-SLVFDFMETDLEVIIKDNSLVLTPSH----IKAYMLMTLQGLEYLHQ 118
Query: 134 GYDIPIVHCDMKPSNILLDRDFEAHVSDFGTSRMLDVHLQDLSSLSTAFQGTIGYLAPEF 193
+ I+H D+KP+N+LLD + ++DFG ++ + T T Y APE
Sbjct: 119 HW---ILHRDLKPNNLLLDENGVLKLADFGLAKSFGSPNR----AYTHQVVTRWYRAPEL 171
Query: 194 AY-MRIVTTKVDVFSFGIVVMEFLTKRRP-TGLDEENGLSPI-SLRQLVEKALANGINGV 250
+ R+ VD+++ G ++ E L + G + + L+ I + + +
Sbjct: 172 LFGARMYGVGVDMWAVGCILAELLLRVPFLPGDSDLDQLTRIFETLGTPTEEQWPDMCSL 231
Query: 251 RQITDPKLVSSIYEEQEQHQVLEELFKLALVCTSSNPEDRPNMNELL 297
K I ++L L NP R + L
Sbjct: 232 PDYVTFKSFPGIPLHHIFSAAGDDLLDLIQGLFLFNPCARITATQAL 278
|
| >d1p4oa_ d.144.1.7 (A:) Insulin-like growth factor 1 receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 308 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Insulin-like growth factor 1 receptor species: Human (Homo sapiens) [TaxId: 9606]
Score = 143 bits (360), Expect = 3e-41
Identities = 68/296 (22%), Positives = 120/296 (40%), Gaps = 43/296 (14%)
Query: 14 FSENNIIGNSNLSTVYKGRL------EDGEIVAVKKLNFHQFSAESDKSFYREAKTLKEL 67
+ + +G + VY+G E VA+K +N S F EA +KE
Sbjct: 22 ITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVN-EAASMRERIEFLNEASVMKEF 80
Query: 68 KHRNLVKVLGYAWESGKLKALILEYMENGSLESVIHGPGVDHSRW------TLPKRIDVL 121
++V++LG + +I+E M G L+S + + +L K I +
Sbjct: 81 NCHHVVRLLGVVSQGQPT-LVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQMA 139
Query: 122 ISVANGLDYLHSGYDIPIVHCDMKPSNILLDRDFEAHVSDFGTSRMLDVHLQDLSSLSTA 181
+A+G+ YL++ VH D+ N ++ DF + DFG +R + D
Sbjct: 140 GEIADGMAYLNA---NKFVHRDLAARNCMVAEDFTVKIGDFGMTRDIYET--DYYRKGGK 194
Query: 182 FQGTIGYLAPEFAYMRIVTTKVDVFSFGIVVMEFLTKRRPTGLDEENGLSPISLRQLVEK 241
+ +++PE + TT DV+SFG+V+ E T GLS +
Sbjct: 195 GLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQP----YQGLSNEQV------ 244
Query: 242 ALANGINGVRQITDPKLVSSIYEEQEQHQVLEELFKLALVCTSSNPEDRPNMNELL 297
+R + + L+ + + LF+L +C NP+ RP+ E++
Sbjct: 245 --------LRFVMEGGLLD------KPDNCPDMLFELMRMCWQYNPKMRPSFLEII 286
|
| >d1ob3a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmodium falciparum) [TaxId: 5833]} Length = 286 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK2 species: (Plasmodium falciparum) [TaxId: 5833]
Score = 141 bits (357), Expect = 5e-41
Identities = 60/283 (21%), Positives = 105/283 (37%), Gaps = 14/283 (4%)
Query: 18 NIIGNSNLSTVYKGRLEDGEIVAVKKLNFHQFSAESDKSFYREAKTLKELKHRNLVKVLG 77
IG VYK + GE A+KK+ + + RE LKELKH N+VK+
Sbjct: 8 EKIGEGTYGVVYKAQNNYGETFALKKIRLEKEDEGIPSTTIREISILKELKHSNIVKLYD 67
Query: 78 YAWESGKLKALILEYMENGSLESVIHGPGVDHSRWTLPKRIDVLISVANGLDYLHSGYDI 137
+L L+ E+++ + + G L+ + NG+ Y H
Sbjct: 68 VIHTKKRL-VLVFEHLDQDLKKLLDVCEG----GLESVTAKSFLLQLLNGIAYCHD---R 119
Query: 138 PIVHCDMKPSNILLDRDFEAHVSDFGTSRMLDVHLQDLSSLSTAFQGTIGYLAPEFAYMR 197
++H D+KP N+L++R+ E ++DFG +R + + +
Sbjct: 120 RVLHRDLKPQNLLINREGELKIADFGLARAFG---IPVRKYTHEIVTLWYRAPDVLMGSK 176
Query: 198 IVTTKVDVFSFGIVVMEFLTKRRP-TGLDEENGLSPI--SLRQLVEKALANGINGVRQIT 254
+T +D++S G + E + G+ E + L I L K N +
Sbjct: 177 KYSTTIDIWSVGCIFAEMVNGTPLFPGVSEADQLMRIFRILGTPNSKNWPNVTELPKYDP 236
Query: 255 DPKLVSSIYEEQEQHQVLEELFKLALVCTSSNPEDRPNMNELL 297
+ + + E + E L +P R + L
Sbjct: 237 NFTVYEPLPWESFLKGLDESGIDLLSKMLKLDPNQRITAKQAL 279
|
| >d1koba_ d.144.1.7 (A:) Twitchin, kinase domain {California sea hare (Aplysia californica), twk43 [TaxId: 6500]} Length = 352 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Twitchin, kinase domain species: California sea hare (Aplysia californica), twk43 [TaxId: 6500]
Score = 142 bits (360), Expect = 8e-41
Identities = 51/281 (18%), Positives = 96/281 (34%), Gaps = 39/281 (13%)
Query: 20 IGNSNLSTVYKGR-LEDGEIVAVKKLNFHQFSAESDKSFYREAKTLKELKHRNLVKVLGY 78
+G+ V++ G + K +N + E + +L H L+ +
Sbjct: 37 LGSGAFGVVHRCVEKATGRVFVAKFINTP--YPLDKYTVKNEISIMNQLHHPKLINLHDA 94
Query: 79 AWESGKLKALILEYMENGSLESVIHGPGVDHSRWTLPKRIDVLISVANGLDYLHSGYDIP 138
+ ++ LILE++ G L I + + + I+ + GL ++H
Sbjct: 95 FEDKYEM-VLILEFLSGGELFDRIAAEDY---KMSEAEVINYMRQACEGLKHMHE---HS 147
Query: 139 IVHCDMKPSNILLDRDFEAHV--SDFGTSRMLDVHLQDLSSLSTAFQGTIGYLAPEFAYM 196
IVH D+KP NI+ + + V DFG + L+ + T + APE
Sbjct: 148 IVHLDIKPENIMCETKKASSVKIIDFGLATKLNPD-----EIVKVTTATAEFAAPEIVDR 202
Query: 197 RIVTTKVDVFSFGIVVMEFLTKRRPTGLDEENGLSPISLRQLVEKALANGINGVRQITDP 256
V D+++ G++ L+ P G + Q V++
Sbjct: 203 EPVGFYTDMWAIGVLGYVLLSGLSPF-----AGEDDLETLQNVKRCDWE----------- 246
Query: 257 KLVSSIYEEQEQHQVLEELFKLALVCTSSNPEDRPNMNELL 297
++E V E P R +++ L
Sbjct: 247 ------FDEDAFSSVSPEAKDFIKNLLQKEPRKRLTVHDAL 281
|
| >d1q5ka_ d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gsk3b) {Human (Homo sapiens) [TaxId: 9606]} Length = 350 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Glycogen synthase kinase-3 beta (Gsk3b) species: Human (Homo sapiens) [TaxId: 9606]
Score = 139 bits (352), Expect = 1e-39
Identities = 62/295 (21%), Positives = 115/295 (38%), Gaps = 24/295 (8%)
Query: 13 SFSENNIIGNSNLSTVYKGRL-EDGEIVAVKKLNFHQFSAESDKSFYREAKTLKELKHRN 71
S+++ +IGN + VY+ +L + GE+VA+KK+ + + RE + +++L H N
Sbjct: 21 SYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVL------QDKRFKNRELQIMRKLDHCN 74
Query: 72 LVKVLGYAWESGKLK-----ALILEYMENGSLESVIHGPGVDHSRWTLPKRIDVLISVAN 126
+V++ + + SG+ K L+L+Y+ H + + +
Sbjct: 75 IVRLRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHY-SRAKQTLPVIYVKLYMYQLFR 133
Query: 127 GLDYLHSGYDIPIVHCDMKPSNILLDRDFEAH-VSDFGTSRMLDVHLQDLSSLSTAFQGT 185
L Y+HS I H D+KP N+LLD D + DFG+++ L +
Sbjct: 134 SLAYIHSF---GICHRDIKPQNLLLDPDTAVLKLCDFGSAK----QLVRGEPNVSYICSR 186
Query: 186 IGYLAPEFAYMRIVTTKVDVFSFGIVVMEFLTKRRP-TGLDEENGLSPI--SLRQLVEKA 242
T+ +DV+S G V+ E L + G + L I L +
Sbjct: 187 YYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQPIFPGDSGVDQLVEIIKVLGTPTREQ 246
Query: 243 LANGINGVRQITDPKLVSSIYEEQEQHQVLEELFKLALVCTSSNPEDRPNMNELL 297
+ + P++ + + + + + E L P R E
Sbjct: 247 IREMNPNYTEFKFPQIKAHPWTKVFRPRTPPEAIALCSRLLEYTPTARLTPLEAC 301
|
| >d1ywna1 d.144.1.7 (A:818-1166) Vascular endothelial growth factor receptor 2 (kdr) {Human (Homo sapiens) [TaxId: 9606]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Vascular endothelial growth factor receptor 2 (kdr) species: Human (Homo sapiens) [TaxId: 9606]
Score = 138 bits (348), Expect = 1e-39
Identities = 62/314 (19%), Positives = 111/314 (35%), Gaps = 46/314 (14%)
Query: 2 FDRTEIENATGSFSENNIIGNSNLSTVYKGR------LEDGEIVAVKKLNFHQFSAESDK 55
+D ++ E +G V + VAVK L +E
Sbjct: 3 YDASKWEFPRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRA 62
Query: 56 SFYREAKTLKELKHRNLVKVLGYAWESGKLKALILEYMENGSLESVIHGPGVDHSRW--- 112
+ H N+V +LG + G +I+E+ + G+L + + + +
Sbjct: 63 LMSELKILIHIGHHLNVVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVA 122
Query: 113 ---------TLPKRIDVLISVANGLDYLHSGYDIPIVHCDMKPSNILLDRDFEAHVSDFG 163
TL I VA G+++L S +H D+ NILL + DFG
Sbjct: 123 PEDLYKDFLTLEHLICYSFQVAKGMEFLAS---RKCIHRDLAARNILLSEKNVVKICDFG 179
Query: 164 TSRMLDVHLQDLSSLSTAFQGTIGYLAPEFAYMRIVTTKVDVFSFGIVVMEFLTKRRPTG 223
+R + + + ++APE + R+ T + DV+SFG+++ E +
Sbjct: 180 LARDIYK--DPDYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGAS-- 235
Query: 224 LDEENGLSPISLRQLVEKALANGINGVRQITDPKLVSSIYEEQEQHQVLEELFKLALVCT 283
P ++ E+ G R + P + E+++ L C
Sbjct: 236 --------PYPGVKIDEEFCRRLKEGTR-MRAPDYTT------------PEMYQTMLDCW 274
Query: 284 SSNPEDRPNMNELL 297
P RP +EL+
Sbjct: 275 HGEPSQRPTFSELV 288
|
| >d1fgka_ d.144.1.7 (A:) Fibroblast growth factor receptor 1 {Human (Homo sapiens) [TaxId: 9606]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Fibroblast growth factor receptor 1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 137 bits (346), Expect = 3e-39
Identities = 62/301 (20%), Positives = 114/301 (37%), Gaps = 52/301 (17%)
Query: 18 NIIGNSNLSTVYKGRL--------EDGEIVAVKKLNFHQFSAESDKSFYREAKTLKEL-K 68
+G V VAVK L + + E + +K + K
Sbjct: 19 KPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLK-SDATEKDLSDLISEMEMMKMIGK 77
Query: 69 HRNLVKVLGYAWESGKLKALILEYMENGSLESVIHGPGVDHSRW------------TLPK 116
H+N++ +LG + G L +I+EY G+L + + +
Sbjct: 78 HKNIINLLGACTQDGPL-YVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKD 136
Query: 117 RIDVLISVANGLDYLHSGYDIPIVHCDMKPSNILLDRDFEAHVSDFGTSRMLDVHLQDLS 176
+ VA G++YL S +H D+ N+L+ D ++DFG +R + D
Sbjct: 137 LVSCAYQVARGMEYLAS---KKCIHRDLAARNVLVTEDNVMKIADFGLARDIHH--IDYY 191
Query: 177 SLSTAFQGTIGYLAPEFAYMRIVTTKVDVFSFGIVVMEFLTKRRPTGLDEENGLSPISLR 236
+T + + ++APE + RI T + DV+SFG+++ E T G+ L
Sbjct: 192 KKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSP----YPGVPVEELF 247
Query: 237 QLVEKALANGINGVRQITDPKLVSSIYEEQEQHQVLEELFKLALVCTSSNPEDRPNMNEL 296
+L+++ ++ P + EL+ + C + P RP +L
Sbjct: 248 KLLKEG--------HRMDKPSNCT------------NELYMMMRDCWHAVPSQRPTFKQL 287
Query: 297 L 297
+
Sbjct: 288 V 288
|
| >d1tkia_ d.144.1.7 (A:) Titin, kinase domain {Human (Homo sapiens) [TaxId: 9606]} Length = 321 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Titin, kinase domain species: Human (Homo sapiens) [TaxId: 9606]
Score = 137 bits (346), Expect = 5e-39
Identities = 48/299 (16%), Positives = 97/299 (32%), Gaps = 49/299 (16%)
Query: 2 FDRTEIENATGSFSENNIIGNSNLSTVYKGR-LEDGEIVAVKKLNFHQFSAESDKSFYRE 60
+++ I +G V++ + K + +E
Sbjct: 4 YEKYMIAE---------DLGRGEFGIVHRCVETSSKKTYMAKFVKV---KGTDQVLVKKE 51
Query: 61 AKTLKELKHRNLVKVLGYAWESGKLKALILEYMENGSLESVIHGPGVDHSRWTLPKRIDV 120
L +HRN++ + +ES + +I E++ + I+ + +
Sbjct: 52 ISILNIARHRNILHLHES-FESMEELVMIFEFISGLDIFERINTSAF---ELNEREIVSY 107
Query: 121 LISVANGLDYLHSGYDIPIVHCDMKPSNILLDRDFEAHV--SDFGTSRMLDVHLQDLSSL 178
+ V L +LHS I H D++P NI+ + + +FG +R L
Sbjct: 108 VHQVCEALQFLHS---HNIGHFDIRPENIIYQTRRSSTIKIIEFGQARQLKPG-----DN 159
Query: 179 STAFQGTIGYLAPEFAYMRIVTTKVDVFSFGIVVMEFLTKRRPTGLDEENGLSPISLRQL 238
Y APE +V+T D++S G +V L+ P + +Q+
Sbjct: 160 FRLLFTAPEYYAPEVHQHDVVSTATDMWSLGTLVYVLLSGINP--------FLAETNQQI 211
Query: 239 VEKALANGINGVRQITDPKLVSSIYEEQEQHQVLEELFKLALVCTSSNPEDRPNMNELL 297
+E + ++E+ ++ E + R +E L
Sbjct: 212 IENIMNAEYT--------------FDEEAFKEISIEAMDFVDRLLVKERKSRMTASEAL 256
|
| >d3blha1 d.144.1.7 (A:8-325) Cell division protein kinase 9, CDK9 {Human (Homo sapiens) [TaxId: 9606]} Length = 318 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell division protein kinase 9, CDK9 species: Human (Homo sapiens) [TaxId: 9606]
Score = 135 bits (341), Expect = 2e-38
Identities = 61/295 (20%), Positives = 115/295 (38%), Gaps = 22/295 (7%)
Query: 18 NIIGNSNLSTVYKGR-LEDGEIVAVKKLNFHQFSAESDKSFYREAKTLKELKHRNLVKVL 76
IG V+K R + G+ VA+KK+ + RE K L+ LKH N+V ++
Sbjct: 16 AKIGQGTFGEVFKARHRKTGQKVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLI 75
Query: 77 GYAWESGKLKA-------LILEYMENGSLESVIHGPGVDHSRWTLPKRIDVLISVANGLD 129
L+ ++ E+ + + KR+ ++ L+
Sbjct: 76 EICRTKASPYNRCKGSIYLVFDFCEHDLAGLLSNVLVKFTLSEI--KRVMQML-----LN 128
Query: 130 YLHSGYDIPIVHCDMKPSNILLDRDFEAHVSDFGTSRMLDVHLQDLSSLSTAFQGTIGYL 189
L+ + I+H DMK +N+L+ RD ++DFG +R + + T T+ Y
Sbjct: 129 GLYYIHRNKILHRDMKAANVLITRDGVLKLADFGLARAFSLAKNSQPNRYTNRVVTLWYR 188
Query: 190 APEF-AYMRIVTTKVDVFSFGIVVMEFLTKRRP-TGLDEENGLSPIS--LRQLVEKALAN 245
PE R +D++ G ++ E T+ G E++ L+ IS + + N
Sbjct: 189 PPELLLGERDYGPPIDLWGAGCIMAEMWTRSPIMQGNTEQHQLALISQLCGSITPEVWPN 248
Query: 246 GING--VRQITDPKLVSSIYEEQEQHQVLEELFK-LALVCTSSNPEDRPNMNELL 297
N ++ K +++ + V + L +P R + ++ L
Sbjct: 249 VDNYELYEKLELVKGQKRKVKDRLKAYVRDPYALDLIDKLLVLDPAQRIDSDDAL 303
|
| >d1phka_ d.144.1.7 (A:) gamma-subunit of glycogen phosphorylase kinase (Phk) {Rabbit (Oryctolagus cuniculus) [TaxId: 9986]} Length = 277 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: gamma-subunit of glycogen phosphorylase kinase (Phk) species: Rabbit (Oryctolagus cuniculus) [TaxId: 9986]
Score = 134 bits (339), Expect = 2e-38
Identities = 61/303 (20%), Positives = 111/303 (36%), Gaps = 54/303 (17%)
Query: 14 FSEN----NIIGNSNLSTVYKGR-LEDGEIVAVKKLNFHQFSAESDK-------SFYREA 61
F EN I+G S V + + AVK ++ + S + + +E
Sbjct: 1 FYENYEPKEILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEV 60
Query: 62 KTLKELK-HRNLVKVLGYAWESGKLKALILEYMENGSLESVIHGPGVDHSRWTLPKRIDV 120
L+++ H N++++ + L+ + M+ G L + + + + +
Sbjct: 61 DILRKVSGHPNIIQLKDTYETNTFF-FLVFDLMKKGELFDYLT----EKVTLSEKETRKI 115
Query: 121 LISVANGLDYLHSGYDIPIVHCDMKPSNILLDRDFEAHVSDFGTSRMLDVHLQDLSSLST 180
+ ++ + LH + IVH D+KP NILLD D ++DFG S LD
Sbjct: 116 MRALLEVICALHK---LNIVHRDLKPENILLDDDMNIKLTDFGFSCQLDP-----GEKLR 167
Query: 181 AFQGTIGYLAPEFAYMRIV------TTKVDVFSFGIVVMEFLTKRRPTGLDEENGLSPIS 234
GT YLAPE + +VD++S G+++ L P +
Sbjct: 168 EVCGTPSYLAPEIIECSMNDNHPGYGKEVDMWSTGVIMYTLLAGSPPF-----WHRKQML 222
Query: 235 LRQLVEKALANGINGVRQITDPKLVSSIYEEQEQHQVLEELFKLALVCTSSNPEDRPNMN 294
+ +++ ++G Q P E + + L P+ R
Sbjct: 223 MLRMI-------MSGNYQFGSP----------EWDDYSDTVKDLVSRFLVVQPQKRYTAE 265
Query: 295 ELL 297
E L
Sbjct: 266 EAL 268
|
| >d1gz8a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [TaxId: 9606]} Length = 298 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 134 bits (339), Expect = 3e-38
Identities = 71/289 (24%), Positives = 116/289 (40%), Gaps = 16/289 (5%)
Query: 14 FSENNIIGNSNLSTVYKGR-LEDGEIVAVKKLNFHQFSAESDKSFYREAKTLKELKHRNL 72
F + IG VYK R GE+VA+KK+ + + RE LKEL H N+
Sbjct: 4 FQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNI 63
Query: 73 VKVLGYAWESGKLKALILEYMENGSLESVIHGPGVDHSRWTLPKRIDVLISVANGLDYLH 132
VK+L KL L+ E++ + + + LP L + GL + H
Sbjct: 64 VKLLDVIHTENKL-YLVFEFLHQDLKKFMDASA---LTGIPLPLIKSYLFQLLQGLAFCH 119
Query: 133 SGYDIPIVHCDMKPSNILLDRDFEAHVSDFGTSRMLDVHLQDLSSLSTAFQGTIGYLAPE 192
S ++H D+KP N+L++ + ++DFG +R V ++ T T+ Y APE
Sbjct: 120 SHR---VLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRT----YTHEVVTLWYRAPE 172
Query: 193 FAYM-RIVTTKVDVFSFGIVVMEFLTKRRP-TGLDEENGLSPI--SLRQLVEKALANGIN 248
+ +T VD++S G + E +T+R G E + L I +L E +
Sbjct: 173 ILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTS 232
Query: 249 GVRQITDPKLVSSIYEEQEQHQVLEELFKLALVCTSSNPEDRPNMNELL 297
+ + + E+ L +P R + L
Sbjct: 233 MPDYKPSFPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAAL 281
|
| >d1blxa_ d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [TaxId: 9606]} Length = 305 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK6 species: Human (Homo sapiens) [TaxId: 9606]
Score = 134 bits (338), Expect = 4e-38
Identities = 64/287 (22%), Positives = 107/287 (37%), Gaps = 15/287 (5%)
Query: 18 NIIGNSNLSTVYKGR--LEDGEIVAVKKLNFHQFSAESDKSFYREAKTLKELK---HRNL 72
IG V+K R G VA+K++ S RE L+ L+ H N+
Sbjct: 13 AEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETFEHPNV 72
Query: 73 VKVLGYAWES-GKLKALILEYMENGSLESVIHGPGVDHSRWTLPKRIDVLISVANGLDYL 131
V++ S + + E+ + + V D++ + GLD+L
Sbjct: 73 VRLFDVCTVSRTDRETKLTLVFEHVDQDLTTYLDKVPEPGVPTETIKDMMFQLLRGLDFL 132
Query: 132 HSGYDIPIVHCDMKPSNILLDRDFEAHVSDFGTSRMLDVHLQDLSSLSTAFQGTIGYLAP 191
HS +VH D+KP NIL+ + ++DFG +R+ + T+ T+ Y AP
Sbjct: 133 HS---HRVVHRDLKPQNILVTSSGQIKLADFGLARIYSFQMAL-----TSVVVTLWYRAP 184
Query: 192 EFAYMRIVTTKVDVFSFGIVVMEFLTKRRP-TGLDEENGLSPISLRQLVEKALANGINGV 250
E T VD++S G + E ++ G + + L I + +
Sbjct: 185 EVLLQSSYATPVDLWSVGCIFAEMFRRKPLFRGSSDVDQLGKILDVIGLPGEEDWPRDVA 244
Query: 251 RQITDPKLVSSIYEEQEQHQVLEELFKLALVCTSSNPEDRPNMNELL 297
S+ E+ + E L L C + NP R + L
Sbjct: 245 LPRQAFHSKSAQPIEKFVTDIDELGKDLLLKCLTFNPAKRISAYSAL 291
|
| >d1xjda_ d.144.1.7 (A:) Protein kinase C, theta type {Human (Homo sapiens) [TaxId: 9606]} Length = 320 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase C, theta type species: Human (Homo sapiens) [TaxId: 9606]
Score = 133 bits (335), Expect = 2e-37
Identities = 59/287 (20%), Positives = 103/287 (35%), Gaps = 41/287 (14%)
Query: 14 FSENNIIGNSNLSTVYKGR-LEDGEIVAVKKLNFHQFSAESD-KSFYREAKTL-KELKHR 70
F + ++G + V+ + + A+K L + D + E + L +H
Sbjct: 4 FILHKMLGKGSFGKVFLAEFKKTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHP 63
Query: 71 NLVKVLGYAWESGKLKALILEYMENGSLESVIHGPGVDHSRWTLPKRIDVLISVANGLDY 130
L + L ++EY+ G L I ++ L + + GL +
Sbjct: 64 FLTHMFCTFQTKENL-FFVMEYLNGGDLMYHIQ----SCHKFDLSRATFYAAEIILGLQF 118
Query: 131 LHSGYDIPIVHCDMKPSNILLDRDFEAHVSDFGTSRMLDVHLQDLSSLSTAFQGTIGYLA 190
LHS IV+ D+K NILLD+D ++DFG + + + F GT Y+A
Sbjct: 119 LHS---KGIVYRDLKLDNILLDKDGHIKIADFGMCK----ENMLGDAKTNTFCGTPDYIA 171
Query: 191 PEFAYMRIVTTKVDVFSFGIVVMEFLTKRRPTGLDEENGLSPISLRQLVEKALANGINGV 250
PE + VD +SFG+++ E L + P +G L +
Sbjct: 172 PEILLGQKYNHSVDWWSFGVLLYEMLIGQSPF-----HGQDEEELFHSIRMD-------- 218
Query: 251 RQITDPKLVSSIYEEQEQHQVLEELFKLALVCTSSNPEDRPNMNELL 297
P+ + +E L + PE R + +
Sbjct: 219 -NPFYPRWLE------------KEAKDLLVKLFVREPEKRLGVRGDI 252
|
| >d1ckia_ d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Casein kinase-1, CK1 species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 133 bits (334), Expect = 2e-37
Identities = 51/285 (17%), Positives = 101/285 (35%), Gaps = 36/285 (12%)
Query: 20 IGNSNLSTVYKGR-LEDGEIVAVKKLNFHQFSAESDKSFYREAKTLKELKHRNLVKVLGY 78
IG+ + +Y G + GE VA+K + E+K K ++ + + +
Sbjct: 15 IGSGSFGDIYLGTDIAAGEEVAIKLEC----VKTKHPQLHIESKIYKMMQGGVGIPTIRW 70
Query: 79 AWESGKLKALILEYMENGSLESVIHGPGVDHSRWTLPKRIDVLISVANGLDYLHSGYDIP 138
G +++E + + +++L + + + + ++Y+HS
Sbjct: 71 CGAEGDYNVMVMELLGPSLEDLFNFCSR----KFSLKTVLLLADQMISRIEYIHSKN--- 123
Query: 139 IVHCDMKPSNIL---LDRDFEAHVSDFGTSRMLD---VHLQDLSSLSTAFQGTIGYLAPE 192
+H D+KP N L + ++ DFG ++ H + GT Y +
Sbjct: 124 FIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYRDARTHQHIPYRENKNLTGTARYASIN 183
Query: 193 FAYMRIVTTKVDVFSFGIVVMEFLTKRRPTGLDEENGLSPISLRQLVEKALANGINGVRQ 252
+ + D+ S G V+M F P GL + RQ E+ ++
Sbjct: 184 THLGIEQSRRDDLESLGYVLMYFNLGSLPW-----QGLKAATKRQKYER------ISEKK 232
Query: 253 ITDPKLVSSIYEEQEQHQVLEELFKLALVCTSSNPEDRPNMNELL 297
++ P E E C S +D+P+ + L
Sbjct: 233 MSTPI-------EVLCKGYPSEFATYLNFCRSLRFDDKPDYSYLR 270
|
| >d1fota_ d.144.1.7 (A:) cAMP-dependent PK, catalytic subunit {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} Length = 316 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: cAMP-dependent PK, catalytic subunit species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]
Score = 131 bits (331), Expect = 7e-37
Identities = 51/206 (24%), Positives = 92/206 (44%), Gaps = 17/206 (8%)
Query: 18 NIIGNSNLSTVYKGR-LEDGEIVAVKKLNFHQFSAESD-KSFYREAKTLKELKHRNLVKV 75
+G + V+ R +G A+K L + E L + H ++++
Sbjct: 10 RTLGTGSFGRVHLIRSRHNGRYYAMKVLKKEIVVRLKQVEHTNDERLMLSIVTHPFIIRM 69
Query: 76 LGYAWESGKLKALILEYMENGSLESVIHGPGVDHSRWTLPKRIDVLISVANGLDYLHSGY 135
G ++ ++ +I++Y+E G L S++ R+ P V L+YLHS
Sbjct: 70 WGTFQDAQQI-FMIMDYIEGGELFSLLR----KSQRFPNPVAKFYAAEVCLALEYLHS-- 122
Query: 136 DIPIVHCDMKPSNILLDRDFEAHVSDFGTSRMLDVHLQDLSSLSTAFQGTIGYLAPEFAY 195
I++ D+KP NILLD++ ++DFG ++ + ++ GT Y+APE
Sbjct: 123 -KDIIYRDLKPENILLDKNGHIKITDFGFAKYVP-------DVTYTLCGTPDYIAPEVVS 174
Query: 196 MRIVTTKVDVFSFGIVVMEFLTKRRP 221
+ +D +SFGI++ E L P
Sbjct: 175 TKPYNKSIDWWSFGILIYEMLAGYTP 200
|
| >d1omwa3 d.144.1.7 (A:186-549) G-protein coupled receptor kinase 2 {Cow (Bos taurus) [TaxId: 9913]} Length = 364 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: G-protein coupled receptor kinase 2 species: Cow (Bos taurus) [TaxId: 9913]
Score = 132 bits (333), Expect = 9e-37
Identities = 50/214 (23%), Positives = 84/214 (39%), Gaps = 20/214 (9%)
Query: 14 FSENNIIGNSNLSTVYKGR-LEDGEIVAVKKLNFHQFSAESDKSFY----REAKTLKELK 68
FS + IIG VY R + G++ A+K L+ + + ++ +
Sbjct: 6 FSVHRIIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGD 65
Query: 69 HRNLVKVLGYAWESGKLKALILEYMENGSLESVIHGPGVDHSRWTLPKRIDVLISVANGL 128
+V + KL + IL+ M G L + H ++ + GL
Sbjct: 66 CPFIVCMSYAFHTPDKL-SFILDLMNGGDLHYHLS----QHGVFSEADMRFYAAEIILGL 120
Query: 129 DYLHSGYDIPIVHCDMKPSNILLDRDFEAHVSDFGTSRMLDVHLQDLSSLSTAFQGTIGY 188
+++H+ +V+ D+KP+NILLD +SD G + A GT GY
Sbjct: 121 EHMHN---RFVVYRDLKPANILLDEHGHVRISDLGLACDFS------KKKPHASVGTHGY 171
Query: 189 LAPE-FAYMRIVTTKVDVFSFGIVVMEFLTKRRP 221
+APE + D FS G ++ + L P
Sbjct: 172 MAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSP 205
|
| >d1unla_ d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [TaxId: 9606]} Length = 292 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK5 species: Human (Homo sapiens) [TaxId: 9606]
Score = 130 bits (327), Expect = 1e-36
Identities = 63/285 (22%), Positives = 106/285 (37%), Gaps = 16/285 (5%)
Query: 18 NIIGNSNLSTVYKGR-LEDGEIVAVKKLNFHQFSAESDKSFYREAKTLKELKHRNLVKVL 76
IG TV+K + E EIVA+K++ S RE LKELKH+N+V++
Sbjct: 8 EKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLH 67
Query: 77 GYAWESGKLKALILEYMENGSLESVIHGPGVDHSRWTLPKRIDVLISVANGLDYLHSGYD 136
S K L+ E+ + + G L + GL + H
Sbjct: 68 DV-LHSDKKLTLVFEFCDQDLKKYFDSCNGDLDPEI----VKSFLFQLLKGLGFCH---S 119
Query: 137 IPIVHCDMKPSNILLDRDFEAHVSDFGTSRMLDVHLQDLSSLSTAFQGTIGYLAPEFAYM 196
++H D+KP N+L++R+ E +++FG +R + S
Sbjct: 120 RNVLHRDLKPQNLLINRNGELKLANFGLARAFG---IPVRCYSAEVVTLWYRPPDVLFGA 176
Query: 197 RIVTTKVDVFSFGIVVMEFLTKRRP--TGLDEENGLSPI--SLRQLVEKALANGINGVRQ 252
++ +T +D++S G + E RP G D ++ L I L E+ +
Sbjct: 177 KLYSTSIDMWSAGCIFAELANAGRPLFPGNDVDDQLKRIFRLLGTPTEEQWPSMTKLPDY 236
Query: 253 ITDPKLVSSIYEEQEQHQVLEELFKLALVCTSSNPEDRPNMNELL 297
P ++ ++ L NP R + E L
Sbjct: 237 KPYPMYPATTSLVNVVPKLNATGRDLLQNLLKCNPVQRISAEEAL 281
|
| >d1xwsa_ d.144.1.7 (A:) Proto-oncogene serine/threonine-protein kinase Pim-1 {Human (Homo sapiens) [TaxId: 9606]} Length = 273 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Proto-oncogene serine/threonine-protein kinase Pim-1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 129 bits (324), Expect = 3e-36
Identities = 60/288 (20%), Positives = 99/288 (34%), Gaps = 54/288 (18%)
Query: 19 IIGNSNLSTVYKGR-LEDGEIVAVKKLNFHQFSAESD----KSFYREAKTLKELK--HRN 71
++G+ +VY G + D VA+K + + S + E LK++
Sbjct: 11 LLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSG 70
Query: 72 LVKVLGYAWESGKLKALILEYMENGSLESVIHGPGVDHSRWTLPKRIDVLISVANGLDYL 131
++++L + LILE E + V + +
Sbjct: 71 VIRLLDWFERPDSF-VLILERPEPVQDLFDFI---TERGALQEELARSFFWQVLEAVRHC 126
Query: 132 HSGYDIPIVHCDMKPSNILLDRD-FEAHVSDFGTSRMLDVHLQDLSSLSTAFQGTIGYLA 190
H+ ++H D+K NIL+D + E + DFG+ +L ++ T F GT Y
Sbjct: 127 HN---CGVLHRDIKDENILIDLNRGELKLIDFGSGALLK------DTVYTDFDGTRVYSP 177
Query: 191 PE-FAYMRIVTTKVDVFSFGIVVMEFLTKRRPTGLDEENGLSPISLRQLVEKALANGING 249
PE Y R V+S GI++ + + P DEE + RQ
Sbjct: 178 PEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHDEEIIRGQVFFRQ------------ 225
Query: 250 VRQITDPKLVSSIYEEQEQHQVLEELFKLALVCTSSNPEDRPNMNELL 297
+V E L C + P DRP E+
Sbjct: 226 --------------------RVSSECQHLIRWCLALRPSDRPTFEEIQ 253
|
| >d1csna_ d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]} Length = 293 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Casein kinase-1, CK1 species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]
Score = 129 bits (325), Expect = 3e-36
Identities = 49/286 (17%), Positives = 97/286 (33%), Gaps = 38/286 (13%)
Query: 20 IGNSNLSTVYKGR-LEDGEIVAVKKLNFHQFSAESDKSFYREAKTLKELKHRNLVKVLGY 78
IG + +++G L + + VA+K E +T K L + + Y
Sbjct: 13 IGEGSFGVIFEGTNLLNNQQVAIKFEPRRS----DAPQLRDEYRTYKLLAGCTGIPNVYY 68
Query: 79 AWESGKLKALILEYMENGSLESVIHGPGVDHSRWTLPKRIDVLISVANGLDYLHSGYDIP 138
+ G L+++ + + + ++++ + + +H
Sbjct: 69 FGQEGLHNVLVIDLLGPSLEDLLDL----CGRKFSVKTVAMAAKQMLARVQSIHE---KS 121
Query: 139 IVHCDMKPSNILLDRDFEAH-----VSDFGTSRMLD---VHLQDLSSLSTAFQGTIGYLA 190
+V+ D+KP N L+ R + V DFG + GT Y++
Sbjct: 122 LVYRDIKPDNFLIGRPNSKNANMIYVVDFGMVKFYRDPVTKQHIPYREKKNLSGTARYMS 181
Query: 191 PEFAYMRIVTTKVDVFSFGIVVMEFLTKRRPTGLDEENGLSPISLRQLVEKALANGINGV 250
R + + D+ + G V M FL G GL + +Q E+ I
Sbjct: 182 INTHLGREQSRRDDLEALGHVFMYFL-----RGSLPWQGLKAATNKQKYER-----IGEK 231
Query: 251 RQITDPKLVSSIYEEQEQHQVLEELFKLALVCTSSNPEDRPNMNEL 296
+Q T + + + EE +K + + P+ + L
Sbjct: 232 KQSTPLRELCA--------GFPEEFYKYMHYARNLAFDATPDYDYL 269
|
| >d2ozaa1 d.144.1.7 (A:51-385) MAP kinase activated protein kinase 2, mapkap2 {Human (Homo sapiens) [TaxId: 9606]} Length = 335 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase activated protein kinase 2, mapkap2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 129 bits (326), Expect = 6e-36
Identities = 55/287 (19%), Positives = 103/287 (35%), Gaps = 43/287 (14%)
Query: 19 IIGNSNLSTVYKGR-LEDGEIVAVKKLNFHQFSAESDKSFYREAKTL-KELKHRNLVKVL 76
++G V + E A+K L RE + + + ++V+++
Sbjct: 19 VLGLGINGKVLQIFNKRTQEKFALKMLQ-------DCPKARREVELHWRASQCPHIVRIV 71
Query: 77 GY---AWESGKLKALILEYMENGSLESVIHGPGVDHSRWTLPKRIDVLISVANGLDYLHS 133
+ K +++E ++ G L S I G +T + +++ S+ + YLHS
Sbjct: 72 DVYENLYAGRKCLLIVMECLDGGELFSRIQDRG--DQAFTEREASEIMKSIGEAIQYLHS 129
Query: 134 GYDIPIVHCDMKPSNILLDRDFE---AHVSDFGTSRMLDVHLQDLSSLSTAFQGTIGYLA 190
I I H D+KP N+L ++DFG ++ H + T T Y+A
Sbjct: 130 ---INIAHRDVKPENLLYTSKRPNAILKLTDFGFAKETTSH-----NSLTTPCYTPYYVA 181
Query: 191 PEFAYMRIVTTKVDVFSFGIVVMEFLTKRRPTGLDEENGLSPISLRQLVEKALANGINGV 250
PE D++S G+++ L P + +SP ++
Sbjct: 182 PEVLGPEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAISPGMKTRIRMGQYE------ 235
Query: 251 RQITDPKLVSSIYEEQEQHQVLEELFKLALVCTSSNPEDRPNMNELL 297
+ E +V EE+ L + P R + E +
Sbjct: 236 ------------FPNPEWSEVSEEVKMLIRNLLKTEPTQRMTITEFM 270
|
| >d1pmea_ d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606]} Length = 345 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase Erk2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 128 bits (321), Expect = 3e-35
Identities = 54/299 (18%), Positives = 104/299 (34%), Gaps = 20/299 (6%)
Query: 9 NATGSFSENNIIGNSNLSTVYKGR-LEDGEIVAVKKLNFHQFSAESDKSFYREAKTLKEL 67
+ ++ + IG V + VA+KK++ + + RE K L
Sbjct: 5 DVGPRYTNLSYIGEGAYGMVCSAYDNVNKVRVAIKKISPFEHQTYCQR-TLREIKILLRF 63
Query: 68 KHRNLVKVLGYAWESG---KLKALILEYMENGSLESVIHGPGVDHSRWTLPKRIDVLISV 124
+H N++ + ++ ++ L ++ + L +
Sbjct: 64 RHENIIGINDIIRAPTIEQMKDVYLVTHLMGADLYKLLK-----TQHLSNDHICYFLYQI 118
Query: 125 ANGLDYLHSGYDIPIVHCDMKPSNILLDRDFEAHVSDFGTSRMLDVHLQDLSSLSTAFQG 184
GL Y+HS ++H D+KPSN+LL+ + + DFG +R+ D D + T +
Sbjct: 119 LRGLKYIHSA---NVLHRDLKPSNLLLNTTCDLKICDFGLARVADPD-HDHTGFLTEYVA 174
Query: 185 TIGYLAPEFAYMRIVTT-KVDVFSFGIVVMEFLTKRRPTGLDEENGLSPISLRQLV---- 239
T Y APE T +D++S G ++ E L+ R L L
Sbjct: 175 TRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGILGSPSQ 234
Query: 240 -EKALANGINGVRQITDPKLVSSIYEEQEQHQVLEELFKLALVCTSSNPEDRPNMNELL 297
+ + + + + + + L + NP R + + L
Sbjct: 235 EDLNCIINLKARNYLLSLPHKNKVPWNRLFPNADSKALDLLDKMLTFNPHKRIEVEQAL 293
|
| >d1jksa_ d.144.1.7 (A:) Death-associated protein kinase, Dap {Human (Homo sapiens) [TaxId: 9606]} Length = 293 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Death-associated protein kinase, Dap species: Human (Homo sapiens) [TaxId: 9606]
Score = 125 bits (315), Expect = 1e-34
Identities = 56/287 (19%), Positives = 101/287 (35%), Gaps = 44/287 (15%)
Query: 20 IGNSNLSTVYKGR-LEDGEIVAVKKLNFHQFSAESD----KSFYREAKTLKELKHRNLVK 74
+G+ + V K R G A K + + + + RE LKE++H N++
Sbjct: 18 LGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQHPNVIT 77
Query: 75 VLGYAWESGKLKALILEYMENGSLESVIHGPGVDHSRWTLPKRIDVLISVANGLDYLHSG 134
+ + LILE + G L + + T + + L + NG+ YLHS
Sbjct: 78 LHEVYENKTDV-ILILELVAGGELFDFLA----EKESLTEEEATEFLKQILNGVYYLHSL 132
Query: 135 YDIPIVHCDMKPSNILLDRD----FEAHVSDFGTSRMLDVHLQDLSSLSTAFQGTIGYLA 190
I H D+KP NI+L + DFG + +D + GT ++A
Sbjct: 133 Q---IAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDF-----GNEFKNIFGTPEFVA 184
Query: 191 PEFAYMRIVTTKVDVFSFGIVVMEFLTKRRPTGLDEENGLSPISLRQLVEKALANGINGV 250
PE + + D++S G++ L+ P G
Sbjct: 185 PEIVNYEPLGLEADMWSIGVITYILLSGASPF----------------------LGDTKQ 222
Query: 251 RQITDPKLVSSIYEEQEQHQVLEELFKLALVCTSSNPEDRPNMNELL 297
+ + V+ +E++ +P+ R + + L
Sbjct: 223 ETLANVSAVNYEFEDEYFSNTSALAKDFIRRLLVKDPKKRMTIQDSL 269
|
| >d1cm8a_ d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo sapiens) [TaxId: 9606]} Length = 346 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase p38-gamma species: Human (Homo sapiens) [TaxId: 9606]
Score = 121 bits (303), Expect = 1e-32
Identities = 67/317 (21%), Positives = 110/317 (34%), Gaps = 42/317 (13%)
Query: 2 FDRTEIENATGSFSEN----NIIGNSNLSTVYKGR-LEDGEIVAVKKLNFHQFSAESDKS 56
F R E+ +G+ V G VA+KKL S K
Sbjct: 4 FYRQEVTKTAWEVRAVYRDLQPVGSGAYGAVCSAVDGRTGAKVAIKKLYRPFQSELFAKR 63
Query: 57 FYREAKTLKELKHRNLVKVLGYAWESGKLKA-----LILEYMENGSLESVIHGPGVDHSR 111
YRE + LK ++H N++ +L L L++ +M + + H +
Sbjct: 64 AYRELRLLKHMRHENVIGLLDVFTPDETLDDFTDFYLVMPFMGTDLGKLMKHE------K 117
Query: 112 WTLPKRIDVLISVANGLDYLHSGYDIPIVHCDMKPSNILLDRDFEAHVSDFGTSRMLDVH 171
+ ++ + GL Y+H+ I+H D+KP N+ ++ D E + DFG +R D
Sbjct: 118 LGEDRIQFLVYQMLKGLRYIHAAG---IIHRDLKPGNLAVNEDCELKILDFGLARQADSE 174
Query: 172 LQDLSSLSTAFQGTIGYLAPEFAY-MRIVTTKVDVFSFGIVVMEFLTKRRPTGLDEEN-- 228
+ T + T Y APE T VD++S G ++ E +T + +
Sbjct: 175 M-------TGYVVTRWYRAPEVILNWMRYTQTVDIWSVGCIMAEMITGKTLFKGSDHLDQ 227
Query: 229 --------GLSPISLRQLVEKALANGINGVRQITDPKLVSSIYEEQEQHQVLEELFKLAL 280
G P Q ++ A + K +SI L
Sbjct: 228 LKEIMKVTGTPPAEFVQRLQSDEAKNYMKGLPELEKKDFASILTN-----ASPLAVNLLE 282
Query: 281 VCTSSNPEDRPNMNELL 297
+ E R E L
Sbjct: 283 KMLVLDAEQRVTAGEAL 299
|
| >d3bqca1 d.144.1.7 (A:3-330) Protein kinase CK2, alpha subunit {Rattus norvegicus [TaxId: 10116]} Length = 328 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase CK2, alpha subunit species: Rattus norvegicus [TaxId: 10116]
Score = 117 bits (293), Expect = 2e-31
Identities = 53/297 (17%), Positives = 101/297 (34%), Gaps = 37/297 (12%)
Query: 18 NIIGNSNLSTVYKGR-LEDGEIVAVKKLNFHQFSAESDKSFYREAKTLKELK-HRNLVKV 75
+G S V++ + + E V VK L K RE K L+ L+ N++ +
Sbjct: 41 RKLGRGKYSEVFEAINITNNEKVVVKILK-----PVKKKKIKREIKILENLRGGPNIITL 95
Query: 76 LG-YAWESGKLKALILEYMENGSLESVIHGPGVDHSRWTLPKRIDVLISVANGLDYLHSG 134
+ AL+ E++ N + + R+ + + LDY HS
Sbjct: 96 ADIVKDPVSRTPALVFEHVNNTDFKQLYQTLTDYDIRF-------YMYEILKALDYCHS- 147
Query: 135 YDIPIVHCDMKPSNILLDRDF-EAHVSDFGTSRMLDVHLQDLSSLSTAFQGTIGYLAPE- 192
+ I+H D+KP N+++D + + + D+G + + + PE
Sbjct: 148 --MGIMHRDVKPHNVMIDHEHRKLRLIDWGLAEFYHP-----GQEYNVRVASRYFKGPEL 200
Query: 193 FAYMRIVTTKVDVFSFGIVVMEFLTKRRP--TGLDEENGLSPI----------SLRQLVE 240
++ +D++S G ++ + ++ P G D + L I
Sbjct: 201 LVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVRIAKVLGTEDLYDYIDKYN 260
Query: 241 KALANGINGVRQITDPKLVSSIYEEQEQHQVLEELFKLALVCTSSNPEDRPNMNELL 297
L N + K + QH V E + + R E +
Sbjct: 261 IELDPRFNDILGRHSRKRWERFVHSENQHLVSPEALDFLDKLLRYDHQSRLTAREAM 317
|
| >d1o6la_ d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9606]} Length = 337 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Pkb kinase (Akt-2) species: Human (Homo sapiens) [TaxId: 9606]
Score = 117 bits (293), Expect = 3e-31
Identities = 57/284 (20%), Positives = 97/284 (34%), Gaps = 40/284 (14%)
Query: 14 FSENNIIGNSNLSTVYKGR-LEDGEIVAVKKLNFHQFSAESD-KSFYREAKTLKELKHRN 71
F ++G V R G A+K L A+ + E++ L+ +H
Sbjct: 7 FDYLKLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPF 66
Query: 72 LVKVLGYAWESGKLKALILEYMENGSLESVIHGPGVDHSRWTLPKRIDVLISVANGLDYL 131
L + +L ++EY G L + +T + + + L+YL
Sbjct: 67 LTALKYAFQTHDRL-CFVMEYANGGELFFHLS----RERVFTEERARFYGAEIVSALEYL 121
Query: 132 HSGYDIPIVHCDMKPSNILLDRDFEAHVSDFGTSRMLDVHLQDLSSLSTAFQGTIGYLAP 191
H +V+ D+K N++LD+D ++DFG + + F GT YLAP
Sbjct: 122 H---SRDVVYRDIKLENLMLDKDGHIKITDFGLCK----EGISDGATMKTFCGTPEYLAP 174
Query: 192 EFAYMRIVTTKVDVFSFGIVVMEFLTKRRPTGLDEENGLSPISLRQLVEKALANGINGVR 251
E VD + G+V+ E + R P L +L+
Sbjct: 175 EVLEDNDYGRAVDWWGLGVVMYEMMCGRLPF-----YNQDHERLFELILM---------E 220
Query: 252 QITDPKLVSSIYEEQEQHQVLEELFKLALVCTSSNPEDRPNMNE 295
+I P+ +S E L +P+ R
Sbjct: 221 EIRFPRTLS------------PEAKSLLAGLLKKDPKQRLGGGP 252
|
| >d1rdqe_ d.144.1.7 (E:) cAMP-dependent PK, catalytic subunit {Mouse (Mus musculus) [TaxId: 10090]} Length = 350 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: cAMP-dependent PK, catalytic subunit species: Mouse (Mus musculus) [TaxId: 10090]
Score = 113 bits (283), Expect = 1e-29
Identities = 44/205 (21%), Positives = 85/205 (41%), Gaps = 17/205 (8%)
Query: 19 IIGNSNLSTVYKGR-LEDGEIVAVKKLNFHQFSAESD-KSFYREAKTLKELKHRNLVKVL 76
+G + V + E G A+K L+ + + E + L+ + LVK+
Sbjct: 48 TLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLE 107
Query: 77 GYAWESGKLKALILEYMENGSLESVIHGPGVDHSRWTLPKRIDVLISVANGLDYLHSGYD 136
++ L ++EY+ G + S + R++ P + +YLHS
Sbjct: 108 FSFKDNSNLYM-VMEYVAGGEMFSHLR----RIGRFSEPHARFYAAQIVLTFEYLHS--- 159
Query: 137 IPIVHCDMKPSNILLDRDFEAHVSDFGTSRMLDVHLQDLSSLSTAFQGTIGYLAPEFAYM 196
+ +++ D+KP N+L+D+ V+DFG ++ + + GT LAPE
Sbjct: 160 LDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGR-------TWTLCGTPEALAPEIILS 212
Query: 197 RIVTTKVDVFSFGIVVMEFLTKRRP 221
+ VD ++ G+++ E P
Sbjct: 213 KGYNKAVDWWALGVLIYEMAAGYPP 237
|
| >d2b1pa1 d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3s) {Human (Homo sapiens) [TaxId: 9606]} Length = 355 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-jun N-terminal kinase (jnk3s) species: Human (Homo sapiens) [TaxId: 9606]
Score = 111 bits (279), Expect = 4e-29
Identities = 62/301 (20%), Positives = 111/301 (36%), Gaps = 37/301 (12%)
Query: 19 IIGNSNLSTVYKGR-LEDGEIVAVKKLNFHQFSAESDKSFYREAKTLKELKHRNLVKVLG 77
IG+ V VA+KKL+ + K YRE +K + H+N++ +L
Sbjct: 24 PIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISLLN 83
Query: 78 YAWESGKLK-----ALILEYMENGSLESVIHGPGVDHSRWTLPKRIDVLISVANGLDYLH 132
L+ L++E M+ + + + +L + G+ +LH
Sbjct: 84 VFTPQKTLEEFQDVYLVMELMDANLCQVIQM-------ELDHERMSYLLYQMLCGIKHLH 136
Query: 133 SGYDIPIVHCDMKPSNILLDRDFEAHVSDFGTSRMLDVHLQDLSSLSTAFQGTIGYLAPE 192
S I+H D+KPSNI++ D + DFG +R S + T + T Y APE
Sbjct: 137 SAG---IIHRDLKPSNIVVKSDCTLKILDFGLAR-----TAGTSFMMTPYVVTRYYRAPE 188
Query: 193 FAYMRIVTTKVDVFSFGIVVMEFLTKRRP-TGLDEENGLSPI-------------SLRQL 238
VD++S G ++ E + + G D + + + L+
Sbjct: 189 VILGMGYKENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQLGTPCPEFMKKLQPT 248
Query: 239 VEKALANGINGVRQITDPKLVSSIYEEQEQHQVL--EELFKLALVCTSSNPEDRPNMNEL 296
V + N S++ +H L + L +P R ++++
Sbjct: 249 VRNYVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRISVDDA 308
Query: 297 L 297
L
Sbjct: 309 L 309
|
| >d1vzoa_ d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5, Msk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 322 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Ribosomal protein S6 kinase alpha 5, Msk1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 111 bits (277), Expect = 4e-29
Identities = 57/230 (24%), Positives = 103/230 (44%), Gaps = 19/230 (8%)
Query: 18 NIIGNSNLSTVYKGRL----EDGEIVAVKKLNFHQFSAESD--KSFYREAKTLKELKHRN 71
++G V+ R + G++ A+K L ++ + E + L+ ++
Sbjct: 30 KVLGTGAYGKVFLVRKISGHDTGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSP 89
Query: 72 LVKVLGYAWESGKLKALILEYMENGSLESVIHGPGVDHSRWTLPKRIDVLISVANGLDYL 131
+ L YA+++ LIL+Y+ G L + + R+T + + + L++L
Sbjct: 90 FLVTLHYAFQTETKLHLILDYINGGELFTHLS----QRERFTEHEVQIYVGEIVLALEHL 145
Query: 132 HSGYDIPIVHCDMKPSNILLDRDFEAHVSDFGTSRMLDVHLQDLSSLSTAFQGTIGYLAP 191
H + I++ D+K NILLD + ++DFG S+ + + F GTI Y+AP
Sbjct: 146 H---KLGIIYRDIKLENILLDSNGHVVLTDFGLSKEFVAD---ETERAYDFCGTIEYMAP 199
Query: 192 EFAYM--RIVTTKVDVFSFGIVVMEFLTKRRP-TGLDEENGLSPISLRQL 238
+ VD +S G+++ E LT P T E+N + IS R L
Sbjct: 200 DIVRGGDSGHDKAVDWWSLGVLMYELLTGASPFTVDGEKNSQAEISRRIL 249
|
| >d2gfsa1 d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606]} Length = 348 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase p38 species: Human (Homo sapiens) [TaxId: 9606]
Score = 110 bits (276), Expect = 9e-29
Identities = 63/310 (20%), Positives = 109/310 (35%), Gaps = 28/310 (9%)
Query: 2 FDRTEIENATGSFSEN----NIIGNSNLSTVYKGR-LEDGEIVAVKKLNFHQFSAESDKS 56
F R E+ E + +G+ +V + G VAVKKL+ S K
Sbjct: 4 FYRQELNKTIWEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKR 63
Query: 57 FYREAKTLKELKHRNLVKVLGYAWESGKLK----ALILEYMENGSLESVIHGPGVDHSRW 112
YRE + LK +KH N++ +L + L+ ++ ++ L +++ +
Sbjct: 64 TYRELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVK-----CQKL 118
Query: 113 TLPKRIDVLISVANGLDYLHSGYDIPIVHCDMKPSNILLDRDFEAHVSDFGTSRMLDVHL 172
T ++ + GL Y+HS I+H D+KPSN+ ++ D E + DFG +R D +
Sbjct: 119 TDDHVQFLIYQILRGLKYIHSAD---IIHRDLKPSNLAVNEDCELKILDFGLARHTDDEM 175
Query: 173 QDLSSLSTAFQGTIGYLAPEFAYMRIVTTKVDVFSFGIVVMEFLTKRRP-TGLDEENGLS 231
VD++S G ++ E LT R G D + L
Sbjct: 176 T------GYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLK 229
Query: 232 PISLRQLVEKA----LANGINGVRQITDPKLVSSIYEEQEQHQVLEELFKLALVCTSSNP 287
I A + + I + + L +
Sbjct: 230 LILRLVGTPGAELLKKISSESARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDS 289
Query: 288 EDRPNMNELL 297
+ R + L
Sbjct: 290 DKRITAAQAL 299
|
| >d1q8ya_ d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} Length = 362 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Sky1p species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]
Score = 92.0 bits (227), Expect = 7e-22
Identities = 49/315 (15%), Positives = 96/315 (30%), Gaps = 46/315 (14%)
Query: 20 IGNSNLSTVYKGR-LEDGEIVAVKKLNFHQFSAESDKSFYREAKTLKELKHRNLVKVLG- 77
+G + STV+ + + + VA+K + + E+ E K L+ + + K
Sbjct: 21 LGWGHFSTVWLAKDMVNNTHVAMKIVRGDKVYTEA---AEDEIKLLQRVNDADNTKEDSM 77
Query: 78 -------------YAWESGKLKALILEYMENGSLESVIHGPGVDHSRWTLPKRIDVLISV 124
+ +G ++ E + L + H L + +
Sbjct: 78 GANHILKLLDHFNHKGPNGVHVVMVFEVLGENLLALIKKYE---HRGIPLIYVKQISKQL 134
Query: 125 ANGLDYLHSGYDIPIVHCDMKPSNILLDRDFEAHVSDFGTSRMLDVHLQDLSSLSTAFQG 184
GLDY+H I+H D+KP N+L++ L T
Sbjct: 135 LLGLDYMH--RRCGIIHTDIKPENVLMEIVDSPENLIQIKIADLGNACWYDEH-YTNSIQ 191
Query: 185 TIGYLAPEFAYMRIVTTKVDVFSFGIVVMEFLTKRRP-TGLDEENGLSPISLRQLVEKAL 243
T Y +PE D++S ++ E +T + + + + L
Sbjct: 192 TREYRSPEVLLGAPWGCGADIWSTACLIFELITGDFLFEPDEGHSYTKDDDHIAQIIELL 251
Query: 244 -----------------ANGINGVRQITDPKLVSSIYEEQEQHQVLEELFKLAL----VC 282
N +R I+ K E+++ ++ K
Sbjct: 252 GELPSYLLRNGKYTRTFFNSRGLLRNISKLKFWPLEDVLTEKYKFSKDEAKEISDFLSPM 311
Query: 283 TSSNPEDRPNMNELL 297
+P R + L+
Sbjct: 312 LQLDPRKRADAGGLV 326
|
| >d1zara2 d.144.1.9 (A:91-281) Rio2 serine protein kinase C-terminal domain {Archaeoglobus fulgidus [TaxId: 2234]} Length = 191 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: RIO1-like kinases domain: Rio2 serine protein kinase C-terminal domain species: Archaeoglobus fulgidus [TaxId: 2234]
Score = 78.3 bits (192), Expect = 5e-18
Identities = 37/205 (18%), Positives = 64/205 (31%), Gaps = 27/205 (13%)
Query: 18 NIIGNSNLSTVYKGRLEDGEIVAVKKLNFHQFSAES--------DKSFYREAKTLKELKH 69
++G S V+ E VK S + D F A +
Sbjct: 6 KLMGEGKESAVFNCYSEKFGECVVKFHKVGHTSFKKVKEKRDYGDLHFSVLAIRSARNEF 65
Query: 70 RNLVKVLGYAWESGKLKALILEYMENGSLESVIHGPGVDHSRWTLPKRIDVLISVANGLD 129
R L K+ G A + + N L +I + R P + L + +
Sbjct: 66 RALQKLQGLAVPK------VYAWEGNAVLMELIDAKELYRVRVENPDEV--LDMILEEVA 117
Query: 130 YLHSGYDIPIVHCDMKPSNILLDRDFEAHVSDFGTSRMLDVHLQDLSSLSTAFQGTIGYL 189
+ IVH D+ N+L+ + + DF S + L + I Y
Sbjct: 118 KFYHRG---IVHGDLSQYNVLVS-EEGIWIIDFPQSVEVG-EEGWREILERDVRNIITY- 171
Query: 190 APEFAYMRIVTTKVDVFSFGIVVME 214
+ R T+ D+ S +++
Sbjct: 172 -----FSRTYRTEKDINSAIDRILQ 191
|
Homologous Domains Detected by HHsearch
Original result of HHsearch against SCOP70(version1.75) database
| ID | Alignment Graph | Length |
Definition |
Probability |
| Query | 299 | |||
| d2java1 | 269 | Serine/threonine-protein kinase Nek2 {Human (Homo | 100.0 | |
| d1nvra_ | 271 | Cell cycle checkpoint kinase chk1 {Human (Homo sap | 100.0 | |
| d1yhwa1 | 293 | pak1 {Human (Homo sapiens) [TaxId: 9606]} | 100.0 | |
| d2j4za1 | 263 | Aurora-related kinase 1 (aurora-2) {Human (Homo sa | 100.0 | |
| d1t4ha_ | 270 | Protein kinase wnk1 {Human (Homo sapiens) [TaxId: | 100.0 | |
| d1s9ja_ | 322 | Dual specificity mitogen-activated protein kinase | 100.0 | |
| d2jfla1 | 288 | STE20-like serine/threonine-protein kinase, SLK {H | 100.0 | |
| d1a06a_ | 307 | Calmodulin-dependent protein kinase {Rat (Rattus n | 100.0 | |
| d1uu3a_ | 288 | 3-phosphoinositide dependent protein kinase-1 Pdk1 | 100.0 | |
| d1uwha_ | 276 | B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]} | 100.0 | |
| d1jksa_ | 293 | Death-associated protein kinase, Dap {Human (Homo | 100.0 | |
| d1koaa2 | 350 | Twitchin, kinase domain {Caenorhabditis elegans, p | 100.0 | |
| d1u5ra_ | 309 | Serine/threonine protein kinase TAO2 {Rat (Rattus | 100.0 | |
| d1qpca_ | 272 | Lymphocyte kinase (lck) {Human (Homo sapiens) [Tax | 100.0 | |
| d1koba_ | 352 | Twitchin, kinase domain {California sea hare (Aply | 100.0 | |
| d1opja_ | 287 | Abelsone tyrosine kinase (abl) {Mouse (Mus musculu | 100.0 | |
| d1o6la_ | 337 | Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9 | 100.0 | |
| d1sm2a_ | 263 | Tyrosine-protein kinase Itk/Tsk {Human (Homo sapie | 100.0 | |
| d1k2pa_ | 258 | Bruton's tyrosine kinase (Btk) {Human (Homo sapien | 100.0 | |
| d1fota_ | 316 | cAMP-dependent PK, catalytic subunit {Baker's yeas | 100.0 | |
| d1tkia_ | 321 | Titin, kinase domain {Human (Homo sapiens) [TaxId: | 100.0 | |
| d1rdqe_ | 350 | cAMP-dependent PK, catalytic subunit {Mouse (Mus m | 100.0 | |
| d1phka_ | 277 | gamma-subunit of glycogen phosphorylase kinase (Ph | 100.0 | |
| d1xbba_ | 277 | Tyrosine-protein kinase SYK {Human (Homo sapiens) | 100.0 | |
| d1jpaa_ | 299 | ephb2 receptor tyrosine kinase {Mouse (Mus musculu | 100.0 | |
| d1rjba_ | 325 | Fl cytokine receptor {Human (Homo sapiens) [TaxId: | 100.0 | |
| d1fmka3 | 285 | c-src tyrosine kinase {Human (Homo sapiens) [TaxId | 100.0 | |
| d1xjda_ | 320 | Protein kinase C, theta type {Human (Homo sapiens) | 100.0 | |
| d2ozaa1 | 335 | MAP kinase activated protein kinase 2, mapkap2 {Hu | 100.0 | |
| d1omwa3 | 364 | G-protein coupled receptor kinase 2 {Cow (Bos taur | 100.0 | |
| d1ob3a_ | 286 | Cyclin-dependent PK, CDK2 {(Plasmodium falciparum) | 100.0 | |
| d1u59a_ | 285 | Tyrosine-protein kinase ZAP-70 {Human (Homo sapien | 100.0 | |
| d1ua2a_ | 299 | Cell division protein kinase 7, CDK7 {Human (Homo | 100.0 | |
| d1o6ya_ | 277 | Mycobacterial protein kinase PknB, catalytic domai | 100.0 | |
| d1gz8a_ | 298 | Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [T | 100.0 | |
| d1mp8a_ | 273 | Focal adhesion kinase 1 (fak) {Human (Homo sapiens | 100.0 | |
| d1blxa_ | 305 | Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [T | 100.0 | |
| d1mqba_ | 283 | epha2 receptor tyrosine kinase {Human (Homo sapien | 100.0 | |
| d3blha1 | 318 | Cell division protein kinase 9, CDK9 {Human (Homo | 100.0 | |
| d1xwsa_ | 273 | Proto-oncogene serine/threonine-protein kinase Pim | 100.0 | |
| d1ywna1 | 299 | Vascular endothelial growth factor receptor 2 (kdr | 100.0 | |
| d1byga_ | 262 | Carboxyl-terminal src kinase (csk) {Human (Homo sa | 100.0 | |
| d1cm8a_ | 346 | MAP kinase p38-gamma {Human (Homo sapiens) [TaxId: | 100.0 | |
| d1xkka_ | 317 | EGF receptor tyrosine kinase, Erbb-1 {Human (Homo | 100.0 | |
| d1unla_ | 292 | Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [T | 100.0 | |
| d1r0pa_ | 311 | Hepatocyte growth factor receptor, c-MET {Human (H | 100.0 | |
| d1vjya_ | 303 | Type I TGF-beta receptor R4 {Human (Homo sapiens) | 100.0 | |
| d2b1pa1 | 355 | c-jun N-terminal kinase (jnk3s) {Human (Homo sapie | 100.0 | |
| d1lufa_ | 301 | Musk tyrosine kinase {Rat (Rattus norvegicus) [Tax | 100.0 | |
| d1u46a_ | 273 | Activated CDC42 kinase 1, ACK1 {Human (Homo sapien | 100.0 | |
| d1pmea_ | 345 | MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606 | 100.0 | |
| d1fgka_ | 299 | Fibroblast growth factor receptor 1 {Human (Homo s | 100.0 | |
| d3bqca1 | 328 | Protein kinase CK2, alpha subunit {Rattus norvegic | 100.0 | |
| d1q5ka_ | 350 | Glycogen synthase kinase-3 beta (Gsk3b) {Human (Ho | 100.0 | |
| d1fvra_ | 309 | Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]} | 100.0 | |
| d1t46a_ | 311 | c-KIT receptor {Human (Homo sapiens) [TaxId: 9606] | 100.0 | |
| d2gfsa1 | 348 | MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606] | 100.0 | |
| d1vzoa_ | 322 | Ribosomal protein S6 kinase alpha 5, Msk1 {Human ( | 100.0 | |
| d1p4oa_ | 308 | Insulin-like growth factor 1 receptor {Human (Homo | 100.0 | |
| d1ckia_ | 299 | Casein kinase-1, CK1 {Rat (Rattus norvegicus) [Tax | 100.0 | |
| d1csna_ | 293 | Casein kinase-1, CK1 {Fission yeast (Schizosacchar | 100.0 | |
| d1q8ya_ | 362 | Sky1p {Baker's yeast (Saccharomyces cerevisiae) [T | 100.0 | |
| d1zara2 | 191 | Rio2 serine protein kinase C-terminal domain {Arch | 99.92 | |
| d1j7la_ | 263 | Type IIIa 3',5"-aminoglycoside phosphotransferase | 98.84 | |
| d1nd4a_ | 255 | Aminoglycoside 3'-phosphotransferase IIa (Kanamyci | 98.3 | |
| d2pula1 | 392 | Methylthioribose kinase MtnK {Bacillus subtilis [T | 98.1 | |
| d2ppqa1 | 316 | Homoserine kinase ThrB {Agrobacterium tumefaciens | 97.78 | |
| d1nw1a_ | 395 | Choline kinase {Caenorhabditis elegans [TaxId: 623 | 97.66 | |
| d1zyla1 | 325 | RdoA {Escherichia coli [TaxId: 562]} | 97.27 |
| >d2java1 d.144.1.7 (A:3-271) Serine/threonine-protein kinase Nek2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Serine/threonine-protein kinase Nek2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2e-58 Score=379.64 Aligned_cols=260 Identities=24% Similarity=0.352 Sum_probs=201.3
Q ss_pred hCCCCCCceeecCCcceEEEEEeC-CCcEEEEEEeccCcCChhhhHHHHHHHHHHHhcCCcceeeeeeEEEcC-CCeeEE
Q 038766 11 TGSFSENNIIGNSNLSTVYKGRLE-DGEIVAVKKLNFHQFSAESDKSFYREAKTLKELKHRNLVKVLGYAWES-GKLKAL 88 (299)
Q Consensus 11 ~~~y~~~~~lg~g~~~~v~~~~~~-~~~~~~vK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~-~~~~~l 88 (299)
.++|.+.+.||+|+||+||+|.+. +|+.||+|++..........+.+.+|++++++++||||+++++++.+. ++.+++
T Consensus 3 ~edy~~~~~iG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~~~i 82 (269)
T d2java1 3 AEDYEVLYTIGTGSYGRCQKIRRKSDGKILVWKELDYGSMTEAEKQMLVSEVNLLRELKHPNIVRYYDRIIDRTNTTLYI 82 (269)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECCTTSCHHHHHHHHHHHHHTTSCCCTTBCCEEEEEEC----CEEE
T ss_pred chhCEEeEEEecCCCeEEEEEEECCCCCEEEEEEEChhhCCHHHHHHHHHHHHHHHHCCCCCEeeEEEEEEeCCCCEEEE
Confidence 468999999999999999999874 689999999987776777778899999999999999999999987653 455689
Q ss_pred EEeecCCCChHHHhcCCCCCCCCCChhhHHHHHHHHHHHHHHhhcCC--CCCeeeecccCCceeeCCCCcEEEeeecccc
Q 038766 89 ILEYMENGSLESVIHGPGVDHSRWTLPKRIDVLISVANGLDYLHSGY--DIPIVHCDMKPSNILLDRDFEAHVSDFGTSR 166 (299)
Q Consensus 89 v~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lh~~~--~~~~~H~dl~~~nil~~~~~~v~l~df~~~~ 166 (299)
||||+++|+|.+++.........+++..++.++.|++.||+|||+.+ ..+++||||||+|||++.++.+||+|||++.
T Consensus 83 vmEy~~~g~L~~~i~~~~~~~~~l~e~~~~~i~~qi~~al~ylH~~~~~~~~IiHrDiKp~NIll~~~~~vkl~DFG~a~ 162 (269)
T d2java1 83 VMEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLALKECHRRSDGGHTVLHRDLKPANVFLDGKQNVKLGDFGLAR 162 (269)
T ss_dssp EEECCTTEEHHHHHHHHHHHTCCCCHHHHHHHHHHHHHHHHHHHHHCC---------CCGGGEEECTTSCEEECCHHHHH
T ss_pred EEecCCCCcHHHHHHhccccCCCCCHHHHHHHHHHHHHHHHHHHHhcCCCCCEEeCcCchhhcCcCCCCcEEEeecccee
Confidence 99999999999988643324567999999999999999999999861 1149999999999999999999999999998
Q ss_pred ccccccccccccccccccCcccCChhhhcccCcCccccchhhhHHHHHHHhCCCCCCCCccCCCCchhHHHHHHHHHhcC
Q 038766 167 MLDVHLQDLSSLSTAFQGTIGYLAPEFAYMRIVTTKVDVFSFGIVVMEFLTKRRPTGLDEENGLSPISLRQLVEKALANG 246 (299)
Q Consensus 167 ~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~DiwslG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~ 246 (299)
.+.. .........+|+.|+|||++.+..++.++|||||||++|+|++|..||... ... +.........
T Consensus 163 ~~~~----~~~~~~~~~gt~~Y~APE~l~~~~~~~~~DIwSlGvilyel~tg~~Pf~~~-----~~~---~~~~~i~~~~ 230 (269)
T d2java1 163 ILNH----DTSFAKAFVGTPYYMSPEQMNRMSYNEKSDIWSLGCLLYELCALMPPFTAF-----SQK---ELAGKIREGK 230 (269)
T ss_dssp HC---------------CCCSCCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCSCCCS-----SHH---HHHHHHHHTC
T ss_pred eccc----CCCccccCCCCcccCCHHHHcCCCCChHHHHHhhCHHHHHHhhCCCCCCCC-----CHH---HHHHHHHcCC
Confidence 6542 122334567899999999999999999999999999999999999999532 222 2222222211
Q ss_pred ccCcccccCccccchhhHhHHHHHHHHHHHHHHHHhcCCCCCCCCChhhhhcC
Q 038766 247 INGVRQITDPKLVSSIYEEQEQHQVLEELFKLALVCTSSNPEDRPNMNELLIT 299 (299)
Q Consensus 247 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rpt~~~il~~ 299 (299)
.... +..+++++.+||++||..||++|||++|+|+|
T Consensus 231 ~~~~-----------------~~~~s~~l~~li~~~L~~dp~~Rps~~ell~h 266 (269)
T d2java1 231 FRRI-----------------PYRYSDELNEIITRMLNLKDYHRPSVEEILEN 266 (269)
T ss_dssp CCCC-----------------CTTSCHHHHHHHHHHTCSSGGGSCCHHHHHTS
T ss_pred CCCC-----------------CcccCHHHHHHHHHHcCCChhHCcCHHHHHhC
Confidence 1111 12345689999999999999999999999997
|
| >d1nvra_ d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell cycle checkpoint kinase chk1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=9.2e-58 Score=375.59 Aligned_cols=256 Identities=25% Similarity=0.325 Sum_probs=204.0
Q ss_pred HhCCCCCCceeecCCcceEEEEEeC-CCcEEEEEEeccCcCChhhhHHHHHHHHHHHhcCCcceeeeeeEEEcCCCeeEE
Q 038766 10 ATGSFSENNIIGNSNLSTVYKGRLE-DGEIVAVKKLNFHQFSAESDKSFYREAKTLKELKHRNLVKVLGYAWESGKLKAL 88 (299)
Q Consensus 10 ~~~~y~~~~~lg~g~~~~v~~~~~~-~~~~~~vK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~l 88 (299)
..++|++.+.||+|+||+||+|.+. +|+.||+|++.... ..+..+.+.+|+.++++++||||+++++++.+ ++..++
T Consensus 3 f~~dy~~~~~lG~G~fg~V~~~~~~~~~~~vAiK~i~~~~-~~~~~~~~~~Ei~~l~~l~HpnIv~~~~~~~~-~~~~~i 80 (271)
T d1nvra_ 3 FVEDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKR-AVDCPENIKKEICINKMLNHENVVKFYGHRRE-GNIQYL 80 (271)
T ss_dssp TTTEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECC--------CHHHHHHHHHTCCCTTBCCEEEEEEE-TTEEEE
T ss_pred CCcceEEEEEEecCcCeEEEEEEECCCCCEEEEEEEehhh-cchHHHHHHHHHHHHHhCCCCCEeeEeeeecc-CceeEE
Confidence 3578999999999999999999874 68999999997543 23345678899999999999999999997665 556699
Q ss_pred EEeecCCCChHHHhcCCCCCCCCCChhhHHHHHHHHHHHHHHhhcCCCCCeeeecccCCceeeCCCCcEEEeeecccccc
Q 038766 89 ILEYMENGSLESVIHGPGVDHSRWTLPKRIDVLISVANGLDYLHSGYDIPIVHCDMKPSNILLDRDFEAHVSDFGTSRML 168 (299)
Q Consensus 89 v~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lh~~~~~~~~H~dl~~~nil~~~~~~v~l~df~~~~~~ 168 (299)
||||+++++|.+++. ....+++.+++.++.||++||+|||++ +++||||||+|||++.++.+||+|||++...
T Consensus 81 vmEy~~gg~L~~~l~----~~~~l~e~~~~~i~~qi~~al~ylH~~---~IiHrDiKp~NILl~~~~~~KL~DFG~a~~~ 153 (271)
T d1nvra_ 81 FLEYCSGGELFDRIE----PDIGMPEPDAQRFFHQLMAGVVYLHGI---GITHRDIKPENLLLDERDNLKISDFGLATVF 153 (271)
T ss_dssp EEECCTTEEGGGGSB----TTTBCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCCGGGEEECTTCCEEECCCTTCEEC
T ss_pred EEeccCCCcHHHHHh----cCCCCCHHHHHHHHHHHHHHHHHHHHc---CCccCcccHHHEEECCCCCEEEccchhheee
Confidence 999999999999997 556899999999999999999999999 9999999999999999999999999999865
Q ss_pred ccccccccccccccccCcccCChhhhcccCc-CccccchhhhHHHHHHHhCCCCCCCCccCCCCchhHHHHHHHHHhcCc
Q 038766 169 DVHLQDLSSLSTAFQGTIGYLAPEFAYMRIV-TTKVDVFSFGIVVMEFLTKRRPTGLDEENGLSPISLRQLVEKALANGI 247 (299)
Q Consensus 169 ~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~-~~~~DiwslG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 247 (299)
.... .........||+.|+|||++.+..+ +.++|||||||++|+|++|..||....... .... .... ..
T Consensus 154 ~~~~--~~~~~~~~~GT~~Y~APE~~~~~~~~~~~~DiwSlGvilyeml~G~~pf~~~~~~~---~~~~----~~~~-~~ 223 (271)
T d1nvra_ 154 RYNN--RERLLNKMCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSC---QEYS----DWKE-KK 223 (271)
T ss_dssp EETT--EECCBCCCCSCGGGSCTHHHHCSSBCHHHHHHHHHHHHHHHHHHSSCSCSSSSTTS---HHHH----HHHT-TC
T ss_pred ccCC--ccccccceeeCcCccCHhHhcCCCCCCCceeeeHhHHHHHHHHhCCCCCCCCChHH---HHHH----HHhc-CC
Confidence 4221 1233455679999999999988776 578999999999999999999996442211 0111 1110 00
Q ss_pred cCcccccCccccchhhHhHHHHHHHHHHHHHHHHhcCCCCCCCCChhhhhcC
Q 038766 248 NGVRQITDPKLVSSIYEEQEQHQVLEELFKLALVCTSSNPEDRPNMNELLIT 299 (299)
Q Consensus 248 ~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rpt~~~il~~ 299 (299)
.... ....+++++.+||++||+.||++|||++|+|+|
T Consensus 224 ----~~~~-----------~~~~~s~~~~~li~~~L~~dP~~R~t~~eil~h 260 (271)
T d1nvra_ 224 ----TYLN-----------PWKKIDSAPLALLHKILVENPSARITIPDIKKD 260 (271)
T ss_dssp ----TTST-----------TGGGSCHHHHHHHHHHSCSSTTTSCCHHHHTTC
T ss_pred ----CCCC-----------ccccCCHHHHHHHHHHcCCChhHCcCHHHHhcC
Confidence 0000 022345688999999999999999999999987
|
| >d1yhwa1 d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: pak1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.6e-56 Score=370.69 Aligned_cols=250 Identities=25% Similarity=0.372 Sum_probs=206.3
Q ss_pred CCCCCCceeecCCcceEEEEEe-CCCcEEEEEEeccCcCChhhhHHHHHHHHHHHhcCCcceeeeeeEEEcCCCeeEEEE
Q 038766 12 GSFSENNIIGNSNLSTVYKGRL-EDGEIVAVKKLNFHQFSAESDKSFYREAKTLKELKHRNLVKVLGYAWESGKLKALIL 90 (299)
Q Consensus 12 ~~y~~~~~lg~g~~~~v~~~~~-~~~~~~~vK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~lv~ 90 (299)
++|.+.+.||+|+||+||+|.+ .+|+.||||++.... ....+.+.+|+.+++.++||||+++++++.. ++..++||
T Consensus 20 ~~Y~~~~~iG~G~fg~Vy~a~~~~~~~~vAvK~~~~~~--~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~-~~~~~ivm 96 (293)
T d1yhwa1 20 KKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQ--QPKKELIINEILVMRENKNPNIVNYLDSYLV-GDELWVVM 96 (293)
T ss_dssp TTBCSCEECCCSSSCEEEEEEBTTTCCEEEEEEEEGGG--CSCHHHHHHHHHHHHHCCCTTBCCEEEEEEE-TTEEEEEE
T ss_pred cccEEEEEEecCcCcEEEEEEECCCCCEEEEEEEeccc--ChHHHHHHHHHHHHHhCCCCCEeeEeEEEEE-CCEEEEEE
Confidence 4799999999999999999987 469999999987443 2345678999999999999999999997665 55669999
Q ss_pred eecCCCChHHHhcCCCCCCCCCChhhHHHHHHHHHHHHHHhhcCCCCCeeeecccCCceeeCCCCcEEEeeecccccccc
Q 038766 91 EYMENGSLESVIHGPGVDHSRWTLPKRIDVLISVANGLDYLHSGYDIPIVHCDMKPSNILLDRDFEAHVSDFGTSRMLDV 170 (299)
Q Consensus 91 e~~~~~~L~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lh~~~~~~~~H~dl~~~nil~~~~~~v~l~df~~~~~~~~ 170 (299)
||+++++|.+++. ...+++.+++.++.||+.||+|||++ +++||||||+|||++.+|.+||+|||++..+..
T Consensus 97 Ey~~gg~L~~~~~-----~~~l~~~~~~~i~~qi~~aL~yLH~~---~iiHrDiKp~NILl~~~~~vkl~DFG~a~~~~~ 168 (293)
T d1yhwa1 97 EYLAGGSLTDVVT-----ETCMDEGQIAAVCRECLQALEFLHSN---QVIHRDIKSDNILLGMDGSVKLTDFGFCAQITP 168 (293)
T ss_dssp ECCTTCBHHHHHH-----HSCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECTTCCEEECCCTTCEECCS
T ss_pred EecCCCcHHHHhh-----ccCCCHHHHHHHHHHHHHHHHHHHHC---CCcccCCcHHHeEECCCCcEeeccchhheeecc
Confidence 9999999999885 34699999999999999999999999 999999999999999999999999999986542
Q ss_pred ccccccccccccccCcccCChhhhcccCcCccccchhhhHHHHHHHhCCCCCCCCccCCCCchhHHHHHHHHHhcCccCc
Q 038766 171 HLQDLSSLSTAFQGTIGYLAPEFAYMRIVTTKVDVFSFGIVVMEFLTKRRPTGLDEENGLSPISLRQLVEKALANGINGV 250 (299)
Q Consensus 171 ~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~DiwslG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 250 (299)
.........||+.|+|||++.+..++.++|||||||++|+|++|..||.... . .+.+...........
T Consensus 169 ----~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~DiwSlGvilyemltG~~Pf~~~~-----~---~~~~~~~~~~~~~~~ 236 (293)
T d1yhwa1 169 ----EQSKRSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMIEGEPPYLNEN-----P---LRALYLIATNGTPEL 236 (293)
T ss_dssp ----TTCCBCCCCSCGGGCCHHHHSSSCBCTHHHHHHHHHHHHHHHHSSCTTTTSC-----H---HHHHHHHHHHCSCCC
T ss_pred ----ccccccccccCCCccChhhhcCCCCCchhceehHhHHHHHHhhCCCCCCCCC-----H---HHHHHHHHhCCCCCC
Confidence 1223345578999999999999999999999999999999999999995331 1 122222222221111
Q ss_pred ccccCccccchhhHhHHHHHHHHHHHHHHHHhcCCCCCCCCChhhhhcC
Q 038766 251 RQITDPKLVSSIYEEQEQHQVLEELFKLALVCTSSNPEDRPNMNELLIT 299 (299)
Q Consensus 251 ~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rpt~~~il~~ 299 (299)
.. +..++.++.+||.+||..||++|||++|+|+|
T Consensus 237 ---~~------------~~~~s~~~~~li~~~L~~dP~~R~s~~eil~H 270 (293)
T d1yhwa1 237 ---QN------------PEKLSAIFRDFLNRCLDMDVEKRGSAKELLQH 270 (293)
T ss_dssp ---SS------------GGGSCHHHHHHHHHHTCSSTTTSCCHHHHTTC
T ss_pred ---CC------------cccCCHHHHHHHHHHccCChhHCcCHHHHhcC
Confidence 11 22346789999999999999999999999987
|
| >d2j4za1 d.144.1.7 (A:126-388) Aurora-related kinase 1 (aurora-2) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Aurora-related kinase 1 (aurora-2) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.4e-57 Score=373.06 Aligned_cols=248 Identities=29% Similarity=0.421 Sum_probs=205.9
Q ss_pred CCCCCCceeecCCcceEEEEEeC-CCcEEEEEEeccCcC-ChhhhHHHHHHHHHHHhcCCcceeeeeeEEEcCCCeeEEE
Q 038766 12 GSFSENNIIGNSNLSTVYKGRLE-DGEIVAVKKLNFHQF-SAESDKSFYREAKTLKELKHRNLVKVLGYAWESGKLKALI 89 (299)
Q Consensus 12 ~~y~~~~~lg~g~~~~v~~~~~~-~~~~~~vK~~~~~~~-~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~lv 89 (299)
++|.+.+.||+|+||+||+|.+. +++.||+|++..... .....+.+.+|+.+++.++||||+++++++.+ ++..++|
T Consensus 6 ~dy~i~~~iG~G~fg~Vy~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~-~~~~~iv 84 (263)
T d2j4za1 6 EDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLYGYFHD-ATRVYLI 84 (263)
T ss_dssp GGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTCCCTTBCCEEEEEEC-SSEEEEE
T ss_pred hHeEEEEEEecCCCcEEEEEEECCCCcEEEEEEEchHHccChHHHHHHHHHHHHHHhcCCCCCCeEEEEEEE-CCEEEEE
Confidence 57999999999999999999875 589999999864332 23346678899999999999999999997665 5566999
Q ss_pred EeecCCCChHHHhcCCCCCCCCCChhhHHHHHHHHHHHHHHhhcCCCCCeeeecccCCceeeCCCCcEEEeeeccccccc
Q 038766 90 LEYMENGSLESVIHGPGVDHSRWTLPKRIDVLISVANGLDYLHSGYDIPIVHCDMKPSNILLDRDFEAHVSDFGTSRMLD 169 (299)
Q Consensus 90 ~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lh~~~~~~~~H~dl~~~nil~~~~~~v~l~df~~~~~~~ 169 (299)
|||+++++|.+++. ....+++.+++.++.||+.||+|||++ +++||||||+|||++.++.+||+|||++....
T Consensus 85 mEy~~~g~L~~~l~----~~~~l~e~~~~~i~~qi~~al~~lH~~---~ivHrDiKp~Nill~~~~~~kl~DFG~a~~~~ 157 (263)
T d2j4za1 85 LEYAPLGTVYRELQ----KLSKFDEQRTATYITELANALSYCHSK---RVIHRDIKPENLLLGSAGELKIADFGWSVHAP 157 (263)
T ss_dssp EECCTTCBHHHHHH----HHSSCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEECTTSCEEECCCCSCSCCC
T ss_pred EeecCCCcHHHHHh----hcCCCCHHHHHHHHHHHHHHHHHHHHC---CeeeeeeccccceecCCCCEeecccceeeecC
Confidence 99999999999987 445799999999999999999999999 99999999999999999999999999997543
Q ss_pred cccccccccccccccCcccCChhhhcccCcCccccchhhhHHHHHHHhCCCCCCCCccCCCCchhHHHHHHHHHhcCccC
Q 038766 170 VHLQDLSSLSTAFQGTIGYLAPEFAYMRIVTTKVDVFSFGIVVMEFLTKRRPTGLDEENGLSPISLRQLVEKALANGING 249 (299)
Q Consensus 170 ~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~DiwslG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 249 (299)
........||+.|+|||++.+..++.++|||||||++|+|++|..||... .. .+.+........ .
T Consensus 158 ------~~~~~~~~Gt~~Y~APE~~~~~~~~~~~DiwSlGvilyell~G~~Pf~~~-----~~---~~~~~~i~~~~~-~ 222 (263)
T d2j4za1 158 ------SSRRTTLCGTLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEAN-----TY---QETYKRISRVEF-T 222 (263)
T ss_dssp ------CCCCEETTEEGGGCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCTTCCS-----SH---HHHHHHHHTTCC-C
T ss_pred ------CCcccccCCCCcccCHHHHcCCCCCchhhhhhHhHHHHHHhcCCCCCCCC-----CH---HHHHHHHHcCCC-C
Confidence 12234557899999999999999999999999999999999999999533 11 222222221110 0
Q ss_pred cccccCccccchhhHhHHHHHHHHHHHHHHHHhcCCCCCCCCChhhhhcC
Q 038766 250 VRQITDPKLVSSIYEEQEQHQVLEELFKLALVCTSSNPEDRPNMNELLIT 299 (299)
Q Consensus 250 ~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rpt~~~il~~ 299 (299)
. +..+++++.+||.+||..||++|||++|+|+|
T Consensus 223 -----~------------p~~~s~~~~~li~~~L~~dp~~R~t~~eil~h 255 (263)
T d2j4za1 223 -----F------------PDFVTEGARDLISRLLKHNPSQRPMLREVLEH 255 (263)
T ss_dssp -----C------------CTTSCHHHHHHHHHHTCSSGGGSCCHHHHHTC
T ss_pred -----C------------CccCCHHHHHHHHHHccCCHhHCcCHHHHHcC
Confidence 0 12345689999999999999999999999987
|
| >d1t4ha_ d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase wnk1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.2e-56 Score=366.38 Aligned_cols=251 Identities=25% Similarity=0.378 Sum_probs=202.7
Q ss_pred CCC-CCCceeecCCcceEEEEEeC-CCcEEEEEEeccCcCChhhhHHHHHHHHHHHhcCCcceeeeeeEEEc---CCCee
Q 038766 12 GSF-SENNIIGNSNLSTVYKGRLE-DGEIVAVKKLNFHQFSAESDKSFYREAKTLKELKHRNLVKVLGYAWE---SGKLK 86 (299)
Q Consensus 12 ~~y-~~~~~lg~g~~~~v~~~~~~-~~~~~~vK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~---~~~~~ 86 (299)
++| +..+.||+|+||+||+|.+. ++..||+|++..........+.+.+|++++++++||||+++++++.. .+...
T Consensus 8 gry~~~~~~iG~G~fg~Vy~~~~~~~~~~va~K~i~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~~~~ 87 (270)
T d1t4ha_ 8 GRFLKFDIEIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQHPNIVRFYDSWESTVKGKKCI 87 (270)
T ss_dssp SCEEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEEESSSCEEE
T ss_pred CCEEEeeeEEecCcCcEEEEEEECCCCeEEEEEEEchhhCCHHHHHHHHHHHHHHHhCCCCCeeeEEEEEeeccccCCEE
Confidence 455 56778999999999999875 58899999998766666677889999999999999999999998754 24557
Q ss_pred EEEEeecCCCChHHHhcCCCCCCCCCChhhHHHHHHHHHHHHHHhhcCCCCC--eeeecccCCceeeC-CCCcEEEeeec
Q 038766 87 ALILEYMENGSLESVIHGPGVDHSRWTLPKRIDVLISVANGLDYLHSGYDIP--IVHCDMKPSNILLD-RDFEAHVSDFG 163 (299)
Q Consensus 87 ~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lh~~~~~~--~~H~dl~~~nil~~-~~~~v~l~df~ 163 (299)
++||||+++++|.+++. ....+++.+++.++.||++||+|||++ + ++||||||+|||++ .++.+||+|||
T Consensus 88 ~ivmE~~~~g~L~~~l~----~~~~~~~~~~~~~~~qi~~gl~yLH~~---~~~IiHrDiKp~NILl~~~~~~~Kl~DFG 160 (270)
T d1t4ha_ 88 VLVTELMTSGTLKTYLK----RFKVMKIKVLRSWCRQILKGLQFLHTR---TPPIIHRDLKCDNIFITGPTGSVKIGDLG 160 (270)
T ss_dssp EEEEECCCSCBHHHHHH----HHSSCCHHHHHHHHHHHHHHHHHHHTS---SSCCCCSCCCGGGEEESSTTSCEEECCTT
T ss_pred EEEEeCCCCCcHHHHHh----ccccccHHHHHHHHHHHHHHHHHHHHC---CCCEEeCCcChhhceeeCCCCCEEEeecC
Confidence 89999999999999987 456899999999999999999999998 7 99999999999996 57899999999
Q ss_pred cccccccccccccccccccccCcccCChhhhcccCcCccccchhhhHHHHHHHhCCCCCCCCccCCCCchhHHHHHHHHH
Q 038766 164 TSRMLDVHLQDLSSLSTAFQGTIGYLAPEFAYMRIVTTKVDVFSFGIVVMEFLTKRRPTGLDEENGLSPISLRQLVEKAL 243 (299)
Q Consensus 164 ~~~~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~DiwslG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~ 243 (299)
++.... ........||+.|+|||++.+ .++.++|||||||++|+|++|..||.... .. .......
T Consensus 161 la~~~~------~~~~~~~~GT~~Y~aPE~~~~-~~~~~~DIwSlGvilyel~~g~~Pf~~~~----~~---~~~~~~i- 225 (270)
T d1t4ha_ 161 LATLKR------ASFAKAVIGTPEFMAPEMYEE-KYDESVDVYAFGMCMLEMATSEYPYSECQ----NA---AQIYRRV- 225 (270)
T ss_dssp GGGGCC------TTSBEESCSSCCCCCGGGGGT-CCCTHHHHHHHHHHHHHHHHSSCTTTTCS----SH---HHHHHHH-
T ss_pred cceecc------CCccCCcccCccccCHHHhCC-CCCCcCchhhHHHHHHHHHHCCCCCCCcc----cH---HHHHHHH-
Confidence 997533 223345678999999998876 58999999999999999999999995321 11 1111111
Q ss_pred hcCccCcccccCccccchhhHhHHHHHHHHHHHHHHHHhcCCCCCCCCChhhhhcC
Q 038766 244 ANGINGVRQITDPKLVSSIYEEQEQHQVLEELFKLALVCTSSNPEDRPNMNELLIT 299 (299)
Q Consensus 244 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rpt~~~il~~ 299 (299)
..+... .. .....++++.+||++||..||++|||++|+|+|
T Consensus 226 ~~~~~~------~~---------~~~~~~~~~~~li~~~l~~dp~~R~s~~ell~H 266 (270)
T d1t4ha_ 226 TSGVKP------AS---------FDKVAIPEVKEIIEGCIRQNKDERYSIKDLLNH 266 (270)
T ss_dssp TTTCCC------GG---------GGGCCCHHHHHHHHHHSCSSGGGSCCHHHHHTS
T ss_pred HcCCCC------cc---------cCccCCHHHHHHHHHHccCCHhHCcCHHHHhCC
Confidence 111100 00 022234578999999999999999999999998
|
| >d1s9ja_ d.144.1.7 (A:) Dual specificity mitogen-activated protein kinase kinase 1, Mek1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Dual specificity mitogen-activated protein kinase kinase 1, Mek1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.7e-56 Score=376.76 Aligned_cols=277 Identities=25% Similarity=0.346 Sum_probs=206.1
Q ss_pred HHHhCCCCCCceeecCCcceEEEEEeC-CCcEEEEEEeccCcCChhhhHHHHHHHHHHHhcCCcceeeeeeEEEcCCCee
Q 038766 8 ENATGSFSENNIIGNSNLSTVYKGRLE-DGEIVAVKKLNFHQFSAESDKSFYREAKTLKELKHRNLVKVLGYAWESGKLK 86 (299)
Q Consensus 8 ~~~~~~y~~~~~lg~g~~~~v~~~~~~-~~~~~~vK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~ 86 (299)
|...++|.+.+.||+|+||+||+|.+. +|+.||+|++... ........+.+|+.+++.++||||+++++++... ...
T Consensus 2 el~~d~y~~~~~iG~G~fg~V~~~~~~~~~~~vAiK~i~~~-~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~-~~~ 79 (322)
T d1s9ja_ 2 ELKDDDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLE-IKPAIRNQIIRELQVLHECNSPYIVGFYGAFYSD-GEI 79 (322)
T ss_dssp CCCGGGEEEEEEEECCSSCCEEEEEETTTTEEEEEEEEECC-CCTTHHHHHHHHGGGGGGCCCTTBCCEEEEEECS-SEE
T ss_pred CCCccCCEEEEEEecCCCeEEEEEEECCCCcEEEEEEEChh-hCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEEC-CEE
Confidence 445788999999999999999999874 6899999999754 3445567889999999999999999999977664 456
Q ss_pred EEEEeecCCCChHHHhcCCCCCCCCCChhhHHHHHHHHHHHHHHhhc-CCCCCeeeecccCCceeeCCCCcEEEeeeccc
Q 038766 87 ALILEYMENGSLESVIHGPGVDHSRWTLPKRIDVLISVANGLDYLHS-GYDIPIVHCDMKPSNILLDRDFEAHVSDFGTS 165 (299)
Q Consensus 87 ~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lh~-~~~~~~~H~dl~~~nil~~~~~~v~l~df~~~ 165 (299)
++||||+.+++|.+++. ....+++..++.++.|++.||.|||+ + +++||||||+|||++.+|.+||+|||++
T Consensus 80 ~iVmEy~~gg~L~~~l~----~~~~l~~~~~~~~~~qil~aL~yLH~~~---~IiHRDiKP~NILl~~~~~vkl~DFGla 152 (322)
T d1s9ja_ 80 SICMEHMDGGSLDQVLK----KAGRIPEQILGKVSIAVIKGLTYLREKH---KIMHRDVKPSNILVNSRGEIKLCDFGVS 152 (322)
T ss_dssp EEEEECCTTEEHHHHHH----HHSSCCHHHHHHHHHHHHHHHHHHHHHH---CCCCSCCSGGGEEECTTCCEEECCCCCC
T ss_pred EEEEEcCCCCcHHHHHh----hcCCCCHHHHHHHHHHHHHHHHHHHHhC---CEEccccCHHHeeECCCCCEEEeeCCCc
Confidence 99999999999999997 44579999999999999999999996 5 8999999999999999999999999999
Q ss_pred cccccccccccccccccccCcccCChhhhcccCcCccccchhhhHHHHHHHhCCCCCCCCccCCCCchhHHHHHHHHH--
Q 038766 166 RMLDVHLQDLSSLSTAFQGTIGYLAPEFAYMRIVTTKVDVFSFGIVVMEFLTKRRPTGLDEENGLSPISLRQLVEKAL-- 243 (299)
Q Consensus 166 ~~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~DiwslG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~-- 243 (299)
..... .......||+.|+|||++.+..++.++||||+||++|+|++|..||.....................
T Consensus 153 ~~~~~------~~~~~~~GT~~Y~APEvl~~~~y~~~~DiWSlGvil~ell~G~~Pf~~~~~~~~~~~~~~~~~~~~~~~ 226 (322)
T d1s9ja_ 153 GQLID------SMANSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAVGRYPIPPPDAKELELMFGCQVEGDAAET 226 (322)
T ss_dssp HHHHH------HTC---CCSSCCCCHHHHHCSCCCTTHHHHHHHHHHHHHHHSSCCSSCCCTTHHHHHC-----------
T ss_pred cccCC------CccccccCCccccCchHHcCCCCCcHHHHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHHHhcCCcccC
Confidence 86542 2234567999999999999999999999999999999999999999654221100000000000000
Q ss_pred -----hcCccCcccccCccccchhhHh-----------HHHHHHHHHHHHHHHHhcCCCCCCCCChhhhhcC
Q 038766 244 -----ANGINGVRQITDPKLVSSIYEE-----------QEQHQVLEELFKLALVCTSSNPEDRPNMNELLIT 299 (299)
Q Consensus 244 -----~~~~~~~~~~~~~~~~~~~~~~-----------~~~~~~~~~l~~li~~~l~~dP~~Rpt~~~il~~ 299 (299)
...................... ......+.++.+||++||..||++|||++|+|+|
T Consensus 227 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~~L~~dP~~R~ta~e~L~H 298 (322)
T d1s9ja_ 227 PPRPRTPGRPLSSYGMDSRPPMAIFELLDYIVNEPPPKLPSGVFSLEFQDFVNKCLIKNPAERADLKQLMVH 298 (322)
T ss_dssp -------------------CCCCHHHHHHHHHTSCCCCCCBTTBCHHHHHHHHHHTCSSTTTSCCHHHHHTS
T ss_pred CcccccccccccccccccccchhHHHHHhhhhccCCccCccccCCHHHHHHHHHHcCCChhHCcCHHHHhhC
Confidence 0000000000000000000000 0011235689999999999999999999999988
|
| >d2jfla1 d.144.1.7 (A:21-308) STE20-like serine/threonine-protein kinase, SLK {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: STE20-like serine/threonine-protein kinase, SLK species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.2e-55 Score=366.35 Aligned_cols=252 Identities=23% Similarity=0.319 Sum_probs=203.9
Q ss_pred CCCCCCceeecCCcceEEEEEeC-CCcEEEEEEeccCcCChhhhHHHHHHHHHHHhcCCcceeeeeeEEEcCCCeeEEEE
Q 038766 12 GSFSENNIIGNSNLSTVYKGRLE-DGEIVAVKKLNFHQFSAESDKSFYREAKTLKELKHRNLVKVLGYAWESGKLKALIL 90 (299)
Q Consensus 12 ~~y~~~~~lg~g~~~~v~~~~~~-~~~~~~vK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~lv~ 90 (299)
+.|++.+.||+|+||+||+|.+. ++..||+|++... .....+.+.+|++++++++||||+++++++.. ++..++||
T Consensus 12 d~Y~i~~~iG~G~fg~Vy~~~~~~~~~~vAvK~i~~~--~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~-~~~~~lvm 88 (288)
T d2jfla1 12 DFWEIIGELGDGAFGKVYKAQNKETSVLAAAKVIDTK--SEEELEDYMVEIDILASCDHPNIVKLLDAFYY-ENNLWILI 88 (288)
T ss_dssp GTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECS--SSGGGGGTHHHHHHHHHCCCTTBCCEEEEEEE-TTEEEEEE
T ss_pred cCeEEeEEEeeCCCcEEEEEEECCCCeEEEEEEECcC--CHHHHHHHHHHHHHHHhCCCCCCCeEEEEEee-CCeEEEEE
Confidence 57899999999999999999874 6899999998643 34556788899999999999999999997766 45569999
Q ss_pred eecCCCChHHHhcCCCCCCCCCChhhHHHHHHHHHHHHHHhhcCCCCCeeeecccCCceeeCCCCcEEEeeecccccccc
Q 038766 91 EYMENGSLESVIHGPGVDHSRWTLPKRIDVLISVANGLDYLHSGYDIPIVHCDMKPSNILLDRDFEAHVSDFGTSRMLDV 170 (299)
Q Consensus 91 e~~~~~~L~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lh~~~~~~~~H~dl~~~nil~~~~~~v~l~df~~~~~~~~ 170 (299)
||+++++|.+++.. ...++++..+..++.||+.||.|||++ +++||||||+|||++.+|.+||+|||++.....
T Consensus 89 Ey~~~g~L~~~~~~---~~~~l~e~~~~~i~~qi~~gL~ylH~~---~ivHrDiKp~NIll~~~~~~Kl~DFG~a~~~~~ 162 (288)
T d2jfla1 89 EFCAGGAVDAVMLE---LERPLTESQIQVVCKQTLDALNYLHDN---KIIHRDLKAGNILFTLDGDIKLADFGVSAKNTR 162 (288)
T ss_dssp ECCTTEEHHHHHHH---HTSCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECTTSCEEECCCTTCEECHH
T ss_pred ecCCCCcHHHHHHh---cCCCCCHHHHHHHHHHHHHHHHHHHHC---CEEEeecChhheeECCCCCEEEEechhhhccCC
Confidence 99999999998652 235799999999999999999999999 999999999999999999999999999875432
Q ss_pred ccccccccccccccCcccCChhhhc-----ccCcCccccchhhhHHHHHHHhCCCCCCCCccCCCCchhHHHHHHHHHhc
Q 038766 171 HLQDLSSLSTAFQGTIGYLAPEFAY-----MRIVTTKVDVFSFGIVVMEFLTKRRPTGLDEENGLSPISLRQLVEKALAN 245 (299)
Q Consensus 171 ~~~~~~~~~~~~~~~~~y~~PE~~~-----~~~~~~~~DiwslG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~ 245 (299)
. ........||+.|+|||++. +..++.++|||||||++|+|++|..||... ..... +......
T Consensus 163 ~----~~~~~~~~Gt~~y~APE~l~~~~~~~~~y~~k~DiwSlGvilyemltg~~Pf~~~-----~~~~~---~~~i~~~ 230 (288)
T d2jfla1 163 T----IQRRDSFIGTPYWMAPEVVMCETSKDRPYDYKADVWSLGITLIEMAEIEPPHHEL-----NPMRV---LLKIAKS 230 (288)
T ss_dssp H----HHHHTCCCSCCTTCCHHHHTTCSTTTSSTTTHHHHHHHHHHHHHHHHSSCTTTTS-----CGGGH---HHHHHHS
T ss_pred C----cccccccccccccCCHHHHhhcccCCCCCChhhhHHHHHHHHHHHhhCCCCCCCC-----CHHHH---HHHHHcC
Confidence 1 12234567899999999874 456789999999999999999999999543 22222 2222221
Q ss_pred CccCcccccCccccchhhHhHHHHHHHHHHHHHHHHhcCCCCCCCCChhhhhcC
Q 038766 246 GINGVRQITDPKLVSSIYEEQEQHQVLEELFKLALVCTSSNPEDRPNMNELLIT 299 (299)
Q Consensus 246 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rpt~~~il~~ 299 (299)
..+. ... +..+++++.+||++||+.||++|||++|+|+|
T Consensus 231 ~~~~---~~~------------~~~~s~~~~~li~~~L~~dp~~R~t~~ell~h 269 (288)
T d2jfla1 231 EPPT---LAQ------------PSRWSSNFKDFLKKCLEKNVDARWTTSQLLQH 269 (288)
T ss_dssp CCCC---CSS------------GGGSCHHHHHHHHHHSCSSTTTSCCHHHHTTS
T ss_pred CCCC---CCc------------cccCCHHHHHHHHHHccCChhHCcCHHHHhcC
Confidence 1111 111 22346789999999999999999999999987
|
| >d1a06a_ d.144.1.7 (A:) Calmodulin-dependent protein kinase {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Calmodulin-dependent protein kinase species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=100.00 E-value=8.8e-56 Score=370.35 Aligned_cols=257 Identities=25% Similarity=0.347 Sum_probs=194.0
Q ss_pred HHHHhCCCCCCceeecCCcceEEEEEeC-CCcEEEEEEeccCcCChhhhHHHHHHHHHHHhcCCcceeeeeeEEEcCCCe
Q 038766 7 IENATGSFSENNIIGNSNLSTVYKGRLE-DGEIVAVKKLNFHQFSAESDKSFYREAKTLKELKHRNLVKVLGYAWESGKL 85 (299)
Q Consensus 7 ~~~~~~~y~~~~~lg~g~~~~v~~~~~~-~~~~~~vK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~ 85 (299)
.|.+.++|.+.+.||+|+||+||+|.+. +|+.||||++...... .....+.+|+.+++.++||||+++++++.. ++.
T Consensus 4 ~edi~d~Y~~~~~lG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~-~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~-~~~ 81 (307)
T d1a06a_ 4 AEDIRDIYDFRDVLGTGAFSEVILAEDKRTQKLVAIKCIAKKALE-GKEGSMENEIAVLHKIKHPNIVALDDIYES-GGH 81 (307)
T ss_dssp CSCGGGTEEEEEESBSGGGGGEEEEEETTTCCEEEEEEEEC-----------CHHHHHHHTCCCTTBCCEEEEEEC-SSE
T ss_pred CCCCccceEEEEEEeeccCeEEEEEEECCCCCEEEEEEEchHHhh-hHHHHHHHHHHHHHhCCCCCCCcEEEEEEE-CCE
Confidence 4567889999999999999999999875 5899999999754432 334667899999999999999999997655 556
Q ss_pred eEEEEeecCCCChHHHhcCCCCCCCCCChhhHHHHHHHHHHHHHHhhcCCCCCeeeecccCCceeeC---CCCcEEEeee
Q 038766 86 KALILEYMENGSLESVIHGPGVDHSRWTLPKRIDVLISVANGLDYLHSGYDIPIVHCDMKPSNILLD---RDFEAHVSDF 162 (299)
Q Consensus 86 ~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lh~~~~~~~~H~dl~~~nil~~---~~~~v~l~df 162 (299)
.++||||++|++|.+++. ....+++.++..++.||+.||+|||++ +++||||||+||+++ .++.+||+||
T Consensus 82 ~~lvmE~~~gg~L~~~l~----~~~~l~e~~~~~~~~qi~~al~ylH~~---~iiHrDiKp~Nil~~~~~~~~~vkl~DF 154 (307)
T d1a06a_ 82 LYLIMQLVSGGELFDRIV----EKGFYTERDASRLIFQVLDAVKYLHDL---GIVHRDLKPENLLYYSLDEDSKIMISDF 154 (307)
T ss_dssp EEEEECCCCSCBHHHHHH----TCSCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEESSSSTTCCEEECCC
T ss_pred EEEEEeccCCCcHHHhhh----cccCCCHHHHHHHHHHHHHHHHhhhhc---eeeeEEecccceeecccCCCceEEEecc
Confidence 699999999999999997 456899999999999999999999999 999999999999995 4789999999
Q ss_pred ccccccccccccccccccccccCcccCChhhhcccCcCccccchhhhHHHHHHHhCCCCCCCCccCCCCchhHHHHHHHH
Q 038766 163 GTSRMLDVHLQDLSSLSTAFQGTIGYLAPEFAYMRIVTTKVDVFSFGIVVMEFLTKRRPTGLDEENGLSPISLRQLVEKA 242 (299)
Q Consensus 163 ~~~~~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~DiwslG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~ 242 (299)
|++..... ........||+.|+|||++.+..++.++|||||||++|+|++|..||... .. .+.....
T Consensus 155 G~a~~~~~-----~~~~~~~~GT~~y~APE~~~~~~~~~~~DiwSlGvilyell~g~~Pf~~~-----~~---~~~~~~i 221 (307)
T d1a06a_ 155 GLSKMEDP-----GSVLSTACGTPGYVAPEVLAQKPYSKAVDCWSIGVIAYILLCGYPPFYDE-----ND---AKLFEQI 221 (307)
T ss_dssp -----------------------CTTSCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSCCCS-----SH---HHHHHHH
T ss_pred ceeEEccC-----CCeeeeeeeCccccCcHHHcCCCCCcHHHhhhhhHHHHHHHhCCCCCCCC-----CH---HHHHHHH
Confidence 99975431 22334567899999999999999999999999999999999999999532 11 1222222
Q ss_pred HhcCccCcccccCccccchhhHhHHHHHHHHHHHHHHHHhcCCCCCCCCChhhhhcC
Q 038766 243 LANGINGVRQITDPKLVSSIYEEQEQHQVLEELFKLALVCTSSNPEDRPNMNELLIT 299 (299)
Q Consensus 243 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rpt~~~il~~ 299 (299)
..... ....+ ....+++++.+||++||..||++|||++|+++|
T Consensus 222 ~~~~~----~~~~~----------~~~~~s~~~~~li~~~L~~dP~~R~s~~eil~h 264 (307)
T d1a06a_ 222 LKAEY----EFDSP----------YWDDISDSAKDFIRHLMEKDPEKRFTCEQALQH 264 (307)
T ss_dssp HTTCC----CCCTT----------TTTTSCHHHHHHHHHHSCSSGGGSCCHHHHHHS
T ss_pred hccCC----CCCCc----------cccCCCHHHHHHHHHHccCCHhHCcCHHHHhcC
Confidence 22111 00000 022356789999999999999999999999987
|
| >d1uu3a_ d.144.1.7 (A:) 3-phosphoinositide dependent protein kinase-1 Pdk1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: 3-phosphoinositide dependent protein kinase-1 Pdk1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=4e-56 Score=368.93 Aligned_cols=252 Identities=21% Similarity=0.306 Sum_probs=203.2
Q ss_pred hCCCCCCceeecCCcceEEEEEeC-CCcEEEEEEeccCcC-ChhhhHHHHHHHHHHHhcCCcceeeeeeEEEcCCCeeEE
Q 038766 11 TGSFSENNIIGNSNLSTVYKGRLE-DGEIVAVKKLNFHQF-SAESDKSFYREAKTLKELKHRNLVKVLGYAWESGKLKAL 88 (299)
Q Consensus 11 ~~~y~~~~~lg~g~~~~v~~~~~~-~~~~~~vK~~~~~~~-~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~l 88 (299)
.++|++.+.||+|+||+||+|.+. +|+.||||++..... .....+.+.+|++++++++||||+++++++.+ ++..++
T Consensus 7 p~dy~i~~~lG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~-~~~~~i 85 (288)
T d1uu3a_ 7 PEDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPFFVKLYFTFQD-DEKLYF 85 (288)
T ss_dssp GGGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHCCSTTBCCEEEEEEC-SSEEEE
T ss_pred CCCCEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEehHHccCHHHHHHHHHHHHHHHHcCCCCeeEEEEEEEE-CCEEEE
Confidence 467999999999999999999874 689999999864332 23345778999999999999999999997665 556699
Q ss_pred EEeecCCCChHHHhcCCCCCCCCCChhhHHHHHHHHHHHHHHhhcCCCCCeeeecccCCceeeCCCCcEEEeeecccccc
Q 038766 89 ILEYMENGSLESVIHGPGVDHSRWTLPKRIDVLISVANGLDYLHSGYDIPIVHCDMKPSNILLDRDFEAHVSDFGTSRML 168 (299)
Q Consensus 89 v~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lh~~~~~~~~H~dl~~~nil~~~~~~v~l~df~~~~~~ 168 (299)
||||+++++|.+++. ....+++..++.++.|++.||+|||+. +++||||||+||+++.+|.++|+|||++..+
T Consensus 86 vmEy~~gg~L~~~~~----~~~~l~e~~~~~~~~qi~~al~ylH~~---~iiHrDiKp~NIll~~~~~vkl~DFG~a~~~ 158 (288)
T d1uu3a_ 86 GLSYAKNGELLKYIR----KIGSFDETCTRFYTAEIVSALEYLHGK---GIIHRDLKPENILLNEDMHIQITDFGTAKVL 158 (288)
T ss_dssp EECCCTTEEHHHHHH----HHSSCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEECTTSCEEECCCTTCEEC
T ss_pred EEEccCCCCHHHhhh----ccCCCCHHHHHHHHHHHHHHHHhhccc---cEEcCcCCccccccCCCceEEecccccceec
Confidence 999999999999887 456899999999999999999999999 9999999999999999999999999999865
Q ss_pred ccccccccccccccccCcccCChhhhcccCcCccccchhhhHHHHHHHhCCCCCCCCccCCCCchhHHHHHHHHHhcCcc
Q 038766 169 DVHLQDLSSLSTAFQGTIGYLAPEFAYMRIVTTKVDVFSFGIVVMEFLTKRRPTGLDEENGLSPISLRQLVEKALANGIN 248 (299)
Q Consensus 169 ~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~DiwslG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 248 (299)
.... .........||+.|+|||++.+..++.++|||||||++|+|++|..||... .. .+.+........
T Consensus 159 ~~~~--~~~~~~~~~GT~~Y~APE~~~~~~~~~~~DiwSlGvilyell~g~~Pf~~~-----~~---~~~~~~i~~~~~- 227 (288)
T d1uu3a_ 159 SPES--KQARANSFVGTAQYVSPELLTEKSACKSSDLWALGCIIYQLVAGLPPFRAG-----NE---YLIFQKIIKLEY- 227 (288)
T ss_dssp C------------CCCCGGGCCHHHHHTCCCCHHHHHHHHHHHHHHHHHSSCSSCCS-----SH---HHHHHHHHTTCC-
T ss_pred ccCC--cccccccccCCccccCceeeccCCCCcccceehhhHHHHHHhhCCCCCCCc-----CH---HHHHHHHHcCCC-
Confidence 4221 122334557899999999999999999999999999999999999999533 11 222222222110
Q ss_pred CcccccCccccchhhHhHHHHHHHHHHHHHHHHhcCCCCCCCCChhhhhc
Q 038766 249 GVRQITDPKLVSSIYEEQEQHQVLEELFKLALVCTSSNPEDRPNMNELLI 298 (299)
Q Consensus 249 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rpt~~~il~ 298 (299)
. + +..+++++.+||++||..||++|||++|++.
T Consensus 228 ~---~--------------p~~~s~~~~~li~~~L~~dP~~R~t~~e~~~ 260 (288)
T d1uu3a_ 228 D---F--------------PEKFFPKARDLVEKLLVLDATKRLGCEEMEG 260 (288)
T ss_dssp C---C--------------CTTCCHHHHHHHHTTSCSSGGGSTTSGGGTC
T ss_pred C---C--------------CccCCHHHHHHHHHHccCCHhHCcCHHHHcC
Confidence 0 1 1234567999999999999999999999753
|
| >d1uwha_ d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: B-Raf kinase species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2e-55 Score=362.96 Aligned_cols=263 Identities=27% Similarity=0.452 Sum_probs=204.6
Q ss_pred HHHHHHhCCCCCCceeecCCcceEEEEEeCCCcEEEEEEeccCcCChhhhHHHHHHHHHHHhcCCcceeeeeeEEEcCCC
Q 038766 5 TEIENATGSFSENNIIGNSNLSTVYKGRLEDGEIVAVKKLNFHQFSAESDKSFYREAKTLKELKHRNLVKVLGYAWESGK 84 (299)
Q Consensus 5 ~~~~~~~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~vK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~ 84 (299)
|+||+-.++|.+.+.||+|+||+||+|+++ ..||||+++.........+.+.+|+.++++++||||+++++++. +.
T Consensus 1 ddwei~~~~~~~~~~lG~G~fg~Vy~~~~~--~~vAvK~~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~~~~~~~--~~ 76 (276)
T d1uwha_ 1 DDWEIPDGQITVGQRIGSGSFGTVYKGKWH--GDVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGYST--AP 76 (276)
T ss_dssp CCCBCCTTCCCCCSEEEECSSCEEEEEESS--SEEEEEECCCSSCCTTHHHHHHHHHHHHTTCCCTTBCCEEEEEC--SS
T ss_pred CCcccccccEEEEEEEeeCCCcEEEEEEEC--CEEEEEEEEcccCCHHHHHHHHHHHHHHHhCCCCCEeeeeEEEe--cc
Confidence 467777899999999999999999999865 35999999877667777888999999999999999999999653 33
Q ss_pred eeEEEEeecCCCChHHHhcCCCCCCCCCChhhHHHHHHHHHHHHHHhhcCCCCCeeeecccCCceeeCCCCcEEEeeecc
Q 038766 85 LKALILEYMENGSLESVIHGPGVDHSRWTLPKRIDVLISVANGLDYLHSGYDIPIVHCDMKPSNILLDRDFEAHVSDFGT 164 (299)
Q Consensus 85 ~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lh~~~~~~~~H~dl~~~nil~~~~~~v~l~df~~ 164 (299)
..++|+||+++++|.+++.. ...++++..+..++.||++||+|||++ +++||||||+|||++.++.+||+|||+
T Consensus 77 ~~~lv~Ey~~~g~L~~~l~~---~~~~~~~~~~~~i~~qi~~gl~yLH~~---~ivHrDlKp~NiLl~~~~~~Kl~DFGl 150 (276)
T d1uwha_ 77 QLAIVTQWCEGSSLYHHLHI---IETKFEMIKLIDIARQTAQGMDYLHAK---SIIHRDLKSNNIFLHEDLTVKIGDFGL 150 (276)
T ss_dssp SCEEEEECCCEEEHHHHHHT---SCCCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEEETTSSEEECCCCC
T ss_pred EEEEEEecCCCCCHHHHHhh---ccCCCCHHHHHHHHHHHHHHHHHHhcC---CEeccccCHHHEEEcCCCCEEEccccc
Confidence 45899999999999998863 235699999999999999999999999 999999999999999999999999999
Q ss_pred ccccccccccccccccccccCcccCChhhhccc---CcCccccchhhhHHHHHHHhCCCCCCCCccCCCCchhHHHHHHH
Q 038766 165 SRMLDVHLQDLSSLSTAFQGTIGYLAPEFAYMR---IVTTKVDVFSFGIVVMEFLTKRRPTGLDEENGLSPISLRQLVEK 241 (299)
Q Consensus 165 ~~~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~---~~~~~~DiwslG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~ 241 (299)
+....... .........+|+.|+|||++.+. .++.++|||||||++|+|++|..||..... ...+...+..
T Consensus 151 a~~~~~~~--~~~~~~~~~gt~~y~APE~l~~~~~~~~~~~sDiwS~Gv~l~el~tg~~Pf~~~~~----~~~~~~~~~~ 224 (276)
T d1uwha_ 151 ATVKSRWS--GSHQFEQLSGSILWMAPEVIRMQDKNPYSFQSDVYAFGIVLYELMTGQLPYSNINN----RDQIIFMVGR 224 (276)
T ss_dssp SCC--------------CCCCGGGCCHHHHTTCSSCCCCHHHHHHHHHHHHHHHHHSSCTTTTCCC----HHHHHHHHHH
T ss_pred eeeccccC--CcccccccccCcccCCHHHHhcccCCCCCchhhhhhhHHHHHHHHHCCCCCCCCCh----HHHHHHHHhc
Confidence 97654211 12233456789999999998643 478899999999999999999999953211 1112222111
Q ss_pred HHhcCccCcccccCccccchhhHhHHHHHHHHHHHHHHHHhcCCCCCCCCChhhhhcC
Q 038766 242 ALANGINGVRQITDPKLVSSIYEEQEQHQVLEELFKLALVCTSSNPEDRPNMNELLIT 299 (299)
Q Consensus 242 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rpt~~~il~~ 299 (299)
+.. .+... ..+..+++++.+|+.+||..||++|||+++|+++
T Consensus 225 ----~~~------~p~~~------~~~~~~~~~l~~li~~cl~~dp~~RPt~~~il~~ 266 (276)
T d1uwha_ 225 ----GYL------SPDLS------KVRSNCPKAMKRLMAECLKKKRDERPLFPQILAS 266 (276)
T ss_dssp ----TSC------CCCGG------GSCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred ----CCC------CCcch------hccccchHHHHHHHHHHcCCCHhHCcCHHHHHHH
Confidence 100 00000 0022345689999999999999999999999863
|
| >d1jksa_ d.144.1.7 (A:) Death-associated protein kinase, Dap {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Death-associated protein kinase, Dap species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.2e-54 Score=362.18 Aligned_cols=257 Identities=23% Similarity=0.312 Sum_probs=209.5
Q ss_pred HHHhCCCCCCceeecCCcceEEEEEe-CCCcEEEEEEeccCcCC----hhhhHHHHHHHHHHHhcCCcceeeeeeEEEcC
Q 038766 8 ENATGSFSENNIIGNSNLSTVYKGRL-EDGEIVAVKKLNFHQFS----AESDKSFYREAKTLKELKHRNLVKVLGYAWES 82 (299)
Q Consensus 8 ~~~~~~y~~~~~lg~g~~~~v~~~~~-~~~~~~~vK~~~~~~~~----~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~ 82 (299)
+++.++|.+.+.||+|+||+||+|.+ .+|+.||||++...... ....+.+.+|+.++++++||||+++++++.+
T Consensus 6 ~~i~d~Y~~~~~lG~G~fg~Vy~~~~~~~~~~~AvK~i~~~~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~- 84 (293)
T d1jksa_ 6 ENVDDYYDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQHPNVITLHEVYEN- 84 (293)
T ss_dssp SCGGGTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEBCSSTTCSSSBCHHHHHHHHHHHHHCCCTTBCCEEEEEEC-
T ss_pred CCcccCEEEeEEEecCCCeEEEEEEECCCCCEEEEEEEEhhhcchhhhhHHHHHHHHHHHHHHhCCCCCCCcEEEEEEE-
Confidence 34678999999999999999999987 46899999999654332 2236788999999999999999999997655
Q ss_pred CCeeEEEEeecCCCChHHHhcCCCCCCCCCChhhHHHHHHHHHHHHHHhhcCCCCCeeeecccCCceeeCCCC----cEE
Q 038766 83 GKLKALILEYMENGSLESVIHGPGVDHSRWTLPKRIDVLISVANGLDYLHSGYDIPIVHCDMKPSNILLDRDF----EAH 158 (299)
Q Consensus 83 ~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lh~~~~~~~~H~dl~~~nil~~~~~----~v~ 158 (299)
....++||||+++++|.+++. ....+++..++.++.|+++||+|||+. +++||||||+||+++.++ .+|
T Consensus 85 ~~~~~iv~E~~~gg~L~~~i~----~~~~l~~~~~~~~~~qi~~al~yLH~~---~ivHrDiKp~Nill~~~~~~~~~vk 157 (293)
T d1jksa_ 85 KTDVILILELVAGGELFDFLA----EKESLTEEEATEFLKQILNGVYYLHSL---QIAHFDLKPENIMLLDRNVPKPRIK 157 (293)
T ss_dssp SSEEEEEEECCCSCBHHHHHH----HHSSCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEESCSSSSSCCEE
T ss_pred CCEEEEEEEcCCCccccchhc----cccccchhHHHHHHHHHHHHHHhhhhc---ceeecccccceEEEecCCCcccceE
Confidence 556699999999999999997 445899999999999999999999999 999999999999998776 499
Q ss_pred EeeeccccccccccccccccccccccCcccCChhhhcccCcCccccchhhhHHHHHHHhCCCCCCCCccCCCCchhHHHH
Q 038766 159 VSDFGTSRMLDVHLQDLSSLSTAFQGTIGYLAPEFAYMRIVTTKVDVFSFGIVVMEFLTKRRPTGLDEENGLSPISLRQL 238 (299)
Q Consensus 159 l~df~~~~~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~DiwslG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~ 238 (299)
++|||++..... ........+++.|+|||++.+..++.++||||+||++|+|++|..||.... . .+.
T Consensus 158 l~DfG~a~~~~~-----~~~~~~~~~t~~y~APE~~~~~~~~~~~DiwSlGvilyell~g~~Pf~~~~-----~---~~~ 224 (293)
T d1jksa_ 158 IIDFGLAHKIDF-----GNEFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGDT-----K---QET 224 (293)
T ss_dssp ECCCTTCEECTT-----SCBCSCCCCCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSS-----H---HHH
T ss_pred ecchhhhhhcCC-----CccccccCCCCcccCHHHHcCCCCCCcccchhhhHHHHHHHcCCCCCCCCC-----H---HHH
Confidence 999999976542 223345567899999999999999999999999999999999999995431 1 122
Q ss_pred HHHHHhcCccCcccccCccccchhhHhHHHHHHHHHHHHHHHHhcCCCCCCCCChhhhhcC
Q 038766 239 VEKALANGINGVRQITDPKLVSSIYEEQEQHQVLEELFKLALVCTSSNPEDRPNMNELLIT 299 (299)
Q Consensus 239 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rpt~~~il~~ 299 (299)
+......... ........++.++.+||++||..||++|||++|+|+|
T Consensus 225 ~~~i~~~~~~--------------~~~~~~~~~s~~~~~li~~~L~~dP~~R~s~~eil~h 271 (293)
T d1jksa_ 225 LANVSAVNYE--------------FEDEYFSNTSALAKDFIRRLLVKDPKKRMTIQDSLQH 271 (293)
T ss_dssp HHHHHTTCCC--------------CCHHHHTTSCHHHHHHHHTTSCSSGGGSCCHHHHHHS
T ss_pred HHHHHhcCCC--------------CCchhcCCCCHHHHHHHHHHccCChhHCcCHHHHhcC
Confidence 2222211100 0011134456789999999999999999999999987
|
| >d1koaa2 d.144.1.7 (A:5915-6264) Twitchin, kinase domain {Caenorhabditis elegans, pjk4 [TaxId: 6239]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Twitchin, kinase domain species: Caenorhabditis elegans, pjk4 [TaxId: 6239]
Probab=100.00 E-value=2.5e-54 Score=367.44 Aligned_cols=255 Identities=21% Similarity=0.295 Sum_probs=207.8
Q ss_pred HHhCCCCCCceeecCCcceEEEEEe-CCCcEEEEEEeccCcCChhhhHHHHHHHHHHHhcCCcceeeeeeEEEcCCCeeE
Q 038766 9 NATGSFSENNIIGNSNLSTVYKGRL-EDGEIVAVKKLNFHQFSAESDKSFYREAKTLKELKHRNLVKVLGYAWESGKLKA 87 (299)
Q Consensus 9 ~~~~~y~~~~~lg~g~~~~v~~~~~-~~~~~~~vK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~ 87 (299)
.+.++|.+.+.||+|+||+||+|.+ .+|+.||||++... .....+.+.+|+.++++++||||+++++++.. ++..+
T Consensus 23 ~il~~Y~i~~~lG~G~fg~Vy~~~~~~~g~~vAvK~i~~~--~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~-~~~~~ 99 (350)
T d1koaa2 23 HVLDHYDIHEELGTGAFGVVHRVTERATGNNFAAKFVMTP--HESDKETVRKEIQTMSVLRHPTLVNLHDAFED-DNEMV 99 (350)
T ss_dssp CGGGTEEEEEEEEEETTEEEEEEEETTTTEEEEEEEECCC--SHHHHHHHHHHHHHHHHTCCTTBCCEEEEEEE-TTEEE
T ss_pred CCccCeEEEEEEecCcCeEEEEEEECCCCCEEEEEEEccc--chhhHHHHHHHHHHHHhCCCCCCCcEEEEEEE-CCEEE
Confidence 3567999999999999999999987 46899999998643 34456778899999999999999999997665 55669
Q ss_pred EEEeecCCCChHHHhcCCCCCCCCCChhhHHHHHHHHHHHHHHhhcCCCCCeeeecccCCceeeCC--CCcEEEeeeccc
Q 038766 88 LILEYMENGSLESVIHGPGVDHSRWTLPKRIDVLISVANGLDYLHSGYDIPIVHCDMKPSNILLDR--DFEAHVSDFGTS 165 (299)
Q Consensus 88 lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lh~~~~~~~~H~dl~~~nil~~~--~~~v~l~df~~~ 165 (299)
+||||+++++|.+++.. ...++++.+++.++.||+.||.|||++ +++||||||+|||++. ++.+||+|||++
T Consensus 100 ivmE~~~gg~L~~~l~~---~~~~l~e~~~~~i~~qi~~aL~ylH~~---~iiHrDiKp~NIll~~~~~~~vkL~DFG~a 173 (350)
T d1koaa2 100 MIYEFMSGGELFEKVAD---EHNKMSEDEAVEYMRQVCKGLCHMHEN---NYVHLDLKPENIMFTTKRSNELKLIDFGLT 173 (350)
T ss_dssp EEECCCCSCBHHHHHTC---TTSCBCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEESSTTSCCEEECCCTTC
T ss_pred EEEEcCCCCCHHHHHHh---hcCCCCHHHHHHHHHHHHHHHHHHHhc---CCeeeeechhHeeeccCCCCeEEEeecchh
Confidence 99999999999998853 335799999999999999999999999 9999999999999964 578999999999
Q ss_pred cccccccccccccccccccCcccCChhhhcccCcCccccchhhhHHHHHHHhCCCCCCCCccCCCCchhHHHHHHHHHhc
Q 038766 166 RMLDVHLQDLSSLSTAFQGTIGYLAPEFAYMRIVTTKVDVFSFGIVVMEFLTKRRPTGLDEENGLSPISLRQLVEKALAN 245 (299)
Q Consensus 166 ~~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~DiwslG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~ 245 (299)
..+.. ........+|+.|+|||++.+..++.++|||||||++|+|++|..||... .. .+.+......
T Consensus 174 ~~~~~-----~~~~~~~~gT~~Y~aPEv~~~~~~~~~~DiwSlGvilyell~G~~Pf~~~-----~~---~~~~~~i~~~ 240 (350)
T d1koaa2 174 AHLDP-----KQSVKVTTGTAEFAAPEVAEGKPVGYYTDMWSVGVLSYILLSGLSPFGGE-----ND---DETLRNVKSC 240 (350)
T ss_dssp EECCT-----TSCEEEECSCTTTCCHHHHHTCCBCHHHHHHHHHHHHHHHHHSSCSSCCS-----SH---HHHHHHHHHT
T ss_pred eeccc-----ccccceecCcccccCHHHHcCCCCChhHhhhhhhHHHHHHHhCCCCCCCC-----CH---HHHHHHHHhC
Confidence 76542 22334567899999999999999999999999999999999999999533 11 2233332221
Q ss_pred CccCcccccCccccchhhHhHHHHHHHHHHHHHHHHhcCCCCCCCCChhhhhcC
Q 038766 246 GINGVRQITDPKLVSSIYEEQEQHQVLEELFKLALVCTSSNPEDRPNMNELLIT 299 (299)
Q Consensus 246 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rpt~~~il~~ 299 (299)
.... .. .....+++++.+||++||..||++|||++|+|+|
T Consensus 241 ~~~~----~~----------~~~~~~s~~~~~li~~~L~~dP~~R~t~~eil~h 280 (350)
T d1koaa2 241 DWNM----DD----------SAFSGISEDGKDFIRKLLLADPNTRMTIHQALEH 280 (350)
T ss_dssp CCCS----CC----------GGGGGCCHHHHHHHHHHCCSSGGGSCCHHHHHHS
T ss_pred CCCC----Cc----------ccccCCCHHHHHHHHHHccCChhHCcCHHHHhcC
Confidence 1110 00 0123346789999999999999999999999987
|
| >d1u5ra_ d.144.1.7 (A:) Serine/threonine protein kinase TAO2 {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Serine/threonine protein kinase TAO2 species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=100.00 E-value=2.1e-54 Score=362.00 Aligned_cols=247 Identities=26% Similarity=0.367 Sum_probs=201.4
Q ss_pred CCCCCceeecCCcceEEEEEe-CCCcEEEEEEeccCcCC-hhhhHHHHHHHHHHHhcCCcceeeeeeEEEcCCCeeEEEE
Q 038766 13 SFSENNIIGNSNLSTVYKGRL-EDGEIVAVKKLNFHQFS-AESDKSFYREAKTLKELKHRNLVKVLGYAWESGKLKALIL 90 (299)
Q Consensus 13 ~y~~~~~lg~g~~~~v~~~~~-~~~~~~~vK~~~~~~~~-~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~lv~ 90 (299)
+|...+.||+|+||+||+|.+ .+|+.||||++...... ....+.+.+|+.++++++||||+++++++.. ++..++||
T Consensus 16 ~y~~l~~lG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~~~~~~~~-~~~~~iv~ 94 (309)
T d1u5ra_ 16 LFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQYRGCYLR-EHTAWLVM 94 (309)
T ss_dssp HEEEEEEEEECSSSEEEEEEETTTTEEEEEEEEECCSSCHHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEE-TTEEEEEE
T ss_pred hcEeeEEEecCCCeEEEEEEECCCCcEEEEEEEchhhccCHHHHHHHHHHHHHHHHCCCCCEeeEEEEEEE-CCEEEEEE
Confidence 499999999999999999986 46889999999765443 3345678899999999999999999997665 55669999
Q ss_pred eecCCCChHHHhcCCCCCCCCCChhhHHHHHHHHHHHHHHhhcCCCCCeeeecccCCceeeCCCCcEEEeeecccccccc
Q 038766 91 EYMENGSLESVIHGPGVDHSRWTLPKRIDVLISVANGLDYLHSGYDIPIVHCDMKPSNILLDRDFEAHVSDFGTSRMLDV 170 (299)
Q Consensus 91 e~~~~~~L~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lh~~~~~~~~H~dl~~~nil~~~~~~v~l~df~~~~~~~~ 170 (299)
||+.+++|..++. ...++++.+++.++.||++||.|||++ +++||||||+|||++.++.+||+|||++....
T Consensus 95 E~~~~g~l~~~~~----~~~~l~e~~~~~i~~qi~~aL~yLH~~---~iiHrDiKp~NILl~~~~~~Kl~DFG~a~~~~- 166 (309)
T d1u5ra_ 95 EYCLGSASDLLEV----HKKPLQEVEIAAVTHGALQGLAYLHSH---NMIHRDVKAGNILLSEPGLVKLGDFGSASIMA- 166 (309)
T ss_dssp ECCSEEHHHHHHH----HTSCCCHHHHHHHHHHHHHHHHHHHHT---TCBCCCCSGGGEEEETTTEEEECCCTTCBSSS-
T ss_pred EecCCCchHHHHH----hCCCCCHHHHHHHHHHHHHHHHHHHhC---CEeccCCCcceEEECCCCCEEEeecccccccC-
Confidence 9999988877665 456899999999999999999999999 99999999999999999999999999997543
Q ss_pred ccccccccccccccCcccCChhhhcc---cCcCccccchhhhHHHHHHHhCCCCCCCCccCCCCchhHHHHHHHHHhcCc
Q 038766 171 HLQDLSSLSTAFQGTIGYLAPEFAYM---RIVTTKVDVFSFGIVVMEFLTKRRPTGLDEENGLSPISLRQLVEKALANGI 247 (299)
Q Consensus 171 ~~~~~~~~~~~~~~~~~y~~PE~~~~---~~~~~~~DiwslG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 247 (299)
......||+.|+|||++.+ ..++.++|||||||++|+|++|..||... .. .+.+........
T Consensus 167 -------~~~~~~GT~~Y~APE~~~~~~~~~y~~~~DiwSlGvilyel~~g~~Pf~~~-----~~---~~~~~~i~~~~~ 231 (309)
T d1u5ra_ 167 -------PANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNM-----NA---MSALYHIAQNES 231 (309)
T ss_dssp -------SBCCCCSCGGGCCHHHHTTTTSCCBCTHHHHHHHHHHHHHHHHSSCTTTTS-----CH---HHHHHHHHHSCC
T ss_pred -------CCCccccCccccCHHHHhccCCCCcCchhhhhhHHHHHHHHHHCCCCCCCC-----CH---HHHHHHHHhCCC
Confidence 1234568999999999864 45889999999999999999999999533 11 122222222221
Q ss_pred cCcccccCccccchhhHhHHHHHHHHHHHHHHHHhcCCCCCCCCChhhhhcC
Q 038766 248 NGVRQITDPKLVSSIYEEQEQHQVLEELFKLALVCTSSNPEDRPNMNELLIT 299 (299)
Q Consensus 248 ~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rpt~~~il~~ 299 (299)
+... ...+++++.+||++||..||++|||++|+|+|
T Consensus 232 ~~~~----------------~~~~s~~~~~li~~~L~~dP~~Rpt~~ell~H 267 (309)
T d1u5ra_ 232 PALQ----------------SGHWSEYFRNFVDSCLQKIPQDRPTSEVLLKH 267 (309)
T ss_dssp CCCS----------------CTTSCHHHHHHHHHHTCSSGGGSCCHHHHTTC
T ss_pred CCCC----------------CCCCCHHHHHHHHHHCcCChhHCcCHHHHHhC
Confidence 1110 11235679999999999999999999999987
|
| >d1qpca_ d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Lymphocyte kinase (lck) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=9.4e-55 Score=358.77 Aligned_cols=259 Identities=27% Similarity=0.434 Sum_probs=207.5
Q ss_pred ChHHHHHHhCCCCCCceeecCCcceEEEEEeCCCcEEEEEEeccCcCChhhhHHHHHHHHHHHhcCCcceeeeeeEEEcC
Q 038766 3 DRTEIENATGSFSENNIIGNSNLSTVYKGRLEDGEIVAVKKLNFHQFSAESDKSFYREAKTLKELKHRNLVKVLGYAWES 82 (299)
Q Consensus 3 ~~~~~~~~~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~vK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~ 82 (299)
..++||+-.++|++.+.||+|+||+||+|.++++..||||++.... ...+.+.+|+.++++++||||+++++++. .
T Consensus 4 ~~~~wei~~~~~~~~~~iG~G~fg~Vy~~~~~~~~~vAvK~~~~~~---~~~~~~~~E~~~l~~l~HpnIv~~~g~~~-~ 79 (272)
T d1qpca_ 4 WEDEWEVPRETLKLVERLGAGQFGEVWMGYYNGHTKVAVKSLKQGS---MSPDAFLAEANLMKQLQHQRLVRLYAVVT-Q 79 (272)
T ss_dssp TTCTTBCCGGGEEEEEEEEEETTEEEEEEEETTTEEEEEEEECTTS---SCHHHHHHHHHHHHHCCCTTBCCEEEEEC-S
T ss_pred CCCCeecCHHHeEEeEEEecCCCcEEEEEEECCCCEEEEEEEccCc---CCHHHHHHHHHHHHhCCCCCEeEEEeeec-c
Confidence 4578888889999999999999999999999888899999996433 34567899999999999999999999653 3
Q ss_pred CCeeEEEEeecCCCChHHHhcCCCCCCCCCChhhHHHHHHHHHHHHHHhhcCCCCCeeeecccCCceeeCCCCcEEEeee
Q 038766 83 GKLKALILEYMENGSLESVIHGPGVDHSRWTLPKRIDVLISVANGLDYLHSGYDIPIVHCDMKPSNILLDRDFEAHVSDF 162 (299)
Q Consensus 83 ~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lh~~~~~~~~H~dl~~~nil~~~~~~v~l~df 162 (299)
+ ..++||||+.+|+|.+++... ...++++..++.++.||+.||+|||++ +++||||||+|||++.++.+||+||
T Consensus 80 ~-~~~iv~Ey~~~g~L~~~~~~~--~~~~l~~~~~~~i~~qi~~gl~~lH~~---~ivHrDiKp~NIll~~~~~~Kl~DF 153 (272)
T d1qpca_ 80 E-PIYIITEYMENGSLVDFLKTP--SGIKLTINKLLDMAAQIAEGMAFIEER---NYIHRDLRAANILVSDTLSCKIADF 153 (272)
T ss_dssp S-SCEEEEECCTTCBHHHHTTSH--HHHTCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEECTTSCEEECCC
T ss_pred C-CeEEEEEeCCCCcHHHHHhhc--CCCCCCHHHHHHHHHHHHHHHHHHHhC---CcccCccchhheeeecccceeeccc
Confidence 3 358999999999999877532 233689999999999999999999999 9999999999999999999999999
Q ss_pred ccccccccccccccccccccccCcccCChhhhcccCcCccccchhhhHHHHHHHhCCCCCCCCccCCCCchhHHHHHHHH
Q 038766 163 GTSRMLDVHLQDLSSLSTAFQGTIGYLAPEFAYMRIVTTKVDVFSFGIVVMEFLTKRRPTGLDEENGLSPISLRQLVEKA 242 (299)
Q Consensus 163 ~~~~~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~DiwslG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~ 242 (299)
|++..... ..........+++.|+|||++.+..++.++|||||||++|+|++|..|+... .... +.+...
T Consensus 154 Gla~~~~~---~~~~~~~~~~gt~~y~APE~~~~~~~~~~sDvwS~Gvvl~ellt~~~~~~~~----~~~~---~~~~~i 223 (272)
T d1qpca_ 154 GLARLIED---NEYTAREGAKFPIKWTAPEAINYGTFTIKSDVWSFGILLTEIVTHGRIPYPG----MTNP---EVIQNL 223 (272)
T ss_dssp TTCEECSS---SCEECCTTCCCCTTTSCHHHHHHCEECHHHHHHHHHHHHHHHHTTTCCSSTT----CCHH---HHHHHH
T ss_pred cceEEccC---CccccccccCCcccccChHHHhCCCCCchhhhhhhHHHHHHHHhCCCCCCCC----CCHH---HHHHHH
Confidence 99986542 1122234456788999999999999999999999999999999976665322 1122 222222
Q ss_pred HhcCccCcccccCccccchhhHhHHHHHHHHHHHHHHHHhcCCCCCCCCChhhhhc
Q 038766 243 LANGINGVRQITDPKLVSSIYEEQEQHQVLEELFKLALVCTSSNPEDRPNMNELLI 298 (299)
Q Consensus 243 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rpt~~~il~ 298 (299)
.. +. .... +..+++++.+|+.+||+.||++|||+++|++
T Consensus 224 ~~-~~----~~~~------------p~~~~~~l~~li~~cl~~~P~~Rpt~~ei~~ 262 (272)
T d1qpca_ 224 ER-GY----RMVR------------PDNCPEELYQLMRLCWKERPEDRPTFDYLRS 262 (272)
T ss_dssp HT-TC----CCCC------------CTTCCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred Hh-cC----CCCC------------cccChHHHHHHHHHHcCCCHhHCcCHHHHHH
Confidence 11 10 0001 1234567999999999999999999999975
|
| >d1koba_ d.144.1.7 (A:) Twitchin, kinase domain {California sea hare (Aplysia californica), twk43 [TaxId: 6500]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Twitchin, kinase domain species: California sea hare (Aplysia californica), twk43 [TaxId: 6500]
Probab=100.00 E-value=5e-54 Score=365.82 Aligned_cols=254 Identities=18% Similarity=0.262 Sum_probs=207.0
Q ss_pred HhCCCCCCceeecCCcceEEEEEe-CCCcEEEEEEeccCcCChhhhHHHHHHHHHHHhcCCcceeeeeeEEEcCCCeeEE
Q 038766 10 ATGSFSENNIIGNSNLSTVYKGRL-EDGEIVAVKKLNFHQFSAESDKSFYREAKTLKELKHRNLVKVLGYAWESGKLKAL 88 (299)
Q Consensus 10 ~~~~y~~~~~lg~g~~~~v~~~~~-~~~~~~~vK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~l 88 (299)
+.++|++.+.||+|+||+||+|.+ .+|+.||||++... .......+.+|+.++++++||||+++++++.. +...++
T Consensus 27 ~~d~Y~i~~~lG~G~fg~V~~a~~~~~~~~vAiK~i~~~--~~~~~~~~~~Ei~il~~l~HpnIv~~~~~~~~-~~~~~i 103 (352)
T d1koba_ 27 VYDYYDILEELGSGAFGVVHRCVEKATGRVFVAKFINTP--YPLDKYTVKNEISIMNQLHHPKLINLHDAFED-KYEMVL 103 (352)
T ss_dssp GGGTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECC--SHHHHHHHHHHHHHHTTCCSTTBCCEEEEEEC-SSEEEE
T ss_pred cccceEEEEEEecCCCeEEEEEEECCCCCEEEEEEECCc--chhHHHHHHHHHHHHHhCCCCCCCcEEEEEEE-CCEEEE
Confidence 567899999999999999999987 46999999998643 23445678899999999999999999997665 556699
Q ss_pred EEeecCCCChHHHhcCCCCCCCCCChhhHHHHHHHHHHHHHHhhcCCCCCeeeecccCCceeeC--CCCcEEEeeecccc
Q 038766 89 ILEYMENGSLESVIHGPGVDHSRWTLPKRIDVLISVANGLDYLHSGYDIPIVHCDMKPSNILLD--RDFEAHVSDFGTSR 166 (299)
Q Consensus 89 v~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lh~~~~~~~~H~dl~~~nil~~--~~~~v~l~df~~~~ 166 (299)
||||+++++|.+.+.. ...++++.+++.++.||+.||+|||++ +++||||||+|||++ .++.+||+|||++.
T Consensus 104 vmE~~~gg~L~~~~~~---~~~~l~e~~~~~i~~qi~~aL~ylH~~---~iiHRDiKp~NILl~~~~~~~vkL~DFGla~ 177 (352)
T d1koba_ 104 ILEFLSGGELFDRIAA---EDYKMSEAEVINYMRQACEGLKHMHEH---SIVHLDIKPENIMCETKKASSVKIIDFGLAT 177 (352)
T ss_dssp EEECCCCCBHHHHTTC---TTCCBCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEESSTTCCCEEECCCTTCE
T ss_pred EEEcCCCChHHHHHHh---cCCCCCHHHHHHHHHHHHHHHHHHHHC---CeeecccccccccccccCCCeEEEeecccce
Confidence 9999999999987753 345799999999999999999999999 999999999999997 57899999999998
Q ss_pred ccccccccccccccccccCcccCChhhhcccCcCccccchhhhHHHHHHHhCCCCCCCCccCCCCchhHHHHHHHHHhcC
Q 038766 167 MLDVHLQDLSSLSTAFQGTIGYLAPEFAYMRIVTTKVDVFSFGIVVMEFLTKRRPTGLDEENGLSPISLRQLVEKALANG 246 (299)
Q Consensus 167 ~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~DiwslG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~ 246 (299)
.+.. ........+++.|+|||++.+..++.++|||||||++|+|++|..||.... . .+.+.......
T Consensus 178 ~~~~-----~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvilyelltG~~Pf~~~~-----~---~~~~~~i~~~~ 244 (352)
T d1koba_ 178 KLNP-----DEIVKVTTATAEFAAPEIVDREPVGFYTDMWAIGVLGYVLLSGLSPFAGED-----D---LETLQNVKRCD 244 (352)
T ss_dssp ECCT-----TSCEEEECSSGGGCCHHHHTTCCBCHHHHHHHHHHHHHHHHHSCCSSCCSS-----H---HHHHHHHHHCC
T ss_pred ecCC-----CCceeeccCcccccCHHHHcCCCCCCccchHHHHHHHHHHHhCCCCCCCCC-----H---HHHHHHHHhCC
Confidence 6542 233445668999999999999999999999999999999999999995331 1 12222222211
Q ss_pred ccCcccccCccccchhhHhHHHHHHHHHHHHHHHHhcCCCCCCCCChhhhhcC
Q 038766 247 INGVRQITDPKLVSSIYEEQEQHQVLEELFKLALVCTSSNPEDRPNMNELLIT 299 (299)
Q Consensus 247 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rpt~~~il~~ 299 (299)
.. .... ....++.++.+||++||..||++|||++|+|+|
T Consensus 245 ~~----~~~~----------~~~~~s~~~~~li~~~L~~dp~~R~s~~eil~H 283 (352)
T d1koba_ 245 WE----FDED----------AFSSVSPEAKDFIKNLLQKEPRKRLTVHDALEH 283 (352)
T ss_dssp CC----CCSS----------TTTTSCHHHHHHHHTTSCSSGGGSCCHHHHHTS
T ss_pred CC----CCcc----------cccCCCHHHHHHHHHHccCChhHCcCHHHHhcC
Confidence 11 0000 022346789999999999999999999999987
|
| >d1opja_ d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mouse (Mus musculus) [TaxId: 10090]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Abelsone tyrosine kinase (abl) species: Mouse (Mus musculus) [TaxId: 10090]
Probab=100.00 E-value=1.1e-54 Score=360.80 Aligned_cols=259 Identities=24% Similarity=0.354 Sum_probs=208.0
Q ss_pred hHHHHHHhCCCCCCceeecCCcceEEEEEeC-CCcEEEEEEeccCcCChhhhHHHHHHHHHHHhcCCcceeeeeeEEEcC
Q 038766 4 RTEIENATGSFSENNIIGNSNLSTVYKGRLE-DGEIVAVKKLNFHQFSAESDKSFYREAKTLKELKHRNLVKVLGYAWES 82 (299)
Q Consensus 4 ~~~~~~~~~~y~~~~~lg~g~~~~v~~~~~~-~~~~~~vK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~ 82 (299)
+++||+-.++|++.+.||+|+||+||+|.+. +++.||||++... ....+.+.+|++++++++||||+++++++..
T Consensus 9 ~~~wei~~~~~~~~~~iG~G~fg~Vy~a~~~~~~~~vAvK~i~~~---~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~- 84 (287)
T d1opja_ 9 YDKWEMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKED---TMEVEEFLKEAAVMKEIKHPNLVQLLGVCTR- 84 (287)
T ss_dssp CCTTBCCGGGEEEEEETTTTTTSSEEEEEEGGGTEEEEEEECCTT---CSCHHHHHHHHHHHHHCCCTTBCCEEEEECS-
T ss_pred CcccEecHHHeEEeeEEeeCCCeEEEEEEECCCCeEEEEEEECCc---cchHHHHHHHHHHHHhCCCCCEecCCccEee-
Confidence 4568888899999999999999999999875 5889999998643 3345678999999999999999999997765
Q ss_pred CCeeEEEEeecCCCChHHHhcCCCCCCCCCChhhHHHHHHHHHHHHHHhhcCCCCCeeeecccCCceeeCCCCcEEEeee
Q 038766 83 GKLKALILEYMENGSLESVIHGPGVDHSRWTLPKRIDVLISVANGLDYLHSGYDIPIVHCDMKPSNILLDRDFEAHVSDF 162 (299)
Q Consensus 83 ~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lh~~~~~~~~H~dl~~~nil~~~~~~v~l~df 162 (299)
+...++||||+++|+|.+++... ....+++..++.++.||+.||+|||++ +++||||||+|||++.++.+||+||
T Consensus 85 ~~~~~iv~E~~~~g~l~~~l~~~--~~~~~~~~~~~~i~~qi~~gL~yLH~~---~iiHrDlKp~NILl~~~~~~Kl~DF 159 (287)
T d1opja_ 85 EPPFYIITEFMTYGNLLDYLREC--NRQEVSAVVLLYMATQISSAMEYLEKK---NFIHRDLAARNCLVGENHLVKVADF 159 (287)
T ss_dssp SSSCEEEEECCTTCBHHHHHHHS--CTTTSCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEECGGGCEEECCC
T ss_pred CCeeEEEeecccCcchHHHhhhc--cccchHHHHHHHHHHHHHHHHHHHHHC---CcccCccccCeEEECCCCcEEEccc
Confidence 44559999999999999988533 346789999999999999999999999 9999999999999999999999999
Q ss_pred ccccccccccccccccccccccCcccCChhhhcccCcCccccchhhhHHHHHHHhCCCCCCCCccCCCCchhHHHHHHHH
Q 038766 163 GTSRMLDVHLQDLSSLSTAFQGTIGYLAPEFAYMRIVTTKVDVFSFGIVVMEFLTKRRPTGLDEENGLSPISLRQLVEKA 242 (299)
Q Consensus 163 ~~~~~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~DiwslG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~ 242 (299)
|++..... ..........+++.|+|||.+.+..++.++|||||||++|+|++|..|+... .....+...+
T Consensus 160 G~a~~~~~---~~~~~~~~~~g~~~y~aPE~~~~~~~~~k~DiwS~Gv~l~ell~~~~p~~~~----~~~~~~~~~i--- 229 (287)
T d1opja_ 160 GLSRLMTG---DTYTAHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPG----IDLSQVYELL--- 229 (287)
T ss_dssp CCTTTCCS---SSSEEETTEEECGGGCCHHHHHHCCCSHHHHHHHHHHHHHHHHTTSCCSSTT----CCHHHHHHHH---
T ss_pred cceeecCC---CCceeeccccccccccChHHHcCCCCCchhhhhhHHHHHHHHHhCCCCCCCc----chHHHHHHHH---
Confidence 99976542 1122233445788999999999999999999999999999999987776322 1222222222
Q ss_pred HhcCccCcccccCccccchhhHhHHHHHHHHHHHHHHHHhcCCCCCCCCChhhhhc
Q 038766 243 LANGINGVRQITDPKLVSSIYEEQEQHQVLEELFKLALVCTSSNPEDRPNMNELLI 298 (299)
Q Consensus 243 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rpt~~~il~ 298 (299)
..+.. ... +..+++++.+||.+||..||++|||++++++
T Consensus 230 -~~~~~----~~~------------~~~~~~~l~~li~~cl~~dP~~Rps~~ei~~ 268 (287)
T d1opja_ 230 -EKDYR----MER------------PEGCPEKVYELMRACWQWNPSDRPSFAEIHQ 268 (287)
T ss_dssp -HTTCC----CCC------------CTTCCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred -hcCCC----CCC------------CccchHHHHHHHHHHcCCCHhHCcCHHHHHH
Confidence 11110 000 2234567999999999999999999999874
|
| >d1o6la_ d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Pkb kinase (Akt-2) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=4.4e-54 Score=363.85 Aligned_cols=251 Identities=22% Similarity=0.262 Sum_probs=207.9
Q ss_pred hCCCCCCceeecCCcceEEEEEe-CCCcEEEEEEeccCcC-ChhhhHHHHHHHHHHHhcCCcceeeeeeEEEcCCCeeEE
Q 038766 11 TGSFSENNIIGNSNLSTVYKGRL-EDGEIVAVKKLNFHQF-SAESDKSFYREAKTLKELKHRNLVKVLGYAWESGKLKAL 88 (299)
Q Consensus 11 ~~~y~~~~~lg~g~~~~v~~~~~-~~~~~~~vK~~~~~~~-~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~l 88 (299)
.++|.+.+.||+|+||.||+|++ .+|+.||+|++..... .....+.+.+|+.+++.++||||+++++++.+ ...+++
T Consensus 4 l~dy~~~~~lG~G~fg~V~~~~~~~~~~~~AiK~i~k~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~-~~~~~i 82 (337)
T d1o6la_ 4 MNDFDYLKLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTALKYAFQT-HDRLCF 82 (337)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCCCTTBCCEEEEEEC-SSEEEE
T ss_pred hHhcEEEEEEecCcCeEEEEEEECCCCCEEEEEEEchhhccCHHHHHHHHHHHHHHHhCCCCCEEEEEeeecc-cccccc
Confidence 46799999999999999999987 4699999999964332 23346778899999999999999999996665 556699
Q ss_pred EEeecCCCChHHHhcCCCCCCCCCChhhHHHHHHHHHHHHHHhhcCCCCCeeeecccCCceeeCCCCcEEEeeecccccc
Q 038766 89 ILEYMENGSLESVIHGPGVDHSRWTLPKRIDVLISVANGLDYLHSGYDIPIVHCDMKPSNILLDRDFEAHVSDFGTSRML 168 (299)
Q Consensus 89 v~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lh~~~~~~~~H~dl~~~nil~~~~~~v~l~df~~~~~~ 168 (299)
||||+.+++|.+++. ....+++..++.++.||+.||+|||++ +++||||||+|||++.+|.+||+|||++...
T Consensus 83 v~ey~~gg~L~~~~~----~~~~~~e~~~~~~~~qil~al~ylH~~---~iiHRDlKP~NILl~~~g~vkl~DFG~a~~~ 155 (337)
T d1o6la_ 83 VMEYANGGELFFHLS----RERVFTEERARFYGAEIVSALEYLHSR---DVVYRDIKLENLMLDKDGHIKITDFGLCKEG 155 (337)
T ss_dssp EEECCTTCBHHHHHH----HHSCCCHHHHHHHHHHHHHHHHHHHHT---TCBCCCCCGGGEEECTTSCEEECCCTTCBCS
T ss_pred ceeccCCCchhhhhh----cccCCcHHHHHHHHHHHhhhhhhhhhc---CccccccCHHHeEecCCCCEEEeeccccccc
Confidence 999999999999987 556899999999999999999999999 9999999999999999999999999999754
Q ss_pred ccccccccccccccccCcccCChhhhcccCcCccccchhhhHHHHHHHhCCCCCCCCccCCCCchhHHHHHHHHHhcCcc
Q 038766 169 DVHLQDLSSLSTAFQGTIGYLAPEFAYMRIVTTKVDVFSFGIVVMEFLTKRRPTGLDEENGLSPISLRQLVEKALANGIN 248 (299)
Q Consensus 169 ~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~DiwslG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 248 (299)
.. .........||+.|+|||++.+..++.++|+|||||++|+|++|..||.... . .+..........
T Consensus 156 ~~----~~~~~~~~~GT~~Y~aPE~~~~~~y~~~~DiwSlGvilyeml~G~~pf~~~~-----~---~~~~~~i~~~~~- 222 (337)
T d1o6la_ 156 IS----DGATMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQD-----H---ERLFELILMEEI- 222 (337)
T ss_dssp CC----TTCCBCCCEECGGGCCGGGGSSSCBCTTHHHHHHHHHHHHHHHSSCSSCCSS-----H---HHHHHHHHHCCC-
T ss_pred cc----CCcccccceeCHHHhhhhhccCCCCChhhcccchhhHHHHHHHCCCCCCCcC-----H---HHHHHHHhcCCC-
Confidence 32 1233445678999999999999999999999999999999999999996442 1 222222222111
Q ss_pred CcccccCccccchhhHhHHHHHHHHHHHHHHHHhcCCCCCCCCC-----hhhhhcC
Q 038766 249 GVRQITDPKLVSSIYEEQEQHQVLEELFKLALVCTSSNPEDRPN-----MNELLIT 299 (299)
Q Consensus 249 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rpt-----~~~il~~ 299 (299)
. . +..+++++.+||++||..||++||+ ++|+++|
T Consensus 223 ~-----~------------p~~~s~~~~dli~~~L~~dP~~R~~~~~~~~~eil~H 261 (337)
T d1o6la_ 223 R-----F------------PRTLSPEAKSLLAGLLKKDPKQRLGGGPSDAKEVMEH 261 (337)
T ss_dssp C-----C------------CTTSCHHHHHHHHHHTCSSTTTSTTCSTTTHHHHHTS
T ss_pred C-----C------------CccCCHHHHHHHHhhccCCchhhcccccccHHHHHcC
Confidence 1 1 2234568999999999999999994 8999987
|
| >d1sm2a_ d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase Itk/Tsk species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.6e-53 Score=348.58 Aligned_cols=252 Identities=23% Similarity=0.366 Sum_probs=193.3
Q ss_pred hCCCCCCceeecCCcceEEEEEeCCCcEEEEEEeccCcCChhhhHHHHHHHHHHHhcCCcceeeeeeEEEcCCCeeEEEE
Q 038766 11 TGSFSENNIIGNSNLSTVYKGRLEDGEIVAVKKLNFHQFSAESDKSFYREAKTLKELKHRNLVKVLGYAWESGKLKALIL 90 (299)
Q Consensus 11 ~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~vK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~lv~ 90 (299)
.++|.+.+.||+|+||+||+|.+.++..||||++.... ...+.+.+|++.+++++||||+++++++...+ ..++|+
T Consensus 4 p~~~~~~~~iG~G~fg~Vy~~~~~~~~~vAvK~i~~~~---~~~~~~~~E~~~l~~l~HpnIv~~~g~~~~~~-~~~lv~ 79 (263)
T d1sm2a_ 4 PSELTFVQEIGSGQFGLVHLGYWLNKDKVAIKTIREGA---MSEEDFIEEAEVMMKLSHPKLVQLYGVCLEQA-PICLVF 79 (263)
T ss_dssp CSCEEEEEEEECCSSCCEEEEEETTTEEEEEEECCSSS---SCHHHHHHHHHHHHHCCCTTBCCEEEEECSSS-SCEEEE
T ss_pred hHHcEEEEEEeeCCCeEEEEEEECCCCEEEEEEECCCc---CcHHHHHHHHHHHHhcCCCCcccccceeccCC-ceEEEE
Confidence 36889999999999999999999888899999986433 34567899999999999999999999776654 459999
Q ss_pred eecCCCChHHHhcCCCCCCCCCChhhHHHHHHHHHHHHHHhhcCCCCCeeeecccCCceeeCCCCcEEEeeecccccccc
Q 038766 91 EYMENGSLESVIHGPGVDHSRWTLPKRIDVLISVANGLDYLHSGYDIPIVHCDMKPSNILLDRDFEAHVSDFGTSRMLDV 170 (299)
Q Consensus 91 e~~~~~~L~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lh~~~~~~~~H~dl~~~nil~~~~~~v~l~df~~~~~~~~ 170 (299)
||+++++|.+++.. ....+++..++.++.||+.||+|||+. +++||||||+||+++.++.+||+|||++.....
T Consensus 80 E~~~~g~L~~~l~~---~~~~~~~~~~~~i~~qia~gl~~lH~~---~iiHrDlKp~Nill~~~~~~Kl~DFGla~~~~~ 153 (263)
T d1sm2a_ 80 EFMEHGCLSDYLRT---QRGLFAAETLLGMCLDVCEGMAYLEEA---CVIHRDLAARNCLVGENQVIKVSDFGMTRFVLD 153 (263)
T ss_dssp ECCTTCBHHHHHHT---TTTCCCHHHHHHHHHHHHHHHHHHHHT---TCCCTTCSGGGEEECGGGCEEECSCC-------
T ss_pred EecCCCcHHHHhhc---cccCCCHHHHHHHHHHHHHHHHhhhcc---ceeecccchhheeecCCCCeEecccchheeccC
Confidence 99999999998763 345788999999999999999999999 999999999999999999999999999976542
Q ss_pred ccccccccccccccCcccCChhhhcccCcCccccchhhhHHHHHHHhCCCCCCCCccCCCCchhHHHHHHHHHhcCccCc
Q 038766 171 HLQDLSSLSTAFQGTIGYLAPEFAYMRIVTTKVDVFSFGIVVMEFLTKRRPTGLDEENGLSPISLRQLVEKALANGINGV 250 (299)
Q Consensus 171 ~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~DiwslG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 250 (299)
. .........+|+.|+|||++.+..++.++|||||||++|+|+++..|+... .....+.. .......
T Consensus 154 ~---~~~~~~~~~gt~~y~aPE~l~~~~~~~k~DVwS~Gvil~el~t~~~~~~~~----~~~~~~~~---~i~~~~~--- 220 (263)
T d1sm2a_ 154 D---QYTSSTGTKFPVKWASPEVFSFSRYSSKSDVWSFGVLMWEVFSEGKIPYEN----RSNSEVVE---DISTGFR--- 220 (263)
T ss_dssp --------------CTTSCCHHHHTTCCCCHHHHHHHHHHHHHHHHTTSCCTTCS----CCHHHHHH---HHHHTCC---
T ss_pred C---CceeecceecCcccCChHHhcCCCCCchhhhcchHHHHHHHHHCCCCCCCC----CCHHHHHH---HHHhcCC---
Confidence 1 112223456789999999999999999999999999999999965554321 12222222 2221110
Q ss_pred ccccCccccchhhHhHHHHHHHHHHHHHHHHhcCCCCCCCCChhhhhcC
Q 038766 251 RQITDPKLVSSIYEEQEQHQVLEELFKLALVCTSSNPEDRPNMNELLIT 299 (299)
Q Consensus 251 ~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rpt~~~il~~ 299 (299)
... +...++++.+|+.+||..||++|||+++|+++
T Consensus 221 --~~~------------p~~~~~~l~~li~~cl~~~p~~Rps~~~il~~ 255 (263)
T d1sm2a_ 221 --LYK------------PRLASTHVYQIMNHCWKERPEDRPAFSRLLRQ 255 (263)
T ss_dssp --CCC------------CTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred --CCC------------ccccCHHHHHHHHHHccCCHhHCcCHHHHHHH
Confidence 011 11234578999999999999999999999874
|
| >d1k2pa_ d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Bruton's tyrosine kinase (Btk) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.3e-53 Score=348.75 Aligned_cols=251 Identities=23% Similarity=0.366 Sum_probs=204.1
Q ss_pred hCCCCCCceeecCCcceEEEEEeCCCcEEEEEEeccCcCChhhhHHHHHHHHHHHhcCCcceeeeeeEEEcCCCeeEEEE
Q 038766 11 TGSFSENNIIGNSNLSTVYKGRLEDGEIVAVKKLNFHQFSAESDKSFYREAKTLKELKHRNLVKVLGYAWESGKLKALIL 90 (299)
Q Consensus 11 ~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~vK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~lv~ 90 (299)
.++|.+.+.||+|+||+||++++++++.||||+++... ...+.+.+|+.++++++||||+++++++... +..++|+
T Consensus 3 ~~~~~~~~~iG~G~fg~Vy~~~~~~~~~vAvK~l~~~~---~~~~~~~~Ev~~~~~l~HpnIv~~~g~~~~~-~~~~iv~ 78 (258)
T d1k2pa_ 3 PKDLTFLKELGTGQFGVVKYGKWRGQYDVAIKMIKEGS---MSEDEFIEEAKVMMNLSHEKLVQLYGVCTKQ-RPIFIIT 78 (258)
T ss_dssp CCCCCCCCCCCEETTEEEEEEEETTTEEEEEEEEESSS---SCHHHHHHHHHHHHTCCCTTBCCEEEEECCS-SSEEEEE
T ss_pred hHHCEEeEEEecCCCeEEEEEEECCCCEEEEEEECcCc---CCHHHHHHHHHHHHhcCCCceeeEEEEEeeC-CceEEEE
Confidence 36899999999999999999999888899999997543 3456789999999999999999999977654 4569999
Q ss_pred eecCCCChHHHhcCCCCCCCCCChhhHHHHHHHHHHHHHHhhcCCCCCeeeecccCCceeeCCCCcEEEeeecccccccc
Q 038766 91 EYMENGSLESVIHGPGVDHSRWTLPKRIDVLISVANGLDYLHSGYDIPIVHCDMKPSNILLDRDFEAHVSDFGTSRMLDV 170 (299)
Q Consensus 91 e~~~~~~L~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lh~~~~~~~~H~dl~~~nil~~~~~~v~l~df~~~~~~~~ 170 (299)
||+.+|+|..++.. ....+++..++.++.|+++||+|||+. +++||||||+||+++.++.+||+|||++.....
T Consensus 79 Ey~~~g~l~~~~~~---~~~~~~~~~~~~i~~qi~~gl~~LH~~---~iiH~dlk~~Nill~~~~~~kl~DfG~a~~~~~ 152 (258)
T d1k2pa_ 79 EYMANGCLLNYLRE---MRHRFQTQQLLEMCKDVCEAMEYLESK---QFLHRDLAARNCLVNDQGVVKVSDFGLSRYVLD 152 (258)
T ss_dssp ECCTTEEHHHHHHS---GGGCCCHHHHHHHHHHHHHHHHHHHHT---TBCCSCCSGGGEEECTTCCEEECCCSSCCBCSS
T ss_pred EccCCCcHHHhhhc---cccCCcHHHHHHHHHHHHHHHHHHhhc---CcccccccceeEEEcCCCcEEECcchhheeccC
Confidence 99999999888653 345788999999999999999999999 999999999999999999999999999976542
Q ss_pred ccccccccccccccCcccCChhhhcccCcCccccchhhhHHHHHHHh-CCCCCCCCccCCCCchhHHHHHHHHHhcCccC
Q 038766 171 HLQDLSSLSTAFQGTIGYLAPEFAYMRIVTTKVDVFSFGIVVMEFLT-KRRPTGLDEENGLSPISLRQLVEKALANGING 249 (299)
Q Consensus 171 ~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~DiwslG~~l~~l~~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 249 (299)
. .........+|+.|+|||.+.+..++.++||||||+++|+|++ |..||... ...++. ..... +.
T Consensus 153 ~---~~~~~~~~~~t~~y~aPE~~~~~~~~~ksDiwS~G~~l~el~t~g~~Pf~~~-----~~~~~~---~~i~~-~~-- 218 (258)
T d1k2pa_ 153 D---EYTSSVGSKFPVRWSPPEVLMYSKFSSKSDIWAFGVLMWEIYSLGKMPYERF-----TNSETA---EHIAQ-GL-- 218 (258)
T ss_dssp S---SCCCCCCSCCCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTS-----CHHHHH---HHHHT-TC--
T ss_pred C---CceeecccCCCCCcCCcHHhcCCCCCcceeecccchhhHhHHhcCCCCCCCC-----CHHHHH---HHHHh-CC--
Confidence 1 1222334567889999999999999999999999999999998 78888433 222222 22221 11
Q ss_pred cccccCccccchhhHhHHHHHHHHHHHHHHHHhcCCCCCCCCChhhhhcC
Q 038766 250 VRQITDPKLVSSIYEEQEQHQVLEELFKLALVCTSSNPEDRPNMNELLIT 299 (299)
Q Consensus 250 ~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rpt~~~il~~ 299 (299)
.... +...+..+.+||++||+.||++|||++++|+|
T Consensus 219 --~~~~------------p~~~~~~l~~li~~cl~~dP~~RPt~~eil~~ 254 (258)
T d1k2pa_ 219 --RLYR------------PHLASEKVYTIMYSCWHEKADERPTFKILLSN 254 (258)
T ss_dssp --CCCC------------CTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHH
T ss_pred --CCCC------------cccccHHHHHHHHHHccCCHhHCcCHHHHHHH
Confidence 1111 11234579999999999999999999999875
|
| >d1fota_ d.144.1.7 (A:) cAMP-dependent PK, catalytic subunit {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: cAMP-dependent PK, catalytic subunit species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]
Probab=100.00 E-value=1.3e-53 Score=358.58 Aligned_cols=247 Identities=23% Similarity=0.332 Sum_probs=205.3
Q ss_pred CCCCCCceeecCCcceEEEEEe-CCCcEEEEEEeccCcC-ChhhhHHHHHHHHHHHhcCCcceeeeeeEEEcCCCeeEEE
Q 038766 12 GSFSENNIIGNSNLSTVYKGRL-EDGEIVAVKKLNFHQF-SAESDKSFYREAKTLKELKHRNLVKVLGYAWESGKLKALI 89 (299)
Q Consensus 12 ~~y~~~~~lg~g~~~~v~~~~~-~~~~~~~vK~~~~~~~-~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~lv 89 (299)
++|++.+.||+|+||+||+|++ .+|+.||||++..... .....+.+.+|+.+++.++||||+++++++.. +...++|
T Consensus 4 ~dy~i~~~lG~G~fg~Vy~a~~~~~g~~vAvK~i~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~-~~~~~iv 82 (316)
T d1fota_ 4 QDFQILRTLGTGSFGRVHLIRSRHNGRYYAMKVLKKEIVVRLKQVEHTNDERLMLSIVTHPFIIRMWGTFQD-AQQIFMI 82 (316)
T ss_dssp GGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCCBTTBCCEEEEEEC-SSEEEEE
T ss_pred hHeEEEEEEecCcCcEEEEEEECCCCCEEEEEEEchHHccCHHHHHHHHHHHHHHHhccCcChhheeeeEee-CCeeeeE
Confidence 5799999999999999999997 4699999999864322 23345778899999999999999999997665 5566999
Q ss_pred EeecCCCChHHHhcCCCCCCCCCChhhHHHHHHHHHHHHHHhhcCCCCCeeeecccCCceeeCCCCcEEEeeeccccccc
Q 038766 90 LEYMENGSLESVIHGPGVDHSRWTLPKRIDVLISVANGLDYLHSGYDIPIVHCDMKPSNILLDRDFEAHVSDFGTSRMLD 169 (299)
Q Consensus 90 ~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lh~~~~~~~~H~dl~~~nil~~~~~~v~l~df~~~~~~~ 169 (299)
|||+.|++|..++. ....+++..++.++.||+.||+|||++ +++||||||+|||++.+|.+||+|||++....
T Consensus 83 mE~~~gg~l~~~~~----~~~~~~~~~~~~~~~qi~~al~~lH~~---~iiHrDiKp~NILl~~~g~vkL~DFG~a~~~~ 155 (316)
T d1fota_ 83 MDYIEGGELFSLLR----KSQRFPNPVAKFYAAEVCLALEYLHSK---DIIYRDLKPENILLDKNGHIKITDFGFAKYVP 155 (316)
T ss_dssp ECCCCSCBHHHHHH----HTSSCCHHHHHHHHHHHHHHHHHHHTT---TEECCCCCGGGEEECTTSCEEECCCSSCEECS
T ss_pred eeecCCcccccccc----ccccccccHHHHHHHHHHHhhhhhccC---cEEccccCchheeEcCCCCEEEecCccceEec
Confidence 99999999999887 556889999999999999999999999 99999999999999999999999999997654
Q ss_pred cccccccccccccccCcccCChhhhcccCcCccccchhhhHHHHHHHhCCCCCCCCccCCCCchhHHHHHHHHHhcCccC
Q 038766 170 VHLQDLSSLSTAFQGTIGYLAPEFAYMRIVTTKVDVFSFGIVVMEFLTKRRPTGLDEENGLSPISLRQLVEKALANGING 249 (299)
Q Consensus 170 ~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~DiwslG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 249 (299)
.......||+.|+|||++.+..++.++|||||||++|+|++|..||... .. .+.+........ .
T Consensus 156 -------~~~~~~~Gt~~Y~APE~l~~~~y~~~~DiwSlGvilyemltG~~Pf~~~-----~~---~~~~~~i~~~~~-~ 219 (316)
T d1fota_ 156 -------DVTYTLCGTPDYIAPEVVSTKPYNKSIDWWSFGILIYEMLAGYTPFYDS-----NT---MKTYEKILNAEL-R 219 (316)
T ss_dssp -------SCBCCCCSCTTTCCHHHHTTCCBCTTHHHHHHHHHHHHHHHSSCTTCCS-----SH---HHHHHHHHHCCC-C
T ss_pred -------cccccccCcccccCHHHHcCCCCCchhhccccchhHHHHHhCCCCCCCc-----CH---HHHHHHHHcCCC-C
Confidence 2234567899999999999999999999999999999999999999543 11 222222222111 0
Q ss_pred cccccCccccchhhHhHHHHHHHHHHHHHHHHhcCCCCCCCC-----ChhhhhcC
Q 038766 250 VRQITDPKLVSSIYEEQEQHQVLEELFKLALVCTSSNPEDRP-----NMNELLIT 299 (299)
Q Consensus 250 ~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rp-----t~~~il~~ 299 (299)
. +..+++++.++|++||..||.+|| |++++++|
T Consensus 220 ~-----------------p~~~s~~~~~li~~~L~~dp~~R~~~~r~t~~~il~H 257 (316)
T d1fota_ 220 F-----------------PPFFNEDVKDLLSRLITRDLSQRLGNLQNGTEDVKNH 257 (316)
T ss_dssp C-----------------CTTSCHHHHHHHHHHTCSCTTTCTTSSTTTTHHHHTS
T ss_pred C-----------------CCCCCHHHHHHHHHHhhhCHHhccccchhhHHHHHcC
Confidence 0 123456799999999999999996 99999987
|
| >d1tkia_ d.144.1.7 (A:) Titin, kinase domain {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Titin, kinase domain species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.7e-53 Score=356.72 Aligned_cols=254 Identities=18% Similarity=0.243 Sum_probs=206.6
Q ss_pred HHhCCCCCCceeecCCcceEEEEEeC-CCcEEEEEEeccCcCChhhhHHHHHHHHHHHhcCCcceeeeeeEEEcCCCeeE
Q 038766 9 NATGSFSENNIIGNSNLSTVYKGRLE-DGEIVAVKKLNFHQFSAESDKSFYREAKTLKELKHRNLVKVLGYAWESGKLKA 87 (299)
Q Consensus 9 ~~~~~y~~~~~lg~g~~~~v~~~~~~-~~~~~~vK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~ 87 (299)
.+.++|.+.+.||+|+||+||+|.+. +|+.||+|++.... .....+.+|+++++.++||||+++++++.+ ++.++
T Consensus 2 ~~~~rY~i~~~lG~G~fg~Vy~~~~~~~~~~~AiK~i~~~~---~~~~~~~~Ei~il~~l~HpnIv~~~~~~~~-~~~~~ 77 (321)
T d1tkia_ 2 ELYEKYMIAEDLGRGEFGIVHRCVETSSKKTYMAKFVKVKG---TDQVLVKKEISILNIARHRNILHLHESFES-MEELV 77 (321)
T ss_dssp CCTTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECCCT---HHHHHHHHHHHHHHHSCCTTBCCEEEEEEE-TTEEE
T ss_pred CCccceEEEEEEecCCCeEEEEEEECCCCcEEEEEEEcCCc---ccHHHHHHHHHHHHhCCCCCCCeEEEEEEE-CCEEE
Confidence 36789999999999999999999875 68899999996432 344568899999999999999999997665 55669
Q ss_pred EEEeecCCCChHHHhcCCCCCCCCCChhhHHHHHHHHHHHHHHhhcCCCCCeeeecccCCceeeCCC--CcEEEeeeccc
Q 038766 88 LILEYMENGSLESVIHGPGVDHSRWTLPKRIDVLISVANGLDYLHSGYDIPIVHCDMKPSNILLDRD--FEAHVSDFGTS 165 (299)
Q Consensus 88 lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lh~~~~~~~~H~dl~~~nil~~~~--~~v~l~df~~~ 165 (299)
+||||++|++|.+++... ...+++.+++.++.||++||+|||++ +++||||||+|||++.+ +.++|+|||++
T Consensus 78 lvmE~~~gg~L~~~i~~~---~~~l~e~~~~~i~~qi~~al~yLH~~---~iiHrDlKp~NIll~~~~~~~ikl~DFG~~ 151 (321)
T d1tkia_ 78 MIFEFISGLDIFERINTS---AFELNEREIVSYVHQVCEALQFLHSH---NIGHFDIRPENIIYQTRRSSTIKIIEFGQA 151 (321)
T ss_dssp EEECCCCCCBHHHHHTSS---SCCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEESSSSCCCEEECCCTTC
T ss_pred EEEecCCCCcHHHHHHhc---CCCCCHHHHHHHHHHHHHHHHHHHHc---CCCcccccccceeecCCCceEEEEcccchh
Confidence 999999999999999732 34799999999999999999999999 99999999999999854 47999999998
Q ss_pred cccccccccccccccccccCcccCChhhhcccCcCccccchhhhHHHHHHHhCCCCCCCCccCCCCchhHHHHHHHHHhc
Q 038766 166 RMLDVHLQDLSSLSTAFQGTIGYLAPEFAYMRIVTTKVDVFSFGIVVMEFLTKRRPTGLDEENGLSPISLRQLVEKALAN 245 (299)
Q Consensus 166 ~~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~DiwslG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~ 245 (299)
..... ........+++.|+|||...+..++.++|||||||++|+|++|..||.... . .+.+......
T Consensus 152 ~~~~~-----~~~~~~~~~t~~y~ape~~~~~~~~~~~DiWSlGvily~ll~G~~Pf~~~~-----~---~~~~~~i~~~ 218 (321)
T d1tkia_ 152 RQLKP-----GDNFRLLFTAPEYYAPEVHQHDVVSTATDMWSLGTLVYVLLSGINPFLAET-----N---QQIIENIMNA 218 (321)
T ss_dssp EECCT-----TCEEEEEESCGGGSCHHHHTTCEECHHHHHHHHHHHHHHHHHSSCTTCCSS-----H---HHHHHHHHHT
T ss_pred hcccc-----CCcccccccccccccchhccCCCCCchhhcccHHHHHHHHHhCCCCCCCCC-----H---HHHHHHHHhC
Confidence 76442 223344567899999999999999999999999999999999999995432 1 2223222221
Q ss_pred CccCcccccCccccchhhHhHHHHHHHHHHHHHHHHhcCCCCCCCCChhhhhcC
Q 038766 246 GINGVRQITDPKLVSSIYEEQEQHQVLEELFKLALVCTSSNPEDRPNMNELLIT 299 (299)
Q Consensus 246 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rpt~~~il~~ 299 (299)
.. . ........++.++.+||++||..||++|||++|+|+|
T Consensus 219 ~~----~----------~~~~~~~~~s~~~~~li~~~L~~dp~~R~s~~eil~h 258 (321)
T d1tkia_ 219 EY----T----------FDEEAFKEISIEAMDFVDRLLVKERKSRMTASEALQH 258 (321)
T ss_dssp CC----C----------CCHHHHTTSCHHHHHHHHTTSCSSGGGSCCHHHHHHS
T ss_pred CC----C----------CChhhccCCCHHHHHHHHHHccCChhHCcCHHHHhcC
Confidence 10 0 0111133457789999999999999999999999987
|
| >d1rdqe_ d.144.1.7 (E:) cAMP-dependent PK, catalytic subunit {Mouse (Mus musculus) [TaxId: 10090]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: cAMP-dependent PK, catalytic subunit species: Mouse (Mus musculus) [TaxId: 10090]
Probab=100.00 E-value=2.3e-53 Score=361.70 Aligned_cols=248 Identities=21% Similarity=0.286 Sum_probs=205.6
Q ss_pred hCCCCCCceeecCCcceEEEEEeC-CCcEEEEEEeccCcC-ChhhhHHHHHHHHHHHhcCCcceeeeeeEEEcCCCeeEE
Q 038766 11 TGSFSENNIIGNSNLSTVYKGRLE-DGEIVAVKKLNFHQF-SAESDKSFYREAKTLKELKHRNLVKVLGYAWESGKLKAL 88 (299)
Q Consensus 11 ~~~y~~~~~lg~g~~~~v~~~~~~-~~~~~~vK~~~~~~~-~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~l 88 (299)
.++|.+.+.||+|+||+||+|.++ +|+.||||++..... .....+.+.+|+++++.++||||+++++++.. ....++
T Consensus 40 ld~y~i~~~lG~G~fg~Vy~a~~~~~g~~~AvK~i~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~-~~~~~~ 118 (350)
T d1rdqe_ 40 LDQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEFSFKD-NSNLYM 118 (350)
T ss_dssp GGGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTCCCTTBCCEEEEEEC-SSEEEE
T ss_pred ccCeEEEEEeecCcCcEEEEEEECCCCCEEEEEEEchHHccCHHHHHHHHHHHHHHHHcCCCcEeeccccccc-cccccc
Confidence 368999999999999999999874 699999999864322 23345678899999999999999999996665 556699
Q ss_pred EEeecCCCChHHHhcCCCCCCCCCChhhHHHHHHHHHHHHHHhhcCCCCCeeeecccCCceeeCCCCcEEEeeecccccc
Q 038766 89 ILEYMENGSLESVIHGPGVDHSRWTLPKRIDVLISVANGLDYLHSGYDIPIVHCDMKPSNILLDRDFEAHVSDFGTSRML 168 (299)
Q Consensus 89 v~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lh~~~~~~~~H~dl~~~nil~~~~~~v~l~df~~~~~~ 168 (299)
|+|++.+++|...+. ....+++..++.++.||+.||.|||++ +++||||||+|||++.+|.+||+|||++...
T Consensus 119 v~e~~~~g~l~~~l~----~~~~l~e~~~~~i~~qi~~aL~yLH~~---~iiHRDIKP~NILl~~~g~ikL~DFG~a~~~ 191 (350)
T d1rdqe_ 119 VMEYVAGGEMFSHLR----RIGRFSEPHARFYAAQIVLTFEYLHSL---DLIYRDLKPENLLIDQQGYIQVTDFGFAKRV 191 (350)
T ss_dssp EEECCTTCBHHHHHH----HHCCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECTTSCEEECCCTTCEEC
T ss_pred ccccccccchhhhHh----hcCCCCHHHHHHHHHHHHHHHHHHHhC---CEecCcCCHHHcccCCCCCEEeeeceeeeec
Confidence 999999999999886 445799999999999999999999999 9999999999999999999999999999765
Q ss_pred ccccccccccccccccCcccCChhhhcccCcCccccchhhhHHHHHHHhCCCCCCCCccCCCCchhHHHHHHHHHhcCcc
Q 038766 169 DVHLQDLSSLSTAFQGTIGYLAPEFAYMRIVTTKVDVFSFGIVVMEFLTKRRPTGLDEENGLSPISLRQLVEKALANGIN 248 (299)
Q Consensus 169 ~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~DiwslG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 248 (299)
. .......||+.|+|||++.+..++.++|||||||++|+|++|..||... .. ...+........
T Consensus 192 ~-------~~~~~~~Gt~~Y~APE~~~~~~~~~~~DiwSlGvilyemltG~~Pf~~~-----~~---~~~~~~i~~~~~- 255 (350)
T d1rdqe_ 192 K-------GRTWTLCGTPEALAPEIILSKGYNKAVDWWALGVLIYEMAAGYPPFFAD-----QP---IQIYEKIVSGKV- 255 (350)
T ss_dssp S-------SCBCCCEECGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCS-----SH---HHHHHHHHHCCC-
T ss_pred c-------cccccccCccccCCHHHHcCCCCCccccccchhHHHHHHHhCCCCCCCc-----CH---HHHHHHHhcCCC-
Confidence 4 2234567899999999999999999999999999999999999999533 11 222222222111
Q ss_pred CcccccCccccchhhHhHHHHHHHHHHHHHHHHhcCCCCCCCC-----ChhhhhcC
Q 038766 249 GVRQITDPKLVSSIYEEQEQHQVLEELFKLALVCTSSNPEDRP-----NMNELLIT 299 (299)
Q Consensus 249 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rp-----t~~~il~~ 299 (299)
.. +..+++++.+||++||..||.+|+ |++++++|
T Consensus 256 ~~-----------------p~~~s~~~~~li~~~L~~dP~kR~~~~r~t~~ell~H 294 (350)
T d1rdqe_ 256 RF-----------------PSHFSSDLKDLLRNLLQVDLTKRFGNLKNGVNDIKNH 294 (350)
T ss_dssp CC-----------------CTTCCHHHHHHHHHHSCSCTTTCTTSSTTTTHHHHTS
T ss_pred CC-----------------CccCCHHHHHHHHHHhhhCHHhccccccccHHHHHcC
Confidence 00 123456899999999999999995 99999987
|
| >d1phka_ d.144.1.7 (A:) gamma-subunit of glycogen phosphorylase kinase (Phk) {Rabbit (Oryctolagus cuniculus) [TaxId: 9986]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: gamma-subunit of glycogen phosphorylase kinase (Phk) species: Rabbit (Oryctolagus cuniculus) [TaxId: 9986]
Probab=100.00 E-value=1.7e-52 Score=345.35 Aligned_cols=254 Identities=22% Similarity=0.292 Sum_probs=205.6
Q ss_pred hCCCCCCceeecCCcceEEEEEe-CCCcEEEEEEeccCcCChh-------hhHHHHHHHHHHHhcC-CcceeeeeeEEEc
Q 038766 11 TGSFSENNIIGNSNLSTVYKGRL-EDGEIVAVKKLNFHQFSAE-------SDKSFYREAKTLKELK-HRNLVKVLGYAWE 81 (299)
Q Consensus 11 ~~~y~~~~~lg~g~~~~v~~~~~-~~~~~~~vK~~~~~~~~~~-------~~~~~~~e~~~l~~l~-h~~i~~~~~~~~~ 81 (299)
.++|.+.+.||+|+||+||+|++ .+|+.||||++........ ..+.+.+|+.++++++ ||||+++++++.+
T Consensus 2 ~~~y~~~~~iG~G~~g~V~~~~~~~~~~~~AvK~i~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~hpnIv~~~~~~~~ 81 (277)
T d1phka_ 2 YENYEPKEILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDILRKVSGHPNIIQLKDTYET 81 (277)
T ss_dssp TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEETTCSTTCCHHHHHHHHHHHHHHHHHHHHHTTCTTBCCEEEEEEC
T ss_pred cccCEEceEEecCcCeEEEEEEECCCCCEEEEEEEecccccchhHHHHHHHHHHHHHHHHHHHHhcCCCCeEEEEeeccc
Confidence 57999999999999999999987 4689999999976543322 2346788999999997 9999999997665
Q ss_pred CCCeeEEEEeecCCCChHHHhcCCCCCCCCCChhhHHHHHHHHHHHHHHhhcCCCCCeeeecccCCceeeCCCCcEEEee
Q 038766 82 SGKLKALILEYMENGSLESVIHGPGVDHSRWTLPKRIDVLISVANGLDYLHSGYDIPIVHCDMKPSNILLDRDFEAHVSD 161 (299)
Q Consensus 82 ~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lh~~~~~~~~H~dl~~~nil~~~~~~v~l~d 161 (299)
++..++||||+++++|.+++. ...++++..++.++.||++||+|||++ +++||||||+||+++.++.+||+|
T Consensus 82 -~~~~~ivmE~~~~g~L~~~l~----~~~~l~e~~~~~~~~qi~~al~~lH~~---~ivHrDlkp~Nill~~~~~~kl~D 153 (277)
T d1phka_ 82 -NTFFFLVFDLMKKGELFDYLT----EKVTLSEKETRKIMRALLEVICALHKL---NIVHRDLKPENILLDDDMNIKLTD 153 (277)
T ss_dssp -SSEEEEEEECCTTCBHHHHHH----HHSSCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEECTTCCEEECC
T ss_pred -CcceEEEEEcCCCchHHHHHH----hcCCCCHHHHHHHHHHHHHHHHHHHHc---CCcccccccceEEEcCCCCeEEcc
Confidence 556699999999999999997 456899999999999999999999999 999999999999999999999999
Q ss_pred eccccccccccccccccccccccCcccCChhhhcc------cCcCccccchhhhHHHHHHHhCCCCCCCCccCCCCchhH
Q 038766 162 FGTSRMLDVHLQDLSSLSTAFQGTIGYLAPEFAYM------RIVTTKVDVFSFGIVVMEFLTKRRPTGLDEENGLSPISL 235 (299)
Q Consensus 162 f~~~~~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~------~~~~~~~DiwslG~~l~~l~~g~~p~~~~~~~~~~~~~~ 235 (299)
||++..... ........+|+.|+|||.+.+ ..++.++||||+||++|+|++|..||.... .
T Consensus 154 FG~a~~~~~-----~~~~~~~~gt~~y~~PE~~~~~~~~~~~~~~~~~DiwslGvilyeml~g~~Pf~~~~-----~--- 220 (277)
T d1phka_ 154 FGFSCQLDP-----GEKLREVCGTPSYLAPEIIECSMNDNHPGYGKEVDMWSTGVIMYTLLAGSPPFWHRK-----Q--- 220 (277)
T ss_dssp CTTCEECCT-----TCCBCCCCSCGGGCCHHHHHHHHCTTSCCBCTHHHHHHHHHHHHHHHHSSCSSCCSS-----H---
T ss_pred chheeEccC-----CCceeeeeccCCCCCHHHhhccccccCCCCCchheEcccchhhhhhccCCCCCCCCC-----H---
Confidence 999986542 223345678999999998764 346789999999999999999999996432 1
Q ss_pred HHHHHHHHhcCccCcccccCccccchhhHhHHHHHHHHHHHHHHHHhcCCCCCCCCChhhhhcC
Q 038766 236 RQLVEKALANGINGVRQITDPKLVSSIYEEQEQHQVLEELFKLALVCTSSNPEDRPNMNELLIT 299 (299)
Q Consensus 236 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rpt~~~il~~ 299 (299)
.+.......... ....+ ....+++++.+||.+||..||++|||++|+|+|
T Consensus 221 ~~~~~~i~~~~~----~~~~~----------~~~~~s~~~~~li~~~L~~~p~~R~s~~eil~h 270 (277)
T d1phka_ 221 MLMLRMIMSGNY----QFGSP----------EWDDYSDTVKDLVSRFLVVQPQKRYTAEEALAH 270 (277)
T ss_dssp HHHHHHHHHTCC----CCCTT----------TGGGSCHHHHHHHHHHCCSSGGGSCCHHHHTTS
T ss_pred HHHHHHHHhCCC----CCCCc----------ccccCCHHHHHHHHHHccCChhHCcCHHHHHcC
Confidence 222222222111 01111 022456789999999999999999999999987
|
| >d1xbba_ d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase SYK species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.6e-53 Score=350.61 Aligned_cols=246 Identities=24% Similarity=0.354 Sum_probs=193.4
Q ss_pred ceeecCCcceEEEEEeC---CCcEEEEEEeccCcCChhhhHHHHHHHHHHHhcCCcceeeeeeEEEcCCCeeEEEEeecC
Q 038766 18 NIIGNSNLSTVYKGRLE---DGEIVAVKKLNFHQFSAESDKSFYREAKTLKELKHRNLVKVLGYAWESGKLKALILEYME 94 (299)
Q Consensus 18 ~~lg~g~~~~v~~~~~~---~~~~~~vK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~lv~e~~~ 94 (299)
++||+|+||+||+|.++ .++.||||++......+...+.+.+|+.++++++||||+++++++.. +. .++||||++
T Consensus 13 k~iG~G~fG~Vy~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~g~~~~-~~-~~lvmE~~~ 90 (277)
T d1xbba_ 13 KELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRMIGICEA-ES-WMLVMEMAE 90 (277)
T ss_dssp EEEEECSSEEEEEEEEECSSSEEEEEEEEEC-----CHHHHHHHHHHHHHHTCCCTTBCCEEEEEES-SS-EEEEEECCT
T ss_pred CCcccCCCeEEEEEEEccCCcCeEEEEEEEChhhCCHHHHHHHHHHHHHHHhCCCCCCceEEEEecc-CC-EEEEEEcCC
Confidence 47999999999999753 35689999997655556667889999999999999999999997643 33 589999999
Q ss_pred CCChHHHhcCCCCCCCCCChhhHHHHHHHHHHHHHHhhcCCCCCeeeecccCCceeeCCCCcEEEeeecccccccccccc
Q 038766 95 NGSLESVIHGPGVDHSRWTLPKRIDVLISVANGLDYLHSGYDIPIVHCDMKPSNILLDRDFEAHVSDFGTSRMLDVHLQD 174 (299)
Q Consensus 95 ~~~L~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lh~~~~~~~~H~dl~~~nil~~~~~~v~l~df~~~~~~~~~~~~ 174 (299)
+|+|.+++. ...++++..++.++.||+.||+|||++ +++||||||+||+++.++.++|+|||++..+.....
T Consensus 91 ~g~L~~~l~----~~~~l~~~~~~~i~~qi~~gl~ylH~~---~iiHrDlKp~Nill~~~~~~kl~DFGla~~~~~~~~- 162 (277)
T d1xbba_ 91 LGPLNKYLQ----QNRHVKDKNIIELVHQVSMGMKYLEES---NFVHRDLAARNVLLVTQHYAKISDFGLSKALRADEN- 162 (277)
T ss_dssp TEEHHHHHH----HCTTCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEEEETTEEEECCCTTCEECCTTCS-
T ss_pred CCcHHHHHh----hccCCCHHHHHHHHHHHHHHHhhHHhC---CcccCCCcchhhcccccCcccccchhhhhhcccccc-
Confidence 999999987 456799999999999999999999999 999999999999999999999999999976542211
Q ss_pred ccccccccccCcccCChhhhcccCcCccccchhhhHHHHHHHh-CCCCCCCCccCCCCchhHHHHHHHHHhcCccCcccc
Q 038766 175 LSSLSTAFQGTIGYLAPEFAYMRIVTTKVDVFSFGIVVMEFLT-KRRPTGLDEENGLSPISLRQLVEKALANGINGVRQI 253 (299)
Q Consensus 175 ~~~~~~~~~~~~~y~~PE~~~~~~~~~~~DiwslG~~l~~l~~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 253 (299)
.........+|+.|+|||.+.+..++.++|||||||++|+|++ |..||... ...++...+. .... .
T Consensus 163 ~~~~~~~~~gt~~y~APE~l~~~~~~~~sDiwS~Gv~l~ellt~g~~Pf~~~-----~~~~~~~~i~---~~~~-----~ 229 (277)
T d1xbba_ 163 YYKAQTHGKWPVKWYAPECINYYKFSSKSDVWSFGVLMWEAFSYGQKPYRGM-----KGSEVTAMLE---KGER-----M 229 (277)
T ss_dssp EEEC----CCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTTCCSSTTC-----CHHHHHHHHH---TTCC-----C
T ss_pred ccccccccCCCceecCchhhcCCCCCchhhhccchhhhhHHhhCCCCCCCCC-----CHHHHHHHHH---cCCC-----C
Confidence 1122334567899999999999999999999999999999997 89998532 2333322221 1110 0
Q ss_pred cCccccchhhHhHHHHHHHHHHHHHHHHhcCCCCCCCCChhhhhc
Q 038766 254 TDPKLVSSIYEEQEQHQVLEELFKLALVCTSSNPEDRPNMNELLI 298 (299)
Q Consensus 254 ~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rpt~~~il~ 298 (299)
.. +..+++++.+||.+||..||++|||+++|++
T Consensus 230 ~~------------p~~~~~~~~~li~~cl~~dp~~RPs~~~i~~ 262 (277)
T d1xbba_ 230 GC------------PAGCPREMYDLMNLCWTYDVENRPGFAAVEL 262 (277)
T ss_dssp CC------------CTTCCHHHHHHHHHHTCSSTTTSCCHHHHHH
T ss_pred CC------------CcccCHHHHHHHHHHcCCCHhHCcCHHHHHH
Confidence 00 1234568999999999999999999999853
|
| >d1jpaa_ d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mouse (Mus musculus) [TaxId: 10090]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: ephb2 receptor tyrosine kinase species: Mouse (Mus musculus) [TaxId: 10090]
Probab=100.00 E-value=5.3e-53 Score=352.55 Aligned_cols=255 Identities=27% Similarity=0.426 Sum_probs=190.7
Q ss_pred hCCCCCCceeecCCcceEEEEEeCC-C---cEEEEEEeccCcCChhhhHHHHHHHHHHHhcCCcceeeeeeEEEcCCCee
Q 038766 11 TGSFSENNIIGNSNLSTVYKGRLED-G---EIVAVKKLNFHQFSAESDKSFYREAKTLKELKHRNLVKVLGYAWESGKLK 86 (299)
Q Consensus 11 ~~~y~~~~~lg~g~~~~v~~~~~~~-~---~~~~vK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~ 86 (299)
.++|++.+.||+|+||+||+|.++. + ..||||++.. .......+.+.+|+.++++++||||+++++++... ...
T Consensus 25 ~~~~~~~~~lG~G~fg~Vy~~~~~~~~~~~~~vavK~~~~-~~~~~~~~~~~~E~~~l~~l~HpnIv~l~g~~~~~-~~~ 102 (299)
T d1jpaa_ 25 ISCVKIEQVIGAGEFGEVCSGHLKLPGKREIFVAIKTLKS-GYTEKQRRDFLSEASIMGQFDHPNVIHLEGVVTKS-TPV 102 (299)
T ss_dssp GGGEEEEEEEEECSSSEEEEEEECC---CCEEEEEEECCS-SCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECSS-SSC
T ss_pred hhhcEEeeEEeeCCCeEEEEEEEeCCCCEEEEEEEEEECc-ccCHHHHHHHHHHHHHHHhCCCCCCccEEEEEeeC-CEE
Confidence 4667888999999999999998742 3 3588888753 33455567899999999999999999999977654 456
Q ss_pred EEEEeecCCCChHHHhcCCCCCCCCCChhhHHHHHHHHHHHHHHhhcCCCCCeeeecccCCceeeCCCCcEEEeeecccc
Q 038766 87 ALILEYMENGSLESVIHGPGVDHSRWTLPKRIDVLISVANGLDYLHSGYDIPIVHCDMKPSNILLDRDFEAHVSDFGTSR 166 (299)
Q Consensus 87 ~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lh~~~~~~~~H~dl~~~nil~~~~~~v~l~df~~~~ 166 (299)
++||||+++++|.+++.. ....+++.+++.++.||+.||.|||++ +++||||||+|||++.++.+||+|||++.
T Consensus 103 ~iv~Ey~~~g~L~~~~~~---~~~~l~~~~~~~i~~qia~gl~yLH~~---~iiHrDlKp~NILl~~~~~~Kl~DFGla~ 176 (299)
T d1jpaa_ 103 MIITEFMENGSLDSFLRQ---NDGQFTVIQLVGMLRGIAAGMKYLADM---NYVHRDLAARNILVNSNLVCKVSDFGLSR 176 (299)
T ss_dssp EEEEECCTTEEHHHHHHT---TTTCSCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEECTTCCEEECCC----
T ss_pred EEEEEecCCCcceeeecc---ccCCCCHHHHHHHHHHHHHHHHHHhhC---CCccCccccceEEECCCCcEEECCcccce
Confidence 999999999999998763 245789999999999999999999999 99999999999999999999999999998
Q ss_pred cccccccccc-ccccccccCcccCChhhhcccCcCccccchhhhHHHHHHHh-CCCCCCCCccCCCCchhHHHHHHHHHh
Q 038766 167 MLDVHLQDLS-SLSTAFQGTIGYLAPEFAYMRIVTTKVDVFSFGIVVMEFLT-KRRPTGLDEENGLSPISLRQLVEKALA 244 (299)
Q Consensus 167 ~~~~~~~~~~-~~~~~~~~~~~y~~PE~~~~~~~~~~~DiwslG~~l~~l~~-g~~p~~~~~~~~~~~~~~~~~~~~~~~ 244 (299)
.......... .......+|+.|+|||.+.+..++.++|||||||++|+|++ |..||... ...++.. ....
T Consensus 177 ~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~sDvwS~Gvvl~el~t~g~~Pf~~~-----~~~~~~~---~i~~ 248 (299)
T d1jpaa_ 177 FLEDDTSDPTYTSALGGKIPIRWTAPEAIQYRKFTSASDVWSYGIVMWEVMSYGERPYWDM-----TNQDVIN---AIEQ 248 (299)
T ss_dssp -------------------CGGGSCHHHHHSCCCCHHHHHHHHHHHHHHHHTTSCCTTTTC-----CHHHHHH---HHHT
T ss_pred EccCCCCcceeeecccccCCccccCHHHHhcCCCCcccccccchHHHHHHHhCCCCCCCCC-----CHHHHHH---HHHc
Confidence 6543211111 11223456889999999999999999999999999999998 88898532 2222222 2211
Q ss_pred cCccCcccccCccccchhhHhHHHHHHHHHHHHHHHHhcCCCCCCCCChhhhhc
Q 038766 245 NGINGVRQITDPKLVSSIYEEQEQHQVLEELFKLALVCTSSNPEDRPNMNELLI 298 (299)
Q Consensus 245 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rpt~~~il~ 298 (299)
... ... +..++.++.+|+.+||..||++|||+.||++
T Consensus 249 ~~~-----~~~------------~~~~~~~l~~li~~cl~~~P~~RPs~~ei~~ 285 (299)
T d1jpaa_ 249 DYR-----LPP------------PMDCPSALHQLMLDCWQKDRNHRPKFGQIVN 285 (299)
T ss_dssp TCC-----CCC------------CTTCCHHHHHHHHHHTCSSTTTSCCHHHHHH
T ss_pred CCC-----CCC------------CccchHHHHHHHHHHcCCCHhHCcCHHHHHH
Confidence 110 000 2234567999999999999999999999875
|
| >d1rjba_ d.144.1.7 (A:) Fl cytokine receptor {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Fl cytokine receptor species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=9.9e-53 Score=355.26 Aligned_cols=262 Identities=23% Similarity=0.333 Sum_probs=201.6
Q ss_pred HHHHhCCCCCCceeecCCcceEEEEEeCC------CcEEEEEEeccCcCChhhhHHHHHHHHHHHhc-CCcceeeeeeEE
Q 038766 7 IENATGSFSENNIIGNSNLSTVYKGRLED------GEIVAVKKLNFHQFSAESDKSFYREAKTLKEL-KHRNLVKVLGYA 79 (299)
Q Consensus 7 ~~~~~~~y~~~~~lg~g~~~~v~~~~~~~------~~~~~vK~~~~~~~~~~~~~~~~~e~~~l~~l-~h~~i~~~~~~~ 79 (299)
||.-.++|.+.+.||+|+||+||+|++.. ...||+|++... ........+.+|+.+++++ +||||+++++++
T Consensus 32 wei~~~~~~l~~~lG~G~fG~Vy~a~~~~~~~~~~~~~vavK~~~~~-~~~~~~~~~~~E~~~l~~l~~HpnIv~l~~~~ 110 (325)
T d1rjba_ 32 WEFPRENLEFGKVLGSGAFGKVMNATAYGISKTGVSIQVAVKMLKEK-ADSSEREALMSELKMMTQLGSHENIVNLLGAC 110 (325)
T ss_dssp GBCCGGGEEEEEEEEECSSEEEEEEEEESCSSSSCEEEEEEEEECC-------CHHHHHHHHHHHHHCCCTTBCCEEEEE
T ss_pred ccCCHHHeEEeeEEeeCCCeEEEEEEEcCCCcccceeEEEEEEeccc-cCHHHHHHHHHHHHHHHHhcCCCcEeEEEEEE
Confidence 55566889999999999999999998642 236899988643 2344566788999999998 799999999976
Q ss_pred EcCCCeeEEEEeecCCCChHHHhcCCCC-------------------CCCCCChhhHHHHHHHHHHHHHHhhcCCCCCee
Q 038766 80 WESGKLKALILEYMENGSLESVIHGPGV-------------------DHSRWTLPKRIDVLISVANGLDYLHSGYDIPIV 140 (299)
Q Consensus 80 ~~~~~~~~lv~e~~~~~~L~~~~~~~~~-------------------~~~~~~~~~~~~i~~qi~~~l~~lh~~~~~~~~ 140 (299)
...+ ..++||||+++|+|.+++..... ....+++..++.++.||++||+|||++ +++
T Consensus 111 ~~~~-~~~lv~Ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~gl~yLH~~---~Ii 186 (325)
T d1rjba_ 111 TLSG-PIYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEEDLNVLTFEDLLCFAYQVAKGMEFLEFK---SCV 186 (325)
T ss_dssp CSSS-SCEEEEECCTTCBHHHHHHTTTTCC---------------------CCHHHHHHHHHHHHHHHHHHHHT---TEE
T ss_pred eeCC-eEEEEEEcCCCCcHHHHHHhccCCCcchhhhhccccccccccccCCCCHHHHHHHHHHHHHHHHHHHhC---Cee
Confidence 6544 55999999999999999864321 124689999999999999999999999 999
Q ss_pred eecccCCceeeCCCCcEEEeeeccccccccccccccccccccccCcccCChhhhcccCcCccccchhhhHHHHHHHh-CC
Q 038766 141 HCDMKPSNILLDRDFEAHVSDFGTSRMLDVHLQDLSSLSTAFQGTIGYLAPEFAYMRIVTTKVDVFSFGIVVMEFLT-KR 219 (299)
Q Consensus 141 H~dl~~~nil~~~~~~v~l~df~~~~~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~DiwslG~~l~~l~~-g~ 219 (299)
||||||+||+++.++.+||+|||++...... ..........+|+.|+|||.+.+..++.++|||||||++|+|++ |.
T Consensus 187 HRDlKp~Nill~~~~~~Kl~DFGla~~~~~~--~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~DiwS~Gvil~emlt~g~ 264 (325)
T d1rjba_ 187 HRDLAARNVLVTHGKVVKICDFGLARDIMSD--SNYVVRGNARLPVKWMAPESLFEGIYTIKSDVWSYGILLWEIFSLGV 264 (325)
T ss_dssp ETTCSGGGEEEETTTEEEECCCGGGSCGGGC--TTSEEETTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHTTTSC
T ss_pred eccCchhccccccCCeEEEeeccccccccCC--CceeeeccccCCCccCChHHHcCCCCCcceeccchhHHHHHHHhCCC
Confidence 9999999999999999999999999764421 11122345567999999999999999999999999999999997 89
Q ss_pred CCCCCCccCCCCchhHHHHHHHHHhcCccCcccccCccccchhhHhHHHHHHHHHHHHHHHHhcCCCCCCCCChhhhhcC
Q 038766 220 RPTGLDEENGLSPISLRQLVEKALANGINGVRQITDPKLVSSIYEEQEQHQVLEELFKLALVCTSSNPEDRPNMNELLIT 299 (299)
Q Consensus 220 ~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rpt~~~il~~ 299 (299)
.||...... ..+.. ....+.. ... +..+++++.+||.+||+.||++|||++||++|
T Consensus 265 ~Pf~~~~~~----~~~~~----~~~~~~~----~~~------------p~~~~~~l~~li~~cl~~dP~~RPt~~ei~~~ 320 (325)
T d1rjba_ 265 NPYPGIPVD----ANFYK----LIQNGFK----MDQ------------PFYATEEIYIIMQSCWAFDSRKRPSFPNLTSF 320 (325)
T ss_dssp CSSTTCCCS----HHHHH----HHHTTCC----CCC------------CTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred CCCCCCCHH----HHHHH----HHhcCCC----CCC------------CCcCCHHHHHHHHHHcCCChhHCcCHHHHHHH
Confidence 998543221 12222 2222110 001 22345689999999999999999999999875
|
| >d1fmka3 d.144.1.7 (A:249-533) c-src tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-src tyrosine kinase species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.9e-53 Score=350.36 Aligned_cols=258 Identities=27% Similarity=0.403 Sum_probs=202.0
Q ss_pred hHHHHHHhCCCCCCceeecCCcceEEEEEeCCCcEEEEEEeccCcCChhhhHHHHHHHHHHHhcCCcceeeeeeEEEcCC
Q 038766 4 RTEIENATGSFSENNIIGNSNLSTVYKGRLEDGEIVAVKKLNFHQFSAESDKSFYREAKTLKELKHRNLVKVLGYAWESG 83 (299)
Q Consensus 4 ~~~~~~~~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~vK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~ 83 (299)
.++||+-.++|++.+.||+|+||.||+|.+++++.||||++.... ...+.+.+|+.++++++||||+++++++. .+
T Consensus 9 ~~~~~i~~~~~~i~~~iG~G~fg~Vy~~~~~~~~~vAiK~l~~~~---~~~~~~~~E~~~l~~l~h~nIv~~~g~~~-~~ 84 (285)
T d1fmka3 9 KDAWEIPRESLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTLKPGT---MSPEAFLQEAQVMKKLRHEKLVQLYAVVS-EE 84 (285)
T ss_dssp TTCSBCCGGGEEEEEEEEECSSCEEEEEEETTTEEEEEEECCTTS---SCHHHHHHHHHHHHHCCCTTBCCEEEEEC-SS
T ss_pred CcceEcCHHHEEEeeEEeeCCCeEEEEEEECCCCEEEEEEECccc---CCHHHHHHHHHHHHhcccCCEeEEEEEEe-cC
Confidence 466777889999999999999999999999888889999986443 33467899999999999999999999764 34
Q ss_pred CeeEEEEeecCCCChHHHhcCCCCCCCCCChhhHHHHHHHHHHHHHHhhcCCCCCeeeecccCCceeeCCCCcEEEeeec
Q 038766 84 KLKALILEYMENGSLESVIHGPGVDHSRWTLPKRIDVLISVANGLDYLHSGYDIPIVHCDMKPSNILLDRDFEAHVSDFG 163 (299)
Q Consensus 84 ~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lh~~~~~~~~H~dl~~~nil~~~~~~v~l~df~ 163 (299)
+ .++|+||+++|+|.+++... ....+++.+++.++.||+.||+|||++ +++||||||+|||++.++.+||+|||
T Consensus 85 ~-~~lv~Ey~~~g~l~~~~~~~--~~~~l~~~~~~~i~~~i~~gl~~LH~~---~ivH~DlKp~NIll~~~~~~kl~DfG 158 (285)
T d1fmka3 85 P-IYIVTEYMSKGSLLDFLKGE--TGKYLRLPQLVDMAAQIASGMAYVERM---NYVHRDLRAANILVGENLVCKVADFG 158 (285)
T ss_dssp S-CEEEECCCTTCBHHHHHSHH--HHTTCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEECGGGCEEECCCC
T ss_pred C-eEEEEEecCCCchhhhhhhc--ccccchHHHHHHHHHHHHHHHHHHhhh---heecccccceEEEECCCCcEEEcccc
Confidence 4 58999999999999887532 234689999999999999999999999 99999999999999999999999999
Q ss_pred cccccccccccccccccccccCcccCChhhhcccCcCccccchhhhHHHHHHHhCCCCCCCCccCCCCchhHHHHHHHHH
Q 038766 164 TSRMLDVHLQDLSSLSTAFQGTIGYLAPEFAYMRIVTTKVDVFSFGIVVMEFLTKRRPTGLDEENGLSPISLRQLVEKAL 243 (299)
Q Consensus 164 ~~~~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~DiwslG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~ 243 (299)
++..... ..........+|+.|+|||++....++.++|||||||++|+|++|..|+... ... .+.+....
T Consensus 159 la~~~~~---~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDI~S~Giil~el~t~~~p~~~~----~~~---~~~~~~i~ 228 (285)
T d1fmka3 159 LARLIED---NEYTARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPG----MVN---REVLDQVE 228 (285)
T ss_dssp TTC-----------------CCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCSSTT----CCH---HHHHHHHH
T ss_pred hhhhccC---CCceeeccccccccccChHHHhCCCCCcHHhhhcchHHHHHHHhCCCCCCCC----CCH---HHHHHHHH
Confidence 9976541 1122233456789999999999999999999999999999999977766422 112 22222222
Q ss_pred hcCccCcccccCccccchhhHhHHHHHHHHHHHHHHHHhcCCCCCCCCChhhhhc
Q 038766 244 ANGINGVRQITDPKLVSSIYEEQEQHQVLEELFKLALVCTSSNPEDRPNMNELLI 298 (299)
Q Consensus 244 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rpt~~~il~ 298 (299)
...... . +..++.++.+||.+||..||++|||+++|++
T Consensus 229 ~~~~~~-----~------------~~~~~~~l~~li~~cl~~dP~~Rps~~~i~~ 266 (285)
T d1fmka3 229 RGYRMP-----C------------PPECPESLHDLMCQCWRKEPEERPTFEYLQA 266 (285)
T ss_dssp TTCCCC-----C------------CTTSCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred hcCCCC-----C------------CcccCHHHHHHHHHHcccCHhHCcCHHHHHH
Confidence 111000 0 2234567999999999999999999999874
|
| >d1xjda_ d.144.1.7 (A:) Protein kinase C, theta type {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase C, theta type species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.2e-52 Score=353.29 Aligned_cols=250 Identities=22% Similarity=0.318 Sum_probs=201.9
Q ss_pred CCCCCCceeecCCcceEEEEEeC-CCcEEEEEEeccCcC-ChhhhHHHHHHHHHHH-hcCCcceeeeeeEEEcCCCeeEE
Q 038766 12 GSFSENNIIGNSNLSTVYKGRLE-DGEIVAVKKLNFHQF-SAESDKSFYREAKTLK-ELKHRNLVKVLGYAWESGKLKAL 88 (299)
Q Consensus 12 ~~y~~~~~lg~g~~~~v~~~~~~-~~~~~~vK~~~~~~~-~~~~~~~~~~e~~~l~-~l~h~~i~~~~~~~~~~~~~~~l 88 (299)
++|.+.+.||+|+||+||+|++. +|+.||||++..... .....+....|...+. .++||||+++++++.. ++..++
T Consensus 2 ddy~i~~~iG~G~fg~Vy~~~~~~t~~~vAvK~i~k~~~~~~~~~~~~~~e~~~l~~~~~hp~Iv~~~~~~~~-~~~~yi 80 (320)
T d1xjda_ 2 EDFILHKMLGKGSFGKVFLAEFKKTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTHMFCTFQT-KENLFF 80 (320)
T ss_dssp TTEEEEEEEEECSSSEEEEEEETTTTEEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHHTTCTTBCCEEEEEEC-SSEEEE
T ss_pred CCeEEeeEEecCCCcEEEEEEECCCCCEEEEEEEchhhccChHHHHHHHHHHHHHHHhCCCCcEEEEEEEEcc-CCceeE
Confidence 68999999999999999999874 699999999964322 2233455566666654 6899999999997655 556799
Q ss_pred EEeecCCCChHHHhcCCCCCCCCCChhhHHHHHHHHHHHHHHhhcCCCCCeeeecccCCceeeCCCCcEEEeeecccccc
Q 038766 89 ILEYMENGSLESVIHGPGVDHSRWTLPKRIDVLISVANGLDYLHSGYDIPIVHCDMKPSNILLDRDFEAHVSDFGTSRML 168 (299)
Q Consensus 89 v~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lh~~~~~~~~H~dl~~~nil~~~~~~v~l~df~~~~~~ 168 (299)
||||+++|+|..++. ....+++.+++.++.||+.||+|||++ +++||||||+|||++.++.+||+|||++...
T Consensus 81 vmEy~~~g~L~~~i~----~~~~~~e~~~~~~~~qi~~al~ylH~~---~iiHrDikp~NiL~~~~~~~kl~DFG~a~~~ 153 (320)
T d1xjda_ 81 VMEYLNGGDLMYHIQ----SCHKFDLSRATFYAAEIILGLQFLHSK---GIVYRDLKLDNILLDKDGHIKIADFGMCKEN 153 (320)
T ss_dssp EEECCTTCBHHHHHH----HHSSCCHHHHHHHHHHHHHHHHHHHHT---TCBCCCCCGGGEEECTTSCEEECCCTTCBCC
T ss_pred EEeecCCCcHHHHhh----ccCCCCHHHHHHHHHHHHHHHHHHHhC---CeeeccCcccceeecCCCceeccccchhhhc
Confidence 999999999999997 556799999999999999999999999 9999999999999999999999999999754
Q ss_pred ccccccccccccccccCcccCChhhhcccCcCccccchhhhHHHHHHHhCCCCCCCCccCCCCchhHHHHHHHHHhcCcc
Q 038766 169 DVHLQDLSSLSTAFQGTIGYLAPEFAYMRIVTTKVDVFSFGIVVMEFLTKRRPTGLDEENGLSPISLRQLVEKALANGIN 248 (299)
Q Consensus 169 ~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~DiwslG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 248 (299)
.. .........||+.|+|||++.+..++.++|||||||++|+|++|..||... ... +.+....... .
T Consensus 154 ~~----~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvilyemltG~~PF~~~-----~~~---~~~~~i~~~~-~ 220 (320)
T d1xjda_ 154 ML----GDAKTNTFCGTPDYIAPEILLGQKYNHSVDWWSFGVLLYEMLIGQSPFHGQ-----DEE---ELFHSIRMDN-P 220 (320)
T ss_dssp CC----TTCCBCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCS-----SHH---HHHHHHHHCC-C
T ss_pred cc----ccccccccCCCCCcCCHHHHcCCCCCchhhhhhhhHHHHHHHhCCCCCCCC-----CHH---HHHHHHHcCC-C
Confidence 42 123344567899999999999999999999999999999999999999543 222 2222222111 1
Q ss_pred CcccccCccccchhhHhHHHHHHHHHHHHHHHHhcCCCCCCCCChh-hhhcC
Q 038766 249 GVRQITDPKLVSSIYEEQEQHQVLEELFKLALVCTSSNPEDRPNMN-ELLIT 299 (299)
Q Consensus 249 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rpt~~-~il~~ 299 (299)
.. +..+++++.+||++||..||++|||++ ++++|
T Consensus 221 ~~-----------------p~~~s~~~~dli~~~L~~dP~~R~s~~~~l~~h 255 (320)
T d1xjda_ 221 FY-----------------PRWLEKEAKDLLVKLFVREPEKRLGVRGDIRQH 255 (320)
T ss_dssp CC-----------------CTTSCHHHHHHHHHHSCSSGGGSBTTBSCGGGS
T ss_pred CC-----------------CccCCHHHHHHHHHhcccCCCCCcCHHHHHHhC
Confidence 10 123456799999999999999999996 78876
|
| >d2ozaa1 d.144.1.7 (A:51-385) MAP kinase activated protein kinase 2, mapkap2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase activated protein kinase 2, mapkap2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.9e-52 Score=352.25 Aligned_cols=255 Identities=20% Similarity=0.227 Sum_probs=200.4
Q ss_pred HhCCCCCCc-eeecCCcceEEEEEe-CCCcEEEEEEeccCcCChhhhHHHHHHHHHHHhc-CCcceeeeeeEEEc---CC
Q 038766 10 ATGSFSENN-IIGNSNLSTVYKGRL-EDGEIVAVKKLNFHQFSAESDKSFYREAKTLKEL-KHRNLVKVLGYAWE---SG 83 (299)
Q Consensus 10 ~~~~y~~~~-~lg~g~~~~v~~~~~-~~~~~~~vK~~~~~~~~~~~~~~~~~e~~~l~~l-~h~~i~~~~~~~~~---~~ 83 (299)
+.++|.+.+ .||+|+||+||+|.+ .+++.||||++.. ...+.+|+.++.++ +||||+++++++.. .+
T Consensus 9 i~~~y~i~~~~lG~G~fg~Vy~a~~~~~~~~vAiK~i~~-------~~~~~~E~~~~~~~~~hpnIv~l~~~~~~~~~~~ 81 (335)
T d2ozaa1 9 IIDDYKVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQD-------CPKARREVELHWRASQCPHIVRIVDVYENLYAGR 81 (335)
T ss_dssp GGGTEEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEC-------SHHHHHHHHHHHHHTTSTTBCCEEEEEEEEETTE
T ss_pred cccCEEEeeEEeeeccCeEEEEEEECCCCCEEEEEEECC-------cHHHHHHHHHHHHhcCCCCCCeEEEEEeecccCC
Confidence 567898875 599999999999987 5689999999852 34677899887655 79999999997653 34
Q ss_pred CeeEEEEeecCCCChHHHhcCCCCCCCCCChhhHHHHHHHHHHHHHHhhcCCCCCeeeecccCCceeeCC---CCcEEEe
Q 038766 84 KLKALILEYMENGSLESVIHGPGVDHSRWTLPKRIDVLISVANGLDYLHSGYDIPIVHCDMKPSNILLDR---DFEAHVS 160 (299)
Q Consensus 84 ~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lh~~~~~~~~H~dl~~~nil~~~---~~~v~l~ 160 (299)
..+++||||++||+|.+++... ...++++.+++.++.||+.||+|||++ +++||||||+||+++. ++.+||+
T Consensus 82 ~~~~ivmEy~~gg~L~~~i~~~--~~~~l~e~~~~~i~~qi~~al~ylH~~---~iiHRDiKp~NIll~~~~~~~~~Kl~ 156 (335)
T d2ozaa1 82 KCLLIVMECLDGGELFSRIQDR--GDQAFTEREASEIMKSIGEAIQYLHSI---NIAHRDVKPENLLYTSKRPNAILKLT 156 (335)
T ss_dssp EEEEEEEECCCSEEHHHHHHSC--SCCCEEHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEESCSSTTCCEEEC
T ss_pred CEEEEEEECCCCCcHHHHHHhc--CCCCcCHHHHHHHHHHHHHHHHHHHHc---CCcccccccccccccccccccccccc
Confidence 6679999999999999999743 235799999999999999999999999 9999999999999985 4679999
Q ss_pred eeccccccccccccccccccccccCcccCChhhhcccCcCccccchhhhHHHHHHHhCCCCCCCCccCCCCchhHHHHHH
Q 038766 161 DFGTSRMLDVHLQDLSSLSTAFQGTIGYLAPEFAYMRIVTTKVDVFSFGIVVMEFLTKRRPTGLDEENGLSPISLRQLVE 240 (299)
Q Consensus 161 df~~~~~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~DiwslG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~ 240 (299)
|||++..... ........||+.|+|||++.+..++.++|||||||++|+|++|..||........ ...+
T Consensus 157 DFG~a~~~~~-----~~~~~~~~gt~~y~aPE~~~~~~y~~~~DiwSlGvily~lltg~~Pf~~~~~~~~-----~~~~- 225 (335)
T d2ozaa1 157 DFGFAKETTS-----HNSLTTPCYTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAI-----SPGM- 225 (335)
T ss_dssp CCTTCEECCC-----CCCCCCCSCCCSSCCCCCCCGGGGSHHHHHHHHHHHHHHHTTSSCSCEETTCC------------
T ss_pred ccceeeeccC-----CCccccccCCcccCCcHHHcCCCCCHHHHHHhhchhHHHHhhCCCCCCCCCHHHH-----HHHH-
Confidence 9999976542 2233456789999999999999999999999999999999999999964422110 0000
Q ss_pred HHHhcCccCcccccCccccchhhHhHHHHHHHHHHHHHHHHhcCCCCCCCCChhhhhcC
Q 038766 241 KALANGINGVRQITDPKLVSSIYEEQEQHQVLEELFKLALVCTSSNPEDRPNMNELLIT 299 (299)
Q Consensus 241 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rpt~~~il~~ 299 (299)
.... ..... .. .......+++++.+||++||..||++|||++|+++|
T Consensus 226 --~~~i--~~~~~---~~-----~~~~~~~~s~~~~~li~~~L~~dP~~R~s~~eil~h 272 (335)
T d2ozaa1 226 --KTRI--RMGQY---EF-----PNPEWSEVSEEVKMLIRNLLKTEPTQRMTITEFMNH 272 (335)
T ss_dssp ----CC--CSCSS---SC-----CTTHHHHSCHHHHHHHHHHSCSSTTTSCCHHHHHHS
T ss_pred --HHHH--hcCCC---CC-----CCcccccCCHHHHHHHHHHccCChhHCcCHHHHHcC
Confidence 0000 00000 00 111244677899999999999999999999999987
|
| >d1omwa3 d.144.1.7 (A:186-549) G-protein coupled receptor kinase 2 {Cow (Bos taurus) [TaxId: 9913]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: G-protein coupled receptor kinase 2 species: Cow (Bos taurus) [TaxId: 9913]
Probab=100.00 E-value=1.3e-52 Score=358.98 Aligned_cols=252 Identities=21% Similarity=0.251 Sum_probs=198.5
Q ss_pred hCCCCCCceeecCCcceEEEEEeC-CCcEEEEEEeccCcCCh-hhhHHHHH---HHHHHHhcCCcceeeeeeEEEcCCCe
Q 038766 11 TGSFSENNIIGNSNLSTVYKGRLE-DGEIVAVKKLNFHQFSA-ESDKSFYR---EAKTLKELKHRNLVKVLGYAWESGKL 85 (299)
Q Consensus 11 ~~~y~~~~~lg~g~~~~v~~~~~~-~~~~~~vK~~~~~~~~~-~~~~~~~~---e~~~l~~l~h~~i~~~~~~~~~~~~~ 85 (299)
.++|.+.+.||+|+||.||+|++. +|+.||+|++....... .....+.+ ++.+++.+.||||+++++++.. .+.
T Consensus 3 lddy~i~~~lG~G~fg~Vy~~~~~~t~~~vAiK~i~~~~~~~~~~~~~~~~e~~~~~~l~~~~hpnIv~l~~~~~~-~~~ 81 (364)
T d1omwa3 3 MNDFSVHRIIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMSYAFHT-PDK 81 (364)
T ss_dssp STTEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHHTCHHHHHHHHHHHHHHSSSCCTTBCCEEEEEEC-SSE
T ss_pred HHhCeeeeEEecCCCeEEEEEEECCCCCEEEEEEEchHHcchhhHHHHHHHHHHHHHHHhcCCCCcEEEEEEEEEE-CCE
Confidence 368999999999999999999875 69999999986432221 12233334 4666777789999999997665 556
Q ss_pred eEEEEeecCCCChHHHhcCCCCCCCCCChhhHHHHHHHHHHHHHHhhcCCCCCeeeecccCCceeeCCCCcEEEeeeccc
Q 038766 86 KALILEYMENGSLESVIHGPGVDHSRWTLPKRIDVLISVANGLDYLHSGYDIPIVHCDMKPSNILLDRDFEAHVSDFGTS 165 (299)
Q Consensus 86 ~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lh~~~~~~~~H~dl~~~nil~~~~~~v~l~df~~~ 165 (299)
.++||||+.+++|.+++. ....+++..++.++.||+.||.|||++ +++||||||+|||++.+|.+||+|||++
T Consensus 82 ~~ivmE~~~gg~L~~~l~----~~~~~~e~~~~~~~~qi~~aL~ylH~~---~iiHrDlKP~NILl~~~g~iKl~DFGla 154 (364)
T d1omwa3 82 LSFILDLMNGGDLHYHLS----QHGVFSEADMRFYAAEIILGLEHMHNR---FVVYRDLKPANILLDEHGHVRISDLGLA 154 (364)
T ss_dssp EEEEECCCCSCBHHHHHH----HHCSCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECSSSCEEECCCTTC
T ss_pred EEEEEEecCCCcHHHHHH----hcccccHHHHHHHHHHHHHHHHHHHHC---CccceeeccceeEEcCCCcEEEeeecee
Confidence 699999999999999987 456789999999999999999999999 9999999999999999999999999999
Q ss_pred cccccccccccccccccccCcccCChhhhc-ccCcCccccchhhhHHHHHHHhCCCCCCCCccCCCCchhHHHHHHHHHh
Q 038766 166 RMLDVHLQDLSSLSTAFQGTIGYLAPEFAY-MRIVTTKVDVFSFGIVVMEFLTKRRPTGLDEENGLSPISLRQLVEKALA 244 (299)
Q Consensus 166 ~~~~~~~~~~~~~~~~~~~~~~y~~PE~~~-~~~~~~~~DiwslG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~ 244 (299)
..+.. .......||+.|+|||++. +..++.++|||||||++|+|++|..||...... ..........
T Consensus 155 ~~~~~------~~~~~~~GT~~y~APE~~~~~~~~~~~~DiwSlGvilyemltG~~Pf~~~~~~-----~~~~~~~~~~- 222 (364)
T d1omwa3 155 CDFSK------KKPHASVGTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTK-----DKHEIDRMTL- 222 (364)
T ss_dssp EECSS------SCCCSCCSCGGGCCHHHHSTTCCCCTHHHHHHHHHHHHHHHHSSCSSCSSCSS-----CHHHHHHHSS-
T ss_pred eecCC------CcccccccccccchhHHhhcCCCCCcccchhHHHHHHHHHHhCCCCCCCCCHH-----HHHHHHHhcc-
Confidence 76542 2234557899999999986 456899999999999999999999999654222 1122111110
Q ss_pred cCccCcccccCccccchhhHhHHHHHHHHHHHHHHHHhcCCCCCCCCC-----hhhhhcC
Q 038766 245 NGINGVRQITDPKLVSSIYEEQEQHQVLEELFKLALVCTSSNPEDRPN-----MNELLIT 299 (299)
Q Consensus 245 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rpt-----~~~il~~ 299 (299)
.. ... . +..+++++.+||.+||..||++||| ++|+++|
T Consensus 223 ~~---~~~--~------------~~~~s~~~~~li~~~L~~dP~~R~t~~~~~a~eil~H 265 (364)
T d1omwa3 223 TM---AVE--L------------PDSFSPELRSLLEGLLQRDVNRRLGCLGRGAQEVKES 265 (364)
T ss_dssp SC---CCC--C------------CSSSCHHHHHHHHHHTCSSTTTSTTTSSSTHHHHHTS
T ss_pred cC---CCC--C------------CCCCCHHHHHHHHHHcccCHHHhCCCcccCHHHHHcC
Confidence 00 000 0 1234568999999999999999999 7999987
|
| >d1ob3a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmodium falciparum) [TaxId: 5833]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK2 species: (Plasmodium falciparum) [TaxId: 5833]
Probab=100.00 E-value=3.2e-52 Score=346.72 Aligned_cols=271 Identities=21% Similarity=0.262 Sum_probs=204.3
Q ss_pred CCCCCCceeecCCcceEEEEEeCCCcEEEEEEeccCcCChhhhHHHHHHHHHHHhcCCcceeeeeeEEEcCCCeeEEEEe
Q 038766 12 GSFSENNIIGNSNLSTVYKGRLEDGEIVAVKKLNFHQFSAESDKSFYREAKTLKELKHRNLVKVLGYAWESGKLKALILE 91 (299)
Q Consensus 12 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~vK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~lv~e 91 (299)
++|.+.+.||+|+||+||+|.+++|+.||||++..........+.+.+|+.++++++||||+++++++...+ ..++++|
T Consensus 2 ~~Y~~~~~iG~G~fg~Vy~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~-~~~i~~e 80 (286)
T d1ob3a_ 2 EKYHGLEKIGEGTYGVVYKAQNNYGETFALKKIRLEKEDEGIPSTTIREISILKELKHSNIVKLYDVIHTKK-RLVLVFE 80 (286)
T ss_dssp CSEEEEEEEEEETTEEEEEEEETTSCEEEEEEECCSSGGGCCCHHHHHHHHGGGGCCCTTBCCEEEEEECSS-CEEEEEE
T ss_pred CCceeccEEecCCCcEEEEEEeCCCCEEEEEEEehhhcChHHHHHHHHHHHHHHhCCCCcEEeeeeecccCC-ceeEEEE
Confidence 689999999999999999999988999999999766555556788999999999999999999999776654 5599999
Q ss_pred ecCCCChHHHhcCCCCCCCCCChhhHHHHHHHHHHHHHHhhcCCCCCeeeecccCCceeeCCCCcEEEeeeccccccccc
Q 038766 92 YMENGSLESVIHGPGVDHSRWTLPKRIDVLISVANGLDYLHSGYDIPIVHCDMKPSNILLDRDFEAHVSDFGTSRMLDVH 171 (299)
Q Consensus 92 ~~~~~~L~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lh~~~~~~~~H~dl~~~nil~~~~~~v~l~df~~~~~~~~~ 171 (299)
++.++.+..+.. ....+++..++.++.||+.||+|||+. +++||||||+|||++.++.+|++|||.+......
T Consensus 81 ~~~~~~~~~~~~----~~~~l~~~~~~~i~~qi~~~L~~LH~~---~IvHrDiKp~NIll~~~~~~kl~DfG~a~~~~~~ 153 (286)
T d1ob3a_ 81 HLDQDLKKLLDV----CEGGLESVTAKSFLLQLLNGIAYCHDR---RVLHRDLKPQNLLINREGELKIADFGLARAFGIP 153 (286)
T ss_dssp CCSEEHHHHHHT----STTCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEECTTSCEEECCTTHHHHHCC-
T ss_pred eehhhhHHHHHh----hcCCcchhhhHHHHHHHHHHHHHhccC---cEEecCCCCceeeEcCCCCEEecccccceecccC
Confidence 997766666665 557899999999999999999999999 9999999999999999999999999999765421
Q ss_pred cccccccccccccCcccCChhhhccc-CcCccccchhhhHHHHHHHhCCCCCCCCccCCCCchhHHHHHHHHHhc-CccC
Q 038766 172 LQDLSSLSTAFQGTIGYLAPEFAYMR-IVTTKVDVFSFGIVVMEFLTKRRPTGLDEENGLSPISLRQLVEKALAN-GING 249 (299)
Q Consensus 172 ~~~~~~~~~~~~~~~~y~~PE~~~~~-~~~~~~DiwslG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~-~~~~ 249 (299)
........+++.|+|||.+.+. .++.++|||||||++|+|++|..||.... .......+...... ....
T Consensus 154 ----~~~~~~~~~~~~y~~pE~~~~~~~~~~~~DiwslGv~l~el~~G~~pf~~~~-----~~~~~~~i~~~~~~~~~~~ 224 (286)
T d1ob3a_ 154 ----VRKYTHEIVTLWYRAPDVLMGSKKYSTTIDIWSVGCIFAEMVNGTPLFPGVS-----EADQLMRIFRILGTPNSKN 224 (286)
T ss_dssp ------------CCCTTCCHHHHTTCCSCCTHHHHHHHHHHHHHHHHSSCSCCCSS-----HHHHHHHHHHHHCCCCTTT
T ss_pred ----ccccceecccchhhhHHHHhCCCCCCcceeehhcCcHHHHHHHCCCCCCCCC-----HHHHHHHHHHhhCCCChhh
Confidence 1223344578899999988754 56899999999999999999999995432 11111111111110 0000
Q ss_pred cccccC-------ccccchhhHhHHHHHHHHHHHHHHHHhcCCCCCCCCChhhhhcC
Q 038766 250 VRQITD-------PKLVSSIYEEQEQHQVLEELFKLALVCTSSNPEDRPNMNELLIT 299 (299)
Q Consensus 250 ~~~~~~-------~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rpt~~~il~~ 299 (299)
...... ................++++.+||++||..||++|||++|+|+|
T Consensus 225 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~~L~~dP~~R~s~~ell~H 281 (286)
T d1ob3a_ 225 WPNVTELPKYDPNFTVYEPLPWESFLKGLDESGIDLLSKMLKLDPNQRITAKQALEH 281 (286)
T ss_dssp STTGGGSTTCCTTCCCCCCCCGGGTCCSCCHHHHHHHHHHTCSSTTTSCCHHHHHTS
T ss_pred ccchhhhhhcccccccccCcchhhhcccCCHHHHHHHHHHccCChhHCcCHHHHhcC
Confidence 000000 00000111112233456789999999999999999999999987
|
| >d1u59a_ d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase ZAP-70 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.1e-52 Score=346.16 Aligned_cols=252 Identities=23% Similarity=0.357 Sum_probs=199.9
Q ss_pred CCCCCCce-eecCCcceEEEEEeC---CCcEEEEEEeccCcCChhhhHHHHHHHHHHHhcCCcceeeeeeEEEcCCCeeE
Q 038766 12 GSFSENNI-IGNSNLSTVYKGRLE---DGEIVAVKKLNFHQFSAESDKSFYREAKTLKELKHRNLVKVLGYAWESGKLKA 87 (299)
Q Consensus 12 ~~y~~~~~-lg~g~~~~v~~~~~~---~~~~~~vK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~ 87 (299)
++|.+.+. ||+|+||+||+|.++ ++..||||++... ......+.+.+|++++++++||||+++++++.. + ..+
T Consensus 8 ~~~~~~~~~iG~G~fg~Vy~~~~~~~~~~~~vAvK~l~~~-~~~~~~~~~~~E~~il~~l~HpnIv~l~g~~~~-~-~~~ 84 (285)
T d1u59a_ 8 DNLLIADIELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQG-TEKADTEEMMREAQIMHQLDNPYIVRLIGVCQA-E-ALM 84 (285)
T ss_dssp GGEEEEEEEEECCTTEEEEEEEEC---CCEEEEEEEECSS-CCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEES-S-SEE
T ss_pred cCeEECCcEEecccCeEEEEEEEecCCCcEEEEEEEEChh-cCHHHHHHHHHHHHHHHhCCCCCEeeEeeeecc-C-eEE
Confidence 56667774 999999999999763 3557999998643 345567789999999999999999999997653 3 458
Q ss_pred EEEeecCCCChHHHhcCCCCCCCCCChhhHHHHHHHHHHHHHHhhcCCCCCeeeecccCCceeeCCCCcEEEeeeccccc
Q 038766 88 LILEYMENGSLESVIHGPGVDHSRWTLPKRIDVLISVANGLDYLHSGYDIPIVHCDMKPSNILLDRDFEAHVSDFGTSRM 167 (299)
Q Consensus 88 lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lh~~~~~~~~H~dl~~~nil~~~~~~v~l~df~~~~~ 167 (299)
+||||+++|+|.+++.. .+..+++..++.++.|++.||+|||++ +++||||||+||+++.++.+||+|||++..
T Consensus 85 lvmE~~~~g~L~~~l~~---~~~~l~~~~~~~i~~qi~~gL~ylH~~---~iiHrDlKp~Nill~~~~~~Kl~DFGla~~ 158 (285)
T d1u59a_ 85 LVMEMAGGGPLHKFLVG---KREEIPVSNVAELLHQVSMGMKYLEEK---NFVHRDLAARNVLLVNRHYAKISDFGLSKA 158 (285)
T ss_dssp EEEECCTTEEHHHHHTT---CTTTSCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEEEETTEEEECCCTTCEE
T ss_pred EEEEeCCCCcHHHHhhc---cccCCCHHHHHHHHHHHHHHHHHHHhC---CeecCcCchhheeeccCCceeeccchhhhc
Confidence 99999999999998753 345799999999999999999999999 999999999999999999999999999986
Q ss_pred cccccccccccccccccCcccCChhhhcccCcCccccchhhhHHHHHHHh-CCCCCCCCccCCCCchhHHHHHHHHHhcC
Q 038766 168 LDVHLQDLSSLSTAFQGTIGYLAPEFAYMRIVTTKVDVFSFGIVVMEFLT-KRRPTGLDEENGLSPISLRQLVEKALANG 246 (299)
Q Consensus 168 ~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~DiwslG~~l~~l~~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~ 246 (299)
+..... .........+|+.|+|||++.+..++.++|||||||++|+|++ |..||... ...++...+ . .+
T Consensus 159 ~~~~~~-~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDVwS~Gv~l~E~lt~G~~Pf~~~-----~~~~~~~~i---~-~~ 228 (285)
T d1u59a_ 159 LGADDS-YYTARSAGKWPLKWYAPECINFRKFSSRSDVWSYGVTMWEALSYGQKPYKKM-----KGPEVMAFI---E-QG 228 (285)
T ss_dssp CTTCSC-EECCCCSSCCCGGGCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCTTTTC-----CTHHHHHHH---H-TT
T ss_pred cccccc-ccccccccccCccccChHHHhCCCCCccchhhcchHHHHHHHhCCCCCCCCC-----CHHHHHHHH---H-cC
Confidence 543211 1122234457889999999999999999999999999999998 89999532 222222222 1 11
Q ss_pred ccCcccccCccccchhhHhHHHHHHHHHHHHHHHHhcCCCCCCCCChhhhhc
Q 038766 247 INGVRQITDPKLVSSIYEEQEQHQVLEELFKLALVCTSSNPEDRPNMNELLI 298 (299)
Q Consensus 247 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rpt~~~il~ 298 (299)
.. ... +..+++++.+||.+||..||++|||+.+|++
T Consensus 229 ~~----~~~------------p~~~~~~l~~li~~cl~~~p~~RPs~~~i~~ 264 (285)
T d1u59a_ 229 KR----MEC------------PPECPPELYALMSDCWIYKWEDRPDFLTVEQ 264 (285)
T ss_dssp CC----CCC------------CTTCCHHHHHHHHHTTCSSGGGSCCHHHHHH
T ss_pred CC----CCC------------CCcCCHHHHHHHHHHcCCCHhHCcCHHHHHH
Confidence 10 000 2234568999999999999999999999864
|
| >d1ua2a_ d.144.1.7 (A:) Cell division protein kinase 7, CDK7 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell division protein kinase 7, CDK7 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=6.8e-52 Score=346.80 Aligned_cols=266 Identities=24% Similarity=0.301 Sum_probs=195.7
Q ss_pred CceeecCCcceEEEEEeC-CCcEEEEEEeccCcCCh---hhhHHHHHHHHHHHhcCCcceeeeeeEEEcCCCeeEEEEee
Q 038766 17 NNIIGNSNLSTVYKGRLE-DGEIVAVKKLNFHQFSA---ESDKSFYREAKTLKELKHRNLVKVLGYAWESGKLKALILEY 92 (299)
Q Consensus 17 ~~~lg~g~~~~v~~~~~~-~~~~~~vK~~~~~~~~~---~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~lv~e~ 92 (299)
.++||+|+||+||+|.+. +|+.||||++....... .....+.+|+.+++.++||||+++++++... +..++||||
T Consensus 3 l~~lG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~~~~~~~~~-~~~~ivmE~ 81 (299)
T d1ua2a_ 3 LDFLGEGQFATVYKARDKNTNQIVAIKKIKLGHRSEAKDGINRTALREIKLLQELSHPNIIGLLDAFGHK-SNISLVFDF 81 (299)
T ss_dssp EEEEEEETTEEEEEEECSSCCSEEEEEEC------------CTHHHHHHHHHHHCCCTTBCCEEEEECCT-TCCEEEEEC
T ss_pred ceEeccCcCeEEEEEEECCCCcEEEEEEEehhhhhhhhHHHHHHHHHHHHHHHhCCCCCEeEEEeeeccC-Cceeehhhh
Confidence 478999999999999974 58999999986543322 2245788999999999999999999976654 456999999
Q ss_pred cCCCChHHHhcCCCCCCCCCChhhHHHHHHHHHHHHHHhhcCCCCCeeeecccCCceeeCCCCcEEEeeecccccccccc
Q 038766 93 MENGSLESVIHGPGVDHSRWTLPKRIDVLISVANGLDYLHSGYDIPIVHCDMKPSNILLDRDFEAHVSDFGTSRMLDVHL 172 (299)
Q Consensus 93 ~~~~~L~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lh~~~~~~~~H~dl~~~nil~~~~~~v~l~df~~~~~~~~~~ 172 (299)
+.++++..+.. .+..+++.++..++.||++||+|||++ +++||||||+|||++.++.+||+|||++......
T Consensus 82 ~~~~~~~~~~~----~~~~l~~~~~~~~~~qil~aL~~lH~~---~iiHrDiKp~NIli~~~~~~KL~DFG~a~~~~~~- 153 (299)
T d1ua2a_ 82 METDLEVIIKD----NSLVLTPSHIKAYMLMTLQGLEYLHQH---WILHRDLKPNNLLLDENGVLKLADFGLAKSFGSP- 153 (299)
T ss_dssp CSEEHHHHHTT----CCSSCCSSHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEECTTCCEEECCCGGGSTTTSC-
T ss_pred hcchHHhhhhh----cccCCCHHHHHHHHHHHHHHHHHhhcc---ceecccCCcceEEecCCCccccccCccccccCCC-
Confidence 98877776665 556899999999999999999999999 9999999999999999999999999999765421
Q ss_pred ccccccccccccCcccCChhhhcc-cCcCccccchhhhHHHHHHHhCCCCCCCCccCCCCchhHHHHHHHHHhcC----c
Q 038766 173 QDLSSLSTAFQGTIGYLAPEFAYM-RIVTTKVDVFSFGIVVMEFLTKRRPTGLDEENGLSPISLRQLVEKALANG----I 247 (299)
Q Consensus 173 ~~~~~~~~~~~~~~~y~~PE~~~~-~~~~~~~DiwslG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~----~ 247 (299)
........+|+.|+|||++.. ..++.++|||||||++|+|++|..||.... .......+....... +
T Consensus 154 ---~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGvil~el~~g~~pf~~~~-----~~~~l~~i~~~~~~~~~~~~ 225 (299)
T d1ua2a_ 154 ---NRAYTHQVVTRWYRAPELLFGARMYGVGVDMWAVGCILAELLLRVPFLPGDS-----DLDQLTRIFETLGTPTEEQW 225 (299)
T ss_dssp ---CCCCCCSCCCCTTCCHHHHTTCSCCCHHHHHHHHHHHHHHHHHSSCSSCCSS-----HHHHHHHHHHHHCCCCTTTS
T ss_pred ---cccccceecChhhccHHHHccCCCCChhhhhhhcchHHHHHHhCcCCCCCCC-----HHHHHHHHHHhcCCCChhhc
Confidence 222334568999999998865 457999999999999999999999985432 222222121111110 0
Q ss_pred cCcccccCcc---ccchhhHhHHHHHHHHHHHHHHHHhcCCCCCCCCChhhhhcC
Q 038766 248 NGVRQITDPK---LVSSIYEEQEQHQVLEELFKLALVCTSSNPEDRPNMNELLIT 299 (299)
Q Consensus 248 ~~~~~~~~~~---~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rpt~~~il~~ 299 (299)
.......... .............+++++.+||++||..||++|||++|+|+|
T Consensus 226 ~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dll~~~L~~dP~~R~sa~e~L~H 280 (299)
T d1ua2a_ 226 PDMCSLPDYVTFKSFPGIPLHHIFSAAGDDLLDLIQGLFLFNPCARITATQALKM 280 (299)
T ss_dssp SSTTSSTTCCCCCCCCCCCHHHHCTTCCHHHHHHHHHHHCSSTTTSCCHHHHHTS
T ss_pred cchhccchhhhhccCCCCChHHhcccCCHHHHHHHHHHccCChhhCcCHHHHhCC
Confidence 0000000000 000001111123456789999999999999999999999987
|
| >d1o6ya_ d.144.1.7 (A:) Mycobacterial protein kinase PknB, catalytic domain {Mycobacterium tuberculosis [TaxId: 1773]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Mycobacterial protein kinase PknB, catalytic domain species: Mycobacterium tuberculosis [TaxId: 1773]
Probab=100.00 E-value=3.8e-52 Score=344.52 Aligned_cols=260 Identities=26% Similarity=0.352 Sum_probs=201.0
Q ss_pred HHhCCCCCCceeecCCcceEEEEEe-CCCcEEEEEEeccCcC-ChhhhHHHHHHHHHHHhcCCcceeeeeeEEEcCCC--
Q 038766 9 NATGSFSENNIIGNSNLSTVYKGRL-EDGEIVAVKKLNFHQF-SAESDKSFYREAKTLKELKHRNLVKVLGYAWESGK-- 84 (299)
Q Consensus 9 ~~~~~y~~~~~lg~g~~~~v~~~~~-~~~~~~~vK~~~~~~~-~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~-- 84 (299)
.+.++|++.+.||+|+||+||+|.+ .+|+.||||++..... .......+.+|+++++.++||||+++++++...+.
T Consensus 4 ~l~drY~i~~~lG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~E~~~l~~~~hpniv~~~~~~~~~~~~~ 83 (277)
T d1o6ya_ 4 HLSDRYELGEILGFGGMSEVHLARDLRLHRDVAVKVLRADLARDPSFYLRFRREAQNAAALNHPAIVAVYDTGEAETPAG 83 (277)
T ss_dssp EETTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSTTTTCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEEEECSSS
T ss_pred CccceeEEeEEEeeCCCeEEEEEEECCCCCEEEEEEEchhhccCHHHHHHHHHHHHHHHhcCCCCCCcccceeeeccCCC
Confidence 4678999999999999999999987 4699999999975443 34446778999999999999999999998765443
Q ss_pred -eeEEEEeecCCCChHHHhcCCCCCCCCCChhhHHHHHHHHHHHHHHhhcCCCCCeeeecccCCceeeCCCCcEEEeeec
Q 038766 85 -LKALILEYMENGSLESVIHGPGVDHSRWTLPKRIDVLISVANGLDYLHSGYDIPIVHCDMKPSNILLDRDFEAHVSDFG 163 (299)
Q Consensus 85 -~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lh~~~~~~~~H~dl~~~nil~~~~~~v~l~df~ 163 (299)
..++||||++|++|...+. ...++++.+++.++.||+.||+|||++ +++||||||+||+++.++.++++|||
T Consensus 84 ~~~~lvmE~~~g~~L~~~~~----~~~~l~~~~~~~i~~qi~~al~~lH~~---~iiHrDiKP~NIll~~~~~~~l~d~~ 156 (277)
T d1o6ya_ 84 PLPYIVMEYVDGVTLRDIVH----TEGPMTPKRAIEVIADACQALNFSHQN---GIIHRDVKPANIMISATNAVKVMDFG 156 (277)
T ss_dssp EEEEEEEECCCEEEHHHHHH----HHCSCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEEETTSCEEECCCT
T ss_pred ceEEEEEECCCCCEehhhhc----ccCCCCHHHHHHHHHHHHHHHHHHHhC---CccCccccCcccccCccccceeehhh
Confidence 4689999999999999887 456899999999999999999999999 99999999999999999999999999
Q ss_pred cccccccccccccccccccccCcccCChhhhcccCcCccccchhhhHHHHHHHhCCCCCCCCccCCCCchhHHHHHHHHH
Q 038766 164 TSRMLDVHLQDLSSLSTAFQGTIGYLAPEFAYMRIVTTKVDVFSFGIVVMEFLTKRRPTGLDEENGLSPISLRQLVEKAL 243 (299)
Q Consensus 164 ~~~~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~DiwslG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~ 243 (299)
.+....... ..........||+.|+|||++.+..++.++|||||||++|+|++|..||.... . .+.+....
T Consensus 157 ~~~~~~~~~-~~~~~~~~~~Gt~~Y~aPE~~~~~~~~~~~DiwSlGvilyelltG~~Pf~~~~-----~---~~~~~~~~ 227 (277)
T d1o6ya_ 157 IARAIADSG-NSVTQTAAVIGTAQYLSPEQARGDSVDARSDVYSLGCVLYEVLTGEPPFTGDS-----P---VSVAYQHV 227 (277)
T ss_dssp TCEECC-----------------TTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCSCCCSS-----H---HHHHHHHH
T ss_pred hhhhhcccc-ccccccccccCcccccCHHHHcCCCCCcceecccchHHHHHHHhCCCCCCCcC-----H---HHHHHHHH
Confidence 886543221 11223445678999999999999999999999999999999999999995431 1 12222222
Q ss_pred hcCccCcccccCccccchhhHhHHHHHHHHHHHHHHHHhcCCCCCCCC-Chhhhhc
Q 038766 244 ANGINGVRQITDPKLVSSIYEEQEQHQVLEELFKLALVCTSSNPEDRP-NMNELLI 298 (299)
Q Consensus 244 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rp-t~~~il~ 298 (299)
........ .....+++++.++|++||..||++|| |++++++
T Consensus 228 ~~~~~~~~--------------~~~~~~s~~l~~li~~~L~~dp~~R~~sa~~l~~ 269 (277)
T d1o6ya_ 228 REDPIPPS--------------ARHEGLSADLDAVVLKALAKNPENRYQTAAEMRA 269 (277)
T ss_dssp HCCCCCGG--------------GTSSSCCHHHHHHHHHHTCSSGGGSCSSHHHHHH
T ss_pred hcCCCCCc--------------hhccCCCHHHHHHHHHHccCCHhHCHhHHHHHHH
Confidence 22211100 00223457899999999999999999 7777653
|
| >d1gz8a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.1e-51 Score=345.24 Aligned_cols=271 Identities=27% Similarity=0.354 Sum_probs=200.5
Q ss_pred CCCCCCceeecCCcceEEEEEe-CCCcEEEEEEeccCcCChhhhHHHHHHHHHHHhcCCcceeeeeeEEEcCCCeeEEEE
Q 038766 12 GSFSENNIIGNSNLSTVYKGRL-EDGEIVAVKKLNFHQFSAESDKSFYREAKTLKELKHRNLVKVLGYAWESGKLKALIL 90 (299)
Q Consensus 12 ~~y~~~~~lg~g~~~~v~~~~~-~~~~~~~vK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~lv~ 90 (299)
++|.+.+.||+|+||+||+|.+ .+|+.||+|++..........+.+.+|++++++++||||+++++++.. +...++|+
T Consensus 2 d~Y~~~~~lG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~Ei~il~~l~Hp~Iv~~~~~~~~-~~~~~iv~ 80 (298)
T d1gz8a_ 2 ENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLDVIHT-ENKLYLVF 80 (298)
T ss_dssp TTEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEC-------CCHHHHHHHHHHTTCCCTTBCCEEEEEEE-TTEEEEEE
T ss_pred CCCEeccEEecCcCeEEEEEEECCCCCEEEEEEEehhhcChHHHHHHHHHHHHHHhCCCCcEEEecccccc-ccceeEEE
Confidence 6899999999999999999987 568999999997655555567889999999999999999999997765 55669999
Q ss_pred eecCCCChHHHhcCCCCCCCCCChhhHHHHHHHHHHHHHHhhcCCCCCeeeecccCCceeeCCCCcEEEeeecccccccc
Q 038766 91 EYMENGSLESVIHGPGVDHSRWTLPKRIDVLISVANGLDYLHSGYDIPIVHCDMKPSNILLDRDFEAHVSDFGTSRMLDV 170 (299)
Q Consensus 91 e~~~~~~L~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lh~~~~~~~~H~dl~~~nil~~~~~~v~l~df~~~~~~~~ 170 (299)
||+.+ ++...+... ....+++..++.++.|++.||+|||++ +++||||||+|||++.++.+||+|||.+.....
T Consensus 81 e~~~~-~~~~~~~~~--~~~~l~e~~~~~~~~qil~~L~yLH~~---~IiHrDiKpeNIl~~~~~~~kl~DFG~a~~~~~ 154 (298)
T d1gz8a_ 81 EFLHQ-DLKKFMDAS--ALTGIPLPLIKSYLFQLLQGLAFCHSH---RVLHRDLKPQNLLINTEGAIKLADFGLARAFGV 154 (298)
T ss_dssp ECCSE-EHHHHHHHT--TTTCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEECTTSCEEECSTTHHHHHCC
T ss_pred eecCC-chhhhhhhh--cccCCCHHHHHHHHHHHHHHHHHhhcC---CEEccccCchheeecccCcceeccCCcceeccC
Confidence 99965 544443221 456799999999999999999999999 999999999999999999999999999975432
Q ss_pred ccccccccccccccCcccCChhhhcccC-cCccccchhhhHHHHHHHhCCCCCCCCccCCCCchhHHHHHHHHHhcC---
Q 038766 171 HLQDLSSLSTAFQGTIGYLAPEFAYMRI-VTTKVDVFSFGIVVMEFLTKRRPTGLDEENGLSPISLRQLVEKALANG--- 246 (299)
Q Consensus 171 ~~~~~~~~~~~~~~~~~y~~PE~~~~~~-~~~~~DiwslG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~--- 246 (299)
.........+|+.|+|||.+.... ++.++|||||||++|+|++|..||.... .......+.......
T Consensus 155 ----~~~~~~~~~gt~~y~apE~~~~~~~~~~~~DiwSlGvily~m~~G~~Pf~~~~-----~~~~~~~i~~~~~~~~~~ 225 (298)
T d1gz8a_ 155 ----PVRTYTHEVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDS-----EIDQLFRIFRTLGTPDEV 225 (298)
T ss_dssp ----CSBCTTCCBCCCTTCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSCCCSS-----HHHHHHHHHHHHCCCCTT
T ss_pred ----CcccceeecccceeeehhhhccccCCCccccccccchhhhHHhhCCCCCCCCC-----HHHHHHHHHHhcCCCchh
Confidence 223344557899999999877665 5789999999999999999999995431 111111111111110
Q ss_pred -ccCcccccC-----ccccchhhHhHHHHHHHHHHHHHHHHhcCCCCCCCCChhhhhcC
Q 038766 247 -INGVRQITD-----PKLVSSIYEEQEQHQVLEELFKLALVCTSSNPEDRPNMNELLIT 299 (299)
Q Consensus 247 -~~~~~~~~~-----~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rpt~~~il~~ 299 (299)
+.......+ +..... ........++.++.+||++||..||++|||++|+|+|
T Consensus 226 ~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~s~~~~dll~~mL~~dP~~R~t~~ell~H 283 (298)
T d1gz8a_ 226 VWPGVTSMPDYKPSFPKWARQ-DFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAH 283 (298)
T ss_dssp TSTTGGGSTTCCTTSCCCCCC-CHHHHSTTCCHHHHHHHHHHTCSSTTTSCCHHHHHTS
T ss_pred hcccccccccccccccccccc-chhhhccCCCHHHHHHHHHHccCChhHCcCHHHHhCC
Confidence 000000000 000000 0011123456789999999999999999999999987
|
| >d1mp8a_ d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Focal adhesion kinase 1 (fak) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=8.7e-53 Score=347.56 Aligned_cols=256 Identities=23% Similarity=0.299 Sum_probs=194.6
Q ss_pred HHHHhCCCCCCceeecCCcceEEEEEeCC----CcEEEEEEeccCcCChhhhHHHHHHHHHHHhcCCcceeeeeeEEEcC
Q 038766 7 IENATGSFSENNIIGNSNLSTVYKGRLED----GEIVAVKKLNFHQFSAESDKSFYREAKTLKELKHRNLVKVLGYAWES 82 (299)
Q Consensus 7 ~~~~~~~y~~~~~lg~g~~~~v~~~~~~~----~~~~~vK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~ 82 (299)
||+-.++|.+.+.||+|+||+||+|.+.. +..||||++.. .......+.+.+|+.++++++||||+++++++.
T Consensus 2 ~ei~~~~~~l~~~iG~G~fg~Vy~a~~~~~~~~~~~vaik~~~~-~~~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~-- 78 (273)
T d1mp8a_ 2 YEIQRERIELGRCIGEGQFGDVHQGIYMSPENPALAVAIKTCKN-CTSDSVREKFLQEALTMRQFDHPHIVKLIGVIT-- 78 (273)
T ss_dssp CBCCGGGEEEEEEEEECSSSEEEEEEECCC--CCEEEEEEECTT-TTSHHHHHHHHHHHHHHHTCCCTTBCCEEEEEC--
T ss_pred CCcCHHHeEEEEEEeeCCCcEEEEEEEecCCceeEEEEEEEecc-ccCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEe--
Confidence 56667899999999999999999998642 35688888753 334555678999999999999999999999763
Q ss_pred CCeeEEEEeecCCCChHHHhcCCCCCCCCCChhhHHHHHHHHHHHHHHhhcCCCCCeeeecccCCceeeCCCCcEEEeee
Q 038766 83 GKLKALILEYMENGSLESVIHGPGVDHSRWTLPKRIDVLISVANGLDYLHSGYDIPIVHCDMKPSNILLDRDFEAHVSDF 162 (299)
Q Consensus 83 ~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lh~~~~~~~~H~dl~~~nil~~~~~~v~l~df 162 (299)
.+..++|+||+.+++|.+++.. ....+++..++.++.||++||.|||++ +++||||||+||+++.++.+||+||
T Consensus 79 ~~~~~iv~E~~~~g~l~~~~~~---~~~~l~~~~~~~~~~qi~~gl~ylH~~---~iiHrDlKp~NIll~~~~~~Kl~Df 152 (273)
T d1mp8a_ 79 ENPVWIIMELCTLGELRSFLQV---RKYSLDLASLILYAYQLSTALAYLESK---RFVHRDIAARNVLVSSNDCVKLGDF 152 (273)
T ss_dssp SSSCEEEEECCTTEEHHHHHHH---TTTTSCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEEEETTEEEECC-
T ss_pred cCeEEEEEEeccCCcHHhhhhc---cCCCCCHHHHHHHHHHHHHHhhhhccc---CeeccccchhheeecCCCcEEEccc
Confidence 3456999999999999987652 345789999999999999999999999 9999999999999999999999999
Q ss_pred ccccccccccccccccccccccCcccCChhhhcccCcCccccchhhhHHHHHHHh-CCCCCCCCccCCCCchhHHHHHHH
Q 038766 163 GTSRMLDVHLQDLSSLSTAFQGTIGYLAPEFAYMRIVTTKVDVFSFGIVVMEFLT-KRRPTGLDEENGLSPISLRQLVEK 241 (299)
Q Consensus 163 ~~~~~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~DiwslG~~l~~l~~-g~~p~~~~~~~~~~~~~~~~~~~~ 241 (299)
|++..... ..........+|+.|+|||.+.+..++.++|||||||++|+|++ |..||... ....+...+.
T Consensus 153 G~a~~~~~---~~~~~~~~~~gt~~y~apE~l~~~~~~~~~DiwSlGvil~e~lt~g~~P~~~~-----~~~~~~~~i~- 223 (273)
T d1mp8a_ 153 GLSRYMED---STYYKASKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMHGVKPFQGV-----KNNDVIGRIE- 223 (273)
T ss_dssp ---------------------CCGGGCCHHHHHHCCCSHHHHHHHHHHHHHHHHTTSCCTTTTC-----CGGGHHHHHH-
T ss_pred hhheeccC---CcceeccceecCcccchhhHhccCCCCCccccccchHHHHHHHhcCCCCCCCC-----CHHHHHHHHH-
Confidence 99976542 11222344567899999999999999999999999999999997 78888533 2233332221
Q ss_pred HHhcCccCcccccCccccchhhHhHHHHHHHHHHHHHHHHhcCCCCCCCCChhhhhcC
Q 038766 242 ALANGINGVRQITDPKLVSSIYEEQEQHQVLEELFKLALVCTSSNPEDRPNMNELLIT 299 (299)
Q Consensus 242 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rpt~~~il~~ 299 (299)
..... .. +..+++++.+||.+||..||++|||++||+++
T Consensus 224 --~~~~~-----~~------------~~~~~~~~~~li~~cl~~dp~~Rps~~ei~~~ 262 (273)
T d1mp8a_ 224 --NGERL-----PM------------PPNCPPTLYSLMTKCWAYDPSRRPRFTELKAQ 262 (273)
T ss_dssp --TTCCC-----CC------------CTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred --cCCCC-----CC------------CCCCCHHHHHHHHHHcCCCHhHCcCHHHHHHH
Confidence 11100 00 22345689999999999999999999999863
|
| >d1blxa_ d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK6 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.2e-51 Score=344.85 Aligned_cols=271 Identities=23% Similarity=0.286 Sum_probs=203.1
Q ss_pred hCCCCCCceeecCCcceEEEEEe-CC-CcEEEEEEeccCcCChhhhHHHHHHHHHHHhc---CCcceeeeeeEEEc----
Q 038766 11 TGSFSENNIIGNSNLSTVYKGRL-ED-GEIVAVKKLNFHQFSAESDKSFYREAKTLKEL---KHRNLVKVLGYAWE---- 81 (299)
Q Consensus 11 ~~~y~~~~~lg~g~~~~v~~~~~-~~-~~~~~vK~~~~~~~~~~~~~~~~~e~~~l~~l---~h~~i~~~~~~~~~---- 81 (299)
.++|.+.+.||+|+||+||+|.+ .+ ++.||||++............+.+|+.+++.+ +||||+++++++..
T Consensus 6 ~~~Y~i~~~LG~G~fg~V~~a~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~E~~~l~~l~~~~HpnIv~~~~~~~~~~~~ 85 (305)
T d1blxa_ 6 DQQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETFEHPNVVRLFDVCTVSRTD 85 (305)
T ss_dssp GGTEEEEEEEEEETTEEEEEEEETTTTTEEEEEEEEEEEBCTTSCBCTHHHHHHHHHHHHHTCCTTBCCEEEEEEEEECS
T ss_pred cCCEEEEEEEecccCeEEEEEEEECCCCEEEEEEEEehhhccchHHHHHHHHHHHHHHHhhcCCCCcceeeeeecccccc
Confidence 47999999999999999999987 34 66799999976554544555666788777766 69999999998753
Q ss_pred CCCeeEEEEeecCCCChHHHhcCCCCCCCCCChhhHHHHHHHHHHHHHHhhcCCCCCeeeecccCCceeeCCCCcEEEee
Q 038766 82 SGKLKALILEYMENGSLESVIHGPGVDHSRWTLPKRIDVLISVANGLDYLHSGYDIPIVHCDMKPSNILLDRDFEAHVSD 161 (299)
Q Consensus 82 ~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lh~~~~~~~~H~dl~~~nil~~~~~~v~l~d 161 (299)
.....++++|++.++.+...... ....+++..++.++.|+++||+|||++ +++||||||+|||++.++.+||+|
T Consensus 86 ~~~~~~~~~e~~~~~~~~~~~~~---~~~~~~~~~~~~~~~qi~~aL~yLH~~---~ivHrDiKp~NILi~~~~~~kl~d 159 (305)
T d1blxa_ 86 RETKLTLVFEHVDQDLTTYLDKV---PEPGVPTETIKDMMFQLLRGLDFLHSH---RVVHRDLKPQNILVTSSGQIKLAD 159 (305)
T ss_dssp SEEEEEEEEECCSCBHHHHHHHS---CTTCSCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEECTTCCEEECS
T ss_pred cCceEEEEEEeccCCchhhhhhc---cCCCCCHHHHHHHHHHHHHHHHHHHhC---CEEecCCCccEEEEcCCCCeeecc
Confidence 33467899999987666544332 456789999999999999999999999 999999999999999999999999
Q ss_pred eccccccccccccccccccccccCcccCChhhhcccCcCccccchhhhHHHHHHHhCCCCCCCCccCCCCchhHHHHHHH
Q 038766 162 FGTSRMLDVHLQDLSSLSTAFQGTIGYLAPEFAYMRIVTTKVDVFSFGIVVMEFLTKRRPTGLDEENGLSPISLRQLVEK 241 (299)
Q Consensus 162 f~~~~~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~DiwslG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~ 241 (299)
||++.... .........||+.|+|||++.+..++.++|||||||++|+|++|..||.... .......+..
T Consensus 160 fg~~~~~~-----~~~~~~~~~gT~~Y~APE~~~~~~y~~~~DiwSlG~il~ell~g~~pf~~~~-----~~~~~~~i~~ 229 (305)
T d1blxa_ 160 FGLARIYS-----FQMALTSVVVTLWYRAPEVLLQSSYATPVDLWSVGCIFAEMFRRKPLFRGSS-----DVDQLGKILD 229 (305)
T ss_dssp CCSCCCCC-----GGGGGCCCCCCCTTCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSCCCSS-----HHHHHHHHHH
T ss_pred hhhhhhhc-----ccccCCCcccChhhcCcchhcCCCCChhehhhchHHHHHHHHHCCCCCCCCC-----HHHHHHHHHH
Confidence 99987543 2233456678999999999999999999999999999999999999995432 2222121111
Q ss_pred HHhcCccCcccccC------ccc--cchhhHhHHHHHHHHHHHHHHHHhcCCCCCCCCChhhhhcC
Q 038766 242 ALANGINGVRQITD------PKL--VSSIYEEQEQHQVLEELFKLALVCTSSNPEDRPNMNELLIT 299 (299)
Q Consensus 242 ~~~~~~~~~~~~~~------~~~--~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rpt~~~il~~ 299 (299)
.... +....+.. ... ............+++.+.+||++||..||++|||++|+|+|
T Consensus 230 ~~~~--~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~mL~~dP~~R~sa~e~L~H 293 (305)
T d1blxa_ 230 VIGL--PGEEDWPRDVALPRQAFHSKSAQPIEKFVTDIDELGKDLLLKCLTFNPAKRISAYSALSH 293 (305)
T ss_dssp HHCC--CCGGGSCTTCSSCGGGSCCCCCCCGGGTCCSCCHHHHHHHHHHSCSSTTTSCCHHHHHTS
T ss_pred hhCC--CchhcccccccchhhhhccccccchhhccccCCHHHHHHHHHHCcCChhHCcCHHHHhcC
Confidence 1111 00000000 000 00000111133456788999999999999999999999987
|
| >d1mqba_ d.144.1.7 (A:) epha2 receptor tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: epha2 receptor tyrosine kinase species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.1e-51 Score=340.72 Aligned_cols=258 Identities=26% Similarity=0.451 Sum_probs=195.0
Q ss_pred HHHhCCCCCCceeecCCcceEEEEEeCC-C----cEEEEEEeccCcCChhhhHHHHHHHHHHHhcCCcceeeeeeEEEcC
Q 038766 8 ENATGSFSENNIIGNSNLSTVYKGRLED-G----EIVAVKKLNFHQFSAESDKSFYREAKTLKELKHRNLVKVLGYAWES 82 (299)
Q Consensus 8 ~~~~~~y~~~~~lg~g~~~~v~~~~~~~-~----~~~~vK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~ 82 (299)
|+-.+.|.+.++||+|+||+||+|.+++ + ..||||++... ........+.+|+.++++++||||+++++++...
T Consensus 3 ei~~~~~~~~~~iG~G~fG~Vy~~~~~~~~~~~~~~vAvK~~~~~-~~~~~~~~~~~E~~il~~l~H~nIv~~~g~~~~~ 81 (283)
T d1mqba_ 3 EIHPSCVTRQKVIGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAG-YTEKQRVDFLGEAGIMGQFSHHNIIRLEGVISKY 81 (283)
T ss_dssp BCCTTTEEEEEEEEECSSSEEEEEEEEC---CCEEEEEEEEECTT-CCHHHHHHHHHHHHHHHTCCCTTBCCEEEEECSS
T ss_pred cCCHHHeEeeeEEeeCCCeEEEEEEEeCCCCEEEEEEEEEEECcc-cChHHHHHHHHHHHHHHhcCCCCEeeeeEEEecC
Confidence 4556789999999999999999998643 2 46999998643 3445566788999999999999999999977654
Q ss_pred CCeeEEEEeecCCCChHHHhcCCCCCCCCCChhhHHHHHHHHHHHHHHhhcCCCCCeeeecccCCceeeCCCCcEEEeee
Q 038766 83 GKLKALILEYMENGSLESVIHGPGVDHSRWTLPKRIDVLISVANGLDYLHSGYDIPIVHCDMKPSNILLDRDFEAHVSDF 162 (299)
Q Consensus 83 ~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lh~~~~~~~~H~dl~~~nil~~~~~~v~l~df 162 (299)
+ ..++|+||+.++++.+.+.. ....+++.+++.++.|++.||+|||+. +++||||||+|||++.++.+||+||
T Consensus 82 ~-~~~~v~e~~~~~~l~~~~~~---~~~~~~~~~~~~i~~~i~~gl~~lH~~---~iiHrDlKp~NILl~~~~~~Kl~DF 154 (283)
T d1mqba_ 82 K-PMMIITEYMENGALDKFLRE---KDGEFSVLQLVGMLRGIAAGMKYLANM---NYVHRDLAARNILVNSNLVCKVSDF 154 (283)
T ss_dssp S-SEEEEEECCTTEEHHHHHHH---TTTCSCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEECTTCCEEECCC
T ss_pred C-ceEEEEEecccCcchhhhhc---ccccccHHHHHHHHHHHHHhhhhcccc---ccccCccccceEEECCCCeEEEccc
Confidence 4 45999999999999887653 335799999999999999999999999 9999999999999999999999999
Q ss_pred ccccccccccccccccccccccCcccCChhhhcccCcCccccchhhhHHHHHHHhCCCCCCCCccCCCCchhHHHHHHHH
Q 038766 163 GTSRMLDVHLQDLSSLSTAFQGTIGYLAPEFAYMRIVTTKVDVFSFGIVVMEFLTKRRPTGLDEENGLSPISLRQLVEKA 242 (299)
Q Consensus 163 ~~~~~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~DiwslG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~ 242 (299)
|++..+..... .........+|+.|+|||++.+..++.++|||||||++|+|++|..|+... ....++...+
T Consensus 155 Gla~~~~~~~~-~~~~~~~~~gt~~Y~APE~l~~~~~~~~sDI~S~Gvil~el~t~~~~~~~~----~~~~~~~~~i--- 226 (283)
T d1mqba_ 155 GLSRVLEDDPE-ATYTTSGGKIPIRWTAPEAISYRKFTSASDVWSFGIVMWEVMTYGERPYWE----LSNHEVMKAI--- 226 (283)
T ss_dssp CC------------------CCCGGGSCHHHHHSCCCCHHHHHHHHHHHHHHHHTTSCCTTTT----CCHHHHHHHH---
T ss_pred chhhcccCCCc-cceEeccCCCCccccCHHHHccCCCCCcccccccHHHHHHHHhCCCCcccc----CCHHHHHHHH---
Confidence 99976542111 111223345788999999999999999999999999999999976665322 1222222221
Q ss_pred HhcCccCcccccCccccchhhHhHHHHHHHHHHHHHHHHhcCCCCCCCCChhhhhc
Q 038766 243 LANGINGVRQITDPKLVSSIYEEQEQHQVLEELFKLALVCTSSNPEDRPNMNELLI 298 (299)
Q Consensus 243 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rpt~~~il~ 298 (299)
..+.. ... +...+..+.+||.+||+.||++|||+.+|++
T Consensus 227 -~~~~~----~~~------------~~~~~~~l~~li~~cl~~~p~~RPt~~eil~ 265 (283)
T d1mqba_ 227 -NDGFR----LPT------------PMDCPSAIYQLMMQCWQQERARRPKFADIVS 265 (283)
T ss_dssp -HTTCC----CCC------------CTTCBHHHHHHHHHHTCSSTTTSCCHHHHHH
T ss_pred -hccCC----CCC------------chhhHHHHHHHHHHHCcCCHhHCcCHHHHHH
Confidence 11110 000 1223467899999999999999999999975
|
| >d3blha1 d.144.1.7 (A:8-325) Cell division protein kinase 9, CDK9 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell division protein kinase 9, CDK9 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.6e-50 Score=341.44 Aligned_cols=277 Identities=21% Similarity=0.259 Sum_probs=205.3
Q ss_pred hCCCCCCceeecCCcceEEEEEe-CCCcEEEEEEeccCcCChhhhHHHHHHHHHHHhcCCcceeeeeeEEEcC-------
Q 038766 11 TGSFSENNIIGNSNLSTVYKGRL-EDGEIVAVKKLNFHQFSAESDKSFYREAKTLKELKHRNLVKVLGYAWES------- 82 (299)
Q Consensus 11 ~~~y~~~~~lg~g~~~~v~~~~~-~~~~~~~vK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~------- 82 (299)
.++|.+.+.||+|+||+||+|.+ .+|+.||||++............+.+|+.++++++||||+++++++...
T Consensus 9 ~~rY~i~~~LG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~E~~il~~l~h~nii~~~~~~~~~~~~~~~~ 88 (318)
T d3blha1 9 VSKYEKLAKIGQGTFGEVFKARHRKTGQKVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEICRTKASPYNRC 88 (318)
T ss_dssp GGGEEEEEEEEECSSSEEEEEEETTTCCEEEEEEC----CTTSSCHHHHHHHHHHHHCCCTTBCCEEEEEEC--------
T ss_pred cCCEEEEEEEecCcCeEEEEEEECCCCCEEEEEEEehhhcchHHHHHHHHHHHHHHHhcCCCccceEeeeeccccccccc
Confidence 58999999999999999999987 4699999999977665666678889999999999999999999987542
Q ss_pred CCeeEEEEeecCCCChHHHhcCCCCCCCCCChhhHHHHHHHHHHHHHHhhcCCCCCeeeecccCCceeeCCCCcEEEeee
Q 038766 83 GKLKALILEYMENGSLESVIHGPGVDHSRWTLPKRIDVLISVANGLDYLHSGYDIPIVHCDMKPSNILLDRDFEAHVSDF 162 (299)
Q Consensus 83 ~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lh~~~~~~~~H~dl~~~nil~~~~~~v~l~df 162 (299)
....++|+|++.++.+..... ....+++..++.++.|++.||.|||++ +++||||||+|||++.++.++++||
T Consensus 89 ~~~~~iv~e~~~~~~~~~~~~----~~~~~~~~~~~~i~~qil~~l~~lH~~---~ivHrDlKp~NILl~~~~~~kl~df 161 (318)
T d3blha1 89 KGSIYLVFDFCEHDLAGLLSN----VLVKFTLSEIKRVMQMLLNGLYYIHRN---KILHRDMKAANVLITRDGVLKLADF 161 (318)
T ss_dssp --CEEEEEECCCEEHHHHHTC----TTCCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEECTTSCEEECCC
T ss_pred CceEEEEEeccCCCccchhhh----cccccccHHHHHHHHHHHHHHHHhccC---CEEecCcCchheeecCCCcEEeeec
Confidence 234689999997655554444 456899999999999999999999999 9999999999999999999999999
Q ss_pred ccccccccccccccccccccccCcccCChhhhccc-CcCccccchhhhHHHHHHHhCCCCCCCCccCCCCchhHHHHHHH
Q 038766 163 GTSRMLDVHLQDLSSLSTAFQGTIGYLAPEFAYMR-IVTTKVDVFSFGIVVMEFLTKRRPTGLDEENGLSPISLRQLVEK 241 (299)
Q Consensus 163 ~~~~~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~-~~~~~~DiwslG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~ 241 (299)
|++..................+|+.|+|||.+.+. .++.++|||||||++|+|++|..||... ........+..
T Consensus 162 g~~~~~~~~~~~~~~~~~~~~gT~~Y~aPE~~~~~~~~~~k~DiwSlGvil~el~~g~~pf~~~-----~~~~~~~~i~~ 236 (318)
T d3blha1 162 GLARAFSLAKNSQPNRYTNRVVTLWYRPPELLLGERDYGPPIDLWGAGCIMAEMWTRSPIMQGN-----TEQHQLALISQ 236 (318)
T ss_dssp TTCEECCC-----CCCCCSCCSCGGGCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSCCCS-----SHHHHHHHHHH
T ss_pred ceeeecccccccccccccceecCHHHhhHHHHcCCCCCCcHHHcccCCceeeeHhhCCCCCCCC-----CHHHHHHHHHH
Confidence 99976654333333334455789999999988765 6899999999999999999999999532 22222222322
Q ss_pred HHhcCccCc-ccccC---------ccccc-hhhHhHHHHHHHHHHHHHHHHhcCCCCCCCCChhhhhcC
Q 038766 242 ALANGINGV-RQITD---------PKLVS-SIYEEQEQHQVLEELFKLALVCTSSNPEDRPNMNELLIT 299 (299)
Q Consensus 242 ~~~~~~~~~-~~~~~---------~~~~~-~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rpt~~~il~~ 299 (299)
......... ..... ..... ...........++++.+||.+||..||++|||++|+|+|
T Consensus 237 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dLl~~mL~~dP~~R~sa~elL~H 305 (318)
T d3blha1 237 LCGSITPEVWPNVDNYELYEKLELVKGQKRKVKDRLKAYVRDPYALDLIDKLLVLDPAQRIDSDDALNH 305 (318)
T ss_dssp HHCCCCTTTSTTCCCC-------CCSSCCBCHHHHHHHHHCCHHHHHHHHHHSCSSTTTSCCHHHHHHS
T ss_pred hcCCCChhhccccchhhhhhhhcccccccccchhhhccccCCHHHHHHHHHHCcCChhHCcCHHHHHcC
Confidence 222111111 11000 00000 111112233345678899999999999999999999987
|
| >d1xwsa_ d.144.1.7 (A:) Proto-oncogene serine/threonine-protein kinase Pim-1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Proto-oncogene serine/threonine-protein kinase Pim-1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=9.2e-53 Score=347.13 Aligned_cols=244 Identities=23% Similarity=0.338 Sum_probs=196.8
Q ss_pred HhCCCCCCceeecCCcceEEEEEe-CCCcEEEEEEeccCcCCh----hhhHHHHHHHHHHHhcC--CcceeeeeeEEEcC
Q 038766 10 ATGSFSENNIIGNSNLSTVYKGRL-EDGEIVAVKKLNFHQFSA----ESDKSFYREAKTLKELK--HRNLVKVLGYAWES 82 (299)
Q Consensus 10 ~~~~y~~~~~lg~g~~~~v~~~~~-~~~~~~~vK~~~~~~~~~----~~~~~~~~e~~~l~~l~--h~~i~~~~~~~~~~ 82 (299)
+.++|++.+.||+|+||+||+|.+ .+|+.||||++....... ....++.+|+.++++++ ||||+++++++..
T Consensus 2 l~~~Y~i~~~lG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~~~~E~~il~~l~~~h~nIv~~~~~~~~- 80 (273)
T d1xwsa_ 2 LESQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGVIRLLDWFER- 80 (273)
T ss_dssp CTTTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCCCEEECTTCCEEEHHHHHHHHHCSSSCSBCCEEEEEEC-
T ss_pred CCCeEEEeEEEeeCCCeEEEEEEECCCCCEEEEEEEehHHccchhhhhHHHHHHHHHHHHHHhccCCCCccEEEEEEee-
Confidence 468999999999999999999987 468999999987543322 12344678999999997 8999999997655
Q ss_pred CCeeEEEEeecCC-CChHHHhcCCCCCCCCCChhhHHHHHHHHHHHHHHhhcCCCCCeeeecccCCceeeCC-CCcEEEe
Q 038766 83 GKLKALILEYMEN-GSLESVIHGPGVDHSRWTLPKRIDVLISVANGLDYLHSGYDIPIVHCDMKPSNILLDR-DFEAHVS 160 (299)
Q Consensus 83 ~~~~~lv~e~~~~-~~L~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lh~~~~~~~~H~dl~~~nil~~~-~~~v~l~ 160 (299)
.+..++|+|++.+ +++.+++. ....+++.+++.++.||++||+|||++ +++||||||+||+++. ++.+||+
T Consensus 81 ~~~~~lv~e~~~~~~~l~~~~~----~~~~l~e~~~~~~~~qi~~al~~lH~~---~iiHrDiKp~NIll~~~~~~vkl~ 153 (273)
T d1xwsa_ 81 PDSFVLILERPEPVQDLFDFIT----ERGALQEELARSFFWQVLEAVRHCHNC---GVLHRDIKDENILIDLNRGELKLI 153 (273)
T ss_dssp SSEEEEEEECCSSEEEHHHHHH----HHCSCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEEETTTTEEEEC
T ss_pred CCeEEEEEEeccCcchHHHHHh----ccCCCCHHHHHHHHHHHHHHHHHHHHC---CCccccCcccceEEecCCCeEEEC
Confidence 5566999999975 57777776 456899999999999999999999999 9999999999999985 4789999
Q ss_pred eeccccccccccccccccccccccCcccCChhhhcccCc-CccccchhhhHHHHHHHhCCCCCCCCccCCCCchhHHHHH
Q 038766 161 DFGTSRMLDVHLQDLSSLSTAFQGTIGYLAPEFAYMRIV-TTKVDVFSFGIVVMEFLTKRRPTGLDEENGLSPISLRQLV 239 (299)
Q Consensus 161 df~~~~~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~-~~~~DiwslG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~ 239 (299)
|||++.... ........||+.|+|||++.+..+ +.++|||||||++|+|++|..||.... .
T Consensus 154 DFG~a~~~~------~~~~~~~~GT~~y~aPE~~~~~~~~~~~~DiwSlGvilyell~g~~Pf~~~~----------~-- 215 (273)
T d1xwsa_ 154 DFGSGALLK------DTVYTDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHDE----------E-- 215 (273)
T ss_dssp CCTTCEECC------SSCBCCCCSCGGGSCHHHHHHSCBCHHHHHHHHHHHHHHHHHHSSCSCCSHH----------H--
T ss_pred ccccceecc------cccccccccCCCcCCHHHHcCCCCCCcccccccceeeehhHhhCCCCCCCch----------H--
Confidence 999997543 223345678999999999887765 567899999999999999999995321 1
Q ss_pred HHHHhcCccCcccccCccccchhhHhHHHHHHHHHHHHHHHHhcCCCCCCCCChhhhhcC
Q 038766 240 EKALANGINGVRQITDPKLVSSIYEEQEQHQVLEELFKLALVCTSSNPEDRPNMNELLIT 299 (299)
Q Consensus 240 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rpt~~~il~~ 299 (299)
..... .. + +..+++++.+||++||..||++|||++|+|+|
T Consensus 216 --i~~~~-~~---~--------------~~~~s~~~~~li~~~L~~dp~~R~s~~eil~h 255 (273)
T d1xwsa_ 216 --IIRGQ-VF---F--------------RQRVSSECQHLIRWCLALRPSDRPTFEEIQNH 255 (273)
T ss_dssp --HHHCC-CC---C--------------SSCCCHHHHHHHHHHTCSSGGGSCCHHHHHTS
T ss_pred --Hhhcc-cC---C--------------CCCCCHHHHHHHHHHccCCHhHCcCHHHHhcC
Confidence 11100 00 0 11235689999999999999999999999987
|
| >d1ywna1 d.144.1.7 (A:818-1166) Vascular endothelial growth factor receptor 2 (kdr) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Vascular endothelial growth factor receptor 2 (kdr) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=6.6e-52 Score=346.90 Aligned_cols=268 Identities=23% Similarity=0.334 Sum_probs=201.4
Q ss_pred CChHHHHHHhCCCCCCceeecCCcceEEEEEeC------CCcEEEEEEeccCcCChhhhHHHHHHHHHHHhc-CCcceee
Q 038766 2 FDRTEIENATGSFSENNIIGNSNLSTVYKGRLE------DGEIVAVKKLNFHQFSAESDKSFYREAKTLKEL-KHRNLVK 74 (299)
Q Consensus 2 ~~~~~~~~~~~~y~~~~~lg~g~~~~v~~~~~~------~~~~~~vK~~~~~~~~~~~~~~~~~e~~~l~~l-~h~~i~~ 74 (299)
++.++||+-.++|.+.+.||+|+||.||+|.+. +++.||||++... ........+..|...+.++ .|+||+.
T Consensus 3 ~~~~~wei~~~~y~~~~~iG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~l~~~-~~~~~~~~~~~e~~~l~~~~~h~~iv~ 81 (299)
T d1ywna1 3 YDASKWEFPRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEG-ATHSEHRALMSELKILIHIGHHLNVVN 81 (299)
T ss_dssp CCHHHHBCCGGGEEEEEEEEECSSCEEEEEEEESTTSSSCEEEEEEEEC-----CHHHHHHHHHHHHHHHHHCCCTTBCC
T ss_pred CCCccccccHHHEEEeeEEeecCCeEEEEEEEcCCCcccCCeEEEEEEEccc-cCcHHHHHHHHHHHHHHhhcCCCeEEE
Confidence 567889888999999999999999999999853 3468999998643 3344456677788878777 5899999
Q ss_pred eeeEEEcCCCeeEEEEeecCCCChHHHhcCCC------------CCCCCCChhhHHHHHHHHHHHHHHhhcCCCCCeeee
Q 038766 75 VLGYAWESGKLKALILEYMENGSLESVIHGPG------------VDHSRWTLPKRIDVLISVANGLDYLHSGYDIPIVHC 142 (299)
Q Consensus 75 ~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~------------~~~~~~~~~~~~~i~~qi~~~l~~lh~~~~~~~~H~ 142 (299)
+++++...+..+++||||+++|+|.+++.... .....+++..++.++.||+.||+|||++ +++||
T Consensus 82 ~~~~~~~~~~~~~iv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~gl~ylH~~---~ivHr 158 (299)
T d1ywna1 82 LLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLASR---KCIHR 158 (299)
T ss_dssp EEEEECSTTSCCEEEEECCTTCBHHHHHHHTGGGBCC-----------CBCHHHHHHHHHHHHHHHHHHHHT---TCCCS
T ss_pred eeeeeccCCCeEEEEEEecCCCcHHHHHHhccccccccccchhhhhcccCCHHHHHHHHHHHHHHHHHHHhC---CCcCC
Confidence 99988777777899999999999999885321 1234689999999999999999999999 99999
Q ss_pred cccCCceeeCCCCcEEEeeeccccccccccccccccccccccCcccCChhhhcccCcCccccchhhhHHHHHHHhCC-CC
Q 038766 143 DMKPSNILLDRDFEAHVSDFGTSRMLDVHLQDLSSLSTAFQGTIGYLAPEFAYMRIVTTKVDVFSFGIVVMEFLTKR-RP 221 (299)
Q Consensus 143 dl~~~nil~~~~~~v~l~df~~~~~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~DiwslG~~l~~l~~g~-~p 221 (299)
||||+|||++.++.+||+|||++...... ..........+|+.|+|||.+.+..++.++||||+||++|+|++|. .|
T Consensus 159 DlKp~NILl~~~~~~Kl~DFGla~~~~~~--~~~~~~~~~~gt~~y~APE~l~~~~~~~~sDiwS~Gvil~ellt~~~~p 236 (299)
T d1ywna1 159 DLAARNILLSEKNVVKICDFGLARDIYKD--PDYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASP 236 (299)
T ss_dssp CCCGGGEEECGGGCEEECC------CCSC--TTSCCTTSCCCGGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCS
T ss_pred cCCccceeECCCCcEEEccCcchhhcccc--ccccccCceeeCccccchhHhhcCCCCcccceeehHHHHHHHHhCCCCC
Confidence 99999999999999999999999754421 1122334557899999999999999999999999999999999875 45
Q ss_pred CCCCccCCCCchhHHHHHHHHHhcCccCcccccCccccchhhHhHHHHHHHHHHHHHHHHhcCCCCCCCCChhhhhcC
Q 038766 222 TGLDEENGLSPISLRQLVEKALANGINGVRQITDPKLVSSIYEEQEQHQVLEELFKLALVCTSSNPEDRPNMNELLIT 299 (299)
Q Consensus 222 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rpt~~~il~~ 299 (299)
|..... ...+...+. .+... .. +...++++.++|.+||..||++|||++|+++|
T Consensus 237 ~~~~~~----~~~~~~~~~----~~~~~--~~--------------~~~~~~~l~~li~~cl~~dP~~Rpt~~eil~~ 290 (299)
T d1ywna1 237 YPGVKI----DEEFCRRLK----EGTRM--RA--------------PDYTTPEMYQTMLDCWHGEPSQRPTFSELVEH 290 (299)
T ss_dssp STTCCC----SHHHHHHHH----HTCCC--CC--------------CTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred CCCCCH----HHHHHHHHh----cCCCC--CC--------------CccCCHHHHHHHHHHcCCChhHCcCHHHHHHH
Confidence 643211 112222221 11100 00 12235679999999999999999999999875
|
| >d1byga_ d.144.1.7 (A:) Carboxyl-terminal src kinase (csk) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Carboxyl-terminal src kinase (csk) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.3e-52 Score=341.88 Aligned_cols=251 Identities=25% Similarity=0.343 Sum_probs=194.6
Q ss_pred HHHHhCCCCCCceeecCCcceEEEEEeCCCcEEEEEEeccCcCChhhhHHHHHHHHHHHhcCCcceeeeeeEEEcCCCee
Q 038766 7 IENATGSFSENNIIGNSNLSTVYKGRLEDGEIVAVKKLNFHQFSAESDKSFYREAKTLKELKHRNLVKVLGYAWESGKLK 86 (299)
Q Consensus 7 ~~~~~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~vK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~ 86 (299)
||+-.++|++.+.||+|+||+||+|.++ |..||||++..+ ...+.+.+|++++++++||||+++++++.+..+..
T Consensus 2 w~i~~~~~~~~~~lG~G~fg~Vy~~~~~-~~~vAvK~i~~~----~~~~~~~~E~~~l~~l~HpnIv~~~g~~~~~~~~~ 76 (262)
T d1byga_ 2 WALNMKELKLLQTIGKGEFGDVMLGDYR-GNKVAVKCIKND----ATAQAFLAEASVMTQLRHSNLVQLLGVIVEEKGGL 76 (262)
T ss_dssp CBCCGGGEEEEEEEEECSSCEEEEEEET-TEEEEEEECCCC----C--HHHHHTHHHHTTCCCTTBCCEEEEECCC--CC
T ss_pred CccCHHHeEEeEEEecCCCeEEEEEEEC-CeEEEEEEECcH----HHHHHHHHHHHHHHhCCCCCEeeEEEEEEecCCcE
Confidence 3455678999999999999999999985 788999998632 34567889999999999999999999887655556
Q ss_pred EEEEeecCCCChHHHhcCCCCCCCCCChhhHHHHHHHHHHHHHHhhcCCCCCeeeecccCCceeeCCCCcEEEeeecccc
Q 038766 87 ALILEYMENGSLESVIHGPGVDHSRWTLPKRIDVLISVANGLDYLHSGYDIPIVHCDMKPSNILLDRDFEAHVSDFGTSR 166 (299)
Q Consensus 87 ~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lh~~~~~~~~H~dl~~~nil~~~~~~v~l~df~~~~ 166 (299)
++|+||+++|+|.+++... ....+++..++.++.||+.||.|||+. +++||||||+||+++.++.++++|||++.
T Consensus 77 ~lv~ey~~~g~L~~~l~~~--~~~~l~~~~~~~i~~~i~~al~ylH~~---~ivH~dlkp~Nil~~~~~~~kl~dfg~s~ 151 (262)
T d1byga_ 77 YIVTEYMAKGSLVDYLRSR--GRSVLGGDCLLKFSLDVCEAMEYLEGN---NFVHRDLAARNVLVSEDNVAKVSDFGLTK 151 (262)
T ss_dssp EEEECCCTTEEHHHHHHHH--HHHHCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEECTTSCEEECCCCC--
T ss_pred EEEEeccCCCCHHHHHHhc--CCCCCCHHHHHHHHHHHHhhccccccC---ceeccccchHhheecCCCCEeecccccce
Confidence 9999999999999998532 223589999999999999999999999 99999999999999999999999999987
Q ss_pred ccccccccccccccccccCcccCChhhhcccCcCccccchhhhHHHHHHHh-CCCCCCCCccCCCCchhHHHHHHHHHhc
Q 038766 167 MLDVHLQDLSSLSTAFQGTIGYLAPEFAYMRIVTTKVDVFSFGIVVMEFLT-KRRPTGLDEENGLSPISLRQLVEKALAN 245 (299)
Q Consensus 167 ~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~DiwslG~~l~~l~~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~ 245 (299)
... .......+++.|+|||.+.+..++.++|||||||++|+|++ |..||... ...++...+. .
T Consensus 152 ~~~-------~~~~~~~~~~~y~aPE~l~~~~~t~~sDIwSfG~il~el~t~~~~p~~~~-----~~~~~~~~i~----~ 215 (262)
T d1byga_ 152 EAS-------STQDTGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRI-----PLKDVVPRVE----K 215 (262)
T ss_dssp -----------------CCTTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSCTTS-----CGGGHHHHHT----T
T ss_pred ecC-------CCCccccccccCCChHHHhCCCCChHHHHHhHHHHHHHHHHCCCCCCCCC-----CHHHHHHHHH----c
Confidence 543 22233456889999999999999999999999999999998 56666432 2223332221 1
Q ss_pred CccCcccccCccccchhhHhHHHHHHHHHHHHHHHHhcCCCCCCCCChhhhhcC
Q 038766 246 GINGVRQITDPKLVSSIYEEQEQHQVLEELFKLALVCTSSNPEDRPNMNELLIT 299 (299)
Q Consensus 246 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rpt~~~il~~ 299 (299)
+. ...+ +...++++.+||.+||..||++|||+.+++++
T Consensus 216 ~~--~~~~--------------~~~~~~~~~~li~~cl~~dP~~Rps~~~l~~~ 253 (262)
T d1byga_ 216 GY--KMDA--------------PDGCPPAVYEVMKNCWHLDAAMRPSFLQLREQ 253 (262)
T ss_dssp TC--CCCC--------------CTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred CC--CCCC--------------CccCCHHHHHHHHHHcccCHhHCcCHHHHHHH
Confidence 10 0000 22234678999999999999999999999863
|
| >d1cm8a_ d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase p38-gamma species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=8.4e-51 Score=346.92 Aligned_cols=263 Identities=22% Similarity=0.290 Sum_probs=199.9
Q ss_pred HhCCCCCCceeecCCcceEEEEEeC-CCcEEEEEEeccCcCChhhhHHHHHHHHHHHhcCCcceeeeeeEEEcCCC----
Q 038766 10 ATGSFSENNIIGNSNLSTVYKGRLE-DGEIVAVKKLNFHQFSAESDKSFYREAKTLKELKHRNLVKVLGYAWESGK---- 84 (299)
Q Consensus 10 ~~~~y~~~~~lg~g~~~~v~~~~~~-~~~~~~vK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~---- 84 (299)
+.++|++.+.||+|+||+||+|.+. +|+.||||++..........+.+.+|+++|+.++||||+++++++...+.
T Consensus 16 ~~~~Y~~i~~lG~G~fg~V~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~Ei~il~~l~hpniv~l~~~~~~~~~~~~~ 95 (346)
T d1cm8a_ 16 VRAVYRDLQPVGSGAYGAVCSAVDGRTGAKVAIKKLYRPFQSELFAKRAYRELRLLKHMRHENVIGLLDVFTPDETLDDF 95 (346)
T ss_dssp CBSSEEEEEEC------CEEEEEETTTCCEEEEEECSSTTSSHHHHHHHHHHHHHHHHCCBTTBCCCSEEECSCSSTTTC
T ss_pred cCCcEEEEEEEecCCCeEEEEEEECCCCCEEEEEEEchhhcChHHHHHHHHHHHHHHhcCCCCeeEEEEEeccCcccccc
Confidence 5789999999999999999999874 69999999998666666667889999999999999999999998765442
Q ss_pred -eeEEEEeecCCCChHHHhcCCCCCCCCCChhhHHHHHHHHHHHHHHhhcCCCCCeeeecccCCceeeCCCCcEEEeeec
Q 038766 85 -LKALILEYMENGSLESVIHGPGVDHSRWTLPKRIDVLISVANGLDYLHSGYDIPIVHCDMKPSNILLDRDFEAHVSDFG 163 (299)
Q Consensus 85 -~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lh~~~~~~~~H~dl~~~nil~~~~~~v~l~df~ 163 (299)
..++||||+ +.+|..+++ ..++++..++.++.||+.||+|||++ +++||||||+|||++.++.++++|||
T Consensus 96 ~~~~lv~e~~-~~~l~~~~~-----~~~l~~~~~~~~~~qi~~aL~~LH~~---~IiHrDiKp~NIL~~~~~~~kl~Dfg 166 (346)
T d1cm8a_ 96 TDFYLVMPFM-GTDLGKLMK-----HEKLGEDRIQFLVYQMLKGLRYIHAA---GIIHRDLKPGNLAVNEDCELKILDFG 166 (346)
T ss_dssp CCCEEEEECC-SEEHHHHHH-----HCCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEECTTCCEEECCCT
T ss_pred ceEEEEEecc-cccHHHHHH-----hccccHHHHHHHHHHHHHHHHHHHhC---CCcccccCcchhhccccccccccccc
Confidence 469999999 667888774 34799999999999999999999999 99999999999999999999999999
Q ss_pred cccccccccccccccccccccCcccCChhhhcc-cCcCccccchhhhHHHHHHHhCCCCCCCCccCCCCchhHHHHHHHH
Q 038766 164 TSRMLDVHLQDLSSLSTAFQGTIGYLAPEFAYM-RIVTTKVDVFSFGIVVMEFLTKRRPTGLDEENGLSPISLRQLVEKA 242 (299)
Q Consensus 164 ~~~~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~-~~~~~~~DiwslG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~ 242 (299)
++.... .......+++.|+|||.+.+ ..++.++|||||||++|+|++|..||..... ..........
T Consensus 167 ~a~~~~-------~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlGvil~ell~g~~pf~~~~~-----~~~~~~~~~~ 234 (346)
T d1cm8a_ 167 LARQAD-------SEMTGYVVTRWYRAPEVILNWMRYTQTVDIWSVGCIMAEMITGKTLFKGSDH-----LDQLKEIMKV 234 (346)
T ss_dssp TCEECC-------SSCCSSCSCGGGCCTHHHHTTTCCCTTHHHHHHHHHHHHHHHSSCSSCCSSH-----HHHHHHHHHH
T ss_pred ceeccC-------CccccccccccccCHHHHcCCCCCCccchhhcchHHHHHHHHCcCCCCCCCh-----HHHHHHHHhc
Confidence 997654 22345678999999998876 4568999999999999999999999964321 1111111111
Q ss_pred HhcCccC----------------cccccCccccchhhHhHHHHHHHHHHHHHHHHhcCCCCCCCCChhhhhcC
Q 038766 243 LANGING----------------VRQITDPKLVSSIYEEQEQHQVLEELFKLALVCTSSNPEDRPNMNELLIT 299 (299)
Q Consensus 243 ~~~~~~~----------------~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rpt~~~il~~ 299 (299)
....... ......... ......+++++.+||++||..||++|||++|+|+|
T Consensus 235 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~------~~~~~~~s~~~~dli~~mL~~dP~~R~ta~eiL~H 301 (346)
T d1cm8a_ 235 TGTPPAEFVQRLQSDEAKNYMKGLPELEKKDF------ASILTNASPLAVNLLEKMLVLDAEQRVTAGEALAH 301 (346)
T ss_dssp HCCCCHHHHHTCSCHHHHHHHHHSCCCCCCCG------GGTCTTCCHHHHHHHHHHSCSSTTTSCCHHHHHHS
T ss_pred cCCCcHHHHhhhcchhhhhhhccCCcccccch------HHhccCCCHHHHHHHHHHCcCChhHCcCHHHHhcC
Confidence 1000000 000000000 01122345678999999999999999999999987
|
| >d1xkka_ d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb-1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: EGF receptor tyrosine kinase, Erbb-1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1e-50 Score=341.90 Aligned_cols=252 Identities=23% Similarity=0.410 Sum_probs=194.6
Q ss_pred CCCCCCceeecCCcceEEEEEeC-CCc----EEEEEEeccCcCChhhhHHHHHHHHHHHhcCCcceeeeeeEEEcCCCee
Q 038766 12 GSFSENNIIGNSNLSTVYKGRLE-DGE----IVAVKKLNFHQFSAESDKSFYREAKTLKELKHRNLVKVLGYAWESGKLK 86 (299)
Q Consensus 12 ~~y~~~~~lg~g~~~~v~~~~~~-~~~----~~~vK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~ 86 (299)
++|++.+.||+|+||+||+|.+. +|+ +||+|++.. .......+.+.+|+.++++++||||+++++++.+ +. .
T Consensus 9 ~dy~~~~~lG~G~fG~Vy~~~~~~~~~~~~~~vavK~~~~-~~~~~~~~~~~~E~~~l~~l~HpnIv~l~g~~~~-~~-~ 85 (317)
T d1xkka_ 9 TEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELRE-ATSPKANKEILDEAYVMASVDNPHVCRLLGICLT-ST-V 85 (317)
T ss_dssp TTEEEEEEEEECSSEEEEEEEECC----CCEEEEEEEECC-----CTHHHHHHHHHHHHHCCCTTBCCEEEEEES-SS-E
T ss_pred HHCEEeeEEecCCCeEEEEEEEcCCCCEEEEEEEEEEecc-ccCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEec-CC-e
Confidence 46999999999999999999864 343 588898863 2344556789999999999999999999998765 33 3
Q ss_pred EEEEeecCCCChHHHhcCCCCCCCCCChhhHHHHHHHHHHHHHHhhcCCCCCeeeecccCCceeeCCCCcEEEeeecccc
Q 038766 87 ALILEYMENGSLESVIHGPGVDHSRWTLPKRIDVLISVANGLDYLHSGYDIPIVHCDMKPSNILLDRDFEAHVSDFGTSR 166 (299)
Q Consensus 87 ~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lh~~~~~~~~H~dl~~~nil~~~~~~v~l~df~~~~ 166 (299)
+++++++.+++|.+.+.. ....+++..++.++.||+.||+|||++ +++||||||+||+++.++.+||+|||++.
T Consensus 86 ~~v~e~~~~~~l~~~~~~---~~~~~~~~~~~~i~~qi~~gl~yLH~~---~iiHrDlKp~NIll~~~~~~kl~DFGla~ 159 (317)
T d1xkka_ 86 QLITQLMPFGCLLDYVRE---HKDNIGSQYLLNWCVQIAKGMNYLEDR---RLVHRDLAARNVLVKTPQHVKITDFGLAK 159 (317)
T ss_dssp EEEEECCTTCBHHHHHHH---TSSSCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEEEETTEEEECCCSHHH
T ss_pred eEEEEeccCCcccccccc---cccCCCHHHHHHHHHHHHHHHHHHHHc---CcccCcchhhcceeCCCCCeEeeccccce
Confidence 788899989999887653 346799999999999999999999999 99999999999999999999999999998
Q ss_pred ccccccccccccccccccCcccCChhhhcccCcCccccchhhhHHHHHHHh-CCCCCCCCccCCCCchhHHHHHHHHHhc
Q 038766 167 MLDVHLQDLSSLSTAFQGTIGYLAPEFAYMRIVTTKVDVFSFGIVVMEFLT-KRRPTGLDEENGLSPISLRQLVEKALAN 245 (299)
Q Consensus 167 ~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~DiwslG~~l~~l~~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~ 245 (299)
...... .........+|+.|+|||.+.+..++.++|||||||++|+|++ |..||... ....+...+...
T Consensus 160 ~~~~~~--~~~~~~~~~gt~~y~APE~l~~~~~~~~sDvwS~Gvil~el~t~g~~p~~~~-----~~~~~~~~i~~~--- 229 (317)
T d1xkka_ 160 LLGAEE--KEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGI-----PASEISSILEKG--- 229 (317)
T ss_dssp HTTTTC--C--------CCTTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTS-----CGGGHHHHHHHT---
T ss_pred eccccc--ccccccccccCccccChHHHhcCCCChhhhhhhHHHHHHHHHHCCCCCCCCC-----CHHHHHHHHHcC---
Confidence 654211 1122234457899999999999999999999999999999998 67787433 233333333221
Q ss_pred CccCcccccCccccchhhHhHHHHHHHHHHHHHHHHhcCCCCCCCCChhhhhcC
Q 038766 246 GINGVRQITDPKLVSSIYEEQEQHQVLEELFKLALVCTSSNPEDRPNMNELLIT 299 (299)
Q Consensus 246 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rpt~~~il~~ 299 (299)
. .... +..++.++.+|+.+||..||++|||+.++++|
T Consensus 230 ~-----~~~~------------p~~~~~~~~~li~~cl~~dP~~RPs~~eil~~ 266 (317)
T d1xkka_ 230 E-----RLPQ------------PPICTIDVYMIMVKCWMIDADSRPKFRELIIE 266 (317)
T ss_dssp C-----CCCC------------CTTBCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred C-----CCCC------------CcccCHHHHHHHHHhCCCChhhCcCHHHHHHH
Confidence 0 0000 12334678999999999999999999999864
|
| >d1unla_ d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK5 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.2e-50 Score=338.49 Aligned_cols=272 Identities=22% Similarity=0.292 Sum_probs=208.5
Q ss_pred CCCCCCceeecCCcceEEEEEe-CCCcEEEEEEeccCcCChhhhHHHHHHHHHHHhcCCcceeeeeeEEEcCCCeeEEEE
Q 038766 12 GSFSENNIIGNSNLSTVYKGRL-EDGEIVAVKKLNFHQFSAESDKSFYREAKTLKELKHRNLVKVLGYAWESGKLKALIL 90 (299)
Q Consensus 12 ~~y~~~~~lg~g~~~~v~~~~~-~~~~~~~vK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~lv~ 90 (299)
++|++.+.||+|+||+||+|++ .+|+.||||+++..........++.+|+.+++.++||||+++++++.. ....++|+
T Consensus 2 ~ry~~i~~LG~G~fg~V~~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~E~~il~~l~h~niv~~~~~~~~-~~~~~iv~ 80 (292)
T d1unla_ 2 QKYEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLHDVLHS-DKKLTLVF 80 (292)
T ss_dssp CSEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEESSCSSTTHHHHHHHHHHHHTTCCCTTBCCEEEEEEC-SSEEEEEE
T ss_pred CCCEeeeEEecCcCeEEEEEEECCCCcEEEEEEEehhhCChHHHHHHHHHHHHHHhcCcCCEEeecccccc-ccceeEEe
Confidence 6899999999999999999997 468999999998766666678899999999999999999999997665 45568999
Q ss_pred eecCCCChHHHhcCCCCCCCCCChhhHHHHHHHHHHHHHHhhcCCCCCeeeecccCCceeeCCCCcEEEeeecccccccc
Q 038766 91 EYMENGSLESVIHGPGVDHSRWTLPKRIDVLISVANGLDYLHSGYDIPIVHCDMKPSNILLDRDFEAHVSDFGTSRMLDV 170 (299)
Q Consensus 91 e~~~~~~L~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lh~~~~~~~~H~dl~~~nil~~~~~~v~l~df~~~~~~~~ 170 (299)
+++.+++|..++. ....+++.+++.++.|++.||+|||++ +++||||||+|||++.++.+||+|||.+.....
T Consensus 81 ~~~~~~~l~~~~~----~~~~~~~~~~~~~~~q~~~aL~~lH~~---~IvHrDiKP~NIli~~~~~~kl~DFG~a~~~~~ 153 (292)
T d1unla_ 81 EFCDQDLKKYFDS----CNGDLDPEIVKSFLFQLLKGLGFCHSR---NVLHRDLKPQNLLINRNGELKLANFGLARAFGI 153 (292)
T ss_dssp ECCSEEHHHHHHH----TTTCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECTTCCEEECCCTTCEECCS
T ss_pred eeccccccccccc----cccccchhHHHHHHHHHHHHHHHhhcC---CEeeecccCcccccccCCceeeeecchhhcccC
Confidence 9998888888887 556889999999999999999999999 999999999999999999999999999976542
Q ss_pred ccccccccccccccCcccCChhhhcccC-cCccccchhhhHHHHHHHhCCCCCCCCccCCCCchhHHHHHHHHHhcCccC
Q 038766 171 HLQDLSSLSTAFQGTIGYLAPEFAYMRI-VTTKVDVFSFGIVVMEFLTKRRPTGLDEENGLSPISLRQLVEKALANGING 249 (299)
Q Consensus 171 ~~~~~~~~~~~~~~~~~y~~PE~~~~~~-~~~~~DiwslG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 249 (299)
.........+++.|+|||.+.+.. ++.++|||||||++|+|++|..||.... ........+..........
T Consensus 154 ----~~~~~~~~~~~~~~~~pe~~~~~~~~~~~~DiwSlG~il~ell~g~~p~~~~~----~~~~~~~~~~~~~~~~~~~ 225 (292)
T d1unla_ 154 ----PVRCYSAEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGN----DVDDQLKRIFRLLGTPTEE 225 (292)
T ss_dssp ----CCSCCCSCCSCGGGCCHHHHTTCSCCCTHHHHHHHHHHHHHHTTTSCCSCCCS----SHHHHHHHHHHHHCCCCTT
T ss_pred ----CCccceeeccccchhhhhHhccCCCCCchhhccccchHHHHHhhCCCCCCCCC----CHHHHHHHHHhhcCCCChh
Confidence 122333445678899999887665 6899999999999999999999974221 1111122222211111000
Q ss_pred ----cccccC----ccccchhhHhHHHHHHHHHHHHHHHHhcCCCCCCCCChhhhhcC
Q 038766 250 ----VRQITD----PKLVSSIYEEQEQHQVLEELFKLALVCTSSNPEDRPNMNELLIT 299 (299)
Q Consensus 250 ----~~~~~~----~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rpt~~~il~~ 299 (299)
...... +...............++.+.+||++||..||++|||++|+|+|
T Consensus 226 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dll~~mL~~dP~~R~sa~e~L~H 283 (292)
T d1unla_ 226 QWPSMTKLPDYKPYPMYPATTSLVNVVPKLNATGRDLLQNLLKCNPVQRISAEEALQH 283 (292)
T ss_dssp TCTTGGGSTTCCCCCCCCTTCCCTTTSTTCCHHHHHHHHHHSCSSGGGSCCHHHHTTS
T ss_pred hhhhhhhcccccccccccccchhhhccccCCHHHHHHHHHHccCChhHCcCHHHHhcC
Confidence 000000 00000111112233456789999999999999999999999987
|
| >d1r0pa_ d.144.1.7 (A:) Hepatocyte growth factor receptor, c-MET {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Hepatocyte growth factor receptor, c-MET species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.5e-49 Score=333.18 Aligned_cols=252 Identities=29% Similarity=0.439 Sum_probs=199.7
Q ss_pred CceeecCCcceEEEEEeCC----CcEEEEEEeccCcCChhhhHHHHHHHHHHHhcCCcceeeeeeEEEcCCCeeEEEEee
Q 038766 17 NNIIGNSNLSTVYKGRLED----GEIVAVKKLNFHQFSAESDKSFYREAKTLKELKHRNLVKVLGYAWESGKLKALILEY 92 (299)
Q Consensus 17 ~~~lg~g~~~~v~~~~~~~----~~~~~vK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~lv~e~ 92 (299)
.++||+|+||+||+|.+.+ ...||||++.. .......+.+.+|++++++++||||+++++++...+...++|+||
T Consensus 32 ~~~iG~G~fg~Vyk~~~~~~~~~~~~vAvK~~~~-~~~~~~~~~~~~E~~~l~~l~HpnIv~~~g~~~~~~~~~~lv~E~ 110 (311)
T d1r0pa_ 32 NEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNR-ITDIGEVSQFLTEGIIMKDFSHPNVLSLLGICLRSEGSPLVVLPY 110 (311)
T ss_dssp EEEEEEETTEEEEEEEECC----CEEEEEEEECC-CCCHHHHHHHHHHHHHHHTCCCTTBCCCCEEEEETTTEEEEEEEC
T ss_pred ceEEeecCCeEEEEEEEECCCCEEEEEEEEEECc-ccCHHHHHHHHHHHHHHHhCCCCCEeEEeEEEEecCCceEEEEEE
Confidence 4689999999999998643 23589999863 335566788999999999999999999999887767777999999
Q ss_pred cCCCChHHHhcCCCCCCCCCChhhHHHHHHHHHHHHHHhhcCCCCCeeeecccCCceeeCCCCcEEEeeecccccccccc
Q 038766 93 MENGSLESVIHGPGVDHSRWTLPKRIDVLISVANGLDYLHSGYDIPIVHCDMKPSNILLDRDFEAHVSDFGTSRMLDVHL 172 (299)
Q Consensus 93 ~~~~~L~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lh~~~~~~~~H~dl~~~nil~~~~~~v~l~df~~~~~~~~~~ 172 (299)
+++++|.+++.. ....++...++.++.|++.||.|||+. +++||||||+|||++.++.+||+|||++.......
T Consensus 111 ~~~g~l~~~~~~---~~~~~~~~~~~~i~~qia~gL~~lH~~---~iiHrDLK~~NILl~~~~~~kL~DFG~~~~~~~~~ 184 (311)
T d1r0pa_ 111 MKHGDLRNFIRN---ETHNPTVKDLIGFGLQVAKGMKFLASK---KFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKE 184 (311)
T ss_dssp CTTCBHHHHHHC---TTCCCBHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEECTTCCEEECSSGGGCCTTTTT
T ss_pred eecCchhhhhcc---ccccchHHHHHHHHHHHHHhhhhhccc---CcccCCccHHhEeECCCCCEEEecccchhhccccc
Confidence 999999998864 344677888999999999999999999 99999999999999999999999999998765433
Q ss_pred ccccccccccccCcccCChhhhcccCcCccccchhhhHHHHHHHhCCCCCCCCccCCCCchhHHHHHHHHHhcCccCccc
Q 038766 173 QDLSSLSTAFQGTIGYLAPEFAYMRIVTTKVDVFSFGIVVMEFLTKRRPTGLDEENGLSPISLRQLVEKALANGINGVRQ 252 (299)
Q Consensus 173 ~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~DiwslG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 252 (299)
...........+|+.|+|||.+....++.++||||||+++|+|++|..||..... ...+...+ . .+. .
T Consensus 185 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDI~SfGivl~El~t~~~p~~~~~~----~~~~~~~i---~-~g~----~ 252 (311)
T d1r0pa_ 185 FDSVHNKTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVN----TFDITVYL---L-QGR----R 252 (311)
T ss_dssp CCCTTCTTCSSCCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSCC----------CHHHH---H-TTC----C
T ss_pred cccceecccccccccccChHHHhcCCCCChhHhhhhHHHHHHHHHCCCCCCCCCC----HHHHHHHH---H-cCC----C
Confidence 3333334455688999999999999999999999999999999998888753211 11111111 1 110 0
Q ss_pred ccCccccchhhHhHHHHHHHHHHHHHHHHhcCCCCCCCCChhhhhcC
Q 038766 253 ITDPKLVSSIYEEQEQHQVLEELFKLALVCTSSNPEDRPNMNELLIT 299 (299)
Q Consensus 253 ~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rpt~~~il~~ 299 (299)
... +...++.+.+||.+||..||++|||+.||+++
T Consensus 253 ~~~------------p~~~~~~l~~li~~cl~~dP~~RPs~~ei~~~ 287 (311)
T d1r0pa_ 253 LLQ------------PEYCPDPLYEVMLKCWHPKAEMRPSFSELVSR 287 (311)
T ss_dssp CCC------------CTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred CCC------------cccCcHHHHHHHHHHcCCCHhHCcCHHHHHHH
Confidence 111 12234578999999999999999999999864
|
| >d1vjya_ d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Type I TGF-beta receptor R4 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2e-50 Score=337.73 Aligned_cols=270 Identities=22% Similarity=0.286 Sum_probs=197.2
Q ss_pred HhCCCCCCceeecCCcceEEEEEeCCCcEEEEEEeccCcCChhhhHHHHHHHHHHHhcCCcceeeeeeEEEcCCC---ee
Q 038766 10 ATGSFSENNIIGNSNLSTVYKGRLEDGEIVAVKKLNFHQFSAESDKSFYREAKTLKELKHRNLVKVLGYAWESGK---LK 86 (299)
Q Consensus 10 ~~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~vK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~---~~ 86 (299)
+..+|.+.+.||+|+||+||+|++ +|+.||||++.... ........|+..++.++||||+++++++...+. .+
T Consensus 1 ~~~~~~l~~~iG~G~fg~Vy~~~~-~g~~vAvK~~~~~~---~~~~~~e~ei~~~~~~~HpnIv~~~~~~~~~~~~~~~~ 76 (303)
T d1vjya_ 1 IARTIVLQESIGKGRFGEVWRGKW-RGEEVAVKIFSSRE---ERSWFREAEIYQTVMLRHENILGFIAADNKDNGTWTQL 76 (303)
T ss_dssp CGGGEEEEEEEECCSSSEEEEEEE-TTEEEEEEEECGGG---HHHHHHHHHHHTSTTCCCTTBCCEEEEEEEECSSSEEE
T ss_pred CCcEEEEEEEEeeCCCeEEEEEEE-CCEEEEEEEECccc---hhHHHHHHHHHHHhhCCCCcCcceEEEEEeCCCcceEE
Confidence 356788999999999999999987 48899999985321 222223345555567889999999998876543 56
Q ss_pred EEEEeecCCCChHHHhcCCCCCCCCCChhhHHHHHHHHHHHHHHhhcC-----CCCCeeeecccCCceeeCCCCcEEEee
Q 038766 87 ALILEYMENGSLESVIHGPGVDHSRWTLPKRIDVLISVANGLDYLHSG-----YDIPIVHCDMKPSNILLDRDFEAHVSD 161 (299)
Q Consensus 87 ~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lh~~-----~~~~~~H~dl~~~nil~~~~~~v~l~d 161 (299)
++|+||+++++|.++++. .+++...++.++.|++.||+|+|+. ++.+++||||||+|||++.++.+||+|
T Consensus 77 ~lv~Ey~~~g~L~~~l~~-----~~l~~~~~~~~~~~ia~gl~~lH~~~~~~~~~~~IvHrDlKp~NILl~~~~~~Kl~D 151 (303)
T d1vjya_ 77 WLVSDYHEHGSLFDYLNR-----YTVTVEGMIKLALSTASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIAD 151 (303)
T ss_dssp EEEEECCTTCBHHHHHHH-----CCBCHHHHHHHHHHHHHHHHHHHCCBCSTTCBCEEECSCCCGGGEEECTTSCEEECC
T ss_pred EEEEecccCCCHHHHHhc-----CCCCHHHHHHHHHHHHHHHHHHHHhhhhhccCCCeeccccCccceEEcCCCCeEEEe
Confidence 899999999999999963 3689999999999999999999962 123999999999999999999999999
Q ss_pred eccccccccccccccccccccccCcccCChhhhcccC------cCccccchhhhHHHHHHHhCCCCCCCCccCCCCchh-
Q 038766 162 FGTSRMLDVHLQDLSSLSTAFQGTIGYLAPEFAYMRI------VTTKVDVFSFGIVVMEFLTKRRPTGLDEENGLSPIS- 234 (299)
Q Consensus 162 f~~~~~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~------~~~~~DiwslG~~l~~l~~g~~p~~~~~~~~~~~~~- 234 (299)
||++..................+|+.|+|||++.+.. ++.++|||||||++|+|++|..|+............
T Consensus 152 FGl~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~k~Di~S~Gvvl~el~tg~~~~~~~~~~~~~~~~~ 231 (303)
T d1vjya_ 152 LGLAVRHDSATDTIDIAPNHRVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHEDYQLPYYDL 231 (303)
T ss_dssp CTTCEEEETTTTEECC----CCSCGGGCCHHHHTTCSCTTCHHHHHHHHHHHHHHHHHHHHHTBCBTTBCCCCCCTTTTT
T ss_pred cCccccccCCCcceeccccceecccCcCChhhccccccccCCCcCcchhhhhhHHHHHHHhhCCCCCCcccccccchhhc
Confidence 9999876533322233345567899999999987653 677899999999999999999887654333222111
Q ss_pred -----HHHHHHHHHhcCccCcccccCccccchhhHhHHHHHHHHHHHHHHHHhcCCCCCCCCChhhhhc
Q 038766 235 -----LRQLVEKALANGINGVRQITDPKLVSSIYEEQEQHQVLEELFKLALVCTSSNPEDRPNMNELLI 298 (299)
Q Consensus 235 -----~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rpt~~~il~ 298 (299)
....+........ ..+.... .......+..+.+|+.+||..||++|||+.||++
T Consensus 232 ~~~~~~~~~~~~~~~~~~------~~p~~~~----~~~~~~~~~~l~~li~~cl~~dp~~Rps~~ei~~ 290 (303)
T d1vjya_ 232 VPSDPSVEEMRKVVCEQK------LRPNIPN----RWQSCEALRVMAKIMRECWYANGAARLTALRIKK 290 (303)
T ss_dssp SCSSCCHHHHHHHHTTSC------CCCCCCG----GGGGCHHHHHHHHHHHTTCCSSGGGSCCHHHHHH
T ss_pred ccccchHHHHHHHHhccc------cCCCCCc----ccCChHHHHHHHHHHHHHcccCHhHCcCHHHHHH
Confidence 1122222221110 0111111 1112335567899999999999999999999975
|
| >d2b1pa1 d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3s) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-jun N-terminal kinase (jnk3s) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.1e-49 Score=339.01 Aligned_cols=270 Identities=23% Similarity=0.247 Sum_probs=199.0
Q ss_pred HhCCCCCCceeecCCcceEEEEEeC-CCcEEEEEEeccCcCChhhhHHHHHHHHHHHhcCCcceeeeeeEEEcC-----C
Q 038766 10 ATGSFSENNIIGNSNLSTVYKGRLE-DGEIVAVKKLNFHQFSAESDKSFYREAKTLKELKHRNLVKVLGYAWES-----G 83 (299)
Q Consensus 10 ~~~~y~~~~~lg~g~~~~v~~~~~~-~~~~~~vK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~-----~ 83 (299)
+.++|++.+.||+|+||+||+|.+. +|+.||||++...........++.+|+.++++++||||+++++++... .
T Consensus 15 i~~~Y~i~~~LG~G~fg~V~~~~d~~t~~~vAvK~i~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~~~~~f~~~~~~~~~ 94 (355)
T d2b1pa1 15 VLKRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISLLNVFTPQKTLEEF 94 (355)
T ss_dssp EETTEEEEEECSCC--CEEEEEEETTTTEEEEEEEEESTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCCSTTTC
T ss_pred ecCCeEEEEEeecCcCeEEEEEEECCCCCEEEEEEEChhhcCHHHHHHHHHHHHHHHhcCCCCeeEEEEEEecccccccC
Confidence 4579999999999999999999875 699999999987666666777899999999999999999999987643 3
Q ss_pred CeeEEEEeecCCCChHHHhcCCCCCCCCCChhhHHHHHHHHHHHHHHhhcCCCCCeeeecccCCceeeCCCCcEEEeeec
Q 038766 84 KLKALILEYMENGSLESVIHGPGVDHSRWTLPKRIDVLISVANGLDYLHSGYDIPIVHCDMKPSNILLDRDFEAHVSDFG 163 (299)
Q Consensus 84 ~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lh~~~~~~~~H~dl~~~nil~~~~~~v~l~df~ 163 (299)
...|+|+||+.+ ++...+. ..+++..++.++.|++.||.|||++ +++||||||+|||++.++.++++|||
T Consensus 95 ~~~~iv~Ey~~~-~l~~~~~------~~~~~~~i~~~~~qil~gl~~LH~~---giiHrDlKP~Nil~~~~~~~kl~df~ 164 (355)
T d2b1pa1 95 QDVYLVMELMDA-NLCQVIQ------MELDHERMSYLLYQMLCGIKHLHSA---GIIHRDLKPSNIVVKSDCTLKILDFG 164 (355)
T ss_dssp CEEEEEEECCSE-EHHHHHT------SCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEECTTCCEEECCCC
T ss_pred ceeEEEEeccch-HHHHhhh------cCCCHHHHHHHHHHHHHHHHHhhhc---ccccccCCccccccccccceeeechh
Confidence 678999999966 5555553 3589999999999999999999999 99999999999999999999999999
Q ss_pred cccccccccccccccccccccCcccCChhhhcccCcCccccchhhhHHHHHHHhCCCCCCCCccCCCCchhHHHHHH---
Q 038766 164 TSRMLDVHLQDLSSLSTAFQGTIGYLAPEFAYMRIVTTKVDVFSFGIVVMEFLTKRRPTGLDEENGLSPISLRQLVE--- 240 (299)
Q Consensus 164 ~~~~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~DiwslG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~--- 240 (299)
++..... ........+|+.|+|||.+.+..++.++||||+||++++|++|..||...... ......+.
T Consensus 165 ~~~~~~~-----~~~~~~~~~t~~y~aPE~l~~~~~~~~~DiwSlG~~l~ell~g~~pF~~~~~~----~~~~~i~~~~~ 235 (355)
T d2b1pa1 165 LARTAGT-----SFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMVRHKILFPGRDYI----DQWNKVIEQLG 235 (355)
T ss_dssp C--------------------CCTTCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCSSCCSSHH----HHHHHHHHHHC
T ss_pred hhhcccc-----ccccccccccccccChhhhcCCCCCCCcccccccchHHHHhhCCCCCCCCCHH----HHHHHHHHhcc
Confidence 8875442 22334556789999999999999999999999999999999999999543211 00000110
Q ss_pred ---------------HHHhcCccCcccccCccc---cchhhHhHHHHHHHHHHHHHHHHhcCCCCCCCCChhhhhcC
Q 038766 241 ---------------KALANGINGVRQITDPKL---VSSIYEEQEQHQVLEELFKLALVCTSSNPEDRPNMNELLIT 299 (299)
Q Consensus 241 ---------------~~~~~~~~~~~~~~~~~~---~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rpt~~~il~~ 299 (299)
...... ........+.. .............++++.+||++||..||++|||++|+|+|
T Consensus 236 ~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dll~~mL~~dP~~R~ta~elL~H 311 (355)
T d2b1pa1 236 TPCPEFMKKLQPTVRNYVENR-PKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRISVDDALQH 311 (355)
T ss_dssp CCCHHHHTTSCHHHHHHHHTS-CCCCCCCHHHHSCGGGSCCSSHHHHHHHHHHHHHHHHHSCSSTTTSCCHHHHHTS
T ss_pred CCCHHHHHHhhhhHHHHhhcC-ccccccccccccccccccccccccccCCHHHHHHHHHHCcCChhHCcCHHHHhcC
Confidence 000100 00000000000 00011123356678899999999999999999999999988
|
| >d1lufa_ d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Musk tyrosine kinase species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=100.00 E-value=1e-49 Score=333.47 Aligned_cols=260 Identities=26% Similarity=0.374 Sum_probs=201.7
Q ss_pred HHHHhCCCCCCceeecCCcceEEEEEeC------CCcEEEEEEeccCcCChhhhHHHHHHHHHHHhcCCcceeeeeeEEE
Q 038766 7 IENATGSFSENNIIGNSNLSTVYKGRLE------DGEIVAVKKLNFHQFSAESDKSFYREAKTLKELKHRNLVKVLGYAW 80 (299)
Q Consensus 7 ~~~~~~~y~~~~~lg~g~~~~v~~~~~~------~~~~~~vK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~ 80 (299)
+|.=.++|.+.+.||+|+||+||+|++. +++.||||++.. .......+.+.+|++++++++||||+++++++.
T Consensus 8 ~e~p~~~~~~~~~lG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~i~~-~~~~~~~~~~~~E~~il~~l~h~niv~~~~~~~ 86 (301)
T d1lufa_ 8 LEYPRNNIEYVRDIGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKE-EASADMQADFQREAALMAEFDNPNIVKLLGVCA 86 (301)
T ss_dssp TBCCGGGCEEEEEEEECSSCEEEEEEEETSSTTSSEEEEEEEECCT-TCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEC
T ss_pred ccCCHHHcEEeEEEeeCCCeEEEEEEECCCccCCCCeEEEEEEECh-hcChHHHHHHHHHHHHHHhcCCCCcccceeeec
Confidence 4444678999999999999999999863 357899999864 334455678999999999999999999999766
Q ss_pred cCCCeeEEEEeecCCCChHHHhcCCC--------------------CCCCCCChhhHHHHHHHHHHHHHHhhcCCCCCee
Q 038766 81 ESGKLKALILEYMENGSLESVIHGPG--------------------VDHSRWTLPKRIDVLISVANGLDYLHSGYDIPIV 140 (299)
Q Consensus 81 ~~~~~~~lv~e~~~~~~L~~~~~~~~--------------------~~~~~~~~~~~~~i~~qi~~~l~~lh~~~~~~~~ 140 (299)
. +...++++|++.+++|.+++.... .....++...++.++.|++.||+|||++ +++
T Consensus 87 ~-~~~~~~v~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~gl~ylH~~---~iv 162 (301)
T d1lufa_ 87 V-GKPMCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVSSPGPPPLSCAEQLCIARQVAAGMAYLSER---KFV 162 (301)
T ss_dssp S-SSSCEEEEECCTTCBHHHHHHHTCC----------------------CCCCHHHHHHHHHHHHHHHHHHHHT---TCC
T ss_pred c-CCceEEEEEecCCCcHHHHHHhcCccccccccccccchhhhccccCCCCCCHHHHHHHHHHHHHHhhhcccC---CeE
Confidence 5 455699999999999999885321 1233589999999999999999999999 999
Q ss_pred eecccCCceeeCCCCcEEEeeeccccccccccccccccccccccCcccCChhhhcccCcCccccchhhhHHHHHHHhCC-
Q 038766 141 HCDMKPSNILLDRDFEAHVSDFGTSRMLDVHLQDLSSLSTAFQGTIGYLAPEFAYMRIVTTKVDVFSFGIVVMEFLTKR- 219 (299)
Q Consensus 141 H~dl~~~nil~~~~~~v~l~df~~~~~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~DiwslG~~l~~l~~g~- 219 (299)
||||||+||+++.++.+||+|||++...... ..........+++.|+|||.+.+..++.++|||||||++|+|++|.
T Consensus 163 HrDlKp~NILld~~~~~Kl~DFGls~~~~~~--~~~~~~~~~~~~~~y~aPE~~~~~~~t~ksDVwS~Gvvl~ell~~~~ 240 (301)
T d1lufa_ 163 HRDLATRNCLVGENMVVKIADFGLSRNIYSA--DYYKADGNDAIPIRWMPPESIFYNRYTTESDVWAYGVVLWEIFSYGL 240 (301)
T ss_dssp CSCCSGGGEEECGGGCEEECCCSCHHHHTGG--GCBC----CCBCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTC
T ss_pred eeEEcccceEECCCCcEEEccchhheeccCC--ccccccCCCCcCcCcCCHHHHccCCCChhhhhccchhhHHHHHccCC
Confidence 9999999999999999999999999755422 1122334556788999999999999999999999999999999986
Q ss_pred CCCCCCccCCCCchhHHHHHHHHHhcCccCcccccCccccchhhHhHHHHHHHHHHHHHHHHhcCCCCCCCCChhhhhc
Q 038766 220 RPTGLDEENGLSPISLRQLVEKALANGINGVRQITDPKLVSSIYEEQEQHQVLEELFKLALVCTSSNPEDRPNMNELLI 298 (299)
Q Consensus 220 ~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rpt~~~il~ 298 (299)
+||... ...++ +........ ..+ +..+++++.+|+.+||+.||++|||+.||++
T Consensus 241 ~p~~~~-----~~~e~---~~~v~~~~~---~~~--------------p~~~~~~~~~li~~cl~~~P~~RPt~~ev~~ 294 (301)
T d1lufa_ 241 QPYYGM-----AHEEV---IYYVRDGNI---LAC--------------PENCPLELYNLMRLCWSKLPADRPSFCSIHR 294 (301)
T ss_dssp CTTTTS-----CHHHH---HHHHHTTCC---CCC--------------CTTCCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred CCCCCC-----CHHHH---HHHHHcCCC---CCC--------------CccchHHHHHHHHHHcCCChhHCcCHHHHHH
Confidence 456322 22222 222221111 001 1233457899999999999999999999964
|
| >d1u46a_ d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Activated CDC42 kinase 1, ACK1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.6e-50 Score=331.91 Aligned_cols=255 Identities=23% Similarity=0.356 Sum_probs=190.6
Q ss_pred hCCCCCCceeecCCcceEEEEEeC--C--CcEEEEEEeccCcC-ChhhhHHHHHHHHHHHhcCCcceeeeeeEEEcCCCe
Q 038766 11 TGSFSENNIIGNSNLSTVYKGRLE--D--GEIVAVKKLNFHQF-SAESDKSFYREAKTLKELKHRNLVKVLGYAWESGKL 85 (299)
Q Consensus 11 ~~~y~~~~~lg~g~~~~v~~~~~~--~--~~~~~vK~~~~~~~-~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~ 85 (299)
.++|++.+.||+|+||+||+|... + +..||||++..... .....+.+.+|+.++++++||||+++++++.+ . .
T Consensus 7 ~~d~~~~~~iG~G~fg~Vy~~~~~~~~~~~~~vAiK~l~~~~~~~~~~~~~~~~Ei~~l~~l~H~nIv~~~g~~~~-~-~ 84 (273)
T d1u46a_ 7 EKDLRLLEKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNLIRLYGVVLT-P-P 84 (273)
T ss_dssp GGGEEEEEECC----CCCEEEEEECTTSCEEEEEEEC--------CHHHHHHHHHHHHHHHCCCTTBCCEEEEECS-S-S
T ss_pred hHHeEEEEEEecCCCeEEEEEEEECCCCcEEEEEEEEEChhhcCCHHHHHHHHHHHHHHHhCCCCCEEEEEEEEee-c-c
Confidence 467999999999999999999752 2 24689998865433 33445788999999999999999999997754 3 4
Q ss_pred eEEEEeecCCCChHHHhcCCCCCCCCCChhhHHHHHHHHHHHHHHhhcCCCCCeeeecccCCceeeCCCCcEEEeeeccc
Q 038766 86 KALILEYMENGSLESVIHGPGVDHSRWTLPKRIDVLISVANGLDYLHSGYDIPIVHCDMKPSNILLDRDFEAHVSDFGTS 165 (299)
Q Consensus 86 ~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lh~~~~~~~~H~dl~~~nil~~~~~~v~l~df~~~ 165 (299)
.++|+||+.++++.+.+.. ....+++..++.++.|++.||.|||++ +++||||||+||+++.++.+||+|||++
T Consensus 85 ~~lv~e~~~~~~l~~~~~~---~~~~l~~~~~~~~~~qi~~gl~ylH~~---~iiHrDikp~NIll~~~~~vkl~DfGl~ 158 (273)
T d1u46a_ 85 MKMVTELAPLGSLLDRLRK---HQGHFLLGTLSRYAVQVAEGMGYLESK---RFIHRDLAARNLLLATRDLVKIGDFGLM 158 (273)
T ss_dssp CEEEEECCTTCBHHHHHHH---HGGGSCHHHHHHHHHHHHHHHHHHHHT---TEECSCCCGGGEEEEETTEEEECCCTTC
T ss_pred hheeeeeecCcchhhhhhc---ccCCCCHHHHHHHHHHHHHHHHHhhhC---CEeeeeecHHHhccccccceeeccchhh
Confidence 4899999999999887652 335799999999999999999999999 9999999999999999999999999999
Q ss_pred cccccccccccccccccccCcccCChhhhcccCcCccccchhhhHHHHHHHh-CCCCCCCCccCCCCchhHHHHHHHHHh
Q 038766 166 RMLDVHLQDLSSLSTAFQGTIGYLAPEFAYMRIVTTKVDVFSFGIVVMEFLT-KRRPTGLDEENGLSPISLRQLVEKALA 244 (299)
Q Consensus 166 ~~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~DiwslG~~l~~l~~-g~~p~~~~~~~~~~~~~~~~~~~~~~~ 244 (299)
......... ........++..|+|||.+.+..++.++||||||+++|+|++ |..||... ... +.+.....
T Consensus 159 ~~~~~~~~~-~~~~~~~~~~~~~~aPE~~~~~~~~~~~Di~S~Gvil~emlt~G~~Pf~~~-----~~~---~~~~~i~~ 229 (273)
T d1u46a_ 159 RALPQNDDH-YVMQEHRKVPFAWCAPESLKTRTFSHASDTWMFGVTLWEMFTYGQEPWIGL-----NGS---QILHKIDK 229 (273)
T ss_dssp EECCC-CCE-EEC-----CCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTSCCTTTTC-----CHH---HHHHHHHT
T ss_pred hhcccCCCc-ceecCccccCcccCCHHHHhCCCCCcchhhhhhHHHHHHHHhCCCCCCCCc-----CHH---HHHHHHHh
Confidence 876432211 122334456789999999999999999999999999999997 89998422 222 22333222
Q ss_pred cCccCcccccCccccchhhHhHHHHHHHHHHHHHHHHhcCCCCCCCCChhhhhc
Q 038766 245 NGINGVRQITDPKLVSSIYEEQEQHQVLEELFKLALVCTSSNPEDRPNMNELLI 298 (299)
Q Consensus 245 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rpt~~~il~ 298 (299)
.+.. ... +..+++++.+||.+||+.||++|||+++|++
T Consensus 230 ~~~~----~~~------------~~~~~~~l~~li~~cl~~dp~~RPt~~ei~~ 267 (273)
T d1u46a_ 230 EGER----LPR------------PEDCPQDIYNVMVQCWAHKPEDRPTFVALRD 267 (273)
T ss_dssp SCCC----CCC------------CTTCCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred CCCC----CCC------------cccccHHHHHHHHHHcCCChhHCcCHHHHHH
Confidence 2110 000 2234567999999999999999999999874
|
| >d1pmea_ d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase Erk2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.3e-49 Score=337.55 Aligned_cols=273 Identities=21% Similarity=0.252 Sum_probs=198.5
Q ss_pred HhCCCCCCceeecCCcceEEEEEe-CCCcEEEEEEeccCcCChhhhHHHHHHHHHHHhcCCcceeeeeeEEEcCC----C
Q 038766 10 ATGSFSENNIIGNSNLSTVYKGRL-EDGEIVAVKKLNFHQFSAESDKSFYREAKTLKELKHRNLVKVLGYAWESG----K 84 (299)
Q Consensus 10 ~~~~y~~~~~lg~g~~~~v~~~~~-~~~~~~~vK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~----~ 84 (299)
+.++|++++.||+|+||+||+|.+ .+|+.||||++.... .....+.+.+|+.+|+.++||||+++++++.... .
T Consensus 6 i~~rY~~~~~LG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~-~~~~~~~~~~Ei~il~~l~hp~iv~~~~~~~~~~~~~~~ 84 (345)
T d1pmea_ 6 VGPRYTNLSYIGEGAYGMVCSAYDNVNKVRVAIKKISPFE-HQTYCQRTLREIKILLRFRHENIIGINDIIRAPTIEQMK 84 (345)
T ss_dssp CCTTEEEEEECC---CCCEEEEEETTTCSEEEEEEECCTT-CHHHHHHHHHHHHHHHHCCCTTBCCCCEEECCSSTTTCC
T ss_pred cCCCeEEEEEEeeccCeEEEEEEECCCCcEEEEEEEehhc-ChHHHHHHHHHHHHHHHcCCCCCCcEEEEEeeccccccc
Confidence 467899999999999999999986 579999999996432 4455678889999999999999999999775432 2
Q ss_pred eeEEEEeecCCCChHHHhcCCCCCCCCCChhhHHHHHHHHHHHHHHhhcCCCCCeeeecccCCceeeCCCCcEEEeeecc
Q 038766 85 LKALILEYMENGSLESVIHGPGVDHSRWTLPKRIDVLISVANGLDYLHSGYDIPIVHCDMKPSNILLDRDFEAHVSDFGT 164 (299)
Q Consensus 85 ~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lh~~~~~~~~H~dl~~~nil~~~~~~v~l~df~~ 164 (299)
..+++ +++.+++|.++++ ..++++..++.++.|+++||+|||++ +++||||||+|||++.++.+||+|||+
T Consensus 85 ~~~l~-~~~~~g~L~~~l~-----~~~l~~~~i~~i~~qil~al~yLH~~---~iiHRDIKp~NILl~~~~~~kl~DfG~ 155 (345)
T d1pmea_ 85 DVYLV-THLMGADLYKLLK-----TQHLSNDHICYFLYQILRGLKYIHSA---NVLHRDLKPSNLLLNTTCDLKICDFGL 155 (345)
T ss_dssp CEEEE-EECCCEEHHHHHH-----HCCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEECTTCCEEECCCTT
T ss_pred eEEEE-EeecCCchhhhhh-----cCCCCHHHHHHHHHHHHHHHHHHHHC---CCcCCCCCcceEEECCCCCEEEcccCc
Confidence 33555 5556889999995 24699999999999999999999999 999999999999999999999999999
Q ss_pred ccccccccccccccccccccCcccCChhhhc-ccCcCccccchhhhHHHHHHHhCCCCCCCCccCCCCchhHHHHHHHHH
Q 038766 165 SRMLDVHLQDLSSLSTAFQGTIGYLAPEFAY-MRIVTTKVDVFSFGIVVMEFLTKRRPTGLDEENGLSPISLRQLVEKAL 243 (299)
Q Consensus 165 ~~~~~~~~~~~~~~~~~~~~~~~y~~PE~~~-~~~~~~~~DiwslG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~ 243 (299)
+........ .........+++.|+|||++. +..++.++||||+||++|+|++|..||..... ...........
T Consensus 156 a~~~~~~~~-~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~DiwSlG~il~eml~g~~pf~~~~~-----~~~~~~~~~~~ 229 (345)
T d1pmea_ 156 ARVADPDHD-HTGFLTEYVATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHY-----LDQLNHILGIL 229 (345)
T ss_dssp CEECCGGGC-BCCTTCCCCSCGGGCCGGGTTTBCSCSTHHHHHHHHHHHHHHHHSSCSCCCSSH-----HHHHHHHHHHH
T ss_pred eeeccCCCc-cceeeccccccceechHHHhhcCCCCCchhhhhccCceehHHhhCCCCCCCCCH-----HHHHHHHhhhc
Confidence 976542211 122234566899999999875 45678899999999999999999999954321 11111111111
Q ss_pred hcCccCcc-cc----------cCccccchhhHhHHHHHHHHHHHHHHHHhcCCCCCCCCChhhhhcC
Q 038766 244 ANGINGVR-QI----------TDPKLVSSIYEEQEQHQVLEELFKLALVCTSSNPEDRPNMNELLIT 299 (299)
Q Consensus 244 ~~~~~~~~-~~----------~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rpt~~~il~~ 299 (299)
........ .. ..+..... .........+.++.+||.+||..||++|||++|+|+|
T Consensus 230 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~s~~~~~li~~~L~~dP~~R~ta~e~L~h 295 (345)
T d1pmea_ 230 GSPSQEDLNCIINLKARNYLLSLPHKNKV-PWNRLFPNADSKALDLLDKMLTFNPHKRIEVEQALAH 295 (345)
T ss_dssp CSCCHHHHHTCCCHHHHHHHHTSCCCCCC-CHHHHCTTSCHHHHHHHHHHSCSSTTTSCCHHHHHTS
T ss_pred cCCChhhhhhhhhhhhhcccccCCccCCC-CHHHhCCCCCHHHHHHHHHHccCChhHCcCHHHHhcC
Confidence 00000000 00 00000000 0011122345679999999999999999999999987
|
| >d1fgka_ d.144.1.7 (A:) Fibroblast growth factor receptor 1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Fibroblast growth factor receptor 1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=5.4e-50 Score=334.75 Aligned_cols=261 Identities=23% Similarity=0.357 Sum_probs=200.9
Q ss_pred HHHHHhCCCCCCceeecCCcceEEEEEeCC--------CcEEEEEEeccCcCChhhhHHHHHHHHHHHhc-CCcceeeee
Q 038766 6 EIENATGSFSENNIIGNSNLSTVYKGRLED--------GEIVAVKKLNFHQFSAESDKSFYREAKTLKEL-KHRNLVKVL 76 (299)
Q Consensus 6 ~~~~~~~~y~~~~~lg~g~~~~v~~~~~~~--------~~~~~vK~~~~~~~~~~~~~~~~~e~~~l~~l-~h~~i~~~~ 76 (299)
+|++-.++|.+.+.||+|+||.||+|+..+ +..||||++... ........+.+|...+.++ +||||++++
T Consensus 7 ~~~i~~~~~~l~~~iG~G~fg~Vy~~~~~~~~~~~~~~~~~vAvK~~~~~-~~~~~~~~~~~e~~~l~~~~~HpnIv~~~ 85 (299)
T d1fgka_ 7 RWELPRDRLVLGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSD-ATEKDLSDLISEMEMMKMIGKHKNIINLL 85 (299)
T ss_dssp TTBCCGGGEEEEEECC-----CEEEEEEECC----CCCEEEEEEECCCTT-CCHHHHHHHHHHHHHHHHHCCCTTBCCEE
T ss_pred cCcccHHHeEEeeEEeecCCcEEEEEEEcCCCcccccCceEEEEEEECcc-cChHHHHHHHHHHHHHHHhcCCCeEEecc
Confidence 466677899999999999999999997522 347999998643 3445567788899999888 799999999
Q ss_pred eEEEcCCCeeEEEEeecCCCChHHHhcCCCC------------CCCCCChhhHHHHHHHHHHHHHHhhcCCCCCeeeecc
Q 038766 77 GYAWESGKLKALILEYMENGSLESVIHGPGV------------DHSRWTLPKRIDVLISVANGLDYLHSGYDIPIVHCDM 144 (299)
Q Consensus 77 ~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~------------~~~~~~~~~~~~i~~qi~~~l~~lh~~~~~~~~H~dl 144 (299)
+++.+. ...++|+||+.+|+|.+++..... ....+++..++.++.||+.||+|||+. +++||||
T Consensus 86 ~~~~~~-~~~~~v~e~~~~g~l~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~ylH~~---~ivHrDi 161 (299)
T d1fgka_ 86 GACTQD-GPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDLVSCAYQVARGMEYLASK---KCIHRDL 161 (299)
T ss_dssp EEECSS-SSCEEEECCCTTCBHHHHHHTTSCC------------CCCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCC
T ss_pred cccccC-CeEEEEEEccCCCcHHHHHHhhcCCccccccccccCccccCCHHHHHHHHHHHHHHHHHhhhC---CEEeeee
Confidence 977664 455999999999999999864321 235689999999999999999999999 9999999
Q ss_pred cCCceeeCCCCcEEEeeeccccccccccccccccccccccCcccCChhhhcccCcCccccchhhhHHHHHHHh-CCCCCC
Q 038766 145 KPSNILLDRDFEAHVSDFGTSRMLDVHLQDLSSLSTAFQGTIGYLAPEFAYMRIVTTKVDVFSFGIVVMEFLT-KRRPTG 223 (299)
Q Consensus 145 ~~~nil~~~~~~v~l~df~~~~~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~DiwslG~~l~~l~~-g~~p~~ 223 (299)
||+|||++.++.+||+|||++...... ..........+++.|+|||.+.+..++.++||||||+++|+|++ |..||.
T Consensus 162 Kp~NiLl~~~~~~kl~dfg~~~~~~~~--~~~~~~~~~~~~~~y~aPE~l~~~~y~~k~DiwS~Gvvl~ell~~g~~p~~ 239 (299)
T d1fgka_ 162 AARNVLVTEDNVMKIADFGLARDIHHI--DYYKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPYP 239 (299)
T ss_dssp SGGGEEECTTCCEEECSTTCCCCGGGC--CTTCCCTTSCCGGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSST
T ss_pred cccceeecCCCCeEeccchhhcccccc--ccccccccCCCChhhhhhhHhcCCCCCchhhhHHhHHHHHHhccCCCCCCC
Confidence 999999999999999999999866532 12223445667889999999999999999999999999999998 677774
Q ss_pred CCccCCCCchhHHHHHHHHHhcCccCcccccCccccchhhHhHHHHHHHHHHHHHHHHhcCCCCCCCCChhhhhc
Q 038766 224 LDEENGLSPISLRQLVEKALANGINGVRQITDPKLVSSIYEEQEQHQVLEELFKLALVCTSSNPEDRPNMNELLI 298 (299)
Q Consensus 224 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rpt~~~il~ 298 (299)
.. ....+...+ ..+. .... +..+++++.+||.+||+.||++|||+.||++
T Consensus 240 ~~-----~~~~~~~~i----~~~~----~~~~------------p~~~~~~l~~li~~cl~~dP~~Rps~~eil~ 289 (299)
T d1fgka_ 240 GV-----PVEELFKLL----KEGH----RMDK------------PSNCTNELYMMMRDCWHAVPSQRPTFKQLVE 289 (299)
T ss_dssp TC-----CHHHHHHHH----HTTC----CCCC------------CSSCCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred CC-----CHHHHHHHH----HcCC----CCCC------------CccchHHHHHHHHHHccCCHhHCcCHHHHHH
Confidence 22 222222221 1111 0011 1123467999999999999999999999985
|
| >d3bqca1 d.144.1.7 (A:3-330) Protein kinase CK2, alpha subunit {Rattus norvegicus [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase CK2, alpha subunit species: Rattus norvegicus [TaxId: 10116]
Probab=100.00 E-value=2.5e-49 Score=335.46 Aligned_cols=269 Identities=19% Similarity=0.250 Sum_probs=200.0
Q ss_pred hCCCCCCceeecCCcceEEEEEe-CCCcEEEEEEeccCcCChhhhHHHHHHHHHHHhcC-CcceeeeeeEEEcC-CCeeE
Q 038766 11 TGSFSENNIIGNSNLSTVYKGRL-EDGEIVAVKKLNFHQFSAESDKSFYREAKTLKELK-HRNLVKVLGYAWES-GKLKA 87 (299)
Q Consensus 11 ~~~y~~~~~lg~g~~~~v~~~~~-~~~~~~~vK~~~~~~~~~~~~~~~~~e~~~l~~l~-h~~i~~~~~~~~~~-~~~~~ 87 (299)
.++|++.+.||+|+||+||+|++ .+|+.||||++.. ...+.+.+|+++++.++ ||||+++++++... ....+
T Consensus 34 ~d~y~i~~~LG~G~fg~V~~a~~~~~~~~vAiK~i~~-----~~~~~~~~Ei~il~~l~~hpnIv~~~~~~~~~~~~~~~ 108 (328)
T d3bqca1 34 QDDYQLVRKLGRGKYSEVFEAINITNNEKVVVKILKP-----VKKKKIKREIKILENLRGGPNIITLADIVKDPVSRTPA 108 (328)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECS-----SCHHHHHHHHHHHHHHTTSTTBCCEEEEEECTTTCSEE
T ss_pred CcCeEEEEEEecCcCeEEEEEEECCCCCEEEEEEECH-----HHHHHHHHHHHHHHhccCCCCCcEEEEEEEecCCCcee
Confidence 46799999999999999999987 4689999999852 23567889999999996 99999999977643 45679
Q ss_pred EEEeecCCCChHHHhcCCCCCCCCCChhhHHHHHHHHHHHHHHhhcCCCCCeeeecccCCceeeCCCC-cEEEeeecccc
Q 038766 88 LILEYMENGSLESVIHGPGVDHSRWTLPKRIDVLISVANGLDYLHSGYDIPIVHCDMKPSNILLDRDF-EAHVSDFGTSR 166 (299)
Q Consensus 88 lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lh~~~~~~~~H~dl~~~nil~~~~~-~v~l~df~~~~ 166 (299)
+||||+.+++|....+ .+++.+++.++.||+.||+|||++ +++||||||+|||++.++ .++|+|||++.
T Consensus 109 ~v~e~~~~~~L~~~~~-------~l~e~~i~~i~~qil~aL~~LH~~---gIvHrDiKp~NILi~~~~~~vkl~DFG~a~ 178 (328)
T d3bqca1 109 LVFEHVNNTDFKQLYQ-------TLTDYDIRFYMYEILKALDYCHSM---GIMHRDVKPHNVMIDHEHRKLRLIDWGLAE 178 (328)
T ss_dssp EEEECCCSCBGGGTTT-------SCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEEETTTTEEEECCGGGCE
T ss_pred EEEeecCCCcHHHHhc-------CCCHHHHHHHHHHHHHHHHHHhhc---ccccccccccceEEcCCCCeeeecccccce
Confidence 9999999989876653 689999999999999999999999 999999999999998655 68999999997
Q ss_pred ccccccccccccccccccCcccCChhhhccc-CcCccccchhhhHHHHHHHhCCCCCCCCccCCCCchhHHHHHHH----
Q 038766 167 MLDVHLQDLSSLSTAFQGTIGYLAPEFAYMR-IVTTKVDVFSFGIVVMEFLTKRRPTGLDEENGLSPISLRQLVEK---- 241 (299)
Q Consensus 167 ~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~-~~~~~~DiwslG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~---- 241 (299)
.... ........+|+.|+|||.+.+. .++.++||||+||++|+|++|..||............+...+..
T Consensus 179 ~~~~-----~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~~l~e~~~g~~pf~~~~~~~~~~~~i~~~~g~~~~~ 253 (328)
T d3bqca1 179 FYHP-----GQEYNVRVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVRIAKVLGTEDLY 253 (328)
T ss_dssp ECCT-----TCCCCSCCSCGGGCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHTCSSSSCCSSHHHHHHHHHHHHCHHHHH
T ss_pred eccC-----CCcccccccCccccCcccccCCCCCCcccchhhhhhhhHHhccCCCCCCCCchhHHHHHHHHHHHCCchhh
Confidence 6542 2234455678999999987765 47999999999999999999999986442211101111110000
Q ss_pred --HHhcCccC---cccccC---ccccchhhHhHHHHHHHHHHHHHHHHhcCCCCCCCCChhhhhcC
Q 038766 242 --ALANGING---VRQITD---PKLVSSIYEEQEQHQVLEELFKLALVCTSSNPEDRPNMNELLIT 299 (299)
Q Consensus 242 --~~~~~~~~---~~~~~~---~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rpt~~~il~~ 299 (299)
........ ...... ...............+++++.+||++||..||++|||++|+|+|
T Consensus 254 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~mL~~dP~~R~ta~e~L~H 319 (328)
T d3bqca1 254 DYIDKYNIELDPRFNDILGRHSRKRWERFVHSENQHLVSPEALDFLDKLLRYDHQSRLTAREAMEH 319 (328)
T ss_dssp HHHHHTTCCCCGGGGGTCCCCCCCCGGGGCCTTTGGGCCHHHHHHHHHHSCSSGGGSCCHHHHHTS
T ss_pred hhhhhcccccCcccchhcccccccchhhcccccccccCCHHHHHHHHHHccCChhHCcCHHHHhcC
Confidence 00000000 000000 00001111112234456789999999999999999999999998
|
| >d1q5ka_ d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gsk3b) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Glycogen synthase kinase-3 beta (Gsk3b) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.8e-49 Score=336.80 Aligned_cols=268 Identities=23% Similarity=0.306 Sum_probs=193.9
Q ss_pred CCCCCceeecCCcceEEEEEeC-CCcEEEEEEeccCcCChhhhHHHHHHHHHHHhcCCcceeeeeeEEEcC-----CCee
Q 038766 13 SFSENNIIGNSNLSTVYKGRLE-DGEIVAVKKLNFHQFSAESDKSFYREAKTLKELKHRNLVKVLGYAWES-----GKLK 86 (299)
Q Consensus 13 ~y~~~~~lg~g~~~~v~~~~~~-~~~~~~vK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~-----~~~~ 86 (299)
+|+..++||+|+||+||+|++. +|+.||||++..... ...+|++++++++||||+++++++... ..+.
T Consensus 21 ~Y~~~k~LG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~------~~~~Ei~il~~l~h~niv~~~~~~~~~~~~~~~~~~ 94 (350)
T d1q5ka_ 21 SYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDKR------FKNRELQIMRKLDHCNIVRLRYFFYSSGEKKDEVYL 94 (350)
T ss_dssp EEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCSS------SCCHHHHHHHHCCCTTBCCEEEEEEEC--CCSCCEE
T ss_pred CcEeeeEEeeCcCeEEEEEEECCCCCEEEEEEECccch------HHHHHHHHHHhcCCCCCCcEEEEEEecCccCCceEE
Confidence 6888999999999999999974 699999999964321 223699999999999999999987643 3356
Q ss_pred EEEEeecCCCChHHHhcCCCCCCCCCChhhHHHHHHHHHHHHHHhhcCCCCCeeeecccCCceeeCCCC-cEEEeeeccc
Q 038766 87 ALILEYMENGSLESVIHGPGVDHSRWTLPKRIDVLISVANGLDYLHSGYDIPIVHCDMKPSNILLDRDF-EAHVSDFGTS 165 (299)
Q Consensus 87 ~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lh~~~~~~~~H~dl~~~nil~~~~~-~v~l~df~~~ 165 (299)
++||||+.++ +...+.........+++.+++.++.||+.||+|||++ +++||||||+|||++.++ .+||+|||++
T Consensus 95 ~lv~Ey~~~~-~~~~l~~~~~~~~~l~~~~~~~i~~qil~aL~yLH~~---~IiHrDiKp~NILl~~~~~~~kl~DFG~a 170 (350)
T d1q5ka_ 95 NLVLDYVPET-VYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAYIHSF---GICHRDIKPQNLLLDPDTAVLKLCDFGSA 170 (350)
T ss_dssp EEEEECCSEE-HHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHTT---TEECCCCCGGGEEECTTTCCEEECCCTTC
T ss_pred EEEEeccCCc-cHHHHHhhhhccCCCCHHHHHHHHHHHHHHHHHHHhc---CCcccCCCcceEEEecCCCceeEecccch
Confidence 8999999764 4333321111456899999999999999999999999 999999999999999775 8999999998
Q ss_pred cccccccccccccccccccCcccCChhhhcc-cCcCccccchhhhHHHHHHHhCCCCCCCCccCCCCchhHHHHHHHH--
Q 038766 166 RMLDVHLQDLSSLSTAFQGTIGYLAPEFAYM-RIVTTKVDVFSFGIVVMEFLTKRRPTGLDEENGLSPISLRQLVEKA-- 242 (299)
Q Consensus 166 ~~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~-~~~~~~~DiwslG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~-- 242 (299)
..... ........+++.|+|||.+.+ ..++.++||||+||++|+|++|..||...... ..+.......
T Consensus 171 ~~~~~-----~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DIwSlG~il~el~~g~~pf~~~~~~----~~l~~i~~~~g~ 241 (350)
T d1q5ka_ 171 KQLVR-----GEPNVSYICSRYYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQPIFPGDSGV----DQLVEIIKVLGT 241 (350)
T ss_dssp EECCT-----TSCCCSCCSCTTSCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHTSCSSCCSSHH----HHHHHHHHHHCC
T ss_pred hhccC-----CcccccccccccccChHHhhcccCCCcceeecccceEEEehhhCCCCCCCCCHH----HHHHHHHHHhCC
Confidence 76542 233445578999999998765 56899999999999999999999999543211 1111111100
Q ss_pred -----HhcCccCcccccCccccchhhHhHHHHHHHHHHHHHHHHhcCCCCCCCCChhhhhcC
Q 038766 243 -----LANGINGVRQITDPKLVSSIYEEQEQHQVLEELFKLALVCTSSNPEDRPNMNELLIT 299 (299)
Q Consensus 243 -----~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rpt~~~il~~ 299 (299)
.............+...............++++.+||.+||..||++|||++|+|+|
T Consensus 242 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLl~~mL~~dP~~R~ta~e~L~H 303 (350)
T d1q5ka_ 242 PTREQIREMNPNYTEFKFPQIKAHPWTKVFRPRTPPEAIALCSRLLEYTPTARLTPLEACAH 303 (350)
T ss_dssp CCHHHHHHHCC---CCCCCCCCCCCGGGTSCTTSCHHHHHHHHHHSCSSGGGSCCHHHHHTS
T ss_pred ChHHhhhhhccchhhccccccccCchhhhcccCCCHHHHHHHHHHccCChhHCcCHHHHhcC
Confidence 000000000000011111111111123456789999999999999999999999987
|
| >d1fvra_ d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tie2 kinase species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.6e-49 Score=333.44 Aligned_cols=253 Identities=26% Similarity=0.426 Sum_probs=195.0
Q ss_pred CCCCCCceeecCCcceEEEEEeC-CCc--EEEEEEeccCcCChhhhHHHHHHHHHHHhc-CCcceeeeeeEEEcCCCeeE
Q 038766 12 GSFSENNIIGNSNLSTVYKGRLE-DGE--IVAVKKLNFHQFSAESDKSFYREAKTLKEL-KHRNLVKVLGYAWESGKLKA 87 (299)
Q Consensus 12 ~~y~~~~~lg~g~~~~v~~~~~~-~~~--~~~vK~~~~~~~~~~~~~~~~~e~~~l~~l-~h~~i~~~~~~~~~~~~~~~ 87 (299)
++|++.+.||+|+||+||+|.+. +|. .||||++.. ....+..+.+.+|+++++++ +||||+++++++.. ++.++
T Consensus 10 ~~~~~~~~iG~G~fg~Vy~~~~~~~~~~~~vaiK~~~~-~~~~~~~~~~~~E~~~l~~l~~HpnIv~~~~~~~~-~~~~~ 87 (309)
T d1fvra_ 10 NDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKE-YASKDDHRDFAGELEVLCKLGHHPNIINLLGACEH-RGYLY 87 (309)
T ss_dssp GGCEEEEEEECGGGCEEEEEEEEETTEEEEEEEEEEEC-C------CHHHHHHHHHTTCCCCTTBCCEEEEEEE-TTEEE
T ss_pred HHcEEEEEEeeCCCcEEEEEEECCCCeEEEEEEEEECc-ccChHHHHHHHHHHHHHHhccCCCCEeeEEEEEec-CCeeE
Confidence 68899999999999999999874 344 467777652 22344567789999999998 69999999997765 55669
Q ss_pred EEEeecCCCChHHHhcCC------------CCCCCCCChhhHHHHHHHHHHHHHHhhcCCCCCeeeecccCCceeeCCCC
Q 038766 88 LILEYMENGSLESVIHGP------------GVDHSRWTLPKRIDVLISVANGLDYLHSGYDIPIVHCDMKPSNILLDRDF 155 (299)
Q Consensus 88 lv~e~~~~~~L~~~~~~~------------~~~~~~~~~~~~~~i~~qi~~~l~~lh~~~~~~~~H~dl~~~nil~~~~~ 155 (299)
+|+||+++|+|.+++... ......+++..++.++.||+.||.|||++ +++||||||+|||++.++
T Consensus 88 iV~ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qia~gl~~lH~~---~iiHrDlkp~NIL~~~~~ 164 (309)
T d1fvra_ 88 LAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQK---QFIHRDLAARNILVGENY 164 (309)
T ss_dssp EEECCCTTCBHHHHHHTTCHHHHCHHHHHHTTBSCSSCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEECGGG
T ss_pred EEEEecCCCcHHHHHhhccccccchhhhccccccCCCCHHHHHHHHHHHHHHHHhhhcC---CccccccccceEEEcCCC
Confidence 999999999999998643 12456899999999999999999999999 999999999999999999
Q ss_pred cEEEeeeccccccccccccccccccccccCcccCChhhhcccCcCccccchhhhHHHHHHHhCCC-CCCCCccCCCCchh
Q 038766 156 EAHVSDFGTSRMLDVHLQDLSSLSTAFQGTIGYLAPEFAYMRIVTTKVDVFSFGIVVMEFLTKRR-PTGLDEENGLSPIS 234 (299)
Q Consensus 156 ~v~l~df~~~~~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~DiwslG~~l~~l~~g~~-p~~~~~~~~~~~~~ 234 (299)
.+||+|||++...... .......+|..|+|||.+.+..++.++|||||||++|+|++|.. ||.. .....
T Consensus 165 ~~kl~DfG~a~~~~~~-----~~~~~~~gt~~y~aPE~l~~~~~~~~sDvwSfGvil~ell~~~~~p~~~-----~~~~~ 234 (309)
T d1fvra_ 165 VAKIADFGLSRGQEVY-----VKKTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCG-----MTCAE 234 (309)
T ss_dssp CEEECCTTCEESSCEE-----CCC----CCTTTCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCTTTT-----CCHHH
T ss_pred ceEEcccccccccccc-----ccccceecCCcccchHHhccCCCCccceeehhHHHHHHHHhcCCCCCCC-----CCHHH
Confidence 9999999998754421 12234457889999999999999999999999999999999765 4532 22222
Q ss_pred HHHHHHHHHhcCccCcccccCccccchhhHhHHHHHHHHHHHHHHHHhcCCCCCCCCChhhhhcC
Q 038766 235 LRQLVEKALANGINGVRQITDPKLVSSIYEEQEQHQVLEELFKLALVCTSSNPEDRPNMNELLIT 299 (299)
Q Consensus 235 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rpt~~~il~~ 299 (299)
+ +.... .+. .... +..+++++.+||.+||..||++|||+++|+++
T Consensus 235 ~---~~~i~-~~~----~~~~------------~~~~~~~~~~li~~cl~~dP~~RPs~~eil~~ 279 (309)
T d1fvra_ 235 L---YEKLP-QGY----RLEK------------PLNCDDEVYDLMRQCWREKPYERPSFAQILVS 279 (309)
T ss_dssp H---HHHGG-GTC----CCCC------------CTTBCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred H---HHHHH-hcC----CCCC------------CccCCHHHHHHHHHHcCCChhHCcCHHHHHHH
Confidence 2 22211 110 0000 12345689999999999999999999999864
|
| >d1t46a_ d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-KIT receptor species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=4.1e-49 Score=331.21 Aligned_cols=264 Identities=22% Similarity=0.322 Sum_probs=206.0
Q ss_pred HHHHHHhCCCCCCceeecCCcceEEEEEe------CCCcEEEEEEeccCcCChhhhHHHHHHHHHHHhc-CCcceeeeee
Q 038766 5 TEIENATGSFSENNIIGNSNLSTVYKGRL------EDGEIVAVKKLNFHQFSAESDKSFYREAKTLKEL-KHRNLVKVLG 77 (299)
Q Consensus 5 ~~~~~~~~~y~~~~~lg~g~~~~v~~~~~------~~~~~~~vK~~~~~~~~~~~~~~~~~e~~~l~~l-~h~~i~~~~~ 77 (299)
.+||.-.++|.+.+.||+|+||.||+|++ .+++.||||++... ........+.+|+.+++++ +||||+++++
T Consensus 16 ~~~~~~~~~~~l~~~iG~G~fg~Vy~a~~~~~~~~~~~~~vAvK~i~~~-~~~~~~~~~~~E~~~~~~l~~HpnIv~~~g 94 (311)
T d1t46a_ 16 HKWEFPRNRLSFGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPS-AHLTEREALMSELKVLSYLGNHMNIVNLLG 94 (311)
T ss_dssp GGGBCCGGGEEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTT-CCHHHHHHHHHHHHHHHHHCCCTTBCCEEE
T ss_pred ccccCCHHHeEEeeEEeecCCeEEEEEEEeccccCCCCeEEEEEEECcc-cCHHHHHHHHHHHHHHHhccCCCCEEEEEE
Confidence 45777789999999999999999999975 24678999999743 3445566788999999999 5999999999
Q ss_pred EEEcCCCeeEEEEeecCCCChHHHhcCCC--------------CCCCCCChhhHHHHHHHHHHHHHHhhcCCCCCeeeec
Q 038766 78 YAWESGKLKALILEYMENGSLESVIHGPG--------------VDHSRWTLPKRIDVLISVANGLDYLHSGYDIPIVHCD 143 (299)
Q Consensus 78 ~~~~~~~~~~lv~e~~~~~~L~~~~~~~~--------------~~~~~~~~~~~~~i~~qi~~~l~~lh~~~~~~~~H~d 143 (299)
++.. +...++||||+++++|.+++.... .....+++..+..++.||+.||+|||++ +++|||
T Consensus 95 ~~~~-~~~~~lvmE~~~~g~l~~~l~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~gl~~LH~~---~ivHrD 170 (311)
T d1t46a_ 95 ACTI-GGPTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALDLEDLLSFSYQVAKGMAFLASK---NCIHRD 170 (311)
T ss_dssp EECS-SSSCEEEEECCTTEEHHHHHHHTTTTC--------------CCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSC
T ss_pred EEee-CCEEEEEEEcCCCCCHHHHHHhccccccccccccccccccccCCCHHHHHHHHHHHHHHHHHHHhC---Ceeecc
Confidence 7655 445699999999999999885432 1234689999999999999999999999 999999
Q ss_pred ccCCceeeCCCCcEEEeeeccccccccccccccccccccccCcccCChhhhcccCcCccccchhhhHHHHHHHhCCCCCC
Q 038766 144 MKPSNILLDRDFEAHVSDFGTSRMLDVHLQDLSSLSTAFQGTIGYLAPEFAYMRIVTTKVDVFSFGIVVMEFLTKRRPTG 223 (299)
Q Consensus 144 l~~~nil~~~~~~v~l~df~~~~~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~DiwslG~~l~~l~~g~~p~~ 223 (299)
|||+||+++.++.++++|||.+....... .........+|+.|+|||.+.+..++.++|||||||++|+|+++..|+.
T Consensus 171 LKp~NIl~~~~~~~ki~DfG~~~~~~~~~--~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DIwS~G~~l~ellt~g~p~~ 248 (311)
T d1t46a_ 171 LAARNILLTHGRITKICDFGLARDIKNDS--NYVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGIFLWELFSLGSSPY 248 (311)
T ss_dssp CSGGGEEEETTTEEEECCCGGGSCTTSCT--TSEECSSSEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCSS
T ss_pred cccccccccccCcccccccchheeccCCC--cceEeeecccChHHcCHHHhcCCCCCCcccccchHHHHHHHHhCCCCCC
Confidence 99999999999999999999998654211 1223345678999999999999999999999999999999999555543
Q ss_pred CCccCCCCchhHHHHHHHHHhcCccCcccccCccccchhhHhHHHHHHHHHHHHHHHHhcCCCCCCCCChhhhhc
Q 038766 224 LDEENGLSPISLRQLVEKALANGINGVRQITDPKLVSSIYEEQEQHQVLEELFKLALVCTSSNPEDRPNMNELLI 298 (299)
Q Consensus 224 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rpt~~~il~ 298 (299)
..... ...+...+.. +.... . +...+.++.+||.+||..||++|||+++|++
T Consensus 249 ~~~~~---~~~~~~~i~~----~~~~~----~------------~~~~~~~l~~Li~~cl~~dP~~RPs~~~il~ 300 (311)
T d1t46a_ 249 PGMPV---DSKFYKMIKE----GFRML----S------------PEHAPAEMYDIMKTCWDADPLKRPTFKQIVQ 300 (311)
T ss_dssp TTCCS---SHHHHHHHHH----TCCCC----C------------CTTSCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred CCCCH---HHHHHHHHhc----CCCCC----C------------cccccHHHHHHHHHHcCCChhHCcCHHHHHH
Confidence 22111 1122222221 11010 0 1223467999999999999999999999875
|
| >d2gfsa1 d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase p38 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.9e-49 Score=337.07 Aligned_cols=268 Identities=22% Similarity=0.262 Sum_probs=200.5
Q ss_pred HhCCCCCCceeecCCcceEEEEEe-CCCcEEEEEEeccCcCChhhhHHHHHHHHHHHhcCCcceeeeeeEEEcC-----C
Q 038766 10 ATGSFSENNIIGNSNLSTVYKGRL-EDGEIVAVKKLNFHQFSAESDKSFYREAKTLKELKHRNLVKVLGYAWES-----G 83 (299)
Q Consensus 10 ~~~~y~~~~~lg~g~~~~v~~~~~-~~~~~~~vK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~-----~ 83 (299)
+.++|++.+.||+|+||+||+|.+ .+|+.||||++..........+.+.+|+++++.++|||++++++++... .
T Consensus 16 ~~~rY~i~~~LG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~Ei~il~~l~h~~iv~~~~~~~~~~~~~~~ 95 (348)
T d2gfsa1 16 VPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEF 95 (348)
T ss_dssp EETTEEEEEECGGGTTSSEEEEEETTTTEEEEEEECSCTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCSSTTTC
T ss_pred CCCCeEEEEEEecCCCeEEEEEEECCCCCEEEEEEECchhcChHHHHHHHHHHHHHHhcCCCCeeeEEEEEeeccccccC
Confidence 468999999999999999999987 4699999999987666667778899999999999999999999977532 2
Q ss_pred CeeEEEEeecCCCChHHHhcCCCCCCCCCChhhHHHHHHHHHHHHHHhhcCCCCCeeeecccCCceeeCCCCcEEEeeec
Q 038766 84 KLKALILEYMENGSLESVIHGPGVDHSRWTLPKRIDVLISVANGLDYLHSGYDIPIVHCDMKPSNILLDRDFEAHVSDFG 163 (299)
Q Consensus 84 ~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lh~~~~~~~~H~dl~~~nil~~~~~~v~l~df~ 163 (299)
.. +++++++.+++|.+++. ..++++.+++.++.||+.||+|||++ +++||||||+||+++.+|.++++|||
T Consensus 96 ~~-~~i~~~~~gg~L~~~~~-----~~~l~e~~~~~i~~qil~aL~~LH~~---giiHrDiKp~NILi~~~~~~kl~dfg 166 (348)
T d2gfsa1 96 ND-VYLVTHLMGADLNNIVK-----CQKLTDDHVQFLIYQILRGLKYIHSA---DIIHRDLKPSNLAVNEDCELKILDFG 166 (348)
T ss_dssp CC-CEEEEECCSEEHHHHHT-----TCCCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEECTTCCEEECCC-
T ss_pred ce-EEEEEeecCCchhhhcc-----cccccHHHHHHHHHHHHHHHHHHHhC---CCcccccCCccccccccccccccccc
Confidence 33 45566677899999995 34799999999999999999999999 99999999999999999999999999
Q ss_pred cccccccccccccccccccccCcccCChhhhccc-CcCccccchhhhHHHHHHHhCCCCCCCCccCCCCchhHHHHHHHH
Q 038766 164 TSRMLDVHLQDLSSLSTAFQGTIGYLAPEFAYMR-IVTTKVDVFSFGIVVMEFLTKRRPTGLDEENGLSPISLRQLVEKA 242 (299)
Q Consensus 164 ~~~~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~-~~~~~~DiwslG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~ 242 (299)
.+.... .......+++.|+|||...+. .++.++|||||||++|+|++|..||.... .......+...
T Consensus 167 ~a~~~~-------~~~~~~~g~~~y~apE~~~~~~~~~~~~DiwSlGv~l~~ll~g~~pF~~~~-----~~~~~~~i~~~ 234 (348)
T d2gfsa1 167 LARHTD-------DEMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTD-----HIDQLKLILRL 234 (348)
T ss_dssp ---CCT-------GGGSSSCHHHHTSCHHHHTTCSCCCTTHHHHHHHHHHHHHHHSSCSCCCSS-----HHHHHHHHHHH
T ss_pred hhcccC-------cccccccccccccCchhhcCCccCCcccchhhhhHHHHHHHhCCCCCCCCC-----HHHHHHHHHHh
Confidence 987543 233455688999999987665 46889999999999999999999995431 11111111111
Q ss_pred HhcCccCcccccC-----------ccccchhhHhHHHHHHHHHHHHHHHHhcCCCCCCCCChhhhhcC
Q 038766 243 LANGINGVRQITD-----------PKLVSSIYEEQEQHQVLEELFKLALVCTSSNPEDRPNMNELLIT 299 (299)
Q Consensus 243 ~~~~~~~~~~~~~-----------~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rpt~~~il~~ 299 (299)
............. ...... ........+++++.+||++||..||++|||++|+|+|
T Consensus 235 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~s~~~~dli~~mL~~dP~~R~ta~elL~H 301 (348)
T d2gfsa1 235 VGTPGAELLKKISSESARNYIQSLTQMPKM-NFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAH 301 (348)
T ss_dssp HCCCCHHHHTTCCCHHHHHHHTTSCCCCCC-CHHHHSTTCCHHHHHHHHHHSCSSGGGSCCHHHHHTS
T ss_pred cCCCChHHhhhccchhhhhhhhhcccCCCc-chhhhcCCCCHHHHHHHHHHCcCChhhCcCHHHHhcC
Confidence 1110000000000 000000 0001123456789999999999999999999999987
|
| >d1vzoa_ d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5, Msk1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Ribosomal protein S6 kinase alpha 5, Msk1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.1e-49 Score=332.82 Aligned_cols=255 Identities=23% Similarity=0.302 Sum_probs=201.4
Q ss_pred CCCCCCceeecCCcceEEEEEe----CCCcEEEEEEeccCcC--ChhhhHHHHHHHHHHHhcCC-cceeeeeeEEEcCCC
Q 038766 12 GSFSENNIIGNSNLSTVYKGRL----EDGEIVAVKKLNFHQF--SAESDKSFYREAKTLKELKH-RNLVKVLGYAWESGK 84 (299)
Q Consensus 12 ~~y~~~~~lg~g~~~~v~~~~~----~~~~~~~vK~~~~~~~--~~~~~~~~~~e~~~l~~l~h-~~i~~~~~~~~~~~~ 84 (299)
++|++.+.||+|+||+||+|.+ .+|+.||||++..... .....+.+.+|++++++++| |||+++++++.. ..
T Consensus 24 ~~y~~~~~IG~G~fg~Vy~~~~~~~~~~g~~vAvK~i~~~~~~~~~~~~~~~~~E~~il~~l~h~pnIv~~~~~~~~-~~ 102 (322)
T d1vzoa_ 24 ENFELLKVLGTGAYGKVFLVRKISGHDTGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSPFLVTLHYAFQT-ET 102 (322)
T ss_dssp GGEEEEEEEEETTTEEEEEEEECSSTTTTCEEEEEEESEEEEEEEESSGGGCCCHHHHHHHHHTCTTBCCEEEEEEE-TT
T ss_pred hceEEEEEEecCCCeEEEEEEECccCCCCcEEEEEEEehHHhccchHHHHHHHHHHHHHHhccCCCeEEEeeeeecc-CC
Confidence 6799999999999999999975 2478999999865432 22345678899999999987 899999996655 45
Q ss_pred eeEEEEeecCCCChHHHhcCCCCCCCCCChhhHHHHHHHHHHHHHHhhcCCCCCeeeecccCCceeeCCCCcEEEeeecc
Q 038766 85 LKALILEYMENGSLESVIHGPGVDHSRWTLPKRIDVLISVANGLDYLHSGYDIPIVHCDMKPSNILLDRDFEAHVSDFGT 164 (299)
Q Consensus 85 ~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lh~~~~~~~~H~dl~~~nil~~~~~~v~l~df~~ 164 (299)
..++++||+.+++|.+.+. ....+++..++.++.||+.||+|+|++ +++||||||+||+++.+|.++|+|||+
T Consensus 103 ~~~~v~e~~~~~~L~~~i~----~~~~~~e~~~~~~~~Qi~~al~~lH~~---~ivHrDiKp~Nill~~~~~vkL~DFG~ 175 (322)
T d1vzoa_ 103 KLHLILDYINGGELFTHLS----QRERFTEHEVQIYVGEIVLALEHLHKL---GIIYRDIKLENILLDSNGHVVLTDFGL 175 (322)
T ss_dssp EEEEEECCCCSCBHHHHHH----HHSCCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEECTTSCEEESCSSE
T ss_pred ceeeeeecccccHHHHHHH----hcccccHHHHHHHHHHHHHHHHHhhcC---CEEeccCCccceeecCCCCEEEeeccc
Confidence 6699999999999999987 556789999999999999999999999 999999999999999999999999999
Q ss_pred ccccccccccccccccccccCcccCChhhhccc--CcCccccchhhhHHHHHHHhCCCCCCCCccCCCCchhHHHHHHHH
Q 038766 165 SRMLDVHLQDLSSLSTAFQGTIGYLAPEFAYMR--IVTTKVDVFSFGIVVMEFLTKRRPTGLDEENGLSPISLRQLVEKA 242 (299)
Q Consensus 165 ~~~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~--~~~~~~DiwslG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~ 242 (299)
+..+.. ..........+++.|++||.+.+. .++.++|||||||++|+|++|..||........ ........
T Consensus 176 a~~~~~---~~~~~~~~~~g~~~~~~pe~~~~~~~~~~~ksDIWSlG~iLyelltG~~PF~~~~~~~~----~~~i~~~~ 248 (322)
T d1vzoa_ 176 SKEFVA---DETERAYDFCGTIEYMAPDIVRGGDSGHDKAVDWWSLGVLMYELLTGASPFTVDGEKNS----QAEISRRI 248 (322)
T ss_dssp EEECCG---GGGGGGCGGGSCCTTCCHHHHTTCC---CTHHHHHHHHHHHHHHHHSSCTTSCTTSCCC----HHHHHHHH
T ss_pred hhhhcc---cccccccccccccccchhHHhhcCCcCCCchhhhHHHHHHHHHHHhCCCCCCCCCHHHH----HHHHHHhc
Confidence 976542 222334456788999999988754 467899999999999999999999965432221 11121111
Q ss_pred HhcCccCcccccCccccchhhHhHHHHHHHHHHHHHHHHhcCCCCCCCC-----ChhhhhcC
Q 038766 243 LANGINGVRQITDPKLVSSIYEEQEQHQVLEELFKLALVCTSSNPEDRP-----NMNELLIT 299 (299)
Q Consensus 243 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rp-----t~~~il~~ 299 (299)
.... ... +...++++.+||++||..||++|| |++|+++|
T Consensus 249 ~~~~-~~~-----------------~~~~s~~~~~li~~~l~~dP~~R~s~~~~t~~eil~H 292 (322)
T d1vzoa_ 249 LKSE-PPY-----------------PQEMSALAKDLIQRLLMKDPKKRLGCGPRDADEIKEH 292 (322)
T ss_dssp HHCC-CCC-----------------CTTSCHHHHHHHHHHTCSSGGGSTTSSTTTHHHHHTS
T ss_pred ccCC-CCC-----------------cccCCHHHHHHHHHHcccCHHHcCCCCcccHHHHHcC
Confidence 1111 000 223467899999999999999999 58999987
|
| >d1p4oa_ d.144.1.7 (A:) Insulin-like growth factor 1 receptor {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Insulin-like growth factor 1 receptor species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=4.1e-49 Score=330.58 Aligned_cols=263 Identities=26% Similarity=0.387 Sum_probs=206.5
Q ss_pred hHHHHHHhCCCCCCceeecCCcceEEEEEeC------CCcEEEEEEeccCcCChhhhHHHHHHHHHHHhcCCcceeeeee
Q 038766 4 RTEIENATGSFSENNIIGNSNLSTVYKGRLE------DGEIVAVKKLNFHQFSAESDKSFYREAKTLKELKHRNLVKVLG 77 (299)
Q Consensus 4 ~~~~~~~~~~y~~~~~lg~g~~~~v~~~~~~------~~~~~~vK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~ 77 (299)
.++||+-.++|.+.+.||+|+||+||+|.+. ++..||||+++.. ........+.+|+.++++++||||+++++
T Consensus 12 ~~~~ei~~~~~~l~~~lG~G~fG~Vy~a~~~~~~~~~~~~~VAvK~~~~~-~~~~~~~~~~~E~~il~~l~h~nIv~~~~ 90 (308)
T d1p4oa_ 12 PDEWEVAREKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEA-ASMRERIEFLNEASVMKEFNCHHVVRLLG 90 (308)
T ss_dssp CCTTBCCGGGEEEEEEEEECSSSEEEEEEEEEEETTEEEEEEEEEECCTT-SCHHHHHHHHHHHHHGGGCCCTTBCCEEE
T ss_pred ccceeecHHHeEEeeEEeeCCCeEEEEEEECCcccCCCCcEEEEEEECcc-cChHHHHHHHHHHHHHHHcCCCCEeeeee
Confidence 3567888899999999999999999999763 2578999998643 34455667899999999999999999999
Q ss_pred EEEcCCCeeEEEEeecCCCChHHHhcCC------CCCCCCCChhhHHHHHHHHHHHHHHhhcCCCCCeeeecccCCceee
Q 038766 78 YAWESGKLKALILEYMENGSLESVIHGP------GVDHSRWTLPKRIDVLISVANGLDYLHSGYDIPIVHCDMKPSNILL 151 (299)
Q Consensus 78 ~~~~~~~~~~lv~e~~~~~~L~~~~~~~------~~~~~~~~~~~~~~i~~qi~~~l~~lh~~~~~~~~H~dl~~~nil~ 151 (299)
++.. ....++|+||+.+|+|.+++... ......++...+..++.|+++||.|||++ +++||||||+|||+
T Consensus 91 ~~~~-~~~~~lv~e~~~~g~l~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~ia~gl~~LH~~---~ivHrDlk~~NiLl 166 (308)
T d1p4oa_ 91 VVSQ-GQPTLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQMAGEIADGMAYLNAN---KFVHRDLAARNCMV 166 (308)
T ss_dssp EECS-SSSCEEEEECCTTCBHHHHHHHHHHHHHHCTTCCCCCHHHHHHHHHHHHHHHHHHHHT---TCBCSCCSGGGEEE
T ss_pred EEec-CCceeEEEeecCCCCHHHHHHhcccccccccccCCCCHHHHHHHHHHHHHHHHHHhhC---CeeeceEcCCceee
Confidence 7755 44559999999999999877421 01224578889999999999999999999 99999999999999
Q ss_pred CCCCcEEEeeeccccccccccccccccccccccCcccCChhhhcccCcCccccchhhhHHHHHHHhCC-CCCCCCccCCC
Q 038766 152 DRDFEAHVSDFGTSRMLDVHLQDLSSLSTAFQGTIGYLAPEFAYMRIVTTKVDVFSFGIVVMEFLTKR-RPTGLDEENGL 230 (299)
Q Consensus 152 ~~~~~v~l~df~~~~~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~DiwslG~~l~~l~~g~-~p~~~~~~~~~ 230 (299)
+.++.+||+|||++....... .........+++.|+|||.+.+..++.++||||+|+++|+|++|. .||.. .
T Consensus 167 d~~~~~Kl~DFGla~~~~~~~--~~~~~~~~~~t~~y~aPe~l~~~~~~~~~Dv~S~G~il~El~t~~~~p~~~-----~ 239 (308)
T d1p4oa_ 167 AEDFTVKIGDFGMTRDIYETD--YYRKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQG-----L 239 (308)
T ss_dssp CTTCCEEECCTTCCCGGGGGG--CEEGGGSSEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHHTSCCTTTT-----S
T ss_pred cCCceEEEeecccceeccCCc--ceeeccceecccccCCHHHHccCCCCcccccccHHHHHHHHHhCCCCCCCC-----C
Confidence 999999999999997654321 122233446789999999999999999999999999999999985 55532 2
Q ss_pred CchhHHHHHHHHHhcCccCcccccCccccchhhHhHHHHHHHHHHHHHHHHhcCCCCCCCCChhhhhc
Q 038766 231 SPISLRQLVEKALANGINGVRQITDPKLVSSIYEEQEQHQVLEELFKLALVCTSSNPEDRPNMNELLI 298 (299)
Q Consensus 231 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rpt~~~il~ 298 (299)
...+ .+.......... . +..++..+.++|.+||+.||++|||+++|++
T Consensus 240 ~~~~---~~~~i~~~~~~~-----~------------p~~~~~~l~~li~~cl~~~P~~RPs~~~il~ 287 (308)
T d1p4oa_ 240 SNEQ---VLRFVMEGGLLD-----K------------PDNCPDMLFELMRMCWQYNPKMRPSFLEIIS 287 (308)
T ss_dssp CHHH---HHHHHHTTCCCC-----C------------CTTCCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred CHHH---HHHHHHhCCCCC-----C------------cccchHHHHHHHHHHcCCChhHCcCHHHHHH
Confidence 2222 222222111100 0 1223467999999999999999999999986
|
| >d1ckia_ d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Casein kinase-1, CK1 species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=100.00 E-value=2.2e-47 Score=319.36 Aligned_cols=259 Identities=19% Similarity=0.231 Sum_probs=196.5
Q ss_pred HhCCCCCCceeecCCcceEEEEEe-CCCcEEEEEEeccCcCChhhhHHHHHHHHHHHhcCCcceeeeeeEEEcCCCeeEE
Q 038766 10 ATGSFSENNIIGNSNLSTVYKGRL-EDGEIVAVKKLNFHQFSAESDKSFYREAKTLKELKHRNLVKVLGYAWESGKLKAL 88 (299)
Q Consensus 10 ~~~~y~~~~~lg~g~~~~v~~~~~-~~~~~~~vK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~l 88 (299)
+.++|++.+.||+|+||+||+|.+ .+|+.||||++..+. ....+..|+++++.++|++++..+..+...+...++
T Consensus 5 vg~rY~l~~~iG~G~fG~Vy~a~~~~~~~~vAvK~~~~~~----~~~~~~~E~~i~~~l~~~~~i~~~~~~~~~~~~~~i 80 (299)
T d1ckia_ 5 VGNRYRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKT----KHPQLHIESKIYKMMQGGVGIPTIRWCGAEGDYNVM 80 (299)
T ss_dssp ETTTEEEEEEEEECSSSEEEEEEETTTTEEEEEEEEESCT----TSCCHHHHHHHHHHSTTSTTCCCEEEEEEETTEEEE
T ss_pred ECCEEEEeEEEeeCCCcEEEEEEECCCCCEEEEEEEchhc----cCHHHHHHHHHHHHccCCCcccEEEEEEecCCEEEE
Confidence 467899999999999999999987 468999999986533 233577899999999988877776667777778899
Q ss_pred EEeecCCCChHHHhcCCCCCCCCCChhhHHHHHHHHHHHHHHhhcCCCCCeeeecccCCceeeCC---CCcEEEeeeccc
Q 038766 89 ILEYMENGSLESVIHGPGVDHSRWTLPKRIDVLISVANGLDYLHSGYDIPIVHCDMKPSNILLDR---DFEAHVSDFGTS 165 (299)
Q Consensus 89 v~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lh~~~~~~~~H~dl~~~nil~~~---~~~v~l~df~~~ 165 (299)
|+|++ ++++...+.. ....+++..+..++.|++.||+|||++ +++||||||+||+++. +..++|+|||++
T Consensus 81 vme~~-~~~l~~~~~~---~~~~~~~~~~~~~~~qi~~~l~~lH~~---~iiHrDiKp~NIl~~~~~~~~~vkl~DFG~a 153 (299)
T d1ckia_ 81 VMELL-GPSLEDLFNF---CSRKFSLKTVLLLADQMISRIEYIHSK---NFIHRDVKPDNFLMGLGKKGNLVYIIDFGLA 153 (299)
T ss_dssp EEECC-CCBHHHHHHH---TTTCCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCCGGGEEECCGGGTTCEEECCCSSC
T ss_pred EEEEc-CCchhhhhhh---ccCCCcHHHHHHHHHHHHHHHHHHHHC---CeeeccCCHhhccccccCCCceeeeeccCcc
Confidence 99999 5576665542 345799999999999999999999999 9999999999999864 457999999999
Q ss_pred cccccccccc---cccccccccCcccCChhhhcccCcCccccchhhhHHHHHHHhCCCCCCCCccCCCCchhHHHHHHHH
Q 038766 166 RMLDVHLQDL---SSLSTAFQGTIGYLAPEFAYMRIVTTKVDVFSFGIVVMEFLTKRRPTGLDEENGLSPISLRQLVEKA 242 (299)
Q Consensus 166 ~~~~~~~~~~---~~~~~~~~~~~~y~~PE~~~~~~~~~~~DiwslG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~ 242 (299)
..+....... ........||+.|+|||.+.+..++.++|||||||++|+|++|..||........... ........
T Consensus 154 ~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~~l~el~tg~~P~~~~~~~~~~~~-~~~~~~~~ 232 (299)
T d1ckia_ 154 KKYRDARTHQHIPYRENKNLTGTARYASINTHLGIEQSRRDDLESLGYVLMYFNLGSLPWQGLKAATKRQK-YERISEKK 232 (299)
T ss_dssp EECBCTTTCCBCCCCBCCSCCCCSSSCCHHHHTTBCCCHHHHHHHHHHHHHHHHHSSCTTCCCC--------HHHHHHHH
T ss_pred eeccccccccceeccccCCcCCCccccCHHHHhCCCCCChhhEEecCHHHHHHHhCCCcccccchHHHHHH-HHHhhccc
Confidence 8765322211 1233456789999999999999999999999999999999999999964422211111 00000000
Q ss_pred HhcCccCcccccCccccchhhHhHHHHHHHHHHHHHHHHhcCCCCCCCCChhhhh
Q 038766 243 LANGINGVRQITDPKLVSSIYEEQEQHQVLEELFKLALVCTSSNPEDRPNMNELL 297 (299)
Q Consensus 243 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rpt~~~il 297 (299)
... ........+++++.+++.+||+.+|++|||++++.
T Consensus 233 ~~~-----------------~~~~~~~~~p~~~~~li~~cl~~~p~~RP~~~~i~ 270 (299)
T d1ckia_ 233 MST-----------------PIEVLCKGYPSEFATYLNFCRSLRFDDKPDYSYLR 270 (299)
T ss_dssp HHS-----------------CHHHHTTTSCHHHHHHHHHHHHSCTTCCCCHHHHH
T ss_pred CCC-----------------ChhHhccCCCHHHHHHHHHHccCChhHCcCHHHHH
Confidence 000 00111234567899999999999999999998664
|
| >d1csna_ d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Casein kinase-1, CK1 species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]
Probab=100.00 E-value=6.8e-46 Score=308.91 Aligned_cols=258 Identities=17% Similarity=0.206 Sum_probs=197.8
Q ss_pred HhCCCCCCceeecCCcceEEEEEeC-CCcEEEEEEeccCcCChhhhHHHHHHHHHHHhcCC-cceeeeeeEEEcCCCeeE
Q 038766 10 ATGSFSENNIIGNSNLSTVYKGRLE-DGEIVAVKKLNFHQFSAESDKSFYREAKTLKELKH-RNLVKVLGYAWESGKLKA 87 (299)
Q Consensus 10 ~~~~y~~~~~lg~g~~~~v~~~~~~-~~~~~~vK~~~~~~~~~~~~~~~~~e~~~l~~l~h-~~i~~~~~~~~~~~~~~~ 87 (299)
+.++|++.+.||+|+||+||+|.+. +|+.||||++.... ....+.+|++.++.++| +|++.+++++.. +...+
T Consensus 3 ig~~Y~i~~~iG~G~fG~Vy~a~~~~~~~~vAvK~~~~~~----~~~~~~~e~~~~~~l~~~~~i~~~~~~~~~-~~~~~ 77 (293)
T d1csna_ 3 VGVHYKVGRRIGEGSFGVIFEGTNLLNNQQVAIKFEPRRS----DAPQLRDEYRTYKLLAGCTGIPNVYYFGQE-GLHNV 77 (293)
T ss_dssp ETTTEEEEEEEEECSSCEEEEEEETTTTEEEEEEEEECCT----TSCCHHHHHHHHHHTTTCTTCCCEEEEEEE-TTEEE
T ss_pred CCCceEEEEEEecCCCeEEEEEEECCCCCEEEEEEEcccc----CcHHHHHHHHHHHHhcCCCCCCEEEEEeec-CCccE
Confidence 5789999999999999999999874 68999999885432 23456788999999975 899999886554 56669
Q ss_pred EEEeecCCCChHHHhcCCCCCCCCCChhhHHHHHHHHHHHHHHhhcCCCCCeeeecccCCceeeCC-----CCcEEEeee
Q 038766 88 LILEYMENGSLESVIHGPGVDHSRWTLPKRIDVLISVANGLDYLHSGYDIPIVHCDMKPSNILLDR-----DFEAHVSDF 162 (299)
Q Consensus 88 lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lh~~~~~~~~H~dl~~~nil~~~-----~~~v~l~df 162 (299)
+|||++ +++|.+++.. ....++...+..++.|++.||+|||++ +++||||||+||+++. ++.++|+||
T Consensus 78 ~vme~~-~~~l~~~~~~---~~~~~~~~~~~~i~~q~~~~l~~lH~~---giiHrDiKp~Nili~~~~~~~~~~vkl~DF 150 (293)
T d1csna_ 78 LVIDLL-GPSLEDLLDL---CGRKFSVKTVAMAAKQMLARVQSIHEK---SLVYRDIKPDNFLIGRPNSKNANMIYVVDF 150 (293)
T ss_dssp EEEECC-CCBHHHHHHH---TTTCCCHHHHHHHHHHHHHHHHHHHTT---TEECCCCCGGGEEECCSSSTTTTCEEECCC
T ss_pred EEEEec-CCCHHHHHHh---hccchhhHHHHHHHHHHHHHHHHHHHC---CceeccCCccceeecCcccccCCceEEccc
Confidence 999999 6799988864 235789999999999999999999999 9999999999999964 578999999
Q ss_pred ccccccccccccc---cccccccccCcccCChhhhcccCcCccccchhhhHHHHHHHhCCCCCCCCccCCCCchhHHHHH
Q 038766 163 GTSRMLDVHLQDL---SSLSTAFQGTIGYLAPEFAYMRIVTTKVDVFSFGIVVMEFLTKRRPTGLDEENGLSPISLRQLV 239 (299)
Q Consensus 163 ~~~~~~~~~~~~~---~~~~~~~~~~~~y~~PE~~~~~~~~~~~DiwslG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~ 239 (299)
|++..+....... ........||+.|+|||++.+..++.++|||||||++|+|++|..||...... ........+
T Consensus 151 G~a~~~~~~~~~~~~~~~~~~~~~GT~~y~aPE~~~~~~~~~~~DiwSlG~~l~elltg~~Pf~~~~~~--~~~~~~~~i 228 (293)
T d1csna_ 151 GMVKFYRDPVTKQHIPYREKKNLSGTARYMSINTHLGREQSRRDDLEALGHVFMYFLRGSLPWQGLKAA--TNKQKYERI 228 (293)
T ss_dssp TTCEESBCTTTCCBCCCCCCCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTSSCCSC--CHHHHHHHH
T ss_pred ceeEEcccCccccceeecccCceEEchhhcCHHHhcCCCCChHHHHHHhhHHHHHHHhCCCcCCCccch--hHHHHHHHH
Confidence 9998765322211 12234567999999999999999999999999999999999999999643221 111111111
Q ss_pred HHHHhcCccCcccccCccccchhhHhHHHHHHHHHHHHHHHHhcCCCCCCCCChhhhh
Q 038766 240 EKALANGINGVRQITDPKLVSSIYEEQEQHQVLEELFKLALVCTSSNPEDRPNMNELL 297 (299)
Q Consensus 240 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rpt~~~il 297 (299)
....... . .......+++++.+++..|+..+|++||+.+.+.
T Consensus 229 ~~~~~~~--~--------------~~~l~~~~p~~l~~ii~~~~~~~~~~rP~y~~l~ 270 (293)
T d1csna_ 229 GEKKQST--P--------------LRELCAGFPEEFYKYMHYARNLAFDATPDYDYLQ 270 (293)
T ss_dssp HHHHHHS--C--------------HHHHTTTSCHHHHHHHHHHHHCCTTCCCCHHHHH
T ss_pred HhccCCC--C--------------hHHhcCCCCHHHHHHHHHHhcCCcccCcCHHHHH
Confidence 1100000 0 0011233457899999999999999999987664
|
| >d1q8ya_ d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Sky1p species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]
Probab=100.00 E-value=8.6e-43 Score=299.20 Aligned_cols=271 Identities=18% Similarity=0.198 Sum_probs=190.0
Q ss_pred CCCCCCceeecCCcceEEEEEe-CCCcEEEEEEeccCcCChhhhHHHHHHHHHHHhcC-----------CcceeeeeeEE
Q 038766 12 GSFSENNIIGNSNLSTVYKGRL-EDGEIVAVKKLNFHQFSAESDKSFYREAKTLKELK-----------HRNLVKVLGYA 79 (299)
Q Consensus 12 ~~y~~~~~lg~g~~~~v~~~~~-~~~~~~~vK~~~~~~~~~~~~~~~~~e~~~l~~l~-----------h~~i~~~~~~~ 79 (299)
+||++.+.||+|+||+||+|++ .+|+.||||+++.. ....+...+|+.+++.+. |+||+++++++
T Consensus 13 ~rY~i~~~LG~G~fg~Vy~~~~~~~g~~vAvKvi~~~---~~~~~~~~~Ei~~l~~l~~~~~~~~~~~~~~~iv~~~~~~ 89 (362)
T d1q8ya_ 13 ARYILVRKLGWGHFSTVWLAKDMVNNTHVAMKIVRGD---KVYTEAAEDEIKLLQRVNDADNTKEDSMGANHILKLLDHF 89 (362)
T ss_dssp TTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSC---HHHHHHHHHHHHHHHHHHHTCCSHHHHHHHTTBCCCCEEE
T ss_pred CcEEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEecc---ccchHHHHHHHHHHHHhcchhhhhhhhcCcCceEEEEEEe
Confidence 4699999999999999999987 46999999999642 234456778888888775 47899999876
Q ss_pred EcC-CCeeEEEEeecCCCCh-HHHhcCCCCCCCCCChhhHHHHHHHHHHHHHHhhc-CCCCCeeeecccCCceeeCCCCc
Q 038766 80 WES-GKLKALILEYMENGSL-ESVIHGPGVDHSRWTLPKRIDVLISVANGLDYLHS-GYDIPIVHCDMKPSNILLDRDFE 156 (299)
Q Consensus 80 ~~~-~~~~~lv~e~~~~~~L-~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lh~-~~~~~~~H~dl~~~nil~~~~~~ 156 (299)
... ....++++++...... ....... ....+++..++.++.|++.||+|||+ . +++||||||+|||++.++.
T Consensus 90 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~i~~i~~qil~al~~lh~~~---~IvHrDlKp~NIll~~~~~ 164 (362)
T d1q8ya_ 90 NHKGPNGVHVVMVFEVLGENLLALIKKY--EHRGIPLIYVKQISKQLLLGLDYMHRRC---GIIHTDIKPENVLMEIVDS 164 (362)
T ss_dssp EEEETTEEEEEEEECCCCEEHHHHHHHT--TTSCCCHHHHHHHHHHHHHHHHHHHHTT---CEECSCCSGGGEEEEEEET
T ss_pred eeccccceeeeeeecccccccccccccc--cccCCcHHHHHHHHHHHHHHHHHHhhhc---CcccccCChhHeeeeccCc
Confidence 542 3444566666544332 2222211 55688999999999999999999997 6 9999999999999986653
Q ss_pred ------EEEeeeccccccccccccccccccccccCcccCChhhhcccCcCccccchhhhHHHHHHHhCCCCCCCCccCCC
Q 038766 157 ------AHVSDFGTSRMLDVHLQDLSSLSTAFQGTIGYLAPEFAYMRIVTTKVDVFSFGIVVMEFLTKRRPTGLDEENGL 230 (299)
Q Consensus 157 ------v~l~df~~~~~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~DiwslG~~l~~l~~g~~p~~~~~~~~~ 230 (299)
++++|||.+.... .......+++.|+|||++.+..++.++||||+||++++|++|..||........
T Consensus 165 ~~~~~~~kl~dfg~s~~~~-------~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~el~~g~~pF~~~~~~~~ 237 (362)
T d1q8ya_ 165 PENLIQIKIADLGNACWYD-------EHYTNSIQTREYRSPEVLLGAPWGCGADIWSTACLIFELITGDFLFEPDEGHSY 237 (362)
T ss_dssp TTTEEEEEECCCTTCEETT-------BCCCSCCSCGGGCCHHHHHTCCCCTHHHHHHHHHHHHHHHHSSCCC--------
T ss_pred ccccceeeEeecccccccc-------cccccccccccccChhhccccCCCccccccchHHHHHHHHHCCCCCCCCccccc
Confidence 8999999987543 233455689999999999999999999999999999999999999975433222
Q ss_pred CchhHHHHHHHHH-hcCcc-------------------CcccccCccc--cc--hhhHhHHHHHHHHHHHHHHHHhcCCC
Q 038766 231 SPISLRQLVEKAL-ANGIN-------------------GVRQITDPKL--VS--SIYEEQEQHQVLEELFKLALVCTSSN 286 (299)
Q Consensus 231 ~~~~~~~~~~~~~-~~~~~-------------------~~~~~~~~~~--~~--~~~~~~~~~~~~~~l~~li~~~l~~d 286 (299)
... .+.+.... ..+.. ....+..... .. ...........++++.+||.+||..|
T Consensus 238 ~~~--~~~~~~~~~~lg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~mL~~d 315 (362)
T d1q8ya_ 238 TKD--DDHIAQIIELLGELPSYLLRNGKYTRTFFNSRGLLRNISKLKFWPLEDVLTEKYKFSKDEAKEISDFLSPMLQLD 315 (362)
T ss_dssp -CH--HHHHHHHHHHHCSCCHHHHHHCTTHHHHBCC--CBSSCCCCCBCCHHHHHHHTTCCCHHHHHHHHHHHGGGGCSS
T ss_pred cch--hHHHHHHHHHhCCCCHHHhhcccccccccccchhhhccccccCCchhhhcccccccCcccCHHHHHHHHHHCCCC
Confidence 111 11111100 00000 0000000000 00 00011223567889999999999999
Q ss_pred CCCCCChhhhhcC
Q 038766 287 PEDRPNMNELLIT 299 (299)
Q Consensus 287 P~~Rpt~~~il~~ 299 (299)
|.+|||++|+|+|
T Consensus 316 P~~Rpta~e~L~H 328 (362)
T d1q8ya_ 316 PRKRADAGGLVNH 328 (362)
T ss_dssp TTTCBCHHHHHTC
T ss_pred hhHCcCHHHHhcC
Confidence 9999999999998
|
| >d1zara2 d.144.1.9 (A:91-281) Rio2 serine protein kinase C-terminal domain {Archaeoglobus fulgidus [TaxId: 2234]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: RIO1-like kinases domain: Rio2 serine protein kinase C-terminal domain species: Archaeoglobus fulgidus [TaxId: 2234]
Probab=99.92 E-value=2.9e-25 Score=172.30 Aligned_cols=165 Identities=21% Similarity=0.184 Sum_probs=119.4
Q ss_pred CCCCceeecCCcceEEEEEeCCCcEEEEEEeccCcCC----------------hhhhHHHHHHHHHHHhcCCcceeeeee
Q 038766 14 FSENNIIGNSNLSTVYKGRLEDGEIVAVKKLNFHQFS----------------AESDKSFYREAKTLKELKHRNLVKVLG 77 (299)
Q Consensus 14 y~~~~~lg~g~~~~v~~~~~~~~~~~~vK~~~~~~~~----------------~~~~~~~~~e~~~l~~l~h~~i~~~~~ 77 (299)
+.+.++||+|+||+||+|.+.+|+.||||+++..... .........|...+.++.|.+++..++
T Consensus 2 ~~vg~~IG~G~~g~Vy~a~~~~g~~vAvKi~r~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~v~~~~~ 81 (191)
T d1zara2 2 DAIGKLMGEGKESAVFNCYSEKFGECVVKFHKVGHTSFKKVKEKRDYGDLHFSVLAIRSARNEFRALQKLQGLAVPKVYA 81 (191)
T ss_dssp SEEEEEEEECSSEEEEEEEETTTEEEEEEEECC------CCCC-------CHHHHHHHHHHHHHHHHHHTTTSSSCCEEE
T ss_pred chhCCEeeeCcceEEEEEECCCCCEEEEEEEecccchhhhhhhhhhhccHHHHHHHHHHHHHHHHHHHHccCCCcceEEE
Confidence 3567899999999999999888999999987632211 011233456888999999999988876
Q ss_pred EEEcCCCeeEEEEeecCCCChHHHhcCCCCCCCCCChhhHHHHHHHHHHHHHHhhcCCCCCeeeecccCCceeeCCCCcE
Q 038766 78 YAWESGKLKALILEYMENGSLESVIHGPGVDHSRWTLPKRIDVLISVANGLDYLHSGYDIPIVHCDMKPSNILLDRDFEA 157 (299)
Q Consensus 78 ~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lh~~~~~~~~H~dl~~~nil~~~~~~v 157 (299)
.. . .+++||++++..+. .+++..+..++.|++.++++||+. +++|+||||+|||++.++ +
T Consensus 82 ~~---~--~~lvme~~~~~~~~-----------~l~~~~~~~i~~ql~~~l~~lH~~---giiHrDiKP~NILv~~~~-~ 141 (191)
T d1zara2 82 WE---G--NAVLMELIDAKELY-----------RVRVENPDEVLDMILEEVAKFYHR---GIVHGDLSQYNVLVSEEG-I 141 (191)
T ss_dssp EE---T--TEEEEECCCCEEGG-----------GCCCSCHHHHHHHHHHHHHHHHHT---TEECSCCSTTSEEEETTE-E
T ss_pred ec---C--CEEEEEeecccccc-----------chhhHHHHHHHHHHHHHHHHHhhC---CEEEccCChhheeeeCCC-E
Confidence 32 2 27999999765432 345566788999999999999999 999999999999998664 8
Q ss_pred EEeeeccccccccccccccccccccccCcccCChh-----hhcccCcCccccchhhhH
Q 038766 158 HVSDFGTSRMLDVHLQDLSSLSTAFQGTIGYLAPE-----FAYMRIVTTKVDVFSFGI 210 (299)
Q Consensus 158 ~l~df~~~~~~~~~~~~~~~~~~~~~~~~~y~~PE-----~~~~~~~~~~~DiwslG~ 210 (299)
+|+|||.+........ ..|.... .+....|+.++|+||+.-
T Consensus 142 ~liDFG~a~~~~~~~~------------~~~l~rd~~~~~~~f~r~y~~~~d~~s~~~ 187 (191)
T d1zara2 142 WIIDFPQSVEVGEEGW------------REILERDVRNIITYFSRTYRTEKDINSAID 187 (191)
T ss_dssp EECCCTTCEETTSTTH------------HHHHHHHHHHHHHHHHHHHCCCCCHHHHHH
T ss_pred EEEECCCcccCCCCCc------------HHHHHHHHHHHHHHHcCCCCCcccHHHHHH
Confidence 8999998865431100 0111100 122456789999999753
|
| >d1j7la_ d.144.1.6 (A:) Type IIIa 3',5"-aminoglycoside phosphotransferase {Enterococcus faecalis [TaxId: 1351]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: Type IIIa 3',5"-aminoglycoside phosphotransferase species: Enterococcus faecalis [TaxId: 1351]
Probab=98.84 E-value=1.7e-08 Score=80.47 Aligned_cols=149 Identities=17% Similarity=0.125 Sum_probs=99.6
Q ss_pred HHHHHHhCCCCCCceeecCCcceEEEEEeCCCcEEEEEEeccCcCChhhhHHHHHHHHHHHhcC-CcceeeeeeEEEcCC
Q 038766 5 TEIENATGSFSENNIIGNSNLSTVYKGRLEDGEIVAVKKLNFHQFSAESDKSFYREAKTLKELK-HRNLVKVLGYAWESG 83 (299)
Q Consensus 5 ~~~~~~~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~vK~~~~~~~~~~~~~~~~~e~~~l~~l~-h~~i~~~~~~~~~~~ 83 (299)
+++....+.|++++..+.++.+.||++... +..+++|.... ........+..|...++.+. +--+.+++.+... +
T Consensus 7 ~~l~~~~~~~~~~~~~~G~s~~~v~rv~~~-~~~~vlk~~~~--~~~~~~~~~~~E~~~l~~l~~~vpvP~vl~~~~~-~ 82 (263)
T d1j7la_ 7 PELKKLIEKYRCVKDTEGMSPAKVYKLVGE-NENLYLKMTDS--RYKGTTYDVEREKDMMLWLEGKLPVPKVLHFERH-D 82 (263)
T ss_dssp HHHHHHHTTSEEEECSCCCSSSEEEEEECS-SCEEEEEEECG--GGTTSTTCHHHHHHHHHHHTTTSCCCCEEEEEEE-T
T ss_pred HHHHHhhhceEEEEcCCCCCCCcEEEEEeC-CCeEEEEEcCC--CcccchhhHHHHHHHHHHHhccCCCCcEEEEEec-C
Confidence 467777889998887766666789998754 56678887642 22223445677888887775 3224455554433 4
Q ss_pred CeeEEEEeecCCCChHHHhcCCCCCCCCCChhhHHHHHHHHHHHHHHhhcCC----------------------------
Q 038766 84 KLKALILEYMENGSLESVIHGPGVDHSRWTLPKRIDVLISVANGLDYLHSGY---------------------------- 135 (299)
Q Consensus 84 ~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lh~~~---------------------------- 135 (299)
...++|+++++|.++.+... +......++.++...++.||+..
T Consensus 83 ~~~~lv~~~l~G~~~~~~~~---------~~~~~~~~~~~l~~~l~~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 153 (263)
T d1j7la_ 83 GWSNLLMSEADGVLCSEEYE---------DEQSPEKIIELYAECIRLFHSIDISDCPYTNSLDSRLAELDYLLNNDLADV 153 (263)
T ss_dssp TEEEEEEECCSSEEHHHHTT---------TCSCHHHHHHHHHHHHHHHHTSCCTTCSCBCCHHHHHHHHHHHHHTTCSCC
T ss_pred CceEEEEEeccccccccccc---------ccccHHHHHHHHHHHHHHHhccCccccccCcchhhhhhhHHHHHHHHhhhh
Confidence 55689999999888766542 11123344556666666676531
Q ss_pred ----------------------------CCCeeeecccCCceeeCCCCcEEEeeecccc
Q 038766 136 ----------------------------DIPIVHCDMKPSNILLDRDFEAHVSDFGTSR 166 (299)
Q Consensus 136 ----------------------------~~~~~H~dl~~~nil~~~~~~v~l~df~~~~ 166 (299)
...++|+|+.|.||+++.++.+-|+||+.+.
T Consensus 154 ~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~l~HgD~~~~Nil~~~~~~~~lIDwe~a~ 212 (263)
T d1j7la_ 154 DCENWEEDTPFKDPRELYDFLKTEKPEEELVFSHGDLGDSNIFVKDGKVSGFIDLGRSG 212 (263)
T ss_dssp CGGGGSTTCSCSSHHHHHHHHHHSCCCCCEEEECSCCCTTSEEEETTEEEEECCCTTCE
T ss_pred hhhcccccccchHHHHHHHHHHhcCCcCCcEEEEeeccCcceeecCCceEEEeechhcc
Confidence 0127999999999999877666799999775
|
| >d1nd4a_ d.144.1.6 (A:) Aminoglycoside 3'-phosphotransferase IIa (Kanamycin kinase) {Bacteria (Klebsiella pneumoniae) [TaxId: 573]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: Aminoglycoside 3'-phosphotransferase IIa (Kanamycin kinase) species: Bacteria (Klebsiella pneumoniae) [TaxId: 573]
Probab=98.30 E-value=2.1e-06 Score=67.50 Aligned_cols=130 Identities=18% Similarity=0.111 Sum_probs=82.6
Q ss_pred eeecCCc-ceEEEEEeCCCcEEEEEEeccCcCChhhhHHHHHHHHHHHhcCCcc--eeeeeeEEEcCCCeeEEEEeecCC
Q 038766 19 IIGNSNL-STVYKGRLEDGEIVAVKKLNFHQFSAESDKSFYREAKTLKELKHRN--LVKVLGYAWESGKLKALILEYMEN 95 (299)
Q Consensus 19 ~lg~g~~-~~v~~~~~~~~~~~~vK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~--i~~~~~~~~~~~~~~~lv~e~~~~ 95 (299)
.+..|.. +.||++...++..+++|.... .....+..|...++.+.... +.+++.+..+ +...++|+++++|
T Consensus 17 ~~~~G~s~~~v~r~~~~~~~~~vlK~~~~-----~~~~~l~~E~~~l~~L~~~gvpvP~v~~~~~~-~~~~~~v~~~i~G 90 (255)
T d1nd4a_ 17 QQTIGCSDAAVFRLSAQGRPVLFVKTDLS-----GALNELQDEAARLSWLATTGVPCAAVLDVVTE-AGRDWLLLGEVPG 90 (255)
T ss_dssp ECSCTTSSCEEEEEECTTSCCEEEEEECS-----CTTSCHHHHHHHHHHHHTTTCCBCCEEEEEEC-SSCEEEEEECCSS
T ss_pred EcCCcccCCeEEEEEeCCCCEEEEEeCCc-----cCHhHHHHHHHHHHHHHhcCCCCCceeeeccc-ccceEEEEEeeec
Confidence 4445554 678999988888899997642 22335677788887775322 4556664444 4455899999987
Q ss_pred CChHHHhcCCCCCCCCCChhhHHHHHHHHHHHHHHhhcCC----------------------------------------
Q 038766 96 GSLESVIHGPGVDHSRWTLPKRIDVLISVANGLDYLHSGY---------------------------------------- 135 (299)
Q Consensus 96 ~~L~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lh~~~---------------------------------------- 135 (299)
.++.+.. ... ...+.++...|+.||+..
T Consensus 91 ~~~~~~~---------~~~---~~~~~~l~~~la~LH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 158 (255)
T d1nd4a_ 91 QDLLSSH---------LAP---AEKVSIMADAMRRLHTLDPATCPFDHQAKHRIERARTRMEAGLVDQDDLDEEHQGLAP 158 (255)
T ss_dssp EETTTSC---------CCH---HHHHHHHHHHHHHHTTSCGGGCCCBCCHHHHHHHHHHHHHTTCCCTTSCCGGGTTCCH
T ss_pred ccccccc---------ccH---HHHHHHHHHHHHHHccCChhhCCCcccchhhHHHHHHHHHHhhhccccccchhhhhHH
Confidence 6543211 111 112234444444444310
Q ss_pred ---------------CCCeeeecccCCceeeCCCCcEEEeeecccc
Q 038766 136 ---------------DIPIVHCDMKPSNILLDRDFEAHVSDFGTSR 166 (299)
Q Consensus 136 ---------------~~~~~H~dl~~~nil~~~~~~v~l~df~~~~ 166 (299)
+..++|+|+.|.||+++.++.+-|+||+.+.
T Consensus 159 ~~~~~~l~~~~~~~~~~~liHgD~~~~Nvl~~~~~~~~iID~~~~~ 204 (255)
T d1nd4a_ 159 AELFARLKARMPDGEDLVVTHGDACLPNIMVENGRFSGFIDCGRLG 204 (255)
T ss_dssp HHHHHHHHHTCCSSCCEEEECSSCCGGGEEEETTEEEEECCCTTCE
T ss_pred HHHHHHHHHhCCccCCceEEeCCCCCcceEEeCCceEEEEEchhcc
Confidence 1238999999999999887667799999764
|
| >d2pula1 d.144.1.6 (A:5-396) Methylthioribose kinase MtnK {Bacillus subtilis [TaxId: 1423]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: Methylthioribose kinase MtnK species: Bacillus subtilis [TaxId: 1423]
Probab=98.10 E-value=7e-06 Score=68.86 Aligned_cols=78 Identities=14% Similarity=0.079 Sum_probs=49.0
Q ss_pred CceeecCCcceEEEEEeCC-CcEEEEEEeccC-----cCChhhhHHHHHHHHHHHhcC-C-c-ceeeeeeEEEcCCCeeE
Q 038766 17 NNIIGNSNLSTVYKGRLED-GEIVAVKKLNFH-----QFSAESDKSFYREAKTLKELK-H-R-NLVKVLGYAWESGKLKA 87 (299)
Q Consensus 17 ~~~lg~g~~~~v~~~~~~~-~~~~~vK~~~~~-----~~~~~~~~~~~~e~~~l~~l~-h-~-~i~~~~~~~~~~~~~~~ 87 (299)
.+.||.|....||++...+ ++.+++|.-... ...+....++..|...++.+. + | .+.+++. ++... .+
T Consensus 31 ~~eig~G~~N~vfrV~~~~~~~svivKqa~p~~r~~g~~~~~~~~R~~~E~~~L~~~~~~~p~~vP~v~~--~d~~~-~~ 107 (392)
T d2pula1 31 CQEIGDGNLNYVFHIYDQEHDRALIIKQAVPYAKVVGESWPLTIDRARIESSALIRQGEHVPHLVPRVFY--SDTEM-AV 107 (392)
T ss_dssp EEECCSSSSEEEEEEEC----CEEEEEEECCGGGC--CCCCCCTTHHHHHHHHHHHHHTTCGGGSCCEEE--EETTT-TE
T ss_pred EEEeCCCceEeEEEEEeCCCCeEEEEecCCchhcccCCCCCCCHHHHHHHHHHHHHhhhhCCCCcceEEE--EcCCC-CE
Confidence 5578999999999998654 678999964321 112234556777888888774 2 3 3445554 23333 37
Q ss_pred EEEeecCCCC
Q 038766 88 LILEYMENGS 97 (299)
Q Consensus 88 lv~e~~~~~~ 97 (299)
+|||++.+..
T Consensus 108 lvmE~L~~~~ 117 (392)
T d2pula1 108 TVMEDLSHLK 117 (392)
T ss_dssp EEECCCTTSE
T ss_pred EEEeccCCcc
Confidence 9999997644
|
| >d2ppqa1 d.144.1.6 (A:5-320) Homoserine kinase ThrB {Agrobacterium tumefaciens [TaxId: 358]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: Homoserine kinase ThrB species: Agrobacterium tumefaciens [TaxId: 358]
Probab=97.78 E-value=6e-05 Score=60.97 Aligned_cols=160 Identities=10% Similarity=0.055 Sum_probs=85.0
Q ss_pred CChHHHHHHhCCCCCCceee-----cCCcceEEEEEeCCCcEEEEEEeccCcCChhhhHHHHHHHHHHHhcCCcce----
Q 038766 2 FDRTEIENATGSFSENNIIG-----NSNLSTVYKGRLEDGEIVAVKKLNFHQFSAESDKSFYREAKTLKELKHRNL---- 72 (299)
Q Consensus 2 ~~~~~~~~~~~~y~~~~~lg-----~g~~~~v~~~~~~~~~~~~vK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i---- 72 (299)
-+.++++.+.++|.+.+... .|-.-+.|+++..+| .+++|++... ...+.+..+...+..+...++
T Consensus 3 ls~~el~~~l~~Y~lg~~~~~~~i~~G~~N~ny~v~t~~g-~yVLri~~~~----~~~~~l~~~~~~l~~L~~~g~pvp~ 77 (316)
T d2ppqa1 3 ITEDELRNFLTQYDVGSLTSYKGIAEGVENSNFLLHTTKD-PLILTLYEKR----VEKNDLPFFLGLMQHLAAKGLSCPL 77 (316)
T ss_dssp CCHHHHHHHHTTBCCCCEEEEEEECC---EEEEEEEESSC-CEEEEEECC-------CCHHHHHHHHHHHHHHTTCCCCC
T ss_pred CCHHHHHHHHHhCCCCCceEeecCCCCcccCeEEEEECCC-cEEEEEcCCC----CCHHHHHHHHHHHHhhhhccccccc
Confidence 36789999999999876665 455577899987655 5899997532 223445556666666643222
Q ss_pred -eeeee--EEEcCCCeeEEEEeecCCCChH-----H-------------HhcCCCCC-------------------CCCC
Q 038766 73 -VKVLG--YAWESGKLKALILEYMENGSLE-----S-------------VIHGPGVD-------------------HSRW 112 (299)
Q Consensus 73 -~~~~~--~~~~~~~~~~lv~e~~~~~~L~-----~-------------~~~~~~~~-------------------~~~~ 112 (299)
+...+ ...........++.++.+.... . ........ ....
T Consensus 78 pi~~~~g~~~~~~~~~~~~~~~~~~g~~~~~~~~~~~~~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 157 (316)
T d2ppqa1 78 PLPRKDGELLGELSGRPAALISFLEGMWLRKPEAKHCREVGKALAAMHLASEGFEIKRPNALSVDGWKVLWDKSEERADE 157 (316)
T ss_dssp BCCBTTCCSCEEETTEEEEEEECCCCBCCSSCCHHHHHHHHHHHHHHHHHTTTCCCCCBCTTSHHHHHHHHHHHGGGGGG
T ss_pred cceecCCCcceeeecccceeeeecccccccccchhHHHHHHHHHHhhhhhhhhcccccccccchhhcchhhhHHHHhhhh
Confidence 11111 0001112234555555442210 0 00000000 0011
Q ss_pred ChhhHHHHHHHHHHHHHHhhcC-CCCCeeeecccCCceeeCCCCcEEEeeecccc
Q 038766 113 TLPKRIDVLISVANGLDYLHSG-YDIPIVHCDMKPSNILLDRDFEAHVSDFGTSR 166 (299)
Q Consensus 113 ~~~~~~~i~~qi~~~l~~lh~~-~~~~~~H~dl~~~nil~~~~~~v~l~df~~~~ 166 (299)
........+......+...... .+.+++|+|+.++|++++.+...-++||+.+.
T Consensus 158 ~~~~~~~~l~~~~~~~~~~~~~~L~~giIHgDl~~dNvl~~~~~v~gvIDF~~~~ 212 (316)
T d2ppqa1 158 VEKGLREEIRPEIDYLAAHWPKDLPAGVIHADLFQDNVFFLGDELSGLIDFYFAC 212 (316)
T ss_dssp TSTTHHHHHHHHHHHHHHHCCCSSCEEEECSCCCGGGEEEETTEEEEECCCTTCE
T ss_pred cchhHHHHHHHHHHhhhccCccccccccccCCcchhhhhcccccceeEecccccc
Confidence 1122223333333333433321 23479999999999999988777899999886
|
| >d1nw1a_ d.144.1.8 (A:) Choline kinase {Caenorhabditis elegans [TaxId: 6239]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Choline kinase domain: Choline kinase species: Caenorhabditis elegans [TaxId: 6239]
Probab=97.66 E-value=0.00011 Score=61.37 Aligned_cols=83 Identities=18% Similarity=0.218 Sum_probs=51.5
Q ss_pred HHHHhCCCCCCceeecCCcceEEEEEeCC--------CcEEEEEEeccCcCChhhhHHHHHHHHHHHhcCCcce-eeeee
Q 038766 7 IENATGSFSENNIIGNSNLSTVYKGRLED--------GEIVAVKKLNFHQFSAESDKSFYREAKTLKELKHRNL-VKVLG 77 (299)
Q Consensus 7 ~~~~~~~y~~~~~lg~g~~~~v~~~~~~~--------~~~~~vK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i-~~~~~ 77 (299)
|+.+...-..++.|+.|-.-.+|++...+ .+.+++++.-. ........+|..+++.+.-.++ .++++
T Consensus 37 W~~~~~~~l~v~~l~GGltN~~y~v~~~~~~~~~~~~~~~vllRi~g~----~~~~idr~~E~~i~~~ls~~gl~Pkll~ 112 (395)
T d1nw1a_ 37 WKTVPLEHLRISRIKGGMSNMLFLCRLSEVYPPIRNEPNKVLLRVYFN----PETESHLVAESVIFTLLSERHLGPKLYG 112 (395)
T ss_dssp HHHCCGGGEEEEEECCCTTEEEEEEEECTTSCCSSSCCSEEEEEEECS----CCCHHHHHHHHHHHHHHHHTTSSSCEEE
T ss_pred ccCCCccceEEEEcCCccccceEEEEeCCCCccccCCCCcEEEEecCC----cchhhHHHHHHHHHHHHHhCCCCCeEEE
Confidence 44433333345678889999999998643 35677777641 2233456678888888863344 35555
Q ss_pred EEEcCCCeeEEEEeecCCCCh
Q 038766 78 YAWESGKLKALILEYMENGSL 98 (299)
Q Consensus 78 ~~~~~~~~~~lv~e~~~~~~L 98 (299)
.+ . + .+|+||++|.++
T Consensus 113 ~~-~-~---g~I~efi~g~~l 128 (395)
T d1nw1a_ 113 IF-S-G---GRLEEYIPSRPL 128 (395)
T ss_dssp EE-T-T---EEEECCCCEEEC
T ss_pred Ec-C-C---ceEEEEeccccC
Confidence 33 2 2 688999976443
|
| >d1zyla1 d.144.1.6 (A:4-328) RdoA {Escherichia coli [TaxId: 562]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: RdoA species: Escherichia coli [TaxId: 562]
Probab=97.27 E-value=0.00027 Score=57.32 Aligned_cols=139 Identities=12% Similarity=0.068 Sum_probs=77.3
Q ss_pred CCcceEEEEEeCCCcEEEEEEeccCcCChhhhHHHHHHHHHHHhcCCccee--eeee----EEEcCCCeeEEEEeecCCC
Q 038766 23 SNLSTVYKGRLEDGEIVAVKKLNFHQFSAESDKSFYREAKTLKELKHRNLV--KVLG----YAWESGKLKALILEYMENG 96 (299)
Q Consensus 23 g~~~~v~~~~~~~~~~~~vK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~--~~~~----~~~~~~~~~~lv~e~~~~~ 96 (299)
+.--.||++...+|.++++|+.+.. ..+.+.+..|...+..+...++. .... .....+...+.+++++.|.
T Consensus 33 s~EN~vy~v~~~dg~~~VlK~~rp~---~~s~~~i~~E~~~l~~L~~~gipv~~p~~~~g~~~~~~~~~~~~l~~~~~G~ 109 (325)
T d1zyla1 33 SYENRVYQFQDEDRRRFVVKFYRPE---RWTADQILEEHQFALQLVNDEVPVAAPVAFNGQTLLNHQGFYFAVFPSVGGR 109 (325)
T ss_dssp CSSSEEEEECCTTCCCEEEEEECTT---TSCHHHHHHHHHHHHHHHHTTCSBCCCCCBTTBSCEEETTEEEEEEECCCCE
T ss_pred cccceeEEEEcCCCCEEEEEEeCCC---CCCHHHHHHHHHHHHHHHhcCCCCCCceecCCCeeeeeeeEEEEEEeecCCc
Confidence 4446899999989999999987532 23456677788888877532221 1111 1112344567889988653
Q ss_pred Ch-----HH-------------HhcCCC-CCC-------------------CCCChhh---HHHHHHHHHHHHHHhh-cC
Q 038766 97 SL-----ES-------------VIHGPG-VDH-------------------SRWTLPK---RIDVLISVANGLDYLH-SG 134 (299)
Q Consensus 97 ~L-----~~-------------~~~~~~-~~~-------------------~~~~~~~---~~~i~~qi~~~l~~lh-~~ 134 (299)
.+ .. ...... ... ..++... ....+.++...+...- +.
T Consensus 110 ~~~~~~~~~~~~lG~~LA~lH~~~~~~~~~~r~~~d~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~~~~~~ 189 (325)
T d1zyla1 110 QFEADNIDQMEAVGRYLGRMHQTGRKQLFIHRPTIGLNEYLIEPRKLFEDATLIPSGLKAAFLKATDELIAAVTAHWRED 189 (325)
T ss_dssp ECCSSCHHHHHHHHHHHHHHHHHHTSSCCSSSCBCSHHHHTHHHHHHHHTCSSSCTTTHHHHHHHHHHHHHHHHHHCCSC
T ss_pred CCCCCCHHHHHHHHHHHHHHHhhcccCCccccCCCCHHHHhhhhHHHHHHcCcCCHHHHHHHHHHHHHHHHHHHHhcccc
Confidence 21 00 001000 000 1112221 2223333444333322 22
Q ss_pred CCCCeeeecccCCceeeCCCCcEEEeeecccc
Q 038766 135 YDIPIVHCDMKPSNILLDRDFEAHVSDFGTSR 166 (299)
Q Consensus 135 ~~~~~~H~dl~~~nil~~~~~~v~l~df~~~~ 166 (299)
...+++|+|+.+.||+++.+ ..++||+-+.
T Consensus 190 ~p~~liHgDlh~~NvL~~~~--~~~IDFdd~~ 219 (325)
T d1zyla1 190 FTVLRLHGDCHAGNILWRDG--PMFVDLDDAR 219 (325)
T ss_dssp SCCEECCSSCSGGGEEESSS--EEECCCTTCC
T ss_pred CCceeecCCCCcccEEEeCC--ceEEechhcc
Confidence 23478999999999999743 4589999875
|